VARIABLE,TYPE,NGENES,BETA,BETA_STD,SE,P,FULL_NAME,P_FDR
GOMF_UBIQUITIN_MODIFIED_HIST...,SET,7,1.4046,0.02742,0.31486,4.1073e-06,GOMF_UBIQUITIN_MODIFIED_HISTONE_READER_ACTIVITY,0.10798552275
GOBP_IMMUNE_COMPLEX_CLEARANCE,SET,5,1.9349,0.031926,0.44265,6.2141e-06,GOBP_IMMUNE_COMPLEX_CLEARANCE,0.10798552275
HP_BILATERAL_CLEFT_LIP,SET,12,1.0591,0.027068,0.2717,4.8679e-05,HP_BILATERAL_CLEFT_LIP,0.212233205172414
HARALAMBIEVA_PBMC_TIV_AGE_50...3,SET,13,0.89278,0.023748,0.22935,4.9764e-05,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_POSITIVE,0.212233205172414
GSE23505_IL6_IL1_VS_IL6_IL1_...3,SET,169,0.23599,0.022537,0.061541,6.3069e-05,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.212233205172414
BMI1_DN.V1_DN,SET,121,0.32397,0.026214,0.084938,6.8536e-05,BMI1_DN.V1_DN,0.212233205172414
GSE13547_CTRL_VS_ANTI_IGM_ST...2,SET,174,0.23366,0.022638,0.06136,7.0295e-05,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP,0.212233205172414
GOBP_POSITIVE_REGULATION_OF_...728,SET,33,0.57494,0.024353,0.15124,7.2179e-05,GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT,0.212233205172414
GOBP_TRANSCRIPTION_BY_RNA_PO...2,SET,56,0.38805,0.021398,0.10301,8.2899e-05,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.212233205172414
MORF_CDC2L5,SET,134,0.26765,0.022782,0.071329,8.7899e-05,MORF_CDC2L5,0.212233205172414
CHENG_TAF7L_TARGETS,SET,4,1.4596,0.021541,0.3895,8.9683e-05,CHENG_TAF7L_TARGETS,0.212233205172414
GSE41867_NAIVE_VS_DAY30_LCMV...3,SET,180,0.22351,0.022022,0.059653,8.9819e-05,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN,0.212233205172414
GOBP_POSITIVE_REGULATION_OF_...9,SET,7,1.1088,0.021647,0.29718,9.5597e-05,GOBP_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.212233205172414
WP_TAR_SYNDROME,SET,49,0.46153,0.023811,0.12506,0.00011227,WP_TAR_SYNDROME,0.212233205172414
DACOSTA_LOW_DOSE_UV_RESPONSE...1,SET,8,1.0871,0.022688,0.29459,0.00011237,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.212233205172414
HP_DIGESTIVE_SYSTEM_NEOPLASM,SET,343,0.17351,0.023494,0.047073,0.00011424,HP_DIGESTIVE_SYSTEM_NEOPLASM,0.212233205172414
MIR3173_5P,SET,93,0.32438,0.023028,0.088732,0.00012862,MIR3173_5P,0.212233205172414
GOBP_NEGATIVE_REGULATION_OF_...621,SET,11,1.0059,0.024614,0.2755,0.00013092,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ORGANIZATION,0.212233205172414
GOBP_CHOLESTEROL_EFFLUX,SET,53,0.44617,0.023937,0.1224,0.00013397,GOBP_CHOLESTEROL_EFFLUX,0.212233205172414
GOBP_CAVEOLA_ASSEMBLY,SET,6,1.414,0.025558,0.38997,0.00014435,GOBP_CAVEOLA_ASSEMBLY,0.212233205172414
GOMF_UBIQUITIN_LIKE_PROTEIN_...7,SET,19,0.65118,0.020937,0.18043,0.00015413,GOMF_UBIQUITIN_LIKE_PROTEIN_READER_ACTIVITY,0.212233205172414
IVANOV_MUTATED_IN_COLON_CANC...,SET,13,0.68569,0.018239,0.19005,0.0001547,IVANOV_MUTATED_IN_COLON_CANCER,0.212233205172414
GOBP_POSITIVE_REGULATION_OF_...20,SET,24,0.72715,0.026273,0.20198,0.00015948,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.212233205172414
MIR6799_3P,SET,106,0.31901,0.024169,0.088628,0.00015988,MIR6799_3P,0.212233205172414
MIR1298_3P,SET,41,0.48918,0.023091,0.13599,0.00016128,MIR1298_3P,0.212233205172414
HP_ENDOCARDITIS,SET,14,0.80533,0.02223,0.22397,0.00016218,HP_ENDOCARDITIS,0.212233205172414
GSE44732_UNSTIM_VS_IL27_STIM...1,SET,182,0.22618,0.022407,0.063073,0.00016833,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN,0.212233205172414
GOCC_SERINE_PROTEASE_INHIBIT...,SET,6,1.4512,0.026229,0.40605,0.00017633,GOCC_SERINE_PROTEASE_INHIBITOR_COMPLEX,0.212233205172414
WU_APOPTOSIS_BY_CDKN1A_NOT_V...,SET,9,0.9162,0.02028,0.25644,0.00017709,WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,0.212233205172414
MYLLYKANGAS_AMPLIFICATION_HO...9,SET,19,0.70757,0.02275,0.20098,0.00021586,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,0.246912553125
WP_ATM_SIGNALING_IN_DEVELOPM...,SET,43,0.42591,0.020588,0.1214,0.00022607,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,0.246912553125
REACTOME_RNA_POLYMERASE_III_...3,SET,26,0.49402,0.018578,0.14088,0.00022734,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER,0.246912553125
GSE5589_WT_VS_IL10_KO_LPS_AN...5,SET,182,0.21848,0.021644,0.06296,0.00026077,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.26640204
GSE21033_CTRL_VS_POLYIC_STIM...2,SET,144,0.24632,0.021729,0.071083,0.00026546,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP,0.26640204
GOCC_PEPTIDASE_INHIBITOR_COM...,SET,11,0.96613,0.023641,0.27903,0.00026828,GOCC_PEPTIDASE_INHIBITOR_COMPLEX,0.26640204
MIR3913_3P,SET,73,0.35917,0.022603,0.10402,0.00027798,MIR3913_3P,0.268366525
GOBP_DETECTION_OF_LIPOPOLYSA...,SET,5,1.4229,0.023479,0.41623,0.0003154,GOBP_DETECTION_OF_LIPOPOLYSACCHARIDE,0.296262891891892
GOBP_REGULATION_OF_SOMATIC_S...,SET,11,0.9003,0.02203,0.26456,0.00033407,GOBP_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.302591288461538
GOCC_DYSTROPHIN_ASSOCIATED_G...,SET,17,0.72369,0.022011,0.21294,0.00033955,GOCC_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX,0.302591288461538
HP_TYPIFIED_BY_SOMATIC_MOSAI...,SET,162,0.23286,0.021777,0.06899,0.00036941,HP_TYPIFIED_BY_SOMATIC_MOSAICISM,0.306652431521739
GSE36527_CD62L_HIGH_VS_CD62L...1,SET,188,0.20751,0.02089,0.061528,0.00037317,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN,0.306652431521739
HP_ABNORMALITY_OF_THE_PANCRE...,SET,282,0.17281,0.021252,0.051365,0.00038443,HP_ABNORMALITY_OF_THE_PANCREAS,0.306652431521739
BEIER_GLIOMA_STEM_CELL_UP,SET,35,0.53182,0.023198,0.15826,0.00038989,BEIER_GLIOMA_STEM_CELL_UP,0.306652431521739
GSE14415_TCONV_VS_FOXP3_KO_I...1,SET,159,0.22089,0.020466,0.065825,0.00039675,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN,0.306652431521739
GOCC_PROTEASE_INHIBITOR_COMP...,SET,8,1.1078,0.02312,0.33066,0.00040445,GOCC_PROTEASE_INHIBITOR_COMPLEX,0.306652431521739
HP_NEOPLASM_OF_THE_BREAST,SET,95,0.28161,0.020205,0.08408,0.00040587,HP_NEOPLASM_OF_THE_BREAST,0.306652431521739
GOBP_EMBRYONIC_PROCESS_INVOL...,SET,6,1.1632,0.021024,0.34841,0.00042196,GOBP_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.3070314625
chr17q23,SET,51,0.70126,0.036908,0.21014,0.00042404,chr17q23,0.3070314625
HP_SEVERE_EXPRESSIVE_LANGUAG...,SET,9,0.95935,0.021235,0.2892,0.0004554,HP_SEVERE_EXPRESSIVE_LANGUAGE_DELAY,0.321720084
MIR4272,SET,180,0.20782,0.020476,0.062733,0.00046284,MIR4272,0.321720084
GOBP_PLASMA_MEMBRANE_RAFT_AS...,SET,7,1.0898,0.021276,0.32967,0.00047443,GOBP_PLASMA_MEMBRANE_RAFT_ASSEMBLY,0.322098646153846
HP_ORCHITIS,SET,14,0.75309,0.020788,0.22811,0.00048192,HP_ORCHITIS,0.322098646153846
HP_GLOMERULOPATHY,SET,30,0.53546,0.021627,0.16392,0.0005451,HP_GLOMERULOPATHY,0.357451896226415
MIR133A_3P_MIR133B,SET,222,0.18433,0.020146,0.056681,0.00057398,MIR133A_3P_MIR133B,0.365856406363636
GOBP_B_CELL_DIFFERENTIATION,SET,139,0.25056,0.021719,0.077106,0.00057897,GOBP_B_CELL_DIFFERENTIATION,0.365856406363636
GOBP_MEMBRANE_RAFT_ASSEMBLY,SET,11,0.80885,0.019792,0.24944,0.00059318,GOBP_MEMBRANE_RAFT_ASSEMBLY,0.3681423375
MIR10526_3P,SET,105,0.26975,0.020341,0.083377,0.00060876,MIR10526_3P,0.371048241666667
HP_ABDOMINAL_PAIN,SET,308,0.16283,0.020912,0.050409,0.00061963,HP_ABDOMINAL_PAIN,0.371048241666667
GOBP_REGULATION_OF_BILE_ACID...2,SET,14,0.80952,0.022345,0.25154,0.00064598,GOBP_REGULATION_OF_BILE_ACID_METABOLIC_PROCESS,0.371048241666667
GSE11961_MARGINAL_ZONE_BCELL...9,SET,176,0.20103,0.019588,0.062606,0.00066242,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN,0.371048241666667
HP_NEOPLASM_OF_THE_GASTROINT...,SET,285,0.16638,0.020568,0.051885,0.00067252,HP_NEOPLASM_OF_THE_GASTROINTESTINAL_TRACT,0.371048241666667
MIR548H_3P_MIR548Z,SET,547,0.11906,0.020242,0.037134,0.00067361,MIR548H_3P_MIR548Z,0.371048241666667
REACTOME_ACTIVATION_OF_THE_P...2,SET,31,0.45603,0.018723,0.14252,0.00068879,REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,0.371048241666667
MIR548BB_3P,SET,541,0.11938,0.020188,0.037356,0.00069876,MIR548BB_3P,0.371048241666667
GSE17721_PAM3CSK4_VS_CPG_1H_...1,SET,176,0.20183,0.019666,0.063255,0.00071083,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN,0.371048241666667
MIR548AC,SET,545,0.11856,0.020121,0.037192,0.00071813,MIR548AC,0.371048241666667
REACTOME_INTERLEUKIN_35_SIGN...,SET,12,0.84605,0.021623,0.26558,0.00072339,REACTOME_INTERLEUKIN_35_SIGNALLING,0.371048241666667
GOBP_REGULATION_OF_ANDROGEN_...,SET,25,0.50848,0.018751,0.15994,0.00073945,GOBP_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.371048241666667
ESC_V6.5_UP_LATE.V1_UP,SET,161,0.22379,0.020865,0.070518,0.00075415,ESC_V6.5_UP_LATE.V1_UP,0.371048241666667
GOBP_REGULATION_OF_PLASMINOG...,SET,17,0.67079,0.020402,0.21144,0.00075725,GOBP_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.371048241666667
GOBP_NEGATIVE_REGULATION_OF_...26,SET,14,0.68725,0.018971,0.21673,0.00076081,GOBP_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.371048241666667
HP_ANTERIOR_UVEITIS,SET,15,0.80213,0.022918,0.2532,0.00076868,HP_ANTERIOR_UVEITIS,0.371048241666667
GOBP_REGULATION_OF_COMPLEMEN...4,SET,11,0.91269,0.022333,0.28989,0.00082209,GOBP_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.391393670547945
HP_ABNORMALITY_OF_INTRACRANI...,SET,82,0.2834,0.018898,0.09023,0.00084347,HP_ABNORMALITY_OF_INTRACRANIAL_PRESSURE,0.396145943918919
MIR7155_3P,SET,61,0.32257,0.018562,0.10313,0.00088235,MIR7155_3P,0.402467355769231
HP_PAIN,SET,754,0.10081,0.020006,0.032241,0.00088478,HP_PAIN,0.402467355769231
HP_OVARIAN_NEOPLASM,SET,73,0.2982,0.018766,0.095437,0.00089168,HP_OVARIAN_NEOPLASM,0.402467355769231
GOBP_BLEB_ASSEMBLY,SET,11,0.88528,0.021663,0.28367,0.00090325,GOBP_BLEB_ASSEMBLY,0.402467355769231
GOBP_OTOLITH_MORPHOGENESIS,SET,5,1.2805,0.021128,0.41137,0.00092817,GOBP_OTOLITH_MORPHOGENESIS,0.406177340625
GOBP_CENTROMERIC_SISTER_CHRO...,SET,9,0.87499,0.019368,0.28129,0.00093495,GOBP_CENTROMERIC_SISTER_CHROMATID_COHESION,0.406177340625
CHIANG_LIVER_CANCER_SUBCLASS...1,SET,155,0.22489,0.020576,0.072574,0.00097321,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,0.414669023493976
GOBP_COMPLEMENT_DEPENDENT_CY...,SET,13,0.80241,0.021344,0.25918,0.00098232,GOBP_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.414669023493976
REACTOME_SIGNALLING_TO_P38_V...,SET,5,1.0419,0.017192,0.33681,0.00099029,REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,0.414669023493976
REACTOME_INTERLEUKIN_36_PATH...,SET,7,1.4586,0.028474,0.47246,0.001012,REACTOME_INTERLEUKIN_36_PATHWAY,0.418715
GOBP_REGULATION_OF_AGGREPHAGY,SET,7,0.99433,0.019412,0.32403,0.0010766,GOBP_REGULATION_OF_AGGREPHAGY,0.425372536082474
GOBP_CONVERGENT_EXTENSION_IN...2,SET,9,0.90046,0.019932,0.29349,0.0010787,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_GASTRULATION,0.425372536082474
PID_ATM_PATHWAY,SET,29,0.45206,0.017952,0.14754,0.0010937,PID_ATM_PATHWAY,0.425372536082474
TFAM_TARGET_GENES,SET,2,1.8529,0.019338,0.60485,0.0010957,TFAM_TARGET_GENES,0.425372536082474
MIR548D_3P,SET,547,0.11375,0.019339,0.03715,0.0011015,MIR548D_3P,0.425372536082474
HP_SHORT_TELOMERE_LENGTH,SET,14,0.67343,0.018589,0.22056,0.0011335,HP_SHORT_TELOMERE_LENGTH,0.425372536082474
HP_SUDDEN_EPISODIC_APNEA,SET,16,0.65364,0.019287,0.21415,0.0011372,HP_SUDDEN_EPISODIC_APNEA,0.425372536082474
MIR424_5P,SET,476,0.11973,0.019027,0.039227,0.0011375,MIR424_5P,0.425372536082474
GSE11961_MARGINAL_ZONE_BCELL...5,SET,184,0.18709,0.018636,0.061463,0.001169,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.425372536082474
GOBP_RECEPTOR_MEDIATED_ENDOC...3,SET,10,0.91313,0.021305,0.30022,0.0011788,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_OF_VIRUS_BY_HOST_CELL,0.425372536082474
MIR497_5P,SET,476,0.11904,0.018917,0.039144,0.0011807,MIR497_5P,0.425372536082474
HP_KNEE_CLONUS,SET,5,1.2075,0.019923,0.39709,0.0011818,HP_KNEE_CLONUS,0.425372536082474
REACTOME_RNA_POLYMERASE_III_...2,SET,39,0.35692,0.016433,0.11743,0.0011872,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,0.425372536082474
KEGG_MEDICUS_REFERENCE_RECRU...,SET,9,0.96719,0.021409,0.31911,0.0012208,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC,0.430652301980198
GOMF_CHLORIDE_CHANNEL_ACTIVI...,SET,72,0.33844,0.021152,0.11184,0.0012408,GOMF_CHLORIDE_CHANNEL_ACTIVITY,0.430652301980198
ACEVEDO_LIVER_TUMOR_VS_NORMA...2,SET,752,0.093611,0.018553,0.030962,0.0012514,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,0.430652301980198
HP_IMPAIRED_DISTAL_PROPRIOCE...,SET,16,0.5735,0.016923,0.18969,0.0012515,HP_IMPAIRED_DISTAL_PROPRIOCEPTION,0.430652301980198
WP_MITOCHONDRIAL_COMPLEX_IV_...,SET,28,0.42353,0.016527,0.14032,0.0012729,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,0.432682878640777
AGGGCAG_MIR18A,SET,130,0.2351,0.019713,0.077951,0.0012823,AGGGCAG_MIR18A,0.432682878640777
HP_ALBUMINURIA,SET,22,0.52328,0.018103,0.17411,0.0013277,HP_ALBUMINURIA,0.437044125
WP_KLEEFSTRA_SYNDROME,SET,26,0.52623,0.019789,0.17514,0.0013313,WP_KLEEFSTRA_SYNDROME,0.437044125
GOCC_RNA_POLYMERASE_COMPLEX,SET,90,0.24704,0.017254,0.082373,0.001356,GOCC_RNA_POLYMERASE_COMPLEX,0.437044125
GOMF_RNA_POLYMERASE_II_ACTIV...,SET,9,0.75521,0.016717,0.25183,0.0013569,GOMF_RNA_POLYMERASE_II_ACTIVITY,0.437044125
GSE20484_MCSG_VS_CXCL4_MONOC...1,SET,174,0.19213,0.018615,0.064095,0.0013622,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN,0.437044125
GOBP_NEGATIVE_REGULATION_OF_...620,SET,8,0.94374,0.019695,0.31557,0.0013941,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.437044125
HP_BASAL_CELL_CARCINOMA,SET,61,0.30317,0.017446,0.10138,0.0013945,HP_BASAL_CELL_CARCINOMA,0.437044125
HP_URIC_ACID_NEPHROLITHIASIS,SET,11,0.71894,0.017592,0.24127,0.001444,HP_URIC_ACID_NEPHROLITHIASIS,0.437044125
REACTOME_SIGNALING_BY_ALK,SET,26,0.52738,0.019832,0.17735,0.001473,REACTOME_SIGNALING_BY_ALK,0.437044125
GOMF_INOSITOL_BISPHOSPHATE_P...,SET,7,0.89167,0.017407,0.30005,0.0014825,GOMF_INOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.437044125
GOBP_NEGATIVE_REGULATION_OF_...205,SET,12,0.71014,0.018149,0.2391,0.001491,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.437044125
GSE41867_NAIVE_VS_DAY8_LCMV_...4,SET,185,0.1794,0.017917,0.060427,0.0014966,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.437044125
HP_SYNOVIAL_LINING_HYPERPLAS...,SET,8,0.97981,0.020448,0.33019,0.0015037,HP_SYNOVIAL_LINING_HYPERPLASIA,0.437044125
GSE18893_TCONV_VS_TREG_24H_C...1,SET,177,0.199,0.019445,0.06709,0.0015097,GSE18893_TCONV_VS_TREG_24H_CULTURE_DN,0.437044125
GOBP_REGULATION_OF_BILE_ACID...1,SET,11,0.83792,0.020504,0.28262,0.0015161,GOBP_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS,0.437044125
MIR16_5P,SET,532,0.10999,0.01845,0.037104,0.0015184,MIR16_5P,0.437044125
REACTOME_INTERLEUKIN_12_FAMI...,SET,53,0.33492,0.017969,0.11304,0.0015255,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,0.437044125
GRASEMANN_RETINOBLASTOMA_WIT...,SET,14,0.71163,0.019644,0.24028,0.0015316,GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION,0.437044125
MIR3665,SET,73,0.29994,0.018876,0.10138,0.001547,MIR3665,0.437044125
GSE14415_NATURAL_TREG_VS_TCO...1,SET,168,0.18778,0.01788,0.063477,0.0015493,GSE14415_NATURAL_TREG_VS_TCONV_DN,0.437044125
ZHENG_GLIOBLASTOMA_PLASTICIT...1,SET,57,0.36399,0.02025,0.12313,0.0015593,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,0.437044125
KEGG_MEDICUS_PATHOGEN_HPV_E5...1,SET,6,1.2283,0.0222,0.41668,0.0016029,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.441497964566929
KEGG_MEDICUS_PATHOGEN_KSHV_M...1,SET,6,1.2283,0.0222,0.41668,0.0016029,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.441497964566929
GOBP_ENDOCYTOSIS_INVOLVED_IN...,SET,11,0.77012,0.018845,0.26144,0.0016133,GOBP_ENDOCYTOSIS_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.441497964566929
GOBP_CHROMOSOME_MOVEMENT_TOW...,SET,7,0.89737,0.017519,0.30525,0.0016442,GOBP_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE,0.443489965116279
HANN_RESISTANCE_TO_BCL2_INHI...1,SET,40,0.44157,0.020588,0.15022,0.0016461,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,0.443489965116279
MORF_FDXR,SET,210,0.16829,0.017896,0.057322,0.0016647,MORF_FDXR,0.444126772727273
GSE36095_WT_VS_HDAC9_KO_TREG...2,SET,165,0.19141,0.018064,0.065247,0.0016771,GSE36095_WT_VS_HDAC9_KO_TREG_UP,0.444126772727273
HP_NEOPLASM_OF_THE_LARGE_INT...,SET,108,0.23538,0.018,0.080284,0.0016868,HP_NEOPLASM_OF_THE_LARGE_INTESTINE,0.444126772727273
GOMF_RNA_POLYMERASE_III_ACTI...,SET,10,0.72937,0.017017,0.24936,0.001725,GOMF_RNA_POLYMERASE_III_ACTIVITY,0.4476444
GOCC_FLOTILLIN_COMPLEX,SET,9,0.8095,0.017918,0.27694,0.0017358,GOCC_FLOTILLIN_COMPLEX,0.4476444
MIR1260A_MIR1260B,SET,97,0.25582,0.018545,0.087537,0.0017388,MIR1260A_MIR1260B,0.4476444
REACTOME_INTERLEUKIN_6_SIGNA...,SET,11,0.77928,0.019069,0.26707,0.0017645,REACTOME_INTERLEUKIN_6_SIGNALING,0.450920569852941
HP_POST_PARTUM_HEMORRHAGE,SET,13,0.74287,0.01976,0.25529,0.0018101,HP_POST_PARTUM_HEMORRHAGE,0.457154173913044
GOBP_NEGATIVE_REGULATION_OF_...496,SET,8,0.89249,0.018626,0.3068,0.0018152,GOBP_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.457154173913044
GSE3982_EOSINOPHIL_VS_BASOPH...1,SET,177,0.18182,0.017766,0.062631,0.0018505,GSE3982_EOSINOPHIL_VS_BASOPHIL_DN,0.459900364583333
HP_EEG_WITH_GENERALIZED_SLOW...1,SET,32,0.42178,0.017593,0.14539,0.0018619,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY,0.459900364583333
GOMF_RNA_POLYMERASE_ACTIVITY,SET,28,0.41238,0.016092,0.14219,0.0018665,GOMF_RNA_POLYMERASE_ACTIVITY,0.459900364583333
GOMF_PHOSPHATIDYLINOSITOL_3_...12,SET,11,0.70709,0.017302,0.24415,0.0018916,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATORY_SUBUNIT_BINDING,0.459900364583333
NFE2L2.V2,SET,396,0.13227,0.019215,0.045682,0.0018956,NFE2L2.V2,0.459900364583333
WP_FARNESOID_X_RECEPTOR_PATH...,SET,19,0.59393,0.019096,0.20524,0.0019055,WP_FARNESOID_X_RECEPTOR_PATHWAY,0.459900364583333
HASLINGER_B_CLL_WITH_11Q23_D...,SET,20,0.49634,0.016373,0.17171,0.0019255,HASLINGER_B_CLL_WITH_11Q23_DELETION,0.461522431034483
HP_ABNORMAL_LYMPH_NODE_MORPH...,SET,227,0.17134,0.018933,0.059383,0.001958,HP_ABNORMAL_LYMPH_NODE_MORPHOLOGY,0.463541857142857
YTATTTTNR_MEF2_02,SET,627,0.10407,0.018901,0.036076,0.0019606,YTATTTTNR_MEF2_02,0.463541857142857
MIR3136_3P,SET,60,0.30153,0.017209,0.10467,0.0019857,MIR3136_3P,0.465763651006711
GSE12392_WT_VS_IFNAR_KO_CD8A...2,SET,174,0.18623,0.018043,0.064684,0.0019968,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP,0.465763651006711
GOBP_TUBULIN_COMPLEX_ASSEMBLY,SET,8,0.71311,0.014882,0.24799,0.0020186,GOBP_TUBULIN_COMPLEX_ASSEMBLY,0.467558324503311
GOBP_MECHANORECEPTOR_DIFFERE...,SET,65,0.32613,0.01937,0.11349,0.0020314,GOBP_MECHANORECEPTOR_DIFFERENTIATION,0.467558324503311
LFA1_Q6,SET,237,0.16152,0.018232,0.056256,0.0020473,LFA1_Q6,0.468117838815789
GSE4142_PLASMA_CELL_VS_GC_BC...2,SET,181,0.17326,0.017118,0.060419,0.0020698,GSE4142_PLASMA_CELL_VS_GC_BCELL_UP,0.470169274509804
GOMF_CHLORIDE_TRANSMEMBRANE_...,SET,107,0.25337,0.019286,0.08846,0.0020924,GOMF_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.472216636363636
GOBP_REGULATION_OF_PLATELET_...3,SET,5,1.1083,0.018287,0.38736,0.002113,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.473086734939759
SHI_SPARC_TARGETS_UP,SET,24,0.51983,0.018782,0.18191,0.002137,SHI_SPARC_TARGETS_UP,0.473086734939759
CEBP_C,SET,184,0.1831,0.018238,0.064164,0.0021634,CEBP_C,0.473086734939759
GSE1460_INTRATHYMIC_T_PROGEN...6,SET,178,0.17923,0.017561,0.062816,0.0021668,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.473086734939759
ZHONG_PFC_C2_ASCL1_POS_ASTRO...,SET,4,1.4234,0.021008,0.49906,0.0021737,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.473086734939759
GSE19888_ADENOSINE_A3R_INH_P...3,SET,173,0.17211,0.016628,0.060368,0.0021816,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.473086734939759
GSE46606_IRF4_KO_VS_WT_CD40L...3,SET,169,0.17783,0.016983,0.062507,0.0022231,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN,0.473086734939759
GOBP_DETECTION_OF_MOLECULE_O...,SET,12,0.77295,0.019754,0.27176,0.0022287,GOBP_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN,0.473086734939759
CSR_EARLY_UP.V1_UP,SET,143,0.20038,0.017615,0.07046,0.0022309,CSR_EARLY_UP.V1_UP,0.473086734939759
MIR10394_5P,SET,162,0.19065,0.017829,0.067106,0.0022515,MIR10394_5P,0.473086734939759
JINESH_BLEBBISHIELD_VS_LIVE_...2,SET,303,0.13859,0.017657,0.04879,0.0022541,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,0.473086734939759
E2F2_TARGET_GENES,SET,1185,0.071535,0.017577,0.02519,0.0022596,E2F2_TARGET_GENES,0.473086734939759
HP_RETROBULBAR_OPTIC_NEURITIS,SET,15,0.62909,0.017974,0.22182,0.0022866,HP_RETROBULBAR_OPTIC_NEURITIS,0.475872952095808
GOBP_INNER_EAR_RECEPTOR_CELL...3,SET,32,0.45491,0.018975,0.1606,0.002311,GOBP_INNER_EAR_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION,0.476468692982456
GOBP_STRESS_INDUCED_PREMATUR...,SET,7,0.75349,0.01471,0.26609,0.0023177,GOBP_STRESS_INDUCED_PREMATURE_SENESCENCE,0.476468692982456
GSE29164_UNTREATED_VS_CD8_TC...1,SET,183,0.1697,0.016858,0.059991,0.0023385,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.476468692982456
KANNAN_TP53_TARGETS_DN,SET,21,0.55359,0.018712,0.19575,0.0023443,KANNAN_TP53_TARGETS_DN,0.476468692982456
GOCC_HISTONE_METHYLTRANSFERA...,SET,63,0.28105,0.016435,0.099668,0.0024049,GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX,0.483153075842697
AIZARANI_LIVER_C11_HEPATOCYT...,SET,274,0.15831,0.019195,0.056147,0.0024071,AIZARANI_LIVER_C11_HEPATOCYTES_1,0.483153075842697
GOBP_POSITIVE_REGULATION_OF_...682,SET,70,0.30228,0.018629,0.10727,0.00242,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.483153075842697
GOBP_POSITIVE_REGULATION_OF_...847,SET,60,0.32681,0.018652,0.11607,0.0024372,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING,0.483153075842697
KEGG_MEDICUS_PATHOGEN_HTLV_1...1,SET,7,1.0278,0.020066,0.36547,0.0024618,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.483153075842697
STREICHER_LSM1_TARGETS_DN,SET,18,0.56782,0.017771,0.20202,0.0024744,STREICHER_LSM1_TARGETS_DN,0.483153075842697
CACGTG_MYC_Q2,SET,931,0.081203,0.017816,0.028891,0.0024745,CACGTG_MYC_Q2,0.483153075842697
GOBP_STEROL_TRANSPORT,SET,103,0.24148,0.018036,0.086082,0.0025167,GOBP_STEROL_TRANSPORT,0.486029366666667
GSE32986_CURDLAN_HIGHDOSE_VS...2,SET,177,0.17686,0.017281,0.063046,0.0025172,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.486029366666667
REACTOME_FORMATION_OF_WDR5_C...,SET,37,0.36027,0.016157,0.12856,0.0025397,REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,0.486283557692308
MIR15B_5P,SET,532,0.10375,0.017403,0.037035,0.0025465,MIR15B_5P,0.486283557692308
MIR195_5P,SET,534,0.10331,0.01736,0.036928,0.002578,MIR195_5P,0.488812258064516
GSE6674_UNSTIM_VS_PL2_3_STIM...1,SET,152,0.18636,0.016886,0.066654,0.0025903,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN,0.488812258064516
REACTOME_RNA_POLYMERASE_III_...1,SET,16,0.52928,0.015618,0.18952,0.002616,REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION,0.488812258064516
GOCC_RNA_POLYMERASE_III_COMP...,SET,16,0.52928,0.015618,0.18952,0.002616,GOCC_RNA_POLYMERASE_III_COMPLEX,0.488812258064516
MIR508_5P,SET,86,0.26254,0.017926,0.094119,0.0026431,MIR508_5P,0.489709161290323
GOMF_MONOATOMIC_ANION_CHANNE...,SET,88,0.28431,0.019636,0.10213,0.0026892,GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.489709161290323
GSE37605_FOXP3_FUSION_GFP_VS...4,SET,171,0.17699,0.017001,0.063585,0.0026922,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP,0.489709161290323
GOBP_PRESYNAPSE_ORGANIZATION,SET,46,0.38391,0.019192,0.13793,0.0026938,GOBP_PRESYNAPSE_ORGANIZATION,0.489709161290323
GOCC_FACIT_COLLAGEN_TRIMER,SET,6,1.1095,0.020054,0.39917,0.0027244,GOCC_FACIT_COLLAGEN_TRIMER,0.489709161290323
EVI1_03,SET,54,0.33133,0.017943,0.11922,0.0027277,EVI1_03,0.489709161290323
ZHONG_SECRETOME_OF_LUNG_CANC...2,SET,122,0.21049,0.017101,0.075867,0.0027675,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,0.489709161290323
WP_NEUROINFLAMMATION,SET,11,0.82666,0.020228,0.29796,0.0027682,WP_NEUROINFLAMMATION,0.489709161290323
WIKMAN_ASBESTOS_LUNG_CANCER_...1,SET,28,0.44517,0.017371,0.16052,0.0027779,WIKMAN_ASBESTOS_LUNG_CANCER_DN,0.489709161290323
MIR95_3P,SET,5,1.116,0.018414,0.40254,0.0027862,MIR95_3P,0.489709161290323
GOBP_NEGATIVE_REGULATION_OF_...27,SET,18,0.59428,0.018598,0.21478,0.0028324,GOBP_NEGATIVE_REGULATION_OF_ANOIKIS,0.489709161290323
HP_INCREASED_LEVEL_OF_HIPPUR...,SET,5,1.0551,0.017409,0.38198,0.0028745,HP_INCREASED_LEVEL_OF_HIPPURIC_ACID_IN_URINE,0.489709161290323
MIR6838_5P,SET,489,0.10694,0.017219,0.038726,0.0028794,MIR6838_5P,0.489709161290323
GSE29618_LAIV_VS_TIV_FLU_VAC...6,SET,167,0.18333,0.017405,0.066414,0.0028899,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP,0.489709161290323
GUTIERREZ_CHRONIC_LYMPHOCYTI...2,SET,11,0.76555,0.018733,0.27743,0.0028981,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.489709161290323
chr2p24,SET,26,0.71619,0.026932,0.25962,0.0029051,chr2p24,0.489709161290323
REACTOME_RNA_POLYMERASE_III_...4,SET,26,0.40433,0.015205,0.14657,0.0029059,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,0.489709161290323
GOMF_PHOSPHATIDYLCHOLINE_TRA...2,SET,18,0.57034,0.017849,0.20676,0.0029063,GOMF_PHOSPHATIDYLCHOLINE_TRANSPORTER_ACTIVITY,0.489709161290323
GOBERT_OLIGODENDROCYTE_DIFFE...2,SET,525,0.1011,0.016851,0.036654,0.0029076,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,0.489709161290323
REACTOME_B_WICH_COMPLEX_POSI...,SET,28,0.41599,0.016233,0.15088,0.0029194,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,0.489709161290323
REACTOME_SUMOYLATION_OF_TRAN...2,SET,19,0.53224,0.017113,0.19315,0.0029323,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS,0.489709161290323
HP_NEUROMA,SET,6,0.88143,0.015931,0.3199,0.0029344,HP_NEUROMA,0.489709161290323
GOBP_PROTEIN_LOCALIZATION_TO...18,SET,14,0.63761,0.0176,0.23164,0.0029592,GOBP_PROTEIN_LOCALIZATION_TO_CONDENSED_CHROMOSOME,0.489709161290323
REACTOME_EPIGENETIC_REGULATI...,SET,182,0.16413,0.01626,0.05964,0.002965,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.489709161290323
GSE39820_CTRL_VS_TGFBETA3_IL...3,SET,176,0.17663,0.017211,0.064205,0.0029735,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN,0.489709161290323
GSE14308_TH1_VS_INDUCED_TREG...2,SET,180,0.1692,0.016671,0.061575,0.0030019,GSE14308_TH1_VS_INDUCED_TREG_UP,0.489709161290323
GOBP_REGULATION_OF_PEPTIDYL_...3,SET,7,0.7897,0.015417,0.28776,0.0030351,GOBP_REGULATION_OF_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.489709161290323
HP_NON_MIDLINE_CLEFT_PALATE,SET,26,0.48351,0.018182,0.1762,0.0030363,HP_NON_MIDLINE_CLEFT_PALATE,0.489709161290323
HP_ABNORMAL_THALAMIC_MRI_SIG...,SET,32,0.38416,0.016024,0.14005,0.0030478,HP_ABNORMAL_THALAMIC_MRI_SIGNAL_INTENSITY,0.489709161290323
GOBP_ACETATE_ESTER_METABOLIC...,SET,6,1.0091,0.018239,0.36801,0.0030564,GOBP_ACETATE_ESTER_METABOLIC_PROCESS,0.489709161290323
HP_SEROSITIS,SET,88,0.25806,0.017823,0.094118,0.0030576,HP_SEROSITIS,0.489709161290323
HP_SIMPLIFIED_GYRAL_PATTERN,SET,78,0.25331,0.016476,0.092463,0.0030787,HP_SIMPLIFIED_GYRAL_PATTERN,0.490826690366972
GOBP_POSITIVE_REGULATION_OF_...157,SET,25,0.46025,0.016972,0.16828,0.0031224,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.495520602739726
HP_STOMACH_CANCER,SET,33,0.3991,0.016905,0.14613,0.0031585,HP_STOMACH_CANCER,0.496379636363636
GSE26030_TH1_VS_TH17_RESTIMU...4,SET,185,0.17003,0.016982,0.062366,0.0032046,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP,0.496379636363636
GOBP_REGULATION_OF_ACTIVIN_R...,SET,26,0.49027,0.018437,0.17983,0.0032051,GOBP_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.496379636363636
GOMF_INORGANIC_ANION_TRANSME...,SET,146,0.20451,0.018165,0.075063,0.0032223,GOMF_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.496379636363636
GSE15750_DAY6_VS_DAY10_EFF_C...2,SET,179,0.16509,0.016221,0.06065,0.0032485,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP,0.496379636363636
HP_POLYCYSTIC_LIVER_DISEASE,SET,11,0.65942,0.016136,0.24231,0.0032532,HP_POLYCYSTIC_LIVER_DISEASE,0.496379636363636
GSE4748_CTRL_VS_CYANOBACTERI...4,SET,187,0.16825,0.016894,0.061833,0.0032561,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.496379636363636
GOBP_HYALURONAN_CATABOLIC_PR...,SET,15,0.59335,0.016953,0.21814,0.0032665,GOBP_HYALURONAN_CATABOLIC_PROCESS,0.496379636363636
WP_NRF2_PATHWAY,SET,133,0.21955,0.018619,0.080727,0.0032703,WP_NRF2_PATHWAY,0.496379636363636
GSE2124_CTRL_VS_LYMPHOTOXIN_...2,SET,182,0.17801,0.017636,0.065496,0.0032878,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP,0.496379636363636
DACOSTA_UV_RESPONSE_VIA_ERCC...7,SET,79,0.26686,0.017467,0.098213,0.0032954,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.496379636363636
GOBP_NEGATIVE_REGULATION_OF_...130,SET,7,0.84144,0.016427,0.30972,0.0032992,GOBP_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.496379636363636
GSE14415_INDUCED_TREG_VS_FOX...4,SET,149,0.1865,0.016733,0.068899,0.0033994,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP,0.496754023255814
HP_MILD_POSTNATAL_GROWTH_RET...,SET,16,0.62894,0.018558,0.23239,0.0034047,HP_MILD_POSTNATAL_GROWTH_RETARDATION,0.496754023255814
HP_EURYBLEPHARON,SET,9,0.75301,0.016668,0.27863,0.0034433,HP_EURYBLEPHARON,0.496754023255814
GOBP_B_CELL_ACTIVATION,SET,243,0.15461,0.017668,0.05732,0.0034994,GOBP_B_CELL_ACTIVATION,0.496754023255814
GOCC_BLOC_1_COMPLEX,SET,14,0.62189,0.017166,0.23059,0.003502,GOCC_BLOC_1_COMPLEX,0.496754023255814
HP_MICROSCOPIC_HEMATURIA,SET,18,0.55519,0.017375,0.20615,0.0035427,HP_MICROSCOPIC_HEMATURIA,0.496754023255814
TANG_SENESCENCE_TP53_TARGETS...1,SET,51,0.3384,0.017811,0.12571,0.003555,TANG_SENESCENCE_TP53_TARGETS_DN,0.496754023255814
GOMF_QUATERNARY_AMMONIUM_GRO...1,SET,35,0.4075,0.017775,0.15139,0.0035573,GOMF_QUATERNARY_AMMONIUM_GROUP_BINDING,0.496754023255814
HP_NEOPLASM_OF_THE_GENITOURI...,SET,213,0.15663,0.016772,0.05822,0.0035728,HP_NEOPLASM_OF_THE_GENITOURINARY_TRACT,0.496754023255814
GOBP_NEGATIVE_REGULATION_OF_...585,SET,2,1.9248,0.020088,0.7155,0.0035745,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.496754023255814
GOMF_MONOATOMIC_ANION_TRANSM...,SET,131,0.21546,0.018135,0.080143,0.0035921,GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.496754023255814
GOBP_INORGANIC_ANION_TRANSME...,SET,120,0.22346,0.018007,0.083154,0.0036044,GOBP_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT,0.496754023255814
GOCC_GLYCOPROTEIN_COMPLEX,SET,21,0.52617,0.017785,0.19581,0.0036067,GOCC_GLYCOPROTEIN_COMPLEX,0.496754023255814
ZNF626_TARGET_GENES,SET,12,0.63944,0.016342,0.23814,0.0036277,ZNF626_TARGET_GENES,0.496754023255814
MIR1205,SET,160,0.18176,0.016894,0.067727,0.0036434,MIR1205,0.496754023255814
REACTOME_FORMATION_OF_XYLULO...,SET,5,1.0766,0.017763,0.40142,0.0036639,REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE,0.496754023255814
GOBP_GLUCURONATE_CATABOLIC_P...,SET,5,1.0766,0.017763,0.40142,0.0036639,GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE,0.496754023255814
GSE41867_NAIVE_VS_DAY8_LCMV_...2,SET,179,0.1702,0.016724,0.063468,0.0036658,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.496754023255814
GOBP_PLATELET_DERIVED_GROWTH...1,SET,7,0.92921,0.01814,0.34651,0.0036665,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.496754023255814
HP_PLEURAL_EFFUSION,SET,78,0.26169,0.017021,0.097607,0.0036727,HP_PLEURAL_EFFUSION,0.496754023255814
GOBP_ALPHA_BETA_T_CELL_PROLI...,SET,42,0.38893,0.018581,0.1452,0.003701,GOBP_ALPHA_BETA_T_CELL_PROLIFERATION,0.496754023255814
PAX4_01,SET,247,0.14383,0.01657,0.05374,0.0037242,PAX4_01,0.496754023255814
HP_NEOPLASM_OF_THE_LIVER,SET,132,0.20702,0.01749,0.077414,0.0037488,HP_NEOPLASM_OF_THE_LIVER,0.496754023255814
WP_IL10_ANTIINFLAMMATORY_SIG...,SET,12,0.62644,0.01601,0.23449,0.0037787,WP_IL10_ANTIINFLAMMATORY_SIGNALING,0.496754023255814
MIR548G_3P,SET,216,0.15537,0.016753,0.058164,0.0037816,MIR548G_3P,0.496754023255814
GOBP_POSITIVE_REGULATION_OF_...593,SET,7,0.89962,0.017563,0.3368,0.0037838,GOBP_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.496754023255814
ZNF320_TARGET_GENES,SET,1229,0.068093,0.017018,0.025501,0.0037938,ZNF320_TARGET_GENES,0.496754023255814
RAMPON_ENRICHED_LEARNING_ENV...3,SET,21,0.45696,0.015446,0.17116,0.0037977,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,0.496754023255814
GOBP_PYRIMIDINE_DIMER_REPAIR,SET,9,0.60455,0.013382,0.22645,0.0037992,GOBP_PYRIMIDINE_DIMER_REPAIR,0.496754023255814
WP_DNA_REPLICATION,SET,40,0.3421,0.01595,0.12817,0.003807,WP_DNA_REPLICATION,0.496754023255814
GSE37532_TREG_VS_TCONV_PPARG...2,SET,180,0.15981,0.015746,0.059893,0.0038159,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP,0.496754023255814
HP_FOCAL_T2_HYPERINTENSE_BAS...,SET,23,0.43588,0.015418,0.16344,0.0038308,HP_FOCAL_T2_HYPERINTENSE_BASAL_GANGLIA_LESION,0.496754023255814
GOBP_RENAL_SYSTEM_PROCESS,SET,117,0.22892,0.018216,0.085865,0.0038403,GOBP_RENAL_SYSTEM_PROCESS,0.496754023255814
GOBP_ENTERIC_NERVOUS_SYSTEM_...,SET,11,0.70293,0.0172,0.26368,0.0038438,GOBP_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT,0.496754023255814
GSE30083_SP1_VS_SP3_THYMOCYT...1,SET,181,0.17043,0.016838,0.063971,0.0038625,GSE30083_SP1_VS_SP3_THYMOCYTE_DN,0.496754023255814
MIR6811_3P,SET,55,0.3241,0.017712,0.12171,0.0038778,MIR6811_3P,0.496754023255814
QI_PBMC_ZOSTAVAX_AGE_50_75YO...8,SET,13,0.62193,0.016543,0.23358,0.003881,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_EXPANSION_AND_CONTRACTION_1D_NOT_INFORMATIVE_OF_LONG_TERM_RESPONSES_POSITIVE,0.496754023255814
GSE30083_SP2_VS_SP3_THYMOCYT...1,SET,183,0.17065,0.016952,0.064102,0.0038856,GSE30083_SP2_VS_SP3_THYMOCYTE_DN,0.496754023255814
GOBP_POSITIVE_REGULATION_OF_...547,SET,41,0.3773,0.01781,0.14187,0.0039165,GOBP_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.496754023255814
GOBP_REGULATION_OF_TOLL_LIKE...2,SET,14,0.56683,0.015647,0.21314,0.0039168,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.496754023255814
GOBP_IMPORT_INTO_NUCLEUS,SET,159,0.17622,0.016328,0.066267,0.0039198,GOBP_IMPORT_INTO_NUCLEUS,0.496754023255814
GOBP_NUCLEAR_TRANSPORT,SET,306,0.12464,0.015957,0.0469,0.0039378,GOBP_NUCLEAR_TRANSPORT,0.496754023255814
GOBP_NEGATIVE_REGULATION_OF_...431,SET,15,0.6072,0.017349,0.22851,0.0039428,GOBP_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.496754023255814
HP_KETOSIS,SET,60,0.30171,0.017219,0.11356,0.0039474,HP_KETOSIS,0.496754023255814
GSE3982_CTRL_VS_IGE_STIM_MAS...2,SET,183,0.16633,0.016522,0.062613,0.0039521,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP,0.496754023255814
MIR15A_5P,SET,535,0.097945,0.016474,0.036905,0.0039807,MIR15A_5P,0.496754023255814
GOCC_NUCLEAR_PROTEIN_CONTAIN...,SET,1119,0.065619,0.015698,0.024745,0.0040063,GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX,0.496754023255814
GSE29614_DAY3_VS_DAY7_TIV_FL...1,SET,158,0.17977,0.016605,0.067822,0.0040202,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.496754023255814
GOBP_CONVERGENT_EXTENSION,SET,15,0.61491,0.017569,0.23209,0.0040354,GOBP_CONVERGENT_EXTENSION,0.496754023255814
HALLMARK_PROTEIN_SECRETION,SET,85,0.23842,0.016185,0.090026,0.0040481,HALLMARK_PROTEIN_SECRETION,0.496754023255814
GCM_RAD21,SET,32,0.36019,0.015024,0.13621,0.0040962,GCM_RAD21,0.496754023255814
HP_IRIDOCYCLITIS,SET,10,0.84541,0.019725,0.31994,0.0041199,HP_IRIDOCYCLITIS,0.496754023255814
GOBP_PH_REDUCTION,SET,6,1.0246,0.018519,0.38794,0.0041365,GOBP_PH_REDUCTION,0.496754023255814
GOCC_RNA_POLYMERASE_II_HOLOE...,SET,67,0.25064,0.015113,0.094975,0.004161,GOCC_RNA_POLYMERASE_II_HOLOENZYME,0.496754023255814
HP_ENTHESITIS,SET,10,0.84391,0.01969,0.31985,0.004168,HP_ENTHESITIS,0.496754023255814
GOBP_NEGATIVE_REGULATION_OF_...131,SET,11,0.68871,0.016852,0.26115,0.0041829,GOBP_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION,0.496754023255814
NICK_RESPONSE_TO_PROC_TREATM...2,SET,4,1.1286,0.016657,0.42809,0.0041924,NICK_RESPONSE_TO_PROC_TREATMENT_UP,0.496754023255814
PUJANA_CHEK2_PCC_NETWORK,SET,694,0.081931,0.015625,0.031085,0.0042021,PUJANA_CHEK2_PCC_NETWORK,0.496754023255814
GOBP_BLOOD_VESSEL_MORPHOGENE...,SET,578,0.10057,0.017561,0.038158,0.0042023,GOBP_BLOOD_VESSEL_MORPHOGENESIS,0.496754023255814
GOBP_MICROGLIAL_CELL_PROLIFE...,SET,7,0.97183,0.018972,0.36875,0.0042048,GOBP_MICROGLIAL_CELL_PROLIFERATION,0.496754023255814
REACTOME_NONHOMOLOGOUS_END_J...,SET,29,0.36499,0.014494,0.1385,0.0042076,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,0.496754023255814
GSE3039_CD4_TCELL_VS_NKT_CEL...1,SET,180,0.15913,0.015679,0.060391,0.0042102,GSE3039_CD4_TCELL_VS_NKT_CELL_DN,0.496754023255814
MIR3155A_MIR3155B,SET,71,0.26809,0.016639,0.10179,0.0042261,MIR3155A_MIR3155B,0.496754023255814
GSE2585_CTEC_VS_THYMIC_MACRO...2,SET,183,0.1695,0.016838,0.064382,0.0042384,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP,0.496754023255814
HP_PLEURITIS,SET,26,0.46246,0.017391,0.17585,0.0042748,HP_PLEURITIS,0.496754023255814
GOBP_POSITIVE_REGULATION_OF_...16,SET,6,0.96625,0.017465,0.36746,0.0042785,GOBP_POSITIVE_REGULATION_OF_AGGREPHAGY,0.496754023255814
HAY_BONE_MARROW_CD34_POS_PRE...2,SET,96,0.24709,0.017821,0.09401,0.0042935,HAY_BONE_MARROW_CD34_POS_PRE_PC,0.496754023255814
MIR4433B_5P,SET,51,0.33879,0.017831,0.12891,0.0042974,MIR4433B_5P,0.496754023255814
REACTOME_ACROSOME_REACTION_A...,SET,6,1.0437,0.018864,0.39714,0.0042986,REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING,0.496754023255814
BIOCARTA_CASPASE_PATHWAY,SET,21,0.48313,0.01633,0.18386,0.0043022,BIOCARTA_CASPASE_PATHWAY,0.496754023255814
GOBP_POSITIVE_REGULATION_OF_...171,SET,30,0.39879,0.016107,0.15227,0.0044139,GOBP_POSITIVE_REGULATION_OF_COAGULATION,0.503925913043478
REACTOME_DNA_DOUBLE_STRAND_B...2,SET,38,0.3601,0.016366,0.1375,0.0044148,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,0.503925913043478
GOCC_CHLORIDE_CHANNEL_COMPLEX,SET,49,0.36274,0.018714,0.13856,0.0044273,GOCC_CHLORIDE_CHANNEL_COMPLEX,0.503925913043478
GOBP_PROTEIN_LIPID_COMPLEX_A...,SET,26,0.43342,0.016299,0.16579,0.0044748,GOBP_PROTEIN_LIPID_COMPLEX_ASSEMBLY,0.503925913043478
GOBP_VASCULAR_ENDOTHELIAL_GR...1,SET,34,0.39232,0.016867,0.15012,0.0044852,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.503925913043478
GSE3982_MAST_CELL_VS_CENT_ME...2,SET,185,0.16107,0.016087,0.061646,0.0044926,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.503925913043478
GOBP_ESTABLISHMENT_OF_PIGMEN...,SET,21,0.50696,0.017136,0.1941,0.0045069,GOBP_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION,0.503925913043478
TRAVAGLINI_LUNG_SEROUS_CELL,SET,86,0.24889,0.016994,0.095319,0.0045163,TRAVAGLINI_LUNG_SEROUS_CELL,0.503925913043478
HP_HEPATOCELLULAR_CARCINOMA,SET,75,0.26173,0.016694,0.10033,0.0045469,HP_HEPATOCELLULAR_CARCINOMA,0.503925913043478
MIR5581_3P,SET,117,0.20337,0.016183,0.077993,0.0045644,MIR5581_3P,0.503925913043478
WP_EXTRAFOLLICULAR_AND_FOLLI...,SET,65,0.30464,0.018094,0.1169,0.0045833,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,0.503925913043478
HP_CHOROIDAL_HEMANGIOMA,SET,5,0.90827,0.014987,0.34852,0.0045835,HP_CHOROIDAL_HEMANGIOMA,0.503925913043478
KAMMINGA_SENESCENCE,SET,38,0.34532,0.015694,0.13258,0.0046017,KAMMINGA_SENESCENCE,0.503925913043478
GOBP_TOLERANCE_INDUCTION,SET,27,0.4702,0.018018,0.18054,0.0046045,GOBP_TOLERANCE_INDUCTION,0.503925913043478
HP_NEUROINFLAMMATION,SET,18,0.51039,0.015973,0.19599,0.0046091,HP_NEUROINFLAMMATION,0.503925913043478
HP_SPASTIC_ATAXIA,SET,18,0.491,0.015366,0.1886,0.0046201,HP_SPASTIC_ATAXIA,0.503925913043478
GSE7460_FOXP3_MUT_VS_WT_ACT_...4,SET,180,0.16468,0.016225,0.063272,0.0046286,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP,0.503925913043478
GOCC_MEMBRANE_PROTEIN_COMPLEX,SET,1152,0.06871,0.016663,0.026412,0.0046453,GOCC_MEMBRANE_PROTEIN_COMPLEX,0.503925913043478
ALONSO_METASTASIS_EMT_UP,SET,32,0.39749,0.01658,0.15279,0.0046455,ALONSO_METASTASIS_EMT_UP,0.503925913043478
GOBP_AUDITORY_RECEPTOR_CELL_...2,SET,19,0.53181,0.017099,0.20449,0.0046553,GOBP_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS,0.503925913043478
HP_ABNORMAL_CIRCULATING_CREA...1,SET,10,0.64879,0.015137,0.24956,0.0046688,HP_ABNORMAL_CIRCULATING_CREATINE_CONCENTRATION,0.503925913043478
LUDWICZEK_TREATING_IRON_OVER...,SET,7,0.96374,0.018814,0.37105,0.0047013,LUDWICZEK_TREATING_IRON_OVERLOAD,0.505862791021672
GOBP_REGULATION_OF_EPIDERMAL...,SET,15,0.54487,0.015568,0.21007,0.0047515,GOBP_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.509686365740741
RODRIGUES_NTN1_TARGETS_DN,SET,148,0.18812,0.016822,0.072563,0.0047684,RODRIGUES_NTN1_TARGETS_DN,0.50992536
GOBP_OLFACTORY_BEHAVIOR,SET,11,0.75916,0.018576,0.29336,0.004833,GOBP_OLFACTORY_BEHAVIOR,0.5130706875
HP_INHERITANCE_QUALIFIER,SET,302,0.1321,0.016802,0.051055,0.0048402,HP_INHERITANCE_QUALIFIER,0.5130706875
GOBP_ANIMAL_ORGAN_FORMATION,SET,64,0.30412,0.017925,0.11755,0.0048421,GOBP_ANIMAL_ORGAN_FORMATION,0.5130706875
HP_PERICARDITIS,SET,33,0.39953,0.016923,0.1545,0.0048586,HP_PERICARDITIS,0.513254234042553
GSE36826_NORMAL_VS_STAPH_AUR...3,SET,185,0.16317,0.016296,0.063135,0.004881,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN,0.514058045454545
MAX_01,SET,240,0.14211,0.016141,0.05507,0.0049378,MAX_01,0.514353495575221
MIR3140_5P,SET,121,0.19937,0.016131,0.077264,0.0049393,MIR3140_5P,0.514353495575221
GOBP_NEGATIVE_REGULATION_OF_...239,SET,13,0.59953,0.015948,0.23242,0.0049512,GOBP_NEGATIVE_REGULATION_OF_FIBRINOLYSIS,0.514353495575221
MARZEC_IL2_SIGNALING_UP,SET,109,0.21596,0.016591,0.083771,0.0049724,MARZEC_IL2_SIGNALING_UP,0.514353495575221
REACTOME_KILLING_MECHANISMS,SET,11,0.66977,0.016389,0.25994,0.0049924,REACTOME_KILLING_MECHANISMS,0.514353495575221
MIR7852_3P,SET,66,0.27094,0.016215,0.10517,0.005,MIR7852_3P,0.514353495575221
GOBP_REGULATION_OF_VASCULATU...,SET,265,0.14418,0.017196,0.055968,0.0050006,GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.514353495575221
GSE2770_IL12_VS_TGFB_AND_IL1...1,SET,145,0.18865,0.016699,0.07326,0.005015,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.514353495575221
REACTOME_CDC6_ASSOCIATION_WI...,SET,8,0.77858,0.016249,0.30237,0.005017,REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX,0.514353495575221
GOBP_PLASMA_MEMBRANE_RAFT_OR...,SET,11,0.70056,0.017143,0.27234,0.0050536,GOBP_PLASMA_MEMBRANE_RAFT_ORGANIZATION,0.51620112
GSE36009_UNSTIM_VS_LPS_STIM_...4,SET,181,0.16377,0.01618,0.063763,0.005112,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP,0.51620112
GOBP_ERROR_FREE_TRANSLESION_...,SET,5,0.69516,0.01147,0.27074,0.005124,GOBP_ERROR_FREE_TRANSLESION_SYNTHESIS,0.51620112
OUYANG_PROSTATE_CANCER_MARKE...,SET,20,0.50875,0.016782,0.19825,0.0051461,OUYANG_PROSTATE_CANCER_MARKERS,0.51620112
GSE21927_UNTREATED_VS_GMCSF_...3,SET,153,0.17844,0.016221,0.069538,0.005147,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN,0.51620112
GOBP_PROSTATE_GLANDULAR_ACIN...2,SET,6,0.94672,0.017112,0.36899,0.005152,GOBP_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS,0.51620112
GSE20198_IL12_IL18_VS_IFNA_T...2,SET,186,0.15523,0.015545,0.060519,0.0051623,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.51620112
REACTOME_SUMOYLATION_OF_INTR...,SET,28,0.40491,0.0158,0.15787,0.0051647,REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,0.51620112
GOBP_TUBE_MORPHOGENESIS,SET,811,0.081708,0.016789,0.031872,0.0051833,GOBP_TUBE_MORPHOGENESIS,0.51620112
GAJATE_RESPONSE_TO_TRABECTED...2,SET,59,0.29986,0.016971,0.11698,0.0051878,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,0.51620112
GOBP_SPECIFICATION_OF_ANIMAL...,SET,35,0.42116,0.018371,0.16435,0.0051984,GOBP_SPECIFICATION_OF_ANIMAL_ORGAN_IDENTITY,0.51620112
GSE16266_LPS_VS_HEATSHOCK_AN...1,SET,175,0.16474,0.016007,0.06432,0.0052182,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.516536313920455
GOCC_MLL3_4_COMPLEX,SET,10,0.61832,0.014426,0.24149,0.0052315,GOCC_MLL3_4_COMPLEX,0.516536313920455
JOSEPH_RESPONSE_TO_SODIUM_BU...2,SET,26,0.43398,0.01632,0.1696,0.0052552,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,0.517135091666667
GOCC_GATOR1_COMPLEX,SET,5,0.92385,0.015244,0.36123,0.0052757,GOCC_GATOR1_COMPLEX,0.517135091666667
MIR761,SET,209,0.14539,0.015423,0.056863,0.0052855,MIR761,0.517135091666667
GOBP_POSITIVE_REGULATION_OF_...101,SET,10,0.83067,0.019381,0.32517,0.00532,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.517135091666667
HP_SINGLE_VENTRICLE,SET,8,0.73742,0.01539,0.28868,0.0053211,HP_SINGLE_VENTRICLE,0.517135091666667
GOMF_LYSOPHOSPHATIDIC_ACID_B...,SET,7,0.78037,0.015235,0.30567,0.005344,GOMF_LYSOPHOSPHATIDIC_ACID_BINDING,0.517135091666667
DACOSTA_UV_RESPONSE_VIA_ERCC...4,SET,78,0.25323,0.01647,0.099218,0.0053556,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,0.517135091666667
HP_ABNORMAL_MAST_CELL_MORPHO...,SET,8,0.77003,0.01607,0.30171,0.0053566,HP_ABNORMAL_MAST_CELL_MORPHOLOGY,0.517135091666667
HAHTOLA_SEZARY_SYNDROM_UP,SET,83,0.24063,0.016142,0.094333,0.0053771,HAHTOLA_SEZARY_SYNDROM_UP,0.517676206371191
GOCC_CONTRACTILE_RING,SET,11,0.58141,0.014227,0.22825,0.0054338,GOCC_CONTRACTILE_RING,0.52166967768595
ZNF282_TARGET_GENES,SET,850,0.076048,0.01598,0.029867,0.0054486,ZNF282_TARGET_GENES,0.52166967768595
GOBP_MITOTIC_SISTER_CHROMATI...2,SET,3,1.0495,0.013414,0.41266,0.0054959,GOBP_MITOTIC_SISTER_CHROMATID_COHESION_CENTROMERIC,0.524752759615385
GOMF_QUATERNARY_AMMONIUM_GRO...2,SET,13,0.68497,0.01822,0.26944,0.0055114,GOMF_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.524790978082192
GOMF_GROWTH_HORMONE_RECEPTOR...,SET,8,0.86692,0.018092,0.34153,0.0055729,GOMF_GROWTH_HORMONE_RECEPTOR_BINDING,0.529197102459016
BRN2_01,SET,210,0.15329,0.0163,0.060415,0.005591,BRN2_01,0.529469223433242
chr14q22,SET,43,0.66055,0.03193,0.26085,0.0056706,chr14q22,0.532535715384615
HP_FOAMY_URINE,SET,29,0.41332,0.016414,0.16345,0.005728,HP_FOAMY_URINE,0.532535715384615
GOMF_LYSOPHOSPHATIDIC_ACID_R...,SET,4,0.97012,0.014318,0.38381,0.005747,GOMF_LYSOPHOSPHATIDIC_ACID_RECEPTOR_ACTIVITY,0.532535715384615
BIOCARTA_CARM_ER_PATHWAY,SET,22,0.4408,0.015249,0.17441,0.0057512,BIOCARTA_CARM_ER_PATHWAY,0.532535715384615
HALLMARK_G2M_CHECKPOINT,SET,181,0.15546,0.015359,0.06157,0.0057903,HALLMARK_G2M_CHECKPOINT,0.532535715384615
MORF_ATRX,SET,204,0.14325,0.015016,0.056742,0.005795,MORF_ATRX,0.532535715384615
GOBP_FERTILIZATION,SET,183,0.16351,0.016243,0.064769,0.0057964,GOBP_FERTILIZATION,0.532535715384615
MIR130A_5P,SET,307,0.1308,0.016771,0.051864,0.0058399,MIR130A_5P,0.532535715384615
HP_PAIN_IN_HEAD_AND_NECK_REG...,SET,40,0.35063,0.016348,0.13904,0.005841,HP_PAIN_IN_HEAD_AND_NECK_REGION,0.532535715384615
MODULE_60,SET,378,0.11312,0.016063,0.044858,0.0058436,MODULE_60,0.532535715384615
GOCC_GROWTH_CONE_MEMBRANE,SET,7,0.88927,0.01736,0.35273,0.0058534,GOCC_GROWTH_CONE_MEMBRANE,0.532535715384615
MODULE_293,SET,10,0.75153,0.017534,0.2981,0.005855,MODULE_293,0.532535715384615
GOBP_RIBOSOMAL_SMALL_SUBUNIT...1,SET,16,0.51193,0.015106,0.20309,0.0058601,GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY,0.532535715384615
HP_IMPAIRED_NEUTROPHIL_BACTE...,SET,8,0.78456,0.016373,0.31127,0.0058638,HP_IMPAIRED_NEUTROPHIL_BACTERICIDAL_ACTIVITY,0.532535715384615
GOBP_HEART_FORMATION,SET,31,0.43696,0.01794,0.17342,0.0058769,GOBP_HEART_FORMATION,0.532535715384615
WP_MIR517_RELATIONSHIP_WITH_...,SET,5,0.73496,0.012127,0.29178,0.0058906,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,0.532535715384615
ENK_UV_RESPONSE_EPIDERMIS_UP,SET,268,0.1317,0.015795,0.052287,0.0058919,ENK_UV_RESPONSE_EPIDERMIS_UP,0.532535715384615
GOBP_CONVERGENT_EXTENSION_IN...1,SET,5,1.1224,0.01852,0.4458,0.0059095,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION,0.532535715384615
YAMASHITA_LIVER_CANCER_WITH_...2,SET,49,0.29304,0.015118,0.11652,0.0059567,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,0.532535715384615
GOBP_NUCLEOTIDE_BINDING_OLIG...1,SET,7,1.0477,0.020453,0.41663,0.0059624,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_1_SIGNALING_PATHWAY,0.532535715384615
DEBIASI_APOPTOSIS_BY_REOVIRU...1,SET,246,0.13413,0.015422,0.05335,0.0059694,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,0.532535715384615
WP_GANGLIO_SERIES_SPHINGOLIP...,SET,13,0.631,0.016785,0.25099,0.0059722,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.532535715384615
REACTOME_G2_M_DNA_DAMAGE_CHE...,SET,55,0.27732,0.015156,0.11032,0.0059758,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,0.532535715384615
KEGG_MEDICUS_REFERENCE_TELOM...1,SET,3,0.90071,0.011513,0.35886,0.0060423,KEGG_MEDICUS_REFERENCE_TELOMERASE_RNA_MATURATION,0.536947017857143
REACTOME_GPER1_SIGNALING,SET,45,0.33111,0.016372,0.13196,0.0060562,REACTOME_GPER1_SIGNALING,0.536947017857143
HP_LOSS_OF_SUBCUTANEOUS_ADIP...,SET,9,0.72432,0.016033,0.2891,0.0061202,HP_LOSS_OF_SUBCUTANEOUS_ADIPOSE_TISSUE_IN_LIMBS,0.541240587786259
GSE17721_CTRL_VS_LPS_4H_BMDC...2,SET,185,0.15171,0.015152,0.060595,0.0061499,GSE17721_CTRL_VS_LPS_4H_BMDC_UP,0.542486737309645
GOCC_TRANSFERASE_COMPLEX,SET,757,0.075493,0.01501,0.030193,0.0062084,GOCC_TRANSFERASE_COMPLEX,0.544077706549118
HP_ABNORMAL_CORNEAL_EPITHELI...,SET,95,0.21638,0.015524,0.086544,0.0062106,HP_ABNORMAL_CORNEAL_EPITHELIUM_MORPHOLOGY,0.544077706549118
GOBP_PROTEIN_LOCALIZATION_TO...13,SET,21,0.45994,0.015546,0.18398,0.0062149,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION,0.544077706549118
GOBP_CHEMOSENSORY_BEHAVIOR,SET,19,0.52444,0.016862,0.20997,0.006255,GOBP_CHEMOSENSORY_BEHAVIOR,0.54512480798005
CALVET_IRINOTECAN_SENSITIVE_...1,SET,4,1.0135,0.014958,0.4059,0.0062685,CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP,0.54512480798005
chr19q13,SET,714,0.20064,0.03879,0.080383,0.006284,chr19q13,0.54512480798005
HP_HODGKIN_LYMPHOMA,SET,25,0.40821,0.015053,0.16356,0.0062896,HP_HODGKIN_LYMPHOMA,0.54512480798005
REACTOME_NECTIN_NECL_TRANS_H...,SET,3,1.3783,0.017618,0.55251,0.0063082,REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION,0.545376843283582
BIOCARTA_FAS_PATHWAY,SET,30,0.38488,0.015545,0.15436,0.0063311,BIOCARTA_FAS_PATHWAY,0.545998462779156
BIOCARTA_SHH_PATHWAY,SET,16,0.55718,0.016441,0.22368,0.0063755,BIOCARTA_SHH_PATHWAY,0.547532844444444
GOCC_A_BAND,SET,39,0.32603,0.01501,0.1309,0.0063804,GOCC_A_BAND,0.547532844444444
HP_ABNORMAL_CIRCULATING_IGM_...,SET,94,0.22429,0.016007,0.090115,0.0064113,HP_ABNORMAL_CIRCULATING_IGM_LEVEL,0.548829387931034
GOMF_PHOSPHATIDYLCHOLINE_TRA...1,SET,5,0.95558,0.015767,0.38417,0.0064388,GOMF_PHOSPHATIDYLCHOLINE_TRANSFER_ACTIVITY,0.549829223587224
GSE45382_UNTREATED_VS_TGFB_T...2,SET,179,0.16251,0.015968,0.06541,0.0064906,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP,0.552894125
SCHLOSSER_MYC_TARGETS_AND_SE...2,SET,45,0.30091,0.014879,0.12122,0.006529,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,0.554774568292683
GNF2_CD97,SET,36,0.38446,0.017007,0.15492,0.0065446,GNF2_CD97,0.554774568292683
REACTOME_NEGATIVE_EPIGENETIC...,SET,44,0.29977,0.014658,0.1209,0.0065819,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.554800881355932
GOBP_NEGATIVE_REGULATION_OF_...154,SET,11,0.79534,0.019462,0.32079,0.0065857,GOBP_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.554800881355932
HP_BREAST_CARCINOMA,SET,68,0.24423,0.014836,0.098522,0.0065928,HP_BREAST_CARCINOMA,0.554800881355932
REACTOME_RNA_POLYMERASE_III_...5,SET,21,0.40782,0.013785,0.16459,0.0066154,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,0.555358036231884
GSE27786_LIN_NEG_VS_NEUTROPH...1,SET,185,0.15045,0.015026,0.06081,0.0066815,GSE27786_LIN_NEG_VS_NEUTROPHIL_DN,0.556915775
KERLEY_RESPONSE_TO_CISPLATIN...2,SET,44,0.31848,0.015572,0.12877,0.0066994,KERLEY_RESPONSE_TO_CISPLATIN_UP,0.556915775
HP_UNILATERAL_CLEFT_PALATE,SET,18,0.53403,0.016713,0.21599,0.006714,HP_UNILATERAL_CLEFT_PALATE,0.556915775
GOBP_MACROAUTOPHAGY,SET,325,0.11453,0.015102,0.046322,0.0067146,GOBP_MACROAUTOPHAGY,0.556915775
GOMF_NUCLEOSIDE_BINDING,SET,8,0.76674,0.016001,0.31012,0.0067149,GOMF_NUCLEOSIDE_BINDING,0.556915775
MIR11181_3P,SET,182,0.15792,0.015645,0.063893,0.0067301,MIR11181_3P,0.556915775
WINTER_HYPOXIA_DN,SET,42,0.3508,0.016759,0.14202,0.0067593,WINTER_HYPOXIA_DN,0.557074173758865
MYCMAX_01,SET,235,0.14207,0.01597,0.057531,0.0067696,MYCMAX_01,0.557074173758865
HP_ABNORMAL_NASAL_SEPTUM_MOR...,SET,15,0.62052,0.017729,0.25133,0.0067801,HP_ABNORMAL_NASAL_SEPTUM_MORPHOLOGY,0.557074173758865
GOBP_NEGATIVE_REGULATION_OF_...55,SET,29,0.42453,0.016859,0.17205,0.0068074,GOBP_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION,0.55799808254717
GSE37605_C57BL6_VS_NOD_FOXP3...1,SET,169,0.15986,0.015267,0.064818,0.0068295,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN,0.558069480140187
GSE360_HIGH_VS_LOW_DOSE_B_MA...2,SET,179,0.15706,0.015432,0.063712,0.0068528,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP,0.558069480140187
HP_LUPUS_ANTICOAGULANT,SET,4,1.1725,0.017305,0.47573,0.0068623,HP_LUPUS_ANTICOAGULANT,0.558069480140187
GSE9960_GRAM_POS_VS_GRAM_NEG...1,SET,173,0.16739,0.016172,0.067933,0.0068725,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.558069480140187
MODULE_1,SET,334,0.12461,0.016654,0.050589,0.0068888,MODULE_1,0.558089146853147
HE_LIM_SUN_FETAL_LUNG_C5_PRO...,SET,407,0.10175,0.01498,0.041334,0.0069218,HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL,0.559458509302326
HP_ADIPOSE_TISSUE_LOSS,SET,27,0.39644,0.015192,0.16117,0.0069563,HP_ADIPOSE_TISSUE_LOSS,0.559547473441109
HP_DECREASED_CIRCULATING_IGA...,SET,70,0.25258,0.015566,0.10269,0.0069592,HP_DECREASED_CIRCULATING_IGA_LEVEL,0.559547473441109
GOBP_REGULATION_OF_TYPE_B_PA...2,SET,11,0.67607,0.016543,0.27494,0.0069712,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.559547473441109
GOCC_STEREOCILIA_COUPLING_LI...,SET,7,0.8852,0.017281,0.36021,0.0070016,GOCC_STEREOCILIA_COUPLING_LINK,0.56069264516129
GOMF_DNA_REPLICATION_ORIGIN_...,SET,15,0.57695,0.016484,0.23491,0.0070277,GOMF_DNA_REPLICATION_ORIGIN_BINDING,0.560814970183486
GSE27786_ERYTHROBLAST_VS_MON...2,SET,173,0.15392,0.01487,0.062678,0.0070354,GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP,0.560814970183486
COUP_DR1_Q6,SET,217,0.14017,0.015148,0.057121,0.0070707,COUP_DR1_Q6,0.5609286328125
HP_CRANIOSYNOSTOSIS,SET,162,0.16304,0.015247,0.066511,0.0071221,HP_CRANIOSYNOSTOSIS,0.5609286328125
HP_ANOREXIA,SET,107,0.20726,0.015777,0.084689,0.0071999,HP_ANOREXIA,0.5609286328125
KEGG_PYRIMIDINE_METABOLISM,SET,90,0.21044,0.014698,0.08599,0.0072026,KEGG_PYRIMIDINE_METABOLISM,0.5609286328125
HP_CORTICAL_MYOCLONUS,SET,14,0.5393,0.014886,0.22037,0.0072026,HP_CORTICAL_MYOCLONUS,0.5609286328125
GOMF_CYSTEINE_TYPE_ENDOPEPTI...7,SET,18,0.51199,0.016023,0.20922,0.0072048,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.5609286328125
GSE24634_IL4_VS_CTRL_TREATED...3,SET,176,0.1615,0.015736,0.065995,0.0072049,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN,0.5609286328125
HP_GENITAL_NEOPLASM,SET,146,0.1731,0.015375,0.070737,0.007205,HP_GENITAL_NEOPLASM,0.5609286328125
HP_INCREASED_PROPORTION_OF_C...,SET,6,0.81974,0.014816,0.33502,0.0072104,HP_INCREASED_PROPORTION_OF_CD25_MAST_CELLS,0.5609286328125
REACTOME_ADORA2B_MEDIATED_AN...,SET,42,0.33811,0.016153,0.13821,0.0072195,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,0.5609286328125
HP_NEOPLASM_OF_THE_COLON,SET,77,0.22868,0.014778,0.09348,0.0072214,HP_NEOPLASM_OF_THE_COLON,0.5609286328125
REACTOME_INTERLEUKIN_12_SIGN...,SET,43,0.30151,0.014575,0.12328,0.0072305,REACTOME_INTERLEUKIN_12_SIGNALING,0.5609286328125
HP_ABNORMALITY_OF_OCULAR_SMO...,SET,64,0.24451,0.014411,0.10001,0.0072513,HP_ABNORMALITY_OF_OCULAR_SMOOTH_PURSUIT,0.561014938476562
HP_SINGLE_NARIS,SET,19,0.47422,0.015248,0.19411,0.0072855,HP_SINGLE_NARIS,0.561014938476562
HP_INFLAMMATORY_ABNORMALITY_...,SET,188,0.1547,0.015574,0.06335,0.0073071,HP_INFLAMMATORY_ABNORMALITY_OF_THE_EYE,0.561014938476562
FRANCO_BLOOD_SANOFI_PASTEUR_...5,SET,19,0.44969,0.014459,0.18417,0.0073137,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_NEGATIVE,0.561014938476562
CCGNMNNTNACG_UNKNOWN,SET,74,0.22816,0.014456,0.09348,0.0073344,CCGNMNNTNACG_UNKNOWN,0.561014938476562
GSE7218_UNSTIM_VS_ANTIGEN_ST...2,SET,176,0.14978,0.014594,0.061388,0.0073502,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP,0.561014938476562
GOBP_NEURAL_RETINA_DEVELOPME...,SET,79,0.2544,0.016652,0.10427,0.007354,GOBP_NEURAL_RETINA_DEVELOPMENT,0.561014938476562
KEGG_MEDICUS_REFERENCE_REGUL...12,SET,25,0.45866,0.016913,0.18812,0.007387,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL,0.561014938476562
MIR4768_3P,SET,174,0.15186,0.014714,0.062351,0.0074376,MIR4768_3P,0.561014938476562
GSE27241_WT_VS_RORGT_KO_TH17...4,SET,138,0.17181,0.014839,0.070568,0.0074572,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP,0.561014938476562
GOCC_TRANS_GOLGI_NETWORK,SET,228,0.13677,0.015147,0.056194,0.0074736,GOCC_TRANS_GOLGI_NETWORK,0.561014938476562
HP_BRISK_REFLEXES,SET,99,0.1963,0.014376,0.08069,0.0074965,HP_BRISK_REFLEXES,0.561014938476562
GOBP_POSITIVE_REGULATION_OF_...397,SET,7,0.76846,0.015002,0.31589,0.0074979,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.561014938476562
WP_DNA_IRDOUBLE_STRAND_BREAK...,SET,52,0.2615,0.013897,0.10755,0.0075235,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,0.561014938476562
GOBP_AUDITORY_RECEPTOR_CELL_...1,SET,24,0.44296,0.016005,0.18218,0.0075245,GOBP_AUDITORY_RECEPTOR_CELL_DEVELOPMENT,0.561014938476562
NIKOLSKY_BREAST_CANCER_11Q12...,SET,144,0.28717,0.025332,0.11811,0.007527,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,0.561014938476562
GOBP_POSITIVE_REGULATION_OF_...829,SET,28,0.40029,0.01562,0.16468,0.0075388,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.561014938476562
REACTOME_ACTIVATION_OF_ATR_I...,SET,37,0.31847,0.014282,0.13112,0.0075779,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,0.561014938476562
GOBP_REGULATION_OF_HEXOKINAS...,SET,5,1.0008,0.016514,0.41213,0.0075871,GOBP_REGULATION_OF_HEXOKINASE_ACTIVITY,0.561014938476562
RADAEVA_RESPONSE_TO_IFNA1_UP,SET,46,0.31513,0.015754,0.12981,0.007604,RADAEVA_RESPONSE_TO_IFNA1_UP,0.561014938476562
HP_INTERHEMISPHERIC_CYST,SET,5,0.94162,0.015537,0.38797,0.0076166,HP_INTERHEMISPHERIC_CYST,0.561014938476562
HP_MYALGIA,SET,157,0.16521,0.015212,0.068096,0.0076351,HP_MYALGIA,0.561014938476562
GSE12963_ENV_NEF_VS_ENV_NEF_...1,SET,132,0.18,0.015208,0.074211,0.007647,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.561014938476562
AMBROSINI_FLAVOPIRIDOL_TREAT...,SET,99,0.20083,0.014708,0.082833,0.0076685,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,0.561014938476562
WP_NUCLEAR_RECEPTORS_METAPAT...,SET,300,0.12764,0.016182,0.052698,0.007719,WP_NUCLEAR_RECEPTORS_METAPATHWAY,0.561014938476562
GOBP_REGULATION_OF_INTRACELL...5,SET,61,0.2583,0.014864,0.10664,0.0077201,GOBP_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.561014938476562
HP_FOCAL_T2_HYPERINTENSE_THA...,SET,14,0.49462,0.013653,0.20424,0.0077271,HP_FOCAL_T2_HYPERINTENSE_THALAMIC_LESION,0.561014938476562
GOMF_ACTIVIN_RECEPTOR_BINDING,SET,8,0.74067,0.015457,0.30594,0.0077448,GOMF_ACTIVIN_RECEPTOR_BINDING,0.561014938476562
GOBP_RIBOSOME_ASSEMBLY,SET,51,0.27342,0.014391,0.11308,0.0078101,GOBP_RIBOSOME_ASSEMBLY,0.561014938476562
REACTOME_RNA_POLYMERASE_I_TR...3,SET,26,0.35197,0.013236,0.14566,0.0078416,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,0.561014938476562
GOBP_ERYTHROCYTE_DEVELOPMENT,SET,38,0.32867,0.014937,0.13605,0.0078533,GOBP_ERYTHROCYTE_DEVELOPMENT,0.561014938476562
LMO2COM_02,SET,220,0.14349,0.015613,0.0594,0.0078583,LMO2COM_02,0.561014938476562
MIR4732_5P,SET,18,0.46981,0.014703,0.1945,0.0078612,MIR4732_5P,0.561014938476562
GOBP_HAIR_FOLLICLE_PLACODE_F...,SET,4,1.2326,0.018191,0.51043,0.0078779,GOBP_HAIR_FOLLICLE_PLACODE_FORMATION,0.561014938476562
HP_GONADAL_NEOPLASM,SET,100,0.20368,0.014991,0.08435,0.0078793,HP_GONADAL_NEOPLASM,0.561014938476562
WP_DISORDERS_OF_GALACTOSE_ME...,SET,12,0.5714,0.014603,0.23665,0.0078829,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.561014938476562
GOBP_ESTABLISHMENT_OF_SISTER...,SET,7,0.78701,0.015364,0.32608,0.0079044,GOBP_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,0.561014938476562
ROYLANCE_BREAST_CANCER_16Q_C...1,SET,24,0.64092,0.023157,0.26561,0.0079156,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,0.561014938476562
MARIADASON_REGULATED_BY_HIST...1,SET,37,0.34149,0.015315,0.1416,0.0079463,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,0.561014938476562
GSE40273_EOS_KO_VS_WT_TREG_UP,SET,181,0.15066,0.014885,0.062498,0.0079668,GSE40273_EOS_KO_VS_WT_TREG_UP,0.561014938476562
GOBP_REGULATION_OF_ANATOMICA...1,SET,750,0.079769,0.01579,0.033091,0.0079678,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS,0.561014938476562
REACTOME_SIGNALING_BY_RNF43_...,SET,8,0.76815,0.016031,0.31871,0.0079774,REACTOME_SIGNALING_BY_RNF43_MUTANTS,0.561014938476562
GCTNWTTGK_UNKNOWN,SET,279,0.12944,0.015834,0.053709,0.0079827,GCTNWTTGK_UNKNOWN,0.561014938476562
PDGF_ERK_DN.V1_DN,SET,135,0.17554,0.014997,0.07284,0.0079833,PDGF_ERK_DN.V1_DN,0.561014938476562
GAO_LARGE_INTESTINE_24W_C8_G...,SET,38,0.36591,0.01663,0.15185,0.007989,GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL,0.561014938476562
REACTOME_PROCESSING_OF_DNA_D...,SET,57,0.25502,0.014187,0.10583,0.0079895,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,0.561014938476562
GSE9946_IMMATURE_VS_LISTERIA...2,SET,118,0.19056,0.015228,0.079144,0.0080309,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP,0.561014938476562
GOBP_NUCLEUS_LOCALIZATION,SET,31,0.34729,0.014258,0.14424,0.0080313,GOBP_NUCLEUS_LOCALIZATION,0.561014938476562
GATA_Q6,SET,177,0.16388,0.016013,0.068089,0.0080514,GATA_Q6,0.561014938476562
ABRAHAM_ALPC_VS_MULTIPLE_MYE...1,SET,20,0.46492,0.015336,0.19329,0.0080852,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,0.561014938476562
GOBP_RESPONSE_TO_PEPTIDOGLYC...,SET,11,0.61114,0.014954,0.25408,0.0080859,GOBP_RESPONSE_TO_PEPTIDOGLYCAN,0.561014938476562
GOCC_MYOSIN_FILAMENT,SET,24,0.47749,0.017252,0.19853,0.0080887,GOCC_MYOSIN_FILAMENT,0.561014938476562
REACTOME_MRNA_CAPPING,SET,28,0.33996,0.013266,0.14143,0.0081194,REACTOME_MRNA_CAPPING,0.561014938476562
GSE360_T_GONDII_VS_B_MALAYI_...5,SET,181,0.15169,0.014987,0.063124,0.0081343,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN,0.561014938476562
GOBP_NEGATIVE_REGULATION_OF_...320,SET,32,0.36187,0.015094,0.15062,0.0081464,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.561014938476562
GSE32901_NAIVE_VS_TH17_ENRIC...2,SET,137,0.17519,0.015077,0.07293,0.0081552,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP,0.561014938476562
GOMF_5_3_DNA_HELICASE_ACTIVI...,SET,8,0.69478,0.0145,0.28926,0.0081598,GOMF_5_3_DNA_HELICASE_ACTIVITY,0.561014938476562
ODONNELL_TFRC_TARGETS_DN,SET,116,0.1778,0.014088,0.07412,0.0082302,ODONNELL_TFRC_TARGETS_DN,0.561014938476562
GOBP_POSITIVE_REGULATION_OF_...3,SET,57,0.27982,0.015567,0.11667,0.008238,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.561014938476562
HP_SUBACUTE_PROGRESSIVE_VIRA...,SET,9,0.69782,0.015446,0.29096,0.0082403,HP_SUBACUTE_PROGRESSIVE_VIRAL_HEPATITIS,0.561014938476562
GSE22601_IMMATURE_CD4_SINGLE...2,SET,179,0.14504,0.014251,0.060479,0.0082451,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.561014938476562
UBN1_TARGET_GENES,SET,1414,0.056692,0.015115,0.023646,0.0082579,UBN1_TARGET_GENES,0.561014938476562
GSE7460_CTRL_VS_FOXP3_OVEREX...4,SET,181,0.14918,0.014739,0.062225,0.008261,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP,0.561014938476562
PUJANA_BREAST_CANCER_WITH_BR...2,SET,52,0.26328,0.013992,0.10983,0.0082647,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,0.561014938476562
NIKOLSKY_BREAST_CANCER_17Q21...,SET,305,0.20517,0.026223,0.085725,0.008354,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,0.564462479885057
GSE25846_IL10_POS_VS_NEG_CD8...1,SET,176,0.14655,0.014279,0.061259,0.0083785,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN,0.564462479885057
GOBP_POSITIVE_REGULATION_OF_...377,SET,4,1.0453,0.015427,0.43707,0.0083919,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.564462479885057
WP_ENDODERM_DIFFERENTIATION,SET,130,0.18728,0.015703,0.078315,0.0083987,WP_ENDODERM_DIFFERENTIATION,0.564462479885057
ABE_VEGFA_TARGETS,SET,15,0.56759,0.016217,0.23737,0.0084024,ABE_VEGFA_TARGETS,0.564462479885057
MODULE_205,SET,276,0.12578,0.015306,0.052627,0.0084264,MODULE_205,0.564462479885057
GSE23114_PERITONEAL_CAVITY_B...4,SET,164,0.16028,0.01508,0.067109,0.0084676,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP,0.564462479885057
HP_MINIMAL_CHANGE_GLOMERULON...,SET,34,0.36311,0.015611,0.15204,0.008469,HP_MINIMAL_CHANGE_GLOMERULONEPHRITIS,0.564462479885057
GOBP_DETECTION_OF_MUSCLE_STR...,SET,7,0.82486,0.016103,0.34542,0.0084759,GOBP_DETECTION_OF_MUSCLE_STRETCH,0.564462479885057
TESAR_ALK_TARGETS_HUMAN_ES_5...1,SET,5,0.78934,0.013024,0.33056,0.0084779,TESAR_ALK_TARGETS_HUMAN_ES_5D_DN,0.564462479885057
GSE33162_HDAC3_KO_VS_HDAC3_K...1,SET,184,0.15388,0.015327,0.064475,0.0085069,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN,0.56454036
GOBP_CELL_MIGRATION_INVOLVED...1,SET,13,0.54925,0.01461,0.23021,0.008526,GOBP_CELL_MIGRATION_INVOLVED_IN_GASTRULATION,0.56454036
TAKEDA_TARGETS_OF_NUP98_HOXA...1,SET,130,0.19398,0.016265,0.081309,0.0085278,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,0.56454036
GOCC_PRERIBOSOME_SMALL_SUBUN...,SET,14,0.49027,0.013533,0.20557,0.0085455,GOCC_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR,0.564636601711027
MANNO_MIDBRAIN_NEUROTYPES_HE...,SET,803,0.077889,0.015929,0.032694,0.0086056,MANNO_MIDBRAIN_NEUROTYPES_HENDO,0.565803516068053
GOBP_WOUND_HEALING,SET,398,0.107,0.015582,0.044914,0.0086076,GOBP_WOUND_HEALING,0.565803516068053
GSE15624_CTRL_VS_6H_HALOFUGI...1,SET,142,0.16077,0.014084,0.067489,0.008612,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.565803516068053
GSE9239_CTRL_VS_TNF_INHIBITO...1,SET,177,0.1419,0.013866,0.059616,0.0086543,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN,0.566761582568807
BENPORATH_MYC_MAX_TARGETS,SET,687,0.073626,0.013973,0.030958,0.0087027,BENPORATH_MYC_MAX_TARGETS,0.566761582568807
GOBP_PARAXIAL_MESODERM_FORMA...,SET,6,0.93142,0.016835,0.39177,0.0087218,GOBP_PARAXIAL_MESODERM_FORMATION,0.566761582568807
GSE15324_ELF4_KO_VS_WT_NAIVE...1,SET,175,0.15613,0.01517,0.065731,0.0087739,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN,0.566761582568807
GOBP_REGULATION_OF_MESENCHYM...1,SET,32,0.41071,0.017132,0.17295,0.0087854,GOBP_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.566761582568807
GSE3039_ALPHAALPHA_CD8_TCELL...4,SET,180,0.15351,0.015125,0.064649,0.008791,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP,0.566761582568807
GOBP_REGULATION_OF_BODY_FLUI...,SET,351,0.11651,0.015955,0.04907,0.0087927,GOBP_REGULATION_OF_BODY_FLUID_LEVELS,0.566761582568807
GOBP_SPINDLE_ASSEMBLY,SET,119,0.17532,0.014069,0.073854,0.0088051,GOBP_SPINDLE_ASSEMBLY,0.566761582568807
GOCC_SET1C_COMPASS_COMPLEX,SET,14,0.52496,0.014491,0.22121,0.008823,GOCC_SET1C_COMPASS_COMPLEX,0.566761582568807
SIRNA_EIF4GI_DN,SET,84,0.2302,0.015535,0.097011,0.0088289,SIRNA_EIF4GI_DN,0.566761582568807
REACTOME_PKMTS_METHYLATE_HIS...,SET,36,0.32585,0.014415,0.13734,0.0088385,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,0.566761582568807
HP_OLIGOARTHRITIS,SET,12,0.63067,0.016118,0.26586,0.0088461,HP_OLIGOARTHRITIS,0.566761582568807
STONER_ESOPHAGEAL_CARCINOGEN...2,SET,31,0.35041,0.014386,0.14772,0.0088479,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,0.566761582568807
GOBP_REGULATION_OF_MYOTUBE_D...,SET,40,0.34464,0.016069,0.14533,0.0088641,GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.566761582568807
GSE22935_UNSTIM_VS_48H_MBOVI...2,SET,178,0.15353,0.015044,0.064754,0.0088747,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.566761582568807
GOBP_CELL_SURFACE_RECEPTOR_S...2,SET,166,0.1672,0.015826,0.070533,0.0088875,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.566761582568807
HP_OLIGURIA,SET,13,0.58554,0.015575,0.2472,0.0089301,HP_OLIGURIA,0.568435211538462
HP_POIKILODERMA,SET,23,0.38305,0.013549,0.16176,0.0089482,HP_POIKILODERMA,0.568546053016453
MIR147A,SET,57,0.27941,0.015544,0.11807,0.0089852,MIR147A,0.569735555454545
GOBP_REGULATION_OF_FIBRINOLY...,SET,18,0.48104,0.015055,0.20337,0.0090124,GOBP_REGULATION_OF_FIBRINOLYSIS,0.569735555454545
GOBP_MACROPHAGE_PROLIFERATION,SET,10,0.71475,0.016676,0.3022,0.0090161,GOBP_MACROPHAGE_PROLIFERATION,0.569735555454545
GTGACTT_MIR224,SET,139,0.16879,0.014631,0.071427,0.0090666,GTGACTT_MIR224,0.57083519133574
CROONQUIST_NRAS_VS_STROMAL_S...1,SET,86,0.22459,0.015335,0.095081,0.0090904,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,0.57083519133574
HP_GANGRENE,SET,52,0.29334,0.015589,0.1242,0.009098,HP_GANGRENE,0.57083519133574
USF2_Q6,SET,246,0.13429,0.01544,0.056859,0.0090992,USF2_Q6,0.57083519133574
HP_CENTRAL_HYPOTHYROIDISM,SET,63,0.26749,0.015642,0.11336,0.0091487,HP_CENTRAL_HYPOTHYROIDISM,0.572463607014389
HP_ABNORMAL_BRAIN_FDG_POSITR...,SET,22,0.42141,0.014579,0.17861,0.0091581,HP_ABNORMAL_BRAIN_FDG_POSITRON_EMISSION_TOMOGRAPHY,0.572463607014389
GSE13485_CTRL_VS_DAY1_YF17D_...2,SET,179,0.13535,0.013299,0.057384,0.0091771,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP,0.572621383303411
PID_FGF_PATHWAY,SET,54,0.28127,0.015232,0.11929,0.0091962,PID_FGF_PATHWAY,0.572784822580645
BLANCO_MELO_COVID19_SARS_COV...2,SET,68,0.26249,0.015945,0.11138,0.0092264,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,0.573637803220036
ALK_DN.V1_DN,SET,129,0.18502,0.015454,0.078557,0.0092619,ALK_DN.V1_DN,0.573975512131716
MORF_UBE2A,SET,39,0.30987,0.014266,0.1316,0.0092767,MORF_UBE2A,0.573975512131716
REACTOME_SYNTHESIS_OF_PC,SET,27,0.3775,0.014466,0.16043,0.0093135,REACTOME_SYNTHESIS_OF_PC,0.573975512131716
DESCARTES_MAIN_FETAL_CHROMAF...,SET,15,0.4811,0.013746,0.20449,0.0093246,DESCARTES_MAIN_FETAL_CHROMAFFIN_CELLS,0.573975512131716
ATF4_Q2,SET,226,0.13398,0.014773,0.057004,0.0093822,ATF4_Q2,0.573975512131716
GOBP_RESPONSE_TO_HEPATOCYTE_...,SET,17,0.54386,0.016542,0.23147,0.0094009,GOBP_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR,0.573975512131716
GSE24574_BCL6_LOW_TFH_VS_NAI...1,SET,171,0.16062,0.015429,0.068366,0.0094063,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN,0.573975512131716
GOMF_TRANSCRIPTION_REGULATOR...1,SET,5,1.0184,0.016804,0.43354,0.0094148,GOMF_TRANSCRIPTION_REGULATOR_ACTIVATOR_ACTIVITY,0.573975512131716
OISHI_CHOLANGIOMA_STEM_CELL_...1,SET,253,0.13391,0.015611,0.057016,0.0094261,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,0.573975512131716
NELSON_RESPONSE_TO_ANDROGEN_...1,SET,17,0.55923,0.017009,0.23822,0.0094552,NELSON_RESPONSE_TO_ANDROGEN_DN,0.573975512131716
DESCARTES_MAIN_FETAL_HEMATOP...,SET,38,0.31003,0.01409,0.13209,0.0094625,DESCARTES_MAIN_FETAL_HEMATOPOIETIC_STEM_CELLS,0.573975512131716
MIR1184,SET,151,0.15949,0.014404,0.06796,0.0094721,MIR1184,0.573975512131716
GSE27786_LSK_VS_NEUTROPHIL_DN,SET,180,0.14703,0.014486,0.062648,0.0094721,GSE27786_LSK_VS_NEUTROPHIL_DN,0.573975512131716
HP_RECURRENT_CORNEAL_EROSIONS,SET,11,0.63561,0.015553,0.27093,0.0094928,HP_RECURRENT_CORNEAL_EROSIONS,0.573975512131716
MIR765,SET,256,0.13109,0.015371,0.05589,0.0095075,MIR765,0.573975512131716
HP_PROGRESSIVE_LANGUAGE_DETE...,SET,11,0.57476,0.014064,0.2451,0.0095184,HP_PROGRESSIVE_LANGUAGE_DETERIORATION,0.573975512131716
GSE12845_IGD_POS_BLOOD_VS_DA...2,SET,166,0.15188,0.014376,0.064766,0.0095184,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.573975512131716
GOMF_VIRION_BINDING,SET,9,0.70122,0.015521,0.29908,0.0095291,GOMF_VIRION_BINDING,0.573975512131716
GOMF_AMYLASE_ACTIVITY,SET,2,1.4966,0.015619,0.63852,0.0095479,GOMF_AMYLASE_ACTIVITY,0.574112914359862
GSE37532_VISCERAL_ADIPOSE_TI...8,SET,155,0.1562,0.014291,0.066672,0.0095751,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP,0.574754059585492
MIR6740_3P,SET,146,0.1672,0.014851,0.071397,0.0095991,MIR6740_3P,0.575201242241379
MIR6883_3P,SET,50,0.29366,0.015304,0.12552,0.0096602,MIR6883_3P,0.577639881355932
HE_LIM_SUN_FETAL_LUNG_C4_CYC...1,SET,594,0.078121,0.013822,0.033414,0.0096997,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL,0.577639881355932
HP_ABSENCE_OF_SUBCUTANEOUS_F...,SET,13,0.49414,0.013144,0.21135,0.0097002,HP_ABSENCE_OF_SUBCUTANEOUS_FAT,0.577639881355932
LI_PBMC_MENOMUNE_A_C_Y_W_135...1,SET,16,0.54706,0.016143,0.23413,0.0097373,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN,0.577639881355932
GSE22601_IMMATURE_CD4_SINGLE...4,SET,184,0.15226,0.015166,0.06519,0.0097622,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.577639881355932
REACTOME_RHOC_GTPASE_CYCLE,SET,68,0.25494,0.015486,0.1092,0.0097898,REACTOME_RHOC_GTPASE_CYCLE,0.577639881355932
chr11q23,SET,107,0.37885,0.028837,0.16229,0.0097917,chr11q23,0.577639881355932
KEGG_MEDICUS_VARIANT_LMO2_RE...1,SET,5,0.93912,0.015496,0.40237,0.0098037,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_ACTIVATION,0.577639881355932
WP_MITOCHONDRIAL_LONG_CHAIN_...,SET,16,0.50329,0.014851,0.21563,0.0098037,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,0.577639881355932
GOBP_STEROID_HORMONE_MEDIATE...,SET,122,0.17948,0.014582,0.0769,0.009806,GOBP_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.577639881355932
GSE20198_IL12_VS_IFNA_TREATE...2,SET,181,0.14765,0.014587,0.063304,0.0098462,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.578566136287625
DURANTE_ADULT_OLFACTORY_NEUR...14,SET,105,0.21386,0.016126,0.091724,0.0098677,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_ENSHEATHING_GLIA,0.578566136287625
REACTOME_INDUCTION_OF_CELL_C...,SET,12,0.62192,0.015895,0.26684,0.009891,REACTOME_INDUCTION_OF_CELL_CELL_FUSION,0.578566136287625
GOBP_PEXOPHAGY,SET,5,0.86599,0.014289,0.37176,0.0099237,GOBP_PEXOPHAGY,0.578566136287625
GOBP_PLASMINOGEN_ACTIVATION,SET,24,0.4399,0.015894,0.18888,0.009934,GOBP_PLASMINOGEN_ACTIVATION,0.578566136287625
BIOCARTA_RANBP2_PATHWAY,SET,10,0.62589,0.014603,0.26874,0.009936,BIOCARTA_RANBP2_PATHWAY,0.578566136287625
GOBP_REGULATION_OF_MEMBRANE_...2,SET,5,1.0269,0.016944,0.44104,0.0099524,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.578566136287625
GOMF_PHOSPHATASE_REGULATOR_A...,SET,92,0.2016,0.014235,0.086589,0.0099549,GOMF_PHOSPHATASE_REGULATOR_ACTIVITY,0.578566136287625
FISCHER_DREAM_TARGETS,SET,860,0.065853,0.013915,0.028295,0.0099782,FISCHER_DREAM_TARGETS,0.578952155258765
GOCC_SMALL_NUCLEAR_RIBONUCLE...,SET,70,0.19928,0.012281,0.085753,0.010072,GOCC_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX,0.58194551980198
GOBP_INTERLEUKIN_21_PRODUCTI...,SET,2,1.5965,0.016662,0.68732,0.0101,GOBP_INTERLEUKIN_21_PRODUCTION,0.58194551980198
DESCARTES_FETAL_STOMACH_LYMP...2,SET,68,0.24812,0.015072,0.10684,0.010109,DESCARTES_FETAL_STOMACH_LYMPHOID_CELLS,0.58194551980198
NAKAJIMA_MAST_CELL,SET,40,0.33284,0.015519,0.14332,0.010113,NAKAJIMA_MAST_CELL,0.58194551980198
MENON_FETAL_KIDNEY_5_PROXIMA...,SET,88,0.22069,0.015242,0.095036,0.010118,MENON_FETAL_KIDNEY_5_PROXIMAL_TUBULE_CELLS,0.58194551980198
GOBP_ACTIVIN_RECEPTOR_SIGNAL...,SET,44,0.33132,0.0162,0.14271,0.010134,GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.58194551980198
GSE4811_CLASSSICALY_ACTIVATE...1,SET,176,0.15331,0.014939,0.066053,0.010147,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN,0.58194551980198
GOBP_QUATERNARY_AMMONIUM_GRO...,SET,16,0.55369,0.016338,0.23874,0.010196,GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT,0.582061893203883
GOBP_NEGATIVE_REGULATION_OF_...483,SET,39,0.31483,0.014495,0.13575,0.0102,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.582061893203883
GGGTGGRR_PAX4_03,SET,1156,0.060781,0.014763,0.026217,0.01022,GGGTGGRR_PAX4_03,0.582061893203883
MIR484,SET,81,0.2216,0.014686,0.095615,0.010242,MIR484,0.582061893203883
GOBP_MRNA_CIS_SPLICING_VIA_S...,SET,26,0.33627,0.012645,0.14513,0.010256,GOBP_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.582061893203883
HP_PALMOPLANTAR_CUTIS_LAXA,SET,8,0.69684,0.014543,0.30078,0.010264,HP_PALMOPLANTAR_CUTIS_LAXA,0.582061893203883
HP_MYOCLONIC_SPASMS,SET,29,0.36242,0.014393,0.1565,0.010288,HP_MYOCLONIC_SPASMS,0.582061893203883
HP_SACCADIC_SMOOTH_PURSUIT,SET,21,0.41688,0.014091,0.18009,0.010318,HP_SACCADIC_SMOOTH_PURSUIT,0.582061893203883
HP_ADENOMATOUS_COLONIC_POLYP...,SET,17,0.42733,0.012997,0.18467,0.010338,HP_ADENOMATOUS_COLONIC_POLYPOSIS,0.582061893203883
GOBP_NEGATIVE_REGULATION_OF_...281,SET,14,0.65441,0.018064,0.28282,0.010344,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.582061893203883
MIR6813_3P,SET,30,0.35598,0.014378,0.15386,0.01035,MIR6813_3P,0.582061893203883
GSE25677_MPL_VS_R848_STIM_BC...2,SET,161,0.16444,0.015331,0.071077,0.01035,GSE25677_MPL_VS_R848_STIM_BCELL_UP,0.582061893203883
ZERBINI_RESPONSE_TO_SULINDAC...2,SET,9,0.77454,0.017144,0.33505,0.010403,ZERBINI_RESPONSE_TO_SULINDAC_UP,0.582159976303318
MIR4516,SET,271,0.12026,0.014502,0.052023,0.010405,MIR4516,0.582159976303318
GSE1925_CTRL_VS_IFNG_PRIMED_...6,SET,189,0.14618,0.014755,0.063276,0.010443,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP,0.582159976303318
GOCC_SEH1_ASSOCIATED_COMPLEX,SET,12,0.54072,0.013819,0.23406,0.010444,GOCC_SEH1_ASSOCIATED_COMPLEX,0.582159976303318
GOBP_POSITIVE_REGULATION_OF_...485,SET,19,0.45277,0.014558,0.19603,0.010459,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.582159976303318
HP_EEG_WITH_GENERALIZED_SLOW...2,SET,9,0.60993,0.013501,0.26413,0.010472,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY_GRADE_4,0.582159976303318
GOBP_CILIARY_BASAL_BODY_ORGA...,SET,5,0.86994,0.014354,0.37689,0.0105,GOBP_CILIARY_BASAL_BODY_ORGANIZATION,0.582159976303318
GOMF_SYNDECAN_BINDING,SET,5,1.0106,0.016675,0.43798,0.010522,GOMF_SYNDECAN_BINDING,0.582159976303318
MORF_ESR1,SET,159,0.15417,0.014285,0.066826,0.01053,MORF_ESR1,0.582159976303318
HP_ABDOMINAL_SITUS_AMBIGUUS,SET,4,0.98984,0.014609,0.42903,0.01053,HP_ABDOMINAL_SITUS_AMBIGUUS,0.582159976303318
GSE12392_CD8A_POS_VS_NEG_SPL...1,SET,185,0.14131,0.014113,0.061267,0.010549,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN,0.582159976303318
HP_ABNORMALITY_OF_KREBS_CYCL...,SET,8,0.72707,0.015174,0.31543,0.010589,HP_ABNORMALITY_OF_KREBS_CYCLE_METABOLISM,0.582159976303318
GOBP_REVERSE_CHOLESTEROL_TRA...,SET,15,0.55823,0.015949,0.24222,0.010599,GOBP_REVERSE_CHOLESTEROL_TRANSPORT,0.582159976303318
GOBP_POSITIVE_REGULATION_OF_...617,SET,39,0.31716,0.014602,0.13762,0.010601,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.582159976303318
GOMF_AMINO_ACID_PROTON_SYMPO...,SET,6,0.91633,0.016562,0.39762,0.010603,GOMF_AMINO_ACID_PROTON_SYMPORTER_ACTIVITY,0.582159976303318
MIR214_3P,SET,222,0.12688,0.013867,0.055102,0.010657,MIR214_3P,0.583971159874608
GOBP_MEMBRANE_RAFT_ORGANIZAT...,SET,24,0.42207,0.01525,0.18338,0.010683,GOBP_MEMBRANE_RAFT_ORGANIZATION,0.583971159874608
MIR12116,SET,48,0.26366,0.013464,0.11459,0.010706,MIR12116,0.583971159874608
GSE2770_UNTREATED_VS_ACT_CD4...2,SET,180,0.15135,0.014912,0.065788,0.010716,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP,0.583971159874608
HAHTOLA_CTCL_CUTANEOUS,SET,21,0.40296,0.01362,0.17517,0.01072,HAHTOLA_CTCL_CUTANEOUS,0.583971159874608
GOBP_PROXIMAL_DISTAL_PATTERN...1,SET,34,0.37764,0.016236,0.16427,0.010762,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION,0.584094636363636
AP2_Q3,SET,230,0.12773,0.014207,0.055604,0.010809,AP2_Q3,0.584094636363636
GOMF_INTERLEUKIN_17_RECEPTOR...,SET,8,0.74341,0.015515,0.32366,0.010819,GOMF_INTERLEUKIN_17_RECEPTOR_ACTIVITY,0.584094636363636
GEORGES_CELL_CYCLE_MIR192_TA...,SET,58,0.24369,0.013675,0.10611,0.010829,GEORGES_CELL_CYCLE_MIR192_TARGETS,0.584094636363636
GSE7509_UNSTIM_VS_TNFA_IL1B_...2,SET,175,0.14267,0.013863,0.06216,0.010866,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,0.584094636363636
MIR3938,SET,68,0.22766,0.013829,0.099198,0.010872,MIR3938,0.584094636363636
GOBP_PUTRESCINE_BIOSYNTHETIC...,SET,5,0.74429,0.012281,0.32445,0.0109,GOBP_PUTRESCINE_BIOSYNTHETIC_PROCESS,0.584094636363636
KEGG_MEDICUS_REFERENCE_HOMOL...2,SET,12,0.53621,0.013704,0.23378,0.010911,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR,0.584094636363636
GOCC_INNER_KINETOCHORE,SET,14,0.47065,0.012992,0.20524,0.010924,GOCC_INNER_KINETOCHORE,0.584094636363636
GOBP_REGULATION_OF_LAMELLIPO...2,SET,11,0.58606,0.014341,0.2556,0.010933,GOBP_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.584094636363636
GOBP_RESPONSE_TO_FRUCTOSE,SET,10,0.5237,0.012219,0.22848,0.010955,GOBP_RESPONSE_TO_FRUCTOSE,0.584094636363636
WP_PRIMARY_OVARIAN_INSUFFICI...,SET,159,0.14938,0.013841,0.065172,0.010957,WP_PRIMARY_OVARIAN_INSUFFICIENCY,0.584094636363636
HP_WEIGHT_LOSS,SET,351,0.10631,0.014558,0.04639,0.01097,HP_WEIGHT_LOSS,0.584094636363636
MORF_PPP5C,SET,87,0.19251,0.013221,0.084031,0.010989,MORF_PPP5C,0.584094636363636
GOBP_HETEROPHILIC_CELL_CELL_...,SET,45,0.33388,0.016509,0.14579,0.011012,GOBP_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.584094636363636
HP_HYPERMETRIC_SACCADES,SET,11,0.54888,0.013431,0.23972,0.011027,HP_HYPERMETRIC_SACCADES,0.584094636363636
GOBP_HAIR_CELL_DIFFERENTIATI...,SET,50,0.29244,0.015241,0.12775,0.011042,GOBP_HAIR_CELL_DIFFERENTIATION,0.584094636363636
HP_PREMATURE_GRAYING_OF_HAIR,SET,46,0.27873,0.013934,0.12179,0.011057,HP_PREMATURE_GRAYING_OF_HAIR,0.584094636363636
GOCC_SM_LIKE_PROTEIN_FAMILY_...,SET,77,0.18843,0.012177,0.082345,0.011066,GOCC_SM_LIKE_PROTEIN_FAMILY_COMPLEX,0.584094636363636
ZHONG_PFC_C8_ORG_PROLIFERATI...,SET,57,0.24536,0.01365,0.10724,0.011074,ZHONG_PFC_C8_ORG_PROLIFERATING,0.584094636363636
GSE16522_ANTI_CD3CD28_STIM_V...3,SET,179,0.143,0.014051,0.062503,0.011076,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN,0.584094636363636
chr6q21,SET,46,0.50536,0.025264,0.22093,0.011092,chr6q21,0.584094636363636
HP_TEMPORAL_CORTICAL_ATROPHY,SET,17,0.48018,0.014605,0.20999,0.011112,HP_TEMPORAL_CORTICAL_ATROPHY,0.584262571860817
GOBP_NEGATIVE_REGULATION_OF_...388,SET,7,0.84958,0.016586,0.37189,0.011178,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.585415929535232
MYLLYKANGAS_AMPLIFICATION_HO...7,SET,6,0.75208,0.013594,0.32922,0.011179,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21,0.585415929535232
GOBP_REGULATION_OF_CENTROMER...2,SET,4,0.99297,0.014655,0.43481,0.0112,GOBP_REGULATION_OF_CENTROMERIC_SISTER_CHROMATID_COHESION,0.585415929535232
HP_ABSENT_EARLOBE,SET,20,0.42147,0.013903,0.18463,0.011228,HP_ABSENT_EARLOBE,0.585415929535232
GOBP_HEMOSTASIS,SET,220,0.14023,0.015258,0.061434,0.011233,GOBP_HEMOSTASIS,0.585415929535232
CARDOSO_RESPONSE_TO_GAMMA_RA...,SET,11,0.51465,0.012593,0.22547,0.011235,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,0.585415929535232
WP_INTERFERON_TYPE_I_SIGNALI...,SET,51,0.27498,0.014472,0.12055,0.011278,WP_INTERFERON_TYPE_I_SIGNALING,0.586776781437126
REACTOME_DISSOLUTION_OF_FIBR...,SET,13,0.59258,0.015763,0.25994,0.01132,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,0.588081614349776
GOMF_CHROMATIN_INSULATOR_SEQ...,SET,4,0.82305,0.012147,0.3615,0.011406,GOMF_CHROMATIN_INSULATOR_SEQUENCE_BINDING,0.590835
LAKE_ADULT_KIDNEY_C2_PODOCYT...,SET,192,0.15031,0.015291,0.066024,0.01141,LAKE_ADULT_KIDNEY_C2_PODOCYTES,0.590835
MARTENS_BOUND_BY_PML_RARA_FU...,SET,410,0.096899,0.014318,0.042571,0.011424,MARTENS_BOUND_BY_PML_RARA_FUSION,0.590835
GSE24726_WT_VS_E2_2_KO_PDC_D...3,SET,177,0.13873,0.013556,0.060975,0.011452,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP,0.591033034188034
GOBP_VASCULATURE_DEVELOPMENT,SET,690,0.079293,0.01508,0.034861,0.011472,GOBP_VASCULATURE_DEVELOPMENT,0.591033034188034
HP_CONGENITAL_HYPOPLASTIC_AN...,SET,4,0.89198,0.013164,0.39228,0.011494,HP_CONGENITAL_HYPOPLASTIC_ANEMIA,0.591033034188034
ARGGGTTAA_UNKNOWN,SET,110,0.19748,0.01524,0.086853,0.011497,ARGGGTTAA_UNKNOWN,0.591033034188034
GOBP_THALAMUS_DEVELOPMENT,SET,10,0.65424,0.015265,0.28784,0.01152,GOBP_THALAMUS_DEVELOPMENT,0.591033034188034
HP_MEDIAN_CLEFT_UPPER_LIP,SET,32,0.33792,0.014095,0.14874,0.011552,HP_MEDIAN_CLEFT_UPPER_LIP,0.591033034188034
GOBP_PROTEIN_AUTOPROCESSING,SET,26,0.3663,0.013775,0.16131,0.011587,GOBP_PROTEIN_AUTOPROCESSING,0.591033034188034
REACTOME_SPERM_MOTILITY_AND_...,SET,9,0.59081,0.013078,0.26029,0.011616,REACTOME_SPERM_MOTILITY_AND_TAXES,0.591033034188034
GSE18791_CTRL_VS_NEWCASTLE_V...19,SET,178,0.15131,0.014826,0.066663,0.011616,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN,0.591033034188034
GOBP_VESICLE_TRANSPORT_ALONG...1,SET,8,0.67623,0.014113,0.29793,0.011617,GOBP_VESICLE_TRANSPORT_ALONG_ACTIN_FILAMENT,0.591033034188034
WP_DOPAMINERGIC_NEUROGENESIS,SET,28,0.41834,0.016324,0.18451,0.011693,WP_DOPAMINERGIC_NEUROGENESIS,0.591033034188034
GOBP_NEGATIVE_REGULATION_OF_...588,SET,24,0.40135,0.014501,0.17703,0.011695,GOBP_NEGATIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.591033034188034
HP_CORONAL_CRANIOSYNOSTOSIS,SET,26,0.35215,0.013243,0.15536,0.011712,HP_CORONAL_CRANIOSYNOSTOSIS,0.591033034188034
GOCC_9PLUS0_MOTILE_CILIUM,SET,4,1.1429,0.016868,0.50436,0.011728,GOCC_9PLUS0_MOTILE_CILIUM,0.591033034188034
GSE7348_UNSTIM_VS_LPS_STIM_M...1,SET,157,0.16547,0.015236,0.073054,0.011763,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.591033034188034
GOBP_ESTABLISHMENT_OF_LEFT_R...,SET,5,0.92392,0.015245,0.40793,0.011765,GOBP_ESTABLISHMENT_OF_LEFT_RIGHT_ASYMMETRY,0.591033034188034
GSE22045_TREG_VS_TCONV_UP,SET,153,0.15848,0.014406,0.069971,0.011766,GSE22045_TREG_VS_TCONV_UP,0.591033034188034
GOBP_MACROMOLECULE_DEPALMITO...,SET,14,0.47929,0.01323,0.21172,0.011801,GOBP_MACROMOLECULE_DEPALMITOYLATION,0.591033034188034
GOMF_PALMITOYL_HYDROLASE_ACT...,SET,14,0.47929,0.01323,0.21172,0.011801,GOMF_PALMITOYL_HYDROLASE_ACTIVITY,0.591033034188034
GOBP_POSITIVE_REGULATION_OF_...212,SET,5,0.86839,0.014329,0.38363,0.011805,GOBP_POSITIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.591033034188034
KEGG_RNA_POLYMERASE,SET,24,0.357,0.012899,0.15775,0.011823,KEGG_RNA_POLYMERASE,0.591033034188034
MIR4735_3P,SET,107,0.18355,0.013971,0.081119,0.011832,MIR4735_3P,0.591033034188034
HP_VASCULAR_GRANULAR_OSMIOPH...,SET,12,0.52434,0.013401,0.23176,0.011842,HP_VASCULAR_GRANULAR_OSMIOPHILIC_MATERIAL_DEPOSITION,0.591033034188034
LI_PBMC_ZOSTAVAX_AGE_25_40_A...1,SET,7,0.68166,0.013308,0.30137,0.011858,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_1DY_UP,0.591033034188034
KEGG_MEDICUS_REFERENCE_REGUL...5,SET,6,0.90066,0.016279,0.39829,0.011876,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI,0.591033034188034
GOBP_ADHERENS_JUNCTION_ASSEM...,SET,13,0.5352,0.014236,0.2367,0.011883,GOBP_ADHERENS_JUNCTION_ASSEMBLY,0.591033034188034
GSE21670_STAT3_KO_VS_WT_CD4_...1,SET,187,0.14819,0.014879,0.065555,0.0119,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN,0.591033034188034
GOMF_RNA_POLYMERASE_I_ACTIVI...,SET,9,0.57518,0.012732,0.25447,0.011907,GOMF_RNA_POLYMERASE_I_ACTIVITY,0.591033034188034
GSE2706_R848_VS_R848_AND_LPS...2,SET,148,0.15165,0.013561,0.067119,0.011934,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP,0.591033034188034
BYSTRYKH_HEMATOPOIESIS_STEM_...8,SET,7,0.84721,0.016539,0.37498,0.011938,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1,0.591033034188034
ZHOU_PANCREATIC_BETA_CELL,SET,11,0.67262,0.016459,0.29782,0.011963,ZHOU_PANCREATIC_BETA_CELL,0.591428257467994
MODULE_368,SET,17,0.48427,0.014729,0.21455,0.012004,MODULE_368,0.592160402542373
ZHAN_VARIABLE_EARLY_DIFFEREN...2,SET,17,0.47693,0.014506,0.21132,0.012014,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,0.592160402542373
REACTOME_RNA_POLYMERASE_I_PR...,SET,27,0.31973,0.012252,0.14174,0.012047,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,0.592160402542373
MIR569,SET,69,0.23486,0.014371,0.10412,0.012055,MIR569,0.592160402542373
GOBP_NON_MEMBRANE_BOUNDED_OR...,SET,385,0.094659,0.013563,0.041972,0.012063,GOBP_NON_MEMBRANE_BOUNDED_ORGANELLE_ASSEMBLY,0.592160402542373
GSE14415_ACT_TCONV_VS_ACT_NA...2,SET,158,0.15566,0.014378,0.069046,0.01209,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP,0.592648730606488
PUJANA_BRCA1_PCC_NETWORK,SET,1455,0.050501,0.013642,0.022435,0.0122,PUJANA_BRCA1_PCC_NETWORK,0.596233834951456
GOCC_MHC_CLASS_I_PROTEIN_COM...,SET,9,0.71395,0.015803,0.31731,0.01223,GOCC_MHC_CLASS_I_PROTEIN_COMPLEX,0.596233834951456
GOCC_RNA_POLYMERASE_II_CORE_...,SET,13,0.50013,0.013303,0.22237,0.01226,GOCC_RNA_POLYMERASE_II_CORE_COMPLEX,0.596233834951456
REACTOME_PHOSPHOLIPASE_C_MED...3,SET,14,0.55257,0.015253,0.24571,0.012265,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,0.596233834951456
HERNANDEZ_ABERRANT_MITOSIS_B...1,SET,18,0.49022,0.015342,0.21801,0.012273,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,0.596233834951456
GAUTAM_EYE_IRIS_CILIARY_BODY...15,SET,83,0.20545,0.013782,0.091418,0.012315,GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS,0.596233834951456
GSE17721_CTRL_VS_GARDIQUIMOD...10,SET,171,0.14484,0.013913,0.064452,0.012317,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP,0.596233834951456
GHANDHI_BYSTANDER_IRRADIATIO...1,SET,11,0.70073,0.017147,0.31194,0.012347,GHANDHI_BYSTANDER_IRRADIATION_DN,0.596233834951456
NIKOLSKY_MUTATED_AND_AMPLIFI...,SET,87,0.20451,0.014045,0.091056,0.012358,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,0.596233834951456
GOCC_BRCA1_A_COMPLEX,SET,5,0.9196,0.015174,0.40945,0.01236,GOCC_BRCA1_A_COMPLEX,0.596233834951456
GOCC_COPI_VESICLE_COAT,SET,12,0.46215,0.011811,0.20577,0.01236,GOCC_COPI_VESICLE_COAT,0.596233834951456
GOBP_ORGAN_INDUCTION,SET,20,0.47814,0.015772,0.21291,0.012369,GOBP_ORGAN_INDUCTION,0.596233834951456
SREBP1_01,SET,140,0.16023,0.013938,0.071419,0.012437,SREBP1_01,0.5963958
GOBP_REGULATION_OF_PLATELET_...5,SET,22,0.41368,0.014311,0.1844,0.012441,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.5963958
GOBP_REGULATION_OF_LEUKOCYTE...9,SET,245,0.13163,0.015103,0.058687,0.012459,GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.5963958
HP_LARGE_CENTRAL_VISUAL_FIEL...,SET,13,0.5175,0.013765,0.23076,0.012468,HP_LARGE_CENTRAL_VISUAL_FIELD_DEFECT,0.5963958
REACTOME_SIGNALING_BY_BMP,SET,28,0.37657,0.014695,0.16793,0.012471,REACTOME_SIGNALING_BY_BMP,0.5963958
GOBP_REGULATION_OF_GLUCOKINA...,SET,4,1.0141,0.014967,0.45237,0.012492,GOBP_REGULATION_OF_GLUCOKINASE_ACTIVITY,0.5963958
YAO_TEMPORAL_RESPONSE_TO_PRO...8,SET,28,0.36327,0.014176,0.16211,0.012525,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,0.5963958
MIR4784,SET,138,0.16362,0.014132,0.073043,0.01255,MIR4784,0.5963958
GOBP_POSITIVE_REGULATION_OF_...241,SET,4,1.0896,0.01608,0.4865,0.012566,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN,0.5963958
REACTOME_HIV_TRANSCRIPTION_I...,SET,43,0.25745,0.012445,0.11497,0.012573,REACTOME_HIV_TRANSCRIPTION_INITIATION,0.5963958
GOBP_CELLULAR_RESPONSE_TO_VA...,SET,61,0.26697,0.015363,0.11934,0.012649,GOBP_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.5963958
SHEDDEN_LUNG_CANCER_POOR_SUR...,SET,416,0.092754,0.013803,0.041465,0.012652,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,0.5963958
GAO_LARGE_INTESTINE_24W_C7_G...,SET,16,0.49086,0.014484,0.21946,0.01266,GAO_LARGE_INTESTINE_24W_C7_GOBLET_PROGENITOR,0.5963958
GSE29949_MICROGLIA_BRAIN_VS_...3,SET,182,0.14791,0.014653,0.066153,0.012687,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.5963958
STONER_ESOPHAGEAL_CARCINOGEN...1,SET,6,0.74853,0.013529,0.33482,0.012695,STONER_ESOPHAGEAL_CARCINOGENESIS_DN,0.5963958
GSE10325_LUPUS_CD4_TCELL_VS_...2,SET,175,0.15079,0.014651,0.067448,0.012695,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP,0.5963958
ER_Q6_01,SET,239,0.12391,0.014045,0.055425,0.012697,ER_Q6_01,0.5963958
GOBP_NEUROBLAST_DIFFERENTIAT...,SET,6,0.99206,0.017931,0.44391,0.012721,GOBP_NEUROBLAST_DIFFERENTIATION,0.5963958
OHM_EMBRYONIC_CARCINOMA_UP,SET,6,0.79686,0.014403,0.35663,0.012734,OHM_EMBRYONIC_CARCINOMA_UP,0.5963958
MIR218_2_3P,SET,46,0.27947,0.013971,0.1251,0.012749,MIR218_2_3P,0.5963958
HE_LIM_SUN_FETAL_LUNG_C3_CYC...,SET,388,0.094152,0.013542,0.042156,0.012767,HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST,0.5963958
SHEPARD_BMYB_TARGETS,SET,71,0.22511,0.013971,0.10081,0.012781,SHEPARD_BMYB_TARGETS,0.5963958
WNT_SIGNALING,SET,82,0.22302,0.014871,0.099896,0.012796,WNT_SIGNALING,0.5963958
MIR7155_5P,SET,86,0.19483,0.013303,0.087308,0.012828,MIR7155_5P,0.5963958
GOBP_DOPAMINERGIC_NEURON_DIF...,SET,37,0.36298,0.016278,0.16272,0.012859,GOBP_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.5963958
GOBP_FEMALE_GENITALIA_DEVELO...,SET,19,0.47619,0.015311,0.21363,0.012913,GOBP_FEMALE_GENITALIA_DEVELOPMENT,0.5963958
GOCC_NEUROMUSCULAR_JUNCTION,SET,70,0.22698,0.013989,0.10185,0.012925,GOCC_NEUROMUSCULAR_JUNCTION,0.5963958
REACTOME_TRANSCRIPTIONAL_REG...9,SET,337,0.099722,0.013386,0.044749,0.012931,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,0.5963958
ZIC2_01,SET,228,0.12815,0.014191,0.057529,0.012963,ZIC2_01,0.5963958
KEGG_MEDICUS_REFERENCE_CDC25...,SET,9,0.5369,0.011884,0.24106,0.012972,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M,0.5963958
GOBP_NEGATIVE_REGULATION_OF_...344,SET,88,0.22438,0.015497,0.10076,0.012983,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.5963958
GSE11864_UNTREATED_VS_CSF1_I...6,SET,166,0.14398,0.013629,0.064681,0.013012,GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP,0.5963958
PID_HNF3B_PATHWAY,SET,43,0.31344,0.015151,0.14093,0.013075,PID_HNF3B_PATHWAY,0.5963958
GOBP_SPLICEOSOMAL_SNRNP_ASSE...,SET,36,0.26776,0.011845,0.12041,0.013087,GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY,0.5963958
JEON_SMAD6_TARGETS_UP,SET,23,0.45892,0.016233,0.20639,0.013096,JEON_SMAD6_TARGETS_UP,0.5963958
GSE27786_CD4_TCELL_VS_MONO_M...1,SET,180,0.13915,0.01371,0.062591,0.013108,GSE27786_CD4_TCELL_VS_MONO_MAC_DN,0.5963958
HP_PECTORAL_MUSCLE_HYPOPLASI...,SET,7,0.7399,0.014444,0.33287,0.013121,HP_PECTORAL_MUSCLE_HYPOPLASIA_APLASIA,0.5963958
MODULE_103,SET,10,0.51805,0.012087,0.23308,0.013128,MODULE_103,0.5963958
WP_DNA_IRDAMAGE_AND_CELLULAR...,SET,74,0.19622,0.012432,0.088351,0.013184,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,0.5963958
MIR4684_3P,SET,114,0.18882,0.014832,0.085029,0.013194,MIR4684_3P,0.5963958
GOMF_UBIQUITIN_UBIQUITIN_LIG...,SET,13,0.46062,0.012252,0.20744,0.013199,GOMF_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY,0.5963958
MORF_RAGE,SET,136,0.16299,0.013976,0.073414,0.01321,MORF_RAGE,0.5963958
CTTTAAR_UNKNOWN,SET,878,0.067589,0.014423,0.030447,0.013219,CTTTAAR_UNKNOWN,0.5963958
GOBP_EQUILIBRIOCEPTION,SET,8,0.78521,0.016387,0.35384,0.013246,GOBP_EQUILIBRIOCEPTION,0.5963958
CEBPB_01,SET,240,0.12615,0.014328,0.056848,0.013247,CEBPB_01,0.5963958
REACTOME_DISASSEMBLY_OF_THE_...,SET,29,0.35739,0.014193,0.16109,0.013263,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,0.5963958
HP_CURVILINEAR_INTRACELLULAR...,SET,11,0.54683,0.013381,0.24647,0.013264,HP_CURVILINEAR_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.5963958
TESAR_ALK_AND_JAK_TARGETS_MO...1,SET,4,0.76894,0.011349,0.3466,0.013265,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN,0.5963958
GOBP_NEGATIVE_REGULATION_OF_...564,SET,39,0.29049,0.013374,0.13096,0.013279,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.5963958
CREB3L2_TARGET_GENES,SET,115,0.18146,0.014316,0.081809,0.013281,CREB3L2_TARGET_GENES,0.5963958
MORF_RBBP8,SET,200,0.13459,0.01397,0.06069,0.013297,MORF_RBBP8,0.5963958
chr9p13,SET,78,0.4514,0.029359,0.20355,0.013298,chr9p13,0.5963958
REACTOME_FERTILIZATION,SET,26,0.36171,0.013602,0.16311,0.013298,REACTOME_FERTILIZATION,0.5963958
GOBP_MAINTENANCE_OF_BLOOD_BR...,SET,37,0.348,0.015607,0.15693,0.013299,GOBP_MAINTENANCE_OF_BLOOD_BRAIN_BARRIER,0.5963958
CORDENONSI_YAP_CONSERVED_SIG...,SET,52,0.2867,0.015236,0.12936,0.01334,CORDENONSI_YAP_CONSERVED_SIGNATURE,0.597007702702703
KEGG_MEDICUS_REFERENCE_ANTIG...2,SET,12,0.56671,0.014483,0.25572,0.013347,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.597007702702703
BLANCO_MELO_COVID19_SARS_COV...1,SET,90,0.21297,0.014874,0.096157,0.013394,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,0.597812329545454
REACTOME_INTERLEUKIN_27_SIGN...,SET,11,0.59972,0.014675,0.27087,0.013421,REACTOME_INTERLEUKIN_27_SIGNALING,0.597812329545454
WP_CELL_DIFFERENTIATION_INDEX,SET,12,0.59801,0.015284,0.27019,0.013444,WP_CELL_DIFFERENTIATION_INDEX,0.597812329545454
GOCC_MEMBRANE_MICRODOMAIN,SET,269,0.12004,0.014423,0.054277,0.013501,GOCC_MEMBRANE_MICRODOMAIN,0.597812329545454
MODULE_404,SET,25,0.41855,0.015434,0.18925,0.013503,MODULE_404,0.597812329545454
HP_IMPOTENCE,SET,47,0.28365,0.014333,0.12826,0.013506,HP_IMPOTENCE,0.597812329545454
GOMF_GLUCOSIDASE_ACTIVITY,SET,13,0.50844,0.013524,0.23001,0.013542,GOMF_GLUCOSIDASE_ACTIVITY,0.597812329545454
GSE40274_CTRL_VS_FOXP3_AND_H...2,SET,187,0.13535,0.01359,0.061232,0.013546,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.597812329545454
GOBP_NETRIN_ACTIVATED_SIGNAL...,SET,8,0.68173,0.014227,0.30845,0.013553,GOBP_NETRIN_ACTIVATED_SIGNALING_PATHWAY,0.597812329545454
GSE17721_POLYIC_VS_GARDIQUIM...13,SET,191,0.12994,0.013184,0.058794,0.013555,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN,0.597812329545454
SUZUKI_RESPONSE_TO_TSA_AND_D...2,SET,15,0.52348,0.014956,0.23695,0.013585,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,0.597812329545454
GOBP_REGULATION_OF_RECEPTOR_...8,SET,100,0.1991,0.014654,0.090142,0.013603,GOBP_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.597812329545454
GOCC_TRANSCRIPTION_REGULATOR...,SET,477,0.086264,0.013723,0.039059,0.013608,GOCC_TRANSCRIPTION_REGULATOR_COMPLEX,0.597812329545454
GSE360_L_DONOVANI_VS_L_MAJOR...4,SET,180,0.1399,0.013784,0.063348,0.013613,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP,0.597812329545454
chr12p11,SET,31,0.59123,0.024274,0.26775,0.013623,chr12p11,0.597812329545454
GOBP_REGULATION_OF_PROTEOLYS...2,SET,196,0.13307,0.013676,0.060306,0.013678,GOBP_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.598765380299252
GSE43957_UNTREATED_VS_NACL_T...2,SET,181,0.13894,0.013727,0.063007,0.01373,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,0.598765380299252
KEGG_MEDICUS_REFERENCE_IL12_...,SET,10,0.68874,0.01607,0.31257,0.013786,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY,0.598765380299252
GOBP_ACTIN_FILAMENT_BASED_TR...,SET,10,0.57401,0.013393,0.26052,0.013792,GOBP_ACTIN_FILAMENT_BASED_TRANSPORT,0.598765380299252
GOBP_POSITIVE_REGULATION_OF_...731,SET,49,0.28054,0.014474,0.12733,0.013794,GOBP_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY,0.598765380299252
GSE18281_SUBCAPSULAR_CORTICA...4,SET,187,0.12939,0.012991,0.058737,0.01381,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.598765380299252
MIR6507_3P,SET,112,0.1763,0.013728,0.080038,0.013813,MIR6507_3P,0.598765380299252
OHM_METHYLATED_IN_ADULT_CANC...,SET,26,0.38421,0.014448,0.17444,0.013817,OHM_METHYLATED_IN_ADULT_CANCERS,0.598765380299252
HP_BRAIN_NEOPLASM,SET,16,0.42131,0.012432,0.19128,0.013817,HP_BRAIN_NEOPLASM,0.598765380299252
GSE35543_IN_VITRO_ITREG_VS_C...2,SET,183,0.13679,0.013588,0.062102,0.013817,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP,0.598765380299252
GOBP_DNA_TEMPLATED_DNA_REPLI...2,SET,54,0.24473,0.013253,0.11122,0.013893,GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY,0.599845555555556
GOBP_XYLULOSE_5_PHOSPHATE_ME...,SET,6,0.80302,0.014514,0.365,0.013907,GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS,0.599845555555556
HP_DISTURBED_PERCEPTION_WITH...,SET,33,0.3067,0.012991,0.13944,0.01393,HP_DISTURBED_PERCEPTION_WITH_A_STIMULUS,0.599845555555556
HP_ARTERIAL_THROMBOSIS,SET,29,0.34713,0.013785,0.15784,0.013935,HP_ARTERIAL_THROMBOSIS,0.599845555555556
HP_CHROMOSOMAL_BREAKAGE_INDU...2,SET,13,0.49832,0.013255,0.22658,0.013936,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_IONIZING_RADIATION,0.599845555555556
TAXCREB_02,SET,25,0.37833,0.013951,0.17209,0.013965,TAXCREB_02,0.599845555555556
MODULE_2,SET,347,0.1093,0.014884,0.049723,0.013972,MODULE_2,0.599845555555556
KEGG_MEDICUS_PATHOGEN_HCV_CO...3,SET,5,0.8599,0.014188,0.39121,0.01398,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_PPARA_MEDIATED_TRANSCRIPTION,0.599845555555556
WP_PPARALPHA_PATHWAY,SET,26,0.38694,0.014551,0.17613,0.014017,WP_PPARALPHA_PATHWAY,0.6006915351418
BIOCARTA_PLATELETAPP_PATHWAY,SET,11,0.64801,0.015857,0.29512,0.014061,BIOCARTA_PLATELETAPP_PATHWAY,0.600734651589242
GSE10147_IL3_VS_IL3_AND_HIVP...1,SET,131,0.17275,0.01454,0.078706,0.014091,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN,0.600734651589242
AP2_Q6,SET,239,0.121,0.013715,0.055144,0.014113,AP2_Q6,0.600734651589242
HP_ABNORMAL_PREIMPLANTATION_...,SET,6,0.6519,0.011783,0.2971,0.014118,HP_ABNORMAL_PREIMPLANTATION_EMBRYONIC_DEVELOPMENT,0.600734651589242
GOBP_INTRACELLULAR_TRIGLYCER...,SET,9,0.57955,0.012828,0.26414,0.014121,GOBP_INTRACELLULAR_TRIGLYCERIDE_HOMEOSTASIS,0.600734651589242
GOBP_POSITIVE_REGULATION_OF_...204,SET,49,0.27056,0.013959,0.12332,0.014125,GOBP_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION,0.600734651589242
MIR4433A_5P,SET,43,0.28755,0.013899,0.13108,0.014139,MIR4433A_5P,0.600734651589242
MODULE_315,SET,16,0.46953,0.013855,0.21415,0.014177,MODULE_315,0.600922426829268
GOBP_DIGESTIVE_TRACT_MORPHOG...,SET,48,0.2936,0.014992,0.13391,0.014178,GOBP_DIGESTIVE_TRACT_MORPHOGENESIS,0.600922426829268
REACTOME_FIBRONECTIN_MATRIX_...,SET,6,0.85637,0.015479,0.39089,0.014239,REACTOME_FIBRONECTIN_MATRIX_FORMATION,0.601064457177322
QIU_PBMC_HEPTATITIS_B_SURFAC...4,SET,14,0.53695,0.014822,0.24518,0.014267,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_UP,0.601064457177322
REACTOME_GENE_AND_PROTEIN_EX...,SET,35,0.29585,0.012905,0.13509,0.014271,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,0.601064457177322
MIR548AA_MIR548AP_3P_MIR548T...,SET,505,0.084698,0.013852,0.038681,0.014281,MIR548AA_MIR548AP_3P_MIR548T_3P,0.601064457177322
HP_UPPER_LIMB_MUSCLE_WEAKNESS,SET,131,0.16807,0.014146,0.076767,0.014294,HP_UPPER_LIMB_MUSCLE_WEAKNESS,0.601064457177322
HP_RED_EYE,SET,99,0.18641,0.013651,0.085147,0.014295,HP_RED_EYE,0.601064457177322
GSE9988_LPS_VS_LPS_AND_ANTI_...1,SET,170,0.14859,0.014232,0.067883,0.014307,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN,0.601064457177322
GSE22501_PERIPHERAL_BLOOD_VS...2,SET,178,0.14601,0.014307,0.066727,0.014333,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP,0.601064457177322
MORF_RRM1,SET,89,0.18156,0.01261,0.082975,0.014337,MORF_RRM1,0.601064457177322
DANG_BOUND_BY_MYC,SET,941,0.05997,0.013224,0.027428,0.014397,DANG_BOUND_BY_MYC,0.60134425
FOURNIER_ACINAR_DEVELOPMENT_...2,SET,18,0.50008,0.015651,0.22874,0.014405,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,0.60134425
GATA1_02,SET,218,0.13326,0.014434,0.06096,0.014415,GATA1_02,0.60134425
STAT6_01,SET,238,0.12597,0.014249,0.057627,0.014419,STAT6_01,0.60134425
GOBP_GALACTOSE_CATABOLIC_PRO...2,SET,5,0.78594,0.012968,0.35963,0.014436,GOBP_GALACTOSE_CATABOLIC_PROCESS_VIA_UDP_GALACTOSE,0.60134425
GSE33292_WT_VS_TCF1_KO_DN3_T...1,SET,189,0.12802,0.012922,0.058614,0.014486,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN,0.60134425
HP_CEREBRAL_CAVERNOUS_MALFOR...,SET,5,0.73905,0.012194,0.33847,0.014507,HP_CEREBRAL_CAVERNOUS_MALFORMATION,0.60134425
MORF_RAP1A,SET,133,0.15647,0.013269,0.071666,0.014511,MORF_RAP1A,0.60134425
PGM3_TARGET_GENES,SET,214,0.12718,0.013651,0.058252,0.014514,PGM3_TARGET_GENES,0.60134425
HP_VISUAL_AGNOSIA,SET,7,0.65411,0.01277,0.29964,0.014524,HP_VISUAL_AGNOSIA,0.60134425
HP_OVARIAN_PAPILLARY_ADENOCA...,SET,6,0.72335,0.013074,0.3314,0.014534,HP_OVARIAN_PAPILLARY_ADENOCARCINOMA,0.60134425
GSE2770_UNTREATED_VS_TGFB_AN...6,SET,175,0.1306,0.01269,0.059873,0.014587,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.602392482185273
GOBP_REGULATION_OF_CHOLESTER...2,SET,35,0.31537,0.013756,0.14459,0.014594,GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX,0.602392482185273
MODULE_84,SET,488,0.090735,0.014595,0.04163,0.014651,MODULE_84,0.604027882562278
GOCC_METHYLTRANSFERASE_COMPL...,SET,92,0.17757,0.012538,0.081514,0.014694,GOCC_METHYLTRANSFERASE_COMPLEX,0.604350833333333
HP_SQUAMOUS_CELL_CARCINOMA_O...,SET,22,0.35651,0.012334,0.16366,0.014697,HP_SQUAMOUS_CELL_CARCINOMA_OF_THE_SKIN,0.604350833333333
GNF2_CENPE,SET,38,0.30091,0.013675,0.13816,0.014711,GNF2_CENPE,0.604350833333333
GOMF_SOLUTE_PROTON_SYMPORTER...,SET,24,0.41265,0.01491,0.18961,0.014772,GOMF_SOLUTE_PROTON_SYMPORTER_ACTIVITY,0.605460225433526
GOBP_SMOOTH_MUSCLE_TISSUE_DE...,SET,24,0.41775,0.015094,0.19202,0.0148,GOBP_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT,0.605460225433526
HP_VISUAL_ACUITY_TEST_ABNORM...,SET,21,0.40827,0.0138,0.1878,0.01486,HP_VISUAL_ACUITY_TEST_ABNORMALITY,0.605460225433526
WP_THIAMINE_METABOLIC_PATHWA...,SET,8,0.62033,0.012946,0.28537,0.014866,WP_THIAMINE_METABOLIC_PATHWAYS,0.605460225433526
HP_DECREASED_CIRCULATING_TOT...3,SET,66,0.23188,0.013877,0.10668,0.014878,HP_DECREASED_CIRCULATING_TOTAL_IGM,0.605460225433526
GOBP_RESPONSE_TO_WOUNDING,SET,529,0.084643,0.014159,0.038948,0.014888,GOBP_RESPONSE_TO_WOUNDING,0.605460225433526
WEBER_METHYLATED_LCP_IN_SPER...1,SET,6,0.76973,0.013913,0.35421,0.014894,WEBER_METHYLATED_LCP_IN_SPERM_DN,0.605460225433526
GSE1460_INTRATHYMIC_T_PROGEN...2,SET,173,0.13706,0.013242,0.063089,0.014916,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP,0.605460225433526
HP_KERATITIS,SET,70,0.21761,0.013411,0.10023,0.014969,HP_KERATITIS,0.605460225433526
HP_MEMORY_IMPAIRMENT,SET,128,0.16239,0.013511,0.074795,0.014969,HP_MEMORY_IMPAIRMENT,0.605460225433526
TDRD3_TARGET_GENES,SET,3,0.93681,0.011974,0.43154,0.014977,TDRD3_TARGET_GENES,0.605460225433526
HP_TELANGIECTASIA_OF_THE_SKIN,SET,70,0.20448,0.012602,0.094201,0.014986,HP_TELANGIECTASIA_OF_THE_SKIN,0.605460225433526
GOBP_TOLERANCE_INDUCTION_DEP...,SET,4,1.021,0.015069,0.4705,0.015005,GOBP_TOLERANCE_INDUCTION_DEPENDENT_UPON_IMMUNE_RESPONSE,0.605460225433526
GOBP_REGULATION_OF_STEROL_TR...,SET,53,0.26409,0.014169,0.12171,0.015018,GOBP_REGULATION_OF_STEROL_TRANSPORT,0.605460225433526
GSE28737_FOLLICULAR_VS_MARGI...2,SET,175,0.1377,0.01338,0.063472,0.015029,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP,0.605460225433526
HMG20B_TARGET_GENES,SET,1493,0.050521,0.013809,0.02329,0.015038,HMG20B_TARGET_GENES,0.605460225433526
ONO_FOXP3_TARGETS_UP,SET,21,0.46202,0.015616,0.21303,0.015055,ONO_FOXP3_TARGETS_UP,0.605460225433526
GSE34217_MIR17_92_OVEREXPRES...1,SET,126,0.16069,0.013266,0.074099,0.015065,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN,0.605460225433526
REACTOME_CARNITINE_METABOLISM,SET,13,0.492,0.013087,0.22689,0.015069,REACTOME_CARNITINE_METABOLISM,0.605460225433526
GOBP_NEGATIVE_REGULATION_OF_...248,SET,127,0.15848,0.013135,0.073101,0.015087,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.605483469976905
GOBP_PROSTATE_GLANDULAR_ACIN...1,SET,10,0.61255,0.014292,0.28268,0.015128,GOBP_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT,0.606428650519031
HP_ABNORMAL_ATRIOVENTRICULAR...2,SET,14,0.50029,0.01381,0.23094,0.01515,HP_ABNORMAL_ATRIOVENTRICULAR_CONNECTION,0.606517134146342
GSE37532_WT_VS_PPARG_KO_VISC...4,SET,167,0.13995,0.013287,0.064629,0.015182,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP,0.606517134146342
GOBP_ANIMAL_ORGAN_REGENERATI...,SET,61,0.24548,0.014126,0.11337,0.015188,GOBP_ANIMAL_ORGAN_REGENERATION,0.606517134146342
GOMF_PHOSPHATIDYLINOSITOL_3_...10,SET,24,0.39426,0.014245,0.18212,0.015207,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING,0.606517134146342
WP_2Q13_COPY_NUMBER_VARIATIO...,SET,57,0.30201,0.016801,0.1396,0.015263,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,0.606517134146342
GOBP_NEGATIVE_REGULATION_OF_...645,SET,185,0.13625,0.013608,0.062988,0.01527,GOBP_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,0.606517134146342
GOBP_REGULATION_OF_MACROAUTO...,SET,166,0.14383,0.013615,0.066532,0.015321,GOBP_REGULATION_OF_MACROAUTOPHAGY,0.606517134146342
GOCC_DNA_REPAIR_COMPLEX,SET,20,0.35109,0.011581,0.16248,0.015365,GOCC_DNA_REPAIR_COMPLEX,0.606517134146342
GSE22432_UNTREATED_VS_TGFB1_...2,SET,186,0.13326,0.013344,0.061677,0.015371,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP,0.606517134146342
GSE37533_PPARG1_FOXP3_VS_FOX...2,SET,188,0.12844,0.012931,0.059462,0.015388,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.606517134146342
GSE22935_UNSTIM_VS_48H_MBOVI...4,SET,179,0.13575,0.013338,0.06285,0.015398,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.606517134146342
GSE34156_UNTREATED_VS_6H_TLR...1,SET,163,0.14063,0.013192,0.065113,0.015399,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.606517134146342
HP_NON_PERIODIC_RECURRENT_FE...,SET,11,0.52878,0.012939,0.24486,0.015413,HP_NON_PERIODIC_RECURRENT_FEVER,0.606517134146342
QI_PBMC_ZOSTAVAX_AGE_50_75YO...3,SET,159,0.13884,0.012864,0.064294,0.015417,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,0.606517134146342
GOBP_CELLULAR_RESPONSE_TO_GR...,SET,24,0.41312,0.014927,0.19137,0.015442,GOBP_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS,0.606517134146342
GOBP_SYNAPTIC_VESICLE_ENDOSO...,SET,8,0.63069,0.013162,0.29219,0.015451,GOBP_SYNAPTIC_VESICLE_ENDOSOMAL_PROCESSING,0.606517134146342
GSE8835_HEALTHY_VS_CLL_CD8_T...1,SET,180,0.13921,0.013716,0.064504,0.015468,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN,0.606517134146342
LANDIS_ERBB2_BREAST_PRENEOPL...2,SET,17,0.44058,0.0134,0.20422,0.015494,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,0.606517134146342
GOMF_INTRACELLULARLY_CALCIUM...,SET,20,0.46273,0.015264,0.21448,0.015494,GOMF_INTRACELLULARLY_CALCIUM_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.606517134146342
HP_OVERWEIGHT,SET,42,0.27764,0.013264,0.12869,0.015495,HP_OVERWEIGHT,0.606517134146342
CROSBY_E2F4_TARGETS,SET,6,0.70772,0.012792,0.32806,0.015497,CROSBY_E2F4_TARGETS,0.606517134146342
MIR580_5P,SET,210,0.12702,0.013506,0.058908,0.01554,MIR580_5P,0.606517134146342
GOBP_ESTABLISHMENT_OF_BLOOD_...2,SET,4,0.99147,0.014633,0.45987,0.01555,GOBP_ESTABLISHMENT_OF_BLOOD_RETINAL_BARRIER,0.606517134146342
HP_CONFUSION,SET,68,0.22061,0.013401,0.10234,0.015565,HP_CONFUSION,0.606517134146342
GSE29949_MICROGLIA_BRAIN_VS_...1,SET,176,0.14221,0.013857,0.066003,0.015601,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.606517134146342
HP_ABNORMALITY_OF_THE_MUSCUL...3,SET,89,0.19831,0.013774,0.092064,0.015625,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LOWER_LIMBS,0.606517134146342
GOMF_CHROMATIN_BINDING,SET,521,0.080108,0.013302,0.037215,0.015683,GOMF_CHROMATIN_BINDING,0.606517134146342
GOMF_METAL_ION_SEQUESTERING_...,SET,5,0.87976,0.014516,0.40872,0.015687,GOMF_METAL_ION_SEQUESTERING_ACTIVITY,0.606517134146342
MODULE_143,SET,12,0.58054,0.014837,0.26976,0.015702,MODULE_143,0.606517134146342
GOBP_PEPTIDYL_SERINE_DEPHOSP...,SET,14,0.43304,0.011953,0.20123,0.015706,GOBP_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.606517134146342
GSE29614_CTRL_VS_TIV_FLU_VAC...1,SET,152,0.1496,0.013555,0.069518,0.015707,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN,0.606517134146342
GSE9988_ANTI_TREM1_VS_LOW_LP...2,SET,174,0.14079,0.013641,0.065423,0.015707,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP,0.606517134146342
MIR3150B_3P,SET,137,0.15769,0.013571,0.07329,0.01572,MIR3150B_3P,0.606517134146342
GOCC_RNA_POLYMERASE_I_COMPLEX,SET,10,0.52847,0.01233,0.24566,0.015737,GOCC_RNA_POLYMERASE_I_COMPLEX,0.606517134146342
GSE45365_HEALTHY_VS_MCMV_INF...8,SET,184,0.13724,0.01367,0.0638,0.015741,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN,0.606517134146342
GOBP_XENOBIOTIC_EXPORT_FROM_...,SET,13,0.48174,0.012814,0.22404,0.015776,GOBP_XENOBIOTIC_EXPORT_FROM_CELL,0.606772375690608
GSE17974_IL4_AND_ANTI_IL12_V...10,SET,155,0.14982,0.013707,0.069685,0.015787,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP,0.606772375690608
KEGG_N_GLYCAN_BIOSYNTHESIS,SET,44,0.26427,0.012922,0.12294,0.0158,KEGG_N_GLYCAN_BIOSYNTHESIS,0.606772375690608
GSE360_CTRL_VS_L_MAJOR_MAC_UP,SET,182,0.13258,0.013135,0.061695,0.015823,GSE360_CTRL_VS_L_MAJOR_MAC_UP,0.606949377753304
GSE22601_DOUBLE_NEGATIVE_VS_...1,SET,179,0.13256,0.013025,0.061706,0.015854,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.606949377753304
TOMIDA_LUNG_CANCER_POOR_SURV...,SET,5,0.94411,0.015578,0.43949,0.015857,TOMIDA_LUNG_CANCER_POOR_SURVIVAL,0.606949377753304
GOBP_RETINA_MORPHOGENESIS_IN...,SET,62,0.24684,0.01432,0.11499,0.015921,GOBP_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.607506717892426
MIR7108_3P,SET,12,0.53327,0.013629,0.24844,0.015924,MIR7108_3P,0.607506717892426
CAGCAGG_MIR370,SET,138,0.1517,0.013102,0.070673,0.015924,CAGCAGG_MIR370,0.607506717892426
GOBP_RESPONSE_TO_HYDROSTATIC...,SET,7,0.73444,0.014338,0.34229,0.015956,GOBP_RESPONSE_TO_HYDROSTATIC_PRESSURE,0.607888932092004
GTF3A_TARGET_GENES,SET,12,0.52844,0.013505,0.24632,0.015969,GTF3A_TARGET_GENES,0.607888932092004
HP_COLORECTAL_POLYPOSIS,SET,23,0.36335,0.012852,0.16942,0.015996,HP_COLORECTAL_POLYPOSIS,0.608250525164114
GOMF_MITOGEN_ACTIVATED_PROTE...1,SET,29,0.34045,0.01352,0.15884,0.016047,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING,0.60952293442623
CAR_IGFBP1,SET,55,0.27066,0.014792,0.12638,0.01612,CAR_IGFBP1,0.61130141221374
LEE_LIVER_CANCER_MYC_UP,SET,49,0.26779,0.013816,0.12506,0.016129,LEE_LIVER_CANCER_MYC_UP,0.61130141221374
PID_P38_ALPHA_BETA_DOWNSTREA...,SET,37,0.30636,0.013739,0.14311,0.016152,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,0.611506274509804
HP_OBSESSIVE_COMPULSIVE_TRAIT,SET,36,0.29645,0.013114,0.1386,0.016228,HP_OBSESSIVE_COMPULSIVE_TRAIT,0.612121969860065
GSE6269_FLU_VS_STREP_PNEUMO_...2,SET,162,0.13988,0.013082,0.0654,0.016229,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP,0.612121969860065
MIR6804_5P,SET,66,0.22077,0.013213,0.10327,0.01627,MIR6804_5P,0.612121969860065
CAGCACT_MIR5123P,SET,141,0.1657,0.014465,0.077509,0.016271,CAGCACT_MIR5123P,0.612121969860065
HP_MULTIFOCAL_EPILEPTIFORM_D...,SET,66,0.23207,0.013889,0.10856,0.016278,HP_MULTIFOCAL_EPILEPTIFORM_DISCHARGES,0.612121969860065
HP_ABNORMAL_CIRCULATING_ANTI...,SET,8,0.55209,0.011522,0.2583,0.016291,HP_ABNORMAL_CIRCULATING_ANTIMULLERIAN_HORMONE_CONCENTRATION,0.612121969860065
GOBP_PROPIONATE_METABOLIC_PR...,SET,4,0.8772,0.012946,0.41044,0.016297,GOBP_PROPIONATE_METABOLIC_PROCESS,0.612121969860065
WP_WNTBETACATENIN_SIGNALING_...1,SET,4,1.0133,0.014955,0.4743,0.016332,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,0.612121969860065
HP_NEOPLASM,SET,880,0.063176,0.013496,0.029574,0.016339,HP_NEOPLASM,0.612121969860065
GOBP_CELLULAR_RESPONSE_TO_CH...2,SET,17,0.45812,0.013934,0.21448,0.016347,GOBP_CELLULAR_RESPONSE_TO_CHOLESTEROL,0.612121969860065
GOBP_SPLICEOSOMAL_TRI_SNRNP_...,SET,15,0.38629,0.011037,0.18088,0.016362,GOBP_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY,0.612121969860065
XU_AKT1_TARGETS_6HR,SET,25,0.33389,0.012312,0.1565,0.016451,XU_AKT1_TARGETS_6HR,0.614789790322581
ARNT_02,SET,217,0.12074,0.013048,0.056618,0.016491,ARNT_02,0.615622669172932
GSE17301_IFNA2_VS_IFNA2_AND_...2,SET,183,0.13022,0.012936,0.061094,0.016531,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP,0.615691895074946
GOMF_IODIDE_TRANSMEMBRANE_TR...,SET,5,0.66244,0.01093,0.31079,0.016534,GOMF_IODIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.615691895074946
HP_COLON_CANCER,SET,40,0.27929,0.013022,0.13105,0.016546,HP_COLON_CANCER,0.615691895074946
DAIRKEE_CANCER_PRONE_RESPONS...2,SET,107,0.17385,0.013233,0.081707,0.016687,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,0.618213278775079
GOCC_SPLICEOSOMAL_COMPLEX,SET,178,0.12331,0.012082,0.057959,0.016698,GOCC_SPLICEOSOMAL_COMPLEX,0.618213278775079
GOBP_HORMONE_MEDIATED_SIGNAL...,SET,178,0.13696,0.01342,0.064382,0.016704,GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.618213278775079
GSE19941_IL10_KO_VS_IL10_KO_...6,SET,183,0.13814,0.013723,0.064942,0.016711,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP,0.618213278775079
GSE37416_CTRL_VS_48H_F_TULAR...1,SET,167,0.13413,0.012734,0.063064,0.016718,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.618213278775079
GSE15930_STIM_VS_STIM_AND_IF...4,SET,180,0.13391,0.013194,0.063005,0.016786,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP,0.618213278775079
HP_DELAYED_UMBILICAL_CORD_SE...,SET,5,1.0131,0.016716,0.4767,0.016791,HP_DELAYED_UMBILICAL_CORD_SEPARATION,0.618213278775079
GSE40274_EOS_VS_FOXP3_AND_EO...2,SET,135,0.1478,0.012627,0.069547,0.016793,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.618213278775079
HP_HYPOINSULINEMIA,SET,21,0.44168,0.014929,0.20787,0.016807,HP_HYPOINSULINEMIA,0.618213278775079
HOWARD_PBMC_INACT_MONOV_INFL...1,SET,27,0.38703,0.014831,0.18216,0.016814,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN,0.618213278775079
WP_EUKARYOTIC_TRANSCRIPTION_...,SET,41,0.24096,0.011374,0.11343,0.016832,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,0.618213278775079
GOBP_MEIOTIC_CELL_CYCLE_PHAS...,SET,13,0.48598,0.012927,0.2288,0.016841,GOBP_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.618213278775079
GAVISH_3CA_METAPROGRAM_B_CEL...11,SET,41,0.28936,0.013658,0.13624,0.016845,GAVISH_3CA_METAPROGRAM_B_CELLS_RESPIRATION,0.618213278775079
HP_BILATERAL_TONIC_CLONIC_SE...1,SET,322,0.099876,0.01311,0.047108,0.017005,HP_BILATERAL_TONIC_CLONIC_SEIZURE,0.618918761609907
HP_LONG_NECK,SET,3,0.86971,0.011116,0.41035,0.017034,HP_LONG_NECK,0.618918761609907
REACTOME_FGFR2_ALTERNATIVE_S...,SET,27,0.33383,0.012792,0.15751,0.017039,REACTOME_FGFR2_ALTERNATIVE_SPLICING,0.618918761609907
SHAFFER_IRF4_TARGETS_IN_MYEL...,SET,93,0.19388,0.013764,0.091519,0.017076,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,0.618918761609907
HP_GENERALIZED_AMYOTROPHY,SET,78,0.1889,0.012286,0.089168,0.017076,HP_GENERALIZED_AMYOTROPHY,0.618918761609907
GOBP_ESTABLISHMENT_OF_MITOTI...1,SET,5,0.74851,0.012351,0.35336,0.017083,GOBP_ESTABLISHMENT_OF_MITOTIC_SISTER_CHROMATID_COHESION,0.618918761609907
HP_CEREBRAL_CORTICAL_HEMIATR...,SET,5,0.81815,0.0135,0.38628,0.017095,HP_CEREBRAL_CORTICAL_HEMIATROPHY,0.618918761609907
HP_NEOPLASM_OF_THE_PANCREAS,SET,86,0.19228,0.013129,0.090797,0.017105,HP_NEOPLASM_OF_THE_PANCREAS,0.618918761609907
KEGG_MEDICUS_REFERENCE_TRAPP...,SET,8,0.58116,0.012129,0.27443,0.017107,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY,0.618918761609907
WP_PLEURAL_MESOTHELIOMA,SET,418,0.094681,0.014123,0.044717,0.017123,WP_PLEURAL_MESOTHELIOMA,0.618918761609907
HP_ABNORMAL_ORAL_PHYSIOLOGY,SET,286,0.11117,0.013766,0.052505,0.017125,HP_ABNORMAL_ORAL_PHYSIOLOGY,0.618918761609907
GSE6674_UNSTIM_VS_CPG_STIM_B...1,SET,145,0.14726,0.013035,0.06956,0.017138,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN,0.618918761609907
BROWNE_HCMV_INFECTION_8HR_DN,SET,40,0.30396,0.014172,0.14359,0.017141,BROWNE_HCMV_INFECTION_8HR_DN,0.618918761609907
HP_ABNORMAL_LOWER_MOTOR_NEUR...,SET,26,0.33931,0.01276,0.16034,0.017174,HP_ABNORMAL_LOWER_MOTOR_NEURON_MORPHOLOGY,0.618918761609907
HP_EEG_WITH_SERIES_OF_FOCAL_...,SET,10,0.54304,0.01267,0.25663,0.017179,HP_EEG_WITH_SERIES_OF_FOCAL_SPIKES,0.618918761609907
GSE5589_IL6_KO_VS_IL10_KO_LP...6,SET,184,0.12552,0.012503,0.059338,0.017205,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.618918761609907
BARX2_TARGET_GENES,SET,1489,0.048296,0.013184,0.022833,0.017216,BARX2_TARGET_GENES,0.618918761609907
HP_ABNORMAL_THALAMUS_MORPHOL...,SET,53,0.23218,0.012457,0.10978,0.017223,HP_ABNORMAL_THALAMUS_MORPHOLOGY,0.618918761609907
NIKOLSKY_OVERCONNECTED_IN_BR...,SET,21,0.39661,0.013406,0.18754,0.017229,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,0.618918761609907
GOBP_INNER_EAR_RECEPTOR_CELL...1,SET,44,0.29124,0.01424,0.13773,0.017238,GOBP_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT,0.618918761609907
GOBP_NEGATIVE_REGULATION_OF_...616,SET,34,0.31502,0.013544,0.149,0.017255,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.618918761609907
GCM_ANP32B,SET,31,0.31034,0.012741,0.14679,0.017256,GCM_ANP32B,0.618918761609907
KEGG_MEDICUS_REFERENCE_N_GLY...1,SET,16,0.46609,0.013753,0.22053,0.017288,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS,0.619427257731959
HP_EXCESSIVE_WRINKLING_OF_PA...,SET,11,0.52908,0.012947,0.25044,0.017325,HP_EXCESSIVE_WRINKLING_OF_PALMAR_SKIN,0.619744030769231
BIOCARTA_FIBRINOLYSIS_PATHWAY,SET,12,0.60734,0.015522,0.28758,0.017353,BIOCARTA_FIBRINOLYSIS_PATHWAY,0.619744030769231
GOCC_EPSILON_DNA_POLYMERASE_...,SET,5,0.73243,0.012085,0.34684,0.017362,GOCC_EPSILON_DNA_POLYMERASE_COMPLEX,0.619744030769231
HP_DYSGERMINOMA,SET,9,0.59405,0.013149,0.28133,0.017369,HP_DYSGERMINOMA,0.619744030769231
THILLAINADESAN_ZNF217_TARGET...2,SET,38,0.27569,0.012529,0.13059,0.017386,THILLAINADESAN_ZNF217_TARGETS_UP,0.619744030769231
GSE22886_NAIVE_CD8_TCELL_VS_...6,SET,172,0.13896,0.013387,0.065849,0.017422,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP,0.620390993852459
GOMF_PHOSPHATIDYLINOSITOL_4_...2,SET,75,0.21328,0.013604,0.10108,0.01744,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING,0.620396315250768
YGCGYRCGC_UNKNOWN,SET,287,0.10254,0.01272,0.048629,0.017492,YGCGYRCGC_UNKNOWN,0.620433262195122
HE_LIM_SUN_FETAL_LUNG_C1_LAT...3,SET,6,0.81836,0.014792,0.38819,0.017515,HE_LIM_SUN_FETAL_LUNG_C1_LATE_STALK_CELL,0.620433262195122
GOBP_REGULATION_OF_PLASMA_CE...,SET,6,0.69169,0.012502,0.32812,0.01752,GOBP_REGULATION_OF_PLASMA_CELL_DIFFERENTIATION,0.620433262195122
GSE7219_UNSTIM_VS_LPS_AND_AN...4,SET,168,0.14024,0.013353,0.066532,0.017529,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP,0.620433262195122
GOBP_REGULATION_OF_MONOCYTE_...1,SET,25,0.36968,0.013632,0.17541,0.017545,GOBP_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.620433262195122
GSE10325_CD4_TCELL_VS_BCELL_...2,SET,175,0.13753,0.013363,0.065265,0.017554,GSE10325_CD4_TCELL_VS_BCELL_UP,0.620433262195122
RSRFC4_01,SET,219,0.12695,0.013782,0.060249,0.017566,RSRFC4_01,0.620433262195122
HP_FEVER,SET,372,0.095201,0.013413,0.045202,0.017604,HP_FEVER,0.620700379554656
GSE45365_NK_CELL_VS_CD8A_DC_...4,SET,181,0.13077,0.01292,0.062105,0.017627,GSE45365_NK_CELL_VS_CD8A_DC_UP,0.620700379554656
GSE43955_1H_VS_10H_ACT_CD4_T...3,SET,179,0.1377,0.01353,0.065407,0.017644,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.620700379554656
GOBP_REGULATION_OF_PROTEOLYS...1,SET,527,0.081354,0.013584,0.038644,0.017645,GOBP_REGULATION_OF_PROTEOLYSIS,0.620700379554656
CCTGTGA_MIR513,SET,116,0.16633,0.013179,0.079061,0.017707,CCTGTGA_MIR513,0.622251552072801
GOCC_DNA_POLYMERASE_COMPLEX,SET,19,0.36572,0.011759,0.17388,0.017726,GOCC_DNA_POLYMERASE_COMPLEX,0.622258289606458
GOBP_REGULATION_OF_TRANSMEMB...1,SET,247,0.12197,0.014052,0.058001,0.017743,GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.622258289606458
JOHNSTONE_PARVB_TARGETS_2_DN,SET,306,0.10724,0.013728,0.05102,0.017789,JOHNSTONE_PARVB_TARGETS_2_DN,0.622830557788945
HP_FATIGUE,SET,445,0.089786,0.013808,0.042723,0.017801,HP_FATIGUE,0.622830557788945
GEORGES_TARGETS_OF_MIR192_AN...,SET,796,0.064792,0.013195,0.030839,0.017829,GEORGES_TARGETS_OF_MIR192_AND_MIR215,0.622830557788945
LIU_IL13_MEMORY_MODEL_DN,SET,4,0.75933,0.011207,0.36143,0.017831,LIU_IL13_MEMORY_MODEL_DN,0.622830557788945
HP_ELEVATED_TOTAL_SERUM_TRYP...,SET,6,0.7162,0.012945,0.34124,0.017923,HP_ELEVATED_TOTAL_SERUM_TRYPTASE,0.625311681681682
GOBP_ESTABLISHMENT_OF_PROTEI...1,SET,1551,0.046558,0.012948,0.022191,0.017956,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.625311681681682
chr15q24,SET,57,0.48289,0.026864,0.23019,0.017969,chr15q24,0.625311681681682
GOMF_G_PROTEIN_COUPLED_CHEMO...,SET,24,0.4171,0.015071,0.19884,0.017974,GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY,0.625311681681682
NUMATA_CSF3_SIGNALING_VIA_ST...,SET,21,0.40281,0.013615,0.19216,0.018041,NUMATA_CSF3_SIGNALING_VIA_STAT3,0.626838682634731
HP_LARGE_FOR_GESTATIONAL_AGE,SET,49,0.26008,0.013418,0.12411,0.018063,HP_LARGE_FOR_GESTATIONAL_AGE,0.626838682634731
HP_BRAIN_STEM_COMPRESSION,SET,14,0.48002,0.01325,0.22908,0.018072,HP_BRAIN_STEM_COMPRESSION,0.626838682634731
GSE29949_CD8_NEG_DC_SPLEEN_V...5,SET,176,0.13538,0.013192,0.064637,0.018113,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,0.627513201581028
REACTOME_DNA_REPLICATION_INI...,SET,7,0.5595,0.010923,0.26731,0.018179,REACTOME_DNA_REPLICATION_INITIATION,0.627513201581028
MIR12130,SET,29,0.32724,0.012995,0.15635,0.018183,MIR12130,0.627513201581028
GOBP_RECOGNITION_OF_APOPTOTI...,SET,7,0.73272,0.014304,0.35016,0.018203,GOBP_RECOGNITION_OF_APOPTOTIC_CELL,0.627513201581028
KOYAMA_SEMA3B_TARGETS_UP,SET,221,0.12239,0.013347,0.058494,0.018212,KOYAMA_SEMA3B_TARGETS_UP,0.627513201581028
REACTOME_REGULATION_OF_TP53_...5,SET,87,0.18406,0.01264,0.087973,0.018217,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,0.627513201581028
USF_02,SET,237,0.11556,0.013044,0.055247,0.018241,USF_02,0.627513201581028
KANG_DOXORUBICIN_RESISTANCE_...1,SET,16,0.46568,0.013741,0.22265,0.018249,KANG_DOXORUBICIN_RESISTANCE_DN,0.627513201581028
MIR664A_3P,SET,359,0.097546,0.013506,0.046646,0.018263,MIR664A_3P,0.627513201581028
GOBP_SYNAPTIC_ASSEMBLY_AT_NE...,SET,8,0.64572,0.013476,0.30881,0.018272,GOBP_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.627513201581028
HP_CRYPTOPHTHALMOS,SET,5,0.9591,0.015825,0.45883,0.018303,HP_CRYPTOPHTHALMOS,0.627957319842053
GOBP_POSITIVE_REGULATION_OF_...545,SET,14,0.54037,0.014916,0.25858,0.018325,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.628092085798817
GOBP_CYTOPLASMIC_SEQUESTERIN...3,SET,7,0.60652,0.011841,0.29041,0.018383,GOBP_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR,0.628435438596491
MIR568,SET,239,0.11735,0.013301,0.056199,0.018403,MIR568,0.628435438596491
GSE3039_ALPHAALPHA_CD8_TCELL...1,SET,184,0.13317,0.013265,0.0638,0.018436,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN,0.628435438596491
HP_DECREASED_CIRCULATING_PAR...,SET,10,0.62292,0.014534,0.29857,0.018482,HP_DECREASED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.628435438596491
KRAS.DF.V1_UP,SET,174,0.14163,0.013722,0.06789,0.018488,KRAS.DF.V1_UP,0.628435438596491
GSE18203_CTRL_VS_INTRATUMORA...1,SET,176,0.13529,0.013183,0.064851,0.018488,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN,0.628435438596491
MIR6761_5P,SET,108,0.1732,0.013245,0.083028,0.018492,MIR6761_5P,0.628435438596491
GSE26488_WT_VS_VP16_TRANSGEN...1,SET,150,0.15169,0.013655,0.072733,0.018513,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.628435438596491
REACTOME_LOSS_OF_FUNCTION_OF...1,SET,11,0.5512,0.013488,0.26431,0.018522,REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,0.628435438596491
MODULE_203,SET,3,1.0748,0.013738,0.51556,0.01855,MODULE_203,0.628435438596491
GOBP_CHLORIDE_TRANSPORT,SET,113,0.17872,0.013978,0.085727,0.018552,GOBP_CHLORIDE_TRANSPORT,0.628435438596491
GOBP_PIGMENT_GRANULE_LOCALIZ...,SET,23,0.37482,0.013258,0.17979,0.018552,GOBP_PIGMENT_GRANULE_LOCALIZATION,0.628435438596491
IBRAHIM_NRF3_DOWN,SET,13,0.44333,0.011793,0.21275,0.018595,IBRAHIM_NRF3_DOWN,0.629173686770428
GOCC_EXTRINSIC_COMPONENT_OF_...1,SET,47,0.26629,0.013456,0.12781,0.01861,GOCC_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.629173686770428
MOTAMED_RESPONSE_TO_ANDROGEN...1,SET,6,0.71061,0.012844,0.34118,0.018641,MOTAMED_RESPONSE_TO_ANDROGEN_DN,0.629589850096712
GOBP_REGULATION_OF_ODONTOBLA...,SET,10,0.65678,0.015324,0.31542,0.018668,GOBP_REGULATION_OF_ODONTOBLAST_DIFFERENTIATION,0.629589850096712
GOMF_ATP_DEPENDENT_ACTIVITY_...2,SET,71,0.19931,0.01237,0.095729,0.018679,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_RNA,0.629589850096712
GOCC_WASH_COMPLEX,SET,7,0.59983,0.01171,0.2882,0.018711,GOCC_WASH_COMPLEX,0.629589850096712
MORF_MT4,SET,234,0.11541,0.012946,0.055459,0.018725,MORF_MT4,0.629589850096712
BUYTAERT_PHOTODYNAMIC_THERAP...1,SET,578,0.073256,0.012792,0.035205,0.018731,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,0.629589850096712
SCHLESINGER_METHYLATED_IN_CO...,SET,10,0.63532,0.014823,0.3055,0.018789,SCHLESINGER_METHYLATED_IN_COLON_CANCER,0.630521452702703
GOBP_G_QUADRUPLEX_DNA_UNWIND...,SET,7,0.65934,0.012872,0.31707,0.018795,GOBP_G_QUADRUPLEX_DNA_UNWINDING,0.630521452702703
RUBENSTEIN_SKELETAL_MUSCLE_F...2,SET,256,0.11577,0.013574,0.055692,0.01883,RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS,0.631025616113744
CARRILLOREIXACH_HEPATOBLASTO...4,SET,735,0.068425,0.013414,0.03293,0.018868,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP,0.631025616113744
CTIP_DN.V1_DN,SET,114,0.17356,0.013633,0.083572,0.018921,CTIP_DN.V1_DN,0.631025616113744
GSE25088_CTRL_VS_IL4_AND_ROS...3,SET,152,0.14131,0.012804,0.06805,0.01893,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.631025616113744
LE_SKI_TARGETS_DN,SET,6,0.90104,0.016286,0.43398,0.018944,LE_SKI_TARGETS_DN,0.631025616113744
GSE27786_BCELL_VS_ERYTHROBLA...2,SET,179,0.12636,0.012416,0.060873,0.018965,GSE27786_BCELL_VS_ERYTHROBLAST_UP,0.631025616113744
GOCC_COPI_COATED_VESICLE_MEM...,SET,17,0.3722,0.011321,0.17932,0.018972,GOCC_COPI_COATED_VESICLE_MEMBRANE,0.631025616113744
HP_SYNCOPE,SET,116,0.17596,0.013943,0.084778,0.018973,HP_SYNCOPE,0.631025616113744
GOBP_REGULATION_OF_MEMBRANE_...3,SET,4,1.0117,0.014931,0.48763,0.019014,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.631025616113744
GOCC_XY_BODY,SET,14,0.43888,0.012114,0.21158,0.019032,GOCC_XY_BODY,0.631025616113744
WP_MITOCHONDRIAL_FATTY_ACID_...1,SET,18,0.40675,0.01273,0.1961,0.019038,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,0.631025616113744
GOBP_VENTRAL_MIDLINE_DEVELOP...,SET,6,0.78107,0.014117,0.37671,0.019075,GOBP_VENTRAL_MIDLINE_DEVELOPMENT,0.631025616113744
GSE13411_PLASMA_CELL_VS_MEMO...2,SET,161,0.14147,0.013189,0.068246,0.019097,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.631025616113744
HP_ABNORMAL_MACROSCOPIC_URIN...,SET,47,0.25596,0.012934,0.12349,0.019108,HP_ABNORMAL_MACROSCOPIC_URINE_APPEARANCE,0.631025616113744
RUBENSTEIN_SKELETAL_MUSCLE_B...,SET,154,0.13955,0.012727,0.06733,0.019108,RUBENSTEIN_SKELETAL_MUSCLE_B_CELLS,0.631025616113744
GSE39820_TGFBETA1_IL6_VS_TGF...1,SET,181,0.12666,0.012514,0.061111,0.01911,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN,0.631025616113744
JACKSON_DNMT1_TARGETS_UP,SET,80,0.20198,0.013304,0.097481,0.01914,JACKSON_DNMT1_TARGETS_UP,0.631025616113744
GOBP_REGULATION_OF_GLOMERULA...,SET,9,0.69008,0.015275,0.33306,0.019142,GOBP_REGULATION_OF_GLOMERULAR_FILTRATION,0.631025616113744
KEGG_TGF_BETA_SIGNALING_PATH...,SET,84,0.19648,0.013259,0.09484,0.019155,KEGG_TGF_BETA_SIGNALING_PATHWAY,0.631025616113744
GAUCHER_PBMC_YF_VAX_STAMARIL...3,SET,12,0.52972,0.013538,0.25583,0.019207,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_DN,0.631224175306315
GSE10240_CTRL_VS_IL17_AND_IL...2,SET,182,0.12482,0.012366,0.060293,0.019223,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.631224175306315
MOOTHA_ROS,SET,7,0.76581,0.01495,0.37001,0.019248,MOOTHA_ROS,0.631224175306315
GOCC_SPLICEOSOMAL_TRI_SNRNP_...,SET,36,0.24198,0.010705,0.11692,0.019251,GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX,0.631224175306315
chr10q21,SET,41,0.5292,0.02498,0.25573,0.019263,chr10q21,0.631224175306315
GSE3982_NEUTROPHIL_VS_BASOPH...2,SET,176,0.13095,0.012759,0.063283,0.01927,GSE3982_NEUTROPHIL_VS_BASOPHIL_UP,0.631224175306315
GSE7568_IL4_VS_IL4_AND_DEXAM...2,SET,149,0.13592,0.012195,0.065715,0.019313,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP,0.631719399624766
GSE12845_IGD_POS_VS_NEG_BLOO...1,SET,171,0.1324,0.012718,0.064034,0.019343,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN,0.631719399624766
GOBP_RAP_PROTEIN_SIGNAL_TRAN...,SET,12,0.55071,0.014075,0.26639,0.019359,GOBP_RAP_PROTEIN_SIGNAL_TRANSDUCTION,0.631719399624766
HP_ABULIA,SET,10,0.55929,0.013049,0.27055,0.019364,HP_ABULIA,0.631719399624766
KEGG_MEDICUS_REFERENCE_IL10_...,SET,13,0.58619,0.015593,0.2836,0.019376,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.631719399624766
GSE15330_HSC_VS_MEGAKARYOCYT...1,SET,150,0.14538,0.013087,0.070388,0.01945,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.633537722586692
CARRILLOREIXACH_HEPATOBLASTO...1,SET,972,0.060991,0.013657,0.029538,0.019479,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN,0.633888244382022
GOBP_PROTEIN_K6_LINKED_UBIQU...,SET,15,0.44337,0.012668,0.21486,0.019539,GOBP_PROTEIN_K6_LINKED_UBIQUITINATION,0.634294930167598
MODULE_12,SET,322,0.10683,0.014023,0.051774,0.019543,MODULE_12,0.634294930167598
BROWNE_HCMV_INFECTION_6HR_UP,SET,57,0.23162,0.012886,0.11226,0.019552,BROWNE_HCMV_INFECTION_6HR_UP,0.634294930167598
BIOCARTA_PLK3_PATHWAY,SET,8,0.53422,0.011149,0.25897,0.019569,BIOCARTA_PLK3_PATHWAY,0.634294930167598
GOBP_DOUBLE_STRAND_BREAK_REP...5,SET,9,0.54812,0.012133,0.26579,0.019599,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_CLASSICAL_NONHOMOLOGOUS_END_JOINING,0.634294930167598
GOBP_MEIOTIC_DNA_DOUBLE_STRA...,SET,5,0.9527,0.01572,0.46198,0.019601,GOBP_MEIOTIC_DNA_DOUBLE_STRAND_BREAK_FORMATION,0.634294930167598
GSE41176_UNSTIM_VS_ANTI_IGM_...5,SET,170,0.12926,0.012381,0.062699,0.019627,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.634545474418605
GOMF_TUMOR_NECROSIS_FACTOR_R...1,SET,9,0.66885,0.014805,0.32452,0.019659,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_ACTIVITY,0.634989354089219
GOBP_DNA_TEMPLATED_DNA_REPLI...1,SET,154,0.13778,0.012566,0.066871,0.019685,GOBP_DNA_TEMPLATED_DNA_REPLICATION,0.635238788300836
HP_CLEFT_UPPER_LIP,SET,126,0.15688,0.012951,0.076259,0.019843,HP_CLEFT_UPPER_LIP,0.639363277777778
GOMF_SUMO_LIGASE_ACTIVITY,SET,12,0.51821,0.013244,0.25196,0.019862,GOMF_SUMO_LIGASE_ACTIVITY,0.639363277777778
GSE24634_IL4_VS_CTRL_TREATED...2,SET,174,0.13727,0.0133,0.066747,0.019868,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP,0.639363277777778
TERAO_AOX4_TARGETS_SKIN_UP,SET,24,0.33925,0.012257,0.16502,0.019911,TERAO_AOX4_TARGETS_SKIN_UP,0.640154306197965
WP_METHIONINE_DE_NOVO_AND_SA...,SET,21,0.41278,0.013952,0.201,0.020012,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,0.642806894639556
GOCC_TRANSFERASE_COMPLEX_TRA...,SET,263,0.10262,0.012194,0.050019,0.02011,GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,0.644471629834254
GOCC_GAMMA_SECRETASE_COMPLEX,SET,6,0.74639,0.013491,0.36386,0.020125,GOCC_GAMMA_SECRETASE_COMPLEX,0.644471629834254
KRIGE_RESPONSE_TO_TOSEDOSTAT...2,SET,644,0.070179,0.012911,0.034212,0.020127,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,0.644471629834254
GOBP_RESPONSE_TO_INTERLEUKIN...10,SET,32,0.34027,0.014193,0.1659,0.020138,GOBP_RESPONSE_TO_INTERLEUKIN_6,0.644471629834254
REACTOME_ACTIVATED_PKN1_STIM...,SET,6,0.75616,0.013667,0.36879,0.02017,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,0.644901885924563
GOMF_RETINAL_BINDING,SET,17,0.44248,0.013458,0.21585,0.020192,GOMF_RETINAL_BINDING,0.645011911764706
HP_LOW_GRADE_FEVER,SET,11,0.58854,0.014401,0.28718,0.02022,HP_LOW_GRADE_FEVER,0.645313223140496
GOBP_HEPATICOBILIARY_SYSTEM_...,SET,141,0.15193,0.013263,0.074161,0.020254,GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT,0.645436347387718
GOBP_MICROAUTOPHAGY,SET,22,0.35635,0.012328,0.17395,0.020261,GOBP_MICROAUTOPHAGY,0.645436347387718
GSE5589_WT_VS_IL6_KO_LPS_STI...1,SET,129,0.15789,0.013188,0.077115,0.020312,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.646468461538461
REACTOME_POSITIVE_EPIGENETIC...,SET,42,0.24968,0.011928,0.12198,0.020344,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.646894528819762
GSE20152_SPHK1_KO_VS_HTNFA_O...2,SET,171,0.12887,0.012378,0.063015,0.020435,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP,0.648664780821918
GOBP_NEGATIVE_REGULATION_OF_...142,SET,10,0.52021,0.012137,0.25439,0.020437,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.648664780821918
GNF2_CYP2B6,SET,47,0.25312,0.01279,0.12385,0.020495,GNF2_CYP2B6,0.649912157846715
NAKAYA_MONOCYTE_FLUMIST_AGE_...2,SET,436,0.082782,0.012604,0.040524,0.020545,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP,0.650754139344262
GOCC_PLASMA_MEMBRANE_PROTEIN...,SET,566,0.079642,0.013766,0.038993,0.020559,GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX,0.650754139344262
GSE25123_CTRL_VS_ROSIGLITAZO...4,SET,176,0.13801,0.013448,0.067612,0.02062,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.651037303877367
GOBP_NEGATIVE_REGULATION_OF_...57,SET,6,0.82507,0.014913,0.40421,0.020622,GOBP_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.651037303877367
GSE27434_WT_VS_DNMT1_KO_TREG...1,SET,182,0.13581,0.013455,0.066542,0.020633,GSE27434_WT_VS_DNMT1_KO_TREG_DN,0.651037303877367
GSE46606_UNSTIM_VS_CD40L_IL2...5,SET,163,0.1312,0.012307,0.064291,0.020645,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN,0.651037303877367
GOBP_ESTABLISHMENT_OF_LOCALI...,SET,1767,0.042577,0.012557,0.020872,0.020689,GOBP_ESTABLISHMENT_OF_LOCALIZATION_IN_CELL,0.651037303877367
SANSOM_APC_MYC_TARGETS,SET,223,0.11232,0.012304,0.055076,0.020712,SANSOM_APC_MYC_TARGETS,0.651037303877367
MIR338_5P,SET,427,0.088077,0.013275,0.043199,0.02074,MIR338_5P,0.651037303877367
HP_ABNORMAL_NASAL_CAVITY_MOR...,SET,16,0.44539,0.013142,0.21846,0.020742,HP_ABNORMAL_NASAL_CAVITY_MORPHOLOGY,0.651037303877367
HP_EEG_WITH_PHOTOPAROXYSMAL_...,SET,15,0.45731,0.013066,0.22436,0.02077,HP_EEG_WITH_PHOTOPAROXYSMAL_RESPONSE,0.651037303877367
GSE29614_CTRL_VS_DAY7_TIV_FL...1,SET,159,0.13798,0.012785,0.067697,0.020773,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.651037303877367
GSE8685_IL2_ACT_IL2_STARVED_...1,SET,181,0.12851,0.012697,0.063052,0.020774,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,0.651037303877367
GOBP_ANTERIOR_POSTERIOR_PATT...,SET,199,0.14007,0.014504,0.068749,0.020809,GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION,0.65149201620162
MIR7850_5P,SET,110,0.16636,0.012838,0.081666,0.020826,MIR7850_5P,0.65149201620162
REACTOME_SIGNALING_BY_FGFR2_...1,SET,19,0.37233,0.011971,0.18287,0.020883,REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,0.651579085257549
GSE40274_HELIOS_VS_FOXP3_AND...1,SET,179,0.12712,0.012491,0.062448,0.0209,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.651579085257549
GOBP_CELL_DIFFERENTIATION_IN...5,SET,20,0.43074,0.014209,0.21165,0.020923,GOBP_CELL_DIFFERENTIATION_IN_HINDBRAIN,0.651579085257549
GOBP_REGULATION_OF_CAMP_DEPE...,SET,13,0.47279,0.012576,0.23233,0.020934,GOBP_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.651579085257549
KEGG_MEDICUS_PATHOGEN_SHIGEL...6,SET,5,0.63233,0.010434,0.31084,0.020968,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGB1_TO_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.651579085257549
GNF2_SPRR1B,SET,23,0.40216,0.014225,0.1977,0.020973,GNF2_SPRR1B,0.651579085257549
HP_PANCREATIC_ADENOCARCINOMA,SET,35,0.27982,0.012206,0.13757,0.020985,HP_PANCREATIC_ADENOCARCINOMA,0.651579085257549
GSE27786_LIN_NEG_VS_MONO_MAC...1,SET,182,0.12315,0.012201,0.060568,0.021019,GSE27786_LIN_NEG_VS_MONO_MAC_DN,0.651579085257549
MIR4294,SET,69,0.20644,0.012632,0.10153,0.021025,MIR4294,0.651579085257549
LUI_THYROID_CANCER_CLUSTER_5,SET,14,0.46178,0.012747,0.22712,0.021027,LUI_THYROID_CANCER_CLUSTER_5,0.651579085257549
GSE17721_LPS_VS_PAM3CSK4_0.5...1,SET,174,0.13033,0.012628,0.064113,0.02104,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN,0.651579085257549
GOCC_AXONEMAL_B_TUBULE_INNER...,SET,5,0.8887,0.014664,0.43727,0.021066,GOCC_AXONEMAL_B_TUBULE_INNER_SHEATH,0.651579085257549
KEGG_MEDICUS_REFERENCE_LPAR_...,SET,22,0.39008,0.013495,0.19198,0.021092,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY,0.651579085257549
GOBP_EPIGENETIC_REGULATION_O...,SET,209,0.1169,0.012401,0.057536,0.021098,GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.651579085257549
BIOCARTA_IL10_PATHWAY,SET,13,0.50494,0.013431,0.24855,0.02111,BIOCARTA_IL10_PATHWAY,0.651579085257549
GSE41867_NAIVE_VS_DAY6_LCMV_...2,SET,177,0.1303,0.012732,0.064157,0.021138,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.651864409937888
GOBP_GLYCOSIDE_TRANSPORT,SET,5,0.81021,0.013369,0.39913,0.02119,GOBP_GLYCOSIDE_TRANSPORT,0.65243354295837
GOCC_FILOPODIUM,SET,92,0.18999,0.013415,0.093598,0.021194,GOCC_FILOPODIUM,0.65243354295837
CORONEL_RFX7_DIRECT_TARGETS_...,SET,39,0.27135,0.012493,0.13375,0.021247,CORONEL_RFX7_DIRECT_TARGETS_UP,0.653486269911504
TESAR_ALK_TARGETS_HUMAN_ES_4...,SET,4,0.82804,0.012221,0.40831,0.021288,TESAR_ALK_TARGETS_HUMAN_ES_4D_DN,0.653774708480565
GOBP_NEGATIVE_REGULATION_OF_...53,SET,18,0.46293,0.014488,0.22828,0.021294,GOBP_NEGATIVE_REGULATION_OF_BONE_REMODELING,0.653774708480565
HP_ABNORMALITY_OF_NEUTROPHILS,SET,230,0.1129,0.012557,0.055705,0.021349,HP_ABNORMALITY_OF_NEUTROPHILS,0.6544713441331
PID_FCER1_PATHWAY,SET,56,0.22521,0.012419,0.11115,0.021377,PID_FCER1_PATHWAY,0.6544713441331
GOMF_CYSTEINE_TYPE_PEPTIDASE...,SET,145,0.13543,0.011988,0.066839,0.02138,GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY,0.6544713441331
KAN_RESPONSE_TO_ARSENIC_TRIO...,SET,108,0.18466,0.014121,0.091165,0.021413,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,0.6544713441331
HP_MUTISM,SET,46,0.24859,0.012428,0.12273,0.021415,HP_MUTISM,0.6544713441331
GOBP_PROTEIN_DEGLUTAMYLATION,SET,7,0.70031,0.013672,0.34584,0.021445,GOBP_PROTEIN_DEGLUTAMYLATION,0.6544713441331
GOBP_REGULATION_OF_PROTEIN_C...1,SET,317,0.096033,0.012509,0.047433,0.021461,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.6544713441331
SMID_BREAST_CANCER_BASAL_DN,SET,630,0.072939,0.013277,0.036035,0.021487,SMID_BREAST_CANCER_BASAL_DN,0.6544713441331
GOBP_CELLULAR_RESPONSE_TO_IN...2,SET,5,0.8043,0.013271,0.39741,0.0215,GOBP_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL,0.6544713441331
MODULE_198,SET,288,0.097351,0.012097,0.048104,0.021505,MODULE_198,0.6544713441331
PAL_PRMT5_TARGETS_UP,SET,186,0.12239,0.012256,0.060524,0.021589,PAL_PRMT5_TARGETS_UP,0.655181572545612
LANDIS_BREAST_CANCER_PROGRES...2,SET,40,0.27304,0.01273,0.13505,0.021611,LANDIS_BREAST_CANCER_PROGRESSION_UP,0.655181572545612
HP_PULMONARY_INFILTRATES,SET,51,0.25473,0.013407,0.12604,0.021644,HP_PULMONARY_INFILTRATES,0.655181572545612
HP_LIMB_ATAXIA,SET,82,0.18728,0.012488,0.092674,0.021656,HP_LIMB_ATAXIA,0.655181572545612
BROWNE_HCMV_INFECTION_48HR_UP,SET,168,0.13259,0.012625,0.065615,0.021658,BROWNE_HCMV_INFECTION_48HR_UP,0.655181572545612
LEE_EARLY_T_LYMPHOCYTE_DN,SET,54,0.24761,0.013409,0.12255,0.021673,LEE_EARLY_T_LYMPHOCYTE_DN,0.655181572545612
GSE42021_TREG_PLN_VS_CD24HI_...2,SET,184,0.13318,0.013265,0.065922,0.021689,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP,0.655181572545612
KEGG_P53_SIGNALING_PATHWAY,SET,66,0.20777,0.012435,0.10285,0.021693,KEGG_P53_SIGNALING_PATHWAY,0.655181572545612
GOBP_AMINO_ACID_SALVAGE,SET,7,0.76005,0.014838,0.37626,0.021698,GOBP_AMINO_ACID_SALVAGE,0.655181572545612
GOBP_SUGAR_MEDIATED_SIGNALIN...,SET,9,0.58922,0.013042,0.29178,0.021731,GOBP_SUGAR_MEDIATED_SIGNALING_PATHWAY,0.655384294982699
REACTOME_RHOT1_GTPASE_CYCLE,SET,5,0.67361,0.011115,0.33363,0.021748,REACTOME_RHOT1_GTPASE_CYCLE,0.655384294982699
KEGG_MEDICUS_REFERENCE_CXCR4...5,SET,26,0.3548,0.013342,0.17576,0.021769,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.655384294982699
GOMF_LIGAND_GATED_MONOATOMIC...1,SET,42,0.30684,0.014659,0.15202,0.021782,GOMF_LIGAND_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.655384294982699
POU2AF1_TARGET_GENES,SET,664,0.068105,0.012715,0.033747,0.021799,POU2AF1_TARGET_GENES,0.655384294982699
HP_ABNORMAL_MORPHOLOGY_OF_TH...2,SET,24,0.3606,0.013029,0.17877,0.021847,HP_ABNORMAL_MORPHOLOGY_OF_THE_CHOROIDAL_VASCULATURE,0.655471712846348
GAUTSCHI_SRC_SIGNALING,SET,8,0.65348,0.013638,0.324,0.021861,GAUTSCHI_SRC_SIGNALING,0.655471712846348
HP_DIABETIC_KETOACIDOSIS,SET,19,0.44582,0.014334,0.22107,0.021875,HP_DIABETIC_KETOACIDOSIS,0.655471712846348
HP_ABNORMAL_GLOMERULAR_FILTR...,SET,26,0.33008,0.012412,0.16373,0.021909,HP_ABNORMAL_GLOMERULAR_FILTRATION_RATE,0.655471712846348
GSE25123_WT_VS_PPARG_KO_MACR...8,SET,173,0.14267,0.013784,0.070801,0.021955,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP,0.655471712846348
MIR885_5P,SET,102,0.16649,0.012375,0.082655,0.021998,MIR885_5P,0.655471712846348
GOBP_NEURAL_NUCLEUS_DEVELOPM...,SET,57,0.22696,0.012626,0.1127,0.02202,GOBP_NEURAL_NUCLEUS_DEVELOPMENT,0.655471712846348
MODULE_206,SET,144,0.13953,0.012308,0.06929,0.02203,MODULE_206,0.655471712846348
GSE32986_GMCSF_AND_CURDLAN_L...2,SET,178,0.12539,0.012286,0.062276,0.022043,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.655471712846348
HP_INTRAMUSCULAR_HEMATOMA,SET,7,0.70869,0.013835,0.35218,0.022102,HP_INTRAMUSCULAR_HEMATOMA,0.655471712846348
BLANCO_MELO_COVID19_BRONCHIA...1,SET,49,0.2665,0.013749,0.13244,0.022106,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,0.655471712846348
GOBP_INFLAMMATORY_RESPONSE_T...2,SET,24,0.37815,0.013663,0.188,0.02215,GOBP_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.655471712846348
REACTOME_ERYTHROPOIETIN_ACTI...2,SET,7,0.69505,0.013569,0.34564,0.022176,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG,0.655471712846348
GOBP_POSITIVE_REGULATION_OF_...429,SET,79,0.19481,0.012751,0.096883,0.02218,GOBP_POSITIVE_REGULATION_OF_MACROAUTOPHAGY,0.655471712846348
REACTOME_PIWI_INTERACTING_RN...,SET,29,0.28575,0.011348,0.14212,0.022192,REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS,0.655471712846348
ZHAN_MULTIPLE_MYELOMA_HP_UP,SET,39,0.2768,0.012744,0.13769,0.022209,ZHAN_MULTIPLE_MYELOMA_HP_UP,0.655471712846348
BIOCARTA_ETS_PATHWAY,SET,17,0.44718,0.013601,0.22249,0.022228,BIOCARTA_ETS_PATHWAY,0.655471712846348
NKX3A_01,SET,205,0.12851,0.013503,0.063954,0.022256,NKX3A_01,0.655471712846348
YAO_TEMPORAL_RESPONSE_TO_PRO...5,SET,70,0.20595,0.012692,0.10254,0.022308,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,0.655471712846348
GSE24026_PD1_LIGATION_VS_CTR...1,SET,182,0.12587,0.012469,0.06267,0.022308,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN,0.655471712846348
HP_RIDGED_NAIL,SET,20,0.3467,0.011437,0.17264,0.022313,HP_RIDGED_NAIL,0.655471712846348
HP_UTERINE_LEIOMYOMA,SET,8,0.62537,0.013051,0.3114,0.022316,HP_UTERINE_LEIOMYOMA,0.655471712846348
HELLEBREKERS_SILENCED_DURING...,SET,71,0.21735,0.01349,0.10823,0.022321,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,0.655471712846348
REACTOME_RNA_POLYMERASE_II_T...1,SET,71,0.18425,0.011436,0.091759,0.022329,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,0.655471712846348
GSE11961_GERMINAL_CENTER_BCE...5,SET,183,0.12691,0.012607,0.063208,0.022339,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.655471712846348
GCM_RAF1,SET,37,0.25547,0.011457,0.12729,0.022381,GCM_RAF1,0.655471712846348
NIKOLSKY_BREAST_CANCER_19Q13...1,SET,21,0.59071,0.019966,0.29433,0.022385,NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,0.655471712846348
HALLMARK_TGF_BETA_SIGNALING,SET,52,0.24472,0.013005,0.12194,0.022385,HALLMARK_TGF_BETA_SIGNALING,0.655471712846348
GOBP_ATP_EXPORT,SET,6,0.84079,0.015197,0.41898,0.022394,GOBP_ATP_EXPORT,0.655471712846348
HP_GERMINOMA,SET,12,0.51929,0.013271,0.25883,0.022421,HP_GERMINOMA,0.655471712846348
GOBP_LACTATE_TRANSMEMBRANE_T...,SET,8,0.67276,0.01404,0.33535,0.022429,GOBP_LACTATE_TRANSMEMBRANE_TRANSPORT,0.655471712846348
GOBP_MESENCHYMAL_CELL_MIGRAT...,SET,57,0.24327,0.013534,0.12127,0.022431,GOBP_MESENCHYMAL_CELL_MIGRATION,0.655471712846348
GOBP_REGULATION_OF_RESTING_M...,SET,10,0.55372,0.012919,0.27606,0.022446,GOBP_REGULATION_OF_RESTING_MEMBRANE_POTENTIAL,0.655471712846348
GSE3039_CD4_TCELL_VS_B1_BCEL...1,SET,175,0.1311,0.012738,0.065364,0.02245,GSE3039_CD4_TCELL_VS_B1_BCELL_DN,0.655471712846348
HOLLEMAN_PREDNISOLONE_RESIST...3,SET,9,0.58166,0.012875,0.29003,0.022462,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,0.655471712846348
GOBP_MONONUCLEAR_CELL_DIFFER...,SET,486,0.082649,0.013268,0.041222,0.02249,GOBP_MONONUCLEAR_CELL_DIFFERENTIATION,0.655738213087248
GOBP_NEGATIVE_REGULATION_OF_...211,SET,62,0.2304,0.013366,0.11496,0.022531,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.655924280334728
BONOME_OVARIAN_CANCER_POOR_S...2,SET,28,0.33899,0.013228,0.16916,0.022544,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,0.655924280334728
ODONNELL_METASTASIS_DN,SET,23,0.39887,0.014109,0.19905,0.022553,ODONNELL_METASTASIS_DN,0.655924280334728
GOBP_PROTEOLYSIS,SET,1452,0.046964,0.012674,0.02345,0.02261,GOBP_PROTEOLYSIS,0.65674765442404
REACTOME_CHROMATIN_MODIFYING...,SET,183,0.11941,0.011862,0.059636,0.022629,REACTOME_CHROMATIN_MODIFYING_ENZYMES,0.65674765442404
MIR6815_5P,SET,54,0.22767,0.012329,0.11371,0.022638,MIR6815_5P,0.65674765442404
GSE11961_MEMORY_BCELL_DAY7_V...8,SET,185,0.12528,0.012513,0.062585,0.022658,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.656779641367807
GOBP_AMEBOIDAL_TYPE_CELL_MIG...,SET,401,0.090329,0.013203,0.045144,0.022709,GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION,0.656933111480865
GOBP_CELLULAR_RESPONSE_TO_FR...,SET,5,0.67972,0.011215,0.33971,0.02271,GOBP_CELLULAR_RESPONSE_TO_FRUCTOSE_STIMULUS,0.656933111480865
GSE27670_CTRL_VS_BLIMP1_TRAN...2,SET,186,0.12729,0.012747,0.063623,0.02272,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP,0.656933111480865
GOBP_REGULATION_OF_MITOTIC_C...4,SET,16,0.40479,0.011944,0.20238,0.022748,GOBP_REGULATION_OF_MITOTIC_CYTOKINESIS,0.657140843023256
REACTOME_EGR2_AND_SOX10_MEDI...,SET,27,0.35229,0.0135,0.17616,0.022765,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,0.657140843023256
GOBP_TRNA_TRANSCRIPTION,SET,13,0.3812,0.01014,0.1908,0.022871,GOBP_TRNA_TRANSCRIPTION,0.659652784232365
HP_DYSGRAPHIA,SET,51,0.2377,0.012511,0.11906,0.022944,HP_DYSGRAPHIA,0.660544250614251
GSE5589_WT_VS_IL6_KO_LPS_AND...4,SET,175,0.12657,0.012298,0.063403,0.022958,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.660544250614251
REACTOME_CYTOSOLIC_SENSORS_O...,SET,57,0.21344,0.011874,0.10695,0.022994,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,0.660544250614251
GOBP_PROTECTION_FROM_NATURAL...,SET,6,0.76934,0.013906,0.3856,0.023019,GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.660544250614251
GOCC_NODE_OF_RANVIER,SET,16,0.46271,0.013654,0.23195,0.023036,GOCC_NODE_OF_RANVIER,0.660544250614251
SMID_BREAST_CANCER_RELAPSE_I...8,SET,21,0.39844,0.013468,0.19977,0.023054,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,0.660544250614251
GOBP_REGULATION_OF_ASPARTIC_...2,SET,7,0.69093,0.013489,0.34646,0.023069,GOBP_REGULATION_OF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.660544250614251
GERHOLD_ADIPOGENESIS_UP,SET,46,0.26465,0.01323,0.13275,0.023105,GERHOLD_ADIPOGENESIS_UP,0.660544250614251
REACTOME_REGULATION_OF_SIGNA...2,SET,9,0.57651,0.012761,0.2892,0.023114,REACTOME_REGULATION_OF_SIGNALING_BY_NODAL,0.660544250614251
GSE46606_DAY1_VS_DAY3_CD40L_...7,SET,179,0.12308,0.012094,0.061745,0.023119,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN,0.660544250614251
GOBP_REGULATORY_T_CELL_DIFFE...,SET,35,0.29554,0.012892,0.14828,0.023129,GOBP_REGULATORY_T_CELL_DIFFERENTIATION,0.660544250614251
HP_BACK_PAIN,SET,68,0.20545,0.01248,0.1031,0.023152,HP_BACK_PAIN,0.660544250614251
GOBP_ORGANELLE_LOCALIZATION,SET,556,0.071638,0.012276,0.035957,0.023174,GOBP_ORGANELLE_LOCALIZATION,0.660544250614251
BOYLAN_MULTIPLE_MYELOMA_PCA1...1,SET,8,0.65404,0.01365,0.32834,0.023196,BOYLAN_MULTIPLE_MYELOMA_PCA1_DN,0.660544250614251
KEGG_MEDICUS_REFERENCE_CYTOK...,SET,42,0.28965,0.013838,0.14541,0.023198,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY,0.660544250614251
GOBP_CYTOPLASMIC_SEQUESTERIN...1,SET,4,0.78773,0.011626,0.39549,0.023206,GOBP_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB,0.660544250614251
GOBP_CHORIONIC_TROPHOBLAST_C...2,SET,5,0.75878,0.01252,0.38126,0.023293,GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION,0.66247808101473
URS_ADIPOCYTE_DIFFERENTIATIO...1,SET,31,0.32323,0.013271,0.16245,0.023316,URS_ADIPOCYTE_DIFFERENTIATION_DN,0.662590008176615
GOCC_HIGH_DENSITY_LIPOPROTEI...,SET,21,0.40253,0.013606,0.20245,0.023398,GOCC_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.663860187601958
HP_ABNORMALITY_OF_PANCREAS_P...,SET,147,0.14506,0.012928,0.07296,0.023404,HP_ABNORMALITY_OF_PANCREAS_PHYSIOLOGY,0.663860187601958
HP_MATURITY_ONSET_DIABETES_O...,SET,19,0.44015,0.014152,0.22141,0.023418,HP_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.663860187601958
HE_LIM_SUN_FETAL_LUNG_C1_MID...1,SET,14,0.52101,0.014382,0.26219,0.023461,HE_LIM_SUN_FETAL_LUNG_C1_MID_AIRWAY_PROGENITOR_CELL,0.664537127139364
KEGG_MEDICUS_REFERENCE_HEDGE...1,SET,14,0.44004,0.012146,0.22149,0.023485,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY,0.664675223941368
GOMF_R_SMAD_BINDING,SET,25,0.35855,0.013222,0.18056,0.023541,GOMF_R_SMAD_BINDING,0.665506355932203
HP_MENORRHAGIA,SET,34,0.30293,0.013024,0.15263,0.023593,HP_MENORRHAGIA,0.665506355932203
GOBP_NEGATIVE_REGULATION_OF_...669,SET,9,0.50808,0.011246,0.25602,0.023607,GOBP_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.665506355932203
HP_OPEN_OPERCULUM,SET,6,0.67246,0.012154,0.33895,0.023638,HP_OPEN_OPERCULUM,0.665506355932203
HP_HIPPOCAMPAL_ATROPHY,SET,5,0.79091,0.01305,0.39866,0.02364,HP_HIPPOCAMPAL_ATROPHY,0.665506355932203
REACTOME_CD163_MEDIATING_AN_...,SET,8,0.60152,0.012554,0.3032,0.023641,REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE,0.665506355932203
GCCATNTTG_YY1_Q6,SET,385,0.085201,0.012208,0.042951,0.023654,GCCATNTTG_YY1_Q6,0.665506355932203
PID_AR_TF_PATHWAY,SET,49,0.24081,0.012424,0.12147,0.023716,PID_AR_TF_PATHWAY,0.665506355932203
MIR4518,SET,81,0.18254,0.012098,0.092072,0.023717,MIR4518,0.665506355932203
GSE44649_NAIVE_VS_ACTIVATED_...1,SET,176,0.12184,0.011872,0.061458,0.023717,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.665506355932203
HP_POSITIVE_ROMBERG_SIGN,SET,26,0.31079,0.011687,0.15677,0.023725,HP_POSITIVE_ROMBERG_SIGN,0.665506355932203
DESCARTES_MAIN_FETAL_ERYTHRO...,SET,194,0.1222,0.012495,0.061672,0.023774,DESCARTES_MAIN_FETAL_ERYTHROBLASTS,0.666216721641191
EVI1_05,SET,161,0.14008,0.01306,0.070713,0.023807,EVI1_05,0.666216721641191
HOEK_MONOCYTE_2011_2012_TIV_...1,SET,13,0.45516,0.012107,0.22981,0.023825,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_DN,0.666216721641191
HP_CONE_SHAPED_METACARPAL_EP...,SET,4,0.86221,0.012725,0.43533,0.023827,HP_CONE_SHAPED_METACARPAL_EPIPHYSES,0.666216721641191
GOBP_SEGMENT_SPECIFICATION,SET,14,0.50449,0.013926,0.25485,0.023887,GOBP_SEGMENT_SPECIFICATION,0.666429208633094
GSE7852_LN_VS_FAT_TCONV_DN,SET,176,0.13204,0.012865,0.066719,0.023916,GSE7852_LN_VS_FAT_TCONV_DN,0.666429208633094
GOMF_NERVE_GROWTH_FACTOR_BIN...,SET,5,0.84736,0.013982,0.42818,0.023918,GOMF_NERVE_GROWTH_FACTOR_BINDING,0.666429208633094
GOMF_HISTONE_H3K4_TRIMETHYLT...,SET,10,0.55367,0.012918,0.27984,0.023941,GOMF_HISTONE_H3K4_TRIMETHYLTRANSFERASE_ACTIVITY,0.666429208633094
LET_7A_2_3P,SET,265,0.10647,0.012698,0.053821,0.023962,LET_7A_2_3P,0.666429208633094
LET_7G_3P,SET,265,0.10647,0.012698,0.053821,0.023962,LET_7G_3P,0.666429208633094
HP_APLASIA_HYPOPLASIA_OF_THE...27,SET,47,0.25194,0.012731,0.12738,0.023976,HP_APLASIA_HYPOPLASIA_OF_THE_EARLOBES,0.666429208633094
PID_SYNDECAN_4_PATHWAY,SET,31,0.31325,0.012861,0.15839,0.023988,PID_SYNDECAN_4_PATHWAY,0.666429208633094
HP_HEPATOMEGALY,SET,572,0.071509,0.012424,0.036175,0.024043,HP_HEPATOMEGALY,0.666636375598086
GOCC_COPI_COATED_VESICLE,SET,24,0.31657,0.011438,0.16015,0.02405,GOCC_COPI_COATED_VESICLE,0.666636375598086
MORF_LTK,SET,137,0.14657,0.012613,0.074152,0.024053,MORF_LTK,0.666636375598086
MEL18_DN.V1_DN,SET,134,0.16245,0.013827,0.082243,0.024129,MEL18_DN.V1_DN,0.668209876494024
GAVIN_IL2_RESPONSIVE_FOXP3_T...2,SET,15,0.52119,0.014891,0.26396,0.024169,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,0.668784709394904
MIR342_3P,SET,111,0.15781,0.012233,0.079998,0.024276,MIR342_3P,0.670826232283464
HP_CALF_MUSCLE_HYPERTROPHY,SET,42,0.27929,0.013343,0.14159,0.024282,HP_CALF_MUSCLE_HYPERTROPHY,0.670826232283464
GSE4590_LARGE_PRE_BCELL_VS_V...1,SET,172,0.13205,0.012721,0.066976,0.024333,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.670826232283464
MIR2277_3P,SET,15,0.44425,0.012693,0.22539,0.024368,MIR2277_3P,0.670826232283464
MIR6872_3P,SET,61,0.22049,0.012688,0.11189,0.024391,MIR6872_3P,0.670826232283464
HP_ABNORMAL_CALF_MUSCULATURE...,SET,60,0.22377,0.012771,0.11356,0.024401,HP_ABNORMAL_CALF_MUSCULATURE_MORPHOLOGY,0.670826232283464
HP_CONGENITAL_LARYNGEAL_STRI...,SET,7,0.61181,0.011944,0.31064,0.024453,HP_CONGENITAL_LARYNGEAL_STRIDOR,0.670826232283464
HE_LIM_SUN_FETAL_LUNG_C1_EAR...2,SET,497,0.074335,0.012064,0.037747,0.024468,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL,0.670826232283464
HALLMARK_MTORC1_SIGNALING,SET,184,0.12049,0.012001,0.061192,0.024486,HALLMARK_MTORC1_SIGNALING,0.670826232283464
GSE2770_IL12_AND_TGFB_ACT_VS...4,SET,178,0.12348,0.012099,0.06272,0.024503,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP,0.670826232283464
GOBP_VASCULAR_WOUND_HEALING,SET,18,0.41549,0.013003,0.21106,0.024506,GOBP_VASCULAR_WOUND_HEALING,0.670826232283464
KEGG_MEDICUS_VARIANT_MUTATIO...29,SET,15,0.39763,0.011361,0.20199,0.024508,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.670826232283464
HALLMARK_APOPTOSIS,SET,149,0.13987,0.012549,0.071052,0.02451,HALLMARK_APOPTOSIS,0.670826232283464
GOBP_REGULATION_OF_UBIQUITIN...1,SET,149,0.13601,0.012203,0.069095,0.024513,GOBP_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.670826232283464
GOBP_TRANSCRIPTION_BY_RNA_PO...1,SET,58,0.20522,0.011516,0.10431,0.02458,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.671984646226415
MIR1244,SET,86,0.17685,0.012075,0.089903,0.024594,MIR1244,0.671984646226415
NCX_01,SET,160,0.13804,0.01283,0.070199,0.024634,NCX_01,0.672548837391987
GSE39820_IL1B_IL6_VS_IL1B_IL...2,SET,181,0.12659,0.012507,0.064397,0.024672,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP,0.673057582417582
REACTOME_ISG15_ANTIVIRAL_MEC...,SET,70,0.19331,0.011914,0.098384,0.024721,REACTOME_ISG15_ANTIVIRAL_MECHANISM,0.673182188958009
GOBP_TRANSPORT_OF_VIRUS,SET,20,0.37393,0.012335,0.19032,0.02473,GOBP_TRANSPORT_OF_VIRUS,0.673182188958009
GOBP_DENDRITIC_CELL_DIFFEREN...,SET,45,0.27123,0.013412,0.13811,0.02478,GOBP_DENDRITIC_CELL_DIFFERENTIATION,0.673182188958009
GSE3982_BASOPHIL_VS_EFF_MEMO...1,SET,172,0.12495,0.012037,0.063634,0.024795,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.673182188958009
GSE360_LOW_DOSE_B_MALAYI_VS_...2,SET,183,0.11925,0.011846,0.060736,0.024809,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.673182188958009
MAYBURD_RESPONSE_TO_L663536_...2,SET,22,0.35292,0.012209,0.17977,0.024818,MAYBURD_RESPONSE_TO_L663536_UP,0.673182188958009
WP_INTERACTOME_OF_POLYCOMB_R...,SET,15,0.4086,0.011674,0.20816,0.024835,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,0.673182188958009
CCAWYNNGAAR_UNKNOWN,SET,123,0.1541,0.012571,0.078511,0.024845,CCAWYNNGAAR_UNKNOWN,0.673182188958009
GCNF_01,SET,67,0.21283,0.012833,0.10848,0.024893,GCNF_01,0.673182188958009
ZHU_CMV_8_HR_UP,SET,39,0.28387,0.01307,0.1447,0.024898,ZHU_CMV_8_HR_UP,0.673182188958009
HP_TRUNCAL_ATAXIA,SET,66,0.20783,0.012438,0.10594,0.024903,HP_TRUNCAL_ATAXIA,0.673182188958009
KEGG_MEDICUS_VARIANT_MUTATIO...44,SET,5,0.81868,0.013508,0.41734,0.024909,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_EXTRINSIC_APOPTOTIC_PATHWAY,0.673182188958009
HP_ABNORMAL_SHARPEY_FIBER_MO...,SET,31,0.34702,0.014247,0.17698,0.024958,HP_ABNORMAL_SHARPEY_FIBER_MORPHOLOGY,0.673513043478261
GOBP_REGULATION_OF_COMPLEMEN...3,SET,9,0.71351,0.015793,0.36389,0.02496,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.673513043478261
HP_ERECTILE_DYSFUNCTION,SET,60,0.22501,0.012842,0.11478,0.024983,HP_ERECTILE_DYSFUNCTION,0.673610678820791
GAVISH_3CA_METAPROGRAM_MACRO...11,SET,42,0.24057,0.011493,0.12274,0.025012,GAVISH_3CA_METAPROGRAM_MACROPHAGES_RESPIRATION,0.673869813953488
LEE_EARLY_T_LYMPHOCYTE_UP,SET,95,0.17257,0.012382,0.088087,0.025056,LEE_EARLY_T_LYMPHOCYTE_UP,0.674048553240741
GOMF_PHOSPHATIDYLINOSITOL_BI...2,SET,98,0.16952,0.012352,0.086531,0.025058,GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING,0.674048553240741
GOBP_OLIGOSACCHARIDE_CATABOL...,SET,16,0.43531,0.012845,0.2223,0.025112,GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS,0.674048553240741
REACTOME_RHOG_GTPASE_CYCLE,SET,68,0.21492,0.013056,0.10976,0.025113,REACTOME_RHOG_GTPASE_CYCLE,0.674048553240741
GOMF_BILE_ACID_BINDING,SET,10,0.60974,0.014226,0.31141,0.025124,GOMF_BILE_ACID_BINDING,0.674048553240741
GSE3982_MAC_VS_NEUTROPHIL_DN,SET,174,0.12781,0.012384,0.065285,0.025135,GSE3982_MAC_VS_NEUTROPHIL_DN,0.674048553240741
GOBP_HEART_FIELD_SPECIFICATI...,SET,17,0.49633,0.015096,0.25369,0.025216,GOBP_HEART_FIELD_SPECIFICATION,0.674450026902383
GOBP_ADIPOSE_TISSUE_DEVELOPM...,SET,55,0.22605,0.012354,0.11555,0.025228,GOBP_ADIPOSE_TISSUE_DEVELOPMENT,0.674450026902383
HP_CONSTITUTIONAL_SYMPTOM,SET,1128,0.052686,0.012652,0.026936,0.025241,HP_CONSTITUTIONAL_SYMPTOM,0.674450026902383
KEGG_MEDICUS_REFERENCE_BLOOD...1,SET,6,0.73163,0.013224,0.37406,0.025245,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS,0.674450026902383
CROONQUIST_NRAS_SIGNALING_UP,SET,32,0.31544,0.013158,0.16128,0.025247,CROONQUIST_NRAS_SIGNALING_UP,0.674450026902383
HMEF2_Q6,SET,129,0.14949,0.012487,0.076465,0.025297,HMEF2_Q6,0.674912804597701
HP_PREMATURE_LOSS_OF_PERMANE...,SET,7,0.6604,0.012892,0.33782,0.025307,HP_PREMATURE_LOSS_OF_PERMANENT_TEETH,0.674912804597701
GOBP_POSITIVE_REGULATION_OF_...647,SET,140,0.14792,0.012867,0.07568,0.025328,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SECRETION,0.674912804597701
GOBP_NEGATIVE_REGULATION_OF_...462,SET,26,0.31649,0.011901,0.16195,0.025342,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.674912804597701
GOBP_EMBRYO_DEVELOPMENT,SET,1048,0.054445,0.012631,0.02787,0.025388,GOBP_EMBRYO_DEVELOPMENT,0.674963324427481
GSE27434_WT_VS_DNMT1_KO_TREG...2,SET,182,0.11646,0.011537,0.059618,0.025394,GSE27434_WT_VS_DNMT1_KO_TREG_UP,0.674963324427481
GSE7460_CTRL_VS_TGFB_TREATED...2,SET,184,0.12232,0.012184,0.062639,0.025431,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP,0.674963324427481
PID_AVB3_INTEGRIN_PATHWAY,SET,72,0.20666,0.012916,0.10583,0.025432,PID_AVB3_INTEGRIN_PATHWAY,0.674963324427481
MIR3926,SET,160,0.1297,0.012055,0.066426,0.025441,MIR3926,0.674963324427481
GSE28237_EARLY_VS_LATE_GC_BC...1,SET,175,0.12196,0.01185,0.062493,0.025504,GSE28237_EARLY_VS_LATE_GC_BCELL_DN,0.675909310738766
HP_ANKYLOBLEPHARON,SET,13,0.41161,0.010949,0.21094,0.025517,HP_ANKYLOBLEPHARON,0.675909310738766
PARK_APL_PATHOGENESIS_DN,SET,47,0.25754,0.013014,0.132,0.025535,PARK_APL_PATHOGENESIS_DN,0.675909310738766
GSE360_CTRL_VS_L_MAJOR_DC_UP,SET,180,0.12271,0.01209,0.06291,0.025565,GSE360_CTRL_VS_L_MAJOR_DC_UP,0.675938498098859
FEKIR_HEPARG_SPHERE_VS_HEPAR...1,SET,34,0.30524,0.013123,0.15651,0.025575,FEKIR_HEPARG_SPHERE_VS_HEPARG_DN,0.675938498098859
KEGG_MEDICUS_REFERENCE_ALTER...,SET,5,0.86325,0.014244,0.44276,0.025613,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN,0.676257881548975
HP_BIRD_LIKE_FACIES,SET,13,0.40552,0.010787,0.20801,0.025626,HP_BIRD_LIKE_FACIES,0.676257881548975
GOCC_PRESYNAPTIC_ACTIVE_ZONE...2,SET,30,0.32546,0.013145,0.16707,0.025716,GOCC_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,0.677433313161876
chr1q41,SET,31,0.51575,0.021175,0.26482,0.025743,chr1q41,0.677433313161876
GSE17721_CTRL_VS_GARDIQUIMOD...12,SET,184,0.11661,0.011616,0.059879,0.025745,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP,0.677433313161876
REACTOME_RNA_POLYMERASE_I_TR...2,SET,42,0.22807,0.010896,0.11713,0.025763,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,0.677433313161876
GOBP_NEGATIVE_REGULATION_OF_...495,SET,34,0.28692,0.012336,0.14736,0.025768,GOBP_NEGATIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.677433313161876
GOMF_CYSTEINE_TYPE_ENDOPEPTI...8,SET,37,0.28855,0.01294,0.14823,0.025801,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.677788174603175
GOCC_GPI_ANCHOR_TRANSAMIDASE...,SET,5,0.6278,0.010359,0.32265,0.025849,GOCC_GPI_ANCHOR_TRANSAMIDASE_COMPLEX,0.677892739261492
GOBP_NEGATIVE_REGULATION_OF_...541,SET,18,0.38989,0.012202,0.20041,0.025867,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.677892739261492
MIR6128,SET,153,0.13438,0.012216,0.069079,0.02588,MIR6128,0.677892739261492
DURANTE_ADULT_OLFACTORY_NEUR...13,SET,72,0.21477,0.013423,0.11041,0.025883,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS,0.677892739261492
GOBP_POSITIVE_REGULATION_OF_...834,SET,156,0.14238,0.013068,0.073217,0.025918,GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.678164741766467
GSE10240_IL22_VS_IL17_STIM_P...1,SET,174,0.12229,0.011848,0.06291,0.025962,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.678164741766467
MIR6865_5P,SET,55,0.21915,0.011977,0.11277,0.025993,MIR6865_5P,0.678164741766467
TRAVAGLINI_LUNG_IGSF21_DENDR...,SET,43,0.28715,0.01388,0.14777,0.026001,TRAVAGLINI_LUNG_IGSF21_DENDRITIC_CELL,0.678164741766467
BIOCARTA_MCM_PATHWAY,SET,18,0.40382,0.012638,0.20782,0.026008,BIOCARTA_MCM_PATHWAY,0.678164741766467
HP_ABNORMAL_CIRCULATING_VITA...3,SET,19,0.38923,0.012515,0.20035,0.026029,HP_ABNORMAL_CIRCULATING_VITAMIN_E_CONCENTRATION,0.678164741766467
HP_EEG_WITH_SPIKE_WAVE_COMPL...1,SET,88,0.18294,0.012635,0.094176,0.026046,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES,0.678164741766467
GOMF_MANNOSYL_OLIGOSACCHARID...2,SET,9,0.58691,0.012991,0.3022,0.026068,GOMF_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY,0.678164741766467
GOCC_TRANSCRIPTION_REPRESSOR...,SET,72,0.1996,0.012475,0.10277,0.026069,GOCC_TRANSCRIPTION_REPRESSOR_COMPLEX,0.678164741766467
HE_LIM_SUN_FETAL_LUNG_C7_PRO...,SET,909,0.055075,0.011947,0.028382,0.026168,HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL,0.679469307520477
HP_LEUKOCYTOSIS,SET,140,0.14083,0.012251,0.072578,0.026171,HP_LEUKOCYTOSIS,0.679469307520477
GSE22443_IL2_VS_IL12_TREATED...1,SET,188,0.11645,0.011723,0.060017,0.026186,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN,0.679469307520477
HP_INTRACELLULAR_ACCUMULATIO...,SET,13,0.42835,0.011394,0.22081,0.026202,HP_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.679469307520477
HP_ABNORMAL_LEUKOCYTE_COUNT,SET,435,0.079508,0.012092,0.040993,0.026224,HP_ABNORMAL_LEUKOCYTE_COUNT,0.679469307520477
KEGG_MEDICUS_REFERENCE_TRANS...2,SET,28,0.27695,0.010807,0.14283,0.026255,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER,0.679469307520477
MODULE_15,SET,318,0.096236,0.012555,0.049631,0.026256,MODULE_15,0.679469307520477
GOBP_EMBRYONIC_DIGIT_MORPHOG...,SET,53,0.24155,0.012959,0.12463,0.026314,GOBP_EMBRYONIC_DIGIT_MORPHOGENESIS,0.68046359375
HP_EXPRESSIVE_APHASIA,SET,11,0.51454,0.012591,0.26562,0.026373,HP_EXPRESSIVE_APHASIA,0.680569369903632
HP_MONOCYTOPENIA,SET,5,0.89056,0.014694,0.45975,0.026378,HP_MONOCYTOPENIA,0.680569369903632
GOMF_STEROL_TRANSFER_ACTIVITY,SET,23,0.36826,0.013026,0.19013,0.026389,GOMF_STEROL_TRANSFER_ACTIVITY,0.680569369903632
GSE6259_33D1_POS_VS_DEC205_P...3,SET,179,0.13074,0.012846,0.06751,0.026404,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN,0.680569369903632
HP_ABNORMAL_GRANULOCYTE_COUNT,SET,234,0.10705,0.012008,0.055282,0.026416,HP_ABNORMAL_GRANULOCYTE_COUNT,0.680569369903632
GOBP_REGULATION_OF_NUCLEOTID...1,SET,13,0.52123,0.013865,0.26923,0.026441,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.680708855555555
STAMBOLSKY_TARGETS_OF_MUTATE...1,SET,47,0.24459,0.01236,0.12645,0.02655,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,0.682789871134021
HP_FOCAL_SEGMENTAL_GLOMERULO...,SET,51,0.23051,0.012132,0.11921,0.026583,HP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS,0.682789871134021
MIR3157_5P,SET,97,0.16241,0.011774,0.084015,0.026619,MIR3157_5P,0.682789871134021
E2F1_UP.V1_UP,SET,172,0.11875,0.01144,0.06143,0.026619,E2F1_UP.V1_UP,0.682789871134021
GOBP_LOCALIZATION_WITHIN_MEM...,SET,617,0.06706,0.012085,0.034694,0.026633,GOBP_LOCALIZATION_WITHIN_MEMBRANE,0.682789871134021
GOBP_PROTEIN_LOCALIZATION_TO...40,SET,866,0.055503,0.011766,0.02872,0.026654,GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.682789871134021
VANHARANTA_UTERINE_FIBROID_W...1,SET,35,0.29419,0.012833,0.15224,0.026665,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,0.682789871134021
GOBP_POSITIVE_REGULATION_OF_...525,SET,8,0.6268,0.013081,0.32441,0.026679,GOBP_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.682789871134021
BCAT.100_UP.V1_UP,SET,45,0.28061,0.013875,0.14529,0.026728,BCAT.100_UP.V1_UP,0.683540573951435
PITX1_TARGET_GENES,SET,290,0.095373,0.011891,0.049414,0.026807,PITX1_TARGET_GENES,0.685056827205882
HP_ABNORMAL_VISUAL_FIELD_TEST,SET,20,0.3636,0.011994,0.18845,0.026846,HP_ABNORMAL_VISUAL_FIELD_TEST,0.685122610132159
HP_TOTAL_OPHTHALMOPLEGIA,SET,5,0.70595,0.011648,0.36589,0.026849,HP_TOTAL_OPHTHALMOPLEGIA,0.685122610132159
GOBP_BILE_ACID_METABOLIC_PRO...,SET,49,0.24485,0.012632,0.12698,0.026919,GOBP_BILE_ACID_METABOLIC_PROCESS,0.686404875275128
HP_MYOSITIS,SET,34,0.28091,0.012077,0.14574,0.02697,HP_MYOSITIS,0.687201136363636
REACTOME_INTERLEUKIN_21_SIGN...,SET,9,0.66273,0.014669,0.34401,0.02703,REACTOME_INTERLEUKIN_21_SIGNALING,0.687783157894737
ZNF837_TARGET_GENES,SET,5,0.76059,0.01255,0.39485,0.027043,ZNF837_TARGET_GENES,0.687783157894737
REACTOME_RHO_GTPASES_ACTIVAT...6,SET,19,0.36799,0.011832,0.19105,0.027054,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,0.687783157894737
CHESLER_BRAIN_QTL_TRANS,SET,6,0.70721,0.012782,0.36723,0.027072,CHESLER_BRAIN_QTL_TRANS,0.687783157894737
chr1q31,SET,30,0.46126,0.01863,0.23956,0.027096,chr1q31,0.687793839416058
GOCC_NUCLEOLUS,SET,908,0.053512,0.011602,0.027796,0.027112,GOCC_NUCLEOLUS,0.687793839416058
GSE2585_CTEC_VS_THYMIC_DC_UP,SET,178,0.12581,0.012328,0.065367,0.027142,GSE2585_CTEC_VS_THYMIC_DC_UP,0.688052669584245
GOBP_BILE_ACID_BIOSYNTHETIC_...,SET,36,0.27492,0.012162,0.14291,0.027199,GOBP_BILE_ACID_BIOSYNTHETIC_PROCESS,0.688962307412791
GSE18791_UNSTIM_VS_NEWCATSLE...5,SET,159,0.12962,0.012011,0.067411,0.027254,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN,0.688962307412791
MODULE_57,SET,55,0.21085,0.011523,0.10966,0.027261,MODULE_57,0.688962307412791
HP_ABNORMAL_LIVER_MORPHOLOGY,SET,790,0.059459,0.012066,0.030924,0.027265,HP_ABNORMAL_LIVER_MORPHOLOGY,0.688962307412791
MACAEVA_PBMC_RESPONSE_TO_IR,SET,90,0.17127,0.011962,0.089087,0.027277,MACAEVA_PBMC_RESPONSE_TO_IR,0.688962307412791
HP_LIMITED_KNEE_EXTENSION,SET,17,0.42635,0.012968,0.22192,0.027359,HP_LIMITED_KNEE_EXTENSION,0.690531623093682
GOCC_RNA_POLYMERASE_II_TRANS...2,SET,14,0.44285,0.012224,0.23055,0.027386,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REPRESSOR_COMPLEX,0.69071148766328
GOMF_CORECEPTOR_ACTIVITY,SET,52,0.24229,0.012876,0.12618,0.027426,GOMF_CORECEPTOR_ACTIVITY,0.691218730964467
WU_APOPTOSIS_BY_CDKN1A_VIA_T...,SET,50,0.22487,0.011719,0.11714,0.027459,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,0.691548945652174
MIR4432,SET,62,0.2068,0.011997,0.10776,0.027493,MIR4432,0.691780419681621
GOBP_POSITIVE_REGULATION_OF_...296,SET,1056,0.053162,0.012378,0.027705,0.027508,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION,0.691780419681621
GOBP_SENSORY_ORGAN_MORPHOGEN...,SET,261,0.10975,0.012992,0.057206,0.02753,GOBP_SENSORY_ORGAN_MORPHOGENESIS,0.691833080260304
GOBP_POSITIVE_REGULATION_OF_...671,SET,20,0.39782,0.013123,0.20749,0.027609,GOBP_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.692278653017241
MIR4762_3P,SET,242,0.10766,0.012278,0.056161,0.027627,MIR4762_3P,0.692278653017241
TTGCWCAAY_CEBPB_02,SET,60,0.21894,0.012496,0.11422,0.027637,TTGCWCAAY_CEBPB_02,0.692278653017241
REACTOME_ADP_SIGNALLING_THRO...1,SET,25,0.35816,0.013207,0.18688,0.027659,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,0.692278653017241
GSE25088_WT_VS_STAT6_KO_MACR...8,SET,165,0.12495,0.011792,0.065214,0.02769,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP,0.692278653017241
GSE25123_CTRL_VS_IL4_AND_ROS...3,SET,185,0.12144,0.012128,0.063388,0.027707,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.692278653017241
GOBP_POSITIVE_REGULATION_OF_...138,SET,851,0.060242,0.012666,0.031447,0.027713,GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.692278653017241
GSE3982_BCELL_VS_BASOPHIL_UP,SET,164,0.12272,0.011546,0.064067,0.027726,GSE3982_BCELL_VS_BASOPHIL_UP,0.692278653017241
HP_LIMB_MUSCLE_WEAKNESS,SET,306,0.094294,0.012071,0.049228,0.027727,HP_LIMB_MUSCLE_WEAKNESS,0.692278653017241
GOBP_HYALURONAN_METABOLIC_PR...,SET,32,0.29148,0.012158,0.1522,0.027752,GOBP_HYALURONAN_METABOLIC_PROCESS,0.692405427135678
GOBP_RESPONSE_TO_TESTOSTERONE,SET,39,0.26036,0.011987,0.13601,0.027803,GOBP_RESPONSE_TO_TESTOSTERONE,0.692882655913978
MIR6804_3P,SET,85,0.18482,0.012546,0.096556,0.027811,MIR6804_3P,0.692882655913978
REACTOME_NEGATIVE_REGULATION...12,SET,15,0.46174,0.013193,0.24137,0.027881,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,0.694129050859599
GOBP_NEGATIVE_REGULATION_OF_...246,SET,4,0.67328,0.0099367,0.35203,0.02791,GOBP_NEGATIVE_REGULATION_OF_G0_TO_G1_TRANSITION,0.694353650680029
MIR3912_3P,SET,5,0.70526,0.011637,0.36886,0.027947,MIR3912_3P,0.694776813304721
GOBP_NEGATIVE_REGULATION_OF_...200,SET,13,0.44873,0.011936,0.23475,0.027977,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.694777735378031
GOBP_REGULATION_OF_HEART_MOR...,SET,8,0.72865,0.015207,0.38128,0.028006,GOBP_REGULATION_OF_HEART_MORPHOGENESIS,0.694777735378031
HP_DECREASED_CIRCULATING_ACT...,SET,28,0.30914,0.012063,0.16178,0.028017,HP_DECREASED_CIRCULATING_ACTH_CONCENTRATION,0.694777735378031
HP_PERSEVERATIVE_THOUGHT,SET,19,0.36598,0.011767,0.19154,0.028027,HP_PERSEVERATIVE_THOUGHT,0.694777735378031
GOBP_PROTEIN_DEUBIQUITINATION,SET,71,0.17773,0.011031,0.093093,0.028128,GOBP_PROTEIN_DEUBIQUITINATION,0.6954568275154
GSE2770_TGFB_AND_IL4_VS_TGFB...4,SET,171,0.11585,0.011128,0.060706,0.028183,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.6954568275154
GOBP_NEGATIVE_REGULATION_OF_...216,SET,28,0.31298,0.012213,0.16404,0.028207,GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.6954568275154
GSE360_L_MAJOR_VS_B_MALAYI_H...2,SET,177,0.12586,0.012298,0.065993,0.028262,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.6954568275154
GSE15735_2H_VS_12H_HDAC_INHI...1,SET,189,0.11853,0.011964,0.062155,0.028273,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN,0.6954568275154
MORF_DMPK,SET,153,0.13528,0.012297,0.070956,0.028302,MORF_DMPK,0.6954568275154
GOMF_DEATH_RECEPTOR_ACTIVITY,SET,12,0.53609,0.013701,0.28128,0.028338,GOMF_DEATH_RECEPTOR_ACTIVITY,0.6954568275154
GOCC_INCLUSION_BODY,SET,66,0.19593,0.011726,0.10282,0.028354,GOCC_INCLUSION_BODY,0.6954568275154
HP_CALVARIAL_OSTEOSCLEROSIS,SET,7,0.6124,0.011955,0.32135,0.028354,HP_CALVARIAL_OSTEOSCLEROSIS,0.6954568275154
GOBP_PROGESTERONE_RECEPTOR_S...,SET,10,0.54564,0.012731,0.28633,0.028355,GOBP_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY,0.6954568275154
GOBP_INTESTINAL_EPITHELIAL_S...,SET,7,0.67624,0.013202,0.35488,0.028363,GOBP_INTESTINAL_EPITHELIAL_STRUCTURE_MAINTENANCE,0.6954568275154
GSE9960_HEALTHY_VS_GRAM_POS_...2,SET,165,0.11939,0.011267,0.062657,0.028366,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP,0.6954568275154
MOREIRA_RESPONSE_TO_TSA_UP,SET,25,0.32053,0.01182,0.16824,0.028387,MOREIRA_RESPONSE_TO_TSA_UP,0.6954568275154
HOLLERN_EMT_BREAST_TUMOR_DN,SET,115,0.15647,0.012345,0.082133,0.028393,HOLLERN_EMT_BREAST_TUMOR_DN,0.6954568275154
MIR5703,SET,150,0.13243,0.011921,0.069523,0.028408,MIR5703,0.6954568275154
HP_FINGERNAIL_DYSPLASIA,SET,16,0.40889,0.012065,0.21471,0.028438,HP_FINGERNAIL_DYSPLASIA,0.6954568275154
GSE1740_UNSTIM_VS_IFNA_STIMU...2,SET,154,0.12997,0.011854,0.068251,0.028442,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP,0.6954568275154
GOBP_NEGATIVE_REGULATION_OF_...586,SET,3,1.1225,0.014347,0.58962,0.028482,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.6954568275154
GOBP_REGULATION_OF_AUTOPHAGY,SET,333,0.089174,0.0119,0.046851,0.028505,GOBP_REGULATION_OF_AUTOPHAGY,0.6954568275154
WP_NCRNAS_INVOLVED_IN_WNT_SI...,SET,82,0.19452,0.012971,0.10223,0.028543,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.6954568275154
HP_ESOPHAGEAL_CARCINOMA,SET,13,0.4606,0.012252,0.24209,0.028555,HP_ESOPHAGEAL_CARCINOMA,0.6954568275154
HP_SILVER_GRAY_HAIR,SET,6,0.64101,0.011586,0.33693,0.028562,HP_SILVER_GRAY_HAIR,0.6954568275154
GSE15659_NAIVE_VS_PTPRC_NEG_...1,SET,170,0.12581,0.01205,0.066137,0.028581,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN,0.6954568275154
GOBP_LEUKOCYTE_DIFFERENTIATI...,SET,578,0.07223,0.012612,0.037974,0.028589,GOBP_LEUKOCYTE_DIFFERENTIATION,0.6954568275154
HP_DECREASED_CIRCULATING_ANT...,SET,175,0.1228,0.011932,0.064576,0.02862,HP_DECREASED_CIRCULATING_ANTIBODY_LEVEL,0.6954568275154
GOBP_CEREBELLAR_CORTEX_DEVEL...,SET,46,0.23923,0.011959,0.12585,0.028667,GOBP_CEREBELLAR_CORTEX_DEVELOPMENT,0.6954568275154
GSE25123_CTRL_VS_ROSIGLITAZO...3,SET,178,0.12037,0.011794,0.063335,0.028693,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.6954568275154
GOBP_STEROL_HOMEOSTASIS,SET,82,0.18099,0.012068,0.095233,0.028695,GOBP_STEROL_HOMEOSTASIS,0.6954568275154
GSE14415_FOXP3_KO_NATURAL_TR...2,SET,153,0.13189,0.01199,0.069425,0.028737,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP,0.6954568275154
ROESSLER_LIVER_CANCER_METAST...2,SET,100,0.15796,0.011626,0.083157,0.028758,ROESSLER_LIVER_CANCER_METASTASIS_UP,0.6954568275154
MIR518E_5P_MIR519A_5P_MIR519...,SET,82,0.17419,0.011615,0.091727,0.028794,MIR518E_5P_MIR519A_5P_MIR519B_5P_MIR519C_5P_MIR522_5P_MIR523_5P,0.6954568275154
GOBP_UBIQUITIN_DEPENDENT_GLY...,SET,7,0.65459,0.012779,0.34486,0.028847,GOBP_UBIQUITIN_DEPENDENT_GLYCOPROTEIN_ERAD_PATHWAY,0.6954568275154
GOMF_MANNOSYL_OLIGOSACCHARID...1,SET,7,0.65459,0.012779,0.34486,0.028847,GOMF_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY,0.6954568275154
GOBP_NEGATIVE_REGULATION_OF_...282,SET,10,0.65957,0.015389,0.34749,0.028851,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.6954568275154
LEE_CALORIE_RESTRICTION_NEOC...1,SET,59,0.20018,0.011329,0.10547,0.028855,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,0.6954568275154
GOMF_PHOSPHATIDYLCHOLINE_BIN...,SET,27,0.33084,0.012678,0.17432,0.028866,GOMF_PHOSPHATIDYLCHOLINE_BINDING,0.6954568275154
WP_ACQUIRED_PARTIAL_LIPODYST...,SET,10,0.4977,0.011612,0.26228,0.028882,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,0.6954568275154
HP_INTESTINAL_ATRESIA,SET,56,0.21808,0.012025,0.11496,0.028924,HP_INTESTINAL_ATRESIA,0.6954568275154
GSE17721_POLYIC_VS_PAM3CSK4_...6,SET,187,0.11638,0.011686,0.061355,0.028931,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP,0.6954568275154
GSE26727_WT_VS_KLF2_KO_LPS_S...2,SET,179,0.12315,0.012101,0.064924,0.028931,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP,0.6954568275154
GALI_TP53_TARGETS_APOPTOTIC_...2,SET,8,0.61403,0.012815,0.32384,0.028981,GALI_TP53_TARGETS_APOPTOTIC_UP,0.6954568275154
GSE17721_0.5H_VS_12H_GARDIQU...2,SET,184,0.11337,0.011293,0.059806,0.029008,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP,0.6954568275154
QIU_PBMC_HEPTATITIS_B_SURFAC...3,SET,7,0.65406,0.012769,0.34509,0.029032,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_DN,0.6954568275154
SASAKI_TARGETS_OF_TP73_AND_T...,SET,11,0.50892,0.012453,0.26852,0.029035,SASAKI_TARGETS_OF_TP73_AND_TP63,0.6954568275154
GOBP_POSITIVE_REGULATION_OF_...553,SET,61,0.20537,0.011818,0.10837,0.02905,GOBP_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.6954568275154
GAVIN_FOXP3_TARGETS_CLUSTER_...4,SET,84,0.17883,0.012068,0.094395,0.029087,GAVIN_FOXP3_TARGETS_CLUSTER_P6,0.6954568275154
GOBP_RIBOSOMAL_LARGE_SUBUNIT...1,SET,19,0.33631,0.010813,0.17754,0.029105,GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY,0.6954568275154
PAX_Q6,SET,227,0.11286,0.012471,0.059588,0.02912,PAX_Q6,0.6954568275154
GSE7509_DC_VS_MONOCYTE_WITH_...1,SET,185,0.1206,0.012045,0.063678,0.029125,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN,0.6954568275154
HP_COLLECTIONISM,SET,10,0.48905,0.01141,0.25822,0.029127,HP_COLLECTIONISM,0.6954568275154
HP_PANCREATITIS,SET,71,0.20317,0.01261,0.10728,0.029139,HP_PANCREATITIS,0.6954568275154
PARK_HSC_AND_MULTIPOTENT_PRO...,SET,42,0.23437,0.011197,0.12378,0.029162,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,0.6954568275154
MORF_IL13,SET,216,0.11088,0.011955,0.058561,0.029163,MORF_IL13,0.6954568275154
GOCC_SPHERICAL_HIGH_DENSITY_...,SET,7,0.63169,0.012332,0.33369,0.029184,GOCC_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.6954568275154
HOEK_NEUTROPHIL_2011_2012_TI...6,SET,17,0.40028,0.012174,0.21147,0.0292,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP,0.6954568275154
HP_SEMANTIC_DEMENTIA,SET,6,0.69747,0.012607,0.36851,0.029209,HP_SEMANTIC_DEMENTIA,0.6954568275154
HP_MACRODONTIA,SET,27,0.31267,0.011982,0.16522,0.029224,HP_MACRODONTIA,0.6954568275154
YAO_TEMPORAL_RESPONSE_TO_PRO...4,SET,86,0.16018,0.010937,0.084646,0.029232,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,0.6954568275154
GSE42724_NAIVE_VS_MEMORY_BCE...1,SET,172,0.12379,0.011925,0.065418,0.029235,GSE42724_NAIVE_VS_MEMORY_BCELL_DN,0.6954568275154
GOBP_CELLULAR_RESPONSE_TO_NI...1,SET,9,0.55378,0.012258,0.29279,0.029294,GOBP_CELLULAR_RESPONSE_TO_NICOTINE,0.696026483253589
GOCC_NUCLEAR_ENVELOPE_LUMEN,SET,10,0.55082,0.012851,0.29123,0.029299,GOCC_NUCLEAR_ENVELOPE_LUMEN,0.696026483253589
GSE46606_DAY1_VS_DAY3_CD40L_...1,SET,175,0.11873,0.011536,0.062789,0.029329,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN,0.69626324795082
REACTOME_SIGNALING_BY_FGFR2,SET,71,0.19102,0.011856,0.10106,0.02937,REACTOME_SIGNALING_BY_FGFR2,0.696760648464164
GOBP_NEGATIVE_REGULATION_OF_...484,SET,7,0.58781,0.011475,0.3112,0.029463,GOBP_NEGATIVE_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.698490153478854
WP_ANDROGEN_RECEPTOR_SIGNALI...,SET,83,0.17622,0.011822,0.09339,0.029593,WP_ANDROGEN_RECEPTOR_SIGNALING,0.700624911684783
HP_PITUITARY_HYPOTHYROIDISM,SET,35,0.27876,0.01216,0.14774,0.029599,HP_PITUITARY_HYPOTHYROIDISM,0.700624911684783
ATGGYGGA_UNKNOWN,SET,85,0.17373,0.011793,0.092098,0.029633,ATGGYGGA_UNKNOWN,0.700624911684783
GOBP_POSITIVE_REGULATION_OF_...707,SET,38,0.29063,0.013208,0.15408,0.029646,GOBP_POSITIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.700624911684783
GOCC_RESPIRATORY_CHAIN_COMPL...,SET,21,0.34407,0.01163,0.18245,0.029666,GOCC_RESPIRATORY_CHAIN_COMPLEX_IV,0.700624911684783
GSE26488_WT_VS_HDAC7_KO_DOUB...1,SET,157,0.12921,0.011897,0.068518,0.029674,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.700624911684783
REACTOME_ACTIVATION_OF_RAC1,SET,11,0.46693,0.011426,0.24768,0.029708,REACTOME_ACTIVATION_OF_RAC1,0.700951486761711
WP_TRANSCRIPTIONAL_CASCADE_R...,SET,12,0.52969,0.013537,0.28117,0.029798,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,0.701075339153794
HP_ABNORMAL_NEUTROPHIL_COUNT,SET,196,0.11308,0.011622,0.060031,0.029805,HP_ABNORMAL_NEUTROPHIL_COUNT,0.701075339153794
HP_RECURRENT_SYSTEMIC_PYOGEN...,SET,5,0.72575,0.011975,0.38537,0.029841,HP_RECURRENT_SYSTEMIC_PYOGENIC_INFECTIONS,0.701075339153794
NATSUME_RESPONSE_TO_INTERFER...1,SET,51,0.2273,0.011963,0.12071,0.029851,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.701075339153794
GOBP_EMBRYONIC_CAMERA_TYPE_E...2,SET,11,0.51938,0.012709,0.27581,0.029853,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION,0.701075339153794
GOBP_NEGATIVE_REGULATION_OF_...333,SET,155,0.13124,0.012007,0.069702,0.029871,GOBP_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY,0.701075339153794
GOBP_SPINDLE_ORGANIZATION,SET,184,0.11275,0.01123,0.059887,0.029883,GOBP_SPINDLE_ORGANIZATION,0.701075339153794
MIR326,SET,115,0.15653,0.012349,0.083173,0.029928,MIR326,0.701075339153794
TAKAO_RESPONSE_TO_UVB_RADIAT...2,SET,71,0.18055,0.011206,0.095952,0.029949,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,0.701075339153794
GROSS_ELK3_TARGETS_DN,SET,32,0.30385,0.012674,0.16148,0.029953,GROSS_ELK3_TARGETS_DN,0.701075339153794
BAELDE_DIABETIC_NEPHROPATHY_...2,SET,82,0.18775,0.01252,0.099806,0.029981,BAELDE_DIABETIC_NEPHROPATHY_UP,0.701075339153794
REACTOME_DNA_REPAIR,SET,264,0.089406,0.010644,0.047528,0.029985,REACTOME_DNA_REPAIR,0.701075339153794
WP_MBDNF_AND_PROBDNF_REGULAT...,SET,35,0.30338,0.013233,0.16132,0.030019,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,0.701075339153794
REACTOME_RNA_POLYMERASE_I_TR...1,SET,45,0.21364,0.010564,0.1136,0.030024,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,0.701075339153794
ROSS_AML_OF_FAB_M7_TYPE,SET,61,0.20571,0.011837,0.1094,0.030034,ROSS_AML_OF_FAB_M7_TYPE,0.701075339153794
GSE2770_IL12_ACT_VS_ACT_CD4_...4,SET,181,0.11806,0.011664,0.062784,0.030036,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP,0.701075339153794
LEE_RECENT_THYMIC_EMIGRANT,SET,197,0.1161,0.011961,0.061759,0.030072,LEE_RECENT_THYMIC_EMIGRANT,0.701370352112676
DACOSTA_UV_RESPONSE_VIA_ERCC...8,SET,22,0.33967,0.011751,0.18071,0.030089,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.701370352112676
AMEF2_Q6,SET,229,0.11157,0.012383,0.059373,0.030119,AMEF2_Q6,0.701599091823056
WIEMANN_TELOMERE_SHORTENING_...2,SET,9,0.5704,0.012626,0.30366,0.030169,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP,0.702293097789685
LI_ESTROGENE_NON_MCF7_T47D_E...1,SET,6,0.71759,0.01297,0.3821,0.030199,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_DN,0.702306722408027
MIR3192_5P,SET,142,0.13632,0.011943,0.072597,0.03021,MIR3192_5P,0.702306722408027
GOCC_NATA_COMPLEX,SET,4,0.63134,0.0093177,0.33646,0.030309,GOCC_NATA_COMPLEX,0.702805654022237
MULLIGHAN_NPM1_SIGNATURE_3_DN,SET,143,0.13005,0.011433,0.06932,0.030326,MULLIGHAN_NPM1_SIGNATURE_3_DN,0.702805654022237
GOMF_PHOSPHATIDYLINOSITOL_5_...,SET,18,0.36305,0.011362,0.19359,0.030377,GOMF_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING,0.702805654022237
KEGG_GLYCOSAMINOGLYCAN_BIOSY...3,SET,15,0.4555,0.013014,0.24289,0.030384,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,0.702805654022237
GSE45365_NK_CELL_VS_CD8_TCEL...4,SET,143,0.13337,0.011724,0.071121,0.03039,GSE45365_NK_CELL_VS_CD8_TCELL_UP,0.702805654022237
GOBP_SENSORY_PERCEPTION_OF_S...3,SET,7,0.58194,0.011361,0.31041,0.030424,GOBP_SENSORY_PERCEPTION_OF_SWEET_TASTE,0.702805654022237
GOBP_VESICLE_TETHERING,SET,30,0.28232,0.011403,0.15068,0.030504,GOBP_VESICLE_TETHERING,0.702805654022237
HE_LIM_SUN_FETAL_LUNG_C5_LAR...,SET,1181,0.045496,0.011162,0.02429,0.030538,HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL,0.702805654022237
GOBP_DETECTION_OF_BIOTIC_STI...,SET,33,0.30054,0.01273,0.16046,0.030545,GOBP_DETECTION_OF_BIOTIC_STIMULUS,0.702805654022237
QIU_PBMC_HEPTATITIS_B_SURFAC...2,SET,7,0.69778,0.013622,0.37256,0.030549,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0_TO_35DY_JOINTLY_UP,0.702805654022237
GOBP_PROTEIN_LIPID_COMPLEX_O...,SET,49,0.24035,0.0124,0.12834,0.03056,GOBP_PROTEIN_LIPID_COMPLEX_ORGANIZATION,0.702805654022237
GSE6092_B_BURGDOFERI_VS_B_BU...1,SET,170,0.12198,0.011683,0.065143,0.030582,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN,0.702805654022237
GOBP_DOLICHYL_DIPHOSPHATE_ME...,SET,4,0.78786,0.011628,0.42081,0.030594,GOBP_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS,0.702805654022237
NAKAMURA_ADIPOGENESIS_LATE_DN,SET,33,0.29056,0.012307,0.1552,0.030606,NAKAMURA_ADIPOGENESIS_LATE_DN,0.702805654022237
GSE34392_ST2_KO_VS_WT_DAY8_L...2,SET,182,0.11325,0.01122,0.060513,0.030641,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.702805654022237
GOMF_BETA_GLUCOSIDASE_ACTIVI...,SET,5,0.72075,0.011893,0.38513,0.030651,GOMF_BETA_GLUCOSIDASE_ACTIVITY,0.702805654022237
MIR512_3P,SET,94,0.16666,0.011894,0.089062,0.030664,MIR512_3P,0.702805654022237
WP_NOTCH_SIGNALING_WP268,SET,45,0.23137,0.011441,0.12365,0.030665,WP_NOTCH_SIGNALING_WP268,0.702805654022237
GSE40274_CTRL_VS_FOXP3_AND_L...1,SET,147,0.12925,0.011519,0.069076,0.030669,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.702805654022237
HP_HYDROXYPROLINURIA,SET,9,0.65437,0.014485,0.34972,0.030673,HP_HYDROXYPROLINURIA,0.702805654022237
GOBP_CELLULAR_RESPONSE_TO_UV...3,SET,4,0.76306,0.011262,0.40783,0.030679,GOBP_CELLULAR_RESPONSE_TO_UV_C,0.702805654022237
GOMF_HISTONE_H2AX_KINASE_ACT...,SET,5,0.67814,0.011189,0.36246,0.030684,GOMF_HISTONE_H2AX_KINASE_ACTIVITY,0.702805654022237
REACTOME_ANTI_INFLAMMATORY_R...,SET,74,0.19073,0.012084,0.10198,0.03073,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,0.702805654022237
KEGG_MEDICUS_REFERENCE_WNT_S...2,SET,13,0.49799,0.013247,0.26626,0.030731,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4,0.702805654022237
GSE17721_POLYIC_VS_CPG_8H_BM...1,SET,181,0.11562,0.011423,0.061823,0.030739,GSE17721_POLYIC_VS_CPG_8H_BMDC_DN,0.702805654022237
GOBP_REGULATION_OF_TRANSCRIP...3,SET,27,0.30201,0.011573,0.16155,0.03079,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.702805654022237
REACTOME_VASOPRESSIN_REGULAT...,SET,42,0.27008,0.012903,0.14447,0.030794,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,0.702805654022237
GOBP_NEGATIVE_REGULATION_OF_...234,SET,48,0.25163,0.012849,0.13465,0.03083,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.702805654022237
GSE24634_TREG_VS_TCONV_POST_...5,SET,177,0.12384,0.012101,0.066273,0.030846,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN,0.702805654022237
GOMF_VOLTAGE_GATED_CHLORIDE_...,SET,9,0.54727,0.012114,0.29292,0.030868,GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.702805654022237
REACTOME_WNT_MEDIATED_ACTIVA...,SET,8,0.55229,0.011526,0.29562,0.030872,REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL,0.702805654022237
GOBP_OTOLITH_DEVELOPMENT,SET,10,0.53838,0.012561,0.2882,0.030884,GOBP_OTOLITH_DEVELOPMENT,0.702805654022237
GSE3982_MAST_CELL_VS_EFF_MEM...1,SET,171,0.12165,0.011685,0.065137,0.030918,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.702805654022237
chr4q28,SET,19,0.54994,0.017682,0.29447,0.030919,chr4q28,0.702805654022237
GOMF_SCAVENGER_RECEPTOR_ACTI...,SET,25,0.31971,0.01179,0.17126,0.030968,GOMF_SCAVENGER_RECEPTOR_ACTIVITY,0.70345937254902
MIR4804_5P,SET,8,0.5757,0.012015,0.3086,0.031063,MIR4804_5P,0.704991109660574
GOBP_LYMPHOCYTE_ACTIVATION,SET,724,0.062891,0.01224,0.033716,0.031076,GOBP_LYMPHOCYTE_ACTIVATION,0.704991109660574
HARALAMBIEVA_PBMC_M_M_R_II_A...5,SET,13,0.50783,0.013508,0.27237,0.031136,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_UP,0.705366990950226
REACTOME_INTERLEUKIN_23_SIGN...,SET,9,0.5541,0.012265,0.29723,0.031156,REACTOME_INTERLEUKIN_23_SIGNALING,0.705366990950226
GOBP_REGULATION_OF_HUMORAL_I...1,SET,40,0.28082,0.013093,0.15074,0.031239,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.705366990950226
GOBP_TRANSCRIPTION_ELONGATIO...2,SET,8,0.49667,0.010365,0.26664,0.03126,GOBP_TRANSCRIPTION_ELONGATION_COUPLED_CHROMATIN_REMODELING,0.705366990950226
GAVISH_3CA_METAPROGRAM_EPITH...14,SET,44,0.25967,0.012697,0.13942,0.031269,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1,0.705366990950226
GOBP_HEME_TRANSPORT,SET,8,0.57778,0.012058,0.31027,0.031295,GOBP_HEME_TRANSPORT,0.705366990950226
GOMF_HEME_TRANSMEMBRANE_TRAN...,SET,8,0.57778,0.012058,0.31027,0.031295,GOMF_HEME_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.705366990950226
GOCC_PRERIBOSOME,SET,94,0.15445,0.011023,0.082952,0.031313,GOCC_PRERIBOSOME,0.705366990950226
MIR3121_3P,SET,590,0.066546,0.011736,0.035745,0.031333,MIR3121_3P,0.705366990950226
GOBP_NEGATIVE_REGULATION_OF_...312,SET,6,0.7692,0.013903,0.41327,0.031362,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.705366990950226
GSE27670_CTRL_VS_LMP1_TRANSD...2,SET,181,0.11904,0.011761,0.063961,0.031367,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.705366990950226
WP_SEBALEIC_ACID_FORMATION_A...,SET,5,0.77196,0.012738,0.41477,0.031368,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.705366990950226
GOBP_NEGATIVE_REGULATION_OF_...75,SET,47,0.22155,0.011195,0.11906,0.031392,GOBP_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.705366990950226
GSE6875_TCONV_VS_FOXP3_KO_TR...1,SET,177,0.11607,0.011341,0.062376,0.031394,GSE6875_TCONV_VS_FOXP3_KO_TREG_DN,0.705366990950226
GOBP_PRIMARY_AMINO_COMPOUND_...1,SET,6,0.52905,0.0095624,0.28432,0.031397,GOBP_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS,0.705366990950226
GOBP_CELL_VOLUME_HOMEOSTASIS,SET,34,0.27431,0.011794,0.14759,0.031545,GOBP_CELL_VOLUME_HOMEOSTASIS,0.707813603225806
GOBP_RENAL_ABSORPTION,SET,33,0.30742,0.013022,0.16541,0.031557,GOBP_RENAL_ABSORPTION,0.707813603225806
HP_FLAT_NASAL_ALAE,SET,8,0.44454,0.0092773,0.23921,0.031567,HP_FLAT_NASAL_ALAE,0.707813603225806
TCCATTKW_UNKNOWN,SET,217,0.11042,0.011934,0.05945,0.031634,TCCATTKW_UNKNOWN,0.708858588007737
FOXF1_TARGET_GENES,SET,5,0.69201,0.011418,0.37282,0.031725,FOXF1_TARGET_GENES,0.709435607893062
GOBP_REPLICATIVE_SENESCENCE,SET,16,0.3644,0.010753,0.19635,0.031745,GOBP_REPLICATIVE_SENESCENCE,0.709435607893062
GSE36888_UNTREATED_VS_IL2_TR...10,SET,177,0.11662,0.011395,0.062845,0.031755,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP,0.709435607893062
KEGG_MEDICUS_VARIANT_FUS_DDI...,SET,5,0.79552,0.013126,0.42872,0.031767,KEGG_MEDICUS_VARIANT_FUS_DDIT3_FUSION_TO_NFKB_MEDIATED_TRANSCRIPTION,0.709435607893062
GOBP_POSITIVE_REGULATION_OF_...750,SET,29,0.28299,0.011238,0.15258,0.031825,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY,0.709435607893062
HP_ABNORMAL_LARGE_INTESTINE_...1,SET,295,0.093566,0.011765,0.050451,0.031837,HP_ABNORMAL_LARGE_INTESTINE_MORPHOLOGY,0.709435607893062
GOBP_POSITIVE_REGULATION_OF_...214,SET,16,0.39042,0.01152,0.21053,0.031846,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.709435607893062
GSE24972_MARGINAL_ZONE_BCELL...3,SET,184,0.12157,0.01211,0.06556,0.031849,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP,0.709435607893062
HAHTOLA_MYCOSIS_FUNGOIDES_DN,SET,13,0.46596,0.012395,0.2513,0.031863,HAHTOLA_MYCOSIS_FUNGOIDES_DN,0.709435607893062
GOBP_NEGATIVE_REGULATION_OF_...5,SET,6,0.72692,0.013139,0.39211,0.031888,GOBP_NEGATIVE_REGULATION_OF_ACTION_POTENTIAL,0.709435607893062
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SET,157,0.12474,0.011486,0.0673,0.03191,SMIRNOV_RESPONSE_TO_IR_6HR_UP,0.709435607893062
HP_INEFFECTIVE_ESOPHAGEAL_PE...,SET,14,0.41625,0.01149,0.22462,0.031941,HP_INEFFECTIVE_ESOPHAGEAL_PERISTALSIS,0.709435607893062
GOBP_ENDOTHELIAL_CELL_APOPTO...,SET,55,0.23033,0.012588,0.12432,0.031966,GOBP_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.709435607893062
GOMF_OXIDOREDUCTASE_ACTIVITY...27,SET,51,0.23485,0.012361,0.12676,0.03197,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR,0.709435607893062
KOBAYASHI_EGFR_SIGNALING_24H...2,SET,83,0.17252,0.011574,0.093132,0.031989,KOBAYASHI_EGFR_SIGNALING_24HR_UP,0.709435607893062
MIR6806_5P,SET,63,0.19977,0.011682,0.10784,0.031994,MIR6806_5P,0.709435607893062
GSE3565_CTRL_VS_LPS_INJECTED...1,SET,155,0.13121,0.012005,0.070858,0.032036,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN,0.709435607893062
HP_RHEUMATOID_ARTHRITIS,SET,20,0.3763,0.012413,0.20322,0.032041,HP_RHEUMATOID_ARTHRITIS,0.709435607893062
MORF_RAD54L,SET,91,0.15636,0.010981,0.084447,0.032052,MORF_RAD54L,0.709435607893062
GOBP_BICARBONATE_TRANSPORT,SET,36,0.25848,0.011434,0.13962,0.032068,GOBP_BICARBONATE_TRANSPORT,0.709435607893062
GOCC_PRERIBOSOME_LARGE_SUBUN...,SET,18,0.34495,0.010796,0.18637,0.032102,GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR,0.709736011450382
GOMF_PATCHED_BINDING,SET,8,0.57779,0.012058,0.31224,0.032133,GOMF_PATCHED_BINDING,0.709752266666667
GOCC_COMMITMENT_COMPLEX,SET,5,0.52192,0.0086117,0.28209,0.032152,GOCC_COMMITMENT_COMPLEX,0.709752266666667
GSE13485_CTRL_VS_DAY1_YF17D_...1,SET,132,0.14257,0.012045,0.077066,0.032164,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN,0.709752266666667
GOBP_PROTEIN_DNA_COMPLEX_ORG...,SET,725,0.056994,0.0111,0.030813,0.032187,GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION,0.709809127538071
IKEDA_MIR133_TARGETS_UP,SET,40,0.23971,0.011176,0.12963,0.032222,IKEDA_MIR133_TARGETS_UP,0.710120855513308
GAVIN_IL2_RESPONSIVE_FOXP3_T...1,SET,5,0.66556,0.010982,0.35997,0.032242,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN,0.710120855513308
FRASOR_RESPONSE_TO_ESTRADIOL...2,SET,33,0.28345,0.012006,0.15343,0.032352,FRASOR_RESPONSE_TO_ESTRADIOL_UP,0.711644782471627
HP_IMMUNODEFICIENCY,SET,194,0.11755,0.012019,0.063632,0.032359,HP_IMMUNODEFICIENCY,0.711644782471627
REACTOME_SUMOYLATION_OF_DNA_...1,SET,69,0.18536,0.011342,0.10037,0.032403,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,0.711644782471627
HP_ABNORMALITY_OF_ABDOMINAL_...,SET,15,0.42426,0.012122,0.22979,0.032432,HP_ABNORMALITY_OF_ABDOMINAL_SITUS,0.711644782471627
MIR6082,SET,15,0.40478,0.011565,0.21927,0.03245,MIR6082,0.711644782471627
RIGGI_EWING_SARCOMA_PROGENIT...2,SET,389,0.090891,0.013089,0.049239,0.032461,RIGGI_EWING_SARCOMA_PROGENITOR_UP,0.711644782471627
GOBP_WATER_SOLUBLE_VITAMIN_B...,SET,11,0.48572,0.011886,0.26315,0.032466,GOBP_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.711644782471627
GOBP_CORTICOSPINAL_TRACT_MOR...,SET,8,0.62323,0.013007,0.33766,0.032475,GOBP_CORTICOSPINAL_TRACT_MORPHOGENESIS,0.711644782471627
MODULE_195,SET,138,0.13259,0.011452,0.071854,0.032506,MODULE_195,0.711875255198488
KEGG_MEDICUS_REFERENCE_ELECT...3,SET,14,0.37965,0.01048,0.2058,0.032543,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.712029118942731
GOBP_NEGATIVE_REGULATION_OF_...508,SET,2,0.72955,0.0076139,0.3955,0.032554,GOBP_NEGATIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,0.712029118942731
REACTOME_ACTIVATION_OF_ANTER...,SET,60,0.20332,0.011604,0.11025,0.032592,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,0.712117514124294
GOBP_REGULATION_OF_PROTEIN_S...1,SET,245,0.10541,0.012095,0.057163,0.032602,GOBP_REGULATION_OF_PROTEIN_SECRETION,0.712117514124294
GSE15659_RESTING_VS_ACTIVATE...1,SET,167,0.12014,0.011406,0.065172,0.032636,GSE15659_RESTING_VS_ACTIVATED_TREG_DN,0.712117514124294
GOBP_TUBE_DEVELOPMENT,SET,1008,0.052995,0.012072,0.028748,0.03264,GOBP_TUBE_DEVELOPMENT,0.712117514124294
REACTOME_SIGNALING_BY_FGFR_I...,SET,61,0.20516,0.011806,0.11135,0.032707,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,0.7121512640801
GTGCAAA_MIR507,SET,117,0.15409,0.012261,0.083645,0.032732,GTGCAAA_MIR507,0.7121512640801
GOBP_CELLULAR_RESPONSE_TO_ST...2,SET,193,0.11559,0.011789,0.062746,0.032733,GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS,0.7121512640801
HP_FASCICULATIONS,SET,123,0.14372,0.011724,0.078019,0.032742,HP_FASCICULATIONS,0.7121512640801
BIOCARTA_NPC_PATHWAY,SET,11,0.47035,0.011509,0.25534,0.032744,BIOCARTA_NPC_PATHWAY,0.7121512640801
GOBP_POSITIVE_REGULATION_OF_...453,SET,25,0.3653,0.01347,0.19838,0.032794,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.712434645499384
GOBP_REGULATION_OF_CELLULAR_...6,SET,121,0.1431,0.011579,0.077718,0.032799,GOBP_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS,0.712434645499384
GOMF_METALLOCARBOXYPEPTIDASE...,SET,29,0.3344,0.01328,0.18166,0.032835,GOMF_METALLOCARBOXYPEPTIDASE_ACTIVITY,0.712434645499384
HAY_BONE_MARROW_CD34_POS_GRAN,SET,24,0.33333,0.012044,0.18121,0.032933,HAY_BONE_MARROW_CD34_POS_GRAN,0.712434645499384
GLI1_TARGET_GENES,SET,421,0.0776,0.011615,0.042192,0.032952,GLI1_TARGET_GENES,0.712434645499384
GOBP_MICROTUBULE_CYTOSKELETO...2,SET,157,0.1212,0.01116,0.06591,0.032971,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS,0.712434645499384
SMID_BREAST_CANCER_NORMAL_LI...2,SET,422,0.082246,0.012325,0.044728,0.03298,SMID_BREAST_CANCER_NORMAL_LIKE_UP,0.712434645499384
MIR1909_5P,SET,34,0.26138,0.011238,0.14215,0.032987,MIR1909_5P,0.712434645499384
HP_HYDROXYPROLINEMIA,SET,5,0.87196,0.014388,0.47423,0.032989,HP_HYDROXYPROLINEMIA,0.712434645499384
GOBP_REGULATION_OF_RESPONSE_...14,SET,160,0.13068,0.012146,0.071112,0.033062,GOBP_REGULATION_OF_RESPONSE_TO_WOUNDING,0.712434645499384
IIZUKA_LIVER_CANCER_PROGRESS...4,SET,23,0.32811,0.011606,0.17855,0.033068,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,0.712434645499384
ROSS_AML_WITH_AML1_ETO_FUSION,SET,67,0.20562,0.012399,0.1119,0.033069,ROSS_AML_WITH_AML1_ETO_FUSION,0.712434645499384
PID_P38_GAMMA_DELTA_PATHWAY,SET,10,0.50563,0.011797,0.27518,0.03308,PID_P38_GAMMA_DELTA_PATHWAY,0.712434645499384
GOBP_SPINDLE_LOCALIZATION,SET,61,0.20326,0.011697,0.11062,0.03308,GOBP_SPINDLE_LOCALIZATION,0.712434645499384
EGR1_01,SET,240,0.10036,0.011399,0.054622,0.033088,EGR1_01,0.712434645499384
GOBP_TRIPARTITE_REGIONAL_SUB...,SET,17,0.42245,0.012849,0.22995,0.033102,GOBP_TRIPARTITE_REGIONAL_SUBDIVISION,0.712434645499384
GOBP_SOMATIC_STEM_CELL_DIVIS...,SET,10,0.55318,0.012907,0.30114,0.033115,GOBP_SOMATIC_STEM_CELL_DIVISION,0.712434645499384
MIR31_3P,SET,51,0.22117,0.011641,0.12043,0.033146,MIR31_3P,0.712434645499384
GOMF_CARBOXY_LYASE_ACTIVITY,SET,32,0.26599,0.011095,0.14485,0.03316,GOMF_CARBOXY_LYASE_ACTIVITY,0.712434645499384
HP_IMPAIRED_OXIDATIVE_BURST,SET,5,0.7945,0.013109,0.4327,0.033177,HP_IMPAIRED_OXIDATIVE_BURST,0.712434645499384
HP_INCREASED_SENSITIVITY_TO_...,SET,12,0.44188,0.011293,0.24074,0.033224,HP_INCREASED_SENSITIVITY_TO_IONIZING_RADIATION,0.712434645499384
GOMF_BICARBONATE_TRANSMEMBRA...,SET,31,0.27502,0.011291,0.14985,0.03324,GOMF_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.712434645499384
GSE3565_DUSP1_VS_WT_SPLENOCY...1,SET,164,0.12306,0.011579,0.067054,0.033241,GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN,0.712434645499384
GOMF_N_ACETYLGLUCOSAMINE_6_O...,SET,6,0.71064,0.012845,0.38724,0.033249,GOMF_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY,0.712434645499384
ZNF843_TARGET_GENES,SET,675,0.062425,0.011747,0.03403,0.033304,ZNF843_TARGET_GENES,0.712926918103448
GOCC_EXTRINSIC_COMPONENT_OF_...2,SET,167,0.12678,0.012036,0.069116,0.033313,GOCC_EXTRINSIC_COMPONENT_OF_MEMBRANE,0.712926918103448
GSE45365_WT_VS_IFNAR_KO_CD8A...2,SET,171,0.12221,0.011739,0.066702,0.033473,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN,0.715420886075949
BIOCARTA_IL1R_PATHWAY,SET,30,0.30989,0.012517,0.16917,0.033498,BIOCARTA_IL1R_PATHWAY,0.715420886075949
TTCCGTT_MIR191,SET,28,0.28563,0.011146,0.15594,0.033504,TTCCGTT_MIR191,0.715420886075949
GOMF_THIOREDOXIN_DEPENDENT_P...,SET,4,0.72315,0.010673,0.39487,0.033532,GOMF_THIOREDOXIN_DEPENDENT_PEROXIREDOXIN_ACTIVITY,0.715420886075949
HP_DEFECTIVE_DNA_REPAIR_AFTE...,SET,10,0.38692,0.0090276,0.21129,0.03354,HP_DEFECTIVE_DNA_REPAIR_AFTER_ULTRAVIOLET_RADIATION_DAMAGE,0.715420886075949
MIR3619_5P,SET,255,0.094759,0.01109,0.051751,0.033555,MIR3619_5P,0.715420886075949
HP_DEVIATED_NASAL_SEPTUM,SET,6,0.7009,0.012668,0.38306,0.033653,HP_DEVIATED_NASAL_SEPTUM,0.715420886075949
SRPK1_TARGET_GENES,SET,304,0.089276,0.011392,0.048796,0.033665,SRPK1_TARGET_GENES,0.715420886075949
GSE7460_FOXP3_MUT_VS_WT_ACT_...2,SET,181,0.12058,0.011913,0.065908,0.033668,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP,0.715420886075949
GSE3982_CENT_MEMORY_CD4_TCEL...4,SET,169,0.11947,0.011409,0.065325,0.033719,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP,0.715420886075949
REACTOME_ANTIGEN_PRESENTATIO...,SET,28,0.30975,0.012087,0.1694,0.033748,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.715420886075949
GOBP_THIAMINE_TRANSPORT,SET,8,0.59033,0.01232,0.32296,0.033794,GOBP_THIAMINE_TRANSPORT,0.715420886075949
chr19p13,SET,517,0.15753,0.02606,0.08619,0.033802,chr19p13,0.715420886075949
GSE17186_CD21LOW_VS_CD21HIGH...1,SET,175,0.11386,0.011063,0.062299,0.033812,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.715420886075949
GSE29618_PRE_VS_DAY7_POST_TI...7,SET,175,0.11304,0.010984,0.061863,0.033833,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN,0.715420886075949
GOBP_CELLULAR_RESPONSE_TO_HY...3,SET,4,0.80457,0.011874,0.44035,0.03385,GOBP_CELLULAR_RESPONSE_TO_HYPEROXIA,0.715420886075949
REACTOME_METHIONINE_SALVAGE_...,SET,6,0.73434,0.013273,0.40199,0.033877,REACTOME_METHIONINE_SALVAGE_PATHWAY,0.715420886075949
GOBP_REGULATION_OF_PROTEASOM...1,SET,163,0.11906,0.011169,0.065185,0.033891,GOBP_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.715420886075949
GOBP_CYTOKINESIS,SET,164,0.11813,0.011114,0.064695,0.03394,GOBP_CYTOKINESIS,0.715420886075949
GSE3982_EFF_MEMORY_CD4_TCELL...4,SET,173,0.11891,0.011488,0.065148,0.033992,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP,0.715420886075949
GOCC_PERINUCLEOLAR_COMPARTME...,SET,5,0.76001,0.01254,0.41649,0.034026,GOCC_PERINUCLEOLAR_COMPARTMENT,0.715420886075949
GOBP_ANGIOGENESIS_INVOLVED_I...2,SET,27,0.31953,0.012245,0.17512,0.034032,GOBP_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING,0.715420886075949
FAN_EMBRYONIC_CTX_ASTROCYTE_1,SET,73,0.18941,0.011919,0.1038,0.034034,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.715420886075949
WP_SMC1SMC3_ROLE_IN_DNA_DAMA...,SET,9,0.48963,0.010838,0.26836,0.034042,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.715420886075949
GSE30083_SP2_VS_SP4_THYMOCYT...1,SET,186,0.1172,0.011736,0.064238,0.034055,GSE30083_SP2_VS_SP4_THYMOCYTE_DN,0.715420886075949
GOBP_REGULATION_OF_PROGRAMME...1,SET,1345,0.044614,0.011625,0.024456,0.034067,GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.715420886075949
DORSAM_HOXA9_TARGETS_DN,SET,29,0.29674,0.011784,0.16268,0.034079,DORSAM_HOXA9_TARGETS_DN,0.715420886075949
WP_CYTOSOLIC_DNASENSING_PATH...,SET,62,0.19898,0.011543,0.10909,0.034087,WP_CYTOSOLIC_DNASENSING_PATHWAY,0.715420886075949
GOMF_1_PHOSPHATIDYLINOSITOL_...1,SET,10,0.50388,0.011756,0.27626,0.03409,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,0.715420886075949
USF_Q6,SET,227,0.10146,0.011212,0.055632,0.034096,USF_Q6,0.715420886075949
WP_PHYSICOCHEMICAL_FEATURES_...,SET,62,0.20197,0.011717,0.11076,0.034124,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,0.715420886075949
GOBP_POSITIVE_REGULATION_OF_...27,SET,4,0.76277,0.011257,0.41833,0.034133,GOBP_POSITIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.715420886075949
ROESSLER_LIVER_CANCER_METAST...1,SET,46,0.23894,0.011945,0.13105,0.034142,ROESSLER_LIVER_CANCER_METASTASIS_DN,0.715420886075949
GOMF_OXIDATIVE_RNA_DEMETHYLA...,SET,5,0.62475,0.010309,0.34268,0.034149,GOMF_OXIDATIVE_RNA_DEMETHYLASE_ACTIVITY,0.715420886075949
MIR4759,SET,46,0.21855,0.010926,0.11988,0.03415,MIR4759,0.715420886075949
XU_HGF_TARGETS_INDUCED_BY_AK...1,SET,21,0.36995,0.012505,0.20297,0.034181,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,0.715638948795181
HP_APLASIA_OF_THE_PECTORALIS...,SET,4,0.83941,0.012389,0.46069,0.034229,HP_APLASIA_OF_THE_PECTORALIS_MAJOR_MUSCLE,0.71621245936183
GOBP_NEGATIVE_REGULATION_OF_...332,SET,5,0.83603,0.013795,0.45896,0.034268,GOBP_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.716597075812274
LIU_SOX4_TARGETS_DN,SET,286,0.090621,0.011222,0.049778,0.034349,LIU_SOX4_TARGETS_DN,0.717676422261484
GSE43955_TH0_VS_TGFB_IL6_IL2...1,SET,187,0.11361,0.011407,0.062444,0.034434,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.717676422261484
CHARAFE_BREAST_CANCER_LUMINA...2,SET,340,0.085808,0.011568,0.047166,0.034443,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,0.717676422261484
MIR4434,SET,148,0.12714,0.011369,0.069915,0.034501,MIR4434,0.717676422261484
HP_RETINOPATHY,SET,127,0.1392,0.011537,0.076554,0.034517,HP_RETINOPATHY,0.717676422261484
HP_PRIMARY_ADRENAL_INSUFFICI...,SET,55,0.2097,0.01146,0.11533,0.03452,HP_PRIMARY_ADRENAL_INSUFFICIENCY,0.717676422261484
HP_ABNORMALITY_OF_PATTERN_VI...,SET,5,0.86407,0.014257,0.47522,0.034521,HP_ABNORMALITY_OF_PATTERN_VISUAL_EVOKED_POTENTIALS,0.717676422261484
HP_ABNORMAL_METACARPAL_EPIPH...,SET,16,0.40277,0.011885,0.22156,0.034549,HP_ABNORMAL_METACARPAL_EPIPHYSIS_MORPHOLOGY,0.717676422261484
GSE17721_POLYIC_VS_CPG_1H_BM...2,SET,188,0.11014,0.011088,0.060594,0.034561,GSE17721_POLYIC_VS_CPG_1H_BMDC_UP,0.717676422261484
GSE17721_CPG_VS_GARDIQUIMOD_...11,SET,183,0.11291,0.011216,0.06212,0.034567,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN,0.717676422261484
HP_ABNORMALITY_OF_THE_HYPOTH...2,SET,7,0.59329,0.011582,0.32641,0.034568,HP_ABNORMALITY_OF_THE_HYPOTHENAR_EMINENCE,0.717676422261484
GSE41978_ID2_KO_VS_ID2_KO_AN...1,SET,188,0.10951,0.011024,0.060257,0.034591,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.717676422261484
VERRECCHIA_RESPONSE_TO_TGFB1...5,SET,20,0.36053,0.011893,0.19845,0.034637,VERRECCHIA_RESPONSE_TO_TGFB1_C5,0.717676422261484
GROSS_HYPOXIA_VIA_ELK3_AND_H...1,SET,98,0.15658,0.011409,0.086219,0.034684,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,0.717676422261484
GOMF_SOLUTE_MONOATOMIC_CATIO...,SET,114,0.15088,0.011852,0.083086,0.0347,GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.717676422261484
GOBP_PYROPTOSIS,SET,33,0.2764,0.011708,0.15225,0.034736,GOBP_PYROPTOSIS,0.717676422261484
GOBP_PLASMA_CELL_DIFFERENTIA...,SET,9,0.49933,0.011053,0.27508,0.034754,GOBP_PLASMA_CELL_DIFFERENTIATION,0.717676422261484
MIR4509,SET,60,0.19958,0.01139,0.10995,0.034764,MIR4509,0.717676422261484
GSE17186_MEMORY_VS_NAIVE_BCE...1,SET,183,0.11443,0.011367,0.06306,0.034797,GSE17186_MEMORY_VS_NAIVE_BCELL_DN,0.717676422261484
MIR6083,SET,236,0.10504,0.011833,0.057892,0.03481,MIR6083,0.717676422261484
GOBP_MATERNAL_PROCESS_INVOLV...1,SET,52,0.22072,0.01173,0.12166,0.034829,GOBP_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.717676422261484
GOCC_STEREOCILIA_ANKLE_LINK_...,SET,5,0.74886,0.012356,0.41282,0.034846,GOCC_STEREOCILIA_ANKLE_LINK_COMPLEX,0.717676422261484
CAVARD_LIVER_CANCER_MALIGNAN...,SET,28,0.31306,0.012216,0.1726,0.034868,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,0.717676422261484
GSE27786_NKTCELL_VS_NEUTROPH...1,SET,181,0.11673,0.011533,0.064363,0.034876,GSE27786_NKTCELL_VS_NEUTROPHIL_DN,0.717676422261484
GOBP_T_CELL_TOLERANCE_INDUCT...,SET,14,0.44767,0.012357,0.24684,0.034879,GOBP_T_CELL_TOLERANCE_INDUCTION,0.717676422261484
GOBP_MONOSACCHARIDE_BIOSYNTH...,SET,79,0.17266,0.011301,0.095208,0.034885,GOBP_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.717676422261484
MIR4313,SET,26,0.30209,0.01136,0.16659,0.034891,MIR4313,0.717676422261484
MODULE_109,SET,35,0.2793,0.012183,0.15405,0.034919,MODULE_109,0.717676422261484
LEE_AGING_CEREBELLUM_DN,SET,66,0.19951,0.01194,0.11004,0.034921,LEE_AGING_CEREBELLUM_DN,0.717676422261484
GSE18893_CTRL_VS_TNF_TREATED...5,SET,171,0.11606,0.011148,0.064041,0.034985,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN,0.717676422261484
MIR215_3P,SET,119,0.14282,0.011461,0.078831,0.035023,MIR215_3P,0.717676422261484
MIR4700_3P,SET,86,0.16688,0.011394,0.092119,0.035039,MIR4700_3P,0.717676422261484
RICHERT_PBMC_HIV_LIPO_5_AGE_...4,SET,25,0.35445,0.01307,0.19567,0.035045,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP,0.717676422261484
PAL_PRMT5_TARGETS_DN,SET,27,0.3244,0.012431,0.1791,0.035057,PAL_PRMT5_TARGETS_DN,0.717676422261484
GSE8621_UNSTIM_VS_LPS_PRIMED...4,SET,176,0.11627,0.011329,0.064193,0.035058,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP,0.717676422261484
GOBP_POSITIVE_REGULATION_OF_...769,SET,1151,0.047559,0.011529,0.026258,0.035063,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.717676422261484
GOBP_MORPHOGENESIS_OF_AN_END...,SET,16,0.41489,0.012242,0.22925,0.035177,GOBP_MORPHOGENESIS_OF_AN_ENDOTHELIUM,0.717972624249044
MEDINA_SMARCA4_TARGETS,SET,35,0.26192,0.011425,0.14477,0.035217,MEDINA_SMARCA4_TARGETS,0.717972624249044
HP_HYPERGALACTOSEMIA,SET,6,0.63114,0.011408,0.34886,0.035224,HP_HYPERGALACTOSEMIA,0.717972624249044
ZNF419_TARGET_GENES,SET,5,0.70335,0.011605,0.38885,0.03525,ZNF419_TARGET_GENES,0.717972624249044
GOCC_U2_TYPE_SPLICEOSOMAL_CO...,SET,86,0.14292,0.0097584,0.079017,0.035258,GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX,0.717972624249044
GOBP_POSITIVE_REGULATION_OF_...352,SET,44,0.2206,0.010786,0.12197,0.035268,GOBP_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.717972624249044
GOCC_EXTRINSIC_COMPONENT_OF_...5,SET,97,0.16238,0.011771,0.089809,0.03531,GOCC_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE,0.717972624249044
GOBP_CEREBELLAR_PURKINJE_CEL...1,SET,23,0.31143,0.011016,0.17225,0.035312,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT,0.717972624249044
GSE14308_TH2_VS_INDUCED_TREG...1,SET,180,0.10911,0.010751,0.060358,0.035329,GSE14308_TH2_VS_INDUCED_TREG_DN,0.717972624249044
HP_NEOPLASM_OF_THE_STOMACH,SET,85,0.16536,0.011225,0.091492,0.035361,HP_NEOPLASM_OF_THE_STOMACH,0.717972624249044
GAVISH_3CA_MALIGNANT_METAPRO...10,SET,50,0.24421,0.012727,0.13514,0.035381,GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE,0.717972624249044
GOBP_REGULATION_OF_CYTOKINET...,SET,7,0.59216,0.01156,0.32771,0.035391,GOBP_REGULATION_OF_CYTOKINETIC_PROCESS,0.717972624249044
GSE19401_NAIVE_VS_IMMUNIZED_...1,SET,181,0.1151,0.011372,0.063706,0.035404,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN,0.717972624249044
GOBP_CEREBELLAR_PURKINJE_CEL...2,SET,12,0.45992,0.011754,0.25461,0.035436,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION,0.717972624249044
GOCC_POLYPRENYL_DIPHOSPHATE_...,SET,10,0.45029,0.010506,0.24928,0.035438,GOCC_POLYPRENYL_DIPHOSPHATE_SYNTHASE_COMPLEX,0.717972624249044
MIR1266_5P,SET,83,0.16412,0.01101,0.090864,0.035452,MIR1266_5P,0.717972624249044
MIR8064,SET,73,0.18711,0.011775,0.10361,0.03547,MIR8064,0.717972624249044
GOBP_RESPONSE_TO_LIPOTEICHOI...,SET,10,0.49516,0.011553,0.27423,0.035498,GOBP_RESPONSE_TO_LIPOTEICHOIC_ACID,0.717972624249044
GOMF_RIBOSOMAL_PROTEIN_S6_KI...,SET,5,0.65051,0.010733,0.36032,0.035519,GOMF_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY,0.717972624249044
GOBP_NEGATIVE_REGULATION_OF_...707,SET,156,0.12953,0.011888,0.07175,0.035528,GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.717972624249044
MODULE_129,SET,203,0.11626,0.012157,0.06442,0.035569,MODULE_129,0.717972624249044
WP_NANOMATERIALINDUCED_INFLA...,SET,5,0.64714,0.010678,0.35866,0.035599,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,0.717972624249044
GOBP_APOPTOTIC_PROCESS,SET,1728,0.03924,0.011458,0.02175,0.035614,GOBP_APOPTOTIC_PROCESS,0.717972624249044
GOBP_VESICLE_BUDDING_FROM_ME...,SET,82,0.16265,0.010846,0.090189,0.03567,GOBP_VESICLE_BUDDING_FROM_MEMBRANE,0.717972624249044
REACTOME_ZINC_INFLUX_INTO_CE...,SET,10,0.43965,0.010258,0.24389,0.035731,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,0.717972624249044
GOBP_LEUKOTRIENE_SIGNALING_P...,SET,4,0.66819,0.0098615,0.37078,0.035774,GOBP_LEUKOTRIENE_SIGNALING_PATHWAY,0.717972624249044
DUTERTRE_ESTRADIOL_RESPONSE_...2,SET,297,0.085423,0.010776,0.047441,0.035889,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,0.717972624249044
GOBP_MESENCHYMAL_CELL_PROLIF...1,SET,42,0.27539,0.013157,0.15298,0.035922,GOBP_MESENCHYMAL_CELL_PROLIFERATION,0.717972624249044
GOBP_ENAMEL_MINERALIZATION,SET,18,0.37078,0.011604,0.20597,0.035928,GOBP_ENAMEL_MINERALIZATION,0.717972624249044
GOMF_DIACYLGLYCEROL_BINDING,SET,13,0.42533,0.011314,0.23628,0.035931,GOMF_DIACYLGLYCEROL_BINDING,0.717972624249044
GSE9946_MATURE_STIMULATORY_V...3,SET,117,0.1482,0.011793,0.082336,0.035941,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.717972624249044
REACTOME_MATURATION_OF_SARS_...3,SET,5,0.62477,0.010309,0.3471,0.035943,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,0.717972624249044
GOBP_CYTOPLASMIC_SEQUESTERIN...2,SET,13,0.40248,0.010706,0.22361,0.035946,GOBP_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN,0.717972624249044
GSE19923_WT_VS_HEB_AND_E2A_K...2,SET,182,0.10947,0.010845,0.060823,0.035951,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.717972624249044
LAMB3_TARGET_GENES,SET,5,0.67054,0.011064,0.37265,0.035988,LAMB3_TARGET_GENES,0.717972624249044
HP_NON_MEDULLARY_THYROID_CAR...,SET,6,0.6696,0.012103,0.37219,0.036011,HP_NON_MEDULLARY_THYROID_CARCINOMA,0.717972624249044
GOMF_GLYCERALDEHYDE_3_PHOSPH...,SET,7,0.54188,0.010579,0.30123,0.036025,GOMF_GLYCERALDEHYDE_3_PHOSPHATE_DEHYDROGENASE_NADPLUS_NON_PHOSPHORYLATING_ACTIVITY,0.717972624249044
HP_ABNORMALITY_OF_TEMPERATUR...,SET,490,0.071599,0.01154,0.039801,0.036025,HP_ABNORMALITY_OF_TEMPERATURE_REGULATION,0.717972624249044
HNF4_Q6,SET,244,0.09793,0.011214,0.05445,0.036055,HNF4_Q6,0.717972624249044
REACTOME_VIRAL_MESSENGER_RNA...,SET,42,0.22789,0.010887,0.12673,0.03608,REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS,0.717972624249044
RIZ_ERYTHROID_DIFFERENTIATION,SET,73,0.17776,0.011186,0.098881,0.036122,RIZ_ERYTHROID_DIFFERENTIATION,0.717972624249044
HP_BITEMPORAL_HEMIANOPIA,SET,16,0.36411,0.010744,0.20258,0.03615,HP_BITEMPORAL_HEMIANOPIA,0.717972624249044
MIR3150A_3P,SET,85,0.1617,0.010977,0.089975,0.03616,MIR3150A_3P,0.717972624249044
GOMF_MITOGEN_ACTIVATED_PROTE...4,SET,7,0.63392,0.012376,0.35278,0.036183,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_P38_BINDING,0.717972624249044
BAELDE_DIABETIC_NEPHROPATHY_...1,SET,401,0.080368,0.011747,0.044729,0.036195,BAELDE_DIABETIC_NEPHROPATHY_DN,0.717972624249044
MYLLYKANGAS_AMPLIFICATION_HO...17,SET,7,0.6188,0.01208,0.34443,0.036211,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7,0.717972624249044
EHLERS_ANEUPLOIDY_DN,SET,10,0.5342,0.012464,0.29737,0.036223,EHLERS_ANEUPLOIDY_DN,0.717972624249044
GSE16385_UNTREATED_VS_12H_RO...1,SET,173,0.11586,0.011193,0.064495,0.036224,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.717972624249044
MORF_CCNF,SET,72,0.16312,0.010195,0.090805,0.036226,MORF_CCNF,0.717972624249044
ISRE_01,SET,226,0.10622,0.011713,0.059139,0.036241,ISRE_01,0.717972624249044
HP_NON_MIDLINE_CLEFT_OF_THE_...,SET,34,0.25585,0.011,0.14244,0.036243,HP_NON_MIDLINE_CLEFT_OF_THE_UPPER_LIP,0.717972624249044
WP_15Q112_COPY_NUMBER_VARIAT...,SET,4,0.72811,0.010746,0.40544,0.036265,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,0.717972624249044
GOCC_EQUATORIAL_MICROTUBULE_...,SET,4,0.72811,0.010746,0.40544,0.036265,GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER,0.717972624249044
WP_INTEGRATED_CANCER_PATHWAY,SET,43,0.22052,0.010659,0.1228,0.03628,WP_INTEGRATED_CANCER_PATHWAY,0.717972624249044
WP_NGLYCAN_BIOSYNTHESIS,SET,53,0.198,0.010623,0.11027,0.036281,WP_NGLYCAN_BIOSYNTHESIS,0.717972624249044
GSE40666_WT_VS_STAT4_KO_CD8_...2,SET,147,0.13359,0.011905,0.074415,0.036323,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP,0.717972624249044
SHIRAISHI_PLZF_TARGETS_DN,SET,9,0.55021,0.012179,0.30657,0.036356,SHIRAISHI_PLZF_TARGETS_DN,0.717972624249044
HP_GLOMERULONEPHRITIS,SET,86,0.17187,0.011736,0.095779,0.036376,HP_GLOMERULONEPHRITIS,0.717972624249044
MIR3677_3P,SET,5,0.72267,0.011924,0.40284,0.036418,MIR3677_3P,0.717972624249044
GOMF_HELICASE_ACTIVITY,SET,142,0.12303,0.010778,0.068578,0.036418,GOMF_HELICASE_ACTIVITY,0.717972624249044
GOBP_REGULATION_OF_BMP_SIGNA...,SET,93,0.17188,0.012202,0.095812,0.036422,GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.717972624249044
HP_ABNORMAL_ABDOMEN_MORPHOLO...,SET,721,0.058092,0.011284,0.032387,0.036438,HP_ABNORMAL_ABDOMEN_MORPHOLOGY,0.717972624249044
GOBP_POSITIVE_REGULATION_OF_...548,SET,6,0.54355,0.0098245,0.30305,0.036448,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.717972624249044
RICKMAN_METASTASIS_UP,SET,273,0.094192,0.0114,0.052528,0.03648,RICKMAN_METASTASIS_UP,0.717972624249044
REACTOME_KERATAN_SULFATE_BIO...,SET,28,0.30022,0.011715,0.16745,0.036504,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,0.717972624249044
HP_IRREGULAR_ILIAC_CREST,SET,6,0.65842,0.011901,0.36739,0.036562,HP_IRREGULAR_ILIAC_CREST,0.717972624249044
HP_UPLIFTED_EARLOBE,SET,20,0.3543,0.011687,0.19776,0.036614,HP_UPLIFTED_EARLOBE,0.717972624249044
GOBP_REGULATION_OF_PRESYNAPS...,SET,28,0.3345,0.013053,0.18673,0.036632,GOBP_REGULATION_OF_PRESYNAPSE_ORGANIZATION,0.717972624249044
GSE22886_IGA_VS_IGM_MEMORY_B...1,SET,186,0.11206,0.011221,0.062557,0.036632,GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN,0.717972624249044
GOBP_NEGATIVE_REGULATION_OF_...554,SET,22,0.30845,0.010671,0.1722,0.036633,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.717972624249044
GOMF_NETRIN_RECEPTOR_ACTIVITY,SET,5,0.67957,0.011213,0.37941,0.036648,GOMF_NETRIN_RECEPTOR_ACTIVITY,0.717972624249044
ZHENG_CORD_BLOOD_C6_HSC_MULT...,SET,81,0.18422,0.012209,0.10285,0.036652,ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR,0.717972624249044
MGGAAGTG_GABP_B,SET,698,0.057214,0.010942,0.031955,0.036697,MGGAAGTG_GABP_B,0.717972624249044
FARMER_BREAST_CANCER_CLUSTER...5,SET,19,0.37917,0.012191,0.2118,0.036715,FARMER_BREAST_CANCER_CLUSTER_5,0.717972624249044
GAUTAM_EYE_CORNEA_CONJUNCTIV...,SET,92,0.16247,0.011472,0.090766,0.036733,GAUTAM_EYE_CORNEA_CONJUNCTIVAL_CELLS,0.717972624249044
WP_SIGNAL_TRANSDUCTION_THROU...,SET,32,0.28751,0.011992,0.16064,0.036753,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,0.717972624249044
GOBP_REGULATION_OF_DEVELOPME...1,SET,271,0.099199,0.011963,0.055429,0.036762,GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.717972624249044
XU_HGF_SIGNALING_NOT_VIA_AKT...1,SET,18,0.34964,0.010942,0.19537,0.036763,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,0.717972624249044
GSE24634_NAIVE_CD4_TCELL_VS_...6,SET,184,0.11206,0.011162,0.062619,0.036769,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP,0.717972624249044
MIR4418,SET,118,0.14083,0.011254,0.078697,0.036772,MIR4418,0.717972624249044
RODWELL_AGING_KIDNEY_UP,SET,422,0.077476,0.01161,0.043297,0.036781,RODWELL_AGING_KIDNEY_UP,0.717972624249044
GOCC_CYTOPLASMIC_MICROTUBULE,SET,81,0.1721,0.011406,0.096207,0.036832,GOCC_CYTOPLASMIC_MICROTUBULE,0.717972624249044
GOBP_VIRAL_PROTEIN_PROCESSING,SET,31,0.26876,0.011034,0.15027,0.036853,GOBP_VIRAL_PROTEIN_PROCESSING,0.717972624249044
GOBP_RENAL_FILTRATION,SET,27,0.33026,0.012656,0.18472,0.036902,GOBP_RENAL_FILTRATION,0.717972624249044
REACTOME_SIGNALING_BY_FGFR4,SET,39,0.24236,0.011158,0.13556,0.036905,REACTOME_SIGNALING_BY_FGFR4,0.717972624249044
HP_ABNORMAL_PERICARDIUM_MORP...,SET,71,0.18657,0.011579,0.10435,0.036912,HP_ABNORMAL_PERICARDIUM_MORPHOLOGY,0.717972624249044
GOBP_POSITIVE_REGULATION_OF_...222,SET,13,0.41602,0.011066,0.23278,0.036965,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.717972624249044
HP_CLEFT_ALA_NASI,SET,4,0.91107,0.013446,0.50981,0.036972,HP_CLEFT_ALA_NASI,0.717972624249044
HP_ABNORMALITY_OF_THE_ABDOMI...1,SET,1200,0.045014,0.011126,0.025193,0.036992,HP_ABNORMALITY_OF_THE_ABDOMINAL_ORGANS,0.717972624249044
GOBP_ERYTHROCYTE_MATURATION,SET,18,0.35264,0.011036,0.19737,0.037002,GOBP_ERYTHROCYTE_MATURATION,0.717972624249044
GOBP_REGULATION_OF_STRIATED_...1,SET,78,0.18016,0.011718,0.10088,0.037065,GOBP_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.717972624249044
YAGI_AML_WITH_T_8_21_TRANSLO...,SET,325,0.085323,0.011251,0.047777,0.037069,YAGI_AML_WITH_T_8_21_TRANSLOCATION,0.717972624249044
GOBP_OSTEOBLAST_DEVELOPMENT,SET,16,0.38932,0.011488,0.218,0.037071,GOBP_OSTEOBLAST_DEVELOPMENT,0.717972624249044
HP_NEONATAL_INSULIN_DEPENDEN...,SET,20,0.37039,0.012218,0.20747,0.037116,HP_NEONATAL_INSULIN_DEPENDENT_DIABETES_MELLITUS,0.717972624249044
MIR615_3P,SET,6,0.59102,0.010682,0.33114,0.037157,MIR615_3P,0.717972624249044
GOBP_GOLGI_TO_LYSOSOME_TRANS...,SET,12,0.41487,0.010603,0.23246,0.037163,GOBP_GOLGI_TO_LYSOSOME_TRANSPORT,0.717972624249044
GOBP_OSTEOCLAST_FUSION,SET,6,0.67789,0.012253,0.37984,0.037166,GOBP_OSTEOCLAST_FUSION,0.717972624249044
GOBP_BRANCHING_INVOLVED_IN_P...,SET,12,0.49751,0.012715,0.27878,0.037171,GOBP_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.717972624249044
GOMF_TRANSCRIPTION_COREPRESS...2,SET,42,0.23675,0.011311,0.13267,0.037179,GOMF_TRANSCRIPTION_COREPRESSOR_BINDING,0.717972624249044
MIR324_3P,SET,71,0.17626,0.01094,0.098801,0.037223,MIR324_3P,0.717972624249044
GOCC_ESC_E_Z_COMPLEX,SET,14,0.39363,0.010865,0.22068,0.037245,GOCC_ESC_E_Z_COMPLEX,0.717972624249044
HP_ABNORMAL_URINARY_ORGANIC_...,SET,57,0.21001,0.011683,0.11774,0.037254,HP_ABNORMAL_URINARY_ORGANIC_COMPOUND_LEVEL,0.717972624249044
MORF_RUNX1,SET,139,0.12487,0.010824,0.07002,0.037273,MORF_RUNX1,0.717972624249044
HP_HEPATITIS,SET,82,0.1744,0.011629,0.097808,0.037296,HP_HEPATITIS,0.717972624249044
HP_HYPOPLASTIC_LABIA_MAJORA,SET,34,0.26462,0.011377,0.14845,0.037338,HP_HYPOPLASTIC_LABIA_MAJORA,0.717972624249044
GSE23505_UNTREATED_VS_4DAY_I...2,SET,185,0.11221,0.011207,0.062961,0.037363,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.717972624249044
GSE36392_TYPE_2_MYELOID_VS_E...2,SET,177,0.10931,0.010681,0.061332,0.037363,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP,0.717972624249044
HP_DYSPHAGIA,SET,465,0.071746,0.011272,0.040263,0.037391,HP_DYSPHAGIA,0.717972624249044
GOBP_MONOUBIQUITINATED_PROTE...,SET,8,0.4596,0.0095917,0.25794,0.037396,GOBP_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION,0.717972624249044
HP_ABNORMAL_IMMUNE_SYSTEM_MO...,SET,587,0.063598,0.011188,0.035697,0.037415,HP_ABNORMAL_IMMUNE_SYSTEM_MORPHOLOGY,0.717972624249044
GTGGGTGK_UNKNOWN,SET,264,0.097412,0.011597,0.05468,0.037425,GTGGGTGK_UNKNOWN,0.717972624249044
OCT1_03,SET,206,0.1093,0.011513,0.061357,0.037429,OCT1_03,0.717972624249044
REACTOME_PREGNENOLONE_BIOSYN...,SET,10,0.51357,0.011982,0.28829,0.03743,REACTOME_PREGNENOLONE_BIOSYNTHESIS,0.717972624249044
REACTOME_MALATE_ASPARTATE_SH...,SET,9,0.46797,0.010358,0.26271,0.037438,REACTOME_MALATE_ASPARTATE_SHUTTLE,0.717972624249044
MORF_REV3L,SET,55,0.1906,0.010417,0.10702,0.037459,MORF_REV3L,0.717972624249044
GSE43863_TH1_VS_TFH_EFFECTOR...1,SET,173,0.11592,0.011199,0.065095,0.037483,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN,0.717972624249044
MIR6891_5P,SET,109,0.14358,0.01103,0.080649,0.037521,MIR6891_5P,0.717972624249044
PID_LYSOPHOSPHOLIPID_PATHWAY,SET,63,0.199,0.011637,0.1118,0.037545,PID_LYSOPHOSPHOLIPID_PATHWAY,0.717972624249044
GSE20727_CTRL_VS_H2O2_TREATE...1,SET,174,0.11073,0.010728,0.06221,0.037552,GSE20727_CTRL_VS_H2O2_TREATED_DC_DN,0.717972624249044
GOBP_MIGRACYTOSIS,SET,5,0.70344,0.011607,0.39525,0.037568,GOBP_MIGRACYTOSIS,0.717972624249044
MORF_FANCG,SET,156,0.11726,0.010763,0.065904,0.037609,MORF_FANCG,0.717972624249044
GOBP_SALIVA_SECRETION,SET,13,0.47174,0.012548,0.26516,0.037623,GOBP_SALIVA_SECRETION,0.717972624249044
HP_NARROW_NASAL_BRIDGE,SET,41,0.24812,0.011712,0.13951,0.037672,HP_NARROW_NASAL_BRIDGE,0.717972624249044
HP_ENTROPION,SET,20,0.29396,0.0096969,0.16532,0.037697,HP_ENTROPION,0.717972624249044
GOBP_NEGATIVE_REGULATION_OF_...506,SET,812,0.054981,0.011304,0.030921,0.037702,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.717972624249044
GOBP_RNA_SPLICING_VIA_TRANSE...,SET,269,0.083445,0.010026,0.046932,0.037711,GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS,0.717972624249044
HP_EAR_PAIN,SET,15,0.38753,0.011072,0.21797,0.03772,HP_EAR_PAIN,0.717972624249044
REACTOME_NOTCH3_INTRACELLULA...,SET,24,0.30577,0.011048,0.17201,0.037741,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.717972624249044
DESCARTES_FETAL_MUSCLE_SATEL...,SET,41,0.2485,0.01173,0.13982,0.037774,DESCARTES_FETAL_MUSCLE_SATELLITE_CELLS,0.717972624249044
GOBP_REGULATION_OF_BONE_DEVE...,SET,8,0.53392,0.011143,0.30043,0.037778,GOBP_REGULATION_OF_BONE_DEVELOPMENT,0.717972624249044
GOCC_NUCLEAR_ENVELOPE,SET,450,0.07132,0.011028,0.040134,0.03779,GOCC_NUCLEAR_ENVELOPE,0.717972624249044
GAVISH_3CA_MALIGNANT_METAPRO...29,SET,42,0.24081,0.011505,0.13553,0.037809,GAVISH_3CA_MALIGNANT_METAPROGRAM_37_HEMATO_RELATED_2,0.717972624249044
GSE4590_SMALL_VS_VPREB_POS_L...1,SET,139,0.1305,0.011312,0.073454,0.037825,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.717972624249044
GOBP_ENDOTHELIAL_CELL_MIGRAT...,SET,202,0.11245,0.01173,0.063325,0.037893,GOBP_ENDOTHELIAL_CELL_MIGRATION,0.718560572519084
GOBP_RRNA_TRANSCRIPTION,SET,33,0.25013,0.010595,0.14088,0.037914,GOBP_RRNA_TRANSCRIPTION,0.718560572519084
HP_ABNORMAL_CIRCULATING_SERI...2,SET,30,0.28242,0.011407,0.15907,0.037918,HP_ABNORMAL_CIRCULATING_SERINE_FAMILY_AMINO_ACID_CONCENTRATION,0.718560572519084
GOMF_ZINC_ION_BINDING,SET,756,0.055937,0.011115,0.031518,0.037979,GOMF_ZINC_ION_BINDING,0.718666229641694
GOBP_POSITIVE_REGULATION_OF_...623,SET,39,0.24138,0.011113,0.13603,0.038003,GOBP_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.718666229641694
MIR4489,SET,49,0.21248,0.010962,0.11976,0.038025,MIR4489,0.718666229641694
GOCC_CIS_GOLGI_NETWORK,SET,56,0.1929,0.010637,0.10874,0.038046,GOCC_CIS_GOLGI_NETWORK,0.718666229641694
GNF2_BUB3,SET,26,0.26615,0.010009,0.15006,0.038072,GNF2_BUB3,0.718666229641694
MIR6736_3P,SET,113,0.1468,0.011481,0.08277,0.038075,MIR6736_3P,0.718666229641694
MODULE_414,SET,8,0.61713,0.012879,0.34796,0.038075,MODULE_414,0.718666229641694
GOMF_GPI_LINKED_EPHRIN_RECEP...,SET,6,0.69928,0.012639,0.39431,0.038089,GOMF_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY,0.718666229641694
GOBP_GOLGI_TO_PLASMA_MEMBRAN...2,SET,61,0.18917,0.010886,0.10672,0.038159,GOBP_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT,0.719432269522776
GSE46242_CTRL_VS_EGR2_DELETE...4,SET,168,0.11387,0.010843,0.064247,0.038171,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP,0.719432269522776
HP_SPIDER_HEMANGIOMA,SET,5,0.6539,0.010789,0.36903,0.038212,HP_SPIDER_HEMANGIOMA,0.719814666666667
FINAK_BREAST_CANCER_SDPP_SIG...,SET,20,0.37013,0.012209,0.20893,0.038244,FINAK_BREAST_CANCER_SDPP_SIGNATURE,0.720027204767064
GOBP_REGULATION_OF_INCLUSION...,SET,17,0.38121,0.011595,0.21524,0.038282,GOBP_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.720352414726584
GOBP_REGULATION_OF_PINOCYTOS...,SET,12,0.39395,0.010068,0.22249,0.038318,GOBP_REGULATION_OF_PINOCYTOSIS,0.720603264038877
REACTOME_RAC2_GTPASE_CYCLE,SET,78,0.18057,0.011744,0.10201,0.038356,REACTOME_RAC2_GTPASE_CYCLE,0.720603264038877
WP_PGK1_PKM2_KHKCKHKA_ACTING...,SET,10,0.4043,0.0094329,0.22843,0.038382,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,0.720603264038877
GSE411_100MIN_VS_400MIN_IL6_...2,SET,179,0.11057,0.010864,0.062474,0.038387,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.720603264038877
SCHEIDEREIT_IKK_TARGETS,SET,17,0.40073,0.012188,0.22644,0.038399,SCHEIDEREIT_IKK_TARGETS,0.720603264038877
GOBP_INTRACELLULAR_TRANSPORT,SET,1225,0.042993,0.010728,0.024312,0.038507,GOBP_INTRACELLULAR_TRANSPORT,0.721844693053312
WANG_CLASSIC_ADIPOGENIC_TARG...,SET,27,0.29916,0.011464,0.1692,0.038534,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,0.721844693053312
GOBP_AUTONOMIC_NERVOUS_SYSTE...,SET,40,0.25803,0.012031,0.14595,0.038546,GOBP_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,0.721844693053312
REACTOME_DEX_H_BOX_HELICASES...,SET,7,0.54037,0.010549,0.30569,0.038564,REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION,0.721844693053312
GSE19941_UNSTIM_VS_LPS_AND_I...1,SET,184,0.10842,0.0108,0.061338,0.038569,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.721844693053312
PID_HEDGEHOG_2PATHWAY,SET,21,0.34045,0.011507,0.19265,0.038609,PID_HEDGEHOG_2PATHWAY,0.722040266272189
WP_MFAP5MEDIATED_OVARIAN_CAN...,SET,12,0.45278,0.011572,0.25624,0.038621,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,0.722040266272189
GOBP_SENSORY_PERCEPTION_OF_M...,SET,170,0.12413,0.011889,0.070269,0.03866,GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS,0.722380806451613
GOBP_RESPONSE_TO_INDOLE_3_ME...,SET,6,0.63514,0.01148,0.35959,0.038683,GOBP_RESPONSE_TO_INDOLE_3_METHANOL,0.722422173562601
HP_WHITE_LESION_OF_THE_ORAL_...,SET,26,0.31789,0.011954,0.18007,0.038758,HP_WHITE_LESION_OF_THE_ORAL_MUCOSA,0.723030788626609
GOBP_GOLGI_RIBBON_FORMATION,SET,11,0.44323,0.010846,0.25108,0.038769,GOBP_GOLGI_RIBBON_FORMATION,0.723030788626609
GSE27786_LIN_NEG_VS_ERYTHROB...1,SET,181,0.11131,0.010997,0.06306,0.038778,GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN,0.723030788626609
GOMF_HISTONE_H3_KINASE_ACTIV...,SET,10,0.48648,0.01135,0.27584,0.038903,GOMF_HISTONE_H3_KINASE_ACTIVITY,0.724972528150134
TURJANSKI_MAPK14_TARGETS,SET,9,0.5367,0.01188,0.30441,0.038951,TURJANSKI_MAPK14_TARGETS,0.725320122994652
GSE12507_PDC_CELL_LINE_VS_IM...1,SET,119,0.14252,0.011436,0.080847,0.038975,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN,0.725320122994652
LI_PBMC_ZOSTAVAX_AGE_25_40_A...2,SET,7,0.59377,0.011592,0.33687,0.038993,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_3DY_UP,0.725320122994652
TOMIDA_METASTASIS_DN,SET,11,0.45425,0.011115,0.25775,0.039015,TOMIDA_METASTASIS_DN,0.725320122994652
GOBP_POSITIVE_REGULATION_OF_...700,SET,28,0.29121,0.011364,0.16525,0.039026,GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.725320122994652
HASLINGER_B_CLL_WITH_17P13_D...,SET,20,0.31323,0.010332,0.17777,0.039048,HASLINGER_B_CLL_WITH_17P13_DELETION,0.725341122394441
KEGG_MEDICUS_VARIANT_MUTATIO...82,SET,4,0.68004,0.010037,0.38605,0.03908,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY,0.725422532017076
MIR9899,SET,4,0.69919,0.010319,0.397,0.039113,MIR9899,0.725422532017076
GOCC_FICOLIN_1_RICH_GRANULE_...2,SET,52,0.2112,0.011224,0.11992,0.039115,GOCC_FICOLIN_1_RICH_GRANULE_MEMBRANE,0.725422532017076
MODULE_86,SET,42,0.22505,0.010751,0.12781,0.039148,MODULE_86,0.725593992537313
GOBP_NEGATIVE_REGULATION_OF_...206,SET,24,0.30596,0.011055,0.17378,0.039166,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.725593992537313
GSE30153_LUPUS_VS_HEALTHY_DO...2,SET,184,0.10996,0.010953,0.062487,0.039235,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP,0.726032319341127
CAFFAREL_RESPONSE_TO_THC_8HR...1,SET,9,0.4048,0.0089603,0.23004,0.039238,CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,0.726032319341127
CRX_DN.V1_DN,SET,121,0.14411,0.01166,0.081909,0.039269,CRX_DN.V1_DN,0.726032319341127
GSE17974_CTRL_VS_ACT_IL4_AND...11,SET,177,0.1079,0.010543,0.061337,0.039285,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN,0.726032319341127
GOBP_REGULATION_OF_CELLULAR_...14,SET,6,0.71407,0.012907,0.406,0.039313,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.726032319341127
GOBP_POSITIVE_REGULATION_OF_...346,SET,412,0.079222,0.011734,0.045043,0.039315,GOBP_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY,0.726032319341127
GSE2585_CTEC_VS_THYMIC_DC_DN,SET,187,0.11358,0.011405,0.0646,0.039358,GSE2585_CTEC_VS_THYMIC_DC_DN,0.726440408921933
GOBP_POSITIVE_REGULATION_OF_...257,SET,29,0.29952,0.011894,0.17038,0.039387,GOBP_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.726589800955414
GAVISH_3CA_MALIGNANT_METAPRO...27,SET,46,0.24709,0.012352,0.14058,0.039413,GAVISH_3CA_MALIGNANT_METAPROGRAM_35_HEMATO_RELATED_1,0.726683721485411
BIOCARTA_PS1_PATHWAY,SET,13,0.3882,0.010326,0.22092,0.039452,BIOCARTA_PS1_PATHWAY,0.727000190779014
GOBP_SEGMENTATION,SET,92,0.16669,0.01177,0.094876,0.039472,GOBP_SEGMENTATION,0.727000190779014
WP_FAS_LIGAND_PATHWAY_AND_ST...,SET,42,0.23105,0.011038,0.13156,0.039539,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.7278170681458
WP_VITAMIN_B6DEPENDENT_AND_R...,SET,6,0.61145,0.011052,0.34831,0.039596,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,0.7278170681458
GOBP_REGULATION_OF_HEPATOCYT...2,SET,16,0.35763,0.010553,0.20376,0.03963,GOBP_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.7278170681458
GOMF_HISTONE_KINASE_ACTIVITY,SET,21,0.3321,0.011225,0.18923,0.039635,GOMF_HISTONE_KINASE_ACTIVITY,0.7278170681458
GSE41176_UNSTIM_VS_ANTI_IGM_...9,SET,175,0.11131,0.010816,0.063427,0.039638,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN,0.7278170681458
GOBP_REGULATION_OF_CATABOLIC...,SET,914,0.050165,0.010911,0.028585,0.039642,GOBP_REGULATION_OF_CATABOLIC_PROCESS,0.7278170681458
GOCC_SAGA_COMPLEX,SET,21,0.28172,0.0095224,0.16057,0.039675,GOCC_SAGA_COMPLEX,0.727987239199157
GSE2585_CD80_HIGH_VS_LOW_AIR...2,SET,176,0.11597,0.0113,0.066109,0.039706,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP,0.727987239199157
GOBP_MONOATOMIC_ANION_TRANSP...,SET,159,0.12758,0.011821,0.072745,0.039743,GOBP_MONOATOMIC_ANION_TRANSPORT,0.727987239199157
FOSTER_KDM1A_TARGETS_DN,SET,185,0.10291,0.010278,0.058679,0.039747,FOSTER_KDM1A_TARGETS_DN,0.727987239199157
MIR662,SET,4,0.62373,0.0092055,0.35568,0.039756,MIR662,0.727987239199157
REACTOME_SARS_COV_2_TARGETS_...2,SET,3,1.0264,0.01312,0.5854,0.039777,REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION,0.727988222748815
HARALAMBIEVA_PBMC_DRYVAX_AGE...,SET,14,0.43373,0.011973,0.24749,0.039848,HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_9_TO_34MO_UP,0.728542802831673
GOBP_ANDROGEN_RECEPTOR_SIGNA...,SET,43,0.21892,0.010582,0.12493,0.03987,GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.728542802831673
GOBP_HEMATOPOIETIC_STEM_CELL...3,SET,9,0.49825,0.011029,0.28438,0.03989,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION,0.728542802831673
GOMF_MISFOLDED_PROTEIN_BINDI...,SET,15,0.36002,0.010286,0.20555,0.039935,GOMF_MISFOLDED_PROTEIN_BINDING,0.728542802831673
GSE29615_DAY3_VS_DAY7_LAIV_F...2,SET,145,0.12821,0.011348,0.073198,0.03994,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.728542802831673
GSE16385_MONOCYTE_VS_12H_IL4...2,SET,175,0.1182,0.011484,0.06749,0.039954,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP,0.728542802831673
GSE24634_NAIVE_CD4_TCELL_VS_...1,SET,187,0.10883,0.010927,0.062146,0.039963,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN,0.728542802831673
GOBP_SOMATIC_STEM_CELL_POPUL...,SET,61,0.19531,0.011239,0.11154,0.039975,GOBP_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.728542802831673
REACTOME_SIGNALING_BY_FGFR2_...2,SET,42,0.22592,0.010793,0.12905,0.040011,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,0.728551008337676
GSE14415_INDUCED_TREG_VS_TCO...2,SET,158,0.1138,0.010512,0.065033,0.040071,GSE14415_INDUCED_TREG_VS_TCONV_UP,0.728551008337676
HP_CHRONIC_LUNG_DISEASE,SET,39,0.23141,0.010654,0.13225,0.040083,HP_CHRONIC_LUNG_DISEASE,0.728551008337676
GSE35685_CD34POS_CD38NEG_VS_...4,SET,182,0.11149,0.011045,0.063729,0.040121,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.728551008337676
WP_CALCIUM_MEDIATED_TCELL_AP...,SET,20,0.33032,0.010896,0.18886,0.040148,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.728551008337676
PID_BETA_CATENIN_DEG_PATHWAY,SET,17,0.34101,0.010372,0.19497,0.040154,PID_BETA_CATENIN_DEG_PATHWAY,0.728551008337676
GOBP_LIVER_MORPHOGENESIS,SET,25,0.29892,0.011023,0.17092,0.040167,GOBP_LIVER_MORPHOGENESIS,0.728551008337676
GOBP_OPTIC_CUP_MORPHOGENESIS...,SET,7,0.64468,0.012586,0.36864,0.040172,GOBP_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT,0.728551008337676
GOBP_NEGATIVE_REGULATION_OF_...657,SET,3,0.85341,0.010908,0.48801,0.040173,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.728551008337676
GOBP_AXIS_ELONGATION,SET,28,0.31523,0.012301,0.18031,0.040216,GOBP_AXIS_ELONGATION,0.728551008337676
GOBP_POSITIVE_REGULATION_OF_...118,SET,10,0.4234,0.0098787,0.24219,0.040222,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.728551008337676
USF_01,SET,229,0.099183,0.011008,0.056736,0.040227,USF_01,0.728551008337676
GOBP_CEREBELLAR_PURKINJE_CEL...3,SET,15,0.37801,0.0108,0.2163,0.040275,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS,0.728756283124128
GOMF_KINASE_BINDING,SET,730,0.056226,0.010986,0.032177,0.040293,GOMF_KINASE_BINDING,0.728756283124128
GOMF_NUCLEOSOME_BINDING,SET,52,0.19672,0.010454,0.11262,0.040351,GOMF_NUCLEOSOME_BINDING,0.728756283124128
MARSON_BOUND_BY_FOXP3_UNSTIM...,SET,1068,0.048745,0.011409,0.027911,0.040373,MARSON_BOUND_BY_FOXP3_UNSTIMULATED,0.728756283124128
GOBP_ATTACHMENT_OF_GPI_ANCHO...,SET,6,0.51103,0.0092367,0.29263,0.040381,GOBP_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN,0.728756283124128
STAT5A_03,SET,233,0.10235,0.011456,0.058606,0.040383,STAT5A_03,0.728756283124128
MZF1_TARGET_GENES,SET,1375,0.042057,0.01107,0.024086,0.040408,MZF1_TARGET_GENES,0.728756283124128
LEE_LIVER_CANCER_DENA_DN,SET,71,0.17874,0.011093,0.10237,0.040415,LEE_LIVER_CANCER_DENA_DN,0.728756283124128
GOBP_ANATOMICAL_STRUCTURE_FO...,SET,1096,0.04827,0.011436,0.027649,0.040429,GOBP_ANATOMICAL_STRUCTURE_FORMATION_INVOLVED_IN_MORPHOGENESIS,0.728756283124128
GOMF_PDZ_DOMAIN_BINDING,SET,80,0.17702,0.011659,0.10143,0.040475,GOMF_PDZ_DOMAIN_BINDING,0.728756283124128
HP_KERATOCONJUNCTIVITIS,SET,43,0.22286,0.010773,0.12772,0.040509,HP_KERATOCONJUNCTIVITIS,0.728756283124128
HP_EMG_MYOPATHIC_ABNORMALITI...,SET,116,0.13493,0.010691,0.077342,0.040541,HP_EMG_MYOPATHIC_ABNORMALITIES,0.728756283124128
REACTOME_DEFECTIVE_CHST6_CAU...,SET,8,0.5371,0.011209,0.30794,0.040574,REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1,0.728756283124128
GOBP_AMINO_ACID_BETAINE_TRAN...,SET,12,0.4887,0.01249,0.28029,0.040626,GOBP_AMINO_ACID_BETAINE_TRANSPORT,0.728756283124128
GSE43863_NAIVE_VS_TH1_EFF_CD...2,SET,165,0.11548,0.010899,0.066246,0.040653,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...458,SET,14,0.40089,0.011066,0.23,0.040677,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.728756283124128
GOBP_FIBRINOLYSIS,SET,27,0.29732,0.011393,0.17059,0.040691,GOBP_FIBRINOLYSIS,0.728756283124128
GOMF_CELL_CELL_ADHESION_MEDI...,SET,50,0.2392,0.012466,0.13725,0.040692,GOMF_CELL_CELL_ADHESION_MEDIATOR_ACTIVITY,0.728756283124128
GOCC_DESMOSOME,SET,26,0.32104,0.012073,0.18426,0.040735,GOCC_DESMOSOME,0.728756283124128
REACTOME_Z_DECAY_DEGRADATION...,SET,10,0.4569,0.01066,0.26225,0.040739,REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS,0.728756283124128
MIR6763_5P,SET,92,0.15119,0.010675,0.086783,0.040749,MIR6763_5P,0.728756283124128
GOBP_VITAMIN_B6_METABOLIC_PR...,SET,5,0.67973,0.011216,0.39017,0.04075,GOBP_VITAMIN_B6_METABOLIC_PROCESS,0.728756283124128
HP_DECREASED_PROPORTION_OF_C...1,SET,9,0.50336,0.011142,0.28905,0.040814,HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS,0.728756283124128
GSE13547_2H_VS_12_H_ANTI_IGM...3,SET,154,0.12122,0.011055,0.069627,0.040847,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN,0.728756283124128
XU_AKT1_TARGETS_48HR,SET,9,0.51535,0.011407,0.29603,0.04086,XU_AKT1_TARGETS_48HR,0.728756283124128
WP_CYTOKINECYTOKINE_RECEPTOR...,SET,241,0.11014,0.012536,0.063277,0.040879,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.728756283124128
GOBP_TRANSMISSION_OF_NERVE_I...,SET,71,0.18933,0.011751,0.10877,0.04088,GOBP_TRANSMISSION_OF_NERVE_IMPULSE,0.728756283124128
GOBP_REGULATION_OF_NEURON_PR...1,SET,14,0.36745,0.010143,0.21111,0.040892,GOBP_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.728756283124128
GOBP_PROTEIN_LOCALIZATION_TO...39,SET,296,0.085382,0.010753,0.049059,0.040903,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.728756283124128
GAUCHER_PBMC_YF_VAX_STAMARIL...5,SET,12,0.44257,0.011311,0.2543,0.040906,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,0.728756283124128
WP_ALSTROM_SYNDROME,SET,30,0.27121,0.010954,0.15595,0.041016,WP_ALSTROM_SYNDROME,0.728756283124128
MARZEC_IL2_SIGNALING_DN,SET,36,0.23628,0.010452,0.13587,0.041024,MARZEC_IL2_SIGNALING_DN,0.728756283124128
GOBP_REGULATION_OF_COMPLEMEN...1,SET,17,0.41665,0.012672,0.23964,0.041055,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION,0.728756283124128
GOBP_ORGANIC_HYDROXY_COMPOUN...4,SET,251,0.098279,0.011412,0.056541,0.041097,GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT,0.728756283124128
GOBP_NEGATIVE_REGULATION_OF_...485,SET,19,0.36773,0.011823,0.21159,0.041122,GOBP_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS,0.728756283124128
SESTO_RESPONSE_TO_UV_C1,SET,68,0.17711,0.010759,0.10193,0.041152,SESTO_RESPONSE_TO_UV_C1,0.728756283124128
REACTOME_INITIATION_OF_NUCLE...,SET,18,0.32383,0.010134,0.18637,0.041153,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,0.728756283124128
LI_WILMS_TUMOR_ANAPLASTIC_DN,SET,5,0.72376,0.011942,0.41696,0.041309,LI_WILMS_TUMOR_ANAPLASTIC_DN,0.728756283124128
BLANCO_MELO_COVID19_SARS_COV...5,SET,69,0.19106,0.011691,0.11008,0.041322,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...245,SET,32,0.26972,0.011251,0.1554,0.041323,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.728756283124128
BIOCARTA_VIP_PATHWAY,SET,26,0.30874,0.01161,0.17792,0.041357,BIOCARTA_VIP_PATHWAY,0.728756283124128
FAC1_01,SET,189,0.11454,0.011561,0.066008,0.041357,FAC1_01,0.728756283124128
GCM_APEX1,SET,102,0.1328,0.0098709,0.076541,0.041376,GCM_APEX1,0.728756283124128
GOBP_NUCLEOPHAGY,SET,21,0.32539,0.010998,0.18758,0.04141,GOBP_NUCLEOPHAGY,0.728756283124128
GSE411_UNSTIM_VS_400MIN_IL6_...2,SET,183,0.10816,0.010744,0.06237,0.041451,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.728756283124128
GOBP_RESPONSE_TO_GROWTH_FACT...,SET,662,0.06201,0.011561,0.035763,0.041475,GOBP_RESPONSE_TO_GROWTH_FACTOR,0.728756283124128
GOBP_ESTABLISHMENT_OF_ORGANE...,SET,436,0.070485,0.010732,0.040658,0.041503,GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...168,SET,27,0.29192,0.011187,0.16839,0.041504,GOBP_POSITIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.728756283124128
GOBP_TIGHT_JUNCTION_ORGANIZA...,SET,75,0.18186,0.0116,0.10491,0.041507,GOBP_TIGHT_JUNCTION_ORGANIZATION,0.728756283124128
REACTOME_RHOD_GTPASE_CYCLE,SET,48,0.22749,0.011617,0.13124,0.041515,REACTOME_RHOD_GTPASE_CYCLE,0.728756283124128
GOMF_BETA_GALACTOSIDE_CMP_AL...,SET,7,0.4838,0.0094448,0.27917,0.041556,GOMF_BETA_GALACTOSIDE_CMP_ALPHA_2_3_SIALYLTRANSFERASE_ACTIVITY,0.728756283124128
LIU_BREAST_CANCER,SET,25,0.28487,0.010505,0.16439,0.041566,LIU_BREAST_CANCER,0.728756283124128
GOBP_EPITHELIAL_CELL_MATURAT...,SET,26,0.3226,0.012131,0.18619,0.041594,GOBP_EPITHELIAL_CELL_MATURATION,0.728756283124128
MIR3190_3P,SET,109,0.14158,0.010876,0.081749,0.041661,MIR3190_3P,0.728756283124128
GOBP_MITOTIC_SPINDLE_ASSEMBLY,SET,68,0.17159,0.010424,0.099084,0.041663,GOBP_MITOTIC_SPINDLE_ASSEMBLY,0.728756283124128
GSE9037_CTRL_VS_LPS_4H_STIM_...2,SET,177,0.11114,0.01086,0.064207,0.041741,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP,0.728756283124128
GSE2706_R848_VS_R848_AND_LPS...4,SET,156,0.12233,0.011228,0.070686,0.041769,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP,0.728756283124128
GOBP_CELL_CELL_ADHESION_VIA_...,SET,259,0.11364,0.013402,0.065667,0.041776,GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.728756283124128
KAYO_CALORIE_RESTRICTION_MUS...2,SET,89,0.15561,0.010808,0.08993,0.041794,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,0.728756283124128
GSE1448_CTRL_VS_ANTI_VALPHA2...2,SET,178,0.10868,0.010649,0.062815,0.041815,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP,0.728756283124128
WP_METABOLISM_OF_ALPHALINOLE...,SET,6,0.67736,0.012243,0.39152,0.041816,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.728756283124128
ZHENG_CORD_BLOOD_C3_MEGAKARY...,SET,89,0.15375,0.010678,0.088879,0.04184,ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR,0.728756283124128
GSE30962_PRIMARY_VS_SECONDAR...2,SET,183,0.10562,0.010492,0.061065,0.041849,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP,0.728756283124128
HP_ABNORMALITY_OF_SALIVATION,SET,178,0.1152,0.011288,0.066607,0.04186,HP_ABNORMALITY_OF_SALIVATION,0.728756283124128
SHIN_B_CELL_LYMPHOMA_CLUSTER...1,SET,13,0.41376,0.011006,0.23923,0.041862,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,0.728756283124128
ALONSO_METASTASIS_NEURAL_UP,SET,15,0.42354,0.012101,0.24489,0.041869,ALONSO_METASTASIS_NEURAL_UP,0.728756283124128
GOBP_NEGATIVE_REGULATION_OF_...249,SET,14,0.39551,0.010917,0.22874,0.041909,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_METHYLATION,0.728756283124128
REACTOME_CONSTITUTIVE_SIGNAL...3,SET,15,0.33908,0.0096881,0.19612,0.041915,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,0.728756283124128
GOBP_CALCIUM_ACTIVATED_PHOSP...,SET,5,0.73621,0.012148,0.42582,0.041922,GOBP_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING,0.728756283124128
ZHENG_CORD_BLOOD_C7_PUTATIVE...,SET,81,0.166,0.011002,0.096018,0.041924,ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1,0.728756283124128
HP_FLANK_PAIN,SET,14,0.38726,0.01069,0.22403,0.041945,HP_FLANK_PAIN,0.728756283124128
GAO_LARGE_INTESTINE_24W_C1_D...,SET,93,0.16273,0.011552,0.094136,0.041947,GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR,0.728756283124128
GSE40184_HEALTHY_VS_HCV_INFE...1,SET,187,0.10589,0.010632,0.061259,0.041954,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN,0.728756283124128
GSE20727_DNFB_ALLERGEN_VS_RO...2,SET,162,0.12032,0.011252,0.069612,0.041965,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.728756283124128
GOBP_RESPONSE_TO_STEROID_HOR...,SET,310,0.086576,0.011154,0.05009,0.041968,GOBP_RESPONSE_TO_STEROID_HORMONE,0.728756283124128
GOMF_LIPID_PHOSPHATASE_ACTIV...,SET,7,0.55231,0.010782,0.31958,0.041982,GOMF_LIPID_PHOSPHATASE_ACTIVITY,0.728756283124128
MIR6802_5P,SET,22,0.31152,0.010777,0.18027,0.041997,MIR6802_5P,0.728756283124128
BIOCARTA_IL22BP_PATHWAY,SET,9,0.64045,0.014176,0.37068,0.042027,BIOCARTA_IL22BP_PATHWAY,0.728756283124128
REACTOME_VLDL_ASSEMBLY,SET,3,0.67083,0.0085744,0.38834,0.042054,REACTOME_VLDL_ASSEMBLY,0.728756283124128
GOBP_ALDITOL_BIOSYNTHETIC_PR...,SET,5,0.82503,0.013613,0.47773,0.042095,GOBP_ALDITOL_BIOSYNTHETIC_PROCESS,0.728756283124128
GSE15930_NAIVE_VS_48H_IN_VIT...3,SET,181,0.10375,0.010251,0.060079,0.042098,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.728756283124128
ZHOU_PANCREATIC_EXOCRINE_PRO...,SET,11,0.50643,0.012392,0.29328,0.042114,ZHOU_PANCREATIC_EXOCRINE_PROGENITOR,0.728756283124128
GOMF_HISTONE_H4_ACETYLTRANSF...,SET,21,0.27563,0.0093164,0.15964,0.04213,GOMF_HISTONE_H4_ACETYLTRANSFERASE_ACTIVITY,0.728756283124128
GSE31082_CD4_VS_CD8_SP_THYMO...2,SET,178,0.11218,0.010992,0.064998,0.042196,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP,0.728756283124128
GOBP_LEUKOCYTE_PROLIFERATION,SET,322,0.088043,0.011557,0.051015,0.042198,GOBP_LEUKOCYTE_PROLIFERATION,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...455,SET,2,1.1187,0.011676,0.64828,0.042211,GOBP_POSITIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.728756283124128
HP_TRICUSPID_STENOSIS,SET,6,0.66433,0.012007,0.38497,0.042215,HP_TRICUSPID_STENOSIS,0.728756283124128
HP_PULMONARY_VENOUS_HYPERTEN...,SET,9,0.49852,0.011035,0.28891,0.042226,HP_PULMONARY_VENOUS_HYPERTENSION,0.728756283124128
GOBP_PLANAR_CELL_POLARITY_PA...1,SET,6,0.72664,0.013134,0.42115,0.042239,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_AXIS_ELONGATION,0.728756283124128
HP_ABNORMAL_SIZE_OF_PITUITAR...,SET,27,0.28673,0.010988,0.16619,0.042244,HP_ABNORMAL_SIZE_OF_PITUITARY_GLAND,0.728756283124128
GOBP_ETHANOL_METABOLIC_PROCE...,SET,11,0.49882,0.012206,0.28921,0.042296,GOBP_ETHANOL_METABOLIC_PROCESS,0.728756283124128
GSE3691_IFN_PRODUCING_KILLER...4,SET,177,0.11112,0.010858,0.064432,0.04231,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP,0.728756283124128
GSE43863_TH1_VS_LY6C_INT_CXC...2,SET,179,0.10644,0.010458,0.061733,0.042344,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.728756283124128
HP_DECREASED_CIRCULATING_TOT...1,SET,7,0.61741,0.012053,0.35809,0.04235,HP_DECREASED_CIRCULATING_TOTAL_IGA,0.728756283124128
BIOCARTA_AMAN_PATHWAY,SET,15,0.40654,0.011615,0.23587,0.042398,BIOCARTA_AMAN_PATHWAY,0.728756283124128
HP_PROGRESSIVE_PERIPHERAL_NE...,SET,4,0.80864,0.011934,0.46918,0.042408,HP_PROGRESSIVE_PERIPHERAL_NEUROPATHY,0.728756283124128
GSE12003_MIR223_KO_VS_WT_BM_...3,SET,125,0.12835,0.010555,0.074473,0.04241,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN,0.728756283124128
HP_FOCAL_TONIC_SEIZURE,SET,28,0.28342,0.011059,0.16452,0.042481,HP_FOCAL_TONIC_SEIZURE,0.728756283124128
HP_TRANSIENT_GLOBAL_AMNESIA,SET,20,0.33289,0.010981,0.19324,0.042483,HP_TRANSIENT_GLOBAL_AMNESIA,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...655,SET,303,0.086774,0.011055,0.050382,0.042516,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS,0.728756283124128
GSE1432_CTRL_VS_IFNG_24H_MIC...2,SET,186,0.10802,0.010817,0.062718,0.042522,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.728756283124128
GOBP_SECONDARY_HEART_FIELD_S...,SET,11,0.52868,0.012937,0.30706,0.042569,GOBP_SECONDARY_HEART_FIELD_SPECIFICATION,0.728756283124128
REACTOME_ETHANOL_OXIDATION,SET,12,0.52841,0.013505,0.30693,0.04258,REACTOME_ETHANOL_OXIDATION,0.728756283124128
GOCC_CELL_SURFACE,SET,815,0.057988,0.011943,0.033687,0.0426,GOCC_CELL_SURFACE,0.728756283124128
GSE22886_NAIVE_BCELL_VS_BM_P...1,SET,182,0.10921,0.010819,0.063443,0.0426,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN,0.728756283124128
HP_INCREASED_CIRCULATING_PRO...,SET,26,0.27844,0.010471,0.16177,0.04262,HP_INCREASED_CIRCULATING_PROLACTIN_CONCENTRATION,0.728756283124128
HP_APLASIA_HYPOPLASIA_OF_THE...46,SET,7,0.68689,0.01341,0.3991,0.042624,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_BONE,0.728756283124128
CSR_LATE_UP.V1_UP,SET,154,0.11766,0.010731,0.068374,0.042648,CSR_LATE_UP.V1_UP,0.728756283124128
GNF2_PCNA,SET,64,0.17816,0.010501,0.10354,0.042654,GNF2_PCNA,0.728756283124128
HP_ABNORMAL_PERITONEUM_MORPH...,SET,59,0.19478,0.011024,0.1132,0.042661,HP_ABNORMAL_PERITONEUM_MORPHOLOGY,0.728756283124128
GSE557_CIITA_KO_VS_I_AB_KO_D...2,SET,179,0.10682,0.010495,0.062085,0.042682,GSE557_CIITA_KO_VS_I_AB_KO_DC_UP,0.728756283124128
MODULE_222,SET,10,0.48749,0.011374,0.28338,0.0427,MODULE_222,0.728756283124128
HP_ABNORMAL_HEART_RATE_VARIA...,SET,22,0.31303,0.010829,0.18197,0.042707,HP_ABNORMAL_HEART_RATE_VARIABILITY,0.728756283124128
VDR_Q3,SET,212,0.10141,0.010834,0.058978,0.042777,VDR_Q3,0.728756283124128
KEGG_MEDICUS_REFERENCE_PRE_I...,SET,27,0.262,0.01004,0.15241,0.042814,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION,0.728756283124128
FAELT_B_CLL_WITH_VH3_21_UP,SET,38,0.21802,0.0099082,0.12683,0.042817,FAELT_B_CLL_WITH_VH3_21_UP,0.728756283124128
GSE34205_HEALTHY_VS_FLU_INF_...2,SET,173,0.10967,0.010596,0.063804,0.042824,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP,0.728756283124128
GHO_ATF5_TARGETS_DN,SET,16,0.40117,0.011838,0.2334,0.042835,GHO_ATF5_TARGETS_DN,0.728756283124128
GOBP_CORTICAL_ACTIN_CYTOSKEL...,SET,42,0.2182,0.010424,0.12698,0.042876,GOBP_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION,0.728756283124128
BYSTRYKH_HEMATOPOIESIS_STEM_...5,SET,8,0.54234,0.011318,0.31563,0.042881,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA,0.728756283124128
MIR103A_2_5P,SET,140,0.12456,0.010835,0.072497,0.042897,MIR103A_2_5P,0.728756283124128
DESCARTES_FETAL_EYE_RETINAL_...1,SET,63,0.20133,0.011773,0.11719,0.042907,DESCARTES_FETAL_EYE_RETINAL_PIGMENT_CELLS,0.728756283124128
GOBP_REGULATION_OF_ANIMAL_OR...1,SET,26,0.3264,0.012274,0.19,0.042913,GOBP_REGULATION_OF_ANIMAL_ORGAN_FORMATION,0.728756283124128
GOBP_NEGATIVE_REGULATION_OF_...652,SET,137,0.1317,0.011334,0.076671,0.042927,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.728756283124128
HP_CLEFT_SOFT_PALATE,SET,49,0.20476,0.010564,0.11921,0.042948,HP_CLEFT_SOFT_PALATE,0.728756283124128
MCCLUNG_DELTA_FOSB_TARGETS_2...,SET,43,0.24362,0.011776,0.14185,0.042959,MCCLUNG_DELTA_FOSB_TARGETS_2WK,0.728756283124128
WTGAAAT_UNKNOWN,SET,529,0.06716,0.011235,0.039106,0.042963,WTGAAAT_UNKNOWN,0.728756283124128
GOBP_MULTI_CILIATED_EPITHELI...,SET,8,0.49823,0.010398,0.29016,0.042992,GOBP_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.728756283124128
GOBP_RIBOSOMAL_SMALL_SUBUNIT...2,SET,93,0.14784,0.010496,0.086117,0.043017,GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS,0.728756283124128
BRACHAT_RESPONSE_TO_CAMPTOTH...1,SET,39,0.22979,0.01058,0.13394,0.043123,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,0.728756283124128
YAO_TEMPORAL_RESPONSE_TO_PRO...17,SET,46,0.21785,0.010891,0.12699,0.043142,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,0.728756283124128
WP_NCRNAS_INVOLVED_IN_STAT3_...,SET,13,0.43645,0.01161,0.25445,0.043153,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.728756283124128
COLIN_PILOCYTIC_ASTROCYTOMA_...2,SET,33,0.26764,0.011336,0.15605,0.043173,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,0.728756283124128
GSE14908_ATOPIC_VS_NONATOPIC...3,SET,180,0.10375,0.010223,0.060496,0.043179,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN,0.728756283124128
GSE7568_CTRL_VS_24H_TGFB_TRE...2,SET,180,0.1076,0.010601,0.062745,0.043195,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,0.728756283124128
GOBP_SUBSTANTIA_NIGRA_DEVELO...,SET,37,0.22841,0.010243,0.1332,0.043207,GOBP_SUBSTANTIA_NIGRA_DEVELOPMENT,0.728756283124128
GOBP_KINETOCHORE_ASSEMBLY,SET,16,0.35375,0.010438,0.20643,0.043303,GOBP_KINETOCHORE_ASSEMBLY,0.728756283124128
GOBP_INTESTINAL_HEXOSE_ABSOR...,SET,5,0.63243,0.010435,0.36906,0.043308,GOBP_INTESTINAL_HEXOSE_ABSORPTION,0.728756283124128
HP_MALIGNANT_GASTROINTESTINA...,SET,70,0.17059,0.010513,0.099551,0.043308,HP_MALIGNANT_GASTROINTESTINAL_TRACT_TUMORS,0.728756283124128
REACTOME_INHIBITION_OF_DNA_R...,SET,19,0.3102,0.0099737,0.18102,0.043309,REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,0.728756283124128
CUI_DEVELOPING_HEART_LEFT_AT...,SET,16,0.39584,0.01168,0.231,0.043312,CUI_DEVELOPING_HEART_LEFT_ATRIAL_CARDIOMYOCYTE,0.728756283124128
REACTOME_GLUCONEOGENESIS,SET,21,0.29743,0.010053,0.17357,0.043316,REACTOME_GLUCONEOGENESIS,0.728756283124128
MIR548AT_3P,SET,56,0.19045,0.010502,0.11115,0.043322,MIR548AT_3P,0.728756283124128
HP_IMPAIRED_LYMPHOCYTE_TRANS...,SET,10,0.48492,0.011314,0.28302,0.043334,HP_IMPAIRED_LYMPHOCYTE_TRANSFORMATION_WITH_PHYTOHEMAGGLUTININ,0.728756283124128
MIR3156_3P,SET,86,0.14907,0.010179,0.087049,0.043411,MIR3156_3P,0.728756283124128
GSE13547_CTRL_VS_ANTI_IGM_ST...4,SET,169,0.1124,0.010734,0.065636,0.043418,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP,0.728756283124128
HP_TRANSIENT_NEONATAL_DIABET...,SET,15,0.42779,0.012223,0.24984,0.043435,HP_TRANSIENT_NEONATAL_DIABETES_MELLITUS,0.728756283124128
HP_ABNORMAL_HYPOTHALAMUS_PHY...,SET,49,0.22244,0.011476,0.12992,0.043451,HP_ABNORMAL_HYPOTHALAMUS_PHYSIOLOGY,0.728756283124128
GTTGNYNNRGNAAC_UNKNOWN,SET,94,0.15413,0.011,0.090025,0.043452,GTTGNYNNRGNAAC_UNKNOWN,0.728756283124128
HP_INTESTINAL_LYMPHANGIECTAS...,SET,5,0.72869,0.012024,0.42564,0.043459,HP_INTESTINAL_LYMPHANGIECTASIA,0.728756283124128
GSE7548_DAY7_VS_DAY28_PCC_IM...1,SET,174,0.10951,0.01061,0.063968,0.043462,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.728756283124128
GOBP_INTERLEUKIN_17_PRODUCTI...,SET,37,0.26698,0.011973,0.15598,0.043487,GOBP_INTERLEUKIN_17_PRODUCTION,0.728756283124128
TCOF1_TARGET_GENES,SET,12,0.42366,0.010828,0.24753,0.043495,TCOF1_TARGET_GENES,0.728756283124128
GSE1460_INTRATHYMIC_T_PROGEN...3,SET,174,0.11198,0.010849,0.065447,0.043552,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN,0.728756283124128
HP_ABNORMAL_MYELOID_LEUKOCYT...,SET,300,0.084644,0.010731,0.049475,0.043563,HP_ABNORMAL_MYELOID_LEUKOCYTE_MORPHOLOGY,0.728756283124128
GAVISH_3CA_MALIGNANT_METAPRO...15,SET,36,0.22773,0.010074,0.13314,0.043599,GAVISH_3CA_MALIGNANT_METAPROGRAM_24_CILIA,0.728756283124128
MANNO_MIDBRAIN_NEUROTYPES_HP...5,SET,269,0.092571,0.011123,0.054125,0.043613,MANNO_MIDBRAIN_NEUROTYPES_HPROGM,0.728756283124128
GSE17721_CTRL_VS_PAM3CSK4_1H...1,SET,184,0.11114,0.011071,0.064987,0.04362,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN,0.728756283124128
GSE7460_CTRL_VS_TGFB_TREATED...8,SET,181,0.11288,0.011152,0.066004,0.043625,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP,0.728756283124128
FISCHER_G1_S_CELL_CYCLE,SET,172,0.10786,0.01039,0.063071,0.043633,FISCHER_G1_S_CELL_CYCLE,0.728756283124128
GSE9988_ANTI_TREM1_VS_LPS_MO...2,SET,173,0.11245,0.010864,0.065756,0.043637,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP,0.728756283124128
GOBP_ZYMOGEN_ACTIVATION,SET,51,0.21812,0.01148,0.12758,0.043671,GOBP_ZYMOGEN_ACTIVATION,0.728756283124128
REACTOME_MIRO_GTPASE_CYCLE,SET,8,0.45423,0.0094796,0.2657,0.043682,REACTOME_MIRO_GTPASE_CYCLE,0.728756283124128
GOBP_MULTINUCLEAR_OSTEOCLAST...,SET,8,0.56878,0.01187,0.33271,0.043685,GOBP_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...487,SET,5,0.63899,0.010544,0.37382,0.043703,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.728756283124128
WP_MAMMARY_GLAND_DEVELOPMENT...3,SET,32,0.28372,0.011835,0.16602,0.043737,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,0.728756283124128
REACTOME_NOTCH_HLH_TRANSCRIP...,SET,24,0.28371,0.010251,0.16603,0.043757,REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY,0.728756283124128
HP_INFECTIOUS_ENCEPHALITIS,SET,39,0.23422,0.010784,0.1371,0.043786,HP_INFECTIOUS_ENCEPHALITIS,0.728756283124128
WP_HISTONE_MODIFICATIONS,SET,35,0.23618,0.010302,0.13829,0.04384,WP_HISTONE_MODIFICATIONS,0.728756283124128
HP_MEMBRANOPROLIFERATIVE_GLO...,SET,9,0.49679,0.010996,0.29102,0.043913,HP_MEMBRANOPROLIFERATIVE_GLOMERULONEPHRITIS,0.728756283124128
CHARAFE_BREAST_CANCER_BASAL_...2,SET,107,0.14222,0.010826,0.083334,0.043949,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,0.728756283124128
GOBP_STORE_OPERATED_CALCIUM_...,SET,20,0.33253,0.010969,0.19486,0.043972,GOBP_STORE_OPERATED_CALCIUM_ENTRY,0.728756283124128
GSE15930_STIM_VS_STIM_AND_IL...1,SET,174,0.11159,0.010811,0.065394,0.04398,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN,0.728756283124128
GOBP_NEGATIVE_REGULATION_OF_...375,SET,41,0.22761,0.010744,0.13346,0.04407,GOBP_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,0.728756283124128
GOBP_MACROMOLECULE_DEACYLATI...,SET,53,0.1886,0.010118,0.11061,0.044097,GOBP_MACROMOLECULE_DEACYLATION,0.728756283124128
AML_Q6,SET,238,0.095768,0.010833,0.056172,0.044113,AML_Q6,0.728756283124128
HP_ADDICTIVE_BEHAVIOR,SET,29,0.2869,0.011393,0.16828,0.044121,HP_ADDICTIVE_BEHAVIOR,0.728756283124128
GOMF_TRANSLATION_ACTIVATOR_A...,SET,9,0.47879,0.010598,0.28088,0.044142,GOMF_TRANSLATION_ACTIVATOR_ACTIVITY,0.728756283124128
HP_ELEVATED_CREATINE_KINASE_...,SET,10,0.43397,0.010125,0.2546,0.044151,HP_ELEVATED_CREATINE_KINASE_AFTER_EXERCISE,0.728756283124128
HP_SPOTTY_HYPERPIGMENTATION,SET,9,0.45185,0.010002,0.26511,0.044161,HP_SPOTTY_HYPERPIGMENTATION,0.728756283124128
GOBP_RESPONSE_TO_UV,SET,141,0.11717,0.010229,0.068752,0.044176,GOBP_RESPONSE_TO_UV,0.728756283124128
MIR330_5P,SET,169,0.11556,0.011035,0.067815,0.044201,MIR330_5P,0.728756283124128
HP_MUSCULAR_DYSTROPHY,SET,69,0.17912,0.01096,0.10515,0.044243,HP_MUSCULAR_DYSTROPHY,0.728756283124128
GSE360_LOW_DOSE_B_MALAYI_VS_...3,SET,181,0.10579,0.010452,0.062106,0.044261,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.728756283124128
GSE22313_HEALTHY_VS_SLE_MOUS...2,SET,164,0.11376,0.010704,0.066802,0.044298,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP,0.728756283124128
GOCC_PLATELET_ALPHA_GRANULE_...1,SET,59,0.19709,0.011155,0.11574,0.044299,GOCC_PLATELET_ALPHA_GRANULE_LUMEN,0.728756283124128
MORF_SP3,SET,75,0.15864,0.010118,0.093158,0.044305,MORF_SP3,0.728756283124128
NFKB_Q6,SET,236,0.095545,0.010763,0.056127,0.044358,NFKB_Q6,0.728756283124128
GOCC_PRESPLICEOSOME,SET,17,0.3393,0.01032,0.19933,0.044368,GOCC_PRESPLICEOSOME,0.728756283124128
GSE29618_LAIV_VS_TIV_FLU_VAC...8,SET,171,0.10645,0.010225,0.062546,0.044398,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP,0.728756283124128
GSE28783_ANTI_MIR33_VS_UNTRE...1,SET,177,0.11209,0.010953,0.06587,0.044413,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,0.728756283124128
DURANTE_ADULT_OLFACTORY_NEUR...18,SET,11,0.47093,0.011524,0.27675,0.044421,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS,0.728756283124128
GSE6092_CTRL_VS_BORRELIA_BIR...2,SET,143,0.11719,0.010302,0.068876,0.044439,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP,0.728756283124128
GOBP_CALCIUM_INDEPENDENT_CEL...,SET,22,0.35252,0.012196,0.20721,0.044452,GOBP_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.728756283124128
HP_RADIAL_DEVIATION_OF_THE_H...1,SET,8,0.57578,0.012016,0.33843,0.044452,HP_RADIAL_DEVIATION_OF_THE_HAND,0.728756283124128
MIR6794_3P,SET,77,0.17893,0.011563,0.1052,0.044491,MIR6794_3P,0.728756283124128
MULLIGHAN_NPM1_MUTATED_SIGNA...1,SET,110,0.12984,0.01002,0.076337,0.044494,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,0.728756283124128
GOBP_NEGATIVE_REGULATION_OF_...465,SET,312,0.080826,0.010447,0.047523,0.0445,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,0.728756283124128
HP_ACUTE_CORONARY_SYNDROME,SET,101,0.15396,0.011388,0.090527,0.044507,HP_ACUTE_CORONARY_SYNDROME,0.728756283124128
GOCC_BRCA1_C_COMPLEX,SET,5,0.62029,0.010235,0.36473,0.044508,GOCC_BRCA1_C_COMPLEX,0.728756283124128
GSE15659_RESTING_TREG_VS_NON...1,SET,172,0.10982,0.01058,0.064577,0.044513,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN,0.728756283124128
GOBP_CELL_SURFACE_RECEPTOR_P...1,SET,333,0.083908,0.011197,0.049356,0.04457,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.728756283124128
HP_LEG_MUSCLE_STIFFNESS,SET,14,0.36531,0.010084,0.21489,0.044576,HP_LEG_MUSCLE_STIFFNESS,0.728756283124128
MULLIGAN_NTF3_SIGNALING_VIA_...2,SET,20,0.29857,0.0098488,0.17576,0.044696,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,0.728756283124128
NUTT_GBM_VS_AO_GLIOMA_DN,SET,44,0.20121,0.009838,0.11845,0.0447,NUTT_GBM_VS_AO_GLIOMA_DN,0.728756283124128
GSE6269_FLU_VS_E_COLI_INF_PB...1,SET,120,0.13874,0.01118,0.081679,0.044703,GSE6269_FLU_VS_E_COLI_INF_PBMC_DN,0.728756283124128
GOMF_PEROXISOME_PROLIFERATOR...,SET,10,0.54241,0.012655,0.31936,0.044722,GOMF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING,0.728756283124128
GOMF_POTASSIUM_ION_LEAK_CHAN...,SET,16,0.38312,0.011305,0.22561,0.044747,GOMF_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY,0.728756283124128
REACTOME_PHASE_4_RESTING_MEM...,SET,19,0.35748,0.011494,0.21055,0.044781,REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL,0.728756283124128
GOBP_NEGATIVE_REGULATION_OF_...684,SET,46,0.20036,0.010016,0.11801,0.044782,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.728756283124128
MIR3924,SET,306,0.085668,0.010967,0.050468,0.044811,MIR3924,0.728756283124128
MODULE_303,SET,27,0.28104,0.010769,0.16557,0.044821,MODULE_303,0.728756283124128
GOCC_STEREOCILIUM_BASE,SET,7,0.5465,0.010669,0.322,0.044838,GOCC_STEREOCILIUM_BASE,0.728756283124128
JI_RESPONSE_TO_FSH_DN,SET,49,0.20438,0.010544,0.12043,0.044852,JI_RESPONSE_TO_FSH_DN,0.728756283124128
BIOCARTA_STATHMIN_PATHWAY,SET,20,0.32824,0.010828,0.19343,0.044861,BIOCARTA_STATHMIN_PATHWAY,0.728756283124128
GOMF_CYTOKINE_RECEPTOR_ACTIV...,SET,87,0.17566,0.012063,0.10353,0.044885,GOMF_CYTOKINE_RECEPTOR_ACTIVITY,0.728756283124128
HP_SENSORIMOTOR_NEUROPATHY,SET,73,0.17154,0.010795,0.1011,0.044886,HP_SENSORIMOTOR_NEUROPATHY,0.728756283124128
GOBP_DORSAL_VENTRAL_NEURAL_T...,SET,16,0.36868,0.010879,0.21735,0.044928,GOBP_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.728756283124128
GOMF_HISTONE_H3K4_METHYLTRAN...,SET,18,0.36175,0.011321,0.21327,0.044933,GOMF_HISTONE_H3K4_METHYLTRANSFERASE_ACTIVITY,0.728756283124128
BIOCARTA_TOB1_PATHWAY,SET,19,0.35296,0.011348,0.20809,0.044938,BIOCARTA_TOB1_PATHWAY,0.728756283124128
GSE14308_NAIVE_CD4_TCELL_VS_...1,SET,182,0.10463,0.010366,0.061694,0.044948,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...414,SET,81,0.16573,0.010984,0.097735,0.044977,GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT,0.728756283124128
GSE24634_IL4_VS_CTRL_TREATED...4,SET,184,0.10931,0.010888,0.064467,0.044983,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP,0.728756283124128
HP_ABNORMAL_CORONARY_ARTERY_...2,SET,6,0.58513,0.010576,0.34509,0.044988,HP_ABNORMAL_CORONARY_ARTERY_ORIGIN,0.728756283124128
GOBP_CD4_POSITIVE_ALPHA_BETA...4,SET,19,0.36896,0.011863,0.21761,0.044994,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.728756283124128
GSE15659_CD45RA_NEG_CD4_TCEL...5,SET,172,0.1098,0.010578,0.064769,0.045022,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN,0.728756283124128
WP_GLYCEROPHOSPHOLIPID_BIOSY...,SET,27,0.29047,0.011131,0.17138,0.045058,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,0.728756283124128
GSE2770_UNTREATED_VS_IL12_TR...2,SET,176,0.10919,0.010639,0.064426,0.045065,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.728756283124128
MARIADASON_RESPONSE_TO_BUTYR...1,SET,6,0.67918,0.012276,0.40075,0.045068,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1,0.728756283124128
GOBP_NEGATIVE_REGULATION_OF_...371,SET,13,0.40297,0.010719,0.23781,0.045094,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.728756283124128
GOBP_REGULATION_OF_CHRONIC_I...,SET,8,0.50979,0.010639,0.30085,0.045094,GOBP_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE,0.728756283124128
GOBP_POSITIVE_REGULATION_OF_...722,SET,22,0.33933,0.011739,0.20026,0.045103,GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.728756283124128
GOBP_MESONEPHRIC_DUCT_DEVELO...,SET,8,0.53939,0.011257,0.31846,0.045168,GOBP_MESONEPHRIC_DUCT_DEVELOPMENT,0.728919164345404
GOBP_SPECIFICATION_OF_SYMMET...,SET,131,0.12918,0.010873,0.076273,0.045175,GOBP_SPECIFICATION_OF_SYMMETRY,0.728919164345404
HP_HEPATOSPLENOMEGALY,SET,152,0.11715,0.010615,0.06917,0.045176,HP_HEPATOSPLENOMEGALY,0.728919164345404
GTF2E2_TARGET_GENES,SET,263,0.088661,0.010535,0.052361,0.045211,GTF2E2_TARGET_GENES,0.729145385150812
HP_TYPE_I_DIABETES_MELLITUS,SET,51,0.21175,0.011144,0.12508,0.045251,HP_TYPE_I_DIABETES_MELLITUS,0.729451996753247
MIR6783_5P,SET,144,0.12746,0.011244,0.075329,0.045323,MIR6783_5P,0.729470258302583
HP_PROGRESSIVE_MACROCEPHALY,SET,7,0.54125,0.010566,0.31994,0.045359,HP_PROGRESSIVE_MACROCEPHALY,0.729470258302583
DESCARTES_FETAL_LUNG_CSH1_CS...,SET,180,0.10665,0.010508,0.063047,0.045377,DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS,0.729470258302583
MIR5580_3P,SET,222,0.098795,0.010798,0.058427,0.045434,MIR5580_3P,0.729470258302583
HP_DISSEMINATED_INTRAVASCULA...,SET,25,0.30094,0.011097,0.17798,0.045437,HP_DISSEMINATED_INTRAVASCULAR_COAGULATION,0.729470258302583
NFE2L3_TARGET_GENES,SET,10,0.43943,0.010253,0.2599,0.045449,NFE2L3_TARGET_GENES,0.729470258302583
HP_MODERATE_ALBUMINURIA,SET,10,0.48528,0.011322,0.28704,0.045458,HP_MODERATE_ALBUMINURIA,0.729470258302583
GSE2405_HEAT_KILLED_LYSATE_V...4,SET,186,0.10861,0.010876,0.064242,0.045466,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.729470258302583
GSE3039_ALPHABETA_CD8_TCELL_...3,SET,184,0.10249,0.010209,0.060627,0.045475,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN,0.729470258302583
IVANOVA_HEMATOPOIESIS_STEM_C...2,SET,514,0.064893,0.010705,0.038388,0.045477,IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,0.729470258302583
MIR518D_5P_MIR518F_5P_MIR520...,SET,85,0.152,0.010318,0.089929,0.045499,MIR518D_5P_MIR518F_5P_MIR520C_5P_MIR526A_5P,0.729470258302583
BIOCARTA_AKAP13_PATHWAY,SET,11,0.4138,0.010126,0.24482,0.045504,BIOCARTA_AKAP13_PATHWAY,0.729470258302583
HP_ESOPHAGEAL_STENOSIS,SET,29,0.26398,0.010483,0.1562,0.045528,HP_ESOPHAGEAL_STENOSIS,0.729472024793388
GSE39820_CTRL_VS_TGFBETA1_IL...4,SET,172,0.10842,0.010445,0.064177,0.045579,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP,0.729472024793388
HP_ACCESSORY_ORAL_FRENULUM,SET,16,0.36825,0.010866,0.21798,0.045587,HP_ACCESSORY_ORAL_FRENULUM,0.729472024793388
CREB_Q2_01,SET,205,0.10066,0.010577,0.059597,0.045623,CREB_Q2_01,0.729472024793388
GOBP_REGULATION_OF_B_CELL_AC...,SET,115,0.13543,0.010685,0.080186,0.045626,GOBP_REGULATION_OF_B_CELL_ACTIVATION,0.729472024793388
NADERI_BREAST_CANCER_PROGNOS...1,SET,14,0.39951,0.011028,0.23658,0.045645,NADERI_BREAST_CANCER_PROGNOSIS_DN,0.729472024793388
HP_VIRAL_HEPATITIS,SET,13,0.41696,0.011091,0.24693,0.045663,HP_VIRAL_HEPATITIS,0.729472024793388
GSE339_CD8POS_VS_CD4CD8DN_DC...1,SET,182,0.10439,0.010342,0.061838,0.045697,GSE339_CD8POS_VS_CD4CD8DN_DC_DN,0.729472024793388
GSE22935_WT_VS_MYD88_KO_MACR...8,SET,181,0.10951,0.010819,0.064871,0.045705,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP,0.729472024793388
GOCC_LIPOPOLYSACCHARIDE_RECE...,SET,5,0.73801,0.012177,0.43721,0.045714,GOCC_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX,0.729472024793388
GOMF_NUCLEOSIDE_DIPHOSPHATE_...1,SET,17,0.33849,0.010295,0.2006,0.045776,GOMF_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY,0.730126149609913
GOMF_G_PROTEIN_ACTIVITY,SET,46,0.20254,0.010125,0.12014,0.045926,GOMF_G_PROTEIN_ACTIVITY,0.732182628440367
WANG_TARGETS_OF_MLL_CBP_FUSI...1,SET,38,0.24398,0.011088,0.14477,0.04597,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,0.732528461538462
GOCC_FILOPODIUM_MEMBRANE,SET,16,0.37807,0.011156,0.22437,0.045997,GOCC_FILOPODIUM_MEMBRANE,0.732528461538462
MIR3692_5P,SET,128,0.12649,0.010524,0.075079,0.046031,MIR3692_5P,0.732528461538462
GOBP_ENDOTHELIAL_CELL_MATRIX...,SET,6,0.68259,0.012338,0.40517,0.046032,GOBP_ENDOTHELIAL_CELL_MATRIX_ADHESION,0.732528461538462
BENPORATH_MYC_TARGETS_WITH_E...,SET,200,0.10135,0.01052,0.060167,0.046056,BENPORATH_MYC_TARGETS_WITH_EBOX,0.732574956521739
SERVITJA_LIVER_HNF1A_TARGETS...2,SET,132,0.12963,0.010952,0.077,0.046147,SERVITJA_LIVER_HNF1A_TARGETS_UP,0.733349561243144
FEKIR_HEPARG_SIDE_POP_VS_HEP...1,SET,77,0.16232,0.01049,0.096429,0.046162,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_DN,0.733349561243144
MIR651_5P,SET,107,0.14163,0.01078,0.084136,0.046168,MIR651_5P,0.733349561243144
LIU_PROSTATE_CANCER_UP,SET,86,0.16297,0.011128,0.096833,0.046195,LIU_PROSTATE_CANCER_UP,0.733443227501142
GOBP_REGULATION_OF_ASPARTIC_...1,SET,6,0.62907,0.01137,0.37383,0.046219,GOBP_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.733489198630137
GOBP_NEUROEPITHELIAL_CELL_DI...,SET,42,0.24706,0.011803,0.14685,0.046261,GOBP_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.733820654952077
GSE27786_NKTCELL_VS_ERYTHROB...2,SET,185,0.10333,0.01032,0.061433,0.046298,GSE27786_NKTCELL_VS_ERYTHROBLAST_UP,0.734072531934307
GOCC_UBIQUITIN_CONJUGATING_E...,SET,7,0.50899,0.0099366,0.30269,0.046337,GOCC_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX,0.734130102505695
SOBOLEV_PBMC_PANDEMRIX_AGE_1...1,SET,15,0.39149,0.011185,0.23283,0.046351,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP,0.734130102505695
GOMF_VOLTAGE_GATED_MONOATOMI...1,SET,14,0.40641,0.011218,0.24173,0.046365,GOMF_VOLTAGE_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.734130102505695
CDPCR3_01,SET,50,0.22766,0.011864,0.13544,0.046403,CDPCR3_01,0.734334463722398
MORF_PSMF1,SET,159,0.10898,0.010097,0.064844,0.046427,MORF_PSMF1,0.734334463722398
GSE17301_CTRL_VS_48H_IFNA2_S...2,SET,182,0.10561,0.010462,0.062858,0.046483,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP,0.734334463722398
GOBP_REGULATION_OF_WOUND_HEA...1,SET,125,0.1357,0.011158,0.080813,0.046572,GOBP_REGULATION_OF_WOUND_HEALING,0.734334463722398
GSE19888_CTRL_VS_A3R_ACT_TRE...2,SET,185,0.10639,0.010626,0.063362,0.046572,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP,0.734334463722398
COULOUARN_TEMPORAL_TGFB1_SIG...2,SET,101,0.14624,0.010816,0.087092,0.046574,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,0.734334463722398
GOBP_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.38528,0.0098467,0.22946,0.046574,GOBP_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT,0.734334463722398
GOMF_L_PROLINE_TRANSMEMBRANE...,SET,7,0.61632,0.012032,0.36708,0.046587,GOMF_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.734334463722398
GSE41176_WT_VS_TAK1_KO_ANTI_...8,SET,180,0.10489,0.010335,0.062491,0.046632,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP,0.734334463722398
CEBALLOS_TARGETS_OF_TP53_AND...1,SET,29,0.26315,0.01045,0.15684,0.046697,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,0.734334463722398
MIR1296_5P,SET,26,0.26743,0.010057,0.15941,0.046719,MIR1296_5P,0.734334463722398
GOBP_RESPONSE_TO_INTERLEUKIN...12,SET,5,0.75624,0.012478,0.4508,0.046725,GOBP_RESPONSE_TO_INTERLEUKIN_9,0.734334463722398
HP_PICA,SET,8,0.45669,0.009531,0.27225,0.046731,HP_PICA,0.734334463722398
GOMF_CARGO_RECEPTOR_ACTIVITY,SET,71,0.17111,0.01062,0.10201,0.046736,GOMF_CARGO_RECEPTOR_ACTIVITY,0.734334463722398
GOBP_PHAGOCYTOSIS_RECOGNITION,SET,27,0.30956,0.011862,0.18454,0.046737,GOBP_PHAGOCYTOSIS_RECOGNITION,0.734334463722398
GOCC_AXONAL_GROWTH_CONE,SET,23,0.29922,0.010584,0.17839,0.046748,GOCC_AXONAL_GROWTH_CONE,0.734334463722398
GAVISH_3CA_METAPROGRAM_MACRO...5,SET,47,0.22548,0.011394,0.13445,0.046767,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_2,0.734334463722398
WP_DRUG_INDUCTION_OF_BILE_AC...,SET,17,0.36026,0.010957,0.21484,0.046792,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.734334463722398
GOBP_POLY_A_DEPENDENT_SNORNA...,SET,6,0.59084,0.010679,0.35235,0.046794,GOBP_POLY_A_DEPENDENT_SNORNA_3_END_PROCESSING,0.734334463722398
ITO_PTTG1_TARGETS_DN,SET,9,0.4832,0.010696,0.2882,0.046821,ITO_PTTG1_TARGETS_DN,0.734334463722398
LIU_LIVER_CANCER,SET,29,0.25455,0.010108,0.15186,0.046857,LIU_LIVER_CANCER,0.734334463722398
GOCC_M_BAND,SET,27,0.26573,0.010183,0.15855,0.046878,GOCC_M_BAND,0.734334463722398
GNF2_CD53,SET,52,0.20859,0.011085,0.12446,0.04688,GNF2_CD53,0.734334463722398
GOBP_ERYTHROCYTE_HOMEOSTASIS,SET,133,0.12433,0.010543,0.074184,0.046885,GOBP_ERYTHROCYTE_HOMEOSTASIS,0.734334463722398
MIR641,SET,232,0.093753,0.010472,0.055953,0.046921,MIR641,0.734567277027027
GOBP_NEURAL_PLATE_DEVELOPMENT,SET,7,0.53426,0.01043,0.31893,0.046961,GOBP_NEURAL_PLATE_DEVELOPMENT,0.734862474110761
GSE360_T_GONDII_VS_B_MALAYI_...1,SET,186,0.10603,0.010618,0.063317,0.04701,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.734983043184885
SOBOLEV_T_CELL_PANDEMRIX_AGE...2,SET,21,0.30608,0.010346,0.18277,0.047011,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,0.734983043184885
GSE339_CD4POS_VS_CD4CD8DN_DC...4,SET,187,0.099586,0.0099991,0.059488,0.047068,GSE339_CD4POS_VS_CD4CD8DN_DC_UP,0.735398553389455
REACTOME_SEMA4D_IN_SEMAPHORI...,SET,24,0.30044,0.010855,0.1795,0.047101,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,0.735398553389455
GOMF_PEPTIDE_ALPHA_N_ACETYLT...,SET,6,0.48214,0.0087144,0.28807,0.047107,GOMF_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY,0.735398553389455
GOMF_PHOSPHOLIPID_TRANSFER_A...,SET,20,0.29014,0.0095708,0.1734,0.047145,GOMF_PHOSPHOLIPID_TRANSFER_ACTIVITY,0.735398553389455
GOMF_INTRAMOLECULAR_PHOSPHOT...,SET,10,0.42312,0.0098722,0.25293,0.047184,GOMF_INTRAMOLECULAR_PHOSPHOTRANSFERASE_ACTIVITY,0.735398553389455
HP_ANOMIC_APHASIA,SET,6,0.58908,0.010647,0.35215,0.047194,HP_ANOMIC_APHASIA,0.735398553389455
GOBP_ESTABLISHMENT_OF_PLANAR...1,SET,12,0.43157,0.01103,0.25802,0.047209,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.735398553389455
AIZARANI_LIVER_C38_RESIDENT_...,SET,19,0.3458,0.011118,0.20678,0.047242,AIZARANI_LIVER_C38_RESIDENT_B_CELLS_3,0.735398553389455
GSE3982_MAC_VS_EFF_MEMORY_CD...2,SET,180,0.10539,0.010384,0.063022,0.047247,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP,0.735398553389455
GOMF_OXIDIZED_DNA_BINDING,SET,11,0.38869,0.0095111,0.23252,0.047309,GOMF_OXIDIZED_DNA_BINDING,0.735398553389455
GOBP_POST_GOLGI_VESICLE_MEDI...,SET,103,0.13507,0.010088,0.080821,0.047346,GOBP_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.735398553389455
REACTOME_RHO_GTPASES_ACTIVAT...9,SET,19,0.32257,0.010372,0.19306,0.047386,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,0.735398553389455
GOBP_REGULATION_OF_MITOTIC_R...,SET,6,0.51704,0.0093453,0.30946,0.04739,GOBP_REGULATION_OF_MITOTIC_RECOMBINATION,0.735398553389455
LI_WILMS_TUMOR_VS_FETAL_KIDN...1,SET,153,0.11356,0.010323,0.06797,0.047397,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,0.735398553389455
GOBP_ESTABLISHMENT_OF_PROTEI...7,SET,414,0.068465,0.010164,0.04098,0.047398,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.735398553389455
HP_IRRITABILITY,SET,243,0.092643,0.010587,0.055452,0.047401,HP_IRRITABILITY,0.735398553389455
GSE21360_PRIMARY_VS_SECONDAR...1,SET,179,0.10366,0.010186,0.06206,0.047431,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN,0.735398553389455
GSE46606_IRF4HIGH_VS_WT_CD40...4,SET,180,0.10866,0.010707,0.065055,0.047434,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.735398553389455
REACTOME_SIGNALING_BY_FGFR4_...,SET,11,0.37842,0.0092599,0.22659,0.04746,REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,0.735398553389455
HP_ABNORMAL_CIRCULATING_INTE...3,SET,31,0.27895,0.011452,0.16705,0.047487,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_CONCENTRATION,0.735398553389455
GOBP_INTRACELLULAR_ESTROGEN_...,SET,45,0.20085,0.0099315,0.12029,0.047499,GOBP_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.735398553389455
CTGRYYYNATT_UNKNOWN,SET,63,0.18765,0.010973,0.1124,0.047521,CTGRYYYNATT_UNKNOWN,0.735398553389455
HP_MALABSORPTION,SET,212,0.10059,0.010746,0.06026,0.047547,HP_MALABSORPTION,0.735398553389455
MIR3617_5P,SET,232,0.093596,0.010455,0.056079,0.047568,MIR3617_5P,0.735398553389455
WP_GLYCEROLIPIDS_AND_GLYCERO...,SET,21,0.29647,0.010021,0.17765,0.047586,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,0.735398553389455
MIR552_3P,SET,53,0.18655,0.010009,0.11179,0.047596,MIR552_3P,0.735398553389455
GOMF_P53_BINDING,SET,64,0.17925,0.010565,0.10746,0.047653,GOMF_P53_BINDING,0.735398553389455
HP_ABNORMALITY_OF_THE_ANTERI...1,SET,6,0.52205,0.0094358,0.31299,0.047671,HP_ABNORMALITY_OF_THE_ANTERIOR_COMMISSURE,0.735398553389455
GOBP_SCARNA_LOCALIZATION_TO_...,SET,4,0.55891,0.0082488,0.3351,0.047676,GOBP_SCARNA_LOCALIZATION_TO_CAJAL_BODY,0.735398553389455
GOBP_ENTRY_OF_BACTERIUM_INTO...,SET,9,0.4415,0.0097725,0.26473,0.047692,GOBP_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.735398553389455
GSE36078_WT_VS_IL1R_KO_LUNG_...3,SET,179,0.10722,0.010535,0.064306,0.047732,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN,0.735398553389455
BEGUM_TARGETS_OF_PAX3_FOXO1_...2,SET,46,0.23363,0.011679,0.14012,0.047739,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.735398553389455
STK33_NOMO_DN,SET,233,0.094866,0.010619,0.056903,0.047751,STK33_NOMO_DN,0.735398553389455
GOCC_SCHAFFER_COLLATERAL_CA1...,SET,88,0.1585,0.010947,0.095073,0.047757,GOCC_SCHAFFER_COLLATERAL_CA1_SYNAPSE,0.735398553389455
GOBP_CELLULAR_RESPONSE_TO_HO...,SET,568,0.06297,0.010903,0.037793,0.047845,GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS,0.736427358281665
HP_ABNORMAL_CIRCULATING_ADRE...,SET,42,0.22292,0.01065,0.13382,0.047892,HP_ABNORMAL_CIRCULATING_ADRENOCORTICOTROPIN_CONCENTRATION,0.736493250992501
REACTOME_ESTROGEN_DEPENDENT_...1,SET,87,0.15056,0.010339,0.090395,0.047909,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,0.736493250992501
KEGG_MEDICUS_VARIANT_PAX8_PP...,SET,5,0.62991,0.010394,0.37833,0.047969,KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION,0.736493250992501
WP_PREIMPLANTATION_EMBRYO,SET,54,0.20029,0.010846,0.1203,0.047973,WP_PREIMPLANTATION_EMBRYO,0.736493250992501
HOEGERKORP_CD44_TARGETS_TEMP...1,SET,23,0.29793,0.010538,0.17896,0.047989,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,0.736493250992501
HP_PROBOSCIS,SET,16,0.3655,0.010785,0.21958,0.04801,HP_PROBOSCIS,0.736493250992501
ZNF524_TARGET_GENES,SET,277,0.083007,0.010119,0.049874,0.048032,ZNF524_TARGET_GENES,0.736493250992501
MODULE_147,SET,101,0.13979,0.010339,0.083992,0.048036,MODULE_147,0.736493250992501
GOBP_DETECTION_OF_EXTERNAL_B...,SET,23,0.33331,0.01179,0.20027,0.04804,GOBP_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS,0.736493250992501
GOBP_RIBONUCLEOSIDE_DIPHOSPH...,SET,10,0.45211,0.010548,0.27182,0.048141,GOBP_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.737648272962484
GSE22033_WT_VS_PPARG_KO_MEF_...2,SET,173,0.10551,0.010194,0.063453,0.048182,GSE22033_WT_VS_PPARG_KO_MEF_UP,0.737648272962484
ALCALAY_AML_BY_NPM1_LOCALIZA...1,SET,168,0.11014,0.010487,0.066268,0.048264,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,0.737648272962484
GOBP_CYTOSKELETON_DEPENDENT_...1,SET,103,0.13241,0.0098899,0.079673,0.048269,GOBP_CYTOSKELETON_DEPENDENT_CYTOKINESIS,0.737648272962484
LHX4_TARGET_GENES,SET,5,0.58166,0.0095975,0.34999,0.048272,LHX4_TARGET_GENES,0.737648272962484
TRAVAGLINI_LUNG_ALVEOLAR_EPI...1,SET,363,0.079931,0.011128,0.048099,0.048286,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL,0.737648272962484
HP_GAZE_EVOKED_NYSTAGMUS,SET,53,0.18729,0.010048,0.11271,0.048299,HP_GAZE_EVOKED_NYSTAGMUS,0.737648272962484
KAYO_AGING_MUSCLE_UP,SET,208,0.097937,0.010365,0.05894,0.0483,KAYO_AGING_MUSCLE_UP,0.737648272962484
PID_RANBP2_PATHWAY,SET,11,0.43132,0.010554,0.25968,0.048366,PID_RANBP2_PATHWAY,0.737648272962484
GSE4142_GC_BCELL_VS_MEMORY_B...1,SET,180,0.1005,0.0099018,0.06051,0.048382,GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN,0.737648272962484
HILLION_HMGA1B_TARGETS,SET,78,0.16324,0.010618,0.098309,0.048413,HILLION_HMGA1B_TARGETS,0.737648272962484
KEGG_MEDICUS_ENV_FACTOR_ARSE...,SET,16,0.31513,0.0092988,0.18979,0.048422,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.737648272962484
REACTOME_SMOOTH_MUSCLE_CONTR...,SET,40,0.23206,0.01082,0.13977,0.048434,REACTOME_SMOOTH_MUSCLE_CONTRACTION,0.737648272962484
REACTOME_G2_M_CHECKPOINTS,SET,125,0.11797,0.0097009,0.071058,0.048445,REACTOME_G2_M_CHECKPOINTS,0.737648272962484
GSE26669_CD4_VS_CD8_TCELL_IN...2,SET,181,0.10589,0.010462,0.063787,0.048458,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP,0.737648272962484
REACTOME_RNA_POLYMERASE_II_T...2,SET,1233,0.042719,0.010692,0.025733,0.048462,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION,0.737648272962484
WP_DYRK1A_INVOLVEMENT_REGARD...,SET,59,0.1858,0.010516,0.11195,0.048489,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,0.737648272962484
GOBP_REGULATION_OF_METALLOEN...,SET,4,0.81128,0.011973,0.48888,0.04852,GOBP_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.737648272962484
GSE13411_IGM_MEMORY_BCELL_VS...2,SET,178,0.10704,0.010488,0.064508,0.048537,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.737648272962484
GSE17721_CTRL_VS_GARDIQUIMOD...14,SET,185,0.10205,0.010192,0.061505,0.04855,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP,0.737648272962484
REACTOME_GLUCAGON_SIGNALING_...,SET,33,0.26517,0.011232,0.15986,0.048585,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,0.737648272962484
GOBP_POSITIVE_REGULATION_OF_...754,SET,37,0.21585,0.0096802,0.13014,0.04861,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.737648272962484
GSE360_DC_VS_MAC_B_MALAYI_HI...1,SET,181,0.10558,0.010431,0.063662,0.048622,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN,0.737648272962484
QI_PBMC_ZOSTAVAX_AGE_50_75YO...2,SET,35,0.22854,0.0099689,0.13782,0.048638,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE,0.737648272962484
WP_TRANSCRIPTION_FACTOR_REGU...,SET,21,0.36188,0.012232,0.21826,0.048664,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,0.737648272962484
HP_SUBCORTICAL_CEREBRAL_ATRO...,SET,25,0.29083,0.010724,0.17547,0.048732,HP_SUBCORTICAL_CEREBRAL_ATROPHY,0.737648272962484
HP_ABNORMAL_URINE_PROTEIN_LE...,SET,212,0.09822,0.010493,0.059265,0.048738,HP_ABNORMAL_URINE_PROTEIN_LEVEL,0.737648272962484
PID_ARF6_TRAFFICKING_PATHWAY,SET,47,0.21375,0.010801,0.12901,0.048785,PID_ARF6_TRAFFICKING_PATHWAY,0.737648272962484
MIR548Q,SET,43,0.20504,0.0099114,0.12378,0.048824,MIR548Q,0.737648272962484
GOBP_PROTEIN_TARGETING_TO_VA...2,SET,5,0.63385,0.010459,0.38267,0.048832,GOBP_PROTEIN_TARGETING_TO_VACUOLE_INVOLVED_IN_AUTOPHAGY,0.737648272962484
GOMF_PEROXIREDOXIN_ACTIVITY,SET,6,0.52361,0.0094641,0.31618,0.048864,GOMF_PEROXIREDOXIN_ACTIVITY,0.737648272962484
HP_CRANIOFACIAL_HYPEROSTOSIS,SET,24,0.25219,0.0091121,0.1523,0.048876,HP_CRANIOFACIAL_HYPEROSTOSIS,0.737648272962484
RIZKI_TUMOR_INVASIVENESS_3D_...1,SET,242,0.090445,0.010315,0.054625,0.048895,RIZKI_TUMOR_INVASIVENESS_3D_DN,0.737648272962484
GOCC_SARCOLEMMA,SET,136,0.12743,0.010927,0.076962,0.048899,GOCC_SARCOLEMMA,0.737648272962484
GSE15324_NAIVE_VS_ACTIVATED_...2,SET,171,0.10594,0.010176,0.064007,0.048961,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.737648272962484
KEGG_PORPHYRIN_AND_CHLOROPHY...,SET,35,0.27823,0.012136,0.16811,0.048965,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,0.737648272962484
GSE17721_CTRL_VS_PAM3CSK4_0....1,SET,181,0.10262,0.010139,0.062008,0.048972,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN,0.737648272962484
LUI_THYROID_CANCER_CLUSTER_2,SET,43,0.21653,0.010467,0.13084,0.048976,LUI_THYROID_CANCER_CLUSTER_2,0.737648272962484
FEVR_CTNNB1_TARGETS_DN,SET,504,0.06219,0.010161,0.037579,0.048981,FEVR_CTNNB1_TARGETS_DN,0.737648272962484
HAY_BONE_MARROW_CD34_POS_MUL...,SET,17,0.35635,0.010838,0.21539,0.049023,HAY_BONE_MARROW_CD34_POS_MULTILIN,0.737648272962484
HP_SMALL_CEREBRAL_CORTEX,SET,8,0.48504,0.010123,0.29318,0.049032,HP_SMALL_CEREBRAL_CORTEX,0.737648272962484
KOBAYASHI_EGFR_SIGNALING_24H...1,SET,240,0.087557,0.0099449,0.052939,0.049081,KOBAYASHI_EGFR_SIGNALING_24HR_DN,0.737648272962484
GOBP_ACTOMYOSIN_CONTRACTILE_...,SET,10,0.44096,0.010288,0.26663,0.049092,GOBP_ACTOMYOSIN_CONTRACTILE_RING_ORGANIZATION,0.737648272962484
GSE37416_CTRL_VS_6H_F_TULARE...2,SET,164,0.10735,0.010101,0.064915,0.049094,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.737648272962484
GOBP_GLYCEROLIPID_BIOSYNTHET...,SET,226,0.092169,0.010163,0.055745,0.049132,GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS,0.737648272962484
GSE27859_DC_VS_CD11C_INT_F48...1,SET,144,0.11359,0.01002,0.068703,0.049146,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.737648272962484
HP_MACULAR_DYSTROPHY,SET,18,0.33524,0.010492,0.20282,0.049184,HP_MACULAR_DYSTROPHY,0.737648272962484
MIR3200_5P,SET,58,0.18595,0.010435,0.1125,0.049191,MIR3200_5P,0.737648272962484
GOMF_MONOATOMIC_CATION_BICAR...,SET,13,0.3636,0.0096716,0.22,0.049201,GOMF_MONOATOMIC_CATION_BICARBONATE_SYMPORTER_ACTIVITY,0.737648272962484
HP_SECONDARY_GROWTH_HORMONE_...,SET,15,0.34629,0.0098941,0.20953,0.049201,HP_SECONDARY_GROWTH_HORMONE_DEFICIENCY,0.737648272962484
MIR1180_5P,SET,34,0.24341,0.010465,0.14728,0.049207,MIR1180_5P,0.737648272962484
GOBP_HEXOSE_PHOSPHATE_TRANSP...,SET,6,0.57999,0.010483,0.35096,0.049219,GOBP_HEXOSE_PHOSPHATE_TRANSPORT,0.737648272962484
HP_ABNORMAL_THROMBOSIS,SET,185,0.11011,0.010997,0.066672,0.049327,HP_ABNORMAL_THROMBOSIS,0.738739959522795
GOMF_OPSONIN_RECEPTOR_ACTIVI...,SET,4,0.78792,0.011629,0.47737,0.049424,GOMF_OPSONIN_RECEPTOR_ACTIVITY,0.738739959522795
GOMF_CYTOSKELETON_NUCLEAR_ME...,SET,5,0.5938,0.0097978,0.35987,0.049479,GOMF_CYTOSKELETON_NUCLEAR_MEMBRANE_ANCHOR_ACTIVITY,0.738739959522795
HP_NATAL_TOOTH,SET,31,0.25261,0.010371,0.15311,0.049495,HP_NATAL_TOOTH,0.738739959522795
GSE19941_LPS_VS_LPS_AND_IL10...2,SET,161,0.10815,0.010083,0.065553,0.049496,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.738739959522795
GOBP_MHC_CLASS_II_BIOSYNTHET...,SET,19,0.33485,0.010766,0.20302,0.049545,GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.738739959522795
GOBP_REGULATION_OF_T_CELL_PR...,SET,162,0.12123,0.011337,0.073506,0.049558,GOBP_REGULATION_OF_T_CELL_PROLIFERATION,0.738739959522795
MIR6880_5P,SET,87,0.15247,0.010471,0.092459,0.049574,MIR6880_5P,0.738739959522795
DESCARTES_MAIN_FETAL_THYMOCY...,SET,70,0.17818,0.010981,0.10805,0.049574,DESCARTES_MAIN_FETAL_THYMOCYTES,0.738739959522795
REACTOME_DETOXIFICATION_OF_R...,SET,33,0.23722,0.010048,0.14386,0.049593,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,0.738739959522795
LIU_CDX2_TARGETS_UP,SET,32,0.26743,0.011155,0.16219,0.049595,LIU_CDX2_TARGETS_UP,0.738739959522795
GOMF_PHOSPHATASE_ACTIVATOR_A...,SET,16,0.36119,0.010658,0.21908,0.049611,GOMF_PHOSPHATASE_ACTIVATOR_ACTIVITY,0.738739959522795
PETRETTO_LEFT_VENTRICLE_MASS...1,SET,9,0.56616,0.012532,0.34343,0.04963,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN,0.738739959522795
GAVISH_3CA_METAPROGRAM_EPITH...18,SET,47,0.23557,0.011903,0.1429,0.04963,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_1,0.738739959522795
REACTOME_SENSING_OF_DNA_DOUB...,SET,5,0.52576,0.0086751,0.31901,0.049677,REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS,0.738739959522795
MIR3169,SET,54,0.18899,0.010234,0.11469,0.0497,MIR3169,0.738739959522795
SA_CASPASE_CASCADE,SET,18,0.34305,0.010736,0.20818,0.049704,SA_CASPASE_CASCADE,0.738739959522795
HP_LOWER_LIMB_MUSCLE_WEAKNESS,SET,196,0.10212,0.010495,0.061984,0.049725,HP_LOWER_LIMB_MUSCLE_WEAKNESS,0.738739959522795
MIR4433A_3P,SET,53,0.18366,0.0098536,0.11151,0.049789,MIR4433A_3P,0.738739959522795
GOMF_GTPASE_INHIBITOR_ACTIVI...,SET,12,0.41761,0.010673,0.25357,0.049793,GOMF_GTPASE_INHIBITOR_ACTIVITY,0.738739959522795
GOCC_CD95_DEATH_INDUCING_SIG...,SET,6,0.63682,0.01151,0.3867,0.049806,GOCC_CD95_DEATH_INDUCING_SIGNALING_COMPLEX,0.738739959522795
GOMF_VOLTAGE_GATED_CHANNEL_A...,SET,165,0.11974,0.0113,0.072713,0.04981,GOMF_VOLTAGE_GATED_CHANNEL_ACTIVITY,0.738739959522795
KIM_MYCL1_AMPLIFICATION_TARG...2,SET,12,0.45285,0.011574,0.27503,0.049836,KIM_MYCL1_AMPLIFICATION_TARGETS_UP,0.738739959522795
WP_DNA_REPAIR_PATHWAYS_FULL_...,SET,109,0.11418,0.0087718,0.069354,0.04985,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,0.738739959522795
GTTNYYNNGGTNA_UNKNOWN,SET,80,0.15147,0.0099769,0.092006,0.049857,GTTNYYNNGGTNA_UNKNOWN,0.738739959522795
JIANG_MELANOMA_TRM4,SET,185,0.10865,0.010851,0.065997,0.04987,JIANG_MELANOMA_TRM4,0.738739959522795
MIR3683,SET,5,0.59742,0.0098576,0.36293,0.049879,MIR3683,0.738739959522795
MODULE_7,SET,214,0.095923,0.010296,0.058275,0.049887,MODULE_7,0.738739959522795
GOMF_CALCIUM_DEPENDENT_PHOSP...2,SET,52,0.21527,0.01144,0.13082,0.049934,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING,0.738959584382871
WEBER_METHYLATED_LCP_IN_FIBR...1,SET,9,0.4959,0.010977,0.30137,0.049946,WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,0.738959584382871
GSE23502_BM_VS_COLON_TUMOR_H...2,SET,178,0.11114,0.01089,0.067583,0.050047,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.738959584382871
FINETTI_BREAST_CANCER_KINOME...2,SET,16,0.3424,0.010103,0.20826,0.050087,FINETTI_BREAST_CANCER_KINOME_RED,0.738959584382871
REACTOME_SIGNALING_BY_NUCLEA...,SET,225,0.096039,0.010566,0.058416,0.05009,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,0.738959584382871
HP_MYOCLONIC_SEIZURE,SET,210,0.095814,0.010188,0.05828,0.050095,HP_MYOCLONIC_SEIZURE,0.738959584382871
HP_HYPERKETONEMIA,SET,4,0.69929,0.010321,0.42541,0.050116,HP_HYPERKETONEMIA,0.738959584382871
HP_ABNORMALITY_OF_THE_LYMPHA...,SET,692,0.05415,0.010313,0.032945,0.050134,HP_ABNORMALITY_OF_THE_LYMPHATIC_SYSTEM,0.738959584382871
GOCC_ACTIN_BASED_CELL_PROJEC...,SET,207,0.10047,0.010608,0.061135,0.050154,GOCC_ACTIN_BASED_CELL_PROJECTION,0.738959584382871
KEGG_MEDICUS_REFERENCE_BETA_...3,SET,5,0.58723,0.0096894,0.35733,0.050162,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA,0.738959584382871
GNF2_MCM4,SET,52,0.18709,0.0099428,0.11387,0.050199,GNF2_MCM4,0.738959584382871
GGCNNMSMYNTTG_UNKNOWN,SET,69,0.1688,0.010328,0.10274,0.050204,GGCNNMSMYNTTG_UNKNOWN,0.738959584382871
KEGG_JAK_STAT_SIGNALING_PATH...,SET,139,0.13214,0.011454,0.08043,0.050212,KEGG_JAK_STAT_SIGNALING_PATHWAY,0.738959584382871
GOBP_NEGATIVE_REGULATION_OF_...686,SET,15,0.34828,0.0099509,0.21206,0.050268,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.738959584382871
GOBP_MITOTIC_CYTOKINESIS,SET,88,0.14099,0.0097376,0.085848,0.05027,GOBP_MITOTIC_CYTOKINESIS,0.738959584382871
GSE37301_MULTIPOTENT_PROGENI...4,SET,153,0.107,0.0097272,0.065183,0.050349,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.738959584382871
GSE13411_SWITCHED_MEMORY_BCE...1,SET,160,0.11385,0.010582,0.069375,0.050394,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN,0.738959584382871
HP_PULMONARY_EMBOLISM,SET,35,0.23624,0.010305,0.14396,0.0504,HP_PULMONARY_EMBOLISM,0.738959584382871
PAX4_03,SET,234,0.093132,0.010447,0.056752,0.050403,PAX4_03,0.738959584382871
KEGG_MEDICUS_VARIANT_DELETED...,SET,9,0.46558,0.010306,0.28374,0.050423,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX,0.738959584382871
GSE27786_NKCELL_VS_ERYTHROBL...2,SET,181,0.10162,0.01004,0.061935,0.050425,GSE27786_NKCELL_VS_ERYTHROBLAST_UP,0.738959584382871
GOMF_NEUROTROPHIN_RECEPTOR_B...,SET,11,0.40342,0.0098717,0.24594,0.050479,GOMF_NEUROTROPHIN_RECEPTOR_BINDING,0.738959584382871
GOBP_MYELOID_CELL_HOMEOSTASIS,SET,163,0.11071,0.010385,0.067511,0.050523,GOBP_MYELOID_CELL_HOMEOSTASIS,0.738959584382871
MCBRYAN_PUBERTAL_TGFB1_TARGE...1,SET,57,0.20383,0.011339,0.12432,0.050552,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,0.738959584382871
MYC_Q2,SET,180,0.10703,0.010545,0.065277,0.050552,MYC_Q2,0.738959584382871
HOLLERN_SOLID_NODULAR_BREAST...2,SET,9,0.55494,0.012284,0.33848,0.050563,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP,0.738959584382871
KEGG_MEDICUS_PATHOGEN_HIV_GP...3,SET,26,0.28633,0.010768,0.17465,0.050565,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.738959584382871
REACTOME_SIGNALING_BY_FGFR,SET,86,0.154,0.010515,0.09393,0.050565,REACTOME_SIGNALING_BY_FGFR,0.738959584382871
HP_SUBEPENDYMAL_CYSTS,SET,8,0.46651,0.009736,0.28456,0.050569,HP_SUBEPENDYMAL_CYSTS,0.738959584382871
MODULE_354,SET,17,0.38306,0.011651,0.23366,0.050572,MODULE_354,0.738959584382871
PUJANA_BREAST_CANCER_WITH_BR...1,SET,8,0.44102,0.0092039,0.26909,0.050621,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN,0.738959584382871
MIR6775_3P,SET,69,0.16914,0.01035,0.10321,0.050642,MIR6775_3P,0.738959584382871
HP_VITREOUS_FLOATERS,SET,11,0.43311,0.010598,0.2643,0.050644,HP_VITREOUS_FLOATERS,0.738959584382871
GSE2706_2H_VS_8H_LPS_STIM_DC...2,SET,178,0.10498,0.010286,0.064061,0.050644,GSE2706_2H_VS_8H_LPS_STIM_DC_UP,0.738959584382871
PID_RB_1PATHWAY,SET,60,0.18091,0.010325,0.1104,0.050646,PID_RB_1PATHWAY,0.738959584382871
REACTOME_GDP_FUCOSE_BIOSYNTH...,SET,4,0.58519,0.0086366,0.35728,0.050729,REACTOME_GDP_FUCOSE_BIOSYNTHESIS,0.739099742785445
GSE27786_CD4_TCELL_VS_ERYTHT...2,SET,182,0.095681,0.0094789,0.058418,0.050735,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP,0.739099742785445
HP_ABNORMAL_SOCIAL_BEHAVIOR,SET,152,0.11445,0.01037,0.069881,0.050744,HP_ABNORMAL_SOCIAL_BEHAVIOR,0.739099742785445
LAKE_ADULT_KIDNEY_C6_PROXIMA...,SET,171,0.11259,0.010815,0.068764,0.050787,LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3,0.739099742785445
GOBP_POSITIVE_REGULATION_OF_...251,SET,9,0.55003,0.012175,0.33593,0.050792,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING,0.739099742785445
WP_MEASLES_VIRUS_INFECTION,SET,123,0.13492,0.011006,0.082415,0.050811,WP_MEASLES_VIRUS_INFECTION,0.739099742785445
HP_ABNORMAL_PROLACTIN_LEVEL,SET,26,0.28619,0.010762,0.17483,0.05083,HP_ABNORMAL_PROLACTIN_LEVEL,0.739099742785445
HP_SWAN_NECK_LIKE_DEFORMITIE...,SET,8,0.52519,0.01096,0.32084,0.050834,HP_SWAN_NECK_LIKE_DEFORMITIES_OF_THE_FINGERS,0.739099742785445
TITF1_Q3,SET,213,0.099014,0.010603,0.060493,0.050847,TITF1_Q3,0.739099742785445
GOMF_NITRITE_REDUCTASE_ACTIV...,SET,5,0.71135,0.011737,0.43469,0.050883,GOMF_NITRITE_REDUCTASE_ACTIVITY,0.739313823160535
HP_CONGENITAL_FINGER_FLEXION...,SET,11,0.45791,0.011205,0.28013,0.05107,HP_CONGENITAL_FINGER_FLEXION_CONTRACTURES,0.741173956158664
GOBP_POSITIVE_REGULATION_OF_...205,SET,145,0.12198,0.010797,0.074621,0.051071,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.741173956158664
DESCARTES_FETAL_EYE_ASTROCYT...,SET,28,0.3009,0.011742,0.18408,0.051075,DESCARTES_FETAL_EYE_ASTROCYTES,0.741173956158664
GOBP_DORSAL_VENTRAL_PATTERN_...,SET,88,0.16194,0.011184,0.099112,0.05115,GOBP_DORSAL_VENTRAL_PATTERN_FORMATION,0.741710542118432
REACTOME_IONOTROPIC_ACTIVITY...,SET,9,0.47856,0.010593,0.29292,0.051167,REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS,0.741710542118432
GOBP_SUCCINYL_COA_METABOLIC_...,SET,9,0.42131,0.0093257,0.2579,0.051176,GOBP_SUCCINYL_COA_METABOLIC_PROCESS,0.741710542118432
HP_CHRONIC_PAIN,SET,6,0.49998,0.009037,0.3061,0.0512,HP_CHRONIC_PAIN,0.741749062109212
GOBP_G1_TO_G0_TRANSITION_INV...,SET,6,0.52427,0.009476,0.32125,0.051351,GOBP_G1_TO_G0_TRANSITION_INVOLVED_IN_CELL_DIFFERENTIATION,0.74300202247191
GOBP_PROTEIN_TRANSPORT,SET,1298,0.039474,0.010118,0.024189,0.051357,GOBP_PROTEIN_TRANSPORT,0.74300202247191
WP_TROP2_REGULATORY_SIGNALING,SET,48,0.20574,0.010506,0.12608,0.051365,WP_TROP2_REGULATORY_SIGNALING,0.74300202247191
PPAR_DR1_Q2,SET,235,0.090717,0.010197,0.055594,0.051372,PPAR_DR1_Q2,0.74300202247191
HALLMARK_WNT_BETA_CATENIN_SI...,SET,41,0.21992,0.010381,0.13479,0.051397,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.743054382279534
HP_PAPILLOMA,SET,46,0.19364,0.0096803,0.11872,0.051448,HP_PAPILLOMA,0.743482428274428
HP_PARESTHESIA,SET,119,0.12631,0.010136,0.077461,0.05149,HP_PARESTHESIA,0.743613384297521
GSE13229_IMM_VS_INTMATURE_NK...2,SET,180,0.10655,0.010498,0.065348,0.051514,GSE13229_IMM_VS_INTMATURE_NKCELL_UP,0.743613384297521
GNF2_HMMR,SET,47,0.20225,0.01022,0.12407,0.051549,GNF2_HMMR,0.743613384297521
MEF2_03,SET,204,0.1014,0.010629,0.062223,0.051599,MEF2_03,0.743613384297521
GOBP_IODIDE_TRANSPORT,SET,9,0.39636,0.0087735,0.24323,0.051606,GOBP_IODIDE_TRANSPORT,0.743613384297521
GOCC_RECYCLING_ENDOSOME_MEMB...,SET,97,0.14011,0.010157,0.08598,0.05161,GOCC_RECYCLING_ENDOSOME_MEMBRANE,0.743613384297521
HP_ADENOCARCINOMA_OF_THE_COL...,SET,30,0.23576,0.0095223,0.14469,0.051617,HP_ADENOCARCINOMA_OF_THE_COLON,0.743613384297521
GOBP_REGULATION_OF_CYTOKINES...,SET,87,0.14598,0.010025,0.089604,0.051643,GOBP_REGULATION_OF_CYTOKINESIS,0.743613384297521
GOBP_URONIC_ACID_METABOLIC_P...,SET,24,0.41201,0.014886,0.25296,0.051693,GOBP_URONIC_ACID_METABOLIC_PROCESS,0.743613384297521
chr16p11,SET,88,0.31045,0.021441,0.19062,0.051704,chr16p11,0.743613384297521
HP_DIASTEMA,SET,22,0.27799,0.009617,0.17069,0.051709,HP_DIASTEMA,0.743613384297521
GOBP_UROGENITAL_SYSTEM_DEVEL...,SET,64,0.19833,0.011689,0.1218,0.051731,GOBP_UROGENITAL_SYSTEM_DEVELOPMENT,0.743613384297521
WP_COVID19_AND_ENDOTHELIAL_C...,SET,5,0.69315,0.011437,0.4257,0.051744,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,0.743613384297521
KTGGYRSGAA_UNKNOWN,SET,68,0.16647,0.010112,0.10225,0.051762,KTGGYRSGAA_UNKNOWN,0.743613384297521
GSE45739_UNSTIM_VS_ACD3_ACD2...4,SET,181,0.10629,0.010502,0.065293,0.051778,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP,0.743613384297521
HP_APNEIC_EPISODES_PRECIPITA...,SET,11,0.40136,0.0098211,0.2466,0.051818,HP_APNEIC_EPISODES_PRECIPITATED_BY_ILLNESS_FATIGUE_STRESS,0.743797162608337
chr10q26,SET,91,0.28152,0.01977,0.173,0.051844,chr10q26,0.743797162608337
GSE13547_CTRL_VS_ANTI_IGM_ST...8,SET,139,0.11128,0.0096459,0.068388,0.051855,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP,0.743797162608337
HP_PERITONITIS,SET,41,0.22023,0.010395,0.13538,0.051904,HP_PERITONITIS,0.744192871287129
REACTOME_INTERLEUKIN_9_SIGNA...,SET,7,0.67902,0.013256,0.41759,0.051976,REACTOME_INTERLEUKIN_9_SIGNALING,0.744825723413026
REACTOME_RHO_GTPASES_ACTIVAT...7,SET,33,0.24533,0.010392,0.15089,0.051991,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,0.744825723413026
GSE37301_PRO_BCELL_VS_RAG2_K...2,SET,164,0.10877,0.010234,0.066919,0.052044,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP,0.745085992662047
GOBP_REGULATION_OF_HELICASE_...,SET,9,0.37866,0.0083816,0.23305,0.052109,GOBP_REGULATION_OF_HELICASE_ACTIVITY,0.745085992662047
JOSEPH_RESPONSE_TO_SODIUM_BU...1,SET,57,0.19106,0.010629,0.11762,0.052157,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,0.745085992662047
GOBP_AUTOPHAGY_OF_PEROXISOME,SET,13,0.39545,0.010519,0.2435,0.052197,GOBP_AUTOPHAGY_OF_PEROXISOME,0.745085992662047
BIOCARTA_DREAM_PATHWAY,SET,13,0.45982,0.012231,0.28316,0.052208,BIOCARTA_DREAM_PATHWAY,0.745085992662047
REACTOME_NR1H3_NR1H2_REGULAT...,SET,32,0.23693,0.0098828,0.14591,0.052214,REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,0.745085992662047
MIR6746_5P,SET,5,0.65421,0.010795,0.40294,0.052244,MIR6746_5P,0.745085992662047
GSE3982_DC_VS_MAC_UP,SET,174,0.10317,0.0099956,0.063547,0.052255,GSE3982_DC_VS_MAC_UP,0.745085992662047
GOMF_LIPID_BINDING,SET,787,0.051901,0.010513,0.031971,0.05226,GOMF_LIPID_BINDING,0.745085992662047
GAUTAM_EYE_CHOROID_SCLERA_FI...,SET,185,0.10553,0.01054,0.06504,0.052348,GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS,0.745085992662047
GOMF_CYSTEINE_TYPE_ENDOPEPTI...2,SET,80,0.15433,0.010165,0.095136,0.052387,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.745085992662047
HP_HYPOKETOTIC_HYPOGLYCEMIA,SET,14,0.37122,0.010247,0.22887,0.052411,HP_HYPOKETOTIC_HYPOGLYCEMIA,0.745085992662047
GSE25123_ROSIGLITAZONE_VS_IL...1,SET,105,0.1331,0.010037,0.082071,0.052437,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.745085992662047
WALLACE_PROSTATE_CANCER_DN,SET,5,0.69145,0.011409,0.42637,0.05244,WALLACE_PROSTATE_CANCER_DN,0.745085992662047
MODULE_322,SET,51,0.18428,0.0096991,0.11364,0.052445,MODULE_322,0.745085992662047
LEE_LIVER_CANCER_MYC_E2F1_UP,SET,55,0.20481,0.011193,0.1263,0.052457,LEE_LIVER_CANCER_MYC_E2F1_UP,0.745085992662047
GOBP_POSITIVE_REGULATION_OF_...591,SET,7,0.54485,0.010637,0.33601,0.05246,GOBP_POSITIVE_REGULATION_OF_PINOCYTOSIS,0.745085992662047
GNF2_CDC20,SET,52,0.18755,0.0099669,0.11567,0.052473,GNF2_CDC20,0.745085992662047
HP_RECURRENT_STAPHYLOCOCCAL_...,SET,32,0.25653,0.0107,0.15824,0.0525,HP_RECURRENT_STAPHYLOCOCCAL_INFECTIONS,0.745085992662047
PETRETTO_HEART_MASS_QTL_CIS_...1,SET,24,0.28176,0.01018,0.17381,0.05251,PETRETTO_HEART_MASS_QTL_CIS_DN,0.745085992662047
GSE37533_UNTREATED_VS_PIOGLI...5,SET,144,0.11276,0.0099466,0.069564,0.05253,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN,0.745085992662047
HP_GLIOBLASTOMA_MULTIFORME,SET,26,0.25344,0.0095305,0.15636,0.052536,HP_GLIOBLASTOMA_MULTIFORME,0.745085992662047
GOBP_HISTONE_MRNA_CATABOLIC_...,SET,11,0.38631,0.0094529,0.23836,0.052554,GOBP_HISTONE_MRNA_CATABOLIC_PROCESS,0.745085992662047
BUSSLINGER_DUODENAL_EC_CELLS,SET,27,0.30393,0.011647,0.18755,0.052565,BUSSLINGER_DUODENAL_EC_CELLS,0.745085992662047
WP_GASTRIN_SIGNALING,SET,113,0.13543,0.010592,0.08357,0.052569,WP_GASTRIN_SIGNALING,0.745085992662047
GSE17580_UNINFECTED_VS_S_MAN...4,SET,186,0.097914,0.0098051,0.060427,0.052586,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP,0.745085992662047
REACTOME_FORMATION_OF_THE_BE...,SET,31,0.25683,0.010544,0.1585,0.052588,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,0.745085992662047
GSE8921_3H_VS_24H_TLR1_2_STI...2,SET,175,0.10344,0.010051,0.063859,0.052644,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP,0.745506070846906
GSE23568_ID3_KO_VS_WT_CD8_TC...1,SET,185,0.1033,0.010317,0.063777,0.052665,GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN,0.745506070846906
GOBP_IMMUNOLOGICAL_MEMORY_PR...,SET,18,0.37962,0.011881,0.23441,0.052682,GOBP_IMMUNOLOGICAL_MEMORY_PROCESS,0.745506070846906
GOBP_EMBRYONIC_PATTERN_SPECI...,SET,63,0.18376,0.010746,0.11353,0.052772,GOBP_EMBRYONIC_PATTERN_SPECIFICATION,0.745943245856354
GSE21063_CTRL_VS_ANTI_IGM_ST...2,SET,180,0.10198,0.010048,0.063022,0.052827,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP,0.745943245856354
REACTOME_TP53_REGULATES_TRAN...6,SET,57,0.15751,0.0087624,0.097344,0.052836,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,0.745943245856354
GSE30971_WBP7_HET_VS_KO_MACR...2,SET,178,0.10505,0.010293,0.064926,0.052838,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP,0.745943245856354
PID_IL27_PATHWAY,SET,26,0.27967,0.010517,0.17289,0.052885,PID_IL27_PATHWAY,0.745943245856354
GOCC_CASPASE_COMPLEX,SET,10,0.38937,0.0090847,0.24074,0.052908,GOCC_CASPASE_COMPLEX,0.745943245856354
PR_Q2,SET,239,0.093225,0.010567,0.057667,0.052991,PR_Q2,0.745943245856354
GOMF_HISTONE_H3K9ME2_METHYLT...,SET,7,0.47086,0.0091922,0.2913,0.053016,GOMF_HISTONE_H3K9ME2_METHYLTRANSFERASE_ACTIVITY,0.745943245856354
GOBP_REGULATION_OF_PROTEASOM...2,SET,113,0.12581,0.0098395,0.077855,0.053063,GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.745943245856354
MIR4529_5P,SET,45,0.21039,0.010403,0.13021,0.053084,MIR4529_5P,0.745943245856354
REACTOME_TIGHT_JUNCTION_INTE...,SET,27,0.30022,0.011505,0.18585,0.053116,REACTOME_TIGHT_JUNCTION_INTERACTIONS,0.745943245856354
GSE25088_IL4_VS_IL4_AND_ROSI...1,SET,185,0.10094,0.010081,0.062484,0.053121,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.745943245856354
GOCC_IGA_IMMUNOGLOBULIN_COMP...1,SET,2,1.0015,0.010453,0.62014,0.053163,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX,0.745943245856354
GOCC_IGA_IMMUNOGLOBULIN_COMP...2,SET,2,1.0015,0.010453,0.62014,0.053163,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.745943245856354
HP_CRANIOFACIAL_OSTEOSCLEROS...,SET,13,0.38634,0.010277,0.23922,0.053166,HP_CRANIOFACIAL_OSTEOSCLEROSIS,0.745943245856354
REACTOME_LDL_REMODELING,SET,6,0.5125,0.0092632,0.31743,0.053214,REACTOME_LDL_REMODELING,0.745943245856354
GSE32423_CTRL_VS_IL7_IL4_MEM...1,SET,190,0.095523,0.0096669,0.059173,0.053242,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.745943245856354
GSE18893_CTRL_VS_TNF_TREATED...7,SET,179,0.10287,0.010108,0.063735,0.05327,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN,0.745943245856354
REACTOME_SIGNAL_AMPLIFICATION,SET,33,0.25638,0.010859,0.15885,0.053281,REACTOME_SIGNAL_AMPLIFICATION,0.745943245856354
GOBP_OLIGOSACCHARIDE_METABOL...,SET,63,0.17928,0.010484,0.1111,0.053309,GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS,0.745943245856354
GSE10211_UV_INACT_SENDAI_VS_...1,SET,140,0.11678,0.010159,0.07238,0.053333,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN,0.745943245856354
STEGER_ADIPOGENESIS_DN,SET,22,0.30788,0.010651,0.19083,0.053342,STEGER_ADIPOGENESIS_DN,0.745943245856354
GOBP_MITOTIC_SPINDLE_ELONGAT...,SET,11,0.44163,0.010807,0.27375,0.053352,GOBP_MITOTIC_SPINDLE_ELONGATION,0.745943245856354
ZHANG_GATA6_TARGETS_UP,SET,12,0.41894,0.010707,0.2597,0.05336,ZHANG_GATA6_TARGETS_UP,0.745943245856354
GOCC_TRANSCRIPTION_FACTOR_TF...2,SET,30,0.21436,0.0086578,0.13288,0.053363,GOCC_TRANSCRIPTION_FACTOR_TFIID_COMPLEX,0.745943245856354
GOBP_LYMPH_NODE_DEVELOPMENT,SET,19,0.32314,0.01039,0.20032,0.053364,GOBP_LYMPH_NODE_DEVELOPMENT,0.745943245856354
KEGG_MEDICUS_REFERENCE_ORGAN...1,SET,14,0.33733,0.0093115,0.20914,0.053387,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE,0.745943245856354
PKCA_DN.V1_DN,SET,140,0.12117,0.010541,0.075126,0.053389,PKCA_DN.V1_DN,0.745943245856354
GSE11057_PBMC_VS_MEM_CD4_TCE...1,SET,165,0.10699,0.010096,0.06633,0.05339,GSE11057_PBMC_VS_MEM_CD4_TCELL_DN,0.745943245856354
GSE11864_UNTREATED_VS_CSF1_P...1,SET,176,0.098094,0.0095581,0.060823,0.053404,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN,0.745943245856354
MIR1283,SET,434,0.068931,0.010472,0.042744,0.053418,MIR1283,0.745943245856354
MARSON_BOUND_BY_E2F4_UNSTIMU...,SET,613,0.057173,0.010271,0.035455,0.053432,MARSON_BOUND_BY_E2F4_UNSTIMULATED,0.745943245856354
GOBP_INTERLEUKIN_4_PRODUCTION,SET,29,0.2761,0.010964,0.17123,0.053443,GOBP_INTERLEUKIN_4_PRODUCTION,0.745943245856354
HP_BREAST_APLASIA,SET,16,0.35911,0.010596,0.22275,0.053475,HP_BREAST_APLASIA,0.745943245856354
PID_HEDGEHOG_GLI_PATHWAY,SET,46,0.20556,0.010276,0.12752,0.053498,PID_HEDGEHOG_GLI_PATHWAY,0.745943245856354
SAMOLS_TARGETS_OF_KHSV_MIRNA...2,SET,8,0.55876,0.011661,0.34673,0.053541,SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP,0.745943245856354
GOBP_NEGATIVE_REGULATION_OF_...648,SET,89,0.1485,0.010314,0.092181,0.053608,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.745943245856354
HP_ABNORMAL_BLOOD_GLUCOSE_CO...,SET,285,0.081051,0.01002,0.050317,0.053619,HP_ABNORMAL_BLOOD_GLUCOSE_CONCENTRATION,0.745943245856354
GSE5679_RARA_AGONIST_AM580_V...2,SET,182,0.10455,0.010357,0.064906,0.053623,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP,0.745943245856354
HP_COLDNESS,SET,2,1.1096,0.01158,0.68897,0.05365,HP_COLDNESS,0.745943245856354
HP_HAND_APRAXIA,SET,2,1.1096,0.01158,0.68897,0.05365,HP_HAND_APRAXIA,0.745943245856354
NAKAMURA_TUMOR_ZONE_PERIPHER...1,SET,549,0.060356,0.01028,0.037479,0.053666,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,0.745943245856354
GOBP_GANGLIOSIDE_CATABOLIC_P...,SET,7,0.57076,0.011143,0.35445,0.053677,GOBP_GANGLIOSIDE_CATABOLIC_PROCESS,0.745943245856354
GABP_B,SET,239,0.086052,0.0097539,0.05344,0.053681,GABP_B,0.745943245856354
HP_ABNORMAL_CIRCULATING_IGA_...,SET,95,0.14422,0.010347,0.089577,0.053709,HP_ABNORMAL_CIRCULATING_IGA_LEVEL,0.745943245856354
NFMUE1_Q6,SET,216,0.092892,0.010016,0.057701,0.053722,NFMUE1_Q6,0.745943245856354
HP_DEFICIT_IN_GRAMMAR,SET,9,0.4147,0.0091793,0.25765,0.053755,HP_DEFICIT_IN_GRAMMAR,0.745943245856354
GSE22196_HEALTHY_VS_OBESE_MO...1,SET,182,0.10013,0.0099197,0.062214,0.05377,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN,0.745943245856354
GOBP_CHOLESTEROL_STORAGE,SET,23,0.29931,0.010587,0.18598,0.053777,GOBP_CHOLESTEROL_STORAGE,0.745943245856354
GSE3982_MAC_VS_CENT_MEMORY_C...1,SET,167,0.10323,0.0098003,0.064157,0.053816,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN,0.745943245856354
GSE18281_SUBCAPSULAR_VS_CENT...2,SET,168,0.10399,0.0099022,0.064647,0.053855,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP,0.745943245856354
WALLACE_JAK2_TARGETS_UP,SET,19,0.27745,0.0089208,0.17253,0.053915,WALLACE_JAK2_TARGETS_UP,0.745943245856354
GOMF_CALCIUM_ION_BINDING,SET,660,0.058791,0.010945,0.036577,0.054001,GOMF_CALCIUM_ION_BINDING,0.745943245856354
GSE17721_CPG_VS_GARDIQUIMOD_...7,SET,182,0.09815,0.0097236,0.061069,0.054014,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN,0.745943245856354
GOBP_FUCOSYLATION,SET,16,0.34309,0.010124,0.21348,0.054018,GOBP_FUCOSYLATION,0.745943245856354
HP_GRANULOCYTOPENIA,SET,6,0.52988,0.0095774,0.32974,0.054038,HP_GRANULOCYTOPENIA,0.745943245856354
GOBP_CAMERA_TYPE_EYE_MORPHOG...,SET,127,0.13105,0.010862,0.081558,0.054056,GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS,0.745943245856354
GOBP_NEGATIVE_REGULATION_OF_...59,SET,15,0.38955,0.01113,0.24245,0.054064,GOBP_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.745943245856354
GOMF_THIAMINE_PYROPHOSPHATE_...,SET,6,0.55512,0.010034,0.3455,0.054066,GOMF_THIAMINE_PYROPHOSPHATE_BINDING,0.745943245856354
MIR4284,SET,99,0.1348,0.0098716,0.083899,0.054073,MIR4284,0.745943245856354
REACTOME_KIDNEY_DEVELOPMENT,SET,42,0.2408,0.011504,0.14992,0.05413,REACTOME_KIDNEY_DEVELOPMENT,0.745943245856354
GOBP_MITOCHONDRIAL_ELECTRON_...1,SET,16,0.31535,0.0093051,0.19635,0.054139,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN,0.745943245856354
GOTZMANN_EPITHELIAL_TO_MESEN...2,SET,65,0.17676,0.010499,0.11007,0.054166,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.745943245856354
KEGG_MEDICUS_PATHOGEN_SALMON...2,SET,24,0.27228,0.0098377,0.16959,0.054201,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.745943245856354
chr1q23,SET,130,0.25122,0.021065,0.1565,0.054226,chr1q23,0.745943245856354
GOBP_POSITIVE_REGULATION_OF_...325,SET,5,0.64645,0.010667,0.40271,0.05423,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_MATURATION,0.745943245856354
GOMF_OXYGEN_CARRIER_ACTIVITY,SET,10,0.5259,0.01227,0.32765,0.054246,GOMF_OXYGEN_CARRIER_ACTIVITY,0.745943245856354
MONTERO_THYROID_CANCER_POOR_...2,SET,12,0.43132,0.011023,0.26875,0.054266,MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP,0.745943245856354
GSE41176_UNSTIM_VS_ANTI_IGM_...6,SET,180,0.11052,0.010889,0.068866,0.054275,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.745943245856354
GSE5960_TH1_VS_ANERGIC_TH1_DN,SET,184,0.09778,0.0097395,0.06093,0.054277,GSE5960_TH1_VS_ANERGIC_TH1_DN,0.745943245856354
HP_REDUCED_CIRCULATING_PROLA...,SET,20,0.31058,0.010245,0.19359,0.054328,HP_REDUCED_CIRCULATING_PROLACTIN_CONCENTRATION,0.745943245856354
GSE360_CTRL_VS_T_GONDII_DC_UP,SET,177,0.10507,0.010266,0.065493,0.054337,GSE360_CTRL_VS_T_GONDII_DC_UP,0.745943245856354
GAVISH_3CA_METAPROGRAM_CD4_T...3,SET,43,0.2078,0.010045,0.12954,0.05435,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_DYSFUNCTION,0.745943245856354
GSE2128_C57BL6_VS_NOD_CD4CD8...1,SET,187,0.098467,0.0098867,0.061387,0.054362,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN,0.745943245856354
FOXF2_TARGET_GENES,SET,7,0.48984,0.0095629,0.30539,0.054364,FOXF2_TARGET_GENES,0.745943245856354
GOBP_CELL_ADHESION_MOLECULE_...,SET,11,0.46926,0.011483,0.29256,0.054369,GOBP_CELL_ADHESION_MOLECULE_PRODUCTION,0.745943245856354
MIR939_5P,SET,114,0.12778,0.010038,0.079668,0.054371,MIR939_5P,0.745943245856354
GOCC_PHAGOPHORE_ASSEMBLY_SITE,SET,35,0.23769,0.010368,0.1482,0.054387,GOCC_PHAGOPHORE_ASSEMBLY_SITE,0.745943245856354
GRYDER_PAX3FOXO1_ENHANCERS_I...,SET,942,0.048166,0.010627,0.03004,0.054431,GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS,0.746136127760252
GOBP_INORGANIC_ANION_TRANSPO...,SET,159,0.11619,0.010766,0.072472,0.054444,GOBP_INORGANIC_ANION_TRANSPORT,0.746136127760252
HP_ABNORMALITY_OF_GLYCOLIPID...,SET,9,0.43859,0.0097081,0.27366,0.054513,HP_ABNORMALITY_OF_GLYCOLIPID_METABOLISM,0.746787274339771
GSE43955_TH0_VS_TGFB_IL6_TH1...13,SET,183,0.105,0.01043,0.065524,0.054541,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN,0.746876459810875
GOBP_NEGATIVE_REGULATION_OF_...305,SET,13,0.42218,0.01123,0.26352,0.05458,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.74687674015748
GSE40666_WT_VS_STAT1_KO_CD8_...4,SET,178,0.10283,0.010076,0.064186,0.054584,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.74687674015748
GAGCCTG_MIR484,SET,96,0.14076,0.010152,0.087921,0.054697,GAGCCTG_MIR484,0.74812164221219
GOMF_PYRUVATE_DEHYDROGENASE_...1,SET,4,0.6322,0.0093305,0.39504,0.054771,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_KINASE_ACTIVITY,0.74812164221219
GOBP_NEGATIVE_REGULATION_OF_...461,SET,18,0.30055,0.0094061,0.18783,0.054794,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.74812164221219
GSE7460_FOXP3_MUT_VS_HET_ACT...2,SET,183,0.10338,0.010269,0.064613,0.054814,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP,0.74812164221219
HP_HEADACHE,SET,298,0.080747,0.010203,0.05049,0.054888,HP_HEADACHE,0.74812164221219
GRESHOCK_CANCER_COPY_NUMBER_...,SET,309,0.078572,0.010107,0.049133,0.054901,GRESHOCK_CANCER_COPY_NUMBER_UP,0.74812164221219
HP_EEG_WITH_CONTINUOUS_SLOW_...,SET,8,0.46621,0.0097295,0.29157,0.054927,HP_EEG_WITH_CONTINUOUS_SLOW_ACTIVITY,0.74812164221219
HP_METABOLIC_ALKALOSIS,SET,18,0.34754,0.010877,0.21737,0.054935,HP_METABOLIC_ALKALOSIS,0.74812164221219
BURTON_ADIPOGENESIS_9,SET,73,0.17419,0.010962,0.10897,0.054974,BURTON_ADIPOGENESIS_9,0.74812164221219
MYLLYKANGAS_AMPLIFICATION_HO...11,SET,9,0.47115,0.010429,0.29475,0.054976,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25,0.74812164221219
REACTOME_BETA_DEFENSINS,SET,26,0.37048,0.013932,0.23184,0.055033,REACTOME_BETA_DEFENSINS,0.74812164221219
GOBP_PROCESS_UTILIZING_AUTOP...,SET,541,0.057948,0.0097995,0.036263,0.055034,GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM,0.74812164221219
GOMF_RNA_POLYMERASE_II_CORE_...,SET,15,0.35858,0.010245,0.22445,0.055073,GOMF_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.74812164221219
HP_ABNORMAL_CIRCULATING_ACYL...,SET,21,0.28736,0.0097131,0.17992,0.055117,HP_ABNORMAL_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.74812164221219
GOBP_REGULATION_OF_TRANSCRIP...2,SET,39,0.19996,0.009206,0.12523,0.055178,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.74812164221219
GSE45365_CD8A_DC_VS_CD11B_DC...1,SET,173,0.10353,0.010003,0.064848,0.055189,GSE45365_CD8A_DC_VS_CD11B_DC_DN,0.74812164221219
REACTOME_NUCLEAR_RECEPTOR_TR...,SET,50,0.19692,0.010262,0.12334,0.055193,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,0.74812164221219
GOBP_POSITIVE_REGULATION_OF_...683,SET,5,0.67547,0.011145,0.42312,0.055211,GOBP_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.74812164221219
GOBP_NEGATIVE_REGULATION_OF_...74,SET,125,0.12826,0.010547,0.080352,0.055221,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.74812164221219
GOMF_TRANSMEMBRANE_RECEPTOR_...4,SET,18,0.33772,0.010569,0.21173,0.055356,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING,0.74812164221219
GOBP_ENDOSOMAL_VESICLE_FUSION,SET,15,0.32177,0.0091934,0.20178,0.0554,GOBP_ENDOSOMAL_VESICLE_FUSION,0.74812164221219
GOBP_NEGATIVE_REGULATION_OF_...86,SET,28,0.27367,0.010679,0.17162,0.055403,GOBP_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.74812164221219
GSE11961_UNSTIM_VS_ANTI_IGM_...2,SET,182,0.099634,0.0098706,0.062486,0.05542,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP,0.74812164221219
MIR516A_3P_MIR516B_3P,SET,160,0.10887,0.010119,0.068294,0.055464,MIR516A_3P_MIR516B_3P,0.74812164221219
KRAS.DF.V1_DN,SET,168,0.10822,0.010305,0.067907,0.055508,KRAS.DF.V1_DN,0.74812164221219
LASTOWSKA_NEUROBLASTOMA_COPY...2,SET,169,0.10973,0.010479,0.068859,0.055536,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,0.74812164221219
HP_BIFID_NOSE,SET,11,0.41868,0.010245,0.26275,0.055539,HP_BIFID_NOSE,0.74812164221219
GOBP_REGULATION_OF_RESPONSE_...4,SET,74,0.15084,0.0095571,0.094682,0.055573,GOBP_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.74812164221219
PID_TCPTP_PATHWAY,SET,42,0.22354,0.01068,0.14033,0.055591,PID_TCPTP_PATHWAY,0.74812164221219
MIR183_5P,SET,210,0.096147,0.010224,0.060357,0.055591,MIR183_5P,0.74812164221219
GOBP_POSITIVE_REGULATION_OF_...184,SET,46,0.20562,0.01028,0.12909,0.055604,GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS,0.74812164221219
WP_AUTOPHAGY,SET,30,0.2441,0.009859,0.15327,0.055635,WP_AUTOPHAGY,0.74812164221219
HP_FEMALE_REPRODUCTIVE_SYSTE...,SET,70,0.16072,0.0099049,0.10094,0.05567,HP_FEMALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.74812164221219
REACTOME_MECP2_REGULATES_TRA...1,SET,4,0.81965,0.012097,0.51479,0.05568,REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS,0.74812164221219
BIOCARTA_PCAF_PATHWAY,SET,13,0.35513,0.0094464,0.2231,0.055725,BIOCARTA_PCAF_PATHWAY,0.74812164221219
GOBP_NEUROMUSCULAR_PROCESS_C...1,SET,50,0.21109,0.011001,0.13262,0.055737,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE,0.74812164221219
MIR509_5P,SET,141,0.11364,0.0099208,0.071404,0.055749,MIR509_5P,0.74812164221219
GOBP_POSITIVE_REGULATION_OF_...643,SET,4,0.7362,0.010865,0.46256,0.055749,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.74812164221219
MIR4425,SET,84,0.14164,0.0095583,0.089012,0.055792,MIR4425,0.74812164221219
BORLAK_LIVER_CANCER_EGF_UP,SET,49,0.20367,0.010508,0.12804,0.055844,BORLAK_LIVER_CANCER_EGF_UP,0.74812164221219
MIR142_3P,SET,162,0.10866,0.010162,0.068319,0.055868,MIR142_3P,0.74812164221219
MORF_PRKDC,SET,167,0.09902,0.0094007,0.062259,0.055876,MORF_PRKDC,0.74812164221219
GSE17721_CTRL_VS_POLYIC_6H_B...2,SET,174,0.09846,0.0095396,0.061908,0.05588,GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP,0.74812164221219
HP_WEAKNESS_OF_MUSCLES_OF_RE...,SET,99,0.13704,0.010036,0.086187,0.055924,HP_WEAKNESS_OF_MUSCLES_OF_RESPIRATION,0.74812164221219
GSE3982_EOSINOPHIL_VS_DC_UP,SET,173,0.10529,0.010172,0.06622,0.055933,GSE3982_EOSINOPHIL_VS_DC_UP,0.74812164221219
HP_LOWER_LIMB_METAPHYSEAL_IR...,SET,9,0.4205,0.0093077,0.26449,0.05594,HP_LOWER_LIMB_METAPHYSEAL_IRREGULARITY,0.74812164221219
GSE2770_TGFB_AND_IL4_VS_IL4_...2,SET,184,0.097778,0.0097393,0.061505,0.055955,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.74812164221219
HP_ENTEROCOLITIS,SET,19,0.29688,0.0095456,0.18675,0.05596,HP_ENTEROCOLITIS,0.74812164221219
HP_INCREASED_HEPATIC_ECHOGEN...,SET,5,0.61778,0.010194,0.38875,0.056022,HP_INCREASED_HEPATIC_ECHOGENICITY,0.74812164221219
GSE5589_UNSTIM_VS_45MIN_LPS_...2,SET,182,0.097471,0.0096563,0.061336,0.056023,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.74812164221219
DESCARTES_FETAL_CEREBRUM_SKO...,SET,48,0.21354,0.010904,0.13439,0.05604,DESCARTES_FETAL_CEREBRUM_SKOR2_NPSR1_POSITIVE_CELLS,0.74812164221219
KEGG_MEDICUS_REFERENCE_PKA_H...,SET,7,0.55208,0.010778,0.34745,0.056043,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME,0.74812164221219
GOCC_CAMP_DEPENDENT_PROTEIN_...,SET,7,0.55208,0.010778,0.34745,0.056043,GOCC_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.74812164221219
PID_AR_PATHWAY,SET,57,0.18096,0.010067,0.11389,0.056056,PID_AR_PATHWAY,0.74812164221219
GSE46606_UNSTIM_VS_CD40L_IL2...6,SET,180,0.10209,0.010059,0.06426,0.056065,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP,0.74812164221219
KEGG_PHENYLALANINE_METABOLISM,SET,15,0.39379,0.011251,0.24792,0.056109,KEGG_PHENYLALANINE_METABOLISM,0.74812164221219
GSE22140_HEALTHY_VS_ARTHRITI...3,SET,183,0.098665,0.0098012,0.062123,0.056127,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.74812164221219
REACTOME_DOWNSTREAM_SIGNALIN...5,SET,26,0.25548,0.0096072,0.16087,0.056141,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,0.74812164221219
GSE21063_WT_VS_NFATC1_KO_BCE...1,SET,181,0.093474,0.0092351,0.058865,0.056158,GSE21063_WT_VS_NFATC1_KO_BCELL_DN,0.74812164221219
HP_VENOUS_THROMBOSIS,SET,74,0.16442,0.010417,0.10356,0.05618,HP_VENOUS_THROMBOSIS,0.74812164221219
MIR299_5P,SET,134,0.1225,0.010427,0.077158,0.056193,MIR299_5P,0.74812164221219
GAO_LARGE_INTESTINE_24W_C2_M...,SET,104,0.14356,0.010774,0.09043,0.05621,GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR,0.74812164221219
HP_ISOMERISM,SET,4,0.67389,0.0099457,0.42456,0.056237,HP_ISOMERISM,0.74812164221219
GSE17721_POLYIC_VS_CPG_24H_B...1,SET,182,0.10052,0.0099584,0.063333,0.056246,GSE17721_POLYIC_VS_CPG_24H_BMDC_DN,0.74812164221219
GOBP_VESICLE_LOCALIZATION,SET,202,0.093437,0.0097467,0.058883,0.056285,GOBP_VESICLE_LOCALIZATION,0.74812164221219
GOMF_PHOSPHATIDYLINOSITOL_3_...9,SET,6,0.6337,0.011454,0.39936,0.056287,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVATOR_ACTIVITY,0.74812164221219
GOBP_NUCLEAR_MIGRATION,SET,24,0.2538,0.0091701,0.15996,0.056306,GOBP_NUCLEAR_MIGRATION,0.74812164221219
CORRE_MULTIPLE_MYELOMA_UP,SET,64,0.17986,0.0106,0.11336,0.056313,CORRE_MULTIPLE_MYELOMA_UP,0.74812164221219
GAVISH_3CA_METAPROGRAM_FIBRO...16,SET,46,0.21854,0.010925,0.13775,0.05632,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE,0.74812164221219
HP_ANTI_SMOOTH_MUSCLE_ANTIBO...,SET,5,0.5649,0.009321,0.35611,0.056341,HP_ANTI_SMOOTH_MUSCLE_ANTIBODY_POSITIVITY,0.74812164221219
GAVISH_3CA_METAPROGRAM_CD8_T...2,SET,42,0.18598,0.0088848,0.11727,0.056398,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN,0.74812164221219
GOMF_SULFATIDE_BINDING,SET,6,0.5387,0.0097367,0.33978,0.056445,GOMF_SULFATIDE_BINDING,0.74812164221219
chr7q31,SET,58,0.33689,0.018905,0.2125,0.056452,chr7q31,0.74812164221219
KEGG_MEDICUS_PATHOGEN_HCMV_U...7,SET,30,0.25297,0.010218,0.15959,0.056478,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.74812164221219
GOBP_RENAL_ALBUMIN_ABSORPTION,SET,7,0.58867,0.011492,0.37137,0.05648,GOBP_RENAL_ALBUMIN_ABSORPTION,0.74812164221219
GOCC_CELL_BODY_FIBER,SET,8,0.51705,0.010791,0.3262,0.056485,GOCC_CELL_BODY_FIBER,0.74812164221219
MARSON_FOXP3_TARGETS_DN,SET,48,0.21136,0.010793,0.13336,0.056506,MARSON_FOXP3_TARGETS_DN,0.74812164221219
CBX7_TARGET_GENES,SET,725,0.051803,0.010089,0.032689,0.056522,CBX7_TARGET_GENES,0.74812164221219
MIR4422,SET,416,0.070224,0.01045,0.044315,0.056529,MIR4422,0.74812164221219
PARK_TRETINOIN_RESPONSE_AND_...1,SET,27,0.27673,0.010604,0.17465,0.056548,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,0.74812164221219
GOBP_SERTOLI_CELL_DEVELOPMENT,SET,12,0.38808,0.0099182,0.24495,0.056573,GOBP_SERTOLI_CELL_DEVELOPMENT,0.74812164221219
MIR5585_3P,SET,77,0.16046,0.01037,0.10129,0.056583,MIR5585_3P,0.74812164221219
VANDESLUIS_COMMD1_TARGETS_GR...5,SET,13,0.38932,0.010356,0.24576,0.056588,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,0.74812164221219
GNF2_RAP1B,SET,32,0.23715,0.0098919,0.14971,0.056604,GNF2_RAP1B,0.74812164221219
DESCARTES_MAIN_FETAL_GOBLET_...,SET,37,0.25569,0.011467,0.16144,0.056629,DESCARTES_MAIN_FETAL_GOBLET_CELLS,0.74812164221219
GOMF_PROTEIN_DOMAIN_SPECIFIC...,SET,598,0.05579,0.0099034,0.035228,0.056642,GOMF_PROTEIN_DOMAIN_SPECIFIC_BINDING,0.74812164221219
GOBP_POSITIVE_REGULATION_OF_...406,SET,150,0.11783,0.010606,0.07441,0.056666,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.74812164221219
GSE17721_CPG_VS_GARDIQUIMOD_...15,SET,172,0.099901,0.009624,0.063091,0.056668,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN,0.74812164221219
GSE43956_WT_VS_SGK1_KO_TH17_...2,SET,183,0.10083,0.010017,0.063696,0.056715,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP,0.74812164221219
HP_BILIARY_TRACT_NEOPLASM,SET,15,0.36375,0.010393,0.22981,0.056738,HP_BILIARY_TRACT_NEOPLASM,0.74812164221219
GOBP_VESICLE_TETHERING_INVOL...,SET,9,0.42961,0.0095094,0.27144,0.056751,GOBP_VESICLE_TETHERING_INVOLVED_IN_EXOCYTOSIS,0.74812164221219
GAANYNYGACNY_UNKNOWN,SET,65,0.17021,0.01011,0.10756,0.056784,GAANYNYGACNY_UNKNOWN,0.74812164221219
BUSSLINGER_GASTRIC_PPP1R1B_P...,SET,114,0.12506,0.0098237,0.079038,0.056804,BUSSLINGER_GASTRIC_PPP1R1B_POSITIVE_CELLS,0.74812164221219
GOBP_IRON_COORDINATION_ENTIT...,SET,11,0.42533,0.010408,0.26882,0.056807,GOBP_IRON_COORDINATION_ENTITY_TRANSPORT,0.74812164221219
HP_MENINGITIS,SET,65,0.17121,0.010169,0.10823,0.056841,HP_MENINGITIS,0.74812164221219
POMEROY_MEDULLOBLASTOMA_DESM...2,SET,56,0.17641,0.0097281,0.11153,0.056866,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,0.74812164221219
FULLER_PBMC_F_TULARENSIS_VAC...5,SET,54,0.20044,0.010854,0.12673,0.05688,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,0.74812164221219
GOMF_3_PHOSPHOADENOSINE_5_PH...,SET,9,0.45544,0.010081,0.28799,0.056895,GOMF_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING,0.74812164221219
HP_DYSCALCULIA,SET,22,0.2714,0.009389,0.17161,0.056895,HP_DYSCALCULIA,0.74812164221219
GSE1566_WT_VS_EZH2_KO_LN_TCE...1,SET,178,0.10112,0.0099085,0.063947,0.056906,GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN,0.74812164221219
GOMF_CYSTEINE_TYPE_ENDOPEPTI...3,SET,12,0.39733,0.010154,0.25129,0.056935,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.74812164221219
GENTILE_RESPONSE_CLUSTER_D3,SET,50,0.18987,0.0098949,0.12009,0.056946,GENTILE_RESPONSE_CLUSTER_D3,0.74812164221219
HP_CHROMOSOME_BREAKAGE,SET,36,0.20576,0.0091023,0.13015,0.056947,HP_CHROMOSOME_BREAKAGE,0.74812164221219
GOBP_NATURAL_KILLER_CELL_PRO...,SET,14,0.41301,0.011401,0.26127,0.056973,GOBP_NATURAL_KILLER_CELL_PROLIFERATION,0.74812164221219
GOBP_STRESS_ACTIVATED_PROTEI...,SET,52,0.19198,0.010203,0.12148,0.057015,GOBP_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.74812164221219
MIR1286,SET,80,0.14941,0.0098408,0.094544,0.05703,MIR1286,0.74812164221219
GOBP_PLATELET_ACTIVATION,SET,130,0.12745,0.010686,0.080653,0.05704,GOBP_PLATELET_ACTIVATION,0.74812164221219
GSE7548_NAIVE_VS_DAY7_PCC_IM...2,SET,184,0.095012,0.0094637,0.060132,0.057055,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP,0.74812164221219
WP_NEOLACTO_SERIES_SPHINGOLI...,SET,11,0.40545,0.0099212,0.25662,0.057071,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.74812164221219
GOBP_REGULATION_OF_NUCLEOTID...2,SET,9,0.51269,0.011348,0.32456,0.0571,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.74812164221219
GOBP_COLLATERAL_SPROUTING_IN...,SET,4,0.71151,0.010501,0.4505,0.057131,GOBP_COLLATERAL_SPROUTING_IN_ABSENCE_OF_INJURY,0.74812164221219
GSE26290_CTRL_VS_AKT_INHIBIT...1,SET,181,0.10346,0.010222,0.065509,0.05714,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.74812164221219
NOTCH_DN.V1_DN,SET,161,0.11143,0.010389,0.070555,0.057143,NOTCH_DN.V1_DN,0.74812164221219
GSE43955_10H_VS_30H_ACT_CD4_...4,SET,183,0.099738,0.0099078,0.063166,0.05718,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.74812164221219
DACOSTA_LOW_DOSE_UV_RESPONSE...2,SET,11,0.43727,0.0107,0.27693,0.057182,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.74812164221219
GSE22313_HEALTHY_VS_SLE_MOUS...1,SET,179,0.10161,0.0099837,0.06436,0.057206,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN,0.74812164221219
HP_POOR_FINE_MOTOR_COORDINAT...,SET,64,0.16809,0.0099069,0.10647,0.05721,HP_POOR_FINE_MOTOR_COORDINATION,0.74812164221219
GSE18281_SUBCAPSULAR_VS_PERI...1,SET,184,0.1006,0.010021,0.063728,0.057215,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN,0.74812164221219
GSE11057_NAIVE_VS_EFF_MEMORY...2,SET,165,0.10616,0.010019,0.067269,0.057268,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,0.748533034975555
HP_LACTICACIDURIA,SET,20,0.31643,0.010438,0.20053,0.057294,HP_LACTICACIDURIA,0.74854511837655
GOBP_REGULATION_OF_PERK_MEDI...,SET,12,0.40542,0.010361,0.25695,0.057312,GOBP_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.74854511837655
GOBP_ANTERIOR_POSTERIOR_AXIS...,SET,51,0.20076,0.010566,0.12728,0.057376,GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.749012634146341
GOBP_SENSORY_PERCEPTION_OF_B...,SET,43,0.2427,0.011732,0.1539,0.057406,GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE,0.749012634146341
MIR887_3P,SET,5,0.64287,0.010607,0.4077,0.05743,MIR887_3P,0.749012634146341
GSE360_T_GONDII_VS_B_MALAYI_...8,SET,174,0.10095,0.009781,0.064025,0.057434,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.749012634146341
GSE2770_UNTREATED_VS_TGFB_AN...3,SET,175,0.097602,0.0094834,0.06194,0.05755,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.749830335331585
GOBP_NEGATIVE_REGULATION_OF_...544,SET,57,0.1707,0.0094963,0.10833,0.057552,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.749830335331585
GOBP_STABILIZATION_OF_MEMBRA...,SET,17,0.34575,0.010516,0.21945,0.057577,GOBP_STABILIZATION_OF_MEMBRANE_POTENTIAL,0.749830335331585
MIR548AR_3P,SET,512,0.060574,0.0099734,0.038448,0.057583,MIR548AR_3P,0.749830335331585
GOCC_NUCLEAR_MEMBRANE,SET,282,0.079277,0.0097493,0.05033,0.057621,GOCC_NUCLEAR_MEMBRANE,0.750044140449438
GOBP_REGULATION_OF_PRIMARY_M...,SET,5,0.67683,0.011168,0.42985,0.057687,GOBP_REGULATION_OF_PRIMARY_MIRNA_PROCESSING,0.750510291916168
GOMF_CDP_ALCOHOL_PHOSPHATIDY...,SET,7,0.45582,0.0088986,0.28951,0.0577,GOMF_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY,0.750510291916168
HP_POLYURIA,SET,35,0.23902,0.010426,0.15184,0.057733,HP_POLYURIA,0.750546832460733
HP_ELEVATED_CIRCULATING_ACYL...,SET,17,0.31014,0.009433,0.19703,0.057746,HP_ELEVATED_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.750546832460733
REACTOME_SYNTHESIS_OF_BILE_A...4,SET,23,0.29531,0.010445,0.18771,0.057842,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,0.751297640134529
GOBP_POSITIVE_REGULATION_OF_...839,SET,30,0.23116,0.0093365,0.14694,0.057847,GOBP_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.751297640134529
BUSSLINGER_ESOPHAGEAL_QUIESC...,SET,70,0.1655,0.0102,0.10524,0.057903,BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS,0.751568772845953
GOMF_CARBON_CARBON_LYASE_ACT...,SET,50,0.18145,0.0094562,0.11539,0.057926,GOMF_CARBON_CARBON_LYASE_ACTIVITY,0.751568772845953
GOMF_TAP_BINDING,SET,7,0.52356,0.010221,0.333,0.057955,GOMF_TAP_BINDING,0.751568772845953
GSE21670_UNTREATED_VS_TGFB_I...2,SET,170,0.10174,0.0097443,0.064713,0.057969,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP,0.751568772845953
GOCC_DENDRITIC_SHAFT,SET,39,0.22333,0.010282,0.14206,0.057976,GOCC_DENDRITIC_SHAFT,0.751568772845953
GOBP_REGULATION_OF_PROTEIN_L...6,SET,9,0.38256,0.0084679,0.24342,0.058028,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.751816430700447
HP_GERM_CELL_NEOPLASIA,SET,40,0.21683,0.01011,0.13798,0.058056,HP_GERM_CELL_NEOPLASIA,0.751816430700447
GOBP_MESONEPHROS_DEVELOPMENT,SET,97,0.14838,0.010756,0.094427,0.05806,GOBP_MESONEPHROS_DEVELOPMENT,0.751816430700447
GOBP_POSITIVE_REGULATION_OF_...416,SET,6,0.5948,0.010751,0.37866,0.058125,GOBP_POSITIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.752377793296089
HP_ABNORMAL_CIRCULATING_SERI...1,SET,5,0.61314,0.010117,0.39039,0.058148,HP_ABNORMAL_CIRCULATING_SERINE_CONCENTRATION,0.752395286671631
SEITZ_NEOPLASTIC_TRANSFORMAT...2,SET,67,0.18305,0.011037,0.11659,0.058217,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,0.753007754000744
BUSSLINGER_GASTRIC_LYZ_POSIT...,SET,101,0.1367,0.010111,0.087103,0.058291,BUSSLINGER_GASTRIC_LYZ_POSITIVE_CELLS,0.753649702491633
HP_EXERCISE_INDUCED_MYALGIA,SET,31,0.22454,0.0092186,0.14309,0.05831,HP_EXERCISE_INDUCED_MYALGIA,0.753649702491633
TAATTA_CHX10_01,SET,730,0.05348,0.01045,0.034093,0.058374,TAATTA_CHX10_01,0.753932025974026
REACTOME_INTERLEUKIN_20_FAMI...,SET,26,0.28837,0.010844,0.18385,0.058393,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,0.753932025974026
MODULE_72,SET,284,0.079088,0.00976,0.050431,0.058421,MODULE_72,0.753932025974026
GNF2_PTPRC,SET,59,0.17525,0.0099186,0.11176,0.058439,GNF2_PTPRC,0.753932025974026
METTL14_TARGET_GENES,SET,109,0.12895,0.0099059,0.082234,0.058446,METTL14_TARGET_GENES,0.753932025974026
GOBP_PYRIMIDINE_RIBONUCLEOSI...2,SET,11,0.39835,0.0097475,0.25407,0.058462,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.753932025974026
MIR3675_5P,SET,30,0.23466,0.0094777,0.14969,0.058495,MIR3675_5P,0.754077791172107
GOMF_PHOSPHATIDIC_ACID_TRANS...,SET,5,0.60508,0.0099839,0.38626,0.058624,GOMF_PHOSPHATIDIC_ACID_TRANSFER_ACTIVITY,0.755111659941306
GOCC_GTPASE_COMPLEX,SET,38,0.22017,0.010006,0.14058,0.058669,GOCC_GTPASE_COMPLEX,0.755111659941306
KIM_PTEN_TARGETS_DN,SET,4,0.61618,0.009094,0.39345,0.058672,KIM_PTEN_TARGETS_DN,0.755111659941306
REACTOME_RHOB_GTPASE_CYCLE,SET,65,0.16765,0.0099576,0.10705,0.058677,REACTOME_RHOB_GTPASE_CYCLE,0.755111659941306
GSE40277_GATA1_AND_SATB1_TRA...1,SET,180,0.10049,0.0099009,0.064198,0.058769,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.755111659941306
ATF6_01,SET,118,0.11994,0.0095848,0.076635,0.058783,ATF6_01,0.755111659941306
MORF_TTN,SET,45,0.20707,0.010239,0.13231,0.05879,MORF_TTN,0.755111659941306
GNF2_BUB1,SET,26,0.24425,0.0091848,0.15607,0.058798,GNF2_BUB1,0.755111659941306
CROMER_TUMORIGENESIS_DN,SET,46,0.20565,0.010281,0.13141,0.058807,CROMER_TUMORIGENESIS_DN,0.755111659941306
GOBP_GOLGI_TO_PLASMA_MEMBRAN...1,SET,40,0.21412,0.0099833,0.13682,0.058807,GOBP_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.755111659941306
DURANTE_ADULT_OLFACTORY_NEUR...17,SET,70,0.17734,0.010929,0.11334,0.058838,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PERICYTES,0.755111659941306
GSE27786_LSK_VS_CD4_TCELL_DN,SET,177,0.099263,0.0096992,0.063442,0.058844,GSE27786_LSK_VS_CD4_TCELL_DN,0.755111659941306
MEISSNER_NPC_HCP_WITH_H3K4ME2,SET,447,0.066823,0.010299,0.042722,0.058901,MEISSNER_NPC_HCP_WITH_H3K4ME2,0.755111659941306
GSE15930_STIM_VS_STIM_AND_TR...6,SET,180,0.095961,0.0094549,0.061358,0.058923,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP,0.755111659941306
CERIBELLI_PROMOTERS_INACTIVE...,SET,30,0.26082,0.010535,0.16682,0.058978,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,0.755111659941306
HP_HEREDITARY_NONPOLYPOSIS_C...,SET,32,0.23836,0.0099423,0.15246,0.058992,HP_HEREDITARY_NONPOLYPOSIS_COLORECTAL_CARCINOMA,0.755111659941306
GSE6259_BCELL_VS_CD8_TCELL_UP,SET,174,0.10918,0.010578,0.069839,0.058995,GSE6259_BCELL_VS_CD8_TCELL_UP,0.755111659941306
SARRIO_EPITHELIAL_MESENCHYMA...2,SET,159,0.10129,0.0093852,0.064795,0.059004,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,0.755111659941306
REACTOME_REGULATION_OF_CDH19...,SET,7,0.50702,0.0098981,0.32434,0.059008,REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION,0.755111659941306
ERWIN_COHEN_PBMC_TC_83_AGE_1...2,SET,14,0.38097,0.010516,0.24374,0.059032,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_DN,0.755111659941306
GOMF_HISTONE_H3K27_METHYLTRA...,SET,5,0.59192,0.0097668,0.37881,0.059085,GOMF_HISTONE_H3K27_METHYLTRANSFERASE_ACTIVITY,0.755111659941306
GSE22935_UNSTIM_VS_24H_MBOVI...4,SET,191,0.093698,0.0095069,0.05998,0.059134,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.755111659941306
HP_ABNORMAL_FLASH_VISUAL_EVO...,SET,13,0.35254,0.0093775,0.22567,0.059135,HP_ABNORMAL_FLASH_VISUAL_EVOKED_POTENTIALS,0.755111659941306
GOBP_POSITIVE_REGULATION_OF_...477,SET,13,0.35159,0.0093523,0.22508,0.059148,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CYTOKINESIS,0.755111659941306
RORIE_TARGETS_OF_EWSR1_FLI1_...1,SET,25,0.29669,0.010941,0.18997,0.059174,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.755111659941306
GSE16385_UNTREATED_VS_12H_IF...2,SET,159,0.10621,0.0098415,0.068014,0.059193,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.755111659941306
AP2_Q6_01,SET,247,0.084313,0.0097133,0.053992,0.059201,AP2_Q6_01,0.755111659941306
GOBP_G2_MI_TRANSITION_OF_MEI...,SET,6,0.49556,0.008957,0.31734,0.059202,GOBP_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.755111659941306
REACTOME_SIGNALING_BY_PDGF,SET,57,0.18098,0.010068,0.11591,0.059223,REACTOME_SIGNALING_BY_PDGF,0.755111659941306
MIR4436B_3P,SET,97,0.1367,0.0099101,0.087553,0.059227,MIR4436B_3P,0.755111659941306
HP_INSPIRATORY_STRIDOR,SET,14,0.36011,0.0099403,0.2307,0.059277,HP_INSPIRATORY_STRIDOR,0.75547199669967
SOBOLEV_T_CELL_PANDEMRIX_AGE...1,SET,23,0.27594,0.0097604,0.17681,0.059312,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,0.755640967741935
GOBP_RESPONSE_TO_FUNGICIDE,SET,7,0.4573,0.0089274,0.29309,0.059356,GOBP_RESPONSE_TO_FUNGICIDE,0.755708554987212
REACTOME_SUMOYLATION,SET,162,0.10398,0.0097245,0.066655,0.059385,REACTOME_SUMOYLATION,0.755708554987212
PID_INTEGRIN_A4B1_PATHWAY,SET,32,0.24153,0.010075,0.15485,0.059412,PID_INTEGRIN_A4B1_PATHWAY,0.755708554987212
GOBP_MULTI_MULTICELLULAR_ORG...,SET,191,0.10244,0.010394,0.06569,0.059447,GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS,0.755708554987212
MIR2117,SET,112,0.12565,0.0097835,0.080589,0.059496,MIR2117,0.755708554987212
GOBP_REGULATION_OF_TOLL_LIKE...4,SET,4,0.82398,0.012161,0.52851,0.059501,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.755708554987212
GATA3_01,SET,219,0.093658,0.010168,0.060076,0.059508,GATA3_01,0.755708554987212
GOCC_CAJAL_BODY,SET,56,0.15847,0.0087388,0.10165,0.059513,GOCC_CAJAL_BODY,0.755708554987212
HP_ABNORMALITY_OF_RENAL_EXCR...,SET,62,0.17902,0.010386,0.11484,0.059513,HP_ABNORMALITY_OF_RENAL_EXCRETION,0.755708554987212
CEBPZ_TARGET_GENES,SET,1238,0.03906,0.0097948,0.025061,0.059555,CEBPZ_TARGET_GENES,0.755965677501826
GOBP_REGULATION_OF_AMYLOID_B...,SET,16,0.33277,0.0098193,0.21361,0.059639,GOBP_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.756755547645126
GOBP_NEGATIVE_REGULATION_OF_...634,SET,21,0.32773,0.011078,0.21048,0.059731,GOBP_NEGATIVE_REGULATION_OF_TISSUE_REMODELING,0.757646315693431
GOBP_CELLULAR_RESPONSE_TO_PE...3,SET,5,0.57804,0.0095377,0.37127,0.059753,GOBP_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN,0.757648856256841
HOLLEMAN_DAUNORUBICIN_B_ALL_...2,SET,10,0.41576,0.0097003,0.26711,0.059806,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,0.758021792316057
HP_ABNORMAL_CENTRAL_SENSORY_...,SET,12,0.37722,0.0096406,0.2424,0.05984,HP_ABNORMAL_CENTRAL_SENSORY_FUNCTION,0.758021792316057
GSE15659_TREG_VS_TCONV_UP,SET,149,0.10843,0.0097286,0.069701,0.059899,GSE15659_TREG_VS_TCONV_UP,0.758021792316057
HP_ECTROPION_OF_LOWER_EYELIDS,SET,7,0.39409,0.0076935,0.25332,0.059901,HP_ECTROPION_OF_LOWER_EYELIDS,0.758021792316057
E2F5_TARGET_GENES,SET,1007,0.043388,0.0098786,0.027894,0.059926,E2F5_TARGET_GENES,0.758021792316057
GOBP_REGULATION_OF_SKELETAL_...1,SET,5,0.53176,0.0087741,0.34196,0.05998,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.758021792316057
REACTOME_REGULATION_OF_FOXO_...,SET,8,0.46976,0.0098037,0.30216,0.06002,REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,0.758021792316057
GSE12366_PLASMA_CELL_VS_MEMO...2,SET,168,0.10497,0.0099951,0.067523,0.060032,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.758021792316057
WP_PYRIMIDINE_METABOLISM,SET,75,0.14722,0.0093903,0.094709,0.060045,WP_PYRIMIDINE_METABOLISM,0.758021792316057
HALLMARK_GLYCOLYSIS,SET,182,0.099062,0.009814,0.063727,0.060045,HALLMARK_GLYCOLYSIS,0.758021792316057
SETD7_TARGET_GENES,SET,718,0.048258,0.0093548,0.031045,0.060046,SETD7_TARGET_GENES,0.758021792316057
GSE17721_CPG_VS_GARDIQUIMOD_...10,SET,186,0.096419,0.0096554,0.062035,0.060068,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP,0.758021792316057
HP_HYPOGLYCEMIA,SET,230,0.087255,0.0097046,0.056142,0.060079,HP_HYPOGLYCEMIA,0.758021792316057
GSE21670_UNTREATED_VS_IL6_TR...2,SET,168,0.098505,0.0093795,0.063385,0.060093,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP,0.758021792316057
REACTOME_MATURATION_OF_SPIKE...,SET,35,0.21873,0.0095411,0.14076,0.060111,REACTOME_MATURATION_OF_SPIKE_PROTEIN,0.758021792316057
CHENG_RESPONSE_TO_NICKEL_ACE...,SET,40,0.18557,0.0086523,0.11944,0.060137,CHENG_RESPONSE_TO_NICKEL_ACETATE,0.758021792316057
HP_ABNORMAL_THOUGHT_PATTERN,SET,63,0.16527,0.0096644,0.10638,0.060155,HP_ABNORMAL_THOUGHT_PATTERN,0.758021792316057
WP_MIRNA_REGULATION_OF_P53_P...,SET,24,0.26725,0.0096563,0.17205,0.060175,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,0.758021792316057
REACTOME_GABA_B_RECEPTOR_ACT...,SET,43,0.21933,0.010602,0.1413,0.060319,REACTOME_GABA_B_RECEPTOR_ACTIVATION,0.758811210640608
GOBP_NEGATIVE_REGULATION_OF_...636,SET,11,0.4193,0.01026,0.27014,0.060319,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.758811210640608
GSE9988_ANTI_TREM1_VS_VEHICL...2,SET,166,0.11272,0.010669,0.072618,0.060321,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP,0.758811210640608
MIR500A_3P,SET,71,0.16859,0.010464,0.10862,0.060325,MIR500A_3P,0.758811210640608
REACTOME_LGI_ADAM_INTERACTIO...,SET,14,0.35874,0.0099025,0.23116,0.060348,REACTOME_LGI_ADAM_INTERACTIONS,0.758825882778582
KEGG_MEDICUS_REFERENCE_RTK_P...,SET,53,0.20003,0.010732,0.12891,0.060373,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY,0.758865683544304
GSE37532_VISCERAL_ADIPOSE_TI...6,SET,112,0.13049,0.010161,0.08411,0.060404,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP,0.758980845986985
DYRK1A_TARGET_GENES,SET,599,0.055262,0.0098176,0.035637,0.060494,DYRK1A_TARGET_GENES,0.75983699674738
HP_DUODENAL_ATRESIA,SET,39,0.21663,0.0099737,0.13972,0.060519,HP_DUODENAL_ATRESIA,0.759876389089595
HP_ABNORMALITY_OF_THE_INCISOR,SET,93,0.13895,0.009864,0.08964,0.060572,HP_ABNORMALITY_OF_THE_INCISOR,0.759985191128741
GOBP_POLYAMINE_BIOSYNTHETIC_...,SET,12,0.32642,0.0083425,0.21061,0.060592,GOBP_POLYAMINE_BIOSYNTHETIC_PROCESS,0.759985191128741
HP_MALE_SEXUAL_DYSFUNCTION,SET,78,0.15483,0.01007,0.099904,0.060602,HP_MALE_SEXUAL_DYSFUNCTION,0.759985191128741
GOBP_TRANSCRIPTION_INITIATIO...1,SET,8,0.37199,0.0077632,0.24004,0.060621,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_III_PROMOTER,0.759985191128741
GOBP_RETINA_LAYER_FORMATION,SET,22,0.31603,0.010933,0.20395,0.060637,GOBP_RETINA_LAYER_FORMATION,0.759985191128741
OSWALD_HEMATOPOIETIC_STEM_CE...2,SET,208,0.095576,0.010115,0.061707,0.060718,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,0.76063728612509
GOCC_IMMUNOGLOBULIN_COMPLEX_...,SET,3,0.88521,0.011314,0.57179,0.060806,GOCC_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.76063728612509
CARRILLOREIXACH_MRS3_VS_LOWE...2,SET,38,0.20923,0.009509,0.13516,0.060812,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_UP,0.76063728612509
HP_PROTEIN_LOSING_ENTEROPATHY,SET,20,0.28468,0.0093906,0.18391,0.060833,HP_PROTEIN_LOSING_ENTEROPATHY,0.76063728612509
BIOCARTA_GSK3_PATHWAY,SET,19,0.3168,0.010186,0.20468,0.060844,BIOCARTA_GSK3_PATHWAY,0.76063728612509
GSE9960_GRAM_NEG_VS_GRAM_NEG...1,SET,167,0.095537,0.00907,0.061728,0.060855,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.76063728612509
KEGG_MEDICUS_VARIANT_MUTATIO...46,SET,7,0.61202,0.011948,0.39545,0.060864,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION,0.76063728612509
HOXC6_TARGET_GENES,SET,948,0.043531,0.0096328,0.028129,0.060877,HOXC6_TARGET_GENES,0.76063728612509
MIR6728_5P,SET,66,0.156,0.0093365,0.10081,0.060886,MIR6728_5P,0.76063728612509
HP_EXSTROPHY,SET,6,0.55232,0.009983,0.35703,0.060941,HP_EXSTROPHY,0.760929912060302
REACTOME_STIMULI_SENSING_CHA...,SET,99,0.14013,0.010262,0.090596,0.060975,REACTOME_STIMULI_SENSING_CHANNELS,0.760929912060302
GSE7831_1H_VS_4H_CPG_STIM_PD...1,SET,181,0.095471,0.0094325,0.061728,0.060983,GSE7831_1H_VS_4H_CPG_STIM_PDC_DN,0.760929912060302
CREIGHTON_AKT1_SIGNALING_VIA...1,SET,20,0.27517,0.0090769,0.17792,0.060997,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,0.760929912060302
GSE24210_RESTING_TREG_VS_TCO...1,SET,178,0.094455,0.0092552,0.061088,0.061034,GSE24210_RESTING_TREG_VS_TCONV_DN,0.76101981348637
GOMF_ENDOPEPTIDASE_ACTIVITY,SET,362,0.073199,0.010177,0.047344,0.061048,GOMF_ENDOPEPTIDASE_ACTIVITY,0.76101981348637
GOBP_REGULATION_OF_ENDOPLASM...3,SET,27,0.25671,0.009837,0.16608,0.061105,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.761285175564314
VERNELL_RETINOBLASTOMA_PATHW...1,SET,19,0.30354,0.0097595,0.19639,0.061115,VERNELL_RETINOBLASTOMA_PATHWAY_DN,0.761285175564314
GOMF_NUCLEOBASE_CONTAINING_C...1,SET,40,0.20775,0.0096865,0.13443,0.061135,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY,0.761285175564314
GOCC_ENDOPLASMIC_RETICULUM_L...,SET,284,0.082133,0.010136,0.053162,0.061188,GOCC_ENDOPLASMIC_RETICULUM_LUMEN,0.761350941302792
HP_KETOACIDOSIS,SET,35,0.23792,0.010378,0.15401,0.061196,HP_KETOACIDOSIS,0.761350941302792
GOMF_MITOGEN_ACTIVATED_PROTE...3,SET,16,0.30739,0.0090702,0.19898,0.061206,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING,0.761350941302792
YGTCCTTGR_UNKNOWN,SET,85,0.14037,0.0095287,0.090887,0.061252,YGTCCTTGR_UNKNOWN,0.761650540250447
GOBP_RESPONSE_TO_INSULIN,SET,251,0.08371,0.0097205,0.054208,0.061274,GOBP_RESPONSE_TO_INSULIN,0.761651598712446
ZIRN_TRETINOIN_RESPONSE_WT1_...1,SET,5,0.60668,0.01001,0.39299,0.06133,ZIRN_TRETINOIN_RESPONSE_WT1_DN,0.761781970021413
SAKAI_TUMOR_INFILTRATING_MON...1,SET,75,0.14174,0.0090403,0.091823,0.061354,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,0.761781970021413
GOMF_SINGLE_STRANDED_DNA_3_5...,SET,6,0.45104,0.0081524,0.29224,0.061377,GOMF_SINGLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,0.761781970021413
YTAATTAA_LHX3_01,SET,179,0.10816,0.010627,0.070079,0.061385,YTAATTAA_LHX3_01,0.761781970021413
HP_DISTAL_SENSORY_IMPAIRMENT,SET,117,0.11611,0.0092389,0.075238,0.061402,HP_DISTAL_SENSORY_IMPAIRMENT,0.761781970021413
FEV_TARGET_GENES,SET,1337,0.036967,0.0096056,0.023957,0.061416,FEV_TARGET_GENES,0.761781970021413
SCHAEFFER_SOX9_TARGETS_IN_PR...2,SET,19,0.33453,0.010756,0.21683,0.061448,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,0.76190697110239
ACTGCAG_MIR173P,SET,95,0.13496,0.0096827,0.087494,0.061488,ACTGCAG_MIR173P,0.761990710984714
GNF2_VAV1,SET,33,0.23954,0.010146,0.15533,0.061527,GNF2_VAV1,0.761990710984714
GOBP_COPII_COATED_VESICLE_BU...,SET,42,0.19426,0.0092805,0.12598,0.061556,GOBP_COPII_COATED_VESICLE_BUDDING,0.761990710984714
REACTOME_RHO_GTPASES_ACTIVAT...1,SET,19,0.29265,0.0094095,0.18984,0.061598,REACTOME_RHO_GTPASES_ACTIVATE_CIT,0.761990710984714
GOMF_UDP_GLUCOSYLTRANSFERASE...,SET,8,0.40132,0.0083754,0.26034,0.061605,GOMF_UDP_GLUCOSYLTRANSFERASE_ACTIVITY,0.761990710984714
GOBP_REPRODUCTIVE_SYSTEM_DEV...,SET,284,0.083147,0.010261,0.053941,0.061615,GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT,0.761990710984714
MIR509_3_5P,SET,140,0.11041,0.0096043,0.071638,0.061644,MIR509_3_5P,0.761990710984714
GOBP_GOLGI_TO_VACUOLE_TRANSP...,SET,20,0.2791,0.0092066,0.18109,0.061644,GOBP_GOLGI_TO_VACUOLE_TRANSPORT,0.761990710984714
REACTOME_SYNTHESIS_OF_PI,SET,5,0.58478,0.009649,0.37948,0.061669,REACTOME_SYNTHESIS_OF_PI,0.761990710984714
MIR4772_5P,SET,48,0.19548,0.0099821,0.12686,0.061674,MIR4772_5P,0.761990710984714
GSE8685_IL15_ACT_IL2_STARVED...2,SET,149,0.11107,0.0099655,0.0721,0.061723,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.761996011652542
HP_NEOPLASM_OF_THE_PITUITARY...,SET,64,0.15774,0.009297,0.10243,0.06179,HP_NEOPLASM_OF_THE_PITUITARY_GLAND,0.761996011652542
GOMF_OXIDOREDUCTASE_ACTIVITY...18,SET,2,0.92587,0.0096629,0.60132,0.061822,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS_CYTOCHROME_AS_ACCEPTOR,0.761996011652542
GOBP_DEVELOPMENTAL_INDUCTION,SET,30,0.25997,0.0105,0.16886,0.061839,GOBP_DEVELOPMENTAL_INDUCTION,0.761996011652542
GOBP_POSITIVE_REGULATION_OF_...782,SET,95,0.14491,0.010397,0.094124,0.061845,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.761996011652542
GSE22886_NAIVE_CD4_TCELL_VS_...5,SET,182,0.090914,0.0090067,0.059057,0.061859,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN,0.761996011652542
GOBP_PUTRESCINE_METABOLIC_PR...,SET,7,0.44987,0.0087825,0.29228,0.061886,GOBP_PUTRESCINE_METABOLIC_PROCESS,0.761996011652542
BIOCARTA_PLCE_PATHWAY,SET,11,0.44145,0.010802,0.28686,0.061922,BIOCARTA_PLCE_PATHWAY,0.761996011652542
MODULE_90,SET,3,0.59501,0.0076052,0.38666,0.061932,MODULE_90,0.761996011652542
WP_NAD_METABOLISM_SIRTUINS_A...,SET,11,0.42484,0.010396,0.27612,0.061964,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.761996011652542
GOBP_AMINO_ACID_BETAINE_BIOS...,SET,5,0.6607,0.010902,0.42946,0.061981,GOBP_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS,0.761996011652542
WP_GPR40_PATHWAY,SET,15,0.32935,0.0094099,0.21409,0.061986,WP_GPR40_PATHWAY,0.761996011652542
MIR548BA,SET,159,0.10569,0.0097924,0.068703,0.061996,MIR548BA,0.761996011652542
BASSO_CD40_SIGNALING_DN,SET,64,0.1701,0.010025,0.11058,0.062,BASSO_CD40_SIGNALING_DN,0.761996011652542
MIR1229_5P,SET,30,0.25996,0.0105,0.16901,0.062021,MIR1229_5P,0.761996011652542
GOCC_PRESYNAPTIC_ACTIVE_ZONE,SET,73,0.16183,0.010184,0.10523,0.062051,GOCC_PRESYNAPTIC_ACTIVE_ZONE,0.761996011652542
GOBP_BLOOD_VESSEL_MATURATION,SET,8,0.48874,0.0102,0.31783,0.062064,GOBP_BLOOD_VESSEL_MATURATION,0.761996011652542
GOBP_REGULATION_OF_B_CELL_ME...,SET,52,0.18244,0.0096954,0.11866,0.06209,GOBP_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.761996011652542
GOBP_L_METHIONINE_SALVAGE_FR...,SET,5,0.66887,0.011037,0.43503,0.062091,GOBP_L_METHIONINE_SALVAGE_FROM_METHYLTHIOADENOSINE,0.761996011652542
KEGG_MEDICUS_REFERENCE_FE3_F...,SET,5,0.63808,0.010529,0.41524,0.062196,KEGG_MEDICUS_REFERENCE_FE3_FERRITIN_TRANSPORT,0.762344434460888
GOBP_REGULATION_OF_SMAD_PROT...,SET,59,0.19121,0.010822,0.12443,0.062202,GOBP_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.762344434460888
REACTOME_FRUCTOSE_METABOLISM,SET,7,0.42913,0.0083776,0.27928,0.062207,REACTOME_FRUCTOSE_METABOLISM,0.762344434460888
MODULE_218,SET,18,0.34752,0.010876,0.22617,0.062211,MODULE_218,0.762344434460888
HOXA1_TARGET_GENES,SET,955,0.043431,0.0096442,0.02827,0.062242,HOXA1_TARGET_GENES,0.762344434460888
GOCC_SUPRAMOLECULAR_COMPLEX,SET,1253,0.03893,0.0098169,0.025341,0.062251,GOCC_SUPRAMOLECULAR_COMPLEX,0.762344434460888
GSE21033_1H_VS_24H_POLYIC_ST...1,SET,152,0.10476,0.0094926,0.068215,0.062306,GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN,0.762725397887324
MORF_JAK3,SET,90,0.13624,0.0095155,0.088722,0.062326,MORF_JAK3,0.762725397887324
WP_MET_IN_TYPE_1_PAPILLARY_R...,SET,53,0.17929,0.0096191,0.1168,0.062391,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,0.763252096092925
GSE40274_CTRL_VS_EOS_TRANSDU...1,SET,133,0.11792,0.0099998,0.076839,0.062448,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.763376166959578
GOMF_HISTONE_READER_ACTIVITY,SET,16,0.28897,0.0085268,0.18832,0.062467,GOMF_HISTONE_READER_ACTIVITY,0.763376166959578
GCM_FANCL,SET,21,0.24458,0.0082668,0.1594,0.062478,GCM_FANCL,0.763376166959578
GSE43955_1H_VS_60H_ACT_CD4_T...4,SET,185,0.092395,0.0092278,0.06022,0.062489,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.763376166959578
GSE23502_BM_VS_COLON_TUMOR_M...2,SET,184,0.1048,0.010439,0.068328,0.062547,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.763694430979979
CHEN_ETV5_TARGETS_SERTOLI,SET,24,0.29496,0.010657,0.19232,0.062559,CHEN_ETV5_TARGETS_SERTOLI,0.763694430979979
KEGG_MEDICUS_REFERENCE_DNA_E...,SET,13,0.35239,0.0093735,0.22981,0.062598,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING,0.763902208567416
GOBP_CERAMIDE_CATABOLIC_PROC...,SET,20,0.31566,0.010413,0.20595,0.062686,GOBP_CERAMIDE_CATABOLIC_PROCESS,0.764707592137592
GSE2706_UNSTIM_VS_8H_LPS_AND...2,SET,176,0.097257,0.0094765,0.063485,0.062774,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP,0.765512410526316
GOCC_ENDOLYSOSOME_LUMEN,SET,5,0.70968,0.01171,0.46334,0.062813,GOCC_ENDOLYSOSOME_LUMEN,0.765719331813399
HP_RENAL_DYSPLASIA,SET,62,0.16769,0.0097285,0.10956,0.062944,HP_RENAL_DYSPLASIA,0.766227926146307
GOBP_REGULATION_OF_MEIOTIC_C...2,SET,10,0.40088,0.0093531,0.26192,0.062949,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.766227926146307
GSE16450_CTRL_VS_IFNA_12H_ST...3,SET,188,0.090832,0.0091442,0.059347,0.062955,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.766227926146307
GSE36891_UNSTIM_VS_POLYIC_TL...2,SET,141,0.11877,0.010368,0.077604,0.062968,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,0.766227926146307
GSE13547_WT_VS_ZFX_KO_BCELL_...5,SET,164,0.099902,0.0093997,0.065284,0.062985,GSE13547_WT_VS_ZFX_KO_BCELL_DN,0.766227926146307
GSE8921_UNSTIM_0H_VS_TLR1_2_...8,SET,182,0.096547,0.0095648,0.063093,0.062987,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP,0.766227926146307
GOMF_LIGAND_GATED_CHANNEL_AC...,SET,177,0.1062,0.010377,0.069427,0.063063,GOMF_LIGAND_GATED_CHANNEL_ACTIVITY,0.766479462102689
REACTOME_ACTIVATION_OF_KAINA...,SET,29,0.25127,0.0099783,0.1643,0.063098,REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,0.766479462102689
HP_MEDIAN_CLEFT_PALATE,SET,24,0.28817,0.010412,0.18845,0.063124,HP_MEDIAN_CLEFT_PALATE,0.766479462102689
GOBP_GROWTH_HORMONE_RECEPTOR...,SET,10,0.52084,0.012152,0.34063,0.063134,GOBP_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.766479462102689
GSE40225_WT_VS_RIP_B7X_DIABE...2,SET,167,0.096601,0.009171,0.063177,0.063134,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP,0.766479462102689
GOBP_GENITALIA_MORPHOGENESIS,SET,11,0.45441,0.011119,0.2972,0.06314,GOBP_GENITALIA_MORPHOGENESIS,0.766479462102689
HP_NEOPLASM_OF_HEAD_AND_NECK,SET,35,0.23229,0.010133,0.15195,0.063166,HP_NEOPLASM_OF_HEAD_AND_NECK,0.766527349860335
MIR1539,SET,5,0.60199,0.009933,0.39394,0.063247,MIR1539,0.767242403141361
GOBP_SENSORY_PERCEPTION_OF_U...,SET,7,0.44602,0.0087074,0.29198,0.06332,GOBP_SENSORY_PERCEPTION_OF_UMAMI_TASTE,0.767859944173063
RSRFC4_Q2,SET,195,0.097039,0.0099473,0.063556,0.063413,RSRFC4_Q2,0.768719502964771
HP_BAND_KERATOPATHY,SET,14,0.40677,0.011228,0.26648,0.063458,HP_BAND_KERATOPATHY,0.768996788702929
HP_RHOMBENCEPHALOSYNAPSIS,SET,15,0.34153,0.0097579,0.2238,0.06351,HP_RHOMBENCEPHALOSYNAPSIS,0.769358678982224
WP_MAMMALIAN_DISORDER_OF_SEX...,SET,24,0.28335,0.010238,0.18573,0.063566,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,0.769768756097561
PARENT_MTOR_SIGNALING_UP,SET,504,0.056553,0.0092405,0.037081,0.06362,PARENT_MTOR_SIGNALING_UP,0.769770078233658
GOBP_5S_CLASS_RRNA_TRANSCRIP...,SET,6,0.42161,0.0076205,0.27647,0.063643,GOBP_5S_CLASS_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.769770078233658
GOCC_TRANSCRIPTION_FACTOR_TF...4,SET,6,0.42161,0.0076205,0.27647,0.063643,GOCC_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX,0.769770078233658
TCTATGA_MIR376A_MIR376B,SET,79,0.14574,0.0095396,0.095587,0.063674,TCTATGA_MIR376A_MIR376B,0.769770078233658
FARMER_BREAST_CANCER_CLUSTER...4,SET,18,0.33846,0.010592,0.22201,0.063694,FARMER_BREAST_CANCER_CLUSTER_4,0.769770078233658
GOBP_UDP_GLUCOSE_METABOLIC_P...,SET,6,0.41237,0.0074534,0.27049,0.063699,GOBP_UDP_GLUCOSE_METABOLIC_PROCESS,0.769770078233658
GOBP_ACTIN_FILAMENT_SEVERING,SET,16,0.31994,0.0094407,0.20989,0.063723,GOBP_ACTIN_FILAMENT_SEVERING,0.769792445255475
GREGORY_SYNTHETIC_LETHAL_WIT...,SET,128,0.11321,0.0094197,0.074324,0.063861,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,0.771191471507992
AR_01,SET,142,0.11001,0.0096372,0.072246,0.063923,AR_01,0.771228277835588
GSE15330_WT_VS_IKAROS_KO_GRA...1,SET,185,0.095942,0.0095821,0.063012,0.063937,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.771228277835588
DANG_REGULATED_BY_MYC_DN,SET,225,0.088149,0.0096983,0.057897,0.063947,DANG_REGULATED_BY_MYC_DN,0.771228277835588
HP_RECURRENT_HYPOGLYCEMIA,SET,21,0.29165,0.0098579,0.19156,0.063956,HP_RECURRENT_HYPOGLYCEMIA,0.771228277835588
SCIBETTA_KDM5B_TARGETS_UP,SET,18,0.29997,0.0093879,0.19705,0.063975,SCIBETTA_KDM5B_TARGETS_UP,0.771228277835588
REACTOME_LIGAND_RECEPTOR_INT...,SET,8,0.52207,0.010895,0.34301,0.064008,REACTOME_LIGAND_RECEPTOR_INTERACTIONS,0.77135854368932
GSE2128_C57BL6_VS_NOD_THYMOC...1,SET,176,0.094356,0.0091939,0.062015,0.064076,GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN,0.771910357019064
GOBP_POSITIVE_REGULATION_OF_...343,SET,20,0.31987,0.010552,0.21033,0.064164,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.772448208232446
GSE9601_UNTREATED_VS_PI3K_IN...1,SET,131,0.10944,0.0092114,0.071967,0.064175,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.772448208232446
GAO_STOMACH_24W_C6_PIT_CELL,SET,12,0.35763,0.00914,0.23519,0.064189,GAO_STOMACH_24W_C6_PIT_CELL,0.772448208232446
GSE15330_WT_VS_IKAROS_KO_MEG...1,SET,184,0.097006,0.0096624,0.063808,0.064229,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.772448208232446
MATZUK_SPERMATID_DIFFERENTIA...,SET,35,0.22834,0.00996,0.15021,0.064248,MATZUK_SPERMATID_DIFFERENTIATION,0.772448208232446
GNF2_FBL,SET,129,0.10717,0.008952,0.070506,0.064254,GNF2_FBL,0.772448208232446
HP_CENTRAL_DIABETES_INSIPIDUS,SET,20,0.30523,0.010069,0.20089,0.064344,HP_CENTRAL_DIABETES_INSIPIDUS,0.772969403859407
GSE32986_GMCSF_VS_GMCSF_AND_...4,SET,170,0.099732,0.0095522,0.06565,0.06437,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.772969403859407
GOBP_COLLATERAL_SPROUTING,SET,25,0.27635,0.01019,0.18193,0.064396,GOBP_COLLATERAL_SPROUTING,0.772969403859407
HP_DECREASED_CIRCULATING_IGE,SET,5,0.57025,0.0094092,0.37555,0.064465,HP_DECREASED_CIRCULATING_IGE,0.772969403859407
ZHONG_PFC_MAJOR_TYPES_ASTROC...,SET,298,0.080074,0.010118,0.052736,0.064466,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.772969403859407
ACACTCC_MIR122A,SET,68,0.14875,0.0090361,0.097969,0.064469,ACACTCC_MIR122A,0.772969403859407
HP_VAGINAL_ATRESIA,SET,18,0.34699,0.010859,0.22855,0.064487,HP_VAGINAL_ATRESIA,0.772969403859407
GSE26488_CTRL_VS_PEPTIDE_INJ...4,SET,148,0.10652,0.0095247,0.070175,0.064534,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP,0.772969403859407
KEGG_MEDICUS_REFERENCE_MODIF...2,SET,5,0.45612,0.007526,0.3005,0.064536,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_I_SUBUNITS,0.772969403859407
GOMF_OXIDOREDUCTASE_ACTIVITY...17,SET,10,0.4333,0.01011,0.28547,0.064536,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS,0.772969403859407
GOBP_HAIR_FOLLICLE_MATURATION,SET,15,0.36333,0.010381,0.23938,0.064542,GOBP_HAIR_FOLLICLE_MATURATION,0.772969403859407
GSE1432_6H_VS_24H_IFNG_MICRO...2,SET,178,0.096599,0.0094652,0.063698,0.064704,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.774531492460589
BLALOCK_ALZHEIMERS_DISEASE_UP,SET,1508,0.03415,0.0093766,0.022524,0.06475,BLALOCK_ALZHEIMERS_DISEASE_UP,0.774531492460589
CROMER_METASTASIS_UP,SET,58,0.17456,0.0097954,0.11515,0.064789,CROMER_METASTASIS_UP,0.774531492460589
MILI_PSEUDOPODIA_CHEMOTAXIS_...1,SET,419,0.061383,0.0091665,0.0405,0.064814,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,0.774531492460589
GSE4984_UNTREATED_VS_LPS_TRE...2,SET,144,0.10597,0.0093484,0.069923,0.064821,GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP,0.774531492460589
MIR1224_3P,SET,63,0.16339,0.0095545,0.10784,0.064884,MIR1224_3P,0.774531492460589
GOBP_REGULATION_OF_MEIOSIS_I,SET,5,0.52053,0.0085889,0.34365,0.064932,GOBP_REGULATION_OF_MEIOSIS_I,0.774531492460589
VERRECCHIA_DELAYED_RESPONSE_...,SET,36,0.22683,0.010035,0.14975,0.064933,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,0.774531492460589
GOMF_BIOACTIVE_LIPID_RECEPTO...,SET,13,0.36755,0.0097768,0.24266,0.064939,GOMF_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY,0.774531492460589
GOBP_SPINDLE_MIDZONE_ASSEMBLY,SET,13,0.34873,0.0092763,0.23026,0.064958,GOBP_SPINDLE_MIDZONE_ASSEMBLY,0.774531492460589
HOSHIDA_LIVER_CANCER_SUBCLAS...2,SET,108,0.12179,0.009313,0.080415,0.064964,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,0.774531492460589
GSE9316_CD4_TCELL_BALBC_VS_T...2,SET,178,0.097347,0.0095385,0.064279,0.064966,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP,0.774531492460589
GSE11961_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.097888,0.0095648,0.064638,0.064971,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN,0.774531492460589
GSE21927_SPLEEN_VS_BONE_MARR...2,SET,168,0.10128,0.0096438,0.066892,0.065012,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP,0.774531492460589
GSE37605_C57BL6_VS_NOD_FOXP3...4,SET,109,0.13059,0.010032,0.086257,0.065025,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP,0.774531492460589
HP_BLUE_IRIDES,SET,50,0.19104,0.0099562,0.12619,0.065029,HP_BLUE_IRIDES,0.774531492460589
HP_APLASIA_OF_THE_SEMICIRCUL...,SET,16,0.28899,0.0085273,0.19093,0.065081,HP_APLASIA_OF_THE_SEMICIRCULAR_CANAL,0.774885287769784
REACTOME_CONSTITUTIVE_SIGNAL...2,SET,25,0.24519,0.0090416,0.16203,0.065113,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,0.774886632443532
GOBP_REGULATION_OF_CARDIOBLA...,SET,5,0.67072,0.011067,0.44326,0.065129,GOBP_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION,0.774886632443532
HP_ABNORMALITY_OF_THE_FEMALE...,SET,504,0.058784,0.0096049,0.038852,0.065148,HP_ABNORMALITY_OF_THE_FEMALE_GENITALIA,0.774886632443532
GNF2_CDKN1C,SET,25,0.28637,0.01056,0.18936,0.065237,GNF2_CDKN1C,0.775679758809442
GOMF_TRANSITION_METAL_ION_BI...,SET,1007,0.042272,0.0096247,0.027964,0.065316,GOMF_TRANSITION_METAL_ION_BINDING,0.775973353262726
MORF_PRKACA,SET,109,0.12306,0.0094539,0.081411,0.065323,MORF_PRKACA,0.775973353262726
GOBP_ATF6_MEDIATED_UNFOLDED_...,SET,8,0.4066,0.0084856,0.26902,0.06535,GOBP_ATF6_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.775973353262726
KEGG_BETA_ALANINE_METABOLISM,SET,21,0.2939,0.009934,0.19445,0.065351,KEGG_BETA_ALANINE_METABOLISM,0.775973353262726
GOBP_POSITIVE_REGULATION_OF_...831,SET,7,0.54179,0.010577,0.35858,0.065414,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.776297837145783
MODULE_415,SET,11,0.39113,0.0095708,0.25888,0.065423,MODULE_415,0.776297837145783
WELCSH_BRCA1_TARGETS_UP,SET,180,0.094475,0.0093085,0.062544,0.065461,WELCSH_BRCA1_TARGETS_UP,0.77634499318569
TRAVAGLINI_LUNG_MACROPHAGE_C...,SET,189,0.10244,0.010339,0.067833,0.065517,TRAVAGLINI_LUNG_MACROPHAGE_CELL,0.77634499318569
KEGG_MEDICUS_REFERENCE_HEDGE...2,SET,6,0.578,0.010447,0.38278,0.065528,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION,0.77634499318569
GSE2128_C57BL6_VS_NOD_CD4CD8...2,SET,175,0.097942,0.0095164,0.064867,0.065546,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP,0.77634499318569
GOBP_CDP_CHOLINE_PATHWAY,SET,6,0.47499,0.0085853,0.3146,0.065549,GOBP_CDP_CHOLINE_PATHWAY,0.77634499318569
BANDRES_RESPONSE_TO_CARMUSTI...4,SET,18,0.29886,0.0093532,0.19795,0.065561,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,0.77634499318569
REACTOME_PKA_ACTIVATION_IN_G...,SET,17,0.34092,0.010369,0.22592,0.065659,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,0.776385354912915
LIAN_LIPA_TARGETS_3M,SET,52,0.19354,0.010285,0.12828,0.065695,LIAN_LIPA_TARGETS_3M,0.776385354912915
HP_PAINLESS_FRACTURES_DUE_TO...,SET,7,0.45289,0.0088415,0.30028,0.065753,HP_PAINLESS_FRACTURES_DUE_TO_INJURY,0.776385354912915
BOSCO_TH1_CYTOTOXIC_MODULE,SET,107,0.13659,0.010397,0.090578,0.065789,BOSCO_TH1_CYTOTOXIC_MODULE,0.776385354912915
GSE17974_0H_VS_4H_IN_VITRO_A...2,SET,168,0.10022,0.0095427,0.06646,0.065791,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP,0.776385354912915
HP_ABSENT_BRAINSTEM_AUDITORY...,SET,9,0.44021,0.009744,0.29195,0.065807,HP_ABSENT_BRAINSTEM_AUDITORY_RESPONSES,0.776385354912915
HP_ABNORMALITY_OF_THE_EPIPHY...3,SET,5,0.60926,0.010053,0.40412,0.065835,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.776385354912915
ZHANG_TARGETS_OF_EWSR1_FLI1_...,SET,83,0.15695,0.010529,0.10411,0.065856,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,0.776385354912915
GOBP_RESPONSE_TO_HYPEROXIA,SET,17,0.31569,0.0096016,0.20947,0.065901,GOBP_RESPONSE_TO_HYPEROXIA,0.776385354912915
JONES_OVARY_NK_CELL,SET,79,0.15527,0.010163,0.10305,0.065944,JONES_OVARY_NK_CELL,0.776385354912915
HP_ABDOMINAL_SITUS_INVERSUS,SET,12,0.3701,0.0094588,0.24566,0.06597,HP_ABDOMINAL_SITUS_INVERSUS,0.776385354912915
HOUNKPE_HOUSEKEEPING_GENES,SET,1052,0.037849,0.0087967,0.025124,0.065979,HOUNKPE_HOUSEKEEPING_GENES,0.776385354912915
GOBP_TISSUE_MIGRATION,SET,294,0.079674,0.010001,0.05291,0.066062,GOBP_TISSUE_MIGRATION,0.776385354912915
GTGACGY_E4F1_Q6,SET,589,0.053778,0.0094764,0.035714,0.06607,GTGACGY_E4F1_Q6,0.776385354912915
HP_OCULAR_PAIN,SET,20,0.30103,0.0099301,0.19994,0.066092,HP_OCULAR_PAIN,0.776385354912915
HP_EPISTAXIS,SET,96,0.14018,0.01011,0.093113,0.066111,HP_EPISTAXIS,0.776385354912915
MONNIER_POSTRADIATION_TUMOR_...1,SET,335,0.070218,0.009398,0.046643,0.066116,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,0.776385354912915
OCONNOR_PBMC_MENVEO_ACWYVAX_...2,SET,125,0.10902,0.0089644,0.072438,0.066178,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP,0.776385354912915
GSE29614_CTRL_VS_DAY3_TIV_FL...1,SET,138,0.11484,0.0099186,0.076326,0.066227,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN,0.776385354912915
HP_ABNORMAL_METACARPOPHALANG...,SET,19,0.32492,0.010447,0.21598,0.06625,HP_ABNORMAL_METACARPOPHALANGEAL_JOINT_MORPHOLOGY,0.776385354912915
HP_EMG_IMPAIRED_NEUROMUSCULA...,SET,34,0.21753,0.0093522,0.1446,0.066258,HP_EMG_IMPAIRED_NEUROMUSCULAR_TRANSMISSION,0.776385354912915
REACTOME_INFLUENZA_INFECTION,SET,145,0.10195,0.0090242,0.067775,0.066271,REACTOME_INFLUENZA_INFECTION,0.776385354912915
GOBP_NUCLEOSIDE_DIPHOSPHATE_...1,SET,13,0.35849,0.0095359,0.23835,0.066291,GOBP_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.776385354912915
HP_PAPILLARY_RENAL_CELL_CARC...,SET,8,0.52032,0.010859,0.34599,0.066318,HP_PAPILLARY_RENAL_CELL_CARCINOMA,0.776385354912915
KYNG_WERNER_SYNDROM_AND_NORM...2,SET,74,0.14176,0.008982,0.094295,0.066375,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,0.776385354912915
GOBP_VASCULAR_ENDOTHELIAL_GR...4,SET,40,0.22136,0.010321,0.14725,0.066388,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.776385354912915
BIOCARTA_BLYMPHOCYTE_PATHWAY,SET,10,0.47716,0.011133,0.31742,0.066394,BIOCARTA_BLYMPHOCYTE_PATHWAY,0.776385354912915
GOBP_CAMP_PKA_SIGNAL_TRANSDU...,SET,5,0.62508,0.010314,0.41582,0.066397,GOBP_CAMP_PKA_SIGNAL_TRANSDUCTION,0.776385354912915
GOBP_ACTIN_MODIFICATION,SET,4,0.84895,0.012529,0.56477,0.066403,GOBP_ACTIN_MODIFICATION,0.776385354912915
GSE13547_2H_VS_12_H_ANTI_IGM...2,SET,166,0.10084,0.0095452,0.067091,0.066421,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP,0.776385354912915
GOBP_NEGATIVE_REGULATION_OF_...68,SET,4,0.63787,0.0094142,0.42441,0.066434,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.776385354912915
REACTOME_PROSTACYCLIN_SIGNAL...,SET,19,0.31933,0.010267,0.21248,0.066445,REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,0.776385354912915
GSE19941_UNSTIM_VS_LPS_AND_I...4,SET,157,0.10279,0.0094644,0.0684,0.066458,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.776385354912915
GOBP_TRANS_SYNAPTIC_SIGNALIN...3,SET,7,0.54151,0.010572,0.36035,0.066459,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_TRANS_SYNAPTIC_COMPLEX,0.776385354912915
GOBP_RESPONSE_TO_L_LEUCINE,SET,14,0.34749,0.009592,0.23124,0.06646,GOBP_RESPONSE_TO_L_LEUCINE,0.776385354912915
GSE40666_WT_VS_STAT1_KO_CD8_...2,SET,181,0.096752,0.009559,0.064386,0.066467,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP,0.776385354912915
REACTOME_GLUCAGON_TYPE_LIGAN...,SET,33,0.23976,0.010155,0.15957,0.066494,REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,0.776385354912915
REACTOME_HOMOLOGY_DIRECTED_R...,SET,96,0.12023,0.0086712,0.080026,0.066504,REACTOME_HOMOLOGY_DIRECTED_REPAIR,0.776385354912915
HP_LEIOMYOSARCOMA,SET,28,0.25124,0.0098039,0.16726,0.066543,HP_LEIOMYOSARCOMA,0.776385354912915
MIR7843_5P,SET,86,0.13868,0.0094689,0.092337,0.066576,MIR7843_5P,0.776385354912915
MCCOLLUM_GELDANAMYCIN_RESIST...2,SET,9,0.46294,0.010247,0.30825,0.066577,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,0.776385354912915
GOBP_VITAMIN_TRANSPORT,SET,48,0.19298,0.0098543,0.12851,0.066596,GOBP_VITAMIN_TRANSPORT,0.776385354912915
HP_PERSISTENCE_OF_PRIMARY_TE...,SET,22,0.2657,0.0091919,0.17696,0.066631,HP_PERSISTENCE_OF_PRIMARY_TEETH,0.776385354912915
REACTOME_SARS_COV_2_INFECTION,SET,268,0.078098,0.0093665,0.052019,0.066642,REACTOME_SARS_COV_2_INFECTION,0.776385354912915
MIR4646_3P,SET,54,0.17971,0.0097316,0.11973,0.066688,MIR4646_3P,0.776385354912915
GSE20198_UNTREATED_VS_IL12_I...2,SET,183,0.096926,0.0096284,0.064584,0.066717,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.776385354912915
E2F1_Q4,SET,222,0.086629,0.0094681,0.057726,0.066724,E2F1_Q4,0.776385354912915
HP_ABNORMAL_INTERNAL_GENITAL...,SET,467,0.060683,0.0095542,0.040439,0.066735,HP_ABNORMAL_INTERNAL_GENITALIA,0.776385354912915
WP_SELENIUM_METABOLISM_AND_S...,SET,34,0.22918,0.0098533,0.15273,0.066745,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.776385354912915
REACTOME_G_BETA_GAMMA_SIGNAL...1,SET,19,0.30538,0.0098189,0.20355,0.066777,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42,0.776385354912915
CREBL2_TARGET_GENES,SET,7,0.54213,0.010584,0.3614,0.066802,CREBL2_TARGET_GENES,0.776385354912915
GOMF_ISOPRENOID_BINDING,SET,42,0.23433,0.011195,0.15621,0.066807,GOMF_ISOPRENOID_BINDING,0.776385354912915
DESCARTES_MAIN_FETAL_RETINAL...1,SET,106,0.13088,0.0099159,0.08725,0.066808,DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS,0.776385354912915
WP_ENERGY_METABOLISM,SET,47,0.18518,0.0093575,0.12346,0.066818,WP_ENERGY_METABOLISM,0.776385354912915
GCM_NPM1,SET,104,0.11614,0.008716,0.07744,0.066855,GCM_NPM1,0.776385354912915
HP_ABNORMAL_MORPHOLOGY_OF_TH...8,SET,31,0.24057,0.0098769,0.16044,0.066885,HP_ABNORMAL_MORPHOLOGY_OF_THE_OLFACTORY_BULB,0.776385354912915
HP_NAEVUS_FLAMMEUS_OF_THE_EY...,SET,7,0.51371,0.010029,0.34264,0.06691,HP_NAEVUS_FLAMMEUS_OF_THE_EYELID,0.776385354912915
GSE10239_NAIVE_VS_KLRG1HIGH_...2,SET,187,0.091822,0.0092195,0.061258,0.066954,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.776385354912915
WP_DEVELOPMENT_OF_URETERIC_C...,SET,57,0.18889,0.010508,0.12602,0.066959,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,0.776385354912915
GAO_LARGE_INTESTINE_24W_C6_S...,SET,12,0.38314,0.009792,0.25567,0.067005,GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR,0.776385354912915
WP_G1_TO_S_CELL_CYCLE_CONTROL,SET,64,0.15179,0.0089463,0.10129,0.067006,WP_G1_TO_S_CELL_CYCLE_CONTROL,0.776385354912915
GOBP_REGULATION_OF_VASCULAR_...6,SET,9,0.41027,0.0090813,0.2738,0.067022,GOBP_REGULATION_OF_VASCULAR_WOUND_HEALING,0.776385354912915
GOBP_VESICLE_MEDIATED_TRANSP...4,SET,138,0.10788,0.0093176,0.071996,0.067024,GOBP_VESICLE_MEDIATED_TRANSPORT_TO_THE_PLASMA_MEMBRANE,0.776385354912915
REACTOME_TRANSCRIPTIONAL_REG...7,SET,45,0.18328,0.0090627,0.12233,0.067043,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,0.776385354912915
CHEOK_RESPONSE_TO_MERCAPTOPU...3,SET,17,0.33918,0.010316,0.22648,0.067125,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,0.776385354912915
KRAS.LUNG_UP.V1_DN,SET,128,0.11704,0.0097386,0.078164,0.067153,KRAS.LUNG_UP.V1_DN,0.776385354912915
MORF_BUB1B,SET,56,0.16754,0.0092385,0.11189,0.067156,MORF_BUB1B,0.776385354912915
HP_MOTOR_NEURON_ATROPHY,SET,61,0.16,0.0092071,0.10688,0.067209,HP_MOTOR_NEURON_ATROPHY,0.776385354912915
NAKAYA_PBMC_FLUMIST_AGE_18_5...2,SET,30,0.22709,0.0091719,0.1517,0.067217,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,0.776385354912915
KANG_DOXORUBICIN_RESISTANCE_...2,SET,49,0.17759,0.0091624,0.11865,0.067236,KANG_DOXORUBICIN_RESISTANCE_UP,0.776385354912915
MIR6760_5P,SET,105,0.12408,0.0093563,0.082902,0.067248,MIR6760_5P,0.776385354912915
GSE26928_EFF_MEMORY_VS_CXCR5...2,SET,163,0.099452,0.009329,0.066459,0.067277,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.776385354912915
GSE9988_LOW_LPS_VS_ANTI_TREM...1,SET,171,0.10047,0.0096509,0.067141,0.067281,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.776385354912915
GOBP_REGULATION_OF_B_CELL_RE...,SET,21,0.28229,0.0095417,0.18867,0.067304,GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.776385354912915
MIR7157_5P,SET,194,0.094445,0.0096569,0.063133,0.067339,MIR7157_5P,0.776385354912915
HALLMARK_HYPOXIA,SET,178,0.10098,0.0098946,0.067511,0.067364,HALLMARK_HYPOXIA,0.776385354912915
GOBP_POSITIVE_REGULATION_OF_...29,SET,33,0.24266,0.010278,0.16223,0.067369,GOBP_POSITIVE_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.776385354912915
GNF2_BUB1B,SET,49,0.16849,0.0086925,0.11266,0.067397,GNF2_BUB1B,0.776385354912915
HP_MOTOR_DETERIORATION,SET,27,0.24026,0.0092069,0.16066,0.067406,HP_MOTOR_DETERIORATION,0.776385354912915
GOBP_MICROTUBULE_NUCLEATION_...,SET,5,0.57583,0.0095013,0.38512,0.067441,GOBP_MICROTUBULE_NUCLEATION_BY_MICROTUBULE_ORGANIZING_CENTER,0.776385354912915
GOBP_NEUROMUSCULAR_PROCESS,SET,153,0.10643,0.0096754,0.071209,0.06751,GOBP_NEUROMUSCULAR_PROCESS,0.776385354912915
GOBP_OXYGEN_TRANSPORT,SET,11,0.46925,0.011482,0.31397,0.067525,GOBP_OXYGEN_TRANSPORT,0.776385354912915
ZHONG_PFC_C2_UNKNOWN_NPC,SET,72,0.13888,0.0086797,0.092923,0.067528,ZHONG_PFC_C2_UNKNOWN_NPC,0.776385354912915
GIAROLA_SILVA_BLOOD_INFLUENZ...,SET,4,0.70492,0.010404,0.47172,0.06755,GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE_21_51YO_3DY_UP,0.776385354912915
GOBP_NEGATIVE_REGULATION_OF_...696,SET,88,0.14548,0.010047,0.097351,0.067552,GOBP_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.776385354912915
HP_ABNORMAL_FETAL_CENTRAL_NE...,SET,5,0.51319,0.0084678,0.34343,0.067557,HP_ABNORMAL_FETAL_CENTRAL_NERVOUS_SYSTEM_MORPHOLOGY,0.776385354912915
GSE46242_CTRL_VS_EGR2_DELETE...1,SET,167,0.10261,0.0097413,0.06868,0.067598,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN,0.776385354912915
GSE8515_IL1_VS_IL6_4H_STIM_M...1,SET,172,0.097642,0.0094063,0.06536,0.067609,GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN,0.776385354912915
GOBP_REGULATION_OF_TOLERANCE...,SET,17,0.33912,0.010314,0.22703,0.067631,GOBP_REGULATION_OF_TOLERANCE_INDUCTION,0.776385354912915
GOBP_EYE_MORPHOGENESIS,SET,155,0.11056,0.010115,0.074022,0.067648,GOBP_EYE_MORPHOGENESIS,0.776385354912915
HP_NONPROGRESSIVE,SET,18,0.29132,0.0091171,0.19505,0.067658,HP_NONPROGRESSIVE,0.776385354912915
GOBP_POSITIVE_REGULATION_OF_...221,SET,40,0.19748,0.0092077,0.13225,0.067694,GOBP_POSITIVE_REGULATION_OF_DNA_REPLICATION,0.776385354912915
MIR5002_5P,SET,233,0.086288,0.0096587,0.057797,0.067733,MIR5002_5P,0.776385354912915
HP_ABNORMALITY_OF_FIBRINOLYS...,SET,4,0.502,0.0074088,0.33625,0.067735,HP_ABNORMALITY_OF_FIBRINOLYSIS,0.776385354912915
HP_INCREASED_MEAN_CORPUSCULA...,SET,11,0.34024,0.0083256,0.22793,0.067761,HP_INCREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.776385354912915
GOCC_DENDRITE_TERMINUS,SET,11,0.36584,0.0089521,0.24509,0.067767,GOCC_DENDRITE_TERMINUS,0.776385354912915
HP_ABNORMAL_NUMBER_OF_INCISO...,SET,51,0.18316,0.0096401,0.12273,0.067808,HP_ABNORMAL_NUMBER_OF_INCISORS,0.776385354912915
MIR18A_5P_MIR18B_5P,SET,117,0.11628,0.0092528,0.077917,0.067811,MIR18A_5P_MIR18B_5P,0.776385354912915
HP_ABNORMALITY_OF_BLOOD_AND_...,SET,1317,0.036219,0.0093461,0.024276,0.067864,HP_ABNORMALITY_OF_BLOOD_AND_BLOOD_FORMING_TISSUES,0.776385354912915
MODULE_6,SET,381,0.070139,0.0099984,0.047013,0.067872,MODULE_6,0.776385354912915
MIR1226_3P,SET,99,0.1272,0.0093156,0.08527,0.067887,MIR1226_3P,0.776385354912915
GOBP_NEGATIVE_REGULATION_OF_...58,SET,13,0.42188,0.011222,0.28281,0.067891,GOBP_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.776385354912915
TRAVAGLINI_LUNG_BRONCHIAL_VE...2,SET,243,0.085838,0.0098096,0.057543,0.067897,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL,0.776385354912915
HP_ARTHRALGIA,SET,178,0.09972,0.0097711,0.066851,0.067901,HP_ARTHRALGIA,0.776385354912915
GSE25123_IL4_VS_IL4_AND_ROSI...3,SET,170,0.10235,0.0098026,0.068623,0.067933,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,0.776385354912915
MATZUK_SPERMATOCYTE,SET,67,0.14396,0.0086806,0.096539,0.067963,MATZUK_SPERMATOCYTE,0.776385354912915
GOBP_CIRCULATORY_SYSTEM_DEVE...,SET,1046,0.042348,0.0098158,0.028399,0.067964,GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT,0.776385354912915
REACTOME_FORMATION_OF_THE_UR...,SET,19,0.33892,0.010897,0.22729,0.067977,REACTOME_FORMATION_OF_THE_URETERIC_BUD,0.776385354912915
SP3_Q3,SET,211,0.088936,0.0094792,0.059657,0.06802,SP3_Q3,0.776621254927727
CAO_BLOOD_FLUMIST_AGE_05_14Y...6,SET,7,0.44067,0.0086029,0.29573,0.068103,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_UP,0.777069770190414
GSE20366_EX_VIVO_VS_DEC205_C...3,SET,181,0.094063,0.0092933,0.063124,0.068104,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP,0.777069770190414
GSE32034_LY6C_HIGH_VS_LOW_RO...1,SET,182,0.097043,0.0096139,0.065144,0.068164,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN,0.777494891732283
MORF_DNMT1,SET,104,0.11627,0.0087258,0.078058,0.068186,MORF_DNMT1,0.777494891732283
VAN_DEN_BIGGELAAR_PBMC_PREVN...2,SET,4,0.66329,0.0097892,0.44546,0.068255,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_DN,0.777930850819672
HP_2_3_FINGER_SYNDACTYLY,SET,9,0.43857,0.0097077,0.29456,0.068269,HP_2_3_FINGER_SYNDACTYLY,0.777930850819672
MIR4733_5P,SET,83,0.14317,0.0096042,0.096176,0.068307,MIR4733_5P,0.778108746312684
GOBP_NUCLEOTIDE_BINDING_DOMA...,SET,26,0.26971,0.010142,0.18124,0.068363,GOBP_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.778196458197257
MIR1251_3P,SET,140,0.1117,0.009717,0.075075,0.068399,MIR1251_3P,0.778196458197257
HP_HYPOTHALAMIC_HYPOTHYROIDI...,SET,12,0.36026,0.0092072,0.24214,0.068406,HP_HYPOTHALAMIC_HYPOTHYROIDISM,0.778196458197257
BOSCO_EPITHELIAL_DIFFERENTIA...,SET,60,0.17578,0.010032,0.11818,0.068461,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,0.778196458197257
GSE39152_SPLEEN_CD103_NEG_VS...1,SET,188,0.093617,0.0094246,0.062946,0.068482,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN,0.778196458197257
GSE32986_GMCSF_VS_GMCSF_AND_...2,SET,182,0.094104,0.0093228,0.063275,0.068486,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.778196458197257
GOCC_NUCLEAR_OUTER_MEMBRANE,SET,26,0.2357,0.0088634,0.15849,0.0685,GOCC_NUCLEAR_OUTER_MEMBRANE,0.778196458197257
GSE14308_TH17_VS_INDUCED_TRE...2,SET,178,0.090999,0.0089165,0.061193,0.068504,GSE14308_TH17_VS_INDUCED_TREG_UP,0.778196458197257
GOMF_NARROW_PORE_CHANNEL_ACT...,SET,19,0.31369,0.010086,0.21096,0.06852,GOMF_NARROW_PORE_CHANNEL_ACTIVITY,0.778196458197257
KAYO_AGING_MUSCLE_DN,SET,106,0.11441,0.0086682,0.076952,0.068546,KAYO_AGING_MUSCLE_DN,0.778196458197257
FAN_EMBRYONIC_CTX_IN_5_INTER...,SET,5,0.6824,0.01126,0.45902,0.068561,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.778196458197257
GOBP_PHOSPHATIDYLINOSITOL_AC...,SET,6,0.60362,0.01091,0.40636,0.068723,GOBP_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING,0.77978056317336
GOBP_DNA_REPLICATION,SET,260,0.076958,0.009093,0.051821,0.068772,GOBP_DNA_REPLICATION,0.780081873368146
HP_ALZHEIMER_DISEASE,SET,8,0.51309,0.010708,0.34558,0.068819,HP_ALZHEIMER_DISEASE,0.780259382132377
E2F_Q6_01,SET,206,0.086582,0.0091196,0.05832,0.068833,E2F_Q6_01,0.780259382132377
GOMF_FRIZZLED_BINDING,SET,35,0.2251,0.009819,0.15164,0.068855,GOMF_FRIZZLED_BINDING,0.780259382132377
REACTOME_CDH11_HOMOTYPIC_AND...,SET,7,0.51077,0.0099713,0.34424,0.068945,REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS,0.78102460071708
WP_CELL_LINEAGE_MAP_FOR_NEUR...,SET,122,0.1234,0.010025,0.08319,0.069003,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.781138989257812
GSE34156_UNTREATED_VS_24H_TL...1,SET,160,0.095008,0.0088304,0.064053,0.06901,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.781138989257812
GNATENKO_PLATELET_SIGNATURE,SET,34,0.22022,0.0094682,0.14849,0.06903,GNATENKO_PLATELET_SIGNATURE,0.781138989257812
MIR8055,SET,64,0.15979,0.0094177,0.10775,0.069045,MIR8055,0.781138989257812
GOBP_NEGATIVE_REGULATION_OF_...39,SET,7,0.4826,0.0094213,0.32554,0.069118,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.781710410022779
GOBP_RESPONSE_TO_LIPID,SET,853,0.046486,0.0097843,0.031366,0.069174,GOBP_RESPONSE_TO_LIPID,0.78208925504229
MIR6738_3P,SET,137,0.10544,0.0090743,0.071166,0.069227,MIR6738_3P,0.782433946341463
HNF3ALPHA_Q6,SET,184,0.095312,0.0094936,0.064352,0.069297,HNF3ALPHA_Q6,0.782613157638664
GOBP_TOLL_LIKE_RECEPTOR_4_SI...,SET,56,0.16762,0.0092434,0.11318,0.069309,GOBP_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.782613157638664
GOBP_ADAPTIVE_IMMUNE_MEMORY_...,SET,5,0.66999,0.011055,0.45247,0.069345,GOBP_ADAPTIVE_IMMUNE_MEMORY_RESPONSE,0.782613157638664
BIOCARTA_EFP_PATHWAY,SET,16,0.30121,0.0088881,0.20345,0.069373,BIOCARTA_EFP_PATHWAY,0.782613157638664
GOMF_NADPLUS_NUCLEOTIDASE_CY...,SET,14,0.4496,0.01241,0.30369,0.069387,GOMF_NADPLUS_NUCLEOTIDASE_CYCLIC_ADP_RIBOSE_GENERATING,0.782613157638664
SENGUPTA_NASOPHARYNGEAL_CARC...2,SET,285,0.07821,0.0096684,0.052839,0.069422,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,0.782613157638664
GOBP_EPIDERMAL_CELL_DIFFEREN...,SET,225,0.096398,0.010606,0.065126,0.069422,GOBP_EPIDERMAL_CELL_DIFFERENTIATION,0.782613157638664
WANG_RESPONSE_TO_BEXAROTENE_...2,SET,31,0.21435,0.0088002,0.14481,0.069423,WANG_RESPONSE_TO_BEXAROTENE_UP,0.782613157638664
HP_ABNORMAL_SEMICIRCULAR_CAN...,SET,21,0.25211,0.0085214,0.17043,0.069549,HP_ABNORMAL_SEMICIRCULAR_CANAL_MORPHOLOGY,0.783636870748299
GU_PDEF_TARGETS_UP,SET,68,0.17238,0.010471,0.11654,0.069568,GU_PDEF_TARGETS_UP,0.783636870748299
GOBP_PYRIMIDINE_RIBONUCLEOTI...1,SET,21,0.27249,0.0092102,0.18425,0.06959,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.783636870748299
GOBP_RESPONSE_TO_GLYCOPROTEIN,SET,11,0.42484,0.010396,0.28728,0.069604,GOBP_RESPONSE_TO_GLYCOPROTEIN,0.783636870748299
GSE32986_CURDLAN_LOWDOSE_VS_...2,SET,175,0.094108,0.0091439,0.063652,0.069647,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,0.783681497740478
GSE18281_PERIMEDULLARY_CORTI...2,SET,186,0.091105,0.0091233,0.061627,0.06967,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.783681497740478
HP_ORAL_CAVITY_BLEEDING,SET,19,0.31848,0.01024,0.21546,0.06969,HP_ORAL_CAVITY_BLEEDING,0.783681497740478
HP_ABNORMAL_SPINAL_CORD_PHYS...,SET,7,0.4813,0.0093961,0.32569,0.069742,HP_ABNORMAL_SPINAL_CORD_PHYSIOLOGY,0.783681497740478
GOBP_MEMBRANE_FUSION,SET,166,0.098155,0.0092909,0.066429,0.069766,GOBP_MEMBRANE_FUSION,0.783681497740478
GOBP_GALACTOSE_METABOLIC_PRO...,SET,9,0.44499,0.0098498,0.30117,0.069772,GOBP_GALACTOSE_METABOLIC_PROCESS,0.783681497740478
GOBP_POSITIVE_REGULATION_OF_...770,SET,17,0.30149,0.0091698,0.2041,0.069823,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.783681497740478
HP_POOR_MOTOR_COORDINATION,SET,77,0.14332,0.009262,0.097025,0.069827,HP_POOR_MOTOR_COORDINATION,0.783681497740478
GSE37301_MULTIPOTENT_PROGENI...12,SET,182,0.092223,0.0091364,0.062436,0.069835,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.783681497740478
GSE12505_WT_VS_E2_2_HET_PDC_...1,SET,142,0.10479,0.0091801,0.070951,0.069852,GSE12505_WT_VS_E2_2_HET_PDC_DN,0.783681497740478
GOMF_SODIUM_ION_BINDING,SET,8,0.43232,0.0090224,0.29272,0.069856,GOMF_SODIUM_ION_BINDING,0.783681497740478
GSE36476_CTRL_VS_TSST_ACT_40...3,SET,181,0.088186,0.0087127,0.059744,0.069973,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN,0.784378796326136
KASLER_HDAC7_TARGETS_1_DN,SET,16,0.34368,0.010141,0.23287,0.069999,KASLER_HDAC7_TARGETS_1_DN,0.784378796326136
GOBP_DNA_DEAMINATION,SET,11,0.49644,0.012148,0.3364,0.070017,GOBP_DNA_DEAMINATION,0.784378796326136
HOWARD_B_CELL_INACT_MONOV_IN...,SET,14,0.32807,0.0090559,0.22232,0.070021,HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.784378796326136
GOBP_POSITIVE_REGULATION_OF_...380,SET,9,0.41364,0.0091559,0.28031,0.070031,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.784378796326136
GOBP_DEVELOPMENTAL_MATURATION,SET,310,0.075094,0.009675,0.050902,0.07008,GOBP_DEVELOPMENTAL_MATURATION,0.784674742268041
GSE22103_UNSTIM_VS_GMCSF_AND...2,SET,185,0.088787,0.0088675,0.060208,0.07016,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.785317487922705
GOBP_INTERLEUKIN_10_PRODUCTI...,SET,51,0.19844,0.010444,0.13463,0.070252,GOBP_INTERLEUKIN_10_PRODUCTION,0.785972754905114
HP_NEOPLASM_OF_THE_ORAL_CAVI...,SET,63,0.1509,0.0088242,0.10239,0.07028,HP_NEOPLASM_OF_THE_ORAL_CAVITY,0.785972754905114
MIR4648,SET,37,0.19485,0.0087382,0.13222,0.070296,MIR4648,0.785972754905114
SAMOLS_TARGETS_OF_KHSV_MIRNA...1,SET,47,0.20208,0.010211,0.13714,0.070309,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,0.785972754905114
GOMF_CONNEXIN_BINDING,SET,5,0.64748,0.010683,0.43958,0.070394,GOMF_CONNEXIN_BINDING,0.786484088717454
KEGG_MEDICUS_REFERENCE_BCR_P...2,SET,7,0.49834,0.0097287,0.33834,0.0704,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY,0.786484088717454
GOBP_PURINE_RIBONUCLEOSIDE_S...,SET,6,0.5787,0.01046,0.39309,0.070495,GOBP_PURINE_RIBONUCLEOSIDE_SALVAGE,0.787292328084833
GAVISH_3CA_METAPROGRAM_CD8_T...6,SET,47,0.18022,0.0091066,0.12245,0.07055,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK,0.787382439063502
GSE5679_CTRL_VS_RARA_AGONIST...2,SET,179,0.089787,0.0088222,0.061012,0.070569,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.787382439063502
GOBP_LEUKOCYTE_ADHESION_TO_V...,SET,47,0.19822,0.010016,0.13472,0.070606,GOBP_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.787382439063502
GSE17721_POLYIC_VS_GARDIQUIM...4,SET,181,0.091494,0.0090395,0.062185,0.070613,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP,0.787382439063502
ZSCAN2_TARGET_GENES,SET,674,0.050381,0.0094742,0.034246,0.070633,ZSCAN2_TARGET_GENES,0.787382439063502
MIR4678,SET,100,0.12425,0.0091449,0.084461,0.070639,MIR4678,0.787382439063502
WANG_RESPONSE_TO_FORSKOLIN_DN,SET,9,0.37006,0.0081913,0.25171,0.070768,WANG_RESPONSE_TO_FORSKOLIN_DN,0.787827978655623
FREAC3_01,SET,232,0.086664,0.0096802,0.058955,0.070789,FREAC3_01,0.787827978655623
SP1_Q6_01,SET,229,0.081266,0.0090191,0.055287,0.070805,SP1_Q6_01,0.787827978655623
GOCC_EXOCYST,SET,16,0.31162,0.0091953,0.21207,0.070867,GOCC_EXOCYST,0.787827978655623
GOBP_POSITIVE_REGULATION_OF_...34,SET,7,0.52468,0.010243,0.35707,0.070871,GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.787827978655623
HP_SKIN_VESICLE,SET,24,0.23655,0.0085468,0.161,0.070897,HP_SKIN_VESICLE,0.787827978655623
MATZUK_SPERMATOGONIA,SET,25,0.26248,0.009679,0.17865,0.070898,MATZUK_SPERMATOGONIA,0.787827978655623
SEAVEY_EPITHELIOID_HEMANGIOE...,SET,87,0.14297,0.009818,0.09733,0.070943,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,0.787827978655623
GOMF_PHOSPHOLIPID_BINDING,SET,444,0.061089,0.0093844,0.0416,0.070995,GOMF_PHOSPHOLIPID_BINDING,0.787827978655623
GSE32901_TH1_VS_TH17_NEG_CD4...1,SET,104,0.12128,0.009102,0.082588,0.070995,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN,0.787827978655623
REACTOME_E2F_ENABLED_INHIBIT...,SET,9,0.40531,0.0089716,0.2761,0.071059,REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION,0.787827978655623
PID_NETRIN_PATHWAY,SET,32,0.22278,0.0092926,0.15176,0.071065,PID_NETRIN_PATHWAY,0.787827978655623
GOBP_NEPHRON_MORPHOGENESIS,SET,75,0.15727,0.010031,0.10714,0.071071,GOBP_NEPHRON_MORPHOGENESIS,0.787827978655623
REACTOME_THROMBOXANE_SIGNALL...,SET,24,0.27613,0.009977,0.18814,0.0711,REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,0.787827978655623
HP_CERVICAL_SPINAL_CORD_ATRO...,SET,5,0.58072,0.0095821,0.39567,0.071101,HP_CERVICAL_SPINAL_CORD_ATROPHY,0.787827978655623
GOBP_KIDNEY_MORPHOGENESIS,SET,92,0.14341,0.010126,0.097712,0.071103,GOBP_KIDNEY_MORPHOGENESIS,0.787827978655623
GOBP_BLOOD_VESSEL_ENDOTHELIA...2,SET,108,0.12583,0.0096221,0.085733,0.071106,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.787827978655623
GOBP_APICAL_JUNCTION_ASSEMBLY,SET,71,0.15749,0.0097745,0.10731,0.07112,GOBP_APICAL_JUNCTION_ASSEMBLY,0.787827978655623
GSE36891_POLYIC_TLR3_VS_PAM_...2,SET,140,0.11327,0.0098529,0.077181,0.071125,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.787827978655623
REACTOME_TP53_REGULATES_TRAN...2,SET,12,0.31398,0.0080245,0.21396,0.071134,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES,0.787827978655623
LI_WILMS_TUMOR_ANAPLASTIC_UP,SET,17,0.28489,0.0086649,0.19416,0.071155,LI_WILMS_TUMOR_ANAPLASTIC_UP,0.787827978655623
GOCC_PI_BODY,SET,9,0.41709,0.0092323,0.28435,0.071222,GOCC_PI_BODY,0.787905362826225
GOCC_ORIGIN_RECOGNITION_COMP...,SET,8,0.41275,0.008614,0.2814,0.071224,GOCC_ORIGIN_RECOGNITION_COMPLEX,0.787905362826225
HP_ACUTE_KIDNEY_INJURY,SET,34,0.21273,0.0091458,0.14503,0.07123,HP_ACUTE_KIDNEY_INJURY,0.787905362826225
GOBP_FLOOR_PLATE_DEVELOPMENT,SET,10,0.37748,0.0088072,0.25744,0.071294,GOBP_FLOOR_PLATE_DEVELOPMENT,0.78818901240458
GOBP_RESPONSE_TO_MUSCLE_STRE...,SET,24,0.25964,0.0093813,0.17708,0.071301,GOBP_RESPONSE_TO_MUSCLE_STRETCH,0.78818901240458
GSE36527_CD69_NEG_VS_POS_TRE...1,SET,185,0.088364,0.0088252,0.060311,0.071451,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN,0.789215700667302
MIR4698,SET,572,0.054987,0.0095531,0.037532,0.071461,MIR4698,0.789215700667302
GOBP_REGULATION_OF_SYNAPSE_P...,SET,6,0.56563,0.010224,0.38608,0.071462,GOBP_REGULATION_OF_SYNAPSE_PRUNING,0.789215700667302
GSE21063_WT_VS_NFATC1_KO_8H_...2,SET,179,0.088408,0.0086867,0.060381,0.071583,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP,0.789485406091371
DELYS_THYROID_CANCER_DN,SET,213,0.09321,0.0099812,0.063663,0.071589,DELYS_THYROID_CANCER_DN,0.789485406091371
WEBER_METHYLATED_HCP_IN_SPER...2,SET,16,0.29347,0.0086596,0.20045,0.071595,WEBER_METHYLATED_HCP_IN_SPERM_UP,0.789485406091371
REACTOME_RESOLUTION_OF_D_LOO...2,SET,25,0.23401,0.0086293,0.15984,0.071597,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA,0.789485406091371
MIR1287_5P,SET,58,0.15884,0.0089136,0.1085,0.0716,MIR1287_5P,0.789485406091371
MORF_GNB1,SET,272,0.072924,0.0088101,0.049827,0.071669,MORF_GNB1,0.789756135066582
GOMF_11_CIS_RETINAL_BINDING,SET,7,0.48466,0.0094616,0.33116,0.07167,GOMF_11_CIS_RETINAL_BINDING,0.789756135066582
GSE23114_PERITONEAL_CAVITY_B...2,SET,175,0.094332,0.0091657,0.064476,0.071733,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN,0.789815351377018
HP_HEMATOLOGICAL_NEOPLASM,SET,277,0.074469,0.0090777,0.050904,0.071751,HP_HEMATOLOGICAL_NEOPLASM,0.789815351377018
GOBP_NEGATIVE_REGULATION_OF_...499,SET,12,0.3723,0.0095148,0.25449,0.071757,GOBP_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.789815351377018
GSE46606_UNSTIM_VS_CD40L_IL2...14,SET,174,0.095765,0.0092785,0.065469,0.071778,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.789815351377018
GOBP_CELLULAR_METABOLIC_COMP...,SET,30,0.24688,0.0099713,0.16879,0.071789,GOBP_CELLULAR_METABOLIC_COMPOUND_SALVAGE,0.789815351377018
GSE22935_UNSTIM_VS_12H_MBOVI...1,SET,184,0.089354,0.0089002,0.061109,0.071851,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.790151241695666
KEGG_BASAL_CELL_CARCINOMA,SET,53,0.18002,0.0096581,0.12312,0.071865,KEGG_BASAL_CELL_CARCINOMA,0.790151241695666
HP_PARTIAL_ATRIOVENTRICULAR_...,SET,5,0.51884,0.008561,0.35501,0.071953,HP_PARTIAL_ATRIOVENTRICULAR_CANAL_DEFECT,0.79086860056926
HP_ABNORMAL_NASAL_BONE_MORPH...,SET,9,0.48448,0.010724,0.33158,0.072002,HP_ABNORMAL_NASAL_BONE_MORPHOLOGY,0.791098886607707
GUTIERREZ_CHRONIC_LYMPHOCYTI...1,SET,50,0.18051,0.0094073,0.12358,0.072055,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.791098886607707
GSE40274_CTRL_VS_EOS_TRANSDU...2,SET,158,0.098587,0.0091061,0.067495,0.072063,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.791098886607707
HP_ABNORMAL_NASAL_SKELETON_M...,SET,11,0.43755,0.010707,0.29956,0.072065,HP_ABNORMAL_NASAL_SKELETON_MORPHOLOGY,0.791098886607707
GOBP_GLYCOSYL_COMPOUND_METAB...,SET,75,0.15356,0.0097944,0.10518,0.072169,GOBP_GLYCOSYL_COMPOUND_METABOLIC_PROCESS,0.791990399431639
GOBP_OPSONIZATION,SET,15,0.38333,0.010952,0.26263,0.07221,GOBP_OPSONIZATION,0.792190198863636
HSF2_01,SET,229,0.084339,0.0093601,0.057795,0.072253,HSF2_01,0.792249544164038
GSE24026_PD1_LIGATION_VS_CTR...2,SET,180,0.094104,0.0092719,0.064489,0.072261,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP,0.792249544164038
KEGG_MEDICUS_REFERENCE_BASE_...3,SET,9,0.36921,0.0081724,0.25306,0.072295,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE,0.792322280867107
GOCC_CLUSTER_OF_ACTIN_BASED_...,SET,154,0.10118,0.0092277,0.069358,0.072315,GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS,0.792322280867107
GOMF_NADPLUS_PROTEIN_ARGININ...,SET,6,0.5422,0.0098,0.37171,0.072337,GOMF_NADPLUS_PROTEIN_ARGININE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.792322280867107
GOBP_CORPUS_CALLOSUM_MORPHOG...,SET,5,0.53456,0.0088203,0.36661,0.072414,GOBP_CORPUS_CALLOSUM_MORPHOGENESIS,0.792322280867107
GOBP_CEREBELLAR_CORTEX_MORPH...,SET,32,0.22711,0.0094732,0.15577,0.072435,GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS,0.792322280867107
ZHAN_MULTIPLE_MYELOMA_CD2_DN,SET,44,0.19393,0.0094825,0.13302,0.072437,ZHAN_MULTIPLE_MYELOMA_CD2_DN,0.792322280867107
GOBP_REGULATION_OF_PROTEIN_S...2,SET,237,0.081256,0.0091722,0.055739,0.072457,GOBP_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.792322280867107
GOBP_THYROID_STIMULATING_HOR...,SET,6,0.54131,0.009784,0.37138,0.07249,GOBP_THYROID_STIMULATING_HORMONE_SECRETING_CELL_DIFFERENTIATION,0.792322280867107
GOBP_PROTEIN_LOCALIZATION_TO...25,SET,349,0.069037,0.0094273,0.047369,0.072507,GOBP_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION,0.792322280867107
HP_DIGENIC_INHERITANCE,SET,13,0.376,0.010001,0.25798,0.072508,HP_DIGENIC_INHERITANCE,0.792322280867107
GOBP_PARAXIAL_MESODERM_MORPH...,SET,9,0.45683,0.010112,0.3135,0.072542,GOBP_PARAXIAL_MESODERM_MORPHOGENESIS,0.792322280867107
STARK_BRAIN_22Q11_DELETION,SET,10,0.38858,0.0090661,0.26668,0.072557,STARK_BRAIN_22Q11_DELETION,0.792322280867107
MIR510_3P,SET,337,0.06934,0.0093076,0.04759,0.072564,MIR510_3P,0.792322280867107
GOMF_CARBOHYDRATE_PROTON_SYM...,SET,7,0.54034,0.010549,0.371,0.072646,GOMF_CARBOHYDRATE_PROTON_SYMPORTER_ACTIVITY,0.792843666457483
KYNG_DNA_DAMAGE_DN,SET,171,0.094438,0.0090714,0.064854,0.072684,KYNG_DNA_DAMAGE_DN,0.792843666457483
REACTOME_HYALURONAN_METABOLI...,SET,17,0.29335,0.0089221,0.20146,0.07269,REACTOME_HYALURONAN_METABOLISM,0.792843666457483
WILSON_PROTEASES_AT_TUMOR_BO...2,SET,20,0.26513,0.0087458,0.18209,0.072703,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,0.792843666457483
SOX11_TARGET_GENES,SET,35,0.20699,0.0090289,0.1422,0.072755,SOX11_TARGET_GENES,0.793019374805599
SETLUR_PROSTATE_CANCER_TMPRS...2,SET,66,0.15303,0.0091588,0.10514,0.072774,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,0.793019374805599
HP_LOSS_OF_CONSCIOUSNESS,SET,23,0.27319,0.009663,0.18778,0.072869,HP_LOSS_OF_CONSCIOUSNESS,0.793019374805599
GSE5589_WT_VS_IL6_KO_LPS_AND...3,SET,178,0.09201,0.0090156,0.063248,0.072877,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.793019374805599
MIR103A_1_5P,SET,136,0.10688,0.0091649,0.073486,0.072918,MIR103A_1_5P,0.793019374805599
GSE24210_CTRL_VS_IL35_TREATE...2,SET,187,0.093369,0.0093748,0.064198,0.072928,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP,0.793019374805599
TRAVAGLINI_LUNG_CD4_NAIVE_T_...,SET,118,0.11606,0.0092747,0.079804,0.072932,TRAVAGLINI_LUNG_CD4_NAIVE_T_CELL,0.793019374805599
GOBP_REGULATION_OF_SKELETAL_...11,SET,6,0.55856,0.010096,0.38412,0.072965,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.793019374805599
HP_PILL_ROLLING_TREMOR,SET,4,0.70025,0.010335,0.48166,0.073008,HP_PILL_ROLLING_TREMOR,0.793019374805599
GAZDA_DIAMOND_BLACKFAN_ANEMI...2,SET,23,0.25619,0.0090619,0.17623,0.073013,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,0.793019374805599
GOMF_GLUCOSYLTRANSFERASE_ACT...,SET,16,0.2807,0.0082827,0.19311,0.073046,GOMF_GLUCOSYLTRANSFERASE_ACTIVITY,0.793019374805599
GSE8921_UNSTIM_0H_VS_TLR1_2_...4,SET,171,0.096424,0.0092623,0.066338,0.073048,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP,0.793019374805599
GOBP_AGGREPHAGY,SET,16,0.28831,0.0085073,0.19837,0.073066,GOBP_AGGREPHAGY,0.793019374805599
HP_DECREASED_AMPLITUDE_OF_SE...,SET,24,0.25383,0.0091711,0.17465,0.073078,HP_DECREASED_AMPLITUDE_OF_SENSORY_ACTION_POTENTIALS,0.793019374805599
GSE1791_CTRL_VS_NEUROMEDINU_...2,SET,170,0.093118,0.0089187,0.064089,0.073126,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP,0.793019374805599
REACTOME_CELL_CELL_JUNCTION_...,SET,80,0.15582,0.010263,0.10725,0.073137,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,0.793019374805599
GOMF_GPI_ANCHOR_BINDING,SET,8,0.42839,0.0089402,0.29488,0.073154,GOMF_GPI_ANCHOR_BINDING,0.793019374805599
GSE6269_HEALTHY_VS_STAPH_AUR...2,SET,154,0.09661,0.0088109,0.066512,0.073188,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP,0.793019374805599
GOBP_DENTINOGENESIS,SET,6,0.55323,0.0099994,0.38089,0.073195,GOBP_DENTINOGENESIS,0.793019374805599
GSE5455_HEALTHY_VS_TUMOR_BEA...4,SET,178,0.093226,0.0091347,0.064192,0.073217,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP,0.793019374805599
HP_AMAUROSIS_FUGAX,SET,40,0.18631,0.0086869,0.1283,0.073241,HP_AMAUROSIS_FUGAX,0.793019374805599
GSE34006_UNTREATED_VS_A2AR_A...1,SET,182,0.093984,0.0093109,0.064729,0.073265,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN,0.793019374805599
GSE21033_1H_VS_12H_POLYIC_ST...1,SET,124,0.11199,0.0091728,0.077136,0.073272,GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN,0.793019374805599
MIR548AG,SET,158,0.10001,0.0092373,0.068888,0.073295,MIR548AG,0.793019374805599
CAAGGAT_MIR362,SET,59,0.15648,0.008856,0.10779,0.073305,CAAGGAT_MIR362,0.793019374805599
GSE37301_MULTIPOTENT_PROGENI...1,SET,176,0.090979,0.0088648,0.062676,0.073319,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN,0.793019374805599
WP_MESODERMAL_COMMITMENT_PAT...,SET,132,0.1148,0.0096988,0.079092,0.073336,WP_MESODERMAL_COMMITMENT_PATHWAY,0.793019374805599
TRAVAGLINI_LUNG_CAPILLARY_IN...1,SET,150,0.1113,0.010019,0.076692,0.073358,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL,0.793019374805599
ZHAN_V1_LATE_DIFFERENTIATION...1,SET,11,0.3569,0.0087334,0.24607,0.073477,ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,0.793844389182468
GOBP_NK_T_CELL_ACTIVATION,SET,13,0.40116,0.010671,0.27658,0.07348,GOBP_NK_T_CELL_ACTIVATION,0.793844389182468
ISHIDA_TARGETS_OF_SYT_SSX_FU...,SET,6,0.5669,0.010246,0.39103,0.073573,ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS,0.794398457595527
MIR3920,SET,123,0.11528,0.0094039,0.079519,0.073577,MIR3920,0.794398457595527
GOBP_MESODERM_DEVELOPMENT,SET,117,0.1226,0.0097555,0.08458,0.073609,GOBP_MESODERM_DEVELOPMENT,0.794497141304348
GOCC_SAGA_TYPE_COMPLEX,SET,33,0.18724,0.007931,0.1292,0.07365,GOCC_SAGA_TYPE_COMPLEX,0.794501672354949
MOOTHA_PYR,SET,5,0.70354,0.011609,0.48549,0.073658,MOOTHA_PYR,0.794501672354949
HP_ABNORMALITY_OF_THE_MUSCUL...5,SET,243,0.079205,0.0090516,0.054662,0.073678,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_LIMBS,0.794501672354949
HEIDENBLAD_AMPLIFIED_IN_PANC...,SET,53,0.18025,0.0096706,0.12443,0.073733,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,0.794848143610422
GSE29618_PRE_VS_DAY7_POST_LA...8,SET,178,0.093905,0.0092013,0.064848,0.073807,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP,0.795260333230006
GOCC_NEUROFIBRILLARY_TANGLE,SET,5,0.6899,0.011384,0.47645,0.073817,GOCC_NEUROFIBRILLARY_TANGLE,0.795260333230006
NAKAMURA_ADIPOGENESIS_EARLY_...1,SET,33,0.22761,0.0096411,0.15733,0.073996,NAKAMURA_ADIPOGENESIS_EARLY_DN,0.795680158266749
WP_8P231_COPY_NUMBER_VARIATI...,SET,51,0.22889,0.012047,0.15822,0.074008,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,0.795680158266749
GOBP_NEGATIVE_REGULATION_OF_...350,SET,21,0.27377,0.0092536,0.18926,0.074022,GOBP_NEGATIVE_REGULATION_OF_LIPID_STORAGE,0.795680158266749
GSE22886_NAIVE_CD4_TCELL_VS_...8,SET,180,0.093606,0.0092228,0.064715,0.074035,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP,0.795680158266749
AP1_Q4_01,SET,241,0.079793,0.0090817,0.055171,0.07406,AP1_Q4_01,0.795680158266749
MIR3129_5P,SET,144,0.10169,0.0089701,0.070314,0.074073,MIR3129_5P,0.795680158266749
HP_VITREORETINOPATHY,SET,21,0.26267,0.0088783,0.18166,0.074108,HP_VITREORETINOPATHY,0.795680158266749
PAX4_02,SET,217,0.089015,0.00962,0.061569,0.074129,PAX4_02,0.795680158266749
MODULE_180,SET,109,0.12563,0.0096511,0.086897,0.074134,MODULE_180,0.795680158266749
GOCC_BLOC_COMPLEX,SET,19,0.2848,0.0091569,0.19702,0.074162,GOCC_BLOC_COMPLEX,0.795680158266749
LE_NEURONAL_DIFFERENTIATION_...1,SET,18,0.26095,0.0081666,0.18053,0.074172,LE_NEURONAL_DIFFERENTIATION_DN,0.795680158266749
HP_ABNORMALITY_OF_DNA_REPAIR,SET,14,0.25937,0.0071594,0.17944,0.074173,HP_ABNORMALITY_OF_DNA_REPAIR,0.795680158266749
GSE19374_UNINF_VS_LISTERIA_I...1,SET,182,0.090179,0.0089339,0.062405,0.074229,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN,0.795680158266749
HP_ABNORMAL_HEPATIC_ECHOGENI...,SET,7,0.50136,0.0097876,0.34699,0.074257,HP_ABNORMAL_HEPATIC_ECHOGENICITY,0.795680158266749
GOBP_RESPONSE_TO_METHIONINE,SET,5,0.62009,0.010232,0.42917,0.074259,GOBP_RESPONSE_TO_METHIONINE,0.795680158266749
MIR3130_3P,SET,45,0.17814,0.0088082,0.1233,0.074267,MIR3130_3P,0.795680158266749
GSE5542_IFNA_VS_IFNA_AND_IFN...1,SET,182,0.087918,0.0087099,0.060858,0.074288,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.795680158266749
HP_ABNORMALITY_OF_REPRODUCTI...,SET,755,0.045768,0.0090884,0.031687,0.074323,HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.795680158266749
GOBP_REGULATION_OF_CELLULAR_...7,SET,904,0.041759,0.0090352,0.028913,0.074338,GOBP_REGULATION_OF_CELLULAR_LOCALIZATION,0.795680158266749
GSE43863_TFH_VS_LY6C_INT_CXC...3,SET,178,0.094159,0.0092262,0.065207,0.074378,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.795680158266749
GOBP_CELLULAR_RESPONSE_TO_GL...3,SET,43,0.18475,0.0089307,0.12795,0.07438,GOBP_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION,0.795680158266749
GOCC_MALE_GERM_CELL_NUCLEUS,SET,48,0.16551,0.0084515,0.11463,0.074406,GOCC_MALE_GERM_CELL_NUCLEUS,0.795680158266749
GOBP_MULTICELLULAR_ORGANISMA...6,SET,819,0.043911,0.0090651,0.030415,0.074414,GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS,0.795680158266749
HP_INAPPROPRIATE_CRYING,SET,14,0.32991,0.0091068,0.22852,0.074417,HP_INAPPROPRIATE_CRYING,0.795680158266749
HP_SENILE_PLAQUES,SET,10,0.3988,0.0093047,0.27625,0.074435,HP_SENILE_PLAQUES,0.795680158266749
TFIIA_Q6,SET,231,0.083707,0.00933,0.057992,0.074458,TFIIA_Q6,0.795680158266749
BIOCARTA_RNAPOL3_PATHWAY,SET,7,0.342,0.0066766,0.23696,0.07448,BIOCARTA_RNAPOL3_PATHWAY,0.795680158266749
GSE9960_GRAM_POS_VS_GRAM_NEG...2,SET,178,0.089923,0.0088111,0.06231,0.074497,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.795680158266749
GOBP_DETERMINATION_OF_LEFT_R...,SET,10,0.4216,0.0098367,0.29228,0.074593,GOBP_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM,0.796430512741787
GOMF_NITRIC_OXIDE_SYNTHASE_B...,SET,10,0.39156,0.0091356,0.27149,0.074623,GOMF_NITRIC_OXIDE_SYNTHASE_BINDING,0.796430512741787
GSE18281_CORTICAL_THYMOCYTE_...2,SET,173,0.099366,0.0096,0.068901,0.074636,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP,0.796430512741787
GOBP_ADHERENS_JUNCTION_ORGAN...,SET,56,0.17745,0.0097852,0.12309,0.074713,GOBP_ADHERENS_JUNCTION_ORGANIZATION,0.797007463167588
REACTOME_REGULATION_OF_TP53_...1,SET,152,0.097977,0.0088778,0.067974,0.074745,REACTOME_REGULATION_OF_TP53_ACTIVITY,0.797104165388156
WP_REGULATION_OF_WNT_BCATENI...,SET,16,0.33532,0.0098946,0.23271,0.074813,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,0.797349608879493
GSE26495_NAIVE_VS_PD1HIGH_CD...2,SET,151,0.10331,0.0093307,0.071715,0.074857,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP,0.797349608879493
REACTOME_SARS_COV_2_ACTIVATE...,SET,111,0.12056,0.0093458,0.083691,0.074865,REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,0.797349608879493
HP_THYROID_ADENOMA,SET,13,0.35,0.00931,0.24302,0.074909,HP_THYROID_ADENOMA,0.797349608879493
REACTOME_INWARDLY_RECTIFYING...,SET,35,0.23344,0.010183,0.16212,0.074945,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,0.797349608879493
GOMF_HISTONE_METHYLTRANSFERA...2,SET,13,0.30356,0.0080747,0.21082,0.074958,GOMF_HISTONE_METHYLTRANSFERASE_BINDING,0.797349608879493
GOBP_INTERLEUKIN_8_PRODUCTION,SET,77,0.15104,0.0097607,0.1049,0.074966,GOBP_INTERLEUKIN_8_PRODUCTION,0.797349608879493
HP_GENERALIZED_HYPERTRICHOSIS,SET,8,0.46056,0.0096117,0.3199,0.074985,HP_GENERALIZED_HYPERTRICHOSIS,0.797349608879493
FERNANDEZ_BOUND_BY_MYC,SET,169,0.094076,0.0089842,0.065399,0.075154,FERNANDEZ_BOUND_BY_MYC,0.797349608879493
GOCC_FC_RECEPTOR_COMPLEX,SET,5,0.61232,0.010103,0.42574,0.07519,GOCC_FC_RECEPTOR_COMPLEX,0.797349608879493
HP_LARGE_INTESTINAL_POLYPOSIS,SET,31,0.20493,0.0084135,0.14248,0.07519,HP_LARGE_INTESTINAL_POLYPOSIS,0.797349608879493
GSE4984_GALECTIN1_VS_LPS_STI...2,SET,144,0.09696,0.0085532,0.067452,0.075304,GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP,0.797349608879493
BIOCARTA_RANMS_PATHWAY,SET,10,0.36334,0.0084773,0.25278,0.075317,BIOCARTA_RANMS_PATHWAY,0.797349608879493
GSE3337_CTRL_VS_4H_IFNG_IN_C...1,SET,187,0.089073,0.0089435,0.06197,0.075317,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN,0.797349608879493
MIR3158_5P,SET,154,0.099511,0.0090754,0.069233,0.075321,MIR3158_5P,0.797349608879493
MIR3977,SET,139,0.10121,0.0087731,0.070437,0.075379,MIR3977,0.797349608879493
MIR633,SET,128,0.10562,0.0087882,0.07352,0.075421,MIR633,0.797349608879493
HP_DEXAMETHASONE_SUPPRESSIBL...,SET,5,0.6211,0.010248,0.43235,0.075427,HP_DEXAMETHASONE_SUPPRESSIBLE_PRIMARY_HYPERALDOSTERONISM,0.797349608879493
HALLMARK_REACTIVE_OXYGEN_SPE...,SET,45,0.18932,0.0093611,0.13179,0.075437,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.797349608879493
MIR216B_3P,SET,115,0.11233,0.0088622,0.078216,0.075491,MIR216B_3P,0.797349608879493
GSE20715_WT_VS_TLR4_KO_LUNG_...1,SET,175,0.090621,0.0088051,0.063109,0.075516,GSE20715_WT_VS_TLR4_KO_LUNG_DN,0.797349608879493
ZERBINI_RESPONSE_TO_SULINDAC...1,SET,6,0.41161,0.0074396,0.28665,0.075522,ZERBINI_RESPONSE_TO_SULINDAC_DN,0.797349608879493
HP_ABNORMAL_ORAL_GLUCOSE_TOL...,SET,15,0.35863,0.010247,0.24978,0.07554,HP_ABNORMAL_ORAL_GLUCOSE_TOLERANCE,0.797349608879493
HP_CLUMSINESS,SET,84,0.13158,0.0088794,0.091643,0.075546,HP_CLUMSINESS,0.797349608879493
GOBP_REGULATION_OF_CHOLESTER...4,SET,17,0.29903,0.009095,0.20828,0.075552,GOBP_REGULATION_OF_CHOLESTEROL_STORAGE,0.797349608879493
GSE36392_TYPE_2_MYELOID_VS_M...1,SET,181,0.08661,0.0085569,0.060329,0.075563,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN,0.797349608879493
AATGTGA_MIR23A_MIR23B,SET,381,0.063688,0.0090789,0.044365,0.075573,AATGTGA_MIR23A_MIR23B,0.797349608879493
MIR3616_5P,SET,84,0.13521,0.0091243,0.094206,0.075621,MIR3616_5P,0.797349608879493
GSE1460_CD4_THYMOCYTE_VS_NAI...4,SET,191,0.089497,0.0090807,0.062363,0.075639,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.797349608879493
KOHOUTEK_CCNT2_TARGETS,SET,54,0.16825,0.0091112,0.11727,0.075693,KOHOUTEK_CCNT2_TARGETS,0.797349608879493
GOCC_CDC73_PAF1_COMPLEX,SET,6,0.55846,0.010094,0.38925,0.075693,GOCC_CDC73_PAF1_COMPLEX,0.797349608879493
REACTOME_LATE_SARS_COV_2_INF...,SET,66,0.14899,0.0089171,0.10385,0.075699,REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS,0.797349608879493
MIR7974,SET,80,0.13889,0.0091478,0.096817,0.075722,MIR7974,0.797349608879493
GSE17186_MEMORY_VS_CD21LOW_T...2,SET,176,0.087806,0.0085557,0.061224,0.07577,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP,0.797349608879493
XU_GH1_AUTOCRINE_TARGETS_UP,SET,158,0.097499,0.0090057,0.067987,0.075783,XU_GH1_AUTOCRINE_TARGETS_UP,0.797349608879493
KEGG_MEDICUS_REFERENCE_DOUBL...2,SET,11,0.34969,0.0085569,0.24386,0.075797,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING,0.797349608879493
QIU_PBMC_HEPTATITIS_B_SURFAC...6,SET,13,0.38619,0.010273,0.26932,0.075802,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_3DY_UP,0.797349608879493
GSE7219_WT_VS_NIK_NFKB2_KO_L...1,SET,184,0.091531,0.0091171,0.063832,0.075803,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN,0.797349608879493
COLIN_PILOCYTIC_ASTROCYTOMA_...1,SET,26,0.25605,0.0096287,0.17859,0.07583,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,0.797349608879493
REACTOME_PROTEIN_REPAIR,SET,6,0.49485,0.0089443,0.34517,0.075847,REACTOME_PROTEIN_REPAIR,0.797349608879493
REACTOME_OPSINS,SET,7,0.41432,0.0080884,0.289,0.075848,REACTOME_OPSINS,0.797349608879493
HP_CARDIAC_DIVERTICULUM,SET,20,0.24836,0.0081928,0.17325,0.075855,HP_CARDIAC_DIVERTICULUM,0.797349608879493
REACTOME_DISEASES_OF_METABOL...,SET,227,0.08253,0.0091199,0.057578,0.075886,REACTOME_DISEASES_OF_METABOLISM,0.797349608879493
ZHAN_MULTIPLE_MYELOMA_LB_DN,SET,35,0.20718,0.0090373,0.14455,0.075898,ZHAN_MULTIPLE_MYELOMA_LB_DN,0.797349608879493
ZHOU_INFLAMMATORY_RESPONSE_F...1,SET,250,0.07797,0.0090361,0.0544,0.075899,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,0.797349608879493
SOTIRIOU_BREAST_CANCER_GRADE...2,SET,137,0.098745,0.0084979,0.068898,0.075909,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,0.797349608879493
CUI_DEVELOPING_HEART_5TH_WEE...2,SET,64,0.16105,0.0094919,0.11238,0.075926,CUI_DEVELOPING_HEART_5TH_WEEK_VENTRICULAR_CARDIOMYOCYTE,0.797349608879493
REACTOME_LRR_FLII_INTERACTIN...,SET,5,0.5199,0.0085784,0.36279,0.07593,REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION,0.797349608879493
KRASNOSELSKAYA_ILF3_TARGETS_...2,SET,36,0.2147,0.0094979,0.14984,0.075951,KRASNOSELSKAYA_ILF3_TARGETS_UP,0.797349608879493
GOBP_ALDEHYDE_BIOSYNTHETIC_P...,SET,17,0.32009,0.0097355,0.22339,0.075956,GOBP_ALDEHYDE_BIOSYNTHETIC_PROCESS,0.797349608879493
REACTOME_POST_CHAPERONIN_TUB...,SET,21,0.25681,0.0086805,0.17923,0.075961,REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.797349608879493
GOBP_FUNGIFORM_PAPILLA_MORPH...,SET,4,0.68803,0.010154,0.48019,0.075961,GOBP_FUNGIFORM_PAPILLA_MORPHOGENESIS,0.797349608879493
GOBP_HIGH_DENSITY_LIPOPROTEI...1,SET,11,0.32198,0.0078788,0.22476,0.076,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.797499944226711
ITO_PTTG1_TARGETS_UP,SET,11,0.42973,0.010515,0.30006,0.07606,ITO_PTTG1_TARGETS_UP,0.797499944226711
GSE27291_0H_VS_7D_STIM_GAMMA...1,SET,159,0.09595,0.0088904,0.067007,0.076087,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.797499944226711
FAN_EMBRYONIC_CTX_MICROGLIA_1,SET,137,0.10038,0.008639,0.070104,0.07609,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.797499944226711
HP_ABNORMAL_NEURON_MORPHOLOGY,SET,79,0.13628,0.0089198,0.095174,0.076101,HP_ABNORMAL_NEURON_MORPHOLOGY,0.797499944226711
MIYAGAWA_TARGETS_OF_EWSR1_ET...2,SET,239,0.087731,0.0099442,0.061274,0.076113,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,0.797499944226711
GSE360_HIGH_DOSE_B_MALAYI_VS...4,SET,187,0.085189,0.0085535,0.059518,0.076181,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.797710996987952
REACTOME_ATTACHMENT_OF_GPI_A...,SET,7,0.40169,0.0078419,0.28067,0.076199,REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR,0.797710996987952
HERNANDEZ_ABERRANT_MITOSIS_B...2,SET,65,0.1581,0.0093902,0.11047,0.076202,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,0.797710996987952
GOBP_PROTEIN_DNA_COVALENT_CR...,SET,8,0.33872,0.007069,0.23672,0.076241,GOBP_PROTEIN_DNA_COVALENT_CROSS_LINKING_REPAIR,0.797878938572719
KEGG_MEDICUS_REFERENCE_NOTCH...2,SET,6,0.50854,0.0091917,0.35554,0.076317,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING,0.798017015935057
MIR7854_3P,SET,99,0.12168,0.0089107,0.085076,0.076337,MIR7854_3P,0.798017015935057
WEIGEL_OXIDATIVE_STRESS_BY_H...1,SET,31,0.21264,0.0087302,0.14869,0.076352,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,0.798017015935057
GSE21774_CD62L_POS_CD56_BRIG...1,SET,173,0.09459,0.0091385,0.066144,0.07636,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,0.798017015935057
HP_DIAPHYSEAL_UNDERTUBULATION,SET,13,0.32467,0.0086363,0.22705,0.076369,HP_DIAPHYSEAL_UNDERTUBULATION,0.798017015935057
MIR7162_5P,SET,162,0.097218,0.0090916,0.068006,0.076434,MIR7162_5P,0.798239163167367
GOBP_NODAL_SIGNALING_PATHWAY,SET,16,0.33258,0.0098137,0.23267,0.076454,GOBP_NODAL_SIGNALING_PATHWAY,0.798239163167367
GSE3982_NKCELL_VS_TH1_UP,SET,172,0.097405,0.0093835,0.068148,0.076467,GSE3982_NKCELL_VS_TH1_UP,0.798239163167367
BIOCARTA_VDR_PATHWAY,SET,24,0.2438,0.0088087,0.17062,0.076525,BIOCARTA_VDR_PATHWAY,0.798239163167367
RLF_TARGET_GENES,SET,268,0.075363,0.0090385,0.052748,0.076548,RLF_TARGET_GENES,0.798239163167367
GOMF_HISTONE_DECROTONYLASE_A...,SET,4,0.59188,0.0087354,0.41429,0.076557,GOMF_HISTONE_DECROTONYLASE_ACTIVITY,0.798239163167367
GSE25085_FETAL_LIVER_VS_FETA...2,SET,181,0.085546,0.0084519,0.059881,0.076569,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP,0.798239163167367
GSE42088_UNINF_VS_LEISHMANIA...5,SET,178,0.092432,0.009057,0.064703,0.076574,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN,0.798239163167367
KEGG_VIRAL_MYOCARDITIS,SET,64,0.16975,0.010004,0.11885,0.076622,KEGG_VIRAL_MYOCARDITIS,0.798386279209107
FARMER_BREAST_CANCER_CLUSTER...8,SET,7,0.52855,0.010319,0.37014,0.076658,FARMER_BREAST_CANCER_CLUSTER_8,0.798386279209107
GOBP_REGULATION_OF_TRANSLATI...7,SET,8,0.42214,0.0088098,0.29563,0.076667,GOBP_REGULATION_OF_TRANSLATIONAL_TERMINATION,0.798386279209107
GOMF_NUCLEAR_STEROID_RECEPTO...,SET,25,0.25339,0.009344,0.17747,0.07668,GOMF_NUCLEAR_STEROID_RECEPTOR_ACTIVITY,0.798386279209107
GSE30971_WBP7_HET_VS_KO_MACR...1,SET,184,0.097003,0.009662,0.067965,0.076765,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN,0.798720233393178
GSE18791_CTRL_VS_NEWCASTLE_V...1,SET,170,0.098984,0.0094805,0.069357,0.076775,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN,0.798720233393178
BIOCARTA_CDC25_PATHWAY,SET,9,0.37166,0.0082266,0.26045,0.076799,BIOCARTA_CDC25_PATHWAY,0.798720233393178
GOCC_EARLY_ENDOSOME_MEMBRANE,SET,175,0.089642,0.0087099,0.06282,0.076804,GOCC_EARLY_ENDOSOME_MEMBRANE,0.798720233393178
GOBP_MAMMARY_GLAND_EPITHELIA...1,SET,17,0.32318,0.0098295,0.22653,0.076848,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION,0.798776107312723
HP_DECREASED_CIRCULATING_COR...,SET,32,0.21415,0.0089328,0.15017,0.076927,HP_DECREASED_CIRCULATING_CORTISOL_LEVEL,0.798776107312723
GOBP_METENCEPHALON_DEVELOPME...,SET,101,0.12448,0.0092068,0.087299,0.076964,GOBP_METENCEPHALON_DEVELOPMENT,0.798776107312723
GOBP_NEGATIVE_REGULATION_OF_...166,SET,135,0.10338,0.0088324,0.072508,0.076969,GOBP_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.798776107312723
REACTOME_E2F_MEDIATED_REGULA...,SET,20,0.25175,0.0083045,0.17659,0.076995,REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,0.798776107312723
GOCC_PERICENTRIOLAR_MATERIAL,SET,21,0.23601,0.0079772,0.16555,0.076997,GOCC_PERICENTRIOLAR_MATERIAL,0.798776107312723
MIR489_3P,SET,69,0.15229,0.0093185,0.10685,0.077046,MIR489_3P,0.798776107312723
MIR6875_5P,SET,62,0.14936,0.0086648,0.1048,0.077054,MIR6875_5P,0.798776107312723
HP_ABNORMALITY_OF_THE_LIVER,SET,984,0.039532,0.0089034,0.027741,0.077082,HP_ABNORMALITY_OF_THE_LIVER,0.798776107312723
GOBP_ASTRAL_MICROTUBULE_ORGA...,SET,10,0.43485,0.010146,0.30518,0.077103,GOBP_ASTRAL_MICROTUBULE_ORGANIZATION,0.798776107312723
GAVISH_3CA_METAPROGRAM_FIBRO...4,SET,38,0.21766,0.009892,0.15276,0.077111,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3,0.798776107312723
GOBP_MITOTIC_DNA_REPLICATION...,SET,11,0.33003,0.0080756,0.23165,0.077138,GOBP_MITOTIC_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.798776107312723
GSE21670_STAT3_KO_VS_WT_CD4_...6,SET,174,0.097955,0.0094907,0.068771,0.077179,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN,0.798776107312723
GSE30962_ACUTE_VS_CHRONIC_LC...2,SET,176,0.091443,0.0089101,0.064205,0.077196,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,0.798776107312723
HOEK_NK_CELL_2011_2012_TIV_7...,SET,14,0.3111,0.0085873,0.21844,0.077203,HOEK_NK_CELL_2011_2012_TIV_7D_VS_0DY_ADULT_7D_DN,0.798776107312723
GOBP_NUCLEOTIDE_EXCISION_REP...2,SET,6,0.41283,0.0074617,0.28995,0.077264,GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING,0.798776107312723
HP_NEOPLASM_OF_THE_GALLBLADD...,SET,6,0.51746,0.0093529,0.36345,0.077268,HP_NEOPLASM_OF_THE_GALLBLADDER,0.798776107312723
HP_HYPOPIGMENTED_SKIN_PATCHES,SET,105,0.11396,0.008593,0.080041,0.077274,HP_HYPOPIGMENTED_SKIN_PATCHES,0.798776107312723
MIR4708_3P,SET,91,0.12603,0.0088504,0.088524,0.077285,MIR4708_3P,0.798776107312723
WP_CANONICAL_AND_NONCANONICA...1,SET,27,0.23923,0.0091675,0.16805,0.07729,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,0.798776107312723
HP_FRONTOTEMPORAL_DEMENTIA,SET,50,0.17323,0.0090276,0.12169,0.077307,HP_FRONTOTEMPORAL_DEMENTIA,0.798776107312723
PID_NFKAPPAB_ATYPICAL_PATHWAY,SET,15,0.30072,0.0085919,0.21126,0.077315,PID_NFKAPPAB_ATYPICAL_PATHWAY,0.798776107312723
GOBP_CELL_CELL_ADHESION_MEDI...1,SET,48,0.1831,0.0093498,0.12867,0.077376,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.799137978028504
GOMF_UBIQUITIN_CONJUGATING_E...,SET,28,0.2293,0.0089479,0.16117,0.07741,GOMF_UBIQUITIN_CONJUGATING_ENZYME_BINDING,0.799137978028504
GOCC_EARLY_PHAGOSOME,SET,12,0.35418,0.0090518,0.24897,0.077435,GOCC_EARLY_PHAGOSOME,0.799137978028504
WP_LACTO_SERIES_SPHINGOLIPID...,SET,6,0.51434,0.0092964,0.36156,0.077442,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.799137978028504
HP_SHORT_TIBIA,SET,23,0.26323,0.0093108,0.18506,0.077465,HP_SHORT_TIBIA,0.79913804541407
MIR512_5P,SET,49,0.17113,0.0088289,0.12038,0.077585,MIR512_5P,0.799395675198588
GOBP_MONOCARBOXYLIC_ACID_CAT...,SET,125,0.10568,0.0086898,0.074349,0.077618,GOBP_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS,0.799395675198588
GOMF_DOLICHYL_PHOSPHATE_MANN...,SET,8,0.35684,0.0074471,0.25106,0.077623,GOMF_DOLICHYL_PHOSPHATE_MANNOSE_PROTEIN_MANNOSYLTRANSFERASE_ACTIVITY,0.799395675198588
GOBP_MIDBRAIN_DEVELOPMENT,SET,81,0.13739,0.0091056,0.09667,0.07763,GOBP_MIDBRAIN_DEVELOPMENT,0.799395675198588
GOBP_LYMPHOCYTE_DIFFERENTIAT...,SET,401,0.064246,0.0093905,0.045214,0.077678,GOBP_LYMPHOCYTE_DIFFERENTIATION,0.799395675198588
MIR664B_5P,SET,53,0.16394,0.0087957,0.11539,0.077695,MIR664B_5P,0.799395675198588
GOBP_NEGATIVE_REGULATION_OF_...553,SET,19,0.25802,0.0082961,0.18161,0.077702,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.799395675198588
GOBP_NEGATIVE_REGULATION_OF_...678,SET,65,0.16667,0.0098992,0.11734,0.077764,GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.799395675198588
GOBP_CELL_CYCLE_CHECKPOINT_S...,SET,180,0.085441,0.0084184,0.06016,0.077779,GOBP_CELL_CYCLE_CHECKPOINT_SIGNALING,0.799395675198588
WEI_MIR34A_TARGETS,SET,136,0.10551,0.0090473,0.074295,0.077789,WEI_MIR34A_TARGETS,0.799395675198588
HUMMEL_BURKITTS_LYMPHOMA_UP,SET,38,0.20867,0.0094834,0.14694,0.077797,HUMMEL_BURKITTS_LYMPHOMA_UP,0.799395675198588
WP_NUCLEOTIDE_EXCISION_REPAI...,SET,55,0.14117,0.0077148,0.099405,0.077798,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,0.799395675198588
HP_BIRTH_LENGTH_LESS_THAN_3R...,SET,13,0.30892,0.0082173,0.21765,0.077913,HP_BIRTH_LENGTH_LESS_THAN_3RD_PERCENTILE,0.799395675198588
GARGALOVIC_RESPONSE_TO_OXIDI...15,SET,30,0.24581,0.0099281,0.17322,0.077947,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,0.799395675198588
HP_HIGH_MYOPIA,SET,76,0.14103,0.0090546,0.09939,0.077969,HP_HIGH_MYOPIA,0.799395675198588
MYCMAX_03,SET,230,0.07794,0.0086687,0.05493,0.077972,MYCMAX_03,0.799395675198588
ALCALAY_AML_BY_NPM1_LOCALIZA...2,SET,123,0.11598,0.0094607,0.081739,0.077981,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,0.799395675198588
AFFAR_YY1_TARGETS_DN,SET,236,0.081162,0.0091424,0.057206,0.077994,AFFAR_YY1_TARGETS_DN,0.799395675198588
MIR3529_5P,SET,32,0.21564,0.0089949,0.152,0.078002,MIR3529_5P,0.799395675198588
PRKDC_TARGET_GENES,SET,696,0.046683,0.0089153,0.032909,0.078023,PRKDC_TARGET_GENES,0.799395675198588
REACTOME_ORGANIC_ANION_TRANS...2,SET,12,0.37105,0.0094829,0.26159,0.078038,REACTOME_ORGANIC_ANION_TRANSPORTERS,0.799395675198588
REACTOME_NONCANONICAL_ACTIVA...,SET,7,0.46507,0.0090792,0.32793,0.078073,REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3,0.799395675198588
MORF_ESPL1,SET,54,0.15114,0.0081849,0.10657,0.078074,MORF_ESPL1,0.799395675198588
BIOCARTA_BARD1_PATHWAY,SET,8,0.35947,0.0075019,0.25349,0.078095,BIOCARTA_BARD1_PATHWAY,0.799395675198588
HP_ABNORMALITY_OF_HUMORAL_IM...,SET,280,0.073879,0.0090537,0.052099,0.078097,HP_ABNORMALITY_OF_HUMORAL_IMMUNITY,0.799395675198588
GOBP_NEGATIVE_REGULATION_OF_...224,SET,3,0.77349,0.0098865,0.54558,0.078142,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.799395675198588
HP_CONICAL_TOOTH,SET,49,0.1889,0.0097458,0.13325,0.078155,HP_CONICAL_TOOTH,0.799395675198588
DEURIG_T_CELL_PROLYMPHOCYTIC...2,SET,310,0.068267,0.0087955,0.048157,0.078162,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,0.799395675198588
GOMF_3_5_DNA_HELICASE_ACTIVI...,SET,14,0.31777,0.0087716,0.22418,0.07818,GOMF_3_5_DNA_HELICASE_ACTIVITY,0.799395675198588
GOMF_MORPHOGEN_ACTIVITY,SET,6,0.50302,0.0090919,0.35487,0.07818,GOMF_MORPHOGEN_ACTIVITY,0.799395675198588
HP_ABNORMAL_MALE_INTERNAL_GE...,SET,69,0.15285,0.0093526,0.1079,0.078318,HP_ABNORMAL_MALE_INTERNAL_GENITALIA_MORPHOLOGY,0.799936426893717
GOBP_CILIUM_DISASSEMBLY,SET,5,0.5262,0.0086824,0.37149,0.078329,GOBP_CILIUM_DISASSEMBLY,0.799936426893717
MODULE_47,SET,208,0.090497,0.0095776,0.063892,0.078337,MODULE_47,0.799936426893717
GOBP_NEGATIVE_REGULATION_OF_...201,SET,33,0.2356,0.0099793,0.16634,0.078347,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.799936426893717
YAO_TEMPORAL_RESPONSE_TO_PRO...10,SET,169,0.087785,0.0083834,0.061987,0.078371,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,0.799936426893717
MIR145_3P,SET,64,0.15507,0.0091397,0.1095,0.078375,MIR145_3P,0.799936426893717
MIR6735_5P,SET,92,0.1282,0.0090519,0.090533,0.078394,MIR6735_5P,0.799936426893717
PID_EPO_PATHWAY,SET,31,0.2241,0.0092006,0.15829,0.078432,PID_EPO_PATHWAY,0.800089275022014
GOBP_EXPORT_FROM_CELL,SET,833,0.044041,0.0091656,0.031114,0.078476,GOBP_EXPORT_FROM_CELL,0.800303221830986
HP_FOLLICULITIS,SET,7,0.55483,0.010832,0.39208,0.078529,HP_FOLLICULITIS,0.800454913540445
GOBP_NEGATIVE_REGULATION_OF_...268,SET,5,0.58592,0.0096677,0.41412,0.078564,GOBP_NEGATIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.800454913540445
REACTOME_LYSOSPHINGOLIPID_AN...,SET,9,0.44668,0.0098872,0.31571,0.078565,REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS,0.800454913540445
GOBP_PHOSPHATIDYLINOSITOL_ME...2,SET,147,0.096546,0.0086042,0.068244,0.078583,GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS,0.800454913540445
GSE22601_DOUBLE_NEGATIVE_VS_...3,SET,165,0.095697,0.0090311,0.067658,0.078629,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.800688806035746
GSE32034_UNTREATED_VS_ROSIGL...2,SET,178,0.093122,0.0091246,0.065868,0.078723,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP,0.801411208260105
CUI_DEVELOPING_HEART_C2_CARD...,SET,85,0.13594,0.0092284,0.096191,0.078795,CUI_DEVELOPING_HEART_C2_CARDIOMYOCYTE,0.801615323741007
GOBP_PROTEIN_RNA_COMPLEX_ORG...,SET,181,0.079865,0.0078906,0.056515,0.078812,GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION,0.801615323741007
GOBP_POSITIVE_REGULATION_OF_...176,SET,4,0.69968,0.010326,0.49512,0.078817,GOBP_POSITIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.801615323741007
GSE22886_DAY1_VS_DAY7_MONOCY...1,SET,176,0.087323,0.0085086,0.061801,0.078839,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.801615323741007
MIR1277_3P,SET,14,0.31613,0.0087262,0.22377,0.078872,MIR1277_3P,0.801615323741007
GSE41867_LCMV_ARMSTRONG_VS_C...2,SET,175,0.088229,0.0085726,0.062463,0.07891,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP,0.801615323741007
GOBP_SERINE_PHOSPHORYLATION_...,SET,19,0.34295,0.011027,0.24283,0.07894,GOBP_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.801615323741007
GSE39820_CTRL_VS_IL1B_IL6_IL...1,SET,185,0.092152,0.0092036,0.065252,0.078947,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN,0.801615323741007
REACTOME_REGULATION_OF_GENE_...3,SET,8,0.49916,0.010417,0.3535,0.078979,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS,0.801615323741007
GOBP_RENAL_SYSTEM_PROCESS_IN...1,SET,14,0.34302,0.0094686,0.243,0.079043,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME,0.801615323741007
BIOCARTA_PGC1A_PATHWAY,SET,15,0.31422,0.0089777,0.22261,0.079057,BIOCARTA_PGC1A_PATHWAY,0.801615323741007
REACTOME_ESR_MEDIATED_SIGNAL...,SET,157,0.098193,0.0090413,0.069573,0.079078,REACTOME_ESR_MEDIATED_SIGNALING,0.801615323741007
GSE3982_MAST_CELL_VS_CENT_ME...1,SET,163,0.091179,0.0085529,0.064606,0.079087,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.801615323741007
HE_LIM_SUN_FETAL_LUNG_C2_GMP...,SET,33,0.22931,0.0097128,0.16249,0.079097,HE_LIM_SUN_FETAL_LUNG_C2_GMP_CELL,0.801615323741007
BUSSLINGER_DUODENAL_EARLY_IM...,SET,99,0.12431,0.0091039,0.088091,0.079101,BUSSLINGER_DUODENAL_EARLY_IMMATURE_ENTEROCYTES,0.801615323741007
GAO_LARGE_INTESTINE_ADULT_CH...,SET,92,0.11936,0.0084279,0.084613,0.079184,GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS,0.801615323741007
HP_ABNORMAL_BLOOD_UREA_NITRO...,SET,17,0.29411,0.0089454,0.2085,0.079187,HP_ABNORMAL_BLOOD_UREA_NITROGEN_CONCENTRATION,0.801615323741007
DESCARTES_MAIN_FETAL_UNIPOLA...,SET,22,0.27429,0.0094892,0.19448,0.079223,DESCARTES_MAIN_FETAL_UNIPOLAR_BRUSH_CELLS,0.801615323741007
HP_URINARY_TRACT_NEOPLASM,SET,133,0.10545,0.0089426,0.074784,0.079266,HP_URINARY_TRACT_NEOPLASM,0.801615323741007
GOBP_INTERLEUKIN_23_PRODUCTI...,SET,10,0.41963,0.0097907,0.29769,0.079334,GOBP_INTERLEUKIN_23_PRODUCTION,0.801615323741007
GOBP_TISSUE_HOMEOSTASIS,SET,247,0.081913,0.0094367,0.058118,0.079366,GOBP_TISSUE_HOMEOSTASIS,0.801615323741007
GSE41978_WT_VS_ID2_KO_AND_BI...1,SET,179,0.086477,0.008497,0.061369,0.079409,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.801615323741007
BIOCARTA_ATM_PATHWAY,SET,19,0.25439,0.0081792,0.18053,0.07941,BIOCARTA_ATM_PATHWAY,0.801615323741007
MORF_PPP1CC,SET,146,0.094623,0.0084043,0.067164,0.079452,MORF_PPP1CC,0.801615323741007
GOBP_POSITIVE_REGULATION_OF_...806,SET,92,0.13918,0.0098274,0.098799,0.079471,GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.801615323741007
MODULE_491,SET,68,0.14321,0.0086993,0.10167,0.079486,MODULE_491,0.801615323741007
GOBP_GOLGI_ORGANIZATION,SET,136,0.099898,0.0085659,0.070921,0.079489,GOBP_GOLGI_ORGANIZATION,0.801615323741007
GOBP_ACYLGLYCEROL_HOMEOSTASIS,SET,35,0.20454,0.0089221,0.14522,0.079495,GOBP_ACYLGLYCEROL_HOMEOSTASIS,0.801615323741007
GOMF_UBIQUITIN_LIKE_PROTEIN_...4,SET,332,0.065513,0.0087296,0.046515,0.079512,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY,0.801615323741007
GOBP_PEPTIDYL_SERINE_AUTOPHO...,SET,8,0.41701,0.0087028,0.29612,0.079538,GOBP_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION,0.801615323741007
CONRAD_GERMLINE_STEM_CELL,SET,8,0.39736,0.0082928,0.28218,0.079543,CONRAD_GERMLINE_STEM_CELL,0.801615323741007
GSE41867_LCMV_ARMSTRONG_VS_C...4,SET,181,0.085219,0.0084195,0.060517,0.079548,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP,0.801615323741007
GOBP_SPINAL_CORD_MOTOR_NEURO...2,SET,27,0.2438,0.0093424,0.17318,0.079604,GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION,0.801615323741007
GOCC_SIDE_OF_MEMBRANE,SET,659,0.051511,0.0095823,0.036593,0.079622,GOCC_SIDE_OF_MEMBRANE,0.801615323741007
FAN_EMBRYONIC_CTX_MICROGLIA_2,SET,8,0.46737,0.0097539,0.33203,0.079631,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.801615323741007
GCGSCMNTTT_UNKNOWN,SET,62,0.15139,0.0087825,0.10755,0.079641,GCGSCMNTTT_UNKNOWN,0.801615323741007
GSE23505_UNTREATED_VS_4DAY_I...1,SET,178,0.092752,0.0090883,0.065914,0.079698,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,0.801615323741007
GOBP_ODONTOGENESIS_OF_DENTIN...,SET,87,0.14147,0.009715,0.10053,0.0797,GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.801615323741007
GOBP_POSITIVE_REGULATION_OF_...688,SET,1682,0.030803,0.008886,0.021893,0.079727,GOBP_POSITIVE_REGULATION_OF_RNA_METABOLIC_PROCESS,0.801615323741007
GSE17721_LPS_VS_POLYIC_12H_B...2,SET,185,0.086121,0.0086012,0.061215,0.079745,GSE17721_LPS_VS_POLYIC_12H_BMDC_UP,0.801615323741007
MIR185_3P,SET,137,0.10566,0.0090929,0.075104,0.079749,MIR185_3P,0.801615323741007
GSE14000_UNSTIM_VS_4H_LPS_DC...2,SET,178,0.095729,0.00938,0.068046,0.079749,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN,0.801615323741007
JIANG_MELANOMA_TRM9_CD8,SET,459,0.056526,0.0088251,0.040195,0.079829,JIANG_MELANOMA_TRM9_CD8,0.801615323741007
GOBP_HETEROCHROMATIN_FORMATI...,SET,95,0.11879,0.0085225,0.084473,0.079839,GOBP_HETEROCHROMATIN_FORMATION,0.801615323741007
HP_CHIN_WITH_HORIZONTAL_CREA...,SET,8,0.50167,0.01047,0.35675,0.079839,HP_CHIN_WITH_HORIZONTAL_CREASE,0.801615323741007
KEGG_MEDICUS_REFERENCE_LIGHT...,SET,9,0.37767,0.0083596,0.26866,0.079908,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY,0.801615323741007
WP_DISORDERS_OF_FRUCTOSE_MET...,SET,12,0.31443,0.0080361,0.22372,0.079949,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.801615323741007
HP_BRADYPHRENIA,SET,5,0.49108,0.008103,0.34943,0.079963,HP_BRADYPHRENIA,0.801615323741007
GOBP_GLANDULAR_EPITHELIAL_CE...3,SET,8,0.4931,0.010291,0.35089,0.079976,GOBP_GLANDULAR_EPITHELIAL_CELL_MATURATION,0.801615323741007
GSE10325_MYELOID_VS_LUPUS_MY...2,SET,170,0.092037,0.0088152,0.065504,0.080011,GSE10325_MYELOID_VS_LUPUS_MYELOID_UP,0.801615323741007
GSE25088_IL4_VS_IL4_AND_ROSI...3,SET,178,0.089905,0.0088093,0.063989,0.080018,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.801615323741007
KEGG_MEDICUS_PATHOGEN_HIV_VP...2,SET,8,0.34559,0.0072123,0.246,0.080046,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M,0.801615323741007
WP_CORTICOTROPINRELEASING_HO...,SET,89,0.13321,0.0092523,0.09483,0.080056,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,0.801615323741007
GSE3982_EOSINOPHIL_VS_MAC_UP,SET,173,0.092335,0.0089207,0.065732,0.080061,GSE3982_EOSINOPHIL_VS_MAC_UP,0.801615323741007
GOMF_INTERLEUKIN_6_RECEPTOR_...,SET,6,0.4729,0.0085475,0.33668,0.080081,GOMF_INTERLEUKIN_6_RECEPTOR_BINDING,0.801615323741007
REACTOME_CLASS_B_2_SECRETIN_...,SET,90,0.14016,0.009789,0.099792,0.080092,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,0.801615323741007
GOBP_CELL_ACTIVATION,SET,1020,0.040318,0.0092353,0.028706,0.080094,GOBP_CELL_ACTIVATION,0.801615323741007
ZHAN_MULTIPLE_MYELOMA_SUBGRO...,SET,30,0.18441,0.0074484,0.13133,0.080135,ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,0.801615323741007
GOCC_AXONEMAL_OUTER_DOUBLET,SET,14,0.36444,0.01006,0.25953,0.080135,GOCC_AXONEMAL_OUTER_DOUBLET,0.801615323741007
GOMF_NUCLEOCYTOPLASMIC_CARRI...,SET,30,0.20234,0.0081724,0.1441,0.080144,GOMF_NUCLEOCYTOPLASMIC_CARRIER_ACTIVITY,0.801615323741007
GSE4984_GALECTIN1_VS_VEHICLE...2,SET,164,0.090196,0.0084864,0.064236,0.08015,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP,0.801615323741007
GSE3039_CD4_TCELL_VS_NKT_CEL...2,SET,182,0.082862,0.008209,0.059038,0.080236,GSE3039_CD4_TCELL_VS_NKT_CELL_UP,0.801683315356231
GOBP_PIECEMEAL_MICROAUTOPHAG...,SET,17,0.28302,0.008608,0.20172,0.080314,GOBP_PIECEMEAL_MICROAUTOPHAGY_OF_THE_NUCLEUS,0.801683315356231
GSE37301_COMMON_LYMPHOID_PRO...7,SET,177,0.090265,0.00882,0.064343,0.080335,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.801683315356231
HP_REDUCED_CONSCIOUSNESS,SET,206,0.083651,0.0088109,0.059631,0.080345,HP_REDUCED_CONSCIOUSNESS,0.801683315356231
GOBP_POSITIVE_REGULATION_OF_...543,SET,9,0.46961,0.010395,0.33486,0.080407,GOBP_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION,0.801683315356231
GOMF_RS_DOMAIN_BINDING,SET,4,0.50544,0.0074596,0.36045,0.08043,GOMF_RS_DOMAIN_BINDING,0.801683315356231
GOBP_NEGATIVE_REGULATION_OF_...148,SET,19,0.25885,0.0083225,0.1846,0.080437,GOBP_NEGATIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.801683315356231
GOBP_RECEPTOR_DIFFUSION_TRAP...,SET,10,0.40957,0.0095558,0.29213,0.080466,GOBP_RECEPTOR_DIFFUSION_TRAPPING,0.801683315356231
FERRANDO_T_ALL_WITH_MLL_ENL_...2,SET,76,0.14202,0.0091182,0.1013,0.080481,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,0.801683315356231
MODULE_61,SET,47,0.17408,0.0087965,0.12418,0.080495,MODULE_61,0.801683315356231
HP_ESOPHAGEAL_STRICTURE,SET,19,0.27602,0.0088747,0.1969,0.080499,HP_ESOPHAGEAL_STRICTURE,0.801683315356231
GSE13522_WT_VS_IFNG_KO_SKIN_...2,SET,119,0.11549,0.0092678,0.082399,0.080524,GSE13522_WT_VS_IFNG_KO_SKIN_UP,0.801683315356231
GOBP_BONE_RESORPTION,SET,65,0.15817,0.0093947,0.11287,0.080561,GOBP_BONE_RESORPTION,0.801683315356231
PID_ERBB1_INTERNALIZATION_PA...,SET,40,0.17929,0.0083593,0.12795,0.080573,PID_ERBB1_INTERNALIZATION_PATHWAY,0.801683315356231
DESCARTES_MAIN_FETAL_IGFBP1_...,SET,128,0.10919,0.0090855,0.077962,0.080675,DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS,0.801683315356231
GOBP_CELLULAR_RESPONSE_TO_ST...3,SET,22,0.26843,0.0092865,0.19169,0.080715,GOBP_CELLULAR_RESPONSE_TO_STEROL,0.801683315356231
GOCC_CATSPER_COMPLEX,SET,11,0.33715,0.0082501,0.24078,0.080729,GOCC_CATSPER_COMPLEX,0.801683315356231
GOBP_POSITIVE_REGULATION_OF_...633,SET,6,0.4499,0.0081317,0.32131,0.080739,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.801683315356231
DARWICHE_SQUAMOUS_CELL_CARCI...2,SET,136,0.10488,0.0089932,0.074912,0.080758,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,0.801683315356231
GOBP_DE_NOVO_PYRIMIDINE_NUCL...,SET,6,0.48288,0.0087279,0.34493,0.080774,GOBP_DE_NOVO_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.801683315356231
GOCC_IMMUNOGLOBULIN_COMPLEX,SET,10,0.43,0.010033,0.30719,0.080803,GOCC_IMMUNOGLOBULIN_COMPLEX,0.801683315356231
HP_ABNORMAL_GLOMERULAR_MESAN...,SET,44,0.17891,0.0087477,0.12782,0.080811,HP_ABNORMAL_GLOMERULAR_MESANGIUM_MORPHOLOGY,0.801683315356231
GSE29618_BCELL_VS_MONOCYTE_UP,SET,160,0.10009,0.0093029,0.071516,0.080833,GSE29618_BCELL_VS_MONOCYTE_UP,0.801683315356231
IWANAGA_CARCINOGENESIS_BY_KR...1,SET,115,0.11193,0.0088308,0.08,0.080896,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,0.801683315356231
MIR548T_5P,SET,389,0.063254,0.0091091,0.045212,0.080908,MIR548T_5P,0.801683315356231
HP_APLASIA_HYPOPLASIA_OF_THE...69,SET,6,0.49832,0.009007,0.3562,0.080916,HP_APLASIA_HYPOPLASIA_OF_THE_SWEAT_GLANDS,0.801683315356231
GSE39820_CTRL_VS_TGFBETA3_IL...4,SET,173,0.086272,0.0083349,0.061676,0.080947,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP,0.801683315356231
HP_ABNORMAL_CONSUMPTION_BEHA...,SET,253,0.078947,0.0092033,0.05644,0.080948,HP_ABNORMAL_CONSUMPTION_BEHAVIOR,0.801683315356231
GOBP_VACUOLAR_ACIDIFICATION,SET,32,0.21161,0.0088266,0.15129,0.080958,GOBP_VACUOLAR_ACIDIFICATION,0.801683315356231
GOCC_WEIBEL_PALADE_BODY,SET,5,0.51438,0.0084873,0.36777,0.080969,GOCC_WEIBEL_PALADE_BODY,0.801683315356231
KEGG_MEDICUS_VARIANT_FZD7_OV...,SET,36,0.20786,0.0091951,0.14862,0.080976,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.801683315356231
HP_CLEFT_LIP,SET,175,0.08937,0.0086835,0.063921,0.081047,HP_CLEFT_LIP,0.801683315356231
HP_ABNORMAL_MATERNAL_SERUM_S...,SET,6,0.54991,0.0099394,0.39332,0.081048,HP_ABNORMAL_MATERNAL_SERUM_SCREENING,0.801683315356231
GSE18791_CTRL_VS_NEWCASTLE_V...9,SET,162,0.09422,0.0088113,0.067397,0.081069,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN,0.801683315356231
GOBP_GENOMIC_IMPRINTING,SET,17,0.27557,0.0083813,0.19712,0.08107,GOBP_GENOMIC_IMPRINTING,0.801683315356231
GSE39820_TGFBETA1_VS_TGFBETA...3,SET,179,0.087593,0.0086066,0.06266,0.081081,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN,0.801683315356231
BILD_CTNNB1_ONCOGENIC_SIGNAT...,SET,72,0.13788,0.0086174,0.098648,0.081112,BILD_CTNNB1_ONCOGENIC_SIGNATURE,0.801683315356231
GSE17301_IFNA2_VS_IFNA5_STIM...2,SET,176,0.089217,0.0086931,0.063843,0.081148,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP,0.801683315356231
GOBP_RETINA_DEVELOPMENT_IN_C...,SET,155,0.1015,0.0092862,0.07263,0.08115,GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.801683315356231
RICHERT_PBMC_HIV_LIPO_5_AGE_...3,SET,5,0.55844,0.0092145,0.3997,0.081191,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_SIGNIFICANT_VARIATION_UP,0.801683315356231
HAY_BONE_MARROW_IMMATURE_NEU...,SET,173,0.094015,0.0090829,0.067294,0.081206,HAY_BONE_MARROW_IMMATURE_NEUTROPHIL,0.801683315356231
HP_WRIST_FLEXION_CONTRACTURE,SET,33,0.22933,0.0097136,0.16417,0.081228,HP_WRIST_FLEXION_CONTRACTURE,0.801683315356231
GOBP_DETECTION_OF_TEMPERATUR...1,SET,26,0.25032,0.0094133,0.17921,0.081245,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS,0.801683315356231
KIM_GLIS2_TARGETS_DN,SET,6,0.46747,0.0084494,0.33468,0.08125,KIM_GLIS2_TARGETS_DN,0.801683315356231
HP_ABNORMAL_CIRCULATING_VITA...1,SET,17,0.29155,0.0088674,0.20874,0.081258,HP_ABNORMAL_CIRCULATING_VITAMIN_A_CONCENTRATION,0.801683315356231
SASAKI_ADULT_T_CELL_LEUKEMIA,SET,154,0.096965,0.0088432,0.069424,0.081259,SASAKI_ADULT_T_CELL_LEUKEMIA,0.801683315356231
GOMF_POTASSIUM_CHANNEL_INHIB...,SET,5,0.52808,0.0087134,0.37809,0.081259,GOMF_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY,0.801683315356231
GSE2770_TGFB_AND_IL4_VS_IL4_...1,SET,178,0.090308,0.0088488,0.064659,0.081264,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.801683315356231
REACTOME_SEMA4D_INDUCED_CELL...,SET,20,0.27311,0.0090091,0.19557,0.081294,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,0.801751694097616
GOBP_RESPONSE_TO_COBALT_ION,SET,9,0.38166,0.008448,0.27336,0.081337,GOBP_RESPONSE_TO_COBALT_ION,0.801819337776517
GSE21670_UNTREATED_VS_TGFB_T...3,SET,180,0.09172,0.009037,0.065696,0.081347,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN,0.801819337776517
GOBP_EMBRYONIC_BRAIN_DEVELOP...,SET,15,0.32566,0.0093046,0.23329,0.081372,GOBP_EMBRYONIC_BRAIN_DEVELOPMENT,0.801838349872413
GOBP_POSITIVE_REGULATION_OF_...773,SET,9,0.38218,0.0084595,0.27382,0.08141,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.801985416666667
PPARG_01,SET,45,0.17528,0.0086669,0.1256,0.081435,PPARG_01,0.802004370926608
HP_MOTOR_TICS,SET,11,0.37524,0.009182,0.269,0.081523,HP_MOTOR_TICS,0.802643587818697
GOBP_MYELOID_CELL_DEVELOPMENT,SET,80,0.13895,0.0091524,0.099631,0.081562,GOBP_MYELOID_CELL_DEVELOPMENT,0.802720451585504
GOBP_NEGATIVE_REGULATION_OF_...596,SET,50,0.17705,0.0092269,0.12696,0.081577,GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.802720451585504
REACTOME_SYNTHESIS_OF_12_EIC...,SET,7,0.47113,0.0091976,0.33794,0.081647,REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES,0.802970927152318
GOCC_BLEB,SET,9,0.41127,0.0091035,0.29503,0.081669,GOCC_BLEB,0.802970927152318
CDC73_TARGET_GENES,SET,478,0.05283,0.0084126,0.037903,0.081694,CDC73_TARGET_GENES,0.802970927152318
SU_LIVER,SET,55,0.17486,0.0095559,0.12547,0.08173,SU_LIVER,0.802970927152318
GOBP_REGULATION_OF_CILIUM_AS...,SET,89,0.12457,0.0086519,0.089411,0.081788,GOBP_REGULATION_OF_CILIUM_ASSEMBLY,0.802970927152318
JIANG_MELANOMA_TRM6_CD8,SET,122,0.10102,0.0082071,0.072518,0.08182,JIANG_MELANOMA_TRM6_CD8,0.802970927152318
GOMF_HISTONE_H3K4_MONOMETHYL...,SET,8,0.4231,0.00883,0.30379,0.081859,GOMF_HISTONE_H3K4_MONOMETHYLTRANSFERASE_ACTIVITY,0.802970927152318
MIR10397_5P,SET,67,0.13882,0.0083705,0.099679,0.081872,MIR10397_5P,0.802970927152318
OHASHI_AURKA_TARGETS,SET,5,0.50303,0.0083002,0.36122,0.081877,OHASHI_AURKA_TARGETS,0.802970927152318
HP_APLASIA_HYPOPLASIA_OF_THE...73,SET,27,0.24221,0.0092813,0.17393,0.081882,HP_APLASIA_HYPOPLASIA_OF_THE_TIBIA,0.802970927152318
HP_DECREASED_CORNEAL_SENSATI...,SET,5,0.61978,0.010226,0.44518,0.081941,HP_DECREASED_CORNEAL_SENSATION,0.802970927152318
GSE29164_DAY3_VS_DAY7_CD8_TC...4,SET,181,0.088007,0.008695,0.063224,0.081972,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP,0.802970927152318
HP_APLASIA_HYPOPLASIA_OF_THE...43,SET,21,0.29208,0.0098726,0.20987,0.082007,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_5TH_FINGER,0.802970927152318
HP_ASCITES,SET,125,0.11064,0.0090981,0.079506,0.082031,HP_ASCITES,0.802970927152318
HP_PULMONARY_FIBROSIS,SET,68,0.14291,0.0086809,0.1027,0.082049,HP_PULMONARY_FIBROSIS,0.802970927152318
GOBP_AMINE_BIOSYNTHETIC_PROC...,SET,35,0.19791,0.008633,0.14225,0.08207,GOBP_AMINE_BIOSYNTHETIC_PROCESS,0.802970927152318
MIR5006_5P,SET,109,0.11014,0.0084612,0.079165,0.08208,MIR5006_5P,0.802970927152318
FAELT_B_CLL_WITH_VH3_21_DN,SET,44,0.18184,0.008891,0.13071,0.082107,FAELT_B_CLL_WITH_VH3_21_DN,0.802970927152318
REACTOME_ACTIVATION_OF_PPARG...,SET,10,0.39048,0.0091106,0.28076,0.082149,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,0.802970927152318
GU_PDEF_TARGETS_DN,SET,37,0.21454,0.0096211,0.15426,0.082162,GU_PDEF_TARGETS_DN,0.802970927152318
GOMF_STEROL_ESTERASE_ACTIVITY,SET,7,0.45793,0.0089399,0.32935,0.082207,GOMF_STEROL_ESTERASE_ACTIVITY,0.802970927152318
GOBP_TONGUE_MORPHOGENESIS,SET,9,0.44957,0.0099513,0.32339,0.082244,GOBP_TONGUE_MORPHOGENESIS,0.802970927152318
QIU_PBMC_HEPTATITIS_B_SURFAC...1,SET,15,0.33626,0.0096075,0.24192,0.082277,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP,0.802970927152318
GNF2_EIF3S6,SET,106,0.10896,0.0082552,0.078391,0.08228,GNF2_EIF3S6,0.802970927152318
HP_ABNORMALITY_OF_THE_DIENCE...,SET,122,0.10665,0.008665,0.076743,0.082313,HP_ABNORMALITY_OF_THE_DIENCEPHALON,0.802970927152318
NOJIMA_SFRP2_TARGETS_UP,SET,29,0.23997,0.0095296,0.17268,0.082321,NOJIMA_SFRP2_TARGETS_UP,0.802970927152318
HP_ABNORMAL_TALUS_MORPHOLOGY,SET,61,0.15055,0.0086636,0.10834,0.082328,HP_ABNORMAL_TALUS_MORPHOLOGY,0.802970927152318
GOBP_ESTABLISHMENT_OF_MITOTI...2,SET,40,0.19219,0.0089608,0.13831,0.082343,GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION,0.802970927152318
MODULE_134,SET,29,0.25492,0.010123,0.18347,0.082357,MODULE_134,0.802970927152318
KEGG_CYTOKINE_CYTOKINE_RECEP...,SET,245,0.088688,0.010176,0.063872,0.082498,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,0.802970927152318
MIR7107_3P,SET,49,0.17758,0.0091616,0.12794,0.082586,MIR7107_3P,0.802970927152318
GOBP_POSITIVE_REGULATION_OF_...789,SET,7,0.43288,0.0084509,0.31193,0.082612,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY,0.802970927152318
GOBP_NEURAL_PLATE_MORPHOGENE...,SET,4,0.56352,0.0083168,0.40623,0.082702,GOBP_NEURAL_PLATE_MORPHOGENESIS,0.802970927152318
GSE6092_UNSTIM_VS_IFNG_STIM_...2,SET,179,0.085504,0.0084013,0.061644,0.082719,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.802970927152318
GOCC_RNA_POLYMERASE_III_TRAN...,SET,9,0.32624,0.0072212,0.23521,0.082731,GOCC_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATOR_COMPLEX,0.802970927152318
REACTOME_SUMOYLATION_OF_IMMU...,SET,10,0.37429,0.0087328,0.2699,0.082767,REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,0.802970927152318
CAGNWMCNNNGAC_UNKNOWN,SET,79,0.14122,0.0092432,0.10183,0.08277,CAGNWMCNNNGAC_UNKNOWN,0.802970927152318
GOBP_VESICLE_MEDIATED_TRANSP...1,SET,1409,0.032878,0.0087517,0.023712,0.082797,GOBP_VESICLE_MEDIATED_TRANSPORT,0.802970927152318
FAN_EMBRYONIC_CTX_BIG_GROUPS...1,SET,341,0.070636,0.0095367,0.050945,0.082801,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL,0.802970927152318
GOBP_MONOCYTE_CHEMOTAXIS,SET,47,0.18302,0.009248,0.13201,0.082819,GOBP_MONOCYTE_CHEMOTAXIS,0.802970927152318
MIR4632_5P,SET,91,0.12578,0.0088329,0.090726,0.08283,MIR4632_5P,0.802970927152318
GSE46242_TH1_VS_ANERGIC_TH1_...2,SET,168,0.092517,0.0088094,0.066737,0.082837,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP,0.802970927152318
GSE14386_UNTREATED_VS_IFNA_T...1,SET,149,0.1014,0.0090974,0.073154,0.082868,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN,0.802970927152318
KOKKINAKIS_METHIONINE_DEPRIV...1,SET,57,0.15851,0.0088181,0.11437,0.082891,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,0.802970927152318
RUBENSTEIN_SKELETAL_MUSCLE_T...,SET,157,0.093054,0.0085681,0.067143,0.082894,RUBENSTEIN_SKELETAL_MUSCLE_T_CELLS,0.802970927152318
LAKE_ADULT_KIDNEY_C1_EPITHEL...,SET,27,0.23824,0.0091292,0.1719,0.082897,LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED,0.802970927152318
GOBP_RESPONSE_TO_INTERLEUKIN...2,SET,12,0.35972,0.0091935,0.25957,0.082906,GOBP_RESPONSE_TO_INTERLEUKIN_12,0.802970927152318
DESCARTES_MAIN_FETAL_EXTRAVI...,SET,97,0.124,0.0089891,0.08948,0.082916,DESCARTES_MAIN_FETAL_EXTRAVILLOUS_TROPHOBLASTS,0.802970927152318
REACTOME_SYNTHESIS_OF_IP2_IP...,SET,13,0.27423,0.0072946,0.19793,0.082961,REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL,0.802970927152318
KEGG_MEDICUS_VARIANT_LMO2_RE...2,SET,5,0.54715,0.0090281,0.39493,0.082967,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_REPRESSION,0.802970927152318
GSE29164_DAY3_VS_DAY7_CD8_TC...3,SET,183,0.089246,0.0088655,0.064419,0.082975,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN,0.802970927152318
GSE22886_NAIVE_CD8_TCELL_VS_...2,SET,172,0.088319,0.0085082,0.063756,0.082996,GSE22886_NAIVE_CD8_TCELL_VS_DC_UP,0.802970927152318
HP_COLITIS,SET,62,0.15512,0.0089989,0.11198,0.083008,HP_COLITIS,0.802970927152318
GSE39556_CD8A_DC_VS_NK_CELL_...3,SET,179,0.081651,0.0080228,0.05895,0.083021,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP,0.802970927152318
UNTERMAN_IPF_VS_CTRL_NK_CELL...2,SET,2,0.65281,0.006813,0.47138,0.083053,UNTERMAN_IPF_VS_CTRL_NK_CELL_UP,0.802970927152318
KEGG_MEDICUS_REFERENCE_HEDGE...3,SET,9,0.423,0.0093631,0.30544,0.083054,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR,0.802970927152318
RICKMAN_HEAD_AND_NECK_CANCER...1,SET,88,0.13746,0.0094936,0.099259,0.083061,RICKMAN_HEAD_AND_NECK_CANCER_A,0.802970927152318
GAVISH_3CA_MALIGNANT_METAPRO...4,SET,48,0.18823,0.0096116,0.13596,0.083121,GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2,0.802970927152318
GOBP_RESPONSE_TO_PROGESTERONE,SET,42,0.18523,0.0088494,0.1338,0.083129,GOBP_RESPONSE_TO_PROGESTERONE,0.802970927152318
FISCHER_DIRECT_P53_TARGETS_M...,SET,290,0.068153,0.0084974,0.049236,0.083155,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,0.802970927152318
GOMF_PYRIMIDINE_NUCLEOTIDE_S...,SET,10,0.35257,0.008226,0.25473,0.083175,GOMF_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.802970927152318
WP_NEURAL_CREST_DIFFERENTIAT...,SET,94,0.13245,0.0094529,0.095696,0.083179,WP_NEURAL_CREST_DIFFERENTIATION,0.802970927152318
HP_RETROCEREBELLAR_CYST,SET,7,0.3954,0.007719,0.28569,0.083189,HP_RETROCEREBELLAR_CYST,0.802970927152318
GSE21546_UNSTIM_VS_ANTI_CD3_...7,SET,132,0.10553,0.0089161,0.076263,0.083216,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN,0.802970927152318
GOBP_NUCLEOBASE_CONTAINING_S...3,SET,8,0.45123,0.0094171,0.32608,0.083219,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION,0.802970927152318
GOBP_IMMATURE_B_CELL_DIFFERE...,SET,12,0.35993,0.0091988,0.26015,0.08326,GOBP_IMMATURE_B_CELL_DIFFERENTIATION,0.802970927152318
GSE24142_ADULT_VS_FETAL_EARL...1,SET,177,0.091192,0.0089105,0.065915,0.083269,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN,0.802970927152318
GOBP_SNRNA_TRANSCRIPTION_BY_...2,SET,9,0.35029,0.0077536,0.2532,0.083275,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.802970927152318
BOYAULT_LIVER_CANCER_SUBCLAS...11,SET,177,0.087193,0.0085198,0.063043,0.08333,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,0.802970927152318
ETS2_B,SET,256,0.075132,0.0088097,0.054323,0.083331,ETS2_B,0.802970927152318
WP_LDL_INFLUENCE_ON_CD14_AND...,SET,22,0.26403,0.0091343,0.19091,0.083334,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,0.802970927152318
GOBP_RIBOSOME_BIOGENESIS,SET,272,0.066738,0.0080627,0.048261,0.083364,GOBP_RIBOSOME_BIOGENESIS,0.802970927152318
VERRECCHIA_RESPONSE_TO_TGFB1...4,SET,11,0.3898,0.0095384,0.2819,0.083376,VERRECCHIA_RESPONSE_TO_TGFB1_C4,0.802970927152318
HP_LYMPHOMA,SET,112,0.11269,0.008775,0.081508,0.083399,HP_LYMPHOMA,0.802970927152318
GSE26343_WT_VS_NFAT5_KO_MACR...1,SET,186,0.088776,0.00889,0.064211,0.08341,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN,0.802970927152318
GOBP_CHROMATIN_REMODELING,SET,515,0.050652,0.0083634,0.036645,0.08346,GOBP_CHROMATIN_REMODELING,0.802970927152318
GSE20151_CTRL_VS_FUSOBACT_NU...2,SET,178,0.086366,0.0084625,0.062484,0.083463,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP,0.802970927152318
MORF_MBD4,SET,75,0.12314,0.0078546,0.089099,0.083476,MORF_MBD4,0.802970927152318
WP_MRNA_VACCINE_ACTIVATION_O...,SET,7,0.39683,0.007747,0.28714,0.083494,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,0.802970927152318
GOBP_POST_CHAPERONIN_TUBULIN...,SET,6,0.39318,0.0071066,0.28452,0.08351,GOBP_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.802970927152318
ZNF250_TARGET_GENES,SET,444,0.055754,0.0085647,0.040347,0.083519,ZNF250_TARGET_GENES,0.802970927152318
MENON_FETAL_KIDNEY_6_COLLECT...,SET,84,0.1367,0.009225,0.098939,0.083553,MENON_FETAL_KIDNEY_6_COLLECTING_DUCT_CELLS,0.802970927152318
GOMF_HISTONE_H3K9ME2_H3K9ME3...,SET,5,0.44801,0.0073923,0.3243,0.083574,GOMF_HISTONE_H3K9ME2_H3K9ME3_DEMETHYLASE_ACTIVITY,0.802970927152318
KEGG_MEDICUS_REFERENCE_ARL8_...,SET,30,0.21509,0.0086876,0.1557,0.083579,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.802970927152318
GOBP_REGULATION_BY_VIRUS_OF_...,SET,7,0.41035,0.008011,0.29707,0.083595,GOBP_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL,0.802970927152318
HP_BICORONAL_SYNOSTOSIS,SET,9,0.37115,0.0082153,0.26872,0.083626,HP_BICORONAL_SYNOSTOSIS,0.802970927152318
GAUTAM_EYE_CHOROID_SCLERA_ME...,SET,136,0.09807,0.0084092,0.071012,0.083643,GAUTAM_EYE_CHOROID_SCLERA_MELANOCYTES,0.802970927152318
GOBP_REGULATION_OF_CELL_POPU...,SET,1514,0.032823,0.0090285,0.023768,0.083652,GOBP_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.802970927152318
GSE19401_NAIVE_VS_IMMUNIZED_...2,SET,185,0.089711,0.0089598,0.06497,0.083677,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP,0.802970927152318
HP_HYPERCHOLESTEROLEMIA,SET,69,0.15308,0.0093666,0.11087,0.083693,HP_HYPERCHOLESTEROLEMIA,0.802970927152318
MODULE_189,SET,9,0.32829,0.0072667,0.2378,0.083721,MODULE_189,0.802970927152318
HP_HEPATIC_NECROSIS,SET,13,0.31613,0.0084091,0.229,0.083728,HP_HEPATIC_NECROSIS,0.802970927152318
GOBP_POSITIVE_REGULATION_OF_...49,SET,147,0.098488,0.0087772,0.071363,0.083789,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY,0.80307334987593
GOBP_SRP_DEPENDENT_COTRANSLA...3,SET,8,0.41629,0.0086878,0.30166,0.0838,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.80307334987593
GSE22432_MULTIPOTENT_VS_COMM...1,SET,187,0.084923,0.0085268,0.06154,0.083808,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN,0.80307334987593
HU_FETAL_RETINA_RPE,SET,252,0.081129,0.0094393,0.058806,0.083862,HU_FETAL_RETINA_RPE,0.803253073030635
GOMF_MANNOSYLTRANSFERASE_ACT...,SET,24,0.22061,0.0079711,0.15999,0.083962,GOMF_MANNOSYLTRANSFERASE_ACTIVITY,0.803253073030635
GOCC_CEREBELLAR_MOSSY_FIBER,SET,7,0.4471,0.0087285,0.32438,0.084061,GOCC_CEREBELLAR_MOSSY_FIBER,0.803253073030635
GOMF_ALPHA_KETOGLUTARATE_TRA...,SET,6,0.45954,0.0083059,0.33344,0.084084,GOMF_ALPHA_KETOGLUTARATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.803253073030635
GOBP_CELL_SURFACE_PATTERN_RE...,SET,71,0.14278,0.0088619,0.10361,0.084106,GOBP_CELL_SURFACE_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.803253073030635
GSE21546_WT_VS_ELK1_KO_ANTI_...2,SET,183,0.08666,0.0086086,0.06289,0.084117,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.803253073030635
GOBP_DNA_REPLICATION_INITIAT...,SET,35,0.19125,0.0083423,0.13881,0.084143,GOBP_DNA_REPLICATION_INITIATION,0.803253073030635
MIR618,SET,59,0.14935,0.0084529,0.1084,0.084145,MIR618,0.803253073030635
GSE43955_TGFB_IL6_VS_TGFB_IL...4,SET,183,0.084729,0.0084168,0.061502,0.084161,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.803253073030635
REACTOME_PKA_MEDIATED_PHOSPH...1,SET,19,0.30433,0.0097849,0.2209,0.084163,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,0.803253073030635
MIR365A_3P_MIR365B_3P,SET,106,0.11394,0.0086328,0.082715,0.084179,MIR365A_3P_MIR365B_3P,0.803253073030635
KEGG_MEDICUS_REFERENCE_GLOBA...,SET,16,0.23616,0.0069686,0.17147,0.084216,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER,0.803253073030635
KHETCHOUMIAN_TRIM24_TARGETS_...1,SET,7,0.48056,0.0093817,0.34893,0.084225,KHETCHOUMIAN_TRIM24_TARGETS_DN,0.803253073030635
GSE21379_WT_VS_SAP_KO_TFH_CD...2,SET,175,0.090848,0.0088271,0.065964,0.084228,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP,0.803253073030635
HOEK_MYELOID_DENDRITIC_CELL_...3,SET,16,0.28456,0.0083967,0.20662,0.084232,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_DN,0.803253073030635
HP_ABNORMAL_SYNOVIAL_MEMBRAN...,SET,15,0.31173,0.0089066,0.22639,0.084268,HP_ABNORMAL_SYNOVIAL_MEMBRANE_MORPHOLOGY,0.803253073030635
REACTOME_DISEASES_ASSOCIATED...1,SET,38,0.19328,0.0087841,0.14038,0.084286,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,0.803253073030635
HP_EXCESSIVE_SALIVATION,SET,106,0.11712,0.0088731,0.08507,0.084312,HP_EXCESSIVE_SALIVATION,0.803253073030635
GOMF_PROTEIN_SERINE_THREONIN...7,SET,42,0.18722,0.0089441,0.13599,0.084319,GOMF_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY,0.803253073030635
SUH_COEXPRESSED_WITH_ID1_AND...,SET,18,0.29044,0.0090895,0.211,0.084345,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,0.803253073030635
HP_REDUCED_DELAYED_HYPERSENS...,SET,4,0.57689,0.0085141,0.41913,0.084359,HP_REDUCED_DELAYED_HYPERSENSITIVITY,0.803253073030635
MIKKELSEN_IPS_LCP_WITH_H3K4M...2,SET,5,0.62894,0.010378,0.45697,0.084366,MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.803253073030635
GOCC_HOST_CELLULAR_COMPONENT,SET,9,0.37485,0.0082973,0.27243,0.084426,GOCC_HOST_CELLULAR_COMPONENT,0.803253073030635
MIR6764_5P,SET,213,0.082112,0.0087928,0.059679,0.084434,MIR6764_5P,0.803253073030635
GOBP_DETECTION_OF_CELL_DENSI...,SET,8,0.3964,0.0082727,0.28815,0.084471,GOBP_DETECTION_OF_CELL_DENSITY,0.803253073030635
GSE39110_UNTREATED_VS_IL2_TR...1,SET,182,0.085154,0.0084361,0.061901,0.084476,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN,0.803253073030635
WEINBERGER_BLOOD_TWINRIX_AGE...3,SET,6,0.56145,0.010148,0.40816,0.084487,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_4_POST_BOOSTER_VACC_1DY_POSITIVE,0.803253073030635
DPPA3_TARGET_GENES,SET,16,0.26272,0.0077521,0.19099,0.08449,DPPA3_TARGET_GENES,0.803253073030635
HP_DECREASED_URINE_OUTPUT,SET,24,0.25933,0.00937,0.18854,0.084497,HP_DECREASED_URINE_OUTPUT,0.803253073030635
NIKOLSKY_BREAST_CANCER_19P13...,SET,5,0.74689,0.012324,0.54311,0.084539,NIKOLSKY_BREAST_CANCER_19P13_AMPLICON,0.803279450519409
GCM_DPF2,SET,27,0.20139,0.0077172,0.14644,0.084546,GCM_DPF2,0.803279450519409
WP_HOSTPATHOGEN_INTERACTION_...2,SET,18,0.28522,0.0089261,0.20751,0.084659,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,0.803592087537497
GOBP_EMBRYO_DEVELOPMENT_ENDI...,SET,641,0.048334,0.0088721,0.035175,0.084713,GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING,0.803592087537497
HP_ABNORMAL_CIRCULATING_ALBU...,SET,108,0.11114,0.008499,0.080882,0.084713,HP_ABNORMAL_CIRCULATING_ALBUMIN_CONCENTRATION,0.803592087537497
HALLMARK_E2F_TARGETS,SET,188,0.079817,0.0080353,0.058086,0.084713,HALLMARK_E2F_TARGETS,0.803592087537497
GOBP_REGULATION_OF_PROTEIN_A...3,SET,34,0.20438,0.008787,0.14875,0.084732,GOBP_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.803592087537497
GOMF_ASPARTIC_TYPE_ENDOPEPTI...,SET,7,0.47533,0.0092795,0.34598,0.084749,GOMF_ASPARTIC_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.803592087537497
WP_HEDGEHOG_SIGNALING_WP47,SET,14,0.29465,0.0081334,0.21448,0.084762,WP_HEDGEHOG_SIGNALING_WP47,0.803592087537497
GOBP_POSITIVE_REGULATION_OF_...329,SET,6,0.39787,0.0071913,0.28964,0.08478,GOBP_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY,0.803592087537497
GOBP_SEBACEOUS_GLAND_DEVELOP...,SET,10,0.3965,0.0092509,0.28865,0.084787,GOBP_SEBACEOUS_GLAND_DEVELOPMENT,0.803592087537497
HSIAO_LIVER_SPECIFIC_GENES,SET,225,0.083969,0.0092384,0.06115,0.08486,HSIAO_LIVER_SPECIFIC_GENES,0.803790942857143
HOEK_PBMC_INACTIVATED_INFLUE...2,SET,2,0.76727,0.0080076,0.55886,0.084896,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP,0.803790942857143
GOBP_PRIMITIVE_STREAK_FORMAT...,SET,8,0.43416,0.0090608,0.31624,0.084901,GOBP_PRIMITIVE_STREAK_FORMATION,0.803790942857143
HP_BILATERAL_SENSORINEURAL_H...,SET,60,0.15219,0.0086857,0.11088,0.084951,HP_BILATERAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.803790942857143
GOBP_REGULATION_OF_ANTIMICRO...1,SET,11,0.38202,0.0093479,0.27833,0.084957,GOBP_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.803790942857143
MIR6829_5P,SET,89,0.12404,0.0086152,0.090376,0.084965,MIR6829_5P,0.803790942857143
MIR548AI_MIR570_5P,SET,161,0.093643,0.0087305,0.068237,0.084988,MIR548AI_MIR570_5P,0.803790942857143
GOBP_REGULATION_OF_CHONDROCY...1,SET,4,0.72712,0.010731,0.52985,0.084993,GOBP_REGULATION_OF_CHONDROCYTE_DEVELOPMENT,0.803790942857143
HU_FETAL_RETINA_BLOOD,SET,244,0.07818,0.0089526,0.056997,0.085094,HU_FETAL_RETINA_BLOOD,0.804327299428882
GNF2_RRM2,SET,38,0.18623,0.0084637,0.13577,0.085096,GNF2_RRM2,0.804327299428882
PID_PS1_PATHWAY,SET,42,0.19361,0.0092493,0.14117,0.085128,PID_PS1_PATHWAY,0.804410995106036
GSE360_CTRL_VS_B_MALAYI_HIGH...4,SET,178,0.084667,0.0082961,0.061753,0.085186,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.804740263658603
REACTOME_SIGNALING_BY_ERBB4,SET,54,0.15301,0.0082861,0.11162,0.085219,REACTOME_SIGNALING_BY_ERBB4,0.804833245923913
REACTOME_CONSTITUTIVE_SIGNAL...4,SET,18,0.25776,0.0080668,0.18809,0.085283,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,0.805009619771863
MIR6877_3P,SET,31,0.20988,0.0086171,0.15315,0.085284,MIR6877_3P,0.805009619771863
HP_AMYOTROPHIC_LATERAL_SCLER...,SET,48,0.16394,0.0083714,0.11965,0.085329,HP_AMYOTROPHIC_LATERAL_SCLEROSIS,0.805025423452769
GSE7460_CTRL_VS_TGFB_TREATED...6,SET,177,0.08826,0.0086241,0.064418,0.085332,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP,0.805025423452769
HP_KNEE_OSTEOARTHRITIS,SET,14,0.34771,0.0095981,0.25387,0.085402,HP_KNEE_OSTEOARTHRITIS,0.805467166892809
REACTOME_FORMATION_OF_INTERM...,SET,7,0.50585,0.0098753,0.36936,0.085426,REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM,0.805474940314704
GSE17186_NAIVE_VS_CD21HIGH_T...1,SET,178,0.087291,0.0085531,0.063753,0.085478,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.805746647681042
GARGALOVIC_RESPONSE_TO_OXIDI...5,SET,13,0.30246,0.0080455,0.22093,0.085503,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,0.805763764913232
GOCC_CHROMAFFIN_GRANULE,SET,14,0.35996,0.0099362,0.263,0.085557,GOCC_CHROMAFFIN_GRANULE,0.805796228664319
HP_HAMSTRING_CONTRACTURES,SET,5,0.52922,0.0087322,0.38667,0.085564,HP_HAMSTRING_CONTRACTURES,0.805796228664319
HAMAI_APOPTOSIS_VIA_TRAIL_UP,SET,596,0.04757,0.0084304,0.034759,0.085576,HAMAI_APOPTOSIS_VIA_TRAIL_UP,0.805796228664319
CCCAGAG_MIR326,SET,137,0.10095,0.0086878,0.073774,0.085603,CCCAGAG_MIR326,0.805832141115926
EBAUER_TARGETS_OF_PAX3_FOXO1...1,SET,46,0.17801,0.0088989,0.13013,0.08567,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.806244476035743
HP_PARTIAL_ANOMALOUS_PULMONA...,SET,6,0.48477,0.0087621,0.35446,0.085721,HP_PARTIAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.806316
GOBP_NUCLEOTIDE_BINDING_OLIG...2,SET,16,0.31731,0.0093631,0.23209,0.085786,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.806316
GOBP_GENERAL_ADAPTATION_SYND...2,SET,5,0.56212,0.0092751,0.41118,0.085809,GOBP_GENERAL_ADAPTATION_SYNDROME_BEHAVIORAL_PROCESS,0.806316
PID_CDC42_REG_PATHWAY,SET,25,0.2362,0.00871,0.17279,0.08582,PID_CDC42_REG_PATHWAY,0.806316
HP_RECURRENT_ABSCESS_FORMATI...,SET,16,0.34,0.010033,0.24873,0.085829,HP_RECURRENT_ABSCESS_FORMATION,0.806316
GOCC_REPLICATION_FORK,SET,69,0.13068,0.007996,0.095601,0.085837,GOCC_REPLICATION_FORK,0.806316
MIR101_2_5P,SET,6,0.44541,0.0080506,0.32586,0.08584,MIR101_2_5P,0.806316
REACTOME_SULFUR_AMINO_ACID_M...,SET,26,0.24151,0.009082,0.17671,0.085867,REACTOME_SULFUR_AMINO_ACID_METABOLISM,0.806351684679816
GOBP_REGULATION_OF_ANIMAL_OR...2,SET,82,0.14005,0.0093388,0.10249,0.085894,GOBP_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.806387350081037
BERTUCCI_INVASIVE_CARCINOMA_...1,SET,41,0.19026,0.0089809,0.13925,0.085932,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,0.806526238185255
GOBP_REGULATION_OF_ORGAN_GRO...,SET,80,0.14154,0.0093229,0.10361,0.08597,GOBP_REGULATION_OF_ORGAN_GROWTH,0.806665051295896
REACTOME_DUAL_INCISION_IN_TC...,SET,60,0.13468,0.0076868,0.098642,0.086075,REACTOME_DUAL_INCISION_IN_TC_NER,0.807432287449393
GOBP_MORPHOGENESIS_OF_AN_EPI...2,SET,22,0.27378,0.0094713,0.20061,0.086184,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD,0.808159224440248
chr19q12,SET,9,0.53928,0.011937,0.3952,0.086199,chr19q12,0.808159224440248
HP_LOSS_OF_AMBULATION,SET,114,0.10584,0.008314,0.077584,0.086262,HP_LOSS_OF_AMBULATION,0.80853177184466
AAAGGAT_MIR501,SET,111,0.11364,0.0088095,0.083321,0.086306,AAAGGAT_MIR501,0.808611141509434
GOBP_POSITIVE_REGULATION_OF_...58,SET,48,0.18068,0.0092262,0.13248,0.086317,GOBP_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.808611141509434
MIR6865_3P,SET,40,0.17515,0.0081664,0.12845,0.086363,MIR6865_3P,0.808824054163298
BACH2_01,SET,242,0.076188,0.0086891,0.05589,0.086424,BACH2_01,0.809127850794506
REACTOME_FORMATION_OF_THE_EA...,SET,32,0.17817,0.0074318,0.13071,0.086442,REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,0.809127850794506
GOBP_PENETRATION_OF_ZONA_PEL...,SET,9,0.39238,0.0086852,0.28795,0.086507,GOBP_PENETRATION_OF_ZONA_PELLUCIDA,0.809392457649906
HP_HORIZONTAL_PENDULAR_NYSTA...,SET,7,0.4665,0.0091072,0.34243,0.086559,HP_HORIZONTAL_PENDULAR_NYSTAGMUS,0.809392457649906
GSE41176_WT_VS_TAK1_KO_ANTI_...6,SET,174,0.088924,0.0086156,0.065282,0.086583,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP,0.809392457649906
HP_POLYCLONAL_ELEVATION_OF_I...,SET,6,0.44287,0.0080047,0.32513,0.086586,HP_POLYCLONAL_ELEVATION_OF_IGM,0.809392457649906
GOBP_CORPUS_CALLOSUM_DEVELOP...,SET,25,0.2468,0.009101,0.18119,0.08659,GOBP_CORPUS_CALLOSUM_DEVELOPMENT,0.809392457649906
GOBP_NEGATIVE_REGULATION_OF_...123,SET,640,0.049109,0.0090077,0.036057,0.08661,GOBP_NEGATIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.809392457649906
HP_SMALL_THENAR_EMINENCE,SET,10,0.38288,0.0089332,0.28116,0.086642,HP_SMALL_THENAR_EMINENCE,0.809473846774193
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SET,49,0.16906,0.0087219,0.1242,0.086736,SMIRNOV_RESPONSE_TO_IR_2HR_UP,0.809756054750403
GSE24574_NAIVE_VS_TCONV_CD4_...2,SET,181,0.090196,0.0089112,0.066265,0.086745,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP,0.809756054750403
GOCC_POSTSYNAPTIC_CYTOSKELET...,SET,13,0.31253,0.0083132,0.22964,0.086778,GOCC_POSTSYNAPTIC_CYTOSKELETON,0.809756054750403
GOBP_TRANS_SYNAPTIC_SIGNALIN...4,SET,9,0.44732,0.0099013,0.32873,0.086809,GOBP_TRANS_SYNAPTIC_SIGNALING_MODULATING_SYNAPTIC_TRANSMISSION,0.809756054750403
REACTOME_AMINO_ACIDS_REGULAT...,SET,49,0.16116,0.0083147,0.11844,0.086811,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,0.809756054750403
GOBP_NEGATIVE_REGULATION_OF_...584,SET,6,0.5013,0.0090607,0.36841,0.086812,GOBP_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.809756054750403
GOBP_ANATOMICAL_STRUCTURE_MA...,SET,247,0.07781,0.0089641,0.057199,0.08687,GOBP_ANATOMICAL_STRUCTURE_MATURATION,0.810079648510867
GOBP_MITOTIC_SPINDLE_ORGANIZ...,SET,124,0.098955,0.0081048,0.072797,0.087028,GOBP_MITOTIC_SPINDLE_ORGANIZATION,0.810786318681319
GOBP_REGULATION_OF_LAMELLIPO...3,SET,43,0.18343,0.0088665,0.13494,0.087037,GOBP_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.810786318681319
PUJANA_XPRSS_INT_NETWORK,SET,155,0.086551,0.0079188,0.06368,0.087056,PUJANA_XPRSS_INT_NETWORK,0.810786318681319
HP_ABNORMAL_URINE_METABOLITE...,SET,521,0.051016,0.008471,0.037535,0.087057,HP_ABNORMAL_URINE_METABOLITE_LEVEL,0.810786318681319
WP_ADIPOGENESIS,SET,125,0.1093,0.0089874,0.080421,0.087075,WP_ADIPOGENESIS,0.810786318681319
GOBP_PYRIMIDINE_NUCLEOSIDE_M...4,SET,20,0.25236,0.0083245,0.1857,0.087096,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.810786318681319
GOBP_ALDITOL_METABOLIC_PROCE...,SET,21,0.28198,0.0095309,0.20758,0.087179,GOBP_ALDITOL_METABOLIC_PROCESS,0.810786318681319
GOBP_SUCCINYL_COA_CATABOLIC_...,SET,6,0.47804,0.0086403,0.35195,0.087201,GOBP_SUCCINYL_COA_CATABOLIC_PROCESS,0.810786318681319
WP_COMPLEMENT_AND_COAGULATIO...,SET,52,0.17657,0.0093834,0.13002,0.087236,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.810786318681319
REACTOME_ANTIVIRAL_MECHANISM...,SET,135,0.097448,0.0083253,0.07176,0.087246,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,0.810786318681319
MIR4423_5P,SET,26,0.22763,0.0085598,0.16769,0.087336,MIR4423_5P,0.810786318681319
HP_ALEXIA,SET,7,0.424,0.0082774,0.31239,0.087355,HP_ALEXIA,0.810786318681319
HP_DELAYED_EARLY_CHILDHOOD_S...,SET,20,0.25738,0.0084903,0.18964,0.087369,HP_DELAYED_EARLY_CHILDHOOD_SOCIAL_MILESTONE_DEVELOPMENT,0.810786318681319
PEPPER_CHRONIC_LYMPHOCYTIC_L...1,SET,21,0.27838,0.0094093,0.20511,0.08737,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.810786318681319
GOMF_NUCLEOSOMAL_DNA_BINDING,SET,24,0.23186,0.0083774,0.17088,0.087429,GOMF_NUCLEOSOMAL_DNA_BINDING,0.810786318681319
HP_LOW_FRUSTRATION_TOLERANCE,SET,22,0.2438,0.0084342,0.17973,0.08748,HP_LOW_FRUSTRATION_TOLERANCE,0.810786318681319
GOMF_TRANSCRIPTION_COREGULAT...2,SET,105,0.11622,0.008764,0.085687,0.087502,GOMF_TRANSCRIPTION_COREGULATOR_BINDING,0.810786318681319
SARTIPY_BLUNTED_BY_INSULIN_R...2,SET,18,0.28089,0.0087909,0.20711,0.087513,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,0.810786318681319
NEBEN_AML_WITH_FLT3_OR_NRAS_...2,SET,7,0.43964,0.0085827,0.32417,0.087527,NEBEN_AML_WITH_FLT3_OR_NRAS_UP,0.810786318681319
GOBP_REGULATION_OF_G2_MI_TRA...,SET,4,0.51683,0.0076277,0.38112,0.087544,GOBP_REGULATION_OF_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.810786318681319
REACTOME_NEGATIVE_REGULATION...6,SET,14,0.28763,0.0079395,0.21211,0.087552,REACTOME_NEGATIVE_REGULATION_OF_FLT3,0.810786318681319
MIR122B_5P,SET,195,0.080695,0.008272,0.059513,0.087569,MIR122B_5P,0.810786318681319
GOCC_ORGANELLE_ENVELOPE_LUMEN,SET,83,0.12737,0.0085444,0.093944,0.08759,GOCC_ORGANELLE_ENVELOPE_LUMEN,0.810786318681319
GSE3982_MAC_VS_TH1_DN,SET,180,0.083261,0.0082036,0.061412,0.087592,GSE3982_MAC_VS_TH1_DN,0.810786318681319
GSE16450_IMMATURE_VS_MATURE_...2,SET,180,0.087635,0.0086345,0.06464,0.087602,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.810786318681319
GOBP_CELL_DIVISION,SET,577,0.048015,0.0083771,0.035421,0.087632,GOBP_CELL_DIVISION,0.810786318681319
GTACTGT_MIR101,SET,233,0.076898,0.0086077,0.056733,0.087645,GTACTGT_MIR101,0.810786318681319
GSE25088_CTRL_VS_ROSIGLITAZO...1,SET,138,0.095983,0.0082901,0.070823,0.087677,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.810786318681319
REACTOME_DAG_AND_IP3_SIGNALI...,SET,39,0.20081,0.0092451,0.1482,0.087717,REACTOME_DAG_AND_IP3_SIGNALING,0.810786318681319
GOBP_CELLULAR_RESPONSE_TO_CA...2,SET,10,0.35757,0.0083427,0.26391,0.08773,GOBP_CELLULAR_RESPONSE_TO_CAFFEINE,0.810786318681319
KEGG_MEDICUS_REFERENCE_GLUTA...,SET,11,0.34088,0.0083412,0.25166,0.087796,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS,0.810786318681319
REACTOME_SYNTHESIS_OF_DOLICH...,SET,5,0.52451,0.0086546,0.38728,0.087823,REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE,0.810786318681319
GSE45365_NK_CELL_VS_CD8A_DC_...1,SET,181,0.088872,0.0087805,0.065622,0.087829,GSE45365_NK_CELL_VS_CD8A_DC_DN,0.810786318681319
GSE3982_MAST_CELL_VS_TH2_DN,SET,181,0.08208,0.0081094,0.060608,0.087835,GSE3982_MAST_CELL_VS_TH2_DN,0.810786318681319
GSE14000_TRANSLATED_RNA_VS_M...2,SET,146,0.095376,0.0084712,0.070431,0.087849,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP,0.810786318681319
GOBP_PROTEIN_DE_ADP_RIBOSYLA...,SET,4,0.69553,0.010265,0.51367,0.087871,GOBP_PROTEIN_DE_ADP_RIBOSYLATION,0.810786318681319
GSE29618_BCELL_VS_PDC_DAY7_F...2,SET,165,0.095769,0.009038,0.070733,0.087885,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP,0.810786318681319
GSE11057_CD4_CENT_MEM_VS_PBM...2,SET,178,0.085037,0.0083323,0.062807,0.087888,GSE11057_CD4_CENT_MEM_VS_PBMC_UP,0.810786318681319
REACTOME_CELL_CYCLE,SET,591,0.045918,0.0081047,0.033921,0.087931,REACTOME_CELL_CYCLE,0.810786318681319
GOBP_REGULATION_OF_LIPID_STO...,SET,49,0.17286,0.0089184,0.12772,0.087965,GOBP_REGULATION_OF_LIPID_STORAGE,0.810786318681319
BOYLAN_MULTIPLE_MYELOMA_D_UP,SET,82,0.13099,0.0087348,0.096789,0.087972,BOYLAN_MULTIPLE_MYELOMA_D_UP,0.810786318681319
MIR4729,SET,642,0.046985,0.0086311,0.034721,0.087999,MIR4729,0.810786318681319
KARLSSON_TGFB1_TARGETS_UP,SET,113,0.10807,0.0084518,0.079866,0.088022,KARLSSON_TGFB1_TARGETS_UP,0.810786318681319
MIR8068,SET,353,0.064138,0.0088074,0.047402,0.088024,MIR8068,0.810786318681319
GOBP_ORGANELLE_FUSION,SET,152,0.092777,0.0084066,0.068574,0.088045,GOBP_ORGANELLE_FUSION,0.810786318681319
GOBP_REGULATION_OF_HUMORAL_I...2,SET,17,0.33861,0.010299,0.2503,0.08807,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.810786318681319
GOBP_POSITIVE_REGULATION_OF_...411,SET,102,0.11986,0.0089091,0.088643,0.088167,GOBP_POSITIVE_REGULATION_OF_LIPID_LOCALIZATION,0.810786318681319
WP_THYROID_STIMULATING_HORMO...,SET,66,0.15004,0.0089795,0.11097,0.08819,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,0.810786318681319
CHOI_ATL_STAGE_PREDICTOR,SET,39,0.19255,0.0088652,0.14243,0.088206,CHOI_ATL_STAGE_PREDICTOR,0.810786318681319
GSE41867_DAY8_EFFECTOR_VS_DA...1,SET,179,0.086669,0.0085158,0.064108,0.088209,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.810786318681319
MIR376A_3P_MIR376B_3P,SET,133,0.097235,0.0082458,0.071936,0.088247,MIR376A_3P_MIR376B_3P,0.810786318681319
GOBP_SKELETAL_MUSCLE_ACETYLC...,SET,11,0.3225,0.0078916,0.23861,0.088262,GOBP_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.810786318681319
DESCARTES_FETAL_MUSCLE_ERYTH...,SET,101,0.11122,0.0082263,0.08229,0.088268,DESCARTES_FETAL_MUSCLE_ERYTHROBLASTS,0.810786318681319
MIR3173_3P,SET,90,0.11924,0.0083281,0.088233,0.088287,MIR3173_3P,0.810786318681319
HP_APLASIA_HYPOPLASIA_OF_THE...41,SET,51,0.16881,0.0088845,0.12494,0.088348,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_HAND,0.810786318681319
REACTOME_FORMATION_OF_TC_NER...,SET,48,0.15074,0.0076976,0.11158,0.088358,REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,0.810786318681319
GSE46606_DAY1_VS_DAY3_CD40L_...3,SET,177,0.086897,0.0084909,0.064332,0.088394,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN,0.810786318681319
HP_ABNORMAL_CIRCULATING_IGG_...,SET,107,0.11238,0.0085544,0.083213,0.088427,HP_ABNORMAL_CIRCULATING_IGG_LEVEL,0.810786318681319
EPC1_TARGET_GENES,SET,308,0.065584,0.008423,0.048572,0.088476,EPC1_TARGET_GENES,0.810786318681319
MIR4793_3P,SET,68,0.14298,0.0086854,0.1059,0.088484,MIR4793_3P,0.810786318681319
LIU_NASOPHARYNGEAL_CARCINOMA,SET,62,0.14539,0.0084347,0.1077,0.08851,LIU_NASOPHARYNGEAL_CARCINOMA,0.810786318681319
MIKKELSEN_ES_ICP_WITH_H3K4ME3,SET,619,0.046867,0.0084592,0.034717,0.088521,MIKKELSEN_ES_ICP_WITH_H3K4ME3,0.810786318681319
REACTOME_DISEASES_ASSOCIATED...3,SET,19,0.23062,0.0074151,0.17085,0.08854,REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,0.810786318681319
GSE3982_DC_VS_NEUTROPHIL_LPS...1,SET,176,0.088134,0.0085876,0.065298,0.088561,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN,0.810786318681319
REACTOME_SIGNALING_BY_FGFR1_...,SET,37,0.19487,0.0087394,0.14442,0.088617,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,0.810786318681319
JINESH_BLEBBISHIELD_VS_LIVE_...1,SET,241,0.078924,0.0089828,0.05849,0.088619,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,0.810786318681319
MORF_RAB6A,SET,60,0.15348,0.0087595,0.11375,0.088634,MORF_RAB6A,0.810786318681319
CONCANNON_APOPTOSIS_BY_EPOXO...1,SET,146,0.099811,0.0088652,0.073986,0.088669,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,0.810786318681319
MATZUK_OVULATION,SET,15,0.32147,0.0091849,0.2383,0.088677,MATZUK_OVULATION,0.810786318681319
MODULE_165,SET,77,0.14191,0.009171,0.10522,0.088725,MODULE_165,0.810786318681319
GOMF_NUCLEAR_IMPORT_SIGNAL_R...,SET,19,0.23576,0.0075804,0.17481,0.088726,GOMF_NUCLEAR_IMPORT_SIGNAL_RECEPTOR_ACTIVITY,0.810786318681319
JIANG_AGING_HYPOTHALAMUS_UP,SET,39,0.17596,0.0081011,0.13051,0.088792,JIANG_AGING_HYPOTHALAMUS_UP,0.810786318681319
GSE22611_NOD2_TRANSD_VS_CTRL...1,SET,114,0.10889,0.008554,0.080774,0.088817,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN,0.810786318681319
PEDERSEN_METASTASIS_BY_ERBB2...4,SET,11,0.38326,0.0093782,0.28429,0.088818,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,0.810786318681319
GOBP_NEGATIVE_REGULATION_OF_...391,SET,5,0.58487,0.0096506,0.43392,0.088858,GOBP_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.810786318681319
GSE26488_CTRL_VS_PEPTIDE_INJ...1,SET,177,0.087806,0.0085797,0.065152,0.088885,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN,0.810786318681319
GOBP_NEGATIVE_REGULATION_OF_...124,SET,157,0.09205,0.0084756,0.068303,0.08889,GOBP_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.810786318681319
LAKE_ADULT_KIDNEY_C24_ENDOTH...,SET,144,0.10365,0.0091435,0.076913,0.088894,LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR,0.810786318681319
GSE21033_CTRL_VS_POLYIC_STIM...10,SET,183,0.085902,0.0085333,0.063743,0.088897,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP,0.810786318681319
GOBP_SENSORY_PERCEPTION_OF_T...2,SET,29,0.2273,0.0090267,0.16869,0.08892,GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS,0.810786318681319
SCHAEFFER_PROSTATE_DEVELOPME...15,SET,10,0.38746,0.00904,0.28755,0.088925,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,0.810786318681319
GOBP_REGULATION_OF_OVARIAN_F...,SET,6,0.43368,0.0078386,0.32192,0.088971,GOBP_REGULATION_OF_OVARIAN_FOLLICLE_DEVELOPMENT,0.810786318681319
GOBP_PROTEIN_LOCALIZATION_TO...43,SET,6,0.39812,0.0071959,0.29555,0.088991,GOBP_PROTEIN_LOCALIZATION_TO_PHOTORECEPTOR_OUTER_SEGMENT,0.810786318681319
KEGG_SPLICEOSOME,SET,117,0.09349,0.0074393,0.069408,0.089003,KEGG_SPLICEOSOME,0.810786318681319
MODULE_540,SET,10,0.41439,0.0096684,0.30766,0.089011,MODULE_540,0.810786318681319
HP_GALACTOSURIA,SET,4,0.524,0.0077336,0.38905,0.089019,HP_GALACTOSURIA,0.810786318681319
GOMF_LIPOTEICHOIC_ACID_BINDI...,SET,5,0.5409,0.008925,0.40167,0.08906,GOMF_LIPOTEICHOIC_ACID_BINDING,0.810786318681319
HP_LEFT_BUNDLE_BRANCH_BLOCK,SET,18,0.284,0.008888,0.2109,0.089061,HP_LEFT_BUNDLE_BRANCH_BLOCK,0.810786318681319
HP_INCREASED_HEPATIC_GLYCOGE...,SET,11,0.36388,0.0089042,0.27025,0.08908,HP_INCREASED_HEPATIC_GLYCOGEN_CONTENT,0.810786318681319
GOBP_SINGLE_FERTILIZATION,SET,150,0.097064,0.0087375,0.072088,0.089085,GOBP_SINGLE_FERTILIZATION,0.810786318681319
GOBP_NEUROBLAST_MIGRATION,SET,6,0.55329,0.01,0.41092,0.089088,GOBP_NEUROBLAST_MIGRATION,0.810786318681319
TBK1.DN.48HRS_UP,SET,47,0.16094,0.0081325,0.11956,0.089146,TBK1.DN.48HRS_UP,0.810786318681319
HP_ABNORMAL_PANCREAS_MORPHOL...,SET,99,0.11574,0.0084757,0.085984,0.089156,HP_ABNORMAL_PANCREAS_MORPHOLOGY,0.810786318681319
GOBP_PYRIMIDINE_NUCLEOSIDE_M...2,SET,14,0.29795,0.0082245,0.22136,0.089157,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.810786318681319
GOBP_MATERNAL_PLACENTA_DEVEL...,SET,33,0.20188,0.0085512,0.14999,0.089162,GOBP_MATERNAL_PLACENTA_DEVELOPMENT,0.810786318681319
MODULE_214,SET,26,0.24229,0.0091111,0.18006,0.089225,MODULE_214,0.810968003108003
GOBP_MONOSACCHARIDE_METABOLI...,SET,226,0.075622,0.0083383,0.056222,0.089313,GOBP_MONOSACCHARIDE_METABOLIC_PROCESS,0.810968003108003
CLASPER_LYMPHATIC_VESSELS_DU...2,SET,18,0.29537,0.009244,0.21961,0.089318,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,0.810968003108003
HP_REDUCED_FACTOR_VII_ACTIVI...,SET,5,0.48497,0.0080021,0.36058,0.089323,HP_REDUCED_FACTOR_VII_ACTIVITY,0.810968003108003
WP_AMINO_ACID_METABOLISM_PAT...,SET,6,0.48005,0.0086767,0.35703,0.089393,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,0.810968003108003
GSE20198_UNTREATED_VS_IL12_T...2,SET,178,0.081955,0.0080303,0.06096,0.089418,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP,0.810968003108003
MODULE_356,SET,140,0.095515,0.0083087,0.071056,0.089447,MODULE_356,0.810968003108003
HP_AMBIGUOUS_GENITALIA,SET,109,0.10714,0.0082304,0.07971,0.08947,HP_AMBIGUOUS_GENITALIA,0.810968003108003
GOBP_MALONYL_COA_METABOLIC_P...,SET,6,0.48223,0.008716,0.35881,0.089488,GOBP_MALONYL_COA_METABOLIC_PROCESS,0.810968003108003
MORF_EI24,SET,118,0.10151,0.0081115,0.07553,0.089494,MORF_EI24,0.810968003108003
CARRILLOREIXACH_MRS3_VS_LOWE...1,SET,144,0.10274,0.0090633,0.076458,0.08952,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN,0.810968003108003
REACTOME_PHYSIOLOGICAL_FACTO...,SET,14,0.32341,0.0089272,0.24068,0.089528,REACTOME_PHYSIOLOGICAL_FACTORS,0.810968003108003
HP_GENERALIZED_OSTEOSCLEROSIS,SET,8,0.38963,0.0081313,0.28996,0.089531,HP_GENERALIZED_OSTEOSCLEROSIS,0.810968003108003
TSUDA_ALVEOLAR_SOFT_PART_SAR...,SET,10,0.39001,0.0090996,0.29027,0.089542,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,0.810968003108003
GOBP_VERY_LOW_DENSITY_LIPOPR...1,SET,10,0.3791,0.008845,0.28221,0.089594,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.810968003108003
MIR6125,SET,8,0.43032,0.0089807,0.32039,0.089626,MIR6125,0.810968003108003
GLINSKY_CANCER_DEATH_UP,SET,5,0.44553,0.0073513,0.33186,0.089723,GLINSKY_CANCER_DEATH_UP,0.810968003108003
BOYLAN_MULTIPLE_MYELOMA_PCA3...1,SET,63,0.14598,0.0085366,0.10874,0.089724,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,0.810968003108003
GSE5099_MONOCYTE_VS_CLASSICA...1,SET,177,0.083681,0.0081766,0.062332,0.089726,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN,0.810968003108003
GOBP_REGULATION_OF_MONOCYTE_...2,SET,18,0.29359,0.0091881,0.21872,0.089756,GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.810968003108003
BIOCARTA_STAT3_PATHWAY,SET,8,0.4751,0.0099152,0.35395,0.089759,BIOCARTA_STAT3_PATHWAY,0.810968003108003
GSE22025_TGFB1_VS_TGFB1_AND_...1,SET,180,0.090413,0.0089082,0.067365,0.089786,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.810968003108003
GSE27786_CD4_TCELL_VS_NKCELL...1,SET,180,0.084266,0.0083026,0.062786,0.089787,GSE27786_CD4_TCELL_VS_NKCELL_DN,0.810968003108003
KRAS.300_UP.V1_DN,SET,125,0.10615,0.0087285,0.079095,0.089804,KRAS.300_UP.V1_DN,0.810968003108003
GOBP_INNER_CELL_MASS_CELL_DI...,SET,8,0.49127,0.010253,0.36617,0.089865,GOBP_INNER_CELL_MASS_CELL_DIFFERENTIATION,0.810968003108003
GSE17186_CD21LOW_VS_CD21HIGH...4,SET,183,0.088134,0.008755,0.065696,0.08988,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.810968003108003
GOMF_SYMPORTER_ACTIVITY,SET,144,0.10192,0.0089904,0.075977,0.089902,GOMF_SYMPORTER_ACTIVITY,0.810968003108003
BYSTRYKH_HEMATOPOIESIS_STEM_...3,SET,7,0.40097,0.0078278,0.29893,0.089911,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3,0.810968003108003
HP_FOCAL_CORTICAL_DYSPLASIA_...,SET,5,0.54925,0.0090627,0.4095,0.089924,HP_FOCAL_CORTICAL_DYSPLASIA_TYPE_II,0.810968003108003
GSE17301_CTRL_VS_48H_ACD3_AC...4,SET,175,0.085025,0.0082613,0.063403,0.089967,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP,0.810968003108003
GOBP_SPINDLE_ELONGATION,SET,13,0.33003,0.0087787,0.24611,0.089976,GOBP_SPINDLE_ELONGATION,0.810968003108003
RFX1_02,SET,252,0.07153,0.0083224,0.053344,0.089983,RFX1_02,0.810968003108003
E2F1DP1RB_01,SET,208,0.078983,0.0083591,0.058906,0.089995,E2F1DP1RB_01,0.810968003108003
LU_IL4_SIGNALING,SET,86,0.12126,0.0082796,0.090438,0.09,LU_IL4_SIGNALING,0.810968003108003
GOCC_CATALYTIC_COMPLEX,SET,1515,0.029315,0.008066,0.021864,0.090009,GOCC_CATALYTIC_COMPLEX,0.810968003108003
GOBP_EPITHELIAL_MESENCHYMAL_...,SET,5,0.63122,0.010415,0.47087,0.090047,GOBP_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING,0.810968003108003
GSE21670_TGFB_VS_TGFB_AND_IL...3,SET,184,0.080112,0.0079796,0.059764,0.090054,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.810968003108003
HP_HEMIFACIAL_SPASM,SET,12,0.31331,0.0080072,0.23375,0.09008,HP_HEMIFACIAL_SPASM,0.810968003108003
GOBP_MATURATION_OF_5_8S_RRNA,SET,33,0.18388,0.0077888,0.1372,0.090092,GOBP_MATURATION_OF_5_8S_RRNA,0.810968003108003
REACTOME_RORA_ACTIVATES_GENE...,SET,17,0.27375,0.008326,0.20439,0.090237,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,0.812019522885958
REACTOME_PTK6_REGULATES_RTKS...,SET,8,0.42766,0.0089252,0.31934,0.090259,REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1,0.812019522885958
KEGG_MEDICUS_PATHOGEN_SHIGEL...3,SET,9,0.4075,0.00902,0.30433,0.09029,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.812019522885958
HP_ABNORMALITY_OF_JAW_MUSCLES,SET,26,0.2219,0.0083445,0.16575,0.090338,HP_ABNORMALITY_OF_JAW_MUSCLES,0.812019522885958
HP_ACRAL_ULCERATION,SET,8,0.39787,0.0083034,0.2972,0.09034,HP_ACRAL_ULCERATION,0.812019522885958
MIR573,SET,86,0.12461,0.0085083,0.093084,0.090349,MIR573,0.812019522885958
REACTOME_PI3K_AKT_ACTIVATION,SET,9,0.41544,0.0091958,0.3105,0.090458,REACTOME_PI3K_AKT_ACTIVATION,0.812507797527048
HP_EEG_WITH_ABNORMALLY_SLOW_...,SET,86,0.11933,0.0081475,0.089182,0.090458,HP_EEG_WITH_ABNORMALLY_SLOW_FREQUENCIES,0.812507797527048
GOCC_MYOSIN_II_COMPLEX,SET,25,0.24731,0.0091195,0.18489,0.090525,GOCC_MYOSIN_II_COMPLEX,0.812507797527048
MIR548AZ_5P,SET,393,0.060192,0.0087116,0.045004,0.090543,MIR548AZ_5P,0.812507797527048
GSE28783_ANTI_MIR33_VS_UNTRE...2,SET,177,0.085909,0.0083943,0.064247,0.090592,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.812507797527048
GOBP_LIPID_STORAGE,SET,85,0.13025,0.0088416,0.097415,0.090617,GOBP_LIPID_STORAGE,0.812507797527048
GUTIERREZ_WALDENSTROEMS_MACR...2,SET,10,0.38437,0.0089679,0.28754,0.090659,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,0.812507797527048
BASAKI_YBX1_TARGETS_UP,SET,261,0.06917,0.0081883,0.051749,0.090676,BASAKI_YBX1_TARGETS_UP,0.812507797527048
GSE4984_UNTREATED_VS_VEHICLE...2,SET,136,0.097698,0.0083773,0.0731,0.090702,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP,0.812507797527048
MIR8485,SET,922,0.03885,0.0084847,0.029069,0.090704,MIR8485,0.812507797527048
HP_COMA,SET,91,0.11847,0.0083201,0.088646,0.090704,HP_COMA,0.812507797527048
MODULE_500,SET,28,0.20776,0.0081071,0.15547,0.090733,MODULE_500,0.812507797527048
GOCC_SUPRAMOLECULAR_POLYMER,SET,924,0.03993,0.0087295,0.029882,0.090741,GOCC_SUPRAMOLECULAR_POLYMER,0.812507797527048
GOBP_RESPONSE_TO_BMP,SET,147,0.099411,0.0088596,0.074399,0.090753,GOBP_RESPONSE_TO_BMP,0.812507797527048
HP_CRUMPLED_LONG_BONES,SET,6,0.42941,0.0077615,0.32137,0.090754,HP_CRUMPLED_LONG_BONES,0.812507797527048
NIKOLSKY_BREAST_CANCER_7P22_...,SET,37,0.33302,0.014935,0.24928,0.090797,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,0.812683423899047
GOCC_N_TERMINAL_PROTEIN_ACET...,SET,9,0.29873,0.0066125,0.22371,0.090891,GOCC_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX,0.812698623039342
GOMF_NUCLEOSIDE_TRIPHOSPHATE...,SET,9,0.40922,0.009058,0.30646,0.090897,GOMF_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY,0.812698623039342
CROONQUIST_IL6_DEPRIVATION_DN,SET,91,0.11309,0.0079418,0.0847,0.09092,CROONQUIST_IL6_DEPRIVATION_DN,0.812698623039342
GOBP_MEMBRANE_INVAGINATION,SET,65,0.14663,0.0087091,0.10983,0.090929,GOBP_MEMBRANE_INVAGINATION,0.812698623039342
MIR548P,SET,541,0.050411,0.0085249,0.037759,0.090937,MIR548P,0.812698623039342
GSE21927_C26GM_VS_4T1_TUMOR_...2,SET,175,0.086842,0.0084379,0.065048,0.090939,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,0.812698623039342
GOBP_AUTOPHAGOSOME_ORGANIZAT...,SET,112,0.10329,0.0080425,0.077421,0.091094,GOBP_AUTOPHAGOSOME_ORGANIZATION,0.813874542416452
CASTELLANO_NRAS_TARGETS_UP,SET,67,0.14951,0.0090155,0.1121,0.091148,CASTELLANO_NRAS_TARGETS_UP,0.814081402877698
DELLA_RESPONSE_TO_TSA_AND_BU...,SET,20,0.25089,0.0082761,0.18812,0.091164,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,0.814081402877698
GSE26290_WT_VS_PDK1_KO_ANTI_...2,SET,169,0.090359,0.0086292,0.067765,0.091208,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,0.814265101464166
FAN_EMBRYONIC_CTX_EX_1_EXCIT...,SET,5,0.48191,0.0079517,0.36148,0.091251,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.814304094138543
chr4q33,SET,5,0.71808,0.011848,0.53883,0.09133,chr4q33,0.814304094138543
GOBP_RESPONSE_TO_PEPTIDE_HOR...,SET,405,0.058486,0.0085901,0.043888,0.091339,GOBP_RESPONSE_TO_PEPTIDE_HORMONE,0.814304094138543
GSE43955_TH0_VS_TGFB_IL6_IL2...3,SET,187,0.082366,0.0082701,0.061832,0.091422,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,0.814304094138543
MIR22_3P,SET,126,0.10263,0.008473,0.077047,0.091427,MIR22_3P,0.814304094138543
GSE12845_PRE_GC_VS_DARKZONE_...1,SET,176,0.082398,0.0080287,0.061865,0.091454,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.814304094138543
HP_GOUT,SET,15,0.26458,0.0075594,0.19866,0.091464,HP_GOUT,0.814304094138543
GOCC_CATENIN_COMPLEX,SET,31,0.23163,0.0095098,0.17393,0.091488,GOCC_CATENIN_COMPLEX,0.814304094138543
GOBP_PYRIMIDINE_RIBONUCLEOSI...3,SET,15,0.28818,0.0082337,0.21641,0.091493,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.814304094138543
GOCC_LSM2_8_COMPLEX,SET,7,0.40376,0.0078823,0.30323,0.091514,GOCC_LSM2_8_COMPLEX,0.814304094138543
MIR6089,SET,16,0.27577,0.0081374,0.20713,0.091541,MIR6089,0.814304094138543
GCM_BCL2L1,SET,33,0.18326,0.0077625,0.13767,0.091574,GCM_BCL2L1,0.814304094138543
HP_MELANOMA,SET,74,0.12335,0.0078153,0.092678,0.091608,HP_MELANOMA,0.814304094138543
GSE45365_HEALTHY_VS_MCMV_INF...3,SET,162,0.09228,0.0086299,0.069357,0.091684,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN,0.814304094138543
GOBP_ACUTE_PHASE_RESPONSE,SET,44,0.19453,0.0095119,0.14621,0.091687,GOBP_ACUTE_PHASE_RESPONSE,0.814304094138543
GSE42021_CD24HI_TREG_VS_CD24...1,SET,186,0.086748,0.008687,0.065212,0.091725,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN,0.814304094138543
GOBP_EPITHELIAL_CELL_DIFFERE...3,SET,10,0.40402,0.0094264,0.30377,0.091764,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.814304094138543
GSE24574_BCL6_HIGH_VS_LOW_TF...2,SET,183,0.086449,0.0085877,0.065019,0.091833,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP,0.814304094138543
KEGG_PENTOSE_AND_GLUCURONATE...,SET,26,0.28974,0.010896,0.21796,0.091885,KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,0.814304094138543
WP_LET7_INHIBITION_OF_ES_CEL...,SET,6,0.48192,0.0087105,0.36258,0.091907,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,0.814304094138543
WP_T_CELL_MODULATION_IN_PANC...,SET,43,0.18281,0.0088367,0.13754,0.091914,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,0.814304094138543
GOBP_NEUROTRANSMITTER_RECEPT...5,SET,7,0.4847,0.0094625,0.3647,0.091924,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_POSTSYNAPTIC_ENDOSOME_TO_LYSOSOME,0.814304094138543
ZNF579_TARGET_GENES,SET,611,0.046757,0.0083865,0.035181,0.091926,ZNF579_TARGET_GENES,0.814304094138543
LEE_AGING_NEOCORTEX_UP,SET,72,0.13823,0.0086393,0.10403,0.091976,LEE_AGING_NEOCORTEX_UP,0.814304094138543
GOBP_TRICARBOXYLIC_ACID_TRAN...,SET,5,0.52715,0.0086982,0.39676,0.091989,GOBP_TRICARBOXYLIC_ACID_TRANSPORT,0.814304094138543
GOCC_INTEGRATOR_COMPLEX,SET,13,0.29504,0.007848,0.22206,0.091994,GOCC_INTEGRATOR_COMPLEX,0.814304094138543
GOMF_INTERLEUKIN_1_RECEPTOR_...2,SET,17,0.32748,0.0099601,0.24653,0.092039,GOMF_INTERLEUKIN_1_RECEPTOR_BINDING,0.814304094138543
SPIELMAN_LYMPHOBLAST_EUROPEA...1,SET,17,0.29974,0.0091165,0.22567,0.092066,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,0.814304094138543
GSE13306_RA_VS_UNTREATED_TRE...1,SET,190,0.084944,0.0085963,0.063961,0.092089,GSE13306_RA_VS_UNTREATED_TREG_DN,0.814304094138543
GSE21670_UNTREATED_VS_IL6_TR...3,SET,180,0.083231,0.0082006,0.062672,0.092092,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.814304094138543
GOMF_MACROMOLECULE_TRANSMEMB...,SET,29,0.20722,0.0082291,0.15604,0.092093,GOMF_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.814304094138543
HP_ELEVATED_URINARY_MONOCARB...,SET,11,0.34103,0.0083449,0.25687,0.092156,HP_ELEVATED_URINARY_MONOCARBOXYLIC_ACID_LEVEL,0.814304094138543
GSE30962_PRIMARY_VS_SECONDAR...4,SET,180,0.080984,0.0079792,0.061001,0.092168,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP,0.814304094138543
GSE15659_NAIVE_CD4_TCELL_VS_...1,SET,168,0.087674,0.0083482,0.066047,0.09219,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.814304094138543
MIR4483,SET,85,0.12822,0.008704,0.096596,0.092201,MIR4483,0.814304094138543
GOBP_OSTEOCLAST_DIFFERENTIAT...,SET,100,0.12654,0.0093135,0.095335,0.092207,GOBP_OSTEOCLAST_DIFFERENTIATION,0.814304094138543
GSE3982_MAST_CELL_VS_DC_UP,SET,161,0.087965,0.0082011,0.066283,0.092245,GSE3982_MAST_CELL_VS_DC_UP,0.814304094138543
KEGG_T_CELL_RECEPTOR_SIGNALI...,SET,102,0.11298,0.0083975,0.085133,0.092248,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.814304094138543
KEGG_MEDICUS_REFERENCE_TLR4_...,SET,9,0.3511,0.0077717,0.26457,0.092249,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY,0.814304094138543
GOBP_PROGRAMMED_NECROTIC_CEL...,SET,47,0.16587,0.0083817,0.12499,0.092256,GOBP_PROGRAMMED_NECROTIC_CELL_DEATH,0.814304094138543
MODULE_252,SET,226,0.072565,0.0080012,0.054684,0.092265,MODULE_252,0.814304094138543
GSE3982_EOSINOPHIL_VS_EFF_ME...1,SET,171,0.086496,0.0083085,0.065182,0.092266,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.814304094138543
HP_PREAXIAL_FOOT_POLYDACTYLY,SET,16,0.28424,0.0083872,0.21422,0.092285,HP_PREAXIAL_FOOT_POLYDACTYLY,0.814304094138543
GCM_Q2,SET,211,0.079328,0.0084551,0.059791,0.092302,GCM_Q2,0.814304094138543
HP_PALATE_FISTULA,SET,12,0.37023,0.0094619,0.27905,0.092303,HP_PALATE_FISTULA,0.814304094138543
GOBP_RIGHTING_REFLEX,SET,8,0.41708,0.0087043,0.31439,0.092321,GOBP_RIGHTING_REFLEX,0.814304094138543
DURANTE_ADULT_OLFACTORY_NEUR...23,SET,28,0.24122,0.0094128,0.18183,0.092333,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_SECRETORY_CELLS,0.814304094138543
MIR6777_3P,SET,45,0.16823,0.0083183,0.12682,0.092337,MIR6777_3P,0.814304094138543
GOBP_PROTEIN_LOCALIZATION_TO...2,SET,9,0.37136,0.00822,0.28001,0.092391,GOBP_PROTEIN_LOCALIZATION_TO_AXON,0.814521845841785
GSE13547_2H_VS_12_H_ANTI_IGM...1,SET,165,0.082522,0.0077878,0.062234,0.092427,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN,0.814521845841785
GOBP_GALACTOSE_CATABOLIC_PRO...1,SET,6,0.4461,0.0080631,0.33643,0.092432,GOBP_GALACTOSE_CATABOLIC_PROCESS,0.814521845841785
GSE14415_INDUCED_TREG_VS_FOX...2,SET,124,0.10623,0.0087005,0.080133,0.092485,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN,0.814782300380228
RAMJAUN_APOPTOSIS_BY_TGFB1_V...1,SET,8,0.43028,0.0089797,0.32471,0.092574,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN,0.815359698428789
GNF2_NPM1,SET,65,0.12451,0.0073955,0.093983,0.092617,GNF2_NPM1,0.81550125
GSE2197_IMMUNOSUPPRESSIVE_DN...1,SET,178,0.082012,0.0080359,0.061908,0.092637,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN,0.81550125
GSE6674_ANTI_IGM_VS_CPG_STIM...2,SET,180,0.084534,0.008329,0.063833,0.092712,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP,0.815630867256637
PID_EPHA2_FWD_PATHWAY,SET,19,0.2526,0.0081216,0.19076,0.092734,PID_EPHA2_FWD_PATHWAY,0.815630867256637
HP_ABDOMINAL_CRAMPS,SET,7,0.37133,0.0072492,0.28047,0.092765,HP_ABDOMINAL_CRAMPS,0.815630867256637
GSE36392_MAC_VS_NEUTROPHIL_I...2,SET,186,0.080277,0.008039,0.060637,0.092775,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.815630867256637
GSE10239_KLRG1INT_VS_KLRG1HI...2,SET,183,0.081726,0.0081185,0.061739,0.092803,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.815630867256637
HP_GAIT_ATAXIA,SET,217,0.076857,0.008306,0.058061,0.092805,HP_GAIT_ATAXIA,0.815630867256637
GOBP_POSITIVE_REGULATION_OF_...833,SET,4,0.47291,0.0069795,0.35727,0.092816,GOBP_POSITIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.815630867256637
GSE20715_0H_VS_48H_OZONE_LUN...2,SET,180,0.085743,0.0084481,0.064789,0.092858,GSE20715_0H_VS_48H_OZONE_LUNG_UP,0.815793677957533
MORF_JAG1,SET,91,0.12011,0.0084351,0.090791,0.092936,MORF_JAG1,0.815974047738693
GOBP_MONOATOMIC_ION_TRANSPORT,SET,1104,0.036642,0.0087108,0.027698,0.092946,GOBP_MONOATOMIC_ION_TRANSPORT,0.815974047738693
MIR3162_5P,SET,67,0.1338,0.008068,0.10116,0.092986,MIR3162_5P,0.815974047738693
OCT1_Q5_01,SET,224,0.079729,0.0087526,0.060286,0.093007,OCT1_Q5_01,0.815974047738693
ZHENG_CORD_BLOOD_C8_PUTATIVE...,SET,74,0.13542,0.0085802,0.10241,0.093025,ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2,0.815974047738693
GOBP_LIPOPROTEIN_METABOLIC_P...,SET,125,0.1002,0.0082394,0.075776,0.093044,GOBP_LIPOPROTEIN_METABOLIC_PROCESS,0.815974047738693
REACTOME_ALTERNATIVE_COMPLEM...,SET,4,0.63005,0.0092987,0.47653,0.093065,REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION,0.815974047738693
TONKS_TARGETS_OF_RUNX1_RUNX1...5,SET,177,0.090707,0.0088632,0.068618,0.093106,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,0.815974047738693
WP_BLOOD_CLOTTING_CASCADE,SET,20,0.29088,0.0095951,0.22006,0.093127,WP_BLOOD_CLOTTING_CASCADE,0.815974047738693
MIR33A_5P_MIR33B_5P,SET,106,0.11399,0.0086364,0.086247,0.093142,MIR33A_5P_MIR33B_5P,0.815974047738693
MIR23A_5P,SET,30,0.20883,0.0084344,0.158,0.093148,MIR23A_5P,0.815974047738693
GOBP_REGULATION_OF_B_CELL_DI...,SET,31,0.20653,0.0084791,0.15628,0.09318,GOBP_REGULATION_OF_B_CELL_DIFFERENTIATION,0.815974047738693
GSE14026_TH1_VS_TH17_DN,SET,179,0.082009,0.008058,0.062084,0.093271,GSE14026_TH1_VS_TH17_DN,0.815974047738693
GOBP_CELL_DIFFERENTIATION_IN...6,SET,47,0.18136,0.0091643,0.13731,0.093287,GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD,0.815974047738693
GOBP_NEGATIVE_REGULATION_OF_...685,SET,9,0.38022,0.0084161,0.28787,0.093288,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.815974047738693
GOMF_C_C_CHEMOKINE_BINDING,SET,22,0.27659,0.0095686,0.20941,0.093294,GOMF_C_C_CHEMOKINE_BINDING,0.815974047738693
GOBP_APPENDAGE_DEVELOPMENT,SET,173,0.090529,0.0087462,0.068547,0.093313,GOBP_APPENDAGE_DEVELOPMENT,0.815974047738693
HP_CRANIOFACIAL_DYSOSTOSIS,SET,8,0.39407,0.0082241,0.29839,0.093317,HP_CRANIOFACIAL_DYSOSTOSIS,0.815974047738693
KYNG_DNA_DAMAGE_BY_4NQO_OR_G...,SET,15,0.29046,0.0082989,0.21996,0.093341,KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,0.815974047738693
DESCARTES_MAIN_FETAL_PDE11A_...,SET,37,0.21395,0.009595,0.16205,0.09337,DESCARTES_MAIN_FETAL_PDE11A_FAM19A2_POSITIVE_CELLS,0.815974047738693
KEGG_BASAL_TRANSCRIPTION_FAC...,SET,31,0.18214,0.0074781,0.13796,0.093377,KEGG_BASAL_TRANSCRIPTION_FACTORS,0.815974047738693
GOBP_MALATE_METABOLIC_PROCESS,SET,9,0.3834,0.0084865,0.29045,0.093421,GOBP_MALATE_METABOLIC_PROCESS,0.815974047738693
GOBP_HISTONE_MRNA_METABOLIC_...,SET,20,0.21945,0.0072391,0.16626,0.093436,GOBP_HISTONE_MRNA_METABOLIC_PROCESS,0.815974047738693
GOBP_INTRACELLULAR_PH_ELEVAT...,SET,7,0.42866,0.0083684,0.32476,0.093442,GOBP_INTRACELLULAR_PH_ELEVATION,0.815974047738693
GOBP_RENAL_WATER_HOMEOSTASIS,SET,24,0.25962,0.0093804,0.19677,0.093523,GOBP_RENAL_WATER_HOMEOSTASIS,0.816039062968516
GSE7219_UNSTIM_VS_LPS_AND_AN...2,SET,159,0.093349,0.0086493,0.070763,0.093565,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP,0.816039062968516
GOBP_CELLULAR_RESPONSE_TO_PE...2,SET,293,0.067752,0.0084904,0.051364,0.093584,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS,0.816039062968516
GOBP_ENDONUCLEOLYTIC_CLEAVAG...1,SET,7,0.40735,0.0079524,0.30889,0.093636,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_5_ETS_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.816039062968516
HP_HYPOGONADISM,SET,377,0.057965,0.0082204,0.043955,0.093638,HP_HYPOGONADISM,0.816039062968516
MIR7704,SET,5,0.5361,0.0088458,0.40654,0.093646,MIR7704,0.816039062968516
HUMMERICH_MALIGNANT_SKIN_TUM...1,SET,19,0.24785,0.0079689,0.188,0.093698,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,0.816039062968516
MIR9985,SET,570,0.049524,0.0085896,0.037566,0.093702,MIR9985,0.816039062968516
MIR561_5P,SET,131,0.096153,0.008093,0.072944,0.093731,MIR561_5P,0.816039062968516
GOCC_GATOR2_COMPLEX,SET,8,0.35007,0.0073059,0.26559,0.093746,GOCC_GATOR2_COMPLEX,0.816039062968516
GOCC_ENDOSOME_MEMBRANE,SET,518,0.049742,0.0082365,0.037745,0.093787,GOCC_ENDOSOME_MEMBRANE,0.816039062968516
GOBP_POLYKETIDE_METABOLIC_PR...,SET,10,0.45923,0.010715,0.34848,0.093792,GOBP_POLYKETIDE_METABOLIC_PROCESS,0.816039062968516
HP_ADENOCARCINOMA_OF_THE_INT...,SET,38,0.16883,0.0076729,0.12813,0.093819,HP_ADENOCARCINOMA_OF_THE_INTESTINES,0.816039062968516
KEGG_MEDICUS_PATHOGEN_HCV_CO...2,SET,6,0.43335,0.0078325,0.32889,0.093826,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION,0.816039062968516
KEGG_THYROID_CANCER,SET,29,0.20013,0.0079476,0.15189,0.093831,KEGG_THYROID_CANCER,0.816039062968516
MODULE_19,SET,281,0.071196,0.0087402,0.054046,0.093874,MODULE_19,0.816039062968516
GOMF_LIPOPEPTIDE_BINDING,SET,10,0.51129,0.011929,0.38815,0.093886,GOMF_LIPOPEPTIDE_BINDING,0.816039062968516
HP_FASTING_HYPOGLYCEMIA,SET,20,0.26264,0.0086636,0.19941,0.093912,HP_FASTING_HYPOGLYCEMIA,0.816039062968516
PAX6_TARGET_GENES,SET,692,0.04396,0.008372,0.033376,0.093913,PAX6_TARGET_GENES,0.816039062968516
FOXE1_TARGET_GENES,SET,566,0.049123,0.008491,0.0373,0.093932,FOXE1_TARGET_GENES,0.816039062968516
HP_MULTIPLE_JOINT_DISLOCATION,SET,7,0.37546,0.0073298,0.28512,0.093957,HP_MULTIPLE_JOINT_DISLOCATION,0.816039062968516
GOBP_PYRIMIDINE_CONTAINING_C...4,SET,7,0.43293,0.0084517,0.32878,0.093966,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE,0.816039062968516
GSE1460_INTRATHYMIC_T_PROGEN...10,SET,176,0.081777,0.0079681,0.062129,0.094056,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP,0.816564602996255
PID_NFKAPPAB_CANONICAL_PATHW...,SET,21,0.2547,0.008609,0.19353,0.094078,PID_NFKAPPAB_CANONICAL_PATHWAY,0.816564602996255
GAUTAM_EYE_IRIS_CILIARY_BODY...3,SET,316,0.060942,0.007926,0.046309,0.094097,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS,0.816564602996255
HP_PAPULE,SET,92,0.11498,0.0081186,0.087416,0.094212,HP_PAPULE,0.817357249626308
HP_MILD_HEARING_IMPAIRMENT,SET,7,0.36743,0.007173,0.27941,0.094263,HP_MILD_HEARING_IMPAIRMENT,0.817357249626308
GOBP_ENTEROENDOCRINE_CELL_DI...,SET,33,0.21215,0.0089861,0.16135,0.094297,GOBP_ENTEROENDOCRINE_CELL_DIFFERENTIATION,0.817357249626308
KAT5_TARGET_GENES,SET,707,0.04199,0.0080796,0.031939,0.094315,KAT5_TARGET_GENES,0.817357249626308
MODULE_131,SET,31,0.2182,0.0089583,0.16597,0.094325,MODULE_131,0.817357249626308
HE_LIM_SUN_FETAL_LUNG_C0_ADV...,SET,62,0.15025,0.0087165,0.1143,0.094346,HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST,0.817357249626308
GOBP_FRUCTOSE_METABOLIC_PROC...,SET,13,0.26116,0.0069469,0.19868,0.094354,GOBP_FRUCTOSE_METABOLIC_PROCESS,0.817357249626308
GOBP_GLYCOSIDE_METABOLIC_PRO...,SET,19,0.28442,0.0091449,0.21641,0.094391,GOBP_GLYCOSIDE_METABOLIC_PROCESS,0.817357249626308
GOBP_REGULATION_OF_INFLAMMAT...2,SET,39,0.1802,0.0082964,0.13712,0.0944,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.817357249626308
GOBP_ALPHA_KETOGLUTARATE_TRA...,SET,7,0.41597,0.0081207,0.31658,0.094439,GOBP_ALPHA_KETOGLUTARATE_TRANSPORT,0.817425836236934
PUJANA_ATM_PCC_NETWORK,SET,1242,0.031808,0.0079883,0.02421,0.094458,PUJANA_ATM_PCC_NETWORK,0.817425836236934
MODULE_24,SET,407,0.059417,0.0087479,0.04523,0.094489,MODULE_24,0.817425836236934
HALLMARK_IL2_STAT5_SIGNALING,SET,187,0.087112,0.0087466,0.066316,0.094502,HALLMARK_IL2_STAT5_SIGNALING,0.817425836236934
MIR4271,SET,198,0.077143,0.0079678,0.058753,0.094601,MIR4271,0.81800812453393
KEGG_PURINE_METABOLISM,SET,144,0.092582,0.008167,0.070527,0.094648,KEGG_PURINE_METABOLISM,0.81800812453393
TURASHVILI_BREAST_NORMAL_DUC...1,SET,5,0.4704,0.0077618,0.35835,0.094649,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN,0.81800812453393
MIR559,SET,496,0.051449,0.0083413,0.039198,0.094678,MIR559,0.81800812453393
KEGG_MEDICUS_PATHOGEN_HPV_E6...3,SET,13,0.30558,0.0081285,0.23283,0.094687,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382,0.81800812453393
MCLACHLAN_DENTAL_CARIES_UP,SET,211,0.085347,0.0090967,0.065042,0.09474,MCLACHLAN_DENTAL_CARIES_UP,0.818253211624441
GOMF_PHOSPHATIDYLINOSITOL_TR...1,SET,10,0.31384,0.0073223,0.2392,0.094764,GOMF_PHOSPHATIDYLINOSITOL_TRANSFER_ACTIVITY,0.818253211624441
TERAO_AOX4_TARGETS_HG_DN,SET,6,0.51031,0.0092236,0.38898,0.094786,TERAO_AOX4_TARGETS_HG_DN,0.818253211624441
GOMF_GALACTOSYLCERAMIDASE_AC...,SET,4,0.52377,0.0077301,0.39953,0.094943,GOMF_GALACTOSYLCERAMIDASE_ACTIVITY,0.819248413998511
GOBP_REGULATION_OF_CARDIAC_E...,SET,11,0.39207,0.0095939,0.29909,0.094955,GOBP_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.819248413998511
HP_ANTIPHOSPHOLIPID_ANTIBODY...,SET,16,0.27519,0.0081203,0.20994,0.094972,HP_ANTIPHOSPHOLIPID_ANTIBODY_POSITIVITY,0.819248413998511
HP_ABNORMALLY_LOW_T_CELL_REC...,SET,6,0.50962,0.0092111,0.38896,0.09507,HP_ABNORMALLY_LOW_T_CELL_RECEPTOR_EXCISION_CIRCLE_LEVEL,0.819890285359801
KEGG_MEDICUS_REFERENCE_REGUL...10,SET,6,0.38854,0.0070227,0.29663,0.095133,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX,0.82020765625
GSE22432_CONVENTIONAL_CDC_VS...1,SET,185,0.079787,0.0079686,0.060919,0.095154,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN,0.82020765625
GOBP_PROSTATE_GLAND_MORPHOGE...,SET,26,0.25373,0.0095415,0.19379,0.095223,GOBP_PROSTATE_GLAND_MORPHOGENESIS,0.820416107806691
MINGUEZ_LIVER_CANCER_VASCULA...1,SET,21,0.26086,0.0088172,0.19925,0.095239,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,0.820416107806691
GSE3039_NKT_CELL_VS_B2_BCELL...2,SET,190,0.085633,0.0086661,0.065411,0.095249,GSE3039_NKT_CELL_VS_B2_BCELL_UP,0.820416107806691
DAVIES_MULTIPLE_MYELOMA_VS_M...1,SET,23,0.25252,0.008932,0.19292,0.095284,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,0.820514226957384
AFP1_Q6,SET,237,0.078205,0.0088278,0.059769,0.095365,AFP1_Q6,0.82100831681942
ASGHARZADEH_NEUROBLASTOMA_PO...,SET,37,0.18092,0.0081134,0.13829,0.09541,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,0.821192310549777
DESCARTES_FETAL_SPLEEN_MESOT...,SET,177,0.089642,0.0087591,0.06855,0.095497,DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS,0.821737616984402
WHITEHURST_PACLITAXEL_SENSIT...,SET,31,0.18566,0.0076226,0.142,0.095541,WHITEHURST_PACLITAXEL_SENSITIVITY,0.821912736386139
GSE360_L_DONOVANI_VS_B_MALAY...8,SET,185,0.084038,0.0083932,0.0643,0.09562,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.822380304154303
BOYAULT_LIVER_CANCER_SUBCLAS...3,SET,14,0.34159,0.0094291,0.26144,0.095681,BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,0.822380304154303
MIR519A_3P_MIR519B_3P,SET,374,0.057057,0.0080601,0.04367,0.095688,MIR519A_3P_MIR519B_3P,0.822380304154303
GSE23321_CD8_STEM_CELL_MEMOR...4,SET,177,0.082019,0.0080142,0.062775,0.09569,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.822380304154303
GOBP_EPOXIDE_METABOLIC_PROCE...,SET,5,0.55105,0.0090924,0.42199,0.095811,GOBP_EPOXIDE_METABOLIC_PROCESS,0.823216639060569
HP_ABNORMAL_DURA_MATER_MORPH...,SET,23,0.22963,0.0081224,0.1759,0.095877,HP_ABNORMAL_DURA_MATER_MORPHOLOGY,0.823580112456747
GOBP_REGULATION_OF_MAP_KINAS...,SET,122,0.10195,0.0082833,0.07812,0.095936,GOBP_REGULATION_OF_MAP_KINASE_ACTIVITY,0.823759593726846
GOBP_SUCCINATE_TRANSMEMBRANE...,SET,6,0.45905,0.0082972,0.35179,0.095969,GOBP_SUCCINATE_TRANSMEMBRANE_TRANSPORT,0.823759593726846
GOMF_SUCCINATE_TRANSMEMBRANE...,SET,6,0.45905,0.0082972,0.35179,0.095969,GOMF_SUCCINATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.823759593726846
WANG_RESPONSE_TO_GSK3_INHIBI...1,SET,313,0.060818,0.0078729,0.04664,0.096128,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,0.824920651851852
AIZARANI_LIVER_C1_NK_NKT_CEL...,SET,136,0.10092,0.0086537,0.077413,0.09618,AIZARANI_LIVER_C1_NK_NKT_CELLS_1,0.825079582922014
LIANG_HEMATOPOIESIS_STEM_CEL...3,SET,15,0.26942,0.0076976,0.20667,0.096194,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,0.825079582922014
HP_SMALL_ANTERIOR_FONTANELLE,SET,6,0.44272,0.008002,0.33979,0.096311,HP_SMALL_ANTERIOR_FONTANELLE,0.825677663378545
GSE29618_PRE_VS_DAY7_FLU_VAC...7,SET,177,0.078244,0.0076454,0.060054,0.096315,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN,0.825677663378545
REACTOME_METALLOPROTEASE_DUBS,SET,15,0.33006,0.0094303,0.25335,0.096335,REACTOME_METALLOPROTEASE_DUBS,0.825677663378545
GSE22140_HEALTHY_VS_ARTHRITI...2,SET,175,0.080549,0.0078265,0.061842,0.096382,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP,0.825876826923077
GOMF_AMINOACYLTRANSFERASE_AC...,SET,443,0.052035,0.0079846,0.039965,0.096467,GOMF_AMINOACYLTRANSFERASE_ACTIVITY,0.826332147420147
PID_INSULIN_PATHWAY,SET,44,0.16635,0.008134,0.1278,0.096516,PID_INSULIN_PATHWAY,0.826332147420147
HP_INCREASED_WAIST_TO_HIP_RA...,SET,36,0.20545,0.0090885,0.15783,0.096523,HP_INCREASED_WAIST_TO_HIP_RATIO,0.826332147420147
REACTOME_FGFR2_MUTANT_RECEPT...,SET,32,0.20219,0.0084338,0.15536,0.096557,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,0.826332147420147
MIR922,SET,180,0.08043,0.0079246,0.061817,0.096621,MIR922,0.826332147420147
MIR548AY_3P,SET,54,0.14835,0.0080338,0.11402,0.096622,MIR548AY_3P,0.826332147420147
GSE40274_CTRL_VS_HELIOS_TRAN...2,SET,146,0.094593,0.0084017,0.072713,0.096653,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.826332147420147
GOBP_POSITIVE_REGULATION_OF_...668,SET,14,0.29448,0.0081287,0.22639,0.096671,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING,0.826332147420147
GOBP_PHAGOSOME_MATURATION,SET,28,0.22425,0.0087509,0.17244,0.096726,GOBP_PHAGOSOME_MATURATION,0.826332147420147
GOMF_STRUCTURAL_CONSTITUENT_...4,SET,40,0.16826,0.0078452,0.12939,0.096731,GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE,0.826332147420147
GSE17721_POLYIC_VS_CPG_1H_BM...1,SET,183,0.081937,0.0081394,0.063013,0.096753,GSE17721_POLYIC_VS_CPG_1H_BMDC_DN,0.826332147420147
GOMF_PROCOLLAGEN_PROLINE_DIO...,SET,8,0.31904,0.0066582,0.24535,0.096754,GOMF_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY,0.826332147420147
HOFMANN_MYELODYSPLASTIC_SYND...4,SET,20,0.24443,0.0080631,0.18798,0.096756,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,0.826332147420147
GOMF_GTPASE_ACTIVATOR_ACTIVI...,SET,240,0.072407,0.0082242,0.055687,0.096768,GOMF_GTPASE_ACTIVATOR_ACTIVITY,0.826332147420147
MIR582_3P,SET,83,0.12376,0.0083022,0.095192,0.096793,MIR582_3P,0.826342597641857
HP_ADRENAL_INSUFFICIENCY,SET,93,0.11598,0.0082334,0.089221,0.096826,HP_ADRENAL_INSUFFICIENCY,0.82642132367387
GOMF_SEQUENCE_SPECIFIC_DNA_B...,SET,1522,0.032266,0.0088965,0.024829,0.096895,GOMF_SEQUENCE_SPECIFIC_DNA_BINDING,0.826696601941748
GOBP_GANGLIOSIDE_METABOLIC_P...,SET,28,0.21895,0.0085438,0.16858,0.097013,GOBP_GANGLIOSIDE_METABOLIC_PROCESS,0.826696601941748
GSE13946_CTRL_VS_DSS_COLITIS...1,SET,157,0.089833,0.0082715,0.069173,0.097039,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN,0.826696601941748
HP_CONE_SHAPED_EPIPHYSES_OF_...,SET,27,0.21152,0.0081053,0.16288,0.097048,HP_CONE_SHAPED_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.826696601941748
GOMF_TRANSCRIPTION_ELONGATIO...,SET,7,0.43029,0.0084002,0.33138,0.097072,GOMF_TRANSCRIPTION_ELONGATION_FACTOR_ACTIVITY,0.826696601941748
GSE17721_0.5H_VS_4H_POLYIC_B...2,SET,182,0.07772,0.0076997,0.059857,0.097076,GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP,0.826696601941748
HE_LIM_SUN_FETAL_LUNG_C0_EAR...1,SET,71,0.13101,0.0081312,0.10091,0.097104,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST,0.826696601941748
GOBP_PROTEIN_AUTOUBIQUITINAT...,SET,67,0.1339,0.0080739,0.10315,0.097147,GOBP_PROTEIN_AUTOUBIQUITINATION,0.826696601941748
REACTOME_DDX58_IFIH1_MEDIATE...,SET,74,0.13448,0.0085201,0.10361,0.09716,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,0.826696601941748
GOMF_PRERIBOSOME_BINDING,SET,6,0.50227,0.0090783,0.38699,0.09717,GOMF_PRERIBOSOME_BINDING,0.826696601941748
GOBP_LEUKOTRIENE_B4_METABOLI...,SET,5,0.48489,0.0080008,0.37367,0.097213,GOBP_LEUKOTRIENE_B4_METABOLIC_PROCESS,0.826696601941748
HP_PULMONARY_HEMORRHAGE,SET,29,0.22072,0.0087653,0.17013,0.097256,HP_PULMONARY_HEMORRHAGE,0.826696601941748
GSE37532_WT_VS_PPARG_KO_LN_T...4,SET,156,0.084754,0.0077792,0.065329,0.097266,GSE37532_WT_VS_PPARG_KO_LN_TREG_UP,0.826696601941748
GOMF_COBALAMIN_BINDING,SET,8,0.3782,0.0078929,0.29153,0.097271,GOMF_COBALAMIN_BINDING,0.826696601941748
GOCC_LAMELLIPODIUM,SET,187,0.079893,0.0080218,0.061585,0.097275,GOCC_LAMELLIPODIUM,0.826696601941748
HP_CORPUS_CALLOSUM_ATROPHY,SET,37,0.18055,0.0080968,0.13919,0.097305,HP_CORPUS_CALLOSUM_ATROPHY,0.826696601941748
GOBP_ESTABLISHMENT_OF_SPINDL...,SET,42,0.17308,0.0082686,0.13348,0.097388,GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION,0.826696601941748
MIKKELSEN_ES_LCP_WITH_H3K4ME...,SET,7,0.42629,0.0083222,0.3288,0.09741,MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.826696601941748
HP_PROMINENT_ANTITRAGUS,SET,6,0.44792,0.0080959,0.34554,0.097447,HP_PROMINENT_ANTITRAGUS,0.826696601941748
HP_ANTERIOR_PITUITARY_AGENES...,SET,10,0.39192,0.0091441,0.30236,0.097463,HP_ANTERIOR_PITUITARY_AGENESIS,0.826696601941748
HSIAO_HOUSEKEEPING_GENES,SET,344,0.058338,0.0079103,0.045009,0.09747,HSIAO_HOUSEKEEPING_GENES,0.826696601941748
LIM_MAMMARY_LUMINAL_PROGENIT...1,SET,14,0.32424,0.0089502,0.25025,0.097549,LIM_MAMMARY_LUMINAL_PROGENITOR_DN,0.826696601941748
HP_SANDWICH_APPEARANCE_OF_VE...,SET,5,0.51157,0.0084409,0.39483,0.097557,HP_SANDWICH_APPEARANCE_OF_VERTEBRAL_BODIES,0.826696601941748
GOBP_NEGATIVE_REGULATION_OF_...295,SET,26,0.21627,0.0081329,0.16694,0.097573,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.826696601941748
GOBP_POSITIVE_REGULATION_OF_...386,SET,22,0.21707,0.0075097,0.16757,0.097591,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING,0.826696601941748
GOBP_RESPONSE_TO_INTERLEUKIN...7,SET,9,0.46395,0.01027,0.35815,0.097601,GOBP_RESPONSE_TO_INTERLEUKIN_2,0.826696601941748
CHIARETTI_T_ALL_RELAPSE_PROG...,SET,17,0.25835,0.0078576,0.19949,0.097661,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,0.826696601941748
GOBP_DEVELOPMENTAL_PIGMENTAT...,SET,45,0.1773,0.0087669,0.13696,0.097744,GOBP_DEVELOPMENTAL_PIGMENTATION,0.826696601941748
PID_HDAC_CLASSII_PATHWAY,SET,30,0.21223,0.0085718,0.16394,0.09775,PID_HDAC_CLASSII_PATHWAY,0.826696601941748
GOBP_REGULATION_OF_ANTIMICRO...2,SET,9,0.40709,0.0090109,0.31447,0.097751,GOBP_REGULATION_OF_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.826696601941748
GOBP_NEGATIVE_REGULATION_OF_...127,SET,53,0.16014,0.0085918,0.12372,0.097777,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.826696601941748
HP_MINIMAL_SUBCUTANEOUS_FAT,SET,4,0.56579,0.0083502,0.43719,0.097816,HP_MINIMAL_SUBCUTANEOUS_FAT,0.826696601941748
GOMF_CARBOXYPEPTIDASE_ACTIVI...,SET,42,0.17952,0.0085763,0.13872,0.097826,GOMF_CARBOXYPEPTIDASE_ACTIVITY,0.826696601941748
HP_PROLINURIA,SET,7,0.48872,0.0095409,0.37766,0.097831,HP_PROLINURIA,0.826696601941748
HP_MITRAL_ATRESIA,SET,11,0.37385,0.009148,0.28894,0.097861,HP_MITRAL_ATRESIA,0.826696601941748
IWANAGA_CARCINOGENESIS_BY_KR...2,SET,333,0.06145,0.0082003,0.047497,0.097883,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,0.826696601941748
GOBP_EPITHELIAL_CELL_APOPTOT...,SET,128,0.10174,0.0084652,0.078646,0.097904,GOBP_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.826696601941748
WWTAAGGC_UNKNOWN,SET,130,0.10197,0.0085499,0.078825,0.097908,WWTAAGGC_UNKNOWN,0.826696601941748
GOBP_PRIMARY_ALCOHOL_CATABOL...,SET,13,0.35098,0.0093361,0.27132,0.09791,GOBP_PRIMARY_ALCOHOL_CATABOLIC_PROCESS,0.826696601941748
FRIDMAN_SENESCENCE_DN,SET,10,0.31626,0.0073788,0.24448,0.097911,FRIDMAN_SENESCENCE_DN,0.826696601941748
RIZKI_TUMOR_INVASIVENESS_2D_...1,SET,52,0.15798,0.0083955,0.12213,0.097928,RIZKI_TUMOR_INVASIVENESS_2D_DN,0.826696601941748
E2F_03,SET,218,0.073463,0.0079573,0.056798,0.097944,E2F_03,0.826696601941748
GSE2405_0H_VS_9H_A_PHAGOCYTO...1,SET,182,0.078055,0.0077328,0.060349,0.097946,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.826696601941748
WP_DENGUE2_INTERACTIONS_WITH...,SET,53,0.16685,0.0089518,0.12901,0.097948,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.826696601941748
HP_MICROTIA_THIRD_DEGREE,SET,10,0.3447,0.0080425,0.26652,0.097954,HP_MICROTIA_THIRD_DEGREE,0.826696601941748
GOBP_CARDIAC_FIBROBLAST_CELL...,SET,4,0.51824,0.0076486,0.40074,0.097977,GOBP_CARDIAC_FIBROBLAST_CELL_DIFFERENTIATION,0.826696601941748
GSE42088_UNINF_VS_LEISHMANIA...1,SET,184,0.081379,0.0081058,0.06293,0.097986,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN,0.826696601941748
MODULE_530,SET,15,0.2867,0.0081913,0.22172,0.098,MODULE_530,0.826696601941748
GOBP_REGULATION_OF_MESODERM_...,SET,5,0.52148,0.0086045,0.40337,0.098049,GOBP_REGULATION_OF_MESODERM_DEVELOPMENT,0.826750793304221
REACTOME_DEFECTIVE_ST3GAL3_C...,SET,8,0.3789,0.0079075,0.29309,0.098054,REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15,0.826750793304221
HP_ABNORMALITY_OF_CHROMOSOME...2,SET,49,0.14357,0.0074073,0.11109,0.098114,HP_ABNORMALITY_OF_CHROMOSOME_STABILITY,0.827015619544132
REACTOME_SYNTHESIS_OF_PIPS_A...4,SET,10,0.28113,0.0065591,0.21754,0.098133,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE,0.827015619544132
HP_SPLENOMEGALY,SET,429,0.054324,0.0082063,0.042045,0.098179,HP_SPLENOMEGALY,0.827202701818182
GOCC_POST_MRNA_RELEASE_SPLIC...,SET,10,0.33048,0.0077105,0.25587,0.098263,GOCC_POST_MRNA_RELEASE_SPLICEOSOMAL_COMPLEX,0.827510824854651
HP_ELEVATED_SERUM_ANION_GAP,SET,4,0.52988,0.0078203,0.41027,0.098265,HP_ELEVATED_SERUM_ANION_GAP,0.827510824854651
GSE24142_EARLY_THYMIC_PROGEN...4,SET,179,0.083618,0.008216,0.064749,0.098287,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN,0.827510824854651
GOCC_TRANSCRIPTION_FACTOR_TF...1,SET,5,0.43909,0.007245,0.34004,0.098313,GOCC_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX,0.827529260111407
PIAS4_TARGET_GENES,SET,49,0.16195,0.0083553,0.12545,0.098371,PIAS4_TARGET_GENES,0.827816974576271
KEGG_MEDICUS_REFERENCE_CCR2_...,SET,30,0.20523,0.0082891,0.159,0.098407,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.827919458968773
MIR3126_5P,SET,59,0.13859,0.0078439,0.10742,0.098495,MIR3126_5P,0.828212658365571
HP_RENAL_FANCONI_SYNDROME,SET,10,0.35817,0.0083566,0.27762,0.098509,HP_RENAL_FANCONI_SYNDROME,0.828212658365571
GOBP_NEGATIVE_REGULATION_OF_...244,SET,33,0.18709,0.0079246,0.14503,0.09853,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.828212658365571
GOBP_SEROTONIN_SECRETION,SET,9,0.38738,0.0085746,0.30033,0.098559,GOBP_SEROTONIN_SECRETION,0.828212658365571
GOBP_SINGLE_STRAND_BREAK_REP...,SET,11,0.3028,0.0074096,0.23476,0.098561,GOBP_SINGLE_STRAND_BREAK_REPAIR,0.828212658365571
WP_GENES_CONTROLLING_NEPHROG...,SET,41,0.1922,0.0090724,0.14906,0.098634,WP_GENES_CONTROLLING_NEPHROGENESIS,0.828273051337672
GSE43863_TH1_VS_LY6C_INT_CXC...4,SET,187,0.079377,0.00797,0.061566,0.098655,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.828273051337672
LIANG_HEMATOPOIESIS_STEM_CEL...1,SET,37,0.18076,0.0081063,0.1402,0.09866,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,0.828273051337672
GOBP_C_X_C_CHEMOKINE_RECEPTO...,SET,5,0.55132,0.009097,0.42764,0.098669,GOBP_C_X_C_CHEMOKINE_RECEPTOR_CXCR4_SIGNALING_PATHWAY,0.828273051337672
GOMF_ACTIVIN_BINDING,SET,11,0.37315,0.0091308,0.28949,0.098713,GOMF_ACTIVIN_BINDING,0.828273051337672
GSE14415_INDUCED_VS_NATURAL_...1,SET,162,0.085374,0.007984,0.066236,0.098719,GSE14415_INDUCED_VS_NATURAL_TREG_DN,0.828273051337672
ALCALA_APOPTOSIS,SET,80,0.11744,0.0077352,0.091144,0.098796,ALCALA_APOPTOSIS,0.828273051337672
GOBP_REGULATION_OF_STEM_CELL...3,SET,67,0.13353,0.0080517,0.10366,0.098858,GOBP_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.828273051337672
HP_SYNOSTOSIS_OF_METACARPALS...,SET,15,0.2986,0.0085314,0.23181,0.098863,HP_SYNOSTOSIS_OF_METACARPALS_METATARSALS,0.828273051337672
AML1_01,SET,251,0.072883,0.0084632,0.056583,0.09887,AML1_01,0.828273051337672
AML1_Q6,SET,251,0.072883,0.0084632,0.056583,0.09887,AML1_Q6,0.828273051337672
HE_LIM_SUN_FETAL_LUNG_C4_CYC...2,SET,809,0.037498,0.0076959,0.029113,0.098877,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL,0.828273051337672
HP_INCREASED_CONNECTIVE_TISS...,SET,24,0.21653,0.0078234,0.16811,0.098878,HP_INCREASED_CONNECTIVE_TISSUE,0.828273051337672
GOBP_ANTIMICROBIAL_PEPTIDE_P...,SET,12,0.35845,0.009161,0.27838,0.098941,GOBP_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.82834424132948
GOBP_WOUND_HEALING_INVOLVED_...,SET,7,0.47422,0.0092578,0.3683,0.098953,GOBP_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.82834424132948
GSE2706_UNSTIM_VS_8H_LPS_DC_...1,SET,171,0.086006,0.0082615,0.066798,0.098958,GSE2706_UNSTIM_VS_8H_LPS_DC_DN,0.82834424132948
KEGG_GLYCOSPHINGOLIPID_BIOSY...2,SET,13,0.31862,0.0084753,0.24751,0.099001,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,0.828416701154957
GOBP_RESPONSE_TO_MOLECULE_OF...1,SET,326,0.065149,0.0086038,0.05062,0.099052,GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.828416701154957
HP_ULCERATIVE_COLITIS,SET,13,0.32204,0.0085661,0.25022,0.099054,HP_ULCERATIVE_COLITIS,0.828416701154957
GOBP_NEUTROPHIL_CLEARANCE,SET,6,0.50776,0.0091775,0.39454,0.099062,GOBP_NEUTROPHIL_CLEARANCE,0.828416701154957
JOHNSTONE_PARVB_TARGETS_1_UP,SET,6,0.46471,0.0083995,0.36122,0.099139,JOHNSTONE_PARVB_TARGETS_1_UP,0.828720353535353
GOBP_METAPHASE_ANAPHASE_TRAN...,SET,6,0.45643,0.0082497,0.35479,0.099146,GOBP_METAPHASE_ANAPHASE_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.828720353535353
GSE11864_UNTREATED_VS_CSF1_P...2,SET,164,0.084497,0.0079502,0.065694,0.099192,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP,0.828762806722689
HP_GRANULOCYTIC_HYPERPLASIA,SET,6,0.52437,0.0094778,0.40777,0.099238,HP_GRANULOCYTIC_HYPERPLASIA,0.828762806722689
GSE45365_NK_CELL_VS_CD8_TCEL...1,SET,144,0.095888,0.0084586,0.074569,0.099248,GSE45365_NK_CELL_VS_CD8_TCELL_DN,0.828762806722689
WP_ESTROGEN_RECEPTOR_PATHWAY,SET,13,0.3333,0.0088657,0.25925,0.099291,WP_ESTROGEN_RECEPTOR_PATHWAY,0.828762806722689
MIR1915_3P,SET,156,0.089416,0.0082071,0.069549,0.099291,MIR1915_3P,0.828762806722689
REACTOME_SYNTHESIS_OF_15_EIC...,SET,6,0.46592,0.0084214,0.36244,0.099313,REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES,0.828762806722689
GSE11924_TFH_VS_TH2_CD4_TCEL...1,SET,176,0.080188,0.0078133,0.062379,0.099318,GSE11924_TFH_VS_TH2_CD4_TCELL_DN,0.828762806722689
HP_CYCLOPIA,SET,19,0.2521,0.0081057,0.19615,0.099366,HP_CYCLOPIA,0.828798740100792
GOBP_PATTERN_SPECIFICATION_P...,SET,432,0.058281,0.0088341,0.045348,0.09937,GOBP_PATTERN_SPECIFICATION_PROCESS,0.828798740100792
REACTOME_NEF_AND_SIGNAL_TRAN...,SET,8,0.40183,0.008386,0.3127,0.099402,REACTOME_NEF_AND_SIGNAL_TRANSDUCTION,0.828827571942446
GOBP_POSITIVE_REGULATION_OF_...92,SET,13,0.30323,0.0080659,0.23601,0.099442,GOBP_POSITIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.828827571942446
GSE15330_HSC_VS_PRO_BCELL_UP,SET,176,0.079476,0.007744,0.06186,0.099445,GSE15330_HSC_VS_PRO_BCELL_UP,0.828827571942446
LIU_IL13_PRIMING_MODEL,SET,15,0.29598,0.0084567,0.23047,0.09953,LIU_IL13_PRIMING_MODEL,0.829206161035226
HP_UVEITIS,SET,47,0.17674,0.008931,0.13763,0.099548,HP_UVEITIS,0.829206161035226
MIR6165,SET,111,0.099206,0.0076903,0.077257,0.099562,MIR6165,0.829206161035226
HP_SPLIT_NAIL,SET,4,0.41697,0.0061539,0.3248,0.099623,HP_SPLIT_NAIL,0.829259626436782
HP_TIGER_TAIL_BANDING,SET,4,0.41697,0.0061539,0.3248,0.099623,HP_TIGER_TAIL_BANDING,0.829259626436782
MIR325,SET,28,0.20403,0.0079617,0.15894,0.09964,MIR325,0.829259626436782
ZHU_SKIL_TARGETS_UP,SET,19,0.26542,0.0085341,0.20682,0.099695,ZHU_SKIL_TARGETS_UP,0.829407880200861
GSE21380_NON_TFH_VS_TFH_CD4_...2,SET,183,0.082023,0.008148,0.063918,0.099709,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP,0.829407880200861
GCM_PFN1,SET,44,0.1538,0.0075203,0.11987,0.099741,GCM_PFN1,0.829407880200861
WP_COMPLEMENT_SYSTEM,SET,89,0.12854,0.0089279,0.10019,0.099754,WP_COMPLEMENT_SYSTEM,0.829407880200861
HP_ABNORMAL_PROSTATE_MORPHOL...,SET,38,0.18446,0.008383,0.14379,0.099781,HP_ABNORMAL_PROSTATE_MORPHOLOGY,0.829407880200861
GOBP_RENAL_PROTEIN_ABSORPTION,SET,9,0.41365,0.0091562,0.32248,0.099801,GOBP_RENAL_PROTEIN_ABSORPTION,0.829407880200861
GOBP_HOMOPHILIC_CELL_ADHESIO...,SET,157,0.11674,0.010749,0.09104,0.099878,GOBP_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.829849364092756
GAO_LARGE_INTESTINE_24W_C4_P...,SET,5,0.49775,0.008213,0.38825,0.099923,GAO_LARGE_INTESTINE_24W_C4_PROM1LOW_PROGENITOR,0.830024824330784
MIR17_3P,SET,121,0.10213,0.0082637,0.079672,0.09995,MIR17_3P,0.830050716845878
MORF_NF1,SET,160,0.087521,0.0081346,0.068297,0.10002,MORF_NF1,0.830235275853833
CUI_DEVELOPING_HEART_C9_B_T_...,SET,133,0.098824,0.0083806,0.077117,0.10002,CUI_DEVELOPING_HEART_C9_B_T_CELL,0.830235275853833
GSE32901_NAIVE_VS_TH1_CD4_TC...1,SET,152,0.089345,0.0080956,0.069735,0.10007,GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN,0.830419658629745
ATF_01,SET,240,0.072745,0.0082626,0.056785,0.10009,ATF_01,0.830419658629745
GOMF_RNA_POLYMERASE_III_GENE...,SET,12,0.24591,0.0062848,0.192,0.10014,GOMF_RNA_POLYMERASE_III_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.830636205250597
GOBP_FAT_CELL_PROLIFERATION,SET,15,0.31275,0.0089357,0.24421,0.10017,GOBP_FAT_CELL_PROLIFERATION,0.830654448950382
GOBP_AMINO_ACID_BETAINE_META...,SET,16,0.27336,0.0080662,0.21347,0.10019,GOBP_AMINO_ACID_BETAINE_METABOLIC_PROCESS,0.830654448950382
GOBP_GLYCEROPHOSPHOLIPID_BIO...,SET,190,0.078123,0.007906,0.06102,0.10023,GOBP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.830755543633762
MIR409_3P,SET,88,0.11873,0.0082004,0.09275,0.10025,MIR409_3P,0.830755543633762
GOBP_EPITHELIAL_STRUCTURE_MA...,SET,32,0.21169,0.0088301,0.16538,0.10028,GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE,0.830806054827175
GOMF_PROTEIN_TYROSINE_PHOSPH...,SET,89,0.11575,0.0080397,0.090452,0.10033,GOMF_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.830907005003574
WP_RANKLRANK_SIGNALING,SET,53,0.15063,0.0080813,0.11771,0.10034,WP_RANKLRANK_SIGNALING,0.830907005003574
HP_MICRONODULAR_CIRRHOSIS,SET,21,0.23197,0.0078406,0.18136,0.10045,HP_MICRONODULAR_CIRRHOSIS,0.83155475
GOBP_DOUBLE_STRAND_BREAK_REP...8,SET,8,0.28486,0.0059449,0.22273,0.10047,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING,0.83155475
LEE_LIVER_CANCER_CIPROFIBRAT...1,SET,63,0.15003,0.0087734,0.11732,0.10049,LEE_LIVER_CANCER_CIPROFIBRATE_DN,0.83155475
GSE24210_IL35_TREATED_VS_RES...1,SET,181,0.085342,0.0084317,0.066749,0.10054,GSE24210_IL35_TREATED_VS_RESTING_TREG_DN,0.831770459414425
GOCC_MICROTUBULE_ORGANIZING_...2,SET,10,0.32845,0.0076633,0.25698,0.10061,GOCC_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE,0.832133061658398
GOBP_POSITIVE_REGULATION_OF_...656,SET,115,0.10096,0.0079652,0.079021,0.1007,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.832133061658398
GSE17721_4_VS_24H_GARDIQUIMO...1,SET,176,0.079897,0.007785,0.062542,0.10072,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN,0.832133061658398
WHITE_NEUROBLASTOMA_WITH_1P3...,SET,19,0.34355,0.011046,0.26896,0.10075,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,0.832133061658398
GOBP_PROTEIN_MODIFICATION_BY...2,SET,91,0.10401,0.0073044,0.081456,0.10083,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL,0.832133061658398
HP_DECREASED_METHYLMALONYL_C...,SET,5,0.513,0.0084645,0.40178,0.10084,HP_DECREASED_METHYLMALONYL_COA_MUTASE_ACTIVITY,0.832133061658398
KEGG_MEDICUS_REFERENCE_GLYCO...3,SET,5,0.47288,0.0078027,0.37038,0.10085,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_,0.832133061658398
REACTOME_RAC1_GTPASE_CYCLE,SET,167,0.08754,0.0083109,0.068567,0.10086,REACTOME_RAC1_GTPASE_CYCLE,0.832133061658398
GOBP_REGULATION_OF_MRNA_CIS_...,SET,3,0.56396,0.0072084,0.44177,0.10088,GOBP_REGULATION_OF_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.832133061658398
HP_MUSCLE_FIBRILLATION,SET,58,0.14264,0.0080047,0.11176,0.10093,HP_MUSCLE_FIBRILLATION,0.832133061658398
GSE21927_EL4_VS_MCA203_TUMOR...1,SET,153,0.086125,0.0078292,0.067481,0.10094,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN,0.832133061658398
SHAFFER_IRF4_TARGETS_IN_ACTI...2,SET,57,0.14964,0.0083247,0.11727,0.10099,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,0.832133061658398
GSE22196_HEALTHY_VS_OBESE_MO...2,SET,180,0.083161,0.0081937,0.065174,0.10099,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP,0.832133061658398
HP_BIFID_URETER,SET,4,0.53797,0.0079397,0.42165,0.10101,HP_BIFID_URETER,0.832133061658398
GOBP_SRP_DEPENDENT_COTRANSLA...1,SET,16,0.25122,0.0074129,0.19691,0.10102,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.832133061658398
GOBP_ANTIGEN_PROCESSING_AND_...2,SET,5,0.78407,0.012937,0.61469,0.10106,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.832133061658398
GOMF_LIPID_ANTIGEN_BINDING,SET,5,0.78407,0.012937,0.61469,0.10106,GOMF_LIPID_ANTIGEN_BINDING,0.832133061658398
chr4p16,SET,93,0.21564,0.015309,0.16906,0.10107,chr4p16,0.832133061658398
GOBP_NEPHRON_DEVELOPMENT,SET,150,0.096649,0.0087001,0.075782,0.1011,GOBP_NEPHRON_DEVELOPMENT,0.832133061658398
GOMF_PROTEIN_PHOSPHATASE_1_B...,SET,23,0.21195,0.0074971,0.16622,0.10114,GOMF_PROTEIN_PHOSPHATASE_1_BINDING,0.832133061658398
GOMF_PHOSPHATIDYLINOSITOL_PH...3,SET,162,0.085735,0.0080178,0.067245,0.10117,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING,0.832133061658398
GOMF_C4_DICARBOXYLATE_TRANSM...,SET,15,0.27661,0.007903,0.21698,0.1012,GOMF_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.832133061658398
GOMF_INORGANIC_MOLECULAR_ENT...,SET,659,0.044394,0.0082583,0.034824,0.1012,GOMF_INORGANIC_MOLECULAR_ENTITY_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.832133061658398
HP_AORTIC_REGURGITATION,SET,89,0.11654,0.008094,0.09143,0.10124,HP_AORTIC_REGURGITATION,0.832133061658398
COLLIS_PRKDC_REGULATORS,SET,13,0.32888,0.0087481,0.25804,0.10125,COLLIS_PRKDC_REGULATORS,0.832133061658398
GSE411_UNSTIM_VS_100MIN_IL6_...3,SET,186,0.082643,0.0082759,0.064854,0.10129,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.832133061658398
WEST_ADRENOCORTICAL_TUMOR_UP,SET,280,0.064383,0.00789,0.050531,0.10132,WEST_ADRENOCORTICAL_TUMOR_UP,0.832133061658398
HP_DIGITAL_FLEXOR_TENOSYNOVI...,SET,7,0.42131,0.0082249,0.33066,0.10132,HP_DIGITAL_FLEXOR_TENOSYNOVITIS,0.832133061658398
HP_ABNORMALITY_OF_THE_FIFTH_...,SET,8,0.43812,0.0091435,0.34388,0.10133,HP_ABNORMALITY_OF_THE_FIFTH_METATARSAL_BONE,0.832133061658398
HP_COMPULSIVE_BEHAVIORS,SET,137,0.09351,0.0080474,0.073397,0.10134,HP_COMPULSIVE_BEHAVIORS,0.832133061658398
RAMPON_ENRICHED_LEARNING_ENV...1,SET,10,0.374,0.0087261,0.29358,0.10135,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN,0.832133061658398
MORF_DDX11,SET,145,0.085602,0.0075772,0.067194,0.10135,MORF_DDX11,0.832133061658398
AMIT_EGF_RESPONSE_60_MCF10A,SET,36,0.19037,0.0084217,0.1495,0.10144,AMIT_EGF_RESPONSE_60_MCF10A,0.832218706536857
HP_HYPERNATRIURIA,SET,9,0.40216,0.0089018,0.31581,0.10144,HP_HYPERNATRIURIA,0.832218706536857
MIR4501,SET,73,0.12484,0.0078562,0.098043,0.10146,MIR4501,0.832218706536857
WELCH_GATA1_TARGETS,SET,21,0.24146,0.0081616,0.18965,0.10148,WELCH_GATA1_TARGETS,0.832218706536857
GOBP_ENDOCYTOSIS,SET,643,0.044249,0.0081345,0.034756,0.10149,GOBP_ENDOCYTOSIS,0.832218706536857
BURTON_ADIPOGENESIS_PEAK_AT_...3,SET,42,0.16352,0.0078119,0.12848,0.10158,BURTON_ADIPOGENESIS_PEAK_AT_24HR,0.832218706536857
MATZUK_IMPLANTATION_AND_UTER...,SET,18,0.27296,0.0085424,0.21448,0.10158,MATZUK_IMPLANTATION_AND_UTERINE,0.832218706536857
GOBP_NUCLEOSIDE_MONOPHOSPHAT...4,SET,11,0.32299,0.0079036,0.25382,0.1016,GOBP_NUCLEOSIDE_MONOPHOSPHATE_PHOSPHORYLATION,0.832218706536857
RUBENSTEIN_SKELETAL_MUSCLE_N...,SET,198,0.077454,0.0079999,0.06087,0.10161,RUBENSTEIN_SKELETAL_MUSCLE_NK_CELLS,0.832218706536857
PUJANA_BRCA2_PCC_NETWORK,SET,394,0.052216,0.0075666,0.04104,0.10164,PUJANA_BRCA2_PCC_NETWORK,0.832218706536857
PDGF_UP.V1_DN,SET,108,0.11065,0.0084613,0.086979,0.10167,PDGF_UP.V1_DN,0.832218706536857
GOBP_NEGATIVE_REGULATION_OF_...180,SET,796,0.04128,0.0084069,0.032451,0.10168,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.832218706536857
GOCC_PROTEIN_LIPID_COMPLEX,SET,33,0.20618,0.0087331,0.16214,0.10176,GOCC_PROTEIN_LIPID_COMPLEX,0.832218706536857
GSE16385_ROSIGLITAZONE_IL4_V...3,SET,188,0.078038,0.0078563,0.061368,0.10176,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN,0.832218706536857
HP_CELLULAR_IMMUNODEFICIENCY,SET,33,0.18212,0.007714,0.14328,0.10186,HP_CELLULAR_IMMUNODEFICIENCY,0.832218706536857
PID_EPHA_FWDPATHWAY,SET,34,0.19628,0.0084385,0.15445,0.10191,PID_EPHA_FWDPATHWAY,0.832218706536857
GOBP_PROTEIN_LOCALIZATION_TO...22,SET,65,0.12524,0.0074387,0.098556,0.10192,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.832218706536857
GOMF_SMAD_BINDING,SET,74,0.13419,0.008502,0.10561,0.10195,GOMF_SMAD_BINDING,0.832218706536857
GOCC_IGM_IMMUNOGLOBULIN_COMP...,SET,3,0.69528,0.0088869,0.54752,0.10207,GOCC_IGM_IMMUNOGLOBULIN_COMPLEX,0.832218706536857
TONKS_TARGETS_OF_RUNX1_RUNX1...2,SET,143,0.09746,0.0085676,0.076755,0.1021,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,0.832218706536857
GSE19198_CTRL_VS_IL21_TREATE...6,SET,172,0.086145,0.0082988,0.067848,0.10211,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP,0.832218706536857
GSE45365_HEALTHY_VS_MCMV_INF...9,SET,172,0.081943,0.007894,0.064556,0.10217,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP,0.832218706536857
BIOCARTA_HSWI_SNF_PATHWAY,SET,12,0.31464,0.0080414,0.24789,0.10218,BIOCARTA_HSWI_SNF_PATHWAY,0.832218706536857
MIR4531,SET,302,0.063509,0.008078,0.050037,0.10218,MIR4531,0.832218706536857
ATACCTC_MIR202,SET,168,0.083635,0.0079636,0.065902,0.10222,ATACCTC_MIR202,0.832218706536857
GOBP_ADIPONECTIN_ACTIVATED_S...,SET,7,0.43761,0.008543,0.34487,0.10224,GOBP_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY,0.832218706536857
GSE3565_CTRL_VS_LPS_INJECTED...3,SET,155,0.087769,0.0080303,0.069167,0.10224,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN,0.832218706536857
HP_EXCESSIVE_BLEEDING_FROM_S...,SET,5,0.5202,0.0085835,0.40997,0.10225,HP_EXCESSIVE_BLEEDING_FROM_SUPERFICIAL_CUTS,0.832218706536857
MIR2392,SET,68,0.13279,0.0080663,0.10467,0.10228,MIR2392,0.832218706536857
HP_DECREASED_ACTIVITY_OF_MIT...4,SET,41,0.1543,0.0072833,0.12163,0.10231,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_III,0.832218706536857
GSE1432_CTRL_VS_IFNG_1H_MICR...2,SET,171,0.079753,0.0076608,0.06287,0.10231,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.832218706536857
GOBP_POSITIVE_REGULATION_OF_...658,SET,5,0.52901,0.0087287,0.41708,0.10234,GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS,0.832218706536857
GSE6269_FLU_VS_E_COLI_INF_PB...2,SET,147,0.084648,0.0075438,0.066739,0.10235,GSE6269_FLU_VS_E_COLI_INF_PBMC_UP,0.832218706536857
HP_VENOUS_MALFORMATION,SET,11,0.32336,0.0079124,0.25496,0.10236,HP_VENOUS_MALFORMATION,0.832218706536857
GSE16385_UNTREATED_VS_12H_RO...5,SET,165,0.084852,0.0080077,0.066908,0.10237,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.832218706536857
CAO_BLOOD_FLUZONE_AGE_05_14Y...3,SET,7,0.36578,0.0071409,0.28843,0.10238,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_DN,0.832218706536857
ZHAN_EARLY_DIFFERENTIATION_G...2,SET,6,0.43695,0.0078978,0.34461,0.10242,ZHAN_EARLY_DIFFERENTIATION_GENES_UP,0.832218706536857
HP_MICROANGIOPATHIC_HEMOLYTI...,SET,9,0.38358,0.0084905,0.30256,0.10245,HP_MICROANGIOPATHIC_HEMOLYTIC_ANEMIA,0.832218706536857
BOYAULT_LIVER_CANCER_SUBCLAS...16,SET,58,0.13887,0.0077932,0.10956,0.10247,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,0.832218706536857
MUELLER_PLURINET,SET,276,0.06303,0.0076696,0.049724,0.10248,MUELLER_PLURINET,0.832218706536857
MORF_TNFRSF25,SET,244,0.069989,0.0080147,0.055214,0.10248,MORF_TNFRSF25,0.832218706536857
GOBP_NEGATIVE_REGULATION_OF_...512,SET,9,0.3678,0.0081413,0.29018,0.1025,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.832218706536857
GSE5542_IFNG_VS_IFNA_TREATED...4,SET,175,0.076452,0.0074283,0.060339,0.10258,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,0.832218706536857
GCM_PTPRU,SET,50,0.14591,0.0076042,0.11519,0.10264,GCM_PTPRU,0.832218706536857
HP_SHORT_MIDDLE_PHALANX_OF_T...1,SET,7,0.42716,0.0083391,0.33722,0.10264,HP_SHORT_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.832218706536857
GOBP_CYTOKINETIC_PROCESS,SET,46,0.15554,0.0077756,0.1228,0.10266,GOBP_CYTOKINETIC_PROCESS,0.832218706536857
GOBP_REGULATION_OF_ESTABLISH...1,SET,13,0.31902,0.008486,0.25188,0.10266,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY,0.832218706536857
GSE2770_IL12_VS_IL4_TREATED_...6,SET,182,0.077772,0.0077048,0.061403,0.10266,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.832218706536857
GOBP_REGULATION_OF_CELLULAR_...2,SET,413,0.053647,0.007955,0.04236,0.10269,GOBP_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.832218706536857
REACTOME_SIGNALING_BY_WNT_IN...,SET,32,0.19876,0.0082907,0.15699,0.10275,REACTOME_SIGNALING_BY_WNT_IN_CANCER,0.832218706536857
GOBP_NEGATIVE_REGULATION_OF_...491,SET,330,0.060164,0.0079932,0.04752,0.10275,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.832218706536857
HP_VERTIGO,SET,136,0.09565,0.0082017,0.075555,0.10277,HP_VERTIGO,0.832218706536857
GOMF_HISTONE_H3K9_MONOMETHYL...,SET,6,0.39917,0.0072149,0.31533,0.10279,GOMF_HISTONE_H3K9_MONOMETHYLTRANSFERASE_ACTIVITY,0.832218706536857
SENGUPTA_NASOPHARYNGEAL_CARC...1,SET,293,0.063622,0.0079728,0.050264,0.10281,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,0.832218706536857
MYCMAX_02,SET,240,0.070619,0.0080211,0.055796,0.10282,MYCMAX_02,0.832218706536857
MOROSETTI_FACIOSCAPULOHUMERA...2,SET,19,0.24891,0.0080031,0.19668,0.10284,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,0.832218706536857
GSE34515_CD16_NEG_VS_POS_MON...2,SET,181,0.081869,0.0080885,0.064688,0.10284,GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP,0.832218706536857
CHIARETTI_ACUTE_LYMPHOBLASTI...,SET,63,0.12377,0.0072378,0.097803,0.10285,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,0.832218706536857
GOMF_DNA_BINDING_TRANSCRIPTI...2,SET,1329,0.034783,0.0090131,0.027486,0.10286,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.832218706536857
BIOCARTA_CSK_PATHWAY,SET,18,0.26769,0.0083776,0.21159,0.10291,BIOCARTA_CSK_PATHWAY,0.832218706536857
GOBP_POSITIVE_REGULATION_OF_...572,SET,61,0.13485,0.0077598,0.10659,0.10292,GOBP_POSITIVE_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.832218706536857
GOBP_REGULATION_OF_BRANCHING...2,SET,5,0.58267,0.0096141,0.46067,0.10298,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.832218706536857
REACTOME_CARGO_TRAFFICKING_T...,SET,49,0.15045,0.0077621,0.11896,0.10299,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,0.832218706536857
WP_ARACHIDONATE_EPOXYGENASE_...,SET,7,0.36548,0.007135,0.28897,0.10299,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,0.832218706536857
GOMF_AMINO_ACID_MONOATOMIC_C...1,SET,4,0.45894,0.0067734,0.3629,0.103,GOMF_AMINO_ACID_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.832218706536857
PID_IFNG_PATHWAY,SET,40,0.17532,0.0081743,0.13864,0.10303,PID_IFNG_PATHWAY,0.832218706536857
HP_RENAL_CELL_CARCINOMA,SET,70,0.13038,0.0080353,0.10311,0.10304,HP_RENAL_CELL_CARCINOMA,0.832218706536857
MARTINELLI_IMMATURE_NEUTROPH...2,SET,8,0.44669,0.0093223,0.3533,0.10306,MARTINELLI_IMMATURE_NEUTROPHIL_UP,0.832218706536857
BIOCARTA_NO2IL12_PATHWAY,SET,14,0.31364,0.0086575,0.24809,0.10308,BIOCARTA_NO2IL12_PATHWAY,0.832218706536857
GOBP_LAMELLIPODIUM_ORGANIZAT...,SET,79,0.12411,0.0081234,0.098182,0.10311,GOBP_LAMELLIPODIUM_ORGANIZATION,0.832218706536857
REACTOME_DISEASES_OF_CARBOHY...,SET,30,0.18954,0.0076555,0.14995,0.10312,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,0.832218706536857
GOCC_HAUS_COMPLEX,SET,7,0.34243,0.006685,0.27093,0.10314,GOCC_HAUS_COMPLEX,0.832218706536857
GOCC_GERM_CELL_NUCLEUS,SET,62,0.13175,0.0076433,0.10424,0.10315,GOCC_GERM_CELL_NUCLEUS,0.832218706536857
HINATA_NFKB_IMMU_INF,SET,15,0.32278,0.0092224,0.25542,0.10317,HINATA_NFKB_IMMU_INF,0.832218706536857
GSE17721_0.5H_VS_4H_POLYIC_B...1,SET,178,0.081381,0.0079741,0.06441,0.10322,GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN,0.832218706536857
MIR3660,SET,96,0.11122,0.0080214,0.08804,0.10325,MIR3660,0.832218706536857
GAGCCAG_MIR149,SET,130,0.091702,0.0076891,0.072593,0.10326,GAGCCAG_MIR149,0.832218706536857
GOMF_TRANSCRIPTION_REGULATOR...3,SET,26,0.22582,0.0084918,0.17877,0.10327,GOMF_TRANSCRIPTION_REGULATOR_INHIBITOR_ACTIVITY,0.832218706536857
HP_MYOPIC_ASTIGMATISM,SET,6,0.42694,0.0077167,0.33802,0.10329,HP_MYOPIC_ASTIGMATISM,0.832218706536857
GSE360_DC_VS_MAC_T_GONDII_DN,SET,180,0.081966,0.008076,0.064893,0.10329,GSE360_DC_VS_MAC_T_GONDII_DN,0.832218706536857
GOBP_NEGATIVE_REGULATION_OF_...51,SET,52,0.15838,0.0084168,0.1254,0.1033,GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.832218706536857
FLORIO_NEOCORTEX_BASAL_RADIA...1,SET,170,0.081823,0.0078369,0.064796,0.10334,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,0.832301377633712
GOBP_REGULATION_OF_INWARD_RE...,SET,4,0.60823,0.0089766,0.48174,0.10338,GOBP_REGULATION_OF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.832301377633712
REACTOME_RUNX1_REGULATES_GEN...,SET,35,0.18668,0.0081427,0.14788,0.10342,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,0.832301377633712
GOBP_REGULATION_OF_DOPAMINER...,SET,9,0.4132,0.0091461,0.32733,0.10342,GOBP_REGULATION_OF_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.832301377633712
GOBP_MAINTENANCE_OF_CELL_NUM...,SET,170,0.083406,0.0079885,0.066075,0.10343,GOBP_MAINTENANCE_OF_CELL_NUMBER,0.832301377633712
REACTOME_RESOLUTION_OF_D_LOO...1,SET,32,0.175,0.0072996,0.13866,0.10347,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES,0.832430520833333
BIOCARTA_ERYTH_PATHWAY,SET,15,0.31006,0.0088588,0.24576,0.10355,BIOCARTA_ERYTH_PATHWAY,0.832881335339042
GOBP_LAMELLIPODIUM_MORPHOGEN...,SET,18,0.23985,0.0075064,0.19016,0.1036,GOBP_LAMELLIPODIUM_MORPHOGENESIS,0.832965774907749
GOBP_DEVELOPMENTAL_PROCESS_I...,SET,868,0.03762,0.0079841,0.029827,0.10361,GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION,0.832965774907749
PID_VEGFR1_PATHWAY,SET,26,0.20107,0.0075611,0.15946,0.10367,PID_VEGFR1_PATHWAY,0.832965774907749
GSE3982_MAC_VS_NKCELL_UP,SET,180,0.08384,0.0082606,0.066493,0.10368,GSE3982_MAC_VS_NKCELL_UP,0.832965774907749
GOBP_ANATOMICAL_STRUCTURE_RE...,SET,15,0.2775,0.0079285,0.22014,0.10375,GOBP_ANATOMICAL_STRUCTURE_REGRESSION,0.832965774907749
HP_PUBERTY_AND_GONADAL_DISOR...,SET,561,0.045818,0.0078858,0.036357,0.1038,HP_PUBERTY_AND_GONADAL_DISORDERS,0.832965774907749
GSE28237_FOLLICULAR_VS_LATE_...2,SET,180,0.084904,0.0083655,0.067373,0.1038,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP,0.832965774907749
GOBP_WYBUTOSINE_METABOLIC_PR...,SET,6,0.38016,0.0068712,0.30173,0.10385,GOBP_WYBUTOSINE_METABOLIC_PROCESS,0.832965774907749
KEGG_PPAR_SIGNALING_PATHWAY,SET,67,0.13407,0.008084,0.10641,0.10386,KEGG_PPAR_SIGNALING_PATHWAY,0.832965774907749
MIR4292,SET,143,0.087811,0.0077194,0.069695,0.10386,MIR4292,0.832965774907749
GOCC_KATANIN_COMPLEX,SET,5,0.52729,0.0087004,0.41853,0.10387,GOCC_KATANIN_COMPLEX,0.832965774907749
GSE18791_CTRL_VS_NEWCASTLE_V...12,SET,138,0.093799,0.0081015,0.074461,0.1039,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP,0.832965774907749
REACTOME_VITAMIN_B5_PANTOTHE...,SET,19,0.23753,0.0076371,0.18857,0.10391,REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,0.832965774907749
HP_HEMIMEGALENCEPHALY,SET,14,0.29572,0.0081628,0.23477,0.10392,HP_HEMIMEGALENCEPHALY,0.832965774907749
GSE3920_UNTREATED_VS_IFNG_TR...4,SET,156,0.086076,0.0079005,0.068338,0.10392,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP,0.832965774907749
GCM_AQP4,SET,41,0.17533,0.0082762,0.13922,0.10396,GCM_AQP4,0.833030652224015
HP_REACTIVE_HYPOGLYCEMIA,SET,7,0.37828,0.0073849,0.30044,0.104,HP_REACTIVE_HYPOGLYCEMIA,0.833030652224015
HP_SCHWANNOMA,SET,11,0.31012,0.0075885,0.2463,0.104,HP_SCHWANNOMA,0.833030652224015
GAVISH_3CA_METAPROGRAM_B_CEL...12,SET,44,0.17836,0.0087212,0.14168,0.10404,GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS,0.833159032258064
HP_SEPSIS,SET,106,0.10853,0.0082223,0.086234,0.10411,HP_SEPSIS,0.833320115074799
MIR6747_3P,SET,105,0.10816,0.008156,0.085959,0.10415,MIR6747_3P,0.833320115074799
GOMF_ABC_TYPE_XENOBIOTIC_TRA...,SET,14,0.31756,0.0087656,0.25237,0.10415,GOMF_ABC_TYPE_XENOBIOTIC_TRANSPORTER_ACTIVITY,0.833320115074799
GOBP_NUCLEOSIDE_SALVAGE,SET,10,0.36415,0.0084961,0.28942,0.10417,GOBP_NUCLEOSIDE_SALVAGE,0.833320115074799
MIR124_5P,SET,102,0.1066,0.0079232,0.084728,0.10418,MIR124_5P,0.833320115074799
GOBP_ENDOCRINE_PANCREAS_DEVE...,SET,42,0.18163,0.0086772,0.14438,0.10421,GOBP_ENDOCRINE_PANCREAS_DEVELOPMENT,0.833368281178095
GOBP_NEGATIVE_REGULATION_OF_...92,SET,622,0.043397,0.0078511,0.034512,0.1043,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,0.833370866773676
GOCC_PLASMA_MEMBRANE_RAFT,SET,106,0.10891,0.0082517,0.086634,0.10435,GOCC_PLASMA_MEMBRANE_RAFT,0.833370866773676
HP_EUNUCHOID_HABITUS,SET,21,0.25361,0.0085722,0.20175,0.10438,HP_EUNUCHOID_HABITUS,0.833370866773676
HP_ABNORMALITY_OF_THE_SPLEEN,SET,555,0.046075,0.0078888,0.036658,0.1044,HP_ABNORMALITY_OF_THE_SPLEEN,0.833370866773676
MIR103A_3P_MIR107,SET,234,0.070073,0.0078603,0.05576,0.10444,MIR103A_3P_MIR107,0.833370866773676
MIR4252,SET,86,0.1188,0.008112,0.094539,0.10444,MIR4252,0.833370866773676
DANG_REGULATED_BY_MYC_UP,SET,65,0.13384,0.0079493,0.1065,0.10445,DANG_REGULATED_BY_MYC_UP,0.833370866773676
HP_MESOMELIC_LEG_SHORTENING,SET,5,0.4974,0.0082072,0.39581,0.10445,HP_MESOMELIC_LEG_SHORTENING,0.833370866773676
MIR141_5P,SET,91,0.11442,0.0080355,0.09106,0.10447,MIR141_5P,0.833370866773676
NUYTTEN_NIPP1_TARGETS_DN,SET,766,0.03952,0.0079021,0.031458,0.10451,NUYTTEN_NIPP1_TARGETS_DN,0.833370866773676
SMID_BREAST_CANCER_LUMINAL_B...1,SET,494,0.053591,0.0086716,0.042664,0.10454,SMID_BREAST_CANCER_LUMINAL_B_DN,0.833370866773676
GOBP_VENTRICULAR_SEPTUM_DEVE...,SET,70,0.13648,0.0084111,0.10865,0.10455,GOBP_VENTRICULAR_SEPTUM_DEVELOPMENT,0.833370866773676
GSE21063_3H_VS_16H_ANTI_IGM_...3,SET,182,0.077246,0.0076527,0.0615,0.10456,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN,0.833370866773676
LI_PBMC_MENACTRA_AGE_18_45YO...3,SET,25,0.22249,0.0082045,0.17714,0.10456,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.833370866773676
REACTOME_COMPLEX_IV_ASSEMBLY,SET,41,0.14315,0.0067573,0.11398,0.10457,REACTOME_COMPLEX_IV_ASSEMBLY,0.833370866773676
GOBP_PYRIMIDINE_RIBONUCLEOTI...3,SET,29,0.19872,0.0078915,0.15827,0.10464,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS,0.833610535959688
FOROUTAN_PRODRANK_TGFB_EMT_DN,SET,76,0.13143,0.0084384,0.10469,0.10467,FOROUTAN_PRODRANK_TGFB_EMT_DN,0.833610535959688
GOBP_PHOSPHATIDYLINOSITOL_BI...,SET,117,0.095651,0.0076113,0.076193,0.10468,GOBP_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.833610535959688
GOBP_REGULATION_OF_ACTIN_FIL...3,SET,94,0.11494,0.0082034,0.091571,0.10471,GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.833610535959688
HP_FIBROUS_TISSUE_NEOPLASM,SET,78,0.12254,0.0079702,0.097629,0.10472,HP_FIBROUS_TISSUE_NEOPLASM,0.833610535959688
GOBP_POST_TRANSLATIONAL_PROT...3,SET,8,0.40811,0.0085171,0.3253,0.10483,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.833913644667732
GOBP_NEGATIVE_REGULATION_OF_...393,SET,13,0.30014,0.0079838,0.23928,0.10486,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.833913644667732
GOCC_ACETYLTRANSFERASE_COMPL...,SET,89,0.10366,0.0071999,0.082641,0.10486,GOCC_ACETYLTRANSFERASE_COMPLEX,0.833913644667732
MIR4536_3P,SET,19,0.2515,0.0080865,0.2005,0.10487,MIR4536_3P,0.833913644667732
BLANCO_MELO_COVID19_SARS_COV...11,SET,159,0.07927,0.0073448,0.063211,0.10492,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,0.833913644667732
GOBP_REGULATION_OF_PROTEIN_I...,SET,56,0.1431,0.0078908,0.11412,0.10494,GOBP_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.833913644667732
GSE3920_IFNB_VS_IFNG_TREATED...2,SET,144,0.091643,0.0080841,0.073082,0.10494,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.833913644667732
GOMF_INOSITOL_PHOSPHATE_PHOS...,SET,18,0.23115,0.0072339,0.18435,0.10496,GOMF_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.833913644667732
JOHNSTONE_PARVB_TARGETS_2_UP,SET,125,0.099362,0.0081706,0.079273,0.10504,JOHNSTONE_PARVB_TARGETS_2_UP,0.833913644667732
KEGG_MEDICUS_REFERENCE_ORIGI...,SET,29,0.18275,0.0072575,0.14581,0.10504,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION,0.833913644667732
WP_REGULATION_OF_SISTER_CHRO...,SET,13,0.33419,0.0088894,0.26664,0.10505,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,0.833913644667732
REACTOME_APOPTOTIC_EXECUTION...,SET,43,0.16465,0.0079589,0.13138,0.10507,REACTOME_APOPTOTIC_EXECUTION_PHASE,0.833913644667732
MIR6073,SET,95,0.10982,0.0078795,0.087632,0.10507,MIR6073,0.833913644667732
GOMF_MANNOSIDASE_ACTIVITY,SET,15,0.28963,0.0082753,0.23119,0.10515,GOMF_MANNOSIDASE_ACTIVITY,0.834072542102868
GSE37301_COMMON_LYMPHOID_PRO...3,SET,170,0.083158,0.0079648,0.066397,0.10521,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.834072542102868
SEITZ_NEOPLASTIC_TRANSFORMAT...1,SET,30,0.19694,0.0079544,0.15726,0.10524,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,0.834072542102868
HP_SCHISTOCYTOSIS,SET,10,0.3346,0.0078067,0.26722,0.10526,HP_SCHISTOCYTOSIS,0.834072542102868
GSE15330_HSC_VS_GRANULOCYTE_...3,SET,173,0.082319,0.007953,0.065746,0.10528,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.834072542102868
DITTMER_PTHLH_TARGETS_DN,SET,69,0.13313,0.0081462,0.10636,0.10535,DITTMER_PTHLH_TARGETS_DN,0.834072542102868
LEE_LIVER_CANCER_ACOX1_DN,SET,61,0.14225,0.0081857,0.11365,0.10535,LEE_LIVER_CANCER_ACOX1_DN,0.834072542102868
MIR6729_5P,SET,8,0.34841,0.0072712,0.27838,0.10537,MIR6729_5P,0.834072542102868
LMX1B_TARGET_GENES,SET,20,0.2466,0.0081346,0.19703,0.10537,LMX1B_TARGET_GENES,0.834072542102868
GSE8921_3H_VS_24H_TLR1_2_STI...1,SET,184,0.080465,0.0080148,0.064292,0.10537,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN,0.834072542102868
GOCC_OXOGLUTARATE_DEHYDROGEN...,SET,11,0.27689,0.0067754,0.22125,0.10539,GOCC_OXOGLUTARATE_DEHYDROGENASE_COMPLEX,0.834072542102868
MIR519C_3P,SET,375,0.054592,0.0077219,0.043625,0.10541,MIR519C_3P,0.834072542102868
GOBP_REGULATION_OF_AMYLOID_P...,SET,41,0.17111,0.0080769,0.13675,0.10543,GOBP_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.834072542102868
MIR199A_3P_MIR199B_3P,SET,145,0.087853,0.0077765,0.070219,0.10545,MIR199A_3P_MIR199B_3P,0.834072542102868
GSE9006_HEALTHY_VS_TYPE_1_DI...4,SET,183,0.079055,0.0078531,0.063185,0.10545,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP,0.834072542102868
HP_NEONATAL_ASPHYXIA,SET,12,0.30615,0.0078243,0.24474,0.10549,HP_NEONATAL_ASPHYXIA,0.834199078498293
HP_RESTRICTIVE_BEHAVIOR,SET,12,0.31248,0.007986,0.24983,0.10552,HP_RESTRICTIVE_BEHAVIOR,0.834246496815287
HP_ABNORMAL_EMOTION,SET,598,0.044809,0.0079541,0.03583,0.10555,HP_ABNORMAL_EMOTION,0.834293893563793
LIU_TARGETS_OF_VMYB_VS_CMYB_...2,SET,15,0.28915,0.0082613,0.23126,0.10561,LIU_TARGETS_OF_VMYB_VS_CMYB_UP,0.834483265167007
HP_ABNORMAL_NATURAL_KILLER_C...,SET,38,0.16427,0.0074656,0.13141,0.10564,HP_ABNORMAL_NATURAL_KILLER_CELL_MORPHOLOGY,0.834483265167007
KONDO_PROSTATE_CANCER_HCP_WI...,SET,87,0.12651,0.0086881,0.10121,0.10566,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,0.834483265167007
GSE32901_TH17_EMRICHED_VS_TH...1,SET,157,0.083193,0.0076601,0.066558,0.10567,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN,0.834483265167007
WP_MTHFR_DEFICIENCY,SET,22,0.22382,0.0077429,0.17921,0.10586,WP_MTHFR_DEFICIENCY,0.835490043044857
MIR6717_5P,SET,4,0.55405,0.0081771,0.44364,0.10586,MIR6717_5P,0.835490043044857
BIOCARTA_AKAP95_PATHWAY,SET,11,0.28681,0.0070182,0.22969,0.1059,BIOCARTA_AKAP95_PATHWAY,0.835490043044857
HP_EMOTIONAL_LABILITY,SET,154,0.086524,0.007891,0.069298,0.10592,HP_EMOTIONAL_LABILITY,0.835490043044857
HP_HYPERPHOSPHATEMIA,SET,17,0.2768,0.0084188,0.22176,0.10599,HP_HYPERPHOSPHATEMIA,0.835490043044857
HP_APLASIA_HYPOPLASIA_OF_THE...12,SET,66,0.13469,0.0080613,0.10793,0.10602,HP_APLASIA_HYPOPLASIA_OF_THE_BREASTS,0.835490043044857
GOBP_AMELOGENESIS,SET,23,0.22848,0.0080818,0.18309,0.10604,GOBP_AMELOGENESIS,0.835490043044857
REACTOME_DIGESTION_OF_DIETAR...1,SET,7,0.4096,0.0079963,0.32827,0.10607,REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE,0.835490043044857
GSE24634_TEFF_VS_TCONV_DAY7_...2,SET,181,0.074976,0.0074075,0.060094,0.10609,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP,0.835490043044857
GOBP_NUCLEAR_ENVELOPE_ORGANI...,SET,54,0.13982,0.0075716,0.11207,0.1061,GOBP_NUCLEAR_ENVELOPE_ORGANIZATION,0.835490043044857
HP_OSTEOLYTIC_DEFECTS_OF_THE...,SET,5,0.39025,0.0064393,0.31281,0.1061,HP_OSTEOLYTIC_DEFECTS_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.835490043044857
REACTOME_TANDEM_PORE_DOMAIN_...,SET,12,0.33468,0.0085535,0.26827,0.10611,REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS,0.835490043044857
GSE10239_NAIVE_VS_KLRG1HIGH_...1,SET,180,0.080186,0.0079006,0.064277,0.10611,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.835490043044857
MIR7151_5P,SET,42,0.16971,0.0081079,0.13606,0.10615,MIR7151_5P,0.835582209907261
GOBP_SPHINGOMYELIN_CATABOLIC...,SET,8,0.35897,0.0074916,0.28785,0.10619,GOBP_SPHINGOMYELIN_CATABOLIC_PROCESS,0.835582209907261
REACTOME_NUCLEOTIDE_EXCISION...,SET,103,0.095004,0.0070959,0.076195,0.10623,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,0.835582209907261
KEGG_MEDICUS_REFERENCE_AVP_V...,SET,9,0.39735,0.0087954,0.3187,0.10624,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY,0.835582209907261
MIR11399,SET,68,0.12802,0.0077768,0.10269,0.10627,MIR11399,0.835582209907261
HP_MELANOCYTIC_NEVUS,SET,64,0.12274,0.0072338,0.098457,0.10628,HP_MELANOCYTIC_NEVUS,0.835582209907261
GOBP_PLANAR_CELL_POLARITY_PA...2,SET,10,0.35468,0.0082752,0.28453,0.10629,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.835582209907261
GOBP_CELLULAR_PROCESS_INVOLV...,SET,356,0.056563,0.0077995,0.045383,0.10633,GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM,0.83570763229308
BOYAULT_LIVER_CANCER_SUBCLAS...2,SET,43,0.15876,0.0076741,0.12741,0.10638,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,0.835769389830509
GOCC_PARALLEL_FIBER_TO_PURKI...,SET,17,0.25576,0.0077789,0.20527,0.1064,GOCC_PARALLEL_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.835769389830509
GSE12366_PLASMA_CELL_VS_MEMO...1,SET,175,0.077876,0.0075667,0.062506,0.10641,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.835769389830509
NAKAYAMA_SOFT_TISSUE_TUMORS_...1,SET,66,0.14389,0.0086117,0.11552,0.10647,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,0.835827208201893
GOBP_CELLULAR_KETONE_METABOL...,SET,196,0.076793,0.007892,0.061668,0.10652,GOBP_CELLULAR_KETONE_METABOLIC_PROCESS,0.835827208201893
HP_PILI_TORTI,SET,12,0.32378,0.0082748,0.26001,0.10653,HP_PILI_TORTI,0.835827208201893
MIR6860,SET,102,0.10163,0.0075538,0.081632,0.10658,MIR6860,0.835827208201893
MIR6808_5P,SET,164,0.083967,0.0079003,0.067455,0.10661,MIR6808_5P,0.835827208201893
GOCC_MITOTIC_SPINDLE_MICROTU...,SET,13,0.23819,0.0063358,0.19134,0.10661,GOCC_MITOTIC_SPINDLE_MICROTUBULE,0.835827208201893
GOMF_TRANSFORMING_GROWTH_FAC...4,SET,26,0.22709,0.0085398,0.18243,0.10661,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.835827208201893
REACTOME_NR1H2_NR1H3_REGULAT...4,SET,9,0.29034,0.0064268,0.23326,0.10663,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS,0.835827208201893
MODULE_41,SET,510,0.048335,0.0079431,0.038834,0.10664,MODULE_41,0.835827208201893
GOBP_PINOCYTOSIS,SET,20,0.22408,0.0073917,0.18007,0.10668,GOBP_PINOCYTOSIS,0.835827208201893
BREUHAHN_GROWTH_FACTOR_SIGNA...,SET,15,0.31884,0.0091098,0.25627,0.10672,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,0.835827208201893
GOBP_NEGATIVE_REGULATION_OF_...539,SET,4,0.56333,0.0083139,0.45278,0.10673,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.835827208201893
GSE36476_YOUNG_VS_OLD_DONOR_...1,SET,166,0.083413,0.0078955,0.067044,0.10673,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN,0.835827208201893
GSE15330_HSC_VS_GRANULOCYTE_...1,SET,174,0.078885,0.007643,0.063442,0.10686,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.836546587837838
HP_ABNORMAL_PERISTALSIS,SET,21,0.23061,0.0077948,0.18547,0.10687,HP_ABNORMAL_PERISTALSIS,0.836546587837838
GOBP_REGULATION_OF_MITOTIC_S...1,SET,53,0.14228,0.0076332,0.11449,0.107,GOBP_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.836998649561107
GOBP_RESPONSE_TO_MISFOLDED_P...,SET,17,0.25863,0.0078663,0.20813,0.107,GOBP_RESPONSE_TO_MISFOLDED_PROTEIN,0.836998649561107
KRAS.50_UP.V1_DN,SET,44,0.16507,0.0080713,0.13284,0.107,KRAS.50_UP.V1_DN,0.836998649561107
GOBP_POSITIVE_REGULATION_OF_...321,SET,183,0.084019,0.0083462,0.067646,0.10712,GOBP_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY,0.837700174596246
GOCC_OUTER_DENSE_FIBER,SET,4,0.56601,0.0083535,0.45581,0.10717,GOCC_OUTER_DENSE_FIBER,0.837700174596246
GSE15930_STIM_VS_STIM_AND_TR...5,SET,181,0.079871,0.0078911,0.064324,0.10718,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN,0.837700174596246
KEGG_NOTCH_SIGNALING_PATHWAY,SET,46,0.14847,0.0074225,0.11958,0.1072,KEGG_NOTCH_SIGNALING_PATHWAY,0.837700174596246
KEGG_MEDICUS_VARIANT_OLIGOME...,SET,13,0.28169,0.007493,0.22691,0.10724,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.837700174596246
MIR6823_3P,SET,56,0.13877,0.0076525,0.11182,0.1073,MIR6823_3P,0.837700174596246
ZNF418_TARGET_GENES,SET,26,0.21973,0.0082629,0.17705,0.1073,ZNF418_TARGET_GENES,0.837700174596246
KEGG_MEDICUS_PATHOGEN_EBV_LM...3,SET,5,0.51447,0.0084889,0.41463,0.10735,KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY,0.837700174596246
GOBP_REGULATION_OF_CELL_DIVI...,SET,171,0.082108,0.0078871,0.066202,0.10745,GOBP_REGULATION_OF_CELL_DIVISION,0.837700174596246
GOBP_CELLULAR_RESPONSE_TO_TE...1,SET,5,0.44788,0.0073901,0.36115,0.10747,GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS,0.837700174596246
REACTOME_REGULATION_OF_SIGNA...1,SET,21,0.24297,0.0082125,0.19594,0.10749,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,0.837700174596246
GOBP_ENGULFMENT_OF_APOPTOTIC...,SET,15,0.26661,0.0076176,0.21504,0.10753,GOBP_ENGULFMENT_OF_APOPTOTIC_CELL,0.837700174596246
REACTOME_DISEASES_OF_DNA_REP...,SET,49,0.14239,0.0073462,0.11486,0.10756,REACTOME_DISEASES_OF_DNA_REPAIR,0.837700174596246
PAX7_TARGET_GENES,SET,514,0.047357,0.007812,0.038206,0.10758,PAX7_TARGET_GENES,0.837700174596246
GOBP_DETECTION_OF_STIMULUS,SET,532,0.058353,0.0097881,0.047083,0.10762,GOBP_DETECTION_OF_STIMULUS,0.837700174596246
GSE20754_WT_VS_TCF1_KO_MEMOR...1,SET,179,0.079153,0.0077773,0.063871,0.10763,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN,0.837700174596246
GSE42021_CD24HI_VS_CD24INT_T...2,SET,182,0.07793,0.0077204,0.062883,0.10763,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP,0.837700174596246
GOBP_REGULATION_OF_ISOTYPE_S...1,SET,30,0.17869,0.0072172,0.1442,0.10765,GOBP_REGULATION_OF_ISOTYPE_SWITCHING,0.837700174596246
UROSEVIC_RESPONSE_TO_IMIQUIM...,SET,18,0.24811,0.0077647,0.20028,0.10772,UROSEVIC_RESPONSE_TO_IMIQUIMOD,0.837700174596246
MIR329_3P,SET,106,0.10962,0.0083054,0.088543,0.10785,MIR329_3P,0.837700174596246
HP_ABNORMAL_NUMBER_OF_VERTEB...,SET,3,0.55332,0.0070723,0.44694,0.10786,HP_ABNORMAL_NUMBER_OF_VERTEBRAE,0.837700174596246
GSE14308_TH2_VS_TH17_DN,SET,184,0.074843,0.0074548,0.060469,0.10792,GSE14308_TH2_VS_TH17_DN,0.837700174596246
GOBP_POLYPRENOL_METABOLIC_PR...,SET,23,0.19605,0.0069346,0.15841,0.10794,GOBP_POLYPRENOL_METABOLIC_PROCESS,0.837700174596246
HNF4_01_B,SET,233,0.067668,0.0075745,0.054681,0.10796,HNF4_01_B,0.837700174596246
MEF2_02,SET,201,0.076826,0.0079943,0.062085,0.10797,MEF2_02,0.837700174596246
MIR9851_5P,SET,103,0.1018,0.0076034,0.082283,0.10802,MIR9851_5P,0.837700174596246
GOBP_SKIN_MORPHOGENESIS,SET,13,0.28756,0.007649,0.23246,0.10805,GOBP_SKIN_MORPHOGENESIS,0.837700174596246
GSE17721_CTRL_VS_POLYIC_24H_...2,SET,177,0.076219,0.0074475,0.061622,0.10807,GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP,0.837700174596246
GSE10239_NAIVE_VS_KLRG1INT_E...1,SET,184,0.074461,0.0074167,0.060207,0.1081,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN,0.837700174596246
STK33_DN,SET,237,0.069416,0.0078356,0.056139,0.10814,STK33_DN,0.837700174596246
HP_RHEUMATOID_FACTOR_POSITIVE,SET,18,0.25703,0.008044,0.2079,0.10818,HP_RHEUMATOID_FACTOR_POSITIVE,0.837700174596246
HP_HIGH_FREQUENCY_HEARING_IM...,SET,5,0.54255,0.0089523,0.43887,0.10819,HP_HIGH_FREQUENCY_HEARING_IMPAIRMENT,0.837700174596246
GSE39556_CD8A_DC_VS_NK_CELL_...4,SET,181,0.07961,0.0078654,0.064413,0.10825,GSE39556_CD8A_DC_VS_NK_CELL_UP,0.837700174596246
GOMF_K63_LINKED_DEUBIQUITINA...,SET,11,0.29077,0.0071151,0.23531,0.10829,GOMF_K63_LINKED_DEUBIQUITINASE_ACTIVITY,0.837700174596246
GSE16522_MEMORY_VS_NAIVE_ANT...1,SET,183,0.077736,0.0077221,0.06291,0.1083,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN,0.837700174596246
GOBP_REGULATION_OF_FAT_CELL_...2,SET,10,0.37321,0.0087075,0.30204,0.10831,GOBP_REGULATION_OF_FAT_CELL_PROLIFERATION,0.837700174596246
GSE13547_CTRL_VS_ANTI_IGM_ST...3,SET,149,0.08567,0.0076863,0.069338,0.10832,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN,0.837700174596246
GOBP_NEGATIVE_REGULATION_OF_...137,SET,6,0.41566,0.0075129,0.33644,0.10834,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.837700174596246
MIR6753_3P,SET,50,0.15687,0.0081752,0.12698,0.10836,MIR6753_3P,0.837700174596246
CUI_DEVELOPING_HEART_VASCULA...,SET,178,0.083907,0.0082216,0.067923,0.10836,CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL,0.837700174596246
GOMF_SUMO_TRANSFERASE_ACTIVI...,SET,24,0.22427,0.0081032,0.18156,0.10838,GOMF_SUMO_TRANSFERASE_ACTIVITY,0.837700174596246
GOBP_NEGATIVE_REGULATION_OF_...510,SET,33,0.17234,0.0073001,0.13955,0.10842,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.837700174596246
KEGG_TOLL_LIKE_RECEPTOR_SIGN...,SET,95,0.11626,0.0083415,0.094144,0.10843,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.837700174596246
GOBP_CHAPERONE_MEDIATED_AUTO...,SET,14,0.27964,0.007719,0.22645,0.10844,GOBP_CHAPERONE_MEDIATED_AUTOPHAGY,0.837700174596246
REACTOME_REGULATED_PROTEOLYS...,SET,10,0.31469,0.0073421,0.25483,0.10845,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,0.837700174596246
GSE21546_WT_VS_SAP1A_KO_AND_...3,SET,183,0.081283,0.0080745,0.065844,0.10852,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.837700174596246
MODULE_139,SET,73,0.13141,0.0082698,0.10646,0.10854,MODULE_139,0.837700174596246
GOCC_SECRETORY_GRANULE_MEMBR...,SET,291,0.064371,0.0080395,0.052149,0.10854,GOCC_SECRETORY_GRANULE_MEMBRANE,0.837700174596246
GOMF_ENONE_REDUCTASE_ACTIVITY,SET,5,0.47767,0.0078817,0.38706,0.10859,GOMF_ENONE_REDUCTASE_ACTIVITY,0.837700174596246
GOMF_ALDOSE_REDUCTASE_NADPH_...,SET,12,0.39864,0.010188,0.32309,0.10864,GOMF_ALDOSE_REDUCTASE_NADPH_ACTIVITY,0.837700174596246
HP_HYPOPLASTIC_HELICES,SET,10,0.36891,0.0086073,0.299,0.10864,HP_HYPOPLASTIC_HELICES,0.837700174596246
GSE30971_2H_VS_4H_LPS_STIM_M...2,SET,160,0.081893,0.0076115,0.066373,0.10864,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP,0.837700174596246
ZHONG_SECRETOME_OF_LUNG_CANC...1,SET,63,0.13566,0.0079331,0.10996,0.10867,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,0.837700174596246
CHEOK_RESPONSE_TO_MERCAPTOPU...2,SET,4,0.52319,0.0077216,0.42411,0.10868,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP,0.837700174596246
GSE18281_CORTICAL_VS_MEDULLA...1,SET,170,0.08335,0.0079831,0.067564,0.10868,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN,0.837700174596246
GOCC_POTASSIUM_CHANNEL_COMPL...,SET,99,0.11594,0.0084906,0.094002,0.10873,GOCC_POTASSIUM_CHANNEL_COMPLEX,0.837700174596246
HP_ABNORMAL_BLISTERING_OF_TH...,SET,103,0.107,0.007992,0.086763,0.10874,HP_ABNORMAL_BLISTERING_OF_THE_SKIN,0.837700174596246
HP_ABNORMAL_CIRCULATING_GLYC...,SET,27,0.20917,0.0080154,0.16966,0.10881,HP_ABNORMAL_CIRCULATING_GLYCINE_CONCENTRATION,0.837700174596246
WP_PPAR_SIGNALING,SET,66,0.13142,0.0078651,0.1066,0.10884,WP_PPAR_SIGNALING,0.837700174596246
KEGG_MEDICUS_VARIANT_MUTATIO...80,SET,18,0.23721,0.0074237,0.19244,0.10886,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.837700174596246
ESC_J1_UP_LATE.V1_UP,SET,162,0.087232,0.0081578,0.07077,0.10887,ESC_J1_UP_LATE.V1_UP,0.837700174596246
HUANG_DASATINIB_RESISTANCE_DN,SET,66,0.13969,0.0083605,0.11335,0.10891,HUANG_DASATINIB_RESISTANCE_DN,0.837700174596246
IGLESIAS_E2F_TARGETS_UP,SET,135,0.096839,0.0082733,0.078598,0.10897,IGLESIAS_E2F_TARGETS_UP,0.837700174596246
HP_INABILITY_TO_WALK,SET,327,0.056859,0.0075203,0.046149,0.10897,HP_INABILITY_TO_WALK,0.837700174596246
GOBP_LIPOXIN_METABOLIC_PROCE...,SET,5,0.51593,0.0085129,0.41886,0.10903,GOBP_LIPOXIN_METABOLIC_PROCESS,0.837700174596246
PHESSE_TARGETS_OF_APC_AND_MB...2,SET,15,0.30172,0.0086205,0.24496,0.10904,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,0.837700174596246
GOBP_MESONEPHRIC_TUBULE_MORP...,SET,62,0.1436,0.0083306,0.11661,0.10908,GOBP_MESONEPHRIC_TUBULE_MORPHOGENESIS,0.837700174596246
MIR2682_3P,SET,59,0.13998,0.0079223,0.11367,0.10909,MIR2682_3P,0.837700174596246
GSE37416_CTRL_VS_24H_F_TULAR...2,SET,166,0.083088,0.0078647,0.067475,0.1091,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.837700174596246
GOBP_PYRIMIDINE_RIBONUCLEOSI...1,SET,7,0.38736,0.0075622,0.3146,0.10912,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.837700174596246
HP_ABNORMAL_VITREOUS_HUMOR_M...,SET,42,0.15972,0.0076303,0.12972,0.10913,HP_ABNORMAL_VITREOUS_HUMOR_MORPHOLOGY,0.837700174596246
HP_CEREBRAL_DYSMYELINATION,SET,12,0.27021,0.0069058,0.21951,0.10917,HP_CEREBRAL_DYSMYELINATION,0.837700174596246
chr6p23,SET,7,0.53057,0.010358,0.43103,0.10918,chr6p23,0.837700174596246
WOOD_EBV_EBNA1_TARGETS_DN,SET,43,0.16558,0.0080036,0.13452,0.10919,WOOD_EBV_EBNA1_TARGETS_DN,0.837700174596246
GSE30962_ACUTE_VS_CHRONIC_LC...3,SET,185,0.08005,0.0079949,0.065052,0.10925,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN,0.837700174596246
HP_ABNORMAL_ANKLE_MORPHOLOGY,SET,87,0.11496,0.0078944,0.09342,0.10926,HP_ABNORMAL_ANKLE_MORPHOLOGY,0.837700174596246
GNF2_SMC2L1,SET,32,0.18789,0.0078371,0.15276,0.10937,GNF2_SMC2L1,0.837700174596246
GOBP_INTERLEUKIN_12_MEDIATED...,SET,9,0.35291,0.0078117,0.28693,0.10937,GOBP_INTERLEUKIN_12_MEDIATED_SIGNALING_PATHWAY,0.837700174596246
PTEN_DN.V2_DN,SET,119,0.099396,0.0079762,0.080828,0.10941,PTEN_DN.V2_DN,0.837700174596246
GOBP_CARBOHYDRATE_MEDIATED_S...,SET,11,0.33198,0.0081235,0.27,0.10944,GOBP_CARBOHYDRATE_MEDIATED_SIGNALING,0.837700174596246
HP_NEOPLASM_OF_THE_SKIN,SET,198,0.073472,0.0075886,0.059755,0.10944,HP_NEOPLASM_OF_THE_SKIN,0.837700174596246
GOBP_DE_NOVO_CENTRIOLE_ASSEM...2,SET,4,0.45467,0.0067103,0.3698,0.10945,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY_INVOLVED_IN_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.837700174596246
GOBP_PHAGOSOME_LYSOSOME_FUSI...,SET,13,0.30829,0.0082005,0.25078,0.10948,GOBP_PHAGOSOME_LYSOSOME_FUSION,0.837700174596246
HP_LYMPHOCYTOSIS,SET,22,0.21955,0.0075953,0.17863,0.10954,HP_LYMPHOCYTOSIS,0.837700174596246
LEE_AGING_CEREBELLUM_UP,SET,77,0.11682,0.0075493,0.095061,0.10957,LEE_AGING_CEREBELLUM_UP,0.837700174596246
KEGG_MEDICUS_PATHOGEN_SALMON...6,SET,5,0.39333,0.00649,0.32011,0.10959,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOG_SIGNALING_PATHWAY,0.837700174596246
GOBP_NEUROENDOCRINE_CELL_DIF...,SET,16,0.31079,0.0091705,0.25303,0.10968,GOBP_NEUROENDOCRINE_CELL_DIFFERENTIATION,0.837700174596246
GOCC_CHROMAFFIN_GRANULE_MEMB...,SET,9,0.39441,0.0087302,0.32111,0.10968,GOCC_CHROMAFFIN_GRANULE_MEMBRANE,0.837700174596246
GSE22342_CD11C_HIGH_VS_LOW_D...2,SET,174,0.079281,0.0076813,0.06455,0.10969,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP,0.837700174596246
WIELAND_UP_BY_HBV_INFECTION,SET,93,0.11047,0.0078426,0.089953,0.10971,WIELAND_UP_BY_HBV_INFECTION,0.837700174596246
GSE17721_0.5H_VS_4H_LPS_BMDC...2,SET,183,0.074986,0.0074489,0.061066,0.10974,GSE17721_0.5H_VS_4H_LPS_BMDC_UP,0.837700174596246
REACTOME_MRNA_EDITING,SET,9,0.38356,0.0084901,0.31237,0.10975,REACTOME_MRNA_EDITING,0.837700174596246
HP_MILD_MYOPIA,SET,4,0.61113,0.0090194,0.4977,0.10975,HP_MILD_MYOPIA,0.837700174596246
GOBP_INTEGRIN_ACTIVATION,SET,26,0.20815,0.0078276,0.16958,0.10983,GOBP_INTEGRIN_ACTIVATION,0.837700174596246
HP_INCREASED_ADIPOSE_TISSUE,SET,9,0.34834,0.0077104,0.28379,0.10984,HP_INCREASED_ADIPOSE_TISSUE,0.837700174596246
GSE5589_UNSTIM_VS_45MIN_LPS_...1,SET,181,0.076475,0.0075556,0.062306,0.10984,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.837700174596246
HP_EMG_DECREMENTAL_RESPONSE_...,SET,28,0.19425,0.0075802,0.15828,0.10986,HP_EMG_DECREMENTAL_RESPONSE_OF_COMPOUND_MUSCLE_ACTION_POTENTIAL_TO_REPETITIVE_NERVE_STIMULATION,0.837700174596246
SAKAI_CHRONIC_HEPATITIS_VS_L...1,SET,33,0.18806,0.0079659,0.15324,0.10987,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,0.837700174596246
REACTOME_MITOTIC_PROPHASE,SET,77,0.11318,0.0073143,0.092234,0.1099,REACTOME_MITOTIC_PROPHASE,0.837700174596246
HP_CEREBRAL_HEMORRHAGE,SET,63,0.12748,0.0074545,0.10388,0.1099,HP_CEREBRAL_HEMORRHAGE,0.837700174596246
SCHERER_PBMC_APSV_WETVAX_AGE...9,SET,55,0.15575,0.0085117,0.12693,0.10991,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.837700174596246
SCHERER_PBMC_YF_VAX_AGE_18_4...5,SET,55,0.15575,0.0085117,0.12693,0.10991,SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.837700174596246
LI_PBMC_MENACTRA_AGE_18_45YO...4,SET,14,0.29884,0.0082491,0.24356,0.10993,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.837700174596246
GOBP_PLATELET_AGGREGATION,SET,73,0.13221,0.0083199,0.10776,0.10994,GOBP_PLATELET_AGGREGATION,0.837700174596246
HP_APLASIA_HYPOPLASIA_OF_THE...71,SET,36,0.19075,0.0084382,0.15547,0.10994,HP_APLASIA_HYPOPLASIA_OF_THE_THYMUS,0.837700174596246
TGCTGAY_UNKNOWN,SET,483,0.049399,0.0079062,0.040266,0.10995,TGCTGAY_UNKNOWN,0.837700174596246
LAKE_ADULT_KIDNEY_C3_PROXIMA...,SET,194,0.080081,0.0081882,0.065278,0.10996,LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2,0.837700174596246
GSE22140_GERMFREE_VS_SPF_ART...1,SET,175,0.079344,0.0077094,0.064679,0.10997,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.837700174596246
GAUSSMANN_MLL_AF4_FUSION_TAR...2,SET,165,0.085378,0.0080573,0.069604,0.10999,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,0.837700174596246
GSE29164_CD8_TCELL_VS_CD8_TC...1,SET,184,0.079206,0.0078894,0.064576,0.11,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.837700174596246
MIR6502_3P,SET,50,0.15111,0.0078748,0.12321,0.11003,MIR6502_3P,0.837700174596246
GOBP_NEGATIVE_REGULATION_OF_...265,SET,200,0.077884,0.0080844,0.063504,0.11003,GOBP_NEGATIVE_REGULATION_OF_GROWTH,0.837700174596246
GKCGCNNNNNNNTGAYG_UNKNOWN,SET,54,0.12607,0.0068268,0.10281,0.11006,GKCGCNNNNNNNTGAYG_UNKNOWN,0.837700174596246
WP_IL17_SIGNALING,SET,30,0.20065,0.0081042,0.16366,0.1101,WP_IL17_SIGNALING,0.837700174596246
GOMF_SPECTRIN_BINDING,SET,26,0.20836,0.0078355,0.16996,0.11011,GOMF_SPECTRIN_BINDING,0.837700174596246
MODULE_227,SET,14,0.27837,0.0076839,0.22708,0.11013,MODULE_227,0.837700174596246
HP_PANCREATIC_APLASIA,SET,6,0.43562,0.0078736,0.35536,0.11013,HP_PANCREATIC_APLASIA,0.837700174596246
SHAFFER_IRF4_TARGETS_IN_PLAS...,SET,64,0.13967,0.0082319,0.11394,0.11014,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,0.837700174596246
GOMF_RECEPTOR_SERINE_THREONI...,SET,24,0.23033,0.0083221,0.18789,0.11014,GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING,0.837700174596246
GOBP_ISOPRENOID_TRANSPORT,SET,5,0.52688,0.0086936,0.42989,0.11018,GOBP_ISOPRENOID_TRANSPORT,0.837700174596246
REACTOME_NRIF_SIGNALS_CELL_D...,SET,14,0.27511,0.007594,0.2245,0.11021,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,0.837700174596246
GOBP_NEGATIVE_REGULATION_OF_...379,SET,17,0.268,0.0081511,0.21869,0.11021,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.837700174596246
GOMF_OXIDOREDUCTASE_ACTIVITY...4,SET,10,0.31601,0.0073731,0.25787,0.11021,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR,0.837700174596246
GOBP_AMYLOID_PRECURSOR_PROTE...2,SET,53,0.14423,0.007738,0.1177,0.11022,GOBP_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.837700174596246
GOBP_HEMOPOIESIS,SET,877,0.037414,0.0079793,0.030533,0.11023,GOBP_HEMOPOIESIS,0.837700174596246
TOMLINS_PROSTATE_CANCER_DN,SET,36,0.17587,0.0077802,0.14353,0.11024,TOMLINS_PROSTATE_CANCER_DN,0.837700174596246
GOMF_DAMAGED_DNA_BINDING,SET,71,0.10703,0.0066429,0.087374,0.1103,GOMF_DAMAGED_DNA_BINDING,0.837700174596246
GSE8685_IL2_STARVED_VS_IL21_...2,SET,182,0.075878,0.0075172,0.06195,0.11033,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.837700174596246
GSE16451_CTRL_VS_WEST_EQUINE...1,SET,178,0.075641,0.0074117,0.061761,0.11034,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.837700174596246
GOMF_ALKALI_METAL_ION_BINDING,SET,19,0.23896,0.0076831,0.19512,0.11036,GOMF_ALKALI_METAL_ION_BINDING,0.837700174596246
GSE16266_CTRL_VS_LPS_STIM_ME...1,SET,178,0.080498,0.0078876,0.065733,0.11037,GSE16266_CTRL_VS_LPS_STIM_MEF_DN,0.837700174596246
NIKOLSKY_BREAST_CANCER_1Q32_...,SET,13,0.42027,0.011179,0.34321,0.11038,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,0.837700174596246
REACTOME_HATS_ACETYLATE_HIST...,SET,71,0.11754,0.0072952,0.095991,0.11039,REACTOME_HATS_ACETYLATE_HISTONES,0.837700174596246
TONKS_TARGETS_OF_RUNX1_RUNX1...11,SET,14,0.30473,0.0084114,0.24887,0.1104,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,0.837700174596246
GOBP_POSITIVE_REGULATION_OF_...603,SET,121,0.096463,0.0078052,0.078783,0.11041,GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.837700174596246
HP_TYPICALLY_DE_NOVO,SET,11,0.31104,0.0076111,0.25405,0.11042,HP_TYPICALLY_DE_NOVO,0.837700174596246
GSE37534_UNTREATED_VS_GW1929...1,SET,186,0.07333,0.0073433,0.059895,0.11043,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.837700174596246
CHANDRAN_METASTASIS_TOP50_DN,SET,35,0.18223,0.0079487,0.14885,0.11044,CHANDRAN_METASTASIS_TOP50_DN,0.837700174596246
PID_MET_PATHWAY,SET,77,0.11633,0.0075179,0.095024,0.11044,PID_MET_PATHWAY,0.837700174596246
GOBP_CELLULAR_DETOXIFICATION...,SET,9,0.36122,0.0079956,0.29515,0.11052,GOBP_CELLULAR_DETOXIFICATION_OF_ALDEHYDE,0.838092866492147
REACTOME_DNA_DOUBLE_STRAND_B...1,SET,126,0.086273,0.0071225,0.070502,0.11054,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,0.838092866492147
GSE17721_4H_VS_24H_POLYIC_BM...2,SET,179,0.078476,0.0077108,0.064138,0.11057,GSE17721_4H_VS_24H_POLYIC_BMDC_UP,0.838111365113759
GOBP_REGULATION_OF_FC_RECEPT...,SET,10,0.35525,0.0082887,0.29039,0.1106,GOBP_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.838111365113759
REACTOME_TRANSCRIPTIONAL_REG...1,SET,30,0.17695,0.0071471,0.1447,0.1107,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,0.838111365113759
GOBP_BIOLOGICAL_PHASE,SET,11,0.3362,0.0082266,0.27492,0.1107,GOBP_BIOLOGICAL_PHASE,0.838111365113759
GOBP_DENDRITIC_CELL_CYTOKINE...,SET,17,0.27284,0.0082984,0.22313,0.11072,GOBP_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.838111365113759
GOBP_REGULATION_OF_INSULIN_R...,SET,65,0.12647,0.0075118,0.10344,0.11073,GOBP_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.838111365113759
GNF2_SMC1L1,SET,23,0.20861,0.0073791,0.17065,0.11077,GNF2_SMC1L1,0.838111365113759
GSE6674_ANTI_IGM_VS_CPG_STIM...1,SET,179,0.076362,0.0075031,0.062465,0.11077,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN,0.838111365113759
GOBP_ESTABLISHMENT_OF_PROTEI...5,SET,240,0.066096,0.0075073,0.054088,0.11086,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.838111365113759
GOBP_POSITIVE_REGULATION_OF_...26,SET,19,0.23681,0.007614,0.19382,0.1109,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_FORMATION,0.838111365113759
ATOH8_TARGET_GENES,SET,38,0.17071,0.0077583,0.13973,0.11091,ATOH8_TARGET_GENES,0.838111365113759
GOMF_PROTEOGLYCAN_BINDING,SET,34,0.20149,0.0086628,0.16493,0.11093,GOMF_PROTEOGLYCAN_BINDING,0.838111365113759
XIE_ST_HSC_S1PR3_OE_DN,SET,23,0.23761,0.0084047,0.19452,0.11095,XIE_ST_HSC_S1PR3_OE_DN,0.838111365113759
KEGG_MEDICUS_VARIANT_EWSR1_W...,SET,5,0.51048,0.0084231,0.41793,0.11096,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.838111365113759
FOXC1_TARGET_GENES,SET,59,0.14271,0.008077,0.11683,0.11096,FOXC1_TARGET_GENES,0.838111365113759
HP_HYPOGLYCEMIC_SEIZURES,SET,23,0.23344,0.0082571,0.19111,0.11096,HP_HYPOGLYCEMIC_SEIZURES,0.838111365113759
GOMF_GLYCOLIPID_BINDING,SET,28,0.1945,0.0075896,0.15926,0.111,GOMF_GLYCOLIPID_BINDING,0.838111365113759
KRIGE_RESPONSE_TO_TOSEDOSTAT...4,SET,793,0.037431,0.0076093,0.03065,0.11101,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,0.838111365113759
GOBP_PEPTIDYL_SERINE_MODIFIC...,SET,256,0.065695,0.0077032,0.053797,0.11102,GOBP_PEPTIDYL_SERINE_MODIFICATION,0.838111365113759
EMX1_TARGET_GENES,SET,183,0.077673,0.0077159,0.06362,0.11107,EMX1_TARGET_GENES,0.838111365113759
GOBP_SPERMIDINE_METABOLIC_PR...,SET,6,0.38475,0.0069541,0.31515,0.11108,GOBP_SPERMIDINE_METABOLIC_PROCESS,0.838111365113759
CERIBELLI_GENES_INACTIVE_AND...,SET,29,0.21505,0.0085401,0.17618,0.11112,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,0.838111365113759
MIR4653_3P,SET,47,0.15561,0.0078632,0.12749,0.11112,MIR4653_3P,0.838111365113759
GOMF_PRE_MRNA_5_SPLICE_SITE_...,SET,2,0.58243,0.0060786,0.47728,0.11118,GOMF_PRE_MRNA_5_SPLICE_SITE_BINDING,0.838111365113759
MIR24_1_5P_MIR24_2_5P,SET,42,0.15272,0.0072961,0.12515,0.11119,MIR24_1_5P_MIR24_2_5P,0.838111365113759
HP_HEPATOCELLULAR_ADENOMA,SET,17,0.28419,0.0086437,0.23291,0.1112,HP_HEPATOCELLULAR_ADENOMA,0.838111365113759
HP_FAILURE_TO_THRIVE_SECONDA...,SET,6,0.44649,0.0080702,0.36595,0.11122,HP_FAILURE_TO_THRIVE_SECONDARY_TO_RECURRENT_INFECTIONS,0.838111365113759
SCIBETTA_KDM5B_TARGETS_DN,SET,75,0.11869,0.0075707,0.097297,0.11126,SCIBETTA_KDM5B_TARGETS_DN,0.838111365113759
MIR1253,SET,158,0.086157,0.0079581,0.070634,0.11128,MIR1253,0.838111365113759
MIR5685,SET,58,0.13218,0.0074177,0.10837,0.11129,MIR5685,0.838111365113759
GOBP_SYNAPTIC_VESICLE_LOCALI...,SET,53,0.14376,0.007713,0.11786,0.11129,GOBP_SYNAPTIC_VESICLE_LOCALIZATION,0.838111365113759
GOBP_FEMALE_SEX_DIFFERENTIAT...,SET,116,0.10386,0.008229,0.085179,0.11138,GOBP_FEMALE_SEX_DIFFERENTIATION,0.83860743067591
PID_NFAT_TFPATHWAY,SET,42,0.17078,0.0081586,0.14012,0.11148,PID_NFAT_TFPATHWAY,0.839178557504873
KOHN_EMT_EPITHELIAL,SET,22,0.23589,0.0081606,0.19366,0.11161,KOHN_EMT_EPITHELIAL,0.839371667739858
HP_ABNORMAL_VISUAL_ACCOMMODA...,SET,5,0.44176,0.0072891,0.36268,0.11161,HP_ABNORMAL_VISUAL_ACCOMMODATION,0.839371667739858
GOBP_HIS_PURKINJE_SYSTEM_DEV...,SET,7,0.49636,0.0096901,0.40756,0.11164,GOBP_HIS_PURKINJE_SYSTEM_DEVELOPMENT,0.839371667739858
HP_ABSENT_THUMBNAIL,SET,16,0.26746,0.007892,0.2196,0.11164,HP_ABSENT_THUMBNAIL,0.839371667739858
WP_IRON_METABOLISM_DISORDERS,SET,15,0.28522,0.008149,0.23421,0.11166,WP_IRON_METABOLISM_DISORDERS,0.839371667739858
MIR516B_5P,SET,114,0.094331,0.00741,0.077465,0.11167,MIR516B_5P,0.839371667739858
GOCC_PHAGOCYTIC_VESICLE_MEMB...,SET,67,0.12655,0.0076309,0.10393,0.1117,GOCC_PHAGOCYTIC_VESICLE_MEMBRANE,0.839371667739858
GOCC_CALYX_OF_HELD,SET,17,0.26947,0.0081959,0.22134,0.11173,GOCC_CALYX_OF_HELD,0.839371667739858
GOMF_TELOMERIC_DNA_BINDING,SET,37,0.16205,0.0072674,0.13315,0.11179,GOMF_TELOMERIC_DNA_BINDING,0.839371667739858
KRAS.KIDNEY_UP.V1_DN,SET,121,0.10031,0.0081166,0.082429,0.11182,KRAS.KIDNEY_UP.V1_DN,0.839371667739858
WP_STATIN_INHIBITION_OF_CHOL...,SET,26,0.21827,0.0082081,0.17937,0.11183,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,0.839371667739858
GSE21927_BALBC_VS_C57BL6_MON...2,SET,153,0.084859,0.0077142,0.069735,0.11183,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP,0.839371667739858
ABBUD_LIF_SIGNALING_1_UP,SET,38,0.17935,0.0081507,0.14739,0.11184,ABBUD_LIF_SIGNALING_1_UP,0.839371667739858
GOBP_GAMETE_GENERATION,SET,675,0.039861,0.0075012,0.03276,0.11186,GOBP_GAMETE_GENERATION,0.839371667739858
HP_ABNORMAL_MEGAKARYOCYTE_MO...,SET,23,0.21308,0.007537,0.17515,0.11189,HP_ABNORMAL_MEGAKARYOCYTE_MORPHOLOGY,0.839371667739858
GSE26351_WNT_VS_BMP_PATHWAY_...2,SET,182,0.076665,0.0075951,0.063026,0.11192,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.839371667739858
VANDESLUIS_COMMD1_TARGETS_GR...3,SET,70,0.12277,0.0075663,0.10099,0.11206,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,0.839371667739858
GOBP_ODONTOBLAST_DIFFERENTIA...,SET,16,0.29479,0.0086985,0.24249,0.11206,GOBP_ODONTOBLAST_DIFFERENTIATION,0.839371667739858
GSE37301_HEMATOPOIETIC_STEM_...5,SET,162,0.08329,0.0077892,0.068519,0.11208,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN,0.839371667739858
GOBP_POSITIVE_REGULATION_OF_...335,SET,10,0.30382,0.0070886,0.24997,0.11211,GOBP_POSITIVE_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.839371667739858
BIOCARTA_RB_PATHWAY,SET,13,0.25197,0.0067023,0.20732,0.11212,BIOCARTA_RB_PATHWAY,0.839371667739858
MODULE_98,SET,367,0.05131,0.0071815,0.042217,0.11212,MODULE_98,0.839371667739858
GAZDA_DIAMOND_BLACKFAN_ANEMI...3,SET,30,0.19299,0.0077949,0.15881,0.11214,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,0.839371667739858
GOBP_SOMITE_SPECIFICATION,SET,4,0.55479,0.008188,0.45653,0.11215,GOBP_SOMITE_SPECIFICATION,0.839371667739858
GSE10147_IL3_VS_IL3_AND_CPG_...1,SET,147,0.082129,0.0073194,0.067586,0.11215,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN,0.839371667739858
GRAESSMANN_RESPONSE_TO_MC_AN...3,SET,76,0.12046,0.0077343,0.099157,0.11222,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,0.839371667739858
GOBP_BRANCHING_INVOLVED_IN_M...,SET,21,0.24282,0.0082073,0.19991,0.11226,GOBP_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.839371667739858
DESCARTES_FETAL_SPLEEN_ERYTH...,SET,53,0.14424,0.0077387,0.11875,0.11226,DESCARTES_FETAL_SPLEEN_ERYTHROBLASTS,0.839371667739858
GSE25502_WT_VS_KLF13_KO_THYM...2,SET,158,0.082482,0.0076186,0.067921,0.11231,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP,0.839371667739858
GOBP_VITAMIN_TRANSMEMBRANE_T...,SET,20,0.23418,0.007725,0.19288,0.11235,GOBP_VITAMIN_TRANSMEMBRANE_TRANSPORT,0.839371667739858
GARGALOVIC_RESPONSE_TO_OXIDI...14,SET,25,0.20395,0.0075206,0.16798,0.11236,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,0.839371667739858
PUJANA_BREAST_CANCER_LIT_INT...,SET,91,0.097848,0.0068716,0.080597,0.11237,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,0.839371667739858
GOBP_NEPHRIC_DUCT_DEVELOPMENT,SET,14,0.30326,0.0083711,0.24982,0.1124,GOBP_NEPHRIC_DUCT_DEVELOPMENT,0.839371667739858
WP_VITAMIN_B12_DISORDERS,SET,11,0.30187,0.0073868,0.24869,0.11241,WP_VITAMIN_B12_DISORDERS,0.839371667739858
GOBP_EPITHELIUM_DEVELOPMENT,SET,1133,0.034003,0.0081822,0.028014,0.11242,GOBP_EPITHELIUM_DEVELOPMENT,0.839371667739858
HP_GENERALIZED_HYPOPIGMENTAT...2,SET,45,0.15576,0.007702,0.12832,0.11242,HP_GENERALIZED_HYPOPIGMENTATION_OF_HAIR,0.839371667739858
GOMF_GTPASE_BINDING,SET,283,0.061103,0.0075274,0.050349,0.11246,GOMF_GTPASE_BINDING,0.839371667739858
IL2_UP.V1_DN,SET,159,0.086,0.0079684,0.070863,0.11246,IL2_UP.V1_DN,0.839371667739858
MIR337_3P,SET,110,0.097747,0.0075432,0.080548,0.11247,MIR337_3P,0.839371667739858
NEUROG3_TARGET_GENES,SET,15,0.25463,0.0072752,0.20984,0.11249,NEUROG3_TARGET_GENES,0.839371667739858
GOMF_ALDEHYDE_DEHYDROGENASE_...,SET,17,0.24929,0.0075822,0.20546,0.11251,GOMF_ALDEHYDE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.839371667739858
HP_TYPE_E_BRACHYDACTYLY,SET,5,0.49896,0.0082329,0.41124,0.11252,HP_TYPE_E_BRACHYDACTYLY,0.839371667739858
GNF2_CCNB2,SET,53,0.14091,0.0075598,0.11615,0.11255,GNF2_CCNB2,0.839415289699571
GOCC_TRANSPORT_VESICLE,SET,397,0.053444,0.0077735,0.044067,0.11261,GOCC_TRANSPORT_VESICLE,0.839577027027027
LEI_MYB_TARGETS,SET,297,0.062471,0.007881,0.051512,0.11262,LEI_MYB_TARGETS,0.839577027027027
ACEVEDO_METHYLATED_IN_LIVER_...,SET,683,0.043941,0.008316,0.036245,0.1127,ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN,0.839602143163309
VALK_AML_CLUSTER_16,SET,21,0.23657,0.0079963,0.19514,0.11271,VALK_AML_CLUSTER_16,0.839602143163309
VERHAAK_AML_WITH_NPM1_MUTATE...1,SET,224,0.074417,0.0081695,0.061386,0.11271,VERHAAK_AML_WITH_NPM1_MUTATED_DN,0.839602143163309
MIDORIKAWA_AMPLIFIED_IN_LIVE...,SET,51,0.20683,0.010886,0.17062,0.11272,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,0.839602143163309
HP_FEMALE_HYPOGONADISM,SET,28,0.20357,0.0079436,0.16798,0.11279,HP_FEMALE_HYPOGONADISM,0.839838046272493
MIR27A_3P_MIR27B_3P,SET,570,0.045502,0.0078919,0.037548,0.1128,MIR27A_3P_MIR27B_3P,0.839838046272493
GSE5679_CTRL_VS_PPARG_LIGAND...1,SET,177,0.078959,0.0077152,0.065166,0.11283,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.839881484257871
REACTOME_OXIDATIVE_STRESS_IN...,SET,60,0.14131,0.0080651,0.11665,0.11288,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,0.839937296660959
WP_SOMITOGENESIS_IN_THE_CONT...,SET,9,0.3499,0.007745,0.28886,0.1129,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,0.839937296660959
GSE33162_UNTREATED_VS_4H_LPS...1,SET,182,0.076434,0.0075722,0.063103,0.11291,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN,0.839937296660959
WP_G13_SIGNALING,SET,35,0.17917,0.0078151,0.148,0.11304,WP_G13_SIGNALING,0.840355803571428
MULLIGHAN_MLL_SIGNATURE_1_UP,SET,353,0.054581,0.0074951,0.045092,0.11306,MULLIGHAN_MLL_SIGNATURE_1_UP,0.840355803571428
MIR4324,SET,238,0.067968,0.0076882,0.056153,0.11307,MIR4324,0.840355803571428
TESAR_JAK_TARGETS_MOUSE_ES_D...,SET,7,0.43666,0.0085247,0.36079,0.11309,TESAR_JAK_TARGETS_MOUSE_ES_D3_DN,0.840355803571428
LIU_PROSTATE_CANCER_DN,SET,435,0.053092,0.0080748,0.043876,0.11314,LIU_PROSTATE_CANCER_DN,0.840355803571428
MIR4703_5P,SET,225,0.073191,0.0080526,0.060525,0.11329,MIR4703_5P,0.840355803571428
WP_PROGERIAASSOCIATED_LIPODY...,SET,21,0.21398,0.0072327,0.17699,0.11334,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,0.840355803571428
HP_APLASIA_HYPOPLASIA_OF_THE...76,SET,55,0.13204,0.0072161,0.10922,0.11334,HP_APLASIA_HYPOPLASIA_OF_THE_ULNA,0.840355803571428
GOBP_VESICLE_TETHERING_TO_GO...,SET,5,0.50033,0.0082556,0.41385,0.11335,GOBP_VESICLE_TETHERING_TO_GOLGI,0.840355803571428
GOCC_ASTER,SET,10,0.32449,0.0075708,0.2684,0.11335,GOCC_ASTER,0.840355803571428
KEGG_MEDICUS_REFERENCE_LPA_G...2,SET,8,0.38239,0.0079803,0.31632,0.11337,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY,0.840355803571428
HEN1_02,SET,184,0.074429,0.0074136,0.061572,0.11338,HEN1_02,0.840355803571428
CMYB_01,SET,232,0.066848,0.0074668,0.055313,0.11343,CMYB_01,0.840355803571428
PATEL_SKIN_OF_BODY_ZOSTAVAX_...4,SET,91,0.10846,0.0076165,0.089748,0.11345,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_DN,0.840355803571428
GOBP_REGULATION_OF_PROTEIN_T...1,SET,72,0.11722,0.0073261,0.097028,0.11351,GOBP_REGULATION_OF_PROTEIN_TARGETING,0.840355803571428
GOBP_POSITIVE_REGULATION_OF_...848,SET,5,0.47403,0.0078215,0.39241,0.11354,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.840355803571428
SANA_RESPONSE_TO_IFNG_DN,SET,79,0.12111,0.0079271,0.10026,0.11355,SANA_RESPONSE_TO_IFNG_DN,0.840355803571428
GROSS_ELK3_TARGETS_UP,SET,25,0.22873,0.0084344,0.18936,0.11356,GROSS_ELK3_TARGETS_UP,0.840355803571428
GOBP_GASTRULATION_WITH_MOUTH...,SET,23,0.20571,0.0072763,0.17033,0.11359,GOBP_GASTRULATION_WITH_MOUTH_FORMING_SECOND,0.840355803571428
HP_ABSENT_PHALANGEAL_CREASE,SET,15,0.28628,0.0081794,0.23705,0.1136,HP_ABSENT_PHALANGEAL_CREASE,0.840355803571428
GOBP_DETOXIFICATION_OF_INORG...,SET,20,0.29459,0.0097176,0.24396,0.11363,GOBP_DETOXIFICATION_OF_INORGANIC_COMPOUND,0.840355803571428
GOMF_ER_RETENTION_SEQUENCE_B...,SET,5,0.43968,0.0072549,0.36412,0.11363,GOMF_ER_RETENTION_SEQUENCE_BINDING,0.840355803571428
GOBP_CENTRAL_NERVOUS_SYSTEM_...4,SET,4,0.59172,0.0087329,0.4901,0.11366,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,0.840355803571428
GOBP_CYTOKINE_MEDIATED_SIGNA...,SET,472,0.051776,0.0081943,0.042885,0.11366,GOBP_CYTOKINE_MEDIATED_SIGNALING_PATHWAY,0.840355803571428
GOBP_AXON_MIDLINE_CHOICE_POI...,SET,5,0.58588,0.0096672,0.48529,0.11367,GOBP_AXON_MIDLINE_CHOICE_POINT_RECOGNITION,0.840355803571428
HP_DISTICHIASIS,SET,8,0.34966,0.0072973,0.28962,0.11367,HP_DISTICHIASIS,0.840355803571428
MORF_PAPSS1,SET,96,0.10309,0.0074351,0.085402,0.1137,MORF_PAPSS1,0.840355803571428
MIR122_3P,SET,8,0.34905,0.0072846,0.28917,0.11371,MIR122_3P,0.840355803571428
CROONQUIST_NRAS_VS_STROMAL_S...2,SET,36,0.1711,0.0075689,0.14176,0.11373,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,0.840355803571428
GOBP_DEFENSE_RESPONSE_TO_VIR...,SET,280,0.064741,0.0079339,0.053642,0.11374,GOBP_DEFENSE_RESPONSE_TO_VIRUS,0.840355803571428
GOBP_MITOCHONDRION_DISTRIBUT...,SET,18,0.24813,0.0077654,0.20559,0.11374,GOBP_MITOCHONDRION_DISTRIBUTION,0.840355803571428
GSE39382_IL3_VS_IL3_IL33_TRE...1,SET,177,0.079896,0.0078068,0.066197,0.11374,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN,0.840355803571428
PARK_TRETINOIN_RESPONSE_AND_...2,SET,20,0.25166,0.0083016,0.2086,0.11383,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,0.840484735500319
GOBP_POSITIVE_REGULATION_OF_...564,SET,41,0.17561,0.0082895,0.14556,0.11383,GOBP_POSITIVE_REGULATION_OF_ORGAN_GROWTH,0.840484735500319
GOMF_FUCOSE_BINDING,SET,8,0.38234,0.0079793,0.31691,0.11383,GOMF_FUCOSE_BINDING,0.840484735500319
GSE41087_WT_VS_FOXP3_MUT_ANT...1,SET,173,0.076036,0.007346,0.063032,0.11386,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.840527676295667
GSE13306_LAMINA_PROPRIA_VS_S...2,SET,182,0.076227,0.0075517,0.063204,0.11391,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP,0.840582615156018
GOBP_INCLUSION_BODY_ASSEMBLY,SET,22,0.22824,0.0078961,0.18927,0.11394,GOBP_INCLUSION_BODY_ASSEMBLY,0.840582615156018
HP_NEOPLASM_OF_THE_TONGUE,SET,42,0.15301,0.0073097,0.12688,0.11394,HP_NEOPLASM_OF_THE_TONGUE,0.840582615156018
GSE17721_PAM3CSK4_VS_CPG_6H_...1,SET,186,0.073496,0.0073599,0.060966,0.11401,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN,0.840920532682513
GOBP_NEGATIVE_REGULATION_OF_...240,SET,7,0.35281,0.0068877,0.29276,0.11409,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.841227301654646
HP_FRAGMENTED_EPIPHYSES,SET,5,0.53147,0.0087693,0.44104,0.1141,HP_FRAGMENTED_EPIPHYSES,0.841227301654646
CACTGTG_MIR128A_MIR128B,SET,305,0.059788,0.0076417,0.049635,0.1142,CACTGTG_MIR128A_MIR128B,0.841378722728236
GOBP_POSITIVE_REGULATION_OF_...363,SET,36,0.19361,0.0085649,0.16074,0.1142,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.841378722728236
GSE30971_CTRL_VS_LPS_STIM_MA...6,SET,168,0.089918,0.0085618,0.074648,0.1142,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP,0.841378722728236
REICHERT_MITOSIS_LIN9_TARGETS,SET,25,0.18837,0.0069464,0.1564,0.11422,REICHERT_MITOSIS_LIN9_TARGETS,0.841378722728236
REACTOME_MYOGENESIS,SET,28,0.21792,0.0085037,0.18098,0.11429,REACTOME_MYOGENESIS,0.841378722728236
TGGAAA_NFAT_Q4_01,SET,1693,0.027333,0.007908,0.022701,0.11429,TGGAAA_NFAT_Q4_01,0.841378722728236
GSE27786_CD4_VS_CD8_TCELL_DN,SET,175,0.076329,0.0074164,0.063391,0.11429,GSE27786_CD4_VS_CD8_TCELL_DN,0.841378722728236
GSE5542_IFNG_VS_IFNA_TREATED...2,SET,178,0.072478,0.0071018,0.060229,0.11443,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,0.841828733459357
HP_MICROVESICULAR_HEPATIC_ST...,SET,19,0.2233,0.0071798,0.18558,0.11444,HP_MICROVESICULAR_HEPATIC_STEATOSIS,0.841828733459357
GOBP_REGULATION_OF_SERINE_TY...,SET,5,0.51878,0.00856,0.43123,0.11449,GOBP_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.841828733459357
NGUYEN_NOTCH1_TARGETS_UP,SET,25,0.213,0.0078546,0.17707,0.11451,NGUYEN_NOTCH1_TARGETS_UP,0.841828733459357
BIOCARTA_P38MAPK_PATHWAY,SET,35,0.17438,0.0076066,0.14499,0.11455,BIOCARTA_P38MAPK_PATHWAY,0.841828733459357
HOWARD_NEUTROPHIL_INACT_MONO...3,SET,8,0.36475,0.0076123,0.3033,0.11457,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_DN,0.841828733459357
STAMBOLSKY_RESPONSE_TO_VITAM...2,SET,75,0.12089,0.007711,0.10053,0.11458,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,0.841828733459357
GOBP_REGULATION_OF_CHEMOKINE...,SET,9,0.35042,0.0077566,0.29144,0.11461,GOBP_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.841828733459357
GOBP_POSITIVE_REGULATION_OF_...69,SET,73,0.11647,0.0073295,0.0969,0.1147,GOBP_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION,0.841828733459357
REACTOME_ACTIVATION_OF_SMO,SET,17,0.24718,0.0075179,0.2057,0.11476,REACTOME_ACTIVATION_OF_SMO,0.841828733459357
GOBP_REGULATION_OF_TRANSCRIP...1,SET,8,0.31884,0.0066541,0.26534,0.11476,GOBP_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.841828733459357
MATSUMIYA_PBMC_MODIFIED_VACC...6,SET,9,0.34532,0.0076437,0.28742,0.1148,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP,0.841828733459357
GSE2197_IMMUNOSUPPRESSIVE_DN...2,SET,179,0.077257,0.007591,0.064312,0.11483,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP,0.841828733459357
HP_ABNORMALITY_OF_THE_ACOUST...,SET,4,0.55069,0.0081274,0.45844,0.11484,HP_ABNORMALITY_OF_THE_ACOUSTIC_REFLEX,0.841828733459357
HP_ABNORMAL_MIDDLE_EAR_REFLE...,SET,4,0.55069,0.0081274,0.45844,0.11484,HP_ABNORMAL_MIDDLE_EAR_REFLEXES,0.841828733459357
AIZARANI_LIVER_C17_HEPATOCYT...,SET,97,0.11534,0.0083616,0.09602,0.11484,AIZARANI_LIVER_C17_HEPATOCYTES_3,0.841828733459357
NIKOLSKY_BREAST_CANCER_17P11...,SET,9,0.47407,0.010493,0.39479,0.11492,NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,0.841828733459357
MIR769_3P,SET,27,0.19871,0.0076148,0.16548,0.11492,MIR769_3P,0.841828733459357
GOBP_PEROXISOME_PROLIFERATOR...,SET,22,0.24406,0.0084434,0.20326,0.11493,GOBP_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.841828733459357
GOBP_CELLULAR_RESPONSE_TO_OR...2,SET,1775,0.026592,0.0078584,0.022147,0.11494,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE,0.841828733459357
WP_CALORIC_RESTRICTION_AND_A...,SET,8,0.37011,0.0077241,0.30826,0.11495,WP_CALORIC_RESTRICTION_AND_AGING,0.841828733459357
BONOME_OVARIAN_CANCER_SURVIV...2,SET,453,0.048404,0.0075087,0.040327,0.11502,BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,0.841828733459357
HARALAMBIEVA_PBMC_FLUARIX_AG...7,SET,1111,0.032656,0.0077863,0.027208,0.11503,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,0.841828733459357
WU_HBX_TARGETS_2_UP,SET,21,0.23701,0.0080112,0.19748,0.11504,WU_HBX_TARGETS_2_UP,0.841828733459357
GOCC_MCM_COMPLEX,SET,11,0.34308,0.0083951,0.28596,0.11512,GOCC_MCM_COMPLEX,0.841828733459357
GOBP_UV_DAMAGE_EXCISION_REPA...,SET,11,0.24798,0.0060679,0.20669,0.11513,GOBP_UV_DAMAGE_EXCISION_REPAIR,0.841828733459357
HOEK_NK_CELL_2011_2012_TIV_1...,SET,42,0.1657,0.007916,0.13812,0.11514,HOEK_NK_CELL_2011_2012_TIV_1D_VS_0DY_ADULT_1D_DN,0.841828733459357
chr5q13,SET,51,0.26852,0.014133,0.22385,0.11516,chr5q13,0.841828733459357
GOBP_PROTON_TRANSPORTING_V_T...,SET,6,0.41297,0.0074642,0.34427,0.11516,GOBP_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.841828733459357
GSE17721_0.5H_VS_24H_GARDIQU...2,SET,172,0.074671,0.0071934,0.062247,0.11516,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP,0.841828733459357
HP_ABNORMAL_URINE_POTASSIUM_...,SET,16,0.28047,0.0082761,0.23382,0.11517,HP_ABNORMAL_URINE_POTASSIUM_CONCENTRATION,0.841828733459357
CHASSOT_SKIN_WOUND,SET,9,0.39681,0.0087833,0.33085,0.1152,CHASSOT_SKIN_WOUND,0.841828733459357
GOBP_GLYCEROLIPID_METABOLIC_...,SET,354,0.055082,0.0075744,0.045927,0.11521,GOBP_GLYCEROLIPID_METABOLIC_PROCESS,0.841828733459357
GOCC_JUNCTIONAL_MEMBRANE_COM...,SET,6,0.42245,0.0076356,0.35227,0.11523,GOCC_JUNCTIONAL_MEMBRANE_COMPLEX,0.841828733459357
MIR1228_3P,SET,70,0.12401,0.0076428,0.10342,0.11524,MIR1228_3P,0.841828733459357
GOMF_SPHINGOMYELIN_PHOSPHODI...,SET,7,0.36029,0.0070337,0.30046,0.11524,GOMF_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY,0.841828733459357
WP_ATM_SIGNALING,SET,36,0.15091,0.0066758,0.12586,0.11526,WP_ATM_SIGNALING,0.841828733459357
PID_NOTCH_PATHWAY,SET,56,0.13133,0.0072418,0.10954,0.1153,PID_NOTCH_PATHWAY,0.841828733459357
GOCC_PARASPECKLES,SET,7,0.33136,0.0064688,0.27642,0.11532,GOCC_PARASPECKLES,0.841828733459357
HP_ORAL_ULCER,SET,57,0.13783,0.007668,0.11498,0.11532,HP_ORAL_ULCER,0.841828733459357
HP_ABNORMALITY_OF_ADRENAL_PH...,SET,131,0.091696,0.0077178,0.076509,0.11537,HP_ABNORMALITY_OF_ADRENAL_PHYSIOLOGY,0.841913058996431
GOCC_NETWORK_FORMING_COLLAGE...,SET,6,0.45733,0.0082661,0.38161,0.11538,GOCC_NETWORK_FORMING_COLLAGEN_TRIMER,0.841913058996431
GOCC_LATERAL_PLASMA_MEMBRANE,SET,65,0.12947,0.0076899,0.10809,0.11551,GOCC_LATERAL_PLASMA_MEMBRANE,0.842288259236068
WONG_PROTEASOME_GENE_MODULE,SET,47,0.131,0.0066194,0.10937,0.11552,WONG_PROTEASOME_GENE_MODULE,0.842288259236068
HP_PROGRESSIVE_PULMONARY_FUN...,SET,13,0.28272,0.0075202,0.23604,0.11552,HP_PROGRESSIVE_PULMONARY_FUNCTION_IMPAIRMENT,0.842288259236068
KEGG_MEDICUS_REFERENCE_COPI_...,SET,23,0.18809,0.0066531,0.1571,0.1156,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION,0.842288259236068
REACTOME_PHENYLALANINE_METAB...,SET,5,0.53121,0.008765,0.44368,0.11561,REACTOME_PHENYLALANINE_METABOLISM,0.842288259236068
HP_LYMPHANGIECTASIS,SET,10,0.3364,0.0078487,0.28106,0.11568,HP_LYMPHANGIECTASIS,0.842288259236068
GOBP_EMBRYONIC_HINDLIMB_MORP...,SET,27,0.2258,0.0086527,0.18866,0.11569,GOBP_EMBRYONIC_HINDLIMB_MORPHOGENESIS,0.842288259236068
GOBP_MIDBRAIN_DOPAMINERGIC_N...,SET,15,0.30876,0.0088218,0.25801,0.11572,GOBP_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.842288259236068
GSE25088_ROSIGLITAZONE_VS_IL...3,SET,178,0.076259,0.0074722,0.06373,0.11574,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.842288259236068
REACTOME_ADP_SIGNALLING_THRO...2,SET,22,0.2269,0.0078496,0.18965,0.11578,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,0.842288259236068
GOBP_SOMITE_DEVELOPMENT,SET,74,0.12422,0.0078706,0.10384,0.1158,GOBP_SOMITE_DEVELOPMENT,0.842288259236068
GSE29949_CD8_POS_DC_SPLEEN_V...4,SET,171,0.078787,0.0075681,0.065865,0.11582,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.842288259236068
HP_CORONARY_ARTERY_STENOSIS,SET,6,0.39913,0.007214,0.33368,0.11583,HP_CORONARY_ARTERY_STENOSIS,0.842288259236068
ONGUSAHA_TP53_TARGETS,SET,33,0.17753,0.0075199,0.14848,0.11592,ONGUSAHA_TP53_TARGETS,0.842288259236068
REACTOME_VXPX_CARGO_TARGETIN...,SET,20,0.22188,0.0073193,0.18557,0.11592,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,0.842288259236068
GSE3982_MAST_CELL_VS_MAC_UP,SET,175,0.075961,0.0073807,0.06353,0.11592,GSE3982_MAST_CELL_VS_MAC_UP,0.842288259236068
HP_HYPOKALEMIC_METABOLIC_ALK...,SET,9,0.36211,0.0080153,0.30287,0.11593,HP_HYPOKALEMIC_METABOLIC_ALKALOSIS,0.842288259236068
HP_GENERALIZED_CEREBRAL_ATRO...,SET,11,0.29459,0.0072085,0.2464,0.11594,HP_GENERALIZED_CEREBRAL_ATROPHY_HYPOPLASIA,0.842288259236068
BURTON_ADIPOGENESIS_8,SET,70,0.12588,0.0077576,0.10529,0.11595,BURTON_ADIPOGENESIS_8,0.842288259236068
BYSTRYKH_SCP2_QTL,SET,6,0.36546,0.0066056,0.30575,0.116,BYSTRYKH_SCP2_QTL,0.842288259236068
EGFR_TARGET_GENES,SET,20,0.24159,0.0079695,0.20213,0.116,EGFR_TARGET_GENES,0.842288259236068
GOBP_MEMBRANE_BIOGENESIS,SET,60,0.12705,0.0072512,0.1063,0.11602,GOBP_MEMBRANE_BIOGENESIS,0.842288259236068
GSE19941_IL10_KO_VS_IL10_KO_...5,SET,179,0.078263,0.0076898,0.065493,0.11606,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN,0.842288259236068
GOBP_ENDOTHELIAL_CELL_CHEMOT...,SET,26,0.21453,0.0080675,0.17954,0.11607,GOBP_ENDOTHELIAL_CELL_CHEMOTAXIS,0.842288259236068
GOBP_MAMMARY_GLAND_EPITHELIU...,SET,67,0.13575,0.0081856,0.11362,0.11609,GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT,0.842288259236068
KEGG_AXON_GUIDANCE,SET,122,0.09596,0.0077963,0.080319,0.1161,KEGG_AXON_GUIDANCE,0.842288259236068
GSE3982_MEMORY_CD4_TCELL_VS_...3,SET,185,0.071635,0.0071545,0.059958,0.1161,GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN,0.842288259236068
GOBP_CELL_CELL_JUNCTION_ORGA...,SET,199,0.078981,0.008178,0.066109,0.11611,GOBP_CELL_CELL_JUNCTION_ORGANIZATION,0.842288259236068
GOBP_REGULATION_OF_RENAL_SYS...,SET,20,0.25341,0.0083593,0.21216,0.11617,GOBP_REGULATION_OF_RENAL_SYSTEM_PROCESS,0.84244671875
KYNG_DNA_DAMAGE_BY_UV,SET,51,0.1439,0.0075735,0.12051,0.11624,KYNG_DNA_DAMAGE_BY_UV,0.84244671875
TIAN_TNF_SIGNALING_NOT_VIA_N...,SET,21,0.2472,0.0083556,0.20704,0.11625,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,0.84244671875
MIR6134,SET,122,0.09231,0.0074997,0.077319,0.11627,MIR6134,0.84244671875
GSE3920_IFNA_VS_IFNB_TREATED...1,SET,151,0.082696,0.0074687,0.069278,0.11631,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.84244671875
GSE15930_STIM_VS_STIM_AND_IL...6,SET,181,0.072636,0.0071764,0.060854,0.11632,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP,0.84244671875
HOQUE_METHYLATED_IN_CANCER,SET,55,0.14226,0.0077748,0.1192,0.11635,HOQUE_METHYLATED_IN_CANCER,0.84244671875
REACTOME_PI_3K_CASCADE_FGFR4,SET,19,0.24167,0.0077702,0.20249,0.11635,REACTOME_PI_3K_CASCADE_FGFR4,0.84244671875
GOBP_REGULATION_OF_MIRNA_TRA...,SET,72,0.1227,0.0076684,0.1028,0.11635,GOBP_REGULATION_OF_MIRNA_TRANSCRIPTION,0.84244671875
GSE37301_COMMON_LYMPHOID_PRO...4,SET,177,0.075817,0.0074082,0.063541,0.11641,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.842705592584878
MIR510_5P,SET,59,0.12851,0.0072734,0.10774,0.11648,MIR510_5P,0.843036734693878
HP_INTERVERTEBRAL_DISK_DEGEN...,SET,6,0.43582,0.0078773,0.36561,0.11663,HP_INTERVERTEBRAL_DISK_DEGENERATION,0.843524548661548
HP_PANHYPOGAMMAGLOBULINEMIA,SET,16,0.24504,0.0072307,0.2056,0.11666,HP_PANHYPOGAMMAGLOBULINEMIA,0.843524548661548
KRIEG_KDM3A_TARGETS_NOT_HYPO...,SET,176,0.073608,0.0071722,0.061768,0.1167,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,0.843524548661548
KAAB_FAILED_HEART_ATRIUM_DN,SET,133,0.088017,0.0074641,0.073866,0.11672,KAAB_FAILED_HEART_ATRIUM_DN,0.843524548661548
KEGG_MEDICUS_VARIANT_MUTATIO...40,SET,6,0.49033,0.0088625,0.41149,0.11672,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.843524548661548
MIR5191,SET,27,0.20105,0.0077041,0.16875,0.11676,MIR5191,0.843524548661548
GOBP_PYRUVATE_TRANSPORT,SET,7,0.41815,0.0081632,0.35101,0.11678,GOBP_PYRUVATE_TRANSPORT,0.843524548661548
TAGAACC_MIR182,SET,34,0.18173,0.0078133,0.15257,0.11681,TAGAACC_MIR182,0.843524548661548
HP_FATIGABLE_WEAKNESS_OF_SWA...,SET,37,0.1667,0.0074758,0.13995,0.11681,HP_FATIGABLE_WEAKNESS_OF_SWALLOWING_MUSCLES,0.843524548661548
FULLER_PBMC_F_TULARENSIS_VAC...6,SET,31,0.20398,0.0083748,0.17126,0.11682,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN,0.843524548661548
GOBP_REGULATION_OF_CARDIAC_M...1,SET,10,0.35221,0.0082177,0.2958,0.11689,GOBP_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.843524548661548
GSE2770_TGFB_AND_IL4_VS_IL4_...4,SET,177,0.074697,0.0072987,0.062731,0.11689,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.843524548661548
NAISHIRO_CTNNB1_TARGETS_WITH...,SET,8,0.40803,0.0085153,0.3427,0.11691,NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF,0.843524548661548
GOCC_ALPHA_KETOACID_DEHYDROG...,SET,15,0.24354,0.0069581,0.20454,0.11691,GOCC_ALPHA_KETOACID_DEHYDROGENASE_COMPLEX,0.843524548661548
HP_HYPERALDOSTERONISM,SET,30,0.20775,0.0083908,0.1745,0.11693,HP_HYPERALDOSTERONISM,0.843524548661548
GOBP_POSITIVE_REGULATION_OF_...87,SET,9,0.40109,0.008878,0.33691,0.11694,GOBP_POSITIVE_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.843524548661548
GSE16266_LPS_VS_HEATSHOCK_AN...2,SET,181,0.078864,0.0077917,0.066252,0.11696,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.843524548661548
GOBP_POSITIVE_REGULATION_OF_...486,SET,9,0.38559,0.0085349,0.324,0.11702,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.843608438469493
ONO_AML1_TARGETS_UP,SET,23,0.2341,0.0082805,0.19672,0.11703,ONO_AML1_TARGETS_UP,0.843608438469493
GSE3691_IFN_PRODUCING_KILLER...1,SET,177,0.075217,0.0073496,0.063212,0.11705,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN,0.843608438469493
LAKE_ADULT_KIDNEY_C23_ENDOTH...,SET,115,0.098089,0.0077387,0.082453,0.1171,LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR,0.843608438469493
REACTOME_GABA_RECEPTOR_ACTIV...,SET,57,0.15016,0.0083539,0.12625,0.11715,REACTOME_GABA_RECEPTOR_ACTIVATION,0.843608438469493
HMGA1_TARGET_GENES,SET,703,0.039259,0.0075336,0.033012,0.11718,HMGA1_TARGET_GENES,0.843608438469493
WP_IL26_SIGNALING,SET,44,0.1699,0.0083074,0.14289,0.11722,WP_IL26_SIGNALING,0.843608438469493
DI_MARTINO_MATRISOME_HIGHLY_...2,SET,17,0.26089,0.0079349,0.21944,0.11725,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED,0.843608438469493
GOBP_ANTIGEN_PROCESSING_AND_...3,SET,30,0.21646,0.0087428,0.18208,0.11726,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN,0.843608438469493
GOBP_INTERLEUKIN_10_MEDIATED...,SET,11,0.39429,0.0096483,0.33167,0.11726,GOBP_INTERLEUKIN_10_MEDIATED_SIGNALING_PATHWAY,0.843608438469493
HP_LACK_OF_INSIGHT,SET,10,0.29003,0.0067669,0.24398,0.11728,HP_LACK_OF_INSIGHT,0.843608438469493
ZHENG_CORD_BLOOD_C2_PUTATIVE...,SET,86,0.11131,0.0076006,0.093647,0.11729,ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR,0.843608438469493
GOBP_REGULATION_OF_NUCLEOCYT...,SET,108,0.096133,0.0073513,0.080884,0.11732,GOBP_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.843608438469493
HP_CHRONIC_NONINFECTIOUS_LYM...,SET,11,0.31616,0.0077362,0.26602,0.11733,HP_CHRONIC_NONINFECTIOUS_LYMPHADENOPATHY,0.843608438469493
GFI1_01,SET,241,0.067743,0.0077103,0.057006,0.11735,GFI1_01,0.843608438469493
GSE32986_UNSTIM_VS_CURDLAN_L...1,SET,176,0.07652,0.0074559,0.064394,0.11736,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN,0.843608438469493
HP_ABNORMALITY_OF_THE_VERTEB...2,SET,35,0.18198,0.0079381,0.1532,0.11745,HP_ABNORMALITY_OF_THE_VERTEBRAL_ENDPLATES,0.844080800248139
GOBP_REGULATION_OF_INTRACELL...1,SET,29,0.1837,0.007295,0.15472,0.11756,GOBP_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.844665750310045
GOBP_POSITIVE_REGULATION_OF_...796,SET,18,0.23294,0.00729,0.19621,0.11758,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.844665750310045
GOBP_REGULATION_OF_NUCLEAR_C...,SET,12,0.26577,0.0067924,0.22396,0.11768,GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.845116418835192
DURANTE_ADULT_OLFACTORY_NEUR...10,SET,66,0.14078,0.0084256,0.11865,0.11772,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MAST_CELLS,0.845116418835192
KEGG_MEDICUS_VARIANT_MUTATIO...21,SET,28,0.19655,0.0076698,0.16567,0.11774,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY,0.845116418835192
KEGG_MEDICUS_VARIANT_MUTATIO...85,SET,28,0.19655,0.0076698,0.16567,0.11774,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY,0.845116418835192
GOMF_UDP_GALACTOSE_BETA_N_AC...,SET,12,0.3239,0.008278,0.27316,0.11786,GOMF_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.845700216763006
HP_MENINGIOMA,SET,42,0.14952,0.007143,0.12609,0.11787,HP_MENINGIOMA,0.845700216763006
GSE22935_24H_VS_48H_MBOVIS_B...1,SET,182,0.073244,0.0072562,0.061803,0.11799,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.846386470588235
GSE22229_RENAL_TRANSPLANT_VS...2,SET,183,0.07404,0.007355,0.062482,0.11802,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP,0.846426970697482
KEGG_HEDGEHOG_SIGNALING_PATH...,SET,54,0.14436,0.0078177,0.12186,0.11808,KEGG_HEDGEHOG_SIGNALING_PATHWAY,0.846445484536082
GSE40685_NAIVE_CD4_TCELL_VS_...3,SET,179,0.074927,0.0073621,0.063248,0.11809,GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN,0.846445484536082
MORF_DEAF1,SET,46,0.14408,0.0072027,0.12163,0.11811,MORF_DEAF1,0.846445484536082
REACTOME_SYNTHESIS_OF_PE,SET,12,0.28496,0.0072827,0.24058,0.11812,REACTOME_SYNTHESIS_OF_PE,0.846445484536082
GOBP_GOLGI_DISASSEMBLY,SET,6,0.40219,0.0072694,0.33963,0.11817,GOBP_GOLGI_DISASSEMBLY,0.846454730008244
GSE6259_33D1_POS_VS_DEC205_P...1,SET,156,0.081902,0.0075174,0.069161,0.11817,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN,0.846454730008244
REACTOME_MITOCHONDRIAL_FATTY...3,SET,6,0.42521,0.0076854,0.35917,0.11824,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS,0.846585145151328
GSE17721_CTRL_VS_GARDIQUIMOD...15,SET,184,0.074331,0.0074038,0.062788,0.11824,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN,0.846585145151328
chr15q14,SET,23,0.37139,0.013137,0.31378,0.11829,chr15q14,0.846585145151328
GOBP_PROTEIN_LOCALIZATION_TO...23,SET,6,0.35115,0.0063468,0.29667,0.11829,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.846585145151328
GSE2706_2H_VS_8H_R848_STIM_D...1,SET,166,0.078811,0.0074599,0.06659,0.11831,GSE2706_2H_VS_8H_R848_STIM_DC_DN,0.846585145151328
HP_NEUROFIBRILLARY_TANGLES,SET,21,0.24215,0.008185,0.20472,0.11844,HP_NEUROFIBRILLARY_TANGLES,0.847340922190202
RIZ_ERYTHROID_DIFFERENTIATIO...2,SET,38,0.16579,0.0075345,0.1402,0.11851,RIZ_ERYTHROID_DIFFERENTIATION_6HR,0.847667225766619
GSE26343_UNSTIM_VS_LPS_STIM_...3,SET,186,0.076935,0.0077043,0.065072,0.11855,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN,0.847778858024691
GOBP_NEGATIVE_REGULATION_OF_...361,SET,151,0.087649,0.007916,0.074147,0.11859,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.847827606415793
GOBP_POLYAMINE_METABOLIC_PRO...,SET,15,0.23209,0.0066312,0.19637,0.11863,GOBP_POLYAMINE_METABOLIC_PROCESS,0.847827606415793
GOBP_RESPONSE_TO_BACTERIUM,SET,611,0.044974,0.0080666,0.038051,0.11863,GOBP_RESPONSE_TO_BACTERIUM,0.847827606415793
GSE18791_CTRL_VS_NEWCASTLE_V...17,SET,175,0.080835,0.0078542,0.068413,0.11869,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN,0.848082020970395
GOMF_CYTOKINE_ACTIVITY,SET,217,0.080215,0.0086689,0.067898,0.11873,GOMF_CYTOKINE_ACTIVITY,0.848090567200986
GOBP_POSITIVE_REGULATION_OF_...531,SET,8,0.36484,0.007614,0.30883,0.11874,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.848090567200986
MURAKAMI_UV_RESPONSE_6HR_DN,SET,21,0.22524,0.0076133,0.19069,0.11878,MURAKAMI_UV_RESPONSE_6HR_DN,0.848201951921101
GSE6269_FLU_VS_STREP_PNEUMO_...1,SET,146,0.0839,0.007452,0.07106,0.11887,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN,0.848409909725072
GOCC_EXTERNAL_SIDE_OF_PLASMA...,SET,360,0.060366,0.0083696,0.051132,0.11889,GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,0.848409909725072
GSE17721_POLYIC_VS_CPG_12H_B...1,SET,184,0.072592,0.0072306,0.0615,0.11894,GSE17721_POLYIC_VS_CPG_12H_BMDC_DN,0.848409909725072
GSE10240_CTRL_VS_IL17_STIM_P...2,SET,177,0.076384,0.0074636,0.064717,0.11895,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.848409909725072
GSE22886_UNSTIM_VS_STIM_MEMO...2,SET,178,0.077032,0.0075479,0.065269,0.11896,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP,0.848409909725072
GSE27241_WT_VS_RORGT_KO_TH17...3,SET,166,0.07428,0.007031,0.062939,0.11897,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP,0.848409909725072
GOBP_INTEGRIN_MEDIATED_SIGNA...,SET,102,0.1038,0.0077155,0.08796,0.11898,GOBP_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.848409909725072
GSE41867_DAY8_EFFECTOR_VS_DA...2,SET,174,0.074895,0.0072565,0.063474,0.11902,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.848443445309299
GOMF_ANKYRIN_BINDING,SET,19,0.25019,0.0080442,0.21206,0.11905,GOMF_ANKYRIN_BINDING,0.848443445309299
CEBALLOS_TARGETS_OF_TP53_AND...2,SET,18,0.26151,0.0081843,0.22167,0.11906,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,0.848443445309299
chr2p15,SET,15,0.33449,0.0095568,0.28358,0.1191,chr2p15,0.848443445309299
SCHERER_PBMC_YF_VAX_OR_APSV_...,SET,21,0.22189,0.0075,0.18813,0.11912,SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,0.848443445309299
LI_ADIPOGENESIS_BY_ACTIVATED...,SET,18,0.24803,0.0077624,0.21034,0.11917,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,0.848443445309299
MANNO_MIDBRAIN_NEUROTYPES_HO...1,SET,339,0.057812,0.0077828,0.049028,0.11917,MANNO_MIDBRAIN_NEUROTYPES_HOMTN,0.848443445309299
MIR378G,SET,79,0.11137,0.0072896,0.09445,0.11918,MIR378G,0.848443445309299
REACTOME_INOSITOL_PHOSPHATE_...,SET,45,0.13883,0.0068647,0.11776,0.11922,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,0.848457755308392
KEGG_MEDICUS_VARIANT_BCR_ABL...1,SET,11,0.29661,0.0072579,0.25165,0.11928,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,0.848457755308392
GSE17721_CTRL_VS_GARDIQUIMOD...11,SET,179,0.075324,0.0074011,0.063919,0.11932,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN,0.848457755308392
HP_PANHYPOPITUITARISM,SET,25,0.19456,0.0071746,0.16513,0.11935,HP_PANHYPOPITUITARISM,0.848457755308392
GOBP_REGULATION_OF_CELL_CELL...3,SET,11,0.27706,0.0067797,0.23516,0.11937,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.848457755308392
MIR125A_3P,SET,68,0.12141,0.0073751,0.10306,0.11939,MIR125A_3P,0.848457755308392
HP_ABNORMAL_PULMONARY_THORAC...,SET,131,0.090978,0.0076574,0.077241,0.11944,HP_ABNORMAL_PULMONARY_THORACIC_IMAGING_FINDING,0.848457755308392
SATO_SILENCED_BY_DEACETYLATI...,SET,36,0.18211,0.008056,0.15462,0.11945,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,0.848457755308392
ZWANG_EGF_PERSISTENTLY_UP,SET,27,0.19324,0.007405,0.16413,0.11953,ZWANG_EGF_PERSISTENTLY_UP,0.848457755308392
GOBP_AMYLOID_BETA_CLEARANCE,SET,35,0.17163,0.0074866,0.14578,0.11953,GOBP_AMYLOID_BETA_CLEARANCE,0.848457755308392
REACTOME_NR1H2_AND_NR1H3_MED...,SET,42,0.15323,0.0073206,0.13015,0.11954,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,0.848457755308392
AZARE_NEOPLASTIC_TRANSFORMAT...1,SET,17,0.2656,0.0080782,0.22564,0.11959,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,0.848457755308392
REACTOME_TRANSCRIPTIONAL_AND...,SET,42,0.16165,0.0077225,0.13734,0.1196,REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY,0.848457755308392
NABA_SECRETED_FACTORS,SET,318,0.065527,0.0085488,0.055681,0.11964,NABA_SECRETED_FACTORS,0.848457755308392
GSE36888_STAT5_AB_KNOCKIN_VS...3,SET,186,0.075394,0.0075499,0.064067,0.11965,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN,0.848457755308392
HP_GENERALIZED_ONSET_MOTOR_S...,SET,158,0.080783,0.0074616,0.068662,0.1197,HP_GENERALIZED_ONSET_MOTOR_SEIZURE,0.848457755308392
GSE17721_PAM3CSK4_VS_CPG_0.5...2,SET,179,0.073021,0.0071748,0.062064,0.1197,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP,0.848457755308392
GOBP_POSITIVE_REGULATION_OF_...611,SET,46,0.15054,0.0075258,0.12796,0.11972,GOBP_POSITIVE_REGULATION_OF_PROTEIN_BINDING,0.848457755308392
MIR5009_3P,SET,155,0.085005,0.0077774,0.072298,0.11985,MIR5009_3P,0.848457755308392
REACTOME_HYALURONAN_UPTAKE_A...,SET,12,0.27112,0.006929,0.23061,0.11987,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,0.848457755308392
KANG_AR_TARGETS_DN,SET,18,0.25576,0.0080041,0.21756,0.11989,KANG_AR_TARGETS_DN,0.848457755308392
PLASARI_NFIC_TARGETS_BASAL_UP,SET,28,0.21726,0.008478,0.18481,0.11989,PLASARI_NFIC_TARGETS_BASAL_UP,0.848457755308392
GOBP_REGULATION_OF_PROTEIN_T...4,SET,39,0.16235,0.0074745,0.13811,0.1199,GOBP_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.848457755308392
GOBP_ACTIVATION_OF_JANUS_KIN...,SET,13,0.27727,0.0073754,0.23589,0.11992,GOBP_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.848457755308392
MIR9718,SET,95,0.10989,0.0078843,0.093511,0.11997,MIR9718,0.848457755308392
GOBP_CENTRAL_NERVOUS_SYSTEM_...8,SET,27,0.20997,0.0080462,0.17869,0.11999,GOBP_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS,0.848457755308392
GOBP_CELLULAR_RESPONSE_TO_NU...1,SET,45,0.15542,0.0076852,0.13227,0.12,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT,0.848457755308392
GOBP_EMBRYONIC_MORPHOGENESIS,SET,572,0.04494,0.0078077,0.03825,0.12002,GOBP_EMBRYONIC_MORPHOGENESIS,0.848457755308392
KOKKINAKIS_METHIONINE_DEPRIV...3,SET,69,0.1207,0.0073852,0.10273,0.12004,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,0.848457755308392
GOBP_APOPTOTIC_PROCESS_INVOL...1,SET,37,0.17066,0.0076533,0.14526,0.12004,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.848457755308392
GSE3920_IFNB_VS_IFNG_TREATED...1,SET,158,0.076487,0.0070649,0.065104,0.12004,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.848457755308392
MIR7160_5P,SET,171,0.076937,0.0073904,0.065497,0.12007,MIR7160_5P,0.848457755308392
GOBP_REGULATION_OF_SPROUTING...,SET,40,0.16929,0.0078932,0.14414,0.1201,GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.848457755308392
HP_INTRAHEPATIC_BILIARY_ATRE...,SET,7,0.35097,0.0068518,0.29883,0.12011,HP_INTRAHEPATIC_BILIARY_ATRESIA,0.848457755308392
REACTOME_SYNTHESIS_SECRETION...3,SET,12,0.2803,0.0071638,0.23869,0.12014,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP,0.848457755308392
GOBP_DOPAMINE_SECRETION,SET,29,0.19856,0.0078852,0.16911,0.12017,GOBP_DOPAMINE_SECRETION,0.848457755308392
MODULE_307,SET,21,0.20584,0.0069575,0.17539,0.12028,MODULE_307,0.848457755308392
GOBP_NEGATIVE_REGULATION_OF_...501,SET,75,0.1157,0.0073797,0.098592,0.1203,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.848457755308392
GOMF_PROTEIN_TRANSMEMBRANE_T...,SET,24,0.20643,0.0074586,0.1759,0.1203,GOMF_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.848457755308392
GSE11961_PLASMA_CELL_DAY7_VS...4,SET,175,0.07539,0.0073251,0.064249,0.12033,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.848457755308392
GOCC_PLATELET_ALPHA_GRANULE,SET,81,0.11868,0.0078653,0.10115,0.12034,GOCC_PLATELET_ALPHA_GRANULE,0.848457755308392
WANG_SMARCE1_TARGETS_UP,SET,258,0.068093,0.008015,0.058038,0.12035,WANG_SMARCE1_TARGETS_UP,0.848457755308392
ZNF491_TARGET_GENES,SET,6,0.37674,0.0068095,0.3211,0.12035,ZNF491_TARGET_GENES,0.848457755308392
GOMF_NMDA_GLUTAMATE_RECEPTOR...,SET,7,0.40051,0.0078188,0.34135,0.12035,GOMF_NMDA_GLUTAMATE_RECEPTOR_ACTIVITY,0.848457755308392
GSE19825_IL2RALOW_VS_IL2RAHI...2,SET,173,0.073635,0.007114,0.062759,0.12035,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,0.848457755308392
ZNF501_TARGET_GENES,SET,13,0.29332,0.0078024,0.25003,0.12038,ZNF501_TARGET_GENES,0.848457755308392
GOBP_RESPONSE_TO_PHORBOL_13_...,SET,8,0.36508,0.0076191,0.3112,0.12038,GOBP_RESPONSE_TO_PHORBOL_13_ACETATE_12_MYRISTATE,0.848457755308392
REACTOME_DEFECTIVE_B4GALT1_C...,SET,8,0.36799,0.0076799,0.3137,0.12039,REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D,0.848457755308392
HP_ESOPHAGEAL_NEOPLASM,SET,27,0.1986,0.0076105,0.16934,0.12044,HP_ESOPHAGEAL_NEOPLASM,0.848457755308392
WP_MICRORNAS_IN_CARDIOMYOCYT...,SET,81,0.11406,0.0075592,0.097262,0.12047,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,0.848457755308392
GOBP_REGULATION_OF_POLYAMINE...,SET,5,0.36842,0.006079,0.31417,0.12047,GOBP_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT,0.848457755308392
GOMF_ORNITHINE_DECARBOXYLASE...,SET,5,0.36842,0.006079,0.31417,0.12047,GOMF_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY,0.848457755308392
HP_PARIETAL_FORAMINA,SET,12,0.30751,0.0078591,0.26231,0.12054,HP_PARIETAL_FORAMINA,0.848457755308392
ATXN7L3_TARGET_GENES,SET,514,0.045301,0.0074728,0.038643,0.12055,ATXN7L3_TARGET_GENES,0.848457755308392
TONKS_TARGETS_OF_RUNX1_RUNX1...4,SET,47,0.15095,0.0076276,0.12878,0.12057,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,0.848457755308392
HP_SCLERODERMA,SET,11,0.31349,0.007671,0.26751,0.12063,HP_SCLERODERMA,0.848457755308392
chr20p13,SET,78,0.23681,0.015402,0.2021,0.12066,chr20p13,0.848457755308392
GATA6_01,SET,236,0.069691,0.0078503,0.059482,0.12068,GATA6_01,0.848457755308392
KEGG_MEDICUS_REFERENCE_GATOR...,SET,13,0.27593,0.0073398,0.23552,0.12069,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY,0.848457755308392
GAVIN_FOXP3_TARGETS_CLUSTER_...7,SET,91,0.1014,0.0071208,0.08655,0.1207,GAVIN_FOXP3_TARGETS_CLUSTER_T7,0.848457755308392
GSE13547_WT_VS_ZFX_KO_BCELL_...3,SET,148,0.079775,0.0071335,0.068095,0.1207,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN,0.848457755308392
GSE45365_CD8A_DC_VS_CD11B_DC...6,SET,166,0.076273,0.0072196,0.065107,0.12071,GSE45365_CD8A_DC_VS_CD11B_DC_UP,0.848457755308392
GOBP_NEGATIVE_REGULATION_OF_...511,SET,6,0.39782,0.0071905,0.33961,0.12072,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION,0.848457755308392
KEGG_VIBRIO_CHOLERAE_INFECTI...,SET,50,0.14518,0.007566,0.12398,0.1208,KEGG_VIBRIO_CHOLERAE_INFECTION,0.848631072077529
GSE29615_CTRL_VS_DAY3_LAIV_I...2,SET,175,0.076291,0.0074127,0.065155,0.12083,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP,0.848631072077529
DURANTE_ADULT_OLFACTORY_NEUR...4,SET,58,0.1402,0.0078675,0.11974,0.12083,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD8_T_CELLS,0.848631072077529
HP_CEREBRAL_INCLUSION_BODIES,SET,43,0.15782,0.0076286,0.13481,0.12088,HP_CEREBRAL_INCLUSION_BODIES,0.848631072077529
MIR544B,SET,191,0.071757,0.0072807,0.0613,0.12089,MIR544B,0.848631072077529
GSE45365_HEALTHY_VS_MCMV_INF...10,SET,182,0.071544,0.0070877,0.061126,0.12092,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP,0.848631072077529
GSE19888_ADENOSINE_A3R_INH_V...2,SET,173,0.073862,0.0071359,0.06311,0.12093,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP,0.848631072077529
HOLLERN_MICROACINAR_BREAST_T...2,SET,40,0.16438,0.0076643,0.14046,0.12094,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,0.848631072077529
REACTOME_SIRT1_NEGATIVELY_RE...,SET,7,0.34078,0.0066527,0.29127,0.12102,REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,0.848650733668342
MIR642A_3P_MIR642B_3P,SET,126,0.089163,0.007361,0.076212,0.12102,MIR642A_3P_MIR642B_3P,0.848650733668342
GOBP_CEREBELLAR_CORTEX_FORMA...,SET,22,0.22346,0.0077305,0.19102,0.12105,GOBP_CEREBELLAR_CORTEX_FORMATION,0.848650733668342
GOBP_REGULATION_OF_CELL_COMM...1,SET,16,0.29356,0.0086622,0.25096,0.12106,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.848650733668342
GOMF_AMINO_ACID_MONOATOMIC_C...2,SET,27,0.22224,0.0085164,0.19002,0.12109,GOMF_AMINO_ACID_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.848650733668342
HP_JOINT_CONTRACTURE_OF_THE_...2,SET,14,0.26811,0.0074008,0.22924,0.12109,HP_JOINT_CONTRACTURE_OF_THE_5TH_FINGER,0.848650733668342
MIR6781_3P,SET,72,0.12014,0.0075085,0.10276,0.12118,MIR6781_3P,0.848650733668342
MIR1343_5P,SET,114,0.092801,0.0072898,0.079379,0.12119,MIR1343_5P,0.848650733668342
GOMF_STRUCTURAL_CONSTITUENT_...12,SET,4,0.5692,0.0084006,0.487,0.12125,GOMF_STRUCTURAL_CONSTITUENT_OF_TOOTH_ENAMEL,0.848650733668342
HOEGERKORP_CD44_TARGETS_TEMP...2,SET,10,0.33644,0.0078497,0.28788,0.12127,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,0.848650733668342
GSE17721_0.5H_VS_8H_CPG_BMDC...1,SET,183,0.071859,0.0071383,0.061487,0.12127,GSE17721_0.5H_VS_8H_CPG_BMDC_DN,0.848650733668342
REACTOME_MAPK3_ERK1_ACTIVATI...,SET,10,0.35196,0.0082117,0.30118,0.12129,REACTOME_MAPK3_ERK1_ACTIVATION,0.848650733668342
GSE1791_CTRL_VS_NEUROMEDINU_...6,SET,160,0.080227,0.0074566,0.068654,0.1213,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP,0.848650733668342
GOBP_PHAGOCYTOSIS_ENGULFMENT,SET,49,0.15268,0.007877,0.13067,0.12132,GOBP_PHAGOCYTOSIS_ENGULFMENT,0.848650733668342
MOTAMED_RESPONSE_TO_ANDROGEN...2,SET,4,0.58603,0.008649,0.50158,0.12134,MOTAMED_RESPONSE_TO_ANDROGEN_UP,0.848650733668342
REACTOME_COMPLEMENT_CASCADE,SET,49,0.16637,0.0085834,0.14241,0.12135,REACTOME_COMPLEMENT_CASCADE,0.848650733668342
MIR7973,SET,43,0.1474,0.0071248,0.12619,0.12141,MIR7973,0.848650733668342
MORF_TPR,SET,131,0.080764,0.0067977,0.069158,0.12145,MORF_TPR,0.848650733668342
GOMF_RNA_POLYMERASE_BINDING,SET,56,0.13588,0.0074927,0.11636,0.12146,GOMF_RNA_POLYMERASE_BINDING,0.848650733668342
GOCC_EXON_EXON_JUNCTION_COMP...,SET,16,0.24182,0.0071356,0.20709,0.12147,GOCC_EXON_EXON_JUNCTION_COMPLEX,0.848650733668342
GOBP_PARAXIAL_MESODERM_DEVEL...,SET,17,0.24888,0.0075696,0.21314,0.12148,GOBP_PARAXIAL_MESODERM_DEVELOPMENT,0.848650733668342
HP_SOLITARY_MEDIAN_MAXILLARY...,SET,22,0.20191,0.006985,0.17292,0.12148,HP_SOLITARY_MEDIAN_MAXILLARY_CENTRAL_INCISOR,0.848650733668342
KEGG_APOPTOSIS,SET,81,0.11167,0.007401,0.095653,0.12152,KEGG_APOPTOSIS,0.848759565916399
HP_RETROCOLLIS,SET,8,0.32032,0.006685,0.27445,0.12158,HP_RETROCOLLIS,0.849008016877637
KEGG_UBIQUITIN_MEDIATED_PROT...,SET,119,0.084392,0.0067721,0.072318,0.12162,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,0.84901599718819
HALLMARK_PI3K_AKT_MTOR_SIGNA...,SET,102,0.094797,0.0070461,0.081237,0.12163,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.84901599718819
CHICAS_RB1_TARGETS_GROWING,SET,221,0.068384,0.0074574,0.058612,0.12167,CHICAS_RB1_TARGETS_GROWING,0.849023971090142
GSE27786_BCELL_VS_CD4_TCELL_...2,SET,180,0.072522,0.0071455,0.062161,0.12168,GSE27786_BCELL_VS_CD4_TCELL_UP,0.849023971090142
GOCC_PHAGOPHORE_ASSEMBLY_SIT...,SET,20,0.22559,0.0074415,0.1934,0.12172,GOCC_PHAGOPHORE_ASSEMBLY_SITE_MEMBRANE,0.84903193859121
HP_BONE_MARROW_HYPERCELLULAR...,SET,28,0.20448,0.0079792,0.17531,0.12173,HP_BONE_MARROW_HYPERCELLULARITY,0.84903193859121
GOBP_HORMONE_CATABOLIC_PROCE...,SET,12,0.31423,0.0080308,0.26943,0.12176,GOBP_HORMONE_CATABOLIC_PROCESS,0.849070786516854
MIR514B_5P,SET,167,0.076992,0.0073094,0.066022,0.12179,MIR514B_5P,0.84910961885657
GOBP_CARDIAC_MUSCLE_CELL_FAT...,SET,7,0.43803,0.0085513,0.37572,0.12184,GOBP_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT,0.849287845968712
REACTOME_TRIGLYCERIDE_BIOSYN...,SET,12,0.31149,0.0079607,0.26726,0.12192,REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,0.849504731355253
GOBP_SNRNA_METABOLIC_PROCESS,SET,50,0.13041,0.006796,0.11189,0.12192,GOBP_SNRNA_METABOLIC_PROCESS,0.849504731355253
GOBP_CENTRAL_NERVOUS_SYSTEM_...7,SET,163,0.086289,0.0080943,0.074071,0.12203,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,0.849984144144144
GOBP_INTERLEUKIN_2_MEDIATED_...,SET,8,0.41446,0.0086497,0.35587,0.12209,GOBP_INTERLEUKIN_2_MEDIATED_SIGNALING_PATHWAY,0.849984144144144
GSE45739_NRAS_KO_VS_WT_UNSTI...1,SET,169,0.077018,0.0073551,0.066134,0.1221,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN,0.849984144144144
ATGCAGT_MIR217,SET,97,0.10043,0.0072807,0.086246,0.12212,ATGCAGT_MIR217,0.849984144144144
GOBP_MAINTENANCE_OF_LOCATION,SET,310,0.058717,0.007565,0.050423,0.12212,GOBP_MAINTENANCE_OF_LOCATION,0.849984144144144
MODULE_172,SET,89,0.1113,0.0077306,0.095597,0.12216,MODULE_172,0.849984144144144
GSE32901_NAIVE_VS_TH17_NEG_C...1,SET,112,0.097358,0.0075808,0.083619,0.12216,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN,0.849984144144144
GOCC_BASEMENT_MEMBRANE_COLLA...,SET,6,0.44618,0.0080645,0.38326,0.12219,GOCC_BASEMENT_MEMBRANE_COLLAGEN_TRIMER,0.850022708166533
GOMF_SPHINGOLIPID_TRANSFER_A...,SET,7,0.3442,0.0067196,0.29574,0.12225,GOMF_SPHINGOLIPID_TRANSFER_ACTIVITY,0.85017681
MIR12118,SET,90,0.10316,0.0072046,0.088648,0.12229,MIR12118,0.85017681
HP_SENSORY_ATAXIA,SET,14,0.2572,0.0070996,0.22103,0.12229,HP_SENSORY_ATAXIA,0.85017681
GOMF_DNA_HELICASE_ACTIVITY,SET,55,0.12772,0.0069799,0.10977,0.12231,GOMF_DNA_HELICASE_ACTIVITY,0.85017681
TRAVAGLINI_LUNG_PROLIFERATIN...2,SET,872,0.033555,0.0071369,0.028849,0.12239,TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL,0.850314483928928
HALLMARK_APICAL_JUNCTION,SET,183,0.075122,0.0074624,0.06459,0.12241,HALLMARK_APICAL_JUNCTION,0.850314483928928
HP_ABNORMALITY_OF_URINE_HOME...,SET,657,0.039684,0.0073713,0.034127,0.12246,HP_ABNORMALITY_OF_URINE_HOMEOSTASIS,0.850314483928928
GSE37605_C57BL6_VS_NOD_FOXP3...5,SET,148,0.081363,0.0072755,0.069976,0.12248,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN,0.850314483928928
GOBP_NUCLEOLAR_LARGE_RRNA_TR...,SET,19,0.22414,0.0072066,0.1928,0.12251,GOBP_NUCLEOLAR_LARGE_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.850314483928928
GOBP_PODOCYTE_CELL_MIGRATION,SET,7,0.41035,0.0080109,0.35296,0.12251,GOBP_PODOCYTE_CELL_MIGRATION,0.850314483928928
GOBP_DETECTION_OF_MECHANICAL...1,SET,51,0.14428,0.0075938,0.12412,0.12254,GOBP_DETECTION_OF_MECHANICAL_STIMULUS,0.850314483928928
REACTOME_SYNTHESIS_OF_5_EICO...,SET,9,0.36106,0.007992,0.31062,0.12255,REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS,0.850314483928928
GOBP_ISG15_PROTEIN_CONJUGATI...,SET,6,0.38516,0.0069616,0.33135,0.12255,GOBP_ISG15_PROTEIN_CONJUGATION,0.850314483928928
GRYDER_PAX3FOXO1_ENHANCERS_K...,SET,412,0.052953,0.0078428,0.045581,0.12268,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,0.851046586826347
HP_MIDLINE_DEFECT_OF_THE_NOSE,SET,15,0.26534,0.0075811,0.22846,0.12274,HP_MIDLINE_DEFECT_OF_THE_NOSE,0.851067912679426
PURBEY_TARGETS_OF_CTBP1_NOT_...2,SET,262,0.060114,0.0071297,0.051764,0.12276,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,0.851067912679426
GOBP_PYRIMIDINE_NUCLEOTIDE_B...,SET,28,0.18515,0.0072249,0.15944,0.12278,GOBP_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.851067912679426
chr4q32,SET,38,0.26798,0.012179,0.23078,0.1228,chr4q32,0.851067912679426
HP_CATAPLEXY,SET,10,0.32125,0.0074952,0.27668,0.12281,HP_CATAPLEXY,0.851067912679426
YAO_TEMPORAL_RESPONSE_TO_PRO...3,SET,63,0.12102,0.0070769,0.10424,0.12283,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,0.851067912679426
GOBP_POSITIVE_REGULATION_OF_...119,SET,6,0.38828,0.0070181,0.33449,0.12287,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.851144270625747
WP_MIRNA_REGULATION_OF_DNA_D...,SET,67,0.11091,0.0066876,0.095554,0.12289,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,0.851144270625747
REACTOME_HDR_THROUGH_SINGLE_...,SET,36,0.15477,0.0068465,0.13336,0.12292,REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,0.85115839307049
REACTOME_MUSCLE_CONTRACTION,SET,194,0.073925,0.0075588,0.06371,0.12296,REACTOME_MUSCLE_CONTRACTION,0.85115839307049
MIR4751,SET,31,0.16815,0.0069035,0.14491,0.12297,MIR4751,0.85115839307049
MORF_RFC1,SET,99,0.095346,0.0069825,0.082179,0.12299,MORF_RFC1,0.85115839307049
HP_INCREASED_CIRCULATING_IGM...,SET,32,0.18436,0.00769,0.15892,0.12302,HP_INCREASED_CIRCULATING_IGM_LEVEL,0.851196516026279
GSE32423_IL7_VS_IL7_IL4_NAIV...2,SET,172,0.07871,0.0075825,0.067894,0.12317,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP,0.85203352238806
GOBP_VESICLE_TARGETING,SET,62,0.11984,0.0069523,0.10338,0.12319,GOBP_VESICLE_TARGETING,0.85203352238806
GSE360_DC_VS_MAC_M_TUBERCULO...1,SET,180,0.074444,0.0073348,0.064233,0.12324,GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN,0.852209749303621
HP_RAPIDLY_PROGRESSIVE,SET,34,0.16378,0.0070415,0.14137,0.12333,HP_RAPIDLY_PROGRESSIVE,0.852599791210976
BIOCARTA_SLRP_PATHWAY,SET,5,0.62611,0.010331,0.54046,0.12335,BIOCARTA_SLRP_PATHWAY,0.852599791210976
GOBP_NEGATIVE_REGULATION_OF_...71,SET,8,0.34071,0.0071104,0.29413,0.12337,GOBP_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.852599791210976
GSE34156_NOD2_LIGAND_VS_NOD2...1,SET,158,0.075174,0.0069435,0.06493,0.12349,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.852883012693376
MIR147B_5P,SET,285,0.060014,0.007419,0.051847,0.12354,MIR147B_5P,0.852883012693376
GOBP_INTRACELLULAR_GLUTAMATE...,SET,6,0.43495,0.0078615,0.37576,0.12354,GOBP_INTRACELLULAR_GLUTAMATE_HOMEOSTASIS,0.852883012693376
MIR652_5P,SET,34,0.16585,0.0071303,0.14329,0.12355,MIR652_5P,0.852883012693376
REACTOME_METABOLISM_OF_RNA,SET,646,0.036156,0.0066616,0.031242,0.12359,REACTOME_METABOLISM_OF_RNA,0.852883012693376
GOBP_REGULATION_OF_INSULIN_S...2,SET,51,0.13833,0.0072805,0.11954,0.12361,GOBP_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.852883012693376
TSENG_ADIPOGENIC_POTENTIAL_DN,SET,38,0.17716,0.0080515,0.15312,0.12363,TSENG_ADIPOGENIC_POTENTIAL_DN,0.852883012693376
GOCC_WNT_SIGNALOSOME,SET,13,0.29264,0.0077841,0.25291,0.12363,GOCC_WNT_SIGNALOSOME,0.852883012693376
GOBP_POSITIVE_REGULATION_OF_...712,SET,16,0.24222,0.0071473,0.20937,0.12367,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.852883012693376
HP_MODERATE_MYOPIA,SET,3,0.59229,0.0075705,0.51198,0.12367,HP_MODERATE_MYOPIA,0.852883012693376
HP_ACCESSORY_SPLEEN,SET,33,0.15606,0.0066103,0.13492,0.12371,HP_ACCESSORY_SPLEEN,0.852883012693376
PAX4_04,SET,195,0.073902,0.0075756,0.063894,0.12372,PAX4_04,0.852883012693376
GSE1460_NAIVE_CD4_TCELL_ADUL...2,SET,170,0.070387,0.0067415,0.060857,0.12373,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.852883012693376
JONES_OVARY_T_CELL,SET,83,0.1202,0.0080633,0.10394,0.12376,JONES_OVARY_T_CELL,0.852920642474717
MIR6856_3P,SET,65,0.1194,0.0070916,0.10328,0.12385,MIR6856_3P,0.853120393838955
GOBP_PROTEIN_SIDE_CHAIN_DEGL...,SET,5,0.48646,0.0080267,0.42085,0.12387,GOBP_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION,0.853120393838955
GSE43863_NAIVE_VS_MEMORY_LY6...1,SET,184,0.069634,0.006936,0.06025,0.1239,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN,0.853120393838955
GOBP_REPRODUCTIVE_PROCESS,SET,1328,0.028441,0.0073673,0.024611,0.12393,GOBP_REPRODUCTIVE_PROCESS,0.853120393838955
CC2D1A_TARGET_GENES,SET,1191,0.029426,0.0072474,0.025466,0.12396,CC2D1A_TARGET_GENES,0.853120393838955
GAVISH_3CA_MALIGNANT_METAPRO...1,SET,41,0.16477,0.0077775,0.14261,0.12398,GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION,0.853120393838955
GSE17721_CTRL_VS_CPG_6H_BMDC...2,SET,181,0.070207,0.0069363,0.060775,0.12401,GSE17721_CTRL_VS_CPG_6H_BMDC_UP,0.853120393838955
BUCASAS_PBMC_FLUARIX_FLUVIRI...3,SET,5,0.42626,0.0070334,0.36906,0.12405,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_LOW_RESPONDERS_1DY_POSITIVE_PREDICTIVE_OF_TITER,0.853120393838955
KUROZUMI_RESPONSE_TO_ONCOCYT...2,SET,20,0.24315,0.0080207,0.21053,0.12407,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,0.853120393838955
TRAVAGLINI_LUNG_CAPILLARY_IN...2,SET,353,0.052171,0.0071641,0.045175,0.12408,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL,0.853120393838955
GSE33424_CD161_INT_VS_NEG_CD...2,SET,181,0.073486,0.0072603,0.063634,0.12409,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP,0.853120393838955
MIR6878_3P,SET,59,0.12835,0.0072641,0.11118,0.12416,MIR6878_3P,0.853120393838955
NFY_Q6_01,SET,230,0.065016,0.0072312,0.056319,0.12417,NFY_Q6_01,0.853120393838955
BIOCARTA_41BB_PATHWAY,SET,18,0.22589,0.0070694,0.19576,0.12427,BIOCARTA_41BB_PATHWAY,0.853120393838955
GOBP_REGULATION_OF_PLATELET_...1,SET,50,0.15752,0.0082088,0.13654,0.12434,GOBP_REGULATION_OF_PLATELET_ACTIVATION,0.853120393838955
GOBP_SEXUAL_REPRODUCTION,SET,922,0.032857,0.0071758,0.028484,0.12435,GOBP_SEXUAL_REPRODUCTION,0.853120393838955
MODULE_5,SET,398,0.053367,0.0077718,0.046281,0.12444,MODULE_5,0.853120393838955
HP_POLYMORPHIC_VENTRICULAR_T...,SET,6,0.4688,0.0084733,0.40654,0.12444,HP_POLYMORPHIC_VENTRICULAR_TACHYCARDIA,0.853120393838955
GOBP_NEGATIVE_REGULATION_OF_...533,SET,360,0.053072,0.0073584,0.046027,0.12445,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.853120393838955
MOLENAAR_TARGETS_OF_CCND1_AN...2,SET,58,0.12648,0.0070978,0.10971,0.12449,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,0.853120393838955
GOBP_ZINC_ION_IMPORT_ACROSS_...,SET,10,0.30553,0.0071286,0.26502,0.12449,GOBP_ZINC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.853120393838955
GOBP_POSITIVE_REGULATION_OF_...752,SET,17,0.23466,0.0071371,0.20358,0.12453,GOBP_POSITIVE_REGULATION_OF_TELOMERE_CAPPING,0.853120393838955
HP_ABNORMAL_MITOCHONDRIAL_MO...,SET,23,0.18784,0.0066442,0.16296,0.12453,HP_ABNORMAL_MITOCHONDRIAL_MORPHOLOGY,0.853120393838955
REACTOME_FORMATION_OF_INCISI...,SET,38,0.13772,0.0062589,0.11948,0.12454,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,0.853120393838955
HP_GLIOMA,SET,48,0.13614,0.006952,0.11812,0.12455,HP_GLIOMA,0.853120393838955
PID_P38_ALPHA_BETA_PATHWAY,SET,29,0.18726,0.0074366,0.1625,0.12458,PID_P38_ALPHA_BETA_PATHWAY,0.853120393838955
REACTOME_N_GLYCAN_ANTENNAE_E...1,SET,15,0.28103,0.0080293,0.24387,0.1246,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,0.853120393838955
WEST_ADRENOCORTICAL_TUMOR_MA...1,SET,18,0.25868,0.0080956,0.22458,0.1247,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,0.853120393838955
MIR6884_3P,SET,60,0.13316,0.0075996,0.1156,0.1247,MIR6884_3P,0.853120393838955
TATAAA_TATA_01,SET,1141,0.031735,0.0076614,0.027554,0.12473,TATAAA_TATA_01,0.853120393838955
GSE20198_IL12_VS_IFNA_TREATE...1,SET,179,0.073179,0.0071903,0.063562,0.12481,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.853120393838955
GOCC_STEREOCILIUM_BUNDLE,SET,59,0.13259,0.0075041,0.11518,0.12485,GOCC_STEREOCILIUM_BUNDLE,0.853120393838955
HP_ELONGATED_SUPERIOR_CEREBE...,SET,10,0.27345,0.00638,0.23757,0.12487,HP_ELONGATED_SUPERIOR_CEREBELLAR_PEDUNCLE,0.853120393838955
GSE4984_LPS_VS_VEHICLE_CTRL_...1,SET,177,0.075327,0.0073604,0.065448,0.12488,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN,0.853120393838955
GOBP_POSITIVE_REGULATION_OF_...353,SET,18,0.22416,0.0070153,0.19476,0.12489,GOBP_POSITIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.853120393838955
HP_FEMALE_PSEUDOHERMAPHRODIT...,SET,7,0.43146,0.0084231,0.37488,0.12489,HP_FEMALE_PSEUDOHERMAPHRODITISM,0.853120393838955
GOBP_POSITIVE_REGULATION_OF_...90,SET,23,0.22948,0.0081172,0.19941,0.12491,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.853120393838955
HP_HYPOGLYCEMIC_COMA,SET,20,0.21881,0.007218,0.19015,0.12493,HP_HYPOGLYCEMIC_COMA,0.853120393838955
SANSOM_APC_TARGETS_DN,SET,333,0.055595,0.007419,0.048323,0.12498,SANSOM_APC_TARGETS_DN,0.853120393838955
GRAHAM_CML_DIVIDING_VS_NORMA...4,SET,170,0.073436,0.0070336,0.063833,0.12499,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,0.853120393838955
HP_ABNORMAL_5TH_METACARPAL_M...,SET,17,0.24138,0.0073415,0.20981,0.12499,HP_ABNORMAL_5TH_METACARPAL_MORPHOLOGY,0.853120393838955
HP_ANAPHYLACTIC_SHOCK,SET,8,0.35007,0.0073058,0.30438,0.12505,HP_ANAPHYLACTIC_SHOCK,0.853120393838955
DESCARTES_FETAL_LUNG_STROMAL...,SET,37,0.17669,0.0079239,0.15362,0.12505,DESCARTES_FETAL_LUNG_STROMAL_CELLS,0.853120393838955
DORMOY_ELAVL1_TARGETS,SET,17,0.25993,0.0079059,0.22604,0.12509,DORMOY_ELAVL1_TARGETS,0.853120393838955
GOBP_TYROSINE_PHOSPHORYLATIO...,SET,74,0.11904,0.007542,0.10352,0.1251,GOBP_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.853120393838955
MODULE_89,SET,2,0.79134,0.0082588,0.68827,0.12513,MODULE_89,0.853120393838955
HP_PRIMARY_PERITONEAL_CARCIN...,SET,13,0.25915,0.0068933,0.22542,0.12516,HP_PRIMARY_PERITONEAL_CARCINOMA,0.853120393838955
GOBP_POSITIVE_REGULATION_OF_...465,SET,52,0.14279,0.0075886,0.12422,0.12517,GOBP_POSITIVE_REGULATION_OF_MIRNA_TRANSCRIPTION,0.853120393838955
GOBP_PROLINE_TRANSPORT,SET,11,0.32081,0.0078502,0.27908,0.12518,GOBP_PROLINE_TRANSPORT,0.853120393838955
GOMF_RNA_POLYMERASE_I_TRANSC...,SET,9,0.30017,0.0066443,0.26117,0.12521,GOMF_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.853120393838955
REACTOME_INTERLEUKIN_RECEPTO...,SET,23,0.2138,0.0075625,0.18607,0.12528,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,0.853120393838955
GOBP_GENERAL_ADAPTATION_SYND...1,SET,6,0.44083,0.0079678,0.38366,0.12528,GOBP_GENERAL_ADAPTATION_SYNDROME,0.853120393838955
GOCC_CYTOPLASMIC_SIDE_OF_MEM...,SET,186,0.071857,0.0071958,0.062546,0.12531,GOCC_CYTOPLASMIC_SIDE_OF_MEMBRANE,0.853120393838955
WP_MYD88_DISTINCT_INPUTOUTPU...,SET,15,0.29024,0.0082925,0.25263,0.12532,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,0.853120393838955
HP_ABSENT_HAND,SET,17,0.25438,0.007737,0.22143,0.12532,HP_ABSENT_HAND,0.853120393838955
GENTILE_UV_RESPONSE_CLUSTER_...7,SET,36,0.16649,0.0073651,0.14497,0.1254,GENTILE_UV_RESPONSE_CLUSTER_D8,0.853120393838955
KEGG_LIMONENE_AND_PINENE_DEG...,SET,9,0.29963,0.0066323,0.2609,0.1254,KEGG_LIMONENE_AND_PINENE_DEGRADATION,0.853120393838955
MIR301A_5P,SET,75,0.11368,0.0072511,0.098993,0.12541,MIR301A_5P,0.853120393838955
MIR301B_5P,SET,75,0.11368,0.0072511,0.098993,0.12541,MIR301B_5P,0.853120393838955
REACTOME_P75NTR_NEGATIVELY_R...,SET,6,0.407,0.0073564,0.35445,0.12544,REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1,0.853120393838955
HP_ABNORMAL_ASTROCYTE_MORPHO...,SET,45,0.14684,0.0072607,0.12789,0.12545,HP_ABNORMAL_ASTROCYTE_MORPHOLOGY,0.853120393838955
GOMF_ALDEHYDE_LYASE_ACTIVITY,SET,9,0.2965,0.006563,0.25825,0.12547,GOMF_ALDEHYDE_LYASE_ACTIVITY,0.853120393838955
GAVISH_3CA_MALIGNANT_METAPRO...22,SET,47,0.16118,0.0081444,0.14039,0.12548,GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL,0.853120393838955
GOBP_POSITIVE_REGULATION_OF_...779,SET,22,0.19345,0.0066924,0.16852,0.1255,GOBP_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.853120393838955
GSE360_DC_VS_MAC_M_TUBERCULO...2,SET,179,0.074524,0.0073225,0.064919,0.1255,GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP,0.853120393838955
MIR31_5P,SET,129,0.087281,0.0072903,0.076042,0.12553,MIR31_5P,0.853120393838955
HP_HYPOTENSION,SET,103,0.1017,0.0075962,0.088612,0.12555,HP_HYPOTENSION,0.853120393838955
GOBP_MITOTIC_SISTER_CHROMATI...3,SET,178,0.070754,0.0069328,0.06165,0.12556,GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.853120393838955
GOBP_REGULATION_OF_NK_T_CELL...1,SET,11,0.3415,0.0083565,0.29757,0.12557,GOBP_REGULATION_OF_NK_T_CELL_ACTIVATION,0.853120393838955
AGCYRWTTC_UNKNOWN,SET,107,0.094453,0.0071896,0.082328,0.12564,AGCYRWTTC_UNKNOWN,0.853120393838955
PARK_HSC_VS_MULTIPOTENT_PROG...1,SET,14,0.26714,0.0073739,0.23285,0.12565,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,0.853120393838955
GSE33162_HDAC3_KO_VS_HDAC3_K...4,SET,182,0.069754,0.0069104,0.060809,0.12568,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP,0.853120393838955
GSE3982_BASOPHIL_VS_CENT_MEM...1,SET,172,0.073716,0.0071014,0.064263,0.12568,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.853120393838955
GSE27786_NKTCELL_VS_MONO_MAC...2,SET,175,0.071329,0.0069306,0.062186,0.12569,GSE27786_NKTCELL_VS_MONO_MAC_UP,0.853120393838955
GSE3039_CD4_TCELL_VS_ALPHAAL...1,SET,179,0.073148,0.0071873,0.063774,0.1257,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN,0.853120393838955
GSE12845_IGD_POS_VS_NEG_BLOO...2,SET,169,0.072563,0.0069297,0.063271,0.12573,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP,0.853120393838955
GATA1_05,SET,260,0.063859,0.0075452,0.055689,0.12576,GATA1_05,0.853120393838955
GSE11961_MARGINAL_ZONE_BCELL...4,SET,180,0.073672,0.0072588,0.064247,0.12576,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.853120393838955
WU_SILENCED_BY_METHYLATION_I...,SET,46,0.1607,0.0080338,0.14017,0.1258,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,0.853120393838955
LXR_DR4_Q3,SET,79,0.11245,0.0073603,0.098081,0.1258,LXR_DR4_Q3,0.853120393838955
HP_APLASIA_HYPOPLASIA_OF_THE...4,SET,6,0.45511,0.008226,0.39698,0.12582,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_FINGER,0.853120393838955
HP_ABNORMAL_ERYTHROCYTE_MORP...,SET,599,0.040512,0.0071972,0.035346,0.12587,HP_ABNORMAL_ERYTHROCYTE_MORPHOLOGY,0.853120393838955
GSE1460_CD4_THYMOCYTE_VS_NAI...2,SET,182,0.073898,0.0073209,0.064478,0.12589,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.853120393838955
GSE45365_WT_VS_IFNAR_KO_CD8A...4,SET,174,0.075262,0.007292,0.065669,0.12589,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP,0.853120393838955
KEGG_MEDICUS_ENV_FACTOR_BENZ...,SET,11,0.33756,0.0082599,0.29454,0.1259,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM,0.853120393838955
GOBP_AXIAL_MESODERM_DEVELOPM...,SET,7,0.32261,0.006298,0.2815,0.1259,GOBP_AXIAL_MESODERM_DEVELOPMENT,0.853120393838955
HP_RETICULAR_HYPERPIGMENTATI...,SET,9,0.29189,0.006461,0.25475,0.12595,HP_RETICULAR_HYPERPIGMENTATION,0.85329283625731
HP_PATCHY_HYPOPIGMENTATION_O...,SET,21,0.23714,0.0080156,0.207,0.12598,HP_PATCHY_HYPOPIGMENTATION_OF_HAIR,0.853298908807482
DESCARTES_FETAL_LIVER_ERYTHR...,SET,55,0.13462,0.0073569,0.11751,0.126,DESCARTES_FETAL_LIVER_ERYTHROBLASTS,0.853298908807482
GOBP_REGULATION_OF_MULTICELL...1,SET,1270,0.029494,0.0074841,0.025752,0.12605,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISMAL_DEVELOPMENT,0.85334128449281
GSE13522_CTRL_VS_T_CRUZI_BRA...2,SET,130,0.089652,0.0075172,0.078297,0.12611,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP,0.85334128449281
ATF6_TARGET_GENES,SET,864,0.03379,0.0071556,0.029516,0.12615,ATF6_TARGET_GENES,0.85334128449281
GSE15930_NAIVE_VS_24H_IN_VIT...1,SET,189,0.066846,0.0067472,0.058393,0.12616,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN,0.85334128449281
GOBP_RRNA_5_END_PROCESSING,SET,5,0.40426,0.0066703,0.35315,0.12617,GOBP_RRNA_5_END_PROCESSING,0.85334128449281
GSE17721_POLYIC_VS_PAM3CSK4_...17,SET,180,0.068171,0.0067168,0.059556,0.12618,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN,0.85334128449281
MIR1293,SET,55,0.13838,0.0075624,0.1209,0.1262,MIR1293,0.85334128449281
KEGG_MEDICUS_PATHOGEN_HCMV_U...3,SET,33,0.17578,0.0074455,0.15361,0.12625,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY,0.85334128449281
GSE42088_UNINF_VS_LEISHMANIA...4,SET,184,0.074502,0.0074208,0.065104,0.12625,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP,0.85334128449281
GOBP_POSITIVE_REGULATION_OF_...669,SET,51,0.13996,0.0073661,0.12231,0.12626,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.85334128449281
BIOCARTA_IL12_PATHWAY,SET,18,0.23407,0.0073256,0.20462,0.12633,BIOCARTA_IL12_PATHWAY,0.85334128449281
ZNF16_TARGET_GENES,SET,66,0.12949,0.0077497,0.1132,0.12634,ZNF16_TARGET_GENES,0.85334128449281
KEGG_MATURITY_ONSET_DIABETES...,SET,25,0.22419,0.008267,0.19599,0.12635,KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.85334128449281
GOMF_PHOSPHATASE_INHIBITOR_A...,SET,40,0.14816,0.0069079,0.12952,0.12635,GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY,0.85334128449281
GARGALOVIC_RESPONSE_TO_OXIDI...12,SET,11,0.27821,0.0068077,0.24334,0.12646,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,0.853376784677887
GOCC_BASOLATERAL_PLASMA_MEMB...,SET,246,0.066868,0.0076882,0.058488,0.12647,GOCC_BASOLATERAL_PLASMA_MEMBRANE,0.853376784677887
MIR4484,SET,31,0.18035,0.0074046,0.15775,0.12648,MIR4484,0.853376784677887
REACTOME_CA2_ACTIVATED_K_CHA...,SET,9,0.34984,0.0077436,0.30602,0.12649,REACTOME_CA2_ACTIVATED_K_CHANNELS,0.853376784677887
REACTOME_NR1H2_NR1H3_REGULAT...3,SET,5,0.34608,0.0057104,0.30274,0.1265,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE,0.853376784677887
HP_ALACRIMA,SET,17,0.2322,0.0070623,0.20316,0.12654,HP_ALACRIMA,0.853376784677887
HP_HIP_OSTEOARTHRITIS,SET,17,0.26957,0.0081989,0.23589,0.12657,HP_HIP_OSTEOARTHRITIS,0.853376784677887
QIU_PBMC_HEPTATITIS_B_SURFAC...5,SET,12,0.30505,0.0077963,0.26695,0.12658,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_35DY_UP,0.853376784677887
GOBP_SELF_PROTEOLYSIS,SET,12,0.30083,0.0076884,0.26326,0.12659,GOBP_SELF_PROTEOLYSIS,0.853376784677887
GOBP_COTRANSLATIONAL_PROTEIN...,SET,21,0.20401,0.0068957,0.17857,0.12664,GOBP_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.853376784677887
GOMF_OXIDOREDUCTASE_ACTIVITY...30,SET,7,0.38495,0.007515,0.33697,0.12666,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.853376784677887
HP_ABNORMAL_ARM_SPAN,SET,11,0.28638,0.0070076,0.25074,0.12671,HP_ABNORMAL_ARM_SPAN,0.853376784677887
GSE21360_NAIVE_VS_TERTIARY_M...1,SET,178,0.07195,0.00705,0.063012,0.12676,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.853376784677887
MATTIOLI_MGUS_VS_MULTIPLE_MY...,SET,13,0.2893,0.0076955,0.25336,0.12677,MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,0.853376784677887
GSE9601_UNTREATED_VS_NFKB_IN...1,SET,162,0.075993,0.0071067,0.066553,0.12677,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.853376784677887
HP_CENTRAL_OPACIFICATION_OF_...,SET,21,0.24803,0.0083836,0.21723,0.12678,HP_CENTRAL_OPACIFICATION_OF_THE_CORNEA,0.853376784677887
GSE20366_TREG_VS_NAIVE_CD4_T...2,SET,186,0.071973,0.0072074,0.063038,0.12679,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP,0.853376784677887
GOCC_AXONEMAL_MICROTUBULE,SET,26,0.18809,0.0070732,0.16476,0.12681,GOCC_AXONEMAL_MICROTUBULE,0.853376784677887
REACTOME_LEUKOTRIENE_RECEPTO...,SET,4,0.41594,0.0061387,0.36442,0.12687,REACTOME_LEUKOTRIENE_RECEPTORS,0.853376784677887
REACTOME_CALNEXIN_CALRETICUL...,SET,24,0.19402,0.0070102,0.17,0.12688,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,0.853376784677887
GCCNNNWTAAR_UNKNOWN,SET,132,0.086411,0.0073005,0.075718,0.1269,GCCNNNWTAAR_UNKNOWN,0.853376784677887
MIR4310,SET,262,0.061485,0.0072922,0.053879,0.12691,MIR4310,0.853376784677887
HP_ABNORMAL_U_WAVE,SET,5,0.49424,0.0081551,0.43312,0.12692,HP_ABNORMAL_U_WAVE,0.853376784677887
GOBP_LABYRINTHINE_LAYER_BLOO...,SET,18,0.23955,0.007497,0.20998,0.12698,GOBP_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT,0.853565610510046
HP_OVERTUBULATED_LONG_BONES,SET,7,0.35669,0.0069633,0.31271,0.12702,HP_OVERTUBULATED_LONG_BONES,0.853565610510046
GOBP_NEGATIVE_REGULATION_OF_...102,SET,196,0.074554,0.0076618,0.065376,0.12707,GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION,0.853565610510046
NRL_DN.V1_DN,SET,120,0.092144,0.007425,0.080809,0.1271,NRL_DN.V1_DN,0.853565610510046
GOBP_IMMUNE_RESPONSE_INHIBIT...1,SET,8,0.37782,0.0078849,0.33136,0.12711,GOBP_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.853565610510046
HP_PANCREATIC_HYPOPLASIA,SET,24,0.22004,0.0079502,0.19298,0.12711,HP_PANCREATIC_HYPOPLASIA,0.853565610510046
GOMF_SOMATOSTATIN_RECEPTOR_A...,SET,5,0.41843,0.0069042,0.367,0.12712,GOMF_SOMATOSTATIN_RECEPTOR_ACTIVITY,0.853565610510046
GSE3982_EOSINOPHIL_VS_EFF_ME...2,SET,173,0.072181,0.0069735,0.063329,0.1272,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.853840005793743
GOBP_CARNITINE_TRANSPORT,SET,7,0.46407,0.0090598,0.40719,0.12721,GOBP_CARNITINE_TRANSPORT,0.853840005793743
GOBP_POSITIVE_REGULATION_OF_...554,SET,7,0.41069,0.0080176,0.36046,0.12729,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.854027878495661
HP_APLASIA_HYPOPLASIA_OF_THE...47,SET,4,0.55751,0.0082281,0.48946,0.12735,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_SEPTUM,0.854027878495661
GOBP_REGULATION_OF_NON_CANON...2,SET,26,0.20362,0.007657,0.17877,0.12736,GOBP_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.854027878495661
GSE43863_NAIVE_VS_MEMORY_TH1...1,SET,139,0.08041,0.00697,0.070601,0.12737,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN,0.854027878495661
DIAZ_CHRONIC_MYELOGENOUS_LEU...2,SET,1271,0.02719,0.006902,0.023875,0.12739,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP,0.854027878495661
STAT1_03,SET,239,0.063924,0.0072457,0.056133,0.1274,STAT1_03,0.854027878495661
HP_NAUSEA_AND_VOMITING,SET,487,0.044248,0.0071102,0.038857,0.12741,HP_NAUSEA_AND_VOMITING,0.854027878495661
MIR5004_5P,SET,114,0.088635,0.0069625,0.077854,0.12747,MIR5004_5P,0.854073553162853
GOBP_EPIDERMIS_DEVELOPMENT,SET,356,0.057847,0.0079766,0.050825,0.12753,GOBP_EPIDERMIS_DEVELOPMENT,0.854073553162853
GOBP_5_PHOSPHORIBOSE_1_DIPHO...,SET,4,0.60054,0.0088632,0.52768,0.12755,GOBP_5_PHOSPHORIBOSE_1_DIPHOSPHATE_METABOLIC_PROCESS,0.854073553162853
HP_SYMPTOMATIC_SEIZURES,SET,35,0.17576,0.0076666,0.15444,0.12756,HP_SYMPTOMATIC_SEIZURES,0.854073553162853
FREAC2_01,SET,235,0.067692,0.0076092,0.059484,0.12757,FREAC2_01,0.854073553162853
STK33_SKM_UP,SET,229,0.063483,0.0070455,0.055789,0.12759,STK33_SKM_UP,0.854073553162853
GOBP_ESTABLISHMENT_OF_PLANAR...2,SET,15,0.26429,0.0075511,0.23227,0.1276,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_OF_EMBRYONIC_EPITHELIUM,0.854073553162853
GOCC_CYTOCHROME_COMPLEX,SET,34,0.15837,0.0068087,0.13925,0.12772,GOCC_CYTOCHROME_COMPLEX,0.854073553162853
ZNF704_TARGET_GENES,SET,61,0.12491,0.0071878,0.10984,0.12774,ZNF704_TARGET_GENES,0.854073553162853
BIOCARTA_IL17_PATHWAY,SET,15,0.2786,0.0079599,0.245,0.12775,BIOCARTA_IL17_PATHWAY,0.854073553162853
GOBP_OVIDUCT_DEVELOPMENT,SET,6,0.42041,0.0075988,0.36974,0.12776,GOBP_OVIDUCT_DEVELOPMENT,0.854073553162853
AUJLA_IL22_AND_IL17A_SIGNALI...,SET,10,0.30701,0.0071629,0.27001,0.12778,AUJLA_IL22_AND_IL17A_SIGNALING,0.854073553162853
GOMF_KINETOCHORE_BINDING,SET,6,0.50566,0.0091396,0.44477,0.12779,GOMF_KINETOCHORE_BINDING,0.854073553162853
HP_DECREASED_CIRCULATING_COM...1,SET,33,0.17764,0.0075244,0.15625,0.12779,HP_DECREASED_CIRCULATING_COMPLEMENT_C3_CONCENTRATION,0.854073553162853
BROWNE_HCMV_INFECTION_16HR_DN,SET,77,0.11361,0.0073421,0.099935,0.12781,BROWNE_HCMV_INFECTION_16HR_DN,0.854073553162853
RADAEVA_RESPONSE_TO_IFNA1_DN,SET,10,0.36487,0.0085131,0.32095,0.12781,RADAEVA_RESPONSE_TO_IFNA1_DN,0.854073553162853
ZNF610_TARGET_GENES,SET,708,0.03726,0.0071743,0.032787,0.1279,ZNF610_TARGET_GENES,0.854218472622478
GOBP_ACTOMYOSIN_STRUCTURE_OR...,SET,205,0.069295,0.0072813,0.060977,0.1279,GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.854218472622478
REACTOME_PTK6_REGULATES_CELL...,SET,6,0.40169,0.0072604,0.35352,0.12793,REACTOME_PTK6_REGULATES_CELL_CYCLE,0.854218472622478
GSE43957_UNTREATED_VS_NACL_T...1,SET,181,0.072132,0.0071266,0.063483,0.12793,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.854218472622478
MIR6504_3P,SET,342,0.05483,0.0074133,0.048263,0.12797,MIR6504_3P,0.854321427199385
CACBINDINGPROTEIN_Q6,SET,231,0.063876,0.0071196,0.056233,0.12801,CACBINDINGPROTEIN_Q6,0.854399309021113
GOBP_EMBRYONIC_APPENDAGE_MOR...,SET,116,0.097257,0.0077062,0.085635,0.12804,GOBP_EMBRYONIC_APPENDAGE_MORPHOGENESIS,0.854399309021113
GOBP_MEMBRANE_ORGANIZATION,SET,721,0.036641,0.007117,0.032265,0.12807,GOBP_MEMBRANE_ORGANIZATION,0.854399309021113
GSE16385_MONOCYTE_VS_12H_ROS...2,SET,186,0.069743,0.0069841,0.061418,0.12808,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.854399309021113
BIOCARTA_HSP27_PATHWAY,SET,14,0.25436,0.0070212,0.22407,0.12815,BIOCARTA_HSP27_PATHWAY,0.85470221646517
HP_INCREASED_LEFT_VENTRICULA...,SET,21,0.22129,0.0074797,0.19498,0.12821,HP_INCREASED_LEFT_VENTRICULAR_END_DIASTOLIC_VOLUME,0.854938325019186
MODULE_208,SET,108,0.09769,0.0074704,0.086088,0.12825,MODULE_208,0.855041003261078
GOCC_CUTICULAR_PLATE,SET,8,0.35632,0.0074363,0.3141,0.12832,GOCC_CUTICULAR_PLATE,0.855251466359977
REACTOME_INTERLEUKIN_7_SIGNA...,SET,21,0.21908,0.0074051,0.19314,0.12835,REACTOME_INTERLEUKIN_7_SIGNALING,0.855251466359977
MIR204_3P,SET,128,0.084909,0.0070648,0.074864,0.12837,MIR204_3P,0.855251466359977
MIR4690_3P,SET,57,0.12354,0.0068726,0.10893,0.12838,MIR4690_3P,0.855251466359977
REACTOME_NUCLEAR_SIGNALING_B...,SET,30,0.16867,0.0068124,0.14875,0.12842,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,0.85535398620161
REACTOME_SIGNALING_BY_LRP5_M...,SET,6,0.41093,0.0074273,0.36246,0.12846,REACTOME_SIGNALING_BY_LRP5_MUTANTS,0.855456466756084
RIGGINS_TAMOXIFEN_RESISTANCE...2,SET,53,0.1422,0.0076291,0.12545,0.1285,RIGGINS_TAMOXIFEN_RESISTANCE_UP,0.855461606971844
GOBP_REGULATION_OF_EPITHELIA...4,SET,212,0.070354,0.0075162,0.062068,0.12851,GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.855461606971844
BOQUEST_STEM_CELL_CULTURED_V...1,SET,29,0.19838,0.0078781,0.17505,0.12856,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,0.855630563002681
WP_SECRETION_OF_HYDROCHLORIC...,SET,5,0.4683,0.007727,0.41338,0.12864,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,0.855999080987938
KEGG_LEUKOCYTE_TRANSENDOTHEL...,SET,108,0.099601,0.0076166,0.087941,0.1287,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,0.856234398928025
GOMF_CYCLIN_DEPENDENT_PROTEI...1,SET,26,0.17944,0.0067478,0.15852,0.12883,GOMF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.856935244019139
KEGG_MEDICUS_REFERENCE_HEPAR...2,SET,6,0.38615,0.0069796,0.34125,0.12891,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION,0.857139286397551
GSE30971_CTRL_VS_LPS_STIM_MA...8,SET,173,0.081678,0.0078911,0.072181,0.12891,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP,0.857139286397551
HP_GLYCOSURIA,SET,40,0.15543,0.0072471,0.13737,0.12894,HP_GLYCOSURIA,0.857143775100402
GSE36826_WT_VS_IL1R_KO_SKIN_...1,SET,170,0.073313,0.0070218,0.0648,0.12896,GSE36826_WT_VS_IL1R_KO_SKIN_DN,0.857143775100402
LASTOWSKA_COAMPLIFIED_WITH_M...,SET,35,0.20026,0.0087352,0.17707,0.12905,LASTOWSKA_COAMPLIFIED_WITH_MYCN,0.85729
GOBP_CELL_FATE_SPECIFICATION,SET,101,0.10171,0.0075232,0.089943,0.12906,GOBP_CELL_FATE_SPECIFICATION,0.85729
GOBP_POSITIVE_REGULATION_OF_...398,SET,30,0.17927,0.0072406,0.15854,0.12909,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.85729
GCM_TPT1,SET,60,0.11615,0.0066291,0.10272,0.1291,GCM_TPT1,0.85729
REACTOME_SARS_COV_INFECTIONS,SET,378,0.049282,0.0069981,0.04359,0.12913,REACTOME_SARS_COV_INFECTIONS,0.85729
HP_NONSPHEROCYTIC_HEMOLYTIC_...,SET,7,0.32172,0.0062808,0.28458,0.12913,HP_NONSPHEROCYTIC_HEMOLYTIC_ANEMIA,0.85729
GSE12507_PDC_CELL_LINE_VS_IM...2,SET,136,0.082114,0.007041,0.072651,0.12919,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP,0.857396162657503
GSE39916_B_CELL_SPLEEN_VS_PL...2,SET,180,0.073991,0.0072902,0.065468,0.12921,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP,0.857396162657503
GOBP_SIRNA_MEDIATED_RETROTRA...,SET,10,0.26942,0.006286,0.2384,0.12922,GOBP_SIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.857396162657503
REACTOME_SIGNALING_BY_CTNNB1...,SET,14,0.26007,0.0071789,0.23024,0.12933,REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,0.857541847826087
DURAND_STROMA_NS_UP,SET,161,0.0793,0.0073933,0.070211,0.12936,DURAND_STROMA_NS_UP,0.857541847826087
GSE369_SOCS3_KO_VS_IFNG_KO_L...2,SET,170,0.077388,0.0074121,0.068517,0.12936,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP,0.857541847826087
REACTOME_VITAMIN_D_CALCIFERO...,SET,12,0.29344,0.0074996,0.25983,0.12938,REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM,0.857541847826087
GOCC_POSTSYNAPTIC_ACTIN_CYTO...,SET,8,0.33739,0.0070411,0.29876,0.12939,GOCC_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.857541847826087
DESCARTES_MAIN_FETAL_PHOTORE...,SET,67,0.12758,0.0076926,0.11297,0.12939,DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS,0.857541847826087
MIR4722_5P,SET,127,0.087228,0.0072296,0.07726,0.12945,MIR4722_5P,0.857682936356707
GSE26928_NAIVE_VS_EFF_MEMORY...1,SET,168,0.071443,0.0068027,0.063284,0.12947,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.857682936356707
GOMF_GLUTAMATE_RECEPTOR_ACTI...,SET,25,0.2077,0.007659,0.18399,0.12949,GOMF_GLUTAMATE_RECEPTOR_ACTIVITY,0.857682936356707
DING_LUNG_CANCER_EXPRESSION_...,SET,96,0.10079,0.0072689,0.089293,0.12951,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,0.857682936356707
HP_WEAK_VOICE,SET,24,0.18818,0.0067992,0.16675,0.12956,HP_WEAK_VOICE,0.857850600114308
GOBP_POSITIVE_REGULATION_OF_...238,SET,13,0.29317,0.0077982,0.25985,0.12963,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.857987173871643
HP_ABNORMAL_BONE_MARROW_CELL...,SET,199,0.06701,0.0069385,0.059396,0.12963,HP_ABNORMAL_BONE_MARROW_CELL_MORPHOLOGY,0.857987173871643
MIR5590_5P,SET,106,0.093473,0.0070818,0.082868,0.12968,MIR5590_5P,0.858092615150362
ZNF581_TARGET_GENES,SET,266,0.058371,0.0069748,0.051759,0.12972,ZNF581_TARGET_GENES,0.858092615150362
LI_PBMC_MENACTRA_AGE_18_45YO...1,SET,8,0.36375,0.0075912,0.32254,0.12972,LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP,0.858092615150362
GOCC_DNA_DEPENDENT_PROTEIN_K...1,SET,5,0.37401,0.0061712,0.33173,0.12978,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.858228966894977
HP_HYPERECHOGENIC_PANCREAS,SET,4,0.454,0.0067004,0.40269,0.12979,HP_HYPERECHOGENIC_PANCREAS,0.858228966894977
REACTOME_INTERLEUKIN_3_INTER...,SET,43,0.15417,0.0074524,0.13681,0.12989,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,0.858563512742488
GOCC_MISMATCH_REPAIR_COMPLEX,SET,7,0.29349,0.0057296,0.26042,0.12989,GOCC_MISMATCH_REPAIR_COMPLEX,0.858563512742488
GOBP_REGULATION_OF_MYELOID_D...,SET,4,0.55425,0.00818,0.49194,0.12995,GOBP_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION,0.858796776953794
GOMF_PHOSPHORIC_DIESTER_HYDR...,SET,86,0.10144,0.0069264,0.090047,0.12998,GOMF_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY,0.858831730038023
chr1p22,SET,59,0.24291,0.013748,0.21568,0.13004,chr1p22,0.858901596351197
REACTOME_BBSOME_MEDIATED_CAR...,SET,23,0.196,0.006933,0.17403,0.13004,REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,0.858901596351197
GOCC_EXTRINSIC_COMPONENT_OF_...10,SET,11,0.30452,0.0074515,0.27045,0.1301,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE,0.858940284900285
BARHL1_TARGET_GENES,SET,1039,0.030497,0.0070466,0.027087,0.13011,BARHL1_TARGET_GENES,0.858940284900285
HP_DEEP_PHILTRUM,SET,63,0.11846,0.0069271,0.10521,0.13012,HP_DEEP_PHILTRUM,0.858940284900285
KORKOLA_EMBRYONIC_CARCINOMA_...2,SET,16,0.2453,0.0072382,0.21794,0.13019,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,0.859013788195104
GSE27786_LSK_VS_ERYTHROBLAST...1,SET,178,0.069274,0.0067878,0.061548,0.13019,GSE27786_LSK_VS_ERYTHROBLAST_DN,0.859013788195104
MORF_PRKAR1A,SET,125,0.081386,0.0066924,0.072314,0.13021,MORF_PRKAR1A,0.859013788195104
GOBP_RESPONSE_TO_GROWTH_HORM...,SET,35,0.17547,0.007654,0.15593,0.13023,GOBP_RESPONSE_TO_GROWTH_HORMONE,0.859013788195104
MORF_KDR,SET,82,0.11324,0.007551,0.10065,0.13029,MORF_KDR,0.859246480075901
KRAS.LUNG.BREAST_UP.V1_DN,SET,129,0.088053,0.0073548,0.078314,0.13044,KRAS.LUNG.BREAST_UP.V1_DN,0.859663148428625
KEGG_MEDICUS_VARIANT_MUTATIO...49,SET,17,0.2311,0.0070288,0.20556,0.13047,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM,0.859663148428625
HP_SPONTANEOUS_HEMOLYTIC_CRI...,SET,7,0.33693,0.0065775,0.29972,0.13049,HP_SPONTANEOUS_HEMOLYTIC_CRISES,0.859663148428625
BIOCARTA_PPARG_PATHWAY,SET,8,0.36768,0.0076733,0.32711,0.13051,BIOCARTA_PPARG_PATHWAY,0.859663148428625
REACTOME_NEUROFASCIN_INTERAC...,SET,6,0.40427,0.007307,0.35977,0.13058,REACTOME_NEUROFASCIN_INTERACTIONS,0.859663148428625
MODULE_171,SET,122,0.089652,0.0072838,0.079783,0.13058,MODULE_171,0.859663148428625
GSE2405_0H_VS_24H_A_PHAGOCYT...2,SET,187,0.069116,0.0069397,0.061507,0.13058,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.859663148428625
GSE22589_HIV_VS_HIV_AND_SIV_...2,SET,180,0.071175,0.0070128,0.063346,0.1306,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.859663148428625
KEGG_MEDICUS_REFERENCE_TYPE_...3,SET,20,0.26486,0.0087368,0.23574,0.13062,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.859663148428625
GSE9006_HEALTHY_VS_TYPE_1_DI...6,SET,169,0.072596,0.0069328,0.064615,0.13062,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP,0.859663148428625
GOMF_VITAMIN_BINDING,SET,133,0.084372,0.007155,0.075104,0.13064,GOMF_VITAMIN_BINDING,0.859663148428625
MIR1269A_MIR1269B,SET,48,0.17609,0.0089921,0.15676,0.13065,MIR1269A_MIR1269B,0.859663148428625
GAVISH_3CA_METAPROGRAM_FIBRO...13,SET,48,0.15735,0.008035,0.14009,0.13068,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA,0.859697785349233
MIR6879_5P,SET,99,0.098916,0.0072439,0.088081,0.13072,MIR6879_5P,0.85976701986755
GOMF_DNA_DEMETHYLASE_ACTIVITY,SET,5,0.37228,0.0061427,0.33152,0.13074,GOMF_DNA_DEMETHYLASE_ACTIVITY,0.85976701986755
HP_DYSARTHRIA,SET,537,0.040961,0.0069021,0.036489,0.13082,HP_DYSARTHRIA,0.860033412142992
DESCARTES_FETAL_LIVER_STELLA...,SET,122,0.098872,0.0080328,0.088083,0.13083,DESCARTES_FETAL_LIVER_STELLATE_CELLS,0.860033412142992
KEGG_MEDICUS_REFERENCE_DNA_R...1,SET,24,0.17928,0.0064776,0.15975,0.13088,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING,0.860199394856278
REACTOME_HDR_THROUGH_HOMOLOG...,SET,64,0.11054,0.0065152,0.098538,0.13097,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,0.860481339622642
REACTOME_BETA_CATENIN_PHOSPH...,SET,16,0.24506,0.0072313,0.21851,0.13104,REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,0.860481339622642
GOBP_CARNITINE_METABOLIC_PRO...,SET,11,0.26358,0.0064498,0.23505,0.13107,GOBP_CARNITINE_METABOLIC_PROCESS,0.860481339622642
GOBP_POSITIVE_REGULATION_OF_...128,SET,91,0.10793,0.0075796,0.096252,0.13108,GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION,0.860481339622642
REACTOME_FASL_CD95L_SIGNALING,SET,5,0.47549,0.0078456,0.42405,0.13109,REACTOME_FASL_CD95L_SIGNALING,0.860481339622642
GOBP_PHAGOCYTOSIS,SET,221,0.068087,0.007425,0.06074,0.13116,GOBP_PHAGOCYTOSIS,0.860481339622642
FOXJ2_02,SET,213,0.068013,0.007283,0.060678,0.13118,FOXJ2_02,0.860481339622642
GSE13522_WT_VS_IFNAR_KO_SKIN...1,SET,178,0.070193,0.0068778,0.062626,0.13119,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,0.860481339622642
GSE5679_CTRL_VS_PPARG_LIGAND...4,SET,179,0.066336,0.006518,0.059188,0.1312,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP,0.860481339622642
WORSCHECH_TUMOR_EVASION_AND_...2,SET,29,0.19562,0.0077682,0.17454,0.13121,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,0.860481339622642
GOBP_POSITIVE_REGULATION_OF_...594,SET,12,0.32089,0.0082009,0.28632,0.13121,GOBP_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION,0.860481339622642
HP_LOW_SELF_ESTEEM,SET,10,0.35953,0.0083884,0.32081,0.13122,HP_LOW_SELF_ESTEEM,0.860481339622642
BIOCARTA_INFLAM_PATHWAY,SET,25,0.20871,0.0076961,0.18627,0.13127,BIOCARTA_INFLAM_PATHWAY,0.860646830786644
GOBP_DNA_STRAND_RESECTION_IN...,SET,9,0.31178,0.0069013,0.27832,0.13132,GOBP_DNA_STRAND_RESECTION_INVOLVED_IN_REPLICATION_FORK_PROCESSING,0.860812259524708
MAGRANGEAS_MULTIPLE_MYELOMA_...3,SET,22,0.19667,0.0068037,0.17566,0.13145,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,0.861501932868188
GSE13485_DAY1_VS_DAY3_YF17D_...2,SET,141,0.084333,0.007362,0.075341,0.1315,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP,0.86166713800905
TARTE_PLASMA_CELL_VS_B_LYMPH...2,SET,75,0.11192,0.0071383,0.10001,0.13157,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,0.861697972341618
GOLDRATH_EFF_VS_MEMORY_CD8_T...2,SET,183,0.069448,0.0068988,0.062062,0.13157,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP,0.861697972341618
BOUDOUKHA_BOUND_BY_IGF2BP2,SET,92,0.097473,0.0068825,0.08712,0.13161,BOUDOUKHA_BOUND_BY_IGF2BP2,0.861697972341618
WP_ACUTE_VIRAL_MYOCARDITIS,SET,82,0.11153,0.0074367,0.099686,0.13162,WP_ACUTE_VIRAL_MYOCARDITIS,0.861697972341618
GOBP_POSITIVE_REGULATION_OF_...456,SET,5,0.50899,0.0083984,0.45498,0.13164,GOBP_POSITIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.861697972341618
VALK_AML_CLUSTER_2,SET,26,0.20969,0.0078853,0.18745,0.13166,VALK_AML_CLUSTER_2,0.861697972341618
AMIT_EGF_RESPONSE_240_HELA,SET,55,0.13302,0.0072695,0.11893,0.1317,AMIT_EGF_RESPONSE_240_HELA,0.861697972341618
GOBP_POSITIVE_REGULATION_OF_...232,SET,4,0.48831,0.0072069,0.43663,0.13171,GOBP_POSITIVE_REGULATION_OF_ENAMEL_MINERALIZATION,0.861697972341618
RAY_TUMORIGENESIS_BY_ERBB2_C...2,SET,176,0.071949,0.0070106,0.064349,0.13177,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,0.861697972341618
HP_ABNORMALITY_OF_THE_SHOULD...,SET,128,0.083091,0.0069136,0.074343,0.13186,HP_ABNORMALITY_OF_THE_SHOULDER_GIRDLE_MUSCULATURE,0.861697972341618
chr22q11,SET,98,0.17536,0.012777,0.1569,0.13187,chr22q11,0.861697972341618
MCCLUNG_COCAIN_REWARD_4WK,SET,68,0.11654,0.0070795,0.10429,0.1319,MCCLUNG_COCAIN_REWARD_4WK,0.861697972341618
JINESH_BLEBBISHIELD_TRANSFOR...1,SET,247,0.060581,0.0069792,0.054215,0.13192,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,0.861697972341618
GOBP_REGULATION_OF_NUCLEOTID...6,SET,80,0.1082,0.0071267,0.096831,0.13192,GOBP_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.861697972341618
HP_ABNORMAL_PERIPHERAL_ACTIO...,SET,37,0.15595,0.006994,0.13957,0.13192,HP_ABNORMAL_PERIPHERAL_ACTION_POTENTIAL_AMPLITUDE,0.861697972341618
HP_THYROTOXICOSIS_WITH_DIFFU...,SET,4,0.52385,0.0077313,0.46886,0.13195,HP_THYROTOXICOSIS_WITH_DIFFUSE_GOITER,0.861697972341618
WP_PHASE_I_BIOTRANSFORMATION...,SET,8,0.40706,0.0084952,0.36438,0.13197,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,0.861697972341618
HP_ABNORMAL_PHAGOCYTOSIS,SET,3,0.55829,0.0071359,0.49977,0.13198,HP_ABNORMAL_PHAGOCYTOSIS,0.861697972341618
HP_ORTHOSTATIC_HYPOTENSION,SET,38,0.16424,0.0074644,0.14702,0.13198,HP_ORTHOSTATIC_HYPOTENSION,0.861697972341618
GOMF_MALATE_DEHYDROGENASE_AC...,SET,8,0.33805,0.0070549,0.30269,0.13204,GOMF_MALATE_DEHYDROGENASE_ACTIVITY,0.861697972341618
KEGG_MEDICUS_REFERENCE_NODAL...,SET,8,0.3292,0.0068704,0.29479,0.13206,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY,0.861697972341618
GCM_PPM1D,SET,23,0.18676,0.0066061,0.16725,0.13207,GCM_PPM1D,0.861697972341618
BIOCARTA_MITOCHONDRIA_PATHWAY,SET,17,0.22721,0.0069106,0.20348,0.13209,BIOCARTA_MITOCHONDRIA_PATHWAY,0.861697972341618
HP_ABNORMAL_LABIA_MAJORA_MOR...,SET,40,0.15218,0.0070955,0.13631,0.13212,HP_ABNORMAL_LABIA_MAJORA_MORPHOLOGY,0.861697972341618
TRAVAGLINI_LUNG_MYOFIBROBLAS...,SET,60,0.13224,0.0075474,0.11846,0.13214,TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL,0.861697972341618
HP_ILEAL_ATRESIA,SET,4,0.50655,0.0074759,0.45385,0.13219,HP_ILEAL_ATRESIA,0.861697972341618
GNF2_CCNA2,SET,64,0.11871,0.0069964,0.10637,0.13222,GNF2_CCNA2,0.861697972341618
GSE42021_CD24HI_VS_CD24LOW_T...2,SET,178,0.072858,0.007139,0.065285,0.13222,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP,0.861697972341618
REACTOME_MATURATION_OF_PROTE...,SET,9,0.32007,0.0070847,0.28687,0.13227,REACTOME_MATURATION_OF_PROTEIN_3A,0.861697972341618
SCHERER_PBMC_APSV_WETVAX_AGE...7,SET,20,0.23228,0.0076623,0.20821,0.1323,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_DN,0.861697972341618
REACTOME_NUCLEAR_IMPORT_OF_R...,SET,32,0.16172,0.0067455,0.14499,0.13236,REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN,0.861697972341618
GOMF_SIGNAL_SEQUENCE_BINDING,SET,43,0.13616,0.0065817,0.1221,0.1324,GOMF_SIGNAL_SEQUENCE_BINDING,0.861697972341618
GOMF_CELL_ADHESION_MEDIATOR_...,SET,63,0.13359,0.007812,0.1198,0.13241,GOMF_CELL_ADHESION_MEDIATOR_ACTIVITY,0.861697972341618
GSE15930_STIM_VS_STIM_AND_IF...1,SET,178,0.07221,0.0070755,0.064758,0.13241,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN,0.861697972341618
GSE32164_ALTERNATIVELY_ACT_M...2,SET,178,0.069094,0.0067702,0.061972,0.13245,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.861697972341618
HP_THICKENED_CORTEX_OF_LONG_...,SET,14,0.26522,0.0073209,0.23789,0.13246,HP_THICKENED_CORTEX_OF_LONG_BONES,0.861697972341618
MARTENS_TRETINOIN_RESPONSE_DN,SET,683,0.036041,0.0068209,0.03233,0.13247,MARTENS_TRETINOIN_RESPONSE_DN,0.861697972341618
GSE11864_UNTREATED_VS_CSF1_I...2,SET,163,0.073523,0.0068967,0.06595,0.13247,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP,0.861697972341618
ZNF407_TARGET_GENES,SET,1551,0.025379,0.0070579,0.022767,0.13249,ZNF407_TARGET_GENES,0.861697972341618
WP_FATTY_ACID_BETAOXIDATION,SET,31,0.17495,0.0071828,0.15698,0.13255,WP_FATTY_ACID_BETAOXIDATION,0.861697972341618
GOBP_NEGATIVE_REGULATION_OF_...25,SET,18,0.22725,0.007112,0.20393,0.13257,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.861697972341618
MADAN_DPPA4_TARGETS,SET,49,0.13772,0.0071052,0.1236,0.13259,MADAN_DPPA4_TARGETS,0.861697972341618
GSE17301_ACD3_ACD28_VS_ACD3_...3,SET,183,0.072758,0.0072276,0.065305,0.13262,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN,0.861697972341618
GSE21063_CTRL_VS_ANTI_IGM_ST...11,SET,174,0.06825,0.0066127,0.061263,0.13264,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN,0.861697972341618
GOBP_MEMBRANE_LIPID_CATABOLI...,SET,44,0.14385,0.0070338,0.12914,0.13265,GOBP_MEMBRANE_LIPID_CATABOLIC_PROCESS,0.861697972341618
GSE12839_CTRL_VS_IL12_TREATE...2,SET,135,0.081173,0.0069349,0.072867,0.13265,GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP,0.861697972341618
DESCARTES_FETAL_EYE_PDE11A_F...,SET,16,0.27541,0.0081268,0.24726,0.13267,DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS,0.861697972341618
PID_NCADHERIN_PATHWAY,SET,33,0.1703,0.0072136,0.15294,0.13275,PID_NCADHERIN_PATHWAY,0.861895432467775
HP_SMALL_EPIPHYSES,SET,20,0.22309,0.007359,0.20034,0.13275,HP_SMALL_EPIPHYSES,0.861895432467775
GOMF_HISTONE_H3_METHYLTRANSF...,SET,40,0.15174,0.0070751,0.13629,0.13278,GOMF_HISTONE_H3_METHYLTRANSFERASE_ACTIVITY,0.861929193126634
E2F_Q4_01,SET,211,0.064208,0.0068436,0.057682,0.13283,E2F_Q4_01,0.862092745098039
GOBP_PROTEIN_LOCALIZATION_TO...12,SET,95,0.090549,0.0064965,0.081377,0.13293,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.862549421317902
MIKKELSEN_MEF_LCP_WITH_H3K27...,SET,61,0.12966,0.0074613,0.11654,0.13295,MIKKELSEN_MEF_LCP_WITH_H3K27ME3,0.862549421317902
GOBP_RENAL_SODIUM_ION_TRANSP...,SET,14,0.2828,0.0078063,0.25428,0.13304,GOBP_RENAL_SODIUM_ION_TRANSPORT,0.862651475227315
GOBP_DETECTION_OF_TEMPERATUR...2,SET,19,0.2272,0.0073052,0.20431,0.13306,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.862651475227315
HP_PROMINENT_CALCANEUS,SET,9,0.32439,0.0071803,0.29181,0.13315,HP_PROMINENT_CALCANEUS,0.862651475227315
GOBP_NEGATIVE_REGULATION_OF_...570,SET,7,0.31418,0.0061335,0.28264,0.13316,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.862651475227315
GOCC_MITOTIC_SPINDLE,SET,167,0.069168,0.0065666,0.062223,0.13316,GOCC_MITOTIC_SPINDLE,0.862651475227315
GOBP_DUMP_METABOLIC_PROCESS,SET,7,0.37646,0.0073494,0.33869,0.13318,GOBP_DUMP_METABOLIC_PROCESS,0.862651475227315
GOBP_REGULATION_OF_SYNAPSE_A...,SET,105,0.10254,0.0077322,0.092278,0.13325,GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY,0.862651475227315
GOMF_BUBBLE_DNA_BINDING,SET,8,0.34732,0.0072485,0.31257,0.13325,GOMF_BUBBLE_DNA_BINDING,0.862651475227315
AUNG_GASTRIC_CANCER,SET,47,0.13425,0.006784,0.12084,0.13328,AUNG_GASTRIC_CANCER,0.862651475227315
ZNF547_TARGET_GENES,SET,263,0.059812,0.0071072,0.053835,0.13329,ZNF547_TARGET_GENES,0.862651475227315
GOBP_UBIQUITIN_DEPENDENT_END...,SET,7,0.33487,0.0065375,0.30142,0.1333,GOBP_UBIQUITIN_DEPENDENT_ENDOCYTOSIS,0.862651475227315
HP_ABNORMALITY_OF_THE_EPIPHY...2,SET,6,0.41327,0.0074696,0.37198,0.1333,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_FEET,0.862651475227315
GARGALOVIC_RESPONSE_TO_OXIDI...17,SET,24,0.20062,0.0072486,0.18063,0.13336,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,0.862651475227315
GOMF_HISTONE_H3K27ME2_H3K27M...,SET,2,0.59265,0.0061852,0.53372,0.13342,GOMF_HISTONE_H3K27ME2_H3K27ME3_DEMETHYLASE_ACTIVITY,0.862651475227315
DER_IFN_ALPHA_RESPONSE_UP,SET,72,0.11212,0.0070074,0.10098,0.13343,DER_IFN_ALPHA_RESPONSE_UP,0.862651475227315
REACTOME_POTASSIUM_CHANNELS,SET,102,0.1051,0.0078121,0.094668,0.13346,REACTOME_POTASSIUM_CHANNELS,0.862651475227315
HP_ANTERIOR_CHAMBER_SYNECHIAE,SET,27,0.20687,0.0079273,0.18637,0.13351,HP_ANTERIOR_CHAMBER_SYNECHIAE,0.862651475227315
KEGG_MEDICUS_PATHOGEN_KSHV_V...6,SET,29,0.19024,0.0075546,0.17139,0.13352,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY,0.862651475227315
LI_WILMS_TUMOR_VS_FETAL_KIDN...2,SET,169,0.076751,0.0073297,0.069158,0.13355,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,0.862651475227315
GOBP_POSITIVE_REGULATION_OF_...376,SET,58,0.13492,0.007571,0.12157,0.13356,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.862651475227315
GOMF_L_ASCORBIC_ACID_BINDING,SET,20,0.20418,0.0067354,0.18403,0.13362,GOMF_L_ASCORBIC_ACID_BINDING,0.862651475227315
MIR16_2_3P,SET,205,0.067302,0.0070718,0.060663,0.13363,MIR16_2_3P,0.862651475227315
GSE14415_NATURAL_TREG_VS_TCO...2,SET,146,0.080615,0.0071602,0.072665,0.13363,GSE14415_NATURAL_TREG_VS_TCONV_UP,0.862651475227315
GOBP_POSITIVE_REGULATION_OF_...604,SET,497,0.044399,0.0072054,0.040026,0.13367,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.862651475227315
GOMF_VASOPRESSIN_RECEPTOR_AC...,SET,6,0.42547,0.0076901,0.38358,0.13368,GOMF_VASOPRESSIN_RECEPTOR_ACTIVITY,0.862651475227315
GOBP_MODIFIED_AMINO_ACID_TRA...,SET,38,0.16331,0.007422,0.14724,0.13369,GOBP_MODIFIED_AMINO_ACID_TRANSPORT,0.862651475227315
GOBP_POSITIVE_REGULATION_OF_...361,SET,20,0.19633,0.0064762,0.17702,0.1337,GOBP_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.862651475227315
PATEL_SKIN_OF_BODY_ZOSTAVAX_...1,SET,25,0.20415,0.0075281,0.18407,0.13371,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP,0.862651475227315
GOCC_MONOATOMIC_ION_CHANNEL_...,SET,319,0.058282,0.0076153,0.052557,0.13374,GOCC_MONOATOMIC_ION_CHANNEL_COMPLEX,0.862651475227315
MIR216A_3P,SET,408,0.049156,0.0072459,0.044329,0.13375,MIR216A_3P,0.862651475227315
GSE17721_12H_VS_24H_PAM3CSK4...1,SET,185,0.068389,0.0068303,0.061674,0.13375,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN,0.862651475227315
GOBP_REGULATION_OF_GLUCOCORT...2,SET,11,0.31786,0.0077779,0.28666,0.13376,GOBP_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.862651475227315
HP_IMPAIRED_GLUCOSE_TOLERANCE,SET,36,0.17264,0.0076372,0.15572,0.1338,HP_IMPAIRED_GLUCOSE_TOLERANCE,0.862749350649351
GOBP_GRANULOCYTE_COLONY_STIM...2,SET,5,0.39075,0.0064474,0.35252,0.13384,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.86283673189466
GSE15324_ELF4_KO_VS_WT_NAIVE...2,SET,181,0.069373,0.0068539,0.062592,0.13387,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP,0.86283673189466
WP_EFFECT_OF_INTESTINAL_MICR...,SET,8,0.3321,0.0069307,0.29967,0.13389,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,0.86283673189466
NIKOLSKY_BREAST_CANCER_10Q22...,SET,8,0.45586,0.0095135,0.41143,0.13394,NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON,0.86283673189466
WP_PHOTODYNAMIC_THERAPYINDUC...5,SET,25,0.19329,0.0071277,0.17451,0.13402,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,0.86283673189466
KEGG_MEDICUS_REFERENCE_CCR_C...,SET,31,0.18758,0.0077014,0.16937,0.13404,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY,0.86283673189466
WP_CELL_DIFFERENTIATION_EXPA...,SET,18,0.24827,0.0077698,0.22416,0.13404,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,0.86283673189466
ACAWNRNSRCGG_UNKNOWN,SET,57,0.12402,0.0068994,0.11198,0.13404,ACAWNRNSRCGG_UNKNOWN,0.86283673189466
PID_FANCONI_PATHWAY,SET,40,0.13092,0.0061043,0.11825,0.13413,PID_FANCONI_PATHWAY,0.86283673189466
GOBP_COBALAMIN_METABOLIC_PRO...,SET,9,0.3295,0.0072934,0.29761,0.13413,GOBP_COBALAMIN_METABOLIC_PROCESS,0.86283673189466
BROWNE_HCMV_INFECTION_4HR_DN,SET,227,0.062468,0.0069029,0.056428,0.13415,BROWNE_HCMV_INFECTION_4HR_DN,0.86283673189466
NOJIMA_SFRP2_TARGETS_DN,SET,23,0.21955,0.0077659,0.19834,0.13417,NOJIMA_SFRP2_TARGETS_DN,0.86283673189466
GSE19772_CTRL_VS_HCMV_INF_MO...3,SET,144,0.078812,0.0069523,0.071216,0.13423,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN,0.86283673189466
GSE6269_E_COLI_VS_STAPH_AURE...1,SET,162,0.07357,0.0068801,0.066483,0.13424,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN,0.86283673189466
XPO1_TARGET_GENES,SET,19,0.2362,0.0075945,0.21348,0.13428,XPO1_TARGET_GENES,0.86283673189466
GOBP_ENDOLYSOSOMAL_TOLL_LIKE...,SET,45,0.13979,0.0069122,0.12634,0.13428,GOBP_ENDOLYSOSOMAL_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.86283673189466
HP_RIDGED_FINGERNAIL,SET,7,0.37678,0.0073555,0.34056,0.1343,HP_RIDGED_FINGERNAIL,0.86283673189466
HP_DARK_URINE,SET,9,0.31022,0.0068668,0.28042,0.13431,HP_DARK_URINE,0.86283673189466
HP_RADIOULNAR_SYNOSTOSIS,SET,68,0.11791,0.0071623,0.10658,0.13432,HP_RADIOULNAR_SYNOSTOSIS,0.86283673189466
GSE24142_EARLY_THYMIC_PROGEN...1,SET,183,0.068945,0.0068489,0.062324,0.13432,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN,0.86283673189466
MIZUKAMI_HYPOXIA_UP,SET,11,0.31417,0.0076876,0.28412,0.13443,MIZUKAMI_HYPOXIA_UP,0.86283673189466
MIR3187_5P,SET,109,0.087718,0.0067386,0.079341,0.13446,MIR3187_5P,0.86283673189466
XU_GH1_EXOGENOUS_TARGETS_DN,SET,90,0.099335,0.0069378,0.089861,0.1345,XU_GH1_EXOGENOUS_TARGETS_DN,0.86283673189466
GSE9006_HEALTHY_VS_TYPE_1_DI...2,SET,179,0.067327,0.0066153,0.060945,0.13465,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP,0.86283673189466
MIR12114,SET,37,0.1525,0.0068389,0.13806,0.13467,MIR12114,0.86283673189466
GSE8678_IL7R_LOW_VS_HIGH_EFF...2,SET,183,0.069532,0.0069071,0.062947,0.13467,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP,0.86283673189466
SOX3_TARGET_GENES,SET,413,0.047326,0.0070177,0.042845,0.13468,SOX3_TARGET_GENES,0.86283673189466
GOBP_GTP_METABOLIC_PROCESS,SET,22,0.20496,0.0070906,0.18557,0.1347,GOBP_GTP_METABOLIC_PROCESS,0.86283673189466
MIR184,SET,7,0.35701,0.0069697,0.32329,0.13474,MIR184,0.86283673189466
GOBP_NEGATIVE_REGULATION_OF_...601,SET,22,0.21403,0.0074045,0.19382,0.13474,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.86283673189466
MIR101_5P,SET,37,0.15003,0.0067285,0.13587,0.13476,MIR101_5P,0.86283673189466
GOBP_CELLULAR_RESPONSE_TO_UV,SET,81,0.10116,0.0067043,0.091649,0.13485,GOBP_CELLULAR_RESPONSE_TO_UV,0.86283673189466
RPS14_DN.V1_DN,SET,167,0.07056,0.0066988,0.063926,0.13485,RPS14_DN.V1_DN,0.86283673189466
HP_DISTURBANCE_OF_FACIAL_EXP...,SET,40,0.14723,0.0068644,0.1334,0.13487,HP_DISTURBANCE_OF_FACIAL_EXPRESSION,0.86283673189466
HP_IRON_ACCUMULATION_IN_BRAIN,SET,14,0.2432,0.0067131,0.22038,0.1349,HP_IRON_ACCUMULATION_IN_BRAIN,0.86283673189466
GOBP_CD8_POSITIVE_ALPHA_BETA...3,SET,7,0.36831,0.0071902,0.33377,0.13491,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.86283673189466
HP_PITUITARY_ADENOMA,SET,51,0.12591,0.006627,0.11411,0.13492,HP_PITUITARY_ADENOMA,0.86283673189466
GOBP_POSITIVE_REGULATION_OF_...841,SET,60,0.11635,0.0066403,0.10546,0.13496,GOBP_POSITIVE_REGULATION_OF_VIRAL_PROCESS,0.86283673189466
MAINA_HYPOXIA_VHL_TARGETS_UP,SET,6,0.47188,0.0085289,0.42771,0.13497,MAINA_HYPOXIA_VHL_TARGETS_UP,0.86283673189466
GSE1460_INTRATHYMIC_T_PROGEN...9,SET,174,0.076228,0.0073856,0.069094,0.13497,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN,0.86283673189466
GSE2770_IL12_VS_IL4_TREATED_...1,SET,151,0.079344,0.0071659,0.071929,0.135,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.86283673189466
GOMF_IMMUNOGLOBULIN_BINDING,SET,25,0.20068,0.0074003,0.18196,0.13505,GOMF_IMMUNOGLOBULIN_BINDING,0.86283673189466
WATANABE_ULCERATIVE_COLITIS_...2,SET,17,0.23093,0.0070237,0.20942,0.13508,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,0.86283673189466
SOTIRIOU_BREAST_CANCER_GRADE...1,SET,48,0.12997,0.0066371,0.11789,0.13513,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,0.86283673189466
MODULE_568,SET,62,0.116,0.0067294,0.10524,0.13518,MODULE_568,0.86283673189466
PEART_HDAC_PROLIFERATION_CLU...2,SET,51,0.13623,0.0071697,0.1236,0.13522,PEART_HDAC_PROLIFERATION_CLUSTER_UP,0.86283673189466
GSE6269_HEALTHY_VS_STAPH_AUR...1,SET,145,0.078446,0.0069438,0.071181,0.13523,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN,0.86283673189466
MODULE_400,SET,18,0.23831,0.0074583,0.21627,0.13525,MODULE_400,0.86283673189466
GOMF_PEPTIDASE_ACTIVITY,SET,534,0.041985,0.0070554,0.038102,0.13525,GOMF_PEPTIDASE_ACTIVITY,0.86283673189466
MPHOSPH8_TARGET_GENES,SET,7,0.37031,0.0072292,0.33621,0.13536,MPHOSPH8_TARGET_GENES,0.86283673189466
HP_ECTROPION,SET,58,0.11057,0.0062046,0.10038,0.13536,HP_ECTROPION,0.86283673189466
ACGCACA_MIR210,SET,8,0.31381,0.0065491,0.28494,0.13539,ACGCACA_MIR210,0.86283673189466
GOBP_PIGMENT_CELL_DIFFERENTI...,SET,34,0.17592,0.0075632,0.15974,0.13539,GOBP_PIGMENT_CELL_DIFFERENTIATION,0.86283673189466
WP_FOXP3_IN_COVID19,SET,13,0.31794,0.0084572,0.28871,0.1354,WP_FOXP3_IN_COVID19,0.86283673189466
GOBP_UTERUS_DEVELOPMENT,SET,25,0.19855,0.0073216,0.18032,0.13543,GOBP_UTERUS_DEVELOPMENT,0.86283673189466
REACTOME_HIV_TRANSCRIPTION_E...,SET,38,0.13045,0.0059286,0.11847,0.13544,REACTOME_HIV_TRANSCRIPTION_ELONGATION,0.86283673189466
BIOCARTA_PITX2_PATHWAY,SET,15,0.2391,0.0068316,0.21717,0.13545,BIOCARTA_PITX2_PATHWAY,0.86283673189466
GOBP_VASCULAR_ASSOCIATED_SMO...5,SET,57,0.13003,0.007234,0.1181,0.13545,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.86283673189466
GSE22601_CD4_SINGLE_POSITIVE...1,SET,180,0.066027,0.0065055,0.059968,0.13545,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.86283673189466
PID_IL23_PATHWAY,SET,37,0.17548,0.0078694,0.15938,0.13546,PID_IL23_PATHWAY,0.86283673189466
WP_TLR4_SIGNALING_AND_TOLERA...,SET,26,0.17757,0.0066774,0.16128,0.13546,WP_TLR4_SIGNALING_AND_TOLERANCE,0.86283673189466
KEGG_TIGHT_JUNCTION,SET,125,0.087667,0.0072089,0.079634,0.13548,KEGG_TIGHT_JUNCTION,0.86283673189466
GOBP_COLUMNAR_CUBOIDAL_EPITH...3,SET,14,0.26307,0.0072617,0.23896,0.13548,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION,0.86283673189466
GOBP_MITOTIC_RECOMBINATION,SET,24,0.16648,0.0060153,0.15123,0.13549,GOBP_MITOTIC_RECOMBINATION,0.86283673189466
GOBP_ENDOPLASMIC_RETICULUM_O...,SET,84,0.097043,0.006549,0.088163,0.13552,GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION,0.86283673189466
KAMMINGA_EZH2_TARGETS,SET,40,0.1422,0.00663,0.1292,0.13553,KAMMINGA_EZH2_TARGETS,0.86283673189466
GSE26030_TH1_VS_TH17_DAY5_PO...2,SET,183,0.069681,0.006922,0.06331,0.13554,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP,0.86283673189466
MIR376A_5P,SET,56,0.12835,0.0070775,0.11664,0.1356,MIR376A_5P,0.86283673189466
MODULE_44,SET,290,0.059061,0.0073639,0.053677,0.13561,MODULE_44,0.86283673189466
GOBP_NEGATIVE_REGULATION_OF_...173,SET,6,0.38964,0.0070426,0.35414,0.13562,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.86283673189466
GOBP_N_ACYLPHOSPHATIDYLETHAN...,SET,4,0.48743,0.0071938,0.44302,0.13562,GOBP_N_ACYLPHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.86283673189466
GOMF_TYPE_I_TRANSFORMING_GRO...,SET,11,0.31632,0.0077402,0.28755,0.13567,GOMF_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.86283673189466
GOBP_ENDOCARDIAL_CUSHION_FUS...,SET,4,0.57171,0.0084377,0.51976,0.13568,GOBP_ENDOCARDIAL_CUSHION_FUSION,0.86283673189466
GOMF_NFAT_PROTEIN_BINDING,SET,5,0.39087,0.0064494,0.35536,0.13569,GOMF_NFAT_PROTEIN_BINDING,0.86283673189466
CYTAGCAAY_UNKNOWN,SET,135,0.078921,0.0067425,0.071753,0.1357,CYTAGCAAY_UNKNOWN,0.86283673189466
GOBP_SPINAL_CORD_MOTOR_NEURO...1,SET,9,0.31777,0.0070339,0.28894,0.13572,GOBP_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION,0.86283673189466
GOMF_5S_RRNA_BINDING,SET,8,0.32828,0.006851,0.29852,0.13574,GOMF_5S_RRNA_BINDING,0.86283673189466
HP_RECURRENT_ASPERGILLUS_INF...,SET,22,0.21113,0.007304,0.19199,0.13575,HP_RECURRENT_ASPERGILLUS_INFECTIONS,0.86283673189466
GSE27859_DC_VS_CD11C_INT_F48...3,SET,183,0.06467,0.0064241,0.058825,0.13582,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN,0.862998857612868
MIR5001_3P,SET,139,0.079132,0.0068592,0.071988,0.13584,MIR5001_3P,0.862998857612868
GSE17721_POLYIC_VS_PAM3CSK4_...11,SET,186,0.070121,0.0070219,0.063793,0.13585,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN,0.862998857612868
GOBP_CELLULAR_RESPONSE_TO_MA...1,SET,13,0.30188,0.0080299,0.2747,0.1359,GOBP_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.863024522292994
KEGG_STARCH_AND_SUCROSE_META...,SET,45,0.1569,0.0077584,0.14281,0.13596,KEGG_STARCH_AND_SUCROSE_METABOLISM,0.863024522292994
BIDUS_METASTASIS_DN,SET,131,0.082586,0.0069511,0.075188,0.13602,BIDUS_METASTASIS_DN,0.863024522292994
GSE8921_UNSTIM_0H_VS_TLR1_2_...3,SET,184,0.068561,0.0068291,0.062419,0.13602,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN,0.863024522292994
GOBP_POSITIVE_REGULATION_OF_...237,SET,16,0.23904,0.0070534,0.21764,0.13604,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.863024522292994
CREB_Q4_01,SET,191,0.069393,0.0070409,0.063206,0.13613,CREB_Q4_01,0.863024522292994
GOBP_NEGATIVE_REGULATION_OF_...49,SET,31,0.17394,0.0071414,0.15843,0.13613,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.863024522292994
SCIAN_INVERSED_TARGETS_OF_TP...1,SET,25,0.18918,0.0069761,0.17233,0.13616,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,0.863024522292994
GOBP_OLIGOSACCHARIDE_LIPID_I...,SET,20,0.18188,0.0059995,0.16568,0.13617,GOBP_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS,0.863024522292994
GSE3203_INFLUENZA_INF_VS_IFN...1,SET,172,0.072532,0.0069874,0.066074,0.13617,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN,0.863024522292994
GNF2_JAK1,SET,30,0.16191,0.0065393,0.14752,0.13622,GNF2_JAK1,0.863024522292994
GOBP_REGULATION_OF_ACYL_COA_...,SET,4,0.51601,0.0076156,0.4702,0.13624,GOBP_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS,0.863024522292994
GSE21774_CD56_BRIGHT_VS_DIM_...1,SET,178,0.069946,0.0068536,0.063736,0.13624,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN,0.863024522292994
HP_PROTRACTED_DIARRHEA,SET,13,0.26801,0.0071292,0.24424,0.13625,HP_PROTRACTED_DIARRHEA,0.863024522292994
KEGG_MEDICUS_REFERENCE_BASE_...2,SET,8,0.30234,0.0063098,0.27555,0.13627,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE,0.863024522292994
GSE22886_DAY0_VS_DAY1_MONOCY...2,SET,183,0.07141,0.0070937,0.065079,0.13627,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP,0.863024522292994
HP_ABNORMALITY_OF_THE_TEMPOR...,SET,18,0.23896,0.0074785,0.21781,0.1363,HP_ABNORMALITY_OF_THE_TEMPOROMANDIBULAR_JOINT,0.863024522292994
MIR450A_2_3P,SET,114,0.08797,0.0069103,0.080196,0.13634,MIR450A_2_3P,0.863024522292994
GSE17974_IL4_AND_ANTI_IL12_V...3,SET,168,0.076211,0.0072567,0.069489,0.13639,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN,0.863024522292994
GOBP_KIDNEY_EPITHELIUM_DEVEL...,SET,143,0.086928,0.0076418,0.07927,0.13641,GOBP_KIDNEY_EPITHELIUM_DEVELOPMENT,0.863024522292994
RYTAAWNNNTGAY_UNKNOWN,SET,55,0.13099,0.0071584,0.11946,0.13643,RYTAAWNNNTGAY_UNKNOWN,0.863024522292994
MIR940,SET,164,0.073958,0.0069587,0.06745,0.13644,MIR940,0.863024522292994
GOMF_CALCIUM_INDEPENDENT_PHO...,SET,9,0.30079,0.0066579,0.27432,0.13645,GOMF_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,0.863024522292994
GSE14415_TCONV_VS_FOXP3_KO_I...2,SET,151,0.075479,0.0068169,0.068841,0.13645,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP,0.863024522292994
GOBP_NITROGEN_UTILIZATION,SET,5,0.41788,0.0068952,0.38123,0.13651,GOBP_NITROGEN_UTILIZATION,0.863246915938865
HP_DECREASED_SPECIFIC_ANTI_P...,SET,7,0.38568,0.0075293,0.352,0.13662,HP_DECREASED_SPECIFIC_ANTI_POLYSACCHARIDE_ANTIBODY_LEVEL,0.863475122660367
GSE21774_CD56_BRIGHT_VS_DIM_...2,SET,176,0.073867,0.0071975,0.067418,0.13662,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP,0.863475122660367
HP_DECREASED_LYMPHOCYTE_PROL...1,SET,9,0.35712,0.0079049,0.32596,0.13663,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_ANTI_CD3,0.863475122660367
TBX3_TARGET_GENES,SET,627,0.037838,0.006872,0.034539,0.13665,TBX3_TARGET_GENES,0.863475122660367
GSE360_L_MAJOR_VS_M_TUBERCUL...2,SET,167,0.073247,0.0069539,0.06687,0.13669,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP,0.863475122660367
GOBP_NEGATIVE_REGULATION_OF_...476,SET,7,0.41422,0.0080865,0.37818,0.1367,GOBP_NEGATIVE_REGULATION_OF_P38MAPK_CASCADE,0.863475122660367
GOBP_MRNA_5_SPLICE_SITE_RECO...,SET,6,0.31358,0.0056679,0.28633,0.13672,GOBP_MRNA_5_SPLICE_SITE_RECOGNITION,0.863475122660367
GOBP_RESPONSE_TO_BILE_ACID,SET,7,0.38293,0.0074757,0.34976,0.1368,GOBP_RESPONSE_TO_BILE_ACID,0.863563374932176
WP_PERTURBATIONS_TO_HOSTCELL...,SET,42,0.14231,0.0067988,0.13001,0.13685,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,0.863563374932176
BIOCARTA_HDAC_PATHWAY,SET,25,0.19512,0.0071952,0.17826,0.13686,BIOCARTA_HDAC_PATHWAY,0.863563374932176
HP_ABNORMAL_NUMBER_OF_GRANUL...,SET,9,0.31561,0.0069861,0.28843,0.13693,HP_ABNORMAL_NUMBER_OF_GRANULOCYTE_PRECURSORS,0.863563374932176
MEINHOLD_OVARIAN_CANCER_LOW_...1,SET,19,0.2122,0.0068228,0.19394,0.13695,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,0.863563374932176
TERAMOTO_OPN_TARGETS_CLUSTER...3,SET,13,0.22748,0.0060509,0.20792,0.13697,TERAMOTO_OPN_TARGETS_CLUSTER_4,0.863563374932176
GOBP_NEGATIVE_REGULATION_OF_...60,SET,7,0.36892,0.0072021,0.33722,0.13699,GOBP_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.863563374932176
GOBP_POSITIVE_REGULATION_OF_...588,SET,15,0.24643,0.0070407,0.22526,0.13699,GOBP_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.863563374932176
GOMF_FOUR_WAY_JUNCTION_HELIC...,SET,6,0.4102,0.0074141,0.375,0.13702,GOMF_FOUR_WAY_JUNCTION_HELICASE_ACTIVITY,0.863563374932176
GOBP_EYE_PHOTORECEPTOR_CELL_...2,SET,49,0.13962,0.0072032,0.12765,0.13703,GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.863563374932176
MEF2_01,SET,137,0.082648,0.0071126,0.075565,0.13704,MEF2_01,0.863563374932176
GOBP_COLLAGEN_CATABOLIC_PROC...,SET,39,0.16995,0.0078244,0.15539,0.13705,GOBP_COLLAGEN_CATABOLIC_PROCESS,0.863563374932176
GOBP_ORGANELLE_MEMBRANE_FUSI...,SET,114,0.085568,0.0067216,0.078244,0.13707,GOBP_ORGANELLE_MEMBRANE_FUSION,0.863563374932176
GOBP_NEGATIVE_REGULATION_OF_...374,SET,139,0.079946,0.0069298,0.073122,0.13713,GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE,0.863563374932176
GSE5589_WT_VS_IL10_KO_LPS_AN...2,SET,140,0.076199,0.0066285,0.069693,0.13713,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.863563374932176
KEGG_MEDICUS_REFERENCE_CGAS_...,SET,13,0.33519,0.0089162,0.30663,0.13717,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY,0.863563374932176
MIR7159_3P,SET,199,0.068038,0.0070449,0.062242,0.13718,MIR7159_3P,0.863563374932176
GOBP_NUCLEAR_EXPORT,SET,153,0.070397,0.0063995,0.06441,0.13721,GOBP_NUCLEAR_EXPORT,0.863563374932176
GOBP_REGULATION_OF_OPSONIZAT...,SET,10,0.35641,0.0083157,0.32621,0.13729,GOBP_REGULATION_OF_OPSONIZATION,0.863563374932176
GSE3982_DC_VS_NKCELL_UP,SET,181,0.072625,0.0071753,0.06647,0.13729,GSE3982_DC_VS_NKCELL_UP,0.863563374932176
GOCC_AGGRESOME,SET,30,0.16789,0.0067811,0.15367,0.1373,GOCC_AGGRESOME,0.863563374932176
KEGG_MEDICUS_REFERENCE_ATR_P...,SET,8,0.2687,0.0056077,0.24595,0.13731,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M,0.863563374932176
GOMF_TELOMERASE_RNA_BINDING,SET,20,0.19867,0.0065536,0.18186,0.13733,GOMF_TELOMERASE_RNA_BINDING,0.863563374932176
WILSON_PROTEASES_AT_TUMOR_BO...1,SET,5,0.473,0.0078046,0.43304,0.13736,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN,0.863563374932176
HP_PAPILLEDEMA,SET,26,0.18461,0.0069424,0.16902,0.13737,HP_PAPILLEDEMA,0.863563374932176
GOBP_PEPTIDYL_CYSTEINE_MODIF...,SET,39,0.15271,0.0070307,0.13982,0.13738,GOBP_PEPTIDYL_CYSTEINE_MODIFICATION,0.863563374932176
HP_MESANGIAL_HYPERCELLULARITY,SET,5,0.39667,0.0065452,0.36325,0.13742,HP_MESANGIAL_HYPERCELLULARITY,0.863628132344965
MIR6819_3P,SET,32,0.16478,0.0068731,0.1509,0.13744,MIR6819_3P,0.863628132344965
HP_ABNORMAL_VESTIBULAR_FUNCT...,SET,193,0.069087,0.007046,0.063298,0.13754,HP_ABNORMAL_VESTIBULAR_FUNCTION,0.86391358872425
GOBP_REGULATION_OF_NATURAL_K...6,SET,12,0.31025,0.007929,0.28426,0.13756,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.86391358872425
GSE15330_LYMPHOID_MULTIPOTEN...2,SET,187,0.067493,0.0067767,0.061842,0.13756,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.86391358872425
RHEIN_ALL_GLUCOCORTICOID_THE...1,SET,324,0.051254,0.0067484,0.046984,0.13767,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,0.864354841040462
GSE43863_TFH_VS_LY6C_INT_CXC...1,SET,181,0.07253,0.0071659,0.06649,0.13768,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.864354841040462
BIOCARTA_NPP1_PATHWAY,SET,8,0.37458,0.0078174,0.34351,0.13776,BIOCARTA_NPP1_PATHWAY,0.86445778799351
GOBP_NEGATIVE_REGULATION_OF_...77,SET,8,0.32661,0.0068162,0.29955,0.13779,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.86445778799351
WP_GLUCURONIDATION,SET,24,0.26683,0.0096409,0.24474,0.13781,WP_GLUCURONIDATION,0.86445778799351
GOBP_REGULATION_OF_NEUTROPHI...1,SET,5,0.46072,0.007602,0.42266,0.13785,GOBP_REGULATION_OF_NEUTROPHIL_ACTIVATION,0.86445778799351
GOCC_SYNAPSE_ASSOCIATED_EXTR...,SET,12,0.27894,0.0071288,0.25589,0.13785,GOCC_SYNAPSE_ASSOCIATED_EXTRACELLULAR_MATRIX,0.86445778799351
BIOCARTA_NGF_PATHWAY,SET,19,0.2159,0.0069417,0.1981,0.1379,BIOCARTA_NGF_PATHWAY,0.86445778799351
HP_HERPES_SIMPLEX_ENCEPHALIT...,SET,9,0.30974,0.0068561,0.28421,0.1379,HP_HERPES_SIMPLEX_ENCEPHALITIS,0.86445778799351
MIR644A,SET,56,0.12435,0.006857,0.11411,0.13792,MIR644A,0.86445778799351
HP_DIARRHEA,SET,362,0.049921,0.0069403,0.045816,0.13795,HP_DIARRHEA,0.86445778799351
GSE41978_WT_VS_ID2_KO_KLRG1_...1,SET,190,0.069708,0.0070545,0.063975,0.13795,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.86445778799351
MIR4457,SET,112,0.088444,0.0068867,0.081176,0.13797,MIR4457,0.86445778799351
GOMF_RNA_POLYMERASE_CORE_ENZ...,SET,40,0.15112,0.007046,0.13873,0.13801,GOMF_RNA_POLYMERASE_CORE_ENZYME_BINDING,0.864464149414941
WP_APOE_AND_MIR146_IN_INFLAM...,SET,6,0.37864,0.0068438,0.34764,0.13804,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.864464149414941
GOMF_HISTONE_BINDING,SET,204,0.063661,0.006673,0.058455,0.13807,GOMF_HISTONE_BINDING,0.864464149414941
GSE360_L_MAJOR_VS_B_MALAYI_L...2,SET,177,0.068911,0.0067334,0.063278,0.13808,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP,0.864464149414941
GSE17721_PAM3CSK4_VS_GADIQUI...8,SET,181,0.072685,0.0071812,0.066748,0.1381,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP,0.864464149414941
REACTOME_SUMOYLATION_OF_UBIQ...,SET,37,0.14697,0.0065911,0.13499,0.13813,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,0.864464149414941
GOMF_PROTEIN_TYROSINE_KINASE...2,SET,140,0.084808,0.0073774,0.077903,0.13816,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.864464149414941
GOBP_REGULATION_OF_SEROTONIN...,SET,6,0.40118,0.0072512,0.36853,0.13817,GOBP_REGULATION_OF_SEROTONIN_SECRETION,0.864464149414941
GSE27896_HDAC6_KO_VS_WT_TREG...1,SET,150,0.074499,0.0067062,0.068443,0.1382,GSE27896_HDAC6_KO_VS_WT_TREG_DN,0.864496220302376
GOCC_SMALL_SUBUNIT_PROCESSOME,SET,63,0.11113,0.0064986,0.10215,0.13832,GOCC_SMALL_SUBUNIT_PROCESSOME,0.864904964921749
chr1p33,SET,28,0.29097,0.011354,0.26747,0.13834,chr1p33,0.864904964921749
SPIELMAN_LYMPHOBLAST_EUROPEA...3,SET,545,0.038851,0.0065935,0.035714,0.13834,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,0.864904964921749
GOCC_CILIARY_BASE,SET,35,0.15534,0.0067757,0.14283,0.1384,GOCC_CILIARY_BASE,0.865000836030205
GOMF_POTASSIUM_CHANNEL_ACTIV...2,SET,122,0.092953,0.007552,0.085477,0.13842,GOMF_POTASSIUM_CHANNEL_ACTIVITY,0.865000836030205
PID_CD8_TCR_PATHWAY,SET,51,0.12519,0.006589,0.11513,0.13843,PID_CD8_TCR_PATHWAY,0.865000836030205
TRAVAGLINI_LUNG_GOBLET_CELL,SET,138,0.082806,0.007152,0.076163,0.13848,TRAVAGLINI_LUNG_GOBLET_CELL,0.865103381165919
NAKAYA_B_CELL_FLUARIX_FLUVIR...1,SET,261,0.054027,0.0063957,0.049701,0.13851,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.865103381165919
GSE28737_BCL6_HET_VS_BCL6_KO...3,SET,186,0.065619,0.0065711,0.060367,0.13853,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.865103381165919
PRDM4_TARGET_GENES,SET,467,0.044124,0.0069471,0.040596,0.13855,PRDM4_TARGET_GENES,0.865103381165919
MIR4261,SET,387,0.04851,0.0069682,0.044637,0.13858,MIR4261,0.865103381165919
HP_HISTIOCYTOSIS,SET,6,0.40197,0.0072654,0.36993,0.13862,HP_HISTIOCYTOSIS,0.865103381165919
HP_UPPER_LIMB_ASYMMETRY,SET,10,0.31896,0.007442,0.29357,0.13863,HP_UPPER_LIMB_ASYMMETRY,0.865103381165919
GSE34205_HEALTHY_VS_RSV_INF_...1,SET,170,0.072661,0.0069593,0.066882,0.13866,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN,0.865103381165919
REACTOME_FCGR3A_MEDIATED_IL1...,SET,37,0.16068,0.0072059,0.14793,0.1387,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,0.865103381165919
GSE18804_SPLEEN_MACROPHAGE_V...6,SET,170,0.07215,0.0069104,0.066426,0.13871,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP,0.865103381165919
GOMF_PROTEIN_ARGININE_OMEGA_...2,SET,5,0.3985,0.0065754,0.36693,0.13873,GOMF_PROTEIN_ARGININE_OMEGA_N_MONOMETHYLTRANSFERASE_ACTIVITY,0.865103381165919
PEDRIOLI_MIR31_TARGETS_DN,SET,367,0.050191,0.0070249,0.046217,0.13875,PEDRIOLI_MIR31_TARGETS_DN,0.865103381165919
GSE13887_HEALTHY_VS_LUPUS_RE...1,SET,114,0.084236,0.006617,0.077572,0.13877,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN,0.865103381165919
GOBP_REGULATION_OF_FAT_CELL_...1,SET,121,0.090742,0.0073422,0.083574,0.1388,GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.865135222381636
GOBP_POSITIVE_REGULATION_OF_...624,SET,7,0.37153,0.0072532,0.34223,0.13883,GOBP_POSITIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.865167052178591
REACTOME_APOPTOTIC_CLEAVAGE_...1,SET,35,0.15802,0.0068928,0.14559,0.13888,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,0.865323485120115
HP_INTERMITTENT_THROMBOCYTOP...,SET,4,0.49868,0.0073598,0.45961,0.13897,HP_INTERMITTENT_THROMBOCYTOPENIA,0.865485936661299
GOBP_TONIC_SMOOTH_MUSCLE_CON...,SET,11,0.33551,0.0082098,0.30924,0.13898,GOBP_TONIC_SMOOTH_MUSCLE_CONTRACTION,0.865485936661299
GSE2585_CTEC_VS_THYMIC_MACRO...1,SET,187,0.065088,0.0065352,0.059997,0.139,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN,0.865485936661299
KEGG_MEDICUS_REFERENCE_AUTOP...7,SET,5,0.46002,0.0075904,0.42408,0.13903,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2,0.865485936661299
GSE21063_WT_VS_NFATC1_KO_8H_...1,SET,180,0.066993,0.0066007,0.061779,0.1391,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN,0.865485936661299
GOBP_DIADENOSINE_POLYPHOSPHA...1,SET,3,0.58686,0.0075011,0.54126,0.13913,GOBP_DIADENOSINE_POLYPHOSPHATE_CATABOLIC_PROCESS,0.865485936661299
GOBP_DIADENOSINE_POLYPHOSPHA...2,SET,3,0.58686,0.0075011,0.54126,0.13913,GOBP_DIADENOSINE_POLYPHOSPHATE_METABOLIC_PROCESS,0.865485936661299
GSE9946_IMMATURE_VS_MATURE_S...1,SET,124,0.085495,0.0070024,0.078849,0.13913,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN,0.865485936661299
GSE3039_NKT_CELL_VS_ALPHABET...2,SET,182,0.066832,0.006621,0.061642,0.13915,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP,0.865485936661299
HP_ADRENOCORTICOTROPIN_DEFIC...,SET,6,0.37032,0.0066934,0.34159,0.13917,HP_ADRENOCORTICOTROPIN_DEFICIENT_ADRENAL_INSUFFICIENCY,0.865485936661299
GOMF_PROTEIN_TRANSPORTER_ACT...,SET,36,0.15724,0.0069557,0.14504,0.13918,GOMF_PROTEIN_TRANSPORTER_ACTIVITY,0.865485936661299
MIR4311,SET,325,0.051117,0.0067405,0.047167,0.13925,MIR4311,0.865735798604901
HP_ARM_DYSTONIA,SET,12,0.26087,0.0066671,0.24073,0.13927,HP_ARM_DYSTONIA,0.865735798604901
KANG_IMMORTALIZED_BY_TERT_UP,SET,82,0.10829,0.0072206,0.09994,0.1393,KANG_IMMORTALIZED_BY_TERT_UP,0.865767435622318
GOBP_RESPONSE_TO_ACTIVITY,SET,72,0.11413,0.0071333,0.10537,0.13937,GOBP_RESPONSE_TO_ACTIVITY,0.865930711610487
MIR1264,SET,109,0.086881,0.0066743,0.080217,0.13939,MIR1264,0.865930711610487
GSE14415_FOXP3_KO_NATURAL_TR...1,SET,158,0.075093,0.0069361,0.069352,0.13946,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN,0.865930711610487
GRAHAM_CML_DIVIDING_VS_NORMA...2,SET,9,0.30965,0.0068541,0.286,0.13948,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,0.865930711610487
HP_APLASIA_OF_THE_NASAL_BONE,SET,5,0.51766,0.0085416,0.47814,0.13948,HP_APLASIA_OF_THE_NASAL_BONE,0.865930711610487
HP_KINETIC_TREMOR,SET,90,0.094079,0.0065707,0.086905,0.13951,HP_KINETIC_TREMOR,0.865930711610487
GSE22886_NAIVE_CD8_TCELL_VS_...7,SET,171,0.078042,0.0074965,0.072095,0.13952,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN,0.865930711610487
GOBP_ANDROGEN_CATABOLIC_PROC...,SET,5,0.42795,0.0070613,0.39535,0.13953,GOBP_ANDROGEN_CATABOLIC_PROCESS,0.865930711610487
MORF_BCL2,SET,208,0.064479,0.006824,0.059576,0.13957,MORF_BCL2,0.865930711610487
TURASHVILI_BREAST_DUCTAL_CAR...4,SET,71,0.11005,0.0068306,0.10172,0.13964,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,0.865930711610487
GOBP_NEGATIVE_REGULATION_OF_...546,SET,21,0.21843,0.0073832,0.20191,0.13967,GOBP_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.865930711610487
GOBP_REGULATION_OF_OSTEOBLAS...1,SET,116,0.093871,0.0074379,0.086771,0.13967,GOBP_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.865930711610487
HP_APLASTIC_HYPOPLASTIC_LACR...,SET,8,0.36032,0.0075197,0.33308,0.13969,HP_APLASTIC_HYPOPLASTIC_LACRIMAL_GLANDS,0.865930711610487
HP_PROGRESSIVE_CEREBELLAR_AT...,SET,57,0.11836,0.0065845,0.10941,0.13969,HP_PROGRESSIVE_CEREBELLAR_ATAXIA,0.865930711610487
GSE3982_EFF_MEMORY_VS_CENT_M...1,SET,172,0.069192,0.0066656,0.063966,0.1397,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN,0.865930711610487
GOCC_SIN3_TYPE_COMPLEX,SET,19,0.21764,0.0069976,0.20126,0.13977,GOCC_SIN3_TYPE_COMPLEX,0.866090144230769
REACTOME_TRANSCRIPTION_OF_TH...,SET,62,0.10225,0.005932,0.094564,0.13979,REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,0.866090144230769
GOBP_POTASSIUM_ION_HOMEOSTAS...,SET,34,0.16604,0.0071386,0.15358,0.13982,GOBP_POTASSIUM_ION_HOMEOSTASIS,0.866090144230769
REACTOME_STAT3_NUCLEAR_EVENT...,SET,10,0.33889,0.0079069,0.31346,0.13983,REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING,0.866090144230769
HP_ASYMMETRY_OF_THE_EARS,SET,4,0.40467,0.0059723,0.37442,0.13991,HP_ASYMMETRY_OF_THE_EARS,0.866090144230769
GOBP_HAIR_CYCLE_PHASE,SET,9,0.32855,0.0072725,0.30402,0.13993,GOBP_HAIR_CYCLE_PHASE,0.866090144230769
GSE43863_NAIVE_VS_MEMORY_LY6...2,SET,174,0.07024,0.0068054,0.064999,0.13994,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP,0.866090144230769
NFE2_01,SET,237,0.0611,0.006897,0.056543,0.13995,NFE2_01,0.866090144230769
HP_ELEVATED_URINARY_COLLAGEN...,SET,5,0.41482,0.0068446,0.38389,0.13995,HP_ELEVATED_URINARY_COLLAGEN_DEGRADATION_PRODUCTS,0.866090144230769
HP_CEREBELLAR_VERMIS_ATROPHY,SET,49,0.12878,0.0066441,0.11919,0.13998,HP_CEREBELLAR_VERMIS_ATROPHY,0.86612157735446
GSE21360_NAIVE_VS_SECONDARY_...2,SET,172,0.073545,0.007085,0.068085,0.14004,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.866185367372354
MODULE_209,SET,81,0.10802,0.0071591,0.10001,0.14005,MODULE_209,0.866185367372354
GNF2_SPINK1,SET,24,0.21731,0.0078516,0.20121,0.14008,GNF2_SPINK1,0.866185367372354
MIR519D_5P,SET,220,0.060897,0.006626,0.056389,0.14009,MIR519D_5P,0.866185367372354
GOBP_PLATELET_DERIVED_GROWTH...3,SET,53,0.13415,0.0071973,0.12428,0.1402,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.866680793170905
GOBP_PANCREAS_DEVELOPMENT,SET,74,0.11517,0.0072973,0.10671,0.14022,GOBP_PANCREAS_DEVELOPMENT,0.866680793170905
HP_INAPPROPRIATE_LAUGHTER,SET,27,0.18221,0.0069822,0.16885,0.14028,HP_INAPPROPRIATE_LAUGHTER,0.866782786599197
GOBP_BILE_ACID_SIGNALING_PAT...,SET,11,0.29078,0.0071154,0.2696,0.1404,GOBP_BILE_ACID_SIGNALING_PATHWAY,0.866782786599197
HP_ABNORMAL_EARLOBE_MORPHOLO...,SET,107,0.088611,0.0067448,0.0822,0.14053,HP_ABNORMAL_EARLOBE_MORPHOLOGY,0.866782786599197
HARALAMBIEVA_PBMC_FLUARIX_AG...8,SET,555,0.036313,0.0062174,0.033694,0.14058,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE,0.866782786599197
DOANE_BREAST_CANCER_ESR1_DN,SET,42,0.16015,0.0076509,0.1486,0.14059,DOANE_BREAST_CANCER_ESR1_DN,0.866782786599197
HU_GENOTOXIC_DAMAGE_4HR,SET,34,0.14793,0.00636,0.13726,0.14059,HU_GENOTOXIC_DAMAGE_4HR,0.866782786599197
REACTOME_BMAL1_CLOCK_NPAS2_A...,SET,23,0.2087,0.0073821,0.19366,0.1406,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,0.866782786599197
GOBP_REGULATION_OF_RESPONSE_...3,SET,4,0.41432,0.0061147,0.38446,0.1406,GOBP_REGULATION_OF_RESPONSE_TO_DRUG,0.866782786599197
MIR491_3P,SET,108,0.088984,0.0068047,0.082576,0.14061,MIR491_3P,0.866782786599197
GSE20727_CTRL_VS_ROS_INH_AND...2,SET,167,0.069438,0.0065923,0.064435,0.14061,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.866782786599197
HP_PREMATURELY_AGED_APPEARAN...,SET,156,0.071766,0.006587,0.0666,0.14062,HP_PREMATURELY_AGED_APPEARANCE,0.866782786599197
MIR195_3P,SET,206,0.065242,0.0068719,0.060558,0.14067,MIR195_3P,0.866782786599197
GSE11961_FOLLICULAR_BCELL_VS...1,SET,180,0.068318,0.0067313,0.063431,0.14074,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.866782786599197
PID_P75_NTR_PATHWAY,SET,59,0.12009,0.0067967,0.11151,0.14076,PID_P75_NTR_PATHWAY,0.866782786599197
ARP1_01,SET,142,0.075296,0.0065962,0.069921,0.14078,ARP1_01,0.866782786599197
HP_NEOPLASM_OF_THE_ENDOCRINE...,SET,150,0.075557,0.0068015,0.070165,0.14078,HP_NEOPLASM_OF_THE_ENDOCRINE_SYSTEM,0.866782786599197
MIR376A_2_5P,SET,59,0.12378,0.0070056,0.11495,0.1408,MIR376A_2_5P,0.866782786599197
MIR12120,SET,164,0.072043,0.0067784,0.066917,0.14084,MIR12120,0.866782786599197
HP_OVARIAN_CARCINOMA,SET,14,0.23974,0.0066177,0.22271,0.14087,HP_OVARIAN_CARCINOMA,0.866782786599197
GOBP_REGULATION_OF_HAIR_CYCLE,SET,28,0.19088,0.0074484,0.17734,0.14089,GOBP_REGULATION_OF_HAIR_CYCLE,0.866782786599197
GUTIERREZ_WALDENSTROEMS_MACR...1,SET,8,0.32148,0.0067092,0.29871,0.14092,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN,0.866782786599197
MIR11401,SET,7,0.37552,0.0073311,0.34892,0.14092,MIR11401,0.866782786599197
GSE24081_CONTROLLER_VS_PROGR...1,SET,173,0.070719,0.0068323,0.065722,0.14096,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN,0.866782786599197
GSE20198_IL12_IL18_VS_IFNA_T...1,SET,178,0.067344,0.0065987,0.062591,0.14098,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.866782786599197
LENAOUR_DENDRITIC_CELL_MATUR...2,SET,108,0.094649,0.0072379,0.087971,0.14099,LENAOUR_DENDRITIC_CELL_MATURATION_UP,0.866782786599197
REACTOME_PTK6_REGULATES_PROT...,SET,5,0.43951,0.007252,0.4085,0.14099,REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING,0.866782786599197
GSE32986_CURDLAN_LOWDOSE_VS_...1,SET,190,0.069216,0.0070047,0.064334,0.141,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.866782786599197
DESCARTES_FETAL_LUNG_NEUROEN...,SET,76,0.11516,0.0073936,0.10704,0.14102,DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS,0.866782786599197
BIOCARTA_D4GDI_PATHWAY,SET,12,0.25861,0.0066094,0.24046,0.14109,BIOCARTA_D4GDI_PATHWAY,0.866782786599197
GOBP_EAR_DEVELOPMENT,SET,209,0.067998,0.0072135,0.063229,0.1411,GOBP_EAR_DEVELOPMENT,0.866782786599197
GOBP_REGULATION_OF_DEPHOSPHO...,SET,92,0.091621,0.0064693,0.085197,0.14111,GOBP_REGULATION_OF_DEPHOSPHORYLATION,0.866782786599197
GSE36392_EOSINOPHIL_VS_NEUTR...2,SET,183,0.068502,0.0068049,0.063703,0.14112,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.866782786599197
GOBP_TYPE_B_PANCREATIC_CELL_...4,SET,23,0.20461,0.0072373,0.19028,0.14113,GOBP_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.866782786599197
GSE32255_UNSTIM_VS_4H_LPS_ST...1,SET,140,0.07633,0.0066399,0.071,0.14118,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN,0.866782786599197
HP_SPOKEN_WORD_RECOGNITION_D...,SET,8,0.32092,0.0066974,0.29857,0.14123,HP_SPOKEN_WORD_RECOGNITION_DEFICIT,0.866782786599197
MIR6739_5P,SET,243,0.059402,0.0067885,0.055274,0.14127,MIR6739_5P,0.866782786599197
KYNG_ENVIRONMENTAL_STRESS_RE...8,SET,48,0.12833,0.006553,0.11943,0.1413,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,0.866782786599197
HP_RECURRENT_APHTHOUS_STOMAT...,SET,44,0.13947,0.0068192,0.12979,0.1413,HP_RECURRENT_APHTHOUS_STOMATITIS,0.866782786599197
MIR4649_5P,SET,8,0.31307,0.0065337,0.2914,0.14134,MIR4649_5P,0.866782786599197
GSE11924_TFH_VS_TH1_CD4_TCEL...2,SET,185,0.065876,0.0065792,0.061322,0.14136,GSE11924_TFH_VS_TH1_CD4_TCELL_UP,0.866782786599197
GOCC_LATERAL_ELEMENT,SET,13,0.22521,0.0059905,0.20974,0.14147,GOCC_LATERAL_ELEMENT,0.866782786599197
MORF_MSH2,SET,58,0.10319,0.0057909,0.096125,0.14152,MORF_MSH2,0.866782786599197
GSE17721_LPS_VS_GARDIQUIMOD_...2,SET,185,0.065157,0.0065074,0.060694,0.14152,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.866782786599197
GOMF_ACTIVIN_RECEPTOR_ACTIVI...2,SET,5,0.51178,0.0084445,0.47675,0.14153,GOMF_ACTIVIN_RECEPTOR_ACTIVITY_TYPE_I,0.866782786599197
GOMF_GUANYL_RIBONUCLEOTIDE_B...,SET,342,0.050184,0.0067852,0.04675,0.14154,GOMF_GUANYL_RIBONUCLEOTIDE_BINDING,0.866782786599197
GOCC_NUCLEAR_INCLUSION_BODY,SET,11,0.24516,0.0059989,0.2284,0.14156,GOCC_NUCLEAR_INCLUSION_BODY,0.866782786599197
HP_PERITONEAL_ABSCESS,SET,11,0.27291,0.0066781,0.25428,0.14158,HP_PERITONEAL_ABSCESS,0.866782786599197
TESAR_ALK_TARGETS_EPISC_3D_UP,SET,5,0.43261,0.0071382,0.40318,0.14164,TESAR_ALK_TARGETS_EPISC_3D_UP,0.866782786599197
RFX1_01,SET,224,0.060727,0.0066666,0.056604,0.14168,RFX1_01,0.866782786599197
HP_IRIS_ATROPHY,SET,8,0.38425,0.008019,0.35823,0.14173,HP_IRIS_ATROPHY,0.866782786599197
MIR12123,SET,428,0.045328,0.0068396,0.042266,0.14177,MIR12123,0.866782786599197
REACTOME_CHYLOMICRON_ASSEMBLY,SET,8,0.3323,0.0069349,0.3099,0.14181,REACTOME_CHYLOMICRON_ASSEMBLY,0.866782786599197
HP_ELEVATED_LACTATE_PYRUVATE...,SET,18,0.20169,0.0063122,0.18811,0.14181,HP_ELEVATED_LACTATE_PYRUVATE_RATIO,0.866782786599197
GSE13738_RESTING_VS_BYSTANDE...2,SET,152,0.072834,0.0065996,0.067927,0.14181,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.866782786599197
HP_HYPERPIGMENTATION_OF_THE_...1,SET,6,0.40914,0.0073951,0.38159,0.14182,HP_HYPERPIGMENTATION_OF_THE_FUNDUS,0.866782786599197
PYEON_CANCER_HEAD_AND_NECK_V...1,SET,19,0.22234,0.0071487,0.2074,0.14186,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,0.866782786599197
ZNF513_TARGET_GENES,SET,613,0.038451,0.0069077,0.035867,0.14186,ZNF513_TARGET_GENES,0.866782786599197
MIR32_3P,SET,306,0.054178,0.0069358,0.050544,0.14189,MIR32_3P,0.866782786599197
GOMF_MITOGEN_ACTIVATED_PROTE...2,SET,10,0.28051,0.0065449,0.2617,0.14189,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING,0.866782786599197
CACCAGC_MIR138,SET,208,0.066045,0.0069897,0.061621,0.14191,CACCAGC_MIR138,0.866782786599197
NFKAPPAB_01,SET,232,0.061281,0.006845,0.057183,0.14194,NFKAPPAB_01,0.866782786599197
GOBP_REGULATION_OF_IMMUNOGLO...,SET,62,0.11025,0.0063962,0.10288,0.14194,GOBP_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.866782786599197
MIR6867_5P,SET,773,0.035001,0.0070291,0.032665,0.14198,MIR6867_5P,0.866782786599197
GSE17721_POLYIC_VS_PAM3CSK4_...14,SET,180,0.066771,0.0065788,0.062318,0.14199,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP,0.866782786599197
MODULE_495,SET,13,0.27984,0.0074438,0.2612,0.14201,MODULE_495,0.866782786599197
GOBP_HINDBRAIN_MATURATION,SET,5,0.42163,0.006957,0.39367,0.14209,GOBP_HINDBRAIN_MATURATION,0.866782786599197
WP_TYPE_I_INTERFERON_INDUCTI...,SET,28,0.16985,0.0066279,0.1586,0.14211,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,0.866782786599197
HP_HYPERPIGMENTATION_IN_SUN_...,SET,7,0.29586,0.0057758,0.27626,0.14211,HP_HYPERPIGMENTATION_IN_SUN_EXPOSED_AREAS,0.866782786599197
MCCABE_HOXC6_TARGETS_DN,SET,18,0.2181,0.0068257,0.20367,0.14212,MCCABE_HOXC6_TARGETS_DN,0.866782786599197
GSE3982_DC_VS_MAC_DN,SET,178,0.07067,0.0069246,0.06602,0.14222,GSE3982_DC_VS_MAC_DN,0.866782786599197
GSE20727_H2O2_VS_ROS_INHIBIT...1,SET,174,0.070788,0.0068585,0.066133,0.14223,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN,0.866782786599197
HP_SUBCUTANEOUS_HEMORRHAGE,SET,233,0.061503,0.0068843,0.057465,0.14226,HP_SUBCUTANEOUS_HEMORRHAGE,0.866782786599197
MIR4323,SET,37,0.15054,0.0067512,0.14069,0.14231,MIR4323,0.866782786599197
GOBP_ASTROCYTE_ACTIVATION,SET,23,0.21021,0.0074354,0.19646,0.14232,GOBP_ASTROCYTE_ACTIVATION,0.866782786599197
GSE18281_SUBCAPSULAR_CORTICA...2,SET,189,0.066126,0.0066746,0.061806,0.14234,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.866782786599197
GOBP_FATTY_ACID_BETA_OXIDATI...3,SET,12,0.24626,0.0062938,0.2302,0.14237,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE,0.866782786599197
HP_RECURRENT_PHARYNGITIS,SET,7,0.42312,0.0082603,0.39554,0.14238,HP_RECURRENT_PHARYNGITIS,0.866782786599197
RB_DN.V1_UP,SET,111,0.083349,0.0064611,0.077932,0.14243,RB_DN.V1_UP,0.866782786599197
GSE5589_UNSTIM_VS_45MIN_LPS_...4,SET,182,0.065855,0.0065242,0.061577,0.14243,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP,0.866782786599197
REACTOME_RHO_GTPASES_ACTIVAT...3,SET,29,0.17834,0.007082,0.16675,0.14244,REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,0.866782786599197
ZHONG_PFC_C1_ASTROCYTE,SET,26,0.17502,0.0065814,0.16365,0.14244,ZHONG_PFC_C1_ASTROCYTE,0.866782786599197
AIZARANI_LIVER_C14_HEPATOCYT...,SET,208,0.069028,0.0073055,0.064547,0.14245,AIZARANI_LIVER_C14_HEPATOCYTES_2,0.866782786599197
REACTOME_REGULATION_OF_TP53_...6,SET,36,0.15416,0.0068196,0.14416,0.14246,REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,0.866782786599197
GOMF_UBIQUITIN_LIKE_PROTEIN_...6,SET,93,0.084204,0.0059777,0.078742,0.14246,GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY,0.866782786599197
KRAS.BREAST_UP.V1_UP,SET,118,0.09324,0.0074509,0.087201,0.14248,KRAS.BREAST_UP.V1_UP,0.866782786599197
BIOCARTA_TRKA_PATHWAY,SET,14,0.22959,0.0063375,0.21473,0.1425,BIOCARTA_TRKA_PATHWAY,0.866782786599197
GOBP_NEGATIVE_REGULATION_OF_...618,SET,13,0.26834,0.0071378,0.25098,0.14251,GOBP_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.866782786599197
GOBP_POSITIVE_REGULATION_OF_...607,SET,96,0.090779,0.006547,0.08491,0.14252,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.866782786599197
HP_JUVENILE_MYELOMONOCYTIC_L...,SET,18,0.1997,0.0062499,0.1868,0.14253,HP_JUVENILE_MYELOMONOCYTIC_LEUKEMIA,0.866782786599197
GAVISH_3CA_MALIGNANT_METAPRO...9,SET,41,0.15398,0.0072682,0.14407,0.14259,GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2,0.866782786599197
MORF_PRDX3,SET,72,0.10182,0.0063635,0.095264,0.14259,MORF_PRDX3,0.866782786599197
LOPEZ_MESOTHELIOMA_SURVIVAL_...1,SET,10,0.30028,0.0070061,0.281,0.14263,LOPEZ_MESOTHELIOMA_SURVIVAL_DN,0.866782786599197
GOBP_PROTEIN_DEPALMITOYLATION,SET,8,0.3192,0.0066615,0.29871,0.14264,GOBP_PROTEIN_DEPALMITOYLATION,0.866782786599197
MODULE_229,SET,27,0.16869,0.0064643,0.15789,0.14268,MODULE_229,0.866782786599197
GSE17721_12H_VS_24H_POLYIC_B...1,SET,180,0.066417,0.0065439,0.062167,0.14269,GSE17721_12H_VS_24H_POLYIC_BMDC_DN,0.866782786599197
PID_HDAC_CLASSI_PATHWAY,SET,60,0.11509,0.0065687,0.10774,0.1427,PID_HDAC_CLASSI_PATHWAY,0.866782786599197
HP_DICARBOXYLIC_ACIDURIA,SET,64,0.11256,0.0066341,0.10537,0.14271,HP_DICARBOXYLIC_ACIDURIA,0.866782786599197
HP_EUTHYROID_GOITER,SET,4,0.48786,0.0072002,0.45668,0.14271,HP_EUTHYROID_GOITER,0.866782786599197
ZHONG_PFC_C1_OPC,SET,218,0.059527,0.0064478,0.055743,0.14279,ZHONG_PFC_C1_OPC,0.866782786599197
HP_CHIN_WITH_H_SHAPED_CREASE,SET,4,0.56892,0.0083965,0.53283,0.14283,HP_CHIN_WITH_H_SHAPED_CREASE,0.866782786599197
GSE32164_ALTERNATIVELY_ACT_M...1,SET,179,0.066391,0.0065233,0.062181,0.14284,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN,0.866782786599197
chr2q12,SET,24,0.31578,0.01141,0.29578,0.14285,chr2q12,0.866782786599197
GSE8685_IL15_ACT_IL2_STARVED...1,SET,141,0.075638,0.0066029,0.070847,0.14285,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.866782786599197
REACTOME_COBALAMIN_CBL_VITAM...,SET,20,0.20938,0.0069067,0.19613,0.14287,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,0.866782786599197
GSE18791_UNSTIM_VS_NEWCATSLE...7,SET,140,0.075948,0.0066067,0.071142,0.14287,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN,0.866782786599197
GOMF_3_5_RNA_HELICASE_ACTIVI...,SET,5,0.50249,0.0082912,0.47076,0.1429,GOMF_3_5_RNA_HELICASE_ACTIVITY,0.866782786599197
RODRIGUES_THYROID_CARCINOMA_...3,SET,73,0.11684,0.0073527,0.10947,0.14291,RODRIGUES_THYROID_CARCINOMA_DN,0.866782786599197
GSE17721_CTRL_VS_CPG_1H_BMDC...1,SET,187,0.066978,0.006725,0.062756,0.14293,GSE17721_CTRL_VS_CPG_1H_BMDC_DN,0.866782786599197
GOBP_REGULATION_OF_MITOTIC_S...2,SET,22,0.17157,0.0059356,0.16084,0.14305,GOBP_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY,0.867209037824647
GOBP_THERMOCEPTION,SET,8,0.35588,0.0074271,0.33368,0.1431,GOBP_THERMOCEPTION,0.867209037824647
FOURATI_BLOOD_TWINRIX_AGE_25...1,SET,598,0.038046,0.0067537,0.035674,0.14311,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,0.867209037824647
MIR3941,SET,303,0.053039,0.0067572,0.049737,0.14313,MIR3941,0.867209037824647
HP_LIP_PIT,SET,9,0.31954,0.0070729,0.29965,0.14313,HP_LIP_PIT,0.867209037824647
GOBP_SPONTANEOUS_NEUROTRANSM...,SET,7,0.36925,0.0072086,0.34629,0.14315,GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION,0.867209037824647
KEGG_MEDICUS_REFERENCE_WNT_S...5,SET,44,0.14755,0.0072146,0.13841,0.1432,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY,0.867209618400418
DURANTE_ADULT_OLFACTORY_NEUR...1,SET,32,0.16346,0.0068182,0.15333,0.1432,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_BOWMANS_GLAND,0.867209618400418
REACTOME_RAF_INDEPENDENT_MAP...,SET,22,0.21554,0.0074565,0.20222,0.14326,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,0.867211936662607
GSE2770_IL12_ACT_VS_ACT_CD4_...3,SET,178,0.064714,0.0063409,0.06073,0.14331,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN,0.867211936662607
GOBP_ACTIVATION_OF_CYSTEINE_...3,SET,5,0.33887,0.0055914,0.31803,0.14332,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C,0.867211936662607
MIR6791_5P,SET,152,0.072557,0.0065745,0.068103,0.14335,MIR6791_5P,0.867211936662607
GOBP_POSITIVE_REGULATION_OF_...581,SET,24,0.18894,0.0068265,0.17735,0.14337,GOBP_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.867211936662607
GSE2706_UNSTIM_VS_8H_LPS_DC_...2,SET,178,0.066477,0.0065138,0.062402,0.14337,GSE2706_UNSTIM_VS_8H_LPS_DC_UP,0.867211936662607
GSE43955_TGFB_IL6_VS_TGFB_IL...1,SET,176,0.073423,0.0071542,0.068925,0.14338,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.867211936662607
HP_CEREBELLAR_HEMORRHAGE,SET,5,0.47321,0.007808,0.44425,0.1434,HP_CEREBELLAR_HEMORRHAGE,0.867211936662607
DR1_Q3,SET,229,0.059505,0.006604,0.055873,0.14344,DR1_Q3,0.867272969212037
GOBP_INTERLEUKIN_6_MEDIATED_...,SET,18,0.23621,0.0073923,0.22181,0.14346,GOBP_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.867272969212037
GOBP_CELLULAR_RESPONSE_TO_NI...4,SET,6,0.31792,0.0057463,0.29861,0.14352,GOBP_CELLULAR_RESPONSE_TO_NITROSATIVE_STRESS,0.8674848
TGACCTTG_SF1_Q6,SET,214,0.062664,0.0067258,0.058867,0.14356,TGACCTTG_SF1_Q6,0.867575691184142
GOBP_POST_TRANSLATIONAL_PROT...1,SET,869,0.030439,0.0064635,0.028604,0.14364,GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.867576594265856
GSE12392_WT_VS_IFNB_KO_CD8A_...4,SET,176,0.065561,0.0063881,0.061609,0.14364,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP,0.867576594265856
GOBP_REGULATION_OF_ESTABLISH...2,SET,488,0.041396,0.0066586,0.038905,0.14366,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.867576594265856
GOMF_RDNA_BINDING,SET,8,0.28762,0.0060025,0.2703,0.14366,GOMF_RDNA_BINDING,0.867576594265856
GOBP_NEURONAL_SIGNAL_TRANSDU...,SET,6,0.43964,0.0079464,0.41325,0.1437,GOBP_NEURONAL_SIGNAL_TRANSDUCTION,0.867577045336113
GNF2_APEX1,SET,77,0.095353,0.0061621,0.089632,0.14371,GNF2_APEX1,0.867577045336113
GSE24574_BCL6_HIGH_VS_LOW_TF...1,SET,181,0.065219,0.0064436,0.061315,0.14374,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN,0.867607450503647
GSE43955_TH0_VS_TGFB_IL6_TH1...9,SET,184,0.068137,0.0067868,0.064079,0.14382,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN,0.867849244791667
HP_INTERPHALANGEAL_JOINT_ERO...,SET,7,0.34973,0.0068275,0.3289,0.14383,HP_INTERPHALANGEAL_JOINT_EROSIONS,0.867849244791667
GOCC_DISTAL_AXON,SET,249,0.059531,0.0068856,0.056008,0.14392,GOCC_DISTAL_AXON,0.868241555285541
GOBP_MYELOID_CELL_DIFFERENTI...,SET,392,0.047835,0.0069145,0.045027,0.14404,GOBP_MYELOID_CELL_DIFFERENTIATION,0.8682428719903
GOBP_STEM_CELL_DEVELOPMENT,SET,82,0.10677,0.0071197,0.1005,0.14404,GOBP_STEM_CELL_DEVELOPMENT,0.8682428719903
JIANG_MELANOMA_TRM2_CD8,SET,127,0.088562,0.0073402,0.083366,0.14405,JIANG_MELANOMA_TRM2_CD8,0.8682428719903
CHIANG_LIVER_CANCER_SUBCLASS...10,SET,80,0.10695,0.0070441,0.10068,0.14407,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,0.8682428719903
YTCCCRNNAGGY_UNKNOWN,SET,59,0.11656,0.0065966,0.10973,0.14408,YTCCCRNNAGGY_UNKNOWN,0.8682428719903
GAUTAM_EYE_IRIS_CILIARY_BODY...5,SET,76,0.10526,0.0067579,0.099098,0.14409,GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS,0.8682428719903
GOBP_REGULATION_OF_HAIR_FOLL...,SET,20,0.21867,0.0072132,0.20592,0.14415,GOBP_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.8682428719903
HP_ABNORMAL_GLUCOSE_HOMEOSTA...,SET,622,0.036917,0.0066788,0.034768,0.14417,HP_ABNORMAL_GLUCOSE_HOMEOSTASIS,0.8682428719903
GOBP_CYTOSOLIC_TRANSPORT,SET,123,0.076359,0.006229,0.071916,0.14418,GOBP_CYTOSOLIC_TRANSPORT,0.8682428719903
HP_ABNORMAL_BASAL_GANGLIA_MR...,SET,35,0.14298,0.0062366,0.13466,0.14419,HP_ABNORMAL_BASAL_GANGLIA_MRI_SIGNAL_INTENSITY,0.8682428719903
GOBP_REGULATION_OF_MONOCYTE_...3,SET,6,0.37295,0.0067409,0.3513,0.14421,GOBP_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.8682428719903
GOBP_FUNGIFORM_PAPILLA_DEVEL...,SET,5,0.43493,0.0071764,0.40969,0.14422,GOBP_FUNGIFORM_PAPILLA_DEVELOPMENT,0.8682428719903
GOMF_BMP_BINDING,SET,18,0.2304,0.0072105,0.21706,0.14425,GOMF_BMP_BINDING,0.868243090909091
GNF2_PTPN6,SET,41,0.14224,0.0067142,0.13402,0.14427,GNF2_PTPN6,0.868243090909091
HP_CROSSED_FUSED_RENAL_ECTOP...,SET,9,0.28763,0.0063666,0.27104,0.14431,HP_CROSSED_FUSED_RENAL_ECTOPIA,0.868243309676303
REACTOME_SIGNALING_BY_FGFR3,SET,38,0.14566,0.00662,0.13727,0.14432,REACTOME_SIGNALING_BY_FGFR3,0.868243309676303
POMEROY_MEDULLOBLASTOMA_PROG...1,SET,40,0.13834,0.00645,0.13042,0.14442,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,0.868604462895693
BENPORATH_ES_CORE_NINE_CORRE...,SET,94,0.095615,0.006824,0.090154,0.14445,BENPORATH_ES_CORE_NINE_CORRELATED,0.868604462895693
GAUSSMANN_MLL_AF4_FUSION_TAR...8,SET,36,0.15411,0.0068175,0.14532,0.14446,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,0.868604462895693
GSE2935_UV_INACTIVATED_VS_LI...2,SET,163,0.075102,0.0070449,0.070823,0.14448,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP,0.868604462895693
GOCC_TRANSCRIPTION_FACTOR_TF...5,SET,17,0.189,0.0057484,0.17825,0.14451,GOCC_TRANSCRIPTION_FACTOR_TFTC_COMPLEX,0.868634564164649
GOCC_DENSE_BODY,SET,5,0.42118,0.0069496,0.39728,0.14454,GOCC_DENSE_BODY,0.868664655023344
TOYOTA_TARGETS_OF_MIR34B_AND...,SET,399,0.042918,0.0062577,0.040497,0.14463,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,0.868905007770679
GOBP_EXCRETION,SET,28,0.18247,0.0071204,0.17221,0.14467,GOBP_EXCRETION,0.868905007770679
MYAATNNNNNNNGGC_UNKNOWN,SET,103,0.090326,0.0067464,0.085255,0.1447,MYAATNNNNNNNGGC_UNKNOWN,0.868905007770679
GOBP_NEGATIVE_REGULATION_OF_...316,SET,13,0.25804,0.0068639,0.24356,0.14471,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.868905007770679
MISHRA_CARCINOMA_ASSOCIATED_...1,SET,20,0.21827,0.0071999,0.20605,0.14474,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,0.868905007770679
GOBP_METANEPHRIC_PART_OF_URE...,SET,6,0.4364,0.0078877,0.41197,0.14474,GOBP_METANEPHRIC_PART_OF_URETERIC_BUD_DEVELOPMENT,0.868905007770679
HP_ABNORMAL_LYMPHOCYTE_MORPH...,SET,221,0.061971,0.006758,0.058509,0.14477,HP_ABNORMAL_LYMPHOCYTE_MORPHOLOGY,0.868905007770679
RODRIGUES_DCC_TARGETS_DN,SET,110,0.08489,0.006551,0.080151,0.14478,RODRIGUES_DCC_TARGETS_DN,0.868905007770679
GSE17974_0.5H_VS_72H_IL4_AND...1,SET,175,0.063301,0.0061506,0.059803,0.14492,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.869263758389262
MIR92B_5P,SET,8,0.29832,0.0062258,0.28185,0.14494,MIR92B_5P,0.869263758389262
GSE9509_10MIN_VS_30MIN_LPS_A...2,SET,162,0.066568,0.0062253,0.062896,0.14495,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.869263758389262
GSE360_L_MAJOR_VS_B_MALAYI_L...3,SET,176,0.065814,0.0064128,0.062194,0.14499,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.869263758389262
MIR548B_3P,SET,91,0.092615,0.0065041,0.087531,0.14502,MIR548B_3P,0.869263758389262
HP_PROLONGED_BLEEDING_FOLLOW...2,SET,29,0.18147,0.0072065,0.17152,0.14503,HP_PROLONGED_BLEEDING_FOLLOWING_PROCEDURE,0.869263758389262
GSE12484_HEALTHY_VS_PERIDONT...2,SET,120,0.085984,0.0069287,0.081281,0.14507,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP,0.869263758389262
WARTERS_RESPONSE_TO_IR_SKIN,SET,70,0.10555,0.0065047,0.099778,0.14508,WARTERS_RESPONSE_TO_IR_SKIN,0.869263758389262
HP_LEG_DYSTONIA,SET,7,0.33815,0.0066014,0.3197,0.1451,HP_LEG_DYSTONIA,0.869263758389262
REACTOME_CREB1_PHOSPHORYLATI...2,SET,11,0.30982,0.0075811,0.29293,0.14512,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,0.869263758389262
GOBP_CELLULAR_ALDEHYDE_METAB...,SET,74,0.10712,0.0067867,0.1013,0.14516,GOBP_CELLULAR_ALDEHYDE_METABOLIC_PROCESS,0.869263758389262
GSE6092_B_BURGDOFERI_VS_B_BU...2,SET,160,0.072295,0.0067194,0.068387,0.14523,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP,0.869263758389262
GOBP_ACTIN_FILAMENT_BASED_MO...,SET,130,0.083365,0.00699,0.078863,0.14524,GOBP_ACTIN_FILAMENT_BASED_MOVEMENT,0.869263758389262
GOBP_TERTIARY_ALCOHOL_METABO...,SET,22,0.22369,0.0077384,0.21161,0.14525,GOBP_TERTIARY_ALCOHOL_METABOLIC_PROCESS,0.869263758389262
REACTOME_RNA_POLYMERASE_II_P...,SET,72,0.093506,0.0058441,0.088467,0.14527,REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,0.869263758389262
MIR4667_3P,SET,117,0.083441,0.0066397,0.078957,0.14531,MIR4667_3P,0.869263758389262
GOBP_EMBRYONIC_CAMERA_TYPE_E...3,SET,26,0.19216,0.0072259,0.18183,0.14532,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS,0.869263758389262
BASAKI_YBX1_TARGETS_DN,SET,350,0.050013,0.0068391,0.047329,0.14533,BASAKI_YBX1_TARGETS_DN,0.869263758389262
MIR4540,SET,47,0.12732,0.0064338,0.1205,0.14534,MIR4540,0.869263758389262
GOBP_REGULATION_OF_ERYTHROCY...,SET,42,0.14186,0.0067773,0.13426,0.14534,GOBP_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.869263758389262
CAIRO_HEPATOBLASTOMA_CLASSES...2,SET,559,0.037124,0.0063785,0.035151,0.14546,CAIRO_HEPATOBLASTOMA_CLASSES_UP,0.869382154506438
GSE9509_10MIN_VS_30MIN_LPS_S...1,SET,171,0.07215,0.0069305,0.068315,0.14546,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN,0.869382154506438
GSE11973_MIR223_KOVS_WT_BONE...2,SET,179,0.068049,0.0066862,0.064443,0.1455,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP,0.869382154506438
SCHERER_PBMC_APSV_WETVAX_AGE...1,SET,31,0.1527,0.0062692,0.14464,0.14555,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_DN,0.869382154506438
MIR6854_5P,SET,66,0.10938,0.006546,0.1036,0.14556,MIR6854_5P,0.869382154506438
GOCC_SPINDLE_POLE_CENTROSOME,SET,11,0.25238,0.0061756,0.23906,0.14556,GOCC_SPINDLE_POLE_CENTROSOME,0.869382154506438
HP_UNUSUAL_INFECTION_BY_ANAT...,SET,95,0.09383,0.006732,0.088883,0.14557,HP_UNUSUAL_INFECTION_BY_ANATOMICAL_SITE,0.869382154506438
GAVISH_3CA_METAPROGRAM_ENDOT...8,SET,46,0.14614,0.0073057,0.13847,0.14564,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_6,0.869382154506438
HP_DECREASED_ADIPOSE_TISSUE,SET,43,0.13471,0.0065118,0.12766,0.14566,HP_DECREASED_ADIPOSE_TISSUE,0.869382154506438
HP_SPARSE_SCALP_HAIR,SET,127,0.078712,0.0065238,0.074591,0.14566,HP_SPARSE_SCALP_HAIR,0.869382154506438
BIOCARTA_CTCF_PATHWAY,SET,24,0.20704,0.0074807,0.19622,0.14569,BIOCARTA_CTCF_PATHWAY,0.869382154506438
MIR1207_3P,SET,124,0.081987,0.006715,0.077703,0.14569,MIR1207_3P,0.869382154506438
SFMBT1_TARGET_GENES,SET,1309,0.026139,0.006726,0.024774,0.14571,SFMBT1_TARGET_GENES,0.869382154506438
HP_HAND_TREMOR,SET,37,0.15331,0.0068752,0.14531,0.14571,HP_HAND_TREMOR,0.869382154506438
GSE22886_NAIVE_CD4_TCELL_VS_...18,SET,181,0.066403,0.0065605,0.062963,0.1458,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP,0.869409692307692
HP_HEMOGLOBINURIA,SET,8,0.30525,0.0063704,0.28945,0.14582,HP_HEMOGLOBINURIA,0.869409692307692
HALLMARK_APICAL_SURFACE,SET,39,0.15083,0.0069441,0.14304,0.14585,HALLMARK_APICAL_SURFACE,0.869409692307692
HP_URETHRAL_ATRESIA,SET,22,0.1713,0.0059263,0.16248,0.14587,HP_URETHRAL_ATRESIA,0.869409692307692
WP_DNA_DAMAGE_RESPONSE,SET,65,0.10235,0.0060789,0.09711,0.14597,WP_DNA_DAMAGE_RESPONSE,0.869409692307692
P53_DN.V1_DN,SET,177,0.071748,0.0070106,0.068082,0.14598,P53_DN.V1_DN,0.869409692307692
MYLLYKANGAS_AMPLIFICATION_HO...15,SET,6,0.38641,0.0069841,0.36671,0.14601,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5,0.869409692307692
GSE19941_UNSTIM_VS_LPS_STIM_...4,SET,182,0.064764,0.006416,0.061464,0.14602,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.869409692307692
GOMF_GATED_CHANNEL_ACTIVITY,SET,301,0.056848,0.0072189,0.053955,0.14604,GOMF_GATED_CHANNEL_ACTIVITY,0.869409692307692
GOBP_POSITIVE_REGULATION_OF_...31,SET,5,0.4278,0.0070589,0.40611,0.14608,GOBP_POSITIVE_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.869409692307692
GOBP_MACROPHAGE_COLONY_STIMU...2,SET,7,0.38373,0.0074913,0.3643,0.1461,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.869409692307692
GSE27859_CD11C_INT_F480_HI_M...1,SET,179,0.066956,0.0065788,0.063571,0.14612,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN,0.869409692307692
ZHONG_PFC_MAJOR_TYPES_EXCITA...,SET,8,0.32185,0.0067169,0.30558,0.14612,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.869409692307692
LEF1_UP.V1_DN,SET,166,0.072823,0.0068931,0.069154,0.14616,LEF1_UP.V1_DN,0.869409692307692
FERRANDO_LYL1_NEIGHBORS,SET,15,0.26331,0.0075233,0.25006,0.14617,FERRANDO_LYL1_NEIGHBORS,0.869409692307692
GAVISH_3CA_METAPROGRAM_B_CEL...3,SET,48,0.1393,0.0071132,0.13228,0.14617,GAVISH_3CA_METAPROGRAM_B_CELLS_GERMINAL_CENTER,0.869409692307692
WONG_ADULT_TISSUE_STEM_MODULE,SET,658,0.037659,0.0070004,0.035766,0.14619,WONG_ADULT_TISSUE_STEM_MODULE,0.869409692307692
GOMF_DEUBIQUITINASE_ACTIVITY,SET,81,0.090012,0.0059655,0.085488,0.1462,GOMF_DEUBIQUITINASE_ACTIVITY,0.869409692307692
SIRT3_TARGET_GENES,SET,38,0.14481,0.0065811,0.13756,0.14625,SIRT3_TARGET_GENES,0.869409692307692
BAKER_HEMATOPOESIS_STAT1_TAR...,SET,10,0.273,0.0063697,0.25936,0.14627,BAKER_HEMATOPOESIS_STAT1_TARGETS,0.869409692307692
HP_PRIMARY_HYPERALDOSTERONISM,SET,10,0.32256,0.0075258,0.30644,0.14627,HP_PRIMARY_HYPERALDOSTERONISM,0.869409692307692
GCM_ERBB2IP,SET,59,0.11402,0.0064533,0.10835,0.14633,GCM_ERBB2IP,0.869409692307692
GSE17974_IL4_AND_ANTI_IL12_V...8,SET,143,0.07758,0.00682,0.073721,0.14633,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP,0.869409692307692
REACTOME_CHEMOKINE_RECEPTORS...,SET,54,0.14545,0.0078764,0.13822,0.14634,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,0.869409692307692
GOCC_ALPHA_DNA_POLYMERASE_PR...,SET,4,0.38162,0.0056322,0.36266,0.14634,GOCC_ALPHA_DNA_POLYMERASE_PRIMASE_COMPLEX,0.869409692307692
SCHERER_PBMC_APSV_WETVAX_AGE...8,SET,23,0.19287,0.0068222,0.18341,0.14651,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_UP,0.869969040326697
KAAB_HEART_ATRIUM_VS_VENTRIC...2,SET,233,0.061318,0.0068636,0.058321,0.14655,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,0.869969040326697
WP_HFE_EFFECT_ON_HEPCIDIN_PR...,SET,6,0.35337,0.0063871,0.33612,0.14656,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,0.869969040326697
MORF_CDK2,SET,67,0.09994,0.0060262,0.095063,0.14657,MORF_CDK2,0.869969040326697
GSE2706_2H_VS_8H_R848_STIM_D...2,SET,172,0.070041,0.0067474,0.066663,0.14671,GSE2706_2H_VS_8H_R848_STIM_DC_UP,0.869969040326697
RAPA_EARLY_UP.V1_DN,SET,168,0.06596,0.0062806,0.062782,0.14673,RAPA_EARLY_UP.V1_DN,0.869969040326697
MIR924,SET,44,0.12964,0.006339,0.12341,0.14675,MIR924,0.869969040326697
HP_ABNORMALITY_OF_THE_BREAST,SET,393,0.0443,0.0064115,0.042172,0.14676,HP_ABNORMALITY_OF_THE_BREAST,0.869969040326697
GOBP_REGULATION_OF_ANION_CHA...,SET,5,0.45806,0.0075582,0.43608,0.14677,GOBP_REGULATION_OF_ANION_CHANNEL_ACTIVITY,0.869969040326697
GOBP_TRIGLYCERIDE_BIOSYNTHET...,SET,37,0.14423,0.0064682,0.13733,0.14682,GOBP_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.869969040326697
BIOCARTA_EGFR_SMRTE_PATHWAY,SET,11,0.28924,0.0070777,0.27544,0.14684,BIOCARTA_EGFR_SMRTE_PATHWAY,0.869969040326697
GOBP_GOLGI_VESICLE_BUDDING,SET,10,0.27676,0.0064572,0.26354,0.14684,GOBP_GOLGI_VESICLE_BUDDING,0.869969040326697
GOBP_RESPONSE_TO_HORMONE,SET,816,0.033299,0.0068623,0.03171,0.14684,GOBP_RESPONSE_TO_HORMONE,0.869969040326697
REACTOME_CELL_DEATH_SIGNALLI...,SET,67,0.11338,0.0068367,0.10797,0.14685,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,0.869969040326697
GSE9037_WT_VS_IRAK4_KO_LPS_1...2,SET,180,0.067595,0.00666,0.064377,0.14687,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP,0.869969040326697
GOBP_SECRETION,SET,898,0.031491,0.0067921,0.029996,0.1469,GOBP_SECRETION,0.869969040326697
GSE21063_WT_VS_NFATC1_KO_16H...2,SET,175,0.066156,0.0064279,0.063029,0.14696,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP,0.869969040326697
HP_ELEVATED_CIRCULATING_LONG...,SET,3,0.43666,0.0055813,0.41604,0.14697,HP_ELEVATED_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.869969040326697
IRX3_TARGET_GENES,SET,44,0.13717,0.0067069,0.1307,0.14699,IRX3_TARGET_GENES,0.869969040326697
MYLLYKANGAS_AMPLIFICATION_HO...13,SET,8,0.3407,0.0071102,0.32467,0.14701,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29,0.869969040326697
MIR128_3P,SET,408,0.046453,0.0068475,0.04427,0.14702,MIR128_3P,0.869969040326697
HP_ABNORMAL_INCISOR_MORPHOLO...,SET,55,0.13027,0.0071192,0.12415,0.14702,HP_ABNORMAL_INCISOR_MORPHOLOGY,0.869969040326697
GOBP_MULTICELLULAR_ORGANISMA...2,SET,757,0.034672,0.0068937,0.033046,0.14704,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS,0.869969040326697
WP_INTERFERONMEDIATED_SIGNAL...,SET,33,0.18952,0.0080278,0.18064,0.14706,WP_INTERFERONMEDIATED_SIGNALING,0.869969040326697
HP_MADELUNG_DEFORMITY,SET,4,0.42198,0.0062278,0.40223,0.14708,HP_MADELUNG_DEFORMITY,0.869969040326697
MIR1290,SET,241,0.059161,0.0067334,0.056397,0.1471,MIR1290,0.869969040326697
GSE17721_PAM3CSK4_VS_GADIQUI...2,SET,187,0.06484,0.0065104,0.061814,0.14711,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP,0.869969040326697
BILD_SRC_ONCOGENIC_SIGNATURE,SET,55,0.11468,0.0062675,0.1094,0.14726,BILD_SRC_ONCOGENIC_SIGNATURE,0.870381975854447
GOBP_GLUCOSE_METABOLIC_PROCE...,SET,168,0.069114,0.0065809,0.06593,0.14726,GOBP_GLUCOSE_METABOLIC_PROCESS,0.870381975854447
HP_AUTOIMMUNE_ANTIBODY_POSIT...,SET,148,0.077355,0.0069171,0.073792,0.14726,HP_AUTOIMMUNE_ANTIBODY_POSITIVITY,0.870381975854447
KEGG_MEDICUS_REFERENCE_TCR_P...,SET,19,0.20284,0.0065219,0.19352,0.14728,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY,0.870381975854447
GOBP_NEGATIVE_REGULATION_OF_...255,SET,5,0.46353,0.0076484,0.44239,0.14737,GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.870617179269329
GSE22432_MULTIPOTENT_PROGENI...4,SET,187,0.065198,0.0065463,0.062227,0.14739,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP,0.870617179269329
HP_HYPOPLASIA_OF_THE_OLFACTO...,SET,6,0.40455,0.0073121,0.38615,0.1474,HP_HYPOPLASIA_OF_THE_OLFACTORY_BULB,0.870617179269329
GSE2770_IL12_VS_IL4_TREATED_...5,SET,183,0.063233,0.0062815,0.06036,0.14742,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.870617179269329
BIOCARTA_TCR_PATHWAY,SET,43,0.13461,0.0065067,0.12854,0.14751,BIOCARTA_TCR_PATHWAY,0.870733398404346
GSE9006_1MONTH_VS_4MONTH_POS...2,SET,177,0.067619,0.0066071,0.064585,0.14756,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP,0.870733398404346
GSE24634_IL4_VS_CTRL_TREATED...8,SET,177,0.065417,0.0063921,0.062483,0.14757,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP,0.870733398404346
GSE17721_PAM3CSK4_VS_GADIQUI...12,SET,184,0.067984,0.0067716,0.064937,0.14758,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP,0.870733398404346
FRIDMAN_SENESCENCE_UP,SET,75,0.10982,0.0070045,0.1049,0.14759,FRIDMAN_SENESCENCE_UP,0.870733398404346
HP_HYPOPLASTIC_SPLEEN,SET,8,0.33204,0.0069295,0.31717,0.14759,HP_HYPOPLASTIC_SPLEEN,0.870733398404346
GOBP_NITROGEN_COMPOUND_TRANS...,SET,1728,0.022431,0.0065497,0.02144,0.14773,GOBP_NITROGEN_COMPOUND_TRANSPORT,0.870782036130339
GSE9006_TYPE_1_DIABETES_AT_D...3,SET,172,0.065452,0.0063053,0.06256,0.14773,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN,0.870782036130339
GSE36476_CTRL_VS_TSST_ACT_72...3,SET,179,0.06395,0.0062836,0.061127,0.14774,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN,0.870782036130339
MODULE_45,SET,527,0.040879,0.0068257,0.039084,0.1478,MODULE_45,0.870782036130339
GSE2770_TGFB_AND_IL4_VS_IL4_...3,SET,174,0.068821,0.0066679,0.065808,0.14784,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.870782036130339
HP_INTESTINAL_POLYP,SET,63,0.11185,0.0065406,0.10695,0.14785,HP_INTESTINAL_POLYP,0.870782036130339
GOBP_MYELOID_DENDRITIC_CELL_...2,SET,6,0.37192,0.0067224,0.35567,0.14786,GOBP_MYELOID_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.870782036130339
HP_LARYNGOMALACIA,SET,77,0.1011,0.0065334,0.096685,0.14787,HP_LARYNGOMALACIA,0.870782036130339
GOBP_NEGATIVE_REGULATION_OF_...245,SET,4,0.49259,0.0072699,0.47116,0.14791,GOBP_NEGATIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.870782036130339
GSE37416_CTRL_VS_0H_F_TULARE...2,SET,147,0.071597,0.0063808,0.068491,0.14794,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.870782036130339
GOBP_POSITIVE_REGULATION_OF_...28,SET,24,0.18597,0.0067193,0.17792,0.14797,GOBP_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.870782036130339
RICKMAN_HEAD_AND_NECK_CANCER...4,SET,30,0.18584,0.007506,0.17784,0.14802,RICKMAN_HEAD_AND_NECK_CANCER_D,0.870782036130339
GOBP_OVULATION_CYCLE_PROCESS,SET,49,0.14027,0.0072367,0.13423,0.14802,GOBP_OVULATION_CYCLE_PROCESS,0.870782036130339
WP_PHOSPHOINOSITIDES_METABOL...,SET,43,0.13091,0.0063279,0.12528,0.14803,WP_PHOSPHOINOSITIDES_METABOLISM,0.870782036130339
HP_PULMONARY_LYMPHANGIECTASIA,SET,5,0.4826,0.007963,0.46192,0.14807,HP_PULMONARY_LYMPHANGIECTASIA,0.870782036130339
GOMF_PROTEIN_TYROSINE_SERINE...,SET,22,0.18596,0.0064333,0.17799,0.14808,GOMF_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.870782036130339
PARK_APL_PATHOGENESIS_UP,SET,14,0.2365,0.0065283,0.22643,0.14813,PARK_APL_PATHOGENESIS_UP,0.870782036130339
RODRIGUES_THYROID_CARCINOMA_...2,SET,636,0.035739,0.0065356,0.03422,0.14816,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,0.870782036130339
GOBP_3_UTR_MEDIATED_MRNA_DES...,SET,19,0.21102,0.0067849,0.20207,0.14817,GOBP_3_UTR_MEDIATED_MRNA_DESTABILIZATION,0.870782036130339
GSE17721_POLYIC_VS_GARDIQUIM...14,SET,181,0.061628,0.0060888,0.059011,0.14817,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP,0.870782036130339
BIOCARTA_WNT_PATHWAY,SET,23,0.19696,0.0069669,0.1886,0.14818,BIOCARTA_WNT_PATHWAY,0.870782036130339
GOBP_PYRIMIDINE_CONTAINING_C...1,SET,37,0.14659,0.006574,0.14037,0.14818,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.870782036130339
GOMF_STRUCTURAL_CONSTITUENT_...2,SET,100,0.090534,0.0066633,0.086706,0.14822,GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON,0.870782036130339
GOBP_FC_RECEPTOR_SIGNALING_P...,SET,53,0.13278,0.0071237,0.12718,0.14824,GOBP_FC_RECEPTOR_SIGNALING_PATHWAY,0.870782036130339
GOBP_RIBOSOMAL_LARGE_SUBUNIT...2,SET,60,0.1067,0.0060898,0.1022,0.14824,GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS,0.870782036130339
GOMF_AP_1_ADAPTOR_COMPLEX_BI...,SET,5,0.37002,0.0061053,0.35446,0.14828,GOMF_AP_1_ADAPTOR_COMPLEX_BINDING,0.870782036130339
GSE26030_TH1_VS_TH17_DAY15_P...1,SET,176,0.067995,0.0066253,0.065136,0.14828,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN,0.870782036130339
HP_BCGITIS,SET,10,0.30237,0.0070548,0.28975,0.14835,HP_BCGITIS,0.870782036130339
GSE11864_CSF1_IFNG_VS_CSF1_I...1,SET,167,0.067081,0.0063685,0.064279,0.14835,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.870782036130339
GOMF_CHEMOKINE_BINDING,SET,29,0.18554,0.0073681,0.1778,0.14836,GOMF_CHEMOKINE_BINDING,0.870782036130339
GOBP_HOMOTYPIC_CELL_CELL_ADH...,SET,94,0.098157,0.0070054,0.09407,0.14838,GOBP_HOMOTYPIC_CELL_CELL_ADHESION,0.870782036130339
GSE18893_CTRL_VS_TNF_TREATED...3,SET,178,0.063134,0.0061861,0.06051,0.1484,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN,0.870782036130339
HE_PTEN_TARGETS_DN,SET,7,0.38445,0.0075054,0.36861,0.14849,HE_PTEN_TARGETS_DN,0.871163057056043
GOMF_RETINAL_DEHYDROGENASE_A...,SET,9,0.36501,0.0080796,0.35013,0.14859,GOMF_RETINAL_DEHYDROGENASE_ACTIVITY,0.871466049589546
GOBP_NEUTROPHIL_HOMEOSTASIS,SET,19,0.21785,0.0070045,0.20905,0.14869,GOBP_NEUTROPHIL_HOMEOSTASIS,0.871466049589546
VART_KSHV_INFECTION_ANGIOGEN...1,SET,124,0.087272,0.0071479,0.083754,0.14871,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,0.871466049589546
GOBP_PHAGOLYSOSOME_ASSEMBLY,SET,17,0.23524,0.0071547,0.22577,0.14873,GOBP_PHAGOLYSOSOME_ASSEMBLY,0.871466049589546
GOBP_PROTEIN_O_LINKED_GLYCOS...2,SET,8,0.31873,0.0066518,0.3059,0.14873,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_SERINE,0.871466049589546
GOBP_POSITIVE_REGULATION_OF_...560,SET,8,0.37656,0.0078587,0.36146,0.14876,GOBP_POSITIVE_REGULATION_OF_OPSONIZATION,0.871466049589546
PID_IL6_7_PATHWAY,SET,43,0.14281,0.0069029,0.13709,0.14879,PID_IL6_7_PATHWAY,0.871466049589546
GSE6674_UNSTIM_VS_ANTI_IGM_S...1,SET,117,0.083914,0.0066773,0.080559,0.1488,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN,0.871466049589546
GSE22432_UNTREATED_VS_TGFB1_...1,SET,174,0.066401,0.0064335,0.06375,0.14881,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN,0.871466049589546
GOBP_SYNAPTIC_MEMBRANE_ADHES...,SET,26,0.19772,0.0074351,0.18984,0.14883,GOBP_SYNAPTIC_MEMBRANE_ADHESION,0.871466049589546
MIR7853_5P,SET,198,0.064284,0.0066396,0.061752,0.14894,MIR7853_5P,0.871466049589546
GOCC_EUCHROMATIN,SET,49,0.12568,0.0064841,0.12073,0.14894,GOCC_EUCHROMATIN,0.871466049589546
GOCC_INTERSTITIAL_MATRIX,SET,11,0.27762,0.0067934,0.26671,0.14896,GOCC_INTERSTITIAL_MATRIX,0.871466049589546
GOBP_POSITIVE_REGULATION_OF_...673,SET,42,0.15169,0.0072467,0.14576,0.14902,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.871466049589546
NAGY_STAGA_COMPONENTS_HUMAN,SET,13,0.21984,0.0058477,0.21128,0.14906,NAGY_STAGA_COMPONENTS_HUMAN,0.871466049589546
GOBP_PROTEIN_LOCALIZATION_TO...3,SET,7,0.34092,0.0066556,0.32768,0.14908,GOBP_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE,0.871466049589546
GSE6269_E_COLI_VS_STREP_PNEU...1,SET,153,0.07231,0.0065734,0.0695,0.14908,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN,0.871466049589546
MILI_PSEUDOPODIA_HAPTOTAXIS_...1,SET,631,0.03539,0.0064471,0.034017,0.14909,MILI_PSEUDOPODIA_HAPTOTAXIS_DN,0.871466049589546
GSE360_T_GONDII_VS_B_MALAYI_...4,SET,179,0.066869,0.0065703,0.064274,0.14909,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.871466049589546
GSE14908_RESTING_VS_HDM_STIM...4,SET,186,0.06487,0.0064961,0.062357,0.14911,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP,0.871466049589546
GSE40443_INDUCED_VS_TOTAL_TR...2,SET,180,0.066572,0.0065593,0.064,0.14913,GSE40443_INDUCED_VS_TOTAL_TREG_UP,0.871466049589546
REACTOME_MRNA_EDITING_C_TO_U...,SET,7,0.364,0.007106,0.34994,0.14914,REACTOME_MRNA_EDITING_C_TO_U_CONVERSION,0.871466049589546
REACTOME_COENZYME_A_BIOSYNTH...,SET,7,0.31141,0.0060795,0.29942,0.14916,REACTOME_COENZYME_A_BIOSYNTHESIS,0.871466049589546
GOBP_AMYLOID_BETA_METABOLIC_...,SET,51,0.12566,0.0066134,0.12084,0.14921,GOBP_AMYLOID_BETA_METABOLIC_PROCESS,0.871466049589546
GOBP_MESENCHYMAL_EPITHELIAL_...,SET,9,0.34192,0.0075685,0.32884,0.14922,GOBP_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING,0.871466049589546
GSE1460_DP_THYMOCYTE_VS_THYM...1,SET,174,0.06512,0.0063094,0.06263,0.14923,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.871466049589546
MIR6733_5P,SET,240,0.057821,0.0065675,0.055614,0.14925,MIR6733_5P,0.871466049589546
FULLER_PBMC_F_TULARENSIS_VAC...9,SET,43,0.14367,0.0069448,0.13823,0.14932,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP,0.871466049589546
GOCC_RETROMER_COMPLEX,SET,19,0.18693,0.0060102,0.17985,0.14933,GOCC_RETROMER_COMPLEX,0.871466049589546
GOBP_NEGATIVE_REGULATION_OF_...188,SET,31,0.14208,0.0058334,0.13672,0.14936,GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION,0.871466049589546
GOBP_NEGATIVE_REGULATION_OF_...366,SET,31,0.1566,0.0064295,0.15071,0.14938,GOBP_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY,0.871466049589546
GOMF_LBD_DOMAIN_BINDING,SET,6,0.4089,0.0073906,0.39359,0.14943,GOMF_LBD_DOMAIN_BINDING,0.871466049589546
MIR6893_5P,SET,163,0.070245,0.0065893,0.067618,0.14944,MIR6893_5P,0.871466049589546
GSE17721_0.5H_VS_8H_PAM3CSK4...1,SET,185,0.063851,0.006377,0.061468,0.14946,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN,0.871466049589546
GSE32255_WT_VS_JMJD2D_KNOCKD...2,SET,129,0.080348,0.0067112,0.077361,0.1495,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.871466049589546
MIR339_3P,SET,6,0.34471,0.0062305,0.33194,0.14953,MIR339_3P,0.871466049589546
SARTIPY_NORMAL_AT_INSULIN_RE...2,SET,27,0.17772,0.0068102,0.17115,0.14955,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,0.871466049589546
GOMF_C2H2_ZINC_FINGER_DOMAIN...,SET,12,0.26339,0.0067315,0.25368,0.14957,GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING,0.871466049589546
CYCLIN_D1_KE_.V1_UP,SET,176,0.065595,0.0063915,0.063178,0.14958,CYCLIN_D1_KE_.V1_UP,0.871466049589546
FARMER_BREAST_CANCER_CLUSTER...1,SET,38,0.16435,0.0074691,0.1583,0.1496,FARMER_BREAST_CANCER_CLUSTER_1,0.871466049589546
HP_BENIGN_NEOPLASM_OF_THE_CE...,SET,100,0.083965,0.0061798,0.080878,0.1496,HP_BENIGN_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.871466049589546
GOBP_NEUROTRANSMITTER_RECEPT...1,SET,33,0.15646,0.0066274,0.15074,0.14965,GOBP_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.871466049589546
GOBP_INTERLEUKIN_11_MEDIATED...,SET,6,0.36989,0.0066856,0.35637,0.14966,GOBP_INTERLEUKIN_11_MEDIATED_SIGNALING_PATHWAY,0.871466049589546
GOCC_GOLGI_APPARATUS_SUBCOMP...,SET,330,0.048124,0.0063936,0.046368,0.14967,GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT,0.871466049589546
HP_CONGENITAL_THROMBOCYTOPEN...,SET,4,0.38346,0.0056593,0.36946,0.14967,HP_CONGENITAL_THROMBOCYTOPENIA,0.871466049589546
CHEBOTAEV_GR_TARGETS_DN,SET,109,0.091593,0.0070364,0.088289,0.14978,CHEBOTAEV_GR_TARGETS_DN,0.871660971943888
GSE19401_RETINOIC_ACID_VS_RE...1,SET,187,0.060677,0.0060923,0.058489,0.14978,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.871660971943888
HP_LIMITED_PRONATION_SUPINAT...,SET,11,0.30648,0.0074996,0.29546,0.1498,HP_LIMITED_PRONATION_SUPINATION_OF_FOREARM,0.871660971943888
GSE29949_CD8_POS_DC_SPLEEN_V...2,SET,184,0.064834,0.0064579,0.062504,0.14981,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP,0.871660971943888
WP_SULFATASE_AND_AROMATASE_P...,SET,14,0.25221,0.0069619,0.24317,0.14983,WP_SULFATASE_AND_AROMATASE_PATHWAY,0.871660971943888
GSE4535_BM_DERIVED_DC_VS_FOL...2,SET,178,0.068418,0.0067039,0.065977,0.14987,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP,0.871660971943888
GSE16385_MONOCYTE_VS_MACROPH...1,SET,171,0.068115,0.0065429,0.065686,0.14988,GSE16385_MONOCYTE_VS_MACROPHAGE_DN,0.871660971943888
MIR3680_5P,SET,31,0.14707,0.0060382,0.14187,0.14995,MIR3680_5P,0.871660971943888
GSE9509_LPS_VS_LPS_AND_IL10_...5,SET,169,0.068874,0.0065774,0.066436,0.14995,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN,0.871660971943888
MIR619_5P,SET,130,0.076508,0.006415,0.073826,0.15003,MIR619_5P,0.871660971943888
MORF_AP3D1,SET,119,0.073504,0.0058984,0.070926,0.15003,MORF_AP3D1,0.871660971943888
GOCC_POLE_PLASM,SET,23,0.17943,0.0063466,0.17315,0.15005,GOCC_POLE_PLASM,0.871660971943888
GOMF_DIPEPTIDE_TRANSMEMBRANE...,SET,5,0.42179,0.0069596,0.40711,0.1501,GOMF_DIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.871660971943888
GOMF_COMPLEMENT_COMPONENT_C3...,SET,7,0.43314,0.0084558,0.4181,0.15011,GOMF_COMPLEMENT_COMPONENT_C3B_BINDING,0.871660971943888
HP_GINGIVAL_BLEEDING,SET,52,0.13343,0.0070908,0.12879,0.15011,HP_GINGIVAL_BLEEDING,0.871660971943888
HP_FRONTOTEMPORAL_CEREBRAL_A...,SET,14,0.22391,0.0061807,0.21615,0.15013,HP_FRONTOTEMPORAL_CEREBRAL_ATROPHY,0.871660971943888
AP1_C,SET,249,0.056259,0.0065072,0.054312,0.15014,AP1_C,0.871660971943888
MIR24_3P,SET,246,0.056276,0.0064703,0.054334,0.15017,MIR24_3P,0.871660971943888
GSE44955_MCSF_VS_MCSF_AND_IL...2,SET,175,0.066388,0.0064505,0.064101,0.15018,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP,0.871660971943888
GOBP_REGULATION_OF_PEPTIDYL_...1,SET,8,0.32625,0.0068086,0.31506,0.15023,GOBP_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.871718063439065
GOBP_NEGATIVE_REGULATION_OF_...635,SET,6,0.38536,0.0069652,0.37217,0.15024,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.871718063439065
HP_EMG_ABNORMALITY,SET,250,0.056219,0.0065153,0.054303,0.15028,HP_EMG_ABNORMALITY,0.871804606910366
GOBP_SEQUESTERING_OF_IRON_ION,SET,5,0.4289,0.0070769,0.4144,0.15035,GOBP_SEQUESTERING_OF_IRON_ION,0.872030334832584
MIR7114_3P,SET,42,0.13661,0.0065266,0.13201,0.15038,MIR7114_3P,0.872030334832584
REACTOME_N_GLYCAN_TRIMMING_A...,SET,5,0.49186,0.0081158,0.47546,0.15046,REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI,0.872030334832584
HP_NEONATAL_HYPOGLYCEMIA,SET,42,0.13821,0.006603,0.1336,0.15046,HP_NEONATAL_HYPOGLYCEMIA,0.872030334832584
GOBP_REGULATION_OF_MICROVILL...2,SET,7,0.28657,0.0055944,0.27704,0.15048,GOBP_REGULATION_OF_MICROVILLUS_LENGTH,0.872030334832584
GOBP_REGULATION_OF_PROTEIN_A...2,SET,5,0.29868,0.0049283,0.28878,0.15051,GOBP_REGULATION_OF_PROTEIN_ADP_RIBOSYLATION,0.872030334832584
ACTGTGA_MIR27A_MIR27B,SET,434,0.043767,0.006649,0.042318,0.15052,ACTGTGA_MIR27A_MIR27B,0.872030334832584
REACTOME_TRAFFICKING_AND_PRO...,SET,11,0.28709,0.0070251,0.2776,0.15053,REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,0.872030334832584
HP_CEREBRAL_VISUAL_IMPAIRMENT,SET,140,0.072479,0.0063049,0.070099,0.15058,HP_CEREBRAL_VISUAL_IMPAIRMENT,0.872030334832584
GOCC_NUCLEAR_PORE,SET,87,0.091486,0.0062827,0.088485,0.1506,GOCC_NUCLEAR_PORE,0.872030334832584
GOBP_URETER_MORPHOGENESIS,SET,7,0.32128,0.0062721,0.31076,0.15061,GOBP_URETER_MORPHOGENESIS,0.872030334832584
GOBP_POSITIVE_REGULATION_OF_...846,SET,8,0.36039,0.0075211,0.3486,0.15062,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.872030334832584
GOBP_POSITIVE_REGULATION_OF_...559,SET,28,0.19496,0.0076077,0.18867,0.15074,GOBP_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.87257973017988
REACTOME_COLLAGEN_DEGRADATION,SET,61,0.12328,0.0070943,0.11934,0.1508,REACTOME_COLLAGEN_DEGRADATION,0.872750807256991
MORF_RBM8A,SET,77,0.098818,0.006386,0.09567,0.15083,MORF_RBM8A,0.872750807256991
REACTOME_KERATAN_SULFATE_KER...,SET,36,0.15312,0.0067737,0.14826,0.15086,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,0.872750807256991
FOROUTAN_TGFB_EMT_DN,SET,102,0.094949,0.0070574,0.091939,0.15087,FOROUTAN_TGFB_EMT_DN,0.872750807256991
GOBP_B_CELL_RECEPTOR_SIGNALI...,SET,58,0.12318,0.0069124,0.1193,0.15092,GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.872835601397438
HP_RHIZOMELIC_ARM_SHORTENING,SET,9,0.29775,0.0065908,0.28841,0.15095,HP_RHIZOMELIC_ARM_SHORTENING,0.872835601397438
GOBP_MAMMARY_GLAND_DUCT_MORP...,SET,30,0.17556,0.007091,0.17006,0.15096,GOBP_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.872835601397438
REACTOME_CONDENSATION_OF_PRO...1,SET,11,0.22962,0.0056188,0.22258,0.15112,REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES,0.873523243063632
MIR3681_3P,SET,356,0.04859,0.0067001,0.047102,0.15114,MIR3681_3P,0.873523243063632
MIR208A_5P,SET,228,0.059361,0.0065739,0.057548,0.15116,MIR208A_5P,0.873523243063632
HP_PANCREATIC_FIBROSIS,SET,21,0.1631,0.0055128,0.15815,0.15121,HP_PANCREATIC_FIBROSIS,0.873523243063632
WP_MAMMARY_GLAND_DEVELOPMENT...2,SET,10,0.3036,0.0070834,0.2944,0.15123,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,0.873523243063632
GOBP_REGULATION_OF_CELLULAR_...19,SET,24,0.19444,0.0070253,0.18855,0.15123,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.873523243063632
MORI_MATURE_B_LYMPHOCYTE_UP,SET,79,0.10547,0.0069034,0.10229,0.15126,MORI_MATURE_B_LYMPHOCYTE_UP,0.873523243063632
GOMF_INOSITOL_TETRAKISPHOSPH...2,SET,7,0.32397,0.0063247,0.31424,0.15128,GOMF_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.873523243063632
GSE3039_ALPHABETA_CD8_TCELL_...4,SET,180,0.06451,0.006356,0.062587,0.15134,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP,0.873724534883721
GSE15930_STIM_VS_STIM_AND_TR...4,SET,185,0.069296,0.0069208,0.067245,0.1514,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP,0.873896064430422
FAN_OVARY_CL9_PUTATIVE_APOPT...,SET,328,0.048728,0.0064546,0.047291,0.15142,FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL,0.873896064430422
GOBP_CAMERA_TYPE_EYE_PHOTORE...,SET,31,0.16375,0.0067229,0.15894,0.15145,GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.873924082683048
RNTCANNRNNYNATTW_UNKNOWN,SET,58,0.11762,0.0066007,0.1142,0.15152,RNTCANNRNNYNATTW_UNKNOWN,0.874182868525896
GOBP_B_CELL_MEDIATED_IMMUNITY,SET,117,0.084572,0.0067297,0.082125,0.15156,GOBP_B_CELL_MEDIATED_IMMUNITY,0.874268514522822
GSE22432_MULTIPOTENT_VS_COMM...3,SET,174,0.063796,0.0061811,0.061975,0.15166,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP,0.874666539545681
GSE369_PRE_VS_POST_IL6_INJEC...3,SET,193,0.063128,0.0064383,0.061336,0.1517,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN,0.874666539545681
HP_NEOPLASM_BY_HISTOLOGY,SET,331,0.04829,0.0064252,0.046924,0.15172,HP_NEOPLASM_BY_HISTOLOGY,0.874666539545681
MIR4451,SET,132,0.076839,0.0064918,0.074677,0.15176,MIR4451,0.874666539545681
GOBP_NEGATIVE_REGULATION_OF_...147,SET,49,0.12144,0.0062654,0.11803,0.15178,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,0.874666539545681
GOBP_REGULATION_OF_CARDIAC_M...7,SET,35,0.16654,0.0072643,0.16187,0.15178,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.874666539545681
HP_11_PAIRS_OF_RIBS,SET,44,0.13294,0.0065,0.12925,0.15187,HP_11_PAIRS_OF_RIBS,0.874980452436195
GOCC_ENDOPLASMIC_RETICULUM_P...3,SET,111,0.080366,0.0062299,0.078155,0.15191,GOCC_ENDOPLASMIC_RETICULUM_PROTEIN_CONTAINING_COMPLEX,0.874980452436195
GSE42021_CD24HI_TREG_VS_CD24...2,SET,179,0.061612,0.0060538,0.059916,0.15191,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP,0.874980452436195
KONG_E2F3_TARGETS,SET,90,0.089442,0.0062468,0.086996,0.15196,KONG_E2F3_TARGETS,0.875089470198675
BOYAULT_LIVER_CANCER_SUBCLAS...1,SET,45,0.13027,0.0064414,0.12672,0.15199,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,0.875089470198675
MIR3152_5P,SET,55,0.11331,0.0061923,0.11024,0.15201,MIR3152_5P,0.875089470198675
HP_ANKLE_SWELLING,SET,12,0.28125,0.0071879,0.27364,0.15203,HP_ANKLE_SWELLING,0.875089470198675
REACTOME_NS1_MEDIATED_EFFECT...,SET,39,0.13104,0.006033,0.12752,0.15207,REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,0.875089470198675
REACTOME_GAP_JUNCTION_ASSEMB...,SET,33,0.17404,0.007372,0.16937,0.15208,REACTOME_GAP_JUNCTION_ASSEMBLY,0.875089470198675
chr3q27,SET,60,0.24055,0.013729,0.23412,0.15211,chr3q27,0.875117207415991
GOBP_REGULATION_OF_COAGULATI...,SET,72,0.10869,0.0067933,0.10582,0.15217,GOBP_REGULATION_OF_COAGULATION,0.875287679960285
MIR4524B_3P,SET,65,0.11734,0.0069694,0.11424,0.15219,MIR4524B_3P,0.875287679960285
HP_GRAVES_DISEASE,SET,3,0.54618,0.0069812,0.53198,0.15229,HP_GRAVES_DISEASE,0.875717893778954
GSE10147_IL3_AND_HIVP17_VS_I...2,SET,132,0.080104,0.0067677,0.078044,0.15236,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP,0.875915660658178
GSE17974_CTRL_VS_ACT_IL4_AND...9,SET,173,0.063717,0.0061558,0.062083,0.15238,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN,0.875915660658178
chr10q24,SET,109,0.16259,0.01249,0.15844,0.1524,chr10q24,0.875915660658178
HP_PACE_OF_PROGRESSION,SET,400,0.043821,0.0063972,0.04271,0.15245,HP_PACE_OF_PROGRESSION,0.875936223984143
HP_RECURRENT_KLEBSIELLA_INFE...,SET,4,0.50967,0.007522,0.49685,0.1525,HP_RECURRENT_KLEBSIELLA_INFECTIONS,0.875936223984143
BIOCARTA_IRES_PATHWAY,SET,7,0.30555,0.0059651,0.29791,0.15253,BIOCARTA_IRES_PATHWAY,0.875936223984143
REACTOME_G_PROTEIN_ACTIVATION,SET,24,0.19259,0.0069587,0.18777,0.15253,REACTOME_G_PROTEIN_ACTIVATION,0.875936223984143
GSE37319_WT_VS_RC3H1_KO_CD44...1,SET,122,0.081872,0.0066517,0.079836,0.15257,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN,0.875936223984143
GOBP_KERATAN_SULFATE_METABOL...,SET,18,0.21452,0.0067136,0.20919,0.15258,GOBP_KERATAN_SULFATE_METABOLIC_PROCESS,0.875936223984143
GSE26156_DOUBLE_POSITIVE_VS_...1,SET,184,0.062512,0.0062265,0.06096,0.15258,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.875936223984143
GOBP_REGULATION_OF_ANOIKIS,SET,22,0.18591,0.0064317,0.18134,0.15264,GOBP_REGULATION_OF_ANOIKIS,0.876135953757225
GSE22611_UNSTIM_VS_6H_MDP_ST...2,SET,177,0.0658,0.0064294,0.064193,0.15268,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.876220838837517
GOMF_RETROMER_COMPLEX_BINDING,SET,6,0.40131,0.0072535,0.39158,0.15272,GOMF_RETROMER_COMPLEX_BINDING,0.876275784087157
GOMF_AP_2_ADAPTOR_COMPLEX_BI...,SET,10,0.26871,0.0062694,0.26221,0.15274,GOMF_AP_2_ADAPTOR_COMPLEX_BINDING,0.876275784087157
IVANOVA_HEMATOPOIESIS_LATE_P...,SET,466,0.039397,0.0061964,0.038452,0.15279,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,0.876385565819861
RIZ_ERYTHROID_DIFFERENTIATIO...4,SET,38,0.14191,0.0064495,0.13853,0.15283,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,0.876385565819861
CGGAARNGGCNG_UNKNOWN,SET,52,0.11273,0.0059907,0.11005,0.15285,CGGAARNGGCNG_UNKNOWN,0.876385565819861
GSE17721_CTRL_VS_LPS_6H_BMDC...2,SET,178,0.0645,0.0063201,0.062971,0.15286,GSE17721_CTRL_VS_LPS_6H_BMDC_UP,0.876385565819861
REACTOME_HOMOLOGOUS_DNA_PAIR...,SET,41,0.12861,0.0060707,0.12562,0.15297,REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,0.876841597955145
MIR8074,SET,17,0.19969,0.0060736,0.19506,0.15299,MIR8074,0.876841597955145
GSE2706_UNSTIM_VS_2H_R848_DC...1,SET,172,0.072072,0.006943,0.070417,0.15304,GSE2706_UNSTIM_VS_2H_R848_DC_DN,0.876950898154252
HP_WHITE_FORELOCK,SET,14,0.26229,0.0072402,0.25631,0.15308,HP_WHITE_FORELOCK,0.876950898154252
GOBP_ANIMAL_ORGAN_MORPHOGENE...,SET,952,0.030997,0.0068728,0.030292,0.1531,GOBP_ANIMAL_ORGAN_MORPHOGENESIS,0.876950898154252
GOBP_MONOCYTE_DIFFERENTIATION,SET,32,0.16733,0.0069798,0.16354,0.15311,GOBP_MONOCYTE_DIFFERENTIATION,0.876950898154252
HP_KETOTIC_HYPOGLYCEMIA,SET,12,0.25726,0.0065747,0.25149,0.15317,HP_KETOTIC_HYPOGLYCEMIA,0.87715
GOMF_MOLECULAR_CARRIER_ACTIV...,SET,84,0.091585,0.0061806,0.089541,0.1532,GOMF_MOLECULAR_CARRIER_ACTIVITY,0.87717726523888
REACTOME_BETA_OXIDATION_OF_P...,SET,9,0.26111,0.0057797,0.25534,0.15325,REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA,0.87725900708052
MAP2K1_TARGET_GENES,SET,5,0.3788,0.0062503,0.37045,0.15327,MAP2K1_TARGET_GENES,0.87725900708052
chr7p15,SET,40,0.24611,0.011475,0.2407,0.15329,chr7p15,0.87725900708052
HP_URINARY_INCONTINENCE,SET,134,0.07698,0.0065525,0.075311,0.15336,HP_URINARY_INCONTINENCE,0.877515113598946
HP_LIMB_GIRDLE_MUSCULAR_DYST...,SET,13,0.24083,0.006406,0.23572,0.15348,HP_LIMB_GIRDLE_MUSCULAR_DYSTROPHY,0.877556680227827
MTOR_UP.N4.V1_DN,SET,155,0.069314,0.0063417,0.067865,0.15355,MTOR_UP.N4.V1_DN,0.877556680227827
GSE8621_LPS_PRIMED_UNSTIM_VS...2,SET,175,0.063994,0.0062179,0.062658,0.15356,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.877556680227827
MIR6840_3P,SET,154,0.069034,0.0062959,0.067628,0.15368,MIR6840_3P,0.877556680227827
MORF_CASP2,SET,89,0.088946,0.0061778,0.087169,0.15378,MORF_CASP2,0.877556680227827
TAGHAVI_NEOPLASTIC_TRANSFORM...,SET,11,0.23317,0.0057056,0.22852,0.15379,TAGHAVI_NEOPLASTIC_TRANSFORMATION,0.877556680227827
GOCC_9PLUS2_MOTILE_CILIUM,SET,158,0.069874,0.0064541,0.068483,0.15379,GOCC_9PLUS2_MOTILE_CILIUM,0.877556680227827
YANG_BCL3_TARGETS_UP,SET,308,0.050422,0.0064756,0.04942,0.15381,YANG_BCL3_TARGETS_UP,0.877556680227827
NFKB_Q6_01,SET,221,0.058531,0.0063829,0.057378,0.15385,NFKB_Q6_01,0.877556680227827
MATZUK_STEROIDOGENESIS,SET,6,0.40449,0.007311,0.39655,0.15386,MATZUK_STEROIDOGENESIS,0.877556680227827
GOMF_TRANSKETOLASE_OR_TRANSA...,SET,3,0.48073,0.0061445,0.47142,0.15393,GOMF_TRANSKETOLASE_OR_TRANSALDOLASE_ACTIVITY,0.877556680227827
ZHANG_ANTIVIRAL_RESPONSE_TO_...1,SET,43,0.14316,0.00692,0.1404,0.15396,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,0.877556680227827
KEGG_MEDICUS_REFERENCE_GLUCO...,SET,5,0.36688,0.0060536,0.35988,0.154,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS,0.877556680227827
E2F1_Q3,SET,221,0.056804,0.0061945,0.055723,0.15401,E2F1_Q3,0.877556680227827
GOBP_NEGATIVE_REGULATION_OF_...78,SET,9,0.33072,0.0073205,0.32442,0.15401,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.877556680227827
HP_PARKINSONISM,SET,123,0.079,0.0064444,0.077503,0.15403,HP_PARKINSONISM,0.877556680227827
GOBP_POSITIVE_REGULATION_OF_...524,SET,37,0.14851,0.0066601,0.1457,0.15404,GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.877556680227827
FXR1_TARGET_GENES,SET,978,0.027887,0.0062625,0.027362,0.15406,FXR1_TARGET_GENES,0.877556680227827
MIR3190_5P,SET,110,0.081822,0.0063143,0.080285,0.15407,MIR3190_5P,0.877556680227827
GOCC_AZUROPHIL_GRANULE_MEMBR...,SET,51,0.1175,0.0061843,0.11531,0.1541,GOCC_AZUROPHIL_GRANULE_MEMBRANE,0.877556680227827
HP_ABNORMAL_FRONTALIS_MUSCLE...,SET,10,0.2805,0.0065446,0.27527,0.1541,HP_ABNORMAL_FRONTALIS_MUSCLE_PHYSIOLOGY,0.877556680227827
HP_EPISODIC_RESPIRATORY_DIST...,SET,10,0.2805,0.0065446,0.27527,0.1541,HP_EPISODIC_RESPIRATORY_DISTRESS,0.877556680227827
CHIARADONNA_NEOPLASTIC_TRANS...6,SET,113,0.083881,0.0065603,0.082333,0.15416,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,0.877556680227827
HP_DECREASED_LYMPHOCYTE_APOP...,SET,6,0.33067,0.0059767,0.32457,0.15416,HP_DECREASED_LYMPHOCYTE_APOPTOSIS,0.877556680227827
TAKEDA_TARGETS_OF_NUP98_HOXA...9,SET,176,0.069804,0.0068016,0.068526,0.15419,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,0.877556680227827
GOCC_EUKARYOTIC_TRANSLATION_...5,SET,13,0.23148,0.0061573,0.22724,0.15419,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX,0.877556680227827
DESCARTES_FETAL_CEREBELLUM_P...,SET,43,0.14579,0.0070473,0.14312,0.15419,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.877556680227827
ALTEMEIER_RESPONSE_TO_LPS_WI...,SET,112,0.086492,0.0067347,0.08491,0.1542,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,0.877556680227827
GOBP_RESPIRATORY_CHAIN_COMPL...1,SET,8,0.30105,0.0062828,0.29555,0.1542,GOBP_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY,0.877556680227827
HP_AGENESIS_OF_LATERAL_INCIS...,SET,23,0.19617,0.0069388,0.19262,0.15424,HP_AGENESIS_OF_LATERAL_INCISOR,0.877556680227827
DESCARTES_FETAL_INTESTINE_ER...,SET,132,0.07783,0.0065756,0.076425,0.15425,DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS,0.877556680227827
GSE22611_NOD2_TRANSD_VS_CTRL...3,SET,178,0.069133,0.006774,0.067886,0.15426,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN,0.877556680227827
GOBP_NEGATIVE_REGULATION_OF_...292,SET,12,0.28054,0.0071697,0.2755,0.15428,GOBP_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.877556680227827
HP_EMG_CHRONIC_DENERVATION_S...,SET,25,0.16503,0.0060857,0.16208,0.15429,HP_EMG_CHRONIC_DENERVATION_SIGNS,0.877556680227827
GOBP_REGULATION_OF_B_CELL_PR...,SET,61,0.11496,0.0066153,0.11291,0.15431,GOBP_REGULATION_OF_B_CELL_PROLIFERATION,0.877556680227827
GSE2405_0H_VS_9H_A_PHAGOCYTO...2,SET,176,0.064289,0.0062642,0.063147,0.15433,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.877556680227827
GSE41867_DAY15_EFFECTOR_VS_D...3,SET,154,0.067387,0.0061457,0.06619,0.15433,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.877556680227827
GOMF_VOLTAGE_GATED_MONOATOMI...3,SET,11,0.30504,0.0074642,0.29968,0.15438,GOMF_VOLTAGE_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.877556680227827
MORF_CUL1,SET,68,0.09738,0.0059154,0.095685,0.15441,MORF_CUL1,0.877556680227827
KEGG_MEDICUS_VARIANT_MUTATIO...76,SET,20,0.18871,0.0062251,0.18546,0.15446,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.877556680227827
ZHONG_PFC_C3_PROX1_CCK_POS_I...,SET,10,0.33239,0.0077552,0.3267,0.15449,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.877556680227827
GSE42724_B1_BCELL_VS_PLASMAB...1,SET,181,0.062075,0.0061329,0.061016,0.1545,GSE42724_B1_BCELL_VS_PLASMABLAST_DN,0.877556680227827
WP_EBOLA_VIRUS_INFECTION_IN_...,SET,122,0.082075,0.0066682,0.080687,0.15453,WP_EBOLA_VIRUS_INFECTION_IN_HOST,0.877556680227827
AIYAR_COBRA1_TARGETS_DN,SET,27,0.17154,0.0065735,0.16866,0.15456,AIYAR_COBRA1_TARGETS_DN,0.877556680227827
WP_KENNEDY_PATHWAY_FROM_SPHI...,SET,13,0.21878,0.0058197,0.21511,0.15456,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,0.877556680227827
GOBP_GLUCOSYLCERAMIDE_CATABO...,SET,4,0.48827,0.0072062,0.48009,0.15457,GOBP_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,0.877556680227827
GAUSSMANN_MLL_AF4_FUSION_TAR...4,SET,23,0.18475,0.0065349,0.18168,0.1546,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,0.877556680227827
MIR212_5P,SET,86,0.09218,0.006294,0.090649,0.15461,MIR212_5P,0.877556680227827
GSE33425_CD161_HIGH_VS_NEG_C...1,SET,178,0.068449,0.006707,0.067328,0.15467,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.877556680227827
GOBP_ENDOMEMBRANE_SYSTEM_ORG...,SET,531,0.037465,0.0062786,0.036856,0.1547,GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION,0.877556680227827
HP_HYPOPIGMENTATION_OF_THE_S...,SET,179,0.063471,0.0062365,0.062441,0.15471,HP_HYPOPIGMENTATION_OF_THE_SKIN,0.877556680227827
MIR5787,SET,230,0.05794,0.0064443,0.057011,0.15475,MIR5787,0.877556680227827
GOMF_EXTRACELLULAR_MATRIX_ST...3,SET,42,0.14872,0.0071048,0.14633,0.15475,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH,0.877556680227827
GAVISH_3CA_METAPROGRAM_FIBRO...10,SET,48,0.13766,0.0070293,0.13547,0.15479,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9,0.877556680227827
PID_P53_REGULATION_PATHWAY,SET,55,0.11586,0.0063316,0.11404,0.15483,PID_P53_REGULATION_PATHWAY,0.877556680227827
HP_ABNORMALITY_OF_THE_MUSCUL...2,SET,564,0.036909,0.0063689,0.036329,0.15483,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LIMBS,0.877556680227827
HP_APLASIA_HYPOPLASIA_OF_THE...55,SET,6,0.3388,0.0061236,0.33355,0.15489,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HALLUX,0.877556680227827
MIR216A_5P,SET,118,0.082059,0.0065574,0.080793,0.1549,MIR216A_5P,0.877556680227827
GOBP_POSITIVE_REGULATION_OF_...663,SET,5,0.41136,0.0067876,0.40505,0.15492,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_BINDING,0.877556680227827
GSE22432_PDC_VS_TGFB1_TREATE...1,SET,176,0.067566,0.0065835,0.066528,0.15492,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN,0.877556680227827
GSE37301_HEMATOPOIETIC_STEM_...10,SET,185,0.064547,0.0064466,0.063572,0.15498,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP,0.877556680227827
MCBRYAN_PUBERTAL_BREAST_3_4W...2,SET,192,0.067822,0.0068993,0.066809,0.15502,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,0.877556680227827
GOCC_CCR4_NOT_CORE_COMPLEX,SET,5,0.33979,0.0056066,0.33472,0.15502,GOCC_CCR4_NOT_CORE_COMPLEX,0.877556680227827
MIR3943,SET,39,0.14318,0.0065922,0.14105,0.15503,MIR3943,0.877556680227827
GSE15324_NAIVE_VS_ACTIVATED_...4,SET,183,0.06147,0.0061063,0.060554,0.15503,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP,0.877556680227827
DESCARTES_FETAL_PLACENTA_IGF...,SET,94,0.095352,0.0068053,0.093937,0.15504,DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS,0.877556680227827
MIR6766_3P,SET,139,0.073907,0.0064063,0.072819,0.15508,MIR6766_3P,0.877556680227827
GOMF_SNORNA_BINDING,SET,28,0.15276,0.0059609,0.15052,0.1551,GOMF_SNORNA_BINDING,0.877556680227827
HP_PROSTATE_CANCER,SET,32,0.15411,0.0064281,0.15187,0.15512,HP_PROSTATE_CANCER,0.877556680227827
REACTOME_P75_NTR_RECEPTOR_ME...,SET,87,0.094139,0.0064649,0.092778,0.15514,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,0.877556680227827
GOMF_PROTEIN_DISULFIDE_REDUC...,SET,7,0.3008,0.0058722,0.29647,0.15516,GOMF_PROTEIN_DISULFIDE_REDUCTASE_NAD_P_H_ACTIVITY,0.877556680227827
MODULE_332,SET,42,0.12633,0.0060353,0.12454,0.15521,MODULE_332,0.877696640091116
GOBP_ANTIGEN_PROCESSING_AND_...12,SET,17,0.25673,0.0078085,0.25322,0.15533,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_IB,0.877816190553481
GOBP_PARACRINE_SIGNALING,SET,6,0.38857,0.0070232,0.38325,0.15533,GOBP_PARACRINE_SIGNALING,0.877816190553481
ENGELMANN_CANCER_PROGENITORS...1,SET,58,0.11891,0.0066729,0.11731,0.15538,ENGELMANN_CANCER_PROGENITORS_DN,0.877816190553481
GOCC_CHITOSOME,SET,20,0.20668,0.0068177,0.2039,0.15539,GOCC_CHITOSOME,0.877816190553481
GOBP_VESICLE_TARGETING_ROUGH...,SET,24,0.17404,0.0062884,0.17171,0.1554,GOBP_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI,0.877816190553481
GSE37605_C57BL6_VS_NOD_FOXP3...2,SET,148,0.074247,0.0066392,0.073262,0.15543,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP,0.877816190553481
HE_LIM_SUN_FETAL_LUNG_C5_CD5...1,SET,46,0.1338,0.0066891,0.13204,0.15546,HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL,0.877816190553481
GOBP_POSITIVE_REGULATION_OF_...94,SET,483,0.040208,0.0064352,0.039683,0.15548,GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS,0.877816190553481
GSE3982_MAST_CELL_VS_NKCELL_...1,SET,179,0.065672,0.0064527,0.064823,0.15551,GSE3982_MAST_CELL_VS_NKCELL_DN,0.877816190553481
GSE39152_BRAIN_VS_SPLEEN_CD1...1,SET,186,0.061925,0.0062012,0.061125,0.15552,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN,0.877816190553481
GOBP_DNA_DOUBLE_STRAND_BREAK...,SET,19,0.187,0.0060126,0.18461,0.15555,GOBP_DNA_DOUBLE_STRAND_BREAK_PROCESSING,0.877816190553481
HP_MEGALENCEPHALY,SET,40,0.14135,0.0065906,0.13955,0.15556,HP_MEGALENCEPHALY,0.877816190553481
GOCC_SYNAPTIC_MEMBRANE,SET,369,0.048338,0.0067835,0.047726,0.15558,GOCC_SYNAPTIC_MEMBRANE,0.877816190553481
YANG_BREAST_CANCER_ESR1_UP,SET,35,0.15035,0.0065581,0.14846,0.15561,YANG_BREAST_CANCER_ESR1_UP,0.877816190553481
GOMF_TRANSCRIPTION_REGULATOR...2,SET,1780,0.023133,0.0068449,0.022843,0.15561,GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY,0.877816190553481
GOBP_NEGATIVE_REGULATION_OF_...463,SET,14,0.28327,0.0078192,0.27976,0.15565,GOBP_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.877899342745862
GSE369_PRE_VS_POST_IL6_INJEC...1,SET,176,0.063984,0.0062345,0.0632,0.15568,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN,0.877926074963492
HP_EPISODIC_TACHYPNEA,SET,48,0.10948,0.0055905,0.10816,0.15572,HP_EPISODIC_TACHYPNEA,0.878009182349124
REACTOME_RETROGRADE_NEUROTRO...,SET,14,0.22117,0.0061051,0.21857,0.1558,REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,0.878231681803438
HP_ABNORMAL_GLOBUS_PALLIDUS_...,SET,21,0.18837,0.0063672,0.18616,0.15581,HP_ABNORMAL_GLOBUS_PALLIDUS_MORPHOLOGY,0.878231681803438
GSE5589_LPS_AND_IL10_VS_LPS_...3,SET,179,0.06452,0.0063396,0.063785,0.15589,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.878501020408163
AMIT_EGF_RESPONSE_40_HELA,SET,40,0.14637,0.0068244,0.14475,0.15596,AMIT_EGF_RESPONSE_40_HELA,0.878501020408163
GOBP_NEUTRAL_LIPID_BIOSYNTHE...,SET,45,0.12531,0.0061962,0.12392,0.15597,GOBP_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS,0.878501020408163
MORF_PHB,SET,115,0.074196,0.0058537,0.073382,0.15599,MORF_PHB,0.878501020408163
MEF2_Q6_01,SET,221,0.061365,0.0066919,0.060695,0.15601,MEF2_Q6_01,0.878501020408163
MORI_SMALL_PRE_BII_LYMPHOCYT...1,SET,73,0.098203,0.00618,0.097139,0.15603,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,0.878501020408163
GSE24726_WT_VS_E2_2_KO_PDC_D...1,SET,186,0.064435,0.0064526,0.063744,0.15605,GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP,0.878501020408163
HP_ABNORMALITY_OF_THE_MUSCUL...1,SET,111,0.078374,0.0060755,0.077535,0.15606,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_HAND,0.878501020408163
REACTOME_DRUG_MEDIATED_INHIB...,SET,5,0.40121,0.00662,0.39697,0.15609,REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY,0.878527603238866
GOBP_APOPTOTIC_CHROMOSOME_CO...,SET,6,0.36517,0.0066003,0.36147,0.1562,GOBP_APOPTOTIC_CHROMOSOME_CONDENSATION,0.878944836516672
MIR874_3P,SET,49,0.11825,0.0061007,0.11706,0.15622,MIR874_3P,0.878944836516672
HP_CONICAL_INCISOR,SET,34,0.16246,0.0069849,0.16085,0.15624,HP_CONICAL_INCISOR,0.878944836516672
GSE26669_CTRL_VS_COSTIM_BLOC...3,SET,179,0.062651,0.0061559,0.062037,0.15628,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN,0.879027577277877
TIEN_INTESTINE_PROBIOTICS_6H...2,SET,46,0.1256,0.0062788,0.12443,0.1564,TIEN_INTESTINE_PROBIOTICS_6HR_UP,0.87948335755814
REACTOME_TNF_RECEPTOR_SUPERF...,SET,16,0.23304,0.0068764,0.23089,0.15642,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,0.87948335755814
HOFT_PBMC_TICE_BCG_RBCG_AG85...,SET,35,0.15576,0.0067942,0.15436,0.15648,HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE,0.87948335755814
GOBP_INTRINSIC_APOPTOTIC_SIG...5,SET,58,0.10706,0.0060077,0.1061,0.15649,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.87948335755814
RCGCANGCGY_NRF1_Q6,SET,852,0.028944,0.0060887,0.02869,0.15653,RCGCANGCGY_NRF1_Q6,0.87948335755814
GSE28130_ACTIVATED_VS_INDUCE...2,SET,175,0.066908,0.006501,0.066333,0.15657,GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP,0.87948335755814
GOBP_NEGATIVE_REGULATION_OF_...95,SET,92,0.095105,0.0067154,0.094292,0.15658,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.87948335755814
GOCC_MIDBODY,SET,185,0.060772,0.0060695,0.060252,0.15658,GOCC_MIDBODY,0.87948335755814
WANG_CLIM2_TARGETS_UP,SET,214,0.057752,0.0061986,0.05726,0.15659,WANG_CLIM2_TARGETS_UP,0.87948335755814
GOBP_PYRIMIDINE_NUCLEOSIDE_D...1,SET,6,0.3307,0.0059773,0.32795,0.15664,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.87948335755814
GSE13411_NAIVE_VS_IGM_MEMORY...1,SET,183,0.062142,0.006173,0.061628,0.15665,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.87948335755814
HP_ABNORMALITY_OF_THE_OVARY,SET,216,0.057909,0.006244,0.057435,0.15667,HP_ABNORMALITY_OF_THE_OVARY,0.87948335755814
GOMF_ORGANIC_ANION_TRANSMEMB...,SET,253,0.056105,0.0065406,0.05565,0.15669,GOMF_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.87948335755814
GOMF_OXIDOREDUCTASE_ACTIVITY...3,SET,9,0.29168,0.0064563,0.28938,0.15675,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.879678063943162
MIR362_3P,SET,107,0.08934,0.0068004,0.088672,0.15685,MIR362_3P,0.879895425205745
GSE19825_NAIVE_VS_IL2RALOW_D...1,SET,177,0.060542,0.0059157,0.060093,0.15686,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN,0.879895425205745
DESERT_PERIVENOUS_HEPATOCELL...,SET,143,0.07283,0.0064025,0.072295,0.15688,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.879895425205745
REACTOME_NUCLEAR_PORE_COMPLE...,SET,34,0.14054,0.0060423,0.13952,0.15689,REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY,0.879895425205745
GOBP_CELLULAR_RESPONSE_TO_PU...,SET,13,0.24289,0.0064609,0.24121,0.15698,GOBP_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.879944363812288
GSE15930_NAIVE_VS_24H_IN_VIT...3,SET,188,0.059157,0.0059554,0.05875,0.15699,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.879944363812288
MIR4689,SET,78,0.097182,0.0063208,0.096516,0.157,MIR4689,0.879944363812288
GOBP_LIPID_DROPLET_ORGANIZAT...,SET,33,0.14946,0.0063306,0.14843,0.157,GOBP_LIPID_DROPLET_ORGANIZATION,0.879944363812288
GOBP_SMOOTH_MUSCLE_CELL_MATR...,SET,6,0.33387,0.0060345,0.33179,0.15715,GOBP_SMOOTH_MUSCLE_CELL_MATRIX_ADHESION,0.880627898550725
GOMF_ATP_ADP_ANTIPORTER_ACTI...,SET,3,0.46732,0.0059731,0.46447,0.15718,GOMF_ATP_ADP_ANTIPORTER_ACTIVITY,0.880627898550725
GOBP_IMMUNE_RESPONSE_INHIBIT...2,SET,10,0.30119,0.0070273,0.29944,0.15725,GOBP_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION,0.880627898550725
GOMF_AMP_BINDING,SET,15,0.19655,0.0056158,0.19541,0.15725,GOMF_AMP_BINDING,0.880627898550725
KEGG_MEDICUS_REFERENCE_TRANS...3,SET,72,0.097261,0.0060787,0.096704,0.15727,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION,0.880627898550725
GOCC_TRANS_GOLGI_NETWORK_MEM...,SET,95,0.089987,0.0064562,0.089484,0.15731,GOCC_TRANS_GOLGI_NETWORK_MEMBRANE,0.880627898550725
GOBP_NEGATIVE_REGULATION_OF_...706,SET,10,0.30169,0.0070389,0.30003,0.15733,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.880627898550725
GOBP_PERICENTRIC_HETEROCHROM...,SET,3,0.57295,0.0073233,0.56983,0.15734,GOBP_PERICENTRIC_HETEROCHROMATIN_FORMATION,0.880627898550725
GSE28237_FOLLICULAR_VS_EARLY...1,SET,181,0.062432,0.0061682,0.062095,0.15735,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN,0.880627898550725
HP_ELEVATED_CIRCULATING_GLUT...,SET,6,0.35463,0.0064098,0.35289,0.15747,HP_ELEVATED_CIRCULATING_GLUTARIC_ACID_CONCENTRATION,0.881157599420383
DESCARTES_MAIN_FETAL_THYMIC_...,SET,139,0.073288,0.0063526,0.072954,0.15756,DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS,0.881519285254347
GOCC_ENDOPLASMIC_RETICULUM_E...,SET,28,0.15457,0.0060317,0.15389,0.1576,GOCC_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.881601158860454
REACTOME_NOTCH1_INTRACELLULA...,SET,43,0.13438,0.0064956,0.13386,0.15772,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.882130447376891
GOBP_MITOTIC_CELL_CYCLE_CHEC...,SET,134,0.069806,0.0059418,0.069546,0.15776,GOBP_MITOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.882212196299276
GOBP_MYELOID_DENDRITIC_CELL_...3,SET,19,0.2163,0.0069545,0.21559,0.15787,GOBP_MYELOID_DENDRITIC_CELL_DIFFERENTIATION,0.882685304054054
GSE2826_WT_VS_XID_BCELL_UP,SET,183,0.062592,0.0062178,0.062408,0.15795,GSE2826_WT_VS_XID_BCELL_UP,0.882700163475012
GAVISH_3CA_METAPROGRAM_B_CEL...2,SET,40,0.13877,0.0064703,0.13837,0.15796,GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE,0.882700163475012
GOBP_IMMUNOGLOBULIN_V_D_J_RE...,SET,7,0.30785,0.0060099,0.30711,0.15808,GOBP_IMMUNOGLOBULIN_V_D_J_RECOMBINATION,0.882700163475012
HP_CORNEAL_EROSION,SET,40,0.14361,0.006696,0.14327,0.15808,HP_CORNEAL_EROSION,0.882700163475012
GUENTHER_GROWTH_SPHERICAL_VS...1,SET,24,0.1854,0.0066989,0.185,0.15813,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,0.882700163475012
GOMF_FERROUS_IRON_TRANSMEMBR...,SET,5,0.37445,0.0061785,0.37363,0.15813,GOMF_FERROUS_IRON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.882700163475012
GTCTTCC_MIR7,SET,155,0.069531,0.0063616,0.069381,0.15814,GTCTTCC_MIR7,0.882700163475012
REACTOME_CELLULAR_RESPONSE_T...5,SET,140,0.070322,0.0061173,0.070176,0.15816,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,0.882700163475012
HP_BLEPHARITIS,SET,42,0.12226,0.0058408,0.12202,0.15818,HP_BLEPHARITIS,0.882700163475012
GSE37532_WT_VS_PPARG_KO_VISC...3,SET,180,0.065492,0.0064529,0.065367,0.1582,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN,0.882700163475012
GSE27786_BCELL_VS_NKTCELL_UP,SET,180,0.061057,0.0060159,0.060965,0.1583,GSE27786_BCELL_VS_NKTCELL_UP,0.882700163475012
GSE46606_IRF4MID_VS_WT_CD40L...2,SET,171,0.062768,0.0060293,0.062677,0.15831,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.882700163475012
GOBP_REGULATION_OF_BONE_REMO...,SET,50,0.13504,0.0070374,0.13486,0.15835,GOBP_REGULATION_OF_BONE_REMODELING,0.882700163475012
HOLLEMAN_DAUNORUBICIN_B_ALL_...1,SET,12,0.23288,0.0059518,0.2326,0.15837,HOLLEMAN_DAUNORUBICIN_B_ALL_DN,0.882700163475012
GOBP_ESTABLISHMENT_OF_CENTRO...,SET,10,0.30207,0.0070479,0.30171,0.15837,GOBP_ESTABLISHMENT_OF_CENTROSOME_LOCALIZATION,0.882700163475012
chr17p11,SET,61,0.19716,0.011346,0.19693,0.15838,chr17p11,0.882700163475012
KMCATNNWGGA_UNKNOWN,SET,87,0.08974,0.0061628,0.089635,0.15838,KMCATNNWGGA_UNKNOWN,0.882700163475012
GOBP_FORMATION_OF_TRANSLATIO...,SET,5,0.29913,0.0049357,0.29886,0.15844,GOBP_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX,0.882700163475012
GSE26928_EFF_MEM_VS_CENTR_ME...2,SET,164,0.06882,0.0064752,0.068759,0.15845,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP,0.882700163475012
GOBP_PROTEIN_LOCALIZATION_TO...1,SET,6,0.38261,0.0069156,0.3823,0.15846,GOBP_PROTEIN_LOCALIZATION_TO_ADHERENS_JUNCTION,0.882700163475012
GSE22045_TREG_VS_TCONV_DN,SET,157,0.070453,0.0064871,0.070394,0.15846,GSE22045_TREG_VS_TCONV_DN,0.882700163475012
GSE37533_UNTREATED_VS_PIOGLI...2,SET,149,0.068399,0.0061368,0.068341,0.15846,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP,0.882700163475012
GOBP_EXTRACELLULAR_EXOSOME_A...,SET,7,0.33926,0.0066231,0.33902,0.15849,GOBP_EXTRACELLULAR_EXOSOME_ASSEMBLY,0.882700163475012
HP_ABNORMAL_URINE_PH,SET,129,0.076431,0.0063841,0.076384,0.15851,HP_ABNORMAL_URINE_PH,0.882700163475012
HP_PROSTATITIS,SET,6,0.44669,0.0080738,0.44656,0.15859,HP_PROSTATITIS,0.882700163475012
GOBP_COLUMNAR_CUBOIDAL_EPITH...2,SET,119,0.084534,0.0067835,0.084523,0.15863,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION,0.882700163475012
GOBP_CELLULAR_RESPONSE_TO_ES...2,SET,18,0.20034,0.0062698,0.20034,0.15866,GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS,0.882700163475012
GOBP_PROTEIN_INSERTION_INTO_...5,SET,10,0.25831,0.0060269,0.25832,0.15867,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_INNER_MEMBRANE,0.882700163475012
GOBP_LUNG_ASSOCIATED_MESENCH...,SET,9,0.3154,0.0069813,0.31547,0.15872,GOBP_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT,0.882700163475012
GOMF_RETINOIC_ACID_BINDING,SET,26,0.21825,0.008207,0.21833,0.15876,GOMF_RETINOIC_ACID_BINDING,0.882700163475012
GOBP_ACTIN_FILAMENT_ORGANIZA...,SET,412,0.043793,0.0064862,0.043813,0.15877,GOBP_ACTIN_FILAMENT_ORGANIZATION,0.882700163475012
GOBP_REGULATION_OF_DENDRITIC...3,SET,14,0.2401,0.0066275,0.2402,0.15877,GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.882700163475012
GSE20727_CTRL_VS_DNFB_ALLERG...2,SET,179,0.063073,0.0061974,0.063106,0.15879,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP,0.882700163475012
GOBP_MATURATION_OF_5_8S_RRNA...,SET,24,0.15477,0.005592,0.15486,0.15881,GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.882700163475012
YY1_Q6,SET,221,0.056691,0.0061822,0.056734,0.15884,YY1_Q6,0.882700163475012
WP_TGIF_DISRUPTION_OF_SHH_SI...,SET,9,0.29325,0.0064911,0.29348,0.15885,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,0.882700163475012
HP_LIMB_FASCICULATIONS,SET,6,0.32772,0.0059234,0.32799,0.15886,HP_LIMB_FASCICULATIONS,0.882700163475012
MIR4693_5P,SET,100,0.086819,0.0063899,0.086908,0.15891,MIR4693_5P,0.882700163475012
GOMF_PROCOLLAGEN_PROLINE_4_D...,SET,5,0.27509,0.0045391,0.27537,0.15891,GOMF_PROCOLLAGEN_PROLINE_4_DIOXYGENASE_ACTIVITY,0.882700163475012
VALK_AML_CLUSTER_15,SET,28,0.16485,0.0064329,0.16507,0.15899,VALK_AML_CLUSTER_15,0.882700163475012
HP_SUPERNUMERARY_SPLEENS,SET,81,0.087314,0.0057867,0.087433,0.15899,HP_SUPERNUMERARY_SPLEENS,0.882700163475012
MORF_EIF3S2,SET,220,0.053344,0.0058042,0.053442,0.15911,MORF_EIF3S2,0.882700163475012
GOBP_PEPTIDYL_L_CYSTEINE_S_P...,SET,21,0.18773,0.0063455,0.18809,0.15912,GOBP_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION,0.882700163475012
WP_PRION_DISEASE_PATHWAY,SET,31,0.15673,0.0064348,0.15704,0.15914,WP_PRION_DISEASE_PATHWAY,0.882700163475012
MIR4755_3P,SET,133,0.075241,0.0063806,0.075404,0.15919,MIR4755_3P,0.882700163475012
GOBP_POSITIVE_REGULATION_OF_...183,SET,6,0.34171,0.0061762,0.34246,0.15919,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.882700163475012
UNTERMAN_PROGRESSIVE_VS_STAB...1,SET,4,0.50985,0.0075246,0.51108,0.15925,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN,0.882700163475012
GOMF_ADENYLATE_KINASE_ACTIVI...,SET,9,0.29712,0.0065768,0.29791,0.1593,GOMF_ADENYLATE_KINASE_ACTIVITY,0.882700163475012
MARTINEZ_TP53_TARGETS_DN,SET,552,0.036678,0.0062634,0.036778,0.15932,MARTINEZ_TP53_TARGETS_DN,0.882700163475012
REACTOME_DEADENYLATION_DEPEN...,SET,49,0.11601,0.0059852,0.11634,0.15934,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,0.882700163475012
WP_PROSTAGLANDIN_SYNTHESIS_A...,SET,45,0.14624,0.0072311,0.14665,0.15934,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,0.882700163475012
GOCC_MPP7_DLG1_LIN7_COMPLEX,SET,5,0.42811,0.0070639,0.42931,0.15934,GOCC_MPP7_DLG1_LIN7_COMPLEX,0.882700163475012
GOMF_NUCLEOSIDE_KINASE_ACTIV...,SET,9,0.26504,0.0058665,0.26583,0.15939,GOMF_NUCLEOSIDE_KINASE_ACTIVITY,0.882700163475012
GSE22886_UNSTIM_VS_STIM_MEMO...1,SET,182,0.057989,0.0057449,0.058175,0.15943,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN,0.882700163475012
MIR6894_5P,SET,37,0.13524,0.006065,0.13569,0.15946,MIR6894_5P,0.882700163475012
BRACHAT_RESPONSE_TO_METHOTRE...1,SET,23,0.16737,0.0059201,0.16793,0.15947,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,0.882700163475012
VAN_DEN_BIGGELAAR_PBMC_PREVN...1,SET,62,0.10567,0.0061301,0.10602,0.15948,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP,0.882700163475012
GOBP_REGULATION_OF_CARDIOCYT...,SET,25,0.17404,0.0064178,0.17465,0.15951,GOBP_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.882700163475012
SHIN_B_CELL_LYMPHOMA_CLUSTER...3,SET,27,0.17999,0.0068973,0.18064,0.15953,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,0.882700163475012
CACCCBINDINGFACTOR_Q6,SET,242,0.054797,0.0062495,0.054997,0.15955,CACCCBINDINGFACTOR_Q6,0.882700163475012
MIR4465,SET,395,0.04351,0.0063129,0.043672,0.15956,MIR4465,0.882700163475012
GSE7219_WT_VS_NIK_NFKB2_KO_D...1,SET,158,0.069182,0.0063901,0.06944,0.15956,GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN,0.882700163475012
GOBP_IMMUNOLOGICAL_MEMORY_FO...,SET,13,0.273,0.0072617,0.27402,0.15957,GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS,0.882700163475012
MIR4782_3P,SET,140,0.072449,0.0063023,0.072724,0.15958,MIR4782_3P,0.882700163475012
GOBP_MYOTUBE_DIFFERENTIATION,SET,117,0.082776,0.0065868,0.083092,0.15958,GOBP_MYOTUBE_DIFFERENTIATION,0.882700163475012
GOBP_RIBONUCLEOPROTEIN_COMPL...1,SET,397,0.039367,0.0057259,0.039518,0.15959,GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS,0.882700163475012
HP_OLIGODACTYLY,SET,24,0.17762,0.0064176,0.1783,0.15959,HP_OLIGODACTYLY,0.882700163475012
GOBP_REGULATION_OF_GROWTH,SET,526,0.038954,0.0064982,0.039121,0.1597,GOBP_REGULATION_OF_GROWTH,0.882700163475012
GOBP_PIGMENT_GRANULE_MATURAT...,SET,10,0.28076,0.0065506,0.28198,0.15971,GOBP_PIGMENT_GRANULE_MATURATION,0.882700163475012
REACTOME_RHO_GTPASE_EFFECTORS,SET,244,0.054247,0.006212,0.054501,0.15979,REACTOME_RHO_GTPASE_EFFECTORS,0.882700163475012
GSE43700_UNTREATED_VS_IL10_T...2,SET,184,0.06309,0.0062841,0.063388,0.1598,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP,0.882700163475012
REACTOME_INTERACTIONS_OF_REV...,SET,35,0.13611,0.0059371,0.13677,0.15983,REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS,0.882700163475012
GOBP_REGULATION_OF_DEVELOPME...2,SET,13,0.24824,0.0066032,0.24947,0.15985,GOBP_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC,0.882700163475012
GSE22589_HEALTHY_VS_SIV_INFE...2,SET,177,0.062244,0.006082,0.062557,0.15987,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP,0.882700163475012
FULLER_PBMC_F_TULARENSIS_VAC...11,SET,57,0.12862,0.0071556,0.12927,0.15988,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,0.882700163475012
GOMF_COMPLEMENT_RECEPTOR_ACT...,SET,10,0.34787,0.0081163,0.34966,0.15991,GOMF_COMPLEMENT_RECEPTOR_ACTIVITY,0.882700163475012
GOMF_CYSTEINE_TYPE_ENDOPEPTI...4,SET,6,0.35886,0.0064862,0.36071,0.15991,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.882700163475012
MODULE_325,SET,53,0.11719,0.0062873,0.11782,0.15996,MODULE_325,0.882700163475012
TAKAO_RESPONSE_TO_UVB_RADIAT...1,SET,87,0.089514,0.0061473,0.090001,0.15998,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,0.882700163475012
WESTON_VEGFA_TARGETS_6HR,SET,43,0.13879,0.0067089,0.13955,0.15998,WESTON_VEGFA_TARGETS_6HR,0.882700163475012
MIR6874_5P,SET,35,0.15123,0.0065968,0.15206,0.15999,MIR6874_5P,0.882700163475012
GSE6269_STAPH_AUREUS_VS_STRE...2,SET,145,0.071037,0.006288,0.071438,0.16003,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP,0.882700163475012
REACTOME_VEGFR2_MEDIATED_VAS...,SET,26,0.17286,0.0065003,0.17388,0.16009,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,0.882700163475012
MIR4255,SET,155,0.070437,0.0064445,0.070869,0.16014,MIR4255,0.882700163475012
REACTOME_SRP_DEPENDENT_COTRA...,SET,102,0.080409,0.0059767,0.08091,0.16016,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.882700163475012
GOBP_CARDIAC_EPITHELIAL_TO_M...,SET,36,0.15572,0.0068888,0.15669,0.16016,GOBP_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.882700163475012
GSE17721_CPG_VS_GARDIQUIMOD_...2,SET,185,0.060091,0.0060015,0.060468,0.16018,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.882700163475012
GSE30962_ACUTE_VS_CHRONIC_LC...1,SET,184,0.064016,0.0063764,0.064436,0.16025,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN,0.882700163475012
GOBP_REGULATION_OF_ALPHA_BET...1,SET,107,0.088686,0.0067506,0.089285,0.16029,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.882700163475012
MIR4764_3P,SET,62,0.10808,0.0062703,0.10883,0.16032,MIR4764_3P,0.882700163475012
HP_ANTINUCLEAR_ANTIBODY_POSI...,SET,62,0.11778,0.0068328,0.11859,0.16033,HP_ANTINUCLEAR_ANTIBODY_POSITIVITY,0.882700163475012
REACTOME_PLASMA_LIPOPROTEIN_...1,SET,14,0.2223,0.0061363,0.22389,0.16039,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,0.882700163475012
GOCC_NUCLEAR_BODY,SET,746,0.030045,0.0059319,0.03026,0.16039,GOCC_NUCLEAR_BODY,0.882700163475012
HP_HEMATURIA,SET,164,0.068648,0.006459,0.069157,0.16045,HP_HEMATURIA,0.882700163475012
GOCC_EXTRINSIC_COMPONENT_OF_...8,SET,6,0.36833,0.0066573,0.37107,0.16046,GOCC_EXTRINSIC_COMPONENT_OF_PRESYNAPTIC_MEMBRANE,0.882700163475012
YAP1_DN,SET,37,0.15239,0.006834,0.15352,0.16046,YAP1_DN,0.882700163475012
GOBP_NEGATIVE_REGULATION_OF_...412,SET,20,0.16819,0.0055482,0.16945,0.16047,GOBP_NEGATIVE_REGULATION_OF_MRNA_PROCESSING,0.882700163475012
GAVISH_3CA_METAPROGRAM_FIBRO...11,SET,44,0.13199,0.0064539,0.13299,0.16048,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE,0.882700163475012
GOBP_POSITIVE_REGULATION_OF_...41,SET,5,0.39501,0.0065177,0.39799,0.16048,GOBP_POSITIVE_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.882700163475012
HP_MYOCLONIC_ABSENCE_SEIZURE,SET,14,0.23164,0.0063939,0.23341,0.16051,HP_MYOCLONIC_ABSENCE_SEIZURE,0.882700163475012
GOBP_RESPONSE_TO_ENDOPLASMIC...,SET,244,0.05219,0.0059764,0.05261,0.1606,GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.882700163475012
NFXL1_TARGET_GENES,SET,340,0.046966,0.0063318,0.047345,0.16061,NFXL1_TARGET_GENES,0.882700163475012
GOBP_POSITIVE_REGULATION_OF_...495,SET,1502,0.023843,0.0065348,0.024036,0.16061,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.882700163475012
MIR3911,SET,81,0.096655,0.0064057,0.097439,0.16062,MIR3911,0.882700163475012
SIPA1_TARGET_GENES,SET,102,0.08318,0.0061826,0.083863,0.16064,SIPA1_TARGET_GENES,0.882700163475012
GSE17721_CTRL_VS_POLYIC_8H_B...2,SET,177,0.059559,0.0058197,0.060049,0.16064,GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP,0.882700163475012
GOBP_RESPONSE_TO_SODIUM_ARSE...,SET,6,0.35948,0.0064975,0.3626,0.16075,GOBP_RESPONSE_TO_SODIUM_ARSENITE,0.882700163475012
REACTOME_ANTIMICROBIAL_PEPTI...,SET,74,0.12105,0.0076696,0.1221,0.16076,REACTOME_ANTIMICROBIAL_PEPTIDES,0.882700163475012
GSE12366_GC_VS_NAIVE_BCELL_DN,SET,170,0.066621,0.0063808,0.067203,0.16077,GSE12366_GC_VS_NAIVE_BCELL_DN,0.882700163475012
REACTOME_ALK_MUTANTS_BIND_TK...,SET,12,0.23903,0.0061088,0.24112,0.16078,REACTOME_ALK_MUTANTS_BIND_TKIS,0.882700163475012
HP_ABNORMAL_SWEAT_GLAND_MORP...,SET,18,0.21707,0.0067933,0.21898,0.16078,HP_ABNORMAL_SWEAT_GLAND_MORPHOLOGY,0.882700163475012
GOBP_RENAL_SYSTEM_PROCESS_IN...2,SET,24,0.186,0.0067205,0.18767,0.16082,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.882700163475012
HP_MYELOID_LEUKEMIA,SET,30,0.15542,0.0062772,0.15688,0.16094,HP_MYELOID_LEUKEMIA,0.882700163475012
GOBP_SPERM_MOTILITY,SET,122,0.074666,0.0060662,0.075374,0.16095,GOBP_SPERM_MOTILITY,0.882700163475012
GSE15930_STIM_VS_STIM_AND_TR...2,SET,177,0.064008,0.0062543,0.064622,0.16097,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP,0.882700163475012
GSE23308_CTRL_VS_CORTICOSTER...1,SET,186,0.061614,0.0061701,0.062205,0.16097,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN,0.882700163475012
REACTOME_NEGATIVE_REGULATION...5,SET,29,0.1637,0.0065009,0.16528,0.16098,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,0.882700163475012
REACTOME_REGULATION_OF_MECP2...,SET,29,0.1649,0.0065484,0.16651,0.16101,REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,0.882700163475012
MODULE_162,SET,17,0.23096,0.0070246,0.23321,0.16101,MODULE_162,0.882700163475012
GOBP_NEGATIVE_REGULATION_OF_...538,SET,7,0.30556,0.0059652,0.30856,0.16103,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.882700163475012
REACTOME_VLDL_CLEARANCE,SET,4,0.47143,0.0069576,0.47611,0.16105,REACTOME_VLDL_CLEARANCE,0.882700163475012
GSE40274_FOXP3_VS_FOXP3_AND_...13,SET,164,0.064037,0.0060252,0.064672,0.16105,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.882700163475012
MODULE_543,SET,14,0.23413,0.0064626,0.23649,0.16109,MODULE_543,0.882700163475012
CEBP_Q2,SET,205,0.060256,0.0063315,0.060879,0.16115,CEBP_Q2,0.882700163475012
GOCC_SNARE_COMPLEX,SET,48,0.1157,0.0059083,0.11692,0.16119,GOCC_SNARE_COMPLEX,0.882700163475012
MURAKAMI_UV_RESPONSE_24HR,SET,20,0.18882,0.0062286,0.19082,0.16121,MURAKAMI_UV_RESPONSE_24HR,0.882700163475012
HP_CARCINOMA,SET,6,0.32301,0.0058383,0.32643,0.16121,HP_CARCINOMA,0.882700163475012
VERNOCHET_ADIPOGENESIS,SET,18,0.22963,0.0071865,0.23208,0.16123,VERNOCHET_ADIPOGENESIS,0.882700163475012
MORF_BUB1,SET,43,0.11852,0.0057291,0.11979,0.16124,MORF_BUB1,0.882700163475012
GOCC_MITOCHONDRIAL_PERMEABIL...,SET,6,0.34992,0.0063246,0.35371,0.16127,GOCC_MITOCHONDRIAL_PERMEABILITY_TRANSITION_PORE_COMPLEX,0.882700163475012
PID_RXR_VDR_PATHWAY,SET,26,0.1588,0.0059716,0.16058,0.16136,PID_RXR_VDR_PATHWAY,0.882700163475012
HP_FASTING_HYPERINSULINEMIA,SET,9,0.28833,0.0063821,0.29156,0.16136,HP_FASTING_HYPERINSULINEMIA,0.882700163475012
GOBP_REGULATION_OF_MUSCLE_CE...,SET,132,0.074735,0.0063141,0.075592,0.16142,GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.882700163475012
GSE3720_VD1_VS_VD2_GAMMADELT...3,SET,183,0.060216,0.0059817,0.060912,0.16144,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN,0.882700163475012
GSE28726_ACT_CD4_TCELL_VS_AC...1,SET,177,0.063719,0.0062261,0.064457,0.16145,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN,0.882700163475012
GOBP_UDP_N_ACETYLGLUCOSAMINE...3,SET,5,0.32864,0.0054225,0.33246,0.16146,GOBP_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORT,0.882700163475012
GOMF_UDP_N_ACETYLGLUCOSAMINE...,SET,5,0.32864,0.0054225,0.33246,0.16146,GOMF_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.882700163475012
GENTILE_UV_LOW_DOSE_DN,SET,59,0.1192,0.0067464,0.12061,0.16151,GENTILE_UV_LOW_DOSE_DN,0.882700163475012
ZWANG_TRANSIENTLY_UP_BY_2ND_...,SET,1328,0.02473,0.0064059,0.025023,0.16152,ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY,0.882700163475012
GOBP_PROTEIN_LOCALIZATION_TO...48,SET,11,0.23618,0.0057793,0.239,0.16153,GOBP_PROTEIN_LOCALIZATION_TO_SITE_OF_DOUBLE_STRAND_BREAK,0.882700163475012
MIR4763_5P,SET,54,0.11035,0.0059759,0.11167,0.16154,MIR4763_5P,0.882700163475012
HP_ARTHROGRYPOSIS_MULTIPLEX_...,SET,122,0.075575,0.0061401,0.076508,0.16163,HP_ARTHROGRYPOSIS_MULTIPLEX_CONGENITA,0.882700163475012
GSE28783_ANTI_MIR33_VS_CTRL_...2,SET,183,0.064793,0.0064364,0.065598,0.16165,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP,0.882700163475012
GOBP_NEGATIVE_REGULATION_OF_...116,SET,151,0.069981,0.0063203,0.070857,0.16167,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH,0.882700163475012
REACTOME_SARS_COV_2_HOST_INT...,SET,178,0.063308,0.0062032,0.064102,0.16168,REACTOME_SARS_COV_2_HOST_INTERACTIONS,0.882700163475012
MODULE_64,SET,490,0.041622,0.0067083,0.042145,0.16168,MODULE_64,0.882700163475012
GOCC_CORNIFIED_ENVELOPE,SET,58,0.13445,0.0075447,0.13619,0.16177,GOCC_CORNIFIED_ENVELOPE,0.882700163475012
MIR612,SET,97,0.082942,0.0060128,0.084046,0.16186,MIR612,0.882700163475012
GOBP_DETECTION_OF_ABIOTIC_ST...,SET,130,0.077025,0.0064584,0.078051,0.16186,GOBP_DETECTION_OF_ABIOTIC_STIMULUS,0.882700163475012
GOBP_DNA_LIGATION_INVOLVED_I...,SET,5,0.30689,0.0050638,0.31108,0.16194,GOBP_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR,0.882700163475012
REACTOME_GAP_JUNCTION_TRAFFI...,SET,46,0.13721,0.0068595,0.13909,0.16195,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,0.882700163475012
E2F_Q3,SET,196,0.057713,0.0059311,0.058513,0.16199,E2F_Q3,0.882700163475012
HE_LIM_SUN_FETAL_LUNG_C5_DEL...,SET,3,0.53767,0.0068723,0.54512,0.16199,HE_LIM_SUN_FETAL_LUNG_C5_DELTA_SMALL_PRE_B_CELL,0.882700163475012
MIR548AZ_3P,SET,436,0.040879,0.0062243,0.041447,0.162,MIR548AZ_3P,0.882700163475012
SETBP1_TARGET_GENES,SET,149,0.070218,0.0062999,0.071199,0.16202,SETBP1_TARGET_GENES,0.882700163475012
GSE23321_EFFECTOR_MEMORY_VS_...1,SET,172,0.05877,0.0056616,0.059593,0.16203,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.882700163475012
REACTOME_SUMOYLATION_OF_TRAN...1,SET,40,0.12562,0.0058571,0.12739,0.16204,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,0.882700163475012
HP_FRONTAL_CORTICAL_ATROPHY,SET,10,0.274,0.006393,0.27786,0.16204,HP_FRONTAL_CORTICAL_ATROPHY,0.882700163475012
GSE360_CTRL_VS_T_GONDII_DC_DN,SET,175,0.06632,0.0064439,0.067298,0.1622,GSE360_CTRL_VS_T_GONDII_DC_DN,0.882700163475012
GSE45365_NK_CELL_VS_CD8A_DC_...2,SET,161,0.065238,0.0060823,0.066206,0.16222,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN,0.882700163475012
GOBP_CARBOHYDRATE_DERIVATIVE...4,SET,88,0.092418,0.0063829,0.093804,0.16226,GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT,0.882700163475012
GOBP_NEGATIVE_REGULATION_OF_...175,SET,6,0.39574,0.0071528,0.40169,0.16228,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.882700163475012
GSE14350_TREG_VS_TEFF_DN,SET,185,0.06379,0.0063709,0.064758,0.16231,GSE14350_TREG_VS_TEFF_DN,0.882700163475012
LEE_CALORIE_RESTRICTION_MUSC...1,SET,40,0.12041,0.0056142,0.12225,0.16232,LEE_CALORIE_RESTRICTION_MUSCLE_DN,0.882700163475012
GOMF_CADHERIN_BINDING_INVOLV...,SET,18,0.22384,0.0070052,0.22726,0.16234,GOMF_CADHERIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION,0.882700163475012
GSE30971_2H_VS_4H_LPS_STIM_M...1,SET,152,0.07132,0.0064624,0.072413,0.16234,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN,0.882700163475012
HP_WEAK_EXTRAOCULAR_MUSCLES,SET,12,0.23735,0.0060659,0.24099,0.16235,HP_WEAK_EXTRAOCULAR_MUSCLES,0.882700163475012
GNF2_DENR,SET,46,0.11075,0.0055364,0.11245,0.16236,GNF2_DENR,0.882700163475012
HP_ALOBAR_HOLOPROSENCEPHALY,SET,6,0.39636,0.0071641,0.40254,0.16241,HP_ALOBAR_HOLOPROSENCEPHALY,0.882700163475012
GSE7459_UNTREATED_VS_IL6_TRE...1,SET,125,0.077073,0.0063378,0.078303,0.16249,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN,0.882700163475012
GAO_STOMACH_24W_C1_PROCRPOS_...,SET,37,0.12661,0.0056779,0.12864,0.16251,GAO_STOMACH_24W_C1_PROCRPOS_MULTIPOTENT_PROGENITOR,0.882700163475012
HP_ABNORMAL_PEER_RELATIONSHI...,SET,6,0.3261,0.0058941,0.33137,0.16254,HP_ABNORMAL_PEER_RELATIONSHIPS,0.882700163475012
OUELLET_OVARIAN_CANCER_INVAS...2,SET,104,0.077643,0.0058271,0.078907,0.16257,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.882700163475012
GOCC_ADHERENS_JUNCTION,SET,170,0.068836,0.006593,0.069958,0.16257,GOCC_ADHERENS_JUNCTION,0.882700163475012
MORF_DDB1,SET,224,0.05217,0.0057272,0.053028,0.16261,MORF_DDB1,0.882700163475012
GOBP_SOMITOGENESIS,SET,59,0.11469,0.0064912,0.11658,0.16261,GOBP_SOMITOGENESIS,0.882700163475012
GSE1925_CTRL_VS_3H_IFNG_STIM...1,SET,181,0.065123,0.0064341,0.0662,0.16263,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.882700163475012
HP_CERVICAL_SPINAL_CANAL_STE...,SET,9,0.28646,0.0063407,0.2912,0.16264,HP_CERVICAL_SPINAL_CANAL_STENOSIS,0.882700163475012
HP_HYPOPLASTIC_FEMALE_EXTERN...,SET,55,0.11889,0.0064975,0.12086,0.16264,HP_HYPOPLASTIC_FEMALE_EXTERNAL_GENITALIA,0.882700163475012
HP_MYELODYSPLASIA,SET,100,0.079604,0.0058588,0.080924,0.16264,HP_MYELODYSPLASIA,0.882700163475012
GOBP_CDC42_PROTEIN_SIGNAL_TR...,SET,14,0.25716,0.0070984,0.26143,0.16265,GOBP_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.882700163475012
HP_SUPERNUMERARY_MAXILLARY_I...,SET,3,0.55811,0.0071336,0.56738,0.16265,HP_SUPERNUMERARY_MAXILLARY_INCISOR,0.882700163475012
HP_ELEVATED_MATERNAL_CIRCULA...,SET,4,0.47517,0.0070129,0.48314,0.16268,HP_ELEVATED_MATERNAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.882700163475012
GSE10325_LUPUS_CD4_TCELL_VS_...4,SET,172,0.065016,0.0062633,0.066105,0.16268,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP,0.882700163475012
HP_HYPERTHYROIDISM,SET,30,0.16175,0.006533,0.16448,0.16271,HP_HYPERTHYROIDISM,0.882700163475012
GOBP_RESPONSE_TO_EPIDERMAL_G...,SET,42,0.12979,0.0062006,0.132,0.16275,GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR,0.882700163475012
GOBP_PROSTATE_GLAND_GROWTH,SET,10,0.31798,0.007419,0.32343,0.16277,GOBP_PROSTATE_GLAND_GROWTH,0.882700163475012
MODULE_59,SET,22,0.18944,0.0065538,0.19269,0.16278,MODULE_59,0.882700163475012
GOMF_NEUROTROPHIN_TRK_RECEPT...,SET,6,0.29504,0.0053327,0.30014,0.16281,GOMF_NEUROTROPHIN_TRK_RECEPTOR_BINDING,0.882700163475012
MIR3654,SET,43,0.12171,0.0058834,0.12382,0.16282,MIR3654,0.882700163475012
GSE12003_MIR223_KO_VS_WT_BM_...4,SET,105,0.081975,0.0061815,0.083395,0.16282,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP,0.882700163475012
REACTOME_IRE1ALPHA_ACTIVATES...,SET,47,0.11223,0.0056713,0.11419,0.16284,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,0.882700163475012
ATM_DN.V1_UP,SET,138,0.073523,0.0063502,0.074805,0.16284,ATM_DN.V1_UP,0.882700163475012
MIR3688_5P,SET,126,0.076821,0.0063421,0.078177,0.16289,MIR3688_5P,0.882700163475012
WEBER_METHYLATED_IN_COLON_CA...,SET,18,0.21471,0.0067194,0.2185,0.1629,WEBER_METHYLATED_IN_COLON_CANCER,0.882700163475012
CUI_DEVELOPING_HEART_CORONAR...,SET,37,0.1576,0.0070676,0.16041,0.16294,CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL,0.882700163475012
CEBPDELTA_Q6,SET,217,0.058528,0.0063252,0.059576,0.16295,CEBPDELTA_Q6,0.882700163475012
GOBP_REGULATION_OF_TOLL_LIKE...3,SET,28,0.15864,0.0061906,0.16151,0.16299,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.882700163475012
KEGG_MEDICUS_REFERENCE_CA2_E...2,SET,5,0.34708,0.005727,0.35336,0.163,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_STORE_OPERATED_CA2_CHANNEL,0.882700163475012
HE_LIM_SUN_FETAL_LUNG_C1_AT1...,SET,37,0.14795,0.0066349,0.15064,0.16303,HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL,0.882700163475012
GOBP_ESTABLISHMENT_OF_PROTEI...4,SET,38,0.12862,0.0058455,0.13097,0.16304,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.882700163475012
GSE1460_NAIVE_CD4_TCELL_CORD...2,SET,162,0.063534,0.0059416,0.064694,0.16304,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.882700163475012
HP_DEPOSITS_IMMUNOREACTIVE_T...,SET,8,0.31349,0.0065424,0.31923,0.16305,HP_DEPOSITS_IMMUNOREACTIVE_TO_BETA_AMYLOID_PROTEIN,0.882700163475012
HP_ABNORMAL_BASOPHIL_COUNT,SET,5,0.43474,0.0071733,0.44275,0.16308,HP_ABNORMAL_BASOPHIL_COUNT,0.882700163475012
LI_CISPLATIN_RESISTANCE_DN,SET,28,0.17802,0.0069466,0.18132,0.16311,LI_CISPLATIN_RESISTANCE_DN,0.882700163475012
GSE12198_CTRL_VS_HIGH_IL2_ST...2,SET,180,0.062063,0.006115,0.063219,0.16313,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.882700163475012
GSE42724_NAIVE_VS_B1_BCELL_UP,SET,182,0.060999,0.006043,0.062136,0.16313,GSE42724_NAIVE_VS_B1_BCELL_UP,0.882700163475012
GSE22443_NAIVE_VS_ACT_AND_IL...4,SET,188,0.06474,0.0065175,0.065965,0.1632,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP,0.8828296998298
GOBP_SMAD_PROTEIN_SIGNAL_TRA...,SET,76,0.10666,0.0068481,0.10869,0.16321,GOBP_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.8828296998298
GSE10239_MEMORY_VS_KLRG1HIGH...1,SET,182,0.061675,0.0061101,0.062856,0.16325,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.8828296998298
GSE25087_TREG_VS_TCONV_ADULT...2,SET,174,0.065716,0.0063671,0.066988,0.1633,GSE25087_TREG_VS_TCONV_ADULT_UP,0.8828296998298
HP_PARATHYROID_ADENOMA,SET,15,0.24062,0.0068749,0.2453,0.16332,HP_PARATHYROID_ADENOMA,0.8828296998298
GOMF_EPHRIN_RECEPTOR_BINDING,SET,26,0.16472,0.0061943,0.16794,0.16334,GOMF_EPHRIN_RECEPTOR_BINDING,0.8828296998298
GOBP_CYTOCHROME_METABOLIC_PR...,SET,5,0.4119,0.0067964,0.41998,0.16336,GOBP_CYTOCHROME_METABOLIC_PROCESS,0.8828296998298
GOCC_B_WICH_COMPLEX,SET,7,0.30681,0.0059896,0.31289,0.16341,GOCC_B_WICH_COMPLEX,0.8828296998298
HP_EEG_WITH_SPIKE_WAVE_COMPL...2,SET,8,0.3528,0.0073629,0.35979,0.16341,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES_2_5_3_5_HZ,0.8828296998298
GOBP_VACUOLAR_TRANSPORT,SET,161,0.065258,0.0060842,0.066562,0.16345,GOBP_VACUOLAR_TRANSPORT,0.8828296998298
GSE40666_UNTREATED_VS_IFNA_S...1,SET,174,0.059188,0.0057346,0.060384,0.1635,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN,0.8828296998298
LOPES_METHYLATED_IN_COLON_CA...2,SET,27,0.18363,0.0070366,0.18734,0.16351,LOPES_METHYLATED_IN_COLON_CANCER_UP,0.8828296998298
ZWANG_CLASS_3_TRANSIENTLY_IN...,SET,205,0.063186,0.0066394,0.064465,0.16351,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,0.8828296998298
HP_ADVANCED_ERUPTION_OF_TEETH,SET,37,0.13412,0.0060147,0.13683,0.16351,HP_ADVANCED_ERUPTION_OF_TEETH,0.8828296998298
MIR4329,SET,70,0.10231,0.0063051,0.10441,0.16358,MIR4329,0.8828296998298
HP_SPLANCHNIC_VEIN_THROMBOSIS,SET,22,0.18948,0.0065551,0.19341,0.16363,HP_SPLANCHNIC_VEIN_THROMBOSIS,0.8828296998298
MIR3922_5P,SET,92,0.087753,0.0061963,0.089579,0.16364,MIR3922_5P,0.8828296998298
GOBP_RENAL_TUBULAR_SECRETION,SET,18,0.21036,0.0065836,0.21477,0.16368,GOBP_RENAL_TUBULAR_SECRETION,0.8828296998298
GSE42021_TCONV_PLN_VS_CD24LO...2,SET,182,0.060587,0.0060023,0.061858,0.16369,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP,0.8828296998298
E2F_Q2,SET,169,0.06705,0.0064032,0.06846,0.1637,E2F_Q2,0.8828296998298
GSE40666_NAIVE_VS_EFFECTOR_C...2,SET,177,0.06404,0.0062575,0.065414,0.1638,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,0.8828296998298
GOBP_CARNITINE_TRANSMEMBRANE...,SET,6,0.43701,0.0078988,0.44641,0.16381,GOBP_CARNITINE_TRANSMEMBRANE_TRANSPORT,0.8828296998298
BIOCARTA_TCYTOTOXIC_PATHWAY,SET,12,0.26563,0.0067888,0.27135,0.16382,BIOCARTA_TCYTOTOXIC_PATHWAY,0.8828296998298
GOMF_ALL_TRANS_RETINAL_BINDI...,SET,5,0.38184,0.0063005,0.39008,0.16383,GOMF_ALL_TRANS_RETINAL_BINDING,0.8828296998298
KEGG_MEDICUS_VARIANT_MUTATIO...18,SET,17,0.19441,0.005913,0.19863,0.16386,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.8828296998298
GAVISH_3CA_METAPROGRAM_ENDOT...1,SET,45,0.12884,0.0063706,0.13163,0.16386,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE,0.8828296998298
MODULE_402,SET,12,0.26705,0.0068251,0.27296,0.16395,MODULE_402,0.8828296998298
GOBP_RNA_SPLICING,SET,396,0.03904,0.0056713,0.039903,0.16395,GOBP_RNA_SPLICING,0.8828296998298
GOBP_EMBRYONIC_AXIS_SPECIFIC...,SET,35,0.15066,0.0065716,0.15401,0.16399,GOBP_EMBRYONIC_AXIS_SPECIFICATION,0.8828296998298
MODULE_264,SET,10,0.25752,0.0060083,0.26327,0.16401,MODULE_264,0.8828296998298
REACTOME_TRIGLYCERIDE_METABO...,SET,35,0.14949,0.0065205,0.15285,0.16404,REACTOME_TRIGLYCERIDE_METABOLISM,0.8828296998298
GOBP_REGULATION_OF_FATTY_ACI...2,SET,39,0.12748,0.0058692,0.13035,0.16405,GOBP_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.8828296998298
GOBP_LIPID_DROPLET_FORMATION,SET,12,0.2225,0.0056863,0.22753,0.16407,GOBP_LIPID_DROPLET_FORMATION,0.8828296998298
HMCES_TARGET_GENES,SET,6,0.32228,0.0058252,0.32959,0.16409,HMCES_TARGET_GENES,0.8828296998298
GOBP_POSITIVE_REGULATION_OF_...366,SET,26,0.17992,0.006766,0.18402,0.16411,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.8828296998298
GOBP_NEGATIVE_REGULATION_OF_...527,SET,6,0.31631,0.0057172,0.32356,0.16414,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.8828296998298
GOBP_POSITIVE_REGULATION_OF_...558,SET,8,0.34662,0.0072337,0.35457,0.16415,GOBP_POSITIVE_REGULATION_OF_ODONTOGENESIS,0.8828296998298
GOBP_REGULATION_OF_SIGNALING...,SET,88,0.095036,0.0065637,0.097217,0.16415,GOBP_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.8828296998298
HP_X_LINKED_INHERITANCE,SET,11,0.2352,0.0057554,0.2406,0.16415,HP_X_LINKED_INHERITANCE,0.8828296998298
GOMF_DNA_INSERTION_OR_DELETI...,SET,6,0.24708,0.0044658,0.25276,0.16417,GOMF_DNA_INSERTION_OR_DELETION_BINDING,0.8828296998298
GSE2405_0H_VS_12H_A_PHAGOCYT...1,SET,178,0.062187,0.0060934,0.063639,0.16425,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.883123259591584
GSE22611_MUTANT_NOD2_VS_CTRL...1,SET,160,0.066357,0.0061675,0.067921,0.1643,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,0.883226353232292
WANG_CISPLATIN_RESPONSE_AND_...1,SET,207,0.057384,0.0060586,0.05874,0.16432,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,0.883226353232292
GSE12845_IGD_POS_BLOOD_VS_PR...2,SET,169,0.063245,0.0060398,0.064757,0.16438,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.883412231328282
MIZUKAMI_HYPOXIA_DN,SET,6,0.37418,0.0067631,0.3832,0.16443,MIZUKAMI_HYPOXIA_DN,0.883544318181818
DE_YY1_TARGETS_DN,SET,88,0.088939,0.0061426,0.091096,0.16446,DE_YY1_TARGETS_DN,0.883568913278714
GOBP_SINOATRIAL_NODE_DEVELOP...,SET,12,0.27666,0.0070708,0.28342,0.1645,GOBP_SINOATRIAL_NODE_DEVELOPMENT,0.883618080667594
GOCC_CYTOPLASMIC_SIDE_OF_LYS...,SET,9,0.2718,0.0060162,0.27846,0.16452,GOCC_CYTOPLASMIC_SIDE_OF_LYSOSOMAL_MEMBRANE,0.883618080667594
WP_WNTBETACATENIN_SIGNALING_...2,SET,25,0.17901,0.0066012,0.18346,0.1646,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,0.883911155747837
GOBP_VESICLE_ORGANIZATION,SET,336,0.045188,0.0060568,0.046322,0.16466,GOBP_VESICLE_ORGANIZATION,0.884013878591288
HU_ANGIOGENESIS_DN,SET,32,0.13926,0.0058089,0.14277,0.16467,HU_ANGIOGENESIS_DN,0.884013878591288
GSE14026_TH1_VS_TH17_UP,SET,178,0.063754,0.006247,0.065381,0.16476,GSE14026_TH1_VS_TH17_UP,0.884102429805616
GOBP_NEGATIVE_REGULATION_OF_...417,SET,57,0.11132,0.006193,0.11418,0.1648,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.884102429805616
HP_APLASIA_OF_THE_BLADDER,SET,5,0.37529,0.0061924,0.38494,0.1648,HP_APLASIA_OF_THE_BLADDER,0.884102429805616
HP_ABNORMAL_IMMUNE_SERUM_PRO...,SET,42,0.13329,0.0063676,0.13672,0.16482,HP_ABNORMAL_IMMUNE_SERUM_PROTEIN_PHYSIOLOGY,0.884102429805616
GOMF_PHOSPHATIDYLINOSITOL_BI...1,SET,253,0.052034,0.006066,0.053381,0.16484,GOMF_PHOSPHATIDYLINOSITOL_BINDING,0.884102429805616
HP_ANKLE_CONTRACTURE,SET,52,0.11435,0.0060768,0.11731,0.16486,HP_ANKLE_CONTRACTURE,0.884102429805616
AAAGACA_MIR511,SET,185,0.060935,0.0060858,0.062523,0.16489,AAAGACA_MIR511,0.884102429805616
GSE17721_CTRL_VS_GARDIQUIMOD...1,SET,176,0.060052,0.0058513,0.061617,0.16489,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.884102429805616
MIR4780,SET,38,0.13873,0.0063048,0.14237,0.16493,MIR4780,0.884180495141138
GOBP_PROTEIN_TARGETING_TO_ME...,SET,107,0.07825,0.0059562,0.080315,0.16496,GOBP_PROTEIN_TARGETING_TO_MEMBRANE,0.88420493522517
KEGG_MEDICUS_REFERENCE_GPCR_...1,SET,31,0.15403,0.006324,0.15814,0.16503,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY,0.884438939417296
FLECHNER_PBL_KIDNEY_TRANSPLA...2,SET,137,0.067543,0.0058127,0.069359,0.16508,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.884438939417296
LEE_LIVER_CANCER_MYC_TGFA_UP,SET,58,0.11873,0.006663,0.12193,0.16508,LEE_LIVER_CANCER_MYC_TGFA_UP,0.884438939417296
EBAUER_MYOGENIC_TARGETS_OF_P...,SET,43,0.13287,0.0064226,0.13646,0.16511,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,0.88446332459926
LEE_CALORIE_RESTRICTION_NEOC...2,SET,65,0.10327,0.0061336,0.10608,0.16516,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,0.884594822006473
GOMF_ATP_GATED_ION_CHANNEL_A...,SET,9,0.28471,0.0063019,0.29269,0.16535,GOMF_ATP_GATED_ION_CHANNEL_ACTIVITY,0.885075034106412
GOBP_REGULATION_OF_CHAPERONE...,SET,8,0.27002,0.0056352,0.2776,0.16536,GOBP_REGULATION_OF_CHAPERONE_MEDIATED_AUTOPHAGY,0.885075034106412
MIR4668_5P,SET,425,0.040793,0.0061343,0.041947,0.16541,MIR4668_5P,0.885075034106412
PTEN_DN.V1_UP,SET,162,0.068156,0.0063739,0.070092,0.16544,PTEN_DN.V1_UP,0.885075034106412
KEGG_MEDICUS_REFERENCE_GLYCO...1,SET,5,0.33653,0.0055528,0.34614,0.16547,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS,0.885075034106412
YTAAYNGCT_UNKNOWN,SET,130,0.077997,0.0065399,0.080249,0.16555,YTAAYNGCT_UNKNOWN,0.885075034106412
GSE17322_CD103_POS_VS_CD11B_...1,SET,173,0.061247,0.0059172,0.063019,0.16556,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN,0.885075034106412
HP_IMPAIRED_EPINEPHRINE_INDU...,SET,9,0.28662,0.0063443,0.29498,0.16561,HP_IMPAIRED_EPINEPHRINE_INDUCED_PLATELET_AGGREGATION,0.885075034106412
HP_JUVENILE_RHEUMATOID_ARTHR...,SET,5,0.38202,0.0063034,0.39315,0.16561,HP_JUVENILE_RHEUMATOID_ARTHRITIS,0.885075034106412
GOBP_NEGATIVE_REGULATION_OF_...383,SET,6,0.35659,0.0064453,0.36701,0.16562,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.885075034106412
ETF_Q6,SET,110,0.080295,0.0061964,0.082664,0.1657,ETF_Q6,0.885075034106412
REACTOME_PENTOSE_PHOSPHATE_P...,SET,12,0.24907,0.0063654,0.25648,0.16576,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,0.885075034106412
KEGG_MEDICUS_VARIANT_MUTATIO...56,SET,24,0.16861,0.006092,0.17364,0.16578,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.885075034106412
MIR4650_3P,SET,119,0.078029,0.0062616,0.080363,0.16579,MIR4650_3P,0.885075034106412
GOBP_B_CELL_PROLIFERATION,SET,95,0.093031,0.0066746,0.095812,0.16579,GOBP_B_CELL_PROLIFERATION,0.885075034106412
HINATA_NFKB_TARGETS_KERATINO...1,SET,22,0.19739,0.0068288,0.2033,0.1658,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,0.885075034106412
MIR3671,SET,571,0.035889,0.0062299,0.036965,0.16581,MIR3671,0.885075034106412
GSE40225_WT_VS_RIP_B7X_DIABE...1,SET,168,0.060951,0.0058037,0.062778,0.16581,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN,0.885075034106412
GOBP_REGULATION_OF_INFLAMMAT...3,SET,10,0.27422,0.0063979,0.28247,0.16583,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.885075034106412
HP_HYPERGLYCEMIA,SET,77,0.095712,0.0061853,0.098605,0.16587,HP_HYPERGLYCEMIA,0.885075034106412
HP_AV_NODAL_TACHYCARDIA,SET,2,0.68383,0.0071368,0.70458,0.16589,HP_AV_NODAL_TACHYCARDIA,0.885075034106412
HP_COUGH,SET,135,0.072454,0.00619,0.074657,0.16591,HP_COUGH,0.885075034106412
KEGG_MEDICUS_REFERENCE_C9ORF...,SET,8,0.29253,0.0061051,0.30145,0.16593,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION,0.885075034106412
GSE42724_NAIVE_BCELL_VS_PLAS...1,SET,179,0.062321,0.0061235,0.064226,0.16595,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN,0.885075034106412
DHIMAN_PBMC_ATTENUVAX_AGE_15...1,SET,17,0.20778,0.0063195,0.21417,0.166,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_DN,0.885075034106412
HNF4_01,SET,244,0.052195,0.005977,0.053813,0.16604,HNF4_01,0.885075034106412
MIR1265,SET,40,0.12934,0.0060304,0.13335,0.16605,MIR1265,0.885075034106412
CEBPA_01,SET,223,0.057987,0.0063518,0.05981,0.16615,CEBPA_01,0.885075034106412
NAKAYA_PBMC_FLUAD_MALE_AGE_1...2,SET,49,0.12739,0.0065721,0.1314,0.16616,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,0.885075034106412
DUTERTRE_ESTRADIOL_RESPONSE_...4,SET,209,0.057192,0.0060671,0.059002,0.1662,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,0.885075034106412
GSE17721_LPS_VS_POLYIC_16H_B...1,SET,190,0.0614,0.0062137,0.063343,0.1662,GSE17721_LPS_VS_POLYIC_16H_BMDC_DN,0.885075034106412
GSE20198_IL12_VS_IL12_IL18_T...2,SET,175,0.060631,0.0058912,0.062562,0.16624,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.885075034106412
HP_ABNORMAL_OLFACTORY_LOBE_M...,SET,6,0.31816,0.0057506,0.32832,0.16627,HP_ABNORMAL_OLFACTORY_LOBE_MORPHOLOGY,0.885075034106412
HP_ABNORMAL_FALLOPIAN_TUBE_M...,SET,21,0.17015,0.0057512,0.1756,0.16629,HP_ABNORMAL_FALLOPIAN_TUBE_MORPHOLOGY,0.885075034106412
GOMF_IMMUNE_RECEPTOR_ACTIVITY,SET,131,0.084386,0.0071025,0.087103,0.16633,GOMF_IMMUNE_RECEPTOR_ACTIVITY,0.885075034106412
GOBP_PROTEIN_CATABOLIC_PROCE...1,SET,909,0.027223,0.0059056,0.028102,0.16635,GOBP_PROTEIN_CATABOLIC_PROCESS,0.885075034106412
HP_UNDETECTABLE_LIGHT_AND_DA...,SET,13,0.2534,0.0067403,0.26159,0.16636,HP_UNDETECTABLE_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.885075034106412
GSE15330_LYMPHOID_MULTIPOTEN...8,SET,181,0.060034,0.0059313,0.061981,0.16638,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.885075034106412
GOBP_POSITIVE_REGULATION_OF_...324,SET,12,0.25875,0.0066129,0.26723,0.16646,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.885075034106412
HP_CHRONIC_INFECTION,SET,21,0.18712,0.0063249,0.19326,0.16646,HP_CHRONIC_INFECTION,0.885075034106412
CAFFAREL_RESPONSE_TO_THC_24H...1,SET,12,0.24095,0.0061579,0.24885,0.16647,CAFFAREL_RESPONSE_TO_THC_24HR_3_DN,0.885075034106412
GSE9946_IMMATURE_VS_PROSTAGL...1,SET,124,0.075045,0.0061465,0.077509,0.16648,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.885075034106412
GOCC_PERICHROMATIN_FIBRILS,SET,6,0.34179,0.0061777,0.35308,0.16653,GOCC_PERICHROMATIN_FIBRILS,0.885075034106412
GOBP_FUCOSE_METABOLIC_PROCESS,SET,15,0.20912,0.0059748,0.21606,0.16656,GOBP_FUCOSE_METABOLIC_PROCESS,0.885075034106412
GOBP_NUCLEOSIDE_BISPHOSPHATE...1,SET,51,0.12205,0.0064239,0.12611,0.16656,GOBP_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS,0.885075034106412
GOBP_ANTIGEN_PROCESSING_AND_...4,SET,23,0.19122,0.0067639,0.19761,0.16661,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN,0.885075034106412
GOBP_MYELOID_CELL_APOPTOTIC_...,SET,36,0.13291,0.0058794,0.13735,0.16661,GOBP_MYELOID_CELL_APOPTOTIC_PROCESS,0.885075034106412
chr6p22,SET,103,0.13633,0.010182,0.1409,0.16665,chr6p22,0.885075034106412
GOMF_PHOSPHATIDYLINOSITOL_KI...,SET,25,0.17211,0.0063466,0.17789,0.16665,GOMF_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY,0.885075034106412
WP_EPAC1_AND_PKA_REDUCTION_O...,SET,8,0.3111,0.0064925,0.32158,0.16668,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.885075034106412
GOBP_CXCL12_ACTIVATED_CXCR4_...,SET,4,0.46351,0.0068408,0.47913,0.16668,GOBP_CXCL12_ACTIVATED_CXCR4_SIGNALING_PATHWAY,0.885075034106412
GOBP_COMPARTMENT_PATTERN_SPE...,SET,5,0.39849,0.0065752,0.41202,0.16674,GOBP_COMPARTMENT_PATTERN_SPECIFICATION,0.885075034106412
GOBP_PROTEIN_K29_LINKED_DEUB...,SET,4,0.39265,0.005795,0.40603,0.16676,GOBP_PROTEIN_K29_LINKED_DEUBIQUITINATION,0.885075034106412
AMIT_SERUM_RESPONSE_60_MCF10A,SET,54,0.12967,0.007022,0.1341,0.1668,AMIT_SERUM_RESPONSE_60_MCF10A,0.885075034106412
GOBP_RESPONSE_TO_ORGANIC_CYC...,SET,826,0.030146,0.0062487,0.03118,0.16682,GOBP_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.885075034106412
BUSSLINGER_ESOPHAGEAL_PROLIF...,SET,67,0.10497,0.0063298,0.10858,0.16682,BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS,0.885075034106412
HP_GENERALIZED_MYOCLONIC_ATO...,SET,9,0.26214,0.0058025,0.27118,0.16686,HP_GENERALIZED_MYOCLONIC_ATONIC_SEIZURE,0.885075034106412
THRA_TARGET_GENES,SET,66,0.099133,0.0059329,0.10256,0.16689,THRA_TARGET_GENES,0.885075034106412
HP_ABNORMAL_EYELASH_MORPHOLO...,SET,250,0.05225,0.0060554,0.054059,0.1669,HP_ABNORMAL_EYELASH_MORPHOLOGY,0.885075034106412
chr6q13,SET,19,0.29708,0.009552,0.30743,0.16694,chr6q13,0.885075034106412
REACTOME_FGFR1C_LIGAND_BINDI...,SET,13,0.25499,0.0067827,0.26387,0.16694,REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,0.885075034106412
MEBARKI_HCC_PROGENITOR_FZD8C...1,SET,371,0.044539,0.006267,0.046109,0.16704,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,0.885075034106412
NKX62_Q2,SET,220,0.060127,0.0065423,0.062256,0.16708,NKX62_Q2,0.885075034106412
MIR4740_3P,SET,7,0.32046,0.0062561,0.33188,0.16713,MIR4740_3P,0.885075034106412
GSE14908_RESTING_VS_HDM_STIM...3,SET,177,0.060506,0.0059121,0.062664,0.16714,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN,0.885075034106412
GSE3720_LPS_VS_PMA_STIM_VD2_...1,SET,138,0.072669,0.0062765,0.075266,0.16715,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.885075034106412
GSE37301_PRO_BCELL_VS_CD4_TC...1,SET,150,0.068561,0.0061717,0.07101,0.16715,GSE37301_PRO_BCELL_VS_CD4_TCELL_DN,0.885075034106412
GOBP_MICROTUBULE_POLYMERIZAT...1,SET,87,0.085512,0.0058724,0.088578,0.16718,GOBP_MICROTUBULE_POLYMERIZATION,0.885075034106412
GOBP_UTP_BIOSYNTHETIC_PROCESS,SET,9,0.28039,0.0062063,0.29048,0.16722,GOBP_UTP_BIOSYNTHETIC_PROCESS,0.885075034106412
REACTOME_SIGNALING_BY_KIT_IN...,SET,20,0.19166,0.0063222,0.19859,0.16726,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,0.885075034106412
REACTOME_TOLL_LIKE_RECEPTOR_...1,SET,101,0.082827,0.0061263,0.085823,0.16726,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,0.885075034106412
GOBP_POSITIVE_REGULATION_OF_...384,SET,6,0.32666,0.0059043,0.33848,0.16726,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.885075034106412
MODULE_352,SET,17,0.18322,0.0055727,0.1899,0.16732,MODULE_352,0.885075034106412
GSE25088_WT_VS_STAT6_KO_MACR...6,SET,180,0.06038,0.0059491,0.062584,0.16734,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.885075034106412
GOBP_PYRIMIDINE_NUCLEOSIDE_C...,SET,15,0.2748,0.0078513,0.28488,0.16738,GOBP_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.885075034106412
HP_DECREASED_NUMBER_OF_PERIP...,SET,45,0.12245,0.006055,0.12695,0.16738,HP_DECREASED_NUMBER_OF_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.885075034106412
REACTOME_PRE_NOTCH_PROCESSIN...1,SET,18,0.18263,0.0057156,0.18936,0.16741,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,0.885075034106412
ISHIKAWA_STING_SIGNALING,SET,10,0.24356,0.0056826,0.25256,0.16744,ISHIKAWA_STING_SIGNALING,0.885075034106412
TBP_01,SET,223,0.057983,0.0063514,0.060132,0.16746,TBP_01,0.885075034106412
GOCC_STEREOCILIUM_MEMBRANE,SET,5,0.39029,0.0064399,0.40477,0.16747,GOCC_STEREOCILIUM_MEMBRANE,0.885075034106412
CROONQUIST_NRAS_SIGNALING_DN,SET,68,0.095222,0.0057843,0.09876,0.16749,CROONQUIST_NRAS_SIGNALING_DN,0.885075034106412
chr3q13,SET,80,0.16942,0.011159,0.17572,0.1675,chr3q13,0.885075034106412
WP_TOLLLIKE_RECEPTOR_SIGNALI...1,SET,95,0.09146,0.0065619,0.094866,0.1675,WP_TOLLLIKE_RECEPTOR_SIGNALING,0.885075034106412
GOCC_PCG_PROTEIN_COMPLEX,SET,43,0.12127,0.005862,0.12582,0.16756,GOCC_PCG_PROTEIN_COMPLEX,0.885075034106412
GOBP_APOPTOTIC_PROCESS_INVOL...2,SET,4,0.51094,0.0075408,0.53012,0.16757,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_HEART_MORPHOGENESIS,0.885075034106412
GSE22601_DOUBLE_POSITIVE_VS_...1,SET,183,0.05824,0.0057854,0.060435,0.16761,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.885075034106412
MIR3127_3P,SET,95,0.082033,0.0058855,0.08513,0.16763,MIR3127_3P,0.885075034106412
GOMF_MANGANESE_ION_BINDING,SET,61,0.10866,0.0062527,0.11279,0.16769,GOMF_MANGANESE_ION_BINDING,0.885075034106412
GOMF_PEPTIDE_ANTIGEN_BINDING,SET,32,0.16054,0.0066964,0.16667,0.16773,GOMF_PEPTIDE_ANTIGEN_BINDING,0.885075034106412
NAKAYAMA_SOFT_TISSUE_TUMORS_...3,SET,71,0.10797,0.006701,0.1121,0.16774,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,0.885075034106412
GOBP_REGULATION_OF_PROTEIN_T...2,SET,31,0.14521,0.0059619,0.15077,0.16775,GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.885075034106412
GOCC_CELL_CELL_JUNCTION,SET,471,0.040302,0.0063717,0.041846,0.16775,GOCC_CELL_CELL_JUNCTION,0.885075034106412
AP1_Q6_01,SET,239,0.054415,0.0061679,0.056508,0.16779,AP1_Q6_01,0.885075034106412
GSE37605_C57BL6_VS_NOD_FOXP3...6,SET,123,0.075584,0.0061657,0.078498,0.16781,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP,0.885075034106412
HP_LACRIMAL_DUCT_ATRESIA,SET,5,0.42104,0.0069472,0.43732,0.16784,HP_LACRIMAL_DUCT_ATRESIA,0.885075034106412
ZNF507_TARGET_GENES,SET,511,0.036287,0.0059689,0.037695,0.16786,ZNF507_TARGET_GENES,0.885075034106412
GOBP_DE_NOVO_CENTRIOLE_ASSEM...1,SET,5,0.31473,0.005193,0.32694,0.16787,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY,0.885075034106412
GOBP_REGULATION_OF_TELOMERAS...,SET,43,0.12221,0.0059072,0.12695,0.16787,GOBP_REGULATION_OF_TELOMERASE_ACTIVITY,0.885075034106412
BUSSLINGER_DUODENAL_K_CELLS,SET,17,0.2137,0.0064996,0.22201,0.16789,BUSSLINGER_DUODENAL_K_CELLS,0.885075034106412
GOMF_NUCLEAR_LOCALIZATION_SE...,SET,23,0.16544,0.0058519,0.17188,0.1679,GOMF_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING,0.885075034106412
KAECH_DAY8_EFF_VS_MEMORY_CD8...2,SET,183,0.057861,0.0057477,0.060117,0.16791,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP,0.885075034106412
GARGALOVIC_RESPONSE_TO_OXIDI...2,SET,32,0.1528,0.0063735,0.15877,0.16794,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,0.885075034106412
WP_17Q12_COPY_NUMBER_VARIATI...,SET,84,0.17373,0.011724,0.18054,0.16795,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,0.885075034106412
REACTOME_INFECTIOUS_DISEASE,SET,888,0.027072,0.0058079,0.028134,0.16797,REACTOME_INFECTIOUS_DISEASE,0.885075034106412
GNF2_CKS2,SET,49,0.11265,0.0058119,0.11707,0.16797,GNF2_CKS2,0.885075034106412
MIR589_5P,SET,77,0.093338,0.0060319,0.097003,0.16798,MIR589_5P,0.885075034106412
REACTOME_G_ALPHA_12_13_SIGNA...,SET,74,0.099504,0.0063044,0.10342,0.16799,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,0.885075034106412
GOBP_LIVER_REGENERATION,SET,30,0.14961,0.0060426,0.1555,0.168,GOBP_LIVER_REGENERATION,0.885075034106412
HP_CHRONIC_NEUTROPENIA,SET,9,0.24541,0.0054322,0.25513,0.16805,HP_CHRONIC_NEUTROPENIA,0.88512279133202
NAKAYA_PBMC_FLUMIST_AGE_18_5...6,SET,31,0.14822,0.0060855,0.1541,0.16806,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP,0.88512279133202
GSE4590_PRE_BCELL_VS_VPREB_P...2,SET,140,0.070896,0.0061672,0.073733,0.16815,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.885376433408578
REACTOME_CILIUM_ASSEMBLY,SET,182,0.057671,0.0057134,0.059988,0.16819,REACTOME_CILIUM_ASSEMBLY,0.885376433408578
HP_DYSCHROMATOPSIA,SET,29,0.1509,0.0059926,0.15704,0.1683,HP_DYSCHROMATOPSIA,0.885376433408578
HP_INCREASED_B_CELL_COUNT,SET,11,0.27131,0.0066389,0.28238,0.16833,HP_INCREASED_B_CELL_COUNT,0.885376433408578
EIF4E_DN,SET,90,0.088342,0.00617,0.091972,0.1684,EIF4E_DN,0.885376433408578
HP_ABNORMAL_REPRODUCTIVE_SYS...,SET,1236,0.023981,0.006009,0.024972,0.16845,HP_ABNORMAL_REPRODUCTIVE_SYSTEM_MORPHOLOGY,0.885376433408578
GSE13306_RA_VS_UNTREATED_MEM...1,SET,170,0.064406,0.0061687,0.067066,0.16845,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN,0.885376433408578
HE_LIM_SUN_FETAL_LUNG_C7_SST...,SET,333,0.046961,0.0062668,0.048913,0.16851,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.885376433408578
GOBP_POSITIVE_REGULATION_OF_...25,SET,7,0.32091,0.0062648,0.33426,0.16852,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.885376433408578
DESERT_EXTRACELLULAR_MATRIX_...,SET,19,0.1988,0.0063919,0.20708,0.16853,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.885376433408578
REACTOME_LISTERIA_MONOCYTOGE...,SET,18,0.18372,0.0057497,0.19137,0.16853,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,0.885376433408578
MIR3677_5P,SET,24,0.15975,0.0057719,0.16641,0.16854,MIR3677_5P,0.885376433408578
ZNF708_TARGET_GENES,SET,72,0.095449,0.0059655,0.099442,0.16857,ZNF708_TARGET_GENES,0.885376433408578
MIR7158_3P,SET,57,0.11158,0.0062074,0.11627,0.16863,MIR7158_3P,0.885376433408578
KREPPEL_CD99_TARGETS_DN,SET,7,0.32972,0.0064369,0.34362,0.16864,KREPPEL_CD99_TARGETS_DN,0.885376433408578
GOBP_ORGANIC_ANION_TRANSPORT,SET,424,0.042012,0.0063103,0.043789,0.16868,GOBP_ORGANIC_ANION_TRANSPORT,0.885376433408578
GAVISH_3CA_MALIGNANT_METAPRO...24,SET,43,0.12961,0.0062651,0.13511,0.16871,GAVISH_3CA_MALIGNANT_METAPROGRAM_32_SKIN_PIGMENTATION,0.885376433408578
GOBP_PERK_MEDIATED_UNFOLDED_...,SET,20,0.18526,0.0061112,0.19312,0.16871,GOBP_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.885376433408578
HP_HYPOKALEMIC_ALKALOSIS,SET,12,0.25052,0.0064025,0.26124,0.1688,HP_HYPOKALEMIC_ALKALOSIS,0.885376433408578
REACTOME_DCC_MEDIATED_ATTRAC...,SET,14,0.20624,0.0056928,0.21513,0.16887,REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,0.885376433408578
GOCC_ACTIVIN_RECEPTOR_COMPLEX,SET,6,0.37646,0.0068044,0.39272,0.16889,GOCC_ACTIVIN_RECEPTOR_COMPLEX,0.885376433408578
REACTOME_RECYCLING_OF_BILE_A...,SET,18,0.20073,0.0062822,0.20941,0.1689,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,0.885376433408578
MIR500B_3P,SET,76,0.097053,0.0062313,0.10126,0.16891,MIR500B_3P,0.885376433408578
GSE23321_CD8_STEM_CELL_MEMOR...3,SET,180,0.060001,0.0059118,0.062602,0.16892,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.885376433408578
MIR873_3P,SET,55,0.10916,0.0059658,0.1139,0.16894,MIR873_3P,0.885376433408578
MIR4727_5P,SET,103,0.082071,0.0061298,0.085637,0.16895,MIR4727_5P,0.885376433408578
HP_JAW_HYPERREFLEXIA,SET,39,0.12814,0.0058996,0.13373,0.16899,HP_JAW_HYPERREFLEXIA,0.885376433408578
HP_INTRA_EPIDERMAL_BLISTERING,SET,6,0.31018,0.0056064,0.32373,0.169,HP_INTRA_EPIDERMAL_BLISTERING,0.885376433408578
BIOCARTA_DEATH_PATHWAY,SET,28,0.16048,0.0062624,0.1675,0.16901,BIOCARTA_DEATH_PATHWAY,0.885376433408578
GOBP_BONE_REMODELING,SET,89,0.092626,0.0064333,0.096702,0.16908,GOBP_BONE_REMODELING,0.885376433408578
GOBP_SOMATOSTATIN_RECEPTOR_S...,SET,6,0.33307,0.0060201,0.34775,0.16909,GOBP_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY,0.885376433408578
GSE6259_FLT3L_INDUCED_DEC205...3,SET,111,0.081734,0.0063359,0.085342,0.16911,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN,0.885376433408578
REACTOME_NETRIN_1_SIGNALING,SET,42,0.12542,0.0059918,0.13096,0.16912,REACTOME_NETRIN_1_SIGNALING,0.885376433408578
ZA_UNIPROT_Q9UM89_UNREVIEWED...,SET,60,0.10999,0.0062777,0.11486,0.16914,ZA_UNIPROT_Q9UM89_UNREVIEWED_GENES_TARGET_GENES,0.885376433408578
HP_ABNORMALITY_OF_ALKALINE_P...,SET,120,0.075671,0.0060976,0.079021,0.16914,HP_ABNORMALITY_OF_ALKALINE_PHOSPHATASE_LEVEL,0.885376433408578
HP_ABNORMAL_EPIDIDYMIS_MORPH...,SET,10,0.26638,0.006215,0.27818,0.16914,HP_ABNORMAL_EPIDIDYMIS_MORPHOLOGY,0.885376433408578
GOMF_SEMAPHORIN_RECEPTOR_BIN...,SET,23,0.17818,0.0063024,0.1861,0.16918,GOMF_SEMAPHORIN_RECEPTOR_BINDING,0.885376433408578
GSE23568_ID3_KO_VS_WT_CD8_TC...2,SET,174,0.060309,0.0058432,0.06299,0.16918,GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP,0.885376433408578
HP_CACHEXIA,SET,89,0.084218,0.0058494,0.087968,0.1692,HP_CACHEXIA,0.885376433408578
RATTENBACHER_BOUND_BY_CELF1,SET,365,0.042637,0.0059516,0.044537,0.16921,RATTENBACHER_BOUND_BY_CELF1,0.885376433408578
GOBP_REGULATION_OF_ENDOTHELI...4,SET,153,0.069458,0.0063141,0.072553,0.16921,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.885376433408578
KYNG_ENVIRONMENTAL_STRESS_RE...3,SET,33,0.13701,0.0058032,0.14312,0.16922,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,0.885376433408578
GOBP_CARDIAC_SEPTUM_CELL_DIF...,SET,5,0.37851,0.0062456,0.39543,0.16924,GOBP_CARDIAC_SEPTUM_CELL_DIFFERENTIATION,0.885376433408578
GSE19401_UNSTIM_VS_RETINOIC_...1,SET,184,0.061612,0.0061369,0.064366,0.16924,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.885376433408578
HP_CHORDEE,SET,13,0.23328,0.0062051,0.24374,0.16927,HP_CHORDEE,0.885376433408578
GOBP_SIGNAL_COMPLEX_ASSEMBLY,SET,8,0.25861,0.0053971,0.27021,0.16928,GOBP_SIGNAL_COMPLEX_ASSEMBLY,0.885376433408578
GSE3039_ALPHABETA_CD8_TCELL_...2,SET,178,0.059795,0.005859,0.062496,0.16934,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP,0.885528328569279
GOMF_PHOSPHOLIPID_TRANSPORTE...,SET,58,0.10884,0.0061077,0.11376,0.16936,GOMF_PHOSPHOLIPID_TRANSPORTER_ACTIVITY,0.885528328569279
SUMI_HNF4A_TARGETS,SET,28,0.16841,0.0065716,0.17605,0.16939,SUMI_HNF4A_TARGETS,0.88555196299639
HP_BONE_FRACTURE,SET,21,0.16348,0.0055259,0.17093,0.16943,HP_BONE_FRACTURE,0.885627861332531
GOBP_NEGATIVE_REGULATION_OF_...537,SET,80,0.090366,0.005952,0.0945,0.16948,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.885727334235453
MIR613,SET,289,0.048499,0.0060367,0.050721,0.1695,MIR613,0.885727334235453
WP_NEPHROTIC_SYNDROME,SET,42,0.12994,0.0062077,0.13596,0.16961,WP_NEPHROTIC_SYNDROME,0.886035705696678
GOBP_RRNA_METABOLIC_PROCESS,SET,228,0.050289,0.0055692,0.052618,0.16961,GOBP_RRNA_METABOLIC_PROCESS,0.886035705696678
GGTGTGT_MIR329,SET,103,0.087776,0.006556,0.091867,0.16967,GGTGTGT_MIR329,0.886176820843971
GOMF_DOUBLE_STRANDED_METHYLA...,SET,4,0.3926,0.0057942,0.41101,0.16974,GOMF_DOUBLE_STRANDED_METHYLATED_DNA_BINDING,0.886176820843971
WP_INVOLVEMENT_OF_SECRETASE_...,SET,16,0.21368,0.0063052,0.2237,0.16975,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,0.886176820843971
GSE32986_GMCSF_VS_GMCSF_AND_...1,SET,167,0.065128,0.0061831,0.068186,0.16976,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.886176820843971
REACTOME_MET_ACTIVATES_PI3K_...,SET,6,0.36095,0.0065241,0.37792,0.16977,REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING,0.886176820843971
MYLLYKANGAS_AMPLIFICATION_HO...18,SET,12,0.25002,0.0063898,0.2618,0.16979,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8,0.886176820843971
GOBP_DETOXIFICATION,SET,129,0.075462,0.0063031,0.079031,0.16984,GOBP_DETOXIFICATION,0.886299452116482
HP_SOMATIC_SENSORY_DYSFUNCTI...,SET,379,0.041959,0.005966,0.04395,0.16987,HP_SOMATIC_SENSORY_DYSFUNCTION,0.886299452116482
HP_ELEVATED_URINARY_DELTA_AM...,SET,5,0.41393,0.0068299,0.4336,0.16989,HP_ELEVATED_URINARY_DELTA_AMINOLEVULINIC_ACID,0.886299452116482
SIG_REGULATION_OF_THE_ACTIN_...,SET,30,0.14388,0.0058114,0.15079,0.17,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,0.886740207113913
HP_INCREASED_CORNEAL_THICKNE...,SET,5,0.42766,0.0070565,0.4483,0.17006,HP_INCREASED_CORNEAL_THICKNESS,0.886758235823582
KEGG_MEDICUS_REFERENCE_BCR_P...1,SET,16,0.20307,0.0059923,0.21289,0.17007,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.886758235823582
GOBP_NEGATIVE_REGULATION_OF_...520,SET,6,0.32853,0.005938,0.34441,0.17008,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.886758235823582
HP_KETONURIA,SET,32,0.14253,0.0059453,0.14948,0.17016,HP_KETONURIA,0.886851724137931
GOCC_DENDRITIC_SPINE_HEAD,SET,7,0.33621,0.0065635,0.3526,0.17017,GOCC_DENDRITIC_SPINE_HEAD,0.886851724137931
GSE7548_DAY7_VS_DAY28_PCC_IM...2,SET,187,0.060451,0.0060697,0.063405,0.1702,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,0.886851724137931
HOWARD_NK_CELL_INACT_MONOV_I...3,SET,66,0.095885,0.0057386,0.10057,0.1702,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.886851724137931
HP_EOSINOPHILIA,SET,52,0.11457,0.0060889,0.1202,0.17026,HP_EOSINOPHILIA,0.886910955518946
HP_PATCHY_PALMOPLANTAR_HYPER...,SET,6,0.38379,0.0069369,0.40274,0.17031,HP_PATCHY_PALMOPLANTAR_HYPERKERATOSIS,0.886910955518946
GSE12484_HEALTHY_VS_PERIDONT...1,SET,138,0.068853,0.0059469,0.072254,0.17032,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN,0.886910955518946
LEE_LIVER_CANCER_E2F1_DN,SET,59,0.11449,0.0064795,0.12016,0.17035,LEE_LIVER_CANCER_E2F1_DN,0.886910955518946
GOMF_ACYL_COA_BINDING,SET,18,0.19092,0.005975,0.2004,0.17038,GOMF_ACYL_COA_BINDING,0.886910955518946
KEGG_MEDICUS_REFERENCE_LPA_G...1,SET,12,0.21891,0.0055947,0.22979,0.17039,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,0.886910955518946
GOCC_NUCLEAR_STRESS_GRANULE,SET,6,0.31471,0.0056882,0.33035,0.17039,GOCC_NUCLEAR_STRESS_GRANULE,0.886910955518946
BARRIER_CANCER_RELAPSE_NORMA...1,SET,27,0.15205,0.0058266,0.15963,0.17042,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,0.88693427672956
BLALOCK_ALZHEIMERS_DISEASE_I...2,SET,348,0.042601,0.0058092,0.044749,0.17056,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,0.887316322406825
REACTOME_E3_UBIQUITIN_LIGASE...,SET,39,0.12601,0.0058016,0.13237,0.17057,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,0.887316322406825
MORF_RFC5,SET,72,0.089642,0.0056026,0.094166,0.17057,MORF_RFC5,0.887316322406825
MIR584_5P,SET,79,0.094117,0.0061604,0.098898,0.17064,MIR584_5P,0.887431991682757
KEGG_MEDICUS_PATHOGEN_YERSIN...2,SET,6,0.38468,0.0069529,0.40432,0.1707,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.887431991682757
GSE19401_PAM2CSK4_VS_RETINOI...1,SET,178,0.059813,0.0058608,0.062874,0.17073,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.887431991682757
GSE27786_NKCELL_VS_MONO_MAC_...2,SET,178,0.058456,0.0057278,0.061456,0.17076,GSE27786_NKCELL_VS_MONO_MAC_UP,0.887431991682757
MIR4715_5P,SET,39,0.13456,0.0061951,0.14154,0.1709,MIR4715_5P,0.887431991682757
GOBP_REGULATION_OF_PHOSPHATI...4,SET,5,0.24131,0.0039816,0.25385,0.17091,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.887431991682757
GOBP_DNA_REPLICATION_CHECKPO...,SET,20,0.15898,0.0052441,0.16725,0.17092,GOBP_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.887431991682757
GOCC_PWP2P_CONTAINING_SUBCOM...,SET,4,0.36017,0.0053157,0.37893,0.17093,GOCC_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME,0.887431991682757
GSE2706_UNSTIM_VS_8H_R848_DC...1,SET,174,0.066859,0.0064779,0.070346,0.17095,GSE2706_UNSTIM_VS_8H_R848_DC_DN,0.887431991682757
GSE19888_ADENOSINE_A3R_INH_V...5,SET,177,0.064341,0.0062869,0.067702,0.17097,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN,0.887431991682757
SCHLOSSER_MYC_TARGETS_REPRES...,SET,140,0.066811,0.0058118,0.070309,0.171,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.887431991682757
GSE3039_NKT_CELL_VS_B2_BCELL...1,SET,185,0.061022,0.0060945,0.064227,0.17104,GSE3039_NKT_CELL_VS_B2_BCELL_DN,0.887431991682757
GSE26030_UNSTIM_VS_RESTIM_TH...7,SET,180,0.060788,0.0059893,0.063983,0.17105,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN,0.887431991682757
GOBP_MEIOTIC_CHROMOSOME_SEPA...,SET,9,0.24092,0.0053327,0.25362,0.17108,GOBP_MEIOTIC_CHROMOSOME_SEPARATION,0.887431991682757
REACTOME_POST_TRANSLATIONAL_...1,SET,87,0.090143,0.0061905,0.094931,0.17117,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,0.887431991682757
GSE13493_DP_VS_CD4INTCD8POS_...2,SET,177,0.060117,0.0058742,0.063329,0.17125,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP,0.887431991682757
HP_ASTROCYTOMA,SET,22,0.16533,0.0057198,0.17418,0.17126,HP_ASTROCYTOMA,0.887431991682757
AIGNER_ZEB1_TARGETS,SET,33,0.15468,0.006552,0.16296,0.17127,AIGNER_ZEB1_TARGETS,0.887431991682757
GOCC_CYTOPLASMIC_SIDE_OF_PLA...,SET,152,0.06673,0.0060465,0.070311,0.1713,GOCC_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.887431991682757
HP_MICROCEPHALIC_SPERM_HEAD,SET,2,0.6288,0.0065625,0.66255,0.1713,HP_MICROCEPHALIC_SPERM_HEAD,0.887431991682757
GSE18281_MEDULLARY_THYMOCYTE...2,SET,163,0.062268,0.005841,0.065615,0.17132,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP,0.887431991682757
PID_ERBB1_RECEPTOR_PROXIMAL_...,SET,34,0.12854,0.0055263,0.13546,0.17133,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,0.887431991682757
WP_RETT_SYNDROME,SET,41,0.12592,0.005944,0.13271,0.17134,WP_RETT_SYNDROME,0.887431991682757
KEGG_ARGININE_AND_PROLINE_ME...,SET,47,0.10901,0.0055084,0.1149,0.17139,KEGG_ARGININE_AND_PROLINE_METABOLISM,0.887431991682757
MCGOWAN_RSP6_TARGETS_UP,SET,20,0.18929,0.006244,0.1996,0.17149,MCGOWAN_RSP6_TARGETS_UP,0.887431991682757
HP_HYPERCHLOREMIC_ACIDOSIS,SET,13,0.22328,0.0059392,0.23547,0.17151,HP_HYPERCHLOREMIC_ACIDOSIS,0.887431991682757
GOBP_PROTEIN_LOCALIZATION_TO...44,SET,260,0.050736,0.0059948,0.053512,0.17154,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.887431991682757
GAVISH_3CA_METAPROGRAM_EPITH...5,SET,47,0.129,0.0065184,0.13607,0.17156,GAVISH_3CA_METAPROGRAM_EPITHELIAL_COLON_RELATED,0.887431991682757
GSE32986_GMCSF_AND_CURDLAN_L...1,SET,165,0.064662,0.0061023,0.068208,0.17157,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.887431991682757
GSE37416_0H_VS_6H_F_TULARENS...1,SET,182,0.060832,0.0060265,0.064172,0.17158,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.887431991682757
GSE46606_IRF4MID_VS_WT_CD40L...3,SET,185,0.056324,0.0056253,0.059416,0.17158,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.887431991682757
GOBP_BRANCHED_CHAIN_AMINO_AC...4,SET,13,0.2295,0.0061048,0.24214,0.17161,GOBP_BRANCHED_CHAIN_AMINO_ACID_TRANSPORT,0.887431991682757
HP_RECURRENT_BRONCHOPULMONAR...,SET,10,0.21584,0.0050359,0.22772,0.17161,HP_RECURRENT_BRONCHOPULMONARY_INFECTIONS,0.887431991682757
BIOCARTA_ERK5_PATHWAY,SET,14,0.21427,0.0059146,0.2261,0.17165,BIOCARTA_ERK5_PATHWAY,0.887431991682757
GOCC_FIBRINOGEN_COMPLEX,SET,8,0.30896,0.006448,0.32606,0.17168,GOCC_FIBRINOGEN_COMPLEX,0.887431991682757
BIOCARTA_IFNA_PATHWAY,SET,9,0.26934,0.0059619,0.28426,0.17169,BIOCARTA_IFNA_PATHWAY,0.887431991682757
GSE31082_DN_VS_DP_THYMOCYTE_...1,SET,184,0.057233,0.0057008,0.060403,0.17169,GSE31082_DN_VS_DP_THYMOCYTE_DN,0.887431991682757
PIT1_Q6,SET,202,0.060023,0.0062611,0.063359,0.17174,PIT1_Q6,0.887431991682757
MODULE_177,SET,95,0.082714,0.0059344,0.087312,0.17174,MODULE_177,0.887431991682757
MIR5189_5P,SET,139,0.06802,0.005896,0.071806,0.17175,MIR5189_5P,0.887431991682757
GOMF_SERINE_TYPE_CARBOXYPEPT...,SET,5,0.33093,0.0054605,0.34937,0.17177,GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY,0.887431991682757
chr2q11,SET,69,0.21786,0.01333,0.23003,0.1718,chr2q11,0.887431991682757
SWEET_LUNG_CANCER_KRAS_DN,SET,387,0.045069,0.006474,0.047588,0.17181,SWEET_LUNG_CANCER_KRAS_DN,0.887431991682757
MIR34A_3P,SET,64,0.10338,0.0060931,0.10916,0.17181,MIR34A_3P,0.887431991682757
GOCC_ER_UBIQUITIN_LIGASE_COM...,SET,4,0.41503,0.0061253,0.43822,0.17181,GOCC_ER_UBIQUITIN_LIGASE_COMPLEX,0.887431991682757
TURASHVILI_BREAST_CARCINOMA_...2,SET,21,0.19127,0.0064652,0.20197,0.17182,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.887431991682757
GOBP_HIGH_DENSITY_LIPOPROTEI...3,SET,15,0.22621,0.0064633,0.23888,0.17183,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.887431991682757
HP_GENERALIZED_HYPOPIGMENTAT...1,SET,28,0.16936,0.0066089,0.17887,0.17187,HP_GENERALIZED_HYPOPIGMENTATION,0.887431991682757
GOMF_INWARD_RECTIFIER_POTASS...,SET,26,0.18059,0.0067909,0.19074,0.17188,GOMF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.887431991682757
HP_SUDDEN_UNEXPECTED_DEATH_I...,SET,9,0.26823,0.0059373,0.28332,0.17189,HP_SUDDEN_UNEXPECTED_DEATH_IN_EPILEPSY,0.887431991682757
GSE22282_HYPOXIA_VS_NORMOXIA...1,SET,178,0.062942,0.0061674,0.066487,0.17191,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN,0.887431991682757
ZHOU_CELL_CYCLE_GENES_IN_IR_...1,SET,116,0.072736,0.0057632,0.076836,0.17192,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,0.887431991682757
GSE3982_MEMORY_CD4_TCELL_VS_...2,SET,172,0.064138,0.0061788,0.067773,0.17199,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP,0.887661486486487
GOBP_DEVELOPMENTAL_GROWTH,SET,586,0.035601,0.006258,0.037624,0.17202,GOBP_DEVELOPMENTAL_GROWTH,0.887684498886414
GOBP_NEUROTRANSMITTER_LOADIN...,SET,7,0.34356,0.0067072,0.3632,0.1721,GOBP_NEUROTRANSMITTER_LOADING_INTO_SYNAPTIC_VESICLE,0.887828053123609
GSE37416_CTRL_VS_6H_F_TULARE...1,SET,169,0.06151,0.0058742,0.065038,0.17214,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.887828053123609
MIR4455,SET,100,0.083753,0.0061642,0.08856,0.17215,MIR4455,0.887828053123609
GAVISH_3CA_METAPROGRAM_MACRO...13,SET,42,0.12295,0.0058738,0.13001,0.17215,GAVISH_3CA_METAPROGRAM_MACROPHAGES_UNFOLDED_PROTEIN_RESPONSE,0.887828053123609
MIR4445_3P,SET,9,0.27548,0.0060977,0.29135,0.1722,MIR4445_3P,0.887954154302671
chr5p13,SET,54,0.22435,0.012149,0.23738,0.17231,chr5p13,0.888017301704967
WU_HBX_TARGETS_3_UP,SET,18,0.20209,0.0063245,0.21384,0.17232,WU_HBX_TARGETS_3_UP,0.888017301704967
HP_REDUCED_SOCIAL_RECIPROCITY,SET,52,0.10641,0.0056548,0.11259,0.17232,HP_REDUCED_SOCIAL_RECIPROCITY,0.888017301704967
GOBP_MAINTENANCE_OF_PROTEIN_...3,SET,81,0.090151,0.0059747,0.095399,0.17234,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION,0.888017301704967
GOBP_REGULATION_OF_HYPERSENS...,SET,9,0.27343,0.0060523,0.28935,0.17234,GOBP_REGULATION_OF_HYPERSENSITIVITY,0.888017301704967
GOBP_POSITIVE_REGULATION_OF_...229,SET,10,0.22026,0.005139,0.23321,0.17248,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.888578257003112
HP_ABNORMALITY_OF_HAIR_PIGME...,SET,109,0.079174,0.0060823,0.083838,0.1725,HP_ABNORMALITY_OF_HAIR_PIGMENTATION,0.888578257003112
BIOCARTA_PTC1_PATHWAY,SET,11,0.21695,0.0053088,0.22978,0.17254,BIOCARTA_PTC1_PATHWAY,0.888646733333333
GOBP_MESENCHYMAL_CELL_APOPTO...,SET,15,0.24428,0.0069795,0.25876,0.17258,GOBP_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.888646733333333
MIR548BC,SET,433,0.039313,0.0059658,0.041646,0.17259,MIR548BC,0.888646733333333
HE_LIM_SUN_FETAL_LUNG_C7_TM4...2,SET,107,0.08208,0.0062477,0.086958,0.17262,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.888669545252555
GOBP_CELLULAR_RESPONSE_TO_HI...,SET,6,0.34615,0.0062564,0.36686,0.17271,GOBP_CELLULAR_RESPONSE_TO_HISTAMINE,0.888714440993789
HP_HALLUCINATIONS,SET,145,0.066345,0.0058726,0.070329,0.17276,HP_HALLUCINATIONS,0.888714440993789
GSE5589_IL6_KO_VS_IL10_KO_LP...1,SET,179,0.060004,0.0058958,0.063608,0.17276,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.888714440993789
YY1_01,SET,225,0.053631,0.0059005,0.056857,0.17278,YY1_01,0.888714440993789
GOBP_PROGRAMMED_CELL_DEATH_I...1,SET,24,0.16882,0.0060996,0.17898,0.17279,GOBP_PROGRAMMED_CELL_DEATH_INVOLVED_IN_CELL_DEVELOPMENT,0.888714440993789
GSE3982_MAST_CELL_VS_NKCELL_...2,SET,176,0.060842,0.0059283,0.064519,0.17284,GSE3982_MAST_CELL_VS_NKCELL_UP,0.888714440993789
MIR219A_5P,SET,141,0.068311,0.0059634,0.07244,0.17285,MIR219A_5P,0.888714440993789
PGF_UP.V1_UP,SET,167,0.06323,0.0060029,0.067061,0.17288,PGF_UP.V1_UP,0.888714440993789
ALFANO_MYC_TARGETS,SET,223,0.053474,0.0058574,0.056717,0.17289,ALFANO_MYC_TARGETS,0.888714440993789
MIR6858_5P,SET,56,0.10824,0.0059687,0.1148,0.17289,MIR6858_5P,0.888714440993789
HP_PROXIMAL_MUSCLE_WEAKNESS_...2,SET,54,0.1081,0.005854,0.11466,0.17291,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_UPPER_LIMBS,0.888714440993789
GOBP_NEGATIVE_REGULATION_OF_...276,SET,21,0.17934,0.0060617,0.19025,0.17294,GOBP_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING,0.888737202424959
HP_PERIORBITAL_EDEMA,SET,99,0.086326,0.0063219,0.091601,0.173,HP_PERIORBITAL_EDEMA,0.888834079822616
COLLIS_PRKDC_SUBSTRATES,SET,15,0.20539,0.0058682,0.21795,0.17301,COLLIS_PRKDC_SUBSTRATES,0.888834079822616
GOBP_LIPID_LOCALIZATION,SET,449,0.03968,0.0061289,0.042127,0.17313,GOBP_LIPID_LOCALIZATION,0.889174380530974
GOBP_SPERMINE_METABOLIC_PROC...,SET,4,0.35105,0.0051811,0.37275,0.17316,GOBP_SPERMINE_METABOLIC_PROCESS,0.889174380530974
GOMF_POTASSIUM_CHLORIDE_SYMP...,SET,9,0.24385,0.0053977,0.25894,0.17317,GOMF_POTASSIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.889174380530974
GOBP_RESPONSE_TO_PLATELET_DE...,SET,19,0.19462,0.0062577,0.20674,0.17326,GOBP_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR,0.889174380530974
HP_VENTRICULAR_TACHYCARDIA,SET,62,0.10697,0.0062058,0.11364,0.17328,HP_VENTRICULAR_TACHYCARDIA,0.889174380530974
REACTOME_NEGATIVE_REGULATORS...,SET,32,0.14441,0.0060235,0.15344,0.17332,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.889174380530974
TGACAGNY_MEIS1_01,SET,766,0.030303,0.0060592,0.032201,0.17334,TGACAGNY_MEIS1_01,0.889174380530974
HP_ABNORMAL_RESPONSE_TO_ENDO...,SET,130,0.071912,0.0060297,0.076421,0.17336,HP_ABNORMAL_RESPONSE_TO_ENDOCRINE_STIMULATION_TEST,0.889174380530974
FOURNIER_ACINAR_DEVELOPMENT_...4,SET,22,0.1706,0.0059018,0.18131,0.17338,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,0.889174380530974
GOBP_LYMPHOCYTE_AGGREGATION,SET,4,0.42301,0.006243,0.44963,0.17342,GOBP_LYMPHOCYTE_AGGREGATION,0.889174380530974
GSE45739_UNSTIM_VS_ACD3_ACD2...3,SET,178,0.062052,0.0060801,0.065958,0.17342,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN,0.889174380530974
MIR10A_3P,SET,20,0.17858,0.0058907,0.18983,0.17343,MIR10A_3P,0.889174380530974
GSE34156_NOD2_LIGAND_VS_NOD2...3,SET,181,0.060252,0.0059528,0.064051,0.17344,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.889174380530974
GOCC_ALPHA_BETA_T_CELL_RECEP...,SET,4,0.39011,0.0057575,0.41473,0.17345,GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX,0.889174380530974
GOBP_REGULATION_OF_BILE_ACID...3,SET,5,0.33986,0.0056077,0.36132,0.17346,GOBP_REGULATION_OF_BILE_ACID_SECRETION,0.889174380530974
HP_LONG_PALM,SET,3,0.57869,0.0073967,0.61533,0.1735,HP_LONG_PALM,0.889248267217224
REACTOME_REPRESSION_OF_WNT_T...,SET,13,0.23447,0.0062369,0.24936,0.17354,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,0.88932213211442
GOMF_ATP_DEPENDENT_ACTIVITY_...1,SET,109,0.072159,0.0055434,0.076758,0.17359,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_DNA,0.889447213622291
GSE3982_MAC_VS_BASOPHIL_DN,SET,167,0.061757,0.0058631,0.065716,0.17367,GSE3982_MAC_VS_BASOPHIL_DN,0.889691130101665
MIR4427,SET,211,0.056681,0.0060413,0.060319,0.1737,MIR4427,0.889691130101665
MARTORIATI_MDM4_TARGETS_FETA...1,SET,466,0.037049,0.0058271,0.039435,0.17374,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,0.889691130101665
GSE3920_IFNA_VS_IFNG_TREATED...2,SET,153,0.064849,0.0058951,0.069024,0.17374,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.889691130101665
LU_AGING_BRAIN_UP,SET,234,0.055346,0.0062083,0.058923,0.17379,LU_AGING_BRAIN_UP,0.889728
GSE14415_NATURAL_TREG_VS_FOX...2,SET,140,0.067209,0.0058465,0.071561,0.17382,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP,0.889728
CUI_DEVELOPING_HEART_CARDIAC...,SET,100,0.084293,0.0062039,0.089764,0.17386,CUI_DEVELOPING_HEART_CARDIAC_FIBROBLASTS,0.889728
HP_ABNORMAL_DELAYED_HYPERSEN...,SET,10,0.26177,0.0061076,0.27882,0.1739,HP_ABNORMAL_DELAYED_HYPERSENSITIVITY_SKIN_TEST,0.889728
HP_ABNORMAL_RESPONSE_TO_GLUC...,SET,4,0.44242,0.0065295,0.47131,0.17395,HP_ABNORMAL_RESPONSE_TO_GLUCAGON_STIMULATION_TEST,0.889728
HP_INSULIN_RESISTANT_DIABETE...,SET,38,0.13839,0.0062894,0.14743,0.17395,HP_INSULIN_RESISTANT_DIABETES_MELLITUS,0.889728
GOBP_POSITIVE_REGULATION_OF_...383,SET,5,0.3809,0.006285,0.40582,0.17398,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.889728
MIR7154_5P,SET,239,0.053145,0.0060239,0.05663,0.17401,MIR7154_5P,0.889728
BUSSLINGER_DUODENAL_TRANSIT_...,SET,162,0.062064,0.0058041,0.066134,0.17401,BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS,0.889728
GCM_ACTG1,SET,109,0.073305,0.0056314,0.078117,0.17403,GCM_ACTG1,0.889728
GOMF_OPIOID_RECEPTOR_BINDING,SET,7,0.35565,0.0069432,0.37906,0.17406,GOMF_OPIOID_RECEPTOR_BINDING,0.889728
REACTOME_SIGNALING_BY_RECEPT...,SET,508,0.036942,0.0060592,0.039374,0.17407,REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,0.889728
HP_JOINT_HEMORRHAGE,SET,14,0.23262,0.006421,0.24795,0.17408,HP_JOINT_HEMORRHAGE,0.889728
MIR4777_3P,SET,61,0.099553,0.0057288,0.10617,0.17421,MIR4777_3P,0.890101962369543
MIR6757_3P,SET,96,0.08007,0.0057747,0.085397,0.17423,MIR6757_3P,0.890101962369543
MORF_STK17A,SET,158,0.064577,0.0059647,0.068875,0.17423,MORF_STK17A,0.890101962369543
GOBP_REGULATION_OF_KETONE_BI...,SET,19,0.18515,0.0059532,0.1975,0.17427,GOBP_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS,0.890169203643844
chr11q11,SET,10,0.35651,0.0083179,0.38034,0.1743,chr11q11,0.890169203643844
WP_DEREGULATION_OF_RAB_AND_R...,SET,14,0.19186,0.005296,0.20471,0.17432,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,0.890169203643844
GSE12963_UNINF_VS_ENV_AND_NE...3,SET,129,0.070915,0.0059234,0.075675,0.17436,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.890242661965624
GOMF_UBIQUITIN_LIKE_PROTEIN_...3,SET,34,0.13075,0.0056212,0.13954,0.17439,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING,0.890265048472385
GOBP_PATTERN_SPECIFICATION_I...,SET,8,0.35187,0.0073434,0.37575,0.17453,GOBP_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.890705261226886
GOMF_RNA_POLYMERASE_III_TRAN...,SET,8,0.24383,0.0050887,0.26042,0.17456,GOMF_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.890705261226886
LANDIS_ERBB2_BREAST_TUMORS_3...2,SET,140,0.068697,0.0059759,0.073387,0.17462,LANDIS_ERBB2_BREAST_TUMORS_324_UP,0.890705261226886
JI_RESPONSE_TO_FSH_UP,SET,57,0.10205,0.0056774,0.10903,0.17463,JI_RESPONSE_TO_FSH_UP,0.890705261226886
GOBP_POSITIVE_REGULATION_OF_...43,SET,8,0.28249,0.0058954,0.30179,0.17463,GOBP_POSITIVE_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.890705261226886
GOMF_INTEGRIN_BINDING,SET,145,0.069664,0.0061665,0.074425,0.17463,GOMF_INTEGRIN_BINDING,0.890705261226886
GSE40068_CXCR5POS_BCL6POS_TF...2,SET,177,0.057486,0.0056171,0.061424,0.17467,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP,0.890721145665249
MORF_ERCC2,SET,98,0.07715,0.0056215,0.08244,0.17469,MORF_ERCC2,0.890721145665249
REACTOME_UNWINDING_OF_DNA,SET,12,0.22108,0.0056502,0.23627,0.17471,REACTOME_UNWINDING_OF_DNA,0.890721145665249
HP_PELVIC_GIRDLE_AMYOTROPHY,SET,3,0.34651,0.0044289,0.37036,0.17475,HP_PELVIC_GIRDLE_AMYOTROPHY,0.890794404517454
GOBP_POSITIVE_REGULATION_OF_...71,SET,34,0.13189,0.0056705,0.14101,0.17482,GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.890940857771261
REACTOME_TRANSPORT_OF_VITAMI...,SET,38,0.12927,0.0058751,0.13822,0.17483,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,0.890940857771261
GSE43863_NAIVE_VS_TFH_CD4_EF...1,SET,149,0.06854,0.0061494,0.073306,0.1749,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN,0.890955783009212
GOBP_CENTRIOLE_ELONGATION,SET,7,0.27935,0.0054536,0.29884,0.17496,GOBP_CENTRIOLE_ELONGATION,0.890955783009212
MIR4275,SET,139,0.069374,0.0060134,0.074221,0.17498,MIR4275,0.890955783009212
MIR6765_3P,SET,88,0.083743,0.0057838,0.089597,0.17499,MIR6765_3P,0.890955783009212
GSE360_HIGH_VS_LOW_DOSE_B_MA...4,SET,177,0.057854,0.005653,0.061899,0.17499,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP,0.890955783009212
HP_CHRONIC_ORAL_CANDIDIASIS,SET,26,0.15695,0.0059019,0.16793,0.175,HP_CHRONIC_ORAL_CANDIDIASIS,0.890955783009212
BIOCARTA_MAPK_PATHWAY,SET,79,0.090405,0.0059174,0.096761,0.17508,BIOCARTA_MAPK_PATHWAY,0.890955783009212
GOCC_SITE_OF_POLARIZED_GROWTH,SET,153,0.064576,0.0058703,0.069118,0.17509,GOCC_SITE_OF_POLARIZED_GROWTH,0.890955783009212
SHEPARD_BMYB_MORPHOLINO_DN,SET,187,0.058613,0.0058851,0.062742,0.17511,SHEPARD_BMYB_MORPHOLINO_DN,0.890955783009212
SOBOLEV_PBMC_PANDEMRIX_AGE_1...9,SET,18,0.19608,0.0061365,0.20993,0.17515,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_RESPONDERS_VS_NONRESPONDERS_7DY_UP,0.890955783009212
GSE26495_PD1HIGH_VS_PD1LOW_C...2,SET,166,0.061441,0.0058157,0.065802,0.17523,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP,0.890955783009212
HP_ANARTHRIA,SET,15,0.18947,0.0054134,0.20293,0.17525,HP_ANARTHRIA,0.890955783009212
GSE2770_UNTREATED_VS_TGFB_AN...9,SET,184,0.059004,0.0058771,0.063196,0.17525,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.890955783009212
GOBP_PEPTIDYL_TYROSINE_MODIF...,SET,247,0.053542,0.0061682,0.05735,0.17526,GOBP_PEPTIDYL_TYROSINE_MODIFICATION,0.890955783009212
WILLIAMS_ESR2_TARGETS_DN,SET,10,0.25416,0.0059301,0.27227,0.17528,WILLIAMS_ESR2_TARGETS_DN,0.890955783009212
GOBP_BLOOD_VESSEL_ENDOTHELIA...3,SET,23,0.18602,0.0065798,0.19928,0.17529,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.890955783009212
GSE18281_CORTICAL_VS_MEDULLA...2,SET,182,0.06061,0.0060046,0.064927,0.17529,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP,0.890955783009212
MIR6805_5P,SET,40,0.1185,0.0055253,0.12696,0.17531,MIR6805_5P,0.890955783009212
HP_CONGENITAL_MALFORMATION_O...2,SET,76,0.09051,0.0058112,0.096973,0.17532,HP_CONGENITAL_MALFORMATION_OF_THE_RIGHT_HEART,0.890955783009212
HP_PHONIC_TICS,SET,5,0.38122,0.0062902,0.40851,0.17537,HP_PHONIC_TICS,0.891079583333333
chr2p23,SET,84,0.17248,0.01164,0.1849,0.17546,chr2p23,0.891406563367929
GOCC_COHESIN_COMPLEX,SET,8,0.29428,0.0061416,0.31551,0.17549,GOCC_COHESIN_COMPLEX,0.891428668517977
GCGCTTT_MIR518B_MIR518C_MIR5...,SET,17,0.17754,0.0054,0.1904,0.17555,GCGCTTT_MIR518B_MIR518C_MIR518D,0.891462998416583
GSE24634_NAIVE_CD4_TCELL_VS_...8,SET,181,0.05684,0.0056157,0.060964,0.17558,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP,0.891462998416583
GOBP_NEGATIVE_REGULATION_OF_...660,SET,5,0.34221,0.0056465,0.36705,0.17559,GOBP_NEGATIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,0.891462998416583
GSE17721_0.5H_VS_4H_GARDIQUI...2,SET,172,0.058581,0.0056434,0.062842,0.17562,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP,0.891462998416583
GOMF_PROTEIN_PHOSPHATASE_2A_...,SET,26,0.1583,0.0059528,0.16985,0.17568,GOMF_PROTEIN_PHOSPHATASE_2A_BINDING,0.891462998416583
GOBP_ANTIGEN_PROCESSING_AND_...14,SET,24,0.20612,0.0074474,0.22122,0.17574,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB,0.891462998416583
GOBP_T_FOLLICULAR_HELPER_CEL...,SET,7,0.26389,0.0051518,0.28339,0.17588,GOBP_T_FOLLICULAR_HELPER_CELL_DIFFERENTIATION,0.891462998416583
MODULE_429,SET,14,0.2106,0.0058132,0.2262,0.17593,MODULE_429,0.891462998416583
HP_CONVEX_NASAL_RIDGE,SET,82,0.081744,0.0054507,0.087806,0.17594,HP_CONVEX_NASAL_RIDGE,0.891462998416583
HP_SMALL_INTESTINAL_POLYPOSIS,SET,5,0.31307,0.0051658,0.33629,0.17594,HP_SMALL_INTESTINAL_POLYPOSIS,0.891462998416583
GOBP_POSITIVE_REGULATION_OF_...95,SET,768,0.030259,0.0060579,0.03251,0.17599,GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.891462998416583
GOBP_ANTIBACTERIAL_PEPTIDE_P...,SET,10,0.27905,0.0065106,0.29981,0.176,GOBP_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.891462998416583
HP_DEJA_VU_AURA,SET,7,0.29189,0.0056983,0.31361,0.176,HP_DEJA_VU_AURA,0.891462998416583
GSE7852_TREG_VS_TCONV_THYMUS...1,SET,178,0.059453,0.0058255,0.063881,0.17601,GSE7852_TREG_VS_TCONV_THYMUS_DN,0.891462998416583
GOBP_CARDIAC_PACEMAKER_CELL_...1,SET,9,0.28506,0.0063098,0.30633,0.17604,GOBP_CARDIAC_PACEMAKER_CELL_DEVELOPMENT,0.891462998416583
RODWELL_AGING_KIDNEY_NO_BLOO...2,SET,196,0.060517,0.0062192,0.065032,0.17605,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,0.891462998416583
GTAGGCA_MIR189,SET,25,0.15901,0.0058634,0.1709,0.17609,GTAGGCA_MIR189,0.891462998416583
TFDP2_TARGET_GENES,SET,4,0.35112,0.005182,0.37738,0.17609,TFDP2_TARGET_GENES,0.891462998416583
GOMF_LIGAND_ACTIVATED_TRANSC...,SET,52,0.11304,0.0060071,0.1215,0.17611,GOMF_LIGAND_ACTIVATED_TRANSCRIPTION_FACTOR_ACTIVITY,0.891462998416583
HP_THUMB_CONTRACTURE,SET,4,0.48102,0.0070992,0.51708,0.17612,HP_THUMB_CONTRACTURE,0.891462998416583
GOMF_LIPID_TRANSFER_ACTIVITY,SET,49,0.11488,0.0059267,0.1235,0.17615,GOMF_LIPID_TRANSFER_ACTIVITY,0.891462998416583
REACTOME_PHASE_1_INACTIVATIO...,SET,6,0.32332,0.0058439,0.34761,0.17616,REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS,0.891462998416583
KEGG_MEDICUS_REFERENCE_TYPE_...2,SET,20,0.20237,0.0066756,0.2176,0.17619,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY,0.891462998416583
SHEDDEN_LUNG_CANCER_GOOD_SUR...3,SET,64,0.0984,0.0057995,0.10581,0.1762,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,0.891462998416583
HP_ABNORMAL_LEUKOCYTE_PHYSIO...,SET,263,0.049777,0.0059148,0.053539,0.17626,HP_ABNORMAL_LEUKOCYTE_PHYSIOLOGY,0.891462998416583
GOMF_VOLTAGE_GATED_MONOATOMI...2,SET,139,0.074367,0.0064461,0.080002,0.1763,GOMF_VOLTAGE_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.891462998416583
GSE3982_CTRL_VS_LPS_48H_DC_UP,SET,183,0.058766,0.0058377,0.063228,0.17634,GSE3982_CTRL_VS_LPS_48H_DC_UP,0.891462998416583
GSE40277_EOS_AND_LEF1_TRANSD...3,SET,181,0.059233,0.0058522,0.063731,0.17634,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN,0.891462998416583
REACTOME_BICARBONATE_TRANSPO...,SET,10,0.24757,0.0057763,0.26639,0.17636,REACTOME_BICARBONATE_TRANSPORTERS,0.891462998416583
ZBTB12_TARGET_GENES,SET,1036,0.025089,0.0057892,0.026998,0.17637,ZBTB12_TARGET_GENES,0.891462998416583
GOBP_FOLATE_TRANSMEMBRANE_TR...,SET,5,0.42287,0.0069774,0.45502,0.17637,GOBP_FOLATE_TRANSMEMBRANE_TRANSPORT,0.891462998416583
HP_ABNORMAL_TONGUE_PHYSIOLOGY,SET,57,0.10466,0.0058227,0.11264,0.1764,HP_ABNORMAL_TONGUE_PHYSIOLOGY,0.891462998416583
REACTOME_DAP12_INTERACTIONS,SET,36,0.12138,0.0053695,0.13067,0.17648,REACTOME_DAP12_INTERACTIONS,0.891462998416583
GOBP_NEGATIVE_REGULATION_OF_...494,SET,5,0.27538,0.0045439,0.29652,0.17652,GOBP_NEGATIVE_REGULATION_OF_PINOCYTOSIS,0.891462998416583
GOBP_POSITIVE_REGULATION_OF_...758,SET,10,0.26233,0.0061206,0.28249,0.17654,GOBP_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION,0.891462998416583
GOBP_REGULATION_OF_METALLOPE...,SET,9,0.30604,0.0067742,0.3296,0.17657,GOBP_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.891462998416583
HP_DYSPAREUNIA,SET,34,0.14718,0.0063277,0.15851,0.17658,HP_DYSPAREUNIA,0.891462998416583
BEIER_GLIOMA_STEM_CELL_DN,SET,60,0.10151,0.0057934,0.10933,0.17659,BEIER_GLIOMA_STEM_CELL_DN,0.891462998416583
PID_WNT_SIGNALING_PATHWAY,SET,25,0.17619,0.006497,0.18981,0.17665,PID_WNT_SIGNALING_PATHWAY,0.891462998416583
HP_URETEROCELE,SET,25,0.16902,0.0062327,0.18209,0.17665,HP_URETEROCELE,0.891462998416583
PID_CASPASE_PATHWAY,SET,50,0.11124,0.005797,0.11986,0.17669,PID_CASPASE_PATHWAY,0.891462998416583
HP_IMPAIRED_HORIZONTAL_SMOOT...,SET,7,0.28514,0.0055666,0.30727,0.17672,HP_IMPAIRED_HORIZONTAL_SMOOTH_PURSUIT,0.891462998416583
GOBP_COBALAMIN_TRANSPORT,SET,8,0.27992,0.0058417,0.30166,0.17673,GOBP_COBALAMIN_TRANSPORT,0.891462998416583
GOBP_HYDROGEN_PEROXIDE_CATAB...,SET,26,0.17173,0.006458,0.18507,0.17673,GOBP_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS,0.891462998416583
HP_CYANOTIC_EPISODE,SET,7,0.33264,0.006494,0.3585,0.17674,HP_CYANOTIC_EPISODE,0.891462998416583
HP_ABNORMAL_CIRCULATING_INSU...,SET,144,0.067933,0.0059926,0.073225,0.17678,HP_ABNORMAL_CIRCULATING_INSULIN_CONCENTRATION,0.891462998416583
GSE5589_LPS_VS_LPS_AND_IL6_S...6,SET,176,0.059107,0.0057593,0.063729,0.17684,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.891462998416583
GOBP_NEGATIVE_REGULATION_OF_...397,SET,6,0.31458,0.0056859,0.33919,0.17686,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,0.891462998416583
BIOCARTA_GATA3_PATHWAY,SET,14,0.22691,0.0062634,0.24469,0.17688,BIOCARTA_GATA3_PATHWAY,0.891462998416583
HP_ABNORMAL_SYNAPTIC_TRANSMI...,SET,111,0.075844,0.0058794,0.081787,0.17688,HP_ABNORMAL_SYNAPTIC_TRANSMISSION_AT_THE_NEUROMUSCULAR_JUNCTION,0.891462998416583
REACTOME_AMYLOID_FIBER_FORMA...,SET,47,0.12212,0.0061707,0.13171,0.17692,REACTOME_AMYLOID_FIBER_FORMATION,0.891462998416583
YAMASHITA_LIVER_CANCER_WITH_...1,SET,14,0.20218,0.0055809,0.21811,0.17697,YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,0.891462998416583
WP_MIRNAS_INVOLVED_IN_DNA_DA...,SET,14,0.21184,0.0058475,0.22853,0.17698,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,0.891462998416583
GSE20727_DNFB_ALLERGEN_VS_RO...1,SET,188,0.057752,0.005814,0.062314,0.17702,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.891462998416583
GENTLES_LEUKEMIC_STEM_CELL_UP,SET,28,0.16595,0.0064757,0.17907,0.17704,GENTLES_LEUKEMIC_STEM_CELL_UP,0.891462998416583
WP_INCLUSION_BODY_MYOSITIS,SET,10,0.24932,0.0058171,0.26904,0.17704,WP_INCLUSION_BODY_MYOSITIS,0.891462998416583
REACTOME_NUCLEAR_ENVELOPE_BR...,SET,50,0.10606,0.0055275,0.11445,0.17705,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,0.891462998416583
GSE21063_WT_VS_NFATC1_KO_3H_...2,SET,184,0.056013,0.0055793,0.060446,0.17706,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP,0.891462998416583
GSE7831_UNSTIM_VS_CPG_STIM_P...1,SET,175,0.060344,0.0058632,0.065124,0.17707,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN,0.891462998416583
MIR548E_3P,SET,433,0.038593,0.0058564,0.041657,0.17711,MIR548E_3P,0.891462998416583
GOBP_REGULATION_OF_EXTRACELL...3,SET,13,0.22849,0.0060779,0.24666,0.17714,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.891462998416583
GOCC_GOLGI_MEMBRANE,SET,624,0.03244,0.005878,0.035022,0.17716,GOCC_GOLGI_MEMBRANE,0.891462998416583
GOBP_TORC1_SIGNALING,SET,92,0.081262,0.0057379,0.087737,0.17718,GOBP_TORC1_SIGNALING,0.891462998416583
CHEOK_RESPONSE_TO_MERCAPTOPU...6,SET,11,0.2161,0.0052879,0.23345,0.17731,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,0.891462998416583
GOMF_BITTER_TASTE_RECEPTOR_A...,SET,22,0.22761,0.0078743,0.24592,0.17734,GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY,0.891462998416583
HP_CENTRALLY_NUCLEATED_SKELE...,SET,47,0.11305,0.0057123,0.12216,0.17738,HP_CENTRALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.891462998416583
GOBP_PROTEIN_DNA_COMPLEX_ASS...,SET,147,0.061409,0.0054728,0.066372,0.17743,GOBP_PROTEIN_DNA_COMPLEX_ASSEMBLY,0.891462998416583
GSE5589_WT_VS_IL10_KO_LPS_ST...4,SET,179,0.05776,0.0056754,0.062429,0.17743,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.891462998416583
BIOCARTA_BCELLSURVIVAL_PATHW...,SET,14,0.23347,0.0064444,0.25237,0.17747,BIOCARTA_BCELLSURVIVAL_PATHWAY,0.891462998416583
HP_AGENESIS_OF_INCISOR,SET,31,0.15525,0.006374,0.16785,0.17751,HP_AGENESIS_OF_INCISOR,0.891462998416583
HP_DECREASED_CIRCULATING_TOT...2,SET,8,0.30841,0.0064363,0.33344,0.17751,HP_DECREASED_CIRCULATING_TOTAL_IGG,0.891462998416583
BIOCARTA_CALCINEURIN_PATHWAY,SET,18,0.18592,0.0058187,0.20104,0.17754,BIOCARTA_CALCINEURIN_PATHWAY,0.891462998416583
GOBP_REGULATION_OF_COMPLEMEN...2,SET,3,0.51862,0.0066289,0.56086,0.17757,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.891462998416583
ZHOU_CELL_CYCLE_GENES_IN_IR_...2,SET,8,0.2692,0.0056182,0.29114,0.17758,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR,0.891462998416583
MATSUMIYA_PBMC_MODIFIED_VACC...7,SET,9,0.25447,0.0056327,0.2752,0.17758,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP,0.891462998416583
REACTOME_MITOPHAGY,SET,34,0.13291,0.0057143,0.14375,0.1776,REACTOME_MITOPHAGY,0.891462998416583
ZHENG_CORD_BLOOD_C5_SIMILAR_...,SET,53,0.12194,0.0065424,0.13189,0.1776,ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE,0.891462998416583
GSE27786_NKCELL_VS_NEUTROPHI...1,SET,180,0.059623,0.0058746,0.064493,0.17762,GSE27786_NKCELL_VS_NEUTROPHIL_DN,0.891462998416583
MODULE_316,SET,63,0.10835,0.0063362,0.11721,0.17764,MODULE_316,0.891462998416583
HP_ACETABULAR_DYSPLASIA,SET,23,0.15453,0.0054661,0.16719,0.17767,HP_ACETABULAR_DYSPLASIA,0.891462998416583
GSE3039_NKT_CELL_VS_B1_BCELL...1,SET,173,0.060645,0.005859,0.065626,0.17772,GSE3039_NKT_CELL_VS_B1_BCELL_DN,0.891462998416583
GOBP_POSITIVE_REGULATION_OF_...373,SET,23,0.17381,0.0061481,0.1881,0.17774,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.891462998416583
GOBP_POSITIVE_REGULATION_OF_...326,SET,31,0.15856,0.0065097,0.17162,0.17778,GOBP_POSITIVE_REGULATION_OF_HEART_GROWTH,0.891462998416583
HP_ABNORMAL_UTERUS_MORPHOLOGY,SET,138,0.066038,0.0057037,0.071482,0.17779,HP_ABNORMAL_UTERUS_MORPHOLOGY,0.891462998416583
HP_NAIL_PITS,SET,9,0.26065,0.0057695,0.28215,0.1778,HP_NAIL_PITS,0.891462998416583
WP_PI3KAKTMTOR_VITAMIN_D3_SI...,SET,20,0.18719,0.0061749,0.20266,0.17784,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,0.891462998416583
HP_VERRUCAE,SET,25,0.16229,0.0059847,0.17572,0.17785,HP_VERRUCAE,0.891462998416583
REACTOME_INTERLEUKIN_37_SIGN...,SET,19,0.1608,0.0051701,0.1741,0.17786,REACTOME_INTERLEUKIN_37_SIGNALING,0.891462998416583
REACTOME_RRNA_PROCESSING,SET,177,0.056063,0.005478,0.060701,0.17786,REACTOME_RRNA_PROCESSING,0.891462998416583
ZZZ3_TARGET_GENES,SET,233,0.050834,0.0056901,0.055043,0.17787,ZZZ3_TARGET_GENES,0.891462998416583
MIR6864_5P,SET,77,0.093794,0.0060614,0.10157,0.1779,MIR6864_5P,0.891462998416583
LI_ESTROGENE_EARLY_E2_RESPON...1,SET,73,0.10099,0.0063551,0.10937,0.17792,LI_ESTROGENE_EARLY_E2_RESPONSE_DN,0.891462998416583
GSE8921_UNSTIM_VS_TLR1_2_STI...1,SET,179,0.059429,0.0058393,0.064368,0.17794,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN,0.891462998416583
GOMF_AMINOACYL_TRNA_HYDROLAS...,SET,4,0.31049,0.0045824,0.33634,0.17797,GOMF_AMINOACYL_TRNA_HYDROLASE_ACTIVITY,0.891462998416583
MIR361_3P,SET,81,0.086889,0.0057585,0.094128,0.17799,MIR361_3P,0.891462998416583
GOBP_HUMORAL_IMMUNE_RESPONSE...,SET,41,0.1391,0.0065658,0.1507,0.17801,GOBP_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.891462998416583
SRF_01,SET,45,0.12668,0.0062641,0.13727,0.17803,SRF_01,0.891462998416583
IPF1_Q4,SET,215,0.05631,0.0060577,0.06102,0.17806,IPF1_Q4,0.891462998416583
LEE_TARGETS_OF_PTCH1_AND_SUF...2,SET,51,0.11125,0.0058554,0.12058,0.17811,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,0.891462998416583
GAUCHER_PBMC_YF_VAX_STAMARIL...4,SET,53,0.10774,0.0057805,0.11679,0.17813,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_UP,0.891462998416583
WP_PATHOGENESIS_OF_SARSCOV2_...,SET,18,0.20974,0.0065639,0.22735,0.17814,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,0.891462998416583
CCTNTMAGA_UNKNOWN,SET,120,0.073995,0.0059625,0.080211,0.17814,CCTNTMAGA_UNKNOWN,0.891462998416583
ZBTB49_TARGET_GENES,SET,7,0.25131,0.0049062,0.27246,0.17817,ZBTB49_TARGET_GENES,0.891462998416583
GOCC_BETA_CATENIN_DESTRUCTIO...,SET,12,0.21408,0.0054713,0.23211,0.17819,GOCC_BETA_CATENIN_DESTRUCTION_COMPLEX,0.891462998416583
GSE1460_NAIVE_CD4_TCELL_ADUL...1,SET,182,0.057909,0.0057369,0.062787,0.17819,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.891462998416583
QI_PBMC_ZOSTAVAX_AGE_50_75YO...7,SET,13,0.23543,0.0062624,0.25533,0.17825,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_1D_INFORMATIVE_OF_LONG_TERM_RESPONSES_NEGATIVE,0.8916
GOBP_REGULATION_OF_TELOMERE_...1,SET,26,0.14311,0.0053818,0.15522,0.17827,GOBP_REGULATION_OF_TELOMERE_CAPPING,0.8916
GOMF_ABC_TYPE_GLUTATHIONE_S_...,SET,8,0.29801,0.0062194,0.32327,0.1783,GOMF_ABC_TYPE_GLUTATHIONE_S_CONJUGATE_TRANSPORTER_ACTIVITY,0.8916
HP_SELF_BITING,SET,8,0.29143,0.0060821,0.31616,0.17832,HP_SELF_BITING,0.8916
WP_HEDGEHOG_SIGNALING_WP4249,SET,41,0.12582,0.0059392,0.13654,0.1784,WP_HEDGEHOG_SIGNALING_WP4249,0.891680314790858
GOBP_DETECTION_OF_TEMPERATUR...3,SET,5,0.38263,0.0063135,0.41527,0.17843,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_THERMOCEPTION,0.891680314790858
KUMAMOTO_RESPONSE_TO_NUTLIN_...2,SET,9,0.25742,0.005698,0.27941,0.17845,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP,0.891680314790858
HP_ABNORMAL_LACRIMAL_GLAND_M...,SET,9,0.28248,0.0062526,0.30662,0.17846,HP_ABNORMAL_LACRIMAL_GLAND_MORPHOLOGY,0.891680314790858
BIOCARTA_HIVNEF_PATHWAY,SET,54,0.10643,0.0057636,0.11554,0.17849,BIOCARTA_HIVNEF_PATHWAY,0.891680314790858
GSE45365_HEALTHY_VS_MCMV_INF...7,SET,181,0.059506,0.0058791,0.064598,0.17849,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN,0.891680314790858
HP_ACNE,SET,60,0.10229,0.0058378,0.11105,0.17852,HP_ACNE,0.891702012072435
GOBP_MICROGLIA_DIFFERENTIATI...,SET,11,0.25555,0.0062533,0.27758,0.17862,GOBP_MICROGLIA_DIFFERENTIATION,0.892073300761604
GOBP_REGULATION_OF_MITOCHOND...16,SET,136,0.067831,0.0058163,0.073703,0.17871,GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION,0.892394547413793
GSE17721_CTRL_VS_POLYIC_1H_B...2,SET,176,0.056462,0.0055015,0.06136,0.17875,GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP,0.892466060910789
MIR505_5P,SET,50,0.1068,0.0055657,0.1161,0.17882,MIR505_5P,0.892580664847789
HASLINGER_B_CLL_WITH_6Q21_DE...,SET,11,0.21954,0.0053722,0.23869,0.17885,HASLINGER_B_CLL_WITH_6Q21_DELETION,0.892580664847789
GOBP_MITOTIC_G2_M_TRANSITION...,SET,46,0.1062,0.0053091,0.11546,0.17885,GOBP_MITOTIC_G2_M_TRANSITION_CHECKPOINT,0.892580664847789
VALK_AML_CLUSTER_3,SET,27,0.15968,0.0061191,0.17364,0.17888,VALK_AML_CLUSTER_3,0.892602211055276
REACTOME_PRE_NOTCH_EXPRESSIO...,SET,48,0.10702,0.0054648,0.11639,0.17892,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,0.892673643410853
HP_GENERALIZED_HYPERPIGMENTA...,SET,37,0.12537,0.0056226,0.1364,0.17901,HP_GENERALIZED_HYPERPIGMENTATION,0.892795848867221
REACTOME_RETINOID_CYCLE_DISE...,SET,11,0.23811,0.0058266,0.2591,0.17905,REACTOME_RETINOID_CYCLE_DISEASE_EVENTS,0.892795848867221
REACTOME_DOWNREGULATION_OF_E...3,SET,8,0.26749,0.0055824,0.2911,0.17908,REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING,0.892795848867221
HP_SEVERE_FAILURE_TO_THRIVE,SET,16,0.20058,0.0059185,0.2183,0.1791,HP_SEVERE_FAILURE_TO_THRIVE,0.892795848867221
HP_ABNORMAL_ENERGY_EXPENDITU...,SET,12,0.24606,0.0062887,0.26782,0.17911,HP_ABNORMAL_ENERGY_EXPENDITURE,0.892795848867221
GOBP_RESPONSE_TO_MERCURY_ION,SET,10,0.25152,0.0058683,0.27375,0.17912,GOBP_RESPONSE_TO_MERCURY_ION,0.892795848867221
HP_APNEA,SET,213,0.053264,0.0057036,0.057976,0.17913,HP_APNEA,0.892795848867221
HP_DUPLICATION_OF_THUMB_PHAL...,SET,53,0.10408,0.005584,0.1133,0.17915,HP_DUPLICATION_OF_THUMB_PHALANX,0.892795848867221
OUELLET_CULTURED_OVARIAN_CAN...2,SET,60,0.098794,0.0056384,0.10758,0.17922,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.892853410230692
GSE40655_FOXO1_KO_VS_WT_NTRE...2,SET,178,0.056021,0.0054892,0.061007,0.17924,GSE40655_FOXO1_KO_VS_WT_NTREG_UP,0.892853410230692
GSE44649_NAIVE_VS_ACTIVATED_...4,SET,186,0.057893,0.0057975,0.063048,0.17925,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.892853410230692
HP_TRACHEOBRONCHOMALACIA,SET,7,0.27407,0.0053505,0.29849,0.17927,HP_TRACHEOBRONCHOMALACIA,0.892853410230692
GOMF_CARBOXYLESTERASE_ACTIVI...,SET,6,0.3334,0.0060261,0.36315,0.17929,GOMF_CARBOXYLESTERASE_ACTIVITY,0.892853410230692
THAKAR_PBMC_INACTIVATED_INFL...5,SET,785,0.027626,0.0055889,0.030095,0.17933,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,0.892924663323782
GSE17721_CTRL_VS_CPG_24H_BMD...1,SET,182,0.05751,0.0056974,0.062706,0.17954,GSE17721_CTRL_VS_CPG_24H_BMDC_DN,0.893126707056308
YANAGIHARA_ESX1_TARGETS,SET,26,0.16035,0.0060298,0.17484,0.17955,YANAGIHARA_ESX1_TARGETS,0.893126707056308
GOBP_POSITIVE_REGULATION_OF_...474,SET,12,0.25382,0.0064869,0.27679,0.17958,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY,0.893126707056308
GSE27786_CD8_TCELL_VS_NKTCEL...2,SET,176,0.056707,0.0055254,0.061841,0.17958,GSE27786_CD8_TCELL_VS_NKTCELL_UP,0.893126707056308
GOMF_PHOSPHATIDYLINOSITOL_3_...5,SET,8,0.21857,0.0045614,0.23837,0.17959,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.893126707056308
MIR4725_3P,SET,260,0.047431,0.0056042,0.051729,0.1796,MIR4725_3P,0.893126707056308
GTCAACC_MIR3805P,SET,20,0.19398,0.0063987,0.21157,0.17962,GTCAACC_MIR3805P,0.893126707056308
GAVISH_3CA_METAPROGRAM_FIBRO...17,SET,44,0.13747,0.0067214,0.14996,0.17967,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II,0.893126707056308
REACTOME_SULFIDE_OXIDATION_T...,SET,5,0.29225,0.0048223,0.31884,0.17968,REACTOME_SULFIDE_OXIDATION_TO_SULFATE,0.893126707056308
GSE22886_NAIVE_CD8_TCELL_VS_...4,SET,182,0.056613,0.0056086,0.061776,0.17973,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP,0.893126707056308
GSE17974_0H_VS_0.5H_IN_VITRO...1,SET,160,0.059525,0.0055325,0.064961,0.17976,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN,0.893126707056308
KAMIKUBO_MYELOID_MN1_NETWORK,SET,18,0.19058,0.0059644,0.20805,0.17983,KAMIKUBO_MYELOID_MN1_NETWORK,0.893126707056308
GOBP_REGULATION_OF_OLIGODEND...,SET,46,0.13583,0.0067902,0.14828,0.17983,GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.893126707056308
WAKASUGI_HAVE_ZNF143_BINDING...,SET,51,0.093915,0.0049429,0.10253,0.17984,WAKASUGI_HAVE_ZNF143_BINDING_SITES,0.893126707056308
GSE41867_DAY8_EFFECTOR_VS_DA...4,SET,186,0.054529,0.0054605,0.059529,0.17984,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.893126707056308
GSE29617_DAY3_VS_DAY7_TIV_FL...1,SET,151,0.059568,0.0053798,0.065033,0.17985,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,0.893126707056308
GSE39556_UNTREATED_VS_3H_POL...4,SET,178,0.057472,0.0056313,0.062744,0.17985,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP,0.893126707056308
BCAT.100_UP.V1_DN,SET,24,0.1638,0.0059184,0.17886,0.17989,BCAT.100_UP.V1_DN,0.893126707056308
GSE4142_NAIVE_BCELL_VS_PLASM...2,SET,175,0.058041,0.0056394,0.063379,0.1799,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.893126707056308
GCGNNANTTCC_UNKNOWN,SET,115,0.069368,0.0054728,0.075753,0.17991,GCGNNANTTCC_UNKNOWN,0.893126707056308
REACTOME_DISEASES_OF_GLYCOSY...,SET,130,0.068772,0.0057664,0.075114,0.17995,REACTOME_DISEASES_OF_GLYCOSYLATION,0.893126707056308
GSE20727_CTRL_VS_ROS_INHIBIT...1,SET,180,0.05659,0.0055757,0.061812,0.17997,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN,0.893126707056308
REACTOME_G_ALPHA_S_SIGNALLIN...,SET,152,0.069066,0.0062581,0.075466,0.18005,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,0.893126707056308
GOBP_REGULATION_OF_SECRETION,SET,559,0.035014,0.0060158,0.038258,0.18005,GOBP_REGULATION_OF_SECRETION,0.893126707056308
REACTOME_MRNA_SPLICING,SET,191,0.050563,0.0051303,0.055255,0.18008,REACTOME_MRNA_SPLICING,0.893126707056308
GSE9006_HEALTHY_VS_TYPE_2_DI...1,SET,179,0.058246,0.0057231,0.063655,0.1801,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.893126707056308
GSE26669_CD4_VS_CD8_TCELL_IN...3,SET,179,0.057991,0.005698,0.063389,0.18014,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN,0.893126707056308
GSE10239_NAIVE_VS_DAY4.5_EFF...1,SET,186,0.056832,0.0056911,0.062123,0.18015,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN,0.893126707056308
GOBP_GLYCOSYL_COMPOUND_CATAB...,SET,31,0.15411,0.0063273,0.16847,0.18016,GOBP_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS,0.893126707056308
GOBP_POSITIVE_REGULATION_OF_...566,SET,62,0.10885,0.0063145,0.11899,0.18017,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.893126707056308
GOBP_REGULATION_OF_LIPID_TRA...2,SET,4,0.45629,0.0067342,0.49885,0.18019,GOBP_REGULATION_OF_LIPID_TRANSPORTER_ACTIVITY,0.893126707056308
HP_ATROPHY_DEGENERATION_AFFE...1,SET,36,0.13558,0.0059978,0.14824,0.1802,HP_ATROPHY_DEGENERATION_AFFECTING_THE_BRAINSTEM,0.893126707056308
MODULE_168,SET,10,0.27454,0.0064054,0.30023,0.18025,MODULE_168,0.893126707056308
GOBP_DEFENSE_RESPONSE_TO_GRA...1,SET,77,0.10433,0.0067425,0.1141,0.18026,GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM,0.893126707056308
GOBP_REGULATION_OF_VIRAL_GEN...,SET,80,0.089566,0.0058993,0.097953,0.18027,GOBP_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.893126707056308
PURBEY_TARGETS_OF_CTBP1_NOT_...1,SET,353,0.041733,0.0057308,0.045658,0.18035,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,0.893310948853113
LY_AGING_MIDDLE_UP,SET,14,0.24339,0.0067184,0.26631,0.18038,LY_AGING_MIDDLE_UP,0.893310948853113
ATGAAGG_MIR205,SET,139,0.063749,0.0055258,0.069758,0.1804,ATGAAGG_MIR205,0.893310948853113
MIR194_3P,SET,81,0.09102,0.0060323,0.099605,0.18041,MIR194_3P,0.893310948853113
GOBP_BLASTODERM_SEGMENTATION,SET,22,0.18157,0.0062816,0.19873,0.18045,GOBP_BLASTODERM_SEGMENTATION,0.893381730769231
GOMF_DNA_DNA_TETHERING_ACTIV...,SET,5,0.31466,0.0051919,0.34443,0.18048,GOMF_DNA_DNA_TETHERING_ACTIVITY,0.893392396508026
GOBP_POSITIVE_REGULATION_OF_...258,SET,307,0.044,0.0056419,0.048179,0.18056,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.893392396508026
GOBP_INNER_CELL_MASS_CELL_PR...,SET,14,0.20377,0.0056247,0.22314,0.18058,GOBP_INNER_CELL_MASS_CELL_PROLIFERATION,0.893392396508026
GOBP_CONVERGENT_EXTENSION_IN...3,SET,5,0.35295,0.0058237,0.38655,0.18061,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS,0.893392396508026
MIR139_5P,SET,145,0.066993,0.00593,0.073387,0.18066,MIR139_5P,0.893392396508026
GSE19923_E2A_KO_VS_HEB_AND_E...2,SET,180,0.059863,0.0058982,0.065575,0.18066,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.893392396508026
HP_PETECHIAE,SET,54,0.10823,0.005861,0.11859,0.18073,HP_PETECHIAE,0.893392396508026
GOBP_SYNAPTIC_VESICLE_TRANSP...,SET,40,0.12147,0.0056637,0.13312,0.18075,GOBP_SYNAPTIC_VESICLE_TRANSPORT,0.893392396508026
HP_ABNORMALITY_OF_BODY_MASS_...,SET,25,0.16864,0.0062187,0.1848,0.18075,HP_ABNORMALITY_OF_BODY_MASS_INDEX,0.893392396508026
FURUKAWA_DUSP6_TARGETS_PCI35...1,SET,71,0.092861,0.0057635,0.10177,0.18076,FURUKAWA_DUSP6_TARGETS_PCI35_DN,0.893392396508026
GOBP_REGULATION_OF_LYMPHOCYT...1,SET,466,0.037961,0.0059706,0.041602,0.18076,GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.893392396508026
GOMF_PHOSPHATIDYLCHOLINE_FLO...,SET,8,0.29188,0.0060914,0.31992,0.1808,GOMF_PHOSPHATIDYLCHOLINE_FLOPPASE_ACTIVITY,0.893392396508026
MIR3922_3P,SET,89,0.078576,0.0054575,0.086137,0.18083,MIR3922_3P,0.893392396508026
GOBP_NEGATIVE_REGULATION_OF_...492,SET,272,0.048143,0.0058163,0.052792,0.1809,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORYLATION,0.893392396508026
SALL4_TARGET_GENES,SET,1442,0.021207,0.0057052,0.023256,0.18091,SALL4_TARGET_GENES,0.893392396508026
MIR4650_5P,SET,64,0.095364,0.0056206,0.1046,0.18097,MIR4650_5P,0.893392396508026
MODULE_221,SET,29,0.13558,0.005384,0.14871,0.18097,MODULE_221,0.893392396508026
GOBP_ESTABLISHMENT_OF_MITOCH...1,SET,27,0.15407,0.0059042,0.16901,0.18099,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION,0.893392396508026
GOBP_IMMUNE_RESPONSE_REGULAT...1,SET,307,0.04673,0.005992,0.051265,0.18101,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.893392396508026
GSE29618_PRE_VS_DAY7_POST_LA...5,SET,185,0.057158,0.0057086,0.062711,0.18103,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN,0.893392396508026
GOMF_MONOATOMIC_ION_TRANSMEM...,SET,687,0.031057,0.0058941,0.034083,0.1811,GOMF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.893392396508026
KEGG_MEDICUS_VARIANT_MUTATIO...7,SET,29,0.14696,0.005836,0.16129,0.18111,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.893392396508026
GSE29618_LAIV_VS_TIV_FLU_VAC...4,SET,179,0.05996,0.0058915,0.065805,0.18111,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP,0.893392396508026
MIR4526,SET,94,0.080984,0.0057798,0.088893,0.18115,MIR4526,0.893392396508026
GINESTIER_BREAST_CANCER_20Q1...2,SET,95,0.080328,0.0057632,0.088184,0.18118,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,0.893392396508026
MORF_MDM2,SET,248,0.049974,0.0057687,0.054863,0.18118,MORF_MDM2,0.893392396508026
GOBP_REGULATION_OF_CARDIAC_M...4,SET,16,0.18714,0.0055222,0.20548,0.18122,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.893392396508026
DOANE_BREAST_CANCER_CLASSES_...2,SET,66,0.097963,0.0058629,0.10758,0.18125,DOANE_BREAST_CANCER_CLASSES_UP,0.893392396508026
HP_ADRENOCORTICAL_ADENOMA,SET,9,0.2833,0.0062709,0.31111,0.18125,HP_ADRENOCORTICAL_ADENOMA,0.893392396508026
GSE34156_NOD2_LIGAND_VS_TLR1...1,SET,155,0.057679,0.0052773,0.06334,0.18125,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.893392396508026
GOMF_TAT_PROTEIN_BINDING,SET,10,0.2397,0.0055925,0.26329,0.18131,GOMF_TAT_PROTEIN_BINDING,0.893392396508026
MIR6782_3P,SET,79,0.085611,0.0056036,0.09404,0.18132,MIR6782_3P,0.893392396508026
PID_SYNDECAN_1_PATHWAY,SET,43,0.12588,0.0060846,0.13828,0.18134,PID_SYNDECAN_1_PATHWAY,0.893392396508026
GOBP_CHOLINE_TRANSPORT,SET,9,0.27503,0.0060878,0.30225,0.18143,GOBP_CHOLINE_TRANSPORT,0.893392396508026
HP_ABNORMAL_URINE_ALPHA_KETO...,SET,14,0.21463,0.0059244,0.23591,0.18147,HP_ABNORMAL_URINE_ALPHA_KETOGLUTARATE_CONCENTRATION,0.893392396508026
GSE7568_IL4_VS_IL4_AND_TGFB_...1,SET,176,0.055162,0.0053749,0.060638,0.1815,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN,0.893392396508026
GSE39820_CTRL_VS_TGFBETA1_IL...3,SET,179,0.055425,0.0054459,0.060941,0.18155,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN,0.893392396508026
HP_RENAL_MALROTATION,SET,6,0.33526,0.0060597,0.36863,0.18156,HP_RENAL_MALROTATION,0.893392396508026
GOBP_SOMATIC_MOTOR_NEURON_DI...,SET,5,0.35745,0.0058979,0.39313,0.18162,GOBP_SOMATIC_MOTOR_NEURON_DIFFERENTIATION,0.893392396508026
GOBP_CORTICAL_CYTOSKELETON_O...,SET,51,0.10616,0.0055874,0.1168,0.18171,GOBP_CORTICAL_CYTOSKELETON_ORGANIZATION,0.893392396508026
GOBP_PROTEIN_LOCALIZATION_TO...34,SET,11,0.21069,0.0051555,0.23182,0.18172,GOBP_PROTEIN_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.893392396508026
GOMF_PHOSPHATIDYLETHANOLAMIN...1,SET,16,0.19341,0.005707,0.21283,0.18174,GOMF_PHOSPHATIDYLETHANOLAMINE_BINDING,0.893392396508026
GOMF_TRNA_URIDINE_METHYLTRAN...,SET,3,0.36178,0.0046242,0.3981,0.18174,GOMF_TRNA_URIDINE_METHYLTRANSFERASE_ACTIVITY,0.893392396508026
GOBP_CELLULAR_RESPONSE_TO_NI...2,SET,587,0.033183,0.0058376,0.036517,0.18176,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND,0.893392396508026
REACTOME_TRANSCRIPTION_OF_E2...1,SET,19,0.16107,0.0051789,0.17726,0.18177,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,0.893392396508026
FAN_OVARY_CL6_PUTATIVE_EARLY...,SET,259,0.050398,0.0059435,0.055464,0.18177,FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2,0.893392396508026
GSE46606_IRF4_KO_VS_WT_CD40L...4,SET,176,0.062233,0.0060638,0.068497,0.1818,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP,0.893392396508026
REACTOME_COOPERATION_OF_PDCL...,SET,38,0.12534,0.0056961,0.13796,0.18182,REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,0.893392396508026
HP_CONGENITAL_NYSTAGMUS,SET,19,0.19015,0.0061137,0.20933,0.18185,HP_CONGENITAL_NYSTAGMUS,0.893392396508026
WP_MODULATORS_OF_TCR_SIGNALI...,SET,57,0.10242,0.0056979,0.11279,0.18192,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,0.893392396508026
GOBP_INSULIN_RECEPTOR_SIGNAL...,SET,119,0.070251,0.0056374,0.077373,0.18196,GOBP_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.893392396508026
KEGG_MEDICUS_ENV_FACTOR_E2_T...1,SET,7,0.31818,0.0062117,0.35049,0.18199,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.893392396508026
GOBP_RESPONSE_TO_LAMINAR_FLU...,SET,14,0.22146,0.006113,0.24394,0.18199,GOBP_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.893392396508026
chr16q12,SET,35,0.22342,0.0097456,0.24611,0.182,chr16q12,0.893392396508026
HNF1_C,SET,225,0.055435,0.006099,0.061067,0.18201,HNF1_C,0.893392396508026
NADLER_HYPERGLYCEMIA_AT_OBES...,SET,53,0.11178,0.0059971,0.12315,0.18203,NADLER_HYPERGLYCEMIA_AT_OBESITY,0.893392396508026
GAVISH_3CA_METAPROGRAM_B_CEL...7,SET,48,0.10868,0.0055496,0.11975,0.18206,GAVISH_3CA_METAPROGRAM_B_CELLS_METABOLISM_MYC,0.893392396508026
GOMF_1_PHOSPHATIDYLINOSITOL_...3,SET,7,0.3257,0.0063584,0.35889,0.18207,GOMF_1_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY,0.893392396508026
GOBP_BRANCHED_CHAIN_AMINO_AC...1,SET,5,0.38181,0.0062999,0.42079,0.18211,GOBP_BRANCHED_CHAIN_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.893392396508026
REACTOME_TP53_REGULATES_META...,SET,77,0.085693,0.0055379,0.094458,0.18215,REACTOME_TP53_REGULATES_METABOLIC_GENES,0.893392396508026
GSE4590_PRE_BCELL_VS_LARGE_P...1,SET,147,0.061231,0.005457,0.067502,0.18218,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN,0.893392396508026
BIOCARTA_FCER1_PATHWAY,SET,37,0.13079,0.0058653,0.1442,0.18222,BIOCARTA_FCER1_PATHWAY,0.893392396508026
ZF5_01,SET,225,0.051945,0.005715,0.057276,0.18223,ZF5_01,0.893392396508026
BOYAULT_LIVER_CANCER_SUBCLAS...5,SET,37,0.13158,0.0059009,0.14509,0.18224,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,0.893392396508026
FLOTHO_PEDIATRIC_ALL_THERAPY...1,SET,28,0.15557,0.0060706,0.17154,0.18224,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,0.893392396508026
MIR1179,SET,108,0.075022,0.005737,0.082725,0.18224,MIR1179,0.893392396508026
HP_HYPOPLASIA_OF_THE_FOVEA,SET,25,0.16687,0.0061533,0.18406,0.18233,HP_HYPOPLASIA_OF_THE_FOVEA,0.893392396508026
HP_THORACIC_DYSPLASIA,SET,4,0.33811,0.00499,0.37297,0.18233,HP_THORACIC_DYSPLASIA,0.893392396508026
HP_ABNORMAL_URINARY_ELECTROL...,SET,104,0.078377,0.0058821,0.086469,0.18236,HP_ABNORMAL_URINARY_ELECTROLYTE_CONCENTRATION,0.893392396508026
GOBP_NEGATIVE_REGULATION_OF_...222,SET,8,0.27536,0.0057467,0.30383,0.18239,GOBP_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.893392396508026
GOCC_TRAPPIII_PROTEIN_COMPLEX,SET,10,0.21795,0.0050851,0.24048,0.1824,GOCC_TRAPPIII_PROTEIN_COMPLEX,0.893392396508026
PRC2_EZH2_UP.V1_DN,SET,169,0.058067,0.0055453,0.064071,0.1824,PRC2_EZH2_UP.V1_DN,0.893392396508026
REACTOME_NADE_MODULATES_DEAT...,SET,5,0.41876,0.0069096,0.46208,0.18241,REACTOME_NADE_MODULATES_DEATH_SIGNALLING,0.893392396508026
GOBP_NUCLEAR_PORE_LOCALIZATI...,SET,5,0.35435,0.0058468,0.39104,0.18243,GOBP_NUCLEAR_PORE_LOCALIZATION,0.893392396508026
GARCIA_TARGETS_OF_FLI1_AND_D...1,SET,148,0.060792,0.0054361,0.067104,0.18249,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,0.893392396508026
REACTOME_SPECIFICATION_OF_TH...,SET,16,0.2082,0.0061434,0.22984,0.18252,REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER,0.893392396508026
GOMF_ICOSANOID_RECEPTOR_ACTI...,SET,14,0.21336,0.0058895,0.23554,0.18252,GOMF_ICOSANOID_RECEPTOR_ACTIVITY,0.893392396508026
HP_OROMANDIBULAR_DYSTONIA,SET,18,0.16782,0.005252,0.18528,0.18253,HP_OROMANDIBULAR_DYSTONIA,0.893392396508026
GOBP_POSITIVE_REGULATION_OF_...210,SET,199,0.056728,0.0058738,0.06263,0.18254,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.893392396508026
XU_GH1_EXOGENOUS_TARGETS_UP,SET,48,0.11328,0.0057845,0.12507,0.18255,XU_GH1_EXOGENOUS_TARGETS_UP,0.893392396508026
GOCC_PIGMENT_GRANULE,SET,106,0.076692,0.0058105,0.084676,0.18255,GOCC_PIGMENT_GRANULE,0.893392396508026
GSE43863_DAY6_EFF_VS_DAY150_...5,SET,183,0.059613,0.0059218,0.065821,0.18256,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN,0.893392396508026
GSE40666_STAT1_KO_VS_STAT4_K...2,SET,172,0.054387,0.0052393,0.060063,0.18261,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP,0.893427773091523
GOBP_REGULATION_OF_DNA_METAB...,SET,447,0.035858,0.0055265,0.039606,0.18264,GOBP_REGULATION_OF_DNA_METABOLIC_PROCESS,0.893427773091523
HP_NUMEROUS_PIGMENTED_FRECKL...,SET,7,0.25855,0.0050476,0.28561,0.18267,HP_NUMEROUS_PIGMENTED_FRECKLES,0.893427773091523
GOBP_REGULATION_OF_CELLULAR_...18,SET,137,0.068461,0.0058917,0.075645,0.18273,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.893427773091523
MIR7158_5P,SET,63,0.099631,0.0058261,0.11009,0.18274,MIR7158_5P,0.893427773091523
HP_SYNOSTOSIS_INVOLVING_BONE...3,SET,106,0.078435,0.0059425,0.08667,0.18275,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.893427773091523
GOMF_PEPTIDE_HORMONE_BINDING,SET,48,0.12435,0.0063498,0.13741,0.18276,GOMF_PEPTIDE_HORMONE_BINDING,0.893427773091523
HE_LIM_SUN_FETAL_LUNG_C0_MYO...1,SET,46,0.13119,0.0065584,0.145,0.1828,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL,0.893427773091523
REACTOME_SLC_TRANSPORTER_DIS...,SET,92,0.082224,0.0058058,0.090886,0.18282,REACTOME_SLC_TRANSPORTER_DISORDERS,0.893427773091523
GOBP_MULTICELLULAR_ORGANISMA...4,SET,33,0.15223,0.0064479,0.16827,0.18283,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_WATER_HOMEOSTASIS,0.893427773091523
GSE8621_LPS_STIM_VS_LPS_PRIM...1,SET,183,0.057667,0.0057286,0.063751,0.18285,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.893427773091523
HP_ABNORMALITY_OF_BLOOD_CIRC...,SET,333,0.043429,0.0057955,0.048035,0.18298,HP_ABNORMALITY_OF_BLOOD_CIRCULATION,0.893596634281749
PID_ERA_GENOMIC_PATHWAY,SET,61,0.098832,0.0056872,0.10936,0.18307,PID_ERA_GENOMIC_PATHWAY,0.893596634281749
HP_RED_GREEN_DYSCHROMATOPSIA,SET,8,0.23929,0.0049938,0.26486,0.18315,HP_RED_GREEN_DYSCHROMATOPSIA,0.893596634281749
GSE17721_0.5H_VS_8H_POLYIC_B...1,SET,184,0.057142,0.0056917,0.063262,0.1832,GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN,0.893596634281749
GOMF_CHROMATIN_PROTEIN_ADAPT...,SET,24,0.14368,0.0051914,0.15908,0.18321,GOMF_CHROMATIN_PROTEIN_ADAPTOR_ACTIVITY,0.893596634281749
TRAVAGLINI_LUNG_MUCOUS_CELL,SET,116,0.079798,0.0063228,0.088359,0.18324,TRAVAGLINI_LUNG_MUCOUS_CELL,0.893596634281749
HP_ACUTE_LEUKEMIA,SET,110,0.073456,0.0056687,0.081344,0.18326,HP_ACUTE_LEUKEMIA,0.893596634281749
WP_LNCRNA_IN_CANONICAL_WNT_S...,SET,89,0.08796,0.0061093,0.097409,0.18327,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,0.893596634281749
GOBP_INTRACELLULAR_AMINO_ACI...,SET,8,0.28822,0.0060151,0.3192,0.18328,GOBP_INTRACELLULAR_AMINO_ACID_HOMEOSTASIS,0.893596634281749
GSE34179_THPOK_KO_VS_WT_VA14...1,SET,183,0.058722,0.0058333,0.065049,0.18334,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN,0.893596634281749
MATHEW_FANCONI_ANEMIA_GENES,SET,10,0.209,0.0048764,0.23153,0.18335,MATHEW_FANCONI_ANEMIA_GENES,0.893596634281749
GSE15659_CD45RA_NEG_CD4_TCEL...6,SET,158,0.062819,0.0058024,0.069593,0.18336,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP,0.893596634281749
VANLOO_SP3_TARGETS_UP,SET,9,0.27305,0.0060439,0.30253,0.18339,VANLOO_SP3_TARGETS_UP,0.893596634281749
GOMF_ACYLTRANSFERASE_ACTIVITY,SET,650,0.029999,0.0055438,0.033239,0.1834,GOMF_ACYLTRANSFERASE_ACTIVITY,0.893596634281749
GOBP_CELLULAR_RESPONSE_TO_LI...1,SET,106,0.071925,0.0054493,0.079715,0.18346,GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS,0.893596634281749
BERENJENO_TRANSFORMED_BY_RHO...4,SET,25,0.17005,0.0062707,0.18847,0.18347,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,0.893596634281749
REACTOME_ORGANIC_ANION_TRANS...1,SET,5,0.32006,0.005281,0.35473,0.18347,REACTOME_ORGANIC_ANION_TRANSPORT,0.893596634281749
GSE21670_UNTREATED_VS_TGFB_T...4,SET,181,0.055524,0.0054857,0.061542,0.18348,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP,0.893596634281749
GOBP_POSITIVE_REGULATION_OF_...768,SET,31,0.1331,0.0054646,0.14754,0.1835,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.893596634281749
GOBP_TRANS_SYNAPTIC_SIGNALIN...1,SET,4,0.43097,0.0063606,0.47776,0.18351,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_BDNF,0.893596634281749
GOCC_TRANSPORT_VESICLE_MEMBR...,SET,221,0.052856,0.005764,0.058594,0.18351,GOCC_TRANSPORT_VESICLE_MEMBRANE,0.893596634281749
GOCC_CONNEXIN_COMPLEX,SET,18,0.22503,0.0070426,0.24948,0.18353,GOCC_CONNEXIN_COMPLEX,0.893596634281749
GOMF_LOW_DENSITY_LIPOPROTEIN...3,SET,22,0.15833,0.0054773,0.17552,0.18353,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.893596634281749
BRUECKNER_TARGETS_OF_MIRLET7...2,SET,104,0.07978,0.0059874,0.08845,0.18354,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,0.893596634281749
GOBP_EMBRYONIC_EYE_MORPHOGEN...,SET,34,0.14574,0.0062659,0.1616,0.18357,GOBP_EMBRYONIC_EYE_MORPHOGENESIS,0.893596634281749
DESCARTES_MAIN_FETAL_MYELOID...,SET,78,0.090494,0.0058858,0.10037,0.18363,DESCARTES_MAIN_FETAL_MYELOID_CELLS,0.893596634281749
BRUINS_UVC_RESPONSE_LATE,SET,1032,0.023754,0.0054712,0.026354,0.18371,BRUINS_UVC_RESPONSE_LATE,0.893596634281749
HP_ABNORMAL_CIRCULATING_C_PE...,SET,26,0.16664,0.0062665,0.18489,0.18372,HP_ABNORMAL_CIRCULATING_C_PEPTIDE_CONCENTRATION,0.893596634281749
GOBP_MEIOTIC_CELL_CYCLE_CHEC...,SET,9,0.28034,0.0062052,0.31108,0.18375,GOBP_MEIOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.893596634281749
GOBP_VACUOLAR_PROTON_TRANSPO...,SET,5,0.32839,0.0054186,0.36441,0.18376,GOBP_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.893596634281749
TIEN_INTESTINE_PROBIOTICS_2H...1,SET,83,0.088431,0.0059323,0.098135,0.18377,TIEN_INTESTINE_PROBIOTICS_2HR_DN,0.893596634281749
GOBP_REGULATION_OF_NUCLEOTID...4,SET,49,0.10822,0.0055832,0.12011,0.18379,GOBP_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.893596634281749
GSE27786_ERYTHROBLAST_VS_NEU...1,SET,176,0.054388,0.0052995,0.060363,0.1838,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN,0.893596634281749
WP_INTERACTIONS_BETWEEN_IMMU...,SET,24,0.16953,0.0061255,0.18819,0.18384,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.893596634281749
GR_01,SET,183,0.058776,0.0058387,0.065249,0.18386,GR_01,0.893596634281749
BIOCARTA_EEA1_PATHWAY,SET,7,0.26831,0.0052381,0.29797,0.18394,BIOCARTA_EEA1_PATHWAY,0.893596634281749
HOWARD_DENDRITIC_CELL_INACT_...3,SET,9,0.2889,0.0063948,0.32095,0.18403,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.893596634281749
HP_NEUROPATHIC_ARTHROPATHY,SET,5,0.30185,0.0049807,0.33541,0.18408,HP_NEUROPATHIC_ARTHROPATHY,0.893596634281749
HP_TROPHIC_CHANGES_RELATED_T...,SET,5,0.30185,0.0049807,0.33541,0.18408,HP_TROPHIC_CHANGES_RELATED_TO_PAIN,0.893596634281749
GOCC_PERINEURONAL_NET,SET,10,0.2502,0.0058375,0.27803,0.18409,GOCC_PERINEURONAL_NET,0.893596634281749
KEGG_MEDICUS_REFERENCE_HORMO...,SET,17,0.20906,0.0063585,0.23232,0.1841,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.893596634281749
KEGG_MEDICUS_REFERENCE_BREAK...,SET,8,0.26867,0.0056071,0.29858,0.18411,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION,0.893596634281749
GOMF_KETOSTEROID_MONOOXYGENA...,SET,5,0.49637,0.0081901,0.55174,0.18416,GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY,0.893596634281749
GOMF_GAP_JUNCTION_CHANNEL_AC...2,SET,5,0.40189,0.0066313,0.44678,0.18419,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_CONDUCTION_ELECTRICAL_COUPLING,0.893596634281749
GOBP_POSITIVE_REGULATION_OF_...332,SET,6,0.32455,0.0058662,0.36083,0.18421,GOBP_POSITIVE_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.893596634281749
THAKAR_PBMC_INACTIVATED_INFL...9,SET,15,0.1835,0.0052429,0.20402,0.18422,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP,0.893596634281749
GOBP_ENUCLEATE_ERYTHROCYTE_D...1,SET,5,0.3724,0.0061447,0.41414,0.18427,GOBP_ENUCLEATE_ERYTHROCYTE_DEVELOPMENT,0.893596634281749
GARCIA_PINERES_PBMC_HPV_16_L...4,SET,305,0.045211,0.0057786,0.050283,0.1843,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP,0.893596634281749
GOBP_REGULATION_OF_ANTIBACTE...,SET,7,0.31147,0.0060806,0.34643,0.18431,GOBP_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.893596634281749
GSE16450_CTRL_VS_IFNA_6H_STI...2,SET,180,0.058031,0.0057176,0.06455,0.18433,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.893596634281749
GOBP_TYPE_B_PANCREATIC_CELL_...3,SET,27,0.1605,0.0061504,0.17854,0.18435,GOBP_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION,0.893596634281749
ANDERSON_BLOOD_CN54GP140_ADJ...2,SET,63,0.097686,0.0057124,0.10867,0.18435,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP,0.893596634281749
GOBP_POSITIVE_REGULATION_OF_...675,SET,7,0.31364,0.006123,0.34894,0.18437,GOBP_POSITIVE_REGULATION_OF_RESPIRATORY_BURST,0.893596634281749
GSE38304_MYC_NEG_VS_POS_GC_B...2,SET,184,0.058112,0.0057883,0.064655,0.18439,GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP,0.893596634281749
CUI_TCF21_TARGETS_DN,SET,30,0.16422,0.0066327,0.18274,0.18442,CUI_TCF21_TARGETS_DN,0.893596634281749
GOMF_LIGAND_GATED_MONOATOMIC...2,SET,132,0.070911,0.005991,0.078911,0.18443,GOMF_LIGAND_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.893596634281749
REACTOME_GENE_SILENCING_BY_R...,SET,77,0.083901,0.0054221,0.093368,0.18444,REACTOME_GENE_SILENCING_BY_RNA,0.893596634281749
GOBP_NEGATIVE_REGULATION_OF_...614,SET,7,0.33816,0.0066016,0.37636,0.18446,GOBP_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.893596634281749
GOBP_REGULATION_OF_INSULIN_S...1,SET,157,0.063705,0.0058657,0.070911,0.1845,GOBP_REGULATION_OF_INSULIN_SECRETION,0.893596634281749
GOBP_SIALYLATION,SET,10,0.24742,0.0057728,0.27547,0.18455,GOBP_SIALYLATION,0.893596634281749
GOBP_AMINOGLYCOSIDE_ANTIBIOT...,SET,10,0.31403,0.0073269,0.34977,0.18465,GOBP_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS,0.893596634281749
GOBP_TRANSFERRIN_TRANSPORT,SET,10,0.23999,0.0055993,0.26731,0.18465,GOBP_TRANSFERRIN_TRANSPORT,0.893596634281749
GOBP_NEUROTROPHIN_TRK_RECEPT...,SET,24,0.15327,0.0055378,0.17072,0.18466,GOBP_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.893596634281749
CROONQUIST_STROMAL_STIMULATI...1,SET,11,0.24574,0.0060133,0.27374,0.18467,CROONQUIST_STROMAL_STIMULATION_DN,0.893596634281749
GSE22140_HEALTHY_VS_ARTHRITI...1,SET,188,0.058184,0.0058575,0.064814,0.18468,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN,0.893596634281749
HALLMARK_PANCREAS_BETA_CELLS,SET,38,0.14211,0.0064587,0.15832,0.1847,HALLMARK_PANCREAS_BETA_CELLS,0.893596634281749
GOBP_INTRACELLULAR_RECEPTOR_...,SET,335,0.041892,0.0056068,0.046672,0.18471,GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY,0.893596634281749
HP_FLUCTUATIONS_IN_CONSCIOUS...,SET,6,0.35089,0.0063422,0.3911,0.18482,HP_FLUCTUATIONS_IN_CONSCIOUSNESS,0.893596634281749
GSE24671_BAKIMULC_VS_SENDAI_...1,SET,173,0.055022,0.0053157,0.061329,0.18482,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.893596634281749
GOBP_BRAIN_DERIVED_NEUROTROP...,SET,6,0.36043,0.0065147,0.40183,0.18487,GOBP_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.893596634281749
GSE1460_INTRATHYMIC_T_PROGEN...8,SET,184,0.054657,0.0054442,0.060937,0.18488,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.893596634281749
MIR214_5P,SET,49,0.11229,0.0057933,0.1252,0.18489,MIR214_5P,0.893596634281749
GOMF_MONOSACCHARIDE_BINDING,SET,69,0.089443,0.0054729,0.099725,0.18489,GOMF_MONOSACCHARIDE_BINDING,0.893596634281749
PATEL_SKIN_OF_BODY_ZOSTAVAX_...6,SET,259,0.050519,0.0059578,0.056333,0.18492,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,0.893596634281749
GOBP_PRENYLATION,SET,10,0.23207,0.0054145,0.25879,0.18493,GOBP_PRENYLATION,0.893596634281749
WILLIAMS_ESR1_TARGETS_UP,SET,25,0.15911,0.0058672,0.17744,0.18494,WILLIAMS_ESR1_TARGETS_UP,0.893596634281749
GOBP_HOMEOSTASIS_OF_NUMBER_O...1,SET,295,0.045808,0.0057597,0.051085,0.18494,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS,0.893596634281749
GOBP_CELL_CYCLE_DNA_REPLICAT...1,SET,41,0.11188,0.0052811,0.12478,0.18497,GOBP_CELL_CYCLE_DNA_REPLICATION,0.893596634281749
CASTELLANO_HRAS_AND_NRAS_TAR...1,SET,7,0.29305,0.0057211,0.32686,0.18498,CASTELLANO_HRAS_AND_NRAS_TARGETS_DN,0.893596634281749
GOBP_NEGATIVE_REGULATION_OF_...341,SET,12,0.23129,0.005911,0.25802,0.18503,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.893596634281749
FONTAINE_THYROID_TUMOR_UNCER...2,SET,33,0.14193,0.006012,0.15835,0.18505,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,0.893596634281749
MIR200B_5P,SET,95,0.07685,0.0055137,0.08574,0.18505,MIR200B_5P,0.893596634281749
GOBP_REGULATION_OF_VOLTAGE_G...2,SET,6,0.34662,0.006265,0.38681,0.1851,GOBP_REGULATION_OF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.893596634281749
GOBP_REGULATION_OF_LEUKOCYTE...2,SET,30,0.1478,0.0059697,0.16495,0.18512,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.893596634281749
GOBP_RESPONSE_TO_SELENIUM_ION,SET,5,0.3063,0.0050541,0.34184,0.18512,GOBP_RESPONSE_TO_SELENIUM_ION,0.893596634281749
CAMP_UP.V1_UP,SET,179,0.054059,0.0053117,0.06033,0.18512,CAMP_UP.V1_UP,0.893596634281749
REACTOME_DEATH_RECEPTOR_SIGN...,SET,139,0.065448,0.005673,0.073052,0.18516,REACTOME_DEATH_RECEPTOR_SIGNALING,0.893596634281749
GOCC_ENDOLYSOSOME,SET,26,0.14819,0.0055726,0.16541,0.18516,GOCC_ENDOLYSOSOME,0.893596634281749
GSE21360_TERTIARY_VS_QUATERN...2,SET,172,0.059911,0.0057715,0.066885,0.1852,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.893596634281749
NKX22_01,SET,169,0.063257,0.006041,0.070627,0.18523,NKX22_01,0.893596634281749
HP_ABNORMALITY_OF_CIRCULATIN...1,SET,41,0.13006,0.0061393,0.14521,0.18523,HP_ABNORMALITY_OF_CIRCULATING_FIBRINOGEN,0.893596634281749
NPAT_TARGET_GENES,SET,190,0.055365,0.0056029,0.061822,0.18525,NPAT_TARGET_GENES,0.893596634281749
MIR892A,SET,117,0.07545,0.0060038,0.084273,0.18532,MIR892A,0.893734445677813
DCA_UP.V1_UP,SET,161,0.062021,0.0057824,0.069278,0.18533,DCA_UP.V1_UP,0.893734445677813
HP_REDUCED_PANCREATIC_BETA_C...,SET,7,0.35076,0.0068477,0.39208,0.1855,HP_REDUCED_PANCREATIC_BETA_CELLS,0.894278446601942
GOBP_REGULATION_OF_KINASE_AC...,SET,466,0.03629,0.0057076,0.040565,0.18551,GOBP_REGULATION_OF_KINASE_ACTIVITY,0.894278446601942
GOBP_REGULATION_OF_FIBROBLAS...2,SET,29,0.15275,0.0060661,0.17076,0.18552,GOBP_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.894278446601942
STEGMEIER_PREMITOTIC_CELL_CY...,SET,11,0.22292,0.0054549,0.24925,0.18557,STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS,0.894395416724449
HP_CONCAVE_NAIL,SET,11,0.2142,0.0052414,0.23957,0.18564,HP_CONCAVE_NAIL,0.894429438669439
GOBP_DETERMINATION_OF_DORSAL...,SET,10,0.2592,0.0060475,0.28993,0.18567,GOBP_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY,0.894429438669439
GSE37301_PRO_BCELL_VS_CD4_TC...2,SET,155,0.061281,0.0056068,0.068551,0.18568,GSE37301_PRO_BCELL_VS_CD4_TCELL_UP,0.894429438669439
HE_LIM_SUN_FETAL_LUNG_C2_PRO...1,SET,258,0.04653,0.0054769,0.05205,0.18568,HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL,0.894429438669439
HP_RETROGNATHIA,SET,308,0.042701,0.005484,0.047777,0.18574,HP_RETROGNATHIA,0.894594470620843
GSE17721_POLYIC_VS_PAM3CSK4_...3,SET,182,0.055992,0.0055471,0.062676,0.18584,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN,0.894800429422358
KANG_FLUOROURACIL_RESISTANCE...2,SET,19,0.1623,0.0052184,0.18168,0.18585,KANG_FLUOROURACIL_RESISTANCE_UP,0.894800429422358
GOBP_REGULATION_OF_PROTEIN_F...,SET,9,0.25908,0.0057348,0.29003,0.18586,GOBP_REGULATION_OF_PROTEIN_FOLDING,0.894800429422358
GSE3982_EFF_MEMORY_VS_CENT_M...2,SET,174,0.058066,0.0056259,0.065056,0.18605,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP,0.895515205650187
GOBP_IRON_ION_TRANSPORT,SET,48,0.11354,0.0057981,0.12721,0.18606,GOBP_IRON_ION_TRANSPORT,0.895515205650187
MIR10399_5P,SET,332,0.04419,0.0058883,0.049559,0.18629,MIR10399_5P,0.896422054547972
GOBP_NEGATIVE_REGULATION_OF_...2,SET,40,0.11311,0.0052738,0.12686,0.1863,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.896422054547972
GSE22886_UNSTIM_VS_IL2_STIM_...1,SET,185,0.052497,0.0052431,0.05889,0.18635,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN,0.896462532871972
BHAT_ESR1_TARGETS_VIA_AKT1_UP,SET,263,0.049556,0.0058885,0.055592,0.18636,BHAT_ESR1_TARGETS_VIA_AKT1_UP,0.896462532871972
DESCARTES_FETAL_INTESTINE_IN...,SET,208,0.055674,0.0058922,0.062483,0.18646,DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS,0.896763627559491
GSE15330_HSC_VS_GRANULOCYTE_...4,SET,185,0.053262,0.0053194,0.059783,0.18649,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.896763627559491
GOBP_POSITIVE_REGULATION_OF_...299,SET,45,0.12935,0.0063959,0.14519,0.1865,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.896763627559491
GSE37301_COMMON_LYMPHOID_PRO...2,SET,168,0.057182,0.0054448,0.064211,0.1866,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP,0.897044336099585
KEGG_MEDICUS_VARIANT_MUTATIO...26,SET,23,0.16988,0.006009,0.19077,0.18661,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.897044336099585
GSE21927_SPLEEN_VS_C26GM_TUM...2,SET,137,0.067951,0.0058478,0.076327,0.18667,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP,0.897165070480929
GOBP_PROLINE_TRANSMEMBRANE_T...,SET,9,0.2902,0.0064236,0.32603,0.18671,GOBP_PROLINE_TRANSMEMBRANE_TRANSPORT,0.897165070480929
HEBERT_MATRISOME_TNBC_BRAIN_...2,SET,9,0.2729,0.0060407,0.30663,0.18674,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED,0.897165070480929
BCL6B_TARGET_GENES,SET,129,0.067385,0.0056284,0.075713,0.18674,BCL6B_TARGET_GENES,0.897165070480929
HP_CENTRAL_ADRENAL_INSUFFICI...,SET,18,0.17531,0.0054866,0.19701,0.18678,HP_CENTRAL_ADRENAL_INSUFFICIENCY,0.897165070480929
chr17q12,SET,86,0.16923,0.011555,0.19018,0.18679,chr17q12,0.897165070480929
GOBP_AXIS_SPECIFICATION,SET,87,0.088018,0.0060446,0.09897,0.18691,GOBP_AXIS_SPECIFICATION,0.89751342726896
HP_MOTOR_AXONAL_NEUROPATHY,SET,34,0.11773,0.0050616,0.13238,0.18692,HP_MOTOR_AXONAL_NEUROPATHY,0.89751342726896
GSE17721_PAM3CSK4_VS_GADIQUI...10,SET,185,0.055921,0.005585,0.062885,0.18694,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP,0.89751342726896
GSE17186_NAIVE_VS_CD21LOW_TR...3,SET,180,0.055614,0.0054795,0.062574,0.18707,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN,0.897933402317881
WP_8Q1123_RB1CC1_COPY_NUMBER...,SET,16,0.17515,0.0051683,0.19711,0.18711,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,0.897933402317881
REACTOME_CD28_DEPENDENT_PI3K...,SET,22,0.17045,0.0058967,0.19183,0.18713,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,0.897933402317881
ZNF510_TARGET_GENES,SET,36,0.12709,0.0056222,0.14305,0.18715,ZNF510_TARGET_GENES,0.897933402317881
GSE10239_KLRG1INT_VS_KLRG1HI...1,SET,179,0.057586,0.0056582,0.064828,0.1872,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.897933402317881
GOBP_CELL_CELL_JUNCTION_ASSE...,SET,146,0.068572,0.0060905,0.077201,0.18721,GOBP_CELL_CELL_JUNCTION_ASSEMBLY,0.897933402317881
ZNF740_TARGET_GENES,SET,1189,0.022728,0.0055933,0.025588,0.18722,ZNF740_TARGET_GENES,0.897933402317881
FOROUTAN_INTEGRATED_TGFB_EMT...1,SET,70,0.10165,0.0062648,0.11446,0.18725,FOROUTAN_INTEGRATED_TGFB_EMT_DN,0.897933402317881
GOMF_HEXOSAMINIDASE_ACTIVITY,SET,12,0.22267,0.0056907,0.25074,0.18726,GOMF_HEXOSAMINIDASE_ACTIVITY,0.897933402317881
GSE6269_HEALTHY_VS_STAPH_PNE...2,SET,165,0.056115,0.0052958,0.063199,0.1873,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP,0.897991241322989
GOBP_MAMMARY_GLAND_BRANCHING...,SET,6,0.3472,0.0062756,0.39113,0.18736,GOBP_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY,0.897991241322989
GOBP_PROTEIN_POLYMERIZATION,SET,253,0.048088,0.005606,0.054177,0.18738,GOBP_PROTEIN_POLYMERIZATION,0.897991241322989
GOBP_NEGATIVE_REGULATION_OF_...509,SET,44,0.1104,0.0053982,0.12442,0.18745,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.897991241322989
GOBP_REGULATION_OF_PROTEIN_D...1,SET,25,0.1394,0.0051403,0.1571,0.18746,GOBP_REGULATION_OF_PROTEIN_DEACETYLATION,0.897991241322989
HP_DEPRESSION,SET,380,0.040007,0.0056957,0.045089,0.18747,HP_DEPRESSION,0.897991241322989
TGIF_01,SET,229,0.051618,0.0057287,0.058184,0.1875,TGIF_01,0.897991241322989
HE_LIM_SUN_FETAL_LUNG_C1_EAR...3,SET,123,0.065349,0.0053308,0.073662,0.18751,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL,0.897991241322989
GOBP_POSITIVE_REGULATION_OF_...66,SET,40,0.12972,0.0060483,0.1463,0.18763,GOBP_POSITIVE_REGULATION_OF_BONE_MINERALIZATION,0.897991241322989
GOBP_COPII_COATED_VESICLE_CA...,SET,18,0.15934,0.0049868,0.17972,0.18765,GOBP_COPII_COATED_VESICLE_CARGO_LOADING,0.897991241322989
REACTOME_NUCLEAR_ENVELOPE_NE...,SET,71,0.087058,0.0054033,0.098224,0.18773,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,0.897991241322989
GOBP_POSITIVE_REGULATION_OF_...772,SET,7,0.3082,0.0060167,0.34784,0.18781,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET,0.897991241322989
GOCC_MLL1_2_COMPLEX,SET,29,0.12451,0.0049446,0.14054,0.18782,GOCC_MLL1_2_COMPLEX,0.897991241322989
FRANCO_BLOOD_SANOFI_PASTEUR_...7,SET,17,0.18988,0.0057751,0.21438,0.1879,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE,0.897991241322989
REACTOME_SIGNALING_BY_SCF_KIT,SET,42,0.11883,0.0056772,0.13419,0.18793,REACTOME_SIGNALING_BY_SCF_KIT,0.897991241322989
GOMF_IMPORTIN_ALPHA_FAMILY_P...,SET,9,0.22221,0.0049186,0.25098,0.18799,GOMF_IMPORTIN_ALPHA_FAMILY_PROTEIN_BINDING,0.897991241322989
GSE23114_WT_VS_SLE2C1_MOUSE_...3,SET,181,0.056089,0.0055416,0.063355,0.188,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN,0.897991241322989
GOBP_PROTEIN_LOCALIZATION_TO...50,SET,81,0.082376,0.0054594,0.093054,0.18802,GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE,0.897991241322989
HP_IMPAIRED_VISUOSPATIAL_CON...,SET,19,0.17764,0.0057115,0.20068,0.18804,HP_IMPAIRED_VISUOSPATIAL_CONSTRUCTIVE_COGNITION,0.897991241322989
REACTOME_DISEASES_OF_MISMATC...,SET,5,0.25538,0.0042138,0.28853,0.18806,REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR,0.897991241322989
HP_EPIDURAL_HEMORRHAGE,SET,5,0.43057,0.0071044,0.48646,0.18806,HP_EPIDURAL_HEMORRHAGE,0.897991241322989
GOBP_ANTIVIRAL_INNATE_IMMUNE...,SET,49,0.10403,0.0053671,0.11754,0.18807,GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE,0.897991241322989
WP_ALZHEIMERS_DISEASE,SET,247,0.047564,0.0054796,0.053754,0.18812,WP_ALZHEIMERS_DISEASE,0.897991241322989
WP_ALZHEIMERS_DISEASE_AND_MI...,SET,247,0.047564,0.0054796,0.053754,0.18812,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,0.897991241322989
GOMF_POTASSIUM_ION_TRANSMEMB...,SET,156,0.065865,0.0060455,0.074438,0.18813,GOMF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.897991241322989
GOBP_CAMP_CATABOLIC_PROCESS,SET,9,0.26478,0.0058609,0.29929,0.18817,GOBP_CAMP_CATABOLIC_PROCESS,0.897991241322989
GOBP_CELLULAR_RESPONSE_TO_LI...2,SET,557,0.033889,0.0058125,0.038307,0.18817,GOBP_CELLULAR_RESPONSE_TO_LIPID,0.897991241322989
LIEN_BREAST_CARCINOMA_METAPL...1,SET,32,0.1509,0.0062945,0.17059,0.18819,LIEN_BREAST_CARCINOMA_METAPLASTIC,0.897991241322989
PATIL_LIVER_CANCER,SET,584,0.031053,0.0054495,0.035108,0.18822,PATIL_LIVER_CANCER,0.897991241322989
CREIGHTON_ENDOCRINE_THERAPY_...4,SET,266,0.047885,0.0057218,0.05414,0.18823,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,0.897991241322989
KEGG_HUNTINGTONS_DISEASE,SET,153,0.056604,0.0051456,0.064,0.18824,KEGG_HUNTINGTONS_DISEASE,0.897991241322989
BILANGES_RAPAMYCIN_SENSITIVE...1,SET,35,0.12349,0.0053866,0.13964,0.18826,BILANGES_RAPAMYCIN_SENSITIVE_GENES,0.897991241322989
REACTOME_PEXOPHAGY,SET,9,0.27038,0.0059849,0.30577,0.18828,REACTOME_PEXOPHAGY,0.897991241322989
WP_CANCER_IMMUNOTHERAPY_BY_C...,SET,12,0.22737,0.0058109,0.25712,0.18828,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,0.897991241322989
GOBP_PHOTORECEPTOR_CELL_MAIN...,SET,43,0.12046,0.0058226,0.13623,0.1883,GOBP_PHOTORECEPTOR_CELL_MAINTENANCE,0.897991241322989
GSE32901_NAIVE_VS_TH17_NEG_C...2,SET,157,0.059556,0.0054837,0.067358,0.18831,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP,0.897991241322989
GOBP_VASCULAR_ENDOTHELIAL_CE...,SET,25,0.15161,0.0055907,0.17148,0.18832,GOBP_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.897991241322989
MIR503_3P,SET,36,0.13065,0.0057794,0.14782,0.1884,MIR503_3P,0.897991241322989
HP_ATRESIA_OF_THE_EXTERNAL_A...,SET,45,0.11251,0.0055635,0.12734,0.18846,HP_ATRESIA_OF_THE_EXTERNAL_AUDITORY_CANAL,0.897991241322989
chr14q31,SET,15,0.31022,0.0088635,0.35118,0.18852,chr14q31,0.897991241322989
REACTOME_SIGNALING_BY_MEMBRA...,SET,5,0.32921,0.0054321,0.3727,0.18854,REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB,0.897991241322989
HP_ABNORMALITY_OF_THE_PHALAN...2,SET,3,0.44839,0.0057312,0.50765,0.18855,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_3RD_TOE,0.897991241322989
GOBP_NEGATIVE_REGULATION_OF_...171,SET,7,0.31426,0.0061351,0.35582,0.18857,GOBP_NEGATIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.897991241322989
HP_POSTERIOR_PHARYNGEAL_CLEFT,SET,12,0.24756,0.006327,0.2803,0.18857,HP_POSTERIOR_PHARYNGEAL_CLEFT,0.897991241322989
MODULE_48,SET,293,0.04452,0.0055791,0.050424,0.18864,MODULE_48,0.897991241322989
HP_ABNORMALITY_OF_URINARY_UR...,SET,11,0.22457,0.0054951,0.25444,0.18873,HP_ABNORMALITY_OF_URINARY_URIC_ACID_LEVEL,0.897991241322989
GOMF_DIOXYGENASE_ACTIVITY,SET,82,0.079205,0.0052814,0.089742,0.18874,GOMF_DIOXYGENASE_ACTIVITY,0.897991241322989
KYNG_DNA_DAMAGE_BY_4NQO,SET,33,0.12247,0.0051876,0.13877,0.18875,KYNG_DNA_DAMAGE_BY_4NQO,0.897991241322989
GSE15330_MEGAKARYOCYTE_ERYTH...2,SET,188,0.05585,0.0056226,0.063284,0.18875,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP,0.897991241322989
GSE11961_FOLLICULAR_BCELL_VS...10,SET,181,0.054371,0.0053718,0.06161,0.18876,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP,0.897991241322989
PSMB5_TARGET_GENES,SET,196,0.054987,0.005651,0.062318,0.1888,PSMB5_TARGET_GENES,0.897991241322989
HP_PALMAR_TELANGIECTASIA,SET,7,0.30343,0.0059236,0.34398,0.18886,HP_PALMAR_TELANGIECTASIA,0.897991241322989
HUTTMANN_B_CLL_POOR_SURVIVAL...2,SET,240,0.049989,0.0056778,0.056679,0.18891,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,0.897991241322989
GSE22601_DOUBLE_NEGATIVE_VS_...8,SET,172,0.054621,0.0052619,0.061932,0.18891,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP,0.897991241322989
MIR4779,SET,132,0.065505,0.0055343,0.074279,0.18893,MIR4779,0.897991241322989
HP_CYSTIC_LIVER_DISEASE,SET,40,0.10778,0.0050254,0.12222,0.18893,HP_CYSTIC_LIVER_DISEASE,0.897991241322989
GSE17721_CTRL_VS_LPS_12H_BMD...2,SET,173,0.054756,0.0052901,0.06209,0.18893,GSE17721_CTRL_VS_LPS_12H_BMDC_UP,0.897991241322989
GOBP_POSITIVE_REGULATION_OF_...302,SET,68,0.099743,0.0060589,0.11311,0.18894,GOBP_POSITIVE_REGULATION_OF_GLIOGENESIS,0.897991241322989
GOBP_ORNITHINE_METABOLIC_PRO...,SET,9,0.21848,0.004836,0.24779,0.18897,GOBP_ORNITHINE_METABOLIC_PROCESS,0.897991241322989
GOBP_HUMORAL_IMMUNE_RESPONSE,SET,230,0.057571,0.0064032,0.065302,0.189,GOBP_HUMORAL_IMMUNE_RESPONSE,0.897991241322989
GSE25085_FETAL_LIVER_VS_ADUL...1,SET,167,0.054606,0.0051842,0.061942,0.18901,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.897991241322989
MIR1285_3P,SET,151,0.05976,0.0053972,0.067794,0.18903,MIR1285_3P,0.897991241322989
GOCC_SPERM_PRINCIPAL_PIECE,SET,29,0.14278,0.0056701,0.16198,0.18903,GOCC_SPERM_PRINCIPAL_PIECE,0.897991241322989
REACTOME_HYALURONAN_BIOSYNTH...,SET,5,0.36477,0.0060188,0.41388,0.18907,REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT,0.897991241322989
PID_CD40_PATHWAY,SET,30,0.14541,0.005873,0.16501,0.18911,PID_CD40_PATHWAY,0.897991241322989
HP_HYPERESTHESIA,SET,9,0.24827,0.0054955,0.28177,0.18913,HP_HYPERESTHESIA,0.897991241322989
KEGG_MEDICUS_REFERENCE_GENE_...,SET,25,0.14984,0.0055254,0.17008,0.18916,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119,0.897991241322989
GSE46606_UNSTIM_VS_CD40L_IL2...13,SET,179,0.055127,0.0054166,0.062579,0.18918,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.897991241322989
HP_ABNORMALITY_OF_THE_THENAR...,SET,30,0.13231,0.005344,0.15022,0.18922,HP_ABNORMALITY_OF_THE_THENAR_EMINENCE,0.897991241322989
HP_COMMUNICATING_HYDROCEPHAL...,SET,21,0.15901,0.0053747,0.18056,0.18926,HP_COMMUNICATING_HYDROCEPHALUS,0.897991241322989
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...4,SET,7,0.3132,0.0061143,0.35564,0.18926,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_DN,0.897991241322989
REACTOME_LEISHMANIA_INFECTION,SET,152,0.06144,0.0055671,0.06977,0.18927,REACTOME_LEISHMANIA_INFECTION,0.897991241322989
BIOCARTA_EIF_PATHWAY,SET,13,0.18999,0.0050537,0.21577,0.18929,BIOCARTA_EIF_PATHWAY,0.897991241322989
KAUFFMANN_DNA_REPAIR_GENES,SET,208,0.047097,0.0049844,0.053493,0.18932,KAUFFMANN_DNA_REPAIR_GENES,0.897991241322989
REACTOME_SUMOYLATION_OF_CHRO...,SET,52,0.10144,0.005391,0.11522,0.18932,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,0.897991241322989
HP_PARTIAL_AGENESIS_OF_THE_C...,SET,46,0.10386,0.0051922,0.11797,0.18933,HP_PARTIAL_AGENESIS_OF_THE_CORPUS_CALLOSUM,0.897991241322989
WP_GLYCOSYLATION_AND_RELATED...,SET,20,0.14108,0.0046537,0.16025,0.18934,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,0.897991241322989
HP_ABNORMAL_PUTAMEN_MORPHOLO...,SET,5,0.35235,0.0058138,0.40024,0.18934,HP_ABNORMAL_PUTAMEN_MORPHOLOGY,0.897991241322989
GSE22611_UNSTIM_VS_6H_MDP_ST...3,SET,180,0.055784,0.0054963,0.063364,0.18934,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.897991241322989
GSE40274_FOXP3_VS_FOXP3_AND_...3,SET,182,0.053566,0.0053067,0.060855,0.18937,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.897991241322989
ZHAN_MULTIPLE_MYELOMA_CD1_AN...2,SET,78,0.084782,0.0055143,0.096322,0.18938,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,0.897991241322989
GOBP_FC_RECEPTOR_MEDIATED_ST...,SET,30,0.14672,0.0059261,0.16671,0.1894,GOBP_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.897991241322989
KRAS.600.LUNG.BREAST_UP.V1_UP,SET,248,0.05253,0.0060637,0.059699,0.18946,KRAS.600.LUNG.BREAST_UP.V1_UP,0.897991241322989
REACTOME_COLLAGEN_BIOSYNTHES...,SET,65,0.099393,0.0059035,0.113,0.18954,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,0.897991241322989
REACTOME_APOBEC3G_MEDIATED_R...,SET,5,0.29558,0.0048772,0.33606,0.18956,REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION,0.897991241322989
GOCC_BOX_H_ACA_RNP_COMPLEX,SET,3,0.34515,0.0044116,0.39245,0.18958,GOCC_BOX_H_ACA_RNP_COMPLEX,0.897991241322989
GOCC_BOX_H_ACA_TELOMERASE_RN...,SET,3,0.34515,0.0044116,0.39245,0.18958,GOCC_BOX_H_ACA_TELOMERASE_RNP_COMPLEX,0.897991241322989
REACTOME_AUTOPHAGY,SET,144,0.062351,0.0055002,0.070898,0.18959,REACTOME_AUTOPHAGY,0.897991241322989
GOCC_VESICLE_MEMBRANE,SET,1141,0.023318,0.0056296,0.026518,0.18961,GOCC_VESICLE_MEMBRANE,0.897991241322989
GOBP_SHORT_CHAIN_FATTY_ACID_...2,SET,15,0.19236,0.0054961,0.21877,0.18963,GOBP_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.897991241322989
MIR548F_3P,SET,434,0.036653,0.0055683,0.041699,0.18971,MIR548F_3P,0.897991241322989
MIR3691_3P,SET,59,0.093467,0.0052899,0.10634,0.18973,MIR3691_3P,0.897991241322989
GSE28726_NAIVE_VS_ACTIVATED_...4,SET,177,0.056361,0.0055072,0.064129,0.18974,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP,0.897991241322989
HP_DECREASED_URINARY_POTASSI...,SET,4,0.41282,0.0060927,0.46976,0.18976,HP_DECREASED_URINARY_POTASSIUM,0.897991241322989
GSE4590_PRE_BCELL_VS_SMALL_P...2,SET,136,0.064354,0.0055182,0.073234,0.18977,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP,0.897991241322989
GSE19401_PLN_VS_PEYERS_PATCH...2,SET,171,0.056808,0.0054568,0.064648,0.18978,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP,0.897991241322989
MANNE_COVID19_NONICU_VS_HEAL...2,SET,129,0.06558,0.0054777,0.074636,0.1898,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.897991241322989
HP_HYPOPIGMENTATION_OF_HAIR,SET,88,0.083263,0.0057506,0.094773,0.18983,HP_HYPOPIGMENTATION_OF_HAIR,0.897991241322989
GSE2770_TGFB_AND_IL4_ACT_VS_...4,SET,184,0.053803,0.0053591,0.06124,0.18983,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.897991241322989
BAKER_HEMATOPOESIS_STAT5_TAR...,SET,7,0.32694,0.0063826,0.37225,0.1899,BAKER_HEMATOPOESIS_STAT5_TARGETS,0.898200122482308
WP_TRANSLATION_INHIBITORS_IN...,SET,45,0.11374,0.0056242,0.12954,0.18996,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,0.898361654646891
AP4_Q5,SET,235,0.048855,0.0054917,0.055648,0.19,AP4_Q5,0.898428571428571
ZHANG_RESPONSE_TO_CANTHARIDI...1,SET,60,0.089313,0.0050974,0.10175,0.19005,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,0.898542749285811
KEGG_MEDICUS_VARIANT_MUTATIO...50,SET,6,0.3242,0.0058597,0.36952,0.19015,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM,0.898818278253774
GOBP_POSITIVE_REGULATION_OF_...689,SET,40,0.10995,0.0051265,0.12533,0.19016,GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING,0.898818278253774
GOBP_TRANSCRIPTION_ELONGATIO...1,SET,6,0.33695,0.0060903,0.38417,0.19022,GOBP_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_I,0.898979616535219
REACTOME_NEGATIVE_REGULATION...8,SET,19,0.17073,0.0054893,0.19469,0.19027,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,0.899065925774878
GOBP_REGULATION_OF_RELEASE_O...2,SET,77,0.093447,0.006039,0.10657,0.19029,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.899065925774878
OLF1_01,SET,242,0.048695,0.0055536,0.055548,0.19035,OLF1_01,0.899143960597826
HP_ABNORMAL_MORPHOLOGY_OF_TH...10,SET,28,0.13264,0.0051759,0.15132,0.19038,HP_ABNORMAL_MORPHOLOGY_OF_THE_VESTIBULE_OF_THE_INNER_EAR,0.899143960597826
GOBP_LIPOPROTEIN_CATABOLIC_P...,SET,14,0.20378,0.0056251,0.2325,0.19039,GOBP_LIPOPROTEIN_CATABOLIC_PROCESS,0.899143960597826
GOBP_REGULATION_OF_HIPPO_SIG...,SET,36,0.13466,0.005957,0.15365,0.19041,GOBP_REGULATION_OF_HIPPO_SIGNALING,0.899143960597826
HP_STIFF_NECK,SET,5,0.34926,0.0057628,0.39881,0.19059,HP_STIFF_NECK,0.899372171025884
HP_POSTNATAL_GROWTH_RETARDAT...,SET,219,0.051025,0.0055394,0.058271,0.19062,HP_POSTNATAL_GROWTH_RETARDATION,0.899372171025884
GOBP_MOTOR_NEURON_AXON_GUIDA...,SET,23,0.16921,0.0059852,0.19326,0.19065,GOBP_MOTOR_NEURON_AXON_GUIDANCE,0.899372171025884
GOBP_REGULATION_OF_CELL_CYCLE,SET,997,0.024246,0.0054946,0.027695,0.19066,GOBP_REGULATION_OF_CELL_CYCLE,0.899372171025884
GOBP_PYRAMIDAL_NEURON_DEVELO...,SET,9,0.25503,0.005645,0.29133,0.19069,GOBP_PYRAMIDAL_NEURON_DEVELOPMENT,0.899372171025884
AGCATTA_MIR155,SET,124,0.068901,0.0056432,0.078714,0.1907,AGCATTA_MIR155,0.899372171025884
HP_INCREASED_MEGAKARYOCYTE_C...,SET,7,0.2727,0.0053237,0.31154,0.19071,HP_INCREASED_MEGAKARYOCYTE_COUNT,0.899372171025884
SINGH_NFE2L2_TARGETS,SET,13,0.21976,0.0058456,0.25111,0.19075,SINGH_NFE2L2_TARGETS,0.899372171025884
ROSS_LEUKEMIA_WITH_MLL_FUSIO...,SET,75,0.086309,0.0055051,0.09863,0.19077,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,0.899372171025884
MORF_LMO1,SET,48,0.10824,0.0055272,0.12371,0.1908,MORF_LMO1,0.899372171025884
GOBP_GAP_JUNCTION_MEDIATED_I...,SET,6,0.37009,0.0066893,0.42309,0.19087,GOBP_GAP_JUNCTION_MEDIATED_INTERCELLULAR_TRANSPORT,0.899372171025884
HP_MODERATELY_REDUCED_VISUAL...,SET,7,0.31357,0.0061216,0.35849,0.19088,HP_MODERATELY_REDUCED_VISUAL_ACUITY,0.899372171025884
WP_TYPE_I_COLLAGEN_SYNTHESIS...,SET,31,0.13332,0.0054735,0.15243,0.19089,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,0.899372171025884
GOBP_EMBRYONIC_RETINA_MORPHO...,SET,6,0.34101,0.0061637,0.3899,0.1909,GOBP_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.899372171025884
HP_GENETIC_ANTICIPATION,SET,8,0.24515,0.0051162,0.28031,0.19091,HP_GENETIC_ANTICIPATION,0.899372171025884
MANNE_COVID19_COMBINED_COHOR...2,SET,161,0.058778,0.00548,0.067213,0.19092,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,0.899372171025884
KEGG_CYTOSOLIC_DNA_SENSING_P...,SET,45,0.11348,0.005611,0.12976,0.19093,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,0.899372171025884
PID_IL1_PATHWAY,SET,32,0.13058,0.0054466,0.14933,0.19095,PID_IL1_PATHWAY,0.899372171025884
MIR4485_5P,SET,7,0.28911,0.0056441,0.33063,0.19095,MIR4485_5P,0.899372171025884
GOBP_NEGATIVE_REGULATION_OF_...691,SET,20,0.16381,0.0054037,0.1874,0.19103,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.899566077953715
GOBP_POSITIVE_REGULATION_OF_...158,SET,12,0.22169,0.0056659,0.25365,0.19106,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.899566077953715
REACTOME_SUMOYLATION_OF_SUMO...,SET,33,0.12436,0.0052678,0.14231,0.19108,REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS,0.899566077953715
GOBP_SCHWANN_CELL_PROLIFERAT...,SET,9,0.21504,0.0047599,0.24609,0.19112,GOBP_SCHWANN_CELL_PROLIFERATION,0.899566077953715
HP_ABNORMALITY_OF_SKIN_PIGME...,SET,434,0.035572,0.0054041,0.040711,0.19113,HP_ABNORMALITY_OF_SKIN_PIGMENTATION,0.899566077953715
GOCC_ROUGH_ENDOPLASMIC_RETIC...1,SET,52,0.10184,0.0054121,0.11656,0.19115,GOCC_ROUGH_ENDOPLASMIC_RETICULUM,0.899566077953715
HP_ACANTHOCYTOSIS,SET,10,0.23816,0.0055568,0.27264,0.19119,HP_ACANTHOCYTOSIS,0.899566077953715
HOWARD_DENDRITIC_CELL_INACT_...1,SET,39,0.12743,0.005867,0.1459,0.19123,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.899566077953715
GSE5589_WT_VS_IL6_KO_LPS_AND...2,SET,91,0.079401,0.0055761,0.090913,0.19124,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.899566077953715
GOMF_CALCIUM_ACTIVATED_POTAS...,SET,13,0.23015,0.0061221,0.26353,0.19125,GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY,0.899566077953715
YATGNWAAT_OCT_C,SET,315,0.044404,0.0057661,0.050875,0.19139,YATGNWAAT_OCT_C,0.900102767253045
GOBP_CELLULAR_RESPONSE_TO_UV...1,SET,10,0.27266,0.0063615,0.31245,0.19143,GOBP_CELLULAR_RESPONSE_TO_UV_A,0.900169077256122
HP_ONYCHOGRYPOSIS_OF_FINGERN...,SET,9,0.24428,0.0054072,0.28016,0.19163,HP_ONYCHOGRYPOSIS_OF_FINGERNAIL,0.90023676035503
GNF2_CDC2,SET,58,0.09808,0.0055039,0.11249,0.19164,GNF2_CDC2,0.90023676035503
HP_ABDOMINAL_COLIC,SET,5,0.38129,0.0062913,0.43734,0.19166,HP_ABDOMINAL_COLIC,0.90023676035503
MIR3942_3P,SET,299,0.043748,0.0055372,0.050187,0.19169,MIR3942_3P,0.90023676035503
GOBP_RECEPTOR_MEDIATED_ENDOC...1,SET,239,0.048708,0.005521,0.05589,0.19175,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.90023676035503
GSE21927_SPLENIC_VS_TUMOR_MO...1,SET,178,0.053255,0.0052182,0.061127,0.19182,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN,0.90023676035503
HP_MIXED_HEARING_IMPAIRMENT,SET,32,0.13751,0.0057357,0.15783,0.19183,HP_MIXED_HEARING_IMPAIRMENT,0.90023676035503
GOCC_SEPTIN_CYTOSKELETON,SET,2,0.44895,0.0046855,0.51535,0.19184,GOCC_SEPTIN_CYTOSKELETON,0.90023676035503
KIM_LRRC3B_TARGETS,SET,29,0.13685,0.0054344,0.15712,0.19188,KIM_LRRC3B_TARGETS,0.90023676035503
HP_NEOPLASM_OF_THE_RECTUM,SET,46,0.10561,0.0052795,0.12125,0.19188,HP_NEOPLASM_OF_THE_RECTUM,0.90023676035503
PTF1BETA_Q6,SET,213,0.052237,0.0055936,0.059979,0.19191,PTF1BETA_Q6,0.90023676035503
WALLACE_PROSTATE_CANCER_RACE...2,SET,256,0.050785,0.0059549,0.058316,0.19192,WALLACE_PROSTATE_CANCER_RACE_UP,0.90023676035503
GOBP_VAGINA_DEVELOPMENT,SET,10,0.26847,0.0062637,0.30833,0.19196,GOBP_VAGINA_DEVELOPMENT,0.90023676035503
GSE36476_CTRL_VS_TSST_ACT_72...1,SET,181,0.051945,0.0051321,0.059671,0.19201,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN,0.90023676035503
HP_CRANIAL_HYPEROSTOSIS,SET,40,0.10565,0.0049259,0.12138,0.19204,HP_CRANIAL_HYPEROSTOSIS,0.90023676035503
HP_ELEVATED_TISSUE_NON_SPECI...,SET,17,0.18646,0.0056712,0.21422,0.19204,HP_ELEVATED_TISSUE_NON_SPECIFIC_ALKALINE_PHOSPHATASE,0.90023676035503
HP_GENERALIZED_CLONIC_SEIZURE,SET,28,0.14829,0.0057867,0.17039,0.19207,HP_GENERALIZED_CLONIC_SEIZURE,0.90023676035503
HP_LOSS_OF_PURKINJE_CELLS_IN...,SET,5,0.33351,0.005503,0.38321,0.19207,HP_LOSS_OF_PURKINJE_CELLS_IN_THE_CEREBELLAR_VERMIS,0.90023676035503
GOCC_CORTICAL_GRANULE,SET,6,0.28895,0.0052227,0.33206,0.19211,GOCC_CORTICAL_GRANULE,0.90023676035503
TCGA_GLIOBLASTOMA_COPY_NUMBE...2,SET,67,0.11617,0.0070048,0.13351,0.19213,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,0.90023676035503
HP_METAMORPHOPSIA,SET,17,0.18679,0.0056813,0.21473,0.19218,HP_METAMORPHOPSIA,0.90023676035503
TGTTTGY_HNF3_Q6,SET,650,0.030419,0.0056214,0.034975,0.19223,TGTTTGY_HNF3_Q6,0.90023676035503
REACTOME_HUR_ELAVL1_BINDS_AN...,SET,8,0.29891,0.0062382,0.34371,0.19224,REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA,0.90023676035503
GOBP_SPINAL_CORD_OLIGODENDRO...,SET,5,0.40163,0.0066271,0.46184,0.19225,GOBP_SPINAL_CORD_OLIGODENDROCYTE_CELL_DIFFERENTIATION,0.90023676035503
HP_PUNCTATE_OPACIFICATION_OF...,SET,5,0.34766,0.0057364,0.39979,0.19226,HP_PUNCTATE_OPACIFICATION_OF_THE_CORNEA,0.90023676035503
WP_IMMUNE_RESPONSE_TO_TUBERC...,SET,22,0.15595,0.005395,0.17935,0.19229,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.90023676035503
HP_IRON_DEFICIENCY_ANEMIA,SET,27,0.14615,0.0056005,0.16809,0.19229,HP_IRON_DEFICIENCY_ANEMIA,0.90023676035503
CHAF1B_TARGET_GENES,SET,719,0.028758,0.0055785,0.033075,0.1923,CHAF1B_TARGET_GENES,0.90023676035503
GSE26156_DOUBLE_POSITIVE_VS_...2,SET,178,0.05742,0.0056263,0.066042,0.19231,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.90023676035503
GOBP_NEGATIVE_REGULATION_OF_...99,SET,4,0.39727,0.0058632,0.45706,0.19238,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.90023676035503
HP_FUNCTIONAL_INTESTINAL_OBS...,SET,10,0.22213,0.0051828,0.25556,0.19238,HP_FUNCTIONAL_INTESTINAL_OBSTRUCTION,0.90023676035503
GOBP_SNRNA_PROCESSING,SET,22,0.14916,0.0051603,0.17162,0.19239,GOBP_SNRNA_PROCESSING,0.90023676035503
GSE15930_NAIVE_VS_24H_IN_VIT...5,SET,189,0.050587,0.0051061,0.058203,0.19239,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN,0.90023676035503
GSE32533_WT_VS_MIR17_KO_ACT_...1,SET,179,0.052683,0.0051765,0.060619,0.1924,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN,0.90023676035503
NAKAYAMA_SOFT_TISSUE_TUMORS_...4,SET,78,0.084785,0.0055145,0.09758,0.19246,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,0.90023676035503
HP_EVERTED_UPPER_LIP_VERMILI...,SET,19,0.17019,0.0054721,0.19589,0.19248,HP_EVERTED_UPPER_LIP_VERMILION,0.90023676035503
HP_POSTERIOR_STAPHYLOMA,SET,7,0.30944,0.006041,0.35617,0.19248,HP_POSTERIOR_STAPHYLOMA,0.90023676035503
WANG_THOC1_TARGETS_DN,SET,16,0.19863,0.0058611,0.22864,0.19249,WANG_THOC1_TARGETS_DN,0.90023676035503
REACTOME_RELAXIN_RECEPTORS,SET,7,0.32126,0.0062717,0.36988,0.19255,REACTOME_RELAXIN_RECEPTORS,0.90023676035503
MCCLUNG_CREB1_TARGETS_UP,SET,91,0.084489,0.0059334,0.097278,0.19256,MCCLUNG_CREB1_TARGETS_UP,0.90023676035503
chr10q25,SET,51,0.18024,0.009486,0.20753,0.19257,chr10q25,0.90023676035503
chr15q12,SET,4,0.44626,0.0065862,0.51385,0.19257,chr15q12,0.90023676035503
GSE8685_IL2_STARVED_VS_IL2_A...1,SET,177,0.054981,0.0053723,0.063309,0.19258,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN,0.90023676035503
REACTOME_TRANSCRIPTION_COUPL...,SET,73,0.07728,0.0048632,0.088996,0.19261,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,0.90023676035503
GSE41867_LCMV_ARMSTRONG_VS_C...6,SET,174,0.055453,0.0053728,0.063861,0.19261,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP,0.90023676035503
GOBP_ANTERIOR_POSTERIOR_AXON...,SET,7,0.31746,0.0061975,0.36564,0.19264,GOBP_ANTERIOR_POSTERIOR_AXON_GUIDANCE,0.900255909640984
REACTOME_SPHINGOLIPID_CATABO...,SET,9,0.23078,0.0051083,0.26606,0.19287,REACTOME_SPHINGOLIPID_CATABOLISM,0.900586785379569
MODULE_111,SET,140,0.062746,0.0054583,0.072358,0.19293,MODULE_111,0.900586785379569
REACTOME_APEX1_INDEPENDENT_R...,SET,7,0.22815,0.0044541,0.26312,0.19295,REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,0.900586785379569
MANNO_MIDBRAIN_NEUROTYPES_HN...3,SET,287,0.046638,0.0057853,0.053787,0.19295,MANNO_MIDBRAIN_NEUROTYPES_HNBML1,0.900586785379569
GSE45365_WT_VS_IFNAR_KO_BCEL...2,SET,153,0.059802,0.0054364,0.068981,0.193,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN,0.900586785379569
GOBP_PROTEIN_EXPORT_FROM_NUC...,SET,58,0.09375,0.0052609,0.10815,0.19303,GOBP_PROTEIN_EXPORT_FROM_NUCLEUS,0.900586785379569
GSE15750_WT_VS_TRAF6KO_DAY6_...2,SET,176,0.053515,0.0052144,0.061738,0.19303,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP,0.900586785379569
REACTOME_FORMATION_OF_RNA_PO...,SET,52,0.090346,0.0048013,0.10423,0.19304,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,0.900586785379569
GOMF_PHOSPHATIDATE_PHOSPHATA...,SET,3,0.41817,0.005345,0.48247,0.19305,GOMF_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY,0.900586785379569
GSE23114_PERITONEAL_CAVITY_B...3,SET,178,0.057009,0.005586,0.065774,0.19305,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP,0.900586785379569
PBX1_02,SET,113,0.075343,0.0058926,0.086943,0.19309,PBX1_02,0.900586785379569
GOBP_CALCIUM_ION_REGULATED_E...1,SET,62,0.096086,0.0055742,0.11089,0.19311,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS,0.900586785379569
HP_LIMB_MYOCLONUS,SET,25,0.15236,0.0056184,0.17583,0.19311,HP_LIMB_MYOCLONUS,0.900586785379569
MIR5691_MIR6805_3P,SET,144,0.063753,0.0056239,0.073582,0.19313,MIR5691_MIR6805_3P,0.900586785379569
LAKE_ADULT_KIDNEY_C9_THIN_AS...,SET,246,0.048037,0.0055231,0.05545,0.19316,LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB,0.900586785379569
GOBP_REGULATION_OF_VASCULOGE...,SET,15,0.19979,0.0057084,0.23064,0.19318,GOBP_REGULATION_OF_VASCULOGENESIS,0.900586785379569
chr2q34,SET,15,0.3513,0.010037,0.40562,0.19322,chr2q34,0.900586785379569
HP_ASTROCYTOSIS,SET,21,0.17073,0.0057709,0.19715,0.19325,HP_ASTROCYTOSIS,0.900586785379569
GSE22886_NAIVE_CD4_TCELL_VS_...7,SET,188,0.051222,0.0051566,0.059151,0.19327,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN,0.900586785379569
MIR6890_3P,SET,82,0.083976,0.0055996,0.096999,0.19332,MIR6890_3P,0.900586785379569
HALLMARK_COAGULATION,SET,127,0.070812,0.005869,0.081799,0.19334,HALLMARK_COAGULATION,0.900586785379569
HP_BONE_MARROW_HYPOCELLULARI...,SET,64,0.087908,0.0051811,0.10156,0.19336,HP_BONE_MARROW_HYPOCELLULARITY,0.900586785379569
GOBP_NLS_BEARING_PROTEIN_IMP...,SET,18,0.17325,0.0054219,0.20017,0.19339,GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS,0.900586785379569
REACTOME_COBALAMIN_CBL_METAB...,SET,6,0.28971,0.0052365,0.33477,0.19341,REACTOME_COBALAMIN_CBL_METABOLISM,0.900586785379569
GOCC_INSULIN_RESPONSIVE_COMP...,SET,7,0.25745,0.005026,0.29749,0.19341,GOCC_INSULIN_RESPONSIVE_COMPARTMENT,0.900586785379569
GSE14769_UNSTIM_VS_120MIN_LP...2,SET,184,0.05125,0.0051048,0.059221,0.19341,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP,0.900586785379569
MIR3168,SET,122,0.06591,0.0053549,0.076166,0.19343,MIR3168,0.900586785379569
GOBP_POSITIVE_REGULATION_OF_...802,SET,37,0.15131,0.0067858,0.17487,0.19344,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.900586785379569
GOBP_NEPHRON_EPITHELIUM_DEVE...,SET,113,0.076825,0.0060085,0.088796,0.19348,GOBP_NEPHRON_EPITHELIUM_DEVELOPMENT,0.900586785379569
PID_ERBB4_PATHWAY,SET,38,0.11444,0.0052011,0.1323,0.19351,PID_ERBB4_PATHWAY,0.900586785379569
GSE2585_CD80_HIGH_VS_LOW_MTE...1,SET,171,0.056844,0.0054602,0.065713,0.19352,GSE2585_CD80_HIGH_VS_LOW_MTEC_DN,0.900586785379569
GOBP_FIBROBLAST_GROWTH_FACTO...1,SET,7,0.30354,0.0059258,0.35094,0.19354,GOBP_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.900586785379569
HP_IMMOTILE_CILIA,SET,9,0.25382,0.0056183,0.29348,0.19357,HP_IMMOTILE_CILIA,0.900597309957173
REACTOME_SYNTHESIS_OF_BILE_A...3,SET,14,0.22124,0.0061069,0.25587,0.19362,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL,0.900597309957173
GOBP_REGULATION_OF_ENDOPLASM...1,SET,29,0.12502,0.0049648,0.14459,0.19362,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.900597309957173
LAU_APOPTOSIS_CDKN2A_UP,SET,55,0.094388,0.0051584,0.10917,0.19365,LAU_APOPTOSIS_CDKN2A_UP,0.900616318747491
REACTOME_PLATELET_HOMEOSTASIS,SET,81,0.086341,0.0057222,0.099908,0.19374,REACTOME_PLATELET_HOMEOSTASIS,0.900730264741275
MIR8078,SET,28,0.1374,0.0053617,0.15899,0.19375,MIR8078,0.900730264741275
REACTOME_PRESYNAPTIC_NICOTIN...,SET,12,0.23357,0.0059695,0.27029,0.19376,REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.900730264741275
GOBP_POSITIVE_REGULATION_OF_...756,SET,5,0.3219,0.0053114,0.37256,0.1938,GOBP_POSITIVE_REGULATION_OF_THYROID_HORMONE_GENERATION,0.900730264741275
AZARE_NEOPLASTIC_TRANSFORMAT...2,SET,116,0.073614,0.0058328,0.085211,0.19383,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,0.900730264741275
KEGG_MEDICUS_REFERENCE_NOTCH...3,SET,10,0.2152,0.0050209,0.24911,0.19383,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION,0.900730264741275
MIR3915,SET,197,0.051819,0.0053388,0.060006,0.19392,MIR3915,0.900968581081081
GOBP_REGULATION_OF_EATING_BE...,SET,7,0.31872,0.0062222,0.36913,0.19395,GOBP_REGULATION_OF_EATING_BEHAVIOR,0.900968581081081
GOBP_LUNG_GROWTH,SET,5,0.42455,0.0070051,0.4917,0.19396,GOBP_LUNG_GROWTH,0.900968581081081
REACTOME_POU5F1_OCT4_SOX2_NA...1,SET,10,0.23337,0.005445,0.27046,0.19411,REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION,0.900968581081081
WP_METAPATHWAY_BIOTRANSFORMA...,SET,173,0.063702,0.0061543,0.073825,0.19411,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,0.900968581081081
REACTOME_PRC2_METHYLATES_HIS...,SET,12,0.21248,0.0054305,0.24626,0.19412,REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,0.900968581081081
HP_BURKITT_LYMPHOMA,SET,8,0.28588,0.0059663,0.33133,0.19412,HP_BURKITT_LYMPHOMA,0.900968581081081
MIR6798_5P,SET,41,0.11158,0.0052671,0.12934,0.19416,MIR6798_5P,0.900968581081081
GOBP_REGULATION_OF_CLATHRIN_...,SET,16,0.17511,0.005167,0.203,0.19419,GOBP_REGULATION_OF_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.900968581081081
REACTOME_DEADENYLATION_OF_MR...,SET,22,0.15841,0.0054803,0.18366,0.1942,REACTOME_DEADENYLATION_OF_MRNA,0.900968581081081
GSE40274_FOXP3_VS_FOXP3_AND_...6,SET,138,0.064708,0.0055888,0.075019,0.1942,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.900968581081081
GOBP_PROTEIN_LOCALIZATION_TO...11,SET,36,0.11502,0.005088,0.13335,0.19422,GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.900968581081081
MARTIN_INTERACT_WITH_HDAC,SET,37,0.11643,0.0052213,0.13502,0.19427,MARTIN_INTERACT_WITH_HDAC,0.900968581081081
GSE30083_SP1_VS_SP2_THYMOCYT...2,SET,178,0.056293,0.0055158,0.065293,0.19431,GSE30083_SP1_VS_SP2_THYMOCYTE_UP,0.900968581081081
GSE5463_CTRL_VS_DEXAMETHASON...1,SET,177,0.057403,0.005609,0.066593,0.19435,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN,0.900968581081081
GOMF_INORGANIC_DIPHOSPHATE_P...,SET,4,0.42524,0.006276,0.49336,0.19437,GOMF_INORGANIC_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,0.900968581081081
MIKKELSEN_NPC_WITH_LCP_H3K27...,SET,7,0.27799,0.005427,0.32253,0.19438,MIKKELSEN_NPC_WITH_LCP_H3K27ME3,0.900968581081081
GOMF_HYALURONONGLUCOSAMINIDA...,SET,6,0.33069,0.0059771,0.3837,0.19439,GOMF_HYALURONONGLUCOSAMINIDASE_ACTIVITY,0.900968581081081
ROY_WOUND_BLOOD_VESSEL_UP,SET,45,0.11705,0.0057875,0.13582,0.19441,ROY_WOUND_BLOOD_VESSEL_UP,0.900968581081081
MATZUK_CENTRAL_FOR_FEMALE_FE...,SET,29,0.14072,0.0055883,0.16337,0.19452,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,0.900968581081081
GOMF_GLYCINE_BINDING,SET,10,0.25659,0.0059867,0.29789,0.19453,GOMF_GLYCINE_BINDING,0.900968581081081
GOBP_REGULATION_OF_MACROPHAG...8,SET,6,0.32419,0.0058595,0.37642,0.19456,GOBP_REGULATION_OF_MACROPHAGE_PROLIFERATION,0.900968581081081
chr16q22,SET,105,0.1448,0.010919,0.16814,0.19457,chr16q22,0.900968581081081
GOBP_NEGATIVE_REGULATION_OF_...287,SET,4,0.36627,0.0054057,0.42536,0.1946,GOBP_NEGATIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.900968581081081
MIR4486,SET,34,0.11885,0.0051098,0.13803,0.19461,MIR4486,0.900968581081081
GOBP_PHOSPHATIDYLINOSITOL_3_...2,SET,21,0.15345,0.0051866,0.17821,0.19461,GOBP_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.900968581081081
GSE25088_CTRL_VS_IL4_STIM_MA...1,SET,174,0.055219,0.0053501,0.064138,0.19464,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.900968581081081
GSE12198_LOW_IL2_STIM_NK_CEL...2,SET,183,0.051299,0.0050959,0.059601,0.19471,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.900968581081081
GOBP_POSITIVE_REGULATION_OF_...83,SET,7,0.27995,0.0054652,0.32531,0.19474,GOBP_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.900968581081081
HOEGERKORP_CD44_TARGETS_DIRE...1,SET,10,0.22918,0.0053471,0.26633,0.19476,HOEGERKORP_CD44_TARGETS_DIRECT_DN,0.900968581081081
GOBP_L_PHENYLALANINE_METABOL...,SET,8,0.28392,0.0059253,0.32996,0.19477,GOBP_L_PHENYLALANINE_METABOLIC_PROCESS,0.900968581081081
WP_MINERALOCORTICOID_BIOSYNT...,SET,14,0.2275,0.0062797,0.26444,0.19482,WP_MINERALOCORTICOID_BIOSYNTHESIS,0.900968581081081
BROWNE_HCMV_INFECTION_14HR_UP,SET,137,0.059338,0.0051066,0.068979,0.19484,BROWNE_HCMV_INFECTION_14HR_UP,0.900968581081081
HP_EXANTHEM,SET,20,0.16641,0.0054892,0.19347,0.19487,HP_EXANTHEM,0.900968581081081
GOBP_GENITALIA_DEVELOPMENT,SET,46,0.11849,0.0059235,0.13777,0.19489,GOBP_GENITALIA_DEVELOPMENT,0.900968581081081
HP_GASTROINTESTINAL_OBSTRUCT...,SET,85,0.08426,0.0057199,0.098015,0.19499,HP_GASTROINTESTINAL_OBSTRUCTION,0.900968581081081
GSE32255_WT_UNSTIM_VS_JMJD2D...2,SET,160,0.057863,0.0053781,0.067307,0.19499,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.900968581081081
GSE13484_UNSTIM_VS_3H_YF17D_...2,SET,179,0.050839,0.0049952,0.059155,0.19506,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.900968581081081
HP_PALMAR_HYPERHIDROSIS,SET,15,0.20408,0.005831,0.23748,0.19507,HP_PALMAR_HYPERHIDROSIS,0.900968581081081
SASSON_RESPONSE_TO_FORSKOLIN...2,SET,78,0.081414,0.0052952,0.094755,0.19512,SASSON_RESPONSE_TO_FORSKOLIN_UP,0.900968581081081
GOBP_REGULATION_OF_GLIAL_CEL...2,SET,74,0.096686,0.0061259,0.11253,0.19512,GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.900968581081081
GOBP_REGULATION_OF_PRODUCTIO...,SET,171,0.057958,0.0055673,0.067457,0.19512,GOBP_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.900968581081081
DESCARTES_MAIN_FETAL_ADRENOC...,SET,62,0.095936,0.0055655,0.11166,0.19513,DESCARTES_MAIN_FETAL_ADRENOCORTICAL_CELLS,0.900968581081081
GOBP_NEGATIVE_REGULATION_OF_...380,SET,6,0.32551,0.0058834,0.37893,0.19517,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.900968581081081
GOBP_RESPONSE_TO_HYDROPEROXI...,SET,19,0.17791,0.0057202,0.20713,0.19519,GOBP_RESPONSE_TO_HYDROPEROXIDE,0.900968581081081
HOXD1_TARGET_GENES,SET,56,0.095287,0.0052545,0.11094,0.1952,HOXD1_TARGET_GENES,0.900968581081081
GSE3039_B2_VS_B1_BCELL_DN,SET,180,0.051276,0.0050521,0.059705,0.19523,GSE3039_B2_VS_B1_BCELL_DN,0.900968581081081
KEGG_MEDICUS_REFERENCE_PRNP_...,SET,27,0.14589,0.0055907,0.16995,0.19532,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,0.900968581081081
REACTOME_INTEGRIN_CELL_SURFA...,SET,81,0.08946,0.0059289,0.10421,0.19532,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,0.900968581081081
MORF_RAD23B,SET,158,0.052863,0.0048827,0.061581,0.19533,MORF_RAD23B,0.900968581081081
GOBP_REGULATION_OF_TRANSLATI...11,SET,8,0.23185,0.0048386,0.2701,0.19535,GOBP_REGULATION_OF_TRANSLATION_INITIATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.900968581081081
MIR589_3P,SET,229,0.049559,0.0055003,0.05774,0.19536,MIR589_3P,0.900968581081081
PAX5_02,SET,16,0.17361,0.0051229,0.20227,0.19536,PAX5_02,0.900968581081081
LIAN_LIPA_TARGETS_6M,SET,65,0.09933,0.0058997,0.11575,0.1954,LIAN_LIPA_TARGETS_6M,0.900968581081081
REACTOME_ER_QUALITY_CONTROL_...,SET,19,0.16602,0.005338,0.19353,0.19549,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,0.900968581081081
GOBP_LEUKOCYTE_TETHERING_OR_...,SET,34,0.1351,0.0058086,0.1575,0.1955,GOBP_LEUKOCYTE_TETHERING_OR_ROLLING,0.900968581081081
REACTOME_ROLE_OF_SECOND_MESS...,SET,9,0.25603,0.0056673,0.2985,0.19552,REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING,0.900968581081081
MILI_PSEUDOPODIA_CHEMOTAXIS_...2,SET,72,0.079483,0.0049676,0.092669,0.19553,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,0.900968581081081
GOMF_XENOBIOTIC_TRANSMEMBRAN...,SET,32,0.14051,0.0058611,0.16383,0.19554,GOMF_XENOBIOTIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.900968581081081
GOBP_N_TERMINAL_PROTEIN_AMIN...1,SET,13,0.17776,0.0047284,0.20728,0.19557,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION,0.900968581081081
GOBP_PEPTIDYL_ARGININE_METHY...1,SET,10,0.21583,0.0050356,0.25169,0.19559,GOBP_PEPTIDYL_ARGININE_METHYLATION,0.900968581081081
GOMF_HYDROLASE_ACTIVITY_HYDR...1,SET,37,0.1335,0.0059871,0.15569,0.1956,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS,0.900968581081081
HP_ARTHRITIS,SET,206,0.052566,0.0055367,0.061308,0.19562,HP_ARTHRITIS,0.900968581081081
HP_OSTEOMYELITIS,SET,58,0.10222,0.0057362,0.11923,0.19563,HP_OSTEOMYELITIS,0.900968581081081
GSE10239_NAIVE_VS_DAY4.5_EFF...2,SET,187,0.054427,0.0054648,0.063489,0.19565,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP,0.900968581081081
GOBP_ENDOSOMAL_TRANSPORT,SET,255,0.044287,0.005183,0.051662,0.19566,GOBP_ENDOSOMAL_TRANSPORT,0.900968581081081
GOBP_TOLL_LIKE_RECEPTOR_3_SI...,SET,28,0.13407,0.0052316,0.15639,0.19566,GOBP_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.900968581081081
GSE360_L_MAJOR_VS_T_GONDII_M...2,SET,178,0.056247,0.0055114,0.065616,0.19567,GSE360_L_MAJOR_VS_T_GONDII_MAC_UP,0.900968581081081
GSE37532_VISCERAL_ADIPOSE_TI...1,SET,89,0.079745,0.0055387,0.093027,0.19567,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN,0.900968581081081
REACTOME_CYTOKINE_SIGNALING_...,SET,714,0.028395,0.0054897,0.033132,0.19572,REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,0.901052145695364
GOCC_POSTSYNAPTIC_DENSITY_ME...,SET,94,0.078489,0.0056017,0.091589,0.19574,GOCC_POSTSYNAPTIC_DENSITY_MEMBRANE,0.901052145695364
GOBP_PROSTATE_GLAND_DEVELOPM...,SET,47,0.12126,0.0061275,0.14157,0.19586,GOBP_PROSTATE_GLAND_DEVELOPMENT,0.9014578125
GOMF_PROTEIN_HORMONE_RECEPTO...,SET,18,0.18734,0.0058631,0.21874,0.19588,GOMF_PROTEIN_HORMONE_RECEPTOR_ACTIVITY,0.9014578125
MIR3649,SET,18,0.18057,0.005651,0.21088,0.19593,MIR3649,0.90151387822634
GSE28449_WT_VS_LRF_KO_GERMIN...1,SET,171,0.05759,0.0055319,0.067263,0.19595,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN,0.90151387822634
GOMF_MODIFIED_AMINO_ACID_TRA...,SET,30,0.13399,0.0054118,0.15651,0.19597,GOMF_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.90151387822634
BLANCO_MELO_SARS_COV_1_INFEC...1,SET,9,0.25864,0.0057249,0.30227,0.1961,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN,0.901588199233717
GSE23568_CTRL_VS_ID3_TRANSDU...1,SET,179,0.052946,0.0052023,0.061882,0.19612,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN,0.901588199233717
GOBP_PROTEIN_MONOUBIQUITINAT...,SET,42,0.10652,0.0050888,0.12451,0.19614,GOBP_PROTEIN_MONOUBIQUITINATION,0.901588199233717
BIOCARTA_MRP_PATHWAY,SET,6,0.33954,0.006137,0.39691,0.19616,BIOCARTA_MRP_PATHWAY,0.901588199233717
MIR5702,SET,68,0.090031,0.005469,0.10529,0.19625,MIR5702,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...776,SET,4,0.42675,0.0062983,0.49906,0.19625,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.901588199233717
GSE17721_LPS_VS_GARDIQUIMOD_...7,SET,181,0.053753,0.0053107,0.062859,0.19625,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN,0.901588199233717
GSE29618_BCELL_VS_PDC_UP,SET,169,0.060857,0.0058118,0.071175,0.19627,GSE29618_BCELL_VS_PDC_UP,0.901588199233717
SCHAEFFER_PROSTATE_DEVELOPME...1,SET,52,0.10626,0.0056473,0.1243,0.1963,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,0.901588199233717
MNX1_TARGET_GENES,SET,8,0.25854,0.0053957,0.30244,0.19632,MNX1_TARGET_GENES,0.901588199233717
GOMF_CCR_CHEMOKINE_RECEPTOR_...,SET,38,0.14587,0.0066292,0.17064,0.19633,GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING,0.901588199233717
HNF4_DR1_Q3,SET,243,0.046735,0.0053409,0.054678,0.19636,HNF4_DR1_Q3,0.901588199233717
BOHN_PRIMARY_IMMUNODEFICIENC...2,SET,44,0.11599,0.0056714,0.13573,0.19641,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,0.901588199233717
LEE_LIVER_CANCER_ACOX1_UP,SET,62,0.10399,0.0060326,0.12169,0.19641,LEE_LIVER_CANCER_ACOX1_UP,0.901588199233717
SYNCRIP_TARGET_GENES,SET,16,0.17532,0.0051732,0.20518,0.19643,SYNCRIP_TARGET_GENES,0.901588199233717
HP_HYPERURICOSURIA,SET,8,0.24281,0.0050674,0.28417,0.19643,HP_HYPERURICOSURIA,0.901588199233717
WP_SULFATION_BIOTRANSFORMATI...,SET,14,0.22822,0.0062998,0.2671,0.19644,WP_SULFATION_BIOTRANSFORMATION_REACTION,0.901588199233717
HP_LATE_ONSET_PROXIMAL_MUSCL...,SET,6,0.33922,0.0061312,0.39711,0.1965,HP_LATE_ONSET_PROXIMAL_MUSCLE_WEAKNESS,0.901588199233717
HP_CHRONIC_OTITIS_MEDIA,SET,136,0.06448,0.005529,0.075494,0.19653,HP_CHRONIC_OTITIS_MEDIA,0.901588199233717
GSE7348_LPS_VS_TOLERIZED_AND...1,SET,157,0.057173,0.0052643,0.066946,0.19655,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.901588199233717
BYSTROEM_CORRELATED_WITH_IL5...2,SET,38,0.11435,0.0051968,0.1339,0.19656,BYSTROEM_CORRELATED_WITH_IL5_UP,0.901588199233717
PGBD5_TARGET_GENES,SET,14,0.19667,0.0054287,0.23031,0.19658,PGBD5_TARGET_GENES,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...837,SET,10,0.26254,0.0061255,0.3075,0.19662,GOBP_POSITIVE_REGULATION_OF_VESICLE_FUSION,0.901588199233717
GOMF_SH3_DOMAIN_BINDING,SET,111,0.068161,0.0052837,0.079836,0.19663,GOMF_SH3_DOMAIN_BINDING,0.901588199233717
GSE11961_GERMINAL_CENTER_BCE...4,SET,176,0.054225,0.0052836,0.063521,0.19665,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.901588199233717
GSE12198_CTRL_VS_LOW_IL2_STI...1,SET,192,0.051719,0.0052612,0.060619,0.19678,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN,0.901588199233717
GOBP_RESPONSE_TO_MACROPHAGE_...,SET,16,0.20736,0.0061188,0.24309,0.19683,GOBP_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.901588199233717
REACTOME_TRANSPORT_OF_ORGANI...,SET,10,0.26622,0.0062115,0.31213,0.19685,REACTOME_TRANSPORT_OF_ORGANIC_ANIONS,0.901588199233717
REACTOME_P75NTR_SIGNALS_VIA_...,SET,14,0.20801,0.0057417,0.24388,0.19686,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,0.901588199233717
IK2_01,SET,235,0.048874,0.0054938,0.057325,0.19695,IK2_01,0.901588199233717
DUTTA_APOPTOSIS_VIA_NFKB,SET,32,0.13449,0.0056099,0.15777,0.19698,DUTTA_APOPTOSIS_VIA_NFKB,0.901588199233717
GOCC_CONTRACTILE_MUSCLE_FIBER,SET,237,0.04928,0.0055627,0.057809,0.19698,GOCC_CONTRACTILE_MUSCLE_FIBER,0.901588199233717
MIR6756_3P,SET,92,0.074022,0.0052267,0.086835,0.19699,MIR6756_3P,0.901588199233717
HP_DECREASED_CIRCULATING_DEH...,SET,7,0.29153,0.0056914,0.34205,0.19702,HP_DECREASED_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...445,SET,26,0.14526,0.0054624,0.17047,0.19709,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.901588199233717
HP_ABNORMAL_MORPHOLOGY_OF_TH...6,SET,82,0.078255,0.0052181,0.091846,0.19711,HP_ABNORMAL_MORPHOLOGY_OF_THE_MUSCULATURE_OF_THE_NECK,0.901588199233717
GOBP_REGULATION_OF_DNA_CATAB...,SET,10,0.23382,0.0054554,0.27444,0.19712,GOBP_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.901588199233717
GSE4748_CTRL_VS_LPS_AND_CYAN...2,SET,180,0.054612,0.0053808,0.064104,0.19713,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.901588199233717
HP_ABNORMAL_MITOCHONDRIAL_SH...,SET,10,0.22913,0.0053461,0.26897,0.19714,HP_ABNORMAL_MITOCHONDRIAL_SHAPE,0.901588199233717
P53_DECAMER_Q2,SET,233,0.048134,0.0053879,0.05651,0.19717,P53_DECAMER_Q2,0.901588199233717
MIR6771_3P,SET,89,0.077677,0.005395,0.091194,0.19718,MIR6771_3P,0.901588199233717
HP_ABNORMALITY_OF_COAGULATION,SET,201,0.050373,0.0052417,0.059148,0.19721,HP_ABNORMALITY_OF_COAGULATION,0.901588199233717
GSE41978_KLRG1_HIGH_VS_LOW_E...2,SET,182,0.055964,0.0055443,0.065736,0.1973,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP,0.901588199233717
GOMF_GENERAL_TRANSCRIPTION_I...1,SET,46,0.093957,0.0046971,0.11037,0.19731,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.901588199233717
GOBP_KINETOCHORE_ORGANIZATION,SET,20,0.16409,0.0054128,0.1928,0.19737,GOBP_KINETOCHORE_ORGANIZATION,0.901588199233717
GOBP_VESICLE_DOCKING,SET,57,0.096727,0.0053811,0.11366,0.19738,GOBP_VESICLE_DOCKING,0.901588199233717
MIR4694_3P,SET,281,0.044479,0.0054604,0.052269,0.1974,MIR4694_3P,0.901588199233717
HP_SKULL_ASYMMETRY,SET,7,0.27833,0.0054335,0.32709,0.19742,HP_SKULL_ASYMMETRY,0.901588199233717
HP_INCREASED_CIRCULATING_CRE...,SET,3,0.34073,0.0043551,0.40048,0.19744,HP_INCREASED_CIRCULATING_CREATINE_KINASE_MB_ISOFORM,0.901588199233717
ZNF19_TARGET_GENES,SET,10,0.21929,0.0051165,0.25778,0.19747,ZNF19_TARGET_GENES,0.901588199233717
HP_NEVUS,SET,153,0.058454,0.0053138,0.068719,0.1975,HP_NEVUS,0.901588199233717
HP_RECURRENT_STREPTOCOCCAL_I...,SET,3,0.38019,0.0048595,0.4471,0.19757,HP_RECURRENT_STREPTOCOCCAL_INFECTIONS,0.901588199233717
HP_ANORECTAL_ANOMALY,SET,149,0.061048,0.0054772,0.071798,0.19759,HP_ANORECTAL_ANOMALY,0.901588199233717
MIR640,SET,46,0.097992,0.0048988,0.11525,0.1976,MIR640,0.901588199233717
MIR6870_3P,SET,42,0.1096,0.0052362,0.12891,0.1976,MIR6870_3P,0.901588199233717
CARRILLOREIXACH_14Q32OVEREXP...,SET,2,0.65696,0.0068564,0.77269,0.19761,CARRILLOREIXACH_14Q32OVEREXPRESSION_IN_HEPATOBLASTOMA,0.901588199233717
GOBP_PHOSPHATIDYLINOSITOL_ME...1,SET,23,0.15819,0.0055953,0.18608,0.19764,GOBP_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING,0.901588199233717
KIM_WT1_TARGETS_UP,SET,211,0.052603,0.0056066,0.061881,0.19765,KIM_WT1_TARGETS_UP,0.901588199233717
GOBP_TRIGLYCERIDE_METABOLIC_...,SET,93,0.078329,0.0055607,0.092145,0.19765,GOBP_TRIGLYCERIDE_METABOLIC_PROCESS,0.901588199233717
GSE17721_POLYIC_VS_PAM3CSK4_...1,SET,185,0.052307,0.0052241,0.061537,0.19767,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN,0.901588199233717
GOBP_PROTEIN_O_LINKED_MANNOS...,SET,14,0.17947,0.004954,0.21115,0.19768,GOBP_PROTEIN_O_LINKED_MANNOSYLATION,0.901588199233717
GOCC_HIPPOCAMPAL_MOSSY_FIBER...,SET,41,0.11806,0.0055728,0.13899,0.19784,GOCC_HIPPOCAMPAL_MOSSY_FIBER_TO_CA3_SYNAPSE,0.901588199233717
GSE5542_IFNA_VS_IFNA_AND_IFN...4,SET,177,0.051646,0.0050464,0.060823,0.19791,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.901588199233717
WGTTNNNNNAAA_UNKNOWN,SET,484,0.035296,0.0056547,0.041569,0.19792,WGTTNNNNNAAA_UNKNOWN,0.901588199233717
HP_ABNORMALITY_OF_THE_SPINOC...,SET,10,0.23854,0.0055656,0.28096,0.19794,HP_ABNORMALITY_OF_THE_SPINOCEREBELLAR_TRACTS,0.901588199233717
ONGUSAHA_BRCA1_TARGETS_DN,SET,11,0.22263,0.0054477,0.26234,0.19805,ONGUSAHA_BRCA1_TARGETS_DN,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...337,SET,3,0.41214,0.0052679,0.48568,0.19806,GOBP_POSITIVE_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.901588199233717
NAKAYA_MYELOID_DENDRITIC_CEL...1,SET,238,0.04513,0.0051049,0.053186,0.19808,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.901588199233717
GCGCCTT_MIR525_MIR524,SET,15,0.18641,0.0053259,0.21972,0.19812,GCGCCTT_MIR525_MIR524,0.901588199233717
REACTOME_SIGNALING_BY_NODAL,SET,19,0.17829,0.0057324,0.21021,0.19818,REACTOME_SIGNALING_BY_NODAL,0.901588199233717
GOBP_NEGATIVE_REGULATION_OF_...534,SET,68,0.086453,0.0052516,0.10193,0.19818,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.901588199233717
GSE29618_PRE_VS_DAY7_POST_LA...3,SET,172,0.055198,0.0053175,0.065097,0.19824,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...408,SET,47,0.11047,0.0055824,0.13032,0.19831,GOBP_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY,0.901588199233717
LIEN_BREAST_CARCINOMA_METAPL...3,SET,73,0.093469,0.005882,0.11027,0.19833,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,0.901588199233717
GOBP_PERICARDIUM_DEVELOPMENT,SET,18,0.18681,0.0058463,0.22044,0.19839,GOBP_PERICARDIUM_DEVELOPMENT,0.901588199233717
GOCC_RDNA_HETEROCHROMATIN,SET,3,0.3708,0.0047394,0.43757,0.19839,GOCC_RDNA_HETEROCHROMATIN,0.901588199233717
HP_DECREASED_CIRCULATING_AND...,SET,62,0.096148,0.0055778,0.11346,0.1984,HP_DECREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.901588199233717
GSE11057_EFF_MEM_VS_CENT_MEM...2,SET,169,0.057714,0.0055116,0.068117,0.19843,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP,0.901588199233717
GSE15330_WT_VS_IKAROS_KO_HSC...1,SET,184,0.053599,0.0053388,0.063261,0.19843,GSE15330_WT_VS_IKAROS_KO_HSC_DN,0.901588199233717
GSE2770_TGFB_AND_IL4_ACT_VS_...5,SET,174,0.05277,0.0051128,0.062303,0.19851,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.901588199233717
CROONQUIST_STROMAL_STIMULATI...2,SET,49,0.11407,0.005885,0.13468,0.19852,CROONQUIST_STROMAL_STIMULATION_UP,0.901588199233717
GOBP_CELLULAR_CATABOLIC_PROC...,SET,1032,0.022972,0.005291,0.027124,0.19852,GOBP_CELLULAR_CATABOLIC_PROCESS,0.901588199233717
GOBP_REGULATION_OF_SYNAPSE_S...2,SET,230,0.050337,0.0055986,0.059437,0.19853,GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY,0.901588199233717
ZHONG_PFC_MAJOR_TYPES_INTERN...,SET,13,0.22303,0.0059325,0.26334,0.19853,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.901588199233717
CHX10_01,SET,203,0.054606,0.00571,0.06449,0.19858,CHX10_01,0.901588199233717
HP_SELECTIVE_TOOTH_AGENESIS,SET,40,0.12987,0.0060553,0.15338,0.19858,HP_SELECTIVE_TOOTH_AGENESIS,0.901588199233717
HP_LIMITED_KNEE_FLEXION,SET,4,0.36152,0.0053355,0.4271,0.19866,HP_LIMITED_KNEE_FLEXION,0.901588199233717
GOBP_B_CELL_ACTIVATION_INVOL...,SET,75,0.082466,0.0052599,0.097429,0.19867,GOBP_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.901588199233717
PHONG_TNF_TARGETS_DN,SET,8,0.26918,0.0056176,0.31815,0.19876,PHONG_TNF_TARGETS_DN,0.901588199233717
HP_ABNORMAL_PANCREAS_SIZE,SET,33,0.13479,0.0057092,0.15931,0.19876,HP_ABNORMAL_PANCREAS_SIZE,0.901588199233717
MIR548AB,SET,443,0.035007,0.0053717,0.04139,0.19884,MIR548AB,0.901588199233717
GSE13762_CTRL_VS_125_VITAMIN...2,SET,131,0.06379,0.005369,0.075424,0.19885,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP,0.901588199233717
GOBP_NUCLEAR_MEMBRANE_REASSE...,SET,25,0.13749,0.0050702,0.16261,0.19891,GOBP_NUCLEAR_MEMBRANE_REASSEMBLY,0.901588199233717
GSE14308_TH2_VS_TH1_DN,SET,181,0.05276,0.0052126,0.062398,0.19891,GSE14308_TH2_VS_TH1_DN,0.901588199233717
HU_GENOTOXIN_ACTION_DIRECT_V...2,SET,37,0.12025,0.0053927,0.14223,0.19894,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,0.901588199233717
GOBP_TANGENTIAL_MIGRATION_FR...,SET,7,0.28328,0.0055303,0.33512,0.19897,GOBP_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB,0.901588199233717
GOMF_CHEMOATTRACTANT_ACTIVITY,SET,32,0.13368,0.0055759,0.15814,0.19898,GOMF_CHEMOATTRACTANT_ACTIVITY,0.901588199233717
MIR6766_5P,SET,225,0.048809,0.0053701,0.057744,0.19899,MIR6766_5P,0.901588199233717
HP_CNS_HYPOMYELINATION,SET,79,0.075876,0.0049665,0.089769,0.199,HP_CNS_HYPOMYELINATION,0.901588199233717
GOBP_NADPH_REGENERATION,SET,21,0.16085,0.0054368,0.19032,0.19902,GOBP_NADPH_REGENERATION,0.901588199233717
GOMF_CYSTEINE_TYPE_EXOPEPTID...,SET,4,0.35767,0.0052787,0.42324,0.19904,GOMF_CYSTEINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.901588199233717
GSE17721_PAM3CSK4_VS_GADIQUI...14,SET,183,0.052792,0.0052442,0.062469,0.19904,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...565,SET,50,0.10847,0.0056527,0.12836,0.19905,GOBP_POSITIVE_REGULATION_OF_OSSIFICATION,0.901588199233717
HP_SUBMUCOUS_CLEFT_SOFT_PALA...,SET,9,0.23343,0.005167,0.27625,0.19906,HP_SUBMUCOUS_CLEFT_SOFT_PALATE,0.901588199233717
GOBP_FOREBRAIN_NEUROBLAST_DI...,SET,6,0.30852,0.0055764,0.36529,0.19917,GOBP_FOREBRAIN_NEUROBLAST_DIVISION,0.901588199233717
GOBP_METANEPHRIC_S_SHAPED_BO...,SET,5,0.39277,0.0064808,0.46505,0.19918,GOBP_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS,0.901588199233717
GOBP_REGULATION_OF_B_CELL_AP...,SET,18,0.17577,0.0055008,0.20812,0.19919,GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.901588199233717
GSE17721_LPS_VS_POLYIC_0.5H_...2,SET,181,0.051318,0.0050702,0.060768,0.1992,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP,0.901588199233717
HP_IMMUNE_DYSREGULATION,SET,10,0.22005,0.0051342,0.26061,0.19924,HP_IMMUNE_DYSREGULATION,0.901588199233717
ALPHACP1_01,SET,224,0.049911,0.0054792,0.059114,0.19925,ALPHACP1_01,0.901588199233717
WP_AEROBIC_GLYCOLYSIS,SET,10,0.18417,0.0042969,0.21816,0.19929,WP_AEROBIC_GLYCOLYSIS,0.901588199233717
WP_5Q35_COPY_NUMBER_VARIATION,SET,97,0.079786,0.005784,0.094562,0.19941,WP_5Q35_COPY_NUMBER_VARIATION,0.901588199233717
MIR105_5P,SET,198,0.052095,0.0053807,0.061743,0.19941,MIR105_5P,0.901588199233717
HE_LIM_SUN_FETAL_LUNG_C7_MID...,SET,237,0.051055,0.0057631,0.060519,0.19944,HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL,0.901588199233717
GSE2585_CTEC_VS_MTEC_THYMUS_...2,SET,176,0.054261,0.0052871,0.064324,0.19947,GSE2585_CTEC_VS_MTEC_THYMUS_UP,0.901588199233717
BENPORATH_SOX2_TARGETS,SET,663,0.028654,0.0053459,0.03397,0.19948,BENPORATH_SOX2_TARGETS,0.901588199233717
HP_SPHEROPHAKIA,SET,5,0.35328,0.0058291,0.41883,0.19948,HP_SPHEROPHAKIA,0.901588199233717
MIR200A_5P,SET,96,0.072025,0.0051945,0.085405,0.19953,MIR200A_5P,0.901588199233717
GOBP_REGULATION_OF_TRANSFERA...,SET,562,0.030947,0.005331,0.036698,0.19954,GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY,0.901588199233717
DESCARTES_FETAL_ADRENAL_CSH1...,SET,146,0.063539,0.0056435,0.075352,0.19956,DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS,0.901588199233717
HOLLEMAN_VINCRISTINE_RESISTA...2,SET,25,0.13862,0.0051116,0.16441,0.19958,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,0.901588199233717
HE_LIM_SUN_FETAL_LUNG_C3_OMD...,SET,323,0.04308,0.0056635,0.051094,0.19958,HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL,0.901588199233717
GOMF_PYRUVATE_TRANSMEMBRANE_...,SET,5,0.3397,0.0056051,0.40293,0.1996,GOMF_PYRUVATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.901588199233717
KEGG_MEDICUS_VARIANT_MUTATIO...54,SET,14,0.19243,0.0053116,0.22827,0.19962,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.901588199233717
GOBP_ERAD_PATHWAY,SET,104,0.066862,0.005018,0.079335,0.19968,GOBP_ERAD_PATHWAY,0.901588199233717
HP_AXIAL_MUSCLE_WEAKNESS,SET,39,0.11507,0.0052977,0.13654,0.1997,HP_AXIAL_MUSCLE_WEAKNESS,0.901588199233717
GOBP_OVULATION_FROM_OVARIAN_...,SET,9,0.2548,0.00564,0.30239,0.19972,GOBP_OVULATION_FROM_OVARIAN_FOLLICLE,0.901588199233717
HAY_BONE_MARROW_EARLY_ERYTHR...,SET,81,0.079604,0.0052757,0.094483,0.19975,HAY_BONE_MARROW_EARLY_ERYTHROBLAST,0.901588199233717
GOBP_NEURON_PROJECTION_ARBOR...,SET,32,0.121,0.0050473,0.14364,0.19978,GOBP_NEURON_PROJECTION_ARBORIZATION,0.901588199233717
HP_ABNORMAL_PLEURA_MORPHOLOGY,SET,168,0.058053,0.0055277,0.068915,0.19979,HP_ABNORMAL_PLEURA_MORPHOLOGY,0.901588199233717
GSE7509_DC_VS_MONOCYTE_DN,SET,186,0.053179,0.0053253,0.063128,0.19979,GSE7509_DC_VS_MONOCYTE_DN,0.901588199233717
GOBP_FERROPTOSIS,SET,9,0.26164,0.0057913,0.31065,0.19984,GOBP_FERROPTOSIS,0.901588199233717
BUSSLINGER_GASTRIC_G_CELLS,SET,88,0.086234,0.0059558,0.10241,0.19989,BUSSLINGER_GASTRIC_G_CELLS,0.901588199233717
GOBP_RETICULOPHAGY,SET,17,0.16958,0.0051577,0.2014,0.1999,GOBP_RETICULOPHAGY,0.901588199233717
GSE40666_NAIVE_VS_EFFECTOR_C...3,SET,179,0.052255,0.0051344,0.062066,0.19992,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.901588199233717
HP_ABNORMAL_AFFECT,SET,37,0.13198,0.005919,0.15677,0.19993,HP_ABNORMAL_AFFECT,0.901588199233717
GSE12845_NAIVE_VS_DARKZONE_G...2,SET,170,0.056004,0.005364,0.066522,0.19993,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.901588199233717
WP_MONOAMINE_TRANSPORT,SET,30,0.13586,0.0054874,0.16138,0.19994,WP_MONOAMINE_TRANSPORT,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...678,SET,35,0.11537,0.0050322,0.13704,0.19994,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.901588199233717
MIR576_5P,SET,313,0.041921,0.0054267,0.049801,0.19997,MIR576_5P,0.901588199233717
GSE2405_HEAT_KILLED_VS_LIVE_...3,SET,183,0.053246,0.0052893,0.063255,0.19997,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.901588199233717
HP_POSTNATAL_MACROCEPHALY,SET,5,0.28566,0.0047134,0.33946,0.20004,HP_POSTNATAL_MACROCEPHALY,0.901588199233717
NOUSHMEHR_GBM_GERMLINE_MUTAT...,SET,7,0.29071,0.0056753,0.34549,0.20006,NOUSHMEHR_GBM_GERMLINE_MUTATED,0.901588199233717
MIR4671_5P,SET,7,0.27702,0.005408,0.32925,0.20008,MIR4671_5P,0.901588199233717
GOBP_REGULATION_OF_WNT_SIGNA...2,SET,15,0.20297,0.0057991,0.24124,0.20008,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.901588199233717
GOBP_UTP_METABOLIC_PROCESS,SET,11,0.23285,0.0056978,0.27675,0.20008,GOBP_UTP_METABOLIC_PROCESS,0.901588199233717
AMIT_DELAYED_EARLY_GENES,SET,18,0.17936,0.0056133,0.21319,0.20009,AMIT_DELAYED_EARLY_GENES,0.901588199233717
AIZARANI_LIVER_C29_MVECS_2,SET,287,0.046189,0.0057296,0.05491,0.20013,AIZARANI_LIVER_C29_MVECS_2,0.901588199233717
KEGG_MEDICUS_ENV_FACTOR_META...2,SET,9,0.28406,0.0062878,0.33779,0.2002,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY,0.901588199233717
HP_ABNORMAL_BLEEDING,SET,497,0.032513,0.0052765,0.038663,0.2002,HP_ABNORMAL_BLEEDING,0.901588199233717
HOFMANN_MYELODYSPLASTIC_SYND...2,SET,8,0.2613,0.0054532,0.31074,0.20021,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP,0.901588199233717
GOBP_REGULATION_OF_MULTICELL...2,SET,61,0.1016,0.0058465,0.12086,0.20027,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.901588199233717
GOBP_VESICLE_DOCKING_INVOLVE...,SET,35,0.11967,0.0052198,0.14235,0.20028,GOBP_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS,0.901588199233717
GOBP_PROTEIN_O_LINKED_FUCOSY...,SET,4,0.30849,0.0045529,0.36703,0.20032,GOBP_PROTEIN_O_LINKED_FUCOSYLATION,0.901588199233717
HP_ABNORMAL_PORTAL_VENOUS_SY...,SET,13,0.20481,0.0054478,0.2437,0.20035,HP_ABNORMAL_PORTAL_VENOUS_SYSTEM_MORPHOLOGY,0.901588199233717
HP_RETICULOCYTOSIS,SET,41,0.11119,0.0052484,0.13232,0.20038,HP_RETICULOCYTOSIS,0.901588199233717
GOBP_REGULATION_OF_PEROXISOM...,SET,14,0.21879,0.0060392,0.26038,0.20039,GOBP_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.901588199233717
DESCARTES_MAIN_FETAL_SLC26A4...,SET,195,0.048176,0.0049385,0.057349,0.20044,DESCARTES_MAIN_FETAL_SLC26A4_PAEP_POSITIVE_CELLS,0.901588199233717
KEGG_MEDICUS_PATHOGEN_KSHV_V...3,SET,6,0.26028,0.0047044,0.30984,0.20045,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY,0.901588199233717
GOBP_GOLGI_VESICLE_TRANSPORT,SET,281,0.041347,0.0050759,0.049226,0.20047,GOBP_GOLGI_VESICLE_TRANSPORT,0.901588199233717
GOBP_IMMUNE_SYSTEM_DEVELOPME...,SET,181,0.053481,0.0052839,0.063674,0.20048,GOBP_IMMUNE_SYSTEM_DEVELOPMENT,0.901588199233717
GOMF_PROTEIN_ARGININE_N_METH...,SET,12,0.19441,0.0049686,0.23147,0.20049,GOMF_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY,0.901588199233717
GCNP_SHH_UP_LATE.V1_DN,SET,159,0.058032,0.005377,0.069099,0.2005,GCNP_SHH_UP_LATE.V1_DN,0.901588199233717
GNF2_G22P1,SET,31,0.11926,0.0048962,0.142,0.20052,GNF2_G22P1,0.901588199233717
SCHAEFFER_PROSTATE_DEVELOPME...2,SET,102,0.072621,0.0053978,0.086478,0.20053,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,0.901588199233717
GSE46606_UNSTIM_VS_CD40L_IL2...3,SET,171,0.054321,0.0052179,0.064694,0.20056,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.901588199233717
GAUTAM_EYE_IRIS_CILIARY_BODY...10,SET,77,0.089189,0.0057638,0.10622,0.20056,GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS,0.901588199233717
HP_IMPAIRED_SMOOTH_PURSUIT,SET,38,0.11153,0.0050689,0.13284,0.20057,HP_IMPAIRED_SMOOTH_PURSUIT,0.901588199233717
HP_PERSISTENT_BLEEDING_AFTER...,SET,12,0.22707,0.0058032,0.27052,0.20063,HP_PERSISTENT_BLEEDING_AFTER_TRAUMA,0.901588199233717
HP_ABNORMALITY_OF_THE_MIDDLE...4,SET,12,0.21853,0.005585,0.26036,0.20065,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.901588199233717
GOMF_LACTATE_TRANSMEMBRANE_T...,SET,6,0.33337,0.0060256,0.39729,0.2007,GOMF_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.901588199233717
WP_VITAMIN_D_IN_INFLAMMATORY...,SET,20,0.16108,0.0053135,0.19196,0.20071,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,0.901588199233717
GOBP_PIGMENT_ACCUMULATION,SET,11,0.22832,0.005587,0.2721,0.20071,GOBP_PIGMENT_ACCUMULATION,0.901588199233717
DESCARTES_FETAL_MUSCLE_SKELE...,SET,181,0.054258,0.0053606,0.064667,0.20073,DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS,0.901588199233717
GOMF_PROTEIN_KINASE_ACTIVITY,SET,534,0.031461,0.0052869,0.037499,0.20074,GOMF_PROTEIN_KINASE_ACTIVITY,0.901588199233717
GOBP_REGULATION_OF_PROTEIN_M...3,SET,5,0.32198,0.0053128,0.38378,0.20075,GOBP_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...65,SET,32,0.13896,0.0057962,0.16568,0.20083,GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.901588199233717
GAVISH_3CA_MALIGNANT_METAPRO...18,SET,45,0.11507,0.0056897,0.13721,0.20084,GAVISH_3CA_MALIGNANT_METAPROGRAM_27_OLIGO_PROGENITOR,0.901588199233717
GOMF_OXIDOREDUCTASE_ACTIVITY...1,SET,11,0.19206,0.0046997,0.22905,0.20087,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS,0.901588199233717
MODULE_38,SET,422,0.036702,0.0054999,0.04377,0.20088,MODULE_38,0.901588199233717
MATTHEWS_AP1_TARGETS,SET,16,0.19806,0.0058443,0.23625,0.20092,MATTHEWS_AP1_TARGETS,0.901588199233717
GOBP_REGULATION_OF_CELL_PROJ...2,SET,613,0.030065,0.0054011,0.035863,0.20093,GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.901588199233717
GSE17974_CTRL_VS_ACT_IL4_AND...8,SET,167,0.057226,0.0054329,0.068263,0.20093,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP,0.901588199233717
MIR7156_5P,SET,126,0.06597,0.0054463,0.078705,0.20097,MIR7156_5P,0.901588199233717
MANNO_MIDBRAIN_NEUROTYPES_HN...4,SET,413,0.038375,0.0056904,0.045786,0.20098,MANNO_MIDBRAIN_NEUROTYPES_HNBML5,0.901588199233717
LEE_LIVER_CANCER_E2F1_UP,SET,60,0.10613,0.006057,0.12664,0.20102,LEE_LIVER_CANCER_E2F1_UP,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...442,SET,5,0.30159,0.0049764,0.36001,0.2011,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.901588199233717
GSE13411_NAIVE_VS_SWITCHED_M...2,SET,174,0.055254,0.0053534,0.065958,0.2011,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP,0.901588199233717
TGFB_UP.V1_UP,SET,176,0.058967,0.0057456,0.070397,0.20112,TGFB_UP.V1_UP,0.901588199233717
GOBP_RESPONSE_TO_ENDOGENOUS_...,SET,1522,0.01989,0.0054841,0.023749,0.20117,GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS,0.901588199233717
HP_ABNORMAL_ERYTHROCYTE_SEDI...,SET,57,0.10313,0.0057372,0.12314,0.20117,HP_ABNORMAL_ERYTHROCYTE_SEDIMENTATION_RATE,0.901588199233717
GSE5589_LPS_AND_IL10_VS_LPS_...1,SET,177,0.053699,0.005247,0.064122,0.20118,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.901588199233717
WP_FGF23_SIGNALING_IN_HYPOPH...,SET,22,0.16454,0.0056924,0.19649,0.20119,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,0.901588199233717
HP_INCREASED_CIRCULATING_INT...3,SET,11,0.22632,0.0055381,0.27029,0.20121,HP_INCREASED_CIRCULATING_INTERLEUKIN_6_CONCENTRATION,0.901588199233717
BIOCARTA_MPR_PATHWAY,SET,21,0.16041,0.0054219,0.19164,0.20129,BIOCARTA_MPR_PATHWAY,0.901588199233717
ZHU_CMV_ALL_UP,SET,102,0.06997,0.0052008,0.083618,0.20136,ZHU_CMV_ALL_UP,0.901588199233717
GSE12392_CD8A_POS_VS_NEG_SPL...4,SET,188,0.049929,0.0050265,0.059667,0.20136,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP,0.901588199233717
GSE27291_6H_VS_7D_STIM_GAMMA...1,SET,156,0.058673,0.0053853,0.070116,0.20136,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.901588199233717
WP_CANCER_IMMUNOTHERAPY_BY_P...,SET,22,0.16287,0.0056346,0.19465,0.20137,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,0.901588199233717
GSE2770_UNTREATED_VS_IL12_TR...6,SET,177,0.054077,0.005284,0.064633,0.20139,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.901588199233717
NAKAYA_PBMC_FLUARIX_FLUVIRIN...4,SET,489,0.031144,0.0050145,0.037223,0.20139,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.901588199233717
GSE9037_WT_VS_IRAK4_KO_LPS_4...1,SET,187,0.053155,0.0053371,0.063534,0.2014,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN,0.901588199233717
REACTOME_PHOSPHOLIPASE_C_MED...1,SET,16,0.19603,0.0057843,0.23433,0.20143,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1,0.901588199233717
MIR6827_3P,SET,72,0.08397,0.0052481,0.10038,0.20143,MIR6827_3P,0.901588199233717
GOMF_HISTONE_H3K36_TRIMETHYL...,SET,4,0.31557,0.0046573,0.37722,0.20143,GOMF_HISTONE_H3K36_TRIMETHYLTRANSFERASE_ACTIVITY,0.901588199233717
SAKAI_CHRONIC_HEPATITIS_VS_L...2,SET,79,0.074077,0.0048487,0.088561,0.20145,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,0.901588199233717
HP_SPINAL_CORD_TUMOR,SET,9,0.24406,0.0054023,0.29195,0.20159,HP_SPINAL_CORD_TUMOR,0.901588199233717
MIR222_5P,SET,174,0.05312,0.0051467,0.063544,0.2016,MIR222_5P,0.901588199233717
HOUSTIS_ROS,SET,34,0.13408,0.0057647,0.16042,0.20163,HOUSTIS_ROS,0.901588199233717
YYCATTCAWW_UNKNOWN,SET,177,0.053895,0.0052662,0.064481,0.20163,YYCATTCAWW_UNKNOWN,0.901588199233717
GSE10239_NAIVE_VS_MEMORY_CD8...1,SET,181,0.05152,0.0050901,0.061647,0.20166,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.901588199233717
BYSTRYKH_HEMATOPOIESIS_STEM_...4,SET,8,0.22542,0.0047044,0.26975,0.20168,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1,0.901588199233717
chr7q21,SET,73,0.15188,0.0095579,0.18177,0.20171,chr7q21,0.901588199233717
HP_PROXIMAL_FEMORAL_EPIPHYSI...,SET,7,0.24588,0.0048,0.29431,0.20174,HP_PROXIMAL_FEMORAL_EPIPHYSIOLYSIS,0.901588199233717
KEGG_COMPLEMENT_AND_COAGULAT...,SET,61,0.10381,0.0059735,0.12428,0.2018,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,0.901588199233717
GOBP_REGULATION_OF_CELL_CYCL...5,SET,665,0.027609,0.0051583,0.033056,0.20181,GOBP_REGULATION_OF_CELL_CYCLE_PROCESS,0.901588199233717
GOMF_METALLOENDOPEPTIDASE_AC...,SET,102,0.074671,0.0055501,0.089408,0.20182,GOMF_METALLOENDOPEPTIDASE_ACTIVITY,0.901588199233717
MIR7114_5P,SET,136,0.063021,0.0054039,0.075465,0.20183,MIR7114_5P,0.901588199233717
GOBP_OLFACTORY_BULB_INTERNEU...1,SET,7,0.30866,0.0060256,0.36963,0.20185,GOBP_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT,0.901588199233717
MIR4258,SET,5,0.39281,0.0064815,0.47046,0.20188,MIR4258,0.901588199233717
BIOCARTA_NOS1_PATHWAY,SET,21,0.15937,0.0053869,0.19089,0.20189,BIOCARTA_NOS1_PATHWAY,0.901588199233717
GSE411_UNSTIM_VS_100MIN_IL6_...2,SET,185,0.053473,0.0053405,0.064052,0.20191,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP,0.901588199233717
DAZARD_RESPONSE_TO_UV_NHEK_DN,SET,283,0.042994,0.0052965,0.051502,0.20192,DAZARD_RESPONSE_TO_UV_NHEK_DN,0.901588199233717
GSE39864_WT_VS_GATA3_KO_TREG...1,SET,178,0.051486,0.0050448,0.061674,0.20192,GSE39864_WT_VS_GATA3_KO_TREG_DN,0.901588199233717
GOBP_EPIGENETIC_PROGRAMMING_...2,SET,28,0.13181,0.0051434,0.15793,0.20198,GOBP_EPIGENETIC_PROGRAMMING_OF_GENE_EXPRESSION,0.901588199233717
AGGTGCA_MIR500,SET,82,0.080097,0.0053409,0.095973,0.20199,AGGTGCA_MIR500,0.901588199233717
BIOCARTA_PPARA_PATHWAY,SET,52,0.10246,0.0054449,0.12277,0.202,BIOCARTA_PPARA_PATHWAY,0.901588199233717
MIR6873_3P,SET,340,0.040731,0.0054912,0.04881,0.20201,MIR6873_3P,0.901588199233717
HP_APLASIA_HYPOPLASIA_OF_THE...13,SET,18,0.18638,0.0058329,0.22345,0.20212,HP_APLASIA_HYPOPLASIA_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.901588199233717
POU3F2_02,SET,227,0.0483,0.0053373,0.057928,0.20221,POU3F2_02,0.901588199233717
GOBP_DETECTION_OF_VISIBLE_LI...,SET,43,0.10902,0.0052698,0.13075,0.20221,GOBP_DETECTION_OF_VISIBLE_LIGHT,0.901588199233717
GSE3691_IFN_PRODUCING_KILLER...3,SET,176,0.052337,0.0050996,0.06278,0.20224,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN,0.901588199233717
GSE36476_CTRL_VS_TSST_ACT_16...3,SET,185,0.051396,0.0051331,0.061652,0.20225,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN,0.901588199233717
REACTOME_PROCESSING_OF_CAPPE...2,SET,255,0.040099,0.0046928,0.048107,0.20228,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,0.901588199233717
HP_PRURITIS_ON_HAND,SET,5,0.33251,0.0054865,0.39891,0.20228,HP_PRURITIS_ON_HAND,0.901588199233717
HARALAMBIEVA_PBMC_M_M_R_II_A...1,SET,639,0.030358,0.0055642,0.036425,0.2023,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...760,SET,8,0.24594,0.0051326,0.2951,0.20232,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.901588199233717
BURTON_ADIPOGENESIS_PEAK_AT_...1,SET,59,0.095114,0.0053832,0.11414,0.20233,BURTON_ADIPOGENESIS_PEAK_AT_0HR,0.901588199233717
SANSOM_APC_TARGETS_UP,SET,120,0.06678,0.0053812,0.080135,0.20233,SANSOM_APC_TARGETS_UP,0.901588199233717
GOMF_TELETHONIN_BINDING,SET,7,0.30378,0.0059304,0.36455,0.20234,GOMF_TELETHONIN_BINDING,0.901588199233717
GOMF_ANTIOXIDANT_ACTIVITY,SET,72,0.087022,0.0054388,0.10444,0.20236,GOMF_ANTIOXIDANT_ACTIVITY,0.901588199233717
MIR1298_5P,SET,40,0.1058,0.0049328,0.12698,0.20237,MIR1298_5P,0.901588199233717
HP_ULNAR_CLAW,SET,9,0.26169,0.0057924,0.31407,0.20237,HP_ULNAR_CLAW,0.901588199233717
HP_ACANTHOSIS_NIGRICANS,SET,57,0.10001,0.0055635,0.12007,0.20245,HP_ACANTHOSIS_NIGRICANS,0.901588199233717
MODULE_164,SET,58,0.10063,0.0056472,0.12083,0.20247,MODULE_164,0.901588199233717
SRY_02,SET,229,0.050218,0.0055734,0.060305,0.2025,SRY_02,0.901588199233717
GOBP_CERAMIDE_TRANSPORT,SET,15,0.18819,0.0053769,0.226,0.20251,GOBP_CERAMIDE_TRANSPORT,0.901588199233717
MIR4267,SET,203,0.049104,0.0051347,0.058971,0.20252,MIR4267,0.901588199233717
MIR888_3P,SET,105,0.069334,0.0052283,0.08328,0.20256,MIR888_3P,0.901588199233717
MIR5688,SET,714,0.027688,0.005353,0.033259,0.20257,MIR5688,0.901588199233717
GSE7219_UNSTIM_VS_LPS_AND_AN...3,SET,185,0.054076,0.0054007,0.064957,0.20257,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN,0.901588199233717
GSE360_L_MAJOR_VS_B_MALAYI_H...4,SET,181,0.054051,0.0053401,0.064929,0.20258,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.901588199233717
KEGG_PRIMARY_IMMUNODEFICIENCY,SET,30,0.14327,0.0057866,0.17212,0.2026,KEGG_PRIMARY_IMMUNODEFICIENCY,0.901588199233717
GOMF_THIOREDOXIN_DISULFIDE_R...,SET,6,0.28428,0.0051382,0.34157,0.20264,GOMF_THIOREDOXIN_DISULFIDE_REDUCTASE_NADPH_ACTIVITY,0.901588199233717
REACTOME_MISCELLANEOUS_SUBST...,SET,12,0.22334,0.005708,0.26841,0.20268,REACTOME_MISCELLANEOUS_SUBSTRATES,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...510,SET,14,0.19301,0.0053278,0.23198,0.2027,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION,0.901588199233717
HP_NARROW_PALPEBRAL_FISSURE,SET,59,0.089686,0.0050759,0.10779,0.2027,HP_NARROW_PALPEBRAL_FISSURE,0.901588199233717
GOBP_POSITIVE_REGULATION_OF_...493,SET,29,0.11733,0.0046595,0.14104,0.20273,GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING,0.901588199233717
WP_ANDROGEN_RECEPTOR_NETWORK...,SET,106,0.069676,0.0052789,0.083794,0.20285,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,0.901588199233717
KEGG_MEDICUS_REFERENCE_HOMOL...1,SET,31,0.11316,0.0046458,0.13611,0.2029,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION,0.901588199233717
GOBP_NEURAL_CREST_CELL_FATE_...,SET,6,0.34289,0.0061976,0.41251,0.20293,GOBP_NEURAL_CREST_CELL_FATE_COMMITMENT,0.901588199233717
HP_PATCHY_CHANGES_OF_BONE_MI...,SET,5,0.33907,0.0055948,0.40793,0.20293,HP_PATCHY_CHANGES_OF_BONE_MINERAL_DENSITY,0.901588199233717
GOBP_PROPRIOCEPTION,SET,4,0.40572,0.0059879,0.48815,0.20295,GOBP_PROPRIOCEPTION,0.901588199233717
BROWNE_HCMV_INFECTION_24HR_UP,SET,134,0.061635,0.0052463,0.074162,0.20297,BROWNE_HCMV_INFECTION_24HR_UP,0.901588199233717
WP_HIF1A_AND_PPARG_REGULATIO...,SET,6,0.3161,0.0057134,0.38038,0.20299,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,0.901588199233717
chr4q23,SET,18,0.29357,0.0091875,0.35332,0.20303,chr4q23,0.901588199233717
REACTOME_CYTOPROTECTION_BY_H...,SET,51,0.095146,0.0050076,0.11451,0.20303,REACTOME_CYTOPROTECTION_BY_HMOX1,0.901588199233717
DAVIES_MULTIPLE_MYELOMA_VS_M...2,SET,12,0.18193,0.0046497,0.21899,0.20306,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP,0.901588199233717
HP_ABNORMAL_LUNG_LOBATION,SET,37,0.12437,0.0055777,0.14972,0.20307,HP_ABNORMAL_LUNG_LOBATION,0.901588199233717
HP_MULTIPLE_GLOMERULAR_CYSTS,SET,3,0.43733,0.0055898,0.52644,0.20307,HP_MULTIPLE_GLOMERULAR_CYSTS,0.901588199233717
HP_PAST_MEDICAL_HISTORY,SET,156,0.05865,0.0053832,0.0706,0.20307,HP_PAST_MEDICAL_HISTORY,0.901588199233717
HP_INCREASED_C_PEPTIDE_LEVEL,SET,13,0.21871,0.0058176,0.26331,0.2031,HP_INCREASED_C_PEPTIDE_LEVEL,0.901588199233717
HP_STARING_GAZE,SET,20,0.1495,0.0049317,0.17999,0.2031,HP_STARING_GAZE,0.901588199233717
MIR548AR_5P,SET,449,0.034165,0.0052771,0.041134,0.20311,MIR548AR_5P,0.901588199233717
GOMF_SMALL_RIBOSOMAL_SUBUNIT...,SET,7,0.25902,0.0050566,0.31186,0.20312,GOMF_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.901588199233717
REACTOME_TRANSPORT_OF_FATTY_...,SET,8,0.24412,0.0050947,0.29397,0.20315,REACTOME_TRANSPORT_OF_FATTY_ACIDS,0.901601154822335
GSE9946_MATURE_STIMULATORY_V...4,SET,120,0.064383,0.005188,0.077559,0.20324,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.901601154822335
GSE411_UNSTIM_VS_100MIN_IL6_...1,SET,186,0.049817,0.0049887,0.060014,0.20325,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN,0.901601154822335
GSE1448_ANTI_VALPHA2_VS_VBET...1,SET,177,0.054905,0.0053648,0.066146,0.20326,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN,0.901601154822335
GOBP_LAMELLIPODIUM_ASSEMBLY,SET,61,0.095384,0.0054888,0.11493,0.2033,GOBP_LAMELLIPODIUM_ASSEMBLY,0.901601154822335
HP_INCREASED_TOTAL_BILIRUBIN,SET,14,0.17637,0.0048684,0.21251,0.2033,HP_INCREASED_TOTAL_BILIRUBIN,0.901601154822335
GSE20366_TREG_VS_NAIVE_CD4_T...6,SET,181,0.054051,0.0053402,0.065145,0.20336,GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP,0.901601154822335
UDAYAKUMAR_MED1_TARGETS_DN,SET,212,0.048647,0.0051972,0.058638,0.20338,UDAYAKUMAR_MED1_TARGETS_DN,0.901601154822335
MIR1468_3P,SET,589,0.030123,0.0053081,0.036324,0.20348,MIR1468_3P,0.901601154822335
BOYAULT_LIVER_CANCER_SUBCLAS...12,SET,15,0.19783,0.0056522,0.23857,0.20349,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,0.901601154822335
WP_DEVELOPMENT_OF_PULMONARY_...,SET,13,0.19954,0.0053079,0.24065,0.2035,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,0.901601154822335
GOMF_3_5_DNA_EXONUCLEASE_ACT...,SET,13,0.18477,0.0049149,0.22283,0.2035,GOMF_3_5_DNA_EXONUCLEASE_ACTIVITY,0.901601154822335
GOMF_INTEGRIN_BINDING_INVOLV...,SET,5,0.34186,0.0056408,0.41228,0.2035,GOMF_INTEGRIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,0.901601154822335
GOCC_NUCLEOTIDE_ACTIVATED_PR...,SET,10,0.21152,0.0049351,0.25513,0.20354,GOCC_NUCLEOTIDE_ACTIVATED_PROTEIN_KINASE_COMPLEX,0.901601154822335
HP_ENCEPHALOCELE,SET,110,0.066426,0.0051262,0.080124,0.20355,HP_ENCEPHALOCELE,0.901601154822335
GOBP_POSITIVE_REGULATION_OF_...595,SET,12,0.23654,0.0060454,0.28548,0.20367,GOBP_POSITIVE_REGULATION_OF_PLATELET_AGGREGATION,0.901601154822335
GOBP_GLYCEROPHOSPHOLIPID_MET...,SET,276,0.042415,0.0051611,0.051193,0.20369,GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS,0.901601154822335
GOBP_TRANSLATIONAL_TERMINATI...,SET,13,0.20021,0.0053257,0.24165,0.20369,GOBP_TRANSLATIONAL_TERMINATION,0.901601154822335
LEE_METASTASIS_AND_ALTERNATI...1,SET,44,0.1084,0.0053003,0.13084,0.2037,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,0.901601154822335
GOBP_NUCLEOSIDE_BISPHOSPHATE...2,SET,11,0.21426,0.0052429,0.25862,0.2037,GOBP_NUCLEOSIDE_BISPHOSPHATE_CATABOLIC_PROCESS,0.901601154822335
GOBP_NEGATIVE_REGULATION_OF_...472,SET,31,0.14158,0.0058129,0.17093,0.20376,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.901601154822335
GOBP_PROTEIN_MODIFICATION_BY...1,SET,744,0.025501,0.0050284,0.030795,0.20381,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION,0.901601154822335
GOMF_SPHINGOSINE_1_PHOSPHATE...1,SET,2,0.47373,0.0049441,0.57213,0.20384,GOMF_SPHINGOSINE_1_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.901601154822335
GOMF_PHOSPHOPROTEIN_BINDING,SET,86,0.075734,0.0051711,0.091475,0.20386,GOMF_PHOSPHOPROTEIN_BINDING,0.901601154822335
MODULE_244,SET,172,0.051141,0.0049266,0.0618,0.20398,MODULE_244,0.901601154822335
USF_C,SET,262,0.044355,0.0052606,0.053604,0.20399,USF_C,0.901601154822335
REACTOME_UNFOLDED_PROTEIN_RE...,SET,87,0.070382,0.0048334,0.085081,0.20406,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,0.901601154822335
BIOCARTA_RARRXR_PATHWAY,SET,7,0.2424,0.0047323,0.29304,0.20407,BIOCARTA_RARRXR_PATHWAY,0.901601154822335
MIR1976,SET,79,0.078679,0.0051499,0.095118,0.20407,MIR1976,0.901601154822335
HNF3_Q6,SET,165,0.058038,0.0054771,0.070161,0.20407,HNF3_Q6,0.901601154822335
PID_P38_MKK3_6PATHWAY,SET,26,0.13077,0.0049177,0.15814,0.20413,PID_P38_MKK3_6PATHWAY,0.901601154822335
GOBP_MESODERMAL_CELL_MIGRATI...,SET,5,0.34022,0.0056137,0.4114,0.20413,GOBP_MESODERMAL_CELL_MIGRATION,0.901601154822335
GSE38697_LIGHT_ZONE_VS_DARK_...1,SET,113,0.069272,0.0054178,0.083781,0.20417,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.901601154822335
GSE45365_WT_VS_IFNAR_KO_BCEL...1,SET,149,0.058662,0.0052632,0.070947,0.20417,GSE45365_WT_VS_IFNAR_KO_BCELL_DN,0.901601154822335
KEGG_ENDOCYTOSIS,SET,174,0.054033,0.0052352,0.065355,0.20419,KEGG_ENDOCYTOSIS,0.901601154822335
MIR556_5P,SET,39,0.1119,0.0051518,0.13535,0.20419,MIR556_5P,0.901601154822335
REACTOME_INNATE_IMMUNE_SYSTEM,SET,961,0.023739,0.005287,0.028718,0.20424,REACTOME_INNATE_IMMUNE_SYSTEM,0.901601154822335
GOBP_PARTURITION,SET,14,0.18723,0.0051681,0.22653,0.20427,GOBP_PARTURITION,0.901601154822335
GOMF_GAMMA_TUBULIN_BINDING,SET,28,0.13525,0.0052777,0.16365,0.20428,GOMF_GAMMA_TUBULIN_BINDING,0.901601154822335
REACTOME_REGULATION_OF_GLUCO...,SET,30,0.12277,0.0049586,0.14855,0.20429,REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,0.901601154822335
HP_ABNORMAL_LARYNX_PHYSIOLOGY,SET,43,0.10906,0.0052718,0.13197,0.20429,HP_ABNORMAL_LARYNX_PHYSIOLOGY,0.901601154822335
GOCC_DYNACTIN_COMPLEX,SET,8,0.21773,0.0045439,0.26348,0.20431,GOCC_DYNACTIN_COMPLEX,0.901601154822335
GOBP_RNA_POLYMERASE_I_PREINI...,SET,9,0.2248,0.0049758,0.27205,0.20432,GOBP_RNA_POLYMERASE_I_PREINITIATION_COMPLEX_ASSEMBLY,0.901601154822335
GOBP_TRANSCRIPTION_INITIATIO...3,SET,9,0.2248,0.0049758,0.27205,0.20432,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_I_PROMOTER,0.901601154822335
GOBP_REGULATION_OF_WNT_SIGNA...1,SET,301,0.043259,0.0054933,0.052355,0.20433,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.901601154822335
GOBP_GTP_BIOSYNTHETIC_PROCESS,SET,10,0.22451,0.0052381,0.27173,0.20434,GOBP_GTP_BIOSYNTHETIC_PROCESS,0.901601154822335
GOCC_DENDRITIC_GROWTH_CONE,SET,7,0.243,0.004744,0.29417,0.20439,GOCC_DENDRITIC_GROWTH_CONE,0.901601154822335
HP_PENDULAR_NYSTAGMUS,SET,37,0.11675,0.0052356,0.14134,0.20441,HP_PENDULAR_NYSTAGMUS,0.901601154822335
ENK_UV_RESPONSE_EPIDERMIS_DN,SET,481,0.03361,0.0053684,0.040692,0.20442,ENK_UV_RESPONSE_EPIDERMIS_DN,0.901601154822335
HP_MEDULLOBLASTOMA,SET,18,0.1702,0.0053267,0.20607,0.20442,HP_MEDULLOBLASTOMA,0.901601154822335
REACTOME_SELECTIVE_AUTOPHAGY,SET,80,0.080369,0.0052936,0.097327,0.20448,REACTOME_SELECTIVE_AUTOPHAGY,0.901751351351351
KEGG_MEDICUS_VARIANT_MUTATIO...69,SET,6,0.33157,0.005993,0.40162,0.20453,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.901760882800609
GOMF_VINCULIN_BINDING,SET,11,0.22707,0.0055564,0.27507,0.20455,GOMF_VINCULIN_BINDING,0.901760882800609
WYAAANNRNNNGCG_UNKNOWN,SET,62,0.091152,0.005288,0.11043,0.20456,WYAAANNRNNNGCG_UNKNOWN,0.901760882800609
GOMF_HYDROLASE_ACTIVITY_ACTI...9,SET,121,0.067645,0.0054734,0.081961,0.20459,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS,0.901778401727862
GOBP_REGULATION_OF_MRNA_3_EN...,SET,9,0.21787,0.0048225,0.26404,0.20465,GOBP_REGULATION_OF_MRNA_3_END_PROCESSING,0.901778401727862
WENG_POR_TARGETS_GLOBAL_DN,SET,23,0.15187,0.005372,0.18411,0.20471,WENG_POR_TARGETS_GLOBAL_DN,0.901778401727862
KEGG_MEDICUS_REFERENCE_HYDRO...,SET,8,0.23797,0.0049664,0.28849,0.20472,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN,0.901778401727862
GSE13738_TCR_VS_BYSTANDER_AC...1,SET,169,0.054538,0.0052083,0.066124,0.20475,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.901778401727862
GSE15330_MEGAKARYOCYTE_ERYTH...3,SET,180,0.053101,0.005232,0.064384,0.20476,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.901778401727862
GOBP_REGULATION_OF_MAST_CELL...3,SET,7,0.26191,0.0051131,0.31766,0.20483,GOBP_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.901778401727862
GOBP_GLUTAMATE_SECRETION_NEU...,SET,8,0.27354,0.0057087,0.3318,0.20486,GOBP_GLUTAMATE_SECRETION_NEUROTRANSMISSION,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...578,SET,7,0.29307,0.0057214,0.35557,0.20491,GOBP_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.901778401727862
WP_AMYOTROPHIC_LATERAL_SCLER...,SET,36,0.11174,0.0049431,0.13561,0.20498,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.901778401727862
BIOCARTA_CFTR_PATHWAY,SET,10,0.24554,0.0057288,0.29802,0.205,BIOCARTA_CFTR_PATHWAY,0.901778401727862
MIR493_3P,SET,61,0.085459,0.0049177,0.10376,0.20509,MIR493_3P,0.901778401727862
SABATES_COLORECTAL_ADENOMA_S...2,SET,15,0.17614,0.0050326,0.21391,0.20514,SABATES_COLORECTAL_ADENOMA_SIZE_UP,0.901778401727862
ABE_VEGFA_TARGETS_30MIN,SET,25,0.14498,0.0053461,0.17607,0.20515,ABE_VEGFA_TARGETS_30MIN,0.901778401727862
MODULE_184,SET,28,0.12456,0.0048605,0.15127,0.20515,MODULE_184,0.901778401727862
HAN_SATB1_TARGETS_UP,SET,387,0.037497,0.0053863,0.04556,0.20525,HAN_SATB1_TARGETS_UP,0.901778401727862
STAT1_02,SET,233,0.045624,0.005107,0.055452,0.20532,STAT1_02,0.901778401727862
REACTOME_MUSCARINIC_ACETYLCH...,SET,5,0.30716,0.0050682,0.37335,0.20534,REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS,0.901778401727862
GOBP_CELLULAR_RESPONSE_TO_RA...,SET,161,0.052835,0.0049259,0.064229,0.20537,GOBP_CELLULAR_RESPONSE_TO_RADIATION,0.901778401727862
HP_CERVICAL_C2_C3_VERTEBRAL_...,SET,11,0.21182,0.0051832,0.25757,0.20544,HP_CERVICAL_C2_C3_VERTEBRAL_FUSION,0.901778401727862
REACTOME_CLEC7A_INFLAMMASOME...,SET,5,0.32334,0.0053353,0.39321,0.20546,REACTOME_CLEC7A_INFLAMMASOME_PATHWAY,0.901778401727862
HP_INCREASED_CIRCULATING_IRO...,SET,11,0.21567,0.0052775,0.26229,0.20547,HP_INCREASED_CIRCULATING_IRON_CONCENTRATION,0.901778401727862
GOBP_ACTIN_MYOSIN_FILAMENT_S...,SET,15,0.18566,0.0053046,0.22589,0.20557,GOBP_ACTIN_MYOSIN_FILAMENT_SLIDING,0.901778401727862
GOBP_TRANSDIFFERENTIATION,SET,7,0.29849,0.0058272,0.36319,0.20558,GOBP_TRANSDIFFERENTIATION,0.901778401727862
WP_HIPPOYAP_SIGNALING,SET,22,0.15081,0.0052174,0.1835,0.20559,WP_HIPPOYAP_SIGNALING,0.901778401727862
GOBP_PHOSPHATIDYLETHANOLAMIN...3,SET,23,0.14554,0.0051479,0.17711,0.20562,GOBP_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.901778401727862
MODULE_213,SET,74,0.085925,0.0054441,0.10459,0.20567,MODULE_213,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...230,SET,17,0.15461,0.0047025,0.18821,0.20568,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.901778401727862
GOBP_T_HELPER_17_TYPE_IMMUNE...,SET,45,0.11248,0.0055618,0.13692,0.20568,GOBP_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.901778401727862
GOBP_REGULATION_OF_SKELETAL_...12,SET,7,0.26858,0.0052433,0.32697,0.20571,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.901778401727862
NAKAJIMA_EOSINOPHIL,SET,22,0.17148,0.0059325,0.2088,0.20575,NAKAJIMA_EOSINOPHIL,0.901778401727862
GSE21063_3H_VS_16H_ANTI_IGM_...1,SET,168,0.049783,0.0047402,0.060619,0.20576,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN,0.901778401727862
HP_ABNORMALITY_OF_HEPATOBILI...,SET,181,0.050191,0.0049588,0.061119,0.20577,HP_ABNORMALITY_OF_HEPATOBILIARY_SYSTEM_PHYSIOLOGY,0.901778401727862
GSE11864_CSF1_IFNG_VS_CSF1_P...1,SET,161,0.055287,0.0051545,0.067324,0.20577,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN,0.901778401727862
HP_SNORING,SET,6,0.28885,0.0052209,0.35192,0.20589,HP_SNORING,0.901778401727862
GSE16522_MEMORY_VS_NAIVE_CD8...2,SET,170,0.051393,0.0049224,0.062618,0.2059,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.901778401727862
GOMF_ALPHA_CATENIN_BINDING,SET,10,0.23695,0.0055283,0.28871,0.20592,GOMF_ALPHA_CATENIN_BINDING,0.901778401727862
ZNF169_TARGET_GENES,SET,35,0.10941,0.0047722,0.13332,0.20594,ZNF169_TARGET_GENES,0.901778401727862
DESCARTES_FETAL_MUSCLE_LYMPH...2,SET,96,0.070485,0.0050834,0.085919,0.20601,DESCARTES_FETAL_MUSCLE_LYMPHOID_CELLS,0.901778401727862
GOBERT_CORE_OLIGODENDROCYTE_...,SET,40,0.11758,0.0054822,0.14335,0.20605,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,0.901778401727862
GSE15930_STIM_VS_STIM_AND_TR...1,SET,177,0.050729,0.0049568,0.061847,0.20605,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN,0.901778401727862
GSE3982_EOSINOPHIL_VS_CENT_M...2,SET,180,0.05271,0.0051934,0.06427,0.20608,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.901778401727862
RTTTNNNYTGGM_UNKNOWN,SET,141,0.063349,0.0055302,0.07725,0.2061,RTTTNNNYTGGM_UNKNOWN,0.901778401727862
HP_CHRONIC_HEPATIC_FAILURE,SET,14,0.1809,0.0049934,0.2206,0.20611,HP_CHRONIC_HEPATIC_FAILURE,0.901778401727862
GOBP_REGULATION_OF_PHOSPHOLI...7,SET,27,0.12618,0.0048354,0.15389,0.20613,GOBP_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.901778401727862
GOBP_CAMP_METABOLIC_PROCESS,SET,23,0.15776,0.0055802,0.19241,0.20614,GOBP_CAMP_METABOLIC_PROCESS,0.901778401727862
GSE21670_TGFB_VS_TGFB_AND_IL...1,SET,175,0.050688,0.004925,0.061832,0.20618,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.901778401727862
GOBP_ENDONUCLEOLYTIC_CLEAVAG...2,SET,9,0.23029,0.0050976,0.28097,0.20621,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_ITS1_TO_SEPARATE_SSU_RRNA_FROM_5_8S_RRNA_AND_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.901778401727862
HP_LYMPHANGIOMA,SET,11,0.23614,0.0057784,0.28822,0.20631,HP_LYMPHANGIOMA,0.901778401727862
GOBP_MICROTUBULE_SEVERING,SET,9,0.21024,0.0046536,0.25667,0.20637,GOBP_MICROTUBULE_SEVERING,0.901778401727862
GOMF_CATALYTIC_ACTIVITY_ACTI...6,SET,341,0.03528,0.0047632,0.043075,0.20639,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA,0.901778401727862
GOMF_CALCITONIN_FAMILY_RECEP...,SET,6,0.30828,0.005572,0.37642,0.20641,GOMF_CALCITONIN_FAMILY_RECEPTOR_ACTIVITY,0.901778401727862
HP_TESTICULAR_ADRENAL_REST_T...,SET,8,0.26469,0.005524,0.32321,0.20641,HP_TESTICULAR_ADRENAL_REST_TUMOR,0.901778401727862
MIR3126_3P,SET,43,0.10773,0.0052075,0.13156,0.20643,MIR3126_3P,0.901778401727862
GOBP_REGULATION_OF_PROTEIN_D...2,SET,69,0.082395,0.0050416,0.10063,0.20645,GOBP_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.901778401727862
HP_ABNORMAL_MAGNESIUM_CONCEN...,SET,31,0.13642,0.0056007,0.16661,0.20647,HP_ABNORMAL_MAGNESIUM_CONCENTRATION,0.901778401727862
GSE29618_PRE_VS_DAY7_FLU_VAC...1,SET,175,0.050416,0.0048986,0.061581,0.20649,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN,0.901778401727862
GOBP_SNRNA_MODIFICATION,SET,6,0.24365,0.0044039,0.29765,0.20652,GOBP_SNRNA_MODIFICATION,0.901778401727862
REACTOME_REPRODUCTION,SET,93,0.069518,0.0049351,0.084934,0.20655,REACTOME_REPRODUCTION,0.901778401727862
GOBP_ER_OVERLOAD_RESPONSE,SET,10,0.26372,0.006153,0.32221,0.20655,GOBP_ER_OVERLOAD_RESPONSE,0.901778401727862
HP_PERIVENTRICULAR_HETEROTOP...,SET,37,0.10667,0.0047836,0.13033,0.20657,HP_PERIVENTRICULAR_HETEROTOPIA,0.901778401727862
GOBP_MANNOSYLATION,SET,20,0.15261,0.0050342,0.18652,0.20663,GOBP_MANNOSYLATION,0.901778401727862
RIGGI_EWING_SARCOMA_PROGENIT...1,SET,172,0.058629,0.005648,0.071662,0.20665,RIGGI_EWING_SARCOMA_PROGENITOR_DN,0.901778401727862
SAGIV_CD24_TARGETS_UP,SET,21,0.15943,0.0053888,0.19491,0.20669,SAGIV_CD24_TARGETS_UP,0.901778401727862
MIR4497,SET,8,0.27608,0.0057617,0.33751,0.20669,MIR4497,0.901778401727862
GSE30083_SP3_VS_SP4_THYMOCYT...2,SET,179,0.054966,0.0054008,0.067196,0.20669,GSE30083_SP3_VS_SP4_THYMOCYTE_UP,0.901778401727862
GOBP_DNA_ALKYLATION_REPAIR,SET,11,0.18142,0.0044392,0.22182,0.20673,GOBP_DNA_ALKYLATION_REPAIR,0.901778401727862
GOBP_RECEPTOR_GUANYLYL_CYCLA...,SET,8,0.25942,0.0054139,0.3172,0.20673,GOBP_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY,0.901778401727862
ZHU_CMV_8_HR_DN,SET,44,0.11775,0.0057572,0.14403,0.20683,ZHU_CMV_8_HR_DN,0.901778401727862
GSE36392_EOSINOPHIL_VS_MAC_I...1,SET,177,0.050472,0.0049317,0.061743,0.20684,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN,0.901778401727862
GSE46143_CTRL_VS_LMP2A_TRANS...2,SET,181,0.052877,0.0052242,0.064684,0.20684,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP,0.901778401727862
MIR4726_5P,SET,89,0.069374,0.0048184,0.08487,0.20685,MIR4726_5P,0.901778401727862
DESCARTES_FETAL_INTESTINE_VA...,SET,38,0.12227,0.005557,0.1496,0.20688,DESCARTES_FETAL_INTESTINE_VASCULAR_ENDOTHELIAL_CELLS,0.901778401727862
GSE15750_DAY6_VS_DAY10_TRAF6...2,SET,180,0.050047,0.004931,0.061239,0.2069,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP,0.901778401727862
GOMF_HYALURONIC_ACID_BINDING,SET,24,0.14169,0.0051194,0.17338,0.20691,GOMF_HYALURONIC_ACID_BINDING,0.901778401727862
GOBP_HEMATOPOIETIC_STEM_CELL...4,SET,5,0.28457,0.0046955,0.34823,0.20692,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION_TO_BONE_MARROW,0.901778401727862
MIR208B_5P,SET,232,0.046699,0.0052162,0.057148,0.20693,MIR208B_5P,0.901778401727862
GOBP_ENDODERMAL_CELL_FATE_CO...,SET,14,0.20236,0.0055858,0.24767,0.20695,GOBP_ENDODERMAL_CELL_FATE_COMMITMENT,0.901778401727862
GOBP_MEDIUM_CHAIN_FATTY_ACID...3,SET,15,0.16709,0.004774,0.20456,0.20702,GOBP_MEDIUM_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.901778401727862
GSE22886_NAIVE_CD4_TCELL_VS_...14,SET,172,0.05452,0.0052522,0.066747,0.20702,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP,0.901778401727862
GOBP_PYRIMIDINE_RIBONUCLEOSI...4,SET,13,0.19149,0.0050936,0.23446,0.20704,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.901778401727862
REACTOME_INITIAL_TRIGGERING_...,SET,17,0.2009,0.0061104,0.24599,0.20705,REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT,0.901778401727862
WP_CARDIAC_PROGENITOR_DIFFER...,SET,50,0.10876,0.0056681,0.13317,0.20705,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,0.901778401727862
XIE_ST_HSC_S1PR3_OE_UP,SET,175,0.05837,0.0056715,0.07148,0.20708,XIE_ST_HSC_S1PR3_OE_UP,0.901778401727862
GOBP_ACETYL_COA_BIOSYNTHETIC...1,SET,15,0.19235,0.0054958,0.23555,0.20708,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS,0.901778401727862
GOBP_PROTEOLYSIS_INVOLVED_IN...,SET,696,0.025738,0.0049152,0.031519,0.20709,GOBP_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.901778401727862
REACTOME_RESPIRATORY_SYNCYTI...2,SET,21,0.15948,0.0053907,0.19533,0.20712,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY,0.901778401727862
GOCC_B_CELL_RECEPTOR_COMPLEX,SET,5,0.34318,0.0056626,0.42037,0.20715,GOCC_B_CELL_RECEPTOR_COMPLEX,0.901778401727862
HP_IMPAIRMENT_IN_PERSONALITY...,SET,199,0.049922,0.0051691,0.061158,0.20717,HP_IMPAIRMENT_IN_PERSONALITY_FUNCTIONING,0.901778401727862
GSE24634_IL4_VS_CTRL_TREATED...5,SET,183,0.054323,0.0053963,0.0666,0.20735,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN,0.901778401727862
HP_OROMOTOR_APRAXIA,SET,24,0.14615,0.0052807,0.17919,0.20736,HP_OROMOTOR_APRAXIA,0.901778401727862
MANNO_MIDBRAIN_NEUROTYPES_HDA,SET,435,0.036629,0.0055709,0.044909,0.20736,MANNO_MIDBRAIN_NEUROTYPES_HDA,0.901778401727862
WP_MIRNA_ROLE_IN_IMMUNE_RESP...,SET,32,0.12624,0.0052658,0.15481,0.20741,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.901778401727862
GSE22611_MUTANT_NOD2_TRANSDU...1,SET,184,0.050686,0.0050486,0.062158,0.20742,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN,0.901778401727862
GSE2706_2H_VS_8H_LPS_STIM_DC...1,SET,162,0.055419,0.0051827,0.067969,0.20744,GSE2706_2H_VS_8H_LPS_STIM_DC_DN,0.901778401727862
KRAS.600.LUNG.BREAST_UP.V1_DN,SET,254,0.045251,0.0052855,0.055514,0.2075,KRAS.600.LUNG.BREAST_UP.V1_DN,0.901778401727862
MIR6826_3P,SET,93,0.069109,0.0049061,0.084785,0.20751,MIR6826_3P,0.901778401727862
GOBP_HOMOLOGOUS_RECOMBINATION,SET,58,0.084437,0.0047383,0.1036,0.20753,GOBP_HOMOLOGOUS_RECOMBINATION,0.901778401727862
TAGGTCA_MIR192_MIR215,SET,36,0.10863,0.0048053,0.13329,0.20755,TAGGTCA_MIR192_MIR215,0.901778401727862
HP_ACHOLIC_STOOLS,SET,8,0.24954,0.0052077,0.30619,0.20755,HP_ACHOLIC_STOOLS,0.901778401727862
KARLSSON_TGFB1_TARGETS_DN,SET,175,0.052806,0.0051308,0.064801,0.20757,KARLSSON_TGFB1_TARGETS_DN,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...828,SET,17,0.16785,0.005105,0.20598,0.20758,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.901778401727862
GOMF_C_X_C_CHEMOKINE_BINDING,SET,4,0.33826,0.0049923,0.41515,0.2076,GOMF_C_X_C_CHEMOKINE_BINDING,0.901778401727862
HP_ABSENT_TESTIS,SET,24,0.12342,0.0044594,0.15153,0.20768,HP_ABSENT_TESTIS,0.901778401727862
GCM_HMGA2,SET,107,0.065149,0.004959,0.079987,0.20769,GCM_HMGA2,0.901778401727862
HP_TONGUE_ATROPHY,SET,49,0.099895,0.0051537,0.12265,0.20769,HP_TONGUE_ATROPHY,0.901778401727862
SA_REG_CASCADE_OF_CYCLIN_EXPR,SET,13,0.19374,0.0051536,0.23789,0.2077,SA_REG_CASCADE_OF_CYCLIN_EXPR,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...763,SET,6,0.3054,0.00552,0.37506,0.20775,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.901778401727862
GOBP_DE_NOVO_NAD_BIOSYNTHETI...,SET,8,0.26765,0.0055857,0.32871,0.20776,GOBP_DE_NOVO_NAD_BIOSYNTHETIC_PROCESS,0.901778401727862
REACTOME_KSRP_KHSRP_BINDS_AN...,SET,16,0.16676,0.0049206,0.20487,0.20784,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,0.901778401727862
GOBP_REGULATION_OF_EPITHELIA...1,SET,97,0.074003,0.0053648,0.090922,0.20785,GOBP_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.901778401727862
MIR1250_5P,SET,6,0.25992,0.0046979,0.31937,0.20787,MIR1250_5P,0.901778401727862
VALK_AML_CLUSTER_8,SET,22,0.15398,0.005327,0.18923,0.20791,VALK_AML_CLUSTER_8,0.901778401727862
GOCC_MITOTIC_SPINDLE_POLE,SET,36,0.11278,0.004989,0.13864,0.20797,GOCC_MITOTIC_SPINDLE_POLE,0.901778401727862
CHUANG_OXIDATIVE_STRESS_RESP...2,SET,26,0.14324,0.0053866,0.17615,0.20806,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...567,SET,11,0.21775,0.0053284,0.26778,0.20807,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.901778401727862
MARSON_FOXP3_TARGETS_STIMULA...2,SET,29,0.14313,0.0056839,0.17603,0.20808,MARSON_FOXP3_TARGETS_STIMULATED_UP,0.901778401727862
WP_SARSCOV2_B117_VARIANT_ANT...,SET,7,0.25736,0.0050243,0.31651,0.20808,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.901778401727862
GOBP_IRES_DEPENDENT_VIRAL_TR...,SET,10,0.21049,0.0049111,0.25888,0.2081,GOBP_IRES_DEPENDENT_VIRAL_TRANSLATIONAL_INITIATION,0.901778401727862
GOCC_EXOCYTIC_VESICLE,SET,217,0.048522,0.0052438,0.059681,0.20811,GOCC_EXOCYTIC_VESICLE,0.901778401727862
MODULE_125,SET,42,0.10451,0.004993,0.12856,0.20813,MODULE_125,0.901778401727862
GOBP_RENAL_WATER_ABSORPTION,SET,6,0.31848,0.0057563,0.39188,0.2082,GOBP_RENAL_WATER_ABSORPTION,0.901778401727862
HP_ABNORMAL_TIBIA_MORPHOLOGY,SET,90,0.07686,0.0053681,0.094582,0.20822,HP_ABNORMAL_TIBIA_MORPHOLOGY,0.901778401727862
GOBP_GROOMING_BEHAVIOR,SET,18,0.18793,0.0058813,0.23128,0.20824,GOBP_GROOMING_BEHAVIOR,0.901778401727862
GOMF_RETINOIC_ACID_RESPONSIV...,SET,6,0.26665,0.0048196,0.3282,0.20827,GOMF_RETINOIC_ACID_RESPONSIVE_ELEMENT_BINDING,0.901778401727862
chr20q11,SET,118,0.16853,0.013468,0.20747,0.20831,chr20q11,0.901778401727862
VANGURP_PANCREATIC_ALPHA_CELL,SET,38,0.12282,0.0055818,0.1512,0.20832,VANGURP_PANCREATIC_ALPHA_CELL,0.901778401727862
GOCC_MICROFIBRIL,SET,11,0.20934,0.0051226,0.25774,0.20833,GOCC_MICROFIBRIL,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...507,SET,16,0.17395,0.0051327,0.21416,0.20834,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.901778401727862
GOCC_PROTEASOME_CORE_COMPLEX...2,SET,11,0.19368,0.0047393,0.23847,0.20834,GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX,0.901778401727862
GSE24634_NAIVE_CD4_TCELL_VS_...4,SET,172,0.051914,0.0050011,0.063932,0.2084,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP,0.901778401727862
REACTOME_RHOF_GTPASE_CYCLE,SET,39,0.11409,0.0052529,0.14055,0.20847,REACTOME_RHOF_GTPASE_CYCLE,0.901778401727862
GOBP_CORNEA_DEVELOPMENT_IN_C...,SET,12,0.2388,0.0061031,0.29418,0.20847,GOBP_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.901778401727862
GOBP_RESPONSE_TO_TRANSFORMIN...,SET,255,0.045396,0.0053127,0.055923,0.20847,GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,0.901778401727862
HP_DECREASED_CIRCULATING_COM...2,SET,27,0.14217,0.0054481,0.17516,0.2085,HP_DECREASED_CIRCULATING_COMPLEMENT_C4_CONCENTRATION,0.901778401727862
MIR548A_3P,SET,431,0.033957,0.0051412,0.041839,0.20851,MIR548A_3P,0.901778401727862
KASLER_HDAC7_TARGETS_2_UP,SET,5,0.40883,0.0067458,0.50381,0.20855,KASLER_HDAC7_TARGETS_2_UP,0.901778401727862
HP_TONGUE_THRUSTING,SET,13,0.18726,0.004981,0.23078,0.20857,HP_TONGUE_THRUSTING,0.901778401727862
GSE3982_MAST_CELL_VS_BCELL_DN,SET,161,0.052992,0.0049405,0.065324,0.20863,GSE3982_MAST_CELL_VS_BCELL_DN,0.901778401727862
HOFMANN_MYELODYSPLASTIC_SYND...6,SET,19,0.1419,0.0045626,0.17497,0.20868,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,0.901778401727862
MIR4514,SET,162,0.054732,0.0051184,0.067484,0.20868,MIR4514,0.901778401727862
HP_INCREASED_CIRCULATING_REN...,SET,18,0.18443,0.0057718,0.22744,0.20872,HP_INCREASED_CIRCULATING_RENIN_LEVEL,0.901778401727862
REACTOME_GENERATION_OF_SECON...,SET,27,0.13813,0.005293,0.17035,0.20874,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,0.901778401727862
MIR8066,SET,142,0.058712,0.0051434,0.072447,0.20885,MIR8066,0.901778401727862
LI_PBMC_MENOMUNE_A_C_Y_W_135...3,SET,19,0.17351,0.0055787,0.21412,0.20888,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE,0.901778401727862
HP_BILATERAL_RENAL_AGENESIS,SET,10,0.25068,0.0058488,0.30948,0.20897,HP_BILATERAL_RENAL_AGENESIS,0.901778401727862
HP_DECREASED_BODY_MASS_INDEX,SET,20,0.16836,0.0055538,0.20791,0.20904,HP_DECREASED_BODY_MASS_INDEX,0.901778401727862
OSADA_ASCL1_TARGETS_UP,SET,43,0.11381,0.0055014,0.14058,0.2091,OSADA_ASCL1_TARGETS_UP,0.901778401727862
REACTOME_G_ALPHA_Z_SIGNALLIN...,SET,48,0.10583,0.0054041,0.13078,0.2092,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,0.901778401727862
MORF_ATF2,SET,288,0.041754,0.0051883,0.051603,0.20922,MORF_ATF2,0.901778401727862
WP_MICROGLIA_PATHOGEN_PHAGOC...,SET,37,0.11967,0.0053667,0.1479,0.20923,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.901778401727862
GOBP_FC_RECEPTOR_MEDIATED_IN...,SET,5,0.36521,0.0060261,0.45138,0.20923,GOBP_FC_RECEPTOR_MEDIATED_INHIBITORY_SIGNALING_PATHWAY,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...187,SET,26,0.14148,0.0053204,0.17488,0.20925,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.901778401727862
GOMF_CLATHRIN_BINDING,SET,53,0.09517,0.0051059,0.11764,0.20927,GOMF_CLATHRIN_BINDING,0.901778401727862
SU_PLACENTA,SET,23,0.15059,0.0053265,0.18615,0.20928,SU_PLACENTA,0.901778401727862
GOBP_REGULATION_OF_AUTOPHAGO...1,SET,43,0.10228,0.004944,0.12645,0.2093,GOBP_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.901778401727862
REACTOME_ACTIVATION_OF_TRKA_...,SET,6,0.30862,0.0055783,0.38158,0.20932,REACTOME_ACTIVATION_OF_TRKA_RECEPTORS,0.901778401727862
MIR513A_5P,SET,346,0.038814,0.0052778,0.047992,0.20934,MIR513A_5P,0.901778401727862
GOBP_IONOTROPIC_GLUTAMATE_RE...,SET,21,0.16493,0.0055748,0.20394,0.20934,GOBP_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.901778401727862
GSE13946_CTRL_VS_DSS_COLITIS...2,SET,163,0.056812,0.0053292,0.070251,0.20935,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP,0.901778401727862
MIR10398_3P,SET,5,0.32844,0.0054194,0.40616,0.20936,MIR10398_3P,0.901778401727862
GOBP_PERIPHERAL_NERVOUS_SYST...2,SET,8,0.25833,0.0053913,0.31946,0.20936,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION,0.901778401727862
GOBP_REGULATION_OF_MITOPHAGY,SET,33,0.12388,0.0052472,0.1532,0.20937,GOBP_REGULATION_OF_MITOPHAGY,0.901778401727862
HP_ARTHRALGIA_OF_THE_HIP,SET,8,0.24277,0.0050665,0.30024,0.20938,HP_ARTHRALGIA_OF_THE_HIP,0.901778401727862
HOFT_CD4_POSITIVE_ALPHA_BETA...7,SET,12,0.21373,0.0054623,0.26434,0.20939,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_DN,0.901778401727862
GOMF_HISTONE_MODIFYING_ACTIV...,SET,182,0.04834,0.004789,0.059789,0.2094,GOMF_HISTONE_MODIFYING_ACTIVITY,0.901778401727862
MIR548I,SET,441,0.033439,0.0051198,0.041366,0.20945,MIR548I,0.901778401727862
GOBP_PLACENTA_BLOOD_VESSEL_D...,SET,29,0.13748,0.0054596,0.1701,0.20949,GOBP_PLACENTA_BLOOD_VESSEL_DEVELOPMENT,0.901778401727862
GOCC_SMOOTH_ENDOPLASMIC_RETI...1,SET,28,0.1311,0.0051158,0.16221,0.2095,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM,0.901778401727862
GOMF_NUCLEAR_ANDROGEN_RECEPT...,SET,25,0.127,0.0046833,0.15716,0.20952,GOMF_NUCLEAR_ANDROGEN_RECEPTOR_BINDING,0.901778401727862
KEGG_MEDICUS_VARIANT_EML4_AL...1,SET,5,0.42272,0.0069749,0.52318,0.20956,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY,0.901778401727862
GSE37301_RAG2_KO_VS_RAG2_AND...1,SET,182,0.049744,0.004928,0.061591,0.20965,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN,0.901778401727862
HP_HYPOPITUITARISM,SET,159,0.056138,0.0052016,0.06951,0.20966,HP_HYPOPITUITARISM,0.901778401727862
HP_PANCREATIC_CYSTS,SET,33,0.10756,0.004556,0.13318,0.20966,HP_PANCREATIC_CYSTS,0.901778401727862
GSE24142_ADULT_VS_FETAL_DN3_...2,SET,179,0.05231,0.0051398,0.064769,0.20966,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP,0.901778401727862
REACTOME_SIGNALING_BY_RHO_GT...,SET,608,0.028056,0.0050203,0.034744,0.20969,REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,0.901778401727862
REACTOME_DOWNSTREAM_SIGNALIN...4,SET,24,0.13382,0.004835,0.16572,0.2097,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,0.901778401727862
GOMF_POLY_PYRIMIDINE_TRACT_B...,SET,25,0.13804,0.0050902,0.17097,0.20973,GOMF_POLY_PYRIMIDINE_TRACT_BINDING,0.901778401727862
GALIE_TUMOR_STEMNESS_GENES,SET,6,0.32391,0.0058545,0.40129,0.20979,GALIE_TUMOR_STEMNESS_GENES,0.901778401727862
GSE41867_DAY8_EFFECTOR_VS_DA...3,SET,185,0.049499,0.0049437,0.061344,0.20986,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.901778401727862
HE_LIM_SUN_FETAL_LUNG_C0_INT...2,SET,9,0.25637,0.0056748,0.31773,0.20987,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_FIBROBLAST,0.901778401727862
GOBP_PHOSPHATIDYLCHOLINE_ACY...,SET,13,0.19281,0.0051288,0.23898,0.20989,GOBP_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING,0.901778401727862
HP_DISTAL_UPPER_LIMB_AMYOTRO...,SET,58,0.089313,0.0050119,0.11072,0.20993,HP_DISTAL_UPPER_LIMB_AMYOTROPHY,0.901778401727862
REACTOME_ERYTHROPOIETIN_ACTI...1,SET,12,0.22838,0.0058368,0.28314,0.20995,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,0.901778401727862
MIR371B_3P,SET,36,0.11898,0.0052634,0.14752,0.20998,MIR371B_3P,0.901778401727862
GSE5503_LIVER_DC_VS_SPLEEN_D...1,SET,173,0.050033,0.0048337,0.062055,0.21005,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.901778401727862
GOBP_REGULATION_OF_DNA_TEMPL...2,SET,15,0.17405,0.0049729,0.21588,0.21006,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION_INITIATION,0.901778401727862
GSE7852_LN_VS_FAT_TREG_DN,SET,181,0.053587,0.0052943,0.066466,0.21006,GSE7852_LN_VS_FAT_TREG_DN,0.901778401727862
GSE9946_MATURE_STIMULATORY_V...2,SET,117,0.061879,0.0049239,0.076751,0.21006,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP,0.901778401727862
REACTOME_REGULATION_OF_COMMI...,SET,10,0.25125,0.0058622,0.31168,0.21009,REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO,0.901778401727862
HP_ABNORMAL_HIP_JOINT_MORPHO...,SET,336,0.037146,0.0049789,0.04608,0.21009,HP_ABNORMAL_HIP_JOINT_MORPHOLOGY,0.901778401727862
MIR5697,SET,139,0.057165,0.004955,0.070917,0.2101,MIR5697,0.901778401727862
MIR7847_3P,SET,65,0.088065,0.0052306,0.10925,0.2101,MIR7847_3P,0.901778401727862
HP_APLASIA_HYPOPLASIA_OF_THE...53,SET,27,0.14503,0.0055577,0.17995,0.21013,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_FINGER,0.901778401727862
HERNANDEZ_MITOTIC_ARREST_BY_...3,SET,14,0.17441,0.0048143,0.21646,0.2102,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,0.901778401727862
GOCC_NUCLEOLAR_EXOSOME_RNASE...,SET,9,0.21684,0.0047998,0.26914,0.21022,GOCC_NUCLEOLAR_EXOSOME_RNASE_COMPLEX,0.901778401727862
HP_NARROW_PELVIS_BONE,SET,7,0.25412,0.0049611,0.31546,0.21025,HP_NARROW_PELVIS_BONE,0.901778401727862
REACTOME_RAS_PROCESSING,SET,21,0.14459,0.0048873,0.17953,0.2103,REACTOME_RAS_PROCESSING,0.901778401727862
HP_SUBRETINAL_FLUID,SET,9,0.24675,0.0054617,0.30637,0.2103,HP_SUBRETINAL_FLUID,0.901778401727862
RASHI_RESPONSE_TO_IONIZING_R...6,SET,73,0.077117,0.004853,0.095773,0.21036,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,0.901778401727862
FAN_EMBRYONIC_CTX_IN_3_INTER...,SET,5,0.33046,0.0054527,0.41044,0.21037,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.901778401727862
GOCC_ORGANELLE_ENVELOPE,SET,1109,0.020727,0.0049377,0.025745,0.21039,GOCC_ORGANELLE_ENVELOPE,0.901778401727862
REACTOME_SUMOYLATION_OF_DNA_...3,SET,43,0.10058,0.0048619,0.12494,0.2104,REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,0.901778401727862
HP_HIATUS_HERNIA,SET,32,0.11654,0.0048611,0.14485,0.21054,HP_HIATUS_HERNIA,0.901778401727862
VALK_AML_WITH_FLT3_ITD,SET,36,0.12556,0.0055544,0.15606,0.21055,VALK_AML_WITH_FLT3_ITD,0.901778401727862
DESERT_STEM_CELL_HEPATOCELLU...,SET,229,0.046612,0.0051731,0.057942,0.21057,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.901778401727862
MIR548AP_5P_MIR548J_5P,SET,441,0.033319,0.0051015,0.041423,0.2106,MIR548AP_5P_MIR548J_5P,0.901778401727862
GOBP_GLUCOSE_6_PHOSPHATE_MET...,SET,26,0.13737,0.0051656,0.17079,0.21062,GOBP_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS,0.901778401727862
HP_APLASIA_OF_THE_MIDDLE_PHA...,SET,7,0.24779,0.0048375,0.30813,0.21065,HP_APLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_HAND,0.901778401727862
MIR7845_5P,SET,54,0.090486,0.0049001,0.11253,0.21067,MIR7845_5P,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...73,SET,8,0.2407,0.0050233,0.29938,0.2107,GOBP_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.901778401727862
MODULE_497,SET,29,0.13934,0.0055334,0.17332,0.21072,MODULE_497,0.901778401727862
REACTOME_SCAVENGING_BY_CLASS...3,SET,6,0.28517,0.0051544,0.35473,0.21073,REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS,0.901778401727862
GOMF_TYPE_I_INTERFERON_RECEP...,SET,13,0.29697,0.0078993,0.36942,0.21074,GOMF_TYPE_I_INTERFERON_RECEPTOR_BINDING,0.901778401727862
GARGALOVIC_RESPONSE_TO_OXIDI...18,SET,16,0.17308,0.005107,0.21531,0.21075,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,0.901778401727862
GOBP_REGULATION_OF_MIRNA_MET...,SET,81,0.076001,0.005037,0.09455,0.21075,GOBP_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.901778401727862
BIOCARTA_GPCR_PATHWAY,SET,28,0.13841,0.0054012,0.1722,0.21076,BIOCARTA_GPCR_PATHWAY,0.901778401727862
WP_VEGFAVEGFR2_SIGNALING,SET,404,0.034677,0.005087,0.043155,0.21083,WP_VEGFAVEGFR2_SIGNALING,0.901778401727862
REACTOME_TYSND1_CLEAVES_PERO...,SET,7,0.25542,0.0049863,0.31787,0.21084,REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS,0.901778401727862
GOBP_TELOMERE_MAINTENANCE_VI...2,SET,9,0.21944,0.0048572,0.2732,0.21093,GOBP_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION,0.901778401727862
SMITH_TERT_TARGETS_DN,SET,83,0.079934,0.0053623,0.099555,0.21102,SMITH_TERT_TARGETS_DN,0.901778401727862
GOBP_REGULATION_OF_TOLL_LIKE...1,SET,11,0.22298,0.0054562,0.27774,0.21105,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.901778401727862
MORF_PML,SET,133,0.058877,0.0049929,0.073347,0.21108,MORF_PML,0.901778401727862
HP_HEPATIC_FAILURE,SET,133,0.057879,0.0049083,0.072104,0.21108,HP_HEPATIC_FAILURE,0.901778401727862
HP_UNILATERAL_CLEFT_LIP,SET,8,0.20432,0.0042642,0.25457,0.2111,HP_UNILATERAL_CLEFT_LIP,0.901778401727862
BIOCARTA_TERT_PATHWAY,SET,8,0.22469,0.0046893,0.27997,0.21112,BIOCARTA_TERT_PATHWAY,0.901778401727862
GSE40274_FOXP3_VS_FOXP3_AND_...16,SET,134,0.059412,0.0050571,0.07403,0.21113,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.901778401727862
GSE6674_ANTI_IGM_VS_PL2_3_ST...1,SET,176,0.050461,0.0049169,0.062882,0.21114,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN,0.901778401727862
GOBP_AIM2_INFLAMMASOME_COMPL...,SET,5,0.25415,0.0041936,0.31675,0.21117,GOBP_AIM2_INFLAMMASOME_COMPLEX_ASSEMBLY,0.901778401727862
GSE22886_NAIVE_TCELL_VS_DC_UP,SET,178,0.049362,0.0048367,0.061543,0.21126,GSE22886_NAIVE_TCELL_VS_DC_UP,0.901778401727862
BHATI_G2M_ARREST_BY_2METHOXY...2,SET,107,0.065322,0.0049722,0.081459,0.21131,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,0.901778401727862
GSE3982_DC_VS_BASOPHIL_UP,SET,182,0.051761,0.0051279,0.064554,0.21133,GSE3982_DC_VS_BASOPHIL_UP,0.901778401727862
GOMF_CARBOHYDRATE_MONOATOMIC...,SET,16,0.1765,0.0052082,0.22013,0.21134,GOMF_CARBOHYDRATE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.901778401727862
GSE29618_BCELL_VS_MDC_DN,SET,183,0.052843,0.0052493,0.065907,0.21134,GSE29618_BCELL_VS_MDC_DN,0.901778401727862
HP_CLAW_HAND_DEFORMITY,SET,8,0.24971,0.0052114,0.3115,0.21139,HP_CLAW_HAND_DEFORMITY,0.901778401727862
KEGG_MEDICUS_VARIANT_MUTATIO...35,SET,8,0.25715,0.0053667,0.32091,0.21148,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006,0.901778401727862
REACTOME_REGULATION_OF_TP53_...4,SET,17,0.17524,0.0053299,0.21869,0.21148,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,0.901778401727862
GOCC_PROTEIN_PHOSPHATASE_TYP...2,SET,16,0.17251,0.0050903,0.21539,0.2116,GOCC_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX,0.901778401727862
GOBP_REGULATION_OF_PROTEIN_L...1,SET,10,0.20421,0.0047645,0.25506,0.21168,GOBP_REGULATION_OF_PROTEIN_LIPIDATION,0.901778401727862
REACTOME_NOD1_2_SIGNALING_PA...,SET,32,0.12247,0.0051085,0.15297,0.21169,REACTOME_NOD1_2_SIGNALING_PATHWAY,0.901778401727862
KEGG_MEDICUS_REFERENCE_N_GLY...3,SET,5,0.25318,0.0041776,0.31629,0.21173,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11,0.901778401727862
GOBP_PROTEIN_LOCALIZATION_TO...41,SET,6,0.24026,0.0043426,0.30019,0.21176,GOBP_PROTEIN_LOCALIZATION_TO_PERINUCLEAR_REGION_OF_CYTOPLASM,0.901778401727862
GSE41176_UNSTIM_VS_ANTI_IGM_...3,SET,180,0.052239,0.005147,0.065275,0.21178,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN,0.901778401727862
GOBP_URATE_METABOLIC_PROCESS,SET,10,0.23101,0.0053899,0.28867,0.21179,GOBP_URATE_METABOLIC_PROCESS,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...628,SET,451,0.03224,0.0049905,0.040291,0.21181,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION,0.901778401727862
BIOCARTA_TALL1_PATHWAY,SET,15,0.19393,0.0055409,0.24238,0.21183,BIOCARTA_TALL1_PATHWAY,0.901778401727862
GOMF_SECONDARY_ACTIVE_TRANSM...,SET,274,0.042803,0.0051898,0.053498,0.21183,GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.901778401727862
GSE3039_CD4_TCELL_VS_ALPHABE...2,SET,174,0.051954,0.0050337,0.064936,0.21184,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP,0.901778401727862
GOMF_PASSIVE_TRANSMEMBRANE_T...,SET,453,0.035192,0.0054592,0.043991,0.21187,GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.901778401727862
GOMF_NUCLEOSIDE_MONOPHOSPHAT...,SET,19,0.15848,0.0050956,0.19815,0.21192,GOMF_NUCLEOSIDE_MONOPHOSPHATE_KINASE_ACTIVITY,0.901778401727862
GSE32034_UNTREATED_VS_ROSIGL...4,SET,154,0.053612,0.0048894,0.067047,0.21197,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP,0.901778401727862
GSE21063_CTRL_VS_ANTI_IGM_ST...5,SET,178,0.051201,0.0050169,0.06404,0.212,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN,0.901778401727862
DESCARTES_FETAL_KIDNEY_MESAN...,SET,42,0.11897,0.0056839,0.14882,0.21201,DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS,0.901778401727862
GOCC_SPERM_MIDPIECE,SET,50,0.10468,0.0054551,0.13093,0.21202,GOCC_SPERM_MIDPIECE,0.901778401727862
SHEPARD_CRASH_AND_BURN_MUTAN...1,SET,179,0.051744,0.0050842,0.064729,0.21203,SHEPARD_CRASH_AND_BURN_MUTANT_DN,0.901778401727862
GOBP_RHODOPSIN_MEDIATED_SIGN...,SET,10,0.20488,0.0047803,0.25632,0.21205,GOBP_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY,0.901778401727862
KEGG_MEDICUS_VARIANT_MUTATIO...81,SET,5,0.2781,0.0045887,0.34794,0.21207,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.901778401727862
GOBP_SYNAPSE_PRUNING,SET,14,0.2186,0.0060341,0.27351,0.21208,GOBP_SYNAPSE_PRUNING,0.901778401727862
GOBP_GLYCOSYLATION,SET,223,0.046712,0.0051168,0.058448,0.21209,GOBP_GLYCOSYLATION,0.901778401727862
REACTOME_ABORTIVE_ELONGATION...,SET,23,0.12799,0.0045273,0.16015,0.2121,REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...40,SET,44,0.10222,0.004998,0.12793,0.21215,GOBP_NEGATIVE_REGULATION_OF_AXONOGENESIS,0.901778401727862
CHANG_POU5F1_TARGETS_UP,SET,13,0.21026,0.005593,0.26318,0.21217,CHANG_POU5F1_TARGETS_UP,0.901778401727862
GOMF_CYCLASE_INHIBITOR_ACTIV...,SET,4,0.31414,0.0046363,0.39325,0.2122,GOMF_CYCLASE_INHIBITOR_ACTIVITY,0.901778401727862
NATSUME_RESPONSE_TO_INTERFER...2,SET,68,0.086809,0.0052732,0.10869,0.21224,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.901778401727862
YAGI_AML_WITH_11Q23_REARRANG...,SET,304,0.038985,0.0049748,0.048815,0.21226,YAGI_AML_WITH_11Q23_REARRANGED,0.901778401727862
REACTOME_PEROXISOMAL_LIPID_M...,SET,28,0.12458,0.0048614,0.15603,0.21231,REACTOME_PEROXISOMAL_LIPID_METABOLISM,0.901778401727862
REACTOME_GLUCOSE_METABOLISM,SET,77,0.073744,0.0047657,0.092367,0.21233,REACTOME_GLUCOSE_METABOLISM,0.901778401727862
CAO_BLOOD_FLUZONE_AGE_05_14Y...1,SET,6,0.27025,0.0048846,0.33849,0.21233,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_DN,0.901778401727862
MORI_PLASMA_CELL_UP,SET,45,0.10124,0.0050062,0.12682,0.21234,MORI_PLASMA_CELL_UP,0.901778401727862
GSE411_UNSTIM_VS_400MIN_IL6_...1,SET,180,0.048872,0.0048153,0.061217,0.21234,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN,0.901778401727862
OKAWA_NEUROBLASTOMA_1P36_31_...,SET,22,0.22977,0.0079489,0.28784,0.21237,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,0.901778401727862
HP_HYPOGONADOTROPIC_HYPOGONA...,SET,146,0.057347,0.0050935,0.07185,0.2124,HP_HYPOGONADOTROPIC_HYPOGONADISM,0.901778401727862
GSE6674_ANTI_IGM_VS_PL2_3_ST...2,SET,178,0.04763,0.004667,0.059681,0.21242,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP,0.901778401727862
GAUTAM_EYE_IRIS_CILIARY_BODY...4,SET,83,0.075598,0.0050714,0.094731,0.21243,GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS,0.901778401727862
MIR6127,SET,185,0.050238,0.0050174,0.062967,0.21249,MIR6127,0.901778401727862
FUJIWARA_PARK2_IN_LIVER_CANC...2,SET,8,0.25139,0.0052464,0.31512,0.21251,FUJIWARA_PARK2_IN_LIVER_CANCER_UP,0.901778401727862
ROAZ_01,SET,8,0.21653,0.0045189,0.27142,0.21251,ROAZ_01,0.901778401727862
MIKKELSEN_DEDIFFERENTIATED_S...1,SET,7,0.30395,0.0059339,0.38102,0.21252,MIKKELSEN_DEDIFFERENTIATED_STATE_DN,0.901778401727862
MATSUMIYA_PBMC_MODIFIED_VACC...5,SET,26,0.13674,0.0051419,0.17141,0.21252,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_WILD_TYPE_MVA_6HR_UP,0.901778401727862
GOCC_GINS_COMPLEX,SET,5,0.31166,0.0051425,0.39071,0.21253,GOCC_GINS_COMPLEX,0.901778401727862
GSE38304_MYC_NEG_VS_POS_GC_B...1,SET,182,0.051889,0.0051406,0.065061,0.21257,GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN,0.901778401727862
MIR125A_5P,SET,298,0.038993,0.0049272,0.048905,0.21264,MIR125A_5P,0.901778401727862
GOCC_LOW_DENSITY_LIPOPROTEIN...,SET,11,0.21001,0.0051388,0.26341,0.21266,GOCC_LOW_DENSITY_LIPOPROTEIN_PARTICLE,0.901778401727862
WP_ANGIOPOIETINLIKE_PROTEIN_...,SET,125,0.062895,0.005172,0.078911,0.21272,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,0.901778401727862
GSE40274_CTRL_VS_FOXP3_AND_I...1,SET,147,0.054401,0.0048483,0.068255,0.21272,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.901778401727862
chr16q21,SET,37,0.20971,0.0094049,0.26313,0.21273,chr16q21,0.901778401727862
GOBP_INTERLEUKIN_18_PRODUCTI...,SET,12,0.18247,0.0046634,0.22896,0.21275,GOBP_INTERLEUKIN_18_PRODUCTION,0.901778401727862
CCAGGTT_MIR490,SET,58,0.084863,0.0047622,0.10649,0.21277,CCAGGTT_MIR490,0.901778401727862
GOMF_CAMP_DEPENDENT_PROTEIN_...2,SET,10,0.22476,0.0052441,0.28205,0.21277,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY,0.901778401727862
REACTOME_IRF3_MEDIATED_ACTIV...,SET,5,0.25775,0.0042529,0.32349,0.21279,REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN,0.901778401727862
HP_APLASIA_OF_THE_MUSCULATURE,SET,9,0.25213,0.005581,0.31645,0.2128,HP_APLASIA_OF_THE_MUSCULATURE,0.901778401727862
TESAR_ALK_TARGETS_EPISC_4D_UP,SET,5,0.32068,0.0052913,0.40251,0.21282,TESAR_ALK_TARGETS_EPISC_4D_UP,0.901778401727862
GNF2_ZAP70,SET,23,0.1353,0.0047858,0.16984,0.21283,GNF2_ZAP70,0.901778401727862
SA_FAS_SIGNALING,SET,9,0.22727,0.0050305,0.28529,0.21284,SA_FAS_SIGNALING,0.901778401727862
MIR495_3P,SET,639,0.027997,0.0051313,0.035145,0.21285,MIR495_3P,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...434,SET,124,0.062097,0.005086,0.077955,0.21285,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.901778401727862
BUSSLINGER_GASTRIC_ANTRAL_ECS,SET,10,0.24959,0.0058234,0.31337,0.21288,BUSSLINGER_GASTRIC_ANTRAL_ECS,0.901778401727862
GSE34217_MIR17_92_OVEREXPRES...2,SET,122,0.061731,0.0050153,0.077506,0.21289,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP,0.901778401727862
GOMF_TRANSPORTER_ACTIVITY,SET,1107,0.021768,0.0051815,0.027333,0.21291,GOMF_TRANSPORTER_ACTIVITY,0.901778401727862
GSE1460_DP_VS_CD4_THYMOCYTE_...1,SET,189,0.053654,0.0054156,0.067372,0.21291,GSE1460_DP_VS_CD4_THYMOCYTE_DN,0.901778401727862
RUBENSTEIN_SKELETAL_MUSCLE_P...1,SET,202,0.050972,0.0053171,0.064007,0.21292,RUBENSTEIN_SKELETAL_MUSCLE_PCV_ENDOTHELIAL_CELLS,0.901778401727862
REACTOME_N_GLYCAN_TRIMMING_I...,SET,33,0.11644,0.0049319,0.14623,0.21294,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,0.901778401727862
MIR7705,SET,45,0.10218,0.0050524,0.12833,0.21295,MIR7705,0.901778401727862
GOBP_HYDROGEN_PEROXIDE_METAB...,SET,46,0.10724,0.0053611,0.13469,0.21297,GOBP_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...767,SET,6,0.24403,0.0044107,0.30652,0.21298,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.901778401727862
HMX1_01,SET,39,0.1164,0.0053592,0.14622,0.21299,HMX1_01,0.901778401727862
KEGG_MEDICUS_REFERENCE_ACTH_...,SET,32,0.1229,0.0051263,0.15438,0.213,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY,0.901778401727862
GOBP_APPENDAGE_MORPHOGENESIS,SET,139,0.062347,0.0054043,0.078332,0.21304,GOBP_APPENDAGE_MORPHOGENESIS,0.901778401727862
GOBP_CENTRAL_NERVOUS_SYSTEM_...5,SET,35,0.12216,0.0053286,0.15354,0.21314,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS,0.901778401727862
GSE22886_UNSTIM_VS_IL15_STIM...2,SET,171,0.050833,0.0048829,0.063897,0.21315,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP,0.901778401727862
GSE28783_ANTI_MIR33_VS_CTRL_...1,SET,166,0.054423,0.0051515,0.068415,0.21317,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN,0.901778401727862
GOBP_NUCLEOTIDE_EXCISION_REP...1,SET,80,0.068726,0.0045267,0.086403,0.21319,GOBP_NUCLEOTIDE_EXCISION_REPAIR,0.901778401727862
HP_GONADAL_DYSGENESIS,SET,28,0.11681,0.0045581,0.14685,0.21319,HP_GONADAL_DYSGENESIS,0.901778401727862
GOBP_DNA_INTEGRITY_CHECKPOIN...,SET,125,0.0554,0.0045556,0.069653,0.21321,GOBP_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.901778401727862
KIM_WT1_TARGETS_12HR_UP,SET,154,0.056462,0.0051493,0.071,0.21324,KIM_WT1_TARGETS_12HR_UP,0.901778401727862
MOROSETTI_FACIOSCAPULOHUMERA...1,SET,12,0.19933,0.0050944,0.25073,0.2133,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,0.901778401727862
COBLL1_TARGET_GENES,SET,115,0.059902,0.004726,0.075362,0.21335,COBLL1_TARGET_GENES,0.901778401727862
GOCC_CYTOPLASMIC_UBIQUITIN_L...,SET,6,0.28584,0.0051665,0.35963,0.21336,GOCC_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX,0.901778401727862
MORF_HEAB,SET,79,0.071818,0.0047009,0.090364,0.21338,MORF_HEAB,0.901778401727862
HP_POOR_SUCK,SET,126,0.063723,0.0052607,0.080176,0.21338,HP_POOR_SUCK,0.901778401727862
GSE2770_UNTREATED_VS_ACT_CD4...6,SET,180,0.050428,0.0049686,0.063452,0.21339,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...235,SET,5,0.34328,0.0056642,0.43196,0.2134,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION,0.901778401727862
FARMER_BREAST_CANCER_CLUSTER...2,SET,32,0.12172,0.0050771,0.15317,0.21341,FARMER_BREAST_CANCER_CLUSTER_2,0.901778401727862
RICKMAN_TUMOR_DIFFERENTIATED...4,SET,97,0.069093,0.0050088,0.086957,0.21344,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,0.901778401727862
JOHNSTONE_PARVB_TARGETS_3_DN,SET,757,0.024529,0.004877,0.030881,0.21351,JOHNSTONE_PARVB_TARGETS_3_DN,0.901778401727862
GGCGGCA_MIR371,SET,5,0.27841,0.0045939,0.35056,0.21354,GGCGGCA_MIR371,0.901778401727862
GSE22886_CD8_TCELL_VS_BCELL_...2,SET,183,0.048547,0.0048225,0.061125,0.21354,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP,0.901778401727862
GROSS_HYPOXIA_VIA_ELK3_AND_H...2,SET,125,0.063295,0.0052048,0.07971,0.21358,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,0.901778401727862
GOBP_MUSCLE_CELL_DEVELOPMENT,SET,185,0.051201,0.0051137,0.06448,0.21358,GOBP_MUSCLE_CELL_DEVELOPMENT,0.901778401727862
GOBP_SMOOTHENED_SIGNALING_PA...1,SET,129,0.058799,0.0049113,0.074047,0.21358,GOBP_SMOOTHENED_SIGNALING_PATHWAY,0.901778401727862
GOMF_RETINOL_BINDING,SET,14,0.19307,0.0053293,0.24317,0.21361,GOMF_RETINOL_BINDING,0.901778401727862
MORI_MATURE_B_LYMPHOCYTE_DN,SET,69,0.078182,0.0047839,0.098485,0.21365,MORI_MATURE_B_LYMPHOCYTE_DN,0.901778401727862
WP_PRIMARY_FOCAL_SEGMENTAL_G...,SET,70,0.083434,0.005142,0.1051,0.21365,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,0.901778401727862
YANG_BREAST_CANCER_ESR1_BULK...2,SET,25,0.11784,0.0043452,0.14845,0.21366,YANG_BREAST_CANCER_ESR1_BULK_UP,0.901778401727862
MIR1249_5P,SET,177,0.051405,0.0050229,0.06476,0.21367,MIR1249_5P,0.901778401727862
GAVISH_3CA_MALIGNANT_METAPRO...16,SET,46,0.1139,0.0056942,0.14351,0.21369,GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES,0.901778401727862
GSE14308_TH17_VS_INDUCED_TRE...1,SET,186,0.046821,0.0046886,0.058995,0.21371,GSE14308_TH17_VS_INDUCED_TREG_DN,0.901778401727862
FOXN3_TARGET_GENES,SET,1155,0.021401,0.0051961,0.026967,0.21372,FOXN3_TARGET_GENES,0.901778401727862
GOCC_NUCLEOCYTOPLASMIC_TRANS...,SET,12,0.18317,0.0046814,0.23087,0.21377,GOCC_NUCLEOCYTOPLASMIC_TRANSPORT_COMPLEX,0.901778401727862
REACTOME_AQUAPORIN_MEDIATED_...,SET,50,0.1061,0.0055292,0.13378,0.21386,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,0.901778401727862
GOMF_VOLTAGE_GATED_SODIUM_CH...1,SET,23,0.15331,0.0054228,0.19331,0.21388,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.901778401727862
REACTOME_INSULIN_PROCESSING,SET,23,0.14358,0.0050785,0.18105,0.21389,REACTOME_INSULIN_PROCESSING,0.901778401727862
MIR6845_5P,SET,56,0.089167,0.004917,0.11244,0.21389,MIR6845_5P,0.901778401727862
HP_ACUTE_HEPATIC_FAILURE,SET,31,0.11558,0.0047455,0.14577,0.21391,HP_ACUTE_HEPATIC_FAILURE,0.901778401727862
MIR4318,SET,100,0.069453,0.0051117,0.087601,0.21394,MIR4318,0.901778401727862
HP_CHOROIDAL_NEOVASCULARIZAT...,SET,19,0.1651,0.0053084,0.20825,0.21396,HP_CHOROIDAL_NEOVASCULARIZATION,0.901778401727862
GOBP_CELLULAR_RESPONSE_TO_SO...,SET,5,0.3066,0.0050589,0.38675,0.21397,GOBP_CELLULAR_RESPONSE_TO_SODIUM_ARSENITE,0.901778401727862
GOBP_NEURAL_CREST_CELL_DIFFE...,SET,87,0.078502,0.005391,0.099025,0.21397,GOBP_NEURAL_CREST_CELL_DIFFERENTIATION,0.901778401727862
GOCC_TRIGLYCERIDE_RICH_PLASM...,SET,14,0.20458,0.0056471,0.25811,0.21401,GOCC_TRIGLYCERIDE_RICH_PLASMA_LIPOPROTEIN_PARTICLE,0.901778401727862
GOBP_GANGLIOSIDE_BIOSYNTHETI...2,SET,6,0.25263,0.0045662,0.31881,0.21407,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS_VIA_LACTOSYLCERAMIDE,0.901778401727862
HP_ABNORMALITY_OF_EXOCRINE_P...,SET,66,0.084973,0.0050855,0.10724,0.21407,HP_ABNORMALITY_OF_EXOCRINE_PANCREAS_PHYSIOLOGY,0.901778401727862
HP_RENAL_STEATOSIS,SET,9,0.26189,0.005797,0.3305,0.21407,HP_RENAL_STEATOSIS,0.901778401727862
REACTOME_GLYCOGEN_STORAGE_DI...,SET,13,0.18551,0.0049347,0.23418,0.21413,REACTOME_GLYCOGEN_STORAGE_DISEASES,0.901778401727862
DESCARTES_FETAL_STOMACH_CILI...,SET,225,0.043944,0.0048348,0.055473,0.21414,DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS,0.901778401727862
GOBP_CELLULAR_RESPONSE_TO_OR...1,SET,483,0.032128,0.005142,0.04056,0.21415,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.901778401727862
HP_BROAD_PALM,SET,24,0.13787,0.0049815,0.17405,0.21415,HP_BROAD_PALM,0.901778401727862
TCGATGG_MIR213,SET,5,0.27638,0.0045603,0.34895,0.21417,TCGATGG_MIR213,0.901778401727862
MIR3606_5P,SET,141,0.058912,0.0051429,0.074384,0.21419,MIR3606_5P,0.901778401727862
KEGG_MEDICUS_REFERENCE_KINET...2,SET,19,0.16602,0.0053378,0.20968,0.21426,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT,0.901778401727862
HP_THICKENED_NUCHAL_SKIN_FOLD,SET,49,0.091121,0.0047011,0.11511,0.21429,HP_THICKENED_NUCHAL_SKIN_FOLD,0.901778401727862
GOBP_OLIGOPEPTIDE_IMPORT_ACR...,SET,5,0.32573,0.0053746,0.41149,0.21431,GOBP_OLIGOPEPTIDE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.901778401727862
KARAKAS_TGFB1_SIGNALING,SET,18,0.16091,0.0050357,0.20331,0.21435,KARAKAS_TGFB1_SIGNALING,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...467,SET,26,0.1393,0.0052382,0.17601,0.21435,GOBP_NEGATIVE_REGULATION_OF_ORGAN_GROWTH,0.901778401727862
GOBP_CENTRAL_NERVOUS_SYSTEM_...2,SET,6,0.29248,0.0052864,0.36959,0.21437,GOBP_CENTRAL_NERVOUS_SYSTEM_MATURATION,0.901778401727862
GOBP_REGULATION_OF_GROWTH_HO...,SET,6,0.30024,0.0054267,0.37939,0.21437,GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.901778401727862
GOCC_BARR_BODY,SET,2,0.53377,0.0055707,0.67455,0.21439,GOCC_BARR_BODY,0.901778401727862
HP_ORGANIC_ACIDURIA,SET,112,0.064866,0.0050508,0.081981,0.21441,HP_ORGANIC_ACIDURIA,0.901778401727862
GOBP_BARBED_END_ACTIN_FILAME...,SET,21,0.14259,0.0048195,0.18023,0.21444,GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING,0.901778401727862
GOBP_REGULATION_OF_FATTY_ACI...1,SET,17,0.1588,0.00483,0.20075,0.21446,GOBP_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.901778401727862
GOBP_GASTRULATION,SET,177,0.052995,0.0051782,0.066997,0.21448,GOBP_GASTRULATION,0.901778401727862
GOBP_SYNAPTIC_VESICLE_CLUSTE...,SET,15,0.18876,0.005393,0.23864,0.21449,GOBP_SYNAPTIC_VESICLE_CLUSTERING,0.901778401727862
HP_ABNORMAL_CIRCULATING_CREA...2,SET,49,0.095338,0.0049187,0.12053,0.21449,HP_ABNORMAL_CIRCULATING_CREATININE_CONCENTRATION,0.901778401727862
DARWICHE_SKIN_TUMOR_PROMOTER...2,SET,128,0.060157,0.0050054,0.076062,0.2145,DARWICHE_SKIN_TUMOR_PROMOTER_UP,0.901778401727862
CUI_DEVELOPING_HEART_SMOOTH_...,SET,41,0.11241,0.0053062,0.14214,0.21452,CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL,0.901778401727862
GSE19941_IL10_KO_VS_IL10_KO_...2,SET,177,0.051101,0.0049932,0.064617,0.21453,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.901778401727862
BROWNE_HCMV_INFECTION_20HR_DN,SET,90,0.073296,0.0051192,0.092699,0.21457,BROWNE_HCMV_INFECTION_20HR_DN,0.901778401727862
PID_S1P_S1P2_PATHWAY,SET,23,0.14069,0.0049766,0.17794,0.21457,PID_S1P_S1P2_PATHWAY,0.901778401727862
NAKAMURA_METASTASIS_MODEL_DN,SET,43,0.11053,0.0053427,0.13979,0.21458,NAKAMURA_METASTASIS_MODEL_DN,0.901778401727862
WP_H19_RBE2F1_AND_CDKBETACAT...,SET,13,0.17753,0.0047223,0.2246,0.21464,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,0.901778401727862
GSE28726_NAIVE_VS_ACTIVATED_...2,SET,173,0.052647,0.0050864,0.066608,0.21465,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP,0.901778401727862
AIZARANI_LIVER_C8_RESIDENT_B...,SET,30,0.12365,0.0049943,0.15644,0.21465,AIZARANI_LIVER_C8_RESIDENT_B_CELLS_1,0.901778401727862
HP_LOSS_OF_SPEECH,SET,45,0.09855,0.004873,0.1247,0.21468,HP_LOSS_OF_SPEECH,0.901778401727862
GSE37605_NOD_VS_C57BL6_IRES_...2,SET,140,0.058988,0.0051313,0.074661,0.21475,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP,0.901778401727862
YAMASHITA_METHYLATED_IN_PROS...,SET,59,0.094255,0.0053345,0.11931,0.21477,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,0.901778401727862
HP_ABNORMALITY_OF_THROMBOCYT...,SET,425,0.033059,0.0049712,0.041851,0.21479,HP_ABNORMALITY_OF_THROMBOCYTES,0.901778401727862
GOBP_REGULATION_OF_CENTRIOLE...,SET,22,0.13746,0.0047555,0.17403,0.21481,GOBP_REGULATION_OF_CENTRIOLE_REPLICATION,0.901778401727862
GOBP_MATURE_B_CELL_DIFFERENT...2,SET,29,0.12787,0.0050778,0.1619,0.21484,GOBP_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.901778401727862
BIOCARTA_FXR_PATHWAY,SET,7,0.25573,0.0049924,0.32385,0.21487,BIOCARTA_FXR_PATHWAY,0.901778401727862
KEGG_AUTOIMMUNE_THYROID_DISE...,SET,44,0.12066,0.0058996,0.15281,0.21489,KEGG_AUTOIMMUNE_THYROID_DISEASE,0.901778401727862
GOCC_CELL_BODY,SET,507,0.031306,0.00513,0.039651,0.2149,GOCC_CELL_BODY,0.901778401727862
KORKOLA_TERATOMA,SET,38,0.11559,0.0052532,0.1464,0.21491,KORKOLA_TERATOMA,0.901778401727862
GOMF_ATP_DEPENDENT_DNA_DNA_A...,SET,4,0.33173,0.0048959,0.42019,0.21492,GOMF_ATP_DEPENDENT_DNA_DNA_ANNEALING_ACTIVITY,0.901778401727862
GSE360_T_GONDII_VS_M_TUBERCU...3,SET,176,0.050398,0.0049106,0.063848,0.21496,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN,0.901778401727862
chr17q24,SET,32,0.20194,0.0084231,0.25586,0.21499,chr17q24,0.901778401727862
GCM_PPP1CC,SET,51,0.080636,0.004244,0.10217,0.21499,GCM_PPP1CC,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...481,SET,23,0.13144,0.0046491,0.16654,0.215,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.901778401727862
SMID_BREAST_CANCER_LUMINAL_A...2,SET,78,0.081146,0.0052778,0.10282,0.21501,SMID_BREAST_CANCER_LUMINAL_A_UP,0.901778401727862
chr1q25,SET,73,0.1738,0.010937,0.22026,0.21504,chr1q25,0.901778401727862
MOOTHA_GLYCOLYSIS,SET,17,0.13869,0.0042184,0.17577,0.21505,MOOTHA_GLYCOLYSIS,0.901778401727862
ZHONG_PFC_C6_PLXNA4_POS_EXCI...,SET,6,0.30203,0.005459,0.38278,0.21505,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.901778401727862
GOBP_REGULATION_OF_PHOSPHOLI...1,SET,7,0.27355,0.0053402,0.3467,0.21506,GOBP_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.901778401727862
HOEK_T_CELL_2011_2012_TIV_AD...3,SET,8,0.28339,0.0059142,0.35917,0.21506,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_DN,0.901778401727862
HP_NARROW_FACE,SET,83,0.075997,0.0050982,0.096325,0.21507,HP_NARROW_FACE,0.901778401727862
ZHENG_CORD_BLOOD_C4_PUTATIVE...,SET,86,0.075561,0.0051593,0.095782,0.21509,ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT,0.901778401727862
HP_RESPIRATORY_PARALYSIS,SET,7,0.28153,0.005496,0.35687,0.2151,HP_RESPIRATORY_PARALYSIS,0.901778401727862
KEGG_MEDICUS_VARIANT_MUTATIO...51,SET,9,0.19913,0.0044077,0.25248,0.21515,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.901778401727862
GOBP_CARBOHYDRATE_METABOLIC_...,SET,516,0.029948,0.0049496,0.037979,0.2152,GOBP_CARBOHYDRATE_METABOLIC_PROCESS,0.901778401727862
SA_G2_AND_M_PHASES,SET,8,0.20132,0.0042014,0.25532,0.21522,SA_G2_AND_M_PHASES,0.901778401727862
MIR1910_5P,SET,76,0.076431,0.0049073,0.096945,0.21524,MIR1910_5P,0.901778401727862
GSE20152_SPHK1_KO_VS_HTNFA_O...1,SET,177,0.048167,0.0047065,0.061096,0.21524,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN,0.901778401727862
GOBP_ATP_TRANSPORT,SET,19,0.1706,0.0054853,0.21644,0.21529,GOBP_ATP_TRANSPORT,0.901778401727862
GSE32423_IL7_VS_IL4_MEMORY_C...1,SET,181,0.047732,0.0047158,0.060559,0.2153,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN,0.901778401727862
HP_MILD_PROTEINURIA,SET,4,0.30603,0.0045166,0.3883,0.21532,HP_MILD_PROTEINURIA,0.901778401727862
BIOCARTA_EICOSANOID_PATHWAY,SET,21,0.16568,0.0056,0.21027,0.21537,BIOCARTA_EICOSANOID_PATHWAY,0.901778401727862
GOBP_CYTOLYSIS,SET,6,0.36165,0.0065367,0.45915,0.21545,GOBP_CYTOLYSIS,0.901778401727862
GOBP_REGULATION_OF_URINE_VOL...,SET,19,0.16693,0.0053672,0.21193,0.21546,GOBP_REGULATION_OF_URINE_VOLUME,0.901778401727862
HP_ABNORMAL_FETAL_GENITOURIN...,SET,11,0.22425,0.0054874,0.28475,0.21549,HP_ABNORMAL_FETAL_GENITOURINARY_SYSTEM_MORPHOLOGY,0.901778401727862
MODULE_395,SET,12,0.18814,0.0048084,0.23892,0.2155,MODULE_395,0.901778401727862
HP_TACHYPNEA,SET,88,0.067546,0.0046651,0.085775,0.21551,HP_TACHYPNEA,0.901778401727862
HP_SEVERE_POSTNATAL_GROWTH_R...,SET,32,0.12536,0.0052288,0.15921,0.21554,HP_SEVERE_POSTNATAL_GROWTH_RETARDATION,0.901778401727862
NUNODA_RESPONSE_TO_DASATINIB...2,SET,29,0.11893,0.0047228,0.15107,0.21558,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,0.901778401727862
GOMF_MRNA_3_UTR_BINDING,SET,98,0.065719,0.0047886,0.083499,0.21563,GOMF_MRNA_3_UTR_BINDING,0.901778401727862
GSE45739_NRAS_KO_VS_WT_UNSTI...2,SET,178,0.049802,0.0048799,0.063276,0.21563,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP,0.901778401727862
MIR511_3P,SET,154,0.053589,0.0048873,0.068093,0.21565,MIR511_3P,0.901778401727862
GOBP_POSITIVE_REGULATION_OF_...277,SET,61,0.091268,0.005252,0.11597,0.21565,GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.901778401727862
HP_DELAYED_PUBERTY,SET,177,0.051121,0.0049951,0.064979,0.21572,HP_DELAYED_PUBERTY,0.901778401727862
ARID3B_TARGET_GENES,SET,114,0.064684,0.0050811,0.082224,0.21574,ARID3B_TARGET_GENES,0.901778401727862
XBP1_01,SET,113,0.062862,0.0049165,0.079908,0.21574,XBP1_01,0.901778401727862
HP_IMPAIRED_DISTAL_VIBRATION...,SET,47,0.094209,0.0047605,0.11978,0.21578,HP_IMPAIRED_DISTAL_VIBRATION_SENSATION,0.901778401727862
GOBP_BONE_TRABECULA_FORMATION,SET,11,0.20759,0.0050796,0.26398,0.21583,GOBP_BONE_TRABECULA_FORMATION,0.901778401727862
GOBP_NUCLEUS_ORGANIZATION,SET,132,0.055867,0.00472,0.071055,0.21587,GOBP_NUCLEUS_ORGANIZATION,0.901778401727862
HP_EYE_OF_THE_TIGER_ANOMALY_...,SET,9,0.22586,0.0049994,0.28728,0.21588,HP_EYE_OF_THE_TIGER_ANOMALY_OF_GLOBUS_PALLIDUS,0.901778401727862
GSE5589_UNSTIM_VS_45MIN_LPS_...3,SET,178,0.047953,0.0046986,0.060994,0.21588,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN,0.901778401727862
GOBP_REGULATION_OF_SPERM_CAP...,SET,4,0.38436,0.0056726,0.48894,0.21591,GOBP_REGULATION_OF_SPERM_CAPACITATION,0.901778401727862
KEGG_MEDICUS_REFERENCE_ANTER...,SET,23,0.1386,0.0049025,0.17632,0.21592,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT,0.901778401727862
E2F_01,SET,59,0.08356,0.0047292,0.10633,0.21598,E2F_01,0.901778401727862
HASEGAWA_TUMORIGENESIS_BY_RE...,SET,9,0.20811,0.0046064,0.26489,0.21605,HASEGAWA_TUMORIGENESIS_BY_RET_C634R,0.901778401727862
MIR3659,SET,73,0.080092,0.0050402,0.10197,0.2161,MIR3659,0.901778401727862
GOMF_LONG_CHAIN_FATTY_ACID_B...,SET,16,0.15804,0.0046633,0.2012,0.2161,GOMF_LONG_CHAIN_FATTY_ACID_BINDING,0.901778401727862
HP_HYPEROSTOSIS,SET,47,0.090972,0.0045969,0.11582,0.2161,HP_HYPEROSTOSIS,0.901778401727862
GOBP_EYE_PIGMENTATION,SET,4,0.3413,0.0050372,0.43458,0.21613,GOBP_EYE_PIGMENTATION,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...79,SET,6,0.28782,0.0052022,0.36649,0.21613,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.901778401727862
MIR6852_3P,SET,134,0.059016,0.0050234,0.075148,0.21614,MIR6852_3P,0.901778401727862
GTCTACC_MIR379,SET,22,0.1615,0.005587,0.20565,0.21615,GTCTACC_MIR379,0.901778401727862
HP_PROPTOSIS,SET,257,0.041423,0.0048664,0.052755,0.21618,HP_PROPTOSIS,0.901778401727862
GSE10856_CTRL_VS_TNFRSF6B_IN...2,SET,157,0.054977,0.0050621,0.070019,0.21618,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP,0.901778401727862
GOBP_NEGATIVE_REGULATION_OF_...455,SET,61,0.081788,0.0047065,0.10417,0.21619,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION,0.901778401727862
GSE40274_CTRL_VS_FOXP3_AND_X...2,SET,148,0.050827,0.004545,0.06474,0.2162,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.901778401727862
GOBP_REGULATION_OF_STORE_OPE...2,SET,14,0.18812,0.0051927,0.23963,0.21622,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY,0.901778401727862
HP_ABNORMALITY_OF_THE_MENSTR...,SET,290,0.039967,0.0049832,0.050916,0.21624,HP_ABNORMALITY_OF_THE_MENSTRUAL_CYCLE,0.901778401727862
MIR5011_3P,SET,46,0.10413,0.0052057,0.13268,0.21628,MIR5011_3P,0.90183700059988
FIGUEROA_AML_METHYLATION_CLU...12,SET,127,0.060943,0.005051,0.077682,0.21637,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,0.902104048704415
HP_IMPAIRMENT_OF_ACTIVITIES_...,SET,170,0.052708,0.0050483,0.067201,0.21643,HP_IMPAIRMENT_OF_ACTIVITIES_OF_DAILY_LIVING,0.9022459697733
GOBP_REGULATION_OF_CELLULAR_...10,SET,285,0.042135,0.0052088,0.053744,0.21653,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.902538438024455
GOBP_ACUTE_INFLAMMATORY_RESP...1,SET,99,0.073614,0.005391,0.093918,0.21658,GOBP_ACUTE_INFLAMMATORY_RESPONSE,0.902538438024455
DESCARTES_FETAL_STOMACH_VASC...,SET,28,0.14212,0.0055459,0.18135,0.21661,DESCARTES_FETAL_STOMACH_VASCULAR_ENDOTHELIAL_CELLS,0.902538438024455
GOBP_POSITIVE_REGULATION_OF_...185,SET,454,0.033053,0.0051329,0.042177,0.21662,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.902538438024455
MORF_GPX4,SET,47,0.090871,0.0045918,0.11596,0.21663,MORF_GPX4,0.902538438024455
WP_PI3KAKT_SIGNALING,SET,322,0.039615,0.0052001,0.050573,0.21672,WP_PI3KAKT_SIGNALING,0.902605589503954
KEGG_MEDICUS_REFERENCE_TYPE_...1,SET,18,0.20832,0.0065196,0.26596,0.21673,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.902605589503954
GOBP_ORGANIC_HYDROXY_COMPOUN...2,SET,50,0.1022,0.0053261,0.13048,0.21674,GOBP_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS,0.902605589503954
ZHONG_SECRETOME_OF_LUNG_CANC...3,SET,69,0.079685,0.0048758,0.10174,0.21675,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,0.902605589503954
MMEF2_Q6,SET,245,0.044305,0.0050837,0.056572,0.21678,MMEF2_Q6,0.902622367317599
GOBP_PROTEIN_LOCALIZATION_TO...9,SET,318,0.037798,0.0049312,0.048283,0.21687,GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.902888937470053
GOBP_REGULATION_OF_NEUROMUSC...,SET,7,0.26045,0.0050846,0.33292,0.21702,GOBP_REGULATION_OF_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.903305459116485
HE_LIM_SUN_FETAL_LUNG_C0_ASP...,SET,105,0.069219,0.0052196,0.088485,0.21703,HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE,0.903305459116485
GOBP_POSITIVE_REGULATION_OF_...817,SET,92,0.070882,0.005005,0.090623,0.21706,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.903305459116485
KEGG_GLYCOSAMINOGLYCAN_DEGRA...,SET,20,0.1602,0.0052844,0.20483,0.21708,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,0.903305459116485
GOBP_ALCOHOL_CATABOLIC_PROCE...,SET,31,0.1333,0.0054729,0.17046,0.2171,GOBP_ALCOHOL_CATABOLIC_PROCESS,0.903305459116485
KORKOLA_EMBRYONAL_CARCINOMA,SET,8,0.22449,0.004685,0.28712,0.21715,KORKOLA_EMBRYONAL_CARCINOMA,0.90333881508079
GOBP_SEMICIRCULAR_CANAL_MORP...,SET,7,0.28762,0.005615,0.36787,0.21716,GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS,0.90333881508079
REACTOME_PHOSPHOLIPID_METABO...,SET,189,0.048476,0.004893,0.062016,0.21721,REACTOME_PHOSPHOLIPID_METABOLISM,0.903438672809957
MIR549A_3P,SET,69,0.08151,0.0049875,0.10432,0.2173,MIR549A_3P,0.903480444656945
GOMF_BETA_CATENIN_BINDING,SET,98,0.071215,0.005189,0.091148,0.21731,GOMF_BETA_CATENIN_BINDING,0.903480444656945
GOBP_PHOSPHATIDYLINOSITOL_PH...,SET,59,0.085876,0.0048603,0.10992,0.21734,GOBP_PHOSPHATIDYLINOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.903480444656945
WANG_NFKB_TARGETS,SET,24,0.13406,0.0048439,0.17165,0.2174,WANG_NFKB_TARGETS,0.903480444656945
PID_PLK1_PATHWAY,SET,42,0.095363,0.0045559,0.1221,0.2174,PID_PLK1_PATHWAY,0.903480444656945
chr8q12,SET,27,0.23942,0.0091746,0.30661,0.21744,chr8q12,0.903480444656945
OHGUCHI_LIVER_HNF4A_TARGETS_...2,SET,45,0.10375,0.0051299,0.13286,0.21744,OHGUCHI_LIVER_HNF4A_TARGETS_UP,0.903480444656945
CHIARADONNA_NEOPLASTIC_TRANS...3,SET,49,0.10212,0.0052683,0.13079,0.21748,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,0.903480444656945
FREDERICK_PRKCI_TARGETS,SET,9,0.22273,0.00493,0.28527,0.21748,FREDERICK_PRKCI_TARGETS,0.903480444656945
MIR4749_3P,SET,49,0.092569,0.0047758,0.11857,0.21748,MIR4749_3P,0.903480444656945
MIR8070,SET,116,0.065925,0.0052235,0.084453,0.21752,MIR8070,0.903538615991395
GSE3920_UNTREATED_VS_IFNB_TR...1,SET,157,0.052501,0.0048341,0.067311,0.21771,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.904200839085932
GOBP_PROTEIN_N_LINKED_GLYCOS...1,SET,69,0.078318,0.0047922,0.10043,0.21774,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION,0.904200839085932
GSE5589_UNSTIM_VS_45MIN_LPS_...5,SET,182,0.04623,0.0045799,0.0593,0.21782,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN,0.904200839085932
GOBP_SUCCINATE_METABOLIC_PRO...,SET,7,0.27928,0.0054522,0.35827,0.21784,GOBP_SUCCINATE_METABOLIC_PROCESS,0.904200839085932
MIR548AS_5P,SET,441,0.032284,0.004943,0.041417,0.21785,MIR548AS_5P,0.904200839085932
HP_ABNORMALITY_OF_AMINO_ACID...,SET,7,0.24705,0.004823,0.31701,0.2179,HP_ABNORMALITY_OF_AMINO_ACID_METABOLISM,0.904200839085932
FOURNIER_ACINAR_DEVELOPMENT_...1,SET,6,0.31075,0.0056166,0.39876,0.21791,FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN,0.904200839085932
HP_INTERMITTENT_EPISODES_OF_...,SET,13,0.19202,0.0051076,0.24651,0.21801,HP_INTERMITTENT_EPISODES_OF_RESPIRATORY_INSUFFICIENCY_DUE_TO_MUSCLE_WEAKNESS,0.904200839085932
WHITFIELD_CELL_CYCLE_G2,SET,152,0.051867,0.0046998,0.066594,0.21804,WHITFIELD_CELL_CYCLE_G2,0.904200839085932
HP_ABNORMAL_ARACHNOID_MATER_...,SET,48,0.091124,0.0046532,0.117,0.21804,HP_ABNORMAL_ARACHNOID_MATER_MORPHOLOGY,0.904200839085932
GOBP_MODIFICATION_DEPENDENT_...,SET,565,0.027053,0.0046722,0.034739,0.21806,GOBP_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS,0.904200839085932
HP_SLOW_SACCADIC_EYE_MOVEMEN...,SET,34,0.1098,0.0047207,0.14101,0.21808,HP_SLOW_SACCADIC_EYE_MOVEMENTS,0.904200839085932
FARDIN_HYPOXIA_9,SET,7,0.24638,0.0048099,0.31644,0.21812,FARDIN_HYPOXIA_9,0.904200839085932
MORF_PTEN,SET,77,0.071572,0.0046253,0.091943,0.21816,MORF_PTEN,0.904200839085932
HP_ABNORMAL_LYMPHOCYTE_APOPT...,SET,8,0.22366,0.0046677,0.28734,0.21818,HP_ABNORMAL_LYMPHOCYTE_APOPTOSIS,0.904200839085932
MIR6873_5P,SET,93,0.070141,0.0049793,0.090131,0.21823,MIR6873_5P,0.904200839085932
TAKEDA_TARGETS_OF_NUP98_HOXA...3,SET,111,0.067237,0.0052122,0.086413,0.21826,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,0.904200839085932
GOCC_PHAGOCYTIC_CUP,SET,26,0.13089,0.0049222,0.16823,0.21827,GOCC_PHAGOCYTIC_CUP,0.904200839085932
GOMF_INOSITOL_1_3_4_5_TETRAK...,SET,5,0.30224,0.0049871,0.38846,0.21827,GOMF_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_BINDING,0.904200839085932
GOBP_PHOSPHOLIPID_DEPHOSPHOR...,SET,27,0.10928,0.0041876,0.1405,0.21835,GOBP_PHOSPHOLIPID_DEPHOSPHORYLATION,0.904200839085932
GSE17721_LPS_VS_POLYIC_6H_BM...2,SET,182,0.050466,0.0049996,0.064891,0.21838,GSE17721_LPS_VS_POLYIC_6H_BMDC_UP,0.904200839085932
FAN_EMBRYONIC_CTX_ASTROCYTE_2,SET,138,0.063652,0.0054977,0.081856,0.2184,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.904200839085932
GOBP_ZYGOTIC_DETERMINATION_O...,SET,6,0.36491,0.0065955,0.46942,0.21848,GOBP_ZYGOTIC_DETERMINATION_OF_ANTERIOR_POSTERIOR_AXIS_EMBRYO,0.904200839085932
GSE2128_CTRL_VS_MIMETOPE_NEG...2,SET,158,0.054183,0.0050047,0.069707,0.2185,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP,0.904200839085932
GRE_C,SET,112,0.06485,0.0050496,0.08344,0.21852,GRE_C,0.904200839085932
GOBP_NEURONAL_ACTION_POTENTI...1,SET,33,0.12357,0.0052343,0.159,0.21852,GOBP_NEURONAL_ACTION_POTENTIAL,0.904200839085932
REACTOME_SIGNALING_BY_PDGFR_...,SET,20,0.14189,0.0046807,0.18258,0.21853,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,0.904200839085932
GOBP_REGULATION_OF_SISTER_CH...1,SET,11,0.22214,0.0054356,0.28582,0.21853,GOBP_REGULATION_OF_SISTER_CHROMATID_COHESION,0.904200839085932
GOBP_POSITIVE_REGULATION_OF_...665,SET,9,0.21678,0.0047983,0.27895,0.21855,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CLUSTERING,0.904200839085932
GOBP_LUTEINIZATION,SET,11,0.22156,0.0054215,0.28512,0.21856,GOBP_LUTEINIZATION,0.904200839085932
GOLUB_ALL_VS_AML_UP,SET,24,0.14215,0.0051362,0.18295,0.21858,GOLUB_ALL_VS_AML_UP,0.904200839085932
MIR6821_3P,SET,47,0.092771,0.0046878,0.11939,0.21858,MIR6821_3P,0.904200839085932
HP_KNEE_DISLOCATION,SET,13,0.18228,0.0048488,0.2346,0.21858,HP_KNEE_DISLOCATION,0.904200839085932
GOMF_CIS_REGULATORY_REGION_S...,SET,1110,0.02228,0.0053101,0.028676,0.21859,GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.904200839085932
HP_RECURRENT_BACTERIAL_INFEC...,SET,184,0.049792,0.0049596,0.064085,0.21859,HP_RECURRENT_BACTERIAL_INFECTIONS,0.904200839085932
GOBP_DUCTUS_ARTERIOSUS_CLOSU...,SET,5,0.35094,0.0057906,0.4518,0.21866,GOBP_DUCTUS_ARTERIOSUS_CLOSURE,0.904382756158515
GOMF_ALPHA_TUBULIN_BINDING,SET,35,0.10374,0.0045251,0.1336,0.21874,GOMF_ALPHA_TUBULIN_BINDING,0.904572564529559
MINGUEZ_LIVER_CANCER_VASCULA...2,SET,13,0.17294,0.0046002,0.22278,0.2188,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,0.904572564529559
GSE20151_CTRL_VS_FUSOBACT_NU...1,SET,174,0.049167,0.0047637,0.063341,0.21881,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN,0.904572564529559
GSE37533_PPARG2_FOXP3_VS_FOX...2,SET,172,0.048481,0.0046704,0.062457,0.21881,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.904572564529559
CHICAS_RB1_TARGETS_CONFLUENT,SET,500,0.031832,0.0051811,0.041016,0.21885,CHICAS_RB1_TARGETS_CONFLUENT,0.904630322312084
GSE21670_UNTREATED_VS_TGFB_I...4,SET,180,0.048568,0.0047853,0.062592,0.2189,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.904695318997267
GAVISH_3CA_MALIGNANT_METAPRO...7,SET,45,0.10896,0.0053877,0.14045,0.21894,GAVISH_3CA_MALIGNANT_METAPROGRAM_16_MES_GLIOMA,0.904695318997267
KEGG_PANTOTHENATE_AND_COA_BI...,SET,16,0.17125,0.0050532,0.2208,0.219,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,0.904695318997267
GOBP_GLYCOSAMINOGLYCAN_CATAB...,SET,26,0.13109,0.0049296,0.16903,0.21901,GOBP_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS,0.904695318997267
REACTOME_SENSORY_PERCEPTION_...2,SET,45,0.11346,0.0056103,0.14632,0.21904,REACTOME_SENSORY_PERCEPTION_OF_TASTE,0.904695318997267
HP_LIMITED_EXTRAOCULAR_MOVEM...,SET,14,0.16985,0.0046884,0.21905,0.21907,HP_LIMITED_EXTRAOCULAR_MOVEMENTS,0.904695318997267
MIR5587_5P,SET,101,0.065445,0.0048406,0.08441,0.21908,MIR5587_5P,0.904695318997267
WANG_BARRETTS_ESOPHAGUS_AND_...1,SET,33,0.11499,0.0048706,0.14832,0.2191,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,0.904695318997267
GSE11924_TFH_VS_TH17_CD4_TCE...2,SET,176,0.046609,0.0045415,0.060121,0.2191,GSE11924_TFH_VS_TH17_CD4_TCELL_UP,0.904695318997267
WEBER_METHYLATED_LCP_IN_FIBR...2,SET,11,0.19827,0.0048516,0.25579,0.21914,WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP,0.904752993585175
GSE14000_TRANSLATED_RNA_VS_M...3,SET,152,0.052133,0.0047238,0.067296,0.21927,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN,0.905173566084788
ZHAN_MULTIPLE_MYELOMA_PR_UP,SET,41,0.10178,0.0048042,0.1314,0.2193,ZHAN_MULTIPLE_MYELOMA_PR_UP,0.905173566084788
HAY_BONE_MARROW_FOLLICULAR_B...,SET,125,0.062672,0.0051536,0.080919,0.21932,HAY_BONE_MARROW_FOLLICULAR_B_CELL,0.905173566084788
GOCC_CILIARY_TRANSITION_FIBER,SET,8,0.23324,0.0048677,0.30123,0.21938,GOCC_CILIARY_TRANSITION_FIBER,0.905247471209783
GOCC_CHROMOSOME_TELOMERIC_RE...1,SET,134,0.053656,0.0045671,0.069298,0.21939,GOCC_CHROMOSOME_TELOMERIC_REGION,0.905247471209783
HP_X_LINKED_RECESSIVE_INHERI...,SET,10,0.19832,0.004627,0.25617,0.21943,HP_X_LINKED_RECESSIVE_INHERITANCE,0.905305039173789
GOBP_ALTERNATIVE_MRNA_SPLICI...,SET,67,0.075463,0.0045503,0.097512,0.2195,GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.905395176219295
MIR659_5P,SET,25,0.13621,0.0050228,0.17601,0.21951,MIR659_5P,0.905395176219295
GOBP_CELLULAR_RESPONSE_TO_IN...5,SET,196,0.047022,0.0048324,0.06077,0.21953,GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.905395176219295
KEGG_MEDICUS_REFERENCE_RIG_I...2,SET,17,0.20069,0.0061041,0.25947,0.21963,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY,0.905517783444023
GOBP_MUSCLE_CELL_MIGRATION,SET,80,0.077553,0.0051081,0.10027,0.21964,GOBP_MUSCLE_CELL_MIGRATION,0.905517783444023
GSE339_CD4POS_VS_CD8POS_DC_UP,SET,183,0.049213,0.0048887,0.063636,0.21967,GSE339_CD4POS_VS_CD8POS_DC_UP,0.905517783444023
GSE46606_UNSTIM_VS_CD40L_IL2...8,SET,182,0.045801,0.0045375,0.059229,0.21968,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.905517783444023
RYTTCCTG_ETS2_B,SET,1007,0.02202,0.0050137,0.028477,0.21969,RYTTCCTG_ETS2_B,0.905517783444023
HP_ABNORMALITY_THIGH_MUSCULA...,SET,15,0.1818,0.0051944,0.23529,0.21987,HP_ABNORMALITY_THIGH_MUSCULATURE_MORPHOLOGY,0.905968407960199
DESCARTES_MAIN_FETAL_INTESTI...,SET,69,0.081611,0.0049937,0.10563,0.21989,DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS,0.905968407960199
KEGG_MEDICUS_PATHOGEN_HTLV_1...3,SET,5,0.30578,0.0050454,0.3958,0.2199,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_E47_MEDIATED_TRANSCRIPTION,0.905968407960199
GOBP_CELLULAR_RESPONSE_TO_IN...8,SET,78,0.077778,0.0050587,0.1007,0.21995,GOBP_CELLULAR_RESPONSE_TO_INTERLEUKIN_1,0.905968407960199
GOBP_LOCALIZATION_OF_CELL,SET,5,0.29182,0.0048152,0.37788,0.21998,GOBP_LOCALIZATION_OF_CELL,0.905968407960199
GOBP_SNRNA_TRANSCRIPTION,SET,20,0.13728,0.0045284,0.17776,0.21998,GOBP_SNRNA_TRANSCRIPTION,0.905968407960199
GOBP_POSITIVE_REGULATION_OF_...358,SET,28,0.12087,0.0047168,0.15652,0.21999,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.905968407960199
DESCARTES_FETAL_PANCREAS_CCL...,SET,43,0.11146,0.0053876,0.14434,0.22001,DESCARTES_FETAL_PANCREAS_CCL19_CCL21_POSITIVE_CELLS,0.905968407960199
GAVISH_3CA_MALIGNANT_METAPRO...23,SET,48,0.1024,0.0052288,0.13263,0.22006,GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR,0.905968407960199
GOBP_PLATELET_ACTIVATING_FAC...,SET,8,0.23242,0.0048504,0.30105,0.22006,GOBP_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS,0.905968407960199
GSE27670_BLIMP1_VS_LMP1_TRAN...2,SET,177,0.050235,0.0049086,0.065082,0.2201,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.906000781620085
GSE1740_MCSF_VS_MCSF_AND_IFN...2,SET,161,0.052901,0.0049321,0.068543,0.22012,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP,0.906000781620085
MIR8082,SET,104,0.064134,0.0048132,0.08312,0.22018,MIR8082,0.906140426287744
LE_EGR2_TARGETS_DN,SET,103,0.06642,0.0049609,0.086118,0.22028,LE_EGR2_TARGETS_DN,0.906378471646739
GOBP_MYELOID_LEUKOCYTE_CYTOK...,SET,47,0.10396,0.0052534,0.1348,0.22029,GOBP_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION,0.906378471646739
TGASTMAGC_NFE2_01,SET,172,0.049686,0.0047865,0.064458,0.22041,TGASTMAGC_NFE2_01,0.906502314049587
REACTOME_SYNTHESIS_OF_WYBUTO...,SET,6,0.22873,0.0041342,0.2968,0.22046,REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE,0.906502314049587
GOBP_RESPONSE_TO_XENOBIOTIC_...,SET,417,0.034292,0.005109,0.044507,0.22051,GOBP_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.906502314049587
GSE12845_IGD_NEG_BLOOD_VS_PR...1,SET,182,0.046307,0.0045876,0.060103,0.22052,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.906502314049587
DEMAGALHAES_AGING_DN,SET,13,0.17646,0.004694,0.22907,0.22055,DEMAGALHAES_AGING_DN,0.906502314049587
KEGG_MEDICUS_REFERENCE_THYRO...,SET,8,0.22546,0.0047053,0.2928,0.22065,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY,0.906502314049587
GOBP_DISTAL_TUBULE_DEVELOPME...,SET,11,0.22251,0.0054448,0.28904,0.2207,GOBP_DISTAL_TUBULE_DEVELOPMENT,0.906502314049587
GOBP_EMBRYONIC_SKELETAL_JOIN...1,SET,14,0.19325,0.0053344,0.25104,0.22071,GOBP_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT,0.906502314049587
KEGG_GLYCOLYSIS_GLUCONEOGENE...,SET,54,0.091439,0.0049517,0.1188,0.22074,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,0.906502314049587
VALK_AML_CLUSTER_13,SET,29,0.13402,0.0053222,0.17413,0.22075,VALK_AML_CLUSTER_13,0.906502314049587
HOEK_B_CELL_2011_2012_TIV_AD...3,SET,30,0.1166,0.0047094,0.15149,0.22075,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_UP,0.906502314049587
GSE17974_0H_VS_72H_IN_VITRO_...2,SET,162,0.053374,0.0049914,0.069347,0.22076,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP,0.906502314049587
HP_CUBITUS_VALGUS,SET,45,0.094269,0.0046613,0.12249,0.22077,HP_CUBITUS_VALGUS,0.906502314049587
chr12q14,SET,32,0.18633,0.0077722,0.24214,0.2208,chr12q14,0.906502314049587
ZNF486_TARGET_GENES,SET,160,0.052765,0.0049042,0.06857,0.2208,ZNF486_TARGET_GENES,0.906502314049587
GSE15659_NONSUPPRESSIVE_TCEL...2,SET,161,0.053077,0.0049484,0.068973,0.2208,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP,0.906502314049587
REACTOME_INTERLEUKIN_6_FAMIL...,SET,24,0.1311,0.004737,0.17038,0.22081,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,0.906502314049587
HP_SKIN_RASH,SET,147,0.056741,0.0050568,0.073746,0.22083,HP_SKIN_RASH,0.906502314049587
GSE19888_ADENOSINE_A3R_INH_V...8,SET,183,0.048683,0.0048361,0.063282,0.22086,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.906502314049587
COLDREN_GEFITINIB_RESISTANCE...1,SET,205,0.048206,0.0050653,0.062667,0.22088,COLDREN_GEFITINIB_RESISTANCE_DN,0.906502314049587
GOBP_FC_GAMMA_RECEPTOR_SIGNA...,SET,31,0.13157,0.0054018,0.17107,0.22092,GOBP_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY,0.906502314049587
GOBP_MYOFIBROBLAST_DIFFERENT...,SET,10,0.18463,0.0043078,0.24006,0.22092,GOBP_MYOFIBROBLAST_DIFFERENTIATION,0.906502314049587
GOBP_RESPONSE_TO_INTERLEUKIN...9,SET,35,0.11167,0.0048709,0.14519,0.22092,GOBP_RESPONSE_TO_INTERLEUKIN_4,0.906502314049587
HP_PITUITARY_GROWTH_HORMONE_...,SET,16,0.15239,0.0044966,0.19817,0.22096,HP_PITUITARY_GROWTH_HORMONE_CELL_ADENOMA,0.906559414472907
GOBP_CONDITIONED_PLACE_PREFE...,SET,5,0.29969,0.004945,0.38982,0.22101,GOBP_CONDITIONED_PLACE_PREFERENCE,0.906657524787535
GOBP_STRESS_FIBER_ASSEMBLY,SET,103,0.06767,0.0050542,0.088065,0.22113,GOBP_STRESS_FIBER_ASSEMBLY,0.907042741649947
GSE19888_CTRL_VS_A3R_ACT_TRE...1,SET,178,0.047655,0.0046694,0.062031,0.22118,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN,0.907094469260609
GSE5455_HEALTHY_VS_TUMOR_BEA...1,SET,179,0.05019,0.0049316,0.065345,0.22122,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN,0.907094469260609
HP_EPISPADIAS,SET,25,0.12758,0.0047045,0.16612,0.22125,HP_EPISPADIAS,0.907094469260609
GSE29618_LAIV_VS_TIV_FLU_VAC...7,SET,173,0.050459,0.0048749,0.065711,0.22128,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN,0.907094469260609
HP_ABNORMAL_JEJUNUM_MORPHOLO...,SET,9,0.21933,0.0048549,0.28579,0.22141,HP_ABNORMAL_JEJUNUM_MORPHOLOGY,0.907094469260609
MIR4708_5P,SET,80,0.071083,0.0046819,0.092623,0.22142,MIR4708_5P,0.907094469260609
HP_FOCAL_ONSET_SEIZURE,SET,296,0.037679,0.0047455,0.049098,0.22142,HP_FOCAL_ONSET_SEIZURE,0.907094469260609
GNF2_HLA_C,SET,40,0.10365,0.0048326,0.13506,0.22143,GNF2_HLA_C,0.907094469260609
MAFG_TARGET_GENES,SET,1313,0.018508,0.0047691,0.024124,0.22149,MAFG_TARGET_GENES,0.907094469260609
GOBP_CELLULAR_RESPONSE_TO_ZI...,SET,20,0.16942,0.0055885,0.22088,0.22154,GOBP_CELLULAR_RESPONSE_TO_ZINC_ION,0.907094469260609
GOCC_INTERCALATED_DISC,SET,50,0.098774,0.0051475,0.12879,0.22155,GOCC_INTERCALATED_DISC,0.907094469260609
MORF_SS18,SET,56,0.082131,0.004529,0.10711,0.22161,MORF_SS18,0.907094469260609
GOCC_GBAF_COMPLEX,SET,12,0.18933,0.0048386,0.24691,0.22161,GOCC_GBAF_COMPLEX,0.907094469260609
REACTOME_THE_CANONICAL_RETIN...,SET,22,0.14196,0.0049112,0.18514,0.22162,REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION,0.907094469260609
GSE11864_CSF1_IFNG_VS_CSF1_P...2,SET,174,0.048861,0.004734,0.063725,0.22162,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP,0.907094469260609
MIR6820_3P,SET,88,0.069728,0.0048158,0.090943,0.22163,MIR6820_3P,0.907094469260609
GOBP_POSITIVE_REGULATION_OF_...616,SET,6,0.24806,0.0044835,0.32362,0.22169,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION,0.907094469260609
GSE46606_DAY1_VS_DAY3_CD40L_...6,SET,176,0.050361,0.0049071,0.065711,0.22172,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP,0.907094469260609
GOBP_NEGATIVE_REGULATION_OF_...19,SET,5,0.28539,0.0047089,0.37238,0.22173,GOBP_NEGATIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.907094469260609
GSE37534_UNTREATED_VS_GW1929...2,SET,183,0.049437,0.0049109,0.064508,0.22173,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.907094469260609
REACTOME_GAMMA_CARBOXYLATION...2,SET,9,0.21572,0.0047749,0.28152,0.22177,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,0.907094469260609
GOCC_POSTSYNAPTIC_SPECIALIZA...2,SET,19,0.14759,0.0047454,0.19262,0.22178,GOCC_POSTSYNAPTIC_SPECIALIZATION_INTRACELLULAR_COMPONENT,0.907094469260609
KEGG_MEDICUS_REFERENCE_CXCR4...4,SET,31,0.12495,0.00513,0.16309,0.2218,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.907094469260609
GOBP_REGULATION_OF_TRIGLYCER...1,SET,18,0.14272,0.0044664,0.18633,0.22186,GOBP_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.907094469260609
MORF_RAB5A,SET,85,0.062822,0.0042646,0.082026,0.22188,MORF_RAB5A,0.907094469260609
GOBP_CELL_CYCLE_DNA_REPLICAT...2,SET,4,0.31426,0.0046381,0.41034,0.22188,GOBP_CELL_CYCLE_DNA_REPLICATION_INITIATION,0.907094469260609
GSE16385_UNTREATED_VS_12H_RO...6,SET,142,0.058402,0.0051162,0.076256,0.22188,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.907094469260609
GCM_MAP4K4,SET,161,0.048964,0.004565,0.063941,0.22191,GCM_MAP4K4,0.907094469260609
ZNF816_TARGET_GENES,SET,419,0.032673,0.0048792,0.042672,0.22194,ZNF816_TARGET_GENES,0.907094469260609
GOBP_REGULATION_OF_SPINDLE_A...,SET,32,0.1044,0.0043547,0.13636,0.22196,GOBP_REGULATION_OF_SPINDLE_ASSEMBLY,0.907094469260609
GOBP_TELOMERASE_RNA_LOCALIZA...,SET,18,0.14053,0.0043979,0.18357,0.22199,GOBP_TELOMERASE_RNA_LOCALIZATION,0.907094469260609
GOBP_REGULATION_OF_BONE_RESO...,SET,42,0.11173,0.0053377,0.14596,0.222,GOBP_REGULATION_OF_BONE_RESORPTION,0.907094469260609
MIR9903,SET,44,0.099012,0.0048413,0.12937,0.22203,MIR9903,0.907094469260609
HP_INTESTINAL_PERFORATION,SET,5,0.25956,0.0042828,0.33914,0.22203,HP_INTESTINAL_PERFORATION,0.907094469260609
MODULE_123,SET,232,0.044451,0.0049651,0.058098,0.22211,MODULE_123,0.907203820870994
GSE23505_IL6_IL1_VS_IL6_IL1_...2,SET,178,0.048066,0.0047097,0.06283,0.22214,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.907203820870994
MIR5589_3P,SET,149,0.055504,0.0049798,0.072564,0.22217,MIR5589_3P,0.907203820870994
GSE31082_DP_VS_CD8_SP_THYMOC...2,SET,180,0.045877,0.0045202,0.059984,0.22219,GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP,0.907203820870994
HP_AXONAL_DEGENERATION,SET,20,0.13976,0.0046102,0.18276,0.22223,HP_AXONAL_DEGENERATION,0.907203820870994
GSE12392_WT_VS_IFNB_KO_CD8A_...1,SET,183,0.050156,0.0049824,0.065592,0.22224,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN,0.907203820870994
CTCAGGG_MIR125B_MIR125A,SET,303,0.036566,0.0046586,0.047822,0.22225,CTCAGGG_MIR125B_MIR125A,0.907203820870994
LEE_LIVER_CANCER_MYC_TGFA_DN,SET,57,0.091318,0.0050802,0.11946,0.22232,LEE_LIVER_CANCER_MYC_TGFA_DN,0.907203820870994
GSE43863_DAY6_EFF_VS_DAY150_...6,SET,179,0.050246,0.004937,0.065737,0.22233,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP,0.907203820870994
GOMF_PROTEIN_TYROSINE_KINASE...3,SET,117,0.059742,0.0047539,0.078166,0.22235,GOMF_PROTEIN_TYROSINE_KINASE_BINDING,0.907203820870994
WP_TCELL_ANTIGEN_RECEPTOR_TC...,SET,59,0.084827,0.0048009,0.111,0.22237,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,0.907203820870994
HP_WRIST_DROP,SET,7,0.25908,0.0050577,0.339,0.22237,HP_WRIST_DROP,0.907203820870994
WP_FIBRIN_COMPLEMENT_RECEPTO...,SET,41,0.10602,0.0050044,0.13879,0.22247,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.907478078817734
KAAB_FAILED_HEART_ATRIUM_UP,SET,32,0.11467,0.0047833,0.15015,0.22252,KAAB_FAILED_HEART_ATRIUM_UP,0.907478078817734
GSE30971_WBP7_HET_VS_KO_MACR...5,SET,179,0.053736,0.0052799,0.070374,0.22257,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN,0.907478078817734
GOBP_ENDOPLASMIC_RETICULUM_T...2,SET,126,0.055099,0.0045488,0.072162,0.22258,GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.907478078817734
GAO_SMALL_INTESTINE_24W_C2_P...,SET,17,0.16403,0.0049889,0.21484,0.2226,GAO_SMALL_INTESTINE_24W_C2_PROCRPOS_PROGENITOR,0.907478078817734
GOCC_MITOTIC_SPINDLE_ASTRAL_...,SET,7,0.23371,0.0045625,0.30615,0.22262,GOCC_MITOTIC_SPINDLE_ASTRAL_MICROTUBULE,0.907478078817734
GSE360_CTRL_VS_L_DONOVANI_DC...2,SET,178,0.047917,0.0046951,0.062769,0.22262,GSE360_CTRL_VS_L_DONOVANI_DC_UP,0.907478078817734
WORSCHECH_TUMOR_REJECTION_DN,SET,8,0.22617,0.00472,0.29634,0.22268,WORSCHECH_TUMOR_REJECTION_DN,0.907616207341386
ZF5_B,SET,214,0.045009,0.0048308,0.059016,0.22284,ZF5_B,0.90772886977887
GALE_APL_WITH_FLT3_MUTATED_UP,SET,55,0.086347,0.0047189,0.11322,0.22285,GALE_APL_WITH_FLT3_MUTATED_UP,0.90772886977887
GSE24972_WT_VS_IRF8_KO_SPLEE...1,SET,176,0.049015,0.0047759,0.064278,0.22287,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,0.90772886977887
GOMF_ATP_DEPENDENT_CHROMATIN...,SET,33,0.10652,0.0045118,0.13973,0.22294,GOMF_ATP_DEPENDENT_CHROMATIN_REMODELER_ACTIVITY,0.90772886977887
GOBP_BONE_TRABECULA_MORPHOGE...,SET,14,0.18181,0.0050185,0.23853,0.22298,GOBP_BONE_TRABECULA_MORPHOGENESIS,0.90772886977887
GOBP_ENZYME_LINKED_RECEPTOR_...,SET,890,0.023412,0.0050282,0.03072,0.223,GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,0.90772886977887
GSE40655_FOXO1_KO_VS_WT_NTRE...1,SET,169,0.046611,0.0044513,0.061164,0.22302,GSE40655_FOXO1_KO_VS_WT_NTREG_DN,0.90772886977887
MIR1973,SET,6,0.28038,0.0050677,0.36794,0.22303,MIR1973,0.90772886977887
MURARO_PANCREAS_MESENCHYMAL_...,SET,620,0.027961,0.0050506,0.036696,0.22305,MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL,0.90772886977887
GOBP_PYRAMIDAL_NEURON_DIFFER...,SET,12,0.18799,0.0048045,0.24674,0.22306,GOBP_PYRAMIDAL_NEURON_DIFFERENTIATION,0.90772886977887
GOMF_LYSINE_N_METHYLTRANSFER...,SET,49,0.094293,0.0048648,0.12376,0.22307,GOMF_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,0.90772886977887
GOBP_CARDIOBLAST_PROLIFERATI...,SET,9,0.23759,0.005259,0.31188,0.2231,GOBP_CARDIOBLAST_PROLIFERATION,0.90772886977887
HP_DIFFUSE_MESANGIAL_SCLEROS...,SET,38,0.10443,0.0047462,0.13709,0.2231,HP_DIFFUSE_MESANGIAL_SCLEROSIS,0.90772886977887
MIR548BB_5P,SET,446,0.031399,0.0048339,0.041224,0.22314,MIR548BB_5P,0.90772886977887
GOBP_POSITIVE_REGULATION_OF_...519,SET,10,0.23418,0.0054639,0.3075,0.22316,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.90772886977887
GOCC_PHOSPHATIDYLINOSITOL_3_...2,SET,9,0.23781,0.0052639,0.31227,0.22317,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I,0.90772886977887
GOBP_REGULATION_OF_FATTY_ACI...3,SET,80,0.071814,0.0047301,0.094307,0.22319,GOBP_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.90772886977887
WP_WNT_SIGNALING_IN_KIDNEY_D...,SET,34,0.12444,0.0053503,0.16343,0.2232,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,0.90772886977887
GOMF_2_ACYLGLYCEROL_O_ACYLTR...,SET,6,0.28455,0.0051431,0.37372,0.22322,GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.90772886977887
GSE43955_TH0_VS_TGFB_IL6_TH1...7,SET,176,0.048122,0.0046889,0.063208,0.22323,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN,0.90772886977887
GOBP_STARTLE_RESPONSE,SET,25,0.13549,0.0049964,0.17806,0.22336,GOBP_STARTLE_RESPONSE,0.908025731665328
GSE29618_PRE_VS_DAY7_FLU_VAC...2,SET,177,0.049747,0.0048609,0.065391,0.22341,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP,0.908025731665328
OCT1_04,SET,201,0.049334,0.0051335,0.064858,0.22344,OCT1_04,0.908025731665328
GOMF_MISMATCHED_DNA_BINDING,SET,14,0.13528,0.0037342,0.17785,0.22344,GOMF_MISMATCHED_DNA_BINDING,0.908025731665328
HE_LIM_SUN_FETAL_LUNG_C2_NEU...,SET,58,0.091753,0.0051489,0.12064,0.22347,HE_LIM_SUN_FETAL_LUNG_C2_NEUTROPHIL_CELL,0.908025731665328
GOBP_REGULATION_OF_LIPOPROTE...1,SET,10,0.2103,0.0049067,0.27668,0.2236,GOBP_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.908025731665328
KEGG_MEDICUS_REFERENCE_CXCR_...1,SET,27,0.12864,0.0049295,0.16925,0.22362,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY,0.908025731665328
GSE45365_WT_VS_IFNAR_KO_CD11...1,SET,154,0.050155,0.0045741,0.065995,0.22364,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN,0.908025731665328
DESCARTES_FETAL_STOMACH_ENS_...2,SET,64,0.086783,0.0051148,0.1142,0.22365,DESCARTES_FETAL_STOMACH_ENS_NEURONS,0.908025731665328
GSE37301_COMMON_LYMPHOID_PRO...8,SET,166,0.050179,0.0047497,0.066041,0.22369,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.908025731665328
FAN_EMBRYONIC_CTX_BRAIN_NAIV...,SET,139,0.05844,0.0050656,0.076928,0.22373,FAN_EMBRYONIC_CTX_BRAIN_NAIVE_LIKE_T_CELL,0.908025731665328
BENPORATH_ES_2,SET,32,0.10564,0.0044064,0.13909,0.22378,BENPORATH_ES_2,0.908025731665328
MIR217_3P,SET,83,0.070566,0.0047339,0.09292,0.2238,MIR217_3P,0.908025731665328
DORSAM_HOXA9_TARGETS_UP,SET,35,0.1102,0.0048069,0.14511,0.22381,DORSAM_HOXA9_TARGETS_UP,0.908025731665328
KEGG_DNA_REPLICATION,SET,34,0.10186,0.0043795,0.13414,0.22382,KEGG_DNA_REPLICATION,0.908025731665328
GRATIAS_RETINOBLASTOMA_16Q24,SET,17,0.18915,0.0057529,0.24919,0.22392,GRATIAS_RETINOBLASTOMA_16Q24,0.908025731665328
REACTOME_SIGNALING_BY_ACTIVA...,SET,11,0.21657,0.0052995,0.28536,0.22395,REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,0.908025731665328
REACTOME_HDACS_DEACETYLATE_H...,SET,29,0.11138,0.0044232,0.14683,0.22405,REACTOME_HDACS_DEACETYLATE_HISTONES,0.908025731665328
MIR627_3P,SET,423,0.032508,0.0048771,0.042857,0.22407,MIR627_3P,0.908025731665328
GOBP_INTERLEUKIN_1_MEDIATED_...,SET,29,0.11769,0.0046737,0.1552,0.22413,GOBP_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.908025731665328
HP_DECREASED_CERVICAL_SPINE_...1,SET,5,0.30038,0.0049564,0.39611,0.22413,HP_DECREASED_CERVICAL_SPINE_FLEXION_DUE_TO_CONTRACTURES_OF_POSTERIOR_CERVICAL_MUSCLES,0.908025731665328
GOBP_RESPONSE_TO_GONADOTROPI...,SET,5,0.27934,0.0046092,0.36845,0.22419,GOBP_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE,0.908025731665328
GSE42021_CD24LO_TREG_VS_CD24...2,SET,184,0.048934,0.0048741,0.064546,0.22419,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP,0.908025731665328
MENON_FETAL_KIDNEY_2_NEPHRON...,SET,35,0.11248,0.0049064,0.14837,0.2242,MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS,0.908025731665328
HP_ABNORMALITY_OF_IMMUNE_SYS...,SET,1559,0.017265,0.0048125,0.022778,0.22425,HP_ABNORMALITY_OF_IMMUNE_SYSTEM_PHYSIOLOGY,0.908025731665328
GOCC_DNA_REPLICATION_PREINIT...,SET,13,0.17603,0.0046823,0.23229,0.22429,GOCC_DNA_REPLICATION_PREINITIATION_COMPLEX,0.908025731665328
GOBP_IRIS_MORPHOGENESIS,SET,9,0.25223,0.0055831,0.33295,0.22436,GOBP_IRIS_MORPHOGENESIS,0.908025731665328
GSE17721_POLYIC_VS_PAM3CSK4_...15,SET,178,0.045973,0.0045046,0.060704,0.22443,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN,0.908025731665328
GOBP_CELL_MATURATION,SET,188,0.049297,0.0049628,0.065105,0.22447,GOBP_CELL_MATURATION,0.908025731665328
HP_SUBCUTANEOUS_NODULE,SET,87,0.069018,0.0047397,0.091152,0.22448,HP_SUBCUTANEOUS_NODULE,0.908025731665328
GOMF_THIAMINE_TRANSMEMBRANE_...,SET,7,0.26052,0.0050859,0.34408,0.22449,GOMF_THIAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.908025731665328
GOBP_NAIL_DEVELOPMENT,SET,11,0.22009,0.0053855,0.2907,0.2245,GOBP_NAIL_DEVELOPMENT,0.908025731665328
GTAAACC_MIR2995P,SET,42,0.10127,0.0048382,0.13379,0.22453,GTAAACC_MIR2995P,0.908025731665328
MIR34A_5P,SET,283,0.038178,0.0047033,0.050435,0.22454,MIR34A_5P,0.908025731665328
GSE39820_CTRL_VS_IL1B_IL6_CD...1,SET,182,0.049188,0.0048729,0.064983,0.22455,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN,0.908025731665328
GOBP_RESPONSE_TO_ZINC_ION_ST...,SET,8,0.20587,0.0042963,0.27201,0.22458,GOBP_RESPONSE_TO_ZINC_ION_STARVATION,0.908025731665328
GOMF_RRNA_BINDING,SET,56,0.080203,0.0044227,0.10597,0.22458,GOMF_RRNA_BINDING,0.908025731665328
LUCAS_HNF4A_TARGETS_DN,SET,7,0.24774,0.0048365,0.32735,0.22459,LUCAS_HNF4A_TARGETS_DN,0.908025731665328
GOBP_GASTRIC_MOTILITY,SET,5,0.29012,0.0047871,0.38336,0.22459,GOBP_GASTRIC_MOTILITY,0.908025731665328
GOBP_ADHESION_OF_SYMBIONT_TO...2,SET,8,0.25681,0.0053596,0.33948,0.22469,GOBP_ADHESION_OF_SYMBIONT_TO_HOST_CELL,0.908025731665328
HP_INTERMITTENT_DIARRHEA,SET,21,0.13068,0.0044171,0.17276,0.2247,HP_INTERMITTENT_DIARRHEA,0.908025731665328
KEGG_MEDICUS_VARIANT_MUTATIO...27,SET,11,0.19252,0.0047108,0.25453,0.22472,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.908025731665328
GSE41867_DAY6_VS_DAY15_LCMV_...2,SET,161,0.055737,0.0051965,0.073694,0.22473,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.908025731665328
BUSSLINGER_GASTRIC_NECK_CELLS,SET,34,0.12122,0.0052116,0.16032,0.2248,BUSSLINGER_GASTRIC_NECK_CELLS,0.908025731665328
GOMF_POTASSIUM_ION_BINDING,SET,13,0.19266,0.0051248,0.25485,0.22483,GOMF_POTASSIUM_ION_BINDING,0.908025731665328
MIR4749_5P,SET,4,0.33769,0.0049838,0.44669,0.22484,MIR4749_5P,0.908025731665328
GOMF_GLUTAMATE_GATED_RECEPTO...,SET,15,0.17781,0.0050804,0.23528,0.2249,GOMF_GLUTAMATE_GATED_RECEPTOR_ACTIVITY,0.908025731665328
GOBP_NEGATIVE_REGULATION_OF_...571,SET,91,0.071383,0.005013,0.094458,0.22492,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.908025731665328
MIKKELSEN_MCV6_LCP_WITH_H3K2...,SET,24,0.13617,0.0049202,0.1802,0.22493,MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,0.908025731665328
HP_GASTROINTESTINAL_ATRESIA,SET,75,0.073383,0.0046806,0.09711,0.22493,HP_GASTROINTESTINAL_ATRESIA,0.908025731665328
HP_MUSCLE_FLACCIDITY,SET,13,0.19713,0.0052437,0.26092,0.22497,HP_MUSCLE_FLACCIDITY,0.908025731665328
GOBP_NEGATIVE_REGULATION_OF_...237,SET,8,0.24719,0.0051587,0.32728,0.22504,GOBP_NEGATIVE_REGULATION_OF_FERROPTOSIS,0.908025731665328
AREB6_01,SET,247,0.042286,0.0048716,0.055993,0.22507,AREB6_01,0.908025731665328
MODULE_87,SET,41,0.097618,0.0046079,0.12929,0.22513,MODULE_87,0.908025731665328
GOBP_AXONOGENESIS_INVOLVED_I...,SET,9,0.2298,0.0050866,0.30443,0.22517,GOBP_AXONOGENESIS_INVOLVED_IN_INNERVATION,0.908025731665328
GSE32034_LY6C_HIGH_VS_LOW_MO...2,SET,181,0.049527,0.0048932,0.065624,0.22522,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP,0.908025731665328
GSE36476_CTRL_VS_TSST_ACT_16...1,SET,181,0.045382,0.0044837,0.06014,0.22525,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN,0.908025731665328
GOBP_NUCLEAR_PORE_COMPLEX_AS...,SET,11,0.18304,0.0044789,0.24258,0.22526,GOBP_NUCLEAR_PORE_COMPLEX_ASSEMBLY,0.908025731665328
GOBP_INSULIN_SECRETION,SET,187,0.048423,0.004862,0.064181,0.22528,GOBP_INSULIN_SECRETION,0.908025731665328
GOBP_DNA_METABOLIC_PROCESS,SET,870,0.021399,0.0045465,0.028365,0.22531,GOBP_DNA_METABOLIC_PROCESS,0.908025731665328
GOBP_REGULATION_OF_KIDNEY_DE...,SET,31,0.13,0.0053372,0.17232,0.22532,GOBP_REGULATION_OF_KIDNEY_DEVELOPMENT,0.908025731665328
KRIEG_HYPOXIA_NOT_VIA_KDM3A,SET,663,0.025681,0.0047912,0.034049,0.22536,KRIEG_HYPOXIA_NOT_VIA_KDM3A,0.908025731665328
HP_ANTI_ACETYLCHOLINE_RECEPT...,SET,21,0.13627,0.0046059,0.18068,0.22537,HP_ANTI_ACETYLCHOLINE_RECEPTOR_ANTIBODY_POSITIVITY,0.908025731665328
HP_EARLY_ONSET_OF_SEXUAL_MAT...,SET,150,0.054762,0.0049295,0.072609,0.22537,HP_EARLY_ONSET_OF_SEXUAL_MATURATION,0.908025731665328
HP_BRONCHOMALACIA,SET,23,0.13091,0.0046305,0.1736,0.2254,HP_BRONCHOMALACIA,0.908025731665328
STANHILL_HRAS_TRANSFROMATION...,SET,5,0.36664,0.0060497,0.48622,0.22541,STANHILL_HRAS_TRANSFROMATION_UP,0.908025731665328
GOBP_CELL_CYCLE,SET,1476,0.017149,0.0046627,0.022748,0.22547,GOBP_CELL_CYCLE,0.908025731665328
LEE_NEURAL_CREST_STEM_CELL_UP,SET,139,0.059546,0.0051615,0.078992,0.22548,LEE_NEURAL_CREST_STEM_CELL_UP,0.908025731665328
GSE24574_BCL6_HIGH_TFH_VS_TF...2,SET,176,0.049528,0.0048259,0.065701,0.22548,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP,0.908025731665328
STAT1_01,SET,62,0.079797,0.0046293,0.10587,0.22551,STAT1_01,0.908025731665328
GSE26928_CENTR_MEMORY_VS_CXC...1,SET,158,0.049821,0.0046018,0.066104,0.22553,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.908025731665328
HP_FUNCTIONAL_ABNORMALITY_OF...2,SET,1079,0.020308,0.0047764,0.026947,0.22554,HP_FUNCTIONAL_ABNORMALITY_OF_THE_GASTROINTESTINAL_TRACT,0.908025731665328
GOBP_PANCREATIC_A_CELL_DIFFE...,SET,10,0.25342,0.0059128,0.33635,0.22559,GOBP_PANCREATIC_A_CELL_DIFFERENTIATION,0.908025731665328
GOBP_SIGNAL_TRANSDUCTION_INV...,SET,23,0.14399,0.0050932,0.19111,0.2256,GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION,0.908025731665328
HP_ABNORMAL_UMBILICAL_STUMP_...,SET,8,0.25576,0.0053376,0.33946,0.2256,HP_ABNORMAL_UMBILICAL_STUMP_BLEEDING,0.908025731665328
GOBP_PYRIMIDINE_NUCLEOSIDE_D...2,SET,9,0.2094,0.004635,0.27797,0.22563,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.908025731665328
E2F_Q4,SET,212,0.043484,0.0046455,0.057746,0.22572,E2F_Q4,0.908025731665328
SCHERER_PBMC_APSV_WETVAX_AGE...4,SET,156,0.054054,0.0049613,0.071787,0.22574,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP,0.908025731665328
HP_DECREASED_CIRCULATING_FOL...,SET,30,0.12257,0.0049506,0.16281,0.22577,HP_DECREASED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,0.908025731665328
REACTOME_GLYCEROPHOSPHOLIPID...1,SET,113,0.062943,0.0049228,0.083617,0.2258,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,0.908025731665328
GSE22601_IMMATURE_CD4_SINGLE...3,SET,184,0.048893,0.00487,0.064951,0.2258,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.908025731665328
WANG_HCP_PROSTATE_CANCER,SET,100,0.064482,0.0047459,0.08568,0.22585,WANG_HCP_PROSTATE_CANCER,0.908025731665328
HP_LENS_SUBLUXATION,SET,13,0.1877,0.0049929,0.24942,0.22586,HP_LENS_SUBLUXATION,0.908025731665328
GOBP_VENTRICULAR_SYSTEM_DEVE...,SET,30,0.11185,0.0045175,0.14863,0.22588,GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT,0.908025731665328
REACTOME_POLYMERASE_SWITCHING,SET,13,0.16389,0.0043596,0.21782,0.2259,REACTOME_POLYMERASE_SWITCHING,0.908025731665328
GOBP_SMOOTH_MUSCLE_CELL_PROL...,SET,130,0.058667,0.0049191,0.077972,0.22591,GOBP_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.908025731665328
MIR6502_5P,SET,51,0.090948,0.0047867,0.12088,0.22592,MIR6502_5P,0.908025731665328
REACTOME_NEUROTRANSMITTER_RE...1,SET,191,0.049758,0.0050486,0.066144,0.22595,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,0.908025731665328
GOCC_ATAC_COMPLEX,SET,12,0.16682,0.0042636,0.2218,0.22599,GOCC_ATAC_COMPLEX,0.908025731665328
GAVISH_3CA_METAPROGRAM_CD8_T...4,SET,46,0.098752,0.0049368,0.1313,0.226,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_DYSFUNCTION,0.908025731665328
GOBP_MOTOR_LEARNING,SET,8,0.24626,0.0051394,0.32748,0.22603,GOBP_MOTOR_LEARNING,0.908025731665328
GSE17974_0.5H_VS_72H_UNTREAT...2,SET,160,0.050641,0.0047068,0.067349,0.22606,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.908025731665328
HP_ABNORMAL_ILEUM_MORPHOLOGY,SET,33,0.10399,0.0044048,0.13834,0.22612,HP_ABNORMAL_ILEUM_MORPHOLOGY,0.908025731665328
HP_NARROW_JAW,SET,13,0.18483,0.0049165,0.24588,0.22612,HP_NARROW_JAW,0.908025731665328
HP_HIGH_ANTERIOR_HAIRLINE,SET,59,0.081652,0.0046212,0.10864,0.22615,HP_HIGH_ANTERIOR_HAIRLINE,0.908025731665328
MIR548AL,SET,10,0.2107,0.004916,0.28035,0.22616,MIR548AL,0.908025731665328
GOBP_ESTABLISHMENT_OF_BLOOD_...1,SET,14,0.19454,0.0053699,0.25885,0.22617,GOBP_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER,0.908025731665328
HP_MACRODONTIA_OF_PERMANENT_...,SET,12,0.20094,0.0051354,0.26737,0.22617,HP_MACRODONTIA_OF_PERMANENT_MAXILLARY_CENTRAL_INCISOR,0.908025731665328
HP_NOCTURIA,SET,14,0.17743,0.0048976,0.23609,0.22617,HP_NOCTURIA,0.908025731665328
MIR3199,SET,41,0.09958,0.0047005,0.13253,0.22621,MIR3199,0.908025731665328
GSE36888_STAT5_AB_KNOCKIN_VS...2,SET,182,0.04641,0.0045978,0.061765,0.22621,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP,0.908025731665328
GOBP_GLYCOSIDE_CATABOLIC_PRO...,SET,7,0.227,0.0044315,0.30215,0.22625,GOBP_GLYCOSIDE_CATABOLIC_PROCESS,0.908025731665328
HP_RENAL_POTASSIUM_WASTING,SET,6,0.29514,0.0053346,0.3929,0.22628,HP_RENAL_POTASSIUM_WASTING,0.908025731665328
GSE17721_LPS_VS_GARDIQUIMOD_...10,SET,182,0.048166,0.0047718,0.064129,0.22631,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP,0.908025731665328
GOBP_INSEMINATION,SET,13,0.19807,0.0052688,0.26374,0.22633,GOBP_INSEMINATION,0.908025731665328
GSE23321_CENTRAL_VS_EFFECTOR...2,SET,181,0.048021,0.0047444,0.063942,0.22633,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.908025731665328
GOMF_GTPASE_ACTIVITY,SET,287,0.038991,0.0048366,0.051923,0.22635,GOMF_GTPASE_ACTIVITY,0.908025731665328
GSE17721_12H_VS_24H_LPS_BMDC...2,SET,190,0.047367,0.0047935,0.06308,0.22636,GSE17721_12H_VS_24H_LPS_BMDC_UP,0.908025731665328
ZNF493_TARGET_GENES,SET,6,0.26253,0.0047451,0.34965,0.22638,ZNF493_TARGET_GENES,0.908025731665328
HP_RESPIRATORY_FAILURE_REQUI...,SET,29,0.11666,0.0046329,0.15538,0.22638,HP_RESPIRATORY_FAILURE_REQUIRING_ASSISTED_VENTILATION,0.908025731665328
GOBP_INNER_EAR_RECEPTOR_CELL...2,SET,4,0.33983,0.0050154,0.45262,0.22639,GOBP_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT,0.908025731665328
GSE15215_CD2_POS_VS_NEG_PDC_...1,SET,179,0.04484,0.0044059,0.059722,0.22639,GSE15215_CD2_POS_VS_NEG_PDC_DN,0.908025731665328
VAN_DEN_BIGGELAAR_PBMC_PREVN...3,SET,102,0.059728,0.0044395,0.07955,0.22639,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP,0.908025731665328
GOBP_DETECTION_OF_STIMULUS_I...2,SET,27,0.12872,0.0049326,0.17148,0.22644,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.908025731665328
BIOCARTA_CTL_PATHWAY,SET,13,0.18707,0.004976,0.24932,0.22654,BIOCARTA_CTL_PATHWAY,0.908025731665328
GOBP_NEGATIVE_REGULATION_OF_...514,SET,101,0.062413,0.0046164,0.083185,0.22655,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.908025731665328
REACTOME_GOLGI_CISTERNAE_PER...,SET,14,0.14997,0.0041397,0.19992,0.22658,REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,0.908025731665328
BYSTRYKH_HEMATOPOIESIS_STEM_...9,SET,26,0.13258,0.0049857,0.17687,0.22675,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,0.908025731665328
HP_ABNORMALITY_OF_MULTIPLE_C...,SET,165,0.048266,0.004555,0.064388,0.22675,HP_ABNORMALITY_OF_MULTIPLE_CELL_LINEAGES_IN_THE_BONE_MARROW,0.908025731665328
HP_DECREASED_NUMBER_OF_LARGE...,SET,18,0.13881,0.0043442,0.18518,0.22675,HP_DECREASED_NUMBER_OF_LARGE_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.908025731665328
WP_CONSTITUTIVE_ANDROSTANE_R...,SET,29,0.12569,0.0049913,0.16768,0.22676,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,0.908025731665328
GOBP_REGULATION_OF_SYNAPTIC_...1,SET,5,0.29938,0.0049399,0.3994,0.22676,GOBP_REGULATION_OF_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.908025731665328
HP_ABNORMALITY_OF_THE_GLENOI...,SET,6,0.28794,0.0052044,0.38418,0.22678,HP_ABNORMALITY_OF_THE_GLENOID_FOSSA,0.908025731665328
GSE11961_FOLLICULAR_BCELL_VS...7,SET,178,0.04791,0.0046944,0.063934,0.22682,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.908025731665328
GOBP_POSITIVE_REGULATION_OF_...400,SET,27,0.1325,0.0050774,0.17687,0.22689,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.908025731665328
GOBP_POSITIVE_REGULATION_OF_...463,SET,58,0.086061,0.0048295,0.11489,0.22691,GOBP_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.908025731665328
MIR9983_3P,SET,423,0.032167,0.004826,0.042945,0.22693,MIR9983_3P,0.908025731665328
GOBP_POTASSIUM_ION_IMPORT_AC...,SET,44,0.10701,0.0052321,0.14286,0.22693,GOBP_POTASSIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.908025731665328
DR3_Q4,SET,133,0.057252,0.0048552,0.076442,0.22694,DR3_Q4,0.908025731665328
GOBP_INTERFERON_ALPHA_PRODUC...,SET,26,0.11766,0.0044246,0.15712,0.22698,GOBP_INTERFERON_ALPHA_PRODUCTION,0.908025731665328
GOBP_GLIAL_CELL_ACTIVATION,SET,53,0.095512,0.0051243,0.12755,0.22699,GOBP_GLIAL_CELL_ACTIVATION,0.908025731665328
HOSHIDA_LIVER_CANCER_SURVIVA...1,SET,99,0.063819,0.0046737,0.08524,0.22702,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,0.908025731665328
GOBP_TRANSCRIPTION_INITIATIO...2,SET,142,0.051374,0.0045005,0.068622,0.22704,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_II_PROMOTER,0.908025731665328
LI_PBMC_MENACTRA_AGE_18_45YO...7,SET,34,0.1242,0.0053397,0.16591,0.22706,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,0.908025731665328
PID_INTEGRIN3_PATHWAY,SET,39,0.11871,0.0054654,0.1586,0.22709,PID_INTEGRIN3_PATHWAY,0.908025731665328
GOMF_MICROTUBULE_MINUS_END_B...,SET,12,0.16581,0.0042376,0.22153,0.2271,GOMF_MICROTUBULE_MINUS_END_BINDING,0.908025731665328
HP_ABNORMAL_METAPHYSEAL_TRAB...,SET,21,0.13657,0.0046162,0.18249,0.22712,HP_ABNORMAL_METAPHYSEAL_TRABECULATION,0.908025731665328
GOMF_SIALYLTRANSFERASE_ACTIV...,SET,21,0.14642,0.0049492,0.19568,0.22716,GOMF_SIALYLTRANSFERASE_ACTIVITY,0.908025731665328
WP_AFFECTED_PATHWAYS_IN_DUCH...,SET,67,0.083442,0.0050314,0.11155,0.22723,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,0.908025731665328
GOBP_REGULATION_OF_LEUKOCYTE...10,SET,18,0.1575,0.0049292,0.21056,0.22723,GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.908025731665328
KRAS.PROSTATE_UP.V1_DN,SET,124,0.060299,0.0049387,0.080617,0.22725,KRAS.PROSTATE_UP.V1_DN,0.908025731665328
HP_SEVERE_LACTIC_ACIDOSIS,SET,11,0.19457,0.0047611,0.26015,0.22726,HP_SEVERE_LACTIC_ACIDOSIS,0.908025731665328
GOBP_REGULATION_OF_PLATELET_...2,SET,29,0.13323,0.0052908,0.17815,0.22728,GOBP_REGULATION_OF_PLATELET_AGGREGATION,0.908025731665328
MODULE_363,SET,41,0.092837,0.0043822,0.12415,0.22729,MODULE_363,0.908025731665328
HP_SPINOCEREBELLAR_TRACT_DEG...,SET,8,0.23001,0.0048003,0.30759,0.2273,HP_SPINOCEREBELLAR_TRACT_DEGENERATION,0.908025731665328
GOBP_SHORT_CHAIN_FATTY_ACID_...1,SET,7,0.26512,0.0051756,0.35457,0.22732,GOBP_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.908025731665328
LEE_LIVER_CANCER_MYC_E2F1_DN,SET,58,0.091761,0.0051493,0.12274,0.22735,LEE_LIVER_CANCER_MYC_E2F1_DN,0.908025731665328
YAATNANRNNNCAG_UNKNOWN,SET,61,0.083275,0.004792,0.11138,0.22735,YAATNANRNNNCAG_UNKNOWN,0.908025731665328
KEGG_MEDICUS_REFERENCE_MISMA...,SET,26,0.11176,0.0042026,0.14952,0.2274,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR,0.908025731665328
QIU_PBMC_HEPTATITIS_B_SURFAC...7,SET,28,0.13351,0.0052099,0.17863,0.22741,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_7DY_UP,0.908025731665328
KEGG_MEDICUS_REFERENCE_TLR7_...2,SET,15,0.19627,0.0056076,0.2626,0.22742,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY,0.908025731665328
GSE2770_UNTREATED_VS_TGFB_AN...10,SET,131,0.056892,0.0047885,0.076122,0.22742,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.908025731665328
BROWNE_HCMV_INFECTION_1HR_DN,SET,186,0.045784,0.0045848,0.061265,0.22744,BROWNE_HCMV_INFECTION_1HR_DN,0.908025731665328
WP_INSULIN_SIGNALING_IN_ADIP...1,SET,8,0.24292,0.0050696,0.32505,0.22744,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,0.908025731665328
WP_INSULIN_SIGNALING_IN_ADIP...2,SET,8,0.24292,0.0050696,0.32505,0.22744,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,0.908025731665328
TOOKER_GEMCITABINE_RESISTANC...2,SET,73,0.077331,0.0048665,0.10349,0.22746,TOOKER_GEMCITABINE_RESISTANCE_UP,0.908025731665328
HP_LIMITED_HIP_EXTENSION,SET,5,0.31286,0.0051622,0.41879,0.22752,HP_LIMITED_HIP_EXTENSION,0.908025731665328
GSE41867_NAIVE_VS_DAY15_LCMV...2,SET,179,0.045001,0.0044216,0.06024,0.22753,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.908025731665328
RICKMAN_TUMOR_DIFFERENTIATED...1,SET,15,0.16873,0.0048207,0.22588,0.22755,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN,0.908025731665328
GOBP_MYELOID_LEUKOCYTE_DIFFE...,SET,218,0.046565,0.0050438,0.062345,0.22757,GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.908025731665328
HP_WEAKNESS_OF_THE_INTRINSIC...,SET,24,0.1179,0.0042598,0.15785,0.22757,HP_WEAKNESS_OF_THE_INTRINSIC_HAND_MUSCLES,0.908025731665328
PYEON_HPV_POSITIVE_TUMORS_UP,SET,81,0.067679,0.0044854,0.090629,0.2276,PYEON_HPV_POSITIVE_TUMORS_UP,0.908025731665328
GSE40068_CXCR5NEG_BCL6NEG_CD...1,SET,183,0.047713,0.0047397,0.063896,0.22762,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN,0.908025731665328
MIR4774_3P,SET,75,0.076588,0.004885,0.10257,0.22763,MIR4774_3P,0.908025731665328
GSE1460_CD4_THYMOCYTE_VS_THY...1,SET,174,0.049738,0.0048191,0.066611,0.22763,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.908025731665328
PID_WNT_CANONICAL_PATHWAY,SET,20,0.13129,0.0043308,0.17583,0.22764,PID_WNT_CANONICAL_PATHWAY,0.908025731665328
REACTOME_REGULATION_OF_CDH11...1,SET,10,0.21245,0.0049567,0.28459,0.22769,REACTOME_REGULATION_OF_CDH11_FUNCTION,0.908029669762642
GOBP_ATRIAL_SEPTUM_DEVELOPME...,SET,21,0.15723,0.0053145,0.21064,0.2277,GOBP_ATRIAL_SEPTUM_DEVELOPMENT,0.908029669762642
TAKEDA_TARGETS_OF_NUP98_HOXA...10,SET,144,0.058249,0.0051384,0.078059,0.22777,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,0.908029669762642
DARWICHE_PAPILLOMA_RISK_HIGH...2,SET,137,0.055773,0.0047998,0.074746,0.22779,DARWICHE_PAPILLOMA_RISK_HIGH_UP,0.908029669762642
HP_LYMPHOPENIA,SET,163,0.051116,0.0047949,0.068514,0.22782,HP_LYMPHOPENIA,0.908029669762642
GOMF_CALCIUM_DEPENDENT_PROTE...2,SET,10,0.20194,0.0047115,0.27071,0.22785,GOMF_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.908029669762642
GSE21360_NAIVE_VS_QUATERNARY...2,SET,188,0.046122,0.0046432,0.061828,0.22785,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.908029669762642
GSE40685_TREG_VS_FOXP3_KO_TR...1,SET,182,0.04741,0.0046968,0.063554,0.22785,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.908029669762642
MODULE_158,SET,41,0.096969,0.0045773,0.13001,0.22788,MODULE_158,0.908045104333868
HP_DIFFICULTY_CLIMBING_STAIRS,SET,58,0.082233,0.0046146,0.11027,0.22792,HP_DIFFICULTY_CLIMBING_STAIRS,0.908100378310214
NABA_MATRISOME_METASTATIC_CO...,SET,26,0.14433,0.0054275,0.19361,0.22801,NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS,0.908291577019913
BLANCO_MELO_INFLUENZA_A_INFE...1,SET,101,0.060526,0.0044768,0.081208,0.22804,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,0.908291577019913
HP_PROXIMAL_MUSCLE_WEAKNESS_...1,SET,62,0.08193,0.004753,0.10993,0.22805,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_LOWER_LIMBS,0.908291577019913
GOBP_CARDIAC_MUSCLE_CELL_PRO...,SET,45,0.10482,0.0051832,0.14071,0.22815,GOBP_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.908291577019913
BUSSLINGER_GASTRIC_METALLOTH...,SET,91,0.070292,0.0049364,0.094355,0.22815,BUSSLINGER_GASTRIC_METALLOTHIONEIN_CELLS,0.908291577019913
REACTOME_TNFS_BIND_THEIR_PHY...,SET,27,0.14002,0.0053655,0.188,0.22821,REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,0.908291577019913
GOBP_MELANOCYTE_DIFFERENTIAT...,SET,23,0.14713,0.0052043,0.19756,0.22821,GOBP_MELANOCYTE_DIFFERENTIATION,0.908291577019913
ZNF669_TARGET_GENES,SET,95,0.066566,0.0047758,0.089382,0.22822,ZNF669_TARGET_GENES,0.908291577019913
GSE1740_UNSTIM_VS_IFNA_STIMU...3,SET,166,0.047665,0.0045117,0.064009,0.22824,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN,0.908291577019913
GOBP_DECIDUALIZATION,SET,24,0.13412,0.0048458,0.18011,0.22825,GOBP_DECIDUALIZATION,0.908291577019913
HP_ABNORMALITY_OF_NEUTROPHIL...,SET,14,0.17231,0.0047562,0.23145,0.2283,HP_ABNORMALITY_OF_NEUTROPHIL_PHYSIOLOGY,0.908291577019913
WANG_BARRETTS_ESOPHAGUS_DN,SET,24,0.14278,0.0051588,0.19181,0.22833,WANG_BARRETTS_ESOPHAGUS_DN,0.908291577019913
REACTOME_DUAL_INCISION_IN_GG...,SET,38,0.092019,0.004182,0.12363,0.22834,REACTOME_DUAL_INCISION_IN_GG_NER,0.908291577019913
GOBP_NOTCH_RECEPTOR_PROCESSI...,SET,8,0.20726,0.0043254,0.27845,0.22835,GOBP_NOTCH_RECEPTOR_PROCESSING,0.908291577019913
ROPERO_HDAC2_TARGETS,SET,98,0.064469,0.0046975,0.086619,0.22836,ROPERO_HDAC2_TARGETS,0.908291577019913
GOCC_CELL_CORTEX,SET,288,0.038253,0.0047533,0.051402,0.22839,GOCC_CELL_CORTEX,0.908306951596293
BIOCARTA_ASBCELL_PATHWAY,SET,10,0.22638,0.0052819,0.30428,0.22844,BIOCARTA_ASBCELL_PATHWAY,0.908321588188348
GAVISH_3CA_METAPROGRAM_ENDOT...13,SET,49,0.098871,0.0051009,0.1329,0.22846,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NF_KB,0.908321588188348
MIR4446_5P,SET,271,0.039458,0.0047583,0.053061,0.22856,MIR4446_5P,0.908321588188348
chr1q24,SET,54,0.15953,0.0086387,0.21455,0.22858,chr1q24,0.908321588188348
GOBP_POSITIVE_REGULATION_OF_...506,SET,32,0.12165,0.0050742,0.16362,0.2286,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.908321588188348
HP_VAGINAL_NEOPLASM,SET,8,0.28,0.0058436,0.37672,0.22867,HP_VAGINAL_NEOPLASM,0.908321588188348
SCGGAAGY_ELK1_02,SET,1125,0.018913,0.004536,0.025452,0.22872,SCGGAAGY_ELK1_02,0.908321588188348
GSE17186_CD21LOW_VS_CD21HIGH...2,SET,184,0.045058,0.0044881,0.060635,0.22872,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.908321588188348
HP_ABNORMAL_EUSTACHIAN_TUBE_...,SET,4,0.40367,0.0059577,0.54331,0.22875,HP_ABNORMAL_EUSTACHIAN_TUBE_MORPHOLOGY,0.908321588188348
REACTOME_NGF_STIMULATED_TRAN...,SET,38,0.10799,0.0049078,0.14537,0.22878,REACTOME_NGF_STIMULATED_TRANSCRIPTION,0.908321588188348
HP_DECREASED_MINIATURE_ENDPL...,SET,13,0.16062,0.0042724,0.21621,0.22878,HP_DECREASED_MINIATURE_ENDPLATE_POTENTIALS,0.908321588188348
STARK_HYPPOCAMPUS_22Q11_DELE...1,SET,19,0.19024,0.0061168,0.25611,0.2288,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,0.908321588188348
GAVISH_3CA_METAPROGRAM_B_CEL...4,SET,45,0.091958,0.004547,0.1238,0.2288,GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS,0.908321588188348
HP_ABNORMAL_CARDIAC_BIOMARKE...,SET,6,0.30167,0.0054525,0.40614,0.22881,HP_ABNORMAL_CARDIAC_BIOMARKER_TEST,0.908321588188348
GOBP_POSITIVE_REGULATION_OF_...825,SET,6,0.27646,0.0049969,0.37227,0.22885,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.908321588188348
GOBP_RIBOFLAVIN_TRANSPORT,SET,6,0.28435,0.0051395,0.38295,0.22889,GOBP_RIBOFLAVIN_TRANSPORT,0.908321588188348
GOMF_RIBOFLAVIN_TRANSMEMBRAN...,SET,6,0.28435,0.0051395,0.38295,0.22889,GOMF_RIBOFLAVIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.908321588188348
REACTOME_P130CAS_LINKAGE_TO_...,SET,15,0.18372,0.0052491,0.24746,0.22892,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.908321588188348
DESCARTES_FETAL_STOMACH_ERYT...,SET,86,0.067898,0.0046361,0.091463,0.22894,DESCARTES_FETAL_STOMACH_ERYTHROBLASTS,0.908321588188348
GOBP_UTERUS_MORPHOGENESIS,SET,6,0.2507,0.0045314,0.33773,0.22895,GOBP_UTERUS_MORPHOGENESIS,0.908321588188348
GSE5589_LPS_VS_LPS_AND_IL6_S...4,SET,172,0.049603,0.0047785,0.066822,0.22895,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.908321588188348
GOBP_MONOATOMIC_ANION_HOMEOS...,SET,20,0.14145,0.0046659,0.19057,0.22898,GOBP_MONOATOMIC_ANION_HOMEOSTASIS,0.908321588188348
KAT2A_TARGET_GENES,SET,901,0.021617,0.0046698,0.029136,0.22907,KAT2A_TARGET_GENES,0.908321588188348
GOCC_DNA_REPLICATION_FACTOR_...2,SET,5,0.27709,0.004572,0.3735,0.22909,GOCC_DNA_REPLICATION_FACTOR_C_COMPLEX,0.908321588188348
HP_NEPHRITIS,SET,113,0.061208,0.004787,0.082504,0.22909,HP_NEPHRITIS,0.908321588188348
HP_OCCIPITAL_ENCEPHALOCELE,SET,36,0.10337,0.0045727,0.13934,0.2291,HP_OCCIPITAL_ENCEPHALOCELE,0.908321588188348
GOBP_CENTRIOLE_ASSEMBLY,SET,45,0.087719,0.0043374,0.11829,0.22918,GOBP_CENTRIOLE_ASSEMBLY,0.908321588188348
HILLION_HMGA1_TARGETS,SET,75,0.074199,0.0047326,0.10007,0.2292,HILLION_HMGA1_TARGETS,0.908321588188348
KEGG_MEDICUS_VARIANT_MUTATIO...36,SET,6,0.24647,0.0044548,0.3324,0.22921,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION,0.908321588188348
HP_UNUSUAL_VIRUS_REACTIVATION,SET,21,0.1461,0.0049383,0.19705,0.22922,HP_UNUSUAL_VIRUS_REACTIVATION,0.908321588188348
GOCC_PROTON_TRANSPORTING_TWO...3,SET,10,0.1851,0.0043187,0.24967,0.22923,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN,0.908321588188348
GOCC_PROTON_TRANSPORTING_V_T...2,SET,10,0.1851,0.0043187,0.24967,0.22923,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.908321588188348
GOCC_RNA_CAP_BINDING_COMPLEX,SET,15,0.14884,0.0042524,0.20086,0.22936,GOCC_RNA_CAP_BINDING_COMPLEX,0.908567997960571
GOMF_HORMONE_BINDING,SET,88,0.071671,0.00495,0.096736,0.22938,GOMF_HORMONE_BINDING,0.908567997960571
BRUINS_UVC_RESPONSE_VIA_TP53...2,SET,493,0.028783,0.0046529,0.038854,0.22941,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,0.908567997960571
GOBP_SEMICIRCULAR_CANAL_DEVE...,SET,9,0.24072,0.0053283,0.32505,0.22949,GOBP_SEMICIRCULAR_CANAL_DEVELOPMENT,0.908567997960571
GOBP_POSITIVE_REGULATION_OF_...533,SET,9,0.2246,0.0049715,0.30332,0.22951,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.908567997960571
MIR125B_5P,SET,296,0.036324,0.0045748,0.049057,0.22952,MIR125B_5P,0.908567997960571
VALK_AML_WITH_CEBPA,SET,31,0.12335,0.0050641,0.16661,0.22956,VALK_AML_WITH_CEBPA,0.908567997960571
NAKAMURA_METASTASIS,SET,42,0.093054,0.0044455,0.1257,0.22958,NAKAMURA_METASTASIS,0.908567997960571
MIR936,SET,127,0.054674,0.0045314,0.073866,0.2296,MIR936,0.908567997960571
KEGG_MEDICUS_REFERENCE_TGFA_...2,SET,7,0.25276,0.0049345,0.34153,0.22962,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY,0.908567997960571
GOBP_RESPONSE_TO_ETHANOL,SET,118,0.061057,0.0048791,0.082496,0.22962,GOBP_RESPONSE_TO_ETHANOL,0.908567997960571
MIR520A_5P,SET,146,0.052329,0.0046478,0.070738,0.22973,MIR520A_5P,0.908567997960571
HP_POSTERIOR_FOSSA_CYST,SET,15,0.16143,0.0046122,0.21824,0.22975,HP_POSTERIOR_FOSSA_CYST,0.908567997960571
KEGG_MEDICUS_VARIANT_MUTATIO...79,SET,6,0.23689,0.0042817,0.32027,0.22976,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050,0.908567997960571
WP_INDUCTION_OF_AUTOPHAGY_AN...,SET,11,0.1847,0.0045196,0.24972,0.22977,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,0.908567997960571
GSE12366_GC_VS_NAIVE_BCELL_UP,SET,178,0.045979,0.0045053,0.062172,0.22979,GSE12366_GC_VS_NAIVE_BCELL_UP,0.908567997960571
ACCAAAG_MIR9,SET,467,0.029591,0.0046589,0.040015,0.22981,ACCAAAG_MIR9,0.908567997960571
REACTOME_MECP2_REGULATES_TRA...2,SET,7,0.29557,0.0057703,0.39973,0.22983,REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS,0.908567997960571
GSE19888_CTRL_VS_TCELL_MEMBR...2,SET,171,0.048588,0.0046673,0.065727,0.22988,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP,0.908567997960571
GSE6092_IFNG_VS_IFNG_AND_B_B...2,SET,166,0.050077,0.0047401,0.067741,0.22988,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.908567997960571
GSE27786_NKTCELL_VS_MONO_MAC...1,SET,178,0.047878,0.0046913,0.064778,0.22992,GSE27786_NKTCELL_VS_MONO_MAC_DN,0.908567997960571
HP_ABSENT_VAS_DEFERENS,SET,19,0.15709,0.0050509,0.21255,0.22993,HP_ABSENT_VAS_DEFERENS,0.908567997960571
MIR16_1_3P,SET,173,0.048704,0.0047054,0.065909,0.22997,MIR16_1_3P,0.908567997960571
REACTOME_TELOMERE_MAINTENANCE,SET,61,0.075583,0.0043494,0.10229,0.22999,REACTOME_TELOMERE_MAINTENANCE,0.908567997960571
MIR3973,SET,233,0.042197,0.0047234,0.057118,0.23003,MIR3973,0.908567997960571
GOBP_ACROSOME_REACTION,SET,39,0.10679,0.0049165,0.14459,0.23009,GOBP_ACROSOME_REACTION,0.908567997960571
HP_ABNORMAL_URETER_MORPHOLOGY,SET,136,0.053203,0.004562,0.072036,0.23009,HP_ABNORMAL_URETER_MORPHOLOGY,0.908567997960571
GOMF_HISTONE_H3K9_METHYLTRAN...,SET,12,0.17804,0.0045502,0.24113,0.23015,GOMF_HISTONE_H3K9_METHYLTRANSFERASE_ACTIVITY,0.908567997960571
GOBP_MYOBLAST_MIGRATION,SET,12,0.18032,0.0046085,0.24422,0.23016,GOBP_MYOBLAST_MIGRATION,0.908567997960571
GOMF_NUCLEAR_RECEPTOR_BINDING,SET,126,0.055362,0.0045705,0.074987,0.23017,GOMF_NUCLEAR_RECEPTOR_BINDING,0.908567997960571
GOBP_TONGUE_DEVELOPMENT,SET,19,0.16475,0.005297,0.22316,0.23018,GOBP_TONGUE_DEVELOPMENT,0.908567997960571
POU1F1_Q6,SET,218,0.045353,0.0049125,0.061442,0.23022,POU1F1_Q6,0.908567997960571
GOBP_NEGATIVE_REGULATION_OF_...241,SET,3,0.41191,0.0052649,0.55808,0.23024,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.908567997960571
GOBP_INTRINSIC_APOPTOTIC_SIG...1,SET,282,0.036569,0.0044972,0.049548,0.23025,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.908567997960571
GOBP_RESPONSE_TO_AMYLOID_BETA,SET,50,0.098106,0.0051127,0.13293,0.23026,GOBP_RESPONSE_TO_AMYLOID_BETA,0.908567997960571
HP_DEGENERATION_OF_THE_LATER...,SET,19,0.13246,0.0042589,0.17953,0.23032,HP_DEGENERATION_OF_THE_LATERAL_CORTICOSPINAL_TRACTS,0.908567997960571
GOBP_KERATINOCYTE_DEVELOPMENT,SET,13,0.19321,0.0051395,0.2619,0.23034,GOBP_KERATINOCYTE_DEVELOPMENT,0.908567997960571
GOBP_DOPAMINE_TRANSPORT,SET,43,0.1006,0.004863,0.13643,0.23044,GOBP_DOPAMINE_TRANSPORT,0.908567997960571
CTR9_TARGET_GENES,SET,46,0.085359,0.0042673,0.11576,0.23045,CTR9_TARGET_GENES,0.908567997960571
GSE15930_STIM_VS_STIM_AND_IF...6,SET,171,0.048199,0.0046299,0.065365,0.23045,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP,0.908567997960571
GOBP_TRYPTOPHAN_METABOLIC_PR...,SET,10,0.23207,0.0054145,0.31474,0.23047,GOBP_TRYPTOPHAN_METABOLIC_PROCESS,0.908567997960571
KEGG_MEDICUS_REFERENCE_ACTIV...3,SET,8,0.24214,0.0050533,0.32843,0.23049,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY,0.908567997960571
HOOI_ST7_TARGETS_DN,SET,95,0.069492,0.0049858,0.094261,0.2305,HOOI_ST7_TARGETS_DN,0.908567997960571
SU_SALIVARY_GLAND,SET,10,0.20987,0.0048967,0.28468,0.2305,SU_SALIVARY_GLAND,0.908567997960571
HP_DYSDIADOCHOKINESIS,SET,49,0.08485,0.0043776,0.11509,0.2305,HP_DYSDIADOCHOKINESIS,0.908567997960571
GSE22886_IL2_VS_IL15_STIM_NK...1,SET,166,0.046793,0.0044292,0.063482,0.23053,GSE22886_IL2_VS_IL15_STIM_NKCELL_DN,0.908567997960571
MORF_RFC4,SET,132,0.052316,0.00442,0.070981,0.23055,MORF_RFC4,0.908567997960571
WP_GENE_REGULATORY_NETWORK_M...,SET,11,0.19209,0.0047004,0.26064,0.23057,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,0.908567997960571
GATAAGR_GATA_C,SET,277,0.03916,0.0047735,0.053146,0.23062,GATAAGR_GATA_C,0.908567997960571
GOBP_WNT_SIGNALING_PATHWAY_C...,SET,5,0.35032,0.0057803,0.47547,0.23063,GOBP_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY,0.908567997960571
GOBP_RESPONSE_TO_NITROSATIVE...,SET,10,0.18613,0.0043428,0.25268,0.23067,GOBP_RESPONSE_TO_NITROSATIVE_STRESS,0.908567997960571
KEGG_MEDICUS_REFERENCE_ESTAB...,SET,5,0.26191,0.0043216,0.35557,0.23069,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION,0.908567997960571
GSE36476_CTRL_VS_TSST_ACT_40...1,SET,181,0.043097,0.0042579,0.058513,0.2307,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN,0.908567997960571
GOBP_REGULATION_OF_SOMITOGEN...,SET,6,0.28617,0.0051724,0.38856,0.23072,GOBP_REGULATION_OF_SOMITOGENESIS,0.908567997960571
GOMF_PHOSPHORIC_ESTER_HYDROL...,SET,318,0.034226,0.0044652,0.046473,0.23073,GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY,0.908567997960571
GSE37416_12H_VS_24H_F_TULARE...1,SET,166,0.048305,0.0045723,0.065602,0.23077,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.908622561459159
GSE14308_TH1_VS_TH17_DN,SET,176,0.04516,0.0044003,0.061348,0.23083,GSE14308_TH1_VS_TH17_DN,0.908755850702311
MIR2052,SET,220,0.042279,0.0046002,0.05744,0.23086,MIR2052,0.908761980523157
LINDVALL_IMMORTALIZED_BY_TER...2,SET,59,0.089875,0.0050866,0.12213,0.2309,LINDVALL_IMMORTALIZED_BY_TERT_UP,0.908761980523157
MIR554,SET,16,0.15617,0.0046083,0.21223,0.23091,MIR554,0.908761980523157
HP_PANCREATIC_CALCIFICATION,SET,8,0.25188,0.0052566,0.34233,0.23094,HP_PANCREATIC_CALCIFICATION,0.908777139945652
HP_RECTAL_ABSCESS,SET,7,0.28426,0.0055494,0.3864,0.23097,HP_RECTAL_ABSCESS,0.908792295935696
HP_DELAYED_FINE_MOTOR_DEVELO...,SET,45,0.096424,0.0047679,0.13109,0.23101,HP_DELAYED_FINE_MOTOR_DEVELOPMENT,0.908846790808241
chr1p12,SET,16,0.26434,0.0078001,0.35957,0.23112,chr1p12,0.909176638370119
ZNF582_TARGET_GENES,SET,51,0.086045,0.0045287,0.11708,0.23119,ZNF582_TARGET_GENES,0.909212816742081
HP_ABNORMAL_CORNEAL_REFLEX,SET,11,0.18297,0.0044772,0.24896,0.23119,HP_ABNORMAL_CORNEAL_REFLEX,0.909212816742081
ATGTACA_MIR493,SET,294,0.037923,0.0047602,0.051605,0.23122,ATGTACA_MIR493,0.909212816742081
REACTOME_CARDIOGENESIS,SET,24,0.13721,0.0049576,0.18673,0.23124,REACTOME_CARDIOGENESIS,0.909212816742081
GSE21033_3H_VS_24H_POLYIC_ST...2,SET,148,0.052052,0.0046545,0.070846,0.23126,GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP,0.909212816742081
GSE29949_CD8_NEG_DC_SPLEEN_V...4,SET,167,0.049794,0.0047273,0.067781,0.23129,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP,0.909227909738717
KEGG_MEDICUS_REFERENCE_MICRO...1,SET,22,0.13405,0.0046376,0.18252,0.23134,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION,0.90923982706002
GSE7460_CD8_TCELL_VS_TREG_AC...2,SET,179,0.045659,0.0044863,0.062174,0.23136,GSE7460_CD8_TCELL_VS_TREG_ACT_UP,0.90923982706002
GOBP_POSITIVE_REGULATION_OF_...621,SET,19,0.14332,0.0046082,0.19522,0.23143,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.90923982706002
GOBP_RRNA_CATABOLIC_PROCESS,SET,12,0.16517,0.0042212,0.22498,0.23143,GOBP_RRNA_CATABOLIC_PROCESS,0.90923982706002
GSE13493_CD4INTCD8POS_VS_CD8...2,SET,168,0.046776,0.004454,0.063715,0.23144,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP,0.90923982706002
WP_WHITE_FAT_CELL_DIFFERENTI...,SET,31,0.12371,0.0050789,0.16852,0.23145,WP_WHITE_FAT_CELL_DIFFERENTIATION,0.90923982706002
HP_ABNORMAL_MEAN_CORPUSCULAR...1,SET,16,0.14926,0.0044043,0.20335,0.23148,HP_ABNORMAL_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.909254905063291
MULLIGHAN_MLL_SIGNATURE_1_DN,SET,216,0.044242,0.0047704,0.060292,0.23154,MULLIGHAN_MLL_SIGNATURE_1_DN,0.909342075855063
MIR6818_5P,SET,100,0.063351,0.0046626,0.086345,0.23157,MIR6818_5P,0.909342075855063
GOBP_MUSCLE_CELL_FATE_COMMIT...,SET,16,0.18985,0.0056021,0.25879,0.2316,GOBP_MUSCLE_CELL_FATE_COMMITMENT,0.909342075855063
GOBP_MELANOCYTE_PROLIFERATION,SET,5,0.30186,0.0049807,0.41162,0.23168,GOBP_MELANOCYTE_PROLIFERATION,0.909342075855063
GOBP_CHROMOSOME_ORGANIZATION,SET,543,0.025808,0.0043722,0.035196,0.2317,GOBP_CHROMOSOME_ORGANIZATION,0.909342075855063
CREB3L4_TARGET_GENES,SET,1159,0.018589,0.0045207,0.025355,0.23174,CREB3L4_TARGET_GENES,0.909342075855063
GSE3565_DUSP1_VS_WT_SPLENOCY...3,SET,141,0.051242,0.0044732,0.069892,0.23174,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP,0.909342075855063
HP_INFANTILE_AXIAL_HYPOTONIA,SET,42,0.09999,0.0047769,0.13639,0.23175,HP_INFANTILE_AXIAL_HYPOTONIA,0.909342075855063
GOBP_COMPLEMENT_RECEPTOR_MED...,SET,13,0.20685,0.0055022,0.28218,0.23177,GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.909342075855063
HP_MOTTLED_PIGMENTATION,SET,8,0.23296,0.0048617,0.31781,0.23178,HP_MOTTLED_PIGMENTATION,0.909342075855063
GOMF_C_X_C_CHEMOKINE_RECEPTO...,SET,7,0.2415,0.0047146,0.32947,0.23179,GOMF_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY,0.909342075855063
HADDAD_B_LYMPHOCYTE_PROGENIT...,SET,248,0.041834,0.0048291,0.0571,0.23189,HADDAD_B_LYMPHOCYTE_PROGENITOR,0.909607499153594
GOLDRATH_NAIVE_VS_EFF_CD8_TC...1,SET,180,0.045824,0.004515,0.062552,0.23191,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN,0.909607499153594
HP_DUPLICATION_OF_RENAL_PELV...,SET,3,0.43124,0.005512,0.58886,0.23199,HP_DUPLICATION_OF_RENAL_PELVIS,0.909614822734947
GOMF_CYTOKINE_BINDING,SET,130,0.05803,0.0048657,0.079254,0.23203,GOMF_CYTOKINE_BINDING,0.909614822734947
GOBP_INTERLEUKIN_27_MEDIATED...,SET,7,0.24596,0.0048017,0.33599,0.23207,GOBP_INTERLEUKIN_27_MEDIATED_SIGNALING_PATHWAY,0.909614822734947
GOBP_REGULATION_OF_MITOTIC_C...3,SET,9,0.18854,0.0041732,0.25757,0.23209,GOBP_REGULATION_OF_MITOTIC_CENTROSOME_SEPARATION,0.909614822734947
GOMF_LIPOPOLYSACCHARIDE_IMMU...,SET,6,0.24689,0.0044624,0.33728,0.23209,GOMF_LIPOPOLYSACCHARIDE_IMMUNE_RECEPTOR_ACTIVITY,0.909614822734947
KEGG_ASCORBATE_AND_ALDARATE_...,SET,23,0.1722,0.0060909,0.2353,0.23214,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,0.909614822734947
GOBP_BONE_MATURATION,SET,24,0.13472,0.0048676,0.18409,0.23215,GOBP_BONE_MATURATION,0.909614822734947
REACTOME_GLUCAGON_LIKE_PEPTI...,SET,42,0.10172,0.0048596,0.13909,0.2323,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,0.909614822734947
REACTOME_ADRENALINE_NORADREN...,SET,28,0.12707,0.0049587,0.17377,0.23231,REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,0.909614822734947
WP_NUCLEAR_RECEPTORS,SET,36,0.10505,0.004647,0.14366,0.23233,WP_NUCLEAR_RECEPTORS,0.909614822734947
WU_HBX_TARGETS_1_UP,SET,13,0.18428,0.0049019,0.25203,0.23234,WU_HBX_TARGETS_1_UP,0.909614822734947
KEGG_MEDICUS_REFERENCE_ACTIV...2,SET,23,0.12672,0.0044822,0.17331,0.23234,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES,0.909614822734947
HP1SITEFACTOR_Q6,SET,204,0.045187,0.0047366,0.0618,0.23234,HP1SITEFACTOR_Q6,0.909614822734947
GOBP_REGULATION_OF_PROTEIN_L...8,SET,10,0.17793,0.0041515,0.24336,0.23235,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.909614822734947
GOBP_NEURON_FATE_SPECIFICATI...,SET,32,0.1201,0.0050094,0.16428,0.23238,GOBP_NEURON_FATE_SPECIFICATION,0.909614822734947
WP_NEUROGENESIS_REGULATION_I...,SET,55,0.090994,0.0049729,0.12449,0.23241,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,0.909614822734947
ZNF85_TARGET_GENES,SET,252,0.039419,0.0045863,0.053934,0.23243,ZNF85_TARGET_GENES,0.909614822734947
GOTTWEIN_TARGETS_OF_KSHV_MIR...,SET,58,0.082838,0.0046486,0.11336,0.23247,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,0.909614822734947
GOBP_PYRIMIDINE_NUCLEOSIDE_M...3,SET,8,0.22507,0.004697,0.30801,0.23248,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.909614822734947
GOBP_REGULATION_OF_AXONOGENE...,SET,125,0.057324,0.0047138,0.078454,0.2325,GOBP_REGULATION_OF_AXONOGENESIS,0.909614822734947
GSE10240_CTRL_VS_IL17_AND_IL...1,SET,190,0.043539,0.0044062,0.059589,0.2325,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.909614822734947
HP_ABNORMAL_SACCADIC_EYE_MOV...,SET,84,0.067481,0.0045539,0.092359,0.23251,HP_ABNORMAL_SACCADIC_EYE_MOVEMENTS,0.909614822734947
HERNANDEZ_MITOTIC_ARREST_BY_...4,SET,53,0.086315,0.0046308,0.11815,0.23254,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,0.909614822734947
GOBP_REGULATION_OF_SKELETAL_...4,SET,14,0.16491,0.0045522,0.22575,0.23254,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.909614822734947
GOBP_NEGATIVE_REGULATION_OF_...61,SET,15,0.16118,0.0046052,0.2207,0.2326,GOBP_NEGATIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.909620623312331
GOMF_MAP_KINASE_PHOSPHATASE_...,SET,13,0.18139,0.0048251,0.24838,0.23261,GOMF_MAP_KINASE_PHOSPHATASE_ACTIVITY,0.909620623312331
GSE10240_IL22_VS_IL22_AND_IL...2,SET,185,0.045406,0.0045349,0.062178,0.23262,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.909620623312331
GSE17974_CTRL_VS_ACT_IL4_AND...18,SET,172,0.048606,0.0046825,0.066574,0.23267,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP,0.909713786702666
METHYLCYTOSINE_DIOXYGENASE_T...,SET,117,0.054502,0.0043369,0.074686,0.23278,METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED_TARGET_GENES,0.909842529510961
LIU_TARGETS_OF_VMYB_VS_CMYB_...1,SET,38,0.10372,0.0047139,0.14215,0.23281,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,0.909842529510961
REACTOME_ARMS_MEDIATED_ACTIV...,SET,7,0.24758,0.0048332,0.33932,0.23281,REACTOME_ARMS_MEDIATED_ACTIVATION,0.909842529510961
MORF_G22P1,SET,152,0.046949,0.0042541,0.064348,0.23282,MORF_G22P1,0.909842529510961
REACTOME_SIGNALING_BY_ALK_IN...,SET,86,0.066489,0.0045399,0.091141,0.23285,REACTOME_SIGNALING_BY_ALK_IN_CANCER,0.909842529510961
GOMF_SODIUM_BICARBONATE_SYMP...,SET,6,0.23745,0.0042917,0.32551,0.23286,GOMF_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY,0.909842529510961
MIR548L,SET,333,0.034775,0.0046407,0.047687,0.23293,MIR548L,0.909902224969098
HP_PROGRESSIVE_DISTAL_MUSCUL...,SET,37,0.10152,0.004553,0.13922,0.23293,HP_PROGRESSIVE_DISTAL_MUSCULAR_ATROPHY,0.909902224969098
WP_ANGIOGENESIS,SET,24,0.13282,0.0047991,0.18216,0.23296,WP_ANGIOGENESIS,0.909902224969098
GOBP_PROSTANOID_METABOLIC_PR...,SET,45,0.094852,0.0046901,0.1301,0.23298,GOBP_PROSTANOID_METABOLIC_PROCESS,0.909902224969098
MIR6878_5P,SET,197,0.045735,0.0047119,0.062738,0.23301,MIR6878_5P,0.909917140449438
GOBP_GLYCOSYLCERAMIDE_CATABO...,SET,6,0.25307,0.0045742,0.34725,0.23307,GOBP_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS,0.909922829383354
GOMF_INOSITOL_TRISPHOSPHATE_...,SET,12,0.16311,0.0041686,0.22381,0.23307,GOMF_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.909922829383354
GOBP_REGULATION_OF_TRANSCRIP...4,SET,11,0.17081,0.0041796,0.23439,0.23309,GOBP_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.909922829383354
MIR378A_3P_MIR378C_MIR378D_M...,SET,38,0.095769,0.0043524,0.13146,0.23315,MIR378A_3P_MIR378C_MIR378D_MIR378I,0.910031212189111
GGGYGTGNY_UNKNOWN,SET,598,0.025712,0.0045641,0.035304,0.23322,GGGYGTGNY_UNKNOWN,0.910031212189111
GSE7218_UNSTIM_VS_ANTIGEN_ST...4,SET,109,0.059483,0.0045696,0.081673,0.23322,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP,0.910031212189111
BMI1_DN_MEL18_DN.V1_DN,SET,128,0.059326,0.0049362,0.081488,0.2333,BMI1_DN_MEL18_DN.V1_DN,0.910031212189111
REACTOME_NEGATIVE_REGULATION...7,SET,40,0.09963,0.0046453,0.13687,0.23335,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,0.910031212189111
GSE37533_PPARG1_FOXP3_VS_PPA...2,SET,189,0.047447,0.0047891,0.065204,0.23341,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.910031212189111
GTAAGAT_MIR200A,SET,44,0.09604,0.0046959,0.132,0.23344,GTAAGAT_MIR200A,0.910031212189111
GOBP_INFLAMMATORY_RESPONSE_T...1,SET,70,0.080103,0.0049367,0.1101,0.23345,GOBP_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.910031212189111
MURARO_PANCREAS_DELTA_CELL,SET,222,0.046503,0.0050826,0.063919,0.23345,MURARO_PANCREAS_DELTA_CELL,0.910031212189111
MODULE_534,SET,9,0.22413,0.0049612,0.30811,0.23348,MODULE_534,0.910031212189111
GOBP_MYOTUBE_CELL_DEVELOPMENT,SET,37,0.10569,0.0047398,0.1453,0.23349,GOBP_MYOTUBE_CELL_DEVELOPMENT,0.910031212189111
HP_DECREASED_CIRCULATING_ADE...,SET,7,0.24914,0.0048637,0.34254,0.23352,HP_DECREASED_CIRCULATING_ADENOSYLCOBALAMIN_CONCENTRATION,0.910031212189111
GOMF_RECEPTOR_ANTAGONIST_ACT...,SET,16,0.156,0.0046031,0.21452,0.23356,GOMF_RECEPTOR_ANTAGONIST_ACTIVITY,0.910031212189111
KEGG_MEDICUS_REFERENCE_BLOOD...2,SET,7,0.26021,0.0050799,0.35787,0.23359,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS,0.910031212189111
GOCC_RNA_POLYMERASE_I_TRANSC...,SET,5,0.25348,0.0041826,0.34863,0.23359,GOCC_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATOR_COMPLEX,0.910031212189111
GOCC_RNA_POLYMERASE_TRANSCRI...,SET,5,0.25348,0.0041826,0.34863,0.23359,GOCC_RNA_POLYMERASE_TRANSCRIPTION_FACTOR_SL1_COMPLEX,0.910031212189111
KINNEY_DNMT1_METHYLATION_TAR...,SET,14,0.18017,0.0049734,0.24781,0.2336,KINNEY_DNMT1_METHYLATION_TARGETS,0.910031212189111
GSE14000_UNSTIM_VS_16H_LPS_D...2,SET,176,0.048566,0.0047322,0.066798,0.2336,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN,0.910031212189111
MIR4646_5P,SET,133,0.053346,0.0045239,0.073401,0.23369,MIR4646_5P,0.910031212189111
HP_ANTIMITOCHONDRIAL_ANTIBOD...,SET,11,0.22664,0.0055457,0.31185,0.23369,HP_ANTIMITOCHONDRIAL_ANTIBODY_POSITIVITY,0.910031212189111
GSE3982_EFF_MEMORY_CD4_TCELL...3,SET,181,0.044883,0.0044344,0.061758,0.23369,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN,0.910031212189111
LINDGREN_BLADDER_CANCER_CLUS...7,SET,288,0.035902,0.0044611,0.049403,0.2337,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,0.910031212189111
KEGG_MEDICUS_REFERENCE_WNT_S...4,SET,27,0.13018,0.0049885,0.17915,0.23372,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR,0.910031212189111
GSE45365_NK_CELL_VS_CD8A_DC_...3,SET,154,0.050658,0.00462,0.069723,0.23375,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP,0.910046068107987
HP_INCREASED_NEURONAL_AUTOFL...,SET,9,0.20714,0.004585,0.28514,0.23379,HP_INCREASED_NEURONAL_AUTOFLUORESCENT_LIPOPIGMENT,0.910090615901456
REACTOME_REGULATION_OF_INSUL...1,SET,115,0.064321,0.0050746,0.088559,0.23383,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,0.910090615901456
GOBP_REGULATION_OF_GAMMA_DEL...2,SET,9,0.21169,0.0046857,0.29147,0.23384,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.910090615901456
CIITA_TARGET_GENES,SET,973,0.020198,0.0045249,0.027826,0.23396,CIITA_TARGET_GENES,0.91028148852826
KEGG_MEDICUS_VARIANT_MUTATIO...53,SET,5,0.26715,0.0044081,0.36809,0.23399,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.91028148852826
MIR4477B,SET,242,0.040064,0.0045692,0.055203,0.234,MIR4477B,0.91028148852826
ZNF292_TARGET_GENES,SET,21,0.12828,0.0043361,0.17677,0.23402,ZNF292_TARGET_GENES,0.91028148852826
GOBP_POSITIVE_REGULATION_OF_...259,SET,32,0.10202,0.0042554,0.14058,0.23402,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.91028148852826
GNF2_CDH11,SET,24,0.14967,0.0054077,0.20629,0.23407,GNF2_CDH11,0.910374087958818
HP_AVASCULAR_NECROSIS,SET,83,0.069116,0.0046366,0.095285,0.23412,HP_AVASCULAR_NECROSIS,0.910466666666667
GOBP_ECTOPIC_GERM_CELL_PROGR...,SET,17,0.15404,0.0046852,0.2124,0.23415,GOBP_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH,0.910481455582904
HP_FEMORAL_HERNIA,SET,17,0.1589,0.004833,0.21919,0.23425,HP_FEMORAL_HERNIA,0.910618312458063
BACH1_01,SET,238,0.041272,0.0046685,0.056938,0.23427,BACH1_01,0.910618312458063
GOBP_REGULATION_OF_MRNA_PROC...,SET,117,0.052217,0.0041551,0.072035,0.23427,GOBP_REGULATION_OF_MRNA_PROCESSING,0.910618312458063
WP_SOMATIC_SEX_DETERMINATION,SET,13,0.17827,0.0047421,0.24596,0.23429,WP_SOMATIC_SEX_DETERMINATION,0.910618312458063
GSE13485_DAY1_VS_DAY7_YF17D_...2,SET,140,0.053701,0.0046714,0.074102,0.23433,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.910671938946662
GOBP_RENAL_WATER_TRANSPORT,SET,9,0.23399,0.0051794,0.32309,0.23447,GOBP_RENAL_WATER_TRANSPORT,0.910740561622465
GSE2770_UNTREATED_VS_IL12_TR...3,SET,180,0.043312,0.0042675,0.059806,0.23447,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.910740561622465
GOBP_T_TUBULE_ORGANIZATION,SET,6,0.23912,0.004322,0.33021,0.23449,GOBP_T_TUBULE_ORGANIZATION,0.910740561622465
MIR6081,SET,97,0.065155,0.0047233,0.090005,0.23457,MIR6081,0.910740561622465
GOBP_INHIBITION_OF_NEUROEPIT...,SET,6,0.24568,0.0044406,0.33942,0.23459,GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.910740561622465
GSE17974_0H_VS_72H_IN_VITRO_...1,SET,170,0.045214,0.0043306,0.062467,0.2346,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN,0.910740561622465
MIR3672,SET,41,0.094118,0.0044427,0.13006,0.23464,MIR3672,0.910740561622465
BIOCARTA_G2_PATHWAY,SET,24,0.11503,0.0041562,0.15897,0.23467,BIOCARTA_G2_PATHWAY,0.910740561622465
GOBP_MONOCYTE_EXTRAVASATION,SET,9,0.21811,0.0048278,0.30151,0.23472,GOBP_MONOCYTE_EXTRAVASATION,0.910740561622465
WP_MFAP5_EFFECT_ON_PERMEABIL...,SET,17,0.15862,0.0048245,0.2193,0.23474,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,0.910740561622465
ATCTTGC_MIR31,SET,70,0.072787,0.0044858,0.10064,0.23476,ATCTTGC_MIR31,0.910740561622465
HP_PROTRUSIO_ACETABULI,SET,12,0.19475,0.0049772,0.26932,0.23481,HP_PROTRUSIO_ACETABULI,0.910740561622465
CYCLIN_D1_KE_.V1_DN,SET,179,0.046383,0.0045575,0.064151,0.23483,CYCLIN_D1_KE_.V1_DN,0.910740561622465
GOBP_NEGATIVE_REGULATION_OF_...190,SET,22,0.13236,0.004579,0.18306,0.23484,GOBP_NEGATIVE_REGULATION_OF_DNA_REPLICATION,0.910740561622465
GOBP_NEGATIVE_REGULATION_OF_...394,SET,33,0.10393,0.0044024,0.14376,0.23485,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.910740561622465
GNF2_CASP8,SET,24,0.1358,0.0049068,0.18788,0.2349,GNF2_CASP8,0.910740561622465
HP_SYNOSTOSIS_OF_CARPAL_BONES,SET,23,0.13852,0.0048999,0.19165,0.2349,HP_SYNOSTOSIS_OF_CARPAL_BONES,0.910740561622465
REACTOME_TOLL_LIKE_RECEPTOR_...2,SET,159,0.050863,0.0047128,0.070374,0.23492,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,0.910740561622465
HP_XEROSTOMIA,SET,52,0.089092,0.0047347,0.12329,0.23495,HP_XEROSTOMIA,0.910740561622465
GSE21033_CTRL_VS_POLYIC_STIM...1,SET,177,0.047146,0.0046067,0.065245,0.23497,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN,0.910740561622465
GOBP_IMP_SALVAGE,SET,4,0.31575,0.0046601,0.43701,0.23499,GOBP_IMP_SALVAGE,0.910740561622465
GSE15271_CXCR4_POS_VS_NEG_GC...2,SET,158,0.046836,0.0043261,0.06483,0.23501,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP,0.910740561622465
GOBP_INTRACELLULAR_PROTEIN_T...1,SET,29,0.1138,0.0045192,0.15754,0.23504,GOBP_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.910740561622465
VANASSE_BCL2_TARGETS_DN,SET,53,0.080975,0.0043444,0.1121,0.23505,VANASSE_BCL2_TARGETS_DN,0.910740561622465
ZNF134_TARGET_GENES,SET,843,0.021366,0.0044718,0.02958,0.23506,ZNF134_TARGET_GENES,0.910740561622465
MODULE_71,SET,19,0.15566,0.005005,0.21551,0.23506,MODULE_71,0.910740561622465
KEGG_MEDICUS_VARIANT_MUTATIO...59,SET,11,0.18765,0.0045917,0.25983,0.23509,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.910740561622465
GOMF_TRANSLATION_TERMINATION...,SET,4,0.28924,0.0042688,0.40051,0.2351,GOMF_TRANSLATION_TERMINATION_FACTOR_ACTIVITY,0.910740561622465
HP_ABNORMAL_MIDDLE_PHALANX_M...,SET,58,0.084417,0.0047372,0.1169,0.23512,HP_ABNORMAL_MIDDLE_PHALANX_MORPHOLOGY_OF_THE_HAND,0.910740561622465
HP_ABNORMALITY_OF_FACIAL_ADI...,SET,10,0.201,0.0046897,0.27839,0.23514,HP_ABNORMALITY_OF_FACIAL_ADIPOSE_TISSUE,0.910740561622465
GOBP_DNA_REPAIR,SET,530,0.025245,0.0042269,0.034968,0.23516,GOBP_DNA_REPAIR,0.910740561622465
GSE1460_INTRATHYMIC_T_PROGEN...4,SET,171,0.047485,0.0045612,0.065786,0.23521,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP,0.910832707520891
ZWANG_DOWN_BY_2ND_EGF_PULSE,SET,210,0.041377,0.0043998,0.05734,0.23527,ZWANG_DOWN_BY_2ND_EGF_PULSE,0.910963552807487
HP_ESOPHAGITIS,SET,33,0.11489,0.0048666,0.15926,0.23533,HP_ESOPHAGITIS,0.911080815894924
GSE41978_WT_VS_BIM_KO_KLRG1_...2,SET,184,0.044009,0.0043836,0.061013,0.23536,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.911080815894924
MIR580_3P,SET,190,0.045515,0.0046061,0.063122,0.23544,MIR580_3P,0.911080815894924
GSE40666_WT_VS_STAT1_KO_CD8_...3,SET,185,0.043597,0.0043542,0.060461,0.23544,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.911080815894924
HP_LINEAR_ARRAYS_OF_MACULAR_...,SET,5,0.2988,0.0049303,0.4144,0.23545,HP_LINEAR_ARRAYS_OF_MACULAR_HYPERKERATOSES_IN_FLEXURAL_AREAS,0.911080815894924
GSE17721_POLYIC_VS_CPG_16H_B...1,SET,180,0.044836,0.0044176,0.062188,0.23547,GSE17721_POLYIC_VS_CPG_16H_BMDC_DN,0.911080815894924
KEGG_MEDICUS_VARIANT_AMPLIFI...10,SET,5,0.2627,0.0043347,0.36443,0.2355,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION,0.911080815894924
GOBP_DEVELOPMENT_OF_PRIMARY_...2,SET,213,0.044492,0.0047643,0.061723,0.23551,GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS,0.911080815894924
BIOCARTA_THELPER_PATHWAY,SET,12,0.1962,0.0050142,0.27223,0.23555,BIOCARTA_THELPER_PATHWAY,0.911134140233723
HP_HYPERHIDROSIS,SET,149,0.051229,0.0045963,0.071104,0.23562,HP_HYPERHIDROSIS,0.911279425837321
MIR12132,SET,134,0.05181,0.00441,0.071915,0.23564,MIR12132,0.911279425837321
MIR598_5P,SET,4,0.30404,0.0044872,0.42217,0.23571,MIR598_5P,0.911400583982202
HP_ABNORMALITY_OF_THE_ANKLE,SET,159,0.050201,0.0046514,0.069715,0.23574,HP_ABNORMALITY_OF_THE_ANKLE,0.911400583982202
BUSSLINGER_GASTRIC_X_CELLS,SET,172,0.049677,0.0047856,0.068989,0.23575,BUSSLINGER_GASTRIC_X_CELLS,0.911400583982202
GOBP_NEGATIVE_REGULATION_OF_...692,SET,5,0.31035,0.0051209,0.43115,0.23582,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.911479397068621
MODULE_379,SET,178,0.046867,0.0045923,0.065116,0.23585,MODULE_379,0.911479397068621
HP_EXPRESSIVE_LANGUAGE_DELAY,SET,50,0.084948,0.004427,0.11804,0.23587,HP_EXPRESSIVE_LANGUAGE_DELAY,0.911479397068621
GOBP_REGULATION_OF_TOLL_LIKE...5,SET,11,0.19939,0.0048791,0.27708,0.23589,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.911479397068621
MIR429,SET,457,0.030534,0.004757,0.042438,0.23592,MIR429,0.911479397068621
WP_SPLICING_FACTOR_NOVA_REGU...,SET,41,0.096503,0.0045553,0.13414,0.23594,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,0.911479397068621
ROVERSI_GLIOMA_LOH_REGIONS,SET,45,0.11797,0.0058331,0.16402,0.236,ROVERSI_GLIOMA_LOH_REGIONS,0.911479397068621
GOCC_U1_SNRNP,SET,18,0.13231,0.0041406,0.18399,0.23605,GOCC_U1_SNRNP,0.911479397068621
GOBP_POSITIVE_REGULATION_OF_...687,SET,5,0.2897,0.00478,0.40288,0.23606,GOBP_POSITIVE_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.911479397068621
GSE16385_IFNG_TNF_VS_IL4_STI...4,SET,184,0.045539,0.0045359,0.063334,0.23607,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.911479397068621
HP_FEMALE_SEXUAL_DYSFUNCTION,SET,61,0.082223,0.0047315,0.11436,0.23608,HP_FEMALE_SEXUAL_DYSFUNCTION,0.911479397068621
LIU_COMMON_CANCER_GENES,SET,59,0.074015,0.004189,0.10295,0.23609,LIU_COMMON_CANCER_GENES,0.911479397068621
GOCC_RECYCLING_ENDOSOME,SET,187,0.043831,0.0044009,0.060978,0.23614,GOCC_RECYCLING_ENDOSOME,0.911479397068621
GOBP_RESPONSE_TO_TUMOR_NECRO...,SET,213,0.043227,0.0046288,0.060147,0.23617,GOBP_RESPONSE_TO_TUMOR_NECROSIS_FACTOR,0.911479397068621
GSE10325_BCELL_VS_LUPUS_BCEL...1,SET,186,0.044841,0.0044904,0.062397,0.23618,GSE10325_BCELL_VS_LUPUS_BCELL_DN,0.911479397068621
MIR494_3P,SET,346,0.034048,0.0046298,0.047379,0.23619,MIR494_3P,0.911479397068621
REACTOME_FRUCTOSE_CATABOLISM,SET,5,0.22083,0.0036438,0.3074,0.23626,REACTOME_FRUCTOSE_CATABOLISM,0.911648306872433
ZNF391_TARGET_GENES,SET,752,0.022826,0.004524,0.031778,0.23629,ZNF391_TARGET_GENES,0.911662849689165
WP_EXTRACELLULAR_VESICLES_IN...,SET,19,0.15887,0.005108,0.22136,0.23648,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,0.912294638694639
GOCC_NUCLEAR_EXOSOME_RNASE_C...,SET,14,0.15303,0.004224,0.21327,0.23653,GOCC_NUCLEAR_EXOSOME_RNASE_COMPLEX,0.912386254162042
AACTGAC_MIR223,SET,90,0.06396,0.0044671,0.089151,0.23656,AACTGAC_MIR223,0.912400710243036
REACTOME_RESPONSE_TO_ELEVATE...,SET,120,0.058399,0.0047058,0.081433,0.23665,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,0.912545295684012
GOBP_SECONDARY_PALATE_DEVELO...,SET,26,0.13653,0.0051341,0.19038,0.23665,GOBP_SECONDARY_PALATE_DEVELOPMENT,0.912545295684012
HP_EXCESSIVE_SHYNESS,SET,8,0.18815,0.0039266,0.26241,0.23669,HP_EXCESSIVE_SHYNESS,0.912598285999556
GOBP_NEGATIVE_REGULATION_OF_...643,SET,808,0.022313,0.0045766,0.031129,0.23676,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.912766921797005
GOBP_RIBOFLAVIN_METABOLIC_PR...,SET,5,0.2813,0.0046415,0.39252,0.2368,GOBP_RIBOFLAVIN_METABOLIC_PROCESS,0.912809694216707
HP_SMALL_FACE,SET,112,0.059612,0.0046417,0.083229,0.23692,HP_SMALL_FACE,0.912809694216707
GOMF_LIGAND_GATED_SODIUM_CHA...,SET,16,0.15265,0.0045044,0.21315,0.23694,GOMF_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY,0.912809694216707
GSE9946_IMMATURE_VS_MATURE_S...2,SET,124,0.051652,0.0042305,0.072125,0.23695,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP,0.912809694216707
GCATTTG_MIR105,SET,153,0.050611,0.0046009,0.070678,0.23697,GCATTTG_MIR105,0.912809694216707
GSE13485_CTRL_VS_DAY21_YF17D...2,SET,177,0.043257,0.0042267,0.060406,0.23697,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.912809694216707
REACTOME_METABOLISM_OF_CARBO...,SET,267,0.037551,0.0044953,0.052443,0.23699,REACTOME_METABOLISM_OF_CARBOHYDRATES,0.912809694216707
GOBP_REGULATION_OF_ACTOMYOSI...,SET,94,0.065407,0.004668,0.091346,0.23699,GOBP_REGULATION_OF_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.912809694216707
GOBP_TOLL_LIKE_RECEPTOR_8_SI...,SET,2,0.51051,0.0053279,0.71311,0.23703,GOBP_TOLL_LIKE_RECEPTOR_8_SIGNALING_PATHWAY,0.912809694216707
GGGCATT_MIR365,SET,100,0.061106,0.0044974,0.085365,0.23706,GGGCATT_MIR365,0.912809694216707
GOBP_MATURE_B_CELL_DIFFERENT...1,SET,34,0.10826,0.0046543,0.15123,0.23706,GOBP_MATURE_B_CELL_DIFFERENTIATION,0.912809694216707
GOBP_REGULATION_OF_GLUCAGON_...,SET,8,0.21876,0.0045654,0.3057,0.23713,GOBP_REGULATION_OF_GLUCAGON_SECRETION,0.912978082419408
REACTOME_TELOMERE_EXTENSION_...,SET,22,0.12444,0.004305,0.17397,0.23722,REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,0.913122283752353
HP_GENERALIZED_TONIC_SEIZURE,SET,50,0.085914,0.0044773,0.12011,0.23722,HP_GENERALIZED_TONIC_SEIZURE,0.913122283752353
GSE21546_SAP1A_KO_VS_SAP1A_K...3,SET,185,0.043043,0.0042988,0.060206,0.23733,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.913444534883721
GOBP_CARDIAC_PACEMAKER_CELL_...2,SET,11,0.20118,0.0049229,0.28145,0.23737,GOBP_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION,0.913473145482728
HP_ABNORMALITY_OF_CIRCULATIN...2,SET,62,0.079342,0.0046029,0.11101,0.23739,HP_ABNORMALITY_OF_CIRCULATING_GLUCOCORTICOID_LEVEL,0.913473145482728
ACAACCT_MIR453,SET,36,0.10098,0.0044672,0.14133,0.23747,ACAACCT_MIR453,0.913494455445545
THEODOROU_MAMMARY_TUMORIGENE...,SET,27,0.13718,0.0052569,0.19203,0.23749,THEODOROU_MAMMARY_TUMORIGENESIS,0.913494455445545
GSE19198_1H_VS_24H_IL21_TREA...1,SET,182,0.046868,0.0046431,0.065628,0.23757,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN,0.913494455445545
HP_SLOPING_FOREHEAD,SET,165,0.044155,0.004167,0.061833,0.23759,HP_SLOPING_FOREHEAD,0.913494455445545
GOBP_POSITIVE_REGULATION_OF_...762,SET,3,0.44186,0.0056477,0.61888,0.23763,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.913494455445545
REACTOME_GLYCOGEN_SYNTHESIS,SET,12,0.17487,0.0044691,0.24494,0.23764,REACTOME_GLYCOGEN_SYNTHESIS,0.913494455445545
HP_HYPERPLASTIC_CALLUS_FORMA...,SET,5,0.29214,0.0048204,0.40924,0.23766,HP_HYPERPLASTIC_CALLUS_FORMATION,0.913494455445545
GSE21033_CTRL_VS_POLYIC_STIM...6,SET,142,0.0525,0.0045992,0.073552,0.23768,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP,0.913494455445545
GSE43863_TH1_VS_LY6C_LOW_CXC...2,SET,179,0.043025,0.0042275,0.060279,0.23769,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.913494455445545
SCHRAETS_MLL_TARGETS_UP,SET,29,0.12764,0.0050689,0.17884,0.2377,SCHRAETS_MLL_TARGETS_UP,0.913494455445545
GOMF_ACTIVIN_RECEPTOR_ACTIVI...1,SET,9,0.23162,0.0051269,0.32452,0.2377,GOMF_ACTIVIN_RECEPTOR_ACTIVITY,0.913494455445545
HP_CORTICAL_SCLEROSIS,SET,5,0.27984,0.0046174,0.39216,0.23774,HP_CORTICAL_SCLEROSIS,0.913494455445545
FAN_EMBRYONIC_CTX_BIG_GROUPS...2,SET,131,0.055837,0.0046997,0.078252,0.23776,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.913494455445545
COLINA_TARGETS_OF_4EBP1_AND_...,SET,319,0.03475,0.0045406,0.048706,0.23778,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,0.913494455445545
HP_ABNORMAL_BRAINSTEM_MORPHO...,SET,249,0.037656,0.0043554,0.0528,0.23787,HP_ABNORMAL_BRAINSTEM_MORPHOLOGY,0.913494455445545
AIZARANI_LIVER_C22_RESIDENT_...,SET,26,0.11946,0.0044922,0.16753,0.23791,AIZARANI_LIVER_C22_RESIDENT_B_CELLS_2,0.913494455445545
HP_ABNORMALITY_OF_THE_PREMAX...,SET,11,0.18042,0.0044149,0.25304,0.23792,HP_ABNORMALITY_OF_THE_PREMAXILLA,0.913494455445545
MIR5089_3P,SET,62,0.075553,0.0043831,0.10597,0.23794,MIR5089_3P,0.913494455445545
GOMF_O_ACETYLTRANSFERASE_ACT...,SET,9,0.21203,0.0046932,0.29744,0.23798,GOMF_O_ACETYLTRANSFERASE_ACTIVITY,0.913494455445545
GOBP_DIGESTIVE_SYSTEM_DEVELO...,SET,140,0.054382,0.0047306,0.0763,0.23801,GOBP_DIGESTIVE_SYSTEM_DEVELOPMENT,0.913494455445545
MIR4636,SET,3,0.47038,0.0060122,0.66001,0.23803,MIR4636,0.913494455445545
GOBP_PYRIMIDINE_NUCLEOSIDE_T...1,SET,17,0.14715,0.0044754,0.2065,0.23806,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.913494455445545
GOBP_ODONTOGENESIS,SET,122,0.060906,0.0049483,0.085479,0.23808,GOBP_ODONTOGENESIS,0.913494455445545
GSE9988_ANTI_TREM1_VS_VEHICL...1,SET,183,0.044533,0.0044238,0.062502,0.23808,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN,0.913494455445545
GOCC_MITOCHONDRIAL_INTERMEMB...,SET,5,0.24794,0.004091,0.3481,0.23816,GOCC_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX,0.913494455445545
GSE40666_STAT1_KO_VS_STAT4_K...4,SET,168,0.043118,0.0041057,0.060544,0.23818,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.913494455445545
GOBP_VENOUS_BLOOD_VESSEL_MOR...,SET,9,0.22112,0.0048945,0.31054,0.23822,GOBP_VENOUS_BLOOD_VESSEL_MORPHOGENESIS,0.913494455445545
YAO_HOXA10_TARGETS_VIA_PROGE...1,SET,18,0.16937,0.0053006,0.23788,0.23824,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,0.913494455445545
HP_GASTROINTESTINAL_HEMORRHA...,SET,154,0.049806,0.0045424,0.069963,0.23827,HP_GASTROINTESTINAL_HEMORRHAGE,0.913494455445545
HP_PHIMOSIS,SET,9,0.19543,0.0043257,0.27457,0.23831,HP_PHIMOSIS,0.913494455445545
PID_ECADHERIN_NASCENT_AJ_PAT...,SET,38,0.10183,0.0046279,0.14308,0.23832,PID_ECADHERIN_NASCENT_AJ_PATHWAY,0.913494455445545
MYCMAX_B,SET,245,0.040082,0.0045992,0.056326,0.23836,MYCMAX_B,0.913494455445545
GSE6259_DEC205_POS_DC_VS_CD4...1,SET,181,0.04385,0.0043323,0.061632,0.2384,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN,0.913494455445545
WP_GENES_ASSOCIATED_WITH_THE...,SET,17,0.16334,0.004968,0.22959,0.23841,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,0.913494455445545
MIR587,SET,337,0.034526,0.0046345,0.048543,0.23847,MIR587,0.913494455445545
GNF2_PTX3,SET,34,0.11873,0.0051048,0.16697,0.23851,GNF2_PTX3,0.913494455445545
NAGASHIMA_NRG1_SIGNALING_UP,SET,166,0.049988,0.0047317,0.070305,0.23854,NAGASHIMA_NRG1_SIGNALING_UP,0.913494455445545
MIR635,SET,40,0.10089,0.0047042,0.1419,0.23854,MIR635,0.913494455445545
GOBP_CELLULAR_RESPONSE_TO_VI...1,SET,70,0.079676,0.0049103,0.11206,0.23855,GOBP_CELLULAR_RESPONSE_TO_VIRUS,0.913494455445545
GSE22432_CONVENTIONAL_CDC_VS...2,SET,180,0.043885,0.0043239,0.061736,0.23859,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP,0.913494455445545
WP_METABOLIC_PATHWAYS_OF_FIB...,SET,32,0.10413,0.0043434,0.14651,0.23863,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,0.913494455445545
GOBP_RESPONSE_TO_CORTICOTROP...,SET,5,0.31662,0.0052244,0.4455,0.23863,GOBP_RESPONSE_TO_CORTICOTROPIN_RELEASING_HORMONE,0.913494455445545
GSE41867_NAIVE_VS_DAY6_LCMV_...1,SET,187,0.045306,0.004549,0.063754,0.23866,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.913494455445545
LIU_CMYB_TARGETS_UP,SET,147,0.05209,0.0046423,0.073309,0.23868,LIU_CMYB_TARGETS_UP,0.913494455445545
GOBP_LEPTIN_MEDIATED_SIGNALI...,SET,10,0.19535,0.0045578,0.27495,0.2387,GOBP_LEPTIN_MEDIATED_SIGNALING_PATHWAY,0.913494455445545
GSE46606_DAY1_VS_DAY3_CD40L_...5,SET,180,0.044493,0.0043838,0.062622,0.2387,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN,0.913494455445545
GSE29615_CTRL_VS_DAY3_LAIV_I...1,SET,153,0.046576,0.004234,0.065557,0.23871,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN,0.913494455445545
GSE21546_UNSTIM_VS_ANTI_CD3_...6,SET,147,0.052225,0.0046543,0.073511,0.23872,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.913494455445545
BOSCO_ALLERGEN_INDUCED_TH2_A...,SET,133,0.057413,0.0048688,0.080815,0.23873,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,0.913494455445545
GOBP_NEGATIVE_REGULATION_OF_...150,SET,51,0.092097,0.0048472,0.12966,0.23876,GOBP_NEGATIVE_REGULATION_OF_COAGULATION,0.913494455445545
BURTON_ADIPOGENESIS_3,SET,95,0.058401,0.00419,0.082227,0.23878,BURTON_ADIPOGENESIS_3,0.913494455445545
GOBP_RESPONSE_TO_CALCIUM_ION,SET,124,0.057365,0.0046984,0.080788,0.23883,GOBP_RESPONSE_TO_CALCIUM_ION,0.913494455445545
GOBP_INSULIN_SECRETION_INVOL...,SET,59,0.077689,0.0043969,0.10941,0.23884,GOBP_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.913494455445545
REACTOME_NRAGE_SIGNALS_DEATH...,SET,53,0.087418,0.00469,0.12313,0.23886,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,0.913494455445545
LEE_SP4_THYMOCYTE,SET,15,0.16663,0.0047608,0.23471,0.23888,LEE_SP4_THYMOCYTE,0.913494455445545
GOBP_PHOSPHOLIPID_EFFLUX,SET,11,0.19443,0.0047576,0.27388,0.23889,GOBP_PHOSPHOLIPID_EFFLUX,0.913494455445545
GSE23925_LIGHT_ZONE_VS_NAIVE...2,SET,181,0.046201,0.0045646,0.065088,0.23891,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP,0.913494455445545
MIR4498,SET,231,0.04059,0.0045242,0.057184,0.23892,MIR4498,0.913494455445545
GOBP_POSITIVE_REGULATION_OF_...721,SET,12,0.16237,0.0041497,0.22882,0.23899,GOBP_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT,0.913598192307692
WU_CELL_MIGRATION,SET,167,0.050459,0.0047905,0.071123,0.23902,WU_CELL_MIGRATION,0.913598192307692
GOMF_ATPASE_COUPLED_INORGANI...,SET,10,0.20344,0.0047467,0.28678,0.23904,GOMF_ATPASE_COUPLED_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.913598192307692
REACTOME_SIGNALING_BY_ERBB2_...1,SET,15,0.14103,0.0040294,0.19887,0.23912,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,0.913598192307692
BIOCARTA_TCRA_PATHWAY,SET,10,0.19623,0.0045785,0.27676,0.23915,BIOCARTA_TCRA_PATHWAY,0.913598192307692
REACTOME_RSV_HOST_INTERACTIO...,SET,84,0.066989,0.0045208,0.094488,0.23918,REACTOME_RSV_HOST_INTERACTIONS,0.913598192307692
GSE22443_NAIVE_VS_ACT_AND_IL...1,SET,185,0.044895,0.0044838,0.063324,0.23918,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN,0.913598192307692
GALIE_TUMOR_ANGIOGENESIS,SET,7,0.25158,0.0049114,0.35489,0.2392,GALIE_TUMOR_ANGIOGENESIS,0.913598192307692
GOBP_NADP_METABOLIC_PROCESS,SET,40,0.098155,0.0045765,0.13846,0.2392,GOBP_NADP_METABOLIC_PROCESS,0.913598192307692
ROZANOV_MMP14_TARGETS_SUBSET,SET,32,0.126,0.0052557,0.17775,0.23921,ROZANOV_MMP14_TARGETS_SUBSET,0.913598192307692
HAY_BONE_MARROW_CD34_POS_ERP,SET,8,0.22371,0.0046688,0.31582,0.23937,HAY_BONE_MARROW_CD34_POS_ERP,0.913965861275477
HP_OSTEOPENIA,SET,288,0.035765,0.0044441,0.050496,0.23939,HP_OSTEOPENIA,0.913965861275477
WOO_LIVER_CANCER_RECURRENCE_...1,SET,74,0.071744,0.0045455,0.10132,0.23946,WOO_LIVER_CANCER_RECURRENCE_DN,0.913965861275477
MIR4666B,SET,111,0.060861,0.0047179,0.085977,0.23952,MIR4666B,0.913965861275477
HP_MYOPATHY,SET,280,0.035889,0.0043981,0.050709,0.23956,HP_MYOPATHY,0.913965861275477
RPS14_DN.V1_UP,SET,180,0.047217,0.0046522,0.066715,0.23956,RPS14_DN.V1_UP,0.913965861275477
MIR219B_3P,SET,54,0.084875,0.0045962,0.11997,0.23963,MIR219B_3P,0.913965861275477
GOBP_ORGANOPHOSPHATE_BIOSYNT...,SET,508,0.026764,0.0043899,0.03783,0.23964,GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.913965861275477
LI_ESTROGENE_MID_E2_RESPONSE...1,SET,40,0.10454,0.0048741,0.14778,0.23966,LI_ESTROGENE_MID_E2_RESPONSE_DN,0.913965861275477
GOBP_NEGATIVE_REGULATION_OF_...687,SET,4,0.34019,0.0050207,0.48091,0.23967,GOBP_NEGATIVE_REGULATION_OF_URINE_VOLUME,0.913965861275477
REACTOME_DEFECTS_IN_COBALAMI...,SET,12,0.16859,0.0043086,0.23842,0.23976,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,0.913965861275477
GSE43863_TH1_VS_LY6C_LOW_CXC...1,SET,184,0.044378,0.0044204,0.062763,0.23976,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.913965861275477
GOMF_IGE_BINDING,SET,5,0.25516,0.0042102,0.36093,0.2398,GOMF_IGE_BINDING,0.913965861275477
WP_SUDDEN_INFANT_DEATH_SYNDR...,SET,148,0.055214,0.0049372,0.078115,0.23984,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,0.913965861275477
GOBP_REGULATION_OF_PRESYNAPT...1,SET,12,0.19614,0.0050127,0.27749,0.23984,GOBP_REGULATION_OF_PRESYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.913965861275477
KEGG_MEDICUS_PATHOGEN_SHIGEL...2,SET,10,0.19503,0.0045503,0.27598,0.23989,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.913965861275477
REACTOME_NEPHRIN_FAMILY_INTE...,SET,21,0.12766,0.004315,0.18065,0.23989,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,0.913965861275477
REACTOME_REGULATION_OF_FZD_B...,SET,20,0.1468,0.0048425,0.20776,0.23992,REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,0.913965861275477
HP_INTEROSSEUS_MUSCLE_ATROPHY,SET,4,0.24924,0.0036785,0.35274,0.23992,HP_INTEROSSEUS_MUSCLE_ATROPHY,0.913965861275477
GOBP_POSITIVE_REGULATION_OF_...51,SET,68,0.076418,0.004642,0.10816,0.23993,GOBP_POSITIVE_REGULATION_OF_AXONOGENESIS,0.913965861275477
GOBP_MRNA_3_END_PROCESSING,SET,36,0.091832,0.0040624,0.12999,0.23995,GOBP_MRNA_3_END_PROCESSING,0.913965861275477
GSE1432_CTRL_VS_IFNG_1H_MICR...1,SET,185,0.043737,0.0043682,0.061909,0.23995,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.913965861275477
MODULE_127,SET,11,0.15978,0.0039099,0.22619,0.23997,MODULE_127,0.913965861275477
GOMF_ALPHA_GLUCOSIDASE_ACTIV...,SET,7,0.22781,0.0044474,0.32251,0.23998,GOMF_ALPHA_GLUCOSIDASE_ACTIVITY,0.913965861275477
MODULE_236,SET,16,0.16068,0.0047414,0.22748,0.23999,MODULE_236,0.913965861275477
HP_TRUNCAL_TITUBATION,SET,7,0.23893,0.0046644,0.33826,0.23999,HP_TRUNCAL_TITUBATION,0.913965861275477
GSE24142_EARLY_THYMIC_PROGEN...11,SET,180,0.046561,0.0045875,0.065935,0.24005,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP,0.914094198531829
GSE17721_LPS_VS_CPG_1H_BMDC_...1,SET,192,0.044463,0.004523,0.062974,0.24008,GSE17721_LPS_VS_CPG_1H_BMDC_DN,0.914108282208589
MODULE_14,SET,13,0.18806,0.0050023,0.26644,0.24015,MODULE_14,0.914233220338983
GOBP_NEGATIVE_REGULATION_OF_...152,SET,8,0.25185,0.005256,0.35684,0.24017,GOBP_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.914233220338983
GSE29618_PRE_VS_DAY7_POST_TI...8,SET,176,0.045626,0.0044457,0.064668,0.24024,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP,0.914233220338983
GOBP_MITOTIC_CELL_CYCLE,SET,838,0.020795,0.0043401,0.029478,0.24027,GOBP_MITOTIC_CELL_CYCLE,0.914233220338983
GOBP_BIOMINERAL_TISSUE_DEVEL...,SET,161,0.050832,0.0047391,0.072065,0.2403,GOBP_BIOMINERAL_TISSUE_DEVELOPMENT,0.914233220338983
GOBP_REGULATION_OF_MICROVILL...3,SET,13,0.15928,0.0042367,0.22581,0.2403,GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION,0.914233220338983
HP_ABNORMAL_ANTITRAGUS_MORPH...,SET,10,0.19423,0.0045316,0.27539,0.24032,HP_ABNORMAL_ANTITRAGUS_MORPHOLOGY,0.914233220338983
GOBP_REGULATION_OF_ENDODEOXY...,SET,8,0.22111,0.0046144,0.31355,0.24035,GOBP_REGULATION_OF_ENDODEOXYRIBONUCLEASE_ACTIVITY,0.914233220338983
GOBP_REGULATION_OF_ALTERNATI...,SET,50,0.079057,0.00412,0.11214,0.24041,GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.914233220338983
GOBP_POSITIVE_REGULATION_OF_...431,SET,18,0.14415,0.0045111,0.2045,0.24045,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.914233220338983
GSE18893_CTRL_VS_TNF_TREATED...1,SET,177,0.045931,0.004488,0.065163,0.24045,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN,0.914233220338983
GOCC_L_TYPE_VOLTAGE_GATED_CA...,SET,12,0.19571,0.0050019,0.27774,0.24051,GOCC_L_TYPE_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.914233220338983
HP_HYPERNASAL_SPEECH,SET,88,0.06707,0.0046322,0.095184,0.24052,HP_HYPERNASAL_SPEECH,0.914233220338983
BYSTRYKH_HEMATOPOIESIS_STEM_...1,SET,64,0.068813,0.0040557,0.097666,0.24054,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,0.914233220338983
GOMF_BETA_TUBULIN_BINDING,SET,35,0.097413,0.0042491,0.13826,0.24054,GOMF_BETA_TUBULIN_BINDING,0.914233220338983
GSE10147_IL3_AND_HIVP17_VS_I...1,SET,134,0.050035,0.0042589,0.071013,0.24054,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN,0.914233220338983
GOBP_POSITIVE_REGULATION_OF_...357,SET,81,0.068075,0.0045116,0.096628,0.24056,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION,0.914233220338983
GOCC_FILTRATION_DIAPHRAGM,SET,9,0.2153,0.0047656,0.30572,0.24065,GOCC_FILTRATION_DIAPHRAGM,0.914315673108418
GSE37416_0H_VS_3H_F_TULARENS...1,SET,182,0.044096,0.0043686,0.062618,0.24065,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.914315673108418
MODULE_576,SET,102,0.060668,0.0045093,0.086184,0.24074,MODULE_576,0.914315673108418
HP_UNDETECTABLE_ELECTRORETIN...,SET,33,0.11163,0.0047286,0.1586,0.24076,HP_UNDETECTABLE_ELECTRORETINOGRAM,0.914315673108418
GOBP_BONE_MARROW_DEVELOPMENT,SET,9,0.20894,0.0046249,0.29687,0.24078,GOBP_BONE_MARROW_DEVELOPMENT,0.914315673108418
HP_DUPLICATION_OF_THE_DISTAL...2,SET,6,0.23749,0.0042925,0.33745,0.24079,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.914315673108418
HP_INTRAHEPATIC_BILE_DUCT_DI...,SET,3,0.35172,0.0044956,0.49981,0.24081,HP_INTRAHEPATIC_BILE_DUCT_DILATATION,0.914315673108418
GOMF_CULLIN_FAMILY_PROTEIN_B...,SET,21,0.12153,0.0041079,0.17272,0.24084,GOMF_CULLIN_FAMILY_PROTEIN_BINDING,0.914315673108418
MIR548AD_5P_MIR548AE_5P_MIR5...,SET,444,0.029045,0.0044617,0.041286,0.24088,MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P,0.914315673108418
HP_COOMBS_POSITIVE_HEMOLYTIC...,SET,9,0.20462,0.0045292,0.2909,0.24091,HP_COOMBS_POSITIVE_HEMOLYTIC_ANEMIA,0.914315673108418
HP_ABNORMALITY_OF_THE_HAMATE...,SET,9,0.21072,0.0046643,0.29959,0.24092,HP_ABNORMALITY_OF_THE_HAMATE_BONE,0.914315673108418
WP_PLURIPOTENT_STEM_CELL_DIF...,SET,46,0.095866,0.0047925,0.1363,0.24093,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,0.914315673108418
GOBP_CARDIOBLAST_DIFFERENTIA...,SET,16,0.17415,0.0051389,0.24762,0.24093,GOBP_CARDIOBLAST_DIFFERENTIATION,0.914315673108418
HP_CUTANEOUS_CYST,SET,21,0.12695,0.004291,0.18051,0.24095,HP_CUTANEOUS_CYST,0.914315673108418
GOBP_POSITIVE_REGULATION_OF_...550,SET,12,0.17103,0.0043711,0.24333,0.24107,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.914647194629407
GOMF_ALPHA_1_4_GLUCOSIDASE_A...,SET,5,0.27019,0.0044582,0.38444,0.24109,GOMF_ALPHA_1_4_GLUCOSIDASE_ACTIVITY,0.914647194629407
GOBP_SPERM_CAPACITATION,SET,29,0.1163,0.0046186,0.16554,0.24117,GOBP_SPERM_CAPACITATION,0.914730975237264
HP_ADRENAL_OVERACTIVITY,SET,49,0.094074,0.0048534,0.1339,0.24117,HP_ADRENAL_OVERACTIVITY,0.914730975237264
HP_NONCOMMUNICATING_HYDROCEP...,SET,6,0.26909,0.0048637,0.38313,0.24124,HP_NONCOMMUNICATING_HYDROCEPHALUS,0.914730975237264
GOBP_POINTED_END_ACTIN_FILAM...,SET,7,0.20635,0.0040283,0.29381,0.24125,GOBP_POINTED_END_ACTIN_FILAMENT_CAPPING,0.914730975237264
GOBP_SMOOTH_MUSCLE_CELL_MIGR...,SET,67,0.077811,0.0046919,0.1108,0.24126,GOBP_SMOOTH_MUSCLE_CELL_MIGRATION,0.914730975237264
GOBP_PROTEIN_REPAIR,SET,7,0.2083,0.0040665,0.29662,0.24127,GOBP_PROTEIN_REPAIR,0.914730975237264
GOMF_MONOCARBOXYLIC_ACID_BIN...,SET,82,0.072537,0.0048368,0.10332,0.24133,GOMF_MONOCARBOXYLIC_ACID_BINDING,0.914858655104712
GOBP_TOLL_LIKE_RECEPTOR_7_SI...,SET,8,0.23604,0.004926,0.33625,0.24136,GOBP_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.914872592431017
MIR449A,SET,280,0.03569,0.0043737,0.05085,0.24139,MIR449A,0.914886526717557
GSE17301_IFNA2_VS_IFNA2_AND_...1,SET,182,0.04647,0.0046037,0.066221,0.24143,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN,0.914938354596009
GOBP_NEGATIVE_REGULATION_OF_...597,SET,95,0.061625,0.0044214,0.08785,0.24151,GOBP_NEGATIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.915015650185145
FAELT_B_CLL_WITH_VH_REARRANG...2,SET,44,0.09126,0.0044622,0.13015,0.24159,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,0.915015650185145
GOBP_PROTEIN_INSERTION_INTO_...6,SET,6,0.21495,0.0038851,0.30655,0.2416,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE,0.915015650185145
REACTOME_ORGANELLE_BIOGENESI...,SET,250,0.036529,0.0042335,0.052109,0.24165,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,0.915015650185145
REACTOME_TRANSCRIPTION_OF_E2...2,SET,16,0.14239,0.0042016,0.20312,0.24165,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,0.915015650185145
PID_HIV_NEF_PATHWAY,SET,35,0.10096,0.0044038,0.14403,0.24166,PID_HIV_NEF_PATHWAY,0.915015650185145
GRABARCZYK_BCL11B_TARGETS_DN,SET,56,0.08074,0.0044523,0.11519,0.24168,GRABARCZYK_BCL11B_TARGETS_DN,0.915015650185145
XU_RESPONSE_TO_TRETINOIN_AND...2,SET,14,0.17867,0.0049318,0.25491,0.24169,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,0.915015650185145
GOBP_REGULATION_OF_LIPASE_AC...,SET,59,0.08252,0.0046703,0.11775,0.24171,GOBP_REGULATION_OF_LIPASE_ACTIVITY,0.915015650185145
GOBP_REGULATION_OF_CELL_ACTI...,SET,577,0.026467,0.0046176,0.037767,0.24172,GOBP_REGULATION_OF_CELL_ACTIVATION,0.915015650185145
WP_COHESIN_COMPLEX_CORNELIA_...,SET,27,0.10807,0.0041413,0.15423,0.24174,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,0.915015650185145
KEGG_MEDICUS_REFERENCE_ANGII...,SET,7,0.25485,0.0049753,0.36377,0.24179,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,0.915105243384515
MIR6817_3P,SET,203,0.043492,0.0045478,0.062095,0.24184,MIR6817_3P,0.915194817073171
GOMF_VOLTAGE_GATED_POTASSIUM...1,SET,96,0.068649,0.004951,0.098063,0.24195,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.915347292006525
GSE3982_BCELL_VS_TH1_UP,SET,163,0.046908,0.0044001,0.067008,0.24196,GSE3982_BCELL_VS_TH1_UP,0.915347292006525
HP_ABNORMAL_HALLUX_PHALANX_M...,SET,37,0.09523,0.0042707,0.13606,0.242,HP_ABNORMAL_HALLUX_PHALANX_MORPHOLOGY,0.915347292006525
HP_FETAL_PYELECTASIS,SET,9,0.22089,0.0048893,0.31562,0.24201,HP_FETAL_PYELECTASIS,0.915347292006525
SWEET_KRAS_TARGETS_UP,SET,74,0.07596,0.0048127,0.10858,0.2421,SWEET_KRAS_TARGETS_UP,0.915347292006525
MIR548AK_MIR548AM_5P_MIR548C...,SET,443,0.028931,0.0044395,0.041355,0.2421,MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P,0.915347292006525
MIR548O_5P_MIR548W,SET,443,0.028931,0.0044395,0.041355,0.2421,MIR548O_5P_MIR548W,0.915347292006525
GOBP_PROTEIN_DEUBIQUITINATIO...,SET,5,0.26739,0.004412,0.38224,0.24211,GOBP_PROTEIN_DEUBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.915347292006525
HP_FOLLICULAR_HYPERPLASIA,SET,14,0.16527,0.004562,0.23627,0.24212,HP_FOLLICULAR_HYPERPLASIA,0.915347292006525
GSE24210_CTRL_VS_IL35_TREATE...1,SET,180,0.04243,0.0041806,0.060669,0.24216,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN,0.915347292006525
MODULE_312,SET,46,0.087654,0.004382,0.12533,0.24217,MODULE_312,0.915347292006525
GOMF_CARGO_ADAPTOR_ACTIVITY,SET,20,0.13226,0.004363,0.18924,0.2423,GOMF_CARGO_ADAPTOR_ACTIVITY,0.915595207563573
GSE41867_NAIVE_VS_DAY30_LCMV...2,SET,182,0.041321,0.0040936,0.059132,0.24235,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP,0.915595207563573
GOBP_RESPONSE_TO_IRON_II_ION,SET,6,0.25512,0.0046112,0.36514,0.24237,GOBP_RESPONSE_TO_IRON_II_ION,0.915595207563573
GOBP_RESPONSE_TO_VIRUS,SET,368,0.032303,0.0045272,0.046233,0.24238,GOBP_RESPONSE_TO_VIRUS,0.915595207563573
GSE39556_CD8A_DC_VS_NK_CELL_...2,SET,180,0.045444,0.0044775,0.065045,0.24239,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN,0.915595207563573
GOMF_CYCLOSPORIN_A_BINDING,SET,17,0.13105,0.0039858,0.18758,0.2424,GOMF_CYCLOSPORIN_A_BINDING,0.915595207563573
GSE26030_UNSTIM_VS_RESTIM_TH...1,SET,178,0.04457,0.0043672,0.063802,0.24242,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN,0.915595207563573
GOBP_MITOTIC_CYTOKINETIC_PRO...,SET,31,0.10466,0.004297,0.14987,0.24249,GOBP_MITOTIC_CYTOKINETIC_PROCESS,0.915670688350983
GOBP_PYRIMIDINE_NUCLEOBASE_B...,SET,7,0.21735,0.0042431,0.31129,0.24253,GOBP_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.915670688350983
GSE45365_NK_CELL_VS_BCELL_MC...2,SET,181,0.045205,0.0044662,0.064766,0.2426,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP,0.915670688350983
GOBP_EPITHELIAL_FLUID_TRANSP...,SET,12,0.18486,0.0047245,0.26486,0.24261,GOBP_EPITHELIAL_FLUID_TRANSPORT,0.915670688350983
GOBP_NEGATIVE_REGULATION_OF_...591,SET,13,0.17891,0.004759,0.25635,0.24263,GOBP_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.915670688350983
MIR7976,SET,91,0.06037,0.0042396,0.086511,0.24265,MIR7976,0.915670688350983
WP_NAD_METABOLISM_IN_ONCOGEN...,SET,22,0.11933,0.0041282,0.17104,0.2427,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.915670688350983
GOBP_NUCLEAR_PORE_ORGANIZATI...,SET,15,0.14573,0.0041638,0.20889,0.2427,GOBP_NUCLEAR_PORE_ORGANIZATION,0.915670688350983
BIOCARTA_RHO_PATHWAY,SET,18,0.14028,0.0043903,0.20112,0.24274,BIOCARTA_RHO_PATHWAY,0.915670688350983
MODULE_70,SET,39,0.097339,0.0044815,0.13955,0.24274,MODULE_70,0.915670688350983
HAN_JNK_SINGALING_UP,SET,34,0.1088,0.0046776,0.15599,0.24277,HAN_JNK_SINGALING_UP,0.915670688350983
GOCC_ACTIN_CYTOSKELETON,SET,481,0.027978,0.0044687,0.040115,0.24277,GOCC_ACTIN_CYTOSKELETON,0.915670688350983
KEGG_MEDICUS_REFERENCE_TLR1_...,SET,18,0.13944,0.0043638,0.19995,0.2428,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY,0.915670688350983
GOMF_CHLORIDE_CHANNEL_REGULA...,SET,13,0.15135,0.0040258,0.21707,0.24283,GOMF_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY,0.915670688350983
REACTOME_HISTIDINE_CATABOLISM,SET,7,0.24144,0.0047135,0.34633,0.24286,REACTOME_HISTIDINE_CATABOLISM,0.915670688350983
GOCC_CARDIAC_MYOFIBRIL,SET,6,0.25848,0.0046719,0.37087,0.24292,GOCC_CARDIAC_MYOFIBRIL,0.915670688350983
DAUER_STAT3_TARGETS_DN,SET,46,0.091489,0.0045737,0.13128,0.24294,DAUER_STAT3_TARGETS_DN,0.915670688350983
BEGUM_TARGETS_OF_PAX3_FOXO1_...3,SET,54,0.087904,0.0047602,0.12614,0.24295,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.915670688350983
HP_FINGER_APLASIA,SET,77,0.065724,0.0042474,0.094317,0.24296,HP_FINGER_APLASIA,0.915670688350983
GOBP_RESPONSE_TO_UV_C,SET,12,0.17729,0.0045311,0.25444,0.24297,GOBP_RESPONSE_TO_UV_C,0.915670688350983
E2F_Q3_01,SET,209,0.040262,0.0042712,0.057801,0.24304,E2F_Q3_01,0.915670688350983
HP_ABNORMALITY_OF_THE_DORSAL...,SET,5,0.22644,0.0037362,0.32514,0.24309,HP_ABNORMALITY_OF_THE_DORSAL_COLUMN_OF_THE_SPINAL_CORD,0.915670688350983
GOBP_NEURAL_TUBE_PATTERNING,SET,28,0.12152,0.0047421,0.17455,0.24316,GOBP_NEURAL_TUBE_PATTERNING,0.915670688350983
GOBP_REGULATION_OF_CYCLASE_A...,SET,51,0.09116,0.0047979,0.13096,0.24318,GOBP_REGULATION_OF_CYCLASE_ACTIVITY,0.915670688350983
GOBP_TRANSFORMING_GROWTH_FAC...4,SET,196,0.044109,0.004533,0.063364,0.24318,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.915670688350983
GOBP_REGULATION_OF_METAPHASE...,SET,14,0.16287,0.0044957,0.23398,0.24319,GOBP_REGULATION_OF_METAPHASE_PLATE_CONGRESSION,0.915670688350983
EN1_01,SET,98,0.063696,0.0046412,0.091527,0.24324,EN1_01,0.915670688350983
DAVICIONI_MOLECULAR_ARMS_VS_...2,SET,301,0.034979,0.0044418,0.05027,0.24328,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,0.915670688350983
HP_PAROXYSMAL_BURSTS_OF_LAUG...,SET,9,0.19258,0.0042628,0.27687,0.24335,HP_PAROXYSMAL_BURSTS_OF_LAUGHTER,0.915670688350983
GSE37605_TREG_VS_TCONV_C57BL...4,SET,114,0.056528,0.0044404,0.081271,0.24336,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP,0.915670688350983
HP_ABNORMAL_SOFT_PALATE_MORP...,SET,224,0.038687,0.004247,0.055623,0.24337,HP_ABNORMAL_SOFT_PALATE_MORPHOLOGY,0.915670688350983
HP_GENERALIZED_DYSTONIA,SET,27,0.10927,0.0041872,0.15714,0.24342,HP_GENERALIZED_DYSTONIA,0.915670688350983
MIR1291,SET,97,0.061491,0.0044577,0.088434,0.24343,MIR1291,0.915670688350983
KAUFFMANN_DNA_REPLICATION_GE...,SET,135,0.050765,0.004337,0.073033,0.2435,KAUFFMANN_DNA_REPLICATION_GENES,0.915670688350983
MIR4661_5P,SET,36,0.094518,0.0041812,0.13598,0.24351,MIR4661_5P,0.915670688350983
GOMF_SPLICING_FACTOR_BINDING,SET,5,0.2396,0.0039535,0.34474,0.24353,GOMF_SPLICING_FACTOR_BINDING,0.915670688350983
HP_PEG_SHAPED_MAXILLARY_LATE...,SET,24,0.13517,0.0048838,0.19448,0.24353,HP_PEG_SHAPED_MAXILLARY_LATERAL_INCISORS,0.915670688350983
GSE9960_HEALTHY_VS_GRAM_NEG_...1,SET,163,0.044991,0.0042203,0.064736,0.24354,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.915670688350983
HP_OSTEOSARCOMA,SET,32,0.098642,0.0041145,0.14195,0.24357,HP_OSTEOSARCOMA,0.915670688350983
GOMF_G_PROTEIN_BETA_GAMMA_SU...,SET,21,0.13038,0.0044071,0.18771,0.24365,GOMF_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING,0.915670688350983
HP_ACUTE_RHABDOMYOLYSIS,SET,5,0.25517,0.0042103,0.36734,0.24365,HP_ACUTE_RHABDOMYOLYSIS,0.915670688350983
GOCC_CELL_DIVISION_SITE,SET,58,0.078615,0.0044116,0.11319,0.24368,GOCC_CELL_DIVISION_SITE,0.915670688350983
HP_ABNORMAL_CIRCULATING_ANDR...1,SET,89,0.064134,0.0044545,0.092341,0.24368,HP_ABNORMAL_CIRCULATING_ANDROGEN_LEVEL,0.915670688350983
SMID_BREAST_CANCER_RELAPSE_I...2,SET,87,0.067667,0.004647,0.097438,0.2437,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,0.915670688350983
MIR548A_5P,SET,443,0.028703,0.0044045,0.041331,0.2437,MIR548A_5P,0.915670688350983
GOBP_POSITIVE_REGULATION_OF_...695,SET,297,0.036384,0.0045899,0.052393,0.24371,GOBP_POSITIVE_REGULATION_OF_SECRETION,0.915670688350983
NAKAYAMA_SOFT_TISSUE_TUMORS_...2,SET,69,0.076848,0.0047022,0.11067,0.24373,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,0.915670688350983
MURAKAMI_UV_RESPONSE_1HR_DN,SET,10,0.19106,0.0044577,0.27518,0.24375,MURAKAMI_UV_RESPONSE_1HR_DN,0.915670688350983
GOBP_PIGMENT_CATABOLIC_PROCE...,SET,11,0.18234,0.0044619,0.26263,0.24376,GOBP_PIGMENT_CATABOLIC_PROCESS,0.915670688350983
HOFFMANN_LARGE_TO_SMALL_PRE_...1,SET,60,0.076666,0.0043755,0.11044,0.2438,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,0.915670688350983
MIR1915_5P,SET,42,0.096388,0.0046048,0.13886,0.2438,MIR1915_5P,0.915670688350983
REACTOME_GLI_PROTEINS_BIND_P...,SET,7,0.23483,0.0045845,0.33832,0.24381,REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION,0.915670688350983
GOCC_TRAPP_COMPLEX,SET,14,0.15267,0.0042143,0.21999,0.24385,GOCC_TRAPP_COMPLEX,0.91569812554019
GSE29615_CTRL_VS_LAIV_FLU_VA...2,SET,175,0.046281,0.0044968,0.066695,0.24387,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP,0.91569812554019
TESAR_ALK_AND_JAK_TARGETS_MO...2,SET,4,0.30387,0.0044847,0.43811,0.24397,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP,0.915974651614994
HP_COGNITIVE_DISTORTION,SET,29,0.11131,0.0044203,0.16058,0.24411,HP_COGNITIVE_DISTORTION,0.91634990300679
GSE18804_SPLEEN_MACROPHAGE_V...1,SET,170,0.044843,0.004295,0.064725,0.24422,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN,0.91634990300679
GOBP_TRNA_TRANSPORT,SET,6,0.20448,0.0036959,0.29517,0.24424,GOBP_TRNA_TRANSPORT,0.91634990300679
KEGG_MEDICUS_PATHOGEN_SALMON...7,SET,8,0.21339,0.0044533,0.30807,0.24427,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY,0.91634990300679
GSE3039_ALPHABETA_CD8_TCELL_...1,SET,179,0.043753,0.004299,0.063167,0.24427,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN,0.91634990300679
KEGG_MEDICUS_REFERENCE_BASE_...1,SET,8,0.19191,0.0040051,0.27712,0.24431,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE,0.91634990300679
SIX1_TARGET_GENES,SET,292,0.035836,0.0044833,0.051752,0.24433,SIX1_TARGET_GENES,0.91634990300679
AMIT_SERUM_RESPONSE_120_MCF1...,SET,63,0.077114,0.0045094,0.11138,0.24436,AMIT_SERUM_RESPONSE_120_MCF10A,0.91634990300679
HP_REDUCED_FORCED_EXPIRATORY...,SET,27,0.11521,0.0044149,0.16641,0.24437,HP_REDUCED_FORCED_EXPIRATORY_VOLUME_IN_ONE_SECOND,0.91634990300679
MIZUSHIMA_AUTOPHAGOSOME_FORM...,SET,12,0.16677,0.0042621,0.2409,0.24438,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,0.91634990300679
GOBP_NEGATIVE_REGULATION_OF_...459,SET,1304,0.016996,0.0043657,0.024553,0.24441,GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.91634990300679
GOCC_ZONA_PELLUCIDA_RECEPTOR...,SET,8,0.1776,0.0037064,0.25661,0.24444,GOCC_ZONA_PELLUCIDA_RECEPTOR_COMPLEX,0.91634990300679
GSE22886_DAY0_VS_DAY1_MONOCY...1,SET,185,0.044427,0.0044371,0.0642,0.24447,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN,0.91634990300679
GSE45365_WT_VS_IFNAR_KO_CD8A...3,SET,186,0.042534,0.0042594,0.061469,0.24448,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP,0.91634990300679
ABE_VEGFA_TARGETS_2HR,SET,27,0.11799,0.0045214,0.17053,0.2445,ABE_VEGFA_TARGETS_2HR,0.91634990300679
GSE6875_WT_VS_FOXP3_KO_TREG_...1,SET,179,0.044706,0.0043927,0.064617,0.24451,GSE6875_WT_VS_FOXP3_KO_TREG_DN,0.91634990300679
PBRM1_TARGET_GENES,SET,5,0.31351,0.005173,0.45319,0.24454,PBRM1_TARGET_GENES,0.91634990300679
GOCC_X_CHROMOSOME,SET,6,0.26184,0.0047326,0.37854,0.24456,GOCC_X_CHROMOSOME,0.91634990300679
HP_SIMPLE_FEBRILE_SEIZURE,SET,25,0.12753,0.0047027,0.18441,0.24461,HP_SIMPLE_FEBRILE_SEIZURE,0.91634990300679
MIR2278,SET,95,0.060566,0.0043454,0.087595,0.24465,MIR2278,0.91634990300679
GOMF_AMMONIA_LYASE_ACTIVITY,SET,5,0.29887,0.0049314,0.43225,0.24465,GOMF_AMMONIA_LYASE_ACTIVITY,0.91634990300679
HP_BLADDER_NEOPLASM,SET,33,0.10022,0.0042452,0.14495,0.24465,HP_BLADDER_NEOPLASM,0.91634990300679
GCNP_SHH_UP_EARLY.V1_UP,SET,156,0.046087,0.0042301,0.066673,0.24471,GCNP_SHH_UP_EARLY.V1_UP,0.916475867456897
MANNO_MIDBRAIN_NEUROTYPES_HG...,SET,972,0.020358,0.0045586,0.02946,0.24477,MANNO_MIDBRAIN_NEUROTYPES_HGABA,0.916479203921146
GOBP_REGULATION_OF_CILIUM_BE...2,SET,9,0.19213,0.0042528,0.27804,0.24478,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY,0.916479203921146
GOBP_PURINE_NUCLEOSIDE_DIPHO...,SET,6,0.25952,0.0046908,0.37558,0.24479,GOBP_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.916479203921146
GSE24634_IL4_VS_CTRL_TREATED...6,SET,180,0.045921,0.0045245,0.066486,0.24489,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP,0.916754841663076
GOBP_RESPONSE_TO_ALDOSTERONE,SET,17,0.1491,0.004535,0.21593,0.24494,GOBP_RESPONSE_TO_ALDOSTERONE,0.916774878915079
SCHMIDT_POR_TARGETS_IN_LIMB_...1,SET,8,0.22672,0.0047315,0.32838,0.24497,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN,0.916774878915079
GSE5503_PLN_DC_VS_SPLEEN_DC_...1,SET,181,0.042696,0.0042184,0.061844,0.24498,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.916774878915079
HP_INCREASED_CIRCULATING_INT...2,SET,5,0.27516,0.0045402,0.39867,0.24504,HP_INCREASED_CIRCULATING_INTERLEUKIN_18_CONCENTRATION,0.916774878915079
SERVITJA_ISLET_HNF1A_TARGETS...2,SET,154,0.051444,0.0046917,0.074542,0.24506,SERVITJA_ISLET_HNF1A_TARGETS_UP,0.916774878915079
BIOCARTA_CDC42RAC_PATHWAY,SET,8,0.19573,0.0040848,0.28363,0.24507,BIOCARTA_CDC42RAC_PATHWAY,0.916774878915079
WP_ESTROGEN_SIGNALING,SET,21,0.13282,0.0044893,0.19247,0.24508,WP_ESTROGEN_SIGNALING,0.916774878915079
GSE19198_6H_VS_24H_IL21_TREA...2,SET,178,0.045989,0.0045062,0.066665,0.24515,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP,0.916938038097288
MIR181C_3P,SET,10,0.16091,0.0037542,0.23332,0.24521,MIR181C_3P,0.917063763047455
HP_ALVEOLAR_RIDGE_OVERGROWTH,SET,11,0.17461,0.0042726,0.25322,0.24524,HP_ALVEOLAR_RIDGE_OVERGROWTH,0.917077275661717
WP_POSTCOVID_NEUROINFLAMMATI...,SET,20,0.14564,0.0048042,0.21129,0.24532,WP_POSTCOVID_NEUROINFLAMMATION,0.917171782604021
GOBP_MYELOID_DENDRITIC_CELL_...1,SET,26,0.12805,0.0048154,0.18582,0.24537,GOBP_MYELOID_DENDRITIC_CELL_ACTIVATION,0.917171782604021
HP_NEOPLASM_OF_THE_HEART,SET,15,0.14376,0.0041074,0.20861,0.24537,HP_NEOPLASM_OF_THE_HEART,0.917171782604021
KEGG_MEDICUS_REFERENCE_EGF_E...4,SET,16,0.14416,0.0042538,0.20921,0.2454,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.917171782604021
LEE_AGING_MUSCLE_UP,SET,34,0.1067,0.0045875,0.15488,0.24544,LEE_AGING_MUSCLE_UP,0.917171782604021
GSE9988_ANTI_TREM1_VS_CTRL_T...2,SET,172,0.049214,0.0047411,0.071437,0.24544,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP,0.917171782604021
MIR4253,SET,45,0.092876,0.0045924,0.13482,0.24545,MIR4253,0.917171782604021
HP_APATHY,SET,82,0.066417,0.0044287,0.096436,0.2455,HP_APATHY,0.917259997849925
GOMF_CARNITINE_O_ACYLTRANSFE...,SET,6,0.21001,0.0037959,0.305,0.24555,GOMF_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY,0.917327361126034
MODULE_524,SET,27,0.11987,0.0045935,0.17412,0.24559,MODULE_524,0.917327361126034
REACTOME_TRANSPORT_OF_RCBL_W...,SET,8,0.21115,0.0044066,0.30674,0.24562,REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY,0.917327361126034
GOBP_PRESYNAPTIC_MEMBRANE_OR...,SET,6,0.23899,0.0043197,0.34721,0.24563,GOBP_PRESYNAPTIC_MEMBRANE_ORGANIZATION,0.917327361126034
GOBP_NECROPTOTIC_PROCESS,SET,36,0.10257,0.0045373,0.14902,0.24565,GOBP_NECROPTOTIC_PROCESS,0.917327361126034
HP_FATIGABLE_WEAKNESS_OF_RES...,SET,57,0.077947,0.0043364,0.11331,0.24575,HP_FATIGABLE_WEAKNESS_OF_RESPIRATORY_MUSCLES,0.917333463975089
GOMF_PALMITOYLTRANSFERASE_AC...,SET,35,0.096113,0.0041924,0.13973,0.24577,GOMF_PALMITOYLTRANSFERASE_ACTIVITY,0.917333463975089
GOMF_TPR_DOMAIN_BINDING,SET,7,0.20265,0.0039562,0.2946,0.24577,GOMF_TPR_DOMAIN_BINDING,0.917333463975089
GOBP_PULMONARY_ARTERY_MORPHO...,SET,6,0.28005,0.0050618,0.40716,0.24579,GOBP_PULMONARY_ARTERY_MORPHOGENESIS,0.917333463975089
HP_EXCESSIVE_DAYTIME_SOMNOLE...,SET,64,0.073702,0.0043439,0.10716,0.2458,HP_EXCESSIVE_DAYTIME_SOMNOLENCE,0.917333463975089
GOBP_AMELOBLAST_DIFFERENTIAT...,SET,5,0.31896,0.0052629,0.46378,0.24581,GOBP_AMELOBLAST_DIFFERENTIATION,0.917333463975089
GSE45365_BCELL_VS_CD8_TCELL_...1,SET,137,0.051082,0.0043961,0.074285,0.24584,GSE45365_BCELL_VS_CD8_TCELL_DN,0.917346918617135
HP_ABNORMAL_CIRCULATING_INTE...1,SET,23,0.12328,0.0043605,0.17939,0.24598,HP_ABNORMAL_CIRCULATING_INTERFERON_CONCENTRATION,0.9177183538874
GOMF_PROTEIN_BINDING_INVOLVE...,SET,12,0.19343,0.0049434,0.28151,0.24602,GOMF_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION,0.9177183538874
GOBP_RETROGRADE_VESICLE_MEDI...,SET,48,0.078146,0.0039905,0.11374,0.24604,GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM,0.9177183538874
GOMF_PROTEIN_TYROSINE_THREON...,SET,9,0.2282,0.0050511,0.33221,0.24607,GOMF_PROTEIN_TYROSINE_THREONINE_PHOSPHATASE_ACTIVITY,0.9177183538874
MIR889_5P,SET,110,0.055544,0.0042864,0.080865,0.24608,MIR889_5P,0.9177183538874
HE_LIM_SUN_FETAL_LUNG_C3_SCG...,SET,522,0.02683,0.0044591,0.039063,0.2461,HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL,0.9177183538874
GSE11864_CSF1_VS_CSF1_IFNG_P...1,SET,173,0.043481,0.0042008,0.063318,0.24614,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.9177183538874
HP_SPARSE_EYELASHES,SET,61,0.075302,0.0043332,0.10967,0.24616,HP_SPARSE_EYELASHES,0.9177183538874
MIR6824_5P,SET,73,0.075386,0.0047441,0.10982,0.24621,MIR6824_5P,0.9177183538874
HP_ABNORMAL_URINE_CARBOHYDRA...,SET,37,0.092969,0.0041693,0.13543,0.24621,HP_ABNORMAL_URINE_CARBOHYDRATE_LEVEL,0.9177183538874
GOBP_LYMPHOCYTE_ANERGY,SET,7,0.22126,0.0043196,0.32235,0.24623,GOBP_LYMPHOCYTE_ANERGY,0.9177183538874
HP_ABNORMAL_ENDOCARDIUM_MORP...,SET,54,0.081305,0.0044029,0.11847,0.24627,HP_ABNORMAL_ENDOCARDIUM_MORPHOLOGY,0.917769016727429
HP_CONGENITAL_HEMOLYTIC_ANEM...,SET,8,0.20633,0.004306,0.30079,0.24637,HP_CONGENITAL_HEMOLYTIC_ANEMIA,0.918009583690069
GOBP_INTRACELLULAR_PROTEIN_T...2,SET,628,0.022901,0.0041624,0.033389,0.2464,GOBP_INTRACELLULAR_PROTEIN_TRANSPORT,0.918009583690069
MIR6887_3P,SET,176,0.045084,0.0043929,0.065758,0.24649,MIR6887_3P,0.918009583690069
RIZ_ERYTHROID_DIFFERENTIATIO...3,SET,24,0.127,0.0045888,0.18526,0.24651,RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,0.918009583690069
GOBP_RESPONSE_TO_ERYTHROPOIE...,SET,6,0.2832,0.0051188,0.41317,0.24654,GOBP_RESPONSE_TO_ERYTHROPOIETIN,0.918009583690069
MIR8075,SET,90,0.065258,0.0045577,0.095227,0.24659,MIR8075,0.918009583690069
GSE41867_DAY8_VS_DAY15_LCMV_...2,SET,147,0.04903,0.0043696,0.071557,0.24662,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.918009583690069
MCCOLLUM_GELDANAMYCIN_RESIST...1,SET,7,0.23507,0.0045891,0.3431,0.24664,MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN,0.918009583690069
GOCC_U6_SNRNP,SET,8,0.18025,0.0037618,0.26312,0.24666,GOCC_U6_SNRNP,0.918009583690069
GOBP_AZOLE_TRANSMEMBRANE_TRA...,SET,13,0.17186,0.0045716,0.25092,0.2467,GOBP_AZOLE_TRANSMEMBRANE_TRANSPORT,0.918009583690069
HP_EXTRAHEPATIC_CHOLESTASIS,SET,10,0.17636,0.0041148,0.25755,0.24675,HP_EXTRAHEPATIC_CHOLESTASIS,0.918009583690069
GREB1_TARGET_GENES,SET,682,0.022985,0.004347,0.033568,0.24676,GREB1_TARGET_GENES,0.918009583690069
MORF_MTA1,SET,93,0.057061,0.0040508,0.083331,0.24676,MORF_MTA1,0.918009583690069
GOMF_BETA_1_3_GALACTOSYLTRAN...,SET,14,0.17343,0.0047871,0.25327,0.24676,GOMF_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.918009583690069
REACTOME_RND2_GTPASE_CYCLE,SET,40,0.087329,0.0040717,0.12755,0.24679,REACTOME_RND2_GTPASE_CYCLE,0.918009583690069
GOBP_ORGANISM_EMERGENCE_FROM...,SET,22,0.12045,0.0041671,0.17594,0.24679,GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE,0.918009583690069
GOMF_CHLORIDE_CHANNEL_INHIBI...,SET,7,0.20191,0.0039418,0.29495,0.24681,GOMF_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY,0.918009583690069
HP_URINARY_BLADDER_SPHINCTER...,SET,28,0.10606,0.0041385,0.15492,0.24681,HP_URINARY_BLADDER_SPHINCTER_DYSFUNCTION,0.918009583690069
GOMF_PHOSPHOLIPASE_INHIBITOR...,SET,11,0.19314,0.0047262,0.28237,0.24699,GOMF_PHOSPHOLIPASE_INHIBITOR_ACTIVITY,0.918580786516854
GCM_PSME1,SET,75,0.063163,0.0040287,0.092357,0.24702,GCM_PSME1,0.918594061630644
YNTTTNNNANGCARM_UNKNOWN,SET,63,0.080603,0.0047135,0.11788,0.24707,YNTTTNNNANGCARM_UNKNOWN,0.918630773327652
MIR4492,SET,387,0.030208,0.0043392,0.044201,0.24718,MIR4492,0.918630773327652
REACTOME_ABERRANT_REGULATION...2,SET,17,0.13654,0.0041529,0.19983,0.24722,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,0.918630773327652
GOBP_REGULATION_OF_TELOMERE_...4,SET,57,0.073596,0.0040943,0.10771,0.24723,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.918630773327652
GOBP_CELLULAR_RESPONSE_TO_CG...,SET,7,0.20951,0.0040901,0.30669,0.24727,GOBP_CELLULAR_RESPONSE_TO_CGMP,0.918630773327652
HP_ABNORMAL_ATRIOVENTRICULAR...4,SET,183,0.043486,0.0043198,0.063665,0.24729,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_PHYSIOLOGY,0.918630773327652
MYLLYKANGAS_AMPLIFICATION_HO...2,SET,9,0.20699,0.0045817,0.30307,0.24731,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,0.918630773327652
REACTOME_FGFR1_MUTANT_RECEPT...,SET,30,0.11799,0.0047654,0.17276,0.24732,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,0.918630773327652
GOBP_NUCLEOTIDE_SUGAR_METABO...,SET,34,0.091187,0.0039204,0.13353,0.24733,GOBP_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS,0.918630773327652
BEGUM_TARGETS_OF_PAX3_FOXO1_...1,SET,7,0.26225,0.0051198,0.38406,0.24735,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3,0.918630773327652
GENTILE_UV_RESPONSE_CLUSTER_...3,SET,52,0.077983,0.0041443,0.11423,0.2474,GENTILE_UV_RESPONSE_CLUSTER_D4,0.918630773327652
WP_DIFFERENTIATION_OF_WHITE_...,SET,25,0.13214,0.0048726,0.19355,0.24741,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,0.918630773327652
GSE21379_WT_VS_SAP_KO_CD4_TC...2,SET,185,0.042386,0.0042332,0.062091,0.24742,GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP,0.918630773327652
GOBP_LIPOPROTEIN_BIOSYNTHETI...,SET,90,0.059254,0.0041384,0.086841,0.24752,GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS,0.918630773327652
GOMF_NADPLUS_NUCLEOSIDASE_AC...,SET,9,0.26006,0.0057564,0.38113,0.24752,GOMF_NADPLUS_NUCLEOSIDASE_ACTIVITY,0.918630773327652
ONDER_CDH1_TARGETS_3_UP,SET,15,0.16002,0.0045721,0.23454,0.24753,ONDER_CDH1_TARGETS_3_UP,0.918630773327652
MIKHAYLOVA_OXIDATIVE_STRESS_...2,SET,6,0.24656,0.0044565,0.36138,0.24754,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP,0.918630773327652
GOCC_CATALYTIC_STEP_2_SPLICE...,SET,83,0.056649,0.0038002,0.083053,0.2476,GOCC_CATALYTIC_STEP_2_SPLICEOSOME,0.918630773327652
GOBP_REGULATION_OF_MONOATOMI...1,SET,6,0.27015,0.0048829,0.39612,0.24762,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORT,0.918630773327652
GOCC_DYNEIN_AXONEMAL_PARTICLE,SET,14,0.13969,0.0038559,0.20484,0.24765,GOCC_DYNEIN_AXONEMAL_PARTICLE,0.918630773327652
GOBP_NEGATIVE_REGULATION_OF_...579,SET,9,0.21776,0.00482,0.31937,0.24768,GOBP_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.918630773327652
GOMF_1_PHOSPHATIDYLINOSITOL_...6,SET,15,0.15367,0.0043905,0.22539,0.2477,GOMF_1_PHOSPHATIDYLINOSITOL_BINDING,0.918630773327652
GOCC_TRICARBOXYLIC_ACID_CYCL...,SET,18,0.12216,0.003823,0.17929,0.24784,GOCC_TRICARBOXYLIC_ACID_CYCLE_HETEROMERIC_ENZYME_COMPLEX,0.918630773327652
GOBP_NEGATIVE_REGULATION_OF_...587,SET,1297,0.016901,0.0043304,0.024807,0.24785,GOBP_NEGATIVE_REGULATION_OF_SIGNALING,0.918630773327652
GOCC_GAMMA_TUBULIN_COMPLEX,SET,17,0.12962,0.0039425,0.19027,0.24785,GOCC_GAMMA_TUBULIN_COMPLEX,0.918630773327652
KEGG_MEDICUS_VARIANT_LRP6_OV...,SET,43,0.095524,0.0046174,0.14023,0.24788,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.918630773327652
WESTON_VEGFA_TARGETS,SET,85,0.066989,0.0045474,0.098351,0.2479,WESTON_VEGFA_TARGETS,0.918630773327652
REACTOME_CLASS_C_3_METABOTRO...,SET,37,0.11388,0.005107,0.1672,0.24791,REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS,0.918630773327652
HP_ABNORMAL_SPERM_AXONEME_MO...,SET,6,0.25266,0.0045667,0.37097,0.24791,HP_ABNORMAL_SPERM_AXONEME_MORPHOLOGY,0.918630773327652
HP_DEVIATION_OF_THE_3RD_FING...,SET,10,0.19132,0.0044639,0.28095,0.24794,HP_DEVIATION_OF_THE_3RD_FINGER,0.918630773327652
GOBP_AUTOPHAGOSOME_LYSOSOME_...,SET,11,0.17558,0.0042963,0.25788,0.24799,GOBP_AUTOPHAGOSOME_LYSOSOME_FUSION,0.918630773327652
GSE7219_WT_VS_NIK_NFKB2_KO_L...2,SET,180,0.045926,0.0045251,0.067461,0.24801,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP,0.918630773327652
MIR4529_3P,SET,43,0.089736,0.0043377,0.13182,0.24802,MIR4529_3P,0.918630773327652
MORF_MSH3,SET,225,0.038377,0.0042223,0.056383,0.24805,MORF_MSH3,0.918630773327652
CUI_TCF21_TARGETS_2_UP,SET,390,0.030146,0.0043468,0.044292,0.24806,CUI_TCF21_TARGETS_2_UP,0.918630773327652
GSE40274_CTRL_VS_SATB1_TRANS...1,SET,151,0.046127,0.004166,0.067773,0.24806,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.918630773327652
KEGG_MEDICUS_VARIANT_MUTATIO...52,SET,11,0.18018,0.0044089,0.26474,0.24807,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.918630773327652
DESCARTES_FETAL_PLACENTA_STR...,SET,56,0.088953,0.0049052,0.1307,0.24808,DESCARTES_FETAL_PLACENTA_STROMAL_CELLS,0.918630773327652
GOBP_MORPHOGENESIS_OF_AN_EPI...1,SET,13,0.18737,0.004984,0.27534,0.24809,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD,0.918630773327652
GOMF_ALCOHOL_TRANSMEMBRANE_T...,SET,6,0.23606,0.0042667,0.34691,0.24811,GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.918630773327652
GSE21360_SECONDARY_VS_QUATER...2,SET,173,0.048518,0.0046874,0.071309,0.24813,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.918630773327652
GOBP_REGULATION_OF_CIRCADIAN...2,SET,5,0.29819,0.0049202,0.43827,0.24814,GOBP_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,0.918630773327652
GSE43955_10H_VS_30H_ACT_CD4_...2,SET,183,0.043968,0.0043676,0.064658,0.24825,GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP,0.918728332092331
HP_BULBAR_PALSY,SET,39,0.088249,0.004063,0.12979,0.24827,HP_BULBAR_PALSY,0.918728332092331
GOBP_REGULATION_OF_CRISTAE_F...,SET,5,0.27573,0.0045497,0.40553,0.24828,GOBP_REGULATION_OF_CRISTAE_FORMATION,0.918728332092331
GSE32423_MEMORY_VS_NAIVE_CD8...2,SET,177,0.04282,0.004184,0.06299,0.24832,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN,0.918728332092331
HP_EEG_WITH_GENERALIZED_POLY...,SET,6,0.24661,0.0044574,0.36284,0.24836,HP_EEG_WITH_GENERALIZED_POLYSPIKES,0.918728332092331
GOCC_MYOFILAMENT,SET,25,0.11809,0.0043547,0.17376,0.24837,GOCC_MYOFILAMENT,0.918728332092331
GSE37416_0H_VS_12H_F_TULAREN...1,SET,178,0.043387,0.0042512,0.063849,0.24841,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.918728332092331
HP_EXTRA_AXIAL_CEREBROSPINAL...,SET,14,0.14831,0.0040939,0.21829,0.24843,HP_EXTRA_AXIAL_CEREBROSPINAL_FLUID_ACCUMULATION,0.918728332092331
HP_ABNORMAL_SCALP_MORPHOLOGY,SET,385,0.029506,0.0042276,0.043432,0.24846,HP_ABNORMAL_SCALP_MORPHOLOGY,0.918728332092331
GSE15330_HSC_VS_MEGAKARYOCYT...4,SET,149,0.047335,0.0042468,0.069677,0.24846,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.918728332092331
GOBP_CHROMOSOME_SEGREGATION,SET,383,0.028644,0.0040938,0.042166,0.24847,GOBP_CHROMOSOME_SEGREGATION,0.918728332092331
GATA1_04,SET,222,0.041127,0.0044949,0.060547,0.24849,GATA1_04,0.918728332092331
REACTOME_ASPARAGINE_N_LINKED...,SET,291,0.033185,0.0041446,0.048858,0.24851,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,0.918728332092331
SMID_BREAST_CANCER_LUMINAL_A...1,SET,16,0.14158,0.0041776,0.20849,0.24855,SMID_BREAST_CANCER_LUMINAL_A_DN,0.918778477983408
FOXJ2_01,SET,168,0.048187,0.0045883,0.070997,0.24866,FOXJ2_01,0.918989610803913
HAY_BONE_MARROW_DENDRITIC_CE...,SET,167,0.046179,0.0043841,0.068038,0.24866,HAY_BONE_MARROW_DENDRITIC_CELL,0.918989610803913
ARID5B_TARGET_GENES,SET,725,0.021961,0.0042769,0.032374,0.24879,ARID5B_TARGET_GENES,0.919287668757308
GOMF_PEPTIDE_TRANSMEMBRANE_T...,SET,9,0.20767,0.0045968,0.30619,0.24881,GOMF_PEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.919287668757308
EWSR1_TARGET_GENES,SET,769,0.02111,0.0042289,0.031126,0.24882,EWSR1_TARGET_GENES,0.919287668757308
GOBP_CARDIAC_ATRIUM_DEVELOPM...,SET,34,0.1124,0.0048325,0.16578,0.24888,GOBP_CARDIAC_ATRIUM_DEVELOPMENT,0.919387767031566
RICKMAN_HEAD_AND_NECK_CANCER...3,SET,101,0.062171,0.0045985,0.091704,0.2489,RICKMAN_HEAD_AND_NECK_CANCER_C,0.919387767031566
GOBP_RESPONSE_TO_CAFFEINE,SET,14,0.15127,0.0041755,0.2232,0.24898,GOBP_RESPONSE_TO_CAFFEINE,0.919524752948677
MIR186_3P,SET,131,0.050343,0.0042373,0.074286,0.24899,MIR186_3P,0.919524752948677
GOMF_PROFILIN_BINDING,SET,10,0.18856,0.0043994,0.27827,0.24902,GOMF_PROFILIN_BINDING,0.919537834679133
MIR649,SET,62,0.072595,0.0042115,0.10721,0.24917,MIR649,0.919800780420472
HP_ABNORMAL_SEXUAL_BEHAVIOR,SET,7,0.22103,0.0043149,0.32647,0.2492,HP_ABNORMAL_SEXUAL_BEHAVIOR,0.919800780420472
GSE27786_BCELL_VS_CD4_TCELL_...1,SET,177,0.043628,0.0042629,0.06444,0.2492,GSE27786_BCELL_VS_CD4_TCELL_DN,0.919800780420472
GOBP_VESICLE_MEDIATED_CHOLES...,SET,9,0.19179,0.0042454,0.28331,0.24921,GOBP_VESICLE_MEDIATED_CHOLESTEROL_TRANSPORT,0.919800780420472
GOMF_OUTWARD_RECTIFIER_POTAS...,SET,26,0.12142,0.0045661,0.17937,0.24923,GOMF_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.919800780420472
DAZARD_UV_RESPONSE_CLUSTER_G4,SET,17,0.14432,0.0043896,0.21323,0.24925,DAZARD_UV_RESPONSE_CLUSTER_G4,0.919800780420472
GOBP_CELL_MIGRATION_IN_HINDB...,SET,16,0.15186,0.0044811,0.22441,0.2493,GOBP_CELL_MIGRATION_IN_HINDBRAIN,0.919839900222906
ZNF322_TARGET_GENES,SET,714,0.021447,0.0041464,0.031699,0.24933,ZNF322_TARGET_GENES,0.919839900222906
GSE17721_PAM3CSK4_VS_GADIQUI...17,SET,183,0.042018,0.004174,0.062103,0.24934,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN,0.919839900222906
GOMF_NUCLEOTIDYLTRANSFERASE_...,SET,120,0.048822,0.0039341,0.072201,0.24946,GOMF_NUCLEOTIDYLTRANSFERASE_ACTIVITY,0.920184918276374
MIR3160_3P,SET,66,0.074026,0.0044304,0.10951,0.24953,MIR3160_3P,0.920345447309774
AIZARANI_LIVER_C33_STELLATE_...,SET,117,0.057827,0.0046015,0.085576,0.24961,AIZARANI_LIVER_C33_STELLATE_CELLS_2,0.920387006127192
GOBP_SPLEEN_DEVELOPMENT,SET,37,0.097782,0.0043852,0.14475,0.24968,GOBP_SPLEEN_DEVELOPMENT,0.920387006127192
REACTOME_SIGNALING_BY_HIPPO,SET,19,0.14845,0.0047729,0.21978,0.24971,REACTOME_SIGNALING_BY_HIPPO,0.920387006127192
HOEK_MONOCYTE_2011_2012_TIV_...4,SET,2,0.50079,0.0052265,0.74155,0.24974,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_UP,0.920387006127192
GOBP_POSITIVE_REGULATION_OF_...573,SET,152,0.048971,0.0044373,0.07256,0.24988,GOBP_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,0.920387006127192
HP_AORTIC_VALVE_STENOSIS,SET,51,0.082083,0.0043201,0.12167,0.24996,HP_AORTIC_VALVE_STENOSIS,0.920387006127192
GOBP_MEIOSIS_I_CELL_CYCLE_PR...,SET,120,0.04863,0.0039186,0.072092,0.24998,GOBP_MEIOSIS_I_CELL_CYCLE_PROCESS,0.920387006127192
HP_COMBINED_IMMUNODEFICIENCY,SET,35,0.10397,0.004535,0.15413,0.24999,HP_COMBINED_IMMUNODEFICIENCY,0.920387006127192
TOOKER_GEMCITABINE_RESISTANC...1,SET,115,0.055738,0.0043975,0.082635,0.25,TOOKER_GEMCITABINE_RESISTANCE_DN,0.920387006127192
VIETOR_IFRD1_TARGETS,SET,20,0.13466,0.0044421,0.19965,0.25,VIETOR_IFRD1_TARGETS,0.920387006127192
GSE22886_CD8_VS_CD4_NAIVE_TC...1,SET,175,0.044374,0.0043116,0.0658,0.25004,GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN,0.920387006127192
GOBP_INTERNAL_PEPTIDYL_LYSIN...,SET,8,0.16446,0.0034323,0.24391,0.25007,GOBP_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION,0.920387006127192
FAN_OVARY_CL5_HEALTHY_SELECT...,SET,281,0.036408,0.0044695,0.053999,0.25009,FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL,0.920387006127192
GSE8621_UNSTIM_VS_LPS_PRIMED...2,SET,179,0.042578,0.0041836,0.063155,0.2501,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.920387006127192
GOBP_NEGATIVE_REGULATION_OF_...396,SET,8,0.21456,0.0044777,0.31829,0.25013,GOBP_NEGATIVE_REGULATION_OF_MIRNA_PROCESSING,0.920387006127192
WP_VITAMIN_B12_METABOLISM,SET,48,0.088222,0.004505,0.1309,0.25016,WP_VITAMIN_B12_METABOLISM,0.920387006127192
GTF2A2_TARGET_GENES,SET,384,0.030238,0.004327,0.044869,0.25019,GTF2A2_TARGET_GENES,0.920387006127192
GSE14000_TRANSLATED_RNA_VS_M...1,SET,162,0.043504,0.0040684,0.064559,0.2502,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN,0.920387006127192
HP_SUBUNGUAL_HYPERKERATOSIS,SET,6,0.24163,0.0043674,0.35861,0.25022,HP_SUBUNGUAL_HYPERKERATOSIS,0.920387006127192
GOCC_PROTEIN_DNA_COMPLEX,SET,1226,0.017043,0.0042546,0.025296,0.25024,GOCC_PROTEIN_DNA_COMPLEX,0.920387006127192
GOBP_REGULATION_OF_ANTIGEN_P...3,SET,4,0.31823,0.0046967,0.47242,0.25028,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,0.920387006127192
GOBP_REGULATION_OF_PIGMENTAT...,SET,17,0.14394,0.0043779,0.21368,0.25028,GOBP_REGULATION_OF_PIGMENTATION,0.920387006127192
MODULE_503,SET,103,0.057712,0.0043105,0.085682,0.2503,MODULE_503,0.920387006127192
TRAVAGLINI_LUNG_LIPOFIBROBLA...,SET,138,0.053063,0.0045831,0.078778,0.2503,TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL,0.920387006127192
RORA1_01,SET,217,0.039125,0.0042283,0.05811,0.25039,RORA1_01,0.920387006127192
GOBP_CARBON_CATABOLITE_REGUL...,SET,7,0.19477,0.0038023,0.28929,0.2504,GOBP_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION,0.920387006127192
GOBP_EMBRYONIC_CAMERA_TYPE_E...1,SET,37,0.10096,0.0045278,0.14998,0.25042,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.920387006127192
GSE28726_NAIVE_VS_ACTIVATED_...1,SET,185,0.041711,0.0041659,0.061965,0.25043,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN,0.920387006127192
GSE21927_SPLEEN_VS_TUMOR_MON...3,SET,149,0.048336,0.0043367,0.071813,0.25045,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN,0.920387006127192
GSE6674_ANTI_IGM_VS_ANTI_IGM...2,SET,183,0.041661,0.0041386,0.0619,0.25046,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.920387006127192
RUAN_RESPONSE_TO_TROGLITAZON...1,SET,16,0.16148,0.004765,0.23995,0.25048,RUAN_RESPONSE_TO_TROGLITAZONE_DN,0.920387006127192
GOBP_LIPID_HOMEOSTASIS,SET,147,0.046958,0.0041849,0.069774,0.25048,GOBP_LIPID_HOMEOSTASIS,0.920387006127192
KEGG_MEDICUS_REFERENCE_AUTOP...8,SET,9,0.20833,0.0046114,0.30957,0.25049,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1,0.920387006127192
HP_BRUISING_SUSCEPTIBILITY,SET,162,0.04616,0.0043168,0.068599,0.25051,HP_BRUISING_SUSCEPTIBILITY,0.920387006127192
HP_TYPE_A_BRACHYDACTYLY,SET,20,0.1408,0.0046447,0.20926,0.25052,HP_TYPE_A_BRACHYDACTYLY,0.920387006127192
GOBP_MALE_GAMETE_GENERATION,SET,529,0.024705,0.0041327,0.036719,0.25053,GOBP_MALE_GAMETE_GENERATION,0.920387006127192
GSE40068_CXCR5NEG_BCL6NEG_CD...2,SET,184,0.042298,0.0042131,0.062865,0.25053,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP,0.920387006127192
GSE8685_IL2_STARVED_VS_IL2_A...2,SET,183,0.04208,0.0041801,0.062559,0.25059,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP,0.920387006127192
GOBP_NEGATIVE_REGULATION_OF_...542,SET,63,0.073067,0.0042728,0.10864,0.25062,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.920387006127192
GOMF_CHROMATIN_DNA_BINDING,SET,95,0.057864,0.0041515,0.086034,0.25062,GOMF_CHROMATIN_DNA_BINDING,0.920387006127192
PID_S1P_META_PATHWAY,SET,21,0.12392,0.0041887,0.1843,0.25067,PID_S1P_META_PATHWAY,0.920387006127192
GOBP_ADULT_FEEDING_BEHAVIOR,SET,9,0.21763,0.0048172,0.32366,0.25067,GOBP_ADULT_FEEDING_BEHAVIOR,0.920387006127192
GOMF_UBIQUITIN_SPECIFIC_PROT...,SET,14,0.13315,0.0036753,0.19802,0.25068,GOMF_UBIQUITIN_SPECIFIC_PROTEASE_BINDING,0.920387006127192
HP_WIDE_NOSE,SET,108,0.0554,0.0042364,0.082455,0.25083,HP_WIDE_NOSE,0.920540748966942
GOBP_MAINTENANCE_OF_PROTEIN_...5,SET,7,0.25468,0.004972,0.37918,0.2509,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION,0.920540748966942
GSE2770_IL12_AND_TGFB_VS_IL4...2,SET,179,0.041645,0.0040919,0.062007,0.25092,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.920540748966942
GSE2770_IL12_VS_TGFB_AND_IL1...5,SET,184,0.040759,0.0040598,0.060708,0.25099,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.920540748966942
GOBP_ESTABLISHMENT_OF_SERTOL...,SET,4,0.2599,0.0038358,0.38719,0.25104,GOBP_ESTABLISHMENT_OF_SERTOLI_CELL_BARRIER,0.920540748966942
IM_SREBF1A_TARGETS,SET,5,0.24711,0.0040774,0.36821,0.25108,IM_SREBF1A_TARGETS,0.920540748966942
FONTAINE_PAPILLARY_THYROID_C...2,SET,61,0.077817,0.004478,0.11597,0.25112,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,0.920540748966942
SU_PANCREAS,SET,39,0.089729,0.0041311,0.13373,0.25113,SU_PANCREAS,0.920540748966942
UNTERMAN_IPF_VS_CTRL_CD8T_DN,SET,2,0.47139,0.0049197,0.70269,0.25117,UNTERMAN_IPF_VS_CTRL_CD8T_DN,0.920540748966942
BURTON_ADIPOGENESIS_1,SET,28,0.11519,0.0044948,0.17173,0.25119,BURTON_ADIPOGENESIS_1,0.920540748966942
YAGI_AML_WITH_T_9_11_TRANSLO...,SET,114,0.055913,0.0043921,0.083391,0.25128,YAGI_AML_WITH_T_9_11_TRANSLOCATION,0.920540748966942
ACAACTT_MIR382,SET,62,0.072217,0.0041895,0.10772,0.2513,ACAACTT_MIR382,0.920540748966942
GOBP_REGULATION_OF_ESTABLISH...6,SET,22,0.12197,0.0042196,0.18195,0.25132,GOBP_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,0.920540748966942
NFE2L1_TARGET_GENES,SET,1471,0.015303,0.0041545,0.022836,0.25139,NFE2L1_TARGET_GENES,0.920540748966942
GOCC_ENDOPLASMIC_RETICULUM_G...1,SET,121,0.051165,0.00414,0.076353,0.25139,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT,0.920540748966942
HP_ABNORMAL_LABIA_MORPHOLOGY,SET,72,0.071641,0.0044775,0.10692,0.25142,HP_ABNORMAL_LABIA_MORPHOLOGY,0.920540748966942
GSE21379_WT_VS_SAP_KO_CD4_TC...1,SET,183,0.043485,0.0043197,0.064927,0.25151,GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN,0.920540748966942
GOBP_INNER_EAR_MORPHOGENESIS,SET,98,0.061377,0.0044722,0.091669,0.25158,GOBP_INNER_EAR_MORPHOGENESIS,0.920540748966942
MODULE_519,SET,15,0.15281,0.004366,0.22824,0.25159,MODULE_519,0.920540748966942
GSE14308_TH1_VS_NATURAL_TREG...1,SET,181,0.041266,0.004077,0.061635,0.25159,GSE14308_TH1_VS_NATURAL_TREG_DN,0.920540748966942
MORF_CDC16,SET,63,0.069728,0.0040775,0.10415,0.2516,MORF_CDC16,0.920540748966942
GOBP_BUD_ELONGATION_INVOLVED...,SET,7,0.24324,0.0047487,0.36337,0.25162,GOBP_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING,0.920540748966942
KEGG_PENTOSE_PHOSPHATE_PATHW...,SET,22,0.11364,0.0039313,0.16979,0.25166,KEGG_PENTOSE_PHOSPHATE_PATHWAY,0.920540748966942
GOBP_VITAMIN_E_METABOLIC_PRO...,SET,6,0.22032,0.0039822,0.32925,0.2517,GOBP_VITAMIN_E_METABOLIC_PROCESS,0.920540748966942
REACTOME_NFE2L2_REGULATES_PE...,SET,7,0.22281,0.0043497,0.33298,0.25171,REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES,0.920540748966942
GOBP_CELL_PROLIFERATION_INVO...3,SET,9,0.23402,0.00518,0.34975,0.25172,GOBP_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.920540748966942
GOMF_GLUCOSE_SODIUM_SYMPORTE...,SET,7,0.2234,0.0043614,0.33388,0.25172,GOMF_GLUCOSE_SODIUM_SYMPORTER_ACTIVITY,0.920540748966942
GSE42021_CD24HI_VS_CD24LOW_T...4,SET,171,0.043035,0.0041338,0.064319,0.25172,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP,0.920540748966942
chr1p35,SET,77,0.13397,0.0086579,0.20024,0.25173,chr1p35,0.920540748966942
MIR206,SET,340,0.031381,0.0042307,0.046903,0.25174,MIR206,0.920540748966942
HP_RECURRENT_SPONTANEOUS_ABO...,SET,11,0.17989,0.0044019,0.2689,0.25175,HP_RECURRENT_SPONTANEOUS_ABORTION,0.920540748966942
KEGG_MEDICUS_REFERENCE_COHES...4,SET,6,0.25438,0.0045979,0.38032,0.25179,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING,0.920540748966942
DESCARTES_FETAL_HEART_VISCER...,SET,73,0.071915,0.0045257,0.10752,0.25179,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.920540748966942
KEGG_MEDICUS_REFERENCE_TRANS...4,SET,5,0.2649,0.004371,0.39612,0.25183,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM,0.920540748966942
GOBP_DEVELOPMENT_OF_PRIMARY_...1,SET,101,0.06085,0.0045008,0.090995,0.25184,GOBP_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS,0.920540748966942
HP_ABNORMAL_URINARY_NUCLEOBA...,SET,11,0.20541,0.0050264,0.30726,0.2519,HP_ABNORMAL_URINARY_NUCLEOBASE_CONCENTRATION,0.920540748966942
WP_VITAMIN_K_METABOLISM_AND_...,SET,12,0.15376,0.0039298,0.23003,0.25192,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.920540748966942
MORF_CASP10,SET,109,0.054891,0.0042168,0.082113,0.25192,MORF_CASP10,0.920540748966942
GOBP_RESPONSE_TO_FOLLICLE_ST...,SET,15,0.16417,0.0046906,0.24565,0.25197,GOBP_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE,0.920540748966942
GSE14415_ACT_VS_CTRL_NATURAL...2,SET,157,0.044284,0.0040775,0.066264,0.25198,GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP,0.920540748966942
GOCC_MEIOTIC_COHESIN_COMPLEX,SET,6,0.22549,0.0040756,0.33744,0.252,GOCC_MEIOTIC_COHESIN_COMPLEX,0.920540748966942
HP_INCREASED_JITTER_AT_SINGL...,SET,7,0.23799,0.0046462,0.3562,0.25202,HP_INCREASED_JITTER_AT_SINGLE_FIBER_EMG,0.920540748966942
XU_HGF_SIGNALING_NOT_VIA_AKT...2,SET,32,0.10404,0.0043397,0.15574,0.25207,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,0.920540748966942
GTATTAT_MIR3693P,SET,192,0.044699,0.004547,0.066915,0.25207,GTATTAT_MIR3693P,0.920540748966942
GOBP_CELLULAR_RESPONSE_TO_NU...2,SET,223,0.039254,0.0042998,0.058791,0.25217,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS,0.920540748966942
GOMF_LARGE_RIBOSOMAL_SUBUNIT...,SET,5,0.23773,0.0039225,0.35606,0.25218,GOMF_LARGE_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.920540748966942
GOBP_EGG_ACTIVATION,SET,11,0.16194,0.0039627,0.2426,0.25222,GOBP_EGG_ACTIVATION,0.920540748966942
MIR760,SET,116,0.052262,0.004141,0.078303,0.25225,MIR760,0.920540748966942
KEGG_MEDICUS_REFERENCE_RIG_I...1,SET,20,0.14385,0.0047451,0.21555,0.25227,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY,0.920540748966942
CHANDRAN_METASTASIS_DN,SET,288,0.035021,0.0043516,0.052479,0.25229,CHANDRAN_METASTASIS_DN,0.920540748966942
GOBP_GLUTAMINE_FAMILY_AMINO_...2,SET,24,0.12475,0.0045073,0.18697,0.25233,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.920540748966942
GSE15659_CD45RA_NEG_CD4_TCEL...1,SET,164,0.043652,0.0041071,0.065432,0.25235,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.920540748966942
GOBP_RESPONSE_TO_CGMP,SET,8,0.1954,0.004078,0.29293,0.25237,GOBP_RESPONSE_TO_CGMP,0.920540748966942
GOBP_EPITHELIAL_CELL_DIFFERE...1,SET,681,0.024535,0.0046367,0.036783,0.25239,GOBP_EPITHELIAL_CELL_DIFFERENTIATION,0.920540748966942
HP_SLOWED_SLURRED_SPEECH,SET,6,0.22716,0.0041058,0.34057,0.25239,HP_SLOWED_SLURRED_SPEECH,0.920540748966942
REACTOME_FORMATION_OF_THE_NE...,SET,17,0.15598,0.0047443,0.23387,0.2524,REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT,0.920540748966942
GOBP_POSITIVE_REGULATION_OF_...163,SET,12,0.14355,0.0036687,0.21524,0.25241,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,0.920540748966942
GOMF_DNA_DNA_ANNEALING_ACTIV...,SET,7,0.21784,0.0042527,0.32666,0.25243,GOMF_DNA_DNA_ANNEALING_ACTIVITY,0.920540748966942
AP1_Q2,SET,242,0.03727,0.0042506,0.055901,0.25248,AP1_Q2,0.920540748966942
REACTOME_BETA_OXIDATION_OF_B...,SET,5,0.25752,0.0042492,0.38627,0.25249,REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA,0.920540748966942
GOMF_SERINE_HYDROLASE_ACTIVI...,SET,182,0.045944,0.0045516,0.068958,0.25263,GOMF_SERINE_HYDROLASE_ACTIVITY,0.920540748966942
GOBP_CENTROMERE_COMPLEX_ASSE...,SET,26,0.10154,0.0038184,0.15244,0.25268,GOBP_CENTROMERE_COMPLEX_ASSEMBLY,0.920540748966942
HP_ABNORMAL_CIRCULATING_GLOB...,SET,10,0.18745,0.0043736,0.28154,0.25277,HP_ABNORMAL_CIRCULATING_GLOBULIN_CONCENTRATION,0.920540748966942
MIR4505,SET,237,0.037358,0.004217,0.056137,0.25287,MIR4505,0.920540748966942
GSE24210_IL35_TREATED_VS_UNT...1,SET,182,0.042823,0.0042424,0.064361,0.25291,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN,0.920540748966942
GOCC_TRNA_SPLICING_LIGASE_CO...,SET,7,0.21716,0.0042394,0.32641,0.25293,GOCC_TRNA_SPLICING_LIGASE_COMPLEX,0.920540748966942
HP_COMPLETE_ATRIOVENTRICULAR...,SET,16,0.13854,0.004088,0.20826,0.25296,HP_COMPLETE_ATRIOVENTRICULAR_CANAL_DEFECT,0.920540748966942
GOBP_WALKING_BEHAVIOR,SET,34,0.10132,0.0043563,0.15235,0.253,GOBP_WALKING_BEHAVIOR,0.920540748966942
ONO_AML1_TARGETS_DN,SET,37,0.10626,0.0047654,0.15978,0.25301,ONO_AML1_TARGETS_DN,0.920540748966942
GSE19941_LPS_VS_LPS_AND_IL10...4,SET,183,0.042602,0.004232,0.064056,0.25301,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.920540748966942
HWANG_PROSTATE_CANCER_MARKERS,SET,25,0.11241,0.0041454,0.1691,0.2531,HWANG_PROSTATE_CANCER_MARKERS,0.920540748966942
HP_CAROTID_ARTERY_STENOSIS,SET,6,0.23107,0.0041765,0.34769,0.25316,HP_CAROTID_ARTERY_STENOSIS,0.920540748966942
GSE19888_CTRL_VS_A3R_INHIBIT...2,SET,179,0.039312,0.0038627,0.059155,0.25317,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP,0.920540748966942
chr14q21,SET,33,0.15987,0.0067718,0.24058,0.25318,chr14q21,0.920540748966942
GOBP_MUSCLE_CELL_DIFFERENTIA...,SET,376,0.030281,0.0042888,0.045573,0.25321,GOBP_MUSCLE_CELL_DIFFERENTIATION,0.920540748966942
GOBP_NEGATIVE_REGULATION_OF_...302,SET,17,0.15718,0.0047805,0.23656,0.25321,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.920540748966942
HP_UPPER_LIMB_UNDERGROWTH,SET,78,0.060808,0.003955,0.091523,0.25322,HP_UPPER_LIMB_UNDERGROWTH,0.920540748966942
GSE9988_ANTI_TREM1_VS_CTRL_T...1,SET,188,0.040156,0.0040426,0.060442,0.25323,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN,0.920540748966942
DASU_IL6_SIGNALING_UP,SET,56,0.079574,0.004388,0.11978,0.25324,DASU_IL6_SIGNALING_UP,0.920540748966942
HP_FACIAL_EDEMA,SET,122,0.054751,0.0044482,0.082431,0.25328,HP_FACIAL_EDEMA,0.920540748966942
HOFMANN_MYELODYSPLASTIC_SYND...1,SET,20,0.12332,0.004068,0.18569,0.25331,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,0.920540748966942
GOBP_PROXIMAL_DISTAL_PATTERN...2,SET,5,0.31803,0.0052475,0.47906,0.2534,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT,0.920540748966942
KEGG_MEDICUS_REFERENCE_P300_...,SET,15,0.13518,0.0038623,0.20369,0.25345,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S,0.920540748966942
MODULE_242,SET,187,0.042052,0.0042223,0.063369,0.25347,MODULE_242,0.920540748966942
HP_DILATATION_OF_THE_BLADDER,SET,11,0.19086,0.0046704,0.28761,0.25347,HP_DILATATION_OF_THE_BLADDER,0.920540748966942
GOBP_POSITIVE_REGULATION_OF_...391,SET,4,0.28571,0.0042167,0.43054,0.25348,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_APOPTOTIC_PROCESS,0.920540748966942
HP_ACCELERATED_ATHEROSCLEROS...,SET,7,0.21267,0.0041518,0.32048,0.25348,HP_ACCELERATED_ATHEROSCLEROSIS,0.920540748966942
GSE22589_HEALTHY_VS_HIV_AND_...1,SET,171,0.04124,0.0039614,0.062157,0.25351,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN,0.920540748966942
ATAACCT_MIR154,SET,59,0.071231,0.0040315,0.10736,0.25352,ATAACCT_MIR154,0.920540748966942
GOBP_CD4_POSITIVE_ALPHA_BETA...1,SET,110,0.057967,0.0044734,0.087409,0.25361,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.920540748966942
GSE17721_CPG_VS_GARDIQUIMOD_...13,SET,177,0.042176,0.0041211,0.06361,0.25366,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN,0.920540748966942
GOBP_MUSCLE_CELL_PROLIFERATI...,SET,188,0.043217,0.0043507,0.065185,0.25367,GOBP_MUSCLE_CELL_PROLIFERATION,0.920540748966942
GSE30971_CTRL_VS_LPS_STIM_MA...2,SET,167,0.048834,0.0046362,0.073674,0.25372,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP,0.920540748966942
GOBP_MICROGLIAL_CELL_MIGRATI...,SET,8,0.22432,0.0046816,0.33852,0.25378,GOBP_MICROGLIAL_CELL_MIGRATION,0.920540748966942
KEGG_EPITHELIAL_CELL_SIGNALI...,SET,65,0.069479,0.0041267,0.10488,0.25384,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,0.920540748966942
GOBP_FATTY_ACID_HOMEOSTASIS,SET,14,0.14526,0.0040097,0.21927,0.25384,GOBP_FATTY_ACID_HOMEOSTASIS,0.920540748966942
YU_BAP1_TARGETS,SET,29,0.096868,0.0038468,0.14623,0.25386,YU_BAP1_TARGETS,0.920540748966942
MODULE_178,SET,15,0.1659,0.0047401,0.25046,0.25386,MODULE_178,0.920540748966942
GOMF_GANGLIOSIDE_BINDING,SET,5,0.28414,0.0046883,0.42894,0.25386,GOMF_GANGLIOSIDE_BINDING,0.920540748966942
HP_PORTAL_VEIN_THROMBOSIS,SET,11,0.17672,0.0043243,0.26679,0.25386,HP_PORTAL_VEIN_THROMBOSIS,0.920540748966942
GOBP_HEMOGLOBIN_METABOLIC_PR...,SET,17,0.13916,0.0042326,0.2101,0.25387,GOBP_HEMOGLOBIN_METABOLIC_PROCESS,0.920540748966942
GOCC_ELONGATOR_HOLOENZYME_CO...,SET,5,0.27001,0.0044552,0.40764,0.25387,GOCC_ELONGATOR_HOLOENZYME_COMPLEX,0.920540748966942
SMID_BREAST_CANCER_LUMINAL_B...2,SET,155,0.048076,0.0043986,0.072597,0.25392,SMID_BREAST_CANCER_LUMINAL_B_UP,0.920540748966942
REACTOME_RECOGNITION_OF_DNA_...,SET,28,0.099321,0.0038757,0.15,0.25394,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,0.920540748966942
GOBP_NK_T_CELL_PROLIFERATION,SET,8,0.22816,0.0047616,0.34458,0.25395,GOBP_NK_T_CELL_PROLIFERATION,0.920540748966942
GOBP_CELLULAR_RESPONSE_TO_GL...1,SET,12,0.1786,0.0045645,0.26976,0.25397,GOBP_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS,0.920540748966942
GSE32128_INOS_DEPENDENT_VS_I...2,SET,186,0.042159,0.0042218,0.063682,0.25398,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP,0.920540748966942
BIOCARTA_AKT_PATHWAY,SET,20,0.12687,0.0041851,0.19165,0.25399,BIOCARTA_AKT_PATHWAY,0.920540748966942
MIR1324,SET,107,0.055387,0.0042159,0.083669,0.254,MIR1324,0.920540748966942
GOBP_MRNA_3_END_PROCESSING_B...,SET,6,0.18937,0.0034227,0.28608,0.25401,GOBP_MRNA_3_END_PROCESSING_BY_STEM_LOOP_BINDING_AND_CLEAVAGE,0.920540748966942
GOBP_IN_UTERO_EMBRYONIC_DEVE...,SET,377,0.029198,0.0041408,0.044114,0.25403,GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT,0.920540748966942
KEGG_MEDICUS_VARIANT_CYP11B1...,SET,31,0.10314,0.0042346,0.15584,0.25404,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.920540748966942
OVSYANNIKOVA_PBMC_FLUARIX_AG...2,SET,6,0.23098,0.0041749,0.34905,0.25408,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.920540748966942
REACTOME_FORMATION_OF_AXIAL_...,SET,13,0.16553,0.0044031,0.25019,0.25411,REACTOME_FORMATION_OF_AXIAL_MESODERM,0.920540748966942
GSE15735_CTRL_VS_HDAC_INHIBI...1,SET,185,0.041885,0.0041832,0.063306,0.25411,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN,0.920540748966942
KEGG_MEDICUS_PATHOGEN_ESCHER...3,SET,16,0.14917,0.0044016,0.22549,0.25414,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.920540748966942
VILIMAS_NOTCH1_TARGETS_UP,SET,49,0.083501,0.004308,0.12623,0.25415,VILIMAS_NOTCH1_TARGETS_UP,0.920540748966942
GOMF_ORGANIC_ACID_BINDING,SET,188,0.044062,0.0044358,0.06661,0.25415,GOMF_ORGANIC_ACID_BINDING,0.920540748966942
REACTOME_REGULATION_OF_IFNA_...,SET,22,0.14265,0.004935,0.21569,0.25419,REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING,0.920540748966942
GOBP_CATECHOL_CONTAINING_COM...1,SET,20,0.13782,0.0045463,0.20841,0.25422,GOBP_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.920540748966942
AGARWAL_AKT_PATHWAY_TARGETS,SET,10,0.20654,0.0048188,0.31234,0.25423,AGARWAL_AKT_PATHWAY_TARGETS,0.920540748966942
BIOCARTA_MAL_PATHWAY,SET,19,0.12901,0.0041481,0.19515,0.25428,BIOCARTA_MAL_PATHWAY,0.920540748966942
MIR6755_5P,SET,32,0.09559,0.0039872,0.14461,0.25431,MIR6755_5P,0.920540748966942
GOCC_RNA_POLYMERASE_II_TRANS...1,SET,233,0.035258,0.0039466,0.053343,0.25432,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX,0.920540748966942
WP_HAIR_FOLLICLE_DEVELOPMENT...2,SET,31,0.1138,0.0046721,0.17219,0.25435,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,0.920540748966942
GOBP_POSITIVE_REGULATION_OF_...300,SET,11,0.19166,0.0046899,0.29003,0.25437,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.920540748966942
GSE13484_12H_UNSTIM_VS_YF17D...1,SET,177,0.043621,0.0042623,0.066023,0.25441,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.920540748966942
BENPORATH_ES_WITH_H3K27ME3,SET,1000,0.020632,0.0046822,0.031231,0.25443,BENPORATH_ES_WITH_H3K27ME3,0.920540748966942
WP_FAMILIAL_PARTIAL_LIPODYST...,SET,30,0.1043,0.0042125,0.15791,0.25447,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,0.920540748966942
HP_INAPPROPRIATE_ANTIDIURETI...,SET,8,0.19885,0.0041499,0.3011,0.2545,HP_INAPPROPRIATE_ANTIDIURETIC_HORMONE_SECRETION,0.920540748966942
WANG_RESPONSE_TO_GSK3_INHIBI...2,SET,310,0.032229,0.0041524,0.048815,0.25456,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,0.920540748966942
MIR921,SET,57,0.07942,0.0044183,0.12031,0.25459,MIR921,0.920540748966942
HP_PERCUSSION_MYOTONIA,SET,9,0.18832,0.0041685,0.2853,0.2546,HP_PERCUSSION_MYOTONIA,0.920540748966942
MIR2467_5P,SET,102,0.055154,0.0040995,0.083561,0.25462,MIR2467_5P,0.920540748966942
KENNY_CTNNB1_TARGETS_DN,SET,49,0.079719,0.0041128,0.1208,0.25465,KENNY_CTNNB1_TARGETS_DN,0.920540748966942
REACTOME_ANCHORING_OF_THE_BA...,SET,91,0.053516,0.0037583,0.0811,0.25467,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,0.920540748966942
GSE7460_CTRL_VS_TGFB_TREATED...10,SET,183,0.039072,0.0038813,0.059213,0.25468,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP,0.920540748966942
GSE360_T_GONDII_VS_B_MALAYI_...6,SET,174,0.044026,0.0042656,0.066734,0.25472,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP,0.920540748966942
GOBP_TOLL_SIGNALING_PATHWAY,SET,11,0.16816,0.0041148,0.25492,0.25475,GOBP_TOLL_SIGNALING_PATHWAY,0.920540748966942
HP_SOFT_TISSUE_SARCOMA,SET,124,0.051791,0.0042419,0.078525,0.25478,HP_SOFT_TISSUE_SARCOMA,0.920540748966942
GSE17721_LPS_VS_CPG_24H_BMDC...1,SET,190,0.040246,0.0040729,0.061022,0.25478,GSE17721_LPS_VS_CPG_24H_BMDC_DN,0.920540748966942
MIR4714_3P,SET,53,0.080391,0.004313,0.12193,0.25485,MIR4714_3P,0.920540748966942
GOMF_TRANSCRIPTION_COACTIVAT...1,SET,250,0.034636,0.0040141,0.052535,0.25486,GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY,0.920540748966942
CAIRO_LIVER_DEVELOPMENT_DN,SET,203,0.041083,0.004296,0.062333,0.25492,CAIRO_LIVER_DEVELOPMENT_DN,0.920540748966942
GOCC_ANKYRIN_1_COMPLEX,SET,8,0.21921,0.0045748,0.33258,0.25492,GOCC_ANKYRIN_1_COMPLEX,0.920540748966942
GOBP_HYPERSENSITIVITY,SET,15,0.16618,0.0047481,0.25217,0.25495,GOBP_HYPERSENSITIVITY,0.920540748966942
HP_ANISOCORIA,SET,15,0.14966,0.0042761,0.22714,0.25498,HP_ANISOCORIA,0.920540748966942
RODRIGUES_NTN1_TARGETS_UP,SET,14,0.16762,0.0046269,0.2544,0.25499,RODRIGUES_NTN1_TARGETS_UP,0.920540748966942
GOBP_PHOSPHATIDYLETHANOLAMIN...2,SET,9,0.18014,0.0039874,0.27342,0.25501,GOBP_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS,0.920540748966942
MIR6754_5P,SET,111,0.053026,0.0041106,0.080492,0.25502,MIR6754_5P,0.920540748966942
GOMF_ANKYRIN_REPEAT_BINDING,SET,6,0.19739,0.0035678,0.29966,0.25504,GOMF_ANKYRIN_REPEAT_BINDING,0.920540748966942
GSE360_CTRL_VS_M_TUBERCULOSI...2,SET,184,0.041979,0.0041813,0.063732,0.25506,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP,0.920540748966942
QI_HYPOXIA,SET,128,0.050052,0.0041645,0.075998,0.25508,QI_HYPOXIA,0.920540748966942
GSE17721_PAM3CSK4_VS_CPG_8H_...1,SET,183,0.040621,0.0040352,0.061684,0.2551,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN,0.920540748966942
TBX1_TARGET_GENES,SET,166,0.042375,0.004011,0.064367,0.25517,TBX1_TARGET_GENES,0.920540748966942
GOBP_NEGATIVE_REGULATION_OF_...543,SET,193,0.042231,0.0043071,0.064156,0.25519,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS,0.920540748966942
REACTOME_SYNTHESIS_OF_PIPS_A...5,SET,48,0.076618,0.0039124,0.11642,0.25523,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,0.920540748966942
REACTOME_TRANSPORT_OF_NUCLEO...2,SET,8,0.18132,0.003784,0.27551,0.25523,REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS,0.920540748966942
GSE369_SOCS3_KO_VS_WT_LIVER_...4,SET,178,0.039511,0.0038715,0.060035,0.25523,GSE369_SOCS3_KO_VS_WT_LIVER_UP,0.920540748966942
GSE11961_FOLLICULAR_BCELL_VS...9,SET,179,0.041223,0.0040504,0.062639,0.25524,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.920540748966942
HP_ABNORMAL_BRONCHUS_PHYSIOL...,SET,20,0.1233,0.0040674,0.18738,0.25526,HP_ABNORMAL_BRONCHUS_PHYSIOLOGY,0.920540748966942
HP_ABNORMAL_EOSINOPHIL_MORPH...,SET,65,0.070759,0.0042028,0.10753,0.25526,HP_ABNORMAL_EOSINOPHIL_MORPHOLOGY,0.920540748966942
GOBP_POSITIVE_REGULATION_OF_...641,SET,1109,0.017651,0.004205,0.026824,0.25527,GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.920540748966942
RAX2_TARGET_GENES,SET,62,0.073827,0.0042829,0.1122,0.25528,RAX2_TARGET_GENES,0.920540748966942
HP_ABNORMAL_HAIRSHAFT_MORPHO...,SET,25,0.10829,0.0039934,0.16459,0.25529,HP_ABNORMAL_HAIRSHAFT_MORPHOLOGY,0.920540748966942
MIR378B,SET,37,0.087449,0.0039218,0.13292,0.2553,MIR378B,0.920540748966942
GOBP_AORTA_DEVELOPMENT,SET,60,0.077346,0.0044144,0.11757,0.25531,GOBP_AORTA_DEVELOPMENT,0.920540748966942
HP_ELEVATED_URINARY_CARBOXYL...,SET,94,0.05901,0.0042115,0.089715,0.25535,HP_ELEVATED_URINARY_CARBOXYLIC_ACID,0.920540748966942
chr11q22,SET,51,0.14719,0.007747,0.22379,0.25536,chr11q22,0.920540748966942
HP_SPEECH_ARTICULATION_DIFFI...,SET,29,0.11502,0.0045676,0.17487,0.25536,HP_SPEECH_ARTICULATION_DIFFICULTIES,0.920540748966942
HP_VENOUS_INSUFFICIENCY,SET,35,0.101,0.0044058,0.15357,0.25537,HP_VENOUS_INSUFFICIENCY,0.920540748966942
GSE17721_CTRL_VS_POLYIC_8H_B...1,SET,183,0.04165,0.0041374,0.063326,0.25537,GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN,0.920540748966942
GSE360_L_MAJOR_VS_T_GONDII_D...1,SET,176,0.042144,0.0041064,0.06408,0.25537,GSE360_L_MAJOR_VS_T_GONDII_DC_DN,0.920540748966942
HOFT_CD4_POSITIVE_ALPHA_BETA...1,SET,43,0.084677,0.0040931,0.12877,0.2554,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.920540748966942
GSE13738_RESTING_VS_TCR_ACTI...2,SET,155,0.044773,0.0040964,0.068094,0.25543,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP,0.920540748966942
GOBP_PEPTIDYL_LYSINE_ACETYLA...,SET,22,0.10571,0.0036572,0.1608,0.25545,GOBP_PEPTIDYL_LYSINE_ACETYLATION,0.920540748966942
HP_WIDE_PUBIC_SYMPHYSIS,SET,7,0.24201,0.0047245,0.36816,0.25549,HP_WIDE_PUBIC_SYMPHYSIS,0.920540748966942
GOBP_POSITIVE_REGULATION_OF_...452,SET,8,0.24162,0.0050425,0.3676,0.2555,GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION,0.920540748966942
MIR6793_5P,SET,56,0.079246,0.0043699,0.12057,0.25552,MIR6793_5P,0.920540748966942
GSE16755_CTRL_VS_IFNA_TREATE...2,SET,179,0.040104,0.0039405,0.061024,0.25554,GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP,0.920540748966942
SHETH_LIVER_CANCER_VS_TXNIP_...5,SET,96,0.060854,0.0043888,0.092626,0.2556,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,0.920540748966942
CONRAD_STEM_CELL,SET,35,0.10197,0.004448,0.15524,0.25564,CONRAD_STEM_CELL,0.920540748966942
RUBENSTEIN_SKELETAL_MUSCLE_M...,SET,306,0.031851,0.0040776,0.048499,0.25568,RUBENSTEIN_SKELETAL_MUSCLE_MYELOID_CELLS,0.920540748966942
JIANG_AGING_CEREBRAL_CORTEX_...2,SET,31,0.10297,0.0042276,0.15681,0.2557,JIANG_AGING_CEREBRAL_CORTEX_UP,0.920540748966942
GOBP_NEGATIVE_REGULATION_OF_...118,SET,28,0.10789,0.0042101,0.16432,0.25573,GOBP_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.920540748966942
JISON_SICKLE_CELL_DISEASE_UP,SET,165,0.044234,0.0041744,0.067376,0.25575,JISON_SICKLE_CELL_DISEASE_UP,0.920540748966942
GOBP_POSITIVE_REGULATION_OF_...371,SET,7,0.24664,0.004815,0.37573,0.25578,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION,0.920540748966942
HP_VITREOUS_HEMORRHAGE,SET,16,0.13722,0.004049,0.20908,0.25582,HP_VITREOUS_HEMORRHAGE,0.920540748966942
GOBP_NEGATIVE_REGULATION_OF_...315,SET,15,0.14681,0.0041945,0.22371,0.25583,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.920540748966942
GOBP_PROTEIN_RETENTION_IN_GO...,SET,5,0.27631,0.0045592,0.42104,0.25583,GOBP_PROTEIN_RETENTION_IN_GOLGI_APPARATUS,0.920540748966942
GSE40274_HELIOS_VS_FOXP3_AND...2,SET,182,0.042316,0.0041922,0.064484,0.25584,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.920540748966942
GSE3982_MAC_VS_BASOPHIL_UP,SET,181,0.040982,0.004049,0.06246,0.25587,GSE3982_MAC_VS_BASOPHIL_UP,0.920540748966942
HP_NEPHROCALCINOSIS,SET,86,0.064568,0.0044087,0.098414,0.25589,HP_NEPHROCALCINOSIS,0.920540748966942
GOBP_REGULATION_OF_GASTRULAT...,SET,15,0.14242,0.004069,0.21711,0.25593,GOBP_REGULATION_OF_GASTRULATION,0.920540748966942
GSE36078_UNTREATED_VS_AD5_IN...4,SET,185,0.042195,0.0042142,0.064339,0.25597,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP,0.920540748966942
HP_DECREASED_LYMPHOCYTE_PROL...2,SET,27,0.1145,0.0043876,0.17462,0.25601,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_MITOGEN,0.920540748966942
WP_HIPPOMERLIN_SIGNALING_DYS...,SET,113,0.056791,0.0044416,0.086615,0.25602,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,0.920540748966942
GOBP_REGULATION_OF_ENDOTHELI...1,SET,19,0.14246,0.0045805,0.21734,0.25609,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.920540748966942
GOBP_PROTEIN_DEPHOSPHORYLATI...,SET,187,0.039426,0.0039586,0.060151,0.2561,GOBP_PROTEIN_DEPHOSPHORYLATION,0.920540748966942
GOBP_NEGATIVE_REGULATION_OF_...602,SET,44,0.087975,0.0043016,0.13424,0.25612,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.920540748966942
GOBP_MITOTIC_NUCLEAR_DIVISION,SET,265,0.033294,0.0039709,0.050804,0.25613,GOBP_MITOTIC_NUCLEAR_DIVISION,0.920540748966942
GSE5589_LPS_AND_IL10_VS_LPS_...5,SET,184,0.041254,0.0041092,0.062953,0.25614,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.920540748966942
GOBP_CMP_METABOLIC_PROCESS,SET,8,0.20641,0.0043078,0.31503,0.25617,GOBP_CMP_METABOLIC_PROCESS,0.920540748966942
JU_AGING_TERC_TARGETS_UP,SET,6,0.23488,0.0042454,0.35854,0.2562,JU_AGING_TERC_TARGETS_UP,0.920540748966942
HP_SPONTANEOUS_RECURRENT_EPI...,SET,13,0.16865,0.004486,0.25746,0.25623,HP_SPONTANEOUS_RECURRENT_EPISTAXIS,0.920540748966942
ZNF423_TARGET_GENES,SET,844,0.019776,0.0041414,0.030192,0.25624,ZNF423_TARGET_GENES,0.920540748966942
HP_ABNORMALITY_OF_FUNDUS_PIG...,SET,39,0.088334,0.0040669,0.13486,0.25624,HP_ABNORMALITY_OF_FUNDUS_PIGMENTATION,0.920540748966942
ONGUSAHA_BRCA1_TARGETS_UP,SET,10,0.1979,0.0046172,0.30216,0.25626,ONGUSAHA_BRCA1_TARGETS_UP,0.920540748966942
GRABARCZYK_BCL11B_TARGETS_UP,SET,68,0.066174,0.0040197,0.10106,0.25629,GRABARCZYK_BCL11B_TARGETS_UP,0.920540748966942
GSE17974_IL4_AND_ANTI_IL12_V...13,SET,153,0.047862,0.0043509,0.073102,0.25633,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN,0.920540748966942
MIR4481,SET,121,0.05082,0.004112,0.077626,0.25634,MIR4481,0.920540748966942
REACTOME_SIGNALING_BY_INTERL...,SET,430,0.027639,0.00418,0.04222,0.25635,REACTOME_SIGNALING_BY_INTERLEUKINS,0.920540748966942
GSE40274_CTRL_VS_FOXP3_AND_L...2,SET,153,0.048083,0.004371,0.073459,0.25638,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.920540748966942
GOBP_REGULATION_OF_MEMBRANE_...4,SET,15,0.16674,0.0047641,0.25475,0.25639,GOBP_REGULATION_OF_MEMBRANE_INVAGINATION,0.920540748966942
KEGG_MEDICUS_PATHOGEN_KSHV_V...4,SET,31,0.10457,0.0042932,0.1598,0.25644,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY,0.920625162689805
GSE7831_UNSTIM_VS_CPG_STIM_P...2,SET,180,0.041812,0.0041197,0.063912,0.25649,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP,0.920709558975418
GOBP_POSITIVE_REGULATION_OF_...99,SET,41,0.095294,0.0044982,0.14571,0.25655,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.92077063197026
GOMF_TRNA_CYTIDINE_5_METHYLT...,SET,5,0.20595,0.0033982,0.31491,0.25656,GOMF_TRNA_CYTIDINE_5_METHYLTRANSFERASE_ACTIVITY,0.92077063197026
GOMF_STORE_OPERATED_CALCIUM_...,SET,9,0.19201,0.0042501,0.29368,0.25662,GOMF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.920844255187365
INGRAM_SHH_TARGETS_UP,SET,113,0.056489,0.004418,0.086411,0.25665,INGRAM_SHH_TARGETS_UP,0.920844255187365
CAO_BLOOD_FLUZONE_AGE_05_14Y...2,SET,5,0.25463,0.0042015,0.38953,0.25666,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP,0.920844255187365
MIR26A_5P,SET,455,0.026758,0.0041598,0.040941,0.2567,MIR26A_5P,0.920892702312139
WANG_IMMORTALIZED_BY_HOXA9_A...2,SET,29,0.11428,0.0045382,0.17492,0.25678,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,0.921025433436533
GSE18281_SUBCAPSULAR_VS_PERI...2,SET,182,0.040773,0.0040393,0.062411,0.25679,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP,0.921025433436533
GOBP_NEGATIVE_REGULATION_OF_...558,SET,18,0.13188,0.0041272,0.20193,0.25686,GOBP_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.921027220674714
GOBP_RESPONSE_TO_LITHIUM_ION,SET,16,0.14351,0.0042346,0.21976,0.25687,GOBP_RESPONSE_TO_LITHIUM_ION,0.921027220674714
AIZARANI_LIVER_C3_NK_NKT_CEL...,SET,139,0.048324,0.0041887,0.073998,0.25687,AIZARANI_LIVER_C3_NK_NKT_CELLS_2,0.921027220674714
REACTOME_SIGNALING_BY_PTK6,SET,53,0.078897,0.0042328,0.12084,0.25691,REACTOME_SIGNALING_BY_PTK6,0.92107561893955
GOBP_POSITIVE_REGULATION_OF_...674,SET,85,0.06265,0.0042529,0.095967,0.25694,GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.921088158844765
ZNF784_TARGET_GENES,SET,432,0.026972,0.0040884,0.04133,0.25701,ZNF784_TARGET_GENES,0.921191852919971
GOBP_POSITIVE_REGULATION_OF_...21,SET,28,0.10451,0.0040781,0.16018,0.25706,GOBP_POSITIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.921191852919971
HALLMARK_P53_PATHWAY,SET,187,0.040659,0.0040824,0.062319,0.25707,HALLMARK_P53_PATHWAY,0.921191852919971
REACTOME_REGULATION_OF_KIT_S...,SET,15,0.14863,0.0042465,0.22787,0.25712,REACTOME_REGULATION_OF_KIT_SIGNALING,0.921191852919971
MIR3120_3P,SET,320,0.031266,0.0040916,0.047942,0.25715,MIR3120_3P,0.921191852919971
GSE17721_PAM3CSK4_VS_CPG_16H...1,SET,176,0.041308,0.0040249,0.063346,0.25718,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN,0.921191852919971
GSE36826_WT_VS_IL1R_KO_SKIN_...2,SET,176,0.044223,0.004309,0.067821,0.25719,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN,0.921191852919971
AGUIRRE_PANCREATIC_CANCER_CO...2,SET,271,0.03633,0.0043811,0.055727,0.25723,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,0.921191852919971
GSE13485_DAY1_VS_DAY21_YF17D...1,SET,165,0.039889,0.0037644,0.061198,0.25727,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.921191852919971
LIANG_SILENCED_BY_METHYLATIO...1,SET,45,0.087465,0.0043248,0.13421,0.2573,LIANG_SILENCED_BY_METHYLATION_2,0.921191852919971
HP_SUDDEN_LOSS_OF_VISUAL_ACU...,SET,5,0.22749,0.0037536,0.34906,0.2573,HP_SUDDEN_LOSS_OF_VISUAL_ACUITY,0.921191852919971
QI_HYPOXIA_TARGETS_OF_HIF1A_...,SET,32,0.10262,0.0042804,0.15749,0.25734,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,0.921191852919971
HP_EMBRYONAL_RENAL_NEOPLASM,SET,41,0.097981,0.004625,0.15037,0.25734,HP_EMBRYONAL_RENAL_NEOPLASM,0.921191852919971
GSE5589_IL6_KO_VS_IL10_KO_LP...3,SET,179,0.041769,0.0041041,0.064105,0.25734,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.921191852919971
HP_PELVIC_GIRDLE_MUSCLE_WEAK...,SET,42,0.084183,0.0040218,0.12922,0.25737,HP_PELVIC_GIRDLE_MUSCLE_WEAKNESS,0.921204361483007
KEGG_MEDICUS_PATHOGEN_HSV_GD...,SET,11,0.16378,0.0040077,0.25154,0.25749,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY,0.921479870263591
GOBP_NEGATIVE_REGULATION_OF_...199,SET,17,0.12455,0.0037882,0.1913,0.2575,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.921479870263591
GOBP_COENZYME_A_BIOSYNTHETIC...,SET,10,0.16793,0.0039181,0.25803,0.25759,GOBP_COENZYME_A_BIOSYNTHETIC_PROCESS,0.921588836850232
HP_ABNORMAL_BLOOD_POTASSIUM_...,SET,105,0.056141,0.0042335,0.086266,0.25759,HP_ABNORMAL_BLOOD_POTASSIUM_CONCENTRATION,0.921588836850232
GOBP_NEGATIVE_REGULATION_OF_...568,SET,1519,0.015078,0.0041537,0.02317,0.25761,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS,0.921588836850232
BIOCARTA_TOLL_PATHWAY,SET,22,0.12462,0.0043113,0.19156,0.25766,BIOCARTA_TOLL_PATHWAY,0.921672838616715
GOBP_NEGATIVE_REGULATION_OF_...111,SET,272,0.032606,0.0039392,0.05014,0.25775,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.921862131147541
GSE19198_6H_VS_24H_IL21_TREA...1,SET,177,0.041756,0.0040801,0.06424,0.25785,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN,0.921862131147541
GSE9601_NFKB_INHIBITOR_VS_PI...1,SET,185,0.043755,0.00437,0.067329,0.25789,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.921862131147541
GSE31082_DN_VS_CD4_SP_THYMOC...2,SET,172,0.039057,0.0037626,0.060102,0.2579,GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP,0.921862131147541
KANG_IMMORTALIZED_BY_TERT_DN,SET,95,0.06069,0.0043542,0.093409,0.25794,KANG_IMMORTALIZED_BY_TERT_DN,0.921862131147541
REACTOME_ASSEMBLY_OF_THE_ORC...,SET,9,0.16654,0.0036864,0.25634,0.25795,REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,0.921862131147541
GOBP_GLAND_DEVELOPMENT,SET,427,0.028856,0.0043492,0.044424,0.25799,GOBP_GLAND_DEVELOPMENT,0.921862131147541
DESCARTES_MAIN_FETAL_CARDIOM...,SET,24,0.11524,0.0041639,0.17746,0.25804,DESCARTES_MAIN_FETAL_CARDIOMYOCYTES,0.921862131147541
GOBP_NEGATIVE_REGULATION_OF_...573,SET,20,0.12226,0.0040331,0.18833,0.25811,GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.921862131147541
MIR3161,SET,69,0.071166,0.0043545,0.10963,0.25813,MIR3161,0.921862131147541
YBX3_TARGET_GENES,SET,52,0.074643,0.0039668,0.115,0.25816,YBX3_TARGET_GENES,0.921862131147541
BONCI_TARGETS_OF_MIR15A_AND_...,SET,90,0.058567,0.0040905,0.09024,0.25817,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,0.921862131147541
GSE25123_WT_VS_PPARG_KO_MACR...3,SET,161,0.043347,0.0040413,0.066801,0.25821,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP,0.921862131147541
GSE15930_NAIVE_VS_72H_IN_VIT...3,SET,183,0.039212,0.0038953,0.060437,0.25823,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.921862131147541
GOBP_NEGATIVE_REGULATION_OF_...296,SET,8,0.20222,0.0042202,0.3117,0.25825,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.921862131147541
HE_LIM_SUN_FETAL_LUNG_C3_AER...,SET,84,0.065117,0.0043944,0.10037,0.25826,HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE,0.921862131147541
DURANTE_ADULT_OLFACTORY_NEUR...2,SET,29,0.10377,0.0041211,0.15999,0.25829,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_B_CELLS,0.921862131147541
HAHTOLA_CTCL_PATHOGENESIS,SET,15,0.1533,0.0043799,0.23645,0.25839,HAHTOLA_CTCL_PATHOGENESIS,0.921862131147541
HP_SUPRANUCLEAR_OPHTHALMOPLE...,SET,4,0.25113,0.0037063,0.38734,0.25839,HP_SUPRANUCLEAR_OPHTHALMOPLEGIA,0.921862131147541
GSE32423_IL7_VS_IL4_MEMORY_C...2,SET,182,0.039666,0.0039297,0.061195,0.25844,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP,0.921862131147541
MIR323B_5P,SET,38,0.088274,0.0040118,0.1362,0.25845,MIR323B_5P,0.921862131147541
KEGG_MEDICUS_VARIANT_TMPRSS2...,SET,7,0.2327,0.0045428,0.35907,0.25848,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.921862131147541
GOBP_MITOCHONDRION_LOCALIZAT...,SET,45,0.082826,0.0040955,0.12781,0.25849,GOBP_MITOCHONDRION_LOCALIZATION,0.921862131147541
TAKADA_GASTRIC_CANCER_COPY_N...2,SET,7,0.20754,0.0040516,0.32029,0.2585,TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP,0.921862131147541
chr5p14,SET,5,0.36945,0.006096,0.57023,0.25853,chr5p14,0.921862131147541
GSE21670_IL6_VS_TGFB_AND_IL6...3,SET,178,0.040267,0.0039455,0.062152,0.25853,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.921862131147541
GOBP_GLANDULAR_EPITHELIAL_CE...2,SET,68,0.073107,0.0044409,0.11284,0.25854,GOBP_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION,0.921862131147541
HP_OPEN_ANGLE_GLAUCOMA,SET,12,0.17865,0.0045657,0.2758,0.25858,HP_OPEN_ANGLE_GLAUCOMA,0.921862131147541
UNTERMAN_PROGRESSIVE_VS_STAB...3,SET,5,0.26632,0.0043943,0.41136,0.25869,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_UP,0.921862131147541
MIR23C,SET,538,0.024825,0.0041868,0.038346,0.25869,MIR23C,0.921862131147541
HP_ABNORMALITY_OF_THE_EXTRIN...,SET,20,0.10651,0.0035135,0.16454,0.25871,HP_ABNORMALITY_OF_THE_EXTRINSIC_PATHWAY,0.921862131147541
GOBP_CHEMOREPULSION_OF_AXON,SET,6,0.25012,0.0045208,0.3864,0.25872,GOBP_CHEMOREPULSION_OF_AXON,0.921862131147541
GNF2_SNRK,SET,26,0.10836,0.0040747,0.16743,0.25877,GNF2_SNRK,0.921862131147541
GOBP_CELL_JUNCTION_DISASSEMB...,SET,27,0.12476,0.0047808,0.19278,0.25877,GOBP_CELL_JUNCTION_DISASSEMBLY,0.921862131147541
GOBP_POSITIVE_REGULATION_OF_...706,SET,5,0.24236,0.003999,0.37452,0.25878,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.921862131147541
REACTOME_FORMYL_PEPTIDE_RECE...,SET,8,0.23476,0.0048992,0.3628,0.2588,REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS,0.921862131147541
GSE20366_TREG_VS_NAIVE_CD4_T...4,SET,184,0.042155,0.0041989,0.065149,0.2588,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN,0.921862131147541
GSE22140_GERMFREE_VS_SPF_MOU...1,SET,187,0.040682,0.0040847,0.062876,0.25882,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN,0.921862131147541
HOFMANN_CELL_LYMPHOMA_UP,SET,44,0.07876,0.003851,0.12174,0.25883,HOFMANN_CELL_LYMPHOMA_UP,0.921862131147541
MIR8054,SET,268,0.034158,0.0040967,0.052796,0.25883,MIR8054,0.921862131147541
GSE41978_WT_VS_ID2_KO_AND_BI...2,SET,179,0.038639,0.0037965,0.059729,0.25885,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.921862131147541
chr2q36,SET,34,0.16015,0.0068854,0.24758,0.25886,chr2q36,0.921862131147541
GOBP_REGULATION_OF_NK_T_CELL...3,SET,7,0.23501,0.004588,0.3633,0.25886,GOBP_REGULATION_OF_NK_T_CELL_PROLIFERATION,0.921862131147541
MODULE_120,SET,67,0.067003,0.0040402,0.10359,0.25888,MODULE_120,0.921862131147541
MIR1251_5P,SET,23,0.10734,0.0037968,0.16603,0.25898,MIR1251_5P,0.921937423406863
GOBP_RESPONSE_TO_FIBROBLAST_...,SET,107,0.058228,0.0044322,0.090084,0.25902,GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR,0.921937423406863
GOBP_RAS_PROTEIN_SIGNAL_TRAN...,SET,116,0.050746,0.0040209,0.078533,0.25909,GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.921937423406863
NFY_C,SET,212,0.038652,0.0041294,0.059836,0.25915,NFY_C,0.921937423406863
TAKADA_GASTRIC_CANCER_COPY_N...1,SET,28,0.12285,0.0047939,0.19022,0.25919,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,0.921937423406863
GOBP_POSITIVE_REGULATION_OF_...835,SET,11,0.16718,0.0040908,0.2589,0.25924,GOBP_POSITIVE_REGULATION_OF_VASCULOGENESIS,0.921937423406863
HP_SMOOTH_TONGUE,SET,5,0.27483,0.0045348,0.42582,0.25933,HP_SMOOTH_TONGUE,0.921937423406863
HP_CONGENITAL_CONTRACTURE,SET,156,0.044132,0.0040507,0.068394,0.25938,HP_CONGENITAL_CONTRACTURE,0.921937423406863
REACTOME_DIGESTION_OF_DIETAR...2,SET,6,0.29449,0.0053228,0.4564,0.25939,REACTOME_DIGESTION_OF_DIETARY_LIPID,0.921937423406863
KEGG_MEDICUS_PATHOGEN_HIV_GP...2,SET,17,0.13168,0.0040049,0.20408,0.2594,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN,0.921937423406863
KEGG_MEDICUS_REFERENCE_DYNEI...,SET,29,0.098082,0.003895,0.15203,0.25942,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE,0.921937423406863
LHX9_TARGET_GENES,SET,1163,0.016942,0.0041267,0.026263,0.25944,LHX9_TARGET_GENES,0.921937423406863
GSE15330_HSC_VS_GRANULOCYTE_...2,SET,172,0.040886,0.0039387,0.063387,0.25946,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.921937423406863
GOBP_SYMPATHETIC_NERVOUS_SYS...,SET,21,0.135,0.0045629,0.20932,0.25949,GOBP_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,0.921937423406863
HP_TERATOMA,SET,12,0.15441,0.0039462,0.23941,0.25949,HP_TERATOMA,0.921937423406863
HOWARD_DENDRITIC_CELL_INACT_...2,SET,140,0.050162,0.0043636,0.077782,0.2595,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.921937423406863
EGR3_01,SET,72,0.06496,0.00406,0.10074,0.25953,EGR3_01,0.921937423406863
GOBP_GLOMERULAR_ENDOTHELIUM_...,SET,4,0.33859,0.0049972,0.52512,0.25953,GOBP_GLOMERULAR_ENDOTHELIUM_DEVELOPMENT,0.921937423406863
HP_VASCULITIS,SET,65,0.070891,0.0042106,0.10994,0.25953,HP_VASCULITIS,0.921937423406863
GSE6259_FLT3L_INDUCED_DEC205...6,SET,134,0.0481,0.0040943,0.074601,0.25954,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP,0.921937423406863
GOBP_ACETYL_COA_BIOSYNTHETIC...2,SET,8,0.21711,0.004531,0.3368,0.25959,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE,0.921937423406863
GOMF_NODAL_BINDING,SET,2,0.45989,0.0047996,0.71341,0.25959,GOMF_NODAL_BINDING,0.921937423406863
REACTOME_PYRIMIDINE_CATABOLI...,SET,12,0.1657,0.0042347,0.25708,0.25962,REACTOME_PYRIMIDINE_CATABOLISM,0.921937423406863
GOMF_CARBONATE_DEHYDRATASE_A...,SET,14,0.16077,0.0044377,0.24944,0.25962,GOMF_CARBONATE_DEHYDRATASE_ACTIVITY,0.921937423406863
GSE45739_NRAS_KO_VS_WT_ACD3_...1,SET,166,0.041623,0.0039398,0.064578,0.25962,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN,0.921937423406863
KEGG_MEDICUS_REFERENCE_IFN_R...,SET,28,0.12387,0.0048336,0.19225,0.25969,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY,0.921937423406863
LAMB_CCND1_TARGETS,SET,18,0.13598,0.0042557,0.21107,0.2597,LAMB_CCND1_TARGETS,0.921937423406863
GOMF_LIGAND_GATED_CALCIUM_CH...,SET,30,0.10315,0.0041662,0.1601,0.2597,GOMF_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY,0.921937423406863
ZNF354A_TARGET_GENES,SET,15,0.13863,0.0039609,0.21518,0.25971,ZNF354A_TARGET_GENES,0.921937423406863
MIR4435,SET,79,0.061113,0.0040001,0.094862,0.25972,MIR4435,0.921937423406863
REACTOME_ACETYLCHOLINE_BINDI...,SET,14,0.1618,0.0044663,0.25117,0.25973,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,0.921937423406863
GOBP_REGULATION_OF_CELL_FATE...2,SET,23,0.11265,0.0039846,0.17488,0.25975,GOBP_REGULATION_OF_CELL_FATE_SPECIFICATION,0.921937423406863
GOMF_PROTEIN_PHOSPHATASE_BIN...,SET,136,0.045929,0.0039382,0.071329,0.25982,GOMF_PROTEIN_PHOSPHATASE_BINDING,0.922059123379937
HP_ABNORMAL_INTRAOCULAR_PRES...,SET,36,0.098173,0.0043429,0.15249,0.25986,HP_ABNORMAL_INTRAOCULAR_PRESSURE,0.922059123379937
GOBP_REGULATION_OF_PROTEIN_S...4,SET,20,0.10938,0.0036082,0.16994,0.2599,GOBP_REGULATION_OF_PROTEIN_SUMOYLATION,0.922059123379937
GOBP_RESPONSE_TO_INTERLEUKIN...1,SET,100,0.057829,0.0042562,0.089848,0.25991,GOBP_RESPONSE_TO_INTERLEUKIN_1,0.922059123379937
GOCC_CILIARY_ROOTLET,SET,12,0.1633,0.0041735,0.25373,0.25992,GOCC_CILIARY_ROOTLET,0.922059123379937
KEGG_MEDICUS_PATHOGEN_SHIGEL...9,SET,7,0.19672,0.0038404,0.30572,0.25997,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY,0.922059123379937
GOBP_REGULATION_OF_SALIVA_SE...,SET,7,0.2711,0.0052924,0.42131,0.25997,GOBP_REGULATION_OF_SALIVA_SECRETION,0.922059123379937
MATZUK_SPERMATOZOA,SET,105,0.054698,0.0041246,0.085036,0.26004,MATZUK_SPERMATOZOA,0.922063473694943
MIR4270,SET,164,0.042525,0.0040011,0.066118,0.26006,MIR4270,0.922063473694943
GCM_CHUK,SET,69,0.063375,0.0038779,0.098543,0.26008,GCM_CHUK,0.922063473694943
HP_HYPERKALEMIA,SET,35,0.095162,0.004151,0.148,0.26012,HP_HYPERKALEMIA,0.922063473694943
HP_ABNORMAL_CIRCULATING_SEX_...,SET,108,0.052934,0.0040479,0.082327,0.26013,HP_ABNORMAL_CIRCULATING_SEX_HORMONE_CONCENTRATION,0.922063473694943
GOBP_POSITIVE_REGULATION_OF_...777,SET,16,0.14795,0.0043656,0.23016,0.26018,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.922063473694943
GOMF_ACTIN_FILAMENT_BINDING,SET,197,0.040172,0.0041389,0.062496,0.26018,GOMF_ACTIN_FILAMENT_BINDING,0.922063473694943
GOBP_NEUROTRANSMITTER_RECEPT...3,SET,24,0.12195,0.0044064,0.18974,0.2602,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT,0.922063473694943
REACTOME_ENDOSOMAL_VACUOLAR_...,SET,11,0.17805,0.0043567,0.27703,0.26021,REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,0.922063473694943
GSE29618_PRE_VS_DAY7_POST_LA...2,SET,181,0.039925,0.0039446,0.062128,0.26024,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP,0.922075767152615
RGAANNTTC_HSF1_01,SET,406,0.027951,0.0041103,0.043531,0.26041,RGAANNTTC_HSF1_01,0.922401228426396
GOBP_REGULATION_OF_PROTEIN_K...2,SET,12,0.16383,0.004187,0.25518,0.26044,GOBP_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.922401228426396
REACTOME_PHENYLALANINE_AND_T...,SET,10,0.18641,0.0043492,0.29038,0.26046,REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM,0.922401228426396
GOBP_SKIN_DEVELOPMENT,SET,301,0.035955,0.0045658,0.056028,0.26052,GOBP_SKIN_DEVELOPMENT,0.922401228426396
MAGRANGEAS_MULTIPLE_MYELOMA_...2,SET,16,0.13959,0.0041191,0.21755,0.26055,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,0.922401228426396
TARTE_PLASMA_CELL_VS_PLASMAB...2,SET,350,0.0311,0.0042528,0.048471,0.26056,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,0.922401228426396
GOMF_U1_SNRNP_BINDING,SET,6,0.19435,0.0035127,0.30291,0.26057,GOMF_U1_SNRNP_BINDING,0.922401228426396
GOBP_ESTABLISHMENT_OF_PROTEI...11,SET,61,0.069855,0.0040198,0.10888,0.26058,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE,0.922401228426396
MODULE_23,SET,517,0.025257,0.0041782,0.039388,0.26069,MODULE_23,0.922401228426396
GSE5542_IFNG_VS_IFNA_AND_IFN...2,SET,179,0.039103,0.0038421,0.061001,0.26076,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.922401228426396
GOBP_NEGATIVE_REGULATION_OF_...639,SET,43,0.083633,0.0040426,0.13048,0.26077,GOBP_NEGATIVE_REGULATION_OF_TORC1_SIGNALING,0.922401228426396
GOBP_DIGESTIVE_SYSTEM_PROCESS,SET,102,0.056845,0.0042252,0.088687,0.26078,GOBP_DIGESTIVE_SYSTEM_PROCESS,0.922401228426396
GOBP_FUCOSE_CATABOLIC_PROCESS,SET,9,0.21186,0.0046896,0.33058,0.2608,GOBP_FUCOSE_CATABOLIC_PROCESS,0.922401228426396
KEGG_MEDICUS_REFERENCE_BRANC...,SET,30,0.10018,0.0040462,0.15632,0.26081,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION,0.922401228426396
YAO_TEMPORAL_RESPONSE_TO_PRO...15,SET,71,0.071405,0.0044318,0.11143,0.26083,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,0.922401228426396
HP_ADRENAL_HYPOPLASIA,SET,28,0.10563,0.0041219,0.16485,0.26085,HP_ADRENAL_HYPOPLASIA,0.922401228426396
BOYAULT_LIVER_CANCER_SUBCLAS...6,SET,106,0.051465,0.0038992,0.080345,0.26091,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,0.922401228426396
HP_AORTIC_TORTUOSITY,SET,6,0.25837,0.0046698,0.40334,0.26091,HP_AORTIC_TORTUOSITY,0.922401228426396
MIR20A_3P,SET,173,0.041516,0.0040109,0.064818,0.26093,MIR20A_3P,0.922401228426396
GOMF_INTRACELLULARLY_LIGAND_...,SET,30,0.1008,0.0040714,0.15739,0.26094,GOMF_INTRACELLULARLY_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.922401228426396
BIOCARTA_LEPTIN_PATHWAY,SET,11,0.16044,0.0039258,0.25055,0.26098,BIOCARTA_LEPTIN_PATHWAY,0.922401228426396
GOBP_NOTOCHORD_MORPHOGENESIS,SET,6,0.23259,0.0042039,0.36325,0.26099,GOBP_NOTOCHORD_MORPHOGENESIS,0.922401228426396
GSE37319_WT_VS_RC3H1_KO_CD44...2,SET,130,0.049867,0.0041813,0.077883,0.261,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP,0.922401228426396
GSE2706_LPS_VS_R848_AND_LPS_...2,SET,146,0.044407,0.0039442,0.069358,0.26101,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP,0.922401228426396
SASSON_RESPONSE_TO_GONADOTRO...2,SET,76,0.060784,0.0039026,0.094955,0.26105,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,0.922401228426396
GOBP_CORONARY_VASCULATURE_DE...,SET,45,0.08351,0.0041293,0.13049,0.2611,GOBP_CORONARY_VASCULATURE_DEVELOPMENT,0.922401228426396
REACTOME_DEFENSINS,SET,32,0.12854,0.0053618,0.20091,0.26115,REACTOME_DEFENSINS,0.922401228426396
GSE13738_RESTING_VS_TCR_ACTI...1,SET,178,0.040804,0.0039982,0.063785,0.26119,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN,0.922401228426396
HP_TORSION_DYSTONIA,SET,7,0.19547,0.0038159,0.30559,0.26121,HP_TORSION_DYSTONIA,0.922401228426396
GSE17301_ACD3_ACD28_VS_ACD3_...2,SET,170,0.040281,0.0038581,0.062979,0.26122,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP,0.922401228426396
GOBP_POSITIVE_REGULATION_OF_...134,SET,55,0.075878,0.0041468,0.11866,0.26127,GOBP_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.922401228426396
GSE2770_IL4_ACT_VS_ACT_CD4_T...4,SET,177,0.041226,0.0040283,0.064476,0.26128,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.922401228426396
MIR6779_3P,SET,64,0.070488,0.0041544,0.11025,0.2613,MIR6779_3P,0.922401228426396
GOBP_POSITIVE_REGULATION_OF_...517,SET,5,0.273,0.0045046,0.42703,0.26131,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.922401228426396
HP_ABNORMAL_MUSCLE_FIBER_MOR...,SET,233,0.034787,0.0038939,0.054414,0.26132,HP_ABNORMAL_MUSCLE_FIBER_MORPHOLOGY,0.922401228426396
GOMF_HORMONE_RECEPTOR_BINDING,SET,29,0.1128,0.0044797,0.17648,0.26136,GOMF_HORMONE_RECEPTOR_BINDING,0.922401228426396
GOCC_UNCONVENTIONAL_MYOSIN_C...,SET,9,0.17311,0.0038319,0.27085,0.26137,GOCC_UNCONVENTIONAL_MYOSIN_COMPLEX,0.922401228426396
GOMF_CARBON_SULFUR_LYASE_ACT...,SET,10,0.18377,0.0042876,0.28753,0.26137,GOMF_CARBON_SULFUR_LYASE_ACTIVITY,0.922401228426396
MORF_RAD51L3,SET,343,0.030223,0.0040922,0.04729,0.26138,MORF_RAD51L3,0.922401228426396
HP_ABNORMALITY_OF_COMPLEMENT...,SET,49,0.083302,0.0042977,0.13035,0.2614,HP_ABNORMALITY_OF_COMPLEMENT_SYSTEM,0.922401228426396
STEINER_ERYTHROCYTE_MEMBRANE...,SET,14,0.13728,0.0037893,0.21483,0.26142,STEINER_ERYTHROCYTE_MEMBRANE_GENES,0.922401228426396
GNF2_KISS1,SET,43,0.094696,0.0045774,0.14824,0.26148,GNF2_KISS1,0.922519277230738
ARNT_01,SET,238,0.03597,0.0040687,0.056332,0.26157,ARNT_01,0.922569324406573
GSE17721_CTRL_VS_CPG_1H_BMDC...2,SET,186,0.037966,0.0038019,0.059462,0.26158,GSE17721_CTRL_VS_CPG_1H_BMDC_UP,0.922569324406573
GSE33425_CD8_ALPHAALPHA_VS_A...2,SET,186,0.039014,0.0039069,0.061123,0.26165,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,0.922569324406573
REACTOME_RECEPTOR_MEDIATED_M...,SET,10,0.16481,0.0038453,0.25822,0.26166,REACTOME_RECEPTOR_MEDIATED_MITOPHAGY,0.922569324406573
GOBP_PREPULSE_INHIBITION,SET,13,0.15752,0.0041901,0.2468,0.26166,GOBP_PREPULSE_INHIBITION,0.922569324406573
MISIAK_ANAPLASTIC_THYROID_CA...2,SET,44,0.087053,0.0042565,0.1364,0.26167,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP,0.922569324406573
REACTOME_RHO_GTPASES_ACTIVAT...2,SET,129,0.047336,0.0039539,0.074173,0.26168,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,0.922569324406573
PCGF6_TARGET_GENES,SET,64,0.063766,0.0037583,0.099955,0.26176,PCGF6_TARGET_GENES,0.922618028797404
GOBP_CELL_CELL_ADHESION,SET,896,0.020523,0.0044218,0.032172,0.26177,GOBP_CELL_CELL_ADHESION,0.922618028797404
REACTOME_HEME_BIOSYNTHESIS,SET,13,0.14851,0.0039504,0.23285,0.2618,REACTOME_HEME_BIOSYNTHESIS,0.922618028797404
MAPK3_TARGET_GENES,SET,69,0.064899,0.0039711,0.10175,0.2618,MAPK3_TARGET_GENES,0.922618028797404
KIM_LIVER_CANCER_POOR_SURVIV...1,SET,41,0.085928,0.0040561,0.13476,0.26185,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,0.922700674237048
HP_IRREGULAR_VERTEBRAL_ENDPL...,SET,27,0.10828,0.0041492,0.16983,0.26189,HP_IRREGULAR_VERTEBRAL_ENDPLATES,0.922748068734793
WP_CYTOSINE_METHYLATION,SET,7,0.22255,0.0043448,0.34931,0.26203,WP_CYTOSINE_METHYLATION,0.922766356275304
GOCC_NLS_DEPENDENT_PROTEIN_N...,SET,10,0.1534,0.003579,0.24077,0.26203,GOCC_NLS_DEPENDENT_PROTEIN_NUCLEAR_IMPORT_COMPLEX,0.922766356275304
REACTOME_CELLULAR_RESPONSE_T...1,SET,191,0.037679,0.0038231,0.059146,0.26205,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,0.922766356275304
HUMMEL_BURKITTS_LYMPHOMA_DN,SET,14,0.16264,0.0044894,0.25534,0.26209,HUMMEL_BURKITTS_LYMPHOMA_DN,0.922766356275304
LI_DCP2_BOUND_MRNA,SET,78,0.05782,0.0037607,0.090791,0.26212,LI_DCP2_BOUND_MRNA,0.922766356275304
GOBP_METANEPHRIC_DISTAL_TUBU...,SET,6,0.2485,0.0044915,0.39024,0.26214,GOBP_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT,0.922766356275304
NCOA2_TARGET_GENES,SET,380,0.028877,0.0041112,0.045352,0.26216,NCOA2_TARGET_GENES,0.922766356275304
MIR106A_3P,SET,99,0.057333,0.0041987,0.090057,0.26219,MIR106A_3P,0.922766356275304
MIR3135B,SET,97,0.055078,0.0039928,0.086516,0.26219,MIR3135B,0.922766356275304
GOBP_LIPID_DROPLET_FUSION,SET,5,0.28122,0.0046402,0.44175,0.26219,GOBP_LIPID_DROPLET_FUSION,0.922766356275304
GOBP_CEREBELLAR_GRANULAR_LAY...1,SET,12,0.17025,0.004351,0.26749,0.26224,GOBP_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT,0.922766356275304
GOCC_PROCENTRIOLE_REPLICATIO...,SET,6,0.18377,0.0033215,0.28873,0.26224,GOCC_PROCENTRIOLE_REPLICATION_COMPLEX,0.922766356275304
GOBP_CELLULAR_RESPONSE_TO_AM...2,SET,40,0.092447,0.0043103,0.14525,0.26225,GOBP_CELLULAR_RESPONSE_TO_AMYLOID_BETA,0.922766356275304
BAKKER_FOXO3_TARGETS_DN,SET,157,0.042393,0.0039034,0.066617,0.26228,BAKKER_FOXO3_TARGETS_DN,0.922766356275304
REACTOME_MASTL_FACILITATES_M...,SET,10,0.16382,0.0038222,0.25749,0.26232,REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION,0.922766356275304
REACTOME_PRESYNAPTIC_FUNCTIO...,SET,21,0.12343,0.004172,0.194,0.26232,REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS,0.922766356275304
GSE3920_UNTREATED_VS_IFNA_TR...2,SET,163,0.043942,0.0041219,0.069083,0.26237,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP,0.922848836150187
GOBP_NEGATIVE_REGULATION_OF_...179,SET,82,0.063202,0.0042143,0.0994,0.26245,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.923036809350334
GSE17974_CTRL_VS_ACT_IL4_AND...13,SET,178,0.037506,0.003675,0.059002,0.2625,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN,0.923096175637394
CAO_BLOOD_FLUZONE_AGE_05_14Y...4,SET,7,0.21014,0.0041024,0.33061,0.26252,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_UP,0.923096175637394
HARALAMBIEVA_PBMC_FLUARIX_AG...9,SET,317,0.030145,0.0039267,0.047434,0.26255,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE,0.923108270106222
HP_ABNORMAL_NECK_PHYSIOLOGY,SET,29,0.10597,0.0042083,0.1668,0.26262,HP_ABNORMAL_NECK_PHYSIOLOGY,0.923260985231641
WP_OSTEOBLAST_DIFFERENTIATIO...,SET,116,0.055805,0.0044217,0.087853,0.26265,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,0.923273060584606
GOBP_SEQUESTERING_OF_BMP_IN_...,SET,4,0.31135,0.0045951,0.49048,0.26279,GOBP_SEQUESTERING_OF_BMP_IN_EXTRACELLULAR_MATRIX,0.923648655071291
HP_HOODED_EYELID,SET,6,0.20541,0.0037127,0.32362,0.26281,HP_HOODED_EYELID,0.923648655071291
HP_OPPORTUNISTIC_INFECTION,SET,43,0.085644,0.0041399,0.13497,0.26286,HP_OPPORTUNISTIC_INFECTION,0.923730970677452
HP_SLEEP_WAKE_CYCLE_DISTURBA...,SET,35,0.096251,0.0041984,0.1517,0.26289,HP_SLEEP_WAKE_CYCLE_DISTURBANCE,0.923742993630573
HP_DECREASED_LDL_CHOLESTEROL...,SET,13,0.14757,0.0039252,0.23263,0.26293,HP_DECREASED_LDL_CHOLESTEROL_CONCENTRATION,0.923790148604933
GSE5589_WT_VS_IL6_KO_LPS_AND...1,SET,133,0.045826,0.0038862,0.072256,0.26297,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.923837294046295
WP_MACROPHAGE_MARKERS,SET,8,0.20371,0.0042512,0.32133,0.26306,WP_MACROPHAGE_MARKERS,0.923839089807051
TSENG_IRS1_TARGETS_UP,SET,94,0.056625,0.0040413,0.08933,0.26308,TSENG_IRS1_TARGETS_UP,0.923839089807051
GSE45365_HEALTHY_VS_MCMV_INF...1,SET,167,0.041703,0.0039592,0.065791,0.26309,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN,0.923839089807051
GOBP_REGULATION_OF_COPII_VES...,SET,5,0.21109,0.003483,0.33306,0.26311,GOBP_REGULATION_OF_COPII_VESICLE_COATING,0.923839089807051
GSE3337_CTRL_VS_4H_IFNG_IN_C...2,SET,185,0.039448,0.0039398,0.062241,0.26311,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP,0.923839089807051
GSE29164_DAY3_VS_DAY7_UNTREA...1,SET,175,0.041019,0.0039855,0.064726,0.26313,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN,0.923839089807051
BIOCARTA_EPHA4_PATHWAY,SET,8,0.20411,0.0042598,0.32222,0.26322,BIOCARTA_EPHA4_PATHWAY,0.923980382750959
ALX4_01,SET,15,0.14928,0.0042651,0.23569,0.26325,ALX4_01,0.923980382750959
GSE30083_SP1_VS_SP2_THYMOCYT...1,SET,184,0.041536,0.0041372,0.06558,0.26325,GSE30083_SP1_VS_SP2_THYMOCYTE_DN,0.923980382750959
MORF_RAC1,SET,186,0.037666,0.0037719,0.059482,0.26329,MORF_RAC1,0.924004346728595
GOBP_RESPONSE_TO_OXYGEN_GLUC...,SET,9,0.17772,0.0039337,0.28067,0.26331,GOBP_RESPONSE_TO_OXYGEN_GLUCOSE_DEPRIVATION,0.924004346728595
REACTOME_INHIBITION_OF_REPLI...,SET,11,0.14543,0.0035586,0.22972,0.26334,REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1,0.924016325088339
MIR297,SET,130,0.050151,0.0042051,0.079238,0.2634,MIR297,0.924133555420957
ZNF549_TARGET_GENES,SET,1015,0.017167,0.0039233,0.027134,0.26348,ZNF549_TARGET_GENES,0.924143210621605
HP_ABNORMAL_CIRCULATING_FATT...2,SET,68,0.063139,0.0038354,0.099863,0.26361,HP_ABNORMAL_CIRCULATING_FATTY_ACID_CONCENTRATION,0.924143210621605
GOBP_COMPLEMENT_ACTIVATION_C...,SET,29,0.11555,0.0045889,0.18278,0.26363,GOBP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.924143210621605
MORF_BMI1,SET,73,0.061163,0.003849,0.096748,0.26364,MORF_BMI1,0.924143210621605
GSE9946_IMMATURE_VS_LISTERIA...1,SET,112,0.050964,0.0039683,0.080616,0.26364,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN,0.924143210621605
GOBP_POSITIVE_REGULATION_OF_...399,SET,23,0.11578,0.0040954,0.18318,0.26367,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.924143210621605
GSE3982_DC_VS_TH1_UP,SET,186,0.040412,0.0040469,0.063947,0.26371,GSE3982_DC_VS_TH1_UP,0.924143210621605
BENPORATH_CYCLING_GENES,SET,589,0.021772,0.0038366,0.034457,0.26374,BENPORATH_CYCLING_GENES,0.924143210621605
GOBP_POSITIVE_REGULATION_OF_...523,SET,61,0.07327,0.0042163,0.11596,0.26375,GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.924143210621605
REACTOME_SYNTHESIS_OF_IP3_AN...,SET,25,0.10409,0.0038385,0.16478,0.26379,REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL,0.924143210621605
GOBP_BONE_CELL_DEVELOPMENT,SET,18,0.13932,0.00436,0.22055,0.2638,GOBP_BONE_CELL_DEVELOPMENT,0.924143210621605
HP_ILEUS,SET,29,0.10629,0.0042212,0.16828,0.26381,HP_ILEUS,0.924143210621605
WP_PATHWAYS_AFFECTED_IN_ADEN...,SET,56,0.068765,0.003792,0.10894,0.26395,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,0.924143210621605
GOBP_ORGAN_GROWTH,SET,151,0.046904,0.0042361,0.074306,0.26395,GOBP_ORGAN_GROWTH,0.924143210621605
HP_REPETITIVE_COMPULSIVE_BEH...,SET,12,0.17771,0.0045418,0.28159,0.26399,HP_REPETITIVE_COMPULSIVE_BEHAVIOR,0.924143210621605
TCTCTCC_MIR185,SET,115,0.051818,0.0040882,0.082113,0.26401,TCTCTCC_MIR185,0.924143210621605
HP_ABNORMAL_BRAINSTEM_WHITE_...,SET,15,0.12332,0.0035235,0.19545,0.26404,HP_ABNORMAL_BRAINSTEM_WHITE_MATTER_MORPHOLOGY,0.924143210621605
HP_GENERALIZED_HYPERREFLEXIA,SET,10,0.14129,0.0032965,0.22393,0.26404,HP_GENERALIZED_HYPERREFLEXIA,0.924143210621605
GSE17721_LPS_VS_POLYIC_24H_B...2,SET,173,0.038413,0.0037112,0.060887,0.26406,GSE17721_LPS_VS_POLYIC_24H_BMDC_UP,0.924143210621605
GOBP_POSITIVE_REGULATION_OF_...808,SET,8,0.19444,0.0040579,0.30826,0.2641,GOBP_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION,0.924143210621605
OVOL3_TARGET_GENES,SET,392,0.026788,0.0038723,0.042473,0.26412,OVOL3_TARGET_GENES,0.924143210621605
GSE17721_LPS_VS_GARDIQUIMOD_...15,SET,180,0.039168,0.0038591,0.062102,0.26412,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN,0.924143210621605
GOMF_FERRIC_IRON_BINDING,SET,8,0.21104,0.0044042,0.33462,0.26413,GOMF_FERRIC_IRON_BINDING,0.924143210621605
HAY_BONE_MARROW_NAIVE_T_CELL,SET,324,0.030903,0.0040689,0.049008,0.26417,HAY_BONE_MARROW_NAIVE_T_CELL,0.924143210621605
GOBP_REGULATION_OF_DOPAMINE_...2,SET,24,0.12126,0.0043814,0.19233,0.26419,GOBP_REGULATION_OF_DOPAMINE_SECRETION,0.924143210621605
JAZAG_TGFB1_SIGNALING_DN,SET,32,0.087264,0.00364,0.13842,0.2642,JAZAG_TGFB1_SIGNALING_DN,0.924143210621605
GSE23321_CD8_STEM_CELL_MEMOR...2,SET,174,0.042721,0.0041392,0.067765,0.26421,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP,0.924143210621605
GOBP_REGULATION_OF_CELLULAR_...13,SET,70,0.063289,0.0039004,0.10041,0.26425,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.924143210621605
HP_RESTRICTIVE_CARDIOMYOPATHY,SET,22,0.12115,0.0041911,0.1922,0.26425,HP_RESTRICTIVE_CARDIOMYOPATHY,0.924143210621605
MIR623,SET,107,0.051777,0.0039411,0.082154,0.26427,MIR623,0.924143210621605
WP_PENTOSE_PHOSPHATE_PATHWAY...,SET,7,0.2127,0.0041523,0.3375,0.26428,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,0.924143210621605
HP_CHOKING_EPISODES,SET,16,0.13665,0.0040323,0.21683,0.26428,HP_CHOKING_EPISODES,0.924143210621605
MIR513C_5P,SET,164,0.04172,0.0039254,0.066208,0.26431,MIR513C_5P,0.924143210621605
DESCARTES_FETAL_INTESTINE_LY...1,SET,26,0.11076,0.0041651,0.17579,0.26433,DESCARTES_FETAL_INTESTINE_LYMPHATIC_ENDOTHELIAL_CELLS,0.924143210621605
HP_HYPERTENSIVE_CRISIS,SET,14,0.15624,0.0043129,0.24799,0.26434,HP_HYPERTENSIVE_CRISIS,0.924143210621605
BURTON_ADIPOGENESIS_PEAK_AT_...4,SET,40,0.090099,0.0042009,0.14302,0.26436,BURTON_ADIPOGENESIS_PEAK_AT_2HR,0.924143210621605
KEGG_MEDICUS_PATHOGEN_KSHV_V...2,SET,5,0.22203,0.0036635,0.35254,0.26442,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY,0.9242019961786
HALLMARK_ADIPOGENESIS,SET,186,0.038321,0.0038375,0.06085,0.26443,HALLMARK_ADIPOGENESIS,0.9242019961786
BRAUNE_GEIST_20_GENE_NOTCH_S...,SET,20,0.13258,0.0043734,0.2106,0.26451,BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER,0.924208251404494
GOBP_PROTEIN_LOCALIZATION_TO...17,SET,67,0.062995,0.0037985,0.10009,0.26456,GOBP_PROTEIN_LOCALIZATION_TO_CILIUM,0.924208251404494
MIR5007_5P,SET,53,0.074557,0.004,0.11847,0.26458,MIR5007_5P,0.924208251404494
GOBP_RESPONSE_TO_MINERALOCOR...,SET,36,0.096003,0.0042469,0.15267,0.26473,GOBP_RESPONSE_TO_MINERALOCORTICOID,0.924208251404494
GSE39022_LN_VS_SPLEEN_DC_DN,SET,175,0.040682,0.0039528,0.064693,0.26473,GSE39022_LN_VS_SPLEEN_DC_DN,0.924208251404494
GOMF_NEUTRAL_L_AMINO_ACID_SO...,SET,8,0.21966,0.0045842,0.34933,0.26474,GOMF_NEUTRAL_L_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.924208251404494
GSE32901_NAIVE_VS_TH1_CD4_TC...2,SET,113,0.051493,0.0040273,0.081917,0.26481,GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP,0.924208251404494
GOBP_CELLULAR_RESPONSE_TO_IN...6,SET,7,0.20916,0.0040833,0.33282,0.26486,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA,0.924208251404494
WP_TARGET_OF_RAPAMYCIN_SIGNA...,SET,35,0.094263,0.0041117,0.15002,0.26489,WP_TARGET_OF_RAPAMYCIN_SIGNALING,0.924208251404494
GOBP_MODULATION_OF_INHIBITOR...,SET,7,0.23107,0.0045111,0.36774,0.26489,GOBP_MODULATION_OF_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.924208251404494
GOBP_POSITIVE_REGULATION_OF_...146,SET,4,0.28236,0.0041673,0.44945,0.26493,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_ELONGATION,0.924208251404494
HP_APLASIA_HYPOPLASIA_OF_THE...8,SET,11,0.17174,0.0042025,0.27337,0.26493,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_METACARPAL,0.924208251404494
MIR4700_5P,SET,200,0.038836,0.0040312,0.061827,0.26496,MIR4700_5P,0.924208251404494
GOBP_CARDIAC_VENTRICLE_DEVEL...,SET,121,0.052531,0.0042504,0.083636,0.26498,GOBP_CARDIAC_VENTRICLE_DEVELOPMENT,0.924208251404494
HP_INCREASED_BODY_WEIGHT,SET,424,0.026884,0.004038,0.042803,0.26498,HP_INCREASED_BODY_WEIGHT,0.924208251404494
SUZUKI_CTCFL_TARGETS_UP,SET,11,0.1623,0.0039714,0.25842,0.26499,SUZUKI_CTCFL_TARGETS_UP,0.924208251404494
GTCNYYATGR_UNKNOWN,SET,103,0.053741,0.0040139,0.085572,0.265,GTCNYYATGR_UNKNOWN,0.924208251404494
GOMF_MAP_KINASE_KINASE_ACTIV...,SET,15,0.13938,0.0039824,0.22196,0.26501,GOMF_MAP_KINASE_KINASE_ACTIVITY,0.924208251404494
GOBP_NEGATIVE_REGULATION_OF_...204,SET,35,0.098926,0.0043151,0.15756,0.26505,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,0.924208251404494
HP_STUTTERING,SET,9,0.17255,0.0038195,0.27483,0.26505,HP_STUTTERING,0.924208251404494
GSE27241_CTRL_VS_DIGOXIN_TRE...4,SET,175,0.039026,0.0037919,0.062157,0.26505,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.924208251404494
GSE1112_OT1_VS_HY_CD8AB_THYM...2,SET,180,0.03888,0.0038308,0.061928,0.26506,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP,0.924208251404494
GSE5463_CTRL_VS_DEXAMETHASON...2,SET,187,0.039093,0.0039252,0.062266,0.26506,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP,0.924208251404494
GSE37416_0H_VS_6H_F_TULARENS...2,SET,166,0.041778,0.0039545,0.066547,0.26507,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.924208251404494
DURANTE_ADULT_OLFACTORY_NEUR...19,SET,119,0.047719,0.0038293,0.076026,0.26511,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS,0.924232011033099
GSE11924_TH1_VS_TH17_CD4_TCE...2,SET,182,0.039927,0.0039555,0.063617,0.26513,GSE11924_TH1_VS_TH17_CD4_TCELL_UP,0.924232011033099
GOBP_ACINAR_CELL_DIFFERENTIA...,SET,5,0.27138,0.0044779,0.43247,0.26517,GOBP_ACINAR_CELL_DIFFERENTIATION,0.924278743355732
WP_TYPE_2_PAPILLARY_RENAL_CE...,SET,31,0.097189,0.0039902,0.15497,0.26529,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,0.92460428700361
GCM_PRKAG1,SET,44,0.075018,0.0036681,0.11967,0.26537,GCM_PRKAG1,0.92479036899629
BIOCARTA_IL6_PATHWAY,SET,20,0.12435,0.004102,0.19848,0.26549,BIOCARTA_IL6_PATHWAY,0.924792784176264
MODULE_39,SET,9,0.17699,0.0039178,0.28253,0.26551,MODULE_39,0.924792784176264
CYCLIN_D1_UP.V1_DN,SET,175,0.040254,0.0039112,0.064263,0.26553,CYCLIN_D1_UP.V1_DN,0.924792784176264
BENPORATH_NOS_TARGETS,SET,160,0.044525,0.0041384,0.071085,0.26554,BENPORATH_NOS_TARGETS,0.924792784176264
REACTOME_SYNTHESIS_OF_LIPOXI...,SET,6,0.23211,0.0041953,0.37068,0.26561,REACTOME_SYNTHESIS_OF_LIPOXINS_LX,0.924792784176264
WP_SMITHMAGENIS_AND_POTOCKIL...,SET,144,0.048905,0.0043141,0.078109,0.26562,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,0.924792784176264
MORF_MYL3,SET,63,0.070572,0.0041269,0.11271,0.26562,MORF_MYL3,0.924792784176264
GOBP_MAINTENANCE_OF_APICAL_B...,SET,9,0.20907,0.0046278,0.33395,0.26564,GOBP_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY,0.924792784176264
KEGG_PROTEIN_EXPORT,SET,22,0.10782,0.0037301,0.17224,0.26566,KEGG_PROTEIN_EXPORT,0.924792784176264
RADMACHER_AML_PROGNOSIS,SET,73,0.066445,0.0041814,0.10615,0.26567,RADMACHER_AML_PROGNOSIS,0.924792784176264
JINESH_BLEBBISHIELD_TRANSFOR...2,SET,154,0.046462,0.0042374,0.074228,0.26568,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,0.924792784176264
GOMF_DNA_BINDING_TRANSCRIPTI...1,SET,442,0.026813,0.0041099,0.04284,0.26569,GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY,0.924792784176264
REACTOME_VITAMIN_B2_RIBOFLAV...,SET,7,0.2113,0.004125,0.33785,0.26585,REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM,0.925233989185942
REACTOME_SHC_MEDIATED_CASCAD...3,SET,19,0.12237,0.0039345,0.19568,0.26587,REACTOME_SHC_MEDIATED_CASCADE_FGFR4,0.925233989185942
GOBP_POSITIVE_REGULATION_OF_...526,SET,226,0.037333,0.0041164,0.059706,0.2659,GOBP_POSITIVE_REGULATION_OF_NEUROGENESIS,0.925245744893873
WP_PI3KAKTMTOR_SIGNALING_AND...,SET,31,0.10095,0.0041448,0.16151,0.26596,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,0.925338828828829
WP_NIPBL_ROLE_IN_DNA_DAMAGE_...,SET,7,0.18176,0.0035484,0.2908,0.26598,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.925338828828829
GSE23321_CENTRAL_VS_EFFECTOR...1,SET,178,0.038731,0.003795,0.061979,0.26602,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.925385356821139
GOCC_REPLISOME,SET,22,0.10212,0.003533,0.16345,0.26606,GOCC_REPLISOME,0.9254318755004
REACTOME_SLC_MEDIATED_TRANSM...,SET,235,0.036239,0.0040735,0.058037,0.26618,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,0.925676704318273
HE_LIM_SUN_FETAL_LUNG_C0_MES...3,SET,156,0.046563,0.0042738,0.07458,0.26621,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL,0.925676704318273
YAO_HOXA10_TARGETS_VIA_PROGE...2,SET,75,0.066168,0.0042204,0.10601,0.26627,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,0.925676704318273
GOBP_NEGATIVE_REGULATION_OF_...581,SET,8,0.16687,0.0034826,0.2674,0.2663,GOBP_NEGATIVE_REGULATION_OF_SCHWANN_CELL_PROLIFERATION,0.925676704318273
GOERING_BLOOD_HDL_CHOLESTERO...2,SET,12,0.16469,0.004209,0.26395,0.26634,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS,0.925676704318273
GOCC_SCHMIDT_LANTERMAN_INCIS...,SET,10,0.17881,0.004172,0.2866,0.26635,GOCC_SCHMIDT_LANTERMAN_INCISURE,0.925676704318273
REACTOME_TOLL_LIKE_RECEPTOR_...3,SET,108,0.053112,0.0040615,0.085132,0.26636,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,0.925676704318273
E47_02,SET,222,0.03736,0.0040833,0.059884,0.26636,E47_02,0.925676704318273
GSE4142_PLASMA_CELL_VS_MEMOR...1,SET,184,0.039475,0.003932,0.063282,0.26638,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.925676704318273
MIR3159,SET,84,0.059071,0.0039864,0.094705,0.26641,MIR3159,0.925676704318273
REACTOME_MRNA_DECAY_BY_3_TO_...,SET,12,0.13523,0.0034562,0.21685,0.26644,REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,0.925676704318273
WP_UNFOLDED_PROTEIN_RESPONSE,SET,22,0.11431,0.0039546,0.18331,0.26645,WP_UNFOLDED_PROTEIN_RESPONSE,0.925676704318273
GOBP_REGULATION_OF_EXTENT_OF...,SET,83,0.059132,0.0039668,0.094837,0.26648,GOBP_REGULATION_OF_EXTENT_OF_CELL_GROWTH,0.925688395802099
MIR577,SET,300,0.031081,0.0039404,0.049874,0.26658,MIR577,0.925723778843272
GOBP_POSITIVE_REGULATION_OF_...479,SET,6,0.18014,0.0032559,0.28907,0.26659,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.925723778843272
GSE17974_IL4_AND_ANTI_IL12_V...15,SET,173,0.041088,0.0039696,0.065942,0.26661,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN,0.925723778843272
REACTOME_RHOH_GTPASE_CYCLE,SET,35,0.090011,0.0039263,0.14449,0.26665,REACTOME_RHOH_GTPASE_CYCLE,0.925723778843272
WP_SRF_AND_MIRS_IN_SMOOTH_MU...,SET,10,0.18938,0.0044186,0.30399,0.26665,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,0.925723778843272
GSE17721_POLYIC_VS_CPG_8H_BM...2,SET,180,0.038252,0.0037689,0.061401,0.26665,GSE17721_POLYIC_VS_CPG_8H_BMDC_UP,0.925723778843272
GSE360_LOW_DOSE_B_MALAYI_VS_...1,SET,184,0.039458,0.0039303,0.06335,0.26669,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,0.925735776335497
HP_MULTIPLE_CAFE_AU_LAIT_SPO...,SET,61,0.062683,0.0036071,0.10064,0.26671,HP_MULTIPLE_CAFE_AU_LAIT_SPOTS,0.925735776335497
DESCARTES_FETAL_HEART_CLC_IL...,SET,17,0.13751,0.0041824,0.22084,0.26675,DESCARTES_FETAL_HEART_CLC_IL5RA_POSITIVE_CELLS,0.925735776335497
TORCHIA_TARGETS_OF_EWSR1_FLI...1,SET,291,0.032842,0.0041018,0.052746,0.26676,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.925735776335497
HE_LIM_SUN_FETAL_LUNG_C3_DEF...1,SET,23,0.10622,0.0037573,0.17062,0.26679,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST,0.92574744908147
HP_4_5_TOE_SYNDACTYLY,SET,8,0.20697,0.0043194,0.33249,0.26682,HP_4_5_TOE_SYNDACTYLY,0.925759119496855
GSE36888_STAT5_AB_KNOCKIN_VS...4,SET,169,0.041677,0.0039801,0.066967,0.26686,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP,0.925805480135756
GOBP_POSITIVE_REGULATION_OF_...764,SET,6,0.23159,0.0041858,0.37219,0.2669,GOBP_POSITIVE_REGULATION_OF_TOOTH_MINERALIZATION,0.925851831520112
ABBUD_LIF_SIGNALING_2_DN,SET,7,0.23803,0.0046469,0.38268,0.26697,ABBUD_LIF_SIGNALING_2_DN,0.925909824368825
GOMF_RACEMASE_AND_EPIMERASE_...1,SET,15,0.13268,0.003791,0.21332,0.26697,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY,0.925909824368825
GSE16451_CTRL_VS_WEST_EQUINE...2,SET,178,0.040295,0.0039483,0.064796,0.26702,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.925990830173618
GSE25123_ROSIGLITAZONE_VS_IL...4,SET,178,0.038882,0.0038098,0.062534,0.26705,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.926002469320563
REACTOME_GLUCURONIDATION,SET,23,0.15471,0.0054723,0.24894,0.26715,REACTOME_GLUCURONIDATION,0.926049227318046
MIR656_3P,SET,358,0.028865,0.0039912,0.04646,0.26721,MIR656_3P,0.926049227318046
GOBP_REGULATORY_NCRNA_MEDIAT...2,SET,16,0.12904,0.0038076,0.20772,0.26723,GOBP_REGULATORY_NCRNA_MEDIATED_HETEROCHROMATIN_FORMATION,0.926049227318046
MIR5196_3P,SET,60,0.067751,0.0038667,0.10907,0.26724,MIR5196_3P,0.926049227318046
GSE19401_UNSTIM_VS_RETINOIC_...4,SET,183,0.038724,0.0038467,0.062336,0.26724,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.926049227318046
REACTOME_CYTOSOLIC_IRON_SULF...,SET,10,0.15489,0.0036139,0.24936,0.26725,REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY,0.926049227318046
HP_VIRAL_INFECTION_INDUCED_R...,SET,9,0.16849,0.0037295,0.27125,0.26725,HP_VIRAL_INFECTION_INDUCED_RHABDOMYOLYSIS,0.926049227318046
KORKOLA_SEMINOMA_UP,SET,29,0.11633,0.0046196,0.18736,0.26734,KORKOLA_SEMINOMA_UP,0.926176405502392
GOBP_NEGATIVE_REGULATION_OF_...184,SET,30,0.098268,0.003969,0.15827,0.26734,GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.926176405502392
HP_ABNORMAL_CELLULAR_PHENOTY...,SET,573,0.0217,0.0037733,0.034957,0.26738,HP_ABNORMAL_CELLULAR_PHENOTYPE,0.926188197489039
WP_VITAMIN_DSENSITIVE_CALCIU...,SET,34,0.094931,0.0040814,0.15295,0.26742,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,0.926188197489039
TRAVAGLINI_LUNG_CD8_NAIVE_T_...,SET,131,0.049261,0.0041462,0.079373,0.26743,TRAVAGLINI_LUNG_CD8_NAIVE_T_CELL,0.926188197489039
KEGG_TYPE_I_DIABETES_MELLITUS,SET,39,0.098063,0.0045148,0.15802,0.26745,KEGG_TYPE_I_DIABETES_MELLITUS,0.926188197489039
REACTOME_RAC3_GTPASE_CYCLE,SET,82,0.062267,0.004152,0.10037,0.26752,REACTOME_RAC3_GTPASE_CYCLE,0.926246025104602
NAKAYA_MYELOID_DENDRITIC_CEL...4,SET,337,0.028367,0.0038078,0.045728,0.26752,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.926246025104602
FAN_EMBRYONIC_CTX_IN_4_INTER...,SET,8,0.20806,0.004342,0.33553,0.2676,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.926373062749004
HP_LIMB_GIRDLE_MUSCLE_WEAKNE...,SET,86,0.0561,0.0038305,0.090472,0.26761,HP_LIMB_GIRDLE_MUSCLE_WEAKNESS,0.926373062749004
BIERIE_INFLAMMATORY_RESPONSE...,SET,5,0.29988,0.0049481,0.48373,0.26765,BIERIE_INFLAMMATORY_RESPONSE_TGFB1,0.926419256050194
GSE17721_POLYIC_VS_PAM3CSK4_...13,SET,182,0.037584,0.0037234,0.060663,0.26778,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN,0.926662492581602
GOBP_SISTER_CHROMATID_SEGREG...,SET,218,0.0347,0.0037587,0.056042,0.2679,GOBP_SISTER_CHROMATID_SEGREGATION,0.926662492581602
REACTOME_TRANSPORT_TO_THE_GO...,SET,181,0.038505,0.0038043,0.062205,0.26796,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,0.926662492581602
GCM_LTK,SET,40,0.078629,0.0036661,0.12703,0.26797,GCM_LTK,0.926662492581602
LEE_LIVER_CANCER_DENA_UP,SET,56,0.075153,0.0041442,0.12142,0.26798,LEE_LIVER_CANCER_DENA_UP,0.926662492581602
MIR10392_3P,SET,5,0.222,0.0036631,0.35869,0.26798,MIR10392_3P,0.926662492581602
WU_HBX_TARGETS_3_DN,SET,13,0.15617,0.004154,0.25232,0.26799,WU_HBX_TARGETS_3_DN,0.926662492581602
GSE43955_TH0_VS_TGFB_IL6_TH1...11,SET,190,0.038678,0.0039142,0.062495,0.268,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN,0.926662492581602
REACTOME_CASPASE_ACTIVATION_...3,SET,25,0.10947,0.0040367,0.17688,0.26801,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,0.926662492581602
HP_LATE_YOUNG_ADULT_ONSET,SET,42,0.078937,0.0037712,0.12757,0.26803,HP_LATE_YOUNG_ADULT_ONSET,0.926662492581602
DESCARTES_FETAL_STOMACH_PARI...,SET,36,0.094445,0.004178,0.15273,0.26816,DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS,0.926662492581602
GAO_STOMACH_24W_C2_TFF2POS_M...,SET,6,0.25711,0.0046471,0.41577,0.26816,GAO_STOMACH_24W_C2_TFF2POS_MULTIPOTENT_PROGENITOR,0.926662492581602
GOBP_CHRONIC_INFLAMMATORY_RE...,SET,18,0.13007,0.0040707,0.21036,0.26819,GOBP_CHRONIC_INFLAMMATORY_RESPONSE,0.926662492581602
JONES_OVARY_PERICYTE,SET,151,0.045982,0.0041529,0.074375,0.26821,JONES_OVARY_PERICYTE,0.926662492581602
MIR6859_3P,SET,33,0.091585,0.0038793,0.14816,0.26824,MIR6859_3P,0.926662492581602
GOMF_OLIGOSACCHARYL_TRANSFER...,SET,5,0.244,0.004026,0.39474,0.26825,GOMF_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY,0.926662492581602
HP_CIRRHOSIS,SET,146,0.044127,0.0039194,0.071393,0.26826,HP_CIRRHOSIS,0.926662492581602
GSE22611_MUTANT_NOD2_TRANSDU...2,SET,170,0.040013,0.0038324,0.064739,0.26827,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP,0.926662492581602
HP_NEOPLASM_OF_THE_THYROID_G...,SET,87,0.056701,0.0038939,0.091761,0.26832,HP_NEOPLASM_OF_THE_THYROID_GLAND,0.926662492581602
JIANG_MELANOMA_TRM5_CD8,SET,180,0.040241,0.0039649,0.065131,0.26834,JIANG_MELANOMA_TRM5_CD8,0.926662492581602
ABBUD_LIF_SIGNALING_1_DN,SET,21,0.12504,0.0042264,0.20238,0.26835,ABBUD_LIF_SIGNALING_1_DN,0.926662492581602
HP_ABNORMAL_FACIAL_EXPRESSION,SET,165,0.041585,0.0039245,0.067322,0.26839,HP_ABNORMAL_FACIAL_EXPRESSION,0.926662492581602
TONKS_TARGETS_OF_RUNX1_RUNX1...9,SET,42,0.081451,0.0038912,0.13187,0.2684,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,0.926662492581602
HP_ABNORMAL_SPERM_MOTILITY,SET,93,0.053528,0.0038,0.086679,0.26844,HP_ABNORMAL_SPERM_MOTILITY,0.926662492581602
GSE22935_UNSTIM_VS_48H_MBOVI...1,SET,180,0.039689,0.0039105,0.06427,0.26845,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.926662492581602
HP_TINNITUS,SET,65,0.063648,0.0037804,0.1031,0.2685,HP_TINNITUS,0.926662492581602
GOBP_REGULATION_OF_OOCYTE_MA...,SET,7,0.18606,0.0036324,0.30139,0.26851,GOBP_REGULATION_OF_OOCYTE_MATURATION,0.926662492581602
MIR520G_3P_MIR520H,SET,182,0.038347,0.003799,0.062125,0.26854,MIR520G_3P_MIR520H,0.926662492581602
GSE3982_DC_VS_CENT_MEMORY_CD...2,SET,186,0.03856,0.0038614,0.062483,0.26858,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP,0.926662492581602
GOCC_PRECATALYTIC_SPLICEOSOME,SET,48,0.064703,0.003304,0.10487,0.26863,GOCC_PRECATALYTIC_SPLICEOSOME,0.926662492581602
HP_CHRONIC_PANCREATITIS,SET,4,0.25881,0.0038197,0.41954,0.26865,HP_CHRONIC_PANCREATITIS,0.926662492581602
GSE10273_HIGH_IL7_VS_HIGH_IL...2,SET,182,0.038479,0.003812,0.062374,0.26865,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.926662492581602
MIR660_5P,SET,68,0.065944,0.0040058,0.1069,0.26866,MIR660_5P,0.926662492581602
HE_LIM_SUN_FETAL_LUNG_C2_PLA...,SET,316,0.030073,0.0039113,0.048753,0.26867,HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL,0.926662492581602
MARTINEZ_RB1_TARGETS_DN,SET,496,0.024025,0.0038952,0.038951,0.26868,MARTINEZ_RB1_TARGETS_DN,0.926662492581602
GAVIN_FOXP3_TARGETS_CLUSTER_...3,SET,92,0.058817,0.0041531,0.09537,0.26871,GAVIN_FOXP3_TARGETS_CLUSTER_P4,0.926662492581602
GSE21546_ELK1_KO_VS_SAP1A_KO...3,SET,180,0.036908,0.0036365,0.059843,0.26871,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.926662492581602
GOBP_CELL_MOTILITY,SET,1577,0.014402,0.0040355,0.023355,0.26874,GOBP_CELL_MOTILITY,0.926662492581602
GOBP_NEGATIVE_REGULATION_OF_...191,SET,10,0.15446,0.0036038,0.25058,0.26882,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.926662492581602
SCHEIDEREIT_IKK_INTERACTING_...,SET,52,0.073802,0.0039221,0.11976,0.26886,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,0.926662492581602
GOBP_REGULATION_OF_PROTEIN_M...2,SET,1097,0.016447,0.0038984,0.026692,0.26889,GOBP_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.926662492581602
chr6q26,SET,6,0.26881,0.0048586,0.4364,0.26896,chr6q26,0.926662492581602
GOBP_RESPONSE_TO_STILBENOID,SET,7,0.25199,0.0049193,0.40913,0.26898,GOBP_RESPONSE_TO_STILBENOID,0.926662492581602
GSE18281_MEDULLARY_THYMOCYTE...1,SET,167,0.039673,0.0037665,0.064416,0.26899,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN,0.926662492581602
GSE14415_ACT_VS_CTRL_NATURAL...1,SET,157,0.041845,0.003853,0.067948,0.269,GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN,0.926662492581602
HP_GENERALIZED_LIMB_MUSCLE_A...,SET,18,0.11562,0.0036185,0.18781,0.26907,HP_GENERALIZED_LIMB_MUSCLE_ATROPHY,0.926662492581602
WATANABE_COLON_CANCER_MSI_VS...2,SET,28,0.10261,0.004004,0.16671,0.26912,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,0.926662492581602
GOBP_HINDBRAIN_MORPHOGENESIS,SET,40,0.085444,0.0039838,0.13883,0.26913,GOBP_HINDBRAIN_MORPHOGENESIS,0.926662492581602
GSE16385_ROSIGLITAZONE_IL4_V...6,SET,177,0.041358,0.0040412,0.067217,0.26918,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP,0.926662492581602
WP_ETHANOL_METABOLISM_PRODUC...,SET,9,0.19216,0.0042535,0.31233,0.2692,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.926662492581602
GSE3691_CONVENTIONAL_VS_PLAS...2,SET,188,0.038498,0.0038757,0.062588,0.26925,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP,0.926662492581602
GOBP_RESPONSE_TO_GAMMA_RADIA...,SET,47,0.075032,0.0037914,0.122,0.26928,GOBP_RESPONSE_TO_GAMMA_RADIATION,0.926662492581602
GSE26890_CXCR1_NEG_VS_POS_EF...2,SET,180,0.040185,0.0039594,0.065348,0.2693,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP,0.926662492581602
TONKS_TARGETS_OF_RUNX1_RUNX1...8,SET,191,0.038862,0.0039431,0.0632,0.26931,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,0.926662492581602
COUP_01,SET,235,0.033889,0.0038095,0.055115,0.26932,COUP_01,0.926662492581602
GOBP_EMBRYONIC_CLEAVAGE,SET,8,0.18288,0.0038167,0.29746,0.26934,GOBP_EMBRYONIC_CLEAVAGE,0.926662492581602
REACTOME_FLT3_SIGNALING_BY_C...,SET,6,0.19571,0.0035373,0.31832,0.26935,REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS,0.926662492581602
MIR5001_5P,SET,159,0.039737,0.0036819,0.064643,0.26937,MIR5001_5P,0.926662492581602
HARALAMBIEVA_PBMC_FLUARIX_AG...6,SET,14,0.16565,0.0045726,0.26947,0.26937,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_POSITIVE,0.926662492581602
REACTOME_CYP2E1_REACTIONS,SET,11,0.17189,0.0042062,0.27969,0.26942,REACTOME_CYP2E1_REACTIONS,0.926662492581602
GOMF_HISTONE_CHAPERONE_ACTIV...,SET,12,0.14944,0.0038193,0.24323,0.26948,GOMF_HISTONE_CHAPERONE_ACTIVITY,0.926662492581602
GSE20715_0H_VS_6H_OZONE_TLR4...2,SET,178,0.039203,0.0038413,0.063809,0.26949,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP,0.926662492581602
BIOCARTA_MTA3_PATHWAY,SET,17,0.12501,0.0038023,0.2035,0.26951,BIOCARTA_MTA3_PATHWAY,0.926662492581602
MODULE_16,SET,461,0.024659,0.003858,0.040141,0.26951,MODULE_16,0.926662492581602
MIR4640_5P,SET,118,0.045799,0.0036598,0.07456,0.26953,MIR4640_5P,0.926662492581602
GSE20500_RETINOIC_ACID_VS_RA...2,SET,182,0.039893,0.0039521,0.064946,0.26953,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,0.926662492581602
GSE2405_S_AUREUS_VS_A_PHAGOC...1,SET,189,0.036611,0.0036954,0.059603,0.26953,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN,0.926662492581602
GOBP_AROMATIC_AMINO_ACID_FAM...,SET,16,0.14675,0.0043302,0.23893,0.26955,GOBP_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS,0.926662492581602
MIR1288_3P,SET,36,0.089572,0.0039624,0.14584,0.26956,MIR1288_3P,0.926662492581602
GSE28408_LY6G_POS_VS_NEG_DC_...2,SET,175,0.038849,0.0037747,0.063277,0.26963,GSE28408_LY6G_POS_VS_NEG_DC_UP,0.926788543314873
ZHANG_RESPONSE_TO_IKK_INHIBI...2,SET,213,0.038267,0.0040977,0.062335,0.26965,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,0.926788543314873
GOBP_NEGATIVE_REGULATION_OF_...76,SET,6,0.23131,0.0041808,0.37694,0.26973,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.926971833283892
GOBP_L_ALANINE_TRANSPORT,SET,10,0.17613,0.0041093,0.28709,0.26978,GOBP_L_ALANINE_TRANSPORT,0.926983216368489
GROSS_HYPOXIA_VIA_HIF1A_ONLY,SET,8,0.20639,0.0043072,0.33648,0.26982,GROSS_HYPOXIA_VIA_HIF1A_ONLY,0.926983216368489
MIR422A,SET,37,0.081388,0.00365,0.1327,0.26983,MIR422A,0.926983216368489
MIR4664_5P,SET,76,0.060138,0.0038612,0.098053,0.26984,MIR4664_5P,0.926983216368489
BAKKER_FOXO3_TARGETS_UP,SET,51,0.073381,0.0038621,0.1197,0.26992,BAKKER_FOXO3_TARGETS_UP,0.927166396521052
GOBP_REGULATION_OF_INTRACELL...2,SET,9,0.1708,0.0037808,0.27871,0.26999,GOBP_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.927315194189149
HP_PILOMATRIXOMA,SET,7,0.21471,0.0041917,0.35042,0.27003,HP_PILOMATRIXOMA,0.927360767559024
GOMF_ACETYLCHOLINE_RECEPTOR_...1,SET,22,0.11671,0.0040375,0.1905,0.27006,GOMF_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.927360767559024
MODULE_253,SET,20,0.1126,0.0037143,0.18382,0.27009,MODULE_253,0.927360767559024
WP_RIOK1_AND_RIOK2_IN_EGFR_A...,SET,15,0.14061,0.0040175,0.22958,0.27011,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,0.927360767559024
HP_TISSUE_ISCHEMIA,SET,108,0.053052,0.0040569,0.08664,0.27017,HP_TISSUE_ISCHEMIA,0.927383540740741
GSE20366_EX_VIVO_VS_DEC205_C...2,SET,182,0.038929,0.0038566,0.063578,0.27017,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN,0.927383540740741
NKX25_02,SET,232,0.036645,0.0040932,0.05987,0.27025,NKX25_02,0.927566082708251
GSE3920_UNTREATED_VS_IFNG_TR...2,SET,136,0.045564,0.003907,0.074457,0.27029,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.927566082708251
QI_PLASMACYTOMA_UP,SET,245,0.035108,0.0040285,0.057394,0.27037,QI_PLASMACYTOMA_UP,0.927566082708251
HP_UNICORONAL_SYNOSTOSIS,SET,7,0.2297,0.0044842,0.3755,0.27037,HP_UNICORONAL_SYNOSTOSIS,0.927566082708251
GSE41978_WT_VS_ID2_KO_KLRG1_...2,SET,187,0.03905,0.0039209,0.06384,0.27037,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.927566082708251
MIR4273,SET,94,0.054741,0.0039068,0.089496,0.27039,MIR4273,0.927566082708251
ARHGAP35_TARGET_GENES,SET,87,0.054785,0.0037623,0.089581,0.27041,ARHGAP35_TARGET_GENES,0.927566082708251
DARWICHE_PAPILLOMA_RISK_LOW_...2,SET,148,0.043814,0.0039178,0.07166,0.27047,DARWICHE_PAPILLOMA_RISK_LOW_UP,0.927680336524228
GOBP_REGULATION_OF_HEART_GRO...,SET,55,0.076984,0.0042072,0.12594,0.27051,GOBP_REGULATION_OF_HEART_GROWTH,0.927713823703412
GOBP_REGULATION_OF_OSTEOBLAS...2,SET,26,0.11175,0.0042025,0.18289,0.27058,GOBP_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.927713823703412
KEGG_MEDICUS_PATHOGEN_HPV_E6...2,SET,12,0.15526,0.0039679,0.25412,0.27062,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381,0.927713823703412
GSE37532_VISCERAL_ADIPOSE_TI...3,SET,120,0.045622,0.0036762,0.074674,0.27062,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN,0.927713823703412
HP_PROLONGED_BLEEDING_AFTER_...1,SET,21,0.13057,0.0044134,0.21375,0.27065,HP_PROLONGED_BLEEDING_AFTER_DENTAL_EXTRACTION,0.927713823703412
HALLMARK_DNA_REPAIR,SET,136,0.041016,0.003517,0.067156,0.27068,HALLMARK_DNA_REPAIR,0.927713823703412
REACTOME_MYD88_INDEPENDENT_T...,SET,103,0.051976,0.0038821,0.085102,0.27069,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,0.927713823703412
DESCARTES_FETAL_LIVER_HEPATO...,SET,378,0.029477,0.0041858,0.048269,0.27071,DESCARTES_FETAL_LIVER_HEPATOBLASTS,0.927713823703412
E2F3_UP.V1_UP,SET,175,0.039265,0.0038151,0.0643,0.27072,E2F3_UP.V1_UP,0.927713823703412
XIE_LT_HSC_S1PR3_OE_UP,SET,26,0.11027,0.0041465,0.18066,0.27082,XIE_LT_HSC_S1PR3_OE_UP,0.927850586495811
REACTOME_PLATELET_SENSITIZAT...,SET,16,0.13003,0.0038369,0.21304,0.27082,REACTOME_PLATELET_SENSITIZATION_BY_LDL,0.927850586495811
DORSEY_GAB2_TARGETS,SET,27,0.1113,0.0042649,0.18237,0.27084,DORSEY_GAB2_TARGETS,0.927850586495811
GOMF_SNRNP_BINDING,SET,9,0.1596,0.0035328,0.26159,0.2709,GOMF_SNRNP_BINDING,0.927964665878178
GOMF_4_IRON_4_SULFUR_CLUSTER...,SET,44,0.075998,0.003716,0.12461,0.27098,GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING,0.928009862068966
GOMF_GLYCINE_N_ACYLTRANSFERA...,SET,4,0.37067,0.0054706,0.60783,0.27099,GOMF_GLYCINE_N_ACYLTRANSFERASE_ACTIVITY,0.928009862068966
chr3q24,SET,15,0.20741,0.005926,0.34016,0.27102,chr3q24,0.928009862068966
HP_DIAPHRAGMATIC_EVENTRATION,SET,18,0.11583,0.003625,0.18996,0.27102,HP_DIAPHRAGMATIC_EVENTRATION,0.928009862068966
RUBENSTEIN_SKELETAL_MUSCLE_S...1,SET,264,0.031888,0.0037961,0.052313,0.27108,RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS,0.92806668144208
GOMF_1_PHOSPHATIDYLINOSITOL_...4,SET,7,0.20454,0.0039932,0.33557,0.27109,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY,0.92806668144208
GOBP_REGULATION_OF_PRESYNAPT...2,SET,28,0.10873,0.0042431,0.17843,0.27114,GOBP_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.928100531757755
MIR1911_5P,SET,24,0.10128,0.0036596,0.16623,0.27116,MIR1911_5P,0.928100531757755
HP_RADIAL_DEVIATION_OF_THE_2...,SET,6,0.23173,0.0041884,0.38034,0.27118,HP_RADIAL_DEVIATION_OF_THE_2ND_FINGER,0.928100531757755
PID_P73PATHWAY,SET,76,0.055066,0.0035355,0.090419,0.27126,PID_P73PATHWAY,0.92828291650256
HP_ABNORMAL_LIVER_METABOLITE...,SET,181,0.037503,0.0037052,0.061594,0.27131,HP_ABNORMAL_LIVER_METABOLITE_CONCENTRATION,0.92836261199173
MODULE_107,SET,73,0.064405,0.004053,0.10582,0.2714,MODULE_107,0.928441806908769
chr5q34,SET,12,0.2241,0.0057274,0.36829,0.27143,chr5q34,0.928441806908769
ROSTY_CERVICAL_CANCER_PROLIF...,SET,130,0.042881,0.0035955,0.070468,0.27143,ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,0.928441806908769
GENTILE_UV_RESPONSE_CLUSTER_...6,SET,30,0.093542,0.0037781,0.15373,0.27144,GENTILE_UV_RESPONSE_CLUSTER_D7,0.928441806908769
GOBP_POSITIVE_REGULATION_OF_...45,SET,29,0.1003,0.0039832,0.16493,0.27154,GOBP_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS,0.928574432989691
GAO_LARGE_INTESTINE_ADULT_CA...,SET,260,0.034119,0.0040314,0.056113,0.27158,GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS,0.928574432989691
MIR378E,SET,37,0.080747,0.0036212,0.13283,0.27163,MIR378E,0.928574432989691
REACTOME_INACTIVATION_OF_CDC...,SET,8,0.19874,0.0041476,0.32703,0.27169,REACTOME_INACTIVATION_OF_CDC42_AND_RAC1,0.928574432989691
MIR4490,SET,95,0.053341,0.003827,0.087772,0.27169,MIR4490,0.928574432989691
HP_INFANTILE_SENSORINEURAL_H...,SET,5,0.22049,0.0036381,0.36291,0.27174,HP_INFANTILE_SENSORINEURAL_HEARING_IMPAIRMENT,0.928574432989691
RIZKI_TUMOR_INVASIVENESS_3D_...2,SET,186,0.037949,0.0038002,0.062464,0.27175,RIZKI_TUMOR_INVASIVENESS_3D_UP,0.928574432989691
GOBP_POSITIVE_REGULATION_OF_...496,SET,30,0.10156,0.0041018,0.16717,0.27176,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.928574432989691
GSE5589_LPS_VS_LPS_AND_IL10_...6,SET,184,0.03669,0.0036545,0.060405,0.2718,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP,0.928574432989691
GOBP_RETROTRANSPOSON_SILENCI...,SET,15,0.12323,0.003521,0.20293,0.27184,GOBP_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.928574432989691
REACTOME_PINK1_PRKN_MEDIATED...,SET,28,0.095936,0.0037436,0.15798,0.27185,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,0.928574432989691
GOMF_ADENYLATE_CYCLASE_REGUL...,SET,8,0.18708,0.0039042,0.30811,0.27187,GOMF_ADENYLATE_CYCLASE_REGULATOR_ACTIVITY,0.928574432989691
GOBP_DEVELOPMENT_OF_SECONDAR...2,SET,9,0.19747,0.0043711,0.32526,0.27189,GOBP_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS,0.928574432989691
GOBP_FEEDING_BEHAVIOR,SET,97,0.059047,0.0042806,0.097256,0.27189,GOBP_FEEDING_BEHAVIOR,0.928574432989691
HP_DECREASED_SPECIFIC_ANTIBO...2,SET,3,0.37168,0.0047508,0.61229,0.27192,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_CONJUGATED_POLYSACCHARIDE_VACCINE,0.928574432989691
HP_POOR_GROSS_MOTOR_COORDINA...,SET,12,0.16259,0.0041553,0.26784,0.27192,HP_POOR_GROSS_MOTOR_COORDINATION,0.928574432989691
WP_PTF1A_RELATED_REGULATORY_...,SET,11,0.17628,0.0043136,0.29055,0.27202,WP_PTF1A_RELATED_REGULATORY_PATHWAY,0.928574432989691
GOMF_GLYCOSAMINOGLYCAN_BINDI...,SET,225,0.038245,0.0042078,0.063044,0.27205,GOMF_GLYCOSAMINOGLYCAN_BINDING,0.928574432989691
HP_VERY_LONG_CHAIN_FATTY_ACI...,SET,15,0.13077,0.0037362,0.21557,0.27205,HP_VERY_LONG_CHAIN_FATTY_ACID_ACCUMULATION,0.928574432989691
MIR148A_5P,SET,102,0.051875,0.0038558,0.085523,0.27207,MIR148A_5P,0.928574432989691
GOBP_REGULATION_OF_CEREBELLA...,SET,9,0.17965,0.0039764,0.29616,0.27207,GOBP_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,0.928574432989691
BECKER_TAMOXIFEN_RESISTANCE_...2,SET,51,0.076085,0.0040045,0.12547,0.27212,BECKER_TAMOXIFEN_RESISTANCE_UP,0.928574432989691
MODULE_444,SET,17,0.14302,0.0043499,0.23583,0.27212,MODULE_444,0.928574432989691
HP_CARPAL_SYNOSTOSIS,SET,33,0.098568,0.0041751,0.16254,0.27212,HP_CARPAL_SYNOSTOSIS,0.928574432989691
MODULE_433,SET,59,0.077352,0.0043779,0.12761,0.27221,MODULE_433,0.928606959976457
GSE12845_IGD_NEG_BLOOD_VS_DA...1,SET,182,0.035505,0.0035174,0.058576,0.27222,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.928606959976457
GOBP_REGULATION_OF_PROTEIN_B...,SET,111,0.048285,0.003743,0.079676,0.27226,GOBP_REGULATION_OF_PROTEIN_BINDING,0.928606959976457
REACTOME_SYNTHESIS_OF_BILE_A...1,SET,33,0.093756,0.0039713,0.15472,0.27227,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,0.928606959976457
GSE14386_UNTREATED_VS_IFNA_T...2,SET,126,0.048542,0.0040075,0.080123,0.27231,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP,0.928606959976457
GSE5099_UNSTIM_VS_MCSF_TREAT...2,SET,177,0.03806,0.0037189,0.062824,0.27232,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP,0.928606959976457
GSE24142_EARLY_THYMIC_PROGEN...3,SET,183,0.038027,0.0037775,0.062777,0.27235,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN,0.928606959976457
WP_DISORDERS_OF_BILE_ACID_SY...,SET,29,0.098205,0.0038999,0.16213,0.27236,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,0.928606959976457
LXR_Q3,SET,73,0.059123,0.0037206,0.097614,0.27237,LXR_Q3,0.928606959976457
GOBP_NEGATIVE_REGULATION_OF_...517,SET,70,0.058665,0.0036154,0.096898,0.27245,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.928723103212577
TRAVAGLINI_LUNG_MESOTHELIAL_...,SET,580,0.022071,0.0038604,0.036459,0.27247,TRAVAGLINI_LUNG_MESOTHELIAL_CELL,0.928723103212577
GSE37533_UNTREATED_VS_PIOGLI...3,SET,180,0.03837,0.0037805,0.063409,0.27256,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.928723103212577
GSE37605_FOXP3_FUSION_GFP_VS...2,SET,174,0.041549,0.0040256,0.068665,0.27256,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP,0.928723103212577
REACTOME_CELL_CYCLE_MITOTIC,SET,469,0.022933,0.0036183,0.037913,0.27263,REACTOME_CELL_CYCLE_MITOTIC,0.928723103212577
SWEET_KRAS_TARGETS_DN,SET,56,0.073938,0.0040772,0.12232,0.27277,SWEET_KRAS_TARGETS_DN,0.928723103212577
MIR383_5P,SET,70,0.061233,0.0037737,0.10132,0.2728,MIR383_5P,0.928723103212577
GSE17721_0.5H_VS_4H_PAM3CSK4...2,SET,181,0.038434,0.0037972,0.063605,0.27284,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP,0.928723103212577
REACTOME_SEROTONIN_NEUROTRAN...,SET,16,0.13375,0.0039468,0.22139,0.27287,REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE,0.928723103212577
MIR6824_3P,SET,99,0.050289,0.0036828,0.083245,0.27289,MIR6824_3P,0.928723103212577
HP_COARCTATION_OF_AORTA,SET,128,0.045203,0.0037612,0.074827,0.27289,HP_COARCTATION_OF_AORTA,0.928723103212577
GSE24634_TEFF_VS_TCONV_DAY10...1,SET,185,0.039126,0.0039076,0.064778,0.27293,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN,0.928723103212577
HP_PERIANAL_ABSCESS,SET,8,0.19979,0.0041696,0.33082,0.27295,HP_PERIANAL_ABSCESS,0.928723103212577
MIR1238_5P_MIR4758_5P,SET,43,0.080307,0.0038819,0.13299,0.27297,MIR1238_5P_MIR4758_5P,0.928723103212577
GSE43955_TH0_VS_TGFB_IL6_TH1...8,SET,191,0.039466,0.0040044,0.065371,0.27302,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP,0.928723103212577
GOBP_AXON_CHOICE_POINT_RECOG...,SET,7,0.24369,0.0047573,0.40369,0.27304,GOBP_AXON_CHOICE_POINT_RECOGNITION,0.928723103212577
CHIANG_LIVER_CANCER_SUBCLASS...5,SET,24,0.11379,0.0041113,0.1885,0.27305,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,0.928723103212577
HP_PHOTOSENSITIVE_MYOCLONIC_...,SET,7,0.20604,0.0040224,0.34139,0.27308,HP_PHOTOSENSITIVE_MYOCLONIC_SEIZURE,0.928723103212577
GSE29949_DC_BRAIN_VS_MONOCYT...1,SET,178,0.039475,0.0038679,0.065417,0.27311,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.928723103212577
HP_PSYCHIC_EPILEPTIC_AURA,SET,10,0.15898,0.0037092,0.26354,0.27318,HP_PSYCHIC_EPILEPTIC_AURA,0.928723103212577
DESCARTES_MAIN_FETAL_INHIBIT...1,SET,25,0.11758,0.0043359,0.19493,0.27319,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.928723103212577
BIOCARTA_VOBESITY_PATHWAY,SET,8,0.2042,0.0042616,0.3386,0.27323,BIOCARTA_VOBESITY_PATHWAY,0.928723103212577
HP_SPARSE_OR_ABSENT_EYELASHES,SET,80,0.058847,0.003876,0.097578,0.27323,HP_SPARSE_OR_ABSENT_EYELASHES,0.928723103212577
GOBP_PHOTORECEPTOR_CELL_DIFF...,SET,63,0.068756,0.0040207,0.11401,0.27324,GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.928723103212577
GOBP_SARCOMERE_ORGANIZATION,SET,50,0.073764,0.0038442,0.12232,0.27324,GOBP_SARCOMERE_ORGANIZATION,0.928723103212577
GOMF_HYDROLASE_ACTIVITY_HYDR...2,SET,83,0.058112,0.0038984,0.096366,0.27325,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS,0.928723103212577
MOOTHA_GLUCONEOGENESIS,SET,27,0.093316,0.0035759,0.15476,0.27326,MOOTHA_GLUCONEOGENESIS,0.928723103212577
GSE24726_WT_VS_E2_22_KO_PDC_...,SET,177,0.038428,0.0037549,0.063735,0.27328,GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN,0.928723103212577
GSE17721_CTRL_VS_PAM3CSK4_6H...2,SET,178,0.038512,0.0037736,0.063883,0.27331,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP,0.928723103212577
GSE19888_ADENOSINE_A3R_INH_V...1,SET,179,0.039215,0.0038532,0.06506,0.27334,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN,0.928723103212577
E2F_Q6,SET,209,0.035023,0.0037153,0.058129,0.27343,E2F_Q6,0.928723103212577
STEGER_ADIPOGENESIS_UP,SET,21,0.11959,0.0040423,0.19853,0.27346,STEGER_ADIPOGENESIS_UP,0.928723103212577
GOBP_PEPTIDE_MODIFICATION,SET,5,0.23315,0.003847,0.38704,0.27346,GOBP_PEPTIDE_MODIFICATION,0.928723103212577
GOBP_CELLULAR_RESPONSE_TO_SA...1,SET,6,0.21943,0.0039661,0.3643,0.27348,GOBP_CELLULAR_RESPONSE_TO_SALT,0.928723103212577
GOBP_REGULATION_OF_PHOSPHATI...3,SET,4,0.24319,0.0035891,0.40379,0.2735,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.928723103212577
GOBP_REGULATION_OF_HIGH_DENS...,SET,4,0.25012,0.0036915,0.41532,0.27351,GOBP_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.928723103212577
GSE21033_3H_VS_24H_POLYIC_ST...1,SET,108,0.047173,0.0036073,0.078329,0.27351,GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN,0.928723103212577
chr11q12,SET,178,0.087776,0.0086007,0.14576,0.27353,chr11q12,0.928723103212577
GOBP_TELOMERE_MAINTENANCE_VI...3,SET,74,0.055318,0.0035048,0.09186,0.27353,GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.928723103212577
EVI1_06,SET,19,0.11637,0.0037415,0.19329,0.27358,EVI1_06,0.928723103212577
GOBP_POSITIVE_REGULATION_OF_...390,SET,27,0.10109,0.0038739,0.16793,0.27359,GOBP_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,0.928723103212577
GOMF_VITAMIN_TRANSMEMBRANE_T...,SET,33,0.092969,0.0039379,0.15444,0.2736,GOMF_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.928723103212577
GENTLES_LEUKEMIC_STEM_CELL_DN,SET,16,0.13251,0.00391,0.22014,0.27362,GENTLES_LEUKEMIC_STEM_CELL_DN,0.928723103212577
GOBP_REGULATION_OF_PHOSPHORU...,SET,1027,0.016809,0.0038628,0.027928,0.27363,GOBP_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.928723103212577
GSE21546_UNSTIM_VS_ANTI_CD3_...4,SET,160,0.042189,0.0039212,0.0701,0.27364,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP,0.928723103212577
KEGG_MEDICUS_VARIANT_MUTATIO...17,SET,7,0.18572,0.0036256,0.30861,0.27366,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY,0.928723103212577
GSE36826_NORMAL_VS_STAPH_AUR...2,SET,187,0.038055,0.003821,0.063236,0.27366,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP,0.928723103212577
HP_SPINAL_CANAL_STENOSIS,SET,35,0.088309,0.003852,0.14679,0.27372,HP_SPINAL_CANAL_STENOSIS,0.928765857226448
KEGG_MEDICUS_REFERENCE_PURIN...1,SET,11,0.15138,0.0037043,0.25164,0.27373,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP,0.928765857226448
HP_CHONDROCALCINOSIS,SET,21,0.12765,0.0043148,0.21233,0.27385,HP_CHONDROCALCINOSIS,0.928765857226448
GOBP_DISACCHARIDE_METABOLIC_...,SET,11,0.15666,0.0038334,0.26058,0.27386,GOBP_DISACCHARIDE_METABOLIC_PROCESS,0.928765857226448
GSE35825_UNTREATED_VS_IFNA_S...1,SET,159,0.04218,0.0039082,0.07016,0.27386,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN,0.928765857226448
GSE17721_CTRL_VS_CPG_12H_BMD...1,SET,184,0.03731,0.0037163,0.062066,0.27388,GSE17721_CTRL_VS_CPG_12H_BMDC_DN,0.928765857226448
GSE3982_CTRL_VS_LPS_4H_MAC_UP,SET,177,0.035977,0.0035153,0.059859,0.27392,GSE3982_CTRL_VS_LPS_4H_MAC_UP,0.928765857226448
GOBP_NEGATIVE_REGULATION_OF_...595,SET,20,0.12844,0.004237,0.21372,0.27393,GOBP_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.928765857226448
ZHANG_RESPONSE_TO_CANTHARIDI...2,SET,14,0.14001,0.0038649,0.23302,0.27396,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,0.928765857226448
GSE22601_DOUBLE_POSITIVE_VS_...3,SET,183,0.036949,0.0036704,0.061493,0.27397,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.928765857226448
GOBP_MONOATOMIC_ION_TRANSMEM...,SET,904,0.018309,0.0039615,0.030475,0.27399,GOBP_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.928765857226448
GCTCTTG_MIR335,SET,80,0.05325,0.0035074,0.088638,0.274,GCTCTTG_MIR335,0.928765857226448
REACTOME_WNT_LIGAND_BIOGENES...,SET,24,0.1142,0.0041261,0.1901,0.27402,REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,0.928765857226448
SOX9_B1,SET,213,0.036629,0.0039224,0.060997,0.27409,SOX9_B1,0.928855840483619
GOMF_DISULFIDE_OXIDOREDUCTAS...,SET,37,0.081139,0.0036388,0.13513,0.2741,GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.928855840483619
REACTOME_NEF_MEDIATED_CD8_DO...,SET,7,0.1887,0.0036838,0.31433,0.27415,REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION,0.92893470312957
WANG_NEOPLASTIC_TRANSFORMATI...,SET,17,0.14922,0.0045385,0.24862,0.2742,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,0.928967953216374
NABA_COLLAGENS,SET,42,0.087392,0.0041751,0.14564,0.27424,NABA_COLLAGENS,0.928967953216374
REACTOME_COLLAGEN_CHAIN_TRIM...,SET,42,0.087392,0.0041751,0.14564,0.27424,REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,0.928967953216374
REACTOME_CASPASE_ACTIVATION_...2,SET,9,0.17873,0.0039563,0.298,0.27433,REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,0.929182258064516
KEGG_MEDICUS_VARIANT_SCRAPIE...4,SET,16,0.13073,0.0038576,0.21806,0.27441,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM,0.929271376388077
GOBP_3_PHOSPHOADENOSINE_5_PH...,SET,15,0.14803,0.0042294,0.24693,0.27443,GOBP_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS,0.929271376388077
PID_PI3K_PLC_TRK_PATHWAY,SET,36,0.08813,0.0038986,0.14702,0.27444,PID_PI3K_PLC_TRK_PATHWAY,0.929271376388077
MIR4758_3P,SET,50,0.065612,0.0034193,0.10948,0.27448,MIR4758_3P,0.929271376388077
GSE4748_CYANOBACTERIUM_LPSLI...2,SET,166,0.041822,0.0039587,0.069784,0.27449,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.929271376388077
MIR376B_5P_MIR376C_5P,SET,44,0.079284,0.0038766,0.13234,0.27456,MIR376B_5P_MIR376C_5P,0.929361156018699
HFH4_01,SET,180,0.040032,0.0039443,0.066825,0.27457,HFH4_01,0.929361156018699
GOBP_POSITIVE_REGULATION_OF_...274,SET,33,0.091908,0.003893,0.15348,0.27465,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.929404510948905
GOMF_BETA_2_MICROGLOBULIN_BI...,SET,8,0.19007,0.0039667,0.31746,0.27468,GOMF_BETA_2_MICROGLOBULIN_BINDING,0.929404510948905
chr8p21,SET,79,0.11731,0.0076784,0.19594,0.27469,chr8p21,0.929404510948905
KAECH_DAY15_EFF_VS_MEMORY_CD...2,SET,186,0.037862,0.0037915,0.063245,0.2747,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP,0.929404510948905
GSE22886_NEUTROPHIL_VS_MONOC...2,SET,169,0.040983,0.0039139,0.068473,0.27475,GSE22886_NEUTROPHIL_VS_MONOCYTE_UP,0.929404510948905
DAZARD_RESPONSE_TO_UV_SCC_UP,SET,88,0.05509,0.0038048,0.092049,0.27476,DAZARD_RESPONSE_TO_UV_SCC_UP,0.929404510948905
HP_ABNORMALITY_OF_PERIPHERAL...,SET,129,0.043826,0.0036607,0.073231,0.27477,HP_ABNORMALITY_OF_PERIPHERAL_NERVE_CONDUCTION,0.929404510948905
GSE339_CD4POS_VS_CD8POS_DC_I...1,SET,180,0.036456,0.0035919,0.060939,0.27485,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN,0.929539010507881
GOCC_LAMIN_FILAMENT,SET,5,0.21699,0.0035804,0.36281,0.27489,GOCC_LAMIN_FILAMENT,0.929539010507881
HP_OVERGROWTH_OF_EXTERNAL_GE...,SET,9,0.19152,0.0042392,0.32021,0.27489,HP_OVERGROWTH_OF_EXTERNAL_GENITALIA,0.929539010507881
GOBP_POSITIVE_REGULATION_OF_...650,SET,27,0.094223,0.0036106,0.15757,0.27494,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.929561016536965
GOBP_MIRNA_METABOLIC_PROCESS,SET,92,0.053021,0.0037438,0.088678,0.27495,GOBP_MIRNA_METABOLIC_PROCESS,0.929561016536965
GOBP_NEGATIVE_REGULATION_OF_...690,SET,10,0.17308,0.0040383,0.28958,0.27502,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.929594009530293
REACTOME_OTHER_INTERLEUKIN_S...,SET,24,0.10807,0.0039048,0.18082,0.27503,REACTOME_OTHER_INTERLEUKIN_SIGNALING,0.929594009530293
GOBP_REGULATION_OF_MEIOTIC_C...1,SET,63,0.063061,0.0036876,0.10551,0.27504,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.929594009530293
GOBP_ERYTHROSE_4_PHOSPHATE_P...,SET,17,0.13432,0.0040853,0.22478,0.27507,GOBP_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.929605002917153
HP_MISCARRIAGE,SET,32,0.096338,0.0040184,0.16129,0.27516,HP_MISCARRIAGE,0.929784269175108
HALLMARK_UNFOLDED_PROTEIN_RE...,SET,104,0.049285,0.0036988,0.082526,0.27519,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.929784269175108
MIR5695,SET,87,0.055908,0.0038395,0.093629,0.27522,MIR5695,0.929784269175108
GOMF_L_ASPARTATE_TRANSMEMBRA...,SET,9,0.16458,0.003643,0.27566,0.27525,GOMF_L_ASPARTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.929784269175108
GOBP_SPINAL_CORD_DEVELOPMENT,SET,93,0.057459,0.0040791,0.09626,0.27529,GOBP_SPINAL_CORD_DEVELOPMENT,0.929784269175108
SHIN_B_CELL_LYMPHOMA_CLUSTER...5,SET,10,0.18764,0.004378,0.31438,0.2753,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,0.929784269175108
GOMF_RACEMASE_AND_EPIMERASE_...2,SET,9,0.16118,0.0035678,0.27011,0.27535,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES,0.929784269175108
GSE17974_IL4_AND_ANTI_IL12_V...11,SET,163,0.040984,0.0038445,0.068691,0.27538,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN,0.929784269175108
GOBP_GLAND_MORPHOGENESIS,SET,121,0.050011,0.0040466,0.083824,0.27539,GOBP_GLAND_MORPHOGENESIS,0.929784269175108
GOBP_REGULATION_OF_CD4_POSIT...3,SET,4,0.28525,0.0042099,0.47819,0.27542,GOBP_REGULATION_OF_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.929784269175108
GOBP_CGAS_STING_SIGNALING_PA...,SET,15,0.11648,0.003328,0.19529,0.27544,GOBP_CGAS_STING_SIGNALING_PATHWAY,0.929784269175108
GOMF_DICARBOXYLIC_ACID_TRANS...,SET,30,0.091335,0.003689,0.15316,0.27547,GOMF_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.929784269175108
HP_INFECTION_FOLLOWING_LIVE_...,SET,20,0.11962,0.0039458,0.2006,0.27549,HP_INFECTION_FOLLOWING_LIVE_VACCINATION,0.929784269175108
XU_CREBBP_TARGETS_UP,SET,20,0.10743,0.0035436,0.1802,0.27555,XU_CREBBP_TARGETS_UP,0.929784269175108
REACTOME_PROTON_COUPLED_MONO...,SET,6,0.23228,0.0041984,0.38965,0.27555,REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT,0.929784269175108
GSE43260_BTLA_POS_VS_NEG_INT...2,SET,182,0.037966,0.0037613,0.0637,0.27559,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP,0.929784269175108
GOBP_POSITIVE_REGULATION_OF_...280,SET,9,0.1815,0.0040176,0.30459,0.27563,GOBP_POSITIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.929784269175108
GOBP_NEGATIVE_REGULATION_OF_...659,SET,11,0.15498,0.0037924,0.26015,0.27568,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.929784269175108
MIR1282,SET,10,0.16602,0.0038736,0.27871,0.2757,MIR1282,0.929784269175108
DEMAGALHAES_AGING_UP,SET,48,0.074,0.0037788,0.12425,0.27574,DEMAGALHAES_AGING_UP,0.929784269175108
GSE3982_BCELL_VS_NKCELL_DN,SET,171,0.040297,0.0038708,0.067708,0.27587,GSE3982_BCELL_VS_NKCELL_DN,0.929784269175108
MIR12125,SET,101,0.051757,0.0038282,0.086993,0.27594,MIR12125,0.929784269175108
MODULE_267,SET,14,0.13216,0.003648,0.2222,0.276,MODULE_267,0.929784269175108
GOBP_CLATHRIN_DEPENDENT_ENDO...,SET,47,0.072985,0.003688,0.12272,0.27602,GOBP_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.929784269175108
chr8q23,SET,16,0.22812,0.0067314,0.38365,0.27605,chr8q23,0.929784269175108
GOMF_POLY_A_BINDING,SET,21,0.11304,0.0038208,0.19014,0.27609,GOMF_POLY_A_BINDING,0.929784269175108
GOBP_C21_STEROID_HORMONE_BIO...,SET,19,0.12559,0.004038,0.2113,0.27614,GOBP_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.929784269175108
GSE21927_SPLENIC_C26GM_TUMOR...2,SET,151,0.040575,0.0036645,0.068278,0.27617,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP,0.929784269175108
HP_DIMINISHED_MOTIVATION,SET,563,0.021776,0.0037543,0.036652,0.27622,HP_DIMINISHED_MOTIVATION,0.929784269175108
HP_ABNORMAL_MORPHOLOGY_OF_MU...,SET,4,0.22984,0.0033921,0.38693,0.27626,HP_ABNORMAL_MORPHOLOGY_OF_MUSCULATURE_OF_PHARYNX,0.929784269175108
HP_ABNORMAL_VOCAL_CORD_MORPH...,SET,4,0.22984,0.0033921,0.38693,0.27626,HP_ABNORMAL_VOCAL_CORD_MORPHOLOGY,0.929784269175108
MIR6762_5P,SET,54,0.068067,0.003686,0.11463,0.27632,MIR6762_5P,0.929784269175108
NAKAYA_PBMC_IMUVAC_MALE_AGE_...,SET,38,0.083376,0.0037892,0.14041,0.27633,NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP,0.929784269175108
REACTOME_RHOBTB1_GTPASE_CYCLE,SET,22,0.098156,0.0033957,0.16533,0.27636,REACTOME_RHOBTB1_GTPASE_CYCLE,0.929784269175108
MORF_RPA2,SET,173,0.036159,0.0034934,0.060906,0.27637,MORF_RPA2,0.929784269175108
GOBP_POSITIVE_REGULATION_OF_...180,SET,35,0.095762,0.0041771,0.16132,0.27639,GOBP_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY,0.929784269175108
HP_MICROGRAPHIA,SET,13,0.14871,0.0039556,0.25051,0.27639,HP_MICROGRAPHIA,0.929784269175108
HORIUCHI_WTAP_TARGETS_DN,SET,284,0.02967,0.0036615,0.049991,0.27642,HORIUCHI_WTAP_TARGETS_DN,0.929784269175108
GOBP_CELL_REDOX_HOMEOSTASIS,SET,34,0.086552,0.0037212,0.14583,0.27642,GOBP_CELL_REDOX_HOMEOSTASIS,0.929784269175108
REACTOME_BACTERIAL_INFECTION...,SET,67,0.061457,0.0037058,0.10356,0.27644,REACTOME_BACTERIAL_INFECTION_PATHWAYS,0.929784269175108
PID_NECTIN_PATHWAY,SET,26,0.10642,0.004002,0.17934,0.27645,PID_NECTIN_PATHWAY,0.929784269175108
GGCACTT_MIR519E,SET,109,0.048426,0.0037202,0.081611,0.27647,GGCACTT_MIR519E,0.929784269175108
REACTOME_TGFBR3_PTM_REGULATI...,SET,9,0.17268,0.0038222,0.29103,0.27648,REACTOME_TGFBR3_PTM_REGULATION,0.929784269175108
HP_PAIN_INSENSITIVITY,SET,26,0.09939,0.0037376,0.16754,0.27651,HP_PAIN_INSENSITIVITY,0.929784269175108
HP_GLUTARIC_ACIDURIA,SET,7,0.18288,0.0035703,0.30831,0.27653,HP_GLUTARIC_ACIDURIA,0.929784269175108
GOBP_REGULATION_OF_PH,SET,95,0.051784,0.0037153,0.087315,0.27657,GOBP_REGULATION_OF_PH,0.929784269175108
NAKAYA_PLASMACYTOID_DENDRITI...4,SET,1082,0.015212,0.0035824,0.025649,0.27657,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.929784269175108
DESCARTES_FETAL_HEART_ELF3_A...,SET,34,0.088602,0.0038093,0.1494,0.27658,DESCARTES_FETAL_HEART_ELF3_AGBL2_POSITIVE_CELLS,0.929784269175108
GSE28783_CTRL_ANTI_MIR_VS_UN...2,SET,171,0.038036,0.0036536,0.064148,0.27662,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.929784269175108
HP_INTERMEDIATE_YOUNG_ADULT_...,SET,19,0.11207,0.0036034,0.18902,0.27663,HP_INTERMEDIATE_YOUNG_ADULT_ONSET,0.929784269175108
HP_ACUTE_MYELOID_LEUKEMIA,SET,68,0.060559,0.0036787,0.10216,0.27667,HP_ACUTE_MYELOID_LEUKEMIA,0.929784269175108
GOMF_NEUROTROPHIN_BINDING,SET,9,0.18972,0.0041994,0.32006,0.27668,GOMF_NEUROTROPHIN_BINDING,0.929784269175108
GOBP_THYROID_HORMONE_MEDIATE...,SET,7,0.20621,0.0040258,0.34791,0.27669,GOBP_THYROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.929784269175108
ZIC3_01,SET,235,0.033565,0.003773,0.056656,0.27678,ZIC3_01,0.929784269175108
CREBP1_Q2,SET,231,0.03331,0.0037127,0.056234,0.27681,CREBP1_Q2,0.929784269175108
REACTOME_IKBA_VARIANT_LEADS_...,SET,6,0.19207,0.0034716,0.32426,0.27682,REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID,0.929784269175108
GOBP_POST_EMBRYONIC_EYE_MORP...,SET,7,0.2106,0.0041113,0.35564,0.27687,GOBP_POST_EMBRYONIC_EYE_MORPHOGENESIS,0.929784269175108
ZHAN_MULTIPLE_MYELOMA_SPIKED,SET,20,0.12126,0.004,0.20479,0.27689,ZHAN_MULTIPLE_MYELOMA_SPIKED,0.929784269175108
HP_DEFORMED_TARSAL_BONES,SET,13,0.16785,0.0044649,0.28349,0.2769,HP_DEFORMED_TARSAL_BONES,0.929784269175108
GOBP_TRNA_AMINOACYLATION_FOR...,SET,7,0.16297,0.0031816,0.27528,0.27692,GOBP_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION,0.929784269175108
HP_POLYCYTHEMIA,SET,22,0.11115,0.0038454,0.18778,0.27695,HP_POLYCYTHEMIA,0.929784269175108
WP_NANOPARTICLE_TRIGGERED_AU...,SET,22,0.1078,0.0037294,0.18217,0.27701,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,0.929784269175108
MIR23B_5P,SET,43,0.079726,0.0038538,0.13475,0.27704,MIR23B_5P,0.929784269175108
MODULE_130,SET,18,0.13527,0.0042335,0.22864,0.27705,MODULE_130,0.929784269175108
GGATTA_PITX2_Q2,SET,522,0.023785,0.0039531,0.040208,0.27708,GGATTA_PITX2_Q2,0.929784269175108
REACTOME_CA_DEPENDENT_EVENTS,SET,35,0.095448,0.0041634,0.16137,0.2771,REACTOME_CA_DEPENDENT_EVENTS,0.929784269175108
HP_FRAGILE_NAILS,SET,23,0.10347,0.00366,0.17495,0.27712,HP_FRAGILE_NAILS,0.929784269175108
GOBP_GERMINAL_CENTER_B_CELL_...,SET,8,0.21734,0.0045358,0.36755,0.27715,GOBP_GERMINAL_CENTER_B_CELL_DIFFERENTIATION,0.929784269175108
GOMF_ICOSANOID_TRANSMEMBRANE...,SET,13,0.15092,0.0040145,0.25522,0.27715,GOMF_ICOSANOID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.929784269175108
REACTOME_REGULATION_OF_NFE2L...,SET,8,0.18965,0.0039578,0.32072,0.27716,REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION,0.929784269175108
GOBP_NEGATIVE_REGULATION_OF_...708,SET,69,0.06517,0.0039876,0.11023,0.27719,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING,0.929784269175108
GOMF_RETINYL_PALMITATE_ESTER...,SET,6,0.23578,0.0042616,0.39884,0.27721,GOMF_RETINYL_PALMITATE_ESTERASE_ACTIVITY,0.929784269175108
HP_EROSION_OF_ORAL_MUCOSA,SET,89,0.05536,0.003845,0.093644,0.27721,HP_EROSION_OF_ORAL_MUCOSA,0.929784269175108
GOBP_ESTABLISHMENT_OF_PROTEI...9,SET,58,0.066793,0.0037482,0.11299,0.27722,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.929784269175108
GOBP_PYRIMIDINE_RIBONUCLEOSI...5,SET,16,0.13118,0.0038709,0.22192,0.27722,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.929784269175108
REACTOME_RECYCLING_PATHWAY_O...,SET,40,0.081613,0.0038052,0.13809,0.27726,REACTOME_RECYCLING_PATHWAY_OF_L1,0.929784269175108
MODULE_36,SET,145,0.040471,0.0035823,0.068482,0.27727,MODULE_36,0.929784269175108
GOBP_T_HELPER_17_CELL_DIFFER...,SET,33,0.095309,0.004037,0.16127,0.27727,GOBP_T_HELPER_17_CELL_DIFFERENTIATION,0.929784269175108
GOBP_CENTRIOLE_CENTRIOLE_COH...,SET,14,0.13936,0.0038468,0.23584,0.27729,GOBP_CENTRIOLE_CENTRIOLE_COHESION,0.929784269175108
GOBP_REGULATION_OF_ACUTE_INF...2,SET,13,0.1436,0.0038199,0.24302,0.27729,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.929784269175108
GOCC_VESICLE_COAT,SET,59,0.062516,0.0035382,0.10579,0.27729,GOCC_VESICLE_COAT,0.929784269175108
GOBP_REGULATION_OF_ALDOSTERO...,SET,8,0.19659,0.0041028,0.33277,0.27734,GOBP_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS,0.929861327032501
GOBP_PEPTIDYL_PROLINE_HYDROX...1,SET,11,0.12598,0.0030828,0.21328,0.27737,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION,0.929861327032501
GOBP_REGULATION_OF_AUTOPHAGO...2,SET,15,0.1232,0.0035199,0.2086,0.2774,GOBP_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.929861327032501
YOKOE_CANCER_TESTIS_ANTIGENS,SET,33,0.084198,0.0035664,0.14258,0.27742,YOKOE_CANCER_TESTIS_ANTIGENS,0.929861327032501
GOCC_R2TP_COMPLEX,SET,5,0.22236,0.003669,0.37675,0.27753,GOCC_R2TP_COMPLEX,0.930084148105294
GSE22611_UNSTIM_VS_2H_MDP_ST...4,SET,168,0.038854,0.0036997,0.065833,0.27754,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.930084148105294
VEGF_A_UP.V1_DN,SET,181,0.036191,0.0035757,0.06134,0.27759,VEGF_A_UP.V1_DN,0.930162017932896
GSE21546_SAP1A_KO_VS_SAP1A_K...2,SET,178,0.037418,0.0036664,0.063429,0.27762,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.930172862238504
GOBP_SYNAPTIC_VESICLE_CYTOSK...,SET,18,0.11933,0.0037346,0.20232,0.27766,GOBP_SYNAPTIC_VESICLE_CYTOSKELETAL_TRANSPORT,0.930217206477733
GSE17721_PAM3CSK4_VS_GADIQUI...13,SET,181,0.037358,0.0036909,0.063364,0.27774,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN,0.930385170591062
HP_ERYTHROID_HYPOPLASIA,SET,26,0.093232,0.003506,0.15817,0.27778,HP_ERYTHROID_HYPOPLASIA,0.930385170591062
GSE9316_IL6_KO_VS_IFNG_KO_IN...1,SET,188,0.037558,0.003781,0.063733,0.27783,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN,0.930385170591062
chr17q11,SET,76,0.12526,0.0080425,0.21258,0.27785,chr17q11,0.930385170591062
ZNF101_TARGET_GENES,SET,360,0.026314,0.0036484,0.044668,0.2779,ZNF101_TARGET_GENES,0.930385170591062
REACTOME_FATTY_ACIDS,SET,15,0.14803,0.0042295,0.25131,0.27792,REACTOME_FATTY_ACIDS,0.930385170591062
GSE17186_BLOOD_VS_CORD_BLOOD...3,SET,182,0.036961,0.0036617,0.062751,0.27793,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN,0.930385170591062
KEGG_MEDICUS_VARIANT_AMPLIFI...3,SET,8,0.16447,0.0034324,0.27934,0.27801,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S,0.930385170591062
HP_APLASIA_HYPOPLASIA_OF_THE...24,SET,4,0.23568,0.0034783,0.4003,0.27802,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.930385170591062
HP_LEFT_ANTERIOR_FASCICULAR_...,SET,7,0.21024,0.0041044,0.35717,0.27806,HP_LEFT_ANTERIOR_FASCICULAR_BLOCK,0.930385170591062
MIR1_3P,SET,337,0.027663,0.0037133,0.047003,0.27809,MIR1_3P,0.930385170591062
GSE21033_1H_VS_12H_POLYIC_ST...2,SET,166,0.03926,0.0037161,0.066711,0.2781,GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP,0.930385170591062
COLE_BLOOD_FLUMIST_QUADRIVAL...,SET,5,0.27191,0.0044865,0.46204,0.27811,COLE_BLOOD_FLUMIST_QUADRIVALENT_AGE_03_17YO_7DY_UP,0.930385170591062
GOCC_DEATH_INDUCING_SIGNALIN...,SET,9,0.18165,0.0040207,0.30888,0.27824,GOCC_DEATH_INDUCING_SIGNALING_COMPLEX,0.930385170591062
WP_SARS_CORONAVIRUS_AND_INNA...,SET,26,0.11018,0.0041434,0.18739,0.27827,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,0.930385170591062
HP_SKELETAL_MUSCLE_ATROPHY,SET,497,0.022699,0.0036838,0.038611,0.2783,HP_SKELETAL_MUSCLE_ATROPHY,0.930385170591062
HP_CENTRAL_PRIMITIVE_NEUROEC...,SET,6,0.22905,0.00414,0.38963,0.27832,HP_CENTRAL_PRIMITIVE_NEUROECTODERMAL_TUMOR,0.930385170591062
GSE24634_TREG_VS_TCONV_POST_...1,SET,188,0.038281,0.0038538,0.065124,0.27833,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN,0.930385170591062
KEGG_MEDICUS_REFERENCE_BILE_...,SET,14,0.1314,0.0036271,0.22357,0.27836,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS,0.930385170591062
GOBP_IMPORT_INTO_CELL,SET,844,0.018102,0.003791,0.030813,0.27844,GOBP_IMPORT_INTO_CELL,0.930385170591062
GOBP_MULTICELLULAR_ORGANISMA...1,SET,75,0.060641,0.0038678,0.10322,0.27845,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_CHEMICAL_HOMEOSTASIS,0.930385170591062
HP_ESOPHAGEAL_ULCERATION,SET,7,0.18605,0.0036321,0.31672,0.27846,HP_ESOPHAGEAL_ULCERATION,0.930385170591062
HP_POSTPRANDIAL_HYPERGLYCEMIA,SET,7,0.20227,0.0039487,0.34432,0.27846,HP_POSTPRANDIAL_HYPERGLYCEMIA,0.930385170591062
HP_MUSCULAR_VENTRICULAR_SEPT...,SET,22,0.11043,0.0038202,0.18799,0.27847,HP_MUSCULAR_VENTRICULAR_SEPTAL_DEFECT,0.930385170591062
HP_ABNORMAL_DENTAL_PULP_MORP...,SET,50,0.072148,0.0037599,0.12286,0.27852,HP_ABNORMAL_DENTAL_PULP_MORPHOLOGY,0.930385170591062
HP_PARTIAL_DUPLICATION_OF_TH...1,SET,6,0.19876,0.0035925,0.33847,0.27852,HP_PARTIAL_DUPLICATION_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.930385170591062
IWANAGA_CARCINOGENESIS_BY_KR...4,SET,158,0.040854,0.0037736,0.069573,0.27853,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,0.930385170591062
GOBP_CELL_CYCLE_PROCESS,SET,1143,0.014957,0.003614,0.025471,0.27853,GOBP_CELL_CYCLE_PROCESS,0.930385170591062
WAKABAYASHI_ADIPOGENESIS_PPA...3,SET,143,0.042961,0.0037767,0.073163,0.27854,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,0.930385170591062
GOMF_CYTIDYLYLTRANSFERASE_AC...,SET,8,0.18272,0.0038133,0.31117,0.27854,GOMF_CYTIDYLYLTRANSFERASE_ACTIVITY,0.930385170591062
GSE3982_EOSINOPHIL_VS_TH1_UP,SET,178,0.037064,0.0036317,0.063121,0.27854,GSE3982_EOSINOPHIL_VS_TH1_UP,0.930385170591062
GOBP_NEGATIVE_REGULATION_OF_...426,SET,10,0.17304,0.0040374,0.29476,0.27858,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.930427266615444
GSE11057_NAIVE_CD4_VS_PBMC_C...2,SET,163,0.038541,0.0036153,0.06566,0.27862,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP,0.930427266615444
GSE22886_IGG_IGA_MEMORY_BCEL...1,SET,170,0.037613,0.0036025,0.064092,0.27865,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.930427266615444
BIOCARTA_BCR_PATHWAY,SET,31,0.090477,0.0037146,0.15418,0.27867,BIOCARTA_BCR_PATHWAY,0.930427266615444
GOBP_RESPONSE_TO_CYTOKINE,SET,857,0.018419,0.0038855,0.031392,0.27869,GOBP_RESPONSE_TO_CYTOKINE,0.930427266615444
HP_MEGAKARYOCYTE_DYSPLASIA,SET,4,0.26104,0.0038526,0.44498,0.27873,HP_MEGAKARYOCYTE_DYSPLASIA,0.930427266615444
GSE3691_IFN_PRODUCING_KILLER...2,SET,173,0.036652,0.003541,0.062483,0.27874,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP,0.930427266615444
MIR19B_1_5P_MIR19B_2_5P,SET,160,0.041516,0.0038587,0.070784,0.27877,MIR19B_1_5P_MIR19B_2_5P,0.930438043791415
HP_PAPILLARY_CYSTADENOMA_OF_...,SET,5,0.23465,0.0038718,0.4004,0.27893,HP_PAPILLARY_CYSTADENOMA_OF_THE_EPIDIDYMIS,0.930692061816088
HE_LIM_SUN_FETAL_LUNG_C0_MES...1,SET,264,0.032804,0.0039052,0.055977,0.27893,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL,0.930692061816088
GSE9316_IL6_KO_VS_IFNG_KO_IN...2,SET,184,0.037397,0.003725,0.063823,0.27896,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP,0.930692061816088
GSE40274_FOXP3_VS_FOXP3_AND_...4,SET,183,0.038466,0.0038211,0.065653,0.27898,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.930692061816088
GSE46606_UNSTIM_VS_CD40L_IL2...16,SET,168,0.040376,0.0038445,0.068914,0.27898,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.930692061816088
GOBP_NUCLEAR_MEMBRANE_ORGANI...,SET,44,0.072558,0.0035478,0.12387,0.27902,GOBP_NUCLEAR_MEMBRANE_ORGANIZATION,0.930736164699107
STAT5A_01,SET,227,0.034402,0.0038015,0.058759,0.27912,STAT5A_01,0.930788697611969
HP_APLASIA_HYPOPLASIA_OF_THE...2,SET,15,0.1311,0.0037456,0.22394,0.27914,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_FINGER,0.930788697611969
GOCC_GOLGI_ASSOCIATED_VESICL...,SET,52,0.064665,0.0034365,0.11047,0.27916,GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE,0.930788697611969
GOCC_NUCLEAR_PORE_NUCLEAR_BA...,SET,11,0.143,0.0034992,0.24432,0.27917,GOCC_NUCLEAR_PORE_NUCLEAR_BASKET,0.930788697611969
HP_ABNORMAL_RENAL_ECHOGENICI...,SET,31,0.091912,0.0037736,0.15703,0.27917,HP_ABNORMAL_RENAL_ECHOGENICITY,0.930788697611969
GOBP_CYTIDINE_TO_URIDINE_EDI...,SET,10,0.20992,0.0048979,0.35876,0.27923,GOBP_CYTIDINE_TO_URIDINE_EDITING,0.930788697611969
HP_ABNORMAL_CIRCULATING_VITA...2,SET,24,0.10846,0.0039189,0.18536,0.27923,HP_ABNORMAL_CIRCULATING_VITAMIN_B12_CONCENTRATION,0.930788697611969
GSE15330_HSC_VS_MEGAKARYOCYT...3,SET,188,0.037033,0.0037281,0.063294,0.27925,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.930788697611969
HP_TURRICEPHALY,SET,42,0.077109,0.0036838,0.13186,0.27935,HP_TURRICEPHALY,0.930907762338285
MIR26B_5P,SET,455,0.023926,0.0037195,0.040919,0.27938,MIR26B_5P,0.930907762338285
GSE40273_XBP1_KO_VS_WT_TREG_...2,SET,185,0.036883,0.0036836,0.063084,0.27939,GSE40273_XBP1_KO_VS_WT_TREG_UP,0.930907762338285
GOBP_POSITIVE_REGULATION_OF_...206,SET,9,0.18738,0.0041478,0.32054,0.27941,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION,0.930907762338285
GOBP_MAST_CELL_CHEMOTAXIS,SET,11,0.15875,0.0038846,0.27156,0.27942,GOBP_MAST_CELL_CHEMOTAXIS,0.930907762338285
GOCC_NSL_COMPLEX,SET,9,0.14449,0.0031983,0.24724,0.27947,GOCC_NSL_COMPLEX,0.930907762338285
GOCC_SEX_CHROMOSOME,SET,26,0.091429,0.0034381,0.15646,0.27949,GOCC_SEX_CHROMOSOME,0.930907762338285
TIEN_INTESTINE_PROBIOTICS_2H...2,SET,28,0.094544,0.0036893,0.1618,0.2795,TIEN_INTESTINE_PROBIOTICS_2HR_UP,0.930907762338285
MIR490_3P,SET,40,0.079682,0.0037152,0.13643,0.2796,MIR490_3P,0.931094439655172
GOBP_TRANSFORMING_GROWTH_FAC...2,SET,8,0.18497,0.0038603,0.31675,0.27963,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION,0.931094439655172
GOMF_EPINEPHRINE_BINDING,SET,6,0.22532,0.0040725,0.38592,0.27967,GOMF_EPINEPHRINE_BINDING,0.931094439655172
KEGG_MEDICUS_REFERENCE_KITLG...1,SET,11,0.15354,0.003757,0.26299,0.27968,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY,0.931094439655172
REACTOME_EXTRA_NUCLEAR_ESTRO...,SET,74,0.061533,0.0038986,0.10541,0.27969,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,0.931094439655172
GOBP_NEGATIVE_REGULATION_OF_...229,SET,5,0.24235,0.0039988,0.41527,0.27975,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.931204985154679
REACTOME_LOSS_OF_MECP2_BINDI...,SET,5,0.19808,0.0032683,0.3396,0.27986,REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX,0.931436662198391
GSE2770_TGFB_AND_IL4_VS_TGFB...2,SET,139,0.043798,0.0037964,0.075098,0.27988,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.931436662198391
GOBP_BLOOD_COAGULATION_FIBRI...,SET,14,0.16322,0.0045055,0.2799,0.2799,GOBP_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION,0.931436662198391
KEGG_GLYCOSPHINGOLIPID_BIOSY...3,SET,26,0.10502,0.0039493,0.18015,0.27997,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,0.931464434608795
GOMF_MAP_KINASE_TYROSINE_SER...,SET,11,0.16362,0.0040037,0.28073,0.28001,GOMF_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.931464434608795
MORF_MYC,SET,75,0.057312,0.0036555,0.098357,0.28005,MORF_MYC,0.931464434608795
HOXA3_01,SET,14,0.13374,0.0036917,0.22956,0.28009,HOXA3_01,0.931464434608795
GSE2770_IL12_VS_TGFB_AND_IL1...4,SET,179,0.038421,0.0037751,0.065966,0.28014,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.931464434608795
GOBP_POSITIVE_REGULATION_OF_...15,SET,10,0.15469,0.0036091,0.26579,0.28029,GOBP_POSITIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.931464434608795
GOCC_JUNCTIONAL_SARCOPLASMIC...,SET,9,0.18879,0.004179,0.32442,0.2803,GOCC_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE,0.931464434608795
MIR6501_5P,SET,65,0.062124,0.0036899,0.10676,0.28032,MIR6501_5P,0.931464434608795
HP_BULL_S_EYE_MACULOPATHY,SET,9,0.16958,0.0037537,0.29142,0.28032,HP_BULL_S_EYE_MACULOPATHY,0.931464434608795
GOMF_CARBOHYDRATE_BINDING,SET,248,0.033504,0.0038675,0.057586,0.28035,GOMF_CARBOHYDRATE_BINDING,0.931464434608795
GOBP_POSITIVE_REGULATION_OF_...417,SET,547,0.022933,0.0038989,0.039431,0.28042,GOBP_POSITIVE_REGULATION_OF_LOCOMOTION,0.931464434608795
MIR548V,SET,124,0.045083,0.0036925,0.07752,0.28043,MIR548V,0.931464434608795
BIOCARTA_IL2RB_PATHWAY,SET,35,0.089055,0.0038846,0.15317,0.28048,BIOCARTA_IL2RB_PATHWAY,0.931464434608795
MODULE_318,SET,27,0.086105,0.0032996,0.14809,0.28048,MODULE_318,0.931464434608795
GSE3720_UNSTIM_VS_PMA_STIM_V...4,SET,148,0.039437,0.0035265,0.067839,0.28051,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,0.931464434608795
MIR4796_5P,SET,89,0.055883,0.0038814,0.096138,0.28053,MIR4796_5P,0.931464434608795
HP_ABNORMAL_MORPHOLOGY_OF_TH...5,SET,43,0.076147,0.0036808,0.13101,0.28054,HP_ABNORMAL_MORPHOLOGY_OF_THE_LIMBIC_SYSTEM,0.931464434608795
GSE46606_UNSTIM_VS_CD40L_IL2...9,SET,189,0.036825,0.003717,0.063366,0.28057,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.931464434608795
GAUSSMANN_MLL_AF4_FUSION_TAR...10,SET,90,0.055166,0.0038529,0.09493,0.28058,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,0.931464434608795
ROSS_AML_WITH_PML_RARA_FUSION,SET,69,0.057853,0.00354,0.099553,0.28058,ROSS_AML_WITH_PML_RARA_FUSION,0.931464434608795
KEGG_CELL_ADHESION_MOLECULES...,SET,119,0.050536,0.0040554,0.086962,0.28058,KEGG_CELL_ADHESION_MOLECULES_CAMS,0.931464434608795
MIR525_5P,SET,143,0.041298,0.0036305,0.071075,0.28061,MIR525_5P,0.931464434608795
MIR373_5P,SET,852,0.017422,0.003665,0.029991,0.28065,MIR373_5P,0.931464434608795
CHARAFE_BREAST_CANCER_LUMINA...4,SET,401,0.025429,0.0037167,0.043776,0.28067,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,0.931464434608795
WP_TP53_NETWORK,SET,19,0.12316,0.00396,0.21204,0.28068,WP_TP53_NETWORK,0.931464434608795
HP_ABNORMAL_URINE_SODIUM_CON...,SET,16,0.12855,0.0037932,0.22133,0.28069,HP_ABNORMAL_URINE_SODIUM_CONCENTRATION,0.931464434608795
FUNG_IL2_SIGNALING_1,SET,9,0.16478,0.0036474,0.28382,0.28076,FUNG_IL2_SIGNALING_1,0.931464434608795
NABA_MATRISOME_ASSOCIATED,SET,698,0.021631,0.0041366,0.037257,0.28077,NABA_MATRISOME_ASSOCIATED,0.931464434608795
GOMF_PHOSPHATIDYLINOSITOL_3_...13,SET,10,0.16686,0.003893,0.28746,0.28081,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.931464434608795
MIR7978,SET,78,0.054622,0.0035527,0.094111,0.28083,MIR7978,0.931464434608795
DELASERNA_MYOD_TARGETS_UP,SET,81,0.055685,0.0036905,0.095952,0.28085,DELASERNA_MYOD_TARGETS_UP,0.931464434608795
GSE33162_UNTREATED_VS_4H_LPS...3,SET,186,0.036382,0.0036433,0.062694,0.28086,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN,0.931464434608795
HEBERT_MATRISOME_TNBC_BRAIN_...1,SET,23,0.11141,0.0039406,0.192,0.28088,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS,0.931464434608795
GOBP_PHOSPHOLIPID_BIOSYNTHET...,SET,230,0.03209,0.0035691,0.055311,0.2809,GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.931464434608795
GOBP_PYRIMIDINE_DEOXYRIBONUC...2,SET,11,0.14748,0.0036089,0.25422,0.28092,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.931464434608795
GOMF_GTPASE_ACTIVATING_PROTE...,SET,11,0.14926,0.0036523,0.25736,0.28097,GOMF_GTPASE_ACTIVATING_PROTEIN_BINDING,0.931464434608795
GOCC_ENDOPLASMIC_RETICULUM_G...2,SET,72,0.057603,0.0036002,0.099385,0.2811,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE,0.931464434608795
JIANG_MELANOMA_TRM1_CD8,SET,152,0.04241,0.0038428,0.073179,0.28112,JIANG_MELANOMA_TRM1_CD8,0.931464434608795
GOMF_PROTEIN_DIMERIZATION_AC...,SET,893,0.017252,0.0037111,0.029771,0.28113,GOMF_PROTEIN_DIMERIZATION_ACTIVITY,0.931464434608795
GOBP_NEGATIVE_REGULATION_OF_...362,SET,34,0.085279,0.0036664,0.14717,0.28114,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.931464434608795
GSE26912_TUMORICIDAL_VS_CTRL...1,SET,184,0.035559,0.0035419,0.061364,0.28114,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN,0.931464434608795
HP_HYPERINSULINEMIC_HYPOGLYC...,SET,25,0.10397,0.0038338,0.17943,0.28115,HP_HYPERINSULINEMIC_HYPOGLYCEMIA,0.931464434608795
GOBP_PHOTOTRANSDUCTION_VISIB...,SET,16,0.12453,0.0036747,0.21494,0.28116,GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT,0.931464434608795
GOBP_REGULATION_OF_CELL_SIZE,SET,156,0.040819,0.0037466,0.070451,0.28116,GOBP_REGULATION_OF_CELL_SIZE,0.931464434608795
GOBP_REGULATION_OF_NEURAL_PR...,SET,96,0.053402,0.0038514,0.092173,0.28117,GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.931464434608795
HP_MANDIBULAR_APLASIA,SET,10,0.16332,0.0038106,0.28191,0.28118,HP_MANDIBULAR_APLASIA,0.931464434608795
GOBP_REGULATION_OF_CDC42_PRO...,SET,7,0.21718,0.0042399,0.37491,0.2812,GOBP_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.931464434608795
MODULE_567,SET,90,0.050855,0.0035518,0.0878,0.28123,MODULE_567,0.931464434608795
MODULE_11,SET,494,0.023842,0.0038578,0.041178,0.2813,MODULE_11,0.931464434608795
AMIT_EGF_RESPONSE_40_MCF10A,SET,15,0.13775,0.0039356,0.23798,0.28136,AMIT_EGF_RESPONSE_40_MCF10A,0.931464434608795
GSE43863_NAIVE_VS_TH1_EFF_CD...1,SET,147,0.042368,0.0037759,0.073201,0.28137,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN,0.931464434608795
GOBP_REFLEX,SET,22,0.10857,0.0037562,0.18761,0.28139,GOBP_REFLEX,0.931464434608795
HP_WHITE_HAIR,SET,21,0.10847,0.0036663,0.18743,0.28139,HP_WHITE_HAIR,0.931464434608795
MARKS_HDAC_TARGETS_UP,SET,20,0.11841,0.0039059,0.20469,0.28148,MARKS_HDAC_TARGETS_UP,0.931464434608795
HP_ABNORMAL_QRS_COMPLEX,SET,9,0.18608,0.0041188,0.32172,0.28151,HP_ABNORMAL_QRS_COMPLEX,0.931464434608795
P53_DN.V1_UP,SET,178,0.03948,0.0038685,0.06826,0.28151,P53_DN.V1_UP,0.931464434608795
GOCC_MYOSIN_COMPLEX,SET,55,0.070445,0.0038498,0.12182,0.28154,GOCC_MYOSIN_COMPLEX,0.931464434608795
GSE18281_PERIMEDULLARY_CORTI...1,SET,170,0.038138,0.0036528,0.065949,0.28154,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,0.931464434608795
GAVISH_3CA_METAPROGRAM_ENDOT...7,SET,48,0.078143,0.0039903,0.13514,0.28155,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_5,0.931464434608795
GOBP_RECEPTOR_LOCALIZATION_T...1,SET,4,0.23485,0.0034661,0.40616,0.28156,GOBP_RECEPTOR_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.931464434608795
GSE17721_POLYIC_VS_GARDIQUIM...6,SET,186,0.0365,0.0036551,0.063123,0.28156,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP,0.931464434608795
GSE17721_LPS_VS_CPG_0.5H_BMD...1,SET,179,0.036047,0.0035419,0.062345,0.28157,GSE17721_LPS_VS_CPG_0.5H_BMDC_DN,0.931464434608795
GOBP_OOCYTE_MATURATION,SET,30,0.091895,0.0037116,0.15898,0.28162,GOBP_OOCYTE_MATURATION,0.931541172551632
GOMF_PROTEIN_CARRIER_CHAPERO...,SET,31,0.085132,0.0034952,0.14735,0.28172,GOMF_PROTEIN_CARRIER_CHAPERONE,0.931558243011979
SMID_BREAST_CANCER_RELAPSE_I...7,SET,37,0.082593,0.003704,0.14297,0.28174,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,0.931558243011979
GOBP_NEGATIVE_REGULATION_OF_...398,SET,11,0.15782,0.0038619,0.2733,0.28181,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.931558243011979
MARTINEZ_RB1_AND_TP53_TARGET...1,SET,549,0.021289,0.0036259,0.036868,0.28182,MARTINEZ_RB1_AND_TP53_TARGETS_DN,0.931558243011979
GOBP_POSITIVE_REGULATION_OF_...521,SET,270,0.031999,0.0038519,0.055413,0.28182,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.931558243011979
GOBP_SECRETION_OF_LYSOSOMAL_...,SET,6,0.17219,0.0031122,0.29818,0.28182,GOBP_SECRETION_OF_LYSOSOMAL_ENZYMES,0.931558243011979
MIR7855_5P,SET,70,0.061441,0.0037865,0.10641,0.28184,MIR7855_5P,0.931558243011979
HP_FLAT_CORNEA,SET,19,0.12681,0.0040773,0.21965,0.28186,HP_FLAT_CORNEA,0.931558243011979
REACTOME_MISCELLANEOUS_TRANS...,SET,21,0.11394,0.0038511,0.19737,0.28188,REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,0.931558243011979
FOURATI_BLOOD_TWINRIX_AGE_65...1,SET,4,0.27544,0.0040652,0.47719,0.2819,FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_UP,0.931558243011979
GOMF_MRNA_CDS_BINDING,SET,3,0.2756,0.0035226,0.4775,0.28192,GOMF_MRNA_CDS_BINDING,0.931558243011979
GSE24671_CTRL_VS_SENDAI_VIRU...1,SET,177,0.034623,0.003383,0.060004,0.28197,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.931588554732041
GSE13485_DAY1_VS_DAY21_YF17D...2,SET,160,0.037636,0.003498,0.065237,0.28201,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.931588554732041
GOBP_EMBRYONIC_ORGAN_MORPHOG...,SET,280,0.03171,0.003886,0.054969,0.28202,GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS,0.931588554732041
GOBP_CARBOHYDRATE_HOMEOSTASIS,SET,229,0.033401,0.0037069,0.057906,0.28204,GOBP_CARBOHYDRATE_HOMEOSTASIS,0.931588554732041
GOBP_REGULATION_OF_ATTACHMEN...1,SET,9,0.15861,0.0035108,0.27502,0.28207,GOBP_REGULATION_OF_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.931588554732041
KEGG_MEDICUS_ENV_FACTOR_NNK_...3,SET,12,0.1479,0.0037799,0.25648,0.28209,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350,0.931588554732041
GSE14350_IL2RB_KO_VS_WT_TREG...2,SET,183,0.036226,0.0035986,0.062842,0.28215,GSE14350_IL2RB_KO_VS_WT_TREG_UP,0.931698171021378
KYNG_RESPONSE_TO_H2O2,SET,64,0.060753,0.0035807,0.10545,0.28226,KYNG_RESPONSE_TO_H2O2,0.931884326018809
MIR711,SET,36,0.081428,0.0036022,0.14133,0.28226,MIR711,0.931884326018809
MIR3059_5P,SET,274,0.029731,0.0036049,0.051611,0.28229,MIR3059_5P,0.931894847074468
REACTOME_TP53_REGULATES_TRAN...4,SET,42,0.074172,0.0035435,0.12881,0.28237,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,0.932070410295375
MIR8052,SET,40,0.07776,0.0036256,0.13511,0.28247,MIR8052,0.93220090676035
WP_GENES_TARGETED_BY_MIRNAS_...,SET,11,0.16307,0.0039903,0.28338,0.28249,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,0.93220090676035
GOBP_GALACTOLIPID_METABOLIC_...,SET,9,0.17833,0.0039474,0.3099,0.28249,GOBP_GALACTOLIPID_METABOLIC_PROCESS,0.93220090676035
GCACCTT_MIR18A_MIR18B,SET,112,0.046428,0.0036151,0.080711,0.28257,GCACCTT_MIR18A_MIR18B,0.93237637425235
HP_ABNORMALITY_OF_URINE_CALC...,SET,63,0.067132,0.0039257,0.11679,0.28272,HP_ABNORMALITY_OF_URINE_CALCIUM_CONCENTRATION,0.932547528877107
MTF1_Q4,SET,221,0.033897,0.0036965,0.058986,0.28276,MTF1_Q4,0.932547528877107
GOBP_LATE_ENDOSOME_TO_GOLGI_...,SET,3,0.24044,0.0030732,0.41848,0.2828,GOBP_LATE_ENDOSOME_TO_GOLGI_TRANSPORT,0.932547528877107
GSE40274_CTRL_VS_FOXP3_AND_H...1,SET,171,0.03689,0.0035436,0.064206,0.2828,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.932547528877107
MIKKELSEN_DEDIFFERENTIATED_S...2,SET,6,0.20651,0.0037325,0.35952,0.28285,MIKKELSEN_DEDIFFERENTIATED_STATE_UP,0.932547528877107
GOBP_NEUROMUSCULAR_PROCESS_C...2,SET,16,0.1225,0.0036148,0.21327,0.28285,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE,0.932547528877107
MODULE_257,SET,153,0.03677,0.0033426,0.064019,0.28286,MODULE_257,0.932547528877107
HP_LIVEDO,SET,6,0.17246,0.0031171,0.30025,0.28286,HP_LIVEDO,0.932547528877107
GOBP_POSITIVE_REGULATION_OF_...339,SET,17,0.13062,0.0039729,0.22749,0.28292,GOBP_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.932547528877107
GSE22886_TH1_VS_TH2_48H_ACT_...1,SET,182,0.036687,0.0036345,0.063895,0.28293,GSE22886_TH1_VS_TH2_48H_ACT_DN,0.932547528877107
HP_APHASIA,SET,70,0.06158,0.0037951,0.10728,0.28299,HP_APHASIA,0.932547528877107
GOBP_TRANSITION_METAL_ION_TR...,SET,89,0.050977,0.0035406,0.088828,0.28303,GOBP_TRANSITION_METAL_ION_TRANSPORT,0.932547528877107
HP_MYELIN_OUTFOLDINGS,SET,7,0.18506,0.0036128,0.32249,0.28303,HP_MYELIN_OUTFOLDINGS,0.932547528877107
GOBP_VESICLE_FUSION_WITH_GOL...,SET,8,0.15756,0.0032881,0.27459,0.28306,GOBP_VESICLE_FUSION_WITH_GOLGI_APPARATUS,0.932547528877107
HP_INCISOR_MACRODONTIA,SET,15,0.14039,0.0040112,0.24468,0.28307,HP_INCISOR_MACRODONTIA,0.932547528877107
HP_VIRAL_ENCEPHALITIS,SET,11,0.14779,0.0036163,0.25763,0.28311,HP_VIRAL_ENCEPHALITIS,0.932547528877107
REACTOME_NUCLEOTIDE_BINDING_...,SET,50,0.070265,0.0036618,0.1225,0.28312,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,0.932547528877107
BLANCO_MELO_BRONCHIAL_EPITHE...1,SET,159,0.036997,0.003428,0.064518,0.28318,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,0.932547528877107
GSE11057_CD4_EFF_MEM_VS_PBMC...2,SET,176,0.036665,0.0035725,0.063939,0.28318,GSE11057_CD4_EFF_MEM_VS_PBMC_UP,0.932547528877107
WP_MITOCHONDRIAL_COMPLEX_III...,SET,15,0.11411,0.0032603,0.19914,0.28332,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,0.932547528877107
HOXD11_TARGET_GENES,SET,117,0.04456,0.0035458,0.077764,0.28332,HOXD11_TARGET_GENES,0.932547528877107
HP_VELOPHARYNGEAL_INSUFFICIE...,SET,26,0.096815,0.0036407,0.16896,0.28332,HP_VELOPHARYNGEAL_INSUFFICIENCY,0.932547528877107
MIR19A_5P,SET,161,0.040423,0.0037687,0.070551,0.28334,MIR19A_5P,0.932547528877107
GOBP_RESPONSE_TO_RAPAMYCIN,SET,4,0.26004,0.0038378,0.45386,0.28334,GOBP_RESPONSE_TO_RAPAMYCIN,0.932547528877107
REACTOME_SIGNALING_BY_NOTCH1,SET,68,0.05898,0.0035827,0.10295,0.28336,REACTOME_SIGNALING_BY_NOTCH1,0.932547528877107
HOEBEKE_LYMPHOID_STEM_CELL_UP,SET,86,0.052737,0.0036009,0.092068,0.28339,HOEBEKE_LYMPHOID_STEM_CELL_UP,0.932547528877107
GOBP_POSITIVE_REGULATION_OF_...48,SET,7,0.17023,0.0033233,0.29721,0.2834,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.932547528877107
HP_LEUKEMIA,SET,162,0.037791,0.0035341,0.065979,0.2834,HP_LEUKEMIA,0.932547528877107
GSE17974_IL4_AND_ANTI_IL12_V...17,SET,173,0.037739,0.003646,0.065888,0.2834,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN,0.932547528877107
RASHI_RESPONSE_TO_IONIZING_R...2,SET,116,0.047427,0.0037579,0.082819,0.28344,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,0.932587567414136
REACTOME_TRANSLATION_OF_SARS...2,SET,54,0.064489,0.0034923,0.11265,0.28351,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,0.932587567414136
FAN_EMBRYONIC_CTX_BIG_GROUPS...4,SET,43,0.079841,0.0038594,0.13948,0.28353,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.932587567414136
GSE4535_BM_DERIVED_DC_VS_FOL...1,SET,177,0.036012,0.0035188,0.062917,0.28354,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN,0.932587567414136
GSE10240_IL22_VS_IL17_STIM_P...2,SET,171,0.035647,0.0034242,0.062291,0.28357,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.932587567414136
GSE3982_BCELL_VS_EFF_MEMORY_...2,SET,171,0.036732,0.0035284,0.06419,0.28358,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.932587567414136
WP_MAPK_SIGNALING,SET,234,0.033361,0.0037422,0.058304,0.2836,WP_MAPK_SIGNALING,0.932587567414136
GOBP_REGULATION_OF_PHOSPHOLI...2,SET,45,0.076979,0.0038064,0.13461,0.28371,GOBP_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.932660415090772
BYSTRYKH_HEMATOPOIESIS_STEM_...7,SET,719,0.018365,0.0035624,0.032118,0.28374,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,0.932660415090772
BLANCO_MELO_COVID19_SARS_COV...4,SET,425,0.024134,0.0036291,0.042211,0.28375,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.932660415090772
GOBP_INNATE_IMMUNE_RESPONSE_...1,SET,88,0.053962,0.003727,0.094382,0.28375,GOBP_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.932660415090772
FAN_EMBRYONIC_CTX_BRAIN_EFFE...,SET,116,0.048134,0.0038139,0.084202,0.28378,FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL,0.932660415090772
GOCC_PRESYNAPTIC_ACTIVE_ZONE...1,SET,16,0.128,0.003777,0.22392,0.28379,GOCC_PRESYNAPTIC_ACTIVE_ZONE_CYTOPLASMIC_COMPONENT,0.932660415090772
HP_INCREASED_BONE_MINERAL_DE...,SET,95,0.052315,0.0037534,0.091526,0.28381,HP_INCREASED_BONE_MINERAL_DENSITY,0.932660415090772
GSE5589_UNSTIM_VS_180MIN_LPS...2,SET,183,0.035682,0.0035446,0.062445,0.28386,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.932736532097948
GSE17721_0.5H_VS_12H_LPS_BMD...1,SET,184,0.035453,0.0035313,0.062073,0.28395,GSE17721_0.5H_VS_12H_LPS_BMDC_DN,0.932923265691364
GOBP_REGULATION_OF_CYSTEINE_...3,SET,11,0.13814,0.0033803,0.24194,0.28401,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.932923265691364
GSE12392_IFNAR_KO_VS_IFNB_KO...1,SET,185,0.03778,0.0037732,0.066167,0.28401,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN,0.932923265691364
HP_SMALL_EARLOBE,SET,23,0.10621,0.0037568,0.18604,0.28404,HP_SMALL_EARLOBE,0.932923265691364
REACTOME_SUMO_IS_PROTEOLYTIC...,SET,6,0.16995,0.0030717,0.29771,0.28406,REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED,0.932923265691364
GOBP_GERM_CELL_MIGRATION,SET,9,0.18829,0.0041678,0.32991,0.2841,GOBP_GERM_CELL_MIGRATION,0.932923265691364
GOBP_REGULATION_OF_VENTRICUL...1,SET,12,0.16157,0.0041292,0.28317,0.28415,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.932923265691364
GOBP_NEGATIVE_REGULATION_OF_...82,SET,26,0.10154,0.0038183,0.17798,0.28418,GOBP_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.932923265691364
KEGG_MEDICUS_VARIANT_MUTATIO...37,SET,17,0.12307,0.0037431,0.21578,0.28423,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT,0.932923265691364
NAKAYA_PBMC_FLUMIST_AGE_18_5...3,SET,502,0.021154,0.0034497,0.037107,0.28432,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,0.932923265691364
SOBOLEV_PBMC_PANDEMRIX_AGE_1...2,SET,32,0.096257,0.0040151,0.16885,0.28432,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN,0.932923265691364
GOBP_POSITIVE_REGULATION_OF_...11,SET,7,0.16861,0.0032916,0.2958,0.28434,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.932923265691364
TRAVAGLINI_LUNG_EREG_DENDRIT...,SET,525,0.022688,0.0037813,0.039805,0.28435,TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL,0.932923265691364
GOBP_NEGATIVE_REGULATION_OF_...243,SET,8,0.17292,0.0036088,0.3034,0.28436,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.932923265691364
GOMF_CYSTEINE_TYPE_ENDOPEPTI...5,SET,5,0.22363,0.0036899,0.39237,0.28436,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.932923265691364
HP_EPIDERMOID_CYST,SET,15,0.11706,0.0033446,0.20539,0.28436,HP_EPIDERMOID_CYST,0.932923265691364
MIR4753_3P,SET,513,0.02237,0.0036866,0.039253,0.28438,MIR4753_3P,0.932923265691364
KEGG_MEDICUS_REFERENCE_AUTOP...6,SET,16,0.12192,0.0035977,0.21397,0.2844,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1,0.932923265691364
HP_ABNORMAL_PREPUTIUM_MORPHO...,SET,30,0.078834,0.0031841,0.13838,0.28444,HP_ABNORMAL_PREPUTIUM_MORPHOLOGY,0.932966421291053
TAFAZZIN_TARGET_GENES,SET,367,0.025316,0.0035433,0.044455,0.28452,TAFAZZIN_TARGET_GENES,0.933093705865738
GOBP_GLYCOPHAGY,SET,11,0.15537,0.0038018,0.27286,0.28455,GOBP_GLYCOPHAGY,0.933093705865738
IGLV5_37_TARGET_GENES,SET,473,0.023358,0.0037005,0.041024,0.28456,IGLV5_37_TARGET_GENES,0.933093705865738
GNF2_CENPF,SET,57,0.064506,0.0035886,0.11332,0.28459,GNF2_CENPF,0.933093705865738
HP_INCREASED_ENDOMYSIAL_CONN...,SET,27,0.096968,0.0037158,0.1704,0.28466,HP_INCREASED_ENDOMYSIAL_CONNECTIVE_TISSUE,0.933093705865738
GOBP_CARDIAC_MUSCLE_CELL_MYO...,SET,11,0.16876,0.0041294,0.29667,0.28474,GOBP_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION,0.933093705865738
GSE17721_LPS_VS_GARDIQUIMOD_...5,SET,180,0.036325,0.003579,0.063861,0.28475,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN,0.933093705865738
NIKOLSKY_BREAST_CANCER_12Q24...,SET,14,0.25154,0.0069432,0.44229,0.28478,NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,0.933093705865738
GNF2_RPA1,SET,25,0.088565,0.0032659,0.15574,0.28479,GNF2_RPA1,0.933093705865738
MATZUK_MATERNAL_EFFECT,SET,7,0.18374,0.003587,0.32314,0.28482,MATZUK_MATERNAL_EFFECT,0.933093705865738
SIG_CHEMOTAXIS,SET,39,0.075202,0.0034623,0.13227,0.28484,SIG_CHEMOTAXIS,0.933093705865738
chr16p12,SET,78,0.10333,0.0067209,0.18176,0.28485,chr16p12,0.933093705865738
XU_RESPONSE_TO_TRETINOIN_DN,SET,10,0.16686,0.0038932,0.29362,0.28492,XU_RESPONSE_TO_TRETINOIN_DN,0.933093705865738
LEONARD_HYPOXIA,SET,38,0.076605,0.0034815,0.13481,0.28493,LEONARD_HYPOXIA,0.933093705865738
HP_ABNORMALITY_OF_ENDOCRINE_...,SET,28,0.099198,0.0038709,0.17461,0.28499,HP_ABNORMALITY_OF_ENDOCRINE_PANCREAS_PHYSIOLOGY,0.933093705865738
GSE6681_DELETED_FOXP3_VS_WT_...2,SET,174,0.038024,0.003684,0.066941,0.28501,GSE6681_DELETED_FOXP3_VS_WT_TREG_UP,0.933093705865738
MIR223_3P,SET,112,0.045649,0.0035545,0.080368,0.28502,MIR223_3P,0.933093705865738
HP_HYPERGONADOTROPIC_HYPOGON...,SET,54,0.062201,0.0033684,0.10952,0.28504,HP_HYPERGONADOTROPIC_HYPOGONADISM,0.933093705865738
GOMF_TRIPEPTIDE_TRANSMEMBRAN...,SET,9,0.16436,0.0036382,0.28942,0.28505,GOMF_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.933093705865738
HP_BROAD_COLUMELLA,SET,12,0.13587,0.0034723,0.23925,0.28506,HP_BROAD_COLUMELLA,0.933093705865738
LI_ESTROGENE_MCF7_E2_RESPONS...1,SET,35,0.092669,0.0040422,0.16319,0.28507,LI_ESTROGENE_MCF7_E2_RESPONSE_DN,0.933093705865738
AIZARANI_LIVER_C21_STELLATE_...,SET,176,0.041165,0.004011,0.072492,0.28507,AIZARANI_LIVER_C21_STELLATE_CELLS_1,0.933093705865738
MODULE_112,SET,237,0.034973,0.0039477,0.061604,0.28512,MODULE_112,0.933093705865738
HP_ABNORMAL_MORPHOLOGY_OF_UL...,SET,140,0.041556,0.0036149,0.073205,0.28514,HP_ABNORMAL_MORPHOLOGY_OF_ULNA,0.933093705865738
GSE27786_LSK_VS_BCELL_DN,SET,182,0.035695,0.0035363,0.062885,0.28515,GSE27786_LSK_VS_BCELL_DN,0.933093705865738
HP_RECURRENT_PNEUMONIA,SET,113,0.045655,0.0035707,0.080457,0.28521,HP_RECURRENT_PNEUMONIA,0.933147048856255
GOBP_NEGATIVE_REGULATION_OF_...31,SET,212,0.033305,0.0035581,0.058695,0.28522,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.933147048856255
MIR3714,SET,404,0.024548,0.0036011,0.043286,0.28532,MIR3714,0.933386351656627
GOBP_PROTEIN_DEGLYCOSYLATION,SET,14,0.13333,0.0036803,0.2352,0.2854,GOBP_PROTEIN_DEGLYCOSYLATION,0.933560188235294
DURANTE_ADULT_OLFACTORY_NEUR...21,SET,15,0.13048,0.003728,0.23027,0.28548,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_EPITHELIAL_CELLS,0.933733992094862
GAO_LARGE_INTESTINE_24W_C11_...,SET,293,0.030644,0.0038402,0.05411,0.28559,GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL,0.933895526390065
FAN_EMBRYONIC_CTX_BRAIN_B_CE...,SET,84,0.056211,0.0037934,0.099261,0.2856,FAN_EMBRYONIC_CTX_BRAIN_B_CELL,0.933895526390065
GOBP_BRANCH_ELONGATION_OF_AN...,SET,19,0.12518,0.0040249,0.22106,0.28561,GOBP_BRANCH_ELONGATION_OF_AN_EPITHELIUM,0.933895526390065
HP_MICROMELIA,SET,86,0.052377,0.0035763,0.092537,0.2857,HP_MICROMELIA,0.934101928504233
NAKAYA_PBMC_FLUAD_MALE_AGE_1...3,SET,17,0.13392,0.0040731,0.23665,0.28574,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_UP,0.934144831154172
MIR7706,SET,10,0.16935,0.0039511,0.29942,0.28585,MIR7706,0.934301940789474
chr5q32,SET,44,0.13511,0.0066061,0.2389,0.28586,chr5q32,0.934301940789474
REACTOME_RHOJ_GTPASE_CYCLE,SET,50,0.069873,0.0036414,0.12358,0.2859,REACTOME_RHOJ_GTPASE_CYCLE,0.934301940789474
SCHERER_PBMC_APSV_WETVAX_AGE...3,SET,130,0.041608,0.0034888,0.073602,0.28593,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,0.934301940789474
GSE2128_C57BL6_VS_NOD_THYMOC...4,SET,179,0.034823,0.0034216,0.061611,0.28597,GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP,0.934301940789474
CYCLIN_D1_UP.V1_UP,SET,169,0.037672,0.0035977,0.066657,0.28598,CYCLIN_D1_UP.V1_UP,0.934301940789474
MIR548AJ_3P_MIR548X_3P,SET,835,0.017205,0.0035848,0.030446,0.286,MIR548AJ_3P_MIR548X_3P,0.934301940789474
HP_INCREASED_FEMALE_LIBIDO,SET,18,0.12289,0.0038459,0.21748,0.28602,HP_INCREASED_FEMALE_LIBIDO,0.934301940789474
GSE17721_CTRL_VS_POLYIC_24H_...1,SET,186,0.035277,0.0035326,0.062433,0.28603,GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN,0.934301940789474
HP_ONYCHOGRYPOSIS,SET,27,0.095598,0.0036633,0.16931,0.28617,HP_ONYCHOGRYPOSIS,0.934478442861161
REACTOME_CELLULAR_RESPONSES_...,SET,699,0.018012,0.003447,0.031903,0.28618,REACTOME_CELLULAR_RESPONSES_TO_STIMULI,0.934478442861161
HP_SEPTIC_ARTHRITIS,SET,7,0.1638,0.0031977,0.29012,0.28618,HP_SEPTIC_ARTHRITIS,0.934478442861161
GOMF_SCAFFOLD_PROTEIN_BINDING,SET,65,0.06167,0.0036629,0.10924,0.2862,GOMF_SCAFFOLD_PROTEIN_BINDING,0.934478442861161
HP_PALMAR_PITS,SET,8,0.13203,0.0027554,0.23392,0.28624,HP_PALMAR_PITS,0.934478442861161
HNF1_01,SET,219,0.035625,0.0038675,0.063144,0.28632,HNF1_01,0.934478442861161
CUI_DEVELOPING_HEART_RIGHT_A...,SET,36,0.082908,0.0036676,0.14695,0.28632,CUI_DEVELOPING_HEART_RIGHT_ATRIAL_CARDIOMYOCYTE,0.934478442861161
GOBP_POSITIVE_REGULATION_OF_...557,SET,34,0.087517,0.0037626,0.15518,0.28639,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.934478442861161
REACTOME_NEUROTRANSMITTER_CL...,SET,9,0.16738,0.003705,0.29684,0.28643,REACTOME_NEUROTRANSMITTER_CLEARANCE,0.934478442861161
GSE2706_UNSTIM_VS_8H_LPS_AND...1,SET,173,0.038284,0.0036987,0.067902,0.28644,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN,0.934478442861161
HP_OSTEOARTHRITIS,SET,57,0.066513,0.0037003,0.11798,0.28646,HP_OSTEOARTHRITIS,0.934478442861161
HP_DECREASED_LACRIMATION,SET,26,0.098357,0.0036987,0.17449,0.28648,HP_DECREASED_LACRIMATION,0.934478442861161
HP_ACIDEMIA,SET,22,0.10045,0.003475,0.1782,0.28649,HP_ACIDEMIA,0.934478442861161
GSE43955_10H_VS_60H_ACT_CD4_...2,SET,177,0.035248,0.0034441,0.062547,0.28654,GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP,0.934478442861161
BIOCARTA_NOTCH_PATHWAY,SET,6,0.17254,0.0031186,0.30622,0.28657,BIOCARTA_NOTCH_PATHWAY,0.934478442861161
GOBP_POSITIVE_REGULATION_OF_...295,SET,5,0.26034,0.0042957,0.4621,0.28659,GOBP_POSITIVE_REGULATION_OF_GASTRULATION,0.934478442861161
GNF2_BNIP2,SET,32,0.078355,0.0032683,0.1391,0.28662,GNF2_BNIP2,0.934478442861161
GOBP_POSITIVE_REGULATION_OF_...207,SET,1215,0.014999,0.0037286,0.026632,0.28665,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.934478442861161
FUJIWARA_PARK2_HEPATOCYTE_PR...1,SET,7,0.20515,0.004005,0.36434,0.2867,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN,0.934478442861161
GOBP_PROTEIN_SUMOYLATION,SET,59,0.059477,0.0033662,0.10564,0.28671,GOBP_PROTEIN_SUMOYLATION,0.934478442861161
BIOCARTA_STEM_PATHWAY,SET,15,0.12941,0.0036976,0.22986,0.28672,BIOCARTA_STEM_PATHWAY,0.934478442861161
JEPSEN_SMRT_TARGETS,SET,29,0.090832,0.0036071,0.1614,0.28679,JEPSEN_SMRT_TARGETS,0.934478442861161
REACTOME_TP53_REGULATES_TRAN...7,SET,19,0.11376,0.0036578,0.20214,0.28679,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,0.934478442861161
GOBP_HINDLIMB_MORPHOGENESIS,SET,34,0.093632,0.0040256,0.16637,0.28679,GOBP_HINDLIMB_MORPHOGENESIS,0.934478442861161
GOMF_METALLOPEPTIDASE_ACTIVI...,SET,173,0.039136,0.003781,0.069543,0.2868,GOMF_METALLOPEPTIDASE_ACTIVITY,0.934478442861161
RYTGCNWTGGNR_UNKNOWN,SET,100,0.048441,0.0035653,0.086083,0.28681,RYTGCNWTGGNR_UNKNOWN,0.934478442861161
GOBP_NEGATIVE_REGULATION_OF_...160,SET,7,0.175,0.0034164,0.31097,0.28681,GOBP_NEGATIVE_REGULATION_OF_CYTOKINESIS,0.934478442861161
ATGCTGG_MIR338,SET,108,0.045244,0.0034598,0.080419,0.28686,ATGCTGG_MIR338,0.93449872059237
MIR6835_3P,SET,414,0.025231,0.0037458,0.044849,0.28687,MIR6835_3P,0.93449872059237
REACTOME_METABOLISM_OF_ANGIO...,SET,15,0.14892,0.004255,0.26485,0.28696,REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS,0.934593427208084
chr6q27,SET,25,0.14661,0.0054064,0.26088,0.28706,chr6q27,0.934593427208084
GOBP_REGULATION_OF_ESTABLISH...4,SET,43,0.068683,0.00332,0.12224,0.28711,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.934593427208084
TERAO_AOX4_TARGETS_HG_UP,SET,27,0.087677,0.0033598,0.15606,0.28712,TERAO_AOX4_TARGETS_HG_UP,0.934593427208084
GOBP_REGULATION_OF_GTP_BINDI...,SET,8,0.18624,0.0038868,0.33152,0.28714,GOBP_REGULATION_OF_GTP_BINDING,0.934593427208084
GSE25123_WT_VS_PPARG_KO_MACR...7,SET,181,0.035712,0.0035283,0.063574,0.28715,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,0.934593427208084
REACTOME_BILE_ACID_AND_BILE_...,SET,44,0.074968,0.0036656,0.13347,0.28717,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,0.934593427208084
SF1_Q6,SET,233,0.031565,0.0035332,0.056201,0.28718,SF1_Q6,0.934593427208084
GOBP_NEGATIVE_REGULATION_OF_...464,SET,42,0.070028,0.0033455,0.1247,0.2872,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.934593427208084
DESCARTES_FETAL_LIVER_HEMATO...,SET,23,0.10854,0.0038393,0.19327,0.2872,DESCARTES_FETAL_LIVER_HEMATOPOIETIC_STEM_CELLS,0.934593427208084
HP_ABNORMAL_CIRCULATING_FATT...1,SET,39,0.07242,0.0033342,0.12897,0.28722,HP_ABNORMAL_CIRCULATING_FATTY_ACID_ANION_CONCENTRATION,0.934593427208084
TORCHIA_TARGETS_OF_EWSR1_FLI...4,SET,240,0.031572,0.0035861,0.056232,0.28724,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.934593427208084
GSE2706_UNSTIM_VS_2H_LPS_AND...2,SET,162,0.035806,0.0033486,0.063777,0.28726,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP,0.934593427208084
GOBP_RESPONSE_TO_PROSTAGLAND...2,SET,5,0.26706,0.0044066,0.47584,0.28732,GOBP_RESPONSE_TO_PROSTAGLANDIN_D,0.934593427208084
GOMF_CHOLINE_TRANSMEMBRANE_T...,SET,7,0.20079,0.0039198,0.35776,0.28732,GOMF_CHOLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.934593427208084
GOBP_PRIMITIVE_HEMOPOIESIS,SET,8,0.18272,0.0038132,0.32557,0.28733,GOBP_PRIMITIVE_HEMOPOIESIS,0.934593427208084
GOBP_EMBRYONIC_SKELETAL_JOIN...2,SET,10,0.16861,0.003934,0.30052,0.28738,GOBP_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS,0.934593427208084
BENPORATH_ES_1,SET,337,0.025681,0.0034472,0.045774,0.28739,BENPORATH_ES_1,0.934593427208084
GOBP_PRIMARY_MIRNA_PROCESSING,SET,18,0.10167,0.0031819,0.18124,0.28741,GOBP_PRIMARY_MIRNA_PROCESSING,0.934593427208084
HP_ABNORMALITY_OF_COORDINATI...,SET,1040,0.014944,0.0034544,0.026648,0.28747,HP_ABNORMALITY_OF_COORDINATION,0.934701080550098
GOBP_RESPONSE_TO_NITROGEN_CO...,SET,991,0.015818,0.0035745,0.028213,0.28751,GOBP_RESPONSE_TO_NITROGEN_COMPOUND,0.934716831822006
ASTIER_INTEGRIN_SIGNALING,SET,54,0.069555,0.0037666,0.12407,0.28753,ASTIER_INTEGRIN_SIGNALING,0.934716831822006
KEGG_MEDICUS_VARIANT_SCRAPIE...5,SET,5,0.23996,0.0039594,0.42817,0.28759,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.934716831822006
REACTOME_REGULATION_OF_INNAT...,SET,13,0.13575,0.0036109,0.24224,0.28761,REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,0.934716831822006
GOBP_PROTEIN_LOCALIZATION_TO...28,SET,53,0.064898,0.0034818,0.11584,0.28765,GOBP_PROTEIN_LOCALIZATION_TO_LYSOSOME,0.934716831822006
HP_AGAMMAGLOBULINEMIA,SET,19,0.11578,0.0037227,0.20667,0.28767,HP_AGAMMAGLOBULINEMIA,0.934716831822006
HP_METATARSAL_SYNOSTOSIS,SET,7,0.19558,0.0038182,0.34914,0.28768,HP_METATARSAL_SYNOSTOSIS,0.934716831822006
JIANG_MELANOMA_TRM_HIGH_SURV...,SET,19,0.11376,0.0036578,0.2031,0.28769,JIANG_MELANOMA_TRM_HIGH_SURVIVAL_22_GENE_SIGNATURE,0.934716831822006
MIR410_5P,SET,38,0.074572,0.0033891,0.13319,0.28777,MIR410_5P,0.934733746967718
HP_ABNORMAL_SERUM_ESTRADIOL,SET,59,0.061589,0.0034858,0.11001,0.28779,HP_ABNORMAL_SERUM_ESTRADIOL,0.934733746967718
GSE16450_IMMATURE_VS_MATURE_...3,SET,177,0.035811,0.0034991,0.063978,0.28783,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.934733746967718
GOBP_POSITIVE_REGULATION_OF_...726,SET,11,0.16196,0.0039632,0.28942,0.28788,GOBP_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION,0.934733746967718
chr10q23,SET,81,0.10098,0.0066923,0.18049,0.28792,chr10q23,0.934733746967718
GOCC_HISTONE_DEACETYLASE_COM...,SET,73,0.052546,0.0033067,0.093917,0.28792,GOCC_HISTONE_DEACETYLASE_COMPLEX,0.934733746967718
GSE13411_SWITCHED_MEMORY_BCE...2,SET,178,0.035486,0.003477,0.063439,0.28796,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.934733746967718
GOMF_C_PALMITOYLTRANSFERASE_...,SET,5,0.22759,0.0037553,0.4069,0.28797,GOMF_C_PALMITOYLTRANSFERASE_ACTIVITY,0.934733746967718
GOBP_ALDEHYDE_CATABOLIC_PROC...,SET,13,0.12676,0.0033719,0.22665,0.28798,GOBP_ALDEHYDE_CATABOLIC_PROCESS,0.934733746967718
GOBP_POSITIVE_REGULATION_OF_...651,SET,236,0.031232,0.0035181,0.055855,0.28803,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT,0.934733746967718
AMUNDSON_RESPONSE_TO_ARSENITE,SET,193,0.034319,0.0035001,0.061382,0.28805,AMUNDSON_RESPONSE_TO_ARSENITE,0.934733746967718
MIR616_5P,SET,856,0.016704,0.0035216,0.02988,0.28807,MIR616_5P,0.934733746967718
GSE25088_CTRL_VS_ROSIGLITAZO...2,SET,183,0.035613,0.0035378,0.063723,0.28813,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.934733746967718
HP_ABNORMALITY_OF_THE_UTERUS,SET,225,0.032149,0.0035371,0.057534,0.28816,HP_ABNORMALITY_OF_THE_UTERUS,0.934733746967718
GOBP_NEGATIVE_REGULATION_OF_...42,SET,8,0.17414,0.0036342,0.31169,0.28819,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.934733746967718
GOBP_REGULATION_OF_TRANSPORT,SET,1447,0.013453,0.0036248,0.02408,0.2882,GOBP_REGULATION_OF_TRANSPORT,0.934733746967718
SASSON_FSH_RESPONSE,SET,7,0.20414,0.0039852,0.36549,0.28825,SASSON_FSH_RESPONSE,0.934733746967718
KEGG_MEDICUS_VARIANT_MUTATIO...34,SET,11,0.158,0.0038662,0.28289,0.28825,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004,0.934733746967718
GOCC_GAP_JUNCTION,SET,27,0.10629,0.0040732,0.19032,0.28825,GOCC_GAP_JUNCTION,0.934733746967718
HE_LIM_SUN_FETAL_LUNG_C1_PRO...1,SET,176,0.039354,0.0038346,0.070462,0.28825,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL,0.934733746967718
GSE4984_GALECTIN1_VS_VEHICLE...1,SET,176,0.033937,0.0033068,0.060768,0.28826,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN,0.934733746967718
GOBP_NEURAL_FOLD_FORMATION,SET,7,0.17615,0.0034389,0.31546,0.28829,GOBP_NEURAL_FOLD_FORMATION,0.934743814721522
GOBP_OLFACTORY_BULB_INTERNEU...2,SET,12,0.15968,0.0040811,0.28609,0.28837,GOBP_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION,0.934915984141791
ZIC1_01,SET,234,0.030336,0.0034029,0.054365,0.28842,ZIC1_01,0.934990868389143
MULLIGHAN_NPM1_MUTATED_SIGNA...3,SET,65,0.053266,0.0031637,0.095471,0.28845,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,0.935000909345271
GOBP_POSITIVE_REGULATION_OF_...254,SET,15,0.11332,0.0032378,0.20317,0.2885,GOBP_POSITIVE_REGULATION_OF_ERAD_PATHWAY,0.935075771705679
HOEK_MYELOID_DENDRITIC_CELL_...2,SET,16,0.12194,0.0035983,0.21869,0.28856,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_UP,0.935183028720627
GOBP_L_HISTIDINE_TRANSMEMBRA...,SET,4,0.25862,0.0038168,0.46391,0.2886,GOBP_L_HISTIDINE_TRANSMEMBRANE_TRANSPORT,0.935203067313071
POS_HISTAMINE_RESPONSE_NETWO...,SET,27,0.095221,0.0036489,0.17082,0.28862,POS_HISTAMINE_RESPONSE_NETWORK,0.935203067313071
MENON_FETAL_KIDNEY_9_ENDOTHE...,SET,91,0.056304,0.0039541,0.10107,0.28874,MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS,0.935328834355828
GSE20152_SPHK1_KO_VS_WT_HTNF...2,SET,179,0.035844,0.0035219,0.064356,0.28878,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP,0.935328834355828
HP_LIMITED_ELBOW_EXTENSION,SET,45,0.07085,0.0035033,0.12721,0.28879,HP_LIMITED_ELBOW_EXTENSION,0.935328834355828
GROSS_HYPOXIA_VIA_ELK3_DN,SET,137,0.044211,0.0038048,0.079388,0.2888,GROSS_HYPOXIA_VIA_ELK3_DN,0.935328834355828
GOBP_MOLTING_CYCLE,SET,114,0.049641,0.0038995,0.089138,0.2888,GOBP_MOLTING_CYCLE,0.935328834355828
HP_DEPRESSED_NASAL_TIP,SET,22,0.10544,0.0036477,0.18937,0.28884,HP_DEPRESSED_NASAL_TIP,0.935328834355828
GOBP_POSITIVE_REGULATION_OF_...612,SET,178,0.0358,0.0035079,0.064325,0.28892,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.935328834355828
GOBP_TRIPEPTIDE_TRANSPORT,SET,11,0.15025,0.0036766,0.27002,0.28895,GOBP_TRIPEPTIDE_TRANSPORT,0.935328834355828
MORF_FLT1,SET,116,0.045749,0.0036249,0.082222,0.28897,MORF_FLT1,0.935328834355828
HP_SKIN_NODULE,SET,120,0.044374,0.0035756,0.079774,0.28903,HP_SKIN_NODULE,0.935328834355828
MIR150_3P,SET,118,0.044054,0.0035203,0.079246,0.28914,MIR150_3P,0.935328834355828
HP_ABSENT_DISTAL_INTERPHALAN...,SET,7,0.18466,0.0036049,0.33223,0.28917,HP_ABSENT_DISTAL_INTERPHALANGEAL_CREASES,0.935328834355828
KEGG_MEDICUS_VARIANT_MUTATIO...39,SET,25,0.094518,0.0034854,0.17009,0.28921,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.935328834355828
HP_ABNORMAL_SHOULDER_MORPHOL...,SET,79,0.055337,0.0036221,0.099591,0.28923,HP_ABNORMAL_SHOULDER_MORPHOLOGY,0.935328834355828
GSE11961_FOLLICULAR_BCELL_VS...3,SET,182,0.0352,0.0034872,0.06335,0.28923,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.935328834355828
GSE36888_STAT5_AB_KNOCKIN_VS...1,SET,177,0.036138,0.0035311,0.06504,0.28924,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN,0.935328834355828
GOBP_RETROGRADE_TRANSPORT_EN...,SET,88,0.046166,0.0031885,0.083099,0.28926,GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.935328834355828
REACTOME_ERYTHROPOIETIN_ACTI...4,SET,7,0.22201,0.0043342,0.39965,0.28927,REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5,0.935328834355828
GOBP_NEGATIVE_REGULATION_OF_...404,SET,5,0.25089,0.0041397,0.45164,0.28928,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.935328834355828
GOBP_REGULATION_OF_CHOLESTER...1,SET,16,0.11647,0.0034367,0.20966,0.28928,GOBP_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.935328834355828
FAN_EMBRYONIC_CTX_NSC_2,SET,215,0.031404,0.0033784,0.056535,0.28929,FAN_EMBRYONIC_CTX_NSC_2,0.935328834355828
WEBER_METHYLATED_LCP_IN_SPER...2,SET,14,0.13092,0.0036139,0.23574,0.28932,WEBER_METHYLATED_LCP_IN_SPERM_UP,0.935328834355828
GOBP_ENDOCYTIC_RECYCLING,SET,74,0.055714,0.0035299,0.10033,0.28934,GOBP_ENDOCYTIC_RECYCLING,0.935328834355828
SCIAN_CELL_CYCLE_TARGETS_OF_...1,SET,22,0.10078,0.0034864,0.18149,0.28936,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,0.935328834355828
HP_PREAXIAL_HAND_POLYDACTYLY,SET,53,0.060128,0.0032259,0.10831,0.28939,HP_PREAXIAL_HAND_POLYDACTYLY,0.935328834355828
GOBP_REGULATION_OF_NADP_META...,SET,8,0.17523,0.003657,0.31565,0.2894,GOBP_REGULATION_OF_NADP_METABOLIC_PROCESS,0.935328834355828
GSE17721_POLYIC_VS_CPG_24H_B...2,SET,188,0.034276,0.0034506,0.061741,0.2894,GSE17721_POLYIC_VS_CPG_24H_BMDC_UP,0.935328834355828
HP_TOTAL_ANOMALOUS_PULMONARY...,SET,11,0.13037,0.0031902,0.23491,0.28945,HP_TOTAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.935328834355828
HP_ABNORMALITY_OF_THE_THYROI...,SET,461,0.023021,0.0036018,0.04149,0.2895,HP_ABNORMALITY_OF_THE_THYROID_GLAND,0.935328834355828
REACTOME_TRAF3_DEPENDENT_IRF...,SET,14,0.12368,0.003414,0.22291,0.28951,REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,0.935328834355828
KLEIN_PRIMARY_EFFUSION_LYMPH...2,SET,46,0.067566,0.0033777,0.12178,0.28952,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,0.935328834355828
HP_ABNORMAL_MITOCHONDRIAL_NU...,SET,6,0.15986,0.0028894,0.28815,0.28952,HP_ABNORMAL_MITOCHONDRIAL_NUMBER,0.935328834355828
GOBP_RENAL_SYSTEM_DEVELOPMENT,SET,315,0.029015,0.0037677,0.052317,0.28959,GOBP_RENAL_SYSTEM_DEVELOPMENT,0.935391051017563
PHF21A_TARGET_GENES,SET,224,0.032127,0.0035269,0.057935,0.28961,PHF21A_TARGET_GENES,0.935391051017563
GOBP_PURKINJE_MYOCYTE_TO_VEN...,SET,6,0.2131,0.0038517,0.38432,0.28962,GOBP_PURKINJE_MYOCYTE_TO_VENTRICULAR_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.935391051017563
PILON_KLF1_TARGETS_UP,SET,439,0.023243,0.0035508,0.041932,0.28969,PILON_KLF1_TARGETS_UP,0.935530194201821
GOBP_POSITIVE_REGULATION_OF_...407,SET,13,0.13341,0.0035487,0.24072,0.28972,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.935540146799219
GOBP_PROTON_TRANSMEMBRANE_TR...,SET,118,0.043142,0.0034475,0.077877,0.2898,GOBP_PROTON_TRANSMEMBRANE_TRANSPORT,0.935552728791535
HP_PREMATURE_ATRIAL_CONTRACT...,SET,6,0.23537,0.0042541,0.42486,0.2898,HP_PREMATURE_ATRIAL_CONTRACTIONS,0.935552728791535
GOBP_REGULATION_OF_STRESS_AC...,SET,36,0.081031,0.0035846,0.14631,0.28985,GOBP_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.935552728791535
PROVENZANI_METASTASIS_DN,SET,134,0.041973,0.0035727,0.075817,0.28993,PROVENZANI_METASTASIS_DN,0.935552728791535
GOBP_REGULATION_OF_APOPTOTIC...5,SET,346,0.025578,0.003478,0.046208,0.28995,GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.935552728791535
GOBP_POSITIVE_REGULATION_OF_...121,SET,17,0.10606,0.0032259,0.19162,0.28996,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.935552728791535
GSE21360_TERTIARY_VS_QUATERN...1,SET,161,0.039833,0.0037137,0.071973,0.28998,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.935552728791535
REACTOME_SELENOAMINO_ACID_ME...,SET,99,0.046478,0.0034037,0.083981,0.28999,REACTOME_SELENOAMINO_ACID_METABOLISM,0.935552728791535
AACTGGA_MIR145,SET,216,0.03148,0.0033943,0.056882,0.28999,AACTGGA_MIR145,0.935552728791535
MIR548Y,SET,450,0.022787,0.0035235,0.041181,0.29001,MIR548Y,0.935552728791535
DESCARTES_FETAL_KIDNEY_METAN...,SET,110,0.049939,0.0038539,0.090251,0.29002,DESCARTES_FETAL_KIDNEY_METANEPHRIC_CELLS,0.935552728791535
GOBP_SENSORY_ORGAN_DEVELOPME...,SET,554,0.021908,0.0037477,0.039606,0.29008,GOBP_SENSORY_ORGAN_DEVELOPMENT,0.93565943387471
GOBP_REGULATION_OF_SPINDLE_O...,SET,46,0.064598,0.0032294,0.11683,0.29016,GOBP_REGULATION_OF_SPINDLE_ORGANIZATION,0.935743787696019
HP_NARROW_PALM,SET,13,0.14947,0.0039759,0.27032,0.29016,HP_NARROW_PALM,0.935743787696019
GSE19923_WT_VS_HEB_KO_DP_THY...2,SET,183,0.035495,0.003526,0.064208,0.2902,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP,0.93578345236991
GOCC_ACROSOMAL_MEMBRANE,SET,30,0.097482,0.0039373,0.17639,0.29025,GOCC_ACROSOMAL_MEMBRANE,0.93578345236991
REACTOME_HYDROLYSIS_OF_LPC,SET,9,0.16448,0.0036408,0.29763,0.29026,REACTOME_HYDROLYSIS_OF_LPC,0.93578345236991
GSE33162_HDAC3_KO_VS_HDAC3_K...2,SET,180,0.033782,0.0033285,0.061136,0.29028,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP,0.93578345236991
GOBP_MEMBRANE_DEPOLARIZATION...4,SET,5,0.2241,0.0036977,0.40582,0.2904,GOBP_MEMBRANE_DEPOLARIZATION_DURING_SA_NODE_CELL_ACTION_POTENTIAL,0.935929396240393
MIR558,SET,106,0.047121,0.0035701,0.085334,0.29041,MIR558,0.935929396240393
OVSYANNIKOVA_PBMC_FLUARIX_AG...7,SET,6,0.18814,0.0034005,0.34083,0.29048,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_DN,0.935929396240393
HNF4ALPHA_Q6,SET,236,0.030471,0.0034324,0.055213,0.29052,HNF4ALPHA_Q6,0.935929396240393
GOBP_REGULATION_OF_NEUROBLAS...,SET,51,0.069142,0.003639,0.12528,0.29052,GOBP_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.935929396240393
GOBP_INTERLEUKIN_33_MEDIATED...,SET,7,0.17818,0.0034784,0.3229,0.29054,GOBP_INTERLEUKIN_33_MEDIATED_SIGNALING_PATHWAY,0.935929396240393
FRASOR_RESPONSE_TO_SERM_OR_F...2,SET,21,0.10366,0.0035036,0.18785,0.29055,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,0.935929396240393
chr3q25,SET,61,0.11175,0.0064304,0.20254,0.29057,chr3q25,0.935929396240393
GOMF_INOSITOL_1_4_5_TRISPHOS...1,SET,6,0.16774,0.0030318,0.30404,0.29058,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.935929396240393
GOCC_VOLTAGE_GATED_CALCIUM_C...,SET,41,0.076799,0.0036251,0.13923,0.29061,GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.935929396240393
GOBP_NEGATIVE_REGULATION_OF_...555,SET,21,0.1076,0.0036371,0.19514,0.29068,GOBP_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.935929396240393
KEGG_LYSINE_DEGRADATION,SET,37,0.07306,0.0032765,0.1325,0.29069,KEGG_LYSINE_DEGRADATION,0.935929396240393
WP_TRANSCRIPTIONAL_ACTIVATIO...,SET,15,0.12425,0.00355,0.22537,0.29071,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,0.935929396240393
HP_SLOW_PUPILLARY_LIGHT_RESP...,SET,17,0.11419,0.0034732,0.20713,0.29071,HP_SLOW_PUPILLARY_LIGHT_RESPONSE,0.935929396240393
REACTOME_TRAIL_SIGNALING,SET,8,0.19837,0.0041399,0.35988,0.29075,REACTOME_TRAIL_SIGNALING,0.935929396240393
HP_UNCOMBABLE_HAIR,SET,4,0.27347,0.004036,0.49623,0.29079,HP_UNCOMBABLE_HAIR,0.935929396240393
OCT_Q6,SET,217,0.0335,0.0036204,0.060794,0.29081,OCT_Q6,0.935929396240393
MODULE_521,SET,35,0.089633,0.0039098,0.16266,0.29081,MODULE_521,0.935929396240393
DESCARTES_FETAL_CEREBELLUM_G...,SET,26,0.10048,0.0037784,0.18238,0.29085,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.935971458333333
GOBP_THIOESTER_BIOSYNTHETIC_...,SET,41,0.079031,0.0037305,0.14348,0.29089,GOBP_THIOESTER_BIOSYNTHETIC_PROCESS,0.935991209961118
GOMF_AZOLE_TRANSMEMBRANE_TRA...,SET,12,0.14282,0.0036501,0.25933,0.29091,GOMF_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.935991209961118
GSE28737_BCL6_HET_VS_BCL6_KO...2,SET,179,0.033978,0.0033386,0.061732,0.29102,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.936258455984449
GOMF_HISTONE_UBIQUITIN_LIGAS...,SET,10,0.14506,0.0033845,0.26367,0.29111,GOMF_HISTONE_UBIQUITIN_LIGASE_ACTIVITY,0.936394313870639
GOBP_CELLULAR_RESPONSE_TO_IO...,SET,66,0.054352,0.0032529,0.098816,0.29115,GOBP_CELLULAR_RESPONSE_TO_IONIZING_RADIATION,0.936394313870639
REACTOME_GLYCOSPHINGOLIPID_C...,SET,31,0.084039,0.0034503,0.1528,0.29116,REACTOME_GLYCOSPHINGOLIPID_CATABOLISM,0.936394313870639
GSE26495_PD1HIGH_VS_PD1LOW_C...1,SET,148,0.038394,0.0034332,0.069809,0.29117,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN,0.936394313870639
GOBP_INTERNAL_PROTEIN_AMINO_...,SET,10,0.12597,0.002939,0.22913,0.29124,GOBP_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION,0.936455952821461
STAT3_02,SET,135,0.040436,0.0034546,0.07356,0.29126,STAT3_02,0.936455952821461
GOBP_REGULATION_OF_PROTEIN_T...3,SET,400,0.023816,0.0034768,0.043326,0.29127,GOBP_REGULATION_OF_PROTEIN_TRANSPORT,0.936455952821461
GSE7764_NKCELL_VS_SPLENOCYTE...2,SET,184,0.036109,0.0035967,0.065724,0.29136,GSE7764_NKCELL_VS_SPLENOCYTE_UP,0.936613983168408
REACTOME_RESOLUTION_OF_ABASI...,SET,37,0.069584,0.0031206,0.12667,0.29139,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,0.936613983168408
MIR494_5P,SET,38,0.074315,0.0033774,0.13529,0.2914,MIR494_5P,0.936613983168408
MIR6764_3P,SET,98,0.045874,0.0033426,0.083527,0.29143,MIR6764_3P,0.936623788607361
GSE4748_CTRL_VS_CYANOBACTERI...3,SET,178,0.032995,0.003233,0.060089,0.29147,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.93666572815534
CENPT_TARGET_GENES,SET,49,0.064759,0.003341,0.11795,0.2915,CENPT_TARGET_GENES,0.936675526997041
HP_VACUOLATED_LYMPHOCYTES,SET,11,0.15015,0.0036741,0.27357,0.29156,HP_VACUOLATED_LYMPHOCYTES,0.936781713968753
GSE17721_LPS_VS_CPG_6H_BMDC_...1,SET,180,0.03451,0.0034002,0.062907,0.29165,GSE17721_LPS_VS_CPG_6H_BMDC_DN,0.936984262340544
MIR370_3P,SET,88,0.049057,0.0033882,0.089495,0.2918,MIR370_3P,0.937073309033866
DAVICIONI_PAX_FOXO1_SIGNATUR...2,SET,52,0.07112,0.0037795,0.12977,0.29184,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,0.937073309033866
HP_LOW_SET_NIPPLES,SET,6,0.15259,0.002758,0.27845,0.29185,HP_LOW_SET_NIPPLES,0.937073309033866
REACTOME_AKT_PHOSPHORYLATES_...2,SET,9,0.14698,0.0032534,0.26824,0.29187,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,0.937073309033866
MIR4499,SET,103,0.047921,0.0035792,0.08747,0.2919,MIR4499,0.937073309033866
AMIT_EGF_RESPONSE_480_HELA,SET,154,0.038987,0.0035556,0.071171,0.29192,AMIT_EGF_RESPONSE_480_HELA,0.937073309033866
REACTOME_PKR_MEDIATED_SIGNAL...,SET,65,0.056356,0.0033473,0.10288,0.29193,REACTOME_PKR_MEDIATED_SIGNALING,0.937073309033866
HP_CONGENITAL_FIBROSIS_OF_EX...,SET,6,0.19318,0.0034916,0.3527,0.29195,HP_CONGENITAL_FIBROSIS_OF_EXTRAOCULAR_MUSCLES,0.937073309033866
GOBP_POSITIVE_REGULATION_OF_...555,SET,12,0.14199,0.0036288,0.25925,0.29196,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.937073309033866
GSE17721_PAM3CSK4_VS_CPG_8H_...2,SET,183,0.033851,0.0033627,0.061826,0.29201,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP,0.937073309033866
FLECHNER_PBL_KIDNEY_TRANSPLA...4,SET,57,0.061151,0.003402,0.11174,0.2921,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.937073309033866
GOBP_NATURAL_KILLER_CELL_ACT...1,SET,89,0.053349,0.0037054,0.09748,0.2921,GOBP_NATURAL_KILLER_CELL_ACTIVATION,0.937073309033866
REACTOME_SIGNALING_BY_NTRK2_...,SET,25,0.087661,0.0032325,0.16019,0.29211,REACTOME_SIGNALING_BY_NTRK2_TRKB,0.937073309033866
HP_ACUTE_LYMPHOBLASTIC_LEUKE...,SET,40,0.074112,0.0034555,0.13543,0.29211,HP_ACUTE_LYMPHOBLASTIC_LEUKEMIA,0.937073309033866
PR_02,SET,123,0.043071,0.0035135,0.078712,0.29213,PR_02,0.937073309033866
GOMF_CARBOHYDRATE_PHOSPHATAS...,SET,8,0.15703,0.0032772,0.28704,0.29217,GOMF_CARBOHYDRATE_PHOSPHATASE_ACTIVITY,0.937073309033866
GOBP_REGULATION_OF_FIBROBLAS...4,SET,86,0.052068,0.0035552,0.095187,0.29219,GOBP_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.937073309033866
GOMF_WNT_PROTEIN_BINDING,SET,30,0.097557,0.0039403,0.17835,0.29219,GOMF_WNT_PROTEIN_BINDING,0.937073309033866
GSE7509_DC_VS_MONOCYTE_WITH_...2,SET,182,0.034532,0.0034211,0.06313,0.29219,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP,0.937073309033866
GSE33292_WT_VS_TCF1_KO_DN3_T...2,SET,175,0.036487,0.0035452,0.06672,0.29224,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP,0.937147185827643
GOBP_SIGNALING_RECEPTOR_LIGA...,SET,36,0.080587,0.0035649,0.14742,0.29231,GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING,0.937230774907749
GSE18893_TCONV_VS_TREG_2H_TN...2,SET,185,0.034045,0.0034002,0.062281,0.29232,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP,0.937230774907749
GOBP_REGULATION_OF_SYNAPTIC_...13,SET,22,0.094708,0.0032764,0.1733,0.29236,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.937272557882114
EHRLICH_ICF_SYNDROM_UP,SET,9,0.15333,0.003394,0.2808,0.29252,EHRLICH_ICF_SYNDROM_UP,0.937612524209167
LIN_TUMOR_ESCAPE_FROM_IMMUNE...,SET,17,0.11584,0.0035234,0.21215,0.29252,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,0.937612524209167
HP_PREMATURE_VENTRICULAR_CON...,SET,27,0.099296,0.003805,0.18193,0.29261,HP_PREMATURE_VENTRICULAR_CONTRACTION,0.937692975663717
HP_PARTIAL_ABSENCE_OF_SPECIF...2,SET,6,0.20533,0.0037113,0.37629,0.29265,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,0.937692975663717
GOCC_FANCONI_ANAEMIA_NUCLEAR...,SET,7,0.14744,0.0028784,0.27023,0.29267,GOCC_FANCONI_ANAEMIA_NUCLEAR_COMPLEX,0.937692975663717
GOMF_INTRAMOLECULAR_TRANSFER...,SET,26,0.08425,0.0031682,0.15441,0.29267,GOMF_INTRAMOLECULAR_TRANSFERASE_ACTIVITY,0.937692975663717
REACTOME_MAPK1_ERK2_ACTIVATI...,SET,9,0.16868,0.0037337,0.30916,0.29268,REACTOME_MAPK1_ERK2_ACTIVATION,0.937692975663717
REACTOME_INTERLEUKIN_2_FAMIL...,SET,39,0.0828,0.0038121,0.15183,0.29276,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,0.937797339643448
GOBP_NEGATIVE_REGULATION_OF_...389,SET,2,0.4059,0.0042362,0.74444,0.29279,GOBP_NEGATIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.937797339643448
PID_ECADHERIN_KERATINOCYTE_P...,SET,21,0.098869,0.0033418,0.18133,0.2928,PID_ECADHERIN_KERATINOCYTE_PATHWAY,0.937797339643448
REACTOME_PROTEIN_FOLDING,SET,92,0.045922,0.0032426,0.084294,0.29295,REACTOME_PROTEIN_FOLDING,0.937797339643448
GSE12003_4D_VS_8D_CULTURE_MI...2,SET,133,0.042714,0.0036223,0.078404,0.29295,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP,0.937797339643448
GOBP_TUBULIN_DEACETYLATION,SET,18,0.099717,0.0031207,0.18305,0.29296,GOBP_TUBULIN_DEACETYLATION,0.937797339643448
NEMETH_INFLAMMATORY_RESPONSE...1,SET,28,0.092539,0.0036111,0.16989,0.29298,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,0.937797339643448
HP_TIBIAL_BOWING,SET,33,0.088771,0.0037601,0.16298,0.29299,HP_TIBIAL_BOWING,0.937797339643448
GOBP_NEGATIVE_REGULATION_OF_...500,SET,11,0.14692,0.0035951,0.26978,0.29302,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.937797339643448
GSE7568_CTRL_VS_24H_TGFB_TRE...1,SET,180,0.036457,0.003592,0.066959,0.29306,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,0.937797339643448
GOBP_DETECTION_OF_CALCIUM_ION,SET,13,0.13515,0.0035951,0.24827,0.29309,GOBP_DETECTION_OF_CALCIUM_ION,0.937797339643448
HP_SHAWL_SCROTUM,SET,18,0.11009,0.0034452,0.20221,0.29309,HP_SHAWL_SCROTUM,0.937797339643448
REACTOME_ADHERENS_JUNCTIONS_...,SET,51,0.072779,0.0038305,0.1337,0.2931,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,0.937797339643448
MIR6826_5P,SET,34,0.07675,0.0032997,0.14101,0.29313,MIR6826_5P,0.937797339643448
HP_SUPRANUCLEAR_GAZE_PALSY,SET,49,0.066598,0.0034359,0.12237,0.29314,HP_SUPRANUCLEAR_GAZE_PALSY,0.937797339643448
MIR762,SET,163,0.034629,0.0032484,0.063662,0.29324,MIR762,0.937797339643448
GOBP_ACROSOMAL_VESICLE_EXOCY...,SET,9,0.16097,0.003563,0.29593,0.29324,GOBP_ACROSOMAL_VESICLE_EXOCYTOSIS,0.937797339643448
GOBP_POSITIVE_REGULATION_OF_...269,SET,47,0.072787,0.003678,0.13384,0.29328,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.937797339643448
MIR6819_5P,SET,75,0.051983,0.0033156,0.095607,0.29332,MIR6819_5P,0.937797339643448
GOBP_SPONTANEOUS_SYNAPTIC_TR...,SET,13,0.13901,0.0036978,0.25568,0.29333,GOBP_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.937797339643448
HP_TONGUE_FASCICULATIONS,SET,36,0.07733,0.0034209,0.14223,0.29333,HP_TONGUE_FASCICULATIONS,0.937797339643448
GSE29164_CD8_TCELL_VS_CD8_TC...2,SET,175,0.033712,0.0032755,0.062022,0.29338,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.937797339643448
GOMF_HISTONE_ACETYLTRANSFERA...,SET,23,0.097264,0.0034404,0.17896,0.2934,GOMF_HISTONE_ACETYLTRANSFERASE_BINDING,0.937797339643448
HP_DECREASED_CORNEAL_REFLEX,SET,9,0.14404,0.0031883,0.26509,0.29345,HP_DECREASED_CORNEAL_REFLEX,0.937797339643448
GOBP_L_SERINE_BIOSYNTHETIC_P...,SET,6,0.17185,0.0031061,0.31637,0.29351,GOBP_L_SERINE_BIOSYNTHETIC_PROCESS,0.937797339643448
HP_IMMUNOLOGIC_HYPERSENSITIV...,SET,209,0.032928,0.0034931,0.06062,0.29351,HP_IMMUNOLOGIC_HYPERSENSITIVITY,0.937797339643448
HP_MEGACYSTIS,SET,9,0.16988,0.0037602,0.31274,0.29351,HP_MEGACYSTIS,0.937797339643448
LI_WILMS_TUMOR_VS_FETAL_KIDN...4,SET,25,0.096901,0.0035733,0.17841,0.29352,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,0.937797339643448
GSE45365_HEALTHY_VS_MCMV_INF...11,SET,157,0.037216,0.0034267,0.068525,0.29353,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN,0.937797339643448
GSE19888_ADENOSINE_A3R_ACT_V...2,SET,166,0.032984,0.0031221,0.060737,0.29355,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP,0.937797339643448
KEGG_MEDICUS_VARIANT_TEL_AML...,SET,10,0.15688,0.0036602,0.28894,0.29359,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION,0.937797339643448
REACTOME_EVASION_BY_RSV_OF_H...,SET,28,0.098944,0.003861,0.18226,0.29361,REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,0.937797339643448
MIR371B_5P,SET,856,0.016233,0.0034225,0.029904,0.29362,MIR371B_5P,0.937797339643448
GOBP_REGULATION_OF_GLYCOGEN_...4,SET,4,0.20931,0.0030891,0.38559,0.29363,GOBP_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY,0.937797339643448
WP_INITIATION_OF_TRANSCRIPTI...,SET,31,0.078831,0.0032365,0.14525,0.29367,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,0.937838909308095
GAVISH_3CA_METAPROGRAM_B_CEL...5,SET,50,0.069204,0.0036065,0.12764,0.29385,GAVISH_3CA_METAPROGRAM_B_CELLS_INTERFERON,0.938142849284928
GOBP_RETINAL_CELL_PROGRAMMED...,SET,6,0.19927,0.0036017,0.36758,0.29387,GOBP_RETINAL_CELL_PROGRAMMED_CELL_DEATH,0.938142849284928
GSE7568_IL4_TGFB_DEXAMETHASO...2,SET,154,0.035107,0.0032017,0.064788,0.29396,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP,0.938142849284928
GOBP_REGULATION_OF_CELL_ADHE...2,SET,46,0.06698,0.0033485,0.12363,0.29399,GOBP_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.938142849284928
GSE17186_BLOOD_VS_CORD_BLOOD...4,SET,189,0.032801,0.0033108,0.060543,0.29399,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP,0.938142849284928
KEGG_REGULATION_OF_AUTOPHAGY,SET,31,0.095542,0.0039226,0.17636,0.294,KEGG_REGULATION_OF_AUTOPHAGY,0.938142849284928
GOBP_POSITIVE_REGULATION_OF_...249,SET,189,0.035437,0.0035769,0.065414,0.294,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.938142849284928
MODULE_298,SET,26,0.095844,0.0036042,0.17695,0.29403,MODULE_298,0.938142849284928
GOBP_REGULATION_OF_ATP_METAB...,SET,63,0.057924,0.0033872,0.10699,0.29412,GOBP_REGULATION_OF_ATP_METABOLIC_PROCESS,0.938142849284928
GOMF_GDP_BINDING,SET,70,0.055737,0.003435,0.10295,0.29413,GOMF_GDP_BINDING,0.938142849284928
ATGCTGC_MIR103_MIR107,SET,197,0.032238,0.0033214,0.059557,0.29415,ATGCTGC_MIR103_MIR107,0.938142849284928
PID_FAS_PATHWAY,SET,36,0.080681,0.0035691,0.14905,0.29416,PID_FAS_PATHWAY,0.938142849284928
GSE26488_CTRL_VS_PEPTIDE_INJ...2,SET,188,0.03563,0.0035869,0.06583,0.29418,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP,0.938142849284928
GSE1112_HY_CD8AB_VS_HY_CD8AA...2,SET,160,0.036933,0.0034327,0.068249,0.2942,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.938142849284928
BIOCARTA_CXCR4_PATHWAY,SET,19,0.11087,0.0035648,0.20489,0.29422,BIOCARTA_CXCR4_PATHWAY,0.938142849284928
HP_ABNORMAL_CONUS_TERMINALIS...,SET,29,0.083672,0.0033228,0.15463,0.29422,HP_ABNORMAL_CONUS_TERMINALIS_MORPHOLOGY,0.938142849284928
GOBP_NORADRENERGIC_NEURON_DI...,SET,9,0.19253,0.0042617,0.35592,0.29428,GOBP_NORADRENERGIC_NEURON_DIFFERENTIATION,0.938142849284928
HP_ABSENT_OUTER_DYNEIN_ARMS,SET,9,0.14639,0.0032404,0.27062,0.29428,HP_ABSENT_OUTER_DYNEIN_ARMS,0.938142849284928
chr3q28,SET,12,0.14143,0.0036145,0.26153,0.29433,chr3q28,0.938142849284928
REACTOME_EICOSANOID_LIGAND_B...,SET,14,0.12725,0.0035125,0.2353,0.29433,REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,0.938142849284928
BROWNE_HCMV_INFECTION_18HR_UP,SET,156,0.036819,0.0033794,0.068089,0.29434,BROWNE_HCMV_INFECTION_18HR_UP,0.938142849284928
GSE34179_THPOK_KO_VS_WT_VA14...2,SET,187,0.032012,0.0032142,0.05922,0.29441,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP,0.938142849284928
GOBP_REGULATION_OF_LIGASE_AC...,SET,5,0.16647,0.0027469,0.30798,0.29442,GOBP_REGULATION_OF_LIGASE_ACTIVITY,0.938142849284928
HAN_SATB1_TARGETS_DN,SET,346,0.025995,0.0035348,0.048097,0.29444,HAN_SATB1_TARGETS_DN,0.938142849284928
CCTGCTG_MIR214,SET,218,0.030007,0.0032503,0.055522,0.29444,CCTGCTG_MIR214,0.938142849284928
GNF2_ELAC2,SET,40,0.064291,0.0029976,0.119,0.29452,GNF2_ELAC2,0.93815576218395
GSE45365_WT_VS_IFNAR_KO_BCEL...4,SET,161,0.034802,0.0032446,0.064423,0.29453,GSE45365_WT_VS_IFNAR_KO_BCELL_UP,0.93815576218395
HP_HEMIHYPERTROPHY,SET,14,0.11525,0.0031814,0.21337,0.29455,HP_HEMIHYPERTROPHY,0.93815576218395
GOBP_POSITIVE_REGULATION_OF_...711,SET,15,0.1198,0.0034228,0.22188,0.29463,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.93815576218395
ATCMNTCCGY_UNKNOWN,SET,47,0.064541,0.0032613,0.11954,0.29464,ATCMNTCCGY_UNKNOWN,0.93815576218395
HP_HYPERAMMONEMIA,SET,66,0.054006,0.0032322,0.10004,0.29466,HP_HYPERAMMONEMIA,0.93815576218395
GSE11961_FOLLICULAR_BCELL_VS...6,SET,180,0.034652,0.0034142,0.064191,0.29466,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP,0.93815576218395
GSE17721_LPS_VS_CPG_8H_BMDC_...2,SET,186,0.034389,0.0034437,0.063704,0.29466,GSE17721_LPS_VS_CPG_8H_BMDC_UP,0.93815576218395
HP_IMMOTILE_SPERM,SET,14,0.12431,0.0034315,0.23034,0.29471,HP_IMMOTILE_SPERM,0.938171779141104
RGTTAMWNATT_HNF1_01,SET,64,0.062092,0.0036596,0.11508,0.29475,RGTTAMWNATT_HNF1_01,0.938171779141104
GOCC_TRAMP_COMPLEX,SET,2,0.2723,0.0028419,0.50469,0.29476,GOCC_TRAMP_COMPLEX,0.938171779141104
GOBP_NATURAL_KILLER_CELL_CYT...,SET,8,0.1837,0.0038337,0.3405,0.29478,GOBP_NATURAL_KILLER_CELL_CYTOKINE_PRODUCTION,0.938171779141104
KEGG_MEDICUS_VARIANT_MUTATIO...33,SET,13,0.13816,0.003675,0.25612,0.2948,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM,0.938171779141104
KEGG_TASTE_TRANSDUCTION,SET,48,0.077891,0.0039774,0.14446,0.29489,KEGG_TASTE_TRANSDUCTION,0.938318181818182
BASSO_B_LYMPHOCYTE_NETWORK,SET,129,0.038312,0.0032001,0.071062,0.2949,BASSO_B_LYMPHOCYTE_NETWORK,0.938318181818182
VALK_AML_WITH_EVI1,SET,22,0.10837,0.003749,0.20121,0.2951,VALK_AML_WITH_EVI1,0.938782654462243
MIR6769A_3P,SET,17,0.11951,0.003635,0.22191,0.2951,MIR6769A_3P,0.938782654462243
GOBP_TYPE_B_PANCREATIC_CELL_...2,SET,22,0.10412,0.0036021,0.19342,0.29518,GOBP_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.938897085201794
HP_ATONIC_SEIZURE,SET,87,0.048184,0.003309,0.089511,0.29519,HP_ATONIC_SEIZURE,0.938897085201794
AHR_Q5,SET,195,0.033609,0.0034452,0.062466,0.29528,AHR_Q5,0.938975790531895
GOBP_GLIAL_CELL_FATE_COMMITM...,SET,13,0.14799,0.0039366,0.27515,0.29534,GOBP_GLIAL_CELL_FATE_COMMITMENT,0.938975790531895
GOBP_CARDIAC_MUSCLE_CELL_CAR...,SET,7,0.20471,0.0039964,0.38073,0.29541,GOBP_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION,0.938975790531895
MIR6741_5P,SET,22,0.088707,0.0030688,0.165,0.29542,MIR6741_5P,0.938975790531895
GOBP_REGULATION_OF_MACROPHAG...1,SET,54,0.068093,0.0036874,0.12666,0.29543,GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION,0.938975790531895
GOBP_REGULATION_OF_APOPTOTIC...4,SET,4,0.24984,0.0036873,0.4648,0.29546,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.938975790531895
GOCC_VESICLE_TETHERING_COMPL...,SET,62,0.055502,0.0032198,0.10327,0.29547,GOCC_VESICLE_TETHERING_COMPLEX,0.938975790531895
GOCC_DEUTEROSOME,SET,5,0.16302,0.0026899,0.30332,0.29548,GOCC_DEUTEROSOME,0.938975790531895
HP_SMALL_JOINT_HYPERMOBILTY,SET,52,0.064765,0.0034418,0.12051,0.29549,HP_SMALL_JOINT_HYPERMOBILTY,0.938975790531895
HP_BRONCHIECTASIS,SET,154,0.037466,0.0034169,0.069717,0.2955,HP_BRONCHIECTASIS,0.938975790531895
HOLLERN_EMT_BREAST_TUMOR_UP,SET,128,0.042205,0.0035117,0.078545,0.29552,HOLLERN_EMT_BREAST_TUMOR_UP,0.938975790531895
DACOSTA_ERCC3_ALLELE_XPCS_VS...1,SET,31,0.082345,0.0033808,0.1533,0.29559,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,0.938975790531895
GOMF_PIRNA_BINDING,SET,5,0.21966,0.0036245,0.40902,0.29562,GOMF_PIRNA_BINDING,0.938975790531895
HP_PENETRATING_FOOT_ULCERS,SET,6,0.17602,0.0031815,0.32775,0.29562,HP_PENETRATING_FOOT_ULCERS,0.938975790531895
GSE22886_NAIVE_VS_IGM_MEMORY...2,SET,173,0.035006,0.003382,0.065182,0.29562,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.938975790531895
RUAN_RESPONSE_TO_TNF_UP,SET,13,0.13367,0.0035555,0.24896,0.29567,RUAN_RESPONSE_TO_TNF_UP,0.939048784611167
GOBP_ISOLEUCINE_METABOLIC_PR...,SET,6,0.19218,0.0034735,0.35804,0.29573,GOBP_ISOLEUCINE_METABOLIC_PROCESS,0.939067715851987
GSE13411_IGM_VS_SWITCHED_MEM...2,SET,173,0.035638,0.0034431,0.066398,0.29573,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP,0.939067715851987
GOBP_EPITHELIAL_CELL_PROLIFE...1,SET,407,0.024055,0.0035416,0.044851,0.29586,GOBP_EPITHELIAL_CELL_PROLIFERATION,0.939314889051228
HP_HYPERSPLENISM,SET,20,0.10383,0.0034251,0.19364,0.29591,HP_HYPERSPLENISM,0.939314889051228
WP_TH17_CELL_DIFFERENTIATION...,SET,67,0.060356,0.0036394,0.11258,0.29595,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,0.939314889051228
KEGG_RIBOSOME,SET,79,0.04911,0.0032145,0.091609,0.29596,KEGG_RIBOSOME,0.939314889051228
SESTO_RESPONSE_TO_UV_C0,SET,98,0.045176,0.0032917,0.084275,0.29597,SESTO_RESPONSE_TO_UV_C0,0.939314889051228
GOBP_DNA_REPLICATION_SYNTHES...,SET,6,0.16946,0.0030629,0.31614,0.29597,GOBP_DNA_REPLICATION_SYNTHESIS_OF_PRIMER,0.939314889051228
HMGIY_Q6,SET,237,0.031329,0.0035364,0.058494,0.29612,HMGIY_Q6,0.93969219919664
WP_HOMOLOGOUS_RECOMBINATION,SET,12,0.11506,0.0029406,0.21486,0.29615,WP_HOMOLOGOUS_RECOMBINATION,0.93969219919664
ZNF10_TARGET_GENES,SET,643,0.018204,0.0033466,0.033998,0.29617,ZNF10_TARGET_GENES,0.93969219919664
MIR134_3P,SET,81,0.050898,0.0033733,0.095103,0.29626,MIR134_3P,0.939695673164511
ZHU_CMV_ALL_DN,SET,108,0.046396,0.0035479,0.086694,0.29627,ZHU_CMV_ALL_DN,0.939695673164511
GOBP_VESICLE_CARGO_LOADING,SET,31,0.078167,0.0032092,0.14607,0.29628,GOBP_VESICLE_CARGO_LOADING,0.939695673164511
GOBP_HEAT_ACCLIMATION,SET,5,0.21891,0.0036121,0.40921,0.29634,GOBP_HEAT_ACCLIMATION,0.939695673164511
GOBP_REGULATION_OF_INTEGRIN_...3,SET,18,0.11213,0.0035093,0.20962,0.29635,GOBP_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.939695673164511
chr18q23,SET,15,0.19415,0.0055471,0.36296,0.29636,chr18q23,0.939695673164511
HP_ABNORMALITY_OF_THE_PHALAN...1,SET,16,0.11738,0.0034637,0.21954,0.29644,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_2ND_FINGER,0.939695673164511
GOBP_POSITIVE_REGULATION_OF_...267,SET,6,0.23028,0.0041622,0.43075,0.29647,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.939695673164511
REACTOME_ROLE_OF_PHOSPHOLIPI...,SET,23,0.095323,0.0033717,0.17837,0.29654,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,0.939695673164511
HP_PRIMARY_AMENORRHEA,SET,108,0.044982,0.0034398,0.084178,0.29655,HP_PRIMARY_AMENORRHEA,0.939695673164511
HP_TIBIAL_TORSION,SET,20,0.09884,0.0032604,0.18497,0.29655,HP_TIBIAL_TORSION,0.939695673164511
HP_ABNORMAL_SALIVARY_GLAND_M...,SET,27,0.084894,0.0032532,0.1589,0.29659,HP_ABNORMAL_SALIVARY_GLAND_MORPHOLOGY,0.939695673164511
HP_BROAD_METATARSAL,SET,12,0.13763,0.0035174,0.25765,0.29661,HP_BROAD_METATARSAL,0.939695673164511
GOBP_PROTEIN_IMPORT_INTO_PER...4,SET,5,0.18904,0.0031193,0.35393,0.29663,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE,0.939695673164511
GOBP_POSITIVE_REGULATION_OF_...677,SET,61,0.057498,0.0033087,0.10765,0.29664,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.939695673164511
LY_AGING_OLD_UP,SET,7,0.20482,0.0039986,0.38355,0.29667,LY_AGING_OLD_UP,0.939695673164511
GOBP_APOPTOTIC_PROCESS_IN_BO...,SET,5,0.2209,0.0036449,0.4137,0.29669,GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.939695673164511
REACTOME_EXPORT_OF_VIRAL_RIB...,SET,31,0.079609,0.0032685,0.14912,0.29672,REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS,0.939695673164511
GOBP_INTRACELLULAR_PH_REDUCT...,SET,51,0.065559,0.0034505,0.12281,0.29673,GOBP_INTRACELLULAR_PH_REDUCTION,0.939695673164511
KEGG_MEDICUS_REFERENCE_CROSS...,SET,15,0.12144,0.0034698,0.22754,0.29677,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.939695673164511
WILCOX_RESPONSE_TO_PROGESTER...2,SET,136,0.039995,0.0034295,0.074942,0.29678,WILCOX_RESPONSE_TO_PROGESTERONE_UP,0.939695673164511
MARTINEZ_RESPONSE_TO_TRABECT...1,SET,45,0.069266,0.003425,0.12979,0.29679,MARTINEZ_RESPONSE_TO_TRABECTEDIN,0.939695673164511
TMTCGCGANR_UNKNOWN,SET,148,0.036657,0.0032779,0.068699,0.29682,TMTCGCGANR_UNKNOWN,0.939695673164511
GOBP_TRANSEPITHELIAL_TRANSPO...,SET,35,0.084875,0.0037022,0.15907,0.29682,GOBP_TRANSEPITHELIAL_TRANSPORT,0.939695673164511
WIEDERSCHAIN_TARGETS_OF_BMI1...,SET,55,0.066923,0.0036574,0.12545,0.29686,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,0.939736706439566
MODULE_346,SET,17,0.12119,0.003686,0.22723,0.29691,MODULE_346,0.939787100446225
HP_SUDDEN_DEATH,SET,123,0.043664,0.0035619,0.08188,0.29693,HP_SUDDEN_DEATH,0.939787100446225
MODULE_220,SET,309,0.02849,0.0036648,0.053434,0.29696,MODULE_220,0.939796466945912
GSE26488_WT_VS_VP16_TRANSGEN...2,SET,181,0.034325,0.0033913,0.064408,0.29704,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.939887833409194
GOBP_INTRACELLULAR_MRNA_LOCA...,SET,15,0.12674,0.0036212,0.23784,0.29706,GOBP_INTRACELLULAR_MRNA_LOCALIZATION,0.939887833409194
GOBP_INSULIN_PROCESSING,SET,7,0.17719,0.0034592,0.33254,0.29707,GOBP_INSULIN_PROCESSING,0.939887833409194
GOBP_SKELETAL_MUSCLE_TISSUE_...1,SET,10,0.15425,0.003599,0.28954,0.2971,GOBP_SKELETAL_MUSCLE_TISSUE_GROWTH,0.939897187329328
HP_ELEVATED_URINARY_3_HYDROX...,SET,5,0.20917,0.0034514,0.39278,0.29718,HP_ELEVATED_URINARY_3_HYDROXYBUTYRIC_ACID,0.93994401449932
GOBP_REGULATION_OF_MRNA_SPLI...,SET,97,0.041849,0.0030338,0.078593,0.2972,GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,0.93994401449932
GSE2770_IL12_AND_TGFB_VS_IL4...5,SET,175,0.036488,0.0035453,0.068529,0.29721,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.93994401449932
GOBP_TOLL_LIKE_RECEPTOR_9_SI...,SET,18,0.10944,0.0034252,0.2056,0.29726,GOBP_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.93994401449932
GSE13306_TREG_VS_TCONV_UP,SET,187,0.033335,0.0033471,0.062625,0.29726,GSE13306_TREG_VS_TCONV_UP,0.93994401449932
chr13q14,SET,81,0.10276,0.0068102,0.19312,0.29733,chr13q14,0.93994401449932
REACTOME_TCF_DEPENDENT_SIGNA...,SET,165,0.034865,0.0032903,0.06553,0.29735,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,0.93994401449932
GOBP_POSITIVE_REGULATION_OF_...424,SET,17,0.1191,0.0036224,0.2239,0.29739,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.93994401449932
GSE19888_NO_PRETREAT_VS_ADEN...2,SET,176,0.033314,0.0032461,0.06265,0.29745,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP,0.93994401449932
GOBP_BILE_ACID_SECRETION,SET,10,0.13709,0.0031985,0.25781,0.29746,GOBP_BILE_ACID_SECRETION,0.93994401449932
DACOSTA_UV_RESPONSE_VIA_ERCC...3,SET,808,0.016431,0.0033703,0.030907,0.29749,DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,0.93994401449932
HP_IMPAIRED_PROPRIOCEPTION,SET,136,0.038141,0.0032705,0.071752,0.29751,HP_IMPAIRED_PROPRIOCEPTION,0.93994401449932
REACTOME_MELANIN_BIOSYNTHESIS,SET,5,0.24612,0.0040611,0.46304,0.29753,REACTOME_MELANIN_BIOSYNTHESIS,0.93994401449932
GOBP_SEQUESTERING_OF_EXTRACE...,SET,10,0.16776,0.0039141,0.31562,0.29753,GOBP_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR,0.93994401449932
TSUTSUMI_FBXW8_TARGETS,SET,9,0.14578,0.0032268,0.27438,0.2976,TSUTSUMI_FBXW8_TARGETS,0.93994401449932
GOMF_2_OXOGLUTARATE_DEPENDEN...,SET,52,0.05561,0.0029553,0.10467,0.29762,GOMF_2_OXOGLUTARATE_DEPENDENT_DIOXYGENASE_ACTIVITY,0.93994401449932
GOBP_ARTERY_DEVELOPMENT,SET,99,0.049606,0.0036328,0.093386,0.29765,GOBP_ARTERY_DEVELOPMENT,0.93994401449932
GOBP_VESICLE_TARGETING_TO_FR...,SET,31,0.077407,0.003178,0.14573,0.29766,GOBP_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI,0.93994401449932
GOCC_ENDOPLASMIC_RETICULUM_Q...,SET,15,0.11139,0.0031826,0.2098,0.29774,GOCC_ENDOPLASMIC_RETICULUM_QUALITY_CONTROL_COMPARTMENT,0.93994401449932
REACTOME_DIGESTION_AND_ABSOR...,SET,22,0.10926,0.0037798,0.20581,0.29775,REACTOME_DIGESTION_AND_ABSORPTION,0.93994401449932
BARRIER_COLON_CANCER_RECURRE...1,SET,16,0.11173,0.003297,0.2105,0.29778,BARRIER_COLON_CANCER_RECURRENCE_DN,0.93994401449932
HP_ABNORMAL_STOMACH_MORPHOLO...,SET,244,0.029629,0.0033928,0.05583,0.29782,HP_ABNORMAL_STOMACH_MORPHOLOGY,0.93994401449932
GOBP_TRABECULA_MORPHOGENESIS,SET,46,0.072553,0.0036271,0.13672,0.29783,GOBP_TRABECULA_MORPHOGENESIS,0.93994401449932
HP_FREQUENT_TEMPER_TANTRUMS,SET,8,0.14491,0.0030242,0.27312,0.29786,HP_FREQUENT_TEMPER_TANTRUMS,0.93994401449932
GOBP_SEX_DIFFERENTIATION,SET,260,0.029782,0.0035189,0.05614,0.29789,GOBP_SEX_DIFFERENTIATION,0.93994401449932
MIR425_5P,SET,78,0.050281,0.0032703,0.094791,0.2979,MIR425_5P,0.93994401449932
HP_ABNORMAL_CELL_MORPHOLOGY,SET,42,0.065767,0.003142,0.12398,0.2979,HP_ABNORMAL_CELL_MORPHOLOGY,0.93994401449932
REACTOME_RHO_GTPASE_CYCLE,SET,412,0.022336,0.0033082,0.042119,0.29795,REACTOME_RHO_GTPASE_CYCLE,0.93994401449932
GGARNTKYCCA_UNKNOWN,SET,70,0.057638,0.0035522,0.1087,0.29797,GGARNTKYCCA_UNKNOWN,0.93994401449932
GOMF_PEPTIDYL_PROLINE_DIOXYG...,SET,12,0.10952,0.0027991,0.20657,0.29799,GOMF_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY,0.93994401449932
HP_EPISODIC_HYPOKALEMIA,SET,4,0.25173,0.0037152,0.47478,0.29799,HP_EPISODIC_HYPOKALEMIA,0.93994401449932
GOBP_AUTOPHAGOSOME_MATURATION,SET,60,0.053962,0.0030797,0.1018,0.29804,GOBP_AUTOPHAGOSOME_MATURATION,0.93994401449932
KEGG_MEDICUS_REFERENCE_TBK1_...,SET,10,0.14427,0.003366,0.27231,0.29813,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION,0.93994401449932
HP_OPHTHALMOPARESIS,SET,244,0.028358,0.0032473,0.05354,0.29818,HP_OPHTHALMOPARESIS,0.93994401449932
GOMF_STRUCTURAL_CONSTITUENT_...6,SET,22,0.091564,0.0031677,0.1729,0.29821,GOMF_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE,0.93994401449932
HP_NEONATAL_OMPHALITIS,SET,10,0.16116,0.0037601,0.30436,0.29823,HP_NEONATAL_OMPHALITIS,0.93994401449932
HP_CHOLANGIOCARCINOMA,SET,8,0.16554,0.0034548,0.31267,0.29825,HP_CHOLANGIOCARCINOMA,0.93994401449932
HP_CHRONIC_SINUSITIS,SET,57,0.056952,0.0031683,0.10758,0.29827,HP_CHRONIC_SINUSITIS,0.93994401449932
GOMF_SOLUTE_INORGANIC_ANION_...,SET,31,0.081588,0.0033497,0.15415,0.29831,GOMF_SOLUTE_INORGANIC_ANION_ANTIPORTER_ACTIVITY,0.93994401449932
REACTOME_TRANSPORT_OF_INORGA...,SET,103,0.046984,0.0035092,0.088774,0.29832,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,0.93994401449932
MIR6889_5P,SET,11,0.14351,0.0035117,0.27116,0.29832,MIR6889_5P,0.93994401449932
GOBP_POSITIVE_REGULATION_OF_...435,SET,25,0.093982,0.0034656,0.17758,0.29833,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.93994401449932
REACTOME_CREB1_PHOSPHORYLATI...3,SET,8,0.17846,0.0037245,0.33726,0.29835,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE,0.93994401449932
HP_DYSLEXIA,SET,29,0.086447,0.0034329,0.16339,0.29838,HP_DYSLEXIA,0.93994401449932
GSE37416_CTRL_VS_12H_F_TULAR...2,SET,169,0.035472,0.0033875,0.067054,0.2984,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.93994401449932
GOMF_C_METHYLTRANSFERASE_ACT...,SET,6,0.16586,0.0029978,0.31355,0.29842,GOMF_C_METHYLTRANSFERASE_ACTIVITY,0.93994401449932
MIR6759_3P,SET,93,0.049395,0.0035066,0.093394,0.29844,MIR6759_3P,0.93994401449932
MORF_TFDP2,SET,211,0.031351,0.0033415,0.059275,0.29844,MORF_TFDP2,0.93994401449932
HP_GENERALIZED_LIPODYSTROPHY,SET,8,0.17863,0.0037279,0.33773,0.29844,HP_GENERALIZED_LIPODYSTROPHY,0.93994401449932
GOBP_PROTEIN_K63_LINKED_DEUB...,SET,21,0.093313,0.003154,0.17645,0.29847,GOBP_PROTEIN_K63_LINKED_DEUBIQUITINATION,0.939953320949619
GOBP_PROTEIN_TARGETING,SET,295,0.02587,0.0032527,0.048959,0.29862,GOBP_PROTEIN_TARGETING,0.94011850276093
PID_HNF3A_PATHWAY,SET,42,0.071451,0.0034135,0.13523,0.29863,PID_HNF3A_PATHWAY,0.94011850276093
GOMF_NON_MEMBRANE_SPANNING_P...1,SET,43,0.075738,0.003661,0.14336,0.29864,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.94011850276093
ER_Q6_02,SET,234,0.030022,0.0033676,0.056837,0.29868,ER_Q6_02,0.94011850276093
GOCC_SOMATODENDRITIC_COMPART...,SET,770,0.017163,0.0034404,0.032494,0.29868,GOCC_SOMATODENDRITIC_COMPARTMENT,0.94011850276093
HAY_BONE_MARROW_PRO_B,SET,255,0.027439,0.0032111,0.051948,0.29869,HAY_BONE_MARROW_PRO_B,0.94011850276093
WP_BMP2WNT4FOXO1_PATHWAY_IN_...,SET,13,0.14942,0.0039747,0.283,0.29875,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,0.94011850276093
GOMF_MOLECULAR_CONDENSATE_SC...,SET,33,0.07193,0.0030468,0.13623,0.29875,GOMF_MOLECULAR_CONDENSATE_SCAFFOLD_ACTIVITY,0.94011850276093
MODULE_135,SET,25,0.098993,0.0036504,0.18755,0.29882,MODULE_135,0.94011850276093
GSE13306_RA_VS_UNTREATED_TCO...1,SET,179,0.034748,0.0034142,0.065832,0.29882,GSE13306_RA_VS_UNTREATED_TCONV_DN,0.94011850276093
GSE22886_CD8_VS_CD4_NAIVE_TC...2,SET,176,0.032672,0.0031835,0.061901,0.29882,GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP,0.94011850276093
GOMF_DNA_TRANSLOCASE_ACTIVITY,SET,2,0.22749,0.0023742,0.43118,0.29889,GOMF_DNA_TRANSLOCASE_ACTIVITY,0.940192700135685
GSE21379_TFH_VS_NON_TFH_SAP_...2,SET,179,0.032415,0.003185,0.061452,0.29893,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP,0.940192700135685
PEPPER_CHRONIC_LYMPHOCYTIC_L...2,SET,29,0.08947,0.003553,0.16965,0.29897,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.940192700135685
HP_NEOPLASM_OF_THE_PERIPHERA...,SET,68,0.053446,0.0032466,0.10134,0.29897,HP_NEOPLASM_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,0.940192700135685
MIR548AE_3P_MIR548AQ_3P,SET,720,0.01716,0.0033309,0.03254,0.29898,MIR548AE_3P_MIR548AQ_3P,0.940192700135685
LI_PBMC_MENACTRA_AGE_18_45YO...9,SET,53,0.070634,0.0037895,0.13396,0.29901,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,0.940192700135685
GOBP_CYTOCHROME_COMPLEX_ASSE...,SET,32,0.070727,0.0029501,0.13416,0.29904,GOBP_CYTOCHROME_COMPLEX_ASSEMBLY,0.940192700135685
GSE17721_LPS_VS_PAM3CSK4_2H_...1,SET,178,0.033028,0.0032363,0.062658,0.29906,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN,0.940192700135685
GOBP_PLASMA_MEMBRANE_TUBULAT...,SET,18,0.099755,0.0031219,0.18928,0.29909,GOBP_PLASMA_MEMBRANE_TUBULATION,0.940201967257598
BIOCARTA_TSP1_PATHWAY,SET,7,0.18617,0.0036345,0.35338,0.29916,BIOCARTA_TSP1_PATHWAY,0.940251926207271
MIR891A_3P,SET,119,0.043503,0.0034909,0.082574,0.29916,MIR891A_3P,0.940251926207271
MIR33A_3P,SET,393,0.023026,0.0033326,0.04372,0.29921,MIR33A_3P,0.940324039244054
HP_SCLEROTIC_VERTEBRAL_ENDPL...,SET,5,0.22964,0.0037891,0.43626,0.29931,HP_SCLEROTIC_VERTEBRAL_ENDPLATES,0.940553259493671
GSE20198_UNTREATED_VS_IL12_I...1,SET,176,0.031532,0.0030725,0.059931,0.2994,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.940751017087063
MIR23A_3P_MIR23B_3P,SET,536,0.020214,0.003403,0.038425,0.29943,MIR23A_3P_MIR23B_3P,0.940760228710902
GOBP_COLLAGEN_METABOLIC_PROC...,SET,90,0.05218,0.0036443,0.099209,0.29946,GOBP_COLLAGEN_METABOLIC_PROCESS,0.940769438669439
KEGG_MEDICUS_VARIANT_MUTATIO...58,SET,6,0.19499,0.0035244,0.37094,0.29956,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY,0.940998535791757
GOBP_RNA_TEMPLATED_DNA_BIOSY...,SET,66,0.052006,0.0031125,0.098977,0.29964,GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS,0.941164771802983
HOFT_CD4_POSITIVE_ALPHA_BETA...5,SET,36,0.072111,0.00319,0.13726,0.29967,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.941173942707392
GOBP_SKELETAL_MUSCLE_CONTRAC...,SET,43,0.06828,0.0033005,0.13002,0.29974,GOBP_SKELETAL_MUSCLE_CONTRACTION,0.941232843978679
LEE_LIVER_CANCER_SURVIVAL_DN,SET,165,0.034815,0.0032855,0.066305,0.29977,LEE_LIVER_CANCER_SURVIVAL_DN,0.941232843978679
MIR4662A_3P,SET,63,0.057615,0.0033692,0.10973,0.29977,MIR4662A_3P,0.941232843978679
HP_SPASTIC_HYPERACTIVE_BLADD...,SET,9,0.15483,0.0034271,0.29499,0.29984,HP_SPASTIC_HYPERACTIVE_BLADDER,0.941367588075881
GSE22601_DOUBLE_NEGATIVE_VS_...2,SET,182,0.033967,0.0033651,0.064751,0.29994,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.941524040021633
GOMF_OXIDOREDUCTASE_ACTIVITY...12,SET,4,0.25859,0.0038165,0.49315,0.30001,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_OXYGEN_AS_ACCEPTOR,0.941524040021633
GOBP_XENOBIOTIC_TRANSPORT,SET,47,0.069929,0.0035336,0.13336,0.30002,GOBP_XENOBIOTIC_TRANSPORT,0.941524040021633
ACOSTA_PROLIFERATION_INDEPEN...2,SET,77,0.049406,0.0031928,0.094289,0.30015,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.941524040021633
REACTOME_COPII_MEDIATED_VESI...,SET,66,0.053823,0.0032212,0.10274,0.30018,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,0.941524040021633
ACEVEDO_LIVER_CANCER_UP,SET,860,0.01525,0.0032222,0.029109,0.30019,ACEVEDO_LIVER_CANCER_UP,0.941524040021633
LU_EZH2_TARGETS_DN,SET,343,0.024519,0.0033198,0.046803,0.30019,LU_EZH2_TARGETS_DN,0.941524040021633
MEISSNER_BRAIN_HCP_WITH_H3K4...2,SET,54,0.064539,0.003495,0.1232,0.3002,MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.941524040021633
HP_ABNORMAL_DENTAL_ROOT_MORP...,SET,47,0.065632,0.0033164,0.12531,0.30022,HP_ABNORMAL_DENTAL_ROOT_MORPHOLOGY,0.941524040021633
HP_ELEVATED_CIRCULATING_ASPA...,SET,67,0.053244,0.0032105,0.10165,0.30022,HP_ELEVATED_CIRCULATING_ASPARTATE_AMINOTRANSFERASE_CONCENTRATION,0.941524040021633
GRAESSMANN_APOPTOSIS_BY_SERU...2,SET,509,0.019946,0.0032746,0.038081,0.30023,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,0.941524040021633
GAVISH_3CA_METAPROGRAM_EPITH...3,SET,44,0.06888,0.0033679,0.13152,0.30024,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE,0.941524040021633
HP_RETINAL_VEIN_OCCLUSION,SET,6,0.18473,0.0033389,0.35274,0.30025,HP_RETINAL_VEIN_OCCLUSION,0.941524040021633
GSE2124_CTRL_VS_LYMPHOTOXIN_...1,SET,178,0.032983,0.0032318,0.063,0.3003,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN,0.941524040021633
HE_LIM_SUN_FETAL_LUNG_C7_PCP...,SET,48,0.07024,0.0035868,0.13418,0.30032,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.941524040021633
GSE14413_UNSTIM_VS_IFNB_STIM...3,SET,124,0.038537,0.0031563,0.073618,0.30033,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN,0.941524040021633
CEBP_01,SET,238,0.03091,0.0034964,0.059069,0.30039,CEBP_01,0.941524040021633
GOBP_VENTRICULAR_CARDIAC_MUS...2,SET,10,0.16667,0.0038886,0.31867,0.30049,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.941524040021633
chr21q22,SET,149,0.075447,0.0067691,0.14429,0.30053,chr21q22,0.941524040021633
GOBP_ACTIVATION_OF_MEIOSIS,SET,5,0.21593,0.0035628,0.41296,0.30053,GOBP_ACTIVATION_OF_MEIOSIS,0.941524040021633
GOBP_REGULATION_OF_DNA_REPAIR,SET,194,0.030309,0.0030991,0.057964,0.30053,GOBP_REGULATION_OF_DNA_REPAIR,0.941524040021633
GOBP_MATURATION_OF_SSU_RRNA_...,SET,30,0.080112,0.0032357,0.15322,0.30054,GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.941524040021633
GOBP_REGULATION_OF_EXCITATOR...,SET,17,0.10839,0.0032967,0.2073,0.30054,GOBP_REGULATION_OF_EXCITATORY_SYNAPSE_ASSEMBLY,0.941524040021633
GSE15139_GMCSF_TREATED_VS_UN...1,SET,186,0.031812,0.0031857,0.060845,0.30054,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN,0.941524040021633
GSE14000_UNSTIM_VS_16H_LPS_D...1,SET,174,0.033709,0.003266,0.064499,0.30062,GSE14000_UNSTIM_VS_16H_LPS_DC_DN,0.941689779179811
chr3p21,SET,185,0.078557,0.0078458,0.15038,0.30071,chr3p21,0.941766567567567
MODULE_512,SET,36,0.074448,0.0032934,0.14253,0.30073,MODULE_512,0.941766567567567
VISALA_AGING_LYMPHOCYTE_DN,SET,16,0.10471,0.0030898,0.20053,0.30077,VISALA_AGING_LYMPHOCYTE_DN,0.941766567567567
MIR151A_5P_MIR151B,SET,10,0.13387,0.0031234,0.25636,0.30077,MIR151A_5P_MIR151B,0.941766567567567
GSE369_PRE_VS_POST_IL6_INJEC...5,SET,184,0.031453,0.0031329,0.060237,0.30078,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN,0.941766567567567
BERTUCCI_INVASIVE_CARCINOMA_...2,SET,20,0.10259,0.0033841,0.19654,0.30085,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.941878656998739
CDC5_01,SET,228,0.031378,0.0034749,0.060123,0.30087,CDC5_01,0.941878656998739
TEF_Q6,SET,235,0.030962,0.0034804,0.059335,0.3009,TEF_Q6,0.941887733045123
AP1_Q6,SET,233,0.029649,0.0033188,0.056854,0.30102,AP1_Q6,0.942006419131529
HP_ABNORMAL_RECTUM_MORPHOLOGY,SET,124,0.040561,0.0033221,0.077797,0.30106,HP_ABNORMAL_RECTUM_MORPHOLOGY,0.942006419131529
GOBP_ER_NUCLEUS_SIGNALING_PA...,SET,44,0.06706,0.0032789,0.12864,0.30108,GOBP_ER_NUCLEUS_SIGNALING_PATHWAY,0.942006419131529
VALK_AML_WITH_T_8_21_TRANSLO...,SET,4,0.25848,0.0038148,0.49606,0.30116,VALK_AML_WITH_T_8_21_TRANSLOCATION,0.942006419131529
MIR1301_5P,SET,50,0.063312,0.0032995,0.12152,0.30118,MIR1301_5P,0.942006419131529
GOBP_NEGATIVE_REGULATION_OF_...335,SET,5,0.20212,0.0033351,0.38794,0.30118,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.942006419131529
WP_BONE_MORPHOGENIC_PROTEIN_...,SET,11,0.13726,0.0033588,0.26346,0.30119,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,0.942006419131529
GOMF_DNA_RNA_HYBRID_BINDING,SET,5,0.17362,0.0028648,0.33325,0.30119,GOMF_DNA_RNA_HYBRID_BINDING,0.942006419131529
HP_ABNORMAL_URINE_CHLORIDE_C...,SET,5,0.22951,0.003787,0.44062,0.30123,HP_ABNORMAL_URINE_CHLORIDE_CONCENTRATION,0.942006419131529
GSE3982_EOSINOPHIL_VS_MAST_C...2,SET,178,0.033763,0.0033082,0.064826,0.30125,GSE3982_EOSINOPHIL_VS_MAST_CELL_UP,0.942006419131529
GOBP_FC_EPSILON_RECEPTOR_SIG...,SET,24,0.094697,0.0034215,0.18187,0.30129,GOBP_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY,0.942006419131529
REACTOME_CELL_JUNCTION_ORGAN...,SET,105,0.047538,0.0035847,0.091318,0.30133,REACTOME_CELL_JUNCTION_ORGANIZATION,0.942006419131529
WP_BILE_ACID_SYNTHESIS_AND_E...,SET,12,0.1447,0.003698,0.27795,0.30133,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,0.942006419131529
REACTOME_ACETYLCHOLINE_NEURO...,SET,16,0.12585,0.0037135,0.24178,0.30136,REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.942006419131529
CTACTGT_MIR199A,SET,172,0.033553,0.0032323,0.064475,0.3014,CTACTGT_MIR199A,0.942006419131529
HP_HEPATIC_CALCIFICATION,SET,5,0.2161,0.0035656,0.41536,0.30144,HP_HEPATIC_CALCIFICATION,0.942006419131529
GSE2770_IL4_ACT_VS_ACT_CD4_T...3,SET,179,0.033978,0.0033386,0.065312,0.30145,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.942006419131529
GOBP_POSITIVE_REGULATION_OF_...219,SET,65,0.053358,0.0031692,0.10258,0.30147,GOBP_POSITIVE_REGULATION_OF_DNA_RECOMBINATION,0.942006419131529
CAO_BLOOD_FLUMIST_AGE_05_14Y...3,SET,7,0.19255,0.003759,0.37015,0.30147,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_DN,0.942006419131529
GAVISH_3CA_METAPROGRAM_CD4_T...6,SET,44,0.071333,0.0034879,0.13714,0.30148,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_1,0.942006419131529
HP_ABNORMAL_FEMALE_EXTERNAL_...,SET,137,0.039504,0.0033997,0.075981,0.30156,HP_ABNORMAL_FEMALE_EXTERNAL_GENITALIA_MORPHOLOGY,0.942143476506456
REACTOME_EUKARYOTIC_TRANSLAT...1,SET,85,0.045933,0.0031181,0.088399,0.30167,REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,0.942143476506456
GSE23568_CTRL_TRANSDUCED_VS_...2,SET,185,0.033987,0.0033944,0.065417,0.30169,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP,0.942143476506456
GOBP_RESPONSE_TO_OSMOTIC_STR...,SET,78,0.050562,0.0032886,0.097325,0.30171,GOBP_RESPONSE_TO_OSMOTIC_STRESS,0.942143476506456
GOBP_POSITIVE_REGULATION_OF_...584,SET,37,0.077032,0.0034546,0.14831,0.30175,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.942143476506456
HP_FATIGABLE_WEAKNESS_OF_BUL...,SET,52,0.061198,0.0032523,0.11783,0.30176,HP_FATIGABLE_WEAKNESS_OF_BULBAR_MUSCLES,0.942143476506456
GOCC_TRANSCRIPTION_FACTOR_TF...3,SET,11,0.10934,0.0026756,0.21059,0.30181,GOCC_TRANSCRIPTION_FACTOR_TFIIH_HOLO_COMPLEX,0.942143476506456
MISSIAGLIA_REGULATED_BY_METH...2,SET,109,0.044409,0.0034115,0.085534,0.30182,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,0.942143476506456
GOMF_PYRUVATE_DEHYDROGENASE_...2,SET,5,0.18795,0.0031013,0.36209,0.30186,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_PHOSPHATASE_ACTIVITY,0.942143476506456
NIKOLSKY_BREAST_CANCER_19Q13...2,SET,7,0.24679,0.0048179,0.47563,0.30193,NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON,0.942143476506456
KEGG_MEDICUS_PATHOGEN_EBV_LM...2,SET,5,0.20607,0.0034002,0.39727,0.30198,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY,0.942143476506456
MATSUMIYA_PBMC_MODIFIED_VACC...4,SET,81,0.049201,0.0032607,0.094864,0.30201,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,0.942143476506456
GOBP_PROTEIN_TRANSPORT_WITHI...,SET,6,0.17879,0.0032315,0.34475,0.30202,GOBP_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER,0.942143476506456
HP_ABNORMAL_PYRAMIDAL_SIGN,SET,382,0.022229,0.0031729,0.042862,0.30202,HP_ABNORMAL_PYRAMIDAL_SIGN,0.942143476506456
GSE3982_EOSINOPHIL_VS_MAST_C...1,SET,174,0.033908,0.0032853,0.065387,0.30203,GSE3982_EOSINOPHIL_VS_MAST_CELL_DN,0.942143476506456
REACTOME_FGFR2C_LIGAND_BINDI...,SET,12,0.14503,0.0037065,0.27971,0.30206,REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,0.942143476506456
WP_LEUKOCYTEINTRINSIC_HIPPO_...,SET,30,0.081937,0.0033094,0.15805,0.30208,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,0.942143476506456
MIR548AQ_5P,SET,444,0.021458,0.0032964,0.041393,0.30209,MIR548AQ_5P,0.942143476506456
HOWARD_NEUTROPHIL_INACT_MONO...1,SET,102,0.044726,0.0033244,0.086289,0.30212,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.942143476506456
GSE31082_CD4_VS_CD8_SP_THYMO...1,SET,179,0.03281,0.0032238,0.063304,0.30213,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN,0.942143476506456
GOMF_BETA_N_ACETYLHEXOSAMINI...,SET,3,0.2724,0.0034818,0.52565,0.30215,GOMF_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY,0.942143476506456
MIR138_5P,SET,189,0.032571,0.0032876,0.062863,0.30218,MIR138_5P,0.942143476506456
KEGG_MEDICUS_REFERENCE_N_GLY...2,SET,11,0.12705,0.0031088,0.24522,0.3022,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST,0.942143476506456
GOMF_PROSTAGLANDIN_E_RECEPTO...,SET,5,0.23223,0.0038319,0.44823,0.3022,GOMF_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY,0.942143476506456
GOBP_REGULATION_OF_MITOCHOND...3,SET,6,0.16438,0.002971,0.31733,0.30223,GOBP_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,0.942143476506456
HP_AORTIC_ATHEROSCLEROTIC_LE...,SET,8,0.17962,0.0037485,0.34676,0.30224,HP_AORTIC_ATHEROSCLEROTIC_LESION,0.942143476506456
GOBP_INTRACELLULAR_STEROL_TR...,SET,32,0.077775,0.0032441,0.1502,0.3023,GOBP_INTRACELLULAR_STEROL_TRANSPORT,0.942143476506456
HP_ABNORMAL_CIRCULATING_RENIN,SET,29,0.089213,0.0035428,0.17229,0.3023,HP_ABNORMAL_CIRCULATING_RENIN,0.942143476506456
WP_INFLAMMATORY_RESPONSE_PAT...,SET,28,0.089538,0.003494,0.17293,0.30231,WP_INFLAMMATORY_RESPONSE_PATHWAY,0.942143476506456
GSE25502_WT_VS_KLF13_KO_THYM...1,SET,154,0.03762,0.003431,0.072692,0.3024,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN,0.942157367571928
GOBP_INTERLEUKIN_12_PRODUCTI...,SET,61,0.060163,0.003462,0.11626,0.30241,GOBP_INTERLEUKIN_12_PRODUCTION,0.942157367571928
GSE3982_NEUTROPHIL_VS_BCELL_...1,SET,182,0.031237,0.0030946,0.060368,0.30243,GSE3982_NEUTROPHIL_VS_BCELL_DN,0.942157367571928
ROETH_TERT_TARGETS_UP,SET,14,0.13359,0.0036876,0.25819,0.30244,ROETH_TERT_TARGETS_UP,0.942157367571928
MORF_TPT1,SET,90,0.045162,0.0031542,0.087292,0.30245,MORF_TPT1,0.942157367571928
GSE3982_BCELL_VS_CENT_MEMORY...1,SET,175,0.034336,0.0033362,0.066411,0.30257,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.942358067550618
GOBP_IMMUNE_RESPONSE_REGULAT...2,SET,21,0.10329,0.0034913,0.1998,0.30259,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS,0.942358067550618
GSE40666_UNTREATED_VS_IFNA_S...3,SET,177,0.031944,0.0031213,0.061798,0.30261,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN,0.942358067550618
REACTOME_CHROMOSOME_MAINTENA...,SET,83,0.045643,0.0030619,0.088315,0.30264,REACTOME_CHROMOSOME_MAINTENANCE,0.942358067550618
GSE1432_6H_VS_24H_IFNG_MICRO...1,SET,179,0.031647,0.0031096,0.061237,0.30265,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.942358067550618
GSE5589_WT_VS_IL6_KO_LPS_STI...2,SET,119,0.039563,0.0031748,0.076565,0.30268,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.942367051867777
REACTOME_INTRA_GOLGI_AND_RET...,SET,194,0.03019,0.0030869,0.058475,0.30283,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,0.942448967459324
GSE17721_LPS_VS_GARDIQUIMOD_...17,SET,182,0.032329,0.0032027,0.062626,0.30285,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN,0.942448967459324
HP_FEW_CAFE_AU_LAIT_SPOTS,SET,6,0.18143,0.0032792,0.35157,0.30291,HP_FEW_CAFE_AU_LAIT_SPOTS,0.942448967459324
GOBP_FATTY_ACID_CATABOLIC_PR...,SET,101,0.041724,0.0030861,0.08086,0.30293,GOBP_FATTY_ACID_CATABOLIC_PROCESS,0.942448967459324
GOBP_OXALOACETATE_METABOLIC_...,SET,9,0.13868,0.0030697,0.26877,0.30294,GOBP_OXALOACETATE_METABOLIC_PROCESS,0.942448967459324
HP_APLASIA_HYPOPLASIA_OF_THE...74,SET,37,0.066993,0.0030044,0.12985,0.30296,HP_APLASIA_HYPOPLASIA_OF_THE_TONGUE,0.942448967459324
GSE15735_CTRL_VS_HDAC_INHIBI...4,SET,177,0.034544,0.0033754,0.066981,0.30303,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP,0.942448967459324
GOMF_NUCLEAR_EXPORT_SIGNAL_R...,SET,11,0.13108,0.0032076,0.25419,0.30304,GOMF_NUCLEAR_EXPORT_SIGNAL_RECEPTOR_ACTIVITY,0.942448967459324
REACTOME_DOWNSTREAM_SIGNAL_T...,SET,29,0.080044,0.0031787,0.15524,0.30307,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,0.942448967459324
GSE13522_CTRL_VS_T_CRUZI_Y_S...2,SET,120,0.039792,0.0032064,0.077183,0.30309,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP,0.942448967459324
GOMF_HISTONE_H2A_DEUBIQUITIN...,SET,5,0.15824,0.0026111,0.307,0.30312,GOMF_HISTONE_H2A_DEUBIQUITINASE_ACTIVITY,0.942448967459324
HP_ENLARGED_EPIPHYSES,SET,12,0.11869,0.0030335,0.23028,0.30313,HP_ENLARGED_EPIPHYSES,0.942448967459324
HP_URETERAL_DUPLICATION,SET,41,0.063302,0.0029881,0.12287,0.30321,HP_URETERAL_DUPLICATION,0.942448967459324
HP_ABNORMAL_AORTIC_VALVE_PHY...,SET,148,0.036849,0.003295,0.071526,0.30322,HP_ABNORMAL_AORTIC_VALVE_PHYSIOLOGY,0.942448967459324
KRAS.600_UP.V1_DN,SET,254,0.029316,0.0034242,0.056905,0.30322,KRAS.600_UP.V1_DN,0.942448967459324
GOBP_DEFENSE_RESPONSE_TO_TUM...,SET,12,0.13089,0.0033451,0.25415,0.30328,GOBP_DEFENSE_RESPONSE_TO_TUMOR_CELL,0.942448967459324
GOMF_CORE_PROMOTER_SEQUENCE_...,SET,35,0.075101,0.0032759,0.14583,0.30329,GOMF_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.942448967459324
PBXIP1_TARGET_GENES,SET,196,0.03161,0.0032485,0.061385,0.3033,PBXIP1_TARGET_GENES,0.942448967459324
GOCC_FEMALE_GERM_CELL_NUCLEUS,SET,14,0.11951,0.0032988,0.23208,0.3033,GOCC_FEMALE_GERM_CELL_NUCLEUS,0.942448967459324
WP_PEROXIREDOXIN_2_INDUCED_O...,SET,8,0.15894,0.0033171,0.30868,0.30331,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,0.942448967459324
REACTOME_HCMV_EARLY_EVENTS,SET,68,0.053899,0.0032741,0.10468,0.30332,REACTOME_HCMV_EARLY_EVENTS,0.942448967459324
GOBP_PYRIDINE_CONTAINING_COM...3,SET,158,0.034551,0.0031913,0.067103,0.30332,GOBP_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.942448967459324
PELLICCIOTTA_HDAC_IN_ANTIGEN...2,SET,60,0.052621,0.0030032,0.1022,0.30333,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,0.942448967459324
ZNF768_TARGET_GENES,SET,1013,0.014336,0.0032731,0.027856,0.30341,ZNF768_TARGET_GENES,0.942529008759385
GSE18804_SPLEEN_MACROPHAGE_V...2,SET,170,0.034983,0.0033507,0.067977,0.30341,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP,0.942529008759385
HE_LIM_SUN_FETAL_LUNG_C7_SCH...,SET,214,0.029222,0.0031365,0.056845,0.3036,HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL,0.942808928092899
GOMF_LIPOPOLYSACCHARIDE_BIND...,SET,36,0.078029,0.0034518,0.15179,0.30361,GOMF_LIPOPOLYSACCHARIDE_BINDING,0.942808928092899
LAKE_ADULT_KIDNEY_C5_PROXIMA...,SET,359,0.023694,0.0032807,0.046096,0.30362,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.942808928092899
GSE17721_CPG_VS_GARDIQUIMOD_...9,SET,177,0.033094,0.0032336,0.064389,0.30364,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN,0.942808928092899
HP_SEVERE_B_LYMPHOCYTOPENIA,SET,6,0.16584,0.0029975,0.32273,0.30367,HP_SEVERE_B_LYMPHOCYTOPENIA,0.942808928092899
GSE12392_WT_VS_IFNB_KO_CD8A_...2,SET,185,0.031089,0.0031049,0.060497,0.30367,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP,0.942808928092899
GNF2_INPP5D,SET,39,0.074254,0.0034186,0.14451,0.30369,GNF2_INPP5D,0.942808928092899
GOBP_PHOSPHATIDYLINOSITOL_DE...,SET,24,0.075009,0.0027102,0.14604,0.30376,GOBP_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.94288453125
BIOCARTA_CYTOKINE_PATHWAY,SET,19,0.10875,0.0034966,0.21174,0.30377,BIOCARTA_CYTOKINE_PATHWAY,0.94288453125
chr3p25,SET,79,0.11974,0.0078378,0.23322,0.30383,chr3p25,0.94288453125
GOBP_REGULATION_OF_TOLL_SIGN...,SET,5,0.19747,0.0032583,0.38463,0.30384,GOBP_REGULATION_OF_TOLL_SIGNALING_PATHWAY,0.94288453125
REACTOME_FOXO_MEDIATED_TRANS...4,SET,28,0.088159,0.0034402,0.17172,0.30385,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,0.94288453125
GSE30153_LUPUS_VS_HEALTHY_DO...1,SET,180,0.0342,0.0033697,0.066632,0.30388,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN,0.942893438085885
GOMF_PHOSPHATIDYLINOSITOL_3_...8,SET,11,0.10361,0.0025354,0.20194,0.30395,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.943004315808266
WP_SUPPRESSION_OF_HMGB1MEDIA...,SET,8,0.1542,0.0032181,0.30057,0.30397,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.943004315808266
HP_ECTOPIC_ANTERIOR_PITUITAR...,SET,8,0.1627,0.0033955,0.31725,0.30403,HP_ECTOPIC_ANTERIOR_PITUITARY_GLAND,0.943058201246661
GOBP_MUCOPOLYSACCHARIDE_META...,SET,86,0.048659,0.0033225,0.094914,0.30409,GOBP_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS,0.943058201246661
HP_ABNORMAL_PERIPHERAL_NERVO...2,SET,151,0.034887,0.0031508,0.068079,0.30417,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_PHYSIOLOGY,0.943058201246661
GSE41978_ID2_KO_AND_BIM_KO_V...2,SET,174,0.033175,0.0032143,0.064742,0.30418,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.943058201246661
REACTOME_SLBP_DEPENDENT_PROC...,SET,11,0.113,0.002765,0.22059,0.30424,REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,0.943058201246661
GOBP_REGULATION_OF_RAS_PROTE...,SET,46,0.066782,0.0033385,0.13039,0.30427,GOBP_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.943058201246661
GSE6259_FLT3L_INDUCED_33D1_P...3,SET,149,0.034642,0.0031081,0.067645,0.30429,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN,0.943058201246661
NEBEN_AML_WITH_FLT3_OR_NRAS_...1,SET,12,0.12978,0.0033167,0.25345,0.30431,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,0.943058201246661
KEGG_MEDICUS_REFERENCE_NALP1...,SET,4,0.18764,0.0027693,0.36644,0.30431,KEGG_MEDICUS_REFERENCE_NALP12_INFLAMMASOME_SIGNALING_PATHWAY,0.943058201246661
BURTON_ADIPOGENESIS_PEAK_AT_...5,SET,38,0.075917,0.0034502,0.14828,0.30434,BURTON_ADIPOGENESIS_PEAK_AT_8HR,0.943058201246661
DESCARTES_FETAL_LUNG_VASCULA...,SET,43,0.072624,0.0035105,0.1419,0.3044,DESCARTES_FETAL_LUNG_VASCULAR_ENDOTHELIAL_CELLS,0.943058201246661
MODULE_277,SET,47,0.059365,0.0029998,0.11601,0.30442,MODULE_277,0.943058201246661
HP_DISTAL_JOINT_HYPERMOBILITY,SET,7,0.18212,0.0035553,0.35588,0.30442,HP_DISTAL_JOINT_HYPERMOBILITY,0.943058201246661
MODULE_54,SET,236,0.027652,0.0031148,0.054044,0.30445,MODULE_54,0.943058201246661
HP_ABNORMAL_FACIAL_SKELETON_...,SET,1162,0.013058,0.0031795,0.025523,0.30446,HP_ABNORMAL_FACIAL_SKELETON_MORPHOLOGY,0.943058201246661
GNF2_RAD23A,SET,60,0.056571,0.0032286,0.11058,0.30448,GNF2_RAD23A,0.943058201246661
GOBP_GROWTH_INVOLVED_IN_HEAR...,SET,4,0.25551,0.003771,0.49947,0.30448,GOBP_GROWTH_INVOLVED_IN_HEART_MORPHOGENESIS,0.943058201246661
GOMF_PRIMARY_MIRNA_BINDING,SET,9,0.13558,0.0030011,0.26508,0.30451,GOMF_PRIMARY_MIRNA_BINDING,0.943058201246661
GOBP_NEGATIVE_REGULATION_OF_...38,SET,82,0.04743,0.0031627,0.092753,0.30455,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY,0.943058201246661
HP_CHRONIC_FATIGUE,SET,24,0.092359,0.0033371,0.18062,0.30456,HP_CHRONIC_FATIGUE,0.943058201246661
GOMF_PHOSPHOSERINE_RESIDUE_B...,SET,10,0.14275,0.0033307,0.27933,0.30466,GOMF_PHOSPHOSERINE_RESIDUE_BINDING,0.943058201246661
WP_PENTOSE_PHOSPHATE_METABOL...,SET,6,0.17687,0.0031968,0.34611,0.30467,WP_PENTOSE_PHOSPHATE_METABOLISM,0.943058201246661
GSE29614_CTRL_VS_DAY7_TIV_FL...2,SET,145,0.038419,0.0034007,0.07518,0.30467,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.943058201246661
GARGALOVIC_RESPONSE_TO_OXIDI...16,SET,9,0.1598,0.0035371,0.31272,0.30468,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,0.943058201246661
LEIN_LOCALIZED_TO_DISTAL_AND...,SET,16,0.11817,0.0034871,0.23127,0.30468,LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,0.943058201246661
GOMF_PHOSPHATIDYLINOSITOL_PH...4,SET,23,0.077976,0.0027581,0.15261,0.3047,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.943058201246661
GSE21063_3H_VS_16H_ANTI_IGM_...4,SET,179,0.031788,0.0031234,0.062221,0.30472,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP,0.943058201246661
GOCC_BRUSH_BORDER,SET,100,0.043157,0.0031763,0.084532,0.30484,GOCC_BRUSH_BORDER,0.943248348762685
GOBP_POSITIVE_REGULATION_OF_...499,SET,66,0.055806,0.0033399,0.10932,0.30486,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.943248348762685
GOCC_TRANSCRIPTION_FACTOR_AP...,SET,5,0.22884,0.0037759,0.44836,0.30489,GOCC_TRANSCRIPTION_FACTOR_AP_1_COMPLEX,0.943248348762685
HP_LOW_ALKALINE_PHOSPHATASE,SET,10,0.14797,0.0034524,0.28992,0.30489,HP_LOW_ALKALINE_PHOSPHATASE,0.943248348762685
chr3q21,SET,62,0.090029,0.0052229,0.17642,0.30492,chr3q21,0.943257196261682
GSE17721_POLYIC_VS_CPG_2H_BM...2,SET,182,0.031419,0.0031127,0.061584,0.30496,GSE17721_POLYIC_VS_CPG_2H_BMDC_UP,0.943296974012104
GOBP_PROTEIN_TRANSMEMBRANE_T...,SET,68,0.053069,0.0032237,0.10404,0.305,GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.943336744682745
REACTOME_SIGNALING_BY_CYTOSO...,SET,17,0.12029,0.0036587,0.2359,0.30505,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,0.943345595671072
GGCAGTG_MIR3243P,SET,87,0.045676,0.0031367,0.089577,0.30506,GGCAGTG_MIR3243P,0.943345595671072
GNF2_MAP2K3,SET,66,0.053687,0.0032131,0.10532,0.30511,GNF2_MAP2K3,0.943345595671072
GOMF_ARGININE_BINDING,SET,6,0.19728,0.0035658,0.38713,0.30517,GOMF_ARGININE_BINDING,0.943345595671072
HP_MALE_PSEUDOHERMAPHRODITISM,SET,36,0.068346,0.0030234,0.13417,0.30524,HP_MALE_PSEUDOHERMAPHRODITISM,0.943345595671072
MIKKELSEN_MCV6_HCP_WITH_H3K2...,SET,412,0.023759,0.0035189,0.046645,0.30525,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,0.943345595671072
GOBP_POSITIVE_REGULATION_OF_...14,SET,28,0.091719,0.0035791,0.18008,0.30527,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.943345595671072
GOBP_CD4_POSITIVE_CD25_POSIT...,SET,7,0.19335,0.0037746,0.37967,0.30529,GOBP_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.943345595671072
GCAAAAA_MIR129,SET,171,0.033147,0.003184,0.065106,0.30534,GCAAAAA_MIR129,0.943345595671072
GAVISH_3CA_METAPROGRAM_B_CEL...10,SET,44,0.071386,0.0034905,0.14022,0.30535,GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR,0.943345595671072
MIR197_3P,SET,90,0.043648,0.0030485,0.085744,0.30536,MIR197_3P,0.943345595671072
GOBP_URETER_DEVELOPMENT,SET,17,0.11241,0.0034189,0.22084,0.30538,GOBP_URETER_DEVELOPMENT,0.943345595671072
GOBP_REGULATION_OF_EXOSOMAL_...,SET,18,0.09761,0.0030548,0.1918,0.30541,GOBP_REGULATION_OF_EXOSOMAL_SECRETION,0.943345595671072
GOBP_CELLULAR_RESPONSE_TO_AL...2,SET,16,0.1164,0.0034348,0.2288,0.30546,GOBP_CELLULAR_RESPONSE_TO_ALDEHYDE,0.943345595671072
GOMF_N_ACETYLLACTOSAMINIDE_B...,SET,6,0.21464,0.0038795,0.4219,0.30547,GOMF_N_ACETYLLACTOSAMINIDE_BETA_1_3_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.943345595671072
REACTOME_SARS_COV_2_MODULATE...1,SET,11,0.1159,0.002836,0.22782,0.30548,REACTOME_SARS_COV_2_MODULATES_AUTOPHAGY,0.943345595671072
GOBP_POSITIVE_REGULATION_OF_...367,SET,8,0.13216,0.0027581,0.25986,0.30553,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.943345595671072
GOBP_T_CELL_PROLIFERATION,SET,194,0.033055,0.0033798,0.064995,0.30553,GOBP_T_CELL_PROLIFERATION,0.943345595671072
HP_STRIAE_DISTENSAE,SET,33,0.077045,0.0032634,0.15149,0.30553,HP_STRIAE_DISTENSAE,0.943345595671072
CAFFAREL_RESPONSE_TO_THC_24H...4,SET,29,0.074366,0.0029532,0.14624,0.30555,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,0.943345595671072
HP_HEPATIC_CYSTS,SET,23,0.086097,0.0030454,0.16942,0.30566,HP_HEPATIC_CYSTS,0.943345595671072
GSE19888_ADENOSINE_A3R_ACT_V...3,SET,182,0.030905,0.0030617,0.060814,0.30566,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN,0.943345595671072
GSE360_DC_VS_MAC_B_MALAYI_LO...1,SET,175,0.032247,0.0031332,0.063454,0.30566,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN,0.943345595671072
REACTOME_SIGNALLING_TO_ERKS,SET,34,0.074743,0.0032135,0.14708,0.30567,REACTOME_SIGNALLING_TO_ERKS,0.943345595671072
HP_UNILATERAL_PTOSIS,SET,8,0.15682,0.0032728,0.30876,0.30576,HP_UNILATERAL_PTOSIS,0.943345595671072
REACTOME_SYNTHESIS_OF_PG,SET,8,0.15325,0.0031983,0.30181,0.30581,REACTOME_SYNTHESIS_OF_PG,0.943345595671072
REACTOME_DEACTIVATION_OF_THE...,SET,38,0.072585,0.0032988,0.14295,0.30582,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,0.943345595671072
GSE16266_CTRL_VS_HEATSHOCK_A...2,SET,173,0.031916,0.0030835,0.062861,0.30583,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.943345595671072
GSE21670_IL6_VS_TGFB_AND_IL6...2,SET,173,0.033503,0.0032368,0.065991,0.30584,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.943345595671072
BIOCARTA_CARM1_PATHWAY,SET,12,0.13078,0.0033424,0.25763,0.30586,BIOCARTA_CARM1_PATHWAY,0.943345595671072
GSE21063_CTRL_VS_ANTI_IGM_ST...9,SET,164,0.033483,0.0031503,0.065973,0.3059,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN,0.943345595671072
GOBP_MITOPHAGY,SET,57,0.057125,0.003178,0.11258,0.30593,GOBP_MITOPHAGY,0.943345595671072
GSE23321_CD8_STEM_CELL_MEMOR...1,SET,159,0.031648,0.0029324,0.062374,0.30594,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN,0.943345595671072
GOBP_NEGATIVE_REGULATION_OF_...90,SET,7,0.17668,0.0034492,0.34825,0.30596,GOBP_NEGATIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.943345595671072
CCCACAT_MIR2993P,SET,48,0.061087,0.0031193,0.12042,0.30598,CCCACAT_MIR2993P,0.943345595671072
MODULE_492,SET,16,0.11136,0.003286,0.21952,0.30598,MODULE_492,0.943345595671072
FIRESTEIN_PROLIFERATION,SET,150,0.035046,0.0031547,0.069123,0.30608,FIRESTEIN_PROLIFERATION,0.943389425622022
HP_HYPOCALCEMIC_TETANY,SET,7,0.17786,0.0034723,0.35101,0.30618,HP_HYPOCALCEMIC_TETANY,0.943389425622022
MIR4744,SET,155,0.033907,0.0031022,0.066933,0.30623,MIR4744,0.943389425622022
GOCC_ENDOPLASMIC_RETICULUM_C...,SET,11,0.11442,0.0027998,0.22591,0.30626,GOCC_ENDOPLASMIC_RETICULUM_CHAPERONE_COMPLEX,0.943389425622022
REACTOME_HIV_ELONGATION_ARRE...,SET,29,0.073053,0.0029011,0.14428,0.30631,REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY,0.943389425622022
HP_PERIPHERAL_RETINAL_AVASCU...,SET,7,0.17765,0.0034682,0.35084,0.30631,HP_PERIPHERAL_RETINAL_AVASCULARIZATION,0.943389425622022
GOBP_POSITIVE_REGULATION_OF_...608,SET,69,0.052056,0.0031852,0.10284,0.30636,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.943389425622022
HP_LIMITATION_OF_KNEE_MOBILI...,SET,30,0.082849,0.0033462,0.16368,0.30637,HP_LIMITATION_OF_KNEE_MOBILITY,0.943389425622022
INGRAM_SHH_TARGETS_DN,SET,57,0.058178,0.0032366,0.11499,0.30645,INGRAM_SHH_TARGETS_DN,0.943389425622022
GSE17721_0.5H_VS_24H_POLYIC_...2,SET,183,0.031318,0.0031111,0.061912,0.30648,GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP,0.943389425622022
HP_DUPLICATION_OF_THE_DISTAL...1,SET,12,0.12624,0.0032264,0.24958,0.30649,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_HAND,0.943389425622022
GAVISH_3CA_METAPROGRAM_MACRO...3,SET,43,0.069289,0.0033493,0.13699,0.30651,GAVISH_3CA_METAPROGRAM_MACROPHAGES_LIPID_ASSOCIATED,0.943389425622022
GOBP_POSITIVE_REGULATION_OF_...162,SET,9,0.13435,0.0029738,0.26564,0.30651,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_BINDING,0.943389425622022
GOBP_TRNA_THIO_MODIFICATION,SET,5,0.19487,0.0032154,0.38531,0.30652,GOBP_TRNA_THIO_MODIFICATION,0.943389425622022
HEIDENBLAD_AMPLICON_8Q24_UP,SET,35,0.064475,0.0028124,0.12749,0.30653,HEIDENBLAD_AMPLICON_8Q24_UP,0.943389425622022
GSE41176_UNSTIM_VS_ANTI_IGM_...14,SET,179,0.03202,0.0031462,0.063319,0.30654,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP,0.943389425622022
CHIANG_LIVER_CANCER_SUBCLASS...8,SET,161,0.034555,0.0032217,0.068342,0.30656,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,0.943389425622022
GOBP_LATERAL_VENTRICLE_DEVEL...,SET,12,0.12181,0.0031131,0.24095,0.3066,GOBP_LATERAL_VENTRICLE_DEVELOPMENT,0.943389425622022
GOBP_MESODERM_MORPHOGENESIS,SET,68,0.055327,0.0033608,0.10946,0.30662,GOBP_MESODERM_MORPHOGENESIS,0.943389425622022
GOMF_ESTROGEN_RESPONSE_ELEME...,SET,10,0.15548,0.0036276,0.30768,0.30667,GOMF_ESTROGEN_RESPONSE_ELEMENT_BINDING,0.943389425622022
GSE17974_IL4_AND_ANTI_IL12_V...6,SET,151,0.035797,0.003233,0.070848,0.30669,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP,0.943389425622022
REACTOME_CREATION_OF_C4_AND_...,SET,12,0.15184,0.0038805,0.30055,0.30672,REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS,0.943389425622022
GOBP_NEGATIVE_REGULATION_OF_...414,SET,12,0.15134,0.0038678,0.29959,0.30673,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.943389425622022
HP_RIB_SEGMENTATION_ABNORMAL...,SET,11,0.14244,0.0034856,0.28212,0.30682,HP_RIB_SEGMENTATION_ABNORMALITIES,0.943389425622022
GOBP_REGULATION_OF_VERY_LOW_...2,SET,5,0.23077,0.0038077,0.45729,0.30691,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.943389425622022
REACTOME_DISEASES_OF_SIGNAL_...,SET,439,0.020492,0.0031306,0.040617,0.30695,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,0.943389425622022
MODULE_201,SET,48,0.064411,0.0032891,0.12766,0.30695,MODULE_201,0.943389425622022
GSE360_LOW_DOSE_B_MALAYI_VS_...4,SET,184,0.031172,0.003105,0.061788,0.30696,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.943389425622022
HP_LONG_UPPER_LIP,SET,6,0.20447,0.0036958,0.40537,0.30699,HP_LONG_UPPER_LIP,0.943389425622022
MIR6500_3P,SET,73,0.049327,0.0031042,0.097797,0.307,MIR6500_3P,0.943389425622022
GOBP_NEGATIVE_REGULATION_OF_...114,SET,14,0.11998,0.003312,0.23793,0.30703,GOBP_NEGATIVE_REGULATION_OF_CELL_DIVISION,0.943389425622022
HP_SEVERE_COMBINED_IMMUNODEF...,SET,19,0.10398,0.0033432,0.2062,0.30704,HP_SEVERE_COMBINED_IMMUNODEFICIENCY,0.943389425622022
GSE16451_IMMATURE_VS_MATURE_...2,SET,181,0.032294,0.0031906,0.064062,0.3071,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.943389425622022
GSE21546_WT_VS_ELK1_KO_ANTI_...1,SET,177,0.030945,0.0030237,0.061391,0.30711,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.943389425622022
GOBP_EYELID_DEVELOPMENT_IN_C...,SET,13,0.13699,0.003644,0.27182,0.30714,GOBP_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.943389425622022
DESCARTES_MAIN_FETAL_VASCULA...,SET,40,0.07065,0.0032941,0.14021,0.30717,DESCARTES_MAIN_FETAL_VASCULAR_ENDOTHELIAL_CELLS,0.943389425622022
HE_LIM_SUN_FETAL_LUNG_C1_MID...2,SET,136,0.040499,0.0034727,0.080372,0.30717,HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL,0.943389425622022
GOMF_D_LOOP_DNA_BINDING,SET,5,0.22164,0.0036572,0.43988,0.30718,GOMF_D_LOOP_DNA_BINDING,0.943389425622022
REACTOME_SEALING_OF_THE_NUCL...,SET,29,0.078332,0.0031107,0.15547,0.30719,REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III,0.943389425622022
ANDERSON_BLOOD_CN54GP140_ADJ...5,SET,53,0.056362,0.0030239,0.11187,0.30719,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN,0.943389425622022
GOBP_REGULATION_OF_SPONTANEO...,SET,5,0.19511,0.0032194,0.38729,0.30721,GOBP_REGULATION_OF_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.943389425622022
HP_PROMINENT_ANTIHELIX,SET,13,0.11469,0.0030507,0.22774,0.30727,HP_PROMINENT_ANTIHELIX,0.943389425622022
TRAVAGLINI_LUNG_LYMPHATIC_CE...,SET,191,0.033748,0.0034242,0.06701,0.30727,TRAVAGLINI_LUNG_LYMPHATIC_CELL,0.943389425622022
HESSON_TUMOR_SUPPRESSOR_CLUS...,SET,8,0.17921,0.00374,0.35586,0.30728,HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3,0.943389425622022
REACTOME_NGF_INDEPENDANT_TRK...,SET,5,0.20691,0.0034141,0.41092,0.3073,REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION,0.943389425622022
REACTOME_DNA_DAMAGE_REVERSAL,SET,8,0.14939,0.0031178,0.29672,0.30732,REACTOME_DNA_DAMAGE_REVERSAL,0.943389425622022
HP_TETANY,SET,21,0.10434,0.0035266,0.20724,0.30733,HP_TETANY,0.943389425622022
GCM_TPR,SET,29,0.069789,0.0027715,0.13865,0.30736,GCM_TPR,0.943389425622022
WP_TOLLLIKE_RECEPTOR_SIGNALI...2,SET,26,0.079867,0.0030034,0.15873,0.30743,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,0.943389425622022
GSE17721_LPS_VS_PAM3CSK4_8H_...2,SET,182,0.031319,0.0031027,0.06225,0.30745,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP,0.943389425622022
GOBP_ORGANELLE_ASSEMBLY,SET,914,0.014096,0.0030659,0.028024,0.30748,GOBP_ORGANELLE_ASSEMBLY,0.943389425622022
KAUFFMANN_MELANOMA_RELAPSE_DN,SET,6,0.17114,0.0030932,0.34024,0.30749,KAUFFMANN_MELANOMA_RELAPSE_DN,0.943389425622022
HP_ABNORMAL_FOVEAL_MORPHOLOGY,SET,45,0.069918,0.0034572,0.13905,0.30754,HP_ABNORMAL_FOVEAL_MORPHOLOGY,0.943389425622022
GOBP_AXON_EXTENSION,SET,93,0.0448,0.0031804,0.089099,0.30755,GOBP_AXON_EXTENSION,0.943389425622022
GOBP_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.17456,0.0025763,0.34717,0.30755,GOBP_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS,0.943389425622022
GOMF_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.17456,0.0025763,0.34717,0.30755,GOMF_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY,0.943389425622022
DESCARTES_FETAL_INTESTINE_EN...1,SET,46,0.069457,0.0034723,0.13813,0.30755,DESCARTES_FETAL_INTESTINE_ENS_GLIA,0.943389425622022
GOBP_RESPONSE_TO_INTERLEUKIN...8,SET,6,0.17765,0.003211,0.35347,0.30762,GOBP_RESPONSE_TO_INTERLEUKIN_3,0.943389425622022
GOCC_ENDOSOME_LUMEN,SET,37,0.074817,0.0033553,0.14887,0.30763,GOCC_ENDOSOME_LUMEN,0.943389425622022
GOBP_RIBOSOMAL_LARGE_SUBUNIT...3,SET,7,0.15316,0.0029901,0.30478,0.30765,GOBP_RIBOSOMAL_LARGE_SUBUNIT_EXPORT_FROM_NUCLEUS,0.943389425622022
GSE41176_WT_VS_TAK1_KO_ANTI_...4,SET,183,0.032473,0.0032258,0.064618,0.30765,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP,0.943389425622022
GAZDA_DIAMOND_BLACKFAN_ANEMI...1,SET,403,0.020509,0.003005,0.040819,0.30768,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,0.943398182620203
HP_BUDD_CHIARI_SYNDROME,SET,7,0.17814,0.0034777,0.35472,0.30776,HP_BUDD_CHIARI_SYNDROME,0.94356023288638
REACTOME_SIGNALING_BY_CSF1_M...,SET,29,0.078479,0.0031165,0.15633,0.30783,REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS,0.943669672781796
HP_POSTEXERTIONAL_SYMPTOM_EX...,SET,14,0.11639,0.0032127,0.23187,0.30785,HP_POSTEXERTIONAL_SYMPTOM_EXACERBATION,0.943669672781796
GOMF_PHOSPHOLIPASE_C_ACTIVITY,SET,29,0.080649,0.0032027,0.16074,0.30793,GOMF_PHOSPHOLIPASE_C_ACTIVITY,0.943800727128503
REACTOME_NEUROTOXICITY_OF_CL...,SET,10,0.13072,0.0030499,0.26058,0.30796,REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS,0.943800727128503
REACTOME_CYTOSOLIC_SULFONATI...,SET,21,0.099825,0.0033741,0.19903,0.30799,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,0.943800727128503
JECHLINGER_EPITHELIAL_TO_MES...2,SET,65,0.056522,0.0033571,0.11271,0.30802,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.943800727128503
MIR5682,SET,205,0.031011,0.0032585,0.06186,0.30808,MIR5682,0.943800727128503
GOBP_OSTEOBLAST_PROLIFERATION,SET,32,0.07947,0.0033148,0.15853,0.30809,GOBP_OSTEOBLAST_PROLIFERATION,0.943800727128503
GOBP_PONS_DEVELOPMENT,SET,11,0.13285,0.0032509,0.26503,0.30809,GOBP_PONS_DEVELOPMENT,0.943800727128503
GSE14413_UNSTIM_VS_IFNB_STIM...4,SET,129,0.036883,0.0030808,0.073585,0.30811,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP,0.943800727128503
KEGG_NUCLEOTIDE_EXCISION_REP...,SET,40,0.058556,0.0027302,0.11692,0.30825,KEGG_NUCLEOTIDE_EXCISION_REPAIR,0.94382656305037
MIR4482_3P,SET,427,0.021502,0.0032408,0.042937,0.30826,MIR4482_3P,0.94382656305037
KYNG_ENVIRONMENTAL_STRESS_RE...1,SET,16,0.097985,0.0028913,0.19568,0.30828,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,0.94382656305037
GOBP_CYCLIC_NUCLEOTIDE_METAB...,SET,37,0.074489,0.0033406,0.14877,0.3083,GOBP_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,0.94382656305037
GOBP_SMALL_NUCLEOLAR_RIBONUC...,SET,10,0.13694,0.0031951,0.27352,0.3083,GOBP_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY,0.94382656305037
TGCGCANK_UNKNOWN,SET,491,0.019178,0.003094,0.038312,0.30834,TGCGCANK_UNKNOWN,0.94382656305037
GOBP_GLUCOCORTICOID_METABOLI...,SET,24,0.095591,0.0034539,0.19097,0.30834,GOBP_GLUCOCORTICOID_METABOLIC_PROCESS,0.94382656305037
HOFFMANN_IMMATURE_TO_MATURE_...2,SET,35,0.076381,0.0033317,0.15262,0.30837,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,0.94382656305037
GOBP_NEGATIVE_REGULATION_OF_...425,SET,49,0.067642,0.0034898,0.13516,0.30837,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.94382656305037
F10_TARGET_GENES,SET,211,0.030935,0.0032973,0.061818,0.30839,F10_TARGET_GENES,0.94382656305037
PID_S1P_S1P4_PATHWAY,SET,14,0.10479,0.0028926,0.20953,0.3085,PID_S1P_S1P4_PATHWAY,0.943996962493397
REACTOME_TRANSPORT_OF_CONNEX...,SET,18,0.10858,0.003398,0.21711,0.3085,REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE,0.943996962493397
GYORFFY_DOXORUBICIN_RESISTAN...,SET,34,0.072497,0.0031169,0.14509,0.30866,GYORFFY_DOXORUBICIN_RESISTANCE,0.944359519408503
WP_MECP2_AND_ASSOCIATED_RETT...,SET,67,0.056882,0.0034299,0.11387,0.3087,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,0.944359519408503
MIR599,SET,81,0.047942,0.0031773,0.095968,0.3087,MIR599,0.944359519408503
GOBP_REGULATION_OF_FEEDING_B...,SET,25,0.096809,0.0035699,0.1939,0.30879,GOBP_REGULATION_OF_FEEDING_BEHAVIOR,0.944441304730086
LEIN_CHOROID_PLEXUS_MARKERS,SET,98,0.045008,0.0032795,0.090165,0.30883,LEIN_CHOROID_PLEXUS_MARKERS,0.944441304730086
REACTOME_TRANSLATION_OF_REPL...,SET,14,0.11491,0.0031719,0.23024,0.30886,REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,0.944441304730086
GOBP_POSITIVE_REGULATION_OF_...626,SET,10,0.15842,0.0036962,0.31742,0.30886,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,0.944441304730086
REACTOME_INLB_MEDIATED_ENTRY...,SET,13,0.11448,0.003045,0.22942,0.3089,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,0.944441304730086
GOBP_PEPTIDE_TRANSPORT,SET,244,0.028459,0.0032589,0.057055,0.30896,GOBP_PEPTIDE_TRANSPORT,0.944441304730086
HP_ABNORMAL_PROTEIN_O_LINKED...,SET,5,0.16634,0.0027447,0.33353,0.30899,HP_ABNORMAL_PROTEIN_O_LINKED_GLYCOSYLATION,0.944441304730086
GOMF_CALCIUM_DEPENDENT_CYSTE...,SET,15,0.12424,0.0035496,0.24912,0.309,GOMF_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.944441304730086
GSE37301_HEMATOPOIETIC_STEM_...12,SET,176,0.032369,0.003154,0.064915,0.30902,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP,0.944441304730086
HP_GLOBAL_BRAIN_ATROPHY,SET,58,0.055771,0.0031297,0.11185,0.30903,HP_GLOBAL_BRAIN_ATROPHY,0.944441304730086
GSE17974_1H_VS_72H_UNTREATED...2,SET,179,0.030878,0.003034,0.061931,0.30904,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.944441304730086
ZNF138_TARGET_GENES,SET,3,0.207,0.0026458,0.41525,0.30907,ZNF138_TARGET_GENES,0.944441304730086
HP_ABLEPHARON,SET,5,0.19912,0.0032855,0.39946,0.30908,HP_ABLEPHARON,0.944441304730086
GSE339_CD8POS_VS_CD4CD8DN_DC...4,SET,184,0.030512,0.0030391,0.06125,0.30919,GSE339_CD8POS_VS_CD4CD8DN_DC_UP,0.944523624780316
LI_PBMC_MENACTRA_AGE_18_45YO...8,SET,15,0.12283,0.0035093,0.24657,0.30919,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE,0.944523624780316
GOBP_REGULATION_OF_RNA_EXPOR...,SET,14,0.098493,0.0027187,0.19773,0.3092,GOBP_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.944523624780316
HP_ABNORMAL_TRICUSPID_VALVE_...2,SET,72,0.051571,0.0032232,0.10355,0.30924,HP_ABNORMAL_TRICUSPID_VALVE_PHYSIOLOGY,0.944523624780316
WP_BREAST_CANCER_PATHWAY,SET,149,0.03626,0.0032532,0.072814,0.30925,WP_BREAST_CANCER_PATHWAY,0.944523624780316
HP_ABNORMAL_BLOOD_SODIUM_CON...,SET,63,0.057661,0.0033719,0.1158,0.30927,HP_ABNORMAL_BLOOD_SODIUM_CONCENTRATION,0.944523624780316
HEIDENBLAD_AMPLIFIED_IN_BONE...,SET,7,0.18466,0.0036051,0.3711,0.30938,HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER,0.94470603319575
LAKE_ADULT_KIDNEY_C25_ENDOTH...,SET,37,0.079444,0.0035628,0.15968,0.30942,LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED,0.94470603319575
WP_LDLRAD4_AND_WHAT_WE_KNOW_...,SET,7,0.19498,0.0038065,0.39194,0.30943,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,0.94470603319575
HP_INCREASED_SERUM_TESTOSTER...,SET,10,0.14139,0.0032989,0.28425,0.30945,HP_INCREASED_SERUM_TESTOSTERONE_LEVEL,0.94470603319575
KEGG_MEDICUS_VARIANT_CDX2_OV...,SET,5,0.22529,0.0037174,0.453,0.30948,KEGG_MEDICUS_VARIANT_CDX2_OVEREXPRESSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.94470603319575
REACTOME_NTRK2_ACTIVATES_RAC1,SET,5,0.19233,0.0031734,0.38681,0.30952,REACTOME_NTRK2_ACTIVATES_RAC1,0.94470603319575
GOBP_MITOCHONDRIAL_FUSION,SET,30,0.075498,0.0030493,0.15184,0.30952,GOBP_MITOCHONDRIAL_FUSION,0.94470603319575
GSE22886_NAIVE_TCELL_VS_NKCE...2,SET,173,0.032252,0.0031159,0.064888,0.30958,GSE22886_NAIVE_TCELL_VS_NKCELL_UP,0.944806190727081
GSE22025_UNTREATED_VS_TGFB1_...4,SET,184,0.032563,0.0032435,0.06553,0.30963,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP,0.94484437960688
GOBP_CELLULAR_RESPONSE_TO_X_...,SET,11,0.10747,0.0026297,0.21633,0.30968,GOBP_CELLULAR_RESPONSE_TO_X_RAY,0.94484437960688
LAKE_ADULT_KIDNEY_C7_PROXIMA...,SET,129,0.039186,0.0032731,0.078888,0.30969,LAKE_ADULT_KIDNEY_C7_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S3,0.94484437960688
BLANCO_MELO_RESPIRATORY_SYNC...1,SET,103,0.042456,0.003171,0.08548,0.30971,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,0.94484437960688
GOBP_NEGATIVE_REGULATION_OF_...242,SET,16,0.11758,0.0034694,0.23679,0.30976,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.94484437960688
GOBP_CARDIOLIPIN_METABOLIC_P...,SET,13,0.13214,0.003515,0.26616,0.30978,GOBP_CARDIOLIPIN_METABOLIC_PROCESS,0.94484437960688
MODULE_310,SET,19,0.10652,0.003425,0.21459,0.30981,MODULE_310,0.94484437960688
GOCC_SPERM_FIBROUS_SHEATH,SET,5,0.20788,0.00343,0.41877,0.30981,GOCC_SPERM_FIBROUS_SHEATH,0.94484437960688
REACTOME_SARS_COV_1_MODULATE...,SET,32,0.070282,0.0029316,0.14164,0.30988,REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,0.944974940773888
GOBP_POSITIVE_REGULATION_OF_...512,SET,13,0.12703,0.0033791,0.25614,0.30996,GOBP_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.945048254692159
GOMF_METALLOENDOPEPTIDASE_IN...,SET,13,0.11737,0.0031221,0.23666,0.30996,GOMF_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.945048254692159
KEGG_MEDICUS_REFERENCE_FGF_F...1,SET,30,0.084879,0.0034282,0.1712,0.31002,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY,0.945048254692159
GOBP_RESPONSE_TO_KETONE,SET,201,0.031746,0.0033034,0.064032,0.31003,GOBP_RESPONSE_TO_KETONE,0.945048254692159
HP_OCULAR_ALBINISM,SET,27,0.083356,0.0031942,0.16814,0.31004,HP_OCULAR_ALBINISM,0.945048254692159
AKT_UP_MTOR_DN.V1_UP,SET,165,0.033746,0.0031847,0.068116,0.31015,AKT_UP_MTOR_DN.V1_UP,0.945300644567219
HP_ADRENAL_HYPERPLASIA,SET,23,0.094426,0.00334,0.19065,0.3102,HP_ADRENAL_HYPERPLASIA,0.945370133286566
KEGG_MEDICUS_PATHOGEN_SALMON...5,SET,9,0.14518,0.0032135,0.29332,0.31032,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY,0.945652924156072
HP_MALAR_RASH,SET,29,0.084279,0.0033469,0.17031,0.31035,HP_MALAR_RASH,0.945661428195686
GSE32986_GMCSF_VS_GMCSF_AND_...3,SET,161,0.033215,0.0030967,0.067176,0.3105,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.945820755212896
HP_ABNORMAL_BOWMAN_CAPSULE_M...,SET,9,0.13372,0.0029598,0.27046,0.31051,HP_ABNORMAL_BOWMAN_CAPSULE_MORPHOLOGY,0.945820755212896
HP_EXUDATIVE_VITREORETINOPAT...,SET,7,0.13783,0.0026907,0.27877,0.31051,HP_EXUDATIVE_VITREORETINOPATHY,0.945820755212896
HP_PURE_RED_CELL_APLASIA,SET,25,0.079816,0.0029433,0.16145,0.31053,HP_PURE_RED_CELL_APLASIA,0.945820755212896
GOBP_PROTEIN_PALMITOYLATION,SET,28,0.076754,0.0029951,0.1553,0.31058,GOBP_PROTEIN_PALMITOYLATION,0.945820755212896
GOCC_BETA_CATENIN_TCF_COMPLEX,SET,13,0.12294,0.0032701,0.2488,0.31061,GOCC_BETA_CATENIN_TCF_COMPLEX,0.945820755212896
GCM_ERCC4,SET,25,0.082171,0.0030301,0.16631,0.31062,GCM_ERCC4,0.945820755212896
GOCC_U2_TYPE_CATALYTIC_STEP_...,SET,30,0.066655,0.0026922,0.1349,0.31062,GOCC_U2_TYPE_CATALYTIC_STEP_2_SPLICEOSOME,0.945820755212896
FIGUEROA_AML_METHYLATION_CLU...8,SET,99,0.043584,0.0031918,0.088253,0.31071,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,0.945952620967742
SOGA_COLORECTAL_CANCER_MYC_UP,SET,76,0.047173,0.0030288,0.095526,0.31072,SOGA_COLORECTAL_CANCER_MYC_UP,0.945952620967742
LUND_SILENCED_BY_METHYLATION,SET,14,0.10462,0.0028878,0.21188,0.31075,LUND_SILENCED_BY_METHYLATION,0.945952620967742
HE_LIM_SUN_FETAL_LUNG_C2_APO...1,SET,11,0.12731,0.0031153,0.2579,0.31078,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M1_MACROPHAGE_CELL,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...542,SET,16,0.12399,0.0036587,0.25121,0.31081,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.945952620967742
MANNE_COVID19_ICU_VS_HEALTHY...2,SET,117,0.038632,0.0030741,0.078284,0.31084,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.945952620967742
GOBP_HEMIDESMOSOME_ASSEMBLY,SET,6,0.19238,0.0034772,0.38995,0.31088,GOBP_HEMIDESMOSOME_ASSEMBLY,0.945952620967742
GSE360_DC_VS_MAC_UP,SET,178,0.031886,0.0031244,0.06465,0.31093,GSE360_DC_VS_MAC_UP,0.945952620967742
STEARMAN_LUNG_CANCER_EARLY_V...1,SET,55,0.058203,0.0031808,0.11802,0.31095,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...394,SET,8,0.16426,0.0034281,0.33319,0.31101,GOBP_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.945952620967742
KEGG_MEDICUS_ENV_FACTOR_ZN_T...,SET,18,0.10726,0.0033567,0.2176,0.31104,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.945952620967742
FAN_EMBRYONIC_CTX_BIG_GROUPS...6,SET,8,0.18105,0.0037784,0.36731,0.31104,FAN_EMBRYONIC_CTX_BIG_GROUPS_INHIBITORY,0.945952620967742
AP4_Q6_01,SET,233,0.027939,0.0031273,0.056697,0.31109,AP4_Q6_01,0.945952620967742
GOBP_NEGATIVE_REGULATION_OF_...69,SET,56,0.056094,0.0030932,0.11385,0.31112,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.945952620967742
GOBP_REGULATION_OF_CATALYTIC...,SET,1225,0.0128,0.003194,0.025979,0.31112,GOBP_REGULATION_OF_CATALYTIC_ACTIVITY,0.945952620967742
P53_DN.V2_UP,SET,132,0.039601,0.0033457,0.080394,0.31115,P53_DN.V2_UP,0.945952620967742
KEGG_MEDICUS_PATHOGEN_HTLV_1...2,SET,6,0.20399,0.0036871,0.41418,0.31118,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY,0.945952620967742
GOBP_CELL_SURFACE_RECEPTOR_P...3,SET,6,0.16393,0.0029629,0.33291,0.31122,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY,0.945952620967742
GSE7831_UNSTIM_VS_INFLUENZA_...4,SET,184,0.031372,0.0031249,0.063721,0.31124,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP,0.945952620967742
HP_PURPURA,SET,116,0.040695,0.0032245,0.082661,0.31125,HP_PURPURA,0.945952620967742
HP_FIBROADENOMA_OF_THE_BREAST,SET,11,0.12941,0.0031667,0.26296,0.31132,HP_FIBROADENOMA_OF_THE_BREAST,0.945952620967742
E2F1_UP.V1_DN,SET,176,0.031576,0.0030767,0.064166,0.31132,E2F1_UP.V1_DN,0.945952620967742
GSE30971_CTRL_VS_LPS_STIM_MA...3,SET,170,0.030342,0.0029061,0.061664,0.31135,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN,0.945952620967742
GOBP_REGULATION_OF_SECONDARY...1,SET,8,0.1603,0.0033454,0.3259,0.31141,GOBP_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION,0.945952620967742
GSE46606_IRF4HIGH_VS_IRF4MID...4,SET,178,0.029125,0.0028538,0.059215,0.31142,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.945952620967742
GOBP_NORADRENERGIC_NEURON_DE...,SET,4,0.24442,0.0036073,0.49708,0.31146,GOBP_NORADRENERGIC_NEURON_DEVELOPMENT,0.945952620967742
GOMF_SULFOTRANSFERASE_ACTIVI...,SET,49,0.065241,0.0033659,0.1327,0.31149,GOMF_SULFOTRANSFERASE_ACTIVITY,0.945952620967742
REACTOME_PROPIONYL_COA_CATAB...,SET,4,0.24167,0.0035667,0.49159,0.31151,REACTOME_PROPIONYL_COA_CATABOLISM,0.945952620967742
HP_CURLY_EYELASHES,SET,12,0.13474,0.0034435,0.27411,0.31153,HP_CURLY_EYELASHES,0.945952620967742
GARCIA_PINERES_PBMC_HPV_16_L...1,SET,20,0.09758,0.0032189,0.19855,0.31155,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.945952620967742
WP_SYNAPTIC_VESICLE_PATHWAY,SET,49,0.060983,0.0031462,0.12412,0.31161,WP_SYNAPTIC_VESICLE_PATHWAY,0.945952620967742
MIR4786_5P,SET,85,0.045627,0.0030973,0.092913,0.31169,MIR4786_5P,0.945952620967742
IGARASHI_ATF4_TARGETS_UP,SET,4,0.27583,0.0040709,0.56175,0.31171,IGARASHI_ATF4_TARGETS_UP,0.945952620967742
MIR153_3P,SET,308,0.025041,0.003216,0.051001,0.31172,MIR153_3P,0.945952620967742
GSE3039_CD4_TCELL_VS_B2_BCEL...1,SET,181,0.031753,0.0031372,0.064684,0.31175,GSE3039_CD4_TCELL_VS_B2_BCELL_DN,0.945952620967742
HP_PERIPHERAL_AXONAL_DEGENER...,SET,179,0.030483,0.0029951,0.062104,0.31178,HP_PERIPHERAL_AXONAL_DEGENERATION,0.945952620967742
GOBP_GLUCOSYLCERAMIDE_METABO...,SET,7,0.1664,0.0032484,0.33906,0.3118,GOBP_GLUCOSYLCERAMIDE_METABOLIC_PROCESS,0.945952620967742
KEGG_MEDICUS_REFERENCE_HGF_M...1,SET,10,0.13865,0.0032349,0.28258,0.31184,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY,0.945952620967742
GOBP_REGULATION_OF_RNA_SPLIC...,SET,161,0.030703,0.0028625,0.062597,0.3119,GOBP_REGULATION_OF_RNA_SPLICING,0.945952620967742
SMID_BREAST_CANCER_RELAPSE_I...1,SET,275,0.027236,0.0033082,0.055533,0.31191,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...145,SET,31,0.075286,0.0030909,0.1535,0.31191,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.945952620967742
MIR378F,SET,36,0.065766,0.0029093,0.13412,0.31194,MIR378F,0.945952620967742
HP_JERKY_HEAD_MOVEMENTS,SET,11,0.14603,0.0035733,0.29782,0.31195,HP_JERKY_HEAD_MOVEMENTS,0.945952620967742
BIOCARTA_TCAPOPTOSIS_PATHWAY,SET,9,0.1462,0.0032361,0.29819,0.31197,BIOCARTA_TCAPOPTOSIS_PATHWAY,0.945952620967742
NRF1_Q6,SET,231,0.026597,0.0029646,0.054266,0.31203,NRF1_Q6,0.945952620967742
LI_ESTROGENE_META_E2_RESPONS...1,SET,22,0.093954,0.0032503,0.19174,0.31206,LI_ESTROGENE_META_E2_RESPONSE_DN,0.945952620967742
GSE4811_CLASSSICALY_ACTIVATE...2,SET,174,0.030429,0.0029482,0.062103,0.31208,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP,0.945952620967742
GOBP_REGULATION_OF_GAMMA_DEL...1,SET,11,0.12888,0.0031537,0.26313,0.31214,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,0.945952620967742
HP_INTRACTABLE_DIARRHEA,SET,6,0.19399,0.0035063,0.39616,0.31218,HP_INTRACTABLE_DIARRHEA,0.945952620967742
GSE42021_CD24INT_TREG_VS_CD2...2,SET,177,0.029566,0.0028889,0.060382,0.31219,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP,0.945952620967742
GOBP_PROTEIN_K11_LINKED_DEUB...,SET,9,0.12126,0.0026842,0.24791,0.31237,GOBP_PROTEIN_K11_LINKED_DEUBIQUITINATION,0.945952620967742
MALTA_CURATED_STEMNESS_MARKE...,SET,19,0.10617,0.0034136,0.21709,0.31241,MALTA_CURATED_STEMNESS_MARKERS,0.945952620967742
DESCARTES_FETAL_PLACENTA_SMO...,SET,74,0.054671,0.0034639,0.11183,0.31246,DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS,0.945952620967742
KEGG_MEDICUS_PATHOGEN_SARS_C...1,SET,6,0.20744,0.0037495,0.42434,0.31247,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE,0.945952620967742
GOBP_MONOATOMIC_CATION_TRANS...2,SET,917,0.014688,0.0031996,0.030044,0.31247,GOBP_MONOATOMIC_CATION_TRANSPORT,0.945952620967742
HP_APLASIA_HYPOPLASIA_OF_THE...6,SET,4,0.23085,0.003407,0.47222,0.31247,HP_APLASIA_HYPOPLASIA_OF_THE_4TH_FINGER,0.945952620967742
GSE37301_MULTIPOTENT_PROGENI...6,SET,180,0.030869,0.0030415,0.063143,0.31247,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.945952620967742
HP_FETAL_ULTRASOUND_SOFT_MAR...,SET,104,0.039208,0.0029425,0.080265,0.31261,HP_FETAL_ULTRASOUND_SOFT_MARKER,0.945952620967742
IWANAGA_E2F1_TARGETS_INDUCED...,SET,22,0.087713,0.0030345,0.17959,0.31263,IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,0.945952620967742
GSE360_L_MAJOR_VS_B_MALAYI_L...4,SET,178,0.030587,0.002997,0.062626,0.31264,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.945952620967742
REACTOME_RECOGNITION_AND_ASS...,SET,10,0.12606,0.0029411,0.25814,0.31266,REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,0.945952620967742
GOCC_PERIKARYON,SET,131,0.038471,0.003238,0.078781,0.31266,GOCC_PERIKARYON,0.945952620967742
GSE21360_PRIMARY_VS_SECONDAR...2,SET,176,0.031022,0.0030228,0.063545,0.31271,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.945952620967742
GOBP_REGULATION_OF_GAP_JUNCT...,SET,9,0.16518,0.0036562,0.33837,0.31272,GOBP_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.945952620967742
GOCC_COLLAGEN_TYPE_IV_TRIMER,SET,4,0.22901,0.0033798,0.46914,0.31273,GOCC_COLLAGEN_TYPE_IV_TRIMER,0.945952620967742
GOBP_GROWTH,SET,818,0.015479,0.0031936,0.031726,0.31282,GOBP_GROWTH,0.945952620967742
KEGG_MEDICUS_REFERENCE_TSH_T...,SET,29,0.078509,0.0031178,0.16093,0.31283,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY,0.945952620967742
GOBP_RESPONSE_TO_STARVATION,SET,191,0.03071,0.003116,0.062973,0.31289,GOBP_RESPONSE_TO_STARVATION,0.945952620967742
chr7p13,SET,30,0.1455,0.0058766,0.29837,0.3129,chr7p13,0.945952620967742
GAVISH_3CA_METAPROGRAM_FIBRO...21,SET,45,0.06637,0.0032818,0.1361,0.3129,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS,0.945952620967742
CAO_BLOOD_FLUMIST_AGE_05_14Y...4,SET,3,0.24055,0.0030747,0.49332,0.31291,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_UP,0.945952620967742
GOBP_NEGATIVE_REGULATION_OF_...289,SET,181,0.031655,0.0031275,0.064923,0.31293,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE,0.945952620967742
GOBP_NON_PROTEINOGENIC_AMINO...2,SET,14,0.12126,0.0033472,0.2487,0.31293,GOBP_NON_PROTEINOGENIC_AMINO_ACID_CATABOLIC_PROCESS,0.945952620967742
REACTOME_DISPLACEMENT_OF_DNA...,SET,9,0.13287,0.0029411,0.27255,0.31295,REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1,0.945952620967742
HP_POSTERIOR_UVEITIS,SET,5,0.19774,0.0032628,0.40567,0.31297,HP_POSTERIOR_UVEITIS,0.945952620967742
PID_CXCR3_PATHWAY,SET,42,0.066495,0.0031767,0.13642,0.31299,PID_CXCR3_PATHWAY,0.945952620967742
REACTOME_THE_NLRP3_INFLAMMAS...,SET,14,0.10871,0.0030008,0.22306,0.31301,REACTOME_THE_NLRP3_INFLAMMASOME,0.945952620967742
MIR2113,SET,234,0.028046,0.003146,0.057556,0.31303,MIR2113,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...693,SET,5,0.19164,0.0031621,0.3933,0.31304,GOBP_POSITIVE_REGULATION_OF_SARCOMERE_ORGANIZATION,0.945952620967742
PID_AR_NONGENOMIC_PATHWAY,SET,30,0.072487,0.0029277,0.14879,0.31307,PID_AR_NONGENOMIC_PATHWAY,0.945952620967742
HP_VISUALLY_INDUCED_SEIZURE,SET,15,0.11584,0.0033098,0.23782,0.31309,HP_VISUALLY_INDUCED_SEIZURE,0.945952620967742
GOCC_NADPH_OXIDASE_COMPLEX,SET,13,0.11633,0.0030944,0.23888,0.31313,GOCC_NADPH_OXIDASE_COMPLEX,0.945952620967742
GSE27786_BCELL_VS_NKCELL_DN,SET,183,0.030124,0.0029924,0.061862,0.31315,GSE27786_BCELL_VS_NKCELL_DN,0.945952620967742
MODULE_375,SET,85,0.048149,0.0032685,0.098884,0.31316,MODULE_375,0.945952620967742
GSE41176_WT_VS_TAK1_KO_ANTI_...1,SET,174,0.032395,0.0031387,0.066541,0.31319,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN,0.945952620967742
LEIN_PONS_MARKERS,SET,79,0.048099,0.0031483,0.098808,0.31321,LEIN_PONS_MARKERS,0.945952620967742
GOBP_REGULATION_OF_BONE_MINE...2,SET,5,0.198,0.003267,0.40674,0.31321,GOBP_REGULATION_OF_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.945952620967742
GSE37534_GW1929_VS_PIOGLITAZ...1,SET,179,0.031009,0.0030468,0.063709,0.31323,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.945952620967742
GOBP_REGULATION_OF_LYMPHANGI...,SET,6,0.19402,0.0035069,0.3987,0.31326,GOBP_REGULATION_OF_LYMPHANGIOGENESIS,0.945952620967742
GSE21546_SAP1A_KO_VS_SAP1A_K...1,SET,190,0.031062,0.0031435,0.06388,0.3134,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.945952620967742
GSE37301_CD4_TCELL_VS_GRANUL...1,SET,170,0.032977,0.0031585,0.067822,0.31341,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.945952620967742
GOBP_HYPOXIA_INDUCIBLE_FACTO...,SET,3,0.25484,0.0032573,0.52434,0.31348,GOBP_HYPOXIA_INDUCIBLE_FACTOR_1ALPHA_SIGNALING_PATHWAY,0.945952620967742
GOMF_ADP_TRANSMEMBRANE_TRANS...,SET,9,0.14706,0.0032552,0.3026,0.31349,GOMF_ADP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.945952620967742
ZHONG_PFC_C1_MICROGLIA,SET,233,0.025775,0.0028852,0.053071,0.3136,ZHONG_PFC_C1_MICROGLIA,0.945952620967742
MIR4274,SET,51,0.060125,0.0031645,0.12383,0.31364,MIR4274,0.945952620967742
GOBP_REGULATION_OF_NK_T_CELL...2,SET,6,0.1962,0.0035462,0.40408,0.31365,GOBP_REGULATION_OF_NK_T_CELL_DIFFERENTIATION,0.945952620967742
BIOCARTA_TPO_PATHWAY,SET,24,0.088437,0.0031954,0.18216,0.31366,BIOCARTA_TPO_PATHWAY,0.945952620967742
GOBP_LUTEOLYSIS,SET,6,0.1976,0.0035716,0.40701,0.31366,GOBP_LUTEOLYSIS,0.945952620967742
GSE12366_NAIVE_VS_MEMORY_BCE...2,SET,162,0.032923,0.0030789,0.067822,0.31369,GSE12366_NAIVE_VS_MEMORY_BCELL_UP,0.945952620967742
REACTOME_PHOSPHOLIPASE_C_MED...2,SET,17,0.11323,0.003444,0.2333,0.31371,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,0.945952620967742
IK1_01,SET,250,0.026711,0.0030957,0.055041,0.31374,IK1_01,0.945952620967742
MOOTHA_VOXPHOS,SET,68,0.044311,0.0026917,0.091336,0.31379,MOOTHA_VOXPHOS,0.945952620967742
GOBP_REGULATION_OF_T_HELPER_...4,SET,11,0.14281,0.0034945,0.29437,0.31379,GOBP_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,0.945952620967742
GOMF_3_5_CYCLIC_AMP_PHOSPHOD...,SET,22,0.090288,0.0031235,0.18613,0.31381,GOMF_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY,0.945952620967742
WONG_MITOCHONDRIA_GENE_MODULE,SET,190,0.027738,0.0028071,0.057193,0.31384,WONG_MITOCHONDRIA_GENE_MODULE,0.945952620967742
GOBP_NEGATIVE_REGULATION_OF_...187,SET,107,0.038521,0.0029321,0.079423,0.31384,GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.945952620967742
GSE37301_COMMON_LYMPHOID_PRO...6,SET,177,0.031377,0.0030659,0.064698,0.31385,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP,0.945952620967742
HP_APLASIA_HYPOPLASIA_OF_THE...61,SET,74,0.046253,0.0029305,0.095407,0.31391,HP_APLASIA_HYPOPLASIA_OF_THE_RADIUS,0.945952620967742
REACTOME_SNRNP_ASSEMBLY,SET,48,0.054817,0.0027992,0.1131,0.31395,REACTOME_SNRNP_ASSEMBLY,0.945952620967742
WP_MITOCHONDRIAL_BETAOXIDATI...,SET,8,0.15169,0.0031658,0.31304,0.31399,WP_MITOCHONDRIAL_BETAOXIDATION,0.945952620967742
GSE25123_CTRL_VS_IL4_AND_ROS...4,SET,177,0.032064,0.003133,0.066179,0.31402,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.945952620967742
HP_APLASIA_HYPOPLASIA_OF_THE...9,SET,32,0.072172,0.0030104,0.14899,0.31405,HP_APLASIA_HYPOPLASIA_OF_THE_ABDOMINAL_WALL_MUSCULATURE,0.945952620967742
MATZUK_LUTEAL_GENES,SET,8,0.14923,0.0031143,0.30812,0.31408,MATZUK_LUTEAL_GENES,0.945952620967742
GOMF_7SK_SNRNA_BINDING,SET,9,0.11474,0.0025398,0.23692,0.31409,GOMF_7SK_SNRNA_BINDING,0.945952620967742
GOMF_I_SMAD_BINDING,SET,16,0.11585,0.0034185,0.23921,0.31409,GOMF_I_SMAD_BINDING,0.945952620967742
HP_ACUTE_ENCEPHALOPATHY,SET,10,0.13066,0.0030484,0.26986,0.31414,HP_ACUTE_ENCEPHALOPATHY,0.945952620967742
GSE22527_ANTI_CD3_INVIVO_VS_...1,SET,178,0.029253,0.0028664,0.060425,0.31415,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN,0.945952620967742
GOBP_REGULATION_OF_RELEASE_O...1,SET,41,0.0669,0.0031579,0.13824,0.31421,GOBP_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.945952620967742
KEGG_MEDICUS_REFERENCE_COHES...3,SET,14,0.10589,0.0029229,0.21882,0.31422,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE,0.945952620967742
GOBP_CELLULAR_RESPONSE_TO_TE...2,SET,8,0.13362,0.0027887,0.27614,0.31423,GOBP_CELLULAR_RESPONSE_TO_TESTOSTERONE_STIMULUS,0.945952620967742
GOMF_ERBB_3_CLASS_RECEPTOR_B...,SET,5,0.18935,0.0031242,0.39132,0.31424,GOMF_ERBB_3_CLASS_RECEPTOR_BINDING,0.945952620967742
MODULE_196,SET,22,0.086265,0.0029844,0.17829,0.31425,MODULE_196,0.945952620967742
REACTOME_CARDIAC_CONDUCTION,SET,125,0.039033,0.0032097,0.080679,0.31426,REACTOME_CARDIAC_CONDUCTION,0.945952620967742
MIR548AH_3P_MIR548AM_3P,SET,715,0.015807,0.003058,0.03267,0.31426,MIR548AH_3P_MIR548AM_3P,0.945952620967742
GOBP_SKIN_EPIDERMIS_DEVELOPM...,SET,127,0.040797,0.0033813,0.084324,0.31426,GOBP_SKIN_EPIDERMIS_DEVELOPMENT,0.945952620967742
MODULE_291,SET,61,0.056733,0.0032647,0.11736,0.31441,MODULE_291,0.945952620967742
GOBP_CELLULAR_RESPONSE_TO_AL...1,SET,96,0.044971,0.0032433,0.09303,0.31441,GOBP_CELLULAR_RESPONSE_TO_ALCOHOL,0.945952620967742
HP_PUNCTATE_PALMOPLANTAR_HYP...,SET,6,0.15951,0.0028831,0.33003,0.31443,HP_PUNCTATE_PALMOPLANTAR_HYPERKERATOSIS,0.945952620967742
GSE2405_0H_VS_1.5H_A_PHAGOCY...1,SET,181,0.028667,0.0028323,0.059313,0.31444,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.945952620967742
REACTOME_RESPIRATORY_SYNCYTI...1,SET,106,0.039913,0.0030239,0.082599,0.31448,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,0.945952620967742
GOBP_EXPLORATION_BEHAVIOR,SET,28,0.083371,0.0032533,0.17254,0.31448,GOBP_EXPLORATION_BEHAVIOR,0.945952620967742
GOMF_ALCOHOL_DEHYDROGENASE_N...1,SET,7,0.27131,0.0052967,0.56155,0.3145,GOMF_ALCOHOL_DEHYDROGENASE_NADPLUS_ACTIVITY_ZINC_DEPENDENT,0.945952620967742
HP_HYPERPIGMENTATION_OF_THE_...2,SET,289,0.023489,0.0029237,0.048621,0.31452,HP_HYPERPIGMENTATION_OF_THE_SKIN,0.945952620967742
GSE43955_TH0_VS_TGFB_IL6_TH1...2,SET,184,0.030904,0.0030782,0.063973,0.31452,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP,0.945952620967742
GCM_DENR,SET,49,0.054822,0.0028283,0.11349,0.31454,GCM_DENR,0.945952620967742
GOBP_NEGATIVE_REGULATION_OF_...471,SET,5,0.21064,0.0034755,0.43619,0.31459,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.945952620967742
GOMF_ORGANOPHOSPHATE_PHOSPHA...,SET,7,0.15331,0.002993,0.31752,0.31461,GOMF_ORGANOPHOSPHATE_PHOSPHATE_ANTIPORTER_ACTIVITY,0.945952620967742
GSE41176_WT_VS_TAK1_KO_UNSTI...1,SET,175,0.031548,0.0030653,0.065339,0.31461,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN,0.945952620967742
GSE18791_CTRL_VS_NEWCASTLE_V...14,SET,165,0.031607,0.0029828,0.065466,0.31462,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP,0.945952620967742
MATSUMIYA_BLOOD_MODIFIED_VAC...2,SET,13,0.10778,0.0028671,0.22325,0.31462,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_UP,0.945952620967742
HP_PERIPHERAL_AXONAL_NEUROPA...,SET,152,0.032797,0.0029718,0.067964,0.3147,HP_PERIPHERAL_AXONAL_NEUROPATHY,0.945952620967742
GSE17974_2.5H_VS_72H_IL4_AND...1,SET,176,0.030003,0.0029235,0.062177,0.31471,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.945952620967742
ATACTGT_MIR144,SET,181,0.03183,0.0031447,0.065966,0.31472,ATACTGT_MIR144,0.945952620967742
GSE25846_IL10_POS_VS_NEG_CD8...2,SET,175,0.031224,0.0030338,0.064713,0.31473,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP,0.945952620967742
GOBP_FLAVIN_CONTAINING_COMPO...,SET,6,0.16379,0.0029605,0.33954,0.31477,GOBP_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.945952620967742
GSE16385_IFNG_TNF_VS_UNSTIM_...2,SET,153,0.032214,0.0029284,0.066788,0.31479,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.945952620967742
BIOCARTA_FEEDER_PATHWAY,SET,8,0.11775,0.0024574,0.24414,0.3148,BIOCARTA_FEEDER_PATHWAY,0.945952620967742
REACTOME_METABOLISM_OF_PORPH...,SET,26,0.081492,0.0030645,0.16897,0.3148,REACTOME_METABOLISM_OF_PORPHYRINS,0.945952620967742
HE_LIM_SUN_FETAL_LUNG_C2_BAS...,SET,100,0.043722,0.003218,0.090652,0.3148,HE_LIM_SUN_FETAL_LUNG_C2_BASOPHIL_CELL,0.945952620967742
GOCC_INTRACELLULAR_PROTEIN_C...,SET,805,0.014042,0.0028751,0.029118,0.31482,GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX,0.945952620967742
GSE27241_CTRL_VS_DIGOXIN_TRE...3,SET,164,0.032192,0.0030289,0.066757,0.31483,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.945952620967742
MIR6737_5P,SET,72,0.046819,0.0029262,0.097141,0.31492,MIR6737_5P,0.945952620967742
GROSS_HYPOXIA_VIA_HIF1A_UP,SET,75,0.046738,0.0029811,0.096979,0.31493,GROSS_HYPOXIA_VIA_HIF1A_UP,0.945952620967742
HP_MALIGNANT_GENITOURINARY_T...,SET,33,0.065746,0.0027848,0.13645,0.31497,HP_MALIGNANT_GENITOURINARY_TRACT_TUMOR,0.945952620967742
HP_NEONATAL_SEIZURE,SET,8,0.14533,0.0030331,0.30169,0.315,HP_NEONATAL_SEIZURE,0.945952620967742
GOBP_ARGININE_METABOLIC_PROC...,SET,17,0.10031,0.003051,0.20825,0.31502,GOBP_ARGININE_METABOLIC_PROCESS,0.945952620967742
GAUSSMANN_MLL_AF4_FUSION_TAR...7,SET,10,0.13508,0.0031517,0.28046,0.31503,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN,0.945952620967742
BIOCARTA_MTOR_PATHWAY,SET,21,0.09401,0.0031776,0.19518,0.31503,BIOCARTA_MTOR_PATHWAY,0.945952620967742
GOBP_MICROTUBULE_ORGANIZING_...2,SET,143,0.032536,0.0028602,0.067565,0.31506,GOBP_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION,0.945952620967742
GOBP_CHEMOKINE_C_X_C_MOTIF_L...2,SET,6,0.1762,0.0031848,0.366,0.31511,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,0.945952620967742
GOCC_VCP_NPL4_UFD1_AAA_ATPAS...,SET,7,0.15855,0.0030953,0.32935,0.31511,GOCC_VCP_NPL4_UFD1_AAA_ATPASE_COMPLEX,0.945952620967742
GOCC_INTRACILIARY_TRANSPORT_...3,SET,15,0.11979,0.0034225,0.24884,0.31513,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B,0.945952620967742
GOBP_NEGATIVE_REGULATION_OF_...594,SET,5,0.17566,0.0028985,0.36504,0.31518,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.945952620967742
MIR3117_5P,SET,54,0.055586,0.0030102,0.11554,0.31522,MIR3117_5P,0.945952620967742
GSE32986_CURDLAN_LOWDOSE_VS_...4,SET,179,0.029803,0.0029283,0.061949,0.31523,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.945952620967742
GSE7460_CTRL_VS_TGFB_TREATED...4,SET,192,0.028409,0.00289,0.05907,0.31528,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP,0.945952620967742
GOBP_INTRINSIC_APOPTOTIC_SIG...8,SET,10,0.12875,0.0030039,0.26772,0.31529,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.945952620967742
MIR6861_5P,SET,62,0.051104,0.0029647,0.10628,0.31531,MIR6861_5P,0.945952620967742
ABRAMSON_INTERACT_WITH_AIRE,SET,39,0.059525,0.0027405,0.12382,0.31535,ABRAMSON_INTERACT_WITH_AIRE,0.945952620967742
MARCINIAK_ER_STRESS_RESPONSE...,SET,20,0.093487,0.0030839,0.19448,0.31536,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,0.945952620967742
GOBP_CELL_CELL_JUNCTION_DISA...,SET,5,0.22712,0.0037476,0.47254,0.31539,GOBP_CELL_CELL_JUNCTION_DISASSEMBLY,0.945952620967742
GOBP_TRANSCRIPTION_PREINITIA...,SET,64,0.047961,0.0028267,0.099801,0.31541,GOBP_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.945952620967742
HP_ABNORMALITY_OF_THE_DISTAL...5,SET,9,0.13907,0.0030784,0.28948,0.31547,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.945952620967742
GSE33162_UNTREATED_VS_4H_LPS...2,SET,183,0.030117,0.0029917,0.06271,0.31552,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP,0.945952620967742
GSE22611_UNSTIM_VS_6H_MDP_ST...4,SET,176,0.030854,0.0030063,0.064247,0.31553,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.945952620967742
OUILLETTE_CLL_13Q14_DELETION...2,SET,70,0.043583,0.0026859,0.090757,0.31554,OUILLETTE_CLL_13Q14_DELETION_UP,0.945952620967742
MANNO_MIDBRAIN_NEUROTYPES_HP...1,SET,701,0.016627,0.0031863,0.034634,0.31559,MANNO_MIDBRAIN_NEUROTYPES_HPERIC,0.945952620967742
GOMF_CAMP_DEPENDENT_PROTEIN_...3,SET,12,0.1187,0.0030337,0.24729,0.31561,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY,0.945952620967742
GOBP_EXOCYTOSIS,SET,322,0.023059,0.0030269,0.048042,0.31562,GOBP_EXOCYTOSIS,0.945952620967742
GAUTAM_EYE_CORNEA_ELF3_HIGH_...,SET,134,0.035793,0.0030467,0.074586,0.31566,GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS,0.945952620967742
HP_DIFFICULTY_WALKING,SET,277,0.024096,0.0029373,0.050229,0.31571,HP_DIFFICULTY_WALKING,0.945952620967742
STEIN_ESRRA_TARGETS_RESPONSI...2,SET,26,0.081144,0.0030514,0.16917,0.31574,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,0.945952620967742
MIR3180_5P,SET,288,0.024589,0.0030554,0.05127,0.31576,MIR3180_5P,0.945952620967742
GSE15659_NAIVE_CD4_TCELL_VS_...2,SET,160,0.032991,0.0030663,0.068787,0.31576,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.945952620967742
GSE21670_UNTREATED_VS_TGFB_I...1,SET,160,0.032609,0.0030308,0.067999,0.31578,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN,0.945952620967742
GOBP_REGULATION_OF_MICROTUBU...7,SET,56,0.053424,0.002946,0.11143,0.31581,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.945952620967742
HP_SYNOSTOSIS_INVOLVING_BONE...2,SET,43,0.067134,0.0032451,0.14003,0.31582,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_HAND,0.945952620967742
HP_PECTUS_CARINATUM,SET,158,0.031793,0.0029366,0.066331,0.31586,HP_PECTUS_CARINATUM,0.945952620967742
GOBP_MACROPHAGE_APOPTOTIC_PR...,SET,12,0.10522,0.002689,0.21956,0.31589,GOBP_MACROPHAGE_APOPTOTIC_PROCESS,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...430,SET,25,0.092172,0.0033989,0.19233,0.31589,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.945952620967742
GOBP_REGULATION_OF_RYANODINE...,SET,20,0.10577,0.0034891,0.22074,0.31591,GOBP_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.945952620967742
PID_CDC42_PATHWAY,SET,68,0.050955,0.0030952,0.10636,0.31595,PID_CDC42_PATHWAY,0.945952620967742
MULLIGHAN_NPM1_MUTATED_SIGNA...4,SET,114,0.038724,0.0030419,0.080842,0.31597,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,0.945952620967742
MIKHAYLOVA_OXIDATIVE_STRESS_...1,SET,6,0.19723,0.0035648,0.41186,0.31602,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN,0.945952620967742
HP_ABNORMAL_HEMOGLOBIN,SET,65,0.050648,0.0030082,0.10579,0.31606,HP_ABNORMAL_HEMOGLOBIN,0.945952620967742
GOBP_WNT_SIGNALING_PATHWAY,SET,415,0.02138,0.0031778,0.044661,0.31608,GOBP_WNT_SIGNALING_PATHWAY,0.945952620967742
TSENG_IRS1_TARGETS_DN,SET,112,0.041693,0.0032464,0.087103,0.31609,TSENG_IRS1_TARGETS_DN,0.945952620967742
chr9p22,SET,20,0.18834,0.0062129,0.39349,0.3161,chr9p22,0.945952620967742
GSE15930_NAIVE_VS_72H_IN_VIT...1,SET,182,0.029276,0.0029004,0.061171,0.31611,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN,0.945952620967742
HP_IMPAIRED_VIBRATION_SENSAT...1,SET,10,0.11966,0.0027918,0.25005,0.31613,HP_IMPAIRED_VIBRATION_SENSATION_AT_ANKLES,0.945952620967742
GLI4_TARGET_GENES,SET,663,0.01601,0.002987,0.033476,0.31623,GLI4_TARGET_GENES,0.945952620967742
GSE15330_HSC_VS_PRO_BCELL_DN,SET,177,0.028805,0.0028146,0.060244,0.31628,GSE15330_HSC_VS_PRO_BCELL_DN,0.945952620967742
GSE41176_UNSTIM_VS_ANTI_IGM_...7,SET,175,0.030363,0.0029502,0.063512,0.3163,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN,0.945952620967742
WNT_UP.V1_DN,SET,160,0.034256,0.0031839,0.071669,0.31634,WNT_UP.V1_DN,0.945952620967742
RBM17_TARGET_GENES,SET,5,0.17225,0.0028422,0.3604,0.31635,RBM17_TARGET_GENES,0.945952620967742
GSE34515_CD16_NEG_MONOCYTE_V...2,SET,180,0.030959,0.0030503,0.064786,0.31638,GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP,0.945952620967742
TRAVAGLINI_LUNG_SIGNALING_AL...,SET,67,0.053175,0.0032064,0.11128,0.31639,TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,0.945952620967742
MIR744_3P,SET,55,0.053085,0.0029011,0.11112,0.31642,MIR744_3P,0.945952620967742
GSE7400_CTRL_VS_CSF3_IN_VIVO...1,SET,175,0.030687,0.0029817,0.064234,0.31642,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN,0.945952620967742
GOBP_GLYCOSPHINGOLIPID_METAB...,SET,62,0.055008,0.0031912,0.11519,0.31649,GOBP_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,0.945952620967742
GIAROLA_SILVA_BLOOD_PANDEMRI...1,SET,5,0.15516,0.0025602,0.32503,0.31655,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_30DY_UP,0.945952620967742
GOBP_RAB_PROTEIN_SIGNAL_TRAN...,SET,17,0.092868,0.0028246,0.19457,0.31658,GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.945952620967742
GOBP_EXOCYTIC_PROCESS,SET,75,0.045624,0.0029101,0.095629,0.31665,GOBP_EXOCYTIC_PROCESS,0.945952620967742
GOBP_TELOMERE_CAPPING,SET,37,0.061868,0.0027746,0.12968,0.31665,GOBP_TELOMERE_CAPPING,0.945952620967742
chr4p11,SET,8,0.23749,0.0049564,0.49784,0.31667,chr4p11,0.945952620967742
QI_PBMC_ZOSTAVAX_AGE_50_75YO...5,SET,108,0.037175,0.0028428,0.077931,0.31667,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE,0.945952620967742
HP_DELUSION,SET,28,0.081295,0.0031723,0.17047,0.31672,HP_DELUSION,0.945952620967742
GSE40274_CTRL_VS_FOXP3_AND_E...1,SET,148,0.033068,0.0029569,0.069344,0.31673,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.945952620967742
GOBP_NUCLEOSIDE_METABOLIC_PR...,SET,50,0.062632,0.003264,0.13135,0.31675,GOBP_NUCLEOSIDE_METABOLIC_PROCESS,0.945952620967742
GSE37605_C57BL6_VS_NOD_FOXP3...3,SET,178,0.030414,0.0029801,0.063785,0.31675,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN,0.945952620967742
GOMF_OXIDOREDUCTASE_ACTIVITY...32,SET,31,0.068509,0.0028127,0.1437,0.31677,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.945952620967742
GOBP_NEGATIVE_REGULATION_OF_...535,SET,6,0.16668,0.0030127,0.34986,0.31689,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.945952620967742
GOCC_VACUOLAR_PROTON_TRANSPO...,SET,8,0.12892,0.0026904,0.2706,0.31689,GOCC_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.945952620967742
MIR372_5P,SET,226,0.027037,0.0029812,0.056764,0.31693,MIR372_5P,0.945952620967742
REACTOME_RHOQ_GTPASE_CYCLE,SET,57,0.05526,0.0030742,0.11604,0.31696,REACTOME_RHOQ_GTPASE_CYCLE,0.945952620967742
HP_SINGLE_LINEAGE_MYELODYSPL...,SET,5,0.16626,0.0027433,0.34916,0.31698,HP_SINGLE_LINEAGE_MYELODYSPLASIA,0.945952620967742
HP_CLOVERLEAF_SKULL,SET,8,0.13309,0.0027775,0.27951,0.31699,HP_CLOVERLEAF_SKULL,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...661,SET,17,0.10626,0.0032318,0.22324,0.31705,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.945952620967742
LINDSTEDT_DENDRITIC_CELL_MAT...3,SET,60,0.054087,0.0030869,0.11364,0.31706,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,0.945952620967742
NOUZOVA_METHYLATED_IN_APL,SET,57,0.05924,0.0032956,0.12447,0.31706,NOUZOVA_METHYLATED_IN_APL,0.945952620967742
REACTOME_ADENYLATE_CYCLASE_I...,SET,14,0.11406,0.0031483,0.23965,0.31706,REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,0.945952620967742
TAKAYAMA_BOUND_BY_AR,SET,10,0.13237,0.0030885,0.27816,0.31708,TAKAYAMA_BOUND_BY_AR,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...552,SET,6,0.17466,0.0031568,0.36701,0.31708,GOBP_POSITIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.945952620967742
GOBP_SPINAL_CORD_ASSOCIATION...,SET,11,0.14387,0.0035206,0.30235,0.31709,GOBP_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION,0.945952620967742
WEST_ADRENOCORTICAL_TUMOR_DN,SET,479,0.019055,0.0030374,0.040053,0.31713,WEST_ADRENOCORTICAL_TUMOR_DN,0.945952620967742
MIR3612,SET,110,0.038302,0.0029558,0.080514,0.31714,MIR3612,0.945952620967742
GOBP_POSITIVE_REGULATION_OF_...778,SET,111,0.036972,0.0028661,0.077727,0.31716,GOBP_POSITIVE_REGULATION_OF_TRANSLATION,0.945952620967742
GSE42021_TCONV_PLN_VS_CD24HI...1,SET,181,0.030728,0.0030359,0.064616,0.3172,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN,0.945952620967742
HP_INFLAMMATION_OF_THE_LARGE...,SET,104,0.041083,0.0030832,0.086397,0.31721,HP_INFLAMMATION_OF_THE_LARGE_INTESTINE,0.945952620967742
GOMF_RNA_POLYMERASE_II_SPECI...,SET,318,0.0227,0.0029614,0.04774,0.31722,GOMF_RNA_POLYMERASE_II_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.945952620967742
GIAROLA_SILVA_BLOOD_PANDEMRI...2,SET,4,0.17263,0.0025478,0.36307,0.31723,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_3DY_UP,0.945952620967742
GOBP_PYRIMIDINE_NUCLEOTIDE_M...,SET,49,0.057946,0.0029896,0.12188,0.31725,GOBP_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS,0.945952620967742
HP_NON_MENDELIAN_INHERITANCE,SET,86,0.047702,0.0032571,0.10037,0.31731,HP_NON_MENDELIAN_INHERITANCE,0.946050360298533
GOCC_PHOSPHATIDYLINOSITOL_3_...1,SET,29,0.082543,0.0032779,0.17376,0.31739,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX,0.946172909698997
REACTOME_SEMAPHORIN_INTERACT...,SET,61,0.054381,0.0031293,0.11449,0.31741,REACTOME_SEMAPHORIN_INTERACTIONS,0.946172909698997
GOMF_DIACYLGLYCEROL_O_ACYLTR...,SET,5,0.1997,0.0032952,0.42055,0.31744,GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.946172909698997
GOBP_APOPTOTIC_PROCESS_INVOL...3,SET,23,0.09619,0.0034024,0.20258,0.31746,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,0.946172909698997
FOXD3_01,SET,179,0.031911,0.0031355,0.067229,0.31752,FOXD3_01,0.946219253193861
MIR3605_5P,SET,75,0.049491,0.0031567,0.10428,0.31753,MIR3605_5P,0.946219253193861
REACTOME_REGULATION_OF_IFNG_...,SET,13,0.11488,0.0030559,0.24223,0.31765,REACTOME_REGULATION_OF_IFNG_SIGNALING,0.946448874143836
GSE40685_NAIVE_CD4_TCELL_VS_...4,SET,164,0.030936,0.0029107,0.065234,0.31767,GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP,0.946448874143836
MIR4716_5P,SET,107,0.038437,0.0029257,0.081088,0.31775,MIR4716_5P,0.946448874143836
MIR3138,SET,65,0.050628,0.0030071,0.10682,0.31777,MIR3138,0.946448874143836
GOBP_LATE_ENDOSOME_TO_LYSOSO...,SET,21,0.090207,0.0030491,0.19044,0.31787,GOBP_LATE_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.946448874143836
HP_APLASIA_HYPOPLASIA_OF_THE...67,SET,83,0.041934,0.0028131,0.088531,0.31787,HP_APLASIA_HYPOPLASIA_OF_THE_SPLEEN,0.946448874143836
GSE24972_WT_VS_IRF8_KO_MARGI...2,SET,174,0.030799,0.002984,0.065024,0.31788,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP,0.946448874143836
GSE19941_UNSTIM_VS_LPS_AND_I...3,SET,174,0.030028,0.0029094,0.063404,0.31789,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.946448874143836
GOBP_REGULATION_OF_PHOSPHOLI...5,SET,14,0.10722,0.0029597,0.22647,0.31795,GOBP_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.946448874143836
MIR8057,SET,79,0.04574,0.0029939,0.09662,0.31797,MIR8057,0.946448874143836
HP_ABNORMAL_CIRCULATING_IGE_...,SET,44,0.061435,0.0030039,0.12978,0.31797,HP_ABNORMAL_CIRCULATING_IGE_LEVEL,0.946448874143836
HP_AGENESIS_OF_CENTRAL_INCIS...,SET,13,0.12209,0.0032476,0.25791,0.31797,HP_AGENESIS_OF_CENTRAL_INCISOR,0.946448874143836
GSE21670_TGFB_VS_IL6_TREATED...3,SET,185,0.030786,0.0030747,0.065037,0.31798,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.946448874143836
HP_PURSED_LIPS,SET,4,0.23408,0.0034548,0.49471,0.31805,HP_PURSED_LIPS,0.946448874143836
REACTOME_SIGNALING_BY_PDGFRA...,SET,12,0.11217,0.0028667,0.23707,0.31806,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,0.946448874143836
GOBP_POSITIVE_REGULATION_OF_...319,SET,220,0.028433,0.0030937,0.060093,0.31806,GOBP_POSITIVE_REGULATION_OF_GROWTH,0.946448874143836
MORF_RPA1,SET,59,0.046851,0.0026516,0.099028,0.31807,MORF_RPA1,0.946448874143836
GOBP_SYNAPTIC_VESICLE_RECYCL...2,SET,4,0.1783,0.0026314,0.37709,0.31817,GOBP_SYNAPTIC_VESICLE_RECYCLING_VIA_ENDOSOME,0.946665383956853
GOBP_NEUROPEPTIDE_SIGNALING_...,SET,92,0.045768,0.0032317,0.096838,0.31824,GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY,0.946792604006163
REACTOME_TRISTETRAPROLIN_TTP...,SET,16,0.097448,0.0028755,0.20624,0.31829,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,0.946855155741913
MIR4633_5P,SET,38,0.067428,0.0030644,0.14275,0.31834,MIR4633_5P,0.946855155741913
HP_HYPOPLASIA_OF_THE_RADIUS,SET,38,0.063038,0.0028649,0.13346,0.31835,HP_HYPOPLASIA_OF_THE_RADIUS,0.946855155741913
GOBP_PEPTIDYL_AMINO_ACID_MOD...,SET,762,0.014911,0.0029741,0.031574,0.31837,GOBP_PEPTIDYL_AMINO_ACID_MODIFICATION,0.946855155741913
HP_POLYARTICULAR_ARTHROPATHY,SET,18,0.10026,0.0031378,0.21235,0.31841,HP_POLYARTICULAR_ARTHROPATHY,0.946893090613502
REACTOME_METALLOTHIONEINS_BI...,SET,11,0.19246,0.0047095,0.40774,0.31846,REACTOME_METALLOTHIONEINS_BIND_METALS,0.946937059678522
GOMF_CALCIUM_DEPENDENT_PROTE...1,SET,74,0.054131,0.0034296,0.11471,0.31851,GOMF_CALCIUM_DEPENDENT_PROTEIN_BINDING,0.946937059678522
GOBP_PROTEASOMAL_PROTEIN_CAT...,SET,481,0.017668,0.002822,0.037457,0.31858,GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.946937059678522
GNF2_CEBPA,SET,60,0.053241,0.0030386,0.11288,0.31859,GNF2_CEBPA,0.946937059678522
LEIN_MEDULLA_MARKERS,SET,76,0.047556,0.0030533,0.10084,0.31861,LEIN_MEDULLA_MARKERS,0.946937059678522
GOMF_ABC_TYPE_TRANSPORTER_AC...,SET,46,0.064834,0.0032411,0.13749,0.31863,GOMF_ABC_TYPE_TRANSPORTER_ACTIVITY,0.946937059678522
GOBP_MITOCHONDRIAL_ADP_TRANS...,SET,3,0.209,0.0026714,0.44328,0.31865,GOBP_MITOCHONDRIAL_ADP_TRANSMEMBRANE_TRANSPORT,0.946937059678522
REACTOME_NUCLEAR_EVENTS_KINA...,SET,59,0.054569,0.0030884,0.11575,0.31866,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,0.946937059678522
GSE3039_NKT_CELL_VS_B1_BCELL...2,SET,176,0.029598,0.0028839,0.062782,0.31867,GSE3039_NKT_CELL_VS_B1_BCELL_UP,0.946937059678522
HP_ABNORMALITY_OF_RADIAL_EPI...,SET,5,0.18137,0.0029927,0.38535,0.31894,HP_ABNORMALITY_OF_RADIAL_EPIPHYSES,0.947442615529171
MYLLYKANGAS_AMPLIFICATION_HO...1,SET,11,0.1225,0.0029974,0.26029,0.31896,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,0.947442615529171
GOBP_NEGATIVE_REGULATION_OF_...97,SET,41,0.060387,0.0028504,0.12837,0.31904,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.947442615529171
HP_EEG_WITH_FOCAL_SPIKES,SET,30,0.075031,0.0030305,0.1595,0.31904,HP_EEG_WITH_FOCAL_SPIKES,0.947442615529171
ZWANG_CLASS_2_TRANSIENTLY_IN...,SET,47,0.059727,0.003018,0.12699,0.31907,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,0.947442615529171
NAGASHIMA_NRG1_SIGNALING_DN,SET,50,0.057914,0.0030182,0.12315,0.31909,NAGASHIMA_NRG1_SIGNALING_DN,0.947442615529171
ROSS_ACUTE_MYELOID_LEUKEMIA_...,SET,77,0.049517,0.0032,0.1053,0.31909,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,0.947442615529171
CROMER_TUMORIGENESIS_UP,SET,53,0.0648,0.0034766,0.1378,0.3191,CROMER_TUMORIGENESIS_UP,0.947442615529171
GOMF_TAU_PROTEIN_BINDING,SET,41,0.0594,0.0028039,0.12632,0.3191,GOMF_TAU_PROTEIN_BINDING,0.947442615529171
MIR4774_5P,SET,87,0.041571,0.0028548,0.088421,0.31913,MIR4774_5P,0.947442615529171
GOBP_POSITIVE_REGULATION_OF_...705,SET,4,0.22292,0.00329,0.47417,0.31914,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.947442615529171
BRUINS_UVC_RESPONSE_VIA_TP53...4,SET,245,0.026498,0.0030405,0.056386,0.3192,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,0.947539801844892
AR_02,SET,34,0.068304,0.0029366,0.14542,0.31928,AR_02,0.947548220989761
GOBP_RESPONSE_TO_NUTRIENT_LE...,SET,454,0.019644,0.0030505,0.041826,0.3193,GOBP_RESPONSE_TO_NUTRIENT_LEVELS,0.947548220989761
MIR4771,SET,48,0.057009,0.0029111,0.12141,0.31934,MIR4771,0.947548220989761
GOMF_SULFUR_COMPOUND_BINDING,SET,245,0.027657,0.0031735,0.0589,0.31934,GOMF_SULFUR_COMPOUND_BINDING,0.947548220989761
FLETCHER_PBMC_BCG_10W_INFANT...4,SET,89,0.048652,0.0033791,0.10366,0.31941,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP,0.947548220989761
LCORL_TARGET_GENES,SET,359,0.020821,0.0028829,0.044366,0.31943,LCORL_TARGET_GENES,0.947548220989761
GOBP_POSITIVE_REGULATION_OF_...502,SET,21,0.09685,0.0032736,0.2064,0.31945,GOBP_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.947548220989761
HP_SPONDYLOLYSIS,SET,5,0.17084,0.0028189,0.36406,0.31945,HP_SPONDYLOLYSIS,0.947548220989761
GSE13411_NAIVE_VS_IGM_MEMORY...2,SET,171,0.031141,0.0029913,0.066373,0.31947,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.947548220989761
CAR_HPX,SET,69,0.0527,0.0032246,0.11235,0.31951,CAR_HPX,0.947548220989761
HP_EPIDERMAL_NEVUS,SET,11,0.10791,0.0026405,0.23005,0.31951,HP_EPIDERMAL_NEVUS,0.947548220989761
GOBP_DNA_CONFORMATION_CHANGE,SET,83,0.041369,0.0027752,0.088206,0.31953,GOBP_DNA_CONFORMATION_CHANGE,0.947548220989761
HP_MYOCARDITIS,SET,6,0.18706,0.003381,0.39896,0.31959,HP_MYOCARDITIS,0.947563059543022
REACTOME_SIGNALING_BY_EGFR_I...,SET,24,0.080263,0.0029,0.17123,0.31963,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,0.947563059543022
GOBP_ADP_BIOSYNTHETIC_PROCESS,SET,5,0.20474,0.0033783,0.43684,0.31965,GOBP_ADP_BIOSYNTHETIC_PROCESS,0.947563059543022
GOBP_RESPONSE_TO_ACETYLCHOLI...,SET,44,0.063993,0.003129,0.1366,0.31972,GOBP_RESPONSE_TO_ACETYLCHOLINE,0.947563059543022
MIR541_5P,SET,113,0.037687,0.0029475,0.080464,0.31976,MIR541_5P,0.947563059543022
GOBP_MIRNA_CATABOLIC_PROCESS,SET,8,0.12844,0.0026805,0.27431,0.31981,GOBP_MIRNA_CATABOLIC_PROCESS,0.947563059543022
MIR7151_3P,SET,250,0.025151,0.0029148,0.053728,0.31985,MIR7151_3P,0.947563059543022
HP_DUANE_ANOMALY,SET,22,0.084489,0.0029229,0.18053,0.31989,HP_DUANE_ANOMALY,0.947563059543022
HALLMARK_MITOTIC_SPINDLE,SET,187,0.027941,0.0028055,0.0597,0.31989,HALLMARK_MITOTIC_SPINDLE,0.947563059543022
HP_ABNORMAL_LOWER_LIMB_EPIPH...,SET,84,0.04488,0.0030287,0.095919,0.31993,HP_ABNORMAL_LOWER_LIMB_EPIPHYSIS_MORPHOLOGY,0.947563059543022
GOBP_INTERLEUKIN_2_PRODUCTION,SET,60,0.056332,0.003215,0.12044,0.31999,GOBP_INTERLEUKIN_2_PRODUCTION,0.947563059543022
GOBP_NEGATIVE_REGULATION_OF_...449,SET,3,0.24532,0.0031355,0.52456,0.32002,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.947563059543022
WP_JAKSTAT_SIGNALING_IN_THE_...,SET,34,0.071747,0.0030847,0.15347,0.32007,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,0.947563059543022
REACTOME_P75NTR_RECRUITS_SIG...,SET,11,0.12845,0.0031432,0.27486,0.32013,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,0.947563059543022
GOBP_GLUTAMATE_METABOLIC_PRO...,SET,32,0.07168,0.0029899,0.15341,0.32017,GOBP_GLUTAMATE_METABOLIC_PROCESS,0.947563059543022
GOCC_AMPA_GLUTAMATE_RECEPTOR...,SET,23,0.088048,0.0031144,0.18846,0.32018,GOCC_AMPA_GLUTAMATE_RECEPTOR_COMPLEX,0.947563059543022
WP_GLUCOCORTICOID_RECEPTOR_P...,SET,68,0.051585,0.0031335,0.11046,0.32025,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,0.947563059543022
GOMF_OXIDOREDUCTASE_ACTIVITY...33,SET,10,0.12188,0.0028436,0.26098,0.32025,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.947563059543022
WP_16P112_DISTAL_DELETION_SY...,SET,31,0.080036,0.003286,0.1714,0.32027,WP_16P112_DISTAL_DELETION_SYNDROME,0.947563059543022
GSE16450_IMMATURE_VS_MATURE_...5,SET,183,0.028184,0.0027997,0.060358,0.32027,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.947563059543022
WP_GLIOBLASTOMA_SIGNALING,SET,80,0.045153,0.0029741,0.096702,0.32028,WP_GLIOBLASTOMA_SIGNALING,0.947563059543022
GOBP_RNA_GUANINE_N7_METHYLAT...,SET,4,0.16183,0.0023884,0.34673,0.32035,GOBP_RNA_GUANINE_N7_METHYLATION,0.947563059543022
MIR10395_5P,SET,66,0.050617,0.0030294,0.10846,0.32036,MIR10395_5P,0.947563059543022
GOBP_SINOATRIAL_NODE_CELL_DE...,SET,5,0.20491,0.003381,0.43914,0.32039,GOBP_SINOATRIAL_NODE_CELL_DEVELOPMENT,0.947563059543022
GOBP_MATURATION_OF_SSU_RRNA,SET,47,0.058251,0.0029435,0.12488,0.32044,GOBP_MATURATION_OF_SSU_RRNA,0.947563059543022
GOCC_ER_TO_GOLGI_TRANSPORT_V...,SET,56,0.055294,0.0030491,0.11855,0.32046,GOCC_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE,0.947563059543022
GOBP_ENDOSOME_TO_LYSOSOME_TR...2,SET,17,0.091227,0.0027747,0.1956,0.32047,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.947563059543022
MIR548AV_5P_MIR548K,SET,267,0.02473,0.0029604,0.053028,0.32048,MIR548AV_5P_MIR548K,0.947563059543022
GOCC_CILIARY_TIP,SET,40,0.061091,0.0028484,0.131,0.32049,GOCC_CILIARY_TIP,0.947563059543022
GOMF_BRANCHED_CHAIN_AMINO_AC...,SET,9,0.13568,0.0030034,0.29095,0.32049,GOMF_BRANCHED_CHAIN_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.947563059543022
HP_IMPACTED_TOOTH,SET,6,0.17749,0.0032081,0.38061,0.32049,HP_IMPACTED_TOOTH,0.947563059543022
HP_DECREASED_SPECIFIC_ANTIBO...4,SET,29,0.07946,0.0031555,0.17041,0.32051,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_VACCINATION,0.947563059543022
GOCC_ZYMOGEN_GRANULE,SET,18,0.096619,0.0030238,0.20739,0.32065,GOCC_ZYMOGEN_GRANULE,0.947563059543022
REACTOME_FRS_MEDIATED_FGFR4_...,SET,21,0.084642,0.002861,0.18169,0.32066,REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,0.947563059543022
REACTOME_SIGNALING_BY_NOTCH1...2,SET,52,0.055166,0.0029317,0.11842,0.32067,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,0.947563059543022
MIR6721_5P,SET,316,0.022728,0.002956,0.048792,0.32068,MIR6721_5P,0.947563059543022
HP_LEWY_BODIES,SET,25,0.080882,0.0029825,0.17364,0.32068,HP_LEWY_BODIES,0.947563059543022
KEGG_MEDICUS_REFERENCE_CONDE...,SET,19,0.085305,0.0027428,0.18316,0.3207,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING,0.947563059543022
GOBP_NEURON_APOPTOTIC_PROCESS,SET,262,0.025266,0.0029966,0.054247,0.3207,GOBP_NEURON_APOPTOTIC_PROCESS,0.947563059543022
HP_SPOTTY_HYPOPIGMENTATION,SET,7,0.15525,0.0030308,0.33332,0.3207,HP_SPOTTY_HYPOPIGMENTATION,0.947563059543022
HP_BIFID_NASAL_TIP,SET,13,0.108,0.0028728,0.23191,0.32072,HP_BIFID_NASAL_TIP,0.947563059543022
GSE29949_MICROGLIA_BRAIN_VS_...5,SET,182,0.029063,0.0028793,0.062428,0.32077,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.947563059543022
HP_LEUKOPENIA,SET,129,0.034016,0.0028413,0.073069,0.32078,HP_LEUKOPENIA,0.947563059543022
GOBP_ENDOCRINE_SYSTEM_DEVELO...,SET,130,0.03836,0.0032164,0.082413,0.3208,GOBP_ENDOCRINE_SYSTEM_DEVELOPMENT,0.947563059543022
HP_BROAD_PHALANX_OF_THE_TOES,SET,38,0.066906,0.0030407,0.14378,0.32084,HP_BROAD_PHALANX_OF_THE_TOES,0.947563059543022
HP_DECREASED_NASAL_NITRIC_OX...,SET,24,0.079643,0.0028776,0.17116,0.32085,HP_DECREASED_NASAL_NITRIC_OXIDE,0.947563059543022
WP_SEROTONIN_TRANSPORTER_ACT...,SET,10,0.12733,0.0029707,0.27367,0.32088,WP_SEROTONIN_TRANSPORTER_ACTIVITY,0.947563059543022
GSE26023_PHD3_KO_VS_WT_NEUTR...1,SET,178,0.028882,0.00283,0.062079,0.32088,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN,0.947563059543022
GSE24102_GRANULOCYSTIC_MDSC_...2,SET,183,0.029012,0.002882,0.062371,0.32091,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP,0.947563059543022
WP_GPCRS_OTHER,SET,86,0.045281,0.0030918,0.097354,0.32093,WP_GPCRS_OTHER,0.947563059543022
GOCC_MEMBRANE_COAT,SET,93,0.039225,0.0027846,0.084356,0.32097,GOCC_MEMBRANE_COAT,0.947563059543022
GSE19401_RETINOIC_ACID_VS_RE...2,SET,176,0.031079,0.0030282,0.066838,0.32097,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.947563059543022
GSE360_DC_VS_MAC_T_GONDII_UP,SET,182,0.031148,0.0030858,0.06699,0.32098,GSE360_DC_VS_MAC_T_GONDII_UP,0.947563059543022
WP_P38_MAPK_SIGNALING,SET,33,0.068764,0.0029127,0.14795,0.32105,WP_P38_MAPK_SIGNALING,0.947689209274673
MIR6756_5P,SET,241,0.026046,0.0029645,0.056055,0.32109,MIR6756_5P,0.947691951095262
GSE5542_UNTREATED_VS_IFNA_AN...1,SET,179,0.028507,0.002801,0.061361,0.32112,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.947691951095262
GSE11057_EFF_MEM_VS_CENT_MEM...1,SET,158,0.030987,0.0028622,0.066709,0.32114,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN,0.947691951095262
HP_THENAR_MUSCLE_ATROPHY,SET,13,0.093577,0.0024891,0.20147,0.32116,HP_THENAR_MUSCLE_ATROPHY,0.947691951095262
PID_P53_DOWNSTREAM_PATHWAY,SET,134,0.033539,0.0028548,0.072225,0.3212,PID_P53_DOWNSTREAM_PATHWAY,0.947705484856197
GOBP_REGULATION_OF_EOSINOPHI...,SET,5,0.19245,0.0031755,0.41466,0.32128,GOBP_REGULATION_OF_EOSINOPHIL_MIGRATION,0.947705484856197
REACTOME_INTESTINAL_ABSORPTI...,SET,5,0.18622,0.0030727,0.40124,0.32129,REACTOME_INTESTINAL_ABSORPTION,0.947705484856197
TESAR_ALK_TARGETS_HUMAN_ES_5...2,SET,4,0.21393,0.0031573,0.46098,0.3213,TESAR_ALK_TARGETS_HUMAN_ES_5D_UP,0.947705484856197
GOBP_CELL_PROLIFERATION_IN_M...,SET,7,0.16334,0.0031887,0.35203,0.32133,GOBP_CELL_PROLIFERATION_IN_MIDBRAIN,0.947705484856197
HP_LONG_CLAVICLES,SET,13,0.11268,0.0029972,0.2429,0.32136,HP_LONG_CLAVICLES,0.947705484856197
GOBP_NEUROTRANSMITTER_SECRET...,SET,135,0.03416,0.0029184,0.073639,0.32137,GOBP_NEUROTRANSMITTER_SECRETION,0.947705484856197
GSE20366_EX_VIVO_VS_DEC205_C...4,SET,182,0.029113,0.0028842,0.062772,0.3214,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP,0.947705484856197
DESCARTES_FETAL_HEART_MYELOI...,SET,104,0.040562,0.0030441,0.087464,0.32141,DESCARTES_FETAL_HEART_MYELOID_CELLS,0.947705484856197
HP_FUSED_CERVICAL_VERTEBRAE,SET,30,0.06922,0.0027957,0.14936,0.32152,HP_FUSED_CERVICAL_VERTEBRAE,0.947866314852492
OUELLET_OVARIAN_CANCER_INVAS...1,SET,11,0.133,0.0032544,0.28706,0.32157,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,0.947866314852492
GSE23308_WT_VS_MINERALCORTIC...4,SET,187,0.028192,0.0028306,0.060863,0.32161,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP,0.947866314852492
HP_DIFFUSE_DEMYELINATION_OF_...,SET,8,0.14587,0.0030443,0.31493,0.32162,HP_DIFFUSE_DEMYELINATION_OF_THE_CEREBRAL_WHITE_MATTER,0.947866314852492
GNF2_TIMP2,SET,39,0.072221,0.003325,0.15593,0.32163,GNF2_TIMP2,0.947866314852492
HE_LIM_SUN_FETAL_LUNG_C4_T_A...,SET,66,0.051011,0.0030529,0.11015,0.32165,HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL,0.947866314852492
WELCSH_BRCA1_TARGETS_DN,SET,125,0.033502,0.0027549,0.072353,0.32167,WELCSH_BRCA1_TARGETS_DN,0.947866314852492
HUANG_GATA2_TARGETS_DN,SET,66,0.048879,0.0029253,0.10558,0.32169,HUANG_GATA2_TARGETS_DN,0.947866314852492
CHEN_HOXA5_TARGETS_6HR_DN,SET,4,0.19614,0.0028948,0.42369,0.32171,CHEN_HOXA5_TARGETS_6HR_DN,0.947866314852492
GOBP_MAINTENANCE_OF_GASTROIN...,SET,21,0.097394,0.003292,0.21046,0.32177,GOBP_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM,0.947962732050521
GOBP_LEUKOCYTE_CELL_CELL_ADH...,SET,383,0.021806,0.0031164,0.047143,0.32185,GOBP_LEUKOCYTE_CELL_CELL_ADHESION,0.948016258474576
GOBP_POSITIVE_REGULATION_OF_...18,SET,67,0.052412,0.0031604,0.11332,0.32186,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.948016258474576
GOBP_GLYCERALDEHYDE_3_PHOSPH...,SET,11,0.10925,0.0026734,0.23623,0.32187,GOBP_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS,0.948016258474576
GSE19401_PAM2CSK4_VS_RETINOI...4,SET,179,0.028912,0.0028408,0.06253,0.32191,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.94804832683836
GOBP_POSITIVE_REGULATION_OF_...70,SET,15,0.09619,0.0027483,0.20808,0.32194,GOBP_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.94804832683836
GOBP_CYTOSOLIC_RIBOSOME_ASSE...,SET,7,0.13756,0.0026854,0.2976,0.32197,GOBP_CYTOSOLIC_RIBOSOME_ASSEMBLY,0.94804832683836
GNF2_BNIP3L,SET,61,0.050633,0.0029137,0.10956,0.32199,GNF2_BNIP3L,0.94804832683836
GOBP_NUCLEOSIDE_MONOPHOSPHAT...1,SET,36,0.065492,0.0028972,0.14174,0.32203,GOBP_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.94805094004065
GOMF_TRANSLATION_INITIATION_...2,SET,28,0.066946,0.0026124,0.14493,0.32207,GOMF_TRANSLATION_INITIATION_FACTOR_BINDING,0.94805094004065
GSE45365_CD8A_DC_VS_CD11B_DC...3,SET,142,0.034694,0.0030394,0.075118,0.32209,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN,0.94805094004065
GSE29615_CTRL_VS_LAIV_FLU_VA...1,SET,135,0.033664,0.0028761,0.072891,0.3221,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN,0.94805094004065
GOBP_OVULATION,SET,16,0.11063,0.0032644,0.2396,0.32215,GOBP_OVULATION,0.94811781268524
REACTOME_OPIOID_SIGNALLING,SET,88,0.043754,0.0030219,0.094808,0.32222,REACTOME_OPIOID_SIGNALLING,0.948243530906012
HP_COXA_VARA,SET,58,0.051689,0.0029006,0.11203,0.32227,HP_COXA_VARA,0.948310375920752
AP1_Q2_01,SET,247,0.025612,0.0029507,0.055523,0.3223,AP1_Q2_01,0.948318362682018
MODULE_146,SET,96,0.042708,0.0030802,0.092677,0.32246,MODULE_146,0.948552467466622
GSE10273_HIGH_IL7_VS_HIGH_IL...1,SET,174,0.029591,0.002867,0.064209,0.32246,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.948552467466622
SHARMA_PILOCYTIC_ASTROCYTOMA...1,SET,6,0.19007,0.0034355,0.41248,0.32247,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN,0.948552467466622
HP_ABNORMAL_HARD_PALATE_MORP...,SET,71,0.046005,0.0028553,0.099847,0.32249,HP_ABNORMAL_HARD_PALATE_MORPHOLOGY,0.948552467466622
MUELLER_COMMON_TARGETS_OF_AM...1,SET,28,0.078727,0.0030721,0.17095,0.32258,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,0.948552467466622
CERVERA_SDHB_TARGETS_1_DN,SET,34,0.071113,0.0030574,0.15449,0.32265,CERVERA_SDHB_TARGETS_1_DN,0.948552467466622
GOBP_B_CELL_APOPTOTIC_PROCESS,SET,24,0.0849,0.0030676,0.18444,0.32265,GOBP_B_CELL_APOPTOTIC_PROCESS,0.948552467466622
MODULE_58,SET,17,0.10764,0.003274,0.23386,0.32266,MODULE_58,0.948552467466622
GOMF_ADP_BINDING,SET,32,0.068709,0.002866,0.14932,0.32271,GOMF_ADP_BINDING,0.948552467466622
BOYERINAS_ONCOFETAL_TARGETS_...,SET,10,0.1316,0.0030704,0.28608,0.32276,BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,0.948552467466622
GOMF_GLYCOLIPID_MANNOSYLTRAN...,SET,5,0.1423,0.002348,0.30934,0.32276,GOMF_GLYCOLIPID_MANNOSYLTRANSFERASE_ACTIVITY,0.948552467466622
HP_ABNORMAL_FEMALE_REPRODUCT...,SET,354,0.021294,0.0029282,0.046314,0.32284,HP_ABNORMAL_FEMALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.948552467466622
REACTOME_G0_AND_EARLY_G1,SET,27,0.07071,0.0027096,0.15382,0.32287,REACTOME_G0_AND_EARLY_G1,0.948552467466622
GSE5503_MLN_DC_VS_PLN_DC_ACT...2,SET,179,0.029029,0.0028523,0.063161,0.3229,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.948552467466622
GOCC_CHROMOSOME_CENTROMERIC_...1,SET,2,0.29641,0.0030935,0.645,0.32292,GOCC_CHROMOSOME_CENTROMERIC_CORE_DOMAIN,0.948552467466622
GOBP_RETINAL_METABOLIC_PROCE...,SET,18,0.10018,0.0031351,0.218,0.32293,GOBP_RETINAL_METABOLIC_PROCESS,0.948552467466622
HP_PULMONARY_ARTERY_ATRESIA,SET,29,0.074254,0.0029487,0.16159,0.32294,HP_PULMONARY_ARTERY_ATRESIA,0.948552467466622
THAKAR_PBMC_INACTIVATED_INFL...1,SET,56,0.051761,0.0028543,0.11265,0.32294,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_DN,0.948552467466622
MANNO_MIDBRAIN_NEUROTYPES_HS...,SET,389,0.021566,0.0031057,0.046939,0.32296,MANNO_MIDBRAIN_NEUROTYPES_HSERT,0.948552467466622
TGACCTY_ERR1_Q2,SET,933,0.013252,0.0029105,0.028845,0.32297,TGACCTY_ERR1_Q2,0.948552467466622
GOBP_POSITIVE_REGULATION_OF_...317,SET,8,0.13479,0.0028129,0.29339,0.32297,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.948552467466622
MOSERLE_IFNA_RESPONSE,SET,30,0.084065,0.0033954,0.18299,0.32298,MOSERLE_IFNA_RESPONSE,0.948552467466622
MORF_ETV3,SET,60,0.050809,0.0028998,0.11067,0.32308,MORF_ETV3,0.94865572296784
MIR3130_5P,SET,49,0.056085,0.0028935,0.12217,0.32309,MIR3130_5P,0.94865572296784
MARTIN_VIRAL_GPCR_SIGNALING_...1,SET,47,0.057522,0.0029066,0.12531,0.3231,MARTIN_VIRAL_GPCR_SIGNALING_DN,0.94865572296784
GOBP_INTRACELLULAR_GLUCOSE_H...,SET,142,0.033674,0.00295,0.07338,0.32316,GOBP_INTRACELLULAR_GLUCOSE_HOMEOSTASIS,0.94865572296784
GOBP_CELLULAR_LIPID_CATABOLI...,SET,220,0.02632,0.0028638,0.057358,0.32317,GOBP_CELLULAR_LIPID_CATABOLIC_PROCESS,0.94865572296784
MODULE_52,SET,392,0.020725,0.0029957,0.045168,0.32318,MODULE_52,0.94865572296784
YAN_ESCAPE_FROM_ANOIKIS,SET,23,0.079852,0.0028245,0.17406,0.32321,YAN_ESCAPE_FROM_ANOIKIS,0.94865572296784
GOBP_INNER_MITOCHONDRIAL_MEM...,SET,35,0.063808,0.0027833,0.13913,0.32326,GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.94865572296784
VALK_AML_CLUSTER_4,SET,25,0.084485,0.0031154,0.18428,0.32331,VALK_AML_CLUSTER_4,0.94865572296784
HP_DERMAL_ATROPHY,SET,90,0.040911,0.0028573,0.089238,0.32332,HP_DERMAL_ATROPHY,0.94865572296784
VECCHI_GASTRIC_CANCER_EARLY_...2,SET,386,0.019965,0.0028643,0.043556,0.32334,VECCHI_GASTRIC_CANCER_EARLY_UP,0.94865572296784
GOBP_REGULATION_OF_NUCLEOTID...3,SET,22,0.087215,0.0030172,0.19028,0.32335,GOBP_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.94865572296784
HP_ABNORMAL_RENAL_CORTEX_MOR...,SET,200,0.027835,0.0028893,0.060736,0.32337,HP_ABNORMAL_RENAL_CORTEX_MORPHOLOGY,0.94865572296784
DESCARTES_MAIN_FETAL_MICROGL...,SET,121,0.037254,0.0030143,0.081319,0.32344,DESCARTES_MAIN_FETAL_MICROGLIA,0.948780992572586
REACTOME_N_GLYCAN_ANTENNAE_E...2,SET,26,0.083597,0.0031436,0.18262,0.32357,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,0.948908554796254
GOBP_REGULATION_OF_NON_MOTIL...,SET,9,0.11835,0.0026197,0.25855,0.32357,GOBP_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.948908554796254
WP_THYMIC_STROMAL_LYMPHOPOIE...,SET,44,0.063452,0.0031025,0.13863,0.32358,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,0.948908554796254
GOBP_NEGATIVE_REGULATION_OF_...683,SET,16,0.1054,0.0031101,0.23033,0.32362,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.948908554796254
GOMF_RRNA_CYTOSINE_METHYLTRA...,SET,4,0.17314,0.0025553,0.37835,0.32362,GOMF_RRNA_CYTOSINE_METHYLTRANSFERASE_ACTIVITY,0.948908554796254
KEGG_MEDICUS_VARIANT_MUTATIO...31,SET,19,0.092899,0.002987,0.20306,0.32366,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY,0.94894578201451
GOBP_STRIATED_MUSCLE_CELL_DI...,SET,281,0.024294,0.0029824,0.053116,0.32371,GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.949012319696331
REACTOME_UPTAKE_AND_FUNCTION...1,SET,11,0.13626,0.0033341,0.29798,0.32374,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,0.949020217611336
PID_AJDISS_2PATHWAY,SET,46,0.059249,0.0029619,0.1296,0.32378,PID_AJDISS_2PATHWAY,0.949057425993084
REACTOME_MET_RECEPTOR_ACTIVA...,SET,6,0.16608,0.0030019,0.36349,0.32387,REACTOME_MET_RECEPTOR_ACTIVATION,0.949241174734357
GOBP_KERATINOCYTE_APOPTOTIC_...,SET,7,0.15204,0.0029681,0.33287,0.32393,GOBP_KERATINOCYTE_APOPTOTIC_PROCESS,0.949243373798685
GOBP_POSITIVE_REGULATION_OF_...347,SET,5,0.15922,0.0026271,0.3486,0.32394,GOBP_POSITIVE_REGULATION_OF_HYPERSENSITIVITY,0.949243373798685
ARNT2_TARGET_GENES,SET,552,0.016619,0.002838,0.036392,0.32396,ARNT2_TARGET_GENES,0.949243373798685
MODULE_377,SET,10,0.13049,0.0030446,0.28578,0.32398,MODULE_377,0.949243373798685
MEIS1_01,SET,225,0.026163,0.0028785,0.057312,0.32402,MEIS1_01,0.949280544550282
GSE32423_CTRL_VS_IL4_MEMORY_...1,SET,178,0.028149,0.0027582,0.061675,0.32405,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN,0.949288414531355
GOBP_CELL_CELL_ADHESION_MEDI...2,SET,17,0.091453,0.0027815,0.20044,0.32411,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.949384159292035
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,SET,28,0.069317,0.0027049,0.152,0.32418,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,0.949509177481881
MIR3657,SET,49,0.057022,0.0029419,0.12508,0.32424,MIR3657,0.94959572731838
GSE17721_LPS_VS_PAM3CSK4_1H_...1,SET,189,0.029285,0.0029559,0.064249,0.32427,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN,0.94959572731838
WP_NUCLEOTIDE_EXCISION_REPAIR,SET,41,0.053019,0.0025027,0.11635,0.32431,WP_NUCLEOTIDE_EXCISION_REPAIR,0.94959572731838
HP_ABNORMALITY_OF_THE_MUSCUL...4,SET,12,0.11626,0.0029713,0.25524,0.32438,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_ARM,0.94959572731838
GOBP_REGULATION_OF_MATRIX_ME...,SET,5,0.20789,0.0034302,0.45698,0.32459,GOBP_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION,0.94959572731838
HP_UPPER_LIMB_AMYOTROPHY,SET,70,0.04677,0.0028824,0.10282,0.3246,HP_UPPER_LIMB_AMYOTROPHY,0.94959572731838
MIR6768_3P,SET,127,0.035237,0.0029205,0.07747,0.32461,MIR6768_3P,0.94959572731838
MIR646,SET,225,0.025764,0.0028346,0.056651,0.32464,MIR646,0.94959572731838
GOBP_SYNAPSE_MATURATION,SET,33,0.071445,0.0030262,0.15711,0.32464,GOBP_SYNAPSE_MATURATION,0.94959572731838
HP_REDUCED_TENDON_REFLEXES,SET,521,0.016716,0.0027756,0.036757,0.32464,HP_REDUCED_TENDON_REFLEXES,0.94959572731838
GOCC_LSM1_7_PAT1_COMPLEX,SET,5,0.14618,0.002412,0.32148,0.32466,GOCC_LSM1_7_PAT1_COMPLEX,0.94959572731838
RICKMAN_TUMOR_DIFFERENTIATED...6,SET,212,0.025525,0.0027269,0.056138,0.32467,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,0.94959572731838
GOBP_RESPIRATORY_BURST,SET,30,0.074874,0.0030241,0.16474,0.32474,GOBP_RESPIRATORY_BURST,0.94959572731838
GOMF_PHOSPHATIDYLINOSITOL_MO...,SET,11,0.098719,0.0024156,0.21722,0.32475,GOMF_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY,0.94959572731838
GOBP_POSITIVE_REGULATION_OF_...355,SET,11,0.11493,0.0028123,0.25295,0.32479,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.94959572731838
GOMF_SPHINGOLIPID_TRANSPORTE...,SET,18,0.091707,0.0028701,0.20189,0.32483,GOMF_SPHINGOLIPID_TRANSPORTER_ACTIVITY,0.94959572731838
MIR513A_3P_MIR513C_3P,SET,409,0.019753,0.0029152,0.043499,0.32488,MIR513A_3P_MIR513C_3P,0.94959572731838
GOMF_HISTONE_H4_DEMETHYLASE_...,SET,4,0.18746,0.0027666,0.41292,0.32493,GOMF_HISTONE_H4_DEMETHYLASE_ACTIVITY,0.94959572731838
GOBP_CONSTITUTIVE_HETEROCHRO...,SET,8,0.1291,0.0026942,0.28443,0.32496,GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION,0.94959572731838
GSE21063_CTRL_VS_ANTI_IGM_ST...3,SET,149,0.030422,0.0027295,0.067045,0.325,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.94959572731838
GOBP_NEGATIVE_REGULATION_OF_...611,SET,6,0.18112,0.0032737,0.39916,0.32501,GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.94959572731838
MIR6800_5P,SET,42,0.056308,0.0026901,0.1241,0.32502,MIR6800_5P,0.94959572731838
HP_APLASIA_HYPOPLASIA_INVOLV...5,SET,90,0.039767,0.0027774,0.087661,0.32505,HP_APLASIA_HYPOPLASIA_INVOLVING_FOREARM_BONES,0.94959572731838
GSE45365_NK_CELL_VS_BCELL_UP,SET,186,0.028275,0.0028314,0.062341,0.32508,GSE45365_NK_CELL_VS_BCELL_UP,0.94959572731838
HP_DIFFICULTY_STANDING,SET,28,0.071426,0.0027872,0.1575,0.3251,HP_DIFFICULTY_STANDING,0.94959572731838
MODULE_417,SET,20,0.094941,0.0031318,0.20938,0.32512,MODULE_417,0.94959572731838
GOBP_REGULATION_OF_CYSTEINE_...4,SET,5,0.15947,0.0026313,0.35178,0.32516,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.94959572731838
GOMF_IMMUNOGLOBULIN_RECEPTOR...1,SET,12,0.13637,0.0034852,0.30081,0.32516,GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY,0.94959572731838
GSE2706_LPS_VS_R848_AND_LPS_...1,SET,128,0.035453,0.0029499,0.078207,0.32516,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN,0.94959572731838
PLASARI_TGFB1_TARGETS_1HR_UP,SET,33,0.075761,0.003209,0.16718,0.32522,PLASARI_TGFB1_TARGETS_1HR_UP,0.94959572731838
GOBP_MUSCLE_HYPERTROPHY_IN_R...,SET,24,0.080237,0.0028991,0.17709,0.32525,GOBP_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS,0.94959572731838
GSE28737_FOLLICULAR_VS_MARGI...4,SET,185,0.026525,0.0026492,0.058557,0.32529,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP,0.94959572731838
GOBP_REGULATION_OF_OSTEOCLAS...2,SET,65,0.054221,0.0032205,0.11973,0.32532,GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.94959572731838
NAKAYA_PBMC_FLUAD_IMUVAC_MAL...,SET,17,0.090696,0.0027585,0.20028,0.32534,NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE,0.94959572731838
CASORELLI_APL_SECONDARY_VS_D...,SET,34,0.069813,0.0030015,0.1542,0.32537,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,0.94959572731838
WP_PROLACTIN_SIGNALING,SET,72,0.04822,0.0030137,0.10651,0.32537,WP_PROLACTIN_SIGNALING,0.94959572731838
GSE24210_TCONV_VS_TREG_DN,SET,176,0.027686,0.0026977,0.061162,0.32539,GSE24210_TCONV_VS_TREG_DN,0.94959572731838
MODULE_525,SET,58,0.049836,0.0027966,0.1101,0.3254,MODULE_525,0.94959572731838
MACLACHLAN_BRCA1_TARGETS_UP,SET,19,0.088058,0.0028313,0.19456,0.32542,MACLACHLAN_BRCA1_TARGETS_UP,0.94959572731838
DAZARD_RESPONSE_TO_UV_SCC_DN,SET,110,0.036924,0.0028495,0.081588,0.32543,DAZARD_RESPONSE_TO_UV_SCC_DN,0.94959572731838
GOCC_POLYMERIC_CYTOSKELETAL_...,SET,687,0.01554,0.0029493,0.034338,0.32544,GOCC_POLYMERIC_CYTOSKELETAL_FIBER,0.94959572731838
GOBP_TETRAPYRROLE_CATABOLIC_...,SET,13,0.10658,0.0028352,0.23554,0.32545,GOBP_TETRAPYRROLE_CATABOLIC_PROCESS,0.94959572731838
GOMF_TRANSMEMBRANE_EPHRIN_RE...,SET,15,0.1157,0.0033056,0.25567,0.32545,GOMF_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY,0.94959572731838
KEGG_AMYOTROPHIC_LATERAL_SCL...,SET,52,0.052054,0.0027663,0.11506,0.32549,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.94959572731838
MIR7162_3P,SET,201,0.027767,0.0028894,0.061383,0.32551,MIR7162_3P,0.94959572731838
WP_CANCER_PATHWAYS,SET,483,0.018535,0.0029665,0.040978,0.32552,WP_CANCER_PATHWAYS,0.94959572731838
REACTOME_PROLONGED_ERK_ACTIV...,SET,14,0.10893,0.0030069,0.24089,0.32556,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,0.94959572731838
REACTOME_REMOVAL_OF_AMINOTER...,SET,8,0.13994,0.0029205,0.3095,0.32558,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,0.94959572731838
GSE15930_NAIVE_VS_72H_IN_VIT...7,SET,188,0.026648,0.0026827,0.058941,0.32559,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN,0.94959572731838
OSMAN_BLOOD_CHAD63_KH_AGE_18...2,SET,1574,0.010504,0.0029409,0.023233,0.32559,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,0.94959572731838
TRAVAGLINI_LUNG_NEUROENDOCRI...,SET,114,0.03865,0.003036,0.085519,0.32566,TRAVAGLINI_LUNG_NEUROENDOCRINE_CELL,0.94959572731838
MIR1236_5P,SET,73,0.044279,0.0027865,0.097987,0.32568,MIR1236_5P,0.94959572731838
JI_CARCINOGENESIS_BY_KRAS_AN...1,SET,16,0.11204,0.003306,0.24796,0.3257,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,0.94959572731838
TRAVAGLINI_LUNG_ADVENTITIAL_...,SET,279,0.025466,0.0031153,0.056391,0.32578,TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL,0.94959572731838
MIR4520_2_3P,SET,111,0.037286,0.0028904,0.082611,0.32587,MIR4520_2_3P,0.94959572731838
MIR5010_3P,SET,269,0.024146,0.0029012,0.053497,0.32587,MIR5010_3P,0.94959572731838
BIOCARTA_IL5_PATHWAY,SET,9,0.1363,0.0030171,0.30204,0.3259,BIOCARTA_IL5_PATHWAY,0.94959572731838
HP_DERMATAN_SULFATE_EXCRETIO...,SET,4,0.17768,0.0026224,0.39382,0.32593,HP_DERMATAN_SULFATE_EXCRETION_IN_URINE,0.94959572731838
HP_ACANTHOLYSIS,SET,10,0.12677,0.0029578,0.28099,0.32594,HP_ACANTHOLYSIS,0.94959572731838
GSE11961_MARGINAL_ZONE_BCELL...2,SET,179,0.027029,0.0026558,0.059915,0.32595,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.94959572731838
GSE22935_WT_VS_MYD88_KO_MACR...4,SET,180,0.027615,0.0027209,0.061211,0.32595,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP,0.94959572731838
GOBP_AMYLOID_PRECURSOR_PROTE...3,SET,70,0.045246,0.0027885,0.10031,0.32597,GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS,0.94959572731838
GOBP_REGULATION_OF_EPITHELIA...8,SET,6,0.1802,0.0032571,0.39954,0.32599,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,0.94959572731838
GOMF_PHOTORECEPTOR_ACTIVITY,SET,13,0.10573,0.0028124,0.23442,0.32599,GOMF_PHOTORECEPTOR_ACTIVITY,0.94959572731838
REACTOME_RELEASE_OF_HH_NP_FR...,SET,8,0.12924,0.0026972,0.28656,0.326,REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL,0.94959572731838
OLSSON_E2F3_TARGETS_DN,SET,33,0.074568,0.0031585,0.16545,0.3261,OLSSON_E2F3_TARGETS_DN,0.94959572731838
GOBP_STRIATED_MUSCLE_CELL_DE...,SET,77,0.044147,0.0028529,0.097949,0.3261,GOBP_STRIATED_MUSCLE_CELL_DEVELOPMENT,0.94959572731838
GOBP_POSITIVE_REGULATION_OF_...744,SET,33,0.072921,0.0030887,0.16179,0.32611,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.94959572731838
GSE411_UNSTIM_VS_400MIN_IL6_...4,SET,188,0.027241,0.0027424,0.060447,0.32612,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.94959572731838
HP_ABNORMAL_CORTICAL_GYRATION,SET,347,0.020524,0.0027948,0.04556,0.32618,HP_ABNORMAL_CORTICAL_GYRATION,0.94959572731838
CUI_DEVELOPING_HEART_RIGHT_V...,SET,20,0.080008,0.0026392,0.17761,0.32619,CUI_DEVELOPING_HEART_RIGHT_VENTRICULAR_CARDIOMYOCYTE,0.94959572731838
GOMF_URIDYLYLTRANSFERASE_ACT...,SET,5,0.14355,0.0023686,0.31869,0.3262,GOMF_URIDYLYLTRANSFERASE_ACTIVITY,0.94959572731838
REACTOME_COPI_MEDIATED_ANTER...,SET,99,0.036367,0.0026632,0.08075,0.32623,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,0.94959572731838
PAX8_B,SET,91,0.041751,0.002932,0.092709,0.32624,PAX8_B,0.94959572731838
GOBP_POSITIVE_REGULATION_OF_...605,SET,7,0.15668,0.0030587,0.34797,0.32626,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.94959572731838
BARIS_THYROID_CANCER_UP,SET,23,0.071136,0.0025162,0.15807,0.32635,BARIS_THYROID_CANCER_UP,0.94959572731838
GARGALOVIC_RESPONSE_TO_OXIDI...9,SET,71,0.050188,0.0031149,0.11154,0.32638,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,0.94959572731838
GOBP_PROTEIN_GERANYLGERANYLA...,SET,6,0.14417,0.0026059,0.32042,0.32638,GOBP_PROTEIN_GERANYLGERANYLATION,0.94959572731838
BRUNO_HEMATOPOIESIS,SET,61,0.051582,0.0029683,0.11465,0.32639,BRUNO_HEMATOPOIESIS,0.94959572731838
REACTOME_THROMBIN_SIGNALLING...,SET,32,0.071233,0.0029713,0.15835,0.32642,REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,0.94959572731838
LI_ESTROGENE_EARLY_E2_RESPON...2,SET,82,0.044565,0.0029716,0.099086,0.32645,LI_ESTROGENE_EARLY_E2_RESPONSE_UP,0.94959572731838
GOBP_REGULATION_OF_ADENYLATE...2,SET,42,0.063926,0.003054,0.14213,0.32645,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.94959572731838
GOBP_COENZYME_A_METABOLIC_PR...,SET,18,0.08862,0.0027734,0.1972,0.32658,GOBP_COENZYME_A_METABOLIC_PROCESS,0.949745199063232
REACTOME_DISEASES_ASSOCIATED...2,SET,13,0.094313,0.0025087,0.2099,0.3266,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,0.949745199063232
HP_ABNORMAL_CIRCULATING_ATRI...,SET,8,0.11406,0.0023803,0.25389,0.32663,HP_ABNORMAL_CIRCULATING_ATRIAL_NATRIURETIC_PEPTIDE_PRO_HORMONE_CONCENTRATION,0.949745199063232
HP_ABNORMAL_MORPHOLOGY_OF_TH...1,SET,52,0.05272,0.0028017,0.11736,0.32664,HP_ABNORMAL_MORPHOLOGY_OF_THE_ABDOMINAL_MUSCULATURE,0.949745199063232
OCT1_01,SET,227,0.027178,0.0030033,0.060528,0.32671,OCT1_01,0.949745199063232
HP_TRICUSPID_ATRESIA,SET,11,0.14214,0.0034782,0.31656,0.32671,HP_TRICUSPID_ATRESIA,0.949745199063232
GOBP_REGULATION_OF_PROGRAMME...2,SET,27,0.074662,0.0028611,0.16629,0.32672,GOBP_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.949745199063232
GSE2706_UNSTIM_VS_8H_R848_DC...2,SET,172,0.029469,0.0028389,0.065632,0.32672,GSE2706_UNSTIM_VS_8H_R848_DC_UP,0.949745199063232
GOBP_7_METHYLGUANOSINE_CAP_H...,SET,8,0.1191,0.0024856,0.2655,0.32687,GOBP_7_METHYLGUANOSINE_CAP_HYPERMETHYLATION,0.949900263355907
GOBP_PROTEIN_LINEAR_POLYUBIQ...,SET,3,0.19629,0.0025089,0.43764,0.32689,GOBP_PROTEIN_LINEAR_POLYUBIQUITINATION,0.949900263355907
GOMF_PROTEIN_ARGININE_OMEGA_...1,SET,7,0.15089,0.0029458,0.33644,0.3269,GOMF_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY,0.949900263355907
chr12q13,SET,248,0.060456,0.0069788,0.1348,0.32691,chr12q13,0.949900263355907
GSE18791_CTRL_VS_NEWCASTLE_V...5,SET,166,0.030819,0.0029172,0.06872,0.32691,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN,0.949900263355907
GSE19888_CTRL_VS_T_CELL_MEMB...2,SET,185,0.026752,0.0026718,0.059666,0.32695,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP,0.949915769455822
REACTOME_TRANSPORT_OF_MATURE...1,SET,40,0.055503,0.0025878,0.12381,0.32697,REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,0.949915769455822
HALLMARK_MYC_TARGETS_V2,SET,56,0.047592,0.0026244,0.1062,0.32704,HALLMARK_MYC_TARGETS_V2,0.949919676718737
GOMF_L_LEUCINE_BINDING,SET,6,0.13296,0.0024033,0.29679,0.32708,GOMF_L_LEUCINE_BINDING,0.949919676718737
LOPEZ_MESOTHELIOMA_SURVIVAL_...6,SET,12,0.11607,0.0029664,0.25915,0.32712,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,0.949919676718737
GOBP_TERPENOID_CATABOLIC_PRO...,SET,7,0.15609,0.0030472,0.34854,0.32713,GOBP_TERPENOID_CATABOLIC_PROCESS,0.949919676718737
MODULE_419,SET,30,0.071031,0.0028689,0.15862,0.32715,MODULE_419,0.949919676718737
KEGG_GALACTOSE_METABOLISM,SET,24,0.074947,0.002708,0.16739,0.32717,KEGG_GALACTOSE_METABOLISM,0.949919676718737
NAGY_PCAF_COMPONENTS_HUMAN,SET,9,0.11777,0.0026069,0.26306,0.32718,NAGY_PCAF_COMPONENTS_HUMAN,0.949919676718737
GOMF_HYDROPEROXY_ICOSATETRAE...,SET,7,0.15832,0.0030908,0.35365,0.32719,GOMF_HYDROPEROXY_ICOSATETRAENOATE_DEHYDRATASE_ACTIVITY,0.949919676718737
MIR6882_5P,SET,154,0.030683,0.0027983,0.06855,0.32722,MIR6882_5P,0.949927422318744
GOBP_HEPATOCYTE_GROWTH_FACTO...,SET,11,0.12338,0.0030191,0.27579,0.32731,GOBP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.949979674321503
HP_CEREBRAL_VENOUS_THROMBOSIS,SET,8,0.12012,0.0025069,0.2685,0.32731,HP_CEREBRAL_VENOUS_THROMBOSIS,0.949979674321503
HP_HYPOMETRIC_SACCADES,SET,13,0.10851,0.0028863,0.24257,0.32732,HP_HYPOMETRIC_SACCADES,0.949979674321503
MIR4534,SET,146,0.031518,0.0027994,0.07049,0.32739,MIR4534,0.950053185271771
MEISSNER_NPC_HCP_WITH_H3_UNM...,SET,487,0.018211,0.0029264,0.040732,0.3274,MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,0.950053185271771
GOBP_PROTEIN_STABILIZATION,SET,186,0.027322,0.002736,0.061121,0.32744,GOBP_PROTEIN_STABILIZATION,0.950089931541159
HP_INTRACRANIAL_HEMORRHAGE,SET,141,0.033017,0.0028823,0.073901,0.32752,HP_INTRACRANIAL_HEMORRHAGE,0.950129714426391
HP_GENERALIZED_MUSCLE_WEAKNE...,SET,120,0.034809,0.0028049,0.077932,0.32757,HP_GENERALIZED_MUSCLE_WEAKNESS,0.950129714426391
GSE12845_IGD_NEG_BLOOD_VS_PR...2,SET,169,0.02889,0.0027589,0.064697,0.32761,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.950129714426391
GOBP_REGULATION_OF_CHROMATIN...1,SET,10,0.11148,0.0026009,0.24966,0.32762,GOBP_REGULATION_OF_CHROMATIN_BINDING,0.950129714426391
HP_CORTICAL_THICKENING_OF_LO...,SET,5,0.16744,0.0027628,0.3751,0.32766,HP_CORTICAL_THICKENING_OF_LONG_BONE_DIAPHYSES,0.950129714426391
GOBP_REGULATION_OF_MEMBRANE_...1,SET,41,0.066102,0.0031202,0.14816,0.32775,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.950129714426391
HALLMARK_ALLOGRAFT_REJECTION,SET,183,0.029648,0.0029452,0.066467,0.32778,HALLMARK_ALLOGRAFT_REJECTION,0.950129714426391
HP_SCAPHOCEPHALY,SET,38,0.06054,0.0027513,0.1358,0.32787,HP_SCAPHOCEPHALY,0.950129714426391
HP_AMBIGUOUS_GENITALIA_FEMALE,SET,8,0.13832,0.0028867,0.31041,0.32794,HP_AMBIGUOUS_GENITALIA_FEMALE,0.950129714426391
HP_BIVENTRICULAR_HYPERTROPHY,SET,13,0.099689,0.0026517,0.22386,0.32805,HP_BIVENTRICULAR_HYPERTROPHY,0.950129714426391
GOBP_SPROUTING_ANGIOGENESIS,SET,126,0.036398,0.0030049,0.081747,0.32807,GOBP_SPROUTING_ANGIOGENESIS,0.950129714426391
KEGG_MEDICUS_VARIANT_DUPLICA...1,SET,4,0.24291,0.003585,0.54561,0.32809,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY,0.950129714426391
GSE25123_CTRL_VS_IL4_AND_ROS...1,SET,172,0.027974,0.0026949,0.062835,0.32809,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.950129714426391
GSE25088_IL4_VS_IL4_AND_ROSI...2,SET,183,0.027823,0.0027638,0.062497,0.3281,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.950129714426391
GSE7831_1H_VS_4H_INFLUENZA_S...2,SET,182,0.028361,0.0028097,0.063712,0.32811,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP,0.950129714426391
MATZUK_PREOVULATORY_FOLLICLE,SET,9,0.14911,0.0033004,0.33506,0.32816,MATZUK_PREOVULATORY_FOLLICLE,0.950129714426391
GOCC_MUSCLE_MYOSIN_COMPLEX,SET,14,0.11899,0.0032845,0.26748,0.32822,GOCC_MUSCLE_MYOSIN_COMPLEX,0.950129714426391
WEST_ADRENOCORTICAL_CARCINOM...1,SET,22,0.089816,0.0031072,0.20197,0.32828,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,0.950129714426391
MIR6834_5P,SET,53,0.051195,0.0027466,0.11513,0.32828,MIR6834_5P,0.950129714426391
GOBP_POSITIVE_REGULATION_OF_...511,SET,11,0.11655,0.0028519,0.26216,0.32831,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,0.950129714426391
LI_INDUCED_T_TO_NATURAL_KILL...1,SET,127,0.033716,0.0027945,0.075844,0.32833,LI_INDUCED_T_TO_NATURAL_KILLER_DN,0.950129714426391
MULLIGHAN_MLL_SIGNATURE_2_UP,SET,387,0.019114,0.0027457,0.042998,0.32833,MULLIGHAN_MLL_SIGNATURE_2_UP,0.950129714426391
GOCC_OTHER_ORGANISM_PART,SET,4,0.20937,0.00309,0.47118,0.32839,GOCC_OTHER_ORGANISM_PART,0.950129714426391
HP_CUTANEOUS_ABSCESS,SET,23,0.079446,0.0028101,0.17878,0.32839,HP_CUTANEOUS_ABSCESS,0.950129714426391
GOBP_REGULATION_OF_FEMALE_GO...,SET,7,0.15815,0.0030874,0.35601,0.32844,GOBP_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT,0.950129714426391
GSE32533_MIR17_KO_VS_MIR17_O...1,SET,175,0.028231,0.002743,0.063564,0.32848,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.950129714426391
GOCC_SPERM_HEAD_PLASMA_MEMBR...,SET,6,0.15059,0.0027219,0.33914,0.32851,GOCC_SPERM_HEAD_PLASMA_MEMBRANE,0.950129714426391
BHAT_ESR1_TARGETS_NOT_VIA_AK...2,SET,201,0.028059,0.0029198,0.063194,0.32852,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,0.950129714426391
HP_BROAD_FOREHEAD,SET,167,0.029618,0.0028119,0.066725,0.32856,HP_BROAD_FOREHEAD,0.950129714426391
GSE4142_NAIVE_VS_GC_BCELL_DN,SET,179,0.026938,0.0026468,0.060722,0.32866,GSE4142_NAIVE_VS_GC_BCELL_DN,0.950129714426391
GOBP_REGULATION_OF_ENAMEL_MI...,SET,7,0.1527,0.0029811,0.34432,0.32871,GOBP_REGULATION_OF_ENAMEL_MINERALIZATION,0.950129714426391
HP_NONKETOTIC_HYPOGLYCEMIA,SET,13,0.097069,0.002582,0.2189,0.32873,HP_NONKETOTIC_HYPOGLYCEMIA,0.950129714426391
MIR3622A_5P,SET,37,0.066648,0.0029889,0.15031,0.32874,MIR3622A_5P,0.950129714426391
MIR766_3P,SET,142,0.032479,0.0028452,0.073333,0.32893,MIR766_3P,0.950129714426391
BHAT_ESR1_TARGETS_NOT_VIA_AK...1,SET,84,0.044629,0.0030118,0.10083,0.32902,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,0.950129714426391
REACTOME_SEMA4D_MEDIATED_INH...,SET,8,0.15101,0.0031516,0.34118,0.32902,REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION,0.950129714426391
GOMF_NERVE_GROWTH_FACTOR_REC...,SET,4,0.22866,0.0033747,0.51659,0.32902,GOMF_NERVE_GROWTH_FACTOR_RECEPTOR_BINDING,0.950129714426391
WANG_BARRETTS_ESOPHAGUS_UP,SET,50,0.058304,0.0030385,0.13173,0.32903,WANG_BARRETTS_ESOPHAGUS_UP,0.950129714426391
WP_NUCLEOTIDEBINDING_OLIGOME...,SET,37,0.061265,0.0027475,0.13847,0.32909,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,0.950129714426391
REACTOME_ATF6_ATF6_ALPHA_ACT...1,SET,11,0.10084,0.0024675,0.22794,0.3291,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,0.950129714426391
AP1_01,SET,235,0.025074,0.0028185,0.056685,0.32913,AP1_01,0.950129714426391
HP_CORNEAL_ULCERATION,SET,18,0.088206,0.0027605,0.19946,0.32917,HP_CORNEAL_ULCERATION,0.950129714426391
GENTILE_UV_HIGH_DOSE_DN,SET,268,0.022847,0.0027401,0.05167,0.32919,GENTILE_UV_HIGH_DOSE_DN,0.950129714426391
GOBP_RESPONSE_TO_MECHANICAL_...,SET,209,0.027269,0.0028928,0.061672,0.32919,GOBP_RESPONSE_TO_MECHANICAL_STIMULUS,0.950129714426391
GOMF_CARBOHYDRATE_DERIVATIVE...,SET,54,0.053974,0.0029228,0.12208,0.32921,GOMF_CARBOHYDRATE_DERIVATIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.950129714426391
JOHANSSON_GLIOMAGENESIS_BY_P...2,SET,55,0.052788,0.0028849,0.11942,0.32923,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,0.950129714426391
chr17p13,SET,218,0.059603,0.0064561,0.13492,0.32933,chr17p13,0.950129714426391
GOBP_HEME_B_METABOLIC_PROCESS,SET,9,0.12064,0.0026704,0.27314,0.32936,GOBP_HEME_B_METABOLIC_PROCESS,0.950129714426391
GOBP_REGULATION_OF_CYTOPLASM...2,SET,101,0.036268,0.0026825,0.082122,0.32938,GOBP_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.950129714426391
PAX8_TARGET_GENES,SET,65,0.044189,0.0026246,0.10007,0.32939,PAX8_TARGET_GENES,0.950129714426391
GOBP_PLASMA_MEMBRANE_TO_ENDO...,SET,8,0.13268,0.002769,0.30047,0.3294,GOBP_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT,0.950129714426391
GOBP_NEGATIVE_REGULATION_OF_...413,SET,998,0.012706,0.0028808,0.028786,0.32947,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.950129714426391
GOBP_INTERMEMBRANE_LIPID_TRA...,SET,28,0.067387,0.0026296,0.15269,0.32948,GOBP_INTERMEMBRANE_LIPID_TRANSFER,0.950129714426391
GOBP_NEGATIVE_REGULATION_OF_...338,SET,51,0.053683,0.0028254,0.12164,0.3295,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.950129714426391
HP_ABNORMAL_EXTEROCEPTIVE_SE...,SET,219,0.025524,0.002771,0.057847,0.32952,HP_ABNORMAL_EXTEROCEPTIVE_SENSATION,0.950129714426391
HP_DILATATION_OF_THE_CEREBRA...,SET,49,0.056175,0.0028982,0.12745,0.3297,HP_DILATATION_OF_THE_CEREBRAL_ARTERY,0.950129714426391
HP_DECREASED_SPECIFIC_ANTIBO...1,SET,12,0.10758,0.0027494,0.24409,0.32971,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_POLYSACCHARIDE_VACCINE,0.950129714426391
REACTOME_INTERLEUKIN_2_SIGNA...,SET,11,0.12428,0.003041,0.282,0.32972,REACTOME_INTERLEUKIN_2_SIGNALING,0.950129714426391
MIR4639_3P,SET,66,0.046861,0.0028046,0.10634,0.32972,MIR4639_3P,0.950129714426391
HP_CHRONIC_HEMOLYTIC_ANEMIA,SET,5,0.17363,0.002865,0.39408,0.32975,HP_CHRONIC_HEMOLYTIC_ANEMIA,0.950129714426391
GOBP_TOOTH_MINERALIZATION,SET,28,0.072607,0.0028333,0.16482,0.32978,GOBP_TOOTH_MINERALIZATION,0.950129714426391
GSE23321_CD8_STEM_CELL_MEMOR...5,SET,178,0.027639,0.0027082,0.062744,0.32979,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.950129714426391
REACTOME_DOWNSTREAM_SIGNALIN...3,SET,29,0.069243,0.0027498,0.15723,0.32983,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,0.950129714426391
GOCC_MICOS_COMPLEX,SET,5,0.15719,0.0025937,0.35695,0.32983,GOCC_MICOS_COMPLEX,0.950129714426391
WONG_EMBRYONIC_STEM_CELL_CORE,SET,309,0.020227,0.0026019,0.045933,0.32984,WONG_EMBRYONIC_STEM_CELL_CORE,0.950129714426391
MIR198,SET,76,0.046574,0.0029903,0.10577,0.32985,MIR198,0.950129714426391
OVSYANNIKOVA_PBMC_FLUARIX_AG...4,SET,23,0.07949,0.0028117,0.18052,0.32985,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.950129714426391
GOBP_OSTEOBLAST_DIFFERENTIAT...,SET,209,0.02751,0.0029184,0.062478,0.32986,GOBP_OSTEOBLAST_DIFFERENTIATION,0.950129714426391
REACTOME_HDL_REMODELING,SET,8,0.1345,0.0028071,0.30551,0.32987,REACTOME_HDL_REMODELING,0.950129714426391
GOMF_STRUCTURAL_CONSTITUENT_...1,SET,3,0.22388,0.0028616,0.50848,0.32987,GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN,0.950129714426391
LIU_OVARIAN_CANCER_TUMORS_AN...3,SET,74,0.043009,0.002725,0.097705,0.3299,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP,0.950129714426391
MIR645,SET,35,0.061482,0.0026818,0.13967,0.3299,MIR645,0.950129714426391
GOCC_EXTRINSIC_COMPONENT_OF_...4,SET,22,0.081319,0.0028132,0.18474,0.3299,GOCC_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,0.950129714426391
CHUNG_BLISTER_CYTOTOXICITY_UP,SET,120,0.033834,0.0027263,0.076896,0.32997,CHUNG_BLISTER_CYTOTOXICITY_UP,0.950129714426391
GSE20152_SPHK1_KO_VS_WT_HTNF...1,SET,180,0.026499,0.0026109,0.060226,0.32997,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN,0.950129714426391
GOCC_SPERM_HEAD,SET,17,0.086902,0.0026431,0.19753,0.32999,GOCC_SPERM_HEAD,0.950129714426391
GOBP_INNERVATION,SET,26,0.083286,0.0031319,0.18937,0.33004,GOBP_INNERVATION,0.950129714426391
KEGG_ABC_TRANSPORTERS,SET,42,0.063811,0.0030485,0.14511,0.33007,KEGG_ABC_TRANSPORTERS,0.950129714426391
REACTOME_CD209_DC_SIGN_SIGNA...,SET,19,0.084044,0.0027022,0.19112,0.33007,REACTOME_CD209_DC_SIGN_SIGNALING,0.950129714426391
MIR1278,SET,56,0.049594,0.0027348,0.11279,0.33008,MIR1278,0.950129714426391
GOCC_CMG_COMPLEX,SET,11,0.10819,0.0026475,0.24607,0.33008,GOCC_CMG_COMPLEX,0.950129714426391
OCT1_07,SET,143,0.033513,0.0029461,0.076226,0.3301,OCT1_07,0.950129714426391
MIR200B_3P,SET,448,0.018922,0.0029195,0.043058,0.33017,MIR200B_3P,0.950129714426391
MIR200C_3P,SET,448,0.018922,0.0029195,0.043058,0.33017,MIR200C_3P,0.950129714426391
GOBP_CORNIFICATION,SET,9,0.15204,0.0033653,0.34597,0.33017,GOBP_CORNIFICATION,0.950129714426391
MODULE_207,SET,207,0.026621,0.0028107,0.060583,0.33018,MODULE_207,0.950129714426391
REACTOME_GROWTH_HORMONE_RECE...,SET,22,0.09114,0.003153,0.20744,0.33021,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,0.950129714426391
GOBP_GAP_JUNCTION_ASSEMBLY,SET,16,0.11236,0.0033154,0.25574,0.33021,GOBP_GAP_JUNCTION_ASSEMBLY,0.950129714426391
GOTZMANN_EPITHELIAL_TO_MESEN...1,SET,192,0.02713,0.0027598,0.061756,0.33022,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.950129714426391
GSE41978_WT_VS_BIM_KO_KLRG1_...1,SET,178,0.028332,0.0027762,0.064496,0.33023,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.950129714426391
REACTOME_RHO_GTPASES_ACTIVAT...8,SET,9,0.12775,0.0028278,0.29088,0.33026,REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS,0.950129714426391
HP_ORTHOKERATOSIS,SET,18,0.090282,0.0028254,0.20558,0.33027,HP_ORTHOKERATOSIS,0.950129714426391
REACTOME_TRAF6_MEDIATED_IRF7...1,SET,26,0.082899,0.0031174,0.1888,0.3303,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,0.950129714426391
GOMF_MOLECULAR_TRANSDUCER_AC...,SET,1298,0.012507,0.0032059,0.028488,0.33032,GOMF_MOLECULAR_TRANSDUCER_ACTIVITY,0.950129714426391
WP_LTF_DANGER_SIGNAL_RESPONS...,SET,18,0.095573,0.002991,0.21774,0.33036,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,0.950129714426391
MODULE_65,SET,7,0.13907,0.002715,0.31687,0.33037,MODULE_65,0.950129714426391
HP_OPPORTUNISTIC_FUNGAL_INFE...,SET,13,0.10199,0.0027129,0.23241,0.3304,HP_OPPORTUNISTIC_FUNGAL_INFECTION,0.950129714426391
GSE10463_CD40L_AND_VA347_VS_...2,SET,167,0.028912,0.0027448,0.065887,0.3304,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP,0.950129714426391
HP_ABNORMAL_BLOOD_MONOVALENT...,SET,140,0.032919,0.0028636,0.075027,0.33042,HP_ABNORMAL_BLOOD_MONOVALENT_INORGANIC_CATION_CONCENTRATION,0.950129714426391
TEAD2_TARGET_GENES,SET,1171,0.011411,0.0027884,0.026017,0.33048,TEAD2_TARGET_GENES,0.950129714426391
GSE11961_MEMORY_BCELL_DAY7_V...5,SET,181,0.027064,0.0026739,0.061707,0.33048,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.950129714426391
HP_CERVICAL_LYMPHADENOPATHY,SET,9,0.11035,0.0024427,0.25163,0.3305,HP_CERVICAL_LYMPHADENOPATHY,0.950129714426391
HP_SOFT_TISSUE_NEOPLASM,SET,5,0.19248,0.003176,0.43897,0.33052,HP_SOFT_TISSUE_NEOPLASM,0.950129714426391
GOBP_UBIQUITIN_DEPENDENT_PRO...1,SET,12,0.10727,0.0027416,0.24475,0.33059,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY,0.950129714426391
ESC_V6.5_UP_EARLY.V1_UP,SET,154,0.031249,0.0028499,0.071302,0.3306,ESC_V6.5_UP_EARLY.V1_UP,0.950129714426391
REACTOME_SCAVENGING_BY_CLASS...2,SET,6,0.17584,0.0031782,0.40132,0.33064,REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS,0.950129714426391
REACTOME_ANTIGEN_ACTIVATES_B...,SET,27,0.070163,0.0026887,0.16017,0.33068,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,0.950129714426391
GAVIN_FOXP3_TARGETS_CLUSTER_...5,SET,82,0.041915,0.0027949,0.095699,0.3307,GAVIN_FOXP3_TARGETS_CLUSTER_P7,0.950129714426391
GOMF_ACTIVE_TRANSMEMBRANE_TR...,SET,421,0.018482,0.0027664,0.04221,0.33075,GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.950129714426391
CAO_BLOOD_FLUMIST_AGE_05_14Y...7,SET,9,0.12785,0.00283,0.29201,0.33076,CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE,0.950129714426391
PID_TNF_PATHWAY,SET,43,0.053209,0.002572,0.1216,0.33085,PID_TNF_PATHWAY,0.950129714426391
HP_ABNORMAL_ESOPHAGUS_PHYSIO...,SET,773,0.013774,0.0027661,0.031479,0.33086,HP_ABNORMAL_ESOPHAGUS_PHYSIOLOGY,0.950129714426391
GOMF_PHOSPHATIDYLINOSITOL_3_...14,SET,41,0.058973,0.0027837,0.13479,0.33087,GOMF_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING,0.950129714426391
BAE_BRCA1_TARGETS_DN,SET,29,0.072264,0.0028697,0.16523,0.33093,BAE_BRCA1_TARGETS_DN,0.950129714426391
WP_PREGNANE_X_RECEPTOR_PATHW...,SET,31,0.075998,0.0031202,0.17379,0.33095,WP_PREGNANE_X_RECEPTOR_PATHWAY,0.950129714426391
GOBP_REGULATION_OF_RESPONSE_...13,SET,14,0.093342,0.0025765,0.21345,0.33095,GOBP_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.950129714426391
GOBP_NEGATIVE_REGULATION_OF_...694,SET,16,0.099745,0.0029432,0.22811,0.33096,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.950129714426391
FERREIRA_EWINGS_SARCOMA_UNST...2,SET,148,0.02837,0.0025369,0.064882,0.33097,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,0.950129714426391
HP_ABNORMAL_PROPORTION_OF_ME...,SET,5,0.17649,0.0029122,0.40364,0.33097,HP_ABNORMAL_PROPORTION_OF_MEMORY_T_CELLS,0.950129714426391
REACTOME_BIOSYNTHESIS_OF_THE...,SET,72,0.041609,0.0026005,0.095185,0.33101,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,0.950129714426391
CADWELL_ATG16L1_TARGETS_DN,SET,61,0.044191,0.0025429,0.10111,0.33103,CADWELL_ATG16L1_TARGETS_DN,0.950129714426391
GSE28726_ACT_CD4_TCELL_VS_AC...3,SET,185,0.027644,0.0027609,0.06326,0.33106,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN,0.950129714426391
GSE23925_DARK_ZONE_VS_NAIVE_...1,SET,188,0.027028,0.002721,0.061857,0.33108,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN,0.950129714426391
GOMF_NUCLEAR_RETINOID_X_RECE...,SET,17,0.091245,0.0027752,0.20884,0.33109,GOMF_NUCLEAR_RETINOID_X_RECEPTOR_BINDING,0.950129714426391
GRANDVAUX_IRF3_TARGETS_DN,SET,17,0.096989,0.0029499,0.222,0.3311,GRANDVAUX_IRF3_TARGETS_DN,0.950129714426391
KYNG_NORMAL_AGING_DN,SET,16,0.0952,0.0028091,0.21792,0.33111,KYNG_NORMAL_AGING_DN,0.950129714426391
GOBP_NEGATIVE_REGULATION_OF_...297,SET,83,0.040084,0.002689,0.091768,0.33113,GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.950129714426391
HP_SHORT_THUMB,SET,104,0.036776,0.00276,0.084195,0.33113,HP_SHORT_THUMB,0.950129714426391
MIR5087,SET,85,0.040953,0.0027801,0.09377,0.33115,MIR5087,0.950129714426391
GAO_SMALL_INTESTINE_24W_C7_S...,SET,38,0.059369,0.0026982,0.13595,0.33117,GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR,0.950129714426391
PID_ATR_PATHWAY,SET,38,0.055896,0.0025403,0.12804,0.33122,PID_ATR_PATHWAY,0.950129714426391
GOBP_NEURON_FATE_COMMITMENT,SET,67,0.05179,0.0031229,0.11864,0.33122,GOBP_NEURON_FATE_COMMITMENT,0.950129714426391
HP_ABNORMAL_EPIPHYSIS_MORPHO...2,SET,36,0.064064,0.002834,0.14676,0.33124,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY_OF_THE_PHALANGES_OF_THE_HAND,0.950129714426391
HP_NEURONAL_LOSS_IN_CENTRAL_...,SET,34,0.060978,0.0026217,0.1397,0.33124,HP_NEURONAL_LOSS_IN_CENTRAL_NERVOUS_SYSTEM,0.950129714426391
REACTOME_ROLE_OF_LAT2_NTAL_L...,SET,16,0.090637,0.0026745,0.20767,0.33126,REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,0.950129714426391
GAVISH_3CA_METAPROGRAM_EPITH...13,SET,43,0.064535,0.0031195,0.14786,0.33126,GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC,0.950129714426391
MIR500B_5P,SET,51,0.051498,0.0027104,0.11802,0.33129,MIR500B_5P,0.950129714426391
GSE41176_WT_VS_TAK1_KO_ANTI_...5,SET,176,0.028027,0.0027309,0.064235,0.3313,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN,0.950129714426391
GOBP_VASCULOGENESIS,SET,79,0.04449,0.0029121,0.102,0.33135,GOBP_VASCULOGENESIS,0.950129714426391
REACTOME_NF_KB_IS_ACTIVATED_...,SET,11,0.11705,0.0028641,0.26837,0.33137,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,0.950129714426391
NAKAMURA_ALVEOLAR_EPITHELIUM,SET,5,0.1747,0.0028826,0.40064,0.3314,NAKAMURA_ALVEOLAR_EPITHELIUM,0.950129714426391
GOBP_POSITIVE_REGULATION_OF_...175,SET,9,0.12673,0.0028051,0.29066,0.33142,GOBP_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.950129714426391
RBM15_TARGET_GENES,SET,141,0.032297,0.0028195,0.074109,0.33149,RBM15_TARGET_GENES,0.950129714426391
HP_ATELECTASIS,SET,67,0.046585,0.002809,0.10693,0.33155,HP_ATELECTASIS,0.950129714426391
chr5q22,SET,26,0.14884,0.005597,0.34176,0.3316,chr5q22,0.950129714426391
GOCC_SPINDLE_MICROTUBULE,SET,76,0.040145,0.0025775,0.09222,0.33167,GOCC_SPINDLE_MICROTUBULE,0.950129714426391
HP_APLASIA_HYPOPLASIA_INVOLV...10,SET,4,0.21606,0.0031887,0.49639,0.33169,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_MUSCULATURE_OF_THE_EXTREMITIES,0.950129714426391
LHX3_TARGET_GENES,SET,18,0.089988,0.0028162,0.20679,0.33172,LHX3_TARGET_GENES,0.950129714426391
GOBP_NEGATIVE_REGULATION_OF_...439,SET,146,0.032397,0.0028775,0.074466,0.33176,GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.950129714426391
KEGG_MEDICUS_REFERENCE_NOD_N...,SET,8,0.13485,0.0028142,0.31002,0.3318,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY,0.950129714426391
HELLER_SILENCED_BY_METHYLATI...1,SET,100,0.040382,0.0029722,0.092847,0.33181,HELLER_SILENCED_BY_METHYLATION_DN,0.950129714426391
GSE11367_CTRL_VS_IL17_TREATE...2,SET,119,0.034597,0.0027763,0.079549,0.33181,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP,0.950129714426391
GOMF_NEUROTRANSMITTER_TRANSM...,SET,20,0.089057,0.0029377,0.2048,0.33184,GOMF_NEUROTRANSMITTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.950129714426391
MIR362_5P,SET,50,0.051711,0.0026949,0.11893,0.33185,MIR362_5P,0.950129714426391
NUYTTEN_EZH2_TARGETS_DN,SET,908,0.012023,0.0026068,0.027653,0.33186,NUYTTEN_EZH2_TARGETS_DN,0.950129714426391
GSE21546_ELK1_KO_VS_SAP1A_KO...1,SET,187,0.02698,0.002709,0.062054,0.33186,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.950129714426391
REACTOME_IKK_COMPLEX_RECRUIT...,SET,21,0.085125,0.0028773,0.19582,0.33189,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,0.950129714426391
MELLMAN_TUT1_TARGETS_UP,SET,19,0.084124,0.0027048,0.19364,0.33199,MELLMAN_TUT1_TARGETS_UP,0.950129714426391
GSE3720_UNSTIM_VS_PMA_STIM_V...2,SET,158,0.028267,0.0026109,0.06508,0.33202,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.950129714426391
GSE19772_CTRL_VS_HCMV_INF_MO...1,SET,184,0.02716,0.0027053,0.062547,0.33206,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.950129714426391
HP_REDUCED_FACTOR_XIII_ACTIV...,SET,6,0.14757,0.0026673,0.33987,0.33208,HP_REDUCED_FACTOR_XIII_ACTIVITY,0.950129714426391
GSE17721_LPS_VS_POLYIC_2H_BM...2,SET,187,0.028115,0.002823,0.064761,0.33209,GSE17721_LPS_VS_POLYIC_2H_BMDC_UP,0.950129714426391
GOCC_SECRETORY_VESICLE,SET,986,0.012436,0.0028036,0.028654,0.33214,GOCC_SECRETORY_VESICLE,0.950129714426391
HP_KNEE_PAIN,SET,15,0.10496,0.0029988,0.24184,0.33215,HP_KNEE_PAIN,0.950129714426391
GSE7348_UNSTIM_VS_LPS_STIM_M...2,SET,141,0.029974,0.0026166,0.069103,0.33224,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.950129714426391
GSE11057_NAIVE_CD4_VS_PBMC_C...1,SET,186,0.02698,0.0027018,0.062205,0.33225,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN,0.950129714426391
LI_ESTROGENE_MCF7_E2_RESPONS...2,SET,46,0.058787,0.0029389,0.13557,0.33228,LI_ESTROGENE_MCF7_E2_RESPONSE_UP,0.950129714426391
GAVISH_3CA_METAPROGRAM_CD4_T...1,SET,45,0.059264,0.0029304,0.13669,0.33231,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE,0.950129714426391
GOBP_PROTEIN_DEACETYLATION,SET,37,0.057333,0.0025712,0.13224,0.33231,GOBP_PROTEIN_DEACETYLATION,0.950129714426391
KEGG_MEDICUS_REFERENCE_CA2_E...1,SET,12,0.11263,0.0028785,0.25981,0.33233,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL,0.950129714426391
MIR6727_3P,SET,102,0.037392,0.0027793,0.086263,0.33234,MIR6727_3P,0.950129714426391
HP_INVOLUNTARY_VOCALIZATION,SET,42,0.055831,0.0026673,0.12881,0.33235,HP_INVOLUNTARY_VOCALIZATION,0.950129714426391
BUSSLINGER_DUODENAL_LATE_IMM...,SET,164,0.029816,0.0028054,0.068798,0.33237,BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES,0.950129714426391
HP_CEREBRAL_HYPOPLASIA,SET,53,0.04807,0.002579,0.11093,0.33239,HP_CEREBRAL_HYPOPLASIA,0.950129714426391
MIR6788_5P,SET,115,0.035568,0.0028061,0.082091,0.33241,MIR6788_5P,0.950129714426391
WP_DRAVET_SYNDROME,SET,26,0.08071,0.0030351,0.18629,0.33242,WP_DRAVET_SYNDROME,0.950129714426391
HP_BASAL_GANGLIA_GLIOSIS,SET,8,0.14122,0.0029473,0.32596,0.33242,HP_BASAL_GANGLIA_GLIOSIS,0.950129714426391
DESCARTES_FETAL_HEART_CARDIO...,SET,6,0.16665,0.0030122,0.3847,0.33243,DESCARTES_FETAL_HEART_CARDIOMYOCYTES,0.950129714426391
HP_ABNORMAL_LYMPHATIC_VESSEL...,SET,16,0.094176,0.0027789,0.21742,0.33245,HP_ABNORMAL_LYMPHATIC_VESSEL_MORPHOLOGY,0.950129714426391
GOMF_BICARBONATE_MONOATOMIC_...,SET,12,0.10528,0.0026906,0.24312,0.3325,GOMF_BICARBONATE_MONOATOMIC_ANION_ANTIPORTER_ACTIVITY,0.950129714426391
MIR4287,SET,115,0.034518,0.0027233,0.079721,0.33252,MIR4287,0.950129714426391
WP_CANONICAL_NFKB_PATHWAY,SET,7,0.13456,0.002627,0.31084,0.33254,WP_CANONICAL_NFKB_PATHWAY,0.950129714426391
GSE41867_MEMORY_VS_EXHAUSTED...2,SET,186,0.027175,0.0027213,0.062771,0.33254,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP,0.950129714426391
HP_LIPOATROPHY,SET,71,0.045168,0.0028034,0.10436,0.33257,HP_LIPOATROPHY,0.950129714426391
GSE2405_S_AUREUS_VS_A_PHAGOC...2,SET,182,0.028753,0.0028486,0.066432,0.33257,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP,0.950129714426391
CAIRO_HEPATOBLASTOMA_UP,SET,189,0.027572,0.002783,0.06372,0.33262,CAIRO_HEPATOBLASTOMA_UP,0.950129714426391
HP_PROGRESSIVE_PTOSIS,SET,4,0.16492,0.0024341,0.38123,0.33265,HP_PROGRESSIVE_PTOSIS,0.950129714426391
THUM_SYSTOLIC_HEART_FAILURE_...2,SET,366,0.01975,0.0027606,0.04568,0.33274,THUM_SYSTOLIC_HEART_FAILURE_UP,0.950129714426391
HP_CHEILITIS,SET,48,0.05814,0.0029689,0.13447,0.33274,HP_CHEILITIS,0.950129714426391
GOBP_REGULATION_OF_CELL_CYCL...3,SET,103,0.035094,0.0026212,0.081173,0.33275,GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.950129714426391
GOCC_APICAL_JUNCTION_COMPLEX,SET,130,0.033597,0.002817,0.077727,0.33279,GOCC_APICAL_JUNCTION_COMPLEX,0.950129714426391
HP_SPHEROCYTOSIS,SET,8,0.13754,0.0028705,0.31824,0.3328,HP_SPHEROCYTOSIS,0.950129714426391
WP_COVID19_THROMBOSIS_AND_AN...,SET,7,0.17598,0.0034355,0.40746,0.33291,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,0.950129714426391
GOBP_DETECTION_OF_OTHER_ORGA...,SET,17,0.10337,0.0031438,0.23934,0.33292,GOBP_DETECTION_OF_OTHER_ORGANISM,0.950129714426391
CHIARADONNA_NEOPLASTIC_TRANS...2,SET,102,0.038672,0.0028745,0.08955,0.33293,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,0.950129714426391
HAEGERSTRAND_RESPONSE_TO_IMA...,SET,9,0.14942,0.0033074,0.346,0.33293,HAEGERSTRAND_RESPONSE_TO_IMATINIB,0.950129714426391
MIR6778_3P,SET,204,0.024709,0.00259,0.057222,0.33294,MIR6778_3P,0.950129714426391
GOBP_RESPONSE_TO_POTASSIUM_I...,SET,18,0.0929,0.0029074,0.21517,0.33297,GOBP_RESPONSE_TO_POTASSIUM_ION,0.950129714426391
HP_ABNORMAL_OPTIC_CHIASM_MOR...,SET,6,0.17744,0.0032072,0.411,0.33297,HP_ABNORMAL_OPTIC_CHIASM_MORPHOLOGY,0.950129714426391
GSE2706_LPS_VS_R848_AND_LPS_...4,SET,166,0.028191,0.0026685,0.065308,0.33299,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP,0.950129714426391
REACTOME_DEFECTIVE_CHST3_CAU...,SET,7,0.12623,0.0024643,0.29247,0.33302,REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD,0.950129714426391
GOBP_MAINTENANCE_OF_DNA_REPE...,SET,7,0.12646,0.0024688,0.29309,0.33306,GOBP_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS,0.950129714426391
HP_ABNORMALITY_OF_THE_COMMON...,SET,61,0.048707,0.0028028,0.11289,0.33307,HP_ABNORMALITY_OF_THE_COMMON_COAGULATION_PATHWAY,0.950129714426391
HP_ABNORMAL_CIRCULATING_LONG...,SET,16,0.089353,0.0026366,0.2071,0.33307,HP_ABNORMAL_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.950129714426391
GOBP_NUCLEOSIDE_MONOPHOSPHAT...3,SET,69,0.044884,0.0027464,0.10406,0.33312,GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.950129714426391
GOBP_MYELOID_PROGENITOR_CELL...,SET,9,0.11338,0.0025096,0.26289,0.33313,GOBP_MYELOID_PROGENITOR_CELL_DIFFERENTIATION,0.950129714426391
ZHONG_PFC_MAJOR_TYPES_MICROG...,SET,389,0.019703,0.0028373,0.045683,0.33313,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.950129714426391
GOBP_NEGATIVE_REGULATION_OF_...223,SET,30,0.071568,0.0028906,0.16595,0.33314,GOBP_NEGATIVE_REGULATION_OF_EXOCYTOSIS,0.950129714426391
GSE27786_CD8_TCELL_VS_MONO_M...2,SET,171,0.027144,0.0026074,0.062979,0.33324,GSE27786_CD8_TCELL_VS_MONO_MAC_UP,0.950336932797243
MENSE_HYPOXIA_UP,SET,89,0.038889,0.002701,0.090247,0.33327,MENSE_HYPOXIA_UP,0.950344506892025
HP_ABNORMAL_BRONCHUS_MORPHOL...,SET,186,0.0272,0.0027238,0.063134,0.3333,HP_ABNORMAL_BRONCHUS_MORPHOLOGY,0.950352079744031
REACTOME_RET_SIGNALING,SET,40,0.058022,0.0027053,0.13475,0.33338,REACTOME_RET_SIGNALING,0.950502206726825
GOBP_DENSE_CORE_GRANULE_TRAN...,SET,10,0.1161,0.0027088,0.26986,0.33352,GOBP_DENSE_CORE_GRANULE_TRANSPORT,0.950823361496186
HP_CHOROID_PLEXUS_CARCINOMA,SET,5,0.18935,0.0031243,0.44027,0.33357,HP_CHOROID_PLEXUS_CARCINOMA,0.950861007707445
GOMF_DEMETHYLASE_ACTIVITY,SET,33,0.055834,0.002365,0.12986,0.33362,GOMF_DEMETHYLASE_ACTIVITY,0.950861007707445
GOMF_PHOSPHATIDYLCHOLINE_STE...,SET,4,0.21348,0.0031506,0.49658,0.33364,GOMF_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY,0.950861007707445
GAZIN_EPIGENETIC_SILENCING_B...,SET,24,0.077031,0.0027832,0.17923,0.33367,GAZIN_EPIGENETIC_SILENCING_BY_KRAS,0.950861007707445
HP_LATE_FIRST_TRIMESTER_ONSET,SET,7,0.13413,0.0026185,0.31208,0.33367,HP_LATE_FIRST_TRIMESTER_ONSET,0.950861007707445
GOBP_REGULATION_OF_EPIDERMIS...,SET,58,0.052688,0.0029567,0.1227,0.33382,GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.95099159154237
HP_SMALL_PITUITARY_GLAND,SET,12,0.11136,0.0028461,0.25934,0.33382,HP_SMALL_PITUITARY_GLAND,0.95099159154237
GSE16266_CTRL_VS_LPS_STIM_ME...2,SET,182,0.028404,0.0028139,0.066155,0.33384,GSE16266_CTRL_VS_LPS_STIM_MEF_UP,0.95099159154237
MORF_DAP,SET,69,0.040306,0.0024663,0.093886,0.33385,MORF_DAP,0.95099159154237
LINDSTEDT_DENDRITIC_CELL_MAT...1,SET,61,0.051383,0.0029568,0.11969,0.33386,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,0.95099159154237
GSE13484_UNSTIM_VS_12H_YF17D...2,SET,185,0.026543,0.0026509,0.061839,0.33388,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP,0.95099159154237
REACTOME_NONSENSE_MEDIATED_D...,SET,103,0.034794,0.0025988,0.081113,0.33398,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,0.951156501433839
GOBP_REGULATION_OF_HOMOTYPIC...,SET,36,0.067666,0.0029934,0.15778,0.33401,GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.951156501433839
E2F4DP1_01,SET,209,0.025242,0.0026778,0.058863,0.33402,E2F4DP1_01,0.951156501433839
GOBP_HINDBRAIN_DEVELOPMENT,SET,142,0.032119,0.0028138,0.074935,0.3341,GOBP_HINDBRAIN_DEVELOPMENT,0.951246369812556
GOBP_SYNAPSE_ASSEMBLY,SET,190,0.029282,0.0029634,0.068324,0.33412,GOBP_SYNAPSE_ASSEMBLY,0.951246369812556
HP_FOOT_OLIGODACTYLY,SET,10,0.11033,0.0025742,0.25749,0.33415,HP_FOOT_OLIGODACTYLY,0.951246369812556
GOBP_PHOSPHATIDYLGLYCEROL_AC...,SET,9,0.13819,0.0030588,0.32255,0.33417,GOBP_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING,0.951246369812556
WP_IL18_SIGNALING,SET,259,0.023663,0.0027906,0.055245,0.33421,WP_IL18_SIGNALING,0.951246369812556
GOBP_PROTON_TRANSPORTING_TWO...,SET,11,0.11238,0.00275,0.26242,0.33424,GOBP_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY,0.951246369812556
LEE_BMP2_TARGETS_UP,SET,698,0.014664,0.0028044,0.034246,0.33425,LEE_BMP2_TARGETS_UP,0.951246369812556
WP_IMMUNE_INFILTRATION_IN_PA...,SET,38,0.062445,0.0028379,0.14591,0.33434,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.951246369812556
GSE21927_SPLEEN_MONOCYTE_VS_...1,SET,166,0.027841,0.0026353,0.06506,0.33436,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN,0.951246369812556
DESCARTES_FETAL_HEART_ENDOCA...,SET,29,0.075628,0.0030033,0.17674,0.33436,DESCARTES_FETAL_HEART_ENDOCARDIAL_CELLS,0.951246369812556
BIOCARTA_MALATEX_PATHWAY,SET,7,0.1519,0.0029654,0.355,0.33437,BIOCARTA_MALATEX_PATHWAY,0.951246369812556
REACTOME_PI_METABOLISM,SET,77,0.039103,0.002527,0.091394,0.33438,REACTOME_PI_METABOLISM,0.951246369812556
HP_ABNORMAL_SACROILIAC_JOINT...,SET,6,0.17942,0.003243,0.41947,0.33443,HP_ABNORMAL_SACROILIAC_JOINT_MORPHOLOGY,0.951310742347356
GSE9006_HEALTHY_VS_TYPE_1_DI...3,SET,176,0.025414,0.0024763,0.059428,0.33446,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN,0.951318217530076
GOBP_POSITIVE_REGULATION_OF_...690,SET,9,0.12862,0.0028471,0.30085,0.3345,GOBP_POSITIVE_REGULATION_OF_RRNA_PROCESSING,0.951354132569558
GOBP_REGULATION_OF_ODONTOGEN...2,SET,12,0.12241,0.0031285,0.28637,0.33453,GOBP_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.95136160297848
GROSS_HYPOXIA_VIA_HIF1A_DN,SET,98,0.037861,0.0027587,0.088642,0.33465,GROSS_HYPOXIA_VIA_HIF1A_DN,0.95160401292645
MIR5088_3P,SET,121,0.032862,0.002659,0.076947,0.33467,MIR5088_3P,0.95160401292645
GOBP_AUTOPHAGY_OF_MITOCHONDR...,SET,91,0.037814,0.0026556,0.088607,0.33478,GOBP_AUTOPHAGY_OF_MITOCHONDRION,0.951838915248691
HP_GENERALIZED_MYOCLONIC_SEI...,SET,114,0.034476,0.0027082,0.080804,0.33481,HP_GENERALIZED_MYOCLONIC_SEIZURE,0.951846343558282
GSE13522_CTRL_VS_T_CRUZI_G_S...1,SET,121,0.032992,0.0026695,0.077369,0.3349,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN,0.951974895722581
GOBP_POSITIVE_REGULATION_OF_...288,SET,26,0.070652,0.0026568,0.16569,0.33491,GOBP_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY,0.951974895722581
YAGUE_PRETUMOR_DRUG_RESISTAN...2,SET,7,0.15566,0.0030389,0.36522,0.33498,YAGUE_PRETUMOR_DRUG_RESISTANCE_UP,0.952046565540927
MIR548J_3P,SET,717,0.01391,0.0026946,0.032638,0.33499,MIR548J_3P,0.952046565540927
GOCC_PIP_BODY,SET,5,0.13223,0.0021818,0.31053,0.33513,GOCC_PIP_BODY,0.95231086316822
GOBP_LEUKOCYTE_APOPTOTIC_PRO...,SET,111,0.035229,0.0027309,0.082744,0.33514,GOBP_LEUKOCYTE_APOPTOTIC_PROCESS,0.95231086316822
KEGG_MEDICUS_ENV_FACTOR_PHIP...,SET,3,0.23872,0.0030512,0.56086,0.33519,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS,0.95231086316822
MIR506_5P,SET,118,0.033078,0.0026433,0.077724,0.33521,MIR506_5P,0.95231086316822
HP_ABNORMAL_EKG,SET,120,0.034582,0.0027866,0.081262,0.33522,HP_ABNORMAL_EKG,0.95231086316822
GOBP_RANDOM_INACTIVATION_OF_...,SET,6,0.14437,0.0026095,0.33954,0.33535,GOBP_RANDOM_INACTIVATION_OF_X_CHROMOSOME,0.952419308063067
HP_ABNORMAL_T_CELL_MORPHOLOGY,SET,105,0.03586,0.0027041,0.084353,0.33538,HP_ABNORMAL_T_CELL_MORPHOLOGY,0.952419308063067
ERWIN_COHEN_BLOOD_VACCINE_TC...3,SET,5,0.15887,0.0026214,0.37373,0.33539,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_DN,0.952419308063067
GOMF_ISOCITRATE_DEHYDROGENAS...,SET,4,0.18531,0.0027349,0.43596,0.3354,GOMF_ISOCITRATE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.952419308063067
MIR4695_3P,SET,70,0.045322,0.0027932,0.10664,0.33542,MIR4695_3P,0.952419308063067
REACTOME_TP53_REGULATES_TRAN...1,SET,20,0.081644,0.0026932,0.19214,0.33545,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN,0.952419308063067
HP_LABIAL_HYPERTROPHY,SET,7,0.15206,0.0029685,0.35784,0.33545,HP_LABIAL_HYPERTROPHY,0.952419308063067
GOBP_LYMPH_VESSEL_DEVELOPMENT,SET,29,0.07183,0.0028525,0.1691,0.33551,GOBP_LYMPH_VESSEL_DEVELOPMENT,0.952449865295126
GOBP_DETECTION_OF_CHEMICAL_S...,SET,45,0.062236,0.0030774,0.14654,0.33553,GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE,0.952449865295126
GSE17974_0H_VS_48H_IN_VITRO_...2,SET,164,0.029699,0.0027943,0.069937,0.33555,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP,0.952449865295126
GSE26343_UNSTIM_VS_LPS_STIM_...1,SET,182,0.025961,0.0025719,0.061146,0.33558,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.952449865295126
GAVISH_3CA_MALIGNANT_METAPRO...6,SET,43,0.060657,0.002932,0.14292,0.33563,GAVISH_3CA_MALIGNANT_METAPROGRAM_15_EMT_4,0.952449865295126
MODULE_106,SET,14,0.10664,0.0029436,0.25126,0.33564,MODULE_106,0.952449865295126
GOBP_NEGATIVE_REGULATION_OF_...619,SET,136,0.030293,0.0025975,0.07139,0.33567,GOBP_NEGATIVE_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.952449865295126
HP_MYOCARDIAL_FIBROSIS,SET,17,0.09237,0.0028094,0.2177,0.33568,HP_MYOCARDIAL_FIBROSIS,0.952449865295126
WP_GLYCOSPHINGOLIPID_METABOL...,SET,19,0.087059,0.0027992,0.20524,0.33572,WP_GLYCOSPHINGOLIPID_METABOLISM,0.9524856
HP_DERMOID_CYST,SET,6,0.16045,0.0029001,0.37834,0.33575,HP_DERMOID_CYST,0.952492959758387
KORKOLA_YOLK_SAC_TUMOR,SET,53,0.053666,0.0028792,0.12661,0.33583,KORKOLA_YOLK_SAC_TUMOR,0.952642152301665
GSE25677_MPL_VS_MPL_AND_R848...2,SET,141,0.030181,0.0026347,0.071241,0.33591,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP,0.952785929853181
GOBP_NEGATIVE_REGULATION_OF_...376,SET,9,0.13366,0.0029586,0.31569,0.336,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION,0.952785929853181
GSE37605_TREG_VS_TCONV_C57BL...3,SET,136,0.030024,0.0025744,0.070908,0.336,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN,0.952785929853181
GSE3982_MAC_VS_NEUTROPHIL_UP,SET,181,0.026269,0.0025954,0.06205,0.33602,GSE3982_MAC_VS_NEUTROPHIL_UP,0.952785929853181
YAGI_AML_RELAPSE_PROGNOSIS,SET,33,0.065133,0.0027589,0.15388,0.33605,YAGI_AML_RELAPSE_PROGNOSIS,0.952785929853181
ZNF454_TARGET_GENES,SET,11,0.11112,0.0027192,0.26258,0.33608,ZNF454_TARGET_GENES,0.952785929853181
GSE7831_CPG_VS_INFLUENZA_STI...3,SET,177,0.026154,0.0025556,0.061808,0.33609,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN,0.952785929853181
REACTOME_REGULATION_OF_GLYCO...,SET,11,0.10344,0.0025311,0.24446,0.3361,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,0.952785929853181
MODULE_408,SET,18,0.089896,0.0028134,0.21254,0.33616,MODULE_408,0.952857274506606
GSE16451_CTRL_VS_WEST_EQUINE...4,SET,181,0.025977,0.0025665,0.061421,0.33618,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.952857274506606
WP_HEPATITIS_C_AND_HEPATOCEL...,SET,49,0.053966,0.0027842,0.12763,0.33621,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,0.952864596754465
CTTGTAT_MIR381,SET,185,0.026801,0.0026767,0.06341,0.33627,CTTGTAT_MIR381,0.952879237668162
GOMF_PROTEIN_SERINE_THREONIN...2,SET,392,0.018095,0.0026156,0.042809,0.33627,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.952879237668162
HP_MECHANICAL_ILEUS,SET,21,0.086254,0.0029154,0.20426,0.33641,HP_MECHANICAL_ILEUS,0.953198234958422
RUIZ_TNC_TARGETS_UP,SET,137,0.033712,0.0029012,0.079887,0.33652,RUIZ_TNC_TARGETS_UP,0.953236330320059
SALVADOR_MARTIN_PEDIATRIC_TB...1,SET,21,0.075795,0.0025619,0.17962,0.33652,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,0.953236330320059
HP_PROXIMAL_AMYOTROPHY,SET,48,0.052543,0.002683,0.12452,0.33653,HP_PROXIMAL_AMYOTROPHY,0.953236330320059
GSE35435_RESTING_VS_IL4_TREA...1,SET,170,0.027866,0.002669,0.066061,0.33658,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN,0.953236330320059
GOBP_POSITIVE_REGULATION_OF_...372,SET,33,0.069939,0.0029624,0.16584,0.33662,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.953236330320059
HP_HYPOPLASTIC_VERTEBRAL_BOD...,SET,17,0.085821,0.0026102,0.20353,0.33664,HP_HYPOPLASTIC_VERTEBRAL_BODIES,0.953236330320059
GOBP_RENAL_TUBULE_DEVELOPMENT,SET,96,0.040365,0.0029111,0.09575,0.33667,GOBP_RENAL_TUBULE_DEVELOPMENT,0.953236330320059
GOBP_PROTEIN_LOCALIZATION_TO...8,SET,4,0.17323,0.0025566,0.41102,0.33671,GOBP_PROTEIN_LOCALIZATION_TO_CELL_LEADING_EDGE,0.953236330320059
GOBP_REGULATION_OF_CELL_CELL...2,SET,19,0.077686,0.0024978,0.18432,0.33671,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.953236330320059
chr13q31,SET,9,0.16786,0.0037155,0.39829,0.33672,chr13q31,0.953236330320059
WP_BURN_WOUND_HEALING,SET,95,0.041172,0.002954,0.09772,0.33676,WP_BURN_WOUND_HEALING,0.953236330320059
GOMF_ATPASE_COUPLED_LIPID_TR...,SET,8,0.13616,0.0028416,0.32316,0.33676,GOMF_ATPASE_COUPLED_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.953236330320059
GOBP_REGULATION_OF_OPSIN_MED...,SET,8,0.11914,0.0024863,0.28279,0.33678,GOBP_REGULATION_OF_OPSIN_MEDIATED_SIGNALING_PATHWAY,0.953236330320059
BOYAULT_LIVER_CANCER_SUBCLAS...14,SET,26,0.082856,0.0031158,0.19673,0.33682,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,0.953271913680782
REACTOME_INTERFERON_ALPHA_BE...,SET,72,0.045999,0.0028749,0.10926,0.33688,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.953329310485184
AGUIRRE_PANCREATIC_CANCER_CO...1,SET,221,0.025971,0.0028322,0.0617,0.33691,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,0.953329310485184
HOEK_NEUTROPHIL_2011_2012_TI...5,SET,37,0.064758,0.0029042,0.15387,0.33693,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_DN,0.953329310485184
REACTOME_CELL_CELL_COMMUNICA...,SET,139,0.032847,0.0028472,0.07806,0.33695,REACTOME_CELL_CELL_COMMUNICATION,0.953329310485184
KINSEY_TARGETS_OF_EWSR1_FLII...1,SET,299,0.021566,0.0027296,0.051278,0.33704,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,0.95333973660678
GSE17721_LPS_VS_GARDIQUIMOD_...16,SET,187,0.026233,0.002634,0.062389,0.33707,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP,0.95333973660678
GOBP_ISOLEUCINE_TRANSPORT,SET,5,0.16234,0.0026787,0.38613,0.33708,GOBP_ISOLEUCINE_TRANSPORT,0.95333973660678
GOMF_L_ALANINE_TRANSMEMBRANE...,SET,9,0.12574,0.0027833,0.29911,0.3371,GOMF_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.95333973660678
HP_CONJUNCTIVAL_HYPEREMIA,SET,5,0.17234,0.0028437,0.41001,0.33712,HP_CONJUNCTIVAL_HYPEREMIA,0.95333973660678
GOMF_TRANSFERASE_ACTIVITY_TR...4,SET,822,0.012562,0.0025978,0.029896,0.33718,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,0.95333973660678
WP_RALA_DOWNSTREAM_REGULATED...,SET,12,0.097595,0.0024942,0.23228,0.33719,WP_RALA_DOWNSTREAM_REGULATED_GENES,0.95333973660678
GOBP_APOPTOTIC_SIGNALING_PAT...,SET,557,0.01539,0.0026396,0.036636,0.33721,GOBP_APOPTOTIC_SIGNALING_PATHWAY,0.95333973660678
GOBP_REGULATION_OF_GLUTAMATE...4,SET,5,0.17006,0.002806,0.40486,0.33723,GOBP_REGULATION_OF_GLUTAMATE_SECRETION_NEUROTRANSMISSION,0.95333973660678
DESCARTES_MAIN_FETAL_ENDOCAR...,SET,66,0.044666,0.0026732,0.10636,0.33727,DESCARTES_MAIN_FETAL_ENDOCARDIAL_CELLS,0.95333973660678
GOCC_NEURONAL_DENSE_CORE_VES...1,SET,25,0.08124,0.0029958,0.19353,0.33733,GOCC_NEURONAL_DENSE_CORE_VESICLE,0.95333973660678
DING_LUNG_CANCER_BY_MUTATION...,SET,20,0.084849,0.0027989,0.20216,0.33735,DING_LUNG_CANCER_BY_MUTATION_RATE,0.95333973660678
GOBP_PEPTIDYL_ARGININE_METHY...2,SET,8,0.11626,0.0024264,0.27702,0.33735,GOBP_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE,0.95333973660678
GOCC_NURD_COMPLEX,SET,14,0.088369,0.0024393,0.21059,0.33738,GOCC_NURD_COMPLEX,0.95333973660678
GOBP_POSITIVE_REGULATION_OF_...740,SET,10,0.1086,0.0025339,0.25881,0.33739,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY,0.95333973660678
MIR561_3P,SET,437,0.017989,0.0027421,0.042876,0.33741,MIR561_3P,0.95333973660678
chr16q24,SET,72,0.085388,0.0053367,0.20353,0.33742,chr16q24,0.95333973660678
chr20q13,SET,207,0.056444,0.0059594,0.13458,0.33746,chr20q13,0.953355037783375
WP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,6,0.15863,0.0028673,0.37833,0.3375,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,0.953355037783375
GOBP_NEURAL_TUBE_DEVELOPMENT,SET,150,0.029978,0.0026985,0.071499,0.33751,GOBP_NEURAL_TUBE_DEVELOPMENT,0.953355037783375
GOBP_POSITIVE_REGULATION_OF_...293,SET,6,0.17217,0.0031119,0.41077,0.33756,GOBP_POSITIVE_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.953355037783375
CHEN_ETV5_TARGETS_TESTIS,SET,21,0.075674,0.0025578,0.18055,0.33757,CHEN_ETV5_TARGETS_TESTIS,0.953355037783375
GOBP_CHROMOSOME_ATTACHMENT_T...,SET,4,0.15025,0.0022175,0.35855,0.33759,GOBP_CHROMOSOME_ATTACHMENT_TO_THE_NUCLEAR_ENVELOPE,0.953355037783375
GSE16385_UNTREATED_VS_12H_RO...4,SET,186,0.025056,0.0025091,0.059824,0.33767,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.953476729457616
GOBP_POSITIVE_REGULATION_OF_...104,SET,205,0.025457,0.0026749,0.060818,0.33776,GOBP_POSITIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.953476729457616
VANTVEER_BREAST_CANCER_BRCA1...2,SET,31,0.0614,0.0025208,0.14669,0.33777,VANTVEER_BREAST_CANCER_BRCA1_UP,0.953476729457616
GOBP_INTERLEUKIN_17_MEDIATED...,SET,11,0.1176,0.0028776,0.28096,0.33777,GOBP_INTERLEUKIN_17_MEDIATED_SIGNALING_PATHWAY,0.953476729457616
HP_EEG_WITH_FOCAL_EPILEPTIFO...,SET,108,0.035333,0.0027019,0.084455,0.33785,HP_EEG_WITH_FOCAL_EPILEPTIFORM_DISCHARGES,0.953476729457616
GRAESSMANN_RESPONSE_TO_MC_AN...1,SET,696,0.013216,0.0025239,0.031594,0.33786,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,0.953476729457616
GOBP_POSITIVE_REGULATION_OF_...402,SET,89,0.040285,0.002798,0.096312,0.33787,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.953476729457616
GSE22282_HYPOXIA_VS_NORMOXIA...2,SET,174,0.026888,0.0026051,0.06428,0.33787,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP,0.953476729457616
GOCC_FAR_SIN_STRIPAK_COMPLEX,SET,16,0.091255,0.0026927,0.21818,0.33788,GOCC_FAR_SIN_STRIPAK_COMPLEX,0.953476729457616
GOBP_HINDBRAIN_TANGENTIAL_CE...,SET,5,0.15475,0.0025535,0.37018,0.33796,GOBP_HINDBRAIN_TANGENTIAL_CELL_MIGRATION,0.953526658007955
MIR610,SET,77,0.043114,0.0027862,0.10315,0.33798,MIR610,0.953526658007955
GOBP_BRADYKININ_CATABOLIC_PR...,SET,7,0.15104,0.0029487,0.36135,0.33798,GOBP_BRADYKININ_CATABOLIC_PROCESS,0.953526658007955
REACTOME_SYNDECAN_INTERACTIO...,SET,26,0.073242,0.0027542,0.17535,0.33808,REACTOME_SYNDECAN_INTERACTIONS,0.953731363636364
GSE8621_UNSTIM_VS_LPS_PRIMED...1,SET,188,0.025835,0.0026008,0.06188,0.33816,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.953826347135564
GOMF_CCR5_CHEMOKINE_RECEPTOR...,SET,7,0.15028,0.0029339,0.36003,0.33819,GOMF_CCR5_CHEMOKINE_RECEPTOR_BINDING,0.953826347135564
VALK_AML_WITH_11Q23_REARRANG...,SET,16,0.092319,0.0027241,0.2212,0.33821,VALK_AML_WITH_11Q23_REARRANGED,0.953826347135564
GOBP_FORMATION_OF_PRIMARY_GE...,SET,118,0.035133,0.0028075,0.084246,0.33833,GOBP_FORMATION_OF_PRIMARY_GERM_LAYER,0.953826347135564
GOBP_MALE_MEIOSIS_I,SET,25,0.066563,0.0024545,0.15961,0.33833,GOBP_MALE_MEIOSIS_I,0.953826347135564
MIR6507_5P,SET,306,0.021314,0.0027286,0.051114,0.33835,MIR6507_5P,0.953826347135564
GOBP_NEGATIVE_REGULATION_OF_...545,SET,4,0.19022,0.0028074,0.45621,0.33836,GOBP_NEGATIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.953826347135564
GOMF_METHYL_CPG_BINDING,SET,25,0.069087,0.0025476,0.16576,0.33842,GOMF_METHYL_CPG_BINDING,0.953826347135564
HP_T_CELL_LYMPHOMA,SET,14,0.095067,0.0026242,0.22811,0.33843,HP_T_CELL_LYMPHOMA,0.953826347135564
GOBP_NEGATIVE_REGULATION_OF_...681,SET,8,0.14648,0.003057,0.35158,0.33847,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.953826347135564
REACTOME_POST_TRANSLATIONAL_...2,SET,1288,0.010151,0.0025926,0.024368,0.3385,REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.953826347135564
HP_CEREBRAL_HYPOMYELINATION,SET,25,0.062826,0.0023168,0.15082,0.3385,HP_CEREBRAL_HYPOMYELINATION,0.953826347135564
GSE23984_CTRL_VS_HYPOCALEMIC...1,SET,168,0.027637,0.0026316,0.066361,0.33853,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN,0.953826347135564
LEE_LIVER_CANCER_CIPROFIBRAT...2,SET,57,0.049367,0.0027464,0.11855,0.33855,LEE_LIVER_CANCER_CIPROFIBRATE_UP,0.953826347135564
GOCC_DYSTROGLYCAN_COMPLEX,SET,7,0.14811,0.0028915,0.35571,0.33857,GOCC_DYSTROGLYCAN_COMPLEX,0.953826347135564
GSE5542_UNTREATED_VS_IFNA_AN...2,SET,180,0.025334,0.0024961,0.060844,0.33857,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.953826347135564
GOBP_ESTABLISHMENT_OF_PROTEI...2,SET,5,0.14485,0.0023901,0.34806,0.33864,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.953826347135564
GOBP_VITAMIN_K_METABOLIC_PRO...,SET,11,0.10417,0.002549,0.25033,0.33866,GOBP_VITAMIN_K_METABOLIC_PROCESS,0.953826347135564
GOBP_SINGLE_STRANDED_VIRAL_R...,SET,17,0.096636,0.0029392,0.23225,0.33868,GOBP_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.953826347135564
GOBP_POSITIVE_REGULATION_OF_...448,SET,10,0.12438,0.002902,0.29895,0.33869,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.953826347135564
HP_INTRAVENTRICULAR_HEMORRHA...,SET,7,0.14871,0.0029031,0.35742,0.33869,HP_INTRAVENTRICULAR_HEMORRHAGE,0.953826347135564
HP_OXYCEPHALY,SET,7,0.12602,0.0024602,0.30304,0.33876,HP_OXYCEPHALY,0.953897181796253
KEGG_CARDIAC_MUSCLE_CONTRACT...,SET,68,0.043859,0.0026643,0.1055,0.33881,KEGG_CARDIAC_MUSCLE_CONTRACTION,0.953897181796253
YWATTWNNRGCT_UNKNOWN,SET,63,0.046546,0.0027219,0.11196,0.33881,YWATTWNNRGCT_UNKNOWN,0.953897181796253
HP_NEVUS_SEBACEOUS,SET,5,0.13713,0.0022627,0.32995,0.33885,HP_NEVUS_SEBACEOUS,0.953897181796253
REACTOME_ZINC_TRANSPORTERS,SET,15,0.086406,0.0024687,0.20804,0.33895,REACTOME_ZINC_TRANSPORTERS,0.953897181796253
GSE3982_DC_VS_CENT_MEMORY_CD...1,SET,165,0.027874,0.0026306,0.067121,0.33897,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN,0.953897181796253
ACTGAAA_MIR30A3P_MIR30E3P,SET,180,0.025709,0.002533,0.06191,0.33898,ACTGAAA_MIR30A3P_MIR30E3P,0.953897181796253
FULCHER_INFLAMMATORY_RESPONS...1,SET,404,0.018317,0.002687,0.044129,0.33905,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,0.953897181796253
MIR548S,SET,119,0.031498,0.0025276,0.075888,0.33905,MIR548S,0.953897181796253
GOBP_MITOTIC_G2_DNA_DAMAGE_C...,SET,29,0.057538,0.0022849,0.13869,0.33912,GOBP_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.953897181796253
MIR6132,SET,119,0.032327,0.0025941,0.077947,0.33917,MIR6132,0.953897181796253
KANG_CISPLATIN_RESISTANCE_DN,SET,8,0.1176,0.0024543,0.2836,0.33919,KANG_CISPLATIN_RESISTANCE_DN,0.953897181796253
GSE29618_PRE_VS_DAY7_FLU_VAC...8,SET,175,0.026308,0.0025562,0.063442,0.33919,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP,0.953897181796253
GGCNKCCATNK_UNKNOWN,SET,111,0.032325,0.0025058,0.078,0.33928,GGCNKCCATNK_UNKNOWN,0.953897181796253
GSE18804_SPLEEN_MACROPHAGE_V...5,SET,173,0.027434,0.0026504,0.066248,0.3394,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN,0.953897181796253
MIR6752_3P,SET,131,0.030471,0.0025647,0.073611,0.33946,MIR6752_3P,0.953897181796253
REACTOME_SIGNALING_BY_HEDGEH...,SET,144,0.027788,0.0024513,0.067176,0.33956,REACTOME_SIGNALING_BY_HEDGEHOG,0.953897181796253
HP_NONTUBERCULOUS_MYCOBACTER...,SET,19,0.084093,0.0027038,0.20328,0.33956,HP_NONTUBERCULOUS_MYCOBACTERIAL_PULMONARY_INFECTION,0.953897181796253
ZHENG_FOXP3_TARGETS_IN_T_LYM...2,SET,12,0.098427,0.0025155,0.23818,0.33972,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP,0.953897181796253
GSE24292_WT_VS_PPARG_KO_MACR...1,SET,178,0.025689,0.0025171,0.062188,0.33977,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN,0.953897181796253
GATA1_03,SET,218,0.024577,0.0026621,0.059506,0.3398,GATA1_03,0.953897181796253
ESC_J1_UP_EARLY.V1_DN,SET,153,0.029013,0.0026375,0.070259,0.33983,ESC_J1_UP_EARLY.V1_DN,0.953897181796253
VANGURP_PANCREATIC_GAMMA_CELL,SET,41,0.06256,0.002953,0.15151,0.33984,VANGURP_PANCREATIC_GAMMA_CELL,0.953897181796253
GOBP_ADP_TRANSPORT,SET,10,0.11663,0.0027211,0.28249,0.33986,GOBP_ADP_TRANSPORT,0.953897181796253
GSE20500_CTRL_VS_RETINOIC_AC...1,SET,174,0.027402,0.0026549,0.066372,0.33986,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN,0.953897181796253
HP_MENTAL_DETERIORATION,SET,333,0.01933,0.0025796,0.046829,0.33989,HP_MENTAL_DETERIORATION,0.953897181796253
ONDER_CDH1_TARGETS_1_UP,SET,122,0.032487,0.0026394,0.078712,0.3399,ONDER_CDH1_TARGETS_1_UP,0.953897181796253
HP_CARDIORESPIRATORY_ARREST,SET,10,0.11933,0.0027841,0.28916,0.33992,HP_CARDIORESPIRATORY_ARREST,0.953897181796253
HP_MOON_FACIES,SET,12,0.10233,0.0026153,0.24802,0.33995,HP_MOON_FACIES,0.953897181796253
GOBP_NEGATIVE_REGULATION_OF_...647,SET,9,0.13133,0.002907,0.31839,0.34,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.953897181796253
GSE26912_TUMORICIDAL_VS_CTRL...2,SET,187,0.026307,0.0026414,0.063801,0.34005,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP,0.953897181796253
REACTOME_M_DECAY_DEGRADATION...,SET,31,0.06287,0.0025812,0.15248,0.34006,REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS,0.953897181796253
HP_DECREASED_CIRCULATING_COM...4,SET,3,0.23875,0.0030516,0.5791,0.34007,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_I_CONCENTRATION,0.953897181796253
GOBP_REGULATION_OF_STORE_OPE...1,SET,5,0.14703,0.002426,0.35664,0.34008,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.953897181796253
REACTOME_FORMATION_OF_THE_PO...,SET,9,0.12872,0.0028492,0.31229,0.3401,REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE,0.953897181796253
WP_REGULATION_OF_ACTIN_CYTOS...,SET,140,0.031269,0.0027201,0.075871,0.34012,WP_REGULATION_OF_ACTIN_CYTOSKELETON,0.953897181796253
MIR3145_5P,SET,93,0.035157,0.0024958,0.085322,0.34015,MIR3145_5P,0.953897181796253
HP_BROAD_HALLUX_PHALANX,SET,19,0.085323,0.0027433,0.20707,0.34015,HP_BROAD_HALLUX_PHALANX,0.953897181796253
NAGY_TFTC_COMPONENTS_HUMAN,SET,17,0.072879,0.0022166,0.17689,0.34017,NAGY_TFTC_COMPONENTS_HUMAN,0.953897181796253
GOMF_MONOATOMIC_CATION_CHANN...,SET,302,0.02177,0.002769,0.052844,0.34018,GOMF_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.953897181796253
GOBP_RIBOSOMAL_SUBUNIT_EXPOR...,SET,15,0.091383,0.0026109,0.22191,0.34025,GOBP_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.953897181796253
GOBP_MIDGUT_DEVELOPMENT,SET,11,0.12777,0.0031266,0.31031,0.34026,GOBP_MIDGUT_DEVELOPMENT,0.953897181796253
GSE18148_CBFB_KO_VS_WT_TREG_...1,SET,174,0.027955,0.0027085,0.067922,0.34033,GSE18148_CBFB_KO_VS_WT_TREG_DN,0.953897181796253
GOBP_NEGATIVE_REGULATION_OF_...7,SET,16,0.10019,0.0029563,0.24346,0.34035,GOBP_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.953897181796253
HAY_BONE_MARROW_CD34_POS_PRE...1,SET,80,0.041839,0.0027558,0.10168,0.34036,HAY_BONE_MARROW_CD34_POS_PRE_B,0.953897181796253
HP_EBSTEIN_ANOMALY_OF_THE_TR...,SET,5,0.1848,0.0030492,0.44915,0.34038,HP_EBSTEIN_ANOMALY_OF_THE_TRICUSPID_VALVE,0.953897181796253
REACTOME_ACTIVATION_OF_AMPK_...,SET,26,0.071624,0.0026934,0.17413,0.34042,REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,0.953897181796253
GOBP_VENTRICULAR_CARDIAC_MUS...5,SET,60,0.05129,0.0029273,0.12469,0.34042,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.953897181796253
NRF2_Q4,SET,227,0.023463,0.0025927,0.057063,0.34048,NRF2_Q4,0.953897181796253
GOBP_NEGATIVE_REGULATION_OF_...327,SET,5,0.1637,0.0027011,0.39815,0.34049,GOBP_NEGATIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.953897181796253
HSF1_01,SET,246,0.022576,0.0025957,0.054919,0.34051,HSF1_01,0.953897181796253
HP_URETHROVESICAL_OCCLUSION,SET,10,0.10956,0.0025561,0.26653,0.34052,HP_URETHROVESICAL_OCCLUSION,0.953897181796253
WP_JOUBERT_SYNDROME,SET,69,0.03975,0.0024322,0.096736,0.34057,WP_JOUBERT_SYNDROME,0.953897181796253
GSE16385_IFNG_TNF_VS_ROSIGLI...2,SET,160,0.027275,0.002535,0.066375,0.34057,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.953897181796253
GOBP_CELLULAR_RESPONSE_TO_LA...,SET,7,0.13782,0.0026906,0.33546,0.34059,GOBP_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.953897181796253
HP_BELL_SHAPED_THORAX,SET,32,0.064904,0.0027072,0.15797,0.34059,HP_BELL_SHAPED_THORAX,0.953897181796253
WP_MALE_STEROID_HORMONES_IN_...,SET,13,0.099223,0.0026393,0.24152,0.3406,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.953897181796253
GOCC_FHF_COMPLEX,SET,4,0.14021,0.0020693,0.34128,0.3406,GOCC_FHF_COMPLEX,0.953897181796253
MIR1323,SET,285,0.021528,0.0026613,0.052404,0.34061,MIR1323,0.953897181796253
WP_B_CELL_RECEPTOR_SIGNALING,SET,93,0.036692,0.0026048,0.089344,0.34066,WP_B_CELL_RECEPTOR_SIGNALING,0.953897181796253
GOBP_LOCOMOTOR_RHYTHM,SET,16,0.09251,0.0027298,0.22548,0.3408,GOBP_LOCOMOTOR_RHYTHM,0.953897181796253
chr3p11,SET,7,0.19723,0.0038504,0.48073,0.34081,chr3p11,0.953897181796253
GSE33425_CD161_HIGH_VS_INT_C...1,SET,178,0.026405,0.0025873,0.064375,0.34084,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.953897181796253
GSE40274_CTRL_VS_FOXP3_AND_X...1,SET,133,0.031133,0.0026402,0.075906,0.34085,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.953897181796253
GSE7460_CTRL_VS_TGFB_TREATED...9,SET,185,0.02562,0.0025587,0.062464,0.34085,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN,0.953897181796253
GSE40274_GATA1_VS_FOXP3_AND_...1,SET,181,0.026554,0.0026235,0.064753,0.34088,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.953897181796253
GOBP_NEGATIVE_REGULATION_OF_...238,SET,7,0.12568,0.0024536,0.3065,0.34089,GOBP_NEGATIVE_REGULATION_OF_FERTILIZATION,0.953897181796253
GOBP_RESPONSE_TO_L_ASCORBIC_...,SET,5,0.17572,0.0028994,0.42855,0.34089,GOBP_RESPONSE_TO_L_ASCORBIC_ACID,0.953897181796253
HP_METAPHYSEAL_STRIATIONS,SET,11,0.10512,0.0025722,0.25636,0.34089,HP_METAPHYSEAL_STRIATIONS,0.953897181796253
HP_AIRWAY_HYPERRESPONSIVENESS,SET,8,0.13405,0.0027975,0.32695,0.34091,HP_AIRWAY_HYPERRESPONSIVENESS,0.953897181796253
KEGG_MEDICUS_REFERENCE_CD40_...,SET,6,0.14684,0.002654,0.35816,0.34092,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY,0.953897181796253
MIR4533,SET,303,0.019824,0.0025256,0.048357,0.34092,MIR4533,0.953897181796253
HP_ABNORMALITY_OF_THE_FOOT_M...,SET,11,0.10946,0.0026784,0.267,0.34092,HP_ABNORMALITY_OF_THE_FOOT_MUSCULATURE,0.953897181796253
CUI_DEVELOPING_HEART_TRABECU...1,SET,161,0.028108,0.0026206,0.068562,0.34092,CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE,0.953897181796253
KEGG_ALLOGRAFT_REJECTION,SET,32,0.069698,0.0029072,0.1701,0.341,KEGG_ALLOGRAFT_REJECTION,0.953897181796253
GOBP_TRANSCRIPTION_COUPLED_N...,SET,10,0.1048,0.0024453,0.25578,0.341,GOBP_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR,0.953897181796253
GOCC_IMMUNOLOGICAL_SYNAPSE,SET,43,0.054841,0.0026509,0.13384,0.341,GOCC_IMMUNOLOGICAL_SYNAPSE,0.953897181796253
GOBP_VITAMIN_METABOLIC_PROCE...,SET,109,0.033253,0.0025545,0.081163,0.34102,GOBP_VITAMIN_METABOLIC_PROCESS,0.953897181796253
HP_ACROMESOMELIA,SET,5,0.13983,0.0023072,0.34131,0.34102,HP_ACROMESOMELIA,0.953897181796253
ZNF136_TARGET_GENES,SET,5,0.15732,0.0025957,0.38409,0.34106,ZNF136_TARGET_GENES,0.953897181796253
MIR1279,SET,167,0.028267,0.0026836,0.069027,0.34109,MIR1279,0.953897181796253
WP_LEPTIN_AND_ADIPONECTIN,SET,10,0.10774,0.0025138,0.26316,0.34112,WP_LEPTIN_AND_ADIPONECTIN,0.953897181796253
GSE17721_CTRL_VS_POLYIC_2H_B...1,SET,188,0.025473,0.0025645,0.06222,0.34112,GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN,0.953897181796253
GATA1_01,SET,216,0.024358,0.0026265,0.059506,0.34115,GATA1_01,0.953897181796253
GOBP_MYELOID_LEUKOCYTE_MIGRA...,SET,217,0.026189,0.0028302,0.063981,0.34116,GOBP_MYELOID_LEUKOCYTE_MIGRATION,0.953897181796253
GSE24634_TEFF_VS_TCONV_DAY5_...1,SET,174,0.026062,0.0025251,0.063672,0.34116,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN,0.953897181796253
GSE29615_CTRL_VS_DAY7_LAIV_F...2,SET,153,0.028559,0.0025962,0.069773,0.34116,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.953897181796253
REACTOME_REGULATION_OF_TLR_B...,SET,20,0.091201,0.0030084,0.22288,0.3412,REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND,0.953897181796253
GOBP_DETECTION_OF_STIMULUS_I...1,SET,418,0.02297,0.0034263,0.056173,0.3413,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.953897181796253
GOBP_HEMOGLOBIN_BIOSYNTHETIC...,SET,13,0.098704,0.0026255,0.24138,0.34131,GOBP_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.953897181796253
GSE24142_DN2_VS_DN3_THYMOCYT...2,SET,173,0.026603,0.0025702,0.06506,0.34131,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP,0.953897181796253
NIKOLSKY_BREAST_CANCER_7Q21_...,SET,72,0.075586,0.0047241,0.18486,0.34132,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,0.953897181796253
GOMF_STRUCTURAL_CONSTITUENT_...11,SET,23,0.075184,0.0026594,0.1839,0.34133,GOMF_STRUCTURAL_CONSTITUENT_OF_SYNAPSE,0.953897181796253
GOBP_NEGATIVE_REGULATION_OF_...408,SET,7,0.13849,0.0027037,0.33876,0.34134,GOBP_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.953897181796253
GSE8621_LPS_PRIMED_UNSTIM_VS...1,SET,177,0.024776,0.0024209,0.060605,0.34134,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.953897181796253
GOBP_ANAGEN,SET,5,0.17906,0.0029545,0.43803,0.34135,GOBP_ANAGEN,0.953897181796253
GOBP_DEADENYLATION_DEPENDENT...,SET,10,0.11555,0.0026959,0.28272,0.34138,GOBP_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA,0.953904317414375
GOBP_ALDITOL_CATABOLIC_PROCE...,SET,5,0.17642,0.0029109,0.432,0.3415,GOBP_ALDITOL_CATABOLIC_PROCESS,0.954162915025324
GOMF_HISTONE_H3K36_METHYLTRA...,SET,11,0.10646,0.002605,0.26079,0.34156,GOMF_HISTONE_H3K36_METHYLTRANSFERASE_ACTIVITY,0.95425384244373
GSE43955_1H_VS_10H_ACT_CD4_T...4,SET,173,0.027094,0.0026176,0.066429,0.34169,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.954451095857418
MODULE_181,SET,270,0.021641,0.002605,0.05307,0.34172,MODULE_181,0.954451095857418
GSE29949_MICROGLIA_VS_DC_BRA...2,SET,185,0.025717,0.0025685,0.063081,0.34176,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.954451095857418
GOBP_REGULATION_OF_PROTEIN_S...3,SET,285,0.020367,0.0025177,0.049966,0.34178,GOBP_REGULATION_OF_PROTEIN_STABILITY,0.954451095857418
MIR4763_3P,SET,228,0.023459,0.002598,0.057584,0.34186,MIR4763_3P,0.954451095857418
GOBP_NEGATIVE_REGULATION_OF_...177,SET,6,0.14473,0.0026159,0.35525,0.34186,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.954451095857418
HP_ANKLE_WEAKNESS,SET,17,0.076741,0.0023341,0.18839,0.34188,HP_ANKLE_WEAKNESS,0.954451095857418
GSE17721_LPS_VS_CPG_16H_BMDC...1,SET,183,0.023883,0.0023724,0.05863,0.34188,GSE17721_LPS_VS_CPG_16H_BMDC_DN,0.954451095857418
GOBP_CDP_DIACYLGLYCEROL_BIOS...,SET,11,0.11547,0.0028256,0.28357,0.34193,GOBP_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.954451095857418
CHIBA_RESPONSE_TO_TSA_UP,SET,48,0.054617,0.002789,0.13414,0.34194,CHIBA_RESPONSE_TO_TSA_UP,0.954451095857418
GSE20366_EX_VIVO_VS_HOMEOSTA...2,SET,180,0.02476,0.0024395,0.060815,0.34196,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP,0.954451095857418
GOCC_T_TUBULE,SET,52,0.050332,0.0026748,0.12365,0.34199,GOCC_T_TUBULE,0.954451095857418
HE_LIM_SUN_FETAL_LUNG_C4_TRE...,SET,36,0.066741,0.0029525,0.16401,0.34203,HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL,0.954451095857418
GSE14415_INDUCED_TREG_VS_FOX...3,SET,161,0.028712,0.0026768,0.070564,0.34205,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP,0.954451095857418
GSE18791_UNSTIM_VS_NEWCATSLE...6,SET,143,0.031142,0.0027376,0.076536,0.34205,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP,0.954451095857418
BOYLAN_MULTIPLE_MYELOMA_D_DN,SET,72,0.043772,0.0027357,0.1076,0.34207,BOYLAN_MULTIPLE_MYELOMA_D_DN,0.954451095857418
CHIARETTI_T_ALL_REFRACTORY_T...,SET,25,0.069645,0.0025682,0.17123,0.34211,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,0.954480233397498
KEGG_MEDICUS_VARIANT_ERBB2_O...1,SET,7,0.14502,0.0028312,0.35663,0.34214,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY,0.954480233397498
GSE10239_MEMORY_VS_KLRG1INT_...2,SET,179,0.02619,0.0025734,0.064419,0.34217,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.954480233397498
MIR4712_3P,SET,57,0.047458,0.0026402,0.11679,0.34224,MIR4712_3P,0.954480233397498
GAZDA_DIAMOND_BLACKFAN_ANEMI...4,SET,27,0.065038,0.0024922,0.16006,0.34225,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,0.954480233397498
GSE40274_FOXP3_VS_FOXP3_AND_...11,SET,182,0.025952,0.002571,0.063879,0.34227,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.954480233397498
GOBP_TETRAPYRROLE_METABOLIC_...,SET,57,0.044964,0.0025014,0.11072,0.34234,GOBP_TETRAPYRROLE_METABOLIC_PROCESS,0.954480233397498
BUCKANOVICH_T_LYMPHOCYTE_HOM...2,SET,18,0.084934,0.0026581,0.20918,0.34236,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,0.954480233397498
GSE2770_TGFB_AND_IL4_VS_IL12...1,SET,182,0.025835,0.0025594,0.063624,0.34236,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.954480233397498
SCHLOSSER_SERUM_RESPONSE_DN,SET,634,0.013755,0.0025115,0.033885,0.3424,SCHLOSSER_SERUM_RESPONSE_DN,0.954480233397498
GOBP_ESTABLISHMENT_OF_SKIN_B...,SET,33,0.065938,0.002793,0.16243,0.3424,GOBP_ESTABLISHMENT_OF_SKIN_BARRIER,0.954480233397498
SMID_BREAST_CANCER_ERBB2_DN,SET,5,0.16314,0.0026919,0.40193,0.34241,SMID_BREAST_CANCER_ERBB2_DN,0.954480233397498
WEBER_METHYLATED_HCP_IN_FIBR...2,SET,6,0.14501,0.002621,0.35749,0.34251,WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP,0.954561671961874
GOBP_NEGATIVE_REGULATION_OF_...146,SET,83,0.036984,0.002481,0.091219,0.34258,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.954561671961874
REACTOME_VIRAL_INFECTION_PAT...,SET,707,0.012587,0.0024219,0.031047,0.34259,REACTOME_VIRAL_INFECTION_PATHWAYS,0.954561671961874
IZADPANAH_STEM_CELL_ADIPOSE_...2,SET,117,0.033186,0.0026407,0.081932,0.34273,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,0.954561671961874
HP_ABNORMAL_NUMBER_OF_PERMAN...,SET,30,0.063176,0.0025516,0.15598,0.34273,HP_ABNORMAL_NUMBER_OF_PERMANENT_TEETH,0.954561671961874
HP_POLYSPLENIA,SET,49,0.046306,0.002389,0.11435,0.34275,HP_POLYSPLENIA,0.954561671961874
VECCHI_GASTRIC_CANCER_EARLY_...1,SET,306,0.021834,0.0027952,0.053923,0.34277,VECCHI_GASTRIC_CANCER_EARLY_DN,0.954561671961874
HP_DISCOID_LUPUS_RASH,SET,28,0.0719,0.0028057,0.17759,0.34279,HP_DISCOID_LUPUS_RASH,0.954561671961874
GSE1925_CTRL_VS_IFNG_PRIMED_...5,SET,184,0.024957,0.0024859,0.061654,0.34282,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN,0.954561671961874
MIR4692,SET,202,0.024442,0.0025496,0.060394,0.34285,MIR4692,0.954561671961874
HP_INCREASED_CIRCULATING_LAC...2,SET,73,0.041215,0.0025937,0.10186,0.34287,HP_INCREASED_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,0.954561671961874
GSE15659_CD45RA_NEG_CD4_TCEL...4,SET,154,0.02849,0.0025983,0.070413,0.34288,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,0.954561671961874
RUTELLA_RESPONSE_TO_HGF_UP,SET,377,0.018716,0.0026542,0.046273,0.34294,RUTELLA_RESPONSE_TO_HGF_UP,0.954561671961874
CCANNAGRKGGC_UNKNOWN,SET,106,0.033643,0.0025489,0.08318,0.34294,CCANNAGRKGGC_UNKNOWN,0.954561671961874
KEGG_MEDICUS_REFERENCE_AUTOP...4,SET,7,0.13596,0.0026543,0.33631,0.343,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN,0.954561671961874
MIR141_3P,SET,369,0.018731,0.0026286,0.046333,0.34301,MIR141_3P,0.954561671961874
GSE21678_WT_VS_FOXO1_FOXO3_K...1,SET,163,0.025711,0.0024118,0.063639,0.34311,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN,0.954561671961874
GSE13547_CTRL_VS_ANTI_IGM_ST...7,SET,149,0.027581,0.0024745,0.068284,0.34314,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN,0.954561671961874
REACTOME_INLA_MEDIATED_ENTRY...,SET,8,0.12422,0.0025925,0.30768,0.34321,REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS,0.954561671961874
HARALAMBIEVA_PBMC_M_M_R_II_A...6,SET,40,0.060336,0.0028132,0.14946,0.34322,HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP,0.954561671961874
KEGG_MEDICUS_REFERENCE_GH_JA...,SET,7,0.15176,0.0029626,0.37604,0.34327,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY,0.954561671961874
GCNP_SHH_UP_LATE.V1_UP,SET,163,0.026402,0.0024766,0.065459,0.34335,GCNP_SHH_UP_LATE.V1_UP,0.954561671961874
GOBP_ALANINE_TRANSPORT,SET,16,0.096793,0.0028561,0.24001,0.34337,GOBP_ALANINE_TRANSPORT,0.954561671961874
GNF2_CD48,SET,30,0.062234,0.0025136,0.15434,0.3434,GNF2_CD48,0.954561671961874
GOCC_TIGHT_JUNCTION,SET,116,0.033432,0.002649,0.082914,0.3434,GOCC_TIGHT_JUNCTION,0.954561671961874
GSE28737_WT_VS_BCL6_KO_FOLLI...2,SET,180,0.025803,0.0025423,0.063999,0.34341,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.954561671961874
GSE13411_IGM_VS_SWITCHED_MEM...1,SET,176,0.025366,0.0024716,0.062921,0.34342,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN,0.954561671961874
HP_CARDIOGENIC_SHOCK,SET,6,0.14026,0.0025352,0.34798,0.34345,HP_CARDIOGENIC_SHOCK,0.954561671961874
GOBP_REGULATION_OF_TRIGLYCER...3,SET,37,0.057803,0.0025922,0.14342,0.34346,GOBP_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.954561671961874
MIR9902,SET,259,0.021996,0.002594,0.054577,0.34347,MIR9902,0.954561671961874
GOBP_ORGANONITROGEN_COMPOUND...2,SET,1305,0.0097483,0.0025049,0.024195,0.34351,GOBP_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS,0.954561671961874
GSE19772_CTRL_VS_HCMV_INF_MO...4,SET,182,0.025635,0.0025396,0.063641,0.34355,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP,0.954561671961874
SIMBULAN_UV_RESPONSE_IMMORTA...,SET,31,0.063228,0.0025959,0.15699,0.34357,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,0.954561671961874
REACTOME_SMAC_XIAP_REGULATED...,SET,6,0.11973,0.0021641,0.29734,0.3436,REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE,0.954561671961874
HUANG_AML_LSC47,SET,41,0.060863,0.0028729,0.15116,0.34361,HUANG_AML_LSC47,0.954561671961874
MIR942_5P,SET,194,0.024716,0.0025272,0.061434,0.34373,MIR942_5P,0.954561671961874
HP_INCOORDINATION,SET,251,0.021552,0.0025027,0.053588,0.34378,HP_INCOORDINATION,0.954561671961874
GOMF_CYCLIN_BINDING,SET,33,0.056394,0.0023887,0.14031,0.34387,GOMF_CYCLIN_BINDING,0.954561671961874
GOBP_POSITIVE_REGULATION_OF_...811,SET,18,0.084399,0.0026413,0.21006,0.34392,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.954561671961874
MORI_EMU_MYC_LYMPHOMA_BY_ONS...1,SET,16,0.081808,0.002414,0.20361,0.34393,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,0.954561671961874
ZFP91_TARGET_GENES,SET,1121,0.010557,0.0025278,0.026299,0.34405,ZFP91_TARGET_GENES,0.954561671961874
GOMF_FMN_BINDING,SET,15,0.08829,0.0025226,0.22001,0.3441,GOMF_FMN_BINDING,0.954561671961874
GOMF_MONOATOMIC_ION_GATED_CH...,SET,30,0.067039,0.0027077,0.16707,0.34411,GOMF_MONOATOMIC_ION_GATED_CHANNEL_ACTIVITY,0.954561671961874
HP_STOMATITIS,SET,66,0.043778,0.00262,0.1091,0.34412,HP_STOMATITIS,0.954561671961874
SCHAEFFER_PROSTATE_DEVELOPME...4,SET,404,0.018197,0.0026695,0.045354,0.34413,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,0.954561671961874
HP_HYPERKERATOTIC_PAPULE,SET,12,0.089292,0.002282,0.22258,0.34415,HP_HYPERKERATOTIC_PAPULE,0.954561671961874
GOBP_REGULATION_OF_RETROGRAD...1,SET,12,0.084345,0.0021556,0.21028,0.34417,GOBP_REGULATION_OF_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL,0.954561671961874
HP_BONE_MARROW_FOAM_CELLS,SET,5,0.19701,0.0032507,0.49116,0.34417,HP_BONE_MARROW_FOAM_CELLS,0.954561671961874
HP_INCREASED_BODY_MASS_INDEX,SET,4,0.16908,0.0024954,0.42153,0.34417,HP_INCREASED_BODY_MASS_INDEX,0.954561671961874
ZHENG_CORD_BLOOD_C9_GRANULOC...,SET,90,0.035802,0.0025005,0.089269,0.34419,ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR,0.954561671961874
MIR8071,SET,31,0.056004,0.0022993,0.13965,0.3442,MIR8071,0.954561671961874
HP_HYPOPLASTIC_ILIAC_WING,SET,27,0.070358,0.0026961,0.17553,0.34427,HP_HYPOPLASTIC_ILIAC_WING,0.954561671961874
GSE25890_CTRL_VS_IL33_IL7_TR...1,SET,185,0.024862,0.0024831,0.062023,0.34427,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN,0.954561671961874
MIR15B_3P,SET,73,0.040817,0.0025686,0.10187,0.34433,MIR15B_3P,0.954561671961874
GOBP_DIAPHRAGM_DEVELOPMENT,SET,9,0.12639,0.0027976,0.31544,0.34433,GOBP_DIAPHRAGM_DEVELOPMENT,0.954561671961874
GOBP_REGULATION_OF_MACROPHAG...7,SET,42,0.05462,0.0026094,0.13636,0.34437,GOBP_REGULATION_OF_MACROPHAGE_MIGRATION,0.954561671961874
GOBP_CHONDROBLAST_DIFFERENTI...,SET,4,0.15828,0.002336,0.39516,0.34438,GOBP_CHONDROBLAST_DIFFERENTIATION,0.954561671961874
GOMF_NAADP_SENSITIVE_CALCIUM...,SET,5,0.15276,0.0025206,0.38143,0.3444,GOMF_NAADP_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.954561671961874
NMYC_01,SET,257,0.021399,0.002514,0.053441,0.34443,NMYC_01,0.954561671961874
GOBP_FAT_SOLUBLE_VITAMIN_MET...,SET,47,0.051032,0.0025787,0.1275,0.34449,GOBP_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.954561671961874
DESCARTES_FETAL_INTESTINE_ST...,SET,33,0.066763,0.0028279,0.16683,0.34451,DESCARTES_FETAL_INTESTINE_STROMAL_CELLS,0.954561671961874
KEGG_MEDICUS_REFERENCE_HEME_...,SET,8,0.11583,0.0024174,0.28961,0.3446,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS,0.954561671961874
WP_HEMESYNTHESIS_DEFECTS_AND...,SET,8,0.11583,0.0024174,0.28961,0.3446,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,0.954561671961874
WP_HEME_BIOSYNTHESIS,SET,8,0.11583,0.0024174,0.28961,0.3446,WP_HEME_BIOSYNTHESIS,0.954561671961874
GOBP_REGULATION_OF_PLATELET_...4,SET,8,0.12372,0.0025819,0.30939,0.34462,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.954561671961874
WP_RESISTIN_AS_A_REGULATOR_O...,SET,32,0.060883,0.0025395,0.15232,0.34469,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.954561671961874
GOBP_ISOPRENOID_CATABOLIC_PR...,SET,9,0.12431,0.0027516,0.31101,0.34469,GOBP_ISOPRENOID_CATABOLIC_PROCESS,0.954561671961874
GOBP_POSITIVE_REGULATION_OF_...63,SET,8,0.14546,0.0030357,0.36396,0.3447,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.954561671961874
HP_SHORT_5TH_TOE,SET,5,0.17035,0.0028108,0.42626,0.34472,HP_SHORT_5TH_TOE,0.954561671961874
GOBP_DCMP_CATABOLIC_PROCESS,SET,6,0.14281,0.0025812,0.35739,0.34473,GOBP_DCMP_CATABOLIC_PROCESS,0.954561671961874
DESCARTES_FETAL_LUNG_LYMPHOI...,SET,118,0.033448,0.0026728,0.083721,0.34476,DESCARTES_FETAL_LUNG_LYMPHOID_CELLS,0.954561671961874
GOBP_CELLULAR_RESPONSE_TO_EX...1,SET,13,0.091067,0.0024224,0.22797,0.34478,GOBP_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA,0.954561671961874
GOMF_RNA_POLYMERASE_III_TYPE...,SET,6,0.11957,0.0021612,0.29934,0.34478,GOMF_RNA_POLYMERASE_III_TYPE_3_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.954561671961874
PTEN_DN.V1_DN,SET,152,0.029303,0.0026552,0.073373,0.34481,PTEN_DN.V1_DN,0.954561671961874
REACTOME_THE_ROLE_OF_NEF_IN_...,SET,27,0.064019,0.0024532,0.16031,0.34482,REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,0.954561671961874
WP_TYPE_III_INTERFERON_SIGNA...,SET,10,0.10364,0.0024181,0.25958,0.34485,WP_TYPE_III_INTERFERON_SIGNALING,0.954561671961874
HP_SPEECH_APRAXIA,SET,28,0.065674,0.0025628,0.16449,0.34485,HP_SPEECH_APRAXIA,0.954561671961874
GSE17721_CTRL_VS_LPS_24H_BMD...2,SET,187,0.024906,0.0025007,0.06238,0.34485,GSE17721_CTRL_VS_LPS_24H_BMDC_UP,0.954561671961874
STK33_UP,SET,253,0.021883,0.0025511,0.05486,0.34499,STK33_UP,0.954561671961874
HP_MULTIPLE_IMPACTED_TEETH,SET,4,0.19519,0.0028807,0.48941,0.34501,HP_MULTIPLE_IMPACTED_TEETH,0.954561671961874
PID_PDGFRA_PATHWAY,SET,21,0.076158,0.0025742,0.19096,0.34502,PID_PDGFRA_PATHWAY,0.954561671961874
WILCOX_RESPONSE_TO_PROGESTER...1,SET,57,0.047239,0.002628,0.11848,0.34505,WILCOX_RESPONSE_TO_PROGESTERONE_DN,0.954561671961874
WP_ACTIVATION_OF_NLRP3_INFLA...,SET,6,0.12878,0.0023276,0.32303,0.34508,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,0.954561671961874
HP_WIDENED_CEREBRAL_SUBARACH...,SET,3,0.25136,0.0032128,0.63057,0.34509,HP_WIDENED_CEREBRAL_SUBARACHNOID_SPACE,0.954561671961874
WP_NOTCH_SIGNALING_WP61,SET,58,0.043387,0.0024347,0.10886,0.34512,WP_NOTCH_SIGNALING_WP61,0.954561671961874
GSE15930_NAIVE_VS_24H_IN_VIT...4,SET,188,0.024497,0.0024661,0.061469,0.34513,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.954561671961874
MODULE_226,SET,27,0.065523,0.0025108,0.16443,0.34514,MODULE_226,0.954561671961874
GOMF_3_BETA_HYDROXY_DELTA5_S...,SET,5,0.14428,0.0023807,0.36213,0.34516,GOMF_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY,0.954561671961874
GOBP_MRNA_PROCESSING,SET,423,0.015123,0.0022689,0.037961,0.34517,GOBP_MRNA_PROCESSING,0.954561671961874
HP_DEXTROTRANSPOSITION_OF_TH...,SET,5,0.13404,0.0022116,0.33664,0.34526,HP_DEXTROTRANSPOSITION_OF_THE_GREAT_ARTERIES,0.954561671961874
GSE42021_CD24LO_TREG_VS_CD24...1,SET,184,0.023736,0.0023643,0.05962,0.34527,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN,0.954561671961874
HP_GRANULOMATOSIS,SET,8,0.15038,0.0031383,0.37778,0.3453,HP_GRANULOMATOSIS,0.954561671961874
GSE5589_LPS_VS_LPS_AND_IL10_...2,SET,181,0.025004,0.0024703,0.062819,0.34531,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP,0.954561671961874
MORF_CD8A,SET,111,0.034586,0.002681,0.086901,0.34532,MORF_CD8A,0.954561671961874
GSE19941_UNSTIM_VS_LPS_STIM_...2,SET,178,0.025564,0.0025049,0.064232,0.34532,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.954561671961874
INSM2_TARGET_GENES,SET,747,0.012698,0.0025087,0.031907,0.34533,INSM2_TARGET_GENES,0.954561671961874
HP_ABNORMAL_DUODENUM_MORPHOL...,SET,81,0.036551,0.0024224,0.091856,0.34535,HP_ABNORMAL_DUODENUM_MORPHOLOGY,0.954561671961874
GOBP_POSITIVE_REGULATION_OF_...132,SET,99,0.036878,0.0027007,0.092688,0.34536,GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.954561671961874
GOBP_LEUKOCYTE_ACTIVATION_IN...,SET,48,0.053657,0.00274,0.13487,0.34537,GOBP_LEUKOCYTE_ACTIVATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.954561671961874
DESCARTES_FETAL_CEREBELLUM_V...,SET,506,0.01655,0.0027094,0.04161,0.34541,DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS,0.954561671961874
GGGGCCC_MIR296,SET,66,0.040172,0.0024042,0.101,0.34542,GGGGCCC_MIR296,0.954561671961874
HP_ABNORMALITY_OF_CYTOKINE_S...,SET,6,0.15433,0.0027895,0.38805,0.34542,HP_ABNORMALITY_OF_CYTOKINE_SECRETION,0.954561671961874
GSE26928_NAIVE_VS_CENT_MEMOR...1,SET,170,0.025199,0.0024135,0.063364,0.34543,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,0.954561671961874
GOMF_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.093356,0.0023859,0.23476,0.34544,GOMF_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.954561671961874
GOBP_TRIPEPTIDE_TRANSMEMBRAN...,SET,10,0.11101,0.0025901,0.27918,0.34545,GOBP_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.954561671961874
HP_HYPERMAGNESEMIA,SET,7,0.13444,0.0026246,0.3381,0.34545,HP_HYPERMAGNESEMIA,0.954561671961874
HP_LONG_FOOT,SET,22,0.066033,0.0022844,0.16606,0.34545,HP_LONG_FOOT,0.954561671961874
GOBP_TYPE_II_HYPERSENSITIVITY,SET,8,0.14479,0.0030218,0.36428,0.34551,GOBP_TYPE_II_HYPERSENSITIVITY,0.954561671961874
KANG_CISPLATIN_RESISTANCE_UP,SET,18,0.078525,0.0024575,0.19765,0.34558,KANG_CISPLATIN_RESISTANCE_UP,0.954561671961874
REACTOME_GLYCOSPHINGOLIPID_M...,SET,50,0.049165,0.0025622,0.12375,0.34558,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,0.954561671961874
GOBP_SMOOTH_MUSCLE_CELL_APOP...,SET,29,0.064843,0.002575,0.16323,0.34559,GOBP_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.954561671961874
HP_IMPAIRED_VIBRATORY_SENSAT...,SET,113,0.031026,0.0024265,0.0781,0.34559,HP_IMPAIRED_VIBRATORY_SENSATION,0.954561671961874
GSE15330_MEGAKARYOCYTE_ERYTH...4,SET,175,0.025459,0.0024737,0.064091,0.3456,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.954561671961874
GSE27291_0H_VS_6H_STIM_GAMMA...1,SET,157,0.026601,0.0024493,0.066965,0.3456,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN,0.954561671961874
GOMF_VITAMIN_D_BINDING,SET,6,0.15622,0.0028236,0.39334,0.34563,GOMF_VITAMIN_D_BINDING,0.954561671961874
HP_ABNORMAL_RENAL_TUBULAR_RE...,SET,19,0.080502,0.0025883,0.20271,0.34564,HP_ABNORMAL_RENAL_TUBULAR_RESORPTION,0.954561671961874
SOBOLEV_PBMC_PANDEMRIX_AGE_1...4,SET,18,0.09078,0.002841,0.22867,0.34569,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP,0.954561671961874
KEGG_MEDICUS_REFERENCE_EARLY...,SET,8,0.11164,0.0023298,0.28126,0.34572,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION,0.954561671961874
WP_SELENIUM_MICRONUTRIENT_NE...,SET,70,0.043418,0.0026758,0.10943,0.34577,WP_SELENIUM_MICRONUTRIENT_NETWORK,0.954561671961874
GOBP_NEGATIVE_REGULATION_OF_...381,SET,4,0.1848,0.0027274,0.46575,0.34577,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CHROMOSOME_SEPARATION,0.954561671961874
HP_ENAMEL_HYPOMINERALIZATION,SET,8,0.12206,0.0025473,0.30766,0.34578,HP_ENAMEL_HYPOMINERALIZATION,0.954561671961874
MODULE_104,SET,314,0.019373,0.0025118,0.048833,0.34579,MODULE_104,0.954561671961874
GOBP_MAST_CELL_MIGRATION,SET,14,0.096602,0.0026666,0.24365,0.34588,GOBP_MAST_CELL_MIGRATION,0.954679424374752
GSE3982_MAST_CELL_VS_BASOPHI...2,SET,174,0.026056,0.0025245,0.065726,0.3459,GSE3982_MAST_CELL_VS_BASOPHIL_UP,0.954679424374752
NABA_MATRISOME,SET,950,0.01263,0.0027977,0.031865,0.34592,NABA_MATRISOME,0.954679424374752
GOCC_OUTER_MEMBRANE,SET,207,0.023298,0.0024598,0.058796,0.34596,GOCC_OUTER_MEMBRANE,0.954679424374752
GOBP_MINERALOCORTICOID_BIOSY...,SET,12,0.11161,0.0028524,0.28167,0.34597,GOBP_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS,0.954679424374752
GSE22140_GERMFREE_VS_SPF_MOU...2,SET,184,0.025247,0.0025147,0.063748,0.34604,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP,0.95468675
MIR6776_3P,SET,57,0.045978,0.0025579,0.1161,0.34605,MIR6776_3P,0.95468675
BILANGES_SERUM_SENSITIVE_VIA...1,SET,20,0.0788,0.0025994,0.199,0.34606,BILANGES_SERUM_SENSITIVE_VIA_TSC1,0.95468675
MORF_RAD23A,SET,303,0.01823,0.0023225,0.046046,0.34609,MORF_RAD23A,0.95468675
GSE17721_PAM3CSK4_VS_GADIQUI...11,SET,182,0.024087,0.0023862,0.06085,0.34611,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN,0.95468675
GOBP_POSITIVE_REGULATION_OF_...836,SET,30,0.068729,0.0027759,0.17373,0.3462,GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION,0.954762842180433
GOBP_SMOOTHENED_SIGNALING_PA...2,SET,5,0.15266,0.0025189,0.38591,0.34621,GOBP_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.954762842180433
HP_ABNORMAL_CIRCULATING_MONO...,SET,66,0.041131,0.0024616,0.10398,0.34622,HP_ABNORMAL_CIRCULATING_MONOCARBOXYLIC_ACID_CONCENTRATION,0.954762842180433
GOCC_TORC1_COMPLEX,SET,6,0.11782,0.0021296,0.29799,0.34628,GOCC_TORC1_COMPLEX,0.954852538876547
HP_LARGE_HANDS,SET,29,0.056649,0.0022496,0.14332,0.34632,HP_LARGE_HANDS,0.954887076556922
HP_ABNORMAL_FACTOR_IX_ACTIVI...,SET,5,0.12714,0.0020978,0.32171,0.34635,HP_ABNORMAL_FACTOR_IX_ACTIVITY,0.95489403855307
GOBP_B_CELL_PROLIFERATION_IN...,SET,6,0.15921,0.0028776,0.40313,0.34645,GOBP_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,0.955093975569128
WP_CHEMOKINE_SIGNALING,SET,157,0.028103,0.0025876,0.071203,0.34654,WP_CHEMOKINE_SIGNALING,0.955197490087232
ACEVEDO_LIVER_CANCER_WITH_H3...4,SET,111,0.034948,0.0027092,0.088555,0.34655,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,0.955197490087232
MODULE_194,SET,15,0.083669,0.0023905,0.21203,0.34657,MODULE_194,0.955197490087232
GOCC_TERTIARY_GRANULE,SET,147,0.028253,0.0025179,0.071614,0.3466,GOCC_TERTIARY_GRANULE,0.955204424708588
GSE23505_UNTREATED_VS_4DAY_I...3,SET,183,0.023907,0.0023748,0.060613,0.34664,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.955218290652501
REACTOME_COPI_DEPENDENT_GOLG...,SET,95,0.031961,0.0022931,0.081044,0.34666,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,0.955218290652501
HP_MECONIUM_STAINED_AMNIOTIC...,SET,8,0.12596,0.0026288,0.31949,0.3467,HP_MECONIUM_STAINED_AMNIOTIC_FLUID,0.955252774694784
GOBP_FIBROBLAST_ACTIVATION,SET,15,0.10013,0.0028609,0.25418,0.34681,GOBP_FIBROBLAST_ACTIVATION,0.955376945324881
REACTOME_RRNA_MODIFICATION_I...2,SET,51,0.044293,0.0023312,0.11246,0.34684,REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.955376945324881
HP_RECURRENT_PATELLAR_DISLOC...,SET,3,0.22353,0.0028571,0.56766,0.34688,HP_RECURRENT_PATELLAR_DISLOCATION,0.955376945324881
SAGIV_CD24_TARGETS_DN,SET,43,0.05142,0.0024855,0.13061,0.34691,SAGIV_CD24_TARGETS_DN,0.955376945324881
MIR6820_5P,SET,11,0.10082,0.0024671,0.2561,0.34691,MIR6820_5P,0.955376945324881
HP_ABNORMAL_TISSUE_METABOLIT...,SET,237,0.021194,0.0023924,0.053835,0.34691,HP_ABNORMAL_TISSUE_METABOLITE_CONCENTRATION,0.955376945324881
NAKAMURA_BRONCHIAL_AND_BRONC...,SET,5,0.15343,0.0025316,0.38984,0.34695,NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA,0.955411397670549
GOBP_PROTEIN_N_LINKED_GLYCOS...2,SET,23,0.07226,0.002556,0.18371,0.34704,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE,0.955583520836634
GSE7852_LN_VS_THYMUS_TREG_UP,SET,182,0.025128,0.0024894,0.06394,0.34716,GSE7852_LN_VS_THYMUS_TREG_UP,0.955721431384906
GOBP_OBSERVATIONAL_LEARNING,SET,7,0.12989,0.0025357,0.33063,0.34722,GOBP_OBSERVATIONAL_LEARNING,0.955721431384906
MIR567,SET,95,0.034321,0.0024624,0.087375,0.34724,MIR567,0.955721431384906
GSE46606_DAY1_VS_DAY3_CD40L_...8,SET,182,0.025022,0.0024788,0.063707,0.34725,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP,0.955721431384906
HP_PROGRESSIVE_VISUAL_FIELD_...,SET,13,0.090135,0.0023976,0.22959,0.34731,HP_PROGRESSIVE_VISUAL_FIELD_DEFECTS,0.955721431384906
GOMF_VOLTAGE_GATED_CALCIUM_C...1,SET,41,0.056353,0.00266,0.14355,0.34732,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.955721431384906
GOBP_REGULATION_OF_TISSUE_RE...,SET,72,0.042847,0.0026779,0.10915,0.34733,GOBP_REGULATION_OF_TISSUE_REMODELING,0.955721431384906
chr8p22,SET,20,0.13731,0.0045293,0.35006,0.34744,chr8p22,0.955721431384906
GOMF_OMEGA_PEPTIDASE_ACTIVITY,SET,12,0.10288,0.0026294,0.26229,0.34744,GOMF_OMEGA_PEPTIDASE_ACTIVITY,0.955721431384906
GSE3720_VD1_VS_VD2_GAMMADELT...4,SET,172,0.0253,0.0024372,0.064497,0.34744,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP,0.955721431384906
HP_ABNORMALITY_OF_VITAMIN_B1...,SET,30,0.06249,0.0025239,0.15935,0.34747,HP_ABNORMALITY_OF_VITAMIN_B12_METABOLISM,0.955721431384906
WP_CEREBRAL_ORGANIC_ACIDURIA...,SET,8,0.11447,0.002389,0.29196,0.3475,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,0.955721431384906
GOBP_PROTEIN_ACTIVATION_CASC...,SET,18,0.093687,0.002932,0.23898,0.34752,GOBP_PROTEIN_ACTIVATION_CASCADE,0.955721431384906
GOBP_FOREBRAIN_MORPHOGENESIS,SET,13,0.099602,0.0026494,0.25413,0.34756,GOBP_FOREBRAIN_MORPHOGENESIS,0.955721431384906
GSE24142_EARLY_THYMIC_PROGEN...10,SET,187,0.024503,0.0024602,0.062524,0.34757,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN,0.955721431384906
GSE14908_RESTING_VS_HDM_STIM...1,SET,185,0.024103,0.0024073,0.061529,0.34763,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN,0.955721431384906
LIN_MELANOMA_COPY_NUMBER_DN,SET,38,0.054289,0.0024673,0.13861,0.34765,LIN_MELANOMA_COPY_NUMBER_DN,0.955721431384906
MIR8076,SET,116,0.029695,0.0023529,0.075818,0.34766,MIR8076,0.955721431384906
GSE13485_DAY1_VS_DAY7_YF17D_...1,SET,180,0.024755,0.002439,0.063227,0.34771,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.955721431384906
PRC1_BMI_UP.V1_UP,SET,162,0.027222,0.0025457,0.06954,0.34773,PRC1_BMI_UP.V1_UP,0.955721431384906
GOBP_RESPONSE_TO_TOXIC_SUBST...,SET,225,0.023254,0.0025584,0.05941,0.34775,GOBP_RESPONSE_TO_TOXIC_SUBSTANCE,0.955721431384906
GOBP_POSITIVE_REGULATION_OF_...780,SET,4,0.13941,0.0020574,0.35632,0.34781,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.955721431384906
GSE30971_WBP7_HET_VS_KO_MACR...6,SET,184,0.024762,0.0024665,0.063293,0.34781,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP,0.955721431384906
HE_LIM_SUN_FETAL_LUNG_C2_DC2...,SET,49,0.050652,0.0026132,0.12947,0.34781,HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL,0.955721431384906
GOBP_TELENCEPHALON_DEVELOPME...,SET,257,0.02204,0.0025893,0.056343,0.34784,GOBP_TELENCEPHALON_DEVELOPMENT,0.955721431384906
GAO_LARGE_INTESTINE_ADULT_CI...,SET,307,0.020172,0.0025866,0.051596,0.34791,GAO_LARGE_INTESTINE_ADULT_CI_MESENCHYMAL_CELLS,0.955721431384906
MODULE_254,SET,59,0.042918,0.002429,0.10978,0.34792,MODULE_254,0.955721431384906
GSE34156_UNTREATED_VS_6H_NOD...1,SET,146,0.027626,0.0024537,0.070681,0.34795,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.955721431384906
PID_BARD1_PATHWAY,SET,28,0.055261,0.0021564,0.14143,0.348,PID_BARD1_PATHWAY,0.955721431384906
GOBP_LYSOSOMAL_TRANSPORT,SET,126,0.029862,0.0024653,0.076427,0.348,GOBP_LYSOSOMAL_TRANSPORT,0.955721431384906
GOBP_ABSCISSION,SET,5,0.12871,0.0021237,0.32958,0.34808,GOBP_ABSCISSION,0.955721431384906
GOBP_TOLL_LIKE_RECEPTOR_2_SI...,SET,16,0.089314,0.0026354,0.22872,0.34809,GOBP_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.955721431384906
GSE27786_NEUTROPHIL_VS_MONO_...2,SET,176,0.025035,0.0024393,0.064131,0.34813,GSE27786_NEUTROPHIL_VS_MONO_MAC_UP,0.955721431384906
WP_TAMOXIFEN_METABOLISM,SET,21,0.078611,0.0026571,0.20138,0.34814,WP_TAMOXIFEN_METABOLISM,0.955721431384906
WP_MECHANOREGULATION_AND_PAT...,SET,44,0.052691,0.0025764,0.135,0.34816,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,0.955721431384906
GSE25146_UNSTIM_VS_HELIOBACT...2,SET,165,0.024032,0.002268,0.061586,0.34819,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP,0.955721431384906
GSE46242_CTRL_VS_EGR2_DELETE...3,SET,161,0.026794,0.0024981,0.068684,0.34823,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN,0.955721431384906
HP_PHOTOPSIA,SET,90,0.034732,0.0024257,0.089063,0.34828,HP_PHOTOPSIA,0.955721431384906
GSE39382_IL3_VS_IL3_IL33_TRE...2,SET,182,0.023962,0.0023739,0.061446,0.34828,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP,0.955721431384906
ACACTAC_MIR1423P,SET,118,0.031154,0.0024895,0.079897,0.3483,ACACTAC_MIR1423P,0.955721431384906
PID_SYNDECAN_3_PATHWAY,SET,15,0.0875,0.0025,0.22449,0.34835,PID_SYNDECAN_3_PATHWAY,0.955721431384906
GOBP_PROTEIN_ACYLATION,SET,83,0.034454,0.0023113,0.088398,0.34836,GOBP_PROTEIN_ACYLATION,0.955721431384906
NAKAYA_B_CELL_FLUMIST_AGE_18...2,SET,416,0.015844,0.0023578,0.040659,0.34839,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.955721431384906
LIU_VAV3_PROSTATE_CARCINOGEN...2,SET,82,0.039036,0.002603,0.10018,0.3484,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,0.955721431384906
TURJANSKI_MAPK7_TARGETS,SET,7,0.14168,0.0027659,0.36366,0.34842,TURJANSKI_MAPK7_TARGETS,0.955721431384906
HP_UNDERDEVELOPED_SUPRAORBIT...,SET,55,0.04707,0.0025724,0.12083,0.34844,HP_UNDERDEVELOPED_SUPRAORBITAL_RIDGES,0.955721431384906
MIR448,SET,327,0.018967,0.0025086,0.048709,0.3485,MIR448,0.955721431384906
MIR6822_3P,SET,49,0.04786,0.0024692,0.12293,0.34851,MIR6822_3P,0.955721431384906
HU_FETAL_RETINA_FIBROBLAST,SET,337,0.019802,0.002658,0.050865,0.34853,HU_FETAL_RETINA_FIBROBLAST,0.955721431384906
GOBP_REGULATION_OF_CD4_POSIT...1,SET,71,0.042185,0.0026183,0.10838,0.34855,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.955721431384906
KYNG_DNA_DAMAGE_UP,SET,188,0.02411,0.0024272,0.061955,0.34858,KYNG_DNA_DAMAGE_UP,0.955721431384906
GOBP_LIPID_DROPLET_DISASSEMB...,SET,6,0.12626,0.002282,0.32469,0.34869,GOBP_LIPID_DROPLET_DISASSEMBLY,0.955721431384906
GSE6269_STAPH_AUREUS_VS_STRE...1,SET,158,0.025756,0.002379,0.066249,0.34872,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN,0.955721431384906
HP_ABNORMAL_PROPORTION_OF_DO...,SET,6,0.14526,0.0026255,0.37365,0.34873,HP_ABNORMAL_PROPORTION_OF_DOUBLE_NEGATIVE_ALPHA_BETA_REGULATORY_T_CELL,0.955721431384906
GOBP_POSITIVE_REGULATION_OF_...198,SET,11,0.10466,0.002561,0.26923,0.34874,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.955721431384906
HP_ABNORMAL_GASTROINTESTINAL...1,SET,87,0.035578,0.0024433,0.091525,0.34874,HP_ABNORMAL_GASTROINTESTINAL_MOTILITY,0.955721431384906
MIR7153_3P,SET,43,0.048756,0.0023568,0.12544,0.34875,MIR7153_3P,0.955721431384906
REACTOME_G_PROTEIN_MEDIATED_...,SET,52,0.050004,0.0026574,0.12865,0.34876,REACTOME_G_PROTEIN_MEDIATED_EVENTS,0.955721431384906
WP_RAS_SIGNALING,SET,174,0.025763,0.0024961,0.066282,0.34876,WP_RAS_SIGNALING,0.955721431384906
GSE13547_2H_VS_12_H_ANTI_IGM...4,SET,153,0.026731,0.00243,0.068781,0.34877,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP,0.955721431384906
GSE17721_CTRL_VS_CPG_4H_BMDC...2,SET,188,0.023551,0.0023709,0.060613,0.34881,GSE17721_CTRL_VS_CPG_4H_BMDC_UP,0.955721431384906
GOBP_RECEPTOR_MEDIATED_VIRIO...,SET,5,0.17275,0.0028505,0.44468,0.34883,GOBP_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL,0.955721431384906
MIKKELSEN_MEF_LCP_WITH_H3K4M...,SET,112,0.031296,0.0024369,0.080567,0.34884,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,0.955721431384906
HLF_01,SET,228,0.02258,0.0025006,0.058137,0.34886,HLF_01,0.955721431384906
GOBP_NEUTROPHIL_MEDIATED_KIL...2,SET,13,0.10759,0.002862,0.27709,0.3489,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL,0.955721431384906
FORTSCHEGGER_PHF8_TARGETS_UP,SET,230,0.022161,0.0024648,0.057106,0.34898,FORTSCHEGGER_PHF8_TARGETS_UP,0.955721431384906
GSE3920_UNTREATED_VS_IFNG_TR...1,SET,174,0.024234,0.002348,0.062447,0.34898,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.955721431384906
GSE8921_UNSTIM_0H_VS_TLR1_2_...5,SET,186,0.024463,0.0024497,0.063038,0.34899,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN,0.955721431384906
GOCC_CONDENSED_CHROMOSOME,SET,250,0.020058,0.0023245,0.051707,0.34904,GOCC_CONDENSED_CHROMOSOME,0.955721431384906
FOXO4_01,SET,229,0.023076,0.002561,0.059489,0.34905,FOXO4_01,0.955721431384906
REACTOME_SIGNALING_BY_MST1,SET,5,0.13089,0.0021597,0.33746,0.34906,REACTOME_SIGNALING_BY_MST1,0.955721431384906
WP_PTDINS45P2_IN_CYTOKINESIS...,SET,9,0.1099,0.0024326,0.28336,0.34907,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.955721431384906
TEL2_Q6,SET,221,0.021719,0.0023685,0.056024,0.34913,TEL2_Q6,0.95572144432194
GOBP_NEGATIVE_REGULATION_OF_...705,SET,8,0.12924,0.0026972,0.33348,0.34917,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.95572144432194
HP_ABNORMAL_AMPLITUDE_OF_PAT...,SET,6,0.14118,0.0025517,0.3643,0.34918,HP_ABNORMAL_AMPLITUDE_OF_PATTERN_ELECTRORETINOGRAM,0.95572144432194
GSE21927_SPLEEN_VS_TUMOR_MON...4,SET,156,0.026616,0.002443,0.06868,0.34918,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP,0.95572144432194
HE_PTEN_TARGETS_UP,SET,18,0.075554,0.0023645,0.1951,0.34929,HE_PTEN_TARGETS_UP,0.955878796945122
MIKKELSEN_IPS_WITH_HCP_H3K27...,SET,97,0.038977,0.0028256,0.10067,0.34932,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,0.955878796945122
HP_PANCREATIC_ISLET_CELL_HYP...,SET,10,0.12393,0.0028915,0.3201,0.34932,HP_PANCREATIC_ISLET_CELL_HYPERPLASIA,0.955878796945122
MIR3182,SET,238,0.021864,0.0024731,0.056504,0.3494,MIR3182,0.955947177832008
GOBP_REGULATION_OF_AMIDE_MET...,SET,63,0.041116,0.0024044,0.10626,0.3494,GOBP_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.955947177832008
GOBP_RENAL_RESPONSE_TO_BLOOD...,SET,7,0.15389,0.0030043,0.398,0.34951,GOBP_RENAL_RESPONSE_TO_BLOOD_FLOW_INVOLVED_IN_CIRCULATORY_RENIN_ANGIOTENSIN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.956015457549768
GSE360_L_DONOVANI_VS_B_MALAY...5,SET,181,0.024161,0.0023871,0.062497,0.34953,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN,0.956015457549768
REACTOME_METABOLISM_OF_STERO...2,SET,33,0.060156,0.0025481,0.15562,0.34954,REACTOME_METABOLISM_OF_STEROID_HORMONES,0.956015457549768
GOBP_COMPLEMENT_ACTIVATION,SET,46,0.056921,0.0028456,0.14728,0.34957,GOBP_COMPLEMENT_ACTIVATION,0.956015457549768
GOBP_CELL_CYCLE_G2_M_PHASE_T...,SET,139,0.027716,0.0024024,0.071716,0.34958,GOBP_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.956015457549768
GOBP_MACROPHAGE_CYTOKINE_PRO...,SET,35,0.06079,0.0026517,0.15731,0.34959,GOBP_MACROPHAGE_CYTOKINE_PRODUCTION,0.956015457549768
MIR6888_3P,SET,87,0.036095,0.0024788,0.093461,0.34967,MIR6888_3P,0.956049528079283
REACTOME_DNA_STRAND_ELONGATI...,SET,31,0.055089,0.0022617,0.14268,0.34972,REACTOME_DNA_STRAND_ELONGATION,0.956049528079283
KAZMIN_PBMC_P_FALCIPARUM_RTS...1,SET,39,0.05635,0.0025943,0.14597,0.34973,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE,0.956049528079283
GSE45365_WT_VS_IFNAR_KO_BCEL...3,SET,150,0.02568,0.0023117,0.066526,0.34974,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP,0.956049528079283
SCHERER_PBMC_APSV_WETVAX_AGE...5,SET,171,0.02475,0.0023774,0.064117,0.34974,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,0.956049528079283
GOBP_MOLTING_CYCLE_PROCESS,SET,95,0.037859,0.0027162,0.098144,0.34984,GOBP_MOLTING_CYCLE_PROCESS,0.956199120603015
GOBP_NATURAL_KILLER_CELL_ACT...2,SET,29,0.071349,0.0028334,0.18498,0.34986,GOBP_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.956199120603015
ZNF140_TARGET_GENES,SET,550,0.013955,0.0023789,0.036202,0.34995,ZNF140_TARGET_GENES,0.956199120603015
GOBP_LIPOSACCHARIDE_METABOLI...,SET,103,0.032077,0.0023958,0.083223,0.34996,GOBP_LIPOSACCHARIDE_METABOLIC_PROCESS,0.956199120603015
GOCC_MOTILE_CILIUM,SET,229,0.021772,0.0024164,0.056506,0.35001,GOCC_MOTILE_CILIUM,0.956199120603015
GOBP_POSITIVE_REGULATION_OF_...364,SET,42,0.056022,0.0026764,0.14543,0.35004,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,0.956199120603015
KEGG_INOSITOL_PHOSPHATE_META...,SET,52,0.04503,0.002393,0.11692,0.35007,KEGG_INOSITOL_PHOSPHATE_METABOLISM,0.956199120603015
GOBP_DNA_DAMAGE_RESPONSE,SET,793,0.011279,0.0022929,0.029287,0.35008,GOBP_DNA_DAMAGE_RESPONSE,0.956199120603015
MIR6769A_5P,SET,43,0.050298,0.0024313,0.13062,0.35009,MIR6769A_5P,0.956199120603015
MIR3164,SET,93,0.033954,0.0024104,0.0882,0.35014,MIR3164,0.956199120603015
DESCARTES_MAIN_FETAL_STC2_TL...,SET,16,0.090003,0.0026558,0.23383,0.35016,DESCARTES_MAIN_FETAL_STC2_TLX1_POSITIVE_CELLS,0.956199120603015
HP_HYPOPIGMENTED_MACULE,SET,24,0.064162,0.0023183,0.16673,0.35018,HP_HYPOPIGMENTED_MACULE,0.956199120603015
GSE17721_CTRL_VS_PAM3CSK4_4H...2,SET,182,0.023679,0.0023458,0.061546,0.35022,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP,0.956199120603015
LAKE_ADULT_KIDNEY_C4_PROXIMA...,SET,159,0.028942,0.0026816,0.07525,0.35027,LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2,0.956199120603015
GOBP_GLUTAMATE_CATABOLIC_PRO...,SET,7,0.12489,0.0024381,0.32477,0.35029,GOBP_GLUTAMATE_CATABOLIC_PROCESS,0.956199120603015
HP_PERIPHERAL_NEUROPATHY,SET,407,0.016036,0.0023609,0.041705,0.3503,HP_PERIPHERAL_NEUROPATHY,0.956199120603015
LANDIS_BREAST_CANCER_PROGRES...1,SET,68,0.043025,0.0026135,0.11191,0.35033,LANDIS_BREAST_CANCER_PROGRESSION_DN,0.956199120603015
WP_EPITHELIAL_TO_MESENCHYMAL...,SET,153,0.028795,0.0026177,0.074902,0.35033,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,0.956199120603015
GAVISH_3CA_METAPROGRAM_ENDOT...4,SET,48,0.052668,0.0026895,0.13701,0.35033,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_2,0.956199120603015
chr2q35,SET,64,0.08154,0.0048058,0.21221,0.3504,chr2q35,0.956199120603015
SRF_C,SET,198,0.023512,0.0024284,0.061188,0.3504,SRF_C,0.956199120603015
GCM_SMARCC1,SET,32,0.054881,0.0022892,0.14282,0.3504,GCM_SMARCC1,0.956199120603015
HP_BROAD_FIRST_METATARSAL,SET,5,0.15681,0.0025874,0.40827,0.35046,HP_BROAD_FIRST_METATARSAL,0.956287767920232
KEGG_MEDICUS_VARIANT_CDH1_RE...,SET,8,0.11067,0.0023096,0.28825,0.35051,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.956335384615385
GSE30971_CTRL_VS_LPS_STIM_MA...1,SET,173,0.025073,0.0024223,0.06532,0.35055,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN,0.956335384615385
KEGG_MEDICUS_REFERENCE_RORA_...,SET,5,0.1373,0.0022654,0.35771,0.35056,KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION,0.956335384615385
FUJIWARA_PARK2_IN_LIVER_CANC...1,SET,5,0.15915,0.002626,0.41486,0.35063,FUJIWARA_PARK2_IN_LIVER_CANCER_DN,0.956335859017157
GOBP_AMYLOID_BETA_CLEARANCE_...2,SET,7,0.11478,0.0022407,0.29924,0.35066,GOBP_AMYLOID_BETA_CLEARANCE_BY_TRANSCYTOSIS,0.956335859017157
FONTAINE_THYROID_TUMOR_UNCER...1,SET,26,0.068141,0.0025624,0.17768,0.35068,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,0.956335859017157
GSE22601_IMMATURE_CD4_SINGLE...1,SET,180,0.023829,0.0023478,0.062171,0.35076,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.956335859017157
GOBP_REGULATION_OF_GLUCOCORT...1,SET,9,0.12185,0.002697,0.31801,0.35081,GOBP_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.956335859017157
BIOCARTA_LYM_PATHWAY,SET,13,0.10134,0.0026957,0.26452,0.35082,BIOCARTA_LYM_PATHWAY,0.956335859017157
MORF_IL16,SET,214,0.022612,0.002427,0.059026,0.35083,MORF_IL16,0.956335859017157
chr7q35,SET,17,0.12417,0.0037766,0.32436,0.35093,chr7q35,0.956335859017157
GNF2_CDC27,SET,56,0.043917,0.0024217,0.11474,0.35096,GNF2_CDC27,0.956335859017157
GSE11924_TFH_VS_TH1_CD4_TCEL...1,SET,174,0.024289,0.0023533,0.063503,0.35105,GSE11924_TFH_VS_TH1_CD4_TCELL_DN,0.956335859017157
GSE20715_WT_VS_TLR4_KO_LUNG_...2,SET,179,0.024888,0.0024454,0.065068,0.35105,GSE20715_WT_VS_TLR4_KO_LUNG_UP,0.956335859017157
HP_HYPERPROSTAGLANDINURIA,SET,6,0.15494,0.0028005,0.40513,0.35107,HP_HYPERPROSTAGLANDINURIA,0.956335859017157
BANDRES_RESPONSE_TO_CARMUSTI...5,SET,9,0.11952,0.0026456,0.31254,0.35108,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN,0.956335859017157
KEGG_PROPANOATE_METABOLISM,SET,31,0.059041,0.002424,0.15439,0.35108,KEGG_PROPANOATE_METABOLISM,0.956335859017157
GOCC_MHC_PROTEIN_COMPLEX,SET,21,0.08483,0.0028673,0.22189,0.35112,GOCC_MHC_PROTEIN_COMPLEX,0.956335859017157
GOBP_REGULATION_OF_GOLGI_TO_...,SET,8,0.11157,0.0023285,0.29212,0.35125,GOBP_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.956335859017157
HEN1_01,SET,182,0.024309,0.0024083,0.063678,0.35133,HEN1_01,0.956335859017157
GOBP_EXCITATORY_CHEMICAL_SYN...,SET,10,0.11229,0.0026199,0.29424,0.35137,GOBP_EXCITATORY_CHEMICAL_SYNAPTIC_TRANSMISSION,0.956335859017157
GOBP_NEGATIVE_REGULATION_OF_...442,SET,113,0.030636,0.0023961,0.080284,0.35138,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.956335859017157
GOMF_UBIQUITIN_LIKE_PROTEIN_...8,SET,5,0.13008,0.0021463,0.34086,0.35138,GOMF_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_ENDOPEPTIDASE_ACTIVITY,0.956335859017157
WINNEPENNINCKX_MELANOMA_META...1,SET,38,0.055926,0.0025417,0.14657,0.35139,WINNEPENNINCKX_MELANOMA_METASTASIS_DN,0.956335859017157
MIR6890_5P,SET,18,0.072279,0.002262,0.18947,0.35143,MIR6890_5P,0.956335859017157
WEIGEL_OXIDATIVE_STRESS_RESP...,SET,32,0.056229,0.0023454,0.14742,0.35144,WEIGEL_OXIDATIVE_STRESS_RESPONSE,0.956335859017157
GOBP_DENDRITIC_CELL_APOPTOTI...,SET,12,0.10372,0.0026509,0.27194,0.35145,GOBP_DENDRITIC_CELL_APOPTOTIC_PROCESS,0.956335859017157
GOBP_REGULATION_OF_BLOOD_BRA...,SET,9,0.12819,0.0028374,0.33611,0.35146,GOBP_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.956335859017157
GSE37534_UNTREATED_VS_ROSIGL...1,SET,182,0.024675,0.0024446,0.0647,0.35146,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.956335859017157
MIR302F,SET,167,0.0258,0.0024494,0.067651,0.35147,MIR302F,0.956335859017157
GOCC_PARANODAL_JUNCTION,SET,8,0.10668,0.0022263,0.27972,0.35147,GOCC_PARANODAL_JUNCTION,0.956335859017157
GOMF_EXTRACELLULAR_LIGAND_GA...,SET,67,0.044044,0.0026558,0.1155,0.35148,GOMF_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.956335859017157
MIR6869_5P,SET,37,0.05284,0.0023697,0.13865,0.35156,MIR6869_5P,0.956335859017157
GSE11924_TFH_VS_TH2_CD4_TCEL...2,SET,183,0.022917,0.0022765,0.060156,0.35162,GSE11924_TFH_VS_TH2_CD4_TCELL_UP,0.956335859017157
HP_APLASIA_HYPOPLASIA_OF_THE...7,SET,58,0.044524,0.0024986,0.11695,0.35171,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_FINGER,0.956335859017157
HP_ABNORMAL_RETICULOCYTE_MOR...,SET,73,0.03673,0.0023114,0.096485,0.35172,HP_ABNORMAL_RETICULOCYTE_MORPHOLOGY,0.956335859017157
NAKAMURA_METASTASIS_MODEL_UP,SET,39,0.04853,0.0022343,0.12751,0.35176,NAKAMURA_METASTASIS_MODEL_UP,0.956335859017157
REACTOME_CD28_CO_STIMULATION,SET,32,0.059789,0.0024939,0.1571,0.35176,REACTOME_CD28_CO_STIMULATION,0.956335859017157
SUZUKI_RESPONSE_TO_TSA_AND_D...1,SET,20,0.080377,0.0026514,0.21126,0.3518,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,0.956335859017157
HP_ABNORMALITY_OF_THE_ENDOCR...,SET,1248,0.009494,0.0023896,0.024953,0.3518,HP_ABNORMALITY_OF_THE_ENDOCRINE_SYSTEM,0.956335859017157
HP_ABNORMALITY_OF_THE_SUBUNG...,SET,11,0.093502,0.002288,0.2458,0.35183,HP_ABNORMALITY_OF_THE_SUBUNGUAL_REGION,0.956335859017157
REACTOME_ACTIVATED_NTRK2_SIG...3,SET,7,0.12826,0.0025039,0.33722,0.35185,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN,0.956335859017157
KEGG_MEDICUS_REFERENCE_TLR3_...1,SET,9,0.10764,0.0023826,0.28304,0.35186,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY,0.956335859017157
GSE9037_CTRL_VS_LPS_1H_STIM_...1,SET,176,0.024816,0.002418,0.06525,0.35186,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN,0.956335859017157
WP_GENES_RELATED_TO_PRIMARY_...,SET,88,0.03224,0.0022267,0.084776,0.35187,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,0.956335859017157
GSE17721_LPS_VS_PAM3CSK4_6H_...2,SET,185,0.023358,0.0023329,0.06143,0.35188,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP,0.956335859017157
KEGG_MEDICUS_PATHOGEN_HPV_E6...1,SET,12,0.097264,0.0024858,0.25583,0.3519,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380,0.956335859017157
BIOCARTA_CD40_PATHWAY,SET,12,0.096159,0.0024576,0.25293,0.35191,BIOCARTA_CD40_PATHWAY,0.956335859017157
GSE22025_UNTREATED_VS_TGFB1_...2,SET,177,0.024689,0.0024124,0.064942,0.35191,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.956335859017157
GOBP_CARBOHYDRATE_BIOSYNTHET...,SET,186,0.023954,0.0023988,0.063065,0.35204,GOBP_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,0.956335859017157
GSE12003_4D_VS_8D_CULTURE_BM...2,SET,153,0.026212,0.0023829,0.069034,0.35208,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP,0.956335859017157
RAMJAUN_APOPTOSIS_BY_TGFB1_V...4,SET,10,0.10961,0.0025574,0.28868,0.35209,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,0.956335859017157
GOMF_CHEMOREPELLENT_ACTIVITY,SET,28,0.065015,0.002537,0.17124,0.3521,GOMF_CHEMOREPELLENT_ACTIVITY,0.956335859017157
REACTOME_TRIGLYCERIDE_CATABO...,SET,23,0.070715,0.0025013,0.18629,0.35212,REACTOME_TRIGLYCERIDE_CATABOLISM,0.956335859017157
GSE3982_BCELL_VS_CENT_MEMORY...2,SET,177,0.024067,0.0023516,0.063412,0.35215,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.956335859017157
chr8p11,SET,50,0.084534,0.0044054,0.22278,0.35218,chr8p11,0.956335859017157
GOMF_LYSOPHOSPHOLIPASE_ACTIV...,SET,26,0.06139,0.0023085,0.16179,0.35218,GOMF_LYSOPHOSPHOLIPASE_ACTIVITY,0.956335859017157
GOBP_REGULATION_OF_ADIPOSE_T...,SET,14,0.086918,0.0023992,0.22911,0.35221,GOBP_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.956335859017157
HP_HYPERGRANULOSIS,SET,20,0.072576,0.0023941,0.19136,0.35225,HP_HYPERGRANULOSIS,0.956335859017157
GSE40274_CTRL_VS_XBP1_TRANSD...1,SET,148,0.02526,0.0022587,0.066619,0.35228,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.956335859017157
GSE8685_IL2_ACT_IL2_STARVED_...4,SET,161,0.026202,0.0024428,0.069115,0.35231,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.956335859017157
WP_NEURAL_CREST_CELL_MIGRATI...1,SET,37,0.057142,0.0025626,0.15083,0.3524,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,0.956335859017157
MIR298,SET,170,0.024672,0.0023631,0.065123,0.3524,MIR298,0.956335859017157
GAVISH_3CA_MALIGNANT_METAPRO...34,SET,36,0.049708,0.002199,0.13124,0.35244,GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED,0.956335859017157
EPPERT_LSC_R,SET,36,0.048572,0.0021487,0.12828,0.35248,EPPERT_LSC_R,0.956335859017157
HP_ABNORMAL_LARGE_INTESTINE_...2,SET,52,0.046624,0.0024778,0.12316,0.3525,HP_ABNORMAL_LARGE_INTESTINE_PHYSIOLOGY,0.956335859017157
GOBP_NEGATIVE_REGULATION_OF_...8,SET,10,0.10928,0.0025497,0.28868,0.35251,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.956335859017157
GOCC_TOR_COMPLEX,SET,12,0.090037,0.0023011,0.23789,0.35254,GOCC_TOR_COMPLEX,0.956335859017157
ACEVEDO_LIVER_CANCER_DN,SET,490,0.0147,0.0023693,0.038845,0.35256,ACEVEDO_LIVER_CANCER_DN,0.956335859017157
GOBP_NEGATIVE_REGULATION_OF_...195,SET,17,0.069699,0.0021199,0.18423,0.3526,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.956335859017157
HP_LONG_EYELASHES,SET,115,0.02914,0.002299,0.077022,0.3526,HP_LONG_EYELASHES,0.956335859017157
GUCY1B1_TARGET_GENES,SET,517,0.014352,0.0023742,0.03794,0.35261,GUCY1B1_TARGET_GENES,0.956335859017157
REACTOME_BASE_EXCISION_REPAIR,SET,44,0.044448,0.0021733,0.1175,0.35262,REACTOME_BASE_EXCISION_REPAIR,0.956335859017157
EBNA1BP2_TARGET_GENES,SET,290,0.019123,0.0023843,0.050557,0.35263,EBNA1BP2_TARGET_GENES,0.956335859017157
HP_RENAL_AGENESIS,SET,178,0.023983,0.00235,0.063416,0.35265,HP_RENAL_AGENESIS,0.956335859017157
MIR200A_3P,SET,366,0.017579,0.0024571,0.046496,0.35269,MIR200A_3P,0.956335859017157
HP_LOW_1_MINUTE_APGAR_SCORE,SET,6,0.1637,0.0029589,0.43298,0.35269,HP_LOW_1_MINUTE_APGAR_SCORE,0.956335859017157
GAVISH_3CA_METAPROGRAM_FIBRO...12,SET,41,0.054844,0.0025888,0.1451,0.35272,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_COMPLEMENT,0.956335859017157
MIR6780A_3P,SET,138,0.027536,0.0023783,0.072864,0.35275,MIR6780A_3P,0.956335859017157
KORKOLA_CHORIOCARCINOMA_UP,SET,3,0.21039,0.0026892,0.55679,0.35277,KORKOLA_CHORIOCARCINOMA_UP,0.956335859017157
GOBP_NEGATIVE_REGULATION_OF_...210,SET,46,0.052636,0.0026314,0.13931,0.35278,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.956335859017157
GSE17721_POLYIC_VS_GARDIQUIM...16,SET,186,0.024259,0.0024293,0.064208,0.35278,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP,0.956335859017157
REACTOME_NRCAM_INTERACTIONS,SET,6,0.1326,0.0023966,0.351,0.3528,REACTOME_NRCAM_INTERACTIONS,0.956335859017157
KEGG_MEDICUS_REFERENCE_MDA5_...,SET,21,0.07807,0.0026388,0.20667,0.35281,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY,0.956335859017157
chr5q11,SET,34,0.095379,0.0041007,0.25258,0.35286,chr5q11,0.956335859017157
PETRETTO_BLOOD_PRESSURE_DN,SET,7,0.12919,0.0025222,0.34221,0.35289,PETRETTO_BLOOD_PRESSURE_DN,0.956335859017157
HP_ABNORMAL_ENDOMETRIUM_MORP...,SET,28,0.055145,0.0021519,0.14606,0.35289,HP_ABNORMAL_ENDOMETRIUM_MORPHOLOGY,0.956335859017157
REACTOME_TRANSMISSION_ACROSS...,SET,252,0.021899,0.0025479,0.058016,0.35292,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,0.956335859017157
GOBP_U4_SNRNA_3_END_PROCESSI...,SET,7,0.11648,0.0022739,0.30865,0.35295,GOBP_U4_SNRNA_3_END_PROCESSING,0.956335859017157
HP_HYPOPLASTIC_LABIA_MINORA,SET,28,0.066979,0.0026137,0.17755,0.353,HP_HYPOPLASTIC_LABIA_MINORA,0.956335859017157
REACTOME_CELLULAR_SENESCENCE,SET,122,0.029018,0.0023575,0.076941,0.35304,REACTOME_CELLULAR_SENESCENCE,0.956335859017157
BUSSLINGER_GASTRIC_D_CELLS,SET,24,0.074985,0.0027093,0.19899,0.35315,BUSSLINGER_GASTRIC_D_CELLS,0.956335859017157
GOMF_SNARE_BINDING,SET,102,0.031598,0.0023486,0.083855,0.35316,GOMF_SNARE_BINDING,0.956335859017157
HP_DISTAL_UPPER_LIMB_MUSCLE_...,SET,37,0.056342,0.0025267,0.14952,0.35316,HP_DISTAL_UPPER_LIMB_MUSCLE_WEAKNESS,0.956335859017157
GOBP_POSITIVE_REGULATION_OF_...704,SET,18,0.08193,0.0025641,0.21756,0.35324,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,0.956335859017157
GOBP_MONOACYLGLYCEROL_BIOSYN...,SET,7,0.12934,0.002525,0.34352,0.35327,GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.956335859017157
GOBP_NITRIC_OXIDE_SYNTHASE_B...,SET,18,0.089005,0.0027855,0.23641,0.35328,GOBP_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.956335859017157
GOBP_PROTEIN_PROCESSING,SET,217,0.021843,0.0023606,0.058018,0.35328,GOBP_PROTEIN_PROCESSING,0.956335859017157
REACTOME_ALPHA_LINOLENIC_OME...,SET,12,0.09485,0.0024241,0.25201,0.35332,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,0.956335859017157
HP_PANCYTOPENIA,SET,116,0.028802,0.0022821,0.076564,0.35339,HP_PANCYTOPENIA,0.956335859017157
GSE9037_CTRL_VS_LPS_4H_STIM_...3,SET,183,0.024357,0.0024195,0.064755,0.35341,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN,0.956335859017157
REACTOME_TRANSCRIPTIONAL_REG...2,SET,57,0.04477,0.0024906,0.11904,0.35343,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,0.956335859017157
GOBP_ANTIBACTERIAL_INNATE_IM...,SET,8,0.11499,0.0023998,0.30577,0.35343,GOBP_ANTIBACTERIAL_INNATE_IMMUNE_RESPONSE,0.956335859017157
GOMF_HISTONE_H4K16_ACETYLTRA...,SET,8,0.10485,0.0021883,0.2788,0.35343,GOMF_HISTONE_H4K16_ACETYLTRANSFERASE_ACTIVITY,0.956335859017157
GOMF_INTERLEUKIN_12_RECEPTOR...,SET,5,0.18117,0.0029894,0.48186,0.35347,GOMF_INTERLEUKIN_12_RECEPTOR_BINDING,0.956335859017157
HOXB7_TARGET_GENES,SET,24,0.066391,0.0023988,0.17663,0.35351,HOXB7_TARGET_GENES,0.956335859017157
GOBP_RELAXATION_OF_SMOOTH_MU...,SET,6,0.14145,0.0025567,0.3764,0.35353,GOBP_RELAXATION_OF_SMOOTH_MUSCLE,0.956335859017157
GOBP_REGULATION_OF_CYCLIN_DE...,SET,73,0.036984,0.0023274,0.098425,0.35355,GOBP_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.956335859017157
GOBP_POSITIVE_REGULATION_OF_...714,SET,79,0.038206,0.0025008,0.1017,0.35358,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.956335859017157
GOMF_PROMOTER_SPECIFIC_CHROM...,SET,61,0.039311,0.0022621,0.10467,0.35362,GOMF_PROMOTER_SPECIFIC_CHROMATIN_BINDING,0.956335859017157
HP_BILATERAL_CAMPTODACTYLY,SET,5,0.13851,0.0022854,0.3689,0.35366,HP_BILATERAL_CAMPTODACTYLY,0.956335859017157
HP_RESTLESSNESS,SET,127,0.029544,0.0024486,0.078701,0.35369,HP_RESTLESSNESS,0.956335859017157
REACTOME_SIGNALING_BY_TGFB_F...,SET,149,0.027216,0.0024418,0.072505,0.3537,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,0.956335859017157
GOBP_DEVELOPMENTAL_GROWTH_IN...,SET,211,0.023175,0.0024701,0.061741,0.3537,GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS,0.956335859017157
GSE22886_IGA_VS_IGM_MEMORY_B...2,SET,172,0.025049,0.0024131,0.066739,0.35371,GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP,0.956335859017157
PID_IL3_PATHWAY,SET,25,0.06712,0.0024751,0.17889,0.35375,PID_IL3_PATHWAY,0.956335859017157
WP_G_PROTEIN_SIGNALING,SET,90,0.034535,0.002412,0.092048,0.35376,WP_G_PROTEIN_SIGNALING,0.956335859017157
PIEPOLI_LGI1_TARGETS_UP,SET,12,0.10869,0.0027777,0.28973,0.35378,PIEPOLI_LGI1_TARGETS_UP,0.956335859017157
WP_GLYCOSAMINOGLYCAN_DEGRADA...,SET,16,0.084324,0.0024882,0.22486,0.35383,WP_GLYCOSAMINOGLYCAN_DEGRADATION,0.956335859017157
GOBP_DNA_METHYLATION_DEPENDE...,SET,30,0.057707,0.0023308,0.15393,0.35387,GOBP_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.956335859017157
REACTOME_DARPP_32_EVENTS,SET,24,0.063237,0.0022848,0.16871,0.3539,REACTOME_DARPP_32_EVENTS,0.956335859017157
MIR6780B_5P,SET,258,0.019461,0.0022907,0.05195,0.35398,MIR6780B_5P,0.956335859017157
HP_ECTOPIC_THYROID,SET,5,0.16582,0.002736,0.44263,0.35398,HP_ECTOPIC_THYROID,0.956335859017157
GOBP_POSITIVE_REGULATION_OF_...177,SET,3,0.18903,0.0024161,0.50481,0.35404,GOBP_POSITIVE_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,0.956335859017157
HP_BRUSHFIELD_SPOTS,SET,12,0.087046,0.0022247,0.23254,0.35408,HP_BRUSHFIELD_SPOTS,0.956335859017157
NAKAYA_PBMC_FLUARIX_FLUVIRIN...6,SET,379,0.016617,0.0023627,0.044393,0.35409,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,0.956335859017157
HP_ABNORMAL_4TH_METACARPAL_M...,SET,14,0.093596,0.0025836,0.25011,0.35412,HP_ABNORMAL_4TH_METACARPAL_MORPHOLOGY,0.956335859017157
GSE3982_MAST_CELL_VS_NEUTROP...1,SET,176,0.024064,0.0023447,0.064306,0.35413,GSE3982_MAST_CELL_VS_NEUTROPHIL_DN,0.956335859017157
MIR3140_3P,SET,207,0.022865,0.0024141,0.061108,0.35414,MIR3140_3P,0.956335859017157
REACTOME_TP53_REGULATES_TRAN...9,SET,18,0.070306,0.0022003,0.18794,0.35417,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,0.956335859017157
GOBP_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.14302,0.002585,0.38229,0.35417,GOBP_L_LYSINE_TRANSMEMBRANE_TRANSPORT,0.956335859017157
GOBP_ORNITHINE_TRANSPORT,SET,6,0.14302,0.002585,0.38229,0.35417,GOBP_ORNITHINE_TRANSPORT,0.956335859017157
GOMF_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.14302,0.002585,0.38229,0.35417,GOMF_L_LYSINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.956335859017157
REACTOME_SIGNALING_BY_LTK,SET,10,0.10093,0.0023549,0.26988,0.35421,REACTOME_SIGNALING_BY_LTK,0.956335859017157
GSE28737_WT_VS_BCL6_KO_MARGI...1,SET,174,0.023844,0.0023102,0.063765,0.35423,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.956335859017157
GOBP_CANONICAL_WNT_SIGNALING...,SET,287,0.0201,0.0024933,0.053767,0.35427,GOBP_CANONICAL_WNT_SIGNALING_PATHWAY,0.956335859017157
GSE14350_TREG_VS_TEFF_IN_IL2...2,SET,183,0.022585,0.0022435,0.060418,0.35428,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP,0.956335859017157
TRAVAGLINI_LUNG_PERICYTE_CELL,SET,109,0.034192,0.0026267,0.091472,0.35428,TRAVAGLINI_LUNG_PERICYTE_CELL,0.956335859017157
KEGG_MEDICUS_VARIANT_BCL2_OV...,SET,7,0.11454,0.0022361,0.30658,0.35435,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.956335859017157
HP_ABNORMAL_MIDBRAIN_MORPHOL...,SET,72,0.034961,0.002185,0.093579,0.35435,HP_ABNORMAL_MIDBRAIN_MORPHOLOGY,0.956335859017157
MODULE_159,SET,69,0.03477,0.0021275,0.093111,0.35442,MODULE_159,0.956335859017157
GOBP_CARDIAC_MUSCLE_CELL_ACT...1,SET,77,0.039767,0.0025699,0.10651,0.35444,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.956335859017157
GSE3982_MAC_VS_CENT_MEMORY_C...2,SET,179,0.022991,0.002259,0.061578,0.35444,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP,0.956335859017157
DESCARTES_FETAL_PANCREAS_VAS...,SET,54,0.047577,0.0025764,0.12742,0.35444,DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS,0.956335859017157
REACTOME_CD22_MEDIATED_BCR_R...,SET,4,0.17607,0.0025986,0.47221,0.35463,REACTOME_CD22_MEDIATED_BCR_REGULATION,0.956699965070248
DESCARTES_FETAL_HEART_VASCUL...,SET,16,0.086904,0.0025643,0.23308,0.35463,DESCARTES_FETAL_HEART_VASCULAR_ENDOTHELIAL_CELLS,0.956699965070248
REACTOME_HEMOSTASIS,SET,570,0.014303,0.0024808,0.038374,0.35468,REACTOME_HEMOSTASIS,0.956713306169965
MODULE_176,SET,209,0.02447,0.0025958,0.065654,0.35469,MODULE_176,0.956713306169965
KEGG_MEDICUS_REFERENCE_PDGF_...1,SET,13,0.092615,0.0024636,0.24857,0.35473,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY,0.956726643128734
GOBP_INTRACELLULAR_POTASSIUM...,SET,15,0.09331,0.002666,0.25048,0.35475,GOBP_INTRACELLULAR_POTASSIUM_ION_HOMEOSTASIS,0.956726643128734
ATF1_Q6,SET,219,0.022774,0.0024724,0.061152,0.3548,ATF1_Q6,0.956787243947858
HP_INCREASED_CEREBRAL_LIPOFU...,SET,11,0.092576,0.0022653,0.24871,0.35487,HP_INCREASED_CEREBRAL_LIPOFUSCIN,0.956901765070991
GOBP_INTRACELLULAR_TRANSPORT...,SET,10,0.099659,0.0023252,0.26783,0.35491,GOBP_INTRACELLULAR_TRANSPORT_OF_VIRUS,0.956927645143787
GOBP_PRODUCTION_OF_MOLECULAR...2,SET,205,0.022775,0.0023931,0.061251,0.35501,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.956927645143787
HP_ATROPHY_DEGENERATION_INVO...2,SET,34,0.0545,0.0023431,0.14658,0.35502,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.956927645143787
MURARO_PANCREAS_DUCTAL_CELL,SET,1166,0.010119,0.0024677,0.027221,0.35505,MURARO_PANCREAS_DUCTAL_CELL,0.956927645143787
GOMF_OXIDOREDUCTASE_ACTIVITY...28,SET,23,0.07311,0.002586,0.19669,0.35506,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN,0.956927645143787
GOBP_VENTRAL_SPINAL_CORD_INT...,SET,13,0.096953,0.002579,0.2609,0.35509,GOBP_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION,0.956927645143787
GSE13522_WT_VS_IFNG_KO_SKING...2,SET,107,0.031404,0.0023904,0.084518,0.35511,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,0.956927645143787
HP_POOR_COORDINATION,SET,32,0.056708,0.0023654,0.15265,0.35513,HP_POOR_COORDINATION,0.956927645143787
ACOSTA_PROLIFERATION_INDEPEN...1,SET,105,0.032186,0.0024271,0.086645,0.35515,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,0.956927645143787
YIH_RESPONSE_TO_ARSENITE_C1,SET,21,0.069638,0.0023538,0.1875,0.35517,YIH_RESPONSE_TO_ARSENITE_C1,0.956927645143787
HP_ABSCESS,SET,61,0.041736,0.0024017,0.11241,0.35521,HP_ABSCESS,0.956927645143787
GSE46606_IRF4HIGH_VS_WT_CD40...1,SET,185,0.023568,0.0023539,0.063475,0.35521,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.956927645143787
GOBP_REGULATION_OF_T_HELPER_...3,SET,31,0.059108,0.0024268,0.15931,0.35531,GOBP_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.957055308431494
DAVICIONI_TARGETS_OF_PAX_FOX...1,SET,62,0.043956,0.00255,0.11848,0.35532,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,0.957055308431494
GOBP_POSITIVE_REGULATION_OF_...734,SET,41,0.052734,0.0024892,0.14216,0.35534,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.957055308431494
GOBP_REGULATION_OF_TRANSMISS...,SET,13,0.095145,0.0025309,0.25658,0.35539,GOBP_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.95710875813449
GOMF_PENTOSYLTRANSFERASE_ACT...,SET,47,0.045969,0.0023229,0.12403,0.35546,GOMF_PENTOSYLTRANSFERASE_ACTIVITY,0.95710875813449
chr9p21,SET,42,0.082981,0.0039643,0.22391,0.35547,chr9p21,0.95710875813449
REACTOME_DNA_DAMAGE_BYPASS,SET,44,0.041924,0.0020499,0.11313,0.35547,REACTOME_DNA_DAMAGE_BYPASS,0.95710875813449
GOMF_HISTONE_H3K4_DEMETHYLAS...,SET,4,0.1525,0.0022507,0.41178,0.35556,GOMF_HISTONE_H3K4_DEMETHYLASE_ACTIVITY,0.957276923076923
MIR2115_5P,SET,123,0.028106,0.0022928,0.075923,0.35562,MIR2115_5P,0.957317066842228
HP_ABNORMAL_PLATELET_FUNCTION,SET,58,0.04033,0.0022632,0.10895,0.35563,HP_ABNORMAL_PLATELET_FUNCTION,0.957317066842228
PID_ALK1_PATHWAY,SET,24,0.064988,0.0023481,0.17566,0.3557,PID_ALK1_PATHWAY,0.957384112909471
GOMF_KINESIN_BINDING,SET,39,0.047787,0.0022001,0.12917,0.35571,GOMF_KINESIN_BINDING,0.957384112909471
GOBP_CARDIAC_MUSCLE_CELL_ACT...2,SET,57,0.047573,0.0026466,0.12868,0.3558,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION,0.95749782861124
GOCC_PHOSPHATIDYLINOSITOL_3_...3,SET,8,0.12846,0.0026808,0.3475,0.35582,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III,0.95749782861124
GSE26559_TCF1_KO_VS_WT_LIN_N...1,SET,174,0.023799,0.0023058,0.064389,0.35584,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN,0.95749782861124
MIR6883_5P,SET,372,0.016457,0.0023187,0.044537,0.35588,MIR6883_5P,0.95749782861124
VERRECCHIA_RESPONSE_TO_TGFB1...1,SET,19,0.069539,0.0022359,0.18822,0.35589,VERRECCHIA_RESPONSE_TO_TGFB1_C1,0.95749782861124
GOMF_PRE_MRNA_3_SPLICE_SITE_...,SET,3,0.17284,0.0022092,0.46804,0.35596,GOMF_PRE_MRNA_3_SPLICE_SITE_BINDING,0.957571395402833
GOBP_MRNA_TRANSCRIPTION,SET,46,0.042553,0.0021273,0.11525,0.35598,GOBP_MRNA_TRANSCRIPTION,0.957571395402833
HP_APLASTIC_ANEMIA,SET,24,0.062216,0.002248,0.16852,0.356,HP_APLASTIC_ANEMIA,0.957571395402833
chr3p26,SET,14,0.15138,0.0041785,0.41016,0.35604,chr3p26,0.957604875406284
HP_VENTRICULAR_ESCAPE_RHYTHM,SET,8,0.11674,0.0024364,0.31639,0.35607,HP_VENTRICULAR_ESCAPE_RHYTHM,0.957611456318192
GOCC_CYTOPLASMIC_SIDE_OF_END...1,SET,18,0.064787,0.0020276,0.17563,0.35611,GOCC_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.957644928040854
BENPORATH_OCT4_TARGETS,SET,258,0.020377,0.0023985,0.055283,0.35622,BENPORATH_OCT4_TARGETS,0.957792518954046
WP_DEGRADATION_PATHWAY_OF_SP...,SET,15,0.092232,0.0026352,0.25024,0.35622,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,0.957792518954046
MIR374C_3P,SET,47,0.049001,0.002476,0.13303,0.35631,MIR374C_3P,0.957960396843815
MIR6126,SET,106,0.029527,0.0022371,0.080224,0.35642,MIR6126,0.957972813732313
GOCC_DENDRITIC_TREE,SET,570,0.013754,0.0023855,0.037369,0.35642,GOCC_DENDRITIC_TREE,0.957972813732313
HP_MOTOR_REGRESSION,SET,19,0.07254,0.0023323,0.1971,0.35643,HP_MOTOR_REGRESSION,0.957972813732313
GOMF_STRUCTURAL_MOLECULE_ACT...1,SET,651,0.0128,0.0023671,0.034781,0.35644,GOMF_STRUCTURAL_MOLECULE_ACTIVITY,0.957972813732313
HP_ABNORMAL_DISTAL_FEMORAL_M...,SET,5,0.14882,0.0024556,0.40452,0.35648,HP_ABNORMAL_DISTAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.957972813732313
HP_PERINEAL_HYPOSPADIAS,SET,4,0.13898,0.0020511,0.37776,0.35648,HP_PERINEAL_HYPOSPADIAS,0.957972813732313
REACTOME_ZBP1_DAI_MEDIATED_I...,SET,20,0.066731,0.0022013,0.18162,0.35666,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,0.9583824261636
GSE43955_TH0_VS_TGFB_IL6_TH1...14,SET,183,0.023478,0.0023322,0.063944,0.35675,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP,0.958502922077922
GOBP_REGULATION_OF_RECEPTOR_...1,SET,13,0.089201,0.0023727,0.24296,0.35676,GOBP_REGULATION_OF_RECEPTOR_BINDING,0.958502922077922
REACTOME_ACTIVATION_OF_IRF3_...,SET,17,0.073045,0.0022217,0.1992,0.35693,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE,0.958769731149567
HP_ABNORMAL_ANTERIOR_CHAMBER...,SET,54,0.045855,0.0024832,0.12509,0.35697,HP_ABNORMAL_ANTERIOR_CHAMBER_MORPHOLOGY,0.958769731149567
HP_ASYMMETRY_OF_THE_THORAX,SET,6,0.12893,0.0023304,0.35172,0.35697,HP_ASYMMETRY_OF_THE_THORAX,0.958769731149567
HP_BILATERAL_TONIC_CLONIC_SE...2,SET,47,0.042461,0.0021456,0.11589,0.35704,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_FOCAL_ONSET,0.958769731149567
GSE13738_TCR_VS_BYSTANDER_AC...2,SET,178,0.023603,0.0023127,0.064425,0.35705,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.958769731149567
GAVISH_3CA_MALIGNANT_METAPRO...40,SET,45,0.046927,0.0023204,0.1281,0.35706,GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA,0.958769731149567
GOBP_HEMATOPOIETIC_OR_LYMPHO...,SET,96,0.0329,0.0023728,0.08982,0.35708,GOBP_HEMATOPOIETIC_OR_LYMPHOID_ORGAN_DEVELOPMENT,0.958769731149567
GOBP_MITOTIC_METAPHASE_CHROM...,SET,62,0.037263,0.0021618,0.10173,0.35708,GOBP_MITOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.958769731149567
GSE2585_THYMIC_MACROPHAGE_VS...2,SET,173,0.023623,0.0022823,0.064523,0.35714,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP,0.958856755504056
GOBP_CELL_FATE_COMMITMENT_IN...1,SET,31,0.058712,0.0024105,0.16041,0.35718,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER,0.958890074154179
WP_NRXN1_DELETION_SYNDROME,SET,14,0.089364,0.0024667,0.24424,0.35723,WP_NRXN1_DELETION_SYNDROME,0.958950231713911
GOMF_TRANSMEMBRANE_RECEPTOR_...3,SET,18,0.081233,0.0025423,0.22225,0.35737,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.959097899838449
GSE15930_STIM_VS_STIM_AND_IF...5,SET,181,0.022513,0.0022242,0.061651,0.3575,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN,0.959097899838449
GOBP_HEAD_MORPHOGENESIS,SET,35,0.054864,0.0023931,0.15029,0.35754,GOBP_HEAD_MORPHOGENESIS,0.959097899838449
GOBP_LEUKOTRIENE_TRANSPORT,SET,7,0.12457,0.0024318,0.34129,0.35756,GOBP_LEUKOTRIENE_TRANSPORT,0.959097899838449
REACTOME_DAP12_SIGNALING,SET,27,0.055013,0.0021081,0.15079,0.35762,REACTOME_DAP12_SIGNALING,0.959097899838449
REACTOME_INTERLEUKIN_17_SIGN...,SET,65,0.041268,0.0024511,0.11312,0.35762,REACTOME_INTERLEUKIN_17_SIGNALING,0.959097899838449
GOBP_ORGANELLE_FISSION,SET,450,0.01426,0.002205,0.039091,0.35764,GOBP_ORGANELLE_FISSION,0.959097899838449
DESCARTES_FETAL_THYMUS_STROM...,SET,116,0.030433,0.0024114,0.083453,0.35768,DESCARTES_FETAL_THYMUS_STROMAL_CELLS,0.959097899838449
CASTELLANO_NRAS_TARGETS_DN,SET,13,0.091285,0.0024282,0.25043,0.35774,CASTELLANO_NRAS_TARGETS_DN,0.959097899838449
GOBP_NEGATIVE_REGULATION_OF_...423,SET,17,0.0716,0.0021777,0.19655,0.35783,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.959097899838449
GOBP_POSTSYNAPTIC_MEMBRANE_A...,SET,7,0.11421,0.0022297,0.3136,0.35786,GOBP_POSTSYNAPTIC_MEMBRANE_ASSEMBLY,0.959097899838449
HAND1E47_01,SET,245,0.020858,0.0023934,0.057279,0.35787,HAND1E47_01,0.959097899838449
GSE29618_PRE_VS_DAY7_FLU_VAC...3,SET,178,0.022331,0.0021881,0.06132,0.35787,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN,0.959097899838449
HP_ANGLE_CLOSURE_GLAUCOMA,SET,5,0.15715,0.0025931,0.43165,0.3579,HP_ANGLE_CLOSURE_GLAUCOMA,0.959097899838449
GOBP_VENOUS_BLOOD_VESSEL_DEV...,SET,16,0.083601,0.0024669,0.22966,0.35792,GOBP_VENOUS_BLOOD_VESSEL_DEVELOPMENT,0.959097899838449
MIR4740_5P,SET,61,0.046125,0.0026542,0.12672,0.35794,MIR4740_5P,0.959097899838449
HP_NONPROGRESSIVE_CEREBELLAR...,SET,8,0.11852,0.0024735,0.32563,0.35794,HP_NONPROGRESSIVE_CEREBELLAR_ATAXIA,0.959097899838449
CHEN_LVAD_SUPPORT_OF_FAILING...2,SET,88,0.035022,0.0024188,0.096229,0.35795,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,0.959097899838449
GOBP_POSITIVE_REGULATION_OF_...72,SET,42,0.048205,0.002303,0.13249,0.35799,GOBP_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.959097899838449
REACTOME_ADVANCED_GLYCOSYLAT...,SET,13,0.083152,0.0022118,0.22861,0.35803,REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,0.959097899838449
GOMF_OXIDOREDUCTASE_ACTIVITY...2,SET,51,0.04305,0.0022658,0.1184,0.35809,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS,0.959097899838449
FLECHNER_PBL_KIDNEY_TRANSPLA...3,SET,50,0.041538,0.0021647,0.11428,0.35812,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,0.959097899838449
KEGG_MEDICUS_REFERENCE_CXCR4...3,SET,21,0.067333,0.0022759,0.18526,0.35813,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.959097899838449
MEF2_04,SET,23,0.064927,0.0022966,0.17866,0.35815,MEF2_04,0.959097899838449
GOBP_POSITIVE_REGULATION_OF_...117,SET,304,0.019049,0.0024308,0.052417,0.35815,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION,0.959097899838449
GOBP_PROTEIN_POLYUBIQUITINAT...,SET,251,0.018896,0.0021942,0.051999,0.35816,GOBP_PROTEIN_POLYUBIQUITINATION,0.959097899838449
GOMF_COA_TRANSFERASE_ACTIVITY,SET,5,0.15129,0.0024963,0.41638,0.35818,GOMF_COA_TRANSFERASE_ACTIVITY,0.959097899838449
GOBP_PROTEIN_INSERTION_INTO_...4,SET,4,0.12338,0.0018209,0.33969,0.35823,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE_FROM_INNER_SIDE,0.959097899838449
GOCC_MITOTIC_SPINDLE_MIDZONE,SET,13,0.083572,0.002223,0.23012,0.35824,GOCC_MITOTIC_SPINDLE_MIDZONE,0.959097899838449
GOBP_SEROTONIN_TRANSPORT,SET,20,0.078189,0.0025792,0.21533,0.35826,GOBP_SEROTONIN_TRANSPORT,0.959097899838449
GOBP_UNSATURATED_FATTY_ACID_...2,SET,104,0.032135,0.0024117,0.088498,0.35826,GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS,0.959097899838449
JAZAG_TGFB1_SIGNALING_VIA_SM...1,SET,59,0.040255,0.0022783,0.11089,0.3583,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,0.959097899838449
REACTOME_ORGANIC_CATION_ANIO...,SET,15,0.083958,0.0023988,0.23137,0.35835,REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,0.959097899838449
MIR449B_3P,SET,110,0.03088,0.002383,0.085107,0.35837,MIR449B_3P,0.959097899838449
GSE15930_NAIVE_VS_48H_IN_VIT...2,SET,181,0.023588,0.0023304,0.065031,0.35841,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP,0.959097899838449
HP_ASTERIXIS,SET,5,0.15297,0.0025241,0.42177,0.35842,HP_ASTERIXIS,0.959097899838449
HP_LOW_PLASMA_CITRULLINE,SET,5,0.12876,0.0021246,0.35508,0.35844,HP_LOW_PLASMA_CITRULLINE,0.959097899838449
WP_OXYSTEROLS_DERIVED_FROM_C...,SET,49,0.045693,0.0023574,0.12601,0.35845,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,0.959097899838449
GOBP_NEGATIVE_REGULATION_OF_...226,SET,13,0.094982,0.0025265,0.26202,0.35849,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.959097899838449
HP_CEPHALOHEMATOMA,SET,9,0.11034,0.0024424,0.3044,0.35849,HP_CEPHALOHEMATOMA,0.959097899838449
MURAKAMI_UV_RESPONSE_1HR_UP,SET,14,0.081445,0.0022482,0.22471,0.35851,MURAKAMI_UV_RESPONSE_1HR_UP,0.959097899838449
MIR4662A_5P,SET,81,0.034379,0.0022784,0.094865,0.35853,MIR4662A_5P,0.959097899838449
WP_IL4_SIGNALING,SET,50,0.046014,0.002398,0.127,0.35856,WP_IL4_SIGNALING,0.959097899838449
BYSTROEM_CORRELATED_WITH_IL5...1,SET,55,0.041481,0.0022669,0.11452,0.3586,BYSTROEM_CORRELATED_WITH_IL5_DN,0.959097899838449
GOBP_REGULATION_OF_SYNAPTIC_...8,SET,12,0.086561,0.0022122,0.23901,0.35861,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CYCLE,0.959097899838449
GOCC_SIGNAL_PEPTIDASE_COMPLEX,SET,5,0.12668,0.0020902,0.34979,0.35862,GOCC_SIGNAL_PEPTIDASE_COMPLEX,0.959097899838449
GOBP_VESICLE_MEDIATED_TRANSP...3,SET,209,0.021552,0.0022864,0.059531,0.35866,GOBP_VESICLE_MEDIATED_TRANSPORT_IN_SYNAPSE,0.959097899838449
GOCC_FLEMMING_BODY,SET,34,0.053896,0.0023172,0.14886,0.35866,GOCC_FLEMMING_BODY,0.959097899838449
DESCARTES_MAIN_FETAL_SATELLI...,SET,44,0.045652,0.0022322,0.12609,0.35866,DESCARTES_MAIN_FETAL_SATELLITE_CELLS,0.959097899838449
GOBP_PROTEIN_CONTAINING_COMP...1,SET,1372,0.0084175,0.0022134,0.023257,0.3587,GOBP_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.959097899838449
REACTOME_GRB7_EVENTS_IN_ERBB...,SET,5,0.15367,0.0025355,0.42463,0.35872,REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.959097899838449
GOBP_LENS_MORPHOGENESIS_IN_C...,SET,19,0.079876,0.0025682,0.22073,0.35872,GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.959097899838449
KYNG_ENVIRONMENTAL_STRESS_RE...4,SET,29,0.056796,0.0022555,0.15706,0.35882,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,0.959131266794626
WP_GLUCOCORTICOID_BIOSYNTHES...,SET,14,0.093066,0.0025689,0.25737,0.35883,WP_GLUCOCORTICOID_BIOSYNTHESIS,0.959131266794626
WP_REGULATORY_CIRCUITS_OF_ST...,SET,72,0.040673,0.0025421,0.11254,0.3589,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,0.959131266794626
GOCC_AXON,SET,601,0.013339,0.0023736,0.036909,0.3589,GOCC_AXON,0.959131266794626
HP_RAGGED_RED_MUSCLE_FIBERS,SET,40,0.04695,0.0021891,0.12993,0.35892,HP_RAGGED_RED_MUSCLE_FIBERS,0.959131266794626
BOQUEST_STEM_CELL_CULTURED_V...2,SET,383,0.01722,0.002461,0.047664,0.35895,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,0.959131266794626
HP_ABNORMAL_CIRCULATING_HAPT...,SET,11,0.08906,0.0021793,0.24662,0.35901,HP_ABNORMAL_CIRCULATING_HAPTOGLOBIN_CONCENTRATION,0.959131266794626
HP_INCREASED_CIRCULATING_INS...,SET,5,0.12784,0.0021094,0.35404,0.35901,HP_INCREASED_CIRCULATING_INSULIN_LIKE_GROWTH_FACTOR_1_CONCENTRATION,0.959131266794626
GSE45382_UNTREATED_VS_TGFB_T...1,SET,166,0.023533,0.0022275,0.065186,0.35905,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN,0.959131266794626
KEGG_PROXIMAL_TUBULE_BICARBO...,SET,21,0.069344,0.0023439,0.1921,0.35906,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,0.959131266794626
KEGG_MEDICUS_REFERENCE_RAB7_...,SET,40,0.04837,0.0022553,0.13404,0.3591,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT,0.959131266794626
GSE34156_UNTREATED_VS_24H_TL...2,SET,148,0.026165,0.0023397,0.072538,0.35916,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.959131266794626
GSE44955_MCSF_VS_MCSF_AND_IL...1,SET,180,0.022923,0.0022585,0.063588,0.35924,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN,0.959131266794626
BOHN_PRIMARY_IMMUNODEFICIENC...1,SET,36,0.052447,0.0023201,0.14552,0.35927,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,0.959131266794626
GSE22886_NAIVE_CD8_TCELL_VS_...10,SET,175,0.022966,0.0022315,0.063721,0.35927,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP,0.959131266794626
WP_IRON_METABOLISM_IN_PLACEN...,SET,12,0.095181,0.0024325,0.2641,0.35928,WP_IRON_METABOLISM_IN_PLACENTA,0.959131266794626
REACTOME_ADENYLATE_CYCLASE_A...,SET,10,0.10599,0.002473,0.29414,0.35929,REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY,0.959131266794626
GSE18791_CTRL_VS_NEWCASTLE_V...13,SET,142,0.026516,0.0023229,0.073633,0.35938,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN,0.959131266794626
JAZAG_TGFB1_SIGNALING_UP,SET,93,0.030662,0.0021767,0.085151,0.35939,JAZAG_TGFB1_SIGNALING_UP,0.959131266794626
MIR3619_3P,SET,49,0.051071,0.0026349,0.14182,0.35939,MIR3619_3P,0.959131266794626
GOBP_PYRIMIDINE_NUCLEOSIDE_M...1,SET,22,0.072015,0.0024914,0.19999,0.35939,GOBP_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS,0.959131266794626
GOMF_PHOSPHODIESTERASE_I_ACT...,SET,5,0.14303,0.0023601,0.39722,0.35939,GOMF_PHOSPHODIESTERASE_I_ACTIVITY,0.959131266794626
MCGARVEY_SILENCED_BY_METHYLA...,SET,41,0.052443,0.0024755,0.14566,0.35942,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,0.959131266794626
HP_SPINAL_CORD_LESION,SET,41,0.045674,0.0021559,0.12689,0.35944,HP_SPINAL_CORD_LESION,0.959131266794626
HP_NEURODEGENERATION,SET,76,0.034568,0.0022195,0.09604,0.35945,HP_NEURODEGENERATION,0.959131266794626
GSE32423_IL7_VS_IL7_IL4_NAIV...1,SET,172,0.022967,0.0022125,0.063806,0.35945,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN,0.959131266794626
GOBP_POSTSYNAPTIC_NEUROTRANS...,SET,26,0.058867,0.0022137,0.16365,0.35953,GOBP_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.95927108475357
GOBP_REGULATION_OF_GONAD_DEV...,SET,12,0.097914,0.0025024,0.27232,0.35959,GOBP_REGULATION_OF_GONAD_DEVELOPMENT,0.959274250325945
REACTOME_BETA_OXIDATION_OF_V...,SET,10,0.10044,0.0023434,0.27957,0.3597,REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS,0.959274250325945
GOCC_DNA_REPLICATION_FACTOR_...1,SET,12,0.07917,0.0020234,0.2205,0.35978,GOCC_DNA_REPLICATION_FACTOR_A_COMPLEX,0.959274250325945
GERHOLD_RESPONSE_TO_TZD_DN,SET,11,0.11052,0.0027043,0.30781,0.35979,GERHOLD_RESPONSE_TO_TZD_DN,0.959274250325945
GSE10273_LOW_IL7_VS_HIGH_IL7...1,SET,178,0.022335,0.0021885,0.062226,0.35982,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.959274250325945
ZNF20_TARGET_GENES,SET,5,0.12244,0.0020203,0.34115,0.35983,ZNF20_TARGET_GENES,0.959274250325945
GOBP_INTEGRATED_STRESS_RESPO...,SET,44,0.047092,0.0023026,0.13121,0.35983,GOBP_INTEGRATED_STRESS_RESPONSE_SIGNALING,0.959274250325945
GOBP_REGULATION_OF_MITOCHOND...5,SET,27,0.061316,0.0023496,0.17085,0.35984,GOBP_REGULATION_OF_MITOCHONDRIAL_FISSION,0.959274250325945
GOCC_KINETOCHORE_MICROTUBULE,SET,19,0.069447,0.0022329,0.19351,0.35984,GOCC_KINETOCHORE_MICROTUBULE,0.959274250325945
MORF_HDAC2,SET,248,0.018279,0.0021101,0.050939,0.35986,MORF_HDAC2,0.959274250325945
GSE32164_RESTING_DIFFERENTIA...2,SET,186,0.022283,0.0022314,0.062096,0.35986,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP,0.959274250325945
GOCC_CENTROSOME,SET,666,0.011587,0.0021665,0.032297,0.35989,GOCC_CENTROSOME,0.959274250325945
GSE22935_24H_VS_48H_MBOVIS_B...3,SET,178,0.023442,0.0022969,0.06534,0.35989,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.959274250325945
GOBP_HISTIDINE_METABOLIC_PRO...,SET,8,0.11481,0.0023961,0.32014,0.35994,GOBP_HISTIDINE_METABOLIC_PROCESS,0.95932428166424
GOBP_AGGRESSIVE_BEHAVIOR,SET,8,0.13097,0.0027334,0.36533,0.35998,GOBP_AGGRESSIVE_BEHAVIOR,0.95932428166424
REACTOME_HEME_SIGNALING,SET,45,0.04748,0.0023477,0.13248,0.36003,REACTOME_HEME_SIGNALING,0.95932428166424
GSE22886_IGM_MEMORY_BCELL_VS...4,SET,180,0.022829,0.0022493,0.063723,0.36008,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.95932428166424
GOBP_CELLULAR_RESPONSE_TO_WA...,SET,6,0.13303,0.0024044,0.37136,0.36009,GOBP_CELLULAR_RESPONSE_TO_WATER_STIMULUS,0.95932428166424
GOBP_ESTABLISHMENT_OF_ENDOTH...2,SET,13,0.090669,0.0024118,0.25316,0.36012,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER,0.95932428166424
BIOCARTA_ATRBRCA_PATHWAY,SET,21,0.057159,0.001932,0.15964,0.36015,BIOCARTA_ATRBRCA_PATHWAY,0.95932428166424
HP_HAND_MUSCLE_ATROPHY,SET,48,0.043475,0.00222,0.12142,0.36016,HP_HAND_MUSCLE_ATROPHY,0.95932428166424
SIMBULAN_UV_RESPONSE_NORMAL_...1,SET,33,0.057014,0.002415,0.1593,0.36021,SIMBULAN_UV_RESPONSE_NORMAL_DN,0.95932428166424
HP_AMENORRHEA,SET,171,0.02359,0.002266,0.065911,0.36021,HP_AMENORRHEA,0.95932428166424
GOBP_PROTEIN_LOCALIZATION_TO...37,SET,15,0.074355,0.0021244,0.20776,0.36022,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.95932428166424
GSE18791_CTRL_VS_NEWCASTLE_V...3,SET,169,0.024521,0.0023417,0.068527,0.36024,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN,0.95932428166424
REACTOME_CATION_COUPLED_CHLO...,SET,7,0.10592,0.0020677,0.29612,0.36029,REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS,0.95934981233244
REACTOME_MEIOTIC_SYNAPSIS,SET,31,0.052443,0.0021531,0.14667,0.36034,REACTOME_MEIOTIC_SYNAPSIS,0.95934981233244
GOBP_RENAL_SODIUM_ION_ABSORP...,SET,12,0.097599,0.0024943,0.27295,0.36034,GOBP_RENAL_SODIUM_ION_ABSORPTION,0.95934981233244
GSE17812_WT_VS_THPOK_KO_MEMO...2,SET,182,0.022246,0.0022038,0.062226,0.36036,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP,0.95934981233244
GOCC_MICROTUBULE_MINUS_END,SET,6,0.1485,0.0026842,0.41555,0.36041,GOCC_MICROTUBULE_MINUS_END,0.959409432444853
HP_NEOPLASM_OF_THE_SKELETAL_...,SET,97,0.030137,0.0021847,0.084356,0.36045,HP_NEOPLASM_OF_THE_SKELETAL_SYSTEM,0.959442425518879
GOBP_NEGATIVE_REGULATION_OF_...460,SET,23,0.061603,0.002179,0.17256,0.36055,GOBP_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.959499739782642
GSE36888_UNTREATED_VS_IL2_TR...8,SET,169,0.023117,0.0022076,0.064759,0.36056,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP,0.959499739782642
HP_ABNORMALLY_FOLDED_HELIX,SET,71,0.037387,0.0023204,0.10475,0.36058,HP_ABNORMALLY_FOLDED_HELIX,0.959499739782642
GOMF_MEMBRANE_POTENTIAL_DRIV...,SET,5,0.16015,0.0026425,0.44886,0.36062,GOMF_MEMBRANE_POTENTIAL_DRIVEN_UNIPORTER_ACTIVITY,0.959499739782642
GSE3982_EOSINOPHIL_VS_TH2_UP,SET,174,0.022796,0.0022086,0.063916,0.36068,GSE3982_EOSINOPHIL_VS_TH2_UP,0.959499739782642
FEKIR_HEPARG_SIDE_POP_VS_HEP...2,SET,77,0.034082,0.0022026,0.095572,0.36069,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP,0.959499739782642
HP_ALLERGIC_RHINITIS,SET,10,0.089769,0.0020945,0.25174,0.3607,HP_ALLERGIC_RHINITIS,0.959499739782642
GOBP_MIRNA_MEDIATED_GENE_SIL...2,SET,8,0.10526,0.0021968,0.2952,0.36071,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_MRNA_DESTABILIZATION,0.959499739782642
HP_MATERNAL_DIABETES,SET,39,0.051052,0.0023504,0.14319,0.36072,HP_MATERNAL_DIABETES,0.959499739782642
HP_POPLITEAL_PTERYGIUM,SET,8,0.11929,0.0024896,0.33471,0.36077,HP_POPLITEAL_PTERYGIUM,0.959559298232188
RHODES_UNDIFFERENTIATED_CANC...,SET,64,0.036066,0.0021257,0.10123,0.36081,RHODES_UNDIFFERENTIATED_CANCER,0.959592252066116
AREB6_03,SET,242,0.02018,0.0023015,0.056661,0.36086,AREB6_03,0.959611315125086
GSE37532_TREG_VS_TCONV_CD4_T...2,SET,181,0.021765,0.0021504,0.061118,0.36088,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP,0.959611315125086
HP_DUPLICATION_OF_PHALANX_OF...,SET,12,0.078854,0.0020153,0.22147,0.3609,HP_DUPLICATION_OF_PHALANX_OF_TOE,0.959611315125086
GOBP_REGULATION_OF_PROTEIN_L...12,SET,9,0.091981,0.002036,0.25839,0.36093,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.95961766753366
PAX3_TARGET_GENES,SET,1195,0.0093333,0.0023023,0.026249,0.36108,PAX3_TARGET_GENES,0.959922785681505
GOBP_ROOF_OF_MOUTH_DEVELOPME...,SET,89,0.036387,0.0025273,0.10235,0.3611,GOBP_ROOF_OF_MOUTH_DEVELOPMENT,0.959922785681505
MIR4704_3P,SET,124,0.027995,0.0022929,0.07884,0.36126,MIR4704_3P,0.960274669216061
GOBP_RETINAL_PIGMENT_EPITHEL...,SET,6,0.1368,0.0024725,0.38546,0.36134,GOBP_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT,0.960371124933221
MIR671_5P,SET,117,0.027993,0.0022275,0.078889,0.36136,MIR671_5P,0.960371124933221
GOCC_AMINOACYL_TRNA_SYNTHETA...,SET,3,0.13877,0.0017737,0.39117,0.36139,GOCC_AMINOACYL_TRNA_SYNTHETASE_MULTIENZYME_COMPLEX,0.960371124933221
GOBP_ENDOPLASMIC_RETICULUM_T...4,SET,19,0.067382,0.0021665,0.19004,0.36146,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.960371124933221
GOBP_PHOSPHATIDYLETHANOLAMIN...1,SET,7,0.12634,0.0024665,0.35642,0.36149,GOBP_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING,0.960371124933221
GOMF_INTRACELLULARLY_GATED_C...,SET,18,0.071076,0.0022244,0.20053,0.36151,GOMF_INTRACELLULARLY_GATED_CALCIUM_CHANNEL_ACTIVITY,0.960371124933221
GGCCAGT_MIR193A_MIR193B,SET,84,0.031232,0.0021077,0.088156,0.36157,GGCCAGT_MIR193A_MIR193B,0.960371124933221
GOBP_PROTEIN_DNA_COMPLEX_DIS...,SET,21,0.070656,0.0023882,0.19944,0.36157,GOBP_PROTEIN_DNA_COMPLEX_DISASSEMBLY,0.960371124933221
HP_APLASIA_OF_THE_ULNA,SET,5,0.1723,0.0028429,0.48633,0.36157,HP_APLASIA_OF_THE_ULNA,0.960371124933221
GOCC_CUL4B_RING_E3_UBIQUITIN...,SET,5,0.1195,0.0019718,0.33748,0.36163,GOCC_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.960371124933221
GOBP_NEGATIVE_REGULATION_OF_...523,SET,6,0.12059,0.0021796,0.34069,0.36169,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION,0.960371124933221
GSE6259_FLT3L_INDUCED_VS_WT_...2,SET,165,0.024446,0.002307,0.069064,0.36169,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP,0.960371124933221
GNF2_TAL1,SET,61,0.038424,0.0022111,0.10857,0.3617,GNF2_TAL1,0.960371124933221
HP_TYPE_II_TRANSFERRIN_ISOFO...,SET,13,0.081611,0.0021708,0.23062,0.36172,HP_TYPE_II_TRANSFERRIN_ISOFORM_PROFILE,0.960371124933221
GSE17721_0.5H_VS_8H_LPS_BMDC...2,SET,189,0.022073,0.002228,0.062392,0.36175,GSE17721_0.5H_VS_8H_LPS_BMDC_UP,0.960371124933221
HP_HYPERCOAGULABILITY,SET,15,0.081526,0.0023293,0.23046,0.36177,HP_HYPERCOAGULABILITY,0.960371124933221
DESCARTES_FETAL_HEART_ERYTHR...,SET,242,0.018131,0.0020679,0.051269,0.3618,DESCARTES_FETAL_HEART_ERYTHROBLASTS,0.960371124933221
WP_EDA_SIGNALING_IN_HAIR_FOL...,SET,11,0.099076,0.0024244,0.28017,0.36181,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,0.960371124933221
MIR139_3P,SET,14,0.088694,0.0024483,0.25089,0.36185,MIR139_3P,0.960371124933221
REACTOME_REGULATION_OF_BETA_...,SET,41,0.049227,0.0023237,0.13928,0.36188,REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,0.960371124933221
MIR4638_3P,SET,56,0.04088,0.0022542,0.11566,0.36188,MIR4638_3P,0.960371124933221
GOBP_MACROMOLECULE_CATABOLIC...,SET,1245,0.0085753,0.002156,0.024273,0.36194,GOBP_MACROMOLECULE_CATABOLIC_PROCESS,0.960371124933221
GOBP_PROTEIN_O_LINKED_GLYCOS...1,SET,87,0.033047,0.0022694,0.093552,0.36196,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION,0.960371124933221
GOCC_CUL4A_RING_E3_UBIQUITIN...,SET,12,0.089159,0.0022786,0.25241,0.36196,GOCC_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.960371124933221
HP_ABNORMAL_PAROTID_GLAND_MO...,SET,8,0.10916,0.0022781,0.30917,0.36202,HP_ABNORMAL_PAROTID_GLAND_MORPHOLOGY,0.960371124933221
MIR938,SET,69,0.034415,0.0021058,0.097495,0.36205,MIR938,0.960371124933221
WP_HAIR_FOLLICLE_DEVELOPMENT...1,SET,86,0.036852,0.0025163,0.10441,0.36206,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,0.960371124933221
GSE17721_12H_VS_24H_CPG_BMDC...2,SET,186,0.022166,0.0022197,0.062803,0.36207,GSE17721_12H_VS_24H_CPG_BMDC_UP,0.960371124933221
HP_PETERS_ANOMALY,SET,18,0.074609,0.0023349,0.21147,0.36212,HP_PETERS_ANOMALY,0.960408784041498
GOBP_N_GLYCAN_PROCESSING,SET,17,0.074964,0.00228,0.21259,0.36218,GOBP_N_GLYCAN_PROCESSING,0.960408784041498
SEMBA_FHIT_TARGETS_UP,SET,11,0.093737,0.0022937,0.26586,0.3622,SEMBA_FHIT_TARGETS_UP,0.960408784041498
GSE5542_IFNG_VS_IFNA_TREATED...3,SET,172,0.023801,0.0022928,0.067505,0.36221,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.960408784041498
REACTOME_ER_TO_GOLGI_ANTEROG...,SET,150,0.02358,0.0021226,0.066898,0.36224,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,0.960408784041498
GSE4590_PRE_BCELL_VS_VPREB_P...1,SET,147,0.02352,0.0020961,0.066731,0.36225,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.960408784041498
GSE40274_CTRL_VS_IRF4_TRANSD...2,SET,150,0.024858,0.0022377,0.070542,0.36228,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.960415057208238
GOBP_POSITIVE_REGULATION_OF_...271,SET,12,0.091704,0.0023437,0.26037,0.36234,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.960500854244527
REACTOME_ROS_AND_RNS_PRODUCT...,SET,33,0.054282,0.0022993,0.15423,0.36243,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,0.960546149153576
GSE27859_DC_VS_CD11C_INT_F48...4,SET,184,0.021939,0.0021853,0.06233,0.36243,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP,0.960546149153576
HP_NEOPLASM_OF_THE_NERVOUS_S...,SET,184,0.021728,0.0021642,0.061734,0.36244,HP_NEOPLASM_OF_THE_NERVOUS_SYSTEM,0.960546149153576
GSE10463_CD40L_AND_VA347_VS_...1,SET,147,0.02492,0.0022208,0.070858,0.36254,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN,0.960686654478976
HP_AORTIC_VALVE_CALCIFICATION,SET,8,0.1144,0.0023874,0.32532,0.36255,HP_AORTIC_VALVE_CALCIFICATION,0.960686654478976
KEGG_MEDICUS_REFERENCE_DNA_R...2,SET,17,0.066866,0.0020337,0.19022,0.3626,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION,0.960686654478976
MIR6768_5P,SET,186,0.022662,0.0022694,0.064493,0.36265,MIR6768_5P,0.960686654478976
GOBP_CELLULAR_RESPONSE_TO_FO...,SET,9,0.11824,0.0026172,0.33651,0.36266,GOBP_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS,0.960686654478976
GCM_HDAC1,SET,35,0.047333,0.0020646,0.13473,0.36268,GCM_HDAC1,0.960686654478976
BOYLAN_MULTIPLE_MYELOMA_C_CL...1,SET,27,0.0674,0.0025828,0.19192,0.36273,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,0.960686654478976
HP_GENERALIZED_LYMPHADENOPAT...,SET,9,0.10926,0.0024185,0.31125,0.36278,HP_GENERALIZED_LYMPHADENOPATHY,0.960686654478976
MARKEY_RB1_ACUTE_LOF_UP,SET,215,0.019928,0.0021438,0.056787,0.36283,MARKEY_RB1_ACUTE_LOF_UP,0.960686654478976
DURANTE_ADULT_OLFACTORY_NEUR...3,SET,21,0.067146,0.0022696,0.19135,0.36283,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD4_T_CELLS,0.960686654478976
GOBP_NEGATIVE_REGULATION_OF_...493,SET,6,0.13666,0.0024701,0.3895,0.36285,GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.960686654478976
GAVISH_3CA_MALIGNANT_METAPRO...36,SET,48,0.046837,0.0023917,0.13351,0.36287,GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS,0.960686654478976
GOCC_CHROMATOID_BODY,SET,12,0.097017,0.0024795,0.27655,0.36287,GOCC_CHROMATOID_BODY,0.960686654478976
GCM_CDH5,SET,31,0.051944,0.0021326,0.14808,0.36288,GCM_CDH5,0.960686654478976
MIR605_5P,SET,125,0.028324,0.0023291,0.08082,0.363,MIR605_5P,0.960870415778252
ZNF184_TARGET_GENES,SET,1075,0.0093026,0.0021841,0.026551,0.36303,ZNF184_TARGET_GENES,0.960870415778252
GOMF_CYCLIN_DEPENDENT_PROTEI...2,SET,14,0.077214,0.0021314,0.2204,0.36305,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.960870415778252
GSE26343_WT_VS_NFAT5_KO_MACR...4,SET,181,0.020954,0.0020702,0.059821,0.36306,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP,0.960870415778252
GOBP_RESPONSE_TO_FOLIC_ACID,SET,9,0.10209,0.0022597,0.29154,0.36311,GOBP_RESPONSE_TO_FOLIC_ACID,0.960929570547476
GNF2_MMP11,SET,36,0.056468,0.002498,0.16151,0.36331,GNF2_MMP11,0.961271922813428
BANDRES_RESPONSE_TO_CARMUSTI...8,SET,18,0.065202,0.0020406,0.18652,0.36333,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,0.961271922813428
GOBP_POSITIVE_REGULATION_OF_...481,SET,1054,0.0097157,0.0022601,0.027793,0.36333,GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.961271922813428
GOBP_ANDROGEN_METABOLIC_PROC...,SET,28,0.059685,0.002329,0.17076,0.36335,GOBP_ANDROGEN_METABOLIC_PROCESS,0.961271922813428
GOCC_NEURON_PROJECTION_TERMI...,SET,117,0.029468,0.0023448,0.084366,0.36344,GOCC_NEURON_PROJECTION_TERMINUS,0.961295009509319
GSE26669_CTRL_VS_COSTIM_BLOC...1,SET,174,0.022446,0.0021748,0.064265,0.36345,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN,0.961295009509319
FIGUEROA_AML_METHYLATION_CLU...2,SET,105,0.02987,0.0022524,0.085534,0.36346,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,0.961295009509319
HP_HYPERPIGMENTED_PAPULE,SET,5,0.11458,0.0018906,0.32814,0.36348,HP_HYPERPIGMENTED_PAPULE,0.961295009509319
HP_CHRONIC_FURUNCULOSIS,SET,4,0.15513,0.0022895,0.44449,0.36354,HP_CHRONIC_FURUNCULOSIS,0.961295009509319
GOBP_NEGATIVE_REGULATION_OF_...322,SET,96,0.029665,0.0021395,0.085012,0.36356,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.961295009509319
GSE13229_IMM_VS_MATURE_NKCEL...2,SET,181,0.021946,0.0021682,0.062895,0.36357,GSE13229_IMM_VS_MATURE_NKCELL_UP,0.961295009509319
HP_EPIPHORA,SET,22,0.065018,0.0022493,0.18635,0.36358,HP_EPIPHORA,0.961295009509319
GOMF_GLUCOSE_BINDING,SET,9,0.1068,0.002364,0.30619,0.36362,GOMF_GLUCOSE_BINDING,0.961319758156514
GOMF_GUANINE_NUCLEOTIDE_TRAN...,SET,5,0.1629,0.0026879,0.46713,0.36365,GOMF_GUANINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.961319758156514
MIR221_3P,SET,161,0.024329,0.0022682,0.06978,0.36368,MIR221_3P,0.961319758156514
GARGALOVIC_RESPONSE_TO_OXIDI...3,SET,59,0.036919,0.0020895,0.10591,0.3637,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,0.961319758156514
GOBP_REGULATION_OF_MEIOTIC_N...,SET,32,0.05302,0.0022116,0.15216,0.36376,GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.961350672799149
HP_ABNORMAL_PULMONARY_ALVEOL...,SET,5,0.15886,0.0026212,0.45598,0.36378,HP_ABNORMAL_PULMONARY_ALVEOLAR_SYSTEM_MORPHOLOGY,0.961350672799149
HP_NEUTROPENIA_IN_PRESENCE_O...,SET,21,0.066115,0.0022347,0.18982,0.36381,HP_NEUTROPENIA_IN_PRESENCE_OF_ANTI_NEUTROPIL_ANTIBODIES,0.961350672799149
KEGG_MEDICUS_ENV_FACTOR_NICO...2,SET,5,0.15738,0.0025968,0.4519,0.36383,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.961350672799149
GSE22886_NAIVE_TCELL_VS_NEUT...1,SET,173,0.024309,0.0023486,0.069815,0.36385,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN,0.961350672799149
GSE2770_UNTREATED_VS_IL12_TR...4,SET,179,0.021916,0.0021534,0.062971,0.36391,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.961426073131955
REACTOME_PYROPTOSIS,SET,26,0.063525,0.0023888,0.18259,0.36395,REACTOME_PYROPTOSIS,0.961426073131955
HP_PREMATURE_ARTERIOSCLEROSIS,SET,8,0.12162,0.0025382,0.34974,0.36401,HP_PREMATURE_ARTERIOSCLEROSIS,0.961426073131955
GSE22611_MUTANT_NOD2_VS_CTRL...2,SET,176,0.022167,0.00216,0.063757,0.36404,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,0.961426073131955
GOBP_CEREBROSPINAL_FLUID_CIR...,SET,9,0.10714,0.0023715,0.30821,0.36407,GOBP_CEREBROSPINAL_FLUID_CIRCULATION,0.961426073131955
HAY_BONE_MARROW_CD34_POS_LYM...,SET,7,0.13216,0.0025801,0.38036,0.36412,HAY_BONE_MARROW_CD34_POS_LYMPHOID_UNK,0.961426073131955
GOBP_PROTEIN_ACETYLATION,SET,49,0.038977,0.0020109,0.1122,0.36416,GOBP_PROTEIN_ACETYLATION,0.961426073131955
MODULE_392,SET,14,0.075541,0.0020852,0.21761,0.36424,MODULE_392,0.961426073131955
HP_INSULIN_RESISTANCE,SET,104,0.030629,0.0022987,0.088231,0.36424,HP_INSULIN_RESISTANCE,0.961426073131955
HP_REDUCED_FACTOR_XII_ACTIVI...,SET,6,0.11551,0.0020878,0.33287,0.3643,HP_REDUCED_FACTOR_XII_ACTIVITY,0.961426073131955
GSE10240_IL17_VS_IL17_AND_IL...2,SET,180,0.02178,0.002146,0.062769,0.3643,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.961426073131955
SANSOM_APC_TARGETS_REQUIRE_M...,SET,210,0.019488,0.0020722,0.056184,0.36435,SANSOM_APC_TARGETS_REQUIRE_MYC,0.961426073131955
GSE14699_DELETIONAL_TOLERANC...2,SET,169,0.022483,0.0021471,0.064817,0.36435,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.961426073131955
HP_ABNORMAL_PARATHYROID_MORP...,SET,22,0.06855,0.0023715,0.19769,0.36439,HP_ABNORMAL_PARATHYROID_MORPHOLOGY,0.961426073131955
GOBP_IRE1_MEDIATED_UNFOLDED_...,SET,20,0.068482,0.002259,0.19752,0.36441,GOBP_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.961426073131955
HP_DECREASED_CERVICAL_SPINE_...2,SET,11,0.087772,0.0021478,0.25315,0.36441,HP_DECREASED_CERVICAL_SPINE_MOBILITY,0.961426073131955
BOWIE_RESPONSE_TO_EXTRACELLU...,SET,17,0.068786,0.0020921,0.19846,0.36445,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,0.961426073131955
REACTOME_CLEC7A_DECTIN_1_IND...,SET,11,0.08292,0.002029,0.23937,0.36452,REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,0.961426073131955
AP2GAMMA_01,SET,232,0.019357,0.0021622,0.055897,0.36456,AP2GAMMA_01,0.961426073131955
GOBP_VENTRICULAR_TRABECULA_M...,SET,14,0.090213,0.0024902,0.26052,0.36457,GOBP_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS,0.961426073131955
chr3q22,SET,54,0.081331,0.0044043,0.23491,0.36459,chr3q22,0.961426073131955
GOBP_EAR_MORPHOGENESIS,SET,117,0.029145,0.0023192,0.084186,0.3646,GOBP_EAR_MORPHOGENESIS,0.961426073131955
GOCC_NUCLEAR_SPECK,SET,374,0.014708,0.0020777,0.042505,0.36466,GOCC_NUCLEAR_SPECK,0.961426073131955
chr4p14,SET,29,0.10554,0.0041913,0.3052,0.36474,chr4p14,0.961426073131955
HP_HYPOKINESIA,SET,46,0.040088,0.002004,0.11592,0.36474,HP_HYPOKINESIA,0.961426073131955
REACTOME_REGULATION_OF_GENE_...2,SET,21,0.070632,0.0023874,0.20427,0.36476,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,0.961426073131955
HP_HETEROTAXY,SET,21,0.064202,0.0021701,0.1857,0.36478,HP_HETEROTAXY,0.961426073131955
GSE17721_CTRL_VS_GARDIQUIMOD...13,SET,183,0.021846,0.0021702,0.063193,0.36478,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN,0.961426073131955
HP_ABNORMAL_RENAL_CORPUSCLE_...,SET,164,0.02321,0.0021838,0.067156,0.36482,HP_ABNORMAL_RENAL_CORPUSCLE_MORPHOLOGY,0.961426073131955
MIR1296_3P,SET,34,0.048534,0.0020866,0.14044,0.36483,MIR1296_3P,0.961426073131955
REACTOME_NOSTRIN_MEDIATED_EN...,SET,5,0.12545,0.0020699,0.36305,0.36485,REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING,0.961426073131955
GOBP_IMMUNOGLOBULIN_PRODUCTI...2,SET,47,0.041622,0.0021032,0.1205,0.36489,GOBP_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE,0.961426073131955
MIR539_5P,SET,341,0.016583,0.0022389,0.048041,0.36498,MIR539_5P,0.961426073131955
chr18p11,SET,63,0.074274,0.0043433,0.21527,0.36504,chr18p11,0.961426073131955
GOMF_BIOTIN_BINDING,SET,5,0.14012,0.002312,0.40614,0.36505,GOMF_BIOTIN_BINDING,0.961426073131955
KEGG_MEDICUS_VARIANT_LOSS_OF...3,SET,6,0.10082,0.0018223,0.29228,0.36507,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY,0.961426073131955
GOBP_POSITIVE_REGULATION_OF_...123,SET,31,0.054527,0.0022387,0.15809,0.36508,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.961426073131955
GSE12839_CTRL_VS_IL12_TREATE...1,SET,111,0.028181,0.0021846,0.081709,0.36509,GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN,0.961426073131955
MIR4660,SET,124,0.026624,0.0021806,0.07722,0.36513,MIR4660,0.961426073131955
GOBP_RESPONSE_TO_DSRNA,SET,49,0.045636,0.0023545,0.13239,0.36516,GOBP_RESPONSE_TO_DSRNA,0.961426073131955
GOMF_TUMOR_NECROSIS_FACTOR_B...,SET,6,0.11016,0.0019911,0.31959,0.36516,GOMF_TUMOR_NECROSIS_FACTOR_BINDING,0.961426073131955
GSE41867_DAY8_VS_DAY15_LCMV_...3,SET,178,0.020426,0.0020014,0.059259,0.36517,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.961426073131955
GOBP_UMP_CATABOLIC_PROCESS,SET,5,0.13176,0.0021741,0.38232,0.36519,GOBP_UMP_CATABOLIC_PROCESS,0.961426073131955
HP_ABNORMAL_CIRCULATING_C_RE...,SET,59,0.039635,0.0022432,0.1151,0.36529,HP_ABNORMAL_CIRCULATING_C_REACTIVE_PROTEIN_CONCENTRATION,0.961426073131955
WP_MICROTUBULE_CYTOSKELETON_...,SET,48,0.041727,0.0021307,0.12119,0.3653,WP_MICROTUBULE_CYTOSKELETON_REGULATION,0.961426073131955
GARCIA_PINERES_PBMC_HPV_16_L...5,SET,12,0.087239,0.0022296,0.25336,0.3653,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.961426073131955
REACTOME_GLOBAL_GENOME_NUCLE...,SET,79,0.029894,0.0019567,0.086823,0.36531,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,0.961426073131955
HE_LIM_SUN_FETAL_LUNG_C0_MYO...2,SET,78,0.036899,0.0023999,0.10717,0.36531,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL,0.961426073131955
GSE36891_UNSTIM_VS_PAM_TLR2_...2,SET,173,0.022926,0.0022149,0.066603,0.36534,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.961426073131955
GOBP_POSITIVE_REGULATION_OF_...224,SET,66,0.033779,0.0020216,0.098145,0.36536,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.961426073131955
PTEN_DN.V2_UP,SET,126,0.027946,0.0023072,0.081199,0.36536,PTEN_DN.V2_UP,0.961426073131955
MIR548O_3P,SET,250,0.019104,0.002214,0.055516,0.36538,MIR548O_3P,0.961426073131955
MIR6837_5P,SET,116,0.026893,0.0021308,0.078157,0.36539,MIR6837_5P,0.961426073131955
SQSTM1_TARGET_GENES,SET,30,0.052153,0.0021065,0.15156,0.36539,SQSTM1_TARGET_GENES,0.961426073131955
GOBP_NEURON_CELLULAR_HOMEOST...,SET,58,0.037717,0.0021166,0.10962,0.3654,GOBP_NEURON_CELLULAR_HOMEOSTASIS,0.961426073131955
GSE27786_LSK_VS_LIN_NEG_CELL...2,SET,179,0.021905,0.0021523,0.063694,0.36546,GSE27786_LSK_VS_LIN_NEG_CELL_UP,0.961511150643452
HP_TALL_CHIN,SET,5,0.10559,0.0017422,0.30714,0.36551,HP_TALL_CHIN,0.961569907652714
MIR3613_5P,SET,64,0.039173,0.0023088,0.114,0.36557,MIR3613_5P,0.961654961398728
RIEGE_DELTANP63_DIRECT_TARGE...,SET,130,0.026394,0.0022131,0.076836,0.36561,RIEGE_DELTANP63_DIRECT_TARGETS_UP,0.961687394989783
GOMF_PROTEIN_ARGININE_DEIMIN...,SET,5,0.15641,0.0025808,0.45636,0.3659,GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY,0.961878192333863
GOBP_LIPID_BIOSYNTHETIC_PROC...,SET,668,0.011587,0.0021695,0.033809,0.36591,GOBP_LIPID_BIOSYNTHETIC_PROCESS,0.961878192333863
HP_REDUCED_NATURAL_KILLER_CE...2,SET,24,0.058641,0.0021188,0.17111,0.36591,HP_REDUCED_NATURAL_KILLER_CELL_COUNT,0.961878192333863
HP_PERIPHERAL_RETINAL_DEGENE...,SET,6,0.13393,0.0024208,0.39084,0.36592,HP_PERIPHERAL_RETINAL_DEGENERATION,0.961878192333863
GOBP_REGULATION_OF_MACROPHAG...2,SET,9,0.088151,0.0019512,0.25726,0.36593,GOBP_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.961878192333863
GSE2585_CTEC_VS_MTEC_THYMUS_...1,SET,187,0.021651,0.0021739,0.063195,0.36595,GSE2585_CTEC_VS_MTEC_THYMUS_DN,0.961878192333863
HP_ABNORMAL_SERUM_INSULIN_LI...,SET,26,0.056996,0.0021433,0.16639,0.36597,HP_ABNORMAL_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1_LEVEL,0.961878192333863
WP_MRNA_PROCESSING,SET,116,0.024865,0.0019702,0.072591,0.36598,WP_MRNA_PROCESSING,0.961878192333863
GOBP_REGULATION_OF_EMBRYONIC...,SET,81,0.03196,0.0021182,0.093338,0.36602,GOBP_REGULATION_OF_EMBRYONIC_DEVELOPMENT,0.961878192333863
ROVERSI_GLIOMA_COPY_NUMBER_UP,SET,80,0.040358,0.0026582,0.11787,0.36603,ROVERSI_GLIOMA_COPY_NUMBER_UP,0.961878192333863
WP_GPCRS_CLASS_A_RHODOPSINLI...,SET,230,0.021967,0.0024432,0.064165,0.36604,WP_GPCRS_CLASS_A_RHODOPSINLIKE,0.961878192333863
MIR155_5P,SET,215,0.020797,0.0022373,0.06075,0.36605,MIR155_5P,0.961878192333863
GOBP_RECEPTOR_CATABOLIC_PROC...,SET,26,0.057106,0.0021474,0.16683,0.36606,GOBP_RECEPTOR_CATABOLIC_PROCESS,0.961878192333863
GOBP_ADULT_HEART_DEVELOPMENT,SET,13,0.088873,0.002364,0.25965,0.36607,GOBP_ADULT_HEART_DEVELOPMENT,0.961878192333863
chr1q43,SET,21,0.10873,0.0036751,0.31793,0.36618,chr1q43,0.962094488962806
CADWELL_ATG16L1_TARGETS_UP,SET,93,0.031806,0.002258,0.093058,0.36626,CADWELL_ATG16L1_TARGETS_UP,0.962212205793603
GOCC_KAINATE_SELECTIVE_GLUTA...,SET,5,0.1329,0.0021929,0.38914,0.36636,GOCC_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,0.962212205793603
GOMF_KAINATE_SELECTIVE_GLUTA...,SET,5,0.1329,0.0021929,0.38914,0.36636,GOMF_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY,0.962212205793603
WP_HEPATITIS_B_INFECTION,SET,141,0.025326,0.0022109,0.074173,0.36639,WP_HEPATITIS_B_INFECTION,0.962212205793603
LEF1_UP.V1_UP,SET,173,0.023574,0.0022775,0.069057,0.36641,LEF1_UP.V1_UP,0.962212205793603
REACTOME_DIGESTION,SET,17,0.081837,0.0024891,0.23983,0.36647,REACTOME_DIGESTION,0.962212205793603
GOBP_NEUROMUSCULAR_JUNCTION_...,SET,47,0.042238,0.0021343,0.12379,0.36648,GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.962212205793603
HP_RECURRENT_LOWER_RESPIRATO...,SET,212,0.020634,0.0022044,0.060488,0.36651,HP_RECURRENT_LOWER_RESPIRATORY_TRACT_INFECTIONS,0.962212205793603
TASOR_TARGET_GENES,SET,209,0.020584,0.0021837,0.060349,0.36652,TASOR_TARGET_GENES,0.962212205793603
RYBP_TARGET_GENES,SET,1410,0.0082601,0.0021994,0.024224,0.36656,RYBP_TARGET_GENES,0.962212205793603
MODULE_308,SET,63,0.035828,0.0020951,0.10511,0.36661,MODULE_308,0.962212205793603
WOOD_EBV_EBNA1_TARGETS_UP,SET,103,0.030005,0.0022411,0.088058,0.36665,WOOD_EBV_EBNA1_TARGETS_UP,0.962212205793603
GSE43955_1H_VS_20H_ACT_CD4_T...4,SET,184,0.021566,0.0021481,0.063298,0.36667,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.962212205793603
WP_PHOTODYNAMIC_THERAPYINDUC...3,SET,23,0.069175,0.0024468,0.20311,0.36671,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,0.962212205793603
GILMORE_CORE_NFKB_PATHWAY,SET,10,0.090453,0.0021104,0.26562,0.36673,GILMORE_CORE_NFKB_PATHWAY,0.962212205793603
KEGG_MEDICUS_PATHOGEN_HCMV_U...4,SET,8,0.10948,0.0022848,0.32152,0.36674,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.962212205793603
GOMF_FATTY_ACID_DERIVATIVE_B...,SET,18,0.06832,0.0021381,0.20064,0.36674,GOMF_FATTY_ACID_DERIVATIVE_BINDING,0.962212205793603
GOCC_F_ACTIN_CAPPING_PROTEIN...,SET,8,0.095467,0.0019923,0.28044,0.36677,GOCC_F_ACTIN_CAPPING_PROTEIN_COMPLEX,0.962212205793603
MIR450B_3P,SET,42,0.044019,0.002103,0.12939,0.36685,MIR450B_3P,0.962212205793603
GOCC_90S_PRERIBOSOME,SET,23,0.059306,0.0020978,0.17432,0.36685,GOCC_90S_PRERIBOSOME,0.962212205793603
REACTOME_PP2A_MEDIATED_DEPHO...,SET,6,0.12126,0.0021918,0.35664,0.36692,REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.962212205793603
GAUTAM_EYE_IRIS_CILIARY_BODY...8,SET,99,0.031098,0.0022774,0.091468,0.36693,GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS,0.962212205793603
GOBP_UDP_N_ACETYLGLUCOSAMINE...1,SET,9,0.10059,0.0022265,0.29586,0.36694,GOBP_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS,0.962212205793603
HP_COARSE_HAIR,SET,48,0.038521,0.0019671,0.11332,0.36696,HP_COARSE_HAIR,0.962212205793603
REACTOME_ACTIVATION_OF_CASPA...,SET,5,0.11763,0.0019409,0.34607,0.36697,REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE,0.962212205793603
GSE37301_RAG2_KO_VS_RAG2_AND...2,SET,181,0.021415,0.0021157,0.063004,0.36697,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP,0.962212205793603
GOBP_SOFT_PALATE_DEVELOPMENT,SET,5,0.15489,0.0025557,0.45573,0.36698,GOBP_SOFT_PALATE_DEVELOPMENT,0.962212205793603
MIR555,SET,39,0.04844,0.0022302,0.14255,0.367,MIR555,0.962212205793603
GOCC_NBAF_COMPLEX,SET,16,0.076991,0.0022718,0.22668,0.36706,GOCC_NBAF_COMPLEX,0.96225055438226
MIR4443,SET,155,0.024114,0.0022063,0.071002,0.36707,MIR4443,0.96225055438226
HP_CONGENITAL_ABNORMAL_HAIR_...,SET,272,0.017397,0.0021017,0.051263,0.36717,HP_CONGENITAL_ABNORMAL_HAIR_PATTERN,0.962440104834452
HP_PARANOIA,SET,20,0.061949,0.0020435,0.18284,0.36738,HP_PARANOIA,0.962651680735604
REN_ALVEOLAR_RHABDOMYOSARCOM...1,SET,369,0.015471,0.0021711,0.045672,0.3674,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,0.962651680735604
FRASOR_RESPONSE_TO_ESTRADIOL...1,SET,69,0.036986,0.0022631,0.10922,0.36744,FRASOR_RESPONSE_TO_ESTRADIOL_DN,0.962651680735604
HP_ABNORMALITY_OF_THE_ADRENA...,SET,199,0.020782,0.0021519,0.061371,0.36744,HP_ABNORMALITY_OF_THE_ADRENAL_GLANDS,0.962651680735604
TSANG_PBMC_FLUVIRIN_PANDEMRI...,SET,65,0.037004,0.0021978,0.10927,0.36744,TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE,0.962651680735604
GOCC_NONHOMOLOGOUS_END_JOINI...,SET,7,0.093214,0.0018198,0.27532,0.36747,GOCC_NONHOMOLOGOUS_END_JOINING_COMPLEX,0.962651680735604
MIR4761_3P,SET,46,0.042732,0.0021362,0.12622,0.36748,MIR4761_3P,0.962651680735604
HDGF_TARGET_GENES,SET,717,0.010916,0.0021146,0.032248,0.3675,HDGF_TARGET_GENES,0.962651680735604
GSE41176_UNSTIM_VS_ANTI_IGM_...12,SET,181,0.020021,0.001978,0.05915,0.3675,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP,0.962651680735604
GOBP_MEDIUM_CHAIN_FATTY_ACYL...,SET,6,0.11829,0.0021381,0.3496,0.36754,GOBP_MEDIUM_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,0.962663312274368
GOBP_CELL_RECOGNITION,SET,152,0.025153,0.0022791,0.074406,0.36767,GOBP_CELL_RECOGNITION,0.962663312274368
KEGG_MEDICUS_ENV_FACTOR_IRON...,SET,18,0.072706,0.0022754,0.21516,0.36771,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.962663312274368
HARALAMBIEVA_PBMC_FLUARIX_AG...4,SET,15,0.08328,0.0023794,0.24646,0.36772,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_POSITIVE,0.962663312274368
MIR574_3P,SET,5,0.13933,0.002299,0.4124,0.36774,MIR574_3P,0.962663312274368
GSE32423_IL7_VS_IL7_IL4_MEMO...1,SET,180,0.020288,0.0019989,0.060082,0.36781,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.962663312274368
GOBP_PHOSPHORYLATION,SET,1255,0.0085441,0.0021561,0.025305,0.36782,GOBP_PHOSPHORYLATION,0.962663312274368
GSE19888_ADENOSINE_A3R_ACT_V...5,SET,160,0.021829,0.0020289,0.064664,0.36784,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN,0.962663312274368
GOBP_MULTICELLULAR_ORGANISM_...,SET,136,0.026089,0.002237,0.077298,0.36787,GOBP_MULTICELLULAR_ORGANISM_GROWTH,0.962663312274368
GOBP_CYTOPLASM_ORGANIZATION,SET,15,0.076037,0.0021725,0.22537,0.36791,GOBP_CYTOPLASM_ORGANIZATION,0.962663312274368
GSE23502_WT_VS_HDC_KO_MYELOI...4,SET,184,0.021347,0.0021263,0.063276,0.36792,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP,0.962663312274368
MIR4319,SET,404,0.014194,0.0020823,0.042084,0.36795,MIR4319,0.962663312274368
DESCARTES_MAIN_FETAL_ENS_NEU...,SET,27,0.059876,0.0022944,0.17752,0.36795,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.962663312274368
HP_THIN_RIBS,SET,46,0.042437,0.0021215,0.1259,0.36804,HP_THIN_RIBS,0.962663312274368
GOBP_NEGATIVE_REGULATION_OF_...480,SET,5,0.12644,0.0020863,0.37517,0.36805,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.962663312274368
WP_TCELL_ACTIVATION_SARSCOV2,SET,86,0.032422,0.0022138,0.096205,0.36806,WP_TCELL_ACTIVATION_SARSCOV2,0.962663312274368
GOBP_DIACYLGLYCEROL_BIOSYNTH...,SET,9,0.097466,0.0021574,0.28933,0.36811,GOBP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.962663312274368
GSE5679_PPARG_LIGAND_ROSIGLI...2,SET,181,0.020555,0.0020308,0.061021,0.36812,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.962663312274368
chr10p11,SET,23,0.10195,0.0036061,0.30268,0.36813,chr10p11,0.962663312274368
REACTOME_PROLACTIN_RECEPTOR_...,SET,14,0.077529,0.0021401,0.23019,0.36813,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,0.962663312274368
MIR6892_3P,SET,92,0.030641,0.0021636,0.090969,0.36813,MIR6892_3P,0.962663312274368
GSE32986_UNSTIM_VS_GMCSF_AND...2,SET,180,0.020919,0.0020611,0.062123,0.36816,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.962663312274368
MIR6844,SET,306,0.016868,0.0021595,0.050104,0.36819,MIR6844,0.962663312274368
GOBP_VESICLE_MEDIATED_TRANSP...2,SET,44,0.044563,0.0021789,0.13237,0.3682,GOBP_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS,0.962663312274368
GOBP_TRANSITION_BETWEEN_FAST...,SET,7,0.1067,0.002083,0.317,0.36822,GOBP_TRANSITION_BETWEEN_FAST_AND_SLOW_FIBER,0.962663312274368
KEGG_MEDICUS_REFERENCE_CCR5_...,SET,26,0.057826,0.0021745,0.17182,0.36823,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY,0.962663312274368
HP_NECK_MUSCLE_WEAKNESS,SET,84,0.030521,0.0020597,0.090708,0.36826,HP_NECK_MUSCLE_WEAKNESS,0.962663312274368
REACTOME_REGULATION_OF_GENE_...4,SET,5,0.15109,0.002493,0.44909,0.36828,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS,0.962663312274368
GSE24081_CONTROLLER_VS_PROGR...2,SET,178,0.022155,0.0021709,0.065928,0.36842,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP,0.962956839888697
REACTOME_DOPAMINE_NEUROTRANS...,SET,20,0.069533,0.0022937,0.20706,0.36851,REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.962979762887371
MIR5195_3P,SET,290,0.017261,0.0021522,0.051432,0.36858,MIR5195_3P,0.962979762887371
LIN_SILENCED_BY_TUMOR_MICROE...,SET,96,0.031873,0.0022987,0.094976,0.36859,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,0.962979762887371
GSE369_IFNG_KO_VS_WT_LIVER_DN,SET,170,0.020826,0.0019947,0.062062,0.3686,GSE369_IFNG_KO_VS_WT_LIVER_DN,0.962979762887371
BIOCARTA_CPSF_PATHWAY,SET,9,0.095721,0.0021188,0.28536,0.36865,BIOCARTA_CPSF_PATHWAY,0.962979762887371
HP_INCREASED_CUP_TO_DISC_RAT...,SET,8,0.11693,0.0024402,0.34862,0.36866,HP_INCREASED_CUP_TO_DISC_RATIO,0.962979762887371
FAN_EMBRYONIC_CTX_EX_2_EXCIT...,SET,15,0.082691,0.0023626,0.24659,0.36869,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.962979762887371
GOMF_OXIDOREDUCTASE_ACTIVITY...31,SET,59,0.034521,0.0019537,0.10298,0.36873,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS,0.962979762887371
GOBP_PYRUVATE_METABOLIC_PROC...,SET,109,0.027123,0.0020836,0.080922,0.36875,GOBP_PYRUVATE_METABOLIC_PROCESS,0.962979762887371
GCM_ATM,SET,23,0.05743,0.0020314,0.17139,0.36879,GCM_ATM,0.962979762887371
GOMF_RNA_POLYMERASE_II_C_TER...,SET,10,0.079168,0.0018471,0.23631,0.36881,GOMF_RNA_POLYMERASE_II_C_TERMINAL_DOMAIN_BINDING,0.962979762887371
GOBP_REGULATION_OF_T_HELPER_...1,SET,22,0.063659,0.0022023,0.19016,0.36891,GOBP_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.962979762887371
GSE40068_BCL6_POS_VS_NEG_CXC...2,SET,186,0.020908,0.0020938,0.062477,0.36894,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP,0.962979762887371
PASINI_SUZ12_TARGETS_UP,SET,93,0.031248,0.0022183,0.093377,0.36895,PASINI_SUZ12_TARGETS_UP,0.962979762887371
MORF_PAX7,SET,242,0.01875,0.0021384,0.056029,0.36895,MORF_PAX7,0.962979762887371
REACTOME_CIPROFLOXACIN_ADME,SET,5,0.13287,0.0021923,0.39716,0.36899,REACTOME_CIPROFLOXACIN_ADME,0.962979762887371
GOBP_POSITIVE_REGULATION_OF_...534,SET,17,0.073385,0.002232,0.2194,0.36901,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.962979762887371
GSE31082_DN_VS_CD4_SP_THYMOC...1,SET,180,0.020623,0.0020319,0.061663,0.36903,GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN,0.962979762887371
HP_INCREASED_T_CELL_COUNT,SET,4,0.15494,0.0022867,0.46341,0.36906,HP_INCREASED_T_CELL_COUNT,0.962979762887371
GSE5589_IL6_KO_VS_IL10_KO_LP...2,SET,179,0.020997,0.0020631,0.062807,0.36907,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.962979762887371
GOBP_BASE_CONVERSION_OR_SUBS...,SET,16,0.088001,0.0025967,0.26326,0.36909,GOBP_BASE_CONVERSION_OR_SUBSTITUTION_EDITING,0.962979762887371
MIR6753_5P,SET,20,0.065116,0.002148,0.19487,0.36913,MIR6753_5P,0.962979762887371
HP_AXIAL_DYSTONIA,SET,15,0.070794,0.0020227,0.21187,0.36914,HP_AXIAL_DYSTONIA,0.962979762887371
WP_NICOTINE_METABOLISM_IN_LI...,SET,6,0.14678,0.002653,0.43937,0.36916,WP_NICOTINE_METABOLISM_IN_LIVER_CELLS,0.962979762887371
KAPOSI_LIVER_CANCER_MET_UP,SET,18,0.062123,0.0019442,0.186,0.36919,KAPOSI_LIVER_CANCER_MET_UP,0.962979762887371
SAUL_SEN_MAYO,SET,123,0.029627,0.0024168,0.088719,0.36921,SAUL_SEN_MAYO,0.962979762887371
BIOCARTA_P53_PATHWAY,SET,16,0.066435,0.0019603,0.19899,0.36924,BIOCARTA_P53_PATHWAY,0.962979762887371
KEGG_MEDICUS_PATHOGEN_SARS_C...3,SET,3,0.24635,0.0031488,0.73794,0.36925,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE,0.962979762887371
REACTOME_ACTIVATED_NTRK2_SIG...4,SET,7,0.11772,0.0022982,0.35266,0.36926,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K,0.962979762887371
GOMF_MANNOSE_BINDING,SET,22,0.06285,0.0021743,0.18828,0.36926,GOMF_MANNOSE_BINDING,0.962979762887371
WP_TCA_CYCLE_AND_DEFICIENCY_...,SET,15,0.076236,0.0021782,0.22854,0.36935,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,0.963055809766709
HP_ELEVATED_SERUM_11_DEOXYCO...,SET,9,0.10569,0.0023394,0.31683,0.36935,HP_ELEVATED_SERUM_11_DEOXYCORTISOL,0.963055809766709
JIANG_MELANOMA_TRM7_CD8,SET,78,0.031453,0.0020458,0.094319,0.36939,JIANG_MELANOMA_TRM7_CD8,0.963055809766709
GAVISH_3CA_METAPROGRAM_CD8_T...1,SET,44,0.045347,0.0022173,0.13599,0.3694,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE,0.963055809766709
GOBP_L_LEUCINE_TRANSPORT,SET,10,0.092958,0.0021689,0.27887,0.36944,GOBP_L_LEUCINE_TRANSPORT,0.963087848784878
HP_IMPAIRED_CORTISOL_RESPONS...,SET,5,0.1387,0.0022885,0.41626,0.3695,HP_IMPAIRED_CORTISOL_RESPONSE_TO_INSULIN_STIMULATION_TEST,0.963125847457627
GOBP_VASCULOGENESIS_INVOLVED...,SET,4,0.1681,0.0024809,0.50454,0.36951,GOBP_VASCULOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.963125847457627
GOBP_NEGATIVE_REGULATION_OF_...236,SET,5,0.14783,0.0024392,0.44409,0.36962,GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.963219676186193
WP_AMINO_ACID_METABOLISM_IN_...,SET,7,0.11035,0.0021543,0.33162,0.36966,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.963219676186193
WP_ALTERNATIVE_PATHWAY_OF_FE...,SET,11,0.086723,0.0021221,0.2607,0.3697,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,0.963219676186193
GOBP_MESODERMAL_CELL_DIFFERE...,SET,31,0.052503,0.0021556,0.15784,0.3697,GOBP_MESODERMAL_CELL_DIFFERENTIATION,0.963219676186193
MIR6790_3P,SET,4,0.16124,0.0023797,0.48481,0.36973,MIR6790_3P,0.963219676186193
DESCARTES_MAIN_FETAL_SKELETA...,SET,134,0.024515,0.0020867,0.073712,0.36973,DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS,0.963219676186193
CAHOY_NEURONAL,SET,97,0.031607,0.0022913,0.095045,0.36974,CAHOY_NEURONAL,0.963219676186193
GOBP_MATURE_CONVENTIONAL_DEN...,SET,5,0.1453,0.0023974,0.43704,0.36977,GOBP_MATURE_CONVENTIONAL_DENDRITIC_CELL_DIFFERENTIATION,0.963225629590766
DESCARTES_FETAL_PLACENTA_TRO...,SET,66,0.039218,0.0023471,0.11803,0.36984,DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS,0.963333501910542
GOBP_REGULATION_OF_CENTROSOM...,SET,52,0.037663,0.0020015,0.11342,0.36992,GOBP_REGULATION_OF_CENTROSOME_CYCLE,0.963333501910542
RUBENSTEIN_SKELETAL_MUSCLE_F...1,SET,154,0.024394,0.0022248,0.073469,0.36993,RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS,0.963333501910542
WP_SARSCOV2_MITOCHONDRIAL_CH...,SET,22,0.061573,0.0021301,0.18545,0.36994,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.963333501910542
KEGG_MEDICUS_REFERENCE_GHRHR...,SET,28,0.054246,0.0021168,0.16339,0.36995,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY,0.963333501910542
GSE3039_CD4_TCELL_VS_B1_BCEL...2,SET,184,0.020817,0.0020735,0.062726,0.37,GSE3039_CD4_TCELL_VS_B1_BCELL_UP,0.963391519328738
HP_EMG_NEUROPATHIC_CHANGES,SET,48,0.039134,0.0019984,0.11799,0.37007,HP_EMG_NEUROPATHIC_CHANGES,0.963455460674157
GSE1460_CD4_THYMOCYTE_VS_NAI...3,SET,176,0.021526,0.0020975,0.064905,0.37008,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.963455460674157
GSE43955_TH0_VS_TGFB_IL6_TH1...6,SET,173,0.021845,0.0021105,0.065882,0.37011,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP,0.963461392405063
AR_Q2,SET,115,0.027061,0.0021349,0.081728,0.37028,AR_Q2,0.963622484898203
ZFP28_TARGET_GENES,SET,69,0.034204,0.0020929,0.10332,0.3703,ZFP28_TARGET_GENES,0.963622484898203
GRUETZMANN_PANCREATIC_CANCER...1,SET,182,0.021058,0.0020862,0.063649,0.37038,GRUETZMANN_PANCREATIC_CANCER_DN,0.963622484898203
GSE15659_NAIVE_CD4_TCELL_VS_...6,SET,156,0.022605,0.0020748,0.068329,0.37039,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP,0.963622484898203
HP_SCAPULAR_WINGING,SET,88,0.029549,0.0020408,0.089328,0.3704,HP_SCAPULAR_WINGING,0.963622484898203
GOBP_REGULATION_OF_CALCIUM_I...1,SET,5,0.13023,0.0021489,0.39371,0.37041,GOBP_REGULATION_OF_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.963622484898203
MIR3120_5P,SET,77,0.03158,0.0020408,0.095507,0.37045,MIR3120_5P,0.963622484898203
HP_UPPER_AIRWAY_OBSTRUCTION,SET,15,0.078365,0.002239,0.23702,0.37046,HP_UPPER_AIRWAY_OBSTRUCTION,0.963622484898203
GSE360_CTRL_VS_L_MAJOR_MAC_DN,SET,171,0.021121,0.0020288,0.063882,0.37047,GSE360_CTRL_VS_L_MAJOR_MAC_DN,0.963622484898203
DESCARTES_FETAL_STOMACH_MUC1...,SET,81,0.033439,0.0022161,0.10114,0.37047,DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS,0.963622484898203
GNF2_MCM5,SET,54,0.037256,0.0020175,0.11274,0.37053,GNF2_MCM5,0.963622484898203
MODULE_560,SET,10,0.078903,0.0018409,0.23879,0.37054,MODULE_560,0.963622484898203
MIR1273C,SET,6,0.10574,0.0019112,0.32013,0.37059,MIR1273C,0.963622484898203
REACTOME_COMPLEX_III_ASSEMBLY,SET,22,0.055542,0.0019215,0.16826,0.37067,REACTOME_COMPLEX_III_ASSEMBLY,0.963622484898203
HP_ABNORMALITY_OF_SKELETAL_M...1,SET,358,0.014796,0.0020458,0.044834,0.3707,HP_ABNORMALITY_OF_SKELETAL_MATURATION,0.963622484898203
HP_ABNORMAL_TRABECULAR_BONE_...,SET,28,0.053368,0.0020825,0.16172,0.3707,HP_ABNORMAL_TRABECULAR_BONE_MORPHOLOGY,0.963622484898203
GOBP_POSITIVE_REGULATION_OF_...52,SET,31,0.049075,0.0020148,0.14874,0.37072,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION,0.963622484898203
GOBP_REGULATION_OF_PLASMA_LI...,SET,72,0.034683,0.0021677,0.10517,0.37079,GOBP_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS,0.963622484898203
HP_FOOT_DORSIFLEXOR_WEAKNESS,SET,128,0.024695,0.0020548,0.074899,0.37081,HP_FOOT_DORSIFLEXOR_WEAKNESS,0.963622484898203
GSE37534_UNTREATED_VS_ROSIGL...2,SET,177,0.020999,0.0020519,0.063702,0.37083,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.963622484898203
REACTOME_RAB_GERANYLGERANYLA...,SET,57,0.03743,0.0020823,0.11356,0.37085,REACTOME_RAB_GERANYLGERANYLATION,0.963622484898203
GOBP_ATRIAL_CARDIAC_MUSCLE_T...1,SET,20,0.072583,0.0023943,0.22027,0.37088,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.963622484898203
KEGG_MEDICUS_REFERENCE_CA2_C...2,SET,12,0.078937,0.0020174,0.23959,0.37091,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY,0.963622484898203
GOBP_REGULATION_OF_RIBOSOME_...,SET,6,0.10985,0.0019855,0.33359,0.37097,GOBP_REGULATION_OF_RIBOSOME_BIOGENESIS,0.963622484898203
TIMOFEEVA_GROWTH_STRESS_VIA_...,SET,16,0.071807,0.0021188,0.21809,0.37099,TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,0.963622484898203
REACTOME_DOWNREGULATION_OF_T...,SET,25,0.054834,0.002022,0.16658,0.37101,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,0.963622484898203
MORF_BRCA1,SET,242,0.017713,0.0020201,0.053841,0.37109,MORF_BRCA1,0.963622484898203
GOBP_POST_TRANSLATIONAL_PROT...2,SET,14,0.071381,0.0019704,0.21705,0.37113,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_ENDOPLASMIC_RETICULUM_MEMBRANE,0.963622484898203
DESCARTES_FETAL_INTESTINE_EN...2,SET,131,0.027162,0.0022861,0.082591,0.37113,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.963622484898203
WP_ENTEROHEPATIC_CIRCULATION...,SET,12,0.084554,0.0021609,0.25715,0.37115,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,0.963622484898203
GOBP_REGULATION_OF_LENS_FIBE...,SET,8,0.10905,0.0022758,0.33169,0.37117,GOBP_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.963622484898203
HEBERT_MATRISOME_TNBC_LIVER_...,SET,13,0.085213,0.0022667,0.25922,0.37118,HEBERT_MATRISOME_TNBC_LIVER_METASTASIS,0.963622484898203
BERENJENO_TRANSFORMED_BY_RHO...1,SET,354,0.014981,0.0020601,0.045575,0.37119,BERENJENO_TRANSFORMED_BY_RHOA_DN,0.963622484898203
GOCC_MANCHETTE,SET,20,0.065294,0.0021539,0.19863,0.37119,GOCC_MANCHETTE,0.963622484898203
GSE1791_CTRL_VS_NEUROMEDINU_...4,SET,173,0.021047,0.0020334,0.06405,0.37123,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP,0.963622484898203
REACTOME_DEGRADATION_OF_CYST...,SET,14,0.07537,0.0020805,0.22955,0.37133,REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,0.963622484898203
LINDGREN_BLADDER_CANCER_CLUS...5,SET,343,0.016277,0.0022039,0.04958,0.37135,LINDGREN_BLADDER_CANCER_CLUSTER_2B,0.963622484898203
HP_CRANIAL_ASYMMETRY,SET,15,0.071099,0.0020314,0.21666,0.3714,HP_CRANIAL_ASYMMETRY,0.963622484898203
GOBP_POSITIVE_REGULATION_OF_...38,SET,123,0.026439,0.0021568,0.080579,0.37141,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.963622484898203
REACTOME_EPHA_MEDIATED_GROWT...,SET,29,0.056087,0.0022273,0.17094,0.37142,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,0.963622484898203
chr2p22,SET,40,0.086536,0.0040348,0.26383,0.37146,chr2p22,0.963622484898203
PUJANA_BRCA_CENTERED_NETWORK,SET,110,0.024642,0.0019017,0.07513,0.37146,PUJANA_BRCA_CENTERED_NETWORK,0.963622484898203
MIR1257,SET,88,0.030405,0.0021,0.092726,0.37149,MIR1257,0.963622484898203
REACTOME_DEVELOPMENTAL_BIOLO...,SET,1245,0.008702,0.0021879,0.026546,0.37153,REACTOME_DEVELOPMENTAL_BIOLOGY,0.963622484898203
HP_PSEUDOEPIPHYSES_OF_THE_PH...,SET,5,0.14147,0.0023343,0.43173,0.37158,HP_PSEUDOEPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.963622484898203
GOBP_POSITIVE_REGULATION_OF_...809,SET,11,0.087356,0.0021376,0.26662,0.37159,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.963622484898203
GOMF_RNA_POLYMERASE_II_GENER...1,SET,35,0.041895,0.0018275,0.12788,0.37161,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.963622484898203
LINDGREN_BLADDER_CANCER_CLUS...1,SET,348,0.015074,0.0020555,0.046025,0.37164,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,0.963622484898203
E2F1DP1_01,SET,209,0.019253,0.0020425,0.058795,0.37166,E2F1DP1_01,0.963622484898203
E2F1DP2_01,SET,209,0.019253,0.0020425,0.058795,0.37166,E2F1DP2_01,0.963622484898203
E2F4DP2_01,SET,209,0.019253,0.0020425,0.058795,0.37166,E2F4DP2_01,0.963622484898203
E2F_02,SET,209,0.019253,0.0020425,0.058795,0.37166,E2F_02,0.963622484898203
GSE8835_CD4_VS_CD8_TCELL_CLL...1,SET,185,0.021033,0.0021006,0.064232,0.37167,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN,0.963622484898203
REACTOME_METAL_ION_SLC_TRANS...,SET,23,0.056704,0.0020057,0.17319,0.37168,REACTOME_METAL_ION_SLC_TRANSPORTERS,0.963622484898203
chr8p23,SET,42,0.079102,0.003779,0.2417,0.37173,chr8p23,0.963622484898203
HP_FRONTAL_HIRSUTISM,SET,8,0.083342,0.0017393,0.25465,0.37173,HP_FRONTAL_HIRSUTISM,0.963622484898203
MIR616_3P,SET,41,0.045829,0.0021633,0.14007,0.37177,MIR616_3P,0.963622484898203
GOBP_REGULATION_OF_SYNAPTIC_...9,SET,17,0.064448,0.0019602,0.197,0.37178,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.963622484898203
REACTOME_RND3_GTPASE_CYCLE,SET,41,0.043212,0.0020397,0.13213,0.37182,REACTOME_RND3_GTPASE_CYCLE,0.963654295302013
GOBP_NEGATIVE_REGULATION_OF_...62,SET,7,0.11343,0.0022144,0.34709,0.37191,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.963695509428337
GOBP_PROTEIN_LOCALIZATION_TO...33,SET,4,0.12224,0.0018042,0.37415,0.37194,GOBP_PROTEIN_LOCALIZATION_TO_MOTILE_CILIUM,0.963695509428337
REACTOME_CASPASE_ACTIVATION_...1,SET,16,0.071824,0.0021194,0.21985,0.37195,REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,0.963695509428337
GOBP_DNA_UNWINDING_INVOLVED_...,SET,20,0.061048,0.0020138,0.18686,0.37195,GOBP_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION,0.963695509428337
HP_RETINOSCHISIS,SET,7,0.12667,0.002473,0.38783,0.37198,HP_RETINOSCHISIS,0.963695509428337
MIR8088,SET,5,0.092721,0.0015299,0.284,0.37203,MIR8088,0.963695509428337
GSE22935_24H_VS_48H_MBOVIS_B...2,SET,178,0.020999,0.0020575,0.064317,0.37203,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.963695509428337
ODONNELL_TARGETS_OF_MYC_AND_...1,SET,42,0.040213,0.0019211,0.12322,0.37208,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,0.963753197197794
GOBP_NEUTROPHIL_DIFFERENTIAT...,SET,11,0.086683,0.0021211,0.2657,0.37212,GOBP_NEUTROPHIL_DIFFERENTIATION,0.963770833022875
HP_DIAPHRAGMATIC_PARALYSIS,SET,6,0.11964,0.0021624,0.36684,0.37216,HP_DIAPHRAGMATIC_PARALYSIS,0.963770833022875
GSE3982_BASOPHIL_VS_NKCELL_DN,SET,182,0.021013,0.0020818,0.064436,0.37217,GSE3982_BASOPHIL_VS_NKCELL_DN,0.963770833022875
KEGG_MEDICUS_VARIANT_SCRAPIE...2,SET,17,0.068616,0.0020869,0.21054,0.37225,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.963802372805713
KEGG_MEDICUS_VARIANT_AMPLIFI...1,SET,6,0.099642,0.001801,0.30581,0.37228,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S,0.963802372805713
HP_VARICOSE_VEINS,SET,29,0.055528,0.0022051,0.17044,0.37229,HP_VARICOSE_VEINS,0.963802372805713
HP_INTERSTITIAL_CARDIAC_FIBR...,SET,9,0.097845,0.0021658,0.30035,0.3723,HP_INTERSTITIAL_CARDIAC_FIBROSIS,0.963802372805713
HP_RECURRENT_CANDIDA_INFECTI...,SET,17,0.073141,0.0022246,0.22474,0.37242,HP_RECURRENT_CANDIDA_INFECTIONS,0.963802372805713
CUI_GLUCOSE_DEPRIVATION,SET,52,0.040145,0.0021335,0.1234,0.37247,CUI_GLUCOSE_DEPRIVATION,0.963802372805713
HP_METACARPOPHALANGEAL_JOINT...,SET,3,0.19849,0.0025371,0.61016,0.37247,HP_METACARPOPHALANGEAL_JOINT_CONTRACTURE,0.963802372805713
GOMF_METAL_DEPENDENT_DEUBIQU...,SET,11,0.087772,0.0021478,0.26993,0.37253,GOMF_METAL_DEPENDENT_DEUBIQUITINASE_ACTIVITY,0.963802372805713
HONMA_DOCETAXEL_RESISTANCE,SET,32,0.051348,0.0021418,0.15793,0.37254,HONMA_DOCETAXEL_RESISTANCE,0.963802372805713
GSE8621_UNSTIM_VS_LPS_STIM_M...1,SET,175,0.020247,0.0019673,0.062272,0.37254,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.963802372805713
GOBP_REGULATION_OF_CARDIAC_M...2,SET,27,0.056646,0.0021707,0.17426,0.37257,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.963802372805713
GSE11961_MEMORY_BCELL_DAY7_V...3,SET,179,0.0207,0.0020339,0.063678,0.37257,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.963802372805713
KEGG_GLUTATHIONE_METABOLISM,SET,45,0.04464,0.0022073,0.13737,0.37261,KEGG_GLUTATHIONE_METABOLISM,0.963802372805713
GOBP_REGULATION_OF_UBIQUITIN...3,SET,34,0.045412,0.0019524,0.13975,0.37261,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.963802372805713
MIR34C_3P,SET,58,0.036158,0.0020291,0.11129,0.37263,MIR34C_3P,0.963802372805713
HP_PRENATAL_MOVEMENT_ABNORMA...,SET,211,0.019577,0.0020867,0.060283,0.37268,HP_PRENATAL_MOVEMENT_ABNORMALITY,0.963802372805713
GOBP_TRICARBOXYLIC_ACID_CYCLE,SET,28,0.048451,0.0018907,0.14922,0.37271,GOBP_TRICARBOXYLIC_ACID_CYCLE,0.963802372805713
GOBP_POSITIVE_REGULATION_OF_...649,SET,11,0.069434,0.001699,0.21391,0.37274,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.963802372805713
GOCC_EMC_COMPLEX,SET,8,0.090279,0.0018841,0.27824,0.37279,GOCC_EMC_COMPLEX,0.963802372805713
DESCARTES_FETAL_MUSCLE_MEGAK...,SET,195,0.019494,0.0019983,0.060087,0.37281,DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES,0.963802372805713
PIONTEK_PKD1_TARGETS_UP,SET,39,0.044242,0.0020369,0.13639,0.37282,PIONTEK_PKD1_TARGETS_UP,0.963802372805713
GOCC_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.21009,0.0026853,0.64761,0.37282,GOCC_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_COMPLEX,0.963802372805713
GOMF_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.21009,0.0026853,0.64761,0.37282,GOMF_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY,0.963802372805713
GOBP_POSITIVE_REGULATION_OF_...498,SET,26,0.054513,0.0020499,0.16813,0.37288,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,0.963839948683623
GOMF_HEPARAN_SULFATE_BINDING,SET,7,0.1104,0.0021552,0.34052,0.37289,GOMF_HEPARAN_SULFATE_BINDING,0.963839948683623
HP_TEMPERATURE_INSTABILITY,SET,34,0.048591,0.0020891,0.14994,0.37295,HP_TEMPERATURE_INSTABILITY,0.963849264049955
GOBP_PHOSPHATE_ION_TRANSMEMB...,SET,14,0.076233,0.0021043,0.23536,0.37301,GOBP_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT,0.963849264049955
HP_ABNORMALITY_OF_MASSETER_M...,SET,5,0.12818,0.002115,0.3958,0.37302,HP_ABNORMALITY_OF_MASSETER_MUSCLE,0.963849264049955
GSE39110_DAY3_VS_DAY6_POST_I...4,SET,183,0.019876,0.0019744,0.06137,0.37302,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP,0.963849264049955
GSE29618_PRE_VS_DAY7_POST_TI...2,SET,168,0.023116,0.0022011,0.071385,0.37304,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP,0.963849264049955
HP_CONTRACTURE_OF_THE_DISTAL...,SET,6,0.12764,0.002307,0.39424,0.37306,HP_CONTRACTURE_OF_THE_DISTAL_INTERPHALANGEAL_JOINT_OF_THE_FINGERS,0.963849264049955
GOBP_ICOSANOID_METABOLIC_PRO...,SET,110,0.027546,0.0021257,0.085138,0.37314,GOBP_ICOSANOID_METABOLIC_PROCESS,0.963984293466141
GOBP_CORTISOL_METABOLIC_PROC...,SET,12,0.086174,0.0022024,0.26643,0.37318,GOBP_CORTISOL_METABOLIC_PROCESS,0.964013519839501
GOCC_MEIOTIC_SPINDLE,SET,12,0.081579,0.0020849,0.25237,0.37326,GOCC_MEIOTIC_SPINDLE,0.964013519839501
GSE1448_ANTI_VALPHA2_VS_VBET...2,SET,184,0.020258,0.0020179,0.062677,0.37327,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP,0.964013519839501
WP_EXTRACELLULAR_VESICLEMEDI...,SET,29,0.053553,0.0021267,0.16571,0.37328,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,0.964013519839501
GOMF_MANGANESE_ION_TRANSMEMB...,SET,9,0.08949,0.0019808,0.27693,0.37329,GOMF_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.964013519839501
HP_DIPLOPIA,SET,85,0.029284,0.0019879,0.090638,0.37332,HP_DIPLOPIA,0.964019362508359
GSE360_DC_VS_MAC_L_MAJOR_UP,SET,172,0.021239,0.0020461,0.065779,0.37339,GSE360_DC_VS_MAC_L_MAJOR_UP,0.964128488112927
HP_AUTOIMMUNITY,SET,264,0.017859,0.0021261,0.055354,0.37349,HP_AUTOIMMUNITY,0.964192606339544
GCM_FCGR2B,SET,35,0.04494,0.0019603,0.13931,0.3735,GCM_FCGR2B,0.964192606339544
GOCC_GAMMA_DELTA_T_CELL_RECE...,SET,3,0.1568,0.0020042,0.48623,0.37354,GOCC_GAMMA_DELTA_T_CELL_RECEPTOR_COMPLEX,0.964192606339544
GSE34156_UNTREATED_VS_6H_NOD...4,SET,159,0.021633,0.0020044,0.067118,0.37361,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.964192606339544
TCCCRNNRTGC_UNKNOWN,SET,189,0.019411,0.0019593,0.060233,0.37363,TCCCRNNRTGC_UNKNOWN,0.964192606339544
GOCC_AUTOLYSOSOME,SET,12,0.082558,0.00211,0.2562,0.37364,GOCC_AUTOLYSOSOME,0.964192606339544
GOBP_NEGATIVE_REGULATION_OF_...3,SET,54,0.036544,0.0019789,0.11343,0.37366,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,0.964192606339544
FLOTHO_PEDIATRIC_ALL_THERAPY...2,SET,50,0.03719,0.0019381,0.11545,0.37368,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,0.964192606339544
CCCNNGGGAR_OLF1_01,SET,293,0.016194,0.0020293,0.050278,0.3737,CCCNNGGGAR_OLF1_01,0.964192606339544
HP_EEG_WITH_IRREGULAR_GENERA...,SET,11,0.085128,0.0020831,0.26434,0.37371,HP_EEG_WITH_IRREGULAR_GENERALIZED_SPIKE_AND_WAVE_COMPLEXES,0.964192606339544
AMIT_SERUM_RESPONSE_20_MCF10A,SET,15,0.074851,0.0021386,0.23244,0.37372,AMIT_SERUM_RESPONSE_20_MCF10A,0.964192606339544
GSE5589_LPS_VS_LPS_AND_IL10_...9,SET,176,0.020402,0.0019879,0.063413,0.37383,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.964296266005477
MIR222_3P,SET,158,0.022658,0.0020928,0.070451,0.37387,MIR222_3P,0.964296266005477
HUMMERICH_BENIGN_SKIN_TUMOR_...1,SET,19,0.068298,0.0021959,0.21241,0.3739,HUMMERICH_BENIGN_SKIN_TUMOR_DN,0.964296266005477
HP_ABNORMAL_PULMONARY_INTERS...,SET,135,0.023335,0.0019936,0.072573,0.37391,HP_ABNORMAL_PULMONARY_INTERSTITIAL_MORPHOLOGY,0.964296266005477
GOMF_PHOSPHATIDYLINOSITOL_4_...4,SET,27,0.051472,0.0019724,0.16011,0.37392,GOMF_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING,0.964296266005477
MODULE_552,SET,7,0.10461,0.0020422,0.32545,0.37395,MODULE_552,0.964296266005477
REACTOME_RHOA_GTPASE_CYCLE,SET,138,0.024011,0.0020738,0.07471,0.37396,REACTOME_RHOA_GTPASE_CYCLE,0.964296266005477
GOBP_EXTRACELLULAR_MATRIX_DI...,SET,58,0.039002,0.0021887,0.12139,0.37399,GOBP_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.964296266005477
GOBP_CELLULAR_RESPONSE_TO_L_...2,SET,11,0.08021,0.0019627,0.24975,0.37405,GOBP_CELLULAR_RESPONSE_TO_L_LEUCINE,0.964296266005477
GOBP_ECTODERMAL_CELL_DIFFERE...,SET,5,0.14009,0.0023115,0.43631,0.37408,GOBP_ECTODERMAL_CELL_DIFFERENTIATION,0.964296266005477
GSE37533_PPARG2_FOXP3_VS_FOX...4,SET,175,0.020786,0.0020196,0.064743,0.37409,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.964296266005477
GOMF_DOUBLE_STRANDED_RNA_ADE...,SET,6,0.12466,0.0022531,0.3885,0.37416,GOMF_DOUBLE_STRANDED_RNA_ADENOSINE_DEAMINASE_ACTIVITY,0.964296266005477
GSE12003_4D_VS_8D_CULTURE_MI...1,SET,153,0.021714,0.0019739,0.067691,0.37419,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN,0.964296266005477
PID_MAPK_TRK_PATHWAY,SET,33,0.048975,0.0020745,0.15274,0.37424,PID_MAPK_TRK_PATHWAY,0.964296266005477
GOBP_VIRION_ASSEMBLY,SET,33,0.045168,0.0019132,0.14087,0.37424,GOBP_VIRION_ASSEMBLY,0.964296266005477
PID_INTEGRIN_A9B1_PATHWAY,SET,22,0.063939,0.002212,0.19944,0.37426,PID_INTEGRIN_A9B1_PATHWAY,0.964296266005477
GOBP_CELLULAR_RESPONSE_TO_CA...5,SET,137,0.023853,0.0020528,0.074405,0.37426,GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS,0.964296266005477
GSE21063_WT_VS_NFATC1_KO_3H_...1,SET,190,0.02008,0.0020321,0.062642,0.37428,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN,0.964296266005477
WP_CONTROL_OF_IMMUNE_TOLERAN...,SET,13,0.081925,0.0021792,0.25569,0.37433,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.964296266005477
HP_CYTOCHROME_C_OXIDASE_NEGA...,SET,26,0.04948,0.0018607,0.15448,0.37437,HP_CYTOCHROME_C_OXIDASE_NEGATIVE_MUSCLE_FIBERS,0.964296266005477
BENNETT_SYSTEMIC_LUPUS_ERYTH...,SET,25,0.059269,0.0021856,0.18505,0.37438,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.964296266005477
GOBP_BEHAVIORAL_RESPONSE_TO_...3,SET,8,0.11052,0.0023064,0.34536,0.37448,GOBP_BEHAVIORAL_RESPONSE_TO_NICOTINE,0.964296266005477
GSE3982_EOSINOPHIL_VS_NEUTRO...1,SET,170,0.02069,0.0019817,0.064697,0.37456,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN,0.964296266005477
BIOCARTA_LYMPHOCYTE_PATHWAY,SET,9,0.10712,0.0023711,0.33499,0.37457,BIOCARTA_LYMPHOCYTE_PATHWAY,0.964296266005477
GOBP_CARDIAC_CELL_FATE_COMMI...,SET,12,0.091755,0.002345,0.28705,0.37462,GOBP_CARDIAC_CELL_FATE_COMMITMENT,0.964296266005477
HP_HYPOVOLEMIA,SET,30,0.055676,0.0022487,0.1742,0.37463,HP_HYPOVOLEMIA,0.964296266005477
GSE14000_4H_VS_16H_LPS_DC_TR...2,SET,170,0.021457,0.0020551,0.067145,0.37465,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP,0.964296266005477
HP_APLASIA_HYPOPLASIA_OF_THE...26,SET,186,0.019307,0.0019334,0.060436,0.37469,HP_APLASIA_HYPOPLASIA_OF_THE_EAR,0.964296266005477
HP_HEMOPTYSIS,SET,81,0.033124,0.0021953,0.1037,0.37471,HP_HEMOPTYSIS,0.964296266005477
GOBP_REGULATION_OF_CALCIUM_I...2,SET,29,0.051126,0.0020303,0.16016,0.37478,GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.964296266005477
GSE18804_BRAIN_VS_COLON_TUMO...2,SET,144,0.024165,0.0021317,0.075707,0.37479,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP,0.964296266005477
GOBP_POSITIVE_REGULATION_OF_...50,SET,15,0.07409,0.0021169,0.23212,0.3748,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.964296266005477
HP_REDUCED_NUMBER_OF_CORNEAL...,SET,8,0.10693,0.0022316,0.33505,0.37481,HP_REDUCED_NUMBER_OF_CORNEAL_ENDOTHELIAL_CELLS,0.964296266005477
GOBP_REGULATION_OF_CANONICAL...,SET,233,0.018885,0.0021139,0.05918,0.37482,GOBP_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.964296266005477
KEGG_MEDICUS_REFERENCE_PTH_P...,SET,15,0.076832,0.0021952,0.24079,0.37483,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY,0.964296266005477
REACTOME_DISEASES_OF_BASE_EX...,SET,5,0.12668,0.0020902,0.39705,0.37485,REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR,0.964296266005477
GOBP_EXTRACELLULAR_REGULATIO...,SET,12,0.087793,0.0022437,0.2752,0.37486,GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION,0.964296266005477
GOBP_PHOSPHATIDYLCHOLINE_BIO...,SET,26,0.051844,0.0019496,0.16251,0.37486,GOBP_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,0.964296266005477
HP_DECREASED_CIRCULATING_ALD...,SET,18,0.067545,0.0021139,0.21174,0.37486,HP_DECREASED_CIRCULATING_ALDOSTERONE_LEVEL,0.964296266005477
GSE27786_LSK_VS_MONO_MAC_UP,SET,174,0.019848,0.001923,0.062223,0.37487,GSE27786_LSK_VS_MONO_MAC_UP,0.964296266005477
GOBP_EXTRACELLULAR_MATRIX_CE...,SET,4,0.15025,0.0022175,0.4712,0.37492,GOBP_EXTRACELLULAR_MATRIX_CELL_SIGNALING,0.964304287613561
HENDRICKS_SMARCA4_TARGETS_DN,SET,41,0.045837,0.0021636,0.14391,0.37505,HENDRICKS_SMARCA4_TARGETS_DN,0.964304287613561
GNF2_TYK2,SET,28,0.046918,0.0018308,0.14733,0.37507,GNF2_TYK2,0.964304287613561
GOBP_RNA_EXPORT_FROM_NUCLEUS,SET,80,0.028027,0.001846,0.088055,0.37513,GOBP_RNA_EXPORT_FROM_NUCLEUS,0.964304287613561
GSE22342_CD11C_HIGH_VS_LOW_D...1,SET,154,0.022273,0.0020313,0.069974,0.37513,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN,0.964304287613561
KEGG_MEDICUS_REFERENCE_TESTO...,SET,11,0.078939,0.0019316,0.24801,0.37514,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS,0.964304287613561
GOBP_CELLULAR_RESPONSE_TO_VI...2,SET,27,0.056375,0.0021603,0.17713,0.37514,GOBP_CELLULAR_RESPONSE_TO_VITAMIN,0.964304287613561
MIR185_5P,SET,266,0.017315,0.002069,0.054405,0.37515,MIR185_5P,0.964304287613561
KEGG_MEDICUS_PATHOGEN_EBV_EB...3,SET,9,0.085848,0.0019002,0.26985,0.37519,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483,0.964304287613561
GOBP_FEMALE_MEIOSIS_CHROMOSO...,SET,6,0.093162,0.0016839,0.29286,0.3752,GOBP_FEMALE_MEIOSIS_CHROMOSOME_SEGREGATION,0.964304287613561
GSE5099_UNSTIM_VS_MCSF_TREAT...3,SET,173,0.020461,0.0019768,0.064343,0.37524,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN,0.964304287613561
GOBP_PHOSPHATE_ION_HOMEOSTAS...,SET,19,0.073684,0.0023691,0.23178,0.37528,GOBP_PHOSPHATE_ION_HOMEOSTASIS,0.964304287613561
MIR6508_3P,SET,46,0.04171,0.0020851,0.13125,0.37532,MIR6508_3P,0.964304287613561
TGTYNNNNNRGCARM_UNKNOWN,SET,79,0.031197,0.002042,0.098166,0.37532,TGTYNNNNNRGCARM_UNKNOWN,0.964304287613561
WHN_B,SET,228,0.018208,0.0020164,0.057301,0.37534,WHN_B,0.964304287613561
HP_ABNORMAL_FRONTAL_BONE_MOR...,SET,365,0.013842,0.0019322,0.043584,0.3754,HP_ABNORMAL_FRONTAL_BONE_MORPHOLOGY,0.964304287613561
GSE42088_UNINF_VS_LEISHMANIA...8,SET,183,0.021208,0.0021068,0.066785,0.37541,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP,0.964304287613561
GOBP_LIGAND_GATED_ION_CHANNE...,SET,30,0.054144,0.0021868,0.17051,0.37542,GOBP_LIGAND_GATED_ION_CHANNEL_SIGNALING_PATHWAY,0.964304287613561
GSE17721_LPS_VS_PAM3CSK4_0.5...2,SET,180,0.01986,0.0019568,0.062562,0.37546,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP,0.964304287613561
HP_HYPOREFLEXIA,SET,349,0.014212,0.0019407,0.04478,0.37548,HP_HYPOREFLEXIA,0.964304287613561
GOMF_ALANINE_TRANSMEMBRANE_T...,SET,14,0.081158,0.0022402,0.25587,0.37555,GOMF_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.964304287613561
BACOLOD_RESISTANCE_TO_ALKYLA...1,SET,44,0.041522,0.0020303,0.13094,0.37558,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,0.964304287613561
GSE41867_NAIVE_VS_DAY6_LCMV_...4,SET,185,0.019199,0.0019175,0.060544,0.37558,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP,0.964304287613561
MIR933,SET,6,0.12694,0.0022943,0.40033,0.37559,MIR933,0.964304287613561
MIR1306_5P,SET,45,0.039034,0.0019301,0.12311,0.3756,MIR1306_5P,0.964304287613561
MIR6797_5P,SET,181,0.020279,0.0020035,0.063959,0.3756,MIR6797_5P,0.964304287613561
HP_DECREASED_ACTIVITY_OF_MIT...5,SET,60,0.030788,0.0017572,0.097139,0.37564,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_IV,0.964304287613561
GOBP_CARDIAC_CONDUCTION_SYST...,SET,36,0.050477,0.002233,0.15927,0.37565,GOBP_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT,0.964304287613561
HP_APLASIA_HYPOPLASIA_INVOLV...7,SET,4,0.13024,0.0019222,0.41119,0.37572,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.964372972972973
chr16q13,SET,25,0.087812,0.0032381,0.27731,0.37575,chr16q13,0.964372972972973
HOLLEMAN_VINCRISTINE_RESISTA...4,SET,36,0.04311,0.0019071,0.13614,0.37576,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,0.964372972972973
GAVISH_3CA_METAPROGRAM_MACRO...2,SET,47,0.041909,0.0021177,0.13241,0.37581,GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON,0.964430078269216
GOMF_METAL_ION_TRANSMEMBRANE...,SET,426,0.013806,0.0020785,0.043636,0.37585,GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.964461514323686
GOBP_POSITIVE_REGULATION_OF_...201,SET,4,0.15025,0.0022175,0.47499,0.37588,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.964467286821705
HP_ASTIGMATISM,SET,196,0.018741,0.001926,0.059317,0.37603,HP_ASTIGMATISM,0.964780942713716
MIR1343_3P,SET,144,0.022259,0.0019636,0.070504,0.37611,MIR1343_3P,0.964849487047014
GOCC_NUCLEAR_LAMINA,SET,10,0.080938,0.0018884,0.25641,0.37613,GOCC_NUCLEAR_LAMINA,0.964849487047014
WP_POLYCYSTIC_KIDNEY_DISEASE...,SET,82,0.03118,0.0020791,0.098785,0.37614,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,0.964849487047014
GSE32034_LY6C_HIGH_VS_LOW_RO...2,SET,183,0.019114,0.0018987,0.060607,0.37624,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP,0.965034774907749
GOBP_LYMPHOCYTE_ACTIVATION_I...,SET,192,0.020322,0.0020673,0.064471,0.3763,GOBP_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.965117445206996
WGGAATGY_TEF1_Q6,SET,329,0.015555,0.0020636,0.049377,0.37637,WGGAATGY_TEF1_Q6,0.965166130934827
KUMAR_PATHOGEN_LOAD_BY_MACRO...,SET,228,0.0179,0.0019823,0.056837,0.37641,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,0.965166130934827
ZHAN_MULTIPLE_MYELOMA_UP,SET,47,0.035444,0.001791,0.11255,0.37642,ZHAN_MULTIPLE_MYELOMA_UP,0.965166130934827
GOBP_OVULATION_CYCLE,SET,71,0.034335,0.002131,0.10906,0.37644,GOBP_OVULATION_CYCLE,0.965166130934827
MIR2114_3P,SET,40,0.041282,0.0019248,0.13119,0.37651,MIR2114_3P,0.965166130934827
GSE41867_LCMV_ARMSTRONG_VS_C...3,SET,186,0.01848,0.0018506,0.058735,0.37652,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN,0.965166130934827
VERHAAK_GLIOBLASTOMA_MESENCH...,SET,203,0.020036,0.0020951,0.063699,0.37656,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,0.965166130934827
GSE36392_EOSINOPHIL_VS_NEUTR...1,SET,179,0.019485,0.0019145,0.061968,0.3766,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.965166130934827
HP_DECREASED_DISTAL_SENSORY_...,SET,9,0.093558,0.0020709,0.29757,0.37661,HP_DECREASED_DISTAL_SENSORY_NERVE_ACTION_POTENTIAL,0.965166130934827
GOBP_REGULATION_OF_GUANYL_NU...,SET,6,0.12387,0.0022389,0.39408,0.37664,GOBP_REGULATION_OF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.965166130934827
STAMBOLSKY_TARGETS_OF_MUTATE...2,SET,45,0.04077,0.0020159,0.12973,0.37666,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,0.965166130934827
MIR493_5P,SET,431,0.013554,0.0020521,0.043135,0.37668,MIR493_5P,0.965166130934827
GTGTGAG_MIR342,SET,56,0.035177,0.0019398,0.11195,0.37668,GTGTGAG_MIR342,0.965166130934827
YAO_TEMPORAL_RESPONSE_TO_PRO...2,SET,62,0.037683,0.0021861,0.11996,0.37671,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,0.965171842978253
GOBP_MALE_MEIOTIC_NUCLEAR_DI...,SET,49,0.034988,0.0018051,0.11142,0.37676,GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION,0.9651946827327
GOBP_REGULATION_OF_HETEROCHR...,SET,18,0.056532,0.0017692,0.18008,0.37679,GOBP_REGULATION_OF_HETEROCHROMATIN_FORMATION,0.9651946827327
GOCC_CELL_CELL_CONTACT_ZONE,SET,68,0.033702,0.0020472,0.10737,0.37681,GOCC_CELL_CELL_CONTACT_ZONE,0.9651946827327
PID_CXCR4_PATHWAY,SET,95,0.027589,0.0019794,0.087912,0.37683,PID_CXCR4_PATHWAY,0.9651946827327
GOCC_CYTOPLASMIC_SIDE_OF_END...2,SET,6,0.08875,0.0016041,0.28288,0.37686,GOCC_CYTOPLASMIC_SIDE_OF_ENDOSOME_MEMBRANE,0.965200390567428
MIR593_3P,SET,127,0.024799,0.0020554,0.079095,0.37694,MIR593_3P,0.965217509025271
PID_SMAD2_3PATHWAY,SET,16,0.069813,0.00206,0.22268,0.37695,PID_SMAD2_3PATHWAY,0.965217509025271
HP_PERIPHERAL_HYPERMYELINATI...,SET,9,0.091417,0.0020235,0.2916,0.37695,HP_PERIPHERAL_HYPERMYELINATION,0.965217509025271
RODRIGUES_NTN1_AND_DCC_TARGE...,SET,28,0.053706,0.0020957,0.17135,0.37698,RODRIGUES_NTN1_AND_DCC_TARGETS,0.96522321349639
GOBP_REGULATION_OF_PROTEIN_K...5,SET,18,0.066918,0.0020942,0.21365,0.37706,GOBP_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.965356928176796
WP_OSTEOCLAST_SIGNALING,SET,16,0.069027,0.0020368,0.22052,0.37714,WP_OSTEOCLAST_SIGNALING,0.965419510937615
GSE360_CTRL_VS_B_MALAYI_LOW_...1,SET,177,0.020593,0.0020121,0.065788,0.37714,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN,0.965419510937615
GOCC_CAVEOLA,SET,75,0.032344,0.002063,0.1034,0.37722,GOCC_CAVEOLA,0.965462164948454
GOMF_JUN_KINASE_KINASE_KINAS...,SET,9,0.094157,0.0020842,0.30105,0.37723,GOMF_JUN_KINASE_KINASE_KINASE_ACTIVITY,0.965462164948454
KOINUMA_COLON_CANCER_MSI_UP,SET,16,0.062767,0.0018521,0.2007,0.37724,KOINUMA_COLON_CANCER_MSI_UP,0.965462164948454
GOBP_PANTOTHENATE_METABOLIC_...,SET,7,0.10186,0.0019886,0.32579,0.37727,GOBP_PANTOTHENATE_METABOLIC_PROCESS,0.965467848464767
GOMF_L_HISTIDINE_TRANSMEMBRA...,SET,3,0.16396,0.0020957,0.52462,0.37732,GOMF_L_HISTIDINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.965524709173907
GSE16385_MONOCYTE_VS_12H_ROS...4,SET,173,0.019434,0.0018775,0.062196,0.37735,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.965530387248767
GOBP_NEUTRAL_LIPID_METABOLIC...,SET,119,0.02503,0.0020086,0.080143,0.3774,GOBP_NEUTRAL_LIPID_METABOLIC_PROCESS,0.965587234982332
FOXM1_01,SET,226,0.018265,0.002014,0.058608,0.37765,FOXM1_01,0.965705961044521
GERHOLD_RESPONSE_TO_TZD_UP,SET,6,0.12178,0.0022011,0.39092,0.3777,GERHOLD_RESPONSE_TO_TZD_UP,0.965705961044521
HP_REFLEX_SEIZURE,SET,19,0.062375,0.0020055,0.20025,0.37772,HP_REFLEX_SEIZURE,0.965705961044521
GOMF_PHOSPHATASE_ACTIVITY,SET,231,0.01687,0.0018804,0.054166,0.37773,GOMF_PHOSPHATASE_ACTIVITY,0.965705961044521
GOCC_SYNAPTIC_VESICLE_MEMBRA...,SET,124,0.024502,0.0020068,0.078743,0.37784,GOCC_SYNAPTIC_VESICLE_MEMBRANE,0.965705961044521
MIR100_5P_MIR99A_5P_MIR99B_5P,SET,17,0.070196,0.002135,0.22568,0.37788,MIR100_5P_MIR99A_5P_MIR99B_5P,0.965705961044521
GSE21546_ELK1_KO_VS_SAP1A_KO...2,SET,176,0.019196,0.0018704,0.061727,0.37791,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.965705961044521
HP_ABNORMAL_RESPONSE_TO_INSU...,SET,8,0.098523,0.0020561,0.31685,0.37792,HP_ABNORMAL_RESPONSE_TO_INSULIN_TOLERANCE_TEST,0.965705961044521
HP_PULMONARY_EDEMA,SET,25,0.055216,0.0020361,0.17764,0.37797,HP_PULMONARY_EDEMA,0.965705961044521
ZHU_CMV_24_HR_UP,SET,79,0.028874,0.0018899,0.092907,0.37799,ZHU_CMV_24_HR_UP,0.965705961044521
GOBP_INTESTINAL_EPITHELIAL_C...3,SET,6,0.10411,0.0018818,0.33515,0.37803,GOBP_INTESTINAL_EPITHELIAL_CELL_MATURATION,0.965705961044521
ACEVEDO_LIVER_CANCER_WITH_H3...1,SET,141,0.024376,0.002128,0.078499,0.37808,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,0.965705961044521
REACTOME_REGULATION_OF_NF_KA...,SET,16,0.062083,0.0018319,0.19995,0.37809,REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING,0.965705961044521
PID_AVB3_OPN_PATHWAY,SET,31,0.052271,0.0021461,0.16851,0.37821,PID_AVB3_OPN_PATHWAY,0.965705961044521
GOBP_T_HELPER_1_CELL_DIFFERE...,SET,22,0.061442,0.0021256,0.19811,0.37823,GOBP_T_HELPER_1_CELL_DIFFERENTIATION,0.965705961044521
MA_MYELOID_DIFFERENTIATION_DN,SET,40,0.04283,0.0019969,0.13816,0.37828,MA_MYELOID_DIFFERENTIATION_DN,0.965705961044521
GSE34205_HEALTHY_VS_FLU_INF_...1,SET,174,0.020856,0.0020207,0.067306,0.37833,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN,0.965705961044521
MIR4530,SET,133,0.023204,0.0019678,0.074892,0.37834,MIR4530,0.965705961044521
GOBP_ACTIN_FILAMENT_BUNDLE_O...,SET,152,0.022214,0.0020128,0.071699,0.37835,GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION,0.965705961044521
MIR6886_3P,SET,84,0.027638,0.0018652,0.089225,0.37837,MIR6886_3P,0.965705961044521
DESCARTES_FETAL_CEREBELLUM_A...,SET,112,0.028066,0.0021854,0.090605,0.37837,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.965705961044521
GSE16450_CTRL_VS_IFNA_6H_STI...1,SET,157,0.021136,0.0019461,0.068261,0.37842,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.965705961044521
GSE28737_FOLLICULAR_VS_MARGI...1,SET,184,0.019571,0.0019494,0.063218,0.37844,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN,0.965705961044521
MIR6511B_5P,SET,66,0.03386,0.0020265,0.10938,0.37845,MIR6511B_5P,0.965705961044521
DANG_MYC_TARGETS_DN,SET,27,0.05303,0.0020321,0.17132,0.37846,DANG_MYC_TARGETS_DN,0.965705961044521
GSE3982_NEUTROPHIL_VS_CENT_M...1,SET,183,0.018221,0.0018101,0.0589,0.37853,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.965705961044521
GOBP_RESPONSE_TO_AMINO_ACID_...,SET,50,0.037034,0.00193,0.11983,0.37864,GOBP_RESPONSE_TO_AMINO_ACID_STARVATION,0.965705961044521
MURARO_PANCREAS_ACINAR_CELL,SET,659,0.010858,0.0020198,0.03514,0.37867,MURARO_PANCREAS_ACINAR_CELL,0.965705961044521
HP_ACTION_TREMOR,SET,167,0.020125,0.0019106,0.065139,0.37868,HP_ACTION_TREMOR,0.965705961044521
MIR4504,SET,142,0.022896,0.0020058,0.074113,0.37869,MIR4504,0.965705961044521
PID_LPA4_PATHWAY,SET,14,0.078862,0.0021769,0.2553,0.3787,PID_LPA4_PATHWAY,0.965705961044521
HP_BIFID_UVULA,SET,139,0.022064,0.0019125,0.07144,0.37872,HP_BIFID_UVULA,0.965705961044521
MIR628_5P,SET,75,0.032314,0.0020611,0.1047,0.3788,MIR628_5P,0.965705961044521
GCM_AIP,SET,34,0.042497,0.0018271,0.1377,0.37881,GCM_AIP,0.965705961044521
KEGG_MEDICUS_PATHOGEN_HCMV_U...1,SET,26,0.052044,0.0019571,0.16867,0.37883,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,0.965705961044521
HP_SUPERNUMERARY_CUSP,SET,4,0.13529,0.0019966,0.43874,0.37891,HP_SUPERNUMERARY_CUSP,0.965705961044521
PRC2_SUZ12_UP.V1_DN,SET,168,0.020968,0.0019965,0.068023,0.37895,PRC2_SUZ12_UP.V1_DN,0.965705961044521
HP_SEVERE_TEMPER_TANTRUMS,SET,6,0.11324,0.0020467,0.3674,0.37896,HP_SEVERE_TEMPER_TANTRUMS,0.965705961044521
GOCC_SPINDLE,SET,386,0.012817,0.0018387,0.041592,0.37898,GOCC_SPINDLE,0.965705961044521
GSE12707_AT16L1_HYPOMORPH_VS...1,SET,113,0.024586,0.0019229,0.079804,0.37901,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN,0.965705961044521
GSE3982_MAC_VS_NKCELL_DN,SET,177,0.020247,0.0019784,0.065742,0.37905,GSE3982_MAC_VS_NKCELL_DN,0.965705961044521
BIOCARTA_EIF4_PATHWAY,SET,24,0.057317,0.0020709,0.18615,0.37908,BIOCARTA_EIF4_PATHWAY,0.965705961044521
REACTOME_G1_S_SPECIFIC_TRANS...,SET,28,0.045885,0.0017906,0.14905,0.3791,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...83,SET,307,0.014732,0.0018889,0.047852,0.3791,GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS,0.965705961044521
GSE3039_NKT_CELL_VS_ALPHAALP...1,SET,188,0.019781,0.0019914,0.064257,0.37911,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN,0.965705961044521
GOCC_CORTICAL_CYTOSKELETON,SET,103,0.025995,0.0019415,0.084454,0.37912,GOCC_CORTICAL_CYTOSKELETON,0.965705961044521
GSE22025_UNTREATED_VS_TGFB1_...3,SET,184,0.020049,0.001997,0.065144,0.37913,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN,0.965705961044521
GOBP_UBIQUINONE_METABOLIC_PR...,SET,16,0.057675,0.0017019,0.18748,0.37918,GOBP_UBIQUINONE_METABOLIC_PROCESS,0.965705961044521
GOCC_GLYCOSYLPHOSPHATIDYLINO...,SET,6,0.10931,0.0019757,0.35535,0.37919,GOCC_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX,0.965705961044521
GSE26030_TH1_VS_TH17_RESTIMU...3,SET,180,0.019415,0.0019129,0.063123,0.37921,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN,0.965705961044521
HP_OVERHANGING_NASAL_TIP,SET,7,0.082806,0.0016166,0.26926,0.37922,HP_OVERHANGING_NASAL_TIP,0.965705961044521
HP_STAPES_ANKYLOSIS,SET,6,0.11555,0.0020884,0.37579,0.37924,HP_STAPES_ANKYLOSIS,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...283,SET,6,0.10755,0.0019439,0.34981,0.37925,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,0.965705961044521
PKCA_DN.V1_UP,SET,143,0.022184,0.0019502,0.07216,0.37926,PKCA_DN.V1_UP,0.965705961044521
chr9p24,SET,33,0.079743,0.0033777,0.25955,0.37933,chr9p24,0.965705961044521
ANASTASSIOU_MULTICANCER_INVA...,SET,61,0.035983,0.0020706,0.11717,0.37939,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,0.965705961044521
MORF_MLLT10,SET,268,0.016326,0.001958,0.053164,0.37939,MORF_MLLT10,0.965705961044521
MIR1284,SET,214,0.01853,0.0019889,0.060348,0.3794,MIR1284,0.965705961044521
GOBP_REGULATION_OF_CONNECTIV...,SET,5,0.11573,0.0019096,0.37699,0.37943,GOBP_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,0.965705961044521
HE_LIM_SUN_FETAL_LUNG_C2_DC3...,SET,6,0.10665,0.0019276,0.34744,0.37944,HE_LIM_SUN_FETAL_LUNG_C2_DC3_CELL,0.965705961044521
GOBP_THROMBOPOIETIN_MEDIATED...,SET,5,0.11656,0.0019232,0.37978,0.37946,GOBP_THROMBOPOIETIN_MEDIATED_SIGNALING_PATHWAY,0.965705961044521
HP_ABNORMAL_PULMONARY_VALVE_...2,SET,52,0.036095,0.0019182,0.11763,0.37948,HP_ABNORMAL_PULMONARY_VALVE_MORPHOLOGY,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...695,SET,4,0.14382,0.0021226,0.46882,0.37951,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.965705961044521
HP_BARRETT_ESOPHAGUS,SET,6,0.11035,0.0019945,0.35977,0.37953,HP_BARRETT_ESOPHAGUS,0.965705961044521
MORI_EMU_MYC_LYMPHOMA_BY_ONS...2,SET,104,0.024767,0.0018587,0.080789,0.37959,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,0.965705961044521
CHICAS_RB1_TARGETS_SENESCENT,SET,506,0.011899,0.001948,0.03882,0.3796,CHICAS_RB1_TARGETS_SENESCENT,0.965705961044521
MIR492,SET,23,0.052698,0.001864,0.17191,0.3796,MIR492,0.965705961044521
HP_SARCOMA,SET,167,0.020504,0.0019466,0.066918,0.37965,HP_SARCOMA,0.965705961044521
GOBP_POSITIVE_REGULATION_OF_...226,SET,6,0.12322,0.0022272,0.40231,0.3797,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION,0.965705961044521
GOBP_REGULATION_OF_TRANSLATI...2,SET,10,0.072869,0.0017001,0.23791,0.3797,GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION,0.965705961044521
GOBP_STRIATED_MUSCLE_CELL_PR...,SET,67,0.033893,0.0020437,0.11067,0.37971,GOBP_STRIATED_MUSCLE_CELL_PROLIFERATION,0.965705961044521
GSE36476_CTRL_VS_TSST_ACT_16...4,SET,173,0.020503,0.0019808,0.06695,0.37971,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...202,SET,4,0.14888,0.0021973,0.48631,0.37975,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.965705961044521
WP_UDPDERIVED_SUGARS_SYNTHES...,SET,11,0.079681,0.0019498,0.26035,0.37978,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,0.965705961044521
GOBP_CONNECTIVE_TISSUE_REPLA...2,SET,5,0.12953,0.0021372,0.42329,0.37981,GOBP_CONNECTIVE_TISSUE_REPLACEMENT_INVOLVED_IN_INFLAMMATORY_RESPONSE_WOUND_HEALING,0.965705961044521
HP_BILATERAL_MICROPHTHALMOS,SET,19,0.056434,0.0018145,0.18451,0.37986,HP_BILATERAL_MICROPHTHALMOS,0.965705961044521
KEGG_MEDICUS_REFERENCE_REGUL...4,SET,4,0.14806,0.0021852,0.48416,0.37988,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH,0.965705961044521
REACTOME_ATF6_ATF6_ALPHA_ACT...2,SET,10,0.072219,0.001685,0.23617,0.37988,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,0.965705961044521
GOBP_REGULATION_OF_HEMOGLOBI...,SET,8,0.091264,0.0019046,0.29859,0.37994,GOBP_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.965705961044521
GOCC_ROUGH_ENDOPLASMIC_RETIC...2,SET,20,0.058167,0.0019188,0.19036,0.37997,GOCC_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.965705961044521
HP_FETAL_NECK_ANOMALY,SET,92,0.027477,0.0019401,0.089925,0.37997,HP_FETAL_NECK_ANOMALY,0.965705961044521
GSE29164_UNTREATED_VS_CD8_TC...5,SET,182,0.019664,0.0019481,0.064397,0.38005,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN,0.965705961044521
GOBP_REGULATION_OF_ACTIVATIO...,SET,8,0.097274,0.0020301,0.31858,0.38006,GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.965705961044521
KEGG_MEDICUS_REFERENCE_CXCR4...1,SET,9,0.085516,0.0018929,0.2804,0.3802,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY,0.965705961044521
GSE40274_EOS_VS_FOXP3_AND_EO...1,SET,108,0.026065,0.0019932,0.085507,0.38025,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.965705961044521
HP_REDUNDANT_NECK_SKIN,SET,28,0.043719,0.001706,0.14343,0.38026,HP_REDUNDANT_NECK_SKIN,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...22,SET,9,0.082903,0.0018351,0.27202,0.38027,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.965705961044521
MORF_CAMK4,SET,253,0.016753,0.001953,0.054982,0.3803,MORF_CAMK4,0.965705961044521
GOBP_FAT_CELL_DIFFERENTIATION,SET,218,0.018768,0.0020329,0.061605,0.38032,GOBP_FAT_CELL_DIFFERENTIATION,0.965705961044521
HP_SECONDARY_AMENORRHEA,SET,62,0.031482,0.0018264,0.10334,0.38032,HP_SECONDARY_AMENORRHEA,0.965705961044521
GOBP_POSITIVE_REGULATION_OF_...579,SET,9,0.10241,0.0022669,0.33621,0.38033,GOBP_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.965705961044521
FAN_EMBRYONIC_CTX_BRAIN_MYEL...,SET,121,0.025143,0.0020344,0.082564,0.38036,FAN_EMBRYONIC_CTX_BRAIN_MYELOID,0.965705961044521
KEGG_MEDICUS_REFERENCE_MACHR...,SET,18,0.063003,0.0019717,0.20693,0.38039,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY,0.965705961044521
ZNF528_TARGET_GENES,SET,595,0.010749,0.0019034,0.035312,0.38041,ZNF528_TARGET_GENES,0.965705961044521
WAMUNYOKOLI_OVARIAN_CANCER_L...1,SET,173,0.020576,0.0019879,0.067597,0.38042,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,0.965705961044521
GOBP_AMINOGLYCAN_CATABOLIC_P...,SET,32,0.046812,0.0019526,0.1538,0.38043,GOBP_AMINOGLYCAN_CATABOLIC_PROCESS,0.965705961044521
HP_FOLLICULAR_THYROID_CARCIN...,SET,16,0.064155,0.0018931,0.21085,0.38046,HP_FOLLICULAR_THYROID_CARCINOMA,0.965705961044521
HE_LIM_SUN_FETAL_LUNG_C1_PUL...2,SET,270,0.016919,0.0020366,0.05563,0.38051,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL,0.965705961044521
GOBP_REGULATION_OF_POSTSYNAP...9,SET,18,0.06023,0.001885,0.19805,0.38052,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.965705961044521
HP_PUNDING,SET,6,0.12673,0.0022906,0.41669,0.38052,HP_PUNDING,0.965705961044521
GSE21678_WT_VS_FOXO1_FOXO3_K...2,SET,161,0.020899,0.0019485,0.068734,0.38054,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP,0.965705961044521
GOBP_DIGESTION,SET,127,0.024804,0.0020558,0.081582,0.38055,GOBP_DIGESTION,0.965705961044521
GOMF_SOLUTE_SODIUM_SYMPORTER...,SET,77,0.031256,0.0020199,0.1028,0.38055,GOMF_SOLUTE_SODIUM_SYMPORTER_ACTIVITY,0.965705961044521
GSE7460_TREG_VS_TCONV_ACT_DN,SET,173,0.020244,0.0019558,0.066589,0.38056,GSE7460_TREG_VS_TCONV_ACT_DN,0.965705961044521
WILLIAMS_ESR1_TARGETS_DN,SET,6,0.10465,0.0018914,0.34434,0.3806,WILLIAMS_ESR1_TARGETS_DN,0.965705961044521
GSE5542_UNTREATED_VS_IFNA_AN...4,SET,163,0.020106,0.001886,0.066157,0.3806,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.965705961044521
GSE7768_OVA_ALONE_VS_OVA_WIT...4,SET,164,0.019836,0.0018663,0.065322,0.38069,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.965705961044521
MIR6752_5P,SET,112,0.025224,0.001964,0.083141,0.3808,MIR6752_5P,0.965705961044521
RYAN_MANTLE_CELL_LYMPHOMA_NO...,SET,143,0.023775,0.00209,0.078371,0.38081,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,0.965705961044521
GSE2405_HEAT_KILLED_VS_LIVE_...4,SET,178,0.018222,0.0017855,0.060085,0.38084,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.965705961044521
MIR145_5P,SET,285,0.015652,0.0019349,0.051643,0.38092,MIR145_5P,0.965705961044521
GSE25087_TREG_VS_TCONV_FETUS...1,SET,162,0.020157,0.0018851,0.06651,0.38092,GSE25087_TREG_VS_TCONV_FETUS_DN,0.965705961044521
MIR5093,SET,221,0.017636,0.0019232,0.058205,0.38095,MIR5093,0.965705961044521
HP_DECREASED_THYROID_STIMULA...,SET,11,0.084375,0.0020646,0.27851,0.38096,HP_DECREASED_THYROID_STIMULATING_HORMONE_LEVEL,0.965705961044521
GOBP_EPITHELIAL_TUBE_MORPHOG...,SET,315,0.015064,0.0019561,0.049728,0.38097,GOBP_EPITHELIAL_TUBE_MORPHOGENESIS,0.965705961044521
KEGG_MEDICUS_REFERENCE_CORE_...,SET,27,0.040632,0.001557,0.13416,0.381,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION,0.965705961044521
GOBP_REGULATION_OF_CELL_MORP...,SET,222,0.017512,0.0019139,0.05783,0.38102,GOBP_REGULATION_OF_CELL_MORPHOGENESIS,0.965705961044521
GOMF_LIPASE_ACTIVITY,SET,127,0.023488,0.0019468,0.077581,0.38104,GOMF_LIPASE_ACTIVITY,0.965705961044521
GSE28726_ACT_CD4_TCELL_VS_AC...4,SET,183,0.018829,0.0018704,0.062207,0.38107,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP,0.965705961044521
GSE40068_CXCR5POS_BCL6POS_TF...1,SET,183,0.020212,0.0020078,0.066801,0.38111,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN,0.965705961044521
REACTOME_FCERI_MEDIATED_CA_2...,SET,30,0.046219,0.0018668,0.15276,0.38112,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...445,SET,7,0.089085,0.0017391,0.29447,0.38113,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.965705961044521
WP_OVARIAN_INFERTILITY,SET,38,0.041804,0.0018999,0.13824,0.38117,WP_OVARIAN_INFERTILITY,0.965705961044521
GSE21380_NON_TFH_VS_TFH_CD4_...1,SET,180,0.01953,0.0019242,0.064582,0.38118,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN,0.965705961044521
HP_CORNEAL_DYSTROPHY,SET,29,0.052443,0.0020826,0.17345,0.38119,HP_CORNEAL_DYSTROPHY,0.965705961044521
GOBP_CHROMOSOME_ORGANIZATION...,SET,55,0.031275,0.0017092,0.10345,0.3812,GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE,0.965705961044521
GOBP_T_CELL_ACTIVATION_VIA_T...,SET,10,0.083648,0.0019517,0.27666,0.3812,GOBP_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.965705961044521
HP_BROAD_NAIL,SET,8,0.098145,0.0020482,0.32464,0.3812,HP_BROAD_NAIL,0.965705961044521
GSE360_L_MAJOR_VS_B_MALAYI_L...1,SET,178,0.01858,0.0018206,0.061457,0.3812,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN,0.965705961044521
GOBP_REGULATION_OF_LYMPHOCYT...4,SET,205,0.01854,0.0019481,0.061332,0.38122,GOBP_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.965705961044521
HP_ABNORMALITY_OF_THE_FRONTA...,SET,184,0.018642,0.0018569,0.06167,0.38122,HP_ABNORMALITY_OF_THE_FRONTAL_HAIRLINE,0.965705961044521
GOBP_PROTEIN_RETENTION_IN_ER...,SET,8,0.085563,0.0017857,0.28319,0.38128,GOBP_PROTEIN_RETENTION_IN_ER_LUMEN,0.965705961044521
GSE14769_UNSTIM_VS_360MIN_LP...2,SET,176,0.018269,0.0017801,0.060468,0.38128,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP,0.965705961044521
REACTOME_SERINE_BIOSYNTHESIS,SET,9,0.080868,0.00179,0.26779,0.38133,REACTOME_SERINE_BIOSYNTHESIS,0.965705961044521
GOBP_ENDOSOME_TO_LYSOSOME_TR...1,SET,68,0.031877,0.0019364,0.10556,0.38134,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.965705961044521
MIR6864_3P,SET,39,0.040024,0.0018427,0.13259,0.38138,MIR6864_3P,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...113,SET,581,0.011423,0.0019996,0.037843,0.38139,GOBP_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.965705961044521
HP_BLUE_NEVUS,SET,11,0.078339,0.0019169,0.25959,0.38141,HP_BLUE_NEVUS,0.965705961044521
RORIE_TARGETS_OF_EWSR1_FLI1_...2,SET,24,0.061163,0.0022099,0.20269,0.38142,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.965705961044521
GSE29164_UNTREATED_VS_CD8_TC...8,SET,187,0.018963,0.001904,0.062863,0.38146,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP,0.965705961044521
GSE2770_IL12_VS_TGFB_AND_IL1...3,SET,184,0.018945,0.001887,0.062819,0.38149,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.965705961044521
LEI_HOXC8_TARGETS_UP,SET,11,0.077011,0.0018844,0.25544,0.38152,LEI_HOXC8_TARGETS_UP,0.965705961044521
LANDEMAINE_LUNG_METASTASIS,SET,20,0.0609,0.0020089,0.20203,0.38154,LANDEMAINE_LUNG_METASTASIS,0.965705961044521
MIR617,SET,57,0.032593,0.0018132,0.10813,0.38155,MIR617,0.965705961044521
HP_CHRONIC_PULMONARY_OBSTRUC...,SET,30,0.052107,0.0021046,0.17292,0.38158,HP_CHRONIC_PULMONARY_OBSTRUCTION,0.965705961044521
HP_ABNORMAL_NUMBER_OF_ERYTHR...,SET,42,0.03745,0.0017891,0.12436,0.38166,HP_ABNORMAL_NUMBER_OF_ERYTHROID_PRECURSORS,0.965705961044521
GSE3982_NEUTROPHIL_VS_TH1_DN,SET,179,0.018279,0.001796,0.060699,0.38166,GSE3982_NEUTROPHIL_VS_TH1_DN,0.965705961044521
GSE36078_UNTREATED_VS_AD5_IN...1,SET,183,0.018765,0.0018641,0.062326,0.38168,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.965705961044521
WP_MAMMARY_GLAND_DEVELOPMENT...1,SET,15,0.071479,0.0020422,0.23749,0.38172,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,0.965705961044521
HP_SPASTIC_PARAPARETIC_GAIT,SET,9,0.096033,0.0021257,0.31919,0.38176,HP_SPASTIC_PARAPARETIC_GAIT,0.965705961044521
GSE17580_TREG_VS_TEFF_S_MANS...2,SET,180,0.01921,0.0018927,0.063876,0.38181,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP,0.965705961044521
GOBP_POSITIVE_REGULATION_OF_...365,SET,14,0.066558,0.0018372,0.22137,0.38184,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,0.965705961044521
GOMF_SIGNALING_RECEPTOR_BIND...,SET,1324,0.0076893,0.001989,0.025581,0.38187,GOMF_SIGNALING_RECEPTOR_BINDING,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...424,SET,76,0.032098,0.0020609,0.10689,0.38198,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.965705961044521
KEGG_SNARE_INTERACTIONS_IN_V...,SET,36,0.04076,0.0018031,0.13587,0.38209,KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,0.965705961044521
HP_PYRIDOXINE_RESPONSIVE_SID...,SET,22,0.047116,0.00163,0.15712,0.38214,HP_PYRIDOXINE_RESPONSIVE_SIDEROBLASTIC_ANEMIA,0.965705961044521
HP_CONGENITAL_PTOSIS,SET,4,0.12834,0.0018942,0.42808,0.38216,HP_CONGENITAL_PTOSIS,0.965705961044521
GAVISH_3CA_MALIGNANT_METAPRO...28,SET,19,0.06851,0.0022028,0.22855,0.38218,GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG,0.965705961044521
HP_CONE_SHAPED_EPIPHYSIS,SET,72,0.029222,0.0018264,0.097505,0.3822,HP_CONE_SHAPED_EPIPHYSIS,0.965705961044521
GOBP_CYTOKINE_PRODUCTION_INV...2,SET,57,0.033137,0.0018435,0.11062,0.38226,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.965705961044521
REACTOME_NR1H2_NR1H3_REGULAT...5,SET,5,0.09256,0.0015273,0.30909,0.38229,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE,0.965705961044521
GOBP_GLYCOSYLCERAMIDE_BIOSYN...,SET,8,0.092512,0.0019307,0.30899,0.38232,GOBP_GLYCOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.965705961044521
GOMF_PRE_MRNA_BINDING,SET,36,0.038812,0.0017169,0.12966,0.38234,GOMF_PRE_MRNA_BINDING,0.965705961044521
HP_ABNORMAL_PROXIMAL_FEMORAL...,SET,8,0.082446,0.0017206,0.27541,0.38234,HP_ABNORMAL_PROXIMAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.965705961044521
GOBP_ALPHA_LINOLENIC_ACID_ME...,SET,9,0.084982,0.0018811,0.28391,0.38235,GOBP_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS,0.965705961044521
HP_FACIAL_GRIMACING,SET,10,0.07451,0.0017384,0.24894,0.38235,HP_FACIAL_GRIMACING,0.965705961044521
GOMF_PHOSPHATE_ION_BINDING,SET,8,0.097602,0.0020369,0.3261,0.38236,GOMF_PHOSPHATE_ION_BINDING,0.965705961044521
MIR4697_3P,SET,99,0.025756,0.0018862,0.086061,0.38237,MIR4697_3P,0.965705961044521
HOWARD_NEUTROPHIL_INACT_MONO...4,SET,113,0.024848,0.0019433,0.08303,0.38237,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.965705961044521
GOBP_MEIOTIC_CELL_CYCLE_PROC...2,SET,6,0.11032,0.001994,0.36867,0.38238,GOBP_MEIOTIC_CELL_CYCLE_PROCESS_INVOLVED_IN_OOCYTE_MATURATION,0.965705961044521
GAVISH_3CA_METAPROGRAM_EPITH...15,SET,47,0.038265,0.0019335,0.12792,0.38242,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_2,0.965705961044521
GSE6674_UNSTIM_VS_ANTI_IGM_A...1,SET,178,0.017902,0.0017542,0.059856,0.38244,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.965705961044521
GOBP_REGULATION_OF_PEPTIDYL_...6,SET,199,0.018998,0.0019671,0.06354,0.38247,GOBP_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.965705961044521
BIOCARTA_PDZS_PATHWAY,SET,15,0.064925,0.001855,0.21716,0.38248,BIOCARTA_PDZS_PATHWAY,0.965705961044521
GOMF_DIPHOSPHOTRANSFERASE_AC...,SET,4,0.17255,0.0025466,0.57713,0.38248,GOMF_DIPHOSPHOTRANSFERASE_ACTIVITY,0.965705961044521
GOBP_PROTEIN_HYDROXYLATION,SET,23,0.048294,0.0017082,0.16158,0.38252,GOBP_PROTEIN_HYDROXYLATION,0.965705961044521
GOBP_RESPONSE_TO_PROTOZOAN,SET,27,0.055127,0.0021125,0.18445,0.38252,GOBP_RESPONSE_TO_PROTOZOAN,0.965705961044521
REACTOME_FGFR1_LIGAND_BINDIN...,SET,17,0.071052,0.002161,0.23774,0.38253,REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,0.965705961044521
GAVISH_3CA_METAPROGRAM_EPITH...21,SET,34,0.041484,0.0017836,0.13888,0.38259,GAVISH_3CA_METAPROGRAM_EPITHELIAL_RESPIRATION,0.965705961044521
GOMF_GLUTAMATE_GATED_CALCIUM...,SET,7,0.10117,0.001975,0.33882,0.38263,GOMF_GLUTAMATE_GATED_CALCIUM_ION_CHANNEL_ACTIVITY,0.965705961044521
KANG_AR_TARGETS_UP,SET,16,0.073349,0.0021644,0.24575,0.38268,KANG_AR_TARGETS_UP,0.965705961044521
HP_NARROW_FORAMEN_OBTURATORI...,SET,4,0.11739,0.0017325,0.39335,0.38269,HP_NARROW_FORAMEN_OBTURATORIUM,0.965705961044521
KEGG_MEDICUS_ENV_FACTOR_NNK_...5,SET,5,0.13089,0.0021597,0.4387,0.38272,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS,0.965705961044521
HP_BREAST_HYPOPLASIA,SET,42,0.042945,0.0020517,0.14401,0.38277,HP_BREAST_HYPOPLASIA,0.965705961044521
GSE21379_TFH_VS_NON_TFH_CD4_...2,SET,178,0.019408,0.0019017,0.06508,0.38277,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP,0.965705961044521
GSE24210_IL35_TREATED_VS_RES...2,SET,178,0.019685,0.0019288,0.066006,0.38277,GSE24210_IL35_TREATED_VS_RESTING_TREG_UP,0.965705961044521
GOBP_PHOSPHATIDYLGLYCEROL_ME...,SET,32,0.048739,0.002033,0.16357,0.38286,GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS,0.965705961044521
LIM_MAMMARY_LUMINAL_MATURE_UP,SET,97,0.027084,0.0019634,0.0909,0.38287,LIM_MAMMARY_LUMINAL_MATURE_UP,0.965705961044521
GOMF_CYCLIC_NUCLEOTIDE_PHOSP...,SET,26,0.050218,0.0018884,0.16864,0.38294,GOMF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,0.965705961044521
DESCARTES_MAIN_FETAL_GANGLIO...,SET,19,0.064819,0.0020841,0.2177,0.38295,DESCARTES_MAIN_FETAL_GANGLION_CELLS,0.965705961044521
GSE9960_HEALTHY_VS_GRAM_NEG_...2,SET,148,0.021058,0.001883,0.070732,0.38296,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.965705961044521
XU_HGF_SIGNALING_NOT_VIA_AKT...3,SET,23,0.056311,0.0019918,0.18924,0.38302,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...197,SET,63,0.031233,0.0018264,0.10497,0.38303,GOBP_NEGATIVE_REGULATION_OF_ENDOCYTOSIS,0.965705961044521
HP_ABNORMALITY_OF_THE_POSTER...,SET,99,0.02484,0.0018191,0.083492,0.38304,HP_ABNORMALITY_OF_THE_POSTERIOR_HAIRLINE,0.965705961044521
HP_HYPERTYROSINEMIA,SET,6,0.11298,0.0020421,0.37977,0.38304,HP_HYPERTYROSINEMIA,0.965705961044521
MIR3668,SET,95,0.025887,0.0018573,0.087069,0.38311,MIR3668,0.965705961044521
GOBP_REGULATION_OF_RESPONSE_...6,SET,15,0.071187,0.0020339,0.23941,0.38311,GOBP_REGULATION_OF_RESPONSE_TO_FOOD,0.965705961044521
GOBP_CELLULAR_RESPONSE_TO_NI...3,SET,11,0.076657,0.0018758,0.25784,0.38312,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS,0.965705961044521
BIOCARTA_PELP1_PATHWAY,SET,6,0.10147,0.0018341,0.34134,0.38313,BIOCARTA_PELP1_PATHWAY,0.965705961044521
MIR7110_5P,SET,154,0.020949,0.0019105,0.070525,0.38322,MIR7110_5P,0.965705961044521
HP_ENLARGED_JOINTS,SET,12,0.069832,0.0017847,0.23516,0.38325,HP_ENLARGED_JOINTS,0.965705961044521
GOBP_RESPONSE_TO_IRON_ION,SET,27,0.051059,0.0019566,0.17196,0.38326,GOBP_RESPONSE_TO_IRON_ION,0.965705961044521
GOBP_RENAL_SODIUM_EXCRETION,SET,11,0.081355,0.0019907,0.2741,0.38331,GOBP_RENAL_SODIUM_EXCRETION,0.965705961044521
chr11p11,SET,62,0.065978,0.0038276,0.22235,0.38334,chr11p11,0.965705961044521
REACTOME_SARS_COV_1_INFECTION,SET,129,0.021481,0.0017943,0.07242,0.38338,REACTOME_SARS_COV_1_INFECTION,0.965705961044521
GOBP_EMBRYONIC_HEART_TUBE_MO...,SET,70,0.030669,0.0018901,0.10339,0.38338,GOBP_EMBRYONIC_HEART_TUBE_MORPHOGENESIS,0.965705961044521
WP_BIOGENIC_AMINE_SYNTHESIS,SET,13,0.073144,0.0019456,0.24661,0.38339,WP_BIOGENIC_AMINE_SYNTHESIS,0.965705961044521
KRAS.AMP.LUNG_UP.V1_DN,SET,120,0.023864,0.0019229,0.080459,0.38339,KRAS.AMP.LUNG_UP.V1_DN,0.965705961044521
HP_DECREASED_BODY_WEIGHT,SET,1374,0.007028,0.0018493,0.023704,0.38343,HP_DECREASED_BODY_WEIGHT,0.965705961044521
ZHONG_PFC_C1_DLX5_POS_INTERN...,SET,6,0.12336,0.0022297,0.41613,0.38344,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,0.965705961044521
GOMF_AMINO_ACID_BINDING,SET,43,0.040476,0.0019565,0.13654,0.38345,GOMF_AMINO_ACID_BINDING,0.965705961044521
MIR3117_3P,SET,30,0.047264,0.001909,0.15945,0.38346,MIR3117_3P,0.965705961044521
GOBP_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.097907,0.0016155,0.33036,0.38348,GOBP_CERAMIDE_1_PHOSPHATE_TRANSPORT,0.965705961044521
GOMF_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.097907,0.0016155,0.33036,0.38348,GOMF_CERAMIDE_1_PHOSPHATE_TRANSFER_ACTIVITY,0.965705961044521
WP_STRIATED_MUSCLE_CONTRACTI...,SET,37,0.041896,0.0018789,0.14138,0.38349,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,0.965705961044521
MIR670_3P,SET,268,0.015832,0.0018988,0.05343,0.3835,MIR670_3P,0.965705961044521
GOBP_OSTEOCLAST_PROLIFERATION,SET,11,0.078141,0.0019121,0.26391,0.38358,GOBP_OSTEOCLAST_PROLIFERATION,0.965705961044521
HP_FEMALE_INFERTILITY,SET,69,0.029201,0.0017868,0.098639,0.3836,HP_FEMALE_INFERTILITY,0.965705961044521
ZNF350_TARGET_GENES,SET,1153,0.0076902,0.0018657,0.025981,0.38362,ZNF350_TARGET_GENES,0.965705961044521
WP_PEPTIDE_GPCRS,SET,66,0.035201,0.0021068,0.11905,0.38374,WP_PEPTIDE_GPCRS,0.965705961044521
WHITFIELD_CELL_CYCLE_G2_M,SET,183,0.018328,0.0018206,0.062002,0.38377,WHITFIELD_CELL_CYCLE_G2_M,0.965705961044521
HP_PTERYGIUM,SET,45,0.036556,0.0018076,0.12369,0.38379,HP_PTERYGIUM,0.965705961044521
REACTOME_TERMINATION_OF_TRAN...,SET,30,0.041875,0.0016913,0.14173,0.38383,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,0.965705961044521
GOBP_MONOCARBOXYLIC_ACID_BIO...,SET,202,0.018258,0.0019045,0.061805,0.38384,GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.965705961044521
GOBP_PYRIDINE_CONTAINING_COM...2,SET,91,0.025442,0.0017867,0.086136,0.38386,GOBP_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.965705961044521
GOBP_RECEPTOR_METABOLIC_PROC...,SET,66,0.030567,0.0018294,0.10355,0.38392,GOBP_RECEPTOR_METABOLIC_PROCESS,0.965705961044521
KERLEY_RESPONSE_TO_CISPLATIN...1,SET,5,0.11931,0.0019686,0.40421,0.38393,KERLEY_RESPONSE_TO_CISPLATIN_DN,0.965705961044521
LI_PBMC_MENACTRA_AGE_18_45YO...5,SET,30,0.049439,0.0019968,0.16753,0.38396,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.965705961044521
GSE5589_LPS_AND_IL10_VS_LPS_...2,SET,178,0.01924,0.0018852,0.065237,0.38403,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.965705961044521
GOBP_PROTEIN_AUTOPHOSPHORYLA...,SET,175,0.019529,0.0018975,0.066223,0.38404,GOBP_PROTEIN_AUTOPHOSPHORYLATION,0.965705961044521
GOBP_PLATELET_MORPHOGENESIS,SET,23,0.048053,0.0016997,0.16303,0.38409,GOBP_PLATELET_MORPHOGENESIS,0.965705961044521
REACTOME_DOWNSTREAM_SIGNALIN...2,SET,31,0.044865,0.001842,0.1523,0.38416,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,0.965705961044521
GSE9509_LPS_VS_LPS_AND_IL10_...3,SET,173,0.018526,0.0017898,0.062895,0.38417,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN,0.965705961044521
GOBP_CARDIAC_MUSCLE_CONTRACT...,SET,131,0.023417,0.0019709,0.079525,0.3842,GOBP_CARDIAC_MUSCLE_CONTRACTION,0.965705961044521
GSE23398_WT_VS_IL2_KO_CD4_TC...1,SET,180,0.018172,0.0017905,0.061718,0.38421,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN,0.965705961044521
REACTOME_TRANSCRIPTIONAL_REG...4,SET,170,0.01897,0.001817,0.064456,0.38426,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,0.965705961044521
GOMF_SINGLE_STRANDED_DNA_HEL...,SET,23,0.049752,0.0017598,0.16907,0.38428,GOMF_SINGLE_STRANDED_DNA_HELICASE_ACTIVITY,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...682,SET,5,0.12956,0.0021377,0.44069,0.38439,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...629,SET,8,0.073657,0.0015372,0.25062,0.38442,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_CAPPING,0.965705961044521
GSE21380_TFH_VS_GERMINAL_CEN...1,SET,179,0.017788,0.0017478,0.060543,0.38445,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,0.965705961044521
MIR6803_5P,SET,52,0.0357,0.0018972,0.12152,0.38447,MIR6803_5P,0.965705961044521
HP_HEPARAN_SULFATE_EXCRETION...,SET,8,0.082537,0.0017225,0.28097,0.38447,HP_HEPARAN_SULFATE_EXCRETION_IN_URINE,0.965705961044521
GOBP_RNA_POLYMERASE_II_PREIN...,SET,52,0.031946,0.0016977,0.10882,0.38454,GOBP_RNA_POLYMERASE_II_PREINITIATION_COMPLEX_ASSEMBLY,0.965705961044521
GOCC_CALCITONIN_FAMILY_RECEP...,SET,5,0.12613,0.0020811,0.42967,0.38455,GOCC_CALCITONIN_FAMILY_RECEPTOR_COMPLEX,0.965705961044521
GOBP_GALACTOSYLCERAMIDE_BIOS...,SET,6,0.11084,0.0020033,0.37768,0.38458,GOBP_GALACTOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.965705961044521
HP_HEMOPHAGOCYTOSIS,SET,19,0.063638,0.0020461,0.21696,0.38464,HP_HEMOPHAGOCYTOSIS,0.965705961044521
GOCC_SCF_UBIQUITIN_LIGASE_CO...,SET,59,0.033055,0.0018708,0.1127,0.38465,GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX,0.965705961044521
GOBP_PROTEIN_LOCALIZATION_TO...16,SET,8,0.077482,0.001617,0.2642,0.38466,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_TRANSITION_ZONE,0.965705961044521
JONES_OVARY_STROMAL,SET,134,0.02331,0.0019842,0.079502,0.38468,JONES_OVARY_STROMAL,0.965705961044521
GSE7831_CPG_VS_INFLUENZA_STI...4,SET,175,0.018732,0.0018201,0.063907,0.38472,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP,0.965705961044521
ZHONG_PFC_C2_THY1_POS_OPC,SET,22,0.059372,0.002054,0.20267,0.38478,ZHONG_PFC_C2_THY1_POS_OPC,0.965705961044521
GOBP_ACTIN_MEDIATED_CELL_CON...,SET,106,0.025772,0.0019526,0.087978,0.38479,GOBP_ACTIN_MEDIATED_CELL_CONTRACTION,0.965705961044521
ZNF257_TARGET_GENES,SET,446,0.011762,0.0018108,0.040194,0.3849,ZNF257_TARGET_GENES,0.965705961044521
TBK1.DN.48HRS_DN,SET,46,0.037248,0.0018621,0.1273,0.38492,TBK1.DN.48HRS_DN,0.965705961044521
REACTOME_TAK1_DEPENDENT_IKK_...,SET,40,0.040101,0.0018697,0.13707,0.38493,REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION,0.965705961044521
GOBP_ESTABLISHMENT_OF_MITOCH...2,SET,22,0.054605,0.0018891,0.18664,0.38493,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED,0.965705961044521
HP_LETHARGY,SET,191,0.017594,0.0017852,0.060151,0.38495,HP_LETHARGY,0.965705961044521
GRAHAM_CML_QUIESCENT_VS_CML_...1,SET,10,0.091709,0.0021397,0.31368,0.385,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,0.965705961044521
HP_NECK_PAIN,SET,5,0.11502,0.0018979,0.39343,0.38501,HP_NECK_PAIN,0.965705961044521
GSE7831_UNSTIM_VS_INFLUENZA_...1,SET,182,0.018884,0.0018708,0.0646,0.38502,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN,0.965705961044521
HP_BIFID_TONGUE,SET,22,0.051396,0.0017781,0.17599,0.38513,HP_BIFID_TONGUE,0.965705961044521
GSE22935_UNSTIM_VS_48H_MBOVI...3,SET,177,0.019147,0.0018709,0.065564,0.38513,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.965705961044521
GOBP_NERVE_GROWTH_FACTOR_SIG...,SET,14,0.073649,0.002033,0.25223,0.38515,GOBP_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY,0.965705961044521
RAFFEL_VEGFA_TARGETS_UP,SET,9,0.091943,0.0020351,0.31528,0.38529,RAFFEL_VEGFA_TARGETS_UP,0.965705961044521
GSE27092_WT_VS_HDAC7_PHOSPHO...2,SET,185,0.018564,0.001854,0.063655,0.38529,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP,0.965705961044521
MANNO_MIDBRAIN_NEUROTYPES_HM...,SET,521,0.011392,0.0018916,0.039084,0.38535,MANNO_MIDBRAIN_NEUROTYPES_HMGL,0.965705961044521
GSE17721_0.5H_VS_24H_POLYIC_...1,SET,183,0.017696,0.0017579,0.060749,0.38541,GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN,0.965705961044521
HP_ANEMIA_DUE_TO_REDUCED_LIF...,SET,139,0.020978,0.0018184,0.072029,0.38543,HP_ANEMIA_DUE_TO_REDUCED_LIFE_SPAN_OF_RED_CELLS,0.965705961044521
GOBP_CHROMOSOME_LOCALIZATION,SET,112,0.022727,0.0017697,0.078038,0.38544,GOBP_CHROMOSOME_LOCALIZATION,0.965705961044521
GSE17721_0.5H_VS_24H_CPG_BMD...1,SET,188,0.01909,0.0019218,0.065567,0.38547,GSE17721_0.5H_VS_24H_CPG_BMDC_DN,0.965705961044521
chr9q31,SET,55,0.061522,0.0033622,0.21133,0.38548,chr9q31,0.965705961044521
HP_PRECOCIOUS_ATHEROSCLEROSIS,SET,12,0.0785,0.0020062,0.26968,0.38549,HP_PRECOCIOUS_ATHEROSCLEROSIS,0.965705961044521
PRC2_EED_DN.V1_UP,SET,172,0.019493,0.0018779,0.066967,0.38549,PRC2_EED_DN.V1_UP,0.965705961044521
GOBP_REGULATION_OF_LIPOPHAGY,SET,5,0.11661,0.001924,0.4006,0.3855,GOBP_REGULATION_OF_LIPOPHAGY,0.965705961044521
HP_TYPE_2_MUSCLE_FIBER_PREDO...,SET,9,0.085328,0.0018887,0.29316,0.3855,HP_TYPE_2_MUSCLE_FIBER_PREDOMINANCE,0.965705961044521
HP_ELEVATED_CIRCULATING_CREA...,SET,265,0.01504,0.0017938,0.051673,0.38551,HP_ELEVATED_CIRCULATING_CREATINE_KINASE_CONCENTRATION,0.965705961044521
MODULE_249,SET,21,0.051283,0.0017334,0.17622,0.38552,MODULE_249,0.965705961044521
GOCC_EXTERNAL_SIDE_OF_APICAL...,SET,6,0.1055,0.0019069,0.3625,0.38552,GOCC_EXTERNAL_SIDE_OF_APICAL_PLASMA_MEMBRANE,0.965705961044521
GSE10325_CD4_TCELL_VS_MYELOI...2,SET,179,0.018728,0.0018401,0.064361,0.38554,GSE10325_CD4_TCELL_VS_MYELOID_UP,0.965705961044521
REACTOME_LDL_CLEARANCE,SET,19,0.057481,0.0018482,0.19759,0.38556,REACTOME_LDL_CLEARANCE,0.965705961044521
chr3p23,SET,3,0.17141,0.002191,0.58932,0.38558,chr3p23,0.965705961044521
ACACTGG_MIR199A_MIR199B,SET,139,0.021029,0.0018228,0.072329,0.38562,ACACTGG_MIR199A_MIR199B,0.965705961044521
MOHANKUMAR_HOXA1_TARGETS_UP,SET,364,0.012594,0.0017556,0.043339,0.38568,MOHANKUMAR_HOXA1_TARGETS_UP,0.965705961044521
ELVIDGE_HYPOXIA_DN,SET,137,0.019845,0.0017078,0.068309,0.38571,ELVIDGE_HYPOXIA_DN,0.965705961044521
MODULE_489,SET,26,0.049068,0.0018452,0.16904,0.3858,MODULE_489,0.965705961044521
WP_CARDIAC_HYPERTROPHIC_RESP...,SET,53,0.035529,0.0019062,0.12242,0.38582,WP_CARDIAC_HYPERTROPHIC_RESPONSE,0.965705961044521
GSE12963_UNINF_VS_ENV_AND_NE...1,SET,121,0.022478,0.0018188,0.077456,0.38583,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.965705961044521
GSE15330_MEGAKARYOCYTE_ERYTH...1,SET,174,0.018248,0.001768,0.062886,0.38584,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN,0.965705961044521
HP_POLYCYSTIC_KIDNEY_DYSPLAS...,SET,48,0.03659,0.0018685,0.12612,0.38586,HP_POLYCYSTIC_KIDNEY_DYSPLASIA,0.965705961044521
GSE7460_CD8_TCELL_VS_CD4_TCE...2,SET,173,0.018898,0.0018258,0.065141,0.38587,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP,0.965705961044521
PID_HDAC_CLASSIII_PATHWAY,SET,23,0.050727,0.0017943,0.17494,0.38592,PID_HDAC_CLASSIII_PATHWAY,0.965705961044521
GSE360_CTRL_VS_B_MALAYI_HIGH...3,SET,189,0.017315,0.0017477,0.059712,0.38592,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.965705961044521
MORF_PSMC2,SET,101,0.02196,0.0016243,0.075772,0.38598,MORF_PSMC2,0.965705961044521
CARRILLOREIXACH_HEPATOBLASTO...3,SET,156,0.020937,0.0019217,0.072247,0.38599,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP,0.965705961044521
GOBP_POSITIVE_REGULATION_OF_...719,SET,5,0.11035,0.0018208,0.38107,0.38607,GOBP_POSITIVE_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...260,SET,6,0.091401,0.001652,0.31567,0.38609,GOBP_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.965705961044521
HP_ABNORMALITY_OF_THE_PROXIM...1,SET,4,0.11924,0.0017599,0.41195,0.38612,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_5TH_FINGER,0.965705961044521
REACTOME_INTEGRIN_SIGNALING,SET,27,0.048165,0.0018457,0.16647,0.38617,REACTOME_INTEGRIN_SIGNALING,0.965705961044521
GOBP_RESPONSE_TO_HEPARIN,SET,6,0.12286,0.0022206,0.425,0.38626,GOBP_RESPONSE_TO_HEPARIN,0.965705961044521
HP_REDUCED_PROTEIN_S_ACTIVITY,SET,8,0.068187,0.001423,0.23591,0.38628,HP_REDUCED_PROTEIN_S_ACTIVITY,0.965705961044521
HP_ECLAMPSIA,SET,7,0.1007,0.0019658,0.34842,0.38629,HP_ECLAMPSIA,0.965705961044521
HP_DECREASED_SPECIFIC_ANTIBO...3,SET,13,0.078055,0.0020763,0.2701,0.3863,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_VACCINE,0.965705961044521
GSE17974_IL4_AND_ANTI_IL12_V...14,SET,164,0.018328,0.0017245,0.063429,0.38631,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP,0.965705961044521
GOBP_REGULATION_OF_CARDIAC_M...3,SET,7,0.079713,0.0015562,0.2759,0.38632,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION,0.965705961044521
KEGG_ETHER_LIPID_METABOLISM,SET,30,0.048065,0.0019413,0.1664,0.38635,KEGG_ETHER_LIPID_METABOLISM,0.965705961044521
GCM_BECN1,SET,62,0.029172,0.0016923,0.10109,0.38645,GCM_BECN1,0.965705961044521
GSE17974_IL4_AND_ANTI_IL12_V...7,SET,163,0.020247,0.0018993,0.070161,0.38645,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN,0.965705961044521
GSE22025_UNTREATED_VS_PROGES...2,SET,181,0.018507,0.0018285,0.064139,0.38646,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP,0.965705961044521
WP_CYTOPLASMIC_RIBOSOMAL_PRO...,SET,78,0.026736,0.0017389,0.092727,0.38655,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,0.965705961044521
HP_INFRA_ORBITAL_CREASE,SET,7,0.093668,0.0018286,0.32492,0.38657,HP_INFRA_ORBITAL_CREASE,0.965705961044521
WP_TCA_CYCLE_IN_SENESCENCE,SET,9,0.088492,0.0019588,0.30708,0.38661,WP_TCA_CYCLE_IN_SENESCENCE,0.965705961044521
IVANOVA_HEMATOPOIESIS_STEM_C...4,SET,18,0.05394,0.0016881,0.18724,0.38664,IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,0.965705961044521
BUSSLINGER_GASTRIC_IMMUNE_CE...,SET,1342,0.006944,0.0018075,0.024104,0.38664,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.965705961044521
FIGUEROA_AML_METHYLATION_CLU...4,SET,47,0.037022,0.0018707,0.12852,0.38665,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,0.965705961044521
MIR4795_5P,SET,62,0.03195,0.0018535,0.11092,0.38666,MIR4795_5P,0.965705961044521
ZHANG_BREAST_CANCER_PROGENIT...2,SET,396,0.012033,0.001748,0.041787,0.38669,ZHANG_BREAST_CANCER_PROGENITORS_UP,0.965705961044521
HP_INCREASED_SERUM_ESTRADIOL,SET,8,0.089583,0.0018696,0.31113,0.3867,HP_INCREASED_SERUM_ESTRADIOL,0.965705961044521
GSE12392_WT_VS_IFNB_KO_CD8A_...3,SET,183,0.018275,0.0018154,0.063477,0.38671,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN,0.965705961044521
GOBP_PLASMA_MEMBRANE_FUSION,SET,25,0.053606,0.0019767,0.18623,0.38673,GOBP_PLASMA_MEMBRANE_FUSION,0.965705961044521
CDP_02,SET,96,0.026409,0.0019047,0.091778,0.38677,CDP_02,0.965705961044521
SA_G1_AND_S_PHASES,SET,15,0.062894,0.001797,0.21874,0.38686,SA_G1_AND_S_PHASES,0.965705961044521
BIOCARTA_CHEMICAL_PATHWAY,SET,18,0.057392,0.0017961,0.19967,0.38689,BIOCARTA_CHEMICAL_PATHWAY,0.965705961044521
GOBP_LYMPH_VESSEL_MORPHOGENE...,SET,21,0.055448,0.0018742,0.1929,0.38689,GOBP_LYMPH_VESSEL_MORPHOGENESIS,0.965705961044521
GOMF_S_ACYLTRANSFERASE_ACTIV...,SET,28,0.043442,0.0016952,0.15115,0.3869,GOMF_S_ACYLTRANSFERASE_ACTIVITY,0.965705961044521
GSE3982_CTRL_VS_LPS_48H_DC_DN,SET,180,0.019179,0.0018897,0.066736,0.38691,GSE3982_CTRL_VS_LPS_48H_DC_DN,0.965705961044521
HP_RECURRENT_THROMBOPHLEBITIS,SET,6,0.088774,0.0016046,0.30898,0.38694,HP_RECURRENT_THROMBOPHLEBITIS,0.965705961044521
GOMF_CYTOCHROME_B5_REDUCTASE...,SET,6,0.094065,0.0017002,0.32746,0.38696,GOMF_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,0.965705961044521
ZHAN_MULTIPLE_MYELOMA_MF_UP,SET,40,0.038706,0.0018047,0.13479,0.38699,ZHAN_MULTIPLE_MYELOMA_MF_UP,0.965705961044521
GOBP_RESPONSE_TO_ACTINOMYCIN...,SET,5,0.10438,0.0017222,0.36356,0.38702,GOBP_RESPONSE_TO_ACTINOMYCIN_D,0.965705961044521
GNF2_ITGAL,SET,51,0.034904,0.001837,0.12166,0.38709,GNF2_ITGAL,0.965705961044521
GSE15659_NAIVE_CD4_TCELL_VS_...3,SET,175,0.018734,0.0018202,0.065311,0.38712,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.965705961044521
HP_RECURRENT_MYCOBACTERIAL_I...,SET,48,0.034579,0.0017657,0.12056,0.38713,HP_RECURRENT_MYCOBACTERIAL_INFECTIONS,0.965705961044521
KEGG_MEDICUS_PATHOGEN_KSHV_K...,SET,7,0.0855,0.0016692,0.29828,0.38719,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY,0.965705961044521
REACTOME_TRANSPORT_OF_THE_SL...,SET,33,0.039198,0.0016603,0.13678,0.38722,REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,0.965705961044521
GOBP_RRNA_PROCESSING,SET,194,0.016231,0.0016596,0.056646,0.38724,GOBP_RRNA_PROCESSING,0.965705961044521
HOXB4_TARGET_GENES,SET,929,0.0079454,0.0017415,0.027732,0.38725,HOXB4_TARGET_GENES,0.965705961044521
REACTOME_DISEASES_OF_IMMUNE_...,SET,29,0.047847,0.0019001,0.16722,0.38739,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,0.965705961044521
REACTOME_MOLYBDENUM_COFACTOR...,SET,6,0.10923,0.0019742,0.38185,0.38742,REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS,0.965705961044521
GOBP_POSITIVE_REGULATION_OF_...784,SET,5,0.12306,0.0020306,0.4302,0.38742,GOBP_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.965705961044521
GOBP_PROSTHETIC_GROUP_METABO...,SET,6,0.10923,0.0019742,0.38185,0.38742,GOBP_PROSTHETIC_GROUP_METABOLIC_PROCESS,0.965705961044521
BIOCARTA_BBCELL_PATHWAY,SET,6,0.11544,0.0020865,0.40363,0.38744,BIOCARTA_BBCELL_PATHWAY,0.965705961044521
HP_ONYCHOGRYPOSIS_OF_TOENAILS,SET,7,0.091665,0.0017895,0.32049,0.38744,HP_ONYCHOGRYPOSIS_OF_TOENAILS,0.965705961044521
GSE369_PRE_VS_POST_IL6_INJEC...4,SET,177,0.019173,0.0018734,0.067075,0.3875,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP,0.965705961044521
BUSSLINGER_DUODENAL_STEM_CEL...,SET,281,0.014986,0.0018398,0.052475,0.3876,BUSSLINGER_DUODENAL_STEM_CELLS,0.965705961044521
HP_CUTANEOUS_MELANOMA,SET,19,0.04952,0.0015922,0.17346,0.38764,HP_CUTANEOUS_MELANOMA,0.965705961044521
HP_SPONDYLOEPIMETAPHYSEAL_DY...,SET,15,0.060929,0.0017408,0.21348,0.38767,HP_SPONDYLOEPIMETAPHYSEAL_DYSPLASIA,0.965705961044521
CATGTAA_MIR496,SET,161,0.019297,0.0017991,0.067653,0.38773,CATGTAA_MIR496,0.965705961044521
ALONSO_METASTASIS_DN,SET,23,0.054169,0.001916,0.18993,0.38775,ALONSO_METASTASIS_DN,0.965705961044521
PID_MYC_REPRESS_PATHWAY,SET,60,0.030576,0.0017451,0.10723,0.38777,PID_MYC_REPRESS_PATHWAY,0.965705961044521
BILD_E2F3_ONCOGENIC_SIGNATURE,SET,223,0.016553,0.0018131,0.058062,0.38779,BILD_E2F3_ONCOGENIC_SIGNATURE,0.965705961044521
GSE25088_ROSIGLITAZONE_VS_IL...2,SET,180,0.018272,0.0018003,0.064103,0.38781,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.965705961044521
MIR6501_3P,SET,132,0.021641,0.0018284,0.075934,0.38782,MIR6501_3P,0.965705961044521
BOYLAN_MULTIPLE_MYELOMA_PCA3...2,SET,75,0.031493,0.0020087,0.11053,0.38785,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,0.965705961044521
REACTOME_COHESIN_LOADING_ONT...,SET,7,0.098901,0.0019308,0.34712,0.38785,REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,0.965705961044521
GOBP_ERROR_PRONE_TRANSLESION...,SET,12,0.057498,0.0014695,0.20194,0.38793,GOBP_ERROR_PRONE_TRANSLESION_SYNTHESIS,0.965705961044521
GSE17721_LPS_VS_GARDIQUIMOD_...14,SET,177,0.017743,0.0017337,0.062337,0.38796,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP,0.965705961044521
HP_METHYLMALONIC_ACIDURIA,SET,18,0.05664,0.0017726,0.199,0.38797,HP_METHYLMALONIC_ACIDURIA,0.965705961044521
GSE14413_UNSTIM_VS_IFNB_STIM...6,SET,123,0.022021,0.0017964,0.077411,0.38803,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP,0.965705961044521
GOBP_CYCLIC_NUCLEOTIDE_CATAB...,SET,14,0.06602,0.0018224,0.23221,0.38809,GOBP_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS,0.965705961044521
REACTOME_INTERCONVERSION_OF_...,SET,28,0.048964,0.0019107,0.17227,0.38812,REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,0.965705961044521
MARIADASON_REGULATED_BY_HIST...2,SET,55,0.032742,0.0017893,0.11521,0.38813,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,0.965705961044521
MIR6734_3P,SET,134,0.020865,0.001776,0.073419,0.38814,MIR6734_3P,0.965705961044521
MIR4496,SET,268,0.015528,0.0018623,0.05466,0.38817,MIR4496,0.965705961044521
GOMF_CCR2_CHEMOKINE_RECEPTOR...,SET,5,0.12403,0.0020465,0.4366,0.38818,GOMF_CCR2_CHEMOKINE_RECEPTOR_BINDING,0.965705961044521
HP_METATARSUS_ADDUCTUS,SET,44,0.037093,0.0018137,0.13064,0.38823,HP_METATARSUS_ADDUCTUS,0.965705961044521
REACTOME_PI3K_AKT_SIGNALING_...,SET,108,0.024395,0.0018655,0.085933,0.38825,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,0.965705961044521
GOMF_KINASE_ACTIVITY,SET,682,0.0093724,0.0017725,0.033027,0.38829,GOMF_KINASE_ACTIVITY,0.965705961044521
HP_OROFACIAL_DYSKINESIA,SET,24,0.04839,0.0017484,0.17053,0.3883,HP_OROFACIAL_DYSKINESIA,0.965705961044521
TERF2_TARGET_GENES,SET,97,0.024536,0.0017787,0.086513,0.38835,TERF2_TARGET_GENES,0.965705961044521
GSE12845_IGD_NEG_BLOOD_VS_DA...2,SET,162,0.0192,0.0017955,0.067694,0.38835,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.965705961044521
HP_EARLY_SATIETY,SET,6,0.091574,0.0016552,0.32289,0.38836,HP_EARLY_SATIETY,0.965705961044521
MCBRYAN_PUBERTAL_BREAST_4_5W...2,SET,242,0.016852,0.0019219,0.059429,0.38838,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,0.965705961044521
PODAR_RESPONSE_TO_ADAPHOSTIN...2,SET,127,0.023067,0.0019119,0.081358,0.38839,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,0.965705961044521
GSE10273_LOW_IL7_VS_HIGH_IL7...2,SET,176,0.018052,0.0017589,0.063673,0.3884,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.965705961044521
GAVISH_3CA_METAPROGRAM_B_CEL...1,SET,41,0.036359,0.0017162,0.12826,0.38841,GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1,0.965705961044521
KRAS.300_UP.V1_UP,SET,127,0.024056,0.0019938,0.084876,0.38842,KRAS.300_UP.V1_UP,0.965705961044521
chr14q32,SET,129,0.043091,0.0035993,0.15204,0.38843,chr14q32,0.965705961044521
GSE16385_ROSIGLITAZONE_IL4_V...1,SET,169,0.019373,0.0018501,0.068369,0.38845,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN,0.965705961044521
MZF1_01,SET,222,0.016,0.0017487,0.056466,0.38846,MZF1_01,0.965705961044521
GOBP_REGULATION_OF_INTRINSIC...6,SET,8,0.086332,0.0018017,0.30469,0.38846,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.965705961044521
REACTOME_DEFECTIVE_LFNG_CAUS...,SET,5,0.1134,0.0018712,0.40036,0.3885,REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3,0.965705961044521
GOBP_CENTRAL_NERVOUS_SYSTEM_...1,SET,930,0.0084279,0.0018482,0.029757,0.3885,GOBP_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT,0.965705961044521
MIR652_3P,SET,4,0.13859,0.0020454,0.48939,0.38852,MIR652_3P,0.965705961044521
GOBP_SRP_DEPENDENT_COTRANSLA...2,SET,3,0.1113,0.0014226,0.39331,0.3886,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_SIGNAL_SEQUENCE_RECOGNITION,0.965705961044521
GSE22886_NAIVE_TCELL_VS_MONO...2,SET,177,0.017731,0.0017325,0.062663,0.38861,GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP,0.965705961044521
GSE27786_ERYTHROBLAST_VS_MON...1,SET,184,0.017072,0.0017005,0.060348,0.38863,GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN,0.965705961044521
CHANG_IMMORTALIZED_BY_HPV31_...2,SET,65,0.029673,0.0017624,0.1049,0.38864,CHANG_IMMORTALIZED_BY_HPV31_UP,0.965705961044521
KEGG_MEDICUS_VARIANT_MUTATIO...32,SET,20,0.055212,0.0018213,0.1952,0.38865,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.965705961044521
HP_HYPOPLASTIC_HEART,SET,43,0.03845,0.0018586,0.13594,0.38865,HP_HYPOPLASTIC_HEART,0.965705961044521
NOUSHMEHR_GBM_SOMATIC_MUTATED,SET,9,0.092238,0.0020417,0.32615,0.38866,NOUSHMEHR_GBM_SOMATIC_MUTATED,0.965705961044521
GSE360_CTRL_VS_T_GONDII_MAC_...2,SET,180,0.017545,0.0017287,0.062038,0.38866,GSE360_CTRL_VS_T_GONDII_MAC_UP,0.965705961044521
GSE40274_FOXP3_VS_FOXP3_AND_...7,SET,174,0.018247,0.0017679,0.064528,0.38867,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.965705961044521
GOBP_POSITIVE_REGULATION_OF_...467,SET,8,0.093518,0.0019517,0.33088,0.38873,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.965705961044521
HP_ABNORMAL_JAW_MORPHOLOGY,SET,987,0.0077747,0.0017535,0.027533,0.38883,HP_ABNORMAL_JAW_MORPHOLOGY,0.965705961044521
GOBP_RESPONSE_TO_NICOTINE,SET,51,0.03808,0.0020042,0.13487,0.38884,GOBP_RESPONSE_TO_NICOTINE,0.965705961044521
WP_LEPTIN_SIGNALING,SET,74,0.028629,0.0018139,0.1014,0.38885,WP_LEPTIN_SIGNALING,0.965705961044521
FOXD3_TARGET_GENES,SET,29,0.04635,0.0018406,0.1642,0.38887,FOXD3_TARGET_GENES,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...519,SET,10,0.063511,0.0014818,0.22503,0.38888,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.965705961044521
GOBP_FOLIC_ACID_TRANSPORT,SET,10,0.090755,0.0021175,0.3217,0.38893,GOBP_FOLIC_ACID_TRANSPORT,0.965705961044521
GSE13522_CTRL_VS_T_CRUZI_Y_S...6,SET,184,0.018146,0.0018075,0.064329,0.38894,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP,0.965705961044521
GOBP_REGULATION_OF_PATTERN_R...,SET,149,0.019046,0.0017088,0.067526,0.38895,GOBP_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.965705961044521
GOBP_EPITHELIAL_CILIUM_MOVEM...,SET,9,0.073026,0.0016164,0.25891,0.38896,GOBP_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY,0.965705961044521
HP_ABNORMALITY_OF_THE_EXTRAO...,SET,11,0.063632,0.0015571,0.22565,0.38898,HP_ABNORMALITY_OF_THE_EXTRAOCULAR_MUSCLES,0.965705961044521
ZBTB5_TARGET_GENES,SET,395,0.012479,0.0018107,0.044263,0.389,ZBTB5_TARGET_GENES,0.965705961044521
GOCC_CYTOPLASMIC_STRESS_GRAN...,SET,83,0.025289,0.0016965,0.089696,0.389,GOCC_CYTOPLASMIC_STRESS_GRANULE,0.965705961044521
GSE8515_CTRL_VS_IL1_4H_STIM_...1,SET,172,0.018138,0.0017473,0.064372,0.38906,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN,0.965705961044521
GOBP_CEREBELLAR_GRANULAR_LAY...3,SET,8,0.10508,0.0021929,0.37295,0.38907,GOBP_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS,0.965705961044521
KYNG_WERNER_SYNDROM_DN,SET,18,0.058222,0.0018221,0.20667,0.38908,KYNG_WERNER_SYNDROM_DN,0.965705961044521
MIR6807_5P,SET,53,0.032221,0.0017287,0.11437,0.38908,MIR6807_5P,0.965705961044521
GSE40274_FOXP3_VS_FOXP3_AND_...10,SET,185,0.017288,0.0017266,0.061368,0.38908,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.965705961044521
KYNG_ENVIRONMENTAL_STRESS_RE...5,SET,28,0.042773,0.0016691,0.15187,0.38911,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,0.965705961044521
GSE36009_WT_VS_NLRP10_KO_DC_...4,SET,184,0.017428,0.001736,0.061886,0.38912,GSE36009_WT_VS_NLRP10_KO_DC_UP,0.965705961044521
GOBP_CELLULAR_RESPONSE_TO_ST...1,SET,157,0.019536,0.0017988,0.069381,0.38914,GOBP_CELLULAR_RESPONSE_TO_STARVATION,0.965705961044521
GOBP_CELLULAR_RESPONSE_TO_MO...,SET,209,0.017651,0.0018725,0.062692,0.38915,GOBP_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.965705961044521
GOMF_GLYCINE_TRANSMEMBRANE_T...,SET,9,0.082638,0.0018292,0.29359,0.38918,GOMF_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.965705961044521
GSE22601_CD4_SINGLE_POSITIVE...2,SET,181,0.016752,0.0016551,0.059519,0.38918,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.965705961044521
HP_THROMBOEMBOLISM,SET,91,0.026838,0.0018848,0.095376,0.38921,HP_THROMBOEMBOLISM,0.965705961044521
REACTOME_MITOCHONDRIAL_FATTY...2,SET,11,0.067283,0.0016464,0.23918,0.38924,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,0.965705961044521
GOBP_RESPONSE_TO_HISTAMINE,SET,10,0.08124,0.0018955,0.2888,0.38924,GOBP_RESPONSE_TO_HISTAMINE,0.965705961044521
GSE46606_DAY1_VS_DAY3_CD40L_...4,SET,186,0.016873,0.0016896,0.059985,0.38925,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP,0.965705961044521
REACTOME_CYCLIN_A_B1_B2_ASSO...,SET,24,0.045277,0.0016359,0.16099,0.38927,REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,0.965705961044521
WP_BENZOAPYRENE_METABOLISM,SET,9,0.092184,0.0020405,0.3278,0.38927,WP_BENZOAPYRENE_METABOLISM,0.965705961044521
GOBP_NEGATIVE_REGULATION_OF_...337,SET,5,0.12208,0.0020143,0.43422,0.3893,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.965705961044521
HP_OCCIPITAL_MENINGOCELE,SET,7,0.098515,0.0019232,0.35044,0.38931,HP_OCCIPITAL_MENINGOCELE,0.965705961044521
GOBP_C_TERMINAL_PROTEIN_AMIN...,SET,16,0.062254,0.001837,0.22148,0.38933,GOBP_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.965705961044521
MORF_BNIP1,SET,174,0.017939,0.0017381,0.063832,0.38934,MORF_BNIP1,0.965705961044521
CCATCCA_MIR432,SET,50,0.033585,0.0017503,0.11953,0.38937,CCATCCA_MIR432,0.965705961044521
HP_SHORTENED_PR_INTERVAL,SET,6,0.10034,0.0018137,0.35722,0.3894,HP_SHORTENED_PR_INTERVAL,0.965705961044521
GOBP_REGULATION_OF_NEURON_PR...2,SET,402,0.012442,0.0018207,0.0443,0.38941,GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.965705961044521
HP_WHITE_EYEBROW,SET,11,0.079341,0.0019415,0.28255,0.38943,HP_WHITE_EYEBROW,0.965705961044521
BIOCARTA_TH1TH2_PATHWAY,SET,18,0.058237,0.0018226,0.20743,0.38945,BIOCARTA_TH1TH2_PATHWAY,0.965705961044521
GOMF_ALPHA_N_ACETYLNEURAMINA...,SET,6,0.12075,0.0021825,0.4301,0.38945,GOMF_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY,0.965705961044521
GSE15330_WT_VS_IKAROS_KO_LYM...2,SET,188,0.016969,0.0017083,0.060456,0.38948,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP,0.965711450381679
GOBP_HEART_GROWTH,SET,76,0.029944,0.0019226,0.10679,0.38958,GOBP_HEART_GROWTH,0.965771781437126
GSE41867_DAY6_VS_DAY15_LCMV_...4,SET,147,0.02056,0.0018323,0.073355,0.38963,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.965771781437126
GSE2770_IL4_ACT_VS_ACT_CD4_T...5,SET,173,0.017352,0.0016764,0.061935,0.38968,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.965771781437126
REACTOME_NEGATIVE_REGULATION...11,SET,5,0.10416,0.0017187,0.37183,0.38969,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS,0.965771781437126
MIR485_5P,SET,127,0.020806,0.0017244,0.07428,0.3897,MIR485_5P,0.965771781437126
GARCIA_PINERES_PBMC_HPV_16_L...3,SET,256,0.015145,0.0017759,0.054077,0.38971,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,0.965771781437126
HP_IMPAIRED_TEMPERATURE_SENS...,SET,34,0.04335,0.0018637,0.15479,0.38972,HP_IMPAIRED_TEMPERATURE_SENSATION,0.965771781437126
GOBP_POSITIVE_REGULATION_OF_...152,SET,5,0.11114,0.0018339,0.39697,0.38975,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,0.965771781437126
GOCC_INTRACILIARY_TRANSPORT_...1,SET,22,0.052814,0.0018271,0.18865,0.38976,GOCC_INTRACILIARY_TRANSPORT_PARTICLE,0.965771781437126
MODULE_115,SET,25,0.044545,0.0016426,0.1592,0.38981,MODULE_115,0.965771781437126
HP_LUPUS_NEPHRITIS,SET,25,0.052121,0.001922,0.18626,0.38981,HP_LUPUS_NEPHRITIS,0.965771781437126
HP_LIMB_GIRDLE_MUSCLE_ATROPHY,SET,31,0.04336,0.0017802,0.15501,0.38985,HP_LIMB_GIRDLE_MUSCLE_ATROPHY,0.965802035070212
MIR30C_2_3P,SET,117,0.022736,0.0018092,0.081385,0.38999,MIR30C_2_3P,0.96580701167426
GOCC_KERATIN_FILAMENT,SET,81,0.036288,0.002405,0.12992,0.39001,GOCC_KERATIN_FILAMENT,0.96580701167426
GSE2770_UNTREATED_VS_IL12_TR...5,SET,178,0.017499,0.0017147,0.062663,0.39002,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.96580701167426
GOBP_CELLULAR_RESPONSE_TO_TY...,SET,91,0.025704,0.0018051,0.092054,0.39004,GOBP_CELLULAR_RESPONSE_TO_TYPE_II_INTERFERON,0.96580701167426
MORF_ITGA2,SET,47,0.035938,0.001816,0.12888,0.39018,MORF_ITGA2,0.96580701167426
MIR6796_5P,SET,67,0.028643,0.0017272,0.10273,0.39019,MIR6796_5P,0.96580701167426
GOBP_REGULATION_OF_NEURON_AP...,SET,219,0.016893,0.001834,0.06059,0.3902,GOBP_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.96580701167426
NAKAYA_PLASMACYTOID_DENDRITI...3,SET,804,0.0086087,0.0017616,0.030877,0.3902,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.96580701167426
GSE18791_CTRL_VS_NEWCASTLE_V...7,SET,168,0.018902,0.0017998,0.067827,0.39025,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN,0.96580701167426
REACTOME_REGULATION_OF_GENE_...5,SET,15,0.059362,0.0016961,0.2131,0.39029,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS,0.96580701167426
GSE40441_NRP1_POS_INDUCED_TR...2,SET,184,0.018278,0.0018206,0.065611,0.39029,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP,0.96580701167426
BIOCARTA_RAC1_PATHWAY,SET,21,0.053453,0.0018067,0.1919,0.3903,BIOCARTA_RAC1_PATHWAY,0.96580701167426
GSE17721_CTRL_VS_PAM3CSK4_8H...2,SET,178,0.017354,0.0017004,0.062304,0.3903,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP,0.96580701167426
GSE43955_1H_VS_60H_ACT_CD4_T...2,SET,184,0.017734,0.0017664,0.063672,0.39031,GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP,0.96580701167426
GOCC_ENDOSOME,SET,961,0.0078725,0.0017533,0.028269,0.39032,GOCC_ENDOSOME,0.96580701167426
KEGG_MEDICUS_VARIANT_EGFR_OV...,SET,10,0.075591,0.0017637,0.2715,0.39034,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.96580701167426
GOCC_CHYLOMICRON,SET,10,0.091972,0.0021459,0.33038,0.39036,GOCC_CHYLOMICRON,0.96580701167426
GOBP_BONE_MINERALIZATION,SET,113,0.023805,0.0018618,0.085515,0.39037,GOBP_BONE_MINERALIZATION,0.96580701167426
GOMF_LONG_CHAIN_FATTY_ACYL_C...,SET,12,0.063156,0.0016141,0.2269,0.39038,GOMF_LONG_CHAIN_FATTY_ACYL_COA_HYDROLASE_ACTIVITY,0.96580701167426
HP_ABNORMAL_LIMB_EPIPHYSIS_M...,SET,120,0.022309,0.0017977,0.080171,0.39041,HP_ABNORMAL_LIMB_EPIPHYSIS_MORPHOLOGY,0.965812481315396
GOBP_NEGATIVE_REGULATION_OF_...110,SET,59,0.028731,0.0016261,0.10331,0.39047,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.965892160142349
GOBP_EMBRYONIC_HEART_TUBE_DE...,SET,82,0.026859,0.001791,0.09665,0.39055,GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT,0.965944194236926
MIR12122,SET,193,0.017296,0.001764,0.062257,0.39058,MIR12122,0.965944194236926
MORF_ARL3,SET,280,0.014585,0.0017873,0.052521,0.39062,MORF_ARL3,0.965944194236926
HAHTOLA_SEZARY_SYNDROM_DN,SET,38,0.038973,0.0017712,0.14035,0.39063,HAHTOLA_SEZARY_SYNDROM_DN,0.965944194236926
MODULE_457,SET,10,0.072671,0.0016955,0.2617,0.39063,MODULE_457,0.965944194236926
GSE6259_FLT3L_INDUCED_DEC205...5,SET,161,0.019417,0.0018103,0.069981,0.39071,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN,0.96599073902838
MIR4724_5P,SET,116,0.02244,0.0017781,0.080907,0.39075,MIR4724_5P,0.96599073902838
MIR759,SET,65,0.032348,0.0019213,0.11662,0.39075,MIR759,0.96599073902838
GSE24726_WT_VS_E2_2_KO_PDC_D...2,SET,175,0.017778,0.0017274,0.064104,0.39076,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN,0.96599073902838
GOBP_VACUOLE_ORGANIZATION,SET,212,0.015733,0.0016808,0.056753,0.39081,GOBP_VACUOLE_ORGANIZATION,0.966045629445235
AAGTCCA_MIR422B_MIR422A,SET,63,0.028646,0.0016752,0.10339,0.39086,AAGTCCA_MIR422B_MIR422A,0.966100512054619
WAMUNYOKOLI_OVARIAN_CANCER_G...2,SET,125,0.02177,0.0017902,0.078595,0.39089,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,0.966105955767316
GOBP_POSITIVE_REGULATION_OF_...143,SET,10,0.076251,0.001779,0.27545,0.39096,GOBP_POSITIVE_REGULATION_OF_CELL_SIZE,0.966190976962457
HP_MESOMELIA,SET,32,0.041165,0.0017171,0.14873,0.39098,HP_MESOMELIA,0.966190976962457
GOBP_CELL_PROLIFERATION_IN_H...,SET,13,0.065344,0.0017381,0.23623,0.39104,GOBP_CELL_PROLIFERATION_IN_HINDBRAIN,0.966226556945827
AP2ALPHA_01,SET,221,0.015533,0.0016939,0.056162,0.39105,AP2ALPHA_01,0.966226556945827
GOBP_POSITIVE_REGULATION_OF_...840,SET,22,0.047647,0.0016484,0.1724,0.39113,GOBP_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,0.966355523565792
GERY_CEBP_TARGETS,SET,118,0.023798,0.0019017,0.086165,0.3912,GERY_CEBP_TARGETS,0.966371791044776
WP_ARYLAMINE_METABOLISM,SET,6,0.12541,0.0022668,0.45409,0.39121,WP_ARYLAMINE_METABOLISM,0.966371791044776
chr2q22,SET,11,0.11112,0.0027191,0.40239,0.39122,chr2q22,0.966371791044776
GSE39820_CTRL_VS_IL1B_IL6_IL...2,SET,180,0.017754,0.0017493,0.064321,0.39126,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP,0.966374149900822
GOBP_DEFINITIVE_HEMOPOIESIS,SET,18,0.062138,0.0019447,0.22515,0.39128,GOBP_DEFINITIVE_HEMOPOIESIS,0.966374149900822
HP_SALIVARY_GLAND_NEOPLASM,SET,12,0.061729,0.0015776,0.22384,0.39136,HP_SALIVARY_GLAND_NEOPLASM,0.966374149900822
REACTOME_PYRIMIDINE_SALVAGE,SET,10,0.074069,0.0017281,0.26866,0.39139,REACTOME_PYRIMIDINE_SALVAGE,0.966374149900822
GSE7764_IL15_TREATED_VS_CTRL...1,SET,180,0.01826,0.0017992,0.066258,0.39143,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN,0.966374149900822
GOBP_CHORION_DEVELOPMENT,SET,10,0.084504,0.0019716,0.30672,0.39147,GOBP_CHORION_DEVELOPMENT,0.966374149900822
GOMF_HISTONE_H2A_UBIQUITIN_L...,SET,6,0.091161,0.0016477,0.3311,0.39153,GOMF_HISTONE_H2A_UBIQUITIN_LIGASE_ACTIVITY,0.966374149900822
REACTOME_TGF_BETA_RECEPTOR_S...1,SET,46,0.03479,0.0017392,0.12638,0.39155,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,0.966374149900822
GSE12845_IGD_POS_BLOOD_VS_DA...1,SET,174,0.016743,0.0016222,0.060829,0.39157,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.966374149900822
GOBP_MRNA_METABOLIC_PROCESS,SET,641,0.0087721,0.0016102,0.031884,0.39161,GOBP_MRNA_METABOLIC_PROCESS,0.966374149900822
GSE27786_NKCELL_VS_ERYTHROBL...1,SET,185,0.016995,0.0016973,0.061817,0.39169,GSE27786_NKCELL_VS_ERYTHROBLAST_DN,0.966374149900822
GOBP_NEGATIVE_REGULATION_OF_...680,SET,10,0.074972,0.0017492,0.27281,0.39173,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.966374149900822
GSE5542_IFNA_VS_IFNA_AND_IFN...2,SET,183,0.017402,0.0017286,0.063325,0.39174,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.966374149900822
AP3_Q6,SET,228,0.016811,0.0018617,0.061188,0.39176,AP3_Q6,0.966374149900822
AZARE_STAT3_TARGETS,SET,23,0.049188,0.0017398,0.1791,0.3918,AZARE_STAT3_TARGETS,0.966374149900822
HP_SHORT_LINGUAL_FRENULUM,SET,11,0.068755,0.0016824,0.25037,0.39181,HP_SHORT_LINGUAL_FRENULUM,0.966374149900822
GSE37532_VISCERAL_ADIPOSE_TI...7,SET,139,0.019007,0.0016476,0.069239,0.39184,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN,0.966374149900822
HP_ALOPECIA_TOTALIS,SET,13,0.071588,0.0019042,0.26087,0.39188,HP_ALOPECIA_TOTALIS,0.966374149900822
GSE45739_NRAS_KO_VS_WT_ACD3_...2,SET,180,0.016709,0.0016463,0.060893,0.39189,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP,0.966374149900822
GOBP_FERMENTATION,SET,3,0.13462,0.0017206,0.49063,0.3919,GOBP_FERMENTATION,0.966374149900822
HOLLEMAN_PREDNISOLONE_RESIST...1,SET,11,0.072685,0.0017786,0.26493,0.39191,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,0.966374149900822
GSE8835_HEALTHY_VS_CLL_CD8_T...2,SET,183,0.016949,0.0016837,0.061802,0.39195,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP,0.966374149900822
CHESLER_BRAIN_QTL_CIS,SET,68,0.02876,0.001747,0.10488,0.39196,CHESLER_BRAIN_QTL_CIS,0.966374149900822
WP_SARSCOV2_INNATE_IMMUNITY_...,SET,62,0.030791,0.0017863,0.11231,0.39198,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.966374149900822
REACTOME_CYCLIN_D_ASSOCIATED...,SET,45,0.033732,0.0016679,0.1231,0.39204,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,0.966374149900822
GNF2_GLTSCR2,SET,30,0.040062,0.0016181,0.14622,0.39205,GNF2_GLTSCR2,0.966374149900822
GRYDER_PAX3FOXO1_TOP_ENHANCE...,SET,415,0.012133,0.0018034,0.044302,0.39209,GRYDER_PAX3FOXO1_TOP_ENHANCERS,0.966374149900822
GOBP_INTESTINAL_EPITHELIAL_C...1,SET,16,0.06191,0.0018268,0.22614,0.39213,GOBP_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT,0.966374149900822
GOBP_POSITIVE_REGULATION_OF_...236,SET,13,0.070995,0.0018885,0.25932,0.39213,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.966374149900822
GOBP_CLEARANCE_OF_FOREIGN_IN...,SET,6,0.13253,0.0023954,0.48413,0.39214,GOBP_CLEARANCE_OF_FOREIGN_INTRACELLULAR_NUCLEIC_ACIDS,0.966374149900822
KEGG_MEDICUS_REFERENCE_CX3CR...,SET,17,0.060906,0.0018524,0.22251,0.39215,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY,0.966374149900822
GOBP_TELOMERE_TETHERING_AT_N...,SET,3,0.11113,0.0014204,0.40619,0.3922,GOBP_TELOMERE_TETHERING_AT_NUCLEAR_PERIPHERY,0.966374149900822
KRAS.50_UP.V1_UP,SET,44,0.0394,0.0019265,0.14405,0.39223,KRAS.50_UP.V1_UP,0.966374149900822
HP_ABNORMALITY_OF_THE_CURVAT...,SET,305,0.013212,0.0016887,0.04832,0.39227,HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_CORNEA,0.966374149900822
GOBP_NERVOUS_SYSTEM_PROCESS,SET,1292,0.0074893,0.0019155,0.0274,0.3923,GOBP_NERVOUS_SYSTEM_PROCESS,0.966374149900822
REACTOME_SODIUM_COUPLED_PHOS...,SET,5,0.11814,0.0019493,0.43232,0.39233,REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS,0.966374149900822
HP_HAIR_PULLING,SET,7,0.10234,0.0019979,0.37465,0.39236,HP_HAIR_PULLING,0.966374149900822
GOBP_POSITIVE_REGULATION_OF_...520,SET,5,0.11192,0.0018466,0.4097,0.39237,GOBP_POSITIVE_REGULATION_OF_NECROPTOTIC_PROCESS,0.966374149900822
GOMF_MAP_KINASE_KINASE_KINAS...2,SET,6,0.096051,0.0017361,0.35168,0.39238,GOMF_MAP_KINASE_KINASE_KINASE_KINASE_ACTIVITY,0.966374149900822
HP_DELAYED_MENARCHE,SET,23,0.046089,0.0016302,0.16875,0.39238,HP_DELAYED_MENARCHE,0.966374149900822
GSE32986_UNSTIM_VS_GMCSF_STI...2,SET,166,0.017538,0.0016601,0.064239,0.39242,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP,0.966374149900822
GSE37533_PPARG1_FOXP3_VS_FOX...3,SET,189,0.017278,0.001744,0.063288,0.39242,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.966374149900822
GSE29949_MICROGLIA_BRAIN_VS_...2,SET,180,0.017684,0.0017423,0.0648,0.39247,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.966374149900822
GOBP_DNA_REPLICATION_DEPENDE...,SET,6,0.0818,0.0014785,0.29978,0.39248,GOBP_DNA_REPLICATION_DEPENDENT_CHROMATIN_ASSEMBLY,0.966374149900822
OCT1_02,SET,187,0.018296,0.0018371,0.067064,0.3925,OCT1_02,0.966374149900822
GOCC_PRESYNAPTIC_MEMBRANE,SET,159,0.020113,0.0018636,0.073724,0.3925,GOCC_PRESYNAPTIC_MEMBRANE,0.966374149900822
BREDEMEYER_RAG_SIGNALING_VIA...1,SET,38,0.038136,0.0017332,0.13985,0.39254,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,0.966392746389125
NERF_Q2,SET,228,0.015394,0.0017048,0.056477,0.39259,NERF_Q2,0.966392746389125
WP_ARSENIC_METABOLISM_AND_RE...,SET,9,0.080176,0.0017747,0.29423,0.39262,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.966392746389125
GSE15735_CTRL_VS_HDAC_INHIBI...2,SET,178,0.017142,0.0016797,0.062909,0.39262,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP,0.966392746389125
GSE22886_NEUTROPHIL_VS_DC_UP,SET,164,0.019453,0.0018303,0.071415,0.39266,GSE22886_NEUTROPHIL_VS_DC_UP,0.966392746389125
KUMAR_AUTOPHAGY_NETWORK,SET,59,0.030206,0.0017095,0.11093,0.3927,KUMAR_AUTOPHAGY_NETWORK,0.966392746389125
KEGG_PATHWAYS_IN_CANCER,SET,310,0.013703,0.0017655,0.050339,0.39273,KEGG_PATHWAYS_IN_CANCER,0.966392746389125
WP_LEUKOTRIENE_METABOLIC_PAT...,SET,13,0.064936,0.0017273,0.23855,0.39273,WP_LEUKOTRIENE_METABOLIC_PATHWAY,0.966392746389125
BOWIE_RESPONSE_TO_TAMOXIFEN,SET,18,0.052479,0.0016424,0.19284,0.39276,BOWIE_RESPONSE_TO_TAMOXIFEN,0.966398145132743
REACTOME_SIGNALING_BY_VEGF,SET,101,0.023652,0.0017494,0.086935,0.39279,REACTOME_SIGNALING_BY_VEGF,0.966403543111992
GSE43955_10H_VS_30H_ACT_CD4_...3,SET,182,0.017552,0.0017389,0.064543,0.39283,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.966414336778029
HP_ABNORMALITY_OF_THE_PERIOR...,SET,229,0.015737,0.0017465,0.057877,0.39285,HP_ABNORMALITY_OF_THE_PERIORBITAL_REGION,0.966414336778029
GSE43955_1H_VS_60H_ACT_CD4_T...1,SET,182,0.017806,0.001764,0.065502,0.39288,GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN,0.966416716196137
GOBP_REGULATION_OF_PEPTIDE_T...,SET,187,0.017878,0.0017951,0.065793,0.39292,GOBP_REGULATION_OF_PEPTIDE_TRANSPORT,0.966416716196137
GAVISH_3CA_METAPROGRAM_MACRO...7,SET,45,0.035784,0.0017694,0.13176,0.39298,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS,0.966416716196137
GOBP_AUTOSOME_GENOMIC_IMPRIN...,SET,5,0.094957,0.0015668,0.34966,0.39298,GOBP_AUTOSOME_GENOMIC_IMPRINTING,0.966416716196137
GOBP_DNA_SYNTHESIS_INVOLVED_...,SET,38,0.03214,0.0014607,0.11837,0.39299,GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR,0.966416716196137
GOBP_REGULATION_OF_RECEPTOR_...7,SET,25,0.045045,0.0016611,0.166,0.39306,GOBP_REGULATION_OF_RECEPTOR_RECYCLING,0.966520468374133
KEGG_MEDICUS_REFERENCE_BMP_S...2,SET,14,0.066944,0.0018479,0.24685,0.39313,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST,0.966536623753272
TERAMOTO_OPN_TARGETS_CLUSTER...2,SET,7,0.072902,0.0014232,0.26885,0.39314,TERAMOTO_OPN_TARGETS_CLUSTER_3,0.966536623753272
MIR136_5P,SET,102,0.022971,0.0017074,0.084724,0.39315,MIR136_5P,0.966536623753272
PID_TCR_PATHWAY,SET,59,0.028223,0.0015973,0.10416,0.39321,PID_TCR_PATHWAY,0.966607308535464
HP_PRIMARY_HYPERCORTISOLISM,SET,9,0.076295,0.0016888,0.2817,0.39326,HP_PRIMARY_HYPERCORTISOLISM,0.966607308535464
AGCGCTT_MIR518F_MIR518E_MIR5...,SET,16,0.056761,0.0016749,0.20961,0.39328,AGCGCTT_MIR518F_MIR518E_MIR518A,0.966607308535464
GOCC_CYTOSOLIC_LARGE_RIBOSOM...,SET,50,0.030944,0.0016126,0.11428,0.39329,GOCC_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT,0.966607308535464
HP_ABNORMAL_RELATIONSHIP,SET,11,0.07421,0.0018159,0.2743,0.39337,HP_ABNORMAL_RELATIONSHIP,0.96672709437964
HP_CONGENITAL_ONSET,SET,951,0.0076506,0.0016955,0.028289,0.39341,HP_CONGENITAL_ONSET,0.96672709437964
MIR556_3P,SET,129,0.020285,0.0016943,0.075024,0.39344,MIR556_3P,0.96672709437964
HP_ABNORMAL_CELLULAR_COMPOSI...,SET,8,0.09037,0.001886,0.33428,0.39345,HP_ABNORMAL_CELLULAR_COMPOSITION_OF_BRONCHOALVEOLAR_FLUID,0.96672709437964
HP_ENLARGED_NARIS,SET,5,0.10187,0.0016809,0.37706,0.39351,HP_ENLARGED_NARIS,0.966806167821292
HELLER_HDAC_TARGETS_DN,SET,266,0.014813,0.00177,0.054854,0.39356,HELLER_HDAC_TARGETS_DN,0.966819123154102
HP_ABNORMAL_ERYTHROCYTE_PHYS...,SET,15,0.060956,0.0017416,0.22585,0.39362,HP_ABNORMAL_ERYTHROCYTE_PHYSIOLOGY,0.966819123154102
GOBP_PARENTAL_BEHAVIOR,SET,13,0.075817,0.0020167,0.28095,0.39364,GOBP_PARENTAL_BEHAVIOR,0.966819123154102
WP_THERMOGENESIS,SET,105,0.022704,0.001712,0.084149,0.39366,WP_THERMOGENESIS,0.966819123154102
HP_GINGIVAL_FIBROMATOSIS,SET,22,0.05125,0.001773,0.19,0.39368,HP_GINGIVAL_FIBROMATOSIS,0.966819123154102
MEISSNER_NPC_ICP_WITH_H3K4ME3,SET,17,0.050188,0.0015265,0.18609,0.3937,MEISSNER_NPC_ICP_WITH_H3K4ME3,0.966819123154102
GOBP_NEGATIVE_REGULATION_OF_...299,SET,9,0.085909,0.0019016,0.31857,0.39371,GOBP_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.966819123154102
GOBP_INTRACILIARY_ANTEROGRAD...,SET,15,0.059417,0.0016976,0.22045,0.39376,GOBP_INTRACILIARY_ANTEROGRADE_TRANSPORT,0.966873590504451
HP_ABNORMAL_CIRCULATING_DICA...,SET,139,0.019496,0.0016899,0.072411,0.39387,HP_ABNORMAL_CIRCULATING_DICARBOXYLIC_ACID_CONCENTRATION,0.96694312486765
FAN_EMBRYONIC_CTX_OLIG,SET,671,0.0092428,0.0017344,0.034335,0.39389,FAN_EMBRYONIC_CTX_OLIG,0.96694312486765
GSE15330_WT_VS_IKAROS_KO_HSC...2,SET,178,0.017079,0.0016735,0.063469,0.39393,GSE15330_WT_VS_IKAROS_KO_HSC_UP,0.96694312486765
FOURATI_BLOOD_TWINRIX_AGE_65...3,SET,4,0.10612,0.0015662,0.39448,0.39396,FOURATI_BLOOD_TWINRIX_AGE_65_83YO_POOR_RESPONDERS_VS_RESPONDERS_0DY_NETWORK_INFERENCE_UP,0.96694312486765
GSE360_HIGH_DOSE_B_MALAYI_VS...3,SET,178,0.01797,0.0017608,0.06681,0.39397,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.96694312486765
MIR186_5P,SET,507,0.010434,0.0017098,0.038794,0.39398,MIR186_5P,0.96694312486765
HP_ARTERIAL_STENOSIS,SET,94,0.025083,0.0017902,0.093276,0.394,HP_ARTERIAL_STENOSIS,0.96694312486765
GOMF_PROTEIN_SERINE_KINASE_A...,SET,334,0.012471,0.0016667,0.046402,0.39406,GOMF_PROTEIN_SERINE_KINASE_ACTIVITY,0.96694312486765
MIR4652_3P,SET,290,0.014058,0.0017528,0.052333,0.39411,MIR4652_3P,0.96694312486765
ISSAEVA_MLL2_TARGETS,SET,52,0.035524,0.0018879,0.13226,0.39412,ISSAEVA_MLL2_TARGETS,0.96694312486765
MIR8062,SET,97,0.022889,0.0016593,0.085229,0.39414,MIR8062,0.96694312486765
HP_MACULAR_HYPERPIGMENTATION,SET,6,0.10846,0.0019603,0.40389,0.39414,HP_MACULAR_HYPERPIGMENTATION,0.96694312486765
GOBP_NUCLEAR_CHROMOSOME_SEGR...,SET,293,0.013016,0.001631,0.048471,0.39415,GOBP_NUCLEAR_CHROMOSOME_SEGREGATION,0.96694312486765
GOBP_NEGATIVE_REGULATION_OF_...503,SET,17,0.0621,0.0018888,0.23132,0.39418,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.966948468379446
GOMF_INTERLEUKIN_1_RECEPTOR_...1,SET,6,0.10324,0.001866,0.38501,0.39429,GOMF_INTERLEUKIN_1_RECEPTOR_ACTIVITY,0.966999696606223
HP_SEVERE_PLATYSPONDYLY,SET,8,0.078278,0.0016336,0.29194,0.3943,HP_SEVERE_PLATYSPONDYLY,0.966999696606223
KEGG_MEDICUS_VARIANT_ERBB2_O...2,SET,12,0.066341,0.0016955,0.24744,0.39431,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.966999696606223
BIOCARTA_PEPI_PATHWAY,SET,8,0.087434,0.0018247,0.32617,0.39433,BIOCARTA_PEPI_PATHWAY,0.966999696606223
GOBP_ADULT_BEHAVIOR,SET,141,0.020367,0.001778,0.075992,0.39434,GOBP_ADULT_BEHAVIOR,0.966999696606223
GSE23505_IL6_IL1_VS_IL6_IL1_...4,SET,186,0.016543,0.0016566,0.061741,0.39437,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.967005033864823
GSE17721_PAM3CSK4_VS_GADIQUI...3,SET,194,0.016242,0.0016607,0.060697,0.39451,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN,0.967063694043003
GOBP_STRIATED_MUSCLE_CONTRAC...,SET,173,0.018067,0.0017455,0.067531,0.39453,GOBP_STRIATED_MUSCLE_CONTRACTION,0.967063694043003
GOBP_FOREBRAIN_NEURON_FATE_C...,SET,7,0.10343,0.0020192,0.38669,0.39455,GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT,0.967063694043003
HP_ABNORMAL_LABIA_MINORA_MOR...,SET,34,0.043553,0.0018725,0.16283,0.39455,HP_ABNORMAL_LABIA_MINORA_MORPHOLOGY,0.967063694043003
HP_COMPLETE_OR_NEAR_COMPLETE...1,SET,7,0.10357,0.002022,0.3874,0.3946,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.967063694043003
SPIELMAN_LYMPHOBLAST_EUROPEA...4,SET,429,0.010614,0.0016033,0.039703,0.39461,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,0.967063694043003
KEGG_MEDICUS_REFERENCE_P16_C...,SET,10,0.069895,0.0016308,0.26149,0.39462,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S,0.967063694043003
GSE13485_DAY7_VS_DAY21_YF17D...2,SET,183,0.017459,0.0017343,0.06533,0.39464,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.967063694043003
MORF_SUPT3H,SET,288,0.013819,0.0017171,0.051727,0.39468,MORF_SUPT3H,0.967063694043003
HP_UROGENITAL_SINUS_ANOMALY,SET,15,0.061803,0.0017658,0.23134,0.39468,HP_UROGENITAL_SINUS_ANOMALY,0.967063694043003
GNF2_MLH1,SET,36,0.033563,0.0014847,0.12566,0.3947,GNF2_MLH1,0.967063694043003
HP_ABNORMALITY_OF_THE_TONGUE...,SET,3,0.10638,0.0013597,0.39883,0.39484,HP_ABNORMALITY_OF_THE_TONGUE_MUSCLE,0.967338516847596
HP_INCREASED_INFLAMMATORY_RE...,SET,1101,0.0071517,0.001698,0.026821,0.39487,HP_INCREASED_INFLAMMATORY_RESPONSE,0.967343825333052
REACTOME_SYNTHESIS_OF_SUBSTR...,SET,58,0.028943,0.0016242,0.10857,0.3949,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,0.9673491330702
GOBP_LIPID_CATABOLIC_PROCESS,SET,322,0.012905,0.001694,0.048428,0.39494,GOBP_LIPID_CATABOLIC_PROCESS,0.967378934385792
HP_CEREBELLAR_ATROPHY,SET,393,0.010994,0.0015911,0.041295,0.39503,HP_CEREBELLAR_ATROPHY,0.967531194503171
GNF2_TST,SET,99,0.023037,0.0016871,0.086599,0.39511,GNF2_TST,0.967622478518101
KONDO_HYPOXIA,SET,6,0.089732,0.0016219,0.33746,0.39516,KONDO_HYPOXIA,0.967622478518101
RASHI_NFKB1_TARGETS,SET,16,0.062261,0.0018372,0.23418,0.39517,RASHI_NFKB1_TARGETS,0.967622478518101
HP_PROLONGED_QT_INTERVAL,SET,45,0.03533,0.0017469,0.13292,0.3952,HP_PROLONGED_QT_INTERVAL,0.967622478518101
GOBP_GERM_CELL_PROLIFERATION,SET,10,0.063858,0.0014899,0.24038,0.39525,GOBP_GERM_CELL_PROLIFERATION,0.967622478518101
GOBP_SOMATIC_DIVERSIFICATION...3,SET,55,0.02856,0.0015608,0.10752,0.39527,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS,0.967622478518101
GOMF_TYPE_II_TRANSFORMING_GR...,SET,11,0.077882,0.0019058,0.29321,0.39527,GOMF_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.967622478518101
BERNARD_PPAPDC1B_TARGETS_DN,SET,53,0.033055,0.0017734,0.12447,0.39529,BERNARD_PPAPDC1B_TARGETS_DN,0.967622478518101
MODULE_163,SET,489,0.010603,0.0017072,0.039943,0.39533,MODULE_163,0.967652239594338
REACTOME_EICOSANOIDS,SET,12,0.07823,0.0019993,0.29486,0.39539,REACTOME_EICOSANOIDS,0.967668081960287
GOBP_HINDGUT_DEVELOPMENT,SET,8,0.097291,0.0020304,0.36675,0.3954,GOBP_HINDGUT_DEVELOPMENT,0.967668081960287
WP_CLASSICAL_PATHWAY_OF_STER...,SET,16,0.06061,0.0017885,0.22853,0.39542,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.967668081960287
CAO_BLOOD_FLUZONE_AGE_05_14Y...6,SET,5,0.089352,0.0014743,0.33703,0.39546,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_UP,0.967697831444061
GNF2_SMC4L1,SET,80,0.023735,0.0015633,0.089572,0.39551,GNF2_SMC4L1,0.967752045198536
GOCC_PLATELET_DENSE_TUBULAR_...2,SET,8,0.075071,0.0015667,0.28363,0.39563,GOCC_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE,0.967977518479409
REACTOME_DIFFERENTIATION_OF_...,SET,37,0.039675,0.0017793,0.14999,0.39569,REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN,0.967993285472973
REACTOME_MET_RECEPTOR_RECYCL...,SET,10,0.069846,0.0016296,0.26407,0.3957,REACTOME_MET_RECEPTOR_RECYCLING,0.967993285472973
GSE45365_NK_CELL_VS_BCELL_DN,SET,126,0.020517,0.0016938,0.077588,0.39572,GSE45365_NK_CELL_VS_BCELL_DN,0.967993285472973
GSE12198_NK_VS_NK_ACT_EXPANS...2,SET,182,0.017514,0.0017351,0.066266,0.39578,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP,0.968071919206137
HP_MITOCHONDRIAL_INHERITANCE,SET,4,0.10111,0.0014922,0.38273,0.39582,HP_MITOCHONDRIAL_INHERITANCE,0.968101625615764
GSE26488_HDAC7_KO_VS_VP16_TR...2,SET,157,0.018304,0.0016854,0.069319,0.39587,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.968155784251636
HP_CALCIUM_NEPHROLITHIASIS,SET,18,0.051811,0.0016215,0.19633,0.39593,HP_CALCIUM_NEPHROLITHIASIS,0.968234389952153
LI_PBMC_MENOMUNE_A_C_Y_W_135...4,SET,41,0.03824,0.001805,0.14501,0.39601,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,0.968342665681722
GOBP_NEGATIVE_REGULATION_OF_...129,SET,5,0.11067,0.001826,0.41978,0.39603,GOBP_NEGATIVE_REGULATION_OF_CELL_VOLUME,0.968342665681722
HP_ABNORMAL_CILIARY_BODY_MOR...,SET,6,0.087001,0.0015725,0.33082,0.39628,HP_ABNORMAL_CILIARY_BODY_MORPHOLOGY,0.968749894736842
JINESH_BLEBBISHIELD_TO_IMMUN...2,SET,341,0.013054,0.0017625,0.049646,0.3963,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,0.968749894736842
GSE10147_IL3_VS_IL3_AND_CPG_...2,SET,132,0.019551,0.0016518,0.074399,0.39636,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP,0.968749894736842
GOBP_DEVELOPMENT_OF_SECONDAR...1,SET,6,0.10186,0.001841,0.38762,0.39637,GOBP_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS,0.968749894736842
GSE25123_IL4_VS_IL4_AND_ROSI...1,SET,177,0.016502,0.0016124,0.062807,0.39638,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.968749894736842
GOCC_POSTSYNAPTIC_MEMBRANE,SET,257,0.015134,0.001778,0.057638,0.39644,GOCC_POSTSYNAPTIC_MEMBRANE,0.968749894736842
REACTOME_CS_DS_DEGRADATION,SET,12,0.060271,0.0015404,0.22968,0.3965,REACTOME_CS_DS_DEGRADATION,0.968749894736842
GOBP_CELL_CELL_SIGNALING_INV...,SET,30,0.045404,0.0018338,0.17302,0.3965,GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION,0.968749894736842
GSE26928_NAIVE_VS_CENT_MEMOR...2,SET,163,0.016931,0.0015882,0.064526,0.39651,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.968749894736842
GOMF_DNA_ENDONUCLEASE_ACTIVI...2,SET,9,0.069181,0.0015313,0.26374,0.39654,GOMF_DNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.968749894736842
GOBP_ACTIVATION_OF_GTPASE_AC...,SET,81,0.025252,0.0016736,0.09632,0.3966,GOBP_ACTIVATION_OF_GTPASE_ACTIVITY,0.968749894736842
HP_RECEPTIVE_LANGUAGE_DELAY,SET,13,0.061726,0.0016419,0.23552,0.39663,HP_RECEPTIVE_LANGUAGE_DELAY,0.968749894736842
GSE3982_NEUTROPHIL_VS_TH2_DN,SET,182,0.015635,0.0015489,0.059669,0.39665,GSE3982_NEUTROPHIL_VS_TH2_DN,0.968749894736842
GOBP_THREONINE_METABOLIC_PRO...,SET,4,0.11582,0.0017094,0.44224,0.3967,GOBP_THREONINE_METABOLIC_PROCESS,0.968749894736842
GOBP_C21_STEROID_HORMONE_MET...,SET,35,0.042295,0.0018449,0.16153,0.39673,GOBP_C21_STEROID_HORMONE_METABOLIC_PROCESS,0.968749894736842
KATSANOU_ELAVL1_TARGETS_DN,SET,133,0.020268,0.0017188,0.077424,0.39675,KATSANOU_ELAVL1_TARGETS_DN,0.968749894736842
GOMF_TASTE_RECEPTOR_ACTIVITY,SET,28,0.050716,0.0019791,0.19379,0.39677,GOMF_TASTE_RECEPTOR_ACTIVITY,0.968749894736842
GSE26928_EFF_MEMORY_VS_CXCR5...1,SET,164,0.01726,0.001624,0.065958,0.39678,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.968749894736842
GOBP_REGULATION_OF_CELL_SUBS...1,SET,202,0.016355,0.0017061,0.062524,0.39682,GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.968749894736842
MIR3074_3P,SET,79,0.026096,0.0017081,0.099831,0.39689,MIR3074_3P,0.968749894736842
PID_THROMBIN_PAR4_PATHWAY,SET,15,0.063059,0.0018017,0.24139,0.39696,PID_THROMBIN_PAR4_PATHWAY,0.968749894736842
REACTOME_G_ALPHA_I_SIGNALLIN...,SET,296,0.01426,0.0017959,0.054591,0.39697,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,0.968749894736842
HP_ABNORMAL_CIRCULATING_PROT...3,SET,606,0.0092362,0.0016501,0.035364,0.39698,HP_ABNORMAL_CIRCULATING_PROTEIN_CONCENTRATION,0.968749894736842
WP_MITOCHONDRIAL_IMMUNE_RESP...,SET,23,0.045182,0.0015982,0.17301,0.39699,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.968749894736842
GSE11818_WT_VS_DICER_KO_TREG...2,SET,129,0.021384,0.0017861,0.081889,0.397,GSE11818_WT_VS_DICER_KO_TREG_UP,0.968749894736842
HOFT_CD4_POSITIVE_ALPHA_BETA...2,SET,17,0.054712,0.0016641,0.20954,0.39701,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,0.968749894736842
KEGG_MEDICUS_REFERENCE_TIGHT...,SET,34,0.040744,0.0017517,0.15608,0.39703,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY,0.968749894736842
GOBP_RESPONSE_TO_PARATHYROID...,SET,10,0.076321,0.0017807,0.29243,0.39705,GOBP_RESPONSE_TO_PARATHYROID_HORMONE,0.968749894736842
GOBP_PLATELET_DERIVED_GROWTH...2,SET,14,0.063877,0.0017632,0.24477,0.39706,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.968749894736842
WP_NAD_BIOSYNTHETIC_PATHWAYS,SET,22,0.048935,0.0016929,0.18753,0.39707,WP_NAD_BIOSYNTHETIC_PATHWAYS,0.968749894736842
PRAMOONJAGO_SOX4_TARGETS_UP,SET,48,0.034264,0.0017497,0.13132,0.39708,PRAMOONJAGO_SOX4_TARGETS_UP,0.968749894736842
NICK_RESPONSE_TO_PROC_TREATM...1,SET,23,0.04102,0.0014509,0.15725,0.3971,NICK_RESPONSE_TO_PROC_TREATMENT_DN,0.968749894736842
GOBP_POSITIVE_CHEMOTAXIS,SET,60,0.030666,0.0017502,0.11759,0.39713,GOBP_POSITIVE_CHEMOTAXIS,0.968749894736842
WANG_BARRETTS_ESOPHAGUS_AND_...2,SET,24,0.049694,0.0017955,0.19061,0.39716,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,0.968749894736842
HP_ABNORMAL_RESPONSE_TO_SOCI...,SET,61,0.030248,0.0017406,0.11605,0.39719,HP_ABNORMAL_RESPONSE_TO_SOCIAL_NORMS,0.968749894736842
GSE21927_SPLEEN_VS_4T1_TUMOR...1,SET,173,0.016715,0.0016149,0.064141,0.3972,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,0.968749894736842
GOBP_VASCULAR_ASSOCIATED_SMO...3,SET,28,0.046518,0.0018152,0.17863,0.39727,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.968833423379175
NKX2_8_TARGET_GENES,SET,31,0.043275,0.0017767,0.1662,0.39729,NKX2_8_TARGET_GENES,0.968833423379175
KEGG_MEDICUS_REFERENCE_WNT_S...1,SET,18,0.059342,0.0018572,0.22828,0.39745,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO,0.969155598821301
HE_LIM_SUN_FETAL_LUNG_C2_MYE...,SET,15,0.064786,0.001851,0.24941,0.39753,HE_LIM_SUN_FETAL_LUNG_C2_MYELOCYTE_LIKE_CELL,0.969242106552786
E2F1_Q6_01,SET,214,0.014761,0.0015843,0.05684,0.39755,E2F1_Q6_01,0.969242106552786
HES4_TARGET_GENES,SET,489,0.010101,0.0016264,0.038934,0.39765,HES4_TARGET_GENES,0.969242106552786
HP_ALBINISM,SET,18,0.056006,0.0017528,0.21587,0.39765,HP_ALBINISM,0.969242106552786
CEBP_Q3,SET,218,0.01614,0.0017483,0.062218,0.39766,CEBP_Q3,0.969242106552786
CTGCAGY_UNKNOWN,SET,678,0.0088853,0.0016756,0.03425,0.39766,CTGCAGY_UNKNOWN,0.969242106552786
HP_DECREASED_CIRCULATING_GON...,SET,37,0.038397,0.001722,0.14814,0.39774,HP_DECREASED_CIRCULATING_GONADOTROPIN_CONCENTRATION,0.969242106552786
HP_NORMOCHROMIC_ANEMIA,SET,33,0.035683,0.0015114,0.13774,0.3978,HP_NORMOCHROMIC_ANEMIA,0.969242106552786
GOBP_PROTEIN_UFMYLATION,SET,6,0.084264,0.001523,0.3255,0.39787,GOBP_PROTEIN_UFMYLATION,0.969242106552786
DESCARTES_FETAL_EYE_BIPOLAR_...,SET,19,0.057975,0.0018641,0.224,0.39789,DESCARTES_FETAL_EYE_BIPOLAR_CELLS,0.969242106552786
HP_ABNORMALITY_OF_THE_CALCAN...,SET,31,0.044536,0.0018285,0.1721,0.3979,HP_ABNORMALITY_OF_THE_CALCANEUS,0.969242106552786
HP_WIDE_INTERMAMILLARY_DISTA...,SET,103,0.021256,0.0015876,0.082146,0.39791,HP_WIDE_INTERMAMILLARY_DISTANCE,0.969242106552786
GOCC_CATION_CHANNEL_COMPLEX,SET,195,0.017317,0.0017751,0.066946,0.39795,GOCC_CATION_CHANNEL_COMPLEX,0.969242106552786
GOBP_HOMEOSTATIC_PROCESS,SET,1566,0.0060422,0.0016877,0.023362,0.39796,GOBP_HOMEOSTATIC_PROCESS,0.969242106552786
REACTOME_DEFECTIVE_B4GALT7_C...,SET,17,0.054068,0.0016445,0.20908,0.39797,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,0.969242106552786
GOBP_RIBOSOMAL_SMALL_SUBUNIT...3,SET,8,0.089838,0.0018749,0.34748,0.398,GOBP_RIBOSOMAL_SMALL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.969242106552786
GSE2405_0H_VS_6H_A_PHAGOCYTO...1,SET,170,0.017598,0.0016855,0.068087,0.39802,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.969242106552786
MIR1537_3P,SET,9,0.086148,0.0019069,0.33344,0.39806,MIR1537_3P,0.969242106552786
MODULE_328,SET,13,0.061006,0.0016228,0.23613,0.39807,MODULE_328,0.969242106552786
KEGG_MEDICUS_REFERENCE_NON_H...,SET,13,0.048855,0.0012996,0.18912,0.39808,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING,0.969242106552786
HE_LIM_SUN_FETAL_LUNG_C4_ILC...1,SET,135,0.020447,0.0017468,0.079147,0.39808,HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL,0.969242106552786
TIEN_INTESTINE_PROBIOTICS_24...2,SET,513,0.0093886,0.0015473,0.036387,0.3982,TIEN_INTESTINE_PROBIOTICS_24HR_UP,0.969242106552786
HP_RED_HAIR,SET,8,0.085784,0.0017903,0.33253,0.39821,HP_RED_HAIR,0.969242106552786
GSE11864_CSF1_VS_CSF1_IFNG_P...2,SET,167,0.016063,0.001525,0.062288,0.39825,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.969242106552786
HP_LIMB_UNDERGROWTH,SET,220,0.014921,0.0016235,0.057862,0.39826,HP_LIMB_UNDERGROWTH,0.969242106552786
GOBP_RESPONSE_TO_RADIATION,SET,390,0.010976,0.0015827,0.042585,0.3983,GOBP_RESPONSE_TO_RADIATION,0.969242106552786
HP_ERYTHEMATOUS_PAPULE,SET,10,0.057168,0.0013338,0.22183,0.39831,HP_ERYTHEMATOUS_PAPULE,0.969242106552786
WP_MAJOR_RECEPTORS_TARGETED_...,SET,16,0.06107,0.001802,0.23698,0.39832,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,0.969242106552786
WP_NEURAL_CREST_CELL_MIGRATI...2,SET,40,0.037813,0.001763,0.14675,0.39833,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,0.969242106552786
MIR3606_3P,SET,331,0.012382,0.0016475,0.04806,0.39834,MIR3606_3P,0.969242106552786
SCHAEFFER_PROSTATE_DEVELOPME...9,SET,7,0.085695,0.001673,0.33264,0.39835,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN,0.969242106552786
HP_PATELLAR_APLASIA,SET,20,0.051614,0.0017026,0.20051,0.39843,HP_PATELLAR_APLASIA,0.969368893944697
GOBP_FEMALE_MEIOSIS_I,SET,9,0.080746,0.0017873,0.31399,0.39853,GOBP_FEMALE_MEIOSIS_I,0.969544319613608
GOBP_NEGATIVE_REGULATION_OF_...67,SET,21,0.048976,0.0016554,0.19053,0.39857,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.969573762861342
GSE33513_TCF7_KO_VS_HET_EARL...2,SET,178,0.017251,0.0016903,0.067127,0.3986,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP,0.969578877379619
STAT5B_01,SET,223,0.01511,0.0016551,0.058821,0.39864,STAT5B_01,0.96960831408776
WP_NONSMALL_CELL_LUNG_CANCER,SET,71,0.025406,0.0015769,0.099032,0.39877,WP_NONSMALL_CELL_LUNG_CANCER,0.969856637508747
GOCC_FASCIA_ADHERENS,SET,9,0.083908,0.0018573,0.32721,0.39881,GOCC_FASCIA_ADHERENS,0.969877007835455
GSE17721_PAM3CSK4_VS_GADIQUI...15,SET,182,0.016605,0.0016451,0.064791,0.39886,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN,0.969877007835455
HP_SEPTO_OPTIC_DYSPLASIA,SET,18,0.056563,0.0017702,0.22071,0.39887,HP_SEPTO_OPTIC_DYSPLASIA,0.969877007835455
GSE7852_THYMUS_VS_FAT_TREG_DN,SET,178,0.016677,0.0016341,0.06509,0.39889,GSE7852_THYMUS_VS_FAT_TREG_DN,0.969877007835455
GOBP_ESTABLISHMENT_OF_RNA_LO...,SET,143,0.016939,0.0014891,0.066145,0.39894,GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION,0.969911499720201
HP_GLOMERULAR_SCLEROSIS,SET,78,0.024243,0.0015768,0.094681,0.39896,HP_GLOMERULAR_SCLEROSIS,0.969911499720201
GSE22886_CTRL_VS_LPS_24H_DC_...1,SET,176,0.017091,0.0016653,0.066773,0.39899,GSE22886_CTRL_VS_LPS_24H_DC_DN,0.969916587395957
MIR5089_5P,SET,103,0.020971,0.0015663,0.082003,0.39908,MIR5089_5P,0.970067519932858
GOBP_NEGATIVE_REGULATION_OF_...592,SET,2,0.15972,0.0016669,0.6248,0.39912,GOBP_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,0.97009690188125
GSE42021_TREG_PLN_VS_CD24HI_...1,SET,183,0.014952,0.0014853,0.058543,0.39921,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN,0.970136421479513
REACTOME_DEGRADATION_OF_THE_...,SET,132,0.021078,0.0017808,0.082539,0.39922,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,0.970136421479513
HP_MECKEL_DIVERTICULUM,SET,25,0.038747,0.0014288,0.15173,0.39922,HP_MECKEL_DIVERTICULUM,0.970136421479513
HP_ABSENCE_OF_PUBERTAL_DEVEL...,SET,30,0.042828,0.0017298,0.16778,0.39926,HP_ABSENCE_OF_PUBERTAL_DEVELOPMENT,0.970165790393624
LET_7I_3P,SET,5,0.10079,0.0016631,0.39501,0.3993,LET_7I_3P,0.970195155201342
HP_SCLERAL_STAPHYLOMA,SET,9,0.07506,0.0016614,0.29447,0.3994,HP_SCLERAL_STAPHYLOMA,0.970289202762084
ZHAN_MULTIPLE_MYELOMA_PR_DN,SET,45,0.035373,0.0017491,0.13878,0.39941,ZHAN_MULTIPLE_MYELOMA_PR_DN,0.970289202762084
MIR4519,SET,73,0.02519,0.0015852,0.098862,0.39944,MIR4519,0.970289202762084
GSE25123_CTRL_VS_IL4_STIM_MA...1,SET,174,0.016464,0.0015952,0.064637,0.39947,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.970289202762084
MORF_MAP2K2,SET,116,0.018749,0.0014856,0.073642,0.39952,MORF_MAP2K2,0.970289202762084
HP_SLURRED_SPEECH,SET,45,0.031972,0.0015809,0.12569,0.3996,HP_SLURRED_SPEECH,0.970289202762084
GOBP_REGULATION_OF_CELL_JUNC...,SET,198,0.016584,0.0017129,0.065196,0.39961,GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.970289202762084
KEGG_MEDICUS_REFERENCE_ITGA_...5,SET,27,0.042008,0.0016098,0.16526,0.39967,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.970289202762084
GSE15330_LYMPHOID_MULTIPOTEN...7,SET,149,0.018267,0.0016389,0.07189,0.39971,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.970289202762084
GSE19888_ADENOSINE_A3R_ACT_V...6,SET,178,0.016537,0.0016204,0.065126,0.39978,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP,0.970289202762084
HP_LACRIMATION_ABNORMALITY,SET,76,0.026206,0.0016825,0.10321,0.39979,HP_LACRIMATION_ABNORMALITY,0.970289202762084
GSE43863_DAY6_EFF_VS_DAY150_...3,SET,181,0.016896,0.0016693,0.06656,0.39981,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN,0.970289202762084
REACTOME_HIGHLY_SODIUM_PERME...,SET,7,0.077973,0.0015222,0.30733,0.39986,REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS,0.970289202762084
HP_ABNORMAL_TRANSFERRIN_SATU...,SET,12,0.06193,0.0015827,0.24412,0.39987,HP_ABNORMAL_TRANSFERRIN_SATURATION,0.970289202762084
GOBP_NON_LYTIC_VIRAL_RELEASE,SET,14,0.056458,0.0015584,0.22267,0.39992,GOBP_NON_LYTIC_VIRAL_RELEASE,0.970289202762084
TERAMOTO_OPN_TARGETS_CLUSTER...6,SET,17,0.053639,0.0016314,0.21159,0.39994,TERAMOTO_OPN_TARGETS_CLUSTER_7,0.970289202762084
GOMF_POLYSACCHARIDE_BINDING,SET,21,0.050993,0.0017236,0.20119,0.39996,GOMF_POLYSACCHARIDE_BINDING,0.970289202762084
HP_ENLARGED_KIDNEY,SET,41,0.033288,0.0015713,0.13133,0.39996,HP_ENLARGED_KIDNEY,0.970289202762084
GSE9960_HEALTHY_VS_SEPSIS_PB...2,SET,166,0.016803,0.0015905,0.066313,0.39998,GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP,0.970289202762084
HE_LIM_SUN_FETAL_LUNG_C3_INT...,SET,353,0.012399,0.0017027,0.048939,0.4,HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL,0.970289202762084
WP_IL7_SIGNALING,SET,24,0.048818,0.0017638,0.19276,0.40004,WP_IL7_SIGNALING,0.970289202762084
GOBP_GANGLIOSIDE_BIOSYNTHETI...1,SET,17,0.055957,0.0017019,0.22096,0.40004,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS,0.970289202762084
GSE29618_MONOCYTE_VS_MDC_DN,SET,170,0.017241,0.0016513,0.06809,0.40005,GSE29618_MONOCYTE_VS_MDC_DN,0.970289202762084
REACTOME_MITOTIC_TELOPHASE_C...,SET,10,0.065831,0.0015359,0.26,0.40006,REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,0.970289202762084
GOBP_REGULATION_OF_CELLULAR_...11,SET,16,0.056128,0.0016562,0.22171,0.40008,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT,0.970289202762084
MORF_ZNF10,SET,46,0.035016,0.0017505,0.13835,0.4001,MORF_ZNF10,0.970289202762084
HP_HYPOCALCEMIC_SEIZURES,SET,12,0.065517,0.0016744,0.25893,0.40013,HP_HYPOCALCEMIC_SEIZURES,0.970289202762084
BIOCARTA_RANKL_PATHWAY,SET,14,0.064213,0.0017725,0.25384,0.40015,BIOCARTA_RANKL_PATHWAY,0.970289202762084
GSE29618_PRE_VS_DAY7_POST_TI...1,SET,172,0.015367,0.0014803,0.060756,0.40017,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN,0.970289202762084
GSE1925_CTRL_VS_IFNG_PRIMED_...3,SET,115,0.020764,0.0016382,0.082142,0.40022,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN,0.970289202762084
GSE7460_CTRL_VS_FOXP3_OVEREX...3,SET,173,0.016311,0.0015758,0.064536,0.40024,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN,0.970289202762084
MODULE_465,SET,13,0.05923,0.0015755,0.23439,0.40025,MODULE_465,0.970289202762084
HP_AGITATION,SET,95,0.022716,0.0016298,0.089899,0.40026,HP_AGITATION,0.970289202762084
GOMF_PHOSPHATIDYLINOSITOL_PH...2,SET,12,0.053603,0.0013699,0.21231,0.40034,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.970415448458641
GOBP_RESPONSE_TO_SORBITOL,SET,6,0.096656,0.001747,0.38302,0.40039,GOBP_RESPONSE_TO_SORBITOL,0.97046896227073
MIR892C_5P,SET,252,0.01405,0.0016347,0.055711,0.40045,MIR892C_5P,0.97054670502092
GOBP_PROTEIN_LOCALIZATION_TO...42,SET,15,0.054882,0.0015681,0.2177,0.40048,GOBP_PROTEIN_LOCALIZATION_TO_PHAGOPHORE_ASSEMBLY_SITE,0.970551732794087
GSE43955_10H_VS_60H_ACT_CD4_...3,SET,184,0.016509,0.0016444,0.065512,0.40052,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.970580992888021
HP_ELEVATED_CIRCULATING_ALAN...,SET,69,0.024438,0.0014953,0.097062,0.40061,HP_ELEVATED_CIRCULATING_ALANINE_AMINOTRANSFERASE_CONCENTRATION,0.97073140556369
GOBP_ORGANELLE_INHERITANCE,SET,15,0.052287,0.0014939,0.20781,0.40067,GOBP_ORGANELLE_INHERITANCE,0.970809108337981
GCM_RBM8A,SET,70,0.024762,0.0015261,0.098508,0.40076,GCM_RBM8A,0.970959484140816
GSE22611_UNSTIM_VS_2H_MDP_ST...3,SET,176,0.016409,0.0015988,0.065303,0.4008,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.970980973605404
GOMF_NUCLEAR_ESTROGEN_RECEPT...,SET,35,0.036077,0.0015737,0.14365,0.40085,GOMF_NUCLEAR_ESTROGEN_RECEPTOR_BINDING,0.970980973605404
MIR1247_5P,SET,4,0.11481,0.0016944,0.45786,0.401,MIR1247_5P,0.970980973605404
WHITEFORD_PEDIATRIC_CANCER_M...,SET,111,0.020201,0.0015659,0.080564,0.40101,WHITEFORD_PEDIATRIC_CANCER_MARKERS,0.970980973605404
MIR496,SET,95,0.022526,0.0016161,0.089835,0.40101,MIR496,0.970980973605404
GOBP_PIRNA_PROCESSING,SET,21,0.042863,0.0014488,0.17102,0.40105,GOBP_PIRNA_PROCESSING,0.970980973605404
GSE3982_NEUTROPHIL_VS_NKCELL...1,SET,176,0.015175,0.0014787,0.060581,0.4011,GSE3982_NEUTROPHIL_VS_NKCELL_DN,0.970980973605404
GSE37532_TREG_VS_TCONV_PPARG...4,SET,186,0.015531,0.0015552,0.062015,0.40113,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,0.970980973605404
GSE40666_UNTREATED_VS_IFNA_S...2,SET,147,0.018288,0.0016298,0.073028,0.40113,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP,0.970980973605404
HP_JOINT_SWELLING,SET,46,0.03345,0.0016722,0.1336,0.40115,HP_JOINT_SWELLING,0.970980973605404
GSE2585_THYMIC_DC_VS_THYMIC_...1,SET,177,0.016031,0.0015664,0.06403,0.40115,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN,0.970980973605404
GSE34006_WT_VS_A2AR_KO_TREG_...2,SET,183,0.016296,0.0016188,0.065082,0.40115,GSE34006_WT_VS_A2AR_KO_TREG_UP,0.970980973605404
FAN_OVARY_CL12_T_LYMPHOCYTE_...,SET,138,0.018377,0.0015872,0.073394,0.40115,FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2,0.970980973605404
HP_ANGULAR_CHEILITIS,SET,11,0.07087,0.0017342,0.28309,0.40116,HP_ANGULAR_CHEILITIS,0.970980973605404
GOBP_MITOTIC_SISTER_CHROMATI...4,SET,60,0.026446,0.0015093,0.10572,0.40124,GOBP_MITOTIC_SISTER_CHROMATID_SEPARATION,0.971106977715877
GOBP_POST_EMBRYONIC_ANIMAL_M...,SET,4,0.10294,0.0015192,0.41182,0.40131,GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS,0.971208763317318
GOBP_POSITIVE_REGULATION_OF_...351,SET,974,0.0072306,0.0016206,0.028975,0.40147,GOBP_POSITIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.971375519072912
REACTOME_MEIOTIC_RECOMBINATI...,SET,26,0.038525,0.0014487,0.15442,0.4015,REACTOME_MEIOTIC_RECOMBINATION,0.971375519072912
HP_FETAL_POLYURIA,SET,11,0.068844,0.0016846,0.27622,0.40159,HP_FETAL_POLYURIA,0.971375519072912
WANG_LSD1_TARGETS_DN,SET,34,0.038934,0.0016739,0.15642,0.40172,WANG_LSD1_TARGETS_DN,0.971375519072912
HP_ABNORMAL_URINARY_COLOR,SET,18,0.047046,0.0014723,0.1892,0.40181,HP_ABNORMAL_URINARY_COLOR,0.971375519072912
GOBP_CELLULAR_COMPONENT_DISA...2,SET,31,0.039162,0.0016078,0.15752,0.40183,GOBP_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.971375519072912
HP_FOCAL_MOTOR_SEIZURE,SET,100,0.021557,0.0015866,0.086719,0.40184,HP_FOCAL_MOTOR_SEIZURE,0.971375519072912
KEGG_MEDICUS_VARIANT_MUTATIO...66,SET,12,0.06217,0.0015889,0.25022,0.40189,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY,0.971375519072912
WP_CONVERSION_OF_ANGIOTENSIN...,SET,5,0.1174,0.0019372,0.47285,0.40196,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,0.971375519072912
ATGTCAC_MIR489,SET,77,0.025091,0.0016215,0.10108,0.40198,ATGTCAC_MIR489,0.971375519072912
HP_LARYNGEAL_STRIDOR,SET,4,0.11266,0.0016627,0.45411,0.40204,HP_LARYNGEAL_STRIDOR,0.971375519072912
GSE17721_CTRL_VS_POLYIC_12H_...1,SET,188,0.014886,0.0014986,0.060017,0.40205,GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN,0.971375519072912
GOBP_NEGATIVE_REGULATION_OF_...80,SET,18,0.05227,0.0016358,0.21076,0.40207,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH,0.971375519072912
MORF_IL4,SET,162,0.017101,0.0015993,0.068967,0.40208,MORF_IL4,0.971375519072912
KEGG_MEDICUS_REFERENCE_MODIF...1,SET,6,0.075479,0.0013643,0.30443,0.40209,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS,0.971375519072912
HE_LIM_SUN_FETAL_LUNG_C1_GHR...2,SET,376,0.011387,0.0016128,0.045944,0.40213,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL,0.971375519072912
GOBP_SYNCYTIUM_FORMATION,SET,60,0.028274,0.0016137,0.11411,0.40215,GOBP_SYNCYTIUM_FORMATION,0.971375519072912
HP_APLASIA_HYPOPLASIA_OF_THE...44,SET,5,0.10238,0.0016892,0.41325,0.40217,HP_APLASIA_HYPOPLASIA_OF_THE_MUSCULATURE_OF_THE_PELVIS,0.971375519072912
GOBP_CARDIAC_ATRIUM_MORPHOGE...,SET,26,0.04681,0.0017603,0.18897,0.40218,GOBP_CARDIAC_ATRIUM_MORPHOGENESIS,0.971375519072912
HP_ABNORMAL_ACETABULUM_MORPH...,SET,84,0.022383,0.0015105,0.090452,0.40228,HP_ABNORMAL_ACETABULUM_MORPHOLOGY,0.971375519072912
PID_BCR_5PATHWAY,SET,59,0.027741,0.00157,0.11212,0.40229,PID_BCR_5PATHWAY,0.971375519072912
MODULE_33,SET,346,0.012025,0.0016352,0.048608,0.4023,MODULE_33,0.971375519072912
MIR942_3P,SET,104,0.02014,0.0015115,0.081415,0.40231,MIR942_3P,0.971375519072912
HP_ALOPECIA_UNIVERSALIS,SET,11,0.071536,0.0017505,0.28926,0.40234,HP_ALOPECIA_UNIVERSALIS,0.971375519072912
GSE22611_NOD2_TRANSD_VS_CTRL...2,SET,163,0.016303,0.0015292,0.065946,0.40237,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP,0.971375519072912
MIR4701_5P,SET,107,0.020927,0.0015929,0.08466,0.40238,MIR4701_5P,0.971375519072912
CASORELLI_ACUTE_PROMYELOCYTI...1,SET,590,0.0085377,0.0015057,0.03456,0.40244,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,0.971375519072912
MORF_PRKAG1,SET,203,0.013876,0.0014509,0.05621,0.40251,MORF_PRKAG1,0.971375519072912
GOBP_REGULATION_OF_DNA_DAMAG...2,SET,33,0.037715,0.0015975,0.15281,0.40253,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.971375519072912
KEGG_MEDICUS_VARIANT_MUTATIO...45,SET,21,0.046799,0.0015819,0.18966,0.40255,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.971375519072912
HP_REDUCED_BRAIN_N_ACETYL_AS...,SET,16,0.050747,0.0014974,0.20578,0.40261,HP_REDUCED_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.971375519072912
BIOCARTA_IFNG_PATHWAY,SET,6,0.097181,0.0017565,0.39431,0.40266,BIOCARTA_IFNG_PATHWAY,0.971375519072912
MIR4793_5P,SET,58,0.028147,0.0015795,0.11427,0.40272,MIR4793_5P,0.971375519072912
GSE43955_TH0_VS_TGFB_IL6_TH1...12,SET,176,0.015895,0.0015488,0.064557,0.40276,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP,0.971375519072912
TFEB_TARGET_GENES,SET,1067,0.0067397,0.0015768,0.027403,0.40286,TFEB_TARGET_GENES,0.971375519072912
REACTOME_METABOLISM_OF_INGES...,SET,7,0.089565,0.0017485,0.36419,0.40287,REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE,0.971375519072912
SCHAVOLT_TARGETS_OF_TP53_AND...,SET,15,0.047549,0.0013585,0.19343,0.40291,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,0.971375519072912
PID_KIT_PATHWAY,SET,51,0.031947,0.0016814,0.13001,0.40295,PID_KIT_PATHWAY,0.971375519072912
WP_GLP1_SECRETION_FROM_INTES...,SET,5,0.11072,0.0018268,0.45061,0.40296,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,0.971375519072912
GTTAAAG_MIR302B,SET,63,0.026529,0.0015514,0.108,0.40298,GTTAAAG_MIR302B,0.971375519072912
FAN_EMBRYONIC_CTX_EX_4_EXCIT...,SET,133,0.018443,0.001564,0.075079,0.40298,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.971375519072912
GOBP_HEME_A_METABOLIC_PROCESS,SET,10,0.065842,0.0015362,0.26807,0.40299,GOBP_HEME_A_METABOLIC_PROCESS,0.971375519072912
HP_RENAL_CORTICAL_MICROCYSTS,SET,4,0.10454,0.0015429,0.42577,0.40302,HP_RENAL_CORTICAL_MICROCYSTS,0.971375519072912
GSE40274_CTRL_VS_GATA1_TRANS...1,SET,147,0.016966,0.001512,0.069114,0.40304,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.971375519072912
MORF_MAGEA9,SET,376,0.011145,0.0015784,0.045448,0.40315,MORF_MAGEA9,0.971375519072912
GOCC_AXONEMAL_A_TUBULE_INNER...,SET,9,0.078761,0.0017434,0.32124,0.40316,GOCC_AXONEMAL_A_TUBULE_INNER_SHEATH,0.971375519072912
GSE8515_CTRL_VS_IL6_4H_STIM_...1,SET,170,0.016682,0.0015978,0.068049,0.40317,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN,0.971375519072912
HP_VARIABLE_EXPRESSIVITY,SET,63,0.025888,0.0015139,0.10562,0.40319,HP_VARIABLE_EXPRESSIVITY,0.971375519072912
HOXC13_TARGET_GENES,SET,95,0.020598,0.0014778,0.08406,0.40322,HOXC13_TARGET_GENES,0.971375519072912
CHARAFE_BREAST_CANCER_BASAL_...1,SET,50,0.032182,0.0016771,0.13136,0.40323,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,0.971375519072912
GOBP_OLIGODENDROCYTE_DIFFERE...,SET,104,0.022073,0.0016566,0.090092,0.40323,GOBP_OLIGODENDROCYTE_DIFFERENTIATION,0.971375519072912
FEVR_CTNNB1_TARGETS_UP,SET,635,0.0086177,0.0015747,0.035184,0.40326,FEVR_CTNNB1_TARGETS_UP,0.971375519072912
GSE11961_MEMORY_BCELL_DAY40_...1,SET,178,0.015683,0.0015367,0.064032,0.40326,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.971375519072912
GSE2585_CD80_HIGH_VS_LOW_AIR...1,SET,183,0.015623,0.0015519,0.063812,0.4033,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN,0.971375519072912
KIM_MYC_AMPLIFICATION_TARGET...1,SET,87,0.023648,0.001624,0.096601,0.40331,KIM_MYC_AMPLIFICATION_TARGETS_DN,0.971375519072912
WP_KETOGENESIS_AND_KETOLYSIS,SET,8,0.081033,0.0016911,0.33101,0.40331,WP_KETOGENESIS_AND_KETOLYSIS,0.971375519072912
MIR10525_3P,SET,55,0.029577,0.0016164,0.12085,0.40333,MIR10525_3P,0.971375519072912
SCHAEFFER_PROSTATE_DEVELOPME...12,SET,33,0.033522,0.0014199,0.13701,0.40336,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,0.971375519072912
WP_FEMALE_STEROID_HORMONES_I...,SET,14,0.053763,0.001484,0.21983,0.4034,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.971375519072912
GOBP_ADENYLATE_CYCLASE_ACTIV...3,SET,162,0.017732,0.0016583,0.072511,0.4034,GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.971375519072912
GOCC_FICOLIN_1_RICH_GRANULE,SET,172,0.015909,0.0015326,0.065054,0.4034,GOCC_FICOLIN_1_RICH_GRANULE,0.971375519072912
AGGCACT_MIR5153P,SET,80,0.023702,0.0015612,0.09694,0.40342,AGGCACT_MIR5153P,0.971375519072912
GOBP_NEGATIVE_REGULATION_OF_...155,SET,15,0.054737,0.0015639,0.22392,0.40344,GOBP_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY,0.971375519072912
GOBP_SEQUESTERING_OF_CALCIUM...,SET,126,0.019696,0.0016261,0.080617,0.40349,GOBP_SEQUESTERING_OF_CALCIUM_ION,0.971375519072912
GSE21670_UNTREATED_VS_IL6_TR...4,SET,167,0.016571,0.0015732,0.067898,0.40359,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.971375519072912
HP_METHEMOGLOBINEMIA,SET,5,0.098017,0.0016173,0.40172,0.40362,HP_METHEMOGLOBINEMIA,0.971375519072912
MORF_XPC,SET,53,0.025503,0.0013682,0.10458,0.40367,MORF_XPC,0.971375519072912
GOBP_CENP_A_CONTAINING_CHROM...,SET,9,0.064304,0.0014234,0.26374,0.40369,GOBP_CENP_A_CONTAINING_CHROMATIN_ASSEMBLY,0.971375519072912
BOYAULT_LIVER_CANCER_SUBCLAS...15,SET,19,0.049395,0.0015882,0.20265,0.40372,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,0.971375519072912
GOBP_DETECTION_OF_LIGHT_STIM...2,SET,19,0.047973,0.0015425,0.19686,0.40373,GOBP_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.971375519072912
HP_HYPEREXTENSIBILITY_AT_ELB...,SET,6,0.087585,0.0015831,0.35944,0.40374,HP_HYPEREXTENSIBILITY_AT_ELBOW,0.971375519072912
HP_LEFT_VENTRICULAR_DIASTOLI...,SET,7,0.0787,0.0015364,0.32304,0.40376,HP_LEFT_VENTRICULAR_DIASTOLIC_DYSFUNCTION,0.971375519072912
MODULE_150,SET,12,0.050442,0.0012892,0.20708,0.40378,MODULE_150,0.971375519072912
LINDSTEDT_DENDRITIC_CELL_MAT...4,SET,60,0.027239,0.0015546,0.11187,0.40381,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,0.971375519072912
GOBP_VENTRAL_SPINAL_CORD_DEV...,SET,44,0.03374,0.0016497,0.13856,0.40381,GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT,0.971375519072912
GOBP_RESPONSE_TO_SALT,SET,22,0.047923,0.0016579,0.19683,0.40382,GOBP_RESPONSE_TO_SALT,0.971375519072912
KEGG_MEDICUS_REFERENCE_LHCGR...,SET,16,0.057242,0.0016891,0.23523,0.40387,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY,0.971375519072912
GOBP_INTRACELLULAR_WATER_HOM...,SET,6,0.094986,0.0017168,0.39053,0.40392,GOBP_INTRACELLULAR_WATER_HOMEOSTASIS,0.971375519072912
GOBP_BOX_C_D_SNORNP_ASSEMBLY,SET,8,0.071593,0.0014941,0.29444,0.40394,GOBP_BOX_C_D_SNORNP_ASSEMBLY,0.971375519072912
MIR1245A,SET,34,0.038511,0.0016557,0.15843,0.40398,MIR1245A,0.971375519072912
MIR3064_5P,SET,133,0.017997,0.0015262,0.074055,0.40399,MIR3064_5P,0.971375519072912
HE_LIM_SUN_FETAL_LUNG_C4_CD1...,SET,16,0.06196,0.0018283,0.25499,0.40401,HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL,0.971375519072912
REACTOME_RESPONSE_OF_EIF2AK4...,SET,91,0.021138,0.0014845,0.087022,0.40404,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,0.971375519072912
GSE3982_BASOPHIL_VS_CENT_MEM...2,SET,176,0.015733,0.001533,0.064772,0.40404,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.971375519072912
WP_OVERVIEW_OF_PROINFLAMMATO...,SET,121,0.022765,0.001842,0.093754,0.40408,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,0.971375519072912
GOBP_POSITIVE_REGULATION_OF_...759,SET,6,0.086386,0.0015614,0.35578,0.40408,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.971375519072912
MODULE_284,SET,40,0.032265,0.0015044,0.13291,0.40409,MODULE_284,0.971375519072912
LEE_CALORIE_RESTRICTION_MUSC...2,SET,36,0.03498,0.0015474,0.14412,0.40412,LEE_CALORIE_RESTRICTION_MUSCLE_UP,0.971375519072912
HP_PERIFOVEAL_RING_OF_HYPERA...,SET,15,0.054937,0.0015696,0.22644,0.40416,HP_PERIFOVEAL_RING_OF_HYPERAUTOFLUORESCENCE,0.971375519072912
MIR147B_3P,SET,5,0.10161,0.0016766,0.41921,0.40424,MIR147B_3P,0.971375519072912
MIR18B_3P,SET,46,0.030299,0.0015147,0.125,0.40424,MIR18B_3P,0.971375519072912
GSE34515_CD16_NEG_VS_POS_MON...1,SET,163,0.016091,0.0015094,0.066387,0.40424,GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN,0.971375519072912
MIR1292_5P,SET,15,0.051725,0.0014779,0.21345,0.40426,MIR1292_5P,0.971375519072912
HP_FOCAL_CORTICAL_DYSPLASIA,SET,15,0.053157,0.0015188,0.21938,0.40427,HP_FOCAL_CORTICAL_DYSPLASIA,0.971375519072912
REACTOME_ACTIVATED_NTRK2_SIG...1,SET,6,0.090687,0.0016391,0.37439,0.4043,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5,0.971375519072912
GSE19198_1H_VS_24H_IL21_TREA...2,SET,179,0.016216,0.0015934,0.066979,0.40435,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP,0.971375519072912
SHETH_LIVER_CANCER_VS_TXNIP_...2,SET,152,0.017098,0.0015493,0.07064,0.40437,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,0.971375519072912
GOBP_GOLGI_TO_ENDOSOME_TRANS...,SET,15,0.050447,0.0014413,0.20844,0.40438,GOBP_GOLGI_TO_ENDOSOME_TRANSPORT,0.971375519072912
HP_ABNORMALITY_OF_THE_EPIPHY...1,SET,5,0.097691,0.0016119,0.40369,0.40439,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_DISTAL_PHALANX_OF_FINGER,0.971375519072912
MODULE_458,SET,31,0.037556,0.0015419,0.15527,0.40444,MODULE_458,0.971375519072912
MODULE_464,SET,14,0.053378,0.0014734,0.22074,0.40446,MODULE_464,0.971375519072912
HP_ABNORMALITY_OF_THYROID_PH...,SET,346,0.011475,0.0015603,0.047448,0.40446,HP_ABNORMALITY_OF_THYROID_PHYSIOLOGY,0.971375519072912
HP_NEURONAL_LOSS_IN_THE_CERE...,SET,12,0.057653,0.0014734,0.23842,0.40446,HP_NEURONAL_LOSS_IN_THE_CEREBRAL_CORTEX,0.971375519072912
TAAWWATAG_RSRFC4_Q2,SET,148,0.017316,0.0015484,0.071636,0.4045,TAAWWATAG_RSRFC4_Q2,0.971375519072912
GSE37605_FOXP3_FUSION_GFP_VS...3,SET,151,0.017343,0.0015663,0.071765,0.40452,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN,0.971375519072912
GSE14769_UNSTIM_VS_60MIN_LPS...2,SET,180,0.014917,0.0014698,0.061731,0.40453,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP,0.971375519072912
KEGG_MEDICUS_REFERENCE_WEE1_...,SET,6,0.0707,0.0012779,0.29266,0.40456,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M,0.971375519072912
FREAC7_01,SET,173,0.016748,0.0016181,0.069335,0.40456,FREAC7_01,0.971375519072912
REACTOME_INCRETIN_SYNTHESIS_...,SET,23,0.044766,0.0015835,0.18536,0.40458,REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,0.971375519072912
GAVISH_3CA_METAPROGRAM_FIBRO...1,SET,47,0.032225,0.0016283,0.13343,0.40458,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1,0.971375519072912
GOBP_NON_CANONICAL_WNT_SIGNA...,SET,68,0.026785,0.001627,0.11096,0.40463,GOBP_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.971375519072912
MIR4786_3P,SET,149,0.017998,0.0016148,0.074592,0.40467,MIR4786_3P,0.971375519072912
MIR4687_3P,SET,76,0.024458,0.0015703,0.1014,0.4047,MIR4687_3P,0.971375519072912
HP_HYPNOPOMPIC_HALLUCINATION,SET,6,0.092181,0.0016661,0.38224,0.40472,HP_HYPNOPOMPIC_HALLUCINATION,0.971375519072912
GSE5589_IL6_KO_VS_IL10_KO_LP...9,SET,180,0.015066,0.0014844,0.062473,0.40472,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.971375519072912
KINSEY_TARGETS_OF_EWSR1_FLII...2,SET,1155,0.0060854,0.0014775,0.025244,0.40475,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP,0.971375519072912
GOBP_REGULATION_OF_MITOCHOND...12,SET,18,0.047789,0.0014956,0.19824,0.40475,GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.971375519072912
GOBP_NEPHRIC_DUCT_MORPHOGENE...,SET,10,0.076112,0.0017758,0.31581,0.40478,GOBP_NEPHRIC_DUCT_MORPHOGENESIS,0.971375519072912
GSE1925_CTRL_VS_3H_IFNG_STIM...3,SET,177,0.016172,0.0015802,0.067122,0.4048,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN,0.971375519072912
GOBP_ENDOTHELIAL_CELL_MORPHO...,SET,9,0.080403,0.0017797,0.33381,0.40483,GOBP_ENDOTHELIAL_CELL_MORPHOGENESIS,0.971375519072912
HP_OPPORTUNISTIC_BACTERIAL_I...,SET,22,0.046645,0.0016137,0.19372,0.40486,HP_OPPORTUNISTIC_BACTERIAL_INFECTION,0.971375519072912
MIR4251,SET,353,0.011398,0.0015651,0.047337,0.40487,MIR4251,0.971375519072912
GSE22886_NAIVE_TCELL_VS_DC_DN,SET,189,0.014984,0.0015124,0.062243,0.40488,GSE22886_NAIVE_TCELL_VS_DC_DN,0.971375519072912
WP_HEART_DEVELOPMENT,SET,42,0.035688,0.001705,0.14838,0.40497,WP_HEART_DEVELOPMENT,0.971375519072912
GOBP_SPLICEOSOMAL_COMPLEX_AS...,SET,68,0.021446,0.0013027,0.089172,0.40497,GOBP_SPLICEOSOMAL_COMPLEX_ASSEMBLY,0.971375519072912
HP_SMALL_FOR_GESTATIONAL_AGE,SET,226,0.013548,0.0014939,0.056332,0.40497,HP_SMALL_FOR_GESTATIONAL_AGE,0.971375519072912
HP_ARTERIOVENOUS_MALFORMATION,SET,53,0.027097,0.0014538,0.11269,0.40499,HP_ARTERIOVENOUS_MALFORMATION,0.971375519072912
GOBP_MICROTUBULE_BASED_PROCE...,SET,831,0.0070792,0.0014716,0.029449,0.40502,GOBP_MICROTUBULE_BASED_PROCESS,0.971375519072912
HP_HYPOCHLOREMIA,SET,6,0.097629,0.0017646,0.40626,0.40505,HP_HYPOCHLOREMIA,0.971375519072912
GOBP_ADRENAL_GLAND_DEVELOPME...,SET,26,0.045199,0.0016997,0.18817,0.40509,GOBP_ADRENAL_GLAND_DEVELOPMENT,0.971375519072912
GOBP_REGULATION_OF_CARDIAC_M...6,SET,25,0.042784,0.0015777,0.17817,0.40512,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.971375519072912
MIR3651,SET,18,0.051097,0.0015991,0.2129,0.40516,MIR3651,0.971375519072912
MODULE_95,SET,485,0.0096193,0.0015426,0.040079,0.40516,MODULE_95,0.971375519072912
MIR8086,SET,21,0.04657,0.0015741,0.19404,0.40517,MIR8086,0.971375519072912
GSE7852_LN_VS_THYMUS_TCONV_UP,SET,177,0.015897,0.0015533,0.066241,0.40517,GSE7852_LN_VS_THYMUS_TCONV_UP,0.971375519072912
GSE17721_POLYIC_VS_CPG_2H_BM...1,SET,182,0.01501,0.0014871,0.062554,0.40518,GSE17721_POLYIC_VS_CPG_2H_BMDC_DN,0.971375519072912
GOBP_PIRNA_MEDIATED_RETROTRA...,SET,5,0.079921,0.0013187,0.33329,0.40525,GOBP_PIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.971400692769008
GOBP_REGULATION_OF_BIOMINERA...,SET,89,0.023054,0.0016012,0.096157,0.40526,GOBP_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.971400692769008
GSE46468_LUNG_INNATE_LYMPHOI...2,SET,164,0.01481,0.0013934,0.061857,0.40539,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP,0.971400692769008
GOBP_NEGATIVE_REGULATION_OF_...9,SET,4,0.12002,0.0017714,0.50133,0.4054,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.971400692769008
GSE10239_MEMORY_VS_KLRG1HIGH...2,SET,180,0.015108,0.0014886,0.063108,0.4054,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.971400692769008
MARIADASON_RESPONSE_TO_BUTYR...4,SET,16,0.050577,0.0014924,0.21129,0.40541,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,0.971400692769008
REACTOME_EXTRINSIC_PATHWAY_O...,SET,4,0.1229,0.0018138,0.5134,0.40541,REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.971400692769008
HNF6_Q6,SET,217,0.014897,0.00161,0.062249,0.40543,HNF6_Q6,0.971400692769008
GSE1925_CTRL_VS_IFNG_PRIMED_...1,SET,183,0.015465,0.0015363,0.064643,0.40546,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN,0.971400692769008
HP_MELENA,SET,21,0.045655,0.0015432,0.19086,0.40547,HP_MELENA,0.971400692769008
GSE360_CTRL_VS_B_MALAYI_LOW_...4,SET,181,0.014998,0.0014818,0.062728,0.40552,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.971453515301902
GSE5589_LPS_VS_LPS_AND_IL6_S...3,SET,188,0.014873,0.0014973,0.062249,0.40558,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.971477721275426
REACTOME_CDC42_GTPASE_CYCLE,SET,142,0.017526,0.0015354,0.07341,0.40565,REACTOME_CDC42_GTPASE_CYCLE,0.971477721275426
GOBP_PROTEIN_UNFOLDING,SET,5,0.081941,0.001352,0.34319,0.40565,GOBP_PROTEIN_UNFOLDING,0.971477721275426
NIKOLSKY_BREAST_CANCER_8P12_...,SET,50,0.052932,0.0027585,0.22182,0.4057,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,0.971477721275426
MODULE_412,SET,13,0.063289,0.0016835,0.26526,0.40571,MODULE_412,0.971477721275426
YANG_BREAST_CANCER_ESR1_LASE...2,SET,27,0.037992,0.0014558,0.1593,0.40575,YANG_BREAST_CANCER_ESR1_LASER_UP,0.971477721275426
HP_ACUTE_OTITIS_MEDIA,SET,5,0.10129,0.0016713,0.42509,0.40583,HP_ACUTE_OTITIS_MEDIA,0.971477721275426
BLANCO_MELO_HUMAN_PARAINFLUE...1,SET,100,0.020956,0.0015424,0.087992,0.40588,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,0.971477721275426
KEGG_MEDICUS_REFERENCE_LONG_...,SET,17,0.04581,0.0013933,0.19247,0.40594,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER,0.971477721275426
BIOCARTA_CB1R_PATHWAY,SET,7,0.077583,0.0015146,0.3261,0.40598,BIOCARTA_CB1R_PATHWAY,0.971477721275426
HP_ABNORMAL_GALLBLADDER_PHYS...,SET,18,0.047355,0.001482,0.19906,0.40599,HP_ABNORMAL_GALLBLADDER_PHYSIOLOGY,0.971477721275426
GSE27786_LSK_VS_CD8_TCELL_DN,SET,182,0.014719,0.0014582,0.061874,0.40599,GSE27786_LSK_VS_CD8_TCELL_DN,0.971477721275426
MIR3944_5P,SET,103,0.019621,0.0014655,0.082502,0.40601,MIR3944_5P,0.971477721275426
DESCARTES_FETAL_PANCREAS_ISL...,SET,117,0.02117,0.0016846,0.08909,0.40609,DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS,0.971477721275426
GOBP_REGULATION_OF_MYELOID_C...1,SET,29,0.036582,0.0014527,0.15404,0.40614,GOBP_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.971477721275426
ERCC8_TARGET_GENES,SET,7,0.081219,0.0015856,0.34205,0.40615,ERCC8_TARGET_GENES,0.971477721275426
GOBP_MICROTUBULE_NUCLEATION,SET,41,0.028858,0.0013622,0.12152,0.40615,GOBP_MICROTUBULE_NUCLEATION,0.971477721275426
GSE17721_CTRL_VS_LPS_12H_BMD...1,SET,182,0.014812,0.0014674,0.062373,0.40615,GSE17721_CTRL_VS_LPS_12H_BMDC_DN,0.971477721275426
GOBP_RESPONSE_TO_MITOCHONDRI...,SET,16,0.051817,0.001529,0.21828,0.40618,GOBP_RESPONSE_TO_MITOCHONDRIAL_DEPOLARISATION,0.971477721275426
HP_RHABDOMYOMA,SET,5,0.10145,0.001674,0.42752,0.40621,HP_RHABDOMYOMA,0.971477721275426
GOBP_NEGATIVE_T_CELL_SELECTI...,SET,13,0.064257,0.0017092,0.2708,0.40622,GOBP_NEGATIVE_T_CELL_SELECTION,0.971477721275426
HP_UPPER_EXTREMITY_JOINT_DIS...,SET,81,0.022673,0.0015027,0.095568,0.40623,HP_UPPER_EXTREMITY_JOINT_DISLOCATION,0.971477721275426
GOBP_PROTEIN_LOCALIZATION_TO...15,SET,11,0.052049,0.0012736,0.2194,0.40624,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_MEMBRANE,0.971477721275426
HP_LYMPHADENITIS,SET,13,0.054248,0.001443,0.22891,0.40634,HP_LYMPHADENITIS,0.971477721275426
GSE9509_10MIN_VS_30MIN_LPS_S...2,SET,174,0.014973,0.0014507,0.063194,0.40635,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.971477721275426
BIOCARTA_CDK5_PATHWAY,SET,13,0.059864,0.0015924,0.25278,0.4064,BIOCARTA_CDK5_PATHWAY,0.971477721275426
chr2q37,SET,107,0.038008,0.0028931,0.16053,0.40642,chr2q37,0.971477721275426
REACTOME_INACTIVATION_OF_CSF...,SET,22,0.050851,0.0017592,0.21479,0.40643,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,0.971477721275426
HP_ABNORMAL_BLOOD_PHOSPHATE_...,SET,58,0.028323,0.0015894,0.11969,0.40647,HP_ABNORMAL_BLOOD_PHOSPHATE_CONCENTRATION,0.971477721275426
GOBP_METANEPHRIC_PROXIMAL_TU...,SET,5,0.099842,0.0016474,0.42206,0.4065,GOBP_METANEPHRIC_PROXIMAL_TUBULE_DEVELOPMENT,0.971477721275426
HP_UPPER_MOTOR_NEURON_DYSFUN...,SET,1034,0.0063557,0.0014652,0.026867,0.4065,HP_UPPER_MOTOR_NEURON_DYSFUNCTION,0.971477721275426
HP_VERY_LOW_VISUAL_ACUITY,SET,5,0.09808,0.0016183,0.41469,0.40652,HP_VERY_LOW_VISUAL_ACUITY,0.971477721275426
GOMF_TRAIL_BINDING,SET,5,0.1105,0.0018232,0.46727,0.40654,GOMF_TRAIL_BINDING,0.971477721275426
HP_HEMIATROPHY,SET,4,0.093422,0.0013788,0.39519,0.40656,HP_HEMIATROPHY,0.971477721275426
WP_FLUOROACETIC_ACID_TOXICITY,SET,6,0.063522,0.0011481,0.26872,0.40657,WP_FLUOROACETIC_ACID_TOXICITY,0.971477721275426
GOBP_DOPAMINE_BIOSYNTHETIC_P...,SET,12,0.0628,0.001605,0.26573,0.40659,GOBP_DOPAMINE_BIOSYNTHETIC_PROCESS,0.971477721275426
GOBP_REGULATION_OF_ORGANELLE...1,SET,231,0.012823,0.0014292,0.054259,0.40659,GOBP_REGULATION_OF_ORGANELLE_ASSEMBLY,0.971477721275426
MIR6862_5P,SET,44,0.032433,0.0015858,0.13727,0.40661,MIR6862_5P,0.971477721275426
GSE17974_CTRL_VS_ACT_IL4_AND...5,SET,176,0.014402,0.0014033,0.061013,0.4067,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN,0.971477721275426
SCHWAB_TARGETS_OF_BMYB_POLYM...2,SET,12,0.057117,0.0014597,0.242,0.40671,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,0.971477721275426
GOBP_GRANZYME_MEDIATED_PROGR...,SET,8,0.077947,0.0016267,0.33027,0.40671,GOBP_GRANZYME_MEDIATED_PROGRAMMED_CELL_DEATH_SIGNALING_PATHWAY,0.971477721275426
HP_PERSISTENT_OPEN_ANTERIOR_...,SET,7,0.067312,0.0013141,0.28524,0.40672,HP_PERSISTENT_OPEN_ANTERIOR_FONTANELLE,0.971477721275426
GOBP_RESPONSE_TO_ALCOHOL,SET,244,0.013599,0.0015572,0.057634,0.40674,GOBP_RESPONSE_TO_ALCOHOL,0.971477721275426
PID_IL4_2PATHWAY,SET,55,0.028522,0.0015587,0.12091,0.40676,PID_IL4_2PATHWAY,0.971477721275426
HP_WRIST_HYPERMOBILITY,SET,7,0.086036,0.0016796,0.36487,0.40679,HP_WRIST_HYPERMOBILITY,0.971482611832612
GOMF_PHOSPHATIDYLCHOLINE_FLI...,SET,5,0.094696,0.0015625,0.40205,0.4069,GOMF_PHOSPHATIDYLCHOLINE_FLIPPASE_ACTIVITY,0.971678541981586
JONES_OVARY_OOCYTE,SET,64,0.024884,0.0014666,0.10572,0.40696,JONES_OVARY_OOCYTE,0.971755053246307
ZNF502_TARGET_GENES,SET,25,0.038072,0.0014039,0.16189,0.40704,ZNF502_TARGET_GENES,0.971812543793364
GSE3982_BASOPHIL_VS_TH2_DN,SET,179,0.014828,0.0014569,0.063054,0.40704,GSE3982_BASOPHIL_VS_TH2_DN,0.971812543793364
ZNF680_TARGET_GENES,SET,614,0.0080126,0.0014406,0.034096,0.4071,ZNF680_TARGET_GENES,0.97188903008655
REACTOME_INTERACTIONS_OF_VPR...,SET,33,0.03235,0.0013703,0.13772,0.40715,REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,0.97189875
HP_UNCONJUGATED_HYPERBILIRUB...,SET,11,0.05585,0.0013666,0.23779,0.40716,HP_UNCONJUGATED_HYPERBILIRUBINEMIA,0.97189875
GAVISH_3CA_METAPROGRAM_MACRO...1,SET,41,0.032302,0.0015248,0.13763,0.40722,GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE,0.971942045454545
HP_MALE_REPRODUCTIVE_SYSTEM_...,SET,59,0.027092,0.0015333,0.11546,0.40725,HP_MALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.971942045454545
GOBP_REGULATION_OF_LIPID_TRA...1,SET,122,0.018645,0.0015148,0.079495,0.40728,GOBP_REGULATION_OF_LIPID_TRANSPORT,0.971942045454545
GOCC_CYTOSOLIC_SMALL_RIBOSOM...,SET,35,0.032453,0.0014156,0.13837,0.40729,GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT,0.971942045454545
KEGG_MEDICUS_VARIANT_AMPLIFI...8,SET,12,0.054331,0.0013886,0.23175,0.40733,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S,0.971961460049423
GOBP_GLYCINE_IMPORT_ACROSS_P...,SET,5,0.1047,0.0017276,0.44676,0.40736,GOBP_GLYCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.971961460049423
ATCATGA_MIR433,SET,107,0.019079,0.0014523,0.081444,0.40739,ATCATGA_MIR433,0.971961460049423
GOBP_POSITIVE_REGULATION_OF_...471,SET,6,0.080355,0.0014524,0.34308,0.40741,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,0.971961460049423
HP_ENLARGED_CISTERNA_MAGNA,SET,52,0.025476,0.0013539,0.10886,0.40748,HP_ENLARGED_CISTERNA_MAGNA,0.972061733818381
HP_ABNORMAL_FEMORAL_HEAD_MOR...,SET,87,0.02177,0.0014951,0.09305,0.40751,HP_ABNORMAL_FEMORAL_HEAD_MORPHOLOGY,0.972066578586136
GOBP_HOMEOSTASIS_OF_NUMBER_O...2,SET,33,0.036515,0.0015467,0.15613,0.40754,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE,0.972071422688903
HP_CHRONIC_AXONAL_NEUROPATHY,SET,7,0.08282,0.0016168,0.35424,0.40757,HP_CHRONIC_AXONAL_NEUROPATHY,0.972076266126819
GOBP_MULTIVESICULAR_BODY_SOR...,SET,45,0.028067,0.0013878,0.1201,0.40761,GOBP_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.972104957798669
GSE32986_UNSTIM_VS_CURDLAN_L...2,SET,190,0.013891,0.0014058,0.059478,0.40767,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP,0.97210531280011
MIR6758_3P,SET,99,0.020626,0.0015105,0.088324,0.40768,MIR6758_3P,0.97210531280011
GOCC_SECRETORY_GRANULE,SET,826,0.0072576,0.0015044,0.031087,0.4077,GOCC_SECRETORY_GRANULE,0.97210531280011
GSE17721_LPS_VS_PAM3CSK4_8H_...1,SET,181,0.014201,0.0014031,0.060846,0.40773,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN,0.97210531280011
NFKBIA_TARGET_GENES,SET,964,0.0066482,0.0014829,0.028491,0.40775,NFKBIA_TARGET_GENES,0.97210531280011
PTPRA_TARGET_GENES,SET,94,0.020603,0.0014704,0.088385,0.40784,PTPRA_TARGET_GENES,0.972253186089581
GOBP_POSITIVE_REGULATION_OF_...235,SET,9,0.058045,0.0012848,0.24914,0.40789,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.972286677868459
KEGG_MEDICUS_REFERENCE_COPII...,SET,12,0.052875,0.0013513,0.22701,0.40791,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION,0.972286677868459
MIR6870_5P,SET,199,0.013965,0.001446,0.05998,0.40795,MIR6870_5P,0.972315337402277
GSE43863_NAIVE_VS_MEMORY_TFH...1,SET,183,0.014525,0.0014429,0.062487,0.4081,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN,0.972410924110509
SUNG_METASTASIS_STROMA_DN,SET,51,0.028187,0.0014835,0.12129,0.40812,SUNG_METASTASIS_STROMA_DN,0.972410924110509
TTTGTAG_MIR520D,SET,310,0.011746,0.0015133,0.050541,0.40812,TTTGTAG_MIR520D,0.972410924110509
GSE14769_UNSTIM_VS_40MIN_LPS...1,SET,189,0.015117,0.0015259,0.065053,0.40812,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN,0.972410924110509
HP_CONSPICUOUSLY_HAPPY_DISPO...,SET,5,0.11711,0.0019323,0.50397,0.40813,HP_CONSPICUOUSLY_HAPPY_DISPOSITION,0.972410924110509
GSE11057_NAIVE_VS_MEMORY_CD4...2,SET,158,0.016641,0.0015371,0.071746,0.40829,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP,0.972630333036387
GSE36888_UNTREATED_VS_IL2_TR...9,SET,162,0.015933,0.00149,0.068709,0.40831,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN,0.972630333036387
GSE18281_CORTEX_VS_MEDULLA_T...1,SET,158,0.01606,0.0014834,0.069272,0.40833,GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN,0.972630333036387
HP_CEREBRAL_CORTICAL_ATROPHY,SET,276,0.011818,0.001438,0.050984,0.40835,HP_CEREBRAL_CORTICAL_ATROPHY,0.972630333036387
GOMF_PHOSPHATIDYLINOSITOL_4_...1,SET,9,0.054727,0.0012114,0.23621,0.40839,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.972630333036387
GOMF_PHOSPHATIDYLINOSITOL_4_...3,SET,9,0.054727,0.0012114,0.23621,0.40839,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.972630333036387
GSE26343_WT_VS_NFAT5_KO_MACR...3,SET,189,0.014414,0.0014549,0.062246,0.40844,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP,0.972644724582077
BANG_VERTEPORFIN_ENDOMETRIAL...2,SET,16,0.049669,0.0014656,0.21457,0.40847,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP,0.972644724582077
GOCC_CYTOPLASMIC_SIDE_OF_ROU...,SET,4,0.083966,0.0012392,0.36276,0.40848,GOCC_CYTOPLASMIC_SIDE_OF_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.972644724582077
GOBP_REGULATION_OF_RESPONSE_...2,SET,158,0.015612,0.001442,0.0675,0.40855,GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.972682916638126
GOBP_NEGATIVE_REGULATION_OF_...212,SET,120,0.01934,0.0015585,0.083638,0.40857,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.972682916638126
HP_PERIVENTRICULAR_CYSTS,SET,12,0.059567,0.0015224,0.25763,0.40858,HP_PERIVENTRICULAR_CYSTS,0.972682916638126
GSE360_L_DONOVANI_VS_M_TUBER...2,SET,177,0.014843,0.0014503,0.064295,0.40872,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP,0.972906728991165
GOBP_PROTEIN_CONTAINING_COMP...4,SET,34,0.03631,0.0015611,0.15731,0.40873,GOBP_PROTEIN_CONTAINING_COMPLEX_REMODELING,0.972906728991165
GOBP_POSTREPLICATION_REPAIR,SET,32,0.029217,0.0012187,0.12664,0.40877,GOBP_POSTREPLICATION_REPAIR,0.972911583487369
HP_NEONATAL_RESPIRATORY_DIST...,SET,136,0.016632,0.0014261,0.072123,0.40881,HP_NEONATAL_RESPIRATORY_DISTRESS,0.972911583487369
GOBP_REGULATION_OF_T_CELL_AC...2,SET,6,0.077184,0.0013951,0.33483,0.40885,GOBP_REGULATION_OF_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.972911583487369
GOBP_POSITIVE_REGULATION_OF_...292,SET,7,0.083765,0.0016353,0.36348,0.40887,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.972911583487369
YAMAZAKI_TCEB3_TARGETS_UP,SET,155,0.016555,0.0015146,0.071851,0.40889,YAMAZAKI_TCEB3_TARGETS_UP,0.972911583487369
GOBP_REGULATION_OF_PRE_MIRNA...,SET,5,0.085076,0.0014038,0.36927,0.4089,GOBP_REGULATION_OF_PRE_MIRNA_PROCESSING,0.972911583487369
BIOCARTA_AKAPCENTROSOME_PATH...,SET,14,0.050928,0.0014058,0.22117,0.40894,BIOCARTA_AKAPCENTROSOME_PATHWAY,0.972916433997126
MIR4733_3P,SET,66,0.023434,0.0014025,0.1018,0.40898,MIR4733_3P,0.972916433997126
GSE4984_LPS_VS_VEHICLE_CTRL_...2,SET,168,0.01497,0.0014254,0.065058,0.40901,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP,0.972916433997126
MORF_ACTG1,SET,126,0.017064,0.0014088,0.074185,0.40904,MORF_ACTG1,0.972916433997126
HP_POIKILOCYTOSIS,SET,49,0.028072,0.0014483,0.12205,0.40905,HP_POIKILOCYTOSIS,0.972916433997126
GOBP_RETINA_HOMEOSTASIS,SET,53,0.02852,0.0015301,0.12403,0.40907,GOBP_RETINA_HOMEOSTASIS,0.972916433997126
GOMF_LIPOPROTEIN_PARTICLE_RE...2,SET,27,0.037769,0.0014473,0.16437,0.40913,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.972992551662789
HE_LIM_SUN_FETAL_LUNG_C7_MFN...,SET,17,0.049505,0.0015057,0.21554,0.40917,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.973021098186794
MIR7_5P,SET,241,0.012908,0.0014691,0.056219,0.4092,MIR7_5P,0.973025862068965
HP_ABNORMAL_JOINT_MORPHOLOGY,SET,1067,0.0061356,0.0014355,0.026736,0.40925,HP_ABNORMAL_JOINT_MORPHOLOGY,0.973040149805048
GRAHAM_CML_DIVIDING_VS_NORMA...1,SET,9,0.078642,0.0017407,0.34284,0.40929,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN,0.973040149805048
MIR499B_5P,SET,86,0.021469,0.0014659,0.093601,0.40929,MIR499B_5P,0.973040149805048
GOBP_REGULATION_OF_HOMOPHILI...,SET,5,0.091824,0.0015151,0.40066,0.40937,GOBP_REGULATION_OF_HOMOPHILIC_CELL_ADHESION,0.973163772229822
GSE40666_UNTREATED_VS_IFNA_S...4,SET,185,0.015148,0.0015128,0.066176,0.40948,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP,0.973358689556118
chr11q14,SET,48,0.054167,0.002766,0.23681,0.40954,chr11q14,0.973391933939684
GOBP_CYTOKINE_PRODUCTION_INV...1,SET,115,0.019671,0.001552,0.086015,0.40955,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.973391933939684
MIKI_COEXPRESSED_WITH_CYP19A1,SET,7,0.072347,0.0014124,0.31651,0.4096,MIKI_COEXPRESSED_WITH_CYP19A1,0.973401405128205
HP_IRREGULAR_HYPERPIGMENTATI...,SET,211,0.012918,0.0013768,0.056518,0.40961,HP_IRREGULAR_HYPERPIGMENTATION,0.973401405128205
SIG_CD40PATHWAYMAP,SET,33,0.034631,0.0014669,0.15158,0.40964,SIG_CD40PATHWAYMAP,0.973406139751128
MEISSNER_BRAIN_HCP_WITH_H3K2...,SET,251,0.013681,0.0015887,0.059902,0.40967,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,0.97341087372667
GSE39820_TGFBETA3_IL6_VS_TGF...2,SET,181,0.014332,0.001416,0.062822,0.40977,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP,0.973448616803279
GOBP_CELL_PROLIFERATION_INVO...1,SET,17,0.05289,0.0016086,0.23192,0.40981,GOBP_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.973448616803279
GOBP_MEMBRANOUS_SEPTUM_MORPH...,SET,6,0.096884,0.0017511,0.42486,0.40981,GOBP_MEMBRANOUS_SEPTUM_MORPHOGENESIS,0.973448616803279
GOBP_CELLULAR_DEFENSE_RESPON...,SET,47,0.029583,0.0014948,0.1298,0.40986,GOBP_CELLULAR_DEFENSE_RESPONSE,0.973448616803279
REACTOME_BUTYRATE_RESPONSE_F...,SET,16,0.046475,0.0013714,0.20395,0.40987,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,0.973448616803279
NAM_FXYD5_TARGETS_DN,SET,17,0.044218,0.0013449,0.19406,0.40988,NAM_FXYD5_TARGETS_DN,0.973448616803279
GOCC_U7_SNRNP,SET,7,0.075095,0.001466,0.32967,0.40991,GOCC_U7_SNRNP,0.973448616803279
HP_RENAL_SALT_WASTING,SET,20,0.04701,0.0015507,0.20652,0.40997,HP_RENAL_SALT_WASTING,0.973448616803279
chr19p12,SET,29,0.058047,0.0023052,0.25505,0.40998,chr19p12,0.973448616803279
REACTOME_TRANSLESION_SYNTHES...3,SET,36,0.02865,0.0012674,0.12589,0.40999,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,0.973448616803279
HOFFMANN_SMALL_PRE_BII_TO_IM...1,SET,35,0.032581,0.0014212,0.14324,0.41003,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,0.973448616803279
MEBARKI_HCC_PROGENITOR_FZD8C...2,SET,477,0.0087461,0.0013913,0.038458,0.41005,MEBARKI_HCC_PROGENITOR_FZD8CRD_UP,0.973448616803279
HP_PROXIMAL_MUSCLE_WEAKNESS,SET,219,0.013237,0.001437,0.058206,0.41005,HP_PROXIMAL_MUSCLE_WEAKNESS,0.973448616803279
TGTATGA_MIR4853P,SET,145,0.016522,0.0014624,0.072684,0.41009,TGTATGA_MIR4853P,0.973477081483505
MIR3176,SET,67,0.022556,0.0013601,0.099339,0.41019,MIR3176,0.973647961344079
MIR511_5P,SET,291,0.011423,0.0014266,0.050417,0.41038,MIR511_5P,0.973951566980746
HP_SMALL_INTESTINAL_STENOSIS,SET,27,0.033266,0.0012748,0.14682,0.41038,HP_SMALL_INTESTINAL_STENOSIS,0.973951566980746
HP_SUBCORTICAL_HETEROTOPIA,SET,11,0.052966,0.0012961,0.23388,0.41042,HP_SUBCORTICAL_HETEROTOPIA,0.973951566980746
CHANDRAN_METASTASIS_TOP50_UP,SET,29,0.033223,0.0013194,0.14671,0.41043,CHANDRAN_METASTASIS_TOP50_UP,0.973951566980746
HP_DIFFUSE_ALVEOLAR_HEMORRHA...,SET,16,0.050814,0.0014994,0.2245,0.41047,HP_DIFFUSE_ALVEOLAR_HEMORRHAGE,0.973979985662593
KEGG_MEDICUS_REFERENCE_NLRC4...,SET,4,0.074278,0.0010962,0.32895,0.41068,KEGG_MEDICUS_REFERENCE_NLRC4_INFLAMMASOME_SIGNALING_PATHWAY,0.974163390361938
GOMF_NUCLEAR_RETINOIC_ACID_R...,SET,24,0.038148,0.0013784,0.169,0.41071,GOMF_NUCLEAR_RETINOIC_ACID_RECEPTOR_BINDING,0.974163390361938
RP58_01,SET,191,0.014541,0.0014754,0.06447,0.41078,RP58_01,0.974163390361938
REACTOME_TRANSLESION_SYNTHES...1,SET,17,0.041812,0.0012717,0.18541,0.41079,REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,0.974163390361938
HP_LENTICONUS,SET,8,0.070774,0.001477,0.31386,0.4108,HP_LENTICONUS,0.974163390361938
HP_PREGNANCY_EXPOSURE,SET,5,0.084857,0.0014002,0.37636,0.41081,HP_PREGNANCY_EXPOSURE,0.974163390361938
GOBP_REGULATION_OF_JNK_CASCA...,SET,131,0.016912,0.0014234,0.07506,0.41087,GOBP_REGULATION_OF_JNK_CASCADE,0.974163390361938
GSE14308_TH1_VS_NAIVE_CD4_TC...2,SET,178,0.014004,0.0013722,0.062184,0.41091,GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP,0.974163390361938
GSE19888_CTRL_VS_A3R_ACTIVAT...1,SET,171,0.015023,0.001443,0.066714,0.41092,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN,0.974163390361938
WP_INFLAMMATORY_BOWEL_DISEAS...,SET,41,0.032477,0.001533,0.14427,0.41095,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,0.974163390361938
MIR371A_5P,SET,159,0.015231,0.0014113,0.06768,0.41097,MIR371A_5P,0.974163390361938
GSE3720_LPS_VS_PMA_STIM_VD1_...2,SET,124,0.017078,0.0013988,0.075883,0.41097,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.974163390361938
GOBP_PLASMA_MEMBRANE_ORGANIZ...,SET,149,0.016055,0.0014405,0.07135,0.41098,GOBP_PLASMA_MEMBRANE_ORGANIZATION,0.974163390361938
MIR6855_5P,SET,60,0.02447,0.0013965,0.10875,0.41099,MIR6855_5P,0.974163390361938
HP_VEGETATIVE_STATE,SET,9,0.061872,0.0013695,0.27502,0.411,HP_VEGETATIVE_STATE,0.974163390361938
WP_SYNAPTIC_SIGNALING_ASSOCI...,SET,50,0.02773,0.0014451,0.12331,0.41104,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,0.974163390361938
MODULE_478,SET,18,0.045324,0.0014185,0.20155,0.41104,MODULE_478,0.974163390361938
GAVISH_3CA_METAPROGRAM_CD4_T...2,SET,44,0.033034,0.0016152,0.14697,0.41108,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CYTOTOXIC,0.974163390361938
GSE17721_PAM3CSK4_VS_GADIQUI...5,SET,180,0.013903,0.0013699,0.061856,0.41108,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN,0.974163390361938
HP_ABNORMAL_EATING_BEHAVIOR,SET,114,0.019081,0.0014989,0.084986,0.41118,HP_ABNORMAL_EATING_BEHAVIOR,0.974163390361938
GSE21546_WT_VS_SAP1A_KO_ANTI...1,SET,183,0.014008,0.0013915,0.062389,0.41118,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.974163390361938
GOBP_TETRAPYRROLE_BIOSYNTHET...,SET,29,0.033518,0.0013311,0.14931,0.41119,GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS,0.974163390361938
GOBP_PLASMA_MEMBRANE_REPAIR,SET,27,0.036656,0.0014046,0.1633,0.4112,GOBP_PLASMA_MEMBRANE_REPAIR,0.974163390361938
HP_ASYMMETRIC_SEPTAL_HYPERTR...,SET,13,0.057437,0.0015278,0.25595,0.41122,HP_ASYMMETRIC_SEPTAL_HYPERTROPHY,0.974163390361938
GOBP_REGULATION_OF_PHOSPHORY...,SET,888,0.0067187,0.0014414,0.029997,0.41139,GOBP_REGULATION_OF_PHOSPHORYLATION,0.974241907062185
GAO_SMALL_INTESTINE_24W_C6_G...,SET,40,0.029648,0.0013823,0.13242,0.41142,GAO_SMALL_INTESTINE_24W_C6_GOBLET_CELLS,0.974241907062185
HP_ELEVATED_ALKALINE_PHOSPHA...,SET,13,0.055539,0.0014773,0.2481,0.41144,HP_ELEVATED_ALKALINE_PHOSPHATASE_OF_BONE_ORIGIN,0.974241907062185
BLANCO_MELO_COVID19_SARS_COV...3,SET,370,0.010103,0.0014196,0.045141,0.41146,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,0.974241907062185
GOBP_POSITIVE_REGULATION_OF_...89,SET,8,0.063195,0.0013189,0.28239,0.41146,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.974241907062185
GSE3982_EOSINOPHIL_VS_BASOPH...2,SET,172,0.014677,0.0014139,0.065589,0.41147,GSE3982_EOSINOPHIL_VS_BASOPHIL_UP,0.974241907062185
GOBP_REGULATION_OF_INNER_EAR...,SET,8,0.071227,0.0014865,0.31842,0.4115,GOBP_REGULATION_OF_INNER_EAR_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION,0.974241907062185
BILANGES_SERUM_AND_RAPAMYCIN...,SET,60,0.023529,0.0013429,0.1052,0.41151,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,0.974241907062185
MIR1183,SET,112,0.018286,0.0014238,0.081805,0.41156,MIR1183,0.974241907062185
HP_ABNORMAL_B_CELL_MORPHOLOGY,SET,90,0.020456,0.0014287,0.09152,0.41157,HP_ABNORMAL_B_CELL_MORPHOLOGY,0.974241907062185
MIR300,SET,406,0.0097292,0.0014307,0.043578,0.41167,MIR300,0.974241907062185
PALOMERO_GSI_SENSITIVITY_DN,SET,3,0.11724,0.0014985,0.52519,0.41168,PALOMERO_GSI_SENSITIVITY_DN,0.974241907062185
GSE29949_MICROGLIA_BRAIN_VS_...4,SET,180,0.014575,0.0014361,0.0653,0.41169,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.974241907062185
GSE360_CTRL_VS_L_DONOVANI_MA...2,SET,183,0.013781,0.001369,0.061739,0.41169,GSE360_CTRL_VS_L_DONOVANI_MAC_UP,0.974241907062185
HP_PARTIAL_DUPLICATION_OF_TH...2,SET,38,0.029184,0.0013263,0.13084,0.41175,HP_PARTIAL_DUPLICATION_OF_THE_PHALANX_OF_HAND,0.974241907062185
GSE40666_UNTREATED_VS_IFNA_S...8,SET,188,0.014152,0.0014247,0.063445,0.41175,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP,0.974241907062185
PITX2_Q2,SET,235,0.013072,0.0014694,0.05861,0.41176,PITX2_Q2,0.974241907062185
GNF2_PRDX2,SET,27,0.037636,0.0014422,0.1688,0.41179,GNF2_PRDX2,0.974241907062185
GOBP_REGULATION_OF_ENDOSOME_...2,SET,9,0.065762,0.0014556,0.29524,0.41187,GOBP_REGULATION_OF_ENDOSOME_SIZE,0.974241907062185
MIR454_5P,SET,21,0.041613,0.0014065,0.18697,0.41194,MIR454_5P,0.974241907062185
MIR6742_3P,SET,94,0.019204,0.0013706,0.086287,0.41194,MIR6742_3P,0.974241907062185
HP_KINKED_BRAINSTEM,SET,4,0.086921,0.0012828,0.39057,0.41194,HP_KINKED_BRAINSTEM,0.974241907062185
HP_MENINGOENCEPHALOCELE,SET,4,0.086921,0.0012828,0.39057,0.41194,HP_MENINGOENCEPHALOCELE,0.974241907062185
GOBP_COLLAGEN_BIOSYNTHETIC_P...,SET,39,0.033589,0.0015464,0.15095,0.41196,GOBP_COLLAGEN_BIOSYNTHETIC_PROCESS,0.974241907062185
HP_MOTOR_STEREOTYPY,SET,224,0.012535,0.0013761,0.056342,0.41197,HP_MOTOR_STEREOTYPY,0.974241907062185
GSE41867_DAY6_EFFECTOR_VS_DA...4,SET,183,0.014111,0.0014017,0.063444,0.412,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.974241907062185
GOBP_INDOLALKYLAMINE_METABOL...,SET,11,0.064164,0.0015701,0.28854,0.41201,GOBP_INDOLALKYLAMINE_METABOLIC_PROCESS,0.974241907062185
GOBP_BIOLOGICAL_PROCESS_INVO...3,SET,1525,0.0052752,0.0014558,0.023743,0.41209,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS,0.974288808406448
GOBP_REGULATION_OF_MICROGLIA...,SET,17,0.048764,0.0014832,0.21962,0.41214,GOBP_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.974288808406448
GOBP_VENTRICULAR_CARDIAC_MUS...1,SET,33,0.036885,0.0015624,0.16613,0.41215,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.974288808406448
GOBP_RESOLUTION_OF_DNA_RECOM...,SET,6,0.067913,0.0012275,0.30592,0.41216,GOBP_RESOLUTION_OF_DNA_RECOMBINATION_INTERMEDIATES,0.974288808406448
HP_DISTAL_PERIPHERAL_SENSORY...,SET,6,0.079717,0.0014408,0.35912,0.41217,HP_DISTAL_PERIPHERAL_SENSORY_NEUROPATHY,0.974288808406448
WP_QUERCETIN_AND_NFKB_AP1_IN...,SET,15,0.052873,0.0015107,0.23834,0.41222,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.974340730413493
GOBP_ENDODERM_FORMATION,SET,56,0.026952,0.0014862,0.12162,0.41231,GOBP_ENDODERM_FORMATION,0.974481255924171
GOBP_RESPONSE_TO_CARBOHYDRATE,SET,212,0.01315,0.0014049,0.059418,0.41242,GOBP_RESPONSE_TO_CARBOHYDRATE,0.974481255924171
ZHANG_PROLIFERATING_VS_QUIES...,SET,45,0.02876,0.0014221,0.13003,0.41247,ZHANG_PROLIFERATING_VS_QUIESCENT,0.974481255924171
GOBP_MANGANESE_ION_TRANSPORT,SET,11,0.05681,0.0013901,0.25687,0.41248,GOBP_MANGANESE_ION_TRANSPORT,0.974481255924171
GOBP_L_ASPARTATE_TRANSMEMBRA...,SET,11,0.056801,0.0013899,0.25684,0.41249,GOBP_L_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.974481255924171
GOCC_BRISC_COMPLEX,SET,3,0.1097,0.0014021,0.49617,0.41251,GOCC_BRISC_COMPLEX,0.974481255924171
GOBP_DNA_TEMPLATED_TRANSCRIP...2,SET,175,0.013702,0.0013313,0.062013,0.41257,GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.974481255924171
MIR3194_5P,SET,71,0.021546,0.0013373,0.097634,0.41267,MIR3194_5P,0.974481255924171
GOBP_NEGATIVE_REGULATION_OF_...663,SET,56,0.026682,0.0014713,0.12096,0.41271,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.974481255924171
chr10p15,SET,30,0.054732,0.0022106,0.24818,0.41273,chr10p15,0.974481255924171
HP_CHYLOTHORAX,SET,16,0.045251,0.0013353,0.20522,0.41274,HP_CHYLOTHORAX,0.974481255924171
GOBP_NUCLEOBASE_CONTAINING_S...2,SET,28,0.040632,0.0015855,0.18429,0.41275,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS,0.974481255924171
GSE33425_CD8_ALPHAALPHA_VS_A...1,SET,183,0.013574,0.0013484,0.061572,0.41276,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,0.974481255924171
GOBP_LIPOXYGENASE_PATHWAY,SET,11,0.06509,0.0015927,0.2955,0.41283,GOBP_LIPOXYGENASE_PATHWAY,0.974481255924171
CAIRO_HEPATOBLASTOMA_CLASSES...1,SET,194,0.013952,0.0014266,0.063365,0.41286,CAIRO_HEPATOBLASTOMA_CLASSES_DN,0.974481255924171
GSE28726_NAIVE_CD4_TCELL_VS_...3,SET,173,0.014519,0.0014027,0.065937,0.41286,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN,0.974481255924171
HP_ANISOCYTOSIS,SET,17,0.048238,0.0014671,0.21909,0.41287,HP_ANISOCYTOSIS,0.974481255924171
GOBP_REGULATION_OF_GLIAL_CEL...3,SET,18,0.045579,0.0014264,0.20703,0.41288,GOBP_REGULATION_OF_GLIAL_CELL_MIGRATION,0.974481255924171
REACTOME_FORMATION_OF_THE_AN...,SET,9,0.069219,0.0015321,0.31449,0.4129,REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE,0.974481255924171
HP_CONGENITAL_POSTERIOR_URET...,SET,8,0.063983,0.0013353,0.29073,0.41291,HP_CONGENITAL_POSTERIOR_URETHRAL_VALVE,0.974481255924171
REACTOME_PROCESSING_OF_CAPPE...1,SET,28,0.031618,0.0012338,0.14378,0.41298,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,0.974481255924171
MIR6895_3P,SET,85,0.021008,0.0014261,0.095549,0.41299,MIR6895_3P,0.974481255924171
RICKMAN_HEAD_AND_NECK_CANCER...2,SET,33,0.035487,0.0015031,0.16144,0.41301,RICKMAN_HEAD_AND_NECK_CANCER_B,0.974481255924171
GOBP_REGULATION_OF_LEUKOCYTE...6,SET,308,0.011162,0.0014335,0.050788,0.41303,GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,0.974481255924171
GOMF_PROTEIN_LYSINE_DEACETYL...,SET,21,0.039622,0.0013392,0.1803,0.41303,GOMF_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.974481255924171
MIR3661,SET,62,0.024387,0.0014148,0.11104,0.41308,MIR3661,0.974481255924171
GOBP_REGULATION_OF_APOPTOTIC...2,SET,9,0.065078,0.0014405,0.29633,0.41309,GOBP_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION,0.974481255924171
GOBP_POSITIVE_REGULATION_OF_...278,SET,5,0.088881,0.0014665,0.40518,0.41319,GOBP_POSITIVE_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.974481255924171
MIR3177_3P,SET,8,0.074807,0.0015612,0.34108,0.4132,MIR3177_3P,0.974481255924171
KEGG_HYPERTROPHIC_CARDIOMYOP...,SET,79,0.02247,0.0014708,0.10249,0.41323,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,0.974481255924171
HP_CHRONIC_DIARRHEA,SET,93,0.019287,0.0013692,0.087967,0.41323,HP_CHRONIC_DIARRHEA,0.974481255924171
GSE25088_WT_VS_STAT6_KO_MACR...7,SET,167,0.013428,0.0012748,0.061316,0.41333,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,0.974481255924171
GOBP_REGULATION_OF_SNARE_COM...,SET,13,0.049579,0.0013188,0.22642,0.41334,GOBP_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY,0.974481255924171
GOBP_REGULATION_OF_THYROID_H...,SET,7,0.072091,0.0014074,0.32924,0.41334,GOBP_REGULATION_OF_THYROID_HORMONE_GENERATION,0.974481255924171
MIR5195_5P,SET,18,0.04395,0.0013755,0.20085,0.4134,MIR5195_5P,0.974481255924171
MOOTHA_FFA_OXYDATION,SET,22,0.039103,0.0013528,0.17872,0.41341,MOOTHA_FFA_OXYDATION,0.974481255924171
CCAGGGG_MIR331,SET,83,0.01919,0.0012873,0.087711,0.41341,CCAGGGG_MIR331,0.974481255924171
KEGG_MEDICUS_REFERENCE_CENPE...,SET,12,0.051231,0.0013093,0.23417,0.41342,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX,0.974481255924171
GSE21063_CTRL_VS_ANTI_IGM_ST...12,SET,173,0.014225,0.0013743,0.065038,0.41344,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP,0.974481255924171
BARRIER_CANCER_RELAPSE_TUMOR...2,SET,15,0.047209,0.0013488,0.21621,0.41358,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,0.974481255924171
CAMP_UP.V1_DN,SET,178,0.014172,0.0013886,0.064929,0.41361,CAMP_UP.V1_DN,0.974481255924171
GOBP_POSITIVE_REGULATION_OF_...360,SET,11,0.055433,0.0013564,0.254,0.41362,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.974481255924171
GOMF_ORGANIC_CATION_TRANSMEM...,SET,75,0.023051,0.0014702,0.10563,0.41363,GOMF_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.974481255924171
GAJATE_RESPONSE_TO_TRABECTED...1,SET,16,0.051598,0.0015225,0.23654,0.41366,GAJATE_RESPONSE_TO_TRABECTEDIN_DN,0.974481255924171
MIR1295B_3P,SET,18,0.050293,0.001574,0.23056,0.41366,MIR1295B_3P,0.974481255924171
GSE26488_WT_VS_HDAC7_KO_DOUB...2,SET,159,0.014806,0.0013718,0.067893,0.41369,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.974481255924171
HP_RETICULATED_SKIN_PIGMENTA...,SET,5,0.08122,0.0013401,0.37249,0.4137,HP_RETICULATED_SKIN_PIGMENTATION,0.974481255924171
HP_PECTUS_EXCAVATUM,SET,263,0.011389,0.0013533,0.052247,0.41373,HP_PECTUS_EXCAVATUM,0.974481255924171
GOBP_VENTRICULAR_COMPACT_MYO...,SET,7,0.078586,0.0015342,0.36063,0.41375,GOBP_VENTRICULAR_COMPACT_MYOCARDIUM_MORPHOGENESIS,0.974481255924171
GOBP_LYSOSOMAL_LUMEN_ACIDIFI...,SET,20,0.040739,0.0013438,0.18699,0.41377,GOBP_LYSOSOMAL_LUMEN_ACIDIFICATION,0.974481255924171
GOBP_SUPPRESSION_OF_VIRAL_RE...,SET,14,0.053114,0.0014661,0.244,0.41384,GOBP_SUPPRESSION_OF_VIRAL_RELEASE_BY_HOST,0.974481255924171
REACTOME_LECTIN_PATHWAY_OF_C...,SET,8,0.07523,0.00157,0.34563,0.41385,REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION,0.974481255924171
MODULE_438,SET,64,0.024076,0.001419,0.11063,0.41386,MODULE_438,0.974481255924171
GOBP_RESPONSE_TO_PHEROMONE,SET,6,0.073039,0.0013201,0.33572,0.41389,GOBP_RESPONSE_TO_PHEROMONE,0.974481255924171
KEGG_MEDICUS_REFERENCE_PDL_P...,SET,8,0.068092,0.0014211,0.31308,0.41391,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY,0.974481255924171
HP_TENDON_RUPTURE,SET,5,0.085157,0.0014051,0.39152,0.41391,HP_TENDON_RUPTURE,0.974481255924171
GOBP_PANCREATIC_JUICE_SECRET...,SET,11,0.05356,0.0013106,0.24635,0.41394,GOBP_PANCREATIC_JUICE_SECRETION,0.974481255924171
WORSCHECH_TUMOR_REJECTION_UP,SET,58,0.025623,0.0014379,0.11787,0.41396,WORSCHECH_TUMOR_REJECTION_UP,0.974481255924171
BIOCARTA_CARDIACEGF_PATHWAY,SET,17,0.049899,0.0015177,0.22955,0.41396,BIOCARTA_CARDIACEGF_PATHWAY,0.974481255924171
MIR4685_3P,SET,117,0.017244,0.0013722,0.079411,0.41405,MIR4685_3P,0.974481255924171
REACTOME_APOPTOTIC_CLEAVAGE_...2,SET,11,0.063212,0.0015468,0.29117,0.41407,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS,0.974481255924171
GSE39820_TGFBETA3_IL6_VS_TGF...1,SET,179,0.013343,0.0013111,0.061464,0.41407,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN,0.974481255924171
GUILLAUMOND_KLF10_TARGETS_UP,SET,48,0.027449,0.0014017,0.12646,0.41408,GUILLAUMOND_KLF10_TARGETS_UP,0.974481255924171
GOBP_REGULATION_OF_APPETITE,SET,20,0.045001,0.0014845,0.20733,0.41408,GOBP_REGULATION_OF_APPETITE,0.974481255924171
WP_TUMOR_SUPPRESSOR_ACTIVITY...,SET,29,0.034604,0.0013742,0.15951,0.41413,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,0.974481255924171
GOBP_RETINAL_ROD_CELL_DIFFER...,SET,16,0.047184,0.0013923,0.2175,0.41413,GOBP_RETINAL_ROD_CELL_DIFFERENTIATION,0.974481255924171
HP_UNILATERAL_PRIMARY_PULMON...,SET,3,0.094419,0.0012068,0.43567,0.41421,HP_UNILATERAL_PRIMARY_PULMONARY_DYSGENESIS,0.974603517026606
GOBP_NEGATIVE_REGULATION_OF_...387,SET,10,0.069163,0.0016137,0.31923,0.41424,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.974608123476848
WP_PATHOPHYSIOLOGICAL_ROLES_...,SET,15,0.050416,0.0014405,0.23277,0.41427,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,0.974612729303459
GOBP_IMMUNOGLOBULIN_PRODUCTI...1,SET,91,0.018496,0.0012989,0.085458,0.41433,GOBP_IMMUNOGLOBULIN_PRODUCTION,0.974645461928934
GOMF_HEPARIN_BINDING,SET,159,0.016265,0.0015071,0.075166,0.41434,GOMF_HEPARIN_BINDING,0.974645461928934
GSE17721_CTRL_VS_CPG_2H_BMDC...1,SET,189,0.013811,0.001394,0.063842,0.41437,GSE17721_CTRL_VS_CPG_2H_BMDC_DN,0.974650064293449
GOBP_REGULATION_OF_DEFENSE_R...2,SET,18,0.043225,0.0013528,0.19989,0.4144,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.974654666035054
GOMF_PROTEIN_DEMETHYLASE_ACT...,SET,24,0.032737,0.0011828,0.15147,0.41445,GOMF_PROTEIN_DEMETHYLASE_ACTIVITY,0.974706303288672
MIR6797_3P,SET,58,0.025021,0.0014041,0.11586,0.41451,MIR6797_3P,0.97471549729364
GOBP_POSITIVE_REGULATION_OF_...432,SET,22,0.04296,0.0014862,0.19892,0.41451,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.97471549729364
GOCC_PICLN_SM_PROTEIN_COMPLEX,SET,6,0.063628,0.0011501,0.29487,0.41458,GOCC_PICLN_SM_PROTEIN_COMPLEX,0.974814146539476
GSE39820_CTRL_VS_TGFBETA3_IL...1,SET,182,0.01369,0.0013563,0.063516,0.41467,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN,0.974959805844946
GSE19401_UNSTIM_VS_RETINOIC_...3,SET,168,0.013954,0.0013286,0.064794,0.41475,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,0.975062997159091
GSE557_WT_VS_CIITA_KO_DC_UP,SET,182,0.012781,0.0012661,0.059365,0.41477,GSE557_WT_VS_CIITA_KO_DC_UP,0.975062997159091
GSE10239_MEMORY_VS_DAY4.5_EF...1,SET,181,0.013407,0.0013246,0.062384,0.41492,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN,0.975192839764817
GSE46606_IRF4_KO_VS_WT_UNSTI...2,SET,186,0.013007,0.0013025,0.060528,0.41493,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP,0.975192839764817
HP_NON_HODGKIN_LYMPHOMA,SET,38,0.030662,0.0013935,0.14272,0.41495,HP_NON_HODGKIN_LYMPHOMA,0.975192839764817
GOBP_PRIMITIVE_ERYTHROCYTE_D...,SET,4,0.10782,0.0015913,0.50227,0.41501,GOBP_PRIMITIVE_ERYTHROCYTE_DIFFERENTIATION,0.975192839764817
GNF2_CBFB,SET,28,0.032889,0.0012834,0.1533,0.41506,GNF2_CBFB,0.975192839764817
HP_ABNORMAL_CEREBRAL_VASCULA...,SET,307,0.010659,0.0013667,0.049681,0.41506,HP_ABNORMAL_CEREBRAL_VASCULAR_MORPHOLOGY,0.975192839764817
HP_BILATERAL_COXA_VALGA,SET,13,0.056849,0.0015122,0.26497,0.41506,HP_BILATERAL_COXA_VALGA,0.975192839764817
GOBP_NEGATIVE_REGULATION_OF_...314,SET,43,0.029229,0.0014129,0.13628,0.41509,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,0.975192839764817
MIR5693,SET,78,0.021154,0.0013759,0.098715,0.41516,MIR5693,0.975192839764817
GOBP_DIRECT_OSSIFICATION,SET,7,0.066755,0.0013032,0.31155,0.41517,GOBP_DIRECT_OSSIFICATION,0.975192839764817
HP_EPISODIC_METABOLIC_ACIDOS...,SET,4,0.10335,0.0015253,0.4823,0.41517,HP_EPISODIC_METABOLIC_ACIDOSIS,0.975192839764817
GSE360_L_MAJOR_VS_M_TUBERCUL...4,SET,172,0.014473,0.0013943,0.067552,0.41518,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP,0.975192839764817
GOBP_NEGATIVE_REGULATION_OF_...121,SET,8,0.065034,0.0013572,0.30358,0.41519,GOBP_NEGATIVE_REGULATION_OF_CELL_MATURATION,0.975192839764817
GOMF_ANGIOTENSIN_RECEPTOR_AC...,SET,4,0.10552,0.0015574,0.49289,0.41524,GOMF_ANGIOTENSIN_RECEPTOR_ACTIVITY,0.975244370860927
GOBP_SIGNAL_TRANSDUCTION_IN_...2,SET,170,0.013351,0.0012787,0.062449,0.41536,GOBP_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE,0.975252765957447
HP_APLASIA_HYPOPLASIA_INVOLV...8,SET,40,0.029004,0.0013523,0.13567,0.41536,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.975252765957447
GSE37533_PPARG2_FOXP3_VS_FOX...3,SET,175,0.013925,0.001353,0.065141,0.41536,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.975252765957447
HP_HYPERORALITY,SET,15,0.048919,0.0013977,0.22889,0.41538,HP_HYPERORALITY,0.975252765957447
GOBP_REGULATION_OF_CAMP_MEDI...,SET,19,0.043136,0.0013869,0.20185,0.41539,GOBP_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.975252765957447
LET_7D_3P,SET,8,0.070938,0.0014805,0.33209,0.41543,LET_7D_3P,0.975252765957447
MIR7111_5P,SET,189,0.012972,0.0013094,0.060736,0.41544,MIR7111_5P,0.975252765957447
GSE19198_1H_VS_6H_IL21_TREAT...1,SET,186,0.013675,0.0013694,0.06408,0.41551,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN,0.975351212346346
MIKKELSEN_NPC_HCP_WITH_H3K4M...,SET,201,0.014034,0.0014603,0.065807,0.41557,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.975383772285251
BOGNI_TREATMENT_RELATED_MYEL...1,SET,31,0.030666,0.001259,0.14382,0.41558,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,0.975383772285251
GSE14308_NAIVE_CD4_TCELL_VS_...4,SET,177,0.013243,0.001294,0.06215,0.41564,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP,0.975458721048011
CGCAAAA_MIR450,SET,9,0.059665,0.0013207,0.28013,0.41567,CGCAAAA_MIR450,0.975463257933828
KEGG_MEDICUS_REFERENCE_ITGA_...2,SET,29,0.035838,0.0014232,0.16847,0.41577,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY,0.975589650283554
KEGG_MEDICUS_REFERENCE_EREG_...1,SET,11,0.056042,0.0013713,0.26347,0.41578,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY,0.975589650283554
GSE37416_CTRL_VS_12H_F_TULAR...1,SET,175,0.01327,0.0012893,0.062468,0.41589,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.97560692260981
MODULE_516,SET,15,0.052188,0.0014911,0.24596,0.41598,MODULE_516,0.97560692260981
VDR_Q6,SET,236,0.012008,0.0013526,0.056597,0.41599,VDR_Q6,0.97560692260981
MORF_BCL2L11,SET,161,0.014699,0.0013704,0.069279,0.41599,MORF_BCL2L11,0.97560692260981
MIR4639_5P,SET,86,0.020904,0.0014273,0.09854,0.416,MIR4639_5P,0.97560692260981
HP_GASTROINTESTINAL_INFLAMMA...,SET,150,0.01553,0.001398,0.073211,0.416,HP_GASTROINTESTINAL_INFLAMMATION,0.97560692260981
HP_OLIVOPONTOCEREBELLAR_ATRO...,SET,6,0.068788,0.0012433,0.32432,0.41602,HP_OLIVOPONTOCEREBELLAR_ATROPHY,0.97560692260981
GSE10325_CD4_TCELL_VS_BCELL_...1,SET,166,0.015039,0.0014235,0.070916,0.41603,GSE10325_CD4_TCELL_VS_BCELL_DN,0.97560692260981
MIR302C_5P,SET,524,0.0082545,0.0013745,0.03893,0.41604,MIR302C_5P,0.97560692260981
GSE26890_CXCR1_NEG_VS_POS_EF...1,SET,176,0.012979,0.0012647,0.061231,0.41607,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN,0.975611445823775
GOBP_POSITIVE_REGULATION_OF_...793,SET,104,0.018903,0.0014186,0.089245,0.41613,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.975686308439587
GOBP_ACTIN_POLYMERIZATION_OR...,SET,171,0.014184,0.0013625,0.066986,0.41616,GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION,0.975690825688073
GOBP_REGULATION_OF_KIDNEY_SI...,SET,5,0.08662,0.0014292,0.40941,0.41622,GOBP_REGULATION_OF_KIDNEY_SIZE,0.975712887948408
REACTOME_TRIF_MEDIATED_PROGR...,SET,9,0.06372,0.0014104,0.3012,0.41623,REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH,0.975712887948408
CRX_NRL_DN.V1_DN,SET,112,0.017891,0.0013931,0.084609,0.41627,CRX_NRL_DN.V1_DN,0.975712887948408
GOBP_CYTIDINE_METABOLIC_PROC...,SET,11,0.073793,0.0018057,0.34913,0.4163,GOBP_CYTIDINE_METABOLIC_PROCESS,0.975712887948408
KEGG_MEDICUS_PATHOGEN_HIV_TA...2,SET,14,0.066364,0.0018319,0.31402,0.41631,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY,0.975712887948408
GAVISH_3CA_MALIGNANT_METAPRO...32,SET,40,0.025936,0.0012093,0.12276,0.41634,GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH,0.975712887948408
HP_ABNORMAL_CORONARY_ARTERY_...1,SET,67,0.023743,0.0014317,0.11261,0.4165,HP_ABNORMAL_CORONARY_ARTERY_MORPHOLOGY,0.975712887948408
MIR6511A_3P_MIR6511B_3P,SET,55,0.023641,0.001292,0.11215,0.41652,MIR6511A_3P_MIR6511B_3P,0.975712887948408
RECHTIEN_PBMC_RVSV_ZEBOV_AGE...,SET,10,0.063075,0.0014716,0.29922,0.41652,RECHTIEN_PBMC_RVSV_ZEBOV_AGE_18_55YO_1DY_UP,0.975712887948408
HP_ABNORMAL_UVULA_MORPHOLOGY,SET,168,0.013475,0.0012831,0.063931,0.41653,HP_ABNORMAL_UVULA_MORPHOLOGY,0.975712887948408
GOBP_FORMATION_OF_ANATOMICAL...,SET,6,0.072881,0.0013173,0.34597,0.41658,GOBP_FORMATION_OF_ANATOMICAL_BOUNDARY,0.975712887948408
GOMF_CYTIDINE_DEAMINASE_ACTI...,SET,10,0.077612,0.0018108,0.36844,0.41658,GOMF_CYTIDINE_DEAMINASE_ACTIVITY,0.975712887948408
HP_ABNORMAL_PUPILLARY_LIGHT_...,SET,28,0.035322,0.0013783,0.16775,0.41662,HP_ABNORMAL_PUPILLARY_LIGHT_REFLEX,0.975712887948408
NABA_BASEMENT_MEMBRANES,SET,37,0.031992,0.0014347,0.15201,0.41666,NABA_BASEMENT_MEMBRANES,0.975712887948408
GOBP_ACTIVATION_OF_PHOSPHOLI...,SET,21,0.042152,0.0014248,0.20035,0.41668,GOBP_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.975712887948408
HP_NEOPLASM_OF_THE_LARYNX,SET,18,0.040385,0.0012639,0.19197,0.41669,HP_NEOPLASM_OF_THE_LARYNX,0.975712887948408
DESCARTES_FETAL_EYE_SKELETAL...,SET,132,0.016112,0.0013613,0.076623,0.41673,DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS,0.975712887948408
LAKE_ADULT_KIDNEY_C21_COLLEC...,SET,98,0.01979,0.001442,0.09421,0.41681,LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B,0.975712887948408
SOX10_TARGET_GENES,SET,205,0.012797,0.0013446,0.060926,0.41682,SOX10_TARGET_GENES,0.975712887948408
GSE21927_EL4_VS_MCA203_TUMOR...2,SET,149,0.015509,0.0013915,0.073886,0.41687,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP,0.975712887948408
DNMT1_TARGET_GENES,SET,173,0.0136,0.0013139,0.064794,0.41688,DNMT1_TARGET_GENES,0.975712887948408
GSE14308_TH1_VS_TH17_UP,SET,177,0.013215,0.0012913,0.062969,0.41688,GSE14308_TH1_VS_TH17_UP,0.975712887948408
DEBOSSCHER_NFKB_TARGETS_REPR...,SET,21,0.041248,0.0013942,0.19654,0.41689,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,0.975712887948408
GOBP_NEGATIVE_REGULATION_OF_...120,SET,32,0.03383,0.0014111,0.16133,0.41695,GOBP_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.975712887948408
GOMF_HISTONE_H4K12_ACETYLTRA...,SET,12,0.048829,0.0012479,0.23285,0.41695,GOMF_HISTONE_H4K12_ACETYLTRANSFERASE_ACTIVITY,0.975712887948408
WP_DOPAMINE_METABOLISM,SET,11,0.056186,0.0013749,0.26799,0.41697,WP_DOPAMINE_METABOLISM,0.975712887948408
GSE3400_UNTREATED_VS_IFNB_TR...1,SET,154,0.014498,0.0013222,0.069214,0.41704,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN,0.975712887948408
REACTOME_BETA_OXIDATION_OF_L...,SET,5,0.084833,0.0013998,0.4052,0.41708,REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA,0.975712887948408
BLUM_RESPONSE_TO_SALIRASIB_DN,SET,308,0.00986,0.0012663,0.047124,0.41713,BLUM_RESPONSE_TO_SALIRASIB_DN,0.975712887948408
PANAPASA_BLOOD_FLUENZ_AGE_03...2,SET,9,0.066269,0.0014669,0.31681,0.41716,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_6DY_7DY_UP,0.975712887948408
GOBP_MYD88_INDEPENDENT_TOLL_...,SET,16,0.041917,0.0012369,0.20044,0.41718,GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.975712887948408
GSE3039_ALPHAALPHA_CD8_TCELL...2,SET,189,0.012797,0.0012916,0.061205,0.41719,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP,0.975712887948408
GSE8921_UNSTIM_VS_TLR1_2_STI...2,SET,183,0.013479,0.001339,0.064503,0.41724,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP,0.975712887948408
REACTOME_MRNA_DECAY_BY_5_TO_...,SET,15,0.043693,0.0012484,0.20912,0.41725,REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE,0.975712887948408
AMIT_EGF_RESPONSE_60_HELA,SET,42,0.028293,0.0013517,0.13552,0.41731,AMIT_EGF_RESPONSE_60_HELA,0.975712887948408
HP_ABNORMAL_UPPER_LIMB_EPIPH...,SET,54,0.025288,0.0013694,0.12117,0.41734,HP_ABNORMAL_UPPER_LIMB_EPIPHYSIS_MORPHOLOGY,0.975712887948408
MIR6895_5P,SET,38,0.028859,0.0013116,0.13831,0.41736,MIR6895_5P,0.975712887948408
GSE17974_2H_VS_72H_UNTREATED...2,SET,174,0.012961,0.0012557,0.062112,0.41736,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.975712887948408
WP_HIPPO_SIGNALING_REGULATION,SET,98,0.019267,0.0014039,0.092385,0.4174,WP_HIPPO_SIGNALING_REGULATION,0.975712887948408
EVI1_02,SET,112,0.017199,0.0013392,0.082464,0.4174,EVI1_02,0.975712887948408
HP_UNDERFOLDED_HELIX,SET,4,0.09785,0.0014441,0.46927,0.41741,HP_UNDERFOLDED_HELIX,0.975712887948408
GCM_MLL,SET,157,0.013198,0.0012152,0.063297,0.41742,GCM_MLL,0.975712887948408
GOBP_POSITIVE_REGULATION_OF_...585,SET,9,0.054771,0.0012124,0.26275,0.41744,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.975712887948408
GOCC_PROTEIN_COMPLEX_INVOLVE...2,SET,5,0.073408,0.0012112,0.35227,0.41747,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_CELL_ADHESION,0.975712887948408
GOMF_ANDROSTAN_3_ALPHA_17_BE...,SET,8,0.07219,0.0015066,0.34648,0.41748,GOMF_ANDROSTAN_3_ALPHA_17_BETA_DIOL_DEHYDROGENASE_ACTIVITY,0.975712887948408
GNF2_IGFBP1,SET,30,0.036832,0.0014876,0.1768,0.41749,GNF2_IGFBP1,0.975712887948408
GOBP_FATTY_ACYL_COA_CATABOLI...,SET,5,0.073097,0.0012061,0.35108,0.41754,GOBP_FATTY_ACYL_COA_CATABOLIC_PROCESS,0.975712887948408
GOMF_AMINE_BINDING,SET,12,0.049202,0.0012575,0.23654,0.41761,GOMF_AMINE_BINDING,0.975712887948408
GOBP_NEGATIVE_REGULATION_OF_...356,SET,293,0.010975,0.0013753,0.05278,0.41764,GOBP_NEGATIVE_REGULATION_OF_LOCOMOTION,0.975712887948408
HP_ABNORMAL_CORTICOSPINAL_TR...,SET,44,0.026315,0.0012867,0.12662,0.41768,HP_ABNORMAL_CORTICOSPINAL_TRACT_MORPHOLOGY,0.975712887948408
HP_ABNORMALITY_OF_THE_UPPER_...3,SET,442,0.0086181,0.001321,0.041498,0.41774,HP_ABNORMALITY_OF_THE_UPPER_RESPIRATORY_TRACT,0.975712887948408
GOCC_EXTRINSIC_COMPONENT_OF_...3,SET,6,0.065677,0.0011871,0.31639,0.41778,GOCC_EXTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE,0.975712887948408
GOBP_INTERLEUKIN_5_MEDIATED_...,SET,6,0.077903,0.0014081,0.37538,0.4178,GOBP_INTERLEUKIN_5_MEDIATED_SIGNALING_PATHWAY,0.975712887948408
MIR3170,SET,46,0.025421,0.0012708,0.12253,0.41782,MIR3170,0.975712887948408
GSE8921_UNSTIM_VS_TLR1_2_STI...7,SET,178,0.012942,0.0012682,0.062407,0.41786,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN,0.975712887948408
GSE21927_SPLEEN_C57BL6_VS_4T...2,SET,182,0.012375,0.001226,0.059679,0.41787,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP,0.975712887948408
MURARO_PANCREAS_PANCREATIC_P...,SET,134,0.016885,0.0014372,0.08143,0.41787,MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL,0.975712887948408
MIR1200,SET,301,0.010455,0.0013276,0.050427,0.41788,MIR1200,0.975712887948408
GOBP_COLUMNAR_CUBOIDAL_EPITH...1,SET,49,0.027036,0.0013948,0.13042,0.41789,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT,0.975712887948408
KEGG_PRIMARY_BILE_ACID_BIOSY...,SET,16,0.045376,0.0013389,0.21895,0.41791,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,0.975712887948408
GOBP_COPULATION,SET,19,0.046039,0.0014803,0.22215,0.41791,GOBP_COPULATION,0.975712887948408
GSE9037_CTRL_VS_LPS_4H_STIM_...4,SET,174,0.013229,0.0012817,0.063832,0.41791,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP,0.975712887948408
KEGG_SPHINGOLIPID_METABOLISM,SET,34,0.031407,0.0013503,0.15161,0.41795,KEGG_SPHINGOLIPID_METABOLISM,0.97573724089354
GOBP_CELL_JUNCTION_ASSEMBLY,SET,421,0.0093474,0.0013991,0.045159,0.41801,GOBP_CELL_JUNCTION_ASSEMBLY,0.97573724089354
BILD_MYC_ONCOGENIC_SIGNATURE,SET,181,0.012634,0.0012482,0.061051,0.41803,BILD_MYC_ONCOGENIC_SIGNATURE,0.97573724089354
HP_ABNORMAL_CIRCULATING_IRON...,SET,17,0.04176,0.0012701,0.20186,0.41805,HP_ABNORMAL_CIRCULATING_IRON_CONCENTRATION,0.97573724089354
HP_CENTRAL_SLEEP_APNEA,SET,37,0.030994,0.00139,0.14985,0.41807,HP_CENTRAL_SLEEP_APNEA,0.97573724089354
GOBP_REGULATION_OF_DEOXYRIBO...,SET,10,0.056932,0.0013283,0.27535,0.4181,GOBP_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,0.97573724089354
FAN_OVARY_CL13_MONOCYTE_MACR...,SET,411,0.0088825,0.001314,0.043003,0.41818,FAN_OVARY_CL13_MONOCYTE_MACROPHAGE,0.97573724089354
ROSS_AML_WITH_MLL_FUSIONS,SET,68,0.021418,0.001301,0.1037,0.41819,ROSS_AML_WITH_MLL_FUSIONS,0.97573724089354
GSE21360_SECONDARY_VS_TERTIA...1,SET,149,0.01395,0.0012516,0.067576,0.41823,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.97573724089354
GSE339_EX_VIVO_VS_IN_CULTURE...5,SET,187,0.013219,0.0013272,0.064044,0.41824,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN,0.97573724089354
GSE46606_IRF4_KO_VS_WT_CD40L...1,SET,168,0.013317,0.001268,0.064523,0.41825,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN,0.97573724089354
GOMF_CYTOKINE_RECEPTOR_BINDI...,SET,247,0.012127,0.0013971,0.058793,0.41829,GOMF_CYTOKINE_RECEPTOR_BINDING,0.97573724089354
PID_ANGIOPOIETIN_RECEPTOR_PA...,SET,47,0.025475,0.0012873,0.12353,0.41831,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,0.97573724089354
H1_6_TARGET_GENES,SET,405,0.0089407,0.0013132,0.043389,0.41837,H1_6_TARGET_GENES,0.97573724089354
MODULE_493,SET,58,0.023577,0.0013231,0.11444,0.41839,MODULE_493,0.97573724089354
GOCC_LEWY_BODY,SET,7,0.063247,0.0012347,0.30704,0.4184,GOCC_LEWY_BODY,0.97573724089354
GOBP_SNO_S_RNA_PROCESSING,SET,9,0.057996,0.0012837,0.28168,0.41844,GOBP_SNO_S_RNA_PROCESSING,0.97573724089354
HP_HYPOPLASTIC_PUBIC_RAMUS,SET,6,0.077129,0.0013941,0.37479,0.41848,HP_HYPOPLASTIC_PUBIC_RAMUS,0.97573724089354
MODULE_247,SET,35,0.03252,0.0014185,0.15805,0.41849,MODULE_247,0.97573724089354
TRAVAGLINI_LUNG_NATURAL_KILL...1,SET,121,0.017216,0.001393,0.083672,0.41849,TRAVAGLINI_LUNG_NATURAL_KILLER_CELL,0.97573724089354
MIR5193,SET,158,0.014046,0.0012974,0.068281,0.41851,MIR5193,0.97573724089354
GSE17721_0.5H_VS_8H_GARDIQUI...1,SET,184,0.012871,0.001282,0.062606,0.41856,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN,0.975788355245506
REACTOME_BETA_OXIDATION_OF_O...,SET,5,0.082353,0.0013588,0.40112,0.41867,REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA,0.975912943345625
GSE43955_1H_VS_42H_ACT_CD4_T...1,SET,186,0.012837,0.0012855,0.062554,0.4187,GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN,0.975912943345625
HP_NREM_PARASOMNIA,SET,16,0.047048,0.0013883,0.22935,0.41873,HP_NREM_PARASOMNIA,0.975912943345625
DICER1_TARGET_GENES,SET,52,0.023518,0.0012498,0.11465,0.41874,DICER1_TARGET_GENES,0.975912943345625
WP_2Q37_COPY_NUMBER_VARIATIO...,SET,124,0.020629,0.0016896,0.10064,0.41879,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,0.975912943345625
HP_MACROCEPHALY,SET,375,0.0090259,0.0012767,0.044038,0.4188,HP_MACROCEPHALY,0.975912943345625
GOBP_RESPONSE_TO_ANTIBIOTIC,SET,36,0.029658,0.001312,0.14472,0.41881,GOBP_RESPONSE_TO_ANTIBIOTIC,0.975912943345625
HP_NEUROFIBROMA,SET,19,0.039262,0.0012624,0.19176,0.41888,HP_NEUROFIBROMA,0.976010619469026
GSE360_CTRL_VS_B_MALAYI_LOW_...3,SET,179,0.012964,0.0012738,0.063351,0.41893,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.976061684655092
NAKAMURA_ADIPOGENESIS_LATE_UP,SET,93,0.017892,0.0012702,0.087516,0.419,NAKAMURA_ADIPOGENESIS_LATE_UP,0.976098367962467
REACTOME_DEFECTIVE_INTRINSIC...,SET,25,0.036263,0.0013372,0.17741,0.41902,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,0.976098367962467
MODULE_191,SET,19,0.047624,0.0015312,0.23302,0.41903,MODULE_191,0.976098367962467
KRAS.600_UP.V1_UP,SET,249,0.01229,0.0014215,0.060176,0.41909,KRAS.600_UP.V1_UP,0.976172706252932
HP_CLITORAL_HYPERTROPHY,SET,60,0.022922,0.0013082,0.11236,0.41917,HP_CLITORAL_HYPERTROPHY,0.976228194732963
GSE18893_CTRL_VS_TNF_TREATED...4,SET,182,0.0125,0.0012384,0.06127,0.41917,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP,0.976228194732963
WP_DISORDERS_IN_KETONE_BODY_...,SET,5,0.07812,0.001289,0.38306,0.4192,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,0.976232645403377
GOBP_GOLGI_LUMEN_ACIDIFICATI...,SET,9,0.053675,0.0011881,0.26343,0.41927,GOBP_GOLGI_LUMEN_ACIDIFICATION,0.97633024120603
GOMF_ANTIPORTER_ACTIVITY,SET,126,0.015188,0.0012539,0.074585,0.41932,GOMF_ANTIPORTER_ACTIVITY,0.976381254187324
CTCCAAG_MIR432,SET,74,0.019576,0.0012403,0.096182,0.41936,CTCCAAG_MIR432,0.976399008707301
RIZ_ERYTHROID_DIFFERENTIATIO...1,SET,32,0.033877,0.0014131,0.16651,0.41939,RIZ_ERYTHROID_DIFFERENTIATION_12HR,0.976399008707301
GOBP_REGULATION_OF_JUN_KINAS...,SET,39,0.027201,0.0012523,0.13374,0.41942,GOBP_REGULATION_OF_JUN_KINASE_ACTIVITY,0.976399008707301
GSE29614_DAY3_VS_DAY7_TIV_FL...2,SET,143,0.015286,0.0013438,0.075181,0.41944,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.976399008707301
GSE29614_CTRL_VS_DAY3_TIV_FL...2,SET,151,0.014518,0.0013112,0.071474,0.41952,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP,0.97645553585764
KEGG_MEDICUS_ENV_FACTOR_NNK_...2,SET,11,0.053062,0.0012984,0.26132,0.41955,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339,0.97645553585764
GOBP_PROTEIN_LOCALIZATION_TO...19,SET,7,0.061105,0.0011929,0.30122,0.41962,GOBP_PROTEIN_LOCALIZATION_TO_CYTOPLASMIC_STRESS_GRANULE,0.97645553585764
GOCC_SYNAPSE,SET,1365,0.0050137,0.0013153,0.024737,0.41969,GOCC_SYNAPSE,0.97645553585764
GOBP_NEGATIVE_REGULATION_OF_...81,SET,11,0.054317,0.0013291,0.26806,0.41971,GOBP_NEGATIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.97645553585764
AIZARANI_LIVER_C34_MHC_II_PO...,SET,118,0.016907,0.0013511,0.083441,0.41972,AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS,0.97645553585764
GAUSSMANN_MLL_AF4_FUSION_TAR...3,SET,6,0.078684,0.0014222,0.38844,0.41974,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN,0.97645553585764
GSE15930_NAIVE_VS_48H_IN_VIT...1,SET,183,0.01198,0.0011901,0.059147,0.41974,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN,0.97645553585764
GSE12001_MIR223_KO_VS_WT_NEU...2,SET,150,0.014138,0.0012727,0.069809,0.41975,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP,0.97645553585764
MORF_PPP2R5E,SET,72,0.018549,0.0011593,0.091649,0.4198,MORF_PPP2R5E,0.97645553585764
HP_ABNORMAL_VENTRICULAR_AXIS,SET,5,0.086231,0.0014228,0.42616,0.41982,HP_ABNORMAL_VENTRICULAR_AXIS,0.97645553585764
WP_OCTADECANOID_FORMATION_FR...,SET,12,0.054756,0.0013994,0.27073,0.41986,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,0.97645553585764
NIKOLSKY_BREAST_CANCER_22Q13...,SET,16,0.067493,0.0019915,0.33372,0.41987,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,0.97645553585764
GSE7831_CPG_VS_INFLUENZA_STI...2,SET,181,0.012125,0.001198,0.059973,0.41989,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP,0.97645553585764
GOBP_HIPPOCAMPAL_NEURON_APOP...,SET,6,0.080759,0.0014597,0.39958,0.41992,GOBP_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.97645553585764
GOMF_CELL_ADHESION_MOLECULE_...,SET,501,0.0078586,0.0012803,0.038895,0.41994,GOMF_CELL_ADHESION_MOLECULE_BINDING,0.97645553585764
GOMF_LYSOPHOSPHOLIPID_ACYLTR...,SET,18,0.044436,0.0013907,0.21994,0.41995,GOMF_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY,0.97645553585764
TATCTGG_MIR488,SET,58,0.022983,0.0012897,0.11379,0.41997,TATCTGG_MIR488,0.97645553585764
GOCC_RIBONUCLEOPROTEIN_COMPL...,SET,620,0.0065309,0.0011797,0.032404,0.42014,GOCC_RIBONUCLEOPROTEIN_COMPLEX,0.976611826109936
GSE17721_LPS_VS_GARDIQUIMOD_...9,SET,176,0.012614,0.0012291,0.062585,0.42014,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN,0.976611826109936
GOBP_SNRNA_TRANSCRIPTION_BY_...1,SET,16,0.038483,0.0011355,0.19104,0.42018,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.976611826109936
GSE16385_UNTREATED_VS_12H_RO...2,SET,183,0.012712,0.0012628,0.063137,0.42022,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.976611826109936
HP_ABNORMAL_CEREBRAL_CORTEX_...,SET,676,0.0066775,0.0012575,0.03319,0.42028,HP_ABNORMAL_CEREBRAL_CORTEX_MORPHOLOGY,0.976611826109936
MIR6772_5P,SET,31,0.029692,0.001219,0.14761,0.42029,MIR6772_5P,0.976611826109936
chr9q33,SET,74,0.043427,0.0027515,0.21594,0.42031,chr9q33,0.976611826109936
GSE13411_NAIVE_BCELL_VS_PLAS...2,SET,169,0.013448,0.0012842,0.066905,0.42035,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.976611826109936
GOCC_ACETYLCHOLINE_GATED_CHA...,SET,16,0.04665,0.0013765,0.23218,0.42038,GOCC_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX,0.976611826109936
HP_DISTAL_MUSCLE_WEAKNESS,SET,205,0.01168,0.0012272,0.058154,0.42041,HP_DISTAL_MUSCLE_WEAKNESS,0.976611826109936
MIR3059_3P,SET,47,0.023101,0.0011673,0.11506,0.42044,MIR3059_3P,0.976611826109936
HP_UVEAL_MELANOMA,SET,8,0.054537,0.0011382,0.27178,0.42048,HP_UVEAL_MELANOMA,0.976611826109936
WP_LEPTININSULIN_SIGNALING_O...,SET,16,0.04781,0.0014108,0.2384,0.42053,WP_LEPTININSULIN_SIGNALING_OVERLAP,0.976611826109936
GSE22886_NAIVE_CD4_TCELL_VS_...9,SET,188,0.012432,0.0012515,0.061989,0.42053,GSE22886_NAIVE_CD4_TCELL_VS_DC_DN,0.976611826109936
GOBP_NEGATIVE_REGULATION_OF_...488,SET,5,0.082822,0.0013666,0.41312,0.42055,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.976611826109936
BIOCARTA_EPO_PATHWAY,SET,17,0.043123,0.0013116,0.21511,0.42056,BIOCARTA_EPO_PATHWAY,0.976611826109936
GSE4984_UNTREATED_VS_GALECTI...1,SET,154,0.014089,0.0012849,0.070316,0.4206,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN,0.976611826109936
KEGG_MEDICUS_REFERENCE_MICRO...4,SET,20,0.038948,0.0012848,0.19442,0.42061,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.976611826109936
HP_ADRENOCORTICAL_ABNORMALITY,SET,9,0.0585,0.0012949,0.29244,0.42073,HP_ADRENOCORTICAL_ABNORMALITY,0.976611826109936
REACTOME_GPCR_LIGAND_BINDING,SET,426,0.0093352,0.0014054,0.046678,0.42074,REACTOME_GPCR_LIGAND_BINDING,0.976611826109936
HP_MACULAR_PURPURA,SET,78,0.019813,0.0012887,0.099125,0.42079,HP_MACULAR_PURPURA,0.976611826109936
TRAVAGLINI_LUNG_PLATELET_MEG...,SET,513,0.0076351,0.0012583,0.038198,0.42079,TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL,0.976611826109936
MIR29A_5P,SET,183,0.012899,0.0012813,0.06455,0.42081,MIR29A_5P,0.976611826109936
HELLER_HDAC_TARGETS_UP,SET,251,0.010719,0.0012447,0.053659,0.42084,HELLER_HDAC_TARGETS_UP,0.976611826109936
GSE20198_IL12_VS_IL12_IL18_T...1,SET,191,0.012245,0.0012424,0.061309,0.42085,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.976611826109936
GSE18791_UNSTIM_VS_NEWCATSLE...8,SET,135,0.015131,0.0012927,0.075774,0.42087,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP,0.976611826109936
REACTOME_SEMA3A_PAK_DEPENDEN...,SET,14,0.045065,0.0012439,0.22589,0.42094,REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,0.976611826109936
DASU_IL6_SIGNALING_SCAR_UP,SET,30,0.031321,0.001265,0.1571,0.42099,DASU_IL6_SIGNALING_SCAR_UP,0.976611826109936
MIR3679_5P,SET,70,0.020096,0.0012385,0.10083,0.42101,MIR3679_5P,0.976611826109936
GOBP_POST_EMBRYONIC_CAMERA_T...,SET,8,0.068311,0.0014256,0.34273,0.42101,GOBP_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.976611826109936
WHITESIDE_CISPLATIN_RESISTAN...1,SET,12,0.044001,0.0011245,0.22097,0.42108,WHITESIDE_CISPLATIN_RESISTANCE_DN,0.976611826109936
GSE22432_CDC_VS_COMMON_DC_PR...1,SET,184,0.012345,0.0012296,0.062039,0.42114,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN,0.976611826109936
GOCC_BRAHMA_COMPLEX,SET,14,0.050817,0.0014027,0.2555,0.42118,GOCC_BRAHMA_COMPLEX,0.976611826109936
GOBP_FORMATE_METABOLIC_PROCE...,SET,6,0.076784,0.0013878,0.38614,0.42119,GOBP_FORMATE_METABOLIC_PROCESS,0.976611826109936
MIR4658,SET,44,0.027724,0.0013556,0.13954,0.42126,MIR4658,0.976611826109936
DOANE_BREAST_CANCER_CLASSES_...1,SET,32,0.033441,0.0013949,0.16848,0.42133,DOANE_BREAST_CANCER_CLASSES_DN,0.976611826109936
GOMF_ATPASE_COUPLED_ION_TRAN...,SET,22,0.036133,0.00125,0.18207,0.42135,GOMF_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976611826109936
GSE24634_NAIVE_CD4_TCELL_VS_...7,SET,178,0.012083,0.001184,0.060888,0.42135,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN,0.976611826109936
GSE17721_LPS_VS_GARDIQUIMOD_...12,SET,183,0.013381,0.0013292,0.06745,0.42137,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP,0.976611826109936
ZNF577_TARGET_GENES,SET,381,0.0087569,0.0012483,0.044179,0.42144,ZNF577_TARGET_GENES,0.976611826109936
GOMF_CLASS_I_DNA_APURINIC_OR...,SET,8,0.055837,0.0011653,0.28179,0.42146,GOMF_CLASS_I_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.976611826109936
GOBP_ROUNDABOUT_SIGNALING_PA...,SET,5,0.084738,0.0013982,0.42766,0.42147,GOBP_ROUNDABOUT_SIGNALING_PATHWAY,0.976611826109936
GOMF_ACTIVE_MONOATOMIC_ION_T...,SET,261,0.010332,0.0012231,0.052167,0.4215,GOMF_ACTIVE_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976611826109936
GSE22886_DC_VS_MONOCYTE_UP,SET,186,0.012451,0.0012469,0.062863,0.4215,GSE22886_DC_VS_MONOCYTE_UP,0.976611826109936
GOCC_PERICENTRIC_HETEROCHROM...,SET,27,0.032942,0.0012623,0.16638,0.42153,GOCC_PERICENTRIC_HETEROCHROMATIN,0.976611826109936
HP_ABNORMAL_HYPNAGOGIA,SET,8,0.065082,0.0013582,0.32874,0.42153,HP_ABNORMAL_HYPNAGOGIA,0.976611826109936
BIOCARTA_IL7_PATHWAY,SET,16,0.043322,0.0012783,0.21887,0.42155,BIOCARTA_IL7_PATHWAY,0.976611826109936
GOBP_POSITIVE_REGULATION_OF_...156,SET,8,0.058153,0.0012136,0.29378,0.42155,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.976611826109936
ELK1_02,SET,235,0.01047,0.0011769,0.05292,0.42159,ELK1_02,0.976611826109936
HP_RETINAL_FLECKS,SET,8,0.064624,0.0013487,0.32668,0.42159,HP_RETINAL_FLECKS,0.976611826109936
GOBP_LIMB_JOINT_MORPHOGENESIS,SET,7,0.068464,0.0013366,0.34623,0.42163,GOBP_LIMB_JOINT_MORPHOGENESIS,0.976611826109936
GOBP_REGULATION_OF_NOTCH_SIG...,SET,86,0.018871,0.0012885,0.095442,0.42163,GOBP_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.976611826109936
MIR5002_3P,SET,41,0.025525,0.0012049,0.12911,0.42164,MIR5002_3P,0.976611826109936
HP_MYOPATHIC_FACIES,SET,46,0.026279,0.0013137,0.13292,0.42164,HP_MYOPATHIC_FACIES,0.976611826109936
GOCC_HEMOGLOBIN_COMPLEX,SET,8,0.071621,0.0014947,0.36232,0.42165,GOCC_HEMOGLOBIN_COMPLEX,0.976611826109936
YKACATTT_UNKNOWN,SET,257,0.010929,0.0012839,0.055334,0.42172,YKACATTT_UNKNOWN,0.976611826109936
HP_GLAUCOMA,SET,316,0.0098078,0.0012756,0.04968,0.42175,HP_GLAUCOMA,0.976611826109936
NAKAMURA_TUMOR_ZONE_PERIPHER...2,SET,249,0.010553,0.0012206,0.053466,0.42177,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,0.976611826109936
GOBP_NEGATIVE_REGULATION_OF_...321,SET,46,0.023616,0.0011806,0.11987,0.42191,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.976611826109936
GOBP_REGULATION_OF_ALCOHOL_B...,SET,44,0.026447,0.0012931,0.13426,0.42192,GOBP_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.976611826109936
GAVISH_3CA_MALIGNANT_METAPRO...25,SET,42,0.026793,0.00128,0.13604,0.42193,GAVISH_3CA_MALIGNANT_METAPROGRAM_33_RBCS,0.976611826109936
MIR524_3P_MIR525_3P,SET,11,0.050682,0.0012402,0.2574,0.42196,MIR524_3P_MIR525_3P,0.976611826109936
GSE26488_WT_VS_HDAC7_DELTAP_...1,SET,184,0.012492,0.0012443,0.063449,0.42196,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN,0.976611826109936
HP_DISTAL_LOWER_LIMB_MUSCLE_...,SET,84,0.018583,0.0012541,0.094443,0.42201,HP_DISTAL_LOWER_LIMB_MUSCLE_WEAKNESS,0.976611826109936
KRAS.AMP.LUNG_UP.V1_UP,SET,117,0.01636,0.0013019,0.0832,0.42206,KRAS.AMP.LUNG_UP.V1_UP,0.976611826109936
KEGG_MEDICUS_REFERENCE_LECTI...1,SET,10,0.066663,0.0015554,0.33922,0.4221,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN,0.976611826109936
MIR412_5P,SET,5,0.073286,0.0012092,0.3729,0.4221,MIR412_5P,0.976611826109936
PID_E2F_PATHWAY,SET,70,0.019037,0.0011732,0.096902,0.42213,PID_E2F_PATHWAY,0.976611826109936
GOBP_TRABECULA_FORMATION,SET,27,0.034266,0.0013131,0.17447,0.42215,GOBP_TRABECULA_FORMATION,0.976611826109936
MIR3688_3P,SET,368,0.0089823,0.0012589,0.045744,0.42216,MIR3688_3P,0.976611826109936
GOMF_ACTIN_BINDING,SET,400,0.0086081,0.0012567,0.043886,0.42225,GOMF_ACTIN_BINDING,0.976611826109936
RICHERT_PBMC_HIV_LIPO_5_AGE_...2,SET,5,0.076905,0.0012689,0.39209,0.42225,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_INTERFERON_SUBSET_UP,0.976611826109936
REACTOME_CELL_SURFACE_INTERA...,SET,131,0.016059,0.0013517,0.081977,0.42235,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,0.976611826109936
MIR6884_5P,SET,132,0.014346,0.001212,0.073235,0.42235,MIR6884_5P,0.976611826109936
HP_DECREASED_FERTILITY_IN_FE...,SET,87,0.017274,0.0011863,0.088182,0.42235,HP_DECREASED_FERTILITY_IN_FEMALES,0.976611826109936
LOPEZ_EPITHELIOID_MESOTHELIO...,SET,15,0.042327,0.0012094,0.21637,0.42245,LOPEZ_EPITHELIOID_MESOTHELIOMA,0.976611826109936
HP_ABNORMALITY_OF_THE_TONSILS,SET,29,0.032732,0.0012998,0.16731,0.42245,HP_ABNORMALITY_OF_THE_TONSILS,0.976611826109936
HP_SHORT_PROXIMAL_PHALANX_OF...,SET,7,0.063409,0.0012379,0.32413,0.42245,HP_SHORT_PROXIMAL_PHALANX_OF_FINGER,0.976611826109936
GOBP_POSITIVE_REGULATION_OF_...10,SET,26,0.034481,0.0012967,0.17628,0.42246,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.976611826109936
HP_CARDIOMEGALY,SET,114,0.015719,0.0012348,0.080369,0.42247,HP_CARDIOMEGALY,0.976611826109936
TERF1_TARGET_GENES,SET,214,0.011565,0.0012412,0.059148,0.42249,TERF1_TARGET_GENES,0.976611826109936
REACTOME_FATTY_ACID_METABOLI...,SET,167,0.013194,0.0012526,0.067492,0.42251,REACTOME_FATTY_ACID_METABOLISM,0.976611826109936
HERNANDEZ_ABERRANT_MITOSIS_B...3,SET,5,0.090842,0.0014989,0.46534,0.42261,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN,0.976611826109936
HP_RECURRENT_HAEMOPHILUS_INF...,SET,22,0.039041,0.0013506,0.19999,0.42261,HP_RECURRENT_HAEMOPHILUS_INFLUENZAE_INFECTIONS,0.976611826109936
MIR8065,SET,134,0.013831,0.0011773,0.070866,0.42263,MIR8065,0.976611826109936
GNF2_MYL3,SET,31,0.032076,0.0013169,0.16435,0.42263,GNF2_MYL3,0.976611826109936
REACTOME_REGULATION_OF_ENDOG...2,SET,47,0.022761,0.0011501,0.1167,0.42268,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS,0.976611826109936
GSE3982_BCELL_VS_EFF_MEMORY_...1,SET,177,0.012749,0.0012458,0.065383,0.4227,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.976611826109936
HP_RECURRENT_MALADAPTIVE_BEH...,SET,960,0.0055614,0.001238,0.028532,0.42273,HP_RECURRENT_MALADAPTIVE_BEHAVIOR,0.976611826109936
ZNF2_TARGET_GENES,SET,940,0.0055521,0.0012237,0.028501,0.42277,ZNF2_TARGET_GENES,0.976611826109936
REACTOME_TRAF6_MEDIATED_NF_K...,SET,23,0.034885,0.0012339,0.17912,0.42279,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,0.976611826109936
HP_Y_SHAPED_METACARPALS,SET,12,0.042131,0.0010767,0.21643,0.42283,HP_Y_SHAPED_METACARPALS,0.976611826109936
SPIELMAN_LYMPHOBLAST_EUROPEA...2,SET,12,0.04622,0.0011812,0.23749,0.42285,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,0.976611826109936
HP_NEOPLASM_OF_THE_TRACHEOBR...,SET,19,0.038653,0.0012428,0.19864,0.42286,HP_NEOPLASM_OF_THE_TRACHEOBRONCHIAL_SYSTEM,0.976611826109936
HP_DECREASED_SERUM_INSULIN_L...,SET,21,0.036416,0.0012309,0.18723,0.42289,HP_DECREASED_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1,0.976611826109936
GOBP_SEPTUM_PRIMUM_DEVELOPME...,SET,4,0.087849,0.0012965,0.4517,0.4229,GOBP_SEPTUM_PRIMUM_DEVELOPMENT,0.976611826109936
GSE1925_CTRL_VS_24H_IFNG_STI...1,SET,185,0.012072,0.0012057,0.062119,0.42295,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.976611826109936
HP_GLOSSITIS,SET,10,0.060519,0.001412,0.31144,0.42296,HP_GLOSSITIS,0.976611826109936
GOBP_REGULATION_OF_PROTEIN_P...1,SET,179,0.012357,0.0012141,0.063635,0.42302,GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION,0.976611826109936
GSE25088_WT_VS_STAT6_KO_MACR...4,SET,167,0.013155,0.0012489,0.06775,0.42302,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN,0.976611826109936
HP_ABNORMAL_MOTOR_EVOKED_POT...,SET,10,0.055004,0.0012833,0.28343,0.42306,HP_ABNORMAL_MOTOR_EVOKED_POTENTIALS,0.976611826109936
GSE40274_SATB1_VS_FOXP3_AND_...2,SET,155,0.012736,0.0011652,0.065634,0.42307,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.976611826109936
WP_ESTRADIOL_REGULATION_IN_P...,SET,5,0.079535,0.0013123,0.40994,0.42308,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.976611826109936
GOBP_AMIDE_TRANSPORT,SET,295,0.010116,0.001272,0.052162,0.42311,GOBP_AMIDE_TRANSPORT,0.976611826109936
GSE14350_IL2RB_KO_VS_WT_TREG...1,SET,181,0.012358,0.0012209,0.063716,0.42311,GSE14350_IL2RB_KO_VS_WT_TREG_DN,0.976611826109936
GSE41867_NAIVE_VS_EFFECTOR_C...2,SET,187,0.01131,0.0011355,0.058354,0.42316,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,0.976611826109936
DAIRKEE_CANCER_PRONE_RESPONS...3,SET,27,0.034216,0.0013112,0.17659,0.42318,DAIRKEE_CANCER_PRONE_RESPONSE_E2,0.976611826109936
HP_ECHOGENIC_FETAL_BOWEL,SET,5,0.070823,0.0011686,0.36553,0.42319,HP_ECHOGENIC_FETAL_BOWEL,0.976611826109936
MIR6074,SET,249,0.010949,0.0012665,0.056533,0.42321,MIR6074,0.976611826109936
GOMF_ACETYLCHOLINE_GATED_MON...,SET,16,0.044609,0.0013163,0.23034,0.42322,GOMF_ACETYLCHOLINE_GATED_MONOATOMIC_CATION_SELECTIVE_CHANNEL_ACTIVITY,0.976611826109936
KEGG_MEDICUS_REFERENCE_MDM2_...1,SET,13,0.043815,0.0011655,0.22639,0.42327,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066,0.976611826109936
GABRIELY_MIR21_TARGETS,SET,261,0.010382,0.001229,0.053655,0.42329,GABRIELY_MIR21_TARGETS,0.976611826109936
GSE339_CD4POS_VS_CD8POS_DC_DN,SET,185,0.01193,0.0011915,0.061697,0.42334,GSE339_CD4POS_VS_CD8POS_DC_DN,0.976611826109936
GSE11961_MARGINAL_ZONE_BCELL...6,SET,181,0.012141,0.0011995,0.062837,0.4234,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP,0.976611826109936
GOBP_REGULATION_OF_CHROMOSOM...1,SET,11,0.043226,0.0010577,0.22381,0.42343,GOBP_REGULATION_OF_CHROMOSOME_CONDENSATION,0.976611826109936
GOMF_PROTON_TRANSMEMBRANE_TR...,SET,143,0.01299,0.001142,0.067382,0.42356,GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976611826109936
HP_ABDOMINAL_OBESITY,SET,24,0.034647,0.0012519,0.1797,0.42356,HP_ABDOMINAL_OBESITY,0.976611826109936
HP_ABNORMAL_PARANASAL_SINUS_...,SET,158,0.013505,0.0012474,0.070042,0.42356,HP_ABNORMAL_PARANASAL_SINUS_MORPHOLOGY,0.976611826109936
GOMF_T_CELL_RECEPTOR_BINDING,SET,10,0.054035,0.0012607,0.28048,0.42362,GOMF_T_CELL_RECEPTOR_BINDING,0.976611826109936
GOBP_POSITIVE_REGULATION_OF_...213,SET,4,0.072839,0.001075,0.37813,0.42363,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.976611826109936
HP_GENERALIZED_ICHTHYOSIS,SET,4,0.073607,0.0010863,0.38226,0.42365,HP_GENERALIZED_ICHTHYOSIS,0.976611826109936
GOBP_REGULATION_OF_MYELOID_C...2,SET,186,0.012765,0.0012783,0.06633,0.4237,GOBP_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.976611826109936
GSE41176_WT_VS_TAK1_KO_ANTI_...2,SET,183,0.012074,0.0011994,0.062757,0.42372,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP,0.976611826109936
GOBP_NEUROTRANSMITTER_TRANSP...,SET,194,0.012059,0.001233,0.062706,0.42375,GOBP_NEUROTRANSMITTER_TRANSPORT,0.976611826109936
HP_INERTIA,SET,4,0.088265,0.0013027,0.45902,0.42376,HP_INERTIA,0.976611826109936
LEE_TARGETS_OF_PTCH1_AND_SUF...1,SET,80,0.018702,0.0012318,0.097286,0.42378,LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,0.976611826109936
REACTOME_REGULATED_NECROSIS,SET,54,0.023561,0.0012759,0.12256,0.42378,REACTOME_REGULATED_NECROSIS,0.976611826109936
HP_POSTERIOR_POLAR_CATARACT,SET,8,0.065812,0.0013735,0.34234,0.42378,HP_POSTERIOR_POLAR_CATARACT,0.976611826109936
GSE21033_CTRL_VS_POLYIC_STIM...9,SET,147,0.012915,0.001151,0.067179,0.42378,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN,0.976611826109936
chr4q21,SET,60,0.038908,0.0022206,0.20244,0.4238,chr4q21,0.976611826109936
GOBP_POSITIVE_REGULATION_OF_...450,SET,11,0.052988,0.0012966,0.27582,0.42383,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL,0.976611826109936
MIR6728_3P,SET,134,0.014096,0.0011999,0.07342,0.42387,MIR6728_3P,0.976611826109936
GOBP_MESENDODERM_DEVELOPMENT,SET,9,0.054649,0.0012097,0.28469,0.42389,GOBP_MESENDODERM_DEVELOPMENT,0.976611826109936
MODULE_239,SET,108,0.015835,0.0012109,0.082506,0.4239,MODULE_239,0.976611826109936
GSE17721_CTRL_VS_GARDIQUIMOD...8,SET,176,0.012506,0.0012185,0.065177,0.42392,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP,0.976611826109936
GOMF_PRIMARY_AMINE_OXIDASE_A...,SET,7,0.079526,0.0015525,0.41453,0.42393,GOMF_PRIMARY_AMINE_OXIDASE_ACTIVITY,0.976611826109936
GSE6681_DELETED_FOXP3_VS_WT_...1,SET,176,0.012297,0.0011982,0.064093,0.42393,GSE6681_DELETED_FOXP3_VS_WT_TREG_DN,0.976611826109936
HP_DYSPHONIA,SET,111,0.015492,0.0012009,0.080819,0.42399,HP_DYSPHONIA,0.976611826109936
GOCC_SMALL_RIBOSOMAL_SUBUNIT,SET,66,0.01874,0.0011216,0.097773,0.424,GOCC_SMALL_RIBOSOMAL_SUBUNIT,0.976611826109936
WP_FAMILIAL_HYPERLIPIDEMIA_T...4,SET,21,0.036314,0.0012274,0.18951,0.42402,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,0.976611826109936
HP_TRICEPS_WEAKNESS,SET,17,0.036957,0.001124,0.19286,0.42402,HP_TRICEPS_WEAKNESS,0.976611826109936
BIOCARTA_AMI_PATHWAY,SET,18,0.041725,0.0013058,0.21787,0.42406,BIOCARTA_AMI_PATHWAY,0.976611826109936
GOCC_H4_H2A_HISTONE_ACETYLTR...,SET,26,0.031649,0.0011901,0.16529,0.42408,GOCC_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.976611826109936
GOCC_MON1_CCZ1_COMPLEX,SET,4,0.084207,0.0012428,0.44031,0.42417,GOCC_MON1_CCZ1_COMPLEX,0.976611826109936
MIR1297,SET,579,0.0069619,0.0012167,0.036432,0.42423,MIR1297,0.976611826109936
SCHAEFFER_PROSTATE_DEVELOPME...16,SET,5,0.079941,0.001319,0.41862,0.42428,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN,0.976611826109936
BUCASAS_PBMC_FLUARIX_FLUVIRI...1,SET,6,0.0677,0.0012237,0.3546,0.4243,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_3DY_POSITIVE_PREDICTIVE_OF_TITER,0.976611826109936
GOBP_POSITIVE_REGULATION_OF_...349,SET,233,0.011355,0.001271,0.059483,0.42431,GOBP_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.976611826109936
GSE25088_CTRL_VS_IL4_STIM_ST...2,SET,156,0.013367,0.0012269,0.07008,0.42436,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP,0.976611826109936
GSE7768_OVA_ALONE_VS_OVA_WIT...3,SET,148,0.013347,0.0011935,0.070027,0.42442,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.976611826109936
GSE33292_DN3_THYMOCYTE_VS_TC...4,SET,184,0.012138,0.001209,0.063693,0.42443,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP,0.976611826109936
GOBP_REPRODUCTIVE_BEHAVIOR,SET,44,0.027824,0.0013605,0.14603,0.42444,GOBP_REPRODUCTIVE_BEHAVIOR,0.976611826109936
GOMF_FLAP_ENDONUCLEASE_ACTIV...,SET,6,0.057675,0.0010425,0.30288,0.42449,GOMF_FLAP_ENDONUCLEASE_ACTIVITY,0.976611826109936
REACTOME_PI_3K_CASCADE_FGFR3,SET,17,0.040402,0.0012288,0.21243,0.42458,REACTOME_PI_3K_CASCADE_FGFR3,0.976611826109936
AACWWCAANK_UNKNOWN,SET,132,0.014472,0.0012227,0.076092,0.42458,AACWWCAANK_UNKNOWN,0.976611826109936
GOBP_REGULATION_OF_RECEPTOR_...3,SET,14,0.043743,0.0012075,0.23003,0.42459,GOBP_REGULATION_OF_RECEPTOR_CLUSTERING,0.976611826109936
CUI_DEVELOPING_HEART_C3_FIBR...,SET,103,0.017546,0.0013105,0.092266,0.42459,CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL,0.976611826109936
KEGG_MEDICUS_PATHOGEN_YERSIN...1,SET,5,0.072354,0.0011939,0.38065,0.42462,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY,0.976611826109936
GOBP_NEGATIVE_REGULATION_OF_...607,SET,12,0.05002,0.0012784,0.26329,0.42466,GOBP_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.976611826109936
GOBP_REGULATION_OF_DNA_DAMAG...3,SET,6,0.065954,0.0011921,0.34716,0.42466,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.976611826109936
GOBP_POSITIVE_REGULATION_OF_...586,SET,11,0.046835,0.001146,0.24658,0.42468,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.976611826109936
GENTILE_UV_RESPONSE_CLUSTER_...8,SET,24,0.034054,0.0012304,0.17938,0.42472,GENTILE_UV_RESPONSE_CLUSTER_D9,0.976611826109936
GOBP_NEGATIVE_REGULATION_OF_...256,SET,15,0.0419,0.0011971,0.22091,0.42479,GOBP_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS,0.976611826109936
GOBP_NEGATIVE_REGULATION_OF_...617,SET,7,0.065181,0.0012725,0.34371,0.4248,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.976611826109936
HELLER_HDAC_TARGETS_SILENCED...2,SET,370,0.0087542,0.0012302,0.046189,0.42484,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,0.976611826109936
GSE29164_CD8_TCELL_VS_CD8_TC...4,SET,174,0.012113,0.0011736,0.063916,0.42484,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,0.976611826109936
FULLER_PBMC_F_TULARENSIS_VAC...7,SET,42,0.027223,0.0013005,0.14372,0.42488,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP,0.976611826109936
IGLESIAS_E2F_TARGETS_DN,SET,11,0.050615,0.0012385,0.26725,0.42489,IGLESIAS_E2F_TARGETS_DN,0.976611826109936
GOBP_POSITIVE_REGULATION_OF_...113,SET,342,0.0092463,0.0012501,0.048816,0.42489,GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION,0.976611826109936
GSE15659_NONSUPPRESSIVE_TCEL...1,SET,170,0.012153,0.001164,0.064164,0.42489,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN,0.976611826109936
GSE40274_IRF4_VS_FOXP3_AND_I...2,SET,157,0.012193,0.0011227,0.064402,0.42492,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.976611826109936
HP_ABNORMAL_VENOUS_MORPHOLOGY,SET,136,0.013642,0.0011698,0.072066,0.42493,HP_ABNORMAL_VENOUS_MORPHOLOGY,0.976611826109936
GSE43955_10H_VS_60H_ACT_CD4_...1,SET,182,0.012229,0.0012115,0.0646,0.42493,GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN,0.976611826109936
GOBP_SUPRAMOLECULAR_FIBER_OR...,SET,775,0.0060882,0.0012242,0.03218,0.42497,GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.976611826109936
CDPCR3HD_01,SET,213,0.011702,0.0012531,0.06188,0.425,CDPCR3HD_01,0.976611826109936
CUI_TCF21_TARGETS_UP,SET,35,0.029578,0.0012902,0.15647,0.42504,CUI_TCF21_TARGETS_UP,0.976611826109936
GOBP_PROTEIN_TO_MEMBRANE_DOC...,SET,5,0.071565,0.0011808,0.3788,0.42508,GOBP_PROTEIN_TO_MEMBRANE_DOCKING,0.976611826109936
GOBP_NEGATIVE_REGULATION_OF_...654,SET,5,0.07952,0.0013121,0.42112,0.42511,GOBP_NEGATIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.976611826109936
GALE_APL_WITH_FLT3_MUTATED_DN,SET,13,0.044087,0.0011727,0.23351,0.42513,GALE_APL_WITH_FLT3_MUTATED_DN,0.976611826109936
GSE32901_NAIVE_VS_TH17_ENRIC...1,SET,154,0.012903,0.0011768,0.068347,0.42513,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN,0.976611826109936
GCM_DEAF1,SET,24,0.03067,0.0011081,0.16253,0.42516,GCM_DEAF1,0.976611826109936
MORF_CDH4,SET,115,0.015554,0.0012272,0.082427,0.42516,MORF_CDH4,0.976611826109936
REACTOME_CELL_CYCLE_CHECKPOI...,SET,241,0.0098568,0.0011219,0.05228,0.42523,REACTOME_CELL_CYCLE_CHECKPOINTS,0.976611826109936
GOBP_LIPOPOLYSACCHARIDE_MEDI...,SET,54,0.022688,0.0012286,0.12044,0.42529,GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.976611826109936
GSE21360_SECONDARY_VS_QUATER...1,SET,147,0.013922,0.0012408,0.0739,0.42529,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.976611826109936
NABA_MATRISOME_PRIMARY_METAS...,SET,54,0.024353,0.0013188,0.1293,0.4253,NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR,0.976611826109936
GSE339_CD4POS_VS_CD4CD8DN_DC...2,SET,189,0.011675,0.0011785,0.061995,0.42531,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.976611826109936
E2F1_Q4_01,SET,202,0.011189,0.0011672,0.05942,0.42532,E2F1_Q4_01,0.976611826109936
NAKAYA_PBMC_FLUMIST_AGE_18_5...4,SET,764,0.0058644,0.0011711,0.031155,0.42535,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN,0.976616188808879
BIOCARTA_BAD_PATHWAY,SET,24,0.036637,0.0013237,0.19473,0.42539,BIOCARTA_BAD_PATHWAY,0.976643509710662
GOBP_MICTURITION,SET,8,0.060126,0.0012548,0.31998,0.42548,GOBP_MICTURITION,0.976775709945846
HALLMARK_MYC_TARGETS_V1,SET,182,0.010728,0.0010628,0.057135,0.42553,HALLMARK_MYC_TARGETS_V1,0.976775709945846
MIYAGAWA_TARGETS_OF_EWSR1_ET...1,SET,204,0.012538,0.0013142,0.066801,0.42556,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,0.976775709945846
MIR588,SET,108,0.015825,0.0012101,0.084317,0.42556,MIR588,0.976775709945846
GOBP_REGULATION_OF_CELL_GROW...1,SET,353,0.0087455,0.0012009,0.046637,0.42563,GOBP_REGULATION_OF_CELL_GROWTH,0.976834655001651
HP_EMBRYONAL_NEOPLASM,SET,73,0.019879,0.001251,0.10605,0.42566,HP_EMBRYONAL_NEOPLASM,0.976834655001651
GOBP_CARDIAC_MUSCLE_CELL_MEM...,SET,36,0.028104,0.0012432,0.14995,0.42567,GOBP_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.976834655001651
GSE12963_ENV_NEF_VS_ENV_NEF_...2,SET,117,0.014164,0.001127,0.075608,0.4257,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.976839000396144
GOBP_POSITIVE_REGULATION_OF_...792,SET,12,0.042136,0.0010769,0.22533,0.42583,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.976892338150861
GOBP_PRIMARY_ALCOHOL_BIOSYNT...,SET,14,0.045964,0.0012688,0.24581,0.42584,GOBP_PRIMARY_ALCOHOL_BIOSYNTHETIC_PROCESS,0.976892338150861
GOBP_V_D_J_RECOMBINATION,SET,17,0.036769,0.0011183,0.19679,0.42589,GOBP_V_D_J_RECOMBINATION,0.976892338150861
GOBP_GLIAL_CELL_PROLIFERATION,SET,52,0.022698,0.0012062,0.12151,0.42591,GOBP_GLIAL_CELL_PROLIFERATION,0.976892338150861
GSE32901_TH1_VS_TH17_ENRICHE...2,SET,160,0.012352,0.001148,0.066122,0.42591,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP,0.976892338150861
GOBP_REDUCTION_OF_FOOD_INTAK...,SET,6,0.066541,0.0012027,0.35627,0.42592,GOBP_REDUCTION_OF_FOOD_INTAKE_IN_RESPONSE_TO_DIETARY_EXCESS,0.976892338150861
HP_THYROIDITIS,SET,45,0.024022,0.0011878,0.12862,0.42592,HP_THYROIDITIS,0.976892338150861
HP_BICORNUATE_UTERUS,SET,48,0.02213,0.00113,0.11874,0.42608,HP_BICORNUATE_UTERUS,0.977194826448462
FIGUEROA_AML_METHYLATION_CLU...14,SET,104,0.016637,0.0012486,0.089338,0.42613,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,0.977245011547344
HP_DECREASED_CIRCULATING_VIT...2,SET,31,0.027524,0.00113,0.14795,0.42621,HP_DECREASED_CIRCULATING_VITAMIN_D_CONCENTRATION,0.977280884681356
GSE31622_WT_VS_KLF3_KO_BCELL...2,SET,178,0.011665,0.001143,0.062704,0.42621,GSE31622_WT_VS_KLF3_KO_BCELL_UP,0.977280884681356
GOBP_GLYCOSYLCERAMIDE_METABO...,SET,16,0.040706,0.0012011,0.21887,0.42623,GOBP_GLYCOSYLCERAMIDE_METABOLIC_PROCESS,0.977280884681356
GSE5679_PPARG_LIGAND_ROSIGLI...4,SET,178,0.011949,0.0011708,0.064298,0.42629,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.977335359498681
GOBP_REGULATION_OF_SMALL_MOL...,SET,286,0.0096268,0.0011921,0.051821,0.42631,GOBP_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.977335359498681
WP_METABOLIC_PATHWAY_OF_LDL_...,SET,15,0.043074,0.0012307,0.2321,0.42639,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,0.977389819944598
GSE3982_MAC_VS_BCELL_UP,SET,178,0.012072,0.0011829,0.06505,0.42639,GSE3982_MAC_VS_BCELL_UP,0.977389819944598
GOBP_MAMMARY_GLAND_MORPHOGEN...,SET,44,0.02611,0.0012767,0.14082,0.42645,GOBP_MAMMARY_GLAND_MORPHOGENESIS,0.977462886631933
GOBP_ATRIOVENTRICULAR_NODE_D...,SET,9,0.053051,0.0011743,0.28626,0.42649,GOBP_ATRIOVENTRICULAR_NODE_DEVELOPMENT,0.977490104853601
HP_ABDUCENS_PALSY,SET,9,0.056198,0.0012439,0.3035,0.42655,HP_ABDUCENS_PALSY,0.977544530528814
GAVISH_3CA_METAPROGRAM_EPITH...19,SET,46,0.025142,0.0012569,0.13581,0.42657,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_2,0.977544530528814
GOBP_CARBOHYDRATE_CATABOLIC_...,SET,157,0.012321,0.0011344,0.066623,0.42664,GOBP_CARBOHYDRATE_CATABOLIC_PROCESS,0.977640482626755
TONKS_TARGETS_OF_RUNX1_RUNX1...6,SET,166,0.01273,0.001205,0.068906,0.42672,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,0.977717789570835
HP_SELF_MUTILATION,SET,39,0.024665,0.0011356,0.13353,0.42673,HP_SELF_MUTILATION,0.977717789570835
GOBP_MIDBODY_ABSCISSION,SET,17,0.038002,0.0011558,0.20639,0.42696,GOBP_MIDBODY_ABSCISSION,0.977998053487912
VECCHI_GASTRIC_CANCER_ADVANC...1,SET,132,0.013653,0.0011535,0.074211,0.42702,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,0.977998053487912
REACTOME_IRAK4_DEFICIENCY_TL...,SET,17,0.040011,0.0012169,0.21764,0.42707,REACTOME_IRAK4_DEFICIENCY_TLR2_4,0.977998053487912
HP_SCLEROCORNEA,SET,43,0.022874,0.0011057,0.12449,0.42711,HP_SCLEROCORNEA,0.977998053487912
GSE17974_0H_VS_24H_IN_VITRO_...2,SET,162,0.012587,0.0011771,0.068498,0.42711,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP,0.977998053487912
TSUNODA_CISPLATIN_RESISTANCE...1,SET,43,0.025278,0.0012219,0.13761,0.42713,TSUNODA_CISPLATIN_RESISTANCE_DN,0.977998053487912
GSE23568_CTRL_VS_ID3_TRANSDU...2,SET,183,0.011258,0.0011184,0.061292,0.42713,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP,0.977998053487912
REACTOME_SENSORY_PROCESSING_...1,SET,69,0.019908,0.0012181,0.10839,0.42714,REACTOME_SENSORY_PROCESSING_OF_SOUND,0.977998053487912
GSE14413_UNSTIM_VS_IFNB_STIM...5,SET,105,0.015282,0.0011523,0.0832,0.42714,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN,0.977998053487912
KEGG_MEDICUS_REFERENCE_ITGA_...6,SET,29,0.031031,0.0012323,0.16898,0.42715,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.977998053487912
GOBP_NEGATIVE_REGULATION_OF_...56,SET,14,0.04146,0.0011444,0.2259,0.42719,GOBP_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.977998053487912
GOBP_REGULATION_OF_MICROTUBU...6,SET,16,0.034401,0.0010151,0.18744,0.42719,GOBP_REGULATION_OF_MICROTUBULE_NUCLEATION,0.977998053487912
ERWIN_COHEN_BLOOD_VACCINE_TC...4,SET,71,0.019389,0.0012034,0.10571,0.42724,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP,0.978047766570605
WESTON_VEGFA_TARGETS_3HR,SET,59,0.022106,0.0012511,0.12066,0.42732,WESTON_VEGFA_TARGETS_3HR,0.978047766570605
PLASARI_TGFB1_SIGNALING_VIA_...2,SET,51,0.023256,0.001224,0.12698,0.42734,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,0.978047766570605
REACTOME_REGULATION_OF_ENDOG...4,SET,9,0.041722,0.00092351,0.22801,0.42741,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX,0.978047766570605
ZSCAN31_TARGET_GENES,SET,746,0.0058563,0.0011562,0.032009,0.42742,ZSCAN31_TARGET_GENES,0.978047766570605
ETS1_B,SET,241,0.010187,0.0011595,0.05572,0.42747,ETS1_B,0.978047766570605
GSE24972_WT_VS_IRF8_KO_MARGI...1,SET,181,0.011852,0.001171,0.064842,0.42748,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN,0.978047766570605
GOBP_NEUROTRANSMITTER_RECEPT...6,SET,15,0.042634,0.0012181,0.2334,0.42753,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_TO_PLASMA_MEMBRANE,0.978047766570605
MIR93_5P,SET,570,0.006735,0.0011681,0.036901,0.42759,MIR93_5P,0.978047766570605
YAP1_UP,SET,40,0.023766,0.0011081,0.13026,0.42761,YAP1_UP,0.978047766570605
MEBARKI_HCC_PROGENITOR_WNT_U...4,SET,21,0.03495,0.0011813,0.19164,0.42765,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,0.978047766570605
PID_RET_PATHWAY,SET,39,0.025177,0.0011591,0.13805,0.42765,PID_RET_PATHWAY,0.978047766570605
GOBP_POSITIVE_REGULATION_OF_...142,SET,5,0.06033,0.00099546,0.33088,0.42766,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,0.978047766570605
GSE17721_0.5H_VS_12H_POLYIC_...2,SET,180,0.011307,0.0011141,0.062017,0.42767,GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP,0.978047766570605
GOBP_NEGATIVE_REGULATION_OF_...279,SET,12,0.048992,0.0012521,0.26878,0.42768,GOBP_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.978047766570605
HP_ST_SEGMENT_DEPRESSION,SET,13,0.048137,0.0012805,0.26438,0.42776,HP_ST_SEGMENT_DEPRESSION,0.978047766570605
GOBP_POSITIVE_REGULATION_OF_...194,SET,13,0.045511,0.0012106,0.24997,0.42777,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.978047766570605
GOBP_REGULATION_OF_CELL_CELL...1,SET,460,0.0077445,0.0012104,0.04254,0.42777,GOBP_REGULATION_OF_CELL_CELL_ADHESION,0.978047766570605
MIR3200_3P,SET,24,0.033949,0.0012266,0.18657,0.42781,MIR3200_3P,0.978047766570605
REACTOME_VEGF_LIGAND_RECEPTO...,SET,7,0.064378,0.0012568,0.35386,0.42782,REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS,0.978047766570605
GSE23308_WT_VS_MINERALCORTIC...1,SET,174,0.011804,0.0011437,0.06489,0.42783,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN,0.978047766570605
GOBP_RNA_PROCESSING,SET,831,0.0051004,0.0010602,0.028043,0.42784,GOBP_RNA_PROCESSING,0.978047766570605
GSE12392_CD8A_POS_VS_NEG_SPL...2,SET,189,0.01117,0.0011274,0.06145,0.42788,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP,0.978047766570605
GOCC_MCRD_MEDIATED_MRNA_STAB...,SET,5,0.065954,0.0010882,0.36307,0.42793,GOCC_MCRD_MEDIATED_MRNA_STABILITY_COMPLEX,0.978047766570605
GRAHAM_CML_QUIESCENT_VS_CML_...2,SET,23,0.038699,0.0013688,0.21311,0.42795,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,0.978047766570605
GOBP_NEGATIVE_REGULATION_OF_...469,SET,43,0.026336,0.001273,0.14513,0.428,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.978047766570605
RREB1_01,SET,191,0.011255,0.0011419,0.062028,0.42801,RREB1_01,0.978047766570605
MIR767_5P,SET,174,0.012,0.0011627,0.066315,0.4282,MIR767_5P,0.978047766570605
HP_ABNORMAL_NONVERBAL_COMMUN...,SET,89,0.015188,0.0010549,0.083989,0.42825,HP_ABNORMAL_NONVERBAL_COMMUNICATIVE_BEHAVIOR,0.978047766570605
GSE17721_CPG_VS_GARDIQUIMOD_...18,SET,179,0.011408,0.0011209,0.063118,0.42829,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP,0.978047766570605
BIOCARTA_GCR_PATHWAY,SET,17,0.040312,0.0012261,0.22311,0.42831,BIOCARTA_GCR_PATHWAY,0.978047766570605
HP_BILIARY_ATRESIA,SET,11,0.045387,0.0011106,0.25118,0.42831,HP_BILIARY_ATRESIA,0.978047766570605
GTGCCAT_MIR183,SET,159,0.012772,0.0011834,0.070737,0.42836,GTGCCAT_MIR183,0.978047766570605
HP_ABNORMALITY_OF_TUMOR_NECR...,SET,5,0.074933,0.0012364,0.41503,0.42836,HP_ABNORMALITY_OF_TUMOR_NECROSIS_FACTOR_SECRETION,0.978047766570605
GOBP_CELLULAR_RESPONSE_TO_L_...1,SET,6,0.062671,0.0011328,0.34765,0.42847,GOBP_CELLULAR_RESPONSE_TO_L_GLUTAMATE,0.978047766570605
GOBP_DETECTION_OF_MECHANICAL...3,SET,14,0.043119,0.0011902,0.2392,0.42847,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.978047766570605
CTGTTAC_MIR194,SET,92,0.015649,0.001105,0.086822,0.42848,CTGTTAC_MIR194,0.978047766570605
GSE41978_ID2_KO_VS_ID2_KO_AN...2,SET,175,0.012401,0.0012049,0.068886,0.42857,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.978047766570605
GSE1740_MCSF_VS_MCSF_AND_IFN...4,SET,183,0.011099,0.0011026,0.061676,0.42859,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP,0.978047766570605
GOBP_NEGATIVE_REGULATION_OF_...386,SET,7,0.059606,0.0011637,0.33135,0.42862,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.978047766570605
GSE1432_1H_VS_24H_IFNG_MICRO...2,SET,188,0.01157,0.0011648,0.064332,0.42864,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.978047766570605
GSE22443_NAIVE_VS_ACT_AND_IL...3,SET,185,0.011686,0.0011671,0.064993,0.42866,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN,0.978047766570605
GSE9650_GP33_VS_GP276_LCMV_S...1,SET,185,0.010721,0.0010707,0.059627,0.42866,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN,0.978047766570605
HP_FUNCTIONAL_ABNORMALITY_OF...3,SET,919,0.0051329,0.0011193,0.028561,0.42869,HP_FUNCTIONAL_ABNORMALITY_OF_THE_INNER_EAR,0.978047766570605
PID_REELIN_PATHWAY,SET,28,0.030608,0.0011944,0.17035,0.4287,PID_REELIN_PATHWAY,0.978047766570605
MIR4800_5P,SET,23,0.030267,0.0010706,0.16863,0.42878,MIR4800_5P,0.978047766570605
HP_HYDRANENCEPHALY,SET,8,0.054398,0.0011353,0.30309,0.42878,HP_HYDRANENCEPHALY,0.978047766570605
GOBP_SUBSTRATE_DEPENDENT_CEL...2,SET,7,0.05499,0.0010735,0.30647,0.4288,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION,0.978047766570605
GRADE_COLON_VS_RECTAL_CANCER...1,SET,46,0.021476,0.0010736,0.11973,0.42883,GRADE_COLON_VS_RECTAL_CANCER_DN,0.978047766570605
GOMF_K48_LINKED_DEUBIQUITINA...,SET,10,0.04426,0.0010327,0.24685,0.42885,GOMF_K48_LINKED_DEUBIQUITINASE_ACTIVITY,0.978047766570605
BARRIER_CANCER_RELAPSE_NORMA...2,SET,29,0.027563,0.0010946,0.15375,0.42886,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,0.978047766570605
HP_NEOPLASM_OF_THE_AUTONOMIC...,SET,10,0.054706,0.0012764,0.30514,0.42886,HP_NEOPLASM_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,0.978047766570605
GOBP_STEM_CELL_FATE_COMMITME...,SET,10,0.057318,0.0013373,0.31994,0.42891,GOBP_STEM_CELL_FATE_COMMITMENT,0.978047766570605
HP_EPENDYMOMA,SET,19,0.035761,0.0011498,0.1996,0.42891,HP_EPENDYMOMA,0.978047766570605
GSE12366_PLASMA_CELL_VS_NAIV...1,SET,170,0.011509,0.0011023,0.064247,0.42891,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN,0.978047766570605
KIM_GASTRIC_CANCER_CHEMOSENS...,SET,86,0.016508,0.0011272,0.092241,0.42898,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,0.978047766570605
HP_SLENDER_LONG_BONES_WITH_N...,SET,5,0.062503,0.0010313,0.34923,0.42898,HP_SLENDER_LONG_BONES_WITH_NARROW_DIAPHYSES,0.978047766570605
REACTOME_APOPTOSIS_INDUCED_D...,SET,7,0.054554,0.001065,0.30484,0.42899,REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION,0.978047766570605
HP_ABNORMAL_BOWEL_SOUNDS,SET,8,0.048451,0.0010111,0.27096,0.42904,HP_ABNORMAL_BOWEL_SOUNDS,0.978047766570605
GOBP_MUSCLE_CELL_CELLULAR_HO...,SET,21,0.031512,0.0010651,0.17631,0.42907,GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS,0.978047766570605
GSE32533_WT_VS_MIR17_OVEREXP...2,SET,170,0.011687,0.0011194,0.065389,0.42907,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.978047766570605
GSE44649_NAIVE_VS_ACTIVATED_...3,SET,176,0.011291,0.0011002,0.063205,0.42911,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP,0.978047766570605
GSE26669_CD4_VS_CD8_TCELL_IN...1,SET,189,0.011328,0.0011434,0.063429,0.42913,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN,0.978047766570605
GOMF_MITOCHONDRION_TARGETING...,SET,5,0.061346,0.0010122,0.34361,0.42915,GOMF_MITOCHONDRION_TARGETING_SEQUENCE_BINDING,0.978047766570605
GOBP_MYOSIN_FILAMENT_ORGANIZ...,SET,6,0.060912,0.001101,0.34122,0.42916,GOBP_MYOSIN_FILAMENT_ORGANIZATION,0.978047766570605
MIR590_5P,SET,118,0.014142,0.0011301,0.079234,0.42917,MIR590_5P,0.978047766570605
REACTOME_SIGNALING_BY_FGFR1,SET,50,0.022049,0.0011491,0.12364,0.42923,REACTOME_SIGNALING_BY_FGFR1,0.978047766570605
GOBP_ANGIOGENESIS_INVOLVED_I...1,SET,5,0.075808,0.0012508,0.42519,0.42925,GOBP_ANGIOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.978047766570605
GOMF_INOSITOL_1_4_5_TRISPHOS...2,SET,11,0.050185,0.001228,0.28154,0.42926,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING,0.978047766570605
HP_GLANDULAR_HYPOSPADIAS,SET,4,0.07793,0.0011501,0.43716,0.42926,HP_GLANDULAR_HYPOSPADIAS,0.978047766570605
KEGG_MEDICUS_VARIANT_AMPLIFI...12,SET,11,0.042142,0.0010312,0.23676,0.42936,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S,0.978047766570605
MORF_PPP2R5B,SET,156,0.012209,0.0011206,0.068594,0.42937,MORF_PPP2R5B,0.978047766570605
GOBP_POSITIVE_REGULATION_OF_...59,SET,5,0.08048,0.0013279,0.45231,0.42939,GOBP_POSITIVE_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.978047766570605
WP_INTEGRINMEDIATED_CELL_ADH...,SET,95,0.01628,0.001168,0.091503,0.4294,WP_INTEGRINMEDIATED_CELL_ADHESION,0.978047766570605
REACTOME_CIRCADIAN_CLOCK,SET,64,0.019552,0.0011523,0.10992,0.42941,REACTOME_CIRCADIAN_CLOCK,0.978047766570605
GOBP_RESPONSE_TO_OZONE,SET,5,0.079396,0.00131,0.44656,0.42944,GOBP_RESPONSE_TO_OZONE,0.978047766570605
KEGG_MEDICUS_VARIANT_MUTATIO...15,SET,9,0.051968,0.0011503,0.29233,0.42945,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY,0.978047766570605
GSE14699_NAIVE_VS_ACT_CD8_TC...1,SET,158,0.012282,0.0011344,0.0691,0.42946,GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN,0.978047766570605
HE_LIM_SUN_FETAL_LUNG_C7_KCN...,SET,95,0.017634,0.0012652,0.099242,0.42949,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.978047766570605
GAVISH_3CA_METAPROGRAM_EPITH...16,SET,47,0.021352,0.0010789,0.12027,0.42954,GAVISH_3CA_METAPROGRAM_EPITHELIAL_MYC,0.978047766570605
GSE37301_HEMATOPOIETIC_STEM_...1,SET,118,0.014651,0.0011708,0.082518,0.42954,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN,0.978047766570605
CLAUS_PGR_POSITIVE_MENINGIOM...2,SET,8,0.050127,0.0010461,0.28239,0.42956,CLAUS_PGR_POSITIVE_MENINGIOMA_UP,0.978047766570605
HOOI_ST7_TARGETS_UP,SET,84,0.017143,0.0011569,0.096604,0.42958,HOOI_ST7_TARGETS_UP,0.978047766570605
KORKOLA_CORRELATED_WITH_POU5...,SET,25,0.03177,0.0011715,0.17905,0.42958,KORKOLA_CORRELATED_WITH_POU5F1,0.978047766570605
HP_GAIT_DISTURBANCE,SET,1052,0.0047778,0.0011104,0.026953,0.42965,HP_GAIT_DISTURBANCE,0.978047766570605
CHEN_HOXA5_TARGETS_9HR_UP,SET,205,0.010678,0.001122,0.060248,0.42966,CHEN_HOXA5_TARGETS_9HR_UP,0.978047766570605
HP_STOMATOCYTOSIS,SET,12,0.045256,0.0011566,0.25532,0.42966,HP_STOMATOCYTOSIS,0.978047766570605
WP_EICOSANOID_METABOLISM_VIA...2,SET,9,0.050207,0.0011113,0.28367,0.42976,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.978083216554253
WP_FATTY_ACID_TRANSPORTERS,SET,17,0.037995,0.0011556,0.21467,0.42976,WP_FATTY_ACID_TRANSPORTERS,0.978083216554253
GOMF_PHOSPHATIDYL_PHOSPHOLIP...,SET,11,0.046111,0.0011283,0.26054,0.42976,GOMF_PHOSPHATIDYL_PHOSPHOLIPASE_B_ACTIVITY,0.978083216554253
GOMF_POLY_ADP_D_RIBOSE_BINDI...,SET,4,0.060213,0.00088866,0.34037,0.42979,GOMF_POLY_ADP_D_RIBOSE_BINDING,0.978087444342588
GSE369_SOCS3_KO_VS_WT_LIVER_...2,SET,182,0.011225,0.001112,0.063479,0.42982,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN,0.978091671577293
GOBP_POSITIVE_REGULATION_OF_...129,SET,13,0.043357,0.0011533,0.24548,0.4299,GOBP_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.978138134650615
GSE3982_MAC_VS_TH2_DN,SET,187,0.010656,0.0010699,0.06037,0.42995,GSE3982_MAC_VS_TH2_DN,0.978138134650615
GOBP_INTRACILIARY_TRANSPORT,SET,40,0.02407,0.0011223,0.13642,0.42997,GOBP_INTRACILIARY_TRANSPORT,0.978138134650615
DESCARTES_FETAL_PANCREAS_ENS...2,SET,125,0.014588,0.0011996,0.082683,0.42998,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.978138134650615
GOBP_POSITIVE_REGULATION_OF_...297,SET,49,0.021115,0.0010894,0.11969,0.42999,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.978138134650615
DURANTE_ADULT_OLFACTORY_NEUR...9,SET,71,0.019597,0.0012163,0.11112,0.43001,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES,0.978138134650615
MIR5582_5P,SET,357,0.0080824,0.001116,0.045882,0.43009,MIR5582_5P,0.978138134650615
MIR2276_5P,SET,63,0.019702,0.0011521,0.11192,0.43013,MIR2276_5P,0.978138134650615
GSE17721_LPS_VS_PAM3CSK4_16H...1,SET,182,0.011219,0.0011115,0.063736,0.43014,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN,0.978138134650615
BUSSLINGER_DUODENAL_IMMUNE_C...,SET,822,0.0053554,0.0011075,0.030425,0.43014,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.978138134650615
MIR3679_3P,SET,145,0.012412,0.0010987,0.070527,0.43015,MIR3679_3P,0.978138134650615
HP_ABNORMAL_ISOHEMAGGLUTININ...,SET,7,0.063844,0.0012464,0.36334,0.43026,HP_ABNORMAL_ISOHEMAGGLUTININ_LEVEL,0.978254372138653
BROWNE_HCMV_INFECTION_10HR_UP,SET,90,0.015562,0.0010869,0.088583,0.43027,BROWNE_HCMV_INFECTION_10HR_UP,0.978254372138653
HP_ABNORMALITY_OF_DERMAL_MEL...,SET,5,0.069762,0.0011511,0.39727,0.4303,HP_ABNORMALITY_OF_DERMAL_MELANOSOMES,0.978254372138653
MORF_EIF4E,SET,79,0.016106,0.0010542,0.091752,0.43033,MORF_EIF4E,0.978254372138653
GSE5589_LPS_VS_LPS_AND_IL10_...8,SET,179,0.011368,0.001117,0.064783,0.43035,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.978254372138653
AMUNDSON_DNA_DAMAGE_RESPONSE...,SET,16,0.036715,0.0010834,0.20927,0.43037,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,0.978254372138653
HP_SPINAL_MUSCULAR_ATROPHY,SET,51,0.020444,0.001076,0.11668,0.43046,HP_SPINAL_MUSCULAR_ATROPHY,0.97832501142074
GOBP_REGULATION_OF_LAMELLIPO...1,SET,32,0.027775,0.0011586,0.15863,0.4305,GOBP_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.97832501142074
GHANDHI_DIRECT_IRRADIATION_UP,SET,97,0.016642,0.0012064,0.095108,0.43055,GHANDHI_DIRECT_IRRADIATION_UP,0.97832501142074
GSE43863_LY6C_INT_CXCR5POS_V...2,SET,181,0.011759,0.0011618,0.067202,0.43055,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.97832501142074
PHONG_TNF_RESPONSE_VIA_P38_P...,SET,155,0.013072,0.001196,0.074737,0.43058,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,0.97832501142074
GOBP_RESPONSE_TO_NUTRIENT,SET,156,0.012607,0.0011571,0.072077,0.43058,GOBP_RESPONSE_TO_NUTRIENT,0.97832501142074
GSE17721_4_VS_24H_CPG_BMDC_DN,SET,177,0.010702,0.0010457,0.061281,0.43068,GSE17721_4_VS_24H_CPG_BMDC_DN,0.97832501142074
GOMF_5_N_7_METHYLGUANOSINE_5...,SET,9,0.056329,0.0012468,0.32267,0.43071,GOMF_5_N_7_METHYLGUANOSINE_5_TRIPHOSPHO_MRNA_HYDROLASE_ACTIVITY,0.97832501142074
GOBP_RESPONSE_TO_NERVE_GROWT...,SET,51,0.021605,0.0011371,0.12379,0.43072,GOBP_RESPONSE_TO_NERVE_GROWTH_FACTOR,0.97832501142074
VERHAAK_GLIOBLASTOMA_NEURAL,SET,112,0.014389,0.0011204,0.082494,0.43076,VERHAAK_GLIOBLASTOMA_NEURAL,0.97832501142074
GOBP_REGULATION_OF_AXON_EXTE...1,SET,68,0.0179,0.0010873,0.10273,0.43084,GOBP_REGULATION_OF_AXON_EXTENSION,0.97832501142074
RAMJAUN_APOPTOSIS_BY_TGFB1_V...2,SET,6,0.062362,0.0011272,0.35798,0.43085,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP,0.97832501142074
HP_TELANGIECTASIA,SET,136,0.011926,0.0010227,0.068485,0.43088,HP_TELANGIECTASIA,0.97832501142074
GSE6259_FLT3L_INDUCED_VS_WT_...1,SET,145,0.013099,0.0011595,0.075223,0.43088,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN,0.97832501142074
ACEVEDO_LIVER_TUMOR_VS_NORMA...1,SET,241,0.0097829,0.0011135,0.056185,0.43089,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,0.97832501142074
REACTOME_ARACHIDONATE_PRODUC...,SET,5,0.062341,0.0010286,0.35819,0.43092,REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG,0.97832501142074
MIR1281,SET,9,0.050758,0.0011235,0.29166,0.43092,MIR1281,0.97832501142074
GOMF_MONOATOMIC_CATION_TRANS...,SET,580,0.0063708,0.0011143,0.03661,0.43093,GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.97832501142074
GOBP_POSITIVE_REGULATION_OF_...255,SET,29,0.027757,0.0011023,0.15957,0.43095,GOBP_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.97832501142074
MISIAK_ANAPLASTIC_THYROID_CA...1,SET,17,0.038102,0.0011589,0.21938,0.43106,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN,0.97832501142074
MIR1285_5P,SET,60,0.020391,0.0011638,0.1175,0.43111,MIR1285_5P,0.97832501142074
GSE1460_CORD_VS_ADULT_BLOOD_...1,SET,175,0.010919,0.0010609,0.062916,0.43111,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN,0.97832501142074
GSE12198_CTRL_VS_LOW_IL2_STI...2,SET,181,0.010556,0.0010429,0.060841,0.43113,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP,0.97832501142074
MIR1207_5P,SET,305,0.0086824,0.0011097,0.050046,0.43114,MIR1207_5P,0.97832501142074
HP_YOUNG_ADULT_ONSET,SET,512,0.0065994,0.0010866,0.038059,0.43117,HP_YOUNG_ADULT_ONSET,0.97832501142074
GSE22527_ANTI_CD3_INVIVO_VS_...2,SET,176,0.011374,0.0011082,0.065639,0.43122,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP,0.97832501142074
HP_IMPAIRED_DISTAL_TACTILE_S...,SET,18,0.030932,0.00096804,0.17858,0.43124,HP_IMPAIRED_DISTAL_TACTILE_SENSATION,0.97832501142074
MIR5003_3P,SET,293,0.008853,0.0011094,0.051121,0.43126,MIR5003_3P,0.97832501142074
GOBP_REGULATION_OF_DNA_RECOM...,SET,112,0.012985,0.0010111,0.075009,0.43128,GOBP_REGULATION_OF_DNA_RECOMBINATION,0.97832501142074
KEGG_MEDICUS_REFERENCE_KERAT...,SET,5,0.071921,0.0011867,0.41568,0.43132,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION,0.97832501142074
GOMF_OXIDOREDUCTASE_ACTIVITY...21,SET,38,0.024859,0.0011298,0.14368,0.43132,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.97832501142074
GOBP_THYROID_HORMONE_METABOL...,SET,28,0.029651,0.0011571,0.17141,0.43133,GOBP_THYROID_HORMONE_METABOLIC_PROCESS,0.97832501142074
GSE23308_WT_VS_MINERALCORTIC...2,SET,175,0.010906,0.0010597,0.063041,0.43133,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP,0.97832501142074
RAMJAUN_APOPTOSIS_BY_TGFB1_V...3,SET,10,0.04981,0.0011621,0.28813,0.43138,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,0.978356084828711
GOBP_POLY_N_ACETYLLACTOSAMIN...,SET,9,0.053046,0.0011742,0.30694,0.4314,GOBP_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS,0.978356084828711
GOMF_PROTEIN_SERINE_THREONIN...6,SET,11,0.040225,0.00098431,0.23292,0.43144,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY,0.978382957066423
GRADE_COLON_AND_RECTAL_CANCE...2,SET,256,0.0089053,0.0010442,0.051583,0.43147,GRADE_COLON_AND_RECTAL_CANCER_UP,0.978387150127227
WP_ACETYLCHOLINE_SYNTHESIS,SET,5,0.064639,0.0010666,0.37482,0.43154,WP_ACETYLCHOLINE_SYNTHESIS,0.978407144253323
GOBP_REGULATION_OF_NERVOUS_S...1,SET,417,0.0075184,0.0011201,0.043605,0.43156,GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.978407144253323
REACTOME_COSTIMULATION_BY_TH...,SET,62,0.019797,0.0011485,0.11494,0.43162,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,0.978407144253323
GSE21670_TGFB_VS_IL6_TREATED...4,SET,188,0.010753,0.0010825,0.06252,0.43172,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.978407144253323
GOBP_GLYCOSYL_COMPOUND_BIOSY...,SET,21,0.031656,0.00107,0.18406,0.43173,GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS,0.978407144253323
GSE1925_3H_VS_24H_IFNG_STIM_...4,SET,170,0.01132,0.0010842,0.065842,0.43175,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP,0.978407144253323
GOCC_INTRACILIARY_TRANSPORT_...2,SET,8,0.046349,0.00096728,0.26996,0.43184,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_A,0.978407144253323
HP_ABNORMAL_SUBSTANTIA_NIGRA...,SET,18,0.034248,0.0010718,0.19953,0.43186,HP_ABNORMAL_SUBSTANTIA_NIGRA_MORPHOLOGY,0.978407144253323
GOCC_MKS_COMPLEX,SET,13,0.034847,0.00092694,0.20304,0.43187,GOCC_MKS_COMPLEX,0.978407144253323
HP_ABNORMAL_THYROID_MORPHOLO...,SET,166,0.011635,0.0011013,0.067816,0.43189,HP_ABNORMAL_THYROID_MORPHOLOGY,0.978407144253323
GOBP_MAST_CELL_PROLIFERATION,SET,7,0.064225,0.0012538,0.3744,0.4319,GOBP_MAST_CELL_PROLIFERATION,0.978407144253323
GOBP_LEUKOCYTE_ADHESION_TO_A...,SET,5,0.073549,0.0012136,0.42907,0.43195,GOBP_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.978407144253323
ZNF404_TARGET_GENES,SET,17,0.032343,0.00098372,0.18873,0.43197,ZNF404_TARGET_GENES,0.978407144253323
GOBP_NEGATIVE_REGULATION_OF_...390,SET,4,0.08192,0.001209,0.47809,0.43198,GOBP_NEGATIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.978407144253323
GOBP_VESICLE_FUSION_TO_PLASM...,SET,23,0.030864,0.0010917,0.18013,0.43198,GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE,0.978407144253323
GOBP_S_ADENOSYLMETHIONINE_CY...,SET,7,0.057548,0.0011235,0.336,0.43201,GOBP_S_ADENOSYLMETHIONINE_CYCLE,0.978407144253323
RICHERT_PBMC_HIV_LIPO_5_AGE_...1,SET,8,0.083428,0.0017411,0.48746,0.43205,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP,0.978407144253323
GOBP_REGULATION_OF_UNSATURAT...,SET,10,0.043518,0.0010154,0.25431,0.43206,GOBP_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.978407144253323
GOMF_EXTRACELLULAR_MATRIX_CO...,SET,10,0.051229,0.0011953,0.29934,0.43206,GOMF_EXTRACELLULAR_MATRIX_CONSTITUENT_CONFERRING_ELASTICITY,0.978407144253323
HP_NEOPLASM_OF_THE_PARATHYRO...,SET,18,0.037053,0.0011596,0.21651,0.43206,HP_NEOPLASM_OF_THE_PARATHYROID_GLAND,0.978407144253323
GOBP_VITAMIN_BIOSYNTHETIC_PR...,SET,24,0.031069,0.0011226,0.18157,0.43207,GOBP_VITAMIN_BIOSYNTHETIC_PROCESS,0.978407144253323
GOBP_NEGATIVE_REGULATION_OF_...11,SET,5,0.071077,0.0011728,0.41566,0.43211,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.97841551465798
REACTOME_ACTIVATION_OF_NIMA_...,SET,7,0.048517,0.00094716,0.28379,0.43213,REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7,0.97841551465798
REACTOME_INFLAMMASOMES,SET,19,0.032437,0.0010429,0.18991,0.43219,REACTOME_INFLAMMASOMES,0.97848587848398
GSE24142_DN2_VS_DN3_THYMOCYT...4,SET,184,0.010893,0.001085,0.063826,0.43225,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN,0.97848587848398
GOBP_PROTEIN_TRANSPORT_INTO_...,SET,4,0.072981,0.0010771,0.42782,0.43228,GOBP_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT,0.97848587848398
GOBP_REGULATION_OF_CORTISOL_...,SET,7,0.06029,0.001177,0.35365,0.43232,GOBP_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS,0.97848587848398
GSE27786_BCELL_VS_MONO_MAC_UP,SET,170,0.011059,0.0010592,0.064871,0.43232,GSE27786_BCELL_VS_MONO_MAC_UP,0.97848587848398
GOMF_PROLINE_RICH_REGION_BIN...,SET,16,0.039166,0.0011557,0.2298,0.43233,GOMF_PROLINE_RICH_REGION_BINDING,0.97848587848398
GAUTAM_EYE_IRIS_CILIARY_BODY...6,SET,68,0.016515,0.0010032,0.096933,0.43236,GAUTAM_EYE_IRIS_CILIARY_BODY_CYTOTOXIC_T_CELLS,0.97849005665169
GOBP_OOCYTE_ANTERIOR_POSTERI...,SET,6,0.061537,0.0011123,0.36154,0.43242,GOBP_OOCYTE_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.978562123974476
GSE9650_EXHAUSTED_VS_MEMORY_...2,SET,182,0.011006,0.0010903,0.064687,0.43245,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP,0.978566296633895
KEGG_MEDICUS_REFERENCE_II_BL...,SET,7,0.062468,0.0012195,0.36763,0.43254,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS,0.978681799544419
KEGG_MEDICUS_REFERENCE_FAS_J...,SET,7,0.058137,0.001135,0.34229,0.43257,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY,0.978681799544419
WP_COMPLEMENT_SYSTEM_IN_NEUR...,SET,95,0.015699,0.0011264,0.092469,0.43259,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.978681799544419
HP_ABNORMAL_METATARSAL_MORPH...,SET,139,0.012744,0.0011047,0.075105,0.43263,HP_ABNORMAL_METATARSAL_MORPHOLOGY,0.978681799544419
KEGG_MEDICUS_VARIANT_MUTATIO...41,SET,13,0.037891,0.0010079,0.22338,0.43265,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION,0.978681799544419
REACTOME_NEGATIVE_REGULATION...4,SET,27,0.028923,0.0011083,0.17055,0.43267,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,0.978681799544419
HP_POSTAXIAL_FOOT_POLYDACTYLY,SET,63,0.017702,0.0010352,0.10458,0.43279,HP_POSTAXIAL_FOOT_POLYDACTYLY,0.978889525575947
GSE17721_PAM3CSK4_VS_CPG_2H_...2,SET,180,0.011024,0.0010862,0.065309,0.43298,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP,0.979255541094553
GNF2_SPTA1,SET,69,0.017711,0.0010837,0.10503,0.43304,GNF2_SPTA1,0.979280283614129
GSE46606_IRF4HIGH_VS_IRF4MID...3,SET,181,0.011151,0.0011017,0.06616,0.43308,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.979280283614129
chr8q11,SET,19,0.054516,0.0017528,0.32356,0.4331,chr8q11,0.979280283614129
GOBP_REGULATION_OF_T_CELL_AC...1,SET,356,0.0081331,0.0011215,0.048306,0.43315,GOBP_REGULATION_OF_T_CELL_ACTIVATION,0.979280283614129
GOMF_SUPEROXIDE_GENERATING_N...2,SET,7,0.055038,0.0010745,0.32692,0.43315,GOMF_SUPEROXIDE_GENERATING_NAD_P_H_OXIDASE_ACTIVITY,0.979280283614129
HP_ABNORMAL_PERIPHERAL_MYELI...,SET,92,0.014661,0.0010352,0.087096,0.43316,HP_ABNORMAL_PERIPHERAL_MYELINATION,0.979280283614129
HP_ANIRIDIA,SET,41,0.022958,0.0010837,0.13643,0.43319,HP_ANIRIDIA,0.979284405489788
HP_LARGE_ILIAC_WING,SET,3,0.080974,0.001035,0.48154,0.43323,HP_LARGE_ILIAC_WING,0.979311131707317
GOCC_CILIARY_PLASM,SET,135,0.011943,0.0010203,0.071076,0.43328,GOCC_CILIARY_PLASM,0.979360457856399
GOMF_OLIGOPEPTIDE_TRANSMEMBR...,SET,14,0.03945,0.0010889,0.23503,0.43335,GOMF_OLIGOPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.979440600819299
ULE_SPLICING_VIA_NOVA2,SET,42,0.022897,0.0010939,0.13651,0.4334,ULE_SPLICING_VIA_NOVA2,0.979440600819299
HP_BILATERAL_TONIC_CLONIC_SE...3,SET,41,0.023938,0.0011299,0.14271,0.4334,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_GENERALIZED_ONSET,0.979440600819299
KEGG_MEDICUS_REFERENCE_N_GLY...4,SET,7,0.041315,0.00080656,0.24652,0.43345,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL,0.979448819972694
REACTOME_CALCINEURIN_ACTIVAT...,SET,9,0.044293,0.00098042,0.26431,0.43346,REACTOME_CALCINEURIN_ACTIVATES_NFAT,0.979448819972694
GOBP_REGULATION_OF_AXON_EXTE...2,SET,15,0.038222,0.0010921,0.22826,0.43351,GOBP_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.979457036988884
GSE22886_NAIVE_CD8_TCELL_VS_...1,SET,185,0.010431,0.0010417,0.062302,0.43352,GSE22886_NAIVE_CD8_TCELL_VS_DC_DN,0.979457036988884
GOCC_NEUROFILAMENT,SET,10,0.050787,0.0011849,0.30376,0.43361,GOCC_NEUROFILAMENT,0.97947755698422
GOCC_PRESYNAPSE,SET,524,0.0064985,0.0010821,0.038868,0.43361,GOCC_PRESYNAPSE,0.97947755698422
REACTOME_ELEVATION_OF_CYTOSO...,SET,16,0.03708,0.0010942,0.22213,0.43371,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,0.97947755698422
MODULE_50,SET,13,0.03078,0.00081874,0.18469,0.43382,MODULE_50,0.97947755698422
REACTOME_DEFECTIVE_EXT2_CAUS...,SET,12,0.046334,0.0011842,0.27813,0.43385,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,0.97947755698422
GOBP_ATRIAL_CARDIAC_MUSCLE_C...1,SET,8,0.055297,0.001154,0.33194,0.43385,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.97947755698422
GOBP_HIGH_DENSITY_LIPOPROTEI...2,SET,9,0.049285,0.0010909,0.29607,0.4339,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.97947755698422
ERWIN_COHEN_PBMC_TC_83_AGE_1...1,SET,36,0.028457,0.0012589,0.17096,0.4339,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.97947755698422
MIR299_3P,SET,50,0.019448,0.0010135,0.11684,0.43391,MIR299_3P,0.97947755698422
HP_ABSENCE_OF_SECONDARY_SEX_...,SET,40,0.024116,0.0011244,0.1449,0.43391,HP_ABSENCE_OF_SECONDARY_SEX_CHARACTERISTICS,0.97947755698422
FAN_OVARY_CL8_MATURE_CUMULUS...,SET,541,0.0060373,0.001021,0.036274,0.43391,FAN_OVARY_CL8_MATURE_CUMULUS_GRANULOSA_CELL_2,0.97947755698422
REACTOME_DEFECTIVE_CHST14_CA...,SET,7,0.04821,0.00094117,0.28978,0.43393,REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE,0.97947755698422
CSHL1_TARGET_GENES,SET,177,0.010587,0.0010344,0.063634,0.43393,CSHL1_TARGET_GENES,0.97947755698422
GOBP_REGULATION_OF_RESPIRATO...1,SET,16,0.037455,0.0011052,0.22519,0.43395,GOBP_REGULATION_OF_RESPIRATORY_BURST,0.97947755698422
HP_PITUITARY_DWARFISM,SET,9,0.051906,0.0011489,0.3121,0.43396,HP_PITUITARY_DWARFISM,0.97947755698422
MODULE_241,SET,69,0.018327,0.0011214,0.11023,0.43398,MODULE_241,0.97947755698422
GSE19941_LPS_VS_LPS_AND_IL10...3,SET,178,0.010518,0.0010306,0.06338,0.4341,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.979619057510061
GUTIERREZ_MULTIPLE_MYELOMA_UP,SET,30,0.026156,0.0010564,0.15773,0.43415,GUTIERREZ_MULTIPLE_MYELOMA_UP,0.979619057510061
FIGUEROA_AML_METHYLATION_CLU...5,SET,35,0.02516,0.0010975,0.15178,0.43417,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,0.979619057510061
GOBP_PYRIMIDINE_RIBONUCLEOTI...2,SET,8,0.05119,0.0010683,0.30881,0.43417,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_CATABOLIC_PROCESS,0.979619057510061
LIM_MAMMARY_STEM_CELL_DN,SET,385,0.0071504,0.0010245,0.043145,0.43419,LIM_MAMMARY_STEM_CELL_DN,0.979619057510061
HP_ABNORMAL_CLAVICLE_MORPHOL...,SET,94,0.014231,0.0010156,0.085917,0.43422,HP_ABNORMAL_CLAVICLE_MORPHOLOGY,0.979619057510061
GOMF_NON_MEMBRANE_SPANNING_P...2,SET,10,0.044051,0.0010278,0.26601,0.43424,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.979619057510061
HP_AXONAL_REGENERATION,SET,6,0.064238,0.0011611,0.38817,0.43428,HP_AXONAL_REGENERATION,0.979645706497047
GOBP_RESPONSE_TO_ESTROGEN,SET,64,0.017985,0.00106,0.10876,0.43433,GOBP_RESPONSE_TO_ESTROGEN,0.979686573263281
GOBP_REGULATION_OF_GLIAL_CEL...1,SET,12,0.04268,0.0010908,0.25859,0.43445,GOBP_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,0.979686573263281
CATTGTYY_SOX9_B1,SET,330,0.0079403,0.0010549,0.048112,0.43446,CATTGTYY_SOX9_B1,0.979686573263281
ID1_TARGET_GENES,SET,1008,0.0045437,0.001035,0.027555,0.43451,ID1_TARGET_GENES,0.979686573263281
GOCC_BASEMENT_MEMBRANE,SET,85,0.016389,0.0011126,0.099385,0.43451,GOCC_BASEMENT_MEMBRANE,0.979686573263281
REACTOME_SIGNALING_BY_ERBB2_...2,SET,25,0.026591,0.00098057,0.16131,0.43453,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,0.979686573263281
GOBP_CYTOSOL_TO_ENDOPLASMIC_...,SET,4,0.067639,0.00099825,0.41032,0.43454,GOBP_CYTOSOL_TO_ENDOPLASMIC_RETICULUM_TRANSPORT,0.979686573263281
MIR548AW,SET,539,0.0062347,0.0010525,0.037838,0.43456,MIR548AW,0.979686573263281
GOMF_N_ACYLTRANSFERASE_ACTIV...,SET,79,0.014956,0.00097893,0.090767,0.43456,GOMF_N_ACYLTRANSFERASE_ACTIVITY,0.979686573263281
MIR6845_3P,SET,124,0.013095,0.0010726,0.079502,0.43458,MIR6845_3P,0.979686573263281
HP_ABSENT_NIPPLE,SET,9,0.044153,0.00097733,0.26832,0.43465,HP_ABSENT_NIPPLE,0.979780824361136
REACTOME_ECM_PROTEOGLYCANS,SET,73,0.017337,0.001091,0.10548,0.43472,REACTOME_ECM_PROTEOGLYCANS,0.979856595330739
MIR5705,SET,5,0.057347,0.00094624,0.34901,0.43474,MIR5705,0.979856595330739
GOBP_CARDIAC_MUSCLE_TISSUE_M...,SET,58,0.02011,0.0011285,0.12246,0.43478,GOBP_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.979883204720835
GOCC_HISTONE_PRE_MRNA_3_END_...,SET,6,0.05273,0.00095307,0.32194,0.43495,GOCC_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX,0.980202778498249
HP_ABNORMAL_BRAIN_EVOKED_POT...,SET,91,0.014772,0.0010374,0.090233,0.43498,HP_ABNORMAL_BRAIN_EVOKED_POTENTIALS,0.980206827465473
GOBP_PYRIMIDINE_NUCLEOSIDE_T...2,SET,22,0.031152,0.0010777,0.19038,0.43501,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.980210875907676
GOBP_POSTSYNAPTIC_MODULATION...,SET,26,0.027826,0.0010464,0.17023,0.43508,GOBP_POSTSYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.980264031505251
HP_PRODUCTIVE_COUGH,SET,56,0.018049,0.00099531,0.11044,0.43509,HP_PRODUCTIVE_COUGH,0.980264031505251
GSE11961_MARGINAL_ZONE_BCELL...7,SET,175,0.010902,0.0010593,0.066747,0.43513,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.980290604135606
DUNNE_TARGETS_OF_AML1_MTG8_F...1,SET,17,0.034036,0.0010352,0.2085,0.43517,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,0.980296368407412
GSE2770_UNTREATED_VS_ACT_CD4...1,SET,181,0.0099557,0.00098362,0.061044,0.43522,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN,0.980296368407412
GNF2_LCAT,SET,118,0.013108,0.0010475,0.080434,0.43527,GNF2_LCAT,0.980296368407412
GARY_CD5_TARGETS_DN,SET,396,0.006541,0.00095021,0.040156,0.4353,GARY_CD5_TARGETS_DN,0.980296368407412
GOBP_CELLULAR_RESPONSE_TO_CO...3,SET,22,0.035567,0.0012304,0.21838,0.43531,GOBP_CELLULAR_RESPONSE_TO_COPPER_ION,0.980296368407412
REACTOME_RESPIRATORY_ELECTRO...,SET,135,0.010551,0.00090141,0.0648,0.43533,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,0.980296368407412
GOBP_GDP_MANNOSE_METABOLIC_P...,SET,6,0.045462,0.0008217,0.27922,0.43533,GOBP_GDP_MANNOSE_METABOLIC_PROCESS,0.980296368407412
GOBP_LEARNED_VOCALIZATION_BE...,SET,10,0.04955,0.0011561,0.30453,0.43537,GOBP_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING,0.980322925170068
MIR3945,SET,34,0.022964,0.00098731,0.14137,0.43548,MIR3945,0.980507087328323
MAHADEVAN_IMATINIB_RESISTANC...2,SET,17,0.039008,0.0011864,0.24032,0.43553,MAHADEVAN_IMATINIB_RESISTANCE_UP,0.98053765060241
GOBP_NEGATIVE_REGULATION_OF_...609,SET,22,0.031413,0.0010867,0.19358,0.43555,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.98053765060241
GOBP_MEIOTIC_SPINDLE_ORGANIZ...,SET,16,0.034665,0.0010229,0.21386,0.43562,GOBP_MEIOTIC_SPINDLE_ORGANIZATION,0.980565094765343
GARGALOVIC_RESPONSE_TO_OXIDI...6,SET,15,0.032717,0.00093478,0.20203,0.43568,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,0.980565094765343
HP_ALKALOSIS,SET,29,0.02597,0.0010313,0.16051,0.43573,HP_ALKALOSIS,0.980565094765343
MODULE_202,SET,26,0.028496,0.0010716,0.17643,0.43584,MODULE_202,0.980565094765343
THEILGAARD_NEUTROPHIL_AT_SKI...1,SET,213,0.0090407,0.0009681,0.05602,0.4359,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,0.980565094765343
GOBP_MAINTENANCE_OF_ORGANELL...,SET,11,0.03602,0.00088141,0.22323,0.43591,GOBP_MAINTENANCE_OF_ORGANELLE_LOCATION,0.980565094765343
WP_FATTY_ACIDS_AND_LIPOPROTE...,SET,355,0.0074213,0.0010219,0.046005,0.43592,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,0.980565094765343
MIR1913,SET,138,0.011177,0.00096534,0.069294,0.43593,MIR1913,0.980565094765343
GOMF_CAMP_BINDING,SET,23,0.029924,0.0010584,0.18561,0.43596,GOMF_CAMP_BINDING,0.980565094765343
GOMF_3_5_EXONUCLEASE_ACTIVITY,SET,56,0.016624,0.00091672,0.10312,0.43597,GOMF_3_5_EXONUCLEASE_ACTIVITY,0.980565094765343
GOBP_POSITIVE_REGULATION_OF_...190,SET,4,0.055145,0.00081387,0.34226,0.436,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.980565094765343
GSE21927_SPLEEN_C57BL6_VS_4T...1,SET,185,0.010018,0.0010006,0.062197,0.43602,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN,0.980565094765343
REACTOME_O_GLYCOSYLATION_OF_...,SET,36,0.025508,0.0011284,0.15839,0.43603,REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,0.980565094765343
HP_ABNORMALITY_OF_SKELETAL_M...2,SET,106,0.013086,0.00099141,0.081403,0.43615,HP_ABNORMALITY_OF_SKELETAL_MUSCLE_FIBER_SIZE,0.980565094765343
GSE43700_UNTREATED_VS_IL10_T...1,SET,187,0.010261,0.0010303,0.063849,0.43616,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN,0.980565094765343
HP_INCREASED_CIRCULATING_INT...1,SET,20,0.031409,0.0010361,0.19546,0.43617,HP_INCREASED_CIRCULATING_INTERFERON_GAMMA_CONCENTRATION,0.980565094765343
GSE9509_LPS_VS_LPS_AND_IL10_...6,SET,168,0.01067,0.001016,0.066401,0.43617,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP,0.980565094765343
GOBP_NEGATIVE_REGULATION_OF_...382,SET,9,0.048447,0.0010724,0.30189,0.43625,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.980565094765343
GAVISH_3CA_MALIGNANT_METAPRO...21,SET,48,0.018197,0.00092921,0.11346,0.43629,GAVISH_3CA_MALIGNANT_METAPROGRAM_2_CELL_CYCLE_G1_S,0.980565094765343
GOBP_POSITIVE_REGULATION_OF_...112,SET,11,0.041631,0.0010187,0.25956,0.43629,GOBP_POSITIVE_REGULATION_OF_CELLULAR_SENESCENCE,0.980565094765343
BUSSLINGER_GASTRIC_OXYNTIC_E...,SET,74,0.017438,0.0011048,0.10874,0.4363,BUSSLINGER_GASTRIC_OXYNTIC_ENTEROCHROMAFFIN_LIKE_CELLS,0.980565094765343
ROY_WOUND_BLOOD_VESSEL_DN,SET,19,0.032335,0.0010396,0.20167,0.43631,ROY_WOUND_BLOOD_VESSEL_DN,0.980565094765343
VISALA_RESPONSE_TO_HEAT_SHOC...2,SET,14,0.034083,0.00094082,0.21262,0.43632,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,0.980565094765343
GSE36826_NORMAL_VS_STAPH_AUR...1,SET,183,0.0098852,0.00098198,0.061673,0.43633,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN,0.980565094765343
HOLLEMAN_DAUNORUBICIN_ALL_DN,SET,8,0.047064,0.0009822,0.29399,0.43641,HOLLEMAN_DAUNORUBICIN_ALL_DN,0.980565094765343
GSE29617_CTRL_VS_DAY3_TIV_FL...1,SET,178,0.0097589,0.00095622,0.061009,0.43646,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN,0.980565094765343
ZHENG_GLIOBLASTOMA_PLASTICIT...2,SET,227,0.0094468,0.0010439,0.059078,0.43648,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,0.980565094765343
MIR876_3P,SET,80,0.016044,0.0010567,0.10034,0.43648,MIR876_3P,0.980565094765343
WP_LIPID_METABOLISM_PATHWAY,SET,28,0.025487,0.00099455,0.15942,0.43649,WP_LIPID_METABOLISM_PATHWAY,0.980565094765343
HATADA_METHYLATED_IN_LUNG_CA...2,SET,350,0.0075359,0.0010305,0.047144,0.4365,HATADA_METHYLATED_IN_LUNG_CANCER_UP,0.980565094765343
YU_MYC_TARGETS_DN,SET,50,0.019381,0.00101,0.12149,0.43663,YU_MYC_TARGETS_DN,0.980565094765343
HP_TYPE_I_TRANSFERRIN_ISOFOR...,SET,17,0.026915,0.00081861,0.16879,0.43665,HP_TYPE_I_TRANSFERRIN_ISOFORM_PROFILE,0.980565094765343
GOMF_SH2_DOMAIN_BINDING,SET,39,0.023572,0.0010853,0.14784,0.43666,GOMF_SH2_DOMAIN_BINDING,0.980565094765343
NADERI_BREAST_CANCER_PROGNOS...2,SET,47,0.020327,0.0010271,0.12766,0.43675,NADERI_BREAST_CANCER_PROGNOSIS_UP,0.980565094765343
GOBP_BASE_EXCISION_REPAIR_AP...,SET,12,0.03775,0.00096479,0.23729,0.4368,GOBP_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.980565094765343
REACTOME_FORMATION_OF_LATERA...,SET,5,0.063085,0.0010409,0.39671,0.43683,REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM,0.980565094765343
MIR3154,SET,107,0.012938,0.00098478,0.081409,0.43687,MIR3154,0.980565094765343
HP_LONG_NOSE,SET,32,0.023948,0.00099892,0.1507,0.43687,HP_LONG_NOSE,0.980565094765343
chr4p13,SET,12,0.058407,0.0014927,0.36761,0.43688,chr4p13,0.980565094765343
GSE35685_CD34POS_CD10NEG_CD6...2,SET,184,0.0097416,0.00097032,0.061339,0.43691,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.980565094765343
GOBP_REGULATION_OF_MYOFIBROB...,SET,6,0.045275,0.00081832,0.2852,0.43693,GOBP_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.980565094765343
ZHOU_INFLAMMATORY_RESPONSE_L...1,SET,323,0.0073824,0.00097053,0.046506,0.43694,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,0.980565094765343
MIR6760_3P,SET,96,0.01408,0.0010154,0.088731,0.43696,MIR6760_3P,0.980565094765343
ZHANG_ANTIVIRAL_RESPONSE_TO_...2,SET,24,0.02929,0.0010583,0.1846,0.43697,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,0.980565094765343
GOBP_INDOLE_CONTAINING_COMPO...2,SET,9,0.053391,0.0011818,0.33673,0.43701,GOBP_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.980565094765343
KEGG_MEDICUS_REFERENCE_EGF_J...,SET,7,0.066747,0.0013031,0.42102,0.43702,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY,0.980565094765343
GOBP_LATE_ENDOSOME_TO_VACUOL...1,SET,36,0.021051,0.00093125,0.13295,0.43709,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT,0.980565094765343
GOBP_CEREBELLAR_GRANULAR_LAY...2,SET,6,0.069245,0.0012516,0.43796,0.43719,GOBP_CEREBELLAR_GRANULAR_LAYER_FORMATION,0.980565094765343
WP_APOPTOSIS,SET,82,0.015278,0.0010187,0.0967,0.43723,WP_APOPTOSIS,0.980565094765343
MIR5689,SET,137,0.012055,0.0010374,0.07631,0.43724,MIR5689,0.980565094765343
GOBP_POSITIVE_REGULATION_OF_...667,SET,50,0.019867,0.0010354,0.12576,0.43724,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.980565094765343
GSE22886_IL2_VS_IL15_STIM_NK...2,SET,177,0.010796,0.0010549,0.068336,0.43724,GSE22886_IL2_VS_IL15_STIM_NKCELL_UP,0.980565094765343
GOCC_MITOTIC_COHESIN_COMPLEX,SET,4,0.087778,0.0012955,0.55587,0.43726,GOCC_MITOTIC_COHESIN_COMPLEX,0.980565094765343
MIR4769_3P,SET,97,0.013836,0.001003,0.087656,0.43729,MIR4769_3P,0.980565094765343
GSE3982_MAST_CELL_VS_BCELL_UP,SET,180,0.010411,0.0010258,0.065955,0.43729,GSE3982_MAST_CELL_VS_BCELL_UP,0.980565094765343
GOBP_POSITIVE_REGULATION_OF_...62,SET,50,0.019833,0.0010336,0.1257,0.43731,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.980565094765343
GSE17721_LPS_VS_CPG_16H_BMDC...2,SET,182,0.010003,0.00099095,0.063399,0.43732,GSE17721_LPS_VS_CPG_16H_BMDC_UP,0.980565094765343
MARTINEZ_RB1_AND_TP53_TARGET...2,SET,568,0.0057328,0.00099262,0.036342,0.43733,MARTINEZ_RB1_AND_TP53_TARGETS_UP,0.980565094765343
VEGF_A_UP.V1_UP,SET,176,0.010124,0.00098643,0.064176,0.43733,VEGF_A_UP.V1_UP,0.980565094765343
GOMF_CATALYTIC_ACTIVITY_ACTI...2,SET,541,0.0054295,0.00091818,0.03443,0.43735,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_NUCLEIC_ACID,0.980565094765343
REACTOME_EARLY_SARS_COV_2_IN...,SET,34,0.022699,0.00097589,0.14405,0.4374,REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS,0.980565094765343
HP_PROTRUDING_TONGUE,SET,38,0.022304,0.0010136,0.14161,0.43743,HP_PROTRUDING_TONGUE,0.980565094765343
KEGG_RIG_I_LIKE_RECEPTOR_SIG...,SET,61,0.018658,0.0010737,0.11853,0.43746,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.980565094765343
GOBP_MICROTUBULE_POLYMERIZAT...2,SET,124,0.011478,0.00094007,0.07293,0.43747,GOBP_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.980565094765343
GOBP_PEPTIDYL_PROLINE_MODIFI...,SET,29,0.021765,0.00086432,0.1383,0.43748,GOBP_PEPTIDYL_PROLINE_MODIFICATION,0.980565094765343
GSE15624_CTRL_VS_3H_HALOFUGI...1,SET,144,0.010499,0.00092617,0.066731,0.43749,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.980565094765343
RACTNNRTTTNC_UNKNOWN,SET,111,0.013003,0.001008,0.082654,0.4375,RACTNNRTTTNC_UNKNOWN,0.980565094765343
GOBP_POSITIVE_REGULATION_OF_...464,SET,5,0.057774,0.00095328,0.36727,0.4375,GOBP_POSITIVE_REGULATION_OF_MIRNA_PROCESSING,0.980565094765343
GOBP_POSITIVE_REGULATION_OF_...446,SET,17,0.034085,0.0010367,0.21673,0.43752,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.980565094765343
MIR381_3P,SET,407,0.0068272,0.0010052,0.043437,0.43755,MIR381_3P,0.980565094765343
CAR_MYST2,SET,25,0.025636,0.00094536,0.16331,0.43763,CAR_MYST2,0.980565094765343
GOBP_POSITIVE_REGULATION_OF_...150,SET,5,0.060249,0.00099412,0.38381,0.43763,GOBP_POSITIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.980565094765343
GSE13493_CD4INTCD8POS_VS_CD8...1,SET,182,0.0096088,0.00095193,0.061205,0.43763,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN,0.980565094765343
LI_ESTROGENE_T47D_E2_RESPONS...1,SET,33,0.026429,0.0011195,0.16842,0.43765,LI_ESTROGENE_T47D_E2_RESPONSE_DN,0.980565094765343
WP_15Q25_COPY_NUMBER_VARIATI...,SET,42,0.023075,0.0011024,0.14716,0.4377,WP_15Q25_COPY_NUMBER_VARIATION,0.980573098491685
REACTOME_ATF4_ACTIVATES_GENE...,SET,26,0.026054,0.00097976,0.16617,0.43771,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.980573098491685
GOBP_NEURAL_CREST_FORMATION,SET,15,0.037155,0.0010616,0.23718,0.43776,GOBP_NEURAL_CREST_FORMATION,0.98058510021267
MIR3689D,SET,87,0.014095,0.00096798,0.090009,0.43778,MIR3689D,0.98058510021267
GOMF_UBIQUITIN_BINDING,SET,94,0.013786,0.00098393,0.088061,0.4378,GOMF_UBIQUITIN_BINDING,0.98058510021267
HP_ABNORMAL_METACARPAL_MORPH...,SET,196,0.0098185,0.001009,0.062815,0.4379,HP_ABNORMAL_METACARPAL_MORPHOLOGY,0.98060509277155
GOBP_REGULATION_OF_DEFENSE_R...4,SET,52,0.018927,0.0010058,0.12114,0.43793,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,0.98060509277155
YANG_BREAST_CANCER_ESR1_BULK...1,SET,22,0.029213,0.0010106,0.18701,0.43794,YANG_BREAST_CANCER_ESR1_BULK_DN,0.98060509277155
GOBP_GLUCOSE_IMPORT_ACROSS_P...,SET,4,0.074857,0.0011048,0.4793,0.43795,GOBP_GLUCOSE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.98060509277155
GSE44649_WT_VS_MIR155_KO_ACT...2,SET,189,0.0097569,0.00098483,0.062478,0.43795,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP,0.98060509277155
GSE12366_GC_VS_MEMORY_BCELL_...1,SET,179,0.0099486,0.00097752,0.063765,0.43801,GSE12366_GC_VS_MEMORY_BCELL_DN,0.980657862020098
KEGG_MEDICUS_VARIANT_MUTATIO...70,SET,10,0.04155,0.00096944,0.26638,0.43803,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY,0.980657862020098
GOBP_REGULATION_OF_COLLATERA...,SET,18,0.033715,0.0010551,0.21708,0.43829,GOBP_REGULATION_OF_COLLATERAL_SPROUTING,0.980723638637676
GSE34156_UNTREATED_VS_24H_NO...1,SET,144,0.010886,0.00096025,0.070167,0.43836,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.980723638637676
GNF2_HPN,SET,127,0.012056,0.00099922,0.077792,0.43842,GNF2_HPN,0.980723638637676
GOBP_POSITIVE_REGULATION_OF_...275,SET,13,0.038241,0.0010172,0.24675,0.43842,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION,0.980723638637676
WP_NEUROTRANSMITTER_DISORDERS,SET,9,0.046703,0.0010338,0.30141,0.43843,WP_NEUROTRANSMITTER_DISORDERS,0.980723638637676
GOBP_EXOCRINE_PANCREAS_DEVEL...,SET,7,0.057766,0.0011277,0.37296,0.43846,GOBP_EXOCRINE_PANCREAS_DEVELOPMENT,0.980723638637676
GOCC_EARP_COMPLEX,SET,3,0.067901,0.0008679,0.4384,0.43846,GOCC_EARP_COMPLEX,0.980723638637676
GOMF_LIGAND_GATED_MONOATOMIC...3,SET,15,0.036797,0.0010513,0.23765,0.43848,GOMF_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.980723638637676
BIOCARTA_FMLP_PATHWAY,SET,32,0.024315,0.0010142,0.1572,0.43854,BIOCARTA_FMLP_PATHWAY,0.980723638637676
GSE9988_ANTI_TREM1_AND_LPS_V...3,SET,186,0.0096089,0.00096224,0.062127,0.43854,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN,0.980723638637676
WUNDER_INFLAMMATORY_RESPONSE...2,SET,59,0.017796,0.0010072,0.11512,0.43858,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,0.980723638637676
GOBP_RIBONUCLEOSIDE_MONOPHOS...1,SET,29,0.024529,0.00097411,0.15875,0.4386,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.980723638637676
GOBP_MORPHOGENESIS_OF_A_BRAN...,SET,189,0.010246,0.0010341,0.066329,0.43862,GOBP_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.980723638637676
GOBP_ERBB2_ERBB4_SIGNALING_P...,SET,5,0.063533,0.0010483,0.41152,0.43865,GOBP_ERBB2_ERBB4_SIGNALING_PATHWAY,0.980723638637676
GOBP_SERTOLI_CELL_DIFFERENTI...,SET,17,0.031556,0.00095977,0.20458,0.43871,GOBP_SERTOLI_CELL_DIFFERENTIATION,0.980723638637676
GSE15330_LYMPHOID_MULTIPOTEN...5,SET,189,0.009559,0.00096485,0.061991,0.43873,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.980723638637676
LOPEZ_MESOTELIOMA_SURVIVAL_T...2,SET,10,0.042689,0.000996,0.27691,0.43874,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP,0.980723638637676
GOBP_DEFENSE_RESPONSE_TO_BAC...,SET,273,0.0088992,0.0010771,0.057751,0.43877,GOBP_DEFENSE_RESPONSE_TO_BACTERIUM,0.980723638637676
GSE37533_UNTREATED_VS_PIOGLI...1,SET,149,0.010473,0.00093967,0.067967,0.43877,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN,0.980723638637676
WP_ETHANOL_EFFECTS_ON_HISTON...,SET,29,0.024082,0.00095632,0.15637,0.4388,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,0.980723638637676
HP_INCREASED_ARM_SPAN,SET,7,0.045298,0.00088432,0.29415,0.43881,HP_INCREASED_ARM_SPAN,0.980723638637676
GOBP_ACTIN_FILAMENT_BASED_PR...,SET,755,0.0050365,0.0010001,0.032737,0.43887,GOBP_ACTIN_FILAMENT_BASED_PROCESS,0.980723638637676
SPIRA_SMOKERS_LUNG_CANCER_UP,SET,36,0.02272,0.0010051,0.14771,0.43888,SPIRA_SMOKERS_LUNG_CANCER_UP,0.980723638637676
GOBP_REGULATION_OF_MYELOID_L...1,SET,116,0.01318,0.0010443,0.085692,0.43888,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.980723638637676
GOBP_ACTION_POTENTIAL,SET,158,0.011551,0.0010669,0.075179,0.43895,GOBP_ACTION_POTENTIAL,0.980723638637676
GOBP_TOLERANCE_INDUCTION_TO_...,SET,5,0.065315,0.0010777,0.42522,0.43896,GOBP_TOLERANCE_INDUCTION_TO_SELF_ANTIGEN,0.980723638637676
HFH3_01,SET,176,0.010304,0.001004,0.067144,0.43902,HFH3_01,0.980723638637676
GOBP_INTRACELLULAR_IRON_ION_...,SET,60,0.016698,0.00095301,0.10886,0.43905,GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS,0.980723638637676
CHARAFE_BREAST_CANCER_LUMINA...1,SET,414,0.0068943,0.0010235,0.044976,0.43909,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,0.980723638637676
chr7p14,SET,54,0.029669,0.0016066,0.1936,0.4391,chr7p14,0.980723638637676
HP_ABNORMAL_MITRAL_VALVE_PHY...,SET,151,0.010747,0.00097064,0.07019,0.43915,HP_ABNORMAL_MITRAL_VALVE_PHYSIOLOGY,0.980723638637676
HP_LARYNGEAL_CARCINOMA,SET,12,0.03409,0.00087125,0.22264,0.43915,HP_LARYNGEAL_CARCINOMA,0.980723638637676
GSE5542_IFNG_VS_IFNA_AND_IFN...3,SET,174,0.0097743,0.00094701,0.063874,0.43919,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.980723638637676
BLUM_RESPONSE_TO_SALIRASIB_UP,SET,219,0.0086278,0.00093666,0.056456,0.43927,BLUM_RESPONSE_TO_SALIRASIB_UP,0.980723638637676
GOBP_BUNDLE_OF_HIS_CELL_TO_P...1,SET,15,0.040543,0.0011584,0.26538,0.43929,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION,0.980723638637676
MASSARWEH_TAMOXIFEN_RESISTAN...1,SET,212,0.0094661,0.0010113,0.061987,0.43931,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,0.980723638637676
KEGG_AMINO_SUGAR_AND_NUCLEOT...,SET,40,0.019926,0.00092904,0.13047,0.43931,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,0.980723638637676
GILDEA_METASTASIS,SET,28,0.025531,0.00099628,0.16724,0.43933,GILDEA_METASTASIS,0.980723638637676
GOMF_MAP_KINASE_SCAFFOLD_ACT...,SET,12,0.038802,0.00099166,0.25443,0.43939,GOMF_MAP_KINASE_SCAFFOLD_ACTIVITY,0.980723638637676
KEGG_LEISHMANIA_INFECTION,SET,63,0.01855,0.0010848,0.12168,0.43941,KEGG_LEISHMANIA_INFECTION,0.980723638637676
CASP8AP2_TARGET_GENES,SET,262,0.0079483,0.00094268,0.052127,0.43941,CASP8AP2_TARGET_GENES,0.980723638637676
MIR11400,SET,8,0.040979,0.00085521,0.26887,0.43943,MIR11400,0.980723638637676
GSE43863_TFH_VS_LY6C_LOW_CXC...1,SET,174,0.010248,0.00099294,0.067266,0.43945,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.980723638637676
GSE17721_POLYIC_VS_GARDIQUIM...10,SET,184,0.0096717,0.00096336,0.063488,0.43946,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP,0.980723638637676
GSE43863_TFH_VS_LY6C_LOW_CXC...2,SET,184,0.009807,0.00097683,0.064409,0.43949,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.980723638637676
GOBP_POSITIVE_REGULATION_OF_...699,SET,21,0.029537,0.00099836,0.19404,0.43951,GOBP_POSITIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.980723638637676
MIR133A_5P,SET,122,0.011688,0.00094961,0.076807,0.43952,MIR133A_5P,0.980723638637676
GSE5142_CTRL_VS_HTERT_TRANSD...2,SET,188,0.0095193,0.00095832,0.062559,0.43953,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP,0.980723638637676
GOBP_MAINTENANCE_OF_ANIMAL_O...,SET,5,0.062037,0.0010236,0.40793,0.43956,GOBP_MAINTENANCE_OF_ANIMAL_ORGAN_IDENTITY,0.980723638637676
GOBP_MEDIUM_CHAIN_FATTY_ACID...2,SET,5,0.04985,0.00082254,0.32783,0.43957,GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.980723638637676
GOBP_REGULATION_OF_ACUTE_INF...1,SET,44,0.020829,0.0010185,0.13715,0.43964,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.980723638637676
GOBP_REGULATION_OF_BRANCHING...4,SET,17,0.034739,0.0010566,0.22875,0.43965,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS,0.980723638637676
HP_HAND_MUSCLE_WEAKNESS,SET,43,0.018528,0.00089559,0.122,0.43965,HP_HAND_MUSCLE_WEAKNESS,0.980723638637676
GOBP_POSITIVE_REGULATION_OF_...217,SET,271,0.0076866,0.00092694,0.050641,0.43968,GOBP_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.980723638637676
MIR5681B,SET,48,0.018689,0.00095435,0.12316,0.43969,MIR5681B,0.980723638637676
REACTOME_POU5F1_OCT4_SOX2_NA...2,SET,9,0.047448,0.0010503,0.31282,0.43972,REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,0.980723638637676
GNF2_STAT6,SET,73,0.014883,0.00093657,0.09821,0.43978,GNF2_STAT6,0.980723638637676
GOCC_RAGULATOR_COMPLEX,SET,6,0.043671,0.00078934,0.2882,0.43978,GOCC_RAGULATOR_COMPLEX,0.980723638637676
WP_ALTERED_GLYCOSYLATION_OF_...,SET,8,0.041497,0.00086603,0.27401,0.43981,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,0.980723638637676
GOBP_LONG_CHAIN_FATTY_ACID_C...,SET,8,0.046395,0.00096825,0.30632,0.43981,GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.980723638637676
GOBP_REGULATION_OF_BRANCHING...1,SET,6,0.06003,0.001085,0.39718,0.43993,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,0.980723638637676
GOCC_HFE_TRANSFERRIN_RECEPTO...,SET,7,0.049011,0.00095681,0.32427,0.43993,GOCC_HFE_TRANSFERRIN_RECEPTOR_COMPLEX,0.980723638637676
TRAVAGLINI_LUNG_CAPILLARY_AE...,SET,41,0.021509,0.0010153,0.14229,0.43993,TRAVAGLINI_LUNG_CAPILLARY_AEROCYTE_CELL,0.980723638637676
GOBP_POSITIVE_REGULATION_OF_...139,SET,319,0.007463,0.00097513,0.049383,0.43994,GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.980723638637676
GOMF_L_ARGININE_TRANSMEMBRAN...,SET,11,0.044692,0.0010936,0.29571,0.43994,GOMF_L_ARGININE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.980723638637676
GSE32423_MEMORY_VS_NAIVE_CD8...6,SET,184,0.0097095,0.00096713,0.064244,0.43994,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.980723638637676
HP_CUTANEOUS_FINGER_SYNDACTY...,SET,30,0.024783,0.001001,0.16401,0.43995,HP_CUTANEOUS_FINGER_SYNDACTYLY,0.980723638637676
MIR2681_3P,SET,33,0.021382,0.0009057,0.14198,0.44014,MIR2681_3P,0.980734652355014
ZNF394_TARGET_GENES,SET,829,0.0045543,0.00094566,0.030238,0.44014,ZNF394_TARGET_GENES,0.980734652355014
GSE7852_LN_VS_FAT_TCONV_UP,SET,180,0.0093319,0.00091946,0.06197,0.44015,GSE7852_LN_VS_FAT_TCONV_UP,0.980734652355014
GSE411_WT_VS_SOCS3_KO_MACROP...3,SET,186,0.0088803,0.00088927,0.059011,0.44019,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP,0.980734652355014
GOBP_NEGATIVE_REGULATION_OF_...306,SET,3,0.082996,0.0010608,0.55201,0.44024,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.980734652355014
BIOCARTA_ERAD_PATHWAY,SET,19,0.027405,0.00088113,0.18232,0.44026,BIOCARTA_ERAD_PATHWAY,0.980734652355014
TAXCREB_01,SET,121,0.011812,0.00095578,0.078592,0.44026,TAXCREB_01,0.980734652355014
WP_VITAMIN_D_RECEPTOR_PATHWAY,SET,168,0.01076,0.0010245,0.071611,0.44028,WP_VITAMIN_D_RECEPTOR_PATHWAY,0.980734652355014
HOWLIN_CITED1_TARGETS_1_UP,SET,31,0.023946,0.00098314,0.15947,0.44032,HOWLIN_CITED1_TARGETS_1_UP,0.980734652355014
HP_GLUCOSE_INTOLERANCE,SET,420,0.0063887,0.00095516,0.042545,0.44032,HP_GLUCOSE_INTOLERANCE,0.980734652355014
MIR3171,SET,73,0.013863,0.0008724,0.092341,0.44033,MIR3171,0.980734652355014
GCTGAGT_MIR5125P,SET,42,0.018816,0.0008989,0.12532,0.44033,GCTGAGT_MIR5125P,0.980734652355014
GOBP_RESPONSE_TO_UV_A,SET,13,0.040031,0.0010648,0.26661,0.44033,GOBP_RESPONSE_TO_UV_A,0.980734652355014
GOBP_PROTOPORPHYRINOGEN_IX_B...,SET,8,0.043596,0.00090984,0.29049,0.44035,GOBP_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS,0.980734652355014
REACTOME_FCERI_MEDIATED_MAPK...,SET,32,0.022244,0.00092785,0.1483,0.44039,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,0.980760890042291
GOBP_NEGATIVE_REGULATION_OF_...17,SET,13,0.037263,0.0009912,0.24892,0.4405,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.980837117330601
GSE42021_TCONV_PLN_VS_CD24LO...1,SET,179,0.0094715,0.00093064,0.063296,0.44053,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN,0.980837117330601
chr10q22,SET,85,0.02908,0.0019741,0.19444,0.44056,chr10q22,0.980837117330601
HP_IMPAIRED_ANTIGEN_SPECIFIC...,SET,47,0.019783,0.00099965,0.13228,0.44056,HP_IMPAIRED_ANTIGEN_SPECIFIC_RESPONSE,0.980837117330601
GOMF_ACETYLGLUCOSAMINYLTRANS...,SET,40,0.022843,0.0010651,0.15278,0.44057,GOMF_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.980837117330601
HP_STRIDOR,SET,45,0.018899,0.00093448,0.12648,0.44061,HP_STRIDOR,0.980837117330601
HP_FAVORABLE_RESPONSE_OF_WEA...,SET,4,0.065129,0.00096122,0.43605,0.44064,HP_FAVORABLE_RESPONSE_OF_WEAKNESS_TO_ACETYLCHOLINE_ESTERASE_INHIBITORS,0.980837117330601
REACTOME_EPH_EPHRIN_SIGNALING,SET,89,0.013883,0.00096422,0.092968,0.44065,REACTOME_EPH_EPHRIN_SIGNALING,0.980837117330601
GOBP_REGULATION_OF_GTPASE_AC...,SET,245,0.0086723,0.0009951,0.058106,0.44068,GOBP_REGULATION_OF_GTPASE_ACTIVITY,0.980841075888569
DAZARD_UV_RESPONSE_CLUSTER_G6,SET,135,0.011414,0.00097513,0.076759,0.4409,DAZARD_UV_RESPONSE_CLUSTER_G6,0.981160726621466
RGAGGAARY_PU1_Q6,SET,462,0.006135,0.00096087,0.041277,0.44092,RGAGGAARY_PU1_Q6,0.981160726621466
GOBP_DORSAL_VENTRAL_AXIS_SPE...,SET,14,0.037857,0.001045,0.25496,0.44098,GOBP_DORSAL_VENTRAL_AXIS_SPECIFICATION,0.981160726621466
GSE21670_STAT3_KO_VS_WT_CD4_...7,SET,180,0.0090959,0.00089621,0.061316,0.44104,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP,0.981160726621466
GOBP_NOSE_DEVELOPMENT,SET,15,0.034853,0.0009958,0.23498,0.44105,GOBP_NOSE_DEVELOPMENT,0.981160726621466
REACTOME_TP53_REGULATES_TRAN...3,SET,48,0.017868,0.0009124,0.12057,0.44109,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.981160726621466
HP_TYPE_II_DIABETES_MELLITUS,SET,191,0.009486,0.00096249,0.064018,0.4411,HP_TYPE_II_DIABETES_MELLITUS,0.981160726621466
WP_METHYLATION_PATHWAYS,SET,9,0.045737,0.0010124,0.30902,0.44117,WP_METHYLATION_PATHWAYS,0.981160726621466
chr14q13,SET,22,0.037699,0.0013042,0.25479,0.44119,chr14q13,0.981160726621466
MIR548AV_3P,SET,162,0.0099174,0.00092745,0.067035,0.44119,MIR548AV_3P,0.981160726621466
chr4q13,SET,70,0.029575,0.0018227,0.19992,0.4412,chr4q13,0.981160726621466
GOBP_RESPONSE_TO_GONADOTROPIN,SET,27,0.02729,0.0010457,0.18455,0.44122,GOBP_RESPONSE_TO_GONADOTROPIN,0.981160726621466
MORF_CTSB,SET,156,0.010557,0.00096893,0.071426,0.44125,MORF_CTSB,0.981160726621466
GOBP_RESPONSE_TO_VASOPRESSIN,SET,8,0.047515,0.00099161,0.32152,0.44126,GOBP_RESPONSE_TO_VASOPRESSIN,0.981160726621466
BIOCARTA_HER2_PATHWAY,SET,23,0.026723,0.00094522,0.181,0.44131,BIOCARTA_HER2_PATHWAY,0.981160726621466
GOBP_REGULATION_OF_NEUROGENE...,SET,346,0.0070335,0.00095641,0.047633,0.44131,GOBP_REGULATION_OF_NEUROGENESIS,0.981160726621466
WP_SEROTONIN_HTR1_GROUP_AND_...,SET,36,0.023128,0.0010231,0.15669,0.44133,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,0.981160726621466
MIR553,SET,10,0.037426,0.00087321,0.25363,0.44135,MIR553,0.981160726621466
HP_ABNORMAL_PALATE_MORPHOLOGY,SET,991,0.0040604,0.00091753,0.027525,0.44136,HP_ABNORMAL_PALATE_MORPHOLOGY,0.981160726621466
GOBP_SODIUM_INDEPENDENT_ORGA...,SET,15,0.038965,0.0011133,0.26442,0.44142,GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT,0.981168591711435
GOBP_TORC2_SIGNALING,SET,10,0.041354,0.00096486,0.28061,0.44142,GOBP_TORC2_SIGNALING,0.981168591711435
GOMF_ANTIGEN_BINDING,SET,63,0.018132,0.0010603,0.12319,0.44149,GOMF_ANTIGEN_BINDING,0.981261428023278
REACTOME_INTERFERON_SIGNALING,SET,246,0.0082361,0.00094694,0.05607,0.44161,REACTOME_INTERFERON_SIGNALING,0.981465376007162
MIR342_5P,SET,57,0.016605,0.00092379,0.11323,0.4417,MIR342_5P,0.981563300524096
GOMF_TORC2_COMPLEX_BINDING,SET,4,0.06445,0.0009512,0.44011,0.44179,GOMF_TORC2_COMPLEX_BINDING,0.981563300524096
NABA_PROTEOGLYCANS,SET,33,0.023701,0.0010039,0.16193,0.44182,NABA_PROTEOGLYCANS,0.981563300524096
REACTOME_SIGNALING_BY_ERYTHR...,SET,25,0.025488,0.00093987,0.17421,0.44184,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,0.981563300524096
HP_ENLARGED_CEREBELLUM,SET,6,0.05186,0.00093735,0.35443,0.44184,HP_ENLARGED_CEREBELLUM,0.981563300524096
GOBP_RETINAL_GANGLION_CELL_A...,SET,22,0.029641,0.0010254,0.20267,0.44186,GOBP_RETINAL_GANGLION_CELL_AXON_GUIDANCE,0.981563300524096
HP_INTERRUPTED_AORTIC_ARCH,SET,18,0.030412,0.00095176,0.20794,0.44186,HP_INTERRUPTED_AORTIC_ARCH,0.981563300524096
HP_ABNORMAL_BRONCHOALVEOLAR_...,SET,14,0.036837,0.0010168,0.25197,0.44188,HP_ABNORMAL_BRONCHOALVEOLAR_LAVAGE_FLUID_MORPHOLOGY,0.981563300524096
GOBP_NEGATIVE_REGULATION_OF_...112,SET,242,0.0083536,0.00095271,0.057213,0.44196,GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT,0.981578913738019
GSE5589_WT_VS_IL10_KO_LPS_ST...3,SET,185,0.0091189,0.00091073,0.06248,0.44198,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.981578913738019
GAVISH_3CA_METAPROGRAM_CD8_T...8,SET,44,0.020188,0.00098708,0.13837,0.442,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1,0.981578913738019
GOMF_COENZYME_A_DIPHOSPHATAS...,SET,5,0.054514,0.00089948,0.3736,0.442,GOMF_COENZYME_A_DIPHOSPHATASE_ACTIVITY,0.981578913738019
KEGG_MEDICUS_REFERENCE_INACT...,SET,6,0.043537,0.00078692,0.29883,0.44208,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I,0.981693847038528
GOBP_MYOBLAST_FUSION,SET,44,0.019869,0.00097152,0.1365,0.44213,GOBP_MYOBLAST_FUSION,0.981742151162791
GOBP_APOPTOTIC_CELL_CLEARANCE,SET,46,0.018753,0.00093752,0.12893,0.44218,GOBP_APOPTOTIC_CELL_CLEARANCE,0.981772134917593
MIR5190,SET,121,0.011777,0.00095289,0.080995,0.4422,MIR5190,0.981772134917593
GOMF_POLY_ADP_D_RIBOSE_MODIF...,SET,2,0.093402,0.00097479,0.64331,0.44228,GOMF_POLY_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.981887026509103
PUIFFE_INVASION_INHIBITED_BY...2,SET,64,0.015188,0.00089517,0.10474,0.44235,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,0.981903438395415
HP_ABSENT_FINGERNAIL,SET,35,0.021177,0.00092372,0.14602,0.44235,HP_ABSENT_FINGERNAIL,0.981903438395415
HOWARD_T_CELL_INACT_MONOV_IN...,SET,40,0.020375,0.00095,0.14058,0.44238,HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.981903438395415
MIR4474_3P,SET,79,0.014554,0.00095263,0.10056,0.44246,MIR4474_3P,0.981903438395415
MCMURRAY_TP53_HRAS_COOPERATI...1,SET,64,0.016872,0.00099439,0.11659,0.44247,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,0.981903438395415
HP_DOUBLE_AORTIC_ARCH,SET,5,0.053677,0.00088569,0.37102,0.44248,HP_DOUBLE_AORTIC_ARCH,0.981903438395415
MORF_PSMC1,SET,170,0.0085475,0.00081867,0.059194,0.44259,MORF_PSMC1,0.981903438395415
MIR338_3P,SET,132,0.011168,0.00094351,0.077358,0.44261,MIR338_3P,0.981903438395415
DESCARTES_FETAL_CEREBRUM_AST...,SET,141,0.011105,0.0009694,0.076924,0.44261,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.981903438395415
GOCC_GTPASE_ACTIVATOR_COMPLEX,SET,11,0.032451,0.00079408,0.22492,0.44264,GOCC_GTPASE_ACTIVATOR_COMPLEX,0.981903438395415
WP_AEROBIC_GLYCOLYSIS_AUGMEN...,SET,11,0.030121,0.00073706,0.20894,0.44269,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,0.981903438395415
WP_ENDOPLASMIC_RETICULUM_STR...,SET,44,0.017773,0.00086904,0.12354,0.4428,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.981903438395415
GOBP_REGULATION_OF_PIGMENT_C...,SET,8,0.050771,0.0010596,0.3529,0.4428,GOBP_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION,0.981903438395415
GOCC_CHROMOSOMAL_REGION,SET,340,0.0064275,0.00086653,0.044752,0.4429,GOCC_CHROMOSOMAL_REGION,0.981903438395415
HP_COGWHEEL_RIGIDITY,SET,25,0.026188,0.00096571,0.18238,0.44291,HP_COGWHEEL_RIGIDITY,0.981903438395415
HP_ANTERIOR_CREASES_OF_EARLO...,SET,3,0.065667,0.00083933,0.45739,0.44292,HP_ANTERIOR_CREASES_OF_EARLOBE,0.981903438395415
GOCC_PROTEIN_KINASE_COMPLEX,SET,135,0.0099622,0.00085111,0.069406,0.44293,GOCC_PROTEIN_KINASE_COMPLEX,0.981903438395415
GOBP_CALCIUM_DEPENDENT_CELL_...,SET,47,0.020393,0.0010305,0.14209,0.44294,GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.981903438395415
PASTURAL_RIZ1_TARGETS_DN,SET,5,0.061907,0.0010215,0.43182,0.443,PASTURAL_RIZ1_TARGETS_DN,0.981903438395415
GOBP_REGULATION_OF_ATRIAL_CA...2,SET,5,0.059154,0.00097605,0.41262,0.443,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.981903438395415
HP_ABNORMAL_CIRCULATING_CARB...1,SET,55,0.015208,0.00083111,0.10616,0.44305,HP_ABNORMAL_CIRCULATING_CARBOHYDRATE_CONCENTRATION,0.981903438395415
GOBP_POSITIVE_REGULATION_OF_...248,SET,140,0.011045,0.00096081,0.077128,0.44306,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.981903438395415
GOBP_REGULATION_OF_PENTOSE_P...,SET,6,0.0504,0.00091095,0.35209,0.44309,GOBP_REGULATION_OF_PENTOSE_PHOSPHATE_SHUNT,0.981903438395415
HP_PARTIAL_ABSENCE_OF_SPECIF...1,SET,6,0.053904,0.00097429,0.37673,0.44311,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.981903438395415
BIOCARTA_MYOSIN_PATHWAY,SET,11,0.037347,0.00091387,0.26115,0.44314,BIOCARTA_MYOSIN_PATHWAY,0.981903438395415
HP_ABNORMAL_PULMONARY_VALVE_...1,SET,3,0.076981,0.00098395,0.53823,0.44314,HP_ABNORMAL_PULMONARY_VALVE_CUSP_MORPHOLOGY,0.981903438395415
HP_VERTICAL_NYSTAGMUS,SET,21,0.025673,0.00086777,0.1795,0.44314,HP_VERTICAL_NYSTAGMUS,0.981903438395415
REACTOME_POSTMITOTIC_NUCLEAR...,SET,26,0.022863,0.00085975,0.16019,0.44325,REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,0.981903438395415
HP_ABNORMAL_SPEECH_DISCRIMIN...,SET,4,0.058703,0.00086637,0.41154,0.44329,HP_ABNORMAL_SPEECH_DISCRIMINATION,0.981903438395415
MIR4493,SET,88,0.012521,0.00086476,0.087828,0.44332,MIR4493,0.981903438395415
GSE23925_LIGHT_ZONE_VS_DARK_...1,SET,187,0.0088633,0.00088993,0.06217,0.44332,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.981903438395415
GSE2770_UNTREATED_VS_IL4_TRE...2,SET,188,0.0088744,0.0008934,0.062268,0.44334,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.981903438395415
GSE36527_CD62L_HIGH_CD69_NEG...1,SET,178,0.0094356,0.00092455,0.066217,0.44335,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN,0.981903438395415
MIR4268,SET,54,0.017493,0.00094732,0.1228,0.44336,MIR4268,0.981903438395415
WP_CHOLESTASIS,SET,19,0.0308,0.00099031,0.21629,0.44338,WP_CHOLESTASIS,0.981903438395415
TAKEDA_TARGETS_OF_NUP98_HOXA...6,SET,168,0.010348,0.00098529,0.072674,0.44339,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,0.981903438395415
GSE16697_CD4_TCELL_VS_TFH_CD...2,SET,179,0.0093802,0.00092167,0.065976,0.44347,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP,0.981903438395415
GSE3720_VD1_VS_VD2_GAMMADELT...1,SET,184,0.0089398,0.00089046,0.062878,0.44347,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN,0.981903438395415
WP_3Q29_COPY_NUMBER_VARIATIO...,SET,57,0.018099,0.0010069,0.12737,0.4435,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,0.981903438395415
GOBP_SURFACTANT_HOMEOSTASIS,SET,20,0.027759,0.00091567,0.19536,0.44351,GOBP_SURFACTANT_HOMEOSTASIS,0.981903438395415
HP_ABNORMAL_CIRCULATING_FREE...1,SET,9,0.038297,0.00084771,0.26956,0.44351,HP_ABNORMAL_CIRCULATING_FREE_FATTY_ACID_CONCENTRATION,0.981903438395415
GNF2_MMP1,SET,32,0.025089,0.0010465,0.17676,0.44357,GNF2_MMP1,0.981903438395415
GOBP_PROTEIN_NITROSYLATION,SET,13,0.035847,0.00095352,0.25263,0.44358,GOBP_PROTEIN_NITROSYLATION,0.981903438395415
GOBP_NEGATIVE_REGULATION_OF_...32,SET,6,0.045512,0.00082262,0.32091,0.44361,GOBP_NEGATIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.981903438395415
GOBP_CRISTAE_FORMATION,SET,15,0.03218,0.00091944,0.22698,0.44363,GOBP_CRISTAE_FORMATION,0.981903438395415
RICKMAN_TUMOR_DIFFERENTIATED...3,SET,101,0.012226,0.00090427,0.086241,0.44364,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,0.981903438395415
GOBP_C4_DICARBOXYLATE_TRANSP...,SET,28,0.023444,0.00091483,0.16544,0.44366,GOBP_C4_DICARBOXYLATE_TRANSPORT,0.981903438395415
GSE15930_STIM_VS_STIM_AND_IL...5,SET,174,0.009257,0.0008969,0.065343,0.44367,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN,0.981903438395415
MIR8079,SET,30,0.024347,0.00098338,0.17195,0.4437,MIR8079,0.981903438395415
GOBP_PURINE_CONTAINING_COMPO...1,SET,138,0.010203,0.00088126,0.072056,0.4437,GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.981903438395415
KEGG_MEDICUS_REFERENCE_NUCLE...3,SET,5,0.061753,0.0010189,0.43652,0.44375,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,0.981936496025437
HP_METHYLMALONIC_ACIDEMIA,SET,13,0.031739,0.00084425,0.22475,0.44385,HP_METHYLMALONIC_ACIDEMIA,0.981936496025437
KEGG_MEDICUS_VARIANT_MUTATIO...47,SET,44,0.017427,0.00085208,0.12362,0.44395,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT,0.981936496025437
GOBP_GLUTATHIONE_TRANSPORT,SET,9,0.041102,0.00090978,0.29161,0.44396,GOBP_GLUTATHIONE_TRANSPORT,0.981936496025437
GOCC_TUBULAR_ENDOSOME,SET,5,0.052333,0.00086351,0.37167,0.44401,GOCC_TUBULAR_ENDOSOME,0.981936496025437
GSE25677_R848_VS_MPL_AND_R84...1,SET,145,0.0098844,0.00087493,0.070195,0.44401,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN,0.981936496025437
GOCC_SPECIFIC_GRANULE_LUMEN,SET,57,0.016763,0.00093256,0.11912,0.44405,GOCC_SPECIFIC_GRANULE_LUMEN,0.981936496025437
LEE_NAIVE_T_LYMPHOCYTE,SET,16,0.032735,0.00096594,0.2327,0.44406,LEE_NAIVE_T_LYMPHOCYTE,0.981936496025437
LEIN_ASTROCYTE_MARKERS,SET,40,0.019856,0.00092578,0.14115,0.44406,LEIN_ASTROCYTE_MARKERS,0.981936496025437
GOBP_CORTISOL_BIOSYNTHETIC_P...,SET,10,0.043255,0.0010092,0.30744,0.44406,GOBP_CORTISOL_BIOSYNTHETIC_PROCESS,0.981936496025437
HP_IMPAIRED_VIBRATION_SENSAT...2,SET,46,0.017087,0.00085422,0.12146,0.44406,HP_IMPAIRED_VIBRATION_SENSATION_IN_THE_LOWER_LIMBS,0.981936496025437
MIR3618,SET,88,0.01315,0.00090818,0.093712,0.4442,MIR3618,0.981936496025437
GOBP_OLIGOSACCHARIDE_BIOSYNT...,SET,29,0.023946,0.00095093,0.17067,0.44421,GOBP_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.981936496025437
HP_ANOMALOUS_TRICHROMACY,SET,9,0.051315,0.0011358,0.36579,0.44422,HP_ANOMALOUS_TRICHROMACY,0.981936496025437
HP_TRITANOMALY,SET,9,0.051315,0.0011358,0.36579,0.44422,HP_TRITANOMALY,0.981936496025437
MIR375_3P,SET,36,0.021108,0.00093376,0.15052,0.44424,MIR375_3P,0.981936496025437
GSE42021_TREG_PLN_VS_CD24INT...1,SET,184,0.0091798,0.00091437,0.065471,0.44425,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN,0.981936496025437
FERREIRA_EWINGS_SARCOMA_UNST...1,SET,86,0.012873,0.00087896,0.091828,0.44426,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,0.981936496025437
HP_ABNORMALITY_OF_SECONDARY_...,SET,70,0.014502,0.00089374,0.10346,0.44426,HP_ABNORMALITY_OF_SECONDARY_SEXUAL_HAIR,0.981936496025437
HP_ABNORMAL_INTRAHEPATIC_BIL...,SET,28,0.023616,0.00092155,0.16854,0.44428,HP_ABNORMAL_INTRAHEPATIC_BILE_DUCT_MORPHOLOGY,0.981936496025437
HP_HYPOKALEMIA,SET,74,0.014467,0.00091658,0.10336,0.44434,HP_HYPOKALEMIA,0.982006657764212
GOBP_3_UTR_MEDIATED_MRNA_STA...,SET,19,0.028391,0.00091284,0.203,0.44439,GOBP_3_UTR_MEDIATED_MRNA_STABILIZATION,0.982054711642399
GSE13306_LAMINA_PROPRIA_VS_S...1,SET,186,0.0089166,0.00089291,0.063853,0.44447,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN,0.982071131727775
GCM_PTK2,SET,135,0.010007,0.00085495,0.071702,0.4445,GCM_PTK2,0.982071131727775
WP_METASTATIC_BRAIN_TUMOR,SET,6,0.055472,0.0010026,0.39781,0.44455,WP_METASTATIC_BRAIN_TUMOR,0.982071131727775
HP_ABNORMALITY_OF_VITAMIN_D_...,SET,45,0.017752,0.0008778,0.12743,0.4446,HP_ABNORMALITY_OF_VITAMIN_D_METABOLISM,0.982071131727775
HP_DYSMETRIA,SET,158,0.0093738,0.00086582,0.06729,0.44461,HP_DYSMETRIA,0.982071131727775
GOBP_MITOTIC_CELL_CYCLE_PROC...,SET,701,0.0044648,0.0008556,0.032068,0.44463,GOBP_MITOTIC_CELL_CYCLE_PROCESS,0.982071131727775
FUNG_IL2_SIGNALING_2,SET,12,0.034935,0.00089283,0.25094,0.44464,FUNG_IL2_SIGNALING_2,0.982071131727775
GOBP_MITOCHONDRIAL_OUTER_MEM...,SET,26,0.022375,0.00084139,0.1607,0.44464,GOBP_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION,0.982071131727775
GSE22601_DOUBLE_POSITIVE_VS_...4,SET,186,0.009008,0.00090206,0.064745,0.44467,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.982071131727775
GOBP_R_LOOP_PROCESSING,SET,8,0.035538,0.00074166,0.25547,0.44468,GOBP_R_LOOP_PROCESSING,0.982071131727775
THRAP3_TARGET_GENES,SET,19,0.02973,0.00095588,0.21387,0.44472,THRAP3_TARGET_GENES,0.982078829658809
MIR519D_3P,SET,567,0.0051385,0.00088895,0.036977,0.44474,MIR519D_3P,0.982078829658809
REACTOME_HIGHLY_CALCIUM_PERM...1,SET,9,0.049011,0.0010849,0.35331,0.44484,REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.982237242693774
MIR199A_5P,SET,165,0.008985,0.00084793,0.064881,0.44493,MIR199A_5P,0.982261201752158
GOBP_ORGANIC_ACID_CATABOLIC_...,SET,234,0.0076329,0.0008562,0.055146,0.44496,GOBP_ORGANIC_ACID_CATABOLIC_PROCESS,0.982261201752158
GOBP_REGULATION_OF_CELLULAR_...1,SET,12,0.033832,0.00086466,0.24447,0.44497,GOBP_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,0.982261201752158
HAY_BONE_MARROW_CD34_POS_MEP,SET,8,0.043433,0.00090642,0.31384,0.44497,HAY_BONE_MARROW_CD34_POS_MEP,0.982261201752158
GSE23695_CD57_POS_VS_NEG_NK_...1,SET,184,0.0084677,0.00084343,0.061267,0.44504,GSE23695_CD57_POS_VS_NEG_NK_CELL_DN,0.982261201752158
RIZ_ERYTHROID_DIFFERENTIATIO...6,SET,25,0.026557,0.00097931,0.19223,0.44506,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,0.982261201752158
GOBP_STEROID_HORMONE_BIOSYNT...,SET,43,0.018679,0.00090292,0.13526,0.44508,GOBP_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.982261201752158
ZHANG_BREAST_CANCER_PROGENIT...1,SET,131,0.01019,0.00085769,0.073888,0.44515,ZHANG_BREAST_CANCER_PROGENITORS_DN,0.982261201752158
WP_GPCRS_CLASS_C_METABOTROPI...,SET,15,0.033565,0.00095899,0.24345,0.44517,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.982261201752158
GOBP_CORONARY_VASCULATURE_MO...,SET,17,0.031109,0.00094619,0.22563,0.44517,GOBP_CORONARY_VASCULATURE_MORPHOGENESIS,0.982261201752158
GSE10240_CTRL_VS_IL22_STIM_P...2,SET,182,0.0088737,0.0008791,0.064361,0.44517,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.982261201752158
GOMF_ACYLTRANSFERASE_ACTIVIT...1,SET,5,0.056162,0.00092668,0.40747,0.44519,GOMF_ACYLTRANSFERASE_ACTIVITY_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER,0.982261201752158
GOBP_GLYCOLIPID_CATABOLIC_PR...,SET,20,0.027257,0.00089913,0.19802,0.44526,GOBP_GLYCOLIPID_CATABOLIC_PROCESS,0.9822909292878
GSE5589_WT_VS_IL10_KO_LPS_AN...1,SET,102,0.01227,0.00091198,0.089135,0.44526,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.9822909292878
GSE37301_HEMATOPOIETIC_STEM_...13,SET,159,0.0095507,0.00088493,0.069426,0.44529,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN,0.982294760393526
GOBP_REGULATION_OF_ADAPTIVE_...,SET,191,0.0090468,0.00091792,0.065834,0.44535,GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.982364765803504
GOBP_DESMOSOME_ORGANIZATION,SET,9,0.046697,0.0010336,0.34073,0.4455,GOBP_DESMOSOME_ORGANIZATION,0.982596782790786
GSE16266_CTRL_VS_HEATSHOCK_A...1,SET,186,0.0082826,0.00082943,0.060471,0.44553,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.982596782790786
GOBP_MESANGIAL_CELL_DIFFEREN...,SET,6,0.052156,0.0009427,0.3809,0.44554,GOBP_MESANGIAL_CELL_DIFFERENTIATION,0.982596782790786
MIR124_3P,SET,691,0.0045732,0.00087036,0.033422,0.44558,MIR124_3P,0.982622645939086
GSE32255_WT_VS_JMJD2D_KNOCKD...1,SET,129,0.0099955,0.0008349,0.073099,0.44562,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,0.982648505805469
ONDER_CDH1_TARGETS_2_UP,SET,225,0.00846,0.00093078,0.061935,0.44568,ONDER_CDH1_TARGETS_2_UP,0.982700215694982
WP_RETINOBLASTOMA_GENE_IN_CA...,SET,81,0.012216,0.00080961,0.089479,0.4457,WP_RETINOBLASTOMA_GENE_IN_CANCER,0.982700215694982
BIOCARTA_STRESS_PATHWAY,SET,23,0.02455,0.00086838,0.18014,0.4458,BIOCARTA_STRESS_PATHWAY,0.982727586206896
HP_EMG_SLOW_MOTOR_CONDUCTION,SET,5,0.04731,0.00078062,0.34716,0.4458,HP_EMG_SLOW_MOTOR_CONDUCTION,0.982727586206896
MODULE_320,SET,19,0.027263,0.00087657,0.20011,0.44582,MODULE_320,0.982727586206896
GSE2706_UNSTIM_VS_2H_LPS_DC_...2,SET,155,0.0086182,0.0007885,0.063304,0.44586,GSE2706_UNSTIM_VS_2H_LPS_DC_UP,0.982727586206896
GOBP_CELLULAR_RESPONSE_TO_VI...3,SET,19,0.027551,0.00088582,0.20244,0.44588,GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D,0.982727586206896
MIR4710,SET,72,0.013903,0.00086893,0.10235,0.44598,MIR4710,0.982727586206896
NOTCH3_TARGET_GENES,SET,1079,0.0037305,0.00087738,0.027468,0.44599,NOTCH3_TARGET_GENES,0.982727586206896
APPEL_IMATINIB_RESPONSE,SET,28,0.023388,0.00091264,0.1723,0.44601,APPEL_IMATINIB_RESPONSE,0.982727586206896
MAHAJAN_RESPONSE_TO_IL1A_UP,SET,73,0.014398,0.00090606,0.10616,0.44606,MAHAJAN_RESPONSE_TO_IL1A_UP,0.982727586206896
MIR1252_5P,SET,294,0.0068223,0.00085637,0.050302,0.44606,MIR1252_5P,0.982727586206896
GOBP_SYNAPTIC_TRANSMISSION_C...,SET,31,0.022002,0.0009033,0.16225,0.44607,GOBP_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.982727586206896
GOMF_UNIPORTER_ACTIVITY,SET,9,0.045824,0.0010143,0.33792,0.44607,GOMF_UNIPORTER_ACTIVITY,0.982727586206896
GSE17721_0.5H_VS_24H_LPS_BMD...2,SET,182,0.0087235,0.00086423,0.064341,0.44608,GSE17721_0.5H_VS_24H_LPS_BMDC_UP,0.982727586206896
GOBP_REGULATION_OF_PROTEIN_E...2,SET,34,0.020111,0.00086465,0.14848,0.44613,GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.982775442099258
KESHELAVA_MULTIPLE_DRUG_RESI...,SET,66,0.013696,0.00081967,0.10119,0.44617,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,0.982801264418811
GOMF_CYCLIC_NUCLEOTIDE_BINDI...,SET,36,0.01975,0.00087367,0.14607,0.44623,GOMF_CYCLIC_NUCLEOTIDE_BINDING,0.982868758708043
HP_FALCIFORM_RETINAL_FOLD,SET,5,0.053176,0.00087741,0.39377,0.44629,HP_FALCIFORM_RETINAL_FOLD,0.982868758708043
REACTOME_UPTAKE_OF_DIETARY_C...,SET,9,0.043363,0.00095983,0.32122,0.44631,REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES,0.982868758708043
HAY_BONE_MARROW_CD8_T_CELL,SET,61,0.015293,0.00088006,0.11337,0.44635,HAY_BONE_MARROW_CD8_T_CELL,0.982868758708043
GOBP_REGULATION_OF_GUANYLATE...,SET,6,0.058476,0.0010569,0.43395,0.4464,GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,0.982868758708043
GOBP_ADENYLATE_CYCLASE_INHIB...3,SET,9,0.041189,0.00091171,0.30569,0.44641,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.982868758708043
GOMF_G_PROTEIN_COUPLED_GLUTA...1,SET,9,0.041189,0.00091171,0.30569,0.44641,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY,0.982868758708043
TRAVAGLINI_LUNG_BRONCHIAL_VE...1,SET,207,0.0081023,0.00085545,0.060191,0.44646,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL,0.982868758708043
GOMF_RECEPTOR_TYROSINE_KINAS...,SET,75,0.012696,0.00080981,0.094351,0.44648,GOMF_RECEPTOR_TYROSINE_KINASE_BINDING,0.982868758708043
GENTILE_UV_RESPONSE_CLUSTER_...5,SET,33,0.019383,0.000821,0.14408,0.44649,GENTILE_UV_RESPONSE_CLUSTER_D6,0.982868758708043
GOBP_AMYLOID_FIBRIL_FORMATION,SET,34,0.019524,0.00083942,0.14519,0.44652,GOBP_AMYLOID_FIBRIL_FORMATION,0.982868758708043
GSE35543_IN_VIVO_NTREG_VS_CO...2,SET,157,0.0088785,0.0008175,0.066052,0.44654,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP,0.982868758708043
GOBP_DISTAL_CONVOLUTED_TUBUL...,SET,4,0.066751,0.00098516,0.49733,0.44662,GOBP_DISTAL_CONVOLUTED_TUBULE_DEVELOPMENT,0.982942353723404
GOCC_PAM_COMPLEX_TIM23_ASSOC...,SET,5,0.048765,0.00080464,0.36343,0.44663,GOCC_PAM_COMPLEX_TIM23_ASSOCIATED_IMPORT_MOTOR,0.982942353723404
GSE9960_HEALTHY_VS_GRAM_POS_...1,SET,166,0.0089744,0.00084948,0.066978,0.44671,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN,0.982943707289294
WP_IL9_SIGNALING,SET,15,0.034666,0.00099046,0.25927,0.44682,WP_IL9_SIGNALING,0.982943707289294
GOBP_REGULATION_OF_FOCAL_ADH...,SET,6,0.050311,0.00090934,0.37628,0.44682,GOBP_REGULATION_OF_FOCAL_ADHESION_DISASSEMBLY,0.982943707289294
REACTOME_TRAF6_MEDIATED_IRF7...2,SET,10,0.035913,0.00083791,0.26865,0.44683,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,0.982943707289294
KEGG_MEDICUS_VARIANT_MUTATIO...8,SET,24,0.023731,0.00085745,0.17756,0.44684,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.982943707289294
HP_STENOSIS_OF_THE_EXTERNAL_...,SET,32,0.021223,0.00088525,0.15879,0.44684,HP_STENOSIS_OF_THE_EXTERNAL_AUDITORY_CANAL,0.982943707289294
MIR4705,SET,111,0.011298,0.00087585,0.084633,0.4469,MIR4705,0.982943707289294
GOMF_S_METHYLTRANSFERASE_ACT...,SET,8,0.04803,0.0010024,0.35985,0.44691,GOMF_S_METHYLTRANSFERASE_ACTIVITY,0.982943707289294
HP_ABNORMAL_METABOLISM,SET,146,0.0091512,0.0008128,0.068592,0.44693,HP_ABNORMAL_METABOLISM,0.982943707289294
WP_7OXOC_AND_7BETAHC_PATHWAYS,SET,25,0.024141,0.00089019,0.18101,0.44695,WP_7OXOC_AND_7BETAHC_PATHWAYS,0.982943707289294
GSE10856_CTRL_VS_TNFRSF6B_IN...1,SET,164,0.0085966,0.00080884,0.064468,0.44696,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN,0.982943707289294
SREBP1_Q6,SET,233,0.0073953,0.00082779,0.055467,0.44697,SREBP1_Q6,0.982943707289294
GOBP_GONADOTROPIN_SECRETION,SET,17,0.030745,0.00093512,0.23135,0.44714,GOBP_GONADOTROPIN_SECRETION,0.983007350157729
REACTOME_PHASE_2_PLATEAU_PHA...,SET,14,0.030769,0.00084934,0.23159,0.44715,REACTOME_PHASE_2_PLATEAU_PHASE,0.983007350157729
GSE20366_TREG_VS_TCONV_UP,SET,179,0.0086692,0.00085181,0.065268,0.44717,GSE20366_TREG_VS_TCONV_UP,0.983007350157729
GSE1460_DP_THYMOCYTE_VS_NAIV...3,SET,173,0.0088583,0.00085582,0.066712,0.44718,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.983007350157729
MIR6730_3P,SET,74,0.013053,0.00082698,0.098362,0.44722,MIR6730_3P,0.983007350157729
GSE17721_CTRL_VS_LPS_2H_BMDC...2,SET,184,0.0079387,0.00079074,0.059826,0.44722,GSE17721_CTRL_VS_LPS_2H_BMDC_UP,0.983007350157729
GOBP_NEUTROPHIL_MEDIATED_KIL...1,SET,7,0.052776,0.0010303,0.39779,0.44723,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_GRAM_NEGATIVE_BACTERIUM,0.983007350157729
GOBP_ATRIAL_CARDIAC_MUSCLE_T...2,SET,5,0.057955,0.00095627,0.43708,0.44726,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.983007350157729
MIR4312,SET,42,0.017954,0.00085772,0.13584,0.44742,MIR4312,0.983007350157729
GOCC_CYTOPLASMIC_EXOSOME_RNA...,SET,15,0.025024,0.00071496,0.18933,0.44742,GOCC_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX,0.983007350157729
ZNF596_TARGET_GENES,SET,485,0.0052997,0.00084991,0.040107,0.44744,ZNF596_TARGET_GENES,0.983007350157729
GSE13306_TREG_VS_TCONV_SPLEE...1,SET,177,0.0086825,0.00084838,0.065749,0.44747,GSE13306_TREG_VS_TCONV_SPLEEN_DN,0.983007350157729
GSE24574_BCL6_HIGH_TFH_VS_TF...1,SET,185,0.0085418,0.0008531,0.06468,0.44747,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN,0.983007350157729
HP_INCREASED_CIRCULATING_VER...,SET,8,0.042765,0.0008925,0.3244,0.44756,HP_INCREASED_CIRCULATING_VERY_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.983007350157729
GSE17721_CPG_VS_GARDIQUIMOD_...8,SET,190,0.0080879,0.0008185,0.061384,0.44759,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP,0.983007350157729
OUYANG_PROSTATE_CANCER_PROGR...2,SET,18,0.027566,0.00086272,0.20946,0.44765,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,0.983007350157729
GSE23114_WT_VS_SLE2C1_MOUSE_...2,SET,169,0.008494,0.00081117,0.064665,0.44775,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP,0.983007350157729
GOBP_NEGATIVE_REGULATION_OF_...311,SET,26,0.023689,0.00089082,0.18045,0.44778,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.983007350157729
GOMF_EXOGENOUS_PROTEIN_BINDI...,SET,78,0.013645,0.0008875,0.10394,0.44778,GOMF_EXOGENOUS_PROTEIN_BINDING,0.983007350157729
HP_SHORT_PHILTRUM,SET,213,0.0076509,0.00081928,0.058327,0.44782,HP_SHORT_PHILTRUM,0.983007350157729
KEGG_MEDICUS_REFERENCE_TLR3_...2,SET,16,0.034881,0.0010293,0.26613,0.44786,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY,0.983007350157729
GSE15930_STIM_VS_STIM_AND_IF...2,SET,176,0.008058,0.00078515,0.061472,0.44786,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP,0.983007350157729
MIR519A_2_5P_MIR520B_5P,SET,190,0.0080458,0.00081424,0.061462,0.44793,MIR519A_2_5P_MIR520B_5P,0.983007350157729
BILBAN_B_CLL_LPL_DN,SET,37,0.018571,0.00083284,0.14191,0.44794,BILBAN_B_CLL_LPL_DN,0.983007350157729
IRITANI_MAD1_TARGETS_UP,SET,12,0.034981,0.00089401,0.26733,0.44795,IRITANI_MAD1_TARGETS_UP,0.983007350157729
REACTOME_NFE2L2_REGULATING_M...,SET,8,0.042227,0.00088126,0.32313,0.44801,REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES,0.983007350157729
GOBP_NEGATIVE_REGULATION_OF_...91,SET,103,0.010955,0.0008182,0.083852,0.44803,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.983007350157729
GSE24972_MARGINAL_ZONE_BCELL...1,SET,178,0.0084692,0.00082986,0.064834,0.44803,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN,0.983007350157729
GOBP_DIAPEDESIS,SET,6,0.050227,0.00090784,0.38454,0.44804,GOBP_DIAPEDESIS,0.983007350157729
TGAYRTCA_ATF3_Q6,SET,496,0.0052452,0.0008504,0.04017,0.44806,TGAYRTCA_ATF3_Q6,0.983007350157729
CAFFAREL_RESPONSE_TO_THC_8HR...2,SET,5,0.0496,0.00081841,0.37997,0.44807,CAFFAREL_RESPONSE_TO_THC_8HR_3_UP,0.983007350157729
GSE9988_ANTI_TREM1_AND_LPS_V...4,SET,162,0.0094071,0.00087974,0.072064,0.44807,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP,0.983007350157729
PPARA_TARGET_GENES,SET,55,0.014121,0.00077175,0.10821,0.44809,PPARA_TARGET_GENES,0.983007350157729
GOBP_RESPONSE_TO_WATER,SET,13,0.030599,0.00081394,0.23451,0.44809,GOBP_RESPONSE_TO_WATER,0.983007350157729
HP_DECREASED_SIZE_OF_NERVE_T...,SET,15,0.026745,0.00076415,0.20512,0.44813,HP_DECREASED_SIZE_OF_NERVE_TERMINALS,0.983007350157729
HP_SPONDYLOLISTHESIS,SET,19,0.025823,0.00083026,0.19805,0.44813,HP_SPONDYLOLISTHESIS,0.983007350157729
GTGGTGA_MIR197,SET,64,0.013409,0.00079032,0.10286,0.44814,GTGGTGA_MIR197,0.983007350157729
GOBP_REGULATION_OF_HYDROGEN_...2,SET,9,0.038579,0.00085394,0.29611,0.44817,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,0.983007350157729
GSE19512_NAUTRAL_VS_INDUCED_...2,SET,179,0.0086432,0.00084925,0.066375,0.4482,GSE19512_NAUTRAL_VS_INDUCED_TREG_UP,0.983007350157729
ERWIN_COHEN_BLOOD_VACCINE_TC...1,SET,6,0.044316,0.00080099,0.34042,0.44821,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_DN,0.983007350157729
GOBP_REGULATION_OF_INTRINSIC...1,SET,160,0.0085403,0.00079377,0.065643,0.44824,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.983007350157729
KEGG_MEDICUS_REFERENCE_ANXA2...,SET,5,0.053765,0.00088713,0.41338,0.44826,KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON,0.983007350157729
LIEN_BREAST_CARCINOMA_METAPL...2,SET,104,0.010799,0.00081048,0.08305,0.44827,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,0.983007350157729
HP_BILATERAL_CRYPTORCHIDISM,SET,43,0.015424,0.00074558,0.11863,0.44828,HP_BILATERAL_CRYPTORCHIDISM,0.983007350157729
GSE21360_PRIMARY_VS_TERTIARY...1,SET,180,0.0085382,0.00084126,0.065678,0.44828,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.983007350157729
GOCC_SEC61_TRANSLOCON_COMPLEX,SET,4,0.051822,0.00076483,0.39877,0.4483,GOCC_SEC61_TRANSLOCON_COMPLEX,0.983007350157729
WP_CLOCKCONTROLLED_AUTOPHAGY...,SET,77,0.013311,0.00086018,0.1027,0.44844,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.983008000126135
GSE42021_CD24HI_VS_CD24LOW_T...3,SET,183,0.008552,0.00084954,0.065989,0.44844,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN,0.983008000126135
HP_ABNORMAL_FETAL_PHYSIOLOGY,SET,261,0.0068955,0.00081628,0.053209,0.44845,HP_ABNORMAL_FETAL_PHYSIOLOGY,0.983008000126135
RB_P107_DN.V1_UP,SET,121,0.009657,0.00078138,0.074532,0.44845,RB_P107_DN.V1_UP,0.983008000126135
REACTOME_PERK_REGULATES_GENE...,SET,30,0.019841,0.00080136,0.15315,0.44846,REACTOME_PERK_REGULATES_GENE_EXPRESSION,0.983008000126135
GOBP_NEGATIVE_REGULATION_OF_...35,SET,16,0.027505,0.00081162,0.21233,0.44847,GOBP_NEGATIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.983008000126135
IRF5_TARGET_GENES,SET,654,0.0043074,0.00079834,0.033312,0.44856,IRF5_TARGET_GENES,0.98310296936666
DESCARTES_FETAL_MUSCLE_STROM...,SET,65,0.014844,0.00088164,0.11486,0.44859,DESCARTES_FETAL_MUSCLE_STROMAL_CELLS,0.98310296936666
GOBP_INDUCTION_OF_POSITIVE_C...,SET,13,0.034354,0.00091383,0.26598,0.44862,GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS,0.98310296936666
ZHENG_FOXP3_TARGETS_DN,SET,6,0.045204,0.00081704,0.35057,0.4487,ZHENG_FOXP3_TARGETS_DN,0.98310296936666
GSE36009_WT_VS_NLRP10_KO_DC_...3,SET,186,0.0077451,0.00077559,0.060061,0.4487,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP,0.98310296936666
GOBP_REGULATION_OF_PROTEIN_C...5,SET,110,0.010226,0.00078917,0.079371,0.44874,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.98310296936666
GOBP_MUSCLE_HYPERTROPHY,SET,84,0.012733,0.00085928,0.098875,0.44877,GOBP_MUSCLE_HYPERTROPHY,0.98310296936666
GOBP_REGULATION_OF_GLIOGENES...,SET,101,0.011661,0.00086247,0.090616,0.44881,GOBP_REGULATION_OF_GLIOGENESIS,0.98310296936666
GOBP_REGULATION_OF_NODAL_SIG...,SET,7,0.049233,0.00096113,0.38274,0.44883,GOBP_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.98310296936666
GSE17721_LPS_VS_PAM3CSK4_2H_...2,SET,184,0.0084397,0.00084065,0.065661,0.44886,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP,0.98310296936666
MIR1302,SET,63,0.013083,0.00076507,0.10193,0.44893,MIR1302,0.98310296936666
HP_OVAL_FACE,SET,15,0.027892,0.00079693,0.21738,0.44895,HP_OVAL_FACE,0.98310296936666
GSE2770_UNTREATED_VS_TGFB_AN...5,SET,178,0.0079865,0.00078256,0.062318,0.44901,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.98310296936666
GSE17974_CTRL_VS_ACT_IL4_AND...15,SET,178,0.008166,0.00080014,0.063752,0.44904,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN,0.98310296936666
SASAI_TARGETS_OF_CXCR6_AND_P...1,SET,8,0.044593,0.00093065,0.34847,0.44909,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN,0.98310296936666
MIR6784_3P,SET,35,0.017029,0.0007428,0.13309,0.4491,MIR6784_3P,0.98310296936666
MIR20B_5P,SET,571,0.0047072,0.00081711,0.036802,0.44911,MIR20B_5P,0.98310296936666
MIR6124,SET,410,0.0054675,0.00080787,0.042747,0.44911,MIR6124,0.98310296936666
GOMF_CILIARY_NEUROTROPHIC_FA...,SET,6,0.042432,0.00076694,0.33204,0.44916,GOMF_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING,0.98310296936666
HP_ELEVATED_HEMOGLOBIN_A1C,SET,26,0.023507,0.00088398,0.18402,0.44918,HP_ELEVATED_HEMOGLOBIN_A1C,0.98310296936666
HE_LIM_SUN_FETAL_LUNG_C5_CD5...3,SET,587,0.0045407,0.00079882,0.03555,0.44918,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL,0.98310296936666
HP_CONGENITAL_SENSORINEURAL_...,SET,54,0.015733,0.00085199,0.12338,0.44927,HP_CONGENITAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.98310296936666
GOBP_REGULATION_OF_ER_TO_GOL...,SET,10,0.033915,0.00079129,0.26611,0.44929,GOBP_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.98310296936666
GOMF_L_GLUTAMATE_TRANSMEMBRA...,SET,14,0.030013,0.00082846,0.23559,0.44931,GOMF_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.98310296936666
HP_ABNORMAL_CIRCULATING_BILI...,SET,114,0.010233,0.0008038,0.080338,0.44932,HP_ABNORMAL_CIRCULATING_BILIRUBIN_CONCENTRATION,0.98310296936666
KEGG_MEDICUS_REFERENCE_ATR_S...,SET,11,0.029571,0.00072359,0.23227,0.44935,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING,0.98310296936666
HP_ABNORMALITY_OF_THE_MIDDLE...2,SET,19,0.026909,0.00086518,0.21154,0.44939,HP_ABNORMALITY_OF_THE_MIDDLE_EAR_OSSICLES,0.98310296936666
GOCC_DENSE_CORE_GRANULE,SET,38,0.019269,0.00087571,0.15153,0.44941,GOCC_DENSE_CORE_GRANULE,0.98310296936666
BIOCARTA_ECM_PATHWAY,SET,19,0.024815,0.00079786,0.19518,0.44942,BIOCARTA_ECM_PATHWAY,0.98310296936666
GSE1460_DP_THYMOCYTE_VS_NAIV...1,SET,175,0.0082898,0.00080546,0.065242,0.44945,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.98310296936666
CATRRAGC_UNKNOWN,SET,122,0.0096294,0.00078234,0.075912,0.44953,CATRRAGC_UNKNOWN,0.98310296936666
GOMF_DELAYED_RECTIFIER_POTAS...,SET,27,0.024286,0.00093062,0.19165,0.44958,GOMF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.98310296936666
GSE16697_CD4_TCELL_VS_TFH_CD...1,SET,183,0.0080713,0.00080178,0.063692,0.44958,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN,0.98310296936666
GOBP_COPPER_ION_HOMEOSTASIS,SET,18,0.025808,0.00080768,0.20387,0.44963,GOBP_COPPER_ION_HOMEOSTASIS,0.98310296936666
GSE45365_HEALTHY_VS_MCMV_INF...6,SET,154,0.0083656,0.00076294,0.066158,0.44969,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP,0.98310296936666
GSE21546_WT_VS_ELK1_KO_DP_TH...1,SET,179,0.0079049,0.00077671,0.062553,0.44972,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN,0.98310296936666
MIR466,SET,372,0.0056487,0.00079587,0.044725,0.44975,MIR466,0.98310296936666
GOBP_PLASMA_MEMBRANE_PHOSPHO...,SET,24,0.022895,0.00082723,0.18127,0.44975,GOBP_PLASMA_MEMBRANE_PHOSPHOLIPID_SCRAMBLING,0.98310296936666
GSE7509_UNSTIM_VS_IFNA_STIM_...1,SET,163,0.0088035,0.0008258,0.069807,0.44982,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN,0.98310296936666
GOBP_NEGATIVE_REGULATION_OF_...93,SET,8,0.041139,0.00085856,0.32629,0.44983,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.98310296936666
GSE21033_CTRL_VS_POLYIC_STIM...8,SET,179,0.0076556,0.00075221,0.060787,0.44989,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP,0.98310296936666
chr7p12,SET,18,0.044649,0.0013973,0.35458,0.4499,chr7p12,0.98310296936666
GSE27786_CD8_TCELL_VS_NKTCEL...1,SET,178,0.0080396,0.00078776,0.063858,0.44991,GSE27786_CD8_TCELL_VS_NKTCELL_DN,0.98310296936666
GSE9988_LPS_VS_VEHICLE_TREAT...2,SET,162,0.0090953,0.00085058,0.072251,0.44991,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.98310296936666
HP_SEMILOBAR_HOLOPROSENCEPHA...,SET,7,0.041033,0.00080105,0.32604,0.44993,HP_SEMILOBAR_HOLOPROSENCEPHALY,0.98310296936666
CHAMP1_TARGET_GENES,SET,145,0.008717,0.0007716,0.069288,0.44994,CHAMP1_TARGET_GENES,0.98310296936666
NAGASHIMA_EGF_SIGNALING_UP,SET,53,0.016072,0.0008623,0.1279,0.45,NAGASHIMA_EGF_SIGNALING_UP,0.98310296936666
HP_DECREASED_FACIAL_EXPRESSI...,SET,126,0.0097175,0.00080225,0.077381,0.45003,HP_DECREASED_FACIAL_EXPRESSION,0.98310296936666
MORF_TNFRSF6,SET,146,0.0091933,0.00081654,0.073297,0.45009,MORF_TNFRSF6,0.98310296936666
KEGG_MEDICUS_REFERENCE_LOADI...,SET,7,0.043515,0.00084951,0.347,0.4501,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX,0.98310296936666
GOCC_GOLGI_ASSOCIATED_VESICLE,SET,85,0.011363,0.00077136,0.090599,0.4501,GOCC_GOLGI_ASSOCIATED_VESICLE,0.98310296936666
GOBP_TRANSCYTOSIS,SET,21,0.023816,0.000805,0.18997,0.45012,GOBP_TRANSCYTOSIS,0.98310296936666
GOBP_NEGATIVE_REGULATION_OF_...470,SET,12,0.034421,0.0008797,0.27485,0.45017,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.98310296936666
GSE14000_4H_VS_16H_LPS_DC_UP,SET,165,0.0083206,0.00078523,0.066461,0.45019,GSE14000_4H_VS_16H_LPS_DC_UP,0.98310296936666
GOBP_WATER_SOLUBLE_VITAMIN_M...,SET,58,0.013665,0.00076682,0.10917,0.4502,GOBP_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.98310296936666
HP_ABNORMAL_PLATELET_VOLUME,SET,25,0.021589,0.0007961,0.17248,0.4502,HP_ABNORMAL_PLATELET_VOLUME,0.98310296936666
WP_FOCAL_ADHESION,SET,190,0.0081345,0.00082321,0.065,0.45021,WP_FOCAL_ADHESION,0.98310296936666
GSE15330_LYMPHOID_MULTIPOTEN...1,SET,181,0.007648,0.00075562,0.06116,0.45024,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.98310296936666
NAKAYA_PBMC_FLUMIST_AGE_18_5...7,SET,1366,0.0028816,0.00075621,0.023048,0.45025,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP,0.98310296936666
GOBP_MEIOTIC_ATTACHMENT_OF_T...,SET,2,0.056975,0.00059462,0.45623,0.45031,GOBP_MEIOTIC_ATTACHMENT_OF_TELOMERE_TO_NUCLEAR_ENVELOPE,0.98310296936666
FLECHNER_PBL_KIDNEY_TRANSPLA...1,SET,37,0.017712,0.00079432,0.14204,0.45038,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,0.98310296936666
MIR6129,SET,170,0.0081772,0.0007832,0.065641,0.45043,MIR6129,0.98310296936666
GOMF_MICROFILAMENT_MOTOR_ACT...,SET,37,0.018522,0.00083063,0.14868,0.45043,GOMF_MICROFILAMENT_MOTOR_ACTIVITY,0.98310296936666
GOMF_PEPTIDE_BINDING,SET,233,0.0074643,0.00083552,0.059917,0.45043,GOMF_PEPTIDE_BINDING,0.98310296936666
GOBP_ACTIN_FILAMENT_DEPOLYME...,SET,54,0.013947,0.00075525,0.11199,0.45045,GOBP_ACTIN_FILAMENT_DEPOLYMERIZATION,0.98310296936666
GOBP_SODIUM_ION_TRANSPORT,SET,232,0.0075336,0.00084149,0.060524,0.45047,GOBP_SODIUM_ION_TRANSPORT,0.98310296936666
NGUYEN_NOTCH1_TARGETS_DN,SET,78,0.0121,0.00078701,0.097239,0.45049,NGUYEN_NOTCH1_TARGETS_DN,0.98310296936666
REACTOME_NR1H2_NR1H3_REGULAT...1,SET,5,0.041779,0.00068937,0.3359,0.45051,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS,0.98310296936666
HP_POOR_APPETITE,SET,47,0.014934,0.00075462,0.12009,0.45052,HP_POOR_APPETITE,0.98310296936666
ZHONG_PFC_C1_NEUROD1_POS_EXC...,SET,25,0.023917,0.00088196,0.19239,0.45053,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.98310296936666
GOBP_N_TERMINAL_PEPTIDYL_MET...,SET,5,0.037697,0.00062201,0.30336,0.45055,GOBP_N_TERMINAL_PEPTIDYL_METHIONINE_ACETYLATION,0.98310296936666
HP_LIMITED_NECK_RANGE_OF_MOT...,SET,8,0.041639,0.00086899,0.33515,0.45056,HP_LIMITED_NECK_RANGE_OF_MOTION,0.98310296936666
GSE45365_WT_VS_IFNAR_KO_CD11...2,SET,151,0.0089786,0.0008109,0.072355,0.45062,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN,0.98310296936666
MIR8077,SET,61,0.014357,0.00082614,0.11581,0.45067,MIR8077,0.98310296936666
BRCA2_TARGET_GENES,SET,1258,0.0030866,0.00077979,0.024898,0.45067,BRCA2_TARGET_GENES,0.98310296936666
MIR571,SET,61,0.013541,0.00077919,0.10927,0.45069,MIR571,0.98310296936666
GOBP_DGMP_METABOLIC_PROCESS,SET,6,0.042336,0.0007652,0.34203,0.45075,GOBP_DGMP_METABOLIC_PROCESS,0.98310296936666
FOSTER_KDM1A_TARGETS_UP,SET,225,0.0075211,0.00082748,0.060875,0.45084,FOSTER_KDM1A_TARGETS_UP,0.98310296936666
GOMF_NUCLEAR_RECEPTOR_COACTI...,SET,51,0.014015,0.0007376,0.1135,0.45087,GOMF_NUCLEAR_RECEPTOR_COACTIVATOR_ACTIVITY,0.98310296936666
HP_PREAXIAL_POLYDACTYLY,SET,73,0.011623,0.00073141,0.09426,0.45093,HP_PREAXIAL_POLYDACTYLY,0.98310296936666
GOBP_MITOTIC_NUCLEAR_MEMBRAN...2,SET,10,0.028618,0.00066771,0.23235,0.45099,GOBP_MITOTIC_NUCLEAR_MEMBRANE_ORGANIZATION,0.98310296936666
GOBP_RESPONSE_TO_INTERLEUKIN...5,SET,17,0.028994,0.00088185,0.23553,0.45101,GOBP_RESPONSE_TO_INTERLEUKIN_17,0.98310296936666
GSE18893_TCONV_VS_TREG_24H_T...2,SET,176,0.0073816,0.00071925,0.059953,0.45101,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP,0.98310296936666
GSE12505_WT_VS_E2_2_HET_PDC_...2,SET,119,0.0098653,0.00079165,0.080189,0.45104,GSE12505_WT_VS_E2_2_HET_PDC_UP,0.98310296936666
GOBP_MEMBRANE_DEPOLARIZATION...3,SET,21,0.025684,0.00086813,0.20886,0.45107,GOBP_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.98310296936666
GSE26351_UNSTIM_VS_BMP_PATHW...1,SET,176,0.0077867,0.00075872,0.063351,0.45109,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.98310296936666
GSE29949_CD8_NEG_DC_SPLEEN_V...2,SET,176,0.0082996,0.0008087,0.067565,0.45112,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP,0.98310296936666
GOBP_NEGATIVE_REGULATION_OF_...346,SET,52,0.014447,0.00076778,0.11764,0.45113,GOBP_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.98310296936666
MIR4731_5P,SET,238,0.0067132,0.00075936,0.054676,0.45114,MIR4731_5P,0.98310296936666
E2F1_Q6,SET,207,0.0071736,0.0007574,0.058538,0.45123,E2F1_Q6,0.98310296936666
KIM_ALL_DISORDERS_DURATION_C...1,SET,131,0.0084921,0.00071476,0.069341,0.45126,KIM_ALL_DISORDERS_DURATION_CORR_DN,0.98310296936666
LIN_NPAS4_TARGETS_DN,SET,65,0.013701,0.00081379,0.11186,0.45126,LIN_NPAS4_TARGETS_DN,0.98310296936666
GOBP_QUINOLINATE_METABOLIC_P...,SET,5,0.049836,0.00082231,0.40697,0.45127,GOBP_QUINOLINATE_METABOLIC_PROCESS,0.98310296936666
HP_INCREASED_SKULL_OSSIFICAT...,SET,8,0.034713,0.00072444,0.28355,0.45128,HP_INCREASED_SKULL_OSSIFICATION,0.98310296936666
GSE3982_DC_VS_EFF_MEMORY_CD4...2,SET,187,0.0077328,0.00077642,0.063176,0.45129,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP,0.98310296936666
DESCARTES_MAIN_FETAL_BRONCHI...,SET,34,0.020321,0.00087365,0.1661,0.45131,DESCARTES_MAIN_FETAL_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.98310296936666
GSE39110_DAY3_VS_DAY6_POST_I...1,SET,181,0.0076966,0.00076042,0.062914,0.45132,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN,0.98310296936666
GOBP_POSITIVE_REGULATION_OF_...242,SET,96,0.011251,0.0008114,0.092027,0.45135,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.98310296936666
GOBP_EARLY_ENDOSOME_TO_RECYC...,SET,7,0.041951,0.00081898,0.34337,0.45138,GOBP_EARLY_ENDOSOME_TO_RECYCLING_ENDOSOME_TRANSPORT,0.98310296936666
KEGG_NON_SMALL_CELL_LUNG_CAN...,SET,53,0.01394,0.0007479,0.11419,0.45142,KEGG_NON_SMALL_CELL_LUNG_CANCER,0.98310296936666
GSE14415_INDUCED_TREG_VS_FAI...2,SET,169,0.007381,0.00070488,0.060466,0.45142,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP,0.98310296936666
MARIADASON_RESPONSE_TO_CURCU...1,SET,22,0.021247,0.00073505,0.17411,0.45144,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,0.98310296936666
ROVERSI_GLIOMA_COPY_NUMBER_DN,SET,51,0.018928,0.00099621,0.15511,0.45144,ROVERSI_GLIOMA_COPY_NUMBER_DN,0.98310296936666
HP_DYSGENESIS_OF_THE_HIPPOCA...,SET,15,0.025537,0.00072962,0.2094,0.45147,HP_DYSGENESIS_OF_THE_HIPPOCAMPUS,0.98310296936666
HP_SUBSTANTIA_NIGRA_GLIOSIS,SET,10,0.034262,0.00079939,0.28125,0.45152,HP_SUBSTANTIA_NIGRA_GLIOSIS,0.98310296936666
GOMF_UBIQUITIN_LIKE_PROTEIN_...5,SET,291,0.005908,0.00073787,0.048507,0.45153,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING,0.98310296936666
GOMF_GLUTATHIONE_TRANSMEMBRA...,SET,7,0.038545,0.00075249,0.31652,0.45154,GOMF_GLUTATHIONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.98310296936666
GOCC_HETEROCHROMATIN,SET,68,0.012407,0.00075365,0.10196,0.45158,GOCC_HETEROCHROMATIN,0.983128470308193
DESCARTES_FETAL_STOMACH_GOBL...,SET,16,0.029052,0.00085725,0.23913,0.45165,DESCARTES_FETAL_STOMACH_GOBLET_CELLS,0.983186911322645
GOBP_NEGATIVE_REGULATION_OF_...37,SET,4,0.046229,0.00068228,0.38096,0.45171,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.983186911322645
ZHONG_PFC_MAJOR_TYPES_OPC,SET,86,0.01229,0.00083915,0.10128,0.45171,ZHONG_PFC_MAJOR_TYPES_OPC,0.983186911322645
GOBP_POSITIVE_REGULATION_OF_...827,SET,35,0.019479,0.00084965,0.16056,0.45172,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.983186911322645
HP_HYPERGLYCINURIA,SET,14,0.030477,0.00084127,0.25138,0.45175,HP_HYPERGLYCINURIA,0.983190634980274
AIZARANI_LIVER_C30_HEPATOCYT...,SET,369,0.0053616,0.00075243,0.044247,0.45178,AIZARANI_LIVER_C30_HEPATOCYTES_4,0.983194358171572
GOMF_PEPTIDE_LYSINE_N_ACETYL...,SET,43,0.014117,0.00068238,0.1167,0.45186,GOMF_PEPTIDE_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY,0.983288842975207
GOMF_ENZYME_ACTIVATOR_ACTIVI...,SET,539,0.0045422,0.00076675,0.037566,0.45188,GOMF_ENZYME_ACTIVATOR_ACTIVITY,0.983288842975207
GOBP_RESPONSE_TO_METAL_ION,SET,322,0.0060104,0.00078896,0.049835,0.452,GOBP_RESPONSE_TO_METAL_ION,0.983412712975098
GOBP_ALPHA_BETA_T_CELL_ACTIV...,SET,166,0.0085578,0.00081005,0.070963,0.45201,GOBP_ALPHA_BETA_T_CELL_ACTIVATION,0.983412712975098
HP_RECURRENT_INTRAPULMONARY_...,SET,7,0.050398,0.00098389,0.41808,0.45203,HP_RECURRENT_INTRAPULMONARY_HEMORRHAGE,0.983412712975098
GNF2_PCAF,SET,31,0.018549,0.00076156,0.15415,0.45211,GNF2_PCAF,0.983412712975098
GOBP_EPITHELIAL_CELL_DEVELOP...,SET,205,0.0077308,0.00081232,0.064303,0.45215,GOBP_EPITHELIAL_CELL_DEVELOPMENT,0.983412712975098
HP_LARGE_POSTERIOR_FONTANELLE,SET,17,0.026264,0.00079883,0.21844,0.45215,HP_LARGE_POSTERIOR_FONTANELLE,0.983412712975098
KUROKAWA_LIVER_CANCER_EARLY_...2,SET,12,0.026694,0.00068223,0.22229,0.45221,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,0.983412712975098
GOBP_COBALT_ION_TRANSPORT,SET,6,0.043711,0.00079006,0.3642,0.45223,GOBP_COBALT_ION_TRANSPORT,0.983412712975098
GOCC_U5_SNRNP,SET,19,0.020996,0.00067508,0.17503,0.45226,GOCC_U5_SNRNP,0.983412712975098
GOBP_NEGATIVE_REGULATION_OF_...664,SET,15,0.028521,0.00081488,0.23781,0.45227,GOBP_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.983412712975098
HP_ABNORMAL_LENGTH_OF_CORPUS...,SET,6,0.04508,0.00081481,0.37637,0.45233,HP_ABNORMAL_LENGTH_OF_CORPUS_CALLOSUM,0.983412712975098
MIR631,SET,48,0.015207,0.00077654,0.12703,0.45235,MIR631,0.983412712975098
GSE3982_DC_VS_TH1_DN,SET,177,0.0073891,0.000722,0.061719,0.45235,GSE3982_DC_VS_TH1_DN,0.983412712975098
CTCAAGA_MIR526B,SET,61,0.012949,0.00074517,0.1085,0.4525,CTCAAGA_MIR526B,0.983412712975098
GOBP_SECRETION_BY_TISSUE,SET,46,0.016093,0.00080453,0.13486,0.45251,GOBP_SECRETION_BY_TISSUE,0.983412712975098
HP_CONGENITAL_MUSCULAR_TORTI...,SET,6,0.042781,0.00077324,0.35853,0.45251,HP_CONGENITAL_MUSCULAR_TORTICOLLIS,0.983412712975098
HP_PAROXYSMAL_SUPRAVENTRICUL...,SET,5,0.050508,0.0008334,0.42333,0.45251,HP_PAROXYSMAL_SUPRAVENTRICULAR_TACHYCARDIA,0.983412712975098
KEGG_MEDICUS_REFERENCE_IL6_F...,SET,25,0.020842,0.00076858,0.17479,0.45254,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.983412712975098
REACTOME_SIGNALING_BY_NTRKS,SET,132,0.0089645,0.00075738,0.075187,0.45255,REACTOME_SIGNALING_BY_NTRKS,0.983412712975098
GOBP_METANEPHRIC_COLLECTING_...,SET,10,0.037247,0.00086903,0.31266,0.45259,GOBP_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT,0.983412712975098
HP_SHOULDER_DISLOCATION,SET,16,0.024296,0.00071692,0.20397,0.45259,HP_SHOULDER_DISLOCATION,0.983412712975098
GOMF_FIBROBLAST_GROWTH_FACTO...2,SET,5,0.050364,0.00083102,0.42395,0.45272,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_ACTIVITY,0.983412712975098
LOPEZ_MESOTHELIOMA_SURVIVAL_...2,SET,11,0.034158,0.00083585,0.28777,0.45276,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,0.983412712975098
KEGG_MEDICUS_REFERENCE_CXCR_...2,SET,26,0.021077,0.00079259,0.17756,0.45276,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,0.983412712975098
GOCC_BASAL_PART_OF_CELL,SET,297,0.0062671,0.00079062,0.052807,0.45276,GOCC_BASAL_PART_OF_CELL,0.983412712975098
GOBP_NEGATIVE_REGULATION_OF_...599,SET,12,0.032927,0.00084152,0.2775,0.45278,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.983412712975098
HP_PREMATURE_LOSS_OF_TEETH,SET,53,0.014058,0.00075422,0.1185,0.45278,HP_PREMATURE_LOSS_OF_TEETH,0.983412712975098
REACTOME_NEF_MEDIATED_CD4_DO...,SET,9,0.032501,0.00071942,0.27405,0.4528,REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION,0.983412712975098
GOBP_REGULATED_EXOCYTOSIS,SET,210,0.0070481,0.00074946,0.05944,0.45281,GOBP_REGULATED_EXOCYTOSIS,0.983412712975098
chr12p13,SET,133,0.020284,0.0017202,0.17113,0.45283,chr12p13,0.983412712975098
chr15q13,SET,18,0.034165,0.0010692,0.28852,0.45287,chr15q13,0.983412712975098
HP_SUPERNUMERARY_TOOTH,SET,44,0.015678,0.00076659,0.13255,0.45292,HP_SUPERNUMERARY_TOOTH,0.983412712975098
MIR503_5P,SET,95,0.010566,0.00075809,0.089427,0.45297,MIR503_5P,0.983412712975098
HP_DIMPLE_CHIN,SET,14,0.030088,0.00083053,0.25487,0.45301,HP_DIMPLE_CHIN,0.983412712975098
HP_ROTARY_NYSTAGMUS,SET,21,0.022023,0.00074438,0.18669,0.45305,HP_ROTARY_NYSTAGMUS,0.983412712975098
DESCARTES_MAIN_FETAL_SMOOTH_...,SET,37,0.017427,0.00078153,0.1478,0.45307,DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS,0.983412712975098
CUI_DEVELOPING_HEART_COMPACT...2,SET,58,0.014106,0.00079159,0.1197,0.45309,CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE,0.983412712975098
GSE2770_TGFB_AND_IL4_ACT_VS_...3,SET,179,0.0075493,0.00074177,0.064106,0.45313,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.983412712975098
HE_LIM_SUN_FETAL_LUNG_C4_ACT...,SET,46,0.015477,0.00077374,0.13144,0.45313,HE_LIM_SUN_FETAL_LUNG_C4_ACTIVATED_NK_CELL,0.983412712975098
AMIT_EGF_RESPONSE_240_MCF10A,SET,21,0.024555,0.00082996,0.20866,0.45316,AMIT_EGF_RESPONSE_240_MCF10A,0.983412712975098
HP_UNUSUAL_FUNGAL_INFECTION,SET,103,0.010288,0.00076844,0.087546,0.45322,HP_UNUSUAL_FUNGAL_INFECTION,0.983412712975098
GOBP_REGULATION_OF_SEQUESTER...,SET,14,0.028888,0.0007974,0.24606,0.45327,GOBP_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.983412712975098
GOBP_REGULATION_OF_PHAGOCYTO...,SET,90,0.011703,0.00081735,0.099752,0.4533,GOBP_REGULATION_OF_PHAGOCYTOSIS,0.983412712975098
GOCC_SITE_OF_DOUBLE_STRAND_B...,SET,85,0.010113,0.0006865,0.086204,0.45331,GOCC_SITE_OF_DOUBLE_STRAND_BREAK,0.983412712975098
GSE21927_BALBC_VS_C57BL6_MON...1,SET,148,0.0079986,0.00071524,0.068195,0.45332,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN,0.983412712975098
DESCARTES_FETAL_CEREBRUM_VAS...,SET,436,0.005251,0.00079952,0.044783,0.45333,DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS,0.983412712975098
MIR135A_2_3P,SET,48,0.013203,0.00067418,0.11263,0.45334,MIR135A_2_3P,0.983412712975098
MIR135B_3P,SET,48,0.013203,0.00067418,0.11263,0.45334,MIR135B_3P,0.983412712975098
AATGGAG_MIR136,SET,68,0.01208,0.00073382,0.10307,0.45335,AATGGAG_MIR136,0.983412712975098
GSE5542_UNTREATED_VS_IFNG_TR...4,SET,171,0.0077544,0.00074487,0.066186,0.45337,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.983412712975098
HP_CRANIOFACIAL_ASYMMETRY,SET,5,0.048609,0.00080205,0.41502,0.45338,HP_CRANIOFACIAL_ASYMMETRY,0.983412712975098
HP_ABNORMAL_SPUTUM,SET,119,0.0095407,0.00076561,0.081563,0.45344,HP_ABNORMAL_SPUTUM,0.983420106084243
HP_APLASIA_INVOLVING_BONES_O...3,SET,15,0.025827,0.00073791,0.22078,0.45344,HP_APLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.983420106084243
GOBP_NEGATIVE_REGULATION_OF_...339,SET,129,0.009436,0.00078816,0.08072,0.45347,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,0.983423801946836
GR_Q6_01,SET,247,0.0065681,0.00075668,0.056289,0.45356,GR_Q6_01,0.983557609034754
GSE19512_NAUTRAL_VS_INDUCED_...1,SET,173,0.0076839,0.00074235,0.065977,0.45364,GSE19512_NAUTRAL_VS_INDUCED_TREG_DN,0.983666431734548
HP_SUBRETINAL_DEPOSITS,SET,6,0.040583,0.00073351,0.34889,0.4537,HP_SUBRETINAL_DEPOSITS,0.983666431734548
TAAYNRNNTCC_UNKNOWN,SET,159,0.008041,0.00074505,0.069155,0.45372,TAAYNRNNTCC_UNKNOWN,0.983666431734548
GOMF_NADPLUS_PROTEIN_ADP_RIB...,SET,28,0.018733,0.00073099,0.16114,0.45373,GOMF_NADPLUS_PROTEIN_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.983666431734548
LIANG_SILENCED_BY_METHYLATIO...2,SET,9,0.033977,0.00075209,0.29261,0.45378,LIANG_SILENCED_BY_METHYLATION_DN,0.983666431734548
HP_METRORRHAGIA,SET,15,0.027298,0.00077995,0.2351,0.45378,HP_METRORRHAGIA,0.983666431734548
GOMF_LYASE_ACTIVITY,SET,179,0.0074922,0.00073616,0.064711,0.45391,GOMF_LYASE_ACTIVITY,0.983847184284378
HP_ERYTHROMELALGIA,SET,7,0.038779,0.00075705,0.33501,0.45392,HP_ERYTHROMELALGIA,0.983847184284378
HP_PARESIS_OF_EXTENSOR_MUSCL...,SET,6,0.046252,0.00083599,0.40006,0.45398,HP_PARESIS_OF_EXTENSOR_MUSCLES_OF_THE_BIG_TOE,0.983908849750624
chr2p14,SET,17,0.030822,0.00093746,0.26697,0.45404,chr2p14,0.983908849750624
IIZUKA_LIVER_CANCER_PROGRESS...3,SET,8,0.037643,0.00078559,0.32627,0.45408,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN,0.983908849750624
GSE39110_DAY3_VS_DAY6_POST_I...3,SET,178,0.00724,0.00070941,0.062764,0.45408,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN,0.983908849750624
GOBP_MUSCLE_ORGAN_DEVELOPMENT,SET,328,0.0057644,0.00076356,0.049975,0.45409,GOBP_MUSCLE_ORGAN_DEVELOPMENT,0.983908849750624
WU_ALZHEIMER_DISEASE_DN,SET,17,0.024414,0.00074254,0.21216,0.4542,WU_ALZHEIMER_DISEASE_DN,0.984024498192245
KEGG_MEDICUS_REFERENCE_WNT5A...,SET,15,0.027965,0.00079901,0.24305,0.4542,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY,0.984024498192245
HP_ARTHROPATHY,SET,41,0.015924,0.00075167,0.13856,0.45425,HP_ARTHROPATHY,0.98407147977311
GSE360_L_DONOVANI_VS_L_MAJOR...3,SET,176,0.0073482,0.000716,0.064007,0.4543,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN,0.984118455497382
GOBP_MORPHOGENESIS_OF_EMBRYO...,SET,144,0.0084034,0.00074129,0.073317,0.45438,GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM,0.984169070173252
HP_CUTANEOUS_SYNDACTYLY,SET,64,0.012092,0.00071269,0.10552,0.45438,HP_CUTANEOUS_SYNDACTYLY,0.984169070173252
KEGG_MEDICUS_REFERENCE_REGUL...1,SET,4,0.073158,0.0010797,0.63882,0.45441,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR,0.98417271452608
GOBP_REGULATION_OF_DNA_TOPOI...,SET,5,0.045126,0.0007446,0.39499,0.45452,GOBP_REGULATION_OF_DNA_TOPOISOMERASE_ATP_HYDROLYZING_ACTIVITY,0.984248607476635
CHOI_ATL_ACUTE_STAGE,SET,4,0.051902,0.000766,0.45439,0.45453,CHOI_ATL_ACUTE_STAGE,0.984248607476635
GAO_ESOPHAGUS_25W_C4_FGFR1HI...,SET,178,0.0072468,0.00071008,0.063441,0.45453,GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS,0.984248607476635
HP_DELAYED_ERUPTION_OF_PERMA...,SET,32,0.017786,0.00074187,0.15592,0.45459,HP_DELAYED_ERUPTION_OF_PERMANENT_TEETH,0.984317204535543
GOMF_NEUROPEPTIDE_RECEPTOR_B...,SET,29,0.018874,0.00074952,0.16608,0.45476,GOMF_NEUROPEPTIDE_RECEPTOR_BINDING,0.984530184977578
HP_LOBULATED_TONGUE,SET,15,0.022259,0.00063598,0.19588,0.45476,HP_LOBULATED_TONGUE,0.984530184977578
TOP2B_TARGET_GENES,SET,483,0.0045067,0.00072129,0.039671,0.45478,TOP2B_TARGET_GENES,0.984530184977578
GSE39916_B_CELL_SPLEEN_VS_PL...1,SET,179,0.0075783,0.00074462,0.066751,0.45481,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN,0.984530184977578
GSE360_L_DONOVANI_VS_T_GONDI...1,SET,169,0.0073582,0.0007027,0.06485,0.45483,GSE360_L_DONOVANI_VS_T_GONDII_DC_DN,0.984530184977578
WP_HOSTPATHOGEN_INTERACTION_...3,SET,30,0.018039,0.0007286,0.15935,0.45493,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,0.984623997384481
TAGCTTT_MIR9,SET,210,0.0066696,0.00070921,0.058905,0.45493,TAGCTTT_MIR9,0.984623997384481
GSE22601_IMMATURE_CD4_SINGLE...5,SET,180,0.0072361,0.00071296,0.063979,0.45498,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.984670894825332
GOBP_POSITIVE_REGULATION_OF_...215,SET,5,0.043574,0.00071898,0.38567,0.45502,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.984696145703611
KEGG_FRUCTOSE_AND_MANNOSE_ME...,SET,28,0.015844,0.00061828,0.14038,0.45507,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,0.984703361972357
GOBP_CATECHOL_CONTAINING_COM...3,SET,46,0.015735,0.00078661,0.13944,0.45508,GOBP_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.984703361972357
GOBP_GLUCOCORTICOID_BIOSYNTH...,SET,16,0.027066,0.00079865,0.24038,0.45518,GOBP_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.98485842619685
GOMF_5ALPHA_ANDROSTANE_3BETA...,SET,6,0.045211,0.00081718,0.40198,0.45523,GOMF_5ALPHA_ANDROSTANE_3BETA_17BETA_DIOL_DEHYDROGENASE_ACTIVITY,0.984865620915033
GOBP_ORGANELLE_DISASSEMBLY,SET,153,0.0074918,0.00068105,0.066639,0.45524,GOBP_ORGANELLE_DISASSEMBLY,0.984865620915033
GSE23308_CTRL_VS_CORTICOSTER...3,SET,185,0.0068833,0.00068746,0.061277,0.45528,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP,0.984890850242749
BIOCARTA_ARAP_PATHWAY,SET,17,0.021639,0.00065816,0.19279,0.45532,BIOCARTA_ARAP_PATHWAY,0.98489438188266
GOBP_SEMAPHORIN_PLEXIN_SIGNA...,SET,42,0.015869,0.00075811,0.14158,0.45538,GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY,0.98489438188266
HE_LIM_SUN_FETAL_LUNG_C2_HSC...2,SET,350,0.0052103,0.00071249,0.046508,0.4554,HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL,0.98489438188266
GSE23398_WT_VS_IL2_KO_CD4_TC...2,SET,180,0.0071159,0.00070112,0.063586,0.45545,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP,0.98489438188266
HP_PULMONARY_ARTERIOVENOUS_M...,SET,4,0.050288,0.00074219,0.44951,0.45546,HP_PULMONARY_ARTERIOVENOUS_MALFORMATION,0.98489438188266
GSE28726_NAIVE_VS_ACTIVATED_...6,SET,180,0.0069159,0.00068141,0.061822,0.45546,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP,0.98489438188266
GSE22886_TCELL_VS_BCELL_NAIV...2,SET,182,0.0068936,0.00068294,0.061638,0.45548,GSE22886_TCELL_VS_BCELL_NAIVE_UP,0.98489438188266
WP_PHOSPHODIESTERASES_IN_NEU...,SET,52,0.013851,0.00073608,0.12393,0.45551,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.984897974990668
GTGCCTT_MIR506,SET,664,0.0037469,0.00069956,0.033574,0.45557,GTGCCTT_MIR506,0.984926779049515
GOBP_SMOOTH_MUSCLE_ADAPTATION,SET,4,0.058206,0.00085904,0.52167,0.45558,GOBP_SMOOTH_MUSCLE_ADAPTATION,0.984926779049515
GOMF_GROWTH_FACTOR_ACTIVITY,SET,145,0.0083397,0.0007382,0.074829,0.45563,GOMF_GROWTH_FACTOR_ACTIVITY,0.984955575942281
WP_DNA_DAMAGE_RESPONSE_ONLY_...,SET,108,0.0094846,0.00072529,0.085149,0.45565,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,0.984955575942281
KEGG_PATHOGENIC_ESCHERICHIA_...,SET,53,0.012887,0.00069138,0.11599,0.45577,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.985092434701493
WP_PATHOGENIC_ESCHERICHIA_CO...,SET,53,0.012887,0.00069138,0.11599,0.45577,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.985092434701493
GSE7460_WT_VS_FOXP3_HET_ACT_...3,SET,176,0.0070938,0.0006912,0.063976,0.45586,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN,0.985225688700951
WP_COVID19_ADVERSE_OUTCOME_P...,SET,14,0.026942,0.0007437,0.24341,0.45593,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,0.985315703892551
GOBP_DNA_STRAND_INVASION,SET,6,0.033327,0.00060237,0.30218,0.45609,GOBP_DNA_STRAND_INVASION,0.985600195858982
GOMF_MOLECULAR_FUNCTION_INHI...,SET,454,0.0046832,0.00072727,0.042543,0.45617,GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY,0.985650503574759
HP_EEG_WITH_POLYSPIKE_WAVE_C...,SET,46,0.014369,0.00071831,0.13051,0.45617,HP_EEG_WITH_POLYSPIKE_WAVE_COMPLEXES,0.985650503574759
GOBP_MAINTENANCE_OF_LOCATION...,SET,209,0.0066788,0.00070852,0.060767,0.45624,GOBP_MAINTENANCE_OF_LOCATION_IN_CELL,0.985711417029211
HP_TONGUE_NODULES,SET,12,0.022952,0.0005866,0.20907,0.45629,HP_TONGUE_NODULES,0.985711417029211
REACTOME_RESOLUTION_OF_AP_SI...,SET,24,0.017841,0.00064461,0.16261,0.45632,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,0.985711417029211
GSE34515_CD16_POS_MONOCYTE_V...2,SET,188,0.0069732,0.000702,0.063574,0.45633,GSE34515_CD16_POS_MONOCYTE_VS_DC_UP,0.985711417029211
REACTOME_ACYL_CHAIN_REMODELL...4,SET,16,0.025166,0.00074259,0.22947,0.45634,REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,0.985711417029211
KEGG_MEDICUS_VARIANT_ESR1_PO...,SET,5,0.047586,0.00078519,0.43456,0.4564,KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.985774652476108
MODULE_329,SET,50,0.013557,0.00070652,0.124,0.45647,MODULE_329,0.985774652476108
GOZGIT_ESR1_TARGETS_DN,SET,656,0.0039805,0.00073884,0.036464,0.45654,GOZGIT_ESR1_TARGETS_DN,0.985774652476108
GOBP_VESICLE_COATING,SET,37,0.014459,0.00064844,0.13257,0.45657,GOBP_VESICLE_COATING,0.985774652476108
KEGG_MEDICUS_PATHOGEN_HCMV_U...5,SET,13,0.025636,0.00068193,0.23524,0.45661,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY,0.985774652476108
WP_SMALL_LIGAND_GPCRS,SET,18,0.024769,0.00077515,0.22756,0.45666,WP_SMALL_LIGAND_GPCRS,0.985774652476108
KEGG_MEDICUS_VARIANT_AMPLIFI...9,SET,9,0.03194,0.00070698,0.2935,0.45667,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY,0.985774652476108
WP_RESOLVIN_E1_AND_RESOLVIN_...,SET,11,0.029293,0.0007168,0.26918,0.45667,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.985774652476108
GOBP_POSITIVE_REGULATION_OF_...504,SET,9,0.03368,0.00074552,0.31024,0.45678,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.985774652476108
GOBP_CELLULAR_RESPONSE_TO_PR...1,SET,6,0.035305,0.00063813,0.32535,0.45679,GOBP_CELLULAR_RESPONSE_TO_PROGESTERONE_STIMULUS,0.985774652476108
UDAYAKUMAR_MED1_TARGETS_UP,SET,118,0.008217,0.00065662,0.075753,0.45681,UDAYAKUMAR_MED1_TARGETS_UP,0.985774652476108
GAVISH_3CA_METAPROGRAM_EPITH...23,SET,45,0.015215,0.00075233,0.14026,0.45681,GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS,0.985774652476108
GOCC_AZUROPHIL_GRANULE,SET,139,0.0077699,0.0006735,0.071629,0.45681,GOCC_AZUROPHIL_GRANULE,0.985774652476108
GATA2_01,SET,99,0.0095626,0.0007003,0.088166,0.45682,GATA2_01,0.985774652476108
MODULE_83,SET,281,0.0052305,0.00064211,0.048257,0.45685,MODULE_83,0.985774652476108
MODULE_261,SET,89,0.0098171,0.00068185,0.090598,0.45686,MODULE_261,0.985774652476108
HP_UPPER_LIMB_SPASTICITY,SET,22,0.019631,0.00067915,0.18132,0.45689,HP_UPPER_LIMB_SPASTICITY,0.985774652476108
HP_LIMB_DYSTONIA,SET,74,0.010305,0.00065288,0.095313,0.45695,HP_LIMB_DYSTONIA,0.985774652476108
GSE46606_IRF4HIGH_VS_WT_CD40...2,SET,177,0.0066393,0.00064874,0.061403,0.45695,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.985774652476108
GSE339_EX_VIVO_VS_IN_CULTURE...1,SET,180,0.0068003,0.00067002,0.062929,0.45697,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN,0.985774652476108
WP_WNT_SIGNALING_WP428,SET,109,0.0094301,0.00072444,0.087313,0.457,WP_WNT_SIGNALING_WP428,0.985774652476108
TATA_C,SET,258,0.0060844,0.00071617,0.056392,0.45704,TATA_C,0.985774652476108
BRCA1_DN.V1_UP,SET,112,0.009297,0.00072391,0.086165,0.45704,BRCA1_DN.V1_UP,0.985774652476108
VERHAAK_AML_WITH_NPM1_MUTATE...2,SET,168,0.0078829,0.0007506,0.073085,0.45705,VERHAAK_AML_WITH_NPM1_MUTATED_UP,0.985774652476108
PICCALUGA_ANGIOIMMUNOBLASTIC...1,SET,117,0.0090957,0.00072378,0.084439,0.45711,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,0.985842882407695
GSE17186_BLOOD_VS_CORD_BLOOD...6,SET,186,0.0067556,0.00067651,0.062773,0.45715,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP,0.985849931749085
HP_SYNOSTOSIS_INVOLVING_THE_...,SET,10,0.031141,0.00072656,0.28947,0.45717,HP_SYNOSTOSIS_INVOLVING_THE_ELBOW,0.985849931749085
HP_DILATATED_INTERNAL_AUDITO...,SET,3,0.065219,0.00083361,0.60668,0.4572,HP_DILATATED_INTERNAL_AUDITORY_CANAL,0.985853455763743
GOCC_NLRP1_INFLAMMASOME_COMP...,SET,5,0.049214,0.00081204,0.45833,0.45725,GOCC_NLRP1_INFLAMMASOME_COMPLEX,0.985895381686421
HENDRICKS_SMARCA4_TARGETS_UP,SET,51,0.014084,0.00074129,0.1314,0.45732,HENDRICKS_SMARCA4_TARGETS_UP,0.985895381686421
MIR6817_5P,SET,98,0.0093569,0.00068178,0.087292,0.45732,MIR6817_5P,0.985895381686421
GOBP_NEUROINFLAMMATORY_RESPO...,SET,75,0.011613,0.00074073,0.1086,0.45742,GOBP_NEUROINFLAMMATORY_RESPONSE,0.985895381686421
HP_ABNORMAL_MORPHOLOGY_OF_TH...9,SET,6,0.033303,0.00060194,0.3118,0.45747,HP_ABNORMAL_MORPHOLOGY_OF_THE_PROXIMAL_PHALANX_OF_THE_HALLUX,0.985895381686421
GOMF_1_ACYLGLYCEROPHOSPHOCHO...,SET,6,0.043265,0.00078199,0.40518,0.45748,GOMF_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY,0.985895381686421
GOMF_PHOSPHOTRANSFERASE_ACTI...3,SET,34,0.01502,0.00064578,0.14076,0.45751,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR,0.985895381686421
GOMF_AXON_GUIDANCE_RECEPTOR_...,SET,10,0.031521,0.00073544,0.29562,0.45754,GOMF_AXON_GUIDANCE_RECEPTOR_ACTIVITY,0.985895381686421
MIR7106_5P,SET,325,0.0050668,0.00066814,0.047544,0.45756,MIR7106_5P,0.985895381686421
HP_CRANIAL_NERVE_PARALYSIS,SET,258,0.0056503,0.00066508,0.053019,0.45757,HP_CRANIAL_NERVE_PARALYSIS,0.985895381686421
GSE17721_POLYIC_VS_GARDIQUIM...15,SET,184,0.0065147,0.00064891,0.061166,0.45759,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN,0.985895381686421
REACTOME_FGFR3_LIGAND_BINDIN...,SET,12,0.029955,0.00076555,0.28153,0.45763,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,0.985895381686421
REACTOME_MITOTIC_PROMETAPHASE,SET,185,0.0063875,0.00063795,0.060072,0.45766,REACTOME_MITOTIC_PROMETAPHASE,0.985895381686421
GOBP_FATTY_ACID_BETA_OXIDATI...1,SET,70,0.010221,0.00062989,0.096299,0.45774,GOBP_FATTY_ACID_BETA_OXIDATION,0.985895381686421
GSE25677_MPL_VS_R848_STIM_BC...1,SET,166,0.0071361,0.00067547,0.067258,0.45775,GSE25677_MPL_VS_R848_STIM_BCELL_DN,0.985895381686421
HP_SECUNDUM_ATRIAL_SEPTAL_DE...,SET,38,0.015193,0.00069048,0.14329,0.45778,HP_SECUNDUM_ATRIAL_SEPTAL_DEFECT,0.985895381686421
GSE26488_HDAC7_KO_VS_VP16_TR...1,SET,186,0.0066073,0.00066165,0.06238,0.45782,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.985895381686421
PID_VEGFR1_2_PATHWAY,SET,68,0.010856,0.00065947,0.10252,0.45783,PID_VEGFR1_2_PATHWAY,0.985895381686421
KEGG_MEDICUS_REFERENCE_CITRA...2,SET,10,0.026907,0.00062778,0.25417,0.45785,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2,0.985895381686421
KEGG_MEDICUS_REFERENCE_TLR5_...,SET,15,0.023405,0.00066871,0.22157,0.45794,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY,0.985895381686421
HP_ABNORMAL_ERYTHROCYTE_ENZY...,SET,37,0.013678,0.00061342,0.12949,0.45794,HP_ABNORMAL_ERYTHROCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.985895381686421
MIR6715B_3P,SET,116,0.0081177,0.0006432,0.076893,0.45796,MIR6715B_3P,0.985895381686421
BIOCARTA_PDGF_PATHWAY,SET,27,0.017839,0.00068358,0.16911,0.458,BIOCARTA_PDGF_PATHWAY,0.985895381686421
WENG_POR_TARGETS_LIVER_DN,SET,22,0.02189,0.00075729,0.20766,0.45802,WENG_POR_TARGETS_LIVER_DN,0.985895381686421
GSE39022_LN_VS_SPLEEN_DC_UP,SET,180,0.0065555,0.0006459,0.062271,0.45808,GSE39022_LN_VS_SPLEEN_DC_UP,0.985895381686421
GOBP_MEIOTIC_CHROMOSOME_SEGR...,SET,79,0.0096831,0.0006338,0.092052,0.45811,GOBP_MEIOTIC_CHROMOSOME_SEGREGATION,0.985895381686421
GOBP_DEPHOSPHORYLATION,SET,243,0.005531,0.00063208,0.052693,0.4582,GOBP_DEPHOSPHORYLATION,0.985895381686421
HP_ABNORMALITY_OF_IRON_HOMEO...,SET,23,0.018096,0.00064009,0.17245,0.45821,HP_ABNORMALITY_OF_IRON_HOMEOSTASIS,0.985895381686421
CACTTTG_MIR520G_MIR520H,SET,215,0.0063229,0.00068021,0.060392,0.45831,CACTTTG_MIR520G_MIR520H,0.985895381686421
FULLER_PBMC_F_TULARENSIS_VAC...8,SET,30,0.018041,0.00072867,0.17232,0.45831,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_DN,0.985895381686421
JIANG_TIP30_TARGETS_UP,SET,42,0.01437,0.00068652,0.1373,0.45832,JIANG_TIP30_TARGETS_UP,0.985895381686421
GOBP_REGULATION_OF_ISOTYPE_S...2,SET,6,0.035341,0.00063878,0.33773,0.45833,GOBP_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES,0.985895381686421
HP_OSTEOPETROSIS,SET,17,0.023152,0.00070417,0.22125,0.45833,HP_OSTEOPETROSIS,0.985895381686421
WP_CYTOKINES_AND_INFLAMMATOR...,SET,25,0.019485,0.00071852,0.18649,0.45839,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.985895381686421
REACTOME_GOLGI_ASSOCIATED_VE...,SET,50,0.012165,0.00063396,0.11654,0.45843,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,0.985895381686421
GOBP_NEGATIVE_REGULATION_OF_...367,SET,14,0.024842,0.00068572,0.23801,0.45844,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.985895381686421
KEGG_MEDICUS_VARIANT_MUTATIO...62,SET,6,0.036719,0.00066369,0.35226,0.45849,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.985895381686421
HP_ERYTHRODERMA,SET,56,0.011722,0.00064638,0.11248,0.4585,HP_ERYTHRODERMA,0.985895381686421
ZNF622_TARGET_GENES,SET,55,0.012109,0.00066178,0.11634,0.45855,ZNF622_TARGET_GENES,0.985895381686421
GALINDO_IMMUNE_RESPONSE_TO_E...,SET,72,0.011131,0.00069571,0.10697,0.45856,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,0.985895381686421
GOMF_MONOATOMIC_ANION_MONOAT...,SET,24,0.018466,0.00066721,0.17747,0.45856,GOMF_MONOATOMIC_ANION_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.985895381686421
HP_EYE_MOVEMENT_INDUCED_PAIN,SET,5,0.042368,0.00069908,0.40772,0.45862,HP_EYE_MOVEMENT_INDUCED_PAIN,0.985895381686421
HP_BRANCHIAL_CYST,SET,4,0.035625,0.00052578,0.34301,0.45864,HP_BRANCHIAL_CYST,0.985895381686421
REACTOME_INTERLEUKIN_1_FAMIL...,SET,143,0.0071994,0.00063289,0.069395,0.45869,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,0.985895381686421
GOBP_SKELETAL_MUSCLE_THIN_FI...,SET,7,0.03515,0.0006862,0.33883,0.45869,GOBP_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY,0.985895381686421
GOBP_ECTODERM_DEVELOPMENT,SET,19,0.021186,0.00068118,0.20443,0.45873,GOBP_ECTODERM_DEVELOPMENT,0.985895381686421
TSAI_RESPONSE_TO_RADIATION_T...,SET,28,0.019019,0.00074216,0.18365,0.45876,TSAI_RESPONSE_TO_RADIATION_THERAPY,0.985895381686421
GOMF_DNA_SECONDARY_STRUCTURE...,SET,34,0.01549,0.00066595,0.14994,0.45886,GOMF_DNA_SECONDARY_STRUCTURE_BINDING,0.985895381686421
HP_LACUNAR_STROKE,SET,6,0.033685,0.00060884,0.32603,0.45886,HP_LACUNAR_STROKE,0.985895381686421
GOBP_REGULATION_OF_ODONTOGEN...1,SET,19,0.023443,0.00075375,0.22698,0.45887,GOBP_REGULATION_OF_ODONTOGENESIS,0.985895381686421
HP_HEMIPARESIS,SET,79,0.010172,0.00066579,0.098498,0.45888,HP_HEMIPARESIS,0.985895381686421
GOMF_NEUROTROPHIN_RECEPTOR_A...,SET,5,0.043095,0.00071108,0.41744,0.45889,GOMF_NEUROTROPHIN_RECEPTOR_ACTIVITY,0.985895381686421
HANN_RESISTANCE_TO_BCL2_INHI...2,SET,30,0.017871,0.00072178,0.17322,0.45892,HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,0.985895381686421
REACTOME_TERMINATION_OF_O_GL...,SET,21,0.019615,0.00066299,0.19032,0.45896,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,0.985895381686421
REACTOME_METABOLIC_DISORDERS...,SET,32,0.016343,0.00068172,0.15872,0.45899,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,0.985895381686421
GOBP_OOCYTE_DIFFERENTIATION,SET,60,0.011542,0.00065871,0.11207,0.45899,GOBP_OOCYTE_DIFFERENTIATION,0.985895381686421
LOPEZ_MESOTHELIOMA_SURVIVAL_...4,SET,12,0.02438,0.0006231,0.2368,0.459,LOPEZ_MESOTHELIOMA_SURVIVAL_UP,0.985895381686421
GSE13485_DAY7_VS_DAY21_YF17D...1,SET,141,0.0077234,0.00067423,0.075059,0.45902,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.985895381686421
GSE13522_CTRL_VS_T_CRUZI_G_S...2,SET,186,0.0064144,0.00064234,0.062346,0.45903,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP,0.985895381686421
DESCARTES_FETAL_STOMACH_ENS_...1,SET,42,0.014941,0.00071377,0.14523,0.45903,DESCARTES_FETAL_STOMACH_ENS_GLIA,0.985895381686421
HP_APLASIA_HYPOPLASIA_INVOLV...13,SET,3,0.059452,0.00075989,0.57865,0.45908,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SHOULDER_MUSCULATURE,0.985895381686421
GSE37301_MULTIPOTENT_PROGENI...11,SET,184,0.0061904,0.0006166,0.060396,0.45918,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.985895381686421
HP_ABNORMAL_RESPIRATORY_SYST...,SET,1271,0.0025613,0.00065015,0.025022,0.45924,HP_ABNORMAL_RESPIRATORY_SYSTEM_MORPHOLOGY,0.985895381686421
MORF_NOS2A,SET,263,0.0054765,0.00065075,0.053518,0.45925,MORF_NOS2A,0.985895381686421
BERGER_MBD2_TARGETS,SET,4,0.052361,0.00077277,0.51187,0.45926,BERGER_MBD2_TARGETS,0.985895381686421
REACTOME_CELL_EXTRACELLULAR_...,SET,16,0.02242,0.00066156,0.21925,0.45928,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,0.985895381686421
SHARMA_ASTROCYTOMA_WITH_NF1_...,SET,4,0.044259,0.00065321,0.43413,0.4594,SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM,0.985895381686421
WP_LUNG_FIBROSIS,SET,59,0.012511,0.00070811,0.12295,0.45948,WP_LUNG_FIBROSIS,0.985895381686421
HP_TYPE_2_MUSCLE_FIBER_ATROP...,SET,16,0.020049,0.00059161,0.19712,0.45949,HP_TYPE_2_MUSCLE_FIBER_ATROPHY,0.985895381686421
GOERING_BLOOD_HDL_CHOLESTERO...1,SET,8,0.035441,0.00073965,0.34854,0.4595,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS,0.985895381686421
GOCC_PROTON_TRANSPORTING_TWO...1,SET,26,0.016967,0.00063806,0.16697,0.45953,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX,0.985895381686421
GOMF_N_ACETYLLACTOSAMINE_SYN...,SET,5,0.042447,0.00070039,0.41796,0.45955,GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY,0.985895381686421
KEGG_MEDICUS_REFERENCE_TRAIP...,SET,14,0.021848,0.00060307,0.21532,0.45959,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY,0.985895381686421
GSE37533_UNTREATED_VS_PIOGLI...4,SET,181,0.0067831,0.00067016,0.066951,0.45965,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.985895381686421
GOBP_CARDIOLIPIN_ACYL_CHAIN_...,SET,5,0.048308,0.00079709,0.47693,0.45966,GOBP_CARDIOLIPIN_ACYL_CHAIN_REMODELING,0.985895381686421
GOBP_CELLULAR_RESPONSE_TO_LE...1,SET,4,0.051689,0.00076286,0.51067,0.45969,GOBP_CELLULAR_RESPONSE_TO_LEAD_ION,0.985895381686421
GSE18281_CORTEX_VS_MEDULLA_T...2,SET,161,0.0066,0.00061533,0.065224,0.4597,GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP,0.985895381686421
GOBP_FIBROBLAST_PROLIFERATION,SET,104,0.0086466,0.00064892,0.085465,0.45971,GOBP_FIBROBLAST_PROLIFERATION,0.985895381686421
GOCC_SMN_COMPLEX,SET,6,0.030949,0.00055938,0.30596,0.45972,GOCC_SMN_COMPLEX,0.985895381686421
HP_ABNORMAL_ODONTOID_TISSUE_...,SET,207,0.0061062,0.0006447,0.06038,0.45972,HP_ABNORMAL_ODONTOID_TISSUE_MORPHOLOGY,0.985895381686421
GOCC_ENDOLYSOSOME_MEMBRANE,SET,17,0.020522,0.00062418,0.2036,0.45986,GOCC_ENDOLYSOSOME_MEMBRANE,0.985895381686421
MIR650,SET,108,0.0082548,0.00063125,0.081921,0.45987,MIR650,0.985895381686421
GOBP_ENDOTHELIUM_DEVELOPMENT,SET,129,0.0081522,0.00068093,0.081065,0.45995,GOBP_ENDOTHELIUM_DEVELOPMENT,0.985895381686421
REACTOME_DOWNREGULATION_OF_S...,SET,28,0.0162,0.00063216,0.1612,0.45998,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,0.985895381686421
MODULE_388,SET,16,0.019081,0.00056304,0.18991,0.45999,MODULE_388,0.985895381686421
WP_APOPTOSIS_MODULATION_BY_H...,SET,18,0.020327,0.00063615,0.20342,0.4602,WP_APOPTOSIS_MODULATION_BY_HSP70,0.985895381686421
KEGG_MEDICUS_REFERENCE_TLR7_...1,SET,16,0.026619,0.00078547,0.2665,0.46022,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY,0.985895381686421
GOCC_SPINDLE_POLE,SET,162,0.0064427,0.00060251,0.064503,0.46022,GOCC_SPINDLE_POLE,0.985895381686421
GOMF_WNT_RECEPTOR_ACTIVITY,SET,16,0.024735,0.00072987,0.24789,0.46026,GOMF_WNT_RECEPTOR_ACTIVITY,0.985895381686421
GOBP_PROGRAMMED_CELL_DEATH_I...2,SET,12,0.025506,0.00065186,0.25576,0.46028,GOBP_PROGRAMMED_CELL_DEATH_IN_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.985895381686421
PID_DELTA_NP63_PATHWAY,SET,43,0.013629,0.00065879,0.13674,0.4603,PID_DELTA_NP63_PATHWAY,0.985895381686421
REACTOME_REGULATION_OF_MITF_...4,SET,41,0.013734,0.00064829,0.13779,0.4603,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,0.985895381686421
GOBP_HEMATOPOIETIC_STEM_CELL...5,SET,31,0.015512,0.00063687,0.15563,0.4603,GOBP_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.985895381686421
GSE17974_0H_VS_1H_IN_VITRO_A...2,SET,159,0.0066374,0.000615,0.066677,0.46035,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP,0.985895381686421
GOBP_ENUCLEATE_ERYTHROCYTE_M...,SET,3,0.060965,0.00077924,0.61293,0.46039,GOBP_ENUCLEATE_ERYTHROCYTE_MATURATION,0.985895381686421
MARSON_FOXP3_CORE_DIRECT_TAR...,SET,17,0.023734,0.00072186,0.23894,0.46044,MARSON_FOXP3_CORE_DIRECT_TARGETS,0.985895381686421
GSE2405_S_AUREUS_VS_UNTREATE...2,SET,173,0.0060197,0.00058157,0.060603,0.46044,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP,0.985895381686421
HP_INTELLECTUAL_DISABILITY_P...2,SET,31,0.013693,0.00056219,0.13796,0.46047,HP_INTELLECTUAL_DISABILITY_PROGRESSIVE,0.985895381686421
REACTOME_PLATELET_ACTIVATION...,SET,246,0.0056164,0.00064574,0.056673,0.46053,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,0.985895381686421
HP_ATYPICAL_ABSENCE_SEIZURE,SET,31,0.015084,0.0006193,0.15231,0.46055,HP_ATYPICAL_ABSENCE_SEIZURE,0.985895381686421
GOBP_REGULATION_OF_SKELETAL_...9,SET,11,0.024551,0.00060075,0.24792,0.46056,GOBP_REGULATION_OF_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.985895381686421
HP_PROGRESSIVE_SPASTIC_PARAP...1,SET,5,0.03616,0.00059664,0.36513,0.46056,HP_PROGRESSIVE_SPASTIC_PARAPARESIS,0.985895381686421
GSE24671_BAKIMULC_VS_SENDAI_...2,SET,182,0.0059161,0.0005861,0.0598,0.4606,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,0.985895381686421
DALESSIO_TSA_RESPONSE,SET,19,0.022345,0.00071844,0.22617,0.46065,DALESSIO_TSA_RESPONSE,0.985895381686421
GOBP_L_ARGININE_TRANSMEMBRAN...,SET,13,0.026759,0.00071179,0.27103,0.46068,GOBP_L_ARGININE_TRANSMEMBRANE_TRANSPORT,0.985895381686421
MIR6868_5P,SET,111,0.0078667,0.00060982,0.079708,0.46069,MIR6868_5P,0.985895381686421
REACTOME_SYNTHESIS_OF_PIPS_A...1,SET,15,0.018236,0.00052103,0.18496,0.46073,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE,0.985895381686421
HP_MUSCLE_FIBER_NECROSIS,SET,10,0.026882,0.0006272,0.27341,0.46084,HP_MUSCLE_FIBER_NECROSIS,0.985895381686421
GOBP_RESPONSE_TO_MUSCLE_ACTI...,SET,24,0.018979,0.00068574,0.19308,0.46085,GOBP_RESPONSE_TO_MUSCLE_ACTIVITY,0.985895381686421
HP_RIMMED_VACUOLES,SET,38,0.013174,0.00059872,0.13405,0.46086,HP_RIMMED_VACUOLES,0.985895381686421
GOBP_RNA_LOCALIZATION,SET,180,0.005801,0.00057156,0.05905,0.46087,GOBP_RNA_LOCALIZATION,0.985895381686421
REACTOME_SYNTHESIS_OF_BILE_A...2,SET,13,0.025569,0.00068015,0.26035,0.46088,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL,0.985895381686421
GOBP_CYCLIC_NUCLEOTIDE_BIOSY...,SET,17,0.021934,0.00066711,0.22347,0.46091,GOBP_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.985895381686421
NAKAYA_B_CELL_FLUARIX_FLUVIR...2,SET,321,0.0044564,0.00058407,0.045465,0.46096,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.985895381686421
RELA_DN.V1_UP,SET,136,0.0072961,0.00062562,0.074485,0.46099,RELA_DN.V1_UP,0.985895381686421
GOBP_ANIMAL_ORGAN_MATURATION,SET,28,0.016775,0.00065461,0.17138,0.46101,GOBP_ANIMAL_ORGAN_MATURATION,0.985895381686421
GSE2128_C57BL6_VS_NOD_THYMOC...2,SET,181,0.0063238,0.00062479,0.064603,0.46101,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN,0.985895381686421
GOBP_PROTEIN_POLYUFMYLATION,SET,5,0.033819,0.00055801,0.34564,0.46103,GOBP_PROTEIN_POLYUFMYLATION,0.985895381686421
MIR4306,SET,428,0.0041457,0.00062554,0.042399,0.46105,MIR4306,0.985895381686421
WP_PYRIMIDINE_METABOLISM_AND...,SET,19,0.019261,0.0006193,0.1971,0.46108,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.985895381686421
LHX2_TARGET_GENES,SET,1129,0.0025522,0.00061312,0.026123,0.46109,LHX2_TARGET_GENES,0.985895381686421
MIR506_3P,SET,693,0.0032593,0.00062116,0.033372,0.4611,MIR506_3P,0.985895381686421
HP_ABNORMAL_CIRCULATING_NITR...,SET,154,0.0065425,0.00059668,0.067006,0.46111,HP_ABNORMAL_CIRCULATING_NITROGEN_COMPOUND_CONCENTRATION,0.985895381686421
BIOCARTA_HCMV_PATHWAY,SET,17,0.020643,0.00062785,0.21146,0.46112,BIOCARTA_HCMV_PATHWAY,0.985895381686421
GOMF_ZINC_ION_TRANSMEMBRANE_...,SET,24,0.014818,0.00053538,0.15185,0.46113,GOMF_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.985895381686421
GOBP_HEART_MORPHOGENESIS,SET,251,0.0056654,0.00065787,0.058141,0.46119,GOBP_HEART_MORPHOGENESIS,0.985895381686421
GOBP_PRONEPHROS_DEVELOPMENT,SET,9,0.026756,0.00059225,0.27475,0.46121,GOBP_PRONEPHROS_DEVELOPMENT,0.985895381686421
GSE9601_NFKB_INHIBITOR_VS_PI...2,SET,177,0.0061066,0.00059669,0.062739,0.46123,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.985895381686421
THAKAR_PBMC_INACTIVATED_INFL...10,SET,125,0.0075134,0.00061784,0.077211,0.46124,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,0.985895381686421
GSE5589_WT_VS_IL10_KO_LPS_ST...2,SET,140,0.0068054,0.00059199,0.069947,0.46125,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.985895381686421
HP_HAMARTOMA_OF_TONGUE,SET,21,0.016722,0.00056521,0.17205,0.46129,HP_HAMARTOMA_OF_TONGUE,0.985895381686421
GSE19198_CTRL_VS_IL21_TREATE...2,SET,148,0.0068819,0.00061538,0.070833,0.4613,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP,0.985895381686421
YOSHIMURA_MAPK8_TARGETS_UP,SET,1186,0.0026009,0.00063934,0.026773,0.46131,YOSHIMURA_MAPK8_TARGETS_UP,0.985895381686421
MIR6835_5P,SET,30,0.014467,0.00058432,0.14922,0.46138,MIR6835_5P,0.985895381686421
GOBP_NEGATIVE_REGULATION_OF_...516,SET,129,0.007263,0.00060666,0.074945,0.4614,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.985895381686421
HP_MOTOR_SEIZURE,SET,367,0.0042975,0.0006015,0.044371,0.46142,HP_MOTOR_SEIZURE,0.985895381686421
TURASHVILI_BREAST_LOBULAR_CA...3,SET,67,0.01056,0.00063673,0.10916,0.46147,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,0.985895381686421
HP_NEOPLASM_OF_THE_ADRENAL_C...,SET,26,0.017618,0.00066252,0.18223,0.46149,HP_NEOPLASM_OF_THE_ADRENAL_CORTEX,0.985895381686421
MIR433_5P,SET,7,0.030495,0.00059532,0.31548,0.4615,MIR433_5P,0.985895381686421
GOBP_REGULATION_OF_CELL_PROJ...1,SET,202,0.0060057,0.00062647,0.062157,0.46151,GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY,0.985895381686421
GOBP_TRICARBOXYLIC_ACID_META...,SET,15,0.020824,0.00059498,0.2158,0.46156,GOBP_TRICARBOXYLIC_ACID_METABOLIC_PROCESS,0.985895381686421
HP_FOCAL_MOTOR_STATUS_EPILEP...,SET,13,0.022954,0.00061059,0.23789,0.46157,HP_FOCAL_MOTOR_STATUS_EPILEPTICUS,0.985895381686421
GOMF_SIGNAL_RECOGNITION_PART...,SET,7,0.027605,0.00053891,0.28622,0.46158,GOMF_SIGNAL_RECOGNITION_PARTICLE_BINDING,0.985895381686421
FOURATI_BLOOD_TWINRIX_AGE_25...2,SET,406,0.0041818,0.00061494,0.043361,0.46159,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,0.985895381686421
HALLMARK_EPITHELIAL_MESENCHY...,SET,187,0.00663,0.00066569,0.068756,0.46159,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.985895381686421
MA_RAT_AGING_UP,SET,96,0.0087546,0.00063139,0.090815,0.4616,MA_RAT_AGING_UP,0.985895381686421
SHIN_B_CELL_LYMPHOMA_CLUSTER...7,SET,36,0.013595,0.00060139,0.141,0.4616,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,0.985895381686421
BIOCARTA_ARENRF2_PATHWAY,SET,20,0.020339,0.00067091,0.21105,0.46161,BIOCARTA_ARENRF2_PATHWAY,0.985895381686421
GOBP_REGULATION_OF_RNA_BINDI...,SET,6,0.031591,0.00057099,0.32789,0.46162,GOBP_REGULATION_OF_RNA_BINDING,0.985895381686421
GSE3982_CTRL_VS_IGE_STIM_MAS...1,SET,180,0.0060112,0.00059228,0.062422,0.46164,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN,0.985895381686421
GSE17974_0H_VS_4H_IN_VITRO_A...1,SET,179,0.0057624,0.0005662,0.059847,0.46165,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN,0.985895381686421
HP_ACRAL_OVERGROWTH,SET,3,0.040878,0.00052249,0.42488,0.46168,HP_ACRAL_OVERGROWTH,0.985895381686421
GOBP_REGULATION_OF_FERTILIZA...,SET,16,0.020763,0.00061268,0.21594,0.4617,GOBP_REGULATION_OF_FERTILIZATION,0.985895381686421
GTATGAT_MIR154_MIR487,SET,63,0.010797,0.0006314,0.11243,0.46174,GTATGAT_MIR154_MIR487,0.985895381686421
GOBP_REGULATION_OF_TOOTH_MIN...,SET,10,0.025765,0.00060113,0.26826,0.46174,GOBP_REGULATION_OF_TOOTH_MINERALIZATION,0.985895381686421
GOMF_STRUCTURAL_CONSTITUENT_...8,SET,7,0.032752,0.00063939,0.34098,0.46174,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.985895381686421
GOBP_FRUCTOSE_TRANSMEMBRANE_...,SET,9,0.027494,0.00060857,0.28641,0.46176,GOBP_FRUCTOSE_TRANSMEMBRANE_TRANSPORT,0.985895381686421
KOINUMA_COLON_CANCER_MSI_DN,SET,8,0.032833,0.00068522,0.34226,0.46179,KOINUMA_COLON_CANCER_MSI_DN,0.985895381686421
HP_DECREASED_FERTILITY_IN_MA...,SET,183,0.0058766,0.00058376,0.061254,0.46179,HP_DECREASED_FERTILITY_IN_MALES,0.985895381686421
VANTVEER_BREAST_CANCER_ESR1_...2,SET,136,0.0071351,0.00061181,0.074465,0.46183,VANTVEER_BREAST_CANCER_ESR1_UP,0.985895381686421
HP_INAPPROPRIATE_BEHAVIOR,SET,14,0.021638,0.00059728,0.22583,0.46183,HP_INAPPROPRIATE_BEHAVIOR,0.985895381686421
GOBP_COCHLEA_MORPHOGENESIS,SET,22,0.018849,0.00065209,0.19694,0.46188,GOBP_COCHLEA_MORPHOGENESIS,0.985895381686421
GOBP_REGULATION_OF_BONE_MINE...1,SET,70,0.010465,0.00064496,0.10939,0.46189,GOBP_REGULATION_OF_BONE_MINERALIZATION,0.985895381686421
GOBP_RESPONSE_TO_GRAM_POSITI...,SET,6,0.033972,0.00061403,0.35505,0.46189,GOBP_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.985895381686421
MIR4695_5P,SET,79,0.0090147,0.00059006,0.094243,0.4619,MIR4695_5P,0.985895381686421
HP_URTICARIA,SET,49,0.011353,0.0005857,0.11905,0.46201,HP_URTICARIA,0.985940657216495
GOBP_NEGATIVE_REGULATION_OF_...673,SET,9,0.027699,0.00061313,0.29091,0.46207,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.985940657216495
SHEDDEN_LUNG_CANCER_GOOD_SUR...1,SET,252,0.0053372,0.00062098,0.056067,0.46208,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,0.985940657216495
HP_ELEVATED_CIRCULATING_ALDO...,SET,6,0.028706,0.00051885,0.30159,0.46209,HP_ELEVATED_CIRCULATING_ALDOLASE_CONCENTRATION,0.985940657216495
KIM_WT1_TARGETS_8HR_UP,SET,159,0.0064872,0.00060108,0.068196,0.46211,KIM_WT1_TARGETS_8HR_UP,0.985940657216495
WP_METABOLISM_OF_SPHINGOLIPI...,SET,21,0.018644,0.00063018,0.19612,0.46213,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.985940657216495
CAHOY_ASTROGLIAL,SET,89,0.0091267,0.0006339,0.09616,0.46219,CAHOY_ASTROGLIAL,0.985940657216495
GSE24142_DN2_VS_DN3_THYMOCYT...1,SET,180,0.0060761,0.00059867,0.064055,0.46221,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN,0.985940657216495
HP_ABNORMAL_CORNEA_MORPHOLOGY,SET,639,0.0032559,0.00059676,0.034361,0.46225,HP_ABNORMAL_CORNEA_MORPHOLOGY,0.985940657216495
GSE17721_LPS_VS_CPG_12H_BMDC...1,SET,177,0.0061302,0.00059899,0.064694,0.46225,GSE17721_LPS_VS_CPG_12H_BMDC_DN,0.985940657216495
GOBP_NOREPINEPHRINE_UPTAKE,SET,8,0.035494,0.00074074,0.37469,0.46227,GOBP_NOREPINEPHRINE_UPTAKE,0.985940657216495
HP_ACUTE_INFECTIOUS_PNEUMONIA,SET,5,0.039805,0.00065679,0.42035,0.46228,HP_ACUTE_INFECTIOUS_PNEUMONIA,0.985940657216495
HP_APLASIA_CUTIS_CONGENITA_O...2,SET,6,0.034459,0.00062284,0.36403,0.46229,HP_APLASIA_CUTIS_CONGENITA_ON_TRUNK_OR_LIMBS,0.985940657216495
GOBP_ANTIGEN_PROCESSING_AND_...9,SET,7,0.04298,0.00083907,0.45457,0.46234,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.985972418553286
BIOCARTA_PROTEASOME_PATHWAY,SET,17,0.016506,0.00050203,0.17478,0.46238,BIOCARTA_PROTEASOME_PATHWAY,0.985972418553286
HP_ADRENOCORTICOTROPIC_HORMO...1,SET,14,0.022197,0.00061272,0.23513,0.46239,HP_ADRENOCORTICOTROPIC_HORMONE_DEFICIENCY,0.985972418553286
GOMF_NUCLEOSIDE_TRIPHOSPHATA...,SET,445,0.0038025,0.00058476,0.040314,0.46243,GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY,0.985997217791411
GOBP_REGULATION_OF_RIG_I_SIG...,SET,17,0.018258,0.00055533,0.19376,0.46246,GOBP_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.986000693209006
REACTOME_ACETYLCHOLINE_REGUL...,SET,10,0.027965,0.00065246,0.29727,0.46253,REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION,0.986089446080236
HP_MEDIASTINAL_LYMPHADENOPAT...,SET,23,0.017664,0.00062479,0.18816,0.4626,HP_MEDIASTINAL_LYMPHADENOPATHY,0.986139018032385
HP_TELECANTHUS,SET,148,0.0066586,0.00059542,0.070943,0.46261,HP_TELECANTHUS,0.986139018032385
GSE14350_TREG_VS_TEFF_IN_IL2...1,SET,183,0.0058749,0.0005836,0.062675,0.46266,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN,0.9861851149954
HP_POLYGENIC_INHERITANCE,SET,32,0.015204,0.00063417,0.16243,0.46271,HP_POLYGENIC_INHERITANCE,0.986231206304428
ZBED4_TARGET_GENES,SET,248,0.0049885,0.00057585,0.053413,0.4628,ZBED4_TARGET_GENES,0.986362543692893
GOMF_ARYL_SULFOTRANSFERASE_A...,SET,7,0.038331,0.0007483,0.41085,0.46284,GOMF_ARYL_SULFOTRANSFERASE_ACTIVITY,0.986387306843267
FULLER_PBMC_F_TULARENSIS_VAC...10,SET,16,0.020178,0.0005954,0.21659,0.46289,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_DN,0.98643337727635
MODULE_186,SET,19,0.019572,0.00062928,0.21024,0.46292,MODULE_186,0.986436824034335
GOBP_NEGATIVE_REGULATION_OF_...582,SET,5,0.036262,0.00059833,0.38986,0.46295,GOBP_NEGATIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.986440270369689
REACTOME_SENSORY_PROCESSING_...2,SET,49,0.012057,0.00062204,0.12993,0.46303,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,0.986496656451119
GOBP_NEGATIVE_REGULATION_OF_...252,SET,5,0.034656,0.00057183,0.37396,0.46308,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.986496656451119
GOCC_CHROMOSOME_CENTROMERIC_...2,SET,219,0.005244,0.0005693,0.056585,0.46308,GOCC_CHROMOSOME_CENTROMERIC_REGION,0.986496656451119
BUSSLINGER_ESOPHAGEAL_DENDRI...,SET,194,0.005957,0.0006091,0.064285,0.46309,BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS,0.986496656451119
DELASERNA_MYOD_TARGETS_DN,SET,49,0.012225,0.0006307,0.13203,0.46312,DELASERNA_MYOD_TARGETS_DN,0.986500098063251
GOBP_CAMP_BIOSYNTHETIC_PROCE...,SET,10,0.027252,0.00063584,0.29476,0.46317,GOBP_CAMP_BIOSYNTHETIC_PROCESS,0.986546138996139
GSE15659_CD45RA_NEG_CD4_TCEL...3,SET,172,0.005882,0.00056664,0.063686,0.46321,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.986570875720064
GOBP_POSITIVE_REGULATION_OF_...505,SET,97,0.0085115,0.00061703,0.092382,0.4633,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.986666362355248
GOBP_CELLULAR_RESPONSE_TO_PE...1,SET,13,0.023608,0.00062798,0.25644,0.46332,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE,0.986666362355248
FOXO4_02,SET,239,0.0053801,0.00060983,0.058472,0.46334,FOXO4_02,0.986666362355248
GOBP_CELLULAR_RESPONSE_TO_DS...,SET,19,0.018471,0.00059389,0.20109,0.46341,GOBP_CELLULAR_RESPONSE_TO_DSRNA,0.986754965690479
GOMF_MDM2_MDM4_FAMILY_PROTEI...,SET,10,0.026278,0.00061312,0.28735,0.46357,GOMF_MDM2_MDM4_FAMILY_PROTEIN_BINDING,0.986844639578999
GOMF_PHOSPHOPROTEIN_PHOSPHAT...,SET,159,0.0059696,0.00055312,0.065297,0.46358,GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.986844639578999
GOBP_NUCLEAR_BODY_ORGANIZATI...,SET,15,0.018366,0.00052475,0.20103,0.4636,GOBP_NUCLEAR_BODY_ORGANIZATION,0.986844639578999
GSE20366_TREG_VS_NAIVE_CD4_T...1,SET,182,0.0059553,0.00058998,0.065198,0.46361,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN,0.986844639578999
GOBP_NEGATIVE_REGULATION_OF_...18,SET,22,0.015609,0.00054,0.17102,0.46364,GOBP_NEGATIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.986844639578999
GOBP_RESPONSE_TO_OXYGEN_CONT...,SET,1509,0.0021546,0.00059176,0.023623,0.46366,GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,0.986844639578999
MIR5003_5P,SET,177,0.0060092,0.00058717,0.066035,0.46375,MIR5003_5P,0.986844639578999
GSE8868_SPLEEN_VS_INTESTINE_...1,SET,178,0.0058581,0.000574,0.064397,0.46376,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN,0.986844639578999
RAO_BOUND_BY_SALL4_ISOFORM_A,SET,166,0.0061614,0.00058321,0.067816,0.4638,RAO_BOUND_BY_SALL4_ISOFORM_A,0.986844639578999
GSE21670_STAT3_KO_VS_WT_CD4_...4,SET,175,0.0061528,0.00059782,0.067764,0.46383,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN,0.986844639578999
HP_SECOND_DEGREE_ATRIOVENTRI...,SET,12,0.022255,0.00056878,0.24527,0.46385,HP_SECOND_DEGREE_ATRIOVENTRICULAR_BLOCK,0.986844639578999
KEGG_MEDICUS_PATHOGEN_HIV_TA...1,SET,8,0.02601,0.00054282,0.28693,0.46389,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.986844639578999
GSE10094_LCMV_VS_LISTERIA_IN...1,SET,178,0.0058073,0.00056902,0.064109,0.46391,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN,0.986844639578999
MIR8089,SET,155,0.0065675,0.00060088,0.072544,0.46393,MIR8089,0.986844639578999
GOBP_REGULATION_OF_NEURONAL_...1,SET,3,0.052739,0.0006741,0.58279,0.46395,GOBP_REGULATION_OF_NEURONAL_ACTION_POTENTIAL,0.986844639578999
GSE360_CTRL_VS_B_MALAYI_HIGH...1,SET,177,0.0058058,0.0005673,0.064172,0.46396,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.986844639578999
HP_ABNORMAL_PULMONARY_VEIN_M...,SET,66,0.0092364,0.00055279,0.10221,0.464,HP_ABNORMAL_PULMONARY_VEIN_MORPHOLOGY,0.986844639578999
GSE30971_WBP7_HET_VS_KO_MACR...4,SET,178,0.0057829,0.00056664,0.064004,0.464,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP,0.986844639578999
GOCC_SPERM_MITOCHONDRIAL_SHE...,SET,6,0.032547,0.00058827,0.36037,0.46402,GOCC_SPERM_MITOCHONDRIAL_SHEATH,0.986844639578999
GOMF_RIBOSOMAL_SMALL_SUBUNIT...,SET,15,0.018758,0.00053593,0.20771,0.46402,GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING,0.986844639578999
REACTOME_NOTCH4_ACTIVATION_A...,SET,10,0.025304,0.00059038,0.28063,0.46408,REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.986876145610278
GOMF_PROTEIN_KINASE_A_CATALY...,SET,14,0.020579,0.00056806,0.22835,0.4641,GOMF_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING,0.986876145610278
GOMF_SINGLE_STRANDED_DNA_EXO...,SET,10,0.020244,0.00047233,0.22479,0.46412,GOMF_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,0.986876145610278
GSE3982_BASOPHIL_VS_TH1_UP,SET,179,0.0056413,0.0005543,0.062767,0.46419,GSE3982_BASOPHIL_VS_TH1_UP,0.986964606019821
LINSLEY_MIR16_TARGETS,SET,193,0.0052805,0.00053855,0.05886,0.46426,LINSLEY_MIR16_TARGETS,0.98703519696599
GSE46242_TH1_VS_ANERGIC_TH1_...4,SET,166,0.0060037,0.00056828,0.066961,0.46428,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP,0.98703519696599
MIR4718,SET,97,0.0085978,0.00062328,0.096196,0.46439,MIR4718,0.987104912468739
WP_NUCLEAR_RECEPTORS_IN_LIPI...,SET,33,0.013586,0.00057547,0.15219,0.46443,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.987104912468739
GOBP_MEIOTIC_SPINDLE_ASSEMBLY,SET,10,0.025255,0.00058923,0.28294,0.46444,GOBP_MEIOTIC_SPINDLE_ASSEMBLY,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...284,SET,8,0.027172,0.00056706,0.30452,0.46445,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.987104912468739
GOMF_INOSITOL_POLYPHOSPHATE_...,SET,6,0.030236,0.00054651,0.33948,0.46452,GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.987104912468739
KORKOLA_EMBRYONIC_CARCINOMA_...1,SET,19,0.018227,0.00058605,0.20495,0.46457,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,0.987104912468739
GOMF_2_ACYLGLYCEROL_3_PHOSPH...,SET,8,0.029855,0.00062306,0.33618,0.46462,GOMF_2_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,0.987104912468739
HP_PERONEAL_MUSCLE_ATROPHY,SET,10,0.026465,0.00061746,0.29849,0.46468,HP_PERONEAL_MUSCLE_ATROPHY,0.987104912468739
DESCARTES_MAIN_FETAL_STELLAT...,SET,44,0.012607,0.00061645,0.1422,0.46468,DESCARTES_MAIN_FETAL_STELLATE_CELLS,0.987104912468739
SEMENZA_HIF1_TARGETS,SET,32,0.014323,0.00059743,0.16179,0.46473,SEMENZA_HIF1_TARGETS,0.987104912468739
MIR1178_5P,SET,32,0.014096,0.00058797,0.15925,0.46473,MIR1178_5P,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...362,SET,33,0.012538,0.00053107,0.14165,0.46473,GOBP_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.987104912468739
GOBP_NUCLEOTIDE_SALVAGE,SET,16,0.019485,0.00057495,0.22016,0.46474,GOBP_NUCLEOTIDE_SALVAGE,0.987104912468739
HP_TRIPHALANGEAL_THUMB,SET,64,0.0088006,0.00051869,0.099611,0.4648,HP_TRIPHALANGEAL_THUMB,0.987104912468739
GOBP_RESPONSE_TO_MAGNESIUM_I...,SET,20,0.01816,0.00059903,0.20568,0.46482,GOBP_RESPONSE_TO_MAGNESIUM_ION,0.987104912468739
HP_EPILEPTIC_SPASM,SET,167,0.0057992,0.00055056,0.065725,0.46485,HP_EPILEPTIC_SPASM,0.987104912468739
GOBP_MITOCHONDRIAL_RESPIRASO...,SET,7,0.024259,0.00047359,0.27534,0.4649,GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY,0.987104912468739
KEGG_MEDICUS_REFERENCE_REGUL...15,SET,5,0.032703,0.00053961,0.37172,0.46495,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION,0.987104912468739
GOMF_SECONDARY_ACTIVE_MONOCA...,SET,17,0.018051,0.00054901,0.2055,0.465,GOMF_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.987104912468739
GSE19923_WT_VS_E2A_KO_DP_THY...1,SET,176,0.0055453,0.00054032,0.063118,0.465,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN,0.987104912468739
BRUNEAU_SEPTATION_ATRIAL,SET,5,0.036184,0.00059704,0.41291,0.46509,BRUNEAU_SEPTATION_ATRIAL,0.987104912468739
GOBP_REGULATION_OF_CELL_DEVE...,SET,764,0.002835,0.00056614,0.032385,0.46512,GOBP_REGULATION_OF_CELL_DEVELOPMENT,0.987104912468739
GOMF_TOXIN_TRANSMEMBRANE_TRA...,SET,9,0.028414,0.00062895,0.32455,0.46512,GOMF_TOXIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.987104912468739
GOCC_PERICILIARY_MEMBRANE_CO...,SET,4,0.036659,0.00054104,0.4189,0.46513,GOCC_PERICILIARY_MEMBRANE_COMPARTMENT,0.987104912468739
GOMF_ROUNDABOUT_BINDING,SET,8,0.028987,0.00060496,0.33185,0.4652,GOMF_ROUNDABOUT_BINDING,0.987104912468739
REACTOME_PRE_NOTCH_PROCESSIN...2,SET,6,0.025358,0.00045833,0.29038,0.46521,REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM,0.987104912468739
ZID_01,SET,232,0.0047328,0.00052864,0.054219,0.46522,ZID_01,0.987104912468739
GNF2_MLF1,SET,77,0.0085104,0.00054998,0.097561,0.46524,GNF2_MLF1,0.987104912468739
CHYLA_CBFA2T3_TARGETS_DN,SET,212,0.0050951,0.00054433,0.058459,0.46527,CHYLA_CBFA2T3_TARGETS_DN,0.987104912468739
REACTOME_NA_CL_DEPENDENT_NEU...,SET,18,0.020771,0.00065006,0.23845,0.46529,REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,0.987104912468739
GSE1432_CTRL_VS_IFNG_24H_MIC...1,SET,182,0.0057034,0.00056503,0.065575,0.46535,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.987104912468739
MANNO_MIDBRAIN_NEUROTYPES_HRN,SET,300,0.0046528,0.00058987,0.053553,0.46538,MANNO_MIDBRAIN_NEUROTYPES_HRN,0.987104912468739
ZHONG_PFC_C6_DLX5_GAD1_GAD2_...,SET,13,0.021783,0.00057942,0.25067,0.46538,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.987104912468739
GSE33292_DN3_THYMOCYTE_VS_TC...1,SET,183,0.005637,0.00055997,0.065027,0.46546,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN,0.987104912468739
GOBP_ENUCLEATE_ERYTHROCYTE_D...2,SET,12,0.021094,0.00053909,0.24341,0.46547,GOBP_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION,0.987104912468739
GOBP_RESPONSE_TO_FLUID_SHEAR...,SET,33,0.014239,0.00060313,0.16481,0.46558,GOBP_RESPONSE_TO_FLUID_SHEAR_STRESS,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...400,SET,166,0.0055741,0.00052762,0.064926,0.46579,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.987104912468739
GSE16450_IMMATURE_VS_MATURE_...6,SET,164,0.0057261,0.00053876,0.066798,0.46584,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.987104912468739
GSE32423_CTRL_VS_IL7_MEMORY_...2,SET,179,0.0057518,0.00056515,0.067126,0.46586,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP,0.987104912468739
HP_DIMINISHED_MOVEMENT,SET,72,0.0082131,0.00051332,0.095985,0.46591,HP_DIMINISHED_MOVEMENT,0.987104912468739
GOBP_THORAX_AND_ANTERIOR_ABD...,SET,5,0.045326,0.00074789,0.53039,0.46595,GOBP_THORAX_AND_ANTERIOR_ABDOMEN_DETERMINATION,0.987104912468739
KEGG_MEDICUS_REFERENCE_ISOLE...,SET,9,0.024894,0.00055103,0.2914,0.46596,KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...301,SET,19,0.017375,0.00055865,0.20378,0.46603,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.987104912468739
ROSS_AML_WITH_CBFB_MYH11_FUS...,SET,45,0.01137,0.00056223,0.13347,0.46606,ROSS_AML_WITH_CBFB_MYH11_FUSION,0.987104912468739
GOBP_BIOGENIC_AMINE_METABOLI...,SET,83,0.0082999,0.00055679,0.097486,0.46608,GOBP_BIOGENIC_AMINE_METABOLIC_PROCESS,0.987104912468739
GOBP_DNA_REPAIR_DEPENDENT_CH...,SET,18,0.016327,0.00051097,0.19183,0.46609,GOBP_DNA_REPAIR_DEPENDENT_CHROMATIN_REMODELING,0.987104912468739
HP_ABNORMAL_BLOOD_CHLORIDE_C...,SET,10,0.025607,0.00059746,0.30099,0.4661,HP_ABNORMAL_BLOOD_CHLORIDE_CONCENTRATION,0.987104912468739
LAKE_ADULT_KIDNEY_C8_DECENDI...,SET,253,0.0046,0.00053625,0.054111,0.46613,LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB,0.987104912468739
chr2p12,SET,13,0.030795,0.00081915,0.36236,0.46614,chr2p12,0.987104912468739
GOBP_NON_MOTILE_CILIUM_ASSEM...,SET,60,0.0091544,0.00052246,0.10776,0.46615,GOBP_NON_MOTILE_CILIUM_ASSEMBLY,0.987104912468739
GSE14350_IL2RB_KO_VS_WT_TEFF...2,SET,181,0.0053468,0.00052826,0.062937,0.46615,GSE14350_IL2RB_KO_VS_WT_TEFF_UP,0.987104912468739
HP_HETEROTROPIA,SET,234,0.0046695,0.00052379,0.054993,0.46617,HP_HETEROTROPIA,0.987104912468739
THAKAR_PBMC_INACTIVATED_INFL...11,SET,97,0.0071262,0.00051661,0.083985,0.46619,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...627,SET,9,0.026844,0.00059419,0.31671,0.46623,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.987104912468739
HP_RESPIRATORY_ARREST,SET,27,0.014183,0.00054351,0.16748,0.46625,HP_RESPIRATORY_ARREST,0.987104912468739
HP_CALCIFICATION_OF_FALX_CER...,SET,7,0.025792,0.00050352,0.30461,0.46626,HP_CALCIFICATION_OF_FALX_CEREBRI,0.987104912468739
GOCC_MANNOSYLTRANSFERASE_COM...,SET,4,0.028623,0.00042244,0.33825,0.46628,GOCC_MANNOSYLTRANSFERASE_COMPLEX,0.987104912468739
HALLMARK_IL6_JAK_STAT3_SIGNA...,SET,80,0.008674,0.00057132,0.1025,0.46628,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.987104912468739
MIR4713_5P,SET,140,0.0061204,0.00053241,0.072354,0.46629,MIR4713_5P,0.987104912468739
MIR340_3P,SET,44,0.010683,0.00052233,0.12637,0.46631,MIR340_3P,0.987104912468739
NABA_MATRISOME_HIGHLY_METAST...4,SET,12,0.021763,0.00055619,0.25796,0.46638,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,0.987104912468739
HP_RELATIVE_MACROCEPHALY,SET,52,0.0097751,0.00051948,0.11585,0.46638,HP_RELATIVE_MACROCEPHALY,0.987104912468739
XU_CREBBP_TARGETS_DN,SET,35,0.011596,0.00050579,0.13789,0.46649,XU_CREBBP_TARGETS_DN,0.987104912468739
GROSS_HIF1A_TARGETS_DN,SET,21,0.015558,0.00052587,0.18544,0.46657,GROSS_HIF1A_TARGETS_DN,0.987104912468739
SILIGAN_TARGETS_OF_EWS_FLI1_...2,SET,15,0.018029,0.00051512,0.21496,0.46658,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP,0.987104912468739
MIR4795_3P,SET,629,0.002973,0.00054077,0.035458,0.46659,MIR4795_3P,0.987104912468739
GSE3039_ALPHAALPHA_CD8_TCELL...3,SET,181,0.0053793,0.00053147,0.064286,0.46666,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN,0.987104912468739
HP_ABNORMALITY_OF_THE_PHARYNX,SET,197,0.0051988,0.00053562,0.062145,0.46667,HP_ABNORMALITY_OF_THE_PHARYNX,0.987104912468739
GOBP_TELOMERE_LOCALIZATION,SET,8,0.022879,0.00047747,0.27382,0.46671,GOBP_TELOMERE_LOCALIZATION,0.987104912468739
GOBP_BLOOD_COAGULATION_INTRI...,SET,6,0.03458,0.00062502,0.41506,0.4668,GOBP_BLOOD_COAGULATION_INTRINSIC_PATHWAY,0.987104912468739
GOBP_VASCULAR_ASSOCIATED_SMO...6,SET,24,0.016019,0.00057879,0.19277,0.46689,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.987104912468739
GOBP_ACETYLCHOLINE_SECRETION,SET,5,0.030814,0.00050844,0.37108,0.46691,GOBP_ACETYLCHOLINE_SECRETION,0.987104912468739
HP_ABNORMALITY_OF_MUSCLE_SIZE,SET,635,0.0028652,0.00052355,0.034542,0.46695,HP_ABNORMALITY_OF_MUSCLE_SIZE,0.987104912468739
REACTOME_PHASE_I_FUNCTIONALI...,SET,99,0.0079756,0.00058408,0.09619,0.46696,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,0.987104912468739
HP_COR_PULMONALE,SET,10,0.022717,0.00053003,0.274,0.46696,HP_COR_PULMONALE,0.987104912468739
GAVIN_PDE3B_TARGETS,SET,20,0.016278,0.00053696,0.19674,0.46703,GAVIN_PDE3B_TARGETS,0.987104912468739
GOBP_TRANSFORMING_GROWTH_FAC...1,SET,11,0.024521,0.00060002,0.29673,0.46707,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.987104912468739
GCM_CBFB,SET,63,0.0082108,0.00048015,0.09949,0.46711,GCM_CBFB,0.987104912468739
YAO_TEMPORAL_RESPONSE_TO_PRO...16,SET,69,0.0081738,0.00050014,0.099047,0.46712,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,0.987104912468739
GOMF_CHLORIDE_ION_BINDING,SET,9,0.026594,0.00058866,0.32229,0.46712,GOMF_CHLORIDE_ION_BINDING,0.987104912468739
CAO_BLOOD_FLUZONE_AGE_05_14Y...7,SET,6,0.028229,0.00051023,0.3421,0.46712,CAO_BLOOD_FLUZONE_AGE_05_14YO_CORRELATED_WITH_H3N1_HI_TITER_1DY_POSITIVE,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...635,SET,98,0.0069917,0.00050944,0.084756,0.46713,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.987104912468739
GOBP_AXONEMAL_CENTRAL_APPARA...,SET,5,0.031286,0.00051622,0.37957,0.46715,GOBP_AXONEMAL_CENTRAL_APPARATUS_ASSEMBLY,0.987104912468739
GOMF_SPHINGOSINE_N_ACYLTRANS...,SET,6,0.026136,0.0004724,0.31701,0.46715,GOMF_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY,0.987104912468739
KEGG_MEDICUS_VARIANT_AMPLIFI...2,SET,6,0.026851,0.00048531,0.32605,0.46718,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S,0.987104912468739
HP_ABNORMAL_ESOPHAGUS_MORPHO...,SET,207,0.0050124,0.00052922,0.060996,0.46725,HP_ABNORMAL_ESOPHAGUS_MORPHOLOGY,0.987104912468739
GOBP_KETONE_BIOSYNTHETIC_PRO...,SET,42,0.010572,0.00050507,0.12893,0.46733,GOBP_KETONE_BIOSYNTHETIC_PROCESS,0.987104912468739
GSE17721_0.5H_VS_12H_CPG_BMD...1,SET,186,0.0050561,0.00050632,0.061849,0.46742,GSE17721_0.5H_VS_12H_CPG_BMDC_DN,0.987104912468739
WP_IL6_SIGNALING,SET,42,0.011663,0.0005572,0.14281,0.46745,WP_IL6_SIGNALING,0.987104912468739
REACTOME_DOPAMINE_CLEARANCE_...,SET,3,0.052662,0.00067311,0.64547,0.46749,REACTOME_DOPAMINE_CLEARANCE_FROM_THE_SYNAPTIC_CLEFT,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...84,SET,384,0.0036492,0.00052219,0.044805,0.46754,GOBP_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.987104912468739
GOMF_UBIQUITIN_LIKE_MODIFIER...,SET,9,0.019258,0.00042627,0.23649,0.46755,GOMF_UBIQUITIN_LIKE_MODIFIER_ACTIVATING_ENZYME_ACTIVITY,0.987104912468739
SRF_Q6,SET,228,0.0048232,0.00053414,0.059272,0.46757,SRF_Q6,0.987104912468739
HP_ASYMMETRIC_GROWTH,SET,58,0.0093434,0.00052432,0.11486,0.46758,HP_ASYMMETRIC_GROWTH,0.987104912468739
MIR4765,SET,44,0.011222,0.00054872,0.13804,0.4676,MIR4765,0.987104912468739
HP_LIMB_DYSMETRIA,SET,14,0.018872,0.00052093,0.23267,0.46768,HP_LIMB_DYSMETRIA,0.987104912468739
TGACATY_UNKNOWN,SET,612,0.0029566,0.00053073,0.036462,0.46769,TGACATY_UNKNOWN,0.987104912468739
REACTOME_MAP2K_AND_MAPK_ACTI...,SET,38,0.011084,0.00050374,0.13681,0.46771,REACTOME_MAP2K_AND_MAPK_ACTIVATION,0.987104912468739
DODD_NASOPHARYNGEAL_CARCINOM...2,SET,1245,0.0020136,0.00050627,0.024889,0.46776,DODD_NASOPHARYNGEAL_CARCINOMA_UP,0.987104912468739
GSE1448_CTRL_VS_ANTI_VBETA5_...2,SET,187,0.0050968,0.00051175,0.062999,0.46776,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP,0.987104912468739
DESCARTES_MAIN_FETAL_PAEP_ME...,SET,109,0.0067408,0.00051784,0.083406,0.46779,DESCARTES_MAIN_FETAL_PAEP_MECOM_POSITIVE_CELLS,0.987104912468739
MIR6130,SET,164,0.0053842,0.00050659,0.066664,0.46781,MIR6130,0.987104912468739
HP_ETHYLMALONIC_ACIDURIA,SET,9,0.020015,0.00044303,0.24794,0.46783,HP_ETHYLMALONIC_ACIDURIA,0.987104912468739
MIR1301_3P_MIR5047,SET,105,0.0069184,0.0005217,0.085721,0.46784,MIR1301_3P_MIR5047,0.987104912468739
GOMF_EXONUCLEASE_ACTIVITY,SET,82,0.0069413,0.00046285,0.086001,0.46784,GOMF_EXONUCLEASE_ACTIVITY,0.987104912468739
BUSSLINGER_DUODENAL_MX_CELLS,SET,10,0.022372,0.00052198,0.27735,0.46786,BUSSLINGER_DUODENAL_MX_CELLS,0.987104912468739
GOBP_REGULATION_OF_REPRODUCT...,SET,187,0.0050987,0.00051195,0.063336,0.46792,GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS,0.987104912468739
LASTOWSKA_NEUROBLASTOMA_COPY...1,SET,731,0.002965,0.00057973,0.036857,0.46794,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,0.987104912468739
REACTOME_THE_RETINOID_CYCLE_...,SET,3,0.049132,0.00062799,0.61062,0.46794,REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION,0.987104912468739
KEGG_MEDICUS_PATHOGEN_HPV_E7...2,SET,7,0.023287,0.00045461,0.28957,0.46795,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...489,SET,4,0.040086,0.00059162,0.49872,0.46797,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...490,SET,4,0.040086,0.00059162,0.49872,0.46797,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.987104912468739
LHX3_01,SET,211,0.0051105,0.0005447,0.063676,0.46802,LHX3_01,0.987104912468739
GSE31082_DP_VS_CD8_SP_THYMOC...1,SET,179,0.0051046,0.00050156,0.063624,0.46803,GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN,0.987104912468739
GOBP_NUCLEOSIDE_BISPHOSPHATE...3,SET,111,0.0068368,0.00052998,0.085236,0.46804,GOBP_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS,0.987104912468739
MIR6815_3P,SET,187,0.0050266,0.00050471,0.062689,0.46805,MIR6815_3P,0.987104912468739
AAAYRNCTG_UNKNOWN,SET,323,0.0039604,0.00052066,0.049431,0.46807,AAAYRNCTG_UNKNOWN,0.987104912468739
WP_EGFR_TYROSINE_KINASE_INHI...,SET,83,0.0080426,0.00053953,0.1004,0.46808,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,0.987104912468739
HP_SHORT_FOURTH_METATARSAL,SET,15,0.017051,0.00048719,0.21288,0.46808,HP_SHORT_FOURTH_METATARSAL,0.987104912468739
GOBP_TRACHEA_FORMATION,SET,7,0.03145,0.00061398,0.39279,0.46809,GOBP_TRACHEA_FORMATION,0.987104912468739
GOBP_REGULATION_OF_CELL_PROJ...3,SET,11,0.019113,0.00046769,0.23877,0.4681,GOBP_REGULATION_OF_CELL_PROJECTION_SIZE,0.987104912468739
GSE8835_CD4_VS_CD8_TCELL_DN,SET,178,0.0052832,0.00051768,0.066063,0.46813,GSE8835_CD4_VS_CD8_TCELL_DN,0.987104912468739
GOBP_HEART_DEVELOPMENT,SET,557,0.0030531,0.00052365,0.038228,0.46817,GOBP_HEART_DEVELOPMENT,0.987104912468739
HP_ABNORMALITY_OF_LENS_SHAPE,SET,15,0.019197,0.0005485,0.2407,0.46822,HP_ABNORMALITY_OF_LENS_SHAPE,0.987104912468739
GSE14415_INDUCED_TREG_VS_FOX...1,SET,160,0.0054948,0.00051071,0.068954,0.46824,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...370,SET,12,0.021009,0.00053694,0.26367,0.46825,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.987104912468739
GOBP_TRANS_SYNAPTIC_SIGNALIN...2,SET,7,0.028913,0.00056445,0.36308,0.46827,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.987104912468739
HP_HEPATIC_VEIN_THROMBOSIS,SET,9,0.02236,0.00049495,0.28092,0.46828,HP_HEPATIC_VEIN_THROMBOSIS,0.987104912468739
GOBP_REGULATION_OF_MICROTUBU...3,SET,7,0.023004,0.0004491,0.28929,0.46831,GOBP_REGULATION_OF_MICROTUBULE_BINDING,0.987104912468739
MODULE_362,SET,19,0.017719,0.00056972,0.22304,0.46834,MODULE_362,0.987104912468739
PAX5_01,SET,138,0.0059654,0.00051523,0.075158,0.46837,PAX5_01,0.987104912468739
GOCC_NF_KAPPAB_COMPLEX,SET,4,0.034046,0.00050248,0.42982,0.46843,GOCC_NF_KAPPAB_COMPLEX,0.987104912468739
KEGG_MEDICUS_PATHOGEN_SHIGEL...8,SET,6,0.032123,0.00058061,0.40576,0.46845,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.987104912468739
HP_INCREASED_SUSCEPTIBILITY_...,SET,212,0.004676,0.00049955,0.059084,0.46846,HP_INCREASED_SUSCEPTIBILITY_TO_FRACTURES,0.987104912468739
GOCC_MICROBODY_LUMEN,SET,50,0.0095854,0.00049954,0.1212,0.46848,GOCC_MICROBODY_LUMEN,0.987104912468739
HASLINGER_B_CLL_WITH_MUTATED...,SET,16,0.017775,0.00052451,0.2248,0.46849,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,0.987104912468739
KIM_MYCN_AMPLIFICATION_TARGE...1,SET,97,0.0069315,0.00050249,0.087707,0.4685,KIM_MYCN_AMPLIFICATION_TARGETS_DN,0.987104912468739
GSE24142_EARLY_THYMIC_PROGEN...8,SET,186,0.0050489,0.0005056,0.063926,0.46852,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP,0.987104912468739
HP_ABNORMAL_PATTERN_ELECTROR...,SET,7,0.026594,0.00051917,0.33681,0.46853,HP_ABNORMAL_PATTERN_ELECTRORETINOGRAM,0.987104912468739
GSE29618_PRE_VS_DAY7_POST_TI...3,SET,177,0.0048382,0.00047275,0.061357,0.46858,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN,0.987104912468739
HP_ABSENT_SKIN_PIGMENTATION,SET,5,0.034551,0.0005701,0.4386,0.46861,HP_ABSENT_SKIN_PIGMENTATION,0.987104912468739
GOMF_EPHRIN_RECEPTOR_ACTIVITY,SET,18,0.017984,0.00056283,0.22853,0.46864,GOMF_EPHRIN_RECEPTOR_ACTIVITY,0.987104912468739
FIGUEROA_AML_METHYLATION_CLU...6,SET,151,0.0057056,0.0005153,0.072547,0.46866,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,0.987104912468739
HINATA_NFKB_TARGETS_KERATINO...2,SET,84,0.0076068,0.00051335,0.096776,0.46867,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,0.987104912468739
SMID_BREAST_CANCER_RELAPSE_I...4,SET,34,0.012751,0.00054822,0.16254,0.46874,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,0.987104912468739
HP_MALAR_FLATTENING,SET,175,0.0051284,0.0004983,0.065467,0.46878,HP_MALAR_FLATTENING,0.987104912468739
CCACACA_MIR147,SET,56,0.0087819,0.00048426,0.11243,0.46887,CCACACA_MIR147,0.987104912468739
GOMF_AMINO_ACID_SODIUM_SYMPO...,SET,21,0.016904,0.00057136,0.21644,0.46887,GOMF_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.987104912468739
HP_ABNORMALITY_OF_RENIN_ANGI...,SET,35,0.012051,0.00052567,0.15436,0.46889,HP_ABNORMALITY_OF_RENIN_ANGIOTENSIN_SYSTEM,0.987104912468739
GOMF_TESTOSTERONE_DEHYDROGEN...1,SET,7,0.023785,0.00046434,0.30483,0.4689,GOMF_TESTOSTERONE_DEHYDROGENASE_NADPLUS_ACTIVITY,0.987104912468739
GOMF_HAPTOGLOBIN_BINDING,SET,6,0.035826,0.00064755,0.45917,0.46891,GOMF_HAPTOGLOBIN_BINDING,0.987104912468739
HP_REDUCED_FORCED_VITAL_CAPA...,SET,34,0.01106,0.00047549,0.14175,0.46891,HP_REDUCED_FORCED_VITAL_CAPACITY,0.987104912468739
GOBP_REGULATION_OF_PROTEIN_A...1,SET,17,0.014923,0.00045388,0.19153,0.46895,GOBP_REGULATION_OF_PROTEIN_ACETYLATION,0.987104912468739
MIR636,SET,204,0.0049784,0.00052185,0.063923,0.46896,MIR636,0.987104912468739
REACTOME_TRANSCRIPTIONAL_REG...14,SET,12,0.020382,0.0005209,0.26178,0.46897,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_TESTIS_DIFFERENTIATION,0.987104912468739
HP_ANTERIOR_OPEN_BITE_MALOCC...,SET,14,0.018639,0.0005145,0.23946,0.46898,HP_ANTERIOR_OPEN_BITE_MALOCCLUSION,0.987104912468739
FULCHER_INFLAMMATORY_RESPONS...2,SET,525,0.0030577,0.00050962,0.039358,0.46904,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,0.987104912468739
GOBP_REGULATION_OF_MAST_CELL...1,SET,16,0.017811,0.00052556,0.22939,0.46906,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION,0.987104912468739
HP_ABNORMAL_RENAL_TUBULAR_LU...,SET,5,0.032316,0.00053321,0.41662,0.46909,HP_ABNORMAL_RENAL_TUBULAR_LUMEN_MORPHOLOGY,0.987104912468739
GSE17812_WT_VS_THPOK_KO_MEMO...1,SET,181,0.0051682,0.00051062,0.066646,0.46909,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN,0.987104912468739
HP_RECURRENT_RESPIRATORY_INF...,SET,544,0.0029294,0.00049671,0.037779,0.4691,HP_RECURRENT_RESPIRATORY_INFECTIONS,0.987104912468739
HP_FRACTURES_OF_THE_LONG_BON...,SET,12,0.017297,0.00044206,0.22318,0.46911,HP_FRACTURES_OF_THE_LONG_BONES,0.987104912468739
chr6q14,SET,36,0.017954,0.00079424,0.23168,0.46912,chr6q14,0.987104912468739
HU_FETAL_RETINA_RPC,SET,97,0.0071783,0.00052038,0.093056,0.46926,HU_FETAL_RETINA_RPC,0.987104912468739
HIRSCH_CELLULAR_TRANSFORMATI...1,SET,91,0.0070145,0.00049261,0.090978,0.46927,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...318,SET,32,0.010885,0.00045403,0.14123,0.46928,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.987104912468739
GSE21379_WT_VS_SAP_KO_TFH_CD...1,SET,178,0.004935,0.00048356,0.064205,0.46937,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN,0.987104912468739
DESCARTES_FETAL_CEREBRUM_INH...,SET,32,0.014033,0.00058533,0.18267,0.46938,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.987104912468739
GOBP_REGULATION_OF_DENDRITE_...2,SET,24,0.014806,0.00053495,0.19274,0.46939,GOBP_REGULATION_OF_DENDRITE_EXTENSION,0.987104912468739
HP_TALIPES_VALGUS,SET,17,0.016555,0.00050352,0.21565,0.4694,HP_TALIPES_VALGUS,0.987104912468739
GSE17721_PAM3CSK4_VS_CPG_1H_...2,SET,179,0.0047154,0.00046332,0.061434,0.46941,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP,0.987104912468739
chr11p12,SET,6,0.03407,0.00061581,0.44411,0.46943,chr11p12,0.987104912468739
HP_LOCALIZED_OSTEOPOROSIS,SET,19,0.013863,0.00044573,0.18103,0.46948,HP_LOCALIZED_OSTEOPOROSIS,0.987104912468739
HP_APLASIA_HYPOPLASIA_OF_THE...42,SET,5,0.025267,0.00041692,0.33077,0.46956,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.987104912468739
MODULE_537,SET,17,0.016311,0.0004961,0.21373,0.46958,MODULE_537,0.987104912468739
GSE360_L_DONOVANI_VS_M_TUBER...4,SET,184,0.0049385,0.00049191,0.064708,0.46958,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP,0.987104912468739
GOBP_RETINA_VASCULATURE_DEVE...,SET,18,0.01524,0.00047696,0.19991,0.46962,GOBP_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.987104912468739
HP_ABNORMAL_CIRCULATING_PROL...,SET,19,0.013808,0.00044397,0.18131,0.46965,HP_ABNORMAL_CIRCULATING_PROLINE_CONCENTRATION,0.987104912468739
GSE13306_RA_VS_UNTREATED_TCO...2,SET,183,0.004771,0.00047394,0.062644,0.46965,GSE13306_RA_VS_UNTREATED_TCONV_UP,0.987104912468739
GSE11961_MEMORY_BCELL_DAY40_...2,SET,182,0.0047035,0.00046597,0.061827,0.46968,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.987104912468739
GOMF_KINASE_INHIBITOR_ACTIVI...,SET,73,0.0077508,0.00048776,0.10202,0.46972,GOMF_KINASE_INHIBITOR_ACTIVITY,0.987104912468739
MIR4429,SET,275,0.0042106,0.00051144,0.055455,0.46974,MIR4429,0.987104912468739
GOBP_GONADAL_MESODERM_DEVELO...,SET,2,0.049957,0.00052137,0.65797,0.46974,GOBP_GONADAL_MESODERM_DEVELOPMENT,0.987104912468739
MIR1238_3P,SET,30,0.011646,0.00047038,0.15346,0.46975,MIR1238_3P,0.987104912468739
GOBP_REGULATION_OF_FIBROBLAS...3,SET,35,0.010915,0.0004761,0.14397,0.46979,GOBP_REGULATION_OF_FIBROBLAST_MIGRATION,0.987104912468739
REACTOME_ASPIRIN_ADME,SET,41,0.012191,0.00057547,0.16111,0.46984,REACTOME_ASPIRIN_ADME,0.987104912468739
KEGG_MEDICUS_REFERENCE_FANCO...,SET,12,0.015214,0.00038884,0.20147,0.4699,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...575,SET,1108,0.0020047,0.00047738,0.026583,0.46994,GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS,0.987104912468739
HP_ABNORMAL_TEMPER_TANTRUMS,SET,29,0.011658,0.00046298,0.15456,0.46994,HP_ABNORMAL_TEMPER_TANTRUMS,0.987104912468739
GOBP_MATERNAL_PROCESS_INVOLV...2,SET,5,0.02448,0.00040393,0.32469,0.46995,GOBP_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION,0.987104912468739
HP_MUSCLE_FIBER_ATROPHY,SET,61,0.0078152,0.00044972,0.10365,0.46995,HP_MUSCLE_FIBER_ATROPHY,0.987104912468739
GOBP_METHIONINE_BIOSYNTHETIC...,SET,12,0.018784,0.00048007,0.2492,0.46996,GOBP_METHIONINE_BIOSYNTHETIC_PROCESS,0.987104912468739
GSE43955_10H_VS_60H_ACT_CD4_...4,SET,181,0.0046159,0.00045604,0.061252,0.46996,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.987104912468739
MIR4283,SET,185,0.0047238,0.00047178,0.062694,0.46997,MIR4283,0.987104912468739
GSE40666_WT_VS_STAT4_KO_CD8_...1,SET,174,0.0046742,0.00045288,0.062037,0.46997,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN,0.987104912468739
GOMF_EXCITATORY_EXTRACELLULA...,SET,34,0.01213,0.00052151,0.16115,0.47,GOMF_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.987104912468739
DESCARTES_MAIN_FETAL_LIMBIC_...,SET,6,0.026407,0.0004773,0.35105,0.47002,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.987104912468739
PID_SHP2_PATHWAY,SET,55,0.0091584,0.00050051,0.12178,0.47003,PID_SHP2_PATHWAY,0.987104912468739
GOCC_EARLY_ENDOSOME,SET,399,0.0032121,0.00046835,0.04274,0.47005,GOCC_EARLY_ENDOSOME,0.987104912468739
RUAN_RESPONSE_TO_TNF_TROGLIT...2,SET,17,0.016472,0.00050098,0.21944,0.47008,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,0.987104912468739
GOBP_REGULATION_OF_ASTROCYTE...1,SET,5,0.032362,0.00053398,0.43184,0.47013,GOBP_REGULATION_OF_ASTROCYTE_ACTIVATION,0.987104912468739
GOBP_REGULATION_OF_POSTSYNAP...3,SET,9,0.022331,0.0004943,0.29816,0.47015,GOBP_REGULATION_OF_POSTSYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.987104912468739
BIOCARTA_EPONFKB_PATHWAY,SET,11,0.019419,0.00047518,0.25943,0.47017,BIOCARTA_EPONFKB_PATHWAY,0.987104912468739
GOBP_ENDOSOME_TRANSPORT_VIA_...,SET,39,0.00944,0.00043462,0.12653,0.47027,GOBP_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.987104912468739
MIR4796_3P,SET,224,0.0043704,0.00047978,0.05862,0.47029,MIR4796_3P,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...646,SET,6,0.029283,0.00052928,0.39363,0.47035,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.987104912468739
MIR6731_3P,SET,68,0.0077378,0.00047003,0.10415,0.47039,MIR6731_3P,0.987104912468739
REACTOME_PTK6_EXPRESSION,SET,5,0.028001,0.00046202,0.3771,0.47041,REACTOME_PTK6_EXPRESSION,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...239,SET,6,0.026013,0.00047017,0.35037,0.47041,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,0.987104912468739
HP_SPINAL_RIGIDITY,SET,54,0.0084057,0.00045519,0.11336,0.47045,HP_SPINAL_RIGIDITY,0.987104912468739
GOBP_BEHAVIOR,SET,611,0.002724,0.00048858,0.036773,0.47048,GOBP_BEHAVIOR,0.987104912468739
HP_SYNOSTOSIS_OF_CARPALS_TAR...,SET,42,0.010773,0.00051468,0.14554,0.4705,HP_SYNOSTOSIS_OF_CARPALS_TARSALS,0.987104912468739
HE_LIM_SUN_FETAL_LUNG_C7_TM4...1,SET,51,0.0092087,0.00048467,0.12443,0.4705,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.987104912468739
HP_GENERALIZED_NON_CONVULSIV...,SET,16,0.015312,0.00045184,0.20715,0.47054,HP_GENERALIZED_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,0.987104912468739
MIR7106_3P,SET,37,0.0098965,0.00044382,0.13417,0.4706,MIR7106_3P,0.987104912468739
KOKKINAKIS_METHIONINE_DEPRIV...4,SET,113,0.0063066,0.00049324,0.085599,0.47063,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,0.987104912468739
WP_PROXIMAL_TUBULE_TRANSPORT,SET,55,0.0086341,0.00047186,0.11727,0.47065,WP_PROXIMAL_TUBULE_TRANSPORT,0.987104912468739
GCM_HBP1,SET,63,0.0075011,0.00043865,0.10194,0.47067,GCM_HBP1,0.987104912468739
GSE13547_WT_VS_ZFX_KO_BCELL_...2,SET,123,0.0060995,0.00049756,0.082907,0.47068,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP,0.987104912468739
GOBP_REGULATION_OF_CELL_COMM...2,SET,12,0.021073,0.00053857,0.28693,0.47073,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.987104912468739
GAVISH_3CA_MALIGNANT_METAPRO...39,SET,41,0.0095364,0.00045015,0.1301,0.47078,GAVISH_3CA_MALIGNANT_METAPROGRAM_9_UNFOLDED_PROTEIN_RESPONSE,0.987104912468739
GOBP_RESPONSE_TO_INCREASED_O...,SET,23,0.012373,0.00043767,0.16898,0.47082,GOBP_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,0.987104912468739
REACTOME_TRANSCRIPTIONAL_REG...15,SET,79,0.0067809,0.00044384,0.092983,0.47093,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,0.987104912468739
ZNF112_TARGET_GENES,SET,3,0.037482,0.00047908,0.5141,0.47094,ZNF112_TARGET_GENES,0.987104912468739
NR0B1_TARGET_GENES,SET,276,0.0037966,0.00046198,0.052087,0.47095,NR0B1_TARGET_GENES,0.987104912468739
GAVISH_3CA_METAPROGRAM_CD4_T...5,SET,47,0.0092872,0.00046929,0.12746,0.47096,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_INTERFERON,0.987104912468739
GSE37301_HEMATOPOIETIC_STEM_...14,SET,155,0.0050198,0.00045928,0.069002,0.471,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP,0.987104912468739
GOMF_TRNA_PSEUDOURIDINE_SYNT...,SET,8,0.019707,0.00041128,0.27148,0.47107,GOMF_TRNA_PSEUDOURIDINE_SYNTHASE_ACTIVITY,0.987104912468739
GOBP_REGULATION_OF_CHROMATIN...2,SET,28,0.010804,0.00042161,0.14914,0.47112,GOBP_REGULATION_OF_CHROMATIN_ORGANIZATION,0.987104912468739
FONTAINE_FOLLICULAR_THYROID_...1,SET,62,0.0079197,0.00045944,0.10937,0.47114,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,0.987104912468739
GSE13484_UNSTIM_VS_YF17D_VAC...2,SET,179,0.0043365,0.00042609,0.059978,0.47118,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.987104912468739
GOBP_REGULATION_OF_ATTACHMEN...2,SET,22,0.012487,0.00043198,0.17274,0.47119,GOBP_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.987104912468739
DARWICHE_PAPILLOMA_PROGRESSI...,SET,72,0.0073626,0.00046016,0.1019,0.4712,DARWICHE_PAPILLOMA_PROGRESSION_RISK,0.987104912468739
GOCC_FILAMENTOUS_ACTIN,SET,30,0.01103,0.0004455,0.15288,0.47124,GOCC_FILAMENTOUS_ACTIN,0.987104912468739
GOCC_SARCOPLASM,SET,92,0.0063664,0.00044953,0.088223,0.47124,GOCC_SARCOPLASM,0.987104912468739
GOBP_GLYCOLIPID_BIOSYNTHETIC...,SET,74,0.0069769,0.00044204,0.096772,0.47126,GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS,0.987104912468739
MIR3682_5P,SET,88,0.0065296,0.00045097,0.090758,0.47132,MIR3682_5P,0.987104912468739
GSE7460_CTRL_VS_FOXP3_OVEREX...1,SET,184,0.0046069,0.00045888,0.064211,0.4714,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN,0.987104912468739
CTGYNNCTYTAA_UNKNOWN,SET,81,0.0070888,0.00046981,0.098824,0.47141,CTGYNNCTYTAA_UNKNOWN,0.987104912468739
GOMF_HYDROLASE_ACTIVITY_ACTI...1,SET,716,0.0023346,0.00045195,0.032558,0.47142,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES,0.987104912468739
GCM_CASP2,SET,26,0.011555,0.00043454,0.16131,0.47145,GCM_CASP2,0.987104912468739
REACTOME_AKT_PHOSPHORYLATES_...1,SET,14,0.014675,0.00040509,0.20494,0.47146,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,0.987104912468739
REACTOME_VISUAL_PHOTOTRANSDU...,SET,88,0.006743,0.00046571,0.094316,0.4715,REACTOME_VISUAL_PHOTOTRANSDUCTION,0.987104912468739
GOBP_FOREBRAIN_DORSAL_VENTRA...,SET,7,0.026743,0.00052209,0.37444,0.47153,GOBP_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION,0.987104912468739
PAX2_02,SET,241,0.0041598,0.00047345,0.05828,0.47155,PAX2_02,0.987104912468739
GSE27241_CTRL_VS_DIGOXIN_TRE...2,SET,145,0.0051006,0.00045149,0.071543,0.47158,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.987104912468739
GSE22103_UNSTIM_VS_LPS_STIM_...1,SET,177,0.0046209,0.00045152,0.064831,0.47159,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN,0.987104912468739
IKEDA_MIR30_TARGETS_DN,SET,22,0.013737,0.00047522,0.19317,0.47165,IKEDA_MIR30_TARGETS_DN,0.987104912468739
BIOCARTA_P35ALZHEIMERS_PATHW...,SET,8,0.024167,0.00050435,0.34061,0.47172,BIOCARTA_P35ALZHEIMERS_PATHWAY,0.987104912468739
GOBP_REGULATION_OF_TRANSLATI...4,SET,76,0.0064598,0.00041475,0.091046,0.47172,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...518,SET,31,0.012284,0.00050434,0.1732,0.47173,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.987104912468739
GSE21546_ELK1_KO_VS_SAP1A_KO...4,SET,172,0.0045651,0.00043978,0.064362,0.47173,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.987104912468739
KEGG_MEDICUS_VARIANT_MUTATIO...88,SET,11,0.018543,0.00045374,0.26162,0.47175,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY,0.987104912468739
DURANTE_ADULT_OLFACTORY_NEUR...25,SET,25,0.012114,0.00044669,0.17099,0.47176,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED,0.987104912468739
GSE22601_DOUBLE_NEGATIVE_VS_...5,SET,184,0.0042149,0.00041983,0.059549,0.47179,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.987104912468739
GOMF_KINASE_REGULATOR_ACTIVI...,SET,253,0.0038497,0.00044879,0.054559,0.47187,GOMF_KINASE_REGULATOR_ACTIVITY,0.987104912468739
HP_RECURRENT_SINOPULMONARY_I...,SET,58,0.0076838,0.00043119,0.10895,0.47189,HP_RECURRENT_SINOPULMONARY_INFECTIONS,0.987104912468739
GNF2_TTK,SET,39,0.0092402,0.00042542,0.13128,0.47194,GNF2_TTK,0.987104912468739
GOBP_CAMP_MEDIATED_SIGNALING,SET,53,0.0086472,0.00046393,0.12284,0.47194,GOBP_CAMP_MEDIATED_SIGNALING,0.987104912468739
ACTGTAG_MIR139,SET,109,0.0059287,0.00045546,0.084272,0.47196,ACTGTAG_MIR139,0.987104912468739
HP_ABNORMALITY_OF_VITAMIN_ME...,SET,94,0.0062534,0.0004463,0.088933,0.47197,HP_ABNORMALITY_OF_VITAMIN_METABOLISM,0.987104912468739
GOMF_PHOSPHOLIPASE_BINDING,SET,17,0.014989,0.0004559,0.21333,0.47199,GOMF_PHOSPHOLIPASE_BINDING,0.987104912468739
GOCC_GOLGI_APPARATUS,SET,1465,0.0016322,0.00044228,0.023293,0.47207,GOCC_GOLGI_APPARATUS,0.987104912468739
REACTOME_AURKA_ACTIVATION_BY...,SET,67,0.0066418,0.00040049,0.094994,0.47213,REACTOME_AURKA_ACTIVATION_BY_TPX2,0.987104912468739
MIR548N,SET,553,0.0026059,0.00044539,0.037303,0.47215,MIR548N,0.987104912468739
GOBP_REGULATION_OF_POSTSYNAP...5,SET,17,0.015341,0.00046661,0.21987,0.47219,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ORGANIZATION,0.987104912468739
GOBP_RESPIRATORY_SYSTEM_PROC...,SET,40,0.010188,0.00047504,0.14611,0.4722,GOBP_RESPIRATORY_SYSTEM_PROCESS,0.987104912468739
HP_ABNORMALITY_OF_VISUAL_EVO...,SET,63,0.0074876,0.00043785,0.10736,0.4722,HP_ABNORMALITY_OF_VISUAL_EVOKED_POTENTIALS,0.987104912468739
MODULE_68,SET,26,0.012512,0.00047049,0.17956,0.47222,MODULE_68,0.987104912468739
ATTCTTT_MIR186,SET,241,0.0039449,0.00044899,0.056771,0.4723,ATTCTTT_MIR186,0.987104912468739
GOBP_REGULATION_OF_SENSORY_P...,SET,13,0.017313,0.00046053,0.2492,0.47231,GOBP_REGULATION_OF_SENSORY_PERCEPTION,0.987104912468739
MIR663B,SET,28,0.010971,0.00042812,0.15824,0.47236,MIR663B,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...377,SET,5,0.030631,0.00050542,0.44278,0.47242,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.987104912468739
GOCC_RIBONUCLEOPROTEIN_GRANU...,SET,246,0.0036467,0.00041927,0.052726,0.47243,GOCC_RIBONUCLEOPROTEIN_GRANULE,0.987104912468739
HP_HYDROCELE_TESTIS,SET,35,0.0097939,0.00042721,0.1418,0.47247,HP_HYDROCELE_TESTIS,0.987104912468739
GOMF_1_ALKYL_2_ACETYLGLYCERO...,SET,8,0.018058,0.00037687,0.26152,0.47248,GOMF_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY,0.987104912468739
GAUTAM_EYE_CHOROID_SCLERA_MO...,SET,120,0.0053373,0.00043009,0.07742,0.47252,GAUTAM_EYE_CHOROID_SCLERA_MONOCYTES,0.987104912468739
HP_ABNORMAL_PERIPHERAL_NERVO...1,SET,360,0.003099,0.00042967,0.044976,0.47253,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_MORPHOLOGY,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...440,SET,76,0.0070203,0.00045074,0.102,0.47256,GOBP_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...4,SET,9,0.020739,0.00045906,0.30154,0.47258,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.987104912468739
REACTOME_MYOCLONIC_EPILEPSY_...,SET,8,0.020573,0.00042935,0.29965,0.47263,REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA,0.987104912468739
GOMF_PROSTANOID_RECEPTOR_ACT...,SET,11,0.020122,0.00049238,0.29321,0.47264,GOMF_PROSTANOID_RECEPTOR_ACTIVITY,0.987104912468739
GOMF_PHOSPHORUS_OXYGEN_LYASE...,SET,20,0.014321,0.0004724,0.2087,0.47265,GOMF_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY,0.987104912468739
XU_HGF_TARGETS_INDUCED_BY_AK...3,SET,15,0.014984,0.0004281,0.21846,0.47266,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,0.987104912468739
GOBP_FREE_UBIQUITIN_CHAIN_PO...,SET,8,0.021955,0.0004582,0.3209,0.47273,GOBP_FREE_UBIQUITIN_CHAIN_POLYMERIZATION,0.987104912468739
HP_ABNORMAL_RESPONSE_TO_ACTH...,SET,6,0.02552,0.00046126,0.37306,0.47273,HP_ABNORMAL_RESPONSE_TO_ACTH_STIMULATION_TEST,0.987104912468739
KEGG_HEMATOPOIETIC_CELL_LINE...,SET,80,0.0071257,0.00046934,0.10418,0.47274,KEGG_HEMATOPOIETIC_CELL_LINEAGE,0.987104912468739
GSE29618_BCELL_VS_MDC_DAY7_F...1,SET,183,0.0044678,0.00044382,0.065326,0.47274,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN,0.987104912468739
GOBP_REGULATION_OF_EPITHELIA...5,SET,334,0.0033635,0.00044951,0.049236,0.47277,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.987104912468739
FRANCO_BLOOD_SANOFI_PASTEUR_...6,SET,119,0.005462,0.0004383,0.079975,0.47278,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,0.987104912468739
MIR4644,SET,273,0.0036441,0.00044105,0.053384,0.47279,MIR4644,0.987104912468739
GOCC_DENDRITIC_SPINE_MEMBRANE,SET,14,0.015746,0.00043464,0.23091,0.47282,GOCC_DENDRITIC_SPINE_MEMBRANE,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...401,SET,616,0.0024255,0.00043677,0.035593,0.47283,GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.987104912468739
GOBP_WATER_TRANSPORT,SET,25,0.01343,0.00049524,0.19707,0.47283,GOBP_WATER_TRANSPORT,0.987104912468739
HP_MICROPENIS,SET,226,0.0038719,0.00042693,0.056801,0.47283,HP_MICROPENIS,0.987104912468739
GSE18281_CORTICAL_THYMOCYTE_...1,SET,177,0.0040857,0.00039922,0.059993,0.47285,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN,0.987104912468739
GOMF_ATPASE_COUPLED_TRANSMEM...,SET,91,0.0063847,0.00044838,0.09398,0.47292,GOMF_ATPASE_COUPLED_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.987104912468739
GSE5589_IL6_KO_VS_IL10_KO_LP...4,SET,181,0.0044339,0.00043807,0.065454,0.473,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.987104912468739
GAVISH_3CA_METAPROGRAM_B_CEL...9,SET,36,0.009217,0.00040774,0.13626,0.47304,GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA,0.987104912468739
GOBP_PROTEIN_LOCALIZATION_TO...4,SET,4,0.032866,0.00048506,0.48595,0.47304,GOBP_PROTEIN_LOCALIZATION_TO_BICELLULAR_TIGHT_JUNCTION,0.987104912468739
HP_PROGRESSIVE_NIGHT_BLINDNE...,SET,85,0.0062217,0.00042235,0.09214,0.47308,HP_PROGRESSIVE_NIGHT_BLINDNESS,0.987104912468739
GOBP_RESPONSE_TO_UV_B,SET,19,0.0126,0.00040511,0.18682,0.47312,GOBP_RESPONSE_TO_UV_B,0.987104912468739
MIR5704,SET,47,0.0083911,0.00042401,0.12448,0.47313,MIR5704,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...535,SET,22,0.013032,0.00045085,0.19361,0.47317,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.987104912468739
GOBP_TRANSMEMBRANE_TRANSPORT,SET,1409,0.0016485,0.00043882,0.024512,0.47319,GOBP_TRANSMEMBRANE_TRANSPORT,0.987104912468739
GSE17974_CTRL_VS_ACT_IL4_AND...12,SET,155,0.0048943,0.00044779,0.072773,0.47319,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP,0.987104912468739
GOBP_REGULATION_OF_NEUROTRAN...3,SET,72,0.0068585,0.00042866,0.102,0.4732,GOBP_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.987104912468739
HP_ABNORMAL_SUPERIOR_CEREBEL...,SET,12,0.014074,0.00035968,0.20939,0.47321,HP_ABNORMAL_SUPERIOR_CEREBELLAR_PEDUNCLE_MORPHOLOGY,0.987104912468739
HP_OSTEOPOROSIS,SET,281,0.0034893,0.00042836,0.051958,0.47323,HP_OSTEOPOROSIS,0.987104912468739
HP_LOW_MOLECULAR_WEIGHT_PROT...,SET,5,0.026402,0.00043564,0.39376,0.47327,HP_LOW_MOLECULAR_WEIGHT_PROTEINURIA,0.987104912468739
GOBP_REGULATION_OF_LIPID_LOC...,SET,150,0.0048779,0.00043909,0.072816,0.4733,GOBP_REGULATION_OF_LIPID_LOCALIZATION,0.987104912468739
GSE28737_WT_VS_BCL6_KO_MARGI...2,SET,178,0.0042619,0.0004176,0.063662,0.47331,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,0.987104912468739
GSE27670_BLIMP1_VS_LMP1_TRAN...1,SET,184,0.0040875,0.00040714,0.061084,0.47332,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN,0.987104912468739
IZADPANAH_STEM_CELL_ADIPOSE_...1,SET,97,0.0060263,0.00043687,0.090145,0.47335,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,0.987104912468739
GOMF_CALMODULIN_BINDING,SET,197,0.004155,0.00042808,0.062181,0.47336,GOMF_CALMODULIN_BINDING,0.987104912468739
GSE33424_CD161_HIGH_VS_NEG_C...2,SET,189,0.0042904,0.00043306,0.064298,0.4734,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP,0.987104912468739
REACTOME_NEGATIVE_REGULATION...2,SET,31,0.010768,0.00044209,0.16168,0.47345,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,0.987104912468739
HOEK_B_CELL_2011_2012_TIV_AD...1,SET,5,0.021955,0.00036226,0.3298,0.47346,HOEK_B_CELL_2011_2012_TIV_ADULT_1DY_UP,0.987104912468739
HP_MACULE,SET,209,0.0037598,0.00039886,0.056512,0.47348,HP_MACULE,0.987104912468739
BILD_HRAS_ONCOGENIC_SIGNATURE,SET,229,0.0039363,0.00043686,0.059232,0.47351,BILD_HRAS_ONCOGENIC_SIGNATURE,0.987104912468739
MORF_FEN1,SET,56,0.0069879,0.00038534,0.10515,0.47351,MORF_FEN1,0.987104912468739
GOBP_RESPONSE_TO_VITAMIN_E,SET,9,0.019473,0.00043103,0.2936,0.47356,GOBP_RESPONSE_TO_VITAMIN_E,0.987104912468739
GSE36009_UNSTIM_VS_LPS_STIM_...2,SET,174,0.0044294,0.00042915,0.066819,0.47357,GSE36009_UNSTIM_VS_LPS_STIM_DC_UP,0.987104912468739
ONDER_CDH1_TARGETS_3_DN,SET,55,0.0083927,0.00045866,0.12675,0.47361,ONDER_CDH1_TARGETS_3_DN,0.987104912468739
GOCC_COLLAGEN_TRIMER,SET,83,0.0070157,0.00047064,0.10638,0.47371,GOCC_COLLAGEN_TRIMER,0.987104912468739
WP_EICOSANOID_METABOLISM_VIA...1,SET,30,0.010654,0.00043032,0.16179,0.47375,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.987104912468739
GOCC_CYTOSOLIC_PROTEASOME_CO...,SET,5,0.021254,0.0003507,0.32497,0.47393,GOCC_CYTOSOLIC_PROTEASOME_COMPLEX,0.987104912468739
HP_ABDOMINAL_WALL_MUSCLE_WEA...,SET,14,0.014454,0.00039899,0.22115,0.47394,HP_ABDOMINAL_WALL_MUSCLE_WEAKNESS,0.987104912468739
GOBP_CELLULAR_RESPONSE_TO_BI...,SET,232,0.0038884,0.00043433,0.0595,0.47395,GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS,0.987104912468739
GSE5679_CTRL_VS_PPARG_LIGAND...2,SET,179,0.0044593,0.00043815,0.068247,0.47395,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.987104912468739
HP_CONGENITAL_BILATERAL_HIP_...,SET,6,0.026907,0.00048634,0.41207,0.47397,HP_CONGENITAL_BILATERAL_HIP_DISLOCATION,0.987104912468739
GOBP_PHOSPHOLIPID_HOMEOSTASIS,SET,17,0.013708,0.00041692,0.21007,0.47399,GOBP_PHOSPHOLIPID_HOMEOSTASIS,0.987104912468739
GSE17721_0.5H_VS_24H_LPS_BMD...1,SET,183,0.0039821,0.00039557,0.061145,0.47404,GSE17721_0.5H_VS_24H_LPS_BMDC_DN,0.987104912468739
GHO_ATF5_TARGETS_UP,SET,12,0.018056,0.00046146,0.27775,0.47408,GHO_ATF5_TARGETS_UP,0.987104912468739
HP_METAPHYSEAL_CHONDRODYSPLA...,SET,10,0.018954,0.00044223,0.29157,0.47408,HP_METAPHYSEAL_CHONDRODYSPLASIA,0.987104912468739
GOMF_LIPASE_INHIBITOR_ACTIVI...,SET,14,0.016261,0.00044887,0.25024,0.47409,GOMF_LIPASE_INHIBITOR_ACTIVITY,0.987104912468739
ZNF488_TARGET_GENES,SET,25,0.011018,0.00040628,0.1696,0.4741,ZNF488_TARGET_GENES,0.987104912468739
GOBP_REGULATION_OF_AMINE_MET...,SET,27,0.011035,0.00042286,0.17024,0.47416,GOBP_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.987104912468739
HP_PNEUMOCYSTIS_JIROVECII_PN...,SET,3,0.029055,0.00037137,0.44848,0.47417,HP_PNEUMOCYSTIS_JIROVECII_PNEUMONIA,0.987104912468739
GOBP_ENDOTHELIAL_CELL_PROLIF...,SET,146,0.0048485,0.00043064,0.074882,0.47419,GOBP_ENDOTHELIAL_CELL_PROLIFERATION,0.987104912468739
HP_ABNORMAL_TEMPORAL_LOBE_MO...,SET,125,0.005073,0.00041716,0.078406,0.47421,HP_ABNORMAL_TEMPORAL_LOBE_MORPHOLOGY,0.987104912468739
TONKS_TARGETS_OF_RUNX1_RUNX1...10,SET,7,0.022875,0.00044658,0.35394,0.47423,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN,0.987104912468739
GOBP_REGULATION_OF_MYOBLAST_...1,SET,70,0.0067905,0.00041849,0.10509,0.47424,GOBP_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.987104912468739
HP_HYPERTONIC_DEHYDRATION,SET,4,0.031965,0.00047175,0.49546,0.47428,HP_HYPERTONIC_DEHYDRATION,0.987104912468739
MODULE_66,SET,500,0.002651,0.00043149,0.041161,0.47432,MODULE_66,0.987104912468739
HP_CAMPTODACTYLY_OF_TOE,SET,11,0.017328,0.00042401,0.26902,0.47432,HP_CAMPTODACTYLY_OF_TOE,0.987104912468739
ACAWYAAAG_UNKNOWN,SET,91,0.0061036,0.00042864,0.094794,0.47433,ACAWYAAAG_UNKNOWN,0.987104912468739
GOMF_PHOSPHATIDYLINOSITOL_3_...7,SET,26,0.01019,0.00038319,0.15831,0.47434,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING,0.987104912468739
GCM_CSNK2B,SET,85,0.005289,0.00035903,0.082651,0.47449,GCM_CSNK2B,0.987104912468739
HP_DELAYED_ABILITY_TO_CRAWL,SET,8,0.015752,0.00032873,0.24624,0.4745,HP_DELAYED_ABILITY_TO_CRAWL,0.987104912468739
MODULE_37,SET,427,0.0025679,0.00038703,0.040283,0.47459,MODULE_37,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...659,SET,10,0.016215,0.00037831,0.25441,0.47459,GOBP_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...307,SET,2,0.046511,0.00048541,0.73056,0.47462,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,0.987104912468739
OSMAN_BLADDER_CANCER_DN,SET,353,0.0027483,0.0003774,0.043219,0.47465,OSMAN_BLADDER_CANCER_DN,0.987104912468739
REACTOME_TRNA_PROCESSING_IN_...2,SET,53,0.0072211,0.00038741,0.11412,0.47477,REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,0.987104912468739
HP_ABNORMAL_FETAL_MORPHOLOGY,SET,265,0.0033077,0.00039451,0.052351,0.47481,HP_ABNORMAL_FETAL_MORPHOLOGY,0.987104912468739
ENGELMANN_CANCER_PROGENITORS...2,SET,46,0.0085853,0.00042919,0.13599,0.47483,ENGELMANN_CANCER_PROGENITORS_UP,0.987104912468739
SOBOLEV_PBMC_PANDEMRIX_AGE_1...5,SET,9,0.019117,0.00042316,0.30296,0.47484,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_UP,0.987104912468739
MANALO_HYPOXIA_UP,SET,184,0.0042681,0.00042513,0.067737,0.47488,MANALO_HYPOXIA_UP,0.987104912468739
GSE19198_1H_VS_6H_IL21_TREAT...2,SET,145,0.0046584,0.00041235,0.074015,0.47491,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP,0.987104912468739
KENNY_CTNNB1_TARGETS_UP,SET,47,0.0078683,0.00039759,0.12509,0.47492,KENNY_CTNNB1_TARGETS_UP,0.987104912468739
MODULE_484,SET,39,0.0083607,0.00038493,0.13316,0.47497,MODULE_484,0.987104912468739
GSE3982_MEMORY_CD4_TCELL_VS_...6,SET,172,0.004093,0.0003943,0.065223,0.47498,GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP,0.987104912468739
HE_LIM_SUN_FETAL_LUNG_C2_SPP...,SET,44,0.0083979,0.00041062,0.1338,0.47498,HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL,0.987104912468739
MODULE_113,SET,96,0.0056491,0.00040742,0.090366,0.47508,MODULE_113,0.987104912468739
KEGG_MEDICUS_REFERENCE_IGF2_...,SET,11,0.016641,0.0004072,0.26643,0.4751,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY,0.987104912468739
MIR6741_3P,SET,5,0.023624,0.0003898,0.38029,0.47523,MIR6741_3P,0.987104912468739
GAVISH_3CA_METAPROGRAM_ENDOT...12,SET,47,0.0082246,0.00041559,0.13268,0.47529,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON,0.987104912468739
MIR6790_5P,SET,46,0.0084913,0.0004245,0.1371,0.47531,MIR6790_5P,0.987104912468739
GOMF_GLYCEROPHOSPHOLIPID_FLI...,SET,12,0.016659,0.00042576,0.26898,0.47531,GOMF_GLYCEROPHOSPHOLIPID_FLIPPASE_ACTIVITY,0.987104912468739
GOMF_MYOSIN_LIGHT_CHAIN_BIND...,SET,8,0.017259,0.00036019,0.27891,0.47533,GOMF_MYOSIN_LIGHT_CHAIN_BINDING,0.987104912468739
GSE17974_0H_VS_2H_IN_VITRO_A...1,SET,177,0.0037817,0.00036951,0.061327,0.47542,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN,0.987104912468739
BIOCARTA_SM_PATHWAY,SET,13,0.013693,0.00036422,0.22244,0.47546,BIOCARTA_SM_PATHWAY,0.987104912468739
REACTOME_VEGFR2_MEDIATED_CEL...,SET,19,0.011538,0.00037097,0.18752,0.47547,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,0.987104912468739
GSE17721_CTRL_VS_PAM3CSK4_2H...1,SET,183,0.0040937,0.00040666,0.066591,0.47549,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN,0.987104912468739
GSE10325_LUPUS_CD4_TCELL_VS_...3,SET,183,0.0040762,0.00040492,0.066344,0.4755,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN,0.987104912468739
GOBP_RESOLUTION_OF_MEIOTIC_R...,SET,13,0.014049,0.00037371,0.22873,0.47551,GOBP_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES,0.987104912468739
REACTOME_PI_3K_CASCADE_FGFR1,SET,21,0.012016,0.00040616,0.19597,0.47555,REACTOME_PI_3K_CASCADE_FGFR1,0.987104912468739
CAGTATT_MIR200B_MIR200C_MIR4...,SET,422,0.002637,0.00039517,0.043034,0.47557,CAGTATT_MIR200B_MIR200C_MIR429,0.987104912468739
HP_NARROW_ILIAC_WING,SET,8,0.016681,0.00034812,0.27237,0.47558,HP_NARROW_ILIAC_WING,0.987104912468739
GOBP_GLYCEROL_3_PHOSPHATE_ME...,SET,7,0.022529,0.00043981,0.36861,0.47563,GOBP_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS,0.987104912468739
GSE20366_TREG_VS_NAIVE_CD4_T...3,SET,179,0.0040151,0.00039451,0.065756,0.47566,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN,0.987104912468739
MIR583,SET,156,0.0042531,0.00039038,0.069766,0.47569,MIR583,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...319,SET,509,0.0023253,0.00038176,0.038239,0.47576,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.987104912468739
GOCC_PROTON_TRANSPORTING_V_T...1,SET,24,0.010463,0.00037806,0.17209,0.47576,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX,0.987104912468739
PID_UPA_UPAR_PATHWAY,SET,42,0.0092044,0.00043973,0.15174,0.47582,PID_UPA_UPAR_PATHWAY,0.987104912468739
GSE14415_INDUCED_VS_NATURAL_...2,SET,130,0.0044887,0.00037637,0.07403,0.47583,GSE14415_INDUCED_VS_NATURAL_TREG_UP,0.987104912468739
HP_DYSTROPHIC_FINGERNAILS,SET,25,0.0099883,0.00036832,0.16499,0.47586,HP_DYSTROPHIC_FINGERNAILS,0.987104912468739
GSE46606_IRF4_KO_VS_WT_CD40L...2,SET,170,0.0041074,0.0003934,0.068021,0.47593,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP,0.987104912468739
GSE9988_LPS_VS_VEHICLE_TREAT...1,SET,184,0.0037212,0.00037065,0.061649,0.47593,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,0.987104912468739
GOCC_PML_BODY,SET,99,0.0050295,0.00036833,0.083362,0.47595,GOCC_PML_BODY,0.987104912468739
GOMF_SERINE_TYPE_EXOPEPTIDAS...,SET,12,0.014489,0.00037029,0.24053,0.47598,GOMF_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.987104912468739
MIR6750_5P,SET,63,0.0060031,0.00035105,0.099727,0.476,MIR6750_5P,0.987104912468739
GOBP_ANOIKIS,SET,31,0.0094857,0.00038944,0.1578,0.47603,GOBP_ANOIKIS,0.987104912468739
GOBP_ASTROCYTE_CELL_MIGRATION,SET,9,0.016868,0.00037338,0.2807,0.47604,GOBP_ASTROCYTE_CELL_MIGRATION,0.987104912468739
GSE11961_PLASMA_CELL_DAY7_VS...3,SET,177,0.0037868,0.00037002,0.063021,0.47604,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.987104912468739
BILANGES_SERUM_SENSITIVE_VIA...2,SET,24,0.010309,0.00037247,0.17203,0.47611,BILANGES_SERUM_SENSITIVE_VIA_TSC2,0.987104912468739
HP_ABNORMAL_CIRCULATING_LIPI...,SET,288,0.0030864,0.00038352,0.0515,0.47611,HP_ABNORMAL_CIRCULATING_LIPID_CONCENTRATION,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...845,SET,129,0.0048765,0.00040732,0.081431,0.47612,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.987104912468739
GSE27859_MACROPHAGE_VS_CD11C...4,SET,153,0.0041692,0.00037901,0.069599,0.47612,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP,0.987104912468739
GOBP_AUTOPHAGIC_CELL_DEATH,SET,9,0.017208,0.0003809,0.28764,0.47615,GOBP_AUTOPHAGIC_CELL_DEATH,0.987104912468739
CHUANG_OXIDATIVE_STRESS_RESP...1,SET,10,0.014036,0.00032749,0.23491,0.47618,CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,0.987104912468739
DEBIASI_APOPTOSIS_BY_REOVIRU...2,SET,272,0.0031719,0.0003832,0.053106,0.47619,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,0.987104912468739
GOMF_LNCRNA_BINDING,SET,17,0.011289,0.00034334,0.18911,0.4762,GOMF_LNCRNA_BINDING,0.987104912468739
DESCARTES_FETAL_KIDNEY_URETE...,SET,235,0.0036437,0.00040959,0.061068,0.47621,DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS,0.987104912468739
HP_ABNORMAL_CIRCULATING_INTE...2,SET,8,0.019649,0.00041006,0.32948,0.47622,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_10_CONCENTRATION,0.987104912468739
GOBP_STEM_CELL_DIVISION,SET,29,0.0096908,0.00038484,0.16275,0.47626,GOBP_STEM_CELL_DIVISION,0.987104912468739
BOSCO_INTERFERON_INDUCED_ANT...,SET,72,0.0059788,0.00037367,0.10049,0.47628,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,0.987104912468739
MIR1229_3P,SET,75,0.0055755,0.00035562,0.093824,0.47631,MIR1229_3P,0.987104912468739
GOBP_HYDROGEN_SULFIDE_METABO...,SET,4,0.022974,0.00033907,0.38669,0.47631,GOBP_HYDROGEN_SULFIDE_METABOLIC_PROCESS,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...672,SET,23,0.011397,0.00040313,0.19193,0.47632,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.987104912468739
PAF1_TARGET_GENES,SET,55,0.0071703,0.00039186,0.12093,0.47636,PAF1_TARGET_GENES,0.987104912468739
GOBP_EPIGENETIC_PROGRAMMING_...1,SET,12,0.01512,0.00038642,0.25516,0.47637,GOBP_EPIGENETIC_PROGRAMMING_IN_THE_ZYGOTIC_PRONUCLEI,0.987104912468739
GSE43955_1H_VS_10H_ACT_CD4_T...1,SET,185,0.0037129,0.00037082,0.062654,0.47637,GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN,0.987104912468739
WP_UROTENSINIIMEDIATED_SIGNA...,SET,66,0.0063673,0.00038108,0.10749,0.47638,WP_UROTENSINIIMEDIATED_SIGNALING,0.987104912468739
GOMF_TRANSMEMBRANE_RECEPTOR_...1,SET,80,0.0062633,0.00041254,0.10589,0.47642,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY,0.987104912468739
GOMF_MRNA_BINDING,SET,304,0.0027061,0.00034532,0.045792,0.47644,GOMF_MRNA_BINDING,0.987104912468739
GOBP_BLOOD_VESSEL_ENDOTHELIA...1,SET,11,0.016577,0.00040563,0.28065,0.47645,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.987104912468739
GOBP_REGULATION_OF_DELAYED_R...,SET,15,0.014291,0.00040831,0.24207,0.47646,GOBP_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.987104912468739
GSE44649_NAIVE_VS_ACTIVATED_...2,SET,175,0.0035285,0.00034284,0.059803,0.47648,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN,0.987104912468739
REACTOME_POLO_LIKE_KINASE_ME...,SET,16,0.011408,0.00033664,0.19372,0.47652,REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,0.987104912468739
GOBP_CADMIUM_ION_TRANSMEMBRA...,SET,6,0.021691,0.00039205,0.36839,0.47652,GOBP_CADMIUM_ION_TRANSMEMBRANE_TRANSPORT,0.987104912468739
MODULE_539,SET,15,0.013775,0.00039358,0.23402,0.47653,MODULE_539,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...546,SET,6,0.020056,0.00036251,0.34067,0.47653,GOBP_POSITIVE_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.987104912468739
PASQUALUCCI_LYMPHOMA_BY_GC_S...2,SET,262,0.0032178,0.00038164,0.054757,0.47657,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,0.987104912468739
HP_RIGHT_AORTIC_ARCH_WITH_MI...,SET,5,0.020251,0.00033415,0.34454,0.47657,HP_RIGHT_AORTIC_ARCH_WITH_MIRROR_IMAGE_BRANCHING,0.987104912468739
STK33_SKM_DN,SET,239,0.0033334,0.00037783,0.056741,0.47658,STK33_SKM_DN,0.987104912468739
HP_HEMIANOPIA,SET,37,0.0082616,0.0003705,0.14074,0.4766,HP_HEMIANOPIA,0.987104912468739
REACTOME_MATERNAL_TO_ZYGOTIC...,SET,58,0.0065294,0.0003664,0.11136,0.47662,REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,0.987104912468739
GOCC_NUCLEAR_REPLICATION_FORK,SET,39,0.0075662,0.00034835,0.12902,0.47662,GOCC_NUCLEAR_REPLICATION_FORK,0.987104912468739
HP_VISUAL_LOSS,SET,206,0.0035355,0.00037239,0.060309,0.47663,HP_VISUAL_LOSS,0.987104912468739
GOBP_NEGATIVE_REGULATION_OF_...228,SET,28,0.0091531,0.00035717,0.15624,0.47664,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.987104912468739
HOXA10_TARGET_GENES,SET,205,0.003366,0.00035368,0.057505,0.47666,HOXA10_TARGET_GENES,0.987104912468739
HSF_Q6,SET,183,0.0037226,0.0003698,0.063588,0.47666,HSF_Q6,0.987104912468739
GOBP_TYPE_II_PNEUMOCYTE_DIFF...,SET,6,0.019519,0.0003528,0.33391,0.47669,GOBP_TYPE_II_PNEUMOCYTE_DIFFERENTIATION,0.987104912468739
GSE17721_4H_VS_24H_POLYIC_BM...1,SET,179,0.0035402,0.00034785,0.060628,0.47672,GSE17721_4H_VS_24H_POLYIC_BMDC_DN,0.987104912468739
REACTOME_IRON_UPTAKE_AND_TRA...,SET,53,0.007055,0.0003785,0.12121,0.47679,REACTOME_IRON_UPTAKE_AND_TRANSPORT,0.987104912468739
MIR25_5P,SET,6,0.021936,0.00039648,0.37756,0.47683,MIR25_5P,0.987104912468739
HP_TRUE_HERMAPHRODITISM,SET,20,0.0097295,0.00032095,0.16746,0.47683,HP_TRUE_HERMAPHRODITISM,0.987104912468739
GSE42088_UNINF_VS_LEISHMANIA...3,SET,178,0.0038323,0.00037551,0.065962,0.47684,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN,0.987104912468739
GOBP_ICOSANOID_BIOSYNTHETIC_...,SET,50,0.007002,0.0003649,0.1208,0.47689,GOBP_ICOSANOID_BIOSYNTHETIC_PROCESS,0.987104912468739
GOBP_ANTIGEN_RECEPTOR_MEDIAT...,SET,171,0.0038708,0.00037182,0.066878,0.47692,GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.987104912468739
GOBP_POSITIVE_REGULATION_OF_...598,SET,11,0.015576,0.00038113,0.26902,0.47692,GOBP_POSITIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.987104912468739
HP_SYMPHALANGISM_OF_MIDDLE_P...1,SET,4,0.027766,0.00040978,0.48002,0.47694,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_5TH_FINGER,0.987104912468739
GOBP_BRANCHING_MORPHOGENESIS...1,SET,144,0.0043821,0.00038656,0.075857,0.47697,GOBP_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE,0.987104912468739
KEGG_MEDICUS_VARIANT_MUTATIO...86,SET,27,0.0095642,0.0003665,0.16568,0.47698,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.987104912468739
GOMF_NUCLEAR_VITAMIN_D_RECEP...,SET,13,0.01195,0.00031788,0.20808,0.4771,GOMF_NUCLEAR_VITAMIN_D_RECEPTOR_BINDING,0.987197597785319
BIOCARTA_NUCLEARRS_PATHWAY,SET,34,0.0086447,0.00037167,0.15061,0.47711,BIOCARTA_NUCLEARRS_PATHWAY,0.987197597785319
KEGG_CELL_CYCLE,SET,120,0.0043381,0.00034957,0.075579,0.47711,KEGG_CELL_CYCLE,0.987197597785319
GOBP_NEGATIVE_REGULATION_OF_...452,SET,7,0.018231,0.00035591,0.31851,0.47718,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.987224888386213
HP_MULTIPLE_MYELOMA,SET,7,0.020634,0.00040282,0.36051,0.47718,HP_MULTIPLE_MYELOMA,0.987224888386213
GOBP_FIBROBLAST_MIGRATION,SET,49,0.0070947,0.00036603,0.12425,0.47723,GOBP_FIBROBLAST_MIGRATION,0.987231486221058
GSE43863_DAY6_EFF_VS_DAY150_...2,SET,177,0.0037851,0.00036985,0.066318,0.47724,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP,0.987231486221058
MIR3925_5P,SET,141,0.0041746,0.00036443,0.073432,0.47733,MIR3925_5P,0.987320817711123
GOBP_FEMALE_GAMETE_GENERATION,SET,145,0.0040581,0.00035921,0.071409,0.47734,GOBP_FEMALE_GAMETE_GENERATION,0.987320817711123
AMIT_SERUM_RESPONSE_40_MCF10A,SET,29,0.010141,0.00040272,0.17887,0.47739,AMIT_SERUM_RESPONSE_40_MCF10A,0.9873480839036
WANG_ADIPOGENIC_GENES_REPRES...,SET,24,0.0099185,0.00035837,0.17504,0.47741,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,0.9873480839036
GOBP_POSITIVE_REGULATION_OF_...685,SET,9,0.01509,0.00033402,0.26724,0.47749,GOBP_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.987362087912088
REACTOME_PROTEIN_UBIQUITINAT...,SET,57,0.0061269,0.00034085,0.10876,0.47754,REACTOME_PROTEIN_UBIQUITINATION,0.987362087912088
BURTON_ADIPOGENESIS_4,SET,42,0.0072653,0.00034709,0.12903,0.47755,BURTON_ADIPOGENESIS_4,0.987362087912088
SHEN_SMARCA2_TARGETS_DN,SET,265,0.0031035,0.00037016,0.055157,0.47756,SHEN_SMARCA2_TARGETS_DN,0.987362087912088
TRAVAGLINI_LUNG_ALVEOLAR_FIB...,SET,149,0.0043006,0.00038585,0.076561,0.4776,TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL,0.987362087912088
MIR30C_1_3P,SET,119,0.0045103,0.00036193,0.081034,0.47781,MIR30C_1_3P,0.987362087912088
GAVISH_3CA_METAPROGRAM_ENDOT...3,SET,47,0.0078914,0.00039876,0.14182,0.47781,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1,0.987362087912088
HP_HYPOTELORISM,SET,114,0.0042189,0.0003314,0.075807,0.47781,HP_HYPOTELORISM,0.987362087912088
GOBP_PHOSPHATIDYLCHOLINE_MET...,SET,67,0.0058941,0.0003554,0.10603,0.47784,GOBP_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,0.987362087912088
GOCC_TRANSLOCON_COMPLEX,SET,5,0.020791,0.00034305,0.37498,0.47789,GOCC_TRANSLOCON_COMPLEX,0.987362087912088
RORA2_01,SET,134,0.0041826,0.00035601,0.075565,0.47793,RORA2_01,0.987362087912088
TGCTGCT_MIR15A_MIR16_MIR15B_...,SET,554,0.0020214,0.0003458,0.036544,0.47794,TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497,0.987362087912088
GOBP_CELLULAR_RESPONSE_TO_AN...2,SET,11,0.014956,0.00036597,0.27097,0.47799,GOBP_CELLULAR_RESPONSE_TO_ANTIBIOTIC,0.987362087912088
CHEOK_RESPONSE_TO_HD_MTX_DN,SET,19,0.0097233,0.00031263,0.17626,0.478,CHEOK_RESPONSE_TO_HD_MTX_DN,0.987362087912088
BENPORATH_SUZ12_TARGETS,SET,873,0.0018244,0.00038826,0.033181,0.47808,BENPORATH_SUZ12_TARGETS,0.987362087912088
REACTOME_RETROGRADE_TRANSPOR...,SET,46,0.0064455,0.00032222,0.11723,0.47808,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,0.987362087912088
REACTOME_REVERSIBLE_HYDRATIO...,SET,11,0.015111,0.00036975,0.27522,0.47811,REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,0.987362087912088
MIR6734_5P,SET,63,0.0057593,0.00033679,0.10497,0.47812,MIR6734_5P,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...821,SET,12,0.014488,0.00037026,0.26421,0.47814,GOBP_POSITIVE_REGULATION_OF_URINE_VOLUME,0.987362087912088
GOBP_INFLAMMATORY_CELL_APOPT...,SET,21,0.010058,0.00033996,0.18355,0.47815,GOBP_INFLAMMATORY_CELL_APOPTOTIC_PROCESS,0.987362087912088
GOBP_DEOXYRIBONUCLEOSIDE_DIP...,SET,5,0.020591,0.00033975,0.37633,0.47818,GOBP_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.987362087912088
GOBP_REGULATION_OF_CELL_MATR...,SET,115,0.0044847,0.00035382,0.082098,0.47822,GOBP_REGULATION_OF_CELL_MATRIX_ADHESION,0.987362087912088
HP_MALIGNANT_HYPERTHERMIA,SET,25,0.0093402,0.00034443,0.17119,0.47824,HP_MALIGNANT_HYPERTHERMIA,0.987362087912088
GSE27786_NKCELL_VS_MONO_MAC_...1,SET,177,0.0035401,0.00034591,0.064885,0.47825,GSE27786_NKCELL_VS_MONO_MAC_DN,0.987362087912088
CHOP_01,SET,207,0.0033484,0.00035353,0.06149,0.47829,CHOP_01,0.987362087912088
GSE17974_0H_VS_6H_IN_VITRO_A...1,SET,178,0.0032653,0.00031995,0.060035,0.47831,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN,0.987362087912088
MIR3185,SET,188,0.0034303,0.00034533,0.06321,0.47836,MIR3185,0.987362087912088
GOBP_PIGMENTATION,SET,104,0.0047144,0.00035381,0.086879,0.47836,GOBP_PIGMENTATION,0.987362087912088
GOBP_URINARY_TRACT_SMOOTH_MU...,SET,9,0.016564,0.00036664,0.30555,0.47838,GOBP_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION,0.987362087912088
HP_FOOD_INTOLERANCE,SET,9,0.013553,0.00029999,0.25016,0.4784,HP_FOOD_INTOLERANCE,0.987362087912088
GSE6269_HEALTHY_VS_STAPH_PNE...1,SET,151,0.0038009,0.00034328,0.07026,0.47843,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN,0.987362087912088
NIKOLSKY_BREAST_CANCER_14Q22...,SET,12,0.019945,0.00050974,0.36917,0.47846,NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,0.987362087912088
KEGG_MEDICUS_REFERENCE_RETRO...,SET,42,0.0068134,0.00032551,0.12614,0.47846,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT,0.987362087912088
NKX2_2_TARGET_GENES,SET,1061,0.0014221,0.00033184,0.0264,0.47852,NKX2_2_TARGET_GENES,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...178,SET,29,0.0078372,0.00031123,0.146,0.4786,GOBP_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION,0.987362087912088
GOBP_REGULATION_OF_SODIUM_IO...3,SET,76,0.0057218,0.00036737,0.10682,0.47864,GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT,0.987362087912088
HE_LIM_SUN_FETAL_LUNG_C1_PUL...1,SET,202,0.0034901,0.00036407,0.065374,0.47871,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL,0.987362087912088
GSE29949_MICROGLIA_BRAIN_VS_...6,SET,182,0.0034621,0.00034299,0.064866,0.47872,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.987362087912088
GOBP_REGULATION_OF_GERMINAL_...,SET,8,0.01763,0.00036794,0.33049,0.47873,GOBP_REGULATION_OF_GERMINAL_CENTER_FORMATION,0.987362087912088
GOBP_PHOSPHATIDYLGLYCEROL_BI...,SET,9,0.01668,0.00036921,0.31362,0.47879,GOBP_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...114,SET,452,0.0022508,0.00034878,0.042787,0.47902,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION,0.987362087912088
GOBP_CELL_SURFACE_RECEPTOR_S...1,SET,7,0.018749,0.00036603,0.35664,0.47904,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT,0.987362087912088
GAVISH_3CA_MALIGNANT_METAPRO...11,SET,46,0.0060597,0.00030294,0.11561,0.4791,GAVISH_3CA_MALIGNANT_METAPROGRAM_20_MYC,0.987362087912088
HP_PERICARDIAL_EFFUSION,SET,39,0.0072572,0.00033412,0.13858,0.47912,HP_PERICARDIAL_EFFUSION,0.987362087912088
HP_THICKENED_RIBS,SET,7,0.017435,0.00034037,0.33363,0.47916,HP_THICKENED_RIBS,0.987362087912088
GOBP_SNARE_COMPLEX_ASSEMBLY,SET,21,0.0091508,0.0003093,0.17514,0.47917,GOBP_SNARE_COMPLEX_ASSEMBLY,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...126,SET,428,0.0022612,0.0003412,0.043324,0.47919,GOBP_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT,0.987362087912088
GSE9988_ANTI_TREM1_VS_ANTI_T...2,SET,181,0.0031634,0.00031254,0.060614,0.47919,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.987362087912088
KEGG_MEDICUS_REFERENCE_LECTI...2,SET,8,0.017791,0.00037128,0.34185,0.47925,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN,0.987362087912088
GAVISH_3CA_MALIGNANT_METAPRO...12,SET,38,0.0063485,0.00028852,0.12204,0.47926,GAVISH_3CA_MALIGNANT_METAPROGRAM_21_RESPIRATION,0.987362087912088
KEGG_MEDICUS_REFERENCE_PLASM...,SET,8,0.016929,0.00035331,0.32642,0.47932,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA,0.987362087912088
TTTNNANAGCYR_UNKNOWN,SET,79,0.0051739,0.00033866,0.099936,0.47936,TTTNNANAGCYR_UNKNOWN,0.987362087912088
GOBP_EXTRACELLULAR_VESICLE_B...,SET,24,0.0086029,0.00031083,0.16638,0.47938,GOBP_EXTRACELLULAR_VESICLE_BIOGENESIS,0.987362087912088
GOMF_OXIDOREDUCTASE_ACTIVITY...19,SET,164,0.0035461,0.00033365,0.068606,0.47939,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN,0.987362087912088
HP_MESOMELIC_ARM_SHORTENING,SET,3,0.030395,0.0003885,0.58918,0.47943,HP_MESOMELIC_ARM_SHORTENING,0.987362087912088
HP_DECREASED_THALAMIC_VOLUME,SET,9,0.013874,0.0003071,0.26919,0.47945,HP_DECREASED_THALAMIC_VOLUME,0.987362087912088
GSE29949_CD8_NEG_DC_SPLEEN_V...3,SET,179,0.0033628,0.00033042,0.065264,0.47945,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN,0.987362087912088
GOBP_CATECHOLAMINE_SECRETION,SET,46,0.0070138,0.00035063,0.13637,0.47949,GOBP_CATECHOLAMINE_SECRETION,0.987362087912088
GOMF_MOLECULAR_FUNCTION_ACTI...,SET,1017,0.0014807,0.0003387,0.028785,0.47949,GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY,0.987362087912088
TRAYNOR_RETT_SYNDROM_UP,SET,36,0.008738,0.00038655,0.17013,0.47952,TRAYNOR_RETT_SYNDROM_UP,0.987362087912088
GSE46606_IRF4HIGH_VS_WT_CD40...3,SET,183,0.0031903,0.00031692,0.062126,0.47952,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.987362087912088
HEB_Q6,SET,239,0.0027973,0.00031707,0.054505,0.47954,HEB_Q6,0.987362087912088
GSE26488_CTRL_VS_PEPTIDE_INJ...3,SET,172,0.003495,0.00033669,0.068233,0.47957,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN,0.987362087912088
GOBP_CAVEOLIN_MEDIATED_ENDOC...,SET,11,0.013378,0.00032735,0.26163,0.47961,GOBP_CAVEOLIN_MEDIATED_ENDOCYTOSIS,0.987362087912088
GSE39152_CD103_NEG_VS_POS_ME...2,SET,185,0.003296,0.00032918,0.06452,0.47963,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP,0.987362087912088
GOCC_POSTSYNAPTIC_SPECIALIZA...3,SET,121,0.0042142,0.00034098,0.082551,0.47964,GOCC_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.987362087912088
HP_ABNORMAL_PERIOSTEUM_MORPH...,SET,8,0.017698,0.00036936,0.34703,0.47966,HP_ABNORMAL_PERIOSTEUM_MORPHOLOGY,0.987362087912088
AKL_HTLV1_INFECTION_DN,SET,61,0.0058604,0.00033724,0.1154,0.47975,AKL_HTLV1_INFECTION_DN,0.987362087912088
GOBP_SPERM_DNA_CONDENSATION,SET,14,0.011226,0.00030988,0.2212,0.47976,GOBP_SPERM_DNA_CONDENSATION,0.987362087912088
GOBP_MEDIUM_CHAIN_FATTY_ACID...1,SET,6,0.015861,0.00028667,0.31292,0.47979,GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.987362087912088
HP_PLACENTAL_ABRUPTION,SET,4,0.02542,0.00037516,0.50268,0.47983,HP_PLACENTAL_ABRUPTION,0.987362087912088
GOMF_SNAP_RECEPTOR_ACTIVITY,SET,35,0.0068648,0.00029944,0.13715,0.48004,GOMF_SNAP_RECEPTOR_ACTIVITY,0.987362087912088
GAUTAM_EYE_IRIS_CILIARY_BODY...9,SET,200,0.0029607,0.00030733,0.059207,0.48006,GAUTAM_EYE_IRIS_CILIARY_BODY_MELANOCYTES,0.987362087912088
RAAGNYNNCTTY_UNKNOWN,SET,135,0.0039776,0.00033982,0.079722,0.4801,RAAGNYNNCTTY_UNKNOWN,0.987362087912088
HP_TENTED_UPPER_LIP_VERMILION,SET,101,0.0041269,0.00030524,0.082968,0.48017,HP_TENTED_UPPER_LIP_VERMILION,0.987362087912088
FLECHNER_BIOPSY_KIDNEY_TRANS...1,SET,23,0.0081531,0.00028839,0.16466,0.48025,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,0.987362087912088
GSE10240_CTRL_VS_IL17_STIM_P...1,SET,181,0.0031075,0.00030702,0.062754,0.48025,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.987362087912088
MIR3918,SET,83,0.0044844,0.00030083,0.090624,0.48027,MIR3918,0.987362087912088
RUAN_RESPONSE_TO_TROGLITAZON...2,SET,24,0.0096725,0.00034948,0.19561,0.48028,RUAN_RESPONSE_TO_TROGLITAZONE_UP,0.987362087912088
MIR4723_5P,SET,194,0.0029637,0.00030304,0.060151,0.48035,MIR4723_5P,0.987362087912088
HP_FATIGABLE_WEAKNESS_OF_SKE...,SET,42,0.0061633,0.00029444,0.12505,0.48035,HP_FATIGABLE_WEAKNESS_OF_SKELETAL_MUSCLES,0.987362087912088
GOBP_KERATINOCYTE_DIFFERENTI...,SET,161,0.0038992,0.00036353,0.079278,0.48039,GOBP_KERATINOCYTE_DIFFERENTIATION,0.987362087912088
GOBP_DETECTION_OF_MECHANICAL...2,SET,33,0.007795,0.00033018,0.15879,0.48042,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.987362087912088
GSE27241_CTRL_VS_DIGOXIN_TRE...1,SET,176,0.003158,0.00030771,0.064333,0.48042,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.987362087912088
GSE6674_UNSTIM_VS_ANTI_IGM_A...2,SET,185,0.0030223,0.00030184,0.061569,0.48043,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.987362087912088
MATZUK_MEIOTIC_AND_DNA_REPAIR,SET,35,0.0060475,0.00026379,0.12327,0.48044,MATZUK_MEIOTIC_AND_DNA_REPAIR,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...64,SET,2,0.022657,0.00023646,0.46295,0.48048,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_REMODELING,0.987362087912088
GOBP_OSSIFICATION,SET,382,0.0022564,0.00032207,0.046146,0.4805,GOBP_OSSIFICATION,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...115,SET,10,0.016592,0.00038712,0.33977,0.48053,GOBP_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.987362087912088
MORF_NME2,SET,137,0.0033598,0.00028914,0.068843,0.48054,MORF_NME2,0.987362087912088
GOMF_HISTONE_H4_METHYLTRANSF...,SET,13,0.011536,0.00030687,0.23636,0.48054,GOMF_HISTONE_H4_METHYLTRANSFERASE_ACTIVITY,0.987362087912088
HP_CANDIDA_ESOPHAGITIS,SET,5,0.018632,0.00030743,0.38216,0.48056,HP_CANDIDA_ESOPHAGITIS,0.987362087912088
GSE5589_WT_VS_IL10_KO_LPS_ST...1,SET,134,0.0038362,0.00032654,0.078939,0.48062,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.987362087912088
GOBP_NATURAL_KILLER_CELL_MED...1,SET,9,0.014664,0.00032459,0.30266,0.48068,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.987362087912088
SANSOM_WNT_PATHWAY_REQUIRE_M...,SET,60,0.0059676,0.00034059,0.12401,0.48081,SANSOM_WNT_PATHWAY_REQUIRE_MYC,0.987362087912088
HP_RECURRENT_MENINGITIS,SET,3,0.026745,0.00034185,0.55728,0.48086,HP_RECURRENT_MENINGITIS,0.987362087912088
MATTIOLI_MULTIPLE_MYELOMA_SU...,SET,10,0.014333,0.00033441,0.29886,0.48087,MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,0.987362087912088
HP_GOWERS_SIGN,SET,68,0.0052202,0.0003171,0.10922,0.48094,HP_GOWERS_SIGN,0.987362087912088
GOBP_CELLULAR_RESPONSE_TO_GA...,SET,23,0.0080186,0.00028363,0.16798,0.48096,GOBP_CELLULAR_RESPONSE_TO_GAMMA_RADIATION,0.987362087912088
HP_DEMYELINATING_MOTOR_NEURO...,SET,5,0.019517,0.00032203,0.40986,0.48101,HP_DEMYELINATING_MOTOR_NEUROPATHY,0.987362087912088
PID_S1P_S1P1_PATHWAY,SET,21,0.0088214,0.00029817,0.18565,0.48105,PID_S1P_S1P1_PATHWAY,0.987362087912088
GOBP_SINOATRIAL_NODE_CELL_DI...,SET,6,0.018949,0.0003425,0.39884,0.48105,GOBP_SINOATRIAL_NODE_CELL_DIFFERENTIATION,0.987362087912088
GSE1460_CORD_VS_ADULT_BLOOD_...2,SET,165,0.0030967,0.00029225,0.065328,0.4811,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP,0.987362087912088
WP_SREBF_AND_MIR33_IN_CHOLES...,SET,16,0.0094968,0.00028023,0.20079,0.48114,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,0.987362087912088
GSE25088_CTRL_VS_IL4_STIM_MA...2,SET,171,0.0032538,0.00031255,0.068797,0.48114,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...406,SET,7,0.017797,0.00034744,0.37697,0.48117,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.987362087912088
CUI_DEVELOPING_HEART_TRABECU...2,SET,99,0.0040958,0.00029995,0.086728,0.48117,CUI_DEVELOPING_HEART_TRABECULAR_VENTRICULAR_CARDIOMYOCYTE,0.987362087912088
GOBP_CELLULAR_RESPONSE_TO_TO...2,SET,115,0.0038604,0.00030457,0.08183,0.48119,GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE,0.987362087912088
MIR7112_3P,SET,87,0.0043197,0.00029665,0.09163,0.4812,MIR7112_3P,0.987362087912088
HP_DYSMETRIC_SACCADES,SET,15,0.0098653,0.00028187,0.20931,0.4812,HP_DYSMETRIC_SACCADES,0.987362087912088
GSE37532_TREG_VS_TCONV_CD4_T...1,SET,173,0.0030369,0.00029341,0.06446,0.48121,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...648,SET,114,0.0038706,0.00030405,0.082298,0.48124,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.987362087912088
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,SET,55,0.005438,0.00029719,0.11567,0.48125,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,0.987362087912088
DESCARTES_MAIN_FETAL_DUCTAL_...,SET,50,0.0060812,0.00031692,0.12971,0.4813,DESCARTES_MAIN_FETAL_DUCTAL_CELLS,0.987362087912088
HP_ELEVATED_BRONCHOALVEOLAR_...,SET,6,0.019328,0.00034935,0.41252,0.48132,HP_ELEVATED_BRONCHOALVEOLAR_LAVAGE_FLUID_NEUTROPHIL_PROPORTION,0.987362087912088
GOBP_MEIOTIC_CHROMOSOME_COND...,SET,6,0.013636,0.00024647,0.29141,0.48134,GOBP_MEIOTIC_CHROMOSOME_CONDENSATION,0.987362087912088
GSE339_CD4POS_VS_CD4CD8DN_DC...1,SET,179,0.0030018,0.00029494,0.064146,0.48134,GSE339_CD4POS_VS_CD4CD8DN_DC_DN,0.987362087912088
GOBP_ENDODERM_DEVELOPMENT,SET,80,0.0047798,0.00031482,0.10232,0.48137,GOBP_ENDODERM_DEVELOPMENT,0.987362087912088
HP_CHILDHOOD_ONSET_SENSORINE...,SET,18,0.0098613,0.00030862,0.21113,0.48137,HP_CHILDHOOD_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,0.987362087912088
BRUECKNER_TARGETS_OF_MIRLET7...1,SET,72,0.0050683,0.00031676,0.10862,0.48139,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,0.987362087912088
GSE37301_HEMATOPOIETIC_STEM_...6,SET,149,0.0032675,0.00029316,0.070064,0.4814,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP,0.987362087912088
HP_LOBAR_HOLOPROSENCEPHALY,SET,23,0.0072115,0.00025508,0.15538,0.48149,HP_LOBAR_HOLOPROSENCEPHALY,0.987362087912088
ALK_DN.V1_UP,SET,122,0.0037929,0.00030816,0.081709,0.48149,ALK_DN.V1_UP,0.987362087912088
GSE7219_UNSTIM_VS_LPS_AND_AN...1,SET,162,0.0031359,0.00029326,0.067717,0.48153,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN,0.987362087912088
MIR4743_3P,SET,185,0.002943,0.00029393,0.063632,0.48156,MIR4743_3P,0.987362087912088
GOBP_MINERALOCORTICOID_METAB...,SET,14,0.012199,0.00033672,0.26394,0.48157,GOBP_MINERALOCORTICOID_METABOLIC_PROCESS,0.987362087912088
GSE23321_CENTRAL_MEMORY_VS_N...2,SET,182,0.0029134,0.00028863,0.063157,0.4816,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.987362087912088
CEBPB_02,SET,237,0.0026398,0.00029798,0.057239,0.48161,CEBPB_02,0.987362087912088
GOBP_REGULATION_OF_ENDODERMA...,SET,6,0.019783,0.00035756,0.42959,0.48164,GOBP_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION,0.987362087912088
GOBP_ARACHIDONIC_ACID_METABO...,SET,55,0.00562,0.00030713,0.12306,0.48179,GOBP_ARACHIDONIC_ACID_METABOLIC_PROCESS,0.987362087912088
HADDAD_T_LYMPHOCYTE_AND_NK_P...1,SET,59,0.0051996,0.00029428,0.1139,0.4818,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,0.987362087912088
MANNO_MIDBRAIN_NEUROTYPES_HN...2,SET,262,0.002523,0.00029923,0.055361,0.48183,MANNO_MIDBRAIN_NEUROTYPES_HNBM,0.987362087912088
MIR5189_3P,SET,51,0.005404,0.00028442,0.11873,0.48185,MIR5189_3P,0.987362087912088
MARTENS_TRETINOIN_RESPONSE_UP,SET,752,0.0015916,0.00031544,0.034994,0.48186,MARTENS_TRETINOIN_RESPONSE_UP,0.987362087912088
MIR320A_3P_MIR320B_MIR320C_M...,SET,276,0.002496,0.00030373,0.055371,0.48202,MIR320A_3P_MIR320B_MIR320C_MIR320D,0.987362087912088
GOBP_REGULATION_OF_ENTRY_OF_...,SET,7,0.013835,0.00027009,0.30681,0.48202,GOBP_REGULATION_OF_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.987362087912088
SMAD3_Q6,SET,213,0.0027203,0.0002913,0.060435,0.48205,SMAD3_Q6,0.987362087912088
GSE37416_CTRL_VS_24H_F_TULAR...1,SET,176,0.0027992,0.00027274,0.062224,0.48206,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.987362087912088
BIOCARTA_MELANOCYTE_PATHWAY,SET,7,0.01718,0.0003354,0.38224,0.48208,BIOCARTA_MELANOCYTE_PATHWAY,0.987362087912088
MIR4515,SET,38,0.0063624,0.00028915,0.14185,0.48211,MIR4515,0.987362087912088
GSE16385_ROSIGLITAZONE_IFNG_...2,SET,185,0.0027885,0.00027849,0.062355,0.48217,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.987362087912088
REACTOME_STING_MEDIATED_INDU...,SET,13,0.009113,0.00024241,0.20469,0.48224,REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,0.987362087912088
MIR6757_5P,SET,53,0.0050943,0.00027331,0.11468,0.48228,MIR6757_5P,0.987362087912088
REACTOME_MTORC1_MEDIATED_SIG...,SET,23,0.0077968,0.00027579,0.17559,0.48229,REACTOME_MTORC1_MEDIATED_SIGNALLING,0.987362087912088
MIR3670,SET,50,0.0052946,0.00027593,0.11932,0.4823,MIR3670,0.987362087912088
GOBP_L_SERINE_METABOLIC_PROC...,SET,11,0.010756,0.00026319,0.24278,0.48233,GOBP_L_SERINE_METABOLIC_PROCESS,0.987362087912088
GOCC_SYNAPTIC_CLEFT,SET,21,0.009105,0.00030775,0.20581,0.48236,GOCC_SYNAPTIC_CLEFT,0.987362087912088
GOMF_EXTRACELLULAR_MATRIX_ST...2,SET,19,0.0082089,0.00026394,0.18565,0.48237,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE,0.987362087912088
GSE32423_CTRL_VS_IL7_MEMORY_...1,SET,174,0.0029601,0.0002868,0.066954,0.48237,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN,0.987362087912088
WEINBERGER_BLOOD_TWINRIX_AGE...1,SET,32,0.0069499,0.00028989,0.1582,0.48248,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_ANTI_HBS_CONC_PRIMARY_VACC_1DY_SIGNIFICANT,0.987362087912088
GOBP_CELL_GROWTH,SET,427,0.0018765,0.00028283,0.04273,0.48249,GOBP_CELL_GROWTH,0.987362087912088
GOBP_OVARIAN_FOLLICLE_DEVELO...,SET,55,0.0053436,0.00029203,0.12179,0.4825,GOBP_OVARIAN_FOLLICLE_DEVELOPMENT,0.987362087912088
GOBP_PRIMARY_AMINO_COMPOUND_...2,SET,13,0.0097162,0.00025845,0.22138,0.4825,GOBP_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS,0.987362087912088
GOCC_ENDOPLASMIC_RETICULUM_T...1,SET,24,0.0070065,0.00025316,0.16003,0.48254,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK,0.987362087912088
HP_METABOLIC_ACIDOSIS,SET,149,0.0029082,0.00026092,0.066734,0.48262,HP_METABOLIC_ACIDOSIS,0.987362087912088
REACTOME_HDL_ASSEMBLY,SET,7,0.013234,0.00025837,0.30431,0.48266,REACTOME_HDL_ASSEMBLY,0.987362087912088
GSE360_L_MAJOR_VS_B_MALAYI_H...1,SET,180,0.0027461,0.00027057,0.063171,0.48266,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.987362087912088
GSE22140_HEALTHY_VS_ARTHRITI...4,SET,178,0.0027545,0.0002699,0.063569,0.48272,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP,0.987362087912088
REACTOME_DISEASES_OF_HEMOSTA...,SET,17,0.0096731,0.00029421,0.22336,0.48273,REACTOME_DISEASES_OF_HEMOSTASIS,0.987362087912088
GSE11961_GERMINAL_CENTER_BCE...6,SET,179,0.0027757,0.00027273,0.064304,0.48279,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.987362087912088
GOBP_REGULATION_OF_LYSOSOMAL...,SET,27,0.0066844,0.00025615,0.15507,0.48281,GOBP_REGULATION_OF_LYSOSOMAL_LUMEN_PH,0.987362087912088
GOBP_CGMP_BIOSYNTHETIC_PROCE...,SET,7,0.014763,0.00028821,0.34291,0.48283,GOBP_CGMP_BIOSYNTHETIC_PROCESS,0.987362087912088
GOBP_CHEMOKINE_C_X_C_MOTIF_L...1,SET,6,0.016624,0.00030047,0.38662,0.48285,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_12_SIGNALING_PATHWAY,0.987362087912088
GSE15624_CTRL_VS_6H_HALOFUGI...2,SET,123,0.0034129,0.00027841,0.079363,0.48285,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.987362087912088
WP_13Q1212_COPY_NUMBER_VARIA...,SET,31,0.0069632,0.00028588,0.16206,0.48286,WP_13Q1212_COPY_NUMBER_VARIATION,0.987362087912088
GHANDHI_BYSTANDER_IRRADIATIO...2,SET,71,0.0048141,0.00029879,0.11219,0.48289,GHANDHI_BYSTANDER_IRRADIATION_UP,0.987362087912088
GOMF_DOUBLE_STRANDED_TELOMER...,SET,9,0.011482,0.00025416,0.26775,0.4829,GOMF_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING,0.987362087912088
GSE15750_DAY6_VS_DAY10_EFF_C...1,SET,180,0.0026545,0.00026154,0.061894,0.4829,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN,0.987362087912088
GOBP_TELOMERIC_D_LOOP_DISASS...,SET,7,0.014127,0.00027579,0.33015,0.48293,GOBP_TELOMERIC_D_LOOP_DISASSEMBLY,0.987362087912088
GOBP_COCHLEA_DEVELOPMENT,SET,48,0.0057742,0.00029485,0.13496,0.48294,GOBP_COCHLEA_DEVELOPMENT,0.987362087912088
GSE15659_NAIVE_VS_PTPRC_NEG_...2,SET,156,0.0028589,0.0002624,0.066865,0.48295,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP,0.987362087912088
REACTOME_DEFECTIVE_FACTOR_VI...,SET,5,0.017374,0.00028667,0.40661,0.48296,REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A,0.987362087912088
GOBP_SYNAPTIC_VESICLE_LUMEN_...,SET,15,0.0091951,0.00026272,0.21583,0.48301,GOBP_SYNAPTIC_VESICLE_LUMEN_ACIDIFICATION,0.987362087912088
HP_ABNORMALITY_OF_THE_TARSAL...,SET,113,0.0035716,0.00027933,0.083927,0.48303,HP_ABNORMALITY_OF_THE_TARSAL_BONES,0.987362087912088
HP_PHOTOPHOBIA,SET,246,0.0023304,0.00026793,0.055053,0.48312,HP_PHOTOPHOBIA,0.987362087912088
HP_LUMBAR_KYPHOSIS,SET,6,0.014188,0.00025645,0.33632,0.48318,HP_LUMBAR_KYPHOSIS,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...70,SET,21,0.0079673,0.0002693,0.18898,0.48319,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.987362087912088
GSE33162_HDAC3_KO_VS_HDAC3_K...3,SET,176,0.0026967,0.00026277,0.064295,0.48327,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN,0.987362087912088
HP_VENTRICULAR_FIBRILLATION,SET,52,0.0051023,0.00027115,0.12167,0.48328,HP_VENTRICULAR_FIBRILLATION,0.987362087912088
GOBP_NEURAL_PLATE_PATTERN_SP...,SET,7,0.014068,0.00027464,0.33567,0.48329,GOBP_NEURAL_PLATE_PATTERN_SPECIFICATION,0.987362087912088
GOBP_REGULATION_OF_ERAD_PATH...,SET,22,0.0073565,0.0002545,0.17602,0.48333,GOBP_REGULATION_OF_ERAD_PATHWAY,0.987362087912088
GSE45881_CXCR6HI_VS_CXCR1LO_...1,SET,184,0.0026212,0.00026109,0.062799,0.48335,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN,0.987362087912088
HE_LIM_SUN_FETAL_LUNG_C0_MID...2,SET,168,0.0029676,0.00028257,0.071093,0.48335,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL,0.987362087912088
HP_ABSENT_EYEBROW,SET,31,0.0068575,0.00028154,0.16505,0.48343,HP_ABSENT_EYEBROW,0.987362087912088
MIR1468_5P,SET,14,0.008834,0.00024385,0.21299,0.48346,MIR1468_5P,0.987362087912088
GOBP_METANEPHRIC_GLOMERULAR_...,SET,5,0.019329,0.00031893,0.46692,0.48349,GOBP_METANEPHRIC_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.987362087912088
MIR3193,SET,7,0.012451,0.00024307,0.30116,0.48351,MIR3193,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...618,SET,15,0.0095257,0.00027216,0.23075,0.48354,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.987362087912088
LANDIS_ERBB2_BREAST_TUMORS_6...1,SET,36,0.0064291,0.00028441,0.15619,0.48358,LANDIS_ERBB2_BREAST_TUMORS_65_DN,0.987362087912088
GOBP_HEPARAN_SULFATE_PROTEOG...2,SET,11,0.011865,0.00029033,0.2881,0.48358,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...211,SET,68,0.0040549,0.00024632,0.098701,0.48362,GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...328,SET,34,0.005695,0.00024485,0.13886,0.48364,GOBP_NEGATIVE_REGULATION_OF_JNK_CASCADE,0.987362087912088
HP_ESODEVIATION,SET,200,0.0024236,0.00025157,0.059249,0.48369,HP_ESODEVIATION,0.987362087912088
ZHONG_PFC_C3_UNKNOWN_INP,SET,36,0.0056038,0.0002479,0.137,0.48369,ZHONG_PFC_C3_UNKNOWN_INP,0.987362087912088
MURARO_PANCREAS_ALPHA_CELL,SET,470,0.0016843,0.00026601,0.041216,0.4837,MURARO_PANCREAS_ALPHA_CELL,0.987362087912088
GOBP_BLASTOCYST_GROWTH,SET,21,0.0075357,0.00025471,0.18524,0.48378,GOBP_BLASTOCYST_GROWTH,0.987362087912088
ZWANG_EGF_PERSISTENTLY_DN,SET,56,0.0042758,0.00023578,0.1053,0.4838,ZWANG_EGF_PERSISTENTLY_DN,0.987362087912088
MIR27A_5P,SET,34,0.0063542,0.00027319,0.15718,0.48388,MIR27A_5P,0.987362087912088
KEGG_MEDICUS_REFERENCE_GPI_A...,SET,23,0.0065797,0.00023274,0.16287,0.48389,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS,0.987362087912088
HP_COMPLETE_DUPLICATION_OF_P...,SET,11,0.0099237,0.00024283,0.24632,0.48393,HP_COMPLETE_DUPLICATION_OF_PHALANX_OF_HAND,0.987362087912088
GOCC_PROXIMAL_DENDRITE,SET,6,0.01435,0.00025936,0.35676,0.48396,GOCC_PROXIMAL_DENDRITE,0.987362087912088
PID_HES_HEY_PATHWAY,SET,45,0.0051991,0.00025708,0.12938,0.48397,PID_HES_HEY_PATHWAY,0.987362087912088
GOBP_RECEPTOR_RECYCLING,SET,43,0.0051419,0.00024855,0.12852,0.48404,GOBP_RECEPTOR_RECYCLING,0.987362087912088
HP_ABNORMALITY_OF_CORNEAL_TH...,SET,115,0.0031941,0.000252,0.079864,0.48405,HP_ABNORMALITY_OF_CORNEAL_THICKNESS,0.987362087912088
BARRIER_COLON_CANCER_RECURRE...2,SET,37,0.0057535,0.00025802,0.14457,0.48413,BARRIER_COLON_CANCER_RECURRENCE_UP,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...638,SET,18,0.0074026,0.00023167,0.18639,0.48416,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.987362087912088
GOBP_RESPONSE_TO_IONIZING_RA...,SET,129,0.002857,0.00023863,0.071976,0.48417,GOBP_RESPONSE_TO_IONIZING_RADIATION,0.987362087912088
BIOCARTA_RAN_PATHWAY,SET,5,0.013207,0.00021792,0.33363,0.48421,BIOCARTA_RAN_PATHWAY,0.987362087912088
GOBP_SEQUESTERING_OF_ACTIN_M...,SET,6,0.014142,0.00025561,0.35722,0.48421,GOBP_SEQUESTERING_OF_ACTIN_MONOMERS,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...556,SET,20,0.007858,0.00025921,0.20014,0.48434,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.987362087912088
chr4q25,SET,28,0.011241,0.00043865,0.28673,0.48436,chr4q25,0.987362087912088
YAGUE_PRETUMOR_DRUG_RESISTAN...1,SET,12,0.0092321,0.00023595,0.23554,0.48437,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,0.987362087912088
HP_JOINT_DISLOCATION,SET,330,0.0018406,0.00024454,0.04716,0.48443,HP_JOINT_DISLOCATION,0.987362087912088
NRSF_01,SET,93,0.0036314,0.0002578,0.093126,0.48445,NRSF_01,0.987362087912088
CREB3_TARGET_GENES,SET,389,0.0016841,0.00024252,0.043259,0.48447,CREB3_TARGET_GENES,0.987362087912088
MIR6858_3P,SET,41,0.005459,0.00025768,0.14029,0.48448,MIR6858_3P,0.987362087912088
GOBP_REGULATION_OF_FILOPODIU...,SET,41,0.0057608,0.00027193,0.14815,0.48449,GOBP_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.987362087912088
GSE20500_CTRL_VS_RARA_ANTAGO...2,SET,182,0.0023999,0.00023776,0.06181,0.48451,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,0.987362087912088
WANG_PROSTATE_CANCER_ANDROGE...,SET,58,0.0045092,0.00025304,0.11626,0.48453,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,0.987362087912088
GOCC_SPERM_PLASMA_MEMBRANE,SET,14,0.0085768,0.00023675,0.22143,0.48455,GOCC_SPERM_PLASMA_MEMBRANE,0.987362087912088
YAGI_AML_FAB_MARKERS,SET,179,0.0025252,0.00024811,0.065302,0.48458,YAGI_AML_FAB_MARKERS,0.987362087912088
WP_ERBB_SIGNALING,SET,86,0.003613,0.0002467,0.093667,0.48462,WP_ERBB_SIGNALING,0.987362087912088
TBK1.DF_UP,SET,261,0.0020785,0.00024606,0.053908,0.48462,TBK1.DF_UP,0.987362087912088
GOBP_THYROID_HORMONE_GENERAT...,SET,22,0.0072467,0.0002507,0.18803,0.48463,GOBP_THYROID_HORMONE_GENERATION,0.987362087912088
GOBP_REGULATION_OF_OSSIFICAT...,SET,111,0.0033281,0.00025799,0.086482,0.48465,GOBP_REGULATION_OF_OSSIFICATION,0.987362087912088
WP_ZINC_HOMEOSTASIS,SET,36,0.0052415,0.00023187,0.13629,0.48466,WP_ZINC_HOMEOSTASIS,0.987362087912088
HP_INCREASED_LEVEL_OF_L_FUCO...,SET,16,0.0081962,0.00024185,0.21328,0.48467,HP_INCREASED_LEVEL_OF_L_FUCOSE_IN_URINE,0.987362087912088
HP_TACHYCARDIA,SET,134,0.0029203,0.00024857,0.076004,0.48468,HP_TACHYCARDIA,0.987362087912088
GSE17721_CTRL_VS_POLYIC_6H_B...1,SET,189,0.002446,0.00024689,0.063696,0.48468,GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN,0.987362087912088
HP_SHORT_UPPER_LIP,SET,9,0.010844,0.00024004,0.28255,0.48469,HP_SHORT_UPPER_LIP,0.987362087912088
GOCC_MHC_CLASS_I_PEPTIDE_LOA...,SET,8,0.01091,0.00022769,0.28436,0.4847,GOCC_MHC_CLASS_I_PEPTIDE_LOADING_COMPLEX,0.987362087912088
KEGG_MEDICUS_REFERENCE_IL2_F...,SET,20,0.008301,0.00027382,0.21675,0.48473,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.987362087912088
HP_ABNORMAL_QT_INTERVAL,SET,55,0.0046256,0.00025279,0.12095,0.48475,HP_ABNORMAL_QT_INTERVAL,0.987362087912088
BLANCO_MELO_HUMAN_PARAINFLUE...2,SET,188,0.0025869,0.00026043,0.067682,0.48476,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,0.987362087912088
MIR526B_3P,SET,565,0.0014167,0.00024467,0.0371,0.48477,MIR526B_3P,0.987362087912088
GSE27786_LIN_NEG_VS_CD4_TCEL...1,SET,181,0.0023762,0.00023476,0.062246,0.48477,GSE27786_LIN_NEG_VS_CD4_TCELL_DN,0.987362087912088
GAUTAM_EYE_IRIS_CILIARY_BODY...17,SET,104,0.003341,0.00025074,0.0879,0.48484,GAUTAM_EYE_IRIS_CILIARY_BODY_WIF1_HIGH_FIBROBLASTS,0.987362087912088
HP_EXTERNAL_OPHTHALMOPLEGIA,SET,51,0.0044748,0.00023551,0.11801,0.48488,HP_EXTERNAL_OPHTHALMOPLEGIA,0.987362087912088
REACTOME_VLDLR_INTERNALISATI...,SET,15,0.0079013,0.00022575,0.20875,0.4849,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,0.987362087912088
GOBP_BONE_MINERALIZATION_INV...,SET,11,0.010293,0.00025188,0.27179,0.4849,GOBP_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.987362087912088
MIR6131,SET,89,0.0034141,0.00023713,0.090407,0.48494,MIR6131,0.987362087912088
HP_THORACIC_AORTA_CALCIFICAT...,SET,5,0.015967,0.00026346,0.42329,0.48496,HP_THORACIC_AORTA_CALCIFICATION,0.987362087912088
GSE17974_CTRL_VS_ACT_IL4_AND...17,SET,169,0.0024047,0.00022965,0.063799,0.48497,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN,0.987362087912088
GSE9006_HEALTHY_VS_TYPE_1_DI...1,SET,170,0.0023776,0.00022773,0.063449,0.48505,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN,0.987362087912088
HP_ENLARGED_METAPHYSES,SET,5,0.013947,0.00023014,0.37233,0.48506,HP_ENLARGED_METAPHYSES,0.987362087912088
HP_ABNORMAL_DERMOEPIDERMAL_J...,SET,12,0.010031,0.00025635,0.26796,0.48507,HP_ABNORMAL_DERMOEPIDERMAL_JUNCTION_MORPHOLOGY,0.987362087912088
PURBEY_TARGETS_OF_CTBP1_AND_...1,SET,150,0.0025849,0.00023268,0.069393,0.48514,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...350,SET,666,0.0012807,0.00023946,0.034401,0.48515,GOBP_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE,0.987362087912088
GOBP_PROSTANOID_BIOSYNTHETIC...,SET,27,0.0061521,0.00023575,0.16523,0.48515,GOBP_PROSTANOID_BIOSYNTHETIC_PROCESS,0.987362087912088
NABA_ECM_REGULATORS,SET,229,0.0023447,0.00026023,0.06309,0.48518,NABA_ECM_REGULATORS,0.987362087912088
GOMF_DELTA_CATENIN_BINDING,SET,9,0.011471,0.00025391,0.3108,0.48528,GOMF_DELTA_CATENIN_BINDING,0.987362087912088
GSE1460_DP_VS_CD4_THYMOCYTE_...2,SET,176,0.0023659,0.00023053,0.064225,0.48531,GSE1460_DP_VS_CD4_THYMOCYTE_UP,0.987362087912088
MIR6857_5P,SET,72,0.0035963,0.00022477,0.097917,0.48535,MIR6857_5P,0.987362087912088
GOCC_MITOCHONDRIAL_SMALL_RIB...,SET,31,0.0050775,0.00020846,0.13831,0.48536,GOCC_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT,0.987362087912088
GOBP_REGULATION_OF_LYMPHOCYT...2,SET,55,0.004286,0.00023423,0.11715,0.48541,GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.987362087912088
GOBP_NEURAL_CREST_CELL_MIGRA...,SET,6,0.013634,0.00024643,0.37405,0.48546,GOBP_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,0.987362087912088
GSE3982_MAC_VS_NEUTROPHIL_LP...2,SET,173,0.0022862,0.00022087,0.06279,0.48548,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP,0.987362087912088
HP_ECTOPIA_LENTIS,SET,39,0.0054537,0.00025109,0.14987,0.48549,HP_ECTOPIA_LENTIS,0.987362087912088
HP_ATYPICAL_NEVI_IN_NON_SUN_...,SET,5,0.012983,0.00021423,0.35829,0.48555,HP_ATYPICAL_NEVI_IN_NON_SUN_EXPOSED_AREAS,0.987362087912088
GSE13484_UNSTIM_VS_12H_YF17D...1,SET,177,0.0022691,0.00022171,0.062695,0.48556,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN,0.987362087912088
HP_FIRST_DEGREE_ATRIOVENTRIC...,SET,42,0.0050448,0.00024101,0.13947,0.48557,HP_FIRST_DEGREE_ATRIOVENTRICULAR_BLOCK,0.987362087912088
TRAVAGLINI_LUNG_CLUB_CELL,SET,102,0.0032668,0.00024282,0.090279,0.48557,TRAVAGLINI_LUNG_CLUB_CELL,0.987362087912088
SU_KIDNEY,SET,12,0.0095243,0.00024341,0.26352,0.48558,SU_KIDNEY,0.987362087912088
GOBP_REGULATION_OF_AMYLOID_F...,SET,14,0.0076586,0.0002114,0.21193,0.48559,GOBP_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.987362087912088
MIR6133,SET,169,0.0023626,0.00022563,0.065455,0.4856,MIR6133,0.987362087912088
TAVOR_CEBPA_TARGETS_DN,SET,29,0.0058134,0.00023086,0.16192,0.48568,TAVOR_CEBPA_TARGETS_DN,0.987362087912088
HP_ABNORMALITY_OF_THE_MALE_G...,SET,1026,0.00097737,0.0002245,0.027216,0.48568,HP_ABNORMALITY_OF_THE_MALE_GENITALIA,0.987362087912088
GOMF_GLYCOSYLTRANSFERASE_ACT...,SET,254,0.0020309,0.00023721,0.056591,0.48569,GOMF_GLYCOSYLTRANSFERASE_ACTIVITY,0.987362087912088
BIOCARTA_PRC2_PATHWAY,SET,11,0.010012,0.00024499,0.27924,0.4857,BIOCARTA_PRC2_PATHWAY,0.987362087912088
MODULE_505,SET,16,0.0080627,0.00023791,0.22482,0.4857,MODULE_505,0.987362087912088
GOBP_MAST_CELL_ACTIVATION_IN...,SET,52,0.0043824,0.0002329,0.12226,0.4857,GOBP_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.987362087912088
GATA_C,SET,237,0.0020679,0.00023342,0.057727,0.48571,GATA_C,0.987362087912088
DESCARTES_FETAL_LUNG_MEGAKAR...,SET,133,0.0027588,0.00023396,0.077197,0.48575,DESCARTES_FETAL_LUNG_MEGAKARYOCYTES,0.987362087912088
GSE37416_0H_VS_12H_F_TULAREN...2,SET,168,0.0023747,0.00022612,0.066721,0.4858,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.987362087912088
HP_ABNORMAL_TESTIS_MORPHOLOGY,SET,832,0.0010648,0.00022148,0.029975,0.48583,HP_ABNORMAL_TESTIS_MORPHOLOGY,0.987362087912088
GSE15271_CXCR4_POS_VS_NEG_GC...1,SET,164,0.0024018,0.00022598,0.067626,0.48583,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN,0.987362087912088
WP_APOPTOSIS_MODULATION_AND_...,SET,84,0.0033811,0.00022818,0.095537,0.48588,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.987362087912088
GOBP_DERMATAN_SULFATE_METABO...,SET,8,0.011042,0.00023044,0.31274,0.48592,GOBP_DERMATAN_SULFATE_METABOLIC_PROCESS,0.987362087912088
GSE17721_CTRL_VS_PAM3CSK4_6H...1,SET,181,0.0021838,0.00021576,0.062373,0.48604,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN,0.987362087912088
GSE5589_LPS_VS_LPS_AND_IL10_...7,SET,185,0.0022063,0.00022035,0.063319,0.4861,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.987362087912088
GOBP_REGULATION_OF_COLLAGEN_...2,SET,32,0.0057202,0.0002386,0.16519,0.48619,GOBP_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.987362087912088
HP_VENTRICULAR_SEPTAL_HYPERT...,SET,12,0.0078773,0.00020132,0.22751,0.48619,HP_VENTRICULAR_SEPTAL_HYPERTROPHY,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...522,SET,4,0.014221,0.00020989,0.41134,0.48621,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.987362087912088
GOMF_SODIUM_CHANNEL_ACTIVITY,SET,47,0.0046216,0.00023353,0.134,0.48624,GOMF_SODIUM_CHANNEL_ACTIVITY,0.987362087912088
MIR6879_3P,SET,41,0.0045935,0.00021683,0.13327,0.48625,MIR6879_3P,0.987362087912088
HP_ORTHOPNEA,SET,68,0.0036821,0.00022367,0.10686,0.48626,HP_ORTHOPNEA,0.987362087912088
GOBP_SOMATIC_DIVERSIFICATION...1,SET,66,0.0033868,0.0002027,0.098559,0.48629,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...440,SET,68,0.0039252,0.00023843,0.11438,0.48631,GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION,0.987362087912088
HP_HYPERLORDOSIS,SET,184,0.00217,0.00021615,0.063414,0.48635,HP_HYPERLORDOSIS,0.987362087912088
PID_TGFBR_PATHWAY,SET,52,0.0041947,0.00022292,0.12296,0.48639,PID_TGFBR_PATHWAY,0.987362087912088
GOBP_SA_NODE_CELL_TO_ATRIAL_...1,SET,11,0.0096323,0.0002357,0.28254,0.4864,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.987362087912088
MIR4778_5P,SET,161,0.0022754,0.00021214,0.066859,0.48643,MIR4778_5P,0.987362087912088
GOBP_NEUTROPHIL_APOPTOTIC_PR...,SET,7,0.013025,0.00025427,0.38276,0.48643,GOBP_NEUTROPHIL_APOPTOTIC_PROCESS,0.987362087912088
GSE41867_DAY15_EFFECTOR_VS_D...4,SET,177,0.0022111,0.00021605,0.065056,0.48644,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.987362087912088
GOCC_TIM22_MITOCHONDRIAL_IMP...,SET,6,0.011947,0.00021593,0.3532,0.48651,GOCC_TIM22_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_INSERTION_COMPLEX,0.987362087912088
GOBP_PEPTIDYL_PROLINE_HYDROX...2,SET,8,0.0076007,0.00015862,0.22629,0.4866,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE,0.987362087912088
GOMF_PEPTIDYL_PROLINE_4_DIOX...,SET,8,0.0076007,0.00015862,0.22629,0.4866,GOMF_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY,0.987362087912088
FAN_EMBRYONIC_CTX_BRAIN_ENDO...1,SET,402,0.0015501,0.00022684,0.046292,0.48664,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1,0.987362087912088
HP_HYPODONTIA,SET,206,0.0019636,0.00020683,0.058676,0.48665,HP_HYPODONTIA,0.987362087912088
TRAVAGLINI_LUNG_VEIN_CELL,SET,37,0.0050767,0.00022767,0.15168,0.48665,TRAVAGLINI_LUNG_VEIN_CELL,0.987362087912088
GSE14308_TH2_VS_INDUCED_TREG...2,SET,181,0.0021561,0.00021302,0.064503,0.48667,GSE14308_TH2_VS_INDUCED_TREG_UP,0.987362087912088
GSE33292_DN3_THYMOCYTE_VS_TC...3,SET,137,0.002547,0.00021919,0.07628,0.48668,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN,0.987362087912088
HP_LOW_HANGING_COLUMELLA,SET,43,0.0042016,0.0002031,0.12596,0.4867,HP_LOW_HANGING_COLUMELLA,0.987362087912088
GOBP_LATERAL_MESODERM_DEVELO...,SET,18,0.0073772,0.00023088,0.22216,0.48676,GOBP_LATERAL_MESODERM_DEVELOPMENT,0.987362087912088
THUM_MIR21_TARGETS_HEART_DIS...1,SET,7,0.014108,0.00027541,0.42596,0.48679,THUM_MIR21_TARGETS_HEART_DISEASE_DN,0.987362087912088
MIR221_5P,SET,74,0.0033258,0.00021072,0.10039,0.48679,MIR221_5P,0.987362087912088
MIR5094,SET,85,0.0031877,0.0002164,0.096247,0.48679,MIR5094,0.987362087912088
GSE25088_WT_VS_STAT6_KO_MACR...2,SET,178,0.0020454,0.00020042,0.061738,0.48679,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...526,SET,11,0.0098626,0.00024134,0.30007,0.48689,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.987362087912088
GSE20366_EX_VIVO_VS_HOMEOSTA...1,SET,182,0.0020965,0.0002077,0.063763,0.48689,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN,0.987362087912088
CDC5L_TARGET_GENES,SET,225,0.0018656,0.00020526,0.056902,0.48692,CDC5L_TARGET_GENES,0.987362087912088
AMIT_SERUM_RESPONSE_240_MCF1...,SET,53,0.0041877,0.00022467,0.12782,0.48693,AMIT_SERUM_RESPONSE_240_MCF10A,0.987362087912088
GOBP_RESPONSE_TO_STEROL_DEPL...,SET,15,0.0073409,0.00020974,0.2242,0.48694,GOBP_RESPONSE_TO_STEROL_DEPLETION,0.987362087912088
GSE40666_WT_VS_STAT4_KO_CD8_...4,SET,174,0.0021165,0.00020507,0.06471,0.48695,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.987362087912088
HP_HIGH_PITCHED_VOICE,SET,41,0.0045555,0.00021504,0.1394,0.48696,HP_HIGH_PITCHED_VOICE,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...330,SET,8,0.011374,0.00023737,0.34824,0.48697,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.987362087912088
HP_PROFOUND_GLOBAL_DEVELOPME...,SET,59,0.0035514,0.000201,0.10932,0.48704,HP_PROFOUND_GLOBAL_DEVELOPMENTAL_DELAY,0.987362087912088
GOBP_REGULATION_OF_STEROID_H...1,SET,15,0.0079571,0.00022735,0.24594,0.48709,GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.987362087912088
GOBP_UDP_N_ACETYLGLUCOSAMINE...2,SET,14,0.0075214,0.00020762,0.23238,0.48709,GOBP_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.987362087912088
HP_IMPAIRED_PAIN_SENSATION,SET,65,0.0034364,0.00020411,0.10617,0.48709,HP_IMPAIRED_PAIN_SENSATION,0.987362087912088
REACTOME_VITAMIN_B1_THIAMIN_...,SET,5,0.011903,0.00019641,0.36868,0.48712,REACTOME_VITAMIN_B1_THIAMIN_METABOLISM,0.987362087912088
MIR6759_5P,SET,56,0.0039417,0.00021736,0.12207,0.48712,MIR6759_5P,0.987362087912088
GOBP_THIAMINE_CONTAINING_COM...,SET,5,0.011903,0.00019641,0.36868,0.48712,GOBP_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.987362087912088
GOBP_THIAMINE_DIPHOSPHATE_ME...,SET,5,0.011903,0.00019641,0.36868,0.48712,GOBP_THIAMINE_DIPHOSPHATE_METABOLIC_PROCESS,0.987362087912088
BIOCARTA_TUBBY_PATHWAY,SET,4,0.015945,0.00023532,0.49539,0.48716,BIOCARTA_TUBBY_PATHWAY,0.987362087912088
GOMF_GLUTATHIONE_PEROXIDASE_...,SET,21,0.0063916,0.00021604,0.19864,0.48717,GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY,0.987362087912088
REACTOME_NEURONAL_SYSTEM,SET,384,0.0015136,0.0002166,0.047198,0.48721,REACTOME_NEURONAL_SYSTEM,0.987362087912088
GOBP_AROMATIC_AMINO_ACID_MET...,SET,29,0.0054913,0.00021807,0.1714,0.48722,GOBP_AROMATIC_AMINO_ACID_METABOLIC_PROCESS,0.987362087912088
GCM_MSN,SET,23,0.0055251,0.00019543,0.17309,0.48727,GCM_MSN,0.987362087912088
REACTOME_FORMATION_OF_TUBULI...,SET,24,0.0052848,0.00019095,0.16603,0.4873,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,0.987362087912088
HP_LATERAL_CLAVICLE_HOOK,SET,11,0.0078852,0.00019295,0.24798,0.48732,HP_LATERAL_CLAVICLE_HOOK,0.987362087912088
HAY_BONE_MARROW_PLATELET,SET,217,0.0018483,0.00019975,0.05826,0.48735,HAY_BONE_MARROW_PLATELET,0.987362087912088
MIR6831_5P,SET,106,0.0026314,0.00019936,0.083261,0.48739,MIR6831_5P,0.987362087912088
GSE19941_UNSTIM_VS_LPS_STIM_...1,SET,177,0.0020356,0.0001989,0.06438,0.48739,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN,0.987362087912088
GOBP_CARBOHYDRATE_DERIVATIVE...2,SET,249,0.0017507,0.00020249,0.05547,0.48741,GOBP_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS,0.987362087912088
HP_PANCREATIC_PSEUDOCYST,SET,4,0.014948,0.00022061,0.47584,0.48747,HP_PANCREATIC_PSEUDOCYST,0.987362087912088
IRF1_Q6,SET,247,0.0017363,0.00020003,0.055325,0.48748,IRF1_Q6,0.987362087912088
REACTOME_GAP_JUNCTION_DEGRAD...,SET,12,0.0079334,0.00020276,0.25342,0.48751,REACTOME_GAP_JUNCTION_DEGRADATION,0.987362087912088
GOBP_T_CELL_DIFFERENTIATION,SET,294,0.0016194,0.00020328,0.051727,0.48751,GOBP_T_CELL_DIFFERENTIATION,0.987362087912088
GOCC_MICROVILLUS,SET,94,0.0027513,0.00019636,0.087972,0.48753,GOCC_MICROVILLUS,0.987362087912088
HP_CALCIFIC_STIPPLING,SET,3,0.018812,0.00024045,0.6021,0.48754,HP_CALCIFIC_STIPPLING,0.987362087912088
HP_CUTANEOUS_ANERGY,SET,6,0.011665,0.00021084,0.37343,0.48754,HP_CUTANEOUS_ANERGY,0.987362087912088
GOBP_MESANGIAL_CELL_DEVELOPM...,SET,5,0.012831,0.00021171,0.41096,0.48755,GOBP_MESANGIAL_CELL_DEVELOPMENT,0.987362087912088
GOBP_NEGATIVE_REGULATION_OF_...528,SET,32,0.0044633,0.00018617,0.14344,0.48759,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.987362087912088
REACTOME_RAB_GEFS_EXCHANGE_G...,SET,82,0.0028161,0.00018778,0.090673,0.48761,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,0.987362087912088
GSE13229_IMM_VS_INTMATURE_NK...1,SET,177,0.001906,0.00018624,0.061457,0.48763,GSE13229_IMM_VS_INTMATURE_NKCELL_DN,0.987362087912088
GSE22886_NAIVE_VS_MEMORY_TCE...1,SET,183,0.0019645,0.00019515,0.063634,0.48769,GSE22886_NAIVE_VS_MEMORY_TCELL_DN,0.987362087912088
GOBP_NEGATIVE_REGULATION_BY_...2,SET,13,0.0080411,0.00021389,0.26117,0.48772,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.987362087912088
HP_ABNORMALITY_OF_THE_VASCUL...,SET,336,0.0014396,0.00019296,0.04679,0.48773,HP_ABNORMALITY_OF_THE_VASCULATURE_OF_THE_EYE,0.987362087912088
HIRSCH_CELLULAR_TRANSFORMATI...2,SET,227,0.0017707,0.00019567,0.057717,0.48776,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,0.987362087912088
KEGG_CHEMOKINE_SIGNALING_PAT...,SET,176,0.002101,0.00020472,0.068454,0.48776,KEGG_CHEMOKINE_SIGNALING_PATHWAY,0.987362087912088
KEGG_MEDICUS_REFERENCE_CRHR_...,SET,27,0.0052283,0.00020035,0.17034,0.48776,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.987362087912088
GOBP_STEM_CELL_DIFFERENTIATI...,SET,229,0.0017959,0.00019931,0.058556,0.48777,GOBP_STEM_CELL_DIFFERENTIATION,0.987362087912088
KEGG_MEDICUS_REFERENCE_BETA_...1,SET,11,0.0077165,0.00018882,0.25182,0.48778,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION,0.987362087912088
GSE369_SOCS3_KO_VS_WT_LIVER_...1,SET,184,0.0018723,0.00018649,0.061162,0.48779,GSE369_SOCS3_KO_VS_WT_LIVER_DN,0.987362087912088
KALMA_E2F1_TARGETS,SET,11,0.0075785,0.00018544,0.24801,0.48781,KALMA_E2F1_TARGETS,0.987362087912088
GOMF_1_PHOSPHATIDYLINOSITOL_...2,SET,15,0.007436,0.00021246,0.24375,0.48783,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.987362087912088
WP_FATTY_ACID_BIOSYNTHESIS,SET,21,0.0054646,0.00018471,0.17924,0.48784,WP_FATTY_ACID_BIOSYNTHESIS,0.987362087912088
BOYAULT_LIVER_CANCER_SUBCLAS...9,SET,46,0.0035296,0.00017645,0.11597,0.48786,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,0.987362087912088
HP_FOCAL_HEAD_NODDING_AUTOMA...,SET,5,0.011239,0.00018544,0.36979,0.48788,HP_FOCAL_HEAD_NODDING_AUTOMATISM_SEIZURE,0.987362087912088
GSE35825_UNTREATED_VS_IFNA_S...2,SET,161,0.001981,0.00018469,0.065188,0.48788,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP,0.987362087912088
GOBP_VACUOLAR_LOCALIZATION,SET,75,0.0030451,0.00019423,0.1003,0.48789,GOBP_VACUOLAR_LOCALIZATION,0.987362087912088
TURJANSKI_MAPK11_TARGETS,SET,4,0.013792,0.00020356,0.45613,0.48794,TURJANSKI_MAPK11_TARGETS,0.987362087912088
GSE3203_HEALTHY_VS_INFLUENZA...2,SET,177,0.0019614,0.00019165,0.064858,0.48794,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP,0.987362087912088
GSE40277_EOS_AND_LEF1_TRANSD...4,SET,179,0.0019338,0.00019001,0.064392,0.48802,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP,0.987362087912088
WP_METABOLIC_REPROGRAMMING_I...1,SET,39,0.0038544,0.00017746,0.12846,0.48803,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...799,SET,14,0.0071526,0.00019744,0.2386,0.48804,GOBP_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.987362087912088
WP_GLUTATHIONE_METABOLISM,SET,16,0.0064057,0.00018902,0.21442,0.48808,WP_GLUTATHIONE_METABOLISM,0.987362087912088
NABA_MATRISOME_POORLY_METAST...3,SET,35,0.0043262,0.00018871,0.14486,0.48809,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA,0.987362087912088
GOBP_REGULATION_OF_ACTIN_FIL...5,SET,233,0.001708,0.00019119,0.057262,0.4881,GOBP_REGULATION_OF_ACTIN_FILAMENT_ORGANIZATION,0.987362087912088
HP_GENERALIZED_ONSET_SEIZURE,SET,277,0.001539,0.00018761,0.051685,0.48812,HP_GENERALIZED_ONSET_SEIZURE,0.987362087912088
KIM_MYC_AMPLIFICATION_TARGET...2,SET,170,0.0019419,0.00018599,0.065351,0.48815,KIM_MYC_AMPLIFICATION_TARGETS_UP,0.987362087912088
REACTOME_MEIOSIS,SET,56,0.0031839,0.00017557,0.10743,0.48818,REACTOME_MEIOSIS,0.987362087912088
MIR3935,SET,70,0.002977,0.00018347,0.10057,0.48819,MIR3935,0.987362087912088
MARTORIATI_MDM4_TARGETS_NEUR...2,SET,150,0.0020908,0.00018821,0.070787,0.48822,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,0.987362087912088
FUJII_YBX1_TARGETS_DN,SET,183,0.0018194,0.00018073,0.061662,0.48823,FUJII_YBX1_TARGETS_DN,0.987362087912088
GSE6259_33D1_POS_DC_VS_CD8_T...2,SET,122,0.0023013,0.00018697,0.07808,0.48824,GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP,0.987362087912088
LEE_LIVER_CANCER_MYC_DN,SET,56,0.0038768,0.00021378,0.13207,0.48829,LEE_LIVER_CANCER_MYC_DN,0.987362087912088
MODULE_326,SET,13,0.0077331,0.0002057,0.26359,0.4883,MODULE_326,0.987362087912088
GOMF_LYSINE_N_ACETYLTRANSFER...,SET,6,0.010402,0.00018801,0.35579,0.48834,GOMF_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR,0.987362087912088
NAKAYA_PBMC_FLUARIX_FLUVIRIN...8,SET,134,0.0021546,0.0001834,0.073794,0.48835,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE,0.987362087912088
REACTOME_SENSORY_PERCEPTION,SET,513,0.0014007,0.00023084,0.047981,0.48836,REACTOME_SENSORY_PERCEPTION,0.987362087912088
GSE37532_WT_VS_PPARG_KO_LN_T...3,SET,107,0.0024923,0.00018971,0.085742,0.48841,GSE37532_WT_VS_PPARG_KO_LN_TREG_DN,0.987362087912088
GOBP_POSITIVE_REGULATION_OF_...389,SET,89,0.0026952,0.0001872,0.092821,0.48842,GOBP_POSITIVE_REGULATION_OF_JNK_CASCADE,0.987362087912088
TRAVAGLINI_LUNG_PROLIFERATIN...3,SET,121,0.0022231,0.00017988,0.076657,0.48843,TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL,0.987362087912088
GROSS_HYPOXIA_VIA_ELK3_ONLY_...2,SET,30,0.0049089,0.00019827,0.16959,0.48845,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,0.987362087912088
GAVISH_3CA_MALIGNANT_METAPRO...38,SET,46,0.0031897,0.00015946,0.11033,0.48847,GAVISH_3CA_MALIGNANT_METAPROGRAM_8_PROTEASOMAL_DEGRADATION,0.987362087912088
PID_IL12_2PATHWAY,SET,60,0.0034448,0.0001966,0.11959,0.48851,PID_IL12_2PATHWAY,0.987362087912088
HES2_TARGET_GENES,SET,1001,0.00081883,0.00018591,0.028419,0.48851,HES2_TARGET_GENES,0.987362087912088
ANDERSEN_CHOLANGIOCARCINOMA_...1,SET,58,0.0033287,0.00018679,0.11596,0.48855,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,0.987362087912088
GOMF_TRANSPORTER_INHIBITOR_A...,SET,38,0.0041329,0.00018783,0.14413,0.48856,GOMF_TRANSPORTER_INHIBITOR_ACTIVITY,0.987362087912088
GSE19923_HEB_KO_VS_HEB_AND_E...1,SET,190,0.0017779,0.00017993,0.062112,0.48858,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.987362087912088
HP_MOVEMENT_ABNORMALITY_OF_T...,SET,15,0.0063939,0.00018268,0.2235,0.48859,HP_MOVEMENT_ABNORMALITY_OF_THE_TONGUE,0.987362087912088
GOBP_ADAPTIVE_IMMUNE_RESPONS...,SET,281,0.0015674,0.00019242,0.054872,0.48861,GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS,0.987362087912088
HP_ERYSIPELAS,SET,11,0.0076597,0.00018743,0.26931,0.48865,HP_ERYSIPELAS,0.98738550872093
GSE42724_MEMORY_BCELL_VS_PLA...1,SET,175,0.0017569,0.00017071,0.062142,0.48872,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN,0.987469542468461
GOBP_ACTIVATION_OF_ADENYLATE...,SET,23,0.0057501,0.00020339,0.20409,0.48876,GOBP_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.987492954307639
GOBP_URINARY_BLADDER_SMOOTH_...,SET,7,0.0094653,0.00018478,0.33815,0.48883,GOBP_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION,0.98749773716275
GSE16522_MEMORY_VS_NAIVE_CD8...1,SET,180,0.0017878,0.00017615,0.063831,0.48883,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.98749773716275
HP_UTERUS_DIDELPHYS,SET,10,0.0075023,0.00017504,0.26904,0.48888,HP_UTERUS_DIDELPHYS,0.98749773716275
MIR4456,SET,119,0.0021503,0.00017256,0.07724,0.4889,MIR4456,0.98749773716275
FARMER_BREAST_CANCER_APOCRIN...1,SET,297,0.001424,0.00017965,0.051197,0.48891,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,0.98749773716275
GOBP_LYMPHOCYTE_APOPTOTIC_PR...,SET,77,0.0027793,0.00017961,0.10053,0.48897,GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS,0.98749773716275
HP_MATERNAL_HYPERTENSION,SET,7,0.0092521,0.00018062,0.33531,0.48899,HP_MATERNAL_HYPERTENSION,0.98749773716275
SMID_BREAST_CANCER_ERBB2_UP,SET,127,0.0020861,0.0001729,0.07588,0.48903,SMID_BREAST_CANCER_ERBB2_UP,0.98749773716275
GOBP_REGULATION_OF_APOPTOTIC...3,SET,11,0.0083115,0.00020338,0.30248,0.48904,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.98749773716275
LANG_MYB_FAMILY_TARGETS,SET,28,0.004622,0.00018036,0.16873,0.48907,LANG_MYB_FAMILY_TARGETS,0.98749773716275
GOBP_NEGATIVE_REGULATION_OF_...561,SET,5,0.010748,0.00017734,0.3943,0.48913,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.98749773716275
HP_ALVEOLAR_RHABDOMYOSARCOMA,SET,5,0.011884,0.00019608,0.43906,0.4892,HP_ALVEOLAR_RHABDOMYOSARCOMA,0.98749773716275
GOBP_REGULATION_OF_POSITIVE_...,SET,25,0.0050826,0.00018742,0.18785,0.48921,GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS,0.98749773716275
INAMURA_LUNG_CANCER_SCC_SUBT...,SET,12,0.00559,0.00014287,0.20833,0.4893,INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP,0.98749773716275
CAR_TNFRSF25,SET,28,0.0043502,0.00016975,0.16222,0.4893,CAR_TNFRSF25,0.98749773716275
REACTOME_HDL_CLEARANCE,SET,5,0.010762,0.00017757,0.40174,0.48931,REACTOME_HDL_CLEARANCE,0.98749773716275
GOMF_CARD_DOMAIN_BINDING,SET,15,0.0061598,0.000176,0.23002,0.48932,GOMF_CARD_DOMAIN_BINDING,0.98749773716275
HP_ANGIOID_STREAKS_OF_THE_FU...,SET,10,0.0071266,0.00016628,0.26682,0.48935,HP_ANGIOID_STREAKS_OF_THE_FUNDUS,0.98749773716275
HP_MACROVESICULAR_HEPATIC_ST...,SET,15,0.0051268,0.00014648,0.19205,0.48935,HP_MACROVESICULAR_HEPATIC_STEATOSIS,0.98749773716275
GSE22886_NAIVE_CD4_TCELL_VS_...13,SET,189,0.0017196,0.00017357,0.064401,0.48935,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN,0.98749773716275
HP_POLAR_CATARACT,SET,15,0.006275,0.00017929,0.23557,0.48937,HP_POLAR_CATARACT,0.98749773716275
REACTOME_REGULATION_OF_TBK1_...1,SET,13,0.0069003,0.00018355,0.26204,0.4895,REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7,0.98749773716275
GSE360_T_GONDII_VS_B_MALAYI_...3,SET,180,0.001639,0.00016149,0.06231,0.48951,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.98749773716275
KEGG_PHOSPHATIDYLINOSITOL_SI...,SET,75,0.0025949,0.00016551,0.098801,0.48952,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,0.98749773716275
GOBP_RECEPTOR_CLUSTERING,SET,54,0.0030705,0.00016627,0.11699,0.48953,GOBP_RECEPTOR_CLUSTERING,0.98749773716275
MIR7849_3P,SET,105,0.0022671,0.00017096,0.086692,0.48957,MIR7849_3P,0.98749773716275
GSE20366_EX_VIVO_VS_DEC205_C...1,SET,182,0.0016712,0.00016557,0.063921,0.48957,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN,0.98749773716275
GSE17721_PAM3CSK4_VS_GADIQUI...9,SET,186,0.0016142,0.00016164,0.061994,0.48961,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN,0.98749773716275
GOMF_INTERLEUKIN_1_BINDING,SET,8,0.0083615,0.0001745,0.32146,0.48962,GOMF_INTERLEUKIN_1_BINDING,0.98749773716275
HNF3B_01,SET,196,0.001692,0.00017388,0.065143,0.48964,HNF3B_01,0.98749773716275
HP_ALVEOLAR_CELL_CARCINOMA,SET,17,0.0053557,0.00016289,0.20686,0.48967,HP_ALVEOLAR_CELL_CARCINOMA,0.98749773716275
GOBP_CELL_MIGRATION_INVOLVED...4,SET,5,0.0123,0.00020296,0.47605,0.48969,GOBP_CELL_MIGRATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.98749773716275
GOBP_DRINKING_BEHAVIOR,SET,8,0.0091994,0.00019199,0.35627,0.4897,GOBP_DRINKING_BEHAVIOR,0.98749773716275
HP_ENLARGED_THORAX,SET,57,0.0028116,0.00015641,0.10946,0.48975,HP_ENLARGED_THORAX,0.987524299472066
GOBP_POSITIVE_REGULATION_OF_...115,SET,20,0.0051974,0.00017144,0.20273,0.48977,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.987524299472066
GOMF_SELENIUM_BINDING,SET,6,0.010465,0.00018915,0.41072,0.48984,GOMF_SELENIUM_BINDING,0.98760814479638
GOCC_AMPHISOME,SET,13,0.0059204,0.00015748,0.23346,0.48988,GOCC_AMPHISOME,0.987631498346772
GSE19888_NO_PRETREAT_VS_ADEN...1,SET,179,0.0015445,0.00015176,0.061267,0.48994,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN,0.987658038976857
PID_FOXM1_PATHWAY,SET,39,0.0033917,0.00015616,0.1346,0.48995,PID_FOXM1_PATHWAY,0.987658038976857
GSE41176_UNSTIM_VS_ANTI_IGM_...4,SET,183,0.0016682,0.00016571,0.066442,0.48998,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP,0.987661228395778
GOBP_MESENCHYMAL_CELL_PROLIF...2,SET,6,0.010014,0.00018099,0.40316,0.49009,GOBP_MESENCHYMAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_DEVELOPMENT,0.987825665487444
CALVET_IRINOTECAN_SENSITIVE_...3,SET,5,0.010287,0.00016974,0.41815,0.49019,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP,0.987882837031458
HP_ABNORMAL_DRINKING_BEHAVIOR,SET,50,0.0031612,0.00016474,0.12922,0.49024,HP_ABNORMAL_DRINKING_BEHAVIOR,0.987882837031458
GOBP_REGULATION_OF_MYOBLAST_...3,SET,15,0.0054632,0.00015609,0.22389,0.49027,GOBP_REGULATION_OF_MYOBLAST_PROLIFERATION,0.987882837031458
GSE11818_WT_VS_DICER_KO_TREG...1,SET,143,0.0017257,0.0001517,0.070782,0.49027,GSE11818_WT_VS_DICER_KO_TREG_DN,0.987882837031458
GSE37301_LYMPHOID_PRIMED_MPP...8,SET,175,0.0014882,0.0001446,0.061488,0.49035,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP,0.987882837031458
GSE16385_MONOCYTE_VS_12H_ROS...6,SET,171,0.0015954,0.00015325,0.06624,0.49039,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.987882837031458
KEGG_MEDICUS_REFERENCE_MGLUR...2,SET,20,0.004675,0.00015421,0.19422,0.4904,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.987882837031458
GOMF_PROTEIN_PRENYLTRANSFERA...,SET,6,0.0077656,0.00014036,0.3227,0.4904,GOMF_PROTEIN_PRENYLTRANSFERASE_ACTIVITY,0.987882837031458
MIR4430,SET,128,0.0017698,0.00014726,0.073857,0.49044,MIR4430,0.987882837031458
GOMF_G_QUADRUPLEX_DNA_BINDING,SET,11,0.0062552,0.00015306,0.26094,0.49044,GOMF_G_QUADRUPLEX_DNA_BINDING,0.987882837031458
GSE2706_R848_VS_LPS_2H_STIM_...2,SET,142,0.0017667,0.00015477,0.074293,0.49051,GSE2706_R848_VS_LPS_2H_STIM_DC_UP,0.987882837031458
LIM_MAMMARY_LUMINAL_MATURE_DN,SET,89,0.0023536,0.00016347,0.099113,0.49053,LIM_MAMMARY_LUMINAL_MATURE_DN,0.987882837031458
BIOCARTA_AGR_PATHWAY,SET,29,0.0040411,0.00016048,0.17018,0.49053,BIOCARTA_AGR_PATHWAY,0.987882837031458
CUI_DEVELOPING_HEART_LEFT_VE...,SET,37,0.0037707,0.0001691,0.15902,0.49054,CUI_DEVELOPING_HEART_LEFT_VENTRICULAR_CARDIOMYOCYTE,0.987882837031458
HP_IMPAIRED_EXECUTIVE_FUNCTI...,SET,9,0.006894,0.0001526,0.2909,0.49055,HP_IMPAIRED_EXECUTIVE_FUNCTIONING,0.987882837031458
FAN_EMBRYONIC_CTX_IN_1_INTER...,SET,10,0.0072972,0.00017025,0.30942,0.49059,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.987882837031458
GARCIA_PINERES_PBMC_HPV_16_L...7,SET,122,0.0018766,0.00015246,0.07983,0.49062,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN,0.987882837031458
GOBP_POLYOL_CATABOLIC_PROCESS,SET,8,0.0081584,0.00017026,0.34721,0.49063,GOBP_POLYOL_CATABOLIC_PROCESS,0.987882837031458
HP_INCREASED_URINARY_POTASSI...,SET,9,0.0072331,0.0001601,0.31027,0.4907,HP_INCREASED_URINARY_POTASSIUM,0.987887956964368
GSE6269_HEALTHY_VS_FLU_INF_P...1,SET,143,0.0016351,0.00014374,0.070306,0.49072,GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN,0.987887956964368
GOBP_POSITIVE_REGULATION_OF_...252,SET,56,0.0029683,0.00016368,0.12804,0.49075,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.987887956964368
GOCC_NUCLEOSOME,SET,37,0.0031941,0.00014324,0.13837,0.49079,GOCC_NUCLEOSOME,0.987887956964368
GSE37301_LYMPHOID_PRIMED_MPP...4,SET,187,0.0014229,0.00014287,0.061653,0.49079,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.987887956964368
MIR517_5P,SET,78,0.0021859,0.00014217,0.095179,0.49084,MIR517_5P,0.987887956964368
HP_PERIPHERAL_VISUAL_FIELD_L...,SET,92,0.0020453,0.00014442,0.08939,0.49087,HP_PERIPHERAL_VISUAL_FIELD_LOSS,0.987887956964368
REACTOME_SLC15A4_TASL_DEPEND...,SET,4,0.0085545,0.00012625,0.37669,0.49094,REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION,0.987887956964368
MIR498_3P,SET,196,0.0013932,0.00014318,0.061644,0.49098,MIR498_3P,0.987887956964368
KEGG_MEDICUS_REFERENCE_ACH_C...1,SET,7,0.0070686,0.00013799,0.31286,0.49099,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY,0.987887956964368
HP_INCREASED_HEPATOCELLULAR_...,SET,3,0.0096726,0.00012363,0.42921,0.49101,HP_INCREASED_HEPATOCELLULAR_LIPID_DROPLETS,0.987887956964368
chr17q25,SET,176,0.0028891,0.0002815,0.12918,0.49108,chr17q25,0.987887956964368
LIANG_HEMATOPOIESIS_STEM_CEL...5,SET,36,0.00328,0.0001451,0.14694,0.4911,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,0.987887956964368
HP_ABNORMAL_PELVIC_GIRDLE_BO...,SET,548,0.00082128,0.00013975,0.036802,0.4911,HP_ABNORMAL_PELVIC_GIRDLE_BONE_MORPHOLOGY,0.987887956964368
GSE24142_ADULT_VS_FETAL_DN2_...2,SET,186,0.0014583,0.00014604,0.06555,0.49113,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP,0.987887956964368
LIU_OVARIAN_CANCER_TUMORS_AN...2,SET,1379,0.00058881,0.00015519,0.026496,0.49114,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN,0.987887956964368
GSE40274_CTRL_VS_FOXP3_TRANS...2,SET,181,0.0013701,0.00013537,0.061671,0.49114,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.987887956964368
HP_ABNORMAL_PONS_MORPHOLOGY,SET,105,0.0017522,0.00013213,0.079417,0.4912,HP_ABNORMAL_PONS_MORPHOLOGY,0.987887956964368
GSE7348_UNSTIM_VS_TOLERIZED_...2,SET,147,0.0014595,0.00013007,0.066163,0.4912,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.987887956964368
MIR2682_5P,SET,106,0.0018776,0.00014225,0.085355,0.49123,MIR2682_5P,0.987887956964368
THAKAR_PBMC_INACTIVATED_INFL...12,SET,5,0.0066167,0.00010918,0.30166,0.49125,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_VS_21_30YO_0DY_UP,0.987887956964368
HP_CLEFT_PALATE,SET,510,0.0008318,0.00013669,0.038246,0.49132,HP_CLEFT_PALATE,0.987887956964368
REACTOME_FASTK_FAMILY_PROTEI...,SET,4,0.0073824,0.00010895,0.33997,0.49134,REACTOME_FASTK_FAMILY_PROTEINS_REGULATE_PROCESSING_AND_STABILITY_OF_MITOCHONDRIAL_RNAS,0.987887956964368
chr5q15,SET,19,0.0063486,0.00020412,0.29336,0.49137,chr5q15,0.987887956964368
GOBP_ANDROGEN_BIOSYNTHETIC_P...,SET,10,0.0057015,0.00013303,0.26415,0.49139,GOBP_ANDROGEN_BIOSYNTHETIC_PROCESS,0.987887956964368
GOBP_POSITIVE_REGULATION_OF_...173,SET,98,0.0020003,0.00014575,0.092699,0.49139,GOBP_POSITIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,0.987887956964368
HP_ABSENT_FOVEAL_REFLEX,SET,14,0.0050624,0.00013974,0.23495,0.4914,HP_ABSENT_FOVEAL_REFLEX,0.987887956964368
BOYAULT_LIVER_CANCER_SUBCLAS...10,SET,51,0.0028206,0.00014845,0.13152,0.49145,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,0.987927052735053
MIR4671_3P,SET,191,0.0013459,0.00013656,0.063258,0.49151,MIR4671_3P,0.987927052735053
BLANCO_MELO_COVID19_SARS_COV...10,SET,132,0.0016677,0.0001409,0.078587,0.49153,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.987927052735053
MODULE_401,SET,15,0.0053284,0.00015224,0.25199,0.49157,MODULE_401,0.987927052735053
GOMF_TRANSCRIPTION_COREGULAT...1,SET,451,0.00082496,0.0001277,0.039014,0.49157,GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY,0.987927052735053
HP_LARGE_PLACENTA,SET,6,0.0078673,0.0001422,0.37309,0.49159,HP_LARGE_PLACENTA,0.987927052735053
GOBP_CENTROSOME_SEPARATION,SET,16,0.0041605,0.00012277,0.19822,0.49163,GOBP_CENTROSOME_SEPARATION,0.987950312228968
GOBP_RESPONSE_TO_GRANULOCYTE...,SET,9,0.0063448,0.00014044,0.30579,0.49172,GOBP_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.988016916228248
GSE12392_WT_VS_IFNAR_KO_CD8A...1,SET,168,0.001315,0.00012521,0.063373,0.49172,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN,0.988016916228248
GSE3982_DC_VS_EFF_MEMORY_CD4...1,SET,162,0.0013247,0.00012389,0.064157,0.49176,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN,0.988040166493236
GOBP_PROTEIN_RNA_COMPLEX_DIS...,SET,10,0.0050682,0.00011825,0.24625,0.49179,GOBP_PROTEIN_RNA_COMPLEX_DISASSEMBLY,0.988043323313486
GOCC_EXCITATORY_SYNAPSE,SET,57,0.0023562,0.00013108,0.11815,0.49205,GOCC_EXCITATORY_SYNAPSE,0.988076523297491
GOBP_REGULATION_OF_MITOCHOND...2,SET,17,0.0043249,0.00013154,0.21817,0.49209,GOBP_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.988076523297491
HP_MICRORETROGNATHIA,SET,71,0.0019898,0.0001235,0.10033,0.49209,HP_MICRORETROGNATHIA,0.988076523297491
GOBP_NEURAL_TUBE_FORMATION,SET,99,0.0016883,0.00012364,0.0852,0.4921,GOBP_NEURAL_TUBE_FORMATION,0.988076523297491
GSE22886_NEUTROPHIL_VS_DC_DN,SET,177,0.0012135,0.00011857,0.061272,0.4921,GSE22886_NEUTROPHIL_VS_DC_DN,0.988076523297491
GOMF_N_FORMYL_PEPTIDE_RECEPT...,SET,4,0.010758,0.00015878,0.54599,0.49214,GOMF_N_FORMYL_PEPTIDE_RECEPTOR_ACTIVITY,0.988076523297491
WP_EMBRYONIC_STEM_CELL_PLURI...,SET,108,0.0017619,0.00013473,0.089709,0.49217,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,0.988076523297491
GOBP_CELLULAR_RESPONSE_TO_PR...3,SET,20,0.0044137,0.00014559,0.2249,0.49217,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS,0.988076523297491
MIR4441,SET,271,0.0010227,0.00012334,0.052195,0.49218,MIR4441,0.988076523297491
HP_FUNDUS_ATROPHY,SET,3,0.013106,0.00016751,0.66961,0.49219,HP_FUNDUS_ATROPHY,0.988076523297491
MIR597_3P,SET,100,0.0016929,0.0001246,0.08668,0.49221,MIR597_3P,0.988076523297491
GOBP_CELLULAR_RESPONSE_TO_EL...,SET,10,0.005274,0.00012305,0.27045,0.49222,GOBP_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS,0.988076523297491
GOBP_VIRAL_TRANSLATION,SET,18,0.0037765,0.00011819,0.19354,0.49222,GOBP_VIRAL_TRANSLATION,0.988076523297491
GSE1460_INTRATHYMIC_T_PROGEN...1,SET,186,0.0012878,0.00012896,0.066225,0.49224,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN,0.988076523297491
GOBP_MEIOTIC_CELL_CYCLE_PROC...1,SET,189,0.0011275,0.00011381,0.058718,0.49234,GOBP_MEIOTIC_CELL_CYCLE_PROCESS,0.988076523297491
MIR544A,SET,202,0.0011611,0.00012111,0.061375,0.49245,MIR544A,0.988076523297491
MODULE_289,SET,117,0.0016066,0.00012784,0.085247,0.49248,MODULE_289,0.988076523297491
GOBP_REGULATION_OF_POSTSYNAP...1,SET,6,0.0086001,0.00015544,0.45725,0.4925,GOBP_REGULATION_OF_POSTSYNAPSE_ASSEMBLY,0.988076523297491
GOBP_LACTONE_METABOLIC_PROCE...,SET,12,0.0051752,0.00013226,0.27575,0.49251,GOBP_LACTONE_METABOLIC_PROCESS,0.988076523297491
HP_FETAL_DISTRESS,SET,52,0.0020678,0.00010989,0.11082,0.49256,HP_FETAL_DISTRESS,0.988076523297491
HP_3_4_TOE_SYNDACTYLY,SET,6,0.0071132,0.00012857,0.3818,0.49257,HP_3_4_TOE_SYNDACTYLY,0.988076523297491
SP1_Q6,SET,235,0.0010257,0.0001153,0.055212,0.49259,SP1_Q6,0.988076523297491
HP_NECK_FLEXOR_WEAKNESS,SET,43,0.0022714,0.00010979,0.12264,0.49261,HP_NECK_FLEXOR_WEAKNESS,0.988076523297491
HP_CAROTID_ARTERY_DILATATION,SET,23,0.0034765,0.00012297,0.18785,0.49262,HP_CAROTID_ARTERY_DILATATION,0.988076523297491
GAUTAM_EYE_IRIS_CILIARY_BODY...2,SET,93,0.0017262,0.00012254,0.093334,0.49262,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_CELLS,0.988076523297491
GOBP_RRNA_3_END_PROCESSING,SET,10,0.004114,9.5986e-05,0.22385,0.49267,GOBP_RRNA_3_END_PROCESSING,0.988076523297491
MIR1202,SET,67,0.0018629,0.00011233,0.1016,0.49269,MIR1202,0.988076523297491
OCT1_05,SET,222,0.0011291,0.0001234,0.061611,0.49269,OCT1_05,0.988076523297491
MODULE_424,SET,17,0.0039455,0.00012,0.21581,0.49271,MODULE_424,0.988076523297491
GSE11864_CSF1_IFNG_VS_CSF1_I...2,SET,174,0.001187,0.00011501,0.06493,0.49271,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.988076523297491
GOBP_BEHAVIORAL_RESPONSE_TO_...4,SET,19,0.0036275,0.00011663,0.20017,0.49277,GOBP_BEHAVIORAL_RESPONSE_TO_PAIN,0.988076523297491
MORF_PDPK1,SET,65,0.0018475,0.00010973,0.10236,0.4928,MORF_PDPK1,0.988076523297491
GSE9650_EFFECTOR_VS_MEMORY_C...1,SET,184,0.0011269,0.00011225,0.062635,0.49282,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN,0.988076523297491
HP_HEAD_BANGING,SET,9,0.0046365,0.00010263,0.25865,0.49285,HP_HEAD_BANGING,0.988076523297491
GOBP_REGULATION_OF_DOUBLE_ST...3,SET,18,0.0033697,0.00010546,0.18867,0.49288,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.988076523297491
DELACROIX_RAR_BOUND_ES,SET,410,0.00076582,0.00011316,0.043792,0.49302,DELACROIX_RAR_BOUND_ES,0.988076523297491
GOBP_REGULATION_OF_MUSCLE_OR...,SET,23,0.0037006,0.0001309,0.21209,0.49304,GOBP_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,0.988076523297491
GSE43955_TH0_VS_TGFB_IL6_TH1...15,SET,189,0.001099,0.00011093,0.063453,0.49309,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN,0.988076523297491
WP_INTERLEUKIN1_IL1_STRUCTUR...,SET,46,0.0022081,0.00011039,0.12768,0.4931,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,0.988076523297491
PURWIN_MEWO_SOX10_TARGETS,SET,82,0.0016467,0.0001098,0.096205,0.49317,PURWIN_MEWO_SOX10_TARGETS,0.988076523297491
GOBP_REGULATION_OF_NUCLEOBAS...,SET,17,0.0031589,9.6076e-05,0.18476,0.49318,GOBP_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.988076523297491
GERHOLD_ADIPOGENESIS_DN,SET,58,0.001938,0.00010875,0.11377,0.4932,GERHOLD_ADIPOGENESIS_DN,0.988076523297491
GOCC_PLASMA_MEMBRANE_REGION,SET,1187,0.00045136,0.00011099,0.026492,0.4932,GOCC_PLASMA_MEMBRANE_REGION,0.988076523297491
MORI_PRE_BI_LYMPHOCYTE_UP,SET,73,0.001692,0.00010648,0.101,0.49332,MORI_PRE_BI_LYMPHOCYTE_UP,0.988076523297491
GOMF_ADENYLATE_CYCLASE_ACTIV...,SET,14,0.0040344,0.00011136,0.24197,0.49335,GOMF_ADENYLATE_CYCLASE_ACTIVITY,0.988076523297491
TUOMISTO_TUMOR_SUPPRESSION_B...1,SET,19,0.0034276,0.00011021,0.20592,0.49336,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,0.988076523297491
GCM_DDX5,SET,59,0.0017599,9.9602e-05,0.1057,0.49336,GCM_DDX5,0.988076523297491
GOBP_NEGATIVE_REGULATION_OF_...133,SET,11,0.0037965,9.29e-05,0.22973,0.49341,GOBP_NEGATIVE_REGULATION_OF_CGAS_STING_SIGNALING_PATHWAY,0.988076523297491
HP_DEVELOPMENTAL_REGRESSION,SET,360,0.00073226,0.00010153,0.044386,0.49342,HP_DEVELOPMENTAL_REGRESSION,0.988076523297491
GOBP_POSITIVE_REGULATION_OF_...125,SET,239,0.00091572,0.0001038,0.05567,0.49344,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.988076523297491
HP_APLASIA_HYPOPLASIA_OF_THE...32,SET,4,0.0074367,0.00010976,0.45237,0.49344,HP_APLASIA_HYPOPLASIA_OF_THE_FALLOPIAN_TUBE,0.988076523297491
WP_CELL_CYCLE,SET,116,0.0012525,9.924e-05,0.07645,0.49346,WP_CELL_CYCLE,0.988076523297491
GSE24142_EARLY_THYMIC_PROGEN...5,SET,186,0.001069,0.00010705,0.065504,0.49349,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP,0.988076523297491
HOEK_NK_CELL_2011_2012_TIV_3...,SET,208,0.0010346,0.0001095,0.063556,0.49351,HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,0.988076523297491
GAZDA_DIAMOND_BLACKFAN_ANEMI...6,SET,36,0.0024339,0.00010767,0.15192,0.49361,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,0.988076523297491
GOBP_REGULATION_OF_SYNAPTIC_...12,SET,8,0.0038517,8.0384e-05,0.24303,0.49368,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING,0.988076523297491
HP_REDUCED_SPERM_MOTILITY,SET,58,0.0017108,9.6004e-05,0.1081,0.49369,HP_REDUCED_SPERM_MOTILITY,0.988076523297491
WP_FOLATEALCOHOL_AND_CANCER_...,SET,8,0.0050975,0.00010638,0.32894,0.49382,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,0.988076523297491
GSE11961_MEMORY_BCELL_DAY7_V...2,SET,180,0.00095719,9.431e-05,0.062506,0.49389,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.988076523297491
GSE11057_CD4_CENT_MEM_VS_PBM...1,SET,175,0.0010143,9.8549e-05,0.066371,0.4939,GSE11057_CD4_CENT_MEM_VS_PBMC_DN,0.988076523297491
PID_NEPHRIN_NEPH1_PATHWAY,SET,30,0.0023162,9.3552e-05,0.15178,0.49391,PID_NEPHRIN_NEPH1_PATHWAY,0.988076523297491
MIR17_5P,SET,580,0.00055564,9.7185e-05,0.036536,0.49393,MIR17_5P,0.988076523297491
MIR575,SET,49,0.0017585,9.0722e-05,0.11567,0.49394,MIR575,0.988076523297491
GOBP_C_TERMINAL_PROTEIN_LIPI...,SET,8,0.0044308,9.2469e-05,0.29186,0.49394,GOBP_C_TERMINAL_PROTEIN_LIPIDATION,0.988076523297491
GOBP_KERATINOCYTE_MIGRATION,SET,20,0.0031899,0.00010522,0.21013,0.49394,GOBP_KERATINOCYTE_MIGRATION,0.988076523297491
MIR1208,SET,119,0.0011675,9.3686e-05,0.076987,0.49395,MIR1208,0.988076523297491
GOBP_NEGATIVE_REGULATION_OF_...47,SET,20,0.0028644,9.4489e-05,0.18949,0.49397,GOBP_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION,0.988076523297491
REACTOME_ION_CHANNEL_TRANSPO...,SET,170,0.0010235,9.803e-05,0.068251,0.49402,REACTOME_ION_CHANNEL_TRANSPORT,0.988076523297491
WP_ANTIVIRAL_AND_ANTIINFLAMM...,SET,26,0.0026203,9.8537e-05,0.17531,0.49404,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,0.988076523297491
GSE2197_CPG_DNA_VS_UNTREATED...1,SET,175,0.00094127,9.1457e-05,0.063071,0.49405,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN,0.988076523297491
GOBP_ESCRT_COMPLEX_DISASSEMB...,SET,10,0.0035219,8.2171e-05,0.23636,0.49406,GOBP_ESCRT_COMPLEX_DISASSEMBLY,0.988076523297491
GSE11961_MEMORY_BCELL_DAY7_V...7,SET,185,0.0009499,9.487e-05,0.06382,0.49406,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.988076523297491
GOMF_ATP_TRANSMEMBRANE_TRANS...,SET,12,0.0039058,9.9822e-05,0.26305,0.49408,GOMF_ATP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.988076523297491
GOMF_PROTEIN_HOMODIMERIZATIO...,SET,640,0.00051337,9.4164e-05,0.034646,0.49409,GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY,0.988076523297491
MIR4437,SET,96,0.0012855,9.2715e-05,0.08758,0.49414,MIR4437,0.988076523297491
GOBP_NEGATIVE_REGULATION_OF_...105,SET,5,0.0061645,0.00010172,0.42202,0.49417,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.988076523297491
GSE17974_CTRL_VS_ACT_IL4_AND...16,SET,161,0.0009913,9.242e-05,0.06893,0.49426,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP,0.988076523297491
KOKKINAKIS_METHIONINE_DEPRIV...2,SET,125,0.0011498,9.4548e-05,0.080258,0.49428,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,0.988076523297491
GOBP_POSITIVE_REGULATION_OF_...814,SET,9,0.0043818,9.699e-05,0.30793,0.49432,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,0.988076523297491
GOBP_MANCHETTE_ASSEMBLY,SET,8,0.0039133,8.167e-05,0.27764,0.49438,GOBP_MANCHETTE_ASSEMBLY,0.988076523297491
GOBP_POSITIVE_REGULATION_OF_...488,SET,87,0.0013396,9.1993e-05,0.095272,0.49439,GOBP_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.988076523297491
GSE27786_CD8_TCELL_VS_MONO_M...1,SET,179,0.0008733,8.5807e-05,0.062279,0.49441,GSE27786_CD8_TCELL_VS_MONO_MAC_DN,0.988076523297491
PID_ERBB2_ERBB3_PATHWAY,SET,44,0.0017209,8.4146e-05,0.12322,0.49443,PID_ERBB2_ERBB3_PATHWAY,0.988076523297491
GOBP_LIPOPHAGY,SET,7,0.0045075,8.7996e-05,0.32738,0.49451,GOBP_LIPOPHAGY,0.988076523297491
GAVISH_3CA_MALIGNANT_METAPRO...37,SET,37,0.0019513,8.751e-05,0.14338,0.49457,GAVISH_3CA_MALIGNANT_METAPROGRAM_7_STRESS_IN_VITRO,0.988076523297491
HSD17B8_TARGET_GENES,SET,518,0.00052685,8.7236e-05,0.039136,0.49463,HSD17B8_TARGET_GENES,0.988076523297491
HP_TRANSPOSITION_OF_THE_GREA...,SET,68,0.0013357,8.1139e-05,0.10054,0.4947,HP_TRANSPOSITION_OF_THE_GREAT_ARTERIES,0.988076523297491
GOBP_GABAERGIC_NEURON_DIFFER...,SET,18,0.0031681,9.9147e-05,0.24163,0.49477,GOBP_GABAERGIC_NEURON_DIFFERENTIATION,0.988076523297491
REACTOME_SIGNALING_BY_NOTCH3,SET,46,0.0016561,8.2793e-05,0.12682,0.49479,REACTOME_SIGNALING_BY_NOTCH3,0.988076523297491
GOBP_REGULATION_OF_PEPTIDYL_...2,SET,10,0.0034758,8.1097e-05,0.26626,0.49479,GOBP_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,0.988076523297491
GSE17721_LPS_VS_GARDIQUIMOD_...13,SET,176,0.00079945,7.7897e-05,0.061725,0.49483,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN,0.988076523297491
GOCC_HEMIDESMOSOME,SET,7,0.0047147,9.2042e-05,0.36429,0.49484,GOCC_HEMIDESMOSOME,0.988076523297491
GOBP_4FE_4S_CLUSTER_ASSEMBLY,SET,4,0.0053846,7.947e-05,0.41726,0.49485,GOBP_4FE_4S_CLUSTER_ASSEMBLY,0.988076523297491
HP_CERVICAL_KYPHOSIS,SET,8,0.0034144,7.1256e-05,0.26618,0.49488,HP_CERVICAL_KYPHOSIS,0.988076523297491
HP_HYPOPLASIA_OF_THE_MUSCULA...,SET,20,0.0027013,8.9108e-05,0.21086,0.49489,HP_HYPOPLASIA_OF_THE_MUSCULATURE,0.988076523297491
GSE29618_BCELL_VS_MDC_DAY7_F...2,SET,169,0.00089537,8.5507e-05,0.070386,0.49493,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP,0.988076523297491
MORF_MAP2K7,SET,157,0.00089515,8.2422e-05,0.070871,0.49496,MORF_MAP2K7,0.988076523297491
GSE14308_TH1_VS_NAIVE_CD4_TC...1,SET,176,0.00078951,7.6928e-05,0.063288,0.49502,GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN,0.988076523297491
GOCC_PROTEIN_PHOSPHATASE_4_C...,SET,3,0.0053014,6.776e-05,0.42598,0.49504,GOCC_PROTEIN_PHOSPHATASE_4_COMPLEX,0.988076523297491
GOBP_DNA_CYTOSINE_DEAMINATION,SET,8,0.0054391,0.00011351,0.44127,0.49508,GOBP_DNA_CYTOSINE_DEAMINATION,0.988076523297491
BUSSLINGER_DUODENAL_BCHE_CEL...,SET,39,0.0017953,8.2657e-05,0.14647,0.49511,BUSSLINGER_DUODENAL_BCHE_CELLS,0.988076523297491
GOBP_STRESS_GRANULE_DISASSEM...,SET,7,0.0034459,6.7272e-05,0.28353,0.49515,GOBP_STRESS_GRANULE_DISASSEMBLY,0.988076523297491
PEART_HDAC_PROLIFERATION_CLU...1,SET,68,0.001195,7.259e-05,0.10028,0.49525,PEART_HDAC_PROLIFERATION_CLUSTER_DN,0.988076523297491
ACEVEDO_LIVER_CANCER_WITH_H3...2,SET,229,0.00072305,8.0246e-05,0.063501,0.49546,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,0.988076523297491
GOBP_MONOCARBOXYLIC_ACID_MET...,SET,587,0.00041688,7.3339e-05,0.036898,0.49549,GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,0.988076523297491
MULLIGHAN_NPM1_MUTATED_SIGNA...2,SET,234,0.00061895,6.9429e-05,0.056459,0.49563,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,0.988076523297491
GSE10325_CD4_TCELL_VS_LUPUS_...1,SET,178,0.00072506,7.1045e-05,0.066512,0.49565,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN,0.988076523297491
GOBP_FAT_SOLUBLE_VITAMIN_CAT...,SET,12,0.0030432,7.7777e-05,0.28014,0.49567,GOBP_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS,0.988076523297491
KEGG_MEDICUS_REFERENCE_FLCN_...,SET,13,0.0024042,6.3953e-05,0.22299,0.4957,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY,0.988076523297491
GOMF_N_ACYLSPHINGOSINE_AMIDO...,SET,7,0.003962,7.7348e-05,0.37038,0.49573,GOMF_N_ACYLSPHINGOSINE_AMIDOHYDROLASE_ACTIVITY,0.988076523297491
MIR4699_3P,SET,440,0.00045145,6.9046e-05,0.04232,0.49574,MIR4699_3P,0.988076523297491
GOBP_NEGATIVE_REGULATION_OF_...50,SET,7,0.0036708,7.1663e-05,0.34349,0.49574,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.988076523297491
HP_PERONEAL_MUSCLE_WEAKNESS,SET,8,0.0033835,7.0612e-05,0.31949,0.49578,HP_PERONEAL_MUSCLE_WEAKNESS,0.988076523297491
GOBP_RIBONUCLEOSIDE_MONOPHOS...3,SET,52,0.001276,6.7813e-05,0.12099,0.49579,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.988076523297491
HP_EEG_WITH_FOCAL_SPIKE_WAVES,SET,13,0.0025994,6.9145e-05,0.24705,0.4958,HP_EEG_WITH_FOCAL_SPIKE_WAVES,0.988076523297491
GSE25088_ROSIGLITAZONE_VS_IL...1,SET,181,0.00063304,6.2544e-05,0.06148,0.49589,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.988076523297491
HP_ABNORMAL_CIRCULATING_GABA...,SET,6,0.0036893,6.6682e-05,0.35859,0.4959,HP_ABNORMAL_CIRCULATING_GABA_CONCENTRATION,0.988076523297491
chr7p11,SET,14,0.0035148,9.7019e-05,0.34655,0.49595,chr7p11,0.988076523297491
GENTILE_UV_RESPONSE_CLUSTER_...4,SET,35,0.0013844,6.0389e-05,0.13875,0.49602,GENTILE_UV_RESPONSE_CLUSTER_D5,0.988076523297491
GOBP_DEVELOPMENTAL_CELL_GROW...,SET,198,0.00062492,6.4545e-05,0.062794,0.49603,GOBP_DEVELOPMENTAL_CELL_GROWTH,0.988076523297491
GOBP_RIBOSE_PHOSPHATE_BIOSYN...,SET,176,0.00062184,6.0591e-05,0.06244,0.49603,GOBP_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.988076523297491
HP_DECREASED_ACTIVITY_OF_MIT...1,SET,8,0.0024606,5.1352e-05,0.24867,0.49605,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_ATP_SYNTHASE_COMPLEX,0.988076523297491
GSE41867_MEMORY_VS_EXHAUSTED...1,SET,180,0.00062752,6.1829e-05,0.063393,0.49605,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN,0.988076523297491
PARK_HSC_VS_MULTIPOTENT_PROG...2,SET,16,0.002186,6.4504e-05,0.22251,0.49608,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,0.988076523297491
GOBP_MONOATOMIC_CATION_TRANS...1,SET,750,0.00032362,6.4057e-05,0.032964,0.49608,GOBP_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORT,0.988076523297491
MIR217_5P,SET,170,0.00064195,6.1485e-05,0.06548,0.49609,MIR217_5P,0.988076523297491
GOBP_PROTEIN_TARGETING_TO_VA...1,SET,44,0.0012182,5.9564e-05,0.12536,0.49612,GOBP_PROTEIN_TARGETING_TO_VACUOLE,0.988076523297491
HP_LARGE_JOINT_HYPERMOBILTY,SET,6,0.00342,6.1815e-05,0.3545,0.49615,HP_LARGE_JOINT_HYPERMOBILTY,0.988076523297491
GSE44732_UNSTIM_VS_IL27_STIM...2,SET,175,0.00062635,6.0858e-05,0.064919,0.49615,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP,0.988076523297491
GOBP_NEGATIVE_REGULATION_OF_...100,SET,14,0.0023647,6.5273e-05,0.24537,0.49616,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.988076523297491
GOBP_MAST_CELL_DIFFERENTIATI...,SET,6,0.0037592,6.7946e-05,0.39129,0.49617,GOBP_MAST_CELL_DIFFERENTIATION,0.988076523297491
BUSSLINGER_GASTRIC_REG3A_POS...,SET,40,0.0014574,6.7953e-05,0.15182,0.49617,BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS,0.988076523297491
REACTOME_PLASMA_LIPOPROTEIN_...3,SET,33,0.0014509,6.1457e-05,0.15168,0.49618,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,0.988076523297491
REACTOME_TRANSCRIPTIONAL_REG...12,SET,30,0.0015085,6.0926e-05,0.162,0.49629,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,0.988076523297491
GOBP_ENDOTHELIAL_CELL_DEVELO...,SET,64,0.0010558,6.2227e-05,0.11434,0.49632,GOBP_ENDOTHELIAL_CELL_DEVELOPMENT,0.988076523297491
GOMF_DYSTROGLYCAN_BINDING,SET,10,0.0027662,6.454e-05,0.30043,0.49633,GOMF_DYSTROGLYCAN_BINDING,0.988076523297491
MORF_XRCC5,SET,210,0.00049337,5.2462e-05,0.054121,0.49636,MORF_XRCC5,0.988076523297491
GOBP_FATTY_ACID_TRANSPORT,SET,114,0.0007728,6.0706e-05,0.084729,0.49636,GOBP_FATTY_ACID_TRANSPORT,0.988076523297491
MIR6887_5P,SET,120,0.00070668,5.6945e-05,0.078314,0.4964,MIR6887_5P,0.988076523297491
GOBP_ESTABLISHMENT_OF_GOLGI_...,SET,6,0.0032585,5.8897e-05,0.36409,0.49643,GOBP_ESTABLISHMENT_OF_GOLGI_LOCALIZATION,0.988076523297491
GOBP_PROTEIN_IMPORT_INTO_PER...2,SET,5,0.0031463,5.1915e-05,0.36752,0.49658,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_RECEPTOR_RECYCLING,0.988076523297491
GOBP_QUINONE_METABOLIC_PROCE...,SET,21,0.001441,4.8705e-05,0.1686,0.49659,GOBP_QUINONE_METABOLIC_PROCESS,0.988076523297491
GOMF_HISTONE_METHYLTRANSFERA...1,SET,58,0.00092392,5.1847e-05,0.1105,0.49666,GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY,0.988076523297491
REACTOME_REGULATION_OF_PTEN_...1,SET,56,0.00090429,4.9865e-05,0.11021,0.49673,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,0.988076523297491
GOMF_GLIAL_CELL_DERIVED_NEUR...,SET,5,0.0031866,5.2579e-05,0.38865,0.49673,GOMF_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_ACTIVITY,0.988076523297491
GSE45365_NK_CELL_VS_CD8_TCEL...3,SET,183,0.00052348,5.2001e-05,0.063918,0.49673,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP,0.988076523297491
GOMF_WW_DOMAIN_BINDING,SET,21,0.0014915,5.0414e-05,0.18271,0.49674,GOMF_WW_DOMAIN_BINDING,0.988076523297491
GOBP_CELL_COMMUNICATION_INVO...,SET,55,0.0010338,5.6495e-05,0.13058,0.49684,GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION,0.988076523297491
GSE8685_IL2_STARVED_VS_IL15_...2,SET,181,0.00050261,4.9657e-05,0.063419,0.49684,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,0.988076523297491
GOMF_PEPTIDE_N_ACETYLTRANSFE...,SET,46,0.00090224,4.5105e-05,0.11409,0.49685,GOMF_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY,0.988076523297491
GOMF_SHORT_CHAIN_CARBOXYLEST...,SET,6,0.002497,4.5133e-05,0.32676,0.49695,GOMF_SHORT_CHAIN_CARBOXYLESTERASE_ACTIVITY,0.988076523297491
GSE3982_MEMORY_CD4_TCELL_VS_...4,SET,168,0.00050648,4.8226e-05,0.066163,0.49695,GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP,0.988076523297491
GOBP_TYROSINE_CATABOLIC_PROC...,SET,6,0.0028051,5.0701e-05,0.37098,0.49698,GOBP_TYROSINE_CATABOLIC_PROCESS,0.988076523297491
HP_GIANT_SOMATOSENSORY_EVOKE...,SET,5,0.0027824,4.591e-05,0.36922,0.49699,HP_GIANT_SOMATOSENSORY_EVOKED_POTENTIALS,0.988076523297491
YAO_TEMPORAL_RESPONSE_TO_PRO...12,SET,13,0.0019491,5.1845e-05,0.25886,0.497,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,0.988076523297491
MIR3942_5P,SET,197,0.00048797,5.0275e-05,0.065016,0.49701,MIR3942_5P,0.988076523297491
ZNF558_TARGET_GENES,SET,225,0.0004185,4.6044e-05,0.056116,0.49702,ZNF558_TARGET_GENES,0.988076523297491
HP_CONGENITAL_HYPOTHYROIDISM,SET,30,0.0011871,4.7945e-05,0.1618,0.49707,HP_CONGENITAL_HYPOTHYROIDISM,0.988076523297491
MIR6851_5P,SET,94,0.00063389,4.5241e-05,0.086731,0.49708,MIR6851_5P,0.988076523297491
HP_LARYNGEAL_DYSTONIA,SET,13,0.0016968,4.5135e-05,0.23244,0.49709,HP_LARYNGEAL_DYSTONIA,0.988076523297491
MIR199B_5P,SET,164,0.00047119,4.4333e-05,0.065018,0.49711,MIR199B_5P,0.988076523297491
GOBP_POSITIVE_REGULATION_OF_...164,SET,8,0.0018703,3.9033e-05,0.25812,0.49711,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_CONDENSATION,0.988076523297491
GOCC_CONDENSIN_COMPLEX,SET,8,0.0018703,3.9033e-05,0.25812,0.49711,GOCC_CONDENSIN_COMPLEX,0.988076523297491
HALLMARK_INTERFERON_ALPHA_RE...,SET,93,0.00062786,4.4573e-05,0.088319,0.49716,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.988076523297491
HP_ABNORMAL_OSSIFICATION_INV...,SET,23,0.0012225,4.3241e-05,0.17255,0.49717,HP_ABNORMAL_OSSIFICATION_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.988076523297491
GSE2770_TGFB_AND_IL4_VS_IL12...6,SET,184,0.00042955,4.2786e-05,0.060949,0.49719,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.988076523297491
SMID_BREAST_CANCER_RELAPSE_I...3,SET,76,0.0007152,4.5919e-05,0.10349,0.49724,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,0.988076523297491
REACTOME_UPTAKE_AND_ACTIONS_...,SET,28,0.0011602,4.5274e-05,0.16798,0.49724,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,0.988076523297491
HP_ABNORMAL_DESCEMET_MEMBRAN...,SET,14,0.0017831,4.9219e-05,0.26057,0.49727,HP_ABNORMAL_DESCEMET_MEMBRANE_MORPHOLOGY,0.988076523297491
HP_COMMON_ATRIUM,SET,8,0.0020623,4.304e-05,0.30665,0.49732,HP_COMMON_ATRIUM,0.988076523297491
GOBP_REGULATION_OF_LONG_CHAI...1,SET,6,0.002291,4.1409e-05,0.34176,0.49733,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,0.988076523297491
GSE12963_UNINF_VS_ENV_AND_NE...4,SET,127,0.0005092,4.2203e-05,0.076545,0.49735,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.988076523297491
GSE12845_IGD_POS_BLOOD_VS_NA...1,SET,187,0.00039913,4.0075e-05,0.061031,0.49739,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.988076523297491
HP_ABNORMAL_CLITORIS_MORPHOL...,SET,81,0.00063515,4.2094e-05,0.098422,0.49743,HP_ABNORMAL_CLITORIS_MORPHOLOGY,0.988076523297491
PID_RETINOIC_ACID_PATHWAY,SET,30,0.00099003,3.9987e-05,0.15667,0.49748,PID_RETINOIC_ACID_PATHWAY,0.988076523297491
GSE24634_NAIVE_CD4_TCELL_VS_...2,SET,168,0.00041674,3.9682e-05,0.067036,0.49752,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP,0.988076523297491
GOCC_CHROMOCENTER,SET,13,0.001312,3.4899e-05,0.2118,0.49753,GOCC_CHROMOCENTER,0.988076523297491
MIR3622A_3P_MIR3622B_3P,SET,90,0.0005725,3.9985e-05,0.093505,0.49756,MIR3622A_3P_MIR3622B_3P,0.988076523297491
HP_ABNORMALITY_OF_THE_ELBOW,SET,246,0.00033269,3.8251e-05,0.055105,0.49759,HP_ABNORMALITY_OF_THE_ELBOW,0.988076523297491
GOBP_EATING_BEHAVIOR,SET,37,0.00091966,4.1243e-05,0.15294,0.4976,GOBP_EATING_BEHAVIOR,0.988076523297491
chr12q23,SET,68,0.0011956,7.2624e-05,0.1994,0.49761,chr12q23,0.988076523297491
HP_ABNORMAL_ATRIAL_ARRANGEME...,SET,41,0.00074968,3.5387e-05,0.12633,0.49763,HP_ABNORMAL_ATRIAL_ARRANGEMENT,0.988076523297491
MIR3175,SET,158,0.00039158,3.6169e-05,0.066193,0.49764,MIR3175,0.988076523297491
GOBP_REGULATION_OF_CELL_ADHE...1,SET,737,0.00019752,3.8772e-05,0.033339,0.49764,GOBP_REGULATION_OF_CELL_ADHESION,0.988076523297491
GOMF_DNA_BINDING_TRANSCRIPTI...4,SET,263,0.00031744,3.772e-05,0.053996,0.49765,GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY,0.988076523297491
HP_UPPER_EYELID_COLOBOMA,SET,9,0.0017278,3.8245e-05,0.29461,0.49766,HP_UPPER_EYELID_COLOBOMA,0.988076523297491
HP_ALOPECIA_OF_SCALP,SET,37,0.00080941,3.6299e-05,0.13888,0.49767,HP_ALOPECIA_OF_SCALP,0.988076523297491
GOBP_REGULATION_OF_CHOLESTER...3,SET,32,0.00088894,3.7079e-05,0.15443,0.4977,GOBP_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.988076523297491
GOBP_TYPE_II_INTERFERON_MEDI...,SET,26,0.00095909,3.6066e-05,0.16613,0.4977,GOBP_TYPE_II_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.988076523297491
GOBP_GPI_ANCHOR_METABOLIC_PR...,SET,30,0.00079842,3.2248e-05,0.14142,0.49775,GOBP_GPI_ANCHOR_METABOLIC_PROCESS,0.988076523297491
SHIPP_DLBCL_VS_FOLLICULAR_LY...1,SET,36,0.00080317,3.553e-05,0.1443,0.49778,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,0.988076523297491
GSE17974_0.5H_VS_72H_UNTREAT...1,SET,172,0.00034396,3.3135e-05,0.062135,0.49779,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,0.988076523297491
GOMF_DNA_EXONUCLEASE_ACTIVITY,SET,23,0.00088972,3.1471e-05,0.16249,0.49782,GOMF_DNA_EXONUCLEASE_ACTIVITY,0.988076523297491
GOBP_MAINTENANCE_OF_PRESYNAP...,SET,5,0.0022506,3.7135e-05,0.4253,0.49789,GOBP_MAINTENANCE_OF_PRESYNAPTIC_ACTIVE_ZONE_STRUCTURE,0.988076523297491
HP_UNUSUAL_INFECTION,SET,917,0.00015286,3.3298e-05,0.02902,0.4979,HP_UNUSUAL_INFECTION,0.988076523297491
HP_MIGRAINE,SET,120,0.00040197,3.2391e-05,0.079506,0.49798,HP_MIGRAINE,0.988076523297491
GSE15624_CTRL_VS_3H_HALOFUGI...2,SET,147,0.00034613,3.0848e-05,0.068653,0.49799,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.988076523297491
GCM_MYCL1,SET,23,0.00083266,2.9453e-05,0.16598,0.498,GCM_MYCL1,0.988076523297491
GOBP_NEUROFILAMENT_CYTOSKELE...,SET,10,0.0012835,2.9947e-05,0.25884,0.49802,GOBP_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION,0.988076523297491
HOEK_NK_CELL_2011_2012_TIV_A...3,SET,13,0.0012365,3.289e-05,0.24872,0.49802,HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP,0.988076523297491
GOCC_NUCLEAR_INNER_MEMBRANE,SET,48,0.00058754,3.0002e-05,0.11904,0.49803,GOCC_NUCLEAR_INNER_MEMBRANE,0.988076523297491
CREB_Q4,SET,236,0.00027629,3.1122e-05,0.056578,0.49805,CREB_Q4,0.988076523297491
LI_PROSTATE_CANCER_EPIGENETIC,SET,30,0.0007972,3.2199e-05,0.1659,0.49808,LI_PROSTATE_CANCER_EPIGENETIC,0.988076523297491
GOBP_SKELETAL_MUSCLE_CELL_PR...,SET,23,0.00081143,2.8702e-05,0.17322,0.49813,GOBP_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.988076523297491
BIOCARTA_CBL_PATHWAY,SET,11,0.0012,2.9363e-05,0.26073,0.49816,BIOCARTA_CBL_PATHWAY,0.988076523297491
ANDERSEN_LIVER_CANCER_KRT19_...2,SET,33,0.00066603,2.8211e-05,0.14512,0.49817,ANDERSEN_LIVER_CANCER_KRT19_UP,0.988076523297491
MORF_ERCC4,SET,286,0.00023721,2.9374e-05,0.05183,0.49817,MORF_ERCC4,0.988076523297491
GOBP_EOSINOPHIL_DIFFERENTIAT...,SET,6,0.0016307,2.9475e-05,0.36136,0.4982,GOBP_EOSINOPHIL_DIFFERENTIATION,0.988076523297491
MIR3907,SET,49,0.00052803,2.7242e-05,0.1186,0.49822,MIR3907,0.988076523297491
HP_ATROPHY_DEGENERATION_INVO...3,SET,19,0.00083282,2.6777e-05,0.1888,0.49824,HP_ATROPHY_DEGENERATION_INVOLVING_THE_SPINAL_CORD,0.988076523297491
REACTOME_ACTIVATION_OF_NMDA_...,SET,85,0.00042592,2.8913e-05,0.096836,0.49825,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,0.988076523297491
GOBP_REGULATION_OF_MEMBRANE_...12,SET,4,0.0020775,3.0662e-05,0.47242,0.49825,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.988076523297491
GOBP_REGULATION_OF_MEMBRANE_...13,SET,4,0.0020775,3.0662e-05,0.47242,0.49825,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.988076523297491
GOMF_PROTEIN_CONTAINING_COMP...1,SET,1560,9.5911e-05,2.6743e-05,0.022633,0.49831,GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING,0.988076523297491
GOBP_HOMOLOGOUS_CHROMOSOME_S...,SET,56,0.00045149,2.4897e-05,0.10698,0.49832,GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION,0.988076523297491
GARGALOVIC_RESPONSE_TO_OXIDI...13,SET,10,0.0012182,2.8424e-05,0.29085,0.49833,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN,0.988076523297491
HP_SHUFFLING_GAIT,SET,30,0.00064812,2.6177e-05,0.15738,0.49836,HP_SHUFFLING_GAIT,0.988076523297491
GSE32986_CURDLAN_LOWDOSE_VS_...3,SET,180,0.00024911,2.4544e-05,0.060627,0.49836,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.988076523297491
GOMF_FLOPPASE_ACTIVITY,SET,15,0.00095867,2.7391e-05,0.23394,0.49837,GOMF_FLOPPASE_ACTIVITY,0.988076523297491
GSE34156_NOD2_LIGAND_VS_TLR1...2,SET,152,0.00027685,2.5086e-05,0.069134,0.4984,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.988076523297491
AR_03,SET,54,0.00043974,2.3813e-05,0.11395,0.49846,AR_03,0.988076523297491
REACTOME_SIGNALING_BY_MAPK_M...,SET,6,0.0015056,2.7213e-05,0.39607,0.49848,REACTOME_SIGNALING_BY_MAPK_MUTANTS,0.988076523297491
GOBP_TYPE_2_IMMUNE_RESPONSE,SET,41,0.00053443,2.5227e-05,0.14256,0.4985,GOBP_TYPE_2_IMMUNE_RESPONSE,0.988076523297491
GSE14000_UNSTIM_VS_4H_LPS_DC...1,SET,179,0.00025075,2.4637e-05,0.067357,0.49851,GSE14000_UNSTIM_VS_4H_LPS_DC_DN,0.988076523297491
GOBP_NEGATIVE_REGULATION_BY_...3,SET,14,0.00080498,2.222e-05,0.22659,0.49858,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,0.988076523297491
GSE3982_DC_VS_BCELL_UP,SET,183,0.00022432,2.2284e-05,0.065591,0.49864,GSE3982_DC_VS_BCELL_UP,0.988076523297491
GOBP_REGULATION_OF_CELL_FATE...1,SET,38,0.00048602,2.2088e-05,0.14362,0.49865,GOBP_REGULATION_OF_CELL_FATE_COMMITMENT,0.988076523297491
GOBP_ENERGY_HOMEOSTASIS,SET,75,0.0003252,2.0743e-05,0.10444,0.49876,GOBP_ENERGY_HOMEOSTASIS,0.988076523297491
HP_RHABDOMYOLYSIS,SET,37,0.00040844,1.8317e-05,0.13267,0.49877,HP_RHABDOMYOLYSIS,0.988076523297491
HP_ABNORMAL_HAIR_PATTERN,SET,308,0.00014984,1.9244e-05,0.048836,0.49878,HP_ABNORMAL_HAIR_PATTERN,0.988076523297491
GOMF_VOLTAGE_GATED_POTASSIUM...2,SET,14,0.00076873,2.122e-05,0.25314,0.49879,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.988076523297491
GSE43955_TH0_VS_TGFB_IL6_IL2...4,SET,184,0.00018376,1.8304e-05,0.062151,0.49882,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.988076523297491
FAN_OVARY_CL16_LYMPHATIC_END...,SET,206,0.00018624,1.9616e-05,0.062933,0.49882,FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL,0.988076523297491
chr12q24,SET,200,0.00039489,4.099e-05,0.13501,0.49883,chr12q24,0.988076523297491
REACTOME_GOLGI_TO_ER_RETROGR...,SET,129,0.00020144,1.6826e-05,0.070596,0.49886,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,0.988076523297491
GOBP_NEGATIVE_REGULATION_OF_...108,SET,351,0.00012933,1.771e-05,0.045135,0.49886,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE,0.988076523297491
ZAMORA_NOS2_TARGETS_UP,SET,51,0.00033644,1.7707e-05,0.11936,0.49888,ZAMORA_NOS2_TARGETS_UP,0.988076523297491
REN_BOUND_BY_E2F,SET,53,0.00029502,1.5828e-05,0.10817,0.49891,REN_BOUND_BY_E2F,0.988076523297491
GOBP_NEGATIVE_REGULATION_OF_...119,SET,29,0.00042435,1.6852e-05,0.16199,0.49895,GOBP_NEGATIVE_REGULATION_OF_CELL_KILLING,0.988076523297491
GSE17301_CTRL_VS_48H_ACD3_AC...6,SET,177,0.00016208,1.5837e-05,0.063293,0.49898,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP,0.988076523297491
GOBP_POSITIVE_REGULATION_OF_...315,SET,8,0.00086994,1.8155e-05,0.34971,0.49901,GOBP_POSITIVE_REGULATION_OF_GONAD_DEVELOPMENT,0.988076523297491
GOBP_REGULATION_OF_PROTEIN_K...4,SET,3,0.001465,1.8725e-05,0.58894,0.49901,GOBP_REGULATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.988076523297491
GOBP_RRNA_PSEUDOURIDINE_SYNT...,SET,7,0.00071808,1.4018e-05,0.29275,0.49902,GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS,0.988076523297491
NIKOLSKY_BREAST_CANCER_20P13...,SET,7,0.0010815,2.1114e-05,0.44805,0.49904,NIKOLSKY_BREAST_CANCER_20P13_AMPLICON,0.988076523297491
KEGG_NICOTINATE_AND_NICOTINA...,SET,24,0.00044886,1.6218e-05,0.18632,0.49904,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,0.988076523297491
MODULE_4,SET,19,0.00041656,1.3393e-05,0.17393,0.49904,MODULE_4,0.988076523297491
JIANG_HYPOXIA_VIA_VHL,SET,17,0.00047249,1.4371e-05,0.20441,0.49908,JIANG_HYPOXIA_VIA_VHL,0.988076523297491
SCIAN_INVERSED_TARGETS_OF_TP...2,SET,9,0.00068507,1.5164e-05,0.29721,0.49908,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP,0.988076523297491
GOBP_CELLULAR_RESPONSE_TO_PO...,SET,12,0.00062167,1.5888e-05,0.2713,0.49909,GOBP_CELLULAR_RESPONSE_TO_POTASSIUM_ION,0.988076523297491
GNF2_DEK,SET,51,0.00022679,1.1936e-05,0.10957,0.49917,GNF2_DEK,0.988076523297491
GOMF_HISTONE_DEUBIQUITINASE_...,SET,7,0.00048947,9.5555e-06,0.24579,0.49921,GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY,0.988076523297491
HP_ABNORMAL_PERIFOLLICULAR_M...,SET,5,0.0010054,1.659e-05,0.51706,0.49922,HP_ABNORMAL_PERIFOLLICULAR_MORPHOLOGY,0.988076523297491
CUI_DEVELOPING_HEART_C6_EPIC...,SET,178,0.00013021,1.2759e-05,0.069039,0.49925,CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL,0.988076523297491
GSE6269_E_COLI_VS_STREP_PNEU...2,SET,145,0.000135,1.1949e-05,0.073249,0.49926,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP,0.988076523297491
RYAAAKNNNNNNTTGW_UNKNOWN,SET,74,0.00019366,1.227e-05,0.10574,0.49927,RYAAAKNNNNNNTTGW_UNKNOWN,0.988076523297491
KEGG_GRAFT_VERSUS_HOST_DISEA...,SET,33,0.00030164,1.2777e-05,0.16948,0.49929,KEGG_GRAFT_VERSUS_HOST_DISEASE,0.988076523297491
chr6q12,SET,5,0.0010817,1.7848e-05,0.62247,0.49931,chr6q12,0.988076523297491
GRADE_COLON_VS_RECTAL_CANCER...2,SET,34,0.00025755,1.1073e-05,0.14965,0.49931,GRADE_COLON_VS_RECTAL_CANCER_UP,0.988076523297491
MODULE_480,SET,82,0.00015704,1.0471e-05,0.090848,0.49931,MODULE_480,0.988076523297491
MIR8083,SET,49,0.00020468,1.056e-05,0.11944,0.49932,MIR8083,0.988076523297491
GOMF_PHOSPHATE_TRANSMEMBRANE...,SET,16,0.00035339,1.0428e-05,0.22201,0.49936,GOMF_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.988076523297491
MIR6891_3P,SET,62,0.0001638,9.5025e-06,0.10879,0.4994,MIR6891_3P,0.988076523297491
HP_ABNORMAL_FOVEAL_MORPHOLOG...,SET,6,0.00055739,1.0075e-05,0.36917,0.4994,HP_ABNORMAL_FOVEAL_MORPHOLOGY_ON_MACULAR_OCT,0.988076523297491
GAVISH_3CA_METAPROGRAM_EPITH...2,SET,42,0.00019925,9.5191e-06,0.14018,0.49943,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ANDROGEN_PROSTATE,0.988076523297491
GNF2_MBD4,SET,22,0.0002342,8.1022e-06,0.16876,0.49945,GNF2_MBD4,0.988076523297491
KEGG_AMINOACYL_TRNA_BIOSYNTH...,SET,22,0.00022412,7.7535e-06,0.16877,0.49947,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,0.988076523297491
GOBP_POSITIVE_REGULATION_OF_...761,SET,13,0.00029872,7.9459e-06,0.22763,0.49948,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.988076523297491
GOBP_CANNABINOID_SIGNALING_P...,SET,7,0.0004543,8.869e-06,0.35252,0.49949,GOBP_CANNABINOID_SIGNALING_PATHWAY,0.988076523297491
MIR5008_5P,SET,78,0.00011128,7.238e-06,0.092545,0.49952,MIR5008_5P,0.988076523297491
HP_DESMOID_TUMORS,SET,6,0.0004295,7.763e-06,0.37208,0.49954,HP_DESMOID_TUMORS,0.988076523297491
GOBP_POSITIVE_REGULATION_OF_...291,SET,9,0.00035518,7.8619e-06,0.31249,0.49955,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,0.988076523297491
KEGG_MEDICUS_ENV_FACTOR_META...3,SET,14,0.00021649,5.9758e-06,0.21006,0.49959,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY,0.988076523297491
MIR4676_5P,SET,51,0.00011424,6.0128e-06,0.1141,0.4996,MIR4676_5P,0.988076523297491
GOMF_TROPOMYOSIN_BINDING,SET,14,0.00020828,5.7494e-06,0.21888,0.49962,GOMF_TROPOMYOSIN_BINDING,0.988076523297491
PROVENZANI_METASTASIS_UP,SET,169,6.2609e-05,5.9791e-06,0.069308,0.49964,PROVENZANI_METASTASIS_UP,0.988076523297491
GOBP_FORELIMB_MORPHOGENESIS,SET,38,0.00012407,5.6385e-06,0.15236,0.49968,GOBP_FORELIMB_MORPHOGENESIS,0.988076523297491
HP_CALVARIAL_HYPEROSTOSIS,SET,10,0.00018386,4.2897e-06,0.24743,0.4997,HP_CALVARIAL_HYPEROSTOSIS,0.988076523297491
HP_RECURRENT_GRAM_NEGATIVE_B...,SET,32,0.00011976,4.9952e-06,0.1641,0.49971,HP_RECURRENT_GRAM_NEGATIVE_BACTERIAL_INFECTIONS,0.988076523297491
GSE31622_WT_VS_KLF3_KO_BCELL...1,SET,178,3.6967e-05,3.6222e-06,0.065808,0.49978,GSE31622_WT_VS_KLF3_KO_BCELL_DN,0.988158715439754
PID_RAC1_PATHWAY,SET,51,4.0246e-05,2.1182e-06,0.12084,0.49987,PID_RAC1_PATHWAY,0.988280439729222
GOBP_PEPTIDYL_LYSINE_DIMETHY...,SET,4,5.3142e-05,7.843e-07,0.45132,0.49995,GOBP_PEPTIDYL_LYSINE_DIMETHYLATION,0.988312574645965
GOBP_TRANSEPITHELIAL_CHLORID...,SET,8,3.3631e-05,7.0187e-07,0.32419,0.49996,GOBP_TRANSEPITHELIAL_CHLORIDE_TRANSPORT,0.988312574645965
HP_ABNORMAL_CORNEAL_ENDOTHEL...,SET,18,2.9772e-07,9.3175e-09,0.22453,0.5,HP_ABNORMAL_CORNEAL_ENDOTHELIUM_MORPHOLOGY,0.988312574645965
HP_SHORT_NASAL_BRIDGE,SET,5,4.8788e-06,8.0501e-08,0.45855,0.5,HP_SHORT_NASAL_BRIDGE,0.988312574645965
ACCGAGC_MIR423,SET,5,-0.00016174,-2.6688e-06,0.42784,0.50015,ACCGAGC_MIR423,0.988407064475779
HP_FLAT_FOREHEAD,SET,15,-8.7318e-05,-2.4948e-06,0.21439,0.50016,HP_FLAT_FOREHEAD,0.988407064475779
GOBP_CELL_JUNCTION_ORGANIZAT...,SET,704,-1.6619e-05,-3.1912e-06,0.034898,0.50019,GOBP_CELL_JUNCTION_ORGANIZATION,0.988407064475779
GSE11864_CSF1_PAM3CYS_VS_CSF...2,SET,166,-3.1064e-05,-2.9404e-06,0.066562,0.50019,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.988407064475779
TRAVAGLINI_LUNG_BASOPHIL_MAS...2,SET,423,-2.0426e-05,-3.0644e-06,0.042974,0.50019,TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL,0.988407064475779
GOBP_MRNA_TRANSPORT,SET,112,-4.6254e-05,-3.6016e-06,0.075377,0.50024,GOBP_MRNA_TRANSPORT,0.988408891730605
HP_CEREBRAL_WHITE_MATTER_ATR...,SET,56,-7.0006e-05,-3.8604e-06,0.11284,0.50025,HP_CEREBRAL_WHITE_MATTER_ATROPHY,0.988408891730605
HP_QUADRICEPS_MUSCLE_ATROPHY,SET,3,-0.00038358,-4.9027e-06,0.53496,0.50029,HP_QUADRICEPS_MUSCLE_ATROPHY,0.988408891730605
HP_FACIAL_DIPLEGIA,SET,39,-0.00011505,-5.297e-06,0.13403,0.50034,HP_FACIAL_DIPLEGIA,0.988408891730605
GOBP_RESPONSE_TO_RETINOIC_AC...,SET,101,-8.1607e-05,-6.036e-06,0.092225,0.50035,GOBP_RESPONSE_TO_RETINOIC_ACID,0.988408891730605
DESCARTES_FETAL_HEART_STROMA...,SET,25,-0.0001729,-6.3757e-06,0.18495,0.50037,DESCARTES_FETAL_HEART_STROMAL_CELLS,0.988408891730605
GOBP_MYOBLAST_FUSION_INVOLVE...,SET,3,-0.00056027,-7.1612e-06,0.57824,0.50039,GOBP_MYOBLAST_FUSION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.988408891730605
HP_APLASIA_HYPOPLASIA_OF_THE...17,SET,43,-0.00016761,-8.1021e-06,0.12473,0.50054,HP_APLASIA_HYPOPLASIA_OF_THE_CLAVICLES,0.988632312325965
GOBP_VENTRICULAR_CARDIAC_MUS...3,SET,14,-0.00036194,-9.9908e-06,0.25837,0.50056,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.988632312325965
MIR10399_3P,SET,8,-0.00047981,-1.0013e-05,0.29717,0.50064,MIR10399_3P,0.988684080449974
GOLDRATH_ANTIGEN_RESPONSE,SET,322,-7.97e-05,-1.0462e-05,0.047968,0.50066,GOLDRATH_ANTIGEN_RESPONSE,0.988684080449974
REACTOME_CYTOSOLIC_TRNA_AMIN...,SET,6,-0.00048471,-8.7609e-06,0.28392,0.50068,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,0.988684080449974
ZNF544_TARGET_GENES,SET,3,-0.00073473,-9.3911e-06,0.41747,0.5007,ZNF544_TARGET_GENES,0.988684080449974
GOBP_HORMONE_MEDIATED_APOPTO...,SET,5,-0.00083028,-1.37e-05,0.42522,0.50078,GOBP_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY,0.988749443276714
GOBP_REGULATION_OF_CELLULAR_...3,SET,897,-5.781e-05,-1.2462e-05,0.029234,0.50079,GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.988749443276714
BERTUCCI_MEDULLARY_VS_DUCTAL...2,SET,171,-0.00013939,-1.339e-05,0.066492,0.50084,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,0.988791990456714
MODULE_421,SET,15,-0.00050629,-1.4465e-05,0.22243,0.50091,MODULE_421,0.988874015904572
MIR1203,SET,4,-0.00098909,-1.4598e-05,0.41357,0.50095,MIR1203,0.988896810746337
HP_ABNORMAL_MACROPHAGE_MORPH...,SET,41,-0.0003767,-1.7781e-05,0.1516,0.50099,HP_ABNORMAL_MACROPHAGE_MORPHOLOGY,0.988902916288051
HP_AORTIC_DISSECTION,SET,37,-0.00039058,-1.7516e-05,0.15378,0.50101,HP_AORTIC_DISSECTION,0.988902916288051
GOBP_REGULATION_OF_NEURON_MI...,SET,43,-0.00036111,-1.7455e-05,0.13779,0.50105,GOBP_REGULATION_OF_NEURON_MIGRATION,0.988904544422367
HP_NEONATAL_HYPERBILIRUBINEM...,SET,22,-0.0005079,-1.7571e-05,0.18336,0.50111,HP_NEONATAL_HYPERBILIRUBINEMIA,0.988904544422367
HP_PROLONGED_NEONATAL_JAUNDI...,SET,63,-0.00029848,-1.7454e-05,0.10565,0.50113,HP_PROLONGED_NEONATAL_JAUNDICE,0.988904544422367
HOEK_T_CELL_2011_2012_TIV_AD...5,SET,2,-0.0014211,-1.4831e-05,0.4963,0.50114,HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP,0.988904544422367
HP_OCULOMOTOR_NERVE_PALSY,SET,27,-0.00048634,-1.8636e-05,0.16411,0.50118,HP_OCULOMOTOR_NERVE_PALSY,0.988904544422367
GOMF_HMG_BOX_DOMAIN_BINDING,SET,12,-0.00070708,-1.8071e-05,0.23669,0.50119,GOMF_HMG_BOX_DOMAIN_BINDING,0.988904544422367
PID_CD8_TCR_DOWNSTREAM_PATHW...,SET,61,-0.00036347,-2.0916e-05,0.11995,0.50121,PID_CD8_TCR_DOWNSTREAM_PATHWAY,0.988904544422367
RNCTGNYNRNCTGNY_UNKNOWN,SET,65,-0.0003398,-2.0183e-05,0.10776,0.50126,RNCTGNYNRNCTGNY_UNKNOWN,0.988947053814714
KEGG_MEDICUS_PATHOGEN_KSHV_V...5,SET,24,-0.00062334,-2.2522e-05,0.1834,0.50136,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,0.988961335333409
HP_COLOR_VISION_TEST_ABNORMA...,SET,9,-0.0011097,-2.4564e-05,0.32567,0.50136,HP_COLOR_VISION_TEST_ABNORMALITY,0.988961335333409
GSE28737_BCL6_HET_VS_BCL6_KO...1,SET,185,-0.00022595,-2.2567e-05,0.062554,0.50144,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.988961335333409
HP_ABNORMAL_SMALL_INTESTINE_...,SET,244,-0.00020049,-2.2959e-05,0.054518,0.50147,HP_ABNORMAL_SMALL_INTESTINE_MORPHOLOGY,0.988961335333409
GOBP_PROTEIN_INSERTION_INTO_...3,SET,40,-0.00048908,-2.2803e-05,0.13181,0.50148,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE,0.988961335333409
GOBP_ENDOPLASMIC_RETICULUM_P...,SET,5,-0.0015272,-2.52e-05,0.40329,0.50151,GOBP_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_TETHERING,0.988961335333409
GOBP_POSITIVE_REGULATION_OF_...787,SET,12,-0.00085197,-2.1774e-05,0.22269,0.50153,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.988961335333409
MIR6510_5P,SET,78,-0.00036553,-2.3774e-05,0.09411,0.50155,MIR6510_5P,0.988961335333409
GOBP_CILIUM_OR_FLAGELLUM_DEP...,SET,149,-0.00027328,-2.4518e-05,0.068799,0.50158,GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY,0.988961335333409
KIM_TIAL1_TARGETS,SET,29,-0.0006503,-2.5825e-05,0.16358,0.50159,KIM_TIAL1_TARGETS,0.988961335333409
HP_BILATERAL_PTOSIS,SET,63,-0.00045866,-2.6821e-05,0.10867,0.50168,HP_BILATERAL_PTOSIS,0.988961335333409
GSE19888_ADENOSINE_A3R_INH_V...3,SET,179,-0.00028455,-2.7959e-05,0.06487,0.50175,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN,0.988961335333409
HP_HYPERCONVEX_FINGERNAILS,SET,6,-0.0017032,-3.0785e-05,0.38587,0.50176,HP_HYPERCONVEX_FINGERNAILS,0.988961335333409
HP_FINGER_SYNDACTYLY,SET,177,-0.00028451,-2.78e-05,0.063455,0.50179,HP_FINGER_SYNDACTYLY,0.988961335333409
GOBP_FLUID_TRANSPORT,SET,35,-0.00074161,-3.2349e-05,0.16403,0.5018,GOBP_FLUID_TRANSPORT,0.988961335333409
GSE27786_CD8_TCELL_VS_NEUTRO...1,SET,179,-0.00027931,-2.7444e-05,0.061102,0.50182,GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN,0.988961335333409
REACTOME_HEDGEHOG_ON_STATE,SET,82,-0.00039858,-2.6578e-05,0.086262,0.50184,REACTOME_HEDGEHOG_ON_STATE,0.988961335333409
GOMF_FUCOSYLTRANSFERASE_ACTI...,SET,13,-0.0011964,-3.1823e-05,0.2587,0.50184,GOMF_FUCOSYLTRANSFERASE_ACTIVITY,0.988961335333409
HP_HYPOPLASTIC_ILIA,SET,47,-0.00059031,-2.9829e-05,0.12595,0.50187,HP_HYPOPLASTIC_ILIA,0.988961335333409
HP_TONIC_SEIZURE,SET,121,-0.00036226,-2.9312e-05,0.075769,0.50191,HP_TONIC_SEIZURE,0.988961335333409
MIR34B_5P,SET,120,-0.00039314,-3.168e-05,0.080654,0.50194,MIR34B_5P,0.988961335333409
GOBP_METHIONINE_METABOLIC_PR...,SET,15,-0.0011412,-3.2606e-05,0.22762,0.502,GOBP_METHIONINE_METABOLIC_PROCESS,0.988961335333409
GSE18791_UNSTIM_VS_NEWCATSLE...4,SET,176,-0.00030848,-3.0058e-05,0.061545,0.502,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP,0.988961335333409
HU_FETAL_RETINA_RGC,SET,393,-0.00022507,-3.2574e-05,0.044375,0.50202,HU_FETAL_RETINA_RGC,0.988961335333409
GOBP_ENDOPLASMIC_RETICULUM_U...,SET,70,-0.00052311,-3.2239e-05,0.10196,0.50205,GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.988961335333409
GOLDRATH_NAIVE_VS_MEMORY_CD8...1,SET,183,-0.00033056,-3.2837e-05,0.064331,0.50205,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.988961335333409
HU_FETAL_RETINA_AMACRINE,SET,57,-0.00065772,-3.6591e-05,0.12667,0.50207,HU_FETAL_RETINA_AMACRINE,0.988961335333409
GOBP_INTRACELLULAR_DISTRIBUT...,SET,7,-0.0018015,-3.517e-05,0.3462,0.50208,GOBP_INTRACELLULAR_DISTRIBUTION_OF_MITOCHONDRIA,0.988961335333409
HP_SUBCUTANEOUS_LIPOMA,SET,7,-0.0017055,-3.3295e-05,0.32081,0.50212,HP_SUBCUTANEOUS_LIPOMA,0.988961335333409
KEGG_MEDICUS_REFERENCE_ORGAN...2,SET,16,-0.0012222,-3.6064e-05,0.22878,0.50213,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE,0.988961335333409
GOBP_CENTRAL_NERVOUS_SYSTEM_...6,SET,76,-0.00057148,-3.6692e-05,0.10622,0.50215,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT,0.988961335333409
HOLLERN_SOLID_NODULAR_BREAST...1,SET,29,-0.0010127,-4.0215e-05,0.17885,0.50226,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,0.988961335333409
HP_VERTICAL_SUPRANUCLEAR_GAZ...,SET,26,-0.00098368,-3.6991e-05,0.17115,0.50229,HP_VERTICAL_SUPRANUCLEAR_GAZE_PALSY,0.988961335333409
GOMF_PHOSPHATIDYLINOSITOL_3_...2,SET,6,-0.0018086,-3.2689e-05,0.30341,0.50238,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.988961335333409
GSE17721_CTRL_VS_PAM3CSK4_4H...1,SET,187,-0.00037193,-3.7344e-05,0.061822,0.5024,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN,0.988961335333409
YATTNATC_UNKNOWN,SET,340,-0.00029941,-4.0366e-05,0.048747,0.50245,YATTNATC_UNKNOWN,0.988961335333409
HP_PREMATURE_BIRTH,SET,151,-0.00041209,-3.7218e-05,0.06723,0.50245,HP_PREMATURE_BIRTH,0.988961335333409
ZHOU_TNF_SIGNALING_30MIN,SET,42,-0.00079612,-3.8034e-05,0.12864,0.50247,ZHOU_TNF_SIGNALING_30MIN,0.988961335333409
KEGG_MEDICUS_REFERENCE_PRL_J...,SET,5,-0.0031488,-5.1956e-05,0.50712,0.50248,KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY,0.988961335333409
MIR548AD_3P,SET,23,-0.0011711,-4.1424e-05,0.18844,0.50248,MIR548AD_3P,0.988961335333409
GOBP_PORPHYRIN_CONTAINING_CO...,SET,48,-0.00074312,-3.7947e-05,0.11953,0.50248,GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.988961335333409
ROETH_TERT_TARGETS_DN,SET,9,-0.0019041,-4.2147e-05,0.29674,0.50256,ROETH_TERT_TARGETS_DN,0.988961335333409
GOBP_NEGATIVE_REGULATION_OF_...89,SET,9,-0.0019215,-4.2533e-05,0.29798,0.50257,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.988961335333409
YAUCH_HEDGEHOG_SIGNALING_PAR...2,SET,132,-0.00052468,-4.4328e-05,0.079385,0.50264,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,0.988961335333409
HP_MUSCLE_FIBER_TUBULAR_INCL...,SET,7,-0.0020835,-4.0674e-05,0.31334,0.50265,HP_MUSCLE_FIBER_TUBULAR_INCLUSIONS,0.988961335333409
MIR4722_3P,SET,79,-0.00064942,-4.2508e-05,0.097418,0.50266,MIR4722_3P,0.988961335333409
GOBP_NEGATIVE_REGULATION_OF_...250,SET,10,-0.0018754,-4.3756e-05,0.28135,0.50266,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,0.988961335333409
AEBP2_TARGET_GENES,SET,990,-0.0001858,-4.1964e-05,0.0278,0.50267,AEBP2_TARGET_GENES,0.988961335333409
GOBP_STEROID_METABOLIC_PROCE...,SET,299,-0.00034986,-4.4282e-05,0.052342,0.50267,GOBP_STEROID_METABOLIC_PROCESS,0.988961335333409
GOBP_REGULATION_OF_IMMUNE_SY...,SET,1403,-0.00016465,-4.3743e-05,0.024455,0.50269,GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.988961335333409
GOBP_INTEGRIN_BIOSYNTHETIC_P...,SET,4,-0.0034965,-5.1603e-05,0.49676,0.50281,GOBP_INTEGRIN_BIOSYNTHETIC_PROCESS,0.9891414246901
GOBP_MYELOID_LEUKOCYTE_MEDIA...,SET,107,-0.00060063,-4.5719e-05,0.083882,0.50286,GOBP_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.989183795562599
CUI_DEVELOPING_HEART_VALVAR_...,SET,126,-0.00059389,-4.903e-05,0.08211,0.50289,CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL,0.98918682155187
GOBP_CELLULAR_RESPONSE_TO_FL...,SET,19,-0.0016072,-5.1677e-05,0.21598,0.50297,GOBP_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS,0.989288112876774
NAKAMURA_LUNG_CANCER_DIFFERE...,SET,12,-0.0019394,-4.9566e-05,0.25627,0.50302,NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS,0.989288112876774
MIR6747_5P,SET,40,-0.0010011,-4.6677e-05,0.13047,0.50306,MIR6747_5P,0.989288112876774
GOBP_CELL_CELL_SIGNALING,SET,1197,-0.00020808,-5.1368e-05,0.026899,0.50309,GOBP_CELL_CELL_SIGNALING,0.989288112876774
HP_TOXEMIA_OF_PREGNANCY,SET,24,-0.001437,-5.1921e-05,0.1851,0.5031,HP_TOXEMIA_OF_PREGNANCY,0.989288112876774
ZNF236_TARGET_GENES,SET,212,-0.00046126,-4.9279e-05,0.058487,0.50315,ZNF236_TARGET_GENES,0.989288112876774
GSE2706_UNSTIM_VS_2H_LPS_AND...1,SET,169,-0.00055639,-5.3135e-05,0.069973,0.50317,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN,0.989288112876774
BLANCO_MELO_RESPIRATORY_SYNC...2,SET,272,-0.0004514,-5.4534e-05,0.056448,0.50319,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,0.989288112876774
GSE32533_MIR17_KO_VS_MIR17_O...2,SET,180,-0.00050835,-5.0087e-05,0.062877,0.50323,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.989288112876774
HP_SKIN_PICKING,SET,12,-0.0021453,-5.4829e-05,0.25994,0.50329,HP_SKIN_PICKING,0.989288112876774
HP_ABNORMAL_REFLEX,SET,1088,-0.00021602,-5.1003e-05,0.025974,0.50332,HP_ABNORMAL_REFLEX,0.989288112876774
DOANE_RESPONSE_TO_ANDROGEN_UP,SET,162,-0.0005491,-5.1351e-05,0.065688,0.50333,DOANE_RESPONSE_TO_ANDROGEN_UP,0.989288112876774
GOBP_POSITIVE_REGULATION_OF_...313,SET,4,-0.0036842,-5.4374e-05,0.44095,0.50333,GOBP_POSITIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.989288112876774
MODULE_358,SET,71,-0.00084752,-5.2602e-05,0.10117,0.50334,MODULE_358,0.989288112876774
HP_NORMOCYTIC_ANEMIA,SET,15,-0.0017397,-4.9706e-05,0.20278,0.50342,HP_NORMOCYTIC_ANEMIA,0.98935913100017
GSE21546_SAP1A_KO_VS_SAP1A_K...4,SET,175,-0.00053409,-5.1894e-05,0.061475,0.50347,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.98935913100017
HP_DECREASED_SERUM_LEPTIN,SET,11,-0.0021713,-5.3132e-05,0.24896,0.50348,HP_DECREASED_SERUM_LEPTIN,0.98935913100017
GSE30083_SP1_VS_SP4_THYMOCYT...1,SET,189,-0.00055073,-5.5589e-05,0.062993,0.50349,GSE30083_SP1_VS_SP4_THYMOCYTE_DN,0.98935913100017
HP_BILATERAL_CONDUCTIVE_HEAR...,SET,6,-0.002717,-4.9108e-05,0.30342,0.50357,HP_BILATERAL_CONDUCTIVE_HEARING_IMPAIRMENT,0.989378345368385
GOMF_PYRIMIDINE_NUCLEOTIDE_B...,SET,5,-0.0032333,-5.335e-05,0.34412,0.50375,GOMF_PYRIMIDINE_NUCLEOTIDE_BINDING,0.989378345368385
GOBP_PROTEIN_OXIDATION,SET,12,-0.0025827,-6.6005e-05,0.27126,0.5038,GOBP_PROTEIN_OXIDATION,0.989378345368385
GOBP_POSITIVE_REGULATION_OF_...120,SET,300,-0.00049188,-6.2361e-05,0.050474,0.50389,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE,0.989378345368385
REACTOME_TELOMERE_C_STRAND_S...,SET,11,-0.0022584,-5.5263e-05,0.2302,0.50391,REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION,0.989378345368385
REACTOME_TCR_SIGNALING,SET,108,-0.00077464,-5.9237e-05,0.078716,0.50393,REACTOME_TCR_SIGNALING,0.989378345368385
HP_ABNORMAL_ANTERIOR_HORN_CE...,SET,18,-0.0019942,-6.2411e-05,0.2023,0.50393,HP_ABNORMAL_ANTERIOR_HORN_CELL_MORPHOLOGY,0.989378345368385
BIOCARTA_RNA_PATHWAY,SET,10,-0.0026509,-6.185e-05,0.26827,0.50394,BIOCARTA_RNA_PATHWAY,0.989378345368385
GOCC_CALCIUM_CHANNEL_COMPLEX,SET,63,-0.0011057,-6.4657e-05,0.11193,0.50394,GOCC_CALCIUM_CHANNEL_COMPLEX,0.989378345368385
MODULE_311,SET,16,-0.0022456,-6.6263e-05,0.22499,0.50398,MODULE_311,0.989378345368385
GINESTIER_BREAST_CANCER_20Q1...1,SET,157,-0.0006284,-5.7861e-05,0.062475,0.50401,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,0.989378345368385
MIR216B_5P,SET,85,-0.00098152,-6.6629e-05,0.096982,0.50404,MIR216B_5P,0.989378345368385
GOBP_G_PROTEIN_COUPLED_ACETY...,SET,20,-0.0020112,-6.6342e-05,0.19862,0.50404,GOBP_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.989378345368385
SENGUPTA_NASOPHARYNGEAL_CARC...4,SET,362,-0.00047913,-6.6612e-05,0.046921,0.50407,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,0.989378345368385
GOBP_POSITIVE_REGULATION_OF_...639,SET,5,-0.0045501,-7.5077e-05,0.4344,0.50418,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.989378345368385
GOBP_T_CELL_ACTIVATION,SET,524,-0.00041571,-6.922e-05,0.039635,0.50418,GOBP_T_CELL_ACTIVATION,0.989378345368385
GOBP_ESTABLISHMENT_OF_PROTEI...6,SET,30,-0.0015598,-6.2998e-05,0.14862,0.50419,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE,0.989378345368385
GNF2_CD7,SET,34,-0.001589,-6.8316e-05,0.1509,0.5042,GNF2_CD7,0.989378345368385
GOBP_HYALOID_VASCULAR_PLEXUS...,SET,7,-0.0037849,-7.389e-05,0.3589,0.50421,GOBP_HYALOID_VASCULAR_PLEXUS_REGRESSION,0.989378345368385
HP_DECREASED_FERTILITY,SET,312,-0.00050505,-6.5276e-05,0.047762,0.50422,HP_DECREASED_FERTILITY,0.989378345368385
GOBP_NEGATIVE_REGULATION_OF_...215,SET,7,-0.0039675,-7.7454e-05,0.37262,0.50425,GOBP_NEGATIVE_REGULATION_OF_ERAD_PATHWAY,0.989378345368385
GOBP_CELLULAR_RESPONSE_TO_RE...3,SET,63,-0.0012483,-7.2997e-05,0.11596,0.50429,GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID,0.989378345368385
GOMF_ACYL_COA_OXIDASE_ACTIVI...,SET,7,-0.0032394,-6.324e-05,0.29631,0.50436,GOMF_ACYL_COA_OXIDASE_ACTIVITY,0.989378345368385
HP_NUCHAL_RIGIDITY,SET,10,-0.0028836,-6.728e-05,0.26384,0.50436,HP_NUCHAL_RIGIDITY,0.989378345368385
HP_TRICHORRHEXIS_NODOSA,SET,9,-0.0028986,-6.4159e-05,0.26513,0.50436,HP_TRICHORRHEXIS_NODOSA,0.989378345368385
NFKAPPAB65_01,SET,228,-0.00062724,-6.9463e-05,0.05729,0.50437,NFKAPPAB65_01,0.989378345368385
GOBP_LABYRINTHINE_LAYER_DEVE...,SET,42,-0.0015194,-7.2589e-05,0.13834,0.50438,GOBP_LABYRINTHINE_LAYER_DEVELOPMENT,0.989378345368385
KEGG_MEDICUS_REFERENCE_MDM2_...2,SET,11,-0.0026239,-6.4206e-05,0.23802,0.5044,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536,0.989378345368385
HE_LIM_SUN_FETAL_LUNG_C0_MYO...3,SET,22,-0.0022826,-7.8966e-05,0.20489,0.50444,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_3_CELL,0.989378345368385
GSE24634_TREG_VS_TCONV_POST_...8,SET,177,-0.0006812,-6.6561e-05,0.060995,0.50446,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP,0.989378345368385
GOBP_NEGATIVE_REGULATION_OF_...103,SET,272,-0.00061123,-7.3843e-05,0.05438,0.50448,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION,0.989378345368385
GOMF_PROLINE_SODIUM_SYMPORTE...,SET,5,-0.0052775,-8.708e-05,0.46898,0.50449,GOMF_PROLINE_SODIUM_SYMPORTER_ACTIVITY,0.989378345368385
HP_IMPAIRED_MASTICATION,SET,41,-0.0015774,-7.446e-05,0.13972,0.5045,HP_IMPAIRED_MASTICATION,0.989378345368385
GOCC_MITOCHONDRIA_ASSOCIATED...,SET,18,-0.0023385,-7.3184e-05,0.20634,0.50452,GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE,0.989378345368385
GSE3203_INFLUENZA_INF_VS_IFN...2,SET,184,-0.00073375,-7.3086e-05,0.064697,0.50452,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP,0.989378345368385
GOBP_AMINE_METABOLIC_PROCESS,SET,102,-0.0010255,-7.6221e-05,0.08904,0.50459,GOBP_AMINE_METABOLIC_PROCESS,0.989378345368385
chr7q32,SET,43,-0.0029256,-0.00014142,0.25306,0.50461,chr7q32,0.989378345368385
GOBP_LEUKOCYTE_HOMEOSTASIS,SET,101,-0.0010128,-7.491e-05,0.087643,0.50461,GOBP_LEUKOCYTE_HOMEOSTASIS,0.989378345368385
HP_ABNORMAL_JUDGMENT,SET,438,-0.0004812,-7.3432e-05,0.0416,0.50461,HP_ABNORMAL_JUDGMENT,0.989378345368385
WANG_CLIM2_TARGETS_DN,SET,162,-0.00072423,-6.7728e-05,0.062279,0.50464,WANG_CLIM2_TARGETS_DN,0.989381350482315
GCTTGAA_MIR498,SET,98,-0.001066,-7.7674e-05,0.09025,0.50471,GCTTGAA_MIR498,0.989400633695713
GOBP_CATECHOLAMINE_TRANSPORT,SET,61,-0.0013858,-7.9747e-05,0.11671,0.50474,GOBP_CATECHOLAMINE_TRANSPORT,0.989400633695713
GSE17974_CTRL_VS_ACT_IL4_AND...3,SET,178,-0.0007377,-7.2283e-05,0.060387,0.50487,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN,0.989400633695713
GSE19772_HCMV_INFL_VS_HCMV_I...2,SET,187,-0.00076095,-7.6404e-05,0.062311,0.50487,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,0.989400633695713
MIR127_5P,SET,80,-0.0012105,-7.973e-05,0.098954,0.50488,MIR127_5P,0.989400633695713
HP_APLASIA_HYPOPLASIA_OF_THE...52,SET,30,-0.001987,-8.0256e-05,0.16155,0.50491,HP_APLASIA_HYPOPLASIA_OF_THE_PATELLA,0.989400633695713
HEIDENBLAD_AMPLICON_12P11_12...1,SET,20,-0.0023611,-7.7886e-05,0.19114,0.50493,HEIDENBLAD_AMPLICON_12P11_12_DN,0.989400633695713
GOBP_ACTIVATION_OF_PROTEIN_K...3,SET,3,-0.0067585,-8.6386e-05,0.54445,0.50495,GOBP_ACTIVATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.989400633695713
GSE17186_NAIVE_VS_CD21HIGH_T...3,SET,179,-0.00079486,-7.8101e-05,0.063801,0.50497,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.989400633695713
MIR2467_3P,SET,139,-0.0008759,-7.5924e-05,0.069808,0.50501,MIR2467_3P,0.989400633695713
KEGG_MEDICUS_REFERENCE_P4_PR...1,SET,8,-0.0038105,-7.9523e-05,0.30309,0.50502,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY,0.989400633695713
GOBP_POTASSIUM_ION_TRANSPORT,SET,227,-0.00078687,-8.6951e-05,0.061758,0.50508,GOBP_POTASSIUM_ION_TRANSPORT,0.989400633695713
GOBP_EARLY_ENDOSOME_TO_GOLGI...,SET,16,-0.0025487,-7.5207e-05,0.19769,0.50514,GOBP_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT,0.989400633695713
MIR3085_3P,SET,132,-0.00095451,-8.0643e-05,0.073987,0.50515,MIR3085_3P,0.989400633695713
GSE29164_CD8_TCELL_VS_CD8_TC...3,SET,162,-0.00087339,-8.1678e-05,0.067564,0.50516,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.989400633695713
GOBP_POSITIVE_REGULATION_OF_...698,SET,1621,-0.00030053,-8.5265e-05,0.02285,0.50525,GOBP_POSITIVE_REGULATION_OF_SIGNALING,0.989400633695713
HP_MASK_LIKE_FACIES,SET,44,-0.0016151,-7.8969e-05,0.12277,0.50525,HP_MASK_LIKE_FACIES,0.989400633695713
GOBP_REGULATION_OF_DNA_DAMAG...1,SET,18,-0.0024144,-7.556e-05,0.18261,0.50527,GOBP_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.989400633695713
GOBP_LACRIMAL_GLAND_DEVELOPM...,SET,7,-0.0046812,-9.1387e-05,0.35314,0.50529,GOBP_LACRIMAL_GLAND_DEVELOPMENT,0.989400633695713
GOCC_MICROTUBULE,SET,416,-0.00054652,-8.1328e-05,0.041054,0.50531,GOCC_MICROTUBULE,0.989400633695713
GOBP_REGULATION_OF_MACROPHAG...3,SET,27,-0.0022038,-8.4449e-05,0.16475,0.50534,GOBP_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.989400633695713
chr6q16,SET,24,-0.0044132,-0.00015945,0.32868,0.50536,chr6q16,0.989400633695713
ZEILSTRA_CD44_TARGETS_DN,SET,9,-0.0036529,-8.0857e-05,0.27133,0.50537,ZEILSTRA_CD44_TARGETS_DN,0.989400633695713
GSE27786_NKCELL_VS_NKTCELL_DN,SET,182,-0.0008422,-8.3435e-05,0.062595,0.50537,GSE27786_NKCELL_VS_NKTCELL_DN,0.989400633695713
HP_THYROID_DYSGENESIS,SET,7,-0.0050152,-9.7909e-05,0.3713,0.50539,HP_THYROID_DYSGENESIS,0.989400633695713
GSE17721_POLYIC_VS_GARDIQUIM...11,SET,184,-0.00083024,-8.2697e-05,0.061455,0.50539,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN,0.989400633695713
GOBP_2_OXOGLUTARATE_METABOLI...,SET,16,-0.0028901,-8.5279e-05,0.21191,0.50544,GOBP_2_OXOGLUTARATE_METABOLIC_PROCESS,0.989442784724569
DUTERTRE_ESTRADIOL_RESPONSE_...3,SET,86,-0.0013817,-9.4342e-05,0.10081,0.50547,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,0.989445781470008
HP_RECURRENT_CUTANEOUS_FUNGA...,SET,53,-0.0016671,-8.9439e-05,0.11958,0.50556,HP_RECURRENT_CUTANEOUS_FUNGAL_INFECTIONS,0.989522459320984
GNF2_EGFR,SET,29,-0.0025013,-9.9332e-05,0.17915,0.50557,GNF2_EGFR,0.989522459320984
INGA_TP53_TARGETS,SET,16,-0.0029341,-8.6577e-05,0.20913,0.5056,INGA_TP53_TARGETS,0.989522459320984
MIR129_5P,SET,336,-0.00068234,-9.1459e-05,0.048128,0.50566,MIR129_5P,0.989522459320984
GOBP_NEGATIVE_REGULATION_OF_...557,SET,6,-0.0059997,-0.00010844,0.4216,0.50568,GOBP_NEGATIVE_REGULATION_OF_RELAXATION_OF_MUSCLE,0.989522459320984
GOCC_TORC2_COMPLEX,SET,9,-0.0041483,-9.1822e-05,0.29128,0.50568,GOCC_TORC2_COMPLEX,0.989522459320984
HP_GRANULAR_MACULAR_APPEARAN...,SET,8,-0.0048111,-0.0001004,0.33322,0.50576,HP_GRANULAR_MACULAR_APPEARANCE,0.989570561247467
CAGCCTC_MIR4855P,SET,135,-0.0010409,-8.893e-05,0.071972,0.50577,CAGCCTC_MIR4855P,0.989570561247467
TRAVAGLINI_LUNG_CD8_MEMORY_E...,SET,26,-0.00239,-8.9876e-05,0.16458,0.50579,TRAVAGLINI_LUNG_CD8_MEMORY_EFFECTOR_T_CELL,0.989570561247467
MARTINEZ_RB1_TARGETS_UP,SET,643,-0.00049834,-9.1612e-05,0.034023,0.50584,MARTINEZ_RB1_TARGETS_UP,0.98957191210399
GSE2405_0H_VS_3H_A_PHAGOCYTO...2,SET,188,-0.00097719,-9.8375e-05,0.066176,0.50589,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.98957191210399
HP_HYPERTRICHOSIS,SET,234,-0.00081197,-9.1081e-05,0.054742,0.50592,HP_HYPERTRICHOSIS,0.98957191210399
MCBRYAN_PUBERTAL_BREAST_5_6W...2,SET,115,-0.0012639,-9.9714e-05,0.084658,0.50596,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,0.98957191210399
GSE19923_WT_VS_HEB_AND_E2A_K...1,SET,185,-0.00093316,-9.3198e-05,0.06239,0.50597,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.98957191210399
BIOCARTA_P53HYPOXIA_PATHWAY,SET,20,-0.0029032,-9.5767e-05,0.19349,0.50599,BIOCARTA_P53HYPOXIA_PATHWAY,0.98957191210399
GOBP_REGULATION_OF_KERATINOC...1,SET,35,-0.002455,-0.00010709,0.16346,0.50599,GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.98957191210399
MIR548AS_3P,SET,241,-0.00084908,-9.6639e-05,0.055412,0.50611,MIR548AS_3P,0.989673988975758
GOBP_IMMATURE_T_CELL_PROLIFE...,SET,10,-0.0045461,-0.00010607,0.29532,0.50614,GOBP_IMMATURE_T_CELL_PROLIFERATION,0.989673988975758
GSE26559_TCF1_KO_VS_WT_LIN_N...2,SET,182,-0.00098957,-9.8036e-05,0.06419,0.50615,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP,0.989673988975758
HP_NAIL_DYSPLASIA,SET,140,-0.0011432,-9.9443e-05,0.073261,0.50622,HP_NAIL_DYSPLASIA,0.989673988975758
WILLERT_WNT_SIGNALING,SET,21,-0.0028671,-9.6908e-05,0.18307,0.50625,WILLERT_WNT_SIGNALING,0.989673988975758
BARX1_TARGET_GENES,SET,1024,-0.00042045,-9.6486e-05,0.026843,0.50625,BARX1_TARGET_GENES,0.989673988975758
GSE24210_RESTING_TREG_VS_TCO...2,SET,179,-0.0010087,-9.9109e-05,0.064301,0.50626,GSE24210_RESTING_TREG_VS_TCONV_UP,0.989673988975758
MIR592,SET,70,-0.0016113,-9.9303e-05,0.10255,0.50627,MIR592,0.989673988975758
SESTO_RESPONSE_TO_UV_C4,SET,20,-0.0028919,-9.5395e-05,0.18271,0.50631,SESTO_RESPONSE_TO_UV_C4,0.989696515748032
GSE25088_WT_VS_STAT6_KO_MACR...1,SET,181,-0.0010362,-0.00010238,0.063126,0.50655,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN,0.989910617187062
HP_PROMINENT_NOSE,SET,86,-0.0015155,-0.00010348,0.091719,0.50659,HP_PROMINENT_NOSE,0.989910617187062
GOBP_CELLULAR_RESPONSE_TO_CO...4,SET,62,-0.0019651,-0.000114,0.11724,0.50669,GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS,0.989910617187062
KEGG_MEDICUS_REFERENCE_EP_NE...,SET,15,-0.0039449,-0.00011271,0.23399,0.50673,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY,0.989910617187062
GOBP_MUSCLE_CONTRACTION,SET,328,-0.000837,-0.00011087,0.049604,0.50673,GOBP_MUSCLE_CONTRACTION,0.989910617187062
GOMF_RECEPTOR_SIGNALING_PROT...,SET,3,-0.0072919,-9.3203e-05,0.42936,0.50677,GOMF_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.989910617187062
HP_EPIDIDYMITIS,SET,3,-0.0091827,-0.00011737,0.54088,0.50677,HP_EPIDIDYMITIS,0.989910617187062
MIR6516_5P,SET,172,-0.0011167,-0.00010757,0.065302,0.50682,MIR6516_5P,0.989910617187062
HALLMARK_HEME_METABOLISM,SET,178,-0.0011034,-0.00010812,0.064472,0.50683,HALLMARK_HEME_METABOLISM,0.989910617187062
MODULE_501,SET,15,-0.0039028,-0.00011151,0.22767,0.50684,MODULE_501,0.989910617187062
PAX3_B,SET,82,-0.0017473,-0.00011651,0.10154,0.50686,PAX3_B,0.989910617187062
GSE35435_RESTING_VS_IL4_TREA...2,SET,175,-0.0010691,-0.00010388,0.061968,0.50688,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP,0.989910617187062
REACTOME_O_LINKED_GLYCOSYLAT...2,SET,56,-0.0021677,-0.00011954,0.12528,0.5069,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,0.989910617187062
HP_SPARSE_MEDIAL_EYEBROW,SET,5,-0.005732,-9.4579e-05,0.33059,0.50692,HP_SPARSE_MEDIAL_EYEBROW,0.989910617187062
WP_SERINE_METABOLISM,SET,8,-0.0044171,-9.2182e-05,0.2541,0.50693,WP_SERINE_METABOLISM,0.989910617187062
GAVISH_3CA_METAPROGRAM_EPITH...7,SET,47,-0.0023456,-0.00011853,0.13495,0.50693,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_2,0.989910617187062
GSE9037_CTRL_VS_LPS_1H_STIM_...4,SET,185,-0.0010306,-0.00010293,0.059008,0.50697,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP,0.989910617187062
GOBP_ORGANOPHOSPHATE_ESTER_T...,SET,141,-0.0013034,-0.00011378,0.073946,0.50703,GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT,0.989910617187062
GSE21360_PRIMARY_VS_QUATERNA...1,SET,180,-0.0010768,-0.0001061,0.060778,0.50707,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.989910617187062
GOBP_SCHWANN_CELL_MIGRATION,SET,5,-0.0067289,-0.00011103,0.37902,0.50708,GOBP_SCHWANN_CELL_MIGRATION,0.989910617187062
GOBP_MEMORY,SET,117,-0.0014333,-0.00011405,0.080689,0.50709,GOBP_MEMORY,0.989910617187062
GSE42021_CD24HI_VS_CD24INT_T...3,SET,182,-0.0011709,-0.000116,0.065828,0.5071,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN,0.989910617187062
GOCC_PLATELET_DENSE_TUBULAR_...1,SET,10,-0.0047064,-0.00010981,0.26374,0.50712,GOCC_PLATELET_DENSE_TUBULAR_NETWORK,0.989910617187062
NGFIC_01,SET,223,-0.0010101,-0.00011065,0.056265,0.50716,NGFIC_01,0.989910617187062
HP_DISINHIBITION,SET,539,-0.00067542,-0.00011401,0.037579,0.50717,HP_DISINHIBITION,0.989910617187062
GOMF_THIOL_OXIDASE_ACTIVITY,SET,4,-0.0061888,-9.1338e-05,0.34317,0.50719,GOMF_THIOL_OXIDASE_ACTIVITY,0.989910617187062
SREBP_Q3,SET,229,-0.00103,-0.00011431,0.057084,0.5072,SREBP_Q3,0.989910617187062
GSE8515_CTRL_VS_IL6_4H_STIM_...2,SET,179,-0.0011475,-0.00011275,0.062683,0.5073,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP,0.989910617187062
MIR449C_5P,SET,121,-0.0014741,-0.00011928,0.080414,0.50731,MIR449C_5P,0.989910617187062
HP_PSEUDOEPIPHYSES_OF_HAND_B...,SET,14,-0.0044055,-0.00012161,0.23806,0.50738,HP_PSEUDOEPIPHYSES_OF_HAND_BONES,0.989910617187062
MIR6514_5P,SET,47,-0.0024017,-0.00012136,0.12944,0.5074,MIR6514_5P,0.989910617187062
GSE40273_EOS_KO_VS_WT_TREG_DN,SET,188,-0.0011453,-0.0001153,0.061484,0.50743,GSE40273_EOS_KO_VS_WT_TREG_DN,0.989910617187062
GOBP_HOMOLOGOUS_CHROMOSOME_P...,SET,44,-0.0022352,-0.00010929,0.11957,0.50746,GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS,0.989910617187062
KEGG_GLYCINE_SERINE_AND_THRE...,SET,27,-0.0031522,-0.00012079,0.16622,0.50756,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,0.989910617187062
GOBP_POSTSYNAPTIC_SIGNAL_TRA...,SET,46,-0.0023707,-0.00011851,0.12493,0.50757,GOBP_POSTSYNAPTIC_SIGNAL_TRANSDUCTION,0.989910617187062
GOBP_OXIDATIVE_DEMETHYLATION,SET,10,-0.0049377,-0.0001152,0.25942,0.50759,GOBP_OXIDATIVE_DEMETHYLATION,0.989910617187062
MIR3972,SET,62,-0.0020266,-0.00011757,0.10575,0.50764,MIR3972,0.989910617187062
GSE17974_CTRL_VS_ACT_IL4_AND...6,SET,173,-0.0012309,-0.00011892,0.064183,0.50765,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP,0.989910617187062
GOBP_NEGATIVE_REGULATION_OF_...324,SET,28,-0.003099,-0.00012093,0.16143,0.50766,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.989910617187062
HP_PRIMARY_CONGENITAL_GLAUCO...,SET,6,-0.0070364,-0.00012718,0.36639,0.50766,HP_PRIMARY_CONGENITAL_GLAUCOMA,0.989910617187062
REACTOME_ACTIVATED_TAK1_MEDI...,SET,19,-0.0043624,-0.00014026,0.22668,0.50768,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,0.989910617187062
GOBP_RESPONSE_TO_BACTERIAL_L...,SET,8,-0.006238,-0.00013018,0.32339,0.50769,GOBP_RESPONSE_TO_BACTERIAL_LIPOPROTEIN,0.989910617187062
GSE360_L_DONOVANI_VS_B_MALAY...7,SET,179,-0.0012296,-0.00012081,0.063598,0.50771,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.989910617187062
GSE36392_TYPE_2_MYELOID_VS_N...1,SET,180,-0.0012023,-0.00011847,0.062073,0.50773,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.989910617187062
GAUSSMANN_MLL_AF4_FUSION_TAR...9,SET,17,-0.0042195,-0.00012834,0.21593,0.5078,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,0.989910617187062
GSE8515_CTRL_VS_IL1_4H_STIM_...2,SET,177,-0.0012734,-0.00012443,0.064573,0.50787,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP,0.989910617187062
GOBP_SENSORY_PERCEPTION_OF_T...1,SET,65,-0.0023484,-0.00013948,0.11848,0.50791,GOBP_SENSORY_PERCEPTION_OF_TASTE,0.989910617187062
GSE17721_LPS_VS_GARDIQUIMOD_...8,SET,187,-0.0012227,-0.00012277,0.061648,0.50791,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP,0.989910617187062
HP_BLINDNESS,SET,266,-0.0010282,-0.00012286,0.051712,0.50793,HP_BLINDNESS,0.989910617187062
KRAS.LUNG.BREAST_UP.V1_UP,SET,126,-0.0016593,-0.00013699,0.083427,0.50793,KRAS.LUNG.BREAST_UP.V1_UP,0.989910617187062
HP_DECREASED_CIRCULATING_COM...3,SET,3,-0.010457,-0.00013366,0.52516,0.50794,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_B_CONCENTRATION,0.989910617187062
GOBP_RIBONUCLEOPROTEIN_COMPL...2,SET,10,-0.0047252,-0.00011025,0.23702,0.50795,GOBP_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION,0.989910617187062
IRF7_01,SET,224,-0.0011994,-0.00013167,0.060093,0.50796,IRF7_01,0.989910617187062
GOBP_RESPONSE_TO_CHEMOKINE,SET,91,-0.0021297,-0.00014956,0.1062,0.508,GOBP_RESPONSE_TO_CHEMOKINE,0.989910617187062
GSE21670_UNTREATED_VS_IL6_TR...1,SET,183,-0.0012403,-0.00012321,0.061513,0.50804,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN,0.989910617187062
GSE21063_CTRL_VS_ANTI_IGM_ST...4,SET,162,-0.0013887,-0.00012987,0.068674,0.50807,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.989910617187062
GSE28737_WT_VS_BCL6_KO_FOLLI...1,SET,182,-0.0012887,-0.00012767,0.063624,0.50808,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.989910617187062
GSE17721_0.5H_VS_4H_GARDIQUI...1,SET,184,-0.0012679,-0.00012629,0.062522,0.50809,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN,0.989910617187062
GRAHAM_NORMAL_QUIESCENT_VS_N...1,SET,84,-0.001809,-0.00012208,0.08914,0.5081,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.989910617187062
GOBP_POSITIVE_REGULATION_OF_...344,SET,7,-0.007356,-0.0001436,0.35905,0.50817,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.98993075760121
REACTOME_BINDING_OF_TCF_LEF_...,SET,8,-0.0063867,-0.00013329,0.31164,0.50818,REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS,0.98993075760121
P53_DN.V2_DN,SET,134,-0.001559,-0.0001327,0.075685,0.50822,P53_DN.V2_DN,0.98993075760121
REACTOME_CD28_DEPENDENT_VAV1...,SET,11,-0.0052794,-0.00012919,0.25452,0.50827,REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,0.98993075760121
TURASHVILI_BREAST_LOBULAR_CA...2,SET,62,-0.0024025,-0.00013938,0.11521,0.50832,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,0.98993075760121
GOBP_POSITIVE_REGULATION_OF_...116,SET,2,-0.01445,-0.00015081,0.69269,0.50832,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.98993075760121
GOBP_NEGATIVE_REGULATION_OF_...104,SET,11,-0.0046224,-0.00011311,0.22032,0.50837,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.98993075760121
GSE21033_CTRL_VS_POLYIC_STIM...3,SET,175,-0.0013663,-0.00013276,0.065008,0.50838,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN,0.98993075760121
GSE39864_WT_VS_GATA3_KO_TREG...2,SET,188,-0.001354,-0.00013631,0.06444,0.50838,GSE39864_WT_VS_GATA3_KO_TREG_UP,0.98993075760121
HP_MULTIPLE_SUTURE_CRANIOSYN...,SET,11,-0.0059543,-0.0001457,0.28262,0.5084,HP_MULTIPLE_SUTURE_CRANIOSYNOSTOSIS,0.98993075760121
GOBP_GLUCOSE_IMPORT,SET,68,-0.0023397,-0.00014213,0.1095,0.50852,GOBP_GLUCOSE_IMPORT,0.98993075760121
GAVISH_3CA_METAPROGRAM_CD8_T...11,SET,40,-0.0028257,-0.00013175,0.13216,0.50853,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1,0.98993075760121
HP_CORNEAL_GUTTATA,SET,6,-0.0081013,-0.00014643,0.37802,0.50855,HP_CORNEAL_GUTTATA,0.98993075760121
MIR4773,SET,171,-0.0013869,-0.00013322,0.064633,0.50856,MIR4773,0.98993075760121
GOMF_INTERFERON_RECEPTOR_ACT...,SET,5,-0.0089817,-0.0001482,0.41822,0.50857,GOMF_INTERFERON_RECEPTOR_ACTIVITY,0.98993075760121
GOBP_NAD_BIOSYNTHESIS_VIA_NI...,SET,9,-0.0064207,-0.00014212,0.2983,0.50859,GOBP_NAD_BIOSYNTHESIS_VIA_NICOTINAMIDE_RIBOSIDE_SALVAGE_PATHWAY,0.98993075760121
GSE2770_UNTREATED_VS_TGFB_AN...4,SET,175,-0.001335,-0.00012971,0.061826,0.50861,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.98993075760121
GOBP_POSITIVE_REGULATION_OF_...12,SET,116,-0.0018173,-0.00014399,0.08357,0.50867,GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.98993075760121
GOBP_NEGATIVE_REGULATION_OF_...675,SET,5,-0.010214,-0.00016854,0.46916,0.50868,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.98993075760121
GOBP_POSITIVE_REGULATION_OF_...105,SET,459,-0.00088422,-0.00013805,0.040636,0.50868,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.98993075760121
HP_ELEVATED_SERUM_ACID_PHOSP...,SET,5,-0.0084965,-0.00014019,0.38894,0.50871,HP_ELEVATED_SERUM_ACID_PHOSPHATASE,0.989933709406495
HP_SUBCORTICAL_BAND_HETEROTO...,SET,10,-0.0052898,-0.00012342,0.24042,0.50878,HP_SUBCORTICAL_BAND_HETEROTOPIA,0.989942562839389
GOCC_MITOCHONDRIAL_RESPIRATO...,SET,12,-0.0050705,-0.00012959,0.23024,0.50879,GOCC_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III,0.989942562839389
HP_LOW_SERUM_CALCITRIOL,SET,7,-0.0074056,-0.00014457,0.33571,0.5088,HP_LOW_SERUM_CALCITRIOL,0.989942562839389
GOBP_REGULATION_OF_VACUOLE_O...,SET,54,-0.002527,-0.00013684,0.11408,0.50884,GOBP_REGULATION_OF_VACUOLE_ORGANIZATION,0.989964968652038
MIR4298,SET,50,-0.0025421,-0.00013248,0.11435,0.50887,MIR4298,0.989967917716205
HP_APLASIA_HYPOPLASIA_OF_THE...78,SET,27,-0.0032503,-0.00012455,0.14501,0.50894,HP_APLASIA_HYPOPLASIA_OF_THE_UVULA,0.989972052817098
BREDEMEYER_RAG_SIGNALING_VIA...2,SET,46,-0.0030047,-0.00015021,0.13354,0.50898,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,0.989972052817098
GSE40274_FOXP3_VS_FOXP3_AND_...1,SET,180,-0.0013485,-0.00013286,0.05989,0.50898,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.989972052817098
MORF_CNTN1,SET,91,-0.00196,-0.00013764,0.086854,0.509,MORF_CNTN1,0.989972052817098
GOBP_NEGATIVE_REGULATION_OF_...577,SET,23,-0.0036118,-0.00012776,0.15956,0.50903,GOBP_NEGATIVE_REGULATION_OF_RNA_SPLICING,0.989972052817098
HP_PERSISTENT_HEAD_LAG,SET,25,-0.0036171,-0.00013338,0.15936,0.50905,HP_PERSISTENT_HEAD_LAG,0.989972052817098
GOBP_NEGATIVE_REGULATION_OF_...334,SET,3,-0.012717,-0.00016255,0.55833,0.50909,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.989972052817098
GSE18281_SUBCAPSULAR_CORTICA...3,SET,172,-0.0015274,-0.00014715,0.066955,0.5091,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,0.989972052817098
HP_MACROORCHIDISM,SET,10,-0.0066957,-0.00015622,0.29087,0.50918,HP_MACROORCHIDISM,0.99005572027972
BRUINS_UVC_RESPONSE_VIA_TP53...3,SET,85,-0.0022159,-0.00015042,0.096079,0.5092,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,0.99005572027972
REACTOME_BIOTIN_TRANSPORT_AN...,SET,10,-0.0058453,-0.00013638,0.25209,0.50925,REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,0.990097546990378
GOBP_LONG_CHAIN_FATTY_ACID_T...,SET,64,-0.0025523,-0.00015043,0.10893,0.50935,GOBP_LONG_CHAIN_FATTY_ACID_TRANSPORT,0.990236574928679
HP_CLINODACTYLY_OF_THE_3RD_F...,SET,6,-0.0094148,-0.00017017,0.40023,0.50938,HP_CLINODACTYLY_OF_THE_3RD_FINGER,0.990239506656226
PID_TRKR_PATHWAY,SET,60,-0.0026034,-0.00014859,0.11024,0.50942,PID_TRKR_PATHWAY,0.990261877062475
GSE17721_CTRL_VS_LPS_1H_BMDC...1,SET,181,-0.0015598,-0.00015411,0.065859,0.50945,GSE17721_CTRL_VS_LPS_1H_BMDC_DN,0.99026480704698
STEIN_ESRRA_TARGETS_DN,SET,94,-0.0020838,-0.00014872,0.086459,0.50961,STEIN_ESRRA_TARGETS_DN,0.990520415524859
KEGG_MEDICUS_VARIANT_LOSS_OF...1,SET,8,-0.0067179,-0.0001402,0.27768,0.50965,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S,0.990542766469075
GSE26030_UNSTIM_VS_RESTIM_TH...8,SET,180,-0.0015615,-0.00015385,0.064115,0.50972,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP,0.990551506849315
GSE20715_0H_VS_48H_OZONE_TLR...1,SET,190,-0.0014752,-0.00014929,0.060472,0.50973,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN,0.990551506849315
REACTOME_BLOOD_GROUP_SYSTEMS...,SET,21,-0.0048538,-0.00016406,0.19883,0.50974,REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS,0.990551506849315
GOMF_AMP_ACTIVATED_PROTEIN_K...,SET,8,-0.0076915,-0.00016052,0.31008,0.50989,GOMF_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY,0.990768197515735
MIR6730_5P,SET,120,-0.0019057,-0.00015356,0.076409,0.50995,MIR6730_5P,0.990768197515735
GSE21380_NON_TFH_VS_GERMINAL...2,SET,176,-0.0016411,-0.0001599,0.065537,0.50999,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,0.990768197515735
MIR549A_5P,SET,43,-0.0034178,-0.00016521,0.13496,0.5101,MIR549A_5P,0.990768197515735
GSE17974_0H_VS_48H_IN_VITRO_...1,SET,173,-0.0015735,-0.00015202,0.062129,0.5101,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN,0.990768197515735
BIOCARTA_GH_PATHWAY,SET,26,-0.0044367,-0.00016684,0.17402,0.51017,BIOCARTA_GH_PATHWAY,0.990768197515735
GOBP_HEAD_DEVELOPMENT,SET,701,-0.00086928,-0.00016658,0.034086,0.51017,GOBP_HEAD_DEVELOPMENT,0.990768197515735
GOBP_NEGATIVE_REGULATION_OF_...658,SET,5,-0.0098568,-0.00016264,0.38647,0.51017,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.990768197515735
KEGG_MEDICUS_PATHOGEN_SALMON...1,SET,6,-0.0087634,-0.0001584,0.34331,0.51018,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.990768197515735
GOBP_MITOCHONDRIAL_RESPIRATO...,SET,82,-0.002148,-0.00014323,0.084181,0.51018,GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY,0.990768197515735
HP_REDUCED_BLOOD_FOLATE_CONC...,SET,4,-0.011692,-0.00017255,0.45805,0.51018,HP_REDUCED_BLOOD_FOLATE_CONCENTRATION,0.990768197515735
GOBP_INTRA_GOLGI_VESICLE_MED...,SET,32,-0.0035236,-0.00014697,0.13749,0.51022,GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.990768197515735
GOBP_POSITIVE_REGULATION_OF_...844,SET,9,-0.0077057,-0.00017056,0.29934,0.51027,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.990768197515735
ELVIDGE_HIF1A_AND_HIF2A_TARG...1,SET,94,-0.0023377,-0.00016684,0.090747,0.51028,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,0.990768197515735
DESCARTES_MAIN_FETAL_MUC13_D...,SET,48,-0.0032454,-0.00016572,0.12558,0.51031,DESCARTES_MAIN_FETAL_MUC13_DMBT1_POSITIVE_CELLS,0.990768197515735
TFIII_Q6,SET,201,-0.0016182,-0.00016839,0.062496,0.51033,TFIII_Q6,0.990768197515735
REACTOME_EPHRIN_SIGNALING,SET,17,-0.0055638,-0.00016922,0.2138,0.51038,REACTOME_EPHRIN_SIGNALING,0.990768197515735
MIR4495,SET,435,-0.0011339,-0.00017245,0.043326,0.51044,MIR4495,0.990768197515735
HP_METAPHYSEAL_IRREGULARITY,SET,44,-0.0033481,-0.00016371,0.12731,0.51049,HP_METAPHYSEAL_IRREGULARITY,0.990768197515735
GOMF_ACIDIC_AMINO_ACID_TRANS...,SET,18,-0.0055639,-0.00017413,0.211,0.51052,GOMF_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.990768197515735
HP_SHORT_1ST_METACARPAL,SET,21,-0.0052989,-0.00017911,0.20015,0.51056,HP_SHORT_1ST_METACARPAL,0.990768197515735
GOBP_LATE_ENDOSOME_TO_VACUOL...2,SET,26,-0.0040541,-0.00015245,0.15257,0.5106,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.990768197515735
GOBP_FATTY_ACID_ALPHA_OXIDAT...,SET,8,-0.0086328,-0.00018016,0.32441,0.51061,GOBP_FATTY_ACID_ALPHA_OXIDATION,0.990768197515735
HP_ABNORMAL_HEMOGLOBIN_CONCE...,SET,17,-0.0054422,-0.00016553,0.20394,0.51064,HP_ABNORMAL_HEMOGLOBIN_CONCENTRATION,0.990768197515735
MIR1273H_3P,SET,88,-0.0024945,-0.00017228,0.093201,0.51068,MIR1273H_3P,0.990768197515735
MIR4668_3P,SET,277,-0.0013991,-0.00017055,0.051979,0.51074,MIR4668_3P,0.990768197515735
REACTOME_MAP3K8_TPL2_DEPENDE...,SET,14,-0.0061335,-0.00016931,0.22702,0.51078,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,0.990768197515735
HP_CELLULITIS,SET,44,-0.003489,-0.0001706,0.12902,0.51079,HP_CELLULITIS,0.990768197515735
GSE17721_LPS_VS_PAM3CSK4_6H_...1,SET,182,-0.0016372,-0.0001622,0.060117,0.51086,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN,0.990768197515735
GOBP_TUMOR_NECROSIS_FACTOR_M...,SET,104,-0.0023475,-0.00017618,0.085803,0.51091,GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.990768197515735
CHEOK_RESPONSE_TO_MERCAPTOPU...4,SET,8,-0.0094643,-0.00019752,0.34586,0.51092,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,0.990768197515735
REACTOME_HDMS_DEMETHYLATE_HI...,SET,17,-0.0047949,-0.00014584,0.17403,0.51099,REACTOME_HDMS_DEMETHYLATE_HISTONES,0.990768197515735
REACTOME_TRANSPORT_OF_BILE_S...,SET,82,-0.0027473,-0.00018319,0.099694,0.51099,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,0.990768197515735
GOBP_HINDBRAIN_RADIAL_GLIA_G...,SET,8,-0.0096124,-0.00020061,0.34861,0.511,GOBP_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION,0.990768197515735
VANHARANTA_UTERINE_FIBROID_DN,SET,59,-0.0033643,-0.00019041,0.12179,0.51102,VANHARANTA_UTERINE_FIBROID_DN,0.990768197515735
AGTGCGT_MIR521,SET,6,-0.0086908,-0.00015708,0.31427,0.51103,AGTGCGT_MIR521,0.990768197515735
MCBRYAN_TERMINAL_END_BUD_UP,SET,12,-0.0073762,-0.00018851,0.26479,0.51111,MCBRYAN_TERMINAL_END_BUD_UP,0.990768197515735
VARELA_ZMPSTE24_TARGETS_DN,SET,35,-0.0041131,-0.00017941,0.1477,0.51111,VARELA_ZMPSTE24_TARGETS_DN,0.990768197515735
MIR1258,SET,57,-0.0031527,-0.00017539,0.11296,0.51113,MIR1258,0.990768197515735
GOCC_PROTEIN_PHOSPHATASE_TYP...1,SET,18,-0.0051343,-0.00016068,0.18402,0.51113,GOCC_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX,0.990768197515735
AHR_01,SET,54,-0.0032305,-0.00017494,0.11537,0.51117,AHR_01,0.990768197515735
FAN_EMBRYONIC_CTX_BIG_GROUPS...7,SET,333,-0.0013906,-0.00018557,0.049486,0.51121,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.990768197515735
HP_DIABETES_INSIPIDUS,SET,53,-0.0034527,-0.00018524,0.12279,0.51122,HP_DIABETES_INSIPIDUS,0.990768197515735
KEGG_MEDICUS_REFERENCE_AUTOP...2,SET,5,-0.0097246,-0.00016046,0.34366,0.51129,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55,0.990768197515735
HE_LIM_SUN_FETAL_LUNG_C5_LAT...,SET,25,-0.0051957,-0.00019159,0.18347,0.5113,HE_LIM_SUN_FETAL_LUNG_C5_LATE_PRO_B_CELL,0.990768197515735
KEGG_MEDICUS_REFERENCE_BMP_H...2,SET,6,-0.009255,-0.00016728,0.32631,0.51131,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR,0.990768197515735
MIR581,SET,73,-0.0027784,-0.00017484,0.097943,0.51132,MIR581,0.990768197515735
HP_GRANULOMA,SET,6,-0.011054,-0.0001998,0.38799,0.51136,HP_GRANULOMA,0.990768197515735
GOCC_BRUSH_BORDER_MEMBRANE,SET,55,-0.0031328,-0.00017121,0.1098,0.51138,GOCC_BRUSH_BORDER_MEMBRANE,0.990768197515735
GSE41867_DAY6_VS_DAY8_LCMV_A...2,SET,176,-0.0018449,-0.00017976,0.064548,0.5114,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.990768197515735
RAO_BOUND_BY_SALL4,SET,205,-0.0017531,-0.00018421,0.061191,0.51143,RAO_BOUND_BY_SALL4,0.990768197515735
HP_DECREASED_CIRCULATING_FRE...2,SET,4,-0.010702,-0.00015795,0.37129,0.5115,HP_DECREASED_CIRCULATING_FREE_T4_CONCENTRATION,0.990768197515735
OISHI_CHOLANGIOMA_STEM_CELL_...2,SET,324,-0.0013232,-0.00017422,0.045798,0.51152,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,0.990768197515735
HP_HYPERINTENSITY_OF_CEREBRA...,SET,72,-0.0030111,-0.00018819,0.10388,0.51156,HP_HYPERINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,0.990768197515735
HP_SHAGREEN_PATCH,SET,5,-0.012302,-0.00020299,0.42381,0.51158,HP_SHAGREEN_PATCH,0.990768197515735
MCCABE_HOXC6_TARGETS_UP,SET,7,-0.0087791,-0.00017139,0.30176,0.5116,MCCABE_HOXC6_TARGETS_UP,0.990768197515735
GSE27786_LIN_NEG_VS_NKCELL_UP,SET,174,-0.0018287,-0.00017718,0.062743,0.51163,GSE27786_LIN_NEG_VS_NKCELL_UP,0.990768197515735
GSE5589_IL6_KO_VS_IL10_KO_LP...10,SET,175,-0.0018237,-0.0001772,0.062555,0.51163,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.990768197515735
MODULE_333,SET,27,-0.0043232,-0.00016566,0.14797,0.51165,MODULE_333,0.990768197515735
GOBP_REGULATION_OF_DOPAMINE_...1,SET,11,-0.0089777,-0.00021968,0.30733,0.51165,GOBP_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.990768197515735
GOCC_HOPS_COMPLEX,SET,14,-0.0059073,-0.00016306,0.20193,0.51167,GOCC_HOPS_COMPLEX,0.990768197515735
HP_TYPIFIED_BY_INCOMPLETE_PE...,SET,132,-0.0022543,-0.00019045,0.076817,0.51171,HP_TYPIFIED_BY_INCOMPLETE_PENETRANCE,0.990768197515735
GOBP_CELLULAR_RESPONSE_TO_OX...2,SET,11,-0.0078426,-0.00019191,0.26701,0.51172,GOBP_CELLULAR_RESPONSE_TO_OXIDISED_LOW_DENSITY_LIPOPROTEIN_PARTICLE_STIMULUS,0.990768197515735
GOMF_ACYLGLYCEROL_O_ACYLTRAN...,SET,24,-0.0053673,-0.00019393,0.1826,0.51172,GOMF_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.990768197515735
HP_PSEUDOEPIPHYSES_OF_THE_ME...,SET,8,-0.0089464,-0.00018671,0.30384,0.51174,HP_PSEUDOEPIPHYSES_OF_THE_METACARPALS,0.990768197515735
GSE17721_CTRL_VS_POLYIC_12H_...2,SET,178,-0.0018028,-0.00017664,0.061106,0.51177,GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP,0.990768197515735
GSE360_DC_VS_MAC_B_MALAYI_LO...2,SET,177,-0.0018448,-0.00018026,0.062527,0.51177,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP,0.990768197515735
GNF2_ESPL1,SET,35,-0.0040137,-0.00017508,0.13576,0.51179,GNF2_ESPL1,0.990768197515735
MIR335_3P,SET,786,-0.000956,-0.00019352,0.032131,0.51187,MIR335_3P,0.990867876239278
REACTOME_METABOLISM_OF_FAT_S...,SET,43,-0.0042123,-0.00020361,0.14122,0.5119,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,0.990870760233918
MODULE_387,SET,48,-0.0038021,-0.00019415,0.12694,0.51195,MODULE_387,0.990912355201604
GOCC_RADIAL_SPOKE_HEAD,SET,5,-0.011452,-0.00018896,0.37997,0.51202,GOCC_RADIAL_SPOKE_HEAD,0.99095970265605
HP_FOCAL_AWARE_SEIZURE,SET,26,-0.0052139,-0.00019607,0.17271,0.51204,HP_FOCAL_AWARE_SEIZURE,0.99095970265605
MARKEY_RB1_CHRONIC_LOF_UP,SET,106,-0.0024686,-0.00018703,0.081642,0.51206,MARKEY_RB1_CHRONIC_LOF_UP,0.99095970265605
RYCACNNRNNRNCAG_UNKNOWN,SET,63,-0.0032822,-0.00019194,0.10814,0.51211,RYCACNNRNNRNCAG_UNKNOWN,0.991001283407572
HP_LATE_ONSET,SET,122,-0.002406,-0.00019547,0.078946,0.51216,HP_LATE_ONSET,0.991040749707798
GSE34156_UNTREATED_VS_24H_NO...2,SET,154,-0.0021473,-0.00019584,0.070123,0.51221,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.991040749707798
HP_MACROCEPHALY_AT_BIRTH,SET,8,-0.0098956,-0.00020652,0.32309,0.51222,HP_MACROCEPHALY_AT_BIRTH,0.991040749707798
GSE4142_NAIVE_VS_MEMORY_BCEL...1,SET,189,-0.0018971,-0.00019149,0.061504,0.5123,GSE4142_NAIVE_VS_MEMORY_BCELL_DN,0.991040749707798
RAY_TARGETS_OF_P210_BCR_ABL_...2,SET,12,-0.0087068,-0.00022252,0.28197,0.51232,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,0.991040749707798
GOCC_RIBBON_SYNAPSE,SET,15,-0.0074555,-0.00021301,0.24129,0.51232,GOCC_RIBBON_SYNAPSE,0.991040749707798
HP_CONGENITAL_ADRENAL_HYPERP...,SET,5,-0.012368,-0.00020408,0.40019,0.51233,HP_CONGENITAL_ADRENAL_HYPERPLASIA,0.991040749707798
HP_HYPERCAPNIA,SET,12,-0.008142,-0.00020809,0.26275,0.51236,HP_HYPERCAPNIA,0.991043621994657
GOMF_OXIDOREDUCTASE_ACTIVITY...24,SET,9,-0.01011,-0.00022379,0.3245,0.51243,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.991055107945693
GOMF_O_ACYLTRANSFERASE_ACTIV...,SET,47,-0.0039315,-0.00019866,0.12607,0.51244,GOMF_O_ACYLTRANSFERASE_ACTIVITY,0.991055107945693
HP_TOENAIL_DYSPLASIA,SET,15,-0.007688,-0.00021966,0.24582,0.51247,HP_TOENAIL_DYSPLASIA,0.991055107945693
WP_HORMONAL_CONTROL_OF_PUBER...,SET,5,-0.013355,-0.00022036,0.42673,0.51248,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,0.991055107945693
GOBP_STEROID_CATABOLIC_PROCE...,SET,23,-0.0058286,-0.00020617,0.18554,0.51253,GOBP_STEROID_CATABOLIC_PROCESS,0.991096653313303
GOBP_REGULATION_OF_RNA_POLYM...2,SET,6,-0.011125,-0.00020108,0.35264,0.51258,GOBP_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.991102389429764
GOBP_POSITIVE_REGULATION_OF_...824,SET,8,-0.0091321,-0.00019058,0.28926,0.51259,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.991102389429764
HP_ABNORMAL_CIRCULATING_LEPT...,SET,12,-0.0075782,-0.00019368,0.23866,0.51267,HP_ABNORMAL_CIRCULATING_LEPTIN_CONCENTRATION,0.991156818939646
GOBP_CELLULAR_RESPONSE_TO_AL...4,SET,36,-0.004614,-0.00020411,0.14419,0.51276,GOBP_CELLULAR_RESPONSE_TO_ALKALOID,0.991156818939646
GOBP_MITOTIC_INTRA_S_DNA_DAM...,SET,16,-0.0057801,-0.00017056,0.18075,0.51276,GOBP_MITOTIC_INTRA_S_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.991156818939646
GOMF_ACETYLESTERASE_ACTIVITY,SET,5,-0.011129,-0.00018364,0.34678,0.5128,GOMF_ACETYLESTERASE_ACTIVITY,0.991156818939646
MIR4717_5P,SET,94,-0.0027786,-0.00019831,0.086522,0.51281,MIR4717_5P,0.991156818939646
MIR4314,SET,121,-0.002487,-0.00020123,0.077387,0.51282,MIR4314,0.991156818939646
GSE40274_CTRL_VS_FOXP3_AND_S...1,SET,138,-0.0023768,-0.00020528,0.073949,0.51282,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.991156818939646
HP_IMPAIRED_TACTILE_SENSATION,SET,32,-0.0045273,-0.00018884,0.14042,0.51286,HP_IMPAIRED_TACTILE_SENSATION,0.991156818939646
REACTOME_TNFR1_INDUCED_PROAP...,SET,23,-0.0057492,-0.00020336,0.1776,0.51291,REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,0.991156818939646
GSE18791_CTRL_VS_NEWCASTLE_V...8,SET,181,-0.0019852,-0.00019614,0.060961,0.51299,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP,0.991156818939646
GOBP_NUCLEAR_MRNA_SURVEILLAN...,SET,10,-0.0079786,-0.00018615,0.24455,0.51301,GOBP_NUCLEAR_MRNA_SURVEILLANCE,0.991156818939646
DR4_Q2,SET,225,-0.0018439,-0.00020287,0.056359,0.51305,DR4_Q2,0.991156818939646
KEGG_MEDICUS_REFERENCE_IL1_I...2,SET,15,-0.0078221,-0.00022349,0.23859,0.51308,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY,0.991156818939646
MIR5701,SET,179,-0.0021033,-0.00020667,0.064161,0.51308,MIR5701,0.991156818939646
ZNF146_TARGET_GENES,SET,888,-0.00096401,-0.00020682,0.029342,0.5131,ZNF146_TARGET_GENES,0.991156818939646
HP_SYRINGOMYELIA,SET,30,-0.004832,-0.00019516,0.14684,0.51312,HP_SYRINGOMYELIA,0.991156818939646
GSE17721_POLYIC_VS_GARDIQUIM...5,SET,177,-0.0020412,-0.00019945,0.062045,0.51312,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN,0.991156818939646
HP_SCHIZENCEPHALY,SET,9,-0.0097304,-0.00021538,0.29496,0.51316,HP_SCHIZENCEPHALY,0.991156818939646
GSE12845_IGD_POS_BLOOD_VS_PR...1,SET,186,-0.0019886,-0.00019914,0.060274,0.51316,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.991156818939646
BIOCARTA_RAS_PATHWAY,SET,20,-0.0065921,-0.00021745,0.19723,0.51333,BIOCARTA_RAS_PATHWAY,0.991276903215059
GOCC_CUL4_RING_E3_UBIQUITIN_...,SET,31,-0.0049067,-0.00020145,0.14679,0.51333,GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.991276903215059
GSE3982_MAST_CELL_VS_TH1_DN,SET,172,-0.0021695,-0.000209,0.064675,0.51338,GSE3982_MAST_CELL_VS_TH1_DN,0.991276903215059
MIR6868_3P,SET,241,-0.0019318,-0.00021988,0.057469,0.51341,MIR6868_3P,0.991276903215059
HP_ABNORMAL_ERYTHROCYTE_ADEN...,SET,22,-0.0057013,-0.00019724,0.16932,0.51343,HP_ABNORMAL_ERYTHROCYTE_ADENOSINE_DEAMINASE_ACTIVITY,0.991276903215059
HP_METOPIC_SYNOSTOSIS,SET,23,-0.0053369,-0.00018878,0.15837,0.51344,HP_METOPIC_SYNOSTOSIS,0.991276903215059
GOBP_NEGATIVE_REGULATION_OF_...563,SET,79,-0.0032185,-0.00021067,0.09539,0.51346,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.991276903215059
GOCC_GLUTAMATERGIC_SYNAPSE,SET,389,-0.0014981,-0.00021574,0.044282,0.51349,GOCC_GLUTAMATERGIC_SYNAPSE,0.991276903215059
HINATA_NFKB_MATRIX,SET,10,-0.0099835,-0.00023293,0.29448,0.51352,HINATA_NFKB_MATRIX,0.991276903215059
HP_ANTERIOR_SYNECHIAE_OF_THE...,SET,13,-0.0092457,-0.00024594,0.27255,0.51353,HP_ANTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,0.991276903215059
GSE7831_UNSTIM_VS_CPG_STIM_P...4,SET,185,-0.0020946,-0.0002092,0.061528,0.51358,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP,0.991276903215059
GOMF_PROTEASE_BINDING,SET,126,-0.0025988,-0.00021455,0.076241,0.5136,GOMF_PROTEASE_BINDING,0.991276903215059
GOBP_RESPONSE_TO_MURAMYL_DIP...,SET,18,-0.0069808,-0.00021847,0.20424,0.51363,GOBP_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.991276903215059
GAVISH_3CA_MALIGNANT_METAPRO...35,SET,41,-0.0042669,-0.00020141,0.12476,0.51364,GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN,0.991276903215059
HP_VAGINAL_FISTULA,SET,25,-0.0058332,-0.0002151,0.17044,0.51365,HP_VAGINAL_FISTULA,0.991276903215059
GOBP_ESTABLISHMENT_OF_TISSUE...,SET,35,-0.0053338,-0.00023266,0.15516,0.51371,GOBP_ESTABLISHMENT_OF_TISSUE_POLARITY,0.991291162429222
MIR3142,SET,49,-0.0041112,-0.0002121,0.11925,0.51375,MIR3142,0.991291162429222
GSE43863_DAY6_EFF_VS_DAY150_...4,SET,184,-0.0022043,-0.00021956,0.063764,0.51379,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP,0.991291162429222
GOMF_MICROFIBRIL_BINDING,SET,6,-0.014748,-0.00026657,0.42638,0.5138,GOMF_MICROFIBRIL_BINDING,0.991291162429222
GOMF_NADPLUS_PROTEIN_LYSINE_...,SET,5,-0.013098,-0.00021612,0.3787,0.5138,GOMF_NADPLUS_PROTEIN_LYSINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.991291162429222
GOBP_REGULATION_OF_RESPONSE_...7,SET,29,-0.0056365,-0.00022384,0.16257,0.51383,GOBP_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,0.991294013322231
MURARO_PANCREAS_EPSILON_CELL,SET,42,-0.0050033,-0.00023903,0.14342,0.51391,MURARO_PANCREAS_EPSILON_CELL,0.99135032449523
GOBP_NUCLEOSOME_ORGANIZATION,SET,64,-0.0036283,-0.00021384,0.10333,0.514,GOBP_NUCLEOSOME_ORGANIZATION,0.99135032449523
REACTOME_DEFECTIVE_CSF2RB_CA...,SET,7,-0.013873,-0.00027083,0.39375,0.51405,REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5,0.99135032449523
GSE21546_WT_VS_SAP1A_KO_DP_T...2,SET,176,-0.0023387,-0.00022788,0.066333,0.51406,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP,0.99135032449523
GOBP_WHITE_FAT_CELL_DIFFEREN...,SET,16,-0.0078549,-0.00023178,0.22226,0.5141,GOBP_WHITE_FAT_CELL_DIFFERENTIATION,0.99135032449523
KEGG_MEDICUS_VARIANT_MUTATIO...14,SET,5,-0.012245,-0.00020204,0.34598,0.51412,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_LRRK2_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99135032449523
HP_MICROLISSENCEPHALY,SET,5,-0.014406,-0.0002377,0.407,0.51412,HP_MICROLISSENCEPHALY,0.99135032449523
GOBP_NEGATIVE_REGULATION_OF_...66,SET,40,-0.0047168,-0.00021992,0.13312,0.51413,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99135032449523
WP_PROTEASOME_DEGRADATION,SET,56,-0.0036853,-0.00020322,0.1039,0.51415,WP_PROTEASOME_DEGRADATION,0.99135032449523
SARRIO_EPITHELIAL_MESENCHYMA...1,SET,133,-0.0027297,-0.00023148,0.076718,0.51419,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,0.99135032449523
HP_FOLLICULAR_HYPERKERATOSIS,SET,26,-0.0060674,-0.00022816,0.17028,0.51421,HP_FOLLICULAR_HYPERKERATOSIS,0.99135032449523
GSE42021_CD24HI_VS_CD24INT_T...1,SET,187,-0.0023237,-0.00023331,0.06522,0.51421,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN,0.99135032449523
GOBP_THYMOCYTE_MIGRATION,SET,7,-0.012672,-0.00024738,0.35515,0.51423,GOBP_THYMOCYTE_MIGRATION,0.99135032449523
MIR3074_5P,SET,136,-0.0027021,-0.00023169,0.075571,0.51426,MIR3074_5P,0.99135316989295
KEGG_MEDICUS_PATHOGEN_HTLV_1...8,SET,5,-0.014736,-0.00024314,0.41079,0.51431,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SRF_MEDIATED_TRANSCRIPTION,0.991394567387687
GAUTAM_EYE_IRIS_CILIARY_BODY...14,SET,11,-0.0098881,-0.00024196,0.27396,0.5144,GAUTAM_EYE_IRIS_CILIARY_BODY_RIBOSOMAL_GENES_HIGH_FIBROBLASTS,0.991403713968958
KEGG_MEDICUS_VARIANT_AMPLIFI...11,SET,6,-0.010508,-0.00018993,0.29076,0.51441,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION,0.991403713968958
GOBP_REGULATION_OF_HIPPOCAMP...,SET,5,-0.016416,-0.00027087,0.45379,0.51443,GOBP_REGULATION_OF_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.991403713968958
TBK1.DF_DN,SET,264,-0.0018768,-0.00022343,0.051761,0.51446,TBK1.DF_DN,0.991403713968958
KEGG_MEDICUS_ENV_FACTOR_PARA...,SET,5,-0.015741,-0.00025973,0.43294,0.5145,KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY,0.991403713968958
HP_SERTOLI_CELL_NEOPLASM,SET,5,-0.014955,-0.00024676,0.41108,0.51451,HP_SERTOLI_CELL_NEOPLASM,0.991403713968958
GOBP_POSITIVE_REGULATION_OF_...186,SET,76,-0.0037863,-0.0002431,0.10392,0.51453,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.991403713968958
GOBP_POSITIVE_REGULATION_OF_...724,SET,43,-0.0048752,-0.00023566,0.13366,0.51455,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.991403713968958
GOBP_RESPONSE_TO_INACTIVITY,SET,12,-0.0099205,-0.00025354,0.27145,0.51458,GOBP_RESPONSE_TO_INACTIVITY,0.991403713968958
GOBP_METANEPHRIC_GLOMERULUS_...2,SET,9,-0.012841,-0.00028423,0.35087,0.5146,GOBP_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT,0.991403713968958
GOBP_GLUTAMATE_SECRETION,SET,28,-0.0067036,-0.00026159,0.18271,0.51463,GOBP_GLUTAMATE_SECRETION,0.991406554514716
HP_EPILEPSIA_PARTIALIS_CONTI...,SET,8,-0.011054,-0.00023068,0.30031,0.51468,HP_EPILEPSIA_PARTIALIS_CONTINUA,0.991437173732336
KEGG_MEDICUS_VARIANT_MUTATIO...61,SET,8,-0.01052,-0.00021955,0.28486,0.51473,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.991437173732336
GSE33424_CD161_HIGH_VS_NEG_C...1,SET,183,-0.0023408,-0.00023253,0.063295,0.51475,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.991437173732336
GOBP_MITOTIC_DNA_INTEGRITY_C...,SET,79,-0.0032162,-0.00021052,0.086914,0.51476,GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.991437173732336
MIR296_3P,SET,28,-0.0059312,-0.00023145,0.15838,0.51494,MIR296_3P,0.991603112538768
GOMF_ORGANIC_HYDROXY_COMPOUN...,SET,52,-0.0047582,-0.00025287,0.12686,0.51496,GOMF_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.991603112538768
GOBP_POSITIVE_REGULATION_OF_...437,SET,6,-0.014735,-0.00026632,0.38932,0.51509,GOBP_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.991603112538768
MIR10397_3P,SET,42,-0.0052436,-0.00025051,0.13839,0.51511,MIR10397_3P,0.991603112538768
GOCC_LATERAL_PART_OF_CELL,SET,5,-0.015824,-0.0002611,0.41773,0.51511,GOCC_LATERAL_PART_OF_CELL,0.991603112538768
YCATTAA_UNKNOWN,SET,499,-0.0015424,-0.00025079,0.040698,0.51512,YCATTAA_UNKNOWN,0.991603112538768
BILANGES_RAPAMYCIN_SENSITIVE...2,SET,59,-0.0040123,-0.00022708,0.10575,0.51513,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,0.991603112538768
REACTOME_SIGNALING_BY_ROBO_R...,SET,198,-0.0022299,-0.00023032,0.058686,0.51515,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,0.991603112538768
GOBP_REGULATION_OF_GRANULOCY...2,SET,15,-0.0081699,-0.00023342,0.21503,0.51515,GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.991603112538768
HP_BIPOLAR_AFFECTIVE_DISORDER,SET,24,-0.006771,-0.00024464,0.17822,0.51515,HP_BIPOLAR_AFFECTIVE_DISORDER,0.991603112538768
MODULE_215,SET,14,-0.010317,-0.00028479,0.27138,0.51516,MODULE_215,0.991603112538768
HUPER_BREAST_BASAL_VS_LUMINA...2,SET,51,-0.0049781,-0.00026201,0.12998,0.51528,HUPER_BREAST_BASAL_VS_LUMINAL_UP,0.991652906976744
GSE29618_MONOCYTE_VS_MDC_DAY...2,SET,189,-0.0025411,-0.00025649,0.066334,0.51528,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP,0.991652906976744
GOBP_REGULATION_OF_MEMBRANE_...10,SET,33,-0.006035,-0.00025563,0.15746,0.51529,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION,0.991652906976744
TERAMOTO_OPN_TARGETS_CLUSTER...4,SET,6,-0.011436,-0.00020671,0.2982,0.5153,TERAMOTO_OPN_TARGETS_CLUSTER_5,0.991652906976744
GSE3337_CTRL_VS_16H_IFNG_IN_...1,SET,179,-0.002426,-0.00023837,0.062964,0.51537,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN,0.9916613768477
HP_STEROID_RESISTANT_NEPHROT...,SET,14,-0.0079803,-0.00022028,0.20684,0.51539,HP_STEROID_RESISTANT_NEPHROTIC_SYNDROME,0.9916613768477
GSE15767_MED_VS_SCS_MAC_LN_UP,SET,176,-0.0026324,-0.00025649,0.06824,0.51539,GSE15767_MED_VS_SCS_MAC_LN_UP,0.9916613768477
HP_ODONTOGENIC_NEOPLASM,SET,6,-0.012028,-0.00021741,0.31088,0.51543,HP_ODONTOGENIC_NEOPLASM,0.991683439437555
DESCARTES_MAIN_FETAL_CLC_IL5...,SET,151,-0.0026001,-0.00023483,0.067017,0.51547,DESCARTES_MAIN_FETAL_CLC_IL5RA_POSITIVE_CELLS,0.991691902363425
GOBP_DENDRITE_MORPHOGENESIS,SET,131,-0.002988,-0.00025149,0.07686,0.51551,GOBP_DENDRITE_MORPHOGENESIS,0.991691902363425
GOBP_HOST_MEDIATED_REGULATIO...,SET,9,-0.011423,-0.00025285,0.29356,0.51552,GOBP_HOST_MEDIATED_REGULATION_OF_INTESTINAL_MICROBIOTA_COMPOSITION,0.991691902363425
GOBP_IMMUNE_EFFECTOR_PROCESS,SET,580,-0.0014893,-0.00026049,0.038069,0.5156,GOBP_IMMUNE_EFFECTOR_PROCESS,0.991782926626826
REACTOME_RUNX1_AND_FOXP3_CON...,SET,9,-0.011607,-0.00025692,0.29559,0.51566,REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,0.991782926626826
GOBP_REGULATION_OF_MAST_CELL...2,SET,4,-0.017774,-0.00026232,0.45195,0.51569,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.991782926626826
GOMF_STRUCTURAL_CONSTITUENT_...5,SET,9,-0.012328,-0.00027288,0.31341,0.51569,GOMF_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH,0.991782926626826
JAATINEN_HEMATOPOIETIC_STEM_...1,SET,208,-0.0025179,-0.00026648,0.063921,0.51571,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,0.991782926626826
GOBP_REGULATION_OF_FATTY_ACI...4,SET,31,-0.0061085,-0.00025079,0.1544,0.51578,GOBP_REGULATION_OF_FATTY_ACID_OXIDATION,0.99182701394268
GSE37533_PPARG1_FOXP3_VS_FOX...1,SET,189,-0.0025406,-0.00025644,0.064161,0.51579,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.99182701394268
GSE21670_UNTREATED_VS_TGFB_T...1,SET,177,-0.002612,-0.00025523,0.065767,0.51584,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN,0.991867050653145
chr2p21,SET,35,-0.010098,-0.00044046,0.25283,0.51593,chr2p21,0.991867050653145
GOBP_RETINAL_CONE_CELL_DIFFE...,SET,13,-0.010426,-0.00027734,0.26074,0.51595,GOBP_RETINAL_CONE_CELL_DIFFERENTIATION,0.991867050653145
GOMF_POLY_PURINE_TRACT_BINDI...,SET,26,-0.0067369,-0.00025334,0.16849,0.51595,GOMF_POLY_PURINE_TRACT_BINDING,0.991867050653145
HP_ABNORMALITY_OF_THE_FONTAN...,SET,407,-0.0017171,-0.00025281,0.042589,0.51608,HP_ABNORMALITY_OF_THE_FONTANELLES_OR_CRANIAL_SUTURES,0.991867050653145
AP4_Q6,SET,199,-0.0024676,-0.0002555,0.061095,0.51611,AP4_Q6,0.991867050653145
MODULE_485,SET,49,-0.0047161,-0.00024331,0.11663,0.51613,MODULE_485,0.991867050653145
GOBP_MRNA_3_SPLICE_SITE_RECO...,SET,6,-0.013603,-0.00024587,0.33563,0.51616,GOBP_MRNA_3_SPLICE_SITE_RECOGNITION,0.991867050653145
SIMBULAN_PARP1_TARGETS_DN,SET,16,-0.0082027,-0.00024204,0.20219,0.51618,SIMBULAN_PARP1_TARGETS_DN,0.991867050653145
GOCC_COMPACT_MYELIN,SET,13,-0.010327,-0.00027469,0.25416,0.5162,GOCC_COMPACT_MYELIN,0.991867050653145
GOCC_NUCLEAR_PERIPHERY,SET,139,-0.0029329,-0.00025423,0.07192,0.51626,GOCC_NUCLEAR_PERIPHERY,0.991867050653145
GOMF_PROTEIN_MEMBRANE_ADAPTO...,SET,32,-0.0061327,-0.00025581,0.14926,0.51639,GOMF_PROTEIN_MEMBRANE_ADAPTOR_ACTIVITY,0.991867050653145
PID_ATF2_PATHWAY,SET,58,-0.0049744,-0.00027915,0.12074,0.51643,PID_ATF2_PATHWAY,0.991867050653145
REACTOME_G2_PHASE,SET,5,-0.016811,-0.00027739,0.40773,0.51644,REACTOME_G2_PHASE,0.991867050653145
MIR3614_5P,SET,64,-0.0045557,-0.0002685,0.11029,0.51647,MIR3614_5P,0.991867050653145
GOCC_TRANSCRIPTION_PREINITIA...,SET,13,-0.0095299,-0.0002535,0.22971,0.51655,GOCC_TRANSCRIPTION_PREINITIATION_COMPLEX,0.991867050653145
WP_SARSCOV2_AND_ACE2_RECEPTO...,SET,6,-0.017192,-0.00031074,0.41405,0.51656,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,0.991867050653145
HP_UPPER_LIMB_JOINT_CONTRACT...,SET,300,-0.0021177,-0.00026848,0.050994,0.51656,HP_UPPER_LIMB_JOINT_CONTRACTURE,0.991867050653145
GSE15324_NAIVE_VS_ACTIVATED_...1,SET,183,-0.0025203,-0.00025036,0.0607,0.51656,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.991867050653145
GOBP_POST_EMBRYONIC_DEVELOPM...,SET,80,-0.0040456,-0.00026646,0.097379,0.51657,GOBP_POST_EMBRYONIC_DEVELOPMENT,0.991867050653145
HP_CUTIS_LAXA,SET,110,-0.003339,-0.00025767,0.080274,0.51659,HP_CUTIS_LAXA,0.991867050653145
HP_ABNORMALITY_OF_THE_PLANTA...,SET,159,-0.0029661,-0.00027483,0.071204,0.51661,HP_ABNORMALITY_OF_THE_PLANTAR_SKIN_OF_FOOT,0.991867050653145
MIR6866_5P,SET,67,-0.0044171,-0.00026635,0.10567,0.51667,MIR6866_5P,0.991867050653145
GSE36527_CD69_NEG_VS_POS_TRE...2,SET,187,-0.0027404,-0.00027515,0.065551,0.51667,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP,0.991867050653145
GOBP_REGULATION_OF_CARBOHYDR...2,SET,58,-0.0045432,-0.00025495,0.10857,0.51669,GOBP_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS,0.991867050653145
HP_TENDON_XANTHOMATOSIS,SET,14,-0.011043,-0.00030481,0.26331,0.51673,HP_TENDON_XANTHOMATOSIS,0.991867050653145
HP_RENAL_CORTICAL_CYSTS,SET,16,-0.0084192,-0.00024843,0.19945,0.51683,HP_RENAL_CORTICAL_CYSTS,0.991867050653145
GOBP_LUNG_ALVEOLUS_DEVELOPME...,SET,51,-0.0054361,-0.00028611,0.12818,0.51691,GOBP_LUNG_ALVEOLUS_DEVELOPMENT,0.991867050653145
GSE13493_DP_VS_CD8POS_THYMOC...1,SET,180,-0.0026141,-0.00025756,0.061448,0.51697,GSE13493_DP_VS_CD8POS_THYMOCYTE_DN,0.991867050653145
KEGG_MEDICUS_REFERENCE_VGCC_...,SET,20,-0.0084833,-0.00027984,0.19908,0.51699,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY,0.991867050653145
GOBP_REGULATION_OF_LEUKOCYTE...3,SET,83,-0.0040838,-0.00027396,0.095612,0.51703,GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.991867050653145
GOBP_CELL_CELL_ADHESION_INVO...,SET,11,-0.011229,-0.00027478,0.26277,0.51704,GOBP_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION,0.991867050653145
CUI_DEVELOPING_HEART_C1_5TH_...,SET,73,-0.004319,-0.0002718,0.10103,0.51705,CUI_DEVELOPING_HEART_C1_5TH_WEEK_CARDIAC_CELLS,0.991867050653145
REACTOME_TRANSLATION_OF_SARS...1,SET,28,-0.0066853,-0.00026087,0.15591,0.5171,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,0.991867050653145
CCAWWNAAGG_SRF_Q4,SET,77,-0.0045049,-0.00029112,0.10487,0.51713,CCAWWNAAGG_SRF_Q4,0.991867050653145
KRIGE_AMINO_ACID_DEPRIVATION,SET,24,-0.0083939,-0.00030328,0.19493,0.51717,KRIGE_AMINO_ACID_DEPRIVATION,0.991867050653145
GOBP_LEFT_RIGHT_AXIS_SPECIFI...,SET,12,-0.011786,-0.00030122,0.27343,0.51719,GOBP_LEFT_RIGHT_AXIS_SPECIFICATION,0.991867050653145
WIERENGA_STAT5A_TARGETS_GROU...1,SET,117,-0.003515,-0.0002797,0.081502,0.5172,WIERENGA_STAT5A_TARGETS_GROUP1,0.991867050653145
GAVISH_3CA_METAPROGRAM_ENDOT...5,SET,47,-0.0060324,-0.00030482,0.13985,0.5172,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3,0.991867050653145
GOMF_EPOXIDE_HYDROLASE_ACTIV...,SET,8,-0.01444,-0.00030136,0.33428,0.51723,GOMF_EPOXIDE_HYDROLASE_ACTIVITY,0.991867050653145
GOCC_VARICOSITY,SET,8,-0.0159,-0.00033182,0.36756,0.51725,GOCC_VARICOSITY,0.991867050653145
GSE24634_TEFF_VS_TCONV_DAY5_...2,SET,188,-0.002591,-0.00026084,0.059735,0.5173,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP,0.991867050653145
HP_SUBMUCOUS_CLEFT_PALATE,SET,70,-0.0043449,-0.00026777,0.10013,0.51731,HP_SUBMUCOUS_CLEFT_PALATE,0.991867050653145
GSE22611_NOD2_TRANSDUCED_VS_...2,SET,166,-0.002953,-0.00027951,0.067996,0.51732,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP,0.991867050653145
GOMF_CORTICOTROPIN_RELEASING...,SET,5,-0.018099,-0.00029863,0.41641,0.51733,GOMF_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING,0.991867050653145
GSE10273_HIGH_VS_LOW_IL7_TRE...1,SET,175,-0.0027801,-0.00027013,0.063825,0.51737,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN,0.991867050653145
GOBP_ENDOTHELIAL_CELL_ACTIVA...,SET,9,-0.01434,-0.00031741,0.32867,0.5174,GOBP_ENDOTHELIAL_CELL_ACTIVATION,0.991867050653145
GOBP_LUNG_VASCULATURE_DEVELO...,SET,9,-0.013672,-0.00030264,0.31299,0.51742,GOBP_LUNG_VASCULATURE_DEVELOPMENT,0.991867050653145
GOBP_PROTEASOME_MEDIATED_UBI...,SET,369,-0.0018769,-0.00026339,0.042977,0.51742,GOBP_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.991867050653145
REACTOME_M_PHASE,SET,329,-0.0019639,-0.00026053,0.044882,0.51745,REACTOME_M_PHASE,0.991867050653145
GOBP_MALE_MATING_BEHAVIOR,SET,7,-0.016817,-0.0003283,0.38406,0.51746,GOBP_MALE_MATING_BEHAVIOR,0.991867050653145
GOBP_MAPK_CASCADE,SET,684,-0.0015146,-0.00028685,0.034529,0.51749,GOBP_MAPK_CASCADE,0.991867050653145
KEGG_MEDICUS_PATHOGEN_EBV_BA...,SET,7,-0.013526,-0.00026406,0.30817,0.5175,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.991867050653145
GSE6269_E_COLI_VS_STAPH_AURE...2,SET,126,-0.003388,-0.0002797,0.07711,0.51752,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP,0.991867050653145
GOBP_POSITIVE_REGULATION_OF_...747,SET,8,-0.01286,-0.00026839,0.29253,0.51753,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.991867050653145
GOBP_NEGATIVE_REGULATION_OF_...12,SET,14,-0.0093529,-0.00025817,0.21238,0.51756,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.991867050653145
VARELA_ZMPSTE24_TARGETS_UP,SET,40,-0.0059796,-0.0002788,0.13568,0.51758,VARELA_ZMPSTE24_TARGETS_UP,0.991867050653145
REACTOME_ACTIVATION_OF_RAC1_...,SET,7,-0.013755,-0.00026854,0.31205,0.51758,REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS,0.991867050653145
WINNEPENNINCKX_MELANOMA_META...2,SET,151,-0.0028933,-0.00026131,0.06554,0.51761,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,0.991867050653145
NFY_Q6,SET,223,-0.0026056,-0.00028541,0.058999,0.51761,NFY_Q6,0.991867050653145
chr14q11,SET,91,-0.0081359,-0.00057136,0.18399,0.51764,chr14q11,0.991867050653145
HP_MIXED_DEMYELINATING_AND_A...,SET,3,-0.022864,-0.00029225,0.51643,0.51766,HP_MIXED_DEMYELINATING_AND_AXONAL_POLYNEUROPATHY,0.991867050653145
GSE6875_TCONV_VS_TREG_UP,SET,180,-0.002817,-0.00027756,0.063544,0.51768,GSE6875_TCONV_VS_TREG_UP,0.991867050653145
FUNG_IL2_TARGETS_WITH_STAT5_...1,SET,6,-0.016828,-0.00030415,0.37855,0.51773,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,0.991867050653145
CSR_LATE_UP.V1_DN,SET,130,-0.0035724,-0.00029954,0.080332,0.51773,CSR_LATE_UP.V1_DN,0.991867050653145
GOBP_POSITIVE_REGULATION_OF_...387,SET,11,-0.011269,-0.00027575,0.25318,0.51775,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.991867050653145
GSE34156_UNTREATED_VS_6H_NOD...3,SET,166,-0.0029215,-0.00027654,0.065649,0.51775,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN,0.991867050653145
GAVISH_3CA_METAPROGRAM_CD8_T...9,SET,40,-0.0061319,-0.0002859,0.13766,0.51776,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_2,0.991867050653145
PID_IL8_CXCR2_PATHWAY,SET,34,-0.006649,-0.00028586,0.14916,0.51778,PID_IL8_CXCR2_PATHWAY,0.991867050653145
GOBP_ACUTE_INFLAMMATORY_RESP...2,SET,23,-0.0088931,-0.00031456,0.19902,0.51782,GOBP_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.991872648112428
KEGG_MEDICUS_PATHOGEN_HTLV_1...6,SET,8,-0.011713,-0.00024445,0.26178,0.51784,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498,0.991872648112428
GNF2_H2AFX,SET,29,-0.0074266,-0.00029492,0.16574,0.51787,GNF2_H2AFX,0.991875446379367
GOBP_GLUTAMINE_FAMILY_AMINO_...1,SET,14,-0.0099383,-0.00027433,0.22083,0.51795,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.991974003967598
KEGG_MISMATCH_REPAIR,SET,22,-0.0074503,-0.00025774,0.1652,0.51799,KEGG_MISMATCH_REPAIR,0.991995947211814
GOBP_MONOAMINE_TRANSPORT,SET,72,-0.0048863,-0.00030539,0.1078,0.51808,GOBP_MONOAMINE_TRANSPORT,0.992001913862422
MIR4666A_5P,SET,226,-0.0026387,-0.00029095,0.058105,0.51811,MIR4666A_5P,0.992001913862422
MIR379_5P,SET,41,-0.0062113,-0.00029319,0.13653,0.51814,MIR379_5P,0.992001913862422
GOMF_ALKALINE_PHOSPHATASE_AC...,SET,5,-0.019443,-0.00032081,0.427,0.51816,GOMF_ALKALINE_PHOSPHATASE_ACTIVITY,0.992001913862422
QI_PLASMACYTOMA_DN,SET,92,-0.003948,-0.00027877,0.086458,0.51821,QI_PLASMACYTOMA_DN,0.992001913862422
REACTOME_PECAM1_INTERACTIONS,SET,11,-0.011328,-0.0002772,0.24805,0.51821,REACTOME_PECAM1_INTERACTIONS,0.992001913862422
WP_NITRIC_OXIDE_METABOLISM_I...,SET,13,-0.011276,-0.00029995,0.24696,0.51821,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.992001913862422
SPZ1_01,SET,216,-0.0026409,-0.00028476,0.057735,0.51824,SPZ1_01,0.992001913862422
HP_CHOANAL_ATRESIA,SET,107,-0.00366,-0.00027859,0.079966,0.51825,HP_CHOANAL_ATRESIA,0.992001913862422
TGCCAAR_NF1_Q6,SET,639,-0.0016395,-0.00030049,0.035527,0.5184,TGCCAAR_NF1_Q6,0.992196725731895
HP_STEPPAGE_GAIT,SET,49,-0.0054552,-0.00028144,0.11804,0.51843,HP_STEPPAGE_GAIT,0.992196725731895
GNF2_ATM,SET,25,-0.0073293,-0.00027027,0.15841,0.51845,GNF2_ATM,0.992196725731895
GOBP_GLUTATHIONE_TRANSMEMBRA...,SET,8,-0.014087,-0.00029398,0.30325,0.51852,GOBP_GLUTATHIONE_TRANSMEMBRANE_TRANSPORT,0.992196725731895
GOMF_PROTEIN_GERANYLGERANYLT...,SET,4,-0.017931,-0.00026464,0.38612,0.51852,GOMF_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY,0.992196725731895
KAPOSI_LIVER_CANCER_MET_DN,SET,5,-0.018611,-0.00030708,0.40024,0.51854,KAPOSI_LIVER_CANCER_MET_DN,0.992196725731895
GOBP_POSITIVE_REGULATION_OF_...781,SET,5,-0.015514,-0.00025599,0.33283,0.51859,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,0.992196725731895
GSE35825_IFNA_VS_IFNG_STIM_M...1,SET,178,-0.0028754,-0.00028175,0.061548,0.51863,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN,0.992196725731895
GOBP_POSITIVE_REGULATION_OF_...285,SET,14,-0.010847,-0.00029942,0.23185,0.51866,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.992196725731895
HP_TESSIER_CLEFT,SET,17,-0.009958,-0.00030287,0.21246,0.51869,HP_TESSIER_CLEFT,0.992196725731895
KEGG_MEDICUS_REFERENCE_NOTCH...4,SET,13,-0.011521,-0.00030646,0.24553,0.51871,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY,0.992196725731895
chr6p12,SET,59,-0.0097032,-0.00054917,0.20671,0.51872,chr6p12,0.992196725731895
GOBP_UBIQUITIN_INDEPENDENT_P...,SET,5,-0.018617,-0.00030718,0.39565,0.51876,GOBP_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.992196725731895
HP_ABNORMALITY_OF_THE_UPPER_...4,SET,1280,-0.0011674,-0.00029729,0.024812,0.51876,HP_ABNORMALITY_OF_THE_UPPER_URINARY_TRACT,0.992196725731895
GOBP_INTERSTRAND_CROSS_LINK_...,SET,34,-0.0059374,-0.00025527,0.12609,0.51878,GOBP_INTERSTRAND_CROSS_LINK_REPAIR,0.992196725731895
MIR191_5P,SET,19,-0.0089008,-0.00028618,0.18815,0.51887,MIR191_5P,0.992246361986471
GOBP_REGULATION_OF_ARACHIDON...,SET,7,-0.014649,-0.00028598,0.30923,0.51889,GOBP_REGULATION_OF_ARACHIDONIC_ACID_SECRETION,0.992246361986471
GOBP_REGULATION_OF_MESODERMA...1,SET,8,-0.015421,-0.00032184,0.32491,0.51893,GOBP_REGULATION_OF_MESODERMAL_CELL_DIFFERENTIATION,0.992246361986471
HP_ABSENT_CIRCULATING_B_CELLS,SET,6,-0.018108,-0.0003273,0.38103,0.51895,HP_ABSENT_CIRCULATING_B_CELLS,0.992246361986471
HP_FOCAL_DYSTONIA,SET,122,-0.0035934,-0.00029195,0.075604,0.51895,HP_FOCAL_DYSTONIA,0.992246361986471
GOBP_POSITIVE_REGULATION_OF_...109,SET,13,-0.010823,-0.00028789,0.22739,0.51898,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPIRATION,0.992246361986471
SANCHEZ_MDM2_TARGETS,SET,9,-0.013389,-0.00029637,0.28028,0.51905,SANCHEZ_MDM2_TARGETS,0.992246361986471
MIR889_3P,SET,214,-0.0028778,-0.00030888,0.060046,0.51911,MIR889_3P,0.992246361986471
HP_HYPERTROPHIC_NERVE_CHANGES,SET,6,-0.020001,-0.00036151,0.41746,0.51911,HP_HYPERTROPHIC_NERVE_CHANGES,0.992246361986471
GOBP_CELL_CHEMOTAXIS,SET,290,-0.0026256,-0.00032736,0.054771,0.51912,GOBP_CELL_CHEMOTAXIS,0.992246361986471
GOBP_REGULATION_OF_SPINDLE_C...,SET,22,-0.0077706,-0.00026882,0.1621,0.51912,GOBP_REGULATION_OF_SPINDLE_CHECKPOINT,0.992246361986471
GSE17186_NAIVE_VS_CD21LOW_TR...1,SET,186,-0.003048,-0.00030523,0.063446,0.51916,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.992268246810383
CHEN_PDGF_TARGETS,SET,18,-0.011168,-0.00034951,0.23173,0.51922,CHEN_PDGF_TARGETS,0.992328353038218
MIR578,SET,168,-0.0032759,-0.00031193,0.067814,0.51926,MIR578,0.992344950799846
HP_GASTROINTESTINAL_EOSINOPH...,SET,14,-0.011598,-0.00032015,0.2395,0.51931,HP_GASTROINTESTINAL_EOSINOPHILIA,0.992344950799846
TRAVAGLINI_LUNG_PROXIMAL_BAS...,SET,556,-0.001787,-0.00030623,0.036791,0.51937,TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL,0.992344950799846
REACTOME_ACTIVATION_OF_MATRI...,SET,30,-0.0087014,-0.00035145,0.17892,0.51939,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,0.992344950799846
GOBP_NEGATIVE_REGULATION_OF_...172,SET,7,-0.015891,-0.00031024,0.3268,0.51939,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,0.992344950799846
MIR3909,SET,68,-0.005139,-0.00031217,0.10562,0.5194,MIR3909,0.992344950799846
GOMF_ANNEALING_ACTIVITY,SET,8,-0.014902,-0.00031099,0.30483,0.51949,GOMF_ANNEALING_ACTIVITY,0.992350962642892
HP_PERSISTENCE_OF_HEMOGLOBIN...,SET,32,-0.0070467,-0.00029393,0.14412,0.5195,HP_PERSISTENCE_OF_HEMOGLOBIN_F,0.992350962642892
GOBP_SYNAPTIC_VESICLE_MEMBRA...,SET,27,-0.008076,-0.00030947,0.16411,0.51962,GOBP_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.992350962642892
GSE7852_THYMUS_VS_FAT_TCONV_...1,SET,178,-0.0033196,-0.00032527,0.067221,0.51969,GSE7852_THYMUS_VS_FAT_TCONV_DN,0.992350962642892
GSE39820_CTRL_VS_TGFBETA1_IL...2,SET,181,-0.0032012,-0.00031628,0.064783,0.51971,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP,0.992350962642892
REACTOME_CASPASE_MEDIATED_CL...,SET,12,-0.011773,-0.00030088,0.23803,0.51972,REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,0.992350962642892
GSE3982_NKCELL_VS_TH1_DN,SET,180,-0.0031203,-0.00030744,0.063033,0.51974,GSE3982_NKCELL_VS_TH1_DN,0.992350962642892
KEGG_NEUROACTIVE_LIGAND_RECE...,SET,252,-0.0029727,-0.00034587,0.059925,0.51978,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,0.992350962642892
ZHOU_TNF_SIGNALING_4HR,SET,42,-0.0065873,-0.0003147,0.13275,0.51979,ZHOU_TNF_SIGNALING_4HR,0.992350962642892
GOMF_SEQUENCE_SPECIFIC_MRNA_...,SET,11,-0.010912,-0.00026702,0.21986,0.51979,GOMF_SEQUENCE_SPECIFIC_MRNA_BINDING,0.992350962642892
HP_PROMINENT_DIGIT_PAD,SET,35,-0.0072938,-0.00031816,0.14693,0.5198,HP_PROMINENT_DIGIT_PAD,0.992350962642892
GOMF_TRANSCRIPTION_FACTOR_BI...,SET,553,-0.0018418,-0.00031479,0.03707,0.51981,GOMF_TRANSCRIPTION_FACTOR_BINDING,0.992350962642892
GSE22886_TH1_VS_TH2_12H_ACT_...2,SET,180,-0.0031178,-0.00030719,0.062663,0.51984,GSE22886_TH1_VS_TH2_12H_ACT_UP,0.992350962642892
GOBP_SKELETAL_MUSCLE_SATELLI...3,SET,4,-0.024011,-0.00035436,0.48035,0.51993,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.992350962642892
GOBP_SYNAPTIC_VESICLE_MATURA...,SET,21,-0.0092108,-0.00031133,0.18414,0.51995,GOBP_SYNAPTIC_VESICLE_MATURATION,0.992350962642892
GSE22886_NEUTROPHIL_VS_MONOC...1,SET,176,-0.0030929,-0.00030137,0.061779,0.51996,GSE22886_NEUTROPHIL_VS_MONOCYTE_DN,0.992350962642892
GOBP_REGULATION_OF_INOSITOL_...1,SET,4,-0.023309,-0.00034401,0.4651,0.51999,GOBP_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.992350962642892
HE_LIM_SUN_FETAL_LUNG_C2_APO...2,SET,433,-0.0020443,-0.00031022,0.040755,0.52,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL,0.992350962642892
MIR5197_3P,SET,178,-0.0032745,-0.00032085,0.065228,0.52002,MIR5197_3P,0.992350962642892
GSE17721_CTRL_VS_POLYIC_4H_B...2,SET,183,-0.0030455,-0.00030254,0.060616,0.52004,GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP,0.992350962642892
GSE2706_R848_VS_R848_AND_LPS...3,SET,158,-0.0036237,-0.00033471,0.071994,0.52007,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN,0.992350962642892
GOBP_POSITIVE_REGULATION_OF_...610,SET,21,-0.0094935,-0.00032089,0.18828,0.52011,GOBP_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.992350962642892
WP_AUTOPHAGY_IN_PANCREATIC_D...,SET,18,-0.010096,-0.00031596,0.19973,0.52016,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,0.992350962642892
GOBP_SENSORY_SYSTEM_DEVELOPM...,SET,383,-0.0023904,-0.00034162,0.047274,0.52016,GOBP_SENSORY_SYSTEM_DEVELOPMENT,0.992350962642892
TTCYRGAA_UNKNOWN,SET,300,-0.0025482,-0.00032306,0.050059,0.5203,TTCYRGAA_UNKNOWN,0.992350962642892
HP_SEVERE_VIRAL_INFECTION,SET,29,-0.0079086,-0.00031407,0.15518,0.52032,HP_SEVERE_VIRAL_INFECTION,0.992350962642892
TAL1BETAITF2_01,SET,237,-0.0029423,-0.00033213,0.057719,0.52033,TAL1BETAITF2_01,0.992350962642892
GOBP_SKELETAL_MUSCLE_FIBER_D...,SET,11,-0.014314,-0.00035026,0.27983,0.5204,GOBP_SKELETAL_MUSCLE_FIBER_DIFFERENTIATION,0.992350962642892
HP_INCREASED_MUSCLE_FATIGUAB...,SET,16,-0.01081,-0.00031897,0.2112,0.52041,HP_INCREASED_MUSCLE_FATIGUABILITY,0.992350962642892
REACTOME_EXTRACELLULAR_MATRI...,SET,285,-0.002788,-0.00034465,0.054231,0.5205,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,0.992350962642892
MIR4756_3P,SET,106,-0.0043013,-0.00032588,0.083626,0.52051,MIR4756_3P,0.992350962642892
VECCHI_GASTRIC_CANCER_ADVANC...2,SET,154,-0.0038873,-0.00035452,0.075547,0.52052,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,0.992350962642892
GOBP_SKELETAL_MYOFIBRIL_ASSE...,SET,10,-0.014428,-0.00033664,0.2801,0.52054,GOBP_SKELETAL_MYOFIBRIL_ASSEMBLY,0.992350962642892
HP_APLASIA_HYPOPLASIA_OF_THE...77,SET,70,-0.0053663,-0.00033072,0.10408,0.52056,HP_APLASIA_HYPOPLASIA_OF_THE_UTERUS,0.992350962642892
HP_ABNORMAL_TENDON_MORPHOLOGY,SET,751,-0.0016526,-0.00032733,0.032024,0.52058,HP_ABNORMAL_TENDON_MORPHOLOGY,0.992350962642892
GOBP_NEGATIVE_REGULATION_OF_...247,SET,950,-0.0014535,-0.00032196,0.02813,0.5206,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION,0.992350962642892
HP_ABNORMAL_CIRCULATING_BETA...,SET,8,-0.015768,-0.00032907,0.30526,0.5206,HP_ABNORMAL_CIRCULATING_BETA_GLOBULIN_LEVEL,0.992350962642892
KEGG_B_CELL_RECEPTOR_SIGNALI...,SET,72,-0.0052585,-0.00032865,0.1017,0.52062,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.992350962642892
ZNF26_TARGET_GENES,SET,20,-0.0095127,-0.00031379,0.18394,0.52062,ZNF26_TARGET_GENES,0.992350962642892
GOBP_OLIGODENDROCYTE_APOPTOT...,SET,5,-0.021908,-0.00036148,0.42244,0.52068,GOBP_OLIGODENDROCYTE_APOPTOTIC_PROCESS,0.992350962642892
REACTOME_BINDING_AND_UPTAKE_...,SET,38,-0.0077255,-0.0003511,0.1487,0.52072,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,0.992350962642892
GOBP_REGULATION_OF_PROTEIN_L...13,SET,137,-0.0037104,-0.00031932,0.071218,0.52078,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.992350962642892
KEGG_MEDICUS_REFERENCE_FSHR_...,SET,16,-0.0124,-0.0003659,0.23674,0.52089,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY,0.992350962642892
GOBP_ACTIVATION_OF_CYSTEINE_...1,SET,13,-0.013031,-0.00034662,0.24804,0.52095,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.992350962642892
GOBP_DETOXIFICATION_OF_COPPE...,SET,13,-0.017238,-0.00045852,0.32783,0.52097,GOBP_DETOXIFICATION_OF_COPPER_ION,0.992350962642892
GOBP_NEGATIVE_REGULATION_OF_...357,SET,12,-0.014123,-0.00036093,0.26857,0.52097,GOBP_NEGATIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.992350962642892
MIR5192,SET,45,-0.0062455,-0.00030882,0.11852,0.52101,MIR5192,0.992350962642892
GSE11386_NAIVE_VS_MEMORY_BCE...2,SET,159,-0.0034305,-0.00031786,0.065082,0.52102,GSE11386_NAIVE_VS_MEMORY_BCELL_UP,0.992350962642892
MIR7112_5P,SET,7,-0.015337,-0.00029941,0.2908,0.52103,MIR7112_5P,0.992350962642892
chr3q11,SET,20,-0.017163,-0.00056617,0.32526,0.52104,chr3q11,0.992350962642892
GOMF_RISC_COMPLEX_BINDING,SET,4,-0.024472,-0.00036117,0.46296,0.52108,GOMF_RISC_COMPLEX_BINDING,0.992350962642892
MIR5698,SET,187,-0.0032442,-0.00032574,0.061213,0.52113,MIR5698,0.992350962642892
GOCC_TROPONIN_COMPLEX,SET,8,-0.017603,-0.00036737,0.33213,0.52113,GOCC_TROPONIN_COMPLEX,0.992350962642892
WP_15Q133_COPY_NUMBER_VARIAT...,SET,16,-0.011426,-0.00033715,0.21556,0.52114,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,0.992350962642892
GOBP_INTERCELLULAR_TRANSPORT,SET,10,-0.015949,-0.00037211,0.30073,0.52115,GOBP_INTERCELLULAR_TRANSPORT,0.992350962642892
GOBP_REGULATION_OF_VASCULAR_...2,SET,14,-0.012706,-0.00035072,0.23868,0.52123,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.992350962642892
GOBP_STEM_CELL_PROLIFERATION,SET,107,-0.0045775,-0.00034843,0.085956,0.52123,GOBP_STEM_CELL_PROLIFERATION,0.992350962642892
GOMF_FOLIC_ACID_TRANSMEMBRAN...,SET,5,-0.023643,-0.00039011,0.44399,0.52123,GOMF_FOLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.992350962642892
GOBP_CELLULAR_RESPONSE_TO_DE...,SET,27,-0.0098096,-0.0003759,0.18373,0.52129,GOBP_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS,0.992350962642892
GOBP_REGULATION_OF_MESONEPHR...,SET,4,-0.022884,-0.00033774,0.42843,0.5213,GOBP_REGULATION_OF_MESONEPHROS_DEVELOPMENT,0.992350962642892
REACTOME_RHOV_GTPASE_CYCLE,SET,36,-0.0071085,-0.00031446,0.13291,0.52133,REACTOME_RHOV_GTPASE_CYCLE,0.992350962642892
HP_SPONTANEOUS_PNEUMOTHORAX,SET,14,-0.013497,-0.00037257,0.25158,0.52139,HP_SPONTANEOUS_PNEUMOTHORAX,0.992350962642892
GOBP_CELLULAR_RESPONSE_TO_PA...,SET,8,-0.017793,-0.00037133,0.33135,0.52141,GOBP_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS,0.992350962642892
GSE17974_2.5H_VS_72H_IL4_AND...2,SET,178,-0.0032915,-0.00032252,0.06126,0.52143,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.992350962642892
KEGG_GLYCOSYLPHOSPHATIDYLINO...,SET,24,-0.0085051,-0.0003073,0.15813,0.52145,KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,0.992350962642892
HP_HYPOPLASIA_OF_THE_BLADDER,SET,5,-0.019863,-0.00032775,0.36927,0.52145,HP_HYPOPLASIA_OF_THE_BLADDER,0.992350962642892
WP_1Q211_COPY_NUMBER_VARIATI...,SET,23,-0.011044,-0.00039063,0.20454,0.52153,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,0.992350962642892
CAIRO_HEPATOBLASTOMA_DN,SET,243,-0.0031308,-0.0003578,0.057948,0.52154,CAIRO_HEPATOBLASTOMA_DN,0.992350962642892
XU_HGF_TARGETS_REPRESSED_BY_...2,SET,9,-0.015508,-0.00034326,0.28706,0.52154,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,0.992350962642892
GOBP_POSITIVE_REGULATION_OF_...192,SET,155,-0.0041661,-0.00038117,0.07711,0.52154,GOBP_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.992350962642892
HERNANDEZ_MITOTIC_ARREST_BY_...2,SET,23,-0.010979,-0.00038835,0.20247,0.52162,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,0.992350962642892
GOBP_NEGATIVE_REGULATION_OF_...443,SET,16,-0.011616,-0.00034276,0.2142,0.52162,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.992350962642892
WP_GLP1_IN_PANCREATIC_ISLET_...,SET,7,-0.020469,-0.00039961,0.37707,0.52165,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,0.992350962642892
MIR6812_5P,SET,62,-0.0056998,-0.00033066,0.10493,0.52166,MIR6812_5P,0.992350962642892
GOBP_REGULATION_OF_PHENOTYPI...,SET,3,-0.031563,-0.00040343,0.58104,0.52166,GOBP_REGULATION_OF_PHENOTYPIC_SWITCHING,0.992350962642892
GSE37416_12H_VS_48H_F_TULARE...1,SET,148,-0.0038642,-0.00034554,0.071144,0.52166,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.992350962642892
GOBP_NEGATIVE_REGULATION_OF_...598,SET,31,-0.0075513,-0.00031003,0.13895,0.52167,GOBP_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.992350962642892
GOBP_NEGATIVE_REGULATION_OF_...670,SET,22,-0.010091,-0.00034911,0.18547,0.5217,GOBP_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.992350962642892
HP_INCREASED_CIRCULATING_IGE...,SET,39,-0.0075038,-0.00034548,0.13785,0.52171,HP_INCREASED_CIRCULATING_IGE_LEVEL,0.992350962642892
GOCC_ACROSOMAL_VESICLE,SET,132,-0.0042104,-0.00035572,0.077116,0.52177,GOCC_ACROSOMAL_VESICLE,0.992350962642892
HP_TETRAPLEGIA_TETRAPARESIS,SET,124,-0.0041143,-0.00033698,0.075335,0.52178,HP_TETRAPLEGIA_TETRAPARESIS,0.992350962642892
chr14q24,SET,107,-0.0097403,-0.00074141,0.17803,0.52182,chr14q24,0.992350962642892
RICKMAN_TUMOR_DIFFERENTIATED...2,SET,111,-0.0043756,-0.00033919,0.079833,0.52185,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,0.992350962642892
GOBP_VESICLE_CYTOSKELETAL_TR...,SET,55,-0.0062134,-0.00033956,0.11312,0.5219,GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING,0.992350962642892
DER_IFN_BETA_RESPONSE_UP,SET,98,-0.0047919,-0.00034916,0.087068,0.52194,DER_IFN_BETA_RESPONSE_UP,0.992350962642892
KIM_MYCN_AMPLIFICATION_TARGE...2,SET,79,-0.0053915,-0.0003529,0.097972,0.52194,KIM_MYCN_AMPLIFICATION_TARGETS_UP,0.992350962642892
HP_APLASIA_HYPOPLASIA_OF_THE...18,SET,10,-0.015014,-0.00035029,0.27268,0.52195,HP_APLASIA_HYPOPLASIA_OF_THE_COLON,0.992350962642892
GSE17721_PAM3CSK4_VS_CPG_16H...2,SET,177,-0.0034478,-0.00033689,0.062564,0.52197,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP,0.992350962642892
HP_WIDELY_SPACED_MAXILLARY_C...,SET,9,-0.014375,-0.00031818,0.26046,0.52201,HP_WIDELY_SPACED_MAXILLARY_CENTRAL_INCISORS,0.992350962642892
SOX15_TARGET_GENES,SET,3,-0.026092,-0.00033351,0.47258,0.52202,SOX15_TARGET_GENES,0.992350962642892
HP_ANONYCHIA,SET,60,-0.0063268,-0.00036109,0.11456,0.52202,HP_ANONYCHIA,0.992350962642892
ESC_V6.5_UP_LATE.V1_DN,SET,161,-0.0036953,-0.00034452,0.066874,0.52203,ESC_V6.5_UP_LATE.V1_DN,0.992350962642892
REACTOME_RIPK1_MEDIATED_REGU...,SET,28,-0.0091295,-0.00035625,0.1646,0.52212,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,0.992467764165391
REACTOME_CELLULAR_HEXOSE_TRA...,SET,18,-0.01147,-0.00035898,0.20584,0.52222,REACTOME_CELLULAR_HEXOSE_TRANSPORT,0.992517302965755
GOBP_REGULATION_OF_BROWN_FAT...,SET,22,-0.010342,-0.00035779,0.18558,0.52222,GOBP_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.992517302965755
MORF_FOSL1,SET,371,-0.0025495,-0.00035874,0.045655,0.52227,MORF_FOSL1,0.992517302965755
HP_HYPERREFLEXIA,SET,706,-0.0017855,-0.00034334,0.031967,0.52227,HP_HYPERREFLEXIA,0.992517302965755
GOBP_SYNAPTIC_TRANSMISSION_G...3,SET,5,-0.022587,-0.0003727,0.40039,0.52249,GOBP_SYNAPTIC_TRANSMISSION_GLYCINERGIC,0.992517302965755
REACTOME_CHK1_CHK2_CDS1_MEDI...,SET,13,-0.013051,-0.00034715,0.2313,0.5225,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,0.992517302965755
GOCC_APICAL_DENDRITE,SET,16,-0.012045,-0.00035541,0.21341,0.5225,GOCC_APICAL_DENDRITE,0.992517302965755
GOBP_REGULATION_OF_VENTRICUL...3,SET,22,-0.010654,-0.00036857,0.18864,0.52252,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.992517302965755
MIR4716_3P,SET,77,-0.0055998,-0.00036189,0.099005,0.52255,MIR4716_3P,0.992517302965755
HP_PERIORBITAL_ECCHYMOSIS_WI...,SET,7,-0.022548,-0.00044019,0.39775,0.5226,HP_PERIORBITAL_ECCHYMOSIS_WITH_TARSAL_PLATE_SPARING,0.992517302965755
GOBP_REGULATION_OF_DNA_TEMPL...1,SET,47,-0.0068127,-0.00034425,0.12012,0.52261,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.992517302965755
GOBP_S_SHAPED_BODY_MORPHOGEN...,SET,7,-0.022524,-0.00043972,0.39666,0.52264,GOBP_S_SHAPED_BODY_MORPHOGENESIS,0.992517302965755
MIR4680_3P,SET,228,-0.0032478,-0.00035967,0.057134,0.52267,MIR4680_3P,0.992517302965755
GSE41867_DAY6_VS_DAY8_LCMV_A...1,SET,187,-0.0033196,-0.00033331,0.058356,0.52268,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.992517302965755
BUSSLINGER_ESOPHAGEAL_EARLY_...,SET,74,-0.0057373,-0.0003635,0.10083,0.52269,BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS,0.992517302965755
MIR4438,SET,61,-0.0063515,-0.00036549,0.11157,0.5227,MIR4438,0.992517302965755
GOBP_REGULATION_OF_PHOSPHATA...,SET,50,-0.00674,-0.00035125,0.11826,0.52272,GOBP_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.992517302965755
ATGCACG_MIR517B,SET,18,-0.012195,-0.00038165,0.21351,0.52277,ATGCACG_MIR517B,0.992517302965755
GOMF_RNA_CAP_BINDING,SET,17,-0.0108,-0.00032847,0.18907,0.52278,GOMF_RNA_CAP_BINDING,0.992517302965755
BROWNE_HCMV_INFECTION_12HR_DN,SET,88,-0.0054469,-0.0003762,0.095317,0.52279,BROWNE_HCMV_INFECTION_12HR_DN,0.992517302965755
GSE22919_RESTING_VS_IL2_IL12...1,SET,181,-0.0035111,-0.00034689,0.061425,0.52279,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN,0.992517302965755
MIR6513_5P,SET,88,-0.005252,-0.00036274,0.091787,0.52281,MIR6513_5P,0.992517302965755
GOMF_HYDROLASE_ACTIVITY_ACTI...8,SET,10,-0.017371,-0.00040528,0.3033,0.52284,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS,0.992517302965755
GOBP_OLIGODENDROCYTE_PROGENI...,SET,8,-0.019256,-0.00040186,0.33595,0.52285,GOBP_OLIGODENDROCYTE_PROGENITOR_PROLIFERATION,0.992517302965755
HP_REDUCED_CIRCULATING_GROWT...,SET,10,-0.017345,-0.0004047,0.30252,0.52286,HP_REDUCED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,0.992517302965755
GOBP_SUBTELOMERIC_HETEROCHRO...,SET,6,-0.017755,-0.00032092,0.30852,0.52295,GOBP_SUBTELOMERIC_HETEROCHROMATIN_FORMATION,0.992596275376555
MDM2_TARGET_GENES,SET,9,-0.014541,-0.00032187,0.25229,0.52298,MDM2_TARGET_GENES,0.992596275376555
GSE3203_UNTREATED_VS_IFNB_TR...2,SET,169,-0.0036581,-0.00034935,0.063424,0.523,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP,0.992596275376555
GSE15659_NAIVE_CD4_TCELL_VS_...5,SET,171,-0.0036716,-0.00035268,0.063489,0.52306,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN,0.992596275376555
GOBP_GERMINAL_CENTER_FORMATI...,SET,13,-0.013759,-0.00036599,0.23784,0.52307,GOBP_GERMINAL_CENTER_FORMATION,0.992596275376555
GOMF_TRANSCRIPTION_COREPRESS...1,SET,173,-0.0036679,-0.00035436,0.063343,0.52309,GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY,0.992596275376555
MIR4726_3P,SET,65,-0.0063219,-0.00037549,0.10902,0.52312,MIR4726_3P,0.992596275376555
PURBEY_TARGETS_OF_CTBP1_AND_...2,SET,65,-0.0057065,-0.00033894,0.098199,0.52317,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,0.992596275376555
HP_ABNORMAL_SIZE_OF_THE_DENT...,SET,14,-0.014563,-0.00040199,0.25013,0.52321,HP_ABNORMAL_SIZE_OF_THE_DENTAL_ROOT,0.992596275376555
SCHWAB_TARGETS_OF_BMYB_POLYM...1,SET,13,-0.014621,-0.00038892,0.25049,0.52327,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,0.992596275376555
GOCC_CYTOSOLIC_RIBOSOME,SET,102,-0.004692,-0.00034875,0.080381,0.52327,GOCC_CYTOSOLIC_RIBOSOME,0.992596275376555
GSE11057_CD4_EFF_MEM_VS_PBMC...1,SET,183,-0.0038245,-0.00037992,0.065529,0.52327,GSE11057_CD4_EFF_MEM_VS_PBMC_DN,0.992596275376555
GSE11057_NAIVE_VS_CENT_MEMOR...2,SET,153,-0.0040881,-0.00037163,0.069906,0.52332,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.992596275376555
MIR935,SET,106,-0.0050944,-0.00038597,0.087057,0.52333,MIR935,0.992596275376555
GOBP_PHOSPHATIDYLINOSITOL_3_...1,SET,275,-0.0031758,-0.00038575,0.054267,0.52333,GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.992596275376555
GOBP_SUBPALLIUM_DEVELOPMENT,SET,26,-0.010766,-0.00040484,0.18333,0.52341,GOBP_SUBPALLIUM_DEVELOPMENT,0.992623720080694
ZHONG_PFC_C7_SST_LHX6_POS_PU...,SET,13,-0.014502,-0.00038576,0.24704,0.52341,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.992623720080694
GOCC_MRNA_CLEAVAGE_FACTOR_CO...,SET,22,-0.010237,-0.00035416,0.17399,0.52346,GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX,0.992623720080694
GOBP_D_ASPARTATE_TRANSMEMBRA...,SET,5,-0.023217,-0.00038308,0.3938,0.52351,GOBP_D_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.992623720080694
GOBP_GLYCOPROTEIN_CATABOLIC_...,SET,31,-0.010135,-0.0004161,0.17177,0.52353,GOBP_GLYCOPROTEIN_CATABOLIC_PROCESS,0.992623720080694
HP_PERSONALITY_CHANGES,SET,32,-0.0088626,-0.00036967,0.14996,0.52356,HP_PERSONALITY_CHANGES,0.992623720080694
HP_ABNORMAL_MUSCLE_FIBER_MER...,SET,4,-0.024553,-0.00036237,0.4147,0.52361,HP_ABNORMAL_MUSCLE_FIBER_MEROSIN_EXPRESSION,0.992623720080694
HP_REDUCED_PROTEIN_C_ACTIVITY,SET,10,-0.013505,-0.00031509,0.22787,0.52363,HP_REDUCED_PROTEIN_C_ACTIVITY,0.992623720080694
GOCC_AUTOPHAGOSOME,SET,105,-0.0048729,-0.00036745,0.082013,0.52369,GOCC_AUTOPHAGOSOME,0.992623720080694
HE_LIM_SUN_FETAL_LUNG_C4_CD8...,SET,46,-0.0079241,-0.00039614,0.13313,0.52373,HE_LIM_SUN_FETAL_LUNG_C4_CD8_T_CELL,0.992623720080694
MIR3179,SET,117,-0.0044914,-0.0003574,0.075435,0.52374,MIR3179,0.992623720080694
GSE22611_NOD2_TRANSD_VS_CTRL...4,SET,173,-0.0036809,-0.00035562,0.061831,0.52374,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP,0.992623720080694
QI_PBMC_ZOSTAVAX_AGE_50_75YO...4,SET,266,-0.00318,-0.00037998,0.053416,0.52374,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,0.992623720080694
GOBP_RESPONSE_TO_GRAVITY,SET,8,-0.017379,-0.00036268,0.29116,0.5238,GOBP_RESPONSE_TO_GRAVITY,0.992623720080694
GOBP_FACE_MORPHOGENESIS,SET,30,-0.0098749,-0.00039884,0.16525,0.52383,GOBP_FACE_MORPHOGENESIS,0.992623720080694
GOBP_POSITIVE_REGULATION_OF_...88,SET,2,-0.040568,-0.00042338,0.67863,0.52383,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.992623720080694
HE_LIM_SUN_FETAL_LUNG_C4_TH1...,SET,15,-0.014473,-0.00041353,0.24219,0.52383,HE_LIM_SUN_FETAL_LUNG_C4_TH17_CELL,0.992623720080694
GSE360_T_GONDII_VS_M_TUBERCU...4,SET,181,-0.0038135,-0.00037677,0.063686,0.52387,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP,0.99262917461702
GOBP_POSITIVE_REGULATION_OF_...44,SET,37,-0.0079812,-0.00035793,0.13319,0.52389,GOBP_POSITIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.99262917461702
GOBP_HIPPO_SIGNALING,SET,53,-0.007771,-0.00041692,0.12859,0.52409,GOBP_HIPPO_SIGNALING,0.992783883780402
GOBP_SIGNAL_RELEASE,SET,456,-0.0025257,-0.00039306,0.041788,0.5241,GOBP_SIGNAL_RELEASE,0.992783883780402
GSE21927_SPLEEN_VS_BONE_MARR...1,SET,164,-0.0041183,-0.00038748,0.068123,0.5241,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN,0.992783883780402
CHAUHAN_RESPONSE_TO_METHOXYE...1,SET,83,-0.0057288,-0.00038431,0.09444,0.52419,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,0.992783883780402
GOMF_CROSSOVER_JUNCTION_DNA_...,SET,7,-0.017293,-0.00033759,0.28478,0.52421,GOMF_CROSSOVER_JUNCTION_DNA_ENDONUCLEASE_ACTIVITY,0.992783883780402
BACOLOD_RESISTANCE_TO_ALKYLA...2,SET,22,-0.012082,-0.00041799,0.19835,0.52429,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,0.992783883780402
GOBP_NOTCH_SIGNALING_PATHWAY,SET,164,-0.0042685,-0.00040162,0.069995,0.52431,GOBP_NOTCH_SIGNALING_PATHWAY,0.992783883780402
HP_FLAT_OCCIPUT,SET,52,-0.0069553,-0.00036963,0.11399,0.52433,HP_FLAT_OCCIPUT,0.992783883780402
HP_ABNORMAL_PR_INTERVAL,SET,17,-0.013608,-0.00041387,0.22269,0.52436,HP_ABNORMAL_PR_INTERVAL,0.992783883780402
MANN_RESPONSE_TO_AMIFOSTINE_...2,SET,19,-0.011161,-0.00035884,0.18246,0.52439,MANN_RESPONSE_TO_AMIFOSTINE_UP,0.992783883780402
GOBP_RESPONSE_TO_VITAMIN_D,SET,35,-0.0096432,-0.00042064,0.15736,0.52443,GOBP_RESPONSE_TO_VITAMIN_D,0.992783883780402
HP_ABNORMAL_MORPHOLOGY_OF_TH...3,SET,25,-0.0093271,-0.00034394,0.15222,0.52443,HP_ABNORMAL_MORPHOLOGY_OF_THE_CONJUNCTIVAL_VASCULATURE,0.992783883780402
MAGRANGEAS_MULTIPLE_MYELOMA_...4,SET,38,-0.0089393,-0.00040626,0.14571,0.52446,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,0.992783883780402
MIR5684,SET,35,-0.0094929,-0.00041408,0.15446,0.5245,MIR5684,0.992783883780402
GOCC_MITOCHONDRIAL_ENVELOPE,SET,686,-0.001958,-0.00037133,0.031862,0.5245,GOCC_MITOCHONDRIAL_ENVELOPE,0.992783883780402
WP_STEROID_HORMONE_PRECURSOR...,SET,9,-0.018456,-0.00040853,0.30013,0.52452,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,0.992783883780402
GOBP_B_1_B_CELL_DIFFERENTIAT...,SET,5,-0.026145,-0.00043139,0.42479,0.52454,GOBP_B_1_B_CELL_DIFFERENTIATION,0.992783883780402
REACTOME_TRNA_AMINOACYLATION,SET,24,-0.00977,-0.00035301,0.15868,0.52455,REACTOME_TRNA_AMINOACYLATION,0.992783883780402
MIR6809_3P,SET,504,-0.0025003,-0.00040853,0.040544,0.52459,MIR6809_3P,0.992783883780402
GOBP_POSITIVE_REGULATION_OF_...642,SET,681,-0.0020861,-0.00039424,0.033819,0.52459,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.992783883780402
MODULE_157,SET,100,-0.0052556,-0.00038681,0.08498,0.52466,MODULE_157,0.992783883780402
BUCKANOVICH_T_LYMPHOCYTE_HOM...1,SET,19,-0.011553,-0.00037147,0.18663,0.52468,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,0.992783883780402
REACTOME_SIGNALING_BY_BRAF_A...,SET,62,-0.0067774,-0.00039318,0.10938,0.5247,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,0.992783883780402
ZSCAN26_TARGET_GENES,SET,4,-0.028899,-0.0004265,0.46599,0.52472,ZSCAN26_TARGET_GENES,0.992783883780402
GSE10240_CTRL_VS_IL22_STIM_P...1,SET,174,-0.0037528,-0.0003636,0.060385,0.52478,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.992783883780402
GOMF_CYCLIC_NUCLEOTIDE_ACTIV...,SET,10,-0.017328,-0.00040429,0.27811,0.52484,GOMF_CYCLIC_NUCLEOTIDE_ACTIVATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.992783883780402
HP_GASTRITIS,SET,18,-0.012599,-0.00039431,0.20215,0.52485,HP_GASTRITIS,0.992783883780402
KEGG_FATTY_ACID_METABOLISM,SET,41,-0.0083798,-0.00039555,0.13416,0.5249,KEGG_FATTY_ACID_METABOLISM,0.992783883780402
GOBP_NEGATIVE_REGULATION_OF_...419,SET,27,-0.010889,-0.00041729,0.17438,0.5249,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.992783883780402
HP_MYOCLONUS,SET,321,-0.0029859,-0.00039135,0.047815,0.5249,HP_MYOCLONUS,0.992783883780402
GOBP_MITOCHONDRIAL_ATP_TRANS...,SET,6,-0.023679,-0.00042799,0.37888,0.52492,GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT,0.992783883780402
HP_HYPOPLASIA_OF_THE_PONS,SET,82,-0.0057178,-0.00038126,0.09128,0.52497,HP_HYPOPLASIA_OF_THE_PONS,0.992783883780402
HP_DISTAL_SENSORY_IMPAIRMENT...,SET,10,-0.015847,-0.00036974,0.25297,0.52498,HP_DISTAL_SENSORY_IMPAIRMENT_OF_ALL_MODALITIES,0.992783883780402
GOBP_POSITIVE_REGULATION_OF_...282,SET,7,-0.022961,-0.00044825,0.36633,0.52499,GOBP_POSITIVE_REGULATION_OF_FEVER_GENERATION,0.992783883780402
GSE3039_CD4_TCELL_VS_B2_BCEL...2,SET,182,-0.0040671,-0.00040292,0.064882,0.52499,GSE3039_CD4_TCELL_VS_B2_BCELL_UP,0.992783883780402
GOMF_INSULIN_LIKE_GROWTH_FAC...2,SET,8,-0.023286,-0.00048597,0.37129,0.525,GOMF_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING,0.992783883780402
HP_ABNORMAL_HEAD_BLOOD_VESSE...,SET,64,-0.0072769,-0.00042889,0.11541,0.52514,HP_ABNORMAL_HEAD_BLOOD_VESSEL_MORPHOLOGY,0.992959482617921
QUEREC_MODEL_PBMC_YF_17D_VAC...1,SET,46,-0.0075448,-0.00037718,0.11961,0.52515,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_PREDICTIVE,0.992959482617921
GNF2_RRM1,SET,85,-0.0055519,-0.00037688,0.087772,0.52522,GNF2_RRM1,0.992970293717705
FIGUEROA_AML_METHYLATION_CLU...9,SET,42,-0.0097044,-0.00046362,0.15325,0.52525,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,0.992970293717705
GOBP_T_HELPER_17_CELL_LINEAG...,SET,19,-0.01403,-0.00045111,0.22148,0.52525,GOBP_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.992970293717705
DESCARTES_FETAL_EYE_MICROGLIA,SET,127,-0.0049049,-0.00040653,0.077378,0.52527,DESCARTES_FETAL_EYE_MICROGLIA,0.992970293717705
NR4A2_TARGET_GENES,SET,4,-0.029882,-0.00044102,0.46998,0.52535,NR4A2_TARGET_GENES,0.992994638228942
MCGOWAN_RSP6_TARGETS_DN,SET,4,-0.027205,-0.00040151,0.42744,0.52537,MCGOWAN_RSP6_TARGETS_DN,0.992994638228942
HP_MILDLY_ELEVATED_CREATINE_...,SET,53,-0.0071582,-0.00038404,0.11251,0.52537,HP_MILDLY_ELEVATED_CREATINE_KINASE,0.992994638228942
PRAMOONJAGO_SOX4_TARGETS_DN,SET,46,-0.0076263,-0.00038125,0.1197,0.5254,PRAMOONJAGO_SOX4_TARGETS_DN,0.992994638228942
WP_HEMATOPOIETIC_STEM_CELL_G...,SET,19,-0.0131,-0.00042119,0.20455,0.52553,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,0.992994638228942
GAVISH_3CA_METAPROGRAM_FIBRO...14,SET,47,-0.0086156,-0.00043535,0.13439,0.52556,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON,0.992994638228942
BIOCARTA_KREB_PATHWAY,SET,8,-0.018879,-0.00039401,0.29382,0.52562,BIOCARTA_KREB_PATHWAY,0.992994638228942
GOBP_NEGATIVE_REGULATION_OF_...4,SET,8,-0.017545,-0.00036615,0.273,0.52562,GOBP_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION,0.992994638228942
KEGG_MEDICUS_PATHOGEN_KSHV_V...1,SET,6,-0.020127,-0.00036378,0.31247,0.52568,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S,0.992994638228942
HP_FIBROSARCOMA,SET,9,-0.020376,-0.00045102,0.31618,0.52569,HP_FIBROSARCOMA,0.992994638228942
HOEK_MONOCYTE_2011_2012_TIV_...2,SET,7,-0.026258,-0.00051261,0.40755,0.52569,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_UP,0.992994638228942
MIR378A_5P,SET,120,-0.0052277,-0.00042125,0.080972,0.52574,MIR378A_5P,0.992994638228942
GSE16450_CTRL_VS_IFNA_12H_ST...2,SET,172,-0.0043129,-0.00041548,0.066715,0.52577,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.992994638228942
HP_ABNORMALITY_OF_THE_SUPRAO...,SET,87,-0.006176,-0.00042413,0.09514,0.52588,HP_ABNORMALITY_OF_THE_SUPRAORBITAL_RIDGES,0.992994638228942
GSE43955_TH0_VS_TGFB_IL6_TH1...1,SET,180,-0.0041829,-0.00041214,0.06439,0.5259,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN,0.992994638228942
GOCC_ORGANELLE_SUBCOMPARTMENT,SET,1359,-0.0015603,-0.00040849,0.024008,0.52591,GOCC_ORGANELLE_SUBCOMPARTMENT,0.992994638228942
GAVISH_3CA_METAPROGRAM_FIBRO...7,SET,48,-0.0088078,-0.00044976,0.13497,0.52602,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_6,0.992994638228942
CAGTGTT_MIR141_MIR200A,SET,288,-0.0033305,-0.00041384,0.050992,0.52604,CAGTGTT_MIR141_MIR200A,0.992994638228942
BIOCARTA_KERATINOCYTE_PATHWAY,SET,46,-0.0087126,-0.00043556,0.13327,0.52606,BIOCARTA_KERATINOCYTE_PATHWAY,0.992994638228942
MIR665,SET,122,-0.0049462,-0.00040185,0.075572,0.52609,MIR665,0.992994638228942
ERWIN_COHEN_BLOOD_LIVE_VACCI...,SET,617,-0.0022974,-0.00041401,0.035102,0.52609,ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,0.992994638228942
GOBP_REGULATION_OF_CATION_CH...,SET,86,-0.006598,-0.00045051,0.10073,0.52611,GOBP_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.992994638228942
GOMF_SODIUM_PHOSPHATE_SYMPOR...,SET,13,-0.01866,-0.00049635,0.28411,0.52618,GOMF_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY,0.992994638228942
GOBP_NEGATIVE_REGULATION_OF_...566,SET,11,-0.018099,-0.00044287,0.27521,0.52622,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,0.992994638228942
GOBP_CELLULAR_RESPONSE_TO_AM...1,SET,5,-0.029077,-0.00047978,0.44181,0.52624,GOBP_CELLULAR_RESPONSE_TO_AMMONIUM_ION,0.992994638228942
GOBP_RESPONSE_TO_AMMONIUM_ION,SET,5,-0.029077,-0.00047978,0.44181,0.52624,GOBP_RESPONSE_TO_AMMONIUM_ION,0.992994638228942
HP_INCREASED_URINARY_PORPHOB...,SET,5,-0.025864,-0.00042676,0.393,0.52624,HP_INCREASED_URINARY_PORPHOBILINOGEN,0.992994638228942
WEIGEL_OXIDATIVE_STRESS_BY_H...2,SET,59,-0.0077983,-0.00044136,0.1184,0.52626,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,0.992994638228942
HP_ABNORMAL_PROXIMAL_PHALANX...,SET,27,-0.011115,-0.00042592,0.16848,0.5263,HP_ABNORMAL_PROXIMAL_PHALANX_MORPHOLOGY_OF_THE_HAND,0.992994638228942
KEGG_WNT_SIGNALING_PATHWAY,SET,144,-0.0049946,-0.00044059,0.075613,0.52633,KEGG_WNT_SIGNALING_PATHWAY,0.992994638228942
GOBP_PROTEIN_INSERTION_INTO_...2,SET,9,-0.017358,-0.00038421,0.26264,0.52635,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE_BY_STOP_TRANSFER_MEMBRANE_ANCHOR_SEQUENCE,0.992994638228942
GOMF_PHOSPHOLIPASE_ACTIVITY,SET,101,-0.0056018,-0.00041433,0.084694,0.52637,GOMF_PHOSPHOLIPASE_ACTIVITY,0.992994638228942
GOBP_NEGATIVE_REGULATION_OF_...502,SET,21,-0.013905,-0.00046999,0.20961,0.52644,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,0.992994638228942
MARSON_FOXP3_TARGETS_STIMULA...1,SET,10,-0.017011,-0.00039688,0.25629,0.52646,MARSON_FOXP3_TARGETS_STIMULATED_DN,0.992994638228942
GOBP_DICARBOXYLIC_ACID_BIOSY...,SET,12,-0.017667,-0.00045152,0.26615,0.52646,GOBP_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.992994638228942
GSE22886_NAIVE_BCELL_VS_BLOO...2,SET,174,-0.0043034,-0.00041695,0.064827,0.52646,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.992994638228942
HP_BROAD_EYEBROW,SET,23,-0.011668,-0.00041271,0.17554,0.5265,HP_BROAD_EYEBROW,0.992994638228942
HP_ABNORMAL_GLIAL_CELL_MORPH...,SET,143,-0.0046554,-0.00040925,0.069765,0.5266,HP_ABNORMAL_GLIAL_CELL_MORPHOLOGY,0.992994638228942
HOXA9_DN.V1_DN,SET,165,-0.0045013,-0.00042479,0.067461,0.5266,HOXA9_DN.V1_DN,0.992994638228942
NR5A1_TARGET_GENES,SET,11,-0.01799,-0.00044022,0.26949,0.52661,NR5A1_TARGET_GENES,0.992994638228942
WP_TGFBETA_RECEPTOR_SIGNALIN...,SET,55,-0.0086136,-0.00047074,0.12895,0.52663,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,0.992994638228942
MIR9_3P,SET,308,-0.0033649,-0.00043216,0.050374,0.52663,MIR9_3P,0.992994638228942
HP_ABNORMAL_URINE_PHOSPHATE_...,SET,26,-0.011233,-0.00042241,0.16784,0.52668,HP_ABNORMAL_URINE_PHOSPHATE_CONCENTRATION,0.992994638228942
GOMF_OXIDOREDUCTASE_ACTIVITY...25,SET,7,-0.022454,-0.00043836,0.33502,0.52672,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.992994638228942
GOBP_NEGATIVE_REGULATION_OF_...126,SET,8,-0.021378,-0.00044614,0.31859,0.52675,GOBP_NEGATIVE_REGULATION_OF_CELL_SIZE,0.992994638228942
GOBP_TUMOR_NECROSIS_FACTOR_S...,SET,161,-0.0048223,-0.00044959,0.071789,0.52678,GOBP_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.992994638228942
REACTOME_ACTIVATED_NTRK3_SIG...1,SET,6,-0.026385,-0.0004769,0.39168,0.52685,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K,0.992994638228942
HP_ABNORMAL_VISUAL_ELECTROPH...,SET,233,-0.0038268,-0.00042836,0.056777,0.52687,HP_ABNORMAL_VISUAL_ELECTROPHYSIOLOGY,0.992994638228942
GSE23321_CD8_STEM_CELL_MEMOR...6,SET,167,-0.0043572,-0.00041366,0.064584,0.52689,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.992994638228942
REACTOME_PHOSPHATE_BOND_HYDR...2,SET,7,-0.022925,-0.00044754,0.33978,0.5269,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS,0.992994638228942
WINTER_HYPOXIA_METAGENE,SET,216,-0.0041567,-0.00044819,0.061524,0.52693,WINTER_HYPOXIA_METAGENE,0.992994638228942
GOMF_TRANSCRIPTION_COACTIVAT...2,SET,40,-0.009524,-0.00044406,0.1407,0.52698,GOMF_TRANSCRIPTION_COACTIVATOR_BINDING,0.992994638228942
GOBP_REGULATION_OF_SYNAPTIC_...11,SET,12,-0.017653,-0.00045115,0.26057,0.52701,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.992994638228942
HP_MYOFIBER_DISARRAY,SET,10,-0.017222,-0.00040181,0.25415,0.52701,HP_MYOFIBER_DISARRAY,0.992994638228942
GOCC_IGG_IMMUNOGLOBULIN_COMP...,SET,2,-0.049507,-0.00051668,0.72954,0.52705,GOCC_IGG_IMMUNOGLOBULIN_COMPLEX,0.992994638228942
GSE24634_TREG_VS_TCONV_POST_...6,SET,179,-0.0041427,-0.00040705,0.060857,0.52714,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP,0.992994638228942
CROMER_METASTASIS_DN,SET,74,-0.006805,-0.00043115,0.099927,0.52715,CROMER_METASTASIS_DN,0.992994638228942
BROWNE_HCMV_INFECTION_16HR_UP,SET,199,-0.0040119,-0.00041541,0.058721,0.52723,BROWNE_HCMV_INFECTION_16HR_UP,0.992994638228942
BANP_TARGET_GENES,SET,612,-0.0023543,-0.00042261,0.03445,0.52724,BANP_TARGET_GENES,0.992994638228942
WP_ID_SIGNALING,SET,15,-0.013816,-0.00039474,0.20202,0.52726,WP_ID_SIGNALING,0.992994638228942
JACKSON_DNMT1_TARGETS_DN,SET,20,-0.014667,-0.00048383,0.21442,0.52727,JACKSON_DNMT1_TARGETS_DN,0.992994638228942
GOMF_CYSTEINE_TYPE_ENDOPEPTI...6,SET,34,-0.012044,-0.00051781,0.17605,0.52727,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.992994638228942
BROWNE_HCMV_INFECTION_30MIN_...2,SET,47,-0.0089683,-0.00045318,0.13104,0.52728,BROWNE_HCMV_INFECTION_30MIN_UP,0.992994638228942
GOBP_MULTICELLULAR_ORGANISMA...3,SET,24,-0.011609,-0.00041946,0.16952,0.5273,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_IRON_ION_HOMEOSTASIS,0.992994638228942
GOBP_SERINE_FAMILY_AMINO_ACI...1,SET,15,-0.014692,-0.00041978,0.21412,0.52735,GOBP_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.992994638228942
JISON_SICKLE_CELL_DISEASE_DN,SET,167,-0.004382,-0.00041602,0.06385,0.52736,JISON_SICKLE_CELL_DISEASE_DN,0.992994638228942
GOBP_POSITIVE_REGULATION_OF_...790,SET,19,-0.012789,-0.00041121,0.18636,0.52736,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.992994638228942
GARGALOVIC_RESPONSE_TO_OXIDI...23,SET,22,-0.012763,-0.00044155,0.18582,0.52738,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,0.992994638228942
MIR6867_3P,SET,105,-0.0056281,-0.0004244,0.081881,0.5274,MIR6867_3P,0.992994638228942
GOMF_BASAL_TRANSCRIPTION_MAC...,SET,56,-0.007829,-0.00043172,0.11382,0.52742,GOMF_BASAL_TRANSCRIPTION_MACHINERY_BINDING,0.992994638228942
ZHOU_PANCREATIC_ENDOCRINE_PR...,SET,12,-0.019649,-0.00050218,0.2852,0.52746,ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR,0.992994638228942
GOMF_APOLIPOPROTEIN_BINDING,SET,17,-0.014896,-0.00045306,0.21549,0.52755,GOMF_APOLIPOPROTEIN_BINDING,0.992994638228942
GOMF_ORGANOPHOSPHATE_ESTER_T...,SET,35,-0.010692,-0.00046637,0.15459,0.52757,GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.992994638228942
GOBP_PHENOL_CONTAINING_COMPO...2,SET,7,-0.026253,-0.00051251,0.37937,0.52758,GOBP_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.992994638228942
GOMF_CERAMIDE_BINDING,SET,17,-0.014612,-0.00044441,0.21093,0.52761,GOMF_CERAMIDE_BINDING,0.992994638228942
GAUTAM_EYE_CHOROID_SCLERA_AC...,SET,104,-0.0055266,-0.00041477,0.079705,0.52764,GAUTAM_EYE_CHOROID_SCLERA_ACTIVATED_T_CELLS,0.992994638228942
GOBP_RESPONSE_TO_DEXAMETHASO...,SET,42,-0.0099329,-0.00047453,0.14319,0.52765,GOBP_RESPONSE_TO_DEXAMETHASONE,0.992994638228942
HP_ABNORMALITY_OF_THE_PROTEI...,SET,13,-0.014114,-0.00037543,0.20283,0.52774,HP_ABNORMALITY_OF_THE_PROTEIN_C_ANTICOAGULANT_PATHWAY,0.992994638228942
GSE45365_HEALTHY_VS_MCMV_INF...4,SET,160,-0.0046998,-0.00043682,0.067537,0.52774,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN,0.992994638228942
GOBP_RESPIRATORY_CHAIN_COMPL...2,SET,23,-0.010619,-0.0003756,0.15224,0.5278,GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY,0.992994638228942
HP_BILIARY_CIRRHOSIS,SET,19,-0.014868,-0.00047804,0.21314,0.52781,HP_BILIARY_CIRRHOSIS,0.992994638228942
HP_TIBIALIS_ANTERIOR_MUSCLE_...,SET,4,-0.031784,-0.00046909,0.45551,0.52781,HP_TIBIALIS_ANTERIOR_MUSCLE_ATROPHY,0.992994638228942
MIR4801,SET,242,-0.0040349,-0.00046018,0.0577,0.52787,MIR4801,0.992994638228942
GSE411_100MIN_VS_400MIN_IL6_...4,SET,187,-0.0041806,-0.00041976,0.059741,0.52789,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.992994638228942
GAVISH_3CA_METAPROGRAM_FIBRO...22,SET,48,-0.0090671,-0.000463,0.12941,0.52793,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS,0.992994638228942
HP_SHOULDER_GIRDLE_MUSCLE_WE...,SET,50,-0.0082238,-0.00042858,0.11716,0.52798,HP_SHOULDER_GIRDLE_MUSCLE_WEAKNESS,0.992994638228942
HP_ABNORMAL_LUNG_MORPHOLOGY,SET,1068,-0.0019104,-0.00044716,0.027185,0.52801,HP_ABNORMAL_LUNG_MORPHOLOGY,0.992994638228942
GSE17721_CTRL_VS_CPG_0.5H_BM...1,SET,181,-0.0044756,-0.00044219,0.063699,0.52801,GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN,0.992994638228942
GSE22886_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.0043385,-0.00042511,0.061739,0.52801,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP,0.992994638228942
GSE2770_IL12_AND_TGFB_ACT_VS...3,SET,181,-0.0043849,-0.00043323,0.062167,0.52812,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN,0.992994638228942
REACTOME_ACTIVATION_OF_NOXA_...,SET,5,-0.03068,-0.00050623,0.43435,0.52815,REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.992994638228942
HP_ABNORMAL_ANATOMIC_LOCATIO...,SET,127,-0.0050487,-0.00041844,0.071494,0.52815,HP_ABNORMAL_ANATOMIC_LOCATION_OF_THE_HEART,0.992994638228942
GOBP_LIPID_METABOLIC_PROCESS,SET,1263,-0.0018052,-0.00045689,0.025543,0.52817,GOBP_LIPID_METABOLIC_PROCESS,0.992994638228942
REACTOME_NETRIN_MEDIATED_REP...,SET,8,-0.021833,-0.00045565,0.3088,0.52818,REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS,0.992994638228942
REACTOME_PCNA_DEPENDENT_LONG...,SET,21,-0.012347,-0.00041733,0.1742,0.52825,REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.992994638228942
HP_EPIPHYSEAL_DYSPLASIA,SET,28,-0.011403,-0.00044495,0.16088,0.52825,HP_EPIPHYSEAL_DYSPLASIA,0.992994638228942
GOMF_CO_RECEPTOR_BINDING,SET,13,-0.017669,-0.00046999,0.24856,0.52833,GOMF_CO_RECEPTOR_BINDING,0.992994638228942
GSE5542_UNTREATED_VS_IFNA_TR...3,SET,171,-0.0045193,-0.00043411,0.063596,0.52833,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.992994638228942
GOBP_REGULATION_OF_RESPONSE_...1,SET,474,-0.0028432,-0.0004509,0.039959,0.52836,GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.992994638228942
REACTOME_RESPONSE_OF_MTB_TO_...,SET,21,-0.01259,-0.00042555,0.17681,0.52838,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,0.992994638228942
BUYTAERT_PHOTODYNAMIC_THERAP...2,SET,758,-0.0022539,-0.00044842,0.031644,0.52839,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,0.992994638228942
MIR12124,SET,289,-0.0035937,-0.00044732,0.050433,0.5284,MIR12124,0.992994638228942
JIANG_MELANOMA_TRM3_CD8,SET,363,-0.0031947,-0.00044474,0.044801,0.52842,JIANG_MELANOMA_TRM3_CD8,0.992994638228942
GOBP_RETROGRADE_NEURONAL_DEN...,SET,4,-0.031677,-0.00046751,0.44435,0.52842,GOBP_RETROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,0.992994638228942
BURTON_ADIPOGENESIS_11,SET,47,-0.0090147,-0.00045552,0.12637,0.52844,BURTON_ADIPOGENESIS_11,0.992994638228942
GOBP_DOUBLE_STRAND_BREAK_REP...2,SET,7,-0.019749,-0.00038554,0.27683,0.52844,GOBP_DOUBLE_STRAND_BREAK_REPAIR_INVOLVED_IN_MEIOTIC_RECOMBINATION,0.992994638228942
GOMF_ESTROGEN_2_HYDROXYLASE_...,SET,5,-0.031473,-0.00051931,0.44031,0.52849,GOMF_ESTROGEN_2_HYDROXYLASE_ACTIVITY,0.992994638228942
WP_CIRCADIAN_RHYTHM_GENES,SET,190,-0.0046851,-0.00047414,0.065517,0.5285,WP_CIRCADIAN_RHYTHM_GENES,0.992994638228942
VILLANUEVA_LIVER_CANCER_KRT1...2,SET,152,-0.004768,-0.00043203,0.066601,0.52854,VILLANUEVA_LIVER_CANCER_KRT19_UP,0.992994638228942
chr11p13,SET,36,-0.021319,-0.00094309,0.29761,0.52855,chr11p13,0.992994638228942
REACTOME_POTENTIAL_THERAPEUT...,SET,92,-0.0062234,-0.00043943,0.086615,0.52864,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,0.992994638228942
PID_NFAT_3PATHWAY,SET,53,-0.008716,-0.00046762,0.12125,0.52865,PID_NFAT_3PATHWAY,0.992994638228942
MIR6744_3P,SET,56,-0.0085702,-0.00047259,0.11922,0.52865,MIR6744_3P,0.992994638228942
MIR4452,SET,148,-0.0051505,-0.00046056,0.071641,0.52866,MIR4452,0.992994638228942
PYEON_CANCER_HEAD_AND_NECK_V...2,SET,157,-0.0050251,-0.00046269,0.069805,0.52869,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,0.992994638228942
HP_NEOPLASM_OF_THE_EYE,SET,47,-0.0079256,-0.00040049,0.10993,0.52874,HP_NEOPLASM_OF_THE_EYE,0.992994638228942
GOBP_RESPONSE_TO_LIGHT_STIMU...,SET,288,-0.0036008,-0.00044743,0.049915,0.52875,GOBP_RESPONSE_TO_LIGHT_STIMULUS,0.992994638228942
HP_FACIAL_ASYMMETRY,SET,128,-0.0054104,-0.00045017,0.074732,0.52886,HP_FACIAL_ASYMMETRY,0.992994638228942
DI_MARTINO_MATRISOME_HIGHLY_...1,SET,26,-0.012565,-0.0004725,0.17349,0.52887,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC,0.992994638228942
HP_MUSCLE_WEAKNESS,SET,912,-0.0020663,-0.00044894,0.028494,0.5289,HP_MUSCLE_WEAKNESS,0.992994638228942
GOBP_REGULATION_OF_AUTOPHAGY...1,SET,39,-0.010086,-0.00046434,0.13903,0.52891,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.992994638228942
SIMBULAN_UV_RESPONSE_NORMAL_...2,SET,9,-0.021706,-0.00048045,0.29905,0.52893,SIMBULAN_UV_RESPONSE_NORMAL_UP,0.992994638228942
BIOCARTA_SAM68_PATHWAY,SET,6,-0.025512,-0.00046112,0.35142,0.52894,BIOCARTA_SAM68_PATHWAY,0.992994638228942
WATANABE_COLON_CANCER_MSI_VS...1,SET,53,-0.009035,-0.00048473,0.12435,0.52896,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,0.992994638228942
HP_AMINOACIDURIA,SET,123,-0.0054821,-0.0004472,0.075459,0.52896,HP_AMINOACIDURIA,0.992994638228942
HP_TRACTIONAL_RETINAL_DETACH...,SET,7,-0.021526,-0.00042023,0.29594,0.52899,HP_TRACTIONAL_RETINAL_DETACHMENT,0.992994638228942
GOBP_DISRUPTION_OF_ANATOMICA...,SET,81,-0.0076564,-0.00050742,0.10511,0.52903,GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.992994638228942
ZHAN_V2_LATE_DIFFERENTIATION...,SET,36,-0.010743,-0.00047525,0.14743,0.52905,ZHAN_V2_LATE_DIFFERENTIATION_GENES,0.992994638228942
GSE21033_3H_VS_12H_POLYIC_ST...1,SET,122,-0.0058475,-0.00047508,0.080175,0.52907,GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN,0.992994638228942
GOMF_THYROID_HORMONE_BINDING,SET,6,-0.028577,-0.00051652,0.3916,0.52909,GOMF_THYROID_HORMONE_BINDING,0.992994638228942
HP_URETERAL_STENOSIS,SET,29,-0.01114,-0.00044239,0.15251,0.52911,HP_URETERAL_STENOSIS,0.992994638228942
HP_AGENESIS_OF_MAXILLARY_INC...,SET,15,-0.017217,-0.0004919,0.23565,0.52912,HP_AGENESIS_OF_MAXILLARY_INCISOR,0.992994638228942
HP_NEOPLASM_OF_THE_LUNG,SET,60,-0.0081001,-0.00046229,0.11088,0.52912,HP_NEOPLASM_OF_THE_LUNG,0.992994638228942
KEGG_MEDICUS_REFERENCE_GLYCO...2,SET,8,-0.019872,-0.00041472,0.27194,0.52913,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION,0.992994638228942
GOBP_TRIF_DEPENDENT_TOLL_LIK...,SET,11,-0.017706,-0.00043326,0.24218,0.52914,GOBP_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.992994638228942
REACTOME_MITOCHONDRIAL_TRNA_...,SET,18,-0.014032,-0.00043914,0.19166,0.52918,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,0.993016084444684
GOBP_POSITIVE_REGULATION_OF_...632,SET,7,-0.025863,-0.00050491,0.35234,0.52926,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.993104127231663
GOBP_POSITIVE_REGULATION_OF_...589,SET,633,-0.0026242,-0.0004788,0.035649,0.52934,GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.993104127231663
GSE40666_WT_VS_STAT4_KO_CD8_...3,SET,187,-0.0045604,-0.00045789,0.061721,0.52945,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.993104127231663
NFKB_C,SET,243,-0.0041038,-0.00046899,0.055446,0.5295,NFKB_C,0.993104127231663
MIR6842_3P,SET,112,-0.006188,-0.00048183,0.083558,0.52952,MIR6842_3P,0.993104127231663
GSE29618_PDC_VS_MDC_UP,SET,173,-0.0049117,-0.00047453,0.066231,0.52956,GSE29618_PDC_VS_MDC_UP,0.993104127231663
chr12q22,SET,18,-0.025437,-0.00079606,0.3427,0.52958,chr12q22,0.993104127231663
GOBP_REGULATION_OF_ADENYLATE...1,SET,19,-0.013572,-0.00043637,0.18281,0.52959,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.993104127231663
MIR2909,SET,47,-0.0088317,-0.00044627,0.11882,0.52962,MIR2909,0.993104127231663
IKEDA_MIR133_TARGETS_DN,SET,6,-0.031883,-0.00057627,0.428,0.52969,IKEDA_MIR133_TARGETS_DN,0.993104127231663
MODULE_73,SET,20,-0.015775,-0.00052036,0.21174,0.52969,MODULE_73,0.993104127231663
WP_4HYDROXYTAMOXIFEN_DEXAMET...,SET,25,-0.013642,-0.00050306,0.18304,0.52971,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,0.993104127231663
KEGG_MEDICUS_REFERENCE_DISAS...,SET,16,-0.015165,-0.00044748,0.20319,0.52975,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC,0.993104127231663
HP_IMPAIRED_OCULAR_ADDUCTION,SET,9,-0.022504,-0.00049812,0.3005,0.52985,HP_IMPAIRED_OCULAR_ADDUCTION,0.993104127231663
GSE17721_CTRL_VS_PAM3CSK4_2H...2,SET,183,-0.0045908,-0.00045604,0.061246,0.52987,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP,0.993104127231663
HP_SHORT_CLAVICLES,SET,29,-0.011485,-0.0004561,0.15298,0.52992,HP_SHORT_CLAVICLES,0.993104127231663
GSE27786_BCELL_VS_NEUTROPHIL...1,SET,184,-0.0047085,-0.00046899,0.06272,0.52992,GSE27786_BCELL_VS_NEUTROPHIL_DN,0.993104127231663
REACTOME_HIGHLY_CALCIUM_PERM...2,SET,11,-0.023555,-0.00057637,0.3135,0.52995,REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.993104127231663
MODULE_96,SET,36,-0.011339,-0.00050159,0.1509,0.52995,MODULE_96,0.993104127231663
ZNF331_TARGET_GENES,SET,270,-0.0039602,-0.0004767,0.052683,0.52996,ZNF331_TARGET_GENES,0.993104127231663
GOBP_REGULATION_OF_MITOCHOND...11,SET,7,-0.021003,-0.00041003,0.27943,0.52996,GOBP_REGULATION_OF_MITOCHONDRIAL_MRNA_STABILITY,0.993104127231663
GOBP_DORSAL_SPINAL_CORD_DEVE...,SET,19,-0.017291,-0.00055593,0.22984,0.52998,GOBP_DORSAL_SPINAL_CORD_DEVELOPMENT,0.993104127231663
GOBP_REGULATION_OF_PROTEIN_M...1,SET,62,-0.008062,-0.0004677,0.10686,0.53007,GOBP_REGULATION_OF_PROTEIN_MATURATION,0.993104127231663
GOBP_POSITIVE_REGULATION_OF_...42,SET,12,-0.020868,-0.00053334,0.27614,0.53012,GOBP_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.993104127231663
HP_ABSENT_FACIAL_HAIR,SET,33,-0.0121,-0.00051251,0.16,0.53014,HP_ABSENT_FACIAL_HAIR,0.993104127231663
HP_MALIGNANT_NEOPLASM_OF_THE...,SET,95,-0.0065832,-0.00047232,0.087046,0.53014,HP_MALIGNANT_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.993104127231663
GOBP_REGULATION_OF_T_CELL_CH...,SET,15,-0.016588,-0.00047394,0.21904,0.53018,GOBP_REGULATION_OF_T_CELL_CHEMOTAXIS,0.993104127231663
GSE3982_DC_VS_NEUTROPHIL_DN,SET,171,-0.0049088,-0.00047152,0.064775,0.5302,GSE3982_DC_VS_NEUTROPHIL_DN,0.993104127231663
HP_ELLIPTOCYTOSIS,SET,8,-0.021486,-0.0004484,0.28327,0.53023,HP_ELLIPTOCYTOSIS,0.993104127231663
TRAVAGLINI_LUNG_FIBROMYOCYTE...,SET,21,-0.016011,-0.00054119,0.21101,0.53024,TRAVAGLINI_LUNG_FIBROMYOCYTE_CELL,0.993104127231663
RBM34_TARGET_GENES,SET,811,-0.00233,-0.00047875,0.030667,0.53028,RBM34_TARGET_GENES,0.993104127231663
GOBP_DNA_TEMPLATED_TRANSCRIP...1,SET,123,-0.0055728,-0.0004546,0.073225,0.53033,GOBP_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.993104127231663
GOBP_MACROPINOCYTOSIS,SET,8,-0.024436,-0.00050996,0.32074,0.53036,GOBP_MACROPINOCYTOSIS,0.993104127231663
GSE30971_CTRL_VS_LPS_STIM_MA...7,SET,169,-0.0050921,-0.00048629,0.066838,0.53036,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN,0.993104127231663
GOBP_VIRAL_GENOME_REPLICATION,SET,117,-0.0062585,-0.00049801,0.082052,0.5304,GOBP_VIRAL_GENOME_REPLICATION,0.993104127231663
GOBP_TISSUE_REMODELING,SET,166,-0.0053881,-0.00051001,0.070599,0.53042,GOBP_TISSUE_REMODELING,0.993104127231663
ESC_J1_UP_LATE.V1_DN,SET,150,-0.0054222,-0.0004881,0.070982,0.53044,ESC_J1_UP_LATE.V1_DN,0.993104127231663
GOCC_NPBAF_COMPLEX,SET,14,-0.017636,-0.00048682,0.23068,0.53047,GOCC_NPBAF_COMPLEX,0.993104127231663
GOMF_NAD_BINDING,SET,55,-0.0087271,-0.00047694,0.11403,0.5305,GOMF_NAD_BINDING,0.993104127231663
HOLLEMAN_DAUNORUBICIN_ALL_UP,SET,6,-0.025798,-0.00046629,0.33692,0.53052,HOLLEMAN_DAUNORUBICIN_ALL_UP,0.993104127231663
MIR5699_3P,SET,60,-0.0086856,-0.00049571,0.11336,0.53054,MIR5699_3P,0.993104127231663
GOBP_REGULATION_OF_VASCULAR_...5,SET,44,-0.010705,-0.00052342,0.13937,0.53061,GOBP_REGULATION_OF_VASCULAR_PERMEABILITY,0.993104127231663
GSE22601_DOUBLE_POSITIVE_VS_...2,SET,167,-0.0050994,-0.00048413,0.066363,0.53062,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.993104127231663
GOBP_GASTRIC_ACID_SECRETION,SET,13,-0.017957,-0.00047765,0.23366,0.53063,GOBP_GASTRIC_ACID_SECRETION,0.993104127231663
GSE12366_GC_VS_MEMORY_BCELL_...2,SET,174,-0.0048959,-0.00047436,0.063654,0.53065,GSE12366_GC_VS_MEMORY_BCELL_UP,0.993104127231663
GOBP_POSITIVE_REGULATION_OF_...243,SET,87,-0.0073821,-0.00050696,0.095957,0.53066,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,0.993104127231663
WANG_MLL_TARGETS,SET,273,-0.004277,-0.00051764,0.055396,0.53077,WANG_MLL_TARGETS,0.993104127231663
GOBP_PHOSPHOLIPID_METABOLIC_...,SET,340,-0.0035603,-0.00047999,0.046085,0.53079,GOBP_PHOSPHOLIPID_METABOLIC_PROCESS,0.993104127231663
GOBP_POSITIVE_REGULATION_OF_...730,SET,20,-0.013749,-0.00045354,0.17793,0.5308,GOBP_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.993104127231663
GOBP_CGMP_METABOLIC_PROCESS,SET,13,-0.019224,-0.00051135,0.24856,0.53082,GOBP_CGMP_METABOLIC_PROCESS,0.993104127231663
TONKS_TARGETS_OF_RUNX1_RUNX1...12,SET,9,-0.024432,-0.0005408,0.31517,0.53089,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,0.993104127231663
KEGG_MEDICUS_REFERENCE_ASSEM...,SET,17,-0.014351,-0.00043647,0.18505,0.53091,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE,0.993104127231663
REACTOME_HEME_DEGRADATION,SET,15,-0.017344,-0.00049553,0.22349,0.53093,REACTOME_HEME_DEGRADATION,0.993104127231663
GOCC_NEUROTRANSMITTER_RECEPT...,SET,43,-0.010828,-0.00052342,0.13952,0.53093,GOCC_NEUROTRANSMITTER_RECEPTOR_COMPLEX,0.993104127231663
GOBP_REGULATION_OF_SYNAPTIC_...4,SET,8,-0.019798,-0.00041317,0.25472,0.53098,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,0.993104127231663
HP_PROGRESSIVE_VISUAL_LOSS,SET,92,-0.0069388,-0.00048995,0.089192,0.531,HP_PROGRESSIVE_VISUAL_LOSS,0.993104127231663
MIR154_3P,SET,91,-0.0071282,-0.0005006,0.091532,0.53104,MIR154_3P,0.993104127231663
GSE20366_CD103_KLRG1_DP_VS_D...2,SET,180,-0.0049454,-0.00048726,0.063471,0.53105,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP,0.993104127231663
WESTON_VEGFA_TARGETS_12HR,SET,21,-0.016174,-0.00054668,0.2075,0.53106,WESTON_VEGFA_TARGETS_12HR,0.993104127231663
GNF2_SERPINI2,SET,21,-0.016638,-0.00056239,0.21344,0.53107,GNF2_SERPINI2,0.993104127231663
HP_DEPRESSED_NASAL_RIDGE,SET,112,-0.0063424,-0.00049385,0.08115,0.53115,HP_DEPRESSED_NASAL_RIDGE,0.993104127231663
KEGG_MEDICUS_REFERENCE_DEPHO...,SET,12,-0.018816,-0.00048089,0.24057,0.53117,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE,0.993104127231663
HALMOS_CEBPA_TARGETS_UP,SET,46,-0.011037,-0.00055175,0.14106,0.53118,HALMOS_CEBPA_TARGETS_UP,0.993104127231663
JOHANSSON_BRAIN_CANCER_EARLY...2,SET,6,-0.025871,-0.0004676,0.33051,0.5312,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP,0.993104127231663
HP_FATTY_REPLACEMENT_OF_SKEL...,SET,33,-0.010692,-0.00045289,0.13652,0.53121,HP_FATTY_REPLACEMENT_OF_SKELETAL_MUSCLE,0.993104127231663
GOBP_CELLULAR_GLUCURONIDATION,SET,19,-0.025529,-0.00082082,0.32577,0.53123,GOBP_CELLULAR_GLUCURONIDATION,0.993104127231663
GSE14000_4H_VS_16H_LPS_DC_TR...1,SET,172,-0.0049073,-0.00047274,0.062561,0.53126,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN,0.993104127231663
HUANG_GATA2_TARGETS_UP,SET,141,-0.005756,-0.00050248,0.073319,0.53129,HUANG_GATA2_TARGETS_UP,0.993104127231663
GOMF_CALCIUM_SENSITIVE_GUANY...,SET,5,-0.034654,-0.00057179,0.44117,0.5313,GOMF_CALCIUM_SENSITIVE_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY,0.993104127231663
GOBP_DIENCEPHALON_DEVELOPMENT,SET,71,-0.0089116,-0.00055311,0.11343,0.53131,GOBP_DIENCEPHALON_DEVELOPMENT,0.993104127231663
HP_MULTIFOCAL_SEIZURES,SET,16,-0.016619,-0.0004904,0.21152,0.53131,HP_MULTIFOCAL_SEIZURES,0.993104127231663
HP_ACROMICRIA,SET,8,-0.02859,-0.00059666,0.3638,0.53132,HP_ACROMICRIA,0.993104127231663
GCAAGGA_MIR502,SET,65,-0.0080877,-0.00048037,0.10284,0.53134,GCAAGGA_MIR502,0.993104127231663
GOMF_PHOSPHATASE_BINDING,SET,176,-0.0049336,-0.00048072,0.062702,0.53136,GOMF_PHOSPHATASE_BINDING,0.993104127231663
GSE29618_PRE_VS_DAY7_POST_LA...1,SET,174,-0.0052492,-0.00050858,0.066688,0.53137,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN,0.993104127231663
GSE1925_3H_VS_24H_IFNG_STIM_...2,SET,187,-0.0050075,-0.00050279,0.063519,0.53142,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.99314416841426
MIR34C_5P,SET,240,-0.0043687,-0.00049621,0.055182,0.53155,MIR34C_5P,0.993202816447192
GOMF_VOLTAGE_GATED_CALCIUM_C...2,SET,5,-0.03437,-0.00056711,0.43408,0.53155,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.993202816447192
GOBP_DETECTION_OF_BACTERIUM,SET,15,-0.020057,-0.00057306,0.25308,0.53158,GOBP_DETECTION_OF_BACTERIUM,0.993202816447192
REACTOME_PREDNISONE_ADME,SET,9,-0.022202,-0.00049143,0.27987,0.53161,REACTOME_PREDNISONE_ADME,0.993202816447192
HP_ABNORMAL_CIRCULATING_GLUT...2,SET,30,-0.011541,-0.00046613,0.14533,0.53165,HP_ABNORMAL_CIRCULATING_GLUTAMINE_FAMILY_AMINO_ACID_CONCENTRATION,0.993202816447192
GOCC_CBM_COMPLEX,SET,5,-0.028778,-0.00047485,0.36229,0.53166,GOCC_CBM_COMPLEX,0.993202816447192
GSE45365_NK_CELL_VS_BCELL_MC...1,SET,171,-0.0053676,-0.0005156,0.067546,0.53167,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN,0.993202816447192
GOBP_REGULATION_OF_PROTEIN_L...5,SET,12,-0.021601,-0.00055207,0.27175,0.53168,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.993202816447192
MODULE_389,SET,196,-0.0048434,-0.00049775,0.060657,0.53182,MODULE_389,0.993333454223082
MODULE_152,SET,102,-0.0061902,-0.00046011,0.077441,0.53185,MODULE_152,0.993333454223082
GSE8621_UNSTIM_VS_LPS_PRIMED...3,SET,179,-0.0047692,-0.00046861,0.059634,0.53187,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN,0.993333454223082
PID_PTP1B_PATHWAY,SET,52,-0.010336,-0.00054929,0.12917,0.53189,PID_PTP1B_PATHWAY,0.993333454223082
GOMF_PROTEIN_PHOSPHORYLATED_...,SET,57,-0.0093132,-0.00051811,0.11621,0.53194,GOMF_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING,0.993333454223082
GOBP_TAIL_ANCHORED_MEMBRANE_...,SET,12,-0.017156,-0.00043846,0.21401,0.53195,GOBP_TAIL_ANCHORED_MEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.993333454223082
GSE11961_FOLLICULAR_BCELL_VS...12,SET,184,-0.0050279,-0.00050081,0.062709,0.53195,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP,0.993333454223082
GOBP_T_HELPER_1_TYPE_IMMUNE_...,SET,45,-0.011297,-0.00055858,0.14071,0.53199,GOBP_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.993351995273645
GOBP_DERMATAN_SULFATE_PROTEO...2,SET,11,-0.020541,-0.00050264,0.25562,0.53202,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.993351995273645
KEGG_MEDICUS_REFERENCE_BLOCK...,SET,12,-0.019377,-0.00049523,0.24091,0.53205,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2,0.993351995273645
MORF_AATF,SET,197,-0.0045049,-0.00046413,0.055921,0.5321,MORF_AATF,0.993351995273645
GOBP_VASCULAR_ASSOCIATED_SMO...1,SET,11,-0.020705,-0.00050665,0.2569,0.53212,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.993351995273645
GOBP_PHOSPHATIDYLSERINE_EXPO...,SET,8,-0.02348,-0.00049001,0.29106,0.53215,GOBP_PHOSPHATIDYLSERINE_EXPOSURE_ON_APOPTOTIC_CELL_SURFACE,0.993351995273645
MIR106A_5P,SET,596,-0.0029135,-0.00051634,0.036101,0.53216,MIR106A_5P,0.993351995273645
GSE14769_UNSTIM_VS_40MIN_LPS...2,SET,178,-0.0053538,-0.00052459,0.066083,0.53229,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP,0.993372747747748
GOBP_EMBRYONIC_FORELIMB_MORP...,SET,32,-0.013539,-0.00056472,0.16685,0.53234,GOBP_EMBRYONIC_FORELIMB_MORPHOGENESIS,0.993372747747748
HP_PALMOPLANTAR_ERYTHEMA,SET,5,-0.037896,-0.00062529,0.46654,0.53237,HP_PALMOPLANTAR_ERYTHEMA,0.993372747747748
GOMF_MHC_CLASS_I_PROTEIN_BIN...,SET,15,-0.01752,-0.00050059,0.21561,0.53238,GOMF_MHC_CLASS_I_PROTEIN_BINDING,0.993372747747748
MIR3912_5P,SET,77,-0.007989,-0.00051628,0.0983,0.53239,MIR3912_5P,0.993372747747748
MIR4510,SET,166,-0.0053971,-0.00051086,0.06641,0.53239,MIR4510,0.993372747747748
GSE411_WT_VS_SOCS3_KO_MACROP...6,SET,177,-0.0051972,-0.00050783,0.063739,0.53249,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP,0.993372747747748
HP_DECREASED_LIGHT_AND_DARK_...,SET,14,-0.019074,-0.0005265,0.23357,0.53254,HP_DECREASED_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM_AMPLITUDE,0.993372747747748
GOBP_MICROTUBULE_ANCHORING,SET,21,-0.015063,-0.00050915,0.18443,0.53255,GOBP_MICROTUBULE_ANCHORING,0.993372747747748
GOBP_REGULATION_OF_SARCOMERE...,SET,8,-0.0247,-0.00051548,0.3023,0.53256,GOBP_REGULATION_OF_SARCOMERE_ORGANIZATION,0.993372747747748
HOFFMANN_PRE_BI_TO_LARGE_PRE...1,SET,73,-0.0084794,-0.00053361,0.10374,0.53257,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,0.993372747747748
HP_SEVERE_INFECTION,SET,61,-0.0090171,-0.00051889,0.10981,0.53272,HP_SEVERE_INFECTION,0.993372747747748
OSMAN_BLOOD_CHAD63_KH_AGE_18...1,SET,1467,-0.0019388,-0.00052569,0.023614,0.53272,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,0.993372747747748
GOMF_SUPERCOILED_DNA_BINDING,SET,6,-0.028156,-0.00050891,0.34278,0.53273,GOMF_SUPERCOILED_DNA_BINDING,0.993372747747748
MIR659_3P,SET,204,-0.0050357,-0.00052786,0.061209,0.53278,MIR659_3P,0.993372747747748
NADLER_OBESITY_UP,SET,58,-0.009804,-0.00055017,0.11912,0.5328,NADLER_OBESITY_UP,0.993372747747748
GOBP_T_CELL_ACTIVATION_INVOL...,SET,115,-0.0071505,-0.00056414,0.086865,0.5328,GOBP_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.993372747747748
REACTOME_GLYCOSPHINGOLIPID_B...,SET,19,-0.017453,-0.00056115,0.21179,0.53284,REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS,0.993372747747748
MIR6772_3P,SET,66,-0.0085612,-0.00051237,0.10384,0.53285,MIR6772_3P,0.993372747747748
HP_LAGOPHTHALMOS,SET,12,-0.018267,-0.00046684,0.2211,0.53292,HP_LAGOPHTHALMOS,0.993372747747748
GOBP_L_ARGININE_IMPORT_ACROS...,SET,4,-0.04318,-0.00063727,0.52255,0.53293,GOBP_L_ARGININE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.993372747747748
GOBP_PROSTATIC_BUD_FORMATION,SET,7,-0.032495,-0.00063438,0.39309,0.53294,GOBP_PROSTATIC_BUD_FORMATION,0.993372747747748
GOBP_REGULATION_OF_TYPE_I_IN...,SET,40,-0.010981,-0.00051201,0.13282,0.53295,GOBP_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.993372747747748
GSE2770_IL12_ACT_VS_ACT_CD4_...1,SET,181,-0.0050234,-0.00049631,0.060713,0.53297,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN,0.993372747747748
WP_VITAMIN_A1_AND_A5X_PATHWA...,SET,6,-0.02744,-0.00049597,0.33152,0.53298,WP_VITAMIN_A1_AND_A5X_PATHWAYS,0.993372747747748
MIR1268A_MIR1268B,SET,7,-0.028516,-0.00055669,0.34453,0.53298,MIR1268A_MIR1268B,0.993372747747748
GOBP_VASOCONSTRICTION,SET,83,-0.0084157,-0.00056456,0.10168,0.53298,GOBP_VASOCONSTRICTION,0.993372747747748
GOBP_POSITIVE_REGULATION_OF_...422,SET,35,-0.013012,-0.00056756,0.15718,0.53299,GOBP_POSITIVE_REGULATION_OF_LYASE_ACTIVITY,0.993372747747748
MIR10401_5P,SET,73,-0.0086461,-0.0005441,0.10442,0.533,MIR10401_5P,0.993372747747748
GSE23505_UNTREATED_VS_4DAY_I...5,SET,184,-0.0053501,-0.00053291,0.064512,0.53305,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN,0.993412662877366
HALLMARK_ESTROGEN_RESPONSE_L...,SET,185,-0.0054701,-0.00054632,0.065849,0.5331,HALLMARK_ESTROGEN_RESPONSE_LATE,0.993452573726542
GOBP_POSITIVE_REGULATION_OF_...234,SET,142,-0.0063047,-0.00055232,0.07553,0.53326,GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS,0.993480245535714
chr11q13,SET,240,-0.0098082,-0.001114,0.11747,0.53327,chr11q13,0.993480245535714
MIR6832_5P,SET,74,-0.0085877,-0.0005441,0.10264,0.53334,MIR6832_5P,0.993480245535714
GSE10239_MEMORY_VS_DAY4.5_EF...2,SET,187,-0.0051123,-0.00051331,0.061104,0.53334,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP,0.993480245535714
HASINA_NOL7_TARGETS_DN,SET,13,-0.022125,-0.00058854,0.2644,0.53335,HASINA_NOL7_TARGETS_DN,0.993480245535714
HOEK_MYELOID_DENDRITIC_CELL_...4,SET,3,-0.049439,-0.00063191,0.58999,0.53339,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP,0.993480245535714
GOBP_REGULATION_OF_MRNA_EXPO...,SET,8,-0.02136,-0.00044578,0.25446,0.53345,GOBP_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS,0.993480245535714
GSE12845_PRE_GC_VS_DARKZONE_...2,SET,173,-0.0054182,-0.00052346,0.064498,0.53347,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.993480245535714
WP_CODEINE_AND_MORPHINE_META...,SET,14,-0.018878,-0.00052111,0.22466,0.53348,WP_CODEINE_AND_MORPHINE_METABOLISM,0.993480245535714
ZNF274_TARGET_GENES,SET,743,-0.0026649,-0.00052514,0.031708,0.53349,ZNF274_TARGET_GENES,0.993480245535714
GOBP_LOOP_OF_HENLE_DEVELOPME...,SET,11,-0.024481,-0.00059905,0.29084,0.53354,GOBP_LOOP_OF_HENLE_DEVELOPMENT,0.993480245535714
HP_TREMOR,SET,540,-0.0031181,-0.00052682,0.037009,0.53357,HP_TREMOR,0.993480245535714
HE_LIM_SUN_FETAL_LUNG_C2_CYC...,SET,1242,-0.0020006,-0.00050244,0.023738,0.53358,HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL,0.993480245535714
GOBP_POSITIVE_REGULATION_OF_...795,SET,70,-0.0093118,-0.00057388,0.11043,0.5336,GOBP_POSITIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.993480245535714
HP_APLASIA_OF_THE_OLFACTORY_...,SET,13,-0.021099,-0.00056124,0.24998,0.53363,HP_APLASIA_OF_THE_OLFACTORY_BULB,0.993480245535714
BIOCARTA_CHREBP_PATHWAY,SET,19,-0.016453,-0.000529,0.19437,0.53373,BIOCARTA_CHREBP_PATHWAY,0.993480245535714
TGANNYRGCA_TCF11MAFG_01,SET,269,-0.0044706,-0.00053715,0.052788,0.53375,TGANNYRGCA_TCF11MAFG_01,0.993480245535714
GOBP_CELLULAR_SENESCENCE,SET,93,-0.0075711,-0.00053748,0.089391,0.53375,GOBP_CELLULAR_SENESCENCE,0.993480245535714
GRAESSMANN_APOPTOSIS_BY_SERU...1,SET,215,-0.0050283,-0.00054093,0.059183,0.53385,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,0.993480245535714
GSE26030_UNSTIM_VS_RESTIM_TH...3,SET,174,-0.0056879,-0.00055109,0.066962,0.53385,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN,0.993480245535714
GSE37534_GW1929_VS_PIOGLITAZ...2,SET,179,-0.0053776,-0.00052839,0.063167,0.53392,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.993480245535714
MIR3183,SET,75,-0.0083592,-0.00053318,0.098075,0.53396,MIR3183,0.993480245535714
GOMF_SALT_TRANSMEMBRANE_TRAN...,SET,9,-0.022067,-0.00048844,0.25877,0.53398,GOMF_SALT_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.993480245535714
HP_ABNORMAL_RAPID_EYE_MOVEME...,SET,13,-0.022044,-0.00058637,0.25782,0.53407,HP_ABNORMAL_RAPID_EYE_MOVEMENT_SLEEP,0.993480245535714
GATA4_Q3,SET,224,-0.0051665,-0.00056718,0.060413,0.53408,GATA4_Q3,0.993480245535714
TCCAGAT_MIR5165P,SET,96,-0.007652,-0.00055187,0.0894,0.5341,TCCAGAT_MIR5165P,0.993480245535714
GSE41176_WT_VS_TAK1_KO_UNSTI...2,SET,178,-0.0054912,-0.00053805,0.064157,0.5341,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP,0.993480245535714
GOBP_CARDIAC_MUSCLE_MYOBLAST...,SET,3,-0.042897,-0.00054829,0.50109,0.53411,GOBP_CARDIAC_MUSCLE_MYOBLAST_PROLIFERATION,0.993480245535714
GSE14769_UNSTIM_VS_120MIN_LP...1,SET,194,-0.0054431,-0.00055655,0.063576,0.53411,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN,0.993480245535714
RAPA_EARLY_UP.V1_UP,SET,142,-0.0064429,-0.00056442,0.075155,0.53416,RAPA_EARLY_UP.V1_UP,0.993480245535714
RAY_ALZHEIMERS_DISEASE,SET,13,-0.021042,-0.00055972,0.24511,0.5342,RAY_ALZHEIMERS_DISEASE,0.993480245535714
KEGG_INTESTINAL_IMMUNE_NETWO...,SET,40,-0.012449,-0.00058042,0.14497,0.53421,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,0.993480245535714
MORI_LARGE_PRE_BII_LYMPHOCYT...2,SET,81,-0.0082173,-0.0005446,0.095683,0.53422,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,0.993480245535714
GSE41867_NAIVE_VS_DAY30_LCMV...1,SET,175,-0.0053568,-0.00052048,0.062321,0.53425,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN,0.993480245535714
SEMBA_FHIT_TARGETS_DN,SET,9,-0.022891,-0.0005067,0.26619,0.53427,SEMBA_FHIT_TARGETS_DN,0.993480245535714
SCHLESINGER_METHYLATED_DE_NO...,SET,80,-0.0089754,-0.00059117,0.10425,0.5343,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,0.993480245535714
GSE3982_EOSINOPHIL_VS_CENT_M...1,SET,178,-0.0053519,-0.00052441,0.062075,0.53435,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.993480245535714
HP_MUSCLE_FIBER_SPLITTING,SET,19,-0.016051,-0.00051607,0.1856,0.53446,HP_MUSCLE_FIBER_SPLITTING,0.993480245535714
GOBP_DIACYLGLYCEROL_CATABOLI...,SET,5,-0.034785,-0.00057395,0.40208,0.53447,GOBP_DIACYLGLYCEROL_CATABOLIC_PROCESS,0.993480245535714
TOMLINS_METASTASIS_UP,SET,14,-0.01867,-0.00051536,0.21524,0.53456,TOMLINS_METASTASIS_UP,0.993480245535714
GOBP_POSITIVE_REGULATION_OF_...751,SET,14,-0.017629,-0.00048662,0.20327,0.53456,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_RNA_LOCALIZATION_TO_CAJAL_BODY,0.993480245535714
MIR4682,SET,117,-0.0067145,-0.00053429,0.077337,0.53459,MIR4682,0.993480245535714
GOMF_ARMADILLO_REPEAT_DOMAIN...,SET,8,-0.023639,-0.00049334,0.27207,0.53462,GOMF_ARMADILLO_REPEAT_DOMAIN_BINDING,0.993480245535714
GOBP_REGULATION_OF_NATURAL_K...4,SET,8,-0.027648,-0.000577,0.31782,0.53466,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.993480245535714
GOBP_POSITIVE_REGULATION_OF_...144,SET,119,-0.0071448,-0.00057335,0.081933,0.53474,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.993480245535714
HP_PERIPHERAL_HYPOMYELINATION,SET,9,-0.022362,-0.00049499,0.2564,0.53475,HP_PERIPHERAL_HYPOMYELINATION,0.993480245535714
GSE46606_UNSTIM_VS_CD40L_IL2...15,SET,168,-0.0054426,-0.00051824,0.062402,0.53475,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.993480245535714
HP_ABNORMAL_RENAL_VASCULAR_M...,SET,24,-0.014364,-0.00051898,0.1645,0.53479,HP_ABNORMAL_RENAL_VASCULAR_MORPHOLOGY,0.993480245535714
HP_PERIMEMBRANOUS_VENTRICULA...,SET,23,-0.016808,-0.00059454,0.19229,0.53483,HP_PERIMEMBRANOUS_VENTRICULAR_SEPTAL_DEFECT,0.993480245535714
GOMF_PROTEIN_SERINE_THREONIN...5,SET,90,-0.0073164,-0.00051099,0.083643,0.53485,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.993480245535714
REACTOME_MITOTIC_G1_PHASE_AN...,SET,143,-0.0057771,-0.00050786,0.065993,0.53488,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,0.993480245535714
MIR1914_5P,SET,55,-0.010748,-0.00058741,0.1227,0.5349,MIR1914_5P,0.993480245535714
GOMF_ALCOHOL_DEHYDROGENASE_N...3,SET,24,-0.01804,-0.00065183,0.20541,0.53499,GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.993480245535714
WANG_METHYLATED_IN_BREAST_CA...,SET,34,-0.013576,-0.0005837,0.15438,0.53504,WANG_METHYLATED_IN_BREAST_CANCER,0.993480245535714
MIR6793_3P,SET,70,-0.0086671,-0.00053414,0.09855,0.53504,MIR6793_3P,0.993480245535714
GOBP_PLATELET_DENSE_GRANULE_...,SET,24,-0.015755,-0.00056927,0.17875,0.53512,GOBP_PLATELET_DENSE_GRANULE_ORGANIZATION,0.993480245535714
HE_LIM_SUN_FETAL_LUNG_C3_MID...,SET,50,-0.011655,-0.00060738,0.13224,0.53512,HE_LIM_SUN_FETAL_LUNG_C3_MID_CAP_CELL,0.993480245535714
HP_ACCELERATED_SKELETAL_MATU...,SET,63,-0.0098437,-0.00057563,0.11155,0.53516,HP_ACCELERATED_SKELETAL_MATURATION,0.993480245535714
GOBP_REGULATION_OF_POTASSIUM...1,SET,7,-0.029681,-0.00057945,0.33617,0.53518,GOBP_REGULATION_OF_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.993480245535714
MIR3692_3P,SET,261,-0.0048015,-0.0005684,0.054356,0.53519,MIR3692_3P,0.993480245535714
GOMF_SIALIC_ACID_BINDING,SET,20,-0.020462,-0.00067498,0.23157,0.5352,GOMF_SIALIC_ACID_BINDING,0.993480245535714
REACTOME_RESPIRATORY_SYNCYTI...3,SET,16,-0.017209,-0.0005078,0.19447,0.53526,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION,0.993480245535714
TBPL1_TARGET_GENES,SET,135,-0.0066475,-0.00056792,0.075043,0.53529,TBPL1_TARGET_GENES,0.993480245535714
TORCHIA_TARGETS_OF_EWSR1_FLI...3,SET,17,-0.01959,-0.00059584,0.22044,0.53541,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,0.993480245535714
GNF2_HPX,SET,128,-0.0069134,-0.00057523,0.077741,0.53543,GNF2_HPX,0.993480245535714
MIR3916,SET,202,-0.0052001,-0.00054244,0.058394,0.53548,MIR3916,0.993480245535714
GSE29164_UNTREATED_VS_CD8_TC...2,SET,173,-0.0056737,-0.00054815,0.063671,0.5355,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.993480245535714
KEGG_MEDICUS_REFERENCE_DERMA...,SET,7,-0.031355,-0.00061212,0.3517,0.53552,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION,0.993480245535714
MIR4325,SET,244,-0.0050115,-0.00057388,0.056199,0.53553,MIR4325,0.993480245535714
GSE41176_UNSTIM_VS_ANTI_IGM_...15,SET,173,-0.0059305,-0.00057296,0.066505,0.53553,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN,0.993480245535714
LEE_NEURAL_CREST_STEM_CELL_DN,SET,103,-0.0081268,-0.00060698,0.091032,0.53557,LEE_NEURAL_CREST_STEM_CELL_DN,0.993480245535714
GOBP_REGULATION_OF_CARDIAC_M...11,SET,5,-0.042571,-0.00070242,0.47661,0.53559,GOBP_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.993480245535714
GSE35825_IFNA_VS_IFNG_STIM_M...2,SET,154,-0.0062348,-0.00056862,0.069733,0.53562,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP,0.993480245535714
WEINMANN_ADAPTATION_TO_HYPOX...1,SET,37,-0.013844,-0.00062087,0.15479,0.53563,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,0.993480245535714
chr14q12,SET,52,-0.020134,-0.00107,0.22509,0.53564,chr14q12,0.993480245535714
GRAHAM_CML_QUIESCENT_VS_NORM...1,SET,9,-0.029548,-0.00065404,0.3301,0.53566,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.993480245535714
GSE34156_NOD2_LIGAND_VS_NOD2...4,SET,161,-0.0055767,-0.00051993,0.0623,0.53566,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.993480245535714
GSE17721_PAM3CSK4_VS_GADIQUI...16,SET,179,-0.0054208,-0.00053263,0.060488,0.5357,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP,0.993480245535714
GAO_SMALL_INTESTINE_24W_C3_E...,SET,41,-0.011483,-0.00054206,0.12812,0.53571,GAO_SMALL_INTESTINE_24W_C3_ENTEROCYTE_PROGENITOR_SUBTYPE_1,0.993480245535714
HP_CEREBRAL_AMYLOID_ANGIOPAT...,SET,4,-0.045498,-0.0006715,0.50748,0.53572,HP_CEREBRAL_AMYLOID_ANGIOPATHY,0.993480245535714
GOBP_REGULATION_OF_CORE_PROM...,SET,5,-0.034666,-0.000572,0.38637,0.53575,GOBP_REGULATION_OF_CORE_PROMOTER_BINDING,0.993480245535714
GOBP_METANEPHROS_DEVELOPMENT,SET,86,-0.0093274,-0.00063687,0.1039,0.53577,GOBP_METANEPHROS_DEVELOPMENT,0.993480245535714
GOMF_NEUROLIGIN_FAMILY_PROTE...,SET,5,-0.032626,-0.00053833,0.36309,0.5358,GOMF_NEUROLIGIN_FAMILY_PROTEIN_BINDING,0.993480245535714
HP_MYELOPROLIFERATIVE_DISORD...,SET,15,-0.021502,-0.00061434,0.23923,0.53581,HP_MYELOPROLIFERATIVE_DISORDER,0.993480245535714
GOBP_ATRIAL_SEPTUM_MORPHOGEN...,SET,13,-0.023775,-0.00063242,0.26425,0.53585,GOBP_ATRIAL_SEPTUM_MORPHOGENESIS,0.993480245535714
GSE41867_DAY6_EFFECTOR_VS_DA...1,SET,181,-0.0053924,-0.00053277,0.059929,0.53585,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.993480245535714
BIOCARTA_NEUTROPHIL_PATHWAY,SET,8,-0.032408,-0.00067635,0.35983,0.53588,BIOCARTA_NEUTROPHIL_PATHWAY,0.993480245535714
MIKKELSEN_PARTIALLY_REPROGRA...,SET,9,-0.026138,-0.00057857,0.29019,0.53589,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,0.993480245535714
FRANCO_BLOOD_SANOFI_PASTEUR_...4,SET,20,-0.016618,-0.00054819,0.18442,0.5359,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE,0.993480245535714
GOBP_PARASYMPATHETIC_NERVOUS...,SET,17,-0.020253,-0.00061601,0.22439,0.53596,GOBP_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,0.993480245535714
EGFR_UP.V1_UP,SET,169,-0.0064744,-0.0006183,0.0716,0.53602,EGFR_UP.V1_UP,0.993480245535714
MSX2_TARGET_GENES,SET,15,-0.01988,-0.000568,0.21967,0.53605,MSX2_TARGET_GENES,0.993480245535714
FAN_OVARY_CL2_PUTATIVE_EARLY...,SET,82,-0.0089399,-0.00059612,0.098753,0.53607,FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1,0.993480245535714
MIR6504_5P,SET,128,-0.0068225,-0.00056767,0.075284,0.5361,MIR6504_5P,0.993480245535714
HP_ABNORMALITY_OF_LOWER_EYEL...,SET,5,-0.035797,-0.00059066,0.39423,0.53618,HP_ABNORMALITY_OF_LOWER_EYELASHES,0.993480245535714
GOBP_SMOOTH_MUSCLE_CELL_DIFF...,SET,59,-0.010668,-0.00060375,0.11744,0.53619,GOBP_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.993480245535714
HALMOS_CEBPA_TARGETS_DN,SET,40,-0.01383,-0.00064483,0.15218,0.53621,HALMOS_CEBPA_TARGETS_DN,0.993480245535714
GOBP_ARTERY_MORPHOGENESIS,SET,68,-0.010665,-0.00064782,0.11733,0.53621,GOBP_ARTERY_MORPHOGENESIS,0.993480245535714
HP_TRISMUS,SET,13,-0.01972,-0.00052455,0.21655,0.53628,HP_TRISMUS,0.993480245535714
GOBP_POSITIVE_REGULATION_OF_...265,SET,15,-0.01839,-0.00052543,0.20163,0.53634,GOBP_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION,0.993480245535714
HP_SMALL_FORAMEN_MAGNUM,SET,11,-0.020592,-0.00050387,0.22562,0.53636,HP_SMALL_FORAMEN_MAGNUM,0.993480245535714
DESCARTES_MAIN_FETAL_PDE1C_A...,SET,238,-0.0047845,-0.0005412,0.052375,0.53639,DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS,0.993480245535714
REACTOME_SYNTHESIS_OF_EPOXY_...,SET,8,-0.027815,-0.00058049,0.30439,0.5364,REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET,0.993480245535714
MIR629_3P,SET,165,-0.0062017,-0.00058527,0.0678,0.53644,MIR629_3P,0.993480245535714
MODULE_471,SET,9,-0.026653,-0.00058995,0.2913,0.53645,MODULE_471,0.993480245535714
GOBP_POSITIVE_REGULATION_OF_...561,SET,83,-0.0085351,-0.00057257,0.093282,0.53645,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.993480245535714
GNF2_DAP3,SET,105,-0.0070127,-0.00052881,0.07655,0.5365,GNF2_DAP3,0.993480245535714
GOBP_PEPTIDYL_GLUTAMIC_ACID_...,SET,25,-0.01624,-0.00059887,0.17719,0.53651,GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION,0.993480245535714
HOFFMANN_LARGE_TO_SMALL_PRE_...2,SET,142,-0.0063588,-0.00055705,0.069314,0.53655,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,0.993480245535714
REACTOME_G_BETA_GAMMA_SIGNAL...2,SET,25,-0.016494,-0.00060822,0.17975,0.53655,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,0.993480245535714
GOBP_REGULATION_OF_VESICLE_S...,SET,15,-0.020949,-0.00059855,0.22831,0.53655,GOBP_REGULATION_OF_VESICLE_SIZE,0.993480245535714
GOMF_POLYPEPTIDE_N_ACETYLGAL...,SET,17,-0.021881,-0.00066551,0.23845,0.53656,GOMF_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.993480245535714
GOBP_POSITIVE_REGULATION_OF_...323,SET,29,-0.014317,-0.00056854,0.15585,0.5366,GOBP_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.993480245535714
GOBP_REGULATION_OF_PHOSPHOLI...4,SET,32,-0.014915,-0.00062215,0.16234,0.5366,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.993480245535714
MODULE_448,SET,40,-0.011865,-0.00055321,0.12907,0.53662,MODULE_448,0.993480245535714
HP_DERMATOLOGICAL_MANIFESTAT...,SET,301,-0.0044957,-0.0005709,0.048911,0.53662,HP_DERMATOLOGICAL_MANIFESTATIONS_OF_SYSTEMIC_DISORDERS,0.993480245535714
HP_PARADOXICAL_INCREASED_COR...,SET,14,-0.021943,-0.0006057,0.23807,0.53672,HP_PARADOXICAL_INCREASED_CORTISOL_SECRETION_ON_DEXAMETHASONE_SUPPRESSION_TEST,0.993480245535714
HP_NASAL_REGURGITATION,SET,13,-0.021815,-0.00058028,0.23656,0.53674,HP_NASAL_REGURGITATION,0.993480245535714
MIR6516_3P,SET,126,-0.007232,-0.00059705,0.078368,0.53676,MIR6516_3P,0.993480245535714
REACTOME_SARS_COV_2_MODULATE...2,SET,42,-0.011227,-0.00053634,0.12162,0.53677,REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,0.993480245535714
HP_KNEE_JOINT_HYPERMOBILITY,SET,5,-0.040753,-0.00067243,0.44157,0.53677,HP_KNEE_JOINT_HYPERMOBILITY,0.993480245535714
REACTOME_PLASMA_LIPOPROTEIN_...2,SET,67,-0.0098432,-0.00059353,0.10646,0.53683,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,0.993480245535714
HP_ABNORMAL_GLYCOSPHINGOLIPI...,SET,6,-0.03586,-0.00064816,0.38751,0.53686,HP_ABNORMAL_GLYCOSPHINGOLIPID_METABOLISM,0.993480245535714
GOBP_BLASTOCYST_FORMATION,SET,45,-0.011875,-0.0005872,0.12821,0.5369,GOBP_BLASTOCYST_FORMATION,0.993480245535714
HP_FOCAL_IMPAIRED_AWARENESS_...,SET,113,-0.0075814,-0.00059294,0.0818,0.53692,HP_FOCAL_IMPAIRED_AWARENESS_SEIZURE,0.993480245535714
HP_ABSENT_THUMB,SET,51,-0.010284,-0.00054127,0.11088,0.53695,HP_ABSENT_THUMB,0.993480245535714
HP_ENURESIS,SET,29,-0.015485,-0.00061495,0.16669,0.53701,HP_ENURESIS,0.993480245535714
GSE36392_MAC_VS_NEUTROPHIL_I...1,SET,186,-0.0062128,-0.00062216,0.066836,0.53703,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.993480245535714
KEGG_MEDICUS_REFERENCE_TELOM...2,SET,16,-0.018708,-0.00055203,0.20118,0.53704,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION,0.993480245535714
JONES_TCOF1_TARGETS,SET,5,-0.035913,-0.00059258,0.38571,0.53709,JONES_TCOF1_TARGETS,0.993480245535714
HAY_BONE_MARROW_CD34_POS_LMPP,SET,6,-0.03744,-0.00067671,0.40199,0.5371,HAY_BONE_MARROW_CD34_POS_LMPP,0.993480245535714
GOCC_CYTOSKELETON_OF_PRESYNA...,SET,8,-0.031294,-0.00065309,0.33552,0.53715,GOCC_CYTOSKELETON_OF_PRESYNAPTIC_ACTIVE_ZONE,0.993480245535714
DELPUECH_FOXO3_TARGETS_UP,SET,61,-0.010945,-0.00062981,0.11731,0.53717,DELPUECH_FOXO3_TARGETS_UP,0.993480245535714
GOBP_REGULATION_OF_INNATE_IM...,SET,395,-0.0040383,-0.00058592,0.043262,0.53718,GOBP_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.993480245535714
TONKS_TARGETS_OF_RUNX1_RUNX1...7,SET,53,-0.01207,-0.00064758,0.12916,0.53723,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,0.993480245535714
GSE24574_BCL6_HIGH_TFH_VS_NA...2,SET,179,-0.006033,-0.00059279,0.064551,0.53723,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP,0.993480245535714
GSE6259_33D1_POS_VS_DEC205_P...2,SET,159,-0.0064565,-0.00059824,0.069041,0.53725,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP,0.993480245535714
GSE7460_FOXP3_MUT_VS_WT_ACT_...1,SET,184,-0.005898,-0.00058748,0.063072,0.53725,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN,0.993480245535714
RUTELLA_RESPONSE_TO_CSF2RB_A...2,SET,299,-0.0048007,-0.00060763,0.051303,0.53728,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,0.993480245535714
BIOCARTA_AGPCR_PATHWAY,SET,11,-0.026011,-0.00063648,0.27783,0.53729,BIOCARTA_AGPCR_PATHWAY,0.993480245535714
GSE9006_1MONTH_VS_4MONTH_POS...1,SET,169,-0.0063451,-0.00060595,0.067725,0.53732,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN,0.993480245535714
MIR6794_5P,SET,78,-0.0092114,-0.00059912,0.098297,0.53733,MIR6794_5P,0.993480245535714
WP_RIBOFLAVIN_AND_COQ_DISORD...,SET,13,-0.020021,-0.00053256,0.21357,0.53734,WP_RIBOFLAVIN_AND_COQ_DISORDERS,0.993480245535714
GOBP_2FE_2S_CLUSTER_ASSEMBLY,SET,8,-0.029527,-0.00061622,0.31419,0.53744,GOBP_2FE_2S_CLUSTER_ASSEMBLY,0.993480245535714
HP_CEREBRAL_EDEMA,SET,28,-0.014938,-0.00058292,0.15892,0.53744,HP_CEREBRAL_EDEMA,0.993480245535714
GOBP_PROTEASOME_ASSEMBLY,SET,11,-0.022418,-0.00054857,0.23836,0.53747,GOBP_PROTEASOME_ASSEMBLY,0.993480245535714
HE_LIM_SUN_FETAL_LUNG_C4_CD4...,SET,30,-0.015469,-0.00062477,0.16444,0.53747,HE_LIM_SUN_FETAL_LUNG_C4_CD4_T_CELL,0.993480245535714
GOCC_CONDENSED_CHROMOSOME_CE...,SET,164,-0.0060648,-0.00057063,0.064439,0.53749,GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION,0.993480245535714
GOCC_CUL5_RING_UBIQUITIN_LIG...,SET,8,-0.030644,-0.00063953,0.32563,0.53749,GOCC_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX,0.993480245535714
GOBP_MDA_5_SIGNALING_PATHWAY,SET,10,-0.020532,-0.00047905,0.2179,0.53753,GOBP_MDA_5_SIGNALING_PATHWAY,0.993480245535714
GOBP_RADIAL_GLIA_GUIDED_PYRA...,SET,6,-0.035269,-0.00063748,0.37417,0.53755,GOBP_RADIAL_GLIA_GUIDED_PYRAMIDAL_NEURON_MIGRATION,0.993480245535714
GOBP_EPHRIN_RECEPTOR_SIGNALI...,SET,48,-0.011935,-0.00060946,0.1265,0.53758,GOBP_EPHRIN_RECEPTOR_SIGNALING_PATHWAY,0.993480245535714
REACTOME_NUCLEOTIDE_SALVAGE,SET,21,-0.017943,-0.0006065,0.19016,0.53759,REACTOME_NUCLEOTIDE_SALVAGE,0.993480245535714
GOBP_REGULATION_OF_HISTAMINE...,SET,6,-0.032606,-0.00058933,0.34551,0.53759,GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL,0.993480245535714
CHANGOLKAR_H2AFY_TARGETS_DN,SET,35,-0.012816,-0.00055902,0.13564,0.53764,CHANGOLKAR_H2AFY_TARGETS_DN,0.993480245535714
MIR487A_3P,SET,92,-0.008623,-0.00060887,0.091142,0.53769,MIR487A_3P,0.993480245535714
HP_TORTUOUS_CEREBRAL_ARTERIES,SET,5,-0.034596,-0.00057085,0.36542,0.53771,HP_TORTUOUS_CEREBRAL_ARTERIES,0.993480245535714
GSE2706_2H_VS_8H_R848_AND_LP...1,SET,177,-0.0061652,-0.00060242,0.065114,0.53772,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN,0.993480245535714
WP_PANCREATIC_CANCER_SUBTYPES,SET,46,-0.013397,-0.00066974,0.14144,0.53773,WP_PANCREATIC_CANCER_SUBTYPES,0.993480245535714
GSE2826_XID_VS_BTK_KO_BCELL_...1,SET,185,-0.0059543,-0.00059468,0.062869,0.53773,GSE2826_XID_VS_BTK_KO_BCELL_DN,0.993480245535714
GAUTAM_EYE_CORNEA_FIBROBLASTS,SET,147,-0.006777,-0.00060397,0.07152,0.53775,GAUTAM_EYE_CORNEA_FIBROBLASTS,0.993480245535714
KEGG_GLYCEROPHOSPHOLIPID_MET...,SET,69,-0.0099188,-0.00060692,0.10456,0.53779,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,0.993480245535714
GOCC_DNA_DEPENDENT_PROTEIN_K...2,SET,6,-0.027532,-0.00049762,0.28979,0.53784,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_DNA_LIGASE_4_COMPLEX,0.993480245535714
GOCC_PALMITOYLTRANSFERASE_CO...,SET,10,-0.024564,-0.00057312,0.25861,0.53784,GOCC_PALMITOYLTRANSFERASE_COMPLEX,0.993480245535714
GSE360_HIGH_DOSE_B_MALAYI_VS...2,SET,175,-0.0060123,-0.00058417,0.063291,0.53784,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.993480245535714
HU_GENOTOXIN_ACTION_DIRECT_V...1,SET,45,-0.012036,-0.00059512,0.12662,0.53786,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,0.993480245535714
GSE3982_EOSINOPHIL_VS_NKCELL...2,SET,179,-0.0061161,-0.00060095,0.064276,0.5379,GSE3982_EOSINOPHIL_VS_NKCELL_UP,0.993501328585853
WANG_ESOPHAGUS_CANCER_VS_NOR...1,SET,95,-0.008258,-0.00059248,0.086644,0.53796,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,0.993506551889048
HP_ULNAR_DEVIATION_OF_THE_2N...,SET,7,-0.028806,-0.00056235,0.30231,0.53796,HP_ULNAR_DEVIATION_OF_THE_2ND_FINGER,0.993506551889048
GOBP_ERK5_CASCADE,SET,3,-0.046394,-0.00059299,0.48642,0.53799,GOBP_ERK5_CASCADE,0.993509163124336
HP_RESPONSE_TO_DRUGS_ACTING_...,SET,6,-0.033462,-0.0006048,0.35053,0.53802,HP_RESPONSE_TO_DRUGS_ACTING_ON_NEUROMUSCULAR_TRANSMISSION,0.993511774082142
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SET,51,-0.012041,-0.00063373,0.126,0.53807,SMIRNOV_RESPONSE_TO_IR_2HR_DN,0.993519605291118
GOBP_NEGATIVE_REGULATION_OF_...429,SET,4,-0.029429,-0.00043432,0.30776,0.53809,GOBP_NEGATIVE_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.993519605291118
HP_MACROTHROMBOCYTOPENIA,SET,12,-0.024819,-0.00063431,0.2594,0.53811,HP_MACROTHROMBOCYTOPENIA,0.993519605291118
GOMF_STRUCTURAL_CONSTITUENT_...9,SET,148,-0.0062233,-0.00055649,0.064866,0.53822,GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME,0.993617130564113
GSE32164_RESTING_DIFFERENTIA...4,SET,181,-0.0062677,-0.00061924,0.065322,0.53822,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.993617130564113
GOBP_RESPONSE_TO_TYPE_III_IN...,SET,11,-0.028173,-0.0006894,0.29297,0.5383,GOBP_RESPONSE_TO_TYPE_III_INTERFERON,0.993637244493741
GOBP_ARTERIAL_ENDOTHELIAL_CE...,SET,6,-0.037666,-0.0006808,0.39147,0.53833,GOBP_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.993637244493741
GOBP_POSITIVE_REGULATION_OF_...147,SET,8,-0.02665,-0.00055618,0.27689,0.53834,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.993637244493741
GOMF_INTRAMOLECULAR_OXIDORED...2,SET,5,-0.028852,-0.00047607,0.29935,0.53839,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES,0.993637244493741
GOBP_POSITIVE_REGULATION_OF_...797,SET,63,-0.010065,-0.00058856,0.10425,0.53845,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,0.993637244493741
GSE36888_UNTREATED_VS_IL2_TR...3,SET,173,-0.0062157,-0.00060052,0.064252,0.53853,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN,0.993637244493741
REACTOME_BIOSYNTHESIS_OF_SPE...,SET,19,-0.019791,-0.00063632,0.20419,0.53861,REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,0.993637244493741
GSE7460_TREG_VS_TCONV_ACT_WI...1,SET,179,-0.0061109,-0.00060044,0.06303,0.53862,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN,0.993637244493741
HP_MISALIGNMENT_OF_INCISORS,SET,14,-0.019195,-0.00052984,0.19758,0.5387,HP_MISALIGNMENT_OF_INCISORS,0.993637244493741
GOBP_GLANDULAR_EPITHELIAL_CE...1,SET,33,-0.015578,-0.00065985,0.16027,0.53872,GOBP_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT,0.993637244493741
MAINA_VHL_TARGETS_DN,SET,14,-0.025167,-0.00069469,0.25881,0.53873,MAINA_VHL_TARGETS_DN,0.993637244493741
MIR4524A_5P,SET,221,-0.0056995,-0.00062153,0.058591,0.53875,MIR4524A_5P,0.993637244493741
MIR4524B_5P,SET,221,-0.0056995,-0.00062153,0.058591,0.53875,MIR4524B_5P,0.993637244493741
HP_APLASIA_HYPOPLASIA_OF_FIN...,SET,314,-0.0047213,-0.00061213,0.048508,0.53877,HP_APLASIA_HYPOPLASIA_OF_FINGERS,0.993637244493741
GSE37605_FOXP3_FUSION_GFP_VS...1,SET,157,-0.006659,-0.00061313,0.068321,0.53882,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN,0.993637244493741
GOBP_REGULATION_OF_SKELETAL_...8,SET,10,-0.031322,-0.0007308,0.32085,0.53888,GOBP_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,0.993637244493741
MIR6848_5P,SET,70,-0.010112,-0.00062322,0.10357,0.53889,MIR6848_5P,0.993637244493741
MODULE_462,SET,15,-0.024452,-0.00069862,0.25009,0.53894,MODULE_462,0.993637244493741
GOBP_STRIATUM_DEVELOPMENT,SET,20,-0.019937,-0.00065765,0.20377,0.53897,GOBP_STRIATUM_DEVELOPMENT,0.993637244493741
MODULE_29,SET,24,-0.01545,-0.00055824,0.15786,0.53898,MODULE_29,0.993637244493741
MODULE_100,SET,492,-0.0040718,-0.00065756,0.041576,0.53901,MODULE_100,0.993637244493741
GOMF_PROTEIN_SERINE_THREONIN...1,SET,63,-0.010585,-0.00061899,0.10805,0.53902,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.993637244493741
GOBP_REGULATION_OF_TETRAPYRR...,SET,7,-0.033977,-0.00066331,0.34674,0.53903,GOBP_REGULATION_OF_TETRAPYRROLE_METABOLIC_PROCESS,0.993637244493741
UNTERMAN_IPF_VS_CTRL_B_CELL_...,SET,27,-0.018292,-0.00070096,0.18659,0.53905,UNTERMAN_IPF_VS_CTRL_B_CELL_DN,0.993637244493741
GOBP_MUSCLE_SYSTEM_PROCESS,SET,411,-0.0043911,-0.00064959,0.044793,0.53905,GOBP_MUSCLE_SYSTEM_PROCESS,0.993637244493741
MIR6863,SET,8,-0.030393,-0.00063428,0.30973,0.53908,MIR6863,0.993637244493741
MISHRA_CARCINOMA_ASSOCIATED_...2,SET,22,-0.019621,-0.0006788,0.19994,0.53909,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,0.993637244493741
GSE17721_CPG_VS_GARDIQUIMOD_...17,SET,183,-0.0060501,-0.000601,0.061597,0.53912,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN,0.993637244493741
DESCARTES_MAIN_FETAL_TROPHOB...,SET,125,-0.0077605,-0.00063816,0.079017,0.53912,DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS,0.993637244493741
GOBP_MRNA_MODIFICATION,SET,17,-0.01735,-0.00052771,0.17646,0.53916,GOBP_MRNA_MODIFICATION,0.993637244493741
JAEGER_METASTASIS_DN,SET,236,-0.0058053,-0.00065394,0.058892,0.53926,JAEGER_METASTASIS_DN,0.993637244493741
GOBP_NEGATIVE_REGULATION_OF_...14,SET,13,-0.025458,-0.00067719,0.25823,0.53927,GOBP_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.993637244493741
GOBP_POSITIVE_REGULATION_OF_...447,SET,5,-0.04433,-0.00073146,0.44891,0.53933,GOBP_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,0.993637244493741
GOBP_REGULATION_OF_LIPOPROTE...2,SET,15,-0.021725,-0.00062071,0.21996,0.53934,GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.993637244493741
HP_INCREASED_URINE_PROTEINOG...,SET,10,-0.025897,-0.00060421,0.26167,0.53942,HP_INCREASED_URINE_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_LEVEL,0.993637244493741
BIOCARTA_MCALPAIN_PATHWAY,SET,18,-0.021801,-0.00068227,0.22015,0.53944,BIOCARTA_MCALPAIN_PATHWAY,0.993637244493741
GOBP_LOCOMOTORY_BEHAVIOR,SET,193,-0.0063316,-0.00064575,0.063938,0.53944,GOBP_LOCOMOTORY_BEHAVIOR,0.993637244493741
GOMF_STRUCTURAL_CONSTITUENT_...7,SET,18,-0.020121,-0.00062971,0.20321,0.53944,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPSE,0.993637244493741
GSE22033_WT_VS_PPARG_KO_MEF_...1,SET,181,-0.0064504,-0.0006373,0.065135,0.53944,GSE22033_WT_VS_PPARG_KO_MEF_DN,0.993637244493741
GOBP_POSITIVE_REGULATION_OF_...475,SET,7,-0.03462,-0.00067585,0.34949,0.53945,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.993637244493741
HP_PLETHORA,SET,12,-0.02635,-0.00067344,0.26591,0.53947,HP_PLETHORA,0.993637244493741
GOBP_CONNECTIVE_TISSUE_REPLA...1,SET,11,-0.025828,-0.00063201,0.26024,0.53953,GOBP_CONNECTIVE_TISSUE_REPLACEMENT,0.993637244493741
GOMF_FIBRINOGEN_BINDING,SET,6,-0.038067,-0.00068804,0.38335,0.53955,GOMF_FIBRINOGEN_BINDING,0.993637244493741
GOBP_HEPARAN_SULFATE_PROTEOG...4,SET,8,-0.030296,-0.00063227,0.30493,0.53957,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_CATABOLIC_PROCESS,0.993637244493741
GOBP_MATING_BEHAVIOR,SET,36,-0.015858,-0.00070151,0.15957,0.53958,GOBP_MATING_BEHAVIOR,0.993637244493741
HP_ABNORMAL_SPACED_INCISORS,SET,12,-0.020818,-0.00053205,0.2095,0.53958,HP_ABNORMAL_SPACED_INCISORS,0.993637244493741
HOEK_MYELOID_DENDRITIC_CELL_...1,SET,5,-0.038579,-0.00063656,0.38721,0.53968,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_DN,0.993637244493741
GOMF_U1_SNRNA_BINDING,SET,8,-0.026515,-0.00055336,0.26609,0.53969,GOMF_U1_SNRNA_BINDING,0.993637244493741
MIR570_3P,SET,686,-0.0033604,-0.00063731,0.033681,0.53974,MIR570_3P,0.993637244493741
ZHENG_RESPONSE_TO_ARSENITE_UP,SET,14,-0.026956,-0.00074408,0.26995,0.53977,ZHENG_RESPONSE_TO_ARSENITE_UP,0.993637244493741
GOBP_SYNAPTIC_TRANSMISSION_G...2,SET,98,-0.009115,-0.00066416,0.091215,0.5398,GOBP_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.993637244493741
GAUTAM_EYE_CHOROID_SCLERA_CH...,SET,128,-0.0073397,-0.0006107,0.07338,0.53984,GAUTAM_EYE_CHOROID_SCLERA_CHOROID_ENDOTHELIAL_CELLS,0.993637244493741
GSE19923_WT_VS_HEB_KO_DP_THY...1,SET,180,-0.0063098,-0.00062169,0.063068,0.53985,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN,0.993637244493741
WP_AMINO_ACID_METABOLISM,SET,80,-0.0097927,-0.00064501,0.097522,0.53999,WP_AMINO_ACID_METABOLISM,0.993637244493741
GSE9006_TYPE_1_VS_TYPE_2_DIA...1,SET,180,-0.0062249,-0.00061332,0.061958,0.54001,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.993637244493741
SANA_TNF_SIGNALING_DN,SET,74,-0.010557,-0.00066885,0.10484,0.5401,SANA_TNF_SIGNALING_DN,0.993637244493741
GOBP_REGULATION_OF_NEUROTRAN...4,SET,88,-0.0092379,-0.00063802,0.09159,0.54017,GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.993637244493741
GSE5455_HEALTHY_VS_TUMOR_BEA...2,SET,176,-0.0064311,-0.00062664,0.06375,0.54018,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP,0.993637244493741
SCHRAETS_MLL_TARGETS_DN,SET,32,-0.017205,-0.00071766,0.17028,0.54024,SCHRAETS_MLL_TARGETS_DN,0.993637244493741
GSE23321_EFFECTOR_MEMORY_VS_...2,SET,172,-0.0067571,-0.00065094,0.06682,0.54027,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.993637244493741
HP_INCREASED_CIRCULATING_ACT...,SET,14,-0.023082,-0.00063714,0.22786,0.54034,HP_INCREASED_CIRCULATING_ACTH_LEVEL,0.993637244493741
HP_ERUPTION_FAILURE,SET,16,-0.022127,-0.00065293,0.21835,0.54036,HP_ERUPTION_FAILURE,0.993637244493741
HP_RESPIRATORY_TRACT_INFECTI...,SET,680,-0.0034359,-0.00064887,0.033905,0.54036,HP_RESPIRATORY_TRACT_INFECTION,0.993637244493741
HINATA_NFKB_TARGETS_FIBROBLA...,SET,79,-0.010057,-0.00065829,0.099214,0.54037,HINATA_NFKB_TARGETS_FIBROBLAST_UP,0.993637244493741
DESCARTES_FETAL_MUSCLE_MYELO...,SET,106,-0.0089312,-0.00067666,0.088114,0.54037,DESCARTES_FETAL_MUSCLE_MYELOID_CELLS,0.993637244493741
REACTOME_TRANSPORT_OF_MATURE...2,SET,74,-0.0091809,-0.00058168,0.090552,0.54038,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,0.993637244493741
HP_COCHLEAR_MALFORMATION,SET,8,-0.028578,-0.00059641,0.28188,0.54038,HP_COCHLEAR_MALFORMATION,0.993637244493741
REACTOME_CARBOXYTERMINAL_POS...,SET,41,-0.014309,-0.00067541,0.14094,0.54043,REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN,0.993637244493741
GOBP_RESPONSE_TO_CORTICOSTER...1,SET,146,-0.0076705,-0.00068129,0.075557,0.54043,GOBP_RESPONSE_TO_CORTICOSTEROID,0.993637244493741
GOBP_CELLULAR_RESPONSE_TO_AB...,SET,307,-0.0049324,-0.00063245,0.048567,0.54045,GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS,0.993637244493741
GSE26495_NAIVE_VS_PD1LOW_CD8...2,SET,153,-0.00711,-0.00064634,0.069951,0.54048,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP,0.993637244493741
GOBP_NADH_OXIDATION,SET,6,-0.033726,-0.00060959,0.33174,0.54049,GOBP_NADH_OXIDATION,0.993637244493741
MIR4535,SET,26,-0.017038,-0.00064072,0.16744,0.54052,MIR4535,0.993637244493741
BIOCARTA_NFAT_PATHWAY,SET,50,-0.013021,-0.00067858,0.12779,0.54058,BIOCARTA_NFAT_PATHWAY,0.993637244493741
GOMF_PHOSPHOLIPASE_A2_ACTIVI...,SET,28,-0.0165,-0.00064387,0.16194,0.54058,GOMF_PHOSPHOLIPASE_A2_ACTIVITY,0.993637244493741
HP_ASCENDING_TUBULAR_AORTA_A...,SET,26,-0.016633,-0.00062547,0.16322,0.54058,HP_ASCENDING_TUBULAR_AORTA_ANEURYSM,0.993637244493741
GSE15659_CD45RA_NEG_CD4_TCEL...2,SET,163,-0.0068923,-0.00064652,0.067608,0.5406,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.993637244493741
SMID_BREAST_CANCER_RELAPSE_I...9,SET,22,-0.018967,-0.00065617,0.18597,0.54062,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,0.993637244493741
MIR21_5P,SET,133,-0.0076856,-0.00065177,0.075321,0.54064,MIR21_5P,0.993637244493741
HP_ORTHOSTATIC_HYPOTENSION_D...,SET,15,-0.025287,-0.0007225,0.24718,0.54074,HP_ORTHOSTATIC_HYPOTENSION_DUE_TO_AUTONOMIC_DYSFUNCTION,0.993637244493741
HP_NASOGASTRIC_TUBE_FEEDING_...,SET,34,-0.01521,-0.00065391,0.14864,0.54075,HP_NASOGASTRIC_TUBE_FEEDING_IN_INFANCY,0.993637244493741
MIR4704_5P,SET,55,-0.011787,-0.00064415,0.11512,0.54078,MIR4704_5P,0.993637244493741
GOMF_CYCLASE_REGULATOR_ACTIV...,SET,15,-0.02475,-0.00070713,0.24168,0.54078,GOMF_CYCLASE_REGULATOR_ACTIVITY,0.993637244493741
GSE27786_LSK_VS_NKTCELL_DN,SET,173,-0.0063583,-0.00061428,0.062071,0.54079,GSE27786_LSK_VS_NKTCELL_DN,0.993637244493741
NAKAYA_PLASMACYTOID_DENDRITI...2,SET,186,-0.0063441,-0.0006353,0.061935,0.54079,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.993637244493741
GOBP_REGULATION_OF_TOLL_LIKE...6,SET,29,-0.014932,-0.00059298,0.14571,0.54081,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.993637244493741
WIERENGA_PML_INTERACTOME,SET,38,-0.013716,-0.00062336,0.13374,0.54084,WIERENGA_PML_INTERACTOME,0.993637244493741
ZHOU_CELL_CYCLE_GENES_IN_IR_...3,SET,79,-0.0095794,-0.00062702,0.09311,0.54097,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,0.993637244493741
GOBP_REGULATION_OF_CELL_SHAPE,SET,125,-0.0079815,-0.00065633,0.07756,0.54098,GOBP_REGULATION_OF_CELL_SHAPE,0.993637244493741
ZNF530_TARGET_GENES,SET,23,-0.01967,-0.00069576,0.19111,0.54099,ZNF530_TARGET_GENES,0.993637244493741
GOBP_CYTOSKELETON_ORGANIZATI...,SET,1360,-0.0024903,-0.0006522,0.024195,0.54099,GOBP_CYTOSKELETON_ORGANIZATION,0.993637244493741
GOBP_NEGATIVE_REGULATION_OF_...326,SET,50,-0.013386,-0.00069759,0.12989,0.54104,GOBP_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.993637244493741
MANNO_MIDBRAIN_NEUROTYPES_HR...1,SET,316,-0.0053388,-0.00069435,0.051754,0.54108,MANNO_MIDBRAIN_NEUROTYPES_HRGL1,0.993637244493741
GOBP_SNRNA_TRANSPORT,SET,5,-0.03527,-0.00058196,0.34181,0.54109,GOBP_SNRNA_TRANSPORT,0.993637244493741
GOBP_POSITIVE_REGULATION_OF_...676,SET,350,-0.0047455,-0.00064893,0.045968,0.54111,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.993637244493741
MIR29B_1_5P,SET,155,-0.0071254,-0.00065193,0.069001,0.54112,MIR29B_1_5P,0.993637244493741
SASAI_RESISTANCE_TO_NEOPLAST...,SET,45,-0.01425,-0.00070462,0.13794,0.54114,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,0.993637244493741
GOCC_SITE_OF_DNA_DAMAGE,SET,110,-0.0077521,-0.00059824,0.075017,0.54115,GOCC_SITE_OF_DNA_DAMAGE,0.993637244493741
HP_APLASIA_HYPOPLASIA_OF_THE...70,SET,127,-0.0078231,-0.00064839,0.075699,0.54115,HP_APLASIA_HYPOPLASIA_OF_THE_THUMB,0.993637244493741
GSE3982_EFF_MEMORY_CD4_TCELL...5,SET,184,-0.0062229,-0.00061984,0.060164,0.54119,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN,0.993637244493741
HP_CHRONIC_CONSTIPATION,SET,90,-0.0095201,-0.0006649,0.091898,0.54125,HP_CHRONIC_CONSTIPATION,0.993637244493741
GOBP_CELLULAR_RESPONSE_TO_LE...3,SET,10,-0.02662,-0.00062108,0.25689,0.54127,GOBP_CELLULAR_RESPONSE_TO_LEUCINE_STARVATION,0.993637244493741
MIR4789_3P,SET,305,-0.0052447,-0.00067034,0.0506,0.54128,MIR4789_3P,0.993637244493741
GOBP_REGULATION_OF_SUBSTRATE...,SET,58,-0.011739,-0.00065875,0.11324,0.54128,GOBP_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.993637244493741
EPPERT_CE_HSC_LSC,SET,36,-0.016301,-0.00072109,0.15722,0.54129,EPPERT_CE_HSC_LSC,0.993637244493741
GOBP_POSITIVE_REGULATION_OF_...396,SET,23,-0.018958,-0.00067057,0.18285,0.54129,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.993637244493741
GSE6259_33D1_POS_DC_VS_CD4_T...2,SET,161,-0.0068905,-0.00064241,0.066461,0.54129,GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP,0.993637244493741
GOCC_MICROTUBULE_ORGANIZING_...1,SET,779,-0.0031185,-0.00062858,0.030055,0.54132,GOCC_MICROTUBULE_ORGANIZING_CENTER,0.993639833104468
GSE360_DC_VS_MAC_L_MAJOR_DN,SET,177,-0.0064949,-0.00063463,0.062517,0.54137,GSE360_DC_VS_MAC_L_MAJOR_DN,0.993679131238447
GSE35685_CD34POS_CD38NEG_VS_...3,SET,187,-0.0065251,-0.00065516,0.062664,0.54147,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.993684050358953
HALLMARK_UV_RESPONSE_DN,SET,136,-0.0084868,-0.00072772,0.081473,0.54148,HALLMARK_UV_RESPONSE_DN,0.993684050358953
GOBP_PROTEIN_LOCALIZATION_TO...26,SET,29,-0.015568,-0.00061822,0.14931,0.54152,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS,0.993684050358953
HP_PELVIC_KIDNEY,SET,30,-0.016787,-0.000678,0.16092,0.54154,HP_PELVIC_KIDNEY,0.993684050358953
GOBP_MEMBRANE_FISSION,SET,44,-0.012595,-0.00061585,0.12062,0.54158,GOBP_MEMBRANE_FISSION,0.993684050358953
GOBP_POSITIVE_REGULATION_BY_...2,SET,19,-0.020148,-0.0006478,0.19286,0.5416,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.993684050358953
REACTOME_RUNX1_INTERACTS_WIT...,SET,35,-0.015277,-0.00066636,0.1462,0.54161,REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,0.993684050358953
GOMF_CYCLIN_DEPENDENT_PROTEI...3,SET,12,-0.027399,-0.00070025,0.26214,0.54162,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,0.993684050358953
GOBP_PENTOSE_METABOLIC_PROCE...,SET,12,-0.025906,-0.00066209,0.24782,0.54163,GOBP_PENTOSE_METABOLIC_PROCESS,0.993684050358953
HP_RACHITIC_ROSARY,SET,6,-0.039242,-0.00070928,0.37493,0.54168,HP_RACHITIC_ROSARY,0.993689219360287
GOBP_CILIARY_NEUROTROPHIC_FA...,SET,5,-0.042895,-0.00070778,0.40976,0.54169,GOBP_CILIARY_NEUROTROPHIC_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.993689219360287
IIZUKA_LIVER_CANCER_PROGRESS...2,SET,12,-0.025818,-0.00065983,0.24609,0.54178,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,0.993801863091782
GOBP_NEGATIVE_REGULATION_OF_...368,SET,6,-0.031968,-0.0005778,0.30428,0.54184,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.993859468017733
MORF_PCNA,SET,71,-0.0094956,-0.00058935,0.090232,0.5419,MORF_PCNA,0.993917066863687
GOBP_NATURAL_KILLER_CELL_DEG...,SET,10,-0.027691,-0.00064608,0.26268,0.54198,GOBP_NATURAL_KILLER_CELL_DEGRANULATION,0.994011340369393
HP_ABNORMAL_GRANULOCYTOPOIET...,SET,14,-0.024341,-0.00067189,0.23066,0.54202,HP_ABNORMAL_GRANULOCYTOPOIETIC_CELL_MORPHOLOGY,0.994016473195441
HP_COLD_INDUCED_MUSCLE_CRAMPS,SET,6,-0.038388,-0.00069384,0.36364,0.54204,HP_COLD_INDUCED_MUSCLE_CRAMPS,0.994016473195441
KEGG_MEDICUS_REFERENCE_PDGF_...2,SET,17,-0.023572,-0.00071693,0.22279,0.54213,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY,0.994076614434948
HP_BICARBONATURIA,SET,5,-0.037931,-0.00062587,0.3585,0.54213,HP_BICARBONATURIA,0.994076614434948
PUIFFE_INVASION_INHIBITED_BY...1,SET,134,-0.0076588,-0.00065191,0.072112,0.54229,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,0.994288521995991
GOMF_FIBROBLAST_GROWTH_FACTO...1,SET,23,-0.019526,-0.00069066,0.18366,0.54233,GOMF_FIBROBLAST_GROWTH_FACTOR_BINDING,0.994288521995991
HP_INCREASED_CIRCULATING_COR...,SET,29,-0.018154,-0.00072091,0.17068,0.54235,HP_INCREASED_CIRCULATING_CORTISOL_LEVEL,0.994288521995991
GOBP_ENDONUCLEOLYTIC_CLEAVAG...3,SET,16,-0.022434,-0.00066196,0.21089,0.54236,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.994288521995991
GOBP_DICARBOXYLIC_ACID_CATAB...,SET,17,-0.020773,-0.00063182,0.19481,0.54246,GOBP_DICARBOXYLIC_ACID_CATABOLIC_PROCESS,0.994335381288894
GAUTAM_EYE_CORNEA_TGFBI_HIGH...,SET,102,-0.0094469,-0.00070217,0.088586,0.54246,GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS,0.994335381288894
GOBP_REGULATION_OF_LYASE_ACT...,SET,53,-0.013303,-0.0007137,0.12467,0.54249,GOBP_REGULATION_OF_LYASE_ACTIVITY,0.994335381288894
REACTOME_G2_M_DNA_REPLICATIO...,SET,5,-0.0377,-0.00062206,0.35322,0.5425,REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT,0.994335381288894
HP_PULMONIC_STENOSIS,SET,115,-0.008952,-0.00070627,0.083792,0.54254,HP_PULMONIC_STENOSIS,0.994356256921373
HP_GENU_VARUM,SET,54,-0.012465,-0.00067501,0.11651,0.5426,HP_GENU_VARUM,0.994378170467444
HP_FLARED_LOWER_LIMB_METAPHY...,SET,5,-0.038404,-0.00063367,0.35861,0.54264,HP_FLARED_LOWER_LIMB_METAPHYSIS,0.994378170467444
GOBP_MEMBRANE_REPOLARIZATION...2,SET,5,-0.045475,-0.00075035,0.42455,0.54265,GOBP_MEMBRANE_REPOLARIZATION_DURING_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.994378170467444
BIOCARTA_PLC_PATHWAY,SET,9,-0.031412,-0.0006953,0.29292,0.5427,BIOCARTA_PLC_PATHWAY,0.994378170467444
GSE5542_UNTREATED_VS_IFNA_AN...3,SET,177,-0.0069161,-0.00067578,0.064454,0.54273,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.994378170467444
HP_VOLVULUS,SET,13,-0.025136,-0.00066862,0.23392,0.54278,HP_VOLVULUS,0.994378170467444
HP_2_4_TOE_CUTANEOUS_SYNDACT...,SET,4,-0.055685,-0.00082183,0.51686,0.5429,HP_2_4_TOE_CUTANEOUS_SYNDACTYLY,0.994378170467444
GSE3982_BCELL_VS_TH1_DN,SET,176,-0.0070406,-0.00068603,0.065238,0.54297,GSE3982_BCELL_VS_TH1_DN,0.994378170467444
WP_ACETAMINOPHEN_IN_ANALGESI...,SET,9,-0.035003,-0.0007748,0.32404,0.54301,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,0.994378170467444
FAN_EMBRYONIC_CTX_MICROGLIA_3,SET,19,-0.02434,-0.0007826,0.22533,0.54301,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.994378170467444
GOBP_SNO_S_RNA_METABOLIC_PRO...,SET,11,-0.028387,-0.00069462,0.26231,0.54309,GOBP_SNO_S_RNA_METABOLIC_PROCESS,0.994378170467444
MODULE_294,SET,18,-0.019667,-0.0006155,0.18168,0.5431,MODULE_294,0.994378170467444
HP_ABNORMAL_AUTONOMIC_NERVOU...,SET,121,-0.0087086,-0.00070464,0.080448,0.5431,HP_ABNORMAL_AUTONOMIC_NERVOUS_SYSTEM_PHYSIOLOGY,0.994378170467444
HP_PERIPORTAL_FIBROSIS,SET,10,-0.028707,-0.00066979,0.26517,0.54311,HP_PERIPORTAL_FIBROSIS,0.994378170467444
HP_SKIN_ULCER,SET,122,-0.0085372,-0.0006936,0.078798,0.54314,HP_SKIN_ULCER,0.994378170467444
GOBP_REGULATION_OF_DNA_TEMPL...4,SET,79,-0.0098883,-0.00064723,0.091241,0.54315,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.994378170467444
DESERT_PERIPORTAL_HEPATOCELL...,SET,147,-0.00781,-0.00069603,0.072055,0.54316,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.994378170467444
MIR4666A_3P,SET,502,-0.0043393,-0.00070765,0.039996,0.5432,MIR4666A_3P,0.994378170467444
DESCARTES_FETAL_EYE_RETINAL_...2,SET,10,-0.032457,-0.00075727,0.29915,0.5432,DESCARTES_FETAL_EYE_RETINAL_PROGENITORS_AND_MULLER_GLIA,0.994378170467444
LIU_VAV3_PROSTATE_CARCINOGEN...1,SET,14,-0.026479,-0.0007309,0.24377,0.54325,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,0.994378170467444
REACTOME_INFECTION_WITH_MYCO...,SET,25,-0.017938,-0.00066147,0.16511,0.54326,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,0.994378170467444
GSE15330_HSC_VS_LYMPHOID_PRI...4,SET,181,-0.0069049,-0.0006822,0.063529,0.54327,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,0.994378170467444
MIR7108_5P,SET,43,-0.01413,-0.00068301,0.12995,0.54329,MIR7108_5P,0.994378170467444
GOBP_REGULATION_OF_TRIGLYCER...2,SET,12,-0.0284,-0.00072581,0.26094,0.54333,GOBP_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.994378170467444
HP_DACRYOCYSTITIS,SET,7,-0.03503,-0.00068386,0.3219,0.54333,HP_DACRYOCYSTITIS,0.994378170467444
GOBP_GENERATION_OF_NEURONS,SET,1370,-0.0027297,-0.00071729,0.025066,0.54336,GOBP_GENERATION_OF_NEURONS,0.994378170467444
GOBP_UV_PROTECTION,SET,11,-0.024144,-0.00059079,0.22157,0.54338,GOBP_UV_PROTECTION,0.994378170467444
TSAI_RESPONSE_TO_IONIZING_RA...,SET,142,-0.0077405,-0.00067809,0.070948,0.54344,TSAI_RESPONSE_TO_IONIZING_RADIATION,0.994378170467444
GOMF_SODIUM_CHANNEL_REGULATO...,SET,38,-0.015798,-0.00071797,0.14475,0.54345,GOMF_SODIUM_CHANNEL_REGULATOR_ACTIVITY,0.994378170467444
GOMF_ISOMERASE_ACTIVITY,SET,158,-0.0070803,-0.00065398,0.06485,0.54347,GOMF_ISOMERASE_ACTIVITY,0.994378170467444
GSE25123_CTRL_VS_ROSIGLITAZO...1,SET,178,-0.006967,-0.00068266,0.063794,0.54348,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.994378170467444
KEGG_MEDICUS_REFERENCE_REGUL...9,SET,7,-0.030693,-0.00059921,0.28005,0.54364,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP,0.994378170467444
HP_HYPOCALCIURIA,SET,9,-0.035795,-0.00079232,0.32636,0.54367,HP_HYPOCALCIURIA,0.994378170467444
GOCC_MIGRASOME,SET,5,-0.043137,-0.00071177,0.39218,0.54379,GOCC_MIGRASOME,0.994378170467444
HP_DISTAL_AMYOTROPHY,SET,199,-0.0065828,-0.00068161,0.059815,0.54382,HP_DISTAL_AMYOTROPHY,0.994378170467444
TIAN_TNF_SIGNALING_VIA_NFKB,SET,24,-0.021604,-0.00078057,0.19611,0.54386,TIAN_TNF_SIGNALING_VIA_NFKB,0.994378170467444
HP_ABNORMAL_CERVICAL_CURVATU...,SET,11,-0.026358,-0.00064498,0.23914,0.54388,HP_ABNORMAL_CERVICAL_CURVATURE,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...6,SET,13,-0.027685,-0.00073643,0.25077,0.54395,GOBP_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...372,SET,7,-0.043248,-0.00084429,0.39078,0.54406,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.994378170467444
GSE5142_HTERT_TRANSDUCED_VS_...2,SET,177,-0.0065282,-0.00063788,0.058908,0.54412,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP,0.994378170467444
GOCC_RESPIRASOME,SET,82,-0.0092479,-0.00061665,0.083287,0.54421,GOCC_RESPIRASOME,0.994378170467444
GOMF_BMP_RECEPTOR_BINDING,SET,10,-0.032617,-0.00076101,0.29374,0.54421,GOMF_BMP_RECEPTOR_BINDING,0.994378170467444
CCCNNNNNNAAGWT_UNKNOWN,SET,93,-0.0098407,-0.0006986,0.088578,0.54423,CCCNNNNNNAAGWT_UNKNOWN,0.994378170467444
HP_ABNORMAL_CAPILLARY_PHYSIO...,SET,8,-0.035027,-0.00073099,0.31461,0.54432,HP_ABNORMAL_CAPILLARY_PHYSIOLOGY,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...460,SET,7,-0.039383,-0.00076885,0.35367,0.54433,GOBP_POSITIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.994378170467444
GSE17721_CTRL_VS_PAM3CSK4_1H...2,SET,178,-0.0067389,-0.00066031,0.060508,0.54434,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP,0.994378170467444
KEGG_MEDICUS_ENV_FACTOR_DCE_...,SET,15,-0.03304,-0.000944,0.29632,0.54439,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS,0.994378170467444
HP_ENAMEL_HYPOPLASIA,SET,90,-0.010156,-0.00070933,0.091068,0.5444,HP_ENAMEL_HYPOPLASIA,0.994378170467444
MODULE_274,SET,76,-0.011829,-0.00075946,0.10599,0.54443,MODULE_274,0.994378170467444
GOMF_CYCLASE_ACTIVITY,SET,17,-0.024566,-0.00074717,0.22006,0.54444,GOMF_CYCLASE_ACTIVITY,0.994378170467444
HP_RHEGMATOGENOUS_RETINAL_DE...,SET,11,-0.029761,-0.00072824,0.26598,0.54454,HP_RHEGMATOGENOUS_RETINAL_DETACHMENT,0.994378170467444
GOBP_CALCIUM_ION_REGULATED_E...2,SET,21,-0.021117,-0.00071378,0.18848,0.5446,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER,0.994378170467444
GSE17721_CTRL_VS_LPS_8H_BMDC...2,SET,179,-0.0071422,-0.00070177,0.063738,0.54461,GSE17721_CTRL_VS_LPS_8H_BMDC_UP,0.994378170467444
MANNO_MIDBRAIN_NEUROTYPES_HP...3,SET,284,-0.0057807,-0.00071337,0.051582,0.54461,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL,0.994378170467444
LY_AGING_PREMATURE_DN,SET,29,-0.017816,-0.00070749,0.15891,0.54463,LY_AGING_PREMATURE_DN,0.994378170467444
GOBP_REGULATION_OF_MEMBRANE_...9,SET,24,-0.019756,-0.0007138,0.17616,0.54464,GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.994378170467444
GSE40274_FOXP3_VS_FOXP3_AND_...2,SET,184,-0.0070513,-0.00070235,0.062887,0.54464,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.994378170467444
GSE22886_NAIVE_VS_IGM_MEMORY...1,SET,176,-0.0073799,-0.00071908,0.065803,0.54465,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.994378170467444
FOURNIER_ACINAR_DEVELOPMENT_...5,SET,10,-0.034372,-0.00080195,0.30593,0.54473,FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,0.994378170467444
GSE5099_UNSTIM_VS_MCSF_TREAT...4,SET,175,-0.0068832,-0.0006688,0.061255,0.54473,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP,0.994378170467444
GOBP_BRAIN_MORPHOGENESIS,SET,37,-0.015997,-0.00071741,0.14232,0.54475,GOBP_BRAIN_MORPHOGENESIS,0.994378170467444
MILICIC_FAMILIAL_ADENOMATOUS...1,SET,9,-0.035936,-0.00079545,0.31916,0.54482,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN,0.994378170467444
GOCC_ANNULATE_LAMELLAE,SET,5,-0.039721,-0.0006554,0.35245,0.54486,GOCC_ANNULATE_LAMELLAE,0.994378170467444
GOBP_REGULATION_OF_ISOMERASE...,SET,7,-0.038468,-0.00075098,0.3413,0.54487,GOBP_REGULATION_OF_ISOMERASE_ACTIVITY,0.994378170467444
GOMF_APOLIPOPROTEIN_RECEPTOR...,SET,7,-0.036867,-0.00071973,0.32709,0.54487,GOMF_APOLIPOPROTEIN_RECEPTOR_BINDING,0.994378170467444
OLSSON_E2F3_TARGETS_UP,SET,22,-0.022778,-0.00078802,0.20201,0.54489,OLSSON_E2F3_TARGETS_UP,0.994378170467444
GOMF_COMPLEMENT_COMPONENT_C1...,SET,7,-0.03699,-0.00072213,0.32801,0.54489,GOMF_COMPLEMENT_COMPONENT_C1Q_COMPLEX_BINDING,0.994378170467444
KUMAMOTO_RESPONSE_TO_NUTLIN_...1,SET,9,-0.027985,-0.00061944,0.24809,0.5449,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN,0.994378170467444
KEGG_MEDICUS_VARIANT_SCRAPIE...3,SET,6,-0.042319,-0.0007649,0.3749,0.54494,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY,0.994378170467444
HP_ECCHYMOSIS,SET,54,-0.013815,-0.00074815,0.12216,0.54502,HP_ECCHYMOSIS,0.994378170467444
GGCACAT_MIR455,SET,54,-0.012877,-0.00069732,0.11374,0.54507,GGCACAT_MIR455,0.994378170467444
REACTOME_SUPPRESSION_OF_APOP...,SET,7,-0.034509,-0.00067369,0.30476,0.54508,REACTOME_SUPPRESSION_OF_APOPTOSIS,0.994378170467444
TNCATNTCCYR_UNKNOWN,SET,119,-0.0088509,-0.00071026,0.078124,0.5451,TNCATNTCCYR_UNKNOWN,0.994378170467444
WU_HBX_TARGETS_1_DN,SET,22,-0.022205,-0.0007682,0.19595,0.54511,WU_HBX_TARGETS_1_DN,0.994378170467444
GSE9316_CD4_TCELL_BALBC_VS_T...1,SET,180,-0.0075852,-0.00074736,0.066842,0.54517,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN,0.994378170467444
GOBP_ECTODERMAL_PLACODE_DEVE...,SET,12,-0.03039,-0.00077669,0.26766,0.5452,GOBP_ECTODERMAL_PLACODE_DEVELOPMENT,0.994378170467444
HP_FACIAL_ERYTHEMA,SET,11,-0.030204,-0.00073908,0.26591,0.54522,HP_FACIAL_ERYTHEMA,0.994378170467444
MIR6732_5P,SET,25,-0.019326,-0.00071267,0.1701,0.54523,MIR6732_5P,0.994378170467444
HP_APHTHOUS_ULCER,SET,6,-0.045577,-0.00082379,0.40089,0.54526,HP_APHTHOUS_ULCER,0.994378170467444
GSE42021_TCONV_PLN_VS_TREG_P...2,SET,180,-0.0073673,-0.00072589,0.064768,0.54528,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.994378170467444
STAT5A_02,SET,124,-0.009014,-0.00073828,0.079168,0.54532,STAT5A_02,0.994378170467444
GOMF_NEUROPEPTIDE_BINDING,SET,28,-0.020618,-0.00080455,0.18109,0.54532,GOMF_NEUROPEPTIDE_BINDING,0.994378170467444
GSE1740_UNSTIM_VS_IFNA_STIMU...1,SET,159,-0.0077975,-0.00072248,0.068469,0.54533,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN,0.994378170467444
HAY_BONE_MARROW_CD34_POS_ERP...,SET,10,-0.028314,-0.00066062,0.24858,0.54534,HAY_BONE_MARROW_CD34_POS_ERP_EARLY,0.994378170467444
KEGG_NITROGEN_METABOLISM,SET,21,-0.021541,-0.00072809,0.18894,0.54538,KEGG_NITROGEN_METABOLISM,0.994378170467444
GOMF_C_ACYLTRANSFERASE_ACTIV...,SET,19,-0.023153,-0.00074443,0.20294,0.54541,GOMF_C_ACYLTRANSFERASE_ACTIVITY,0.994378170467444
YEGNASUBRAMANIAN_PROSTATE_CA...,SET,100,-0.010078,-0.00074174,0.088313,0.54543,YEGNASUBRAMANIAN_PROSTATE_CANCER,0.994378170467444
KATSANOU_ELAVL1_TARGETS_UP,SET,154,-0.0084417,-0.00076988,0.073954,0.54544,KATSANOU_ELAVL1_TARGETS_UP,0.994378170467444
GSE27786_LSK_VS_LIN_NEG_CELL...1,SET,179,-0.0070843,-0.00069608,0.062039,0.54546,GSE27786_LSK_VS_LIN_NEG_CELL_DN,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...33,SET,25,-0.019788,-0.00072968,0.17318,0.54548,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.994378170467444
KANNAN_BLOOD_2012_2013_TIV_A...1,SET,297,-0.0054433,-0.00068669,0.047648,0.54548,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,0.994378170467444
HP_ABNORMALITY_OF_THE_HEPATI...,SET,84,-0.010632,-0.00071751,0.093034,0.54549,HP_ABNORMALITY_OF_THE_HEPATIC_VASCULATURE,0.994378170467444
FERRANDO_TAL1_NEIGHBORS,SET,17,-0.023427,-0.00071252,0.20492,0.54551,FERRANDO_TAL1_NEIGHBORS,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...688,SET,3,-0.063895,-0.00081669,0.55885,0.54551,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.994378170467444
GSE2770_TGFB_AND_IL4_VS_TGFB...1,SET,166,-0.0074125,-0.00070164,0.064833,0.54551,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.994378170467444
GSE22886_CTRL_VS_LPS_24H_DC_...2,SET,178,-0.0067984,-0.00066614,0.059418,0.54555,GSE22886_CTRL_VS_LPS_24H_DC_UP,0.994378170467444
GOMF_GROWTH_FACTOR_RECEPTOR_...,SET,132,-0.0089879,-0.00075935,0.078525,0.54556,GOMF_GROWTH_FACTOR_RECEPTOR_BINDING,0.994378170467444
HP_WEBBED_NECK,SET,104,-0.0092645,-0.00069529,0.080933,0.54557,HP_WEBBED_NECK,0.994378170467444
PID_DNA_PK_PATHWAY,SET,16,-0.020221,-0.00059668,0.17633,0.54565,PID_DNA_PK_PATHWAY,0.994378170467444
GSE32034_UNTREATED_VS_ROSIGL...3,SET,166,-0.0079355,-0.00075113,0.069131,0.54569,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN,0.994378170467444
ZHENG_IL22_SIGNALING_UP,SET,53,-0.014452,-0.00077533,0.12589,0.5457,ZHENG_IL22_SIGNALING_UP,0.994378170467444
GSE9650_EFFECTOR_VS_MEMORY_C...2,SET,183,-0.0069883,-0.0006942,0.060781,0.54577,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,0.994378170467444
MEISSNER_NPC_HCP_WITH_H3K4ME...2,SET,140,-0.0088364,-0.00076868,0.076798,0.5458,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.994378170467444
HP_PUNCTATE_KERATITIS,SET,5,-0.051627,-0.00085186,0.44854,0.54582,HP_PUNCTATE_KERATITIS,0.994378170467444
GSE28737_WT_VS_BCL6_HET_FOLL...2,SET,183,-0.0072359,-0.00071879,0.06281,0.54586,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP,0.994378170467444
MODULE_169,SET,89,-0.011118,-0.00077219,0.096456,0.54588,MODULE_169,0.994378170467444
PSIP1_TARGET_GENES,SET,547,-0.0041672,-0.00070848,0.036134,0.54591,PSIP1_TARGET_GENES,0.994378170467444
HP_VISUAL_FIELD_DEFECT,SET,256,-0.0061816,-0.00072483,0.053346,0.54612,HP_VISUAL_FIELD_DEFECT,0.994378170467444
KAUFFMANN_MELANOMA_RELAPSE_UP,SET,59,-0.012186,-0.00068969,0.10512,0.54614,KAUFFMANN_MELANOMA_RELAPSE_UP,0.994378170467444
GSE7831_UNSTIM_VS_CPG_STIM_P...3,SET,178,-0.0073862,-0.00072373,0.063724,0.54614,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN,0.994378170467444
MIR2355_5P,SET,118,-0.0087215,-0.00069694,0.075219,0.54615,MIR2355_5P,0.994378170467444
MIR378H,SET,39,-0.014845,-0.00068345,0.12803,0.54615,MIR378H,0.994378170467444
REACTOME_AGGREPHAGY,SET,38,-0.017282,-0.00078541,0.14903,0.54616,REACTOME_AGGREPHAGY,0.994378170467444
SOGA_COLORECTAL_CANCER_MYC_DN,SET,69,-0.012318,-0.0007537,0.10618,0.54617,SOGA_COLORECTAL_CANCER_MYC_DN,0.994378170467444
GOBP_CIRCULATORY_SYSTEM_PROC...,SET,565,-0.0045576,-0.00078712,0.039287,0.54618,GOBP_CIRCULATORY_SYSTEM_PROCESS,0.994378170467444
GSE5679_CTRL_VS_RARA_AGONIST...1,SET,180,-0.0072015,-0.00070955,0.06204,0.5462,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN,0.994378170467444
HALLMARK_INFLAMMATORY_RESPON...,SET,190,-0.0078157,-0.00079095,0.067282,0.54624,HALLMARK_INFLAMMATORY_RESPONSE,0.994378170467444
GOCC_RADIAL_SPOKE,SET,12,-0.022769,-0.00058192,0.19578,0.54629,GOCC_RADIAL_SPOKE,0.994378170467444
RHEIN_ALL_GLUCOCORTICOID_THE...2,SET,67,-0.011911,-0.00071825,0.10236,0.54632,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,0.994378170467444
GSE28726_NAIVE_VS_ACTIVATED_...5,SET,177,-0.007731,-0.00075541,0.066401,0.54634,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...395,SET,27,-0.019074,-0.0007309,0.16375,0.54636,GOBP_NEGATIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.994378170467444
HP_PHOTOSENSITIVE_TONIC_CLON...,SET,12,-0.031257,-0.00079883,0.26816,0.54639,HP_PHOTOSENSITIVE_TONIC_CLONIC_SEIZURE,0.994378170467444
HP_ABNORMALITY_OF_THE_RADIAL...,SET,46,-0.014966,-0.00074819,0.12838,0.5464,HP_ABNORMALITY_OF_THE_RADIAL_HEAD,0.994378170467444
GSE9006_HEALTHY_VS_TYPE_1_DI...5,SET,178,-0.0079627,-0.00078023,0.067992,0.54661,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN,0.994378170467444
KEGG_STEROID_BIOSYNTHESIS,SET,15,-0.024813,-0.00070893,0.21182,0.54662,KEGG_STEROID_BIOSYNTHESIS,0.994378170467444
JIANG_CORE_DUPLICON_GENES,SET,4,-0.045488,-0.00067135,0.38808,0.54665,JIANG_CORE_DUPLICON_GENES,0.994378170467444
GOCC_PROTON_TRANSPORTING_TWO...2,SET,13,-0.028843,-0.00076723,0.246,0.54667,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN,0.994378170467444
GOMF_CAMP_RESPONSE_ELEMENT_B...1,SET,12,-0.030082,-0.00076881,0.25603,0.54676,GOMF_CAMP_RESPONSE_ELEMENT_BINDING,0.994378170467444
HP_MACROSCOPIC_HEMATURIA,SET,8,-0.039938,-0.0008335,0.33993,0.54676,HP_MACROSCOPIC_HEMATURIA,0.994378170467444
GOMF_AMINOACYLASE_ACTIVITY,SET,4,-0.051364,-0.00075806,0.43691,0.54679,GOMF_AMINOACYLASE_ACTIVITY,0.994378170467444
GOMF_N_ACETYLTRANSFERASE_ACT...,SET,61,-0.011914,-0.00068561,0.10136,0.54679,GOMF_N_ACETYLTRANSFERASE_ACTIVITY,0.994378170467444
MIR4278,SET,31,-0.018512,-0.00076002,0.15741,0.54681,MIR4278,0.994378170467444
GOBP_REGULATION_OF_G_PROTEIN...,SET,133,-0.0089215,-0.00075657,0.075854,0.54681,GOBP_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.994378170467444
BUSSLINGER_GASTRIC_PREZYMOGE...,SET,57,-0.014411,-0.00080171,0.12252,0.54681,BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...696,SET,13,-0.030052,-0.00079939,0.25538,0.54684,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION,0.994378170467444
GAVISH_3CA_MALIGNANT_METAPRO...33,SET,50,-0.015818,-0.00082437,0.13417,0.54693,GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED,0.994378170467444
REACTOME_KERATAN_SULFATE_DEG...,SET,15,-0.027212,-0.00077747,0.23052,0.54698,REACTOME_KERATAN_SULFATE_DEGRADATION,0.994378170467444
MIR758_5P,SET,31,-0.017536,-0.00071995,0.14856,0.54698,MIR758_5P,0.994378170467444
GOBP_PHARYNGEAL_ARCH_ARTERY_...,SET,9,-0.03822,-0.00084599,0.32342,0.54703,GOBP_PHARYNGEAL_ARCH_ARTERY_MORPHOGENESIS,0.994378170467444
GOBP_REGULATION_OF_BLOOD_PRE...,SET,170,-0.008316,-0.00079649,0.070322,0.54707,GOBP_REGULATION_OF_BLOOD_PRESSURE,0.994378170467444
LIANG_HEMATOPOIESIS_STEM_CEL...2,SET,39,-0.01609,-0.0007408,0.13602,0.54708,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,0.994378170467444
REACTOME_GLUTAMATE_NEUROTRAN...,SET,23,-0.023615,-0.00083529,0.19964,0.54708,REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,0.994378170467444
GSE22886_NAIVE_CD4_TCELL_VS_...15,SET,174,-0.0082918,-0.00080338,0.070011,0.54714,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN,0.994378170467444
GSE14308_TH2_VS_NAIVE_CD4_TC...2,SET,175,-0.0073189,-0.00071113,0.061695,0.54722,GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP,0.994378170467444
REACTOME_MICRORNA_MIRNA_BIOG...,SET,24,-0.019834,-0.00071661,0.16709,0.54724,REACTOME_MICRORNA_MIRNA_BIOGENESIS,0.994378170467444
HP_ABNORMAL_CIRCULATING_HORM...,SET,434,-0.0050037,-0.00076016,0.042124,0.54728,HP_ABNORMAL_CIRCULATING_HORMONE_CONCENTRATION,0.994378170467444
MIR1245B_5P,SET,53,-0.013756,-0.00073803,0.11562,0.54735,MIR1245B_5P,0.994378170467444
SEF1_C,SET,5,-0.04919,-0.00081165,0.41316,0.54738,SEF1_C,0.994378170467444
GOBP_NOTOCHORD_DEVELOPMENT,SET,16,-0.027017,-0.0007972,0.22682,0.54741,GOBP_NOTOCHORD_DEVELOPMENT,0.994378170467444
GOBP_REGULATION_OF_MEMBRANE_...5,SET,58,-0.013828,-0.00077598,0.11593,0.54747,GOBP_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION,0.994378170467444
GOMF_P_TYPE_POTASSIUM_TRANSM...,SET,8,-0.040923,-0.00085405,0.34313,0.54747,GOMF_P_TYPE_POTASSIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.994378170467444
SOBOLEV_PBMC_PANDEMRIX_AGE_1...6,SET,5,-0.051801,-0.00085473,0.43409,0.54749,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_0DY_DN,0.994378170467444
GOBP_CELL_FATE_SPECIFICATION...,SET,7,-0.038757,-0.00075663,0.32463,0.54752,GOBP_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION,0.994378170467444
GSE3982_BCELL_VS_TH2_DN,SET,173,-0.0077237,-0.0007462,0.064664,0.54754,GSE3982_BCELL_VS_TH2_DN,0.994378170467444
GOBP_SNRNA_3_END_PROCESSING,SET,18,-0.022184,-0.00069428,0.18558,0.54758,GOBP_SNRNA_3_END_PROCESSING,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...788,SET,7,-0.040736,-0.00079527,0.34063,0.5476,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.994378170467444
GOBP_REGULATION_OF_SMOOTH_MU...1,SET,6,-0.041263,-0.00074581,0.34504,0.5476,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.994378170467444
HP_ABNORMAL_CSF_GLUCOSE_CONC...,SET,6,-0.044874,-0.00081107,0.37522,0.5476,HP_ABNORMAL_CSF_GLUCOSE_CONCENTRATION,0.994378170467444
GOBP_EMBRYONIC_HEMOPOIESIS,SET,23,-0.021829,-0.00077214,0.18236,0.54764,GOBP_EMBRYONIC_HEMOPOIESIS,0.994378170467444
GOCC_PHAGOCYTIC_VESICLE,SET,126,-0.0092029,-0.00075976,0.076848,0.54766,GOCC_PHAGOCYTIC_VESICLE,0.994378170467444
GOBP_MOTOR_NEURON_APOPTOTIC_...,SET,21,-0.022153,-0.00074878,0.18491,0.54768,GOBP_MOTOR_NEURON_APOPTOTIC_PROCESS,0.994378170467444
GOBP_NEUTROPHIL_MEDIATED_CYT...,SET,15,-0.029838,-0.00085251,0.24901,0.54769,GOBP_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.994378170467444
GSE15930_NAIVE_VS_48H_IN_VIT...4,SET,183,-0.0075825,-0.00075323,0.063219,0.54773,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,0.994378170467444
GOBP_MEMBRANE_DOCKING,SET,83,-0.011225,-0.00075304,0.093467,0.5478,GOBP_MEMBRANE_DOCKING,0.994378170467444
GOBP_LEUKOTRIENE_METABOLIC_P...,SET,29,-0.020211,-0.00080263,0.16816,0.54783,GOBP_LEUKOTRIENE_METABOLIC_PROCESS,0.994378170467444
GOBP_INTRINSIC_APOPTOTIC_SIG...9,SET,54,-0.013386,-0.0007249,0.11132,0.54786,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...28,SET,9,-0.036287,-0.0008032,0.30169,0.54787,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.994378170467444
GSE22611_UNSTIM_VS_2H_MDP_ST...2,SET,177,-0.0074684,-0.00072975,0.061998,0.54794,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.994378170467444
QUEREC_PBMC_YF_17D_VACCINE_A...1,SET,42,-0.017011,-0.00081268,0.14088,0.54805,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP,0.994378170467444
QUEREC_PBMC_YF_17D_VACCINE_A...2,SET,42,-0.017011,-0.00081268,0.14088,0.54805,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP,0.994378170467444
TTTTGAG_MIR373,SET,212,-0.0070857,-0.00075699,0.058664,0.54807,TTTTGAG_MIR373,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...401,SET,257,-0.0069546,-0.00081704,0.057567,0.54808,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,0.994378170467444
PID_INTEGRIN5_PATHWAY,SET,16,-0.027877,-0.00082258,0.23071,0.54809,PID_INTEGRIN5_PATHWAY,0.994378170467444
MIR604,SET,13,-0.028105,-0.0007476,0.23243,0.54812,MIR604,0.994378170467444
PID_REG_GR_PATHWAY,SET,80,-0.011831,-0.00077924,0.097831,0.54813,PID_REG_GR_PATHWAY,0.994378170467444
GSE18791_UNSTIM_VS_NEWCATSLE...1,SET,171,-0.008169,-0.00078469,0.067432,0.54821,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN,0.994378170467444
HP_ABNORMAL_SEVENTH_CRANIAL_...,SET,167,-0.0078678,-0.00074695,0.064933,0.54822,HP_ABNORMAL_SEVENTH_CRANIAL_PHYSIOLOGY,0.994378170467444
REACTOME_RUNX1_REGULATES_TRA...3,SET,8,-0.033673,-0.00070274,0.27774,0.54825,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES,0.994378170467444
GSE2770_UNTREATED_VS_ACT_CD4...3,SET,164,-0.0081619,-0.00076794,0.067313,0.54825,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN,0.994378170467444
MODULE_114,SET,290,-0.0057898,-0.00072189,0.047711,0.54829,MODULE_114,0.994378170467444
GOBP_OOGENESIS,SET,100,-0.010469,-0.00077052,0.08628,0.54829,GOBP_OOGENESIS,0.994378170467444
KEGG_MEDICUS_PATHOGEN_HTLV_1...5,SET,9,-0.030493,-0.00067497,0.25125,0.5483,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497,0.994378170467444
HP_T_WAVE_INVERSION,SET,5,-0.044375,-0.0007322,0.36565,0.5483,HP_T_WAVE_INVERSION,0.994378170467444
ZHAN_LATE_DIFFERENTIATION_GE...2,SET,28,-0.020245,-0.00079001,0.16672,0.54832,ZHAN_LATE_DIFFERENTIATION_GENES_UP,0.994378170467444
HP_NEUROPATHIC_SPINAL_ARTHRO...,SET,20,-0.021929,-0.00072337,0.18061,0.54832,HP_NEUROPATHIC_SPINAL_ARTHROPATHY,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...106,SET,181,-0.0081903,-0.00080919,0.067436,0.54833,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION,0.994378170467444
MIR3684,SET,30,-0.01961,-0.00079204,0.1614,0.54835,MIR3684,0.994378170467444
MIR8063,SET,362,-0.0055781,-0.0007755,0.045917,0.54835,MIR8063,0.994378170467444
HP_ORTHOKERATOTIC_HYPERKERAT...,SET,7,-0.039336,-0.00076792,0.32367,0.54836,HP_ORTHOKERATOTIC_HYPERKERATOSIS,0.994378170467444
GOMF_PHOSPHATIDYLSERINE_BIND...,SET,65,-0.013929,-0.00082732,0.1146,0.54837,GOMF_PHOSPHATIDYLSERINE_BINDING,0.994378170467444
GSE12845_IGD_NEG_BLOOD_VS_NA...2,SET,173,-0.0076481,-0.0007389,0.062783,0.54848,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,0.994378170467444
GOMF_INOSITOL_TETRAKISPHOSPH...1,SET,5,-0.049734,-0.00082062,0.40787,0.54852,GOMF_INOSITOL_TETRAKISPHOSPHATE_KINASE_ACTIVITY,0.994378170467444
WP_NRF2ARE_REGULATION,SET,23,-0.022196,-0.0007851,0.18188,0.54856,WP_NRF2ARE_REGULATION,0.994378170467444
HP_HYPERNATREMIA,SET,8,-0.040487,-0.00084495,0.33181,0.54856,HP_HYPERNATREMIA,0.994378170467444
GSE19941_IL10_KO_VS_IL10_KO_...3,SET,179,-0.0076706,-0.00075369,0.062829,0.54858,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN,0.994378170467444
HP_PSORIASIFORM_DERMATITIS,SET,28,-0.022115,-0.00086297,0.18101,0.54862,HP_PSORIASIFORM_DERMATITIS,0.994378170467444
GOMF_HSP70_PROTEIN_BINDING,SET,48,-0.015283,-0.00078042,0.12498,0.54866,GOMF_HSP70_PROTEIN_BINDING,0.994378170467444
HP_ANOTIA,SET,12,-0.02902,-0.00074166,0.23729,0.54867,HP_ANOTIA,0.994378170467444
GOBP_VERY_LOW_DENSITY_LIPOPR...2,SET,3,-0.061779,-0.00078964,0.50483,0.5487,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.994378170467444
HP_UPGAZE_PALSY,SET,11,-0.033338,-0.00081577,0.2722,0.54874,HP_UPGAZE_PALSY,0.994378170467444
HEIDENBLAD_AMPLIFIED_IN_SOFT...,SET,13,-0.029343,-0.00078052,0.23948,0.54876,HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER,0.994378170467444
REACTOME_2_LTR_CIRCLE_FORMAT...,SET,7,-0.033348,-0.00065103,0.272,0.54879,REACTOME_2_LTR_CIRCLE_FORMATION,0.994378170467444
CDX1_TARGET_GENES,SET,35,-0.01792,-0.00078165,0.14614,0.54879,CDX1_TARGET_GENES,0.994378170467444
GOCC_TOM_COMPLEX,SET,5,-0.045102,-0.0007442,0.36785,0.54879,GOCC_TOM_COMPLEX,0.994378170467444
HP_HASHIMOTO_THYROIDITIS,SET,15,-0.026928,-0.00076937,0.21962,0.54879,HP_HASHIMOTO_THYROIDITIS,0.994378170467444
GAUTAM_EYE_IRIS_CILIARY_BODY...16,SET,229,-0.0066573,-0.00073884,0.054295,0.54879,GAUTAM_EYE_IRIS_CILIARY_BODY_SMOOTH_MUSCLE_CELLS,0.994378170467444
REACTOME_DEFECTS_IN_VITAMIN_...,SET,20,-0.023104,-0.00076212,0.18821,0.54885,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,0.994378170467444
REACTOME_REGULATION_OF_EXPRE...,SET,154,-0.0079946,-0.0007291,0.065111,0.54886,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,0.994378170467444
MATSUMIYA_PBMC_MODIFIED_VACC...3,SET,10,-0.036821,-0.0008591,0.29977,0.54888,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_LOW_VS_HIGH_RESPONDERS_2DY_GO_T_CELL_ACTIV_AND_CO_STIM_UP,0.994378170467444
HP_PHALANGEAL_DISLOCATION,SET,7,-0.044951,-0.00087755,0.36587,0.54889,HP_PHALANGEAL_DISLOCATION,0.994378170467444
GOBP_SYNAPSE_ORGANIZATION,SET,448,-0.0053358,-0.00082326,0.043423,0.5489,GOBP_SYNAPSE_ORGANIZATION,0.994378170467444
GOBP_REGULATION_OF_MICROTUBU...8,SET,85,-0.01097,-0.00074472,0.089236,0.54892,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.994378170467444
GSE17186_BLOOD_VS_CORD_BLOOD...1,SET,182,-0.0077343,-0.00076623,0.062807,0.549,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN,0.994378170467444
MIR7_2_3P,SET,591,-0.0046026,-0.00081238,0.037311,0.54909,MIR7_2_3P,0.994378170467444
GOBP_ADHESION_OF_SYMBIONT_TO...1,SET,12,-0.035643,-0.00091092,0.28878,0.54911,GOBP_ADHESION_OF_SYMBIONT_TO_HOST,0.994378170467444
GSE26030_TH1_VS_TH17_RESTIMU...2,SET,175,-0.0080538,-0.00078254,0.065195,0.54916,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP,0.994378170467444
HP_VITILIGO,SET,22,-0.024078,-0.00083297,0.1948,0.54918,HP_VITILIGO,0.994378170467444
GOCC_PERINUCLEAR_THECA,SET,4,-0.058901,-0.00086931,0.47563,0.54928,GOCC_PERINUCLEAR_THECA,0.994378170467444
GSE22611_UNSTIM_VS_2H_MDP_ST...1,SET,171,-0.0076014,-0.00073017,0.061363,0.54929,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.994378170467444
GOBP_PURINE_NUCLEOSIDE_METAB...,SET,24,-0.0243,-0.000878,0.19604,0.54932,GOBP_PURINE_NUCLEOSIDE_METABOLIC_PROCESS,0.994378170467444
GSE22025_PROGESTERONE_VS_TGF...1,SET,181,-0.0082396,-0.00081407,0.066472,0.54932,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.994378170467444
NAKAYA_PBMC_FLUAD_MALE_AGE_1...1,SET,36,-0.018203,-0.00080527,0.14688,0.54932,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP,0.994378170467444
DAVICIONI_MOLECULAR_ARMS_VS_...1,SET,166,-0.008827,-0.00083552,0.071184,0.54934,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,0.994378170467444
PID_P38_MK2_PATHWAY,SET,21,-0.025741,-0.00087007,0.20724,0.54942,PID_P38_MK2_PATHWAY,0.994378170467444
WP_MIR124_PREDICTED_INTERACT...,SET,6,-0.03952,-0.00071431,0.31793,0.54946,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,0.994378170467444
GOBP_REGULATION_OF_TRANSLATI...5,SET,12,-0.028665,-0.0007326,0.23043,0.5495,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_BY_EIF2_ALPHA_PHOSPHORYLATION,0.994378170467444
GSE37605_TREG_VS_TCONV_NOD_F...2,SET,133,-0.0096873,-0.00082151,0.077852,0.54951,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP,0.994378170467444
MIR4760_3P,SET,249,-0.0069968,-0.00080928,0.056217,0.54952,MIR4760_3P,0.994378170467444
HP_UNBALANCED_ATRIOVENTRICUL...,SET,5,-0.046547,-0.00076803,0.37383,0.54954,HP_UNBALANCED_ATRIOVENTRICULAR_CANAL_DEFECT,0.994378170467444
DESCARTES_FETAL_ADRENAL_STRO...,SET,122,-0.010505,-0.0008535,0.084386,0.54954,DESCARTES_FETAL_ADRENAL_STROMAL_CELLS,0.994378170467444
GOMF_ENZYME_INHIBITOR_ACTIVI...,SET,352,-0.0059966,-0.00082232,0.048134,0.54957,GOMF_ENZYME_INHIBITOR_ACTIVITY,0.994378170467444
GSE23925_LIGHT_ZONE_VS_DARK_...2,SET,179,-0.0080647,-0.00079241,0.064703,0.5496,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.994378170467444
HP_PROLONGED_QTC_INTERVAL,SET,28,-0.021379,-0.00083427,0.17143,0.54962,HP_PROLONGED_QTC_INTERVAL,0.994378170467444
CORRE_MULTIPLE_MYELOMA_DN,SET,52,-0.016208,-0.00086135,0.12989,0.54965,CORRE_MULTIPLE_MYELOMA_DN,0.994378170467444
ONO_FOXP3_TARGETS_DN,SET,40,-0.017245,-0.00080405,0.13816,0.54967,ONO_FOXP3_TARGETS_DN,0.994378170467444
GLASS_IGF2BP1_CLIP_TARGETS_K...,SET,105,-0.0099776,-0.00075238,0.079918,0.54968,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,0.994378170467444
SREBP1_02,SET,79,-0.011239,-0.00073566,0.090013,0.54968,SREBP1_02,0.994378170467444
GSE36476_CTRL_VS_TSST_ACT_16...2,SET,170,-0.0083216,-0.00079703,0.066653,0.54968,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP,0.994378170467444
HP_IMPULSIVITY,SET,128,-0.0095741,-0.00079661,0.076596,0.54974,HP_IMPULSIVITY,0.994378170467444
BANDRES_RESPONSE_TO_CARMUSTI...7,SET,28,-0.020978,-0.00081859,0.16774,0.54976,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,0.994378170467444
HP_FLEXION_CONTRACTURE_OF_TH...,SET,4,-0.063315,-0.00093444,0.50598,0.54979,HP_FLEXION_CONTRACTURE_OF_THE_2ND_FINGER,0.994378170467444
GOBP_ACID_SECRETION,SET,43,-0.016628,-0.00080375,0.13279,0.54982,GOBP_ACID_SECRETION,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...193,SET,450,-0.005196,-0.00080343,0.041501,0.54982,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...798,SET,61,-0.014313,-0.00082362,0.11423,0.54985,GOBP_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.994378170467444
GSE40685_NAIVE_CD4_TCELL_VS_...1,SET,171,-0.0084714,-0.00081374,0.067624,0.54985,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.994378170467444
MIR409_5P,SET,35,-0.016864,-0.00073561,0.13436,0.54994,MIR409_5P,0.994378170467444
GOBP_ORGANOPHOSPHATE_METABOL...,SET,900,-0.0036443,-0.00078684,0.029018,0.54997,GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS,0.994378170467444
REACTOME_CONSTITUTIVE_SIGNAL...5,SET,10,-0.029148,-0.00068008,0.23169,0.55006,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,0.994378170467444
ZFP37_TARGET_GENES,SET,4,-0.06553,-0.00096713,0.52024,0.55012,ZFP37_TARGET_GENES,0.994378170467444
GOBP_MAINTENANCE_OF_PROTEIN_...4,SET,62,-0.013474,-0.00078166,0.10697,0.55012,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL,0.994378170467444
GSE42724_NAIVE_BCELL_VS_PLAS...2,SET,181,-0.0081632,-0.00080651,0.064795,0.55013,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP,0.994378170467444
GOCC_INTERCELLULAR_BRIDGE,SET,83,-0.011239,-0.00075398,0.089181,0.55014,GOCC_INTERCELLULAR_BRIDGE,0.994378170467444
MCCABE_HOXC6_TARGETS_CANCER_...1,SET,19,-0.024454,-0.00078627,0.194,0.55015,MCCABE_HOXC6_TARGETS_CANCER_DN,0.994378170467444
REACTOME_TRANSCRIPTIONAL_REG...13,SET,28,-0.022505,-0.00087821,0.17855,0.55015,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,0.994378170467444
HP_HYPOTHALAMIC_GONADOTROPIN...,SET,20,-0.02715,-0.00089559,0.21519,0.5502,HP_HYPOTHALAMIC_GONADOTROPIN_RELEASING_HORMONE_DEFICIENCY,0.994378170467444
GOMF_TRNA_CYTIDINE_METHYLTRA...,SET,9,-0.03206,-0.00070966,0.25376,0.55027,GOMF_TRNA_CYTIDINE_METHYLTRANSFERASE_ACTIVITY,0.994378170467444
SIX4_TARGET_GENES,SET,33,-0.018606,-0.00078809,0.14719,0.55029,SIX4_TARGET_GENES,0.994378170467444
TERAMOTO_OPN_TARGETS_CLUSTER...5,SET,25,-0.021831,-0.00080501,0.17259,0.55033,TERAMOTO_OPN_TARGETS_CLUSTER_6,0.994378170467444
GSE23505_UNTREATED_VS_4DAY_I...6,SET,171,-0.0075808,-0.00072819,0.059877,0.55037,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP,0.994378170467444
HP_FAIR_HAIR,SET,17,-0.026758,-0.00081386,0.21134,0.55038,HP_FAIR_HAIR,0.994378170467444
HP_ROUND_EAR,SET,7,-0.046282,-0.00090353,0.36552,0.55038,HP_ROUND_EAR,0.994378170467444
GOBP_TAURINE_METABOLIC_PROCE...,SET,9,-0.040581,-0.00089826,0.32039,0.5504,GOBP_TAURINE_METABOLIC_PROCESS,0.994378170467444
GOBP_REGULATION_OF_GLUTAMINE...,SET,6,-0.047308,-0.00085507,0.37339,0.55041,GOBP_REGULATION_OF_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.994378170467444
WP_IL1_SIGNALING,SET,52,-0.015226,-0.00080916,0.12014,0.55043,WP_IL1_SIGNALING,0.994378170467444
GOBP_CELL_ADHESION,SET,1399,-0.0032304,-0.00085706,0.025451,0.5505,GOBP_CELL_ADHESION,0.994378170467444
GSE35685_CD34POS_CD10NEG_CD6...1,SET,190,-0.0080754,-0.00081723,0.063597,0.55052,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...532,SET,723,-0.0041415,-0.0008055,0.032598,0.55055,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.994378170467444
LIU_SOX4_TARGETS_UP,SET,126,-0.010035,-0.00082846,0.078917,0.55059,LIU_SOX4_TARGETS_UP,0.994378170467444
REACTOME_HIV_LIFE_CYCLE,SET,138,-0.0084208,-0.0007273,0.066157,0.55064,REACTOME_HIV_LIFE_CYCLE,0.994378170467444
GOBP_REGULATION_OF_NEUROTRAN...5,SET,17,-0.025875,-0.00078697,0.20323,0.55065,GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,0.994378170467444
GOBP_GANGLION_DEVELOPMENT,SET,16,-0.030318,-0.00089461,0.23804,0.55067,GOBP_GANGLION_DEVELOPMENT,0.994378170467444
HP_HELICOBACTER_PYLORI_INFEC...,SET,4,-0.054977,-0.00081139,0.43159,0.55068,HP_HELICOBACTER_PYLORI_INFECTION,0.994378170467444
HP_ACUTE_PHASE_RESPONSE,SET,168,-0.0088157,-0.00083942,0.069163,0.55071,HP_ACUTE_PHASE_RESPONSE,0.994378170467444
GSE17721_POLYIC_VS_GARDIQUIM...2,SET,183,-0.008172,-0.00081178,0.064121,0.55071,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.994378170467444
HP_HYPERSEGMENTATION_OF_NEUT...,SET,6,-0.048781,-0.0008817,0.38259,0.55073,HP_HYPERSEGMENTATION_OF_NEUTROPHIL_NUCLEI,0.994378170467444
BERENJENO_ROCK_SIGNALING_NOT...2,SET,28,-0.020337,-0.00079361,0.15937,0.55077,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,0.994378170467444
GOCC_MYELIN_SHEATH_ABAXONAL_...,SET,6,-0.04303,-0.00077774,0.33705,0.55079,GOCC_MYELIN_SHEATH_ABAXONAL_REGION,0.994378170467444
GOBP_REGULATION_OF_MYOBLAST_...2,SET,19,-0.026446,-0.00085032,0.20704,0.55082,GOBP_REGULATION_OF_MYOBLAST_FUSION,0.994378170467444
HP_ABNORMAL_EXPERIENCE_OF_RE...,SET,532,-0.0048575,-0.0008148,0.038021,0.55083,HP_ABNORMAL_EXPERIENCE_OF_REALITY,0.994378170467444
GOBP_PROTEIN_LOCALIZATION_TO...45,SET,5,-0.052292,-0.00086283,0.40864,0.55091,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE_RAFT,0.994378170467444
BOCHKIS_FOXA2_TARGETS,SET,391,-0.0055699,-0.00080413,0.043497,0.55095,BOCHKIS_FOXA2_TARGETS,0.994378170467444
HP_SPRENGEL_ANOMALY,SET,43,-0.016004,-0.00077361,0.12484,0.551,HP_SPRENGEL_ANOMALY,0.994378170467444
HP_ABNORMAL_SCAPULA_MORPHOLO...,SET,159,-0.0085827,-0.00079524,0.06687,0.55106,HP_ABNORMAL_SCAPULA_MORPHOLOGY,0.994378170467444
REACTOME_ADRENOCEPTORS,SET,9,-0.042582,-0.00094255,0.33164,0.55108,REACTOME_ADRENOCEPTORS,0.994378170467444
MIR6875_3P,SET,361,-0.0059045,-0.00081976,0.045956,0.55111,MIR6875_3P,0.994378170467444
GSE30083_SP2_VS_SP4_THYMOCYT...2,SET,182,-0.0085059,-0.00084267,0.066213,0.55111,GSE30083_SP2_VS_SP4_THYMOCYTE_UP,0.994378170467444
GOBP_SMALL_MOLECULE_CATABOLI...,SET,349,-0.0059458,-0.00081193,0.046151,0.55125,GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS,0.994378170467444
AR_Q6,SET,234,-0.007293,-0.00081807,0.056603,0.55126,AR_Q6,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...631,SET,18,-0.026327,-0.00082394,0.20428,0.55127,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE,0.994378170467444
WP_LIVER_X_RECEPTOR_PATHWAY,SET,10,-0.035523,-0.00082882,0.27561,0.55128,WP_LIVER_X_RECEPTOR_PATHWAY,0.994378170467444
MENON_FETAL_KIDNEY_3_STROMAL...,SET,68,-0.014389,-0.00087408,0.1116,0.55129,MENON_FETAL_KIDNEY_3_STROMAL_CELLS,0.994378170467444
HP_SMALL_BASAL_GANGLIA,SET,13,-0.030161,-0.00080229,0.23385,0.55131,HP_SMALL_BASAL_GANGLIA,0.994378170467444
MIR3927_3P,SET,94,-0.011354,-0.0008103,0.087937,0.55136,MIR3927_3P,0.994378170467444
GOCC_GOLGI_CIS_CISTERNA,SET,15,-0.026219,-0.00074911,0.20304,0.55137,GOCC_GOLGI_CIS_CISTERNA,0.994378170467444
HP_ABNORMAL_CALCIFICATION_OF...,SET,5,-0.05704,-0.00094118,0.4416,0.55139,HP_ABNORMAL_CALCIFICATION_OF_THE_CARPAL_BONES,0.994378170467444
KEGG_MEDICUS_VARIANT_MUTATIO...10,SET,8,-0.039751,-0.00082959,0.3076,0.55141,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY,0.994378170467444
GSE11367_CTRL_VS_IL17_TREATE...1,SET,101,-0.011785,-0.00087167,0.091132,0.55145,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN,0.994378170467444
GOMF_TRNA_SPECIFIC_ADENOSINE...,SET,8,-0.039648,-0.00082744,0.30636,0.55148,GOMF_TRNA_SPECIFIC_ADENOSINE_DEAMINASE_ACTIVITY,0.994378170467444
GOBP_CYTOPLASMIC_TRANSLATION,SET,142,-0.00867,-0.00075952,0.066959,0.55151,GOBP_CYTOPLASMIC_TRANSLATION,0.994378170467444
GOBP_MONOCARBOXYLIC_ACID_TRA...,SET,172,-0.0089241,-0.0008597,0.068884,0.55154,GOBP_MONOCARBOXYLIC_ACID_TRANSPORT,0.994378170467444
MITSIADES_RESPONSE_TO_APLIDI...1,SET,229,-0.0071508,-0.00079361,0.055159,0.55157,MITSIADES_RESPONSE_TO_APLIDIN_DN,0.994378170467444
GSE27786_BCELL_VS_CD8_TCELL_...1,SET,180,-0.0081532,-0.00080332,0.062885,0.55158,GSE27786_BCELL_VS_CD8_TCELL_DN,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...384,SET,18,-0.024834,-0.0007772,0.19142,0.55161,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.994378170467444
GSE17580_UNINFECTED_VS_S_MAN...1,SET,175,-0.0082973,-0.00080619,0.063864,0.55168,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN,0.994378170467444
HP_TRIANGULAR_MOUTH,SET,19,-0.023003,-0.0007396,0.17697,0.55171,HP_TRIANGULAR_MOUTH,0.994378170467444
HP_ARTERIAL_DISSECTION,SET,12,-0.03753,-0.00095916,0.28845,0.55176,HP_ARTERIAL_DISSECTION,0.994378170467444
GSE13522_CTRL_VS_T_CRUZI_Y_S...8,SET,146,-0.0091342,-0.00081129,0.070142,0.5518,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP,0.994378170467444
GOMF_TRANSMEMBRANE_RECEPTOR_...6,SET,62,-0.015637,-0.00090717,0.12,0.55184,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.994378170467444
GOBP_CELL_MIGRATION_INVOLVED...5,SET,51,-0.016348,-0.00086041,0.12538,0.55187,GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.994378170467444
ADDYA_ERYTHROID_DIFFERENTIAT...,SET,68,-0.015019,-0.00091231,0.11517,0.55188,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,0.994378170467444
MODULE_575,SET,12,-0.037185,-0.00095035,0.28515,0.55188,MODULE_575,0.994378170467444
GAURNIER_PSMD4_TARGETS,SET,63,-0.015508,-0.00090688,0.1189,0.55189,GAURNIER_PSMD4_TARGETS,0.994378170467444
BIOCARTA_EGF_PATHWAY,SET,26,-0.022298,-0.00083851,0.17095,0.55189,BIOCARTA_EGF_PATHWAY,0.994378170467444
PID_ECADHERIN_STABILIZATION_...,SET,39,-0.017508,-0.00080607,0.13407,0.55195,PID_ECADHERIN_STABILIZATION_PATHWAY,0.994378170467444
SMAD_Q6,SET,232,-0.0076626,-0.0008559,0.058614,0.55201,SMAD_Q6,0.994378170467444
JECHLINGER_EPITHELIAL_TO_MES...1,SET,59,-0.014924,-0.00084466,0.11401,0.55207,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.994378170467444
REACTOME_PEPTIDE_HORMONE_MET...,SET,81,-0.013203,-0.00087504,0.10082,0.55209,REACTOME_PEPTIDE_HORMONE_METABOLISM,0.994378170467444
HP_HEMERALOPIA,SET,8,-0.041702,-0.0008703,0.31844,0.55209,HP_HEMERALOPIA,0.994378170467444
GSE23505_UNTREATED_VS_4DAY_I...4,SET,182,-0.0080596,-0.00079845,0.061524,0.55211,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.994378170467444
REACTOME_ERK_MAPK_TARGETS,SET,20,-0.025525,-0.00084199,0.19481,0.55212,REACTOME_ERK_MAPK_TARGETS,0.994378170467444
NAB2_TARGET_GENES,SET,1207,-0.0033322,-0.00082582,0.025433,0.55212,NAB2_TARGET_GENES,0.994378170467444
MIR520F_5P,SET,182,-0.0085592,-0.00084795,0.065308,0.55213,MIR520F_5P,0.994378170467444
GSE16385_ROSIGLITAZONE_IFNG_...1,SET,174,-0.0084211,-0.00081591,0.064262,0.55213,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,0.994378170467444
HP_HYPOURICEMIA,SET,16,-0.029454,-0.00086912,0.22473,0.55214,HP_HYPOURICEMIA,0.994378170467444
HOEK_NK_CELL_2011_2012_TIV_A...1,SET,7,-0.038994,-0.00076125,0.29733,0.55217,HOEK_NK_CELL_2011_2012_TIV_ADULT_1DY_UP,0.994378170467444
GOMF_CATECHOLAMINE_BINDING,SET,12,-0.036801,-0.00094054,0.28031,0.55223,GOMF_CATECHOLAMINE_BINDING,0.994378170467444
GOCC_TRAPPII_PROTEIN_COMPLEX,SET,9,-0.033339,-0.00073795,0.25388,0.55224,GOCC_TRAPPII_PROTEIN_COMPLEX,0.994378170467444
KEGG_MEDICUS_REFERENCE_PURIN...2,SET,10,-0.034197,-0.00079788,0.26032,0.55226,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP,0.994378170467444
REACTOME_DEFECTS_OF_CONTACT_...,SET,14,-0.032816,-0.00090583,0.24978,0.55226,REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,0.994378170467444
GAVISH_3CA_MALIGNANT_METAPRO...3,SET,42,-0.019291,-0.00092159,0.14656,0.55236,GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1,0.994378170467444
WIERENGA_STAT5A_TARGETS_GROU...2,SET,50,-0.017614,-0.00091795,0.13375,0.55239,WIERENGA_STAT5A_TARGETS_GROUP2,0.994378170467444
ALONSO_METASTASIS_EMT_DN,SET,5,-0.062257,-0.0010273,0.47235,0.55243,ALONSO_METASTASIS_EMT_DN,0.994378170467444
GOBP_INTERMEDIATE_FILAMENT_B...2,SET,7,-0.048062,-0.00093827,0.3646,0.55244,GOBP_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY,0.994378170467444
REACTOME_ABC_TRANSPORTERS_IN...,SET,17,-0.029317,-0.00089167,0.22225,0.55247,REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,0.994378170467444
DANG_MYC_TARGETS_UP,SET,118,-0.010153,-0.00081134,0.076954,0.55248,DANG_MYC_TARGETS_UP,0.994378170467444
GSE6674_CPG_VS_PL2_3_STIM_BC...2,SET,171,-0.0080254,-0.0007709,0.060819,0.55249,GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP,0.994378170467444
GSE17721_CPG_VS_GARDIQUIMOD_...4,SET,184,-0.0086087,-0.00085748,0.065207,0.55252,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP,0.994378170467444
GOBP_REGULATION_OF_CELL_CYCL...1,SET,41,-0.016031,-0.00075673,0.12127,0.55258,GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.994378170467444
HP_ABNORMAL_1ST_METACARPAL_M...,SET,31,-0.020899,-0.00085805,0.15803,0.55261,HP_ABNORMAL_1ST_METACARPAL_MORPHOLOGY,0.994378170467444
GSE2770_UNTREATED_VS_IL4_TRE...5,SET,185,-0.0079863,-0.00079762,0.060381,0.55261,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.994378170467444
CAIRO_HEPATOBLASTOMA_POOR_SU...,SET,12,-0.029846,-0.00076278,0.22529,0.5527,CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,0.994378170467444
GOMF_SULFUR_COMPOUND_TRANSME...,SET,59,-0.014798,-0.00083749,0.11166,0.55272,GOMF_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.994378170467444
GOBP_COPI_COATED_VESICLE_BUD...,SET,6,-0.040357,-0.00072943,0.30425,0.55276,GOBP_COPI_COATED_VESICLE_BUDDING,0.994378170467444
HP_SUBCAPSULAR_CATARACT,SET,104,-0.011022,-0.00082721,0.083001,0.55282,HP_SUBCAPSULAR_CATARACT,0.994378170467444
REACTOME_CITRIC_ACID_CYCLE_T...,SET,32,-0.01899,-0.0007921,0.1428,0.55289,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,0.994378170467444
WP_TGFB_SMAD_SIGNALING,SET,11,-0.039959,-0.0009778,0.30046,0.5529,WP_TGFB_SMAD_SIGNALING,0.994378170467444
GOBP_REGULATION_OF_HORMONE_S...,SET,243,-0.0077939,-0.0008907,0.058599,0.5529,GOBP_REGULATION_OF_HORMONE_SECRETION,0.994378170467444
WP_IL11_SIGNALING,SET,41,-0.018171,-0.00085773,0.13651,0.55295,WP_IL11_SIGNALING,0.994378170467444
HP_RENAL_HYPOPLASIA,SET,116,-0.010671,-0.00084553,0.080169,0.55295,HP_RENAL_HYPOPLASIA,0.994378170467444
KEGG_MEDICUS_VARIANT_MUTATIO...43,SET,11,-0.030845,-0.00075477,0.23168,0.55296,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III,0.994378170467444
GOBP_JNK_CASCADE,SET,159,-0.0091205,-0.00084507,0.06849,0.55297,GOBP_JNK_CASCADE,0.994378170467444
PID_IL5_PATHWAY,SET,14,-0.032017,-0.00088377,0.24036,0.55298,PID_IL5_PATHWAY,0.994378170467444
GSE40277_EOS_AND_LEF1_TRANSD...1,SET,188,-0.0082844,-0.00083401,0.062165,0.55301,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.994378170467444
GOBP_DENDRITE_ARBORIZATION,SET,11,-0.034302,-0.00083935,0.25717,0.55305,GOBP_DENDRITE_ARBORIZATION,0.994378170467444
MIR3192_3P,SET,75,-0.012947,-0.00082577,0.097053,0.55306,MIR3192_3P,0.994378170467444
MARKEY_RB1_CHRONIC_LOF_DN,SET,107,-0.01158,-0.00088141,0.086774,0.55308,MARKEY_RB1_CHRONIC_LOF_DN,0.994378170467444
GOCC_INTERMEDIATE_FILAMENT_C...,SET,208,-0.0095265,-0.0010082,0.071368,0.55309,GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON,0.994378170467444
GSE37605_TREG_VS_TCONV_C57BL...2,SET,122,-0.010942,-0.00088899,0.081788,0.55321,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP,0.994378170467444
WP_VITAMIN_D_METABOLISM,SET,10,-0.035766,-0.00083449,0.26703,0.55328,WP_VITAMIN_D_METABOLISM,0.994378170467444
GOBP_REGULATION_OF_EXOCYTOSIS,SET,155,-0.0094132,-0.00086124,0.070203,0.55333,GOBP_REGULATION_OF_EXOCYTOSIS,0.994378170467444
AP1FJ_Q2,SET,248,-0.0075352,-0.00086982,0.056178,0.55335,AP1FJ_Q2,0.994378170467444
HP_POLYPHAGIA,SET,67,-0.015327,-0.00092421,0.11423,0.55337,HP_POLYPHAGIA,0.994378170467444
GSE3720_UNSTIM_VS_LPS_STIM_V...2,SET,176,-0.0085941,-0.0008374,0.064019,0.55339,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...574,SET,7,-0.037636,-0.00073475,0.28032,0.5534,GOBP_NEGATIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.994378170467444
GOBP_REGULATION_OF_MAST_CELL...4,SET,25,-0.024445,-0.00090143,0.18195,0.55344,GOBP_REGULATION_OF_MAST_CELL_DEGRANULATION,0.994378170467444
GSE6259_33D1_POS_DC_VS_CD8_T...1,SET,112,-0.010883,-0.00084741,0.080998,0.55344,GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN,0.994378170467444
HP_ABNORMAL_URINE_CARBOXYLIC...,SET,117,-0.010865,-0.00086455,0.080845,0.55345,HP_ABNORMAL_URINE_CARBOXYLIC_ACID_LEVEL,0.994378170467444
GOBP_KILLING_BY_HOST_OF_SYMB...,SET,23,-0.027253,-0.00096398,0.20273,0.55347,GOBP_KILLING_BY_HOST_OF_SYMBIONT_CELLS,0.994378170467444
MIR6836_5P,SET,115,-0.010698,-0.00084399,0.079497,0.55352,MIR6836_5P,0.994378170467444
GSE24574_BCL6_HIGH_TFH_VS_TC...2,SET,175,-0.0089523,-0.00086983,0.066524,0.55352,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP,0.994378170467444
GSE43863_TH1_VS_LY6C_INT_CXC...3,SET,177,-0.0087337,-0.00085339,0.064892,0.55353,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.994378170467444
GOBP_SPINDLE_ASSEMBLY_INVOLV...,SET,8,-0.04181,-0.00087255,0.31062,0.55354,GOBP_SPINDLE_ASSEMBLY_INVOLVED_IN_FEMALE_MEIOSIS,0.994378170467444
HP_DIASTASIS_RECTI,SET,21,-0.025154,-0.00085023,0.18679,0.55356,HP_DIASTASIS_RECTI,0.994378170467444
GOBP_REGULATION_OF_HETEROTYP...,SET,24,-0.024982,-0.00090265,0.18545,0.55358,GOBP_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.994378170467444
GOBP_HIPPOCAMPUS_DEVELOPMENT,SET,90,-0.012622,-0.00088157,0.09366,0.5536,GOBP_HIPPOCAMPUS_DEVELOPMENT,0.994378170467444
REACTOME_ATORVASTATIN_ADME,SET,9,-0.040362,-0.0008934,0.29946,0.55361,REACTOME_ATORVASTATIN_ADME,0.994378170467444
GOBP_REGULATION_OF_RAB_PROTE...,SET,7,-0.040809,-0.00079669,0.30269,0.55362,GOBP_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.994378170467444
HP_SCHIZOPHRENIA,SET,61,-0.016741,-0.00096335,0.12409,0.55366,HP_SCHIZOPHRENIA,0.994378170467444
MONTERO_THYROID_CANCER_POOR_...1,SET,9,-0.033139,-0.00073354,0.24559,0.55367,MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,0.994378170467444
GOCC_CONDENSED_NUCLEAR_CHROM...,SET,70,-0.012662,-0.00078033,0.093816,0.55368,GOCC_CONDENSED_NUCLEAR_CHROMOSOME,0.994378170467444
chr4q24,SET,24,-0.044919,-0.001623,0.33273,0.55369,chr4q24,0.994378170467444
DESCARTES_FETAL_KIDNEY_MYELO...,SET,151,-0.0099412,-0.00089784,0.073624,0.5537,DESCARTES_FETAL_KIDNEY_MYELOID_CELLS,0.994378170467444
KEGG_MEDICUS_REFERENCE_AUTOP...3,SET,5,-0.06198,-0.0010227,0.45852,0.55376,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TRANS_SNARE,0.994378170467444
GOMF_CALCIUM_CHANNEL_REGULAT...,SET,47,-0.017972,-0.00090815,0.13296,0.55376,GOMF_CALCIUM_CHANNEL_REGULATOR_ACTIVITY,0.994378170467444
REACTOME_REGULATION_OF_HSF1_...,SET,77,-0.01275,-0.00082394,0.09428,0.55379,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,0.994378170467444
GOBP_NEGATIVE_REGULATION_OF_...637,SET,4,-0.062558,-0.00092328,0.46236,0.55381,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.994378170467444
MIR4730,SET,6,-0.054336,-0.00098209,0.40132,0.55385,MIR4730,0.994378170467444
MIR4725_5P,SET,52,-0.015854,-0.00084256,0.11708,0.55386,MIR4725_5P,0.994378170467444
BIOCARTA_DSP_PATHWAY,SET,8,-0.04783,-0.0009982,0.35311,0.55387,BIOCARTA_DSP_PATHWAY,0.994378170467444
ATF2_S_UP.V1_UP,SET,174,-0.0094528,-0.00091587,0.069792,0.55387,ATF2_S_UP.V1_UP,0.994378170467444
GOBP_LUNG_EPITHELIUM_DEVELOP...,SET,45,-0.018497,-0.00091459,0.13652,0.55388,GOBP_LUNG_EPITHELIUM_DEVELOPMENT,0.994378170467444
HOELZEL_NF1_TARGETS_DN,SET,99,-0.013136,-0.000962,0.096919,0.55391,HOELZEL_NF1_TARGETS_DN,0.994378170467444
WP_OVERLAP_BETWEEN_SIGNAL_TR...,SET,51,-0.016254,-0.00085546,0.11984,0.55394,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,0.994378170467444
KEGG_SMALL_CELL_LUNG_CANCER,SET,80,-0.012673,-0.00083474,0.093387,0.55397,KEGG_SMALL_CELL_LUNG_CANCER,0.994378170467444
MODULE_3,SET,361,-0.0061172,-0.0008493,0.045067,0.55398,MODULE_3,0.994378170467444
GSE25677_R848_VS_MPL_AND_R84...2,SET,134,-0.0099262,-0.00084491,0.073111,0.554,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP,0.994378170467444
GOBP_CARDIAC_MUSCLE_CELL_DIF...,SET,112,-0.011352,-0.00088396,0.083503,0.55407,GOBP_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.994378170467444
LEE_BMP2_TARGETS_DN,SET,824,-0.0039949,-0.00082711,0.029376,0.55409,LEE_BMP2_TARGETS_DN,0.994378170467444
UNTERMAN_PROGRESSIVE_VS_STAB...4,SET,26,-0.027413,-0.0010309,0.20141,0.55413,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_MONOCYTE_DN,0.994378170467444
HP_MULTIPLE_MITOCHONDRIAL_DN...,SET,9,-0.032336,-0.00071574,0.2376,0.55413,HP_MULTIPLE_MITOCHONDRIAL_DNA_DELETIONS,0.994378170467444
PEDERSEN_METASTASIS_BY_ERBB2...2,SET,17,-0.031636,-0.00096222,0.23234,0.55415,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,0.994378170467444
GSE11961_MARGINAL_ZONE_BCELL...10,SET,185,-0.0084083,-0.00083977,0.061729,0.55417,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP,0.994378170467444
HE_LIM_SUN_FETAL_LUNG_C1_GHR...1,SET,140,-0.010634,-0.000925,0.078064,0.55417,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL,0.994378170467444
chr7p22,SET,67,-0.029941,-0.0018054,0.2198,0.55418,chr7p22,0.994378170467444
HOSHIDA_LIVER_CANCER_SUBCLAS...1,SET,216,-0.0078829,-0.00084998,0.057823,0.55422,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,0.994378170467444
TRAVAGLINI_LUNG_BASAL_CELL,SET,174,-0.0092458,-0.00089581,0.067814,0.55422,TRAVAGLINI_LUNG_BASAL_CELL,0.994378170467444
MENON_FETAL_KIDNEY_7_LOOPOF_...,SET,210,-0.0078657,-0.0008364,0.057689,0.55423,MENON_FETAL_KIDNEY_7_LOOPOF_HENLE_CELLS_DISTAL,0.994378170467444
GOBP_ORGANIC_CATION_TRANSPORT,SET,108,-0.012116,-0.0009265,0.088829,0.55424,GOBP_ORGANIC_CATION_TRANSPORT,0.994378170467444
WP_GNAQ_PATHWAYS_IN_PORTWINE...,SET,20,-0.027356,-0.0009024,0.20044,0.55428,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,0.994378170467444
MODULE_340,SET,24,-0.023487,-0.00084861,0.17191,0.55433,MODULE_340,0.994378170467444
HE_LIM_SUN_FETAL_LUNG_C1_EAR...1,SET,32,-0.024232,-0.0010108,0.17734,0.55434,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL,0.994378170467444
CAIRO_PML_TARGETS_BOUND_BY_M...1,SET,12,-0.035478,-0.00090671,0.25943,0.55439,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,0.994378170467444
KUNINGER_IGF1_VS_PDGFB_TARGE...2,SET,75,-0.013534,-0.00086323,0.098894,0.55443,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,0.994378170467444
GOBP_NUCLEOTIDE_SUGAR_BIOSYN...,SET,16,-0.028518,-0.0008415,0.20836,0.55443,GOBP_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS,0.994378170467444
GOBP_POSITIVE_REGULATION_OF_...354,SET,137,-0.010841,-0.00093297,0.079186,0.55445,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,0.994378170467444
GOBP_REGULATION_OF_POSTSYNAP...6,SET,83,-0.01306,-0.00087613,0.095334,0.55448,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_NEUROTRANSMITTER_RECEPTOR_LEVELS,0.994378170467444
WP_PROSTAGLANDIN_SIGNALING,SET,32,-0.022506,-0.00093878,0.16423,0.5545,WP_PROSTAGLANDIN_SIGNALING,0.994378170467444
GOBP_REGULATION_OF_PANCREATI...,SET,7,-0.039782,-0.00077664,0.29021,0.55452,GOBP_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.994378170467444
chr6q15,SET,23,-0.045618,-0.0016136,0.33264,0.55454,chr6q15,0.994378170467444
REACTOME_FBXW7_MUTANTS_AND_N...,SET,5,-0.047656,-0.00078633,0.34713,0.5546,REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER,0.994434452871073
GOBP_REGULATION_OF_OSTEOCLAS...3,SET,6,-0.045253,-0.00081793,0.32891,0.55471,GOBP_REGULATION_OF_OSTEOCLAST_PROLIFERATION,0.994456830136139
GSE40184_HEALTHY_VS_HCV_INFE...2,SET,178,-0.0086909,-0.00085158,0.063171,0.55471,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP,0.994456830136139
HP_RENAL_HYPOPLASIA_APLASIA,SET,298,-0.0067731,-0.00085586,0.049223,0.55472,HP_RENAL_HYPOPLASIA_APLASIA,0.994456830136139
WAKABAYASHI_ADIPOGENESIS_PPA...4,SET,780,-0.0043443,-0.0008762,0.03155,0.55476,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,0.994456830136139
GOBP_POSITIVE_REGULATION_OF_...615,SET,32,-0.020655,-0.00086154,0.14997,0.55477,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.994456830136139
HARALAMBIEVA_PBMC_TIV_AGE_50...1,SET,19,-0.027736,-0.00089178,0.20132,0.55479,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_28DY_NEGATIVE,0.994456830136139
WP_PDGFRBETA_PATHWAY,SET,28,-0.023145,-0.00090318,0.16789,0.55482,WP_PDGFRBETA_PATHWAY,0.994456830136139
GSE1448_CTRL_VS_ANTI_VALPHA2...1,SET,181,-0.0087191,-0.00086144,0.063212,0.55485,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN,0.994456830136139
DESCARTES_FETAL_LUNG_BRONCHI...,SET,48,-0.01917,-0.00097889,0.13894,0.55487,DESCARTES_FETAL_LUNG_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.994456830136139
WP_BIOSYNTHESIS_AND_TURNOVER...,SET,8,-0.040879,-0.00085314,0.29607,0.55491,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,0.994463756313782
GOBP_POSITIVE_REGULATION_OF_...75,SET,13,-0.03342,-0.00088896,0.24181,0.55496,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.994463756313782
GOBP_EXTRACELLULAR_MATRIX_CO...,SET,13,-0.038233,-0.001017,0.27645,0.555,GOBP_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.994463756313782
GOCC_CHROMOSOME_PASSENGER_CO...,SET,6,-0.049124,-0.00088789,0.35497,0.55503,GOCC_CHROMOSOME_PASSENGER_COMPLEX,0.994463756313782
GOMF_PRIMARY_ACTIVE_TRANSMEM...,SET,143,-0.009527,-0.00083751,0.068804,0.55506,GOMF_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.994463756313782
TUBG1_TARGET_GENES,SET,2,-0.059167,-0.0006175,0.42709,0.55509,TUBG1_TARGET_GENES,0.994463756313782
PID_EPHB_FWD_PATHWAY,SET,39,-0.018263,-0.00084083,0.13174,0.55513,PID_EPHB_FWD_PATHWAY,0.994463756313782
GOMF_FATZ_BINDING,SET,5,-0.052956,-0.00087378,0.382,0.55513,GOMF_FATZ_BINDING,0.994463756313782
GOBP_NEGATIVE_REGULATION_OF_...453,SET,6,-0.054249,-0.00098053,0.39122,0.55514,GOBP_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION,0.994463756313782
MCM3_TARGET_GENES,SET,184,-0.0088086,-0.00087739,0.0635,0.55516,MCM3_TARGET_GENES,0.994463756313782
MIR1193,SET,32,-0.021084,-0.00087944,0.1519,0.55519,MIR1193,0.994466239756739
ZNF362_TARGET_GENES,SET,488,-0.005338,-0.00085862,0.03843,0.55524,ZNF362_TARGET_GENES,0.994504545454545
GOMF_LIPID_TRANSPORTER_ACTIV...,SET,156,-0.010004,-0.00091824,0.071883,0.55534,GOMF_LIPID_TRANSPORTER_ACTIVITY,0.994547804915752
GOBP_POSITIVE_REGULATION_OF_...189,SET,15,-0.02979,-0.00085113,0.21403,0.55535,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,0.994547804915752
GOBP_REGULATION_OF_CGMP_MEDI...,SET,10,-0.04013,-0.00093629,0.28828,0.55535,GOBP_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.994547804915752
MODULE_55,SET,758,-0.0046393,-0.00092299,0.033306,0.55539,MODULE_55,0.994568190952185
HP_ABNORMAL_CIRCULATING_AMYL...,SET,6,-0.045909,-0.00082979,0.32931,0.55544,HP_ABNORMAL_CIRCULATING_AMYLASE_CONCENTRATION,0.994606481529188
GOBP_REGULATION_OF_ESTABLISH...5,SET,5,-0.056365,-0.00093003,0.40396,0.55548,GOBP_REGULATION_OF_ESTABLISHMENT_OF_T_CELL_POLARITY,0.99462686244204
HP_SQUAMOUS_CELL_CARCINOMA,SET,62,-0.014381,-0.00083431,0.10297,0.55553,HP_SQUAMOUS_CELL_CARCINOMA,0.994652186679029
GSE27786_BCELL_VS_NKCELL_UP,SET,180,-0.0085509,-0.00084251,0.061186,0.55557,GSE27786_BCELL_VS_NKCELL_UP,0.994652186679029
AKT_UP.V1_UP,SET,149,-0.0099404,-0.00089185,0.071118,0.55558,AKT_UP.V1_UP,0.994652186679029
GOBP_ADENOSINE_TO_INOSINE_ED...,SET,6,-0.054221,-0.00098003,0.38745,0.55565,GOBP_ADENOSINE_TO_INOSINE_EDITING,0.994669078610229
WP_KIT_RECEPTOR_SIGNALING,SET,56,-0.017378,-0.0009583,0.12408,0.55569,WP_KIT_RECEPTOR_SIGNALING,0.994669078610229
HP_NAIL_DYSTROPHY,SET,125,-0.011044,-0.00090815,0.078737,0.55577,HP_NAIL_DYSTROPHY,0.994669078610229
MODULE_262,SET,19,-0.03363,-0.0010813,0.23943,0.55585,MODULE_262,0.994669078610229
GOBP_REGULATION_OF_VENTRICUL...2,SET,7,-0.056044,-0.0010941,0.39902,0.55585,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.994669078610229
GSE41978_KLRG1_HIGH_VS_LOW_E...1,SET,179,-0.0087285,-0.00085764,0.062133,0.55586,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN,0.994669078610229
GOBP_LIPID_GLYCOSYLATION,SET,11,-0.036289,-0.00088798,0.25769,0.556,GOBP_LIPID_GLYCOSYLATION,0.994669078610229
GOBP_NUCLEAR_TRANSCRIBED_MRN...4,SET,35,-0.01956,-0.00085322,0.13879,0.55604,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.994669078610229
KCCGNSWTTT_UNKNOWN,SET,96,-0.01189,-0.00085749,0.084276,0.5561,KCCGNSWTTT_UNKNOWN,0.994669078610229
HP_PREMATURE_RUPTURE_OF_MEMB...,SET,15,-0.028443,-0.00081266,0.20157,0.55611,HP_PREMATURE_RUPTURE_OF_MEMBRANES,0.994669078610229
WHITFIELD_CELL_CYCLE_M_G1,SET,115,-0.011066,-0.00087309,0.078404,0.55612,WHITFIELD_CELL_CYCLE_M_G1,0.994669078610229
MARIADASON_RESPONSE_TO_BUTYR...2,SET,7,-0.046185,-0.00090164,0.32713,0.55614,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2,0.994669078610229
GOBP_SPERMATID_DIFFERENTIATI...,SET,190,-0.0085651,-0.00086679,0.06066,0.55614,GOBP_SPERMATID_DIFFERENTIATION,0.994669078610229
GOBP_FUSED_ANTRUM_STAGE,SET,6,-0.055717,-0.0010071,0.39454,0.55615,GOBP_FUSED_ANTRUM_STAGE,0.994669078610229
DUTERTRE_ESTRADIOL_RESPONSE_...1,SET,475,-0.0060143,-0.00095478,0.042584,0.55616,DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,0.994669078610229
GSE22025_PROGESTERONE_VS_TGF...2,SET,177,-0.0091301,-0.00089211,0.064641,0.55616,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.994669078610229
GOBP_MITOCHONDRIAL_DNA_REPAIR,SET,6,-0.04343,-0.00078498,0.30736,0.55618,GOBP_MITOCHONDRIAL_DNA_REPAIR,0.994669078610229
GOMF_LYSOPHOSPHATIDIC_ACID_P...,SET,2,-0.10221,-0.0010668,0.72316,0.5562,GOMF_LYSOPHOSPHATIDIC_ACID_PHOSPHATASE_ACTIVITY,0.994669078610229
HP_WADDLING_GAIT,SET,116,-0.011212,-0.0008884,0.079277,0.55624,HP_WADDLING_GAIT,0.994669078610229
MODULE_20,SET,77,-0.013232,-0.00085509,0.093534,0.55625,MODULE_20,0.994669078610229
SP1_01,SET,214,-0.0082818,-0.00088889,0.058504,0.55628,SP1_01,0.994669078610229
GSE10325_MYELOID_VS_LUPUS_MY...1,SET,185,-0.009007,-0.00089957,0.06358,0.55633,GSE10325_MYELOID_VS_LUPUS_MYELOID_DN,0.994669078610229
MARTINEZ_TP53_TARGETS_UP,SET,569,-0.0051353,-0.00088992,0.036196,0.55641,MARTINEZ_TP53_TARGETS_UP,0.994669078610229
MIR138_2_3P,SET,154,-0.010386,-0.0009472,0.073198,0.55642,MIR138_2_3P,0.994669078610229
CHEOK_RESPONSE_TO_MERCAPTOPU...5,SET,19,-0.028088,-0.00090311,0.19787,0.55644,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,0.994669078610229
WP_CAMKK2_PATHWAY,SET,32,-0.022327,-0.00093132,0.15712,0.5565,WP_CAMKK2_PATHWAY,0.994669078610229
GOBP_REGULATION_OF_GRANULOCY...1,SET,47,-0.01894,-0.00095704,0.13322,0.55653,GOBP_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.994669078610229
GOBP_POSITIVE_REGULATION_OF_...596,SET,5,-0.055462,-0.00091513,0.38962,0.5566,GOBP_POSITIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.994669078610229
KAECH_NAIVE_VS_DAY15_EFF_CD8...1,SET,183,-0.0091903,-0.00091294,0.064496,0.55665,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN,0.994669078610229
GOMF_SPHINGOLIPID_BINDING,SET,25,-0.023971,-0.00088396,0.16821,0.55666,GOMF_SPHINGOLIPID_BINDING,0.994669078610229
REACTOME_ACTIVATION_OF_THE_P...1,SET,11,-0.034217,-0.00083728,0.23993,0.5567,REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE,0.994669078610229
GOBP_ELASTIC_FIBER_ASSEMBLY,SET,8,-0.042482,-0.00088657,0.2977,0.55674,GOBP_ELASTIC_FIBER_ASSEMBLY,0.994669078610229
MIR181A_3P,SET,7,-0.050133,-0.00097871,0.35118,0.55676,MIR181A_3P,0.994669078610229
MIR1182,SET,28,-0.024222,-0.00094519,0.1696,0.55678,MIR1182,0.994669078610229
REACTOME_DISEASES_ASSOCIATED...5,SET,9,-0.049413,-0.0010938,0.34596,0.55679,REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM,0.994669078610229
GGGACCA_MIR133A_MIR133B,SET,184,-0.0094931,-0.00094557,0.066437,0.55681,GGGACCA_MIR133A_MIR133B,0.994669078610229
HP_PHTHISIS_BULBI,SET,13,-0.035974,-0.00095691,0.25175,0.55681,HP_PHTHISIS_BULBI,0.994669078610229
GOBP_POSITIVE_REGULATION_OF_...140,SET,5,-0.063487,-0.0010476,0.44418,0.55683,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.994669078610229
KEGG_MEDICUS_VARIANT_AMPLIFI...15,SET,14,-0.034333,-0.00094771,0.24006,0.55686,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,0.994669078610229
MIR3936,SET,30,-0.021553,-0.0008705,0.15046,0.55695,MIR3936,0.994669078610229
FAN_EMBRYONIC_CTX_IN_2_INTER...,SET,7,-0.045252,-0.00088342,0.31588,0.55696,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.994669078610229
GOBP_REGULATION_OF_MAMMARY_G...,SET,14,-0.034598,-0.00095503,0.24143,0.55697,GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.994669078610229
GOMF_DIACYLGLYCEROL_DEPENDEN...,SET,16,-0.030556,-0.00090162,0.21318,0.55698,GOMF_DIACYLGLYCEROL_DEPENDENT_SERINE_THREONINE_KINASE_ACTIVITY,0.994669078610229
REACTOME_ATTACHMENT_AND_ENTRY,SET,16,-0.03346,-0.00098732,0.23327,0.55703,REACTOME_ATTACHMENT_AND_ENTRY,0.994669078610229
CRX_NRL_DN.V1_UP,SET,131,-0.0109,-0.00091739,0.075983,0.55703,CRX_NRL_DN.V1_UP,0.994669078610229
GOBP_TERMINATION_OF_RNA_POLY...,SET,10,-0.04152,-0.00096874,0.28942,0.55704,GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION,0.994669078610229
MIR4633_3P_MIR6500_5P,SET,32,-0.0213,-0.00088847,0.1482,0.55714,MIR4633_3P_MIR6500_5P,0.994669078610229
AMIT_SERUM_RESPONSE_480_MCF1...,SET,32,-0.021158,-0.00088254,0.14715,0.55716,AMIT_SERUM_RESPONSE_480_MCF10A,0.994669078610229
HP_ABNORMAL_PROTEIN_GLYCOSYL...,SET,39,-0.017527,-0.00080694,0.12188,0.55717,HP_ABNORMAL_PROTEIN_GLYCOSYLATION,0.994669078610229
GSE9006_TYPE_1_DIABETES_AT_D...1,SET,163,-0.0092736,-0.0008699,0.064478,0.55718,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN,0.994669078610229
REACTOME_BH3_ONLY_PROTEINS_A...,SET,9,-0.047835,-0.0010588,0.33217,0.55725,REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS,0.994669078610229
MIR8080,SET,127,-0.011021,-0.0009134,0.076525,0.55725,MIR8080,0.994669078610229
CHEN_LVAD_SUPPORT_OF_FAILING...1,SET,42,-0.020855,-0.00099631,0.14479,0.55726,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,0.994669078610229
TGTGTGA_MIR377,SET,182,-0.0089905,-0.00089068,0.062382,0.5573,TGTGTGA_MIR377,0.994669078610229
GOBP_PLACENTA_DEVELOPMENT,SET,142,-0.010792,-0.00094539,0.074863,0.55731,GOBP_PLACENTA_DEVELOPMENT,0.994669078610229
GOBP_CALCITONIN_FAMILY_RECEP...,SET,7,-0.051858,-0.0010124,0.35966,0.55732,GOBP_CALCITONIN_FAMILY_RECEPTOR_SIGNALING_PATHWAY,0.994669078610229
HP_ABNORMAL_T_CELL_ACTIVATION,SET,5,-0.055595,-0.00091733,0.38558,0.55732,HP_ABNORMAL_T_CELL_ACTIVATION,0.994669078610229
CASTELLANO_HRAS_TARGETS_UP,SET,5,-0.048188,-0.00079511,0.33396,0.55737,CASTELLANO_HRAS_TARGETS_UP,0.994669078610229
GSE8384_CTRL_VS_B_ABORTUS_4H...2,SET,174,-0.0092398,-0.00089522,0.064015,0.55738,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP,0.994669078610229
KYNG_DNA_DAMAGE_BY_GAMMA_AND...,SET,74,-0.014325,-0.00090759,0.099186,0.55742,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,0.994669078610229
RACCACAR_AML_Q6,SET,240,-0.0081282,-0.00092323,0.056259,0.55744,RACCACAR_AML_Q6,0.994669078610229
HP_SLENDER_LONG_BONE,SET,46,-0.017259,-0.00086283,0.11943,0.55745,HP_SLENDER_LONG_BONE,0.994669078610229
GSE28726_NAIVE_CD4_TCELL_VS_...1,SET,184,-0.0093812,-0.00093442,0.064845,0.55751,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN,0.994669078610229
HP_SEBORRHEIC_DERMATITIS,SET,22,-0.027203,-0.00094108,0.18793,0.55754,HP_SEBORRHEIC_DERMATITIS,0.994669078610229
GSE3982_CTRL_VS_PMA_STIM_EOS...2,SET,174,-0.0091834,-0.00088977,0.063451,0.55754,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP,0.994669078610229
NFAT_Q4_01,SET,243,-0.008241,-0.00094179,0.056932,0.55755,NFAT_Q4_01,0.994669078610229
GOMF_GUANYLATE_CYCLASE_ACTIV...,SET,5,-0.056982,-0.00094022,0.3936,0.55755,GOMF_GUANYLATE_CYCLASE_ACTIVITY,0.994669078610229
GOCC_PEPTIDASE_COMPLEX,SET,115,-0.01055,-0.00083231,0.072831,0.55759,GOCC_PEPTIDASE_COMPLEX,0.994669078610229
GOBP_POSITIVE_REGULATION_OF_...757,SET,11,-0.037895,-0.00092728,0.26147,0.55762,GOBP_POSITIVE_REGULATION_OF_TISSUE_REMODELING,0.994669078610229
HP_NEOPLASM_OF_THE_RESPIRATO...,SET,74,-0.014339,-0.00090849,0.098842,0.55767,HP_NEOPLASM_OF_THE_RESPIRATORY_SYSTEM,0.994669078610229
GOBP_NEGATIVE_REGULATION_OF_...278,SET,10,-0.04241,-0.00098949,0.29194,0.55775,GOBP_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.994669078610229
GSE360_L_DONOVANI_VS_T_GONDI...2,SET,183,-0.0093897,-0.00093275,0.064637,0.55775,GSE360_L_DONOVANI_VS_T_GONDII_DC_UP,0.994669078610229
GOCC_H4_HISTONE_ACETYLTRANSF...,SET,37,-0.01951,-0.00087495,0.13425,0.55777,GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.994669078610229
GOMF_CARNITINE_TRANSMEMBRANE...,SET,5,-0.073955,-0.0012203,0.50891,0.55777,GOMF_CARNITINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.994669078610229
GSE15930_NAIVE_VS_72H_IN_VIT...5,SET,182,-0.0090824,-0.00089978,0.062483,0.55779,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.994669078610229
BROWNE_HCMV_INFECTION_24HR_DN,SET,131,-0.011034,-0.00092867,0.075846,0.55783,BROWNE_HCMV_INFECTION_24HR_DN,0.994669078610229
GSE36888_UNTREATED_VS_IL2_TR...5,SET,178,-0.009033,-0.0008851,0.062069,0.55785,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN,0.994669078610229
UNTERMAN_IPF_VS_CTRL_DC_UP,SET,4,-0.057739,-0.00085214,0.39646,0.55789,UNTERMAN_IPF_VS_CTRL_DC_UP,0.994669078610229
HP_ANTERIOR_POLAR_CATARACT,SET,7,-0.047281,-0.00092303,0.32469,0.55789,HP_ANTERIOR_POLAR_CATARACT,0.994669078610229
HP_NON_SMALL_CELL_LUNG_CARCI...,SET,22,-0.025692,-0.00088883,0.17635,0.55792,HP_NON_SMALL_CELL_LUNG_CARCINOMA,0.994669078610229
BIOCARTA_ALK_PATHWAY,SET,34,-0.022947,-0.00098658,0.15748,0.55793,BIOCARTA_ALK_PATHWAY,0.994669078610229
MURARO_PANCREAS_ENDOTHELIAL_...,SET,337,-0.0073919,-0.00099223,0.050712,0.55794,MURARO_PANCREAS_ENDOTHELIAL_CELL,0.994669078610229
GOBP_SULFUR_AMINO_ACID_BIOSY...,SET,15,-0.032709,-0.00093455,0.22406,0.55803,GOBP_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.994669078610229
GOBP_T_CELL_MEDIATED_CYTOTOX...,SET,56,-0.01906,-0.0010511,0.13053,0.55805,GOBP_T_CELL_MEDIATED_CYTOTOXICITY,0.994669078610229
REACTOME_THE_PHOTOTRANSDUCTI...,SET,31,-0.02149,-0.00088229,0.14715,0.55806,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,0.994669078610229
GOBP_NEGATIVE_REGULATION_OF_...610,SET,23,-0.029078,-0.0010285,0.1989,0.55811,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,0.994669078610229
SIG_PIP3_SIGNALING_IN_B_LYMP...,SET,34,-0.022383,-0.00096234,0.15298,0.55816,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,0.994669078610229
EVI1_01,SET,14,-0.034036,-0.0009395,0.23248,0.5582,EVI1_01,0.994669078610229
HP_NON_CONVULSIVE_STATUS_EPI...,SET,18,-0.029226,-0.00091465,0.19949,0.55824,HP_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,0.994669078610229
GOBP_REGULATION_OF_NEUROTROP...,SET,9,-0.041805,-0.00092536,0.28518,0.55827,GOBP_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.994669078610229
GOBP_SECRETORY_GRANULE_LOCAL...,SET,22,-0.027895,-0.00096504,0.19027,0.55828,GOBP_SECRETORY_GRANULE_LOCALIZATION,0.994669078610229
DESCARTES_FETAL_HEART_EPICAR...,SET,90,-0.014242,-0.0009947,0.097128,0.55829,DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS,0.994669078610229
GOBP_HYDROGEN_PEROXIDE_BIOSY...,SET,14,-0.035891,-0.0009907,0.24464,0.55832,GOBP_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.994669078610229
GOBP_RETINAL_ROD_CELL_DEVELO...,SET,10,-0.041504,-0.00096835,0.28277,0.55834,GOBP_RETINAL_ROD_CELL_DEVELOPMENT,0.994669078610229
REACTOME_IRF3_MEDIATED_INDUC...,SET,11,-0.031484,-0.0007704,0.2145,0.55835,REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN,0.994669078610229
HP_ABNORMALITY_OF_THE_MIDDLE...3,SET,10,-0.038307,-0.00089376,0.26094,0.55836,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.994669078610229
GOMF_OXIDOREDUCTASE_ACTIVITY...14,SET,10,-0.037409,-0.00087282,0.25464,0.5584,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR,0.994669078610229
REACTOME_BASE_EXCISION_REPAI...,SET,17,-0.028757,-0.00087465,0.19569,0.55841,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.994669078610229
REACTOME_TOXICITY_OF_BOTULIN...,SET,5,-0.052453,-0.00086549,0.35671,0.55845,REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD,0.994669078610229
GOBP_TRANSFORMING_GROWTH_FAC...3,SET,31,-0.024639,-0.0010116,0.16753,0.55846,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.994669078610229
NKX2_5_TARGET_GENES,SET,1229,-0.0037515,-0.00093756,0.025498,0.55848,NKX2_5_TARGET_GENES,0.994669078610229
HP_RIGHT_ATRIAL_ENLARGEMENT,SET,23,-0.027152,-0.00096042,0.18443,0.55852,HP_RIGHT_ATRIAL_ENLARGEMENT,0.994689346656418
HP_DOWNSLANTED_PALPEBRAL_FIS...,SET,428,-0.0061106,-0.00092204,0.041416,0.55865,HP_DOWNSLANTED_PALPEBRAL_FISSURES,0.99480342252008
GOBP_EPIDERMAL_GROWTH_FACTOR...,SET,101,-0.012561,-0.00092908,0.084922,0.55879,GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99480342252008
FOSTER_TOLERANT_MACROPHAGE_UP,SET,151,-0.011032,-0.00099632,0.074575,0.5588,FOSTER_TOLERANT_MACROPHAGE_UP,0.99480342252008
REACTOME_RIP_MEDIATED_NFKB_A...,SET,16,-0.031827,-0.00093914,0.21512,0.55881,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,0.99480342252008
GOMF_TRANSPORTER_REGULATOR_A...,SET,141,-0.011115,-0.00097031,0.07505,0.55887,GOMF_TRANSPORTER_REGULATOR_ACTIVITY,0.99480342252008
GOBP_MULTICELLULAR_ORGANISMA...5,SET,58,-0.016791,-0.00094226,0.11335,0.55888,GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT,0.99480342252008
GOBP_PRODUCTION_OF_MOLECULAR...1,SET,84,-0.01368,-0.00092318,0.092317,0.5589,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.99480342252008
HP_ABNORMAL_INTERNAL_CAROTID...,SET,10,-0.04551,-0.0010618,0.30702,0.55892,HP_ABNORMAL_INTERNAL_CAROTID_ARTERY_MORPHOLOGY,0.99480342252008
GOBP_REGULATION_OF_EXTRACELL...2,SET,9,-0.049815,-0.0011026,0.33584,0.55896,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.99480342252008
GOBP_RESPONSE_TO_LUTEINIZING...,SET,7,-0.050444,-0.00098477,0.34005,0.55896,GOBP_RESPONSE_TO_LUTEINIZING_HORMONE,0.99480342252008
GOBP_NEGATIVE_REGULATION_OF_...562,SET,114,-0.011645,-0.00091479,0.078466,0.55899,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.99480342252008
GOBP_POSITIVE_REGULATION_OF_...527,SET,14,-0.036772,-0.001015,0.24763,0.55902,GOBP_POSITIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.99480342252008
GOBP_CELLULAR_RESPONSE_TO_ET...2,SET,6,-0.048358,-0.00087405,0.32558,0.55904,GOBP_CELLULAR_RESPONSE_TO_ETHER,0.99480342252008
HP_MULTIPLE_PULMONARY_CYSTS,SET,18,-0.031298,-0.00097948,0.21056,0.55908,HP_MULTIPLE_PULMONARY_CYSTS,0.99480342252008
GOBP_POSTSYNAPTIC_MEMBRANE_O...,SET,35,-0.021693,-0.00094627,0.14587,0.55911,GOBP_POSTSYNAPTIC_MEMBRANE_ORGANIZATION,0.99480342252008
GOBP_SYNAPTIC_VESICLE_RECYCL...1,SET,74,-0.014501,-0.00091873,0.097484,0.55912,GOBP_SYNAPTIC_VESICLE_RECYCLING,0.99480342252008
REACTOME_MITOCHONDRIAL_RNA_D...,SET,10,-0.033014,-0.00077028,0.22187,0.55914,REACTOME_MITOCHONDRIAL_RNA_DEGRADATION,0.99480342252008
GOBP_REGULATION_OF_HYDROLASE...,SET,641,-0.0054117,-0.00099336,0.036348,0.55918,GOBP_REGULATION_OF_HYDROLASE_ACTIVITY,0.99480342252008
GOBP_MITOTIC_NUCLEAR_MEMBRAN...1,SET,8,-0.043464,-0.00090707,0.2918,0.5592,GOBP_MITOTIC_NUCLEAR_MEMBRANE_DISASSEMBLY,0.99480342252008
GOBP_NUCLEOSIDE_PHOSPHATE_BI...,SET,232,-0.0082621,-0.00092286,0.055475,0.5592,GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99480342252008
HP_ABNORMAL_PROPORTION_OF_NA...,SET,4,-0.072932,-0.0010764,0.48963,0.5592,HP_ABNORMAL_PROPORTION_OF_NAIVE_T_CELLS,0.99480342252008
GSE17721_POLYIC_VS_PAM3CSK4_...18,SET,185,-0.0094832,-0.00094712,0.063612,0.55925,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP,0.99480342252008
GOBP_PROTEIN_AUTO_ADP_RIBOSY...,SET,11,-0.040252,-0.00098495,0.26993,0.55927,GOBP_PROTEIN_AUTO_ADP_RIBOSYLATION,0.99480342252008
GSE1432_1H_VS_24H_IFNG_MICRO...1,SET,181,-0.0096585,-0.00095424,0.064722,0.55931,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.99480342252008
MIR6514_3P,SET,67,-0.01546,-0.00093224,0.10353,0.55935,MIR6514_3P,0.99480342252008
WP_NOTCH1_REGULATION_OF_ENDO...,SET,16,-0.035219,-0.0010392,0.23582,0.55936,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,0.99480342252008
KEGG_MEDICUS_VARIANT_MUTATIO...67,SET,25,-0.025729,-0.00094877,0.1721,0.55942,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99480342252008
MIR6770_3P,SET,4,-0.058444,-0.00086255,0.39095,0.55942,MIR6770_3P,0.99480342252008
GSE29618_PDC_VS_MDC_DN,SET,183,-0.0097266,-0.00096621,0.065064,0.55942,GSE29618_PDC_VS_MDC_DN,0.99480342252008
GSE12845_NAIVE_VS_DARKZONE_G...1,SET,176,-0.0088589,-0.0008632,0.059205,0.55947,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99480342252008
GSE3039_NKT_CELL_VS_ALPHAALP...2,SET,185,-0.0097782,-0.00097658,0.065329,0.55949,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP,0.99480342252008
GOBP_REGULATION_OF_HEMOPOIES...,SET,384,-0.006807,-0.00097408,0.045472,0.5595,GOBP_REGULATION_OF_HEMOPOIESIS,0.99480342252008
GOMF_CUPROUS_ION_BINDING,SET,8,-0.043461,-0.00090701,0.29008,0.55955,GOMF_CUPROUS_ION_BINDING,0.994840579044118
SCHAEFFER_PROSTATE_DEVELOPME...17,SET,7,-0.049338,-0.00096319,0.32904,0.55959,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP,0.994840579044118
STN1_TARGET_GENES,SET,8,-0.048351,-0.0010091,0.32235,0.55962,STN1_TARGET_GENES,0.994840579044118
GOCC_COATED_VESICLE_MEMBRANE,SET,184,-0.0095544,-0.00095168,0.063624,0.55968,GOCC_COATED_VESICLE_MEMBRANE,0.994840579044118
HP_TIBIALIS_MUSCLE_WEAKNESS,SET,6,-0.054784,-0.0009902,0.36467,0.55971,HP_TIBIALIS_MUSCLE_WEAKNESS,0.994840579044118
KEGG_RNA_DEGRADATION,SET,49,-0.017894,-0.00092321,0.119,0.55977,KEGG_RNA_DEGRADATION,0.994840579044118
GSE10325_CD4_TCELL_VS_MYELOI...1,SET,179,-0.010088,-0.00099121,0.06706,0.55979,GSE10325_CD4_TCELL_VS_MYELOID_DN,0.994840579044118
DESCARTES_FETAL_EYE_PHOTOREC...,SET,29,-0.026992,-0.0010719,0.17935,0.55981,DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS,0.994840579044118
GOBP_CELLULAR_RESPONSE_TO_CA...3,SET,69,-0.016425,-0.001005,0.10907,0.55985,GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION,0.994840579044118
GOBP_PROTEIN_FOLDING_IN_ENDO...,SET,10,-0.03793,-0.00088498,0.2515,0.55994,GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM,0.994840579044118
GOBP_REGULATION_OF_POSTSYNAP...4,SET,13,-0.036572,-0.00097283,0.24242,0.55996,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.994840579044118
GOCC_PRONUCLEUS,SET,12,-0.03479,-0.00088913,0.23037,0.56002,GOCC_PRONUCLEUS,0.994840579044118
GAO_STOMACH_24W_C4_PARIETAL_...,SET,8,-0.048541,-0.001013,0.32119,0.56006,GAO_STOMACH_24W_C4_PARIETAL_PROGENITOR,0.994840579044118
HP_FLATTENED_FEMORAL_HEAD,SET,6,-0.04564,-0.00082492,0.30186,0.56009,HP_FLATTENED_FEMORAL_HEAD,0.994840579044118
GOMF_MONOAMINE_TRANSMEMBRANE...,SET,12,-0.041713,-0.0010661,0.27575,0.56012,GOMF_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.994840579044118
GSE360_CTRL_VS_B_MALAYI_HIGH...2,SET,173,-0.0096575,-0.00093303,0.063822,0.56014,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.994840579044118
GSE15750_WT_VS_TRAF6KO_DAY10...1,SET,180,-0.010154,-0.0010005,0.067083,0.56016,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN,0.994840579044118
GSE25087_FETAL_VS_ADULT_TREG...2,SET,176,-0.0093819,-0.00091415,0.061951,0.56018,GSE25087_FETAL_VS_ADULT_TREG_UP,0.994840579044118
MIR4691_5P,SET,119,-0.012054,-0.00096728,0.079594,0.56019,MIR4691_5P,0.994840579044118
HP_REFRACTORY_ANEMIA,SET,6,-0.057564,-0.0010405,0.37981,0.56023,HP_REFRACTORY_ANEMIA,0.994840579044118
IWANAGA_CARCINOGENESIS_BY_KR...3,SET,169,-0.0098114,-0.00093698,0.064701,0.56027,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,0.994840579044118
TENEDINI_MEGAKARYOCYTE_MARKE...,SET,60,-0.017269,-0.00098558,0.11379,0.56031,TENEDINI_MEGAKARYOCYTE_MARKERS,0.994840579044118
HP_PULMONARY_CARCINOID_TUMOR,SET,8,-0.043373,-0.00090517,0.28571,0.56033,HP_PULMONARY_CARCINOID_TUMOR,0.994840579044118
GSE7460_WT_VS_FOXP3_HET_ACT_...2,SET,186,-0.0096391,-0.00096527,0.063468,0.56036,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP,0.994840579044118
GOBP_PYRIMIDINE_CONTAINING_C...5,SET,16,-0.034969,-0.0010319,0.23019,0.56037,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,0.994840579044118
GOBP_NEGATIVE_REGULATION_OF_...444,SET,5,-0.04918,-0.00081148,0.32354,0.56041,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.994840579044118
HP_BRONCHIAL_WALL_THICKENING,SET,6,-0.065125,-0.0011771,0.42804,0.56046,HP_BRONCHIAL_WALL_THICKENING,0.994840579044118
WAMUNYOKOLI_OVARIAN_CANCER_L...2,SET,255,-0.0082442,-0.00096482,0.054135,0.56052,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,0.994840579044118
REACTOME_AMINO_ACID_TRANSPOR...,SET,30,-0.025754,-0.0010402,0.16909,0.56053,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,0.994840579044118
ZWANG_EGF_INTERVAL_DN,SET,185,-0.0096033,-0.00095912,0.063035,0.56054,ZWANG_EGF_INTERVAL_DN,0.994840579044118
MIR8056,SET,40,-0.020708,-0.00096553,0.13591,0.56055,MIR8056,0.994840579044118
GOBP_REGULATION_OF_SYNAPTIC_...7,SET,6,-0.061147,-0.0011052,0.40131,0.56055,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING,0.994840579044118
HP_HYPERACTIVE_RENIN_ANGIOTE...,SET,8,-0.053365,-0.0011137,0.35023,0.56055,HP_HYPERACTIVE_RENIN_ANGIOTENSIN_SYSTEM,0.994840579044118
GOBP_POSITIVE_REGULATION_OF_...516,SET,25,-0.028739,-0.0010598,0.18858,0.56056,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.994840579044118
GSE41176_UNSTIM_VS_ANTI_IGM_...1,SET,177,-0.0098391,-0.0009614,0.064564,0.56056,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN,0.994840579044118
GSE10325_LUPUS_CD4_TCELL_VS_...1,SET,166,-0.010792,-0.0010216,0.070807,0.56057,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN,0.994840579044118
GSE43955_TGFB_IL6_VS_TGFB_IL...2,SET,185,-0.0092119,-0.00092002,0.060433,0.56058,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,0.994840579044118
AGCGCAG_MIR191,SET,12,-0.033656,-0.00086016,0.22043,0.56068,AGCGCAG_MIR191,0.994855222052067
HP_ELEVATED_CIRCULATING_PARA...,SET,18,-0.034393,-0.0010764,0.22522,0.56069,HP_ELEVATED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.994855222052067
GNF2_MYL2,SET,32,-0.024179,-0.0010086,0.15823,0.56073,GNF2_MYL2,0.994855222052067
GOBP_NUCLEOBASE_CONTAINING_C...,SET,207,-0.0087524,-0.00092409,0.057265,0.56074,GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.994855222052067
HP_DEEPLY_SET_EYE,SET,216,-0.0088884,-0.0009584,0.058144,0.56075,HP_DEEPLY_SET_EYE,0.994855222052067
GOBP_INNATE_IMMUNE_RESPONSE,SET,845,-0.004748,-0.00099487,0.031051,0.56076,GOBP_INNATE_IMMUNE_RESPONSE,0.994855222052067
HP_ABNORMAL_DENTIN_MORPHOLOGY,SET,21,-0.027854,-0.00094149,0.18163,0.56094,HP_ABNORMAL_DENTIN_MORPHOLOGY,0.995031687703583
GOBP_REGULATION_OF_MITOCHOND...6,SET,12,-0.034263,-0.00087565,0.22277,0.56112,GOBP_REGULATION_OF_MITOCHONDRIAL_FUSION,0.995031687703583
GSE17721_CTRL_VS_GARDIQUIMOD...6,SET,188,-0.009176,-0.00092377,0.059613,0.56117,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP,0.995031687703583
JINESH_BLEBBISHIELD_TO_IMMUN...1,SET,342,-0.0076873,-0.0010394,0.049915,0.5612,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,0.995031687703583
HP_CHRONIC_GASTRITIS,SET,2,-0.09666,-0.0010088,0.62751,0.56121,HP_CHRONIC_GASTRITIS,0.995031687703583
GOBP_CELLULAR_OXIDANT_DETOXI...,SET,83,-0.014682,-0.00098494,0.095267,0.56124,GOBP_CELLULAR_OXIDANT_DETOXIFICATION,0.995031687703583
GSE2585_AIRE_KO_VS_WT_CD80_H...2,SET,182,-0.0094347,-0.00093469,0.061213,0.56124,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP,0.995031687703583
GOMF_CHROMO_SHADOW_DOMAIN_BI...,SET,5,-0.051248,-0.00084561,0.33246,0.56125,GOMF_CHROMO_SHADOW_DOMAIN_BINDING,0.995031687703583
GOBP_REGULATION_OF_MUSCLE_HY...,SET,53,-0.019682,-0.0010559,0.12767,0.56126,GOBP_REGULATION_OF_MUSCLE_HYPERTROPHY,0.995031687703583
MIR3174,SET,38,-0.022162,-0.0010072,0.14374,0.56127,MIR3174,0.995031687703583
GOBP_POSITIVE_REGULATION_OF_...46,SET,11,-0.035983,-0.0008805,0.23326,0.5613,GOBP_POSITIVE_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.995031687703583
HP_ELEVATED_CIRCULATING_HEPA...,SET,324,-0.007196,-0.00094746,0.046563,0.56141,HP_ELEVATED_CIRCULATING_HEPATIC_TRANSAMINASE_CONCENTRATION,0.995031687703583
REACTOME_SIGNALING_BY_EGFR,SET,51,-0.018034,-0.00094916,0.11662,0.56144,REACTOME_SIGNALING_BY_EGFR,0.995031687703583
ZHENG_FOXP3_TARGETS_UP,SET,24,-0.0287,-0.001037,0.18559,0.56145,ZHENG_FOXP3_TARGETS_UP,0.995031687703583
MIR526B_5P,SET,94,-0.013948,-0.00099548,0.090181,0.56146,MIR526B_5P,0.995031687703583
MIR4521,SET,67,-0.016843,-0.0010156,0.10861,0.56162,MIR4521,0.995031687703583
GOBP_MICROTUBULE_ORGANIZING_...1,SET,30,-0.022746,-0.0009187,0.14662,0.56164,GOBP_MICROTUBULE_ORGANIZING_CENTER_LOCALIZATION,0.995031687703583
GOBP_NEGATIVE_REGULATION_OF_...348,SET,41,-0.020822,-0.00098287,0.13421,0.56164,GOBP_NEGATIVE_REGULATION_OF_LIPID_LOCALIZATION,0.995031687703583
HP_MESOAXIAL_FOOT_POLYDACTYLY,SET,4,-0.079511,-0.0011735,0.51251,0.56164,HP_MESOAXIAL_FOOT_POLYDACTYLY,0.995031687703583
GSE14308_TH2_VS_NATURAL_TREG...1,SET,180,-0.0099979,-0.00098508,0.06444,0.56165,GSE14308_TH2_VS_NATURAL_TREG_DN,0.995031687703583
GATTGGY_NFY_Q6_01,SET,1023,-0.004273,-0.00098014,0.027517,0.5617,GATTGGY_NFY_Q6_01,0.995031687703583
HP_ABNORMAL_VASCULAR_MORPHOL...,SET,1014,-0.0042821,-0.00097815,0.027571,0.56171,HP_ABNORMAL_VASCULAR_MORPHOLOGY,0.995031687703583
KEGG_MEDICUS_REFERENCE_LECTI...3,SET,9,-0.047767,-0.0010573,0.30745,0.56173,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,0.995031687703583
KIM_BIPOLAR_DISORDER_OLIGODE...1,SET,81,-0.015179,-0.001006,0.097644,0.56177,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,0.995031687703583
GOBP_BRANCH_ELONGATION_INVOL...,SET,5,-0.067335,-0.001111,0.43314,0.56177,GOBP_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING,0.995031687703583
SMIRNOV_CIRCULATING_ENDOTHEL...1,SET,5,-0.061862,-0.0010207,0.39782,0.56179,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN,0.995031687703583
GOBP_AMINE_CATABOLIC_PROCESS,SET,14,-0.040369,-0.0011143,0.25958,0.56179,GOBP_AMINE_CATABOLIC_PROCESS,0.995031687703583
MIR4703_3P,SET,37,-0.022633,-0.001015,0.14542,0.56184,MIR4703_3P,0.995031687703583
MIR6792_3P,SET,117,-0.012482,-0.00099324,0.080159,0.56187,MIR6792_3P,0.995031687703583
HP_APLASIA_HYPOPLASIA_OF_THE...16,SET,9,-0.046018,-0.0010186,0.2952,0.56194,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBRAL_WHITE_MATTER,0.995031687703583
HP_CEREBRAL_WHITE_MATTER_HYP...,SET,9,-0.046018,-0.0010186,0.2952,0.56194,HP_CEREBRAL_WHITE_MATTER_HYPOPLASIA,0.995031687703583
GSE15767_MED_VS_SCS_MAC_LN_DN,SET,180,-0.009845,-0.00097001,0.063113,0.56198,GSE15767_MED_VS_SCS_MAC_LN_DN,0.995031687703583
MIR4789_5P,SET,350,-0.0071758,-0.00098127,0.045967,0.56203,MIR4789_5P,0.995031687703583
SMIRNOV_CIRCULATING_ENDOTHEL...2,SET,145,-0.011646,-0.0010309,0.074577,0.56204,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,0.995031687703583
GOMF_INHIBITORY_MHC_CLASS_I_...,SET,8,-0.066697,-0.0013919,0.42666,0.56211,GOMF_INHIBITORY_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.995031687703583
GSE19941_UNSTIM_VS_LPS_STIM_...3,SET,174,-0.010214,-0.00098958,0.065321,0.56212,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.995031687703583
GSE7852_TREG_VS_TCONV_FAT_DN,SET,183,-0.0098603,-0.0009795,0.063067,0.56212,GSE7852_TREG_VS_TCONV_FAT_DN,0.995031687703583
GSE22589_HEALTHY_VS_HIV_INFE...2,SET,188,-0.0091323,-0.00091937,0.058391,0.56214,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP,0.995031687703583
GSE27859_CD11C_INT_F480_HI_M...2,SET,159,-0.010322,-0.00095641,0.065989,0.56215,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP,0.995031687703583
MODULE_13,SET,470,-0.0062544,-0.0009878,0.039918,0.56225,MODULE_13,0.995031687703583
HP_VILLOUS_ATROPHY,SET,24,-0.024828,-0.00089707,0.15846,0.56225,HP_VILLOUS_ATROPHY,0.995031687703583
GOMF_TRANSITION_METAL_ION_TR...,SET,41,-0.019231,-0.00090776,0.12273,0.56226,GOMF_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.995031687703583
HP_RENAL_ARTERY_STENOSIS,SET,21,-0.028083,-0.00094921,0.17917,0.56227,HP_RENAL_ARTERY_STENOSIS,0.995031687703583
HP_DYSTONIA,SET,461,-0.006186,-0.00096784,0.039454,0.56229,HP_DYSTONIA,0.995031687703583
GOMF_STAT_FAMILY_PROTEIN_BIN...,SET,10,-0.042302,-0.00098697,0.26964,0.56233,GOMF_STAT_FAMILY_PROTEIN_BINDING,0.995031687703583
GSE24634_TREG_VS_TCONV_POST_...4,SET,181,-0.0095617,-0.00094468,0.060936,0.56234,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP,0.995031687703583
GSE5679_PPARG_LIGAND_ROSIGLI...3,SET,181,-0.0098773,-0.00097587,0.062917,0.56237,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.995031687703583
KEGG_MEDICUS_PATHOGEN_SALMON...3,SET,8,-0.044095,-0.00092025,0.28081,0.56239,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.995031687703583
SA_B_CELL_RECEPTOR_COMPLEXES,SET,22,-0.029032,-0.0010044,0.18485,0.5624,SA_B_CELL_RECEPTOR_COMPLEXES,0.995031687703583
WP_SMALL_CELL_LUNG_CANCER,SET,93,-0.01341,-0.00095202,0.08539,0.5624,WP_SMALL_CELL_LUNG_CANCER,0.995031687703583
HOLLERN_SQUAMOUS_BREAST_TUMOR,SET,169,-0.011332,-0.0010822,0.072106,0.56244,HOLLERN_SQUAMOUS_BREAST_TUMOR,0.995031687703583
GOMF_MEDIUM_CHAIN_FATTY_ACID...,SET,9,-0.052127,-0.0011538,0.33164,0.56245,GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.995031687703583
GOBP_NEGATIVE_REGULATION_OF_...540,SET,5,-0.062851,-0.0010371,0.39975,0.56246,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION,0.995031687703583
GSE27786_LIN_NEG_VS_BCELL_UP,SET,185,-0.0098816,-0.00098691,0.062858,0.56246,GSE27786_LIN_NEG_VS_BCELL_UP,0.995031687703583
GAVISH_3CA_MALIGNANT_METAPRO...20,SET,47,-0.020619,-0.0010419,0.13108,0.5625,GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC,0.995031687703583
HP_TETRAPARESIS,SET,100,-0.013348,-0.0009824,0.084832,0.56251,HP_TETRAPARESIS,0.995031687703583
GOCC_OMEGASOME,SET,4,-0.064506,-0.00095202,0.40989,0.56252,GOCC_OMEGASOME,0.995031687703583
GSE3982_MAC_VS_TH2_UP,SET,181,-0.010275,-0.0010151,0.065298,0.56252,GSE3982_MAC_VS_TH2_UP,0.995031687703583
HP_DECREASED_HIP_ABDUCTION,SET,7,-0.052299,-0.001021,0.33199,0.56259,HP_DECREASED_HIP_ABDUCTION,0.995056643427815
REACTOME_CAMK_IV_MEDIATED_PH...,SET,10,-0.047979,-0.0011194,0.30447,0.56261,REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB,0.995056643427815
GOBP_RECOMBINATIONAL_REPAIR,SET,165,-0.0098834,-0.00093272,0.062709,0.56262,GOBP_RECOMBINATIONAL_REPAIR,0.995056643427815
GOBP_FOREGUT_MORPHOGENESIS,SET,10,-0.044706,-0.0010431,0.28307,0.56274,GOBP_FOREGUT_MORPHOGENESIS,0.995218232240993
GOBP_REGULATION_OF_ADIPONECT...,SET,7,-0.054411,-0.0010622,0.3443,0.56279,GOBP_REGULATION_OF_ADIPONECTIN_SECRETION,0.995227091491634
HP_ABNORMAL_CIRCULATING_ALPH...,SET,30,-0.02631,-0.0010626,0.16641,0.56281,HP_ABNORMAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.995227091491634
GLI3_TARGET_GENES,SET,588,-0.0055952,-0.00098515,0.035333,0.56291,GLI3_TARGET_GENES,0.995227091491634
HP_EXTERNAL_GENITAL_HYPOPLAS...,SET,436,-0.0065608,-0.00099895,0.041385,0.56298,HP_EXTERNAL_GENITAL_HYPOPLASIA,0.995227091491634
AIZARANI_LIVER_C6_KUPFFER_CE...,SET,203,-0.010092,-0.0010553,0.063658,0.56298,AIZARANI_LIVER_C6_KUPFFER_CELLS_2,0.995227091491634
REACTOME_ACYL_CHAIN_REMODELI...1,SET,5,-0.069252,-0.0011427,0.43668,0.563,REACTOME_ACYL_CHAIN_REMODELING_OF_CL,0.995227091491634
MIR6088,SET,152,-0.010968,-0.0009938,0.069154,0.56301,MIR6088,0.995227091491634
HP_ABNORMALITY_OF_THE_TESTIS...,SET,177,-0.010115,-0.00098835,0.063776,0.56301,HP_ABNORMALITY_OF_THE_TESTIS_SIZE,0.995227091491634
GOBP_TRIGLYCERIDE_RICH_LIPOP...2,SET,10,-0.048254,-0.0011259,0.30406,0.56305,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING,0.995227091491634
GSE19198_CTRL_VS_IL21_TREATE...4,SET,183,-0.010512,-0.0010443,0.06624,0.56305,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP,0.995227091491634
HP_ABNORMAL_STOOL_COMPOSITION,SET,18,-0.03107,-0.00097236,0.19574,0.56306,HP_ABNORMAL_STOOL_COMPOSITION,0.995227091491634
BIOCARTA_DC_PATHWAY,SET,16,-0.038788,-0.0011446,0.2442,0.5631,BIOCARTA_DC_PATHWAY,0.995247177583401
IBRAHIM_NRF2_DOWN,SET,129,-0.012044,-0.001006,0.07567,0.56323,IBRAHIM_NRF2_DOWN,0.995426323417239
HE_LIM_SUN_FETAL_LUNG_C1_SMG...1,SET,347,-0.0079171,-0.0010781,0.049694,0.56329,HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL,0.995481742601444
GSE32986_UNSTIM_VS_CURDLAN_H...1,SET,174,-0.010318,-0.00099972,0.064639,0.56341,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.995599740735092
GOBP_DETECTION_OF_LIGHT_STIM...1,SET,58,-0.018423,-0.0010338,0.11533,0.56345,GOBP_DETECTION_OF_LIGHT_STIMULUS,0.995599740735092
GOBP_POSITIVE_REGULATION_OF_...47,SET,18,-0.032504,-0.0010173,0.20347,0.56346,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.995599740735092
HP_TEMPORAL_PATTERN,SET,18,-0.031616,-0.00098945,0.19781,0.56349,HP_TEMPORAL_PATTERN,0.995599740735092
YANG_BCL3_TARGETS_DN,SET,8,-0.05162,-0.0010773,0.32293,0.5635,YANG_BCL3_TARGETS_DN,0.995599740735092
GOBP_FATTY_ACID_BETA_OXIDATI...2,SET,11,-0.034886,-0.00085365,0.21809,0.56354,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE,0.995619799715332
HP_FRONTAL_BALDING,SET,13,-0.036877,-0.00098094,0.23044,0.56357,HP_FRONTAL_BALDING,0.995622190311595
HP_HYPOPHOSPHATEMIA,SET,41,-0.022813,-0.0010768,0.14247,0.56361,HP_HYPOPHOSPHATEMIA,0.995625102849307
GSE7548_NAIVE_VS_DAY28_PCC_I...1,SET,172,-0.010614,-0.0010225,0.066261,0.56363,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.995625102849307
HP_ABNORMAL_SEPTUM_PELLUCIDU...,SET,92,-0.01404,-0.00099139,0.087591,0.56367,HP_ABNORMAL_SEPTUM_PELLUCIDUM_MORPHOLOGY,0.995625102849307
HP_ABNORMAL_MALE_REPRODUCTIV...,SET,283,-0.0080989,-0.00099772,0.050493,0.56371,HP_ABNORMAL_MALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.995625102849307
GSE23925_DARK_ZONE_VS_NAIVE_...2,SET,182,-0.0098473,-0.00097556,0.061346,0.56376,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP,0.995625102849307
MIR7113_5P,SET,136,-0.011792,-0.0010111,0.073431,0.56379,MIR7113_5P,0.995625102849307
HP_DECREASED_SPECIFIC_PNEUMO...,SET,7,-0.056995,-0.0011127,0.35473,0.56382,HP_DECREASED_SPECIFIC_PNEUMOCOCCAL_ANTIBODY_LEVEL,0.995625102849307
MIR6795_5P,SET,120,-0.01265,-0.0010193,0.078717,0.56383,MIR6795_5P,0.995625102849307
HP_ABNORMAL_CIRCULATING_LACT...,SET,90,-0.014805,-0.001034,0.092092,0.56386,HP_ABNORMAL_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,0.995625102849307
REACTOME_IRS_MEDIATED_SIGNAL...,SET,47,-0.020069,-0.0010141,0.12479,0.56388,REACTOME_IRS_MEDIATED_SIGNALLING,0.995625102849307
PID_ER_NONGENOMIC_PATHWAY,SET,39,-0.021398,-0.00098514,0.13298,0.56392,PID_ER_NONGENOMIC_PATHWAY,0.995625102849307
KLF14_TARGET_GENES,SET,203,-0.0097816,-0.0010228,0.060772,0.56393,KLF14_TARGET_GENES,0.995625102849307
GSE1925_CTRL_VS_IFNG_PRIMED_...2,SET,179,-0.010225,-0.0010046,0.063488,0.56397,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP,0.995625102849307
PETRETTO_LEFT_VENTRICLE_MASS...2,SET,5,-0.059971,-0.00098953,0.37217,0.56401,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP,0.995625102849307
GOCC_GLYCINERGIC_SYNAPSE,SET,7,-0.055676,-0.0010869,0.34539,0.56403,GOCC_GLYCINERGIC_SYNAPSE,0.995625102849307
THAKAR_PBMC_INACTIVATED_INFL...7,SET,546,-0.005749,-0.00097655,0.035666,0.56403,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,0.995625102849307
HP_DIFFICULTY_IN_TONGUE_MOVE...,SET,12,-0.041655,-0.0010646,0.258,0.56413,HP_DIFFICULTY_IN_TONGUE_MOVEMENTS,0.995751048755714
GOBP_MITOCHONDRION_ORGANIZAT...,SET,441,-0.0063863,-0.00097781,0.039527,0.56418,GOBP_MITOCHONDRION_ORGANIZATION,0.995788730892286
MODULE_416,SET,22,-0.02998,-0.0010372,0.18533,0.56425,MODULE_416,0.995861707800122
GOBP_POSITIVE_REGULATION_OF_...720,SET,8,-0.045732,-0.00095441,0.28208,0.5644,GOBP_POSITIVE_REGULATION_OF_SPINDLE_ASSEMBLY,0.996075864520388
GRANDVAUX_IFN_RESPONSE_NOT_V...,SET,14,-0.035185,-0.00097123,0.21665,0.56451,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,0.996219409464812
HP_PSYCHOMOTOR_DETERIORATION,SET,19,-0.031249,-0.0010047,0.19221,0.56457,HP_PSYCHOMOTOR_DETERIORATION,0.996260612058465
KLEIN_TARGETS_OF_BCR_ABL1_FU...,SET,40,-0.023462,-0.0010939,0.14422,0.56462,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,0.996260612058465
GOBP_GLIAL_CELL_FATE_SPECIFI...,SET,7,-0.061335,-0.0011974,0.37682,0.56465,GOBP_GLIAL_CELL_FATE_SPECIFICATION,0.996260612058465
GOBP_SPERM_EGG_RECOGNITION,SET,49,-0.01933,-0.00099726,0.11867,0.5647,GOBP_SPERM_EGG_RECOGNITION,0.996260612058465
GSE36078_UNTREATED_VS_AD5_T4...4,SET,179,-0.010336,-0.0010156,0.063438,0.56471,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP,0.996260612058465
HP_ANTEVERTED_EARS,SET,10,-0.047615,-0.0011109,0.29203,0.56476,HP_ANTEVERTED_EARS,0.996260612058465
GOCC_JUXTAPARANODE_REGION_OF...,SET,12,-0.042909,-0.0010966,0.26311,0.56477,GOCC_JUXTAPARANODE_REGION_OF_AXON,0.996260612058465
KEGG_MEDICUS_VARIANT_MUTATIO...25,SET,16,-0.034402,-0.0010151,0.21091,0.56478,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY,0.996260612058465
HP_ABNORMAL_LEFT_VENTRICULAR...,SET,26,-0.028349,-0.0010661,0.17375,0.5648,HP_ABNORMAL_LEFT_VENTRICULAR_OUTFLOW_TRACT_MORPHOLOGY,0.996260612058465
FAN_EMBRYONIC_CTX_IN_6_INTER...,SET,4,-0.081031,-0.0011959,0.49653,0.56482,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.996260612058465
HP_MEGAKARYOCYTOPENIA,SET,6,-0.053841,-0.00097315,0.32932,0.56493,HP_MEGAKARYOCYTOPENIA,0.996306516837041
HP_RECURRENT_CUTANEOUS_ABSCE...,SET,6,-0.063619,-0.0011499,0.38903,0.56495,HP_RECURRENT_CUTANEOUS_ABSCESS_FORMATION,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...640,SET,24,-0.028536,-0.001031,0.17444,0.56497,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION,0.996306516837041
MIR4728_3P,SET,99,-0.014693,-0.001076,0.089794,0.56499,MIR4728_3P,0.996306516837041
HP_ECTOPIC_CALCIFICATION,SET,209,-0.010116,-0.0010732,0.061707,0.56511,HP_ECTOPIC_CALCIFICATION,0.996306516837041
HP_FACIAL_HYPERTRICHOSIS,SET,174,-0.010397,-0.0010074,0.063338,0.5652,HP_FACIAL_HYPERTRICHOSIS,0.996306516837041
GOBP_DEOXYRIBONUCLEOSIDE_MON...2,SET,14,-0.040059,-0.0011058,0.24388,0.56524,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.996306516837041
GOCC_ZONULA_ADHERENS,SET,7,-0.054138,-0.0010569,0.3293,0.56529,GOCC_ZONULA_ADHERENS,0.996306516837041
PID_AURORA_B_PATHWAY,SET,36,-0.023084,-0.0010212,0.1404,0.5653,PID_AURORA_B_PATHWAY,0.996306516837041
REACTOME_STRIATED_MUSCLE_CON...,SET,35,-0.023421,-0.0010216,0.14244,0.5653,REACTOME_STRIATED_MUSCLE_CONTRACTION,0.996306516837041
ZC3H11A_TARGET_GENES,SET,745,-0.0052552,-0.0010369,0.031942,0.56534,ZC3H11A_TARGET_GENES,0.996306516837041
MIR155_3P,SET,85,-0.014925,-0.0010132,0.090693,0.56536,MIR155_3P,0.996306516837041
DESCARTES_MAIN_FETAL_SCHWANN...,SET,37,-0.023779,-0.0010664,0.14443,0.56538,DESCARTES_MAIN_FETAL_SCHWANN_CELLS,0.996306516837041
HP_AGENESIS_OF_PERMANENT_TEE...,SET,19,-0.030557,-0.0009825,0.18554,0.56541,HP_AGENESIS_OF_PERMANENT_TEETH,0.996306516837041
GSE25088_CTRL_VS_IL4_AND_ROS...1,SET,170,-0.010727,-0.0010274,0.065074,0.56547,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.996306516837041
MIR3919,SET,278,-0.0086594,-0.0010575,0.052424,0.5656,MIR3919,0.996306516837041
GSE5503_LIVER_DC_VS_MLN_DC_A...2,SET,179,-0.010736,-0.0010549,0.064933,0.56566,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.996306516837041
GOBP_INTRINSIC_APOPTOTIC_SIG...3,SET,97,-0.013999,-0.0010149,0.084562,0.56574,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.996306516837041
GSE1925_CTRL_VS_3H_IFNG_STIM...2,SET,155,-0.011286,-0.0010326,0.068151,0.56577,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.996306516837041
MIR630,SET,71,-0.016634,-0.0010324,0.10041,0.56579,MIR630,0.996306516837041
GSE6092_IFNG_VS_IFNG_AND_B_B...1,SET,160,-0.011714,-0.0010887,0.070683,0.56581,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,0.996306516837041
GSE12003_4D_VS_8D_CULTURE_BM...1,SET,127,-0.011844,-0.00098164,0.071428,0.56585,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN,0.996306516837041
GOBP_CELL_PROLIFERATION_IN_B...,SET,8,-0.048485,-0.0010119,0.29232,0.56587,GOBP_CELL_PROLIFERATION_IN_BONE_MARROW,0.996306516837041
HP_INCREASED_CIRCULATING_HEM...,SET,12,-0.041861,-0.0010698,0.25231,0.56588,HP_INCREASED_CIRCULATING_HEMOGLOBIN_CONCENTRATION,0.996306516837041
HP_RETINAL_HOLE,SET,5,-0.062381,-0.0010293,0.37596,0.56589,HP_RETINAL_HOLE,0.996306516837041
KEGG_MEDICUS_REFERENCE_PP2A_...,SET,18,-0.032016,-0.001002,0.19285,0.56593,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY,0.996306516837041
MODULE_273,SET,40,-0.021236,-0.00099012,0.12787,0.56595,MODULE_273,0.996306516837041
NAKAYAMA_FRA2_TARGETS,SET,43,-0.023833,-0.001152,0.14347,0.56596,NAKAYAMA_FRA2_TARGETS,0.996306516837041
GOBP_O_GLYCAN_PROCESSING,SET,41,-0.024062,-0.0011358,0.14476,0.566,GOBP_O_GLYCAN_PROCESSING,0.996306516837041
GOMF_GLUTATHIONE_DISULFIDE_O...,SET,5,-0.071104,-0.0011732,0.42783,0.566,GOMF_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.996306516837041
CHIANG_LIVER_CANCER_SUBCLASS...4,SET,22,-0.033518,-0.0011595,0.20144,0.56607,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,0.996306516837041
BIOCARTA_ACE2_PATHWAY,SET,9,-0.054591,-0.0012084,0.32794,0.5661,BIOCARTA_ACE2_PATHWAY,0.996306516837041
GOBP_REGULATION_OF_EARLY_END...,SET,16,-0.038578,-0.0011383,0.23171,0.56611,GOBP_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,0.996306516837041
GOBP_REGULATION_OF_MONOATOMI...4,SET,410,-0.0074845,-0.0011059,0.044958,0.56611,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.996306516837041
HP_DUPLICATION_INVOLVING_BON...,SET,122,-0.012704,-0.0010321,0.076289,0.56613,HP_DUPLICATION_INVOLVING_BONES_OF_THE_FEET,0.996306516837041
HP_EEG_WITH_CENTROTEMPORAL_E...,SET,3,-0.090538,-0.0011572,0.54346,0.56616,HP_EEG_WITH_CENTROTEMPORAL_EPILEPTIFORM_DISCHARGES,0.996306516837041
BUCASAS_PBMC_FLUARIX_FLUVIRI...2,SET,18,-0.029986,-0.00093843,0.17998,0.56616,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE,0.996306516837041
LAIHO_COLORECTAL_CANCER_SERR...1,SET,67,-0.016875,-0.0010175,0.10126,0.56617,LAIHO_COLORECTAL_CANCER_SERRATED_DN,0.996306516837041
PLASARI_TGFB1_TARGETS_10HR_DN,SET,235,-0.01001,-0.0011252,0.06007,0.56617,PLASARI_TGFB1_TARGETS_10HR_DN,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...745,SET,6,-0.05524,-0.00099845,0.33133,0.56621,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.996306516837041
GOBP_REGULATION_OF_DNA_METHY...,SET,14,-0.034639,-0.00095614,0.20775,0.56621,GOBP_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.996306516837041
GOBP_NEGATIVE_REGULATION_OF_...63,SET,4,-0.084437,-0.0012462,0.50586,0.56628,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.996306516837041
GOBP_REGULATION_OF_PEPTIDASE...,SET,268,-0.0093821,-0.0011252,0.056192,0.5663,GOBP_REGULATION_OF_PEPTIDASE_ACTIVITY,0.996306516837041
GOBP_CARBOHYDRATE_IMPORT_ACR...,SET,5,-0.07293,-0.0012034,0.43673,0.56631,GOBP_CARBOHYDRATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.996306516837041
TOMLINS_PROSTATE_CANCER_UP,SET,36,-0.023484,-0.0010389,0.14059,0.56633,TOMLINS_PROSTATE_CANCER_UP,0.996306516837041
HP_NEUROGENIC_BLADDER,SET,65,-0.016943,-0.0010063,0.1014,0.56635,HP_NEUROGENIC_BLADDER,0.996306516837041
AACATTC_MIR4093P,SET,137,-0.012414,-0.0010683,0.074278,0.56636,AACATTC_MIR4093P,0.996306516837041
GOBP_MONOSACCHARIDE_TRANSMEM...,SET,110,-0.014274,-0.0011016,0.085359,0.5664,GOBP_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORT,0.996306516837041
MIR487A_5P,SET,94,-0.013979,-0.0009977,0.083477,0.5665,MIR487A_5P,0.996306516837041
MIR487B_5P,SET,94,-0.013979,-0.0009977,0.083477,0.5665,MIR487B_5P,0.996306516837041
HP_WIDELY_PATENT_FONTANELLES...,SET,15,-0.038795,-0.0011084,0.23166,0.5665,HP_WIDELY_PATENT_FONTANELLES_AND_SUTURES,0.996306516837041
REACTOME_PROSTANOID_LIGAND_R...,SET,9,-0.054215,-0.0012,0.32359,0.56653,REACTOME_PROSTANOID_LIGAND_RECEPTORS,0.996306516837041
HP_CUPPED_RIBS,SET,23,-0.02923,-0.0010339,0.17435,0.56657,HP_CUPPED_RIBS,0.996306516837041
KEGG_CITRATE_CYCLE_TCA_CYCLE,SET,27,-0.025543,-0.00097881,0.15228,0.56661,KEGG_CITRATE_CYCLE_TCA_CYCLE,0.996306516837041
GOBP_SENSORY_PERCEPTION_OF_C...,SET,403,-0.0098009,-0.001436,0.058388,0.56665,GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS,0.996306516837041
TING_SILENCED_BY_DICER,SET,26,-0.031486,-0.001184,0.18756,0.56666,TING_SILENCED_BY_DICER,0.996306516837041
OCT1_Q6,SET,229,-0.0098243,-0.0010903,0.05846,0.56673,OCT1_Q6,0.996306516837041
HP_POSTAXIAL_HAND_POLYDACTYLY,SET,78,-0.015616,-0.0010157,0.092883,0.56676,HP_POSTAXIAL_HAND_POLYDACTYLY,0.996306516837041
GSE17186_NAIVE_VS_CD21LOW_TR...2,SET,175,-0.010426,-0.001013,0.062001,0.56677,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.996306516837041
GOBP_ERBB3_SIGNALING_PATHWAY,SET,10,-0.048382,-0.0011288,0.28745,0.56683,GOBP_ERBB3_SIGNALING_PATHWAY,0.996306516837041
HP_HYPEREXTENSIBILITY_OF_THE...1,SET,21,-0.033486,-0.0011318,0.19885,0.56686,HP_HYPEREXTENSIBILITY_OF_THE_FINGER_JOINTS,0.996306516837041
REACTOME_ENDOGENOUS_STEROLS,SET,24,-0.031025,-0.001121,0.18421,0.56687,REACTOME_ENDOGENOUS_STEROLS,0.996306516837041
GOBP_CELL_SURFACE_RECEPTOR_P...2,SET,581,-0.0063,-0.0011028,0.037383,0.56692,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY,0.996306516837041
HP_FLARED_NOSTRILS,SET,6,-0.059543,-0.0010762,0.35327,0.56692,HP_FLARED_NOSTRILS,0.996306516837041
GOBP_HEPARAN_SULFATE_PROTEOG...5,SET,15,-0.041816,-0.0011947,0.24784,0.56699,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.996306516837041
BIOCARTA_IL2_PATHWAY,SET,20,-0.034721,-0.0011453,0.20571,0.56702,BIOCARTA_IL2_PATHWAY,0.996306516837041
GOBP_NEGATIVE_REGULATION_OF_...448,SET,11,-0.048448,-0.0011855,0.287,0.56702,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.996306516837041
GOCC_CUL3_RING_UBIQUITIN_LIG...,SET,37,-0.023974,-0.0010752,0.14204,0.56702,GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX,0.996306516837041
KEGG_MEDICUS_REFERENCE_SKELE...,SET,21,-0.034476,-0.0011653,0.20418,0.56704,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING,0.996306516837041
CUI_DEVELOPING_HEART_ENDOCAR...,SET,50,-0.022196,-0.0011567,0.13144,0.56705,CUI_DEVELOPING_HEART_ENDOCARDIAL_CELL,0.996306516837041
GSE360_CTRL_VS_L_DONOVANI_MA...1,SET,175,-0.010778,-0.0010473,0.06381,0.56707,GSE360_CTRL_VS_L_DONOVANI_MAC_DN,0.996306516837041
ZNF354C_TARGET_GENES,SET,10,-0.043582,-0.0010168,0.25786,0.56711,ZNF354C_TARGET_GENES,0.996306516837041
HP_MYELOFIBROSIS,SET,11,-0.0415,-0.0010155,0.24549,0.56712,HP_MYELOFIBROSIS,0.996306516837041
GOBP_NEGATIVE_REGULATION_OF_...666,SET,38,-0.026097,-0.001186,0.15418,0.5672,GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.996306516837041
HP_ABNORMAL_THYMUS_MORPHOLOGY,SET,51,-0.021657,-0.0011398,0.12796,0.5672,HP_ABNORMAL_THYMUS_MORPHOLOGY,0.996306516837041
GOBP_AXONAL_FASCICULATION,SET,20,-0.036051,-0.0011892,0.21298,0.56721,GOBP_AXONAL_FASCICULATION,0.996306516837041
MIR4315,SET,3,-0.07798,-0.00099672,0.46027,0.56727,MIR4315,0.996306516837041
GSE5589_UNSTIM_VS_180MIN_LPS...4,SET,180,-0.010829,-0.001067,0.063919,0.56727,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP,0.996306516837041
PID_IL2_PI3K_PATHWAY,SET,33,-0.025737,-0.0010902,0.15189,0.56728,PID_IL2_PI3K_PATHWAY,0.996306516837041
HP_ABNORMALITY_OF_THE_DISTAL...6,SET,29,-0.026055,-0.0010347,0.15368,0.56731,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.996306516837041
GOMF_RIBOSOMAL_LARGE_SUBUNIT...,SET,12,-0.040428,-0.0010332,0.23835,0.56734,GOMF_RIBOSOMAL_LARGE_SUBUNIT_BINDING,0.996306516837041
GSE3920_IFNA_VS_IFNB_TREATED...2,SET,159,-0.011774,-0.0010909,0.069329,0.56742,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,0.996306516837041
GOMF_ICOSANOID_BINDING,SET,7,-0.05722,-0.0011171,0.33675,0.56746,GOMF_ICOSANOID_BINDING,0.996306516837041
ROZANOV_MMP14_TARGETS_DN,SET,30,-0.028514,-0.0011517,0.16778,0.56747,ROZANOV_MMP14_TARGETS_DN,0.996306516837041
HP_APLASIA_HYPOPLASIA_INVOLV...12,SET,64,-0.018627,-0.0010979,0.10961,0.56747,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_PELVIS,0.996306516837041
GOBP_REGULATION_OF_CELLULAR_...4,SET,310,-0.0083707,-0.0010785,0.049224,0.56752,GOBP_REGULATION_OF_CELLULAR_COMPONENT_SIZE,0.996306516837041
HP_DELAYED_GROSS_MOTOR_DEVEL...,SET,410,-0.0072677,-0.0010739,0.042728,0.56753,HP_DELAYED_GROSS_MOTOR_DEVELOPMENT,0.996306516837041
HP_SHORT_COLUMELLA,SET,24,-0.029312,-0.0010591,0.17232,0.56753,HP_SHORT_COLUMELLA,0.996306516837041
BLANCO_MELO_COVID19_SARS_COV...9,SET,14,-0.044072,-0.0012165,0.25902,0.56755,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,0.996306516837041
GOBP_CHOLINE_METABOLIC_PROCE...,SET,6,-0.067328,-0.0012169,0.39573,0.56755,GOBP_CHOLINE_METABOLIC_PROCESS,0.996306516837041
REACTOME_RUNX3_REGULATES_WNT...,SET,8,-0.051856,-0.0010822,0.30443,0.56763,REACTOME_RUNX3_REGULATES_WNT_SIGNALING,0.996306516837041
GOBP_CORTICOSTERONE_SECRETION,SET,5,-0.073551,-0.0012136,0.43094,0.56776,GOBP_CORTICOSTERONE_SECRETION,0.996306516837041
HP_ATRIAL_FLUTTER,SET,17,-0.038263,-0.0011638,0.22402,0.56781,HP_ATRIAL_FLUTTER,0.996306516837041
GOCC_AP_1_ADAPTOR_COMPLEX,SET,10,-0.045273,-0.0010563,0.26489,0.56785,GOCC_AP_1_ADAPTOR_COMPLEX,0.996306516837041
HP_ABNORMAL_NERVE_CONDUCTION...,SET,104,-0.013868,-0.0010408,0.081078,0.5679,HP_ABNORMAL_NERVE_CONDUCTION_VELOCITY,0.996306516837041
HP_CALCINOSIS,SET,11,-0.047423,-0.0011604,0.27728,0.5679,HP_CALCINOSIS,0.996306516837041
DESCARTES_FETAL_LIVER_LYMPHO...,SET,90,-0.016439,-0.0011481,0.096114,0.5679,DESCARTES_FETAL_LIVER_LYMPHOID_CELLS,0.996306516837041
GOBP_DEFENSE_RESPONSE,SET,1629,-0.003988,-0.001134,0.023304,0.56794,GOBP_DEFENSE_RESPONSE,0.996306516837041
GSE17721_LPS_VS_CPG_1H_BMDC_...2,SET,180,-0.010252,-0.0010101,0.059898,0.56795,GSE17721_LPS_VS_CPG_1H_BMDC_UP,0.996306516837041
HP_ABNORMALITY_OF_VITAMIN_K_...,SET,13,-0.043935,-0.0011687,0.25662,0.56797,HP_ABNORMALITY_OF_VITAMIN_K_METABOLISM,0.996306516837041
GOBP_CELLULAR_RESPONSE_TO_ES...1,SET,36,-0.025983,-0.0011494,0.15174,0.56798,GOBP_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS,0.996306516837041
GOBP_MEIOTIC_CYTOKINESIS,SET,7,-0.061304,-0.0011968,0.35783,0.56801,GOBP_MEIOTIC_CYTOKINESIS,0.996306516837041
SENGUPTA_EBNA1_ANTICORRELATED,SET,126,-0.012948,-0.0010689,0.075526,0.56806,SENGUPTA_EBNA1_ANTICORRELATED,0.996306516837041
WP_CYSTEINE_AND_METHIONINE_C...,SET,13,-0.041714,-0.0011096,0.24322,0.56809,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,0.996306516837041
GOBP_PSEUDOURIDINE_SYNTHESIS,SET,17,-0.031832,-0.00096817,0.18559,0.56809,GOBP_PSEUDOURIDINE_SYNTHESIS,0.996306516837041
GOCC_METHYLOSOME,SET,13,-0.037453,-0.00099624,0.21836,0.56809,GOCC_METHYLOSOME,0.996306516837041
HP_PERINUCLEAR_ANTINEUTROPHI...,SET,6,-0.052148,-0.00094256,0.30402,0.56809,HP_PERINUCLEAR_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,0.996306516837041
HP_INTERMITTENT_HYPERVENTILA...,SET,3,-0.095135,-0.001216,0.55452,0.56811,HP_INTERMITTENT_HYPERVENTILATION,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...369,SET,56,-0.020842,-0.0011493,0.12146,0.56812,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,0.996306516837041
chr5q12,SET,26,-0.047306,-0.0017789,0.27528,0.56822,chr5q12,0.996306516837041
GOMF_MHC_CLASS_IB_PROTEIN_BI...,SET,6,-0.064254,-0.0011614,0.37366,0.56826,GOMF_MHC_CLASS_IB_PROTEIN_BINDING,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...61,SET,30,-0.029071,-0.0011742,0.16905,0.56827,GOBP_POSITIVE_REGULATION_OF_BLOOD_PRESSURE,0.996306516837041
GOCC_TERTIARY_GRANULE_MEMBRA...,SET,63,-0.018371,-0.0010743,0.10682,0.56827,GOCC_TERTIARY_GRANULE_MEMBRANE,0.996306516837041
HP_UNDETECTABLE_LIGHT_ADAPTE...,SET,6,-0.068918,-0.0012457,0.40043,0.56832,HP_UNDETECTABLE_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.996306516837041
HP_INFANTILE_MUSCULAR_HYPOTO...,SET,177,-0.011243,-0.0010986,0.065241,0.56841,HP_INFANTILE_MUSCULAR_HYPOTONIA,0.996306516837041
KEGG_MEDICUS_REFERENCE_ACTIV...1,SET,16,-0.03444,-0.0010162,0.19971,0.56846,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119,0.996306516837041
GSE30083_SP3_VS_SP4_THYMOCYT...1,SET,181,-0.011478,-0.001134,0.066554,0.56846,GSE30083_SP3_VS_SP4_THYMOCYTE_DN,0.996306516837041
KEGG_O_GLYCAN_BIOSYNTHESIS,SET,27,-0.032811,-0.0012573,0.19021,0.56848,KEGG_O_GLYCAN_BIOSYNTHESIS,0.996306516837041
MIR196B_3P,SET,6,-0.068609,-0.0012401,0.39772,0.56848,MIR196B_3P,0.996306516837041
GOBP_CYTOPLASMIC_TRANSLATION...1,SET,4,-0.0623,-0.00091947,0.36106,0.5685,GOBP_CYTOPLASMIC_TRANSLATIONAL_ELONGATION,0.996306516837041
GOBP_SERTOLI_CELL_PROLIFERAT...,SET,5,-0.071766,-0.0011842,0.4157,0.56853,GOBP_SERTOLI_CELL_PROLIFERATION,0.996306516837041
GOBP_ARGININE_BIOSYNTHETIC_P...,SET,4,-0.067662,-0.0009986,0.39183,0.56855,GOBP_ARGININE_BIOSYNTHETIC_PROCESS,0.996306516837041
HP_ABNORMAL_DENTAL_MORPHOLOGY,SET,255,-0.0095077,-0.0011127,0.055037,0.56858,HP_ABNORMAL_DENTAL_MORPHOLOGY,0.996306516837041
MIR8073,SET,76,-0.016974,-0.0010898,0.098211,0.56861,MIR8073,0.996306516837041
GOMF_FRUCTOSE_TRANSMEMBRANE_...,SET,8,-0.052712,-0.0011001,0.30469,0.56867,GOMF_FRUCTOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.996306516837041
GOBP_MITOCHONDRIAL_TRANSLATI...2,SET,5,-0.057985,-0.00095677,0.33513,0.56868,GOBP_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION,0.996306516837041
WP_GLP1_FROM_INTESTINE_AND_P...,SET,6,-0.07167,-0.0012954,0.4138,0.56875,WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS,0.996306516837041
GSE7460_CTRL_VS_TGFB_TREATED...1,SET,185,-0.01104,-0.0011026,0.063731,0.56876,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN,0.996306516837041
REACTOME_FGFR3B_LIGAND_BINDI...,SET,7,-0.065871,-0.001286,0.37995,0.56882,REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION,0.996306516837041
GOBP_ANTIBACTERIAL_HUMORAL_R...,SET,48,-0.026149,-0.0013353,0.15084,0.56882,GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE,0.996306516837041
MIR3652,SET,135,-0.012333,-0.0010536,0.071071,0.56888,MIR3652,0.996306516837041
GOBP_NEURONAL_ACTION_POTENTI...2,SET,10,-0.04873,-0.0011369,0.28083,0.56888,GOBP_NEURONAL_ACTION_POTENTIAL_PROPAGATION,0.996306516837041
GOBP_REGULATION_OF_CILIUM_DE...,SET,27,-0.029028,-0.0011124,0.16725,0.56889,GOBP_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY,0.996306516837041
GSE41867_NAIVE_VS_DAY30_LCMV...4,SET,170,-0.011917,-0.0011414,0.068663,0.56889,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP,0.996306516837041
GOBP_SYNAPTIC_VESICLE_DOCKING,SET,9,-0.048963,-0.0010838,0.28203,0.56891,GOBP_SYNAPTIC_VESICLE_DOCKING,0.996306516837041
HP_PERSISTENT_CMV_VIREMIA,SET,5,-0.066926,-0.0011043,0.38551,0.56891,HP_PERSISTENT_CMV_VIREMIA,0.996306516837041
GOMF_PHOSPHATIDYLSERINE_FLOP...,SET,8,-0.055688,-0.0011622,0.32059,0.56895,GOMF_PHOSPHATIDYLSERINE_FLOPPASE_ACTIVITY,0.996306516837041
GSE20366_TREG_VS_NAIVE_CD4_T...5,SET,178,-0.010946,-0.0010725,0.063017,0.56895,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP,0.996306516837041
BIOCARTA_ARF_PATHWAY,SET,17,-0.035773,-0.001088,0.20587,0.56898,BIOCARTA_ARF_PATHWAY,0.996306516837041
REACTOME_NEGATIVE_REGULATION...3,SET,32,-0.028037,-0.0011695,0.16132,0.56899,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...583,SET,5,-0.074576,-0.0012305,0.42891,0.56902,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.996306516837041
HP_EPISODIC_FLACCID_WEAKNESS,SET,5,-0.073742,-0.0012168,0.42411,0.56902,HP_EPISODIC_FLACCID_WEAKNESS,0.996306516837041
GSE9988_LOW_LPS_VS_VEHICLE_T...2,SET,164,-0.012592,-0.0011848,0.072353,0.56908,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.996306516837041
GOBP_REGULATION_OF_RESPIRATO...5,SET,14,-0.042994,-0.0011868,0.24692,0.56911,GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS,0.996306516837041
HP_ABNORMAL_COLUMELLA_MORPHO...,SET,78,-0.016443,-0.0010695,0.094418,0.56913,HP_ABNORMAL_COLUMELLA_MORPHOLOGY,0.996306516837041
GOBP_LOCOMOTION,SET,1124,-0.0048273,-0.0011573,0.027715,0.56914,GOBP_LOCOMOTION,0.996306516837041
WP_STING_PATHWAY_IN_KAWASAKI...,SET,18,-0.034794,-0.0010889,0.19949,0.56923,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,0.996306516837041
MYLLYKANGAS_AMPLIFICATION_HO...4,SET,18,-0.032649,-0.0010218,0.18713,0.56925,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,0.996306516837041
HP_SHORTENING_OF_ALL_MIDDLE_...,SET,6,-0.064785,-0.001171,0.37122,0.56927,HP_SHORTENING_OF_ALL_MIDDLE_PHALANGES_OF_THE_FINGERS,0.996306516837041
GOBP_NITROGEN_CYCLE_METABOLI...,SET,12,-0.040194,-0.0010273,0.23025,0.56929,GOBP_NITROGEN_CYCLE_METABOLIC_PROCESS,0.996306516837041
GSE41867_NAIVE_VS_DAY8_LCMV_...3,SET,159,-0.011552,-0.0010703,0.066154,0.56931,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.996306516837041
HP_APLASIA_HYPOPLASIA_OF_THE...35,SET,7,-0.051802,-0.0010113,0.29655,0.56934,HP_APLASIA_HYPOPLASIA_OF_THE_GALLBLADDER,0.996306516837041
GOMF_MINOR_GROOVE_OF_ADENINE...,SET,8,-0.059757,-0.0012471,0.34194,0.56936,GOMF_MINOR_GROOVE_OF_ADENINE_THYMINE_RICH_DNA_BINDING,0.996306516837041
GOBP_RNA_STABILIZATION,SET,60,-0.019319,-0.0011026,0.11049,0.5694,GOBP_RNA_STABILIZATION,0.996306516837041
GSE13522_CTRL_VS_T_CRUZI_Y_S...4,SET,121,-0.012537,-0.0010144,0.071639,0.56946,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP,0.996306516837041
GTTTGTT_MIR495,SET,228,-0.010197,-0.0011293,0.058228,0.56951,GTTTGTT_MIR495,0.996306516837041
REACTOME_ONCOGENE_INDUCED_SE...,SET,32,-0.026734,-0.0011151,0.15263,0.56952,REACTOME_ONCOGENE_INDUCED_SENESCENCE,0.996306516837041
GOMF_DOPAMINE_RECEPTOR_BINDI...,SET,13,-0.039359,-0.001047,0.22468,0.56953,GOMF_DOPAMINE_RECEPTOR_BINDING,0.996306516837041
GOCC_MITOCHONDRIAL_CRISTA_JU...,SET,4,-0.076582,-0.0011302,0.4369,0.56957,GOCC_MITOCHONDRIAL_CRISTA_JUNCTION,0.996306516837041
HP_SHORT_PALPEBRAL_FISSURE,SET,107,-0.014041,-0.0010688,0.08011,0.56957,HP_SHORT_PALPEBRAL_FISSURE,0.996306516837041
GSE17974_CTRL_VS_ACT_IL4_AND...1,SET,167,-0.010958,-0.0010404,0.062505,0.56958,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN,0.996306516837041
MIR3678_5P,SET,13,-0.039597,-0.0010533,0.22577,0.56961,MIR3678_5P,0.996306516837041
chr1q42,SET,83,-0.033455,-0.0022443,0.19072,0.56962,chr1q42,0.996306516837041
GSE2770_TGFB_AND_IL4_VS_IL4_...5,SET,171,-0.011206,-0.0010764,0.063863,0.56964,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.996306516837041
GSE41176_UNSTIM_VS_ANTI_IGM_...8,SET,184,-0.011265,-0.001122,0.06417,0.56967,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...563,SET,44,-0.024452,-0.0011956,0.13921,0.56972,GOBP_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.996306516837041
HP_ABNORMALITY_OF_THE_VESTIB...,SET,9,-0.054067,-0.0011968,0.30779,0.56972,HP_ABNORMALITY_OF_THE_VESTIBULOCOCHLEAR_NERVE,0.996306516837041
HP_LAMELLAR_CATARACT,SET,6,-0.060698,-0.0010971,0.34552,0.56972,HP_LAMELLAR_CATARACT,0.996306516837041
HP_DEPLETION_OF_MITOCHONDRIA...,SET,16,-0.033555,-0.00099012,0.19066,0.56985,HP_DEPLETION_OF_MITOCHONDRIAL_DNA_IN_MUSCLE_TISSUE,0.996306516837041
GSE29618_PDC_VS_MDC_DAY7_FLU...1,SET,179,-0.011641,-0.0011439,0.066096,0.5699,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN,0.996306516837041
GOBP_OLIGODENDROCYTE_DEVELOP...,SET,44,-0.023578,-0.0011529,0.13383,0.56992,GOBP_OLIGODENDROCYTE_DEVELOPMENT,0.996306516837041
MIR4524A_3P,SET,200,-0.010673,-0.0011079,0.060433,0.57009,MIR4524A_3P,0.996306516837041
GSE11961_GERMINAL_CENTER_BCE...1,SET,177,-0.011372,-0.0011112,0.064393,0.57009,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.996306516837041
GSE20366_CD103_POS_VS_CD103_...2,SET,181,-0.011365,-0.0011228,0.064345,0.5701,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP,0.996306516837041
MIR6857_3P,SET,68,-0.019309,-0.0011729,0.10924,0.57015,MIR6857_3P,0.996306516837041
GOBP_REGULATION_OF_LYSOSOME_...2,SET,4,-0.082492,-0.0012175,0.46632,0.57021,GOBP_REGULATION_OF_LYSOSOME_SIZE,0.996306516837041
GOCC_BORC_COMPLEX,SET,4,-0.082492,-0.0012175,0.46632,0.57021,GOCC_BORC_COMPLEX,0.996306516837041
GOMF_SULFUR_AMINO_ACID_TRANS...,SET,11,-0.043807,-0.001072,0.2475,0.57024,GOMF_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.996306516837041
HP_GALACTORRHEA,SET,9,-0.048733,-0.0010787,0.27525,0.57026,HP_GALACTORRHEA,0.996306516837041
REACTOME_RAF_ACTIVATION,SET,32,-0.025585,-0.0010672,0.1444,0.57031,REACTOME_RAF_ACTIVATION,0.996306516837041
REACTOME_TICAM1_DEPENDENT_AC...,SET,12,-0.044093,-0.0011269,0.24885,0.57032,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,0.996306516837041
SCHLOSSER_SERUM_RESPONSE_UP,SET,116,-0.014127,-0.0011193,0.079699,0.57034,SCHLOSSER_SERUM_RESPONSE_UP,0.996306516837041
GOMF_PEPTIDASE_ACTIVATOR_ACT...2,SET,21,-0.034981,-0.0011824,0.19733,0.57035,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.996306516837041
HP_APLASIA_HYPOPLASIA_OF_THE...10,SET,13,-0.042955,-0.0011426,0.24228,0.57036,HP_APLASIA_HYPOPLASIA_OF_THE_BLADDER,0.996306516837041
MIR11181_5P,SET,65,-0.018148,-0.0010779,0.10231,0.5704,MIR11181_5P,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...582,SET,172,-0.012459,-0.0012003,0.070226,0.57041,GOBP_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.996306516837041
SWEET_KRAS_ONCOGENIC_SIGNATU...,SET,82,-0.016861,-0.0011243,0.095011,0.57043,SWEET_KRAS_ONCOGENIC_SIGNATURE,0.996306516837041
GNF2_CKS1B,SET,36,-0.023542,-0.0010414,0.13255,0.57048,GNF2_CKS1B,0.996306516837041
GSE15624_3H_VS_6H_HALOFUGINO...2,SET,159,-0.011992,-0.0011111,0.067519,0.57048,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.996306516837041
GOMF_NEUROTRANSMITTER_RECEPT...2,SET,52,-0.023695,-0.0012592,0.13339,0.57049,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY_INVOLVED_IN_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,0.996306516837041
DURANTE_ADULT_OLFACTORY_NEUR...5,SET,103,-0.01578,-0.0011786,0.08882,0.5705,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_DENDRITIC_CELLS,0.996306516837041
GSE6259_FLT3L_INDUCED_DEC205...1,SET,149,-0.012204,-0.001095,0.068683,0.57052,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN,0.996306516837041
GSE27786_LIN_NEG_VS_NKTCELL_...2,SET,179,-0.010664,-0.0010478,0.059981,0.57055,GSE27786_LIN_NEG_VS_NKTCELL_UP,0.996306516837041
GOBP_CYCLOOXYGENASE_PATHWAY,SET,9,-0.049738,-0.0011009,0.27972,0.57057,GOBP_CYCLOOXYGENASE_PATHWAY,0.996306516837041
GOBP_REGULATION_OF_ATRIAL_CA...1,SET,9,-0.060206,-0.0013327,0.3385,0.57058,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.996306516837041
GOBP_ATRIOVENTRICULAR_VALVE_...1,SET,29,-0.031159,-0.0012374,0.17513,0.5706,GOBP_ATRIOVENTRICULAR_VALVE_DEVELOPMENT,0.996306516837041
GOMF_JUN_KINASE_BINDING,SET,11,-0.046248,-0.0011317,0.25994,0.57061,GOMF_JUN_KINASE_BINDING,0.996306516837041
chr2p25,SET,45,-0.039928,-0.0019743,0.2242,0.57067,chr2p25,0.996306516837041
WP_OSTEOARTHRITIC_CHONDROCYT...,SET,47,-0.022998,-0.0011621,0.12903,0.57073,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,0.996306516837041
GOBP_REGULATION_OF_DNA_REPLI...,SET,117,-0.014047,-0.0011178,0.078767,0.57077,GOBP_REGULATION_OF_DNA_REPLICATION,0.996306516837041
GOMF_RNA_EXONUCLEASE_ACTIVITY,SET,43,-0.021447,-0.0010367,0.12024,0.57078,GOMF_RNA_EXONUCLEASE_ACTIVITY,0.996306516837041
GOBP_METANEPHRIC_LOOP_OF_HEN...,SET,5,-0.076188,-0.0012571,0.42707,0.57079,GOBP_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT,0.996306516837041
GCNP_SHH_UP_EARLY.V1_DN,SET,150,-0.012652,-0.0011389,0.070916,0.5708,GCNP_SHH_UP_EARLY.V1_DN,0.996306516837041
chr7q11,SET,71,-0.033334,-0.0020689,0.18678,0.57082,chr7q11,0.996306516837041
GOBP_METAPHASE_CHROMOSOME_AL...,SET,96,-0.01516,-0.0010934,0.084949,0.57082,GOBP_METAPHASE_CHROMOSOME_ALIGNMENT,0.996306516837041
CHAF1A_TARGET_GENES,SET,79,-0.017609,-0.0011526,0.098652,0.57083,CHAF1A_TARGET_GENES,0.996306516837041
HP_ANTALGIC_GAIT,SET,9,-0.059734,-0.0013222,0.3343,0.57091,HP_ANTALGIC_GAIT,0.996306516837041
MODULE_156,SET,16,-0.039467,-0.0011646,0.2208,0.57093,MODULE_156,0.996306516837041
HP_URETHRAL_VALVE,SET,11,-0.046331,-0.0011337,0.25915,0.57094,HP_URETHRAL_VALVE,0.996306516837041
KEGG_BIOSYNTHESIS_OF_UNSATUR...,SET,22,-0.034862,-0.001206,0.1949,0.57098,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,0.996306516837041
GOBP_NEGATIVE_REGULATION_OF_...360,SET,17,-0.036677,-0.0011155,0.20496,0.57101,GOBP_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY,0.996306516837041
GOBP_SEQUESTERING_OF_TRIGLYC...,SET,17,-0.039956,-0.0012153,0.22315,0.57105,GOBP_SEQUESTERING_OF_TRIGLYCERIDE,0.996306516837041
GSE360_L_DONOVANI_VS_B_MALAY...1,SET,177,-0.011274,-0.0011016,0.062969,0.57105,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.996306516837041
GOBP_BUNDLE_OF_HIS_CELL_TO_P...2,SET,7,-0.068747,-0.0013421,0.38379,0.57108,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_SIGNALING,0.996306516837041
WP_GASTRIC_ACID_PRODUCTION,SET,8,-0.059722,-0.0012464,0.33331,0.5711,WP_GASTRIC_ACID_PRODUCTION,0.996306516837041
IIZUKA_LIVER_CANCER_PROGRESS...6,SET,13,-0.042938,-0.0011421,0.23961,0.57111,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,0.996306516837041
DESCARTES_MAIN_FETAL_HEPATOB...,SET,86,-0.016923,-0.0011555,0.094392,0.57114,DESCARTES_MAIN_FETAL_HEPATOBLASTS,0.996306516837041
HP_ABNORMALITY_OF_THE_COSTOC...,SET,17,-0.040272,-0.0012249,0.22432,0.57124,HP_ABNORMALITY_OF_THE_COSTOCHONDRAL_JUNCTION,0.996306516837041
REACTOME_NEF_MEDIATES_DOWN_M...,SET,20,-0.032866,-0.0010841,0.1829,0.5713,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,0.996306516837041
GSE13484_12H_VS_3H_YF17D_VAC...2,SET,174,-0.011586,-0.0011226,0.064406,0.57138,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.996306516837041
GAVISH_3CA_METAPROGRAM_CD4_T...7,SET,38,-0.024328,-0.0011056,0.13521,0.57139,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_2,0.996306516837041
WP_MITOCHONDRIAL_FATTY_ACID_...3,SET,5,-0.065571,-0.0010819,0.36421,0.57144,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,0.996306516837041
MORF_BAG5,SET,52,-0.019279,-0.0010245,0.10706,0.57146,MORF_BAG5,0.996306516837041
CHEOK_RESPONSE_TO_HD_MTX_UP,SET,19,-0.037456,-0.0012043,0.20793,0.57148,CHEOK_RESPONSE_TO_HD_MTX_UP,0.996306516837041
GOBP_REGULATION_OF_AMPA_RECE...,SET,19,-0.036851,-0.0011849,0.20447,0.57151,GOBP_REGULATION_OF_AMPA_RECEPTOR_ACTIVITY,0.996306516837041
GOBP_ZINC_ION_TRANSPORT,SET,29,-0.025976,-0.0010315,0.14414,0.57151,GOBP_ZINC_ION_TRANSPORT,0.996306516837041
LIAO_HAVE_SOX4_BINDING_SITES,SET,40,-0.022912,-0.0010683,0.12706,0.57155,LIAO_HAVE_SOX4_BINDING_SITES,0.996306516837041
GAUTAM_EYE_CORNEA_MELANOCYTES,SET,235,-0.0097136,-0.0010919,0.05385,0.57157,GAUTAM_EYE_CORNEA_MELANOCYTES,0.996306516837041
BRACHAT_RESPONSE_TO_CAMPTOTH...2,SET,19,-0.033879,-0.0010893,0.18779,0.57158,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,0.996306516837041
KEGG_MEDICUS_REFERENCE_AREG_...1,SET,11,-0.04754,-0.0011633,0.26352,0.57158,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY,0.996306516837041
GOBP_NEGATIVE_REGULATION_OF_...273,SET,107,-0.016102,-0.0012256,0.089243,0.57159,GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS,0.996306516837041
WP_THYROID_HORMONES_PRODUCTI...,SET,90,-0.016516,-0.0011535,0.09148,0.57163,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,0.996306516837041
MIR6801_5P,SET,97,-0.016561,-0.0012005,0.09171,0.57165,MIR6801_5P,0.996306516837041
GOBP_POSITIVE_REGULATION_OF_...738,SET,56,-0.023085,-0.001273,0.12782,0.57166,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.996306516837041
GOBP_ACTIVATION_INDUCED_CELL...,SET,8,-0.058484,-0.0012205,0.32375,0.57168,GOBP_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS,0.996306516837041
GOBP_NEGATIVE_REGULATION_OF_...41,SET,28,-0.028669,-0.0011187,0.15863,0.57171,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION,0.996306516837041
GOMF_FIBROBLAST_GROWTH_FACTO...3,SET,24,-0.035393,-0.0012788,0.19569,0.57176,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.996306516837041
HP_TAPERED_FINGER,SET,111,-0.014009,-0.0010859,0.077454,0.57176,HP_TAPERED_FINGER,0.996306516837041
WP_EFFECTS_OF_MFN2_MUTATION,SET,22,-0.034332,-0.0011877,0.18977,0.57178,WP_EFFECTS_OF_MFN2_MUTATION,0.996306516837041
HP_DIAPHRAGMATIC_WEAKNESS,SET,16,-0.040653,-0.0011996,0.22454,0.57183,HP_DIAPHRAGMATIC_WEAKNESS,0.996306516837041
GSE13229_MATURE_VS_INTMATURE...2,SET,173,-0.012237,-0.0011822,0.067589,0.57183,GSE13229_MATURE_VS_INTMATURE_NKCELL_UP,0.996306516837041
GSE3720_VD1_VS_VD2_GAMMADELT...2,SET,171,-0.011724,-0.0011261,0.064759,0.57183,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP,0.996306516837041
KRIEG_HYPOXIA_VIA_KDM3A,SET,46,-0.024513,-0.0012254,0.13533,0.57187,KRIEG_HYPOXIA_VIA_KDM3A,0.996306516837041
GOBP_NATURAL_KILLER_CELL_MED...2,SET,75,-0.01939,-0.0012367,0.10703,0.57188,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.996306516837041
HP_CLASS_III_OBESITY,SET,5,-0.091811,-0.0015149,0.5067,0.57189,HP_CLASS_III_OBESITY,0.996306516837041
GOCC_ATP_BINDING_CASSETTE_AB...,SET,6,-0.067008,-0.0012111,0.36933,0.57198,GOCC_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX,0.996306516837041
HOWLIN_CITED1_TARGETS_1_DN,SET,36,-0.028542,-0.0012626,0.15726,0.57201,HOWLIN_CITED1_TARGETS_1_DN,0.996306516837041
HP_CONNECTIVE_TISSUE_NEVI,SET,6,-0.070298,-0.0012706,0.38732,0.57201,HP_CONNECTIVE_TISSUE_NEVI,0.996306516837041
CHEMNITZ_RESPONSE_TO_PROSTAG...1,SET,348,-0.0085738,-0.0011692,0.047217,0.57204,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,0.996306516837041
GSE7596_AKT_TRANSD_VS_CTRL_C...1,SET,109,-0.015199,-0.0011676,0.08371,0.57204,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN,0.996306516837041
KEGG_ERBB_SIGNALING_PATHWAY,SET,82,-0.017367,-0.0011581,0.095636,0.57205,KEGG_ERBB_SIGNALING_PATHWAY,0.996306516837041
GOBP_CENTROSOME_DUPLICATION,SET,71,-0.017451,-0.0010831,0.09607,0.57207,GOBP_CENTROSOME_DUPLICATION,0.996306516837041
GOMF_PEPTIDASE_ACTIVATOR_ACT...1,SET,52,-0.021857,-0.0011615,0.1201,0.5722,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY,0.996440005510746
HP_THROMBOPHLEBITIS,SET,10,-0.045276,-0.0010564,0.24864,0.57225,HP_THROMBOPHLEBITIS,0.996440005510746
MEISSNER_ES_ICP_WITH_H3K4ME3,SET,29,-0.027527,-0.0010931,0.1511,0.57228,MEISSNER_ES_ICP_WITH_H3K4ME3,0.996440005510746
MANNO_MIDBRAIN_NEUROTYPES_HD...2,SET,450,-0.0080061,-0.001238,0.043943,0.57228,MANNO_MIDBRAIN_NEUROTYPES_HDA2,0.996440005510746
BLANCO_MELO_BETA_INTERFERON_...1,SET,183,-0.011949,-0.0011869,0.065572,0.57229,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,0.996440005510746
REACTOME_INTERLEUKIN_1_PROCE...,SET,9,-0.049484,-0.0010953,0.27117,0.5724,REACTOME_INTERLEUKIN_1_PROCESSING,0.996491829951015
ZNF165_TARGET_GENES,SET,67,-0.018763,-0.0011314,0.10277,0.57243,ZNF165_TARGET_GENES,0.996491829951015
HP_MARCUS_GUNN_JAW_WINKING_S...,SET,10,-0.054185,-0.0012642,0.29675,0.57244,HP_MARCUS_GUNN_JAW_WINKING_SYNKINESIS,0.996491829951015
MCM5_TARGET_GENES,SET,7,-0.056882,-0.0011105,0.31115,0.57253,MCM5_TARGET_GENES,0.996491829951015
GOMF_TRANSFERRIN_RECEPTOR_BI...,SET,9,-0.047309,-0.0010472,0.25868,0.57255,GOMF_TRANSFERRIN_RECEPTOR_BINDING,0.996491829951015
CTACTAG_MIR325,SET,13,-0.040186,-0.0010689,0.21967,0.57257,CTACTAG_MIR325,0.996491829951015
GOMF_TRIGLYCERIDE_LIPASE_ACT...,SET,24,-0.038121,-0.0013774,0.20841,0.57257,GOMF_TRIGLYCERIDE_LIPASE_ACTIVITY,0.996491829951015
REACTOME_TRANSCRIPTIONAL_ACT...2,SET,48,-0.022641,-0.0011561,0.12372,0.5726,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,0.996491829951015
GSE8678_IL7R_LOW_VS_HIGH_EFF...1,SET,171,-0.011913,-0.0011443,0.065043,0.57266,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN,0.996491829951015
GOMF_DNA_DIRECTED_DNA_POLYME...,SET,22,-0.027515,-0.00095189,0.15016,0.5727,GOMF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.996491829951015
GOBP_REGULATION_OF_UBIQUITIN...2,SET,18,-0.034235,-0.0010714,0.1868,0.57271,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.996491829951015
GOBP_NEGATIVE_REGULATION_OF_...693,SET,10,-0.045484,-0.0010612,0.24812,0.57272,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.996491829951015
HP_SLOW_DECREASE_IN_VISUAL_A...,SET,24,-0.031893,-0.0011524,0.17389,0.57276,HP_SLOW_DECREASE_IN_VISUAL_ACUITY,0.996491829951015
GOBP_SKELETAL_MUSCLE_SATELLI...1,SET,9,-0.049873,-0.0011039,0.27189,0.57277,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_ACTIVATION,0.996491829951015
MIR7161_3P,SET,77,-0.017681,-0.0011426,0.09638,0.57278,MIR7161_3P,0.996491829951015
CHEN_LIVER_METABOLISM_QTL_CIS,SET,88,-0.018419,-0.0012722,0.10039,0.57279,CHEN_LIVER_METABOLISM_QTL_CIS,0.996491829951015
GOBP_POSITIVE_REGULATION_OF_...55,SET,22,-0.038455,-0.0013304,0.20936,0.57287,GOBP_POSITIVE_REGULATION_OF_BEHAVIOR,0.996491829951015
TAKEDA_TARGETS_OF_NUP98_HOXA...8,SET,77,-0.018573,-0.0012003,0.10104,0.57292,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,0.996491829951015
GSE11884_WT_VS_FURIN_KO_NAIV...2,SET,121,-0.01437,-0.0011628,0.078092,0.573,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP,0.996491829951015
SUMO1_TARGET_GENES,SET,803,-0.0056565,-0.0011568,0.030714,0.57306,SUMO1_TARGET_GENES,0.996491829951015
GOBP_REGULATION_OF_SODIUM_DE...,SET,5,-0.075327,-0.0012429,0.40893,0.57307,GOBP_REGULATION_OF_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,0.996491829951015
KIM_ALL_DISORDERS_CALB1_CORR...1,SET,35,-0.027624,-0.001205,0.14995,0.57308,KIM_ALL_DISORDERS_CALB1_CORR_DN,0.996491829951015
ACTACCT_MIR196A_MIR196B,SET,133,-0.014185,-0.0012029,0.076977,0.5731,ACTACCT_MIR196A_MIR196B,0.996491829951015
GOBP_ACTIVATION_OF_IMMUNE_RE...,SET,485,-0.0073352,-0.0011763,0.039795,0.57312,GOBP_ACTIVATION_OF_IMMUNE_RESPONSE,0.996491829951015
MIR6871_3P,SET,116,-0.015441,-0.0012235,0.083763,0.57313,MIR6871_3P,0.996491829951015
REACTOME_FOXO_MEDIATED_TRANS...2,SET,16,-0.040315,-0.0011896,0.21863,0.57315,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.996491829951015
GSE37301_LYMPHOID_PRIMED_MPP...2,SET,167,-0.012114,-0.0011501,0.065663,0.57319,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP,0.996491829951015
GOMF_TESTOSTERONE_DEHYDROGEN...2,SET,10,-0.047602,-0.0011106,0.25787,0.57323,GOMF_TESTOSTERONE_DEHYDROGENASE_NAD_P_ACTIVITY,0.996491829951015
REACTOME_AMPK_INHIBITS_CHREB...,SET,8,-0.059358,-0.0012388,0.32149,0.57324,REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY,0.996491829951015
HP_CARDIAC_VALVE_CALCIFICATI...,SET,11,-0.053071,-0.0012986,0.28746,0.57324,HP_CARDIAC_VALVE_CALCIFICATION,0.996491829951015
GOBP_REGULATION_OF_DENDRITE_...3,SET,57,-0.021371,-0.0011889,0.1157,0.57327,GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.996491829951015
HOEBEKE_LYMPHOID_STEM_CELL_DN,SET,82,-0.018152,-0.0012104,0.098243,0.57329,HOEBEKE_LYMPHOID_STEM_CELL_DN,0.996491829951015
GSE13485_DAY3_VS_DAY7_YF17D_...1,SET,175,-0.012344,-0.0011994,0.066816,0.57329,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.996491829951015
WP_4P163_COPY_NUMBER_VARIATI...,SET,27,-0.030302,-0.0011612,0.16389,0.57334,WP_4P163_COPY_NUMBER_VARIATION,0.996491829951015
GOMF_XMP_5_NUCLEOSIDASE_ACTI...,SET,5,-0.083333,-0.001375,0.45067,0.57335,GOMF_XMP_5_NUCLEOSIDASE_ACTIVITY,0.996491829951015
BURTON_ADIPOGENESIS_PEAK_AT_...2,SET,39,-0.023649,-0.0010888,0.12789,0.57336,BURTON_ADIPOGENESIS_PEAK_AT_16HR,0.996491829951015
MIR4787_5P,SET,6,-0.071612,-0.0012944,0.38682,0.57344,MIR4787_5P,0.996491829951015
GOBP_MESENCHYME_MORPHOGENESIS,SET,58,-0.02387,-0.0013395,0.12883,0.57349,GOBP_MESENCHYME_MORPHOGENESIS,0.996491829951015
SA_PTEN_PATHWAY,SET,17,-0.035198,-0.0010705,0.18997,0.5735,SA_PTEN_PATHWAY,0.996491829951015
GOBP_REGULATION_OF_LONG_CHAI...2,SET,7,-0.057059,-0.0011139,0.3079,0.57351,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_INTO_CELL,0.996491829951015
WP_HIJACK_OF_UBIQUITINATION_...,SET,6,-0.058743,-0.0010618,0.31689,0.57353,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,0.996491829951015
BCAT_GDS748_UP,SET,45,-0.025182,-0.0012451,0.13584,0.57353,BCAT_GDS748_UP,0.996491829951015
NABA_CORE_MATRISOME,SET,252,-0.010945,-0.0012735,0.05901,0.57357,NABA_CORE_MATRISOME,0.996491829951015
MCCABE_BOUND_BY_HOXC6,SET,356,-0.0085781,-0.0011828,0.04624,0.57359,MCCABE_BOUND_BY_HOXC6,0.996491829951015
GOBP_AMINO_ACID_BIOSYNTHETIC...,SET,71,-0.019094,-0.0011851,0.10288,0.57361,GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.996491829951015
GOBP_MAST_CELL_ACTIVATION,SET,64,-0.020667,-0.0012181,0.11128,0.57367,GOBP_MAST_CELL_ACTIVATION,0.996499832642254
SARTIPY_NORMAL_AT_INSULIN_RE...1,SET,17,-0.038801,-0.0011801,0.20865,0.57376,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,0.996499832642254
CTGAGCC_MIR24,SET,201,-0.010958,-0.0011402,0.058923,0.57376,CTGAGCC_MIR24,0.996499832642254
STREICHER_LSM1_TARGETS_UP,SET,40,-0.025154,-0.0011728,0.13525,0.57377,STREICHER_LSM1_TARGETS_UP,0.996499832642254
DMRT1_TARGET_GENES,SET,328,-0.0088638,-0.0011741,0.047605,0.57385,DMRT1_TARGET_GENES,0.996499832642254
GSE3982_MAST_CELL_VS_TH2_UP,SET,181,-0.012064,-0.0011919,0.064788,0.57386,GSE3982_MAST_CELL_VS_TH2_UP,0.996499832642254
GSE40274_FOXP3_VS_FOXP3_AND_...5,SET,119,-0.014561,-0.0011684,0.078195,0.57386,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.996499832642254
GSE17721_0.5H_VS_12H_POLYIC_...1,SET,186,-0.011264,-0.0011279,0.060459,0.57389,GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN,0.996499832642254
WP_TCA_CYCLE_NUTRIENT_USE_AN...,SET,5,-0.078678,-0.0012982,0.42225,0.57391,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,0.996499832642254
PID_SMAD2_3NUCLEAR_PATHWAY,SET,75,-0.018443,-0.0011764,0.098964,0.57392,PID_SMAD2_3NUCLEAR_PATHWAY,0.996499832642254
REACTOME_NERVOUS_SYSTEM_DEVE...,SET,533,-0.0070615,-0.0011856,0.037886,0.57393,REACTOME_NERVOUS_SYSTEM_DEVELOPMENT,0.996499832642254
POS_RESPONSE_TO_HISTAMINE_DN,SET,11,-0.042438,-0.0010384,0.22727,0.57406,POS_RESPONSE_TO_HISTAMINE_DN,0.996592292904579
GOBP_DEOXYRIBONUCLEOSIDE_MON...3,SET,24,-0.033092,-0.0011957,0.17708,0.57412,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.996592292904579
PID_TRAIL_PATHWAY,SET,27,-0.031086,-0.0011912,0.16621,0.57418,PID_TRAIL_PATHWAY,0.996592292904579
HP_FULMINANT_HEPATIC_FAILURE,SET,5,-0.062945,-0.0010386,0.33648,0.5742,HP_FULMINANT_HEPATIC_FAILURE,0.996592292904579
HP_HYPERCONVEX_NAIL,SET,16,-0.042469,-0.0012532,0.22699,0.57421,HP_HYPERCONVEX_NAIL,0.996592292904579
GOBP_PROTEIN_POLY_ADP_RIBOSY...,SET,10,-0.048639,-0.0011348,0.25982,0.57425,GOBP_PROTEIN_POLY_ADP_RIBOSYLATION,0.996592292904579
KEGG_MEDICUS_REFERENCE_TYROS...,SET,5,-0.071905,-0.0011865,0.38399,0.57427,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION,0.996592292904579
REACTOME_TYROSINE_CATABOLISM,SET,5,-0.071905,-0.0011865,0.38399,0.57427,REACTOME_TYROSINE_CATABOLISM,0.996592292904579
WP_TYROSINE_METABOLISM_AND_R...,SET,5,-0.071905,-0.0011865,0.38399,0.57427,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,0.996592292904579
HP_HYPOPARATHYROIDISM,SET,28,-0.032595,-0.0012719,0.17408,0.57427,HP_HYPOPARATHYROIDISM,0.996592292904579
GOBP_HYALURONAN_BIOSYNTHETIC...,SET,14,-0.043999,-0.0012145,0.23464,0.57437,GOBP_HYALURONAN_BIOSYNTHETIC_PROCESS,0.996716065008987
GOMF_MOLECULAR_SEQUESTERING_...,SET,41,-0.025082,-0.0011839,0.13365,0.57443,GOMF_MOLECULAR_SEQUESTERING_ACTIVITY,0.996734405569974
GOBP_NEGATIVE_REGULATION_OF_...15,SET,42,-0.026184,-0.0012509,0.13949,0.57445,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.996734405569974
TAKEDA_TARGETS_OF_NUP98_HOXA...7,SET,42,-0.026375,-0.00126,0.14041,0.5745,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,0.996734405569974
GNF2_RBBP6,SET,65,-0.018223,-0.0010823,0.096998,0.57451,GNF2_RBBP6,0.996734405569974
BURTON_ADIPOGENESIS_2,SET,70,-0.019588,-0.0012072,0.1042,0.57455,BURTON_ADIPOGENESIS_2,0.996734405569974
HP_HIP_DISLOCATION,SET,226,-0.010399,-0.0011466,0.055294,0.57459,HP_HIP_DISLOCATION,0.996734405569974
HP_DUPLICATION_OF_BONES_INVO...,SET,193,-0.011492,-0.0011721,0.061095,0.5746,HP_DUPLICATION_OF_BONES_INVOLVING_THE_UPPER_EXTREMITIES,0.996734405569974
GSE17974_IL4_AND_ANTI_IL12_V...16,SET,151,-0.013656,-0.0012334,0.072588,0.57461,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP,0.996734405569974
MIR596,SET,29,-0.030015,-0.001192,0.15944,0.57466,MIR596,0.996756332967362
GOMF_DEACETYLASE_ACTIVITY,SET,35,-0.026614,-0.0011609,0.14133,0.57468,GOMF_DEACETYLASE_ACTIVITY,0.996756332967362
WARTERS_IR_RESPONSE_5GY,SET,44,-0.02319,-0.0011339,0.12304,0.57475,WARTERS_IR_RESPONSE_5GY,0.996797886831994
HP_MACULAR_DRUSEN,SET,5,-0.084925,-0.0014013,0.45044,0.57477,HP_MACULAR_DRUSEN,0.996797886831994
GOMF_L_LEUCINE_TRANSMEMBRANE...,SET,6,-0.068443,-0.0012371,0.36293,0.57479,GOMF_L_LEUCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.996797886831994
HP_SEGMENTAL_PERIPHERAL_DEMY...,SET,10,-0.055629,-0.0012979,0.29464,0.57487,HP_SEGMENTAL_PERIPHERAL_DEMYELINATION_REMYELINATION,0.996886880051891
HP_EPIBLEPHARON,SET,6,-0.063169,-0.0011417,0.33445,0.5749,HP_EPIBLEPHARON,0.996889163298907
GSE14769_UNSTIM_VS_20MIN_LPS...2,SET,174,-0.012312,-0.0011929,0.065123,0.57498,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP,0.996915630767696
OHM_EMBRYONIC_CARCINOMA_DN,SET,8,-0.065765,-0.0013725,0.34759,0.57503,OHM_EMBRYONIC_CARCINOMA_DN,0.996915630767696
GOBP_NEGATIVE_REGULATION_OF_...159,SET,5,-0.064671,-0.0010671,0.34182,0.57503,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.996915630767696
GSE14308_INDUCED_VS_NATURAL_...2,SET,177,-0.011742,-0.0011473,0.062059,0.57503,GSE14308_INDUCED_VS_NATURAL_TREG_UP,0.996915630767696
HP_NASOGASTRIC_TUBE_FEEDING,SET,34,-0.02732,-0.0011746,0.14415,0.57516,HP_NASOGASTRIC_TUBE_FEEDING,0.997028754176849
GSE11961_MARGINAL_ZONE_BCELL...3,SET,182,-0.011634,-0.0011525,0.061379,0.57516,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.997028754176849
ONDER_CDH1_TARGETS_1_DN,SET,157,-0.012829,-0.0011813,0.067644,0.57521,ONDER_CDH1_TARGETS_1_DN,0.997028754176849
HP_ROD_CONE_DYSTROPHY,SET,197,-0.011317,-0.0011659,0.059668,0.57521,HP_ROD_CONE_DYSTROPHY,0.997028754176849
HP_UPPER_LIMB_PAIN,SET,8,-0.060494,-0.0012625,0.31883,0.57524,HP_UPPER_LIMB_PAIN,0.997031029323758
GOBP_SPERM_EJACULATION,SET,6,-0.072377,-0.0013082,0.3812,0.57529,GOBP_SPERM_EJACULATION,0.997067967386426
GSE43955_TH0_VS_TGFB_IL6_TH1...5,SET,179,-0.011878,-0.0011671,0.062518,0.57534,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN,0.997088415910677
KEGG_MEDICUS_REFERENCE_GF_RT...1,SET,81,-0.020153,-0.0013357,0.10598,0.57541,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY,0.997088415910677
GOBP_POSITIVE_REGULATION_OF_...501,SET,25,-0.036649,-0.0013515,0.19271,0.57541,GOBP_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.997088415910677
GOBP_REGULATION_OF_MEMBRANE_...14,SET,5,-0.067,-0.0011055,0.35202,0.57547,GOBP_REGULATION_OF_MEMBRANE_TUBULATION,0.997088415910677
REACTOME_DEPOLYMERIZATION_OF...,SET,14,-0.042858,-0.001183,0.22511,0.5755,REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA,0.997088415910677
GOBP_OUTER_DYNEIN_ARM_ASSEMB...,SET,15,-0.037938,-0.0010839,0.19922,0.57551,GOBP_OUTER_DYNEIN_ARM_ASSEMBLY,0.997088415910677
GOBP_MACROPHAGE_ACTIVATION,SET,103,-0.017606,-0.001315,0.09242,0.57554,GOBP_MACROPHAGE_ACTIVATION,0.997088415910677
GOBP_T_CELL_DIFFERENTIATION_...1,SET,79,-0.019538,-0.0012789,0.10255,0.57555,GOBP_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.997088415910677
WP_NEURODEGENERATION_WITH_BR...,SET,41,-0.025204,-0.0011897,0.13228,0.57556,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,0.997088415910677
WP_PRADERWILLI_AND_ANGELMAN_...,SET,93,-0.018154,-0.0012888,0.095046,0.57574,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,0.997349013452915
GOBP_PROTEIN_LOCALIZATION_TO...38,SET,12,-0.038502,-0.00098401,0.2014,0.57581,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOPLASM,0.997349013452915
GSE17721_LPS_VS_CPG_8H_BMDC_...1,SET,167,-0.012496,-0.0011864,0.065324,0.57585,GSE17721_LPS_VS_CPG_8H_BMDC_DN,0.997349013452915
HP_APLASIA_HYPOPLASIA_OF_THE...11,SET,80,-0.018009,-0.0011862,0.094122,0.57587,HP_APLASIA_HYPOPLASIA_OF_THE_BRAINSTEM,0.997349013452915
GOCC_ACTIN_FILAMENT,SET,105,-0.016162,-0.0012187,0.084448,0.57589,GOCC_ACTIN_FILAMENT,0.997349013452915
GINESTIER_BREAST_CANCER_ZNF2...1,SET,303,-0.0087802,-0.0011186,0.045859,0.57592,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,0.997349013452915
DESCARTES_FETAL_PANCREAS_MYE...,SET,185,-0.012895,-0.0012879,0.067338,0.57593,DESCARTES_FETAL_PANCREAS_MYELOID_CELLS,0.997349013452915
WP_NETWORK_MAP_OF_SARSCOV2_S...,SET,203,-0.012013,-0.0012562,0.062724,0.57594,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,0.997349013452915
REACTOME_OTHER_SEMAPHORIN_IN...,SET,18,-0.043688,-0.0013673,0.22776,0.57605,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,0.997474733459546
HP_APLASIA_INVOLVING_BONES_O...1,SET,22,-0.03596,-0.001244,0.18743,0.57607,HP_APLASIA_INVOLVING_BONES_OF_THE_EXTREMITIES,0.997474733459546
GOMF_HYDRO_LYASE_ACTIVITY,SET,52,-0.023939,-0.0012722,0.1246,0.57618,GOMF_HYDRO_LYASE_ACTIVITY,0.997565801534323
GOMF_PHOSPHATIDIC_ACID_BINDI...,SET,23,-0.03577,-0.0012653,0.18617,0.57618,GOMF_PHOSPHATIDIC_ACID_BINDING,0.997565801534323
GSE5679_PPARG_LIGAND_ROSIGLI...1,SET,184,-0.011913,-0.0011866,0.061928,0.57627,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN,0.997629226752859
HAHTOLA_MYCOSIS_FUNGOIDES_CD...1,SET,101,-0.015852,-0.0011725,0.082304,0.57636,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,0.997629226752859
GOBP_CELLULAR_RESPONSE_TO_GO...,SET,17,-0.046304,-0.0014083,0.2404,0.57637,GOBP_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS,0.997629226752859
GSE41867_LCMV_ARMSTRONG_VS_C...5,SET,178,-0.011815,-0.0011577,0.061276,0.57645,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN,0.997629226752859
TANAKA_METHYLATED_IN_ESOPHAG...,SET,97,-0.02012,-0.0014586,0.10432,0.57647,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,0.997629226752859
HP_AZOOSPERMIA,SET,105,-0.015742,-0.0011871,0.081595,0.57649,HP_AZOOSPERMIA,0.997629226752859
GOMF_MAGNESIUM_ION_BINDING,SET,209,-0.011374,-0.0012066,0.058948,0.5765,GOMF_MAGNESIUM_ION_BINDING,0.997629226752859
KOMMAGANI_TP63_GAMMA_TARGETS,SET,9,-0.053435,-0.0011828,0.27663,0.57658,KOMMAGANI_TP63_GAMMA_TARGETS,0.997629226752859
KEGG_MAPK_SIGNALING_PATHWAY,SET,255,-0.010774,-0.0012608,0.055765,0.5766,KEGG_MAPK_SIGNALING_PATHWAY,0.997629226752859
BIOCARTA_RACCYCD_PATHWAY,SET,25,-0.030784,-0.0011352,0.15924,0.57665,BIOCARTA_RACCYCD_PATHWAY,0.997629226752859
SNF5_DN.V1_UP,SET,147,-0.014071,-0.001254,0.072764,0.57667,SNF5_DN.V1_UP,0.997629226752859
GOLUB_ALL_VS_AML_DN,SET,22,-0.038095,-0.0013179,0.19694,0.57669,GOLUB_ALL_VS_AML_DN,0.997629226752859
GOMF_THYROID_HORMONE_TRANSME...,SET,7,-0.064941,-0.0012678,0.33573,0.57669,GOMF_THYROID_HORMONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.997629226752859
GOBP_ANTEROGRADE_AXONAL_TRAN...2,SET,6,-0.068156,-0.0012319,0.3523,0.5767,GOBP_ANTEROGRADE_AXONAL_TRANSPORT_OF_MITOCHONDRION,0.997629226752859
HP_INCREASED_CIRCULATING_IGG...,SET,23,-0.036402,-0.0012876,0.18807,0.57674,HP_INCREASED_CIRCULATING_IGG_LEVEL,0.997629226752859
GSE42021_TREG_VS_TCONV_PLN_UP,SET,186,-0.01269,-0.0012707,0.065556,0.57674,GSE42021_TREG_VS_TCONV_PLN_UP,0.997629226752859
HP_INTERVERTEBRAL_SPACE_NARR...,SET,6,-0.069177,-0.0012503,0.35686,0.57685,HP_INTERVERTEBRAL_SPACE_NARROWING,0.997629226752859
GOBP_NEUROTROPHIN_SIGNALING_...,SET,38,-0.027496,-0.0012496,0.14162,0.57697,GOBP_NEUROTROPHIN_SIGNALING_PATHWAY,0.997629226752859
HP_REDUCED_FACTOR_XI_ACTIVITY,SET,13,-0.040837,-0.0010863,0.21022,0.57701,HP_REDUCED_FACTOR_XI_ACTIVITY,0.997629226752859
GOMF_POU_DOMAIN_BINDING,SET,2,-0.14379,-0.0015006,0.74008,0.57702,GOMF_POU_DOMAIN_BINDING,0.997629226752859
GOCC_TERMINAL_BOUTON,SET,43,-0.026657,-0.0012886,0.13718,0.57704,GOCC_TERMINAL_BOUTON,0.997629226752859
DER_IFN_GAMMA_RESPONSE_UP,SET,67,-0.020632,-0.0012441,0.10616,0.57705,DER_IFN_GAMMA_RESPONSE_UP,0.997629226752859
GSE37532_WT_VS_PPARG_KO_VISC...2,SET,172,-0.012617,-0.0012154,0.064919,0.57705,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP,0.997629226752859
MIR9900,SET,40,-0.026709,-0.0012453,0.13737,0.57708,MIR9900,0.997629226752859
HP_ANGINA_PECTORIS,SET,36,-0.029921,-0.0013236,0.15389,0.57708,HP_ANGINA_PECTORIS,0.997629226752859
NKX25_01,SET,109,-0.016702,-0.0012831,0.08586,0.57711,NKX25_01,0.997629226752859
HP_ANGULATED_MUSCLE_FIBERS,SET,5,-0.071867,-0.0011858,0.36948,0.57711,HP_ANGULATED_MUSCLE_FIBERS,0.997629226752859
GSE1925_CTRL_VS_3H_IFNG_STIM...4,SET,185,-0.011905,-0.001189,0.061191,0.57713,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP,0.997629226752859
GOCC_SMN_SM_PROTEIN_COMPLEX,SET,13,-0.041944,-0.0011157,0.21554,0.57715,GOCC_SMN_SM_PROTEIN_COMPLEX,0.997629226752859
HP_EPISODIC_VOMITING,SET,37,-0.024203,-0.0010854,0.12437,0.57715,HP_EPISODIC_VOMITING,0.997629226752859
GOMF_PROMOTER_ENHANCER_LOOP_...,SET,4,-0.081255,-0.0011992,0.41731,0.57719,GOMF_PROMOTER_ENHANCER_LOOP_ANCHORING_ACTIVITY,0.997629226752859
GNF2_MATK,SET,23,-0.032275,-0.0011416,0.1657,0.57721,GNF2_MATK,0.997629226752859
WP_VALPROIC_ACID_PATHWAY,SET,11,-0.051358,-0.0012567,0.26365,0.57722,WP_VALPROIC_ACID_PATHWAY,0.997629226752859
GOCC_I_BAND,SET,137,-0.014926,-0.0012846,0.076614,0.57723,GOCC_I_BAND,0.997629226752859
GOMF_O_PALMITOYLTRANSFERASE_...,SET,5,-0.071302,-0.0011765,0.36601,0.57723,GOMF_O_PALMITOYLTRANSFERASE_ACTIVITY,0.997629226752859
PID_ARF6_PATHWAY,SET,35,-0.028238,-0.0012317,0.14492,0.57725,PID_ARF6_PATHWAY,0.997629226752859
YAO_TEMPORAL_RESPONSE_TO_PRO...9,SET,71,-0.020105,-0.0012478,0.10305,0.57734,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,0.997647129436326
GOBP_CELL_SUBSTRATE_JUNCTION...1,SET,8,-0.065374,-0.0013643,0.33504,0.57735,GOBP_CELL_SUBSTRATE_JUNCTION_DISASSEMBLY,0.997647129436326
GSE27786_NKCELL_VS_NKTCELL_UP,SET,187,-0.012154,-0.0012204,0.062245,0.57741,GSE27786_NKCELL_VS_NKTCELL_UP,0.997647129436326
REACTOME_BIOSYNTHESIS_OF_EPA...,SET,6,-0.081402,-0.0014713,0.41662,0.57745,REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS,0.997647129436326
SRF_Q5_01,SET,203,-0.012182,-0.0012738,0.062337,0.57746,SRF_Q5_01,0.997647129436326
SCHAEFFER_PROSTATE_DEVELOPME...14,SET,8,-0.061407,-0.0012815,0.31412,0.57749,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN,0.997647129436326
GOBP_REGULATION_OF_T_HELPER_...7,SET,42,-0.026966,-0.0012883,0.13794,0.57749,GOBP_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.997647129436326
HP_CLITORAL_HYPOPLASIA,SET,26,-0.034704,-0.0013051,0.17754,0.57749,HP_CLITORAL_HYPOPLASIA,0.997647129436326
REACTOME_VITAMINS,SET,6,-0.077004,-0.0013918,0.3933,0.57761,REACTOME_VITAMINS,0.997701788642122
GOBP_REGULATION_OF_LEUKOCYTE...4,SET,115,-0.01662,-0.0013112,0.084858,0.57764,GOBP_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.997701788642122
GNF2_CCNA1,SET,56,-0.02291,-0.0012633,0.1169,0.57769,GNF2_CCNA1,0.997701788642122
GOBP_CELLULAR_RESPONSE_TO_ST...4,SET,14,-0.04522,-0.0012482,0.23073,0.57769,GOBP_CELLULAR_RESPONSE_TO_STEROL_DEPLETION,0.997701788642122
MIR944,SET,381,-0.0088976,-0.0012684,0.045378,0.57772,MIR944,0.997701788642122
GOBP_REGULATION_OF_CELL_GROW...2,SET,14,-0.045442,-0.0012544,0.23177,0.57772,GOBP_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.997701788642122
ZNF41_TARGET_GENES,SET,171,-0.012634,-0.0012136,0.064412,0.57775,ZNF41_TARGET_GENES,0.997701788642122
GOBP_NEGATIVE_REGULATION_OF_...263,SET,4,-0.099244,-0.0014647,0.50587,0.57777,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.997701788642122
MIR1225_5P,SET,25,-0.033028,-0.0012179,0.16833,0.57778,MIR1225_5P,0.997701788642122
HALLMARK_HEDGEHOG_SIGNALING,SET,33,-0.031755,-0.0013451,0.16175,0.57782,HALLMARK_HEDGEHOG_SIGNALING,0.997721288751987
REACTOME_PURINE_CATABOLISM,SET,17,-0.043233,-0.0013149,0.22007,0.57787,REACTOME_PURINE_CATABOLISM,0.997758053057777
GSE2826_WT_VS_XID_BCELL_DN,SET,183,-0.013082,-0.0012996,0.066515,0.57796,GSE2826_WT_VS_XID_BCELL_DN,0.997784234838325
GOBP_TRACHEA_MORPHOGENESIS,SET,11,-0.059806,-0.0014634,0.30401,0.57798,GOBP_TRACHEA_MORPHOGENESIS,0.997784234838325
HP_MYOCLONIC_STATUS_EPILEPTI...,SET,5,-0.084741,-0.0013982,0.43074,0.57798,HP_MYOCLONIC_STATUS_EPILEPTICUS,0.997784234838325
GOBP_NEGATIVE_REGULATION_OF_...209,SET,59,-0.023135,-0.0013094,0.11756,0.578,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.997784234838325
GOBP_BRONCHIOLE_DEVELOPMENT,SET,6,-0.076183,-0.001377,0.38666,0.5781,GOBP_BRONCHIOLE_DEVELOPMENT,0.997816515399494
HP_ANHYDRAMNIOS,SET,6,-0.067458,-0.0012193,0.34228,0.57812,HP_ANHYDRAMNIOS,0.997816515399494
GOCC_PLATELET_DENSE_GRANULE_...1,SET,13,-0.045001,-0.001197,0.22829,0.57813,GOCC_PLATELET_DENSE_GRANULE_LUMEN,0.997816515399494
HP_LOCALIZED_HIRSUTISM,SET,17,-0.037847,-0.0011511,0.19195,0.57815,HP_LOCALIZED_HIRSUTISM,0.997816515399494
MIR218_1_3P,SET,84,-0.018847,-0.0012719,0.095547,0.57818,MIR218_1_3P,0.997816515399494
WP_EGFEGFR_SIGNALING,SET,154,-0.013849,-0.0012631,0.070172,0.57823,WP_EGFEGFR_SIGNALING,0.997816515399494
VART_KSHV_INFECTION_ANGIOGEN...2,SET,152,-0.014992,-0.0013584,0.075917,0.57827,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,0.997816515399494
HALLMARK_NOTCH_SIGNALING,SET,31,-0.030115,-0.0012364,0.15244,0.5783,HALLMARK_NOTCH_SIGNALING,0.997816515399494
GOBP_POSTSYNAPSE_TO_NUCLEUS_...,SET,6,-0.05446,-0.00098434,0.27558,0.57833,GOBP_POSTSYNAPSE_TO_NUCLEUS_SIGNALING_PATHWAY,0.997816515399494
GSE36078_UNTREATED_VS_AD5_IN...3,SET,175,-0.012515,-0.001216,0.063326,0.57833,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN,0.997816515399494
GSE6259_FLT3L_INDUCED_DEC205...2,SET,138,-0.014645,-0.0012649,0.074081,0.57835,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP,0.997816515399494
GOBP_ANTRAL_OVARIAN_FOLLICLE...,SET,12,-0.051078,-0.0013054,0.25823,0.5784,GOBP_ANTRAL_OVARIAN_FOLLICLE_GROWTH,0.997816515399494
VISALA_AGING_LYMPHOCYTE_UP,SET,6,-0.086372,-0.0015611,0.43646,0.57843,VISALA_AGING_LYMPHOCYTE_UP,0.997816515399494
SA_MMP_CYTOKINE_CONNECTION,SET,15,-0.048721,-0.001392,0.24589,0.57853,SA_MMP_CYTOKINE_CONNECTION,0.997816515399494
PID_RHODOPSIN_PATHWAY,SET,21,-0.035321,-0.0011939,0.17823,0.57855,PID_RHODOPSIN_PATHWAY,0.997816515399494
GOBP_RESPONSE_TO_ESTRADIOL,SET,113,-0.016706,-0.0013066,0.084261,0.57858,GOBP_RESPONSE_TO_ESTRADIOL,0.997816515399494
MACLACHLAN_BRCA1_TARGETS_DN,SET,16,-0.041117,-0.0012133,0.20733,0.5786,MACLACHLAN_BRCA1_TARGETS_DN,0.997816515399494
GOBP_NEGATIVE_REGULATION_OF_...225,SET,4,-0.084964,-0.001254,0.42822,0.57864,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.997816515399494
GOCC_PHOSPHATASE_COMPLEX,SET,49,-0.022778,-0.0011752,0.11479,0.57864,GOCC_PHOSPHATASE_COMPLEX,0.997816515399494
HP_EQUINOVARUS_DEFORMITY,SET,13,-0.053603,-0.0014258,0.27016,0.57864,HP_EQUINOVARUS_DEFORMITY,0.997816515399494
HP_ABNORMALITY_OF_THE_GLABEL...,SET,22,-0.037432,-0.001295,0.18843,0.57873,HP_ABNORMALITY_OF_THE_GLABELLA,0.997816515399494
REACTOME_REGULATION_OF_LIPID...,SET,114,-0.015223,-0.0011958,0.076617,0.57874,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,0.997816515399494
GCM_SIRT2,SET,40,-0.026434,-0.0012325,0.13305,0.57874,GCM_SIRT2,0.997816515399494
GSE9509_10MIN_VS_30MIN_LPS_A...1,SET,142,-0.014349,-0.0012571,0.072224,0.57874,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.997816515399494
HP_PENOSCROTAL_HYPOSPADIAS,SET,8,-0.063076,-0.0013164,0.31742,0.57876,HP_PENOSCROTAL_HYPOSPADIAS,0.997816515399494
DESCARTES_FETAL_PANCREAS_LYM...2,SET,112,-0.017442,-0.0013581,0.087748,0.57878,DESCARTES_FETAL_PANCREAS_LYMPHOID_CELLS,0.997816515399494
GOBP_PARATHYROID_GLAND_DEVEL...,SET,7,-0.063186,-0.0012335,0.31758,0.57885,GOBP_PARATHYROID_GLAND_DEVELOPMENT,0.997816515399494
GSE7460_TCONV_VS_TREG_THYMUS...2,SET,182,-0.012552,-0.0012435,0.063091,0.57885,GSE7460_TCONV_VS_TREG_THYMUS_UP,0.997816515399494
GOBP_SNRNA_CATABOLIC_PROCESS,SET,4,-0.06965,-0.0010279,0.34998,0.57887,GOBP_SNRNA_CATABOLIC_PROCESS,0.997816515399494
LOPEZ_MESOTHELIOMA_SURVIVAL_...3,SET,7,-0.06603,-0.001289,0.33177,0.57888,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP,0.997816515399494
HP_CYSTIC_HYGROMA,SET,50,-0.023169,-0.0012074,0.11636,0.57891,HP_CYSTIC_HYGROMA,0.9978187388415
HMGB2_TARGET_GENES,SET,412,-0.0086405,-0.0012797,0.04335,0.57899,HMGB2_TARGET_GENES,0.997824829123328
GOBP_CHORIONIC_TROPHOBLAST_C...1,SET,7,-0.077584,-0.0015146,0.38916,0.57901,GOBP_CHORIONIC_TROPHOBLAST_CELL_DIFFERENTIATION,0.997824829123328
EPPERT_HSC_R,SET,107,-0.017254,-0.0013133,0.086498,0.57905,EPPERT_HSC_R,0.997824829123328
TAANNYSGCG_UNKNOWN,SET,72,-0.02073,-0.0012956,0.10392,0.57905,TAANNYSGCG_UNKNOWN,0.997824829123328
GOMF_RNA_2_O_METHYLTRANSFERA...,SET,6,-0.061605,-0.0011135,0.30853,0.57913,GOMF_RNA_2_O_METHYLTRANSFERASE_ACTIVITY,0.997824829123328
WP_GROWTH_FACTORS_AND_HORMON...,SET,26,-0.033341,-0.0012538,0.16688,0.57917,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,0.997824829123328
GOBP_CELL_PROLIFERATION_INVO...2,SET,21,-0.04242,-0.0014338,0.21235,0.57917,GOBP_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.997824829123328
GOBP_COPPER_ION_TRANSMEMBRAN...,SET,7,-0.061304,-0.0011968,0.30687,0.57917,GOBP_COPPER_ION_TRANSMEMBRANE_TRANSPORT,0.997824829123328
WP_AXON_GUIDANCE,SET,69,-0.021923,-0.0013415,0.10967,0.57922,WP_AXON_GUIDANCE,0.997824829123328
MIR5694,SET,49,-0.025393,-0.0013101,0.12682,0.57935,MIR5694,0.997824829123328
MYB_Q5_01,SET,246,-0.011049,-0.0012703,0.055165,0.57937,MYB_Q5_01,0.997824829123328
SUBTIL_PROGESTIN_TARGETS,SET,31,-0.030311,-0.0012444,0.15132,0.57938,SUBTIL_PROGESTIN_TARGETS,0.997824829123328
PYEON_HPV_POSITIVE_TUMORS_DN,SET,8,-0.067,-0.0013983,0.33434,0.57941,PYEON_HPV_POSITIVE_TUMORS_DN,0.997824829123328
WP_UREA_CYCLE_AND_RELATED_DI...,SET,8,-0.060048,-0.0012532,0.29967,0.57941,WP_UREA_CYCLE_AND_RELATED_DISEASES,0.997824829123328
REACTOME_HDR_THROUGH_MMEJ_AL...,SET,11,-0.047061,-0.0011516,0.23453,0.57952,REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ,0.997824829123328
GSE33424_CD161_HIGH_VS_INT_C...2,SET,183,-0.013243,-0.0013155,0.065993,0.57952,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP,0.997824829123328
GESERICK_TERT_TARGETS_DN,SET,21,-0.041389,-0.001399,0.20614,0.57956,GESERICK_TERT_TARGETS_DN,0.997824829123328
GOBP_NEGATIVE_REGULATION_OF_...450,SET,5,-0.090469,-0.0014928,0.45037,0.5796,GOBP_NEGATIVE_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.997824829123328
GOBP_NUCLEOLAR_CHROMATIN_ORG...,SET,8,-0.058442,-0.0012197,0.29088,0.57961,GOBP_NUCLEOLAR_CHROMATIN_ORGANIZATION,0.997824829123328
GOMF_OXIDOREDUCTASE_ACTIVITY...29,SET,47,-0.025422,-0.0012846,0.12654,0.57961,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS,0.997824829123328
REACTOME_FICOLINS_BIND_TO_RE...,SET,5,-0.085627,-0.0014129,0.4261,0.57963,REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE,0.997824829123328
GOMF_IONOTROPIC_GLUTAMATE_RE...,SET,23,-0.035923,-0.0012707,0.17875,0.57964,GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING,0.997824829123328
HP_FETAL_ANOMALY,SET,490,-0.0077867,-0.001255,0.038745,0.57964,HP_FETAL_ANOMALY,0.997824829123328
MODULE_141,SET,14,-0.052554,-0.0014507,0.26145,0.57965,MODULE_141,0.997824829123328
MIR296_5P,SET,50,-0.022552,-0.0011753,0.11218,0.57966,MIR296_5P,0.997824829123328
GSE7348_UNSTIM_VS_TOLERIZED_...1,SET,144,-0.014233,-0.0012555,0.0708,0.57966,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.997824829123328
DESCARTES_MAIN_FETAL_ACINAR_...,SET,50,-0.026888,-0.0014013,0.13361,0.57975,DESCARTES_MAIN_FETAL_ACINAR_CELLS,0.997930327868852
GOBP_L_PROLINE_TRANSMEMBRANE...,SET,3,-0.10651,-0.0013614,0.52865,0.57983,GOBP_L_PROLINE_TRANSMEMBRANE_TRANSPORT,0.998018603902535
GOBP_REGULATION_OF_RESPONSE_...5,SET,983,-0.0058076,-0.0013073,0.028797,0.57991,GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.998051356359324
HP_MICROGLOSSIA,SET,17,-0.042494,-0.0012925,0.21072,0.57991,HP_MICROGLOSSIA,0.998051356359324
KEGG_MEDICUS_REFERENCE_VALIN...,SET,8,-0.060236,-0.0012571,0.29842,0.57998,KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION,0.998051356359324
CAIRO_LIVER_DEVELOPMENT_UP,SET,145,-0.014739,-0.0013046,0.072981,0.58002,CAIRO_LIVER_DEVELOPMENT_UP,0.998051356359324
GOBP_REGULATION_OF_LIPID_MET...,SET,279,-0.010572,-0.0012933,0.052347,0.58003,GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.998051356359324
MIR4482_5P,SET,32,-0.030824,-0.0012857,0.1525,0.58009,MIR4482_5P,0.998051356359324
HEDENFALK_BREAST_CANCER_BRAC...2,SET,15,-0.045225,-0.0012921,0.22359,0.58014,HEDENFALK_BREAST_CANCER_BRACX_UP,0.998051356359324
SOBOLEV_PBMC_PANDEMRIX_AGE_1...7,SET,4,-0.080987,-0.0011953,0.40038,0.58015,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN,0.998051356359324
HP_FRONTAL_POLYMICROGYRIA,SET,5,-0.087779,-0.0014484,0.43341,0.58025,HP_FRONTAL_POLYMICROGYRIA,0.998051356359324
MOREAUX_B_LYMPHOCYTE_MATURAT...1,SET,69,-0.018995,-0.0011623,0.093713,0.58031,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,0.998051356359324
GOBP_NEGATIVE_REGULATION_OF_...174,SET,9,-0.062793,-0.0013899,0.30962,0.58036,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS,0.998051356359324
HP_GAIT_IMBALANCE,SET,63,-0.022117,-0.0012933,0.10905,0.58036,HP_GAIT_IMBALANCE,0.998051356359324
KEGG_MEDICUS_PATHOGEN_KSHV_L...,SET,7,-0.064108,-0.0012515,0.31603,0.58037,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY,0.998051356359324
MODULE_243,SET,71,-0.020276,-0.0012585,0.099918,0.5804,MODULE_243,0.998051356359324
GOBP_NEGATIVE_REGULATION_OF_...699,SET,51,-0.025508,-0.0013425,0.12563,0.58045,GOBP_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.998051356359324
HP_APLASIA_OF_THE_PHALANGES_...,SET,8,-0.059934,-0.0012508,0.29513,0.58046,HP_APLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.998051356359324
HE_LIM_SUN_FETAL_LUNG_C1_INT...,SET,243,-0.011921,-0.0013623,0.05869,0.58047,HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL,0.998051356359324
GOBP_POSITIVE_REGULATION_OF_...56,SET,8,-0.070971,-0.0014811,0.34927,0.58051,GOBP_POSITIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.998051356359324
GOBP_MODULATION_BY_VIRUS_OF_...,SET,3,-0.099239,-0.0012684,0.48829,0.58052,GOBP_MODULATION_BY_VIRUS_OF_HOST_PROCESS,0.998051356359324
REACTOME_MOLECULES_ASSOCIATE...,SET,35,-0.030963,-0.0013506,0.15232,0.58054,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,0.998051356359324
USF_Q6_01,SET,221,-0.011475,-0.0012514,0.056451,0.58054,USF_Q6_01,0.998051356359324
GTACAGG_MIR486,SET,53,-0.023379,-0.0012543,0.11498,0.58056,GTACAGG_MIR486,0.998051356359324
GSE17721_CTRL_VS_LPS_4H_BMDC...1,SET,181,-0.012836,-0.0012682,0.063119,0.58057,GSE17721_CTRL_VS_LPS_4H_BMDC_DN,0.998051356359324
GSE12366_GC_BCELL_VS_PLASMA_...2,SET,171,-0.012889,-0.0012381,0.06336,0.5806,GSE12366_GC_BCELL_VS_PLASMA_CELL_UP,0.998051356359324
GSE27786_CD8_TCELL_VS_NKCELL...1,SET,182,-0.01274,-0.0012621,0.062584,0.58065,GSE27786_CD8_TCELL_VS_NKCELL_DN,0.998051356359324
BANG_VERTEPORFIN_ENDOMETRIAL...1,SET,13,-0.04742,-0.0012614,0.23283,0.58069,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_DN,0.998051356359324
GOCC_ELASTIC_FIBER,SET,4,-0.093813,-0.0013846,0.46024,0.58076,GOCC_ELASTIC_FIBER,0.998051356359324
CAO_BLOOD_FLUMIST_AGE_05_14Y...2,SET,7,-0.062846,-0.0012269,0.30811,0.58081,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_UP,0.998051356359324
HP_HAPPY_DEMEANOR,SET,23,-0.043928,-0.0015538,0.21535,0.58082,HP_HAPPY_DEMEANOR,0.998051356359324
HP_RECTAL_PROLAPSE,SET,49,-0.026857,-0.0013856,0.13164,0.58083,HP_RECTAL_PROLAPSE,0.998051356359324
GOBP_TELOMERIC_LOOP_DISASSEM...,SET,9,-0.05455,-0.0012075,0.26732,0.58085,GOBP_TELOMERIC_LOOP_DISASSEMBLY,0.998051356359324
GOBP_MAINTENANCE_OF_POSTSYNA...,SET,8,-0.060807,-0.001269,0.29795,0.58086,GOBP_MAINTENANCE_OF_POSTSYNAPTIC_SPECIALIZATION_STRUCTURE,0.998051356359324
CAR_MLANA,SET,40,-0.026725,-0.001246,0.13087,0.5809,CAR_MLANA,0.998051356359324
HP_BICONVEX_VERTEBRAL_BODIES,SET,3,-0.099123,-0.001267,0.48528,0.58092,HP_BICONVEX_VERTEBRAL_BODIES,0.998051356359324
GSE22589_SIV_VS_HIV_AND_SIV_...2,SET,178,-0.013381,-0.0013111,0.065444,0.581,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.998051356359324
MIR421,SET,160,-0.013855,-0.0012877,0.067718,0.58106,MIR421,0.998051356359324
GOBP_ISOTYPE_SWITCHING_TO_IG...2,SET,15,-0.046377,-0.0013251,0.22665,0.58107,GOBP_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.998051356359324
PARK_HSC_MARKERS,SET,40,-0.027664,-0.0012898,0.13516,0.58109,PARK_HSC_MARKERS,0.998051356359324
WP_CELL_INTERACTIONS_OF_THE_...,SET,23,-0.04129,-0.0014605,0.20173,0.58109,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,0.998051356359324
WP_DNA_MISMATCH_REPAIR,SET,23,-0.032704,-0.0011568,0.15974,0.58111,WP_DNA_MISMATCH_REPAIR,0.998051356359324
GOBP_POSITIVE_REGULATION_OF_...580,SET,64,-0.02435,-0.0014351,0.11894,0.58111,GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS,0.998051356359324
REACTOME_SIGNALING_BY_ACTIVIN,SET,16,-0.048513,-0.0014315,0.23693,0.58112,REACTOME_SIGNALING_BY_ACTIVIN,0.998051356359324
ONDER_CDH1_SIGNALING_VIA_CTN...,SET,79,-0.021893,-0.001433,0.10689,0.58114,ONDER_CDH1_SIGNALING_VIA_CTNNB1,0.998051356359324
HP_JOINT_HYPERMOBILITY,SET,476,-0.0080358,-0.001277,0.039226,0.58116,HP_JOINT_HYPERMOBILITY,0.998051356359324
GSE24574_BCL6_LOW_TFH_VS_TCO...2,SET,168,-0.013937,-0.001327,0.068027,0.58116,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP,0.998051356359324
CLAUS_PGR_POSITIVE_MENINGIOM...1,SET,12,-0.057666,-0.0014738,0.28146,0.58117,CLAUS_PGR_POSITIVE_MENINGIOMA_DN,0.998051356359324
BIOCARTA_TNFR2_PATHWAY,SET,15,-0.044308,-0.0012659,0.21605,0.58124,BIOCARTA_TNFR2_PATHWAY,0.998107277667984
HP_RETINAL_FOLD,SET,10,-0.056863,-0.0013267,0.27722,0.58126,HP_RETINAL_FOLD,0.998107277667984
HP_RECURRENT_OPPORTUNISTIC_I...,SET,9,-0.060337,-0.0013355,0.29392,0.58132,HP_RECURRENT_OPPORTUNISTIC_INFECTIONS,0.998128848433949
MIR181C_5P,SET,556,-0.0077431,-0.0013269,0.037715,0.58133,MIR181C_5P,0.998128848433949
GOBP_REGULATION_OF_BINDING,SET,204,-0.01221,-0.0012799,0.059446,0.58137,GOBP_REGULATION_OF_BINDING,0.99814236511456
HP_TRUNCUS_ARTERIOSUS,SET,24,-0.041558,-0.0015015,0.2017,0.58162,HP_TRUNCUS_ARTERIOSUS,0.99814236511456
MEBARKI_HCC_PROGENITOR_WNT_D...4,SET,13,-0.052426,-0.0013945,0.25433,0.58166,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT,0.99814236511456
NUTT_GBM_VS_AO_GLIOMA_UP,SET,41,-0.02896,-0.001367,0.14047,0.58166,NUTT_GBM_VS_AO_GLIOMA_UP,0.99814236511456
GOBP_INHIBITORY_POSTSYNAPTIC...,SET,13,-0.053513,-0.0014234,0.25945,0.5817,GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.99814236511456
GOBP_MEMBRANE_DEPOLARIZATION...1,SET,27,-0.038015,-0.0014567,0.18428,0.58172,GOBP_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.99814236511456
HP_SHOULDER_PAIN,SET,6,-0.08241,-0.0014895,0.39936,0.58174,HP_SHOULDER_PAIN,0.99814236511456
GOBP_CD4_POSITIVE_ALPHA_BETA...3,SET,88,-0.020019,-0.0013826,0.096986,0.58176,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99814236511456
GOMF_ENZYME_REGULATOR_ACTIVI...,SET,1186,-0.0053529,-0.0013158,0.025916,0.58182,GOMF_ENZYME_REGULATOR_ACTIVITY,0.99814236511456
GOCC_CENTRIOLE,SET,144,-0.013899,-0.0012261,0.067279,0.58183,GOCC_CENTRIOLE,0.99814236511456
GOBP_REGULATION_OF_NEURON_PR...3,SET,30,-0.033624,-0.001358,0.1627,0.58186,GOBP_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.99814236511456
GOBP_PHOSPHATE_ION_TRANSPORT,SET,27,-0.037813,-0.001449,0.18294,0.58187,GOBP_PHOSPHATE_ION_TRANSPORT,0.99814236511456
GOBP_REGULATION_OF_SNRNA_TRA...,SET,5,-0.067673,-0.0011166,0.32737,0.58188,GOBP_REGULATION_OF_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.99814236511456
GOBP_REGULATION_OF_ADHERENS_...,SET,5,-0.080728,-0.001332,0.39052,0.58189,GOBP_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,0.99814236511456
SRC_UP.V1_UP,SET,148,-0.014791,-0.0013226,0.071529,0.58191,SRC_UP.V1_UP,0.99814236511456
TACGGGT_MIR99A_MIR100_MIR99B,SET,23,-0.038486,-0.0013613,0.1861,0.58192,TACGGGT_MIR99A_MIR100_MIR99B,0.99814236511456
DEURIG_T_CELL_PROLYMPHOCYTIC...1,SET,282,-0.010531,-0.0012951,0.050917,0.58193,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,0.99814236511456
GSE4590_PRE_BCELL_VS_SMALL_P...1,SET,109,-0.016546,-0.0012711,0.079944,0.58198,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN,0.99814236511456
ZNF223_TARGET_GENES,SET,257,-0.010885,-0.0012788,0.052584,0.58199,ZNF223_TARGET_GENES,0.99814236511456
GOMF_L_ORNITHINE_TRANSMEMBRA...,SET,4,-0.10566,-0.0015595,0.51012,0.58205,GOMF_L_ORNITHINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99814236511456
GOBP_MAMMARY_GLAND_DEVELOPME...,SET,128,-0.016931,-0.0014088,0.081723,0.58206,GOBP_MAMMARY_GLAND_DEVELOPMENT,0.99814236511456
GOBP_CELL_MATRIX_ADHESION,SET,224,-0.012213,-0.0013407,0.05894,0.58208,GOBP_CELL_MATRIX_ADHESION,0.99814236511456
GOBP_PROTEIN_PEPTIDYL_PROLYL...,SET,17,-0.040213,-0.0012231,0.19397,0.58212,GOBP_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION,0.99814236511456
LANDIS_ERBB2_BREAST_PRENEOPL...1,SET,56,-0.024356,-0.0013431,0.11747,0.58213,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,0.99814236511456
GOMF_ACTIN_MONOMER_BINDING,SET,21,-0.038496,-0.0013012,0.18559,0.58216,GOMF_ACTIN_MONOMER_BINDING,0.99814236511456
MIR181A_5P_MIR181B_5P,SET,555,-0.0078323,-0.001341,0.037747,0.58219,MIR181A_5P_MIR181B_5P,0.99814236511456
GOBP_HETEROTYPIC_CELL_CELL_A...,SET,62,-0.024634,-0.0014291,0.1187,0.5822,GOBP_HETEROTYPIC_CELL_CELL_ADHESION,0.99814236511456
GOBP_POSITIVE_REGULATION_OF_...710,SET,33,-0.031247,-0.0013235,0.15052,0.58223,GOBP_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.99814236511456
GSE16385_UNTREATED_VS_12H_RO...3,SET,175,-0.013617,-0.0013231,0.065591,0.58223,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,0.99814236511456
WP_NICOTINE_EFFECT_ON_DOPAMI...,SET,21,-0.040484,-0.0013684,0.19499,0.58224,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.99814236511456
HP_ABNORMAL_LIGHT_AND_DARK_A...,SET,35,-0.031974,-0.0013947,0.15392,0.58228,HP_ABNORMAL_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.99814236511456
GSE17301_CTRL_VS_48H_ACD3_AC...1,SET,173,-0.013048,-0.0012606,0.0628,0.58229,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN,0.99814236511456
KEGG_MEDICUS_REFERENCE_DRD1_...,SET,16,-0.044035,-0.0012994,0.21191,0.58231,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY,0.99814236511456
GSE32423_CTRL_VS_IL4_MEMORY_...2,SET,176,-0.013342,-0.0013,0.064134,0.5824,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP,0.99814236511456
DESCARTES_FETAL_LUNG_CILIATE...,SET,360,-0.009407,-0.0013043,0.045216,0.5824,DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS,0.99814236511456
GRAHAM_CML_QUIESCENT_VS_NORM...3,SET,37,-0.031655,-0.0014196,0.15211,0.58243,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,0.99814236511456
GOCC_NUCLEAR_CHROMOSOME,SET,211,-0.01167,-0.0012438,0.056023,0.58251,GOCC_NUCLEAR_CHROMOSOME,0.99814236511456
HP_COGNITIVE_IMPAIRMENT,SET,876,-0.0061227,-0.0013051,0.029388,0.58252,HP_COGNITIVE_IMPAIRMENT,0.99814236511456
GOBP_SODIUM_ION_TRANSMEMBRAN...,SET,177,-0.014421,-0.0014091,0.06921,0.58253,GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99814236511456
GOBP_MYOBLAST_DIFFERENTIATION,SET,108,-0.017315,-0.0013241,0.083049,0.58258,GOBP_MYOBLAST_DIFFERENTIATION,0.99814236511456
WP_PHYSIOLOGICAL_AND_PATHOLO...,SET,24,-0.038724,-0.0013992,0.18571,0.58259,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,0.99814236511456
MIR6833_5P,SET,119,-0.016878,-0.0013544,0.080895,0.58263,MIR6833_5P,0.99814236511456
HP_ABNORMAL_NEUTROPHIL_MORPH...,SET,18,-0.046667,-0.0014605,0.22369,0.58263,HP_ABNORMAL_NEUTROPHIL_MORPHOLOGY,0.99814236511456
FAN_OVARY_CL17_PUTATIVE_APOP...,SET,209,-0.012043,-0.0012775,0.057692,0.58267,FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL,0.99814236511456
IRF_Q6,SET,218,-0.01242,-0.0013453,0.05949,0.58268,IRF_Q6,0.99814236511456
PHONG_TNF_RESPONSE_VIA_P38_C...,SET,213,-0.012334,-0.0013208,0.059075,0.58269,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,0.99814236511456
WP_EICOSANOID_SYNTHESIS,SET,22,-0.042849,-0.0014824,0.20516,0.58272,WP_EICOSANOID_SYNTHESIS,0.99814236511456
IBRAHIM_NRF2_UP,SET,476,-0.0080679,-0.0012821,0.038599,0.58278,IBRAHIM_NRF2_UP,0.99814236511456
BIOCARTA_LONGEVITY_PATHWAY,SET,15,-0.048098,-0.0013742,0.23001,0.58282,BIOCARTA_LONGEVITY_PATHWAY,0.99814236511456
GSE6259_FLT3L_INDUCED_33D1_P...2,SET,177,-0.012909,-0.0012613,0.061728,0.58282,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP,0.99814236511456
GOBP_NEGATIVE_REGULATION_OF_...309,SET,6,-0.066086,-0.0011945,0.31599,0.58283,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.99814236511456
GSE29617_CTRL_VS_TIV_FLU_VAC...1,SET,171,-0.01318,-0.0012661,0.063009,0.58285,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN,0.99814236511456
MIKKELSEN_MEF_HCP_WITH_H3K27...,SET,557,-0.0084709,-0.0014529,0.04049,0.58286,MIKKELSEN_MEF_HCP_WITH_H3K27ME3,0.99814236511456
GOBP_RESPONSE_TO_PHENYLPROPA...,SET,4,-0.10347,-0.0015271,0.49429,0.5829,GOBP_RESPONSE_TO_PHENYLPROPANOID,0.998161682104848
GSE22589_HIV_VS_HIV_AND_SIV_...1,SET,182,-0.012959,-0.0012839,0.061872,0.58295,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN,0.998187568965517
GAVISH_3CA_MALIGNANT_METAPRO...26,SET,43,-0.028005,-0.0013537,0.1336,0.58301,GAVISH_3CA_MALIGNANT_METAPROGRAM_34_PLATELET_ACTIVATION,0.998187568965517
HP_BROAD_BASED_GAIT,SET,99,-0.017969,-0.0013159,0.085723,0.58302,HP_BROAD_BASED_GAIT,0.998187568965517
GOBP_CELLULAR_COMPONENT_DISA...1,SET,481,-0.0081345,-0.0012993,0.0388,0.58303,GOBP_CELLULAR_COMPONENT_DISASSEMBLY,0.998187568965517
HP_MITRAL_STENOSIS,SET,21,-0.041941,-0.0014176,0.19982,0.58312,HP_MITRAL_STENOSIS,0.99820508420327
GOMF_TRANSLATION_ELONGATION_...,SET,18,-0.036464,-0.0011412,0.17372,0.58313,GOMF_TRANSLATION_ELONGATION_FACTOR_ACTIVITY,0.99820508420327
TCANNTGAY_SREBP1_01,SET,421,-0.0086755,-0.0012986,0.041325,0.58314,TCANNTGAY_SREBP1_01,0.99820508420327
BIOCARTA_CACAM_PATHWAY,SET,9,-0.0701,-0.0015517,0.33371,0.58319,BIOCARTA_CACAM_PATHWAY,0.99820508420327
MORF_PTPRB,SET,222,-0.01235,-0.0013498,0.058789,0.5832,MORF_PTPRB,0.99820508420327
GSE20754_WT_VS_TCF1_KO_MEMOR...2,SET,187,-0.012455,-0.0012505,0.05925,0.58325,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP,0.99820508420327
GSE557_CIITA_KO_VS_I_AB_KO_D...1,SET,183,-0.012788,-0.0012703,0.060835,0.58325,GSE557_CIITA_KO_VS_I_AB_KO_DC_DN,0.99820508420327
MIR1288_5P,SET,46,-0.028382,-0.0014189,0.13499,0.58327,MIR1288_5P,0.99820508420327
MATSUMIYA_BLOOD_MODIFIED_VAC...1,SET,9,-0.06283,-0.0013907,0.29869,0.5833,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_DN,0.998207272637747
GOCC_PERINUCLEAR_ENDOPLASMIC...,SET,19,-0.041112,-0.0013219,0.19515,0.58343,GOCC_PERINUCLEAR_ENDOPLASMIC_RETICULUM,0.998267353418993
GOBP_RESPONSE_TO_DISACCHARIDE,SET,8,-0.059272,-0.001237,0.2813,0.58344,GOBP_RESPONSE_TO_DISACCHARIDE,0.998267353418993
GOBP_COP9_SIGNALOSOME_ASSEMB...,SET,5,-0.082889,-0.0013677,0.39334,0.58345,GOBP_COP9_SIGNALOSOME_ASSEMBLY,0.998267353418993
GOBP_RETINAL_CELL_APOPTOTIC_...,SET,6,-0.075359,-0.0013621,0.3576,0.58345,GOBP_RETINAL_CELL_APOPTOTIC_PROCESS,0.998267353418993
HP_RECURRENT_BRONCHITIS,SET,33,-0.032264,-0.0013666,0.15304,0.58349,HP_RECURRENT_BRONCHITIS,0.998285188646761
HP_ATROPHIC_GASTRITIS,SET,7,-0.062715,-0.0012243,0.29722,0.58356,HP_ATROPHIC_GASTRITIS,0.998285188646761
WANG_ESOPHAGUS_CANCER_VS_NOR...2,SET,114,-0.018236,-0.0014325,0.086324,0.58365,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,0.998285188646761
HP_HYPOPLASIA_OF_THE_UTERUS,SET,47,-0.027433,-0.0013862,0.12978,0.5837,HP_HYPOPLASIA_OF_THE_UTERUS,0.998285188646761
GOCC_STEREOCILIUM_TIP,SET,17,-0.046785,-0.001423,0.22131,0.58371,GOCC_STEREOCILIUM_TIP,0.998285188646761
MIR4777_5P,SET,101,-0.018357,-0.0013578,0.086825,0.58372,MIR4777_5P,0.998285188646761
GSE10325_BCELL_VS_MYELOID_DN,SET,182,-0.013783,-0.0013655,0.06515,0.58377,GSE10325_BCELL_VS_MYELOID_DN,0.998285188646761
GOBP_DNA_TEMPLATED_TRANSCRIP...3,SET,20,-0.043822,-0.0014455,0.20712,0.58378,GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION,0.998285188646761
GOBP_REGULATION_OF_PROTON_TR...,SET,12,-0.053517,-0.0013677,0.25282,0.58382,GOBP_REGULATION_OF_PROTON_TRANSPORT,0.998285188646761
DAVICIONI_TARGETS_OF_PAX_FOX...2,SET,233,-0.013139,-0.0014707,0.062054,0.58384,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,0.998285188646761
GSE37416_CTRL_VS_3H_F_TULARE...2,SET,169,-0.013088,-0.0012498,0.061805,0.58385,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.998285188646761
MIR4446_3P,SET,56,-0.023552,-0.0012987,0.1112,0.58387,MIR4446_3P,0.998285188646761
REACTOME_MITOCHONDRIAL_PROTE...1,SET,78,-0.018975,-0.0012341,0.089559,0.58389,REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION,0.998285188646761
MIR4707_5P,SET,9,-0.060784,-0.0013455,0.28689,0.5839,MIR4707_5P,0.998285188646761
GOCC_RPAP3_R2TP_PREFOLDIN_LI...,SET,9,-0.055671,-0.0012323,0.26274,0.5839,GOCC_RPAP3_R2TP_PREFOLDIN_LIKE_COMPLEX,0.998285188646761
KEGG_MEDICUS_REFERENCE_PYRIN...,SET,4,-0.077186,-0.0011392,0.36418,0.58392,KEGG_MEDICUS_REFERENCE_PYRIN_INFLAMMASOME_SIGNALING_PATHWAY,0.998285188646761
MIR591,SET,44,-0.027671,-0.001353,0.13034,0.58406,MIR591,0.998337161464733
GOBP_VENTRICULAR_CARDIAC_MUS...6,SET,45,-0.030407,-0.0015035,0.14321,0.58407,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.998337161464733
GSE46468_LUNG_INNATE_LYMPHOI...1,SET,178,-0.012904,-0.0012644,0.060754,0.5841,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN,0.998337161464733
GOBP_T_CELL_HOMEOSTASIS,SET,44,-0.02792,-0.0013652,0.1314,0.58413,GOBP_T_CELL_HOMEOSTASIS,0.998337161464733
REACTOME_P2Y_RECEPTORS,SET,9,-0.064228,-0.0014217,0.30219,0.58416,REACTOME_P2Y_RECEPTORS,0.998337161464733
GOBP_REGULATION_OF_ENDOCYTOS...,SET,266,-0.01135,-0.0013563,0.05339,0.58418,GOBP_REGULATION_OF_ENDOCYTOSIS,0.998337161464733
GOBP_PHOSPHOLIPID_CATABOLIC_...,SET,52,-0.025107,-0.0013343,0.11808,0.58419,GOBP_PHOSPHOLIPID_CATABOLIC_PROCESS,0.998337161464733
GSE30083_SP1_VS_SP4_THYMOCYT...2,SET,180,-0.013582,-0.0013383,0.063845,0.58423,GSE30083_SP1_VS_SP4_THYMOCYTE_UP,0.998337161464733
GOBP_POSITIVE_REGULATION_OF_...68,SET,14,-0.048993,-0.0013524,0.23026,0.58425,GOBP_POSITIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.998337161464733
MIR3976,SET,104,-0.018116,-0.0013596,0.085109,0.58428,MIR3976,0.998337161464733
chr10q11,SET,45,-0.047891,-0.0023681,0.22494,0.5843,chr10q11,0.998337161464733
GOBP_G_PROTEIN_COUPLED_RECEP...3,SET,54,-0.026715,-0.0014467,0.12544,0.58432,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER,0.998337161464733
GOBP_FATTY_ACID_BIOSYNTHETIC...,SET,145,-0.01535,-0.0013588,0.072054,0.58435,GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.998337161464733
GOBP_ANTEROGRADE_NEURONAL_DE...,SET,6,-0.071633,-0.0012947,0.33611,0.58438,GOBP_ANTEROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,0.998337161464733
GOBP_REGULATION_OF_NUCLEAR_T...1,SET,21,-0.038616,-0.0013052,0.18115,0.5844,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.998337161464733
ELVIDGE_HIF2A_TARGETS_UP,SET,6,-0.07793,-0.0014086,0.36555,0.58441,ELVIDGE_HIF2A_TARGETS_UP,0.998337161464733
CHESLER_BRAIN_D6MIT150_QTL_C...,SET,3,-0.10783,-0.0013783,0.50551,0.58446,CHESLER_BRAIN_D6MIT150_QTL_CIS,0.99837350339133
GOCC_ENZYME_ACTIVATOR_COMPLEX,SET,13,-0.044504,-0.0011838,0.20836,0.58456,GOCC_ENZYME_ACTIVATOR_COMPLEX,0.998437787441038
GOMF_EFFLUX_TRANSMEMBRANE_TR...,SET,15,-0.048098,-0.0013742,0.22522,0.58456,GOMF_EFFLUX_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.998437787441038
GSE38697_LIGHT_ZONE_VS_DARK_...2,SET,154,-0.014224,-0.0012972,0.066545,0.58463,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.998437787441038
GOBP_POSITIVE_REGULATION_OF_...155,SET,136,-0.016677,-0.00143,0.078006,0.58465,GOBP_POSITIVE_REGULATION_OF_CHEMOTAXIS,0.998437787441038
GOMF_SIGNALING_ADAPTOR_ACTIV...,SET,109,-0.017847,-0.001371,0.083449,0.58467,GOMF_SIGNALING_ADAPTOR_ACTIVITY,0.998437787441038
HP_HYPOAUTOFLUORESCENT_RETIN...,SET,5,-0.097705,-0.0016122,0.45685,0.58467,HP_HYPOAUTOFLUORESCENT_RETINAL_LESION,0.998437787441038
GOMF_PURINE_RIBONUCLEOTIDE_T...,SET,20,-0.044478,-0.0014672,0.20784,0.58472,GOMF_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.998442131767711
MIR708_3P,SET,102,-0.018827,-0.0013994,0.087976,0.58473,MIR708_3P,0.998442131767711
REACTOME_PLATELET_CALCIUM_HO...,SET,27,-0.03604,-0.001381,0.16816,0.58485,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,0.998583063961486
GOBP_REGULATION_OF_INTERLEUK...1,SET,9,-0.058915,-0.0013041,0.27484,0.58487,GOBP_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.998583063961486
MIR4696,SET,91,-0.019295,-0.0013551,0.08992,0.58495,MIR4696,0.998655680813439
BIOCARTA_SET_PATHWAY,SET,10,-0.068486,-0.0015979,0.31907,0.58497,BIOCARTA_SET_PATHWAY,0.998655680813439
HP_CENTRAL_Y_SHAPED_METACARP...,SET,8,-0.052605,-0.0010979,0.24492,0.58503,HP_CENTRAL_Y_SHAPED_METACARPAL,0.998692185888938
GOMF_CALMODULIN_DEPENDENT_PR...2,SET,5,-0.065853,-0.0010866,0.30655,0.58505,GOMF_CALMODULIN_DEPENDENT_PROTEIN_PHOSPHATASE_ACTIVITY,0.998692185888938
ELLWOOD_MYC_TARGETS_UP,SET,13,-0.052075,-0.0013852,0.24222,0.58511,ELLWOOD_MYC_TARGETS_UP,0.998692185888938
HP_DYSESTHESIA,SET,16,-0.049659,-0.0014653,0.23098,0.58511,HP_DYSESTHESIA,0.998692185888938
MIR603,SET,150,-0.015043,-0.0013541,0.069943,0.58514,MIR603,0.998692185888938
GOBP_SULFATION,SET,20,-0.046466,-0.0015328,0.21599,0.58517,GOBP_SULFATION,0.998692185888938
GOBP_GLOMERULAR_BASEMENT_MEM...,SET,11,-0.057329,-0.0014028,0.26638,0.5852,GOBP_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT,0.998692185888938
GOBP_EYE_PHOTORECEPTOR_CELL_...1,SET,36,-0.032233,-0.0014259,0.1497,0.58524,GOBP_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT,0.998692185888938
GOMF_TRANSFERASE_ACTIVITY_TR...1,SET,54,-0.026468,-0.0014333,0.12291,0.58525,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS,0.998692185888938
GOBP_RESPONSE_TO_CYCLOHEXIMI...,SET,5,-0.092475,-0.0015259,0.42886,0.58536,GOBP_RESPONSE_TO_CYCLOHEXIMIDE,0.998830852317361
GSE11961_FOLLICULAR_BCELL_VS...2,SET,186,-0.012787,-0.0012805,0.059248,0.58543,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.998901254357111
HP_DEATH_IN_ADULTHOOD,SET,42,-0.028545,-0.0013637,0.13221,0.58547,HP_DEATH_IN_ADULTHOOD,0.998920463917526
HP_ABNORMAL_CIRCULATING_FOLL...,SET,77,-0.021126,-0.0013652,0.097719,0.58558,HP_ABNORMAL_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,0.998978081284053
GOBP_TISSUE_MORPHOGENESIS,SET,576,-0.0081746,-0.001425,0.037807,0.58559,GOBP_TISSUE_MORPHOGENESIS,0.998978081284053
GOCC_RUFFLE_MEMBRANE,SET,95,-0.018837,-0.0013515,0.087126,0.58559,GOCC_RUFFLE_MEMBRANE,0.998978081284053
KEGG_MEDICUS_REFERENCE_CD80_...1,SET,10,-0.059828,-0.0013959,0.27648,0.58566,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY,0.999048458820065
GSE6259_FLT3L_INDUCED_DEC205...4,SET,147,-0.014313,-0.0012755,0.066081,0.58574,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP,0.999135887116565
GOBP_CYTOPLASMIC_PATTERN_REC...,SET,148,-0.014943,-0.0013363,0.068883,0.58587,GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.999229699690858
GOBP_TROPHOBLAST_CELL_MIGRAT...,SET,15,-0.047897,-0.0013685,0.22077,0.58588,GOBP_TROPHOBLAST_CELL_MIGRATION,0.999229699690858
GSE9960_HEALTHY_VS_GRAM_NEG_...4,SET,186,-0.013396,-0.0013414,0.061731,0.58589,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP,0.999229699690858
GOMF_APOLIPOPROTEIN_A_I_BIND...,SET,5,-0.083094,-0.0013711,0.38283,0.58591,GOMF_APOLIPOPROTEIN_A_I_BINDING,0.999229699690858
HP_ABNORMAL_CIRCULATING_CITR...,SET,10,-0.06084,-0.0014195,0.27963,0.58612,HP_ABNORMAL_CIRCULATING_CITRULLINE_CONCENTRATION,0.999444951923077
HP_ABNORMALITY_OF_THE_THORAC...,SET,46,-0.028372,-0.0014184,0.13038,0.58613,HP_ABNORMALITY_OF_THE_THORACIC_CAVITY,0.999444951923077
HP_ABNORMAL_MENINGEAL_MORPHO...,SET,177,-0.014056,-0.0013735,0.064597,0.58613,HP_ABNORMAL_MENINGEAL_MORPHOLOGY,0.999444951923077
PAX6_01,SET,86,-0.020747,-0.0014166,0.095309,0.58616,PAX6_01,0.999444951923077
ZHONG_PFC_C9_ORG_OTHER,SET,71,-0.024509,-0.0015212,0.11257,0.58618,ZHONG_PFC_C9_ORG_OTHER,0.999444951923077
MIR8085,SET,207,-0.013478,-0.0014231,0.061883,0.58621,MIR8085,0.999447071376012
HP_HYPOTHERMIA,SET,40,-0.029121,-0.0013578,0.13339,0.58641,HP_HYPOTHERMIA,0.999668530868435
GSE19941_LPS_VS_LPS_AND_IL10...1,SET,137,-0.016849,-0.00145,0.077112,0.58648,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.999668530868435
KAYO_CALORIE_RESTRICTION_MUS...1,SET,77,-0.019812,-0.0012803,0.090632,0.58652,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,0.999668530868435
LINDGREN_BLADDER_CANCER_CLUS...3,SET,118,-0.018512,-0.0014793,0.084683,0.58652,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,0.999668530868435
GOBP_VITAMIN_A_METABOLIC_PRO...,SET,8,-0.074293,-0.0015505,0.33986,0.58652,GOBP_VITAMIN_A_METABOLIC_PROCESS,0.999668530868435
GSE2770_TGFB_AND_IL4_ACT_VS_...2,SET,163,-0.014347,-0.0013458,0.065623,0.58653,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,0.999668530868435
GOBP_REGULATION_OF_HEART_RAT...1,SET,39,-0.03309,-0.0015235,0.15127,0.58657,GOBP_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION,0.999668530868435
HP_ABNORMAL_EPIPHYSEAL_OSSIF...,SET,70,-0.022442,-0.0013831,0.1026,0.58657,HP_ABNORMAL_EPIPHYSEAL_OSSIFICATION,0.999668530868435
GOBP_NEGATIVE_REGULATION_OF_...624,SET,8,-0.075231,-0.00157,0.3435,0.58668,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.999713143445436
GSE13485_DAY3_VS_DAY7_YF17D_...2,SET,151,-0.014875,-0.0013434,0.067915,0.58668,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.999713143445436
HP_ABNORMAL_SWEAT_HOMEOSTASIS,SET,28,-0.038957,-0.0015202,0.17777,0.58673,HP_ABNORMAL_SWEAT_HOMEOSTASIS,0.999713143445436
GOBP_REGULATION_OF_SYSTEMIC_...2,SET,15,-0.054747,-0.0015642,0.24979,0.58674,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN,0.999713143445436
DESCARTES_MAIN_FETAL_EPICARD...,SET,38,-0.033786,-0.0015355,0.15416,0.58674,DESCARTES_MAIN_FETAL_EPICARDIAL_FAT_CELLS,0.999713143445436
chr18q12,SET,43,-0.052353,-0.0025306,0.23878,0.58677,chr18q12,0.999715248296485
GOMF_COPPER_ION_TRANSMEMBRAN...,SET,6,-0.07347,-0.0013279,0.335,0.5868,GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999717352941176
MIR149_3P,SET,396,-0.0095266,-0.0013839,0.043396,0.58688,MIR149_3P,0.999757734156742
LIANG_HEMATOPOIESIS_STEM_CEL...4,SET,33,-0.031947,-0.0013532,0.14551,0.58689,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,0.999757734156742
GSE3982_DC_VS_TH2_UP,SET,181,-0.014546,-0.0014371,0.066234,0.58691,GSE3982_DC_VS_TH2_UP,0.999757734156742
GSE22229_UNTREATED_VS_IMMUNO...2,SET,171,-0.014471,-0.0013901,0.065849,0.58697,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP,0.999810936581063
HP_ABNORMAL_HELIX_MORPHOLOGY,SET,151,-0.015321,-0.0013837,0.069669,0.58703,HP_ABNORMAL_HELIX_MORPHOLOGY,0.999814658211732
GOBP_REGULATION_OF_ANTIGEN_R...,SET,61,-0.02412,-0.001388,0.10962,0.58708,GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.999814658211732
HP_VERTEBRAL_WEDGING,SET,16,-0.045434,-0.0013406,0.20631,0.58715,HP_VERTEBRAL_WEDGING,0.999814658211732
HAHTOLA_MYCOSIS_FUNGOIDES_SK...1,SET,26,-0.038973,-0.0014656,0.17694,0.58716,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,0.999814658211732
SS18_SSX1_FUSION_UNIPROT_Q8I...,SET,311,-0.011395,-0.0014705,0.05172,0.58719,SS18_SSX1_FUSION_UNIPROT_Q8IZH1_UNREVIEWED_TARGET_GENES,0.999814658211732
SASSON_RESPONSE_TO_GONADOTRO...1,SET,85,-0.020707,-0.0014056,0.09397,0.5872,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,0.999814658211732
GOBP_GALACTOSE_TRANSMEMBRANE...,SET,4,-0.10894,-0.0016078,0.49417,0.58724,GOBP_GALACTOSE_TRANSMEMBRANE_TRANSPORT,0.999814658211732
COULOUARN_TEMPORAL_TGFB1_SIG...1,SET,124,-0.016788,-0.001375,0.076129,0.58727,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,0.999814658211732
GSE43955_1H_VS_20H_ACT_CD4_T...3,SET,187,-0.014795,-0.0014855,0.06709,0.58727,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.999814658211732
GOBP_VIRAL_PROCESS,SET,396,-0.0096956,-0.0014085,0.043954,0.58729,GOBP_VIRAL_PROCESS,0.999814658211732
GSE22443_NAIVE_VS_ACT_AND_IL...2,SET,187,-0.013623,-0.0013678,0.061717,0.58735,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP,0.999814658211732
GOBP_POSITIVE_REGULATION_OF_...166,SET,27,-0.032272,-0.0012367,0.14618,0.58736,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,0.999814658211732
POU3F2_01,SET,96,-0.02037,-0.0014691,0.092223,0.5874,POU3F2_01,0.999814658211732
HP_ABNORMAL_CONNECTION_OF_TH...,SET,234,-0.012439,-0.0013953,0.056283,0.58745,HP_ABNORMAL_CONNECTION_OF_THE_CARDIAC_SEGMENTS,0.999814658211732
GOBP_RNA_DECAPPING,SET,17,-0.046589,-0.001417,0.21079,0.58746,GOBP_RNA_DECAPPING,0.999814658211732
GSE17721_CTRL_VS_GARDIQUIMOD...4,SET,179,-0.013949,-0.0013706,0.063099,0.58748,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP,0.999814658211732
ZNF595_TARGET_GENES,SET,99,-0.019132,-0.0014011,0.086531,0.58749,ZNF595_TARGET_GENES,0.999814658211732
HP_SMALL_PLACENTA,SET,9,-0.069677,-0.0015423,0.31513,0.58749,HP_SMALL_PLACENTA,0.999814658211732
ZNF660_TARGET_GENES,SET,597,-0.0079347,-0.0014074,0.035826,0.58764,ZNF660_TARGET_GENES,0.999965436389446
GOBP_VALINE_METABOLIC_PROCESS,SET,7,-0.068313,-0.0013336,0.30834,0.58767,GOBP_VALINE_METABOLIC_PROCESS,0.999965436389446
HP_ADRENOCORTICOTROPIC_HORMO...2,SET,4,-0.088766,-0.0013101,0.4006,0.58768,HP_ADRENOCORTICOTROPIC_HORMONE_EXCESS,0.999965436389446
FOXJ2_TARGET_GENES,SET,439,-0.009082,-0.0013875,0.04095,0.58776,FOXJ2_TARGET_GENES,0.999965436389446
BROWNE_INTERFERON_RESPONSIVE...,SET,65,-0.024749,-0.00147,0.11158,0.58777,BROWNE_INTERFERON_RESPONSIVE_GENES,0.999965436389446
GOMF_ACETYLTRANSFERASE_ACTIV...,SET,88,-0.018768,-0.0012962,0.084616,0.58777,GOMF_ACETYLTRANSFERASE_ACTIVITY,0.999965436389446
GOBP_CELL_MORPHOGENESIS_INVO...,SET,534,-0.0087727,-0.0014742,0.039546,0.58778,GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION,0.999965436389446
GOBP_THROMBIN_ACTIVATED_RECE...,SET,13,-0.059323,-0.001578,0.26727,0.58783,GOBP_THROMBIN_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.999986625715824
HP_CARCINOID_TUMOR,SET,12,-0.053124,-0.0013577,0.23927,0.58785,HP_CARCINOID_TUMOR,0.999986625715824
GOBP_NEGATIVE_REGULATION_OF_...198,SET,6,-0.079076,-0.0014293,0.35593,0.58791,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION,0.999997064004698
GOBP_DOUBLE_STRAND_BREAK_REP...7,SET,6,-0.073664,-0.0013314,0.33148,0.58793,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SINGLE_STRAND_ANNEALING,0.999997064004698
GOBP_REGULATION_OF_SMALL_GTP...,SET,279,-0.011749,-0.0014373,0.052854,0.58795,GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.999997064004698
MIR4802_5P,SET,57,-0.025529,-0.0014202,0.1148,0.58799,MIR4802_5P,0.999997064004698
GOCC_POLAR_MICROTUBULE,SET,5,-0.078715,-0.0012988,0.35394,0.588,GOCC_POLAR_MICROTUBULE,0.999997064004698
MODULE_288,SET,34,-0.038935,-0.0016739,0.17479,0.58813,MODULE_288,1
GREENBAUM_E2A_TARGETS_DN,SET,17,-0.047109,-0.0014328,0.21137,0.58818,GREENBAUM_E2A_TARGETS_DN,1
REACTOME_ERKS_ARE_INACTIVATED,SET,13,-0.05121,-0.0013622,0.22972,0.5882,REACTOME_ERKS_ARE_INACTIVATED,1
HP_NARROW_NOSE,SET,21,-0.043006,-0.0014536,0.19285,0.58823,HP_NARROW_NOSE,1
JIANG_HYPOXIA_NORMAL,SET,189,-0.01352,-0.0013646,0.06062,0.58824,JIANG_HYPOXIA_NORMAL,1
MODULE_399,SET,49,-0.02844,-0.0014673,0.12746,0.58828,MODULE_399,1
HP_ABNORMAL_NUMBER_OF_TEETH,SET,356,-0.010154,-0.0014002,0.045495,0.5883,HP_ABNORMAL_NUMBER_OF_TEETH,1
NUNODA_RESPONSE_TO_DASATINIB...1,SET,13,-0.050052,-0.0013314,0.22418,0.58834,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1
GSE18804_BRAIN_VS_COLON_TUMO...1,SET,174,-0.015159,-0.0014687,0.067848,0.5884,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN,1
REACTOME_OLFACTORY_SIGNALING...,SET,316,-0.015611,-0.0020304,0.069853,0.58842,REACTOME_OLFACTORY_SIGNALING_PATHWAY,1
GSE13484_12H_VS_3H_YF17D_VAC...1,SET,178,-0.014078,-0.0013795,0.06299,0.58843,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,1
HP_ABNORMAL_HEART_VALVE_PHYS...,SET,336,-0.010617,-0.0014231,0.047494,0.58845,HP_ABNORMAL_HEART_VALVE_PHYSIOLOGY,1
GSE17721_0.5H_VS_8H_POLYIC_B...2,SET,183,-0.013192,-0.0013105,0.058997,0.58847,GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP,1
QUINTENS_EMBRYONIC_BRAIN_RES...,SET,73,-0.022359,-0.001407,0.099946,0.58851,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1
KEGG_MEDICUS_REFERENCE_BCR_B...,SET,14,-0.053888,-0.0014875,0.24077,0.58855,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY,1
REACTOME_LAGGING_STRAND_SYNT...,SET,19,-0.039946,-0.0012844,0.17845,0.58856,REACTOME_LAGGING_STRAND_SYNTHESIS,1
GSE41867_DAY15_EFFECTOR_VS_D...1,SET,182,-0.013406,-0.0013281,0.059879,0.58857,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,1
HP_OLIGODONTIA,SET,52,-0.026397,-0.0014028,0.11786,0.58861,HP_OLIGODONTIA,1
GOBP_PHOTORECEPTOR_CELL_OUTE...,SET,12,-0.052488,-0.0013414,0.23432,0.58862,GOBP_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION,1
WP_NONALCOHOLIC_FATTY_LIVER_...,SET,146,-0.014832,-0.0013173,0.0662,0.58864,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1
FREAC4_01,SET,134,-0.018075,-0.0015385,0.080651,0.58866,FREAC4_01,1
HP_EXUDATIVE_RETINAL_DETACHM...,SET,5,-0.10337,-0.0017056,0.46106,0.5887,HP_EXUDATIVE_RETINAL_DETACHMENT,1
GAVISH_3CA_MALIGNANT_METAPRO...13,SET,48,-0.029,-0.0014809,0.12921,0.58879,GAVISH_3CA_MALIGNANT_METAPROGRAM_22_SECRETED_1,1
NIKOLSKY_BREAST_CANCER_7P15_...,SET,11,-0.092948,-0.0022744,0.414,0.58882,NIKOLSKY_BREAST_CANCER_7P15_AMPLICON,1
GOBP_CELL_FATE_COMMITMENT_IN...2,SET,11,-0.062361,-0.001526,0.27743,0.58892,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...34,SET,13,-0.045266,-0.0012041,0.20111,0.58904,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_WITH_A_FLAVIN_AS_ACCEPTOR,1
GOBP_MACROPHAGE_MIGRATION,SET,57,-0.025821,-0.0014365,0.11471,0.58905,GOBP_MACROPHAGE_MIGRATION,1
GACAGGG_MIR339,SET,63,-0.023309,-0.001363,0.10352,0.58907,GACAGGG_MIR339,1
HP_CORTICAL_CATARACT,SET,10,-0.062636,-0.0014614,0.27816,0.58908,HP_CORTICAL_CATARACT,1
HP_ERYTHROCYTE_INCLUSION_BOD...,SET,6,-0.068856,-0.0012445,0.30577,0.58908,HP_ERYTHROCYTE_INCLUSION_BODIES,1
ZHENG_FOXP3_TARGETS_IN_T_LYM...1,SET,34,-0.034329,-0.0014759,0.15234,0.58914,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,1
GOBP_IRON_ION_TRANSMEMBRANE_...,SET,18,-0.045059,-0.0014102,0.19987,0.58918,GOBP_IRON_ION_TRANSMEMBRANE_TRANSPORT,1
WP_6Q16_COPY_NUMBER_VARIATION,SET,14,-0.054687,-0.0015095,0.2425,0.58921,WP_6Q16_COPY_NUMBER_VARIATION,1
GSE40274_FOXP3_VS_FOXP3_AND_...12,SET,176,-0.014784,-0.0014406,0.065464,0.58934,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_CARDIAC_CHAMBER_FORMATI...,SET,11,-0.069289,-0.0016955,0.3067,0.58937,GOBP_CARDIAC_CHAMBER_FORMATION,1
GSE19401_PAM2CSK4_VS_RETINOI...3,SET,175,-0.014334,-0.0013927,0.063441,0.58937,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,1
AHRR_TARGET_GENES,SET,1028,-0.006242,-0.0014351,0.027624,0.58938,AHRR_TARGET_GENES,1
HP_POSTERIOR_SYNECHIAE_OF_TH...,SET,10,-0.066513,-0.0015519,0.29414,0.58945,HP_POSTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,1
GOMF_AMIDE_BINDING,SET,230,-0.013367,-0.0014867,0.059091,0.58948,GOMF_AMIDE_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...405,SET,141,-0.01719,-0.0015006,0.075982,0.58949,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,1
GSE43955_1H_VS_42H_ACT_CD4_T...4,SET,180,-0.014227,-0.0014017,0.062882,0.58949,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
GOBP_CELL_CYCLE_PHASE_TRANSI...,SET,495,-0.0086882,-0.0014072,0.038394,0.58951,GOBP_CELL_CYCLE_PHASE_TRANSITION,1
MIR144_5P,SET,47,-0.028295,-0.0014298,0.12499,0.58954,MIR144_5P,1
REACTOME_PLATELET_AGGREGATIO...,SET,39,-0.032015,-0.001474,0.14139,0.58957,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,1
GOBP_MUSCLE_ORGAN_MORPHOGENE...,SET,76,-0.024504,-0.0015733,0.10817,0.5896,GOBP_MUSCLE_ORGAN_MORPHOGENESIS,1
CREIGHTON_ENDOCRINE_THERAPY_...5,SET,429,-0.0096386,-0.001456,0.04254,0.58962,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1
GSE10500_ARTHRITIC_SYNOVIAL_...1,SET,125,-0.017733,-0.0014582,0.078236,0.58966,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN,1
GSE14769_UNSTIM_VS_60MIN_LPS...1,SET,188,-0.015101,-0.0015202,0.066555,0.58974,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...8,SET,72,-0.023733,-0.0014833,0.1046,0.58975,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE,1
HP_SUICIDAL_IDEATION,SET,21,-0.041179,-0.0013919,0.1814,0.58979,HP_SUICIDAL_IDEATION,1
GSE3920_UNTREATED_VS_IFNA_TR...4,SET,158,-0.015841,-0.0014632,0.069773,0.5898,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP,1
GOBP_POSITIVE_REGULATION_OF_...272,SET,9,-0.065314,-0.0014457,0.28764,0.58981,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,1
GSE20500_RETINOIC_ACID_VS_RA...1,SET,175,-0.015061,-0.0014634,0.066306,0.58985,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,1
MORF_RAB11A,SET,51,-0.023878,-0.0012567,0.1051,0.58986,MORF_RAB11A,1
REACTOME_DEPOSITION_OF_NEW_C...,SET,23,-0.03925,-0.0013884,0.17275,0.58987,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,1
GSE15930_STIM_VS_STIM_AND_IF...3,SET,190,-0.01406,-0.0014228,0.061879,0.58987,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN,1
KEGG_MEDICUS_VARIANT_AMPLIFI...5,SET,14,-0.0545,-0.0015044,0.23973,0.58992,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,1
GOCC_P_BODY,SET,93,-0.020078,-0.0014254,0.088307,0.58993,GOCC_P_BODY,1
GOMF_CYCLIN_DEPENDENT_PROTEI...4,SET,45,-0.028241,-0.0013964,0.12421,0.58993,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY,1
GOBP_CELL_ADHESION_INVOLVED_...,SET,7,-0.088311,-0.001724,0.38832,0.58995,GOBP_CELL_ADHESION_INVOLVED_IN_HEART_MORPHOGENESIS,1
MAEKAWA_ATF2_TARGETS,SET,22,-0.041726,-0.0014435,0.18344,0.58996,MAEKAWA_ATF2_TARGETS,1
HP_INFERTILITY,SET,248,-0.012353,-0.0014259,0.054307,0.58997,HP_INFERTILITY,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...2,SET,16,-0.049063,-0.0014477,0.21548,0.59006,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,1
BIOCARTA_PYK2_PATHWAY,SET,27,-0.037692,-0.0014444,0.16546,0.5901,BIOCARTA_PYK2_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...5,SET,4,-0.094551,-0.0013954,0.41498,0.59011,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAH7.8_TO_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
HP_RECURRENT_NEISSERIAL_INFE...,SET,7,-0.076116,-0.001486,0.33385,0.59017,HP_RECURRENT_NEISSERIAL_INFECTIONS,1
HP_ABNORMALITY_OF_CHORIORETI...,SET,12,-0.061633,-0.0015752,0.27031,0.59018,HP_ABNORMALITY_OF_CHORIORETINAL_PIGMENTATION,1
GOMF_D1_DOPAMINE_RECEPTOR_BI...,SET,6,-0.071112,-0.0012853,0.31177,0.59021,GOMF_D1_DOPAMINE_RECEPTOR_BINDING,1
KIM_RESPONSE_TO_TSA_AND_DECI...1,SET,8,-0.060354,-0.0012596,0.26455,0.59023,KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,1
GOBP_REGULATION_OF_RECEPTOR_...6,SET,105,-0.019097,-0.00144,0.083692,0.59025,GOBP_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
REACTOME_RNA_POLYMERASE_II_T...3,SET,60,-0.022649,-0.0012927,0.099122,0.59037,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1
GNF2_MKI67,SET,27,-0.038343,-0.0014693,0.16772,0.59041,GNF2_MKI67,1
GOBP_REGULATION_OF_PHOSPHATI...1,SET,5,-0.09343,-0.0015416,0.40801,0.59056,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,1
GOMF_MONOATOMIC_ANION_SODIUM...,SET,17,-0.053246,-0.0016195,0.23246,0.59058,GOMF_MONOATOMIC_ANION_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_BRANCHED_CHAIN_AMINO_AC...3,SET,27,-0.036757,-0.0014085,0.16037,0.59064,GOBP_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS,1
HP_C1_C2_VERTEBRAL_ABNORMALI...,SET,7,-0.070434,-0.001375,0.30712,0.5907,HP_C1_C2_VERTEBRAL_ABNORMALITY,1
MIR143_3P_MIR4770,SET,187,-0.014529,-0.0014588,0.063317,0.59074,MIR143_3P_MIR4770,1
WP_TCELL_RECEPTOR_SIGNALING,SET,87,-0.021325,-0.0014645,0.092873,0.5908,WP_TCELL_RECEPTOR_SIGNALING,1
GOBP_CELLULAR_RESPONSE_TO_AC...2,SET,79,-0.02248,-0.0014714,0.09784,0.59086,GOBP_CELLULAR_RESPONSE_TO_ACID_CHEMICAL,1
GSE17721_LPS_VS_POLYIC_1H_BM...1,SET,179,-0.013966,-0.0013723,0.06078,0.59087,GSE17721_LPS_VS_POLYIC_1H_BMDC_DN,1
REACTOME_PI_3K_CASCADE_FGFR2,SET,22,-0.044898,-0.0015533,0.19536,0.59088,REACTOME_PI_3K_CASCADE_FGFR2,1
GSE17721_LPS_VS_GARDIQUIMOD_...4,SET,184,-0.014517,-0.001446,0.063131,0.59093,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP,1
HP_ADULT_ONSET,SET,776,-0.0072356,-0.0014558,0.031446,0.59099,HP_ADULT_ONSET,1
WEINMANN_ADAPTATION_TO_HYPOX...2,SET,25,-0.043323,-0.0015976,0.18827,0.591,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,1
GOMF_ADP_D_RIBOSE_MODIFICATI...,SET,4,-0.085593,-0.0012632,0.37183,0.59103,GOMF_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
STTTCRNTTT_IRF_Q6,SET,174,-0.015735,-0.0015245,0.06832,0.59107,STTTCRNTTT_IRF_Q6,1
HP_NEOPLASM_OF_THE_INNER_EAR,SET,8,-0.071455,-0.0014912,0.31028,0.59107,HP_NEOPLASM_OF_THE_INNER_EAR,1
HP_ALOPECIA,SET,218,-0.013833,-0.0014983,0.060032,0.59112,HP_ALOPECIA,1
GOMF_TITIN_BINDING,SET,13,-0.052175,-0.0013879,0.22616,0.59122,GOMF_TITIN_BINDING,1
GOMF_OLFACTORY_RECEPTOR_ACTI...,SET,305,-0.016752,-0.0021412,0.072567,0.59128,GOMF_OLFACTORY_RECEPTOR_ACTIVITY,1
GOBP_TOLL_LIKE_RECEPTOR_SIGN...,SET,68,-0.02345,-0.0014245,0.10158,0.59129,GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
CLIMENT_BREAST_CANCER_COPY_N...1,SET,8,-0.069709,-0.0014548,0.30188,0.59131,CLIMENT_BREAST_CANCER_COPY_NUMBER_DN,1
ENK_UV_RESPONSE_KERATINOCYTE...1,SET,437,-0.0093292,-0.0014221,0.0404,0.59131,ENK_UV_RESPONSE_KERATINOCYTE_DN,1
GSE17721_LPS_VS_PAM3CSK4_4H_...1,SET,188,-0.013307,-0.0013396,0.057607,0.59134,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN,1
GOBP_MAST_CELL_CYTOKINE_PROD...,SET,6,-0.088352,-0.0015969,0.38207,0.59144,GOBP_MAST_CELL_CYTOKINE_PRODUCTION,1
MIR6808_3P,SET,37,-0.033333,-0.0014949,0.14412,0.59145,MIR6808_3P,1
WP_T_CELL_RECEPTOR_AND_COSTI...,SET,27,-0.039414,-0.0015104,0.17034,0.59149,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1
MIR3147,SET,35,-0.037311,-0.0016275,0.16121,0.59151,MIR3147,1
GSE20500_CTRL_VS_RARA_ANTAGO...1,SET,180,-0.014072,-0.0013865,0.060778,0.59155,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,1
GOMF_GUANYLYLTRANSFERASE_ACT...,SET,4,-0.09314,-0.0013746,0.40213,0.59158,GOMF_GUANYLYLTRANSFERASE_ACTIVITY,1
GOCC_STRIATED_MUSCLE_THIN_FI...,SET,21,-0.044373,-0.0014998,0.19152,0.59161,GOCC_STRIATED_MUSCLE_THIN_FILAMENT,1
chr1p31,SET,77,-0.043182,-0.0027906,0.18632,0.59164,chr1p31,1
GNF2_TM4SF2,SET,23,-0.044798,-0.0015846,0.19328,0.59164,GNF2_TM4SF2,1
GSE26351_WNT_VS_BMP_PATHWAY_...1,SET,176,-0.014433,-0.0014063,0.062243,0.59168,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,1
KEGG_MEDICUS_REFERENCE_IRE1A...,SET,7,-0.076927,-0.0015018,0.33155,0.59174,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY,1
GOMF_NAD_DEPENDENT_HISTONE_D...,SET,5,-0.083022,-0.0013699,0.35782,0.59174,GOMF_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY,1
HP_PORPHYRINURIA,SET,7,-0.069571,-0.0013582,0.29983,0.59174,HP_PORPHYRINURIA,1
GSE2770_UNTREATED_VS_TGFB_AN...12,SET,183,-0.014368,-0.0014273,0.061904,0.59177,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP,1
GSE5503_MLN_DC_VS_PLN_DC_ACT...1,SET,183,-0.01483,-0.0014731,0.063883,0.59178,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GOMF_MRNA_METHYLTRANSFERASE_...,SET,12,-0.049495,-0.0012649,0.21315,0.59181,GOMF_MRNA_METHYLTRANSFERASE_ACTIVITY,1
GCM_RAP2A,SET,33,-0.035054,-0.0014848,0.15094,0.59182,GCM_RAP2A,1
HP_B_LYMPHOCYTOPENIA,SET,53,-0.028142,-0.0015099,0.12113,0.59186,HP_B_LYMPHOCYTOPENIA,1
GSE18804_SPLEEN_MACROPHAGE_V...4,SET,182,-0.014845,-0.0014707,0.063876,0.59189,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP,1
YTTCCNNNGGAMR_UNKNOWN,SET,46,-0.029453,-0.0014724,0.1267,0.59191,YTTCCNNNGGAMR_UNKNOWN,1
GSE27786_LSK_VS_NKCELL_DN,SET,182,-0.014825,-0.0014687,0.063722,0.59198,GSE27786_LSK_VS_NKCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_HE...,SET,59,-0.026759,-0.0015145,0.11499,0.592,GOBP_CELLULAR_RESPONSE_TO_HEAT,1
TCF11_01,SET,225,-0.013515,-0.0014869,0.058066,0.59202,TCF11_01,1
GOBP_INTRACELLULAR_LIPID_TRA...,SET,44,-0.028838,-0.00141,0.12386,0.59205,GOBP_INTRACELLULAR_LIPID_TRANSPORT,1
HARALAMBIEVA_PBMC_FLUARIX_AG...1,SET,375,-0.010455,-0.0014789,0.0449,0.59206,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,1
GOMF_PHOSPHOLIPASE_D_ACTIVITY,SET,6,-0.076622,-0.0013849,0.32903,0.59207,GOMF_PHOSPHOLIPASE_D_ACTIVITY,1
GOBP_DOUBLE_STRAND_BREAK_REP...4,SET,12,-0.054967,-0.0014048,0.23601,0.59208,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_BREAK_INDUCED_REPLICATION,1
GOBP_PEPTIDYL_TYROSINE_DEPHO...2,SET,7,-0.079212,-0.0015464,0.34011,0.59208,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION_INVOLVED_IN_INACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,1
GSE18893_TCONV_VS_TREG_2H_CU...1,SET,187,-0.014627,-0.0014686,0.062782,0.59211,GSE18893_TCONV_VS_TREG_2H_CULTURE_DN,1
HOFT_CD4_POSITIVE_ALPHA_BETA...6,SET,39,-0.030849,-0.0014203,0.13239,0.59212,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,1
HP_ABNORMAL_VENA_CAVA_MORPHO...,SET,68,-0.023505,-0.0014278,0.10083,0.59216,HP_ABNORMAL_VENA_CAVA_MORPHOLOGY,1
HP_NIGHT_SWEATS,SET,10,-0.071021,-0.001657,0.30458,0.59219,HP_NIGHT_SWEATS,1
HP_ABNORMALITY_OF_NEURONAL_M...,SET,424,-0.0095218,-0.0014302,0.040807,0.59225,HP_ABNORMALITY_OF_NEURONAL_MIGRATION,1
chr1q22,SET,43,-0.050601,-0.002446,0.21675,0.59229,chr1q22,1
GOBP_POSTSYNAPTIC_CYTOSKELET...,SET,17,-0.05204,-0.0015828,0.2229,0.5923,GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION,1
HP_DEMYELINATING_PERIPHERAL_...,SET,49,-0.026993,-0.0013926,0.11552,0.59238,HP_DEMYELINATING_PERIPHERAL_NEUROPATHY,1
GSE30971_CTRL_VS_LPS_STIM_MA...5,SET,173,-0.015035,-0.0014525,0.06434,0.59238,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN,1
GSE8835_CD4_VS_CD8_TCELL_UP,SET,179,-0.014464,-0.0014212,0.061897,0.59238,GSE8835_CD4_VS_CD8_TCELL_UP,1
HP_ENLARGEMENT_OF_THE_ANKLES,SET,5,-0.09546,-0.0015751,0.40845,0.59239,HP_ENLARGEMENT_OF_THE_ANKLES,1
GOBP_POSITIVE_REGULATION_OF_...528,SET,62,-0.026896,-0.0015603,0.115,0.59246,GOBP_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,1
HP_RECURRENT_JOINT_DISLOCATI...,SET,10,-0.067372,-0.0015719,0.28803,0.59247,HP_RECURRENT_JOINT_DISLOCATION,1
HP_FRONTAL_LOBE_DEMENTIA,SET,18,-0.045425,-0.0014216,0.19411,0.59251,HP_FRONTAL_LOBE_DEMENTIA,1
SA_TRKA_RECEPTOR,SET,16,-0.047933,-0.0014144,0.20478,0.59253,SA_TRKA_RECEPTOR,1
GOBP_NEURAL_PLATE_REGIONALIZ...,SET,5,-0.095761,-0.0015801,0.40897,0.59256,GOBP_NEURAL_PLATE_REGIONALIZATION,1
HP_RECURRENT_FRACTURES,SET,124,-0.018361,-0.0015038,0.078378,0.59261,HP_RECURRENT_FRACTURES,1
MIR1248,SET,120,-0.01909,-0.0015383,0.081481,0.59262,MIR1248,1
GSE1925_CTRL_VS_IFNG_PRIMED_...4,SET,156,-0.01531,-0.0014052,0.06534,0.59262,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP,1
INAMURA_LUNG_CANCER_SCC_DN,SET,13,-0.056865,-0.0015126,0.24262,0.59265,INAMURA_LUNG_CANCER_SCC_DN,1
SANA_RESPONSE_TO_IFNG_UP,SET,68,-0.025146,-0.0015275,0.10726,0.59267,SANA_RESPONSE_TO_IFNG_UP,1
BHATTACHARYA_EMBRYONIC_STEM_...,SET,76,-0.022169,-0.0014233,0.09453,0.59271,BHATTACHARYA_EMBRYONIC_STEM_CELL,1
GSE37533_PPARG1_FOXP3_VS_PPA...4,SET,164,-0.014874,-0.0013995,0.063363,0.5928,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
MARIADASON_RESPONSE_TO_CURCU...2,SET,12,-0.054457,-0.0013918,0.23184,0.59285,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,1
GOCC_TRANS_GOLGI_NETWORK_TRA...2,SET,18,-0.046368,-0.0014511,0.19741,0.59285,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE,1
GSE16385_ROSIGLITAZONE_VS_UN...1,SET,188,-0.01361,-0.0013701,0.057928,0.59287,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN,1
GAUSSMANN_MLL_AF4_FUSION_TAR...13,SET,26,-0.036428,-0.0013699,0.15499,0.59291,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,1
MIR4330,SET,82,-0.021395,-0.0014266,0.09103,0.59291,MIR4330,1
HP_DEEP_SET_NAILS,SET,6,-0.074892,-0.0013536,0.31836,0.59299,HP_DEEP_SET_NAILS,1
DLX6_TARGET_GENES,SET,450,-0.0092358,-0.0014281,0.03924,0.59304,DLX6_TARGET_GENES,1
STAT_Q6,SET,234,-0.013461,-0.0015099,0.057183,0.59305,STAT_Q6,1
GOMF_OXIDOREDUCTASE_ACTIVITY...36,SET,14,-0.062805,-0.0017336,0.26681,0.59305,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
GOMF_HISTONE_H3K36_DEMETHYLA...,SET,7,-0.070388,-0.0013741,0.29891,0.59308,GOMF_HISTONE_H3K36_DEMETHYLASE_ACTIVITY,1
GSE339_CD8POS_VS_CD4CD8DN_DC...3,SET,184,-0.014665,-0.0014607,0.062269,0.59309,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,1
GOCC_CLEAVAGE_FURROW,SET,50,-0.028846,-0.0015033,0.12241,0.59315,GOCC_CLEAVAGE_FURROW,1
GSE2405_HEAT_KILLED_LYSATE_V...3,SET,182,-0.014155,-0.0014024,0.060067,0.59315,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,1
WIERENGA_STAT5A_TARGETS_UP,SET,186,-0.015756,-0.0015778,0.066828,0.59319,WIERENGA_STAT5A_TARGETS_UP,1
MOOTHA_TCA,SET,14,-0.047811,-0.0013198,0.20267,0.59325,MOOTHA_TCA,1
GOMF_STRUCTURAL_MOLECULE_ACT...2,SET,12,-0.063026,-0.0016108,0.26676,0.59339,GOMF_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY,1
GSE36888_UNTREATED_VS_IL2_TR...2,SET,168,-0.01613,-0.0015359,0.068266,0.59339,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP,1
HP_ABNORMAL_INTESTINE_MORPHO...,SET,675,-0.0078921,-0.0014852,0.033384,0.59344,HP_ABNORMAL_INTESTINE_MORPHOLOGY,1
MIR4641,SET,60,-0.025271,-0.0014423,0.10688,0.59345,MIR4641,1
GOBP_CELLULAR_RESPONSE_TO_OS...,SET,51,-0.028281,-0.0014885,0.11954,0.59351,GOBP_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,1
WP_PURINE_METABOLISM,SET,10,-0.070648,-0.0016483,0.29855,0.59353,WP_PURINE_METABOLISM,1
GSE17721_LPS_VS_POLYIC_24H_B...1,SET,178,-0.015017,-0.0014714,0.063458,0.59353,GSE17721_LPS_VS_POLYIC_24H_BMDC_DN,1
CHEN_NEUROBLASTOMA_COPY_NUMB...,SET,48,-0.034045,-0.0017385,0.14383,0.59355,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,1
GOBP_POSITIVE_REGULATION_OF_...765,SET,47,-0.028772,-0.0014539,0.12149,0.5936,GOBP_POSITIVE_REGULATION_OF_TORC1_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...65,SET,5,-0.073144,-0.0012069,0.30884,0.59361,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GSE23505_IL6_IL1_VS_IL6_IL1_...1,SET,184,-0.015115,-0.0015056,0.063778,0.59367,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,1
HP_HYPOMELANOTIC_MACULE,SET,8,-0.069586,-0.0014522,0.29359,0.59368,HP_HYPOMELANOTIC_MACULE,1
JIANG_MELANOMA_TRM8_CD4,SET,364,-0.010732,-0.0014961,0.045272,0.59369,JIANG_MELANOMA_TRM8_CD4,1
GOBP_GLUTAMINE_TRANSPORT,SET,9,-0.074977,-0.0016596,0.31612,0.59374,GOBP_GLUTAMINE_TRANSPORT,1
GOBP_L_CYSTINE_TRANSPORT,SET,6,-0.082622,-0.0014934,0.34829,0.59376,GOBP_L_CYSTINE_TRANSPORT,1
GOBP_REGULATION_OF_ORGANIC_A...,SET,73,-0.025535,-0.0016069,0.10761,0.59378,GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
HP_APLASIA_HYPOPLASIA_OF_THE...5,SET,3,-0.1398,-0.0017869,0.58899,0.59381,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_METACARPAL,1
KEGG_MEDICUS_ENV_FACTOR_NICO...1,SET,11,-0.060603,-0.0014829,0.25525,0.59384,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY,1
MIR6814_5P,SET,100,-0.019711,-0.0014507,0.083013,0.59384,MIR6814_5P,1
GOBP_NUCLEIC_ACID_CATABOLIC_...,SET,606,-0.0078628,-0.0014047,0.033093,0.5939,GOBP_NUCLEIC_ACID_CATABOLIC_PROCESS,1
MIR4681,SET,5,-0.078851,-0.0013011,0.33184,0.59391,MIR4681,1
GSE20715_0H_VS_24H_OZONE_TLR...2,SET,175,-0.015779,-0.0015332,0.066389,0.59393,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP,1
ZSCAN23_TARGET_GENES,SET,63,-0.025701,-0.0015029,0.1081,0.59396,ZSCAN23_TARGET_GENES,1
GOBP_REGULATION_OF_MICROVILL...1,SET,6,-0.092666,-0.0016749,0.38976,0.59396,GOBP_REGULATION_OF_MICROVILLUS_ASSEMBLY,1
HP_ABNORMAL_CIRCULATING_DEHY...,SET,15,-0.055262,-0.0015789,0.23244,0.59396,HP_ABNORMAL_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,1
WORSCHECH_TUMOR_EVASION_AND_...1,SET,14,-0.057171,-0.0015781,0.24046,0.59397,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,1
MIR605_3P,SET,233,-0.013394,-0.0014993,0.056327,0.59398,MIR605_3P,1
GOMF_VASCULAR_ENDOTHELIAL_GR...4,SET,12,-0.062643,-0.001601,0.26343,0.59398,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING,1
GOBP_REGULATION_OF_SKELETAL_...10,SET,24,-0.04336,-0.0015667,0.18227,0.59401,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_RESPONSE_TO_NEMATODE,SET,7,-0.082731,-0.0016151,0.34777,0.59401,GOBP_RESPONSE_TO_NEMATODE,1
MIR885_3P,SET,26,-0.037979,-0.0014282,0.15963,0.59403,MIR885_3P,1
GOBP_MOTILE_CILIUM_ASSEMBLY,SET,64,-0.024057,-0.0014179,0.10107,0.59407,GOBP_MOTILE_CILIUM_ASSEMBLY,1
chr22q13,SET,177,-0.030867,-0.0030161,0.12963,0.5941,chr22q13,1
GOBP_POSITIVE_REGULATION_OF_...13,SET,6,-0.077652,-0.0014035,0.32606,0.59412,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
HERNANDEZ_MITOTIC_ARREST_BY_...1,SET,35,-0.036119,-0.0015755,0.15159,0.59416,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,1
GOBP_POSITIVE_REGULATION_OF_...149,SET,6,-0.093512,-0.0016902,0.39243,0.59417,GOBP_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,1
GOBP_MICROTUBULE_ANCHORING_A...,SET,13,-0.053151,-0.0014138,0.223,0.59419,GOBP_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER,1
GSE21774_CD62L_POS_CD56_DIM_...2,SET,183,-0.015507,-0.0015405,0.065067,0.59419,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,1
WP_BASE_EXCISION_REPAIR,SET,30,-0.033831,-0.0013664,0.14191,0.59421,WP_BASE_EXCISION_REPAIR,1
HP_AQUEDUCTAL_STENOSIS,SET,21,-0.039935,-0.0013498,0.16752,0.59421,HP_AQUEDUCTAL_STENOSIS,1
GOBP_CELLULAR_RESPONSE_TO_AN...1,SET,32,-0.039556,-0.0016499,0.16592,0.59422,GOBP_CELLULAR_RESPONSE_TO_ANGIOTENSIN,1
MIR3121_5P,SET,95,-0.021739,-0.0015597,0.091109,0.59429,MIR3121_5P,1
GNF2_RAB7L1,SET,31,-0.036234,-0.0014876,0.15187,0.59429,GNF2_RAB7L1,1
HP_JAUNDICE,SET,200,-0.014079,-0.0014614,0.058993,0.59431,HP_JAUNDICE,1
MIR450B_5P,SET,421,-0.01029,-0.0015402,0.043053,0.59445,MIR450B_5P,1
GAVISH_3CA_METAPROGRAM_EPITH...17,SET,38,-0.038416,-0.0017459,0.16073,0.59445,GAVISH_3CA_METAPROGRAM_EPITHELIAL_NEUROENDOCRINE,1
GOBP_MEMBRANE_REPOLARIZATION...3,SET,14,-0.061933,-0.0017096,0.25889,0.59453,GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GSE20366_EX_VIVO_VS_HOMEOSTA...4,SET,187,-0.01408,-0.0014137,0.058848,0.59454,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP,1
GOCC_CLATHRIN_COMPLEX,SET,8,-0.066815,-0.0013944,0.27926,0.59455,GOCC_CLATHRIN_COMPLEX,1
MIR4494,SET,52,-0.028732,-0.0015269,0.12007,0.59456,MIR4494,1
HP_ABNORMAL_BRAIN_N_ACETYL_A...,SET,19,-0.045147,-0.0014516,0.18866,0.59456,HP_ABNORMAL_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,1
WENG_POR_DOSAGE,SET,22,-0.047162,-0.0016316,0.19678,0.5947,WENG_POR_DOSAGE,1
MIR7844_5P,SET,139,-0.017503,-0.0015172,0.072964,0.59479,MIR7844_5P,1
HP_ABNORMAL_T_CELL_SUBSET_DI...,SET,69,-0.024925,-0.0015252,0.10383,0.59486,HP_ABNORMAL_T_CELL_SUBSET_DISTRIBUTION,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...2,SET,6,-0.093994,-0.0016989,0.39142,0.59489,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,1
GOBP_PYRIDINE_CONTAINING_COM...1,SET,30,-0.03883,-0.0015683,0.16164,0.59492,GOBP_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
DING_LUNG_CANCER_MUTATED_SIG...,SET,25,-0.040466,-0.0014922,0.16839,0.59496,DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,1
GOBP_POSITIVE_REGULATION_OF_...490,SET,32,-0.038288,-0.001597,0.15932,0.59496,GOBP_POSITIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GSE557_WT_VS_I_AB_KO_DC_DN,SET,181,-0.015136,-0.0014954,0.062982,0.59496,GSE557_WT_VS_I_AB_KO_DC_DN,1
HNF1_Q6,SET,232,-0.014796,-0.0016527,0.06151,0.59505,HNF1_Q6,1
HP_ALTERNATING_ESOTROPIA,SET,10,-0.065362,-0.001525,0.27166,0.59507,HP_ALTERNATING_ESOTROPIA,1
GOBP_ADAPTIVE_IMMUNE_RESPONSE,SET,425,-0.01088,-0.0016361,0.045212,0.59509,GOBP_ADAPTIVE_IMMUNE_RESPONSE,1
MIR4723_3P,SET,76,-0.023484,-0.0015078,0.09754,0.59513,MIR4723_3P,1
HOFFMANN_SMALL_PRE_BII_TO_IM...2,SET,62,-0.027909,-0.0016191,0.11589,0.59515,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1
HP_ANKLE_CLONUS,SET,44,-0.031103,-0.0015208,0.12914,0.59516,HP_ANKLE_CLONUS,1
RUTELLA_RESPONSE_TO_HGF_VS_C...2,SET,371,-0.011171,-0.0015718,0.046347,0.59523,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1
PID_LYMPH_ANGIOGENESIS_PATHW...,SET,24,-0.045196,-0.001633,0.18751,0.59523,PID_LYMPH_ANGIOGENESIS_PATHWAY,1
MIR1843,SET,58,-0.027499,-0.0015431,0.11409,0.59523,MIR1843,1
GOBP_OUTFLOW_TRACT_MORPHOGEN...,SET,75,-0.027662,-0.0017644,0.1147,0.59528,GOBP_OUTFLOW_TRACT_MORPHOGENESIS,1
HP_ATRIAL_STANDSTILL,SET,6,-0.094838,-0.0017142,0.39317,0.5953,HP_ATRIAL_STANDSTILL,1
GOBP_NEGATIVE_REGULATION_OF_...13,SET,4,-0.10905,-0.0016095,0.45197,0.59533,GOBP_NEGATIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,1
WP_RAC1PAK1P38MMP2_PATHWAY,SET,66,-0.024984,-0.0014953,0.10353,0.59534,WP_RAC1PAK1P38MMP2_PATHWAY,1
GOCC_MITOCHONDRIAL_CRISTA,SET,6,-0.09656,-0.0017453,0.40002,0.59537,GOCC_MITOCHONDRIAL_CRISTA,1
HP_HYPOPLASTIC_ANEMIA,SET,6,-0.074045,-0.0013383,0.30664,0.5954,HP_HYPOPLASTIC_ANEMIA,1
MIR6825_5P,SET,379,-0.010952,-0.0015573,0.045344,0.59543,MIR6825_5P,1
HP_TOE_CLINODACTYLY,SET,24,-0.041664,-0.0015054,0.17246,0.59545,HP_TOE_CLINODACTYLY,1
GOCC_LYSOSOMAL_LUMEN,SET,89,-0.022484,-0.0015616,0.093037,0.59548,GOCC_LYSOSOMAL_LUMEN,1
AIZARANI_LIVER_C10_MVECS_1,SET,244,-0.014809,-0.0016959,0.061277,0.59549,AIZARANI_LIVER_C10_MVECS_1,1
GOBP_POSITIVE_REGULATION_OF_...709,SET,126,-0.019212,-0.0015861,0.079472,0.59551,GOBP_POSITIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,1
FRASOR_RESPONSE_TO_SERM_OR_F...1,SET,48,-0.029062,-0.001484,0.12018,0.59554,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,1
AIZARANI_LIVER_C12_NK_NKT_CE...,SET,43,-0.032735,-0.0015824,0.13535,0.59555,AIZARANI_LIVER_C12_NK_NKT_CELLS_4,1
KEGG_MEDICUS_REFERENCE_AUTOP...5,SET,12,-0.058757,-0.0015017,0.2429,0.59557,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION,1
HP_DECREASED_ACTIVITY_OF_THE...,SET,10,-0.075984,-0.0017728,0.31409,0.59558,HP_DECREASED_ACTIVITY_OF_THE_PYRUVATE_DEHYDROGENASE_COMPLEX,1
GOMF_PHOSPHOLIPID_SCRAMBLASE...,SET,15,-0.058871,-0.001682,0.24311,0.59567,GOMF_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY,1
GOBP_4_HYDROXYPROLINE_METABO...,SET,12,-0.050108,-0.0012806,0.20687,0.59569,GOBP_4_HYDROXYPROLINE_METABOLIC_PROCESS,1
GSE40666_STAT1_KO_VS_STAT4_K...1,SET,139,-0.018431,-0.0015976,0.076085,0.5957,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN,1
LMNB2_TARGET_GENES,SET,31,-0.035633,-0.001463,0.14707,0.59572,LMNB2_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...812,SET,6,-0.098217,-0.0017752,0.4051,0.59578,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,1
GOBP_EMBRYO_IMPLANTATION,SET,50,-0.029981,-0.0015624,0.12363,0.5958,GOBP_EMBRYO_IMPLANTATION,1
KEGG_MEDICUS_REFERENCE_CD80_...2,SET,21,-0.044243,-0.0014954,0.18238,0.59584,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY,1
GSE16385_IFNG_TNF_VS_UNSTIM_...1,SET,179,-0.015469,-0.00152,0.063747,0.59587,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,1
GSE21360_NAIVE_VS_PRIMARY_ME...1,SET,169,-0.016456,-0.0015715,0.06779,0.5959,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN,1
COLE_BLOOD_FLUZONE_FLUARIX_A...,SET,7,-0.09312,-0.0018179,0.3836,0.5959,COLE_BLOOD_FLUZONE_FLUARIX_AGE_03_17YO_7DY_DN,1
GOBP_PROTOPORPHYRINOGEN_IX_M...,SET,10,-0.061893,-0.0014441,0.25493,0.59591,GOBP_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS,1
GSE6259_BCELL_VS_CD4_TCELL_UP,SET,154,-0.016339,-0.0014901,0.067301,0.59591,GSE6259_BCELL_VS_CD4_TCELL_UP,1
GSE15930_STIM_VS_STIM_AND_IL...2,SET,179,-0.014761,-0.0014504,0.060781,0.59594,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP,1
GOBP_DNA_RECOMBINATION,SET,284,-0.0118,-0.0014562,0.048582,0.59595,GOBP_DNA_RECOMBINATION,1
GOBP_RNA_3_END_PROCESSING,SET,76,-0.021423,-0.0013755,0.088197,0.59596,GOBP_RNA_3_END_PROCESSING,1
GSE369_PRE_VS_POST_IL6_INJEC...6,SET,175,-0.016012,-0.0015558,0.065922,0.59596,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP,1
WP_CARDIOMYOCYTE_SIGNALING_C...,SET,31,-0.038726,-0.0015899,0.15942,0.59597,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,1
GOBP_PROTEIN_K29_LINKED_UBIQ...,SET,10,-0.063071,-0.0014715,0.25958,0.59599,GOBP_PROTEIN_K29_LINKED_UBIQUITINATION,1
GSE17974_1.5H_VS_72H_IL4_AND...1,SET,165,-0.014861,-0.0014024,0.061129,0.59604,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,1
REACTOME_CHOLINE_CATABOLISM,SET,6,-0.093827,-0.0016959,0.38579,0.59608,REACTOME_CHOLINE_CATABOLISM,1
HP_VESTIBULAR_SCHWANNOMA,SET,6,-0.086231,-0.0015586,0.35448,0.5961,HP_VESTIBULAR_SCHWANNOMA,1
GSE26343_WT_VS_NFAT5_KO_MACR...2,SET,176,-0.015574,-0.0015175,0.064001,0.59613,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN,1
TCCAGAG_MIR518C,SET,137,-0.019424,-0.0016716,0.079805,0.59615,TCCAGAG_MIR518C,1
BIOCARTA_SPRY_PATHWAY,SET,16,-0.051394,-0.0015165,0.21111,0.59617,BIOCARTA_SPRY_PATHWAY,1
URS_ADIPOCYTE_DIFFERENTIATIO...2,SET,64,-0.02619,-0.0015436,0.10748,0.59625,URS_ADIPOCYTE_DIFFERENTIATION_UP,1
GOBP_REGULATION_OF_GENE_SILE...,SET,25,-0.042356,-0.0015619,0.17383,0.59625,GOBP_REGULATION_OF_GENE_SILENCING_BY_REGULATORY_NCRNA,1
GOBP_NEGATIVE_REGULATION_OF_...1,SET,27,-0.042788,-0.0016396,0.17551,0.5963,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
GSE37563_WT_VS_CTLA4_KO_CD4_...2,SET,149,-0.017098,-0.001534,0.070135,0.5963,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP,1
GOBP_POSITIVE_REGULATION_OF_...22,SET,6,-0.092496,-0.0016718,0.37912,0.59637,GOBP_POSITIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,1
HP_ASTHMA,SET,149,-0.017449,-0.0015655,0.071494,0.59641,HP_ASTHMA,1
HP_ABNORMAL_MACULAR_MORPHOLO...,SET,188,-0.01559,-0.0015694,0.063865,0.59642,HP_ABNORMAL_MACULAR_MORPHOLOGY,1
HP_WEAKNESS_OF_LONG_FINGER_E...,SET,20,-0.042163,-0.0013908,0.17272,0.59643,HP_WEAKNESS_OF_LONG_FINGER_EXTENSOR_MUSCLES,1
GOMF_ADENINE_TRANSMEMBRANE_T...,SET,4,-0.11563,-0.0017066,0.47361,0.59644,GOMF_ADENINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...182,SET,120,-0.019622,-0.0015812,0.080365,0.59645,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GSE15930_NAIVE_VS_48H_IN_VIT...5,SET,178,-0.014726,-0.001443,0.06029,0.59648,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,1
GOMF_NUCLEAR_GLUCOCORTICOID_...,SET,12,-0.06737,-0.0017218,0.27571,0.59652,GOMF_NUCLEAR_GLUCOCORTICOID_RECEPTOR_BINDING,1
GOBP_PROTEIN_CONTAINING_COMP...3,SET,177,-0.015866,-0.0015503,0.064921,0.59653,GOBP_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION,1
HP_ABNORMAL_CEREBRAL_ARTERY_...,SET,74,-0.025242,-0.0015993,0.10319,0.59663,HP_ABNORMAL_CEREBRAL_ARTERY_MORPHOLOGY,1
GSE14769_UNSTIM_VS_360MIN_LP...1,SET,192,-0.014865,-0.0015121,0.060754,0.59664,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN,1
MORF_PTPN9,SET,51,-0.027522,-0.0014485,0.11247,0.59666,MORF_PTPN9,1
GSE26290_WT_VS_PDK1_KO_ANTI_...1,SET,169,-0.015301,-0.0014612,0.062459,0.59676,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,1
GOBP_GLOMERULUS_MORPHOGENESIS,SET,9,-0.079448,-0.0017586,0.32429,0.59677,GOBP_GLOMERULUS_MORPHOGENESIS,1
HP_ABNORMAL_FINGER_FLEXION_C...,SET,19,-0.050934,-0.0016377,0.20781,0.59681,HP_ABNORMAL_FINGER_FLEXION_CREASE,1
YORDY_RECIPROCAL_REGULATION_...2,SET,20,-0.0479,-0.0015801,0.1953,0.59687,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,1
HP_INCREASED_LAXITY_OF_ANKLES,SET,5,-0.10679,-0.0017621,0.43487,0.59699,HP_INCREASED_LAXITY_OF_ANKLES,1
chr2q23,SET,21,-0.086604,-0.0029273,0.35248,0.59704,chr2q23,1
GOBP_CELLULAR_RESPONSE_TO_OX...3,SET,1069,-0.0068325,-0.0015999,0.02781,0.59704,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,1
GOCC_CORTICAL_ACTIN_CYTOSKEL...,SET,72,-0.024662,-0.0015414,0.10036,0.59706,GOCC_CORTICAL_ACTIN_CYTOSKELETON,1
HE_LIM_SUN_FETAL_LUNG_C3_LYM...,SET,345,-0.012155,-0.0016505,0.049448,0.59709,HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL,1
REACTOME_KERATINIZATION,SET,183,-0.021687,-0.0021543,0.088213,0.5971,REACTOME_KERATINIZATION,1
GOBP_SENSORY_PERCEPTION_OF_P...,SET,73,-0.02622,-0.00165,0.10659,0.59716,GOBP_SENSORY_PERCEPTION_OF_PAIN,1
GOBP_POSITIVE_REGULATION_OF_...537,SET,4,-0.09588,-0.0014151,0.38963,0.59719,GOBP_POSITIVE_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_PHOSPHATIDYLINOSITOL_3_...3,SET,35,-0.035685,-0.0015566,0.145,0.5972,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING,1
WP_SPINAL_CORD_INJURY,SET,116,-0.021055,-0.0016683,0.085518,0.59724,WP_SPINAL_CORD_INJURY,1
GOBP_REGULATION_OF_MOLECULAR...,SET,1740,-0.0054113,-0.001585,0.021972,0.59726,GOBP_REGULATION_OF_MOLECULAR_FUNCTION,1
WINTER_HYPOXIA_UP,SET,87,-0.021576,-0.0014817,0.087606,0.59727,WINTER_HYPOXIA_UP,1
HP_ABNORMAL_5TH_FINGER_PHALA...,SET,54,-0.02946,-0.0015954,0.1196,0.59728,HP_ABNORMAL_5TH_FINGER_PHALANX_MORPHOLOGY,1
GOMF_ENOYL_COA_HYDRATASE_ACT...,SET,11,-0.07436,-0.0018196,0.30166,0.59735,GOMF_ENOYL_COA_HYDRATASE_ACTIVITY,1
GOBP_PROTEIN_METHYLATION,SET,40,-0.031841,-0.0014846,0.12915,0.59737,GOBP_PROTEIN_METHYLATION,1
MEISSNER_NPC_HCP_WITH_H3K4ME...1,SET,329,-0.012994,-0.0017238,0.052702,0.59738,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1
GOMF_U4_SNRNA_BINDING,SET,5,-0.068815,-0.0011355,0.27902,0.5974,GOMF_U4_SNRNA_BINDING,1
GOBP_CATECHOLAMINE_UPTAKE_IN...,SET,11,-0.065018,-0.001591,0.26358,0.59742,GOBP_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
GOMF_HEXOSYLTRANSFERASE_ACTI...,SET,184,-0.016621,-0.0016555,0.06736,0.59744,GOMF_HEXOSYLTRANSFERASE_ACTIVITY,1
MIR4463,SET,75,-0.0238,-0.001518,0.096425,0.59748,MIR4463,1
GOMF_LIPASE_BINDING,SET,6,-0.096002,-0.0017352,0.38885,0.5975,GOMF_LIPASE_BINDING,1
OSAWA_TNF_TARGETS,SET,10,-0.064252,-0.0014991,0.26019,0.59752,OSAWA_TNF_TARGETS,1
GOBP_GLUTAMATE_RECEPTOR_SIGN...,SET,48,-0.033214,-0.0016961,0.13442,0.59758,GOBP_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
WATANABE_ULCERATIVE_COLITIS_...1,SET,14,-0.057587,-0.0015896,0.23298,0.59761,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,1
REACTOME_COPI_INDEPENDENT_GO...,SET,50,-0.029851,-0.0015557,0.12047,0.59785,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1
GOBP_MESENCHYMAL_CELL_DIFFER...1,SET,237,-0.014632,-0.0016517,0.058997,0.59794,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION,1
MODULE_151,SET,274,-0.012188,-0.0014778,0.049058,0.5981,MODULE_151,1
HP_ABNORMAL_THORAX_MORPHOLOGY,SET,783,-0.0077417,-0.0015643,0.031152,0.59813,HP_ABNORMAL_THORAX_MORPHOLOGY,1
GSE30971_WBP7_HET_VS_KO_MACR...3,SET,173,-0.01613,-0.0015584,0.064903,0.59813,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN,1
GSE5589_WT_VS_IL6_KO_LPS_AND...5,SET,178,-0.015952,-0.001563,0.064183,0.59814,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
GSE17721_0.5H_VS_24H_CPG_BMD...2,SET,182,-0.015624,-0.0015479,0.062836,0.59818,GSE17721_0.5H_VS_24H_CPG_BMDC_UP,1
BANDRES_RESPONSE_TO_CARMUSTI...6,SET,12,-0.05075,-0.001297,0.20408,0.59819,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,1
GOBP_NEGATIVE_REGULATION_BY_...1,SET,8,-0.086146,-0.0017978,0.34641,0.5982,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
HP_EXERCISE_INDUCED_MUSCLE_F...,SET,9,-0.067709,-0.0014987,0.27194,0.59831,HP_EXERCISE_INDUCED_MUSCLE_FATIGUE,1
HP_INTELLECTUAL_DISABILITY_B...,SET,24,-0.044739,-0.0016165,0.1797,0.59831,HP_INTELLECTUAL_DISABILITY_BORDERLINE,1
GOBP_TENDON_DEVELOPMENT,SET,5,-0.11469,-0.0018924,0.46058,0.59832,GOBP_TENDON_DEVELOPMENT,1
REACTOME_COMMON_PATHWAY_OF_F...,SET,21,-0.053166,-0.001797,0.21344,0.59836,REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION,1
GOBP_TRNA_WOBBLE_BASE_MODIFI...,SET,18,-0.047062,-0.0014728,0.18887,0.59839,GOBP_TRNA_WOBBLE_BASE_MODIFICATION,1
REACTOME_TRANSPORT_OF_SMALL_...,SET,684,-0.0085243,-0.0016144,0.0342,0.59841,REACTOME_TRANSPORT_OF_SMALL_MOLECULES,1
WP_PDGF_PATHWAY,SET,38,-0.034362,-0.0015617,0.13783,0.59844,WP_PDGF_PATHWAY,1
GOMF_THIOLESTER_HYDROLASE_AC...,SET,40,-0.032524,-0.0015164,0.13038,0.59849,GOMF_THIOLESTER_HYDROLASE_ACTIVITY,1
GOBP_PRESYNAPTIC_MODULATION_...,SET,33,-0.039243,-0.0016622,0.15728,0.59851,GOBP_PRESYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,1
HP_APLASIA_OF_METACARPAL_BON...,SET,12,-0.061667,-0.001576,0.24693,0.5986,HP_APLASIA_OF_METACARPAL_BONES,1
HP_ABNORMAL_LIVER_ENZYME_ACT...,SET,11,-0.061467,-0.0015041,0.24602,0.59864,HP_ABNORMAL_LIVER_ENZYME_ACTIVITY_OR_CONCENTRATION,1
HP_OVERGROWTH,SET,37,-0.033645,-0.0015089,0.13468,0.59864,HP_OVERGROWTH,1
HP_PREMATURE_THELARCHE,SET,10,-0.067675,-0.001579,0.27081,0.59867,HP_PREMATURE_THELARCHE,1
MIR6842_5P,SET,143,-0.018231,-0.0016027,0.072916,0.59872,MIR6842_5P,1
GOBP_MAINTENANCE_OF_PROTEIN_...1,SET,12,-0.058577,-0.0014971,0.23417,0.59876,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM,1
MIR4679,SET,141,-0.018529,-0.0016175,0.074056,0.59878,MIR4679,1
MODULE_27,SET,333,-0.012568,-0.0016771,0.050229,0.59879,MODULE_27,1
HP_INCREASED_LAXITY_OF_FINGE...,SET,5,-0.10976,-0.001811,0.43858,0.5988,HP_INCREASED_LAXITY_OF_FINGERS,1
HP_ABSENT_DISTAL_PHALANGES,SET,6,-0.097664,-0.0017652,0.39023,0.59881,HP_ABSENT_DISTAL_PHALANGES,1
GOBP_POSITIVE_REGULATION_OF_...151,SET,5,-0.09724,-0.0016045,0.38843,0.59884,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
GSE2770_UNTREATED_VS_IL12_TR...1,SET,172,-0.015649,-0.0015076,0.06249,0.59887,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
HP_PARONYCHIA,SET,16,-0.056136,-0.0016565,0.22406,0.59892,HP_PARONYCHIA,1
FALVELLA_SMOKERS_WITH_LUNG_C...,SET,72,-0.026218,-0.0016386,0.10462,0.59894,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1
HP_ANISOMETROPIA,SET,4,-0.087748,-0.001295,0.35002,0.59897,HP_ANISOMETROPIA,1
GOBP_POSITIVE_REGULATION_OF_...823,SET,23,-0.04414,-0.0015613,0.17605,0.59898,GOBP_POSITIVE_REGULATION_OF_VACUOLE_ORGANIZATION,1
GOMF_BMP_RECEPTOR_ACTIVITY,SET,7,-0.094803,-0.0018508,0.37815,0.59898,GOMF_BMP_RECEPTOR_ACTIVITY,1
GOCC_GUANYL_NUCLEOTIDE_EXCHA...,SET,22,-0.043438,-0.0015027,0.1732,0.59901,GOCC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX,1
GOBP_PEPTIDYL_TYROSINE_DEPHO...1,SET,27,-0.041158,-0.0015772,0.16406,0.59904,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION,1
HDAC8_TARGET_GENES,SET,126,-0.019285,-0.0015921,0.076868,0.59905,HDAC8_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_IGF_I...3,SET,13,-0.057369,-0.001526,0.22857,0.59909,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY,1
IIZUKA_LIVER_CANCER_PROGRESS...8,SET,19,-0.053939,-0.0017343,0.21488,0.5991,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,1
HP_DECREASED_TESTICULAR_SIZE,SET,148,-0.017809,-0.0015925,0.07092,0.59914,HP_DECREASED_TESTICULAR_SIZE,1
chr5q23,SET,35,-0.05824,-0.0025404,0.2319,0.59915,chr5q23,1
HP_ABNORMAL_VESTIBULO_OCULAR...,SET,7,-0.080146,-0.0015646,0.31897,0.59919,HP_ABNORMAL_VESTIBULO_OCULAR_REFLEX,1
GSE37301_LYMPHOID_PRIMED_MPP...1,SET,176,-0.015483,-0.0015087,0.061592,0.59924,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN,1
GOMF_TBP_CLASS_PROTEIN_BINDI...,SET,23,-0.046677,-0.0016511,0.18559,0.59929,GOMF_TBP_CLASS_PROTEIN_BINDING,1
HP_CENTRAL_SCOTOMA,SET,36,-0.03626,-0.001604,0.14409,0.59934,HP_CENTRAL_SCOTOMA,1
SCHLOSSER_SERUM_RESPONSE_AUG...,SET,99,-0.019788,-0.0014491,0.078615,0.59936,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1
GSE3982_EOSINOPHIL_VS_NEUTRO...2,SET,179,-0.015117,-0.0014854,0.060004,0.59945,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP,1
HP_VASCULAR_NEOPLASM,SET,143,-0.017679,-0.0015542,0.070161,0.59947,HP_VASCULAR_NEOPLASM,1
GOBP_CHROMATIN_LOOPING,SET,10,-0.06508,-0.0015184,0.25812,0.59953,GOBP_CHROMATIN_LOOPING,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...2,SET,6,-0.080216,-0.0014499,0.31804,0.59956,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_I_PROTEIN_COMPLEX,1
GOMF_CIS_TRANS_ISOMERASE_ACT...,SET,37,-0.032107,-0.0014399,0.12726,0.59959,GOMF_CIS_TRANS_ISOMERASE_ACTIVITY,1
GSE7568_IL4_TGFB_DEXAMETHASO...1,SET,160,-0.016515,-0.001535,0.065424,0.59965,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN,1
KEGG_MEDICUS_REFERENCE_EGF_E...2,SET,13,-0.05821,-0.0015484,0.23051,0.59968,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY,1
MIR4260,SET,64,-0.026993,-0.0015909,0.10689,0.59968,MIR4260,1
HP_PROGRESSIVE_EXTERNAL_OPHT...,SET,20,-0.043226,-0.0014259,0.17115,0.59969,HP_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA,1
GOBP_POSITIVE_REGULATION_OF_...748,SET,22,-0.046273,-0.0016008,0.18316,0.59972,GOBP_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
GOBP_REGULATION_OF_MESODERMA...2,SET,6,-0.090582,-0.0016372,0.35821,0.59981,GOBP_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION,1
chr13q32,SET,29,-0.074879,-0.0029736,0.29607,0.59983,chr13q32,1
HP_RECURRENT_ACUTE_RESPIRATO...,SET,11,-0.062176,-0.0015214,0.24579,0.59985,HP_RECURRENT_ACUTE_RESPIRATORY_TRACT_INFECTION,1
GOBP_MITOCHONDRIAL_FISSION,SET,37,-0.037104,-0.001664,0.14664,0.59987,GOBP_MITOCHONDRIAL_FISSION,1
GAUCHER_PBMC_YF_VAX_STAMARIL...7,SET,91,-0.022199,-0.001559,0.087713,0.5999,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,1
GOMF_ACETYLCHOLINE_RECEPTOR_...2,SET,11,-0.071067,-0.001739,0.28078,0.59991,GOMF_ACETYLCHOLINE_RECEPTOR_BINDING,1
HP_ABNORMAL_LOWER_LIMB_MOTOR...,SET,5,-0.096481,-0.001592,0.38097,0.59996,HP_ABNORMAL_LOWER_LIMB_MOTOR_EVOKED_POTENTIALS,1
SHEPARD_BMYB_MORPHOLINO_UP,SET,198,-0.015103,-0.0015599,0.059614,0.6,SHEPARD_BMYB_MORPHOLINO_UP,1
GSE22432_MULTIPOTENT_VS_COMM...2,SET,174,-0.015769,-0.0015279,0.062191,0.60008,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN,1
REACTOME_NOTCH2_INTRACELLULA...,SET,11,-0.071681,-0.001754,0.28255,0.60013,REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
HP_INTESTINAL_PSEUDO_OBSTRUC...,SET,18,-0.04543,-0.0014218,0.1789,0.60023,HP_INTESTINAL_PSEUDO_OBSTRUCTION,1
GOBP_BASE_EXCISION_REPAIR,SET,41,-0.029706,-0.0014022,0.11696,0.60025,GOBP_BASE_EXCISION_REPAIR,1
GSE28737_WT_VS_BCL6_HET_FOLL...1,SET,178,-0.015863,-0.0015544,0.062429,0.60029,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN,1
MODULE_75,SET,368,-0.012653,-0.0017734,0.049757,0.60037,MODULE_75,1
GOBP_SCF_DEPENDENT_PROTEASOM...,SET,43,-0.034043,-0.0016456,0.13381,0.60041,GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
REACTOME_P38MAPK_EVENTS,SET,13,-0.061385,-0.0016328,0.24109,0.60049,REACTOME_P38MAPK_EVENTS,1
SEKI_INFLAMMATORY_RESPONSE_L...1,SET,20,-0.056075,-0.0018497,0.22011,0.60054,SEKI_INFLAMMATORY_RESPONSE_LPS_DN,1
WANG_RESPONSE_TO_ANDROGEN_UP,SET,28,-0.040514,-0.001581,0.15904,0.60054,WANG_RESPONSE_TO_ANDROGEN_UP,1
GOBP_COMPLEMENT_ACTIVATION_L...,SET,10,-0.076212,-0.0017781,0.29912,0.60055,GOBP_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY,1
HP_BRACHYTURRICEPHALY,SET,8,-0.08029,-0.0016756,0.31487,0.60063,HP_BRACHYTURRICEPHALY,1
GSE25088_CTRL_VS_ROSIGLITAZO...3,SET,182,-0.015593,-0.0015448,0.061145,0.60065,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,1
GOBP_SENSORY_PERCEPTION_OF_S...1,SET,331,-0.01723,-0.0022926,0.067551,0.60066,GOBP_SENSORY_PERCEPTION_OF_SMELL,1
HP_HYPOPLASIA_OF_THE_COCHLEA,SET,8,-0.079071,-0.0016502,0.30993,0.60069,HP_HYPOPLASIA_OF_THE_COCHLEA,1
GOBP_ACETATE_ESTER_TRANSPORT,SET,9,-0.07121,-0.0015762,0.27907,0.6007,GOBP_ACETATE_ESTER_TRANSPORT,1
GSE5503_LIVER_DC_VS_MLN_DC_A...1,SET,176,-0.015813,-0.0015408,0.061953,0.60073,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GSE22886_NAIVE_BCELL_VS_MONO...2,SET,161,-0.017672,-0.0016476,0.069192,0.60079,GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP,1
REACTOME_TP53_REGULATES_TRAN...8,SET,14,-0.058973,-0.0016278,0.23088,0.6008,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,1
GSE22886_NAIVE_CD4_TCELL_VS_...1,SET,184,-0.014824,-0.0014765,0.058028,0.60081,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN,1
HP_BIFID_RIBS,SET,16,-0.053569,-0.0015807,0.20968,0.60082,HP_BIFID_RIBS,1
REACTOME_PI3K_EVENTS_IN_ERBB...2,SET,10,-0.070666,-0.0016488,0.2765,0.60086,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,1
GSE3982_MAC_VS_EFF_MEMORY_CD...1,SET,173,-0.016387,-0.0015832,0.064103,0.60088,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN,1
GOMF_TAU_PROTEIN_KINASE_ACTI...,SET,22,-0.040023,-0.0013846,0.15644,0.60096,GOMF_TAU_PROTEIN_KINASE_ACTIVITY,1
SMID_BREAST_CANCER_NORMAL_LI...1,SET,6,-0.098094,-0.001773,0.38334,0.60098,SMID_BREAST_CANCER_NORMAL_LIKE_DN,1
ETS_Q4,SET,227,-0.014678,-0.001622,0.05736,0.60098,ETS_Q4,1
KYNG_DNA_DAMAGE_BY_GAMMA_RAD...,SET,69,-0.027325,-0.001672,0.10677,0.60099,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1
PID_TCR_CALCIUM_PATHWAY,SET,27,-0.042238,-0.0016186,0.16502,0.601,PID_TCR_CALCIUM_PATHWAY,1
GOBP_MEMBRANE_PROTEIN_ECTODO...,SET,45,-0.031725,-0.0015687,0.12393,0.60102,GOBP_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,1
GSE8921_UNSTIM_VS_TLR1_2_STI...5,SET,183,-0.016103,-0.0015996,0.062894,0.60103,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN,1
GOBP_NEGATIVE_REGULATION_OF_...153,SET,9,-0.083603,-0.0018505,0.32643,0.60107,GOBP_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING,1
GSE12963_UNINF_VS_ENV_AND_NE...2,SET,119,-0.019936,-0.0015998,0.077835,0.60107,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,1
ELVIDGE_HIF1A_TARGETS_DN,SET,81,-0.0248,-0.0016436,0.096821,0.60108,ELVIDGE_HIF1A_TARGETS_DN,1
GOBP_CELL_CELL_RECOGNITION,SET,71,-0.026239,-0.0016285,0.10243,0.60109,GOBP_CELL_CELL_RECOGNITION,1
SESTO_RESPONSE_TO_UV_C7,SET,64,-0.028508,-0.0016802,0.11126,0.60111,SESTO_RESPONSE_TO_UV_C7,1
MIR4321,SET,4,-0.10387,-0.001533,0.40533,0.60113,MIR4321,1
E4F1_Q6,SET,255,-0.013893,-0.0016259,0.054201,0.60115,E4F1_Q6,1
HP_ABNORMAL_BRAINSTEM_MRI_SI...,SET,31,-0.033533,-0.0013767,0.13079,0.60117,HP_ABNORMAL_BRAINSTEM_MRI_SIGNAL_INTENSITY,1
GOBP_POSITIVE_REGULATION_OF_...270,SET,9,-0.074995,-0.00166,0.2925,0.60118,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,1
GOBP_CALCIUM_ION_IMPORT_INTO...,SET,5,-0.08042,-0.001327,0.31361,0.60119,GOBP_CALCIUM_ION_IMPORT_INTO_SARCOPLASMIC_RETICULUM,1
KEGG_STEROID_HORMONE_BIOSYNT...,SET,52,-0.036506,-0.0019401,0.14233,0.60121,KEGG_STEROID_HORMONE_BIOSYNTHESIS,1
HP_AMEGAKARYOCYTIC_THROMBOCY...,SET,6,-0.085048,-0.0015372,0.3316,0.60121,HP_AMEGAKARYOCYTIC_THROMBOCYTOPENIA,1
HP_OROPHARYNGEAL_SQUAMOUS_CE...,SET,6,-0.08542,-0.0015439,0.33293,0.60124,HP_OROPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA,1
HOEK_PBMC_INACTIVATED_INFLUE...4,SET,6,-0.090306,-0.0016322,0.35194,0.60125,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_UP,1
GSE22919_RESTING_VS_IL2_IL12...2,SET,181,-0.015273,-0.0015089,0.059459,0.60135,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP,1
WP_FERROPTOSIS,SET,56,-0.031164,-0.0017185,0.12127,0.6014,WP_FERROPTOSIS,1
GSE2706_UNSTIM_VS_2H_LPS_DC_...1,SET,168,-0.018004,-0.0017143,0.070056,0.60141,GSE2706_UNSTIM_VS_2H_LPS_DC_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...13,SET,9,-0.067462,-0.0014933,0.26247,0.60142,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_APOPTOTIC_DNA_FRAGMENTA...,SET,18,-0.054155,-0.0016948,0.2106,0.60147,GOBP_APOPTOTIC_DNA_FRAGMENTATION,1
GOBP_DEOXYRIBONUCLEOSIDE_TRI...,SET,9,-0.070657,-0.001564,0.27475,0.60147,GOBP_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GSE17974_0H_VS_0.5H_IN_VITRO...2,SET,162,-0.016817,-0.0015727,0.065382,0.60149,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP,1
GOBP_PROTEIN_K63_LINKED_UBIQ...,SET,64,-0.026815,-0.0015804,0.10421,0.60154,GOBP_PROTEIN_K63_LINKED_UBIQUITINATION,1
BIOCARTA_BOTULIN_PATHWAY,SET,5,-0.10947,-0.0018063,0.42536,0.60155,BIOCARTA_BOTULIN_PATHWAY,1
MIR6774_5P,SET,43,-0.033528,-0.0016207,0.13028,0.60155,MIR6774_5P,1
GOMF_UBIQUINOL_CYTOCHROME_C_...,SET,5,-0.082922,-0.0013682,0.32213,0.60157,GOMF_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...420,SET,9,-0.080699,-0.0017863,0.3133,0.60163,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,1
GOBP_REGULATION_OF_MUSCLE_TI...,SET,42,-0.037186,-0.0017765,0.14428,0.60169,GOBP_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
GSE6269_HEALTHY_VS_FLU_INF_P...2,SET,153,-0.017121,-0.0015564,0.066422,0.6017,GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP,1
KASLER_HDAC7_TARGETS_1_UP,SET,179,-0.016598,-0.0016309,0.064388,0.60171,KASLER_HDAC7_TARGETS_1_UP,1
GOBP_REGULATION_OF_AMINO_ACI...1,SET,14,-0.06286,-0.0017351,0.24383,0.60172,GOBP_REGULATION_OF_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
HP_ABNORMAL_ORAL_FRENULUM_MO...,SET,58,-0.028229,-0.0015841,0.10949,0.60172,HP_ABNORMAL_ORAL_FRENULUM_MORPHOLOGY,1
GSE20715_0H_VS_48H_OZONE_LUN...1,SET,189,-0.015573,-0.0015719,0.060399,0.60173,GSE20715_0H_VS_48H_OZONE_LUNG_DN,1
GOMF_SEROTONIN_BINDING,SET,10,-0.071616,-0.0016709,0.27774,0.60174,GOMF_SEROTONIN_BINDING,1
GOBP_RESPONSE_TO_ISCHEMIA,SET,62,-0.029877,-0.0017332,0.11585,0.60176,GOBP_RESPONSE_TO_ISCHEMIA,1
GOBP_L_ASCORBIC_ACID_METABOL...,SET,9,-0.077265,-0.0017103,0.29945,0.6018,GOBP_L_ASCORBIC_ACID_METABOLIC_PROCESS,1
HP_FACIAL_TELANGIECTASIA,SET,15,-0.053116,-0.0015176,0.20584,0.60181,HP_FACIAL_TELANGIECTASIA,1
BIOCARTA_MEF2D_PATHWAY,SET,18,-0.054452,-0.0017041,0.21099,0.60183,BIOCARTA_MEF2D_PATHWAY,1
GOBP_REGULATION_OF_RAC_PROTE...,SET,23,-0.04631,-0.0016381,0.17931,0.6019,GOBP_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_FOCAL_T2_HYPERINTENSE_BRA...,SET,26,-0.036878,-0.0013868,0.14279,0.6019,HP_FOCAL_T2_HYPERINTENSE_BRAINSTEM_LESION,1
KEGG_DILATED_CARDIOMYOPATHY,SET,85,-0.025816,-0.0017525,0.099943,0.60191,KEGG_DILATED_CARDIOMYOPATHY,1
WP_LIPID_METABOLISM_IN_SENES...,SET,20,-0.051134,-0.0016868,0.19796,0.60191,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,1
HP_HYPOESTHESIA,SET,16,-0.054303,-0.0016024,0.21021,0.60192,HP_HYPOESTHESIA,1
GOBP_PROTEIN_DEMETHYLATION,SET,8,-0.060115,-0.0012546,0.23268,0.60193,GOBP_PROTEIN_DEMETHYLATION,1
GSE45365_HEALTHY_VS_MCMV_INF...12,SET,152,-0.017596,-0.0015944,0.068054,0.60201,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP,1
PID_MTOR_4PATHWAY,SET,67,-0.02734,-0.0016486,0.10572,0.60202,PID_MTOR_4PATHWAY,1
WP_HUNGER_AND_SATIETY,SET,8,-0.080665,-0.0016834,0.31195,0.60202,WP_HUNGER_AND_SATIETY,1
GOBP_LONG_CHAIN_FATTY_ACID_M...,SET,102,-0.022888,-0.0017012,0.088505,0.60203,GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_PERIPH...,SET,405,-0.010967,-0.0016108,0.042402,0.60205,HP_ABNORMALITY_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,1
OSF2_Q6,SET,245,-0.014541,-0.0016685,0.056186,0.6021,OSF2_Q6,1
GOBP_SA_NODE_CELL_TO_ATRIAL_...2,SET,9,-0.081467,-0.0018033,0.31464,0.60215,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALING,1
GOBP_CERAMIDE_BIOSYNTHETIC_P...,SET,66,-0.027467,-0.0016438,0.106,0.60223,GOBP_CERAMIDE_BIOSYNTHETIC_PROCESS,1
HOLLMANN_APOPTOSIS_VIA_CD40_...1,SET,234,-0.014827,-0.0016631,0.057211,0.60224,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1
GOBP_INTRACILIARY_TRANSPORT_...,SET,6,-0.09225,-0.0016674,0.35597,0.60224,GOBP_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_ASSEMBLY,1
DAZARD_UV_RESPONSE_CLUSTER_G...2,SET,17,-0.061993,-0.0018855,0.23909,0.60229,DAZARD_UV_RESPONSE_CLUSTER_G28,1
PETRETTO_BLOOD_PRESSURE_UP,SET,11,-0.064525,-0.0015789,0.24866,0.60237,PETRETTO_BLOOD_PRESSURE_UP,1
GOBP_POSITIVE_REGULATION_OF_...679,SET,576,-0.0095899,-0.0016717,0.036949,0.60239,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
KOHOUTEK_CCNT1_TARGETS,SET,47,-0.033486,-0.0016921,0.12899,0.60241,KOHOUTEK_CCNT1_TARGETS,1
REACTOME_NOREPINEPHRINE_NEUR...,SET,16,-0.060417,-0.0017828,0.23259,0.60247,REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE,1
FAN_OVARY_CL15_SMALL_ANTRAL_...,SET,552,-0.0096731,-0.0016518,0.037237,0.60248,FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL,1
BOYAULT_LIVER_CANCER_SUBCLAS...4,SET,38,-0.034933,-0.0015876,0.13436,0.60257,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,1
YAMASHITA_LIVER_CANCER_STEM_...1,SET,69,-0.028802,-0.0017623,0.11074,0.6026,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,1
HP_OPTIC_ATROPHY,SET,512,-0.009521,-0.0015676,0.036605,0.60261,HP_OPTIC_ATROPHY,1
GOCC_RNA_N6_METHYLADENOSINE_...,SET,8,-0.0763,-0.0015924,0.29316,0.60267,GOCC_RNA_N6_METHYLADENOSINE_METHYLTRANSFERASE_COMPLEX,1
SCHERER_PBMC_APSV_WETVAX_AGE...2,SET,57,-0.030213,-0.0016808,0.11607,0.60268,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_UP,1
GOCC_FIBRILLAR_CENTER,SET,134,-0.018211,-0.0015501,0.069951,0.6027,GOCC_FIBRILLAR_CENTER,1
HP_ABNORMALITY_OF_THE_PERIUN...,SET,20,-0.052294,-0.001725,0.20084,0.60271,HP_ABNORMALITY_OF_THE_PERIUNGUAL_REGION,1
GOBP_RECEPTOR_INTERNALIZATION,SET,120,-0.020567,-0.0016573,0.078979,0.60272,GOBP_RECEPTOR_INTERNALIZATION,1
GSE10240_IL17_VS_IL17_AND_IL...1,SET,187,-0.016691,-0.0016758,0.064097,0.60272,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
GOBP_LUTEINIZING_HORMONE_SEC...,SET,11,-0.075057,-0.0018366,0.2881,0.60277,GOBP_LUTEINIZING_HORMONE_SECRETION,1
GSE22886_NAIVE_VS_IGG_IGA_ME...2,SET,169,-0.017095,-0.0016326,0.065552,0.60287,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP,1
CAHOY_OLIGODENDROCUTIC,SET,88,-0.023945,-0.0016538,0.091679,0.60302,CAHOY_OLIGODENDROCUTIC,1
TRAVAGLINI_LUNG_B_CELL,SET,142,-0.018994,-0.0016639,0.072717,0.60303,TRAVAGLINI_LUNG_B_CELL,1
GSE22886_UNSTIM_VS_IL15_STIM...1,SET,183,-0.015894,-0.0015789,0.06083,0.60306,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN,1
GSE46143_CTRL_VS_LMP2A_TRANS...1,SET,181,-0.016352,-0.0016156,0.062586,0.60306,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN,1
BIOCARTA_CK1_PATHWAY,SET,16,-0.060335,-0.0017804,0.23074,0.60314,BIOCARTA_CK1_PATHWAY,1
HP_U_SHAPED_UPPER_LIP_VERMIL...,SET,6,-0.074376,-0.0013443,0.28425,0.60321,HP_U_SHAPED_UPPER_LIP_VERMILION,1
MIR7_1_3P,SET,593,-0.0097483,-0.0017234,0.037252,0.60322,MIR7_1_3P,1
MODULE_124,SET,92,-0.021764,-0.0015368,0.083165,0.60322,MODULE_124,1
HP_ADRENOCORTICAL_CARCINOMA,SET,17,-0.057145,-0.0017381,0.21837,0.60322,HP_ADRENOCORTICAL_CARCINOMA,1
RODRIGUES_DCC_TARGETS_UP,SET,5,-0.098813,-0.0016304,0.37748,0.60325,RODRIGUES_DCC_TARGETS_UP,1
MIR497_3P,SET,217,-0.015349,-0.0016588,0.058623,0.60327,MIR497_3P,1
WP_BIOMARKERS_FOR_UREA_CYCLE...,SET,11,-0.069706,-0.0017057,0.26615,0.6033,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,1
HP_IRREGULARLY_SHAPED_SPERM_...,SET,11,-0.061592,-0.0015071,0.23509,0.60333,HP_IRREGULARLY_SHAPED_SPERM_TAIL,1
MIR4724_3P,SET,78,-0.023541,-0.0015312,0.089827,0.60337,MIR4724_3P,1
HP_STREAK_OVARY,SET,31,-0.039534,-0.0016231,0.15082,0.60338,HP_STREAK_OVARY,1
GSE21546_WT_VS_SAP1A_KO_AND_...1,SET,181,-0.01667,-0.001647,0.063594,0.60339,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
GSE5099_CLASSICAL_M1_VS_ALTE...2,SET,178,-0.016997,-0.0016654,0.064806,0.60344,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP,1
WP_TYPE_II_INTERFERON_SIGNAL...,SET,35,-0.039981,-0.001744,0.15243,0.60345,WP_TYPE_II_INTERFERON_SIGNALING,1
GOMF_SINGLE_STRANDED_DNA_END...,SET,10,-0.065886,-0.0015372,0.25113,0.60348,GOMF_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY,1
MYLLYKANGAS_AMPLIFICATION_HO...19,SET,7,-0.088695,-0.0017315,0.33792,0.60352,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9,1
GOBP_ORGANIC_ACID_BIOSYNTHET...,SET,301,-0.013313,-0.0016905,0.050719,0.60352,GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS,1
HP_NEONATAL_HYPOTONIA,SET,169,-0.017124,-0.0016353,0.065234,0.60353,HP_NEONATAL_HYPOTONIA,1
GAUSSMANN_MLL_AF4_FUSION_TAR...11,SET,31,-0.043531,-0.0017872,0.16579,0.60355,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,1
GOBP_CELLULAR_RESPONSE_TO_GL...2,SET,53,-0.033044,-0.0017728,0.12584,0.60356,GOBP_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS,1
GSE3982_DC_VS_TH2_DN,SET,178,-0.016167,-0.0015842,0.06157,0.60356,GSE3982_DC_VS_TH2_DN,1
GSE14415_INDUCED_TREG_VS_FAI...1,SET,168,-0.017764,-0.0016915,0.06761,0.60362,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN,1
HP_CAROTID_ARTERY_TORTUOSITY,SET,4,-0.12328,-0.0018194,0.46884,0.6037,HP_CAROTID_ARTERY_TORTUOSITY,1
GOBP_BEHAVIORAL_RESPONSE_TO_...1,SET,16,-0.058416,-0.0017237,0.22189,0.60382,GOBP_BEHAVIORAL_RESPONSE_TO_COCAINE,1
REACTOME_SIGNALING_BY_TGFBR3,SET,44,-0.036101,-0.0017652,0.13712,0.60383,REACTOME_SIGNALING_BY_TGFBR3,1
GOBP_ENDOPLASMIC_RETICULUM_L...,SET,9,-0.083915,-0.0018575,0.31864,0.60386,GOBP_ENDOPLASMIC_RETICULUM_LOCALIZATION,1
GOMF_PROTEIN_DISULFIDE_ISOME...,SET,21,-0.049915,-0.0016872,0.18952,0.60387,GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY,1
HP_RETINAL_ARTERIOLAR_TORTUO...,SET,27,-0.050461,-0.0019337,0.19124,0.60405,HP_RETINAL_ARTERIOLAR_TORTUOSITY,1
GOBP_WOUND_HEALING_SPREADING...,SET,26,-0.044429,-0.0016707,0.16835,0.60407,GOBP_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
GOMF_RNA_EXONUCLEASE_ACTIVIT...,SET,39,-0.033438,-0.0015395,0.12662,0.60414,GOMF_RNA_EXONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
GSE7831_UNSTIM_VS_INFLUENZA_...2,SET,179,-0.016395,-0.001611,0.062087,0.60414,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP,1
REACTOME_FORMATION_OF_PARAXI...,SET,63,-0.025418,-0.0014864,0.09614,0.60426,REACTOME_FORMATION_OF_PARAXIAL_MESODERM,1
GSE19825_NAIVE_VS_DAY3_EFF_C...1,SET,181,-0.015705,-0.0015516,0.059398,0.60426,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN,1
ACEVEDO_NORMAL_TISSUE_ADJACE...1,SET,320,-0.012367,-0.0016183,0.046735,0.60434,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1
REACTOME_ACTIVATION_OF_PUMA_...,SET,9,-0.082442,-0.0018248,0.31152,0.60436,REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA,1
REACTOME_ACTIVATION_OF_RAS_I...,SET,5,-0.08819,-0.0014552,0.3332,0.60437,REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS,1
REACTOME_TRNA_MODIFICATION_I...2,SET,38,-0.032389,-0.001472,0.12237,0.60437,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1
MODULE_563,SET,13,-0.06294,-0.0016742,0.23771,0.60441,MODULE_563,1
HP_ABNORMAL_TRICUSPID_VALVE_...1,SET,35,-0.042588,-0.0018577,0.1607,0.6045,HP_ABNORMAL_TRICUSPID_VALVE_MORPHOLOGY,1
WP_GAMMAGLUTAMYL_CYCLE_FOR_T...,SET,6,-0.086001,-0.0015544,0.32421,0.60459,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,1
GOBP_MICROTUBULE_BASED_MOVEM...,SET,367,-0.011711,-0.0016391,0.044148,0.6046,GOBP_MICROTUBULE_BASED_MOVEMENT,1
GOBP_GLIAL_CELL_APOPTOTIC_PR...,SET,17,-0.052589,-0.0015995,0.19813,0.60466,GOBP_GLIAL_CELL_APOPTOTIC_PROCESS,1
HP_INFANTILE_SPASMS,SET,119,-0.020624,-0.001655,0.077702,0.60466,HP_INFANTILE_SPASMS,1
REACTOME_REACTIONS_SPECIFIC_...,SET,10,-0.077269,-0.0018028,0.29106,0.60468,REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...163,SET,23,-0.043684,-0.0015452,0.16454,0.60468,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
MORF_ATOX1,SET,68,-0.025414,-0.0015438,0.095676,0.60473,MORF_ATOX1,1
KEGG_MEDICUS_REFERENCE_IGG_F...,SET,9,-0.081282,-0.0017992,0.30575,0.60482,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY,1
MIR1912_5P,SET,73,-0.028058,-0.0017657,0.10555,0.60482,MIR1912_5P,1
KEGG_MEDICUS_REFERENCE_NLRP1...,SET,4,-0.096722,-0.0014275,0.36378,0.60483,KEGG_MEDICUS_REFERENCE_NLRP1_INFLAMMASOME_SIGNALING_PATHWAY,1
GOBP_MESENCHYME_DEVELOPMENT,SET,293,-0.014173,-0.0017761,0.053306,0.60483,GOBP_MESENCHYME_DEVELOPMENT,1
HP_TYPE_1_MUSCLE_FIBER_PREDO...,SET,60,-0.027737,-0.001583,0.10428,0.60487,HP_TYPE_1_MUSCLE_FIBER_PREDOMINANCE,1
GAVISH_3CA_METAPROGRAM_CD8_T...12,SET,47,-0.03268,-0.0016514,0.12285,0.60489,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_2,1
HP_HYPOREFLEXIA_OF_UPPER_LIM...,SET,7,-0.099465,-0.0019418,0.37388,0.60489,HP_HYPOREFLEXIA_OF_UPPER_LIMBS,1
MIR6085,SET,35,-0.035178,-0.0015344,0.13214,0.60496,MIR6085,1
HP_TETRALOGY_OF_FALLOT,SET,156,-0.018428,-0.0016915,0.069209,0.60498,HP_TETRALOGY_OF_FALLOT,1
CREB_Q2,SET,237,-0.015084,-0.0017026,0.0566,0.60507,CREB_Q2,1
REACTOME_INTRA_GOLGI_TRAFFIC,SET,43,-0.034433,-0.0016644,0.12913,0.60513,REACTOME_INTRA_GOLGI_TRAFFIC,1
REACTOME_INTRACELLULAR_SIGNA...,SET,299,-0.013102,-0.0016583,0.049128,0.60514,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1
GSE11924_TH2_VS_TH17_CD4_TCE...1,SET,184,-0.016917,-0.0016851,0.063396,0.60521,GSE11924_TH2_VS_TH17_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...606,SET,6,-0.11223,-0.0020285,0.42046,0.60523,GOBP_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,1
GOCC_PRESYNAPTIC_CYTOSOL,SET,12,-0.066884,-0.0017094,0.25051,0.60526,GOCC_PRESYNAPTIC_CYTOSOL,1
KEGG_MEDICUS_REFERENCE_KEAP1...,SET,20,-0.063662,-0.0021,0.23841,0.60527,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY,1
GSE42021_TREG_PLN_VS_CD24INT...2,SET,182,-0.017663,-0.0017498,0.066129,0.6053,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP,1
GOMF_CALCIUM_INDUCED_CALCIUM...,SET,6,-0.089203,-0.0016123,0.33389,0.60533,GOMF_CALCIUM_INDUCED_CALCIUM_RELEASE_ACTIVITY,1
GSE21360_PRIMARY_VS_QUATERNA...2,SET,157,-0.019506,-0.0017961,0.073001,0.60534,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,1
GSE37301_COMMON_LYMPHOID_PRO...1,SET,181,-0.016687,-0.0016486,0.06245,0.60534,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN,1
WP_10Q1121Q1123_COPY_NUMBER_...,SET,55,-0.031288,-0.0017099,0.11706,0.60537,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_REGULATION_OF_LOCOMOTION,SET,960,-0.0079668,-0.0017735,0.029802,0.60539,GOBP_REGULATION_OF_LOCOMOTION,1
GOMF_SODIUM_INDEPENDENT_ORGA...,SET,16,-0.066896,-0.0019739,0.25023,0.60539,GOMF_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATORY_NCRNA_MEDIAT...1,SET,112,-0.020731,-0.0016143,0.077543,0.6054,GOBP_REGULATORY_NCRNA_MEDIATED_GENE_SILENCING,1
MAYBURD_RESPONSE_TO_L663536_...1,SET,51,-0.030597,-0.0016104,0.11444,0.60541,MAYBURD_RESPONSE_TO_L663536_DN,1
GSE37534_PIOGLITAZONE_VS_ROS...2,SET,174,-0.016183,-0.001568,0.060484,0.60548,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,1
HP_ABNORMALITY_OF_EXTRAPYRAM...,SET,268,-0.013956,-0.0016738,0.052146,0.60551,HP_ABNORMALITY_OF_EXTRAPYRAMIDAL_MOTOR_FUNCTION,1
HP_PERIVENTRICULAR_WHITE_MAT...,SET,29,-0.04177,-0.0016588,0.15602,0.60554,HP_PERIVENTRICULAR_WHITE_MATTER_HYPERINTENSITIES,1
VANLOO_SP3_TARGETS_DN,SET,83,-0.023302,-0.0015632,0.087021,0.60556,VANLOO_SP3_TARGETS_DN,1
MODULE_88,SET,760,-0.0088903,-0.0017709,0.033147,0.60573,MODULE_88,1
GSE11924_TFH_VS_TH17_CD4_TCE...1,SET,180,-0.016521,-0.0016278,0.061576,0.60577,GSE11924_TFH_VS_TH17_CD4_TCELL_DN,1
REACTOME_MITOCHONDRIAL_BIOGE...,SET,68,-0.027988,-0.0017001,0.1043,0.60578,REACTOME_MITOCHONDRIAL_BIOGENESIS,1
MEF2C_TARGET_GENES,SET,1332,-0.0064978,-0.0016855,0.024211,0.6058,MEF2C_TARGET_GENES,1
GOMF_GAP_JUNCTION_CHANNEL_AC...1,SET,21,-0.060961,-0.0020605,0.22714,0.6058,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY,1
GSE10147_IL3_VS_IL3_AND_HIVP...2,SET,151,-0.017665,-0.0015954,0.065816,0.6058,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP,1
HP_ABNORMAL_PLACENTAL_SIZE,SET,14,-0.067366,-0.0018595,0.2509,0.60584,HP_ABNORMAL_PLACENTAL_SIZE,1
MAGRANGEAS_MULTIPLE_MYELOMA_...1,SET,24,-0.049099,-0.001774,0.18281,0.60587,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,1
SCHUHMACHER_MYC_TARGETS_DN,SET,7,-0.086079,-0.0016805,0.32044,0.60589,SCHUHMACHER_MYC_TARGETS_DN,1
BIOCARTA_IGF1MTOR_PATHWAY,SET,18,-0.058716,-0.0018376,0.21855,0.6059,BIOCARTA_IGF1MTOR_PATHWAY,1
GSE37605_NOD_VS_C57BL6_IRES_...1,SET,143,-0.019173,-0.0016855,0.071283,0.60602,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN,1
KEGG_MEDICUS_REFERENCE_CXCR4...2,SET,12,-0.066825,-0.0017078,0.2484,0.60604,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
GOBP_GLOMERULUS_DEVELOPMENT,SET,68,-0.031182,-0.0018941,0.1158,0.60614,GOBP_GLOMERULUS_DEVELOPMENT,1
DURANTE_ADULT_OLFACTORY_NEUR...12,SET,35,-0.043118,-0.0018808,0.16011,0.60615,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES,1
GOBP_CELLULAR_HOMEOSTASIS,SET,746,-0.0088057,-0.0017386,0.032675,0.60622,GOBP_CELLULAR_HOMEOSTASIS,1
ACEVEDO_LIVER_CANCER_WITH_H3...3,SET,82,-0.02485,-0.001657,0.092201,0.60623,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1
WP_TGFBETA_RECEPTOR_SIGNALING,SET,51,-0.036332,-0.0019122,0.13478,0.60625,WP_TGFBETA_RECEPTOR_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...374,SET,10,-0.071132,-0.0016596,0.26382,0.60627,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,1
BIOCARTA_CELL2CELL_PATHWAY,SET,12,-0.067953,-0.0017367,0.2519,0.60633,BIOCARTA_CELL2CELL_PATHWAY,1
GOMF_CELL_ADHESIVE_PROTEIN_B...,SET,5,-0.12398,-0.0020457,0.45956,0.60633,GOMF_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION,1
HP_ABNORMAL_CIRCULATING_CARB...2,SET,305,-0.013124,-0.0016774,0.048642,0.60634,HP_ABNORMAL_CIRCULATING_CARBOXYLIC_ACID_CONCENTRATION,1
GSE3982_BCELL_VS_TH2_UP,SET,173,-0.017083,-0.0016504,0.063287,0.60639,GSE3982_BCELL_VS_TH2_UP,1
MIR1289,SET,52,-0.034157,-0.0018152,0.12653,0.6064,MIR1289,1
KEGG_MEDICUS_REFERENCE_TETHE...,SET,9,-0.073129,-0.0016187,0.27082,0.60643,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,1
CP2_01,SET,238,-0.014919,-0.0016876,0.055249,0.60643,CP2_01,1
HP_ABNORMAL_LEFT_ATRIUM_MORP...,SET,22,-0.04904,-0.0016965,0.18157,0.60645,HP_ABNORMAL_LEFT_ATRIUM_MORPHOLOGY,1
HP_DECREASED_PROPORTION_OF_N...,SET,3,-0.1542,-0.0019709,0.57091,0.60645,HP_DECREASED_PROPORTION_OF_NAIVE_T_CELLS,1
GSE43955_TH0_VS_TGFB_IL6_TH1...10,SET,181,-0.016684,-0.0016484,0.061728,0.60653,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP,1
HP_ANTINEUTROPHIL_ANTIBODY_P...,SET,42,-0.035237,-0.0016834,0.13033,0.60656,HP_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,1
REACTOME_NEDDYLATION,SET,227,-0.014801,-0.0016355,0.0547,0.60664,REACTOME_NEDDYLATION,1
HP_TRACHEOMALACIA,SET,43,-0.034664,-0.0016756,0.12811,0.60664,HP_TRACHEOMALACIA,1
GSE17721_CTRL_VS_CPG_24H_BMD...2,SET,180,-0.016631,-0.0016386,0.06146,0.60665,GSE17721_CTRL_VS_CPG_24H_BMDC_UP,1
MIR4276,SET,243,-0.014869,-0.0016992,0.054939,0.60666,MIR4276,1
GOBP_RESPONSE_TO_STEROL,SET,32,-0.04289,-0.001789,0.15843,0.60669,GOBP_RESPONSE_TO_STEROL,1
GNF2_PAK2,SET,25,-0.04445,-0.0016391,0.16408,0.60677,GNF2_PAK2,1
HP_HIP_FLEXOR_WEAKNESS,SET,15,-0.055146,-0.0015756,0.20353,0.60678,HP_HIP_FLEXOR_WEAKNESS,1
MIR101_3P,SET,418,-0.01168,-0.0017421,0.043103,0.60679,MIR101_3P,1
WDHD1_TARGET_GENES,SET,148,-0.019364,-0.0017316,0.07145,0.60681,WDHD1_TARGET_GENES,1
HP_SEVERE_VARICELLA_ZOSTER_I...,SET,13,-0.068488,-0.0018218,0.25272,0.60681,HP_SEVERE_VARICELLA_ZOSTER_INFECTION,1
MASSARWEH_TAMOXIFEN_RESISTAN...2,SET,509,-0.010531,-0.0017289,0.038851,0.60682,MASSARWEH_TAMOXIFEN_RESISTANCE_UP,1
MIR449B_5P,SET,237,-0.015041,-0.0016978,0.055493,0.60682,MIR449B_5P,1
RIZ_ERYTHROID_DIFFERENTIATIO...5,SET,36,-0.043656,-0.0019312,0.16102,0.60685,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,1
GSE339_EX_VIVO_VS_IN_CULTURE...4,SET,185,-0.016571,-0.001655,0.061083,0.60691,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP,1
GSE36888_UNTREATED_VS_IL2_TR...11,SET,174,-0.016816,-0.0016292,0.061987,0.60691,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN,1
GOBP_NEGATIVE_REGULATION_OF_...30,SET,5,-0.12167,-0.0020076,0.44833,0.60695,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
HP_APLASIA_HYPOPLASIA_OF_THE...59,SET,15,-0.058357,-0.0016673,0.21499,0.60697,HP_APLASIA_HYPOPLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
SPIRA_SMOKERS_LUNG_CANCER_DN,SET,14,-0.056479,-0.001559,0.20805,0.60699,SPIRA_SMOKERS_LUNG_CANCER_DN,1
REACTOME_TRYPTOPHAN_CATABOLI...,SET,12,-0.071425,-0.0018254,0.26307,0.607,REACTOME_TRYPTOPHAN_CATABOLISM,1
GOBP_FEVER_GENERATION,SET,11,-0.081045,-0.0019831,0.2984,0.60703,GOBP_FEVER_GENERATION,1
GSE29618_PRE_VS_DAY7_POST_LA...6,SET,182,-0.017152,-0.0016992,0.063135,0.60706,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP,1
BENPORATH_PROLIFERATION,SET,135,-0.019794,-0.0016911,0.072823,0.60711,BENPORATH_PROLIFERATION,1
chr1p34,SET,154,-0.039801,-0.0036298,0.14642,0.60712,chr1p34,1
GSE21670_IL6_VS_TGFB_AND_IL6...4,SET,187,-0.01542,-0.0015482,0.056719,0.60713,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
HP_CAFE_AU_LAIT_SPOT,SET,120,-0.01988,-0.0016019,0.073087,0.60719,HP_CAFE_AU_LAIT_SPOT,1
FAN_OVARY_CL18_B_LYMPHOCYTE,SET,382,-0.011843,-0.0016903,0.043525,0.60722,FAN_OVARY_CL18_B_LYMPHOCYTE,1
SALVADOR_MARTIN_PEDIATRIC_TB...2,SET,19,-0.057372,-0.0018447,0.21065,0.60733,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,1
HOSHIDA_LIVER_CANCER_LATE_RE...2,SET,56,-0.032317,-0.0017821,0.11863,0.60735,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1
HP_IVORY_EPIPHYSES_OF_THE_PH...,SET,6,-0.10797,-0.0019515,0.39627,0.60736,HP_IVORY_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,1
MODULE_451,SET,30,-0.040801,-0.0016479,0.1497,0.6074,MODULE_451,1
GOMF_IGG_BINDING,SET,10,-0.085142,-0.0019865,0.31239,0.6074,GOMF_IGG_BINDING,1
GOMF_ADRENERGIC_RECEPTOR_ACT...,SET,10,-0.086305,-0.0020136,0.31632,0.60751,GOMF_ADRENERGIC_RECEPTOR_ACTIVITY,1
HP_EOSINOPHILIC_INFILTRATION...,SET,10,-0.08428,-0.0019664,0.30885,0.60753,HP_EOSINOPHILIC_INFILTRATION_OF_THE_ESOPHAGUS,1
HU_GENOTOXIC_DAMAGE_24HR,SET,31,-0.03867,-0.0015876,0.14169,0.60754,HU_GENOTOXIC_DAMAGE_24HR,1
GOBP_NEGATIVE_REGULATION_OF_...267,SET,55,-0.032434,-0.0017726,0.11883,0.60755,GOBP_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_LIPID_KINASE_ACTIVITY,SET,39,-0.037251,-0.0017151,0.13648,0.60755,GOMF_LIPID_KINASE_ACTIVITY,1
GSE22611_NOD2_TRANSDUCED_VS_...1,SET,173,-0.016812,-0.0016242,0.061567,0.6076,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN,1
GAVISH_3CA_METAPROGRAM_EPITH...8,SET,49,-0.034471,-0.0017784,0.12621,0.60762,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3,1
GSE360_CTRL_VS_M_TUBERCULOSI...4,SET,179,-0.017081,-0.0016784,0.062509,0.60767,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP,1
ZNF563_TARGET_GENES,SET,472,-0.010867,-0.0017199,0.039764,0.60768,ZNF563_TARGET_GENES,1
GOBP_SYMPATHETIC_GANGLION_DE...,SET,9,-0.088793,-0.0019654,0.32478,0.60772,GOBP_SYMPATHETIC_GANGLION_DEVELOPMENT,1
GSE2706_R848_VS_LPS_8H_STIM_...2,SET,141,-0.020001,-0.001746,0.073161,0.60772,GSE2706_R848_VS_LPS_8H_STIM_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...336,SET,14,-0.067402,-0.0018605,0.24651,0.60773,GOBP_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,1
GOBP_MANNOSE_METABOLIC_PROCE...,SET,9,-0.072431,-0.0016032,0.26486,0.60775,GOBP_MANNOSE_METABOLIC_PROCESS,1
HP_DECREASED_CIRCULATING_VIT...1,SET,8,-0.097497,-0.0020347,0.35646,0.60777,HP_DECREASED_CIRCULATING_VITAMIN_B12_CONCENTRATION,1
GOBP_REGULATION_OF_AMACRINE_...,SET,6,-0.1054,-0.0019051,0.38524,0.6078,GOBP_REGULATION_OF_AMACRINE_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...20,SET,8,-0.083181,-0.001736,0.30398,0.60782,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMAL_OVARIAN_MORPHOLO...,SET,158,-0.018687,-0.0017261,0.068288,0.60782,HP_ABNORMAL_OVARIAN_MORPHOLOGY,1
TURASHVILI_BREAST_DUCTAL_CAR...1,SET,173,-0.01919,-0.001854,0.070115,0.60784,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1
KAECH_NAIVE_VS_DAY8_EFF_CD8_...1,SET,184,-0.017033,-0.0016966,0.062235,0.60784,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN,1
GOBP_RETROGRADE_TRANS_SYNAPT...2,SET,5,-0.1147,-0.0018925,0.41902,0.60785,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,1
HP_MEDULLARY_NEPHROCALCINOSIS,SET,10,-0.082261,-0.0019193,0.30039,0.6079,HP_MEDULLARY_NEPHROCALCINOSIS,1
REACTOME_PEROXISOMAL_PROTEIN...,SET,60,-0.03011,-0.0017184,0.10993,0.60792,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,1
GOBP_MICROTUBULE_CYTOSKELETO...1,SET,577,-0.0095189,-0.0016608,0.034753,0.60792,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
GOBP_DNA_INTEGRATION,SET,7,-0.080413,-0.0015698,0.2935,0.60795,GOBP_DNA_INTEGRATION,1
GOMF_OXIDOREDUCTION_DRIVEN_A...,SET,52,-0.027453,-0.0014589,0.10018,0.60797,GOMF_OXIDOREDUCTION_DRIVEN_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...57,SET,97,-0.024019,-0.0017412,0.087638,0.60798,GOBP_POSITIVE_REGULATION_OF_BINDING,1
HP_DIFFUSE_CEREBELLAR_ATROPHY,SET,15,-0.054163,-0.0015475,0.19759,0.608,HP_DIFFUSE_CEREBELLAR_ATROPHY,1
GOBP_RESPONSE_TO_ARSENIC_CON...,SET,30,-0.042479,-0.0017157,0.15494,0.60802,GOBP_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,1
LOCKWOOD_AMPLIFIED_IN_LUNG_C...,SET,203,-0.018107,-0.0018934,0.066035,0.60803,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1
GOCC_PROTON_TRANSPORTING_V_T...3,SET,12,-0.070128,-0.0017923,0.25565,0.60808,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN,1
GOBP_REGULATION_OF_VASOCONST...,SET,63,-0.032642,-0.0019088,0.11896,0.60811,GOBP_REGULATION_OF_VASOCONSTRICTION,1
HP_ABNORMAL_CORNEAL_STROMA_M...,SET,95,-0.024711,-0.0017729,0.090048,0.60812,HP_ABNORMAL_CORNEAL_STROMA_MORPHOLOGY,1
GOBP_PHOSPHOLIPID_TRANSPORT,SET,92,-0.024634,-0.0017394,0.089747,0.60814,GOBP_PHOSPHOLIPID_TRANSPORT,1
HP_DELAYED_EPIPHYSEAL_OSSIFI...,SET,37,-0.038796,-0.0017399,0.14127,0.6082,HP_DELAYED_EPIPHYSEAL_OSSIFICATION,1
GOMF_L_GLUTAMINE_TRANSMEMBRA...,SET,8,-0.090876,-0.0018965,0.33085,0.60822,GOMF_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_ULNAR_METAPHYSIS...,SET,10,-0.085458,-0.0019939,0.31106,0.60824,HP_ABNORMAL_ULNAR_METAPHYSIS_MORPHOLOGY,1
GAVISH_3CA_MALIGNANT_METAPRO...31,SET,42,-0.03691,-0.0017633,0.13432,0.60826,GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE,1
GOMF_G_PROTEIN_BETA_SUBUNIT_...,SET,21,-0.05603,-0.0018939,0.20372,0.60835,GOMF_G_PROTEIN_BETA_SUBUNIT_BINDING,1
CHEOK_RESPONSE_TO_MERCAPTOPU...1,SET,23,-0.04802,-0.0016986,0.17449,0.60842,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,1
GOBP_MAMMARY_GLAND_ALVEOLUS_...,SET,18,-0.060382,-0.0018897,0.21938,0.60843,GOBP_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...43,SET,11,-0.080253,-0.0019638,0.29148,0.60847,GOBP_NEGATIVE_REGULATION_OF_BEHAVIOR,1
REACTOME_SYNTHESIS_SECRETION...2,SET,20,-0.057132,-0.0018846,0.20742,0.60851,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1,1
GOMF_SINGLE_STRANDED_DNA_BIN...,SET,107,-0.02148,-0.001635,0.077974,0.60852,GOMF_SINGLE_STRANDED_DNA_BINDING,1
WP_MITOCHONDRIAL_COMPLEX_II_...,SET,8,-0.079028,-0.0016493,0.28673,0.60858,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,1
RODRIGUES_THYROID_CARCINOMA_...1,SET,468,-0.010981,-0.0017307,0.039824,0.60862,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,1
GAVISH_3CA_METAPROGRAM_EPITH...22,SET,50,-0.036746,-0.001915,0.1332,0.60868,GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED,1
REACTOME_PROCESSING_OF_INTRO...,SET,19,-0.047985,-0.0015428,0.17392,0.60869,REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,1
GSE26030_TH1_VS_TH17_RESTIMU...1,SET,181,-0.017222,-0.0017015,0.062405,0.60871,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN,1
GOBP_POSITIVE_REGULATION_OF_...228,SET,38,-0.038733,-0.0017603,0.14033,0.60873,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,1
REACTOME_FACTORS_INVOLVED_IN...,SET,144,-0.020565,-0.0018141,0.07442,0.60886,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1
GAO_STOMACH_24W_C5_PUTATIVE_...,SET,51,-0.034419,-0.0018115,0.12453,0.60887,GAO_STOMACH_24W_C5_PUTATIVE_PIT_CELL_PROGENITOR,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...2,SET,726,-0.008996,-0.0017532,0.032547,0.60888,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,1
REACTOME_FGFR1B_LIGAND_BINDI...,SET,8,-0.09051,-0.0018889,0.32734,0.60892,REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION,1
NIKOLSKY_BREAST_CANCER_21Q22...,SET,15,-0.10469,-0.0029913,0.37831,0.60901,NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,1
GOBP_INTERLEUKIN_6_PRODUCTION,SET,136,-0.021488,-0.0018426,0.077641,0.60902,GOBP_INTERLEUKIN_6_PRODUCTION,1
HP_BICARBONATE_WASTING_RENAL...,SET,5,-0.11049,-0.0018232,0.39915,0.60904,HP_BICARBONATE_WASTING_RENAL_TUBULAR_ACIDOSIS,1
HP_RETINAL_NEOVASCULARIZATION,SET,9,-0.084726,-0.0018754,0.30588,0.6091,HP_RETINAL_NEOVASCULARIZATION,1
REACTOME_PARACETAMOL_ADME,SET,25,-0.052433,-0.0019335,0.18925,0.60913,REACTOME_PARACETAMOL_ADME,1
REACTOME_TGFBR3_EXPRESSION,SET,25,-0.050912,-0.0018774,0.18372,0.60915,REACTOME_TGFBR3_EXPRESSION,1
GOMF_VOLTAGE_GATED_POTASSIUM...3,SET,11,-0.081979,-0.002006,0.29565,0.60922,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,1
STEIN_ESRRA_TARGETS_RESPONSI...1,SET,39,-0.038781,-0.0017855,0.13983,0.60924,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,1
NR1H4_TARGET_GENES,SET,328,-0.01337,-0.001771,0.048209,0.60924,NR1H4_TARGET_GENES,1
PEREZ_TP53_TARGETS,SET,1025,-0.0077475,-0.0017787,0.027924,0.60928,PEREZ_TP53_TARGETS,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...3,SET,259,-0.015577,-0.001837,0.056119,0.60933,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
HOSHIDA_LIVER_CANCER_LATE_RE...1,SET,63,-0.030243,-0.0017685,0.10892,0.60936,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,1
GOBP_PROTEIN_INSERTION_INTO_...1,SET,25,-0.046102,-0.0017,0.16602,0.60938,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
GOCC_DENDRITE_CYTOPLASM,SET,26,-0.044916,-0.001689,0.1617,0.6094,GOCC_DENDRITE_CYTOPLASM,1
WP_BRAINDERIVED_NEUROTROPHIC...,SET,135,-0.021992,-0.0018789,0.079151,0.60944,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,1
GOMF_UBIQUITIN_LIGASE_ACTIVA...,SET,9,-0.077537,-0.0017163,0.27878,0.60954,GOMF_UBIQUITIN_LIGASE_ACTIVATOR_ACTIVITY,1
GOBP_PIGMENT_METABOLIC_PROCE...,SET,72,-0.028953,-0.0018096,0.10407,0.60957,GOBP_PIGMENT_METABOLIC_PROCESS,1
ZHENG_CORD_BLOOD_C10_MULTILY...,SET,81,-0.027693,-0.0018353,0.099488,0.60963,ZHENG_CORD_BLOOD_C10_MULTILYMPHOID_PROGENITOR,1
GOMF_ENDOPEPTIDASE_ACTIVATOR...,SET,17,-0.059712,-0.0018161,0.21446,0.60966,GOMF_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,1
GSE25088_CTRL_VS_IL4_AND_ROS...4,SET,172,-0.01677,-0.0016155,0.060214,0.60968,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,1
REACTOME_HIV_INFECTION,SET,215,-0.014747,-0.0015864,0.05294,0.60971,REACTOME_HIV_INFECTION,1
GSE19401_PAM2CSK4_VS_RETINOI...2,SET,170,-0.01808,-0.0017317,0.064881,0.60975,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
MIR4803,SET,411,-0.012196,-0.0018042,0.043754,0.60978,MIR4803,1
GOBP_CELLULAR_RESPONSE_TO_PR...2,SET,15,-0.07119,-0.002034,0.2553,0.60982,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS,1
MIR875_3P,SET,283,-0.014421,-0.0017766,0.051679,0.6099,MIR875_3P,1
REN_ALVEOLAR_RHABDOMYOSARCOM...2,SET,93,-0.027042,-0.0019197,0.096882,0.60992,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,1
HP_EEG_WITH_FOCAL_SHARP_SLOW...,SET,12,-0.072343,-0.0018489,0.25904,0.60998,HP_EEG_WITH_FOCAL_SHARP_SLOW_WAVES,1
HP_UTERINE_RUPTURE,SET,8,-0.10017,-0.0020905,0.35865,0.60999,HP_UTERINE_RUPTURE,1
GOMF_3_CHLOROALLYL_ALDEHYDE_...,SET,5,-0.094367,-0.0015571,0.33776,0.61003,GOMF_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY,1
GOBP_RESPONSE_TO_TYPE_II_INT...,SET,112,-0.023559,-0.0018345,0.084256,0.61011,GOBP_RESPONSE_TO_TYPE_II_INTERFERON,1
GOMF_COPPER_ION_BINDING,SET,57,-0.032341,-0.0017992,0.11559,0.61018,GOMF_COPPER_ION_BINDING,1
GCM_TINF2,SET,38,-0.036096,-0.0016404,0.12895,0.61023,GCM_TINF2,1
REACTOME_SIGNALING_BY_LTK_IN...,SET,7,-0.091598,-0.0017882,0.32717,0.61025,REACTOME_SIGNALING_BY_LTK_IN_CANCER,1
HP_LICHENIFICATION,SET,15,-0.061555,-0.0017587,0.21982,0.61027,HP_LICHENIFICATION,1
HP_PERIVENTRICULAR_NODULAR_H...,SET,14,-0.061383,-0.0016944,0.21917,0.61029,HP_PERIVENTRICULAR_NODULAR_HETEROTOPIA,1
SEIDEN_ONCOGENESIS_BY_MET,SET,79,-0.026374,-0.0017263,0.094139,0.61032,SEIDEN_ONCOGENESIS_BY_MET,1
GOBP_HEMATOPOIETIC_STEM_CELL...1,SET,36,-0.040145,-0.0017759,0.14327,0.61034,GOBP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THE_COAGUL...,SET,136,-0.020372,-0.0017468,0.072687,0.61036,HP_ABNORMALITY_OF_THE_COAGULATION_CASCADE,1
GOBP_LENS_FIBER_CELL_MORPHOG...,SET,6,-0.10516,-0.0019007,0.37507,0.6104,GOBP_LENS_FIBER_CELL_MORPHOGENESIS,1
GSE41176_UNSTIM_VS_ANTI_IGM_...13,SET,181,-0.018352,-0.0018132,0.065445,0.61042,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN,1
GOBP_SPHINGOID_BIOSYNTHETIC_...,SET,13,-0.069435,-0.001847,0.24758,0.61043,GOBP_SPHINGOID_BIOSYNTHETIC_PROCESS,1
HP_DISTURBANCE_DURING_TRANSI...,SET,17,-0.063674,-0.0019367,0.22692,0.61049,HP_DISTURBANCE_DURING_TRANSITIONS_BETWEEN_SLEEP_AND_WAKE_STATES,1
REACTOME_LIPOPHAGY,SET,9,-0.080074,-0.0017724,0.28529,0.61052,REACTOME_LIPOPHAGY,1
MIR1914_3P,SET,23,-0.052643,-0.0018621,0.18754,0.61053,MIR1914_3P,1
MIR4709_3P,SET,148,-0.020014,-0.0017896,0.071301,0.61053,MIR4709_3P,1
HP_GASTROINTESTINAL_STROMA_T...,SET,19,-0.059419,-0.0019105,0.21167,0.61054,HP_GASTROINTESTINAL_STROMA_TUMOR,1
KEGG_MEDICUS_REFERENCE_WNT_S...3,SET,17,-0.062723,-0.0019077,0.22337,0.61057,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION,1
SEKI_INFLAMMATORY_RESPONSE_L...2,SET,72,-0.031788,-0.0019867,0.11317,0.6106,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1
TRAVAGLINI_LUNG_BASOPHIL_MAS...1,SET,248,-0.015835,-0.0018279,0.056374,0.6106,TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL,1
GSE24972_MARGINAL_ZONE_BCELL...2,SET,181,-0.018065,-0.0017848,0.064294,0.61064,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN,1
MIR6515_5P,SET,79,-0.026947,-0.0017638,0.095886,0.61065,MIR6515_5P,1
HP_EXOPHORIA,SET,6,-0.091838,-0.0016599,0.32654,0.61074,HP_EXOPHORIA,1
HP_UPPER_LIMB_POSTURAL_TREMOR,SET,10,-0.088085,-0.0020552,0.3132,0.61074,HP_UPPER_LIMB_POSTURAL_TREMOR,1
GOBP_NEGATIVE_REGULATION_OF_...207,SET,12,-0.07871,-0.0020116,0.27977,0.61077,GOBP_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
GOMF_ATP_ACTIVATED_INWARD_RE...,SET,6,-0.12452,-0.0022507,0.44262,0.61077,GOMF_ATP_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
GSE39110_UNTREATED_VS_IL2_TR...3,SET,186,-0.019019,-0.0019046,0.067565,0.61083,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN,1
HUANG_FOXA2_TARGETS_DN,SET,35,-0.042181,-0.0018399,0.14981,0.61086,HUANG_FOXA2_TARGETS_DN,1
FUNG_IL2_TARGETS_WITH_STAT5_...2,SET,9,-0.088988,-0.0019697,0.316,0.61087,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1,1
SARTIPY_BLUNTED_BY_INSULIN_R...1,SET,17,-0.065617,-0.0019957,0.23298,0.61089,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,1
LE_EGR2_TARGETS_UP,SET,103,-0.022783,-0.0017016,0.080839,0.61096,LE_EGR2_TARGETS_UP,1
GOCC_ENDOPLASMIC_RETICULUM_T...2,SET,4,-0.11164,-0.0016477,0.39616,0.61096,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_MEMBRANE,1
MORF_USP5,SET,46,-0.031479,-0.0015737,0.11168,0.61097,MORF_USP5,1
MIR4778_3P,SET,230,-0.016462,-0.001831,0.058391,0.611,MIR4778_3P,1
KAECH_DAY8_EFF_VS_MEMORY_CD8...1,SET,184,-0.01771,-0.001764,0.062798,0.61103,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN,1
STEIN_ESRRA_TARGETS,SET,473,-0.011185,-0.001772,0.039657,0.61104,STEIN_ESRRA_TARGETS,1
MIR4699_5P,SET,95,-0.025386,-0.0018214,0.089983,0.61107,MIR4699_5P,1
MIR608,SET,195,-0.017942,-0.0018392,0.063602,0.61107,MIR608,1
GSE17721_POLYIC_VS_PAM3CSK4_...5,SET,172,-0.017632,-0.0016986,0.062497,0.61108,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN,1
GOBP_DORSAL_AORTA_MORPHOGENE...,SET,8,-0.094877,-0.00198,0.33626,0.61109,GOBP_DORSAL_AORTA_MORPHOGENESIS,1
GOBP_ISOTYPE_SWITCHING_TO_IG...1,SET,6,-0.083842,-0.0015154,0.2969,0.61117,GOBP_ISOTYPE_SWITCHING_TO_IGA_ISOTYPES,1
GOBP_CLUSTERING_OF_VOLTAGE_G...,SET,6,-0.098571,-0.0017816,0.34903,0.61119,GOBP_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS,1
GSE15330_HSC_VS_LYMPHOID_PRI...3,SET,181,-0.017782,-0.0017568,0.062947,0.61121,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP,1
GOBP_SYNAPTIC_VESICLE_EXOCYT...,SET,90,-0.02509,-0.0017523,0.088793,0.61124,GOBP_SYNAPTIC_VESICLE_EXOCYTOSIS,1
chr13q13,SET,31,-0.076946,-0.0031591,0.27227,0.61126,chr13q13,1
NIKOLSKY_BREAST_CANCER_20Q12...,SET,136,-0.039014,-0.0033453,0.13797,0.61132,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1
GOBP_COMMA_SHAPED_BODY_MORPH...,SET,5,-0.13445,-0.0022185,0.47547,0.61132,GOBP_COMMA_SHAPED_BODY_MORPHOGENESIS,1
GSE22432_CDC_VS_COMMON_DC_PR...2,SET,175,-0.018425,-0.0017903,0.065123,0.61138,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP,1
WP_LUNG_PATHOLOGY_OF_COVID19,SET,15,-0.064002,-0.0018286,0.2262,0.61139,WP_LUNG_PATHOLOGY_OF_COVID19,1
REACTOME_NFE2L2_REGULATING_E...,SET,5,-0.10835,-0.0017878,0.38284,0.61142,REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES,1
GSE27786_LIN_NEG_VS_MONO_MAC...2,SET,181,-0.017045,-0.001684,0.060207,0.61145,GSE27786_LIN_NEG_VS_MONO_MAC_UP,1
HP_ABNORMAL_CIRCULATING_ANDR...2,SET,11,-0.078115,-0.0019115,0.27567,0.61155,HP_ABNORMAL_CIRCULATING_ANDROSTENEDIONE_CONCENTRATION,1
MODULE_349,SET,17,-0.064646,-0.0019662,0.22793,0.61165,MODULE_349,1
MIR6515_3P,SET,199,-0.017155,-0.0017763,0.060467,0.61168,MIR6515_3P,1
BIOCARTA_PML_PATHWAY,SET,17,-0.054588,-0.0016603,0.19237,0.6117,BIOCARTA_PML_PATHWAY,1
KEGG_MEDICUS_REFERENCE_CHOND...,SET,7,-0.095434,-0.0018631,0.33612,0.61177,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...269,SET,10,-0.074225,-0.0017318,0.26127,0.61183,GOBP_NEGATIVE_REGULATION_OF_HEART_RATE,1
ASTON_MAJOR_DEPRESSIVE_DISOR...2,SET,42,-0.039583,-0.001891,0.1393,0.61185,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,1
GOBP_GOLGI_LOCALIZATION,SET,12,-0.064737,-0.0016545,0.22783,0.61185,GOBP_GOLGI_LOCALIZATION,1
GOBP_POSITIVE_REGULATION_OF_...574,SET,106,-0.024536,-0.001859,0.086311,0.6119,GOBP_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION,1
GGCNRNWCTTYS_UNKNOWN,SET,77,-0.027763,-0.0017942,0.097489,0.61209,GGCNRNWCTTYS_UNKNOWN,1
LU_TUMOR_ENDOTHELIAL_MARKERS...1,SET,4,-0.092444,-0.0013644,0.3246,0.6121,LU_TUMOR_ENDOTHELIAL_MARKERS_DN,1
GSE2585_AIRE_KO_VS_WT_CD80_L...1,SET,192,-0.017423,-0.0017723,0.061107,0.61222,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN,1
GOCC_AZUROPHIL_GRANULE_LUMEN,SET,81,-0.027272,-0.0018075,0.095582,0.6123,GOCC_AZUROPHIL_GRANULE_LUMEN,1
GSE22935_WT_VS_MYD88_KO_MACR...2,SET,188,-0.017631,-0.001775,0.061779,0.61233,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP,1
GSE16522_ANTI_CD3CD28_STIM_V...4,SET,173,-0.018231,-0.0017614,0.063872,0.61234,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP,1
GSE3920_IFNA_VS_IFNG_TREATED...1,SET,153,-0.019925,-0.0018113,0.069752,0.61243,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,1
GOBP_GUANINE_METABOLIC_PROCE...,SET,4,-0.11909,-0.0017577,0.4167,0.61248,GOBP_GUANINE_METABOLIC_PROCESS,1
HALLMARK_OXIDATIVE_PHOSPHORY...,SET,169,-0.017753,-0.0016954,0.062088,0.61253,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1
MIR648,SET,47,-0.036531,-0.0018459,0.12773,0.61256,MIR648,1
GOBP_POSITIVE_REGULATION_OF_...76,SET,23,-0.04914,-0.0017382,0.17176,0.6126,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT,1
ELVIDGE_HIF1A_AND_HIF2A_TARG...2,SET,37,-0.038726,-0.0017367,0.13534,0.61261,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,1
HP_PATCHY_ALOPECIA,SET,19,-0.06285,-0.0020208,0.21955,0.61266,HP_PATCHY_ALOPECIA,1
MIR5687,SET,16,-0.058657,-0.0017308,0.20461,0.61282,MIR5687,1
GOBP_REGULATION_OF_EPITHELIA...2,SET,144,-0.022498,-0.0019847,0.078448,0.61286,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
WP_ENVELOPE_PROTEINS_AND_THE...,SET,43,-0.038033,-0.0018384,0.13254,0.61293,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,1
MIR548AT_5P,SET,313,-0.014128,-0.0018289,0.049234,0.61293,MIR548AT_5P,1
HP_ANAL_ATRESIA,SET,111,-0.023148,-0.0017944,0.080662,0.61293,HP_ANAL_ATRESIA,1
GOBP_CALCIUM_MEDIATED_SIGNAL...,SET,214,-0.017745,-0.0019046,0.061821,0.61296,GOBP_CALCIUM_MEDIATED_SIGNALING,1
MIR4672,SET,335,-0.013843,-0.0018528,0.048192,0.61304,MIR4672,1
HP_INTERCOSTAL_MUSCLE_WEAKNE...,SET,9,-0.089335,-0.0019774,0.311,0.61304,HP_INTERCOSTAL_MUSCLE_WEAKNESS,1
NABA_MATRISOME_HIGHLY_METAST...3,SET,18,-0.061168,-0.0019143,0.21292,0.61305,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA,1
GOBP_MACROPHAGE_COLONY_STIMU...1,SET,6,-0.10342,-0.0018692,0.35995,0.61306,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
REICHERT_G1S_REGULATORS_AS_P...,SET,8,-0.074717,-0.0015593,0.26001,0.61308,REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS,1
GCM_FANCC,SET,111,-0.02251,-0.001745,0.078322,0.6131,GCM_FANCC,1
HP_SCAPULOPERONEAL_AMYOTROPHY,SET,5,-0.10807,-0.0017831,0.37597,0.61311,HP_SCAPULOPERONEAL_AMYOTROPHY,1
MIR4711_5P,SET,94,-0.024016,-0.001714,0.083537,0.61313,MIR4711_5P,1
HP_AXIAL_HYPOTONIA,SET,288,-0.014285,-0.001775,0.049664,0.61318,HP_AXIAL_HYPOTONIA,1
REACTOME_RMTS_METHYLATE_HIST...,SET,29,-0.046665,-0.0018531,0.16224,0.61319,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,1
CHEMNITZ_RESPONSE_TO_PROSTAG...2,SET,126,-0.020598,-0.0017005,0.071599,0.6132,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,1
MODULE_533,SET,41,-0.040343,-0.0019043,0.14023,0.61321,MODULE_533,1
MIR483_5P,SET,7,-0.10081,-0.0019681,0.35039,0.61322,MIR483_5P,1
HE_LIM_SUN_FETAL_LUNG_C2_MEG...,SET,615,-0.010326,-0.0018579,0.035885,0.61323,HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE,1
VALK_AML_CLUSTER_6,SET,32,-0.044446,-0.0018539,0.15444,0.61325,VALK_AML_CLUSTER_6,1
HP_THROMBOCYTOSIS,SET,55,-0.032204,-0.0017599,0.11187,0.61327,HP_THROMBOCYTOSIS,1
MIR5680,SET,425,-0.01239,-0.0018631,0.043028,0.6133,MIR5680,1
GOBP_REGULATION_OF_LONG_TERM...1,SET,23,-0.049931,-0.0017662,0.17339,0.61331,GOBP_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
HARALAMBIEVA_PBMC_FLUARIX_AG...5,SET,11,-0.073124,-0.0017893,0.25387,0.61334,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_NEGATIVE,1
HP_FOCAL_MYOCLONIC_SEIZURE,SET,18,-0.059269,-0.0018549,0.20574,0.61336,HP_FOCAL_MYOCLONIC_SEIZURE,1
HP_NASAL_CONGESTION,SET,47,-0.034768,-0.0017569,0.12066,0.61338,HP_NASAL_CONGESTION,1
GOBP_RELAXATION_OF_VASCULAR_...,SET,4,-0.12816,-0.0018915,0.44477,0.61339,GOBP_RELAXATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE,1
GSE41867_NAIVE_VS_DAY15_LCMV...1,SET,178,-0.018054,-0.001769,0.062636,0.61342,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
DESCARTES_MAIN_FETAL_INHIBIT...2,SET,4,-0.14885,-0.0021968,0.51635,0.61343,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,1
MIR3685,SET,166,-0.018863,-0.0017855,0.065429,0.61344,MIR3685,1
HP_ABNORMAL_ELECTRORETINOGRAM,SET,188,-0.018368,-0.0018492,0.06369,0.61348,HP_ABNORMAL_ELECTRORETINOGRAM,1
GOBP_CARDIAC_SEPTUM_DEVELOPM...,SET,104,-0.025783,-0.001935,0.089375,0.61351,GOBP_CARDIAC_SEPTUM_DEVELOPMENT,1
HP_POSTURAL_TREMOR,SET,53,-0.034074,-0.0018281,0.1181,0.61352,HP_POSTURAL_TREMOR,1
NABA_MATRISOME_POORLY_METAST...1,SET,25,-0.047387,-0.0017474,0.16423,0.61353,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER,1
GOBP_REGULATION_OF_SMOOTH_MU...2,SET,34,-0.041166,-0.0017699,0.14268,0.61353,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
MIR12129,SET,131,-0.022562,-0.001899,0.078157,0.61358,MIR12129,1
ONKEN_UVEAL_MELANOMA_UP,SET,718,-0.0095379,-0.0018489,0.033034,0.6136,ONKEN_UVEAL_MELANOMA_UP,1
GOBP_NEGATIVE_REGULATION_OF_...468,SET,35,-0.044169,-0.0019267,0.15297,0.61361,GOBP_NEGATIVE_REGULATION_OF_OSSIFICATION,1
HP_MICROPHTHALMIA,SET,239,-0.015912,-0.0018036,0.055067,0.61369,HP_MICROPHTHALMIA,1
HP_RECTOVAGINAL_FISTULA,SET,20,-0.056101,-0.0018506,0.19407,0.61374,HP_RECTOVAGINAL_FISTULA,1
HP_DELAYED_BRAINSTEM_AUDITOR...,SET,3,-0.15421,-0.0019711,0.53308,0.61382,HP_DELAYED_BRAINSTEM_AUDITORY_EVOKED_RESPONSE_CONDUCTION_TIME,1
REACTOME_METABOLISM_OF_NITRI...,SET,14,-0.066731,-0.001842,0.23062,0.61384,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,1
GOBP_PROTEIN_HOMOTETRAMERIZA...,SET,60,-0.032092,-0.0018316,0.11091,0.61385,GOBP_PROTEIN_HOMOTETRAMERIZATION,1
MYOGNF1_01,SET,41,-0.039703,-0.0018741,0.13719,0.61386,MYOGNF1_01,1
GOBP_THELARCHE,SET,4,-0.1377,-0.0020323,0.47572,0.61388,GOBP_THELARCHE,1
HP_HORIZONTAL_RIBS,SET,15,-0.060863,-0.0017389,0.21012,0.61396,HP_HORIZONTAL_RIBS,1
KORKOLA_CHORIOCARCINOMA,SET,5,-0.12227,-0.0020175,0.42202,0.61398,KORKOLA_CHORIOCARCINOMA,1
GOBP_REGULATION_OF_LEUKOCYTE...1,SET,4,-0.13752,-0.0020297,0.47433,0.61406,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,1
DURANTE_ADULT_OLFACTORY_NEUR...15,SET,17,-0.068411,-0.0020807,0.23587,0.61411,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS,1
REACTOME_SARS_COV_1_HOST_INT...,SET,85,-0.026429,-0.0017941,0.091107,0.61412,REACTOME_SARS_COV_1_HOST_INTERACTIONS,1
MIR4299,SET,67,-0.029788,-0.0017962,0.10268,0.61413,MIR4299,1
GSE26351_UNSTIM_VS_WNT_PATHW...2,SET,178,-0.01761,-0.0017255,0.060702,0.61413,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,1
MIR6769B_3P,SET,76,-0.028274,-0.0018153,0.09745,0.61414,MIR6769B_3P,1
EVI1_04,SET,198,-0.019234,-0.0019866,0.066284,0.61416,EVI1_04,1
HP_ABNORMAL_THIRD_VENTRICLE_...,SET,14,-0.064982,-0.0017937,0.22382,0.61422,HP_ABNORMAL_THIRD_VENTRICLE_MORPHOLOGY,1
GSE360_L_MAJOR_VS_M_TUBERCUL...1,SET,168,-0.019488,-0.0018557,0.067125,0.61422,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN,1
GOCC_SIGNAL_RECOGNITION_PART...,SET,6,-0.078845,-0.0014251,0.27152,0.61424,GOCC_SIGNAL_RECOGNITION_PARTICLE,1
GOBP_REGULATION_OF_RESPIRATO...3,SET,22,-0.05517,-0.0019086,0.18992,0.61428,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE,1
GOBP_GRANULOCYTE_DIFFERENTIA...,SET,38,-0.041082,-0.0018671,0.1414,0.6143,GOBP_GRANULOCYTE_DIFFERENTIATION,1
GOBP_FACULTATIVE_HETEROCHROM...,SET,37,-0.039951,-0.0017916,0.13749,0.61431,GOBP_FACULTATIVE_HETEROCHROMATIN_FORMATION,1
MIR6871_5P,SET,51,-0.038732,-0.0020385,0.13325,0.61435,MIR6871_5P,1
GSE17721_LPS_VS_CPG_12H_BMDC...2,SET,177,-0.018825,-0.0018394,0.064719,0.61442,GSE17721_LPS_VS_CPG_12H_BMDC_UP,1
GOCC_PRC1_COMPLEX,SET,16,-0.060901,-0.0017971,0.20936,0.61443,GOCC_PRC1_COMPLEX,1
GSE22886_IGG_IGA_MEMORY_BCEL...2,SET,180,-0.019255,-0.0018972,0.066179,0.61445,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
GOBP_REGULATION_OF_CALCIUM_I...8,SET,223,-0.017507,-0.0019176,0.06014,0.61451,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT,1
DESCARTES_FETAL_LIVER_MESOTH...,SET,266,-0.016577,-0.0019808,0.056944,0.61451,DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS,1
HP_SHORT_NAIL,SET,13,-0.067502,-0.0017955,0.23177,0.61456,HP_SHORT_NAIL,1
GOMF_CASPASE_BINDING,SET,12,-0.065445,-0.0016726,0.22471,0.61457,GOMF_CASPASE_BINDING,1
GOMF_HEXOSE_TRANSMEMBRANE_TR...,SET,21,-0.05931,-0.0020047,0.20359,0.6146,GOMF_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GAUTAM_EYE_IRIS_CILIARY_BODY...11,SET,111,-0.025089,-0.0019449,0.086117,0.6146,GAUTAM_EYE_IRIS_CILIARY_BODY_MONOCYTES,1
BIOCARTA_RHODOPSIN_PATHWAY,SET,8,-0.083644,-0.0017456,0.28703,0.61463,BIOCARTA_RHODOPSIN_PATHWAY,1
KEGG_OXIDATIVE_PHOSPHORYLATI...,SET,96,-0.023309,-0.0016811,0.079954,0.61467,KEGG_OXIDATIVE_PHOSPHORYLATION,1
GSE8921_UNSTIM_VS_TLR1_2_STI...3,SET,187,-0.018377,-0.0018451,0.063018,0.6147,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN,1
GCM_RING1,SET,98,-0.024034,-0.0017513,0.082387,0.61475,GCM_RING1,1
GOCC_ENDOCYTIC_VESICLE_LUMEN,SET,20,-0.056522,-0.0018645,0.19369,0.61478,GOCC_ENDOCYTIC_VESICLE_LUMEN,1
GOCC_INTERCELLULAR_CANALICUL...,SET,6,-0.11476,-0.0020742,0.39317,0.61481,GOCC_INTERCELLULAR_CANALICULUS,1
GOBP_RNA_CAPPING,SET,13,-0.05864,-0.0015598,0.20082,0.61486,GOBP_RNA_CAPPING,1
GSE13887_HEALTHY_VS_LUPUS_RE...2,SET,104,-0.024843,-0.0018644,0.085,0.61496,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP,1
GGAMTNNNNNTCCY_UNKNOWN,SET,107,-0.022586,-0.0017192,0.077272,0.61497,GGAMTNNNNNTCCY_UNKNOWN,1
GOMF_ARP2_3_COMPLEX_BINDING,SET,13,-0.066756,-0.0017757,0.22837,0.61497,GOMF_ARP2_3_COMPLEX_BINDING,1
HP_HYPOPLASIA_OF_THE_PHALANG...,SET,6,-0.095123,-0.0017193,0.32542,0.61497,HP_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,1
REACTOME_PKA_MEDIATED_PHOSPH...2,SET,4,-0.1286,-0.001898,0.43962,0.61506,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,1
MIR181B_2_3P_MIR181B_3P,SET,188,-0.018322,-0.0018445,0.062631,0.61506,MIR181B_2_3P_MIR181B_3P,1
GOBP_CELL_KILLING,SET,204,-0.019402,-0.0020337,0.066311,0.61508,GOBP_CELL_KILLING,1
GOBP_NEGATIVE_REGULATION_OF_...181,SET,14,-0.07171,-0.0019794,0.24489,0.61517,GOBP_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
COLDREN_GEFITINIB_RESISTANCE...2,SET,72,-0.02872,-0.001795,0.098068,0.61518,COLDREN_GEFITINIB_RESISTANCE_UP,1
HP_HYPOMIMIC_FACE,SET,35,-0.041757,-0.0018215,0.14253,0.61523,HP_HYPOMIMIC_FACE,1
GOMF_DEAMINASE_ACTIVITY,SET,29,-0.052463,-0.0020834,0.17903,0.61525,GOMF_DEAMINASE_ACTIVITY,1
HP_DECREASED_PATELLAR_REFLEX,SET,9,-0.086701,-0.0019191,0.29574,0.6153,HP_DECREASED_PATELLAR_REFLEX,1
GOMF_CLATHRIN_HEAVY_CHAIN_BI...,SET,11,-0.079178,-0.0019375,0.26996,0.61535,GOMF_CLATHRIN_HEAVY_CHAIN_BINDING,1
ZHAN_MULTIPLE_MYELOMA_CD2_UP,SET,42,-0.041997,-0.0020064,0.14311,0.61542,ZHAN_MULTIPLE_MYELOMA_CD2_UP,1
GOBP_HARD_PALATE_DEVELOPMENT,SET,8,-0.10996,-0.0022948,0.37445,0.61549,GOBP_HARD_PALATE_DEVELOPMENT,1
HP_ABNORMAL_ANTERIOR_EYE_SEG...,SET,1152,-0.0076338,-0.0018512,0.025994,0.6155,HP_ABNORMAL_ANTERIOR_EYE_SEGMENT_MORPHOLOGY,1
GSE13762_CTRL_VS_125_VITAMIN...4,SET,122,-0.024633,-0.0020013,0.083868,0.61551,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP,1
GSE2770_UNTREATED_VS_ACT_CD4...4,SET,171,-0.018642,-0.0017907,0.06346,0.61552,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...58,SET,26,-0.050571,-0.0019017,0.17209,0.61556,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,1
HP_SPASTIC_DIPLEGIA,SET,29,-0.047089,-0.00187,0.16018,0.61561,HP_SPASTIC_DIPLEGIA,1
CHANG_IMMORTALIZED_BY_HPV31_...1,SET,58,-0.033369,-0.0018726,0.11347,0.61565,CHANG_IMMORTALIZED_BY_HPV31_DN,1
REACTOME_P75NTR_REGULATES_AX...,SET,9,-0.094438,-0.0020904,0.32113,0.61565,REACTOME_P75NTR_REGULATES_AXONOGENESIS,1
YY1_02,SET,228,-0.016387,-0.0018148,0.055725,0.61565,YY1_02,1
MOOTHA_HUMAN_MITODB_6_2002,SET,381,-0.012674,-0.0018067,0.043095,0.61566,MOOTHA_HUMAN_MITODB_6_2002,1
MIR4280,SET,43,-0.037423,-0.0018089,0.1272,0.6157,MIR4280,1
GSE14699_DELETIONAL_TOLERANC...1,SET,167,-0.019413,-0.001843,0.065971,0.61572,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,1
HP_ABNORMAL_LDL_CHOLESTEROL_...,SET,41,-0.040568,-0.0019149,0.13783,0.61575,HP_ABNORMAL_LDL_CHOLESTEROL_CONCENTRATION,1
WP_FOLLICLE_STIMULATING_HORM...,SET,26,-0.053684,-0.0020188,0.18237,0.61576,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,1
GOMF_NATURAL_KILLER_CELL_LEC...,SET,8,-0.1097,-0.0022894,0.37266,0.61576,GOMF_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING,1
DIERICK_SEROTONIN_FUNCTION_G...,SET,7,-0.088505,-0.0017278,0.30061,0.61578,DIERICK_SEROTONIN_FUNCTION_GENES,1
REACTOME_COLLAGEN_FORMATION,SET,88,-0.028931,-0.0019982,0.098266,0.61578,REACTOME_COLLAGEN_FORMATION,1
GOBP_NEPHRON_TUBULE_FORMATION,SET,18,-0.068676,-0.0021493,0.23318,0.61582,GOBP_NEPHRON_TUBULE_FORMATION,1
GOBP_NEGATIVE_CHEMOTAXIS,SET,46,-0.040438,-0.0020216,0.13727,0.61584,GOBP_NEGATIVE_CHEMOTAXIS,1
HP_ABNORMAL_UVEA_MORPHOLOGY,SET,522,-0.011399,-0.0018946,0.03865,0.61598,HP_ABNORMAL_UVEA_MORPHOLOGY,1
HASINA_NOL7_TARGETS_UP,SET,10,-0.084349,-0.001968,0.28593,0.616,HASINA_NOL7_TARGETS_UP,1
MODULE_255,SET,405,-0.012573,-0.0018467,0.042611,0.61603,MODULE_255,1
KEGG_MEDICUS_REFERENCE_CA2_P...1,SET,6,-0.10997,-0.0019877,0.3726,0.61606,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY,1
BIOCARTA_RAB_PATHWAY,SET,12,-0.069862,-0.0017855,0.23665,0.61608,BIOCARTA_RAB_PATHWAY,1
REACTOME_UBIQUINOL_BIOSYNTHE...,SET,10,-0.072562,-0.001693,0.24578,0.61609,REACTOME_UBIQUINOL_BIOSYNTHESIS,1
MIR5590_3P,SET,317,-0.014192,-0.0018487,0.048064,0.61611,MIR5590_3P,1
GOBP_RESPONSE_TO_HUMAN_CHORI...,SET,5,-0.1321,-0.0021797,0.44715,0.61616,GOBP_RESPONSE_TO_HUMAN_CHORIONIC_GONADOTROPIN,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...1,SET,4,-0.12153,-0.0017936,0.41136,0.61617,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
SP1_Q2_01,SET,235,-0.016989,-0.0019097,0.057498,0.61618,SP1_Q2_01,1
GSE5589_LPS_VS_LPS_AND_IL10_...4,SET,177,-0.018924,-0.0018491,0.064047,0.61618,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
HP_ABNORMAL_PLATELET_AGGREGA...,SET,39,-0.040509,-0.001865,0.13708,0.61619,HP_ABNORMAL_PLATELET_AGGREGATION,1
HP_ABNORMAL_GALLBLADDER_MORP...,SET,84,-0.028026,-0.0018914,0.094841,0.6162,HP_ABNORMAL_GALLBLADDER_MORPHOLOGY,1
HP_LOW_APGAR_SCORE,SET,9,-0.094221,-0.0020856,0.31876,0.61622,HP_LOW_APGAR_SCORE,1
HP_APLASIA_HYPOPLASIA_OF_THE...60,SET,20,-0.057211,-0.0018872,0.19349,0.61626,HP_APLASIA_HYPOPLASIA_OF_THE_PUBIC_BONE,1
GCM_PRKCG,SET,55,-0.031627,-0.0017284,0.10696,0.61627,GCM_PRKCG,1
GOBP_NEGATIVE_REGULATION_OF_...632,SET,23,-0.054161,-0.0019157,0.18314,0.61628,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
KEGG_MEDICUS_REFERENCE_TLR2_...,SET,25,-0.055605,-0.0020505,0.188,0.61629,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY,1
GOMF_TRANSFORMING_GROWTH_FAC...2,SET,13,-0.076081,-0.0020237,0.2572,0.61631,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY,1
HP_HYPOCHOLESTEROLEMIA,SET,17,-0.059697,-0.0018157,0.20177,0.61633,HP_HYPOCHOLESTEROLEMIA,1
MORF_NPM1,SET,147,-0.019861,-0.00177,0.067108,0.61637,MORF_NPM1,1
GOBP_NEGATIVE_REGULATION_OF_...231,SET,32,-0.043528,-0.0018156,0.14704,0.61639,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,1
GSE26495_NAIVE_VS_PD1HIGH_CD...1,SET,181,-0.019429,-0.0019196,0.065633,0.61639,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN,1
LI_ESTROGENE_MID_E2_RESPONSE...2,SET,14,-0.072584,-0.0020036,0.24518,0.6164,LI_ESTROGENE_MID_E2_RESPONSE_UP,1
VALK_AML_CLUSTER_12,SET,24,-0.049966,-0.0018054,0.16878,0.6164,VALK_AML_CLUSTER_12,1
MOOTHA_GLYCOGEN_METABOLISM,SET,18,-0.054798,-0.0017149,0.18508,0.61641,MOOTHA_GLYCOGEN_METABOLISM,1
HP_4_5_FINGER_SYNDACTYLY,SET,5,-0.12486,-0.0020602,0.42158,0.61645,HP_4_5_FINGER_SYNDACTYLY,1
REACTOME_DNA_DAMAGE_RECOGNIT...,SET,35,-0.042867,-0.0018698,0.14467,0.6165,REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,1
REACTOME_RAB_REGULATION_OF_T...,SET,111,-0.022557,-0.0017486,0.076124,0.6165,REACTOME_RAB_REGULATION_OF_TRAFFICKING,1
MIR10522_5P,SET,215,-0.017617,-0.0018952,0.059449,0.61651,MIR10522_5P,1
GOBP_NEGATIVE_REGULATION_OF_...264,SET,8,-0.089847,-0.0018751,0.30318,0.61652,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,1
LIU_TOPBP1_TARGETS,SET,12,-0.07631,-0.0019503,0.25739,0.61657,LIU_TOPBP1_TARGETS,1
MIR4420,SET,176,-0.01915,-0.0018659,0.064572,0.6166,MIR4420,1
HP_ABNORMAL_CARDIAC_TEST,SET,24,-0.054358,-0.001964,0.18328,0.6166,HP_ABNORMAL_CARDIAC_TEST,1
KUROZUMI_RESPONSE_TO_ONCOCYT...1,SET,41,-0.043069,-0.002033,0.1452,0.61662,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1
REACTOME_CREB3_FACTORS_ACTIV...,SET,8,-0.079646,-0.0016622,0.26848,0.61663,REACTOME_CREB3_FACTORS_ACTIVATE_GENES,1
GSE16755_CTRL_VS_IFNA_TREATE...1,SET,174,-0.02007,-0.0019445,0.067643,0.61665,GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN,1
GOBP_CILIUM_MOVEMENT,SET,172,-0.018973,-0.0018278,0.063909,0.61672,GOBP_CILIUM_MOVEMENT,1
HP_INCREASED_CIRCULATING_ANT...,SET,93,-0.027062,-0.0019211,0.091149,0.61673,HP_INCREASED_CIRCULATING_ANTIBODY_LEVEL,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...6,SET,19,-0.058603,-0.0018842,0.19736,0.61674,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,1
MIR6893_3P,SET,86,-0.027628,-0.0018865,0.093039,0.61675,MIR6893_3P,1
GSE17974_1.5H_VS_72H_IL4_AND...2,SET,172,-0.019626,-0.0018907,0.066087,0.61675,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,1
POS_RESPONSE_TO_HISTAMINE_UP,SET,11,-0.072205,-0.0017668,0.24313,0.61676,POS_RESPONSE_TO_HISTAMINE_UP,1
GOBP_DEFENSE_RESPONSE_TO_OTH...,SET,1091,-0.0082694,-0.001955,0.027845,0.61676,GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM,1
GSE26495_NAIVE_VS_PD1LOW_CD8...1,SET,185,-0.019335,-0.001931,0.065097,0.61677,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN,1
REACTOME_DISORDERS_OF_TRANSM...,SET,166,-0.019306,-0.0018275,0.06499,0.61679,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1
GSE40274_CTRL_VS_FOXP3_TRANS...1,SET,182,-0.019222,-0.0019043,0.064698,0.6168,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
WP_FLUOROPYRIMIDINE_ACTIVITY,SET,33,-0.042845,-0.0018148,0.14414,0.61686,WP_FLUOROPYRIMIDINE_ACTIVITY,1
GOBP_REGULATION_OF_ACTIN_NUC...,SET,27,-0.044812,-0.0017172,0.15076,0.61686,GOBP_REGULATION_OF_ACTIN_NUCLEATION,1
GSE9650_NAIVE_VS_EXHAUSTED_C...1,SET,176,-0.019797,-0.0019289,0.066599,0.61686,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN,1
ZNF23_TARGET_GENES,SET,13,-0.07059,-0.0018777,0.23743,0.61688,ZNF23_TARGET_GENES,1
ZBED5_TARGET_GENES,SET,1305,-0.0072714,-0.0018684,0.024447,0.61693,ZBED5_TARGET_GENES,1
LI_CYTIDINE_ANALOG_PATHWAY,SET,17,-0.064768,-0.0019699,0.21774,0.61694,LI_CYTIDINE_ANALOG_PATHWAY,1
MIR323A_5P,SET,39,-0.037388,-0.0017213,0.12567,0.61696,MIR323A_5P,1
REACTOME_ORGANIC_CATION_TRAN...,SET,10,-0.090842,-0.0021195,0.30524,0.617,REACTOME_ORGANIC_CATION_TRANSPORT,1
REACTOME_SIGNALING_BY_TGF_BE...1,SET,91,-0.026715,-0.0018761,0.089753,0.61701,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1
GOBP_REGULATION_OF_TRANSLATI...13,SET,20,-0.053745,-0.0017729,0.18051,0.61704,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,1
MIR4776_3P,SET,152,-0.022091,-0.0020017,0.074173,0.61708,MIR4776_3P,1
MIR4440,SET,5,-0.13932,-0.0022989,0.4676,0.61713,MIR4440,1
GOBP_CELLULAR_RESPONSE_TO_HY...2,SET,9,-0.096535,-0.0021368,0.32384,0.61718,GOBP_CELLULAR_RESPONSE_TO_HYDROPEROXIDE,1
GAUSSMANN_MLL_AF4_FUSION_TAR...12,SET,166,-0.020818,-0.0019706,0.069787,0.61727,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1
GAVISH_3CA_METAPROGRAM_EPITH...9,SET,49,-0.038829,-0.0020033,0.13015,0.61728,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4,1
HP_PROGRESSIVE_DISTAL_MUSCLE...,SET,14,-0.06765,-0.0018674,0.22668,0.61731,HP_PROGRESSIVE_DISTAL_MUSCLE_WEAKNESS,1
GOMF_COMPLEMENT_BINDING,SET,20,-0.062016,-0.0020457,0.20772,0.61736,GOMF_COMPLEMENT_BINDING,1
GCM_PTPRD,SET,53,-0.03464,-0.0018585,0.11602,0.61737,GCM_PTPRD,1
GOMF_IMMUNOGLOBULIN_RECEPTOR...2,SET,9,-0.093736,-0.0020748,0.3139,0.61738,GOMF_IMMUNOGLOBULIN_RECEPTOR_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...156,SET,20,-0.056914,-0.0018774,0.19054,0.61741,GOBP_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
WANG_RECURRENT_LIVER_CANCER_...2,SET,16,-0.065062,-0.0019198,0.21781,0.61742,WANG_RECURRENT_LIVER_CANCER_UP,1
HP_INCREASED_INTRAMYOCELLULA...,SET,18,-0.060665,-0.0018986,0.20307,0.61743,HP_INCREASED_INTRAMYOCELLULAR_LIPID_DROPLETS,1
MIR501_3P_MIR502_3P,SET,65,-0.033311,-0.0019785,0.11145,0.61748,MIR501_3P_MIR502_3P,1
GSE40274_LEF1_VS_FOXP3_AND_L...1,SET,173,-0.019441,-0.0018782,0.065019,0.61753,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOCC_OXIDOREDUCTASE_COMPLEX,SET,102,-0.022888,-0.0017012,0.076542,0.61754,GOCC_OXIDOREDUCTASE_COMPLEX,1
MIR548AU_3P,SET,157,-0.02007,-0.001848,0.067097,0.61758,MIR548AU_3P,1
ER_Q6,SET,245,-0.016563,-0.0019005,0.055366,0.61758,ER_Q6,1
GOMF_MELANOCORTIN_RECEPTOR_B...,SET,5,-0.11323,-0.0018683,0.3785,0.61758,GOMF_MELANOCORTIN_RECEPTOR_BINDING,1
HP_HORNER_SYNDROME,SET,9,-0.099541,-0.0022033,0.33261,0.61763,HP_HORNER_SYNDROME,1
HP_ATLANTOAXIAL_INSTABILITY,SET,5,-0.10903,-0.001799,0.36406,0.61771,HP_ATLANTOAXIAL_INSTABILITY,1
HP_DYSKINESIA,SET,172,-0.019023,-0.0018326,0.063511,0.61773,HP_DYSKINESIA,1
GOMF_AMINE_TRANSMEMBRANE_TRA...,SET,6,-0.11821,-0.0021365,0.39462,0.61774,GOMF_AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
chr6q25,SET,67,-0.067339,-0.0040605,0.22478,0.61775,chr6q25,1
GOBP_POSITIVE_REGULATION_OF_...165,SET,99,-0.023868,-0.0017479,0.079672,0.61775,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
GSE1448_CTRL_VS_ANTI_VBETA5_...1,SET,185,-0.018716,-0.0018693,0.062452,0.61779,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN,1
HP_ENLARGED_INTERPHALANGEAL_...,SET,5,-0.11146,-0.0018392,0.37186,0.61781,HP_ENLARGED_INTERPHALANGEAL_JOINTS,1
GOBP_GLYCINE_TRANSPORT,SET,14,-0.074089,-0.0020451,0.24714,0.61783,GOBP_GLYCINE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...432,SET,10,-0.076406,-0.0017827,0.25486,0.61783,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
GOMF_LEUCINE_ZIPPER_DOMAIN_B...,SET,10,-0.086691,-0.0020226,0.28917,0.61783,GOMF_LEUCINE_ZIPPER_DOMAIN_BINDING,1
GOMF_LIGASE_ACTIVITY_FORMING...1,SET,7,-0.097156,-0.0018967,0.32399,0.61786,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS,1
GOBP_VENTRICULAR_CARDIAC_MUS...4,SET,27,-0.05181,-0.0019854,0.17275,0.61787,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,1
GOBP_EPITHELIAL_CELL_PROLIFE...2,SET,10,-0.098412,-0.0022961,0.32812,0.61788,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
WP_17P133_YWHAE_COPY_NUMBER_...,SET,21,-0.056195,-0.0018994,0.18735,0.61789,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,1
BIOCARTA_CREB_PATHWAY,SET,22,-0.057766,-0.0019984,0.19251,0.61794,BIOCARTA_CREB_PATHWAY,1
GOBP_SPERMATID_NUCLEUS_DIFFE...,SET,22,-0.054491,-0.0018851,0.1816,0.61794,GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION,1
GOBP_FEMALE_MEIOTIC_NUCLEAR_...,SET,32,-0.046516,-0.0019403,0.15484,0.61806,GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION,1
BIOCARTA_ACTINY_PATHWAY,SET,11,-0.064875,-0.0015875,0.21578,0.61816,BIOCARTA_ACTINY_PATHWAY,1
GSE17974_CTRL_VS_ACT_IL4_AND...7,SET,176,-0.01805,-0.0017587,0.060029,0.61817,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN,1
GOBP_REGULATION_OF_EXECUTION...,SET,22,-0.059081,-0.0020439,0.19645,0.61819,GOBP_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,1
GOBP_REGULATION_OF_DEFENSE_R...1,SET,727,-0.0099623,-0.0019428,0.033119,0.61821,GOBP_REGULATION_OF_DEFENSE_RESPONSE,1
JOHNSTONE_PARVB_TARGETS_3_UP,SET,384,-0.013667,-0.0019557,0.045418,0.61826,JOHNSTONE_PARVB_TARGETS_3_UP,1
GSE22935_WT_VS_MYD88_KO_MACR...5,SET,175,-0.019584,-0.0019028,0.065081,0.61826,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN,1
chr15q26,SET,67,-0.062531,-0.0037705,0.20777,0.61828,chr15q26,1
GOBP_NEGATIVE_REGULATION_OF_...525,SET,29,-0.044724,-0.0017761,0.1486,0.61828,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
BOYLAN_MULTIPLE_MYELOMA_C_D_...1,SET,247,-0.017431,-0.0020081,0.057873,0.61836,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1
GOBP_POSITIVE_REGULATION_OF_...413,SET,23,-0.058073,-0.0020541,0.19279,0.61837,GOBP_POSITIVE_REGULATION_OF_LIPID_STORAGE,1
GSE28737_FOLLICULAR_VS_MARGI...3,SET,179,-0.019882,-0.0019535,0.065935,0.61849,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...178,SET,7,-0.10551,-0.0020599,0.34984,0.61852,GOBP_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,1
GOCC_TETRASPANIN_ENRICHED_MI...,SET,10,-0.085427,-0.0019932,0.28319,0.61854,GOCC_TETRASPANIN_ENRICHED_MICRODOMAIN,1
MODULE_170,SET,89,-0.028724,-0.001995,0.095198,0.61857,MODULE_170,1
HP_HIP_PAIN,SET,11,-0.072825,-0.001782,0.24129,0.6186,HP_HIP_PAIN,1
MIR4491,SET,67,-0.031174,-0.0018798,0.10326,0.61863,MIR4491,1
HP_DEFICIENT_EXCISION_OF_UV_...,SET,5,-0.093865,-0.0015488,0.31093,0.61863,HP_DEFICIENT_EXCISION_OF_UV_INDUCED_PYRIMIDINE_DIMERS_IN_DNA,1
WP_METABOLIC_EPILEPTIC_DISOR...,SET,80,-0.028476,-0.0018756,0.094314,0.61864,WP_METABOLIC_EPILEPTIC_DISORDERS,1
HP_ECZEMATOID_DERMATITIS,SET,145,-0.021663,-0.0019175,0.071747,0.61865,HP_ECZEMATOID_DERMATITIS,1
GSE8685_IL2_STARVED_VS_IL21_...1,SET,186,-0.018348,-0.0018373,0.060724,0.61873,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
HP_ABNORMAL_FIFTH_TOE_MORPHO...,SET,83,-0.027849,-0.0018682,0.09215,0.61875,HP_ABNORMAL_FIFTH_TOE_MORPHOLOGY,1
GSE17721_LPS_VS_POLYIC_16H_B...2,SET,176,-0.018498,-0.0018024,0.061183,0.6188,GSE17721_LPS_VS_POLYIC_16H_BMDC_UP,1
HP_ABNORMAL_LEUKOCYTE_ENZYME...,SET,6,-0.10727,-0.0019389,0.35474,0.61883,HP_ABNORMAL_LEUKOCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
WP_NEUROINFLAMMATION_AND_GLU...,SET,135,-0.023944,-0.0020456,0.07916,0.61885,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1
GSE1460_CD4_THYMOCYTE_VS_THY...2,SET,177,-0.018932,-0.0018499,0.062593,0.61885,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...8,SET,17,-0.07102,-0.0021601,0.23478,0.61886,SHIN_B_CELL_LYMPHOMA_CLUSTER_9,1
GSE20366_CD103_POS_VS_CD103_...1,SET,178,-0.019354,-0.0018964,0.063977,0.61887,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN,1
KEGG_MEDICUS_REFERENCE_PROMO...,SET,21,-0.061277,-0.0020712,0.20252,0.61889,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH,1
MIR539_3P,SET,207,-0.019184,-0.0020255,0.063372,0.61894,MIR539_3P,1
GOBP_STEROL_METABOLIC_PROCESS,SET,138,-0.022308,-0.0019268,0.073698,0.61894,GOBP_STEROL_METABOLIC_PROCESS,1
GSE17721_PAM3CSK4_VS_CPG_24H...2,SET,176,-0.018686,-0.0018207,0.061675,0.61904,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP,1
HP_ABNORMALITY_OF_THE_CRUS_O...,SET,10,-0.083208,-0.0019414,0.2744,0.61914,HP_ABNORMALITY_OF_THE_CRUS_OF_THE_HELIX,1
HP_LAMBDOIDAL_CRANIOSYNOSTOS...,SET,15,-0.059569,-0.001702,0.19637,0.61919,HP_LAMBDOIDAL_CRANIOSYNOSTOSIS,1
GSE5503_LIVER_DC_VS_SPLEEN_D...2,SET,182,-0.019619,-0.0019436,0.064657,0.61921,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOBP_FOAM_CELL_DIFFERENTIATI...,SET,37,-0.04586,-0.0020566,0.15111,0.61924,GOBP_FOAM_CELL_DIFFERENTIATION,1
GSE7568_CTRL_VS_3H_TGFB_TREA...1,SET,150,-0.021008,-0.0018911,0.069219,0.61924,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,1
GOBP_POSITIVE_REGULATION_OF_...331,SET,8,-0.084043,-0.001754,0.27688,0.61926,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
HP_SLENDER_BUILD,SET,23,-0.049552,-0.0017527,0.16324,0.61926,HP_SLENDER_BUILD,1
GOBP_CELLULAR_PIGMENTATION,SET,59,-0.034738,-0.0019661,0.11437,0.61933,GOBP_CELLULAR_PIGMENTATION,1
HP_HYPOPLASIA_OF_THE_VENTRAL...,SET,6,-0.11461,-0.0020715,0.37724,0.61936,HP_HYPOPLASIA_OF_THE_VENTRAL_PONS,1
GOMF_DISACCHARIDE_BINDING,SET,5,-0.10706,-0.0017666,0.35219,0.61943,GOMF_DISACCHARIDE_BINDING,1
YAGI_AML_WITH_INV_16_TRANSLO...,SET,371,-0.013527,-0.0019033,0.044474,0.61949,YAGI_AML_WITH_INV_16_TRANSLOCATION,1
HP_NEPHROTIC_SYNDROME,SET,118,-0.023659,-0.0018906,0.077765,0.61953,HP_NEPHROTIC_SYNDROME,1
MIR6076,SET,49,-0.038967,-0.0020104,0.12806,0.61954,MIR6076,1
REACTOME_IRAK1_RECRUITS_IKK_...,SET,11,-0.081705,-0.0019993,0.26841,0.61959,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,1
GOBP_NUCLEOSIDE_PHOSPHATE_CA...,SET,165,-0.020109,-0.0018978,0.066043,0.61962,GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS,1
GOMF_KERATIN_FILAMENT_BINDING,SET,6,-0.099869,-0.0018051,0.32796,0.61963,GOMF_KERATIN_FILAMENT_BINDING,1
GSE16385_MONOCYTE_VS_12H_ROS...1,SET,175,-0.019707,-0.0019148,0.064717,0.61963,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,1
GSE7460_TCONV_VS_TREG_THYMUS...1,SET,184,-0.020106,-0.0020027,0.066011,0.61966,GSE7460_TCONV_VS_TREG_THYMUS_DN,1
HP_HYPERSOMNIA,SET,15,-0.068992,-0.0019712,0.22648,0.61967,HP_HYPERSOMNIA,1
MULLIGHAN_MLL_SIGNATURE_2_DN,SET,255,-0.016933,-0.0019817,0.055576,0.61969,MULLIGHAN_MLL_SIGNATURE_2_DN,1
GOBP_SEROTONIN_UPTAKE,SET,12,-0.082543,-0.0021096,0.27089,0.6197,GOBP_SEROTONIN_UPTAKE,1
STAMBOLSKY_RESPONSE_TO_VITAM...1,SET,22,-0.05611,-0.0019411,0.18411,0.61973,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,1
KEGG_MEDICUS_VARIANT_AMPLIFI...13,SET,15,-0.060281,-0.0017223,0.19771,0.61978,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S,1
GOBP_NEGATIVE_REGULATION_OF_...233,SET,7,-0.096085,-0.0018758,0.31512,0.61978,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,1
HP_WEAKNESS_OF_FACIAL_MUSCUL...,SET,210,-0.017906,-0.001904,0.058714,0.6198,HP_WEAKNESS_OF_FACIAL_MUSCULATURE,1
MIR5092,SET,6,-0.096171,-0.0017382,0.31526,0.61983,MIR5092,1
MORF_PRKCA,SET,154,-0.021608,-0.0019706,0.07081,0.61987,MORF_PRKCA,1
chr20p11,SET,52,-0.066933,-0.0035571,0.21933,0.61988,chr20p11,1
GSE40274_FOXP3_VS_FOXP3_AND_...8,SET,176,-0.020162,-0.0019645,0.066068,0.61988,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
WP_WNT_SIGNALING_AND_PLURIPO...,SET,95,-0.028407,-0.0020381,0.093079,0.61989,WP_WNT_SIGNALING_AND_PLURIPOTENCY,1
S8_01,SET,230,-0.018493,-0.0020568,0.060521,0.62003,S8_01,1
GOBP_ADHERENS_JUNCTION_MAINT...,SET,6,-0.11791,-0.0021313,0.38586,0.62004,GOBP_ADHERENS_JUNCTION_MAINTENANCE,1
GSE6269_HEALTHY_VS_E_COLI_IN...2,SET,157,-0.019937,-0.0018357,0.06523,0.62006,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP,1
GOBP_REGULATION_OF_MITOCHOND...14,SET,6,-0.094804,-0.0017135,0.31,0.62013,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSCRIPTION,1
GOBP_VACUOLE_FUSION,SET,12,-0.073185,-0.0018704,0.23926,0.62015,GOBP_VACUOLE_FUSION,1
GOBP_RESPONSE_TO_DIETARY_EXC...,SET,32,-0.04876,-0.0020339,0.1593,0.62023,GOBP_RESPONSE_TO_DIETARY_EXCESS,1
ZEILSTRA_CD44_TARGETS_UP,SET,8,-0.10053,-0.002098,0.32833,0.62026,ZEILSTRA_CD44_TARGETS_UP,1
REPIN1_TARGET_GENES,SET,5,-0.13051,-0.0021535,0.42627,0.62026,REPIN1_TARGET_GENES,1
LEE_AGING_NEOCORTEX_DN,SET,62,-0.03302,-0.0019156,0.1078,0.62031,LEE_AGING_NEOCORTEX_DN,1
HP_PIERRE_ROBIN_SEQUENCE,SET,25,-0.05378,-0.0019832,0.17537,0.62045,HP_PIERRE_ROBIN_SEQUENCE,1
GOBP_POSITIVE_REGULATION_OF_...393,SET,15,-0.074553,-0.0021301,0.24308,0.62047,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
GOBP_CELLULAR_RESPONSE_TO_IR...,SET,7,-0.097963,-0.0019125,0.31937,0.62048,GOBP_CELLULAR_RESPONSE_TO_IRON_ION,1
HP_DENTAL_MALOCCLUSION,SET,127,-0.023978,-0.0019873,0.078121,0.62055,HP_DENTAL_MALOCCLUSION,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...6,SET,224,-0.017766,-0.0019503,0.057868,0.62058,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,1
GOBP_POSITIVE_REGULATION_OF_...725,SET,44,-0.040323,-0.0019716,0.13128,0.62064,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,1
REACTOME_REGULATION_OF_HOMOT...,SET,30,-0.050679,-0.0020469,0.16487,0.62072,REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
MCM2_TARGET_GENES,SET,75,-0.029229,-0.0018643,0.095014,0.62082,MCM2_TARGET_GENES,1
HP_BILIARY_TRACT_ABNORMALITY,SET,93,-0.027708,-0.001967,0.090019,0.62088,HP_BILIARY_TRACT_ABNORMALITY,1
CHIARADONNA_NEOPLASTIC_TRANS...4,SET,53,-0.036865,-0.0019778,0.1197,0.62095,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1
GOMF_G_PROTEIN_COUPLED_ACETY...,SET,7,-0.10204,-0.0019921,0.33135,0.62095,GOMF_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY,1
HP_ABNORMALITY_OF_TASTE_SENS...,SET,5,-0.12418,-0.002049,0.40317,0.62096,HP_ABNORMALITY_OF_TASTE_SENSATION,1
GOMF_ALDO_KETO_REDUCTASE_NAD...,SET,29,-0.053579,-0.0021277,0.1739,0.62099,GOMF_ALDO_KETO_REDUCTASE_NADPH_ACTIVITY,1
GOBP_POTASSIUM_ION_EXPORT_AC...,SET,18,-0.069759,-0.0021832,0.22631,0.62105,GOBP_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
YAUCH_HEDGEHOG_SIGNALING_PAR...1,SET,237,-0.017689,-0.0019967,0.057379,0.62106,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1
HP_THIN_CLAVICLES,SET,6,-0.11136,-0.0020128,0.36092,0.62117,HP_THIN_CLAVICLES,1
HP_POSTERIOR_HELIX_PIT,SET,4,-0.14517,-0.0021426,0.47031,0.62121,HP_POSTERIOR_HELIX_PIT,1
HP_INGUINAL_FRECKLING,SET,6,-0.093959,-0.0016983,0.30432,0.62124,HP_INGUINAL_FRECKLING,1
MIR4528,SET,203,-0.019517,-0.0020408,0.063201,0.62126,MIR4528,1
GOBP_POSITIVE_REGULATION_OF_...17,SET,24,-0.056099,-0.002027,0.18165,0.62127,GOBP_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,1
WP_GLIAL_CELL_DIFFERENTIATION,SET,5,-0.12112,-0.0019986,0.39219,0.62128,WP_GLIAL_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_POTASSIUM...2,SET,4,-0.14878,-0.0021957,0.48171,0.62128,GOBP_REGULATION_OF_POTASSIUM_ION_IMPORT,1
GOBP_MACROPHAGE_CHEMOTAXIS,SET,39,-0.04152,-0.0019116,0.13441,0.6213,GOBP_MACROPHAGE_CHEMOTAXIS,1
ZNF529_TARGET_GENES,SET,33,-0.04258,-0.0018036,0.13778,0.62135,ZNF529_TARGET_GENES,1
TOMLINS_METASTASIS_DN,SET,18,-0.061727,-0.0019318,0.19959,0.62144,TOMLINS_METASTASIS_DN,1
MIR6847_3P,SET,55,-0.034893,-0.0019069,0.11281,0.62145,MIR6847_3P,1
MIR660_3P,SET,91,-0.027725,-0.0019471,0.089624,0.62147,MIR660_3P,1
MIR10401_3P,SET,6,-0.10398,-0.0018794,0.33602,0.6215,MIR10401_3P,1
KEGG_MEDICUS_REFERENCE_TNF_P...,SET,24,-0.052514,-0.0018974,0.16969,0.62152,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY,1
GNF2_ANK1,SET,61,-0.034356,-0.001977,0.11101,0.62153,GNF2_ANK1,1
GNF2_SPTB,SET,61,-0.034356,-0.001977,0.11101,0.62153,GNF2_SPTB,1
GOBP_REGULATION_OF_OXIDATIVE...2,SET,37,-0.040378,-0.0018108,0.13045,0.62154,GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
PECE_MAMMARY_STEM_CELL_DN,SET,122,-0.023985,-0.0019486,0.077467,0.62157,PECE_MAMMARY_STEM_CELL_DN,1
WP_HYPOTHETICAL_CRANIOFACIAL...,SET,7,-0.10363,-0.0020231,0.33454,0.62163,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,1
FIRESTEIN_CTNNB1_PATHWAY,SET,26,-0.052242,-0.0019646,0.16861,0.62166,FIRESTEIN_CTNNB1_PATHWAY,1
GOCC_GARP_COMPLEX,SET,4,-0.11559,-0.001706,0.37279,0.62175,GOCC_GARP_COMPLEX,1
chr4q27,SET,14,-0.10825,-0.002988,0.34894,0.6218,chr4q27,1
REACTOME_LYSINE_CATABOLISM,SET,12,-0.074316,-0.0018993,0.23955,0.6218,REACTOME_LYSINE_CATABOLISM,1
GOBP_REGULATION_OF_NEUROINFL...,SET,33,-0.050624,-0.0021443,0.16318,0.62181,GOBP_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,1
ATM_DN.V1_DN,SET,124,-0.025184,-0.0020626,0.081147,0.62185,ATM_DN.V1_DN,1
REACTOME_MRNA_SPLICING_MINOR...,SET,48,-0.033814,-0.0017267,0.10892,0.62189,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,1
BARIS_THYROID_CANCER_DN,SET,52,-0.035151,-0.001868,0.11317,0.62195,BARIS_THYROID_CANCER_DN,1
ATF2_UP.V1_UP,SET,171,-0.020643,-0.0019829,0.06646,0.62195,ATF2_UP.V1_UP,1
REACTOME_HEDGEHOG_OFF_STATE,SET,108,-0.024161,-0.0018476,0.077766,0.62198,REACTOME_HEDGEHOG_OFF_STATE,1
HP_ABNORMAL_LACRIMAL_PUNCTUM...,SET,8,-0.095648,-0.0019961,0.30774,0.62202,HP_ABNORMAL_LACRIMAL_PUNCTUM_MORPHOLOGY,1
GOBP_DIPEPTIDE_TRANSMEMBRANE...,SET,8,-0.093612,-0.0019536,0.301,0.6221,GOBP_DIPEPTIDE_TRANSMEMBRANE_TRANSPORT,1
HP_DECREASED_CIRCULATING_BET...,SET,5,-0.12375,-0.0020419,0.39775,0.62215,HP_DECREASED_CIRCULATING_BETA_2_MICROGLOBULIN_LEVEL,1
MIR1304_3P,SET,100,-0.027151,-0.0019983,0.087252,0.62216,MIR1304_3P,1
GOBP_PEPTIDE_CROSS_LINKING,SET,26,-0.05304,-0.0019946,0.17045,0.62216,GOBP_PEPTIDE_CROSS_LINKING,1
GSE40277_GATA1_AND_SATB1_TRA...2,SET,181,-0.019387,-0.0019154,0.062277,0.62221,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,1
HP_ABNORMALITY_OF_THE_FIRST_...,SET,11,-0.08106,-0.0019835,0.26036,0.62222,HP_ABNORMALITY_OF_THE_FIRST_METATARSAL_BONE,1
GSE3982_EOSINOPHIL_VS_BCELL_...2,SET,182,-0.020879,-0.0020685,0.067063,0.62223,GSE3982_EOSINOPHIL_VS_BCELL_UP,1
DESCARTES_MAIN_FETAL_CORNEAL...,SET,218,-0.017992,-0.0019488,0.057786,0.62223,DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,1
GOMF_ACYLTRANSFERASE_ACTIVIT...2,SET,199,-0.018298,-0.0018947,0.058717,0.62234,GOMF_ACYLTRANSFERASE_ACTIVITY_TRANSFERRING_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS,1
ZHENG_IL22_SIGNALING_DN,SET,34,-0.046188,-0.0019858,0.1482,0.62235,ZHENG_IL22_SIGNALING_DN,1
GSE1460_DP_THYMOCYTE_VS_NAIV...2,SET,170,-0.019693,-0.0018862,0.063164,0.62239,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,1
GSE10325_CD4_TCELL_VS_LUPUS_...2,SET,182,-0.019193,-0.0019014,0.06155,0.62241,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP,1
MIR424_3P,SET,34,-0.043937,-0.001889,0.14088,0.62243,MIR424_3P,1
GOBP_SUCKLING_BEHAVIOR,SET,11,-0.081528,-0.001995,0.26129,0.62249,GOBP_SUCKLING_BEHAVIOR,1
GOBP_THYROID_GLAND_DEVELOPME...,SET,30,-0.05103,-0.0020611,0.16352,0.62251,GOBP_THYROID_GLAND_DEVELOPMENT,1
HP_FACIAL_SHAPE_DEFORMATION,SET,14,-0.078592,-0.0021694,0.25183,0.62251,HP_FACIAL_SHAPE_DEFORMATION,1
REACTOME_RUNX3_REGULATES_NOT...,SET,13,-0.06947,-0.0018479,0.22259,0.62252,REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING,1
GSE36888_UNTREATED_VS_IL2_TR...12,SET,167,-0.021676,-0.0020579,0.069424,0.62256,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP,1
GOMF_CADHERIN_BINDING,SET,302,-0.01517,-0.0019295,0.048575,0.62259,GOMF_CADHERIN_BINDING,1
GSE17721_ALL_VS_24H_PAM3CSK4...1,SET,174,-0.019553,-0.0018944,0.0626,0.62261,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN,1
GOBP_ESTABLISHMENT_OR_MAINTE...1,SET,51,-0.038527,-0.0020277,0.12334,0.62262,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY,1
GOBP_POSITIVE_REGULATION_OF_...622,SET,7,-0.090852,-0.0017736,0.29076,0.62265,GOBP_POSITIVE_REGULATION_OF_PROTEIN_GLYCOSYLATION,1
HP_CHOROIDEREMIA,SET,6,-0.12431,-0.0022469,0.3977,0.6227,HP_CHOROIDEREMIA,1
WP_FOLATE_METABOLISM,SET,66,-0.034429,-0.0020605,0.1101,0.62274,WP_FOLATE_METABOLISM,1
GSE16385_MONOCYTE_VS_12H_IL4...1,SET,187,-0.018067,-0.0018141,0.057777,0.62275,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN,1
GSE12001_MIR223_KO_VS_WT_NEU...1,SET,178,-0.019627,-0.0019231,0.062741,0.62279,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN,1
MIR6854_3P,SET,10,-0.096996,-0.0022631,0.30998,0.62282,MIR6854_3P,1
GOBP_OUTFLOW_TRACT_SEPTUM_MO...,SET,26,-0.060847,-0.0022881,0.1944,0.62286,GOBP_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS,1
HP_RENAL_MAGNESIUM_WASTING,SET,7,-0.10071,-0.0019662,0.32169,0.62289,HP_RENAL_MAGNESIUM_WASTING,1
MIR4742_3P,SET,201,-0.019164,-0.0019941,0.061196,0.62291,MIR4742_3P,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...3,SET,119,-0.023895,-0.0019175,0.076294,0.62293,GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
REACTOME_DISEASES_OF_PROGRAM...,SET,42,-0.041436,-0.0019796,0.13229,0.62294,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1
GSE27786_BCELL_VS_ERYTHROBLA...1,SET,178,-0.020087,-0.0019682,0.06413,0.62294,GSE27786_BCELL_VS_ERYTHROBLAST_DN,1
HP_DYSGENESIS_OF_THE_CEREBEL...,SET,7,-0.085136,-0.001662,0.2718,0.62295,HP_DYSGENESIS_OF_THE_CEREBELLAR_VERMIS,1
GSE28726_NAIVE_CD4_TCELL_VS_...4,SET,183,-0.019197,-0.001907,0.06127,0.62298,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP,1
CREL_01,SET,240,-0.017608,-0.0019999,0.056189,0.623,CREL_01,1
LOPES_METHYLATED_IN_COLON_CA...1,SET,28,-0.053911,-0.0021037,0.17193,0.62307,LOPES_METHYLATED_IN_COLON_CANCER_DN,1
GOBP_BINDING_OF_SPERM_TO_ZON...,SET,38,-0.041772,-0.0018984,0.13322,0.62307,GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,1
WP_PANCREATIC_ADENOCARCINOMA...,SET,83,-0.029354,-0.0019692,0.093578,0.62312,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,1
HP_REDUCED_NUMBER_OF_INTRAHE...,SET,5,-0.13402,-0.0022113,0.42721,0.62312,HP_REDUCED_NUMBER_OF_INTRAHEPATIC_BILE_DUCTS,1
REACTOME_REGULATION_OF_ENDOG...1,SET,80,-0.028749,-0.0018936,0.091615,0.62316,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS,1
GOBP_RESPONSE_TO_COPPER_ION,SET,31,-0.054649,-0.0022437,0.17414,0.62317,GOBP_RESPONSE_TO_COPPER_ION,1
GOBP_CARDIOLIPIN_BIOSYNTHETI...,SET,7,-0.10852,-0.0021185,0.34574,0.62319,GOBP_CARDIOLIPIN_BIOSYNTHETIC_PROCESS,1
GOBP_PEPTIDYL_TYROSINE_AUTOP...,SET,16,-0.068071,-0.0020086,0.21684,0.62321,GOBP_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION,1
OHGUCHI_LIVER_HNF4A_TARGETS_...1,SET,153,-0.022738,-0.002067,0.07237,0.62331,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1
PID_SYNDECAN_2_PATHWAY,SET,31,-0.04933,-0.0020253,0.15696,0.62334,PID_SYNDECAN_2_PATHWAY,1
MIR181D_5P,SET,554,-0.01188,-0.0020323,0.037789,0.62338,MIR181D_5P,1
GSE34156_NOD2_LIGAND_VS_TLR1...4,SET,186,-0.020084,-0.0020112,0.063873,0.6234,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,1
STAT4_01,SET,250,-0.017523,-0.0020308,0.055726,0.62341,STAT4_01,1
GOBP_POSITIVE_REGULATION_OF_...702,SET,6,-0.11133,-0.0020123,0.35397,0.62344,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GOMF_MONOCARBOXYLATE_SODIUM_...,SET,13,-0.07119,-0.0018937,0.22625,0.62349,GOMF_MONOCARBOXYLATE_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_EPIDERMAL_CELL_FATE_SPE...,SET,5,-0.13264,-0.0021886,0.42138,0.62353,GOBP_EPIDERMAL_CELL_FATE_SPECIFICATION,1
GSE23114_PERITONEAL_CAVITY_B...1,SET,183,-0.019139,-0.0019012,0.060786,0.62356,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN,1
HP_ABNORMAL_AORTIC_VALVE_CUS...,SET,101,-0.02812,-0.0020799,0.089295,0.62358,HP_ABNORMAL_AORTIC_VALVE_CUSP_MORPHOLOGY,1
GSE27241_WT_VS_RORGT_KO_TH17...1,SET,152,-0.020372,-0.0018459,0.064679,0.6236,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN,1
NAKAMURA_CANCER_MICROENVIRON...1,SET,40,-0.038676,-0.0018033,0.12279,0.62361,NAKAMURA_CANCER_MICROENVIRONMENT_DN,1
GSE17721_POLYIC_VS_CPG_0.5H_...2,SET,184,-0.019657,-0.001958,0.062409,0.62361,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP,1
MIR7160_3P,SET,27,-0.051449,-0.0019715,0.16324,0.62368,MIR7160_3P,1
BIOCARTA_NKCELLS_PATHWAY,SET,18,-0.064936,-0.0020322,0.20599,0.62371,BIOCARTA_NKCELLS_PATHWAY,1
MIR4741,SET,41,-0.040441,-0.0019089,0.12827,0.62373,MIR4741,1
WP_OMEGA3_OMEGA6_FATTY_ACID_...,SET,14,-0.079519,-0.002195,0.25218,0.62374,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...345,SET,10,-0.094601,-0.0022072,0.29995,0.62376,GOBP_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY,1
SIMBULAN_PARP1_TARGETS_UP,SET,27,-0.05719,-0.0021915,0.18131,0.62378,SIMBULAN_PARP1_TARGETS_UP,1
WEST_ADRENOCORTICAL_CARCINOM...2,SET,16,-0.069097,-0.0020389,0.21906,0.62378,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,1
GOBP_GRANULOCYTE_MACROPHAGE_...,SET,17,-0.068253,-0.0020759,0.21638,0.62378,GOBP_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
GSE36392_TYPE_2_MYELOID_VS_E...1,SET,176,-0.020556,-0.0020029,0.065081,0.62394,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN,1
GSE17721_PAM3CSK4_VS_GADIQUI...7,SET,178,-0.020127,-0.0019721,0.063719,0.62395,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN,1
KAAB_FAILED_HEART_VENTRICLE_...,SET,37,-0.044817,-0.0020099,0.14185,0.62398,KAAB_FAILED_HEART_VENTRICLE_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...8,SET,9,-0.092167,-0.0020401,0.29172,0.62398,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,1
GOBP_POSITIVE_REGULATION_OF_...170,SET,16,-0.071898,-0.0021216,0.22754,0.62399,GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM,1
REACTOME_REGULATION_OF_MITF_...2,SET,17,-0.061763,-0.0018785,0.19541,0.62402,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION,1
GOBP_AMINOGLYCAN_METABOLIC_P...,SET,116,-0.025791,-0.0020436,0.081514,0.62415,GOBP_AMINOGLYCAN_METABOLIC_PROCESS,1
GOCC_BBAF_COMPLEX,SET,10,-0.097103,-0.0022656,0.30674,0.62421,GOCC_BBAF_COMPLEX,1
HP_VOMITING,SET,301,-0.015462,-0.0019635,0.048841,0.62422,HP_VOMITING,1
HP_DEATH_IN_INFANCY,SET,221,-0.0178,-0.0019412,0.056222,0.62423,HP_DEATH_IN_INFANCY,1
GOBP_NUCLEAR_MIGRATION_ALONG...,SET,5,-0.11452,-0.0018896,0.36145,0.62431,GOBP_NUCLEAR_MIGRATION_ALONG_MICROTUBULE,1
GOBP_REGULATION_OF_CHROMOSOM...2,SET,225,-0.017489,-0.0019241,0.055158,0.6244,GOBP_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
HP_ABNORMALITY_OF_CHROMOSOME...1,SET,13,-0.08151,-0.0021682,0.25703,0.62442,HP_ABNORMALITY_OF_CHROMOSOME_SEGREGATION,1
DESCARTES_FETAL_ADRENAL_ERYT...,SET,84,-0.029889,-0.002017,0.094219,0.62446,DESCARTES_FETAL_ADRENAL_ERYTHROBLASTS,1
GOMF_ALCOHOL_DEHYDROGENASE_N...2,SET,23,-0.062874,-0.002224,0.19816,0.62449,GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,1
GOBP_ASTROCYTE_DEVELOPMENT,SET,40,-0.0451,-0.0021028,0.14202,0.62459,GOBP_ASTROCYTE_DEVELOPMENT,1
GOBP_GLYCOLIPID_TRANSPORT,SET,8,-0.092894,-0.0019387,0.29241,0.62463,GOBP_GLYCOLIPID_TRANSPORT,1
GOCC_G_PROTEIN_COUPLED_RECEP...2,SET,7,-0.11044,-0.0021561,0.34761,0.62465,GOCC_G_PROTEIN_COUPLED_RECEPTOR_DIMERIC_COMPLEX,1
TAKEDA_TARGETS_OF_NUP98_HOXA...4,SET,160,-0.023586,-0.0021922,0.074187,0.62473,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1
ZHAN_EARLY_DIFFERENTIATION_G...1,SET,41,-0.045329,-0.0021397,0.14254,0.62476,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1
GOCC_NUCLEAR_RNA_EXPORT_FACT...,SET,2,-0.14969,-0.0015623,0.47066,0.62478,GOCC_NUCLEAR_RNA_EXPORT_FACTOR_COMPLEX,1
GSE35825_UNTREATED_VS_IFNG_S...1,SET,167,-0.020388,-0.0019356,0.064095,0.62479,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN,1
HP_ABNORMAL_CIRCULATING_GLUT...1,SET,11,-0.0716,-0.001752,0.22506,0.62481,HP_ABNORMAL_CIRCULATING_GLUTAMINE_CONCENTRATION,1
FXR_IR1_Q6,SET,104,-0.027566,-0.0020688,0.086637,0.62482,FXR_IR1_Q6,1
HP_ADDUCTED_THUMB,SET,97,-0.028177,-0.0020427,0.08856,0.62482,HP_ADDUCTED_THUMB,1
MIKKELSEN_ES_LCP_WITH_H3K27M...,SET,12,-0.081514,-0.0020833,0.25603,0.6249,MIKKELSEN_ES_LCP_WITH_H3K27ME3,1
WP_GENETIC_CAUSES_OF_PORTOSI...,SET,30,-0.051289,-0.0020715,0.16109,0.6249,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,1
MIR6513_3P,SET,133,-0.023916,-0.0020281,0.075092,0.62494,MIR6513_3P,1
HP_TOOTH_ABSCESS,SET,6,-0.12585,-0.0022748,0.39513,0.62495,HP_TOOTH_ABSCESS,1
GSE31082_DP_VS_CD4_SP_THYMOC...2,SET,171,-0.020142,-0.0019348,0.06322,0.62499,GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP,1
GSE2405_HEAT_KILLED_VS_LIVE_...1,SET,173,-0.020324,-0.0019635,0.063746,0.62507,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,1
MIR10393_3P,SET,96,-0.029335,-0.0021157,0.09197,0.62512,MIR10393_3P,1
GSE17721_0.5H_VS_8H_GARDIQUI...2,SET,174,-0.019637,-0.0019026,0.061567,0.62512,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP,1
MILI_PSEUDOPODIA,SET,40,-0.039335,-0.001834,0.12331,0.62513,MILI_PSEUDOPODIA,1
REACTOME_GLYCOGEN_METABOLISM,SET,21,-0.055053,-0.0018608,0.17249,0.62519,REACTOME_GLYCOGEN_METABOLISM,1
ZNF560_TARGET_GENES,SET,42,-0.041723,-0.0019933,0.13072,0.6252,ZNF560_TARGET_GENES,1
HP_MOTOR_DELAY,SET,852,-0.0094541,-0.0019888,0.029606,0.62526,HP_MOTOR_DELAY,1
GOBP_CONSTITUTIVE_SECRETORY_...,SET,7,-0.10377,-0.0020258,0.32484,0.62531,GOBP_CONSTITUTIVE_SECRETORY_PATHWAY,1
GNF2_XRCC5,SET,65,-0.031341,-0.0018615,0.098095,0.62532,GNF2_XRCC5,1
ZHENG_FOXP3_TARGETS_IN_THYMU...2,SET,189,-0.021314,-0.0021513,0.066703,0.62534,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,1
GOBP_ADENYLATE_CYCLASE_INHIB...1,SET,5,-0.13872,-0.002289,0.43411,0.62535,GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
HP_PAPILLARY_THYROID_CARCINO...,SET,24,-0.058502,-0.0021138,0.18302,0.62538,HP_PAPILLARY_THYROID_CARCINOMA,1
GSE20366_CD103_POS_VS_NEG_TR...1,SET,177,-0.020593,-0.0020122,0.064415,0.6254,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN,1
GOBP_POSITIVE_REGULATION_OF_...273,SET,17,-0.065572,-0.0019944,0.20504,0.62544,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
HP_LOP_EAR,SET,3,-0.18038,-0.0023056,0.56386,0.62548,HP_LOP_EAR,1
VANTVEER_BREAST_CANCER_ESR1_...1,SET,207,-0.019671,-0.0020769,0.06148,0.6255,VANTVEER_BREAST_CANCER_ESR1_DN,1
MIR7153_5P,SET,103,-0.026743,-0.0019974,0.083581,0.6255,MIR7153_5P,1
HP_EXTRAMEDULLARY_HEMATOPOIE...,SET,19,-0.062706,-0.0020161,0.19597,0.6255,HP_EXTRAMEDULLARY_HEMATOPOIESIS,1
GOBP_AXON_ENSHEATHMENT_IN_CE...,SET,23,-0.059472,-0.0021036,0.18583,0.62553,GOBP_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM,1
GOBP_REGULATION_OF_TRANSLATI...10,SET,4,-0.12871,-0.0018995,0.40198,0.62558,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE_MODULATING_SYNAPTIC_TRANSMISSION,1
GSE43955_1H_VS_20H_ACT_CD4_T...2,SET,184,-0.020585,-0.0020504,0.064278,0.62561,GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP,1
GSE22935_WT_VS_MYD88_KO_MACR...6,SET,184,-0.020308,-0.0020228,0.063394,0.62565,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP,1
GSE7764_NKCELL_VS_SPLENOCYTE...1,SET,189,-0.019923,-0.002011,0.06217,0.62569,GSE7764_NKCELL_VS_SPLENOCYTE_DN,1
GOBP_VIRAL_RNA_GENOME_REPLIC...,SET,24,-0.061924,-0.0022374,0.1932,0.62571,GOBP_VIRAL_RNA_GENOME_REPLICATION,1
MIR26B_3P,SET,95,-0.027496,-0.0019727,0.085762,0.62574,MIR26B_3P,1
GOBP_MESODERMAL_CELL_FATE_SP...,SET,13,-0.075348,-0.0020042,0.23501,0.62575,GOBP_MESODERMAL_CELL_FATE_SPECIFICATION,1
HP_PERSISTENT_EBV_VIREMIA,SET,12,-0.071692,-0.0018322,0.2235,0.62581,HP_PERSISTENT_EBV_VIREMIA,1
ABDULRAHMAN_KIDNEY_CANCER_VH...,SET,13,-0.070549,-0.0018766,0.21991,0.62582,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,1
GOBP_REGULATION_OF_PROTEIN_D...4,SET,9,-0.08145,-0.0018029,0.25369,0.62592,GOBP_REGULATION_OF_PROTEIN_DEUBIQUITINATION,1
GSE3982_EFF_MEMORY_CD4_TCELL...6,SET,174,-0.020492,-0.0019855,0.063788,0.62599,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP,1
FIRESTEIN_CTNNB1_PATHWAY_AND...,SET,6,-0.10438,-0.0018866,0.32486,0.62601,FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION,1
MIR4487,SET,73,-0.032366,-0.0020368,0.10069,0.62606,MIR4487,1
GOMF_DNA_BINDING_TRANSCRIPTI...3,SET,440,-0.013223,-0.0020224,0.041138,0.62606,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,1
MODULE_528,SET,10,-0.090174,-0.0021039,0.28046,0.62609,MODULE_528,1
MIR4256,SET,68,-0.032176,-0.0019546,0.10006,0.62611,MIR4256,1
GOBP_MACROPHAGE_DIFFERENTIAT...,SET,57,-0.039119,-0.0021763,0.12161,0.62615,GOBP_MACROPHAGE_DIFFERENTIATION,1
REACTOME_INTRAFLAGELLAR_TRAN...,SET,44,-0.042278,-0.0020672,0.13142,0.62616,REACTOME_INTRAFLAGELLAR_TRANSPORT,1
MIR192_3P,SET,95,-0.028866,-0.002071,0.0897,0.6262,MIR192_3P,1
GOMF_LIPID_TRANSMEMBRANE_TRA...,SET,54,-0.038804,-0.0021014,0.12056,0.62622,GOMF_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_OVARIAN_CYST,SET,106,-0.027163,-0.002058,0.084391,0.62622,HP_OVARIAN_CYST,1
GOBP_REGULATION_OF_ERBB_SIGN...,SET,65,-0.034616,-0.002056,0.10754,0.62623,GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY,1
chr1p13,SET,106,-0.05613,-0.0042526,0.17432,0.62627,chr1p13,1
GOBP_GLYCOSPHINGOLIPID_BIOSY...,SET,38,-0.047371,-0.0021529,0.14708,0.6263,GOBP_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
GOBP_FATTY_ACID_TRANSMEMBRAN...,SET,19,-0.061154,-0.0019663,0.18984,0.62632,GOBP_FATTY_ACID_TRANSMEMBRANE_TRANSPORT,1
HP_APLASIA_HYPOPLASIA_OF_THE...54,SET,3,-0.16423,-0.0020992,0.50979,0.62633,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_TOE,1
LAIHO_COLORECTAL_CANCER_SERR...2,SET,103,-0.026563,-0.0019839,0.082434,0.62636,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1
GOCC_NUCLEOTIDE_EXCISION_REP...,SET,11,-0.065841,-0.0016111,0.20432,0.62637,GOCC_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX,1
GOBP_BIOLOGICAL_PROCESS_INVO...4,SET,47,-0.04019,-0.0020309,0.12471,0.62638,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS,1
GOBP_VITAMIN_D_METABOLIC_PRO...,SET,21,-0.06,-0.002028,0.18618,0.62638,GOBP_VITAMIN_D_METABOLIC_PROCESS,1
GSE2770_IL12_AND_TGFB_VS_IL4...4,SET,182,-0.020502,-0.0020311,0.063605,0.6264,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GSE22886_NAIVE_TCELL_VS_NEUT...2,SET,175,-0.019962,-0.0019396,0.061904,0.62645,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP,1
GSE28237_EARLY_VS_LATE_GC_BC...2,SET,183,-0.02127,-0.0021129,0.065949,0.62647,GSE28237_EARLY_VS_LATE_GC_BCELL_UP,1
HP_PROMINENT_INTERPHALANGEAL...,SET,6,-0.11108,-0.0020078,0.34424,0.62653,HP_PROMINENT_INTERPHALANGEAL_JOINTS,1
GSE1432_CTRL_VS_IFNG_6H_MICR...2,SET,183,-0.019825,-0.0019693,0.061435,0.62653,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,1
GOBP_RESPONSE_TO_SYMBIONT,SET,6,-0.10214,-0.0018462,0.31623,0.62665,GOBP_RESPONSE_TO_SYMBIONT,1
AGTCTTA_MIR499,SET,68,-0.032873,-0.0019969,0.10173,0.6267,AGTCTTA_MIR499,1
GOBP_POSITIVE_REGULATION_OF_...286,SET,52,-0.041158,-0.0021873,0.12737,0.6267,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,1
MIR606,SET,87,-0.029492,-0.0020253,0.09126,0.62671,MIR606,1
HP_ABNORMAL_FOREARM_MORPHOLO...,SET,211,-0.019359,-0.0020634,0.0599,0.62672,HP_ABNORMAL_FOREARM_MORPHOLOGY,1
HP_ABNORMALITY_OF_CRANIAL_SU...,SET,338,-0.015146,-0.002036,0.046855,0.62674,HP_ABNORMALITY_OF_CRANIAL_SUTURES,1
REACTOME_TRAFFICKING_OF_MYRI...,SET,4,-0.13197,-0.0019476,0.40824,0.62675,REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM,1
WP_GLYCOGEN_SYNTHESIS_AND_DE...,SET,35,-0.043986,-0.0019187,0.13602,0.62679,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1
HP_APLASIA_OF_THE_2ND_FINGER,SET,4,-0.14231,-0.0021003,0.43976,0.62688,HP_APLASIA_OF_THE_2ND_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...623,SET,6,-0.12936,-0.0023382,0.3996,0.62693,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
MIR4667_5P,SET,157,-0.023191,-0.0021354,0.071617,0.62696,MIR4667_5P,1
GOMF_ALCOHOL_BINDING,SET,85,-0.030953,-0.0021012,0.095591,0.62696,GOMF_ALCOHOL_BINDING,1
MIR6832_3P,SET,233,-0.018739,-0.0020975,0.057858,0.62698,MIR6832_3P,1
GOBP_DORSAL_AORTA_DEVELOPMENT,SET,10,-0.09944,-0.0023201,0.30705,0.62698,GOBP_DORSAL_AORTA_DEVELOPMENT,1
HP_ABSENT_SPERM_FLAGELLA,SET,23,-0.054039,-0.0019114,0.16681,0.62701,HP_ABSENT_SPERM_FLAGELLA,1
HP_ABNORMAL_GLYCOSYLATION,SET,44,-0.037813,-0.0018489,0.11671,0.62702,HP_ABNORMAL_GLYCOSYLATION,1
CTCTATG_MIR368,SET,38,-0.046953,-0.0021339,0.1449,0.62704,CTCTATG_MIR368,1
GOBP_REGULATION_OF_SMOOTHENE...,SET,79,-0.029946,-0.0019601,0.092368,0.62711,GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...2,SET,24,-0.056704,-0.0020488,0.17478,0.62719,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
REACTOME_ERYTHROCYTES_TAKE_U...1,SET,11,-0.087157,-0.0021327,0.26862,0.6272,REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN,1
GOBP_DENDRITIC_SPINE_MORPHOG...,SET,54,-0.039392,-0.0021332,0.1214,0.62722,GOBP_DENDRITIC_SPINE_MORPHOGENESIS,1
GOBP_NOREPINEPHRINE_BIOSYNTH...,SET,6,-0.12799,-0.0023133,0.39434,0.62724,GOBP_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_LIPID_BIO...,SET,159,-0.022251,-0.0020617,0.068554,0.62725,GOBP_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
GSE9946_IMMATURE_VS_PROSTAGL...2,SET,139,-0.023523,-0.002039,0.072454,0.62728,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,1
MIR6886_5P,SET,8,-0.10607,-0.0022136,0.32642,0.62739,MIR6886_5P,1
GOBP_POSITIVE_REGULATION_OF_...244,SET,26,-0.059435,-0.002235,0.18287,0.62741,GOBP_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
GOBP_XENOBIOTIC_TRANSPORT_AC...,SET,6,-0.12887,-0.0023293,0.39634,0.62747,GOBP_XENOBIOTIC_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,1
HP_ABNORMALITY_OF_ACID_BASE_...,SET,378,-0.013748,-0.0019522,0.042277,0.62748,HP_ABNORMALITY_OF_ACID_BASE_HOMEOSTASIS,1
GOBP_INTESTINAL_EPITHELIAL_C...2,SET,26,-0.055854,-0.0021004,0.17154,0.62763,GOBP_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION,1
GSE13485_CTRL_VS_DAY7_YF17D_...1,SET,187,-0.021244,-0.0021331,0.065205,0.62771,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN,1
GSE37301_PRO_BCELL_VS_GRANUL...2,SET,132,-0.024613,-0.0020794,0.075544,0.62771,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
HP_RECURRENT_SINUSITIS,SET,58,-0.036391,-0.0020421,0.11166,0.62775,HP_RECURRENT_SINUSITIS,1
WP_FGFR3_SIGNALING_IN_CHONDR...,SET,27,-0.057636,-0.0022086,0.17683,0.62776,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1
GOBP_REGULATION_OF_GLOMERULU...,SET,4,-0.16129,-0.0023805,0.49483,0.62777,GOBP_REGULATION_OF_GLOMERULUS_DEVELOPMENT,1
WP_FATTY_ACID_OMEGAOXIDATION,SET,15,-0.080396,-0.002297,0.24663,0.62778,WP_FATTY_ACID_OMEGAOXIDATION,1
GSE29164_UNTREATED_VS_CD8_TC...6,SET,175,-0.0204,-0.0019822,0.062576,0.62779,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP,1
GSE17301_CTRL_VS_48H_ACD3_AC...3,SET,186,-0.019902,-0.001993,0.061042,0.6278,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN,1
GOCC_ATG1_ULK1_KINASE_COMPLEX,SET,9,-0.09828,-0.0021754,0.30129,0.62786,GOCC_ATG1_ULK1_KINASE_COMPLEX,1
GOMF_HISTONE_H3K9_DEMETHYLAS...,SET,12,-0.069016,-0.0017638,0.21148,0.62792,GOMF_HISTONE_H3K9_DEMETHYLASE_ACTIVITY,1
GCM_SMARCD1,SET,90,-0.028205,-0.0019699,0.086419,0.62793,GCM_SMARCD1,1
BALDWIN_PRKCI_TARGETS_UP,SET,32,-0.054905,-0.0022902,0.16815,0.62799,BALDWIN_PRKCI_TARGETS_UP,1
GOCC_CILIARY_TRANSITION_ZONE,SET,65,-0.032261,-0.0019162,0.098746,0.62805,GOCC_CILIARY_TRANSITION_ZONE,1
MIR4669,SET,10,-0.078642,-0.0018349,0.24063,0.62809,MIR4669,1
GOBP_REGULATION_OF_SISTER_CH...2,SET,101,-0.026826,-0.0019842,0.082049,0.62815,GOBP_REGULATION_OF_SISTER_CHROMATID_SEGREGATION,1
GOBP_RETINAL_CONE_CELL_DEVEL...,SET,11,-0.095922,-0.0023472,0.29327,0.62819,GOBP_RETINAL_CONE_CELL_DEVELOPMENT,1
GOBP_REGULATION_OF_NITRIC_OX...2,SET,54,-0.041497,-0.0022472,0.12685,0.62821,GOBP_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...5,SET,123,-0.026709,-0.0021788,0.081643,0.62822,FAN_EMBRYONIC_CTX_BIG_GROUPS_GLIAL,1
CHNG_MULTIPLE_MYELOMA_HYPERP...2,SET,50,-0.03674,-0.0019147,0.11221,0.62832,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,1
MIR4277,SET,116,-0.025821,-0.0020459,0.078839,0.62836,MIR4277,1
GOBP_POSITIVE_REGULATION_OF_...250,SET,5,-0.15067,-0.0024861,0.46001,0.62837,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
MIR2276_3P,SET,109,-0.027772,-0.0021335,0.084763,0.62841,MIR2276_3P,1
GSE37532_TREG_VS_TCONV_PPARG...3,SET,172,-0.020867,-0.0020103,0.063689,0.62841,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...405,SET,5,-0.14086,-0.0023241,0.42982,0.62843,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,1
GOCC_CKM_COMPLEX,SET,4,-0.12757,-0.0018827,0.38926,0.62843,GOCC_CKM_COMPLEX,1
CERVERA_SDHB_TARGETS_1_UP,SET,111,-0.02923,-0.0022659,0.089191,0.62844,CERVERA_SDHB_TARGETS_1_UP,1
GOBP_GLOMERULAR_EPITHELIUM_D...,SET,25,-0.063791,-0.0023523,0.19464,0.62844,GOBP_GLOMERULAR_EPITHELIUM_DEVELOPMENT,1
GSE21927_UNTREATED_VS_GMCSF_...4,SET,154,-0.022324,-0.002036,0.068094,0.62848,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP,1
MYOCD_TARGET_GENES,SET,1134,-0.0086474,-0.0020817,0.026375,0.62849,MYOCD_TARGET_GENES,1
TCCCCAC_MIR491,SET,58,-0.034142,-0.001916,0.10408,0.62856,TCCCCAC_MIR491,1
GOBP_POSITIVE_REGULATION_OF_...660,SET,18,-0.068103,-0.0021313,0.20758,0.62857,GOBP_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_GDP_METABOLIC_PROCESS,SET,9,-0.098257,-0.0021749,0.29932,0.62864,GOBP_GDP_METABOLIC_PROCESS,1
GSE17580_UNINFECTED_VS_S_MAN...2,SET,186,-0.020497,-0.0020526,0.062425,0.62867,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP,1
MODULE_46,SET,367,-0.016394,-0.0022946,0.049925,0.62868,MODULE_46,1
HP_ABNORMAL_TEMPORAL_BONE_MO...,SET,4,-0.18281,-0.002698,0.55648,0.62873,HP_ABNORMAL_TEMPORAL_BONE_MORPHOLOGY,1
PETROVA_ENDOTHELIUM_LYMPHATI...2,SET,125,-0.026092,-0.0021456,0.079414,0.62875,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...30,SET,6,-0.12788,-0.0023113,0.38909,0.62879,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY,1
HEIDENBLAD_AMPLICON_8Q24_DN,SET,38,-0.047118,-0.0021414,0.14331,0.62884,HEIDENBLAD_AMPLICON_8Q24_DN,1
GNF2_FEN1,SET,54,-0.035676,-0.0019319,0.1085,0.62885,GNF2_FEN1,1
GOBP_POSITIVE_REGULATION_OF_...514,SET,5,-0.13558,-0.002237,0.41215,0.6289,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,1
GOBP_CARDIAC_CHAMBER_DEVELOP...,SET,162,-0.023816,-0.0022272,0.072381,0.62894,GOBP_CARDIAC_CHAMBER_DEVELOPMENT,1
GSE22886_NAIVE_TCELL_VS_MONO...1,SET,189,-0.021322,-0.0021522,0.064787,0.62896,GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN,1
GSE34205_RSV_VS_FLU_INF_INFA...2,SET,154,-0.023045,-0.0021017,0.070007,0.62899,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP,1
GOBP_N_TERMINAL_PROTEIN_LIPI...,SET,6,-0.12115,-0.0021897,0.36781,0.62906,GOBP_N_TERMINAL_PROTEIN_LIPIDATION,1
HP_BROAD_FINGER,SET,113,-0.026386,-0.0020636,0.080109,0.62906,HP_BROAD_FINGER,1
HP_GLOMUS_JUGULAR_TUMOR,SET,5,-0.11158,-0.001841,0.33875,0.62906,HP_GLOMUS_JUGULAR_TUMOR,1
HOWARD_NK_CELL_INACT_MONOV_I...1,SET,19,-0.067139,-0.0021587,0.20385,0.62906,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
BROWNE_HCMV_INFECTION_18HR_DN,SET,167,-0.022231,-0.0021106,0.067486,0.62908,BROWNE_HCMV_INFECTION_18HR_DN,1
GOMF_FRUCTOSE_BINDING,SET,6,-0.089939,-0.0016256,0.27302,0.62908,GOMF_FRUCTOSE_BINDING,1
ABDELMOHSEN_ELAVL4_TARGETS,SET,15,-0.077843,-0.0022241,0.23629,0.62909,ABDELMOHSEN_ELAVL4_TARGETS,1
GOBP_POSITIVE_REGULATION_OF_...36,SET,5,-0.14789,-0.0024402,0.44892,0.62909,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...37,SET,5,-0.14789,-0.0024402,0.44892,0.62909,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,1
ANDERSON_BLOOD_CN54GP140_ADJ...4,SET,25,-0.054491,-0.0020094,0.16539,0.6291,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_UP,1
HP_GIANT_CELL_HEPATITIS,SET,5,-0.11283,-0.0018617,0.34236,0.62913,HP_GIANT_CELL_HEPATITIS,1
GSE2585_CD80_HIGH_VS_LOW_MTE...2,SET,179,-0.021664,-0.0021286,0.065738,0.62913,GSE2585_CD80_HIGH_VS_LOW_MTEC_UP,1
MOOTHA_PGC,SET,377,-0.014203,-0.0020142,0.043089,0.62915,MOOTHA_PGC,1
GSE36891_UNSTIM_VS_POLYIC_TL...1,SET,178,-0.020891,-0.002047,0.063367,0.62918,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN,1
GOBP_POSITIVE_REGULATION_OF_...276,SET,23,-0.063435,-0.0022438,0.19237,0.6292,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,1
HP_CARDIAC_ARREST,SET,146,-0.024675,-0.0021916,0.074833,0.6292,HP_CARDIAC_ARREST,1
HP_ABNORMAL_ENDOCRINE_MORPHO...,SET,101,-0.0283,-0.0020932,0.085777,0.62927,HP_ABNORMAL_ENDOCRINE_MORPHOLOGY,1
GSE12366_PLASMA_CELL_VS_NAIV...2,SET,165,-0.022216,-0.0020965,0.067323,0.62929,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP,1
MIR6807_3P,SET,128,-0.024863,-0.0020687,0.075254,0.62944,MIR6807_3P,1
GSE411_100MIN_VS_400MIN_IL6_...1,SET,182,-0.019332,-0.0019152,0.058512,0.62945,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN,1
HP_HIGH_PALATE,SET,672,-0.010875,-0.0020422,0.032911,0.62947,HP_HIGH_PALATE,1
GAL_LEUKEMIC_STEM_CELL_DN,SET,212,-0.019284,-0.0020602,0.058349,0.62949,GAL_LEUKEMIC_STEM_CELL_DN,1
chr15q15,SET,86,-0.064743,-0.0044206,0.19586,0.62951,chr15q15,1
HP_FUNCTIONAL_ABNORMALITY_OF...4,SET,330,-0.015483,-0.002057,0.046792,0.62963,HP_FUNCTIONAL_ABNORMALITY_OF_THE_MIDDLE_EAR,1
STAT6_02,SET,239,-0.018974,-0.0021506,0.05734,0.62964,STAT6_02,1
GSE2770_UNTREATED_VS_IL4_TRE...3,SET,173,-0.020282,-0.0019595,0.06129,0.62964,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
KEGG_MEDICUS_REFERENCE_NON_C...,SET,6,-0.13036,-0.0023562,0.39386,0.62967,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY,1
ZSCAN18_TARGET_GENES,SET,33,-0.050276,-0.0021296,0.15187,0.62969,ZSCAN18_TARGET_GENES,1
GOMF_MRNA_5_UTR_BINDING,SET,22,-0.05472,-0.0018931,0.16526,0.62972,GOMF_MRNA_5_UTR_BINDING,1
GSE43863_TH1_VS_TFH_MEMORY_C...1,SET,181,-0.021082,-0.0020829,0.063667,0.62973,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN,1
GOMF_RNA_POLYMERASE_II_CTD_H...1,SET,10,-0.093614,-0.0021842,0.28269,0.62974,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_KINASE_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C3_DEF...2,SET,23,-0.05878,-0.0020791,0.17747,0.62975,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROCYTE,1
HP_ABNORMAL_URINARY_PURINE_L...,SET,7,-0.13056,-0.0025488,0.39413,0.62977,HP_ABNORMAL_URINARY_PURINE_LEVEL,1
GOBP_NEGATIVE_REGULATION_OF_...628,SET,9,-0.10099,-0.0022353,0.30483,0.62978,GOBP_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...746,SET,6,-0.12719,-0.0022988,0.38381,0.62982,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,1
MIR5000_5P,SET,91,-0.0297,-0.0020858,0.089554,0.62992,MIR5000_5P,1
GAUTAM_EYE_IRIS_CILIARY_BODY...1,SET,104,-0.026249,-0.00197,0.079139,0.62993,GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS,1
HP_SPONTANEOUS_HEMATOMAS,SET,18,-0.07526,-0.0023553,0.22688,0.62995,HP_SPONTANEOUS_HEMATOMAS,1
HP_LOW_ANTERIOR_HAIRLINE,SET,130,-0.024136,-0.0020238,0.072712,0.63003,HP_LOW_ANTERIOR_HAIRLINE,1
KEGG_MEDICUS_REFERENCE_FE_TF...,SET,7,-0.11081,-0.0021633,0.33366,0.63009,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT,1
GSE411_UNSTIM_VS_100MIN_IL6_...4,SET,177,-0.020503,-0.0020034,0.061736,0.6301,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,1
WP_LNCRNAMEDIATED_MECHANISMS...,SET,6,-0.11561,-0.0020896,0.34806,0.63011,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,1
SHETH_LIVER_CANCER_VS_TXNIP_...6,SET,51,-0.041135,-0.002165,0.12371,0.63025,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,1
LAKE_ADULT_KIDNEY_C10_THIN_A...,SET,317,-0.016175,-0.002107,0.048623,0.63031,LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB,1
GOCC_NUCLEAR_PORE_CENTRAL_TR...,SET,5,-0.12939,-0.0021349,0.38884,0.63034,GOCC_NUCLEAR_PORE_CENTRAL_TRANSPORT_CHANNEL,1
MORF_RAB1A,SET,173,-0.020299,-0.0019611,0.060991,0.63036,MORF_RAB1A,1
MODULE_204,SET,79,-0.031313,-0.0020496,0.094084,0.63036,MODULE_204,1
REACTOME_HOST_INTERACTIONS_O...,SET,121,-0.023626,-0.0019117,0.070968,0.6304,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1
GOBP_CORTISOL_SECRETION,SET,5,-0.12134,-0.0020021,0.36445,0.63041,GOBP_CORTISOL_SECRETION,1
ADNP_TARGET_GENES,SET,507,-0.012701,-0.0020813,0.038145,0.63042,ADNP_TARGET_GENES,1
HP_ABNORMAL_POSTERIOR_PITUIT...,SET,33,-0.04976,-0.0021077,0.14943,0.63043,HP_ABNORMAL_POSTERIOR_PITUITARY_MORPHOGENESIS,1
HP_PANCREATIC_ISLET_CELL_ADE...,SET,9,-0.10077,-0.0022304,0.30253,0.63046,HP_PANCREATIC_ISLET_CELL_ADENOMA,1
DLX4_TARGET_GENES,SET,686,-0.010903,-0.0020678,0.032711,0.63055,DLX4_TARGET_GENES,1
GOBP_REGULATION_OF_MODIFICAT...3,SET,12,-0.076738,-0.0019612,0.23021,0.63056,GOBP_REGULATION_OF_MODIFICATION_OF_SYNAPTIC_STRUCTURE,1
HP_TICS,SET,22,-0.06039,-0.0020892,0.18098,0.63069,HP_TICS,1
HP_T_LYMPHOCYTOPENIA,SET,60,-0.036733,-0.0020964,0.11008,0.63069,HP_T_LYMPHOCYTOPENIA,1
GOBP_DETECTION_OF_MECHANICAL...4,SET,13,-0.087459,-0.0023264,0.26207,0.6307,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND,1
POMEROY_MEDULLOBLASTOMA_DESM...1,SET,52,-0.041368,-0.0021984,0.12392,0.63074,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,1
DESCARTES_FETAL_INTESTINE_LY...2,SET,129,-0.027107,-0.0022642,0.081173,0.63079,DESCARTES_FETAL_INTESTINE_LYMPHOID_CELLS,1
GOBP_RESPONSE_TO_MUSCLE_INAC...,SET,9,-0.10485,-0.0023208,0.31392,0.63081,GOBP_RESPONSE_TO_MUSCLE_INACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...435,SET,14,-0.077176,-0.0021303,0.23104,0.63082,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
ZNF677_TARGET_GENES,SET,128,-0.025845,-0.0021505,0.077367,0.63083,ZNF677_TARGET_GENES,1
GSE18281_PERIMEDULLARY_CORTI...4,SET,187,-0.020801,-0.0020885,0.062238,0.63089,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,1
GOMF_MUTSALPHA_COMPLEX_BINDI...,SET,7,-0.10494,-0.0020487,0.31395,0.63091,GOMF_MUTSALPHA_COMPLEX_BINDING,1
HP_ABNORMALITY_OF_THE_METOPI...,SET,80,-0.031946,-0.0021042,0.09557,0.63091,HP_ABNORMALITY_OF_THE_METOPIC_SUTURE,1
RUBENSTEIN_SKELETAL_MUSCLE_E...,SET,123,-0.027962,-0.002281,0.083636,0.63093,RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS,1
SAENZ_DETOX_PATHWAY_AND_CARC...,SET,14,-0.073507,-0.002029,0.21983,0.63095,SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN,1
GOBP_EXPORT_ACROSS_PLASMA_ME...,SET,65,-0.038442,-0.0022833,0.11493,0.63098,GOBP_EXPORT_ACROSS_PLASMA_MEMBRANE,1
HELLER_HDAC_TARGETS_SILENCED...1,SET,257,-0.018475,-0.0021705,0.055231,0.631,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,1
PID_ANTHRAX_PATHWAY,SET,17,-0.071857,-0.0021855,0.21477,0.63102,PID_ANTHRAX_PATHWAY,1
GSE6259_BCELL_VS_CD4_TCELL_DN,SET,166,-0.021478,-0.002033,0.064187,0.63104,GSE6259_BCELL_VS_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_AGE_R...,SET,15,-0.072059,-0.0020588,0.21526,0.63109,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY,1
HP_UPPER_EYELID_EDEMA,SET,6,-0.12354,-0.002233,0.36907,0.63109,HP_UPPER_EYELID_EDEMA,1
GSE25123_ROSIGLITAZONE_VS_IL...2,SET,177,-0.02163,-0.0021136,0.064615,0.63109,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
GOBP_REGULATION_OF_SODIUM_IO...1,SET,52,-0.04355,-0.0023144,0.13008,0.63111,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
MIR1204,SET,6,-0.12243,-0.0022129,0.36559,0.63114,MIR1204,1
GSE24574_BCL6_LOW_TFH_VS_TCO...1,SET,179,-0.020612,-0.0020253,0.061545,0.63115,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN,1
GSE36476_YOUNG_VS_OLD_DONOR_...3,SET,179,-0.020513,-0.0020156,0.0612,0.63125,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN,1
GOBP_PIGMENT_BIOSYNTHETIC_PR...,SET,49,-0.041312,-0.0021314,0.12325,0.63126,GOBP_PIGMENT_BIOSYNTHETIC_PROCESS,1
GOBP_PYRIMIDINE_NUCLEOTIDE_C...,SET,21,-0.063236,-0.0021374,0.18863,0.63128,GOBP_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...328,SET,10,-0.10128,-0.0023631,0.30203,0.63131,GOBP_POSITIVE_REGULATION_OF_HEAT_GENERATION,1
HP_CERVICAL_CORD_COMPRESSION,SET,6,-0.12233,-0.0022111,0.36481,0.63131,HP_CERVICAL_CORD_COMPRESSION,1
HP_PERISYLVIAN_POLYMICROGYRIA,SET,32,-0.05435,-0.0022671,0.16208,0.63131,HP_PERISYLVIAN_POLYMICROGYRIA,1
ADCYAP1_TARGET_GENES,SET,7,-0.099498,-0.0019424,0.29667,0.63133,ADCYAP1_TARGET_GENES,1
GOBP_MITOCHONDRIAL_ELECTRON_...4,SET,12,-0.076908,-0.0019656,0.22931,0.63133,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C,1
MIR1827,SET,359,-0.015097,-0.0020903,0.045007,0.63135,MIR1827,1
GSE30962_ACUTE_VS_CHRONIC_LC...4,SET,180,-0.021484,-0.0021168,0.064042,0.63137,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,1
GSE41978_ID2_KO_AND_BIM_KO_V...1,SET,177,-0.022083,-0.0021577,0.065806,0.6314,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
chr2q14,SET,65,-0.062237,-0.0036966,0.18538,0.63146,chr2q14,1
GOBP_CARDIAC_MYOFIBRIL_ASSEM...,SET,19,-0.064952,-0.0020884,0.19345,0.63147,GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY,1
HP_ABNORMAL_LYMPHOCYTE_PROLI...,SET,39,-0.045866,-0.0021116,0.13659,0.63148,HP_ABNORMAL_LYMPHOCYTE_PROLIFERATION,1
GSE27786_NEUTROPHIL_VS_MONO_...1,SET,178,-0.020561,-0.0020147,0.061224,0.6315,GSE27786_NEUTROPHIL_VS_MONO_MAC_DN,1
MIR6792_5P,SET,113,-0.028791,-0.0022517,0.085711,0.63153,MIR6792_5P,1
HP_EPIDERMAL_HYPERKERATOSIS,SET,11,-0.091098,-0.0022291,0.27105,0.6316,HP_EPIDERMAL_HYPERKERATOSIS,1
REACTOME_EUKARYOTIC_TRANSLAT...2,SET,108,-0.026433,-0.0020214,0.078602,0.63167,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,1
MIR382_5P,SET,52,-0.03901,-0.0020731,0.116,0.63167,MIR382_5P,1
chr9q34,SET,183,-0.042409,-0.0042128,0.12606,0.63172,chr9q34,1
GSE43955_TH0_VS_TGFB_IL6_TH1...4,SET,188,-0.021619,-0.0021764,0.064249,0.63175,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP,1
NAKAYA_B_CELL_FLUMIST_AGE_18...1,SET,346,-0.015285,-0.0020785,0.04542,0.63176,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
GOBP_REGULATION_OF_L_GLUTAMA...,SET,8,-0.10302,-0.0021499,0.30603,0.6318,GOBP_REGULATION_OF_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
MIR367_5P,SET,67,-0.033948,-0.002047,0.10084,0.63181,MIR367_5P,1
GOMF_NEUROTRANSMITTER_RECEPT...1,SET,90,-0.033362,-0.0023301,0.099061,0.63186,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
HP_QUADRICEPS_MUSCLE_WEAKNESS,SET,19,-0.070101,-0.0022539,0.20809,0.63189,HP_QUADRICEPS_MUSCLE_WEAKNESS,1
HP_SHORT_MIDDLE_PHALANX_OF_T...2,SET,5,-0.14307,-0.0023606,0.4246,0.63192,HP_SHORT_MIDDLE_PHALANX_OF_TOE,1
GOBP_KETONE_BODY_BIOSYNTHETI...,SET,6,-0.11554,-0.0020884,0.34285,0.63194,GOBP_KETONE_BODY_BIOSYNTHETIC_PROCESS,1
GOBP_RETROGRADE_TRANS_SYNAPT...1,SET,9,-0.1095,-0.0024238,0.32493,0.63194,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING,1
HUANG_FOXA2_TARGETS_UP,SET,45,-0.046838,-0.002316,0.13898,0.63195,HUANG_FOXA2_TARGETS_UP,1
chr7q33,SET,24,-0.078869,-0.0028497,0.23397,0.63197,chr7q33,1
GSE27786_LIN_NEG_VS_NKTCELL_...1,SET,184,-0.020133,-0.0020053,0.059728,0.63197,GSE27786_LIN_NEG_VS_NKTCELL_DN,1
GOCC_PHAGOCYTIC_VESICLE_LUMEN,SET,5,-0.12292,-0.0020283,0.36465,0.63198,GOCC_PHAGOCYTIC_VESICLE_LUMEN,1
HP_ELFIN_FACIES,SET,18,-0.073261,-0.0022928,0.21731,0.63199,HP_ELFIN_FACIES,1
GOBP_DITERPENOID_BIOSYNTHETI...,SET,10,-0.097842,-0.0022828,0.29013,0.63203,GOBP_DITERPENOID_BIOSYNTHETIC_PROCESS,1
chr17q22,SET,42,-0.074328,-0.0035509,0.22032,0.63207,chr17q22,1
REACTOME_SIGNALING_BY_NOTCH,SET,168,-0.021264,-0.0020247,0.063032,0.63207,REACTOME_SIGNALING_BY_NOTCH,1
GOBP_MEMBRANE_DEPOLARIZATION,SET,85,-0.034154,-0.0023185,0.10124,0.63207,GOBP_MEMBRANE_DEPOLARIZATION,1
GOBP_POSITIVE_REGULATION_OF_...345,SET,6,-0.12914,-0.0023342,0.38273,0.6321,GOBP_POSITIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
FRANCO_BLOOD_SANOFI_PASTEUR_...2,SET,19,-0.067682,-0.0021761,0.20053,0.63213,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_POSITIVE,1
GSE24634_IL4_VS_CTRL_TREATED...1,SET,180,-0.021456,-0.002114,0.063545,0.63218,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...4,SET,13,-0.082181,-0.002186,0.24335,0.6322,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY,1
DACH1_TARGET_GENES,SET,741,-0.010675,-0.0021009,0.031614,0.6322,DACH1_TARGET_GENES,1
STAT_01,SET,233,-0.019225,-0.002152,0.056923,0.63222,STAT_01,1
GOBP_REGULATION_OF_DENDRITE_...1,SET,89,-0.032038,-0.0022252,0.094848,0.63224,GOBP_REGULATION_OF_DENDRITE_DEVELOPMENT,1
MIR146A_5P,SET,103,-0.02813,-0.002101,0.083234,0.6323,MIR146A_5P,1
MIR3910,SET,365,-0.015684,-0.0021893,0.046405,0.63231,MIR3910,1
GSE41867_DAY6_EFFECTOR_VS_DA...3,SET,185,-0.020542,-0.0020516,0.060752,0.63236,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,1
GOBP_REGULATION_OF_MYELINATI...,SET,44,-0.044637,-0.0021826,0.132,0.63238,GOBP_REGULATION_OF_MYELINATION,1
GOMF_INTRACILIARY_TRANSPORT_...,SET,2,-0.18914,-0.0019739,0.55908,0.63243,GOMF_INTRACILIARY_TRANSPORT_PARTICLE_B_BINDING,1
MIR450A_1_3P,SET,168,-0.022406,-0.0021334,0.066212,0.63246,MIR450A_1_3P,1
GOCC_PROTEASOME_CORE_COMPLEX,SET,20,-0.05441,-0.0017948,0.16076,0.63249,GOCC_PROTEASOME_CORE_COMPLEX,1
MIR6833_3P,SET,375,-0.015299,-0.002164,0.04519,0.63252,MIR6833_3P,1
GOBP_CALCIUM_ION_TRANSMEMBRA...3,SET,17,-0.077038,-0.0023431,0.2275,0.63255,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,1
GOBP_OSMOSENSORY_SIGNALING_P...,SET,6,-0.1127,-0.0020369,0.33273,0.63258,GOBP_OSMOSENSORY_SIGNALING_PATHWAY,1
FOXR2_TARGET_GENES,SET,168,-0.022466,-0.0021392,0.066311,0.63262,FOXR2_TARGET_GENES,1
HP_RETICULOCYTOPENIA,SET,32,-0.047733,-0.001991,0.14089,0.63262,HP_RETICULOCYTOPENIA,1
HP_SHORT_FACE,SET,17,-0.077103,-0.0023451,0.22753,0.63264,HP_SHORT_FACE,1
GSE12845_IGD_NEG_BLOOD_VS_NA...1,SET,182,-0.020991,-0.0020796,0.061928,0.63268,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,1
MEISSNER_ES_ICP_WITH_H3K4ME3...,SET,11,-0.090905,-0.0022244,0.26811,0.63271,MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
REACTOME_SIGNALLING_TO_RAS,SET,20,-0.06443,-0.0021253,0.18991,0.63279,REACTOME_SIGNALLING_TO_RAS,1
HP_ABNORMAL_NERVOUS_SYSTEM_E...,SET,610,-0.011745,-0.0021049,0.03461,0.63282,HP_ABNORMAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
GOBP_REGULATION_OF_T_CELL_EX...,SET,5,-0.13173,-0.0021736,0.3881,0.63285,GOBP_REGULATION_OF_T_CELL_EXTRAVASATION,1
HP_AREFLEXIA_OF_LOWER_LIMBS,SET,76,-0.032349,-0.002077,0.095306,0.63285,HP_AREFLEXIA_OF_LOWER_LIMBS,1
SMID_BREAST_CANCER_BASAL_UP,SET,588,-0.012783,-0.0022507,0.037659,0.63286,SMID_BREAST_CANCER_BASAL_UP,1
GOMF_SPHINGOSINE_1_PHOSPHATE...2,SET,8,-0.11145,-0.002326,0.32833,0.63286,GOMF_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_CLASS...,SET,4,-0.16879,-0.0024911,0.49723,0.63287,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,1
MANNO_MIDBRAIN_NEUROTYPES_HR...2,SET,513,-0.013833,-0.0022797,0.04075,0.63287,MANNO_MIDBRAIN_NEUROTYPES_HRGL2A,1
HP_TETRAPLEGIA,SET,31,-0.049655,-0.0020386,0.14625,0.63289,HP_TETRAPLEGIA,1
GOBP_SEX_CHROMOSOME_DOSAGE_C...,SET,13,-0.078889,-0.0020984,0.23234,0.6329,GOBP_SEX_CHROMOSOME_DOSAGE_COMPENSATION,1
HP_ABNORMALITY_OF_THE_AXILLA...,SET,51,-0.042697,-0.0022472,0.12573,0.63292,HP_ABNORMALITY_OF_THE_AXILLARY_HAIR,1
DURANTE_ADULT_OLFACTORY_NEUR...16,SET,47,-0.045667,-0.0023076,0.13447,0.63292,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_MICROVILLAR_CELLS,1
HP_ABNORMAL_NEPHRON_MORPHOLO...,SET,219,-0.019779,-0.0021473,0.058236,0.63293,HP_ABNORMAL_NEPHRON_MORPHOLOGY,1
MIR488_5P,SET,71,-0.034495,-0.0021409,0.10152,0.63299,MIR488_5P,1
GOMF_3_HYDROXYACYL_COA_DEHYD...1,SET,7,-0.13993,-0.0027318,0.41173,0.63302,GOMF_3_HYDROXYACYL_COA_DEHYDRATASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...110,SET,24,-0.060086,-0.002171,0.17678,0.63303,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,1
GOBP_SODIUM_ION_HOMEOSTASIS,SET,46,-0.047851,-0.0023921,0.14078,0.63303,GOBP_SODIUM_ION_HOMEOSTASIS,1
GOBP_DNA_PROTECTION,SET,5,-0.12656,-0.0020883,0.37234,0.63304,GOBP_DNA_PROTECTION,1
GSE43955_TH0_VS_TGFB_IL6_TH1...16,SET,184,-0.02175,-0.0021664,0.06394,0.63313,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP,1
THAKAR_PBMC_INACTIVATED_INFL...6,SET,376,-0.014791,-0.0020949,0.043474,0.63316,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,1
HP_HAMMERTOE,SET,52,-0.040085,-0.0021302,0.11777,0.6332,HP_HAMMERTOE,1
BIOCARTA_NTHI_PATHWAY,SET,23,-0.064837,-0.0022934,0.19049,0.63321,BIOCARTA_NTHI_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...498,SET,11,-0.095693,-0.0023416,0.28113,0.63322,GOBP_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION,1
HP_LARYNGEAL_HYPOPLASIA,SET,8,-0.091938,-0.0019187,0.27,0.63326,HP_LARYNGEAL_HYPOPLASIA,1
TURASHVILI_BREAST_DUCTAL_CAR...2,SET,42,-0.044987,-0.0021492,0.13209,0.63329,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1
GOBP_REGULATION_OF_TESTOSTER...,SET,6,-0.13377,-0.0024178,0.39276,0.63329,GOBP_REGULATION_OF_TESTOSTERONE_BIOSYNTHETIC_PROCESS,1
HP_INVERTED_NIPPLES,SET,44,-0.040913,-0.0020005,0.12012,0.6333,HP_INVERTED_NIPPLES,1
HP_BARREL_SHAPED_CHEST,SET,20,-0.066039,-0.0021784,0.19387,0.63331,HP_BARREL_SHAPED_CHEST,1
GOBP_OLEFINIC_COMPOUND_BIOSY...,SET,26,-0.059924,-0.0022534,0.17591,0.63332,GOBP_OLEFINIC_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOCC_BASAL_DENDRITE,SET,6,-0.13352,-0.0024133,0.39195,0.63332,GOCC_BASAL_DENDRITE,1
REACTOME_SIALIC_ACID_METABOL...,SET,33,-0.052079,-0.0022059,0.15268,0.63348,REACTOME_SIALIC_ACID_METABOLISM,1
SCHAEFFER_PROSTATE_DEVELOPME...3,SET,375,-0.016591,-0.0023468,0.0486,0.63359,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,1
GOCC_MRNA_CLEAVAGE_AND_POLYA...,SET,17,-0.064788,-0.0019705,0.18974,0.63361,GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX,1
GSE17721_POLYIC_VS_PAM3CSK4_...4,SET,188,-0.021201,-0.0021343,0.062068,0.63366,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP,1
GAO_ESOPHAGUS_25W_C3_FGFR1LO...,SET,43,-0.043914,-0.0021227,0.12854,0.63369,GAO_ESOPHAGUS_25W_C3_FGFR1LOW_EPITHELIAL_CELLS,1
HP_STATUS_EPILEPTICUS_WITHOU...,SET,24,-0.058651,-0.0021191,0.17166,0.6337,HP_STATUS_EPILEPTICUS_WITHOUT_PROMINENT_MOTOR_SYMPTOMS,1
GOMF_G_PROTEIN_COUPLED_RECEP...3,SET,4,-0.12717,-0.0018768,0.37206,0.63374,GOMF_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...518,SET,25,-0.053714,-0.0019807,0.15713,0.63376,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,1
MIR374A_3P,SET,128,-0.025934,-0.0021578,0.075851,0.63379,MIR374A_3P,1
REACTOME_NEUROTRANSMITTER_RE...2,SET,47,-0.048099,-0.0024305,0.1406,0.63386,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,1
KEGG_MEDICUS_PATHOGEN_HPV_E7...1,SET,6,-0.0979,-0.0017695,0.28608,0.6339,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S,1
TGTTTAC_MIR30A5P_MIR30C_MIR3...,SET,530,-0.012945,-0.0021674,0.037819,0.63393,TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P,1
GOMF_RNA_POLYMERASE_II_CTD_H...3,SET,7,-0.10365,-0.0020234,0.30279,0.63394,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_PHOSPHATASE_ACTIVITY,1
GOBP_PYRIMIDINE_NUCLEOSIDE_B...,SET,4,-0.13205,-0.0019488,0.38548,0.63403,GOBP_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,1
GOBP_RETINAL_BIPOLAR_NEURON_...,SET,7,-0.11634,-0.0022712,0.33961,0.63404,GOBP_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION,1
GSE17721_0.5H_VS_8H_CPG_BMDC...2,SET,188,-0.020781,-0.0020921,0.060635,0.63409,GSE17721_0.5H_VS_8H_CPG_BMDC_UP,1
GSE411_WT_VS_SOCS3_KO_MACROP...4,SET,182,-0.020985,-0.002079,0.061223,0.63411,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN,1
GOBP_INTRINSIC_APOPTOTIC_SIG...2,SET,74,-0.033072,-0.0020954,0.096476,0.63412,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
HP_HYPOLIPIDEMIA,SET,10,-0.095478,-0.0022277,0.27851,0.63413,HP_HYPOLIPIDEMIA,1
GSE25123_IL4_VS_IL4_AND_ROSI...2,SET,190,-0.022267,-0.0022534,0.064939,0.63416,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
HP_CONCENTRIC_HYPERTROPHIC_C...,SET,7,-0.12364,-0.0024138,0.36055,0.63417,HP_CONCENTRIC_HYPERTROPHIC_CARDIOMYOPATHY,1
ZHENG_CORD_BLOOD_C1_PUTATIVE...,SET,92,-0.032555,-0.0022987,0.094916,0.63419,ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR,1
MIKKELSEN_IPS_LCP_WITH_H3K27...,SET,10,-0.085959,-0.0020056,0.2506,0.6342,MIKKELSEN_IPS_LCP_WITH_H3K27ME3,1
BOGNI_TREATMENT_RELATED_MYEL...2,SET,25,-0.060194,-0.0022197,0.17541,0.63426,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,1
GOBP_HETEROCHROMATIN_ORGANIZ...,SET,13,-0.074093,-0.0019709,0.21591,0.63426,GOBP_HETEROCHROMATIN_ORGANIZATION,1
GOCC_PRE_SNORNP_COMPLEX,SET,7,-0.10011,-0.0019544,0.29165,0.6343,GOCC_PRE_SNORNP_COMPLEX,1
GOCC_ESCRT_COMPLEX,SET,29,-0.052827,-0.0020979,0.15384,0.63435,GOCC_ESCRT_COMPLEX,1
HARALAMBIEVA_PBMC_TIV_AGE_50...2,SET,13,-0.068187,-0.0018138,0.19846,0.63442,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_NEGATIVE,1
DURANTE_ADULT_OLFACTORY_NEUR...20,SET,27,-0.062728,-0.0024037,0.18257,0.63442,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_COLUMNAR_CELLS,1
GSE23695_CD57_POS_VS_NEG_NK_...2,SET,185,-0.020573,-0.0020547,0.059867,0.63444,GSE23695_CD57_POS_VS_NEG_NK_CELL_UP,1
SANDERSON_PPARA_TARGETS,SET,15,-0.071189,-0.002034,0.20713,0.63446,SANDERSON_PPARA_TARGETS,1
HP_MUSCLE_SPASM,SET,148,-0.024115,-0.0021564,0.070166,0.63446,HP_MUSCLE_SPASM,1
ZHAN_MULTIPLE_MYELOMA_LB_UP,SET,45,-0.047909,-0.0023689,0.13937,0.63448,ZHAN_MULTIPLE_MYELOMA_LB_UP,1
HP_ABNORMAL_BASOPHIL_MORPHOL...,SET,8,-0.1118,-0.0023333,0.32526,0.63448,HP_ABNORMAL_BASOPHIL_MORPHOLOGY,1
REACTOME_ACYL_CHAIN_REMODELL...2,SET,23,-0.067676,-0.0023938,0.19661,0.63466,REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,1
GSE13306_TREG_RA_VS_TCONV_RA...1,SET,177,-0.022647,-0.0022129,0.065756,0.63473,GSE13306_TREG_RA_VS_TCONV_RA_DN,1
GSE3982_EOSINOPHIL_VS_DC_DN,SET,184,-0.021773,-0.0021687,0.063174,0.63482,GSE3982_EOSINOPHIL_VS_DC_DN,1
GOBP_REGULATION_OF_CATECHOLA...1,SET,15,-0.078564,-0.0022447,0.22791,0.63484,GOBP_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,1
ENK_UV_RESPONSE_KERATINOCYTE...2,SET,469,-0.01357,-0.002141,0.039355,0.63488,ENK_UV_RESPONSE_KERATINOCYTE_UP,1
ERR1_Q2,SET,228,-0.019576,-0.0021679,0.056757,0.63492,ERR1_Q2,1
GOBP_MITOCHONDRION_ENDOPLASM...,SET,7,-0.10619,-0.002073,0.30772,0.63498,GOBP_MITOCHONDRION_ENDOPLASMIC_RETICULUM_MEMBRANE_TETHERING,1
REACTOME_CREB_PHOSPHORYLATION,SET,6,-0.13893,-0.002511,0.4025,0.63501,REACTOME_CREB_PHOSPHORYLATION,1
PID_RAC1_REG_PATHWAY,SET,36,-0.050459,-0.0022322,0.14618,0.63502,PID_RAC1_REG_PATHWAY,1
GOBP_PYRIMIDINE_CONTAINING_C...3,SET,80,-0.034658,-0.0022828,0.10036,0.63508,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_XENOPHAGY,SET,14,-0.08605,-0.0023753,0.24911,0.63511,GOBP_XENOPHAGY,1
GOBP_POSITIVE_REGULATION_OF_...568,SET,28,-0.063468,-0.0024767,0.18369,0.63515,GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,1
HOEK_MONOCYTE_2011_2012_TIV_...3,SET,4,-0.12631,-0.0018641,0.36552,0.63516,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_DN,1
WP_EFFECT_OF_OMEGA3_PUFA_ON_...,SET,114,-0.02908,-0.0022843,0.084135,0.63519,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,1
HP_ABNORMAL_GREATER_SCIATIC_...,SET,19,-0.068717,-0.0022094,0.1988,0.6352,HP_ABNORMAL_GREATER_SCIATIC_NOTCH_MORPHOLOGY,1
MIR541_3P,SET,94,-0.030783,-0.0021969,0.089008,0.63527,MIR541_3P,1
XU_GH1_AUTOCRINE_TARGETS_DN,SET,117,-0.028463,-0.0022649,0.082278,0.6353,XU_GH1_AUTOCRINE_TARGETS_DN,1
BLANCO_MELO_COVID19_SARS_COV...7,SET,16,-0.073236,-0.002161,0.21161,0.63536,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,1
BROWNE_HCMV_INFECTION_14HR_DN,SET,257,-0.018588,-0.0021837,0.053699,0.63538,BROWNE_HCMV_INFECTION_14HR_DN,1
MODULE_317,SET,396,-0.014939,-0.0021702,0.043153,0.6354,MODULE_317,1
GSE17721_LPS_VS_CPG_24H_BMDC...2,SET,179,-0.021851,-0.002147,0.063112,0.63541,GSE17721_LPS_VS_CPG_24H_BMDC_UP,1
GSE5589_IL6_KO_VS_IL10_KO_LP...5,SET,179,-0.022514,-0.0022122,0.065023,0.63542,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
MARKS_ACETYLATED_NON_HISTONE...,SET,11,-0.085664,-0.0020962,0.24738,0.63543,MARKS_ACETYLATED_NON_HISTONE_PROTEINS,1
HOSHIDA_LIVER_CANCER_SUBCLAS...3,SET,241,-0.019315,-0.0021983,0.055758,0.63548,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1
GSE2706_R848_VS_R848_AND_LPS...1,SET,164,-0.024586,-0.0023133,0.070951,0.63552,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN,1
GSE2770_UNTREATED_VS_ACT_CD4...5,SET,178,-0.02157,-0.0021135,0.062219,0.63558,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN,1
GOMF_MOLECULAR_TAG_ACTIVITY,SET,11,-0.089211,-0.002183,0.25732,0.63559,GOMF_MOLECULAR_TAG_ACTIVITY,1
MIR10524_5P,SET,79,-0.03509,-0.0022968,0.10119,0.63562,MIR10524_5P,1
GSE13484_3H_UNSTIM_VS_YF17D_...2,SET,185,-0.021019,-0.0020992,0.060597,0.63565,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
WP_15Q11Q13_COPY_NUMBER_VARI...,SET,48,-0.044189,-0.0022565,0.12738,0.63566,WP_15Q11Q13_COPY_NUMBER_VARIATION,1
GSE43955_TH0_VS_TGFB_IL6_IL2...2,SET,182,-0.022534,-0.0022324,0.064894,0.63579,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,1
UNTERMAN_PROGRESSIVE_VS_STAB...5,SET,8,-0.11651,-0.0024315,0.33546,0.63582,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_DN,1
TTCNRGNNNNTTC_HSF_Q6,SET,137,-0.025764,-0.0022173,0.074137,0.6359,TTCNRGNNNNTTC_HSF_Q6,1
chr6q24,SET,32,-0.099731,-0.00416,0.28691,0.63593,chr6q24,1
GSE42021_TCONV_PLN_VS_TREG_P...1,SET,181,-0.022943,-0.0022667,0.066003,0.63593,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN,1
GSE13484_UNSTIM_VS_3H_YF17D_...1,SET,179,-0.021768,-0.0021388,0.062604,0.63597,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,1
GOBP_ACTIVATION_OF_PROTEIN_K...2,SET,21,-0.070808,-0.0023934,0.20361,0.63599,GOBP_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY,1
MEBARKI_HCC_PROGENITOR_WNT_U...2,SET,72,-0.038572,-0.0024107,0.1109,0.636,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1
HE_LIM_SUN_FETAL_LUNG_C3_GRI...,SET,113,-0.03116,-0.002437,0.089582,0.63602,HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL,1
WANG_TARGETS_OF_MLL_CBP_FUSI...2,SET,43,-0.043577,-0.0021064,0.12517,0.63613,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,1
GOCC_LUMENAL_SIDE_OF_ENDOPLA...,SET,29,-0.054922,-0.0021811,0.15776,0.63613,GOCC_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,1
GSE2585_THYMIC_DC_VS_MTEC_UP,SET,172,-0.022446,-0.0021624,0.064452,0.63618,GSE2585_THYMIC_DC_VS_MTEC_UP,1
WP_IL3_SIGNALING,SET,46,-0.046237,-0.0023115,0.13272,0.63622,WP_IL3_SIGNALING,1
GOCC_LIPID_DROPLET,SET,91,-0.031435,-0.0022076,0.090199,0.63627,GOCC_LIPID_DROPLET,1
GEISS_RESPONSE_TO_DSRNA_DN,SET,15,-0.075827,-0.0021665,0.21754,0.63629,GEISS_RESPONSE_TO_DSRNA_DN,1
SMCHD1_TARGET_GENES,SET,30,-0.056131,-0.0022671,0.16103,0.63629,SMCHD1_TARGET_GENES,1
HP_PROGEROID_FACIAL_APPEARAN...,SET,29,-0.054342,-0.002158,0.1559,0.63629,HP_PROGEROID_FACIAL_APPEARANCE,1
HP_KERATOACANTHOMA,SET,4,-0.12094,-0.0017849,0.34692,0.6363,HP_KERATOACANTHOMA,1
HEDENFALK_BREAST_CANCER_BRAC...1,SET,18,-0.065645,-0.0020544,0.18825,0.63634,HEDENFALK_BREAST_CANCER_BRACX_DN,1
HP_FIBULAR_APLASIA,SET,6,-0.13444,-0.00243,0.38557,0.63634,HP_FIBULAR_APLASIA,1
GSE339_EX_VIVO_VS_IN_CULTURE...2,SET,180,-0.021892,-0.002157,0.062766,0.63637,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP,1
REACTOME_RHO_GTPASES_ACTIVAT...4,SET,11,-0.082966,-0.0020302,0.23784,0.63639,REACTOME_RHO_GTPASES_ACTIVATE_KTN1,1
HP_LIMITED_HIP_MOVEMENT,SET,22,-0.067147,-0.002323,0.19247,0.6364,HP_LIMITED_HIP_MOVEMENT,1
chr17p12,SET,22,-0.097069,-0.0033581,0.27823,0.63641,chr17p12,1
MIR3085_5P,SET,33,-0.051809,-0.0021945,0.14849,0.63642,MIR3085_5P,1
GOBP_NONASSOCIATIVE_LEARNING,SET,6,-0.1238,-0.0022377,0.35483,0.63642,GOBP_NONASSOCIATIVE_LEARNING,1
ELF2_TARGET_GENES,SET,1229,-0.008784,-0.0021953,0.025171,0.63644,ELF2_TARGET_GENES,1
PID_TOLL_ENDOGENOUS_PATHWAY,SET,21,-0.062824,-0.0021235,0.17995,0.6365,PID_TOLL_ENDOGENOUS_PATHWAY,1
BAKER_HEMATOPOIESIS_STAT3_TA...,SET,14,-0.086036,-0.0023749,0.24639,0.63653,BAKER_HEMATOPOIESIS_STAT3_TARGETS,1
GUO_TARGETS_OF_IRS1_AND_IRS2,SET,90,-0.030829,-0.0021532,0.088268,0.63655,GUO_TARGETS_OF_IRS1_AND_IRS2,1
ZNF433_TARGET_GENES,SET,46,-0.042955,-0.0021474,0.12296,0.63658,ZNF433_TARGET_GENES,1
HP_ABSENT_EPIPHYSES,SET,20,-0.073025,-0.0024089,0.20895,0.63663,HP_ABSENT_EPIPHYSES,1
MIR3149,SET,130,-0.02606,-0.0021851,0.074567,0.63664,MIR3149,1
MIR6822_5P,SET,64,-0.034619,-0.0020404,0.099042,0.63666,MIR6822_5P,1
GOBP_SYNAPTIC_SIGNALING,SET,716,-0.011842,-0.0022924,0.033875,0.63667,GOBP_SYNAPTIC_SIGNALING,1
REACTOME_TRAF6_MEDIATED_INDU...,SET,14,-0.08679,-0.0023957,0.24816,0.63673,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,1
GSE46606_UNSTIM_VS_CD40L_IL2...7,SET,180,-0.022658,-0.0022325,0.06478,0.63674,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,1
GSE30083_SP1_VS_SP3_THYMOCYT...2,SET,178,-0.023383,-0.0022912,0.066846,0.63675,GSE30083_SP1_VS_SP3_THYMOCYTE_UP,1
WANG_METASTASIS_OF_BREAST_CA...2,SET,29,-0.057015,-0.0022642,0.16292,0.63681,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,1
GSE17974_0H_VS_2H_IN_VITRO_A...2,SET,166,-0.023182,-0.0021943,0.066243,0.63681,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP,1
GSE19825_IL2RALOW_VS_IL2RAHI...1,SET,182,-0.021476,-0.0021276,0.061348,0.63685,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,1
MEK_UP.V1_UP,SET,175,-0.023797,-0.0023122,0.067973,0.63686,MEK_UP.V1_UP,1
HP_ERLENMEYER_FLASK_DEFORMIT...,SET,8,-0.11785,-0.0024594,0.3366,0.63687,HP_ERLENMEYER_FLASK_DEFORMITY_OF_THE_FEMURS,1
GSE1432_1H_VS_6H_IFNG_MICROG...2,SET,185,-0.02205,-0.0022022,0.062929,0.63698,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,1
GOMF_EPIDERMAL_GROWTH_FACTOR...,SET,33,-0.054473,-0.0023073,0.15543,0.637,GOMF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING,1
GOMF_MYOSIN_II_BINDING,SET,11,-0.089319,-0.0021856,0.25478,0.63705,GOMF_MYOSIN_II_BINDING,1
MODULE_63,SET,197,-0.023156,-0.0023857,0.066035,0.63708,MODULE_63,1
MORF_ACP1,SET,198,-0.019833,-0.0020485,0.056524,0.63716,MORF_ACP1,1
WP_EICOSANOID_METABOLISM_VIA...3,SET,28,-0.056155,-0.0021913,0.16003,0.63717,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,1
GSE15930_NAIVE_VS_72H_IN_VIT...2,SET,188,-0.021357,-0.0021501,0.060852,0.63719,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP,1
GOBP_MHC_CLASS_I_BIOSYNTHETI...,SET,8,-0.12388,-0.0025853,0.35295,0.6372,GOBP_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,1
GOMF_TYPE_2_FIBROBLAST_GROWT...,SET,5,-0.16875,-0.0027845,0.48057,0.63726,GOMF_TYPE_2_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
GOBP_REGULATION_OF_MDA_5_SIG...,SET,6,-0.10386,-0.0018773,0.29563,0.63733,GOBP_REGULATION_OF_MDA_5_SIGNALING_PATHWAY,1
MORF_FSHR,SET,244,-0.019761,-0.0022628,0.056215,0.6374,MORF_FSHR,1
GOBP_REGULATION_OF_CARDIAC_M...8,SET,68,-0.038014,-0.0023092,0.1081,0.63745,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,1
HP_DYSGENESIS_OF_THE_BASAL_G...,SET,5,-0.13129,-0.0021663,0.37333,0.63746,HP_DYSGENESIS_OF_THE_BASAL_GANGLIA,1
HP_STOOPED_POSTURE,SET,8,-0.093891,-0.0019595,0.26695,0.63747,HP_STOOPED_POSTURE,1
HOWARD_NK_CELL_INACT_MONOV_I...2,SET,56,-0.042393,-0.0023377,0.12051,0.63749,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,1
GSE22432_MULTIPOTENT_PROGENI...3,SET,177,-0.021144,-0.0020661,0.060104,0.6375,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN,1
GOBP_CAP_DEPENDENT_TRANSLATI...,SET,7,-0.089097,-0.0017394,0.25304,0.63762,GOBP_CAP_DEPENDENT_TRANSLATIONAL_INITIATION,1
HP_PERIODONTITIS,SET,33,-0.052014,-0.0022032,0.1477,0.63763,HP_PERIODONTITIS,1
WP_RETINOL_METABOLISM,SET,15,-0.08143,-0.0023266,0.23117,0.63767,WP_RETINOL_METABOLISM,1
GOBP_INTERLEUKIN_3_MEDIATED_...,SET,6,-0.14303,-0.0025853,0.40594,0.63771,GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY,1
COREBINDINGFACTOR_Q6,SET,247,-0.019799,-0.002281,0.056167,0.63777,COREBINDINGFACTOR_Q6,1
GOMF_SYNTAXIN_BINDING,SET,59,-0.038174,-0.0021605,0.10828,0.63779,GOMF_SYNTAXIN_BINDING,1
REACTOME_HS_GAG_DEGRADATION,SET,21,-0.070117,-0.00237,0.19885,0.63781,REACTOME_HS_GAG_DEGRADATION,1
HP_ABNORMALITY_OF_OCULAR_ABD...,SET,11,-0.094612,-0.0023151,0.2683,0.63782,HP_ABNORMALITY_OF_OCULAR_ABDUCTION,1
GSE17721_CTRL_VS_GARDIQUIMOD...5,SET,183,-0.022886,-0.0022734,0.064895,0.63783,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN,1
MIR501_5P,SET,125,-0.028263,-0.0023241,0.080128,0.63785,MIR501_5P,1
GOBP_SYNAPTIC_VESICLE_BUDDING,SET,12,-0.085279,-0.0021795,0.24176,0.63786,GOBP_SYNAPTIC_VESICLE_BUDDING,1
REACTOME_SIGNALING_BY_GPCR,SET,652,-0.012982,-0.0024026,0.036755,0.63803,REACTOME_SIGNALING_BY_GPCR,1
HP_ABNORMALITY_OF_FACIAL_MUS...,SET,291,-0.017698,-0.0022104,0.050094,0.63806,HP_ABNORMALITY_OF_FACIAL_MUSCULATURE,1
HP_NEGATIVISM,SET,10,-0.098573,-0.0022999,0.27893,0.6381,HP_NEGATIVISM,1
GOBP_REGULATION_OF_ATP_DEPEN...,SET,58,-0.038663,-0.0021696,0.10939,0.63812,GOBP_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,1
HP_WIDE_ANTERIOR_FONTANEL,SET,80,-0.033902,-0.002233,0.095914,0.63813,HP_WIDE_ANTERIOR_FONTANEL,1
GACAATC_MIR219,SET,134,-0.026706,-0.0022732,0.075543,0.63815,GACAATC_MIR219,1
HAY_BONE_MARROW_NEUTROPHIL,SET,397,-0.015648,-0.002276,0.044255,0.63818,HAY_BONE_MARROW_NEUTROPHIL,1
HP_ABSENT_PATELLAR_REFLEXES,SET,11,-0.09804,-0.002399,0.27724,0.63819,HP_ABSENT_PATELLAR_REFLEXES,1
GOMF_MYOSIN_PHOSPHATASE_ACTI...,SET,69,-0.035052,-0.0021448,0.099085,0.63824,GOMF_MYOSIN_PHOSPHATASE_ACTIVITY,1
AACGGTT_MIR451,SET,9,-0.10884,-0.0024091,0.30756,0.63828,AACGGTT_MIR451,1
HP_BULBAR_SIGNS,SET,32,-0.0505,-0.0021065,0.1427,0.63829,HP_BULBAR_SIGNS,1
GSE32423_MEMORY_VS_NAIVE_CD8...3,SET,178,-0.022715,-0.0022257,0.064184,0.63829,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN,1
GSE27786_BCELL_VS_CD8_TCELL_...2,SET,184,-0.021436,-0.0021351,0.060562,0.63831,GSE27786_BCELL_VS_CD8_TCELL_UP,1
HP_ABNORMAL_OCCIPITAL_BONE_M...,SET,103,-0.02804,-0.0020943,0.07919,0.63836,HP_ABNORMAL_OCCIPITAL_BONE_MORPHOLOGY,1
HP_RADIAL_DEVIATION_OF_THE_H...2,SET,51,-0.042562,-0.0022401,0.12019,0.63838,HP_RADIAL_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
GOBP_RESPONSE_TO_INTERFERON_...1,SET,17,-0.075307,-0.0022904,0.21255,0.63844,GOBP_RESPONSE_TO_INTERFERON_ALPHA,1
GSE28237_FOLLICULAR_VS_EARLY...2,SET,167,-0.022159,-0.0021037,0.06254,0.63844,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP,1
HP_ABNORMAL_SEX_DETERMINATION,SET,18,-0.076342,-0.0023892,0.21546,0.63845,HP_ABNORMAL_SEX_DETERMINATION,1
HP_OPTIC_DISC_PALLOR,SET,216,-0.019893,-0.002145,0.056144,0.63845,HP_OPTIC_DISC_PALLOR,1
MIR4288,SET,144,-0.026446,-0.0023329,0.074619,0.63848,MIR4288,1
MIR4757_5P,SET,55,-0.042344,-0.0023141,0.11948,0.63848,MIR4757_5P,1
HE_LIM_SUN_FETAL_LUNG_C2_DC1...,SET,291,-0.01811,-0.0022618,0.0511,0.63848,HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL,1
GSE39820_CTRL_VS_TGFBETA3_IL...2,SET,177,-0.022277,-0.0021767,0.062821,0.63856,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP,1
HP_ABNORMAL_PROPORTION_OF_CD...3,SET,17,-0.070755,-0.002152,0.1995,0.63858,HP_ABNORMAL_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
PID_PI3KCI_PATHWAY,SET,47,-0.04396,-0.0022213,0.12392,0.6386,PID_PI3KCI_PATHWAY,1
GNF2_KPNB1,SET,65,-0.034827,-0.0020685,0.098163,0.63862,GNF2_KPNB1,1
HP_ABNORMAL_SHAPE_OF_THE_PAL...,SET,51,-0.040683,-0.0021412,0.11466,0.63863,HP_ABNORMAL_SHAPE_OF_THE_PALPEBRAL_FISSURE,1
GOBP_EMBRYONIC_ORGAN_DEVELOP...,SET,429,-0.015653,-0.0023646,0.044112,0.63864,GOBP_EMBRYONIC_ORGAN_DEVELOPMENT,1
YGCANTGCR_UNKNOWN,SET,109,-0.028936,-0.0022229,0.081511,0.6387,YGCANTGCR_UNKNOWN,1
KEGG_MEDICUS_VARIANT_TRK_FUS...,SET,10,-0.089056,-0.0020778,0.25084,0.63871,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_DTMP_METABOLIC_PROCESS,SET,6,-0.11061,-0.0019992,0.31149,0.63874,GOBP_DTMP_METABOLIC_PROCESS,1
HP_CONCAVE_NASAL_RIDGE,SET,21,-0.071038,-0.0024011,0.20006,0.63874,HP_CONCAVE_NASAL_RIDGE,1
GSE27786_CD4_TCELL_VS_NKCELL...2,SET,183,-0.021766,-0.0021622,0.06129,0.63875,GSE27786_CD4_TCELL_VS_NKCELL_UP,1
MIR542_3P,SET,125,-0.027631,-0.0022721,0.077789,0.63878,MIR542_3P,1
GAVISH_3CA_METAPROGRAM_CD8_T...7,SET,48,-0.045575,-0.0023272,0.1283,0.63878,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_INTERFERON,1
KANNAN_TP53_TARGETS_UP,SET,55,-0.039859,-0.0021783,0.11212,0.6389,KANNAN_TP53_TARGETS_UP,1
GSE19401_UNSTIM_VS_RETINOIC_...2,SET,177,-0.021794,-0.0021296,0.061301,0.6389,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
GSE5099_UNSTIM_VS_MCSF_TREAT...1,SET,186,-0.021532,-0.0021562,0.060564,0.6389,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN,1
GOBP_CELLULAR_RESPONSE_TO_ST...5,SET,1635,-0.0076687,-0.0021842,0.021564,0.63894,GOBP_CELLULAR_RESPONSE_TO_STRESS,1
GOBP_WNT_SIGNALING_PATHWAY_P...,SET,48,-0.046378,-0.0023682,0.13037,0.63898,GOBP_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,1
MODULE_149,SET,34,-0.047727,-0.0020519,0.13415,0.639,MODULE_149,1
RAMASWAMY_METASTASIS_DN,SET,51,-0.042153,-0.0022186,0.11846,0.63902,RAMASWAMY_METASTASIS_DN,1
FAN_OVARY_CL7_ANGEIOGENIC_EN...,SET,223,-0.021726,-0.0023798,0.061047,0.63904,FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL,1
GOMF_DEUBIQUITINASE_ACTIVATO...,SET,7,-0.099801,-0.0019483,0.28035,0.63907,GOMF_DEUBIQUITINASE_ACTIVATOR_ACTIVITY,1
MIR151A_3P,SET,30,-0.05914,-0.0023886,0.16611,0.63909,MIR151A_3P,1
GOBP_REGULATION_OF_EXTRINSIC...3,SET,45,-0.043688,-0.0021602,0.12271,0.63909,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
SERVITJA_ISLET_HNF1A_TARGETS...1,SET,100,-0.032392,-0.0023841,0.090932,0.63916,SERVITJA_ISLET_HNF1A_TARGETS_DN,1
CTAWWWATA_RSRFC4_Q2,SET,324,-0.017532,-0.0023084,0.049209,0.63918,CTAWWWATA_RSRFC4_Q2,1
HP_HYPOPLASTIC_SACRUM,SET,6,-0.11608,-0.0020981,0.32578,0.63919,HP_HYPOPLASTIC_SACRUM,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,SET,132,-0.026586,-0.0022461,0.074613,0.6392,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1
WP_MIRNA_REGULATION_OF_PROST...,SET,29,-0.056501,-0.0022438,0.15839,0.63934,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,1
GSE13522_WT_VS_IFNAR_KO_SKIN...2,SET,187,-0.023534,-0.002363,0.065974,0.63935,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,1
FAN_OVARY_CL10_PUTATIVE_EARL...,SET,225,-0.018856,-0.0020746,0.052843,0.63939,FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL,1
MIR346,SET,61,-0.039125,-0.0022514,0.10964,0.6394,MIR346,1
HP_ACROPARESTHESIA,SET,9,-0.11018,-0.0024389,0.30876,0.6394,HP_ACROPARESTHESIA,1
MIR4685_5P,SET,113,-0.028049,-0.0021937,0.078566,0.63946,MIR4685_5P,1
REACTOME_REGULATION_BY_C_FLIP,SET,11,-0.094642,-0.0023159,0.26507,0.63947,REACTOME_REGULATION_BY_C_FLIP,1
ALKBH3_TARGET_GENES,SET,353,-0.016041,-0.0022028,0.044906,0.63953,ALKBH3_TARGET_GENES,1
HP_ABNORMAL_URINE_MAGNESIUM_...,SET,9,-0.10482,-0.0023203,0.29336,0.63957,HP_ABNORMAL_URINE_MAGNESIUM_CONCENTRATION,1
GSE17721_CTRL_VS_LPS_2H_BMDC...1,SET,183,-0.022961,-0.0022809,0.064241,0.63961,GSE17721_CTRL_VS_LPS_2H_BMDC_DN,1
GOMF_CCR1_CHEMOKINE_RECEPTOR...,SET,5,-0.1432,-0.0023628,0.40052,0.63965,GOMF_CCR1_CHEMOKINE_RECEPTOR_BINDING,1
HP_MOTOR_POLYNEUROPATHY,SET,33,-0.051705,-0.0021901,0.14462,0.63965,HP_MOTOR_POLYNEUROPATHY,1
WP_IMATINIB_AND_CHRONIC_MYEL...,SET,19,-0.074664,-0.0024006,0.20881,0.63966,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,1
HP_ANAL_STENOSIS,SET,30,-0.060429,-0.0024407,0.169,0.63966,HP_ANAL_STENOSIS,1
HP_ABNORMALITY_OF_THE_BLADDER,SET,465,-0.014486,-0.0022759,0.040508,0.63968,HP_ABNORMALITY_OF_THE_BLADDER,1
GSE21033_1H_VS_24H_POLYIC_ST...2,SET,154,-0.024768,-0.0022589,0.069223,0.63975,GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP,1
HP_PROGRESSIVE_SPASTICITY,SET,26,-0.059143,-0.002224,0.16525,0.63979,HP_PROGRESSIVE_SPASTICITY,1
REACTOME_ERYTHROCYTES_TAKE_U...2,SET,7,-0.12301,-0.0024015,0.34365,0.63981,REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE,1
HP_LACRIMAL_DUCT_APLASIA,SET,9,-0.1014,-0.0022445,0.28325,0.63982,HP_LACRIMAL_DUCT_APLASIA,1
GSE6259_CD4_TCELL_VS_CD8_TCE...1,SET,165,-0.022714,-0.0021436,0.063446,0.63983,GSE6259_CD4_TCELL_VS_CD8_TCELL_DN,1
HP_2_HYDROXYGLUTARATE_ACIDUR...,SET,5,-0.15242,-0.002515,0.42546,0.63992,HP_2_HYDROXYGLUTARATE_ACIDURIA,1
GOMF_MEMBRANE_INSERTASE_ACTI...,SET,14,-0.074598,-0.0020592,0.20821,0.63993,GOMF_MEMBRANE_INSERTASE_ACTIVITY,1
GOBP_ASPARTATE_TRANSMEMBRANE...,SET,20,-0.069827,-0.0023034,0.19473,0.64005,GOBP_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
NIKOLSKY_BREAST_CANCER_16Q24...,SET,50,-0.081888,-0.0042675,0.22831,0.64007,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,1
GOBP_ADULT_LOCOMOTORY_BEHAVI...,SET,79,-0.036028,-0.0023582,0.1004,0.64014,GOBP_ADULT_LOCOMOTORY_BEHAVIOR,1
GOBP_CELLULAR_RESPONSE_TO_MA...2,SET,7,-0.12027,-0.0023479,0.33514,0.64015,GOBP_CELLULAR_RESPONSE_TO_MAGNESIUM_ION,1
GSE10094_LCMV_VS_LISTERIA_IN...2,SET,175,-0.02204,-0.0021415,0.061378,0.64023,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP,1
GOCC_TRANSCRIPTION_EXPORT_CO...2,SET,4,-0.13816,-0.0020391,0.38467,0.64027,GOCC_TRANSCRIPTION_EXPORT_COMPLEX_2,1
MIR3144_5P,SET,46,-0.04621,-0.0023101,0.12861,0.64031,MIR3144_5P,1
HP_VENTILATOR_DEPENDENCE_WIT...,SET,4,-0.15252,-0.002251,0.42452,0.64031,HP_VENTILATOR_DEPENDENCE_WITH_INABILITY_TO_WEAN,1
WP_ENDOMETRIAL_CANCER,SET,61,-0.038813,-0.0022335,0.108,0.64034,WP_ENDOMETRIAL_CANCER,1
CUI_DEVELOPING_HEART_C7_MAST...,SET,135,-0.027777,-0.0023731,0.077294,0.64034,CUI_DEVELOPING_HEART_C7_MAST_CELL,1
HP_FLAT_FACE,SET,94,-0.031192,-0.0022261,0.086754,0.6404,HP_FLAT_FACE,1
GSE3982_NEUTROPHIL_VS_EFF_ME...1,SET,181,-0.021581,-0.0021322,0.06002,0.64041,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,1
FLECHNER_BIOPSY_KIDNEY_TRANS...4,SET,80,-0.034483,-0.0022713,0.09582,0.64053,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1
HP_RETINAL_PERFORATION,SET,10,-0.098237,-0.002292,0.27291,0.64056,HP_RETINAL_PERFORATION,1
WP_ATR_SIGNALING,SET,11,-0.081766,-0.0020008,0.22706,0.64061,WP_ATR_SIGNALING,1
MIKKELSEN_NPC_HCP_WITH_H3K27...,SET,330,-0.019165,-0.0025462,0.053218,0.64062,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,1
MIR3650,SET,49,-0.043457,-0.0022421,0.12066,0.64063,MIR3650,1
GOBP_HEART_TRABECULA_MORPHOG...,SET,31,-0.060797,-0.0024961,0.1688,0.64064,GOBP_HEART_TRABECULA_MORPHOGENESIS,1
VALK_AML_CLUSTER_11,SET,37,-0.053237,-0.0023875,0.1478,0.64065,VALK_AML_CLUSTER_11,1
REACTOME_TRAFFICKING_OF_GLUR...,SET,15,-0.083812,-0.0023946,0.23255,0.64072,REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,1
GSE21063_CTRL_VS_ANTI_IGM_ST...7,SET,175,-0.022217,-0.0021587,0.061631,0.64075,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...1,SET,179,-0.023868,-0.0023452,0.066205,0.64077,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
MIR92A_1_5P,SET,40,-0.049105,-0.0022895,0.13617,0.6408,MIR92A_1_5P,1
NOUSHMEHR_GBM_SILENCED_BY_ME...,SET,45,-0.04743,-0.0023453,0.13152,0.64081,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,1
HP_IRREGULAR_ACETABULAR_ROOF,SET,6,-0.11478,-0.0020746,0.31821,0.64083,HP_IRREGULAR_ACETABULAR_ROOF,1
GSE9037_CTRL_VS_LPS_1H_STIM_...3,SET,174,-0.023617,-0.0022882,0.065479,0.64083,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_PRO...2,SET,44,-0.046613,-0.0022792,0.12921,0.64085,HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL,1
SHI_SPARC_TARGETS_DN,SET,12,-0.099724,-0.0025487,0.27627,0.64094,SHI_SPARC_TARGETS_DN,1
KONDO_COLON_CANCER_HCP_WITH_...1,SET,22,-0.070241,-0.00243,0.19454,0.64097,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,1
GOBP_RESPONSE_TO_FATTY_ACID,SET,54,-0.046843,-0.0025367,0.12972,0.64098,GOBP_RESPONSE_TO_FATTY_ACID,1
MIR6783_3P,SET,185,-0.022469,-0.0022441,0.062212,0.64101,MIR6783_3P,1
GOBP_DORSAL_ROOT_GANGLION_DE...,SET,7,-0.13778,-0.0026897,0.38128,0.64108,GOBP_DORSAL_ROOT_GANGLION_DEVELOPMENT,1
GOBP_REGULATION_OF_STEROID_B...,SET,68,-0.040219,-0.0024431,0.1113,0.64108,GOBP_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS,1
HP_UNILATERAL_RENAL_HYPOPLAS...,SET,4,-0.15429,-0.0022772,0.42699,0.64108,HP_UNILATERAL_RENAL_HYPOPLASIA,1
GOBP_NEURON_INTRINSIC_APOPTO...,SET,18,-0.078585,-0.0024594,0.21741,0.64112,GOBP_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,1
GOBP_NEGATIVE_REGULATION_OF_...52,SET,15,-0.082076,-0.002345,0.22702,0.64115,GOBP_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION,1
PID_AMB2_NEUTROPHILS_PATHWAY,SET,40,-0.050087,-0.0023353,0.13852,0.64117,PID_AMB2_NEUTROPHILS_PATHWAY,1
MIR5194,SET,33,-0.055654,-0.0023574,0.15388,0.6412,MIR5194,1
GOBP_NEGATIVE_REGULATION_OF_...122,SET,15,-0.082432,-0.0023552,0.22788,0.64122,GOBP_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GOBP_KERATINOCYTE_PROLIFERAT...,SET,56,-0.044702,-0.0024651,0.12357,0.64123,GOBP_KERATINOCYTE_PROLIFERATION,1
GOBP_REGULATION_OF_GLIAL_CEL...4,SET,36,-0.051511,-0.0022787,0.14238,0.64125,GOBP_REGULATION_OF_GLIAL_CELL_PROLIFERATION,1
GOMF_DNA_NUCLEASE_ACTIVITY,SET,59,-0.037958,-0.0021483,0.10491,0.64125,GOMF_DNA_NUCLEASE_ACTIVITY,1
GOMF_CELL_MATRIX_ADHESION_ME...,SET,8,-0.12187,-0.0025433,0.33677,0.64127,GOMF_CELL_MATRIX_ADHESION_MEDIATOR_ACTIVITY,1
HP_ANTERIOR_PLAGIOCEPHALY,SET,5,-0.15544,-0.0025648,0.42933,0.64134,HP_ANTERIOR_PLAGIOCEPHALY,1
MIR4290,SET,62,-0.036377,-0.0021103,0.10047,0.64135,MIR4290,1
DESCARTES_FETAL_PLACENTA_LYM...,SET,114,-0.030504,-0.0023962,0.084242,0.64136,DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS,1
GSE360_T_GONDII_VS_B_MALAYI_...7,SET,184,-0.022055,-0.0021968,0.060902,0.64137,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
GOCC_EUKARYOTIC_TRANSLATION_...2,SET,3,-0.16858,-0.0021547,0.46536,0.64142,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2_COMPLEX,1
GOBP_SPERMIDINE_TRANSPORT,SET,5,-0.16971,-0.0028003,0.46835,0.64146,GOBP_SPERMIDINE_TRANSPORT,1
GSE24142_EARLY_THYMIC_PROGEN...6,SET,188,-0.023993,-0.0024154,0.066211,0.64146,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP,1
GSE6259_DEC205_POS_DC_VS_CD8...2,SET,168,-0.023033,-0.0021932,0.063563,0.64146,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP,1
GOBP_L_LEUCINE_IMPORT_ACROSS...,SET,5,-0.14035,-0.0023158,0.38726,0.64148,GOBP_L_LEUCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_HYPEROXALURIA,SET,6,-0.12128,-0.0021921,0.33465,0.64148,HP_HYPEROXALURIA,1
GOBP_REGULATION_OF_PROTEIN_O...,SET,5,-0.14743,-0.0024326,0.40646,0.64159,GOBP_REGULATION_OF_PROTEIN_OLIGOMERIZATION,1
GOBP_AROMATIC_AMINO_ACID_TRA...,SET,9,-0.10725,-0.0023739,0.2956,0.64163,GOBP_AROMATIC_AMINO_ACID_TRANSPORT,1
GOBP_AMYLOID_BETA_CLEARANCE_...1,SET,8,-0.11305,-0.0023594,0.31145,0.64169,GOBP_AMYLOID_BETA_CLEARANCE_BY_CELLULAR_CATABOLIC_PROCESS,1
GOBP_T_CELL_RECEPTOR_SIGNALI...,SET,127,-0.028166,-0.0023344,0.077579,0.64172,GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
HP_ACQUIRED_ABNORMAL_HAIR_PA...,SET,34,-0.055358,-0.00238,0.15243,0.64176,HP_ACQUIRED_ABNORMAL_HAIR_PATTERN,1
WP_AIRWAY_SMOOTH_MUSCLE_CELL...,SET,15,-0.084171,-0.0024049,0.23172,0.64179,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,1
CDPCR1_01,SET,117,-0.030665,-0.0024401,0.084403,0.64181,CDPCR1_01,1
HOLLEMAN_VINCRISTINE_RESISTA...1,SET,19,-0.071024,-0.0022836,0.19527,0.64196,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,1
PDGF_ERK_DN.V1_UP,SET,125,-0.026386,-0.0021698,0.072527,0.642,PDGF_ERK_DN.V1_UP,1
GOCC_UBIQUITIN_LIGASE_COMPLEX,SET,281,-0.018139,-0.0022268,0.049856,0.64201,GOCC_UBIQUITIN_LIGASE_COMPLEX,1
CHEN_HOXA5_TARGETS_9HR_DN,SET,37,-0.053218,-0.0023866,0.14624,0.64204,CHEN_HOXA5_TARGETS_9HR_DN,1
HP_AUDITORY_HALLUCINATION,SET,16,-0.075457,-0.0022266,0.20729,0.64207,HP_AUDITORY_HALLUCINATION,1
GSE22886_NAIVE_CD4_TCELL_VS_...11,SET,179,-0.022585,-0.0022191,0.062036,0.64209,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN,1
LET_7F_1_3P,SET,663,-0.012512,-0.0023343,0.034354,0.64214,LET_7F_1_3P,1
GOBP_REGULATION_OF_CELL_PROL...2,SET,6,-0.11464,-0.0020722,0.3148,0.64214,GOBP_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,1
TSAI_DNAJB4_TARGETS_DN,SET,6,-0.12826,-0.0023182,0.35202,0.6422,TSAI_DNAJB4_TARGETS_DN,1
GOBP_FIBROBLAST_GROWTH_FACTO...2,SET,74,-0.039488,-0.0025019,0.10837,0.64221,GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_MORPHOGEN...2,SET,46,-0.050067,-0.0025029,0.13733,0.64228,GOBP_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,1
MIR4527,SET,64,-0.039586,-0.0023331,0.10849,0.6424,MIR4527,1
GOBP_MODULATION_OF_MICROTUBU...,SET,4,-0.1488,-0.002196,0.4078,0.6424,GOBP_MODULATION_OF_MICROTUBULE_CYTOSKELETON_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,1
HP_POOR_WOUND_HEALING,SET,40,-0.050321,-0.0023462,0.13783,0.64247,HP_POOR_WOUND_HEALING,1
REACTOME_ASSEMBLY_AND_CELL_S...,SET,39,-0.053301,-0.002454,0.14599,0.64248,REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS,1
GOBP_DEOXYRIBONUCLEOTIDE_CAT...,SET,28,-0.060158,-0.0023475,0.16477,0.64248,GOBP_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,1
MODULE_137,SET,492,-0.015181,-0.0024516,0.041573,0.64251,MODULE_137,1
GOBP_POSITIVE_REGULATION_OF_...148,SET,6,-0.12137,-0.0021937,0.3323,0.64253,GOBP_POSITIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,1
GSE2770_IL12_AND_TGFB_ACT_VS...6,SET,171,-0.024354,-0.0023394,0.066676,0.64254,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP,1
LET_7A_3P,SET,665,-0.012535,-0.0023421,0.034299,0.64262,LET_7A_3P,1
MUNSHI_MULTIPLE_MYELOMA_UP,SET,70,-0.03731,-0.0022994,0.10206,0.64265,MUNSHI_MULTIPLE_MYELOMA_UP,1
GNF2_IGF1,SET,25,-0.06451,-0.0023788,0.17646,0.64266,GNF2_IGF1,1
GSE14908_RESTING_VS_HDM_STIM...2,SET,177,-0.022204,-0.0021696,0.060713,0.64271,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP,1
HP_ABNORMAL_TARSAL_OSSIFICAT...,SET,8,-0.10623,-0.0022171,0.29039,0.64275,HP_ABNORMAL_TARSAL_OSSIFICATION,1
GOBP_CELLULAR_RESPONSE_TO_UV...2,SET,10,-0.098998,-0.0023098,0.27059,0.64276,GOBP_CELLULAR_RESPONSE_TO_UV_B,1
HP_SHORT_STEPPED_SHUFFLING_G...,SET,14,-0.082158,-0.0022678,0.22453,0.64278,HP_SHORT_STEPPED_SHUFFLING_GAIT,1
HOFFMANN_PRE_BI_TO_LARGE_PRE...2,SET,26,-0.059406,-0.0022339,0.16231,0.64281,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,1
TCGA_GLIOBLASTOMA_MUTATED,SET,8,-0.10315,-0.0021527,0.28173,0.64286,TCGA_GLIOBLASTOMA_MUTATED,1
GOBP_ICOSANOID_TRANSPORT,SET,64,-0.042275,-0.0024916,0.11547,0.64286,GOBP_ICOSANOID_TRANSPORT,1
GSE9960_GRAM_NEG_VS_GRAM_NEG...2,SET,151,-0.025482,-0.0023014,0.069567,0.64292,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,1
ODONNELL_METASTASIS_UP,SET,70,-0.039936,-0.0024612,0.10902,0.64293,ODONNELL_METASTASIS_UP,1
GSE27859_MACROPHAGE_VS_CD11C...1,SET,169,-0.023325,-0.0022275,0.063677,0.64293,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,1
GOMF_TRACE_AMINE_RECEPTOR_AC...,SET,6,-0.19217,-0.0034734,0.52451,0.64296,GOMF_TRACE_AMINE_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_FORAMEN_MAGNUM_M...,SET,16,-0.071189,-0.0021006,0.19429,0.64296,HP_ABNORMAL_FORAMEN_MAGNUM_MORPHOLOGY,1
TFCP2_TARGET_GENES,SET,76,-0.035476,-0.0022777,0.096809,0.64298,TFCP2_TARGET_GENES,1
GSE29618_MONOCYTE_VS_PDC_DN,SET,170,-0.024344,-0.0023317,0.066429,0.64299,GSE29618_MONOCYTE_VS_PDC_DN,1
GSE2770_TGFB_AND_IL4_VS_TGFB...3,SET,170,-0.024004,-0.0022991,0.065493,0.64301,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
HP_INCREASED_PULMONARY_VASCU...,SET,13,-0.098029,-0.0026076,0.26743,0.64302,HP_INCREASED_PULMONARY_VASCULAR_RESISTANCE,1
GSE1112_OT1_CD8AB_VS_HY_CD8A...2,SET,132,-0.028177,-0.0023806,0.076844,0.64307,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,1
CREIGHTON_ENDOCRINE_THERAPY_...3,SET,650,-0.013167,-0.0024333,0.035901,0.6431,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,1
HP_RAYNAUD_PHENOMENON,SET,41,-0.050763,-0.0023962,0.1384,0.64311,HP_RAYNAUD_PHENOMENON,1
BIOCARTA_NDKDYNAMIN_PATHWAY,SET,17,-0.07733,-0.002352,0.21079,0.64314,BIOCARTA_NDKDYNAMIN_PATHWAY,1
WP_PARKINSONS_DISEASE_PATHWAY,SET,33,-0.053548,-0.0022682,0.14596,0.64314,WP_PARKINSONS_DISEASE_PATHWAY,1
HP_INCREASED_FECAL_PORPHYRIN,SET,4,-0.14317,-0.002113,0.39023,0.64315,HP_INCREASED_FECAL_PORPHYRIN,1
SILIGAN_TARGETS_OF_EWS_FLI1_...1,SET,17,-0.076648,-0.0023313,0.2089,0.64316,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,1
MIR122_5P,SET,82,-0.033459,-0.0022311,0.091166,0.64319,MIR122_5P,1
GOBP_ESTABLISHMENT_OF_LYMPHO...,SET,15,-0.08419,-0.0024054,0.22935,0.64322,GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY,1
GOBP_AMYGDALA_DEVELOPMENT,SET,5,-0.14269,-0.0023544,0.38868,0.64323,GOBP_AMYGDALA_DEVELOPMENT,1
FONTAINE_FOLLICULAR_THYROID_...2,SET,70,-0.036426,-0.0022449,0.099205,0.64326,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,1
DESCARTES_FETAL_INTESTINE_CH...,SET,86,-0.037053,-0.00253,0.10086,0.64333,DESCARTES_FETAL_INTESTINE_CHROMAFFIN_CELLS,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...2,SET,6,-0.14951,-0.0027024,0.40692,0.64335,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_POSITIVE,1
GSE3982_EOSINOPHIL_VS_MAC_DN,SET,177,-0.0237,-0.0023157,0.064462,0.64343,GSE3982_EOSINOPHIL_VS_MAC_DN,1
GOBP_POSITIVE_REGULATION_OF_...136,SET,19,-0.075476,-0.0024268,0.20528,0.64344,GOBP_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GOMF_OPSONIN_BINDING,SET,16,-0.08634,-0.0025477,0.23476,0.64348,GOMF_OPSONIN_BINDING,1
GSE29949_CD8_POS_DC_SPLEEN_V...1,SET,173,-0.024235,-0.0023414,0.06589,0.64349,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN,1
GOBP_PURINE_CONTAINING_COMPO...3,SET,14,-0.090316,-0.002493,0.24546,0.64354,GOBP_PURINE_CONTAINING_COMPOUND_SALVAGE,1
MODULE_182,SET,89,-0.03242,-0.0022517,0.088107,0.64355,MODULE_182,1
GOMF_ARACHIDONIC_ACID_MONOOX...,SET,18,-0.087117,-0.0027264,0.23673,0.64356,GOMF_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY,1
LAKE_ADULT_KIDNEY_C28_INTERS...,SET,79,-0.038971,-0.0025508,0.1059,0.64356,LAKE_ADULT_KIDNEY_C28_INTERSTITIUM,1
GOBERT_OLIGODENDROCYTE_DIFFE...1,SET,979,-0.010534,-0.0023667,0.028623,0.64357,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN,1
GOBP_EMBRYONIC_DIGESTIVE_TRA...2,SET,17,-0.087116,-0.0026496,0.23664,0.64361,GOBP_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS,1
MIR142_5P,SET,314,-0.017797,-0.0023075,0.048343,0.64362,MIR142_5P,1
WP_CANNABINOID_RECEPTOR_SIGN...,SET,29,-0.06172,-0.002451,0.16763,0.64363,WP_CANNABINOID_RECEPTOR_SIGNALING,1
HP_DILATION_OF_VIRCHOW_ROBIN...,SET,13,-0.090088,-0.0023963,0.24468,0.64363,HP_DILATION_OF_VIRCHOW_ROBIN_SPACES,1
KEGG_MEDICUS_REFERENCE_E2_ER...,SET,22,-0.06348,-0.0021961,0.17239,0.64365,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...522,SET,28,-0.065751,-0.0025658,0.17854,0.64367,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
GOBP_PERICYTE_CELL_DIFFERENT...,SET,10,-0.10499,-0.0024496,0.28498,0.64371,GOBP_PERICYTE_CELL_DIFFERENTIATION,1
SHARMA_PILOCYTIC_ASTROCYTOMA...2,SET,26,-0.064464,-0.0024241,0.17494,0.64374,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,1
GOBP_CIRCADIAN_REGULATION_OF...,SET,61,-0.041585,-0.002393,0.11285,0.64374,GOBP_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION,1
GALI_TP53_TARGETS_APOPTOTIC_...1,SET,6,-0.11106,-0.0020073,0.30133,0.64377,GALI_TP53_TARGETS_APOPTOTIC_DN,1
REACTOME_SHC_MEDIATED_CASCAD...2,SET,17,-0.075429,-0.0022942,0.20458,0.64382,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,1
FULLER_PBMC_F_TULARENSIS_VAC...2,SET,7,-0.11524,-0.0022497,0.31237,0.6439,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_336HR_SUSTAINED_UP,1
MIR6731_5P,SET,206,-0.022802,-0.0024018,0.061766,0.644,MIR6731_5P,1
MIR3166,SET,103,-0.032355,-0.0024166,0.087615,0.64404,MIR3166,1
GGATCCG_MIR127,SET,9,-0.12228,-0.0027067,0.33115,0.64404,GGATCCG_MIR127,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...3,SET,431,-0.015779,-0.0023891,0.042717,0.64408,FAN_EMBRYONIC_CTX_BIG_GROUPS_CAJAL_RETZIUS,1
GOUYER_TATI_TARGETS_UP,SET,10,-0.11503,-0.0026839,0.31137,0.6441,GOUYER_TATI_TARGETS_UP,1
LET_7B_3P,SET,662,-0.012703,-0.0023682,0.034366,0.64417,LET_7B_3P,1
MODULE_265,SET,25,-0.068864,-0.0025394,0.18629,0.64418,MODULE_265,1
GSE37533_PPARG1_FOXP3_VS_PPA...1,SET,183,-0.023067,-0.0022914,0.062402,0.64418,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN,1
MORF_MAGEA8,SET,226,-0.021811,-0.0024049,0.058998,0.64419,MORF_MAGEA8,1
HP_HYPERACUSIS,SET,23,-0.071566,-0.0025314,0.19359,0.64419,HP_HYPERACUSIS,1
REACTOME_SPHINGOLIPID_METABO...,SET,95,-0.032623,-0.0023406,0.088225,0.64422,REACTOME_SPHINGOLIPID_METABOLISM,1
GOBP_STRIATED_MUSCLE_TISSUE_...,SET,239,-0.021718,-0.0024617,0.058734,0.64422,GOBP_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,1
HP_ABNORMAL_BREATH_SOUND,SET,112,-0.029715,-0.0023138,0.080343,0.64425,HP_ABNORMAL_BREATH_SOUND,1
HP_JOINT_CONTRACTURE_OF_THE_...3,SET,237,-0.021218,-0.0023951,0.057371,0.64425,HP_JOINT_CONTRACTURE_OF_THE_HAND,1
chr4p15,SET,46,-0.092192,-0.0046088,0.24923,0.64427,chr4p15,1
NEWMAN_ERCC6_TARGETS_DN,SET,33,-0.062317,-0.0026396,0.16821,0.64448,NEWMAN_ERCC6_TARGETS_DN,1
GOBP_REGULATION_OF_CYTOSOLIC...,SET,52,-0.048622,-0.0025839,0.13121,0.64451,GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GSE3982_EFF_MEMORY_CD4_TCELL...1,SET,172,-0.023878,-0.0023003,0.064422,0.64455,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN,1
GOBP_EPIDIDYMIS_DEVELOPMENT,SET,3,-0.21555,-0.0027551,0.58145,0.64457,GOBP_EPIDIDYMIS_DEVELOPMENT,1
GOMF_NEUREXIN_FAMILY_PROTEIN...,SET,8,-0.11674,-0.0024362,0.31475,0.64463,GOMF_NEUREXIN_FAMILY_PROTEIN_BINDING,1
GSE29617_CTRL_VS_DAY7_TIV_FL...2,SET,170,-0.026334,-0.0025223,0.070993,0.64466,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,1
MIR6892_5P,SET,84,-0.034673,-0.0023399,0.093451,0.64469,MIR6892_5P,1
NOTCH_DN.V1_UP,SET,157,-0.02597,-0.0023912,0.069995,0.64469,NOTCH_DN.V1_UP,1
HP_AUTISTIC_BEHAVIOR,SET,499,-0.014434,-0.0023471,0.038899,0.64471,HP_AUTISTIC_BEHAVIOR,1
BIOCARTA_MSP_PATHWAY,SET,6,-0.12905,-0.0023325,0.34773,0.64472,BIOCARTA_MSP_PATHWAY,1
MIR3622B_5P,SET,46,-0.046237,-0.0023115,0.12455,0.64476,MIR3622B_5P,1
GSE7768_OVA_ALONE_VS_OVA_WIT...2,SET,155,-0.024837,-0.0022724,0.066908,0.64476,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
WP_MACROPHAGESTIMULATING_PRO...,SET,104,-0.033712,-0.0025301,0.090797,0.64479,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,1
GOMF_POTASSIUM_CHANNEL_REGUL...,SET,46,-0.047281,-0.0023636,0.12734,0.64479,GOMF_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_CHROMOSOM...3,SET,125,-0.027569,-0.002267,0.074223,0.64484,GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION,1
GSE14769_40MIN_VS_360MIN_LPS...1,SET,189,-0.022108,-0.0022315,0.059508,0.64487,GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN,1
BIOCARTA_COMP_PATHWAY,SET,15,-0.090675,-0.0025907,0.24406,0.64488,BIOCARTA_COMP_PATHWAY,1
MODULE_210,SET,26,-0.067533,-0.0025396,0.18177,0.64488,MODULE_210,1
GOBP_REGULATION_OF_SKELETAL_...5,SET,16,-0.077238,-0.0022791,0.20789,0.64488,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION,1
GOBP_DNA_STRAND_ELONGATION_I...,SET,14,-0.073494,-0.0020287,0.19778,0.6449,GOBP_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,1
MIR10393_5P,SET,135,-0.027703,-0.0023668,0.074542,0.64492,MIR10393_5P,1
GOBP_RESPONSE_TO_AXON_INJURY,SET,79,-0.036694,-0.0024018,0.098729,0.64493,GOBP_RESPONSE_TO_AXON_INJURY,1
VANDESLUIS_COMMD1_TARGETS_GR...4,SET,17,-0.084673,-0.0025753,0.2278,0.64494,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,1
ZHAN_LATE_DIFFERENTIATION_GE...1,SET,14,-0.077341,-0.0021349,0.20805,0.64496,ZHAN_LATE_DIFFERENTIATION_GENES_DN,1
GOCC_EXORIBONUCLEASE_COMPLEX,SET,22,-0.061352,-0.0021225,0.16503,0.64496,GOCC_EXORIBONUCLEASE_COMPLEX,1
KEGG_MEDICUS_VARIANT_MUTATIO...63,SET,27,-0.05545,-0.0021248,0.14915,0.64497,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT,1
WP_METABOLIC_REPROGRAMMING_I...2,SET,41,-0.050353,-0.0023768,0.13542,0.64498,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,1
MSX1_TARGET_GENES,SET,167,-0.024868,-0.0023609,0.066881,0.64498,MSX1_TARGET_GENES,1
GSE14769_40MIN_VS_360MIN_LPS...2,SET,179,-0.022672,-0.0022277,0.060973,0.64499,GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP,1
MASRI_RESISTANCE_TO_TAMOXIFE...1,SET,16,-0.08818,-0.002602,0.23708,0.64503,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,1
AIZARANI_LIVER_C25_KUPFFER_C...,SET,158,-0.027188,-0.0025112,0.073083,0.64506,AIZARANI_LIVER_C25_KUPFFER_CELLS_4,1
RFX7_TARGET_GENES,SET,402,-0.015804,-0.0023127,0.042476,0.64507,RFX7_TARGET_GENES,1
CREB_01,SET,241,-0.020919,-0.0023809,0.056228,0.64507,CREB_01,1
GOBP_ADENYLATE_CYCLASE_INHIB...5,SET,7,-0.14301,-0.002792,0.3843,0.6451,GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
GSE37533_PPARG2_FOXP3_VS_FOX...1,SET,182,-0.02413,-0.0023905,0.064838,0.64511,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...35,SET,11,-0.076998,-0.0018841,0.20688,0.64512,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_BODY,1
GOMF_NADH_DEHYDROGENASE_ACTI...,SET,8,-0.10155,-0.0021193,0.27285,0.64512,GOMF_NADH_DEHYDROGENASE_ACTIVITY,1
YAO_TEMPORAL_RESPONSE_TO_PRO...11,SET,52,-0.041322,-0.002196,0.11101,0.64514,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,1
GOMF_MELANOCORTIN_RECEPTOR_A...,SET,6,-0.14158,-0.002559,0.38029,0.64516,GOMF_MELANOCORTIN_RECEPTOR_ACTIVITY,1
HP_APLASTIC_CLAVICLE,SET,16,-0.071868,-0.0021206,0.19302,0.64518,HP_APLASTIC_CLAVICLE,1
MODULE_557,SET,9,-0.12721,-0.0028159,0.34144,0.64527,MODULE_557,1
GOCC_AXON_INITIAL_SEGMENT,SET,21,-0.073506,-0.0024845,0.19728,0.64527,GOCC_AXON_INITIAL_SEGMENT,1
GOBP_REGULATION_OF_OXIDATIVE...1,SET,19,-0.069237,-0.0022262,0.18578,0.6453,GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION,1
GOBP_SOMITE_ROSTRAL_CAUDAL_A...,SET,9,-0.10566,-0.0023389,0.28352,0.6453,GOBP_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION,1
REACTOME_FLT3_SIGNALING_IN_D...,SET,27,-0.057286,-0.0021952,0.1537,0.64532,REACTOME_FLT3_SIGNALING_IN_DISEASE,1
GOBP_PROTEIN_TARGETING_TO_LY...,SET,29,-0.058568,-0.0023259,0.15709,0.64536,GOBP_PROTEIN_TARGETING_TO_LYSOSOME,1
HP_CYSTIC_RENAL_DYSPLASIA,SET,8,-0.10658,-0.0022244,0.28589,0.64536,HP_CYSTIC_RENAL_DYSPLASIA,1
GOBP_PENTOSE_PHOSPHATE_SHUNT...,SET,6,-0.12632,-0.0022833,0.33873,0.6454,GOBP_PENTOSE_PHOSPHATE_SHUNT_NON_OXIDATIVE_BRANCH,1
GOBP_REGULATION_OF_PROTEIN_L...11,SET,166,-0.024576,-0.0023262,0.065892,0.64541,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
HP_URETHRAL_STENOSIS,SET,49,-0.04842,-0.0024981,0.12983,0.64541,HP_URETHRAL_STENOSIS,1
GOCC_PLASMA_MEMBRANE_SIGNALI...,SET,180,-0.025431,-0.0025056,0.068159,0.64546,GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX,1
GOBP_RESPONSE_TO_YEAST,SET,6,-0.15072,-0.0027243,0.40388,0.6455,GOBP_RESPONSE_TO_YEAST,1
NFY_01,SET,230,-0.022046,-0.002452,0.059069,0.64551,NFY_01,1
HP_SPARSE_AXILLARY_HAIR,SET,42,-0.05193,-0.0024809,0.13908,0.64556,HP_SPARSE_AXILLARY_HAIR,1
GSE39556_CD8A_DC_VS_NK_CELL_...1,SET,177,-0.025044,-0.0024471,0.067067,0.64558,GSE39556_CD8A_DC_VS_NK_CELL_DN,1
GOBP_DENDRITE_SELF_AVOIDANCE,SET,14,-0.10423,-0.002877,0.279,0.64564,GOBP_DENDRITE_SELF_AVOIDANCE,1
GOBP_RELAXATION_OF_MUSCLE,SET,31,-0.060753,-0.0024943,0.1626,0.64566,GOBP_RELAXATION_OF_MUSCLE,1
GSE39110_UNTREATED_VS_IL2_TR...2,SET,182,-0.02418,-0.0023954,0.064695,0.6457,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP,1
GOBP_CELLULAR_RESPONSE_TO_EX...2,SET,72,-0.041087,-0.0025679,0.10993,0.64571,GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS,1
REACTOME_BUTYROPHILIN_BTN_FA...,SET,12,-0.114,-0.0029134,0.30486,0.64577,REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS,1
GSE36476_YOUNG_VS_OLD_DONOR_...2,SET,174,-0.02435,-0.0023593,0.065107,0.6458,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP,1
HP_B_CELL_LYMPHOMA,SET,21,-0.072842,-0.0024621,0.19474,0.64581,HP_B_CELL_LYMPHOMA,1
GSE22432_MULTIPOTENT_PROGENI...2,SET,183,-0.023918,-0.002376,0.063941,0.64582,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...3,SET,4,-0.14261,-0.0021047,0.38104,0.64589,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M,1
GOBP_POSITIVE_REGULATION_OF_...637,SET,91,-0.032571,-0.0022874,0.087018,0.64591,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
DESCARTES_FETAL_HEART_SMOOTH...,SET,36,-0.058371,-0.0025822,0.15595,0.64591,DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS,1
REACTOME_GLYCOSAMINOGLYCAN_M...,SET,120,-0.030197,-0.0024333,0.080654,0.64595,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1
GOBP_PROTEOGLYCAN_CATABOLIC_...,SET,9,-0.10971,-0.0024284,0.29285,0.64603,GOBP_PROTEOGLYCAN_CATABOLIC_PROCESS,1
HP_PORTAL_INFLAMMATION,SET,4,-0.18638,-0.0027508,0.49737,0.64607,HP_PORTAL_INFLAMMATION,1
IGARASHI_ATF4_TARGETS_DN,SET,88,-0.035298,-0.0024379,0.094175,0.6461,IGARASHI_ATF4_TARGETS_DN,1
PR_01,SET,134,-0.028528,-0.0024282,0.076082,0.64615,PR_01,1
REACTOME_THYROXINE_BIOSYNTHE...,SET,10,-0.11361,-0.0026508,0.30273,0.64628,REACTOME_THYROXINE_BIOSYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...303,SET,17,-0.076935,-0.00234,0.205,0.64628,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,1
HP_CONGENITAL_BLINDNESS,SET,8,-0.1086,-0.0022665,0.28918,0.64637,HP_CONGENITAL_BLINDNESS,1
GOMF_ALPHA_ADRENERGIC_RECEPT...,SET,6,-0.14621,-0.0026427,0.38892,0.64652,GOMF_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY,1
BERENJENO_ROCK_SIGNALING_NOT...1,SET,48,-0.049023,-0.0025033,0.13037,0.64655,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1
OCT_C,SET,220,-0.022631,-0.0024624,0.060159,0.64661,OCT_C,1
HP_FETAL_ASCITES,SET,8,-0.12543,-0.0026176,0.33342,0.64661,HP_FETAL_ASCITES,1
GRAHAM_CML_QUIESCENT_VS_NORM...4,SET,80,-0.03602,-0.0023725,0.095735,0.64663,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1
BIOCARTA_VITCB_PATHWAY,SET,8,-0.10189,-0.0021264,0.27078,0.64664,BIOCARTA_VITCB_PATHWAY,1
HP_PORTAL_FIBROSIS,SET,15,-0.080924,-0.0023121,0.21503,0.64666,HP_PORTAL_FIBROSIS,1
SCHLESINGER_H3K27ME3_IN_NORM...,SET,26,-0.076755,-0.0028864,0.20394,0.64667,SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,1
HP_ABNORMAL_PROPORTION_OF_CD...2,SET,39,-0.049911,-0.0022979,0.13261,0.64668,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_T_CELLS,1
TURASHVILI_BREAST_LOBULAR_CA...1,SET,81,-0.037687,-0.0024977,0.1001,0.64672,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,1
GSE25087_FETAL_VS_ADULT_TCON...2,SET,174,-0.0243,-0.0023544,0.064542,0.64672,GSE25087_FETAL_VS_ADULT_TCONV_UP,1
HP_SYNDACTYLY,SET,346,-0.017417,-0.0023683,0.046259,0.64673,HP_SYNDACTYLY,1
GSE16450_IMMATURE_VS_MATURE_...1,SET,180,-0.023642,-0.0023294,0.062782,0.64675,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,1
MELLMAN_TUT1_TARGETS_DN,SET,45,-0.046613,-0.0023048,0.12374,0.6468,MELLMAN_TUT1_TARGETS_DN,1
GOBP_RESPONSE_TO_2_3_7_8_TET...,SET,5,-0.17575,-0.0029,0.46656,0.6468,GOBP_RESPONSE_TO_2_3_7_8_TETRACHLORODIBENZODIOXINE,1
GSE22886_NAIVE_CD4_TCELL_VS_...4,SET,176,-0.022989,-0.00224,0.061016,0.64682,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP,1
GOBP_MISMATCH_REPAIR,SET,31,-0.052148,-0.002141,0.1384,0.64683,GOBP_MISMATCH_REPAIR,1
GOBP_REGULATION_OF_PLASMA_ME...2,SET,6,-0.1388,-0.0025088,0.36787,0.64703,GOBP_REGULATION_OF_PLASMA_MEMBRANE_REPAIR,1
GSE28130_ACTIVATED_VS_INDUCE...1,SET,171,-0.025452,-0.0024448,0.067451,0.64704,GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN,1
MIR6512_3P,SET,122,-0.028411,-0.0023083,0.075279,0.64706,MIR6512_3P,1
GOBP_MUSCLE_STRUCTURE_DEVELO...,SET,639,-0.013445,-0.0024642,0.035622,0.64707,GOBP_MUSCLE_STRUCTURE_DEVELOPMENT,1
WP_FOXA2_PATHWAY,SET,21,-0.074912,-0.0025321,0.19846,0.64709,WP_FOXA2_PATHWAY,1
MIR7152_5P,SET,223,-0.022438,-0.0024578,0.059436,0.6471,MIR7152_5P,1
GOBP_POSITIVE_REGULATION_OF_...418,SET,8,-0.11487,-0.0023973,0.30426,0.64711,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
BIOCARTA_TNFR1_PATHWAY,SET,29,-0.057766,-0.002294,0.15289,0.64722,BIOCARTA_TNFR1_PATHWAY,1
WP_7Q1123_DISTAL_COPY_NUMBER...,SET,21,-0.078764,-0.0026623,0.20844,0.64723,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,1
GSE37336_LY6C_POS_VS_NEG_NAI...1,SET,140,-0.028029,-0.0024382,0.074164,0.64726,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN,1
HP_NARROW_FOOT,SET,4,-0.17175,-0.0025348,0.45436,0.64728,HP_NARROW_FOOT,1
KEGG_MEDICUS_VARIANT_NOTCH_O...,SET,16,-0.085954,-0.0025363,0.22736,0.6473,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY,1
CGTSACG_PAX3_B,SET,140,-0.028184,-0.0024517,0.074531,0.64734,CGTSACG_PAX3_B,1
FRASOR_TAMOXIFEN_RESPONSE_UP,SET,44,-0.04997,-0.0024433,0.13212,0.64736,FRASOR_TAMOXIFEN_RESPONSE_UP,1
GOMF_NEUTRAL_L_AMINO_ACID_TR...,SET,40,-0.053682,-0.0025029,0.14191,0.64738,GOMF_NEUTRAL_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MODULE_237,SET,54,-0.042875,-0.0023218,0.11334,0.64739,MODULE_237,1
HP_OSTEOCHONDROMA,SET,7,-0.13362,-0.0026085,0.35318,0.6474,HP_OSTEOCHONDROMA,1
GOBP_CELLULAR_RESPONSE_TO_TO...1,SET,95,-0.03321,-0.0023827,0.087776,0.64741,GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,1
GSE2770_TGFB_AND_IL4_VS_IL12...5,SET,180,-0.022678,-0.0022345,0.059938,0.64742,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
MIR146B_5P,SET,102,-0.031655,-0.0023529,0.083649,0.64744,MIR146B_5P,1
KAECH_NAIVE_VS_MEMORY_CD8_TC...1,SET,184,-0.024561,-0.0024464,0.064905,0.64744,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
ZHU_SKIL_TARGETS_DN,SET,9,-0.11081,-0.0024528,0.29277,0.64746,ZHU_SKIL_TARGETS_DN,1
GAVISH_3CA_METAPROGRAM_MACRO...12,SET,48,-0.052795,-0.0026959,0.1395,0.64746,GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP,1
REACTOME_NEGATIVE_REGULATION...9,SET,20,-0.073919,-0.0024384,0.19517,0.64756,REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION,1
GOBP_NEGATIVE_REGULATION_OF_...10,SET,60,-0.045616,-0.0026034,0.12043,0.64757,GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,1
GOMF_METHYLATION_DEPENDENT_P...,SET,66,-0.03735,-0.0022353,0.098608,0.64757,GOMF_METHYLATION_DEPENDENT_PROTEIN_BINDING,1
GOBP_OLFACTORY_LOBE_DEVELOPM...,SET,36,-0.061172,-0.0027061,0.16144,0.64763,GOBP_OLFACTORY_LOBE_DEVELOPMENT,1
GSE25085_FETAL_BM_VS_ADULT_B...1,SET,179,-0.024688,-0.0024258,0.065143,0.64765,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,1
GSE13484_12H_UNSTIM_VS_YF17D...2,SET,177,-0.023732,-0.0023189,0.062612,0.64766,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
GSE5503_MLN_DC_VS_SPLEEN_DC_...2,SET,178,-0.024434,-0.0023942,0.064461,0.64767,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
HP_ABNORMAL_BLADDER_MORPHOLO...,SET,66,-0.041576,-0.0024883,0.10962,0.64776,HP_ABNORMAL_BLADDER_MORPHOLOGY,1
MODULE_155,SET,24,-0.063932,-0.00231,0.16847,0.64783,MODULE_155,1
GOBP_RESPONSE_TO_IMMOBILIZAT...,SET,25,-0.062129,-0.002291,0.16366,0.64788,GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS,1
HP_BLEPHAROCHALASIS,SET,6,-0.14245,-0.0025746,0.37521,0.64789,HP_BLEPHAROCHALASIS,1
GOMF_PRE_MIRNA_BINDING,SET,9,-0.11488,-0.002543,0.3026,0.6479,GOMF_PRE_MIRNA_BINDING,1
GOBP_CELL_COMMUNICATION_BY_E...2,SET,26,-0.072435,-0.0027239,0.1907,0.64796,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,1
GSE360_CTRL_VS_M_TUBERCULOSI...1,SET,183,-0.024188,-0.0024028,0.063662,0.64801,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN,1
MODULE_116,SET,13,-0.088466,-0.0023532,0.23279,0.64803,MODULE_116,1
ZNF260_TARGET_GENES,SET,667,-0.012943,-0.0024216,0.034056,0.64804,ZNF260_TARGET_GENES,1
GAVISH_3CA_METAPROGRAM_CD8_T...10,SET,47,-0.052779,-0.0026669,0.13888,0.64804,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3,1
GOMF_TELOMERASE_INHIBITOR_AC...,SET,5,-0.14715,-0.002428,0.38719,0.64804,GOMF_TELOMERASE_INHIBITOR_ACTIVITY,1
HP_DEMENTIA,SET,186,-0.024123,-0.0024157,0.063476,0.64804,HP_DEMENTIA,1
GOBP_NEGATIVE_REGULATION_OF_...606,SET,4,-0.18683,-0.0027573,0.49139,0.6481,GOBP_NEGATIVE_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,1
TRAVAGLINI_LUNG_DIFFERENTIAT...,SET,148,-0.028229,-0.0025242,0.074247,0.6481,TRAVAGLINI_LUNG_DIFFERENTIATING_BASAL_CELL,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...1,SET,6,-0.12706,-0.0022965,0.33408,0.64815,QI_PBMC_ZOSTAVAX_AGE_50_75YO_1DY_UP,1
GSE13547_WT_VS_ZFX_KO_BCELL_...4,SET,158,-0.0252,-0.0023276,0.066252,0.64816,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP,1
GSE45365_WT_VS_IFNAR_KO_CD11...3,SET,167,-0.024368,-0.0023134,0.064049,0.6482,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP,1
RICKMAN_HEAD_AND_NECK_CANCER...5,SET,75,-0.04036,-0.0025743,0.10606,0.64823,RICKMAN_HEAD_AND_NECK_CANCER_E,1
GOBP_RESPONSE_TO_ZINC_ION,SET,44,-0.051243,-0.0025055,0.13462,0.64826,GOBP_RESPONSE_TO_ZINC_ION,1
chr10p12,SET,45,-0.088781,-0.0043899,0.23323,0.64827,chr10p12,1
HOFMANN_CELL_LYMPHOMA_DN,SET,37,-0.050926,-0.0022838,0.13377,0.64828,HOFMANN_CELL_LYMPHOMA_DN,1
TRAVAGLINI_LUNG_PLASMACYTOID...,SET,101,-0.034158,-0.0025265,0.089708,0.64831,TRAVAGLINI_LUNG_PLASMACYTOID_DENDRITIC_CELL,1
MIR451A,SET,6,-0.14874,-0.0026884,0.3905,0.64835,MIR451A,1
HP_RIGHT_VENTRICULAR_CARDIOM...,SET,7,-0.14451,-0.0028211,0.37913,0.64846,HP_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1
REACTOME_INTERLEUKIN_1_SIGNA...,SET,108,-0.029466,-0.0022533,0.077212,0.64863,REACTOME_INTERLEUKIN_1_SIGNALING,1
KLEIN_PRIMARY_EFFUSION_LYMPH...1,SET,50,-0.049308,-0.0025696,0.12915,0.64869,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,1
MIR12117,SET,84,-0.034453,-0.002325,0.09024,0.64869,MIR12117,1
FOROUTAN_INTEGRATED_TGFB_EMT...2,SET,116,-0.03255,-0.0025791,0.085248,0.6487,FOROUTAN_INTEGRATED_TGFB_EMT_UP,1
GOMF_UBIQUITIN_LIGASE_INHIBI...,SET,9,-0.11923,-0.0026392,0.31228,0.6487,GOMF_UBIQUITIN_LIGASE_INHIBITOR_ACTIVITY,1
HP_ABNORMAL_ERYTHROID_LINEAG...,SET,6,-0.13885,-0.0025097,0.36353,0.64875,HP_ABNORMAL_ERYTHROID_LINEAGE_CELL_MORPHOLOGY,1
GSE17721_POLYIC_VS_GARDIQUIM...18,SET,185,-0.024253,-0.0024222,0.063496,0.64875,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP,1
DITTMER_PTHLH_TARGETS_UP,SET,104,-0.032888,-0.0024682,0.086093,0.64877,DITTMER_PTHLH_TARGETS_UP,1
AAGCCAT_MIR135A_MIR135B,SET,306,-0.01913,-0.002449,0.050067,0.6488,AAGCCAT_MIR135A_MIR135B,1
GOBP_POSITIVE_REGULATION_OF_...470,SET,34,-0.054227,-0.0023314,0.14192,0.64881,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,1
FORTSCHEGGER_PHF8_TARGETS_DN,SET,684,-0.012581,-0.0023827,0.032914,0.64885,FORTSCHEGGER_PHF8_TARGETS_DN,1
HP_MOLAR_TOOTH_SIGN_ON_MRI,SET,37,-0.046958,-0.0021059,0.12281,0.6489,HP_MOLAR_TOOTH_SIGN_ON_MRI,1
HP_RECTAL_POLYPOSIS,SET,5,-0.15117,-0.0024944,0.39536,0.6489,HP_RECTAL_POLYPOSIS,1
KIM_ALL_DISORDERS_OLIGODENDR...2,SET,678,-0.012084,-0.0022788,0.031595,0.64894,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,1
LAKE_ADULT_KIDNEY_C22_ENDOTH...,SET,135,-0.030623,-0.0026162,0.079997,0.64906,LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES,1
GOBP_PHOTORECEPTOR_CELL_DEVE...,SET,49,-0.048776,-0.0025164,0.1274,0.64909,GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT,1
HP_CHROMOSOMAL_BREAKAGE_INDU...1,SET,16,-0.069688,-0.0020563,0.18201,0.64909,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_CROSSLINKING_AGENTS,1
GSE24574_BCL6_LOW_TFH_VS_NAI...2,SET,178,-0.024361,-0.002387,0.063625,0.64909,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...294,SET,5,-0.14075,-0.0023225,0.36757,0.64911,GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,1
GOCC_TELOMERASE_HOLOENZYME_C...,SET,19,-0.069104,-0.0022219,0.18039,0.64917,GOCC_TELOMERASE_HOLOENZYME_COMPLEX,1
HP_SHORT_PHALANX_OF_THE_THUMB,SET,29,-0.065414,-0.0025977,0.17072,0.64919,HP_SHORT_PHALANX_OF_THE_THUMB,1
NKX61_01,SET,215,-0.023908,-0.002572,0.06239,0.64921,NKX61_01,1
WP_TCA_CYCLE_AKA_KREBS_OR_CI...,SET,17,-0.070251,-0.0021367,0.18332,0.64922,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,1
MIR4657,SET,66,-0.040184,-0.002405,0.10486,0.64922,MIR4657,1
GOBP_PURINE_DEOXYRIBONUCLEOT...1,SET,5,-0.14269,-0.0023544,0.37231,0.64923,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
MIR6767_3P,SET,24,-0.065916,-0.0023816,0.17196,0.64926,MIR6767_3P,1
HP_THICKENED_HELICES,SET,43,-0.046131,-0.0022299,0.12032,0.64928,HP_THICKENED_HELICES,1
GSE12392_IFNAR_KO_VS_IFNB_KO...2,SET,177,-0.024157,-0.0023604,0.062981,0.64935,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP,1
GSE17721_0.5H_VS_12H_LPS_BMD...2,SET,174,-0.024001,-0.0023254,0.06257,0.64935,GSE17721_0.5H_VS_12H_LPS_BMDC_UP,1
GSE29164_UNTREATED_VS_CD8_TC...3,SET,181,-0.024576,-0.0024281,0.064075,0.64935,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,1
JAZAG_TGFB1_SIGNALING_VIA_SM...2,SET,98,-0.033123,-0.0024135,0.086333,0.64938,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,1
HP_CORNEAL_OPACITY,SET,246,-0.021301,-0.0024491,0.055497,0.64944,HP_CORNEAL_OPACITY,1
REACTOME_SARS_COV_1_ACTIVATE...,SET,34,-0.055102,-0.002369,0.14353,0.64947,REACTOME_SARS_COV_1_ACTIVATES_MODULATES_INNATE_IMMUNE_RESPONSES,1
HP_ABSENT_HAIR,SET,55,-0.04688,-0.002562,0.12207,0.64952,HP_ABSENT_HAIR,1
MODULE_378,SET,393,-0.016639,-0.0024082,0.043324,0.64953,MODULE_378,1
GOBP_EMBRYONIC_SKELETAL_SYST...1,SET,120,-0.034489,-0.0027791,0.08979,0.64955,GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT,1
JNK_DN.V1_UP,SET,161,-0.026756,-0.0024945,0.069633,0.6496,JNK_DN.V1_UP,1
HP_RIGHT_VENTRICULAR_DILATAT...,SET,17,-0.087315,-0.0026557,0.22722,0.64961,HP_RIGHT_VENTRICULAR_DILATATION,1
GOBP_POSITIVE_REGULATION_OF_...220,SET,118,-0.030053,-0.0024016,0.078192,0.64964,GOBP_POSITIVE_REGULATION_OF_DNA_REPAIR,1
GOBP_CERAMIDE_METABOLIC_PROC...,SET,99,-0.033584,-0.0024595,0.087367,0.64966,GOBP_CERAMIDE_METABOLIC_PROCESS,1
GSE17301_CTRL_VS_48H_ACD3_AC...2,SET,178,-0.02389,-0.0023408,0.062146,0.64966,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP,1
GTTRYCATRR_UNKNOWN,SET,156,-0.026104,-0.002396,0.0679,0.64968,GTTRYCATRR_UNKNOWN,1
GAVISH_3CA_METAPROGRAM_CD4_T...10,SET,46,-0.048614,-0.0024303,0.12644,0.64969,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_UNASSIGNED,1
HP_HALITOSIS,SET,6,-0.14459,-0.0026135,0.37604,0.6497,HP_HALITOSIS,1
WP_HEMATOPOIETIC_STEM_CELL_D...,SET,52,-0.048134,-0.002558,0.12511,0.64978,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
HP_EEG_WITH_GENERALIZED_EPIL...,SET,247,-0.020855,-0.0024026,0.054204,0.64979,HP_EEG_WITH_GENERALIZED_EPILEPTIFORM_DISCHARGES,1
GOCC_SECONDARY_LYSOSOME,SET,19,-0.074492,-0.0023951,0.19357,0.64982,GOCC_SECONDARY_LYSOSOME,1
GOCC_LATE_ENDOSOME_LUMEN,SET,7,-0.13067,-0.0025509,0.3394,0.64988,GOCC_LATE_ENDOSOME_LUMEN,1
REACTOME_SIGNALING_BY_NOTCH2,SET,30,-0.065051,-0.0026274,0.16894,0.6499,REACTOME_SIGNALING_BY_NOTCH2,1
MODULE_410,SET,35,-0.058436,-0.002549,0.15171,0.64995,MODULE_410,1
GOCC_ENDOPLASMIC_RETICULUM_P...1,SET,8,-0.10623,-0.0022169,0.27577,0.64995,GOCC_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX,1
HP_ABNORMAL_CONJUNCTIVA_MORP...,SET,150,-0.026618,-0.0023961,0.069106,0.64995,HP_ABNORMAL_CONJUNCTIVA_MORPHOLOGY,1
MODULE_17,SET,316,-0.017809,-0.0023162,0.046231,0.64996,MODULE_17,1
FOXO3_01,SET,227,-0.023144,-0.0025575,0.060067,0.64999,FOXO3_01,1
PARK_TRETINOIN_RESPONSE,SET,11,-0.11061,-0.0027066,0.28706,0.65,PARK_TRETINOIN_RESPONSE,1
GSE5589_IL6_KO_VS_IL10_KO_LP...7,SET,183,-0.024508,-0.0024346,0.063578,0.65006,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
GOBP_REPLICATION_BORN_DOUBLE...,SET,6,-0.11603,-0.0020972,0.30085,0.65013,GOBP_REPLICATION_BORN_DOUBLE_STRAND_BREAK_REPAIR_VIA_SISTER_CHROMATID_EXCHANGE,1
GOBP_ACTIVATION_OF_INNATE_IM...,SET,266,-0.020154,-0.0024082,0.052217,0.65023,GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE,1
GOBP_ERBB_SIGNALING_PATHWAY,SET,121,-0.030272,-0.0024494,0.078411,0.65027,GOBP_ERBB_SIGNALING_PATHWAY,1
HP_JUVENILE_ONSET,SET,597,-0.01352,-0.0023981,0.03502,0.65028,HP_JUVENILE_ONSET,1
HP_GENERALIZED_ABNORMALITY_O...,SET,944,-0.010876,-0.002402,0.028163,0.65032,HP_GENERALIZED_ABNORMALITY_OF_SKIN,1
WATANABE_RECTAL_CANCER_RADIO...2,SET,96,-0.03088,-0.0022271,0.079947,0.65034,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,1
HP_ABNORMALITY_OF_SOMATOSENS...,SET,14,-0.089561,-0.0024722,0.23174,0.65042,HP_ABNORMALITY_OF_SOMATOSENSORY_EVOKED_POTENTIALS,1
GAO_LARGE_INTESTINE_24W_C5_L...,SET,49,-0.050021,-0.0025807,0.12944,0.65042,GAO_LARGE_INTESTINE_24W_C5_LGR5POS_STEM_CELL,1
GOBP_MEMBRANE_REPOLARIZATION...1,SET,26,-0.072354,-0.0027208,0.18718,0.65045,GOBP_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,1
GOBP_LUNG_SECRETORY_CELL_DIF...,SET,11,-0.1029,-0.0025181,0.26619,0.65046,GOBP_LUNG_SECRETORY_CELL_DIFFERENTIATION,1
GOCC_BLOOD_MICROPARTICLE,SET,97,-0.036589,-0.0026525,0.094634,0.65049,GOCC_BLOOD_MICROPARTICLE,1
GNF2_ST13,SET,57,-0.040437,-0.0022496,0.10457,0.6505,GNF2_ST13,1
RNGTGGGC_UNKNOWN,SET,708,-0.012883,-0.0024806,0.033305,0.65055,RNGTGGGC_UNKNOWN,1
GSE37301_GRANULOCYTE_MONOCYT...2,SET,165,-0.025517,-0.0024081,0.065949,0.65059,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,1
MIR624_5P,SET,97,-0.033363,-0.0024186,0.086122,0.65076,MIR624_5P,1
MIR668_3P,SET,54,-0.044775,-0.0024247,0.11551,0.65085,MIR668_3P,1
GOMF_HYDROLASE_ACTIVITY_ACTI...6,SET,11,-0.10173,-0.0024893,0.26245,0.65085,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES,1
RTAAACA_FREAC2_01,SET,845,-0.012321,-0.0025816,0.03178,0.65087,RTAAACA_FREAC2_01,1
PICCALUGA_ANGIOIMMUNOBLASTIC...2,SET,189,-0.026946,-0.0027198,0.069381,0.65113,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,1
GOBP_CEREBRAL_CORTEX_GABAERG...2,SET,9,-0.13138,-0.0029081,0.33828,0.65113,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...191,SET,167,-0.026117,-0.0024795,0.067243,0.65114,GOBP_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,1
GOBP_RESPONSE_TO_TYPE_I_INTE...,SET,79,-0.039967,-0.002616,0.10289,0.65115,GOBP_RESPONSE_TO_TYPE_I_INTERFERON,1
GOBP_POSITIVE_REGULATION_OF_...503,SET,17,-0.087192,-0.0026519,0.22443,0.65118,GOBP_POSITIVE_REGULATION_OF_MYELINATION,1
GOCC_DOPAMINERGIC_SYNAPSE,SET,13,-0.090237,-0.0024003,0.23224,0.6512,GOCC_DOPAMINERGIC_SYNAPSE,1
JAIN_NFKB_SIGNALING,SET,68,-0.038582,-0.0023436,0.099278,0.65122,JAIN_NFKB_SIGNALING,1
GSE40443_INDUCED_VS_TOTAL_TR...1,SET,179,-0.024976,-0.002454,0.064261,0.65124,GSE40443_INDUCED_VS_TOTAL_TREG_DN,1
MATTIOLI_MULTIPLE_MYELOMA_WI...,SET,31,-0.063933,-0.0026248,0.16442,0.6513,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,1
GOMF_EXONUCLEASE_ACTIVITY_AC...,SET,58,-0.039743,-0.0022302,0.1022,0.65131,GOMF_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
HP_SHORT_FIRST_METATARSAL,SET,4,-0.17224,-0.0025421,0.44289,0.65133,HP_SHORT_FIRST_METATARSAL,1
REACTOME_CHREBP_ACTIVATES_ME...,SET,8,-0.10195,-0.0021277,0.26205,0.65138,REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION,1
GOMF_CCR3_CHEMOKINE_RECEPTOR...,SET,4,-0.17672,-0.0026081,0.45422,0.65138,GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING,1
MIR939_3P,SET,138,-0.027315,-0.0023592,0.070177,0.65145,MIR939_3P,1
GSE39820_CTRL_VS_TGFBETA1_IL...1,SET,183,-0.024467,-0.0024305,0.062853,0.65146,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN,1
GOBP_SEX_DETERMINATION,SET,18,-0.087229,-0.0027299,0.22404,0.65149,GOBP_SEX_DETERMINATION,1
GOBP_NEGATIVE_REGULATION_OF_...134,SET,5,-0.17003,-0.0028055,0.43662,0.65151,GOBP_NEGATIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
ZHENG_FOXP3_TARGETS_IN_THYMU...1,SET,12,-0.090453,-0.0023117,0.23209,0.65163,ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,1
MIR6811_5P,SET,66,-0.042641,-0.002552,0.1094,0.65165,MIR6811_5P,1
WP_OSTEOPONTIN_SIGNALING,SET,13,-0.096491,-0.0025667,0.24754,0.65166,WP_OSTEOPONTIN_SIGNALING,1
GSE25088_WT_VS_STAT6_KO_MACR...3,SET,176,-0.024448,-0.0023822,0.062715,0.65167,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP,1
HP_BROAD_DISTAL_PHALANX_OF_F...,SET,20,-0.07513,-0.0024783,0.19271,0.65168,HP_BROAD_DISTAL_PHALANX_OF_FINGER,1
HP_OPTIC_DISC_COLOBOMA,SET,24,-0.065565,-0.002369,0.1681,0.65174,HP_OPTIC_DISC_COLOBOMA,1
MIR98_3P,SET,667,-0.013362,-0.0025001,0.034258,0.65175,MIR98_3P,1
HP_APLASIA_HYPOPLASIA_OF_THE...72,SET,23,-0.072088,-0.0025499,0.18478,0.65178,HP_APLASIA_HYPOPLASIA_OF_THE_THYROID_GLAND,1
GSE14308_TH17_VS_NATURAL_TRE...1,SET,179,-0.023806,-0.0023391,0.061016,0.65179,GSE14308_TH17_VS_NATURAL_TREG_DN,1
MIR744_5P,SET,10,-0.093995,-0.0021931,0.24088,0.65181,MIR744_5P,1
GLI1_UP.V1_DN,SET,16,-0.079824,-0.0023554,0.20454,0.65182,GLI1_UP.V1_DN,1
SMTTTTGT_UNKNOWN,SET,359,-0.018459,-0.0025559,0.047294,0.65184,SMTTTTGT_UNKNOWN,1
DESCARTES_FETAL_CEREBELLUM_M...,SET,487,-0.016296,-0.0026185,0.041739,0.65188,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,1
WP_LACTATE_SHUTTLE_IN_GLIAL_...,SET,12,-0.10306,-0.0026339,0.26395,0.65189,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,1
GOBP_REGULATION_OF_ANTIGEN_P...2,SET,5,-0.15139,-0.0024979,0.38766,0.65192,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,1
DE_YY1_TARGETS_UP,SET,17,-0.088002,-0.0026766,0.2253,0.65195,DE_YY1_TARGETS_UP,1
MIR598_3P,SET,10,-0.11406,-0.0026611,0.29201,0.65195,MIR598_3P,1
GOBP_SPHINGOID_METABOLIC_PRO...,SET,18,-0.082403,-0.0025789,0.21092,0.65198,GOBP_SPHINGOID_METABOLIC_PROCESS,1
WP_HDAC6_INTERACTIONS_IN_THE...,SET,105,-0.031402,-0.0023679,0.080354,0.65202,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,1
HP_APLASIA_HYPOPLASIA_INVOLV...14,SET,13,-0.090716,-0.002413,0.23203,0.65209,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SINUSES,1
LIN_APC_TARGETS,SET,63,-0.042487,-0.0024845,0.10864,0.65213,LIN_APC_TARGETS,1
GOBP_REGULATION_OF_CYTOPLASM...4,SET,7,-0.10162,-0.0019838,0.25983,0.65213,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
DESCARTES_MAIN_FETAL_ELF3_AG...,SET,127,-0.027729,-0.0022982,0.070845,0.65225,DESCARTES_MAIN_FETAL_ELF3_AGBL2_POSITIVE_CELLS,1
HAY_BONE_MARROW_CD34_POS_HSC,SET,96,-0.036549,-0.002636,0.093379,0.65225,HAY_BONE_MARROW_CD34_POS_HSC,1
REACTOME_MITOCHONDRIAL_IRON_...,SET,12,-0.10423,-0.0026638,0.26627,0.65226,REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS,1
TURASHVILI_BREAST_DUCTAL_CAR...3,SET,60,-0.046979,-0.0026812,0.12,0.65228,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,1
HP_DEHYDRATION,SET,99,-0.035693,-0.0026139,0.091147,0.65232,HP_DEHYDRATION,1
HP_BLEEDING_WITH_MINOR_OR_NO...,SET,7,-0.13307,-0.0025979,0.33978,0.65234,HP_BLEEDING_WITH_MINOR_OR_NO_TRAUMA,1
HP_TRICUSPID_VALVE_PROLAPSE,SET,10,-0.10972,-0.00256,0.28014,0.65235,HP_TRICUSPID_VALVE_PROLAPSE,1
GSE9988_ANTI_TREM1_AND_LPS_V...1,SET,185,-0.023179,-0.002315,0.059166,0.65238,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN,1
GOBP_LUNG_SACCULE_DEVELOPMENT,SET,10,-0.10981,-0.0025619,0.28025,0.6524,GOBP_LUNG_SACCULE_DEVELOPMENT,1
GAVISH_3CA_METAPROGRAM_B_CEL...6,SET,43,-0.051055,-0.0024679,0.13028,0.65243,GAVISH_3CA_METAPROGRAM_B_CELLS_MEMORY,1
CHO_NR4A1_TARGETS,SET,29,-0.068586,-0.0027237,0.175,0.65244,CHO_NR4A1_TARGETS,1
HP_ABNORMALLY_LAX_OR_HYPEREX...,SET,150,-0.02698,-0.0024286,0.06882,0.65248,HP_ABNORMALLY_LAX_OR_HYPEREXTENSIBLE_SKIN,1
GOCC_AP_3_ADAPTOR_COMPLEX,SET,11,-0.097063,-0.0023751,0.24751,0.65253,GOCC_AP_3_ADAPTOR_COMPLEX,1
GOMF_G_PROTEIN_COUPLED_RECEP...1,SET,696,-0.015954,-0.0030469,0.040664,0.6526,GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY,1
GOBP_TESTOSTERONE_BIOSYNTHET...,SET,10,-0.10554,-0.0024624,0.26896,0.65261,GOBP_TESTOSTERONE_BIOSYNTHETIC_PROCESS,1
GOMF_PHOSPHOLIPASE_A1_ACTIVI...,SET,13,-0.092107,-0.00245,0.23474,0.65261,GOMF_PHOSPHOLIPASE_A1_ACTIVITY,1
GOBP_CORONARY_ARTERY_MORPHOG...,SET,8,-0.13276,-0.0027707,0.33834,0.65262,GOBP_CORONARY_ARTERY_MORPHOGENESIS,1
GOMF_TRANSFERASE_ACTIVITY_TR...5,SET,67,-0.04367,-0.0026333,0.11129,0.65262,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_SULPHUR_CONTAINING_GROUPS,1
HP_ABNORMAL_SERUM_BILE_ACID_...,SET,25,-0.070932,-0.0026157,0.18068,0.65269,HP_ABNORMAL_SERUM_BILE_ACID_CONCENTRATION,1
HP_PROGRESSIVE_MUSCLE_WEAKNE...,SET,64,-0.041361,-0.0024378,0.10534,0.65271,HP_PROGRESSIVE_MUSCLE_WEAKNESS,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...3,SET,15,-0.084207,-0.0024059,0.21444,0.65272,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION,1
GSE20152_HTNFA_OVERXPRESS_AN...2,SET,174,-0.02598,-0.0025172,0.066143,0.65276,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP,1
MORF_LCAT,SET,118,-0.03229,-0.0025803,0.082164,0.65284,MORF_LCAT,1
GSE37416_CTRL_VS_3H_F_TULARE...1,SET,176,-0.025288,-0.002464,0.064344,0.65284,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_REGULATION_OF_VERY_LOW_...1,SET,2,-0.22473,-0.0023454,0.57171,0.65287,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GOBP_BROWN_FAT_CELL_DIFFEREN...,SET,50,-0.048878,-0.0025473,0.12431,0.65291,GOBP_BROWN_FAT_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_CAVEOLIN_...,SET,6,-0.14547,-0.0026293,0.36987,0.65295,GOBP_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS,1
MODULE_153,SET,31,-0.060511,-0.0024844,0.15382,0.65299,MODULE_153,1
SATO_SILENCED_EPIGENETICALLY...,SET,39,-0.055435,-0.0025522,0.14085,0.65305,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,1
HP_MICROCYTIC_ANEMIA,SET,37,-0.056929,-0.002553,0.14465,0.65305,HP_MICROCYTIC_ANEMIA,1
GOBP_MORPHOGENESIS_OF_AN_EPI...4,SET,472,-0.016245,-0.0025709,0.041268,0.65307,GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GSE21546_UNSTIM_VS_ANTI_CD3_...1,SET,169,-0.024344,-0.0023248,0.061845,0.65307,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
GOBP_REGULATION_OF_IRE1_MEDI...,SET,14,-0.094847,-0.0026181,0.24094,0.65308,GOBP_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
BIOCARTA_S1P_PATHWAY,SET,7,-0.11758,-0.0022954,0.29855,0.65314,BIOCARTA_S1P_PATHWAY,1
GOBP_CELL_DIFFERENTIATION_IN...4,SET,3,-0.22297,-0.0028499,0.56618,0.65314,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_PHENOTYPIC_SWITCHING,1
GSE20198_UNTREATED_VS_IFNA_T...2,SET,186,-0.024123,-0.0024156,0.061247,0.65315,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,1
DESCARTES_MAIN_FETAL_SYMPATH...,SET,40,-0.056616,-0.0026397,0.14374,0.65316,DESCARTES_MAIN_FETAL_SYMPATHOBLASTS,1
GOBP_NEGATIVE_REGULATION_OF_...149,SET,11,-0.10805,-0.0026439,0.2743,0.65317,GOBP_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM,1
HALLMARK_FATTY_ACID_METABOLI...,SET,145,-0.027233,-0.0024106,0.069118,0.65321,HALLMARK_FATTY_ACID_METABOLISM,1
JAERVINEN_AMPLIFIED_IN_LARYN...,SET,39,-0.053279,-0.002453,0.13522,0.65322,JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,1
GOCC_TRANSPORTER_COMPLEX,SET,428,-0.017015,-0.0025673,0.043173,0.65325,GOCC_TRANSPORTER_COMPLEX,1
REACTOME_PLASMA_LIPOPROTEIN_...4,SET,30,-0.064237,-0.0025945,0.16298,0.65326,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1
HP_ABNORMAL_ACTIVITY_OF_MITO...,SET,125,-0.02709,-0.0022276,0.068726,0.65327,HP_ABNORMAL_ACTIVITY_OF_MITOCHONDRIAL_RESPIRATORY_CHAIN,1
MODULE_43,SET,92,-0.033667,-0.0023772,0.085407,0.65328,MODULE_43,1
GOBP_PROTEIN_LOCALIZATION_TO...32,SET,116,-0.030521,-0.0024183,0.077408,0.65331,GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
JAK2_DN.V1_UP,SET,158,-0.029214,-0.0026984,0.07408,0.65334,JAK2_DN.V1_UP,1
GOBP_LEUKOTRIENE_CATABOLIC_P...,SET,6,-0.13442,-0.0024295,0.34079,0.65336,GOBP_LEUKOTRIENE_CATABOLIC_PROCESS,1
MODULE_459,SET,389,-0.017179,-0.002474,0.04355,0.65338,MODULE_459,1
GSE17186_NAIVE_VS_CD21LOW_TR...4,SET,183,-0.025407,-0.0025239,0.064409,0.65338,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP,1
GOCC_PRESYNAPTIC_CYTOSKELETON,SET,10,-0.10752,-0.0025087,0.27255,0.65339,GOCC_PRESYNAPTIC_CYTOSKELETON,1
HP_INTERMITTENT_JAUNDICE,SET,9,-0.1168,-0.0025853,0.29604,0.6534,HP_INTERMITTENT_JAUNDICE,1
MIR339_5P,SET,65,-0.040757,-0.0024207,0.10329,0.65342,MIR339_5P,1
HP_BROAD_JAW,SET,5,-0.12825,-0.0021161,0.32503,0.65342,HP_BROAD_JAW,1
GOBP_FOREBRAIN_NEURON_DIFFER...,SET,40,-0.060857,-0.0028375,0.15421,0.65344,GOBP_FOREBRAIN_NEURON_DIFFERENTIATION,1
MIR3191_5P,SET,147,-0.0286,-0.0025488,0.072463,0.65346,MIR3191_5P,1
REACTOME_FOXO_MEDIATED_TRANS...1,SET,63,-0.043793,-0.0025609,0.11094,0.65348,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1
GOBP_REGULATION_OF_ATP_BIOSY...,SET,11,-0.09662,-0.0023643,0.24477,0.65348,GOBP_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,1
HP_DIFFICULTY_RUNNING,SET,47,-0.049781,-0.0025155,0.1261,0.65349,HP_DIFFICULTY_RUNNING,1
GOBP_REGULATION_OF_ASTROCYTE...2,SET,27,-0.07179,-0.002751,0.18185,0.6535,GOBP_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,1
GSE37301_LYMPHOID_PRIMED_MPP...5,SET,178,-0.024091,-0.0023606,0.06102,0.6535,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN,1
GOCC_INTERPHOTORECEPTOR_MATR...,SET,5,-0.13575,-0.0022398,0.34371,0.65356,GOCC_INTERPHOTORECEPTOR_MATRIX,1
HP_ABNORMAL_MUSCLE_FIBER_TYP...,SET,76,-0.036134,-0.00232,0.091484,0.65357,HP_ABNORMAL_MUSCLE_FIBER_TYPE_DISTRIBUTION,1
GOBP_POSITIVE_REGULATION_OF_...135,SET,9,-0.11627,-0.0025736,0.29429,0.6536,GOBP_POSITIVE_REGULATION_OF_CELL_MATURATION,1
GOBP_REGULATION_OF_MITOTIC_N...,SET,116,-0.030968,-0.0024537,0.078368,0.65363,GOBP_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
GSE29618_BCELL_VS_MDC_UP,SET,160,-0.028255,-0.0026261,0.071451,0.65374,GSE29618_BCELL_VS_MDC_UP,1
GSE25088_CTRL_VS_IL4_STIM_ST...1,SET,155,-0.027372,-0.0025043,0.069201,0.65378,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN,1
MIR423_5P,SET,124,-0.028565,-0.0023396,0.072208,0.6538,MIR423_5P,1
GOBP_INTERLEUKIN_13_PRODUCTI...,SET,21,-0.074269,-0.0025103,0.18771,0.65382,GOBP_INTERLEUKIN_13_PRODUCTION,1
GSE20715_0H_VS_6H_OZONE_LUNG...1,SET,185,-0.024845,-0.0024813,0.062785,0.65384,GSE20715_0H_VS_6H_OZONE_LUNG_DN,1
HP_ONION_BULB_FORMATION,SET,27,-0.065601,-0.0025138,0.16573,0.65388,HP_ONION_BULB_FORMATION,1
HP_ABNORMALITY_OF_VENOUS_PHY...,SET,11,-0.10903,-0.0026679,0.27533,0.65394,HP_ABNORMALITY_OF_VENOUS_PHYSIOLOGY,1
GOBP_REGULATION_OF_P38MAPK_C...,SET,41,-0.057455,-0.002712,0.14505,0.65398,GOBP_REGULATION_OF_P38MAPK_CASCADE,1
HP_ELEVATED_CIRCULATING_PHYT...,SET,14,-0.089096,-0.0024593,0.22494,0.65398,HP_ELEVATED_CIRCULATING_PHYTANIC_ACID_CONCENTRATION,1
MIR485_3P,SET,207,-0.025153,-0.0026557,0.063475,0.65404,MIR485_3P,1
GOBP_RIBOSE_PHOSPHATE_METABO...,SET,405,-0.016857,-0.0024759,0.042542,0.65404,GOBP_RIBOSE_PHOSPHATE_METABOLIC_PROCESS,1
BIOCARTA_CCR5_PATHWAY,SET,17,-0.09065,-0.0027571,0.22875,0.65405,BIOCARTA_CCR5_PATHWAY,1
MIR6755_3P,SET,72,-0.041838,-0.0026149,0.10556,0.65407,MIR6755_3P,1
MODULE_431,SET,15,-0.097443,-0.0027841,0.24582,0.6541,MODULE_431,1
GSE17974_CTRL_VS_ACT_IL4_AND...2,SET,131,-0.02867,-0.0024131,0.072316,0.65411,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP,1
HP_SUNKEN_CHEEKS,SET,5,-0.15301,-0.0025246,0.38585,0.65415,HP_SUNKEN_CHEEKS,1
GOBP_UBIQUITIN_DEPENDENT_PRO...2,SET,34,-0.054397,-0.0023387,0.13717,0.65416,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,1
HP_TRANSIENT_ISCHEMIC_ATTACK,SET,53,-0.048506,-0.0026024,0.12229,0.65418,HP_TRANSIENT_ISCHEMIC_ATTACK,1
GOBP_INTESTINAL_ABSORPTION,SET,40,-0.055274,-0.0025771,0.13926,0.65428,GOBP_INTESTINAL_ABSORPTION,1
GOBP_NEGATIVE_REGULATION_OF_...253,SET,16,-0.080364,-0.0023714,0.20248,0.65428,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,1
MIR4281,SET,18,-0.087568,-0.0027405,0.22061,0.65429,MIR4281,1
WP_COVID19_STRUCTURAL_COVERA...,SET,19,-0.07893,-0.0025378,0.19881,0.65432,WP_COVID19_STRUCTURAL_COVERAGE_MAP,1
GOBP_INTRINSIC_APOPTOTIC_SIG...6,SET,6,-0.13116,-0.0023706,0.33033,0.65433,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,1
GOMF_UNMETHYLATED_CPG_BINDING,SET,9,-0.095811,-0.0021208,0.2413,0.65433,GOMF_UNMETHYLATED_CPG_BINDING,1
MORF_AP2M1,SET,194,-0.022519,-0.0023025,0.056705,0.65436,MORF_AP2M1,1
TTF1_Q6,SET,238,-0.022305,-0.002523,0.056144,0.65442,TTF1_Q6,1
GOBP_RESPONSE_TO_LEPTIN,SET,21,-0.079107,-0.0026739,0.19901,0.6545,GOBP_RESPONSE_TO_LEPTIN,1
GOBP_MRNA_METHYLGUANOSINE_CA...,SET,14,-0.089818,-0.0024793,0.22592,0.65452,GOBP_MRNA_METHYLGUANOSINE_CAP_DECAPPING,1
GOBP_PROTEIN_LOCALIZATION_TO...36,SET,12,-0.095155,-0.0024319,0.23933,0.65453,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_ENVELOPE,1
GOBP_REGULATION_OF_RRNA_PROC...,SET,15,-0.08982,-0.0025663,0.2259,0.65454,GOBP_REGULATION_OF_RRNA_PROCESSING,1
BRUINS_UVC_RESPONSE_VIA_TP53...1,SET,815,-0.012339,-0.0025414,0.031022,0.65459,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,1
RANKIN_ANGIOGENIC_TARGETS_OF...2,SET,5,-0.17427,-0.0028754,0.43815,0.65459,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP,1
HP_PILI_CANALICULI,SET,5,-0.17904,-0.0029542,0.45014,0.65459,HP_PILI_CANALICULI,1
GSE37301_MULTIPOTENT_PROGENI...2,SET,148,-0.029179,-0.0026092,0.073354,0.6546,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP,1
GOBP_VASCULAR_ASSOCIATED_SMO...4,SET,26,-0.071736,-0.0026976,0.18024,0.65469,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,1
WP_ECTODERM_DIFFERENTIATION,SET,121,-0.033551,-0.0027147,0.084289,0.6547,WP_ECTODERM_DIFFERENTIATION,1
GOCC_SARCOPLASMIC_RETICULUM_...2,SET,42,-0.050569,-0.0024159,0.127,0.65475,GOCC_SARCOPLASMIC_RETICULUM_MEMBRANE,1
REACTOME_CHROMATIN_MODIFICAT...,SET,7,-0.12842,-0.002507,0.32245,0.65477,REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,1
GOBP_POSITIVE_REGULATION_OF_...223,SET,57,-0.042361,-0.0023566,0.10624,0.65495,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
THAKAR_PBMC_INACTIVATED_INFL...3,SET,66,-0.04082,-0.002443,0.10233,0.65502,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN,1
HP_ABNORMAL_NIPPLE_MORPHOLOGY,SET,209,-0.022778,-0.0024164,0.057089,0.65505,HP_ABNORMAL_NIPPLE_MORPHOLOGY,1
MIR1537_5P,SET,109,-0.033389,-0.002565,0.083664,0.65508,MIR1537_5P,1
GOBP_REGULATION_OF_FATTY_ACI...5,SET,31,-0.064973,-0.0026675,0.16277,0.65511,GOBP_REGULATION_OF_FATTY_ACID_TRANSPORT,1
HP_NYSTAGMUS_INDUCED_HEAD_NO...,SET,15,-0.10131,-0.0028945,0.25379,0.65512,HP_NYSTAGMUS_INDUCED_HEAD_NODDING,1
GOBP_REGULATION_OF_HYALURONA...,SET,8,-0.12029,-0.0025105,0.30132,0.65513,GOBP_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS,1
GOBP_NEURON_DEVELOPMENT,SET,1052,-0.011217,-0.0026071,0.028094,0.65515,GOBP_NEURON_DEVELOPMENT,1
HP_INCREASED_CIRCULATING_AND...,SET,17,-0.079938,-0.0024313,0.20012,0.65522,HP_INCREASED_CIRCULATING_ANDROGEN_CONCENTRATION,1
MCCABE_HOXC6_TARGETS_CANCER_...2,SET,23,-0.071911,-0.0025436,0.18,0.65524,MCCABE_HOXC6_TARGETS_CANCER_UP,1
HP_ELBOW_CONTRACTURE,SET,98,-0.035728,-0.0026033,0.089403,0.65528,HP_ELBOW_CONTRACTURE,1
ZHONG_PFC_HES1_POS_C1_NPC,SET,6,-0.1503,-0.0027167,0.376,0.65533,ZHONG_PFC_HES1_POS_C1_NPC,1
HP_INSULINOMA,SET,6,-0.14077,-0.0025443,0.35195,0.65541,HP_INSULINOMA,1
MIR656_5P,SET,32,-0.059732,-0.0024915,0.14926,0.65548,MIR656_5P,1
CREIGHTON_ENDOCRINE_THERAPY_...2,SET,366,-0.017331,-0.0024224,0.043307,0.65549,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,1
HP_PROMINENT_COCCYX,SET,5,-0.17098,-0.0028212,0.42719,0.65551,HP_PROMINENT_COCCYX,1
GOBP_CARDIAC_CELL_DEVELOPMENT,SET,82,-0.039358,-0.0026244,0.098325,0.65552,GOBP_CARDIAC_CELL_DEVELOPMENT,1
GSE26928_EFF_MEM_VS_CENTR_ME...1,SET,146,-0.02839,-0.0025215,0.070923,0.65552,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN,1
GOBP_MYD88_DEPENDENT_TOLL_LI...,SET,18,-0.075025,-0.002348,0.18736,0.65558,GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_MEIOTIC_CELL_CYCLE,SET,249,-0.020533,-0.0023749,0.051247,0.65566,GOBP_MEIOTIC_CELL_CYCLE,1
GOBP_MITOTIC_CELL_CYCLE_PHAS...,SET,403,-0.017097,-0.002505,0.042667,0.65568,GOBP_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
GSE17721_0.5H_VS_4H_LPS_BMDC...1,SET,184,-0.02547,-0.002537,0.06356,0.65569,GSE17721_0.5H_VS_4H_LPS_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...348,SET,4,-0.21817,-0.0032198,0.54426,0.65573,GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,1
HP_SENSORY_AXONAL_NEUROPATHY,SET,36,-0.055456,-0.0024532,0.13835,0.65573,HP_SENSORY_AXONAL_NEUROPATHY,1
GOBP_REGULATION_OF_MELANOCYT...,SET,6,-0.16539,-0.0029894,0.41254,0.65576,GOBP_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,1
WP_FOCAL_ADHESION_PI3KAKTMTO...,SET,288,-0.021284,-0.0026447,0.053039,0.65589,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,1
HP_ABNORMALITY_OF_THE_STAPES,SET,13,-0.10521,-0.0027987,0.26214,0.65593,HP_ABNORMALITY_OF_THE_STAPES,1
HP_LOWER_EYELID_COLOBOMA,SET,10,-0.10268,-0.0023957,0.25581,0.65593,HP_LOWER_EYELID_COLOBOMA,1
REACTOME_HCMV_INFECTION,SET,91,-0.035253,-0.0024758,0.087809,0.65596,REACTOME_HCMV_INFECTION,1
HP_LACK_OF_SKIN_ELASTICITY,SET,56,-0.047342,-0.0026106,0.11785,0.65605,HP_LACK_OF_SKIN_ELASTICITY,1
GSE25123_CTRL_VS_IL4_STIM_PP...1,SET,175,-0.026709,-0.0025952,0.066485,0.65606,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN,1
AKT_UP.V1_DN,SET,178,-0.026543,-0.0026008,0.066065,0.65607,AKT_UP.V1_DN,1
BILBAN_B_CLL_LPL_UP,SET,55,-0.046408,-0.0025362,0.11547,0.65611,BILBAN_B_CLL_LPL_UP,1
HP_URETHRAL_OBSTRUCTION,SET,60,-0.046645,-0.0026621,0.11602,0.65617,HP_URETHRAL_OBSTRUCTION,1
GSE11961_GERMINAL_CENTER_BCE...2,SET,179,-0.025775,-0.0025326,0.064092,0.65622,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOBP_NEGATIVE_REGULATION_OF_...433,SET,21,-0.076882,-0.0025987,0.19115,0.65623,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
GSE17721_POLYIC_VS_GARDIQUIM...3,SET,182,-0.024522,-0.0024293,0.060929,0.65633,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN,1
GOMF_MHC_CLASS_II_PROTEIN_BI...,SET,7,-0.1337,-0.0026101,0.33213,0.65636,GOMF_MHC_CLASS_II_PROTEIN_BINDING,1
GSE17721_CTRL_VS_LPS_8H_BMDC...1,SET,184,-0.025506,-0.0025405,0.06335,0.65638,GSE17721_CTRL_VS_LPS_8H_BMDC_DN,1
GAO_LARGE_INTESTINE_ADULT_CF...,SET,22,-0.077764,-0.0026902,0.19311,0.65641,GAO_LARGE_INTESTINE_ADULT_CF_GOBLET_CELL_SUBTYPE_1,1
GOBP_POSITIVE_REGULATION_OF_...341,SET,14,-0.091617,-0.002529,0.22739,0.65649,GOBP_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
GOBP_RETINOIC_ACID_RECEPTOR_...,SET,31,-0.062907,-0.0025827,0.15611,0.65651,GOBP_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
HP_NECROTIZING_ENTEROCOLITIS,SET,6,-0.13136,-0.0023743,0.32593,0.65653,HP_NECROTIZING_ENTEROCOLITIS,1
HP_AUTOIMMUNE_THROMBOCYTOPEN...,SET,43,-0.054042,-0.0026123,0.13408,0.65654,HP_AUTOIMMUNE_THROMBOCYTOPENIA,1
GOBP_NEURON_RECOGNITION,SET,46,-0.059973,-0.0029982,0.14879,0.65655,GOBP_NEURON_RECOGNITION,1
GOBP_INTERFERON_MEDIATED_SIG...,SET,98,-0.036902,-0.0026889,0.091541,0.65657,GOBP_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...785,SET,772,-0.013055,-0.0026202,0.032378,0.6566,GOBP_POSITIVE_REGULATION_OF_TRANSPORT,1
E47_01,SET,233,-0.0226,-0.0025298,0.056048,0.65661,E47_01,1
GOBP_CLEAVAGE_FURROW_FORMATI...,SET,7,-0.14482,-0.0028272,0.35907,0.65664,GOBP_CLEAVAGE_FURROW_FORMATION,1
BONOME_OVARIAN_CANCER_POOR_S...1,SET,19,-0.070939,-0.0022809,0.17582,0.6567,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,1
HP_FACIAL_HYPOTONIA,SET,41,-0.052601,-0.0024829,0.13037,0.6567,HP_FACIAL_HYPOTONIA,1
HP_SHORT_SPERM_FLAGELLA,SET,27,-0.06354,-0.0024348,0.15748,0.6567,HP_SHORT_SPERM_FLAGELLA,1
GOBP_NEGATIVE_REGULATION_OF_...504,SET,26,-0.075657,-0.0028451,0.18748,0.65672,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
MODULE_234,SET,53,-0.054478,-0.0029228,0.13492,0.65681,MODULE_234,1
HP_ABNORMAL_ENZYME_CONCENTRA...,SET,637,-0.013722,-0.0025111,0.033981,0.65682,HP_ABNORMAL_ENZYME_CONCENTRATION_OR_ACTIVITY,1
MIR4799_3P,SET,78,-0.03913,-0.002545,0.096874,0.65686,MIR4799_3P,1
MIR192_5P,SET,32,-0.06066,-0.0025302,0.15016,0.65688,MIR192_5P,1
HOEK_MYELOID_DENDRITIC_CELL_...5,SET,6,-0.14108,-0.00255,0.34925,0.65688,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_DN,1
GOBP_HEAT_GENERATION,SET,18,-0.095131,-0.0029772,0.23547,0.65689,GOBP_HEAT_GENERATION,1
GSE12366_GC_BCELL_VS_PLASMA_...1,SET,162,-0.027039,-0.0025286,0.066925,0.6569,GSE12366_GC_BCELL_VS_PLASMA_CELL_DN,1
GOBP_ORGANOPHOSPHATE_CATABOL...,SET,220,-0.023225,-0.002527,0.05748,0.65691,GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS,1
GOBP_AORTA_MORPHOGENESIS,SET,33,-0.066218,-0.0028048,0.16385,0.65694,GOBP_AORTA_MORPHOGENESIS,1
REACTOME_SIGNALING_BY_FLT3_F...,SET,19,-0.075693,-0.0024337,0.18713,0.65708,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,1
REACTOME_RESPONSE_TO_METAL_I...,SET,14,-0.11351,-0.0031331,0.28057,0.6571,REACTOME_RESPONSE_TO_METAL_IONS,1
GOBP_NEGATIVE_REGULATION_OF_...24,SET,6,-0.14722,-0.002661,0.36377,0.65715,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,1
HP_MOLLUSCOID_PSEUDOTUMORS,SET,6,-0.15868,-0.0028681,0.39203,0.65717,HP_MOLLUSCOID_PSEUDOTUMORS,1
MIR3144_3P,SET,56,-0.045007,-0.0024819,0.11114,0.65724,MIR3144_3P,1
HP_ABSENT_HYPOPLASTIC_PARANA...,SET,5,-0.16791,-0.0027705,0.41463,0.65724,HP_ABSENT_HYPOPLASTIC_PARANASAL_SINUSES,1
MIR6720_5P,SET,123,-0.03041,-0.0024807,0.075088,0.65725,MIR6720_5P,1
REACTOME_SODIUM_CALCIUM_EXCH...,SET,11,-0.12494,-0.0030573,0.30841,0.6573,REACTOME_SODIUM_CALCIUM_EXCHANGERS,1
WP_MICRORNA_FOR_TARGETING_CA...,SET,7,-0.1245,-0.0024305,0.30732,0.6573,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,1
GOBP_TAXIS,SET,423,-0.018303,-0.002746,0.045173,0.65732,GOBP_TAXIS,1
GSE27786_CD8_TCELL_VS_NEUTRO...2,SET,176,-0.024839,-0.0024202,0.061287,0.65736,GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP,1
GOMF_CLATHRIN_LIGHT_CHAIN_BI...,SET,6,-0.12665,-0.0022891,0.31244,0.65739,GOMF_CLATHRIN_LIGHT_CHAIN_BINDING,1
GOBP_CELLULAR_RESPONSE_TO_SA...2,SET,14,-0.090679,-0.0025031,0.22362,0.65744,GOBP_CELLULAR_RESPONSE_TO_SALT_STRESS,1
HP_TEMPOROMANDIBULAR_JOINT_A...,SET,4,-0.15946,-0.0023534,0.39324,0.65744,HP_TEMPOROMANDIBULAR_JOINT_ANKYLOSIS,1
GOBP_OLFACTORY_NERVE_DEVELOP...,SET,6,-0.15117,-0.0027323,0.37273,0.65747,GOBP_OLFACTORY_NERVE_DEVELOPMENT,1
HOEK_PBMC_INACTIVATED_INFLUE...3,SET,10,-0.11862,-0.0027675,0.2924,0.6575,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_DN,1
GOBP_REGULATION_OF_T_CELL_ME...1,SET,47,-0.058349,-0.0029484,0.14374,0.6576,GOBP_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,1
WP_CHRONIC_HYPERGLYCEMIA_IMP...,SET,43,-0.059419,-0.0028722,0.14637,0.65761,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,1
MODULE_138,SET,80,-0.040048,-0.0026378,0.098617,0.65766,MODULE_138,1
chr13q22,SET,14,-0.16137,-0.0044545,0.39732,0.65768,chr13q22,1
HOEK_T_CELL_2011_2012_TIV_AD...2,SET,8,-0.12323,-0.0025718,0.30338,0.6577,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP,1
HP_SEVERELY_REDUCED_LEFT_VEN...,SET,13,-0.083405,-0.0022186,0.20515,0.65783,HP_SEVERELY_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,1
THILLAINADESAN_ZNF217_TARGET...1,SET,6,-0.16204,-0.0029288,0.39844,0.65788,THILLAINADESAN_ZNF217_TARGETS_DN,1
HERNANDEZ_ABERRANT_MITOSIS_B...4,SET,18,-0.08475,-0.0026523,0.20832,0.65793,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1
REACTOME_SUMOYLATION_OF_DNA_...2,SET,14,-0.092853,-0.0025631,0.22824,0.65793,REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,1
GOBP_MESONEPHRIC_TUBULE_FORM...,SET,8,-0.14058,-0.0029339,0.34549,0.65796,GOBP_MESONEPHRIC_TUBULE_FORMATION,1
GSE11961_MARGINAL_ZONE_BCELL...8,SET,186,-0.026076,-0.0026112,0.064061,0.65801,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP,1
GOBP_TRANSLESION_SYNTHESIS,SET,24,-0.058851,-0.0021264,0.14449,0.65811,GOBP_TRANSLESION_SYNTHESIS,1
REACTOME_TRANSFERRIN_ENDOCYT...,SET,29,-0.065832,-0.0026143,0.1615,0.65822,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,1
SLEBOS_HEAD_AND_NECK_CANCER_...,SET,66,-0.039123,-0.0023415,0.095955,0.65826,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,1
GOMF_ANDROGEN_BINDING,SET,4,-0.14753,-0.0021773,0.3618,0.65827,GOMF_ANDROGEN_BINDING,1
GOBP_REGULATION_OF_VIRAL_PRO...,SET,154,-0.029192,-0.0026624,0.071556,0.65835,GOBP_REGULATION_OF_VIRAL_PROCESS,1
HP_GENERALIZED_AMINOACIDURIA,SET,14,-0.097965,-0.0027042,0.24007,0.65839,HP_GENERALIZED_AMINOACIDURIA,1
GOBP_POSITIVE_REGULATION_OF_...753,SET,66,-0.040046,-0.0023967,0.098121,0.65841,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE,1
GOBP_T_HELPER_2_CELL_CYTOKIN...,SET,13,-0.10614,-0.0028234,0.25999,0.65846,GOBP_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,1
HP_AMYLOIDOSIS,SET,34,-0.063957,-0.0027497,0.15666,0.65846,HP_AMYLOIDOSIS,1
HECKER_IFNB1_TARGETS,SET,88,-0.041655,-0.0028769,0.10201,0.65848,HECKER_IFNB1_TARGETS,1
HP_ABNORMAL_DENTATE_NUCLEUS_...,SET,12,-0.094913,-0.0024257,0.23239,0.65851,HP_ABNORMAL_DENTATE_NUCLEUS_MORPHOLOGY,1
GSE3982_NKCELL_VS_TH2_UP,SET,171,-0.027534,-0.0026448,0.067417,0.65851,GSE3982_NKCELL_VS_TH2_UP,1
GOBP_EXOCYST_LOCALIZATION,SET,5,-0.15547,-0.0025653,0.38063,0.65853,GOBP_EXOCYST_LOCALIZATION,1
GSE411_WT_VS_SOCS3_KO_MACROP...2,SET,183,-0.023972,-0.0023813,0.058688,0.65853,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN,1
GSE23505_IL6_IL1_IL23_VS_IL6...1,SET,179,-0.025207,-0.0024767,0.061675,0.65862,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,1
DORN_ADENOVIRUS_INFECTION_24...2,SET,11,-0.097967,-0.0023972,0.23962,0.65867,DORN_ADENOVIRUS_INFECTION_24HR_UP,1
HP_BIFID_EPIGLOTTIS,SET,5,-0.14327,-0.002364,0.35039,0.65869,HP_BIFID_EPIGLOTTIS,1
GOBP_PSYCHOMOTOR_BEHAVIOR,SET,3,-0.24533,-0.0031358,0.59986,0.65872,GOBP_PSYCHOMOTOR_BEHAVIOR,1
GOBP_PROTEIN_LOCALIZATION_TO...31,SET,37,-0.053998,-0.0024216,0.13201,0.65875,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE_ORGANIZING_CENTER,1
NUYTTEN_NIPP1_TARGETS_UP,SET,665,-0.013624,-0.0025454,0.0333,0.65877,NUYTTEN_NIPP1_TARGETS_UP,1
GOBP_PROSTAGLANDIN_TRANSPORT,SET,29,-0.074582,-0.0029618,0.18229,0.65878,GOBP_PROSTAGLANDIN_TRANSPORT,1
DUNNE_TARGETS_OF_AML1_MTG8_F...2,SET,49,-0.053249,-0.0027472,0.13009,0.65884,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,1
GSE42021_TREG_PLN_VS_TREG_PR...1,SET,188,-0.026857,-0.0027038,0.065617,0.65884,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN,1
GAUTAM_EYE_CORNEA_MONOCYTES,SET,218,-0.022652,-0.0024536,0.055333,0.65887,GAUTAM_EYE_CORNEA_MONOCYTES,1
GOLDRATH_IMMUNE_MEMORY,SET,61,-0.047905,-0.0027567,0.11699,0.6589,GOLDRATH_IMMUNE_MEMORY,1
GAVISH_3CA_METAPROGRAM_MACRO...8,SET,46,-0.057062,-0.0028526,0.13935,0.65891,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MONOCYTE_SECRETED,1
GOMF_ORGANIC_ACID_SODIUM_SYM...,SET,32,-0.063826,-0.0026623,0.15584,0.65893,GOMF_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY,1
OCONNOR_PBMC_MENVEO_ACWYVAX_...1,SET,221,-0.023839,-0.0025997,0.058208,0.65893,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN,1
REACTOME_CYTOCHROME_P450_ARR...,SET,63,-0.049843,-0.0029147,0.12167,0.65897,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...5,SET,315,-0.019373,-0.0025157,0.047292,0.65897,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,1
HP_MODERATELY_SHORT_STATURE,SET,4,-0.15982,-0.0023588,0.39,0.65902,HP_MODERATELY_SHORT_STATURE,1
GAVISH_3CA_METAPROGRAM_B_CEL...8,SET,44,-0.055376,-0.0027076,0.1351,0.65905,GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II,1
WP_IL2_SIGNALING,SET,41,-0.057284,-0.002704,0.13975,0.65906,WP_IL2_SIGNALING,1
GOCC_PRP19_COMPLEX,SET,14,-0.085023,-0.0023469,0.20742,0.65906,GOCC_PRP19_COMPLEX,1
GOBP_NEUTROPHIL_MEDIATED_IMM...,SET,37,-0.057092,-0.0025604,0.13926,0.65908,GOBP_NEUTROPHIL_MEDIATED_IMMUNITY,1
MIR4712_5P,SET,92,-0.037877,-0.0026745,0.092372,0.65911,MIR4712_5P,1
GOBP_REGULATION_OF_ORGANELLE...2,SET,1094,-0.010861,-0.0025711,0.026488,0.65911,GOBP_REGULATION_OF_ORGANELLE_ORGANIZATION,1
GOMF_DEOXYRIBONUCLEASE_I_ACT...,SET,4,-0.18149,-0.0026786,0.44261,0.65911,GOMF_DEOXYRIBONUCLEASE_I_ACTIVITY,1
HP_EPIRETINAL_MEMBRANE,SET,12,-0.10621,-0.0027145,0.25893,0.65917,HP_EPIRETINAL_MEMBRANE,1
GSE26030_TH1_VS_TH17_DAY5_PO...1,SET,182,-0.026239,-0.0025995,0.063968,0.65917,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN,1
BIOCARTA_GABA_PATHWAY,SET,9,-0.12242,-0.0027097,0.29835,0.65921,BIOCARTA_GABA_PATHWAY,1
WP_APOPTOSISRELATED_NETWORK_...,SET,50,-0.053751,-0.0028012,0.13099,0.65922,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1
GOBP_SUBSTRATE_DEPENDENT_CEL...1,SET,23,-0.074933,-0.0026505,0.18259,0.65924,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION,1
REACTOME_NEUREXINS_AND_NEURO...,SET,51,-0.050306,-0.0026477,0.12256,0.65927,REACTOME_NEUREXINS_AND_NEUROLIGINS,1
GOBP_MULTIVESICULAR_BODY_ORG...,SET,32,-0.057438,-0.0023958,0.13991,0.65929,GOBP_MULTIVESICULAR_BODY_ORGANIZATION,1
TRAVAGLINI_LUNG_OLR1_CLASSIC...,SET,652,-0.014415,-0.0026677,0.035108,0.65931,TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL,1
HP_OBSTRUCTIVE_SLEEP_APNEA,SET,72,-0.042395,-0.0026497,0.10324,0.65932,HP_OBSTRUCTIVE_SLEEP_APNEA,1
GOMF_DISORDERED_DOMAIN_SPECI...,SET,27,-0.066248,-0.0025386,0.16133,0.65933,GOMF_DISORDERED_DOMAIN_SPECIFIC_BINDING,1
REACTOME_DNA_REPLICATION_PRE...,SET,94,-0.03264,-0.0023295,0.079466,0.65937,REACTOME_DNA_REPLICATION_PRE_INITIATION,1
GSE4748_LPS_VS_LPS_AND_CYANO...1,SET,142,-0.028402,-0.0024881,0.069126,0.65941,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
HP_AIRWAY_OBSTRUCTION,SET,115,-0.033626,-0.0026529,0.081835,0.65942,HP_AIRWAY_OBSTRUCTION,1
MORF_UNG,SET,65,-0.03874,-0.0023009,0.094264,0.65945,MORF_UNG,1
GOBP_REGULATION_OF_RETINOIC_...,SET,15,-0.087847,-0.0025099,0.21372,0.65948,GOBP_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMAL_CERVICAL_SPINE_M...,SET,19,-0.079734,-0.0025636,0.19392,0.65952,HP_ABNORMAL_CERVICAL_SPINE_MORPHOLOGY,1
BIOCARTA_PTEN_PATHWAY,SET,18,-0.085583,-0.0026784,0.20813,0.65954,BIOCARTA_PTEN_PATHWAY,1
REACTOME_ENOS_ACTIVATION,SET,10,-0.12009,-0.0028018,0.29197,0.65957,REACTOME_ENOS_ACTIVATION,1
HP_WHEEZING,SET,52,-0.047497,-0.0025242,0.11546,0.6596,HP_WHEEZING,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,SET,122,-0.034474,-0.0028008,0.083786,0.65963,ELVIDGE_HYPOXIA_BY_DMOG_UP,1
KEGG_MEDICUS_REFERENCE_AUTOP...9,SET,13,-0.10666,-0.0028372,0.25922,0.65963,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR,1
GOBP_NEGATIVE_REGULATION_OF_...560,SET,6,-0.14969,-0.0027056,0.36382,0.65963,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST,1
HP_SEX_REVERSAL,SET,11,-0.1188,-0.0029071,0.28873,0.65963,HP_SEX_REVERSAL,1
GSE21927_SPLEEN_VS_C26GM_TUM...1,SET,162,-0.027002,-0.0025252,0.065607,0.65967,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN,1
GOBP_CELLULAR_RESPONSE_TO_MU...,SET,8,-0.12299,-0.0025668,0.29864,0.65977,GOBP_CELLULAR_RESPONSE_TO_MURAMYL_DIPEPTIDE,1
GOBP_REGULATORY_NCRNA_PROCES...,SET,65,-0.041241,-0.0024495,0.10013,0.65978,GOBP_REGULATORY_NCRNA_PROCESSING,1
chr10p13,SET,28,-0.10897,-0.0042523,0.26454,0.6598,chr10p13,1
GOMF_TETRAPYRROLE_BINDING,SET,135,-0.033228,-0.0028387,0.080656,0.65981,GOMF_TETRAPYRROLE_BINDING,1
MORF_THPO,SET,109,-0.035064,-0.0026937,0.08511,0.65982,MORF_THPO,1
GOBP_REGULATION_OF_INFLAMMAT...1,SET,357,-0.01973,-0.0027244,0.047885,0.65984,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE,1
GSE21927_SPLEEN_MONOCYTE_VS_...2,SET,151,-0.026474,-0.002391,0.064217,0.65992,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP,1
GOBP_RHO_PROTEIN_SIGNAL_TRAN...,SET,131,-0.031667,-0.0026653,0.076789,0.65997,GOBP_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...179,SET,13,-0.10035,-0.0026694,0.24328,0.66001,GOBP_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY,1
HP_EPILEPTIC_ENCEPHALOPATHY,SET,105,-0.033996,-0.0025635,0.082407,0.66002,HP_EPILEPTIC_ENCEPHALOPATHY,1
GSE18791_CTRL_VS_NEWCASTLE_V...16,SET,182,-0.02496,-0.0024728,0.060505,0.66002,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP,1
HP_ABNORMAL_HEMATOCRIT,SET,11,-0.10732,-0.0026262,0.26011,0.66005,HP_ABNORMAL_HEMATOCRIT,1
GOBP_RENAL_VESICLE_FORMATION,SET,8,-0.13496,-0.0028166,0.327,0.66009,GOBP_RENAL_VESICLE_FORMATION,1
GOBP_REGULATION_OF_CD4_POSIT...2,SET,53,-0.050998,-0.002736,0.12353,0.66013,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
HP_HYPERLIPIDEMIA,SET,136,-0.031486,-0.0026998,0.076254,0.66016,HP_HYPERLIPIDEMIA,1
MIR520F_3P,SET,184,-0.025907,-0.0025805,0.062723,0.66021,MIR520F_3P,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,SET,74,-0.042909,-0.0027187,0.10382,0.66031,BASSO_HAIRY_CELL_LEUKEMIA_UP,1
GOBP_MITOCHONDRIAL_RIBOSOME_...,SET,11,-0.10007,-0.0024487,0.2421,0.66032,GOBP_MITOCHONDRIAL_RIBOSOME_ASSEMBLY,1
GOBP_MICROVILLUS_ORGANIZATION,SET,27,-0.068684,-0.002632,0.16611,0.66037,GOBP_MICROVILLUS_ORGANIZATION,1
GOMF_LIGASE_ACTIVITY_FORMING...4,SET,38,-0.055011,-0.0025001,0.13301,0.66041,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS,1
GSE17974_IL4_AND_ANTI_IL12_V...5,SET,139,-0.030487,-0.0026426,0.073715,0.66041,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN,1
GSE40666_NAIVE_VS_EFFECTOR_C...1,SET,185,-0.026773,-0.0026739,0.064725,0.66043,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,1
FLORIO_HUMAN_NEOCORTEX,SET,28,-0.071703,-0.002798,0.17331,0.66046,FLORIO_HUMAN_NEOCORTEX,1
GEISS_RESPONSE_TO_DSRNA_UP,SET,37,-0.057466,-0.0025772,0.13887,0.66049,GEISS_RESPONSE_TO_DSRNA_UP,1
GOMF_SUGAR_TRANSMEMBRANE_TRA...,SET,25,-0.07365,-0.0027159,0.17784,0.66061,GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_SENSORY_NERVE_CO...,SET,24,-0.068535,-0.0024763,0.16546,0.66063,HP_ABNORMAL_SENSORY_NERVE_CONDUCTION_VELOCITY,1
GOBP_REGULATION_OF_NUCLEAR_D...,SET,142,-0.02959,-0.0025922,0.071402,0.66071,GOBP_REGULATION_OF_NUCLEAR_DIVISION,1
HP_METAPHYSEAL_SCLEROSIS,SET,12,-0.10943,-0.0027968,0.26398,0.66076,HP_METAPHYSEAL_SCLEROSIS,1
LEIN_OLIGODENDROCYTE_MARKERS,SET,72,-0.043781,-0.0027363,0.10561,0.66077,LEIN_OLIGODENDROCYTE_MARKERS,1
GAUCHER_PBMC_YF_VAX_STAMARIL...9,SET,31,-0.061326,-0.0025178,0.14792,0.66078,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_DN,1
GRAESSMANN_RESPONSE_TO_MC_AN...4,SET,200,-0.025665,-0.0026641,0.061895,0.6608,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1
GOBP_REGULATION_OF_TRANSLATI...9,SET,7,-0.13113,-0.0025599,0.31612,0.66086,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE,1
HP_CLINODACTYLY_OF_THE_5TH_T...,SET,13,-0.099355,-0.0026428,0.23951,0.66086,HP_CLINODACTYLY_OF_THE_5TH_TOE,1
GSE25147_UNSTIM_VS_HELIOBACT...1,SET,148,-0.030991,-0.0027712,0.074708,0.66086,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN,1
GOMF_SIGNALING_RECEPTOR_REGU...,SET,489,-0.017875,-0.0028781,0.043076,0.66091,GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY,1
MIR1246,SET,47,-0.053227,-0.0026896,0.12826,0.66092,MIR1246,1
GOBP_VISUAL_BEHAVIOR,SET,53,-0.050483,-0.0027085,0.12162,0.66096,GOBP_VISUAL_BEHAVIOR,1
DESCARTES_FETAL_CEREBRUM_MIC...,SET,362,-0.020118,-0.0027968,0.048462,0.66097,DESCARTES_FETAL_CEREBRUM_MICROGLIA,1
GOBP_REGULATION_OF_ENDOPLASM...2,SET,5,-0.1488,-0.0024552,0.35839,0.661,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,1
PID_RHOA_PATHWAY,SET,42,-0.057526,-0.0027482,0.13854,0.66101,PID_RHOA_PATHWAY,1
GOCC_CELL_BODY_MEMBRANE,SET,32,-0.070989,-0.0029611,0.17096,0.66101,GOCC_CELL_BODY_MEMBRANE,1
GOBP_RETINA_VASCULATURE_MORP...,SET,9,-0.12079,-0.0026736,0.29089,0.66102,GOBP_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
HP_VASCULAR_SKIN_ABNORMALITY,SET,513,-0.01571,-0.0025891,0.037827,0.66104,HP_VASCULAR_SKIN_ABNORMALITY,1
GOBP_MAINTENANCE_OF_PROTEIN_...7,SET,24,-0.069002,-0.0024931,0.16614,0.66105,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS,1
HP_ABNORMAL_HYPOTHALAMUS_MOR...,SET,19,-0.074274,-0.0023881,0.17882,0.66105,HP_ABNORMAL_HYPOTHALAMUS_MORPHOLOGY,1
GOBP_RESPONSE_TO_TEMPERATURE...,SET,160,-0.02844,-0.0026434,0.068473,0.66106,GOBP_RESPONSE_TO_TEMPERATURE_STIMULUS,1
GSE360_DC_VS_MAC_B_MALAYI_HI...2,SET,181,-0.026594,-0.0026275,0.064028,0.66106,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP,1
HP_ABNORMAL_CIRCULATING_CALC...,SET,46,-0.052718,-0.0026355,0.12685,0.66114,HP_ABNORMAL_CIRCULATING_CALCIUM_PHOSPHATE_REGULATING_HORMONE_CONCENTRATION,1
MCCLUNG_COCAINE_REWARD_5D,SET,68,-0.043759,-0.0026582,0.10529,0.66115,MCCLUNG_COCAINE_REWARD_5D,1
GOBP_POSITIVE_REGULATION_OF_...159,SET,7,-0.151,-0.0029478,0.36323,0.66119,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE,1
GOBP_RESPONSE_TO_PEPTIDE,SET,20,-0.084909,-0.0028009,0.20422,0.66121,GOBP_RESPONSE_TO_PEPTIDE,1
SETLUR_PROSTATE_CANCER_TMPRS...1,SET,16,-0.092011,-0.002715,0.22128,0.66122,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,1
REACTOME_ANTIGEN_PROCESSING_...2,SET,287,-0.020001,-0.002481,0.048103,0.66122,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1
GSE37301_HEMATOPOIETIC_STEM_...8,SET,165,-0.027646,-0.002609,0.066479,0.66124,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP,1
WP_PROSURVIVAL_SIGNALING_OF_...,SET,15,-0.091315,-0.002609,0.21957,0.66125,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,1
MIR5006_3P,SET,334,-0.020406,-0.0027271,0.049057,0.66128,MIR5006_3P,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...2,SET,167,-0.027376,-0.002599,0.065803,0.66131,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP,1
WP_ADHD_AND_AUTISM_ASD_PATHW...,SET,342,-0.020476,-0.0027685,0.049198,0.66137,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,1
SHAFFER_IRF4_MULTIPLE_MYELOM...,SET,33,-0.064747,-0.0027425,0.1555,0.66143,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1
MORF_PPP6C,SET,95,-0.032236,-0.0023128,0.077411,0.66145,MORF_PPP6C,1
GOMF_STEROID_DEHYDROGENASE_A...1,SET,36,-0.060351,-0.0026698,0.14487,0.66151,GOMF_STEROID_DEHYDROGENASE_ACTIVITY,1
MOREIRA_RESPONSE_TO_TSA_DN,SET,18,-0.084072,-0.0026311,0.20178,0.66153,MOREIRA_RESPONSE_TO_TSA_DN,1
GAVISH_3CA_METAPROGRAM_ENDOT...6,SET,42,-0.062469,-0.0029844,0.14987,0.66159,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_4,1
GSE39820_TGFBETA1_VS_TGFBETA...1,SET,183,-0.0256,-0.0025431,0.061368,0.66172,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN,1
LU_TUMOR_VASCULATURE_DN,SET,8,-0.10973,-0.0022901,0.26303,0.66173,LU_TUMOR_VASCULATURE_DN,1
HP_SKELETAL_MUSCLE_HYPERTROP...,SET,184,-0.026798,-0.0026692,0.064213,0.66178,HP_SKELETAL_MUSCLE_HYPERTROPHY,1
LAKE_ADULT_KIDNEY_C16_COLLEC...,SET,124,-0.035339,-0.0028944,0.084679,0.66178,LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX,1
GSE27786_BCELL_VS_NEUTROPHIL...2,SET,184,-0.024904,-0.0024806,0.059668,0.6618,GSE27786_BCELL_VS_NEUTROPHIL_UP,1
GOBP_CHROMOSOME_CONDENSATION,SET,31,-0.060985,-0.0025038,0.1461,0.66181,GOBP_CHROMOSOME_CONDENSATION,1
MATZUK_FERTILIZATION,SET,7,-0.13554,-0.002646,0.32431,0.66199,MATZUK_FERTILIZATION,1
HP_THENAR_MUSCLE_WEAKNESS,SET,4,-0.18564,-0.0027399,0.44415,0.66201,HP_THENAR_MUSCLE_WEAKNESS,1
GOMF_NADPLUS_PROTEIN_ASPARTA...,SET,5,-0.1571,-0.0025922,0.37575,0.66206,GOMF_NADPLUS_PROTEIN_ASPARTATE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_TORC2_SIG...,SET,4,-0.17001,-0.002509,0.40659,0.66207,GOBP_REGULATION_OF_TORC2_SIGNALING,1
GOBP_CYTOLYSIS_BY_HOST_OF_SY...,SET,6,-0.14872,-0.002688,0.35551,0.66214,GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS,1
GSE20727_CTRL_VS_DNFB_ALLERG...1,SET,165,-0.027676,-0.0026118,0.066136,0.66219,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN,1
MIR1321,SET,124,-0.033437,-0.0027386,0.079875,0.66225,MIR1321,1
ATATGCA_MIR448,SET,191,-0.028802,-0.0029223,0.068772,0.66232,ATATGCA_MIR448,1
GOBP_NEURON_CELL_CELL_ADHESI...,SET,13,-0.10735,-0.0028556,0.25634,0.66232,GOBP_NEURON_CELL_CELL_ADHESION,1
GSE22103_UNSTIM_VS_GMCSF_AND...1,SET,188,-0.024662,-0.0024828,0.058886,0.66232,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,1
HP_BABINSKI_SIGN,SET,254,-0.022265,-0.0026006,0.053129,0.66241,HP_BABINSKI_SIGN,1
GOBP_REGULATION_OF_PROTEIN_D...3,SET,77,-0.039241,-0.002536,0.093609,0.66246,GOBP_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,1
HP_REDUCED_LEFT_VENTRICULAR_...,SET,55,-0.048319,-0.0026407,0.11526,0.66246,HP_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,1
GSE7831_CPG_VS_INFLUENZA_STI...1,SET,186,-0.026968,-0.0027006,0.064299,0.66254,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN,1
GOBP_NEGATIVE_REGULATION_OF_...189,SET,29,-0.061156,-0.0024286,0.1458,0.66255,GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR,1
GOBP_INTESTINE_SMOOTH_MUSCLE...,SET,8,-0.12328,-0.0025728,0.29384,0.66259,GOBP_INTESTINE_SMOOTH_MUSCLE_CONTRACTION,1
GSE27786_ERYTHROBLAST_VS_NEU...2,SET,178,-0.026482,-0.0025948,0.063122,0.66259,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP,1
GOCC_VESICLE_LUMEN,SET,301,-0.021105,-0.00268,0.050301,0.6626,GOCC_VESICLE_LUMEN,1
HP_SHOULDER_CONTRACTURE,SET,8,-0.12957,-0.0027041,0.30882,0.6626,HP_SHOULDER_CONTRACTURE,1
KEGG_VEGF_SIGNALING_PATHWAY,SET,76,-0.041668,-0.0026753,0.099291,0.66263,KEGG_VEGF_SIGNALING_PATHWAY,1
REACTOME_REGULATION_OF_INSUL...2,SET,77,-0.04429,-0.0028622,0.10552,0.66266,REACTOME_REGULATION_OF_INSULIN_SECRETION,1
GSE30962_PRIMARY_VS_SECONDAR...3,SET,176,-0.028301,-0.0027576,0.06742,0.66267,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN,1
MODULE_79,SET,89,-0.040366,-0.0028036,0.096144,0.6627,MODULE_79,1
WP_DDX1_AS_A_REGULATORY_COMP...,SET,6,-0.12684,-0.0022926,0.30208,0.66272,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,1
GSE18893_TCONV_VS_TREG_24H_T...1,SET,169,-0.026331,-0.0025146,0.062691,0.66276,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN,1
GOCC_VACUOLAR_MEMBRANE,SET,438,-0.017054,-0.0026024,0.040601,0.66277,GOCC_VACUOLAR_MEMBRANE,1
GOBP_SEQUESTERING_OF_METAL_I...,SET,9,-0.12443,-0.0027542,0.29615,0.66281,GOBP_SEQUESTERING_OF_METAL_ION,1
GOCC_MICROTUBULE_CYTOSKELETON,SET,1223,-0.010257,-0.0025576,0.02441,0.66283,GOCC_MICROTUBULE_CYTOSKELETON,1
HP_RESPIRATORY_FAILURE,SET,228,-0.023585,-0.0026119,0.056123,0.66284,HP_RESPIRATORY_FAILURE,1
GSE7459_UNTREATED_VS_IL6_TRE...2,SET,117,-0.033544,-0.0026692,0.079822,0.66284,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP,1
GSE42021_TCONV_PLN_VS_CD24IN...2,SET,177,-0.027326,-0.0026701,0.065016,0.66286,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP,1
GOBP_SPINAL_CORD_PATTERNING,SET,18,-0.088126,-0.002758,0.20965,0.66288,GOBP_SPINAL_CORD_PATTERNING,1
POOLA_INVASIVE_BREAST_CANCER...2,SET,256,-0.024017,-0.0028161,0.057126,0.66291,POOLA_INVASIVE_BREAST_CANCER_UP,1
GSE15930_NAIVE_VS_72H_IN_VIT...6,SET,185,-0.025105,-0.0025073,0.059709,0.66292,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
GOBP_RESPONSE_TO_VITAMIN,SET,85,-0.042404,-0.0028785,0.10084,0.66294,GOBP_RESPONSE_TO_VITAMIN,1
BIOCARTA_EIF2_PATHWAY,SET,9,-0.11539,-0.0025541,0.27439,0.66295,BIOCARTA_EIF2_PATHWAY,1
KEGG_MEDICUS_REFERENCE_ELECT...2,SET,10,-0.101,-0.0023566,0.24012,0.66299,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III,1
MODULE_571,SET,14,-0.098754,-0.002726,0.23475,0.663,MODULE_571,1
JAATINEN_HEMATOPOIETIC_STEM_...2,SET,274,-0.022965,-0.0027845,0.054584,0.66302,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,1
GOBP_PROTEIN_DENEDDYLATION,SET,11,-0.098743,-0.0024162,0.23468,0.66303,GOBP_PROTEIN_DENEDDYLATION,1
MIR490_5P,SET,39,-0.05711,-0.0026294,0.13567,0.6631,MIR490_5P,1
GOBP_GLIAL_CELL_MIGRATION,SET,57,-0.051712,-0.0028768,0.12284,0.66311,GOBP_GLIAL_CELL_MIGRATION,1
GOCC_EUKARYOTIC_TRANSLATION_...4,SET,7,-0.12751,-0.0024893,0.30285,0.66314,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M,1
GSE17301_ACD3_ACD28_VS_ACD3_...1,SET,183,-0.026074,-0.0025901,0.061898,0.66321,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN,1
GOBP_DEOXYRIBONUCLEOSIDE_MON...1,SET,8,-0.12047,-0.0025142,0.2859,0.66326,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
WUNDER_INFLAMMATORY_RESPONSE...1,SET,11,-0.1051,-0.0025717,0.2493,0.66332,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN,1
GAVISH_3CA_METAPROGRAM_CD4_T...8,SET,49,-0.052523,-0.0027098,0.12459,0.66333,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP,1
REACTOME_DEGRADATION_OF_BETA...,SET,80,-0.038411,-0.00253,0.091096,0.66336,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1
CHANDRAN_METASTASIS_UP,SET,176,-0.027028,-0.0026336,0.064048,0.66348,CHANDRAN_METASTASIS_UP,1
HP_DOLICHOCEPHALY,SET,196,-0.02531,-0.0026011,0.059977,0.66348,HP_DOLICHOCEPHALY,1
GOMF_GUANYLATE_KINASE_ACTIVI...,SET,7,-0.14085,-0.0027497,0.33357,0.66358,GOMF_GUANYLATE_KINASE_ACTIVITY,1
CROONQUIST_IL6_DEPRIVATION_UP,SET,17,-0.09019,-0.0027431,0.21357,0.6636,CROONQUIST_IL6_DEPRIVATION_UP,1
GSE24142_EARLY_THYMIC_PROGEN...7,SET,180,-0.026371,-0.0025983,0.062442,0.6636,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN,1
GSE3982_MAC_VS_BCELL_DN,SET,163,-0.027361,-0.0025665,0.064786,0.6636,GSE3982_MAC_VS_BCELL_DN,1
HP_ROUND_FACE,SET,95,-0.035909,-0.0025763,0.085023,0.66361,HP_ROUND_FACE,1
GSE17721_POLYIC_VS_CPG_4H_BM...2,SET,180,-0.026136,-0.0025751,0.06187,0.66364,GSE17721_POLYIC_VS_CPG_4H_BMDC_UP,1
MANNO_MIDBRAIN_NEUROTYPES_HD...1,SET,516,-0.017434,-0.0028814,0.041268,0.66365,MANNO_MIDBRAIN_NEUROTYPES_HDA1,1
GSE17301_ACD3_ACD28_VS_ACD3_...4,SET,175,-0.02659,-0.0025836,0.062931,0.66368,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP,1
GSE22886_NAIVE_VS_IGG_IGA_ME...1,SET,173,-0.028363,-0.0027402,0.067127,0.66368,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN,1
GOBP_SULFUR_AMINO_ACID_METAB...,SET,30,-0.069933,-0.0028246,0.16546,0.66373,GOBP_SULFUR_AMINO_ACID_METABOLIC_PROCESS,1
KEGG_NATURAL_KILLER_CELL_MED...,SET,121,-0.034915,-0.0028251,0.082596,0.66375,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1
HP_DECREASED_COMPOUND_MUSCLE...,SET,13,-0.096851,-0.0025762,0.22911,0.66375,HP_DECREASED_COMPOUND_MUSCLE_ACTION_POTENTIAL_AMPLITUDE,1
GNF2_GSTM1,SET,102,-0.036165,-0.0026881,0.085509,0.66383,GNF2_GSTM1,1
GOBP_SIGNAL_PEPTIDE_PROCESSI...,SET,13,-0.097585,-0.0025957,0.23068,0.66386,GOBP_SIGNAL_PEPTIDE_PROCESSING,1
HP_DISTAL_SYMPHALANGISM,SET,6,-0.14807,-0.0026763,0.34993,0.6639,HP_DISTAL_SYMPHALANGISM,1
HP_ELEVATED_URINARY_HOMOVANI...,SET,9,-0.13832,-0.0030617,0.32688,0.6639,HP_ELEVATED_URINARY_HOMOVANILLIC_ACID,1
GSE3920_IFNA_VS_IFNG_TREATED...4,SET,161,-0.028204,-0.0026295,0.066652,0.66391,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP,1
GSE26030_UNSTIM_VS_RESTIM_TH...5,SET,192,-0.025508,-0.0025948,0.060266,0.66394,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN,1
MIR3202,SET,229,-0.023495,-0.0026075,0.055458,0.66409,MIR3202,1
GOCC_OUTER_MITOCHONDRIAL_MEM...,SET,17,-0.083284,-0.0025331,0.19653,0.66413,GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,1
MIR431_5P,SET,49,-0.049913,-0.0025751,0.11772,0.66422,MIR431_5P,1
GSE43863_NAIVE_VS_LY6C_LOW_C...1,SET,172,-0.02703,-0.0026039,0.063717,0.6643,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN,1
PID_THROMBIN_PAR1_PATHWAY,SET,42,-0.056153,-0.0026826,0.13234,0.66432,PID_THROMBIN_PAR1_PATHWAY,1
GOBP_REGULATION_OF_ACTIN_FIL...4,SET,135,-0.031445,-0.0026865,0.074115,0.66432,GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH,1
MORF_SMC1L1,SET,54,-0.042873,-0.0023217,0.10104,0.66433,MORF_SMC1L1,1
HP_ATRIAL_FIBRILLATION,SET,79,-0.044863,-0.0029365,0.10572,0.66434,HP_ATRIAL_FIBRILLATION,1
MIR3184_5P,SET,120,-0.031067,-0.0025034,0.073194,0.66438,MIR3184_5P,1
MATZUK_EARLY_ANTRAL_FOLLICLE,SET,12,-0.11731,-0.0029981,0.27636,0.66439,MATZUK_EARLY_ANTRAL_FOLLICLE,1
NABA_MATRISOME_HGSOC_OMENTAL...,SET,57,-0.051387,-0.0028587,0.12104,0.66441,NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS,1
REACTOME_DEFECTIVE_CHSY1_CAU...,SET,7,-0.12399,-0.0024205,0.29202,0.66442,REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS,1
REACTOME_GASTRULATION,SET,118,-0.032223,-0.002575,0.075882,0.66445,REACTOME_GASTRULATION,1
GSE360_T_GONDII_VS_M_TUBERCU...1,SET,184,-0.027375,-0.0027267,0.064447,0.66449,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_LIPOPROTEIN_LOCALIZATION,SET,19,-0.074932,-0.0024093,0.17639,0.66451,GOBP_LIPOPROTEIN_LOCALIZATION,1
MIR3125,SET,220,-0.023965,-0.0026076,0.056412,0.66452,MIR3125,1
DESCARTES_FETAL_ADRENAL_SCHW...,SET,108,-0.039104,-0.0029903,0.092029,0.66454,DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS,1
MARSHALL_VIRAL_INFECTION_RES...1,SET,26,-0.070476,-0.0026502,0.1658,0.6646,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,1
GOBP_GLYCEROPHOSPHOLIPID_CAT...,SET,33,-0.062211,-0.0026351,0.14635,0.66461,GOBP_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS,1
REACTOME_INSULIN_RECEPTOR_SI...,SET,53,-0.050154,-0.0026908,0.11798,0.66462,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,1
GOBP_DNA_CATABOLIC_PROCESS,SET,27,-0.070173,-0.002689,0.16502,0.66467,GOBP_DNA_CATABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_LE...2,SET,17,-0.093314,-0.0028381,0.2194,0.66469,GOBP_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS,1
HE_LIM_SUN_FETAL_LUNG_C1_SMG...2,SET,650,-0.014888,-0.0027512,0.034997,0.66472,HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL,1
MIR4645_3P,SET,102,-0.035893,-0.0026678,0.084366,0.66474,MIR4645_3P,1
GOBP_REGULATION_OF_REGULATOR...,SET,15,-0.092528,-0.0026436,0.21746,0.66476,GOBP_REGULATION_OF_REGULATORY_NCRNA_PROCESSING,1
GSE7831_1H_VS_4H_CPG_STIM_PD...2,SET,179,-0.025836,-0.0025385,0.060705,0.66479,GSE7831_1H_VS_4H_CPG_STIM_PDC_UP,1
GOBP_SENSORY_PERCEPTION,SET,812,-0.015378,-0.0031616,0.036124,0.66483,GOBP_SENSORY_PERCEPTION,1
BUSSLINGER_ESOPHAGEAL_LATE_S...,SET,130,-0.034948,-0.0029303,0.082078,0.66487,BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS,1
ZSCAN4_TARGET_GENES,SET,1097,-0.011564,-0.0027409,0.027154,0.66489,ZSCAN4_TARGET_GENES,1
HP_PREMATURE_PUBARCHE,SET,13,-0.1099,-0.0029233,0.25803,0.66491,HP_PREMATURE_PUBARCHE,1
GOBP_INOSITOL_METABOLIC_PROC...,SET,8,-0.10864,-0.0022673,0.25507,0.66492,GOBP_INOSITOL_METABOLIC_PROCESS,1
GOBP_GLYCEROLIPID_CATABOLIC_...,SET,62,-0.047657,-0.0027647,0.11188,0.66493,GOBP_GLYCEROLIPID_CATABOLIC_PROCESS,1
GSE24726_WT_VS_E2_2_KO_PDC_UP,SET,177,-0.027129,-0.0026508,0.063688,0.66493,GSE24726_WT_VS_E2_2_KO_PDC_UP,1
GOCC_COLLAGEN_CONTAINING_EXT...,SET,391,-0.019779,-0.0028555,0.046431,0.66494,GOCC_COLLAGEN_CONTAINING_EXTRACELLULAR_MATRIX,1
GOMF_HIGH_DENSITY_LIPOPROTEI...,SET,11,-0.12686,-0.0031043,0.29776,0.66497,GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,1
GOMF_UBIQUITIN_LIGASE_COMPLE...,SET,6,-0.13637,-0.0024648,0.31992,0.66504,GOMF_UBIQUITIN_LIGASE_COMPLEX_SCAFFOLD_ACTIVITY,1
REACTOME_SPRY_REGULATION_OF_...,SET,15,-0.095117,-0.0027176,0.22311,0.66506,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...549,SET,9,-0.11938,-0.0026426,0.27987,0.66515,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING,1
HP_ABNORMALITY_OF_VITAMIN_B_...,SET,41,-0.057318,-0.0027056,0.13437,0.66515,HP_ABNORMALITY_OF_VITAMIN_B_METABOLISM,1
REACTOME_GERM_LAYER_FORMATIO...,SET,15,-0.094117,-0.0026891,0.2206,0.66518,REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION,1
DESCARTES_FETAL_EYE_STROMAL_...,SET,81,-0.044428,-0.0029444,0.10412,0.6652,DESCARTES_FETAL_EYE_STROMAL_CELLS,1
GOBP_ADRENERGIC_RECEPTOR_SIG...,SET,30,-0.071114,-0.0028723,0.16665,0.66521,GOBP_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_MHC_CLASS_I_RECEPTOR_AC...,SET,10,-0.15238,-0.0035553,0.35709,0.66521,GOMF_MHC_CLASS_I_RECEPTOR_ACTIVITY,1
GOBP_IMMUNOLOGICAL_SYNAPSE_F...,SET,16,-0.097778,-0.0028852,0.22889,0.66538,GOBP_IMMUNOLOGICAL_SYNAPSE_FORMATION,1
HP_AXONAL_LOSS,SET,17,-0.082349,-0.0025046,0.19271,0.66543,HP_AXONAL_LOSS,1
GOCC_TRANS_GOLGI_NETWORK_TRA...1,SET,35,-0.063689,-0.0027781,0.14899,0.66548,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE,1
MIR4999_5P,SET,81,-0.040817,-0.0027051,0.09548,0.66549,MIR4999_5P,1
GOMF_AMYLOID_BETA_BINDING,SET,80,-0.044284,-0.0029168,0.10355,0.66555,GOMF_AMYLOID_BETA_BINDING,1
GSE17186_BLOOD_VS_CORD_BLOOD...5,SET,175,-0.026585,-0.0025831,0.062147,0.66559,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN,1
MORF_ORC1L,SET,62,-0.044364,-0.0025737,0.10364,0.66569,MORF_ORC1L,1
PID_IL8_CXCR1_PATHWAY,SET,27,-0.070923,-0.0027178,0.16565,0.66573,PID_IL8_CXCR1_PATHWAY,1
HP_RETINAL_VASCULAR_TORTUOSI...,SET,38,-0.064335,-0.0029238,0.15024,0.66575,HP_RETINAL_VASCULAR_TORTUOSITY,1
MODULE_97,SET,88,-0.037846,-0.0026138,0.088346,0.66581,MODULE_97,1
REACTOME_ACTIVATION_OF_THE_T...,SET,11,-0.11558,-0.0028281,0.26977,0.66583,REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS,1
HP_DELAYED_SOMATOSENSORY_CEN...,SET,3,-0.21477,-0.0027451,0.50121,0.66585,HP_DELAYED_SOMATOSENSORY_CENTRAL_CONDUCTION_TIME,1
GOCC_SYNAPTONEMAL_STRUCTURE,SET,34,-0.056148,-0.002414,0.13102,0.66587,GOCC_SYNAPTONEMAL_STRUCTURE,1
HP_PROMINENCE_OF_THE_PREMAXI...,SET,7,-0.12607,-0.0024612,0.29419,0.66587,HP_PROMINENCE_OF_THE_PREMAXILLA,1
GOBP_POSITIVE_REGULATION_OF_...97,SET,11,-0.1249,-0.0030562,0.2913,0.66595,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,1
GOBP_REGULATION_OF_CELL_CYCL...4,SET,398,-0.018132,-0.0026406,0.042287,0.66596,GOBP_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
REACTOME_INTERACTION_WITH_CU...,SET,11,-0.10566,-0.0025854,0.24639,0.66597,REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA,1
COWLING_MYCN_TARGETS,SET,38,-0.063037,-0.0028648,0.14698,0.66599,COWLING_MYCN_TARGETS,1
WP_CREATINE_PATHWAY,SET,4,-0.20351,-0.0030035,0.47452,0.66599,WP_CREATINE_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...143,SET,21,-0.088436,-0.0029892,0.20621,0.66599,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_DOUBLE_ST...2,SET,68,-0.041163,-0.0025005,0.095983,0.66599,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,1
GOBP_LIPID_IMPORT_INTO_CELL,SET,19,-0.083903,-0.0026977,0.19552,0.66608,GOBP_LIPID_IMPORT_INTO_CELL,1
IIZUKA_LIVER_CANCER_PROGRESS...5,SET,15,-0.092084,-0.002631,0.21444,0.66619,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,1
MORF_IL9,SET,86,-0.04082,-0.0027872,0.095041,0.66622,MORF_IL9,1
BIOCARTA_EOSINOPHILS_PATHWAY,SET,7,-0.12921,-0.0025225,0.30081,0.66623,BIOCARTA_EOSINOPHILS_PATHWAY,1
GSE13887_RESTING_VS_ACT_CD4_...2,SET,94,-0.037153,-0.0026516,0.086451,0.66631,GSE13887_RESTING_VS_ACT_CD4_TCELL_UP,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...2,SET,30,-0.069256,-0.0027972,0.16112,0.66634,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1
MIR550B_2_5P,SET,46,-0.052378,-0.0026185,0.12183,0.66638,MIR550B_2_5P,1
GOBP_NEGATIVE_REGULATION_OF_...194,SET,5,-0.16211,-0.0026748,0.377,0.6664,GOBP_NEGATIVE_REGULATION_OF_DOPAMINE_SECRETION,1
HP_RESPIRATORY_INSUFFICIENCY,SET,561,-0.015476,-0.0026637,0.03599,0.66641,HP_RESPIRATORY_INSUFFICIENCY,1
GOBP_POSITIVE_REGULATION_OF_...154,SET,67,-0.048016,-0.0028953,0.11162,0.66646,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,1
HP_BUNDLE_BRANCH_BLOCK,SET,68,-0.043478,-0.0026411,0.10107,0.66647,HP_BUNDLE_BRANCH_BLOCK,1
GSE3982_CTRL_VS_LPS_1H_NEUTR...1,SET,174,-0.026971,-0.0026132,0.062693,0.66647,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN,1
GOBP_REGULATION_OF_GLUCOSE_I...,SET,52,-0.054551,-0.002899,0.1268,0.66648,GOBP_REGULATION_OF_GLUCOSE_IMPORT,1
GOMF_PEROXISOME_TARGETING_SE...,SET,3,-0.20881,-0.002669,0.48537,0.66648,GOMF_PEROXISOME_TARGETING_SEQUENCE_BINDING,1
GOMF_INTRONIC_TRANSCRIPTION_...,SET,11,-0.1203,-0.0029438,0.27948,0.66656,GOMF_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
GOBP_REGULATION_OF_CARBOHYDR...3,SET,163,-0.029263,-0.002745,0.067979,0.66657,GOBP_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
GSE36078_WT_VS_IL1R_KO_LUNG_...6,SET,183,-0.027202,-0.0027021,0.063186,0.66658,GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP,1
GSE21546_WT_VS_SAP1A_KO_ANTI...2,SET,183,-0.027317,-0.0027136,0.06345,0.66659,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
ZSCAN5C_TARGET_GENES,SET,111,-0.03582,-0.0027767,0.083187,0.66662,ZSCAN5C_TARGET_GENES,1
HP_APLASTIC_HYPOPLASTIC_TOEN...,SET,105,-0.035867,-0.0027046,0.083293,0.66662,HP_APLASTIC_HYPOPLASTIC_TOENAIL,1
HP_ABNORMAL_MOTOR_NERVE_COND...,SET,60,-0.045715,-0.0026091,0.10616,0.66663,HP_ABNORMAL_MOTOR_NERVE_CONDUCTION_VELOCITY,1
MIR6777_5P,SET,5,-0.17888,-0.0029515,0.41526,0.66667,MIR6777_5P,1
GOBP_LYMPHOCYTE_COSTIMULATION,SET,44,-0.059021,-0.0028859,0.137,0.6667,GOBP_LYMPHOCYTE_COSTIMULATION,1
WP_WARBURG_EFFECT_MODULATED_...,SET,24,-0.077358,-0.0027951,0.17954,0.66672,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,1
GOBP_TELOMERASE_HOLOENZYME_C...,SET,6,-0.12518,-0.0022626,0.29052,0.66672,GOBP_TELOMERASE_HOLOENZYME_COMPLEX_ASSEMBLY,1
MODULE_245,SET,25,-0.07362,-0.0027148,0.17073,0.66684,MODULE_245,1
GOBP_PROXIMAL_TUBULE_DEVELOP...,SET,10,-0.12222,-0.0028515,0.28335,0.66688,GOBP_PROXIMAL_TUBULE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...24,SET,22,-0.085107,-0.0029443,0.19731,0.66689,GOBP_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
HP_ABDOMINAL_AORTIC_ANEURYSM,SET,22,-0.086795,-0.0030027,0.20121,0.66689,HP_ABDOMINAL_AORTIC_ANEURYSM,1
WP_GABA_RECEPTOR_SIGNALING,SET,28,-0.079449,-0.0031003,0.18409,0.66697,WP_GABA_RECEPTOR_SIGNALING,1
GSE3039_ALPHAALPHA_VS_ALPHAB...1,SET,188,-0.027854,-0.0028041,0.064524,0.66701,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN,1
MANALO_HYPOXIA_DN,SET,263,-0.021457,-0.0025496,0.049693,0.66705,MANALO_HYPOXIA_DN,1
VANTVEER_BREAST_CANCER_METAS...1,SET,96,-0.039556,-0.0028528,0.091597,0.66707,VANTVEER_BREAST_CANCER_METASTASIS_DN,1
GOCC_LAMELLIPODIUM_MEMBRANE,SET,22,-0.081022,-0.0028029,0.18746,0.66721,GOCC_LAMELLIPODIUM_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...497,SET,17,-0.1009,-0.0030689,0.23342,0.66723,GOBP_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION,1
GOMF_BILE_ACID_TRANSMEMBRANE...,SET,20,-0.085168,-0.0028094,0.19702,0.66723,GOMF_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HALLMARK_PEROXISOME,SET,98,-0.037213,-0.0027115,0.086074,0.66725,HALLMARK_PEROXISOME,1
MIR4511,SET,139,-0.03144,-0.0027252,0.072692,0.66731,MIR4511,1
SASAI_TARGETS_OF_CXCR6_AND_P...2,SET,12,-0.11769,-0.0030078,0.2721,0.66732,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP,1
SCHAEFFER_PROSTATE_DEVELOPME...10,SET,6,-0.1626,-0.0029389,0.37585,0.66735,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP,1
HP_ACNE_INVERSA,SET,11,-0.095396,-0.0023343,0.22043,0.66741,HP_ACNE_INVERSA,1
GTCGATC_MIR3695P,SET,4,-0.16728,-0.0024688,0.38645,0.66744,GTCGATC_MIR3695P,1
GOBP_RESPONSE_TO_AMINE,SET,50,-0.056412,-0.0029399,0.13032,0.66744,GOBP_RESPONSE_TO_AMINE,1
HP_HYPOREFLEXIA_OF_LOWER_LIM...,SET,33,-0.067364,-0.0028534,0.15563,0.66744,HP_HYPOREFLEXIA_OF_LOWER_LIMBS,1
GOBP_REGULATION_OF_INTEGRIN_...2,SET,3,-0.25073,-0.0032047,0.57918,0.66745,GOBP_REGULATION_OF_INTEGRIN_BIOSYNTHETIC_PROCESS,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...2,SET,33,-0.066138,-0.0028015,0.15278,0.66746,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN,1
BOQUEST_STEM_CELL_DN,SET,205,-0.028744,-0.0030203,0.06638,0.6675,BOQUEST_STEM_CELL_DN,1
HP_ABNORMALLY_OSSIFIED_VERTE...,SET,19,-0.085591,-0.002752,0.19766,0.6675,HP_ABNORMALLY_OSSIFIED_VERTEBRAE,1
GOCC_SARCOPLASMIC_RETICULUM_...1,SET,9,-0.12882,-0.0028513,0.29744,0.66752,GOCC_SARCOPLASMIC_RETICULUM_LUMEN,1
GSE29618_PRE_VS_DAY7_FLU_VAC...4,SET,174,-0.028735,-0.0027841,0.066315,0.6676,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP,1
DAZARD_UV_RESPONSE_CLUSTER_G1,SET,53,-0.050706,-0.0027204,0.11702,0.66761,DAZARD_UV_RESPONSE_CLUSTER_G1,1
HP_THICK_VERMILION_BORDER,SET,226,-0.024011,-0.0026475,0.055384,0.66769,HP_THICK_VERMILION_BORDER,1
GOBP_POSITIVE_REGULATION_OF_...100,SET,33,-0.068885,-0.0029178,0.15885,0.66773,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE360_CTRL_VS_L_DONOVANI_DC...1,SET,180,-0.028413,-0.0027995,0.065506,0.66776,GSE360_CTRL_VS_L_DONOVANI_DC_DN,1
HP_CAVERNOUS_HEMANGIOMA,SET,33,-0.062717,-0.0026565,0.14455,0.6678,HP_CAVERNOUS_HEMANGIOMA,1
GOBP_POSTSYNAPSE_ORGANIZATION,SET,180,-0.028765,-0.0028342,0.066275,0.66787,GOBP_POSTSYNAPSE_ORGANIZATION,1
REACTOME_CELLULAR_RESPONSE_T...2,SET,95,-0.036684,-0.002632,0.084497,0.66791,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1
GOCC_PAR_POLARITY_COMPLEX,SET,6,-0.1599,-0.0028901,0.36815,0.66798,GOCC_PAR_POLARITY_COMPLEX,1
ACAGGGT_MIR10A_MIR10B,SET,111,-0.034173,-0.002649,0.078667,0.668,ACAGGGT_MIR10A_MIR10B,1
KEGG_MEDICUS_VARIANT_MUTATIO...28,SET,43,-0.049439,-0.0023898,0.11376,0.66806,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GSE17721_PAM3CSK4_VS_CPG_12H...2,SET,175,-0.026877,-0.0026115,0.061845,0.66807,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP,1
SCHAEFFER_PROSTATE_DEVELOPME...6,SET,142,-0.030881,-0.0027053,0.071036,0.66811,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1
MIR146B_3P,SET,62,-0.048578,-0.0028182,0.11172,0.66815,MIR146B_3P,1
GOBP_TRIGEMINAL_NERVE_DEVELO...,SET,12,-0.1261,-0.0032228,0.28995,0.66818,GOBP_TRIGEMINAL_NERVE_DEVELOPMENT,1
GOBP_INTERLEUKIN_17A_MEDIATE...,SET,6,-0.16838,-0.0030435,0.38695,0.66827,GOBP_INTERLEUKIN_17A_MEDIATED_SIGNALING_PATHWAY,1
chr1p21,SET,29,-0.11514,-0.0045726,0.26459,0.66828,chr1p21,1
REACTOME_MAPK_FAMILY_SIGNALI...,SET,308,-0.02124,-0.0027278,0.048788,0.66834,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1
HP_FAILURE_TO_THRIVE_IN_INFA...,SET,108,-0.035954,-0.0027494,0.082558,0.6684,HP_FAILURE_TO_THRIVE_IN_INFANCY,1
HP_SKIN_PIT,SET,62,-0.048093,-0.00279,0.11043,0.6684,HP_SKIN_PIT,1
GOBP_TRANSPOSITION,SET,35,-0.0628,-0.0027393,0.14413,0.66848,GOBP_TRANSPOSITION,1
GSE19401_UNSTIM_VS_PAM2CSK4_...2,SET,175,-0.02819,-0.002739,0.064695,0.66848,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
MIR6769B_5P,SET,71,-0.044618,-0.0027692,0.10238,0.6685,MIR6769B_5P,1
GSE41978_ID2_KO_VS_BIM_KO_KL...2,SET,186,-0.028289,-0.0028328,0.064899,0.66854,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
MIR2861,SET,82,-0.0475,-0.0031673,0.10897,0.66855,MIR2861,1
REACTOME_MODULATION_BY_MTB_O...,SET,6,-0.17897,-0.0032348,0.41049,0.66858,REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM,1
GOBP_DETERMINATION_OF_LIVER_...,SET,5,-0.16651,-0.0027475,0.3819,0.66858,GOBP_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY,1
KEGG_MEDICUS_REFERENCE_REGUL...8,SET,19,-0.094669,-0.0030439,0.21702,0.66866,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP,1
GOBP_AMP_BIOSYNTHETIC_PROCESS,SET,10,-0.11489,-0.0026806,0.26339,0.66866,GOBP_AMP_BIOSYNTHETIC_PROCESS,1
CAFFAREL_RESPONSE_TO_THC_8HR...4,SET,13,-0.099956,-0.0026588,0.22912,0.66867,CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,1
ZHAN_MULTIPLE_MYELOMA_MF_DN,SET,40,-0.061326,-0.0028593,0.14057,0.66868,ZHAN_MULTIPLE_MYELOMA_MF_DN,1
HP_ABNORMALITY_OF_FACIAL_SOF...,SET,458,-0.017726,-0.0027646,0.04063,0.66868,HP_ABNORMALITY_OF_FACIAL_SOFT_TISSUE,1
ZNF133_TARGET_GENES,SET,175,-0.027844,-0.0027055,0.063817,0.66869,ZNF133_TARGET_GENES,1
HP_BROAD_DISTAL_PHALANX_OF_T...,SET,5,-0.18342,-0.0030264,0.42025,0.66874,HP_BROAD_DISTAL_PHALANX_OF_THE_TOES,1
SNIP1_TARGET_GENES,SET,593,-0.015252,-0.0026964,0.034938,0.66877,SNIP1_TARGET_GENES,1
GAVISH_3CA_METAPROGRAM_ENDOT...2,SET,47,-0.059338,-0.0029984,0.13591,0.66879,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_COAGULATION,1
KEGG_MEDICUS_VARIANT_EML4_AL...3,SET,13,-0.10595,-0.0028184,0.24261,0.66884,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY,1
HP_RENAL_SODIUM_WASTING,SET,7,-0.13548,-0.0026449,0.31021,0.66885,HP_RENAL_SODIUM_WASTING,1
MIR4537,SET,6,-0.15651,-0.0028289,0.35831,0.66887,MIR4537,1
GOBP_INNER_DYNEIN_ARM_ASSEMB...,SET,11,-0.098747,-0.0024163,0.22606,0.66887,GOBP_INNER_DYNEIN_ARM_ASSEMBLY,1
GOBP_REGULATION_OF_FOREBRAIN...,SET,5,-0.18747,-0.0030932,0.42918,0.66887,GOBP_REGULATION_OF_FOREBRAIN_NEURON_DIFFERENTIATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...22,SET,4,-0.20139,-0.0029722,0.46102,0.66888,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
HP_LOSS_OF_EYELASHES,SET,4,-0.15852,-0.0023395,0.36284,0.6689,HP_LOSS_OF_EYELASHES,1
REACTOME_GRB2_SOS_PROVIDES_L...,SET,15,-0.10473,-0.0029922,0.23963,0.66896,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,1
GSE6259_DEC205_POS_DC_VS_BCE...2,SET,139,-0.033882,-0.0029369,0.077526,0.66896,GSE6259_DEC205_POS_DC_VS_BCELL_UP,1
GOBP_CD40_SIGNALING_PATHWAY,SET,13,-0.095465,-0.0025394,0.21831,0.66904,GOBP_CD40_SIGNALING_PATHWAY,1
WP_NOVEL_INTRACELLULAR_COMPO...,SET,54,-0.050676,-0.0027443,0.11588,0.66905,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,1
KIM_HYPOXIA,SET,15,-0.098709,-0.0028202,0.22566,0.6691,KIM_HYPOXIA,1
GSE21774_CD62L_POS_CD56_BRIG...2,SET,173,-0.030293,-0.0029267,0.069239,0.66913,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,1
GSE5099_MONOCYTE_VS_ALTERNAT...1,SET,166,-0.027146,-0.0025695,0.062042,0.66914,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN,1
CHENG_IMPRINTED_BY_ESTRADIOL,SET,98,-0.039488,-0.0028773,0.090238,0.66916,CHENG_IMPRINTED_BY_ESTRADIOL,1
GOBP_NEGATIVE_REGULATION_OF_...399,SET,214,-0.025021,-0.0026855,0.057168,0.66919,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,1
REACTOME_PROTEIN_HYDROXYLATI...,SET,17,-0.087221,-0.0026528,0.19919,0.66926,REACTOME_PROTEIN_HYDROXYLATION,1
REACTOME_SUPPRESSION_OF_PHAG...,SET,12,-0.099351,-0.0025391,0.22684,0.6693,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,1
GOBP_DENDRITIC_SPINE_DEVELOP...,SET,87,-0.041121,-0.0028239,0.093866,0.66933,GOBP_DENDRITIC_SPINE_DEVELOPMENT,1
HP_INCOMPLETE_PARTITION_OF_T...,SET,7,-0.13678,-0.0026702,0.31221,0.66934,HP_INCOMPLETE_PARTITION_OF_THE_COCHLEA_TYPE_II,1
GOBP_FOLLICLE_STIMULATING_HO...,SET,8,-0.15489,-0.0032326,0.35345,0.66939,GOBP_FOLLICLE_STIMULATING_HORMONE_SECRETION,1
GOBP_REGULATION_OF_HYDROGEN_...1,SET,7,-0.1477,-0.0028833,0.337,0.6694,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,1
GOBP_MITOCHONDRIAL_DEPOLARIZ...,SET,21,-0.087325,-0.0029516,0.19919,0.66945,GOBP_MITOCHONDRIAL_DEPOLARIZATION,1
MANNO_MIDBRAIN_NEUROTYPES_HN...5,SET,197,-0.028026,-0.0028875,0.063914,0.66949,MANNO_MIDBRAIN_NEUROTYPES_HNPROG,1
GOBP_METHYLGLYOXAL_METABOLIC...,SET,4,-0.15348,-0.0022652,0.34999,0.6695,GOBP_METHYLGLYOXAL_METABOLIC_PROCESS,1
WAGSCHAL_EHMT2_TARGETS_UP,SET,10,-0.12211,-0.002849,0.27836,0.66954,WAGSCHAL_EHMT2_TARGETS_UP,1
GOMF_GABA_A_RECEPTOR_ACTIVITY,SET,16,-0.11867,-0.0035016,0.27054,0.66954,GOMF_GABA_A_RECEPTOR_ACTIVITY,1
KEGG_GLYCOSPHINGOLIPID_BIOSY...1,SET,15,-0.10857,-0.003102,0.24741,0.6696,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,1
GOMF_ACETYLCHOLINE_BINDING,SET,10,-0.11843,-0.0027632,0.26987,0.66961,GOMF_ACETYLCHOLINE_BINDING,1
GSE7852_TREG_VS_TCONV_DN,SET,178,-0.02857,-0.0027995,0.065095,0.66963,GSE7852_TREG_VS_TCONV_DN,1
MIR6069,SET,26,-0.071835,-0.0027013,0.16365,0.66965,MIR6069,1
GOMF_HEPARAN_SULFATE_PROTEOG...,SET,17,-0.10267,-0.0031228,0.23391,0.66965,GOMF_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING,1
HP_MYOTONIA,SET,28,-0.07271,-0.0028373,0.16563,0.66966,HP_MYOTONIA,1
CHESLER_BRAIN_HIGHEST_GENETI...,SET,36,-0.064037,-0.0028328,0.14586,0.66967,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,1
HP_LONG_HALLUX,SET,20,-0.085466,-0.0028193,0.19467,0.66968,HP_LONG_HALLUX,1
HP_INSOMNIA,SET,62,-0.050404,-0.0029241,0.1148,0.66969,HP_INSOMNIA,1
GOMF_SODIUM_CHANNEL_INHIBITO...,SET,8,-0.1507,-0.0031451,0.34323,0.6697,GOMF_SODIUM_CHANNEL_INHIBITOR_ACTIVITY,1
HP_SEVERE_INTRAUTERINE_GROWT...,SET,13,-0.11286,-0.0030022,0.25704,0.6697,HP_SEVERE_INTRAUTERINE_GROWTH_RETARDATION,1
GOMF_GLUTAMATE_BINDING,SET,8,-0.15045,-0.0031399,0.34263,0.66971,GOMF_GLUTAMATE_BINDING,1
GOBP_RESPONSE_TO_ANGIOTENSIN,SET,38,-0.067689,-0.0030762,0.15412,0.66973,GOBP_RESPONSE_TO_ANGIOTENSIN,1
MIR4320,SET,48,-0.056915,-0.0029063,0.12956,0.66977,MIR4320,1
REACTOME_REGULATION_OF_NPAS4...2,SET,5,-0.17869,-0.0029485,0.40677,0.66978,REACTOME_REGULATION_OF_NPAS4_GENE_TRANSCRIPTION,1
WP_MAMMARY_GLAND_DEVELOPMENT...4,SET,12,-0.11946,-0.003053,0.27193,0.66978,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,1
WP_SELECTIVE_EXPRESSION_OF_C...,SET,27,-0.079742,-0.0030557,0.18145,0.66983,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,1
FOXO1_01,SET,219,-0.02664,-0.0028921,0.060622,0.66983,FOXO1_01,1
GSE2770_UNTREATED_VS_TGFB_AN...8,SET,177,-0.027522,-0.0026892,0.062629,0.66983,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
HP_ABNORMAL_CAROTID_ARTERY_M...,SET,83,-0.041516,-0.0027851,0.094468,0.66984,HP_ABNORMAL_CAROTID_ARTERY_MORPHOLOGY,1
BUSSLINGER_DUODENAL_DIFFEREN...,SET,266,-0.022818,-0.0027265,0.051913,0.66986,BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS,1
HP_ABNORMAL_CIRCULATING_ORGA...,SET,655,-0.014844,-0.0027532,0.033768,0.66988,HP_ABNORMAL_CIRCULATING_ORGANIC_COMPOUND_CONCENTRATION,1
GOBP_REACTIVE_NITROGEN_SPECI...,SET,73,-0.047709,-0.0030024,0.10853,0.66989,GOBP_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS,1
HP_WEAKNESS_DUE_TO_UPPER_MOT...,SET,426,-0.018155,-0.0027331,0.041297,0.66989,HP_WEAKNESS_DUE_TO_UPPER_MOTOR_NEURON_DYSFUNCTION,1
GSE19923_HEB_KO_VS_HEB_AND_E...2,SET,177,-0.027693,-0.0027059,0.062985,0.66991,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,1
GOCC_TRNA_METHYLTRANSFERASE_...,SET,6,-0.12406,-0.0022424,0.28206,0.66997,GOCC_TRNA_METHYLTRANSFERASE_COMPLEX,1
GOMF_3_HYDROXYACYL_COA_DEHYD...2,SET,5,-0.18751,-0.003094,0.42606,0.67007,GOMF_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...381,SET,127,-0.032334,-0.0026799,0.073441,0.67013,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
GOLDRATH_NAIVE_VS_EFF_CD8_TC...2,SET,181,-0.026592,-0.0026272,0.060399,0.67013,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP,1
CREIGHTON_AKT1_SIGNALING_VIA...2,SET,32,-0.065778,-0.0027437,0.14938,0.67015,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,1
GSE3982_MEMORY_CD4_TCELL_VS_...5,SET,186,-0.026631,-0.0026668,0.060468,0.67018,GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN,1
GOBP_ATRIOVENTRICULAR_CANAL_...,SET,13,-0.11235,-0.0029884,0.25499,0.67024,GOBP_ATRIOVENTRICULAR_CANAL_DEVELOPMENT,1
HP_PERIPHERAL_ARTERIAL_STENO...,SET,30,-0.075535,-0.0030508,0.1714,0.67028,HP_PERIPHERAL_ARTERIAL_STENOSIS,1
GOBP_BLOOD_VESSEL_REMODELING,SET,40,-0.061054,-0.0028466,0.13853,0.67029,GOBP_BLOOD_VESSEL_REMODELING,1
REACTOME_SIGNALING_BY_WNT,SET,260,-0.023667,-0.0027964,0.053641,0.67047,REACTOME_SIGNALING_BY_WNT,1
GOCC_PHOTORECEPTOR_RIBBON_SY...,SET,9,-0.14063,-0.0031129,0.31871,0.67048,GOCC_PHOTORECEPTOR_RIBBON_SYNAPSE,1
MIR6859_5P,SET,189,-0.026552,-0.00268,0.060169,0.67049,MIR6859_5P,1
HP_2_3_TOE_CUTANEOUS_SYNDACT...,SET,13,-0.11053,-0.0029401,0.25041,0.67053,HP_2_3_TOE_CUTANEOUS_SYNDACTYLY,1
GOBP_PHENYLPROPANOID_METABOL...,SET,7,-0.14906,-0.00291,0.33763,0.67057,GOBP_PHENYLPROPANOID_METABOLIC_PROCESS,1
KLF7_TARGET_GENES,SET,736,-0.014094,-0.0027647,0.03191,0.67063,KLF7_TARGET_GENES,1
HP_PREMATURE_SKIN_WRINKLING,SET,61,-0.046707,-0.0026877,0.10573,0.67066,HP_PREMATURE_SKIN_WRINKLING,1
SATO_SILENCED_BY_METHYLATION...1,SET,368,-0.020865,-0.0029242,0.047225,0.67069,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,1
HARALAMBIEVA_PBMC_FLUARIX_AG...2,SET,405,-0.01828,-0.0026848,0.041371,0.6707,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,1
GOBP_REGULATION_OF_PROTEIN_E...1,SET,24,-0.068563,-0.0024773,0.15516,0.67071,GOBP_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
IVANOVA_HEMATOPOIESIS_INTERM...,SET,123,-0.032394,-0.0026425,0.073261,0.67081,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,1
GOCC_T_CELL_RECEPTOR_COMPLEX,SET,15,-0.10496,-0.0029989,0.23725,0.6709,GOCC_T_CELL_RECEPTOR_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...170,SET,15,-0.096066,-0.0027447,0.21709,0.67094,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,1
ZNF586_TARGET_GENES,SET,35,-0.063607,-0.0027745,0.14373,0.67095,ZNF586_TARGET_GENES,1
GOBP_REGULATION_OF_TRANSLATI...6,SET,15,-0.092902,-0.0026543,0.20989,0.67098,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS,1
MIR4308,SET,133,-0.032645,-0.0027684,0.073737,0.67102,MIR4308,1
HP_BROAD_FACE,SET,15,-0.099507,-0.0028431,0.22471,0.67105,HP_BROAD_FACE,1
HP_HYPERTRIGLYCERIDEMIA,SET,110,-0.037202,-0.0028709,0.084002,0.67107,HP_HYPERTRIGLYCERIDEMIA,1
MIR6499_3P,SET,111,-0.036148,-0.0028021,0.081602,0.6711,MIR6499_3P,1
GSE42088_2H_VS_24H_LEISHMANI...1,SET,173,-0.028366,-0.0027405,0.064012,0.67116,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN,1
GSE1925_3H_VS_24H_IFNG_STIM_...1,SET,187,-0.027714,-0.0027827,0.062539,0.67117,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,1
KEGG_MEDICUS_REFERENCE_ADRB3...,SET,35,-0.066919,-0.002919,0.151,0.67118,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY,1
REACTOME_MET_INTERACTS_WITH_...,SET,5,-0.19857,-0.0032764,0.44797,0.67121,REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS,1
WP_PLATELETMEDIATED_INTERACT...,SET,15,-0.10457,-0.0029878,0.23591,0.67122,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,1
HP_ABNORMAL_LIGHT_ADAPTED_EL...,SET,9,-0.14348,-0.0031759,0.32351,0.6713,HP_ABNORMAL_LIGHT_ADAPTED_ELECTRORETINOGRAM,1
REACTOME_ENDOSOMAL_SORTING_C...,SET,30,-0.064906,-0.0026215,0.14633,0.67131,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,1
GSE45365_NK_CELL_VS_CD11B_DC...3,SET,186,-0.028083,-0.0028122,0.063288,0.67138,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP,1
WP_PURINERGIC_SIGNALING,SET,29,-0.072189,-0.0028668,0.16268,0.67139,WP_PURINERGIC_SIGNALING,1
GOBP_TRNA_PSEUDOURIDINE_SYNT...,SET,6,-0.13964,-0.0025239,0.31467,0.67139,GOBP_TRNA_PSEUDOURIDINE_SYNTHESIS,1
GOBP_REGULATION_OF_INTRACELL...6,SET,242,-0.023686,-0.0027013,0.053359,0.67144,GOBP_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
KAECH_DAY15_EFF_VS_MEMORY_CD...1,SET,182,-0.028019,-0.0027758,0.063115,0.67145,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN,1
GSE6875_TCONV_VS_FOXP3_KO_TR...2,SET,179,-0.028737,-0.0028236,0.064716,0.67149,GSE6875_TCONV_VS_FOXP3_KO_TREG_UP,1
GSE7764_IL15_NK_CELL_24H_VS_...1,SET,176,-0.028415,-0.0027687,0.06399,0.6715,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN,1
HP_ABNORMAL_FEMALE_MEIOSIS,SET,6,-0.15294,-0.0027644,0.34437,0.67152,HP_ABNORMAL_FEMALE_MEIOSIS,1
GOBP_ESTABLISHMENT_OF_CELL_P...,SET,145,-0.031897,-0.0028235,0.071779,0.67161,GOBP_ESTABLISHMENT_OF_CELL_POLARITY,1
HP_ABNORMALITY_OF_THE_LEYDIG...,SET,12,-0.11123,-0.0028426,0.25012,0.67172,HP_ABNORMALITY_OF_THE_LEYDIG_CELLS,1
GOBP_DENSE_CORE_GRANULE_EXOC...,SET,10,-0.13514,-0.003153,0.30387,0.67174,GOBP_DENSE_CORE_GRANULE_EXOCYTOSIS,1
KEGG_MEDICUS_REFERENCE_EGF_E...5,SET,15,-0.10421,-0.0029774,0.2343,0.67175,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY,1
MORF_HDAC1,SET,225,-0.023888,-0.0026281,0.053701,0.67177,MORF_HDAC1,1
MIR215_5P,SET,34,-0.065276,-0.0028064,0.14672,0.6718,MIR215_5P,1
GSE2770_IL12_AND_TGFB_VS_IL4...3,SET,162,-0.030217,-0.0028258,0.067878,0.6719,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
GOBP_CELLULAR_RESPONSE_TO_KE...,SET,97,-0.041369,-0.002999,0.092925,0.67191,GOBP_CELLULAR_RESPONSE_TO_KETONE,1
GOCC_KINOCILIUM,SET,10,-0.12759,-0.002977,0.28654,0.67194,GOCC_KINOCILIUM,1
HP_OSTEOPATHIA_STRIATA,SET,3,-0.28603,-0.003656,0.6423,0.67196,HP_OSTEOPATHIA_STRIATA,1
HP_HYPOPHOSPHATEMIC_RICKETS,SET,18,-0.094467,-0.0029564,0.21211,0.67197,HP_HYPOPHOSPHATEMIC_RICKETS,1
HP_PULMONARY_CYST,SET,26,-0.079567,-0.0029921,0.17864,0.67198,HP_PULMONARY_CYST,1
WAGNER_APO2_SENSITIVITY,SET,25,-0.085835,-0.0031652,0.19269,0.672,WAGNER_APO2_SENSITIVITY,1
GAUCHER_PBMC_YF_VAX_STAMARIL...1,SET,96,-0.03899,-0.002812,0.087513,0.67203,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN,1
GOBP_CELL_MOTILITY_INVOLVED_...,SET,5,-0.16712,-0.0027574,0.37499,0.67207,GOBP_CELL_MOTILITY_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,1
HP_ABNORMAL_NASOLABIAL_REGIO...,SET,17,-0.086776,-0.0026393,0.19465,0.67213,HP_ABNORMAL_NASOLABIAL_REGION_MORPHOLOGY,1
SENGUPTA_NASOPHARYNGEAL_CARC...3,SET,146,-0.033935,-0.003014,0.076114,0.67214,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1
HP_WIDOW_S_PEAK,SET,14,-0.10008,-0.0027625,0.22447,0.67214,HP_WIDOW_S_PEAK,1
GSE42021_TREG_PLN_VS_CD24LO_...1,SET,180,-0.029089,-0.002866,0.065225,0.67219,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN,1
GSE17721_LPS_VS_POLYIC_8H_BM...1,SET,177,-0.028027,-0.0027386,0.062834,0.67222,GSE17721_LPS_VS_POLYIC_8H_BMDC_DN,1
HOEK_T_CELL_2011_2012_TIV_AD...4,SET,9,-0.1281,-0.0028355,0.28714,0.67224,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_UP,1
MODULE_212,SET,301,-0.022549,-0.0028634,0.050542,0.67225,MODULE_212,1
DESCARTES_FETAL_ADRENAL_CHRO...,SET,75,-0.049428,-0.0031527,0.11079,0.67225,DESCARTES_FETAL_ADRENAL_CHROMAFFIN_CELLS,1
DESCARTES_FETAL_SPLEEN_MEGAK...,SET,88,-0.04152,-0.0028676,0.093062,0.67225,DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES,1
GSE5542_IFNG_VS_IFNA_AND_IFN...1,SET,182,-0.028145,-0.0027883,0.063029,0.67239,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
GGCKCATGS_UNKNOWN,SET,68,-0.046127,-0.002802,0.10329,0.67241,GGCKCATGS_UNKNOWN,1
GSE9037_CTRL_VS_LPS_1H_STIM_...2,SET,174,-0.028425,-0.002754,0.063648,0.67241,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP,1
PEDERSEN_METASTASIS_BY_ERBB2...1,SET,44,-0.05821,-0.0028462,0.13034,0.67242,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,1
HP_SUPRAVENTRICULAR_ARRHYTHM...,SET,111,-0.039167,-0.0030362,0.087648,0.67251,HP_SUPRAVENTRICULAR_ARRHYTHMIA,1
GOBP_PULMONARY_VALVE_MORPHOG...,SET,20,-0.10105,-0.0033332,0.22602,0.67258,GOBP_PULMONARY_VALVE_MORPHOGENESIS,1
SCHUHMACHER_MYC_TARGETS_UP,SET,74,-0.043822,-0.0027765,0.098005,0.67261,SCHUHMACHER_MYC_TARGETS_UP,1
GSE2197_CPG_DNA_VS_UNTREATED...2,SET,177,-0.028676,-0.002802,0.064084,0.67273,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP,1
GOMF_N_METHYLTRANSFERASE_ACT...,SET,82,-0.04096,-0.0027312,0.091507,0.67278,GOMF_N_METHYLTRANSFERASE_ACTIVITY,1
HP_SHORT_CHIN,SET,56,-0.052578,-0.0028993,0.11746,0.67278,HP_SHORT_CHIN,1
GOBP_T_CELL_APOPTOTIC_PROCESS,SET,56,-0.052673,-0.0029046,0.11766,0.67281,GOBP_T_CELL_APOPTOTIC_PROCESS,1
GSE39556_UNTREATED_VS_3H_POL...1,SET,183,-0.029295,-0.0029101,0.065419,0.67285,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN,1
GSE21033_CTRL_VS_POLYIC_STIM...4,SET,174,-0.029527,-0.0028608,0.065932,0.67286,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP,1
ZNF589_TARGET_GENES,SET,509,-0.017065,-0.0028016,0.038098,0.67289,ZNF589_TARGET_GENES,1
GOBP_PML_BODY_ORGANIZATION,SET,6,-0.15592,-0.0028181,0.34808,0.6729,GOBP_PML_BODY_ORGANIZATION,1
REACTOME_ACETYLCHOLINE_INHIB...,SET,5,-0.19964,-0.003294,0.44558,0.67293,REACTOME_ACETYLCHOLINE_INHIBITS_CONTRACTION_OF_OUTER_HAIR_CELLS,1
GSE17721_PAM3CSK4_VS_GADIQUI...1,SET,180,-0.028133,-0.0027719,0.06279,0.67294,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN,1
GOMF_POSTSYNAPTIC_NEUROTRANS...,SET,67,-0.051502,-0.0031055,0.11493,0.67296,GOMF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
DESCARTES_FETAL_LUNG_SQUAMOU...,SET,176,-0.031269,-0.0030468,0.06978,0.67296,DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS,1
GOCC_CENTRIOLAR_SATELLITE,SET,112,-0.035009,-0.002726,0.078108,0.673,GOCC_CENTRIOLAR_SATELLITE,1
GOBP_REGULATION_OF_SKELETAL_...2,SET,11,-0.11537,-0.0028231,0.25738,0.67301,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION,1
HP_HYPOPLASIA_OF_OLFACTORY_T...,SET,8,-0.11067,-0.0023096,0.24688,0.67301,HP_HYPOPLASIA_OF_OLFACTORY_TRACT,1
GOMF_PSEUDOURIDINE_SYNTHASE_...,SET,12,-0.098514,-0.0025177,0.2197,0.67307,GOMF_PSEUDOURIDINE_SYNTHASE_ACTIVITY,1
REACTOME_DEFECTS_OF_PLATELET...,SET,8,-0.14444,-0.0030145,0.32209,0.67309,REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,1
HP_CONGENITAL_NONBULLOUS_ICH...,SET,20,-0.088034,-0.002904,0.19628,0.6731,HP_CONGENITAL_NONBULLOUS_ICHTHYOSIFORM_ERYTHRODERMA,1
NRL_DN.V1_UP,SET,130,-0.034032,-0.0028535,0.075881,0.6731,NRL_DN.V1_UP,1
MIR4735_5P,SET,170,-0.02908,-0.0027852,0.064825,0.67313,MIR4735_5P,1
HP_ABNORMAL_ANKLE_PHYSIOLOGY,SET,54,-0.053341,-0.0028886,0.11891,0.67313,HP_ABNORMAL_ANKLE_PHYSIOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...289,SET,5,-0.1762,-0.0029073,0.39275,0.67314,GOBP_POSITIVE_REGULATION_OF_G0_TO_G1_TRANSITION,1
GOMF_DNA_TOPOISOMERASE_ACTIV...,SET,7,-0.12993,-0.0025364,0.28956,0.67317,GOMF_DNA_TOPOISOMERASE_ACTIVITY,1
GSE17721_0.5H_VS_4H_CPG_BMDC...2,SET,185,-0.026971,-0.0026937,0.060087,0.67323,GSE17721_0.5H_VS_4H_CPG_BMDC_UP,1
GOBP_MAINTENANCE_OF_SYNAPSE_...,SET,24,-0.083204,-0.0030063,0.18535,0.67325,GOBP_MAINTENANCE_OF_SYNAPSE_STRUCTURE,1
MIR518A_5P_MIR527,SET,237,-0.025696,-0.0029006,0.057237,0.67326,MIR518A_5P_MIR527,1
REACTOME_EXTENSION_OF_TELOME...,SET,48,-0.052035,-0.0026571,0.1159,0.67327,REACTOME_EXTENSION_OF_TELOMERES,1
GOMF_CARBONYL_REDUCTASE_NADP...,SET,9,-0.14108,-0.0031229,0.31423,0.67327,GOMF_CARBONYL_REDUCTASE_NADPH_ACTIVITY,1
ERBB2_UP.V1_UP,SET,168,-0.030884,-0.0029407,0.068782,0.67329,ERBB2_UP.V1_UP,1
REACTOME_VASOPRESSIN_LIKE_RE...,SET,5,-0.20408,-0.0033673,0.45446,0.6733,REACTOME_VASOPRESSIN_LIKE_RECEPTORS,1
HP_LIMITED_ELBOW_MOVEMENT,SET,145,-0.03234,-0.0028626,0.072011,0.67332,HP_LIMITED_ELBOW_MOVEMENT,1
HP_ABNORMALITY_OF_HAIR_GROWTH,SET,29,-0.068515,-0.0027209,0.1525,0.67338,HP_ABNORMALITY_OF_HAIR_GROWTH,1
GSE37301_MULTIPOTENT_PROGENI...10,SET,178,-0.028993,-0.0028409,0.064532,0.67338,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP,1
REACTOME_ARACHIDONIC_ACID_ME...,SET,56,-0.054579,-0.0030097,0.12146,0.67341,REACTOME_ARACHIDONIC_ACID_METABOLISM,1
IBRAHIM_NRF3_UP,SET,5,-0.1774,-0.0029272,0.39468,0.67345,IBRAHIM_NRF3_UP,1
GSE9650_NAIVE_VS_MEMORY_CD8_...1,SET,181,-0.029314,-0.0028962,0.065208,0.67348,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
GOBP_VITAMIN_D3_METABOLIC_PR...,SET,7,-0.12492,-0.0024387,0.27782,0.67351,GOBP_VITAMIN_D3_METABOLIC_PROCESS,1
WP_CELLTYPE_DEPENDENT_SELECT...,SET,13,-0.12125,-0.0032253,0.26958,0.67356,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,1
GOBP_DELAMINATION,SET,7,-0.13392,-0.0026145,0.29776,0.67356,GOBP_DELAMINATION,1
HP_CAVUM_SEPTUM_PELLUCIDUM,SET,30,-0.067705,-0.0027346,0.15053,0.67356,HP_CAVUM_SEPTUM_PELLUCIDUM,1
GOBP_MAINTENANCE_OF_CELL_POL...,SET,15,-0.11527,-0.0032935,0.25628,0.67357,GOBP_MAINTENANCE_OF_CELL_POLARITY,1
ZHAN_MULTIPLE_MYELOMA_DN,SET,35,-0.070901,-0.0030927,0.1576,0.6736,ZHAN_MULTIPLE_MYELOMA_DN,1
CREB_02,SET,232,-0.025355,-0.0028321,0.056342,0.67365,CREB_02,1
REACTOME_BETA_OXIDATION_OF_H...,SET,5,-0.17828,-0.0029417,0.39599,0.67372,REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA,1
GALLUZZI_PREVENT_MITOCHONDIA...,SET,14,-0.10952,-0.0030231,0.24317,0.67378,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,1
GOBP_MEMBRANE_PROTEIN_PROTEO...,SET,56,-0.050191,-0.0027677,0.11144,0.67378,GOBP_MEMBRANE_PROTEIN_PROTEOLYSIS,1
HP_PNEUMONIA,SET,274,-0.023502,-0.0028496,0.05217,0.67382,HP_PNEUMONIA,1
KEGG_MEDICUS_VARIANT_MUTATIO...9,SET,25,-0.077244,-0.0028484,0.17144,0.67384,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
RUIZ_TNC_TARGETS_DN,SET,136,-0.033395,-0.0028636,0.07411,0.67386,RUIZ_TNC_TARGETS_DN,1
MANNO_MIDBRAIN_NEUROTYPES_HR...4,SET,296,-0.024101,-0.0030354,0.053483,0.67387,MANNO_MIDBRAIN_NEUROTYPES_HRGL2C,1
DURANTE_ADULT_OLFACTORY_NEUR...8,SET,128,-0.035911,-0.002988,0.079667,0.67392,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,1
GOMF_INTRACELLULARLY_CAMP_AC...,SET,8,-0.13538,-0.0028253,0.30031,0.67393,GOMF_INTRACELLULARLY_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,1
GOBP_ADENYLATE_CYCLASE_ACTIV...2,SET,9,-0.14108,-0.0031229,0.31295,0.67394,GOBP_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GSE37301_CD4_TCELL_VS_RAG2_K...1,SET,165,-0.028974,-0.0027343,0.064222,0.67406,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN,1
HP_HIGH_PITCHED_CRY,SET,5,-0.15829,-0.0026118,0.35076,0.6741,HP_HIGH_PITCHED_CRY,1
GSE17721_PAM3CSK4_VS_CPG_4H_...1,SET,181,-0.029328,-0.0028976,0.064985,0.67411,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN,1
GOBP_CALMODULIN_DEPENDENT_KI...,SET,12,-0.11589,-0.0029618,0.25676,0.67413,GOBP_CALMODULIN_DEPENDENT_KINASE_SIGNALING_PATHWAY,1
REACTOME_COOPERATION_OF_PREF...,SET,30,-0.0647,-0.0026132,0.14332,0.67416,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,1
KEGG_NEUROTROPHIN_SIGNALING_...,SET,120,-0.03604,-0.0029041,0.079816,0.6742,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_PHOSPHOPR...,SET,38,-0.060732,-0.0027601,0.13447,0.67423,GOBP_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,1
KIM_WT1_TARGETS_8HR_DN,SET,113,-0.03544,-0.0027718,0.078442,0.67429,KIM_WT1_TARGETS_8HR_DN,1
GOBP_ACTIN_FILAMENT_NETWORK_...,SET,6,-0.17042,-0.0030803,0.37709,0.67434,GOBP_ACTIN_FILAMENT_NETWORK_FORMATION,1
JAZAERI_BREAST_CANCER_BRCA1_...2,SET,45,-0.052003,-0.0025714,0.11506,0.67435,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,1
HOSHIDA_LIVER_CANCER_SURVIVA...2,SET,71,-0.048326,-0.0029994,0.1069,0.67438,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1
MIR3609,SET,324,-0.022064,-0.002905,0.048802,0.6744,MIR3609,1
GOCC_AP_TYPE_MEMBRANE_COAT_A...,SET,39,-0.059141,-0.0027229,0.13081,0.6744,GOCC_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX,1
HP_LIMITED_ELBOW_FLEXION,SET,10,-0.13697,-0.0031958,0.30295,0.67441,HP_LIMITED_ELBOW_FLEXION,1
GSE17721_CTRL_VS_GARDIQUIMOD...3,SET,184,-0.028263,-0.0028152,0.062506,0.67442,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN,1
MIR642B_5P,SET,70,-0.046582,-0.0028708,0.10301,0.67444,MIR642B_5P,1
BYSTRYKH_HEMATOPOIESIS_STEM_...2,SET,142,-0.032036,-0.0028065,0.07081,0.67451,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1
REACTOME_SHC_MEDIATED_CASCAD...1,SET,21,-0.085881,-0.0029028,0.18977,0.67456,REACTOME_SHC_MEDIATED_CASCADE_FGFR1,1
REACTOME_CHYLOMICRON_REMODEL...,SET,8,-0.17674,-0.0036885,0.39048,0.67459,REACTOME_CHYLOMICRON_REMODELING,1
GOBP_NEURON_PROJECTION_EXTEN...2,SET,19,-0.093524,-0.003007,0.20659,0.67462,GOBP_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE,1
GOBP_POSITIVE_REGULATION_OF_...727,SET,23,-0.085066,-0.0030089,0.18786,0.67465,GOBP_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
MORF_PTPN11,SET,93,-0.037083,-0.0026326,0.081892,0.67466,MORF_PTPN11,1
MODULE_481,SET,81,-0.042903,-0.0028434,0.094745,0.67466,MODULE_481,1
MODULE_544,SET,81,-0.042903,-0.0028434,0.094745,0.67466,MODULE_544,1
ELVIDGE_HYPOXIA_UP,SET,155,-0.032696,-0.0029915,0.072184,0.67471,ELVIDGE_HYPOXIA_UP,1
GOBP_REGULATION_OF_GERM_CELL...,SET,7,-0.12595,-0.0024588,0.27802,0.67473,GOBP_REGULATION_OF_GERM_CELL_PROLIFERATION,1
REACTOME_RECRUITMENT_OF_NUMA...,SET,87,-0.039097,-0.002685,0.086282,0.67477,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1
GOBP_POSITIVE_REGULATION_OF_...425,SET,19,-0.090656,-0.0029148,0.20004,0.67479,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,1
GOBP_POSITIVE_REGULATION_OF_...509,SET,42,-0.062058,-0.0029647,0.13692,0.67481,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...77,SET,9,-0.11198,-0.0024787,0.24704,0.67483,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_NADPLUS_BINDING,SET,18,-0.091408,-0.0028607,0.20164,0.67484,GOMF_NADPLUS_BINDING,1
CHIBA_RESPONSE_TO_TSA,SET,37,-0.064342,-0.0028855,0.14192,0.67486,CHIBA_RESPONSE_TO_TSA,1
REACTOME_G_PROTEIN_BETA_GAMM...,SET,30,-0.072651,-0.0029344,0.16023,0.67487,REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,1
KEGG_MEDICUS_REFERENCE_NLRP3...,SET,5,-0.15656,-0.0025832,0.34527,0.67488,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...3,SET,17,-0.089259,-0.0027148,0.19685,0.67488,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,1
KEGG_MEDICUS_REFERENCE_ITGA_...4,SET,22,-0.08781,-0.0030378,0.19358,0.67494,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,1
chr21q11,SET,4,-0.25799,-0.0038076,0.56865,0.67497,chr21q11,1
GOBP_POLYAMINE_TRANSPORT,SET,16,-0.098498,-0.0029064,0.21711,0.67497,GOBP_POLYAMINE_TRANSPORT,1
HP_ABNORMAL_CD4_CD8_RATIO,SET,17,-0.094829,-0.0028842,0.20892,0.67504,HP_ABNORMAL_CD4_CD8_RATIO,1
HP_BROAD_CHIN,SET,8,-0.1595,-0.0033287,0.35137,0.67506,HP_BROAD_CHIN,1
GOBP_RESPONSE_TO_FORSKOLIN,SET,13,-0.12595,-0.0033502,0.27718,0.67522,GOBP_RESPONSE_TO_FORSKOLIN,1
GOBP_NEGATIVE_REGULATION_OF_...556,SET,5,-0.18763,-0.003096,0.41292,0.67523,GOBP_NEGATIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,1
GOBP_BODY_FLUID_SECRETION,SET,87,-0.044189,-0.0030346,0.097221,0.67527,GOBP_BODY_FLUID_SECRETION,1
GOBP_SULFUR_COMPOUND_TRANSPO...,SET,60,-0.051476,-0.0029379,0.11324,0.67529,GOBP_SULFUR_COMPOUND_TRANSPORT,1
MIR1180_3P,SET,6,-0.16898,-0.0030542,0.37171,0.6753,MIR1180_3P,1
HP_ABNORMAL_VAGINA_MORPHOLOGY,SET,111,-0.038104,-0.0029538,0.083812,0.67531,HP_ABNORMAL_VAGINA_MORPHOLOGY,1
GOBP_OLIGOPEPTIDE_TRANSPORT,SET,18,-0.092842,-0.0029056,0.20417,0.67535,GOBP_OLIGOPEPTIDE_TRANSPORT,1
GOBP_FATTY_ACID_METABOLIC_PR...,SET,365,-0.020928,-0.0029213,0.046018,0.67536,GOBP_FATTY_ACID_METABOLIC_PROCESS,1
GSE5589_WT_VS_IL10_KO_LPS_AN...3,SET,183,-0.0286,-0.0028411,0.062887,0.67537,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
WEIGEL_OXIDATIVE_STRESS_BY_T...,SET,35,-0.064211,-0.0028009,0.14117,0.67539,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,1
GOBP_INTRACELLULAR_ZINC_ION_...,SET,34,-0.070772,-0.0030427,0.15558,0.67541,GOBP_INTRACELLULAR_ZINC_ION_HOMEOSTASIS,1
SGCGSSAAA_E2F1DP2_01,SET,147,-0.031329,-0.0027921,0.068849,0.67546,SGCGSSAAA_E2F1DP2_01,1
GOBP_REGULATION_OF_GROWTH_RA...,SET,5,-0.17535,-0.0028933,0.38535,0.67546,GOBP_REGULATION_OF_GROWTH_RATE,1
AIZARANI_LIVER_C31_KUPFFER_C...,SET,107,-0.038319,-0.0029168,0.084203,0.67547,AIZARANI_LIVER_C31_KUPFFER_CELLS_5,1
HP_ABNORMAL_NASOPHARYNX_MORP...,SET,159,-0.031541,-0.0029225,0.069271,0.67556,HP_ABNORMAL_NASOPHARYNX_MORPHOLOGY,1
LI_ESTROGENE_T47D_E2_RESPONS...2,SET,56,-0.057416,-0.0031661,0.12607,0.6756,LI_ESTROGENE_T47D_E2_RESPONSE_UP,1
GOMF_EXTRACELLULARLY_ATP_GAT...,SET,7,-0.15945,-0.0031129,0.34996,0.67567,GOMF_EXTRACELLULARLY_ATP_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
KEGG_MEDICUS_VARIANT_LOSS_OF...4,SET,12,-0.1237,-0.0031614,0.27146,0.67569,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY,1
REACTOME_A_TETRASACCHARIDE_L...,SET,23,-0.080457,-0.0028459,0.17656,0.67569,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,1
HP_EXERCISE_INDUCED_MYOGLOBI...,SET,7,-0.11453,-0.0022359,0.25125,0.67575,HP_EXERCISE_INDUCED_MYOGLOBINURIA,1
HP_PALMOPLANTAR_BLISTERING,SET,11,-0.11912,-0.0029148,0.26121,0.67581,HP_PALMOPLANTAR_BLISTERING,1
PLASARI_TGFB1_TARGETS_10HR_UP,SET,186,-0.031246,-0.003129,0.068499,0.67586,PLASARI_TGFB1_TARGETS_10HR_UP,1
MIR122B_3P,SET,124,-0.035943,-0.0029439,0.078791,0.67587,MIR122B_3P,1
HP_HANDGRIP_MYOTONIA,SET,6,-0.17691,-0.0031976,0.38781,0.67587,HP_HANDGRIP_MYOTONIA,1
WAKABAYASHI_ADIPOGENESIS_PPA...1,SET,28,-0.074291,-0.002899,0.16278,0.67594,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,1
KEGG_MEDICUS_VARIANT_MUTATIO...87,SET,5,-0.18992,-0.0031338,0.4161,0.67596,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RUNX1_TO_TRANSCRIPTION,1
KEGG_MEDICUS_REFERENCE_MEMBR...,SET,9,-0.12486,-0.0027638,0.27353,0.67598,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,1
GSE21670_STAT3_KO_VS_WT_CD4_...5,SET,173,-0.028055,-0.0027104,0.061458,0.67598,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP,1
ROZANOV_MMP14_CORRELATED,SET,10,-0.13569,-0.0031659,0.29712,0.67605,ROZANOV_MMP14_CORRELATED,1
chr18q21,SET,76,-0.083493,-0.0053607,0.18279,0.67608,chr18q21,1
KONDO_PROSTATE_CANCER_WITH_H...,SET,178,-0.032455,-0.0031801,0.07104,0.67611,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,1
HP_UNILATERAL_RENAL_AGENESIS,SET,83,-0.042914,-0.0028788,0.093929,0.67612,HP_UNILATERAL_RENAL_AGENESIS,1
HP_FOCAL_WHITE_MATTER_LESIONS,SET,13,-0.10609,-0.002822,0.23217,0.67615,HP_FOCAL_WHITE_MATTER_LESIONS,1
MIR4715_3P,SET,67,-0.050551,-0.0030482,0.11061,0.67617,MIR4715_3P,1
MIR520D_5P,SET,852,-0.013927,-0.0029298,0.030474,0.67617,MIR520D_5P,1
MIR3137,SET,47,-0.061346,-0.0030999,0.1342,0.6762,MIR3137,1
GOBP_REGULATION_OF_VESICLE_F...,SET,22,-0.089778,-0.0031059,0.1964,0.6762,GOBP_REGULATION_OF_VESICLE_FUSION,1
GOBP_MRNA_SPLICE_SITE_RECOGN...,SET,30,-0.066141,-0.0026714,0.14467,0.67623,GOBP_MRNA_SPLICE_SITE_RECOGNITION,1
HP_INCREASED_LDL_CHOLESTEROL...,SET,30,-0.076063,-0.0030721,0.16637,0.67623,HP_INCREASED_LDL_CHOLESTEROL_CONCENTRATION,1
REACTOME_REGULATION_OF_CDH11...3,SET,9,-0.13699,-0.0030324,0.29956,0.67628,REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS,1
HP_TESTICULAR_ATROPHY,SET,9,-0.12086,-0.0026751,0.26427,0.67628,HP_TESTICULAR_ATROPHY,1
GSE3982_MEMORY_CD4_TCELL_VS_...1,SET,174,-0.029359,-0.0028445,0.064177,0.67633,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN,1
HP_EXERCISE_INDUCED_MUSCLE_C...,SET,14,-0.092748,-0.0025602,0.20272,0.67635,HP_EXERCISE_INDUCED_MUSCLE_CRAMPS,1
JONES_OVARY_MACROPHAGE,SET,213,-0.029016,-0.0031071,0.063415,0.67636,JONES_OVARY_MACROPHAGE,1
GOCC_CHAPERONIN_CONTAINING_T...,SET,10,-0.10571,-0.0024665,0.2309,0.67646,GOCC_CHAPERONIN_CONTAINING_T_COMPLEX,1
GSE2706_2H_VS_8H_R848_AND_LP...2,SET,174,-0.028584,-0.0027694,0.062427,0.67647,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP,1
GOCC_CELL_LEADING_EDGE,SET,399,-0.019792,-0.0028858,0.043212,0.67653,GOCC_CELL_LEADING_EDGE,1
CHARAFE_BREAST_CANCER_LUMINA...3,SET,425,-0.020357,-0.0030612,0.044429,0.67659,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,1
GOMF_RNA_7_METHYLGUANOSINE_C...,SET,11,-0.10807,-0.0026445,0.23585,0.6766,GOMF_RNA_7_METHYLGUANOSINE_CAP_BINDING,1
GOBP_REGULATION_OF_STRIATED_...3,SET,18,-0.10744,-0.0033625,0.23429,0.67673,GOBP_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_BLASTOCYST_DEVELOPMENT,SET,110,-0.037281,-0.002877,0.081268,0.67679,GOBP_BLASTOCYST_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...444,SET,10,-0.12657,-0.002953,0.27582,0.67683,GOBP_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
GOMF_DNA_POLYMERASE_ACTIVITY,SET,27,-0.063269,-0.0024245,0.13785,0.67687,GOMF_DNA_POLYMERASE_ACTIVITY,1
GSE34156_TLR1_TLR2_LIGAND_VS...4,SET,184,-0.030851,-0.0030729,0.067219,0.67687,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,1
OSMAN_BLADDER_CANCER_UP,SET,363,-0.020066,-0.0027935,0.043718,0.67688,OSMAN_BLADDER_CANCER_UP,1
MIR4675,SET,38,-0.060839,-0.002765,0.13253,0.6769,MIR4675,1
HP_LONG_THORAX,SET,6,-0.17281,-0.0031235,0.37644,0.67691,HP_LONG_THORAX,1
GSE25123_CTRL_VS_IL4_STIM_MA...2,SET,177,-0.029073,-0.0028408,0.063325,0.67692,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP,1
REACTOME_ENERGY_DEPENDENT_RE...,SET,28,-0.071812,-0.0028023,0.15639,0.67694,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,1
KEGG_MELANOGENESIS,SET,98,-0.042126,-0.0030695,0.091741,0.67695,KEGG_MELANOGENESIS,1
MIR4651,SET,188,-0.030175,-0.0030378,0.065697,0.67699,MIR4651,1
REACTOME_FRS_MEDIATED_FGFR3_...,SET,19,-0.086722,-0.0027883,0.18875,0.67704,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,1
ZHONG_RESPONSE_TO_AZACITIDIN...1,SET,58,-0.046763,-0.0026242,0.10177,0.67705,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,1
GOBP_CHEMICAL_HOMEOSTASIS,SET,934,-0.01359,-0.0029862,0.029568,0.6771,GOBP_CHEMICAL_HOMEOSTASIS,1
REACTOME_INTEGRATION_OF_PROV...,SET,9,-0.10752,-0.00238,0.23391,0.67712,REACTOME_INTEGRATION_OF_PROVIRUS,1
GOBP_PURINE_CONTAINING_COMPO...2,SET,484,-0.018124,-0.0029037,0.039412,0.67719,GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
MODULE_192,SET,99,-0.039429,-0.0028875,0.085737,0.6772,MODULE_192,1
GNF2_SPI1,SET,34,-0.069664,-0.0029951,0.15147,0.67722,GNF2_SPI1,1
GOBP_NEGATIVE_REGULATION_OF_...192,SET,22,-0.081732,-0.0028275,0.17768,0.67724,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
KEGG_OOCYTE_MEIOSIS,SET,105,-0.037829,-0.0028526,0.082154,0.67741,KEGG_OOCYTE_MEIOSIS,1
HP_GLUCOCORTOCOID_INSENSITIV...,SET,5,-0.19299,-0.0031843,0.41911,0.67741,HP_GLUCOCORTOCOID_INSENSITIVE_PRIMARY_HYPERALDOSTERONISM,1
GOMF_AROMATIC_AMINO_ACID_TRA...,SET,8,-0.14293,-0.0029829,0.31029,0.67747,GOMF_AROMATIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOCC_CENTRIOLAR_SUBDISTAL_AP...,SET,9,-0.14285,-0.0031621,0.31008,0.67749,GOCC_CENTRIOLAR_SUBDISTAL_APPENDAGE,1
MIR4473,SET,79,-0.043635,-0.0028561,0.094703,0.67751,MIR4473,1
REACTOME_FGFR2_LIGAND_BINDIN...,SET,19,-0.10812,-0.0034764,0.23456,0.67758,REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,1
MIR6830_3P,SET,191,-0.030695,-0.0031145,0.066569,0.67764,MIR6830_3P,1
HP_THORACIC_PLATYSPONDYLY,SET,6,-0.14271,-0.0025794,0.30948,0.67764,HP_THORACIC_PLATYSPONDYLY,1
HP_ARTERIAL_RUPTURE,SET,8,-0.14768,-0.0030821,0.32008,0.67774,HP_ARTERIAL_RUPTURE,1
KONDO_COLON_CANCER_HCP_WITH_...2,SET,4,-0.22219,-0.0032793,0.48153,0.67775,KONDO_COLON_CANCER_HCP_WITH_H3K27ME3,1
MIR4266,SET,74,-0.045932,-0.0029101,0.09949,0.67784,MIR4266,1
HP_EARLY_YOUNG_ADULT_ONSET,SET,57,-0.051271,-0.0028523,0.11105,0.67784,HP_EARLY_YOUNG_ADULT_ONSET,1
WP_TNFRELATED_WEAK_INDUCER_O...,SET,41,-0.061532,-0.0029045,0.13327,0.67785,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,1
GOMF_IGG_RECEPTOR_ACTIVITY,SET,6,-0.2063,-0.0037288,0.44683,0.67785,GOMF_IGG_RECEPTOR_ACTIVITY,1
GSE28408_LY6G_POS_VS_NEG_DC_...1,SET,176,-0.02813,-0.0027409,0.060922,0.67786,GSE28408_LY6G_POS_VS_NEG_DC_DN,1
GOBP_REGULATION_OF_REGULATED...,SET,104,-0.038939,-0.0029223,0.084319,0.67789,GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,1
HP_ABNORMAL_MAXILLA_MORPHOLO...,SET,133,-0.034726,-0.0029449,0.075184,0.67792,HP_ABNORMAL_MAXILLA_MORPHOLOGY,1
KEGG_FC_GAMMA_R_MEDIATED_PHA...,SET,90,-0.042854,-0.002993,0.092766,0.67794,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1
GOBP_RELEASE_OF_CYTOCHROME_C...,SET,52,-0.057164,-0.0030379,0.12374,0.67794,GOBP_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,1
HP_INSIDIOUS_ONSET,SET,15,-0.099233,-0.0028352,0.21481,0.67794,HP_INSIDIOUS_ONSET,1
GSE43863_DAY6_EFF_VS_DAY150_...1,SET,174,-0.029458,-0.0028541,0.063765,0.67795,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN,1
GSE13485_DAY3_VS_DAY21_YF17D...1,SET,139,-0.035034,-0.0030367,0.075826,0.67797,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
WP_HYPOTHESIZED_PATHWAYS_IN_...,SET,23,-0.086587,-0.0030627,0.18739,0.67798,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,1
MIR4512,SET,17,-0.095876,-0.0029161,0.20738,0.67807,MIR4512,1
PAPASPYRIDONOS_UNSTABLE_ATER...1,SET,39,-0.062368,-0.0028714,0.13487,0.67811,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1
GAVIN_FOXP3_TARGETS_CLUSTER_...1,SET,72,-0.047759,-0.0029849,0.10326,0.67814,GAVIN_FOXP3_TARGETS_CLUSTER_P2,1
GOBP_REGULATION_OF_STRIATED_...2,SET,87,-0.043979,-0.0030202,0.095089,0.67814,GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,1
HP_THROMBOEMBOLIC_STROKE,SET,69,-0.050701,-0.0031023,0.10962,0.67814,HP_THROMBOEMBOLIC_STROKE,1
WP_NONGENOMIC_ACTIONS_OF_125...,SET,69,-0.049132,-0.0030063,0.10622,0.67815,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,1
MCAATNNNNNGCG_UNKNOWN,SET,74,-0.048216,-0.0030549,0.10424,0.67816,MCAATNNNNNGCG_UNKNOWN,1
GOCC_CELL_TRAILING_EDGE,SET,14,-0.10699,-0.0029534,0.2313,0.67816,GOCC_CELL_TRAILING_EDGE,1
GOBP_ACTIVATION_OF_TRANSMEMB...,SET,6,-0.14638,-0.0026457,0.31643,0.67817,GOBP_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
HOLLEMAN_ASPARAGINASE_RESIST...4,SET,24,-0.072421,-0.0026167,0.15654,0.67819,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,1
HP_ABNORMAL_VISUAL_FIXATION,SET,24,-0.082451,-0.0029791,0.17817,0.67823,HP_ABNORMAL_VISUAL_FIXATION,1
HP_IRIS_HYPOPIGMENTATION,SET,58,-0.05549,-0.0031139,0.11988,0.67827,HP_IRIS_HYPOPIGMENTATION,1
GOBP_NEGATIVE_REGULATION_OF_...219,SET,117,-0.035848,-0.0028525,0.077443,0.67828,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
MIR6785_5P,SET,469,-0.018375,-0.0028991,0.039692,0.67829,MIR6785_5P,1
HP_TEMPORAL_OPTIC_DISC_PALLOR,SET,7,-0.15764,-0.0030774,0.34049,0.67831,HP_TEMPORAL_OPTIC_DISC_PALLOR,1
BLANCO_MELO_BRONCHIAL_EPITHE...2,SET,577,-0.017731,-0.0030934,0.038254,0.67849,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP,1
GOBP_DOPAMINE_RECEPTOR_SIGNA...,SET,37,-0.068568,-0.003075,0.14792,0.67851,GOBP_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
HHEX_TARGET_GENES,SET,824,-0.013853,-0.0028681,0.029872,0.67858,HHEX_TARGET_GENES,1
GOMF_HISTONE_H3_ACETYLTRANSF...,SET,15,-0.09683,-0.0027666,0.20875,0.67862,GOMF_HISTONE_H3_ACETYLTRANSFERASE_ACTIVITY,1
GSE40274_GATA1_VS_FOXP3_AND_...2,SET,179,-0.029884,-0.0029363,0.064419,0.67864,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
BIOCARTA_MHC_PATHWAY,SET,10,-0.15119,-0.0035275,0.32587,0.67866,BIOCARTA_MHC_PATHWAY,1
GSE21360_NAIVE_VS_TERTIARY_M...2,SET,168,-0.030794,-0.0029321,0.066373,0.67866,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
MIR620,SET,69,-0.049443,-0.0030253,0.10656,0.67867,MIR620,1
MYOD_Q6,SET,227,-0.026386,-0.0029158,0.056861,0.67869,MYOD_Q6,1
HP_EMG_AXONAL_ABNORMALITY,SET,14,-0.11253,-0.0031063,0.24245,0.67873,HP_EMG_AXONAL_ABNORMALITY,1
HP_INFLEXIBLE_ADHERENCE_TO_R...,SET,2,-0.30537,-0.003187,0.6579,0.67873,HP_INFLEXIBLE_ADHERENCE_TO_ROUTINES,1
HP_HIGHLY_ELEVATED_CREATINE_...,SET,6,-0.15051,-0.0027203,0.32421,0.67875,HP_HIGHLY_ELEVATED_CREATINE_KINASE,1
REACTOME_METAL_SEQUESTRATION...,SET,6,-0.18351,-0.0033168,0.39525,0.67877,REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS,1
GSE1112_OT1_CD8AB_VS_HY_CD8A...1,SET,153,-0.031508,-0.0028643,0.067856,0.67879,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
GOBP_PURINE_NUCLEOSIDE_TRIPH...,SET,5,-0.17081,-0.0028184,0.36764,0.67889,GOBP_PURINE_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,1
BRUINS_UVC_RESPONSE_MIDDLE,SET,92,-0.038829,-0.0027417,0.083567,0.6789,BRUINS_UVC_RESPONSE_MIDDLE,1
DURANTE_ADULT_OLFACTORY_NEUR...24,SET,46,-0.066049,-0.0033019,0.14199,0.67909,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_SUSTENTACULAR_CELLS,1
MIR4426,SET,133,-0.034598,-0.002934,0.074375,0.6791,MIR4426,1
HP_METAPHYSEAL_CUPPING,SET,14,-0.10965,-0.0030266,0.23555,0.67921,HP_METAPHYSEAL_CUPPING,1
GSE43863_TH1_VS_LY6C_INT_CXC...1,SET,189,-0.029108,-0.0029381,0.062532,0.67921,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,1
WP_2Q112_COPY_NUMBER_VARIATI...,SET,32,-0.093948,-0.0039188,0.20181,0.67922,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,1
GSE26351_UNSTIM_VS_BMP_PATHW...2,SET,174,-0.029201,-0.0028292,0.06272,0.67924,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,1
MIR4506,SET,42,-0.0593,-0.002833,0.12736,0.67925,MIR4506,1
MARTINEZ_RESPONSE_TO_TRABECT...3,SET,65,-0.049981,-0.0029686,0.10733,0.67927,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1
MIR495_5P,SET,62,-0.051022,-0.0029599,0.10954,0.67932,MIR495_5P,1
GSE2405_0H_VS_6H_A_PHAGOCYTO...2,SET,171,-0.028704,-0.0027572,0.061621,0.67932,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
VALK_AML_CLUSTER_7,SET,25,-0.08191,-0.0030205,0.17582,0.67935,VALK_AML_CLUSTER_7,1
P300_01,SET,223,-0.027145,-0.0029734,0.058245,0.6794,P300_01,1
GOCC_PHOTORECEPTOR_INNER_SEG...,SET,65,-0.051454,-0.0030561,0.11039,0.67942,GOCC_PHOTORECEPTOR_INNER_SEGMENT,1
WP_16P112_PROXIMAL_DELETION_...,SET,68,-0.055533,-0.0033734,0.11912,0.67946,WP_16P112_PROXIMAL_DELETION_SYNDROME,1
GOBP_SMALL_GTPASE_MEDIATED_S...,SET,461,-0.018907,-0.0029582,0.040538,0.67953,GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
GOBP_ACYL_COA_METABOLIC_PROC...,SET,85,-0.045458,-0.0030859,0.097447,0.67957,GOBP_ACYL_COA_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_CELLULAR_...5,SET,37,-0.067838,-0.0030423,0.14542,0.67957,GOBP_REGULATION_OF_CELLULAR_EXTRAVASATION,1
GOBP_POSITIVE_REGULATION_OF_...342,SET,136,-0.036009,-0.0030877,0.077185,0.67958,GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION,1
MODULE_532,SET,366,-0.020832,-0.0029118,0.044628,0.67967,MODULE_532,1
GOBP_REGULATION_OF_PEPTIDYL_...4,SET,106,-0.039639,-0.0030032,0.084889,0.67973,GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
HP_PARASOMNIA,SET,37,-0.067572,-0.0030304,0.1447,0.67974,HP_PARASOMNIA,1
GSE42021_CD24INT_VS_CD24LOW_...3,SET,179,-0.030332,-0.0029803,0.064953,0.67974,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN,1
GOBP_VITAMIN_D_RECEPTOR_SIGN...,SET,12,-0.11104,-0.0028378,0.23777,0.67975,GOBP_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
HP_RECURRENT_PANCREATITIS,SET,11,-0.14763,-0.0036124,0.31608,0.67976,HP_RECURRENT_PANCREATITIS,1
HP_ABNORMAL_CIRCULATING_FERR...,SET,47,-0.059954,-0.0030295,0.12834,0.6798,HP_ABNORMAL_CIRCULATING_FERRITIN_CONCENTRATION,1
WP_ROBO4_AND_VEGF_SIGNALING_...,SET,6,-0.17915,-0.003238,0.38335,0.67986,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,1
GSE37532_WT_VS_PPARG_KO_LN_T...1,SET,166,-0.030396,-0.0028771,0.06504,0.67987,GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN,1
MCDOWELL_ACUTE_LUNG_INJURY_DN,SET,41,-0.063801,-0.0030116,0.13651,0.67988,MCDOWELL_ACUTE_LUNG_INJURY_DN,1
GOMF_NADPH_OXIDASE_H202_FORM...,SET,5,-0.15999,-0.0026399,0.34232,0.67988,GOMF_NADPH_OXIDASE_H202_FORMING_ACTIVITY,1
KIM_GERMINAL_CENTER_T_HELPER...2,SET,57,-0.056215,-0.0031274,0.12015,0.68007,KIM_GERMINAL_CENTER_T_HELPER_UP,1
GSE32901_TH17_EMRICHED_VS_TH...2,SET,102,-0.040798,-0.0030324,0.087184,0.68009,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP,1
SIG_PIP3_SIGNALING_IN_CARDIA...,SET,62,-0.055192,-0.0032019,0.11793,0.68011,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1
HP_DISPLACEMENT_OF_THE_URETH...,SET,315,-0.022178,-0.00288,0.047384,0.68013,HP_DISPLACEMENT_OF_THE_URETHRAL_MEATUS,1
REACTOME_NF_KB_ACTIVATION_TH...,SET,11,-0.12426,-0.0030405,0.26546,0.68014,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,1
REACTOME_ACYL_CHAIN_REMODELL...1,SET,25,-0.088498,-0.0032634,0.18901,0.68019,REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,1
GOBP_CHROMOSOME_SEPARATION,SET,78,-0.043553,-0.0028328,0.092977,0.68026,GOBP_CHROMOSOME_SEPARATION,1
HP_PATENT_DUCTUS_ARTERIOSUS,SET,334,-0.022032,-0.0029445,0.047033,0.68026,HP_PATENT_DUCTUS_ARTERIOSUS,1
GOCC_GRANULAR_COMPONENT,SET,7,-0.1621,-0.0031647,0.34601,0.68028,GOCC_GRANULAR_COMPONENT,1
HP_ADVANCED_OSSIFICATION_OF_...,SET,10,-0.12109,-0.0028252,0.25844,0.6803,HP_ADVANCED_OSSIFICATION_OF_CARPAL_BONES,1
TCF1P_Q6,SET,238,-0.026624,-0.0030116,0.056818,0.68032,TCF1P_Q6,1
SASSON_RESPONSE_TO_FORSKOLIN...1,SET,84,-0.043276,-0.0029205,0.092333,0.68035,SASSON_RESPONSE_TO_FORSKOLIN_DN,1
LE_NEURONAL_DIFFERENTIATION_...2,SET,17,-0.092817,-0.002823,0.19803,0.68036,LE_NEURONAL_DIFFERENTIATION_UP,1
KEGG_MEDICUS_REFERENCE_MANNO...1,SET,3,-0.24367,-0.0031145,0.51988,0.68036,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE,1
GSE7348_LPS_VS_TOLERIZED_AND...2,SET,170,-0.029678,-0.0028425,0.063305,0.68039,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,1
GOBP_EPITHELIAL_TUBE_FORMATI...,SET,131,-0.035171,-0.0029602,0.075007,0.68043,GOBP_EPITHELIAL_TUBE_FORMATION,1
SMID_BREAST_CANCER_RELAPSE_I...6,SET,6,-0.17432,-0.0031507,0.37173,0.68044,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP,1
BUSSLINGER_GASTRIC_IMMATURE_...,SET,156,-0.034128,-0.0031325,0.072757,0.68049,BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS,1
CREBP1CJUN_01,SET,237,-0.026694,-0.0030132,0.056895,0.68053,CREBP1CJUN_01,1
GSE11884_WT_VS_FURIN_KO_NAIV...1,SET,116,-0.037049,-0.0029356,0.078943,0.68058,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN,1
HP_INCREASED_THETA_FREQUENCY...,SET,10,-0.1391,-0.0032453,0.29621,0.68067,HP_INCREASED_THETA_FREQUENCY_ACTIVITY_IN_EEG,1
GSE3203_WT_VS_IFNAR1_KO_INFL...1,SET,186,-0.02953,-0.0029572,0.062887,0.68067,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN,1
GOMF_PLATELET_DERIVED_GROWTH...2,SET,13,-0.12956,-0.0034462,0.27589,0.68068,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING,1
GSE3982_DC_VS_NEUTROPHIL_UP,SET,181,-0.029055,-0.0028706,0.061872,0.68068,GSE3982_DC_VS_NEUTROPHIL_UP,1
GSE360_L_DONOVANI_VS_L_MAJOR...1,SET,177,-0.029378,-0.0028706,0.062547,0.68071,GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN,1
GSE17721_LPS_VS_PAM3CSK4_12H...1,SET,179,-0.029162,-0.0028654,0.06208,0.68073,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN,1
MORF_JUND,SET,57,-0.050006,-0.002782,0.10644,0.68075,MORF_JUND,1
REACTOME_TP53_REGULATES_TRAN...5,SET,12,-0.12259,-0.0031331,0.26077,0.68086,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS,1
GOBP_CATECHOL_CONTAINING_COM...2,SET,5,-0.20809,-0.0034336,0.44246,0.68093,GOBP_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOMF_KINASE_ACTIVATOR_ACTIVI...,SET,130,-0.03549,-0.0029757,0.075427,0.681,GOMF_KINASE_ACTIVATOR_ACTIVITY,1
REACTOME_CRISTAE_FORMATION,SET,9,-0.12475,-0.0027614,0.26512,0.68102,REACTOME_CRISTAE_FORMATION,1
BENPORATH_NANOG_TARGETS,SET,877,-0.013972,-0.0029799,0.029692,0.68103,BENPORATH_NANOG_TARGETS,1
GOMF_TRNA_BINDING,SET,62,-0.044971,-0.0026089,0.095546,0.68106,GOMF_TRNA_BINDING,1
HP_LACK_OF_T_CELL_FUNCTION,SET,7,-0.16876,-0.0032945,0.35845,0.6811,HP_LACK_OF_T_CELL_FUNCTION,1
KEGG_OTHER_GLYCAN_DEGRADATION,SET,15,-0.11068,-0.0031623,0.23506,0.68112,KEGG_OTHER_GLYCAN_DEGRADATION,1
MIR6853_5P,SET,6,-0.16381,-0.0029608,0.34789,0.68113,MIR6853_5P,1
HP_INCREASED_OVERBITE,SET,8,-0.15036,-0.0031379,0.31931,0.68113,HP_INCREASED_OVERBITE,1
NEWMAN_ERCC6_TARGETS_UP,SET,23,-0.10362,-0.0036652,0.22,0.68118,NEWMAN_ERCC6_TARGETS_UP,1
CHEN_HOXA5_TARGETS_6HR_UP,SET,9,-0.14552,-0.0032211,0.30892,0.6812,CHEN_HOXA5_TARGETS_6HR_UP,1
GSE11924_TH1_VS_TH17_CD4_TCE...1,SET,186,-0.028174,-0.0028214,0.059783,0.68128,GSE11924_TH1_VS_TH17_CD4_TCELL_DN,1
CHAUHAN_RESPONSE_TO_METHOXYE...2,SET,41,-0.057349,-0.002707,0.12168,0.68129,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,1
MIR6773_3P,SET,96,-0.042483,-0.0030639,0.090138,0.68129,MIR6773_3P,1
HP_TYPE_II_LISSENCEPHALY,SET,12,-0.11164,-0.0028531,0.23672,0.68139,HP_TYPE_II_LISSENCEPHALY,1
MIR4764_5P,SET,67,-0.050628,-0.0030528,0.10735,0.6814,MIR4764_5P,1
HP_ACETABULAR_SPURS,SET,5,-0.18079,-0.0029831,0.38332,0.68141,HP_ACETABULAR_SPURS,1
GOBP_RESPONSE_TO_MANGANESE_I...,SET,16,-0.1024,-0.0030217,0.21709,0.68143,GOBP_RESPONSE_TO_MANGANESE_ION,1
GSE29618_PRE_VS_DAY7_POST_LA...7,SET,177,-0.027878,-0.002724,0.059087,0.68146,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN,1
GOBP_REGULATION_OF_CARTILAGE...,SET,62,-0.054714,-0.0031741,0.11595,0.68149,GOBP_REGULATION_OF_CARTILAGE_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...176,SET,11,-0.13033,-0.0031891,0.27615,0.68151,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
HP_ABNORMAL_MUSCULOSKELETAL_...,SET,1455,-0.010921,-0.0029501,0.023141,0.68152,HP_ABNORMAL_MUSCULOSKELETAL_PHYSIOLOGY,1
GOBP_POSITIVE_REGULATION_BY_...4,SET,13,-0.10966,-0.002917,0.23234,0.68153,GOBP_POSITIVE_REGULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,1
HP_HYPOPLASTIC_AORTIC_ARCH,SET,11,-0.12376,-0.0030284,0.2622,0.68154,HP_HYPOPLASTIC_AORTIC_ARCH,1
TTCYNRGAA_STAT5B_01,SET,300,-0.023775,-0.0030141,0.050363,0.68156,TTCYNRGAA_STAT5B_01,1
HP_ARTERIA_LUSORIA,SET,6,-0.19003,-0.0034347,0.40249,0.68158,HP_ARTERIA_LUSORIA,1
GOBP_ENDODERMAL_CELL_FATE_SP...,SET,7,-0.15876,-0.0030994,0.33621,0.68161,GOBP_ENDODERMAL_CELL_FATE_SPECIFICATION,1
GOMF_FERROUS_IRON_BINDING,SET,23,-0.078628,-0.0027812,0.1665,0.68162,GOMF_FERROUS_IRON_BINDING,1
WP_NODLIKE_RECEPTOR_NLR_SIGN...,SET,7,-0.14834,-0.002896,0.31409,0.68164,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,1
HP_LARGE_EARLOBE,SET,28,-0.071497,-0.00279,0.15138,0.68164,HP_LARGE_EARLOBE,1
WP_PHOSPHATIDYL_INOSITOL_PHO...,SET,40,-0.063379,-0.002955,0.13419,0.68165,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,1
MIR4728_5P,SET,516,-0.017864,-0.0029525,0.037821,0.68165,MIR4728_5P,1
HP_PATHOLOGIC_FRACTURE,SET,57,-0.052876,-0.0029416,0.11195,0.68165,HP_PATHOLOGIC_FRACTURE,1
HP_PRELINGUAL_SENSORINEURAL_...,SET,11,-0.13216,-0.0032339,0.27978,0.68167,HP_PRELINGUAL_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE3720_LPS_VS_PMA_STIM_VD1_...1,SET,157,-0.031771,-0.0029253,0.06725,0.68168,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,1
HP_ASPIRATION_PNEUMONIA,SET,88,-0.042676,-0.0029475,0.090298,0.68175,HP_ASPIRATION_PNEUMONIA,1
chr2p13,SET,81,-0.10636,-0.0070489,0.22495,0.68182,chr2p13,1
GOCC_SMC5_SMC6_COMPLEX,SET,6,-0.17705,-0.0032001,0.37442,0.68184,GOCC_SMC5_SMC6_COMPLEX,1
HEBERT_MATRISOME_TNBC_BONE_B...1,SET,13,-0.12302,-0.0032724,0.26016,0.68185,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES,1
GOBP_REGULATION_OF_POSTSYNAP...10,SET,15,-0.10325,-0.0029501,0.21834,0.68185,GOBP_REGULATION_OF_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,1
ROYLANCE_BREAST_CANCER_16Q_C...2,SET,59,-0.080383,-0.0045494,0.16992,0.68191,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,1
GOCC_COPII_VESICLE_COAT,SET,16,-0.095031,-0.0028041,0.20087,0.68192,GOCC_COPII_VESICLE_COAT,1
GSE21927_SPLEEN_VS_TUMOR_MON...2,SET,142,-0.032853,-0.002878,0.069445,0.68192,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP,1
WP_HEPATOCYTE_GROWTH_FACTOR_...,SET,33,-0.072936,-0.0030894,0.15415,0.68194,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,1
GOBP_INTRACILIARY_RETROGRADE...,SET,10,-0.11855,-0.0027659,0.25048,0.68199,GOBP_INTRACILIARY_RETROGRADE_TRANSPORT,1
GOMF_GLYCOSPHINGOLIPID_BINDI...,SET,10,-0.12896,-0.0030089,0.27241,0.68204,GOMF_GLYCOSPHINGOLIPID_BINDING,1
HP_HOLOPROSENCEPHALY,SET,69,-0.046245,-0.0028296,0.097655,0.68209,HP_HOLOPROSENCEPHALY,1
GOBP_TYPE_II_INTERFERON_PROD...,SET,107,-0.042925,-0.0032674,0.090614,0.68215,GOBP_TYPE_II_INTERFERON_PRODUCTION,1
MIKKELSEN_NPC_ICP_WITH_H3K27...,SET,11,-0.14271,-0.003492,0.30123,0.68216,MIKKELSEN_NPC_ICP_WITH_H3K27ME3,1
GSE9650_EFFECTOR_VS_EXHAUSTE...1,SET,177,-0.031528,-0.0030807,0.066537,0.68219,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN,1
GOBP_MUCOCILIARY_CLEARANCE,SET,7,-0.16503,-0.0032218,0.34827,0.6822,GOBP_MUCOCILIARY_CLEARANCE,1
HP_ELEVATED_TRANSFERRIN_SATU...,SET,9,-0.12887,-0.0028525,0.27192,0.68222,HP_ELEVATED_TRANSFERRIN_SATURATION,1
WP_ESTROGEN_METABOLISM_WP5276,SET,23,-0.090089,-0.0031866,0.18998,0.68232,WP_ESTROGEN_METABOLISM_WP5276,1
HP_PARTIAL_ALBINISM,SET,9,-0.14677,-0.0032487,0.30939,0.68238,HP_PARTIAL_ALBINISM,1
chr13q12,SET,65,-0.096555,-0.0057349,0.20352,0.6824,chr13q12,1
GOBP_REGULATION_OF_MRNA_META...,SET,271,-0.02375,-0.0028641,0.050059,0.68241,GOBP_REGULATION_OF_MRNA_METABOLIC_PROCESS,1
GOBP_PROTEIN_KINASE_A_SIGNAL...,SET,37,-0.071828,-0.0032212,0.15135,0.68245,GOBP_PROTEIN_KINASE_A_SIGNALING,1
HP_SPONDYLOMETAPHYSEAL_DYSPL...,SET,8,-0.14256,-0.0029751,0.30035,0.68247,HP_SPONDYLOMETAPHYSEAL_DYSPLASIA,1
MANNO_MIDBRAIN_NEUROTYPES_HR...5,SET,502,-0.0194,-0.0031637,0.040872,0.68248,MANNO_MIDBRAIN_NEUROTYPES_HRGL3,1
REACTOME_HSF1_DEPENDENT_TRAN...,SET,36,-0.069393,-0.0030698,0.14614,0.68254,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,1
LIANG_SILENCED_BY_METHYLATIO...3,SET,26,-0.091089,-0.0034254,0.19182,0.68256,LIANG_SILENCED_BY_METHYLATION_UP,1
GSE24142_ADULT_VS_FETAL_DN2_...1,SET,169,-0.031879,-0.0030444,0.067119,0.68259,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...2,SET,564,-0.016788,-0.0028969,0.035347,0.68259,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,1
GOBP_NEGATIVE_REGULATION_OF_...254,SET,39,-0.066949,-0.0030823,0.14093,0.68262,GOBP_NEGATIVE_REGULATION_OF_GLIOGENESIS,1
HP_FIBER_TYPE_GROUPING,SET,10,-0.10859,-0.0025336,0.22858,0.68263,HP_FIBER_TYPE_GROUPING,1
ZBTB18_TARGET_GENES,SET,670,-0.015869,-0.0029757,0.033399,0.68266,ZBTB18_TARGET_GENES,1
GOBP_CARBOHYDRATE_DERIVATIVE...3,SET,965,-0.013597,-0.0030343,0.028612,0.68269,GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS,1
HP_ABNORMAL_INTONATION,SET,59,-0.05561,-0.0031473,0.11701,0.6827,HP_ABNORMAL_INTONATION,1
HP_MACRODACTYLY,SET,4,-0.18119,-0.0026741,0.38122,0.6827,HP_MACRODACTYLY,1
chr9p23,SET,4,-0.25975,-0.0038336,0.54627,0.68278,chr9p23,1
GOBP_PEPTIDYL_THREONINE_DEPH...,SET,17,-0.10774,-0.0032768,0.2265,0.68284,GOBP_PEPTIDYL_THREONINE_DEPHOSPHORYLATION,1
GOMF_CATALYTIC_ACTIVITY_ACTI...5,SET,225,-0.025175,-0.0027698,0.052924,0.68284,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_DNA,1
GOMF_RNA_POLYMERASE_II_CTD_H...2,SET,17,-0.098288,-0.0029894,0.20663,0.68284,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_MODIFYING_ACTIVITY,1
GOMF_TRANSFORMING_GROWTH_FAC...3,SET,5,-0.20391,-0.0033646,0.42868,0.68284,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY_TYPE_I,1
GSE29615_DAY3_VS_DAY7_LAIV_F...1,SET,162,-0.03227,-0.0030179,0.067837,0.68285,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,1
HP_PARTIAL_ABSENCE_OF_THUMB,SET,9,-0.13093,-0.0028981,0.27513,0.68292,HP_PARTIAL_ABSENCE_OF_THUMB,1
KEGG_MEDICUS_REFERENCE_PINK_...,SET,15,-0.10673,-0.0030494,0.22417,0.683,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
HP_ELBOW_ANKYLOSIS,SET,7,-0.17004,-0.0033196,0.35704,0.68305,HP_ELBOW_ANKYLOSIS,1
KEGG_COLORECTAL_CANCER,SET,61,-0.053014,-0.0030507,0.11126,0.68313,KEGG_COLORECTAL_CANCER,1
HP_ABNORMALITY_OF_FRONTAL_SI...,SET,13,-0.1101,-0.0029287,0.23106,0.68314,HP_ABNORMALITY_OF_FRONTAL_SINUS,1
REACTOME_THE_ACTIVATION_OF_A...,SET,8,-0.13558,-0.0028295,0.28445,0.68319,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,1
GOMF_LEUKOTRIENE_C4_SYNTHASE...,SET,5,-0.20181,-0.0033299,0.4234,0.68319,GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY,1
FERRANDO_T_ALL_WITH_MLL_ENL_...1,SET,78,-0.044819,-0.0029151,0.094024,0.6832,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1
HP_ANTERIOR_RIB_CUPPING,SET,15,-0.1016,-0.0029029,0.21306,0.68326,HP_ANTERIOR_RIB_CUPPING,1
HP_ABNORMAL_RENAL_CORTICOMED...,SET,21,-0.09404,-0.0031786,0.19716,0.68331,HP_ABNORMAL_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
GOBP_REGULATION_OF_MONOATOMI...3,SET,302,-0.025116,-0.0031946,0.052655,0.68332,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
HP_HYPOPLASIA_OF_TEETH,SET,109,-0.038831,-0.0029831,0.081392,0.68335,HP_HYPOPLASIA_OF_TEETH,1
REACTOME_MHC_CLASS_II_ANTIGE...,SET,117,-0.037519,-0.0029855,0.078635,0.68336,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1
LI_ESTROGENE_META_E2_RESPONS...2,SET,61,-0.055084,-0.0031698,0.11539,0.68344,LI_ESTROGENE_META_E2_RESPONSE_UP,1
GOCC_PHOTORECEPTOR_DISC_MEMB...,SET,18,-0.09294,-0.0029086,0.19467,0.68346,GOCC_PHOTORECEPTOR_DISC_MEMBRANE,1
GSE16450_CTRL_VS_IFNA_12H_ST...1,SET,155,-0.033797,-0.0030922,0.070794,0.68346,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,1
GSE33424_CD161_HIGH_VS_INT_C...1,SET,185,-0.029818,-0.0029781,0.062452,0.68348,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN,1
ZHAN_MULTIPLE_MYELOMA_CD1_UP,SET,40,-0.067644,-0.0031539,0.14161,0.68355,ZHAN_MULTIPLE_MYELOMA_CD1_UP,1
PID_PRL_SIGNALING_EVENTS_PAT...,SET,23,-0.08748,-0.0030943,0.1831,0.68359,PID_PRL_SIGNALING_EVENTS_PATHWAY,1
KEGG_MEDICUS_REFERENCE_AMH_S...,SET,9,-0.13793,-0.0030532,0.28866,0.68361,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY,1
REACTOME_TRNA_PROCESSING,SET,96,-0.038493,-0.0027761,0.080519,0.68369,REACTOME_TRNA_PROCESSING,1
GSE34392_ST2_KO_VS_WT_DAY8_L...1,SET,187,-0.031884,-0.0032014,0.066688,0.68371,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,1
GSE24210_TCONV_VS_TREG_UP,SET,184,-0.029988,-0.0029869,0.062718,0.68372,GSE24210_TCONV_VS_TREG_UP,1
GOBP_N_TERMINAL_PROTEIN_AMIN...2,SET,24,-0.075532,-0.0027291,0.1578,0.68391,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,1
REACTOME_INTEGRATION_OF_ENER...,SET,106,-0.042143,-0.0031929,0.088029,0.68393,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1
GSE13887_RESTING_VS_NO_TREAT...1,SET,93,-0.042762,-0.0030357,0.089284,0.68401,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN,1
HP_ABNORMALITY_OF_PULMONARY_...,SET,168,-0.031273,-0.0029778,0.06529,0.68402,HP_ABNORMALITY_OF_PULMONARY_CIRCULATION,1
GOBP_REGULATION_OF_POTASSIUM...4,SET,87,-0.04741,-0.0032558,0.098953,0.68407,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
MODULE_330,SET,27,-0.084423,-0.0032351,0.1762,0.68408,MODULE_330,1
WOTTON_RUNX_TARGETS_DN,SET,26,-0.089515,-0.0033662,0.18667,0.68422,WOTTON_RUNX_TARGETS_DN,1
GOBP_REGULATION_OF_ENDOSOME_...1,SET,4,-0.1711,-0.0025253,0.35676,0.68424,GOBP_REGULATION_OF_ENDOSOME_ORGANIZATION,1
TGACGTCA_ATF3_Q6,SET,210,-0.029238,-0.0031091,0.06095,0.68428,TGACGTCA_ATF3_Q6,1
HALLMARK_KRAS_SIGNALING_UP,SET,186,-0.033155,-0.0033201,0.069115,0.68428,HALLMARK_KRAS_SIGNALING_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...5,SET,21,-0.098922,-0.0033436,0.2062,0.68429,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CELL_JUNCTION,1
HP_GUSTATORY_LACRIMATION,SET,4,-0.23259,-0.0034327,0.4848,0.6843,HP_GUSTATORY_LACRIMATION,1
GOBP_CARBOHYDRATE_TRANSPORT,SET,126,-0.038508,-0.0031791,0.080259,0.68431,GOBP_CARBOHYDRATE_TRANSPORT,1
REACTOME_ONCOGENIC_MAPK_SIGN...,SET,77,-0.046783,-0.0030233,0.097502,0.68432,REACTOME_ONCOGENIC_MAPK_SIGNALING,1
HP_PRECOCIOUS_PUBERTY_IN_FEM...,SET,9,-0.1388,-0.0030723,0.28924,0.68434,HP_PRECOCIOUS_PUBERTY_IN_FEMALES,1
GSE2405_HEAT_KILLED_LYSATE_V...2,SET,188,-0.031638,-0.003185,0.065929,0.68434,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,1
GOBP_MYOBLAST_PROLIFERATION,SET,24,-0.08634,-0.0031196,0.1799,0.68436,GOBP_MYOBLAST_PROLIFERATION,1
HP_BASAL_GANGLIA_CYSTS,SET,6,-0.15144,-0.0027372,0.31555,0.68436,HP_BASAL_GANGLIA_CYSTS,1
GAVISH_3CA_METAPROGRAM_EPITH...4,SET,35,-0.067789,-0.002957,0.14124,0.68437,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CILIA,1
CHEBOTAEV_GR_TARGETS_UP,SET,76,-0.049951,-0.0032071,0.10406,0.68439,CHEBOTAEV_GR_TARGETS_UP,1
REACTOME_VITAMIN_C_ASCORBATE...,SET,7,-0.15422,-0.0030108,0.32127,0.6844,REACTOME_VITAMIN_C_ASCORBATE_METABOLISM,1
GSE20715_WT_VS_TLR4_KO_6H_OZ...1,SET,177,-0.031748,-0.0031021,0.066128,0.68442,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN,1
NELSON_RESPONSE_TO_ANDROGEN_...2,SET,75,-0.049539,-0.0031597,0.10316,0.68446,NELSON_RESPONSE_TO_ANDROGEN_UP,1
KEGG_MEDICUS_REFERENCE_ICOSL...,SET,8,-0.14603,-0.0030476,0.30406,0.68448,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY,1
DESCARTES_MAIN_FETAL_AFP_ALB...,SET,77,-0.046913,-0.0030317,0.09765,0.68453,DESCARTES_MAIN_FETAL_AFP_ALB_POSITIVE_CELLS,1
chr4q12,SET,33,-0.13481,-0.0057102,0.28059,0.68455,chr4q12,1
GSE360_L_DONOVANI_VS_B_MALAY...6,SET,177,-0.032432,-0.0031689,0.067495,0.68456,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP,1
GOBP_MAMMARY_GLAND_EPITHELIA...2,SET,25,-0.090854,-0.0033503,0.18905,0.68459,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
MIR1587,SET,55,-0.051149,-0.0027953,0.10642,0.6846,MIR1587,1
GOBP_UNSATURATED_FATTY_ACID_...1,SET,45,-0.063653,-0.0031474,0.13244,0.6846,GOBP_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
AIZARANI_LIVER_C32_MVECS_3,SET,121,-0.040618,-0.0032865,0.084496,0.68463,AIZARANI_LIVER_C32_MVECS_3,1
MIR12126,SET,34,-0.074802,-0.003216,0.15559,0.68465,MIR12126,1
GOBP_ISOCITRATE_METABOLIC_PR...,SET,5,-0.1616,-0.0026664,0.33609,0.68467,GOBP_ISOCITRATE_METABOLIC_PROCESS,1
HP_TRIGONOCEPHALY,SET,40,-0.06326,-0.0029495,0.13156,0.68469,HP_TRIGONOCEPHALY,1
GOBP_REGULATION_OF_DNA_BIOSY...,SET,111,-0.038124,-0.0029554,0.079274,0.68471,GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_BRAN...,SET,8,-0.14378,-0.0030007,0.29891,0.68475,HP_ABNORMAL_CIRCULATING_BRANCHED_CHAIN_AMINO_ACID_CONCENTRATION,1
HP_BRUXISM,SET,29,-0.076745,-0.0030477,0.15952,0.68478,HP_BRUXISM,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...5,SET,6,-0.17859,-0.003228,0.37115,0.68481,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_DN,1
HP_INCREASED_CIRCULATING_FRE...,SET,5,-0.15814,-0.0026093,0.3286,0.68483,HP_INCREASED_CIRCULATING_FREE_FATTY_ACID_LEVEL,1
GOMF_CAMP_DEPENDENT_PROTEIN_...1,SET,5,-0.15829,-0.0026118,0.32887,0.68485,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
HP_MATERNAL_AUTOIMMUNE_DISEA...,SET,14,-0.11313,-0.0031227,0.23502,0.68486,HP_MATERNAL_AUTOIMMUNE_DISEASE,1
HP_CHORIOCARCINOMA,SET,8,-0.15753,-0.0032877,0.32715,0.68493,HP_CHORIOCARCINOMA,1
GSE2770_IL12_ACT_VS_ACT_CD4_...6,SET,169,-0.030565,-0.0029189,0.063465,0.68495,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP,1
HP_TITUBATION,SET,29,-0.078786,-0.0031287,0.16357,0.68497,HP_TITUBATION,1
chr15q11,SET,8,-0.19939,-0.0041612,0.41396,0.68498,chr15q11,1
GOBP_L_AMINO_ACID_BIOSYNTHET...,SET,55,-0.055409,-0.0030281,0.11504,0.68498,GOBP_L_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
HP_HYPOHIDROSIS_OR_HYPERHIDR...,SET,210,-0.02918,-0.0031028,0.06058,0.68498,HP_HYPOHIDROSIS_OR_HYPERHIDROSIS,1
AFFAR_YY1_TARGETS_UP,SET,178,-0.031649,-0.0031011,0.065683,0.68504,AFFAR_YY1_TARGETS_UP,1
GOCC_APICAL_CORTEX,SET,8,-0.13726,-0.0028646,0.28485,0.68505,GOCC_APICAL_CORTEX,1
HP_PARTIAL_ABSENCE_OF_CEREBE...,SET,4,-0.17905,-0.0026425,0.37156,0.68505,HP_PARTIAL_ABSENCE_OF_CEREBELLAR_VERMIS,1
GOCC_CALCINEURIN_COMPLEX,SET,6,-0.14053,-0.00254,0.29161,0.68506,GOCC_CALCINEURIN_COMPLEX,1
ZNF697_TARGET_GENES,SET,121,-0.036111,-0.0029218,0.074928,0.68507,ZNF697_TARGET_GENES,1
GOBP_REGULATION_OF_CATECHOLA...2,SET,8,-0.15049,-0.0031406,0.31224,0.68508,GOBP_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
GGTAACC_MIR4095P,SET,28,-0.079933,-0.0031192,0.16583,0.6851,GGTAACC_MIR4095P,1
GOBP_POSITIVE_REGULATION_OF_...141,SET,9,-0.15522,-0.0034358,0.32186,0.68519,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_SEROTONIN_RECEPTOR_SIGN...,SET,8,-0.15616,-0.003259,0.32373,0.68522,GOBP_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
HP_LIMB_TREMOR,SET,20,-0.096912,-0.0031968,0.20089,0.68524,HP_LIMB_TREMOR,1
GOBP_CORTICOTROPIN_SECRETION,SET,6,-0.18764,-0.0033914,0.38893,0.68525,GOBP_CORTICOTROPIN_SECRETION,1
HP_NEPHROGENIC_DIABETES_INSI...,SET,7,-0.16292,-0.0031806,0.33769,0.68526,HP_NEPHROGENIC_DIABETES_INSIPIDUS,1
HP_C1_C2_SUBLUXATION,SET,5,-0.16683,-0.0027527,0.34573,0.68529,HP_C1_C2_SUBLUXATION,1
HP_SYMPHALANGISM_AFFECTING_T...,SET,16,-0.10202,-0.0030103,0.21133,0.68536,HP_SYMPHALANGISM_AFFECTING_THE_PHALANGES_OF_THE_HAND,1
GOBP_POSITIVE_REGULATION_OF_...729,SET,4,-0.22338,-0.0032968,0.46266,0.68538,GOBP_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,1
HP_OMPHALOCELE,SET,67,-0.052363,-0.0031574,0.10846,0.68538,HP_OMPHALOCELE,1
GOBP_NEGATIVE_REGULATION_OF_...325,SET,5,-0.17659,-0.0029138,0.36575,0.68539,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
MALIK_REPRESSED_BY_ESTROGEN,SET,13,-0.12221,-0.0032508,0.25307,0.68542,MALIK_REPRESSED_BY_ESTROGEN,1
GOBP_RESPONSE_TO_DIACYL_BACT...,SET,4,-0.21256,-0.0031371,0.43977,0.68557,GOBP_RESPONSE_TO_DIACYL_BACTERIAL_LIPOPEPTIDE,1
GOBP_NEGATIVE_REGULATION_OF_...336,SET,6,-0.19504,-0.0035253,0.40349,0.68559,GOBP_NEGATIVE_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,1
GOMF_FATTY_ACID_TRANSMEMBRAN...,SET,18,-0.098371,-0.0030786,0.20349,0.6856,GOMF_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOUYER_TUMOR_INVASIVENESS,SET,8,-0.17119,-0.0035727,0.35401,0.68566,GOUYER_TUMOR_INVASIVENESS,1
BILANGES_SERUM_SENSITIVE_GEN...,SET,72,-0.04815,-0.0030094,0.099549,0.68569,BILANGES_SERUM_SENSITIVE_GENES,1
LI_ESTROGENE_LATE_E2_RESPONS...1,SET,71,-0.053182,-0.0033008,0.10994,0.68571,LI_ESTROGENE_LATE_E2_RESPONSE_DN,1
GOBP_RNA_MODIFICATION,SET,145,-0.031768,-0.002812,0.065654,0.68576,GOBP_RNA_MODIFICATION,1
AREB6_04,SET,226,-0.029116,-0.0032104,0.06017,0.68577,AREB6_04,1
HP_KERATOSIS_PILARIS,SET,34,-0.074137,-0.0031874,0.15317,0.6858,HP_KERATOSIS_PILARIS,1
HP_ABNORMAL_CSF_LACTATE_CONC...,SET,82,-0.042195,-0.0028136,0.08716,0.68584,HP_ABNORMAL_CSF_LACTATE_CONCENTRATION,1
MIR7515,SET,142,-0.034544,-0.0030262,0.071344,0.68587,MIR7515,1
AAGCACT_MIR520F,SET,219,-0.027993,-0.003039,0.057806,0.68589,AAGCACT_MIR520F,1
NABA_ECM_AFFILIATED,SET,151,-0.03819,-0.0034492,0.078863,0.6859,NABA_ECM_AFFILIATED,1
GOMF_HEPARAN_SULFATE_GLUCOSA...,SET,7,-0.18736,-0.0036578,0.38687,0.68591,GOMF_HEPARAN_SULFATE_GLUCOSAMINE_3_SULFOTRANSFERASE_1_ACTIVITY,1
GOMF_TRNA_METHYLTRANSFERASE_...,SET,30,-0.064979,-0.0026245,0.13417,0.68592,GOMF_TRNA_METHYLTRANSFERASE_ACTIVITY,1
GSE22432_MULTIPOTENT_VS_COMM...4,SET,178,-0.029719,-0.002912,0.061363,0.68592,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP,1
BIOCARTA_PTDINS_PATHWAY,SET,22,-0.079115,-0.002737,0.16334,0.68593,BIOCARTA_PTDINS_PATHWAY,1
SAKAI_TUMOR_INFILTRATING_MON...2,SET,26,-0.080697,-0.0030346,0.16659,0.68595,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,1
VETTER_TARGETS_OF_PRKCA_AND_...2,SET,16,-0.10831,-0.0031959,0.22359,0.68595,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1
GSE7831_UNSTIM_VS_INFLUENZA_...3,SET,181,-0.030749,-0.0030379,0.063477,0.68595,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN,1
MIR3680_3P,SET,491,-0.020316,-0.0032777,0.041928,0.686,MIR3680_3P,1
WONG_ENDOMETRIAL_CANCER_LATE,SET,7,-0.17521,-0.0034204,0.36153,0.68602,WONG_ENDOMETRIAL_CANCER_LATE,1
GSE15750_WT_VS_TRAF6KO_DAY10...2,SET,175,-0.030393,-0.0029531,0.062713,0.68603,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP,1
GSE17721_POLYIC_VS_PAM3CSK4_...7,SET,175,-0.03269,-0.0031763,0.067428,0.68609,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN,1
REACTOME_MEMBRANE_TRAFFICKING,SET,596,-0.016873,-0.0029903,0.034798,0.68612,REACTOME_MEMBRANE_TRAFFICKING,1
HP_PRENATAL_DEATH,SET,61,-0.055239,-0.0031787,0.11392,0.68612,HP_PRENATAL_DEATH,1
HP_ABNORMALLY_SHAPED_CARPAL_...,SET,7,-0.16814,-0.0032825,0.34675,0.68613,HP_ABNORMALLY_SHAPED_CARPAL_BONES,1
GSE13522_WT_VS_IFNAR_KO_SKIN...3,SET,152,-0.034916,-0.0031637,0.071999,0.68614,GSE13522_WT_VS_IFNAR_KO_SKIN_DN,1
GOBP_POSITIVE_REGULATION_OF_...536,SET,5,-0.19985,-0.0032975,0.41209,0.68615,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,1
BECKER_TAMOXIFEN_RESISTANCE_...1,SET,49,-0.060814,-0.0031375,0.12536,0.68619,BECKER_TAMOXIFEN_RESISTANCE_DN,1
GOMF_DYNACTIN_BINDING,SET,11,-0.11589,-0.0028357,0.23891,0.68619,GOMF_DYNACTIN_BINDING,1
GOMF_NUCLEASE_ACTIVITY,SET,197,-0.028156,-0.0029008,0.058031,0.68622,GOMF_NUCLEASE_ACTIVITY,1
GSE40666_UNTREATED_VS_IFNA_S...7,SET,176,-0.031502,-0.0030695,0.064909,0.68627,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN,1
chr11p15,SET,274,-0.05507,-0.0066771,0.11343,0.68633,chr11p15,1
GSE22025_UNTREATED_VS_TGFB1_...1,SET,174,-0.031953,-0.0030959,0.065814,0.68634,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
GOBP_RNA_CATABOLIC_PROCESS,SET,264,-0.024854,-0.0029588,0.051185,0.68636,GOBP_RNA_CATABOLIC_PROCESS,1
MIR6072,SET,72,-0.048406,-0.0030254,0.099681,0.68638,MIR6072,1
GOBP_GLYCINE_METABOLIC_PROCE...,SET,12,-0.11319,-0.0028927,0.23308,0.68638,GOBP_GLYCINE_METABOLIC_PROCESS,1
GSE25087_FETAL_VS_ADULT_TREG...1,SET,157,-0.033345,-0.0030703,0.068659,0.68639,GSE25087_FETAL_VS_ADULT_TREG_DN,1
MIR4643,SET,197,-0.030342,-0.0031261,0.062475,0.6864,MIR4643,1
HP_NODULAR_CHANGES_AFFECTING...,SET,26,-0.091224,-0.0034305,0.18778,0.68644,HP_NODULAR_CHANGES_AFFECTING_THE_EYELIDS,1
WP_BIOTIN_METABOLISM_INCLUDI...,SET,9,-0.14011,-0.0031012,0.28839,0.68645,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,1
REACTOME_MUCOPOLYSACCHARIDOS...,SET,10,-0.13486,-0.0031466,0.27758,0.68646,REACTOME_MUCOPOLYSACCHARIDOSES,1
GOBP_CHOLESTEROL_CATABOLIC_P...,SET,8,-0.15279,-0.0031886,0.31436,0.68652,GOBP_CHOLESTEROL_CATABOLIC_PROCESS,1
MODULE_385,SET,27,-0.092664,-0.0035509,0.19062,0.68655,MODULE_385,1
ERBB2_UP.V1_DN,SET,180,-0.03031,-0.0029864,0.062351,0.68655,ERBB2_UP.V1_DN,1
PARK_OSTEOBLAST_DIFFERENTIAT...2,SET,12,-0.13205,-0.0033749,0.2716,0.68658,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP,1
MODULE_136,SET,447,-0.019368,-0.002985,0.039837,0.68658,MODULE_136,1
GOBP_REGULATION_OF_GLUCOCORT...4,SET,10,-0.13547,-0.0031607,0.27861,0.6866,GOBP_REGULATION_OF_GLUCOCORTICOID_SECRETION,1
MIR1911_3P,SET,42,-0.066522,-0.003178,0.13679,0.68662,MIR1911_3P,1
GOBP_NUCLEOBASE_CONTAINING_S...4,SET,582,-0.01751,-0.0030678,0.036005,0.68663,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_PHOSPHOLI...8,SET,6,-0.17311,-0.0031288,0.3559,0.68665,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
GOBP_VASCULAR_TRANSPORT,SET,81,-0.050855,-0.0033704,0.10453,0.6867,GOBP_VASCULAR_TRANSPORT,1
HP_TREMOR_BY_ANATOMICAL_SITE,SET,86,-0.046461,-0.0031724,0.095458,0.68677,HP_TREMOR_BY_ANATOMICAL_SITE,1
GARGALOVIC_RESPONSE_TO_OXIDI...19,SET,13,-0.12694,-0.0033765,0.26074,0.68681,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,1
MIR10A_5P_MIR10B_5P,SET,99,-0.044007,-0.0032228,0.090379,0.68684,MIR10A_5P_MIR10B_5P,1
GOMF_CERAMIDE_1_PHOSPHATE_BI...,SET,5,-0.17139,-0.002828,0.35193,0.68687,GOMF_CERAMIDE_1_PHOSPHATE_BINDING,1
KRISHNAN_FURIN_TARGETS_UP,SET,8,-0.15981,-0.0033351,0.32811,0.68689,KRISHNAN_FURIN_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...318,SET,14,-0.11444,-0.003159,0.23489,0.68695,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
NUFIP1_TARGET_GENES,SET,39,-0.068783,-0.0031668,0.14116,0.68696,NUFIP1_TARGET_GENES,1
REACTOME_PHASE_0_RAPID_DEPOL...,SET,31,-0.084192,-0.0034566,0.17275,0.687,REACTOME_PHASE_0_RAPID_DEPOLARISATION,1
HP_GASTROINTESTINAL_ARTERIOV...,SET,4,-0.24721,-0.0036485,0.5072,0.68701,HP_GASTROINTESTINAL_ARTERIOVENOUS_MALFORMATION,1
PID_IL12_STAT4_PATHWAY,SET,32,-0.076102,-0.0031743,0.15608,0.68708,PID_IL12_STAT4_PATHWAY,1
WP_GASTRIC_CANCER_NETWORK_1,SET,24,-0.08789,-0.0031756,0.1802,0.68712,WP_GASTRIC_CANCER_NETWORK_1,1
GSE42021_CD24HI_VS_CD24INT_T...4,SET,180,-0.031271,-0.0030811,0.064111,0.68714,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP,1
MYB_Q6,SET,228,-0.027631,-0.0030599,0.056641,0.68716,MYB_Q6,1
REACTOME_BIOSYNTHESIS_OF_MAR...1,SET,8,-0.14254,-0.0029747,0.29209,0.68722,REACTOME_BIOSYNTHESIS_OF_MARESINS,1
MIR5690,SET,110,-0.042104,-0.0032492,0.086266,0.68725,MIR5690,1
GOBP_EXTERNAL_ENCAPSULATING_...,SET,306,-0.025441,-0.003257,0.052125,0.68725,GOBP_EXTERNAL_ENCAPSULATING_STRUCTURE_ORGANIZATION,1
HOEK_MYELOID_DENDRITIC_CELL_...6,SET,20,-0.10806,-0.0035644,0.22137,0.68726,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP,1
GOBP_NUCLEAR_RNA_SURVEILLANCE,SET,14,-0.10254,-0.0028305,0.21003,0.6873,GOBP_NUCLEAR_RNA_SURVEILLANCE,1
GOBP_OXYGEN_METABOLIC_PROCESS,SET,6,-0.17098,-0.0030904,0.35018,0.68732,GOBP_OXYGEN_METABOLIC_PROCESS,1
MULLIGAN_NTF3_SIGNALING_VIA_...1,SET,7,-0.18638,-0.0036385,0.38167,0.68733,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,1
GOBP_CARDIAC_MUSCLE_CELL_CON...,SET,78,-0.05059,-0.0032904,0.1036,0.68734,GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION,1
GOMF_DNA_DAMAGE_SENSOR_ACTIV...,SET,20,-0.075738,-0.0024984,0.15509,0.68734,GOMF_DNA_DAMAGE_SENSOR_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_FIBRO...18,SET,42,-0.069627,-0.0033264,0.14257,0.68736,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II_CYTOKINE,1
DOANE_BREAST_CANCER_ESR1_UP,SET,102,-0.044175,-0.0032834,0.090444,0.68737,DOANE_BREAST_CANCER_ESR1_UP,1
GOBP_EMBRYONIC_SKELETAL_SYST...2,SET,88,-0.049426,-0.0034137,0.10114,0.68746,GOBP_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS,1
HP_OSTEOARTHRITIS_OF_THE_SMA...,SET,4,-0.17797,-0.0026266,0.36408,0.68751,HP_OSTEOARTHRITIS_OF_THE_SMALL_JOINTS_OF_THE_HAND,1
GOBP_NEGATIVE_REGULATION_OF_...29,SET,29,-0.078219,-0.0031062,0.15997,0.68756,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
CARD_MIR302A_TARGETS,SET,74,-0.051846,-0.0032849,0.10602,0.68758,CARD_MIR302A_TARGETS,1
MAML1_TARGET_GENES,SET,212,-0.029301,-0.0031303,0.059909,0.68761,MAML1_TARGET_GENES,1
FARMER_BREAST_CANCER_CLUSTER...3,SET,13,-0.13588,-0.0036143,0.2778,0.68762,FARMER_BREAST_CANCER_CLUSTER_3,1
GOBP_ENDOTHELIAL_CELL_FATE_C...,SET,8,-0.16733,-0.0034921,0.34199,0.68768,GOBP_ENDOTHELIAL_CELL_FATE_COMMITMENT,1
HP_FUNCTIONAL_MOTOR_DEFICIT,SET,450,-0.019488,-0.0030133,0.039827,0.68769,HP_FUNCTIONAL_MOTOR_DEFICIT,1
HP_HEPATIC_ENCEPHALOPATHY,SET,19,-0.10949,-0.0035203,0.22373,0.68771,HP_HEPATIC_ENCEPHALOPATHY,1
GSE12003_MIR223_KO_VS_WT_BM_...2,SET,178,-0.031279,-0.0030648,0.063915,0.68771,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP,1
GOBP_PROTEIN_IMPORT_INTO_PER...3,SET,4,-0.19942,-0.0029431,0.40745,0.68773,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_SUBSTRATE_RELEASE,1
REACTOME_NUCLEOTIDE_CATABOLI...,SET,35,-0.073539,-0.0032078,0.15025,0.68774,REACTOME_NUCLEOTIDE_CATABOLISM,1
GSE34156_UNTREATED_VS_24H_NO...4,SET,150,-0.033588,-0.0030235,0.068614,0.68776,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP,1
MIR5588_5P,SET,80,-0.046832,-0.0030846,0.095642,0.68781,MIR5588_5P,1
GOMF_GAP_JUNCTION_CHANNEL_AC...3,SET,8,-0.17393,-0.0036298,0.35508,0.68787,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,1
ZNF302_TARGET_GENES,SET,4,-0.18171,-0.0026818,0.3707,0.68799,ZNF302_TARGET_GENES,1
GSE33292_DN3_THYMOCYTE_VS_TC...2,SET,154,-0.0314,-0.0028637,0.064052,0.68801,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP,1
GOBP_FIBROBLAST_APOPTOTIC_PR...,SET,24,-0.086068,-0.0031098,0.17545,0.68812,GOBP_FIBROBLAST_APOPTOTIC_PROCESS,1
GOBP_GENERATION_OF_PRECURSOR...,SET,393,-0.020398,-0.0029523,0.041579,0.68814,GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
GOBP_EMBRYONIC_NEUROCRANIUM_...,SET,8,-0.1649,-0.0034414,0.33608,0.68816,GOBP_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS,1
REACTOME_NEPHRON_DEVELOPMENT,SET,12,-0.13711,-0.0035041,0.27939,0.68819,REACTOME_NEPHRON_DEVELOPMENT,1
GOMF_MONOCARBOXYLIC_ACID_TRA...,SET,67,-0.053457,-0.0032234,0.10893,0.68819,GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE22229_RENAL_TRANSPLANT_IM...2,SET,185,-0.030103,-0.0030065,0.061339,0.6882,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP,1
PID_BMP_PATHWAY,SET,38,-0.07408,-0.0033667,0.15094,0.68821,PID_BMP_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...472,SET,7,-0.14247,-0.0027812,0.29025,0.68822,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
HP_MALNUTRITION,SET,41,-0.068425,-0.0032299,0.13938,0.68825,HP_MALNUTRITION,1
HP_DYSMENORRHEA,SET,12,-0.12437,-0.0031786,0.25334,0.68826,HP_DYSMENORRHEA,1
MIR6799_5P,SET,131,-0.035801,-0.0030133,0.072909,0.6883,MIR6799_5P,1
HP_APLASIA_OF_THE_UTERUS,SET,18,-0.1049,-0.0032828,0.2136,0.68831,HP_APLASIA_OF_THE_UTERUS,1
SENESE_HDAC2_TARGETS_DN,SET,110,-0.043387,-0.0033482,0.088347,0.68832,SENESE_HDAC2_TARGETS_DN,1
HP_PUSTULE,SET,25,-0.087074,-0.0032109,0.17723,0.6884,HP_PUSTULE,1
GOBP_REGULATION_OF_HEMATOPOI...3,SET,14,-0.11302,-0.0031196,0.23,0.68841,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
GOBP_GROWTH_PLATE_CARTILAGE_...3,SET,19,-0.097979,-0.0031503,0.19935,0.68846,GOBP_GROWTH_PLATE_CARTILAGE_DEVELOPMENT,1
GOBP_INOSITOL_PHOSPHATE_BIOS...,SET,26,-0.080304,-0.0030198,0.16339,0.68846,GOBP_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_MONOTONIC_SPEECH,SET,8,-0.17235,-0.003597,0.35048,0.68855,HP_MONOTONIC_SPEECH,1
GSE40274_XBP1_VS_FOXP3_AND_X...1,SET,180,-0.029873,-0.0029433,0.060737,0.68858,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOMF_PEPTIDOGLYCAN_BINDING,SET,18,-0.12198,-0.0038175,0.2479,0.68865,GOMF_PEPTIDOGLYCAN_BINDING,1
GSE17301_IFNA2_VS_IFNA5_STIM...1,SET,174,-0.032418,-0.0031409,0.065887,0.68865,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN,1
GOMF_MAP_KINASE_ACTIVITY,SET,16,-0.11909,-0.003514,0.24196,0.6887,GOMF_MAP_KINASE_ACTIVITY,1
GOBP_ALDITOL_PHOSPHATE_METAB...,SET,9,-0.15372,-0.0034026,0.31223,0.68876,GOBP_ALDITOL_PHOSPHATE_METABOLIC_PROCESS,1
MIR524_5P,SET,853,-0.015011,-0.0031595,0.030485,0.68878,MIR524_5P,1
GSE37301_HEMATOPOIETIC_STEM_...7,SET,154,-0.032396,-0.0029546,0.065777,0.68882,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN,1
PHESSE_TARGETS_OF_APC_AND_MB...1,SET,9,-0.15828,-0.0035035,0.32134,0.68884,PHESSE_TARGETS_OF_APC_AND_MBD2_DN,1
GOBP_ENDOPLASMIC_RETICULUM_M...,SET,11,-0.10238,-0.0025053,0.20785,0.68884,GOBP_ENDOPLASMIC_RETICULUM_MEMBRANE_ORGANIZATION,1
GOZGIT_ESR1_TARGETS_UP,SET,130,-0.038346,-0.0032152,0.077835,0.68887,GOZGIT_ESR1_TARGETS_UP,1
GOBP_CGMP_CATABOLIC_PROCESS,SET,5,-0.19149,-0.0031597,0.3887,0.68887,GOBP_CGMP_CATABOLIC_PROCESS,1
GOCC_INTERCHROMATIN_GRANULE,SET,5,-0.18809,-0.0031035,0.38178,0.68887,GOCC_INTERCHROMATIN_GRANULE,1
GOMF_HISTONE_DEACETYLASE_BIN...,SET,102,-0.041125,-0.0030567,0.083476,0.68887,GOMF_HISTONE_DEACETYLASE_BINDING,1
GSE42021_CD24INT_VS_CD24LOW_...2,SET,181,-0.031954,-0.0031571,0.064861,0.68887,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP,1
GSE42021_TREG_PLN_VS_TREG_PR...2,SET,175,-0.031982,-0.0031074,0.06488,0.68897,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP,1
MODULE_101,SET,10,-0.15083,-0.0035191,0.30595,0.68898,MODULE_101,1
HP_HYPOPLASIA_OF_PENIS,SET,340,-0.02322,-0.0031304,0.047099,0.68899,HP_HYPOPLASIA_OF_PENIS,1
REACTOME_GAP_FILLING_DNA_REP...,SET,24,-0.0769,-0.0027785,0.15596,0.68901,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,1
MIR129_1_3P_MIR129_2_3P,SET,120,-0.038557,-0.0031069,0.078198,0.68901,MIR129_1_3P_MIR129_2_3P,1
GSE11864_UNTREATED_VS_CSF1_I...1,SET,172,-0.030843,-0.0029712,0.062553,0.68901,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...169,SET,4,-0.19762,-0.0029167,0.40073,0.68905,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
MIR6503_5P,SET,52,-0.059593,-0.003167,0.12081,0.68909,MIR6503_5P,1
GAVISH_3CA_METAPROGRAM_CD4_T...9,SET,43,-0.069671,-0.0033678,0.14123,0.6891,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG,1
HP_STATUS_EPILEPTICUS,SET,182,-0.031259,-0.0030968,0.063349,0.68914,HP_STATUS_EPILEPTICUS,1
GOCC_INHIBITORY_SYNAPSE,SET,13,-0.12436,-0.0033079,0.25201,0.68915,GOCC_INHIBITORY_SYNAPSE,1
HP_EXERTIONAL_DYSPNEA,SET,134,-0.037343,-0.0031786,0.075672,0.68916,HP_EXERTIONAL_DYSPNEA,1
HP_ABNORMAL_URINE_HORMONE_LE...,SET,16,-0.10878,-0.0032099,0.22042,0.68917,HP_ABNORMAL_URINE_HORMONE_LEVEL,1
HP_HOFFMANN_SIGN,SET,9,-0.12891,-0.0028534,0.26117,0.68919,HP_HOFFMANN_SIGN,1
GOBP_AMP_SALVAGE,SET,4,-0.22861,-0.0033739,0.46312,0.68921,GOBP_AMP_SALVAGE,1
LIM_MAMMARY_STEM_CELL_UP,SET,429,-0.021969,-0.0033187,0.044496,0.68925,LIM_MAMMARY_STEM_CELL_UP,1
DESCARTES_MAIN_FETAL_NEUROEN...,SET,27,-0.086747,-0.0033241,0.17563,0.68931,DESCARTES_MAIN_FETAL_NEUROENDOCRINE_CELLS,1
REACTOME_FATTY_ACIDS_BOUND_T...,SET,8,-0.16227,-0.0033864,0.32842,0.68937,REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION,1
BIOCARTA_CELLCYCLE_PATHWAY,SET,23,-0.08244,-0.002916,0.16684,0.68938,BIOCARTA_CELLCYCLE_PATHWAY,1
GOBP_ACTIVATION_OF_PROTEIN_K...1,SET,75,-0.049469,-0.0031553,0.10012,0.68938,GOBP_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,1
HP_EPIGASTRIC_PAIN,SET,11,-0.13332,-0.0032622,0.26981,0.68938,HP_EPIGASTRIC_PAIN,1
GOBP_NEURON_PROJECTION_EXTEN...1,SET,148,-0.035479,-0.0031726,0.0718,0.68939,GOBP_NEURON_PROJECTION_EXTENSION,1
GOBP_REGULATION_OF_NUCLEAR_T...2,SET,11,-0.12232,-0.0029931,0.24755,0.68939,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
MODULE_18,SET,415,-0.021049,-0.0031287,0.042594,0.68941,MODULE_18,1
NIKOLSKY_BREAST_CANCER_20Q11...,SET,31,-0.12683,-0.0052071,0.25659,0.68945,NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,1
MIR4447,SET,255,-0.026244,-0.0030714,0.05309,0.68946,MIR4447,1
HAY_BONE_MARROW_CD34_POS_EO_...,SET,15,-0.12048,-0.0034422,0.2437,0.68947,HAY_BONE_MARROW_CD34_POS_EO_B_MAST,1
REACTOME_MITOCHONDRIAL_PROTE...2,SET,53,-0.053973,-0.0028957,0.10913,0.68954,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,1
GOBP_REGULATION_OF_RESPONSE_...11,SET,1248,-0.012386,-0.0031176,0.025044,0.68955,GOBP_REGULATION_OF_RESPONSE_TO_STRESS,1
MIR5696,SET,621,-0.017521,-0.0031674,0.035421,0.68957,MIR5696,1
MARTORIATI_MDM4_TARGETS_FETA...2,SET,211,-0.02923,-0.0031155,0.059088,0.68959,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1
KEGG_MEDICUS_VARIANT_TGFA_OV...,SET,8,-0.15105,-0.0031523,0.30525,0.68963,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
STEIN_ESTROGEN_RESPONSE_NOT_...,SET,17,-0.11377,-0.0034602,0.22968,0.68981,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,1
HP_LEFT_VENTRICULAR_OUTFLOW_...,SET,8,-0.17498,-0.0036518,0.3532,0.68984,HP_LEFT_VENTRICULAR_OUTFLOW_TRACT_OBSTRUCTION,1
GOBP_PHENOTYPIC_SWITCHING,SET,7,-0.17307,-0.0033787,0.34928,0.68987,GOBP_PHENOTYPIC_SWITCHING,1
GOBP_MUSCLE_TISSUE_DEVELOPME...,SET,398,-0.022354,-0.0032554,0.045108,0.6899,GOBP_MUSCLE_TISSUE_DEVELOPMENT,1
GOCC_MULTIVESICULAR_BODY_MEM...,SET,27,-0.080558,-0.003087,0.16255,0.68991,GOCC_MULTIVESICULAR_BODY_MEMBRANE,1
HP_PAROXYSMAL_ATRIAL_FIBRILL...,SET,23,-0.093338,-0.0033015,0.18829,0.68995,HP_PAROXYSMAL_ATRIAL_FIBRILLATION,1
GSE19888_ADENOSINE_A3R_INH_V...6,SET,176,-0.031622,-0.0030812,0.063777,0.68999,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP,1
MIR1299,SET,300,-0.024801,-0.0031443,0.05,0.69006,MIR1299,1
HP_RING_SCOTOMA,SET,5,-0.17805,-0.0029379,0.35894,0.69006,HP_RING_SCOTOMA,1
WINZEN_DEGRADED_VIA_KHSRP,SET,96,-0.049593,-0.0035767,0.099933,0.69014,WINZEN_DEGRADED_VIA_KHSRP,1
MIR34B_3P,SET,98,-0.040814,-0.0029739,0.082244,0.69014,MIR34B_3P,1
HP_LARGE_FLESHY_EARS,SET,13,-0.12851,-0.0034185,0.25896,0.69014,HP_LARGE_FLESHY_EARS,1
HP_PROGRESSIVE_GAIT_ATAXIA,SET,26,-0.08097,-0.0030449,0.16314,0.69017,HP_PROGRESSIVE_GAIT_ATAXIA,1
MODULE_92,SET,143,-0.040645,-0.0035731,0.081883,0.69018,MODULE_92,1
HP_MULTIPLE_BLADDER_DIVERTIC...,SET,4,-0.22889,-0.0033781,0.46098,0.69023,HP_MULTIPLE_BLADDER_DIVERTICULA,1
GSE3565_DUSP1_VS_WT_SPLENOCY...2,SET,146,-0.037149,-0.0032996,0.074817,0.69024,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN,1
HP_HYPERCALCEMIA,SET,63,-0.055239,-0.0032302,0.11124,0.69025,HP_HYPERCALCEMIA,1
MIR619_3P,SET,53,-0.058207,-0.0031228,0.11721,0.69026,MIR619_3P,1
GOBP_NEGATIVE_REGULATION_OF_...559,SET,68,-0.051638,-0.0031367,0.10395,0.69031,GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,1
GOBP_P38MAPK_CASCADE,SET,53,-0.0627,-0.0033639,0.12622,0.69031,GOBP_P38MAPK_CASCADE,1
HP_NORMAL_INTERICTAL_EEG,SET,6,-0.17191,-0.0031072,0.34607,0.69031,HP_NORMAL_INTERICTAL_EEG,1
GOBP_NEGATIVE_REGULATION_OF_...418,SET,19,-0.10607,-0.0034103,0.2135,0.69033,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION,1
GOBP_VASCULAR_ENDOTHELIAL_GR...3,SET,53,-0.060551,-0.0032486,0.12186,0.69036,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE7460_WT_VS_FOXP3_HET_ACT_...4,SET,183,-0.031199,-0.0030993,0.06279,0.69036,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP,1
SMN1_SMN2_TARGET_GENES,SET,628,-0.016809,-0.0030551,0.033825,0.69038,SMN1_SMN2_TARGET_GENES,1
GSE17721_LPS_VS_CPG_4H_BMDC_...2,SET,188,-0.03139,-0.0031601,0.063167,0.69038,GSE17721_LPS_VS_CPG_4H_BMDC_UP,1
FRANCO_BLOOD_SANOFI_PASTEUR_...3,SET,24,-0.089892,-0.0032479,0.18089,0.69038,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE,1
BIOCARTA_SRCRPTP_PATHWAY,SET,11,-0.11594,-0.0028371,0.23325,0.69043,BIOCARTA_SRCRPTP_PATHWAY,1
GSE43863_NAIVE_VS_LY6C_INT_C...2,SET,160,-0.034192,-0.003178,0.068783,0.69044,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP,1
GOBP_ANTEROGRADE_DENDRITIC_T...1,SET,9,-0.14251,-0.0031545,0.28664,0.69046,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT,1
HP_SELF_INJURIOUS_BEHAVIOR,SET,166,-0.03356,-0.0031767,0.067503,0.69046,HP_SELF_INJURIOUS_BEHAVIOR,1
GARCIA_TARGETS_OF_FLI1_AND_D...2,SET,46,-0.055693,-0.0027842,0.11201,0.69047,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,1
HP_ABNORMAL_NASAL_MUCOSA_MOR...,SET,69,-0.050755,-0.0031056,0.10207,0.69049,HP_ABNORMAL_NASAL_MUCOSA_MORPHOLOGY,1
GOBP_REGULATION_OF_NITRIC_OX...1,SET,6,-0.18505,-0.0033447,0.37211,0.69051,GOBP_REGULATION_OF_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,1
WP_MAPK_AND_NFKB_SIGNALING_I...,SET,11,-0.12885,-0.003153,0.25908,0.69052,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,1
GOBP_NEGATIVE_REGULATION_OF_...403,SET,103,-0.043881,-0.0032774,0.088224,0.69054,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,1
GOBP_INSULIN_METABOLIC_PROCE...,SET,15,-0.11606,-0.0033159,0.23322,0.69062,GOBP_INSULIN_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...329,SET,12,-0.10988,-0.0028081,0.22077,0.69065,GOBP_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,1
GOMF_INOSITOL_PHOSPHATE_KINA...,SET,11,-0.11001,-0.0026919,0.22102,0.69066,GOMF_INOSITOL_PHOSPHATE_KINASE_ACTIVITY,1
HP_HYPOCHROMIC_ANEMIA,SET,51,-0.059913,-0.0031533,0.12035,0.69069,HP_HYPOCHROMIC_ANEMIA,1
HP_ABSENT_FOREARM_BONE,SET,24,-0.087945,-0.0031776,0.17664,0.69071,HP_ABSENT_FOREARM_BONE,1
HP_REDUCED_C_PEPTIDE_LEVEL,SET,7,-0.17751,-0.0034655,0.35645,0.69076,HP_REDUCED_C_PEPTIDE_LEVEL,1
MIR4739,SET,127,-0.039234,-0.0032518,0.078777,0.69077,MIR4739,1
GOBP_POST_ANAL_TAIL_MORPHOGE...,SET,18,-0.10121,-0.0031674,0.20321,0.69077,GOBP_POST_ANAL_TAIL_MORPHOGENESIS,1
BIOCARTA_TFF_PATHWAY,SET,24,-0.089249,-0.0032247,0.17913,0.69084,BIOCARTA_TFF_PATHWAY,1
GOBP_PROTEIN_TARGETING_TO_MI...,SET,96,-0.042144,-0.0030395,0.084565,0.69088,GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION,1
HP_ABNORMAL_PROPORTION_OF_CD...1,SET,26,-0.083448,-0.0031381,0.16744,0.69089,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_HELPER_T_CELLS,1
GSE369_PRE_VS_POST_IL6_INJEC...2,SET,176,-0.031913,-0.0031096,0.064029,0.6909,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP,1
MIR20A_5P,SET,623,-0.017594,-0.0031854,0.035284,0.69097,MIR20A_5P,1
GOBP_POSITIVE_REGULATION_OF_...423,SET,4,-0.19509,-0.0028793,0.39124,0.69098,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_ANERGY,1
GSE37534_UNTREATED_VS_PIOGLI...2,SET,176,-0.031225,-0.0030425,0.062614,0.691,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,1
GOMF_OXIDOREDUCTASE_ACTIVITY...35,SET,17,-0.11509,-0.0035004,0.23072,0.69104,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS,1
GOMF_CALCIUM_ION_TRANSMEMBRA...,SET,135,-0.038359,-0.0032771,0.076857,0.69114,GOMF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_SYNKINESIS,SET,28,-0.086874,-0.00339,0.17405,0.69115,HP_SYNKINESIS,1
PIEPOLI_LGI1_TARGETS_DN,SET,12,-0.1318,-0.0033684,0.26403,0.69117,PIEPOLI_LGI1_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...304,SET,3,-0.2772,-0.0035431,0.55521,0.6912,GOBP_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT,1
HP_LISSENCEPHALY,SET,166,-0.032683,-0.0030936,0.065462,0.6912,HP_LISSENCEPHALY,1
REACTOME_FCERI_MEDIATED_NF_K...,SET,76,-0.045293,-0.002908,0.090708,0.69122,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1
GOBP_NEGATIVE_REGULATION_OF_...291,SET,10,-0.133,-0.003103,0.26633,0.69124,GOBP_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,1
VERRECCHIA_RESPONSE_TO_TGFB1...3,SET,14,-0.12102,-0.0033406,0.24227,0.69129,VERRECCHIA_RESPONSE_TO_TGFB1_C3,1
GOBP_NEGATIVE_REGULATION_OF_...257,SET,12,-0.12104,-0.0030935,0.24229,0.69131,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT,1
MIR1294,SET,150,-0.035423,-0.0031887,0.070898,0.69133,MIR1294,1
GSE37532_VISCERAL_ADIPOSE_TI...4,SET,156,-0.031689,-0.0029086,0.06341,0.69137,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP,1
PID_AURORA_A_PATHWAY,SET,31,-0.072964,-0.0029956,0.14594,0.69144,PID_AURORA_A_PATHWAY,1
WP_7Q1123_COPY_NUMBER_VARIAT...,SET,86,-0.048016,-0.0032785,0.096042,0.69144,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SET,104,-0.042921,-0.0032212,0.085815,0.69152,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1
GSE17721_0.5H_VS_12H_GARDIQU...1,SET,189,-0.030859,-0.0031148,0.061666,0.69161,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN,1
REACTOME_PEPTIDE_LIGAND_BIND...,SET,180,-0.036756,-0.0036215,0.073444,0.69162,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1
REACTOME_RESOLUTION_OF_SISTE...,SET,113,-0.039589,-0.0030963,0.079107,0.69162,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,1
MIR4683,SET,47,-0.065898,-0.0033299,0.13167,0.69163,MIR4683,1
GOBP_VASCULAR_ASSOCIATED_SMO...2,SET,11,-0.14842,-0.0036319,0.29652,0.69165,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEVELOPMENT,1
MIR302B_5P,SET,187,-0.031574,-0.0031702,0.063075,0.69166,MIR302B_5P,1
GOBP_REGULATION_OF_INOSITOL_...2,SET,15,-0.12189,-0.0034825,0.2435,0.69166,GOBP_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
MIR504_5P,SET,53,-0.058018,-0.0031127,0.11588,0.69169,MIR504_5P,1
HP_RIGHT_BUNDLE_BRANCH_BLOCK,SET,50,-0.059056,-0.0030776,0.11794,0.69171,HP_RIGHT_BUNDLE_BRANCH_BLOCK,1
GOBP_LUNG_LOBE_DEVELOPMENT,SET,7,-0.19624,-0.003831,0.3919,0.69172,GOBP_LUNG_LOBE_DEVELOPMENT,1
HU_FETAL_RETINA_MICROGLIA,SET,338,-0.024358,-0.0032744,0.048636,0.69175,HU_FETAL_RETINA_MICROGLIA,1
GOBP_REGULATION_OF_DNA_TEMPL...3,SET,94,-0.041779,-0.0029817,0.083411,0.69177,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
REACTOME_ACYL_CHAIN_REMODELI...2,SET,5,-0.20567,-0.0033935,0.41041,0.69185,REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG,1
ABRAHAM_ALPC_VS_MULTIPLE_MYE...2,SET,24,-0.091517,-0.0033066,0.18261,0.69187,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,1
NEMETH_INFLAMMATORY_RESPONSE...2,SET,76,-0.053229,-0.0034176,0.1062,0.69188,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,1
WIERENGA_STAT5A_TARGETS_DN,SET,175,-0.033669,-0.0032714,0.067177,0.69188,WIERENGA_STAT5A_TARGETS_DN,1
GOBP_PROTEIN_MATURATION,SET,489,-0.019179,-0.003088,0.038264,0.69189,GOBP_PROTEIN_MATURATION,1
GOBP_REGULATION_OF_INTRINSIC...5,SET,3,-0.2181,-0.0027877,0.43513,0.69189,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,1
HP_PSEUDOHYPOALDOSTERONISM,SET,6,-0.18812,-0.0034002,0.37533,0.69189,HP_PSEUDOHYPOALDOSTERONISM,1
WP_OXIDATION_BY_CYTOCHROME_P...,SET,61,-0.062016,-0.0035687,0.12372,0.6919,WP_OXIDATION_BY_CYTOCHROME_P450,1
GOCC_AP_2_ADAPTOR_COMPLEX,SET,11,-0.13032,-0.003189,0.25995,0.69193,GOCC_AP_2_ADAPTOR_COMPLEX,1
KEGG_MEDICUS_REFERENCE_TGFA_...1,SET,9,-0.14844,-0.0032856,0.296,0.69198,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY,1
HP_APLASIA_INVOLVING_BONES_O...2,SET,13,-0.12218,-0.0032499,0.24361,0.692,HP_APLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
PID_AP1_PATHWAY,SET,68,-0.055235,-0.0033553,0.11011,0.69204,PID_AP1_PATHWAY,1
GOBP_TRIGLYCERIDE_CATABOLIC_...,SET,26,-0.093515,-0.0035166,0.18642,0.69204,GOBP_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GSE11864_CSF1_VS_CSF1_IFNG_I...2,SET,161,-0.033358,-0.0031101,0.066491,0.69206,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP,1
GOBP_POSITIVE_REGULATION_OF_...322,SET,4,-0.25453,-0.0037566,0.5073,0.69207,GOBP_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,1
HP_ABNORMAL_TUBULAR_BASEMENT...,SET,5,-0.17894,-0.0029525,0.35663,0.69207,HP_ABNORMAL_TUBULAR_BASEMENT_MEMBRANE_MORPHOLOGY,1
HP_SCANNING_SPEECH,SET,14,-0.12573,-0.0034705,0.25053,0.69211,HP_SCANNING_SPEECH,1
GOBP_NEGATIVE_REGULATION_OF_...640,SET,61,-0.053071,-0.003054,0.10572,0.69216,GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING,1
REACTOME_SIGNALING_BY_TYPE_1...,SET,52,-0.059992,-0.0031882,0.1195,0.69217,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1
HP_STAGE_5_CHRONIC_KIDNEY_DI...,SET,124,-0.037585,-0.0030784,0.074854,0.6922,HP_STAGE_5_CHRONIC_KIDNEY_DISEASE,1
GSE7852_TREG_VS_TCONV_LN_UP,SET,177,-0.033265,-0.0032504,0.066227,0.69226,GSE7852_TREG_VS_TCONV_LN_UP,1
SA_PROGRAMMED_CELL_DEATH,SET,12,-0.12312,-0.0031465,0.24509,0.69228,SA_PROGRAMMED_CELL_DEATH,1
GSE21927_BALBC_VS_C57BL6_MON...4,SET,181,-0.029905,-0.0029545,0.059531,0.69228,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP,1
MIR3682_3P,SET,72,-0.051126,-0.0031954,0.10177,0.69229,MIR3682_3P,1
GOBP_TRAIL_ACTIVATED_APOPTOT...,SET,9,-0.13997,-0.0030983,0.27861,0.6923,GOBP_TRAIL_ACTIVATED_APOPTOTIC_SIGNALING_PATHWAY,1
GOMF_NF_KAPPAB_BINDING,SET,28,-0.074904,-0.0029229,0.1491,0.6923,GOMF_NF_KAPPAB_BINDING,1
MIR3617_3P,SET,79,-0.048378,-0.0031666,0.096286,0.69232,MIR3617_3P,1
MZF1_02,SET,220,-0.029135,-0.0031701,0.057967,0.69238,MZF1_02,1
GSE5099_DAY3_VS_DAY7_MCSF_TR...2,SET,169,-0.032505,-0.0031042,0.064671,0.69238,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...602,SET,39,-0.073785,-0.003397,0.14679,0.69239,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
GOBP_GLOMERULAR_MESANGIAL_CE...1,SET,4,-0.22308,-0.0032924,0.44378,0.69241,GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT,1
BERENJENO_TRANSFORMED_BY_RHO...5,SET,8,-0.1785,-0.0037252,0.35502,0.69244,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,1
GOMF_PRENYLTRANSFERASE_ACTIV...,SET,16,-0.10385,-0.0030642,0.20654,0.69244,GOMF_PRENYLTRANSFERASE_ACTIVITY,1
GOBP_MAGNESIUM_ION_HOMEOSTAS...,SET,10,-0.13347,-0.0031141,0.26539,0.69249,GOBP_MAGNESIUM_ION_HOMEOSTASIS,1
GAVISH_3CA_METAPROGRAM_EPITH...6,SET,45,-0.068906,-0.0034072,0.137,0.6925,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1,1
GOBP_REGULATION_OF_SKELETAL_...6,SET,7,-0.15624,-0.0030502,0.31055,0.69255,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,1
GOBP_ARGININE_CATABOLIC_PROC...,SET,9,-0.1606,-0.0035549,0.31918,0.69257,GOBP_ARGININE_CATABOLIC_PROCESS,1
GOBP_SPLICEOSOMAL_CONFORMATI...,SET,4,-0.18477,-0.0027269,0.36722,0.69257,GOBP_SPLICEOSOMAL_CONFORMATIONAL_CHANGES_TO_GENERATE_CATALYTIC_CONFORMATION,1
GOBP_SKELETAL_MUSCLE_SATELLI...4,SET,16,-0.098125,-0.0028954,0.195,0.69258,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,1
HP_ABNORMAL_POSTURING,SET,5,-0.17809,-0.0029385,0.35383,0.69263,HP_ABNORMAL_POSTURING,1
HP_APLASIA_OF_THE_DISTAL_PHA...,SET,5,-0.17469,-0.0028824,0.34701,0.69266,HP_APLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
GOBP_MYELOID_LEUKOCYTE_ACTIV...,SET,223,-0.030662,-0.0033586,0.060895,0.6927,GOBP_MYELOID_LEUKOCYTE_ACTIVATION,1
MIR203B_5P,SET,64,-0.054517,-0.0032131,0.10826,0.69271,MIR203B_5P,1
GSE22589_HEALTHY_VS_SIV_INFE...1,SET,186,-0.032411,-0.0032456,0.064353,0.69274,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN,1
GOBP_REGULATION_OF_DENDRITIC...6,SET,41,-0.070795,-0.0033417,0.14053,0.69279,GOBP_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
GSE17721_POLYIC_VS_CPG_16H_B...2,SET,184,-0.031412,-0.0031289,0.062349,0.6928,GSE17721_POLYIC_VS_CPG_16H_BMDC_UP,1
MIR3615,SET,8,-0.17082,-0.003565,0.33905,0.69281,MIR3615,1
HP_ABNORMAL_CIRCULATING_GONA...,SET,110,-0.04158,-0.0032088,0.082525,0.69281,HP_ABNORMAL_CIRCULATING_GONADOTROPIN_CONCENTRATION,1
MIR6748_5P,SET,59,-0.057299,-0.0032429,0.11371,0.69283,MIR6748_5P,1
GOMF_ODORANT_BINDING,SET,95,-0.061136,-0.0043863,0.12132,0.69284,GOMF_ODORANT_BINDING,1
GSE17974_1H_VS_72H_UNTREATED...1,SET,178,-0.029622,-0.0029025,0.058783,0.69284,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
GOMF_SIGNALING_RECEPTOR_INHI...,SET,27,-0.088071,-0.0033749,0.17472,0.69289,GOMF_SIGNALING_RECEPTOR_INHIBITOR_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...1,SET,13,-0.11355,-0.0030204,0.22524,0.69291,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION,1
GOMF_PROTEIN_GLUTAMINE_GAMMA...,SET,9,-0.15196,-0.0033636,0.30144,0.69291,GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY,1
HP_ABNORMAL_FEMORAL_TORSION,SET,9,-0.13266,-0.0029365,0.26306,0.69297,HP_ABNORMAL_FEMORAL_TORSION,1
GOBP_REGULATION_OF_INTRINSIC...3,SET,35,-0.07072,-0.0030848,0.14021,0.693,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,1
HP_RECURRENT_ENTEROVIRAL_INF...,SET,3,-0.25126,-0.0032115,0.49781,0.69312,HP_RECURRENT_ENTEROVIRAL_INFECTIONS,1
GSE17721_0.5H_VS_8H_LPS_BMDC...1,SET,180,-0.032144,-0.0031671,0.063688,0.69312,GSE17721_0.5H_VS_8H_LPS_BMDC_DN,1
GSE17721_CPG_VS_GARDIQUIMOD_...5,SET,180,-0.031141,-0.0030683,0.061695,0.69313,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN,1
GSE19401_PLN_VS_PEYERS_PATCH...1,SET,186,-0.030549,-0.0030592,0.060499,0.6932,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN,1
MIR6885_3P,SET,364,-0.023204,-0.0032346,0.045949,0.69321,MIR6885_3P,1
CHIANG_LIVER_CANCER_SUBCLASS...3,SET,46,-0.064015,-0.0032002,0.12675,0.69323,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,1
GOBP_RESPONSE_TO_BLUE_LIGHT,SET,6,-0.16921,-0.0030585,0.33493,0.69329,GOBP_RESPONSE_TO_BLUE_LIGHT,1
REACTOME_SYNTHESIS_OF_PYROPH...,SET,8,-0.13089,-0.0027316,0.25907,0.6933,REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,1
GOMF_DNA_BINDING_BENDING,SET,17,-0.11481,-0.0034919,0.22724,0.6933,GOMF_DNA_BINDING_BENDING,1
HDAC4_TARGET_GENES,SET,516,-0.019728,-0.0032606,0.039046,0.69331,HDAC4_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_TGF_B...,SET,8,-0.17183,-0.003586,0.34006,0.69332,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY,1
GSE10239_NAIVE_VS_KLRG1INT_E...2,SET,181,-0.031473,-0.0031095,0.062286,0.69332,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP,1
VANDESLUIS_COMMD1_TARGETS_GR...1,SET,15,-0.1125,-0.0032143,0.22263,0.69333,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,1
HP_PARATHYROID_HYPERPLASIA,SET,10,-0.1413,-0.0032969,0.27958,0.69336,HP_PARATHYROID_HYPERPLASIA,1
GOBP_POSITIVE_REGULATION_OF_...732,SET,7,-0.14111,-0.0027548,0.27912,0.69341,GOBP_POSITIVE_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...703,SET,8,-0.17877,-0.0037308,0.35357,0.69343,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,1
KEGG_MEDICUS_VARIANT_AMPLIFI...6,SET,9,-0.14491,-0.0032077,0.28656,0.69346,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY,1
REACTOME_HS_GAG_BIOSYNTHESIS,SET,28,-0.091542,-0.0035722,0.18098,0.6935,REACTOME_HS_GAG_BIOSYNTHESIS,1
HP_PROMINENT_NASAL_BRIDGE,SET,202,-0.029162,-0.003042,0.057643,0.69353,HP_PROMINENT_NASAL_BRIDGE,1
GOBP_MAMMALIAN_OOGENESIS_STA...,SET,12,-0.13775,-0.0035206,0.27223,0.69357,GOBP_MAMMALIAN_OOGENESIS_STAGE,1
GOBP_NEGATIVE_REGULATION_OF_...16,SET,25,-0.091013,-0.0033562,0.17985,0.69359,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOMF_PHOSPHOTYROSINE_RESIDUE...,SET,45,-0.065661,-0.0032467,0.12972,0.69364,GOMF_PHOSPHOTYROSINE_RESIDUE_BINDING,1
GSE5589_WT_VS_IL10_KO_LPS_AN...4,SET,176,-0.031672,-0.0030861,0.062567,0.69364,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
GOBP_MALE_GENITALIA_DEVELOPM...,SET,23,-0.098877,-0.0034974,0.19523,0.69374,GOBP_MALE_GENITALIA_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...419,SET,6,-0.20824,-0.0037638,0.41111,0.69375,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,1
HP_VENTRICULAR_ARRHYTHMIA,SET,188,-0.031875,-0.0032089,0.062926,0.69376,HP_VENTRICULAR_ARRHYTHMIA,1
HP_APLASIA_HYPOPLASIA_OF_THE...1,SET,28,-0.084281,-0.0032888,0.16636,0.69379,HP_APLASIA_HYPOPLASIA_OF_THE_1ST_METACARPAL,1
OUILLETTE_CLL_13Q14_DELETION...1,SET,47,-0.064541,-0.0032613,0.12735,0.69384,OUILLETTE_CLL_13Q14_DELETION_DN,1
BYSTRYKH_HEMATOPOIESIS_STEM_...6,SET,121,-0.037777,-0.0030567,0.074533,0.69387,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,1
REACTOME_O_LINKED_GLYCOSYLAT...1,SET,100,-0.047422,-0.0034903,0.09356,0.69387,REACTOME_O_LINKED_GLYCOSYLATION,1
GOBP_LATERAL_SPROUTING_FROM_...,SET,9,-0.1663,-0.003681,0.32804,0.6939,GOBP_LATERAL_SPROUTING_FROM_AN_EPITHELIUM,1
REACTOME_ZYGOTIC_GENOME_ACTI...,SET,13,-0.12058,-0.0032073,0.23778,0.69395,REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA,1
HP_SLOWLY_PROGRESSIVE,SET,141,-0.036339,-0.0031723,0.071649,0.69399,HP_SLOWLY_PROGRESSIVE,1
WEINBERGER_BLOOD_TWINRIX_AGE...2,SET,7,-0.1791,-0.0034964,0.35306,0.69402,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_30_PRIMARY_VACC_1DY_POSITIVE,1
JAEGER_METASTASIS_UP,SET,38,-0.07206,-0.0032749,0.14205,0.69403,JAEGER_METASTASIS_UP,1
GOBP_REGULATION_OF_SUPRAMOLE...,SET,335,-0.023592,-0.0031575,0.046501,0.69404,GOBP_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,1
GAVISH_3CA_METAPROGRAM_CD4_T...4,SET,46,-0.059815,-0.0029903,0.11789,0.69405,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_GLYCOLYSIS_MYC,1
GOBP_NEGATIVE_REGULATION_OF_...486,SET,19,-0.089532,-0.0028787,0.17641,0.6941,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,1
MIR6862_3P,SET,26,-0.078295,-0.0029443,0.15424,0.69413,MIR6862_3P,1
HP_ABNORMAL_BLOOD_VESSEL_MOR...,SET,854,-0.015278,-0.0032174,0.030093,0.69416,HP_ABNORMAL_BLOOD_VESSEL_MORPHOLOGY,1
HP_RECURRENT_URINARY_TRACT_I...,SET,143,-0.036358,-0.0031962,0.07161,0.69417,HP_RECURRENT_URINARY_TRACT_INFECTIONS,1
GOBP_BILE_ACID_AND_BILE_SALT...,SET,29,-0.082181,-0.0032636,0.16183,0.69421,GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT,1
GOMF_SEQUENCE_SPECIFIC_SINGL...,SET,12,-0.11464,-0.0029298,0.22563,0.69429,GOMF_SEQUENCE_SPECIFIC_SINGLE_STRANDED_DNA_BINDING,1
GSE37301_CD4_TCELL_VS_GRANUL...2,SET,148,-0.036434,-0.003258,0.071709,0.6943,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
GCM_MAPK10,SET,73,-0.052556,-0.0033073,0.10344,0.69431,GCM_MAPK10,1
GOBP_POSITIVE_REGULATION_OF_...794,SET,18,-0.10894,-0.0034093,0.21438,0.69432,GOBP_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
GAVISH_3CA_MALIGNANT_METAPRO...14,SET,49,-0.069866,-0.0036045,0.13748,0.69434,GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2,1
GOBP_POSITIVE_REGULATION_OF_...415,SET,10,-0.14457,-0.0033731,0.28442,0.69437,GOBP_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
LOPEZ_MBD_TARGETS,SET,861,-0.014393,-0.0030429,0.028302,0.69446,LOPEZ_MBD_TARGETS,1
GOBP_REGULATION_OF_CELL_CHEM...,SET,5,-0.20869,-0.0034434,0.41022,0.69452,GOBP_REGULATION_OF_CELL_CHEMOTAXIS_TO_FIBROBLAST_GROWTH_FACTOR,1
REACTOME_BUDDING_AND_MATURAT...,SET,27,-0.080146,-0.0030712,0.15754,0.69453,REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,1
HP_PARATHYROID_CARCINOMA,SET,7,-0.176,-0.003436,0.34596,0.69453,HP_PARATHYROID_CARCINOMA,1
LMTK3_TARGET_GENES,SET,426,-0.021598,-0.0032516,0.042438,0.6946,LMTK3_TARGET_GENES,1
MIR6077,SET,220,-0.029327,-0.003191,0.057619,0.69461,MIR6077,1
HP_SYNOSTOSIS_OF_JOINTS,SET,171,-0.034114,-0.0032768,0.066997,0.69468,HP_SYNOSTOSIS_OF_JOINTS,1
GSE2585_THYMIC_DC_VS_THYMIC_...2,SET,158,-0.035332,-0.0032635,0.069387,0.69469,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP,1
GSE16385_MONOCYTE_VS_MACROPH...2,SET,178,-0.032281,-0.003163,0.063364,0.69478,GSE16385_MONOCYTE_VS_MACROPHAGE_UP,1
GOMF_CALCIUM_DEPENDENT_PROTE...3,SET,7,-0.12605,-0.0024609,0.24742,0.69479,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,1
GOBP_SATELLITE_CELL_ACTIVATI...,SET,6,-0.16356,-0.0029562,0.3209,0.69486,GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
GSE2770_IL12_VS_IL4_TREATED_...2,SET,128,-0.036773,-0.0030597,0.072145,0.69487,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
GOBP_LOBAR_BRONCHUS_EPITHELI...,SET,5,-0.22355,-0.0036887,0.43856,0.69488,GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT,1
SRF_Q4,SET,202,-0.031799,-0.0033171,0.062382,0.69489,SRF_Q4,1
GOMF_ACYL_COA_HYDROLASE_ACTI...,SET,22,-0.093365,-0.00323,0.18315,0.69489,GOMF_ACYL_COA_HYDROLASE_ACTIVITY,1
GNF2_ICAM3,SET,34,-0.073104,-0.003143,0.14339,0.69491,GNF2_ICAM3,1
HP_RENOVASCULAR_HYPERTENSION,SET,25,-0.089274,-0.003292,0.17509,0.69492,HP_RENOVASCULAR_HYPERTENSION,1
GSE18791_CTRL_VS_NEWCASTLE_V...11,SET,150,-0.036404,-0.003277,0.071398,0.69493,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN,1
GSE17974_0.5H_VS_72H_IL4_AND...2,SET,178,-0.032567,-0.003191,0.063848,0.69499,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,1
LAKE_ADULT_KIDNEY_C26_MESANG...,SET,164,-0.036497,-0.0034339,0.071554,0.69499,LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS,1
YEMELYANOV_GR_TARGETS_DN,SET,10,-0.13985,-0.0032629,0.27413,0.69503,YEMELYANOV_GR_TARGETS_DN,1
MODULE_403,SET,43,-0.063301,-0.0030599,0.12405,0.69507,MODULE_403,1
GOBP_ADENYLATE_CYCLASE_ACTIV...1,SET,23,-0.099461,-0.0035181,0.19491,0.69507,GOBP_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
HP_EPIDERMAL_ACANTHOSIS,SET,49,-0.064189,-0.0033116,0.12577,0.6951,HP_EPIDERMAL_ACANTHOSIS,1
GOBP_REGULATION_OF_RESPONSE_...8,SET,16,-0.11438,-0.0033751,0.22409,0.69512,GOBP_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS,1
REACTOME_MITOTIC_G2_G2_M_PHA...,SET,187,-0.029687,-0.0029808,0.058159,0.69513,REACTOME_MITOTIC_G2_G2_M_PHASES,1
GOBP_T_HELPER_CELL_LINEAGE_C...,SET,23,-0.10262,-0.0036299,0.20104,0.69513,GOBP_T_HELPER_CELL_LINEAGE_COMMITMENT,1
HP_INTRINSIC_HAND_MUSCLE_ATR...,SET,24,-0.093074,-0.0033629,0.18229,0.69517,HP_INTRINSIC_HAND_MUSCLE_ATROPHY,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD...2,SET,57,-0.063228,-0.0035175,0.1238,0.69523,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1
GOBP_NEGATIVE_REGULATION_OF_...290,SET,472,-0.020912,-0.0033097,0.040938,0.69526,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,1
MIR1272,SET,80,-0.046753,-0.0030794,0.091493,0.69532,MIR1272,1
GOBP_POSITIVE_REGULATION_OF_...308,SET,40,-0.074121,-0.0034559,0.14502,0.69536,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
HP_GRAY_MATTER_HETEROTOPIA,SET,111,-0.038391,-0.002976,0.075113,0.69536,HP_GRAY_MATTER_HETEROTOPIA,1
GSE7460_TREG_VS_TCONV_ACT_UP,SET,175,-0.034208,-0.0033238,0.066922,0.69538,GSE7460_TREG_VS_TCONV_ACT_UP,1
HP_PSYCHOSIS,SET,94,-0.046839,-0.0033429,0.091578,0.69548,HP_PSYCHOSIS,1
GSE13485_PRE_VS_POST_YF17D_V...2,SET,167,-0.033442,-0.0031749,0.065387,0.69548,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...14,SET,8,-0.15831,-0.0033038,0.30951,0.69549,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY,1
GOMF_DEOXYNUCLEOSIDE_KINASE_...,SET,5,-0.18908,-0.0031199,0.36967,0.69549,GOMF_DEOXYNUCLEOSIDE_KINASE_ACTIVITY,1
HP_ANGIOEDEMA,SET,12,-0.14695,-0.0037555,0.28728,0.6955,HP_ANGIOEDEMA,1
GOBP_NEGATIVE_REGULATION_OF_...300,SET,6,-0.17455,-0.003155,0.34121,0.69552,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,1
MODULE_345,SET,110,-0.042073,-0.0032469,0.082238,0.69553,MODULE_345,1
HP_LACTOSE_INTOLERANCE,SET,5,-0.20253,-0.0033418,0.39578,0.69558,HP_LACTOSE_INTOLERANCE,1
KEGG_CYSTEINE_AND_METHIONINE...,SET,32,-0.085696,-0.0035745,0.16745,0.69559,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,1
chr2q21,SET,33,-0.15496,-0.0065637,0.30276,0.69561,chr2q21,1
GOBP_REGULATION_OF_ANATOMICA...2,SET,444,-0.021611,-0.0033198,0.042219,0.69563,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE,1
GOBP_POSITIVE_REGULATION_OF_...111,SET,29,-0.083357,-0.0033102,0.1627,0.69579,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,1
GNF2_CASP4,SET,21,-0.098119,-0.0033165,0.1915,0.6958,GNF2_CASP4,1
GOCC_CD40_RECEPTOR_COMPLEX,SET,11,-0.1211,-0.0029634,0.23633,0.69583,GOCC_CD40_RECEPTOR_COMPLEX,1
GSE22103_LPS_VS_GMCSF_AND_IF...1,SET,187,-0.031281,-0.0031408,0.061035,0.69585,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,1
HP_ABSENT_PALMAR_CREASE,SET,13,-0.12368,-0.00329,0.24117,0.69597,HP_ABSENT_PALMAR_CREASE,1
BROCKE_APOPTOSIS_REVERSED_BY...,SET,136,-0.038513,-0.0033024,0.075071,0.69603,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1
EINAV_INTERFERON_SIGNATURE_I...,SET,27,-0.084498,-0.003238,0.1647,0.69603,EINAV_INTERFERON_SIGNATURE_IN_CANCER,1
KRAS.KIDNEY_UP.V1_UP,SET,127,-0.043536,-0.0036083,0.084862,0.69603,KRAS.KIDNEY_UP.V1_UP,1
GOCC_EXTRINSIC_COMPONENT_OF_...9,SET,13,-0.11214,-0.002983,0.21857,0.69605,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_MEMBRANE,1
GSE19923_E2A_KO_VS_E2A_AND_H...1,SET,182,-0.033524,-0.0033211,0.065328,0.69608,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN,1
RAMPON_ENRICHED_LEARNING_ENV...2,SET,14,-0.11124,-0.0030705,0.21675,0.69609,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,1
DARWICHE_PAPILLOMA_RISK_LOW_...1,SET,152,-0.034597,-0.0031349,0.067396,0.69614,DARWICHE_PAPILLOMA_RISK_LOW_DN,1
GOBP_REGULATION_OF_NATURAL_K...5,SET,49,-0.067952,-0.0035058,0.13237,0.69614,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
MIR3928_5P,SET,93,-0.046194,-0.0032793,0.089981,0.69615,MIR3928_5P,1
GOBP_FOREBRAIN_VENTRICULAR_Z...,SET,5,-0.23764,-0.0039211,0.46286,0.69617,GOBP_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION,1
HP_ABNORMAL_ARTERIAL_PHYSIOL...,SET,154,-0.036589,-0.0033369,0.071264,0.69617,HP_ABNORMAL_ARTERIAL_PHYSIOLOGY,1
HP_AXILLARY_FRECKLING,SET,5,-0.20167,-0.0033276,0.39277,0.69618,HP_AXILLARY_FRECKLING,1
LAKE_ADULT_KIDNEY_C18_COLLEC...,SET,295,-0.025588,-0.0032173,0.049832,0.69619,LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA,1
DIAZ_CHRONIC_MYELOGENOUS_LEU...1,SET,106,-0.044919,-0.0034032,0.087461,0.69623,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1
WP_GANGLIO_SPHINGOLIPID_META...,SET,13,-0.132,-0.0035111,0.25675,0.6964,WP_GANGLIO_SPHINGOLIPID_METABOLISM,1
WHITFIELD_CELL_CYCLE_G1_S,SET,117,-0.037869,-0.0030134,0.073659,0.69641,WHITFIELD_CELL_CYCLE_G1_S,1
REACTOME_INSERTION_OF_TAIL_A...,SET,18,-0.099625,-0.0031178,0.19376,0.69643,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,1
KEGG_MEDICUS_REFERENCE_P15_C...,SET,13,-0.10969,-0.0029178,0.2133,0.69646,KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S,1
HP_CORNEAL_SCARRING,SET,19,-0.0985,-0.003167,0.19151,0.69649,HP_CORNEAL_SCARRING,1
REACTOME_RHOBTB_GTPASE_CYCLE,SET,34,-0.070162,-0.0030165,0.13641,0.6965,REACTOME_RHOBTB_GTPASE_CYCLE,1
HP_PATELLAR_HYPOPLASIA,SET,14,-0.12325,-0.0034021,0.23958,0.69652,HP_PATELLAR_HYPOPLASIA,1
MIR3128,SET,114,-0.040744,-0.0032006,0.079196,0.69653,MIR3128,1
GOBP_VASCULAR_PROCESS_IN_CIR...,SET,253,-0.030341,-0.003537,0.058973,0.69654,GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM,1
GOMF_RNA_POLYMERASE_I_GENERA...,SET,3,-0.24846,-0.0031757,0.48282,0.69658,GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
MIR515_5P,SET,282,-0.026567,-0.0032672,0.0516,0.69668,MIR515_5P,1
AAACCAC_MIR140,SET,98,-0.045125,-0.003288,0.087619,0.69673,AAACCAC_MIR140,1
HP_HYPOPLASIA_OF_THE_FRONTAL...,SET,33,-0.069579,-0.0029472,0.1351,0.69673,HP_HYPOPLASIA_OF_THE_FRONTAL_LOBES,1
GOMF_SIGNALING_RECEPTOR_COMP...,SET,51,-0.060301,-0.0031737,0.11705,0.69677,GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY,1
OSWALD_HEMATOPOIETIC_STEM_CE...1,SET,241,-0.028237,-0.0032139,0.054806,0.6968,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1
GSE38681_WT_VS_LYL1_KO_LYMPH...1,SET,191,-0.033034,-0.0033518,0.064113,0.69681,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,1
MIR1276,SET,163,-0.034412,-0.003228,0.066771,0.69685,MIR1276,1
GOBP_PROGESTERONE_METABOLIC_...,SET,15,-0.12124,-0.0034641,0.23524,0.69686,GOBP_PROGESTERONE_METABOLIC_PROCESS,1
GSE24634_TEFF_VS_TCONV_DAY10...2,SET,182,-0.032435,-0.0032133,0.062916,0.6969,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP,1
GRADE_COLON_AND_RECTAL_CANCE...1,SET,94,-0.046551,-0.0033223,0.090248,0.697,GRADE_COLON_AND_RECTAL_CANCER_DN,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...2,SET,5,-0.2247,-0.0037075,0.43557,0.69702,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY,1
HP_ABNORMAL_URINE_OSMOLALITY,SET,6,-0.2085,-0.0037686,0.4041,0.69706,HP_ABNORMAL_URINE_OSMOLALITY,1
HU_ANGIOGENESIS_UP,SET,20,-0.10631,-0.0035068,0.20599,0.6971,HU_ANGIOGENESIS_UP,1
HP_BLISTERING_BY_HISTOLOGICA...,SET,13,-0.11892,-0.0031632,0.2304,0.69711,HP_BLISTERING_BY_HISTOLOGICAL_LOCATION,1
MANNO_MIDBRAIN_NEUROTYPES_HP...2,SET,263,-0.027255,-0.0032386,0.052798,0.69714,MANNO_MIDBRAIN_NEUROTYPES_HPROGBP,1
REACTOME_LINOLEIC_ACID_LA_ME...,SET,7,-0.18434,-0.0035988,0.35702,0.69719,REACTOME_LINOLEIC_ACID_LA_METABOLISM,1
GSE3982_DC_VS_MAC_LPS_STIM_UP,SET,173,-0.032353,-0.0031257,0.062641,0.69724,GSE3982_DC_VS_MAC_LPS_STIM_UP,1
DESCARTES_MAIN_FETAL_SLC24A4...,SET,16,-0.12557,-0.0037051,0.24307,0.69727,DESCARTES_MAIN_FETAL_SLC24A4_PEX5L_POSITIVE_CELLS,1
HP_ABNORMAL_PELVIS_BONE_MORP...,SET,18,-0.10485,-0.0032815,0.20293,0.69731,HP_ABNORMAL_PELVIS_BONE_MORPHOLOGY,1
MIR770_5P,SET,93,-0.046821,-0.0033238,0.090601,0.69734,MIR770_5P,1
GSE17721_CTRL_VS_GARDIQUIMOD...2,SET,184,-0.032139,-0.0032012,0.062187,0.69735,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
PPARA_02,SET,124,-0.038108,-0.0031212,0.073728,0.69737,PPARA_02,1
GOMF_OXIDOREDUCTASE_ACTIVITY...9,SET,8,-0.13744,-0.0028684,0.26592,0.69737,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS,1
DEN_INTERACT_WITH_LCA5,SET,24,-0.097058,-0.0035068,0.18763,0.69752,DEN_INTERACT_WITH_LCA5,1
PETROVA_PROX1_TARGETS_DN,SET,55,-0.061026,-0.0033351,0.11796,0.69753,PETROVA_PROX1_TARGETS_DN,1
DURCHDEWALD_SKIN_CARCINOGENE...2,SET,74,-0.053283,-0.0033759,0.10299,0.69755,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1
GOBP_MICROGLIAL_CELL_ACTIVAT...,SET,5,-0.21793,-0.0035959,0.42113,0.69759,GOBP_MICROGLIAL_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GSE24574_NAIVE_VS_TCONV_CD4_...1,SET,185,-0.03106,-0.003102,0.060015,0.6976,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_LI...3,SET,32,-0.081643,-0.0034055,0.15774,0.69762,GOBP_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS,1
WP_ALLOGRAFT_REJECTION,SET,82,-0.054363,-0.0036249,0.10502,0.69764,WP_ALLOGRAFT_REJECTION,1
KUWANO_RNA_STABILIZED_BY_NO,SET,7,-0.20522,-0.0040064,0.39639,0.69767,KUWANO_RNA_STABILIZED_BY_NO,1
GSE37532_WT_VS_PPARG_KO_VISC...1,SET,180,-0.032188,-0.0031714,0.062173,0.69767,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN,1
HP_THORACIC_KYPHOSCOLIOSIS,SET,24,-0.081839,-0.0029569,0.15798,0.69778,HP_THORACIC_KYPHOSCOLIOSIS,1
WANG_LMO4_TARGETS_DN,SET,319,-0.023761,-0.0031046,0.045864,0.69779,WANG_LMO4_TARGETS_DN,1
MIR6751_5P,SET,66,-0.056327,-0.0033711,0.10872,0.69781,MIR6751_5P,1
HP_NUMEROUS_NEVI,SET,11,-0.13341,-0.0032645,0.25748,0.69782,HP_NUMEROUS_NEVI,1
GOCC_BBSOME,SET,8,-0.15628,-0.0032615,0.30155,0.69786,GOCC_BBSOME,1
GOBP_ASPARTATE_FAMILY_AMINO_...2,SET,12,-0.12846,-0.0032832,0.24778,0.69793,GOBP_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
MODULE_179,SET,420,-0.021712,-0.0032462,0.041876,0.69794,MODULE_179,1
GOCC_VACUOLAR_LUMEN,SET,160,-0.035835,-0.0033307,0.069107,0.69796,GOCC_VACUOLAR_LUMEN,1
HP_ABNORMALITY_OF_THE_PUBIC_...,SET,52,-0.060878,-0.0032353,0.1174,0.69796,HP_ABNORMALITY_OF_THE_PUBIC_HAIR,1
MIR4640_3P,SET,14,-0.10257,-0.0028312,0.19776,0.69799,MIR4640_3P,1
MIR6508_5P,SET,300,-0.025644,-0.0032511,0.049443,0.698,MIR6508_5P,1
DARWICHE_SKIN_TUMOR_PROMOTER...1,SET,174,-0.033226,-0.0032192,0.06405,0.69803,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1
RASHI_RESPONSE_TO_IONIZING_R...4,SET,45,-0.064795,-0.0032039,0.12487,0.69808,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,1
GOBP_FACIAL_NERVE_MORPHOGENE...,SET,9,-0.16716,-0.0037,0.32204,0.69814,GOBP_FACIAL_NERVE_MORPHOGENESIS,1
REACTOME_REDUCTION_OF_CYTOSO...,SET,11,-0.133,-0.0032546,0.25622,0.69815,REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS,1
WIZ_TARGET_GENES,SET,14,-0.10967,-0.0030273,0.21127,0.69815,WIZ_TARGET_GENES,1
HP_RENAL_ATROPHY,SET,7,-0.16506,-0.0032224,0.31787,0.69822,HP_RENAL_ATROPHY,1
GOBP_LOW_DENSITY_LIPOPROTEIN...2,SET,15,-0.12671,-0.0036203,0.24388,0.69831,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,1
REACTOME_ACTIVATED_NTRK2_SIG...5,SET,9,-0.13419,-0.0029704,0.25828,0.69832,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS,1
HP_ABNORMALITY_OF_THE_LARYNX,SET,192,-0.032441,-0.0033001,0.062433,0.69833,HP_ABNORMALITY_OF_THE_LARYNX,1
BIOCARTA_VEGF_PATHWAY,SET,24,-0.086147,-0.0031126,0.16577,0.69835,BIOCARTA_VEGF_PATHWAY,1
GSE17721_LPS_VS_POLYIC_12H_B...1,SET,187,-0.031841,-0.0031971,0.061264,0.69837,GSE17721_LPS_VS_POLYIC_12H_BMDC_DN,1
GOBP_ESTROGEN_METABOLIC_PROC...,SET,37,-0.07886,-0.0035366,0.15172,0.69838,GOBP_ESTROGEN_METABOLIC_PROCESS,1
HP_BONE_PAIN,SET,82,-0.051667,-0.0034452,0.099387,0.69842,HP_BONE_PAIN,1
MIR10523_5P,SET,216,-0.031121,-0.0033557,0.059859,0.69844,MIR10523_5P,1
HP_BILE_DUCT_PROLIFERATION,SET,18,-0.095677,-0.0029943,0.18402,0.69844,HP_BILE_DUCT_PROLIFERATION,1
GOBP_FOREBRAIN_GENERATION_OF...,SET,50,-0.070017,-0.0036489,0.13463,0.69848,GOBP_FOREBRAIN_GENERATION_OF_NEURONS,1
GOMF_NAD_P_H_DEHYDROGENASE_Q...,SET,5,-0.20775,-0.0034279,0.39941,0.69851,GOMF_NAD_P_H_DEHYDROGENASE_QUINONE_ACTIVITY,1
REACTOME_ELASTIC_FIBRE_FORMA...,SET,42,-0.072981,-0.0034866,0.1403,0.69853,REACTOME_ELASTIC_FIBRE_FORMATION,1
MIR6846_5P,SET,70,-0.052892,-0.0032596,0.10167,0.69854,MIR6846_5P,1
HP_ABNORMAL_LIBIDO,SET,37,-0.074851,-0.0033568,0.14384,0.6986,HP_ABNORMAL_LIBIDO,1
HP_APLASIA_HYPOPLASIA_OF_THE...45,SET,219,-0.029895,-0.0032455,0.057432,0.69865,HP_APLASIA_HYPOPLASIA_OF_THE_NAILS,1
HP_STEROETYPIC_MOVEMENTS_OF_...,SET,50,-0.061319,-0.0031956,0.11778,0.69868,HP_STEROETYPIC_MOVEMENTS_OF_FACE_AND_HEAD,1
GSE12003_MIR223_KO_VS_WT_BM_...1,SET,187,-0.033571,-0.0033707,0.064448,0.69878,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN,1
GOBP_GLUTAMATE_REUPTAKE,SET,6,-0.21166,-0.0038257,0.40627,0.69881,GOBP_GLUTAMATE_REUPTAKE,1
MIR1825,SET,149,-0.036668,-0.0032898,0.070377,0.69882,MIR1825,1
GOBP_REGULATION_OF_FIBROBLAS...1,SET,18,-0.10532,-0.003296,0.20211,0.69885,GOBP_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
GSE28783_CTRL_ANTI_MIR_VS_UN...1,SET,182,-0.034205,-0.0033887,0.065607,0.69894,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,1
STANELLE_E2F1_TARGETS,SET,26,-0.088283,-0.0033199,0.16932,0.69896,STANELLE_E2F1_TARGETS,1
GSE4142_NAIVE_VS_MEMORY_BCEL...2,SET,184,-0.034009,-0.0033875,0.065219,0.69897,GSE4142_NAIVE_VS_MEMORY_BCELL_UP,1
MIR193A_3P_MIR193B_3P,SET,79,-0.050266,-0.0032901,0.096389,0.69898,MIR193A_3P_MIR193B_3P,1
GOBP_L_ALANINE_TRANSMEMBRANE...,SET,4,-0.2331,-0.0034402,0.44695,0.699,GOBP_L_ALANINE_TRANSMEMBRANE_TRANSPORT,1
GOBP_MESENCHYME_MIGRATION,SET,5,-0.21417,-0.0035339,0.41022,0.69919,GOBP_MESENCHYME_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...422,SET,9,-0.14392,-0.0031858,0.27565,0.69921,GOBP_NEGATIVE_REGULATION_OF_MYELINATION,1
COATES_MACROPHAGE_M1_VS_M2_UP,SET,80,-0.05196,-0.0034224,0.09947,0.69929,COATES_MACROPHAGE_M1_VS_M2_UP,1
PRC2_EED_DN.V1_DN,SET,177,-0.031685,-0.003096,0.060648,0.69931,PRC2_EED_DN.V1_DN,1
HP_ABSENT_TOENAIL,SET,17,-0.10845,-0.0032985,0.20751,0.69938,HP_ABSENT_TOENAIL,1
HP_REDUCED_CEREBRAL_WHITE_MA...,SET,31,-0.081274,-0.0033368,0.15551,0.69938,HP_REDUCED_CEREBRAL_WHITE_MATTER_VOLUME,1
HP_ABNORMALITY_OF_PAIN_SENSA...,SET,90,-0.04736,-0.0033077,0.090606,0.69941,HP_ABNORMALITY_OF_PAIN_SENSATION,1
GOBP_GEPHYRIN_CLUSTERING_INV...,SET,5,-0.20442,-0.003373,0.39097,0.69946,GOBP_GEPHYRIN_CLUSTERING_INVOLVED_IN_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
BURTON_ADIPOGENESIS_7,SET,41,-0.074935,-0.0035371,0.1433,0.69948,BURTON_ADIPOGENESIS_7,1
HP_ABNORMALITY_OF_THE_TONGUE,SET,409,-0.022318,-0.0032937,0.042674,0.6995,HP_ABNORMALITY_OF_THE_TONGUE,1
HP_HYPERVENTILATION,SET,26,-0.098887,-0.0037186,0.18906,0.69952,HP_HYPERVENTILATION,1
GOBP_DEFENSE_RESPONSE_TO_GRA...2,SET,92,-0.050563,-0.0035703,0.096634,0.6996,GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,1
GOMF_FATTY_ACYL_COA_SYNTHASE...,SET,6,-0.23776,-0.0042974,0.45438,0.6996,GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY,1
SRSF9_TARGET_GENES,SET,613,-0.018395,-0.0033047,0.035149,0.69963,SRSF9_TARGET_GENES,1
GOBP_AGGRESOME_ASSEMBLY,SET,4,-0.21484,-0.0031707,0.41038,0.69969,GOBP_AGGRESOME_ASSEMBLY,1
KEGG_MEDICUS_REFERENCE_BETA_...2,SET,10,-0.14004,-0.0032674,0.26735,0.69979,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS,1
REACTOME_CALCITONIN_LIKE_LIG...,SET,9,-0.17721,-0.0039225,0.33829,0.6998,REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS,1
GOCC_DERLIN_1_RETROTRANSLOCA...,SET,7,-0.15201,-0.0029675,0.29011,0.69984,GOCC_DERLIN_1_RETROTRANSLOCATION_COMPLEX,1
TAVOR_CEBPA_TARGETS_UP,SET,47,-0.071799,-0.0036281,0.13703,0.69985,TAVOR_CEBPA_TARGETS_UP,1
GOCC_NEURON_SPINE,SET,167,-0.036387,-0.0034545,0.069441,0.69986,GOCC_NEURON_SPINE,1
WP_VITAMIN_A_AND_CAROTENOID_...,SET,42,-0.071549,-0.0034182,0.13648,0.69994,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,1
MIR1255A_MIR1255B_5P,SET,65,-0.055433,-0.0032924,0.10573,0.69995,MIR1255A_MIR1255B_5P,1
GOCC_SUMO_LIGASE_COMPLEX,SET,10,-0.1488,-0.0034717,0.28377,0.69998,GOCC_SUMO_LIGASE_COMPLEX,1
HP_ATROPHY_OF_ALVEOLAR_RIDGES,SET,3,-0.30492,-0.0038974,0.58149,0.69999,HP_ATROPHY_OF_ALVEOLAR_RIDGES,1
MODULE_382,SET,25,-0.1003,-0.0036986,0.19126,0.7,MODULE_382,1
HP_PERIORBITAL_WRINKLES,SET,4,-0.24255,-0.0035797,0.46251,0.70001,HP_PERIORBITAL_WRINKLES,1
KEGG_MEDICUS_REFERENCE_RELN_...,SET,15,-0.12044,-0.0034411,0.22964,0.70002,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,1
GOCC_CYTOPLASMIC_REGION,SET,251,-0.027948,-0.0032453,0.053288,0.70002,GOCC_CYTOPLASMIC_REGION,1
GOBP_NEGATIVE_REGULATION_OF_...378,SET,5,-0.20554,-0.0033914,0.39172,0.70011,GOBP_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
MIR12135,SET,185,-0.032969,-0.0032927,0.062827,0.70012,MIR12135,1
ZHENG_RESPONSE_TO_ARSENITE_DN,SET,11,-0.12836,-0.0031409,0.24457,0.70014,ZHENG_RESPONSE_TO_ARSENITE_DN,1
REACTOME_RESPONSE_OF_EIF2AK1...,SET,14,-0.12064,-0.0033301,0.22983,0.70018,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1
GOBP_REGULATION_OF_IMMUNE_RE...,SET,833,-0.016314,-0.0033951,0.031077,0.70019,GOBP_REGULATION_OF_IMMUNE_RESPONSE,1
REACTOME_EFFECTS_OF_PIP2_HYD...,SET,26,-0.085404,-0.0032116,0.16265,0.70023,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,1
MODULE_53,SET,360,-0.023912,-0.0033154,0.045519,0.70032,MODULE_53,1
HP_CONTRACTURE_OF_THE_PROXIM...3,SET,5,-0.19467,-0.003212,0.37048,0.70036,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_5TH_FINGER,1
GOBP_TOR_SIGNALING,SET,146,-0.036193,-0.0032147,0.068876,0.70037,GOBP_TOR_SIGNALING,1
HP_HYPERTONIA,SET,975,-0.014478,-0.0032467,0.02755,0.70039,HP_HYPERTONIA,1
MIR152_5P,SET,74,-0.053865,-0.0034128,0.10247,0.70044,MIR152_5P,1
HOEK_PBMC_INACTIVATED_INFLUE...5,SET,16,-0.11254,-0.0033209,0.21402,0.7005,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_DN,1
MIR654_5P,SET,95,-0.046573,-0.0033414,0.088561,0.70051,MIR654_5P,1
HAY_BONE_MARROW_ERYTHROBLAST,SET,1134,-0.012988,-0.0031265,0.024695,0.70052,HAY_BONE_MARROW_ERYTHROBLAST,1
HP_THINNING_OF_DESCEMET_MEMB...,SET,6,-0.21633,-0.00391,0.41109,0.70063,HP_THINNING_OF_DESCEMET_MEMBRANE,1
GOBP_G0_TO_G1_TRANSITION,SET,36,-0.075775,-0.0033521,0.14393,0.70072,GOBP_G0_TO_G1_TRANSITION,1
GOBP_REGULATION_OF_HORMONE_M...,SET,38,-0.077977,-0.0035438,0.14809,0.70074,GOBP_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...57,SET,37,-0.062729,-0.0028132,0.11913,0.70075,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
BIOCARTA_TGFB_PATHWAY,SET,19,-0.11037,-0.0035486,0.20958,0.70076,BIOCARTA_TGFB_PATHWAY,1
chr4q26,SET,15,-0.21403,-0.0061151,0.4064,0.70077,chr4q26,1
GSE4748_CTRL_VS_CYANOBACTERI...1,SET,176,-0.034625,-0.0033738,0.065747,0.70078,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN,1
GSE17974_0H_VS_24H_IN_VITRO_...1,SET,178,-0.03156,-0.0030924,0.059922,0.70079,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN,1
HP_HYPOPLASIA_OF_THE_EAR_CAR...,SET,10,-0.12271,-0.0028629,0.23295,0.70081,HP_HYPOPLASIA_OF_THE_EAR_CARTILAGE,1
REACTOME_ANDROGEN_BIOSYNTHES...,SET,11,-0.14044,-0.0034365,0.2666,0.70082,REACTOME_ANDROGEN_BIOSYNTHESIS,1
GOBP_REGULATION_OF_DENDRITIC...5,SET,11,-0.1442,-0.0035284,0.27372,0.70083,GOBP_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,1
GOBP_CELLULAR_RESPONSE_TO_HY...1,SET,63,-0.057475,-0.003361,0.10909,0.70085,GOBP_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE,1
HP_MACROCYTIC_ANEMIA,SET,63,-0.057162,-0.0033427,0.10849,0.70086,HP_MACROCYTIC_ANEMIA,1
HP_SENSORY_BEHAVIORAL_ABNORM...,SET,295,-0.026695,-0.0033566,0.050655,0.7009,HP_SENSORY_BEHAVIORAL_ABNORMALITY,1
HP_ABNORMAL_CIRCULATING_OSTE...,SET,8,-0.16939,-0.0035352,0.3214,0.70092,HP_ABNORMAL_CIRCULATING_OSTEOCALCIN_LEVEL,1
DESCARTES_FETAL_STOMACH_MESO...,SET,29,-0.093212,-0.0037016,0.17685,0.70092,DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS,1
GOBP_REGULATION_OF_CELL_MATU...,SET,22,-0.099744,-0.0034506,0.18916,0.701,GOBP_REGULATION_OF_CELL_MATURATION,1
GOBP_RIBOSOME_ASSOCIATED_UBI...,SET,7,-0.12951,-0.0025283,0.24551,0.70108,GOBP_RIBOSOME_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
ICSBP_Q6,SET,230,-0.030478,-0.0033898,0.057767,0.70111,ICSBP_Q6,1
GSE7596_AKT_TRANSD_VS_CTRL_C...2,SET,147,-0.036536,-0.0032561,0.069245,0.70112,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP,1
FOSTER_TOLERANT_MACROPHAGE_DN,SET,382,-0.024561,-0.0035057,0.046548,0.70113,FOSTER_TOLERANT_MACROPHAGE_DN,1
REACTOME_ADAPTIVE_IMMUNE_SYS...,SET,707,-0.017222,-0.0033139,0.032639,0.70113,REACTOME_ADAPTIVE_IMMUNE_SYSTEM,1
HP_EXERCISE_INDUCED_RHABDOMY...,SET,6,-0.14985,-0.0027085,0.28398,0.70114,HP_EXERCISE_INDUCED_RHABDOMYOLYSIS,1
MEIS1AHOXA9_01,SET,107,-0.048507,-0.0036922,0.0919,0.70118,MEIS1AHOXA9_01,1
HP_CROHN_S_DISEASE,SET,13,-0.15349,-0.0040829,0.29072,0.70124,HP_CROHN_S_DISEASE,1
GSE2770_TGFB_AND_IL4_VS_IL12...4,SET,173,-0.033715,-0.0032573,0.063851,0.70126,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
HP_PAROTITIS,SET,4,-0.2427,-0.0035819,0.45953,0.7013,HP_PAROTITIS,1
HP_DECREASED_CIRCULATING_CAR...,SET,22,-0.088534,-0.0030628,0.16762,0.70131,HP_DECREASED_CIRCULATING_CARNITINE_CONCENTRATION,1
MARIADASON_RESPONSE_TO_BUTYR...5,SET,40,-0.074473,-0.0034723,0.1409,0.70144,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,1
HP_TESTICULAR_DYSGENESIS,SET,10,-0.15189,-0.0035439,0.28735,0.70145,HP_TESTICULAR_DYSGENESIS,1
SCHAEFFER_PROSTATE_DEVELOPME...8,SET,14,-0.10189,-0.0028125,0.19271,0.70149,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,1
FIGUEROA_AML_METHYLATION_CLU...13,SET,4,-0.26733,-0.0039454,0.50542,0.70157,FIGUEROA_AML_METHYLATION_CLUSTER_7_DN,1
HP_MALE_HYPOGONADISM,SET,38,-0.07601,-0.0034544,0.14368,0.7016,HP_MALE_HYPOGONADISM,1
HP_DELAYED_PROXIMAL_FEMORAL_...,SET,16,-0.11424,-0.0033708,0.21592,0.70161,HP_DELAYED_PROXIMAL_FEMORAL_EPIPHYSEAL_OSSIFICATION,1
REACTOME_CLASS_I_MHC_MEDIATE...,SET,353,-0.023484,-0.0032248,0.04437,0.70169,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1
REACTOME_REGULATION_OF_PLK1_...,SET,81,-0.045833,-0.0030376,0.086592,0.7017,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1
GOBP_REGULATION_OF_EXCRETION,SET,9,-0.15951,-0.0035308,0.30122,0.70178,GOBP_REGULATION_OF_EXCRETION,1
ANDERSEN_CHOLANGIOCARCINOMA_...2,SET,171,-0.036895,-0.003544,0.069669,0.70179,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,1
GOBP_REGULATION_OF_CILIUM_BE...1,SET,15,-0.11515,-0.00329,0.21744,0.70179,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY,1
GOBP_REGULATION_OF_ICOSANOID...,SET,21,-0.10884,-0.0036789,0.20545,0.70186,GOBP_REGULATION_OF_ICOSANOID_SECRETION,1
GSE17721_CTRL_VS_POLYIC_0.5H...1,SET,187,-0.032099,-0.0032229,0.06059,0.70186,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN,1
HP_OVARIAN_GONADOBLASTOMA,SET,9,-0.15699,-0.003475,0.29632,0.70187,HP_OVARIAN_GONADOBLASTOMA,1
MIR6776_5P,SET,83,-0.048102,-0.0032269,0.090774,0.70191,MIR6776_5P,1
ALONSO_METASTASIS_UP,SET,175,-0.033725,-0.0032769,0.063633,0.70194,ALONSO_METASTASIS_UP,1
GSE16385_MONOCYTE_VS_12H_IFN...1,SET,174,-0.035011,-0.0033921,0.066033,0.70201,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,1
HP_CHRONIC_MYELOGENOUS_LEUKE...,SET,9,-0.15771,-0.0034909,0.29739,0.70205,HP_CHRONIC_MYELOGENOUS_LEUKEMIA,1
HP_SHORT_MANDIBULAR_RAMI,SET,6,-0.1927,-0.003483,0.36334,0.70206,HP_SHORT_MANDIBULAR_RAMI,1
ZHONG_PFC_C3_MICROGLIA,SET,431,-0.02252,-0.0034097,0.042461,0.70207,ZHONG_PFC_C3_MICROGLIA,1
MIR4756_5P,SET,123,-0.042539,-0.0034702,0.080198,0.70209,MIR4756_5P,1
GOMF_OXIDOREDUCTASE_ACTIVITY...5,SET,9,-0.13453,-0.0029779,0.25357,0.70213,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
GOBP_POSITIVE_REGULATION_OF_...392,SET,15,-0.13994,-0.0039984,0.26369,0.70219,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
KORKOLA_EMBRYONAL_CARCINOMA_...1,SET,9,-0.18136,-0.0040144,0.34162,0.70224,KORKOLA_EMBRYONAL_CARCINOMA_DN,1
MIR519E_5P,SET,285,-0.027218,-0.0033647,0.051272,0.70224,MIR519E_5P,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...1,SET,176,-0.033998,-0.0033127,0.064042,0.70224,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,1
IVANOVA_HEMATOPOIESIS_STEM_C...3,SET,201,-0.032673,-0.0033999,0.061527,0.7023,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1
FARMER_BREAST_CANCER_CLUSTER...6,SET,14,-0.12382,-0.0034179,0.23315,0.70232,FARMER_BREAST_CANCER_CLUSTER_6,1
MORF_BUB3,SET,242,-0.027191,-0.0031011,0.051184,0.70237,MORF_BUB3,1
HP_PERIPAPILLARY_CHORIORETIN...,SET,5,-0.225,-0.0037125,0.42349,0.70239,HP_PERIPAPILLARY_CHORIORETINAL_ATROPHY,1
REACTOME_DEFECTIVE_FACTOR_IX...,SET,7,-0.18789,-0.0036681,0.35362,0.70241,REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B,1
HP_EXCESSIVE_WRINKLED_SKIN,SET,36,-0.07234,-0.0032001,0.13614,0.70241,HP_EXCESSIVE_WRINKLED_SKIN,1
LEE_DIFFERENTIATING_T_LYMPHO...,SET,170,-0.034466,-0.0033011,0.06486,0.70242,LEE_DIFFERENTIATING_T_LYMPHOCYTE,1
GSE20484_MCSG_VS_CXCL4_MONOC...2,SET,159,-0.036107,-0.0033455,0.06795,0.70242,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP,1
KEGG_ARRHYTHMOGENIC_RIGHT_VE...,SET,70,-0.059118,-0.0036434,0.11123,0.70246,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,1
WP_ARRHYTHMOGENIC_RIGHT_VENT...,SET,70,-0.059118,-0.0036434,0.11123,0.70246,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1
RUBENSTEIN_SKELETAL_MUSCLE_P...2,SET,116,-0.043864,-0.0034756,0.082521,0.70248,RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES,1
GOBP_PHARYNGEAL_SYSTEM_DEVEL...,SET,29,-0.096985,-0.0038514,0.18238,0.70255,GOBP_PHARYNGEAL_SYSTEM_DEVELOPMENT,1
MIR6813_5P,SET,36,-0.069618,-0.0030797,0.13092,0.70256,MIR6813_5P,1
MODULE_573,SET,24,-0.096542,-0.0034882,0.18153,0.70257,MODULE_573,1
KEGG_MEDICUS_REFERENCE_CITRA...1,SET,8,-0.15148,-0.0031613,0.28477,0.70261,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,SET,86,-0.047263,-0.0032271,0.088833,0.70265,MORI_IMMATURE_B_LYMPHOCYTE_DN,1
GOMF_ALKANE_1_MONOOXYGENASE_...,SET,5,-0.21422,-0.0035347,0.40261,0.70266,GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY,1
HP_SEVERE_SHORT_LIMB_DWARFISM,SET,5,-0.2254,-0.0037191,0.42362,0.70266,HP_SEVERE_SHORT_LIMB_DWARFISM,1
DER_IFN_ALPHA_RESPONSE_DN,SET,4,-0.24652,-0.0036383,0.4633,0.70267,DER_IFN_ALPHA_RESPONSE_DN,1
WP_TNFALPHA_SIGNALING,SET,89,-0.04597,-0.0031928,0.08639,0.70268,WP_TNFALPHA_SIGNALING,1
MIR7843_3P,SET,80,-0.05218,-0.0034369,0.098047,0.7027,MIR7843_3P,1
GSE46606_UNSTIM_VS_CD40L_IL2...2,SET,171,-0.034797,-0.0033425,0.065378,0.70272,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,1
REACTOME_NEUTROPHIL_DEGRANUL...,SET,439,-0.02218,-0.0033885,0.04165,0.70282,REACTOME_NEUTROPHIL_DEGRANULATION,1
MIR532_5P,SET,68,-0.054989,-0.0033403,0.10325,0.70283,MIR532_5P,1
PACHER_TARGETS_OF_IGF1_AND_I...,SET,35,-0.085238,-0.0037181,0.16002,0.70286,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1
HP_LIPEMIA_RETINALIS,SET,3,-0.27701,-0.0035406,0.52007,0.70286,HP_LIPEMIA_RETINALIS,1
GTCAGGA_MIR378,SET,50,-0.065086,-0.0033919,0.12217,0.70289,GTCAGGA_MIR378,1
BUSSLINGER_GASTRIC_CHIEF_CEL...,SET,51,-0.066941,-0.0035232,0.12565,0.7029,BUSSLINGER_GASTRIC_CHIEF_CELLS,1
GSE23505_IL6_IL1_IL23_VS_IL6...2,SET,180,-0.033331,-0.003284,0.062543,0.70295,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
MIR188_3P,SET,139,-0.038538,-0.0033405,0.072297,0.703,MIR188_3P,1
GOCC_SHELTERIN_COMPLEX,SET,6,-0.1741,-0.0031467,0.32658,0.70301,GOCC_SHELTERIN_COMPLEX,1
BIOCARTA_PKC_PATHWAY,SET,7,-0.19548,-0.0038163,0.36657,0.70308,BIOCARTA_PKC_PATHWAY,1
GSE24492_LYVE_NEG_VS_POS_MAC...2,SET,168,-0.034291,-0.0032651,0.064301,0.70308,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP,1
GOCC_NUCLEAR_PORE_OUTER_RING,SET,10,-0.12878,-0.0030047,0.24144,0.70311,GOCC_NUCLEAR_PORE_OUTER_RING,1
HP_ABNORMAL_CHOROID_PLEXUS_M...,SET,18,-0.11858,-0.003711,0.22229,0.70313,HP_ABNORMAL_CHOROID_PLEXUS_MORPHOLOGY,1
GOBP_MITOTIC_G1_S_TRANSITION...,SET,30,-0.080063,-0.0032337,0.15006,0.70316,GOBP_MITOTIC_G1_S_TRANSITION_CHECKPOINT_SIGNALING,1
GSE17721_PAM3CSK4_VS_CPG_24H...1,SET,182,-0.032721,-0.0032416,0.061314,0.70321,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN,1
GSE19825_NAIVE_VS_IL2RALOW_D...2,SET,180,-0.035736,-0.003521,0.066963,0.70321,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP,1
REACTOME_FRS_MEDIATED_FGFR1_...,SET,23,-0.094438,-0.0033404,0.17694,0.70324,REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,1
COLLER_MYC_TARGETS_UP,SET,23,-0.098047,-0.0034681,0.18363,0.70331,COLLER_MYC_TARGETS_UP,1
MIR21_3P,SET,122,-0.042931,-0.0034879,0.0804,0.70331,MIR21_3P,1
ZWANG_EGF_INTERVAL_UP,SET,76,-0.053654,-0.0034449,0.10044,0.7034,ZWANG_EGF_INTERVAL_UP,1
PAX8_01,SET,33,-0.082288,-0.0034855,0.15403,0.70341,PAX8_01,1
GOMF_REGULATORY_RNA_BINDING,SET,38,-0.070808,-0.003218,0.13254,0.70341,GOMF_REGULATORY_RNA_BINDING,1
GOBP_URETERIC_BUD_ELONGATION,SET,7,-0.16058,-0.003135,0.30046,0.70348,GOBP_URETERIC_BUD_ELONGATION,1
GOCC_CORE_MEDIATOR_COMPLEX,SET,25,-0.081856,-0.0030185,0.15313,0.70351,GOCC_CORE_MEDIATOR_COMPLEX,1
HP_ABNORMALITY_OF_THE_NECK,SET,611,-0.018596,-0.0033355,0.034786,0.70353,HP_ABNORMALITY_OF_THE_NECK,1
HP_OSTEOCHONDRITIS_DISSECANS,SET,7,-0.18869,-0.0036837,0.35292,0.70355,HP_OSTEOCHONDRITIS_DISSECANS,1
REACTOME_ERCC6_CSB_AND_EHMT2...,SET,15,-0.10941,-0.003126,0.20462,0.70357,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,1
MIR4279,SET,198,-0.033532,-0.0034634,0.062707,0.70358,MIR4279,1
PID_IL2_STAT5_PATHWAY,SET,28,-0.088272,-0.0034446,0.16504,0.70362,PID_IL2_STAT5_PATHWAY,1
MODULE_547,SET,11,-0.14096,-0.0034491,0.26354,0.70362,MODULE_547,1
GOMF_EXTRACELLULAR_MATRIX_ST...1,SET,152,-0.039606,-0.0035887,0.074052,0.70362,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT,1
GOBP_VIRAL_GENE_EXPRESSION,SET,98,-0.043759,-0.0031885,0.081797,0.70366,GOBP_VIRAL_GENE_EXPRESSION,1
HP_OPEN_NEURAL_TUBE_DEFECT,SET,134,-0.039141,-0.0033316,0.073141,0.70372,HP_OPEN_NEURAL_TUBE_DEFECT,1
GOCC_FILOPODIUM_TIP,SET,16,-0.12105,-0.0035719,0.22619,0.70373,GOCC_FILOPODIUM_TIP,1
HP_ABNORMAL_EYELID_MORPHOLOGY,SET,1179,-0.013543,-0.0033199,0.025297,0.7038,HP_ABNORMAL_EYELID_MORPHOLOGY,1
MODULE_51,SET,36,-0.087799,-0.003884,0.16399,0.70381,MODULE_51,1
GSE39820_TGFBETA1_VS_TGFBETA...2,SET,185,-0.032099,-0.0032058,0.059951,0.70382,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP,1
REACTOME_CONSTITUTIVE_SIGNAL...1,SET,82,-0.05428,-0.0036194,0.10137,0.70384,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1
REACTOME_LONG_TERM_POTENTIAT...,SET,22,-0.10476,-0.003624,0.19563,0.70384,REACTOME_LONG_TERM_POTENTIATION,1
BONOME_OVARIAN_CANCER_SURVIV...1,SET,215,-0.03183,-0.0034242,0.059432,0.70387,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1
KEGG_MEDICUS_REFERENCE_HEPAR...1,SET,11,-0.14403,-0.0035244,0.26886,0.70392,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS,1
MIR767_3P,SET,115,-0.046687,-0.0036833,0.087135,0.70395,MIR767_3P,1
MCLACHLAN_DENTAL_CARIES_DN,SET,70,-0.057505,-0.003544,0.10732,0.70397,MCLACHLAN_DENTAL_CARIES_DN,1
GOBP_ENDOCARDIUM_DEVELOPMENT,SET,12,-0.14957,-0.0038225,0.27909,0.70399,GOBP_ENDOCARDIUM_DEVELOPMENT,1
GSE9601_UNTREATED_VS_NFKB_IN...2,SET,145,-0.039387,-0.0034864,0.073492,0.70399,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
GOBP_IMMUNE_RESPONSE_REGULAT...3,SET,478,-0.021705,-0.0034563,0.040493,0.70402,GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY,1
HP_CHILDHOOD_ONSET,SET,774,-0.016582,-0.0033322,0.030929,0.70406,HP_CHILDHOOD_ONSET,1
GOMF_FOUR_WAY_JUNCTION_DNA_B...,SET,16,-0.11008,-0.0032481,0.20531,0.70407,GOMF_FOUR_WAY_JUNCTION_DNA_BINDING,1
GSE40666_WT_VS_STAT1_KO_CD8_...1,SET,181,-0.033582,-0.0033178,0.062636,0.70407,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN,1
HP_AMBIGUOUS_GENITALIA_MALE,SET,11,-0.14008,-0.0034277,0.26115,0.70415,HP_AMBIGUOUS_GENITALIA_MALE,1
HP_PROMINENT_SUPERFICIAL_BLO...,SET,33,-0.073835,-0.0031275,0.13765,0.70415,HP_PROMINENT_SUPERFICIAL_BLOOD_VESSELS,1
GSE21670_TGFB_VS_TGFB_AND_IL...4,SET,180,-0.033962,-0.0033462,0.063295,0.70421,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
LI_PBMC_MENACTRA_AGE_18_45YO...6,SET,25,-0.10265,-0.0037852,0.19123,0.70429,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGATIVE,1
GSE13493_DP_VS_CD4INTCD8POS_...1,SET,183,-0.034081,-0.0033855,0.063464,0.70437,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN,1
MIR4745_5P,SET,79,-0.05133,-0.0033598,0.095569,0.7044,MIR4745_5P,1
GOBP_COLLECTING_DUCT_DEVELOP...,SET,15,-0.13856,-0.0039588,0.25789,0.70446,GOBP_COLLECTING_DUCT_DEVELOPMENT,1
HP_ASTHENIA,SET,8,-0.16207,-0.0033822,0.30146,0.70457,HP_ASTHENIA,1
GOBP_MEMBRANE_DISASSEMBLY,SET,12,-0.1312,-0.003353,0.24394,0.70465,GOBP_MEMBRANE_DISASSEMBLY,1
HP_PSEUDOBULBAR_PARALYSIS,SET,20,-0.10432,-0.0034412,0.19389,0.70472,HP_PSEUDOBULBAR_PARALYSIS,1
FINETTI_BREAST_CANCERS_KINOM...1,SET,20,-0.10129,-0.0033411,0.18824,0.70473,FINETTI_BREAST_CANCERS_KINOME_BLUE,1
GNF2_TNFSF10,SET,30,-0.083778,-0.0033838,0.15566,0.70479,GNF2_TNFSF10,1
GSE411_UNSTIM_VS_400MIN_IL6_...3,SET,175,-0.035368,-0.0034365,0.065712,0.70479,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
MILI_PSEUDOPODIA_HAPTOTAXIS_...2,SET,451,-0.02098,-0.0032475,0.038939,0.70498,MILI_PSEUDOPODIA_HAPTOTAXIS_UP,1
REACTOME_RND1_GTPASE_CYCLE,SET,41,-0.070341,-0.0033203,0.13055,0.70499,REACTOME_RND1_GTPASE_CYCLE,1
GOBP_POSITIVE_REGULATION_OF_...382,SET,52,-0.062104,-0.0033004,0.11525,0.70501,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOMF_VITAMIN_B6_BINDING,SET,48,-0.068173,-0.0034812,0.1265,0.70502,GOMF_VITAMIN_B6_BINDING,1
GOBP_AXONAL_TRANSPORT_OF_MIT...,SET,16,-0.11984,-0.0035363,0.2223,0.70509,GOBP_AXONAL_TRANSPORT_OF_MITOCHONDRION,1
HP_PSYCHOTIC_EPISODES,SET,15,-0.11147,-0.003185,0.20668,0.70517,HP_PSYCHOTIC_EPISODES,1
CTACCTC_LET7A_LET7B_LET7C_LE...,SET,352,-0.025036,-0.0034332,0.046415,0.70519,CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I,1
GOBP_NEGATIVE_REGULATION_OF_...565,SET,363,-0.024904,-0.003467,0.046168,0.7052,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
GOBP_DNA_BIOSYNTHETIC_PROCESS,SET,177,-0.0323,-0.0031561,0.059876,0.70521,GOBP_DNA_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_INTRI...,SET,13,-0.13379,-0.0035587,0.24796,0.70524,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY,1
HP_SYSTEMIC_LUPUS_ERYTHEMATO...,SET,29,-0.092572,-0.0036762,0.17156,0.70526,HP_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
JEON_SMAD6_TARGETS_DN,SET,19,-0.10315,-0.0033166,0.19114,0.70528,JEON_SMAD6_TARGETS_DN,1
MIR3923,SET,45,-0.068649,-0.0033945,0.12721,0.70528,MIR3923,1
GOBP_MESENCHYMAL_TO_EPITHELI...1,SET,18,-0.12772,-0.0039971,0.23666,0.70529,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION,1
GSE2770_IL12_AND_TGFB_ACT_VS...2,SET,174,-0.033896,-0.0032842,0.062745,0.70547,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP,1
GOBP_CYTOPLASMIC_MICROTUBULE...,SET,58,-0.060884,-0.0034166,0.11266,0.70554,GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION,1
GOCC_H3_HISTONE_ACETYLTRANSF...,SET,8,-0.16496,-0.0034426,0.30524,0.70554,GOCC_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX,1
REACTOME_MECP2_REGULATES_NEU...,SET,16,-0.12846,-0.0037905,0.23766,0.70557,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,1
HP_RENAL_DUPLICATION,SET,31,-0.090827,-0.003729,0.16796,0.70566,HP_RENAL_DUPLICATION,1
ONKEN_UVEAL_MELANOMA_DN,SET,473,-0.021936,-0.0034753,0.040562,0.70568,ONKEN_UVEAL_MELANOMA_DN,1
HP_CORONARY_ARTERY_ATHEROSCL...,SET,50,-0.072515,-0.003779,0.13405,0.70572,HP_CORONARY_ARTERY_ATHEROSCLEROSIS,1
MUELLER_COMMON_TARGETS_OF_AM...2,SET,12,-0.13992,-0.003576,0.25864,0.70574,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,1
BIOCARTA_IL4_PATHWAY,SET,10,-0.15365,-0.003585,0.28398,0.70577,BIOCARTA_IL4_PATHWAY,1
BMI1_DN.V1_UP,SET,137,-0.042684,-0.0036733,0.078835,0.70589,BMI1_DN.V1_UP,1
RHODES_CANCER_META_SIGNATURE,SET,58,-0.058279,-0.0032704,0.10761,0.70594,RHODES_CANCER_META_SIGNATURE,1
HP_EPICANTHUS_INVERSUS,SET,13,-0.13702,-0.0036447,0.25297,0.70596,HP_EPICANTHUS_INVERSUS,1
GSE29618_LAIV_VS_TIV_FLU_VAC...5,SET,173,-0.034086,-0.0032931,0.062916,0.70601,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN,1
HP_PROMINENT_OCCIPUT,SET,50,-0.060603,-0.0031583,0.11185,0.70603,HP_PROMINENT_OCCIPUT,1
MIR137_3P,SET,482,-0.022114,-0.0035357,0.040811,0.70604,MIR137_3P,1
GOBP_AV_NODE_CELL_TO_BUNDLE_...1,SET,13,-0.14622,-0.0038893,0.26978,0.70608,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION,1
HP_ABNORMAL_3RD_FINGER_MORPH...,SET,24,-0.10101,-0.0036496,0.18635,0.70611,HP_ABNORMAL_3RD_FINGER_MORPHOLOGY,1
MIR6802_3P,SET,36,-0.076146,-0.0033685,0.14046,0.70613,MIR6802_3P,1
GAVISH_3CA_MALIGNANT_METAPRO...30,SET,45,-0.067867,-0.0033558,0.12516,0.70617,GAVISH_3CA_MALIGNANT_METAPROGRAM_38_GLUTATHIONE,1
GOBP_POSITIVE_REGULATION_OF_...497,SET,4,-0.27158,-0.0040082,0.50078,0.7062,GOBP_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION,1
E12_Q6,SET,245,-0.029767,-0.0034155,0.054882,0.70622,E12_Q6,1
FAN_OVARY_CL1_GPRC5A_TNFRS12...,SET,342,-0.024524,-0.0033158,0.045213,0.70623,FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL,1
MIR548E_5P,SET,659,-0.018736,-0.0034854,0.034536,0.70627,MIR548E_5P,1
GOBP_NEGATIVE_REGULATION_OF_...117,SET,9,-0.14988,-0.0033177,0.27615,0.70635,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
GOMF_PROTON_CHANNEL_ACTIVITY,SET,9,-0.13763,-0.0030465,0.25356,0.70636,GOMF_PROTON_CHANNEL_ACTIVITY,1
GOBP_MITOCHONDRIAL_MEMBRANE_...,SET,98,-0.045716,-0.003331,0.08422,0.70637,GOBP_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...3,SET,8,-0.16682,-0.0034814,0.30719,0.70644,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
MIR3184_3P,SET,66,-0.055602,-0.0033277,0.10234,0.70654,MIR3184_3P,1
KEGG_MEDICUS_REFERENCE_DOUBL...1,SET,4,-0.19661,-0.0029017,0.36185,0.70655,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION,1
HP_SENSORY_SEEKING,SET,24,-0.096879,-0.0035004,0.17827,0.70658,HP_SENSORY_SEEKING,1
GOBP_REGULATION_OF_INTERLEUK...2,SET,4,-0.25184,-0.0037168,0.4634,0.70659,GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,1
REACTOME_OREXIN_AND_NEUROPEP...,SET,6,-0.23948,-0.0043285,0.44063,0.7066,REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS,1
MODULE_281,SET,28,-0.084946,-0.0033148,0.15622,0.7067,MODULE_281,1
REACTOME_ACTIVATED_NOTCH1_TR...,SET,29,-0.084036,-0.0033372,0.15451,0.70674,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,1
KEGG_MEDICUS_REFERENCE_ACH_C...2,SET,20,-0.097093,-0.0032028,0.1785,0.70676,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY,1
HP_ABNORMAL_PITUITARY_GLAND_...,SET,304,-0.027118,-0.0034605,0.049835,0.70683,HP_ABNORMAL_PITUITARY_GLAND_MORPHOLOGY,1
GOMF_METALLOEXOPEPTIDASE_ACT...,SET,63,-0.065996,-0.0038593,0.12128,0.70684,GOMF_METALLOEXOPEPTIDASE_ACTIVITY,1
HP_WRITER_S_CRAMP,SET,18,-0.1055,-0.0033018,0.19381,0.7069,HP_WRITER_S_CRAMP,1
GSE45365_HEALTHY_VS_MCMV_INF...2,SET,184,-0.032788,-0.0032659,0.060234,0.7069,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP,1
BUSSLINGER_GASTRIC_MATURE_PI...,SET,208,-0.03435,-0.0036354,0.0631,0.70691,BUSSLINGER_GASTRIC_MATURE_PIT_CELLS,1
GOCC_CELL_POLE,SET,9,-0.15591,-0.003451,0.28637,0.70692,GOCC_CELL_POLE,1
HP_ABNORMALITY_OF_JOINT_MOBI...,SET,1163,-0.013935,-0.0033943,0.025596,0.70692,HP_ABNORMALITY_OF_JOINT_MOBILITY,1
GOBP_GLUCOSE_IMPORT_IN_RESPO...,SET,5,-0.19828,-0.0032717,0.36404,0.707,GOBP_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS,1
GSE26343_UNSTIM_VS_LPS_STIM_...4,SET,184,-0.033823,-0.003369,0.062096,0.70701,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP,1
GOBP_CELL_SUBSTRATE_ADHESION,SET,332,-0.026452,-0.0035247,0.048554,0.70705,GOBP_CELL_SUBSTRATE_ADHESION,1
HP_ABNORMAL_LOWER_LIMB_METAP...,SET,20,-0.095015,-0.0031343,0.17434,0.70712,HP_ABNORMAL_LOWER_LIMB_METAPHYSIS_MORPHOLOGY,1
GSE16386_IL4_VS_IL4_AND_ROSI...2,SET,181,-0.032356,-0.0031967,0.059355,0.70716,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP,1
GSE22886_UNSTIM_VS_IL2_STIM_...2,SET,169,-0.03484,-0.0033272,0.063894,0.70721,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP,1
MODULE_223,SET,132,-0.0452,-0.0038188,0.082877,0.70725,MODULE_223,1
GOBP_COGNITION,SET,290,-0.028479,-0.0035508,0.05221,0.70728,GOBP_COGNITION,1
BANDRES_RESPONSE_TO_CARMUSTI...1,SET,31,-0.083888,-0.0034441,0.15373,0.70736,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...7,SET,21,-0.099919,-0.0033773,0.1831,0.70736,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,1
GOMF_MICROTUBULE_SEVERING_AT...,SET,9,-0.15552,-0.0034424,0.285,0.70736,GOMF_MICROTUBULE_SEVERING_ATPASE_ACTIVITY,1
GOMF_CHITIN_BINDING,SET,8,-0.17459,-0.0036437,0.31986,0.70741,GOMF_CHITIN_BINDING,1
GSE2405_HEAT_KILLED_VS_LIVE_...2,SET,174,-0.035254,-0.0034157,0.064587,0.70741,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,1
GOBP_ANTIGEN_PROCESSING_AND_...11,SET,36,-0.083725,-0.0037038,0.15332,0.70749,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,1
GOBP_NEGATIVE_REGULATION_OF_...385,SET,12,-0.13867,-0.0035441,0.2539,0.70752,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL,1
KRISHNAN_FURIN_TARGETS_DN,SET,9,-0.12937,-0.0028635,0.23677,0.7076,KRISHNAN_FURIN_TARGETS_DN,1
GSE40274_CTRL_VS_IRF4_TRANSD...1,SET,151,-0.038127,-0.0034434,0.06977,0.70762,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
MIR548AH_5P,SET,321,-0.026721,-0.0035021,0.048896,0.70763,MIR548AH_5P,1
MIR562,SET,59,-0.058673,-0.0033207,0.10734,0.70767,MIR562,1
GOCC_AXON_CYTOPLASM,SET,61,-0.060981,-0.0035091,0.11155,0.7077,GOCC_AXON_CYTOPLASM,1
HP_PALPITATIONS,SET,102,-0.048248,-0.0035862,0.088237,0.70774,HP_PALPITATIONS,1
GOBP_DNA_TOPOLOGICAL_CHANGE,SET,9,-0.13407,-0.0029677,0.24511,0.70781,GOBP_DNA_TOPOLOGICAL_CHANGE,1
HP_BULIMIA,SET,5,-0.26191,-0.0043215,0.47879,0.70781,HP_BULIMIA,1
KENNEDY_PBMC_DRYVAX_AGE_18_4...,SET,31,-0.084146,-0.0034547,0.15378,0.70787,KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN,1
REACTOME_MITOCHONDRIAL_FATTY...1,SET,35,-0.075919,-0.0033116,0.13873,0.7079,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,1
GOBP_REGULATION_OF_PROTEIN_K...1,SET,6,-0.18969,-0.0034286,0.34661,0.7079,GOBP_REGULATION_OF_PROTEIN_K48_LINKED_UBIQUITINATION,1
BCAT_BILD_ET_AL_UP,SET,42,-0.074105,-0.0035403,0.13537,0.70795,BCAT_BILD_ET_AL_UP,1
GOMF_ENDODEOXYRIBONUCLEASE_A...,SET,11,-0.13682,-0.0033479,0.24991,0.70797,GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
GOBP_NEGATIVE_REGULATION_OF_...411,SET,83,-0.049768,-0.0033386,0.090884,0.70801,GOBP_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,1
ZHOU_INFLAMMATORY_RESPONSE_L...2,SET,387,-0.025124,-0.003609,0.04588,0.70802,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1
GOBP_VOCALIZATION_BEHAVIOR,SET,15,-0.13039,-0.0037254,0.23808,0.70804,GOBP_VOCALIZATION_BEHAVIOR,1
GOBP_PHAGOSOME_ACIDIFICATION,SET,7,-0.19716,-0.003849,0.3599,0.70809,GOBP_PHAGOSOME_ACIDIFICATION,1
GOBP_CHOLANGIOCYTE_PROLIFERA...,SET,4,-0.22311,-0.0032928,0.4072,0.70812,GOBP_CHOLANGIOCYTE_PROLIFERATION,1
GSE2405_S_AUREUS_VS_UNTREATE...1,SET,180,-0.035003,-0.0034488,0.063882,0.70813,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN,1
MIR3165,SET,33,-0.079965,-0.0033871,0.14587,0.70821,MIR3165,1
MODULE_49,SET,249,-0.030004,-0.0034704,0.054708,0.7083,MODULE_49,1
SCHERER_PBMC_YF_VAX_AGE_18_4...4,SET,10,-0.15049,-0.0035112,0.27439,0.70831,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_UP,1
GOBP_REGULATION_OF_ENDOTHELI...5,SET,5,-0.25041,-0.0041318,0.45652,0.70833,GOBP_REGULATION_OF_ENDOTHELIAL_TUBE_MORPHOGENESIS,1
GSE35543_IN_VIVO_NTREG_VS_IN...1,SET,144,-0.039789,-0.0035099,0.072538,0.70833,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN,1
HP_APRAXIA,SET,190,-0.032398,-0.0032787,0.059063,0.70834,HP_APRAXIA,1
GAGCTGG_MIR337,SET,144,-0.037476,-0.0033059,0.068308,0.70837,GAGCTGG_MIR337,1
GSE6259_CD4_TCELL_VS_CD8_TCE...2,SET,173,-0.036873,-0.0035624,0.067202,0.70839,GSE6259_CD4_TCELL_VS_CD8_TCELL_UP,1
DELASERNA_TARGETS_OF_MYOD_AN...,SET,10,-0.16266,-0.0037952,0.29641,0.70842,DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4,1
REACTOME_MAPK_TARGETS_NUCLEA...,SET,29,-0.091231,-0.003623,0.16625,0.70842,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,1
GOMF_PHOSPHATIDYLINOSITOL_TR...2,SET,8,-0.15217,-0.0031757,0.27727,0.70843,GOMF_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,1
GOBP_REGULATION_OF_XENOPHAGY,SET,9,-0.16206,-0.0035872,0.29527,0.70845,GOBP_REGULATION_OF_XENOPHAGY,1
TAL1ALPHAE47_01,SET,228,-0.032808,-0.0036333,0.059769,0.70847,TAL1ALPHAE47_01,1
GOBP_CELL_ADHESION_MEDIATED_...,SET,82,-0.052866,-0.0035251,0.096297,0.70849,GOBP_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
HP_ELEVATED_CIRCULATING_LUTE...,SET,35,-0.078129,-0.003408,0.14231,0.70849,HP_ELEVATED_CIRCULATING_LUTEINIZING_HORMONE_LEVEL,1
GSE1460_DP_THYMOCYTE_VS_THYM...2,SET,169,-0.035009,-0.0033433,0.063739,0.70858,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,1
MODULE_280,SET,44,-0.07368,-0.0036026,0.1341,0.70865,MODULE_280,1
GOMF_ACETYL_COA_C_ACYLTRANSF...,SET,7,-0.1672,-0.0032641,0.30429,0.70865,GOMF_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY,1
MIR3162_3P,SET,20,-0.10894,-0.0035934,0.19825,0.70866,MIR3162_3P,1
GOBP_DETOXIFICATION_OF_NITRO...,SET,2,-0.38381,-0.0040056,0.69801,0.70879,GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND,1
GOBP_ANTEROGRADE_DENDRITIC_T...2,SET,5,-0.24696,-0.0040749,0.44912,0.7088,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT_OF_NEUROTRANSMITTER_RECEPTOR_COMPLEX,1
GSE15930_NAIVE_VS_72H_IN_VIT...8,SET,185,-0.033189,-0.0033147,0.060342,0.70884,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP,1
GSE6269_HEALTHY_VS_E_COLI_IN...1,SET,145,-0.040517,-0.0035864,0.073654,0.70887,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN,1
VILLANUEVA_LIVER_CANCER_KRT1...1,SET,55,-0.061407,-0.0033559,0.1116,0.70891,VILLANUEVA_LIVER_CANCER_KRT19_DN,1
REACTOME_KEAP1_NFE2L2_PATHWAY,SET,119,-0.041454,-0.0033265,0.075279,0.70906,REACTOME_KEAP1_NFE2L2_PATHWAY,1
GOBP_RESPONSE_TO_MOLECULE_OF...2,SET,4,-0.24664,-0.0036401,0.44788,0.70907,GOBP_RESPONSE_TO_MOLECULE_OF_FUNGAL_ORIGIN,1
BRUINS_UVC_RESPONSE_EARLY_LA...,SET,286,-0.027349,-0.0033867,0.049661,0.70908,BRUINS_UVC_RESPONSE_EARLY_LATE,1
HP_OVERRIDING_AORTA,SET,21,-0.11826,-0.0039971,0.21474,0.70908,HP_OVERRIDING_AORTA,1
HP_LYMPHOPROLIFERATIVE_DISOR...,SET,13,-0.12817,-0.0034093,0.23272,0.70909,HP_LYMPHOPROLIFERATIVE_DISORDER,1
SHIRAISHI_PLZF_TARGETS_UP,SET,9,-0.151,-0.0033424,0.27416,0.7091,SHIRAISHI_PLZF_TARGETS_UP,1
MIR203A_5P,SET,51,-0.064047,-0.0033709,0.11628,0.70911,MIR203A_5P,1
CAFFAREL_RESPONSE_TO_THC_UP,SET,29,-0.085191,-0.0033831,0.15466,0.70912,CAFFAREL_RESPONSE_TO_THC_UP,1
GOBP_ADENYLATE_CYCLASE_MODUL...,SET,249,-0.032395,-0.0037469,0.058809,0.70913,GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_TRANSFERASE_ACTIVITY_TR...2,SET,25,-0.10034,-0.0037002,0.18216,0.70913,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS,1
MIR6080,SET,42,-0.074874,-0.003577,0.13589,0.70918,MIR6080,1
GOMF_K63_LINKED_POLYUBIQUITI...,SET,22,-0.090753,-0.0031396,0.16468,0.70921,GOMF_K63_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
HP_HYPERGLUTAMINEMIA,SET,8,-0.14393,-0.0030037,0.26115,0.70922,HP_HYPERGLUTAMINEMIA,1
GOBP_MALE_SEX_DIFFERENTIATION,SET,158,-0.039348,-0.0036344,0.071394,0.70923,GOBP_MALE_SEX_DIFFERENTIATION,1
GOMF_BHLH_TRANSCRIPTION_FACT...,SET,31,-0.0867,-0.0035596,0.15731,0.70923,GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING,1
GSE5589_LPS_VS_LPS_AND_IL10_...11,SET,185,-0.033718,-0.0033675,0.06117,0.70925,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
HP_SCLEROSIS_OF_HAND_BONE,SET,11,-0.16003,-0.0039159,0.29031,0.70927,HP_SCLEROSIS_OF_HAND_BONE,1
GSE42021_TCONV_PLN_VS_CD24HI...2,SET,186,-0.034981,-0.003503,0.063457,0.70927,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP,1
HP_NEVUS_FLAMMEUS_OF_THE_FOR...,SET,6,-0.20394,-0.0036861,0.36992,0.70928,HP_NEVUS_FLAMMEUS_OF_THE_FOREHEAD,1
GSE9988_LOW_LPS_VS_ANTI_TREM...2,SET,176,-0.036321,-0.0035391,0.065881,0.70929,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,1
HP_METAPHYSEAL_DYSPLASIA,SET,31,-0.085812,-0.0035231,0.15564,0.7093,HP_METAPHYSEAL_DYSPLASIA,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...1,SET,35,-0.08073,-0.0035214,0.14637,0.70937,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1
GOBP_BRANCHING_INVOLVED_IN_L...,SET,12,-0.14753,-0.0037706,0.26748,0.70938,GOBP_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS,1
HP_ABNORMALITY_OF_T_CELL_PHY...,SET,50,-0.068889,-0.0035901,0.12489,0.70939,HP_ABNORMALITY_OF_T_CELL_PHYSIOLOGY,1
MIR8061,SET,150,-0.039037,-0.003514,0.070742,0.70946,MIR8061,1
LUI_THYROID_CANCER_PAX8_PPAR...1,SET,44,-0.068025,-0.0033261,0.12324,0.70952,LUI_THYROID_CANCER_PAX8_PPARG_DN,1
GOBP_GLUCOCORTICOID_SECRETION,SET,11,-0.14551,-0.0035606,0.26357,0.70955,GOBP_GLUCOCORTICOID_SECRETION,1
GOBP_REGULATION_OF_METANEPHR...,SET,5,-0.25343,-0.0041816,0.45904,0.70955,GOBP_REGULATION_OF_METANEPHROS_DEVELOPMENT,1
REACTOME_SIGNALING_BY_ERBB2,SET,48,-0.067,-0.0034213,0.12133,0.7096,REACTOME_SIGNALING_BY_ERBB2,1
HP_EXERCISE_INTOLERANCE,SET,119,-0.043698,-0.0035066,0.079132,0.7096,HP_EXERCISE_INTOLERANCE,1
GSE2770_IL12_AND_TGFB_ACT_VS...5,SET,180,-0.034673,-0.0034163,0.06276,0.70969,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN,1
GOBP_POSITIVE_REGULATION_OF_...733,SET,12,-0.13656,-0.0034901,0.24714,0.70971,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GSE33425_CD161_INT_VS_NEG_CD...1,SET,190,-0.034824,-0.0035242,0.063013,0.70974,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN,1
MODULE_455,SET,36,-0.077263,-0.0034179,0.13977,0.70979,MODULE_455,1
HP_METAPHYSEAL_SPURS,SET,7,-0.17909,-0.0034962,0.32388,0.70984,HP_METAPHYSEAL_SPURS,1
GSE6259_BCELL_VS_CD8_TCELL_DN,SET,168,-0.037566,-0.003577,0.067938,0.70985,GSE6259_BCELL_VS_CD8_TCELL_DN,1
HP_PALPEBRAL_EDEMA,SET,37,-0.078343,-0.0035134,0.14167,0.70987,HP_PALPEBRAL_EDEMA,1
GSE39556_UNTREATED_VS_3H_POL...3,SET,178,-0.036211,-0.0035481,0.065465,0.70991,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN,1
HP_ABNORMAL_SELLA_TURCICA_MO...,SET,37,-0.076948,-0.0034508,0.1391,0.70993,HP_ABNORMAL_SELLA_TURCICA_MORPHOLOGY,1
GOMF_INSULIN_RECEPTOR_SUBSTR...,SET,13,-0.13211,-0.003514,0.23877,0.70996,GOMF_INSULIN_RECEPTOR_SUBSTRATE_BINDING,1
GSE17721_PAM3CSK4_VS_GADIQUI...4,SET,176,-0.032036,-0.0031215,0.057891,0.71,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP,1
HO_LIVER_CANCER_VASCULAR_INV...,SET,12,-0.14837,-0.0037918,0.26806,0.71003,HO_LIVER_CANCER_VASCULAR_INVASION,1
HARALAMBIEVA_PBMC_M_M_R_II_A...4,SET,11,-0.16375,-0.004007,0.29587,0.71003,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,1
MIR5588_3P,SET,41,-0.071892,-0.0033935,0.12988,0.71004,MIR5588_3P,1
MIR7159_5P,SET,323,-0.027605,-0.003629,0.049872,0.71004,MIR7159_5P,1
HP_ADENOMA_SEBACEUM,SET,26,-0.086916,-0.0032684,0.15699,0.71009,HP_ADENOMA_SEBACEUM,1
KEGG_MEDICUS_REFERENCE_EGF_E...6,SET,14,-0.13117,-0.0036208,0.23688,0.71012,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY,1
LET_7C_3P,SET,536,-0.020918,-0.0035216,0.037765,0.71017,LET_7C_3P,1
GOMF_ATPASE_COUPLED_MONOATOM...,SET,49,-0.069216,-0.003571,0.12494,0.7102,GOMF_ATPASE_COUPLED_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_ESCHER...2,SET,17,-0.10312,-0.0031363,0.18613,0.71021,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY,1
GOBP_KETONE_CATABOLIC_PROCESS,SET,12,-0.13201,-0.0033739,0.23818,0.71029,GOBP_KETONE_CATABOLIC_PROCESS,1
HP_GLOBOZOOSPERMIA,SET,6,-0.2139,-0.0038662,0.3859,0.71031,HP_GLOBOZOOSPERMIA,1
GOBP_ENDOCARDIAL_CELL_DIFFER...,SET,6,-0.21949,-0.0039672,0.39596,0.71032,GOBP_ENDOCARDIAL_CELL_DIFFERENTIATION,1
MIR548M,SET,172,-0.036127,-0.0034803,0.065158,0.71036,MIR548M,1
GOBP_REGULATION_OF_STEROID_M...,SET,90,-0.053441,-0.0037324,0.096387,0.71036,GOBP_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
MIR3188,SET,72,-0.054615,-0.0034134,0.098494,0.71038,MIR3188,1
GOBP_REGULATION_OF_IMMUNE_EF...,SET,356,-0.026756,-0.0036895,0.048253,0.71038,GOBP_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
MORI_LARGE_PRE_BII_LYMPHOCYT...1,SET,53,-0.067983,-0.0036473,0.12258,0.71041,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1
HP_CAPILLARY_FRAGILITY,SET,6,-0.19682,-0.0035575,0.35486,0.71043,HP_CAPILLARY_FRAGILITY,1
REACTOME_FOLDING_OF_ACTIN_BY...,SET,10,-0.12788,-0.0029837,0.23054,0.71045,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,1
HP_ABNORMAL_FINGERNAIL_MORPH...,SET,173,-0.036415,-0.0035181,0.065646,0.71045,HP_ABNORMAL_FINGERNAIL_MORPHOLOGY,1
STEARMAN_LUNG_CANCER_EARLY_V...2,SET,118,-0.041559,-0.003321,0.074874,0.71057,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1
BUFFA_HYPOXIA_METAGENE,SET,44,-0.070818,-0.0034627,0.12758,0.71058,BUFFA_HYPOXIA_METAGENE,1
GSE21360_SECONDARY_VS_TERTIA...2,SET,179,-0.03368,-0.0033093,0.060665,0.71061,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
REACTOME_TRANSLATION,SET,257,-0.0276,-0.0032424,0.049704,0.71065,REACTOME_TRANSLATION,1
SHEN_SMARCA2_TARGETS_UP,SET,389,-0.02365,-0.0034058,0.042589,0.71066,SHEN_SMARCA2_TARGETS_UP,1
HOXC11_TARGET_GENES,SET,48,-0.063434,-0.0032392,0.11421,0.7107,HOXC11_TARGET_GENES,1
GOMF_ACID_THIOL_LIGASE_ACTIV...,SET,29,-0.089338,-0.0035478,0.16083,0.71071,GOMF_ACID_THIOL_LIGASE_ACTIVITY,1
GOCC_MICROVILLUS_MEMBRANE,SET,29,-0.089913,-0.0035706,0.16185,0.71073,GOCC_MICROVILLUS_MEMBRANE,1
GSE22886_NAIVE_CD8_TCELL_VS_...3,SET,181,-0.034777,-0.0034359,0.062597,0.71074,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...22,SET,75,-0.057181,-0.0036472,0.10291,0.71076,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1
HP_ABNORMAL_SPINAL_MENINGEAL...,SET,22,-0.10949,-0.0037877,0.19704,0.71077,HP_ABNORMAL_SPINAL_MENINGEAL_MORPHOLOGY,1
HP_HEPATIC_FIBROSIS,SET,134,-0.03967,-0.0033766,0.071379,0.71081,HP_HEPATIC_FIBROSIS,1
GSE17721_CTRL_VS_LPS_1H_BMDC...2,SET,177,-0.034481,-0.0033692,0.062036,0.71083,GSE17721_CTRL_VS_LPS_1H_BMDC_UP,1
GAVISH_3CA_METAPROGRAM_FIBRO...2,SET,49,-0.078633,-0.0040568,0.14145,0.71085,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_10,1
RAY_TUMORIGENESIS_BY_ERBB2_C...1,SET,243,-0.031513,-0.0036013,0.056685,0.71087,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1
GSE36891_POLYIC_TLR3_VS_PAM_...1,SET,146,-0.038296,-0.0034014,0.068838,0.711,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,1
GOBP_POSITIVE_REGULATION_OF_...749,SET,11,-0.14841,-0.0036316,0.26664,0.71109,GOBP_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GCM_RAB10,SET,162,-0.035098,-0.0032823,0.063052,0.71111,GCM_RAB10,1
HP_HIGHLY_ARCHED_EYEBROW,SET,177,-0.034132,-0.0033351,0.061304,0.71115,HP_HIGHLY_ARCHED_EYEBROW,1
REACTOME_RA_BIOSYNTHESIS_PAT...,SET,22,-0.11111,-0.0038438,0.19955,0.71117,REACTOME_RA_BIOSYNTHESIS_PATHWAY,1
GOMF_CGMP_BINDING,SET,15,-0.12204,-0.0034868,0.21917,0.71117,GOMF_CGMP_BINDING,1
GOBP_REGULATION_OF_SODIUM_IO...2,SET,42,-0.081647,-0.0039006,0.14662,0.71119,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_GDNFRET_SIGNALING_AXIS,SET,20,-0.1258,-0.0041497,0.22587,0.71122,WP_GDNFRET_SIGNALING_AXIS,1
MIR6739_3P,SET,174,-0.037066,-0.0035912,0.066549,0.71122,MIR6739_3P,1
MIR9986,SET,148,-0.03973,-0.0035526,0.071314,0.71127,MIR9986,1
GOCC_MYELIN_SHEATH,SET,41,-0.07433,-0.0035086,0.13338,0.71133,GOCC_MYELIN_SHEATH,1
GOMF_INTERMEDIATE_FILAMENT_B...,SET,10,-0.14859,-0.0034668,0.26646,0.71145,GOMF_INTERMEDIATE_FILAMENT_BINDING,1
MOREAUX_MULTIPLE_MYELOMA_BY_...2,SET,326,-0.027528,-0.0036355,0.049332,0.71158,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1
GOBP_POSITIVE_REGULATION_OF_...218,SET,9,-0.13781,-0.0030505,0.24695,0.71159,GOBP_POSITIVE_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
GOMF_G_PROTEIN_COUPLED_RECEP...2,SET,254,-0.032444,-0.0037895,0.058126,0.71163,GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING,1
GNF2_DDX5,SET,58,-0.058094,-0.00326,0.10406,0.71166,GNF2_DDX5,1
REACTOME_SMAD2_SMAD3_SMAD4_H...,SET,35,-0.084484,-0.0036852,0.15133,0.71167,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,1
MIR6738_5P,SET,25,-0.10036,-0.003701,0.17978,0.71167,MIR6738_5P,1
HP_ABNORMAL_ASCENDING_AORTA_...,SET,26,-0.10278,-0.0038651,0.18407,0.71171,HP_ABNORMAL_ASCENDING_AORTA_MORPHOLOGY,1
PASQUALUCCI_LYMPHOMA_BY_GC_S...1,SET,156,-0.039459,-0.0036218,0.070653,0.71174,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,1
NABA_MATRISOME_POORLY_METAST...2,SET,12,-0.12799,-0.003271,0.22913,0.71177,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,1
HP_ESOPHORIA,SET,5,-0.20048,-0.0033079,0.35882,0.71182,HP_ESOPHORIA,1
GOBP_NEGATIVE_REGULATION_OF_...630,SET,31,-0.080854,-0.0033196,0.1447,0.71184,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE,1
HP_SPASTIC_TETRAPARESIS,SET,59,-0.060746,-0.003438,0.10871,0.71184,HP_SPASTIC_TETRAPARESIS,1
MIR320E,SET,60,-0.064623,-0.0036882,0.11564,0.71185,MIR320E,1
GSE13485_CTRL_VS_DAY3_YF17D_...1,SET,179,-0.035651,-0.003503,0.063773,0.71193,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN,1
REACTOME_NR1H2_NR1H3_REGULAT...2,SET,9,-0.14155,-0.0031332,0.25318,0.71195,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS,1
MIR514A_3P_MIR514B_3P,SET,101,-0.046623,-0.0034485,0.083391,0.71195,MIR514A_3P_MIR514B_3P,1
HE_LIM_SUN_FETAL_LUNG_C2_HSC...1,SET,1384,-0.012954,-0.00342,0.023166,0.71198,HE_LIM_SUN_FETAL_LUNG_C2_HSC_CELL,1
GOBP_HEMATOPOIETIC_STEM_CELL...2,SET,19,-0.11586,-0.0037251,0.20712,0.71204,GOBP_HEMATOPOIETIC_STEM_CELL_HOMEOSTASIS,1
GSE36476_CTRL_VS_TSST_ACT_40...4,SET,177,-0.036653,-0.0035814,0.065515,0.71207,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP,1
GOBP_SPHINGOMYELIN_METABOLIC...,SET,20,-0.10134,-0.0033428,0.18109,0.71211,GOBP_SPHINGOMYELIN_METABOLIC_PROCESS,1
GSE17974_0H_VS_12H_IN_VITRO_...2,SET,167,-0.03749,-0.0035592,0.066971,0.71219,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP,1
CHIANG_LIVER_CANCER_SUBCLASS...7,SET,166,-0.038368,-0.0036317,0.06851,0.71227,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,1
GOBP_HORMONE_BIOSYNTHETIC_PR...,SET,64,-0.062024,-0.0036556,0.11074,0.71229,GOBP_HORMONE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_TYPE_2_IM...,SET,34,-0.086617,-0.0037239,0.15464,0.7123,GOBP_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
HP_REDUCED_SUBCUTANEOUS_ADIP...,SET,30,-0.089086,-0.0035982,0.15899,0.71236,HP_REDUCED_SUBCUTANEOUS_ADIPOSE_TISSUE,1
GOBP_ORGAN_OR_TISSUE_SPECIFI...,SET,26,-0.10546,-0.0039656,0.1882,0.71237,GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE,1
VERHAAK_GLIOBLASTOMA_PRONEUR...,SET,149,-0.040757,-0.0036567,0.072729,0.71239,VERHAAK_GLIOBLASTOMA_PRONEURAL,1
GOBP_POSITIVE_REGULATION_OF_...530,SET,15,-0.11606,-0.0033159,0.20709,0.7124,GOBP_POSITIVE_REGULATION_OF_NEURON_MIGRATION,1
GOCC_COMPLEX_OF_COLLAGEN_TRI...,SET,19,-0.11608,-0.0037322,0.20713,0.7124,GOCC_COMPLEX_OF_COLLAGEN_TRIMERS,1
GOBP_CELLULAR_RESPONSE_TO_MI...,SET,12,-0.15675,-0.0040062,0.27969,0.71241,GOBP_CELLULAR_RESPONSE_TO_MINERALOCORTICOID_STIMULUS,1
HP_YELLOW_WHITE_LESIONS_OF_T...1,SET,16,-0.12597,-0.0037172,0.22475,0.71243,HP_YELLOW_WHITE_LESIONS_OF_THE_MACULA,1
MIR6874_3P,SET,70,-0.056584,-0.0034872,0.10093,0.71247,MIR6874_3P,1
GOBP_EPOXYGENASE_P450_PATHWAY,SET,18,-0.13465,-0.0042139,0.24016,0.71248,GOBP_EPOXYGENASE_P450_PATHWAY,1
GOMF_NAD_DEPENDENT_PROTEIN_L...,SET,7,-0.17044,-0.0033274,0.30399,0.71249,GOMF_NAD_DEPENDENT_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,1
DESCARTES_FETAL_STOMACH_STRO...,SET,42,-0.081026,-0.0038709,0.1445,0.7125,DESCARTES_FETAL_STOMACH_STROMAL_CELLS,1
BOYLAN_MULTIPLE_MYELOMA_C_UP,SET,44,-0.07513,-0.0036735,0.13397,0.71253,BOYLAN_MULTIPLE_MYELOMA_C_UP,1
BLANCO_MELO_MERS_COV_INFECTI...1,SET,30,-0.093351,-0.0037704,0.16643,0.71256,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN,1
REACTOME_NEF_MEDIATED_DOWNRE...,SET,9,-0.14586,-0.0032287,0.26005,0.71257,REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION,1
MORF_IKBKG,SET,121,-0.040965,-0.0033146,0.073033,0.71257,MORF_IKBKG,1
GOBP_REGULATION_OF_ACTIN_FIL...1,SET,39,-0.076288,-0.0035123,0.13598,0.71261,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT,1
YAGI_AML_SURVIVAL,SET,108,-0.046212,-0.0035339,0.082355,0.71264,YAGI_AML_SURVIVAL,1
MIKKELSEN_MEF_ICP_WITH_H3K4M...,SET,37,-0.084528,-0.0037908,0.15061,0.71268,MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
REACTOME_ACTIVATION_OF_C3_AN...,SET,4,-0.24732,-0.0036501,0.44061,0.71271,REACTOME_ACTIVATION_OF_C3_AND_C5,1
CHESLER_BRAIN_HIGHEST_EXPRES...,SET,34,-0.083301,-0.0035814,0.1483,0.71284,CHESLER_BRAIN_HIGHEST_EXPRESSION,1
REACTOME_SIGNALING_BY_RETINO...,SET,40,-0.080953,-0.0037744,0.14412,0.71284,REACTOME_SIGNALING_BY_RETINOIC_ACID,1
HP_ABNORMALITY_OF_THE_GALLBL...,SET,99,-0.049465,-0.0036224,0.08806,0.71284,HP_ABNORMALITY_OF_THE_GALLBLADDER,1
GOBP_DIACYLGLYCEROL_METABOLI...,SET,25,-0.094919,-0.0035002,0.16892,0.71291,GOBP_DIACYLGLYCEROL_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_PROXIM...2,SET,7,-0.17724,-0.0034601,0.31542,0.71291,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_THUMB,1
HP_SKIN_APPENDAGE_NEOPLASM,SET,16,-0.12403,-0.0036599,0.22072,0.71292,HP_SKIN_APPENDAGE_NEOPLASM,1
GOMF_CD4_RECEPTOR_BINDING,SET,7,-0.19685,-0.0038429,0.35026,0.71294,GOMF_CD4_RECEPTOR_BINDING,1
GOCC_CIS_GOLGI_NETWORK_MEMBR...,SET,10,-0.14649,-0.0034178,0.26061,0.71297,GOCC_CIS_GOLGI_NETWORK_MEMBRANE,1
MIR6841_5P,SET,32,-0.083077,-0.0034653,0.14779,0.71298,MIR6841_5P,1
HP_INCREASED_CIRCULATING_IGA...,SET,26,-0.1006,-0.0037829,0.17894,0.713,HP_INCREASED_CIRCULATING_IGA_LEVEL,1
REACTOME_PDH_COMPLEX_SYNTHES...,SET,4,-0.31357,-0.0046279,0.55767,0.71304,REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR,1
GOMF_PYRUVATE_DEHYDROGENASE_...3,SET,4,-0.31357,-0.0046279,0.55767,0.71304,GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY,1
REACTOME_SUMOYLATION_OF_RNA_...,SET,43,-0.069971,-0.0033823,0.12442,0.71307,REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,1
GOCC_INNER_MITOCHONDRIAL_MEM...,SET,113,-0.041478,-0.003244,0.073753,0.71307,GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,1
KOBAYASHI_EGFR_SIGNALING_6HR...2,SET,6,-0.18359,-0.0033183,0.32644,0.71308,KOBAYASHI_EGFR_SIGNALING_6HR_UP,1
GOMF_PEPTIDASE_REGULATOR_ACT...,SET,208,-0.036813,-0.003896,0.065449,0.7131,GOMF_PEPTIDASE_REGULATOR_ACTIVITY,1
GOBP_DETERMINATION_OF_DIGEST...,SET,6,-0.16416,-0.002967,0.29177,0.71315,GOBP_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY,1
GSE46606_IRF4_KO_VS_WT_UNSTI...1,SET,181,-0.037835,-0.003738,0.067239,0.71318,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN,1
DROSHA_TARGET_GENES,SET,36,-0.078708,-0.0034818,0.13984,0.71323,DROSHA_TARGET_GENES,1
REACTOME_VESICLE_MEDIATED_TR...,SET,631,-0.019148,-0.0034883,0.034012,0.71327,REACTOME_VESICLE_MEDIATED_TRANSPORT,1
GOBP_REGULATION_OF_SECONDARY...2,SET,15,-0.13892,-0.0039692,0.24672,0.7133,GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS,1
GSE2826_XID_VS_BTK_KO_BCELL_...2,SET,186,-0.036089,-0.003614,0.064091,0.71331,GSE2826_XID_VS_BTK_KO_BCELL_UP,1
GSE5542_UNTREATED_VS_IFNG_TR...3,SET,180,-0.03638,-0.0035845,0.064597,0.71334,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
GOBP_POSITIVE_REGULATION_OF_...592,SET,97,-0.050678,-0.0036738,0.089983,0.71335,GOBP_POSITIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,1
GOBP_SUBSTRATE_ADHESION_DEPE...,SET,97,-0.04908,-0.003558,0.087137,0.71336,GOBP_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
WP_P53_TRANSCRIPTIONAL_GENE_...,SET,89,-0.049258,-0.0034212,0.087446,0.71338,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1
HP_SOCIAL_AND_OCCUPATIONAL_D...,SET,14,-0.137,-0.0037817,0.24321,0.71338,HP_SOCIAL_AND_OCCUPATIONAL_DETERIORATION,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...2,SET,96,-0.04705,-0.0033933,0.083517,0.7134,GOBP_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS,1
HP_SPASTIC_DYSARTHRIA,SET,22,-0.095196,-0.0032933,0.16894,0.71344,HP_SPASTIC_DYSARTHRIA,1
ANDERSON_BLOOD_CN54GP140_ADJ...1,SET,77,-0.050233,-0.0032463,0.089138,0.71346,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN,1
HP_INTERSTITIAL_PNEUMONITIS,SET,15,-0.1318,-0.0037658,0.23385,0.71349,HP_INTERSTITIAL_PNEUMONITIS,1
GSE9006_TYPE_1_DIABETES_AT_D...2,SET,182,-0.033995,-0.0033678,0.060286,0.71359,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP,1
MIR4731_3P,SET,203,-0.035876,-0.0037515,0.06361,0.71362,MIR4731_3P,1
REACTOME_PURINERGIC_SIGNALIN...,SET,23,-0.097318,-0.0034423,0.17254,0.71363,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,1
WHITFIELD_CELL_CYCLE_LITERAT...,SET,44,-0.064578,-0.0031576,0.11445,0.7137,WHITFIELD_CELL_CYCLE_LITERATURE,1
HP_INTRAALVEOLAR_PHOSPHOLIPI...,SET,7,-0.20201,-0.0039437,0.35787,0.71378,HP_INTRAALVEOLAR_PHOSPHOLIPID_ACCUMULATION,1
GOBP_MIDDLE_EAR_MORPHOGENESIS,SET,19,-0.12276,-0.0039471,0.21746,0.71379,GOBP_MIDDLE_EAR_MORPHOGENESIS,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...5,SET,23,-0.09943,-0.003517,0.17613,0.7138,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
HP_MONOCHROMACY,SET,8,-0.17271,-0.0036043,0.3059,0.71382,HP_MONOCHROMACY,1
KEGG_MEDICUS_REFERENCE_CA2_E...3,SET,24,-0.1083,-0.003913,0.19179,0.71384,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL,1
REACTOME_TRANSCRIPTIONAL_ACT...1,SET,50,-0.06956,-0.0036251,0.12317,0.71388,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1
FOXQ1_TARGET_GENES,SET,34,-0.089096,-0.0038305,0.15773,0.71391,FOXQ1_TARGET_GENES,1
GOBP_SYMBIONT_ENTRY_INTO_HOST,SET,154,-0.040597,-0.0037025,0.071869,0.71392,GOBP_SYMBIONT_ENTRY_INTO_HOST,1
GSE40493_BCL6_KO_VS_WT_TREG_...1,SET,94,-0.050876,-0.003631,0.090034,0.71398,GSE40493_BCL6_KO_VS_WT_TREG_DN,1
NABA_ECM_GLYCOPROTEINS,SET,177,-0.039096,-0.0038202,0.069188,0.71399,NABA_ECM_GLYCOPROTEINS,1
HP_ABNORMAL_AUDITORY_CANAL_M...,SET,76,-0.055562,-0.0035673,0.098307,0.71402,HP_ABNORMAL_AUDITORY_CANAL_MORPHOLOGY,1
GSE1112_HY_CD8AB_VS_HY_CD8AA...1,SET,163,-0.039431,-0.0036988,0.069725,0.71414,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
GOCC_ARYL_HYDROCARBON_RECEPT...,SET,6,-0.16916,-0.0030574,0.29904,0.71418,GOCC_ARYL_HYDROCARBON_RECEPTOR_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...644,SET,5,-0.20405,-0.0033669,0.36072,0.71419,GOBP_POSITIVE_REGULATION_OF_PROTEIN_NEDDYLATION,1
HP_PROLONGED_PARTIAL_THROMBO...,SET,30,-0.093742,-0.0037862,0.16571,0.71419,HP_PROLONGED_PARTIAL_THROMBOPLASTIN_TIME,1
GSE21670_UNTREATED_VS_TGFB_I...3,SET,177,-0.034783,-0.0033987,0.061476,0.71423,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
HP_PERMANENT_ATRIAL_FIBRILLA...,SET,9,-0.17343,-0.0038388,0.30647,0.71426,HP_PERMANENT_ATRIAL_FIBRILLATION,1
REACTOME_MISMATCH_REPAIR,SET,15,-0.10821,-0.0030917,0.19121,0.71427,REACTOME_MISMATCH_REPAIR,1
GSE11864_CSF1_VS_CSF1_IFNG_I...1,SET,168,-0.03725,-0.0035469,0.065823,0.71427,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN,1
KOHN_EMT_MESENCHYMAL,SET,14,-0.12807,-0.0035353,0.22629,0.71429,KOHN_EMT_MESENCHYMAL,1
HARRIS_HYPOXIA,SET,74,-0.060863,-0.0038562,0.10753,0.71431,HARRIS_HYPOXIA,1
HP_ABNORMAL_NASAL_DORSUM_MOR...,SET,228,-0.031162,-0.003451,0.055053,0.71431,HP_ABNORMAL_NASAL_DORSUM_MORPHOLOGY,1
GOBP_LYTIC_VACUOLE_ORGANIZAT...,SET,98,-0.048148,-0.0035083,0.08506,0.71432,GOBP_LYTIC_VACUOLE_ORGANIZATION,1
GSE14308_TH2_VS_TH1_UP,SET,174,-0.035976,-0.0034856,0.063551,0.71433,GSE14308_TH2_VS_TH1_UP,1
HP_CHEST_PAIN,SET,127,-0.045051,-0.0037339,0.07958,0.71434,HP_CHEST_PAIN,1
GSE3039_CD4_TCELL_VS_ALPHAAL...2,SET,180,-0.036575,-0.0036037,0.064605,0.71435,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP,1
HP_LARGE_FORAMEN_MAGNUM,SET,5,-0.21643,-0.0035711,0.38224,0.71437,HP_LARGE_FORAMEN_MAGNUM,1
GOBP_MATURATION_OF_LSU_RRNA_...,SET,16,-0.1069,-0.0031544,0.18873,0.71445,GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
GSE32164_RESTING_DIFFERENTIA...1,SET,182,-0.03654,-0.00362,0.064504,0.71446,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN,1
HP_ABNORMAL_SPERM_TAIL_MORPH...,SET,36,-0.07643,-0.0033811,0.13487,0.71453,HP_ABNORMAL_SPERM_TAIL_MORPHOLOGY,1
HP_MILD_SHORT_STATURE,SET,18,-0.12018,-0.0037612,0.21202,0.71459,HP_MILD_SHORT_STATURE,1
GSE45365_CD8A_DC_VS_CD11B_DC...4,SET,151,-0.039057,-0.0035274,0.068895,0.7146,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP,1
TGGTGCT_MIR29A_MIR29B_MIR29C,SET,470,-0.022887,-0.0036147,0.04037,0.71462,TGGTGCT_MIR29A_MIR29B_MIR29C,1
GOBP_KIDNEY_MESENCHYME_DEVEL...,SET,15,-0.14456,-0.0041302,0.25493,0.71465,GOBP_KIDNEY_MESENCHYME_DEVELOPMENT,1
MIR4649_3P,SET,186,-0.036456,-0.0036507,0.064286,0.71467,MIR4649_3P,1
GOCC_CLATHRIN_VESICLE_COAT,SET,32,-0.087222,-0.0036382,0.15375,0.71474,GOCC_CLATHRIN_VESICLE_COAT,1
GOCC_CEREBELLAR_CLIMBING_FIB...,SET,7,-0.21367,-0.0041714,0.37662,0.71476,GOCC_CEREBELLAR_CLIMBING_FIBER_TO_PURKINJE_CELL_SYNAPSE,1
GOCC_PLATELET_ALPHA_GRANULE_...2,SET,16,-0.13557,-0.0040002,0.23893,0.71477,GOCC_PLATELET_ALPHA_GRANULE_MEMBRANE,1
GOBP_CELLULAR_RESPONSE_TO_ATP,SET,16,-0.12555,-0.0037047,0.22124,0.71481,GOBP_CELLULAR_RESPONSE_TO_ATP,1
GOBP_PHENOL_CONTAINING_COMPO...1,SET,44,-0.080293,-0.003926,0.14149,0.71481,GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
MIR6831_3P,SET,55,-0.062733,-0.0034284,0.11054,0.71482,MIR6831_3P,1
GOBP_PROTEIN_K48_LINKED_UBIQ...,SET,94,-0.048433,-0.0034566,0.085335,0.71483,GOBP_PROTEIN_K48_LINKED_UBIQUITINATION,1
GOBP_REGULATION_OF_BLOOD_VOL...,SET,5,-0.2587,-0.0042686,0.45581,0.71483,GOBP_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN,1
GOBP_REGULATION_OF_TRANSLATI...12,SET,11,-0.13349,-0.0032664,0.23512,0.71489,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
MIR1237_3P,SET,120,-0.045821,-0.0036923,0.080658,0.71501,MIR1237_3P,1
MIR498_5P,SET,215,-0.034528,-0.0037144,0.060778,0.71501,MIR498_5P,1
KEGG_MEDICUS_REFERENCE_TSH_D...,SET,12,-0.14031,-0.0035859,0.24695,0.71503,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_ARP2_3_CO...,SET,18,-0.10239,-0.0032044,0.18013,0.71512,GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
GSE40274_CTRL_VS_GATA1_TRANS...2,SET,128,-0.042038,-0.0034977,0.07395,0.71514,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
FINETTI_BREAST_CANCERS_KINOM...2,SET,15,-0.12532,-0.0035804,0.22043,0.71515,FINETTI_BREAST_CANCERS_KINOME_GRAY,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...8,SET,32,-0.096095,-0.0040083,0.16903,0.71515,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP,1
FUJII_YBX1_TARGETS_UP,SET,36,-0.081176,-0.003591,0.14278,0.71516,FUJII_YBX1_TARGETS_UP,1
JIANG_MELANOMA_TRM10_LAMINA_...,SET,79,-0.061938,-0.0040541,0.10891,0.71521,JIANG_MELANOMA_TRM10_LAMINA_PROPRIA,1
YAMANAKA_GLIOBLASTOMA_SURVIV...1,SET,8,-0.15319,-0.0031969,0.26937,0.71521,YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN,1
HP_ABSENT_LACRIMAL_PUNCTUM,SET,6,-0.2086,-0.0037703,0.36678,0.71522,HP_ABSENT_LACRIMAL_PUNCTUM,1
GSE2706_R848_VS_LPS_2H_STIM_...1,SET,145,-0.041,-0.0036292,0.072075,0.71527,GSE2706_R848_VS_LPS_2H_STIM_DC_DN,1
GSE13522_WT_VS_IFNG_KO_SKING...1,SET,110,-0.04547,-0.003509,0.079927,0.71528,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,1
HP_DECREASED_ACTIVITY_OF_NAD...,SET,3,-0.30219,-0.0038626,0.53112,0.71531,HP_DECREASED_ACTIVITY_OF_NADPH_OXIDASE,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...1,SET,112,-0.044897,-0.0034959,0.078895,0.71534,GOMF_UBIQUITIN_LIKE_PROTEIN_BINDING,1
MIR3667_3P,SET,136,-0.042623,-0.0036548,0.074897,0.71535,MIR3667_3P,1
GOBP_NEGATIVE_REGULATION_OF_...85,SET,13,-0.14545,-0.0038691,0.25555,0.71538,GOBP_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,1
GOBP_IRON_ION_IMPORT_ACROSS_...,SET,4,-0.22864,-0.0033744,0.40166,0.7154,GOBP_IRON_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GSE15330_GRANULOCYTE_MONOCYT...1,SET,184,-0.035057,-0.0034919,0.061582,0.71541,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN,1
HP_HYPERKERATOSIS,SET,212,-0.033728,-0.0036033,0.059242,0.71543,HP_HYPERKERATOSIS,1
REACTOME_CGMP_EFFECTS,SET,15,-0.13486,-0.003853,0.23682,0.71547,REACTOME_CGMP_EFFECTS,1
chr6p25,SET,31,-0.15129,-0.0062114,0.26562,0.71551,chr6p25,1
HP_INTELLECTUAL_DISABILITY_S...,SET,312,-0.027262,-0.0035235,0.047862,0.71552,HP_INTELLECTUAL_DISABILITY_SEVERE,1
HP_CEREBELLAR_DENTATE_NUCLEU...,SET,5,-0.25989,-0.0042882,0.45622,0.71554,HP_CEREBELLAR_DENTATE_NUCLEUS_CALCIFICATION,1
GOBP_CELLULAR_HYPEROSMOTIC_R...,SET,19,-0.10972,-0.0035279,0.19261,0.71555,GOBP_CELLULAR_HYPEROSMOTIC_RESPONSE,1
MODULE_183,SET,62,-0.056886,-0.0033002,0.099841,0.71558,MODULE_183,1
GAVISH_3CA_METAPROGRAM_EPITH...11,SET,48,-0.076192,-0.0038907,0.13371,0.71559,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_1,1
BOYAULT_LIVER_CANCER_SUBCLAS...13,SET,11,-0.16537,-0.0040465,0.29015,0.71564,BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,1
GOMF_NEUROPEPTIDE_RECEPTOR_A...,SET,42,-0.084509,-0.0040373,0.1482,0.71573,GOMF_NEUROPEPTIDE_RECEPTOR_ACTIVITY,1
GOBP_SECONDARY_METABOLIC_PRO...,SET,55,-0.072208,-0.0039462,0.12658,0.71582,GOBP_SECONDARY_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_GLUTAMATE...3,SET,19,-0.12527,-0.0040278,0.21957,0.71584,GOBP_REGULATION_OF_GLUTAMATE_SECRETION,1
HP_ABNORMALITY_OF_BONE_MINER...,SET,572,-0.020713,-0.0035985,0.036294,0.71589,HP_ABNORMALITY_OF_BONE_MINERAL_DENSITY,1
HP_CRACKLES,SET,21,-0.11508,-0.0038898,0.20165,0.71589,HP_CRACKLES,1
REACTOME_MTOR_SIGNALLING,SET,40,-0.075185,-0.0035055,0.13173,0.7159,REACTOME_MTOR_SIGNALLING,1
HP_GONADOBLASTOMA,SET,14,-0.14222,-0.0039257,0.24919,0.7159,HP_GONADOBLASTOMA,1
SNRNP70_TARGET_GENES,SET,684,-0.018573,-0.0035174,0.032541,0.71591,SNRNP70_TARGET_GENES,1
HP_MINICORE_MYOPATHY,SET,8,-0.17004,-0.0035486,0.29785,0.71596,HP_MINICORE_MYOPATHY,1
GOBP_POSITIVE_REGULATION_OF_...231,SET,17,-0.12281,-0.0037354,0.21511,0.71598,GOBP_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,1
MIR148B_5P,SET,70,-0.057453,-0.0035408,0.10062,0.71599,MIR148B_5P,1
GOCC_CATALYTIC_STEP_1_SPLICE...,SET,10,-0.13875,-0.0032372,0.24297,0.71601,GOCC_CATALYTIC_STEP_1_SPLICEOSOME,1
GSE1791_CTRL_VS_NEUROMEDINU_...5,SET,168,-0.036655,-0.0034903,0.064184,0.71603,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN,1
FUJIWARA_PARK2_HEPATOCYTE_PR...2,SET,12,-0.16327,-0.0041727,0.28587,0.71604,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...2,SET,18,-0.12303,-0.0038505,0.21541,0.71605,GOBP_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_PORP...,SET,8,-0.17216,-0.0035929,0.30143,0.71605,HP_ABNORMAL_CIRCULATING_PORPHYRIN_CONCENTRATION,1
GOBP_CLATHRIN_COAT_ASSEMBLY,SET,18,-0.11436,-0.003579,0.20021,0.71607,GOBP_CLATHRIN_COAT_ASSEMBLY,1
GOBP_INTERLEUKIN_4_MEDIATED_...,SET,9,-0.16217,-0.0035897,0.28384,0.71611,GOBP_INTERLEUKIN_4_MEDIATED_SIGNALING_PATHWAY,1
GOMF_PROTEIN_SEQUESTERING_AC...,SET,25,-0.097985,-0.0036132,0.17143,0.71619,GOMF_PROTEIN_SEQUESTERING_ACTIVITY,1
GSE37301_PRO_BCELL_VS_RAG2_K...1,SET,169,-0.038277,-0.0036554,0.066965,0.7162,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN,1
HAHTOLA_MYCOSIS_FUNGOIDES_SK...2,SET,163,-0.037621,-0.003529,0.065779,0.71631,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...3,SET,8,-0.18655,-0.0038931,0.32609,0.71636,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_FORMATION,1
HE_LIM_SUN_FETAL_LUNG_C6_DEU...,SET,190,-0.033649,-0.0034053,0.058813,0.71638,HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL,1
XU_HGF_TARGETS_REPRESSED_BY_...1,SET,81,-0.053291,-0.0035319,0.093127,0.71642,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,1
GOBP_CAMKK_AMPK_SIGNALING_CA...,SET,9,-0.17123,-0.0037901,0.2992,0.71643,GOBP_CAMKK_AMPK_SIGNALING_CASCADE,1
WHITFIELD_CELL_CYCLE_S,SET,127,-0.042027,-0.0034833,0.073434,0.71644,WHITFIELD_CELL_CYCLE_S,1
GOMF_DOPAMINE_BINDING,SET,6,-0.22832,-0.0041267,0.39894,0.71644,GOMF_DOPAMINE_BINDING,1
GSE22611_NOD2_VS_CTRL_TRANSD...1,SET,185,-0.03489,-0.0034846,0.060964,0.71644,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,1
AP2REP_01,SET,156,-0.040324,-0.0037011,0.070454,0.71645,AP2REP_01,1
TET1_TARGET_GENES,SET,1072,-0.015268,-0.0035799,0.026674,0.71646,TET1_TARGET_GENES,1
HP_PERIPHERAL_DEMYELINATION,SET,40,-0.077753,-0.0036253,0.13582,0.71649,HP_PERIPHERAL_DEMYELINATION,1
GOBP_LACTATION,SET,37,-0.083329,-0.003737,0.14554,0.71653,GOBP_LACTATION,1
HP_BROAD_NECK,SET,21,-0.10102,-0.0034146,0.17643,0.71653,HP_BROAD_NECK,1
WP_CILIOPATHIES,SET,162,-0.036998,-0.00346,0.064613,0.71654,WP_CILIOPATHIES,1
BIOCARTA_CTLA4_PATHWAY,SET,17,-0.12242,-0.0037234,0.21374,0.71659,BIOCARTA_CTLA4_PATHWAY,1
HP_ABNORMAL_CIRCULATING_META...,SET,1249,-0.014321,-0.0036059,0.025002,0.71661,HP_ABNORMAL_CIRCULATING_METABOLITE_CONCENTRATION,1
HP_CLUBBING_OF_TOES,SET,28,-0.082698,-0.0032271,0.14436,0.71662,HP_CLUBBING_OF_TOES,1
HP_ABNORMALITY_OF_THE_DENTIT...,SET,875,-0.016878,-0.0035956,0.029455,0.71667,HP_ABNORMALITY_OF_THE_DENTITION,1
GSE34006_A2AR_KO_VS_A2AR_AGO...2,SET,190,-0.037369,-0.0037817,0.065213,0.71668,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP,1
HP_LIMITATION_OF_MOVEMENT_AT...,SET,5,-0.24459,-0.0040358,0.42681,0.71669,HP_LIMITATION_OF_MOVEMENT_AT_ANKLES,1
GSE42724_B1_BCELL_VS_PLASMAB...2,SET,184,-0.034983,-0.0034845,0.061038,0.71672,GSE42724_B1_BCELL_VS_PLASMABLAST_UP,1
HP_TUBE_FEEDING,SET,186,-0.03555,-0.00356,0.062023,0.71673,HP_TUBE_FEEDING,1
BERENJENO_TRANSFORMED_BY_RHO...3,SET,20,-0.11265,-0.003716,0.19653,0.71674,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,1
HP_ABNORMALITY_OF_THE_URINAR...,SET,988,-0.015873,-0.0035817,0.027692,0.71674,HP_ABNORMALITY_OF_THE_URINARY_SYSTEM_PHYSIOLOGY,1
HP_ABNORMAL_CRY,SET,54,-0.066916,-0.0036237,0.11673,0.71676,HP_ABNORMAL_CRY,1
GSE40274_CTRL_VS_FOXP3_AND_I...2,SET,146,-0.041731,-0.0037065,0.072795,0.71677,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOCC_PROTEIN_COMPLEX_INVOLVE...3,SET,17,-0.12247,-0.0037251,0.2136,0.7168,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_MATRIX_ADHESION,1
AKT_UP_MTOR_DN.V1_DN,SET,173,-0.037078,-0.0035822,0.064649,0.71685,AKT_UP_MTOR_DN.V1_DN,1
REACTOME_DOWNREGULATION_OF_E...1,SET,12,-0.14394,-0.0036787,0.25096,0.71686,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,1
HP_LUMBAR_SCOLIOSIS,SET,15,-0.1136,-0.0032458,0.19805,0.71689,HP_LUMBAR_SCOLIOSIS,1
HP_MULTIPLE_EXOSTOSES,SET,7,-0.20357,-0.0039741,0.35472,0.71697,HP_MULTIPLE_EXOSTOSES,1
MIR1909_3P,SET,120,-0.044394,-0.0035773,0.077335,0.71703,MIR1909_3P,1
HP_PROLONGED_BLEEDING_AFTER_...2,SET,16,-0.14071,-0.004152,0.24509,0.71705,HP_PROLONGED_BLEEDING_AFTER_SURGERY,1
HP_SPERMATOCYTE_MATURATION_A...,SET,3,-0.30204,-0.0038606,0.52605,0.71707,HP_SPERMATOCYTE_MATURATION_ARREST,1
GSE37534_GW1929_VS_ROSIGLITA...2,SET,149,-0.039284,-0.0035245,0.068404,0.71711,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,1
BIOCARTA_FBW7_PATHWAY,SET,9,-0.14793,-0.0032744,0.25755,0.71714,BIOCARTA_FBW7_PATHWAY,1
HP_ACHROMATOPSIA,SET,5,-0.25131,-0.0041467,0.43735,0.71723,HP_ACHROMATOPSIA,1
MIR4781_5P,SET,5,-0.23211,-0.0038298,0.40383,0.71727,MIR4781_5P,1
HAY_BONE_MARROW_PLASMA_CELL,SET,85,-0.055007,-0.0037341,0.095704,0.71727,HAY_BONE_MARROW_PLASMA_CELL,1
GOBP_REGULATION_OF_IRON_ION_...2,SET,6,-0.18637,-0.0033685,0.32424,0.71728,GOBP_REGULATION_OF_IRON_ION_TRANSPORT,1
DASU_IL6_SIGNALING_SCAR_DN,SET,13,-0.15013,-0.0039935,0.26113,0.71733,DASU_IL6_SIGNALING_SCAR_DN,1
HP_HYPOPIGMENTATION_OF_THE_F...,SET,22,-0.10422,-0.0036053,0.18126,0.71733,HP_HYPOPIGMENTATION_OF_THE_FUNDUS,1
HP_OTOSCLEROSIS,SET,6,-0.22446,-0.0040571,0.39018,0.71744,HP_OTOSCLEROSIS,1
MODULE_436,SET,118,-0.046698,-0.0037317,0.081166,0.71746,MODULE_436,1
GOBP_REGULATION_OF_CELLULAR_...15,SET,13,-0.14187,-0.0037738,0.2466,0.71746,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,1
BLANCO_MELO_SARS_COV_1_INFEC...2,SET,11,-0.15945,-0.0039018,0.27714,0.71747,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP,1
PID_BETA_CATENIN_NUC_PATHWAY,SET,70,-0.064034,-0.0039463,0.11129,0.71747,PID_BETA_CATENIN_NUC_PATHWAY,1
MODULE_128,SET,87,-0.055755,-0.0038289,0.096904,0.71747,MODULE_128,1
MIR920,SET,47,-0.068572,-0.003465,0.11916,0.71751,MIR920,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,SET,40,-0.078666,-0.0036678,0.13669,0.71752,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1
FAN_EMBRYONIC_CTX_NSC_1,SET,16,-0.13587,-0.0040091,0.23608,0.71752,FAN_EMBRYONIC_CTX_NSC_1,1
HP_DIFFUSE_WHITE_MATTER_ABNO...,SET,29,-0.088731,-0.0035237,0.15414,0.71756,HP_DIFFUSE_WHITE_MATTER_ABNORMALITIES,1
HP_ABNORMAL_MALE_GERM_CELL_M...,SET,57,-0.06393,-0.0035565,0.11105,0.71757,HP_ABNORMAL_MALE_GERM_CELL_MORPHOLOGY,1
WP_SULINDAC_METABOLIC_PATHWAY,SET,5,-0.24589,-0.0040572,0.4271,0.71759,WP_SULINDAC_METABOLIC_PATHWAY,1
HP_SHORT_4TH_METACARPAL,SET,10,-0.16731,-0.0039037,0.29055,0.71764,HP_SHORT_4TH_METACARPAL,1
HP_ABNORMAL_KNEE_PHYSIOLOGY,SET,78,-0.055825,-0.0036309,0.096927,0.71767,HP_ABNORMAL_KNEE_PHYSIOLOGY,1
HP_RENAL_PHOSPHATE_WASTING,SET,11,-0.16191,-0.0039618,0.28098,0.71776,HP_RENAL_PHOSPHATE_WASTING,1
GOBP_REGULATION_OF_SYSTEMIC_...4,SET,33,-0.093035,-0.0039407,0.16144,0.71779,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE,1
HP_ABNORMALITY_OF_DENTAL_STR...,SET,315,-0.027725,-0.0036002,0.048107,0.7178,HP_ABNORMALITY_OF_DENTAL_STRUCTURE,1
HP_KELOIDS,SET,9,-0.16565,-0.0036667,0.28738,0.71783,HP_KELOIDS,1
GSE4590_SMALL_VS_VPREB_POS_L...2,SET,149,-0.039872,-0.0035773,0.069155,0.71788,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,1
HP_CONFUSIONAL_AROUSAL,SET,9,-0.18082,-0.0040024,0.31358,0.7179,HP_CONFUSIONAL_AROUSAL,1
GSE1432_CTRL_VS_IFNG_6H_MICR...1,SET,183,-0.037329,-0.0037082,0.064728,0.71793,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,1
UNTERMAN_PROGRESSIVE_VS_STAB...2,SET,12,-0.17508,-0.0044746,0.30351,0.71798,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_DN,1
BRACHAT_RESPONSE_TO_METHOTRE...2,SET,18,-0.10647,-0.0033321,0.18456,0.71799,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,1
HP_PERSONALITY_DISORDER,SET,16,-0.12212,-0.0036034,0.21161,0.71805,HP_PERSONALITY_DISORDER,1
MIR624_3P,SET,90,-0.051768,-0.0036156,0.08969,0.71809,MIR624_3P,1
REACTOME_MET_ACTIVATES_RAS_S...,SET,10,-0.14054,-0.003279,0.24341,0.71815,REACTOME_MET_ACTIVATES_RAS_SIGNALING,1
GSE3982_DC_VS_BCELL_DN,SET,163,-0.037919,-0.0035569,0.065674,0.71815,GSE3982_DC_VS_BCELL_DN,1
GOBP_MITOCHONDRIAL_RNA_CATAB...,SET,6,-0.1766,-0.003192,0.30583,0.71817,GOBP_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,1
GOBP_MEMBRANE_REPOLARIZATION,SET,48,-0.076311,-0.0038968,0.13215,0.71818,GOBP_MEMBRANE_REPOLARIZATION,1
GSE14699_NAIVE_VS_DELETIONAL...1,SET,185,-0.036513,-0.0036467,0.063227,0.71819,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,1
RUTELLA_RESPONSE_TO_HGF_VS_C...1,SET,223,-0.03432,-0.0037593,0.059427,0.7182,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,1
GOMF_PHOSPHATIDYLETHANOLAMIN...2,SET,5,-0.24364,-0.0040201,0.42183,0.71822,GOMF_PHOSPHATIDYLETHANOLAMINE_FLIPPASE_ACTIVITY,1
GSE7548_NAIVE_VS_DAY7_PCC_IM...1,SET,184,-0.036968,-0.0036822,0.063999,0.71824,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN,1
chr15q25,SET,58,-0.10574,-0.0059337,0.18298,0.71832,chr15q25,1
IGF1R_TARGET_GENES,SET,2,-0.41125,-0.004292,0.71152,0.71836,IGF1R_TARGET_GENES,1
GOMF_DENEDDYLASE_ACTIVITY,SET,6,-0.15616,-0.0028225,0.27018,0.71836,GOMF_DENEDDYLASE_ACTIVITY,1
HP_DEVIATION_OF_THE_THUMB,SET,41,-0.074166,-0.0035009,0.12831,0.71838,HP_DEVIATION_OF_THE_THUMB,1
GROSS_HYPOXIA_VIA_ELK3_UP,SET,192,-0.03517,-0.0035777,0.060826,0.71843,GROSS_HYPOXIA_VIA_ELK3_UP,1
GOBP_NEGATIVE_REGULATION_OF_...220,SET,7,-0.17992,-0.0035125,0.31106,0.71851,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
GOBP_COLLAGEN_ACTIVATED_TYRO...,SET,9,-0.16676,-0.0036912,0.28826,0.71853,GOBP_COLLAGEN_ACTIVATED_TYROSINE_KINASE_RECEPTOR_SIGNALING_PATHWAY,1
GSE41867_DAY6_VS_DAY15_LCMV_...1,SET,169,-0.036647,-0.0034998,0.063338,0.71857,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
GOMF_INTRAMOLECULAR_OXIDORED...1,SET,51,-0.068174,-0.0035881,0.11781,0.71859,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY,1
BIOCARTA_BTG2_PATHWAY,SET,11,-0.13027,-0.0031878,0.22506,0.71865,BIOCARTA_BTG2_PATHWAY,1
GSE22611_NOD2_VS_MUTANT_NOD2...2,SET,170,-0.03647,-0.003493,0.063005,0.71865,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
GOBP_LEUKOCYTE_AGGREGATION,SET,12,-0.15908,-0.0040655,0.27453,0.71885,GOBP_LEUKOCYTE_AGGREGATION,1
BRF1_TARGET_GENES,SET,37,-0.084097,-0.0037714,0.1451,0.7189,BRF1_TARGET_GENES,1
HP_STROKE_LIKE_EPISODE,SET,12,-0.14378,-0.0036747,0.24802,0.71894,HP_STROKE_LIKE_EPISODE,1
BIOCARTA_HIF_PATHWAY,SET,15,-0.12378,-0.0035366,0.21348,0.71898,BIOCARTA_HIF_PATHWAY,1
REACTOME_FCGAMMA_RECEPTOR_FC...,SET,81,-0.054126,-0.0035872,0.093346,0.71899,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1
HP_HAIR_FOLLICLE_NEOPLASM,SET,5,-0.27032,-0.0044603,0.46616,0.719,HP_HAIR_FOLLICLE_NEOPLASM,1
RICKMAN_TUMOR_DIFFERENTIATED...5,SET,356,-0.026852,-0.0037027,0.04628,0.71911,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,1
GOBP_CATECHOLAMINE_UPTAKE,SET,17,-0.12786,-0.003889,0.22035,0.71913,GOBP_CATECHOLAMINE_UPTAKE,1
HP_NEPHROLITHIASIS,SET,131,-0.045732,-0.0038492,0.078794,0.71917,HP_NEPHROLITHIASIS,1
HP_ABNORMAL_PROSODY,SET,61,-0.067179,-0.0038658,0.11572,0.71921,HP_ABNORMAL_PROSODY,1
HP_INCREASED_RED_BLOOD_CELL_...,SET,5,-0.21046,-0.0034727,0.36254,0.71921,HP_INCREASED_RED_BLOOD_CELL_MASS,1
GOBP_CYTOKINE_PRODUCTION,SET,720,-0.019491,-0.0037834,0.033575,0.71922,GOBP_CYTOKINE_PRODUCTION,1
GAGACTG_MIR452,SET,88,-0.052326,-0.0036139,0.090075,0.71935,GAGACTG_MIR452,1
GOCC_AUTOPHAGOSOME_MEMBRANE,SET,49,-0.070519,-0.0036382,0.12138,0.71936,GOCC_AUTOPHAGOSOME_MEMBRANE,1
GOCC_PYRUVATE_DEHYDROGENASE_...,SET,5,-0.27396,-0.0045204,0.4715,0.71939,GOCC_PYRUVATE_DEHYDROGENASE_COMPLEX,1
SMID_BREAST_CANCER_RELAPSE_I...5,SET,10,-0.14975,-0.0034938,0.25767,0.71942,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,1
GSE2128_C57BL6_VS_NOD_THYMOC...3,SET,183,-0.037407,-0.0037159,0.064358,0.71945,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP,1
GOMF_TUMOR_NECROSIS_FACTOR_R...2,SET,28,-0.10094,-0.003939,0.17365,0.71948,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING,1
GSE14308_TH17_VS_NAIVE_CD4_T...1,SET,182,-0.036595,-0.0036254,0.062953,0.71948,GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN,1
HP_HYDROPS_FETALIS,SET,115,-0.045805,-0.0036138,0.078792,0.71949,HP_HYDROPS_FETALIS,1
LOPEZ_TRANSLATION_VIA_FN1_SI...,SET,34,-0.088708,-0.0038139,0.15257,0.71952,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,1
PEREZ_TP63_TARGETS,SET,309,-0.029976,-0.0038559,0.051555,0.71952,PEREZ_TP63_TARGETS,1
GSE24634_NAIVE_CD4_TCELL_VS_...5,SET,187,-0.034366,-0.0034506,0.059099,0.71954,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...11,SET,8,-0.21348,-0.0044552,0.36708,0.71957,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN,1
REACTOME_FORMATION_OF_THE_CO...,SET,120,-0.058563,-0.0047191,0.10069,0.71958,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,1
ATAGGAA_MIR202,SET,95,-0.052445,-0.0037627,0.090159,0.71961,ATAGGAA_MIR202,1
GOCC_PHOSPHORYLASE_KINASE_CO...,SET,3,-0.23795,-0.0030413,0.40903,0.71962,GOCC_PHOSPHORYLASE_KINASE_COMPLEX,1
MIR6795_3P,SET,12,-0.15124,-0.0038654,0.25998,0.71963,MIR6795_3P,1
HP_ABNORMAL_BLOOD_TRANSITION...,SET,37,-0.080856,-0.0036261,0.13899,0.71963,HP_ABNORMAL_BLOOD_TRANSITION_ELEMENT_CATION_CONCENTRATION,1
BUSSLINGER_DUODENAL_I_CELLS,SET,14,-0.13699,-0.0037815,0.23547,0.71964,BUSSLINGER_DUODENAL_I_CELLS,1
HP_ICHTHYOSIS,SET,123,-0.045089,-0.0036781,0.077458,0.71975,HP_ICHTHYOSIS,1
HP_MACULAR_DEGENERATION,SET,87,-0.053623,-0.0036825,0.092113,0.71976,HP_MACULAR_DEGENERATION,1
chr5p12,SET,12,-0.25099,-0.0064145,0.43106,0.7198,chr5p12,1
HP_HEINZ_BODIES,SET,2,-0.32489,-0.0033907,0.55795,0.71981,HP_HEINZ_BODIES,1
HP_THICKENED_EARS,SET,11,-0.15833,-0.0038742,0.27191,0.71981,HP_THICKENED_EARS,1
HP_CARPAL_BONE_HYPOPLASIA,SET,11,-0.13523,-0.003309,0.23218,0.71986,HP_CARPAL_BONE_HYPOPLASIA,1
GOBP_PEPTIDYL_LYSINE_HYDROXY...,SET,8,-0.18044,-0.0037657,0.30965,0.71996,GOBP_PEPTIDYL_LYSINE_HYDROXYLATION,1
PID_RHOA_REG_PATHWAY,SET,42,-0.078777,-0.0037635,0.13514,0.72002,PID_RHOA_REG_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...603,SET,11,-0.16412,-0.0040161,0.28149,0.72007,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
HP_TRANSIENT_NEUTROPENIA,SET,7,-0.16239,-0.0031703,0.27846,0.72011,HP_TRANSIENT_NEUTROPENIA,1
HP_AGYRIA,SET,15,-0.11278,-0.0032222,0.19327,0.72023,HP_AGYRIA,1
MODULE_240,SET,14,-0.13547,-0.0037394,0.23214,0.72024,MODULE_240,1
HP_ABNORMAL_CIRCULATING_ARGI...,SET,8,-0.16081,-0.003356,0.27556,0.72024,HP_ABNORMAL_CIRCULATING_ARGININE_CONCENTRATION,1
MIR3616_3P,SET,54,-0.064342,-0.0034843,0.11025,0.72026,MIR3616_3P,1
AAAYWAACM_HFH4_01,SET,224,-0.035106,-0.003854,0.060133,0.72032,AAAYWAACM_HFH4_01,1
GOBP_DEPYRIMIDINATION,SET,8,-0.16927,-0.0035326,0.28993,0.72033,GOBP_DEPYRIMIDINATION,1
GOBP_PROTEIN_HETEROOLIGOMERI...,SET,29,-0.089113,-0.0035388,0.15264,0.72033,GOBP_PROTEIN_HETEROOLIGOMERIZATION,1
GOMF_MECHANOSENSITIVE_MONOAT...2,SET,16,-0.12841,-0.0037891,0.21994,0.72034,GOMF_MECHANOSENSITIVE_MONOATOMIC_ION_CHANNEL_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...352,SET,13,-0.13259,-0.003527,0.22709,0.72035,GOBP_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMAL_ELASTICITY_OF_SK...,SET,204,-0.034869,-0.003655,0.059713,0.72036,HP_ABNORMAL_ELASTICITY_OF_SKIN,1
HP_HYPEREOSINOPHILIA,SET,5,-0.22869,-0.0037734,0.39162,0.72037,HP_HYPEREOSINOPHILIA,1
HP_HETEROPHORIA,SET,11,-0.14106,-0.0034516,0.24151,0.72041,HP_HETEROPHORIA,1
GOBP_PALLIUM_DEVELOPMENT,SET,174,-0.039752,-0.0038515,0.068032,0.72049,GOBP_PALLIUM_DEVELOPMENT,1
HP_LIMB_PAIN,SET,52,-0.07167,-0.0038088,0.12261,0.72057,HP_LIMB_PAIN,1
GOMF_IRON_ION_BINDING,SET,139,-0.044521,-0.0038591,0.076134,0.72064,GOMF_IRON_ION_BINDING,1
HP_ABNORMALITY_OF_THE_UMBILI...,SET,62,-0.063329,-0.0036739,0.1083,0.72064,HP_ABNORMALITY_OF_THE_UMBILICAL_CORD,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...1,SET,156,-0.042207,-0.003874,0.072174,0.72065,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN,1
GOMF_MRNA_3_UTR_AU_RICH_REGI...,SET,28,-0.09357,-0.0036513,0.15994,0.72073,GOMF_MRNA_3_UTR_AU_RICH_REGION_BINDING,1
UZONYI_RESPONSE_TO_LEUKOTRIE...,SET,34,-0.10249,-0.0044064,0.17517,0.72075,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1
CCAATNNSNNNGCG_UNKNOWN,SET,53,-0.072686,-0.0038996,0.12421,0.72078,CCAATNNSNNNGCG_UNKNOWN,1
MIR6806_3P,SET,93,-0.052476,-0.0037253,0.089649,0.72084,MIR6806_3P,1
YIH_RESPONSE_TO_ARSENITE_C2,SET,14,-0.12657,-0.0034939,0.21621,0.72087,YIH_RESPONSE_TO_ARSENITE_C2,1
WP_OSX_AND_MIRNAS_IN_TOOTH_D...,SET,15,-0.13974,-0.0039925,0.23868,0.72088,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,1
MIR4755_5P,SET,333,-0.028762,-0.0038382,0.049114,0.72093,MIR4755_5P,1
GOBP_INORGANIC_ION_IMPORT_AC...,SET,113,-0.049513,-0.0038724,0.084536,0.72096,GOBP_INORGANIC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GAUCHER_PBMC_YF_VAX_STAMARIL...8,SET,206,-0.035991,-0.0037909,0.061417,0.72106,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,1
GOCC_RECEPTOR_COMPLEX,SET,382,-0.027454,-0.0039187,0.046844,0.72109,GOCC_RECEPTOR_COMPLEX,1
GSE10325_BCELL_VS_LUPUS_BCEL...2,SET,163,-0.039572,-0.003712,0.06751,0.72112,GSE10325_BCELL_VS_LUPUS_BCELL_UP,1
MODULE_396,SET,9,-0.18787,-0.0041585,0.3204,0.72118,MODULE_396,1
HP_TUBULOINTERSTITIAL_NEPHRI...,SET,19,-0.10166,-0.0032685,0.17336,0.72119,HP_TUBULOINTERSTITIAL_NEPHRITIS,1
GOBP_REGULATION_OF_ASYMMETRI...,SET,5,-0.21816,-0.0035997,0.37201,0.72121,GOBP_REGULATION_OF_ASYMMETRIC_CELL_DIVISION,1
HP_SQUARE_FACE,SET,11,-0.17117,-0.0041884,0.29184,0.72123,HP_SQUARE_FACE,1
GOBP_NEUROBLAST_PROLIFERATION,SET,78,-0.057576,-0.0037448,0.09816,0.72125,GOBP_NEUROBLAST_PROLIFERATION,1
GSE22033_UNTREATED_VS_ROSIGL...2,SET,182,-0.035369,-0.0035039,0.060295,0.72126,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP,1
HP_RETINAL_DETACHMENT,SET,97,-0.052527,-0.0038079,0.089537,0.72128,HP_RETINAL_DETACHMENT,1
GOBP_HORMONE_TRANSPORT,SET,304,-0.03017,-0.0038499,0.051423,0.72129,GOBP_HORMONE_TRANSPORT,1
HP_ABDOMINAL_MASS,SET,9,-0.20225,-0.0044767,0.3447,0.72131,HP_ABDOMINAL_MASS,1
MARSON_BOUND_BY_FOXP3_STIMUL...,SET,879,-0.017567,-0.0037506,0.029935,0.72134,MARSON_BOUND_BY_FOXP3_STIMULATED,1
GOBP_GLUTAMATERGIC_NEURON_DI...,SET,15,-0.14861,-0.0042459,0.25318,0.72138,GOBP_GLUTAMATERGIC_NEURON_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...473,SET,25,-0.091907,-0.0033891,0.15657,0.7214,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
WP_GLYCOLYSIS_AND_GLUCONEOGE...,SET,38,-0.079095,-0.0035946,0.13473,0.72142,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,1
GSE8685_IL2_ACT_IL2_STARVED_...2,SET,181,-0.036061,-0.0035628,0.061416,0.72145,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,1
MIR193B_5P,SET,55,-0.066075,-0.003611,0.11251,0.72148,MIR193B_5P,1
MIR7154_3P,SET,56,-0.068096,-0.0037551,0.11596,0.72148,MIR7154_3P,1
GSE13229_IMM_VS_MATURE_NKCEL...1,SET,183,-0.036997,-0.0036752,0.062968,0.72158,GSE13229_IMM_VS_MATURE_NKCELL_DN,1
DOUGLAS_BMI1_TARGETS_UP,SET,513,-0.022608,-0.0037259,0.038476,0.72159,DOUGLAS_BMI1_TARGETS_UP,1
MIR181A_2_3P,SET,99,-0.052429,-0.0038395,0.089228,0.72159,MIR181A_2_3P,1
ZSCAN30_TARGET_GENES,SET,1379,-0.014347,-0.0037815,0.024418,0.72159,ZSCAN30_TARGET_GENES,1
KEGG_ENDOMETRIAL_CANCER,SET,50,-0.071168,-0.0037088,0.12106,0.72168,KEGG_ENDOMETRIAL_CANCER,1
REACTOME_ABACAVIR_TRANSMEMBR...,SET,5,-0.26983,-0.0044523,0.45898,0.7217,REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT,1
GSE9988_LPS_VS_LPS_AND_ANTI_...2,SET,177,-0.038465,-0.0037585,0.065424,0.72171,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP,1
GSE20366_EX_VIVO_VS_HOMEOSTA...3,SET,179,-0.038418,-0.0037748,0.065334,0.72173,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN,1
GSE20715_0H_VS_24H_OZONE_LUN...1,SET,189,-0.037062,-0.0037409,0.06302,0.72176,GSE20715_0H_VS_24H_OZONE_LUNG_DN,1
GOBP_MATURATION_OF_LSU_RRNA,SET,23,-0.091356,-0.0032314,0.15534,0.72177,GOBP_MATURATION_OF_LSU_RRNA,1
GOBP_URIDINE_TRANSMEMBRANE_T...,SET,6,-0.22448,-0.0040574,0.38133,0.72195,GOBP_URIDINE_TRANSMEMBRANE_TRANSPORT,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...9,SET,65,-0.056172,-0.0033363,0.095417,0.72196,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,1
WP_INTERLEUKIN1_INDUCED_ACTI...,SET,9,-0.16671,-0.0036901,0.28312,0.722,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,1
DESCARTES_MAIN_FETAL_MESOTHE...,SET,22,-0.11729,-0.0040576,0.19919,0.72201,DESCARTES_MAIN_FETAL_MESOTHELIAL_CELLS,1
GOCC_ENDOCYTIC_VESICLE_MEMBR...,SET,177,-0.039789,-0.0038878,0.067567,0.72203,GOCC_ENDOCYTIC_VESICLE_MEMBRANE,1
GSE17974_IL4_AND_ANTI_IL12_V...9,SET,144,-0.044386,-0.0039155,0.07535,0.72209,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN,1
KYNG_WERNER_SYNDROM_AND_NORM...1,SET,163,-0.037714,-0.0035377,0.064005,0.72214,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1
GOMF_BETA_2_ADRENERGIC_RECEP...,SET,5,-0.22995,-0.0037943,0.39027,0.72214,GOMF_BETA_2_ADRENERGIC_RECEPTOR_BINDING,1
GOMF_GENERAL_TRANSCRIPTION_I...2,SET,50,-0.070422,-0.00367,0.11947,0.72222,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,1
GOCC_RIBOSOMAL_SUBUNIT,SET,167,-0.036183,-0.0034351,0.061379,0.72223,GOCC_RIBOSOMAL_SUBUNIT,1
GSE7460_TREG_VS_TCONV_ACT_WI...2,SET,175,-0.03882,-0.0037719,0.06585,0.72224,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP,1
GSE21546_UNSTIM_VS_ANTI_CD3_...2,SET,163,-0.040105,-0.003762,0.068009,0.7223,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
GSE42724_NAIVE_VS_B1_BCELL_DN,SET,170,-0.036663,-0.0035115,0.062169,0.72231,GSE42724_NAIVE_VS_B1_BCELL_DN,1
GOBP_REGULATION_OF_MACROPHAG...4,SET,31,-0.097987,-0.0040229,0.16612,0.72236,GOBP_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
HE_LIM_SUN_FETAL_LUNG_C1_MUC...,SET,48,-0.07852,-0.0040096,0.1331,0.72238,HE_LIM_SUN_FETAL_LUNG_C1_MUC5AC_POS_ASCL1_POS_PROGENITOR_CELL,1
BLANCO_MELO_BETA_INTERFERON_...2,SET,337,-0.029639,-0.0039784,0.050231,0.72242,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,1
GOBP_ERBB4_SIGNALING_PATHWAY,SET,9,-0.16662,-0.0036882,0.28235,0.72244,GOBP_ERBB4_SIGNALING_PATHWAY,1
HP_ABNORMAL_PHALANGEAL_JOINT...,SET,194,-0.036867,-0.0037696,0.062458,0.72249,HP_ABNORMAL_PHALANGEAL_JOINT_MORPHOLOGY_OF_THE_HAND,1
GSE43863_LY6C_INT_CXCR5POS_V...1,SET,180,-0.038592,-0.0038024,0.065376,0.7225,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,1
MODULE_81,SET,18,-0.11244,-0.003519,0.19048,0.72251,MODULE_81,1
GOBP_MONOCYTE_ACTIVATION,SET,12,-0.15382,-0.0039312,0.26048,0.72257,GOBP_MONOCYTE_ACTIVATION,1
GSE3720_VD1_VS_VD2_GAMMADELT...6,SET,177,-0.038213,-0.0037339,0.064711,0.72257,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...71,SET,6,-0.20269,-0.0036635,0.3432,0.7226,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY,1
GOBP_BRANCHING_INVOLVED_IN_B...,SET,31,-0.099274,-0.0040758,0.16808,0.72262,GOBP_BRANCHING_INVOLVED_IN_BLOOD_VESSEL_MORPHOGENESIS,1
HAMAI_APOPTOSIS_VIA_TRAIL_DN,SET,176,-0.037396,-0.0036438,0.063296,0.72267,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1
GOCC_CLATHRIN_COAT,SET,48,-0.071867,-0.0036698,0.12164,0.72268,GOCC_CLATHRIN_COAT,1
HP_HEART_BLOCK,SET,116,-0.046835,-0.0037109,0.079261,0.7227,HP_HEART_BLOCK,1
GSE46606_DAY1_VS_DAY3_CD40L_...2,SET,155,-0.043411,-0.0039718,0.073468,0.7227,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP,1
HP_HYPOPLASIA_OF_THE_EPIGLOT...,SET,9,-0.17734,-0.0039255,0.3001,0.72272,HP_HYPOPLASIA_OF_THE_EPIGLOTTIS,1
GSE37532_VISCERAL_ADIPOSE_TI...5,SET,85,-0.05812,-0.0039454,0.098348,0.72272,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN,1
DARWICHE_PAPILLOMA_RISK_HIGH...1,SET,163,-0.038542,-0.0036154,0.065197,0.72279,DARWICHE_PAPILLOMA_RISK_HIGH_DN,1
TURASHVILI_BREAST_LOBULAR_CA...4,SET,90,-0.055617,-0.0038844,0.094043,0.72287,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...65,SET,28,-0.095968,-0.0037449,0.16227,0.72287,HP_APLASIA_HYPOPLASIA_OF_THE_SCAPULAE,1
HP_ABSENT_TIBIA,SET,5,-0.2553,-0.0042125,0.43159,0.72292,HP_ABSENT_TIBIA,1
GOBP_AXONAL_TRANSPORT,SET,62,-0.065552,-0.0038029,0.11079,0.72296,GOBP_AXONAL_TRANSPORT,1
GOBP_CELL_PROJECTION_MORPHOG...,SET,613,-0.021669,-0.0038929,0.036624,0.72296,GOBP_CELL_PROJECTION_MORPHOGENESIS,1
BERENJENO_TRANSFORMED_BY_RHO...2,SET,27,-0.1014,-0.0038856,0.17137,0.72297,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,1
HP_CORONARY_ARTERY_ANEURYSM,SET,7,-0.22791,-0.0044493,0.38516,0.72298,HP_CORONARY_ARTERY_ANEURYSM,1
WP_MAP3K1_ROLE_IN_PROMOTING_...,SET,16,-0.13878,-0.004095,0.23452,0.72299,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,1
GOBP_POSITIVE_REGULATION_OF_...742,SET,6,-0.23575,-0.0042611,0.39836,0.723,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
GSE29164_UNTREATED_VS_CD8_TC...4,SET,172,-0.036972,-0.0035617,0.062464,0.72303,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,1
MODULE_445,SET,11,-0.15894,-0.0038892,0.26852,0.72304,MODULE_445,1
HP_AXILLARY_PTERYGIUM,SET,9,-0.1796,-0.0039754,0.30338,0.72307,HP_AXILLARY_PTERYGIUM,1
BALLIF_DEVELOPMENTAL_DISABIL...,SET,13,-0.144,-0.0038303,0.24321,0.7231,BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION,1
MENON_FETAL_KIDNEY_4_PODOCYT...,SET,181,-0.038544,-0.0038081,0.065097,0.7231,MENON_FETAL_KIDNEY_4_PODOCYTES,1
GOBP_STRIATED_MUSCLE_ADAPTAT...,SET,45,-0.078931,-0.0039029,0.13329,0.72313,GOBP_STRIATED_MUSCLE_ADAPTATION,1
MIR4291,SET,351,-0.026897,-0.0036833,0.045408,0.72319,MIR4291,1
MIR1250_3P,SET,457,-0.024761,-0.0038576,0.04179,0.72324,MIR1250_3P,1
MIR6071,SET,155,-0.040281,-0.0036855,0.067977,0.72326,MIR6071,1
GSE22886_IGG_IGA_MEMORY_BCEL...3,SET,177,-0.038144,-0.0037271,0.064359,0.72329,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,1
PPARA_01,SET,31,-0.09167,-0.0037636,0.15466,0.72331,PPARA_01,1
FERRARI_RESPONSE_TO_FENRETIN...2,SET,20,-0.13152,-0.0043386,0.22189,0.72332,FERRARI_RESPONSE_TO_FENRETINIDE_UP,1
GOBP_MESENCHYMAL_TO_EPITHELI...2,SET,11,-0.18308,-0.00448,0.30888,0.72332,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,1
HP_ANENCEPHALY,SET,37,-0.076644,-0.0034372,0.1293,0.72333,HP_ANENCEPHALY,1
MIR8087,SET,125,-0.045707,-0.0037586,0.077103,0.72334,MIR8087,1
HP_SYMPHALANGISM_OF_MIDDLE_P...2,SET,5,-0.22782,-0.003759,0.3843,0.72334,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_FINGER,1
GSE13738_RESTING_VS_BYSTANDE...1,SET,173,-0.039171,-0.0037844,0.06607,0.72337,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,1
REACTOME_ESTROGEN_BIOSYNTHES...,SET,6,-0.20315,-0.0036719,0.3426,0.7234,REACTOME_ESTROGEN_BIOSYNTHESIS,1
PEA3_Q6,SET,242,-0.033861,-0.0038618,0.057091,0.72344,PEA3_Q6,1
GOMF_P_TYPE_CALCIUM_TRANSPOR...,SET,8,-0.16546,-0.0034531,0.27898,0.72344,GOMF_P_TYPE_CALCIUM_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_ANGIOTENS...,SET,8,-0.19029,-0.0039712,0.32081,0.72346,GOBP_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD,1
GOBP_LYMPHANGIOGENESIS,SET,17,-0.12656,-0.0038494,0.21329,0.72353,GOBP_LYMPHANGIOGENESIS,1
WONG_ENDMETRIUM_CANCER_DN,SET,69,-0.065774,-0.0040246,0.11084,0.72355,WONG_ENDMETRIUM_CANCER_DN,1
KEGG_MEDICUS_ENV_FACTOR_META...1,SET,8,-0.20017,-0.0041774,0.3373,0.72355,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY,1
WEBER_METHYLATED_HCP_IN_FIBR...1,SET,38,-0.078601,-0.0035722,0.13244,0.72357,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,1
MIR6796_3P,SET,55,-0.069505,-0.0037985,0.11711,0.72357,MIR6796_3P,1
KAECH_NAIVE_VS_MEMORY_CD8_TC...2,SET,184,-0.03816,-0.003801,0.064268,0.72366,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
KEGG_ARACHIDONIC_ACID_METABO...,SET,58,-0.075287,-0.0042248,0.12676,0.72372,KEGG_ARACHIDONIC_ACID_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...426,SET,129,-0.045983,-0.0038408,0.077358,0.72388,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,1
GSE15750_WT_VS_TRAF6KO_DAY6_...1,SET,185,-0.03751,-0.0037462,0.06308,0.72395,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...46,SET,24,-0.10534,-0.0038059,0.1771,0.72401,GOBP_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,1
HP_FOCAL_AUTONOMIC_SEIZURE,SET,11,-0.14975,-0.0036644,0.25176,0.72402,HP_FOCAL_AUTONOMIC_SEIZURE,1
HP_PAROXYSMAL_VENTRICULAR_TA...,SET,26,-0.10165,-0.0038226,0.17087,0.72404,HP_PAROXYSMAL_VENTRICULAR_TACHYCARDIA,1
REACTOME_RHOBTB3_ATPASE_CYCLE,SET,8,-0.17292,-0.0036088,0.29065,0.72405,REACTOME_RHOBTB3_ATPASE_CYCLE,1
GSE16385_UNTREATED_VS_12H_IL...1,SET,171,-0.037954,-0.0036457,0.063796,0.72405,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN,1
GOBP_REGULATION_OF_TRANSMEMB...2,SET,420,-0.026632,-0.0039817,0.044739,0.72417,GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
WONG_ENDMETRIUM_CANCER_UP,SET,24,-0.109,-0.0039383,0.18309,0.72418,WONG_ENDMETRIUM_CANCER_UP,1
GOBP_REGULATION_OF_TERMINATI...,SET,5,-0.2328,-0.0038412,0.39104,0.72418,GOBP_REGULATION_OF_TERMINATION_OF_DNA_TEMPLATED_TRANSCRIPTION,1
GSE14350_IL2RB_KO_VS_WT_TEFF...1,SET,184,-0.036841,-0.0036696,0.061881,0.72419,GSE14350_IL2RB_KO_VS_WT_TEFF_DN,1
HP_PROMINENT_SUPRAORBITAL_RI...,SET,33,-0.090187,-0.0038201,0.15147,0.72421,HP_PROMINENT_SUPRAORBITAL_RIDGES,1
MIR132_3P,SET,173,-0.038263,-0.0036967,0.064251,0.72425,MIR132_3P,1
HP_GENERALIZED_NEONATAL_HYPO...,SET,18,-0.10874,-0.003403,0.18258,0.72426,HP_GENERALIZED_NEONATAL_HYPOTONIA,1
WANG_LMO4_TARGETS_UP,SET,310,-0.028325,-0.0036493,0.047548,0.72431,WANG_LMO4_TARGETS_UP,1
ZNF512_TARGET_GENES,SET,327,-0.028992,-0.0038345,0.048659,0.72434,ZNF512_TARGET_GENES,1
REACTOME_FC_EPSILON_RECEPTOR...,SET,125,-0.04288,-0.0035261,0.071956,0.72438,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1
GSE36078_UNTREATED_VS_AD5_IN...2,SET,182,-0.03674,-0.0036397,0.06165,0.72439,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP,1
GOBP_PROTEIN_TRANSPORT_TO_VA...,SET,15,-0.11843,-0.0033838,0.19872,0.7244,GOBP_PROTEIN_TRANSPORT_TO_VACUOLE_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...771,SET,48,-0.068105,-0.0034777,0.11425,0.72444,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_II,1
HP_ABNORMALITY_OF_CENTRAL_NE...,SET,525,-0.022307,-0.0037178,0.037421,0.72445,HP_ABNORMALITY_OF_CENTRAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
GSE43863_TFH_VS_LY6C_INT_CXC...2,SET,182,-0.037408,-0.003706,0.06274,0.72449,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,1
chr7p21,SET,35,-0.14266,-0.0062229,0.23914,0.72459,chr7p21,1
EGUCHI_CELL_CYCLE_RB1_TARGETS,SET,22,-0.10698,-0.0037009,0.17931,0.72462,EGUCHI_CELL_CYCLE_RB1_TARGETS,1
KEGG_MEDICUS_VARIANT_MUTATIO...78,SET,7,-0.17975,-0.0035091,0.30114,0.72471,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048,1
NABA_MATRISOME_HIGHLY_METAST...1,SET,37,-0.080008,-0.0035881,0.13403,0.72472,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER,1
GOBP_PROTEIN_CONTAINING_COMP...2,SET,231,-0.032251,-0.0035947,0.054028,0.72472,GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
HP_ATOPIC_DERMATITIS,SET,35,-0.089863,-0.0039198,0.15052,0.72475,HP_ATOPIC_DERMATITIS,1
GSE22886_NAIVE_BCELL_VS_BLOO...1,SET,175,-0.037605,-0.0036538,0.062978,0.72478,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
GSE38681_WT_VS_LYL1_KO_LYMPH...2,SET,179,-0.037061,-0.0036415,0.062066,0.72478,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,1
MEISSNER_BRAIN_ICP_WITH_H3K4...,SET,27,-0.091315,-0.0034992,0.1529,0.72482,MEISSNER_BRAIN_ICP_WITH_H3K4ME3,1
GOMF_ADP_PHOSPHATASE_ACTIVITY,SET,6,-0.18811,-0.0034,0.31485,0.7249,GOMF_ADP_PHOSPHATASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_HIF_1...,SET,9,-0.18247,-0.0040389,0.30529,0.72497,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY,1
WANG_RESPONSE_TO_BEXAROTENE_...1,SET,28,-0.10049,-0.0039214,0.16809,0.72503,WANG_RESPONSE_TO_BEXAROTENE_DN,1
MIR4520_5P,SET,6,-0.22719,-0.0041063,0.37994,0.72506,MIR4520_5P,1
GOMF_FATTY_ACID_BINDING,SET,44,-0.078061,-0.0038168,0.13054,0.72506,GOMF_FATTY_ACID_BINDING,1
PID_ALPHA_SYNUCLEIN_PATHWAY,SET,30,-0.098411,-0.0039748,0.16453,0.72512,PID_ALPHA_SYNUCLEIN_PATHWAY,1
GSE27291_0H_VS_7D_STIM_GAMMA...2,SET,154,-0.039701,-0.0036207,0.066368,0.72514,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP,1
GOBP_LOCOMOTORY_EXPLORATION_...,SET,14,-0.14458,-0.0039908,0.24167,0.72516,GOBP_LOCOMOTORY_EXPLORATION_BEHAVIOR,1
HP_BONE_CYST,SET,27,-0.097497,-0.0037361,0.16297,0.72516,HP_BONE_CYST,1
HP_ELEVATED_URINARY_VANILLYL...,SET,9,-0.20189,-0.0044689,0.33742,0.72519,HP_ELEVATED_URINARY_VANILLYLMANDELIC_ACID,1
WP_MIR5093P_ALTERATION_OF_YA...,SET,17,-0.14408,-0.004382,0.24064,0.72532,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,1
GOBP_TYPE_I_INTERFERON_PRODU...,SET,106,-0.047745,-0.0036173,0.079739,0.72533,GOBP_TYPE_I_INTERFERON_PRODUCTION,1
MIR6735_3P,SET,33,-0.086722,-0.0036733,0.14483,0.72534,MIR6735_3P,1
GOCC_AXOLEMMA,SET,15,-0.1528,-0.0043659,0.25513,0.72539,GOCC_AXOLEMMA,1
HP_ABNORMALITY_OF_THE_AUTONO...,SET,269,-0.031027,-0.003728,0.051801,0.7254,HP_ABNORMALITY_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,1
GSE29618_PRE_VS_DAY7_POST_LA...4,SET,169,-0.040512,-0.0038688,0.067636,0.7254,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP,1
GOBP_NATURAL_KILLER_CELL_DIF...,SET,24,-0.11058,-0.0039953,0.18458,0.72543,GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION,1
GOMF_TRANSMEMBRANE_RECEPTOR_...2,SET,16,-0.13497,-0.0039827,0.22531,0.72543,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY,1
REACTOME_TICAM1_RIP1_MEDIATE...,SET,17,-0.13484,-0.004101,0.22506,0.72544,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,1
GOBP_NEUROGENESIS,SET,1593,-0.013894,-0.0039111,0.023191,0.72545,GOBP_NEUROGENESIS,1
LE_SKI_TARGETS_UP,SET,17,-0.13101,-0.0039847,0.21865,0.72547,LE_SKI_TARGETS_UP,1
REACTOME_ERYTHROPOIETIN_ACTI...3,SET,14,-0.13325,-0.0036781,0.22235,0.7255,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,1
GOBP_LEUKOCYTE_CHEMOTAXIS,SET,219,-0.037743,-0.0040975,0.062982,0.7255,GOBP_LEUKOCYTE_CHEMOTAXIS,1
GOBP_VERY_LONG_CHAIN_FATTY_A...1,SET,13,-0.1651,-0.0043917,0.27549,0.72551,GOBP_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
MIR874_5P,SET,55,-0.065352,-0.0035715,0.10903,0.72555,MIR874_5P,1
HP_CYANOSIS,SET,100,-0.051832,-0.0038149,0.086472,0.72555,HP_CYANOSIS,1
DUAN_PRDM5_TARGETS,SET,65,-0.067759,-0.0040246,0.11302,0.72559,DUAN_PRDM5_TARGETS,1
MIR6726_5P,SET,45,-0.072291,-0.0035746,0.12054,0.72564,MIR6726_5P,1
LAKE_ADULT_KIDNEY_C17_COLLEC...,SET,225,-0.036948,-0.004065,0.061609,0.72565,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,1
GOBP_LEUKOCYTE_DEGRANULATION,SET,75,-0.059403,-0.0037889,0.099026,0.7257,GOBP_LEUKOCYTE_DEGRANULATION,1
GOBP_ION_CHANNEL_MODULATING_...,SET,8,-0.19578,-0.0040858,0.32632,0.72573,GOBP_ION_CHANNEL_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_CARDIAC_VENTRICLE_FORMA...,SET,7,-0.22879,-0.0044664,0.38121,0.72579,GOBP_CARDIAC_VENTRICLE_FORMATION,1
GOBP_REGULATION_OF_ANAPHASE_...,SET,5,-0.1926,-0.003178,0.32092,0.72579,GOBP_REGULATION_OF_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,1
ZHONG_RESPONSE_TO_AZACITIDIN...2,SET,150,-0.041415,-0.0037281,0.06896,0.72593,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1
GOMF_ATPASE_BINDING,SET,78,-0.061664,-0.0040107,0.10266,0.72596,GOMF_ATPASE_BINDING,1
GOBP_ENDOPLASMIC_RETICULUM_T...1,SET,25,-0.088154,-0.0032507,0.14674,0.726,GOBP_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT,1
GOMF_CALCIUM_POTASSIUM_SODIU...,SET,5,-0.28556,-0.0047118,0.47525,0.72603,GOMF_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY,1
MIR1270,SET,72,-0.062505,-0.0039065,0.10401,0.72605,MIR1270,1
GSE34515_CD16_NEG_MONOCYTE_V...1,SET,176,-0.036571,-0.0035634,0.060852,0.72607,GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN,1
MIR6861_3P,SET,45,-0.074082,-0.0036631,0.12324,0.72611,MIR6861_3P,1
GSE14308_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.038433,-0.0037659,0.063929,0.72614,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP,1
GOBP_REGULATION_OF_WNT_PROTE...,SET,5,-0.23548,-0.0038854,0.39151,0.72623,GOBP_REGULATION_OF_WNT_PROTEIN_SECRETION,1
GOBP_WNT_PROTEIN_SECRETION,SET,5,-0.23548,-0.0038854,0.39151,0.72623,GOBP_WNT_PROTEIN_SECRETION,1
GOBP_GLUCAN_METABOLIC_PROCESS,SET,74,-0.058054,-0.0036782,0.096506,0.72626,GOBP_GLUCAN_METABOLIC_PROCESS,1
WP_MARKERS_OF_KIDNEY_CELL_LI...,SET,57,-0.074339,-0.0041357,0.12357,0.72628,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,1
GSE37534_UNTREATED_VS_PIOGLI...1,SET,185,-0.037883,-0.0037835,0.062928,0.72641,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,1
GOCC_CENTRAL_ELEMENT,SET,7,-0.17751,-0.0034654,0.29479,0.72646,GOCC_CENTRAL_ELEMENT,1
HP_SPASTICITY,SET,776,-0.018441,-0.0037102,0.030623,0.72647,HP_SPASTICITY,1
SYED_ESTRADIOL_RESPONSE,SET,15,-0.13093,-0.0037407,0.21735,0.72654,SYED_ESTRADIOL_RESPONSE,1
GOBP_ELASTIN_CATABOLIC_PROCE...,SET,4,-0.31084,-0.0045876,0.51593,0.72657,GOBP_ELASTIN_CATABOLIC_PROCESS,1
GOBP_ARACHIDONIC_ACID_SECRET...,SET,31,-0.0961,-0.0039455,0.15949,0.72659,GOBP_ARACHIDONIC_ACID_SECRETION,1
GOBP_REGULATION_OF_CALCIUM_I...6,SET,153,-0.043827,-0.0039841,0.072712,0.72666,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_EPITHELIAL_CELL_FATE_CO...,SET,14,-0.1525,-0.0042096,0.25295,0.7267,GOBP_EPITHELIAL_CELL_FATE_COMMITMENT,1
GOBP_GRANULOCYTE_COLONY_STIM...1,SET,5,-0.2361,-0.0038957,0.39161,0.72671,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
GOMF_LRR_DOMAIN_BINDING,SET,15,-0.13888,-0.003968,0.23034,0.72672,GOMF_LRR_DOMAIN_BINDING,1
GAVIN_FOXP3_TARGETS_CLUSTER_...6,SET,82,-0.058493,-0.0039003,0.097005,0.72674,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1
MIR4522,SET,52,-0.073712,-0.0039173,0.12224,0.72674,MIR4522,1
GOBP_MITOCHONDRIAL_ELECTRON_...3,SET,5,-0.21032,-0.0034704,0.34874,0.72677,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_SUCCINATE_TO_UBIQUINONE,1
ZNF318_TARGET_GENES,SET,824,-0.018428,-0.0038154,0.030554,0.72679,ZNF318_TARGET_GENES,1
GSE34156_TLR1_TLR2_LIGAND_VS...2,SET,174,-0.039857,-0.0038617,0.066068,0.72683,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
GOBP_CELLULAR_RESPONSE_TO_AR...,SET,16,-0.12924,-0.0038135,0.21416,0.7269,GOBP_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,1
GOBP_REGULATION_OF_PHOSPHOLI...9,SET,14,-0.13287,-0.0036678,0.22007,0.727,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSPORT,1
HP_REDUCED_FEV1_FVC_RATIO,SET,7,-0.19756,-0.0038569,0.32722,0.727,HP_REDUCED_FEV1_FVC_RATIO,1
GSE40274_CTRL_VS_FOXP3_AND_S...2,SET,150,-0.040825,-0.003675,0.067615,0.727,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
REACTOME_ACTIVATED_NTRK2_SIG...2,SET,11,-0.13793,-0.0033752,0.22842,0.72703,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3,1
HP_ABNORMAL_SERUM_BICARBONAT...,SET,5,-0.23903,-0.0039441,0.39582,0.72704,HP_ABNORMAL_SERUM_BICARBONATE_CONCENTRATION,1
chr8q21,SET,67,-0.11913,-0.0071835,0.19722,0.72709,chr8q21,1
GOBP_REGULATION_OF_MITOCHOND...13,SET,5,-0.18592,-0.0030677,0.30776,0.7271,GOBP_REGULATION_OF_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,1
PID_GLYPICAN_1PATHWAY,SET,26,-0.10353,-0.0038932,0.17135,0.72713,PID_GLYPICAN_1PATHWAY,1
WP_BIOMARKERS_FOR_PYRIMIDINE...,SET,15,-0.13011,-0.0037175,0.21532,0.72716,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,1
REACTOME_SYNTHESIS_OF_PIPS_A...3,SET,16,-0.12152,-0.0035858,0.20108,0.72719,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,1
GOBP_REGULATION_OF_PROTEIN_G...,SET,11,-0.15001,-0.0036707,0.24817,0.72723,GOBP_REGULATION_OF_PROTEIN_GLYCOSYLATION,1
HOEK_MONOCYTE_2011_2012_TIV_...6,SET,5,-0.22824,-0.0037661,0.37759,0.72723,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_UP,1
CAMPS_COLON_CANCER_COPY_NUMB...2,SET,81,-0.064874,-0.0042995,0.10727,0.72734,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1
GOBP_REGULATION_OF_FEVER_GEN...,SET,9,-0.199,-0.0044048,0.32903,0.72734,GOBP_REGULATION_OF_FEVER_GENERATION,1
HP_HAND_POLYDACTYLY,SET,149,-0.042246,-0.0037903,0.069845,0.72736,HP_HAND_POLYDACTYLY,1
WP_INHIBITION_OF_EXOSOME_BIO...,SET,17,-0.11085,-0.0033715,0.18324,0.72739,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,1
GOBP_CELL_COMMUNICATION_BY_E...1,SET,33,-0.10036,-0.0042508,0.16587,0.72742,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,1
HP_BILATERAL_SUPERIOR_VENA_C...,SET,8,-0.19002,-0.0039657,0.31406,0.72743,HP_BILATERAL_SUPERIOR_VENA_CAVA,1
GOBP_MIRNA_MEDIATED_GENE_SIL...1,SET,18,-0.12113,-0.0037909,0.20018,0.72744,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_INHIBITION_OF_TRANSLATION,1
GOCC_PTW_PP1_PHOSPHATASE_COM...,SET,7,-0.16301,-0.0031823,0.26925,0.72755,GOCC_PTW_PP1_PHOSPHATASE_COMPLEX,1
WP_HEREDITARY_LEIOMYOMATOSIS...,SET,18,-0.1152,-0.0036053,0.19019,0.72764,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,1
GOBP_REGULATION_OF_CYSTEINE_...2,SET,146,-0.04405,-0.0039125,0.072722,0.72765,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
LUI_THYROID_CANCER_CLUSTER_4,SET,10,-0.18954,-0.0044224,0.31282,0.72771,LUI_THYROID_CANCER_CLUSTER_4,1
HP_THICK_HAIR,SET,19,-0.10845,-0.0034868,0.17894,0.72775,HP_THICK_HAIR,1
FAN_EMBRYONIC_CTX_OPC,SET,48,-0.08417,-0.0042981,0.13888,0.72776,FAN_EMBRYONIC_CTX_OPC,1
GSE19923_E2A_KO_VS_HEB_AND_E...1,SET,164,-0.042607,-0.0040088,0.070296,0.72777,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,1
GOBP_REGULATION_OF_POTASSIUM...3,SET,45,-0.081386,-0.0040243,0.13426,0.72781,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_ASPARTATE_AND_ASPAR...,SET,11,-0.15418,-0.0037727,0.25424,0.72788,REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM,1
GSE37301_CD4_TCELL_VS_RAG2_K...2,SET,146,-0.04456,-0.0039577,0.073474,0.72789,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP,1
GOBP_REGULATION_OF_MORPHOGEN...1,SET,59,-0.072335,-0.0040939,0.11927,0.7279,GOBP_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
HP_RENAL_INSUFFICIENCY,SET,364,-0.02705,-0.0037709,0.044583,0.72799,HP_RENAL_INSUFFICIENCY,1
PID_TELOMERASE_PATHWAY,SET,64,-0.066184,-0.0039007,0.10907,0.728,PID_TELOMERASE_PATHWAY,1
GOBP_REGULATION_OF_POSTSYNAP...2,SET,99,-0.05461,-0.0039993,0.089998,0.728,GOBP_REGULATION_OF_POSTSYNAPSE_ORGANIZATION,1
GSE7852_TREG_VS_TCONV_FAT_UP,SET,183,-0.038587,-0.0038331,0.063583,0.72803,GSE7852_TREG_VS_TCONV_FAT_UP,1
MODULE_26,SET,187,-0.039068,-0.0039227,0.06437,0.72805,MODULE_26,1
GOBP_POSITIVE_REGULATION_OF_...5,SET,45,-0.079204,-0.0039164,0.13049,0.72806,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,1
TGCACTT_MIR519C_MIR519B_MIR5...,SET,409,-0.026077,-0.0038486,0.042962,0.72807,TGCACTT_MIR519C_MIR519B_MIR519A,1
GOBP_PROTEIN_REFOLDING,SET,24,-0.10616,-0.0038359,0.17491,0.72807,GOBP_PROTEIN_REFOLDING,1
WENDT_COHESIN_TARGETS_UP,SET,31,-0.095745,-0.0039309,0.15773,0.72808,WENDT_COHESIN_TARGETS_UP,1
GSE7219_WT_VS_NIK_NFKB2_KO_D...2,SET,175,-0.040017,-0.0038882,0.065924,0.72808,GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP,1
GOBP_REGULATION_OF_GLUCOSE_T...,SET,70,-0.065981,-0.0040663,0.10868,0.72811,GOBP_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
ZHONG_PFC_C4_PTGDS_POS_OPC,SET,132,-0.047374,-0.0040024,0.078004,0.72818,ZHONG_PFC_C4_PTGDS_POS_OPC,1
GOCC_PRESYNAPTIC_ENDOCYTIC_Z...,SET,9,-0.1823,-0.0040352,0.29999,0.7283,GOCC_PRESYNAPTIC_ENDOCYTIC_ZONE,1
HP_ABNORMAL_ATRIOVENTRICULAR...1,SET,87,-0.057719,-0.0039638,0.094971,0.72832,HP_ABNORMAL_ATRIOVENTRICULAR_CONDUCTION,1
GOCC_CELL_TIP,SET,7,-0.20148,-0.0039334,0.33145,0.72836,GOCC_CELL_TIP,1
ERWIN_COHEN_BLOOD_TC_83_AGE_...,SET,108,-0.052699,-0.0040299,0.086683,0.72839,ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP,1
GOBP_REGULATION_OF_STEM_CELL...4,SET,79,-0.061663,-0.0040361,0.10142,0.7284,GOBP_REGULATION_OF_STEM_CELL_PROLIFERATION,1
GSE25123_WT_VS_PPARG_KO_MACR...1,SET,177,-0.038897,-0.0038007,0.063953,0.72848,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN,1
GOBP_REGULATION_OF_MEGAKARYO...,SET,22,-0.11626,-0.0040222,0.19112,0.72851,GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
WP_MITOCHONDRIAL_COMPLEX_I_A...,SET,45,-0.065844,-0.0032558,0.10823,0.72852,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,1
HP_ABNORMAL_UPPER_MOTOR_NEUR...,SET,14,-0.12691,-0.0035031,0.20856,0.72857,HP_ABNORMAL_UPPER_MOTOR_NEURON_MORPHOLOGY,1
SVIL_TARGET_GENES,SET,10,-0.17266,-0.0040284,0.28373,0.72858,SVIL_TARGET_GENES,1
GOBP_LYMPHOCYTE_HOMEOSTASIS,SET,71,-0.063705,-0.0039539,0.10469,0.72858,GOBP_LYMPHOCYTE_HOMEOSTASIS,1
chr8q22,SET,62,-0.12066,-0.0069999,0.19826,0.7286,chr8q22,1
GOBP_NEGATIVE_REGULATION_OF_...569,SET,8,-0.20402,-0.0042579,0.33507,0.7287,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
GSE37534_GW1929_VS_ROSIGLITA...1,SET,146,-0.04108,-0.0036487,0.067462,0.72871,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
HUMMERICH_BENIGN_SKIN_TUMOR_...2,SET,15,-0.14324,-0.0040926,0.23519,0.72875,HUMMERICH_BENIGN_SKIN_TUMOR_UP,1
VANTVEER_BREAST_CANCER_POOR_...,SET,44,-0.081959,-0.0040074,0.13453,0.7288,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,1
HP_MESOAXIAL_POLYDACTYLY,SET,18,-0.11748,-0.0036765,0.19282,0.72881,HP_MESOAXIAL_POLYDACTYLY,1
GSE17721_LPS_VS_GARDIQUIMOD_...6,SET,186,-0.038342,-0.0038396,0.062927,0.72884,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP,1
GSE27786_CD4_TCELL_VS_MONO_M...2,SET,176,-0.037187,-0.0036235,0.061031,0.72884,GSE27786_CD4_TCELL_VS_MONO_MAC_UP,1
HALLMARK_MYOGENESIS,SET,191,-0.039301,-0.0039876,0.064476,0.72891,HALLMARK_MYOGENESIS,1
WANG_SMARCE1_TARGETS_DN,SET,322,-0.029859,-0.0039194,0.048974,0.72896,WANG_SMARCE1_TARGETS_DN,1
FOROUTAN_PRODRANK_TGFB_EMT_UP,SET,178,-0.041456,-0.0040621,0.067992,0.72897,FOROUTAN_PRODRANK_TGFB_EMT_UP,1
GSE12198_LOW_IL2_STIM_NK_CEL...1,SET,189,-0.03767,-0.0038022,0.061781,0.72897,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...590,SET,564,-0.023076,-0.0039818,0.037844,0.72898,GOBP_POSITIVE_REGULATION_OF_PHOSPHORYLATION,1
MODULE_263,SET,44,-0.10009,-0.004894,0.16414,0.729,MODULE_263,1
ZHONG_PFC_C7_ORG_UNDERGOING_...,SET,61,-0.07271,-0.0041841,0.11923,0.72902,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,1
HP_AMNIOTIC_CONSTRICTION_RING,SET,10,-0.18608,-0.0043416,0.30511,0.72903,HP_AMNIOTIC_CONSTRICTION_RING,1
GOCC_ATG12_ATG5_ATG16_COMPLEX,SET,6,-0.24277,-0.0043879,0.39803,0.72904,GOCC_ATG12_ATG5_ATG16_COMPLEX,1
MIKKELSEN_PLURIPOTENT_STATE_...1,SET,8,-0.22414,-0.0046778,0.36743,0.72908,MIKKELSEN_PLURIPOTENT_STATE_DN,1
GOBP_ANTIGEN_PROCESSING_AND_...10,SET,64,-0.072592,-0.0042784,0.11896,0.72914,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,1
AP4_01,SET,235,-0.034665,-0.0038966,0.056799,0.72916,AP4_01,1
HALLMARK_ESTROGEN_RESPONSE_E...,SET,187,-0.04107,-0.0041237,0.067298,0.72916,HALLMARK_ESTROGEN_RESPONSE_EARLY,1
MODULE_453,SET,40,-0.076579,-0.0035705,0.12547,0.72917,MODULE_453,1
GOBP_FAT_PAD_DEVELOPMENT,SET,8,-0.18475,-0.0038556,0.30266,0.7292,GOBP_FAT_PAD_DEVELOPMENT,1
WP_TRIACYLGLYCERIDE_SYNTHESIS,SET,20,-0.1268,-0.0041828,0.2077,0.72923,WP_TRIACYLGLYCERIDE_SYNTHESIS,1
MIR6787_3P,SET,90,-0.055053,-0.003845,0.090165,0.72926,MIR6787_3P,1
HP_ABNORMALITY_OF_THE_HUMERO...,SET,51,-0.074738,-0.0039335,0.12239,0.72928,HP_ABNORMALITY_OF_THE_HUMERORADIAL_JOINT,1
HP_AVASCULAR_NECROSIS_OF_THE...,SET,29,-0.099085,-0.0039348,0.16225,0.72929,HP_AVASCULAR_NECROSIS_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,1
GOBP_NEGATIVE_REGULATION_OF_...277,SET,13,-0.16135,-0.004292,0.26417,0.72933,GOBP_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
REACTOME_MINERALOCORTICOID_B...,SET,6,-0.23159,-0.0041858,0.37903,0.7294,REACTOME_MINERALOCORTICOID_BIOSYNTHESIS,1
MIF1_01,SET,163,-0.041297,-0.0038738,0.067581,0.72942,MIF1_01,1
HP_ABNORMAL_CORTICAL_BONE_MO...,SET,77,-0.060296,-0.0038966,0.098666,0.72943,HP_ABNORMAL_CORTICAL_BONE_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_CASR_...,SET,7,-0.20503,-0.0040027,0.33549,0.72945,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY,1
STEIN_ESRRA_TARGETS_UP,SET,345,-0.028158,-0.0038234,0.046062,0.7295,STEIN_ESRRA_TARGETS_UP,1
HP_FRECKLING,SET,46,-0.070881,-0.0035434,0.11592,0.72954,HP_FRECKLING,1
HOEK_NEUTROPHIL_2011_2012_TI...1,SET,50,-0.074032,-0.0038581,0.12107,0.72956,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN,1
ASTON_MAJOR_DEPRESSIVE_DISOR...1,SET,146,-0.043054,-0.003824,0.070379,0.72964,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1
WEST_ADRENOCORTICAL_TUMOR_MA...2,SET,22,-0.12529,-0.0043343,0.20473,0.72972,WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,1
GSE40274_CTRL_VS_XBP1_TRANSD...2,SET,156,-0.043262,-0.0039708,0.070667,0.72979,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
UNTERMAN_IPF_VS_CTRL_MONOCYT...2,SET,11,-0.16144,-0.0039503,0.26369,0.7298,UNTERMAN_IPF_VS_CTRL_MONOCYTE_UP,1
MIR6733_3P,SET,128,-0.049157,-0.0040901,0.080287,0.72981,MIR6733_3P,1
REACTOME_TFAP2_AP_2_FAMILY_R...1,SET,5,-0.24428,-0.0040306,0.39894,0.72983,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS,1
WP_RENINANGIOTENSINALDOSTERO...,SET,43,-0.081991,-0.0039633,0.13388,0.72987,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,1
MIR6846_3P,SET,23,-0.10742,-0.0037995,0.17533,0.72994,MIR6846_3P,1
GOCC_CORTICAL_ENDOPLASMIC_RE...,SET,5,-0.21629,-0.0035689,0.35304,0.72994,GOCC_CORTICAL_ENDOPLASMIC_RETICULUM,1
HP_HEAD_TREMOR,SET,39,-0.087228,-0.004016,0.14237,0.72995,HP_HEAD_TREMOR,1
GSE43260_BTLA_POS_VS_NEG_INT...1,SET,173,-0.039865,-0.0038515,0.065045,0.73002,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN,1
WP_ASPIRIN_AND_MIRNAS,SET,9,-0.19866,-0.0043974,0.32412,0.73004,WP_ASPIRIN_AND_MIRNAS,1
GOBP_POSITIVE_REGULATION_OF_...469,SET,4,-0.2184,-0.0032233,0.35632,0.73004,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,1
GOBP_REGULATION_OF_PROTEIN_L...10,SET,4,-0.24914,-0.003677,0.40647,0.73004,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_LYSOSOME,1
FARMER_BREAST_CANCER_CLUSTER...7,SET,19,-0.12056,-0.0038763,0.19665,0.73008,FARMER_BREAST_CANCER_CLUSTER_7,1
MORF_TERF1,SET,61,-0.063172,-0.0036352,0.10304,0.73009,MORF_TERF1,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...2,SET,25,-0.11017,-0.0040625,0.17963,0.73015,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,1
GOBP_SYMPATHETIC_NEURON_PROJ...,SET,5,-0.24302,-0.0040099,0.39627,0.73015,GOBP_SYMPATHETIC_NEURON_PROJECTION_EXTENSION,1
GSE13522_WT_VS_IFNG_KO_SKIN_...1,SET,108,-0.051923,-0.0039706,0.084652,0.73018,GSE13522_WT_VS_IFNG_KO_SKIN_DN,1
MIR7848_3P,SET,26,-0.10387,-0.003906,0.16931,0.73022,MIR7848_3P,1
HP_TRACHEOESOPHAGEAL_FISTULA,SET,82,-0.05755,-0.0038374,0.0938,0.73024,HP_TRACHEOESOPHAGEAL_FISTULA,1
GOBP_NEGATIVE_REGULATION_OF_...20,SET,27,-0.11148,-0.0042719,0.18167,0.73026,GOBP_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT,1
DELYS_THYROID_CANCER_UP,SET,412,-0.02728,-0.0040405,0.044457,0.73027,DELYS_THYROID_CANCER_UP,1
REACTOME_TNF_SIGNALING,SET,51,-0.070677,-0.0037198,0.11516,0.7303,REACTOME_TNF_SIGNALING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...10,SET,15,-0.14393,-0.0041122,0.23451,0.7303,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS,1
GOBP_POSITIVE_REGULATION_OF_...468,SET,19,-0.13047,-0.004195,0.21257,0.73031,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION,1
GSE29618_MONOCYTE_VS_MDC_DAY...1,SET,171,-0.041347,-0.0039717,0.067363,0.73032,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN,1
MODULE_126,SET,166,-0.041617,-0.0039393,0.067799,0.73033,MODULE_126,1
GOBP_MUCOSA_ASSOCIATED_LYMPH...,SET,8,-0.20435,-0.0042647,0.33288,0.73035,GOBP_MUCOSA_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT,1
ATF5_TARGET_GENES,SET,349,-0.028146,-0.0038435,0.045845,0.73037,ATF5_TARGET_GENES,1
IL21_UP.V1_UP,SET,166,-0.041766,-0.0039534,0.068029,0.73037,IL21_UP.V1_UP,1
GOBP_RUFFLE_ASSEMBLY,SET,42,-0.086123,-0.0041144,0.14026,0.73039,GOBP_RUFFLE_ASSEMBLY,1
KIM_PTEN_TARGETS_UP,SET,17,-0.13089,-0.0039811,0.2131,0.73046,KIM_PTEN_TARGETS_UP,1
CEBPGAMMA_Q6,SET,233,-0.03508,-0.0039267,0.057107,0.73048,CEBPGAMMA_Q6,1
HP_PONTOCEREBELLAR_ATROPHY,SET,8,-0.16229,-0.0033868,0.26417,0.73049,HP_PONTOCEREBELLAR_ATROPHY,1
MIR7156_3P,SET,89,-0.054272,-0.0037695,0.088333,0.73052,MIR7156_3P,1
GSE17721_POLYIC_VS_GARDIQUIM...12,SET,177,-0.038882,-0.0037992,0.063274,0.73055,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP,1
REACTOME_IMMUNOREGULATORY_IN...,SET,114,-0.054047,-0.0042456,0.08794,0.73058,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1
MODULE_108,SET,52,-0.089936,-0.0047795,0.14631,0.73062,MODULE_108,1
GSE7400_CTRL_VS_CSF3_IN_VIVO...2,SET,176,-0.037619,-0.0036656,0.061195,0.73063,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP,1
MIR5197_5P,SET,164,-0.041332,-0.0038889,0.06723,0.73065,MIR5197_5P,1
GOBP_POSITIVE_REGULATION_OF_...227,SET,80,-0.058651,-0.0038631,0.095397,0.73066,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,1
MIR551A_MIR551B_3P,SET,5,-0.26227,-0.0043275,0.42656,0.73067,MIR551A_MIR551B_3P,1
GSE22601_DOUBLE_NEGATIVE_VS_...4,SET,163,-0.043601,-0.0040899,0.070906,0.73069,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
WP_IDO_METABOLIC_PATHWAY,SET,9,-0.19966,-0.0044194,0.32465,0.73072,WP_IDO_METABOLIC_PATHWAY,1
WP_SPHINGOLIPID_METABOLISM_I...2,SET,27,-0.10145,-0.0038875,0.16495,0.73072,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,1
HP_ABNORMAL_PULSE,SET,5,-0.21598,-0.0035637,0.35117,0.73073,HP_ABNORMAL_PULSE,1
HE_LIM_SUN_FETAL_LUNG_C0_MID...3,SET,849,-0.01913,-0.0040174,0.031103,0.73073,HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL,1
MIR873_5P,SET,101,-0.053433,-0.0039522,0.086869,0.73075,MIR873_5P,1
HP_ABNORMALITY_OF_FLUID_REGU...,SET,705,-0.020637,-0.0039656,0.03355,0.73076,HP_ABNORMALITY_OF_FLUID_REGULATION,1
HP_INCREASED_NUMBER_OF_SKIN_...,SET,6,-0.19567,-0.0035367,0.31801,0.73082,HP_INCREASED_NUMBER_OF_SKIN_FOLDS,1
MODULE_197,SET,168,-0.041426,-0.0039445,0.067309,0.73087,MODULE_197,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SET,85,-0.05943,-0.0040343,0.096517,0.73096,SAFFORD_T_LYMPHOCYTE_ANERGY,1
GOBP_POSITIVE_REGULATION_OF_...492,SET,125,-0.046108,-0.0037915,0.074875,0.73098,GOBP_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_CANINE,SET,16,-0.13891,-0.0040988,0.22557,0.73098,HP_ABNORMALITY_OF_CANINE,1
GSE5542_UNTREATED_VS_IFNG_TR...1,SET,167,-0.039337,-0.0037345,0.063868,0.73102,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
LEE_LIVER_CANCER_SURVIVAL_UP,SET,166,-0.041618,-0.0039394,0.067563,0.73104,LEE_LIVER_CANCER_SURVIVAL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...530,SET,35,-0.088839,-0.0038751,0.14422,0.73105,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
GSE17721_CTRL_VS_POLYIC_2H_B...2,SET,177,-0.038523,-0.0037642,0.06252,0.73111,GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP,1
GSE40274_FOXP3_VS_FOXP3_AND_...9,SET,179,-0.03904,-0.003836,0.063358,0.73111,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_PERICARDIUM_MORPHOGENES...,SET,8,-0.21343,-0.0044542,0.34635,0.73112,GOBP_PERICARDIUM_MORPHOGENESIS,1
GOBP_RNA_IMPORT_INTO_MITOCHO...,SET,5,-0.18176,-0.0029991,0.29485,0.7312,GOBP_RNA_IMPORT_INTO_MITOCHONDRION,1
GOBP_POSITIVE_REGULATION_OF_...174,SET,22,-0.12169,-0.0042098,0.19739,0.73121,GOBP_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_PHOSPHATE...,SET,7,-0.21312,-0.0041607,0.34569,0.73122,GOBP_REGULATION_OF_PHOSPHATE_TRANSPORT,1
HP_ABSENT_SEPTUM_PELLUCIDUM,SET,54,-0.071195,-0.0038554,0.11547,0.73123,HP_ABSENT_SEPTUM_PELLUCIDUM,1
HP_RENAL_NECROSIS,SET,5,-0.23607,-0.0038952,0.38289,0.73123,HP_RENAL_NECROSIS,1
GOBP_NEURON_GLIAL_CELL_SIGNA...,SET,5,-0.28026,-0.0046244,0.45454,0.73124,GOBP_NEURON_GLIAL_CELL_SIGNALING,1
HP_PROGRESSIVE_PSYCHOMOTOR_D...,SET,12,-0.15445,-0.0039474,0.25048,0.73125,HP_PROGRESSIVE_PSYCHOMOTOR_DETERIORATION,1
HOEK_NEUTROPHIL_2011_2012_TI...4,SET,7,-0.23985,-0.0046825,0.38892,0.73129,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_UP,1
GOBP_GLYCINE_BIOSYNTHETIC_PR...,SET,5,-0.23741,-0.0039173,0.38481,0.73136,GOBP_GLYCINE_BIOSYNTHETIC_PROCESS,1
GSE13485_DAY1_VS_DAY3_YF17D_...1,SET,182,-0.036977,-0.0036633,0.059934,0.73137,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN,1
GOMF_PROTEIN_TYROSINE_KINASE...4,SET,5,-0.25583,-0.0042213,0.41455,0.73143,GOMF_PROTEIN_TYROSINE_KINASE_INHIBITOR_ACTIVITY,1
GSE29618_BCELL_VS_PDC_DN,SET,177,-0.040948,-0.0040011,0.06634,0.73146,GSE29618_BCELL_VS_PDC_DN,1
MIR661,SET,146,-0.043873,-0.0038968,0.071074,0.73148,MIR661,1
OKUMURA_INFLAMMATORY_RESPONS...,SET,156,-0.042805,-0.0039289,0.069324,0.73153,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1
SNACANNNYSYAGA_UNKNOWN,SET,79,-0.057779,-0.0037819,0.093557,0.73157,SNACANNNYSYAGA_UNKNOWN,1
GOBP_MEMBRANE_TUBULATION,SET,4,-0.28525,-0.0042098,0.46188,0.73157,GOBP_MEMBRANE_TUBULATION,1
PID_TCR_RAS_PATHWAY,SET,13,-0.14567,-0.0038749,0.23584,0.7316,PID_TCR_RAS_PATHWAY,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...4,SET,6,-0.20957,-0.0037879,0.33924,0.73163,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
HP_PROGRESSIVE_LEUKOENCEPHAL...,SET,4,-0.2693,-0.0039746,0.43593,0.73163,HP_PROGRESSIVE_LEUKOENCEPHALOPATHY,1
GSE15930_NAIVE_VS_24H_IN_VIT...2,SET,187,-0.038485,-0.0038641,0.062298,0.73163,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP,1
YAMASHITA_SILENCED_BY_METHYL...,SET,7,-0.22074,-0.0043093,0.35729,0.73164,YAMASHITA_SILENCED_BY_METHYLATION,1
REACTOME_TRANSPORT_OF_NUCLEO...1,SET,10,-0.17601,-0.0041066,0.28476,0.73174,REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE,1
GSE22886_CD4_TCELL_VS_BCELL_...2,SET,183,-0.038332,-0.0038078,0.062011,0.73175,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP,1
GSE6259_FLT3L_INDUCED_33D1_P...4,SET,159,-0.041885,-0.0038809,0.067757,0.73176,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP,1
REACTOME_RUNX2_REGULATES_CHO...,SET,5,-0.22612,-0.0037311,0.36578,0.73177,REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION,1
GOBP_MORPHOGENESIS_OF_A_POLA...,SET,58,-0.073115,-0.004103,0.11827,0.73178,GOBP_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM,1
GOBP_POSITIVE_REGULATION_OF_...783,SET,185,-0.041246,-0.0041193,0.066717,0.73178,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
CASTELLANO_HRAS_AND_NRAS_TAR...2,SET,5,-0.21756,-0.0035898,0.35191,0.73179,CASTELLANO_HRAS_AND_NRAS_TARGETS_UP,1
GOBP_PURINE_NUCLEOSIDE_BIOSY...,SET,9,-0.19541,-0.0043255,0.31607,0.73179,GOBP_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,1
GOMF_SODIUM_PROTON_ANTIPORTE...,SET,13,-0.14123,-0.0037566,0.2284,0.73182,GOMF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,1
GOMF_ALL_TRANS_RETINOL_DEHYD...,SET,13,-0.14915,-0.0039675,0.2412,0.73184,GOMF_ALL_TRANS_RETINOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,1
MIR10B_3P,SET,72,-0.06165,-0.0038531,0.099675,0.73188,MIR10B_3P,1
GOBP_MITRAL_VALVE_DEVELOPMENT,SET,14,-0.15274,-0.0042162,0.24694,0.73189,GOBP_MITRAL_VALVE_DEVELOPMENT,1
HP_ABNORMAL_INFERIOR_VENA_CA...,SET,42,-0.075354,-0.0036,0.12181,0.73191,HP_ABNORMAL_INFERIOR_VENA_CAVA_MORPHOLOGY,1
KEGG_MEDICUS_VARIANT_AMPLIFI...4,SET,8,-0.19089,-0.0039839,0.30855,0.73193,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_HEPATOCYTE_DIFFERENTIAT...,SET,13,-0.16418,-0.0043672,0.26531,0.73198,GOBP_HEPATOCYTE_DIFFERENTIATION,1
GOMF_ATP_DEPENDENT_DNA_DAMAG...,SET,16,-0.10603,-0.0031288,0.17131,0.73203,GOMF_ATP_DEPENDENT_DNA_DAMAGE_SENSOR_ACTIVITY,1
GSE21063_WT_VS_NFATC1_KO_16H...1,SET,164,-0.045173,-0.0042502,0.072964,0.73207,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN,1
KEGG_TYROSINE_METABOLISM,SET,38,-0.094551,-0.0042971,0.15271,0.73208,KEGG_TYROSINE_METABOLISM,1
WP_STEROL_REGULATORY_ELEMENT...,SET,67,-0.061843,-0.0037291,0.099885,0.73209,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1
HP_APLASIA_HYPOPLASIA_INVOLV...11,SET,98,-0.054068,-0.0039396,0.087319,0.7321,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_NOSE,1
HP_IMPAIRED_T_CELL_FUNCTION,SET,28,-0.104,-0.0040584,0.16797,0.7321,HP_IMPAIRED_T_CELL_FUNCTION,1
GOBP_B_CELL_LINEAGE_COMMITME...,SET,6,-0.20496,-0.0037045,0.33097,0.73212,GOBP_B_CELL_LINEAGE_COMMITMENT,1
GSE2405_0H_VS_1.5H_A_PHAGOCY...2,SET,188,-0.040116,-0.0040385,0.064772,0.73215,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
MIR190A_5P,SET,105,-0.054477,-0.004108,0.087925,0.73223,MIR190A_5P,1
GOMF_MIRNA_BINDING,SET,28,-0.093455,-0.0036468,0.15084,0.73223,GOMF_MIRNA_BINDING,1
GSE3982_CENT_MEMORY_CD4_TCEL...1,SET,175,-0.040243,-0.0039102,0.064945,0.73225,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN,1
MIR5584_5P,SET,229,-0.035168,-0.003903,0.056745,0.73229,MIR5584_5P,1
GOBP_PROTEIN_LOCALIZATION_TO...30,SET,17,-0.10947,-0.0033295,0.17661,0.73231,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE,1
HP_APLASIA_HYPOPLASIA_OF_THE...28,SET,12,-0.15682,-0.0040079,0.253,0.73231,HP_APLASIA_HYPOPLASIA_OF_THE_EPIGLOTTIS,1
HP_FEMORAL_BOWING,SET,41,-0.088189,-0.0041628,0.14226,0.73234,HP_FEMORAL_BOWING,1
BOYAULT_LIVER_CANCER_SUBCLAS...7,SET,27,-0.11512,-0.0044114,0.18567,0.73237,BOYAULT_LIVER_CANCER_SUBCLASS_G2,1
GOCC_SNO_S_RNA_CONTAINING_RI...,SET,19,-0.10916,-0.0035099,0.17604,0.7324,GOCC_SNO_S_RNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX,1
MIR4305,SET,50,-0.075116,-0.0039146,0.12113,0.73241,MIR4305,1
KEGG_MEDICUS_REFERENCE_SPIND...,SET,20,-0.11834,-0.0039035,0.19071,0.73253,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
CLASPER_LYMPHATIC_VESSELS_DU...1,SET,32,-0.10333,-0.0043099,0.16647,0.73259,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,1
DIRMEIER_LMP1_RESPONSE_LATE_...1,SET,25,-0.10664,-0.0039323,0.17175,0.73266,DIRMEIER_LMP1_RESPONSE_LATE_DN,1
MIR190B_5P,SET,104,-0.054888,-0.0041193,0.088393,0.73268,MIR190B_5P,1
REACTOME_PHASE_3_RAPID_REPOL...,SET,8,-0.1845,-0.0038505,0.29698,0.73278,REACTOME_PHASE_3_RAPID_REPOLARISATION,1
GOBP_REGULATION_OF_GENERATIO...,SET,121,-0.046874,-0.0037927,0.075448,0.73279,GOBP_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
WANG_TNF_TARGETS,SET,24,-0.11709,-0.0042305,0.18844,0.73281,WANG_TNF_TARGETS,1
GOBP_REGULATION_OF_TELOMERE_...2,SET,94,-0.052112,-0.0037192,0.08386,0.73283,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE,1
DLX2_TARGET_GENES,SET,217,-0.037819,-0.0040872,0.060845,0.73288,DLX2_TARGET_GENES,1
CHIN_BREAST_CANCER_COPY_NUMB...2,SET,27,-0.10692,-0.0040971,0.17198,0.73292,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1
MIR4753_5P,SET,156,-0.043746,-0.0040152,0.070361,0.73294,MIR4753_5P,1
JONES_OVARY_GRANULOSA,SET,69,-0.066711,-0.004082,0.10725,0.73302,JONES_OVARY_GRANULOSA,1
WP_EV_RELEASE_FROM_CARDIAC_C...,SET,7,-0.23084,-0.0045066,0.37108,0.73305,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,1
GSE5589_LPS_VS_LPS_AND_IL10_...10,SET,180,-0.040107,-0.0039517,0.064461,0.73309,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
YAO_TEMPORAL_RESPONSE_TO_PRO...1,SET,68,-0.064816,-0.0039372,0.10415,0.73312,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1
GOBP_PROTEIN_LOCALIZATION_TO...20,SET,59,-0.06335,-0.0035854,0.10177,0.73318,GOBP_PROTEIN_LOCALIZATION_TO_CYTOSKELETON,1
GSE17322_CD103_POS_VS_CD11B_...2,SET,176,-0.039968,-0.0038944,0.064198,0.73321,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP,1
CGTCTTA_MIR208,SET,8,-0.19342,-0.0040366,0.31065,0.73323,CGTCTTA_MIR208,1
GOCC_CCR4_NOT_COMPLEX,SET,15,-0.13667,-0.0039049,0.2195,0.73324,GOCC_CCR4_NOT_COMPLEX,1
HP_WIDE_FEMORAL_METAPHYSIS,SET,6,-0.20468,-0.0036995,0.32867,0.73327,HP_WIDE_FEMORAL_METAPHYSIS,1
OZEN_MIR125B1_TARGETS,SET,22,-0.1137,-0.0039334,0.18253,0.73332,OZEN_MIR125B1_TARGETS,1
WP_WNT_SIGNALING_WP363,SET,51,-0.07618,-0.0040094,0.1223,0.73332,WP_WNT_SIGNALING_WP363,1
HP_ABNORMAL_LUNG_DEVELOPMENT,SET,208,-0.037263,-0.0039437,0.059823,0.73332,HP_ABNORMAL_LUNG_DEVELOPMENT,1
GSE10240_IL22_VS_IL22_AND_IL...1,SET,187,-0.037594,-0.0037747,0.060346,0.73335,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
GOBP_L_GLUTAMATE_IMPORT,SET,39,-0.08813,-0.0040575,0.14145,0.73337,GOBP_L_GLUTAMATE_IMPORT,1
HP_ABNORMAL_TOE_PHALANX_MORP...,SET,113,-0.049338,-0.0038587,0.079179,0.73339,HP_ABNORMAL_TOE_PHALANX_MORPHOLOGY,1
HP_ABSENT_AXILLARY_HAIR,SET,11,-0.17039,-0.0041695,0.27344,0.7334,HP_ABSENT_AXILLARY_HAIR,1
GOBP_REGULATION_OF_PROTEIN_N...,SET,18,-0.12575,-0.0039353,0.20172,0.73347,GOBP_REGULATION_OF_PROTEIN_NEDDYLATION,1
GSE16385_IFNG_TNF_VS_IL4_STI...3,SET,161,-0.042466,-0.0039592,0.068126,0.73347,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,1
HP_ABNORMAL_IRIS_PIGMENTATION,SET,131,-0.049198,-0.0041409,0.07889,0.73356,HP_ABNORMAL_IRIS_PIGMENTATION,1
GOBP_HYPEROSMOTIC_RESPONSE,SET,25,-0.10896,-0.0040179,0.17467,0.73362,GOBP_HYPEROSMOTIC_RESPONSE,1
GOCC_ASYMMETRIC_GLUTAMATERGI...,SET,13,-0.15518,-0.0041277,0.24873,0.73364,GOCC_ASYMMETRIC_GLUTAMATERGIC_EXCITATORY_SYNAPSE,1
GOBP_NEGATIVE_REGULATION_OF_...23,SET,10,-0.15524,-0.003622,0.24882,0.73365,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,1
MIR4421,SET,49,-0.077496,-0.0039981,0.1242,0.73366,MIR4421,1
GARGALOVIC_RESPONSE_TO_OXIDI...4,SET,125,-0.048078,-0.0039535,0.077049,0.73368,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1
GOBP_METANEPHRIC_MESENCHYMAL...,SET,5,-0.27838,-0.0045933,0.44609,0.73369,GOBP_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION,1
GSE36888_STAT5_AB_KNOCKIN_VS...6,SET,175,-0.038955,-0.003785,0.06242,0.73371,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP,1
REACTOME_JOSEPHIN_DOMAIN_DUBS,SET,9,-0.1695,-0.0037518,0.27144,0.73383,REACTOME_JOSEPHIN_DOMAIN_DUBS,1
HP_ABNORMAL_POSTERIOR_SEGMEN...,SET,41,-0.089471,-0.0042233,0.14325,0.73387,HP_ABNORMAL_POSTERIOR_SEGMENT_IMAGING,1
GSE39110_UNTREATED_VS_IL2_TR...4,SET,182,-0.040426,-0.0040049,0.064721,0.73388,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP,1
FUKUSHIMA_TNFSF11_TARGETS,SET,16,-0.14683,-0.0043327,0.23505,0.73391,FUKUSHIMA_TNFSF11_TARGETS,1
GOBP_NEGATIVE_REGULATION_OF_...656,SET,57,-0.075671,-0.0042097,0.12108,0.734,GOBP_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,1
HP_SPARSE_LATERAL_EYEBROW,SET,30,-0.093442,-0.0037741,0.14951,0.73401,HP_SPARSE_LATERAL_EYEBROW,1
GSE15659_RESTING_TREG_VS_NON...2,SET,160,-0.042424,-0.0039431,0.067876,0.73402,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP,1
MENON_FETAL_KIDNEY_1_EMBRYON...,SET,83,-0.057404,-0.0038509,0.091843,0.73402,MENON_FETAL_KIDNEY_1_EMBRYONIC_RED_BLOOD_CELLS,1
GSE7218_IGM_VS_IGG_SIGNAL_TH...1,SET,161,-0.043679,-0.0040723,0.069848,0.73412,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN,1
GSE360_CTRL_VS_T_GONDII_MAC_...1,SET,179,-0.039219,-0.0038536,0.062708,0.73415,GSE360_CTRL_VS_T_GONDII_MAC_DN,1
GSE3982_DC_VS_NEUTROPHIL_LPS...2,SET,176,-0.038921,-0.0037924,0.062212,0.73422,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...4,SET,204,-0.039793,-0.0041712,0.063602,0.73422,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL,1
GOBP_POSITIVE_REGULATION_OF_...739,SET,8,-0.19224,-0.004012,0.30723,0.73425,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION,1
GOMF_HETEROTRIMERIC_G_PROTEI...,SET,5,-0.27315,-0.004507,0.43651,0.73426,GOMF_HETEROTRIMERIC_G_PROTEIN_BINDING,1
HP_ABNORMAL_2ND_FINGER_MORPH...,SET,37,-0.08987,-0.0040303,0.14361,0.73427,HP_ABNORMAL_2ND_FINGER_MORPHOLOGY,1
GOBP_NOREPINEPHRINE_METABOLI...,SET,10,-0.19467,-0.004542,0.31106,0.73429,GOBP_NOREPINEPHRINE_METABOLIC_PROCESS,1
KEGG_ADIPOCYTOKINE_SIGNALING...,SET,63,-0.068652,-0.0040146,0.10969,0.7343,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1
MIR205_3P,SET,359,-0.028733,-0.0039783,0.045904,0.73431,MIR205_3P,1
GOBP_CELL_ACTIVATION_INVOLVE...,SET,278,-0.033277,-0.0040637,0.053162,0.73432,GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOMF_U2_SNRNA_BINDING,SET,5,-0.22291,-0.0036781,0.35589,0.73446,GOMF_U2_SNRNA_BINDING,1
GOBP_CELLULAR_RESPONSE_TO_IN...1,SET,10,-0.15028,-0.0035062,0.23985,0.73452,GOBP_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,1
HP_3_4_FINGER_CUTANEOUS_SYND...,SET,6,-0.25488,-0.0046068,0.40667,0.73458,HP_3_4_FINGER_CUTANEOUS_SYNDACTYLY,1
REACTOME_NOTCH4_INTRACELLULA...,SET,19,-0.11744,-0.0037761,0.18737,0.7346,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
MIR3146,SET,44,-0.084023,-0.0041084,0.13402,0.73466,MIR3146,1
MIR3927_5P,SET,35,-0.089343,-0.0038971,0.1425,0.73466,MIR3927_5P,1
CHANG_POU5F1_TARGETS_DN,SET,7,-0.23442,-0.0045764,0.37388,0.73467,CHANG_POU5F1_TARGETS_DN,1
HP_ABNORMAL_HALLUX_MORPHOLOGY,SET,177,-0.041296,-0.0040351,0.065861,0.73467,HP_ABNORMAL_HALLUX_MORPHOLOGY,1
GOBP_ADAPTIVE_THERMOGENESIS,SET,160,-0.043182,-0.0040135,0.068835,0.73477,GOBP_ADAPTIVE_THERMOGENESIS,1
MORF_IFNA1,SET,175,-0.042005,-0.0040813,0.066943,0.73482,MORF_IFNA1,1
GSE13887_ACT_CD4_VS_NO_TREAT...2,SET,116,-0.050065,-0.0039669,0.079785,0.73483,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_STERO...,SET,5,-0.24479,-0.0040391,0.39008,0.73484,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE,1
GOCC_CLATHRIN_COAT_OF_COATED...,SET,18,-0.12203,-0.003819,0.19446,0.73484,GOCC_CLATHRIN_COAT_OF_COATED_PIT,1
KEGG_MEDICUS_VARIANT_MLL_AF4...,SET,25,-0.11401,-0.0042042,0.18167,0.73485,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
GOMF_MONOOXYGENASE_ACTIVITY,SET,100,-0.060268,-0.0044357,0.096033,0.73485,GOMF_MONOOXYGENASE_ACTIVITY,1
GSE3337_4H_VS_16H_IFNG_IN_CD...1,SET,183,-0.039906,-0.0039642,0.06359,0.73485,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN,1
WP_IL5_SIGNALING,SET,38,-0.091414,-0.0041545,0.14559,0.73495,WP_IL5_SIGNALING,1
HP_ABNORMALITY_OF_PREMOLAR,SET,12,-0.17206,-0.0043974,0.27394,0.73502,HP_ABNORMALITY_OF_PREMOLAR,1
GSE17974_0H_VS_1H_IN_VITRO_A...1,SET,183,-0.038187,-0.0037934,0.0608,0.73502,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN,1
DESCARTES_FETAL_PANCREAS_ERY...,SET,107,-0.052475,-0.0039943,0.083536,0.73505,DESCARTES_FETAL_PANCREAS_ERYTHROBLASTS,1
GSE7768_OVA_WITH_LPS_VS_OVA_...2,SET,156,-0.041837,-0.00384,0.066594,0.73507,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
GOMF_K48_LINKED_POLYUBIQUITI...,SET,7,-0.2028,-0.0039591,0.32276,0.7351,GOMF_K48_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
GOBP_RESPONSE_TO_PAIN,SET,35,-0.096023,-0.0041885,0.15281,0.73511,GOBP_RESPONSE_TO_PAIN,1
YRTCANNRCGC_UNKNOWN,SET,61,-0.067435,-0.0038805,0.10731,0.73514,YRTCANNRCGC_UNKNOWN,1
GOBP_ANTIMICROBIAL_HUMORAL_I...,SET,90,-0.066463,-0.0046419,0.10573,0.73519,GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE,1
HP_APLASIA_HYPOPLASIA_AFFECT...2,SET,127,-0.046889,-0.0038862,0.074581,0.73522,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_ANTERIOR_SEGMENT_OF_THE_EYE,1
REACTOME_ALPHA_OXIDATION_OF_...,SET,6,-0.20618,-0.0037266,0.32784,0.73528,REACTOME_ALPHA_OXIDATION_OF_PHYTANATE,1
GOMF_5_3_DNA_EXONUCLEASE_ACT...,SET,9,-0.14669,-0.0032469,0.23322,0.73531,GOMF_5_3_DNA_EXONUCLEASE_ACTIVITY,1
REACTOME_DERMATAN_SULFATE_BI...,SET,10,-0.15708,-0.0036648,0.24969,0.73535,REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS,1
GOCC_GLIAL_CELL_PROJECTION,SET,38,-0.093011,-0.0042271,0.14785,0.73535,GOCC_GLIAL_CELL_PROJECTION,1
GSE7218_IGM_VS_IGG_SIGNAL_TH...2,SET,176,-0.039382,-0.0038373,0.062598,0.73536,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP,1
BIOCARTA_IGF1R_PATHWAY,SET,23,-0.11675,-0.0041296,0.18552,0.73542,BIOCARTA_IGF1R_PATHWAY,1
GOBP_METHYLATION,SET,180,-0.037551,-0.0036998,0.059672,0.73542,GOBP_METHYLATION,1
JI_METASTASIS_REPRESSED_BY_S...,SET,24,-0.12374,-0.004471,0.19655,0.7355,JI_METASTASIS_REPRESSED_BY_STK11,1
WP_PAFAH1B1_COPY_NUMBER_VARI...,SET,10,-0.14943,-0.0034864,0.23735,0.73551,WP_PAFAH1B1_COPY_NUMBER_VARIATION,1
WP_SPHINGOLIPID_METABOLISM_O...,SET,23,-0.11736,-0.0041511,0.1864,0.73552,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,1
GOBP_REGULATION_OF_PROTEIN_L...7,SET,11,-0.12967,-0.0031729,0.20595,0.73552,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,1
GOBP_NEGATIVE_REGULATION_OF_...576,SET,72,-0.06263,-0.0039144,0.099451,0.73557,GOBP_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS,1
GOMF_BASIC_AMINO_ACID_TRANSM...,SET,16,-0.14365,-0.0042387,0.22805,0.73562,GOMF_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MEISSNER_BRAIN_HCP_WITH_H3K4...3,SET,1021,-0.018943,-0.0043411,0.030069,0.73564,MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3,1
chr8p12,SET,22,-0.21109,-0.0073027,0.33491,0.73574,chr8p12,1
GOBP_REGULATION_OF_WOUND_HEA...2,SET,10,-0.17143,-0.0039997,0.27197,0.73575,GOBP_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
HP_ANEMIC_PALLOR,SET,14,-0.14056,-0.0038799,0.22295,0.7358,HP_ANEMIC_PALLOR,1
HP_SHORT_DIGIT,SET,523,-0.023725,-0.0039468,0.037629,0.73581,HP_SHORT_DIGIT,1
GOBP_PROTEIN_O_LINKED_GLYCOS...3,SET,10,-0.19476,-0.0045441,0.30888,0.73583,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_THREONINE,1
DESCARTES_FETAL_CEREBELLUM_O...,SET,68,-0.073006,-0.0044348,0.11574,0.7359,DESCARTES_FETAL_CEREBELLUM_OLIGODENDROCYTES,1
NGO_MALIGNANT_GLIOMA_1P_LOH,SET,13,-0.12964,-0.0034484,0.20547,0.73596,NGO_MALIGNANT_GLIOMA_1P_LOH,1
PXR_Q2,SET,240,-0.035872,-0.0040745,0.056846,0.73599,PXR_Q2,1
GOMF_FIBRONECTIN_BINDING,SET,30,-0.11383,-0.0045976,0.18038,0.73599,GOMF_FIBRONECTIN_BINDING,1
MIR6770_5P,SET,170,-0.041256,-0.0039515,0.065376,0.736,MIR6770_5P,1
GSE26488_WT_VS_HDAC7_DELTAP_...2,SET,184,-0.04195,-0.0041785,0.066473,0.736,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP,1
GOBP_REGULATION_OF_T_CIRCLE_...,SET,5,-0.20095,-0.0033158,0.31836,0.73605,GOBP_REGULATION_OF_T_CIRCLE_FORMATION,1
GSE20727_CTRL_VS_ROS_INHIBIT...2,SET,176,-0.039373,-0.0038364,0.062375,0.73605,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...766,SET,65,-0.06735,-0.0040002,0.10666,0.73612,GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING,1
HP_ABNORMALITY_OF_CARDIOVASC...,SET,494,-0.024697,-0.0039962,0.039106,0.73615,HP_ABNORMALITY_OF_CARDIOVASCULAR_SYSTEM_ELECTROPHYSIOLOGY,1
HP_MUCOSAL_TELANGIECTASIAE,SET,36,-0.081231,-0.0035935,0.12862,0.73615,HP_MUCOSAL_TELANGIECTASIAE,1
MIR514A_5P,SET,61,-0.074086,-0.0042633,0.1173,0.73617,MIR514A_5P,1
WP_THYROXINE_THYROID_HORMONE...,SET,23,-0.11819,-0.0041807,0.18712,0.73618,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,1
HP_PALMAR_HYPERLINEARITY,SET,6,-0.22748,-0.0041116,0.36012,0.7362,HP_PALMAR_HYPERLINEARITY,1
HP_DYSPLASIA_OF_THE_FEMORAL_...,SET,5,-0.23473,-0.0038732,0.37148,0.73627,HP_DYSPLASIA_OF_THE_FEMORAL_HEAD,1
HP_WEAK_CRY,SET,44,-0.081889,-0.004004,0.12959,0.73627,HP_WEAK_CRY,1
GOBP_METANEPHROS_MORPHOGENES...,SET,30,-0.1139,-0.0046005,0.18024,0.73629,GOBP_METANEPHROS_MORPHOGENESIS,1
REACTOME_NITRIC_OXIDE_STIMUL...,SET,19,-0.13655,-0.0043906,0.21606,0.73631,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,1
HP_HYPOAMYLASEMIA,SET,4,-0.23829,-0.0035168,0.37685,0.7364,HP_HYPOAMYLASEMIA,1
MIR433_3P,SET,127,-0.049344,-0.0040897,0.078025,0.73644,MIR433_3P,1
PRMT5_TARGET_GENES,SET,64,-0.067216,-0.0039616,0.10625,0.7365,PRMT5_TARGET_GENES,1
MIR149_5P,SET,133,-0.04534,-0.0038449,0.071666,0.73651,MIR149_5P,1
GOBP_REGULATION_OF_MITOCHOND...1,SET,6,-0.20511,-0.0037072,0.32412,0.73657,GOBP_REGULATION_OF_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,1
GOMF_OXIDOREDUCTASE_ACTIVITY...15,SET,12,-0.14687,-0.0037536,0.23204,0.73661,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR,1
GOBP_RESPONSE_TO_FOOD,SET,35,-0.097243,-0.0042417,0.15361,0.73665,GOBP_RESPONSE_TO_FOOD,1
HP_LOWER_LIMB_UNDERGROWTH,SET,14,-0.14291,-0.0039448,0.22574,0.73666,HP_LOWER_LIMB_UNDERGROWTH,1
GOBP_POSITIVE_REGULATION_OF_...1,SET,3,-0.35587,-0.0045487,0.56201,0.7367,GOBP_POSITIVE_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,1
GOBP_IMP_BIOSYNTHETIC_PROCESS,SET,10,-0.16998,-0.0039659,0.26838,0.73675,GOBP_IMP_BIOSYNTHETIC_PROCESS,1
GOBP_KETONE_BODY_METABOLIC_P...,SET,10,-0.17985,-0.0041962,0.28394,0.73676,GOBP_KETONE_BODY_METABOLIC_PROCESS,1
HP_AUDITORY_HYPERSENSITIVITY,SET,30,-0.10681,-0.0043141,0.16863,0.73676,HP_AUDITORY_HYPERSENSITIVITY,1
HP_ELEVATED_CIRCULATING_CATE...,SET,12,-0.1656,-0.0042324,0.26134,0.73685,HP_ELEVATED_CIRCULATING_CATECHOLAMINE_LEVEL,1
GSE17721_CTRL_VS_POLYIC_1H_B...1,SET,180,-0.041437,-0.0040827,0.06538,0.73688,GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...427,SET,23,-0.11878,-0.0042014,0.18738,0.73692,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
GSE14769_20MIN_VS_360MIN_LPS...1,SET,178,-0.040609,-0.0039791,0.064057,0.73694,GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN,1
WALLACE_PROSTATE_CANCER_UP,SET,18,-0.13236,-0.0041425,0.20879,0.73695,WALLACE_PROSTATE_CANCER_UP,1
HE_LIM_SUN_FETAL_LUNG_C2_S10...,SET,32,-0.099579,-0.0041536,0.15707,0.73695,HE_LIM_SUN_FETAL_LUNG_C2_S100A12_HI_CLASSICAL_MONOCYTE,1
TRAVAGLINI_LUNG_NONCLASSICAL...,SET,171,-0.043602,-0.0041883,0.068772,0.73696,TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL,1
GCM_CRKL,SET,59,-0.066361,-0.0037558,0.10466,0.73697,GCM_CRKL,1
GSE27786_BCELL_VS_NKTCELL_DN,SET,178,-0.040631,-0.0039812,0.064078,0.73698,GSE27786_BCELL_VS_NKTCELL_DN,1
KEGG_MEDICUS_REFERENCE_CARDI...,SET,21,-0.12942,-0.0043743,0.20404,0.73704,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING,1
REACTOME_DECTIN_2_FAMILY,SET,19,-0.13136,-0.0042237,0.207,0.73715,REACTOME_DECTIN_2_FAMILY,1
GSE26030_UNSTIM_VS_RESTIM_TH...6,SET,183,-0.041618,-0.0041343,0.065568,0.73719,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP,1
MODULE_76,SET,78,-0.069524,-0.0045219,0.10951,0.73724,MODULE_76,1
HP_EQUINUS_CALCANEUS,SET,8,-0.22847,-0.0047681,0.35985,0.73725,HP_EQUINUS_CALCANEUS,1
chr3p12,SET,7,-0.28802,-0.0056229,0.45362,0.73726,chr3p12,1
MIR106B_5P,SET,632,-0.022216,-0.0040502,0.034981,0.73731,MIR106B_5P,1
BRIDEAU_IMPRINTED_GENES,SET,59,-0.082813,-0.0046869,0.13039,0.73732,BRIDEAU_IMPRINTED_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...88,SET,20,-0.12743,-0.0042036,0.20055,0.73741,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GAVISH_3CA_MALIGNANT_METAPRO...8,SET,44,-0.087199,-0.0042636,0.13721,0.73745,GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1,1
GSE45365_NK_CELL_VS_CD11B_DC...2,SET,178,-0.040658,-0.0039839,0.063971,0.73747,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN,1
GOBP_L_ASPARTATE_IMPORT_ACRO...,SET,6,-0.24973,-0.0045137,0.39285,0.7375,GOBP_L_ASPARTATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
CAFFAREL_RESPONSE_TO_THC_8HR...3,SET,11,-0.15701,-0.003842,0.24699,0.73751,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,1
HP_INTERNALLY_NUCLEATED_SKEL...,SET,6,-0.24474,-0.0044236,0.385,0.73751,HP_INTERNALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,1
PHONG_TNF_TARGETS_UP,SET,61,-0.080378,-0.0046253,0.12643,0.73753,PHONG_TNF_TARGETS_UP,1
HP_CONGENITAL_HEPATIC_FIBROS...,SET,42,-0.078812,-0.0037652,0.12397,0.73753,HP_CONGENITAL_HEPATIC_FIBROSIS,1
MODULE_256,SET,54,-0.069194,-0.0037471,0.10881,0.73759,MODULE_256,1
HP_ABNORMAL_RESPIRATORY_MOTI...,SET,29,-0.095964,-0.0038109,0.15089,0.73761,HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_PHYSIOLOGY,1
GOBP_TEMPERATURE_HOMEOSTASIS,SET,177,-0.042097,-0.0041134,0.066185,0.73762,GOBP_TEMPERATURE_HOMEOSTASIS,1
HP_FLUSHING,SET,45,-0.078741,-0.0038935,0.1238,0.73762,HP_FLUSHING,1
MODY_HIPPOCAMPUS_POSTNATAL,SET,52,-0.073628,-0.0039129,0.11573,0.73767,MODY_HIPPOCAMPUS_POSTNATAL,1
GOBP_ANTIMICROBIAL_HUMORAL_R...,SET,127,-0.057467,-0.0047629,0.090325,0.73768,GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE,1
GOBP_NEGATIVE_REGULATION_OF_...430,SET,5,-0.20869,-0.0034435,0.32798,0.7377,GOBP_NEGATIVE_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,1
MIR6788_3P,SET,3,-0.30367,-0.0038815,0.47716,0.73774,MIR6788_3P,1
GOBP_NEGATIVE_REGULATION_OF_...259,SET,5,-0.27565,-0.0045484,0.43312,0.73775,GOBP_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
MIR3153,SET,190,-0.040201,-0.0040683,0.063154,0.73779,MIR3153,1
HP_ADENOCARCINOMA_OF_THE_SMA...,SET,9,-0.16737,-0.0037046,0.2629,0.73781,HP_ADENOCARCINOMA_OF_THE_SMALL_INTESTINE,1
GOBP_G_PROTEIN_COUPLED_SEROT...,SET,22,-0.11652,-0.004031,0.183,0.73785,GOBP_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_DNA_N_GLYCOSYLASE_ACTIV...,SET,14,-0.13889,-0.0038339,0.21811,0.73787,GOMF_DNA_N_GLYCOSYLASE_ACTIVITY,1
TSENG_ADIPOGENIC_POTENTIAL_UP,SET,25,-0.11141,-0.0041084,0.17492,0.73791,TSENG_ADIPOGENIC_POTENTIAL_UP,1
GOBP_GLUCOSAMINE_CONTAINING_...1,SET,9,-0.19776,-0.0043774,0.31043,0.73795,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
REACTOME_TRANSLESION_SYNTHES...2,SET,16,-0.12207,-0.0036021,0.1916,0.73797,REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,1
REACTOME_HCMV_LATE_EVENTS,SET,51,-0.071137,-0.003744,0.11163,0.73802,REACTOME_HCMV_LATE_EVENTS,1
GOBP_TERMINAL_BUTTON_ORGANIZ...,SET,6,-0.23163,-0.0041865,0.36347,0.73802,GOBP_TERMINAL_BUTTON_ORGANIZATION,1
KUROKAWA_LIVER_CANCER_EARLY_...1,SET,6,-0.2217,-0.0040072,0.34788,0.73803,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN,1
PID_CONE_PATHWAY,SET,20,-0.12817,-0.0042279,0.20109,0.73805,PID_CONE_PATHWAY,1
GSE4984_UNTREATED_VS_GALECTI...2,SET,169,-0.042015,-0.0040124,0.065907,0.73809,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP,1
GOMF_MHC_PROTEIN_BINDING,SET,26,-0.10775,-0.0040518,0.16898,0.73813,GOMF_MHC_PROTEIN_BINDING,1
BIOCARTA_MONOCYTE_PATHWAY,SET,11,-0.19107,-0.0046755,0.29966,0.73814,BIOCARTA_MONOCYTE_PATHWAY,1
MIR769_5P,SET,46,-0.079499,-0.0039743,0.12467,0.73816,MIR769_5P,1
GOBP_RESPONSE_TO_ALKALOID,SET,97,-0.056403,-0.0040889,0.088447,0.73816,GOBP_RESPONSE_TO_ALKALOID,1
HP_URETERAL_OBSTRUCTION,SET,34,-0.091595,-0.003938,0.14361,0.73819,HP_URETERAL_OBSTRUCTION,1
HP_SKIN_PLAQUE,SET,41,-0.086165,-0.0040673,0.13509,0.73821,HP_SKIN_PLAQUE,1
REACTOME_SCAVENGING_BY_CLASS...1,SET,18,-0.14254,-0.0044609,0.22346,0.73822,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,1
WP_KISSPEPTINKISSPEPTIN_RECE...,SET,38,-0.090419,-0.0041093,0.14171,0.73827,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,1
GSE2405_0H_VS_24H_A_PHAGOCYT...1,SET,183,-0.041363,-0.0041089,0.064828,0.73827,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...64,SET,10,-0.16221,-0.0037847,0.25416,0.73833,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
GOBP_PULMONARY_VALVE_DEVELOP...,SET,24,-0.13159,-0.0047544,0.20607,0.73843,GOBP_PULMONARY_VALVE_DEVELOPMENT,1
GOBP_DOPAMINE_METABOLIC_PROC...,SET,33,-0.1022,-0.004329,0.16,0.73851,GOBP_DOPAMINE_METABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_OF_THE...3,SET,5,-0.27361,-0.0045147,0.42831,0.73853,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_METACARPAL,1
GSE3920_UNTREATED_VS_IFNA_TR...3,SET,179,-0.040315,-0.0039613,0.063096,0.73857,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN,1
DIDO1_TARGET_GENES,SET,1307,-0.015455,-0.0039742,0.024187,0.73858,DIDO1_TARGET_GENES,1
ZNF584_TARGET_GENES,SET,284,-0.032432,-0.0040023,0.050753,0.73859,ZNF584_TARGET_GENES,1
GSE17186_BLOOD_VS_CORD_BLOOD...2,SET,187,-0.039058,-0.0039217,0.061119,0.7386,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...314,SET,7,-0.23808,-0.0046478,0.37249,0.73863,GOBP_POSITIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
GOBP_REGULATION_OF_CELL_SUBS...2,SET,65,-0.069427,-0.0041236,0.10863,0.73863,GOBP_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
GOBP_POSITIVE_REGULATION_OF_...395,SET,273,-0.034078,-0.0041245,0.053306,0.73868,GOBP_POSITIVE_REGULATION_OF_KINASE_ACTIVITY,1
GOBP_REGULATION_OF_MITOCHOND...8,SET,48,-0.076467,-0.0039047,0.1196,0.7387,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,1
GSE10325_LUPUS_BCELL_VS_LUPU...2,SET,161,-0.042773,-0.0039878,0.066895,0.73872,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP,1
GSE3982_MAST_CELL_VS_NEUTROP...2,SET,180,-0.037213,-0.0036666,0.058173,0.73881,GSE3982_MAST_CELL_VS_NEUTROPHIL_UP,1
HP_NEOPLASIA_OF_THE_NASOPHAR...,SET,5,-0.24199,-0.0039929,0.37815,0.73889,HP_NEOPLASIA_OF_THE_NASOPHARYNX,1
GOBP_SULFUR_AMINO_ACID_TRANS...,SET,12,-0.16105,-0.004116,0.25164,0.73891,GOBP_SULFUR_AMINO_ACID_TRANSPORT,1
GOMF_U3_SNORNA_BINDING,SET,8,-0.19182,-0.0040033,0.29971,0.73892,GOMF_U3_SNORNA_BINDING,1
BPTF_TARGET_GENES,SET,885,-0.019244,-0.004122,0.030057,0.73899,BPTF_TARGET_GENES,1
GOCC_THO_COMPLEX,SET,5,-0.22912,-0.0037806,0.35784,0.739,GOCC_THO_COMPLEX,1
GOBP_RESPONSE_TO_LIGHT_INTEN...,SET,15,-0.14048,-0.0040136,0.21939,0.73901,GOBP_RESPONSE_TO_LIGHT_INTENSITY,1
HP_DIFFUSE_CEREBRAL_ATROPHY,SET,45,-0.0808,-0.0039953,0.12615,0.73908,HP_DIFFUSE_CEREBRAL_ATROPHY,1
TRAVAGLINI_LUNG_NEUTROPHIL_C...,SET,293,-0.032019,-0.0040125,0.049987,0.73909,TRAVAGLINI_LUNG_NEUTROPHIL_CELL,1
HP_AUTOPHAGIC_VACUOLES,SET,8,-0.19811,-0.0041344,0.30925,0.73911,HP_AUTOPHAGIC_VACUOLES,1
HE_LIM_SUN_FETAL_LUNG_C0_AIR...,SET,20,-0.13121,-0.0043281,0.20479,0.73913,HE_LIM_SUN_FETAL_LUNG_C0_AIRWAY_FIBROBLAST,1
MIR6748_3P,SET,79,-0.061152,-0.0040027,0.095442,0.73914,MIR6748_3P,1
GOBP_GUANINE_NUCLEOTIDE_TRAN...,SET,11,-0.18662,-0.0045665,0.29127,0.73914,GOBP_GUANINE_NUCLEOTIDE_TRANSPORT,1
GOBP_REGULATION_OF_AXON_GUID...,SET,11,-0.18981,-0.0046445,0.29623,0.73915,GOBP_REGULATION_OF_AXON_GUIDANCE,1
GOBP_ENDOSOME_ORGANIZATION,SET,86,-0.055282,-0.0037746,0.086272,0.73916,GOBP_ENDOSOME_ORGANIZATION,1
RB_P107_DN.V1_DN,SET,110,-0.049365,-0.0038096,0.077035,0.73917,RB_P107_DN.V1_DN,1
GOBP_REGULATION_OF_MONONUCLE...,SET,130,-0.049848,-0.0041797,0.077783,0.73919,GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...131,SET,4,-0.30306,-0.0044728,0.47264,0.7393,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
GSE13485_DAY3_VS_DAY21_YF17D...2,SET,176,-0.040136,-0.0039108,0.062597,0.7393,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
WP_TRANSSULFURATION_PATHWAY,SET,9,-0.21535,-0.0047667,0.33582,0.73932,WP_TRANSSULFURATION_PATHWAY,1
GOCC_CYTOPLASMIC_DYNEIN_COMP...,SET,16,-0.13254,-0.003911,0.20669,0.73932,GOCC_CYTOPLASMIC_DYNEIN_COMPLEX,1
CBX5_TARGET_GENES,SET,592,-0.023015,-0.0040655,0.035888,0.73933,CBX5_TARGET_GENES,1
HP_NEOPLASM_OF_STRIATED_MUSC...,SET,29,-0.10815,-0.004295,0.16865,0.73934,HP_NEOPLASM_OF_STRIATED_MUSCLE,1
EHRLICH_ICF_SYNDROM_DN,SET,12,-0.17132,-0.0043785,0.26711,0.73936,EHRLICH_ICF_SYNDROM_DN,1
GOMF_CHEMOKINE_RECEPTOR_BIND...,SET,60,-0.083802,-0.0047828,0.13061,0.73944,GOMF_CHEMOKINE_RECEPTOR_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...169,SET,13,-0.17042,-0.0045332,0.26554,0.73949,GOBP_POSITIVE_REGULATION_OF_CILIUM_MOVEMENT,1
BIOCARTA_EXTRINSIC_PATHWAY,SET,13,-0.16532,-0.0043976,0.25758,0.7395,BIOCARTA_EXTRINSIC_PATHWAY,1
GSE14000_TRANSLATED_RNA_VS_M...6,SET,178,-0.040115,-0.0039307,0.062497,0.73952,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP,1
chr15q22,SET,65,-0.1287,-0.0076444,0.2005,0.73953,chr15q22,1
REACTOME_ROBO_RECEPTORS_BIND...,SET,9,-0.17529,-0.00388,0.27308,0.73953,REACTOME_ROBO_RECEPTORS_BIND_AKAP5,1
BENPORATH_EED_TARGETS,SET,902,-0.021014,-0.0045419,0.032724,0.73961,BENPORATH_EED_TARGETS,1
GOBP_REGULATION_OF_TAU_PROTE...,SET,4,-0.22173,-0.0032724,0.34528,0.73961,GOBP_REGULATION_OF_TAU_PROTEIN_KINASE_ACTIVITY,1
GOBP_BASIC_AMINO_ACID_TRANSP...,SET,20,-0.12981,-0.004282,0.20198,0.73979,GOBP_BASIC_AMINO_ACID_TRANSPORT,1
GSE7852_LN_VS_THYMUS_TCONV_DN,SET,187,-0.038649,-0.0038806,0.06012,0.73984,GSE7852_LN_VS_THYMUS_TCONV_DN,1
GSE17186_MEMORY_VS_NAIVE_BCE...2,SET,169,-0.042273,-0.0040371,0.065753,0.73986,GSE17186_MEMORY_VS_NAIVE_BCELL_UP,1
GSE3982_MAST_CELL_VS_DC_DN,SET,179,-0.043273,-0.0042518,0.067303,0.73987,GSE3982_MAST_CELL_VS_DC_DN,1
GSE17721_CTRL_VS_LPS_6H_BMDC...1,SET,184,-0.040253,-0.0040095,0.062597,0.7399,GSE17721_CTRL_VS_LPS_6H_BMDC_DN,1
MODULE_148,SET,13,-0.17354,-0.0046161,0.26983,0.73993,MODULE_148,1
GSE20715_0H_VS_24H_OZONE_LUN...2,SET,183,-0.04058,-0.0040311,0.063093,0.73994,GSE20715_0H_VS_24H_OZONE_LUNG_UP,1
GOBP_POSITIVE_REGULATION_OF_...181,SET,14,-0.14019,-0.0038697,0.21794,0.73996,GOBP_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
GOBP_REGULATION_OF_CELL_MIGR...,SET,36,-0.096,-0.0042468,0.14924,0.73997,GOBP_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GOBP_REGULATION_OF_PROTEIN_C...2,SET,11,-0.16343,-0.0039992,0.25404,0.73999,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
HP_MISSING_RIBS,SET,60,-0.070374,-0.0040164,0.10938,0.74,HP_MISSING_RIBS,1
GOBP_MAINTENANCE_OF_PROTEIN_...2,SET,42,-0.081186,-0.0038786,0.12618,0.74001,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE,1
HP_EEG_WITH_BURST_SUPPRESSION,SET,56,-0.072876,-0.0040187,0.11325,0.74005,HP_EEG_WITH_BURST_SUPPRESSION,1
CHIANG_LIVER_CANCER_SUBCLASS...6,SET,67,-0.068458,-0.0041279,0.10637,0.74008,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,1
GOBP_L_GLUTAMATE_TRANSMEMBRA...,SET,29,-0.10468,-0.004157,0.16265,0.74008,GOBP_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT,1
HP_UPSLANTED_PALPEBRAL_FISSU...,SET,270,-0.032507,-0.0039129,0.050473,0.74022,HP_UPSLANTED_PALPEBRAL_FISSURE,1
GSE21670_STAT3_KO_VS_WT_CD4_...2,SET,175,-0.044183,-0.004293,0.068599,0.74023,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN,1
GOMF_DYNEIN_LIGHT_CHAIN_BIND...,SET,5,-0.23474,-0.0038733,0.36436,0.74029,GOMF_DYNEIN_LIGHT_CHAIN_BINDING,1
GOBP_CELLULAR_LIPID_METABOLI...,SET,921,-0.018959,-0.0041383,0.029425,0.74031,GOBP_CELLULAR_LIPID_METABOLIC_PROCESS,1
HP_FOOT_JOINT_CONTRACTURE,SET,123,-0.049622,-0.0040479,0.077002,0.74035,HP_FOOT_JOINT_CONTRACTURE,1
KEGG_MEDICUS_REFERENCE_MLK_J...,SET,10,-0.18384,-0.0042894,0.28526,0.74036,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY,1
TUOMISTO_TUMOR_SUPPRESSION_B...2,SET,17,-0.14859,-0.0045192,0.23054,0.74037,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,1
MIR9898,SET,52,-0.074404,-0.0039541,0.11544,0.74037,MIR9898,1
MIR6090,SET,9,-0.1977,-0.004376,0.30673,0.74038,MIR6090,1
GSE557_WT_VS_I_AB_KO_DC_UP,SET,178,-0.038819,-0.0038037,0.060229,0.74038,GSE557_WT_VS_I_AB_KO_DC_UP,1
HP_BRACHYDACTYLY,SET,337,-0.030146,-0.0040466,0.046748,0.74049,HP_BRACHYDACTYLY,1
HP_LOWER_EXTREMITY_JOINT_DIS...,SET,271,-0.033191,-0.0040026,0.051467,0.7405,HP_LOWER_EXTREMITY_JOINT_DISLOCATION,1
GOBP_MECHANOSENSORY_BEHAVIOR,SET,14,-0.16058,-0.0044325,0.24897,0.74052,GOBP_MECHANOSENSORY_BEHAVIOR,1
GCM_DLG1,SET,69,-0.062188,-0.0038052,0.096416,0.74053,GCM_DLG1,1
GSE19888_ADENOSINE_A3R_INH_P...1,SET,181,-0.040131,-0.0039649,0.062213,0.74055,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN,1
SHETH_LIVER_CANCER_VS_TXNIP_...1,SET,236,-0.036621,-0.0041252,0.056767,0.74057,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1
MIR5583_3P,SET,76,-0.065597,-0.0042117,0.10162,0.7407,MIR5583_3P,1
GOCC_MAIN_AXON,SET,67,-0.074415,-0.0044871,0.11527,0.74071,GOCC_MAIN_AXON,1
GCM_GSPT1,SET,153,-0.040252,-0.0036592,0.062351,0.74072,GCM_GSPT1,1
GOMF_TYPE_1_ANGIOTENSIN_RECE...,SET,6,-0.26413,-0.004774,0.40911,0.74073,GOMF_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING,1
SCIAN_CELL_CYCLE_TARGETS_OF_...2,SET,8,-0.18636,-0.0038892,0.28861,0.74076,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP,1
GSE26023_PHD3_KO_VS_WT_NEUTR...2,SET,171,-0.042673,-0.0040991,0.066084,0.74077,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP,1
HP_GENERALIZED_HYPERKERATOSIS,SET,13,-0.14177,-0.0037711,0.21953,0.74079,HP_GENERALIZED_HYPERKERATOSIS,1
MORF_RAF1,SET,108,-0.047703,-0.0036478,0.073849,0.74084,MORF_RAF1,1
WP_INTERACTIONS_BETWEEN_LOXL...,SET,17,-0.12776,-0.0038858,0.19776,0.74087,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,1
HP_CHORIORETINAL_ATROPHY,SET,40,-0.088794,-0.00414,0.13742,0.7409,HP_CHORIORETINAL_ATROPHY,1
HP_SCLEROSIS_OF_FINGER_PHALA...,SET,8,-0.2224,-0.0046414,0.3442,0.7409,HP_SCLEROSIS_OF_FINGER_PHALANX,1
GSE37532_WT_VS_PPARG_KO_LN_T...2,SET,180,-0.040933,-0.0040331,0.063332,0.74096,GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP,1
HOXB6_TARGET_GENES,SET,514,-0.023918,-0.0039455,0.037001,0.74099,HOXB6_TARGET_GENES,1
GSE6092_CTRL_VS_BORRELIA_BIR...1,SET,140,-0.046583,-0.0040522,0.072054,0.74102,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN,1
GOMF_HEPARAN_SULFATE_SULFOTR...,SET,14,-0.1652,-0.00456,0.25551,0.74103,GOMF_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY,1
GOBP_CYCLIC_NUCLEOTIDE_TRANS...,SET,11,-0.18679,-0.0045708,0.28889,0.74104,GOBP_CYCLIC_NUCLEOTIDE_TRANSPORT,1
CUI_DEVELOPING_HEART_COMPACT...1,SET,15,-0.14915,-0.0042615,0.2306,0.74111,CUI_DEVELOPING_HEART_COMPACT_ATRIAL_CARDIOMYOCYTE,1
GOMF_HISTONE_H3K9_TRIMETHYLT...,SET,4,-0.25613,-0.0037801,0.39591,0.74116,GOMF_HISTONE_H3K9_TRIMETHYLTRANSFERASE_ACTIVITY,1
GAUSSMANN_MLL_AF4_FUSION_TAR...5,SET,20,-0.13977,-0.0046106,0.21603,0.74118,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,1
HALLMARK_KRAS_SIGNALING_DN,SET,175,-0.043627,-0.0042389,0.067407,0.74125,HALLMARK_KRAS_SIGNALING_DN,1
HP_HYPEROPIC_ASTIGMATISM,SET,5,-0.2173,-0.0035856,0.33573,0.74126,HP_HYPEROPIC_ASTIGMATISM,1
GOBP_CARDIAC_VASCULAR_SMOOTH...,SET,8,-0.22333,-0.0046609,0.34501,0.74129,GOBP_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GSE2826_WT_VS_BTK_KO_BCELL_DN,SET,193,-0.040069,-0.0040865,0.061893,0.74131,GSE2826_WT_VS_BTK_KO_BCELL_DN,1
DESCARTES_FETAL_STOMACH_LYMP...1,SET,19,-0.14238,-0.0045779,0.21982,0.74141,DESCARTES_FETAL_STOMACH_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_TRYPTOPHAN_CATABOLIC_PR...,SET,5,-0.30113,-0.0049687,0.46473,0.7415,GOBP_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE,1
GSE43955_TH0_VS_TGFB_IL6_TH1...3,SET,182,-0.041476,-0.004109,0.063995,0.74154,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN,1
GOBP_POSITIVE_REGULATION_OF_...807,SET,17,-0.1376,-0.0041852,0.21227,0.74158,GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
HP_BRAIN_IMAGING_ABNORMALITY,SET,137,-0.047521,-0.0040896,0.073309,0.74158,HP_BRAIN_IMAGING_ABNORMALITY,1
GOMF_LIPASE_ACTIVATOR_ACTIVI...,SET,18,-0.12463,-0.0039004,0.19223,0.74162,GOMF_LIPASE_ACTIVATOR_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C0_MID...1,SET,57,-0.081172,-0.0045158,0.1252,0.74162,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL,1
GOBP_SECRETORY_GRANULE_ORGAN...,SET,61,-0.072243,-0.0041572,0.11138,0.7417,GOBP_SECRETORY_GRANULE_ORGANIZATION,1
YAO_TEMPORAL_RESPONSE_TO_PRO...7,SET,132,-0.047584,-0.0040202,0.073352,0.74173,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,1
HP_ABNORMAL_FUNDUS_AUTOFLUOR...,SET,26,-0.1169,-0.0043961,0.1802,0.74174,HP_ABNORMAL_FUNDUS_AUTOFLUORESCENCE_IMAGING,1
REACTOME_HSF1_ACTIVATION,SET,28,-0.10377,-0.0040494,0.15991,0.74181,REACTOME_HSF1_ACTIVATION,1
GOBP_CELLULAR_RESPONSE_TO_RE...1,SET,14,-0.15743,-0.0043455,0.24256,0.74183,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES,1
GOMF_SODIUM_ION_TRANSMEMBRAN...,SET,156,-0.047018,-0.0043156,0.07244,0.74185,GOMF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_BROAD_METACARPALS,SET,17,-0.1476,-0.0044893,0.22733,0.74192,HP_BROAD_METACARPALS,1
REACTOME_SOMITOGENESIS,SET,52,-0.069003,-0.003667,0.10627,0.74193,REACTOME_SOMITOGENESIS,1
GOMF_CALCIUM_CHANNEL_INHIBIT...,SET,12,-0.17002,-0.0043453,0.26182,0.74195,GOMF_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY,1
T3R_Q6,SET,229,-0.036546,-0.004056,0.056263,0.74201,T3R_Q6,1
GOCC_IRON_SULFUR_CLUSTER_ASS...,SET,8,-0.20301,-0.0042367,0.31253,0.74201,GOCC_IRON_SULFUR_CLUSTER_ASSEMBLY_COMPLEX,1
HP_SOMNAMBULISM,SET,7,-0.22285,-0.0043505,0.34307,0.74201,HP_SOMNAMBULISM,1
GSE7460_FOXP3_MUT_VS_WT_ACT_...3,SET,184,-0.040813,-0.0040652,0.062827,0.74202,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN,1
VERHAAK_GLIOBLASTOMA_CLASSIC...,SET,152,-0.04669,-0.0042306,0.07183,0.74215,VERHAAK_GLIOBLASTOMA_CLASSICAL,1
GOBP_POSITIVE_REGULATION_OF_...587,SET,5,-0.24743,-0.0040826,0.3806,0.74218,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
HP_FATIGUABLE_WEAKNESS_OF_PR...,SET,21,-0.11884,-0.0040169,0.18281,0.74218,HP_FATIGUABLE_WEAKNESS_OF_PROXIMAL_LIMB_MUSCLES,1
GSE3982_NEUTROPHIL_VS_TH1_UP,SET,171,-0.04302,-0.0041324,0.066176,0.74218,GSE3982_NEUTROPHIL_VS_TH1_UP,1
CHICAS_RB1_TARGETS_LOW_SERUM,SET,74,-0.064133,-0.0040634,0.098645,0.74219,CHICAS_RB1_TARGETS_LOW_SERUM,1
MANNO_MIDBRAIN_NEUROTYPES_BA...,SET,64,-0.061855,-0.0036456,0.095102,0.74228,MANNO_MIDBRAIN_NEUROTYPES_BASAL,1
HP_PHYSICAL_URTICARIA,SET,14,-0.15558,-0.0042944,0.23917,0.74231,HP_PHYSICAL_URTICARIA,1
SIG_BCR_SIGNALING_PATHWAY,SET,45,-0.08235,-0.0040719,0.12657,0.74235,SIG_BCR_SIGNALING_PATHWAY,1
GRUETZMANN_PANCREATIC_CANCER...2,SET,330,-0.031538,-0.00419,0.048457,0.74242,GRUETZMANN_PANCREATIC_CANCER_UP,1
HP_RENAL_TUBULAR_ACIDOSIS,SET,39,-0.088587,-0.0040786,0.13612,0.74242,HP_RENAL_TUBULAR_ACIDOSIS,1
HP_ABNORMAL_FOOT_BONE_OSSIFI...,SET,9,-0.17755,-0.00393,0.27271,0.74249,HP_ABNORMAL_FOOT_BONE_OSSIFICATION,1
GOBP_REGULATION_OF_MEMBRANE_...11,SET,7,-0.23313,-0.0045512,0.35798,0.74255,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,1
GOBP_NEGATIVE_REGULATION_OF_...251,SET,24,-0.12824,-0.0046336,0.19689,0.74259,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...138,SET,21,-0.13543,-0.0045776,0.20788,0.74263,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,1
REACTOME_INTRINSIC_PATHWAY_O...,SET,20,-0.13065,-0.0043099,0.20053,0.74265,REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,1
GOLDRATH_EFF_VS_MEMORY_CD8_T...1,SET,186,-0.040144,-0.00402,0.061609,0.74266,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN,1
REACTOME_METABOLISM_OF_NUCLE...,SET,92,-0.060199,-0.0042507,0.092385,0.74267,REACTOME_METABOLISM_OF_NUCLEOTIDES,1
GOBP_KYNURENINE_METABOLIC_PR...,SET,9,-0.21529,-0.0047655,0.33036,0.7427,GOBP_KYNURENINE_METABOLIC_PROCESS,1
HP_PYELONEPHRITIS,SET,20,-0.12333,-0.0040681,0.18922,0.74271,HP_PYELONEPHRITIS,1
REACTOME_IL_6_TYPE_CYTOKINE_...,SET,17,-0.13311,-0.0040487,0.20422,0.74274,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1
GOBP_NADH_DEHYDROGENASE_COMP...,SET,48,-0.070927,-0.0036218,0.1088,0.74277,GOBP_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY,1
GSE4984_UNTREATED_VS_LPS_TRE...1,SET,156,-0.043453,-0.0039883,0.066637,0.74282,GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN,1
GOBP_DNA_STRAND_ELONGATION,SET,35,-0.089131,-0.0038879,0.13666,0.74287,GOBP_DNA_STRAND_ELONGATION,1
HP_SMALL_HAND,SET,94,-0.060245,-0.0042997,0.092369,0.74287,HP_SMALL_HAND,1
MIR10400_3P_MIR4674,SET,33,-0.094745,-0.0040132,0.14523,0.74291,MIR10400_3P_MIR4674,1
MIR103B,SET,36,-0.092637,-0.004098,0.14199,0.74293,MIR103B,1
BIOCARTA_AHSP_PATHWAY,SET,9,-0.18141,-0.0040156,0.27805,0.74294,BIOCARTA_AHSP_PATHWAY,1
HP_ENLARGEMENT_OF_THE_COSTOC...,SET,8,-0.20584,-0.0042958,0.31549,0.74294,HP_ENLARGEMENT_OF_THE_COSTOCHONDRAL_JUNCTION,1
GSE21546_UNSTIM_VS_ANTI_CD3_...3,SET,145,-0.048373,-0.0042819,0.074136,0.74296,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN,1
MIR6506_5P,SET,93,-0.057211,-0.0040614,0.087639,0.74305,MIR6506_5P,1
HP_PROXIMAL_PLACEMENT_OF_THU...,SET,34,-0.094758,-0.0040739,0.14514,0.74307,HP_PROXIMAL_PLACEMENT_OF_THUMB,1
GSE4142_NAIVE_VS_GC_BCELL_UP,SET,181,-0.041443,-0.0040945,0.063472,0.74309,GSE4142_NAIVE_VS_GC_BCELL_UP,1
GOBP_BASOLATERAL_PROTEIN_SEC...,SET,5,-0.23046,-0.0038027,0.35261,0.74331,GOBP_BASOLATERAL_PROTEIN_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...536,SET,63,-0.071886,-0.0042037,0.10998,0.74332,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION,1
GOMF_RNA_STEM_LOOP_BINDING,SET,13,-0.14139,-0.0037609,0.21628,0.74336,GOMF_RNA_STEM_LOOP_BINDING,1
GOCC_MRE11_COMPLEX,SET,3,-0.284,-0.00363,0.43435,0.74339,GOCC_MRE11_COMPLEX,1
MIR5187_5P,SET,97,-0.056415,-0.0040897,0.086278,0.7434,MIR5187_5P,1
GOBP_REGULATION_OF_DNA_STRAN...,SET,17,-0.1412,-0.0042945,0.21594,0.7434,GOBP_REGULATION_OF_DNA_STRAND_ELONGATION,1
SONG_TARGETS_OF_IE86_CMV_PRO...,SET,51,-0.079128,-0.0041646,0.12101,0.74341,SONG_TARGETS_OF_IE86_CMV_PROTEIN,1
GOBP_L_GLUTAMINE_IMPORT_ACRO...,SET,4,-0.29826,-0.0044019,0.45606,0.74344,GOBP_L_GLUTAMINE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
REACTOME_DEUBIQUITINATION,SET,217,-0.03608,-0.0038992,0.055163,0.74346,REACTOME_DEUBIQUITINATION,1
GROSS_HIF1A_TARGETS_UP,SET,7,-0.25287,-0.0049366,0.38652,0.74351,GROSS_HIF1A_TARGETS_UP,1
GOBP_MESODERMAL_CELL_FATE_CO...,SET,17,-0.13677,-0.00416,0.20899,0.74359,GOBP_MESODERMAL_CELL_FATE_COMMITMENT,1
REACTOME_ACYL_CHAIN_REMODELL...3,SET,18,-0.14338,-0.0044873,0.21906,0.74361,REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,1
GOBP_POSITIVE_REGULATION_OF_...412,SET,109,-0.055396,-0.0042556,0.084626,0.74363,GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
HP_URETHRAL_STRICTURE,SET,16,-0.14718,-0.004343,0.22476,0.74371,HP_URETHRAL_STRICTURE,1
MIR2355_3P,SET,97,-0.059173,-0.0042897,0.09036,0.74372,MIR2355_3P,1
GOBP_ANTEROGRADE_AXONAL_TRAN...1,SET,48,-0.080833,-0.0041277,0.12342,0.74374,GOBP_ANTEROGRADE_AXONAL_TRANSPORT,1
GOBP_PERIPHERAL_NERVOUS_SYST...5,SET,14,-0.15909,-0.0043916,0.2429,0.74376,GOBP_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...225,SET,5,-0.31244,-0.0051554,0.47703,0.74376,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_DIET_INDUCED_THERMOGENE...,SET,13,-0.15827,-0.0042099,0.24162,0.74377,GOBP_DIET_INDUCED_THERMOGENESIS,1
GOMF_LOW_DENSITY_LIPOPROTEIN...2,SET,15,-0.15291,-0.0043687,0.23335,0.74385,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...199,SET,6,-0.21573,-0.0038993,0.32911,0.74393,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,1
MIR5187_3P,SET,91,-0.056328,-0.0039558,0.085927,0.74394,MIR5187_3P,1
BIOCARTA_ERK_PATHWAY,SET,26,-0.11675,-0.0043905,0.17804,0.74401,BIOCARTA_ERK_PATHWAY,1
GOMF_PROTEIN_HETERODIMERIZAT...,SET,232,-0.038113,-0.0042572,0.058119,0.74401,GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY,1
MARCHINI_TRABECTEDIN_RESISTA...2,SET,16,-0.14436,-0.0042596,0.22012,0.74402,MARCHINI_TRABECTEDIN_RESISTANCE_UP,1
GOBP_DOUBLE_STRAND_BREAK_REP...6,SET,58,-0.066431,-0.0037279,0.1013,0.74403,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
HP_URETHRAL_DIVERTICULUM,SET,4,-0.30809,-0.004547,0.46977,0.74403,HP_URETHRAL_DIVERTICULUM,1
GSE17721_CTRL_VS_CPG_2H_BMDC...2,SET,176,-0.041798,-0.0040727,0.063726,0.74405,GSE17721_CTRL_VS_CPG_2H_BMDC_UP,1
GSE36009_UNSTIM_VS_LPS_STIM_...3,SET,169,-0.04078,-0.0038945,0.062175,0.74405,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN,1
GOBP_DICARBOXYLIC_ACID_METAB...,SET,89,-0.058683,-0.0040758,0.089442,0.74411,GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS,1
GOBP_RELAXATION_OF_CARDIAC_M...,SET,17,-0.14363,-0.0043684,0.21888,0.74414,GOBP_RELAXATION_OF_CARDIAC_MUSCLE,1
WP_PARKINUBIQUITIN_PROTEASOM...,SET,64,-0.066555,-0.0039226,0.10141,0.74417,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,1
GSE24671_CTRL_VS_BAKIMULC_IN...1,SET,151,-0.048193,-0.0043526,0.073417,0.74422,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN,1
GSE411_WT_VS_SOCS3_KO_MACROP...1,SET,185,-0.040423,-0.0040372,0.06158,0.74422,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN,1
GOBP_ERBB4_ERBB4_SIGNALING_P...,SET,6,-0.22388,-0.0040466,0.34105,0.74423,GOBP_ERBB4_ERBB4_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_RESPIRATO...2,SET,7,-0.22783,-0.0044477,0.34699,0.74427,GOBP_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...16,SET,50,-0.070244,-0.0036607,0.10698,0.74428,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR,1
HP_ABNORMAL_PIGMENTATION_OF_...,SET,35,-0.099239,-0.0043288,0.15113,0.74429,HP_ABNORMAL_PIGMENTATION_OF_THE_ORAL_MUCOSA,1
GSE26030_UNSTIM_VS_RESTIM_TH...4,SET,166,-0.044303,-0.0041935,0.067469,0.74429,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP,1
ZNF37A_TARGET_GENES,SET,116,-0.051997,-0.00412,0.079177,0.74432,ZNF37A_TARGET_GENES,1
GOBP_NEURON_REMODELING,SET,15,-0.16318,-0.0046623,0.24842,0.74437,GOBP_NEURON_REMODELING,1
ZNF766_TARGET_GENES,SET,933,-0.018673,-0.004101,0.02842,0.74441,ZNF766_TARGET_GENES,1
GSE23568_ID3_TRANSDUCED_VS_I...1,SET,182,-0.042248,-0.0041855,0.064296,0.74443,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN,1
KEGG_MEDICUS_ENV_FACTOR_E2_T...2,SET,15,-0.14588,-0.004168,0.22198,0.74446,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY,1
WTTGKCTG_UNKNOWN,SET,455,-0.027773,-0.0043177,0.042263,0.74446,WTTGKCTG_UNKNOWN,1
ZHONG_PFC_C2_SOX5_BCL11B_POS...,SET,24,-0.12622,-0.0045606,0.19205,0.74448,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,1
GOBP_REGULATION_OF_CARDIAC_C...,SET,23,-0.12257,-0.0043353,0.18646,0.74451,GOBP_REGULATION_OF_CARDIAC_CONDUCTION,1
GOBP_EMBRYONIC_DIGESTIVE_TRA...1,SET,33,-0.11134,-0.0047162,0.16934,0.74458,GOBP_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT,1
GSE15139_GMCSF_TREATED_VS_UN...2,SET,180,-0.040817,-0.0040217,0.062072,0.74459,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP,1
GOBP_REGULATION_OF_SYSTEMIC_...8,SET,40,-0.09815,-0.0045763,0.14925,0.7446,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL,1
GSE10500_ARTHRITIC_SYNOVIAL_...2,SET,135,-0.047689,-0.0040742,0.072519,0.7446,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP,1
HP_ERYTHROID_HYPERPLASIA,SET,14,-0.13838,-0.0038197,0.21039,0.74463,HP_ERYTHROID_HYPERPLASIA,1
GOMF_RETINOIC_ACID_4_HYDROXY...,SET,10,-0.20076,-0.004684,0.3052,0.74466,GOMF_RETINOIC_ACID_4_HYDROXYLASE_ACTIVITY,1
GSE15324_NAIVE_VS_ACTIVATED_...3,SET,185,-0.039232,-0.0039183,0.059644,0.74466,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...77,SET,37,-0.078105,-0.0035027,0.11872,0.7447,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
DORN_ADENOVIRUS_INFECTION_48...1,SET,37,-0.088782,-0.0039815,0.13492,0.74474,DORN_ADENOVIRUS_INFECTION_48HR_DN,1
HP_POSTTERM_PREGNANCY,SET,5,-0.30252,-0.0049916,0.45965,0.74477,HP_POSTTERM_PREGNANCY,1
DESCARTES_FETAL_HEART_LYMPHO...,SET,86,-0.064794,-0.0044242,0.098454,0.74477,DESCARTES_FETAL_HEART_LYMPHOID_CELLS,1
REACTOME_PROCESSIVE_SYNTHESI...2,SET,14,-0.13372,-0.003691,0.20313,0.74481,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,1
GSE17721_0.5H_VS_12H_PAM3CSK...2,SET,182,-0.041036,-0.0040654,0.062314,0.7449,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP,1
REACTOME_TRANSPORT_AND_SYNTH...,SET,6,-0.23728,-0.0042888,0.36028,0.74492,REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS,1
KEGG_MEDICUS_VARIANT_MUTATIO...65,SET,37,-0.078165,-0.0035054,0.11862,0.74502,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GSE25123_WT_VS_PPARG_KO_MACR...6,SET,149,-0.04636,-0.0041594,0.070354,0.74503,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,1
GSE7568_IL4_VS_IL4_AND_DEXAM...1,SET,138,-0.047012,-0.0040604,0.071341,0.74504,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN,1
REACTOME_PHOSPHORYLATION_OF_...1,SET,6,-0.19127,-0.0034571,0.29021,0.74507,REACTOME_PHOSPHORYLATION_OF_EMI1,1
GOBP_ENDOCARDIUM_MORPHOGENES...,SET,6,-0.26866,-0.004856,0.40758,0.7451,GOBP_ENDOCARDIUM_MORPHOGENESIS,1
WP_NONCLASSICAL_ROLE_OF_VITA...,SET,6,-0.25481,-0.0046055,0.38633,0.74523,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,1
GOBP_HEPATIC_STELLATE_CELL_A...,SET,9,-0.21167,-0.0046854,0.32093,0.74523,GOBP_HEPATIC_STELLATE_CELL_ACTIVATION,1
HP_USUAL_INTERSTITIAL_PNEUMO...,SET,13,-0.16474,-0.004382,0.24977,0.74523,HP_USUAL_INTERSTITIAL_PNEUMONIA,1
WRNIP1_TARGET_GENES,SET,967,-0.018109,-0.0040451,0.027452,0.74526,WRNIP1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...44,SET,4,-0.23064,-0.0034039,0.34957,0.7453,GOBP_NEGATIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
GOMF_PEPTIDOGLYCAN_IMMUNE_RE...,SET,5,-0.28142,-0.0046435,0.42653,0.7453,GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY,1
HP_HITCHHIKER_THUMB,SET,6,-0.18969,-0.0034285,0.28743,0.74535,HP_HITCHHIKER_THUMB,1
TURJANSKI_MAPK1_AND_MAPK2_TA...,SET,11,-0.18895,-0.0046235,0.28624,0.7454,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,1
CHIARADONNA_NEOPLASTIC_TRANS...1,SET,135,-0.049707,-0.0042467,0.075282,0.74546,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1
MIR3974,SET,86,-0.065035,-0.0044406,0.098494,0.74546,MIR3974,1
HP_ABNORMAL_CARDIOMYOCYTE_MO...,SET,15,-0.13655,-0.0039015,0.20681,0.74546,HP_ABNORMAL_CARDIOMYOCYTE_MORPHOLOGY,1
HP_HYPERMETHIONINEMIA,SET,7,-0.2477,-0.0048357,0.37506,0.74551,HP_HYPERMETHIONINEMIA,1
ZHANG_INTERFERON_RESPONSE,SET,23,-0.13301,-0.0047049,0.20139,0.74553,ZHANG_INTERFERON_RESPONSE,1
PID_FAK_PATHWAY,SET,57,-0.073288,-0.0040772,0.11092,0.74561,PID_FAK_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...87,SET,30,-0.10874,-0.0043918,0.16446,0.74574,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
DACOSTA_ERCC3_ALLELE_XPCS_VS...2,SET,26,-0.11946,-0.0044924,0.18067,0.74576,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,1
GSE32986_UNSTIM_VS_GMCSF_AND...3,SET,174,-0.042255,-0.004094,0.063894,0.7458,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,1
MIR621,SET,30,-0.10909,-0.0044061,0.16491,0.74586,MIR621,1
DESCARTES_FETAL_STOMACH_PDE1...,SET,20,-0.13109,-0.0043242,0.19805,0.74598,DESCARTES_FETAL_STOMACH_PDE1C_ACSM3_POSITIVE_CELLS,1
GOBP_MITOCHONDRIAL_FRAGMENTA...,SET,10,-0.20225,-0.0047187,0.30549,0.74603,GOBP_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS,1
AAAGGGA_MIR204_MIR211,SET,211,-0.039717,-0.0042333,0.059978,0.74607,AAAGGGA_MIR204_MIR211,1
MIR766_5P,SET,195,-0.041279,-0.0042315,0.06232,0.74613,MIR766_5P,1
GOCC_3M_COMPLEX,SET,5,-0.22809,-0.0037635,0.34415,0.74625,GOCC_3M_COMPLEX,1
HP_REDUCED_RENAL_CORTICOMEDU...,SET,14,-0.15359,-0.0042395,0.23171,0.74628,HP_REDUCED_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
HP_HEPATIC_BRIDGING_FIBROSIS,SET,9,-0.18875,-0.0041781,0.28464,0.74637,HP_HEPATIC_BRIDGING_FIBROSIS,1
GOMF_HYDROLASE_ACTIVITY_ACTI...5,SET,69,-0.066475,-0.0040675,0.10021,0.74644,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES,1
HP_TIP_TOE_GAIT,SET,75,-0.064839,-0.0041357,0.097729,0.74648,HP_TIP_TOE_GAIT,1
HP_ABNORMAL_MUSCLE_FIBER_PRO...,SET,25,-0.11737,-0.0043282,0.1769,0.7465,HP_ABNORMAL_MUSCLE_FIBER_PROTEIN_EXPRESSION,1
HP_CHOLESTASIS,SET,257,-0.034864,-0.0040958,0.052525,0.74657,HP_CHOLESTASIS,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...7,SET,10,-0.16662,-0.0038875,0.25098,0.74661,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION,1
KEGG_MEDICUS_REFERENCE_TLR3_...3,SET,9,-0.19321,-0.0042767,0.29098,0.74665,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY,1
KIM_RESPONSE_TO_TSA_AND_DECI...2,SET,108,-0.053905,-0.0041222,0.081177,0.74667,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1
GOBP_REGULATION_OF_SYSTEMIC_...3,SET,6,-0.27055,-0.0048901,0.4074,0.74668,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN,1
MIR4433B_3P,SET,28,-0.11262,-0.0043948,0.16957,0.7467,MIR4433B_3P,1
HP_LOSS_OF_VOICE,SET,6,-0.22694,-0.0041019,0.3417,0.7467,HP_LOSS_OF_VOICE,1
GCM_CSNK1D,SET,29,-0.10038,-0.0039862,0.15111,0.74673,GCM_CSNK1D,1
MCBRYAN_PUBERTAL_BREAST_6_7W...1,SET,71,-0.068629,-0.0042595,0.10331,0.74674,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1
HP_PRIMARY_HYPOTHYROIDISM,SET,6,-0.19549,-0.0035334,0.29429,0.74674,HP_PRIMARY_HYPOTHYROIDISM,1
DESCARTES_FETAL_HEART_LYMPHA...,SET,28,-0.11849,-0.0046239,0.17838,0.74674,DESCARTES_FETAL_HEART_LYMPHATIC_ENDOTHELIAL_CELLS,1
REACTOME_EGFR_DOWNREGULATION,SET,29,-0.11032,-0.004381,0.16603,0.74679,REACTOME_EGFR_DOWNREGULATION,1
GSE17721_LPS_VS_POLYIC_4H_BM...1,SET,174,-0.040003,-0.0038759,0.060202,0.74681,GSE17721_LPS_VS_POLYIC_4H_BMDC_DN,1
GSE9960_HEALTHY_VS_SEPSIS_PB...1,SET,139,-0.049291,-0.0042726,0.074174,0.74682,GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN,1
HP_REDUCED_ANTIGEN_SPECIFIC_...,SET,8,-0.19132,-0.0039928,0.28778,0.74691,HP_REDUCED_ANTIGEN_SPECIFIC_T_CELL_PROLIFERATION,1
WP_IRONSULFUR_CLUSTER_BIOGEN...,SET,13,-0.16025,-0.0042626,0.24097,0.74697,WP_IRONSULFUR_CLUSTER_BIOGENESIS,1
HP_ABNORMAL_DENSE_GRANULES,SET,9,-0.18355,-0.0040629,0.27595,0.74702,HP_ABNORMAL_DENSE_GRANULES,1
KEGG_MEDICUS_VARIANT_MUTATIO...19,SET,11,-0.17403,-0.0042586,0.26163,0.74704,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
chr1p36,SET,326,-0.06947,-0.0091744,0.10436,0.74719,chr1p36,1
GOBP_MODULATION_BY_HOST_OF_V...2,SET,42,-0.092064,-0.0043982,0.1382,0.74735,GOBP_MODULATION_BY_HOST_OF_VIRAL_PROCESS,1
GSE19888_ADENOSINE_A3R_ACT_V...1,SET,183,-0.041352,-0.0041078,0.062071,0.74735,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN,1
HP_ANURIA,SET,11,-0.19439,-0.0047566,0.2917,0.74741,HP_ANURIA,1
HP_TALIPES_EQUINOVALGUS,SET,13,-0.14903,-0.0039642,0.22364,0.74741,HP_TALIPES_EQUINOVALGUS,1
KEGG_MEDICUS_REFERENCE_ELECT...1,SET,36,-0.079959,-0.0035372,0.11998,0.74742,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I,1
KEGG_MEDICUS_VARIANT_EML4_AL...2,SET,8,-0.20375,-0.0042521,0.30571,0.74744,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,1
GOMF_GLUTATHIONE_TRANSFERASE...,SET,23,-0.14471,-0.0051185,0.2171,0.74746,GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY,1
HP_LOWER_LIMB_AMYOTROPHY,SET,69,-0.071076,-0.004349,0.10661,0.74752,HP_LOWER_LIMB_AMYOTROPHY,1
GSE29617_CTRL_VS_DAY7_TIV_FL...1,SET,160,-0.044153,-0.0041038,0.066215,0.74755,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,1
GOBP_AMINO_SUGAR_METABOLIC_P...,SET,38,-0.095892,-0.004358,0.14379,0.74758,GOBP_AMINO_SUGAR_METABOLIC_PROCESS,1
GOMF_LIM_DOMAIN_BINDING,SET,5,-0.27166,-0.0044824,0.40727,0.74761,GOMF_LIM_DOMAIN_BINDING,1
GRANDVAUX_IRF3_TARGETS_UP,SET,13,-0.16567,-0.0044069,0.24837,0.74762,GRANDVAUX_IRF3_TARGETS_UP,1
GSE32901_TH1_VS_TH17_ENRICHE...1,SET,142,-0.048078,-0.0042118,0.072077,0.74762,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN,1
BANDRES_RESPONSE_TO_CARMUSTI...2,SET,8,-0.16625,-0.0034696,0.24913,0.74771,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP,1
MIR10395_3P,SET,130,-0.049032,-0.0041112,0.073475,0.74771,MIR10395_3P,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...1,SET,22,-0.14109,-0.004881,0.21139,0.74775,HE_LIM_SUN_FETAL_LUNG_C1_LATE_AIRWAY_PROGENITOR_CELL,1
REACTOME_NUCLEOTIDE_LIKE_PUR...,SET,13,-0.16661,-0.0044319,0.24955,0.74782,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,1
GSE29618_MONOCYTE_VS_PDC_DAY...1,SET,174,-0.043171,-0.0041828,0.064627,0.74793,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN,1
MIR505_3P,SET,98,-0.057467,-0.0041873,0.08602,0.74795,MIR505_3P,1
KANG_GLIS3_TARGETS,SET,34,-0.11024,-0.0047397,0.16498,0.748,KANG_GLIS3_TARGETS,1
MIR5580_5P,SET,109,-0.05539,-0.0042552,0.082889,0.74801,MIR5580_5P,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...3,SET,6,-0.24757,-0.0044747,0.37043,0.74803,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GOBP_LENS_FIBER_CELL_DEVELOP...,SET,14,-0.16215,-0.0044758,0.24257,0.74807,GOBP_LENS_FIBER_CELL_DEVELOPMENT,1
GOCC_GABA_RECEPTOR_COMPLEX,SET,18,-0.16916,-0.0052939,0.25303,0.7481,GOCC_GABA_RECEPTOR_COMPLEX,1
GAVISH_3CA_METAPROGRAM_FIBRO...5,SET,43,-0.077677,-0.0037547,0.11617,0.74814,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4,1
WP_AMPACTIVATED_PROTEIN_KINA...,SET,67,-0.070124,-0.0042284,0.10482,0.74824,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,1
GSE22935_24H_VS_48H_MBOVIS_B...4,SET,183,-0.042548,-0.0042266,0.063599,0.74825,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
PRDM12_TARGET_GENES,SET,93,-0.057892,-0.0041098,0.086531,0.74826,PRDM12_TARGET_GENES,1
GOBP_INTERNEURON_MIGRATION,SET,13,-0.19097,-0.0050799,0.28537,0.74832,GOBP_INTERNEURON_MIGRATION,1
GOMF_CAMP_RESPONSE_ELEMENT_B...2,SET,8,-0.2131,-0.0044472,0.31838,0.74835,GOMF_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING,1
JIANG_TIP30_TARGETS_DN,SET,22,-0.13825,-0.0047826,0.2065,0.7484,JIANG_TIP30_TARGETS_DN,1
REACTOME_CHAPERONE_MEDIATED_...,SET,19,-0.13998,-0.0045006,0.20908,0.7484,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,1
GOBP_POSITIVE_REGULATION_OF_...680,SET,10,-0.20815,-0.0048565,0.31091,0.7484,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
TRAVAGLINI_LUNG_MYELOID_DEND...,SET,17,-0.14279,-0.0043431,0.21321,0.74849,TRAVAGLINI_LUNG_MYELOID_DENDRITIC_TYPE_1_CELL,1
GSE13484_3H_UNSTIM_VS_YF17D_...1,SET,184,-0.043925,-0.0043752,0.065561,0.74856,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...68,SET,22,-0.12189,-0.004217,0.18192,0.74858,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
REACTOME_ABACAVIR_ADME,SET,9,-0.22726,-0.0050304,0.33918,0.74858,REACTOME_ABACAVIR_ADME,1
GOBP_FATTY_ACID_ELONGATION_S...,SET,8,-0.22927,-0.0047848,0.34216,0.74859,GOBP_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID,1
HP_HYPOCALCEMIA,SET,74,-0.070492,-0.0044662,0.1052,0.7486,HP_HYPOCALCEMIA,1
ANDERSON_BLOOD_CN54GP140_ADJ...9,SET,5,-0.3045,-0.0050243,0.45438,0.74861,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_HIGH_IGM_RESPONDERS_3DY_7D_DN,1
DESCARTES_FETAL_HEART_SCHWAN...,SET,47,-0.087331,-0.0044129,0.13032,0.74861,DESCARTES_FETAL_HEART_SCHWANN_CELLS,1
GOBP_CALCINEURIN_MEDIATED_SI...,SET,47,-0.083031,-0.0041956,0.1239,0.74862,GOBP_CALCINEURIN_MEDIATED_SIGNALING,1
GSE3720_VD1_VS_VD2_GAMMADELT...5,SET,179,-0.041067,-0.0040351,0.061279,0.74862,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN,1
WP_AUTOSOMAL_RECESSIVE_OSTEO...,SET,11,-0.17506,-0.0042836,0.26112,0.7487,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,1
HP_SANDAL_GAP,SET,87,-0.063738,-0.0043772,0.095044,0.74876,HP_SANDAL_GAP,1
HP_ABNORMAL_HEART_VALVE_MORP...,SET,307,-0.033478,-0.0042927,0.049915,0.74879,HP_ABNORMAL_HEART_VALVE_MORPHOLOGY,1
GOBP_MUSCULAR_SEPTUM_MORPHOG...,SET,5,-0.31569,-0.0052089,0.47041,0.74891,GOBP_MUSCULAR_SEPTUM_MORPHOGENESIS,1
GOMF_MODIFICATION_DEPENDENT_...,SET,156,-0.042907,-0.0039382,0.063938,0.74891,GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
GSE24726_WT_VS_E2_2_KO_PDC_DN,SET,180,-0.041721,-0.0041107,0.062168,0.74892,GSE24726_WT_VS_E2_2_KO_PDC_DN,1
GOCC_MESSENGER_RIBONUCLEOPRO...,SET,6,-0.20776,-0.0037552,0.30956,0.74893,GOCC_MESSENGER_RIBONUCLEOPROTEIN_COMPLEX,1
GSE3982_DC_VS_MAC_LPS_STIM_DN,SET,173,-0.044531,-0.0043023,0.06633,0.749,GSE3982_DC_VS_MAC_LPS_STIM_DN,1
GSE10325_LUPUS_BCELL_VS_LUPU...1,SET,188,-0.044121,-0.0044417,0.0657,0.74906,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...11,SET,6,-0.21209,-0.0038333,0.31578,0.74908,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1,1
GOBP_ENERGY_RESERVE_METABOLI...,SET,85,-0.061849,-0.0041985,0.092088,0.74909,GOBP_ENERGY_RESERVE_METABOLIC_PROCESS,1
MUNSHI_MULTIPLE_MYELOMA_DN,SET,9,-0.18911,-0.004186,0.28155,0.7491,MUNSHI_MULTIPLE_MYELOMA_DN,1
RB_P130_DN.V1_UP,SET,117,-0.053035,-0.0042202,0.07895,0.74913,RB_P130_DN.V1_UP,1
REACTOME_EPH_EPHRIN_MEDIATED...,SET,49,-0.08725,-0.0045014,0.12987,0.74915,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,1
GOBP_PLASMA_LIPOPROTEIN_PART...,SET,37,-0.10061,-0.0045119,0.14972,0.74919,GOBP_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE,1
DACOSTA_UV_RESPONSE_VIA_ERCC...1,SET,436,-0.028202,-0.0042941,0.041968,0.7492,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,1
GSE14699_NAIVE_VS_DELETIONAL...2,SET,133,-0.05085,-0.0043122,0.075666,0.74921,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,1
RAY_TARGETS_OF_P210_BCR_ABL_...1,SET,15,-0.15465,-0.0044186,0.2301,0.74923,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,1
BIOCARTA_FOSB_PATHWAY,SET,5,-0.26836,-0.004428,0.39931,0.74923,BIOCARTA_FOSB_PATHWAY,1
GSE18893_TCONV_VS_TREG_2H_CU...2,SET,175,-0.04175,-0.0040566,0.062117,0.74924,GSE18893_TCONV_VS_TREG_2H_CULTURE_UP,1
GSE36078_WT_VS_IL1R_KO_LUNG_...2,SET,182,-0.042765,-0.0042367,0.063596,0.74935,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP,1
PDGF_UP.V1_UP,SET,133,-0.049763,-0.00422,0.073992,0.74938,PDGF_UP.V1_UP,1
HP_OLIGOMENORRHEA,SET,37,-0.092313,-0.0041399,0.13725,0.74939,HP_OLIGOMENORRHEA,1
HP_CHRONIC_KIDNEY_DISEASE,SET,178,-0.042025,-0.0041178,0.062476,0.74941,HP_CHRONIC_KIDNEY_DISEASE,1
GSE10211_UV_INACT_SENDAI_VS_...2,SET,141,-0.048008,-0.0041909,0.071372,0.74941,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP,1
HP_LYMPH_NODE_HYPOPLASIA,SET,3,-0.36458,-0.0046599,0.54197,0.74942,HP_LYMPH_NODE_HYPOPLASIA,1
HOFFMAN_CLOCK_TARGETS_DN,SET,10,-0.17711,-0.0041324,0.26327,0.74945,HOFFMAN_CLOCK_TARGETS_DN,1
MIR331_3P,SET,59,-0.080039,-0.0045299,0.11897,0.74945,MIR331_3P,1
GOBP_STEM_CELL_FATE_SPECIFIC...,SET,6,-0.28198,-0.0050967,0.41912,0.74946,GOBP_STEM_CELL_FATE_SPECIFICATION,1
GSE25087_TREG_VS_TCONV_FETUS...2,SET,175,-0.04352,-0.0042285,0.064673,0.7495,GSE25087_TREG_VS_TCONV_FETUS_UP,1
GOBP_BRAINSTEM_DEVELOPMENT,SET,7,-0.21372,-0.0041723,0.31756,0.74952,GOBP_BRAINSTEM_DEVELOPMENT,1
chr2q32,SET,41,-0.1771,-0.0083595,0.26313,0.74953,chr2q32,1
HUMMERICH_MALIGNANT_SKIN_TUM...2,SET,16,-0.13683,-0.0040377,0.20331,0.74953,HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,1
HP_RESTLESS_LEGS,SET,22,-0.12153,-0.0042042,0.18055,0.74955,HP_RESTLESS_LEGS,1
GOBP_NEGATIVE_REGULATION_OF_...482,SET,16,-0.15122,-0.0044621,0.22466,0.74956,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
GSE23308_CTRL_VS_CORTICOSTER...2,SET,173,-0.042518,-0.0041078,0.063164,0.74957,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN,1
GOBP_DITERPENOID_METABOLIC_P...,SET,86,-0.069696,-0.0047588,0.10353,0.74959,GOBP_DITERPENOID_METABOLIC_PROCESS,1
HP_DISTAL_ARTHROGRYPOSIS,SET,24,-0.11859,-0.0042849,0.17615,0.7496,HP_DISTAL_ARTHROGRYPOSIS,1
HP_SUBVALVULAR_AORTIC_STENOS...,SET,21,-0.12914,-0.0043651,0.19182,0.7496,HP_SUBVALVULAR_AORTIC_STENOSIS,1
GSE27092_WT_VS_HDAC7_PHOSPHO...1,SET,186,-0.040178,-0.0040235,0.059672,0.74962,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN,1
WP_LINOLEIC_ACID_METABOLISM_...,SET,5,-0.27915,-0.004606,0.41456,0.74964,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...2,SET,79,-0.06331,-0.0041439,0.094016,0.74965,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
SCHLOSSER_MYC_AND_SERUM_RESP...,SET,30,-0.10349,-0.0041797,0.15366,0.74968,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,1
GOBP_STEROID_HORMONE_SECRETI...,SET,26,-0.12295,-0.0046234,0.18255,0.74968,GOBP_STEROID_HORMONE_SECRETION,1
GOMF_TAURINE_TRANSMEMBRANE_T...,SET,5,-0.28581,-0.0047159,0.42437,0.74968,GOMF_TAURINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_T_CELL_CHEMOTAXIS,SET,24,-0.11917,-0.0043059,0.17694,0.74969,GOBP_T_CELL_CHEMOTAXIS,1
GOBP_POSITIVE_REGULATION_OF_...338,SET,12,-0.21352,-0.0054569,0.31698,0.74971,GOBP_POSITIVE_REGULATION_OF_HIPPO_SIGNALING,1
HP_STEREOTYPICAL_BODY_ROCKING,SET,6,-0.20517,-0.0037084,0.30453,0.74975,HP_STEREOTYPICAL_BODY_ROCKING,1
HP_HYPERPITUITARISM,SET,110,-0.054237,-0.0041855,0.080487,0.74979,HP_HYPERPITUITARISM,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...3,SET,823,-0.01968,-0.0040721,0.029204,0.7498,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,1
MODY_HIPPOCAMPUS_PRENATAL,SET,42,-0.083511,-0.0039897,0.12392,0.74981,MODY_HIPPOCAMPUS_PRENATAL,1
HP_DISTAL_RENAL_TUBULAR_ACID...,SET,6,-0.23864,-0.0043132,0.35411,0.74981,HP_DISTAL_RENAL_TUBULAR_ACIDOSIS,1
GSE13411_PLASMA_CELL_VS_MEMO...1,SET,175,-0.044149,-0.0042897,0.065486,0.74989,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN,1
REACTOME_SYNTHESIS_OF_LEUKOT...,SET,21,-0.14027,-0.004741,0.20803,0.74993,REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,1
GOMF_DNA_APURINIC_OR_APYRIMI...,SET,12,-0.15282,-0.0039055,0.22658,0.74998,GOMF_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,1
HP_ATTACHED_EARLOBE,SET,6,-0.24505,-0.0044292,0.36334,0.74998,HP_ATTACHED_EARLOBE,1
HP_REDUCED_CIRCULATING_CH50_...,SET,4,-0.30057,-0.0044361,0.44552,0.75005,HP_REDUCED_CIRCULATING_CH50_ACTIVITY,1
GSE2405_0H_VS_3H_A_PHAGOCYTO...1,SET,163,-0.047471,-0.004453,0.070348,0.7501,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
WP_MELATONIN_METABOLISM_AND_...,SET,30,-0.10816,-0.0043686,0.16027,0.75011,WP_MELATONIN_METABOLISM_AND_EFFECTS,1
HP_ABNORMAL_MASTOID_MORPHOLO...,SET,10,-0.17947,-0.0041873,0.26581,0.75021,HP_ABNORMAL_MASTOID_MORPHOLOGY,1
HP_STIFF_SKIN,SET,6,-0.24884,-0.0044976,0.36855,0.75022,HP_STIFF_SKIN,1
GOBP_SYNAPTIC_TRANSMISSION_D...,SET,27,-0.10861,-0.0041619,0.16085,0.75023,GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,1
HP_LEFT_SUPERIOR_VENA_CAVA_D...,SET,3,-0.35102,-0.0044867,0.51972,0.75029,HP_LEFT_SUPERIOR_VENA_CAVA_DRAINING_TO_CORONARY_SINUS,1
MIR502_5P,SET,68,-0.06902,-0.0041926,0.10215,0.75037,MIR502_5P,1
HP_COMPLETE_OR_NEAR_COMPLETE...2,SET,5,-0.23461,-0.0038711,0.34718,0.7504,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,1
GOBP_CELLULAR_RESPONSE_TO_CO...2,SET,13,-0.15861,-0.0042191,0.23471,0.75041,GOBP_CELLULAR_RESPONSE_TO_COLD,1
RUAN_RESPONSE_TO_TNF_DN,SET,75,-0.069667,-0.0044436,0.10308,0.75042,RUAN_RESPONSE_TO_TNF_DN,1
GOBP_REGULATION_OF_SYNAPTIC_...10,SET,37,-0.096881,-0.0043447,0.14333,0.75045,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,1
GOBP_BODY_MORPHOGENESIS,SET,45,-0.088497,-0.0043759,0.13091,0.75047,GOBP_BODY_MORPHOGENESIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...62,SET,44,-0.095852,-0.0046868,0.14179,0.75048,HP_APLASIA_HYPOPLASIA_OF_THE_RETINA,1
GOMF_LIPOPROTEIN_PARTICLE_RE...1,SET,18,-0.1446,-0.0045253,0.21384,0.75054,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,1
chr7q22,SET,121,-0.12419,-0.010049,0.18363,0.75058,chr7q22,1
GSE360_L_MAJOR_VS_B_MALAYI_H...3,SET,183,-0.040617,-0.0040348,0.060039,0.75064,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
GSE21927_SPLEEN_C57BL6_VS_EL...1,SET,184,-0.039703,-0.0039547,0.058677,0.75068,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN,1
DAIRKEE_CANCER_PRONE_RESPONS...1,SET,50,-0.074389,-0.0038767,0.10993,0.7507,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1
HP_ABNORMAL_OPTICAL_COHERENC...,SET,18,-0.14591,-0.0045664,0.21559,0.75072,HP_ABNORMAL_OPTICAL_COHERENCE_TOMOGRAPHY,1
HP_PALMOPLANTAR_HYPERKERATOS...,SET,120,-0.056242,-0.004532,0.08307,0.75081,HP_PALMOPLANTAR_HYPERKERATOSIS,1
MORF_HAT1,SET,153,-0.042048,-0.0038224,0.062091,0.75086,MORF_HAT1,1
GOMF_NUCLEOTIDASE_ACTIVITY,SET,13,-0.14641,-0.0038945,0.21619,0.75086,GOMF_NUCLEOTIDASE_ACTIVITY,1
RUTELLA_RESPONSE_TO_CSF2RB_A...1,SET,295,-0.035031,-0.0044046,0.051722,0.75088,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,1
GOMF_GLUTAMATE_SODIUM_SYMPOR...,SET,5,-0.2981,-0.0049187,0.4401,0.7509,GOMF_GLUTAMATE_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_DENDRITIC_CELL_CHEMOTAX...,SET,24,-0.12249,-0.0044259,0.18079,0.75096,GOBP_DENDRITIC_CELL_CHEMOTAXIS,1
HP_ABSENT_FRONTAL_SINUSES,SET,6,-0.2127,-0.0038445,0.31394,0.75096,HP_ABSENT_FRONTAL_SINUSES,1
GOBP_POSITIVE_REGULATION_OF_...636,SET,5,-0.28944,-0.0047758,0.42699,0.75107,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,1
GSE25123_ROSIGLITAZONE_VS_IL...3,SET,175,-0.044196,-0.0042942,0.06519,0.75109,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,1
GOBP_NEGATIVE_REGULATION_OF_...363,SET,54,-0.083251,-0.0045083,0.1227,0.75127,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,1
GOCC_MULTIVESICULAR_BODY_LUM...,SET,5,-0.26207,-0.0043241,0.38604,0.75138,GOCC_MULTIVESICULAR_BODY_LUMEN,1
GOCC_EUKARYOTIC_TRANSLATION_...1,SET,5,-0.22304,-0.0036802,0.32854,0.75139,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX,1
REACTOME_SYNAPTIC_ADHESION_L...,SET,19,-0.12599,-0.004051,0.18559,0.7514,REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,1
HP_GINGIVITIS,SET,29,-0.11033,-0.0043814,0.1625,0.75141,HP_GINGIVITIS,1
chr1p32,SET,63,-0.12927,-0.0075592,0.19037,0.75143,chr1p32,1
KONDO_EZH2_TARGETS,SET,203,-0.043185,-0.0045157,0.063592,0.75145,KONDO_EZH2_TARGETS,1
GOCC_PINOSOME,SET,7,-0.23065,-0.0045027,0.33965,0.75145,GOCC_PINOSOME,1
GSE2770_TGFB_AND_IL4_VS_TGFB...5,SET,174,-0.044938,-0.004354,0.066168,0.75148,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
PID_ALK2_PATHWAY,SET,10,-0.19071,-0.0044495,0.28077,0.7515,PID_ALK2_PATHWAY,1
MYLLYKANGAS_AMPLIFICATION_HO...6,SET,5,-0.26412,-0.004358,0.38872,0.75157,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2,1
GOBP_TRANSCRIPTION_DEPENDENT...,SET,7,-0.2131,-0.0041602,0.3136,0.7516,GOBP_TRANSCRIPTION_DEPENDENT_TETHERING_OF_RNA_POLYMERASE_II_GENE_DNA_AT_NUCLEAR_PERIPHERY,1
HP_HEMOLYTIC_UREMIC_SYNDROME,SET,14,-0.16734,-0.0046192,0.24626,0.7516,HP_HEMOLYTIC_UREMIC_SYNDROME,1
WP_SOMATROPH_AXIS_GH_AND_ITS...,SET,6,-0.23964,-0.0043314,0.35263,0.75161,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,1
GSE32423_MEMORY_VS_NAIVE_CD8...1,SET,176,-0.044237,-0.0043104,0.065087,0.75164,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
EFC_Q6,SET,242,-0.038071,-0.004342,0.055999,0.7517,EFC_Q6,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...5,SET,55,-0.072634,-0.0039695,0.10681,0.75175,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,1
POMEROY_MEDULLOBLASTOMA_PROG...2,SET,42,-0.086081,-0.0041124,0.12657,0.75178,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,1
DESCARTES_MAIN_FETAL_BIPOLAR...,SET,48,-0.093474,-0.0047732,0.13743,0.75179,DESCARTES_MAIN_FETAL_BIPOLAR_CELLS,1
GOBP_REGULATION_OF_HEMATOPOI...2,SET,17,-0.13454,-0.004092,0.1978,0.7518,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
GSE17721_LPS_VS_POLYIC_1H_BM...2,SET,177,-0.04458,-0.004356,0.065542,0.7518,GSE17721_LPS_VS_POLYIC_1H_BMDC_UP,1
HP_DELAYED_ABILITY_TO_STAND,SET,14,-0.16127,-0.0044517,0.23709,0.75181,HP_DELAYED_ABILITY_TO_STAND,1
REACTOME_ATTENUATION_PHASE,SET,26,-0.11615,-0.0043678,0.17074,0.75183,REACTOME_ATTENUATION_PHASE,1
REACTOME_CROSSLINKING_OF_COL...,SET,16,-0.16405,-0.0048407,0.24106,0.75191,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,1
GSE3982_BASOPHIL_VS_TH1_DN,SET,174,-0.04261,-0.0041284,0.062611,0.75192,GSE3982_BASOPHIL_VS_TH1_DN,1
FARMER_BREAST_CANCER_BASAL_V...,SET,292,-0.034516,-0.0043181,0.0507,0.75199,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,1
YUAN_ZNF143_PARTNERS,SET,20,-0.12798,-0.0042217,0.18797,0.75201,YUAN_ZNF143_PARTNERS,1
WP_DEVELOPMENT_AND_HETEROGEN...,SET,32,-0.11066,-0.0046156,0.16252,0.75202,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,1
WP_OVERVIEW_OF_NANOPARTICLE_...,SET,19,-0.14752,-0.0047432,0.21667,0.75202,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,1
GOBP_NEGATIVE_REGULATION_OF_...447,SET,65,-0.070344,-0.0041781,0.10331,0.75202,GOBP_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOBP_REGULATION_OF_T_CELL_AP...,SET,38,-0.096546,-0.0043877,0.1418,0.75202,GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,1
GOBP_DICARBOXYLIC_ACID_TRANS...,SET,99,-0.062244,-0.0045583,0.091415,0.75203,GOBP_DICARBOXYLIC_ACID_TRANSPORT,1
HP_CRYPTORCHIDISM,SET,636,-0.023211,-0.0042446,0.034082,0.75207,HP_CRYPTORCHIDISM,1
HP_NARROW_VERTEBRAL_INTERPED...,SET,13,-0.1546,-0.0041124,0.22697,0.7521,HP_NARROW_VERTEBRAL_INTERPEDICULAR_DISTANCE,1
REACTOME_SENSORY_PERCEPTION_...1,SET,6,-0.27837,-0.0050315,0.40865,0.75213,REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE,1
KEGG_REGULATION_OF_ACTIN_CYT...,SET,196,-0.04297,-0.0044159,0.063069,0.75216,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1
GOCC_SPECTRIN_ASSOCIATED_CYT...,SET,9,-0.18849,-0.0041723,0.27665,0.75217,GOCC_SPECTRIN_ASSOCIATED_CYTOSKELETON,1
HP_LIPODYSTROPHY,SET,114,-0.054361,-0.0042702,0.079785,0.75217,HP_LIPODYSTROPHY,1
REACTOME_ESTABLISHMENT_OF_SI...,SET,8,-0.20749,-0.0043303,0.30441,0.75226,REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,1
GSE4748_CTRL_VS_LPS_STIM_DC_...2,SET,183,-0.04543,-0.004513,0.066644,0.75228,GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP,1
GSE14000_TRANSLATED_RNA_VS_M...4,SET,174,-0.041688,-0.0040391,0.06115,0.75229,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP,1
GOBP_PHOTOTRANSDUCTION,SET,40,-0.094699,-0.0044154,0.13891,0.7523,GOBP_PHOTOTRANSDUCTION,1
GENTILE_UV_RESPONSE_CLUSTER_...1,SET,17,-0.14591,-0.0044379,0.21402,0.75231,GENTILE_UV_RESPONSE_CLUSTER_D1,1
GOBP_POSITIVE_REGULATION_OF_...735,SET,11,-0.16979,-0.0041547,0.24903,0.75231,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,1
MODULE_32,SET,210,-0.037528,-0.0039905,0.055033,0.75235,MODULE_32,1
REACTOME_SYNTHESIS_OF_UDP_N_...,SET,7,-0.23324,-0.0045534,0.34203,0.75236,REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE,1
GSE44649_WT_VS_MIR155_KO_NAI...1,SET,188,-0.045372,-0.0045677,0.06652,0.7524,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN,1
GSE30971_CTRL_VS_LPS_STIM_MA...4,SET,178,-0.044095,-0.0043206,0.06462,0.75249,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP,1
HP_CEREBRAL_BERRY_ANEURYSM,SET,6,-0.23964,-0.0043315,0.35113,0.75253,HP_CEREBRAL_BERRY_ANEURYSM,1
GOBP_CELLULAR_EXTRAVASATION,SET,69,-0.075514,-0.0046206,0.11063,0.75255,GOBP_CELLULAR_EXTRAVASATION,1
GOBP_MONOACYLGLYCEROL_METABO...,SET,14,-0.15316,-0.0042277,0.22435,0.7526,GOBP_MONOACYLGLYCEROL_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...193,SET,8,-0.23579,-0.0049209,0.34536,0.75261,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
GSE29949_CD8_POS_DC_SPLEEN_V...3,SET,175,-0.044455,-0.0043194,0.0651,0.75265,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,1
GOBP_REGULATION_OF_CALCIUM_I...4,SET,40,-0.091504,-0.0042664,0.13398,0.75269,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT,1
MENON_FETAL_KIDNEY_8_CONNECT...,SET,223,-0.039313,-0.0043063,0.05755,0.75273,MENON_FETAL_KIDNEY_8_CONNECTING_TUBULE_CELLS,1
WANG_METASTASIS_OF_BREAST_CA...3,SET,19,-0.12091,-0.0038875,0.17699,0.75274,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,1
GOBP_NOREPINEPHRINE_TRANSPORT,SET,23,-0.14047,-0.0049687,0.20558,0.75278,GOBP_NOREPINEPHRINE_TRANSPORT,1
GOCC_CHECKPOINT_CLAMP_COMPLEX,SET,5,-0.25813,-0.0042591,0.37774,0.7528,GOCC_CHECKPOINT_CLAMP_COMPLEX,1
HP_UNCONTROLLED_EYE_MOVEMENTS,SET,8,-0.25007,-0.0052188,0.36592,0.75281,HP_UNCONTROLLED_EYE_MOVEMENTS,1
GOBP_MONOTERPENOID_METABOLIC...,SET,6,-0.21261,-0.0038429,0.31109,0.75283,GOBP_MONOTERPENOID_METABOLIC_PROCESS,1
GSE13762_CTRL_VS_125_VITAMIN...1,SET,120,-0.051165,-0.0041229,0.074859,0.75285,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN,1
KEGG_MEDICUS_REFERENCE_RAC_C...,SET,9,-0.18907,-0.004185,0.27657,0.75288,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY,1
GOBP_RIBONUCLEOSIDE_METABOLI...,SET,32,-0.1212,-0.0050553,0.17726,0.75292,GOBP_RIBONUCLEOSIDE_METABOLIC_PROCESS,1
GSE1432_1H_VS_6H_IFNG_MICROG...1,SET,179,-0.043765,-0.0043002,0.063978,0.75303,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,1
HP_ATTENTION_DEFICIT_HYPERAC...,SET,349,-0.031541,-0.0043071,0.04607,0.75321,HP_ATTENTION_DEFICIT_HYPERACTIVITY_DISORDER,1
GOBP_INTRACELLULAR_MONOATOMI...,SET,10,-0.20091,-0.0046876,0.29338,0.75327,GOBP_INTRACELLULAR_MONOATOMIC_ANION_HOMEOSTASIS,1
GSE5503_LIVER_DC_VS_PLN_DC_A...1,SET,176,-0.041748,-0.0040678,0.060949,0.75331,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GOBP_REGULATION_OF_LIPOPOLYS...,SET,27,-0.11364,-0.0043547,0.1659,0.75333,GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_CONNECTIVE...,SET,1351,-0.016519,-0.004313,0.024111,0.75336,HP_ABNORMALITY_OF_CONNECTIVE_TISSUE,1
GSE21033_3H_VS_12H_POLYIC_ST...2,SET,149,-0.046418,-0.0041646,0.06775,0.75337,GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP,1
MIR3914,SET,50,-0.087507,-0.0045604,0.1277,0.7534,MIR3914,1
GOMF_GDP_DISSOCIATION_INHIBI...,SET,15,-0.14465,-0.0041327,0.21105,0.75343,GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY,1
GSE3982_MAST_CELL_VS_TH1_UP,SET,180,-0.044672,-0.0044015,0.065184,0.75343,GSE3982_MAST_CELL_VS_TH1_UP,1
STEIN_ESR1_TARGETS,SET,77,-0.070246,-0.0045396,0.10247,0.75348,STEIN_ESR1_TARGETS,1
GOBP_NEGATIVE_REGULATION_OF_...531,SET,25,-0.11593,-0.0042751,0.16912,0.75348,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION,1
GOBP_RESPONSE_TO_CORTICOSTER...2,SET,15,-0.15874,-0.0045355,0.23154,0.75351,GOBP_RESPONSE_TO_CORTICOSTERONE,1
BAUS_TFF2_TARGETS_DN,SET,11,-0.18245,-0.0044645,0.26611,0.75352,BAUS_TFF2_TARGETS_DN,1
GOCC_CLATHRIN_COATED_PIT,SET,73,-0.067889,-0.0042723,0.099012,0.75353,GOCC_CLATHRIN_COATED_PIT,1
GOCC_PODOSOME,SET,33,-0.1012,-0.0042866,0.14759,0.75354,GOCC_PODOSOME,1
GOMF_INSULIN_LIKE_GROWTH_FAC...4,SET,16,-0.16805,-0.0049589,0.24506,0.75356,GOMF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING,1
HP_CAESARIAN_SECTION,SET,13,-0.16266,-0.0043268,0.23719,0.75357,HP_CAESARIAN_SECTION,1
GCM_ING1,SET,61,-0.063014,-0.0036261,0.091872,0.7536,GCM_ING1,1
PID_ENDOTHELIN_PATHWAY,SET,62,-0.079092,-0.0045884,0.1153,0.75363,PID_ENDOTHELIN_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...305,SET,17,-0.1405,-0.0042733,0.20479,0.75367,GOBP_POSITIVE_REGULATION_OF_GLUCONEOGENESIS,1
MORF_CSNK1D,SET,65,-0.068486,-0.0040678,0.099805,0.7537,MORF_CSNK1D,1
GSE20727_CTRL_VS_ROS_INH_AND...1,SET,170,-0.043932,-0.0042077,0.064015,0.75372,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...816,SET,25,-0.12278,-0.0045275,0.17883,0.75381,GOBP_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,1
HP_CARIOUS_TEETH,SET,147,-0.049339,-0.0043971,0.071867,0.75381,HP_CARIOUS_TEETH,1
GSE4590_SMALL_VS_LARGE_PRE_B...2,SET,164,-0.045623,-0.0042926,0.066437,0.75386,GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP,1
REACTOME_REGULATION_OF_PYRUV...1,SET,12,-0.18708,-0.0047811,0.27241,0.75387,REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX,1
GOBP_T_CELL_LINEAGE_COMMITME...,SET,35,-0.10547,-0.0046004,0.15357,0.75388,GOBP_T_CELL_LINEAGE_COMMITMENT,1
GSE18893_CTRL_VS_TNF_TREATED...2,SET,179,-0.042499,-0.0041758,0.061865,0.75394,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP,1
MIKKELSEN_ES_ICP_WITH_H3K4ME...,SET,126,-0.056586,-0.0046716,0.082363,0.75396,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
REACTOME_BETA_OXIDATION_OF_D...,SET,6,-0.22459,-0.0040594,0.32673,0.75408,REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA,1
GOCC_PROTEIN_COMPLEX_INVOLVE...1,SET,55,-0.082517,-0.0045096,0.12003,0.75409,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION,1
PID_CIRCADIAN_PATHWAY,SET,13,-0.17119,-0.0045536,0.24899,0.75412,PID_CIRCADIAN_PATHWAY,1
GOBP_RESPONSE_TO_AMPHETAMINE,SET,34,-0.11104,-0.0047741,0.16151,0.75412,GOBP_RESPONSE_TO_AMPHETAMINE,1
HP_PROLONGED_PR_INTERVAL,SET,10,-0.20875,-0.0048704,0.30361,0.75413,HP_PROLONGED_PR_INTERVAL,1
GSE43955_1H_VS_42H_ACT_CD4_T...2,SET,180,-0.042817,-0.0042187,0.062248,0.75422,GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP,1
BCAT_BILD_ET_AL_DN,SET,42,-0.087261,-0.0041688,0.12684,0.75425,BCAT_BILD_ET_AL_DN,1
CHIBA_RESPONSE_TO_TSA_DN,SET,20,-0.13349,-0.0044033,0.19397,0.75432,CHIBA_RESPONSE_TO_TSA_DN,1
HP_MITRAL_VALVE_CALCIFICATION,SET,7,-0.23699,-0.0046267,0.34427,0.7544,HP_MITRAL_VALVE_CALCIFICATION,1
GSE3039_CD4_TCELL_VS_ALPHABE...1,SET,183,-0.042521,-0.0042239,0.061754,0.75444,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN,1
GOBP_POST_TRANSCRIPTIONAL_RE...,SET,465,-0.027208,-0.0042747,0.039512,0.75445,GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION,1
GOMF_UBIQUITIN_PROTEIN_TRANS...1,SET,14,-0.15792,-0.0043591,0.22934,0.75445,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVATOR_ACTIVITY,1
REACTOME_METABOLISM_OF_LIPIDS,SET,701,-0.022654,-0.0043412,0.032892,0.7545,REACTOME_METABOLISM_OF_LIPIDS,1
GSE22589_HEALTHY_VS_HIV_INFE...1,SET,183,-0.043734,-0.0043444,0.063493,0.75452,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN,1
GOMF_HYDROXYMETHYL_FORMYL_AN...,SET,8,-0.18586,-0.0038788,0.2698,0.75455,GOMF_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY,1
GOCC_MICROVESICLE,SET,8,-0.22168,-0.0046264,0.32178,0.75456,GOCC_MICROVESICLE,1
MIR4450,SET,66,-0.069983,-0.0041884,0.10155,0.75463,MIR4450,1
HP_CHRONIC_HEPATITIS_DUE_TO_...,SET,5,-0.28975,-0.0047809,0.42044,0.75463,HP_CHRONIC_HEPATITIS_DUE_TO_CRYPTOSPORIDIUM_INFECTION,1
GSE14413_UNSTIM_VS_IFNB_STIM...1,SET,104,-0.059618,-0.0044743,0.086483,0.7547,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN,1
GSE22886_NAIVE_BCELL_VS_NEUT...1,SET,178,-0.046234,-0.0045303,0.067067,0.7547,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN,1
GOBP_REGULATION_OF_SYNAPTIC_...14,SET,3,-0.3539,-0.0045234,0.5133,0.75473,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT,1
GSE5542_IFNA_VS_IFNA_AND_IFN...3,SET,173,-0.043097,-0.0041636,0.062501,0.75475,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
SHAFFER_IRF4_TARGETS_IN_ACTI...1,SET,73,-0.070063,-0.0044091,0.10158,0.75481,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1
GOBP_NEGATIVE_REGULATION_OF_...689,SET,8,-0.21453,-0.0044772,0.311,0.75483,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GSE1740_UNSTIM_VS_IFNA_STIMU...4,SET,164,-0.047845,-0.0045016,0.069357,0.75485,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP,1
GOBP_REGENERATION,SET,180,-0.045649,-0.0044977,0.066142,0.75495,GOBP_REGENERATION,1
GOBP_RESPIRATORY_BURST_INVOL...2,SET,9,-0.20056,-0.0044394,0.29058,0.75497,GOBP_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GOCC_SYNAPTOBREVIN_2_SNAP_25...,SET,5,-0.20847,-0.0034397,0.30198,0.755,GOCC_SYNAPTOBREVIN_2_SNAP_25_SYNTAXIN_1A_COMPLEX,1
GSE41867_NAIVE_VS_DAY15_LCMV...6,SET,183,-0.041901,-0.0041624,0.060686,0.75504,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP,1
GOBP_REGULATION_OF_CALCINEUR...,SET,40,-0.090745,-0.004231,0.13142,0.75506,GOBP_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,1
HP_CONGENITAL_MALFORMATION_O...1,SET,454,-0.027992,-0.0043471,0.040533,0.75509,HP_CONGENITAL_MALFORMATION_OF_THE_GREAT_ARTERIES,1
GOBP_GMP_SALVAGE,SET,4,-0.28447,-0.0041984,0.41182,0.75514,GOBP_GMP_SALVAGE,1
GOBP_POSITIVE_REGULATION_OF_...410,SET,24,-0.12775,-0.0046157,0.18494,0.75514,GOBP_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
GSE9650_NAIVE_VS_EFF_CD8_TCE...1,SET,188,-0.043495,-0.0043787,0.062966,0.75514,GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN,1
GOMF_HEMOGLOBIN_ALPHA_BINDING,SET,4,-0.41294,-0.0060944,0.59778,0.75515,GOMF_HEMOGLOBIN_ALPHA_BINDING,1
GSE17974_IL4_AND_ANTI_IL12_V...4,SET,167,-0.046673,-0.004431,0.067563,0.75515,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP,1
WIKMAN_ASBESTOS_LUNG_CANCER_...2,SET,15,-0.14999,-0.0042854,0.2171,0.75517,WIKMAN_ASBESTOS_LUNG_CANCER_UP,1
GOBP_POSITIVE_REGULATION_OF_...240,SET,10,-0.21063,-0.0049144,0.30488,0.75517,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
MIR12131,SET,154,-0.047702,-0.0043505,0.069033,0.75521,MIR12131,1
ATGTTAA_MIR302C,SET,217,-0.040836,-0.0044132,0.05909,0.75524,ATGTTAA_MIR302C,1
GOBP_CEREBRAL_CORTEX_GABAERG...1,SET,5,-0.29547,-0.0048753,0.4275,0.75526,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT,1
HP_ABNORMAL_RENAL_INSTERSTIT...,SET,52,-0.081201,-0.0043153,0.11748,0.75528,HP_ABNORMAL_RENAL_INSTERSTITIAL_MORPHOLOGY,1
REACTOME_SYNTHESIS_OF_PIPS_A...2,SET,5,-0.28778,-0.0047484,0.41632,0.75529,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE,1
GSE27859_MACROPHAGE_VS_CD11C...2,SET,158,-0.045679,-0.0042192,0.066072,0.75532,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
GSE17721_LPS_VS_POLYIC_2H_BM...1,SET,190,-0.040523,-0.0041009,0.058579,0.75545,GSE17721_LPS_VS_POLYIC_2H_BMDC_DN,1
HP_AREFLEXIA,SET,271,-0.03542,-0.0042714,0.0512,0.75547,HP_AREFLEXIA,1
GOBP_INTRACELLULAR_PHOSPHATE...,SET,9,-0.23635,-0.0052316,0.34162,0.75548,GOBP_INTRACELLULAR_PHOSPHATE_ION_HOMEOSTASIS,1
GOCC_NEURON_PROJECTION,SET,1213,-0.018128,-0.004503,0.026197,0.75552,GOCC_NEURON_PROJECTION,1
GOBP_REGULATION_OF_T_HELPER_...2,SET,10,-0.20608,-0.0048081,0.29775,0.75556,GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,1
WP_ELECTRON_TRANSPORT_CHAIN_...,SET,69,-0.06214,-0.0038023,0.089769,0.7556,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,1
HP_AGGRESSIVE_BEHAVIOR,SET,242,-0.037835,-0.004315,0.054654,0.75561,HP_AGGRESSIVE_BEHAVIOR,1
HP_NEMALINE_BODIES,SET,19,-0.13333,-0.004287,0.19255,0.75567,HP_NEMALINE_BODIES,1
GSE7548_NAIVE_VS_DAY28_PCC_I...2,SET,186,-0.040323,-0.0040379,0.058217,0.75572,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,1
MIR3908,SET,106,-0.062159,-0.0047094,0.089736,0.75574,MIR3908,1
GOBP_CYCLIC_GMP_AMP_TRANSMEM...,SET,8,-0.23504,-0.0049053,0.33933,0.75574,GOBP_CYCLIC_GMP_AMP_TRANSMEMBRANE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HOX13_01,SET,42,-0.096199,-0.0045958,0.13887,0.75576,HOX13_01,1
REACTOME_NOTCH2_ACTIVATION_A...,SET,20,-0.1404,-0.0046314,0.20264,0.75579,REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
GOCC_APICAL_PART_OF_CELL,SET,434,-0.030068,-0.004568,0.043384,0.75586,GOCC_APICAL_PART_OF_CELL,1
TGFB_UP.V1_DN,SET,172,-0.046713,-0.0045001,0.067391,0.75589,TGFB_UP.V1_DN,1
DESCARTES_FETAL_KIDNEY_LYMPH...,SET,150,-0.051795,-0.0046624,0.074718,0.7559,DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS,1
GOBP_ELECTRON_TRANSPORT_CHAIN,SET,107,-0.051971,-0.0039559,0.074966,0.75592,GOBP_ELECTRON_TRANSPORT_CHAIN,1
GSE41867_NAIVE_VS_DAY8_LCMV_...1,SET,180,-0.042466,-0.0041841,0.061236,0.75599,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
GOMF_PROTEIN_KINASE_C_BINDING,SET,48,-0.09169,-0.0046821,0.13219,0.75604,GOMF_PROTEIN_KINASE_C_BINDING,1
MAF_Q6,SET,233,-0.040101,-0.0044887,0.057782,0.75616,MAF_Q6,1
AGGAAGC_MIR5163P,SET,113,-0.058033,-0.0045388,0.083615,0.75617,AGGAAGC_MIR5163P,1
GSE27786_LSK_VS_ERYTHROBLAST...2,SET,178,-0.042866,-0.0042002,0.061762,0.75617,GSE27786_LSK_VS_ERYTHROBLAST_UP,1
HEY2_TARGET_GENES,SET,54,-0.080547,-0.0043618,0.11603,0.75621,HEY2_TARGET_GENES,1
HP_PARALYSIS,SET,146,-0.049885,-0.0044307,0.071856,0.75623,HP_PARALYSIS,1
HP_ANTI_THYROGLOBULIN_ANTIBO...,SET,6,-0.26245,-0.0047437,0.37801,0.75624,HP_ANTI_THYROGLOBULIN_ANTIBODY_POSITIVITY,1
REACTOME_ACTIVATION_OF_THE_M...,SET,52,-0.076919,-0.0040877,0.11076,0.75629,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1
HP_ELEVATED_BRAIN_CHOLINE_LE...,SET,8,-0.19488,-0.004067,0.2806,0.75631,HP_ELEVATED_BRAIN_CHOLINE_LEVEL_BY_MRS,1
HP_UNSTEADY_GAIT,SET,169,-0.045465,-0.0043418,0.065456,0.75634,HP_UNSTEADY_GAIT,1
GOBP_REGULATION_OF_ACTIN_FIL...2,SET,341,-0.032896,-0.0044413,0.047354,0.75637,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS,1
GSE45365_NK_CELL_VS_CD11B_DC...1,SET,184,-0.045208,-0.004503,0.06507,0.75639,GSE45365_NK_CELL_VS_CD11B_DC_DN,1
WANG_CISPLATIN_RESPONSE_AND_...2,SET,158,-0.048023,-0.0044358,0.069121,0.7564,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1
VANTVEER_BREAST_CANCER_METAS...2,SET,41,-0.097078,-0.0045824,0.13969,0.75645,VANTVEER_BREAST_CANCER_METASTASIS_UP,1
HP_ABNORMAL_LARYNX_MORPHOLOGY,SET,130,-0.052779,-0.0044254,0.075941,0.75647,HP_ABNORMAL_LARYNX_MORPHOLOGY,1
REACTOME_UREA_CYCLE,SET,9,-0.19408,-0.0042959,0.2792,0.7565,REACTOME_UREA_CYCLE,1
HP_FEMUR_FRACTURE,SET,5,-0.22972,-0.0037905,0.33036,0.75658,HP_FEMUR_FRACTURE,1
CURSONS_NATURAL_KILLER_CELLS,SET,17,-0.14291,-0.0043465,0.20546,0.75664,CURSONS_NATURAL_KILLER_CELLS,1
HBZ_TARGET_GENES,SET,836,-0.020911,-0.0043595,0.030065,0.75664,HBZ_TARGET_GENES,1
GOBP_MICROVILLUS_ASSEMBLY,SET,19,-0.15349,-0.004935,0.22064,0.75667,GOBP_MICROVILLUS_ASSEMBLY,1
HP_ABNORMAL_LIVER_PARENCHYMA...,SET,10,-0.18086,-0.0042199,0.25999,0.75668,HP_ABNORMAL_LIVER_PARENCHYMA_MORPHOLOGY,1
GSE14000_4H_VS_16H_LPS_DC_DN,SET,161,-0.044356,-0.0041354,0.063746,0.75672,GSE14000_4H_VS_16H_LPS_DC_DN,1
GOMF_SUPEROXIDE_DISMUTASE_AC...,SET,5,-0.2815,-0.0046449,0.40455,0.75673,GOMF_SUPEROXIDE_DISMUTASE_ACTIVITY,1
SUPT20H_TARGET_GENES,SET,1112,-0.018141,-0.0043272,0.02606,0.75682,SUPT20H_TARGET_GENES,1
GOBP_REGULATION_OF_PROSTATIC...,SET,5,-0.32274,-0.0053253,0.46363,0.75682,GOBP_REGULATION_OF_PROSTATIC_BUD_FORMATION,1
GOBP_NEGATIVE_REGULATION_OF_...650,SET,4,-0.29722,-0.0043866,0.42682,0.7569,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_ELONGATION,1
ODONNELL_TFRC_TARGETS_UP,SET,329,-0.033269,-0.0044134,0.047771,0.75691,ODONNELL_TFRC_TARGETS_UP,1
HP_DOWN_SLOPING_SHOULDERS,SET,34,-0.10494,-0.0045118,0.15069,0.75691,HP_DOWN_SLOPING_SHOULDERS,1
GSE21360_NAIVE_VS_QUATERNARY...1,SET,181,-0.043228,-0.0042709,0.062062,0.75695,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
MARTORIATI_MDM4_TARGETS_NEUR...1,SET,147,-0.051979,-0.0046324,0.074622,0.75696,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,1
ZHENG_BOUND_BY_FOXP3,SET,456,-0.029906,-0.0046541,0.042932,0.75696,ZHENG_BOUND_BY_FOXP3,1
KEGG_MEDICUS_REFERENCE_UREA_...,SET,5,-0.2428,-0.0040062,0.34853,0.75698,KEGG_MEDICUS_REFERENCE_UREA_CYCLE,1
GOBP_REGULATION_OF_TRANSLATI...1,SET,333,-0.032116,-0.0042859,0.046099,0.75699,GOBP_REGULATION_OF_TRANSLATION,1
DESCARTES_MAIN_FETAL_CCL19_C...,SET,157,-0.048157,-0.0044341,0.069115,0.75702,DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS,1
AMIT_EGF_RESPONSE_120_MCF10A,SET,38,-0.10313,-0.0046869,0.14797,0.75708,AMIT_EGF_RESPONSE_120_MCF10A,1
GOMF_HYDROLASE_ACTIVITY_ACTI...7,SET,677,-0.022689,-0.0042757,0.032554,0.75708,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS,1
GOBP_CELLULAR_RESPONSE_TO_AL...3,SET,7,-0.25272,-0.0049336,0.36256,0.7571,GOBP_CELLULAR_RESPONSE_TO_ALDOSTERONE,1
GOBP_POSITIVE_REGULATION_OF_...260,SET,9,-0.16346,-0.0036182,0.23443,0.75717,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,1
HP_LARGE_CAFE_AU_LAIT_MACULE...,SET,6,-0.24156,-0.004366,0.34642,0.75718,HP_LARGE_CAFE_AU_LAIT_MACULES_WITH_IRREGULAR_MARGINS,1
WP_KALLMANN_SYNDROME,SET,23,-0.12551,-0.0044394,0.17998,0.7572,WP_KALLMANN_SYNDROME,1
WOO_LIVER_CANCER_RECURRENCE_...2,SET,97,-0.063143,-0.0045775,0.09054,0.75722,WOO_LIVER_CANCER_RECURRENCE_UP,1
GSE27786_LSK_VS_CD8_TCELL_UP,SET,168,-0.044914,-0.0042766,0.064401,0.75722,GSE27786_LSK_VS_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_MITOC...,SET,52,-0.070701,-0.0037573,0.10136,0.75725,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS,1
HP_EPISODIC_ATAXIA,SET,24,-0.12739,-0.0046026,0.18262,0.75726,HP_EPISODIC_ATAXIA,1
GSE16385_IFNG_TNF_VS_IL4_STI...1,SET,150,-0.048789,-0.0043919,0.06992,0.75734,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,1
HP_PHONOPHOBIA,SET,22,-0.14243,-0.0049272,0.20409,0.75736,HP_PHONOPHOBIA,1
GOBP_LEUKOTRIENE_BIOSYNTHETI...,SET,16,-0.16316,-0.0048146,0.2338,0.75737,GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMALITY_OF_DENTAL_ERU...,SET,209,-0.042357,-0.0044934,0.060685,0.7574,HP_ABNORMALITY_OF_DENTAL_ERUPTION,1
PEDERSEN_METASTASIS_BY_ERBB2...6,SET,346,-0.033082,-0.0044985,0.047333,0.7577,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1
HP_SEVERE_CYTOMEGALOVIRUS_IN...,SET,10,-0.18558,-0.0043299,0.26551,0.7577,HP_SEVERE_CYTOMEGALOVIRUS_INFECTION,1
GOBP_NEGATIVE_REGULATION_OF_...373,SET,12,-0.16907,-0.004321,0.24188,0.75772,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_MIGRATION,1
JAK2_DN.V1_DN,SET,116,-0.052073,-0.004126,0.07448,0.75777,JAK2_DN.V1_DN,1
KEGG_MEDICUS_REFERENCE_COHES...1,SET,4,-0.26391,-0.0038949,0.37742,0.75779,KEGG_MEDICUS_REFERENCE_COHESIN_ACETYLATION,1
PARENT_MTOR_SIGNALING_DN,SET,41,-0.095373,-0.0045019,0.13638,0.75781,PARENT_MTOR_SIGNALING_DN,1
GOMF_GTP_DEPENDENT_PROTEIN_B...,SET,20,-0.15051,-0.0049647,0.21516,0.75788,GOMF_GTP_DEPENDENT_PROTEIN_BINDING,1
HP_OPTIC_NERVE_GLIOMA,SET,5,-0.298,-0.0049171,0.42586,0.75796,HP_OPTIC_NERVE_GLIOMA,1
GOBP_SULFUR_AMINO_ACID_CATAB...,SET,9,-0.20298,-0.0044929,0.29002,0.75799,GOBP_SULFUR_AMINO_ACID_CATABOLIC_PROCESS,1
HP_CONFETTI_LIKE_HYPOPIGMENT...,SET,8,-0.21368,-0.0044594,0.3053,0.758,HP_CONFETTI_LIKE_HYPOPIGMENTED_MACULES,1
HP_ARACHNODACTYLY,SET,109,-0.058514,-0.0044952,0.083601,0.75801,HP_ARACHNODACTYLY,1
GOBP_POST_EMBRYONIC_HEMOPOIE...,SET,5,-0.24495,-0.0040416,0.34994,0.75802,GOBP_POST_EMBRYONIC_HEMOPOIESIS,1
GOBP_REGULATION_OF_INTEGRIN_...1,SET,17,-0.15222,-0.0046299,0.21746,0.75803,GOBP_REGULATION_OF_INTEGRIN_ACTIVATION,1
HP_ELEVATED_URINARY_CATECHOL...,SET,27,-0.11407,-0.0043712,0.1629,0.75811,HP_ELEVATED_URINARY_CATECHOLAMINE_LEVEL,1
SCHERER_PBMC_APSV_WETVAX_AGE...6,SET,263,-0.039097,-0.0046457,0.055834,0.75811,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,1
REACTOME_CTLA4_INHIBITORY_SI...,SET,21,-0.12854,-0.0043447,0.18354,0.75813,REACTOME_CTLA4_INHIBITORY_SIGNALING,1
BIOCARTA_MET_PATHWAY,SET,32,-0.11051,-0.0046094,0.15775,0.75819,BIOCARTA_MET_PATHWAY,1
HP_SHOCK,SET,12,-0.18517,-0.0047325,0.26428,0.75825,HP_SHOCK,1
GOBP_CELL_MORPHOGENESIS,SET,895,-0.021234,-0.0045726,0.0303,0.75828,GOBP_CELL_MORPHOGENESIS,1
HP_ABNORMAL_DIGESTIVE_SYSTEM...,SET,923,-0.020271,-0.0044293,0.028924,0.75829,HP_ABNORMAL_DIGESTIVE_SYSTEM_MORPHOLOGY,1
GOBP_GAS_TRANSPORT,SET,18,-0.16695,-0.005225,0.23821,0.7583,GOBP_GAS_TRANSPORT,1
MIR4652_5P,SET,32,-0.1036,-0.0043212,0.14775,0.7584,MIR4652_5P,1
HP_APLASIA_HYPOPLASIA_OF_THE...66,SET,178,-0.044505,-0.0043608,0.063467,0.75842,HP_APLASIA_HYPOPLASIA_OF_THE_SKIN,1
MIR10396A_5P,SET,8,-0.18684,-0.0038992,0.26633,0.7585,MIR10396A_5P,1
GOBP_POSITIVE_REGULATION_OF_...755,SET,5,-0.29784,-0.0049145,0.42456,0.75851,GOBP_POSITIVE_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
GSE7852_TREG_VS_TCONV_THYMUS...2,SET,181,-0.045507,-0.004496,0.064868,0.75851,GSE7852_TREG_VS_TCONV_THYMUS_UP,1
ADA2_TARGET_GENES,SET,753,-0.022383,-0.0044391,0.0319,0.75855,ADA2_TARGET_GENES,1
GSE24634_TREG_VS_TCONV_POST_...2,SET,180,-0.043574,-0.0042933,0.062102,0.75855,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP,1
MIR4720_5P,SET,79,-0.067513,-0.004419,0.096215,0.75856,MIR4720_5P,1
GOBP_POSITIVE_REGULATION_OF_...287,SET,25,-0.13308,-0.0049076,0.18963,0.7586,GOBP_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...7,SET,15,-0.14865,-0.0042472,0.21179,0.75862,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
GOCC_SEMAPHORIN_RECEPTOR_COM...,SET,11,-0.20047,-0.0049054,0.2856,0.75863,GOCC_SEMAPHORIN_RECEPTOR_COMPLEX,1
ESC_J1_UP_EARLY.V1_UP,SET,154,-0.048598,-0.0044321,0.069224,0.75867,ESC_J1_UP_EARLY.V1_UP,1
GOMF_ESTRADIOL_17_BETA_DEHYD...,SET,18,-0.15037,-0.0047058,0.21417,0.75868,GOMF_ESTRADIOL_17_BETA_DEHYDROGENASE_NAD_P_ACTIVITY,1
FOROUTAN_TGFB_EMT_UP,SET,185,-0.046995,-0.0046935,0.066927,0.75871,FOROUTAN_TGFB_EMT_UP,1
REACTOME_SIGNALING_BY_INSULI...,SET,79,-0.067932,-0.0044464,0.096735,0.75873,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1
GOBP_NEGATIVE_REGULATION_OF_...161,SET,263,-0.038304,-0.0045515,0.054546,0.75873,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION,1
GSE41176_UNSTIM_VS_ANTI_IGM_...11,SET,174,-0.046906,-0.0045447,0.066775,0.7588,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN,1
WP_1P36_COPY_NUMBER_VARIATIO...,SET,89,-0.078412,-0.0054461,0.1116,0.75884,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,1
FIGUEROA_AML_METHYLATION_CLU...10,SET,12,-0.16768,-0.0042854,0.23865,0.75885,FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,1
WP_TYPE_II_DIABETES_MELLITUS,SET,20,-0.13803,-0.0045532,0.1964,0.7589,WP_TYPE_II_DIABETES_MELLITUS,1
HONRADO_BREAST_CANCER_BRCA1_...,SET,17,-0.15416,-0.0046889,0.21932,0.75894,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,1
GOBP_SERINE_FAMILY_AMINO_ACI...3,SET,29,-0.10804,-0.0042906,0.15371,0.75894,GOBP_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GOCC_NEURON_PROJECTION_CYTOP...,SET,83,-0.06582,-0.0044155,0.093639,0.75894,GOCC_NEURON_PROJECTION_CYTOPLASM,1
GOBP_PHOSPHATIDIC_ACID_METAB...,SET,35,-0.10683,-0.0046598,0.15197,0.75895,GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS,1
HP_ABNORMAL_RESPIRATORY_EPIT...,SET,23,-0.11083,-0.0039202,0.15766,0.75896,HP_ABNORMAL_RESPIRATORY_EPITHELIUM_MORPHOLOGY,1
GSE5589_LPS_VS_LPS_AND_IL10_...3,SET,185,-0.046015,-0.0045957,0.065449,0.75899,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
GOBP_PURINE_DEOXYRIBONUCLEOS...4,SET,7,-0.21348,-0.0041676,0.30363,0.759,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
BIOCARTA_INTRINSIC_PATHWAY,SET,19,-0.15287,-0.0049152,0.21738,0.75904,BIOCARTA_INTRINSIC_PATHWAY,1
GOBP_ORGANIC_CYCLIC_COMPOUND...,SET,558,-0.025655,-0.0044041,0.03648,0.75905,GOBP_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS,1
HP_ABNORMALITY_OF_GLOBE_LOCA...,SET,965,-0.019596,-0.0043729,0.027865,0.75905,HP_ABNORMALITY_OF_GLOBE_LOCATION,1
MIR4690_5P,SET,68,-0.077138,-0.0046858,0.10968,0.75906,MIR4690_5P,1
GAO_SMALL_INTESTINE_24W_C4_E...,SET,87,-0.067482,-0.0046342,0.095948,0.75907,GAO_SMALL_INTESTINE_24W_C4_ENTEROCYTE_PROGENITOR_SUBTYPE_2,1
HP_PULMONARY_HYPOPLASIA,SET,121,-0.05514,-0.0044615,0.078371,0.75915,HP_PULMONARY_HYPOPLASIA,1
GOBP_ACTIN_CROSSLINK_FORMATI...,SET,13,-0.18729,-0.0049819,0.26618,0.75916,GOBP_ACTIN_CROSSLINK_FORMATION,1
REACTOME_SYNTHESIS_SECRETION...1,SET,18,-0.14762,-0.0046198,0.20976,0.7592,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,1
GOBP_EXECUTION_PHASE_OF_APOP...,SET,77,-0.069419,-0.0044862,0.098637,0.75921,GOBP_EXECUTION_PHASE_OF_APOPTOSIS,1
HP_BLADDER_DIVERTICULUM,SET,29,-0.12003,-0.0047666,0.17055,0.75922,HP_BLADDER_DIVERTICULUM,1
SIRNA_EIF4GI_UP,SET,84,-0.06185,-0.004174,0.087866,0.75925,SIRNA_EIF4GI_UP,1
GOBP_FOREBRAIN_NEURON_DEVELO...,SET,21,-0.14151,-0.0047833,0.20103,0.75927,GOBP_FOREBRAIN_NEURON_DEVELOPMENT,1
WP_INFLUENCE_OF_LAMINOPATHIE...,SET,33,-0.10592,-0.0044863,0.15045,0.75928,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...438,SET,5,-0.29553,-0.0048763,0.41978,0.75928,GOBP_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_ORGANELLE_TRANSPORT_ALO...,SET,79,-0.066908,-0.0043795,0.095034,0.75929,GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
GOBP_DTTP_METABOLIC_PROCESS,SET,5,-0.27915,-0.0046061,0.39649,0.7593,GOBP_DTTP_METABOLIC_PROCESS,1
WP_MRNA_PROTEIN_AND_METABOLI...,SET,7,-0.23217,-0.0045325,0.32974,0.75931,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,1
WP_ROS_IN_COVID19_ENDOTHELIA...,SET,6,-0.27498,-0.0049702,0.39043,0.75937,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,1
HP_ABNORMALITY_OF_THE_DISTAL...3,SET,4,-0.32643,-0.0048177,0.46338,0.75942,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_3RD_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...642,SET,7,-0.17658,-0.0034472,0.25062,0.75946,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,1
WP_PROSTAGLANDIN_AND_LEUKOTR...1,SET,29,-0.11598,-0.0046057,0.16457,0.75951,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,1
KAMIKUBO_MYELOID_CEBPA_NETWO...,SET,27,-0.12437,-0.004766,0.17645,0.75955,KAMIKUBO_MYELOID_CEBPA_NETWORK,1
HP_LONG_TOE,SET,38,-0.099094,-0.0045035,0.14052,0.75965,HP_LONG_TOE,1
GOMF_CATALYTIC_ACTIVITY_ACTI...1,SET,22,-0.14995,-0.0051876,0.2126,0.75969,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_GLYCOPROTEIN,1
GOBP_SKELETAL_MUSCLE_ATROPHY,SET,5,-0.2756,-0.0045474,0.39071,0.75971,GOBP_SKELETAL_MUSCLE_ATROPHY,1
HP_ABNORMAL_COAGULATION_FACT...,SET,5,-0.30273,-0.0049952,0.42913,0.75973,HP_ABNORMAL_COAGULATION_FACTOR_V_ACTIVITY,1
GOBP_L_SERINE_CATABOLIC_PROC...,SET,3,-0.34836,-0.0044526,0.4938,0.75974,GOBP_L_SERINE_CATABOLIC_PROCESS,1
GOMF_ENDONUCLEASE_ACTIVITY_A...1,SET,15,-0.15626,-0.0044646,0.22149,0.75974,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS,1
DAUER_STAT3_TARGETS_UP,SET,41,-0.10233,-0.0048303,0.14503,0.75977,DAUER_STAT3_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...609,SET,11,-0.16364,-0.0040043,0.23192,0.75977,GOBP_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION,1
KORKOLA_CHORIOCARCINOMA_DN,SET,8,-0.25085,-0.0052351,0.35552,0.75978,KORKOLA_CHORIOCARCINOMA_DN,1
HAHTOLA_MYCOSIS_FUNGOIDES_UP,SET,14,-0.17029,-0.0047006,0.24132,0.75979,HAHTOLA_MYCOSIS_FUNGOIDES_UP,1
ZHANG_RESPONSE_TO_IKK_INHIBI...1,SET,96,-0.06396,-0.0046128,0.090619,0.75984,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,1
MODULE_323,SET,52,-0.077673,-0.0041278,0.11005,0.75984,MODULE_323,1
GOBP_NEGATIVE_REGULATION_OF_...428,SET,2,-0.4864,-0.0050764,0.68916,0.75984,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,1
MIR6848_3P,SET,81,-0.071637,-0.0047477,0.10149,0.75985,MIR6848_3P,1
GOBP_POSITIVE_REGULATION_OF_...684,SET,33,-0.11096,-0.0047,0.1572,0.75986,GOBP_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
KEGG_MEDICUS_REFERENCE_AUTOP...1,SET,15,-0.14469,-0.004134,0.20492,0.75992,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR,1
GOBP_INDUCTION_OF_BACTERIAL_...,SET,5,-0.32851,-0.0054205,0.4652,0.75996,GOBP_INDUCTION_OF_BACTERIAL_AGGLUTINATION,1
REACTOME_INSULIN_RECEPTOR_RE...,SET,28,-0.11534,-0.0045006,0.16332,0.75997,REACTOME_INSULIN_RECEPTOR_RECYCLING,1
GOBP_POSITIVE_REGULATION_OF_...309,SET,11,-0.20151,-0.0049308,0.28522,0.76006,GOBP_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
GSE9946_LISTERIA_INF_MATURE_...2,SET,122,-0.052583,-0.0042721,0.074427,0.76006,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,1
GOMF_POTASSIUM_PROTON_ANTIPO...,SET,12,-0.17466,-0.0044639,0.24713,0.76014,GOMF_POTASSIUM_PROTON_ANTIPORTER_ACTIVITY,1
MODULE_80,SET,32,-0.12255,-0.0051118,0.17336,0.76018,MODULE_80,1
GSE25085_FETAL_LIVER_VS_ADUL...2,SET,166,-0.043393,-0.0041074,0.06138,0.7602,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,1
REACTOME_RECYCLING_OF_EIF2_G...,SET,7,-0.1925,-0.0037581,0.27228,0.76021,REACTOME_RECYCLING_OF_EIF2_GDP,1
HP_EEG_WITH_MULTIFOCAL_SLOW_...,SET,49,-0.083609,-0.0043135,0.11824,0.76024,HP_EEG_WITH_MULTIFOCAL_SLOW_ACTIVITY,1
GOBP_PROTEIN_KINASE_C_SIGNAL...,SET,35,-0.10494,-0.0045773,0.1484,0.76025,GOBP_PROTEIN_KINASE_C_SIGNALING,1
GSE41867_NAIVE_VS_DAY15_LCMV...5,SET,177,-0.043115,-0.0042128,0.060923,0.76043,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...253,SET,7,-0.21793,-0.0042545,0.30791,0.76045,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TUBE_FORMATION,1
GSE9006_TYPE_1_DIABETES_AT_D...4,SET,184,-0.044014,-0.004384,0.062186,0.76045,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP,1
GOCC_MALE_PRONUCLEUS,SET,6,-0.21094,-0.0038127,0.29801,0.76047,GOCC_MALE_PRONUCLEUS,1
MIR491_5P,SET,97,-0.060513,-0.0043868,0.085483,0.76049,MIR491_5P,1
WENG_POR_TARGETS_GLOBAL_UP,SET,18,-0.13021,-0.0040749,0.18391,0.76052,WENG_POR_TARGETS_GLOBAL_UP,1
HJURP_TARGET_GENES,SET,27,-0.11039,-0.0042302,0.1559,0.76055,HJURP_TARGET_GENES,1
REACTOME_SARS_COV_1_TARGETS_...,SET,16,-0.1602,-0.0047272,0.22617,0.76063,REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,1
GSE6674_CPG_VS_CPG_AND_ANTI_...2,SET,176,-0.042393,-0.0041307,0.059842,0.76065,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP,1
WP_MATRIX_METALLOPROTEINASES,SET,28,-0.12791,-0.0049912,0.18052,0.76069,WP_MATRIX_METALLOPROTEINASES,1
HP_DECREASED_CD4_CD8_RATIO,SET,8,-0.21135,-0.0044107,0.29824,0.76072,HP_DECREASED_CD4_CD8_RATIO,1
MIR3675_3P,SET,78,-0.071976,-0.0046814,0.10152,0.76082,MIR3675_3P,1
REACTOME_INTERLEUKIN_10_SIGN...,SET,43,-0.10308,-0.0049829,0.14533,0.76093,REACTOME_INTERLEUKIN_10_SIGNALING,1
KEGG_MEDICUS_REFERENCE_BMP_H...1,SET,11,-0.18491,-0.0045248,0.2606,0.76101,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY,1
GSE22611_NOD2_VS_MUTANT_NOD2...1,SET,158,-0.047201,-0.0043598,0.066515,0.76103,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
REACTOME_METABOLISM_OF_STERO...1,SET,146,-0.049967,-0.004438,0.070406,0.76105,REACTOME_METABOLISM_OF_STEROIDS,1
GSE29618_LAIV_VS_TIV_FLU_VAC...2,SET,166,-0.046198,-0.0043729,0.065092,0.76106,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP,1
WP_EXERCISEINDUCED_CIRCADIAN...,SET,46,-0.090794,-0.004539,0.12788,0.76113,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1
GOBP_NEGATIVE_REGULATION_OF_...410,SET,11,-0.17685,-0.0043276,0.24911,0.76113,GOBP_NEGATIVE_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GOBP_DETERMINATION_OF_PANCRE...,SET,4,-0.29425,-0.0043428,0.41444,0.76114,GOBP_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY,1
SIGMAR1_TARGET_GENES,SET,9,-0.19913,-0.0044077,0.2804,0.76119,SIGMAR1_TARGET_GENES,1
MIR657,SET,68,-0.073416,-0.0044597,0.10334,0.76128,MIR657,1
GOBP_INTERMEDIATE_FILAMENT_B...1,SET,92,-0.076671,-0.0054137,0.10791,0.76131,GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...1,SET,159,-0.049853,-0.0046192,0.070151,0.76135,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN,1
GSE8384_CTRL_VS_B_ABORTUS_4H...1,SET,177,-0.047197,-0.0046117,0.066409,0.76136,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN,1
CEBPE_TARGET_GENES,SET,25,-0.1432,-0.0052804,0.20148,0.76137,CEBPE_TARGET_GENES,1
REACTOME_NFE2L2_REGULATING_T...,SET,11,-0.19662,-0.0048112,0.27661,0.7614,REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES,1
GSE29618_MONOCYTE_VS_PDC_UP,SET,185,-0.047489,-0.0047429,0.066807,0.7614,GSE29618_MONOCYTE_VS_PDC_UP,1
HP_ABNORMALITY_OF_THE_ANUS,SET,197,-0.043372,-0.0044686,0.060993,0.76148,HP_ABNORMALITY_OF_THE_ANUS,1
GSE37301_MULTIPOTENT_PROGENI...9,SET,162,-0.05051,-0.0047236,0.07103,0.76149,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN,1
PEDERSEN_TARGETS_OF_611CTF_I...,SET,68,-0.080949,-0.0049172,0.11382,0.76152,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1
GOCC_SARCOPLASMIC_RETICULUM,SET,73,-0.070113,-0.0044122,0.098573,0.76154,GOCC_SARCOPLASMIC_RETICULUM,1
GOBP_FATTY_ACYL_COA_BIOSYNTH...,SET,25,-0.13153,-0.0048504,0.18491,0.76156,GOBP_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_COPP...,SET,11,-0.18639,-0.0045609,0.26198,0.76159,HP_ABNORMAL_CIRCULATING_COPPER_CONCENTRATION,1
GSE13229_MATURE_VS_INTMATURE...1,SET,176,-0.044528,-0.0043387,0.062559,0.76169,GSE13229_MATURE_VS_INTMATURE_NKCELL_DN,1
HP_ABNORMAL_ILIAC_WING_MORPH...,SET,53,-0.085313,-0.0045771,0.11981,0.76179,HP_ABNORMAL_ILIAC_WING_MORPHOLOGY,1
DNMT3A_TARGET_GENES,SET,489,-0.027846,-0.0044835,0.039098,0.76182,DNMT3A_TARGET_GENES,1
LINDVALL_IMMORTALIZED_BY_TER...1,SET,64,-0.079942,-0.0047116,0.11224,0.76184,LINDVALL_IMMORTALIZED_BY_TERT_DN,1
ZNF774_TARGET_GENES,SET,19,-0.1354,-0.0043534,0.19008,0.76187,ZNF774_TARGET_GENES,1
GOBP_EOSINOPHIL_ACTIVATION,SET,8,-0.20265,-0.0042292,0.28443,0.76191,GOBP_EOSINOPHIL_ACTIVATION,1
HP_ABNORMALITY_OF_THE_PINEAL...,SET,14,-0.16182,-0.0044667,0.22708,0.76195,HP_ABNORMALITY_OF_THE_PINEAL_GLAND,1
GOBP_POSITIVE_REGULATION_OF_...130,SET,137,-0.053922,-0.0046405,0.075659,0.76198,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH,1
GOBP_POSITIVE_REGULATION_OF_...681,SET,6,-0.24901,-0.0045008,0.34925,0.76207,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
RAMASWAMY_METASTASIS_UP,SET,60,-0.07841,-0.0044751,0.10997,0.76208,RAMASWAMY_METASTASIS_UP,1
HP_PHARYNGITIS,SET,15,-0.15905,-0.0045442,0.22305,0.76209,HP_PHARYNGITIS,1
GOBP_REGULATION_OF_GLYCOGEN_...1,SET,25,-0.12281,-0.0045287,0.1722,0.76213,GOBP_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
GSE5589_UNSTIM_VS_180MIN_LPS...1,SET,185,-0.043143,-0.0043088,0.060482,0.76217,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,1
HP_ACEPHALIC_SPERMATOZOA,SET,7,-0.25182,-0.0049161,0.35267,0.76239,HP_ACEPHALIC_SPERMATOZOA,1
GSE37416_CTRL_VS_48H_F_TULAR...2,SET,167,-0.048498,-0.0046043,0.067916,0.76241,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
TRAVAGLINI_LUNG_PROLIFERATIN...1,SET,798,-0.021247,-0.0043323,0.029752,0.76242,TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL,1
GTGTTGA_MIR505,SET,89,-0.065845,-0.0045732,0.0922,0.76243,GTGTTGA_MIR505,1
BAUS_TFF2_TARGETS_UP,SET,30,-0.11203,-0.004525,0.15685,0.76247,BAUS_TFF2_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_GF_RT...3,SET,87,-0.071625,-0.0049188,0.10024,0.76254,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY,1
MIR134_5P,SET,68,-0.075825,-0.004606,0.10611,0.76257,MIR134_5P,1
GOBP_POSITIVE_REGULATION_OF_...85,SET,95,-0.067059,-0.0048112,0.093837,0.76258,GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
PRC2_EZH2_UP.V1_UP,SET,171,-0.049711,-0.0047751,0.069557,0.76259,PRC2_EZH2_UP.V1_UP,1
MIR335_5P,SET,105,-0.059469,-0.0044844,0.083207,0.7626,MIR335_5P,1
GOBP_MAINTENANCE_OF_PROTEIN_...6,SET,5,-0.28892,-0.0047672,0.40424,0.7626,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_MITOCHONDRION,1
GSE12707_AT16L1_HYPOMORPH_VS...2,SET,111,-0.060027,-0.0046532,0.083988,0.7626,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP,1
MODULE_292,SET,120,-0.057084,-0.0045999,0.07986,0.76263,MODULE_292,1
HP_ANTERIORLY_PLACED_ANUS,SET,56,-0.081762,-0.0045086,0.11437,0.76265,HP_ANTERIORLY_PLACED_ANUS,1
HOWLIN_CITED1_TARGETS_2_DN,SET,15,-0.17553,-0.0050152,0.24549,0.7627,HOWLIN_CITED1_TARGETS_2_DN,1
GOBP_INNATE_IMMUNE_RESPONSE_...2,SET,12,-0.20497,-0.0052385,0.28667,0.7627,GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA,1
HFH8_01,SET,191,-0.047007,-0.0047695,0.065738,0.76271,HFH8_01,1
REACTOME_METABOLISM_OF_WATER...,SET,120,-0.055529,-0.0044746,0.077609,0.76285,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1
GOBP_SYNAPTIC_VESICLE_PRIMING,SET,19,-0.12483,-0.0040137,0.17444,0.76288,GOBP_SYNAPTIC_VESICLE_PRIMING,1
GSE29949_DC_BRAIN_VS_MONOCYT...2,SET,176,-0.045555,-0.0044388,0.063645,0.76293,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,1
MIR6885_5P,SET,46,-0.089421,-0.0044703,0.12489,0.76299,MIR6885_5P,1
SUNG_METASTASIS_STROMA_UP,SET,102,-0.062071,-0.0046136,0.086691,0.763,SUNG_METASTASIS_STROMA_UP,1
GSE3982_NEUTROPHIL_VS_BASOPH...1,SET,172,-0.045511,-0.0043843,0.063561,0.76301,GSE3982_NEUTROPHIL_VS_BASOPHIL_DN,1
GOMF_NITRIC_OXIDE_SYNTHASE_R...,SET,7,-0.22904,-0.0044715,0.31976,0.76309,GOMF_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...136,SET,4,-0.32576,-0.0048078,0.45475,0.76311,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GSE40493_BCL6_KO_VS_WT_TREG_...2,SET,167,-0.045275,-0.0042983,0.063201,0.76311,GSE40493_BCL6_KO_VS_WT_TREG_UP,1
REACTOME_GPVI_MEDIATED_ACTIV...,SET,33,-0.11076,-0.0046915,0.15454,0.76322,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1
GOBP_POSITIVE_REGULATION_OF_...196,SET,14,-0.18635,-0.0051438,0.26,0.76322,GOBP_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,1
GOBP_DIPHOSPHOINOSITOL_POLYP...,SET,2,-0.56965,-0.0059451,0.79456,0.76329,GOBP_DIPHOSPHOINOSITOL_POLYPHOSPHATE_METABOLIC_PROCESS,1
GOMF_ENDOPOLYPHOSPHATASE_ACT...,SET,2,-0.56965,-0.0059451,0.79456,0.76329,GOMF_ENDOPOLYPHOSPHATASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...298,SET,7,-0.25147,-0.0049093,0.35074,0.7633,GOBP_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE17721_4_VS_24H_GARDIQUIMO...2,SET,179,-0.046213,-0.0045407,0.064447,0.76333,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP,1
GAVISH_3CA_METAPROGRAM_ENDOT...15,SET,49,-0.092043,-0.0047487,0.12834,0.76337,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS,1
GSE22601_DOUBLE_NEGATIVE_VS_...6,SET,167,-0.046335,-0.004399,0.064607,0.76337,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,1
GSE17186_CD21LOW_VS_CD21HIGH...3,SET,184,-0.046697,-0.0046513,0.065101,0.7634,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
REACTOME_NON_INTEGRIN_MEMBRA...,SET,55,-0.086676,-0.0047369,0.12082,0.76342,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1
GSE13493_DP_VS_CD8POS_THYMOC...2,SET,171,-0.045959,-0.0044146,0.064062,0.76343,GSE13493_DP_VS_CD8POS_THYMOCYTE_UP,1
HARALAMBIEVA_PBMC_FLUARIX_AG...3,SET,8,-0.21898,-0.00457,0.3052,0.76346,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE,1
HP_HYPERURICEMIA,SET,23,-0.11794,-0.0041716,0.16436,0.76347,HP_HYPERURICEMIA,1
REACTOME_METABOLISM_OF_POLYA...,SET,55,-0.070879,-0.0038736,0.098776,0.76348,REACTOME_METABOLISM_OF_POLYAMINES,1
GOMF_STEROID_HORMONE_BINDING,SET,6,-0.28274,-0.0051105,0.3939,0.76356,GOMF_STEROID_HORMONE_BINDING,1
GOBP_ENDOSOMAL_LUMEN_ACIDIFI...,SET,11,-0.17719,-0.0043358,0.24684,0.76357,GOBP_ENDOSOMAL_LUMEN_ACIDIFICATION,1
FOX_Q2,SET,191,-0.046243,-0.004692,0.064407,0.76361,FOX_Q2,1
GOBP_ACTIVATION_OF_CYSTEINE_...2,SET,68,-0.078736,-0.0047828,0.10966,0.76362,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
GSE42021_CD24HI_VS_CD24LOW_T...1,SET,183,-0.046411,-0.0046104,0.064637,0.76362,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN,1
MIR5579_5P,SET,71,-0.072935,-0.0045268,0.10157,0.76363,MIR5579_5P,1
GOBP_REGULATION_OF_HORMONE_B...,SET,23,-0.13832,-0.0048927,0.19263,0.76364,GOBP_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
MIR135A_3P,SET,33,-0.10899,-0.0046164,0.15175,0.76368,MIR135A_3P,1
GNF2_PTPN4,SET,45,-0.091617,-0.0045301,0.12755,0.7637,GNF2_PTPN4,1
GOMF_ORGANIC_ACID_TRANSMEMBR...,SET,174,-0.048266,-0.0046764,0.067192,0.76372,GOMF_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ATRIOVENTRICULAR_CANAL_DE...,SET,52,-0.081267,-0.0043188,0.11312,0.76374,HP_ATRIOVENTRICULAR_CANAL_DEFECT,1
MIR345_5P,SET,40,-0.09771,-0.0045557,0.13599,0.76377,MIR345_5P,1
GSE20727_CTRL_VS_H2O2_TREATE...2,SET,178,-0.044461,-0.0043565,0.061875,0.76379,GSE20727_CTRL_VS_H2O2_TREATED_DC_UP,1
VANGURP_PANCREATIC_DELTA_CELL,SET,73,-0.080799,-0.0050847,0.11244,0.76379,VANGURP_PANCREATIC_DELTA_CELL,1
BENPORATH_ES_CORE_NINE,SET,8,-0.2112,-0.0044076,0.29384,0.76384,BENPORATH_ES_CORE_NINE,1
MIR3681_5P,SET,31,-0.11924,-0.0048957,0.16589,0.76387,MIR3681_5P,1
GOBP_PROTEIN_DESUMOYLATION,SET,9,-0.1703,-0.0037696,0.23682,0.76396,GOBP_PROTEIN_DESUMOYLATION,1
HP_REDUCED_NATURAL_KILLER_CE...1,SET,11,-0.19657,-0.0048099,0.27329,0.76401,HP_REDUCED_NATURAL_KILLER_CELL_ACTIVITY,1
GSE7831_1H_VS_4H_INFLUENZA_S...1,SET,186,-0.045326,-0.004539,0.063012,0.76403,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN,1
HP_GENERALIZED_OSTEOPOROSIS,SET,17,-0.15053,-0.0045783,0.20924,0.76405,HP_GENERALIZED_OSTEOPOROSIS,1
GOBP_PARKIN_MEDIATED_STIMULA...,SET,4,-0.33672,-0.0049695,0.46799,0.76408,GOBP_PARKIN_MEDIATED_STIMULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
HP_DECREASED_ACTIVITY_OF_MIT...3,SET,13,-0.15343,-0.0040811,0.21324,0.76408,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_II,1
GOMF_RNA_POLYMERASE_II_INTRO...,SET,8,-0.23412,-0.0048861,0.32535,0.76411,GOMF_RNA_POLYMERASE_II_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
MIR4471,SET,68,-0.073099,-0.0044404,0.10156,0.76416,MIR4471,1
HP_ABNORMALITY_OF_THE_HYPOTH...1,SET,360,-0.03229,-0.004477,0.044862,0.76416,HP_ABNORMALITY_OF_THE_HYPOTHALAMUS_PITUITARY_AXIS,1
WP_HIPPOCAMPAL_SYNAPTOGENESI...,SET,27,-0.13504,-0.0051746,0.18756,0.76422,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,1
GSE17721_POLYIC_VS_GARDIQUIM...1,SET,181,-0.04551,-0.0044964,0.063183,0.76432,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
HP_ABNORMAL_TRACHEOBRONCHIAL...,SET,330,-0.034253,-0.0045507,0.047544,0.76437,HP_ABNORMAL_TRACHEOBRONCHIAL_MORPHOLOGY,1
GSE16385_ROSIGLITAZONE_VS_UN...2,SET,178,-0.048281,-0.0047308,0.066982,0.76448,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP,1
FURUKAWA_DUSP6_TARGETS_PCI35...2,SET,61,-0.084489,-0.0048619,0.11718,0.76454,FURUKAWA_DUSP6_TARGETS_PCI35_UP,1
HP_APPENDICULAR_HYPOTONIA,SET,16,-0.14232,-0.0041996,0.19738,0.76455,HP_APPENDICULAR_HYPOTONIA,1
GSE25677_MPL_VS_MPL_AND_R848...1,SET,118,-0.056575,-0.004521,0.078428,0.76465,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN,1
GSE22886_NAIVE_VS_MEMORY_TCE...2,SET,175,-0.04511,-0.004383,0.062531,0.76466,GSE22886_NAIVE_VS_MEMORY_TCELL_UP,1
ZHU_CMV_24_HR_DN,SET,78,-0.072748,-0.0047316,0.10081,0.76472,ZHU_CMV_24_HR_DN,1
KEGG_MEDICUS_REFERENCE_NOTCH...1,SET,9,-0.22417,-0.004962,0.3106,0.76477,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION,1
MIR3186_5P,SET,2,-0.39534,-0.004126,0.54762,0.76483,MIR3186_5P,1
MIR6775_5P,SET,4,-0.34475,-0.005088,0.47749,0.76485,MIR6775_5P,1
GOCC_RSC_TYPE_COMPLEX,SET,15,-0.1565,-0.0044715,0.21675,0.76486,GOCC_RSC_TYPE_COMPLEX,1
GOCC_NASCENT_POLYPEPTIDE_ASS...,SET,4,-0.27326,-0.0040329,0.37837,0.76491,GOCC_NASCENT_POLYPEPTIDE_ASSOCIATED_COMPLEX,1
GOBP_REGULATION_OF_CALCIUM_I...5,SET,11,-0.16537,-0.0040465,0.22896,0.76493,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOCC_ROD_PHOTORECEPTOR_OUTER...,SET,7,-0.22487,-0.00439,0.31115,0.76506,GOCC_ROD_PHOTORECEPTOR_OUTER_SEGMENT,1
DESCARTES_FETAL_SPLEEN_AFP_A...,SET,170,-0.050467,-0.0048337,0.069829,0.76507,DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS,1
GOMF_7S_RNA_BINDING,SET,7,-0.18834,-0.0036767,0.26055,0.76511,GOMF_7S_RNA_BINDING,1
GSE27786_CD8_TCELL_VS_ERYTHR...1,SET,182,-0.046147,-0.0045717,0.063835,0.76513,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN,1
HP_RENAL_INTERSTITIAL_FIBROS...,SET,6,-0.2283,-0.0041265,0.31576,0.76516,HP_RENAL_INTERSTITIAL_FIBROSIS,1
MIR877_5P,SET,75,-0.071536,-0.0045628,0.098939,0.76517,MIR877_5P,1
GSE15735_2H_VS_12H_HDAC_INHI...2,SET,188,-0.04657,-0.0046883,0.064409,0.76517,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP,1
GSE27786_CD4_TCELL_VS_NEUTRO...1,SET,180,-0.046564,-0.0045878,0.064398,0.76518,GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN,1
MIR4503,SET,248,-0.039929,-0.0046092,0.055202,0.76525,MIR4503,1
GOBP_VITAMIN_CATABOLIC_PROCE...,SET,15,-0.16212,-0.004632,0.22413,0.76526,GOBP_VITAMIN_CATABOLIC_PROCESS,1
GSE40666_STAT1_KO_VS_STAT4_K...3,SET,145,-0.054941,-0.0048632,0.075956,0.76526,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
REACTOME_UPTAKE_AND_FUNCTION...2,SET,6,-0.24922,-0.0045045,0.34444,0.76532,REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN,1
LIU_VMYB_TARGETS_UP,SET,110,-0.059514,-0.0045928,0.082247,0.76534,LIU_VMYB_TARGETS_UP,1
GOBP_HISTAMINE_METABOLIC_PRO...,SET,6,-0.31129,-0.0056265,0.4302,0.76534,GOBP_HISTAMINE_METABOLIC_PROCESS,1
GSE37416_0H_VS_3H_F_TULARENS...2,SET,178,-0.04518,-0.0044269,0.062438,0.76534,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOMF_ELECTRON_TRANSFER_ACTIV...,SET,96,-0.058245,-0.0042007,0.080483,0.76537,GOMF_ELECTRON_TRANSFER_ACTIVITY,1
GSE22886_NAIVE_CD4_TCELL_VS_...17,SET,185,-0.042734,-0.004268,0.059031,0.76544,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN,1
HP_ULNAR_DEVIATION_OF_THE_HA...1,SET,27,-0.12716,-0.0048728,0.17564,0.76545,HP_ULNAR_DEVIATION_OF_THE_HAND,1
HE_LIM_SUN_FETAL_LUNG_C0_MES...2,SET,265,-0.038911,-0.0046409,0.053735,0.7655,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL,1
GOBP_FATTY_ACYL_COA_METABOLI...,SET,37,-0.10783,-0.0048359,0.1489,0.76552,GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...330,SET,6,-0.23141,-0.0041826,0.31953,0.76552,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...370,SET,66,-0.082678,-0.0049482,0.11417,0.76552,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,1
GOBP_RIG_I_SIGNALING_PATHWAY,SET,22,-0.12726,-0.0044026,0.17572,0.76553,GOBP_RIG_I_SIGNALING_PATHWAY,1
chr5q14,SET,46,-0.14419,-0.0072083,0.19904,0.76559,chr5q14,1
INAMURA_LUNG_CANCER_SCC_UP,SET,11,-0.19536,-0.0047805,0.26966,0.76561,INAMURA_LUNG_CANCER_SCC_UP,1
GOMF_DNA_ENDONUCLEASE_ACTIVI...1,SET,38,-0.09685,-0.0044015,0.13368,0.76561,GOMF_DNA_ENDONUCLEASE_ACTIVITY,1
HP_DECREASED_ACHILLES_REFLEX,SET,8,-0.22947,-0.0047889,0.31665,0.76567,HP_DECREASED_ACHILLES_REFLEX,1
ZNF597_TARGET_GENES,SET,606,-0.025363,-0.0045312,0.034995,0.7657,ZNF597_TARGET_GENES,1
HP_DEFICIT_IN_PHONOLOGIC_SHO...,SET,5,-0.33208,-0.0054794,0.45812,0.76573,HP_DEFICIT_IN_PHONOLOGIC_SHORT_TERM_MEMORY,1
NADELLA_PRKAR1A_TARGETS_UP,SET,9,-0.23933,-0.0052975,0.33015,0.76574,NADELLA_PRKAR1A_TARGETS_UP,1
MIR6511A_5P,SET,175,-0.047508,-0.0046161,0.065521,0.76579,MIR6511A_5P,1
FINETTI_BREAST_CANCER_KINOME...1,SET,14,-0.1787,-0.0049327,0.24644,0.7658,FINETTI_BREAST_CANCER_KINOME_GREEN,1
KEGG_MEDICUS_REFERENCE_MICRO...2,SET,19,-0.143,-0.0045978,0.19716,0.76586,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS,1
KOBAYASHI_EGFR_SIGNALING_6HR...1,SET,17,-0.16229,-0.0049361,0.22374,0.76588,KOBAYASHI_EGFR_SIGNALING_6HR_DN,1
SMAD4_Q6,SET,222,-0.043281,-0.0047304,0.059659,0.76591,SMAD4_Q6,1
HP_PULMONARY_ARTERY_ANEURYSM,SET,7,-0.23759,-0.0046382,0.32747,0.76593,HP_PULMONARY_ARTERY_ANEURYSM,1
GOBP_POSITIVE_REGULATION_OF_...686,SET,4,-0.27071,-0.0039953,0.37303,0.76598,GOBP_POSITIVE_REGULATION_OF_RNA_BINDING,1
HP_ABNORMAL_SUBARACHNOID_SPA...,SET,70,-0.074772,-0.0046081,0.10303,0.766,HP_ABNORMAL_SUBARACHNOID_SPACE_MORPHOLOGY,1
GOBP_T_CELL_CYTOKINE_PRODUCT...,SET,36,-0.10798,-0.0047767,0.14877,0.76601,GOBP_T_CELL_CYTOKINE_PRODUCTION,1
MOOTHA_MITOCHONDRIA,SET,396,-0.030691,-0.0044584,0.04227,0.7661,MOOTHA_MITOCHONDRIA,1
PECE_MAMMARY_STEM_CELL_UP,SET,120,-0.053425,-0.004305,0.073582,0.7661,PECE_MAMMARY_STEM_CELL_UP,1
WP_KYNURENINE_PATHWAY_AND_LI...,SET,24,-0.13478,-0.0048697,0.18562,0.7661,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,1
GOBP_REGULATION_OF_SKELETAL_...3,SET,18,-0.13708,-0.0042902,0.18877,0.76613,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
PID_ARF_3PATHWAY,SET,19,-0.14057,-0.0045195,0.19356,0.76614,PID_ARF_3PATHWAY,1
chr3p13,SET,10,-0.3009,-0.0070204,0.41422,0.7662,chr3p13,1
WP_INSULIN_SIGNALING,SET,155,-0.049948,-0.0045699,0.068756,0.76622,WP_INSULIN_SIGNALING,1
GSE8921_UNSTIM_VS_TLR1_2_STI...4,SET,177,-0.047902,-0.0046806,0.065935,0.76623,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP,1
MODULE_174,SET,89,-0.070752,-0.0049141,0.097363,0.76629,MODULE_174,1
GOBP_DNA_MODIFICATION,SET,38,-0.10795,-0.0049059,0.14853,0.76631,GOBP_DNA_MODIFICATION,1
HE_LIM_SUN_FETAL_LUNG_C0_PER...,SET,186,-0.04929,-0.0049359,0.067813,0.76634,HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE,1
GOBP_REGULATION_OF_STEROID_H...2,SET,22,-0.14406,-0.0049838,0.19817,0.76637,GOBP_REGULATION_OF_STEROID_HORMONE_SECRETION,1
REACTOME_INTERACTION_BETWEEN...,SET,30,-0.1245,-0.0050286,0.17123,0.76641,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,1
MIER1_TARGET_GENES,SET,297,-0.036902,-0.0046553,0.050752,0.76641,MIER1_TARGET_GENES,1
ACATATC_MIR190,SET,54,-0.092695,-0.0050197,0.12746,0.76645,ACATATC_MIR190,1
STK33_NOMO_UP,SET,262,-0.040498,-0.0048031,0.055683,0.76647,STK33_NOMO_UP,1
PID_ARF6_DOWNSTREAM_PATHWAY,SET,15,-0.17665,-0.0050472,0.24288,0.76648,PID_ARF6_DOWNSTREAM_PATHWAY,1
GOMF_NUCLEOSIDE_DIPHOSPHATE_...2,SET,17,-0.15005,-0.0045638,0.20631,0.76648,GOMF_NUCLEOSIDE_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,1
HP_LIVEDO_RETICULARIS,SET,4,-0.29082,-0.004292,0.39983,0.76649,HP_LIVEDO_RETICULARIS,1
GOMF_TRANSFERASE_ACTIVITY_TR...3,SET,178,-0.04398,-0.0043093,0.060462,0.7665,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS,1
GOMF_VASCULAR_ENDOTHELIAL_GR...2,SET,9,-0.2262,-0.005007,0.31093,0.76653,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING,1
HP_RETINAL_PIGMENT_EPITHELIA...1,SET,36,-0.09905,-0.0043817,0.13615,0.76654,HP_RETINAL_PIGMENT_EPITHELIAL_ATROPHY,1
REACTOME_ROLE_OF_ABL_IN_ROBO...,SET,8,-0.25303,-0.0052807,0.34775,0.76657,REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING,1
GOBP_MEGAKARYOCYTE_DIFFERENT...,SET,47,-0.094717,-0.0047861,0.13018,0.76657,GOBP_MEGAKARYOCYTE_DIFFERENTIATION,1
HP_SINUS_BRADYCARDIA,SET,30,-0.11894,-0.0048041,0.16343,0.76662,HP_SINUS_BRADYCARDIA,1
GSE43863_TH1_VS_TFH_MEMORY_C...2,SET,179,-0.045015,-0.004423,0.061851,0.76663,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP,1
BIOCARTA_CDMAC_PATHWAY,SET,16,-0.1696,-0.0050045,0.23301,0.76665,BIOCARTA_CDMAC_PATHWAY,1
GOCC_SPINDLE_MIDZONE,SET,35,-0.10294,-0.0044904,0.14142,0.76667,GOCC_SPINDLE_MIDZONE,1
MORF_PPP1CA,SET,145,-0.046894,-0.004151,0.064415,0.76669,MORF_PPP1CA,1
MODULE_132,SET,13,-0.18992,-0.005052,0.26088,0.76669,MODULE_132,1
GSE27786_CD4_VS_CD8_TCELL_UP,SET,188,-0.044478,-0.0044776,0.061092,0.7667,GSE27786_CD4_VS_CD8_TCELL_UP,1
GOBP_HYPOTONIC_RESPONSE,SET,13,-0.18273,-0.0048606,0.25098,0.76671,GOBP_HYPOTONIC_RESPONSE,1
GSE2405_HEAT_KILLED_LYSATE_V...1,SET,182,-0.046278,-0.0045847,0.063562,0.76671,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,1
GENTILE_UV_RESPONSE_CLUSTER_...2,SET,37,-0.10698,-0.0047974,0.14692,0.76672,GENTILE_UV_RESPONSE_CLUSTER_D2,1
GOBP_NEGATIVE_REGULATION_OF_...513,SET,62,-0.0777,-0.0045076,0.10672,0.76672,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING,1
GSE33513_TCF7_KO_VS_HET_EARL...1,SET,181,-0.045274,-0.004473,0.06218,0.76672,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN,1
GOBP_POSITIVE_REGULATION_OF_...359,SET,11,-0.20033,-0.0049019,0.2751,0.76675,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION,1
HP_ABNORMAL_THIRD_TOE_MORPHO...,SET,7,-0.24944,-0.0048695,0.34251,0.76676,HP_ABNORMAL_THIRD_TOE_MORPHOLOGY,1
GOMF_CCR6_CHEMOKINE_RECEPTOR...,SET,5,-0.34408,-0.0056774,0.47243,0.76679,GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING,1
WP_MYOMETRIAL_RELAXATION_AND...,SET,153,-0.053307,-0.0048459,0.073184,0.76681,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1
MIR890,SET,88,-0.06825,-0.0047137,0.093684,0.76684,MIR890,1
GOBP_REGULATION_OF_HYDROGEN_...3,SET,17,-0.15063,-0.0045813,0.20675,0.76685,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...1,SET,216,-0.043523,-0.0046929,0.059733,0.76688,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_HAND_JOINT...,SET,43,-0.097296,-0.0047031,0.1335,0.76694,HP_ABNORMALITY_OF_HAND_JOINT_MOBILITY,1
GOMF_SULFATE_BINDING,SET,4,-0.32702,-0.0048263,0.44868,0.76695,GOMF_SULFATE_BINDING,1
LAU_APOPTOSIS_CDKN2A_DN,SET,5,-0.25406,-0.004192,0.34856,0.76696,LAU_APOPTOSIS_CDKN2A_DN,1
MODULE_327,SET,21,-0.14124,-0.004774,0.19377,0.76696,MODULE_327,1
BIOCARTA_INSULIN_PATHWAY,SET,20,-0.13812,-0.0045561,0.18947,0.76699,BIOCARTA_INSULIN_PATHWAY,1
GSE34156_TLR1_TLR2_LIGAND_VS...3,SET,147,-0.050536,-0.0045038,0.069317,0.76701,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
HP_CONTRACTURE_OF_THE_PROXIM...2,SET,5,-0.28229,-0.0046578,0.38715,0.76704,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_4TH_FINGER,1
GAO_SMALL_INTESTINE_24W_C9_E...,SET,42,-0.1004,-0.0047963,0.13768,0.76706,GAO_SMALL_INTESTINE_24W_C9_ENTEROENDOCRINE_CELL,1
GOCC_CORVET_COMPLEX,SET,7,-0.2096,-0.0040918,0.28739,0.76709,GOCC_CORVET_COMPLEX,1
TRAYNOR_RETT_SYNDROM_DN,SET,14,-0.17569,-0.0048496,0.24085,0.76713,TRAYNOR_RETT_SYNDROM_DN,1
GOMF_LIGASE_ACTIVITY_FORMING...3,SET,22,-0.12168,-0.0042095,0.16675,0.76721,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS,1
MIR7703,SET,101,-0.063499,-0.0046967,0.087001,0.76726,MIR7703,1
HP_LOWER_LIMB_PAIN,SET,37,-0.10667,-0.0047838,0.14611,0.76731,HP_LOWER_LIMB_PAIN,1
GRAHAM_CML_DIVIDING_VS_NORMA...3,SET,77,-0.075652,-0.004889,0.1036,0.76738,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,1
MIR488_3P,SET,168,-0.046713,-0.0044479,0.06396,0.76741,MIR488_3P,1
GOBP_CYTOSKELETON_DEPENDENT_...2,SET,180,-0.046575,-0.004589,0.06377,0.76741,GOBP_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT,1
GSE6875_WT_VS_FOXP3_KO_TREG_...2,SET,177,-0.047707,-0.0046615,0.065311,0.76744,GSE6875_WT_VS_FOXP3_KO_TREG_UP,1
HP_IRREGULAR_MENSTRUATION,SET,58,-0.080835,-0.0045362,0.11064,0.76748,HP_IRREGULAR_MENSTRUATION,1
HP_INTERICTAL_EEG_ABNORMALITY,SET,289,-0.036749,-0.0045741,0.050293,0.76751,HP_INTERICTAL_EEG_ABNORMALITY,1
GSE36476_YOUNG_VS_OLD_DONOR_...5,SET,173,-0.047482,-0.0045874,0.064978,0.76753,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN,1
GOBP_RESPONSE_TO_EPINEPHRINE,SET,14,-0.17978,-0.0049624,0.24589,0.76764,GOBP_RESPONSE_TO_EPINEPHRINE,1
VALK_AML_CLUSTER_10,SET,28,-0.12494,-0.0048756,0.17087,0.76768,VALK_AML_CLUSTER_10,1
GOBP_DENDRITIC_TRANSPORT_OF_...,SET,5,-0.26808,-0.0044233,0.3666,0.76768,GOBP_DENDRITIC_TRANSPORT_OF_RIBONUCLEOPROTEIN_COMPLEX,1
HP_ABNORMAL_GROWTH_HORMONE_L...,SET,25,-0.13056,-0.0048144,0.17854,0.76769,HP_ABNORMAL_GROWTH_HORMONE_LEVEL,1
DESCARTES_FETAL_PANCREAS_STR...,SET,16,-0.16875,-0.0049794,0.23076,0.7677,DESCARTES_FETAL_PANCREAS_STROMAL_CELLS,1
GOBP_REGULATION_OF_IRON_ION_...1,SET,3,-0.32776,-0.0041894,0.44816,0.76771,GOBP_REGULATION_OF_IRON_ION_TRANSMEMBRANE_TRANSPORT,1
MIR212_3P,SET,170,-0.047246,-0.0045252,0.064599,0.76772,MIR212_3P,1
HP_ABNORMAL_ZYGOMATIC_BONE_M...,SET,206,-0.044198,-0.0046553,0.060406,0.76781,HP_ABNORMAL_ZYGOMATIC_BONE_MORPHOLOGY,1
PID_VEGF_VEGFR_PATHWAY,SET,9,-0.23132,-0.0051202,0.31614,0.76782,PID_VEGF_VEGFR_PATHWAY,1
MIR6838_3P,SET,58,-0.083208,-0.0046693,0.11372,0.76782,MIR6838_3P,1
GOBP_FACE_DEVELOPMENT,SET,49,-0.093464,-0.004822,0.12772,0.76784,GOBP_FACE_DEVELOPMENT,1
FU_INTERACT_WITH_ALKBH8,SET,13,-0.14708,-0.0039123,0.20099,0.76785,FU_INTERACT_WITH_ALKBH8,1
WP_CATABOLISM_OF_SKELETAL_MU...,SET,38,-0.10567,-0.0048023,0.14439,0.76785,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,1
GSE3982_MAST_CELL_VS_BASOPHI...1,SET,172,-0.04825,-0.0046481,0.065922,0.76789,GSE3982_MAST_CELL_VS_BASOPHIL_DN,1
DESCARTES_FETAL_CEREBRUM_LIM...,SET,22,-0.14488,-0.005012,0.19789,0.76795,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,1
GCM_SUPT4H1,SET,52,-0.082408,-0.0043795,0.11255,0.76797,GCM_SUPT4H1,1
GSE9946_LISTERIA_INF_MATURE_...1,SET,100,-0.06391,-0.0047038,0.08726,0.76804,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,1
WP_NANOMATERIAL_INDUCED_APOP...,SET,19,-0.14259,-0.0045846,0.19467,0.76805,WP_NANOMATERIAL_INDUCED_APOPTOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...221,SET,9,-0.21094,-0.0046691,0.28797,0.76806,GOBP_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
GOBP_REGULATION_OF_BEHAVIOR,SET,70,-0.082685,-0.0050958,0.11287,0.76809,GOBP_REGULATION_OF_BEHAVIOR,1
GOBP_POSITIVE_REGULATION_OF_...378,SET,89,-0.063382,-0.0044022,0.086482,0.76818,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
PID_GMCSF_PATHWAY,SET,35,-0.10819,-0.0047192,0.1476,0.76822,PID_GMCSF_PATHWAY,1
GOMF_TELOMERASE_ACTIVITY,SET,5,-0.25485,-0.0042051,0.34759,0.76828,GOMF_TELOMERASE_ACTIVITY,1
HP_DECREASED_CIRCULATING_PRE...,SET,4,-0.35561,-0.0052484,0.48481,0.76837,HP_DECREASED_CIRCULATING_PREALBUMIN_CONCENTRATION,1
MIR12119,SET,173,-0.046756,-0.0045172,0.063741,0.76838,MIR12119,1
GSE17721_CTRL_VS_PAM3CSK4_24...1,SET,180,-0.046414,-0.0045731,0.063271,0.76839,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN,1
GOMF_GABA_RECEPTOR_ACTIVITY,SET,19,-0.17982,-0.0057816,0.24508,0.76843,GOMF_GABA_RECEPTOR_ACTIVITY,1
PID_RAS_PATHWAY,SET,29,-0.1084,-0.0043049,0.14771,0.76848,PID_RAS_PATHWAY,1
GSE20727_H2O2_VS_ROS_INHIBIT...2,SET,173,-0.045833,-0.004428,0.062442,0.76852,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP,1
MOHANKUMAR_HOXA1_TARGETS_DN,SET,151,-0.054918,-0.0049599,0.074794,0.7686,MOHANKUMAR_HOXA1_TARGETS_DN,1
MIR1185_5P,SET,53,-0.085669,-0.0045962,0.11667,0.76861,MIR1185_5P,1
GOMF_PHOSPHOTRANSFERASE_ACTI...1,SET,21,-0.13288,-0.0044915,0.18097,0.76861,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS,1
KEGG_MEDICUS_PATHOGEN_SARS_C...2,SET,12,-0.20656,-0.005279,0.28129,0.76862,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,1
MIR4474_5P,SET,44,-0.09871,-0.0048265,0.13442,0.76863,MIR4474_5P,1
HP_ADULT_ONSET_SENSORINEURAL...,SET,5,-0.36743,-0.0060627,0.5003,0.76865,HP_ADULT_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,1
HP_EXAGGERATED_STARTLE_RESPO...,SET,29,-0.12491,-0.0049606,0.17009,0.76865,HP_EXAGGERATED_STARTLE_RESPONSE,1
GOBP_REGULATION_OF_CYCLIC_NU...,SET,6,-0.22869,-0.0041335,0.31136,0.76867,GOBP_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...50,SET,85,-0.067352,-0.0045721,0.091688,0.7687,HP_APLASIA_HYPOPLASIA_OF_THE_OVARY,1
GSE18281_SUBCAPSULAR_CORTICA...1,SET,167,-0.04859,-0.004613,0.066147,0.7687,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...13,SET,15,-0.15353,-0.0043867,0.20895,0.76876,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,1
HP_PROXIMAL_RADIO_ULNAR_SYNO...,SET,6,-0.30604,-0.0055316,0.41637,0.76883,HP_PROXIMAL_RADIO_ULNAR_SYNOSTOSIS,1
GOBP_REGULATION_OF_LIPID_KIN...,SET,8,-0.19387,-0.0040461,0.2637,0.76889,GOBP_REGULATION_OF_LIPID_KINASE_ACTIVITY,1
HAY_BONE_MARROW_NK_CELLS,SET,323,-0.035911,-0.004721,0.048839,0.76891,HAY_BONE_MARROW_NK_CELLS,1
ATF_B,SET,174,-0.048776,-0.0047258,0.066324,0.76895,ATF_B,1
GOBP_NEGATIVE_REGULATION_OF_...369,SET,7,-0.22049,-0.0043044,0.29982,0.76895,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,1
GOBP_POSITIVE_REGULATION_OF_...576,SET,79,-0.075236,-0.0049245,0.10229,0.76898,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
MYLLYKANGAS_AMPLIFICATION_HO...12,SET,10,-0.21377,-0.0049876,0.29061,0.76901,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,1
CGGTGTG_MIR220,SET,5,-0.28978,-0.0047814,0.39392,0.76902,CGGTGTG_MIR220,1
KEGG_MEDICUS_VARIANT_MUTATIO...1,SET,5,-0.30433,-0.0050216,0.41358,0.76908,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY,1
MAHAJAN_RESPONSE_TO_IL1A_DN,SET,63,-0.079151,-0.0046285,0.10756,0.76909,MAHAJAN_RESPONSE_TO_IL1A_DN,1
REACTOME_FGFR2B_LIGAND_BINDI...,SET,10,-0.23557,-0.0054961,0.32007,0.76912,REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION,1
HP_CHORIORETINAL_HYPOPIGMENT...,SET,10,-0.21579,-0.0050348,0.29319,0.76914,HP_CHORIORETINAL_HYPOPIGMENTATION,1
HP_MUSCLE_FIBER_INCLUSION_BO...,SET,36,-0.10307,-0.0045597,0.14002,0.76918,HP_MUSCLE_FIBER_INCLUSION_BODIES,1
MIR597_5P,SET,72,-0.074561,-0.00466,0.10126,0.76922,MIR597_5P,1
BUSSLINGER_GASTRIC_PARIETAL_...,SET,221,-0.040945,-0.0044651,0.055609,0.76922,BUSSLINGER_GASTRIC_PARIETAL_CELLS,1
FAN_OVARY_CL0_XBP1_SELK_HIGH...,SET,123,-0.055862,-0.0045569,0.075863,0.76924,FAN_OVARY_CL0_XBP1_SELK_HIGH_STROMAL_CELL,1
HP_ABNORMAL_ANTIHELIX_MORPHO...,SET,36,-0.10383,-0.0045934,0.141,0.76925,HP_ABNORMAL_ANTIHELIX_MORPHOLOGY,1
GSE36009_WT_VS_NLRP10_KO_DC_...2,SET,180,-0.044414,-0.004376,0.060298,0.7693,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN,1
GOBP_G_PROTEIN_COUPLED_RECEP...4,SET,9,-0.21224,-0.004698,0.28808,0.76936,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS,1
GOCC_SERINE_TYPE_PEPTIDASE_C...,SET,13,-0.21478,-0.0057132,0.29146,0.76941,GOCC_SERINE_TYPE_PEPTIDASE_COMPLEX,1
HP_RECURRENT_HAND_FLAPPING,SET,24,-0.12801,-0.0046254,0.17369,0.76944,HP_RECURRENT_HAND_FLAPPING,1
KEGG_MEDICUS_PATHOGEN_HCMV_G...2,SET,7,-0.24769,-0.0048355,0.33604,0.76946,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY,1
GOBP_PROTEIN_PROCESSING_INVO...,SET,7,-0.24757,-0.0048331,0.33585,0.76948,GOBP_PROTEIN_PROCESSING_INVOLVED_IN_PROTEIN_TARGETING_TO_MITOCHONDRION,1
REACTOME_INTERLEUKIN_4_AND_I...,SET,101,-0.070279,-0.0051982,0.095324,0.76951,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1
KEGG_MEDICUS_REFERENCE_NUCLE...1,SET,27,-0.11296,-0.0043287,0.15322,0.76952,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA,1
GOBP_REGULATION_OF_PHOSPHOLI...6,SET,5,-0.32533,-0.0053681,0.44121,0.76954,GOBP_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS,1
GOBP_LIPID_OXIDATION,SET,107,-0.060759,-0.0046248,0.082365,0.76964,GOBP_LIPID_OXIDATION,1
GOBP_REGULATION_OF_SYSTEMIC_...6,SET,20,-0.1551,-0.0051162,0.21025,0.76964,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN,1
GOBP_ORGANIC_ACID_TRANSPORT,SET,330,-0.036907,-0.0049034,0.05003,0.76965,GOBP_ORGANIC_ACID_TRANSPORT,1
HP_BROAD_LONG_BONES,SET,128,-0.056398,-0.0046926,0.076445,0.76966,HP_BROAD_LONG_BONES,1
GOBP_EOSINOPHIL_MIGRATION,SET,28,-0.14188,-0.0055366,0.19231,0.76968,GOBP_EOSINOPHIL_MIGRATION,1
GOCC_APICOLATERAL_PLASMA_MEM...,SET,23,-0.14593,-0.0051617,0.19777,0.76969,GOCC_APICOLATERAL_PLASMA_MEMBRANE,1
MODULE_299,SET,34,-0.10128,-0.0043543,0.13725,0.76971,MODULE_299,1
GOMF_HISTONE_H4K5_ACETYLTRAN...,SET,11,-0.18366,-0.004494,0.24887,0.76972,GOMF_HISTONE_H4K5_ACETYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_TUMOR_NEC...,SET,57,-0.083097,-0.0046229,0.1126,0.76973,GOBP_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
GOMF_GDP_PHOSPHATASE_ACTIVITY,SET,10,-0.19693,-0.0045947,0.26683,0.76975,GOMF_GDP_PHOSPHATASE_ACTIVITY,1
PEDERSEN_METASTASIS_BY_ERBB2...3,SET,99,-0.067575,-0.0049487,0.091551,0.76977,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1
GOBP_NEGATIVE_REGULATION_OF_...261,SET,14,-0.17575,-0.0048513,0.23811,0.76977,GOBP_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
SMITH_LIVER_CANCER,SET,44,-0.097459,-0.0047653,0.13202,0.7698,SMITH_LIVER_CANCER,1
GOBP_MAINTENANCE_OF_LENS_TRA...,SET,7,-0.28329,-0.0055304,0.38376,0.7698,GOBP_MAINTENANCE_OF_LENS_TRANSPARENCY,1
GSE5589_LPS_VS_LPS_AND_IL6_S...2,SET,180,-0.047546,-0.0046846,0.064407,0.7698,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
IKEDA_MIR30_TARGETS_UP,SET,110,-0.062137,-0.0047951,0.084149,0.76986,IKEDA_MIR30_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...122,SET,54,-0.0846,-0.0045813,0.11457,0.76986,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
MODULE_313,SET,13,-0.17568,-0.0046731,0.23789,0.76988,MODULE_313,1
ZNF410_TARGET_GENES,SET,488,-0.028661,-0.0046102,0.038806,0.76991,ZNF410_TARGET_GENES,1
GOBP_PROTEIN_K48_LINKED_DEUB...,SET,22,-0.11647,-0.0040294,0.15769,0.76992,GOBP_PROTEIN_K48_LINKED_DEUBIQUITINATION,1
HP_SHORT_LOWER_LIMBS,SET,12,-0.17586,-0.0044944,0.23804,0.76997,HP_SHORT_LOWER_LIMBS,1
GOBP_SIGNAL_TRANSDUCTION_BY_...,SET,158,-0.04952,-0.004574,0.067026,0.76998,GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
MIR3151_3P,SET,39,-0.093571,-0.004308,0.12665,0.76999,MIR3151_3P,1
REACTOME_TRANSLOCATION_OF_SL...,SET,69,-0.075655,-0.0046292,0.10239,0.77,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,1
KRAS.LUNG_UP.V1_UP,SET,122,-0.061654,-0.0050091,0.083438,0.77002,KRAS.LUNG_UP.V1_UP,1
HP_REGIONAL_ABNORMALITY_OF_S...,SET,469,-0.029658,-0.0046792,0.040131,0.77005,HP_REGIONAL_ABNORMALITY_OF_SKIN,1
DESCARTES_FETAL_PANCREAS_ENS...1,SET,58,-0.08903,-0.0049961,0.12046,0.77007,DESCARTES_FETAL_PANCREAS_ENS_GLIA,1
GOBP_REGULATION_OF_FLAGELLAT...,SET,18,-0.15507,-0.004853,0.20979,0.77009,GOBP_REGULATION_OF_FLAGELLATED_SPERM_MOTILITY,1
HP_INTERRUPTED_INFERIOR_VENA...,SET,5,-0.22751,-0.003754,0.3078,0.77009,HP_INTERRUPTED_INFERIOR_VENA_CAVA_WITH_AZYGOUS_CONTINUATION,1
HP_SACROCOCCYGEAL_TERATOMA,SET,5,-0.27447,-0.0045289,0.37126,0.77013,HP_SACROCOCCYGEAL_TERATOMA,1
WP_IL19_SIGNALING,SET,28,-0.12557,-0.0049,0.16984,0.77014,WP_IL19_SIGNALING,1
GOBP_THYROID_HORMONE_TRANSPO...,SET,10,-0.20493,-0.0047813,0.27719,0.77014,GOBP_THYROID_HORMONE_TRANSPORT,1
HP_ABNORMAL_PSYCHOTIC_PATTERN,SET,171,-0.051223,-0.0049203,0.069282,0.77014,HP_ABNORMAL_PSYCHOTIC_PATTERN,1
HP_THICK_EYEBROW,SET,134,-0.055442,-0.0047192,0.074988,0.77015,HP_THICK_EYEBROW,1
TRAVAGLINI_LUNG_CAPILLARY_CE...,SET,14,-0.18727,-0.0051694,0.2533,0.77015,TRAVAGLINI_LUNG_CAPILLARY_CELL,1
MIR6882_3P,SET,106,-0.061138,-0.004632,0.08268,0.77018,MIR6882_3P,1
GOCC_CONE_PHOTORECEPTOR_OUTE...,SET,7,-0.29898,-0.0058368,0.4042,0.77025,GOCC_CONE_PHOTORECEPTOR_OUTER_SEGMENT,1
DESCARTES_FETAL_PLACENTA_SYN...,SET,51,-0.09136,-0.0048084,0.12345,0.77036,DESCARTES_FETAL_PLACENTA_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,1
EPPERT_PROGENITOR,SET,124,-0.055675,-0.00456,0.075225,0.77038,EPPERT_PROGENITOR,1
GOBP_ESTABLISHMENT_OF_PROTEI...3,SET,23,-0.11595,-0.0041013,0.15664,0.77041,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
DACOSTA_UV_RESPONSE_VIA_ERCC...5,SET,49,-0.093519,-0.0048248,0.12634,0.77042,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,1
REACTOME_METABOLISM_OF_AMINE...,SET,17,-0.16532,-0.0050283,0.22334,0.77042,REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES,1
WP_SEROTONIN_AND_ANXIETYRELA...,SET,12,-0.21711,-0.0055487,0.29322,0.77048,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,1
GSE7460_TCONV_VS_TREG_LN_DN,SET,181,-0.04851,-0.0047928,0.065515,0.77048,GSE7460_TCONV_VS_TREG_LN_DN,1
HP_ABNORMAL_GASTROINTESTINAL...2,SET,6,-0.2827,-0.0051097,0.38178,0.77049,HP_ABNORMAL_GASTROINTESTINAL_VASCULAR_MORPHOLOGY,1
GSE11924_TH2_VS_TH17_CD4_TCE...2,SET,178,-0.048117,-0.0047148,0.064969,0.77053,GSE11924_TH2_VS_TH17_CD4_TCELL_UP,1
GOMF_NADPH_BINDING,SET,16,-0.13746,-0.0040562,0.18559,0.77056,GOMF_NADPH_BINDING,1
PPARGC1A_TARGET_GENES,SET,79,-0.070435,-0.0046103,0.095051,0.77066,PPARGC1A_TARGET_GENES,1
HP_ABNORMAL_CEREBRAL_VEIN_MO...,SET,8,-0.22687,-0.0047347,0.30613,0.77067,HP_ABNORMAL_CEREBRAL_VEIN_MORPHOLOGY,1
GOBP_BIOLOGICAL_PROCESS_INVO...5,SET,286,-0.038645,-0.0047855,0.052143,0.77069,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,1
ZFHX3_TARGET_GENES,SET,1384,-0.017493,-0.0046183,0.023597,0.77075,ZFHX3_TARGET_GENES,1
HP_ERRATIC_MYOCLONUS,SET,4,-0.27359,-0.0040378,0.36906,0.77075,HP_ERRATIC_MYOCLONUS,1
GSE7460_CD8_TCELL_VS_TREG_AC...1,SET,178,-0.044894,-0.0043989,0.060553,0.77077,GSE7460_CD8_TCELL_VS_TREG_ACT_DN,1
CARM1_TARGET_GENES,SET,8,-0.23756,-0.0049579,0.32035,0.77083,CARM1_TARGET_GENES,1
GSE34006_UNTREATED_VS_A2AR_A...2,SET,176,-0.046588,-0.0045395,0.062814,0.77086,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP,1
HP_BROAD_ALVEOLAR_RIDGES,SET,12,-0.19309,-0.0049348,0.26029,0.7709,HP_BROAD_ALVEOLAR_RIDGES,1
GOBP_TELOMERE_ORGANIZATION,SET,147,-0.048931,-0.0043607,0.065935,0.77098,GOBP_TELOMERE_ORGANIZATION,1
GSE15330_WT_VS_IKAROS_KO_MEG...2,SET,179,-0.045528,-0.0044734,0.061344,0.771,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,1
GOMF_ENDOPEPTIDASE_REGULATOR...,SET,168,-0.054793,-0.0052173,0.073821,0.77102,GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY,1
DESCARTES_FETAL_ADRENAL_SLC2...,SET,32,-0.1137,-0.0047424,0.15317,0.77103,DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS,1
REACTOME_FORMATION_OF_DEFINI...,SET,14,-0.18202,-0.0050243,0.2452,0.77105,REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM,1
MIR6828_3P,SET,107,-0.062632,-0.0047674,0.084362,0.77108,MIR6828_3P,1
GOBP_BIOLOGICAL_PROCESS_INVO...1,SET,190,-0.047467,-0.0048037,0.063933,0.77109,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_HOST,1
GOBP_CARDIOCYTE_DIFFERENTIAT...,SET,142,-0.056021,-0.0049076,0.075442,0.77112,GOBP_CARDIOCYTE_DIFFERENTIATION,1
GOBP_RESPONSE_TO_CORTISOL,SET,6,-0.2946,-0.0053248,0.39671,0.77114,GOBP_RESPONSE_TO_CORTISOL,1
HP_ABNORMALITY_OF_UPPER_LIMB...,SET,489,-0.029571,-0.0047613,0.039801,0.77125,HP_ABNORMALITY_OF_UPPER_LIMB_JOINT,1
GSE43956_WT_VS_SGK1_KO_TH17_...1,SET,179,-0.049146,-0.0048289,0.066136,0.77129,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN,1
REACTOME_REGULATION_OF_GENE_...1,SET,11,-0.19501,-0.0047717,0.26229,0.77139,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,1
GOBP_POSITIVE_REGULATION_OF_...91,SET,6,-0.26847,-0.0048525,0.36105,0.77143,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,1
KEGG_BLADDER_CANCER,SET,40,-0.098576,-0.0045961,0.13255,0.77146,KEGG_BLADDER_CANCER,1
BRCA1_DN.V1_DN,SET,115,-0.061523,-0.0048538,0.082723,0.77147,BRCA1_DN.V1_DN,1
REACTOME_PTK6_REGULATES_RHO_...,SET,14,-0.15668,-0.0043248,0.21065,0.77149,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,1
GAVISH_3CA_METAPROGRAM_FIBRO...15,SET,44,-0.11094,-0.0054246,0.14914,0.77152,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM,1
HP_ABNORMAL_CEREBELLAR_CORTE...,SET,4,-0.25504,-0.0037641,0.34278,0.77157,HP_ABNORMAL_CEREBELLAR_CORTEX_MORPHOLOGY,1
chr6p11,SET,2,-0.48082,-0.0050181,0.64618,0.77159,chr6p11,1
CHEMELLO_SOLEUS_VS_EDL_MYOFI...2,SET,16,-0.15872,-0.0046834,0.21327,0.77162,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,1
NF1_Q6_01,SET,249,-0.041416,-0.0047903,0.055618,0.77175,NF1_Q6_01,1
GOCC_CELL_PROJECTION_MEMBRANE,SET,330,-0.035006,-0.0046508,0.04701,0.77176,GOCC_CELL_PROJECTION_MEMBRANE,1
TURJANSKI_MAPK8_AND_MAPK9_TA...,SET,7,-0.23471,-0.004582,0.31515,0.77178,TURJANSKI_MAPK8_AND_MAPK9_TARGETS,1
MIR136_3P,SET,8,-0.21119,-0.0044075,0.28358,0.77178,MIR136_3P,1
MIR516A_5P,SET,6,-0.25921,-0.004685,0.34798,0.77183,MIR516A_5P,1
GOBP_REGULATION_OF_LONG_TERM...2,SET,12,-0.21923,-0.0056028,0.29426,0.77186,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,1
GSE42021_CD24INT_VS_CD24LOW_...1,SET,175,-0.04955,-0.0048144,0.066487,0.77194,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN,1
GOBP_PORE_COMPLEX_ASSEMBLY,SET,18,-0.15051,-0.0047103,0.20187,0.77203,GOBP_PORE_COMPLEX_ASSEMBLY,1
KEGG_MEDICUS_VARIANT_MLL_ENL...,SET,11,-0.22084,-0.0054039,0.29618,0.77205,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
HP_ABNORMAL_RIB_CAGE_MORPHOL...,SET,339,-0.035144,-0.0047311,0.047126,0.77208,HP_ABNORMAL_RIB_CAGE_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C3_EAR...,SET,592,-0.025637,-0.0045287,0.034379,0.77208,HE_LIM_SUN_FETAL_LUNG_C3_EARLY_CAP_CELL,1
GSE22033_UNTREATED_VS_ROSIGL...1,SET,176,-0.048126,-0.0046893,0.064522,0.77213,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN,1
GSE17721_CPG_VS_GARDIQUIMOD_...12,SET,182,-0.047509,-0.0047066,0.063671,0.77221,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP,1
GSE2770_TGFB_AND_IL4_ACT_VS_...1,SET,176,-0.048153,-0.004692,0.064521,0.77226,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,1
HP_DECREASED_HEAD_CIRCUMFERE...,SET,1163,-0.018838,-0.0045887,0.025238,0.77229,HP_DECREASED_HEAD_CIRCUMFERENCE,1
HP_ABNORMAL_CIRCULATING_CHOL...,SET,138,-0.055785,-0.0048181,0.074722,0.77233,HP_ABNORMAL_CIRCULATING_CHOLESTEROL_CONCENTRATION,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...1,SET,51,-0.095695,-0.0050365,0.12816,0.77237,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,1
GOBP_NEURON_PROJECTION_GUIDA...,SET,217,-0.047682,-0.0051531,0.063854,0.77238,GOBP_NEURON_PROJECTION_GUIDANCE,1
HP_XANTHOMATOSIS,SET,36,-0.11685,-0.005169,0.15647,0.7724,HP_XANTHOMATOSIS,1
LIU_SMARCA4_TARGETS,SET,43,-0.10714,-0.005179,0.14346,0.77242,LIU_SMARCA4_TARGETS,1
GOBP_DEOXYRIBONUCLEOSIDE_MET...,SET,10,-0.21686,-0.0050596,0.29035,0.77243,GOBP_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_INTRIN...,SET,35,-0.096407,-0.0042053,0.12907,0.77244,HP_ABNORMALITY_OF_THE_INTRINSIC_PATHWAY,1
HP_ABNORMAL_TOENAIL_MORPHOLO...,SET,152,-0.051941,-0.0047064,0.069526,0.77249,HP_ABNORMAL_TOENAIL_MORPHOLOGY,1
MIR4436A,SET,77,-0.075461,-0.0048766,0.10098,0.77255,MIR4436A,1
GOBP_NUCLEOBASE_CONTAINING_S...1,SET,15,-0.17234,-0.004924,0.23059,0.77257,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...1,SET,85,-0.062513,-0.0042436,0.083625,0.77262,GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOMF_CYTOSKELETAL_PROTEIN_BI...,SET,909,-0.021607,-0.0046872,0.028895,0.7727,GOMF_CYTOSKELETAL_PROTEIN_BINDING,1
GSE6269_FLU_VS_STAPH_AUREUS_...1,SET,146,-0.053447,-0.0047471,0.07146,0.77274,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN,1
GSE13306_RA_VS_UNTREATED_TRE...2,SET,173,-0.047599,-0.0045986,0.063638,0.77276,GSE13306_RA_VS_UNTREATED_TREG_UP,1
GSE17721_POLYIC_VS_GARDIQUIM...17,SET,180,-0.046029,-0.0045351,0.061537,0.77276,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN,1
REACTOME_TRAFFICKING_OF_AMPA...,SET,29,-0.12212,-0.0048494,0.16325,0.77277,REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,1
GOBP_ESTABLISHMENT_OR_MAINTE...5,SET,11,-0.22103,-0.0054085,0.29546,0.77278,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_TRANSMEMBRANE_ELECTROCHEMICAL_GRADIENT,1
RODRIGUES_THYROID_CARCINOMA_...6,SET,14,-0.19368,-0.0053462,0.25889,0.7728,RODRIGUES_THYROID_CARCINOMA_UP,1
GSE8835_HEALTHY_VS_CLL_CD4_T...2,SET,176,-0.048898,-0.0047646,0.065342,0.77287,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP,1
GOBP_CARDIAC_VENTRICLE_MORPH...,SET,68,-0.086699,-0.0052666,0.11583,0.77292,GOBP_CARDIAC_VENTRICLE_MORPHOGENESIS,1
GOBP_REACTIVE_GLIOSIS,SET,5,-0.32402,-0.0053463,0.43288,0.77292,GOBP_REACTIVE_GLIOSIS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...13,SET,75,-0.067682,-0.004317,0.090403,0.77297,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,1
HP_DEFORMED_SELLA_TURCICA,SET,18,-0.13798,-0.0043183,0.18425,0.77303,HP_DEFORMED_SELLA_TURCICA,1
GOBP_REGULATION_OF_CYTOSKELE...,SET,463,-0.030104,-0.0047199,0.040194,0.77306,GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION,1
TONKS_TARGETS_OF_RUNX1_RUNX1...1,SET,16,-0.16206,-0.004782,0.21634,0.77309,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,1
GOBP_SODIUM_ION_IMPORT_ACROS...,SET,22,-0.13775,-0.0047655,0.18386,0.77313,GOBP_SODIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GSE17974_CTRL_VS_ACT_IL4_AND...14,SET,172,-0.051307,-0.0049427,0.068465,0.77319,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP,1
MIR1_5P,SET,82,-0.071813,-0.0047885,0.095821,0.7732,MIR1_5P,1
GOBP_CYTOPLASMIC_TRANSLATION...2,SET,37,-0.090329,-0.0040509,0.1205,0.77325,GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
GOBP_INFLAMMATORY_RESPONSE,SET,778,-0.024907,-0.0050173,0.033226,0.77326,GOBP_INFLAMMATORY_RESPONSE,1
GOCC_INO80_COMPLEX,SET,16,-0.16382,-0.0048339,0.21853,0.77326,GOCC_INO80_COMPLEX,1
HP_NEUTROPHILIA,SET,21,-0.15329,-0.0051812,0.20445,0.77329,HP_NEUTROPHILIA,1
HP_ANGIOFIBROMAS,SET,31,-0.10621,-0.0043606,0.14165,0.77331,HP_ANGIOFIBROMAS,1
REACTOME_RECRUITMENT_OF_MITO...,SET,74,-0.066835,-0.0042345,0.089131,0.77332,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1
DESCARTES_FETAL_SPLEEN_STC2_...,SET,10,-0.21477,-0.0050109,0.28641,0.77333,DESCARTES_FETAL_SPLEEN_STC2_TLX1_POSITIVE_CELLS,1
GOCC_LUMENAL_SIDE_OF_MEMBRANE,SET,38,-0.10306,-0.0046838,0.13737,0.77344,GOCC_LUMENAL_SIDE_OF_MEMBRANE,1
HP_CEREBELLAR_HEMISPHERE_HYP...,SET,8,-0.20038,-0.0041819,0.26709,0.77344,HP_CEREBELLAR_HEMISPHERE_HYPOPLASIA,1
HP_PERIODIC_PARALYSIS,SET,9,-0.22754,-0.0050365,0.30328,0.77344,HP_PERIODIC_PARALYSIS,1
HP_SIRENOMELIA,SET,11,-0.20603,-0.0050416,0.27452,0.77353,HP_SIRENOMELIA,1
YAO_TEMPORAL_RESPONSE_TO_PRO...14,SET,27,-0.12341,-0.0047289,0.16439,0.77358,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,1
KEGG_PYRUVATE_METABOLISM,SET,38,-0.1028,-0.0046718,0.13693,0.77359,KEGG_PYRUVATE_METABOLISM,1
GOBP_LEYDIG_CELL_DIFFERENTIA...,SET,9,-0.22397,-0.0049576,0.29832,0.7736,GOBP_LEYDIG_CELL_DIFFERENTIATION,1
GOBP_MITOCHONDRIAL_PROTON_TR...,SET,5,-0.30437,-0.0050222,0.40537,0.77363,GOBP_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_ASSEMBLY,1
GSE14769_20MIN_VS_360MIN_LPS...2,SET,177,-0.04571,-0.0044664,0.060873,0.77364,GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP,1
HP_PROMINENT_UMBILICUS,SET,5,-0.30726,-0.0050699,0.40914,0.77367,HP_PROMINENT_UMBILICUS,1
HP_VOCAL_CORD_PARESIS,SET,14,-0.17821,-0.0049191,0.23719,0.77377,HP_VOCAL_CORD_PARESIS,1
GSE40274_FOXP3_VS_FOXP3_AND_...15,SET,151,-0.052171,-0.0047118,0.069425,0.77381,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...736,SET,41,-0.098681,-0.0046581,0.1313,0.77383,GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
HOFMANN_MYELODYSPLASTIC_SYND...3,SET,24,-0.1215,-0.0043899,0.16165,0.77385,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,1
HP_ABSENCE_OF_RENAL_CORTICOM...,SET,6,-0.31416,-0.0056783,0.41788,0.77391,HP_ABSENCE_OF_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
MIR6529_3P,SET,80,-0.076853,-0.005062,0.10219,0.77398,MIR6529_3P,1
GOBP_REGULATION_OF_POSTSYNAP...8,SET,5,-0.32119,-0.0052998,0.42708,0.77399,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
GOMF_CYCLASE_ACTIVATOR_ACTIV...,SET,11,-0.23039,-0.0056377,0.30634,0.774,GOMF_CYCLASE_ACTIVATOR_ACTIVITY,1
PAPASPYRIDONOS_UNSTABLE_ATER...2,SET,51,-0.093644,-0.0049286,0.12449,0.77403,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,1
GOBP_REGULATION_OF_PHOSPHOLI...3,SET,5,-0.33939,-0.0056001,0.45119,0.77404,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_CHOLE...,SET,11,-0.1823,-0.0044609,0.24234,0.77405,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS,1
GOBP_REGULATION_OF_LEUKOCYTE...5,SET,41,-0.10074,-0.0047552,0.1339,0.77407,GOBP_REGULATION_OF_LEUKOCYTE_DEGRANULATION,1
GOBP_POSITIVE_REGULATION_OF_...316,SET,24,-0.14446,-0.0052196,0.192,0.77409,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
MIR6888_5P,SET,45,-0.1037,-0.0051275,0.13782,0.7741,MIR6888_5P,1
GOBP_MEIOTIC_SISTER_CHROMATI...,SET,12,-0.19182,-0.0049024,0.25493,0.7741,GOBP_MEIOTIC_SISTER_CHROMATID_COHESION,1
GOBP_PROTEIN_DESTABILIZATION,SET,45,-0.099326,-0.0049113,0.132,0.77412,GOBP_PROTEIN_DESTABILIZATION,1
HP_CSF_PLEOCYTOSIS,SET,23,-0.12877,-0.0045547,0.17112,0.77412,HP_CSF_PLEOCYTOSIS,1
TGCCTTA_MIR124A,SET,511,-0.028709,-0.0047224,0.038147,0.77415,TGCCTTA_MIR124A,1
GSE13485_CTRL_VS_DAY3_YF17D_...2,SET,151,-0.054219,-0.0048968,0.072034,0.77418,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP,1
HP_RESTRICTIVE_VENTILATORY_D...,SET,90,-0.069453,-0.0048508,0.092269,0.77419,HP_RESTRICTIVE_VENTILATORY_DEFECT,1
GOBP_PEPTIDYL_ARGININE_MODIF...,SET,13,-0.16047,-0.0042684,0.21316,0.77421,GOBP_PEPTIDYL_ARGININE_MODIFICATION,1
HP_ABNORMALITY_OF_CARTILAGE_...,SET,14,-0.17879,-0.0049352,0.23751,0.77421,HP_ABNORMALITY_OF_CARTILAGE_OF_EXTERNAL_EAR,1
GOBP_REGULATION_OF_SULFUR_ME...,SET,12,-0.20653,-0.0052783,0.27434,0.77422,GOBP_REGULATION_OF_SULFUR_METABOLIC_PROCESS,1
HP_DIMINISHED_ABILITY_TO_CON...,SET,9,-0.19021,-0.0042104,0.25265,0.77423,HP_DIMINISHED_ABILITY_TO_CONCENTRATE,1
GOCC_COPII_COATED_ER_TO_GOLG...,SET,84,-0.070287,-0.0047433,0.093354,0.77424,GOCC_COPII_COATED_ER_TO_GOLGI_TRANSPORT_VESICLE,1
ATF3_Q6,SET,229,-0.043819,-0.0048631,0.058193,0.77427,ATF3_Q6,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...3,SET,45,-0.10941,-0.0054102,0.14529,0.77429,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,1
GOCC_ENDODEOXYRIBONUCLEASE_C...,SET,5,-0.25803,-0.0042575,0.34264,0.77429,GOCC_ENDODEOXYRIBONUCLEASE_COMPLEX,1
HP_ABNORMAL_EPIGLOTTIS_MORPH...,SET,20,-0.14422,-0.0047574,0.19149,0.77432,HP_ABNORMAL_EPIGLOTTIS_MORPHOLOGY,1
MIKKELSEN_IPS_HCP_WITH_H3_UN...,SET,77,-0.078904,-0.0050991,0.10475,0.77436,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,1
GCM_NF2,SET,266,-0.036366,-0.0043455,0.048276,0.77436,GCM_NF2,1
LEE_LIVER_CANCER_HEPATOBLAST,SET,15,-0.18521,-0.0052916,0.24585,0.77437,LEE_LIVER_CANCER_HEPATOBLAST,1
GSE15330_MEGAKARYOCYTE_ERYTH...5,SET,178,-0.045328,-0.0044414,0.060164,0.77439,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
GGAANCGGAANY_UNKNOWN,SET,102,-0.058491,-0.0043475,0.077619,0.77444,GGAANCGGAANY_UNKNOWN,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...4,SET,18,-0.15347,-0.0048029,0.20362,0.77448,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY,1
MIR6780A_5P,SET,203,-0.044317,-0.0046342,0.0588,0.77448,MIR6780A_5P,1
REACTOME_BIOSYNTHESIS_OF_MAR...2,SET,6,-0.24244,-0.0043819,0.32164,0.77449,REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS,1
GOBP_POSITIVE_REGULATION_OF_...80,SET,107,-0.065375,-0.0049762,0.086729,0.7745,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,1
REACTOME_TRANSCRIPTIONAL_REG...10,SET,38,-0.1039,-0.0047218,0.13782,0.77453,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1
KEGG_PANCREATIC_CANCER,SET,66,-0.079727,-0.0047716,0.10573,0.77458,KEGG_PANCREATIC_CANCER,1
MILICIC_FAMILIAL_ADENOMATOUS...2,SET,9,-0.23271,-0.0051511,0.30859,0.77461,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,1
WP_BARDETBIEDL_SYNDROME,SET,76,-0.071598,-0.004597,0.094926,0.77465,WP_BARDETBIEDL_SYNDROME,1
GOMF_PROTEIN_KINASE_B_BINDING,SET,10,-0.18128,-0.0042296,0.24034,0.77465,GOMF_PROTEIN_KINASE_B_BINDING,1
GARGALOVIC_RESPONSE_TO_OXIDI...20,SET,10,-0.21964,-0.0051246,0.29119,0.77466,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,1
WP_EFFECT_OF_PROGERIN_ON_GEN...,SET,20,-0.13356,-0.0044057,0.17707,0.77466,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,1
GOBP_EPIGENETIC_PROGRAMING_O...,SET,4,-0.33457,-0.0049378,0.44344,0.77472,GOBP_EPIGENETIC_PROGRAMING_OF_MALE_PRONUCLEUS,1
MIR3160_5P,SET,188,-0.04985,-0.0050185,0.06606,0.77476,MIR3160_5P,1
FERRARI_RESPONSE_TO_FENRETIN...1,SET,5,-0.34188,-0.005641,0.45302,0.77477,FERRARI_RESPONSE_TO_FENRETINIDE_DN,1
GOBP_REGULATION_OF_TRANSLATI...8,SET,5,-0.31374,-0.0051768,0.41571,0.77478,GOBP_REGULATION_OF_TRANSLATION_AT_POSTSYNAPSE,1
GOBP_LUNG_CELL_DIFFERENTIATI...,SET,29,-0.1259,-0.0049995,0.16678,0.77483,GOBP_LUNG_CELL_DIFFERENTIATION,1
GOCC_RUFFLE,SET,172,-0.049201,-0.0047398,0.065174,0.77485,GOCC_RUFFLE,1
HP_SMOOTH_PHILTRUM,SET,159,-0.05043,-0.0046726,0.066799,0.77485,HP_SMOOTH_PHILTRUM,1
GSE17721_POLYIC_VS_PAM3CSK4_...9,SET,179,-0.045917,-0.0045116,0.060823,0.77485,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN,1
DESCARTES_MAIN_FETAL_CILIATE...,SET,450,-0.029705,-0.0045932,0.039349,0.77485,DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS,1
GSE20715_WT_VS_TLR4_KO_6H_OZ...2,SET,183,-0.047214,-0.0046901,0.062532,0.77488,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP,1
GOBP_POSITIVE_REGULATION_OF_...625,SET,230,-0.043372,-0.0048239,0.057431,0.77493,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY,1
LI_ESTROGENE_NON_MCF7_T47D_E...2,SET,15,-0.1653,-0.0047229,0.21887,0.77495,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP,1
HP_ABNORMAL_THUMB_MORPHOLOGY,SET,344,-0.034211,-0.0046388,0.045293,0.77497,HP_ABNORMAL_THUMB_MORPHOLOGY,1
GOBP_RESPONSE_TO_INTERLEUKIN...4,SET,11,-0.22607,-0.005532,0.29926,0.775,GOBP_RESPONSE_TO_INTERLEUKIN_15,1
HP_THICK_UPPER_LIP_VERMILION,SET,20,-0.15478,-0.0051057,0.20489,0.775,HP_THICK_UPPER_LIP_VERMILION,1
MODULE_331,SET,69,-0.075788,-0.0046374,0.10032,0.77502,MODULE_331,1
WP_FTO_OBESITY_VARIANT_MECHA...,SET,8,-0.24404,-0.005093,0.323,0.77503,WP_FTO_OBESITY_VARIANT_MECHANISM,1
HP_MORNING_MYOCLONIC_JERKS,SET,10,-0.22948,-0.0053541,0.30371,0.77505,HP_MORNING_MYOCLONIC_JERKS,1
KEGG_VASCULAR_SMOOTH_MUSCLE_...,SET,109,-0.064463,-0.0049522,0.085303,0.77508,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,1
GOMF_OXYSTEROL_BINDING,SET,16,-0.16801,-0.0049577,0.2223,0.77511,GOMF_OXYSTEROL_BINDING,1
HP_CONGENITAL_GIANT_MELANOCY...,SET,5,-0.25345,-0.004182,0.33532,0.77513,HP_CONGENITAL_GIANT_MELANOCYTIC_NEVUS,1
HP_MYOGLOBINURIA,SET,23,-0.12167,-0.0043036,0.16096,0.77514,HP_MYOGLOBINURIA,1
REACTOME_CONJUGATION_OF_BENZ...,SET,6,-0.36053,-0.0065164,0.47691,0.77516,REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE,1
RAG1_TARGET_GENES,SET,851,-0.022628,-0.0047573,0.029924,0.77522,RAG1_TARGET_GENES,1
GOBP_REGULATION_OF_SYNAPSE_S...1,SET,7,-0.24617,-0.0048057,0.32547,0.77527,GOBP_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY,1
GOBP_INTESTINAL_CHOLESTEROL_...,SET,17,-0.17572,-0.0053444,0.23225,0.77535,GOBP_INTESTINAL_CHOLESTEROL_ABSORPTION,1
GOBP_REGULATION_OF_SYSTEMIC_...5,SET,6,-0.32481,-0.0058709,0.42931,0.77535,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE,1
HP_FOCAL_CLONIC_SEIZURE,SET,39,-0.10412,-0.0047936,0.13761,0.77535,HP_FOCAL_CLONIC_SEIZURE,1
GOBP_REGULATION_OF_EPITHELIA...6,SET,7,-0.28711,-0.0056051,0.37944,0.77537,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
GOBP_PURINE_DEOXYRIBONUCLEOT...3,SET,16,-0.16054,-0.004737,0.21215,0.77538,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
HP_INTELLECTUAL_DISABILITY_P...1,SET,87,-0.065578,-0.0045035,0.086661,0.77539,HP_INTELLECTUAL_DISABILITY_PROFOUND,1
HP_OSTEOMALACIA,SET,22,-0.14811,-0.0051239,0.19572,0.77539,HP_OSTEOMALACIA,1
GOBP_PITUITARY_GLAND_DEVELOP...,SET,39,-0.1177,-0.0054187,0.15553,0.7754,GOBP_PITUITARY_GLAND_DEVELOPMENT,1
WP_KREBS_CYCLE_DISORDERS,SET,13,-0.19104,-0.0050817,0.25241,0.77543,WP_KREBS_CYCLE_DISORDERS,1
HP_FEBRILE_SEIZURE_WITHIN_TH...,SET,123,-0.05963,-0.0048643,0.078784,0.77543,HP_FEBRILE_SEIZURE_WITHIN_THE_AGE_RANGE_OF_3_MONTHS_TO_6_YEARS,1
GOBP_TROPHECTODERMAL_CELL_DI...,SET,19,-0.14783,-0.004753,0.1953,0.77545,GOBP_TROPHECTODERMAL_CELL_DIFFERENTIATION,1
WP_UREA_CYCLE_AND_ASSOCIATED...,SET,23,-0.13346,-0.0047207,0.17631,0.77546,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,1
VANDESLUIS_COMMD1_TARGETS_GR...2,SET,32,-0.13207,-0.005509,0.17444,0.7755,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,1
HP_LEUKONYCHIA,SET,14,-0.18132,-0.0050051,0.23948,0.77551,HP_LEUKONYCHIA,1
HP_NODULAR_GOITER,SET,11,-0.21355,-0.0052255,0.28198,0.77557,HP_NODULAR_GOITER,1
HP_PLATYBASIA,SET,16,-0.18936,-0.0055876,0.24999,0.77561,HP_PLATYBASIA,1
HP_FOOD_ALLERGY,SET,15,-0.17251,-0.0049289,0.22774,0.77562,HP_FOOD_ALLERGY,1
MIR3116,SET,87,-0.068553,-0.0047078,0.090494,0.77563,MIR3116,1
GOBP_SISTER_CHROMATID_COHESI...,SET,42,-0.095571,-0.0045658,0.12616,0.77563,GOBP_SISTER_CHROMATID_COHESION,1
HP_ABNORMAL_CIRCULATING_NON_...,SET,21,-0.14252,-0.0048173,0.18813,0.77563,HP_ABNORMAL_CIRCULATING_NON_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,1
GSE27786_LIN_NEG_VS_CD4_TCEL...2,SET,180,-0.046423,-0.004574,0.061276,0.77565,GSE27786_LIN_NEG_VS_CD4_TCELL_UP,1
GOMF_GAMMA_CATENIN_BINDING,SET,12,-0.19971,-0.0051041,0.26357,0.77569,GOMF_GAMMA_CATENIN_BINDING,1
DORN_ADENOVIRUS_INFECTION_12...2,SET,23,-0.12845,-0.0045435,0.16951,0.7757,DORN_ADENOVIRUS_INFECTION_12HR_UP,1
MIR3118,SET,70,-0.079526,-0.0049011,0.10494,0.77572,MIR3118,1
HP_EYE_POKING,SET,5,-0.29349,-0.0048427,0.38725,0.77573,HP_EYE_POKING,1
HP_ABNORMALITY_OF_THE_INNER_...,SET,79,-0.073375,-0.0048027,0.096813,0.77574,HP_ABNORMALITY_OF_THE_INNER_EAR,1
HE_LIM_SUN_FETAL_LUNG_C2_PDC...,SET,132,-0.058464,-0.0049394,0.077138,0.77574,HE_LIM_SUN_FETAL_LUNG_C2_PDC_CELL,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...1,SET,9,-0.18906,-0.0041848,0.24938,0.77581,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY,1
HP_ABNORMAL_PALM_MORPHOLOGY,SET,445,-0.031265,-0.0048081,0.041235,0.77583,HP_ABNORMAL_PALM_MORPHOLOGY,1
GCM_BNIP1,SET,67,-0.074457,-0.0044896,0.098174,0.77589,GCM_BNIP1,1
GOBP_L_KYNURENINE_METABOLIC_...,SET,5,-0.32598,-0.0053787,0.42978,0.77591,GOBP_L_KYNURENINE_METABOLIC_PROCESS,1
GOBP_TELOMERE_MAINTENANCE,SET,142,-0.050887,-0.0044579,0.067086,0.77593,GOBP_TELOMERE_MAINTENANCE,1
GOMF_CARBOHYDRATE_TRANSMEMBR...,SET,36,-0.11693,-0.0051726,0.15415,0.77593,GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE9946_MATURE_STIMULATORY_V...1,SET,114,-0.062993,-0.0049483,0.083035,0.77596,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN,1
HP_PROGRESSIVE_SPASTIC_PARAP...2,SET,26,-0.1247,-0.0046891,0.16436,0.77597,HP_PROGRESSIVE_SPASTIC_PARAPLEGIA,1
HP_THIN_SKIN,SET,83,-0.068938,-0.0046246,0.090866,0.77597,HP_THIN_SKIN,1
MIR377_3P,SET,216,-0.043801,-0.0047228,0.057721,0.77602,MIR377_3P,1
GOMF_AMMONIUM_TRANSMEMBRANE_...,SET,12,-0.19176,-0.0049009,0.25269,0.77603,GOMF_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE27241_WT_VS_RORGT_KO_TH17...2,SET,164,-0.051013,-0.0047997,0.067221,0.77603,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN,1
HP_CEREBRAL_HAMARTOMA,SET,18,-0.13938,-0.0043619,0.1836,0.7761,HP_CEREBRAL_HAMARTOMA,1
SCHERER_PBMC_YF_VAX_AGE_18_4...2,SET,317,-0.036803,-0.0047939,0.048477,0.77612,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,1
HALLMARK_COMPLEMENT,SET,191,-0.048688,-0.00494,0.064129,0.77613,HALLMARK_COMPLEMENT,1
AGCACTT_MIR93_MIR302A_MIR302...,SET,318,-0.036603,-0.0047753,0.048194,0.77622,AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D,1
REACTOME_INTERLEUKIN_18_SIGN...,SET,8,-0.2526,-0.0052717,0.33256,0.77623,REACTOME_INTERLEUKIN_18_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...353,SET,4,-0.36592,-0.0054004,0.48166,0.77628,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,1
GGCAGCT_MIR22,SET,209,-0.044485,-0.0047192,0.058549,0.77631,GGCAGCT_MIR22,1
GOMF_THIOESTERASE_BINDING,SET,9,-0.19369,-0.0042873,0.25488,0.77634,GOMF_THIOESTERASE_BINDING,1
REACTOME_TNFR1_MEDIATED_CERA...,SET,5,-0.26565,-0.0043832,0.34955,0.77635,REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION,1
GOBP_REGULATION_OF_LYMPHOCYT...3,SET,25,-0.13837,-0.0051024,0.18208,0.77635,GOBP_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,1
HP_BLEPHAROPHIMOSIS,SET,111,-0.064032,-0.0049637,0.084258,0.77635,HP_BLEPHAROPHIMOSIS,1
GOMF_PROTEIN_METHYLTRANSFERA...,SET,80,-0.070568,-0.004648,0.092854,0.77636,GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY,1
HP_ABNORMAL_UPPER_LIMB_BONE_...,SET,398,-0.033063,-0.004815,0.043491,0.77644,HP_ABNORMAL_UPPER_LIMB_BONE_MORPHOLOGY,1
TRAVAGLINI_LUNG_CLASSICAL_MO...,SET,248,-0.042625,-0.0049204,0.056058,0.77648,TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL,1
GOBP_POSITIVE_REGULATION_OF_...507,SET,58,-0.091564,-0.0051383,0.12041,0.77649,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,1
BROWNE_HCMV_INFECTION_30MIN_...1,SET,126,-0.058004,-0.0047887,0.076277,0.7765,BROWNE_HCMV_INFECTION_30MIN_DN,1
GOBP_PURINE_NUCLEOSIDE_CATAB...,SET,7,-0.25033,-0.004887,0.32916,0.77652,GOBP_PURINE_NUCLEOSIDE_CATABOLIC_PROCESS,1
KONG_E2F1_TARGETS,SET,8,-0.21372,-0.0044603,0.28098,0.77656,KONG_E2F1_TARGETS,1
WANG_TUMOR_INVASIVENESS_UP,SET,362,-0.033163,-0.0046105,0.043598,0.77656,WANG_TUMOR_INVASIVENESS_UP,1
GOMF_LAMININ_1_BINDING,SET,7,-0.29775,-0.0058127,0.39134,0.77662,GOMF_LAMININ_1_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...791,SET,7,-0.24092,-0.0047033,0.31664,0.77663,GOBP_POSITIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,1
MANNO_MIDBRAIN_NEUROTYPES_HN...1,SET,619,-0.028425,-0.0051305,0.037352,0.77666,MANNO_MIDBRAIN_NEUROTYPES_HNBGABA,1
GOCC_SERINE_TYPE_ENDOPEPTIDA...,SET,11,-0.24285,-0.0059425,0.31911,0.77667,GOCC_SERINE_TYPE_ENDOPEPTIDASE_COMPLEX,1
HP_SPARSE_EYEBROW,SET,121,-0.057117,-0.0046215,0.075036,0.77672,HP_SPARSE_EYEBROW,1
WP_MITOCHONDRIAL_FATTY_ACID_...2,SET,12,-0.20305,-0.0051894,0.26672,0.77675,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,1
GOBP_POSITIVE_REGULATION_OF_...694,SET,9,-0.24085,-0.0053313,0.31638,0.77675,GOBP_POSITIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
REACTOME_TBC_RABGAPS,SET,40,-0.092198,-0.0042987,0.12109,0.77679,REACTOME_TBC_RABGAPS,1
HP_BLIND_VAGINA,SET,2,-0.46864,-0.004891,0.6155,0.77679,HP_BLIND_VAGINA,1
GSE35543_IN_VIVO_NTREG_VS_IN...2,SET,169,-0.055536,-0.0053037,0.072922,0.77684,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP,1
GSE17721_12H_VS_24H_POLYIC_B...2,SET,178,-0.048832,-0.0047848,0.064115,0.77686,GSE17721_12H_VS_24H_POLYIC_BMDC_UP,1
GOBP_EXTRACELLULAR_TRANSPORT,SET,38,-0.095554,-0.0043426,0.12542,0.77693,GOBP_EXTRACELLULAR_TRANSPORT,1
CIC_TARGET_GENES,SET,376,-0.033504,-0.0047452,0.043964,0.77698,CIC_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...614,SET,178,-0.048794,-0.0047811,0.064027,0.77699,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
GSE15930_NAIVE_VS_48H_IN_VIT...6,SET,187,-0.047899,-0.0048094,0.062841,0.77703,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
GSE16386_IL4_VS_IL4_AND_ROSI...1,SET,173,-0.049955,-0.0048263,0.065532,0.77706,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN,1
HP_MYOKYMIA,SET,18,-0.13826,-0.004327,0.18134,0.7771,HP_MYOKYMIA,1
HP_ENLARGEMENT_OF_THE_WRISTS,SET,6,-0.29007,-0.005243,0.3804,0.77713,HP_ENLARGEMENT_OF_THE_WRISTS,1
HP_ABNORMAL_PENIS_MORPHOLOGY,SET,559,-0.027567,-0.0047364,0.036149,0.77714,HP_ABNORMAL_PENIS_MORPHOLOGY,1
DESCARTES_FETAL_PANCREAS_ACI...,SET,68,-0.087749,-0.0053304,0.11507,0.77714,DESCARTES_FETAL_PANCREAS_ACINAR_CELLS,1
GAO_LARGE_INTESTINE_ADULT_CG...,SET,42,-0.11341,-0.0054179,0.1487,0.77716,GAO_LARGE_INTESTINE_ADULT_CG_GOBLET_CELL_SUBTYPE_2,1
REACTOME_ORC1_REMOVAL_FROM_C...,SET,68,-0.07179,-0.0043609,0.094121,0.77719,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,1
REACTOME_RAS_ACTIVATION_UPON...,SET,19,-0.15088,-0.0048513,0.19779,0.77721,REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR,1
REACTOME_TIE2_SIGNALING,SET,18,-0.14485,-0.0045333,0.18986,0.77724,REACTOME_TIE2_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...539,SET,127,-0.059138,-0.0049015,0.077513,0.77725,GOBP_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,1
MIR6849_5P,SET,28,-0.13577,-0.0052981,0.17791,0.77731,MIR6849_5P,1
WP_MONOAMINE_GPCRS,SET,32,-0.12426,-0.005183,0.1628,0.77733,WP_MONOAMINE_GPCRS,1
AGGGCCA_MIR328,SET,68,-0.07796,-0.0047357,0.10215,0.77733,AGGGCCA_MIR328,1
GSE3982_MAST_CELL_VS_MAC_DN,SET,171,-0.050023,-0.0048051,0.065535,0.77735,GSE3982_MAST_CELL_VS_MAC_DN,1
GOBP_IMP_CATABOLIC_PROCESS,SET,5,-0.29837,-0.0049232,0.39089,0.77736,GOBP_IMP_CATABOLIC_PROCESS,1
HOEK_B_CELL_2011_2012_TIV_AD...4,SET,6,-0.30006,-0.0054235,0.39306,0.77738,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_DN,1
GOBP_PURINE_DEOXYRIBONUCLEOT...2,SET,10,-0.2037,-0.0047527,0.26676,0.77745,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,1
GOBP_OMEGA_HYDROXYLASE_P450_...,SET,11,-0.2156,-0.0052756,0.28227,0.7775,GOBP_OMEGA_HYDROXYLASE_P450_PATHWAY,1
GSE33425_CD161_HIGH_VS_INT_C...2,SET,186,-0.04797,-0.0048038,0.062805,0.7775,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP,1
WP_OMEGA6FATTY_ACIDS_IN_SENE...,SET,55,-0.089314,-0.0048811,0.11692,0.77753,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,1
HP_SPARSE_BONE_TRABECULAE,SET,4,-0.34161,-0.0050417,0.44719,0.77753,HP_SPARSE_BONE_TRABECULAE,1
GOBP_LIMBIC_SYSTEM_DEVELOPME...,SET,118,-0.063874,-0.0051042,0.083606,0.77756,GOBP_LIMBIC_SYSTEM_DEVELOPMENT,1
GSE18791_CTRL_VS_NEWCASTLE_V...20,SET,180,-0.046034,-0.0045357,0.060246,0.77759,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP,1
MIR1206,SET,105,-0.063796,-0.0048107,0.083489,0.7776,MIR1206,1
MIR130B_5P,SET,175,-0.050713,-0.0049275,0.066358,0.77763,MIR130B_5P,1
HP_TORSADE_DE_POINTES,SET,24,-0.1375,-0.0049681,0.1799,0.77766,HP_TORSADE_DE_POINTES,1
KEGG_MEDICUS_REFERENCE_GLYCO...5,SET,5,-0.25943,-0.0042806,0.33927,0.77776,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE,1
MIR582_5P,SET,326,-0.037194,-0.004912,0.048628,0.77782,MIR582_5P,1
REACTOME_FORMATION_OF_FIBRIN...,SET,36,-0.12237,-0.0054133,0.15996,0.77786,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,1
GOBP_MALE_SEX_DETERMINATION,SET,11,-0.21743,-0.0053205,0.28421,0.77787,GOBP_MALE_SEX_DETERMINATION,1
MIR369_3P,SET,276,-0.040141,-0.0048845,0.052454,0.77794,MIR369_3P,1
HP_ABNORMALITY_OF_THUMB_PHAL...,SET,171,-0.048846,-0.004692,0.063816,0.77798,HP_ABNORMALITY_OF_THUMB_PHALANX,1
NIKOLSKY_BREAST_CANCER_12Q13...,SET,42,-0.16883,-0.0080655,0.22056,0.778,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,1
GSE21927_UNTREATED_VS_GMCSF_...1,SET,163,-0.05161,-0.0048412,0.067421,0.778,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
REACTOME_CLASS_A_1_RHODOPSIN...,SET,299,-0.042286,-0.0053521,0.05523,0.77804,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1
GOMF_UBIQUITIN_LIKE_LIGASE_S...,SET,53,-0.091915,-0.0049313,0.12001,0.77812,GOMF_UBIQUITIN_LIKE_LIGASE_SUBSTRATE_ADAPTOR_ACTIVITY,1
GOBP_NEURON_MIGRATION,SET,166,-0.054022,-0.0051134,0.07052,0.77817,GOBP_NEURON_MIGRATION,1
HP_FINGER_SYMPHALANGISM,SET,11,-0.20812,-0.0050926,0.27168,0.77817,HP_FINGER_SYMPHALANGISM,1
HP_ABSENT_PUBIC_HAIR,SET,8,-0.24898,-0.0051961,0.32496,0.77821,HP_ABSENT_PUBIC_HAIR,1
SNAPC2_TARGET_GENES,SET,4,-0.28379,-0.0041884,0.37033,0.77825,SNAPC2_TARGET_GENES,1
GOBP_NEUROTRANSMITTER_RECEPT...4,SET,9,-0.24111,-0.0053368,0.31453,0.77833,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_ENDOSOME_TO_POSTSYNAPTIC_MEMBRANE,1
HP_HAMARTOMATOUS_POLYPOSIS,SET,14,-0.16579,-0.0045762,0.21627,0.77833,HP_HAMARTOMATOUS_POLYPOSIS,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...2,SET,5,-0.35083,-0.0057887,0.45759,0.77836,GOBP_GAMMA_AMINOBUTYRIC_ACID_IMPORT,1
GOBP_PURINE_NUCLEOSIDE_TRANS...,SET,5,-0.30952,-0.0051072,0.40361,0.77842,GOBP_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,1
GSE36078_WT_VS_IL1R_KO_LUNG_...1,SET,184,-0.050789,-0.0050589,0.066226,0.77842,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN,1
GOMF_SERINE_TYPE_ENDOPEPTIDA...,SET,92,-0.079532,-0.0056157,0.10369,0.77846,GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
GOBP_EPITHELIAL_TUBE_BRANCHI...,SET,30,-0.12591,-0.0050855,0.16414,0.77848,GOBP_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,1
HP_CHIARI_TYPE_I_MALFORMATION,SET,41,-0.098671,-0.0046576,0.12862,0.7785,HP_CHIARI_TYPE_I_MALFORMATION,1
REACTOME_PTK6_PROMOTES_HIF1A...,SET,6,-0.2928,-0.0052922,0.38161,0.77854,REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION,1
DESCARTES_FETAL_KIDNEY_ERYTH...,SET,129,-0.059519,-0.0049714,0.077561,0.77857,DESCARTES_FETAL_KIDNEY_ERYTHROBLASTS,1
MIR4477A,SET,329,-0.036214,-0.0048041,0.047184,0.77861,MIR4477A,1
GSE41176_WT_VS_TAK1_KO_ANTI_...3,SET,170,-0.050907,-0.0048758,0.06631,0.77867,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN,1
KEGG_MEDICUS_REFERENCE_FASLG...,SET,5,-0.33045,-0.0054524,0.43033,0.77872,KEGG_MEDICUS_REFERENCE_FASLG_RIPK1_3_SIGNALING_PATHWAY,1
LI_PBMC_MENACTRA_AGE_18_45YO...2,SET,15,-0.18204,-0.005201,0.23704,0.77873,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN,1
MIR5589_5P,SET,67,-0.080079,-0.0048287,0.10428,0.77874,MIR5589_5P,1
HP_SEVERE_GLOBAL_DEVELOPMENT...,SET,197,-0.045289,-0.004666,0.058968,0.77876,HP_SEVERE_GLOBAL_DEVELOPMENTAL_DELAY,1
GOBP_LONG_CHAIN_FATTY_ACID_I...,SET,10,-0.20885,-0.0048728,0.2719,0.77878,GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_GLYCOGEN_BINDING,SET,7,-0.26848,-0.0052413,0.34944,0.77884,GOMF_GLYCOGEN_BINDING,1
HP_LEFT_VENTRICULAR_NONCOMPA...,SET,9,-0.24984,-0.0055301,0.32509,0.7789,HP_LEFT_VENTRICULAR_NONCOMPACTION_CARDIOMYOPATHY,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...1,SET,117,-0.066675,-0.0053055,0.086741,0.77895,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL,1
GOBP_POSITIVE_REGULATION_OF_...172,SET,7,-0.2813,-0.0054915,0.3659,0.77898,GOBP_POSITIVE_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_COA_TRANS...,SET,7,-0.2813,-0.0054915,0.3659,0.77898,GOBP_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,1
GOMF_BILE_ACID_SODIUM_SYMPOR...,SET,5,-0.25275,-0.0041705,0.32873,0.77902,GOMF_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_ESTROGEN_BIOSYNTHETIC_P...,SET,11,-0.19676,-0.0048148,0.25583,0.77908,GOBP_ESTROGEN_BIOSYNTHETIC_PROCESS,1
GSE17721_PAM3CSK4_VS_CPG_4H_...2,SET,177,-0.046723,-0.0045654,0.06075,0.77908,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP,1
MYLLYKANGAS_AMPLIFICATION_HO...10,SET,14,-0.16226,-0.0044789,0.21096,0.77909,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,1
HP_LOWER_LIMB_SPASTICITY,SET,189,-0.046897,-0.0047336,0.060969,0.77911,HP_LOWER_LIMB_SPASTICITY,1
HP_TOE_SYNDACTYLY,SET,199,-0.046872,-0.0048533,0.060927,0.77914,HP_TOE_SYNDACTYLY,1
GOBP_REGULATION_OF_DNA_BINDI...2,SET,319,-0.037325,-0.004877,0.048501,0.77922,GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOBP_CRANIOFACIAL_SUTURE_MOR...,SET,19,-0.16715,-0.0053743,0.21716,0.77926,GOBP_CRANIOFACIAL_SUTURE_MORPHOGENESIS,1
HP_INTESTINAL_HYPOPLASIA,SET,19,-0.15054,-0.0048402,0.19558,0.77926,HP_INTESTINAL_HYPOPLASIA,1
MIR655_5P,SET,75,-0.0804,-0.0051281,0.10445,0.77927,MIR655_5P,1
HP_DELAYED_ABILITY_TO_ROLL_O...,SET,14,-0.1549,-0.0042759,0.20123,0.77928,HP_DELAYED_ABILITY_TO_ROLL_OVER,1
THUM_MIR21_TARGETS_HEART_DIS...2,SET,16,-0.17627,-0.0052014,0.22895,0.77932,THUM_MIR21_TARGETS_HEART_DISEASE_UP,1
GOBP_NUCLEOBASE_BIOSYNTHETIC...,SET,15,-0.16292,-0.004655,0.2116,0.77934,GOBP_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
ZMYM2_TARGET_GENES,SET,109,-0.064078,-0.0049226,0.083216,0.77935,ZMYM2_TARGET_GENES,1
WEI_MYCN_TARGETS_WITH_E_BOX,SET,723,-0.02402,-0.0046718,0.031193,0.77936,WEI_MYCN_TARGETS_WITH_E_BOX,1
HP_ELEVATED_CIRCULATING_CALC...,SET,22,-0.12771,-0.0044183,0.16583,0.77939,HP_ELEVATED_CIRCULATING_CALCITONIN_CONCENTRATION,1
FULLER_PBMC_F_TULARENSIS_VAC...3,SET,37,-0.10327,-0.0046313,0.13409,0.77939,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...40,SET,142,-0.056141,-0.0049182,0.072892,0.7794,HP_APLASIA_HYPOPLASIA_OF_THE_LUNGS,1
HEBERT_MATRISOME_TNBC_BONE_M...2,SET,4,-0.35369,-0.00522,0.45914,0.77945,HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED,1
BIOCARTA_CIRCADIAN_PATHWAY,SET,5,-0.33596,-0.0055435,0.43605,0.77948,BIOCARTA_CIRCADIAN_PATHWAY,1
GSE18791_CTRL_VS_NEWCASTLE_V...10,SET,186,-0.044776,-0.0044838,0.058077,0.77963,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...48,SET,6,-0.28528,-0.0051564,0.37001,0.77964,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY,1
KAECH_NAIVE_VS_DAY8_EFF_CD8_...2,SET,185,-0.046776,-0.0046717,0.060667,0.77965,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP,1
JONES_OVARY_ENDOTHELIAL,SET,144,-0.060461,-0.0053335,0.078417,0.77965,JONES_OVARY_ENDOTHELIAL,1
GSE11961_MEMORY_BCELL_DAY7_V...6,SET,180,-0.048689,-0.0047973,0.063141,0.77968,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,1
MATTIOLI_MGUS_VS_PCL,SET,91,-0.070685,-0.004964,0.091637,0.77975,MATTIOLI_MGUS_VS_PCL,1
GOBP_REGULATION_OF_ACROSOME_...,SET,18,-0.16629,-0.0052043,0.21556,0.77977,GOBP_REGULATION_OF_ACROSOME_REACTION,1
GOBP_REGULATION_OF_SYNAPTIC_...3,SET,8,-0.23573,-0.0049195,0.30552,0.77981,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
GSE13887_RESTING_VS_NO_TREAT...2,SET,113,-0.065353,-0.0051112,0.084697,0.77982,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP,1
GSE22886_DAY0_VS_DAY7_MONOCY...1,SET,182,-0.04895,-0.0048494,0.063432,0.77985,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN,1
GOBP_DEOXYRIBONUCLEOSIDE_CAT...,SET,6,-0.31695,-0.0057287,0.41068,0.77986,GOBP_DEOXYRIBONUCLEOSIDE_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_MITOCHOND...15,SET,23,-0.12318,-0.004357,0.15958,0.77991,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
GSE27859_MACROPHAGE_VS_DC_DN,SET,170,-0.050402,-0.0048274,0.065296,0.77991,GSE27859_MACROPHAGE_VS_DC_DN,1
NFAT_Q6,SET,217,-0.047086,-0.0050887,0.060977,0.78,NFAT_Q6,1
HP_THYMOMA,SET,5,-0.2876,-0.0047455,0.37238,0.78003,HP_THYMOMA,1
GAVISH_3CA_MALIGNANT_METAPRO...19,SET,45,-0.10802,-0.0053413,0.13983,0.78009,GAVISH_3CA_MALIGNANT_METAPROGRAM_28_OLIGO_NORMAL,1
GOBP_PHENOL_CONTAINING_COMPO...3,SET,103,-0.071252,-0.0053218,0.092227,0.78011,GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_EPICANTHUS,SET,527,-0.028459,-0.0047519,0.036832,0.78014,HP_EPICANTHUS,1
MIR183_3P,SET,186,-0.049132,-0.0049201,0.06358,0.78016,MIR183_3P,1
GSE37416_0H_VS_24H_F_TULAREN...1,SET,177,-0.049374,-0.0048244,0.06389,0.78017,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
MIR6722_3P,SET,161,-0.051592,-0.0048101,0.06673,0.78028,MIR6722_3P,1
GOBP_PLATELET_DEGRANULATION,SET,7,-0.27982,-0.0054628,0.36185,0.78032,GOBP_PLATELET_DEGRANULATION,1
chr9q32,SET,31,-0.20137,-0.0082673,0.26039,0.78033,chr9q32,1
GOCC_MMXD_COMPLEX,SET,3,-0.34264,-0.0043795,0.44296,0.78039,GOCC_MMXD_COMPLEX,1
REACTOME_RRNA_MODIFICATION_I...1,SET,4,-0.35434,-0.0052295,0.45802,0.78042,REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION,1
GSE24814_STAT5_KO_VS_WT_PRE_...2,SET,175,-0.052951,-0.0051449,0.068444,0.78042,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP,1
HP_ABNORMALITY_OF_THE_MITOCH...,SET,190,-0.044195,-0.0044726,0.057116,0.78046,HP_ABNORMALITY_OF_THE_MITOCHONDRION,1
LINDGREN_BLADDER_CANCER_CLUS...6,SET,205,-0.045649,-0.0047966,0.058994,0.78047,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,1
HAY_BONE_MARROW_PRE_DENDRITIC,SET,5,-0.30566,-0.0050435,0.39496,0.7805,HAY_BONE_MARROW_PRE_DENDRITIC,1
TTGGGAG_MIR150,SET,82,-0.071072,-0.0047391,0.091825,0.78053,TTGGGAG_MIR150,1
REACTOME_UB_SPECIFIC_PROCESS...,SET,148,-0.050739,-0.0045371,0.065549,0.78054,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1
GOBP_NEGATIVE_REGULATION_OF_...625,SET,4,-0.35293,-0.0052087,0.45588,0.78058,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,1
BUSSLINGER_DUODENAL_GOBLET_C...,SET,15,-0.19785,-0.0056528,0.25552,0.78062,BUSSLINGER_DUODENAL_GOBLET_CELLS,1
SANA_TNF_SIGNALING_UP,SET,79,-0.08088,-0.005294,0.10444,0.78066,SANA_TNF_SIGNALING_UP,1
HP_OSTEOCHONDROSIS,SET,12,-0.19828,-0.0050674,0.25601,0.78068,HP_OSTEOCHONDROSIS,1
GOBP_NEGATIVE_REGULATION_OF_...182,SET,28,-0.12884,-0.0050277,0.16629,0.78076,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING,1
GSE16451_IMMATURE_VS_MATURE_...1,SET,180,-0.047584,-0.0046884,0.061415,0.78076,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,1
GSE21063_3H_VS_16H_ANTI_IGM_...2,SET,179,-0.050953,-0.0050065,0.065757,0.78078,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP,1
HP_RECTAL_FISTULA,SET,23,-0.1403,-0.0049628,0.18105,0.78081,HP_RECTAL_FISTULA,1
HP_FAILURE_OF_ERUPTION_OF_PE...,SET,5,-0.33313,-0.0054967,0.42983,0.78083,HP_FAILURE_OF_ERUPTION_OF_PERMANENT_TEETH,1
GOBP_ANTIFUNGAL_HUMORAL_RESP...,SET,4,-0.36485,-0.0053847,0.47068,0.78087,GOBP_ANTIFUNGAL_HUMORAL_RESPONSE,1
GSE15330_LYMPHOID_MULTIPOTEN...10,SET,182,-0.048703,-0.0048249,0.062826,0.78088,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP,1
GOBP_PURINE_RIBONUCLEOTIDE_S...,SET,7,-0.26042,-0.0050841,0.33592,0.7809,GOBP_PURINE_RIBONUCLEOTIDE_SALVAGE,1
ZAIDI_OSTEOBLAST_TRANSCRIPTI...,SET,13,-0.20997,-0.0055853,0.2708,0.78093,ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,1
GOBP_ACETYL_COA_METABOLIC_PR...,SET,30,-0.12427,-0.0050194,0.16026,0.78095,GOBP_ACETYL_COA_METABOLIC_PROCESS,1
HP_SUBARACHNOID_HEMORRHAGE,SET,36,-0.11846,-0.0052405,0.15276,0.78096,HP_SUBARACHNOID_HEMORRHAGE,1
GOBP_CARDIAC_CONDUCTION,SET,91,-0.075895,-0.0053299,0.097854,0.781,GOBP_CARDIAC_CONDUCTION,1
HP_ABNORMALITY_OF_LOWER_LIMB...,SET,639,-0.026681,-0.0048903,0.034392,0.78106,HP_ABNORMALITY_OF_LOWER_LIMB_JOINT,1
BIOCARTA_DNAFRAGMENT_PATHWAY,SET,10,-0.25256,-0.0058927,0.32544,0.78114,BIOCARTA_DNAFRAGMENT_PATHWAY,1
GSE30971_2H_VS_4H_LPS_STIM_M...4,SET,184,-0.047814,-0.0047625,0.061607,0.78115,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP,1
MIR4254,SET,92,-0.0686,-0.0048438,0.088386,0.78116,MIR4254,1
MSX1_01,SET,158,-0.056489,-0.0052177,0.07276,0.78123,MSX1_01,1
GSE1791_CTRL_VS_NEUROMEDINU_...3,SET,141,-0.058361,-0.0050947,0.075163,0.78125,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN,1
HP_ABNORMALITY_OF_SKULL_OSSI...,SET,46,-0.097249,-0.0048617,0.12524,0.78127,HP_ABNORMALITY_OF_SKULL_OSSIFICATION,1
BIOCARTA_PARKIN_PATHWAY,SET,7,-0.24746,-0.004831,0.31865,0.7813,BIOCARTA_PARKIN_PATHWAY,1
PID_HIF2PATHWAY,SET,30,-0.11388,-0.0045994,0.14663,0.78131,PID_HIF2PATHWAY,1
DESCARTES_FETAL_PANCREAS_LYM...1,SET,41,-0.11092,-0.0052358,0.14281,0.78133,DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS,1
MENON_FETAL_KIDNEY_10_IMMUNE...,SET,71,-0.08075,-0.0050118,0.10393,0.78141,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,1
MIR208B_3P,SET,39,-0.10904,-0.00502,0.14024,0.78156,MIR208B_3P,1
GOMF_S100_PROTEIN_BINDING,SET,14,-0.18367,-0.00507,0.23624,0.78156,GOMF_S100_PROTEIN_BINDING,1
MIR4300,SET,57,-0.08577,-0.0047716,0.11031,0.78158,MIR4300,1
HP_APLASIA_HYPOPLASIA_INVOLV...15,SET,42,-0.11058,-0.0052827,0.1422,0.7816,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETAL_MUSCULATURE,1
GOBP_TRNA_MODIFICATION,SET,83,-0.065875,-0.0044192,0.084694,0.78165,GOBP_TRNA_MODIFICATION,1
WP_RELATIONSHIP_BETWEEN_INFL...,SET,25,-0.13651,-0.005034,0.17548,0.78169,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,1
HP_ABNORMALITY_OF_PRENATAL_D...,SET,881,-0.022538,-0.0048172,0.028972,0.78169,HP_ABNORMALITY_OF_PRENATAL_DEVELOPMENT_OR_BIRTH,1
GSE15659_NAIVE_CD4_TCELL_VS_...4,SET,160,-0.050904,-0.0047313,0.065434,0.78169,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,1
MIR4295,SET,353,-0.03582,-0.0049189,0.046029,0.78177,MIR4295,1
REACTOME_GLYCOGEN_BREAKDOWN_...,SET,11,-0.16913,-0.0041386,0.21731,0.78179,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,1
GSE18791_UNSTIM_VS_NEWCATSLE...3,SET,154,-0.054892,-0.0050062,0.070532,0.78179,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN,1
MIR6889_3P,SET,100,-0.069399,-0.0051078,0.089167,0.7818,MIR6889_3P,1
GOBP_CELLULAR_RESPONSE_TO_ET...1,SET,12,-0.19155,-0.0048954,0.24608,0.78182,GOBP_CELLULAR_RESPONSE_TO_ETHANOL,1
GOCC_NMDA_SELECTIVE_GLUTAMAT...,SET,9,-0.23126,-0.0051189,0.29708,0.78184,GOCC_NMDA_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,1
GOBP_NUCLEOTIDE_TRANSPORT,SET,44,-0.10894,-0.0053269,0.13994,0.78187,GOBP_NUCLEOTIDE_TRANSPORT,1
HP_DECREASED_CIRCULATING_IRO...,SET,5,-0.25981,-0.0042869,0.33369,0.78189,HP_DECREASED_CIRCULATING_IRON_CONCENTRATION,1
GOBP_NUCLEOLUS_ORGANIZATION,SET,14,-0.15985,-0.0044125,0.2053,0.7819,GOBP_NUCLEOLUS_ORGANIZATION,1
HP_ATROPHY_DEGENERATION_AFFE...3,SET,591,-0.02676,-0.0047233,0.034365,0.78192,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CEREBRUM,1
GOBP_URETERIC_BUD_FORMATION,SET,5,-0.33529,-0.0055324,0.43056,0.78193,GOBP_URETERIC_BUD_FORMATION,1
GSE3400_UNTREATED_VS_IFNB_TR...2,SET,167,-0.050521,-0.0047963,0.064875,0.78193,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP,1
GOMF_AMIDE_TRANSMEMBRANE_TRA...,SET,34,-0.11979,-0.00515,0.1538,0.78195,GOMF_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_SPERM_HEAD_MORPH...,SET,26,-0.13593,-0.0051115,0.17453,0.78195,HP_ABNORMAL_SPERM_HEAD_MORPHOLOGY,1
REACTOME_MULTIFUNCTIONAL_ANI...,SET,9,-0.22136,-0.0048997,0.28421,0.78196,REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS,1
GOBP_REGULATION_OF_MACROPHAG...5,SET,23,-0.14683,-0.0051935,0.18852,0.78196,GOBP_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
TAATGTG_MIR323,SET,148,-0.055252,-0.0049407,0.070919,0.78203,TAATGTG_MIR323,1
BIOCARTA_IL3_PATHWAY,SET,13,-0.19531,-0.0051952,0.25065,0.78206,BIOCARTA_IL3_PATHWAY,1
REACTOME_KINESINS,SET,57,-0.085948,-0.0047815,0.1103,0.78206,REACTOME_KINESINS,1
GSE6092_UNSTIM_VS_IFNG_STIM_...3,SET,173,-0.049894,-0.0048204,0.064012,0.78214,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...3,SET,9,-0.25627,-0.0056724,0.32877,0.78214,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_UNKN_AGE_IMM_WITH_ARR_VS_IMM_BY_RRR_PRIMARY_IMMUNIZ_WITH_RECOMB_ADENOVIRUS_35_1DY_UP,1
HP_NEOPLASM_OF_THE_MALE_EXTE...,SET,32,-0.128,-0.0053391,0.1642,0.78216,HP_NEOPLASM_OF_THE_MALE_EXTERNAL_GENITALIA,1
CALVET_IRINOTECAN_SENSITIVE_...2,SET,5,-0.31396,-0.0051804,0.40267,0.78221,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN,1
GOBP_CHEMOKINE_PRODUCTION,SET,90,-0.075743,-0.0052901,0.09714,0.78222,GOBP_CHEMOKINE_PRODUCTION,1
MIR6823_5P,SET,64,-0.082247,-0.0048475,0.10547,0.78224,MIR6823_5P,1
KEGG_ACUTE_MYELOID_LEUKEMIA,SET,54,-0.090883,-0.0049216,0.11654,0.78225,KEGG_ACUTE_MYELOID_LEUKEMIA,1
HP_CONSTRICTION_OF_PERIPHERA...,SET,126,-0.059916,-0.0049465,0.07683,0.78226,HP_CONSTRICTION_OF_PERIPHERAL_VISUAL_FIELD,1
SMARCA1_TARGET_GENES,SET,98,-0.067372,-0.004909,0.086344,0.78238,SMARCA1_TARGET_GENES,1
GOBP_CHIASMA_ASSEMBLY,SET,6,-0.22819,-0.0041245,0.29243,0.7824,GOBP_CHIASMA_ASSEMBLY,1
GOMF_NUCLEOBASE_CONTAINING_C...2,SET,52,-0.095294,-0.0050642,0.1221,0.78244,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
E2F3_UP.V1_DN,SET,131,-0.056606,-0.0047644,0.072521,0.78246,E2F3_UP.V1_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_ALV...,SET,7,-0.29671,-0.0057925,0.38013,0.78246,HE_LIM_SUN_FETAL_LUNG_C0_ALVEOLAR_FIBROBLAST,1
GSE14000_TRANSLATED_RNA_VS_M...5,SET,161,-0.05157,-0.004808,0.066062,0.78249,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN,1
WP_TRANSCRIPTION_FACTORS_REG...,SET,8,-0.21385,-0.004463,0.27383,0.78258,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,1
GOBP_NITRIC_OXIDE_TRANSPORT,SET,3,-0.4662,-0.0059588,0.59686,0.78262,GOBP_NITRIC_OXIDE_TRANSPORT,1
LAKE_ADULT_KIDNEY_C30_IMMUNE...,SET,9,-0.24242,-0.0053659,0.31034,0.78263,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,1
HP_DELAYED_CNS_MYELINATION,SET,171,-0.049915,-0.0047947,0.063897,0.78264,HP_DELAYED_CNS_MYELINATION,1
CUI_DEVELOPING_HEART_5TH_WEE...1,SET,36,-0.11726,-0.0051872,0.15011,0.78264,CUI_DEVELOPING_HEART_5TH_WEEK_ATRIAL_CARDIOMYOCYTE,1
GSE40274_CTRL_VS_FOXP3_AND_E...2,SET,157,-0.054248,-0.004995,0.069419,0.78273,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
KEGG_MEDICUS_PATHOGEN_HIV_GP...1,SET,12,-0.19219,-0.0049118,0.24584,0.78281,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
HP_FOCAL_SENSORY_SEIZURE_WIT...,SET,6,-0.23691,-0.0042821,0.30291,0.78292,HP_FOCAL_SENSORY_SEIZURE_WITH_VISUAL_FEATURES,1
GOBP_FLAVONOID_METABOLIC_PRO...,SET,11,-0.24413,-0.0059739,0.31207,0.78298,GOBP_FLAVONOID_METABOLIC_PROCESS,1
GOBP_RESPONSE_TO_ACID_CHEMIC...,SET,119,-0.062661,-0.0050283,0.080091,0.783,GOBP_RESPONSE_TO_ACID_CHEMICAL,1
STAEGE_EWING_FAMILY_TUMOR,SET,24,-0.15521,-0.005608,0.19837,0.78301,STAEGE_EWING_FAMILY_TUMOR,1
HP_GASTRIC_ULCER,SET,5,-0.2847,-0.0046977,0.3638,0.78306,HP_GASTRIC_ULCER,1
ZNF7_TARGET_GENES,SET,679,-0.026531,-0.0050069,0.0339,0.78307,ZNF7_TARGET_GENES,1
GOBP_RETINOIC_ACID_METABOLIC...,SET,33,-0.13841,-0.0058627,0.17685,0.78308,GOBP_RETINOIC_ACID_METABOLIC_PROCESS,1
HP_CUTANEOUS_SYNDACTYLY_OF_T...,SET,25,-0.13992,-0.0051598,0.17878,0.78308,HP_CUTANEOUS_SYNDACTYLY_OF_TOES,1
GOBP_TELENCEPHALON_REGIONALI...,SET,13,-0.23119,-0.0061497,0.29538,0.78309,GOBP_TELENCEPHALON_REGIONALIZATION,1
WCAANNNYCAG_UNKNOWN,SET,228,-0.045922,-0.0050856,0.058656,0.78315,WCAANNNYCAG_UNKNOWN,1
GSE17721_LPS_VS_CPG_4H_BMDC_...1,SET,172,-0.049234,-0.004743,0.062882,0.78317,GSE17721_LPS_VS_CPG_4H_BMDC_DN,1
GSE29618_LAIV_VS_TIV_FLU_VAC...1,SET,171,-0.050025,-0.0048053,0.063888,0.78318,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN,1
HP_ABNORMAL_PLATELET_GRANULES,SET,12,-0.17664,-0.0045145,0.22559,0.78319,HP_ABNORMAL_PLATELET_GRANULES,1
HP_PSEUDOEPIPHYSES,SET,17,-0.17248,-0.005246,0.22025,0.78322,HP_PSEUDOEPIPHYSES,1
GSE36826_WT_VS_IL1R_KO_SKIN_...3,SET,179,-0.04741,-0.0046584,0.06054,0.78322,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP,1
MIR5088_5P,SET,33,-0.11854,-0.005021,0.15135,0.78325,MIR5088_5P,1
GOMF_POLY_A_SPECIFIC_RIBONUC...,SET,12,-0.1957,-0.0050016,0.24984,0.78327,GOMF_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY,1
GOMF_MRF_BINDING,SET,5,-0.30975,-0.0051109,0.39541,0.78329,GOMF_MRF_BINDING,1
HP_APLASIA_HYPOPLASIA_INVOLV...9,SET,119,-0.06308,-0.0050619,0.080513,0.78332,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_METACARPAL_BONES,1
HP_POOR_SPEECH,SET,167,-0.049649,-0.0047136,0.063361,0.78335,HP_POOR_SPEECH,1
GOBP_IRON_IMPORT_INTO_CELL,SET,9,-0.21512,-0.0047616,0.27452,0.78336,GOBP_IRON_IMPORT_INTO_CELL,1
BROWNE_HCMV_INFECTION_8HR_UP,SET,91,-0.069893,-0.0049084,0.089188,0.78337,BROWNE_HCMV_INFECTION_8HR_UP,1
HP_ARACHNOID_HEMANGIOMATOSIS,SET,16,-0.15009,-0.0044287,0.19147,0.78343,HP_ARACHNOID_HEMANGIOMATOSIS,1
GSE19941_IL10_KO_VS_IL10_KO_...4,SET,181,-0.04979,-0.0049192,0.0635,0.78351,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP,1
GOMF_LEUKOTRIENE_C4_GAMMA_GL...,SET,4,-0.3441,-0.0050785,0.43862,0.78362,GOMF_LEUKOTRIENE_C4_GAMMA_GLUTAMYL_TRANSFERASE_ACTIVITY,1
GOBP_URATE_TRANSPORT,SET,11,-0.20814,-0.0050931,0.26518,0.78373,GOBP_URATE_TRANSPORT,1
MIR6843_3P,SET,82,-0.07919,-0.0052804,0.10089,0.78375,MIR6843_3P,1
MEISSNER_BRAIN_HCP_WITH_H3_U...,SET,31,-0.11948,-0.0049055,0.15221,0.78377,MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,1
HP_SEVERE_EPSTEIN_BARR_VIRUS...,SET,4,-0.37985,-0.005606,0.48386,0.78378,HP_SEVERE_EPSTEIN_BARR_VIRUS_INFECTION,1
HP_ANTECUBITAL_PTERYGIUM,SET,7,-0.2933,-0.0057258,0.37357,0.7838,HP_ANTECUBITAL_PTERYGIUM,1
MIR146A_3P,SET,197,-0.049429,-0.0050925,0.062954,0.78381,MIR146A_3P,1
GSE14000_UNSTIM_VS_16H_LPS_D...3,SET,180,-0.050073,-0.0049336,0.063775,0.78381,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP,1
CAFFAREL_RESPONSE_TO_THC_24H...2,SET,8,-0.21174,-0.004419,0.26968,0.78382,CAFFAREL_RESPONSE_TO_THC_24HR_3_UP,1
MIR4525,SET,32,-0.11996,-0.0050036,0.15276,0.78384,MIR4525,1
GOBP_CHEMOKINE_C_C_MOTIF_LIG...,SET,10,-0.2187,-0.0051026,0.27845,0.78389,GOBP_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
HP_FUNCTIONAL_ABNORMALITY_OF...1,SET,228,-0.043855,-0.0048567,0.055833,0.78391,HP_FUNCTIONAL_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA,1
MIR3065_3P,SET,234,-0.044049,-0.0049411,0.05607,0.78395,MIR3065_3P,1
MIR758_3P,SET,112,-0.062779,-0.0048883,0.079906,0.78396,MIR758_3P,1
MORF_CDC10,SET,140,-0.053917,-0.0046902,0.068623,0.78397,MORF_CDC10,1
GSE5542_IFNG_VS_IFNA_TREATED...1,SET,175,-0.051864,-0.0050393,0.066001,0.78401,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,1
MIR1910_3P,SET,165,-0.05325,-0.0050253,0.067741,0.78408,MIR1910_3P,1
GOBP_NEURONAL_ION_CHANNEL_CL...,SET,12,-0.19407,-0.00496,0.24685,0.78412,GOBP_NEURONAL_ION_CHANNEL_CLUSTERING,1
GSE45739_UNSTIM_VS_ACD3_ACD2...1,SET,176,-0.052973,-0.0051616,0.067371,0.78415,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN,1
GOBP_MITOTIC_CHROMOSOME_COND...,SET,17,-0.14225,-0.0043266,0.18088,0.7842,GOBP_MITOTIC_CHROMOSOME_CONDENSATION,1
GSE15330_GRANULOCYTE_MONOCYT...2,SET,177,-0.047977,-0.0046879,0.060999,0.78421,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP,1
REACTOME_ELECTRIC_TRANSMISSI...,SET,4,-0.36588,-0.0053999,0.4649,0.78435,REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS,1
YANG_BREAST_CANCER_ESR1_DN,SET,21,-0.16257,-0.005495,0.20657,0.78436,YANG_BREAST_CANCER_ESR1_DN,1
ONDER_CDH1_TARGETS_2_DN,SET,443,-0.034573,-0.0053052,0.043925,0.78438,ONDER_CDH1_TARGETS_2_DN,1
GOMF_NUCLEOTIDE_TRANSMEMBRAN...,SET,29,-0.13442,-0.0053381,0.17074,0.78444,GOMF_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR4798_3P,SET,10,-0.17739,-0.0041387,0.2253,0.78445,MIR4798_3P,1
MODULE_9,SET,112,-0.062907,-0.0048982,0.079891,0.78447,MODULE_9,1
GOBP_COMMON_MYELOID_PROGENIT...,SET,9,-0.22403,-0.0049588,0.28451,0.78447,GOBP_COMMON_MYELOID_PROGENITOR_CELL_PROLIFERATION,1
GNF2_HDAC1,SET,99,-0.062107,-0.0045483,0.078856,0.78453,GNF2_HDAC1,1
HP_ABNORMAL_BASAL_GANGLIA_MO...,SET,158,-0.052511,-0.0048503,0.066667,0.78455,HP_ABNORMAL_BASAL_GANGLIA_MORPHOLOGY,1
GSE3982_BASOPHIL_VS_NKCELL_UP,SET,177,-0.05063,-0.0049471,0.064268,0.78459,GSE3982_BASOPHIL_VS_NKCELL_UP,1
MIR5591_5P,SET,59,-0.085806,-0.0048563,0.1089,0.78462,MIR5591_5P,1
KEGG_RIBOFLAVIN_METABOLISM,SET,13,-0.18533,-0.0049299,0.23515,0.78469,KEGG_RIBOFLAVIN_METABOLISM,1
HP_NEONATAL_ONSET,SET,427,-0.032542,-0.0049046,0.04128,0.78474,HP_NEONATAL_ONSET,1
HP_ABNORMALLY_LOW_PITCHED_VO...,SET,10,-0.21484,-0.0050126,0.27249,0.78477,HP_ABNORMALLY_LOW_PITCHED_VOICE,1
GOBP_ALANINE_METABOLIC_PROCE...,SET,5,-0.30704,-0.0050663,0.38925,0.78488,GOBP_ALANINE_METABOLIC_PROCESS,1
HSF2_TARGET_GENES,SET,196,-0.046985,-0.0048285,0.059563,0.78489,HSF2_TARGET_GENES,1
MIR4790_5P,SET,13,-0.1802,-0.0047933,0.22842,0.78491,MIR4790_5P,1
TTGCACT_MIR130A_MIR301_MIR13...,SET,352,-0.03626,-0.0049723,0.045959,0.78493,TTGCACT_MIR130A_MIR301_MIR130B,1
GOBP_UREA_CYCLE,SET,10,-0.1978,-0.0046149,0.25069,0.78494,GOBP_UREA_CYCLE,1
REACTOME_WNT5A_DEPENDENT_INT...2,SET,15,-0.16532,-0.0047234,0.2095,0.78498,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,1
GSE5455_HEALTHY_VS_TUMOR_BEA...3,SET,183,-0.051459,-0.0051118,0.065199,0.78501,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN,1
OHASHI_AURKB_TARGETS,SET,7,-0.25777,-0.0050323,0.32656,0.78504,OHASHI_AURKB_TARGETS,1
GSE1791_CTRL_VS_NEUROMEDINU_...8,SET,175,-0.050793,-0.0049353,0.064339,0.78507,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP,1
GOBP_SULFATE_TRANSPORT,SET,16,-0.16934,-0.004997,0.2145,0.78508,GOBP_SULFATE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...478,SET,112,-0.07033,-0.0054763,0.089065,0.78513,GOBP_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,1
MIR4326,SET,78,-0.080883,-0.0052607,0.10242,0.78515,MIR4326,1
GSE21927_GMCSF_IL6_VS_GMCSF_...1,SET,181,-0.047364,-0.0046795,0.059975,0.78515,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
GOMF_LONG_CHAIN_FATTY_ACID_T...,SET,15,-0.17407,-0.0049733,0.22041,0.78516,GOMF_LONG_CHAIN_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MALONEY_RESPONSE_TO_17AAG_DN,SET,66,-0.080226,-0.0048014,0.10157,0.78518,MALONEY_RESPONSE_TO_17AAG_DN,1
MIR4776_5P,SET,44,-0.097993,-0.0047914,0.12406,0.78519,MIR4776_5P,1
HOWARD_NEUTROPHIL_INACT_MONO...2,SET,358,-0.038532,-0.0053278,0.04878,0.78521,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
GOBP_GRANULOCYTE_ACTIVATION,SET,45,-0.099886,-0.004939,0.12642,0.78527,GOBP_GRANULOCYTE_ACTIVATION,1
SNF5_DN.V1_DN,SET,136,-0.062795,-0.0053845,0.079457,0.78532,SNF5_DN.V1_DN,1
FAN_OVARY_CL3_MATURE_CUMULUS...,SET,200,-0.048275,-0.005011,0.061064,0.78539,FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1,1
REN_MIF_TARGETS_DN,SET,4,-0.33239,-0.0049056,0.42042,0.78541,REN_MIF_TARGETS_DN,1
GOBP_REGULATION_OF_MRNA_CATA...,SET,170,-0.051591,-0.0049413,0.065256,0.78541,GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS,1
HP_HETEROCHROMIA_IRIDIS,SET,23,-0.15096,-0.0053395,0.19093,0.78542,HP_HETEROCHROMIA_IRIDIS,1
KEGG_MEDICUS_REFERENCE_UCHL1...,SET,4,-0.44862,-0.006621,0.56736,0.78544,KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS,1
HP_ECTOPIC_ANUS,SET,72,-0.080655,-0.0050409,0.10199,0.78546,HP_ECTOPIC_ANUS,1
GSE17721_CTRL_VS_GARDIQUIMOD...16,SET,179,-0.049837,-0.0048968,0.063016,0.78548,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP,1
GCM_NUMA1,SET,51,-0.085069,-0.0044773,0.10756,0.7855,GCM_NUMA1,1
GSE24574_BCL6_HIGH_TFH_VS_NA...1,SET,187,-0.048223,-0.0048419,0.060967,0.78551,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN,1
GOMF_STEROID_DEHYDROGENASE_A...2,SET,30,-0.12486,-0.0050431,0.15782,0.78557,GOMF_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
WP_AMINO_ACID_TRANSPORT_DEFE...,SET,8,-0.23551,-0.004915,0.29763,0.78561,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...3,SET,913,-0.023712,-0.0051545,0.029966,0.78561,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,1
MORI_PRE_BI_LYMPHOCYTE_DN,SET,71,-0.080312,-0.0049846,0.10149,0.78562,MORI_PRE_BI_LYMPHOCYTE_DN,1
REACTOME_PROTEIN_PROTEIN_INT...,SET,77,-0.079058,-0.005109,0.099906,0.78562,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1
GSE21774_CD62L_POS_CD56_DIM_...1,SET,181,-0.050519,-0.0049912,0.063841,0.78562,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,1
GSE557_WT_VS_CIITA_KO_DC_DN,SET,186,-0.051138,-0.0051209,0.064622,0.78562,GSE557_WT_VS_CIITA_KO_DC_DN,1
GOBP_MEMBRANE_HYPERPOLARIZAT...,SET,11,-0.20401,-0.0049921,0.25778,0.78564,GOBP_MEMBRANE_HYPERPOLARIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...458,SET,7,-0.24687,-0.0048194,0.31191,0.78566,GOBP_NEGATIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
HATADA_METHYLATED_IN_LUNG_CA...1,SET,31,-0.13148,-0.0053979,0.1661,0.78568,HATADA_METHYLATED_IN_LUNG_CANCER_DN,1
GSE27241_WT_CTRL_VS_DIGOXIN_...2,SET,161,-0.055556,-0.0051796,0.070182,0.7857,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,1
HP_CERVICAL_SPINE_INSTABILITY,SET,8,-0.2734,-0.0057057,0.34526,0.78578,HP_CERVICAL_SPINE_INSTABILITY,1
MIR1470,SET,14,-0.17441,-0.0048143,0.22021,0.78582,MIR1470,1
GOBP_NEGATIVE_REGULATION_OF_...358,SET,8,-0.24961,-0.0052094,0.31509,0.78587,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GOBP_REGULATION_OF_GLUCONEOG...,SET,43,-0.10466,-0.0050593,0.13211,0.78588,GOBP_REGULATION_OF_GLUCONEOGENESIS,1
ATAAGCT_MIR21,SET,111,-0.062919,-0.0048774,0.079407,0.78592,ATAAGCT_MIR21,1
GSE29615_CTRL_VS_DAY7_LAIV_F...1,SET,130,-0.058907,-0.0049392,0.07434,0.78593,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,1
MAZR_01,SET,204,-0.044373,-0.0046513,0.05599,0.78597,MAZR_01,1
GOBP_POSITIVE_REGULATION_OF_...427,SET,39,-0.1142,-0.0052578,0.14405,0.78605,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
GOBP_RESPONSE_TO_CATECHOLAMI...,SET,55,-0.097672,-0.0053378,0.12319,0.78607,GOBP_RESPONSE_TO_CATECHOLAMINE,1
GOBP_STEROID_BIOSYNTHETIC_PR...,SET,166,-0.053871,-0.0050992,0.067942,0.78608,GOBP_STEROID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_NEUTROPHI...2,SET,29,-0.14052,-0.0055804,0.17721,0.7861,GOBP_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS,1
HP_COLPOCEPHALY,SET,28,-0.12348,-0.0048185,0.15571,0.78611,HP_COLPOCEPHALY,1
GOBP_GROWTH_PLATE_CARTILAGE_...1,SET,5,-0.35617,-0.0058769,0.44913,0.78612,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DEVELOPMENT,1
MIR5010_5P,SET,33,-0.11964,-0.0050678,0.15086,0.78613,MIR5010_5P,1
GSE13306_TREG_VS_TCONV_LAMIN...1,SET,181,-0.049823,-0.0049224,0.062821,0.78613,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN,1
MODULE_342,SET,194,-0.051397,-0.0052553,0.064805,0.78614,MODULE_342,1
HP_INTELLECTUAL_DISABILITY_M...1,SET,289,-0.040539,-0.005046,0.051097,0.78622,HP_INTELLECTUAL_DISABILITY_MILD,1
GOMF_NUCLEAR_THYROID_HORMONE...,SET,27,-0.12229,-0.0046863,0.15413,0.78624,GOMF_NUCLEAR_THYROID_HORMONE_RECEPTOR_BINDING,1
GSE31082_DN_VS_CD8_SP_THYMOC...1,SET,188,-0.048644,-0.004897,0.0613,0.78626,GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...39,SET,7,-0.24714,-0.0048248,0.31137,0.78631,GOBP_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
CAFFAREL_RESPONSE_TO_THC_24H...3,SET,44,-0.098285,-0.0048057,0.12381,0.78635,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1
DAVICIONI_RHABDOMYOSARCOMA_P...1,SET,13,-0.22864,-0.0060818,0.28798,0.78638,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1
GOMF_VOLUME_SENSITIVE_ANION_...,SET,9,-0.26025,-0.0057606,0.32774,0.78642,GOMF_VOLUME_SENSITIVE_ANION_CHANNEL_ACTIVITY,1
GSE22589_SIV_VS_HIV_AND_SIV_...1,SET,181,-0.04899,-0.0048401,0.061695,0.78642,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN,1
GSE360_L_MAJOR_VS_T_GONDII_M...1,SET,177,-0.04858,-0.0047468,0.061175,0.78643,GSE360_L_MAJOR_VS_T_GONDII_MAC_DN,1
WP_SYNTHESIS_OF_CERAMIDES_AN...,SET,22,-0.14708,-0.0050882,0.18516,0.7865,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,1
AREB6_02,SET,236,-0.044981,-0.0050669,0.056624,0.78651,AREB6_02,1
GOBP_BRANCHING_MORPHOGENESIS...2,SET,10,-0.24315,-0.0056731,0.30608,0.78651,GOBP_BRANCHING_MORPHOGENESIS_OF_A_NERVE,1
CAGGGTC_MIR504,SET,69,-0.081268,-0.0049727,0.1023,0.78652,CAGGGTC_MIR504,1
HP_MACULAR_COLOBOMA,SET,10,-0.22283,-0.0051989,0.28048,0.78653,HP_MACULAR_COLOBOMA,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...5,SET,28,-0.14246,-0.005559,0.1793,0.78655,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP,1
HP_ABNORMAL_CARDIOVASCULAR_S...,SET,1282,-0.019625,-0.0050016,0.0247,0.78656,HP_ABNORMAL_CARDIOVASCULAR_SYSTEM_PHYSIOLOGY,1
MARKEY_RB1_ACUTE_LOF_DN,SET,211,-0.048597,-0.0051797,0.061154,0.78659,MARKEY_RB1_ACUTE_LOF_DN,1
GOBP_GLUCAN_BIOSYNTHETIC_PRO...,SET,40,-0.10436,-0.004866,0.13132,0.78662,GOBP_GLUCAN_BIOSYNTHETIC_PROCESS,1
HP_PRIMARY_MICROCEPHALY,SET,67,-0.077984,-0.0047024,0.098099,0.78667,HP_PRIMARY_MICROCEPHALY,1
REACTOME_FRS_MEDIATED_FGFR2_...,SET,24,-0.14034,-0.0050709,0.17648,0.78675,REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,1
HP_CEREBRAL_INFARCT,SET,35,-0.11851,-0.0051693,0.14901,0.78677,HP_CEREBRAL_INFARCT,1
GOBP_PROTEIN_FOLDING,SET,200,-0.045376,-0.0047101,0.05705,0.78679,GOBP_PROTEIN_FOLDING,1
HP_ENLARGED_TONSILS,SET,5,-0.28762,-0.0047458,0.36161,0.7868,HP_ENLARGED_TONSILS,1
GOBP_POSITIVE_REGULATION_OF_...652,SET,19,-0.15649,-0.0050315,0.19674,0.78681,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
HP_IVORY_EPIPHYSES,SET,9,-0.24146,-0.0053447,0.30356,0.78681,HP_IVORY_EPIPHYSES,1
MIR5681A,SET,135,-0.056866,-0.0048582,0.071462,0.78691,MIR5681A,1
GSE25088_CTRL_VS_IL4_AND_ROS...2,SET,160,-0.055528,-0.005161,0.069774,0.78693,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...53,SET,7,-0.27011,-0.0052731,0.33937,0.78695,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,1
MARSHALL_VIRAL_INFECTION_RES...2,SET,9,-0.26358,-0.0058344,0.33115,0.78696,MARSHALL_VIRAL_INFECTION_RESPONSE_UP,1
HP_BOWED_FOREARM_BONES,SET,31,-0.13215,-0.0054257,0.16603,0.78696,HP_BOWED_FOREARM_BONES,1
BROWNE_HCMV_INFECTION_10HR_DN,SET,52,-0.099276,-0.0052759,0.12471,0.78699,BROWNE_HCMV_INFECTION_10HR_DN,1
HP_UNDETECTABLE_VISUAL_EVOKE...,SET,8,-0.21951,-0.004581,0.27573,0.787,HP_UNDETECTABLE_VISUAL_EVOKED_POTENTIALS,1
GOBP_RESPONSE_TO_INTERLEUKIN...3,SET,5,-0.32366,-0.0053405,0.40655,0.78701,GOBP_RESPONSE_TO_INTERLEUKIN_13,1
GOMF_STRUCTURAL_CONSTITUENT_...10,SET,36,-0.1406,-0.0062196,0.17659,0.78702,GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS,1
HOLLEMAN_ASPARAGINASE_RESIST...2,SET,21,-0.14665,-0.0049569,0.1842,0.78703,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,1
WP_HOSTPATHOGEN_INTERACTION_...1,SET,21,-0.15669,-0.0052963,0.19681,0.78703,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,1
GSE5503_MLN_DC_VS_SPLEEN_DC_...1,SET,178,-0.048666,-0.0047685,0.061113,0.78707,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GSE21379_TFH_VS_NON_TFH_CD4_...1,SET,176,-0.053251,-0.0051887,0.066866,0.78709,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN,1
GAO_LARGE_INTESTINE_ADULT_CJ...,SET,438,-0.036154,-0.0055172,0.045398,0.78709,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...439,SET,428,-0.034728,-0.0052401,0.043603,0.78711,GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE,1
GSE14308_TH17_VS_NAIVE_CD4_T...2,SET,179,-0.049406,-0.0048545,0.062032,0.78711,GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP,1
GCM_RAN,SET,178,-0.048606,-0.0047626,0.061026,0.78712,GCM_RAN,1
GOMF_TOLL_LIKE_RECEPTOR_BIND...,SET,14,-0.199,-0.0054931,0.2498,0.78717,GOMF_TOLL_LIKE_RECEPTOR_BINDING,1
GOBP_REGULATION_OF_PROTEIN_C...3,SET,13,-0.18444,-0.0049061,0.2315,0.78719,GOBP_REGULATION_OF_PROTEIN_COMPLEX_STABILITY,1
REACTOME_GAMMA_CARBOXYLATION...1,SET,51,-0.091936,-0.0048387,0.11537,0.78723,REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION,1
GSE22886_NAIVE_BCELL_VS_MONO...1,SET,188,-0.049603,-0.0049936,0.062246,0.78724,GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN,1
HE_LIM_SUN_FETAL_LUNG_C4_CD5...,SET,5,-0.29818,-0.00492,0.37415,0.78725,HE_LIM_SUN_FETAL_LUNG_C4_CD56BRIGHT_NK_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...474,SET,9,-0.2406,-0.0053256,0.30189,0.78726,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOMF_OLFACTORY_RECEPTOR_BIND...,SET,6,-0.29993,-0.0054211,0.37634,0.78726,GOMF_OLFACTORY_RECEPTOR_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...483,SET,184,-0.053533,-0.0053322,0.067155,0.78731,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,1
GOBP_ANTERIOR_HEAD_DEVELOPME...,SET,7,-0.28263,-0.0055176,0.35451,0.78734,GOBP_ANTERIOR_HEAD_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...145,SET,4,-0.34281,-0.0050595,0.42987,0.78741,GOBP_NEGATIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...275,SET,4,-0.34281,-0.0050595,0.42987,0.78741,GOBP_NEGATIVE_REGULATION_OF_HETEROCHROMATIN_FORMATION,1
GSE17721_POLYIC_VS_GARDIQUIM...9,SET,176,-0.050151,-0.0048867,0.062887,0.78741,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN,1
GOBP_NEPHRON_TUBULE_EPITHELI...,SET,13,-0.22158,-0.005894,0.27779,0.78746,GOBP_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
HP_GASTROINTESTINAL_INFARCTI...,SET,13,-0.19815,-0.0052708,0.2484,0.78747,HP_GASTROINTESTINAL_INFARCTIONS,1
HP_RENAL_HAMARTOMA,SET,7,-0.27447,-0.0053583,0.34407,0.78748,HP_RENAL_HAMARTOMA,1
GOBP_NUCLEOSIDE_TRANSMEMBRAN...,SET,8,-0.2646,-0.0055221,0.33166,0.7875,GOBP_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,1
GOBP_G_PROTEIN_COUPLED_GLUTA...,SET,15,-0.18334,-0.0052382,0.2298,0.78751,GOBP_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...651,SET,21,-0.12734,-0.0043041,0.15958,0.78755,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,1
GOCC_U2AF_COMPLEX,SET,3,-0.36011,-0.0046028,0.45122,0.78759,GOCC_U2AF_COMPLEX,1
KEGG_MEDICUS_REFERENCE_GLYCO...4,SET,21,-0.1354,-0.0045765,0.16962,0.78763,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS,1
GSE7460_FOXP3_MUT_VS_HET_ACT...1,SET,181,-0.050274,-0.004967,0.062973,0.78766,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...2,SET,188,-0.048451,-0.0048777,0.060689,0.78766,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP,1
GOBP_RESPONSE_TO_AUDITORY_ST...,SET,32,-0.12159,-0.0050718,0.15228,0.7877,GOBP_RESPONSE_TO_AUDITORY_STIMULUS,1
REACTOME_PI3K_EVENTS_IN_ERBB...1,SET,16,-0.17532,-0.0051733,0.21945,0.78782,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,1
HP_ACRAL_BLISTERING,SET,9,-0.22809,-0.0050488,0.28535,0.78794,HP_ACRAL_BLISTERING,1
KEGG_MEDICUS_REFERENCE_EGF_E...3,SET,9,-0.23566,-0.0052164,0.29447,0.78822,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY,1
MIR504_3P,SET,130,-0.056781,-0.004761,0.070936,0.78827,MIR504_3P,1
MIR7975,SET,37,-0.10467,-0.004694,0.13075,0.7883,MIR7975,1
PHONG_TNF_RESPONSE_NOT_VIA_P...,SET,323,-0.041114,-0.0054051,0.051344,0.78836,PHONG_TNF_RESPONSE_NOT_VIA_P38,1
GOCC_VOLTAGE_GATED_SODIUM_CH...,SET,14,-0.21451,-0.0059212,0.26789,0.78836,GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX,1
GOBP_CELL_CELL_JUNCTION_MAIN...,SET,15,-0.19929,-0.005694,0.24886,0.78837,GOBP_CELL_CELL_JUNCTION_MAINTENANCE,1
HP_RECURRENT_UPPER_AND_LOWER...,SET,14,-0.19954,-0.005508,0.24916,0.78839,HP_RECURRENT_UPPER_AND_LOWER_RESPIRATORY_TRACT_INFECTIONS,1
MIR135B_5P,SET,282,-0.042189,-0.0051884,0.052672,0.78843,MIR135B_5P,1
HP_BULBOUS_NOSE,SET,176,-0.050737,-0.0049438,0.06332,0.78851,HP_BULBOUS_NOSE,1
BIOCARTA_ERBB3_PATHWAY,SET,5,-0.3549,-0.0058559,0.44274,0.7886,BIOCARTA_ERBB3_PATHWAY,1
HP_ABNORMAL_SIZE_OF_THE_PALP...,SET,259,-0.04211,-0.0049661,0.052527,0.78863,HP_ABNORMAL_SIZE_OF_THE_PALPEBRAL_FISSURES,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...6,SET,9,-0.21035,-0.004656,0.26234,0.78866,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482,1
GOBP_REGULATION_OF_GASTRIC_A...,SET,6,-0.26748,-0.0048345,0.33356,0.78868,GOBP_REGULATION_OF_GASTRIC_ACID_SECRETION,1
HUNSBERGER_EXERCISE_REGULATE...,SET,28,-0.14025,-0.005473,0.17482,0.7888,HUNSBERGER_EXERCISE_REGULATED_GENES,1
KEGG_MEDICUS_REFERENCE_COHES...2,SET,15,-0.16881,-0.0048232,0.21041,0.7888,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE,1
GCACTTT_MIR175P_MIR20A_MIR10...,SET,545,-0.03013,-0.0051134,0.037554,0.78881,GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D,1
HP_THYROID_DEFECT_IN_OXIDATI...,SET,6,-0.2871,-0.0051892,0.35783,0.78882,HP_THYROID_DEFECT_IN_OXIDATION_AND_ORGANIFICATION_OF_IODIDE,1
GSE13173_UNTREATED_VS_IL12_T...2,SET,113,-0.064949,-0.0050797,0.080948,0.78882,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP,1
GOBP_CELL_JUNCTION_MAINTENAN...,SET,41,-0.11656,-0.0055018,0.14523,0.78889,GOBP_CELL_JUNCTION_MAINTENANCE,1
GOBP_NEGATIVE_REGULATION_OF_...331,SET,21,-0.1646,-0.0055635,0.20508,0.78889,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
GSE2935_UV_INACTIVATED_VS_LI...1,SET,162,-0.056749,-0.005307,0.070706,0.78889,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN,1
GSE17974_2H_VS_72H_UNTREATED...1,SET,164,-0.051639,-0.0048586,0.064335,0.78891,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
REACTOME_PURINE_SALVAGE,SET,12,-0.20558,-0.005254,0.25611,0.78892,REACTOME_PURINE_SALVAGE,1
GOBP_NEGATIVE_REGULATION_OF_...402,SET,79,-0.080437,-0.005265,0.1002,0.78895,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_NUCLEAR_T...3,SET,13,-0.18496,-0.0049198,0.23037,0.78897,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
HP_ABNORMAL_BLOOD_ZINC_CONCE...,SET,6,-0.2771,-0.0050084,0.34508,0.78901,HP_ABNORMAL_BLOOD_ZINC_CONCENTRATION,1
GSE43863_TH1_VS_TFH_EFFECTOR...2,SET,187,-0.051751,-0.0051962,0.064447,0.78901,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP,1
GOBP_REGULATION_OF_MIRNA_CAT...,SET,4,-0.28038,-0.0041381,0.34913,0.78904,GOBP_REGULATION_OF_MIRNA_CATABOLIC_PROCESS,1
GOBP_AMMONIUM_TRANSMEMBRANE_...,SET,13,-0.19628,-0.005221,0.24438,0.78906,GOBP_AMMONIUM_TRANSMEMBRANE_TRANSPORT,1
GSE10325_BCELL_VS_MYELOID_UP,SET,170,-0.053138,-0.0050895,0.066149,0.7891,GSE10325_BCELL_VS_MYELOID_UP,1
HP_ABNORMALITY_OF_THE_PYLORUS,SET,92,-0.075405,-0.0053243,0.093862,0.78911,HP_ABNORMALITY_OF_THE_PYLORUS,1
DESCARTES_MAIN_FETAL_AMACRIN...,SET,16,-0.18535,-0.0054692,0.2306,0.78923,DESCARTES_MAIN_FETAL_AMACRINE_CELLS,1
GSE22886_NAIVE_CD8_TCELL_VS_...8,SET,173,-0.050953,-0.0049226,0.063389,0.78924,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP,1
HP_ABNORMAL_PUBIC_BONE_MORPH...,SET,39,-0.11126,-0.0051226,0.13842,0.78925,HP_ABNORMAL_PUBIC_BONE_MORPHOLOGY,1
GOBP_REGULATION_OF_MITOTIC_C...2,SET,311,-0.038791,-0.0050057,0.048252,0.78927,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
AAGWWRNYGGC_UNKNOWN,SET,111,-0.064256,-0.004981,0.07992,0.7893,AAGWWRNYGGC_UNKNOWN,1
DESCARTES_FETAL_INTESTINE_ME...,SET,67,-0.08719,-0.0052575,0.10843,0.78932,DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS,1
GSE34156_UNTREATED_VS_6H_TLR...2,SET,172,-0.054482,-0.0052486,0.067747,0.78935,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
GSE15735_CTRL_VS_HDAC_INHIBI...3,SET,178,-0.052258,-0.0051205,0.064966,0.78941,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN,1
GSE2128_CTRL_VS_MIMETOPE_NEG...3,SET,164,-0.053205,-0.005006,0.066141,0.78942,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN,1
GOMF_DESUMOYLASE_ACTIVITY,SET,7,-0.20847,-0.0040698,0.25908,0.78948,GOMF_DESUMOYLASE_ACTIVITY,1
HP_ABNORMAL_PLACENTAL_MEMBRA...,SET,13,-0.21668,-0.0057636,0.26927,0.7895,HP_ABNORMAL_PLACENTAL_MEMBRANE_MORPHOLOGY,1
GOBP_VOLUNTARY_SKELETAL_MUSC...,SET,5,-0.27262,-0.0044982,0.33866,0.78958,GOBP_VOLUNTARY_SKELETAL_MUSCLE_CONTRACTION,1
GSE20715_0H_VS_6H_OZONE_TLR4...1,SET,189,-0.050566,-0.005104,0.062817,0.78958,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN,1
LIAN_NEUTROPHIL_GRANULE_CONS...,SET,23,-0.16167,-0.0057186,0.20081,0.78962,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,1
REACTOME_REGULATION_OF_NPAS4...1,SET,13,-0.19974,-0.0053131,0.24806,0.78964,REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION,1
HP_ABSENT_INNER_AND_OUTER_DY...,SET,3,-0.35688,-0.0045615,0.44309,0.78971,HP_ABSENT_INNER_AND_OUTER_DYNEIN_ARMS,1
GOCC_SODIUM_CHANNEL_COMPLEX,SET,24,-0.15961,-0.0057668,0.19815,0.78972,GOCC_SODIUM_CHANNEL_COMPLEX,1
GOBP_REELIN_MEDIATED_SIGNALI...,SET,8,-0.25059,-0.0052297,0.31108,0.78974,GOBP_REELIN_MEDIATED_SIGNALING_PATHWAY,1
BIOCARTA_PRION_PATHWAY,SET,12,-0.1856,-0.0047435,0.23038,0.78977,BIOCARTA_PRION_PATHWAY,1
WP_ESTROGEN_METABOLISM_WP697,SET,14,-0.21115,-0.0058286,0.26209,0.78978,WP_ESTROGEN_METABOLISM_WP697,1
HP_CARDIOVASCULAR_CALCIFICAT...,SET,36,-0.12147,-0.0053737,0.15075,0.78981,HP_CARDIOVASCULAR_CALCIFICATION,1
GAVISH_3CA_METAPROGRAM_ENDOT...9,SET,45,-0.11467,-0.0056701,0.14229,0.78984,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7,1
MIR877_3P,SET,174,-0.052752,-0.0051111,0.065447,0.78988,MIR877_3P,1
MODULE_305,SET,19,-0.14738,-0.0047387,0.18282,0.78992,MODULE_305,1
MIR6894_3P,SET,62,-0.087395,-0.0050701,0.10836,0.79003,MIR6894_3P,1
GOBP_CARDIAC_LEFT_VENTRICLE_...,SET,16,-0.18643,-0.005501,0.23113,0.79004,GOBP_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS,1
HP_PROTRUDING_EAR,SET,168,-0.052046,-0.0049557,0.064526,0.79004,HP_PROTRUDING_EAR,1
HP_ABNORMAL_SYSTEMIC_BLOOD_P...,SET,487,-0.032396,-0.0052057,0.040163,0.79005,HP_ABNORMAL_SYSTEMIC_BLOOD_PRESSURE,1
GOBP_MAMMARY_GLAND_INVOLUTION,SET,8,-0.27479,-0.0057347,0.34065,0.79006,GOBP_MAMMARY_GLAND_INVOLUTION,1
MIR3978,SET,228,-0.046227,-0.0051193,0.057299,0.79009,MIR3978,1
GOBP_FACIAL_NERVE_STRUCTURAL...,SET,8,-0.2738,-0.005714,0.33936,0.7901,GOBP_FACIAL_NERVE_STRUCTURAL_ORGANIZATION,1
SCHMAHL_PDGF_SIGNALING,SET,9,-0.26461,-0.0058571,0.32794,0.79013,SCHMAHL_PDGF_SIGNALING,1
GOBP_REGULATION_OF_ALPHA_BET...2,SET,70,-0.087705,-0.0054051,0.10869,0.79014,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
MIR513B_3P,SET,144,-0.059811,-0.0052761,0.074104,0.79019,MIR513B_3P,1
DESCARTES_MAIN_FETAL_OLIGODE...,SET,40,-0.12004,-0.005597,0.14873,0.7902,DESCARTES_MAIN_FETAL_OLIGODENDROCYTES,1
REACTOME_NFE2L2_REGULATING_I...,SET,5,-0.32998,-0.0054448,0.40877,0.79023,REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES,1
GOMF_COA_LIGASE_ACTIVITY,SET,25,-0.1416,-0.0052216,0.1754,0.79025,GOMF_COA_LIGASE_ACTIVITY,1
GSE28737_BCL6_HET_VS_BCL6_KO...4,SET,184,-0.05251,-0.0052303,0.065028,0.7903,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,1
GSE14308_TH2_VS_NATURAL_TREG...2,SET,168,-0.050585,-0.0048166,0.062638,0.79033,GSE14308_TH2_VS_NATURAL_TREG_UP,1
GOBP_REGULATION_OF_AMINO_ACI...2,SET,40,-0.12092,-0.0056381,0.14967,0.79043,GOBP_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GOMF_GLUCURONOSYL_N_ACETYLGA...,SET,6,-0.28797,-0.005205,0.35643,0.79043,GOMF_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
GOBP_FAS_SIGNALING_PATHWAY,SET,6,-0.25559,-0.0046197,0.31633,0.79044,GOBP_FAS_SIGNALING_PATHWAY,1
REACTOME_NCAM1_INTERACTIONS,SET,41,-0.11643,-0.0054961,0.14409,0.79046,REACTOME_NCAM1_INTERACTIONS,1
MIR210_5P,SET,49,-0.096268,-0.0049667,0.11911,0.79051,MIR210_5P,1
GOBP_APOLIPOPROTEIN_A_I_MEDI...,SET,5,-0.3245,-0.0053542,0.40146,0.79053,GOBP_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY,1
MIR545_3P,SET,349,-0.038908,-0.005313,0.048126,0.79058,MIR545_3P,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...3,SET,117,-0.065906,-0.0052444,0.08151,0.79061,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN,1
HP_LONG_PENIS,SET,11,-0.21446,-0.0052477,0.26516,0.79068,HP_LONG_PENIS,1
GSE18791_UNSTIM_VS_NEWCATSLE...9,SET,172,-0.055721,-0.0053679,0.068894,0.79068,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN,1
GOMF_PHOSPHATIDYLINOSITOL_3_...11,SET,4,-0.33493,-0.0049431,0.41405,0.79071,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_INHIBITOR_ACTIVITY,1
HP_DELIRIUM,SET,8,-0.25267,-0.0052732,0.31232,0.79074,HP_DELIRIUM,1
RB_DN.V1_DN,SET,109,-0.067861,-0.0052132,0.083877,0.79075,RB_DN.V1_DN,1
GOBP_LENS_FIBER_CELL_DIFFERE...,SET,34,-0.12888,-0.0055409,0.15929,0.79076,GOBP_LENS_FIBER_CELL_DIFFERENTIATION,1
HE_LIM_SUN_FETAL_LUNG_C3_HMO...,SET,22,-0.15711,-0.0054351,0.19418,0.79076,HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST,1
MODULE_306,SET,22,-0.13619,-0.0047116,0.16831,0.79078,MODULE_306,1
HP_CHOROID_PLEXUS_CYST,SET,10,-0.24182,-0.0056421,0.29886,0.79078,HP_CHOROID_PLEXUS_CYST,1
MARCHINI_TRABECTEDIN_RESISTA...1,SET,42,-0.11072,-0.0052895,0.13682,0.7908,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1
BIOCARTA_SALMONELLA_PATHWAY,SET,5,-0.25802,-0.0042574,0.31882,0.79082,BIOCARTA_SALMONELLA_PATHWAY,1
GOMF_ADRENERGIC_RECEPTOR_BIN...,SET,16,-0.18026,-0.0053189,0.22272,0.79084,GOMF_ADRENERGIC_RECEPTOR_BINDING,1
HP_APLASIA_OF_THE_PROXIMAL_P...,SET,9,-0.22416,-0.0049617,0.27696,0.79084,HP_APLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
UNTERMAN_IPF_VS_CTRL_CD8T_UP,SET,2,-0.51213,-0.0053448,0.63273,0.79085,UNTERMAN_IPF_VS_CTRL_CD8T_UP,1
GSE29949_CD8_NEG_DC_SPLEEN_V...6,SET,184,-0.051394,-0.0051192,0.063497,0.79085,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,1
HP_HYPERPHENYLALANINEMIA,SET,6,-0.29518,-0.0053353,0.36466,0.79087,HP_HYPERPHENYLALANINEMIA,1
GSE13547_CTRL_VS_ANTI_IGM_ST...1,SET,151,-0.055121,-0.0049782,0.068083,0.79091,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...29,SET,607,-0.028768,-0.0051436,0.035526,0.79096,HP_APLASIA_HYPOPLASIA_OF_THE_EXTREMITIES,1
GOBP_RESPONSE_TO_TUMOR_CELL,SET,38,-0.12276,-0.0055789,0.15157,0.791,GOBP_RESPONSE_TO_TUMOR_CELL,1
GNF2_TDG,SET,33,-0.10891,-0.004613,0.13446,0.79101,GNF2_TDG,1
MIR3156_5P,SET,61,-0.09482,-0.0054564,0.11706,0.79103,MIR3156_5P,1
GTF3C1_TARGET_GENES,SET,4,-0.35564,-0.0052488,0.43906,0.79103,GTF3C1_TARGET_GENES,1
SCHUETZ_BREAST_CANCER_DUCTAL...1,SET,78,-0.084949,-0.0055252,0.10487,0.79104,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1
GYORFFY_MITOXANTRONE_RESISTA...,SET,32,-0.13455,-0.0056124,0.1661,0.79105,GYORFFY_MITOXANTRONE_RESISTANCE,1
HP_REDUCED_PROGRESSIVE_SPERM...,SET,15,-0.16239,-0.0046397,0.20036,0.79117,HP_REDUCED_PROGRESSIVE_SPERM_MOTILITY,1
GSE24102_GRANULOCYSTIC_MDSC_...1,SET,181,-0.050312,-0.0049708,0.062059,0.79123,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN,1
MIR888_5P,SET,220,-0.046827,-0.0050951,0.057752,0.79126,MIR888_5P,1
RICKMAN_HEAD_AND_NECK_CANCER...6,SET,50,-0.10645,-0.0055477,0.13127,0.79129,RICKMAN_HEAD_AND_NECK_CANCER_F,1
GOBP_CD4_POSITIVE_OR_CD8_POS...,SET,29,-0.14412,-0.0057232,0.17768,0.79135,GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT,1
GSE4590_SMALL_VS_LARGE_PRE_B...1,SET,139,-0.061791,-0.0053561,0.076167,0.79139,GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN,1
GOBP_PROTEIN_DELIPIDATION,SET,4,-0.30798,-0.0045454,0.37958,0.79142,GOBP_PROTEIN_DELIPIDATION,1
GOBP_GROWTH_HORMONE_SECRETION,SET,12,-0.21335,-0.0054525,0.26291,0.79144,GOBP_GROWTH_HORMONE_SECRETION,1
GOBP_LYSOSOMAL_PROTEIN_CATAB...,SET,18,-0.16615,-0.0051998,0.2047,0.79151,GOBP_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,1
GOBP_UTERINE_SMOOTH_MUSCLE_C...,SET,10,-0.24089,-0.0056205,0.29678,0.79151,GOBP_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
MIR1305,SET,460,-0.033229,-0.0051934,0.040934,0.79153,MIR1305,1
GOCC_MICROBODY_MEMBRANE,SET,57,-0.090054,-0.0050099,0.1109,0.7916,GOCC_MICROBODY_MEMBRANE,1
HP_ARTERIOSCLEROSIS,SET,85,-0.080505,-0.005465,0.099111,0.79168,HP_ARTERIOSCLEROSIS,1
GOCC_SPERM_ANNULUS,SET,2,-0.52683,-0.0054983,0.64849,0.79171,GOCC_SPERM_ANNULUS,1
GOBP_NEGATIVE_REGULATION_OF_...667,SET,22,-0.15175,-0.0052497,0.18675,0.79176,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOCC_GOLGI_TRANS_CISTERNA,SET,9,-0.25757,-0.0057013,0.31699,0.79176,GOCC_GOLGI_TRANS_CISTERNA,1
ACEVEDO_NORMAL_TISSUE_ADJACE...2,SET,154,-0.053429,-0.0048727,0.065739,0.79181,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,1
ACCAATC_MIR509,SET,45,-0.11916,-0.0058923,0.14661,0.79182,ACCAATC_MIR509,1
GOMF_PEPTIDE_RECEPTOR_ACTIVI...,SET,119,-0.071103,-0.0057057,0.087483,0.79182,GOMF_PEPTIDE_RECEPTOR_ACTIVITY,1
GSE46606_UNSTIM_VS_CD40L_IL2...12,SET,143,-0.058741,-0.0051638,0.07227,0.79183,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP,1
JAZAERI_BREAST_CANCER_BRCA1_...1,SET,40,-0.11911,-0.0055537,0.14653,0.79185,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,1
KEGG_MEDICUS_ENV_FACTOR_META...4,SET,11,-0.20406,-0.0049933,0.25098,0.7919,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE16385_ROSIGLITAZONE_IL4_V...5,SET,181,-0.050412,-0.0049806,0.061986,0.79196,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN,1
GOCC_INTEGRIN_COMPLEX,SET,29,-0.13874,-0.0055095,0.17057,0.79199,GOCC_INTEGRIN_COMPLEX,1
MIR5571_3P,SET,39,-0.1111,-0.0051151,0.13657,0.79203,MIR5571_3P,1
MORF_RAN,SET,232,-0.042744,-0.0047744,0.052529,0.79209,MORF_RAN,1
GOMF_CHOLESTEROL_BINDING,SET,51,-0.098472,-0.0051827,0.121,0.79212,GOMF_CHOLESTEROL_BINDING,1
HP_CHRONIC_RHINITIS,SET,49,-0.095812,-0.0049431,0.11773,0.79213,HP_CHRONIC_RHINITIS,1
HP_CHILLS,SET,18,-0.16455,-0.0051496,0.20216,0.79215,HP_CHILLS,1
HP_FOCAL_EMOTIONAL_SEIZURE,SET,17,-0.17079,-0.0051946,0.20977,0.79222,HP_FOCAL_EMOTIONAL_SEIZURE,1
GOBP_REGULATION_OF_HEART_RAT...2,SET,5,-0.33748,-0.0055684,0.41446,0.79225,GOBP_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL,1
GSE9037_CTRL_VS_LPS_4H_STIM_...1,SET,183,-0.048652,-0.004833,0.059744,0.79227,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...6,SET,174,-0.051526,-0.0049923,0.063268,0.79229,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
REACTOME_MITF_M_REGULATED_ME...,SET,124,-0.063286,-0.0051834,0.077695,0.79233,REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1
GSE25087_TREG_VS_TCONV_ADULT...1,SET,164,-0.054501,-0.0051279,0.066909,0.79233,GSE25087_TREG_VS_TCONV_ADULT_DN,1
KEGG_DRUG_METABOLISM_OTHER_E...,SET,48,-0.12182,-0.0062207,0.14949,0.79243,KEGG_DRUG_METABOLISM_OTHER_ENZYMES,1
MIR4264,SET,97,-0.071206,-0.0051619,0.087376,0.79244,MIR4264,1
POOLA_INVASIVE_BREAST_CANCER...1,SET,123,-0.065122,-0.0053124,0.079898,0.79248,POOLA_INVASIVE_BREAST_CANCER_DN,1
MEBARKI_HCC_PROGENITOR_WNT_D...1,SET,54,-0.097388,-0.0052739,0.11943,0.79259,MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD,1
GOBP_SMOOTH_MUSCLE_CELL_CHEM...,SET,8,-0.25344,-0.0052891,0.31078,0.79259,GOBP_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,1
GSE2770_TGFB_AND_IL4_ACT_VS_...6,SET,177,-0.050484,-0.0049329,0.061906,0.7926,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,1
GOBP_APOPTOTIC_MITOCHONDRIAL...,SET,94,-0.072936,-0.0052054,0.089435,0.79261,GOBP_APOPTOTIC_MITOCHONDRIAL_CHANGES,1
GOCC_G_PROTEIN_COUPLED_RECEP...1,SET,11,-0.23186,-0.0056736,0.28429,0.79262,GOCC_G_PROTEIN_COUPLED_RECEPTOR_COMPLEX,1
NABA_MATRISOME_POORLY_METAST...4,SET,23,-0.14748,-0.0052166,0.18082,0.79264,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,1
GOBP_RHYTHMIC_PROCESS,SET,280,-0.043945,-0.0053854,0.053879,0.79264,GOBP_RHYTHMIC_PROCESS,1
GOBP_KERATINIZATION,SET,72,-0.10281,-0.0064259,0.12604,0.79266,GOBP_KERATINIZATION,1
GOBP_LYSINE_METABOLIC_PROCESS,SET,8,-0.23184,-0.0048384,0.28414,0.79272,GOBP_LYSINE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...653,SET,89,-0.073016,-0.0050713,0.089474,0.79276,GOBP_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,1
HP_ELEVATED_HEPATIC_IRON_CON...,SET,11,-0.22811,-0.0055817,0.27952,0.79276,HP_ELEVATED_HEPATIC_IRON_CONCENTRATION,1
GOBP_DETERMINATION_OF_ADULT_...,SET,31,-0.12393,-0.005088,0.15185,0.79278,GOBP_DETERMINATION_OF_ADULT_LIFESPAN,1
GSE27786_CD4_TCELL_VS_ERYTHT...1,SET,180,-0.049377,-0.004865,0.060493,0.79281,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN,1
HP_INCREASED_MEAN_PLATELET_V...,SET,21,-0.16648,-0.0056273,0.20393,0.79285,HP_INCREASED_MEAN_PLATELET_VOLUME,1
GOBP_PROTEIN_LOCALIZATION_TO...29,SET,9,-0.24046,-0.0053226,0.29453,0.79287,GOBP_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT,1
GOBP_POSITIVE_REGULATION_OF_...449,SET,38,-0.10988,-0.0049939,0.13454,0.79296,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,1
GSE19772_HCMV_INFL_VS_HCMV_I...1,SET,181,-0.050313,-0.0049709,0.061596,0.79298,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,1
WP_GABA_METABOLISM_AKA_GHB,SET,10,-0.24432,-0.0057005,0.29908,0.79301,WP_GABA_METABOLISM_AKA_GHB,1
GOCC_TRANSCRIPTION_EXPORT_CO...1,SET,10,-0.17571,-0.0040996,0.21504,0.79306,GOCC_TRANSCRIPTION_EXPORT_COMPLEX,1
GOMF_EXTRACELLULAR_MATRIX_PR...,SET,6,-0.3314,-0.0059899,0.40557,0.79306,GOMF_EXTRACELLULAR_MATRIX_PROTEIN_BINDING,1
NAKAYA_MONOCYTE_FLUARIX_FLUV...2,SET,74,-0.079533,-0.005039,0.097332,0.79307,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,1
GSE22886_NAIVE_CD4_TCELL_VS_...16,SET,176,-0.051123,-0.0049813,0.062562,0.79308,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP,1
GSE41867_DAY6_VS_DAY15_LCMV_...3,SET,142,-0.060157,-0.00527,0.073618,0.79308,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GSE22611_NOD2_VS_CTRL_TRANSD...2,SET,174,-0.051568,-0.0049963,0.0631,0.7931,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,1
HP_HEPATOBLASTOMA,SET,21,-0.16559,-0.0055971,0.20261,0.79311,HP_HEPATOBLASTOMA,1
GOBP_REGULATION_OF_POLYSACCH...1,SET,33,-0.1222,-0.0051762,0.14952,0.79312,GOBP_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_SYNAPTIC_...6,SET,70,-0.089224,-0.0054987,0.10916,0.79314,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
HP_ABSENT_TOE,SET,61,-0.092025,-0.0052956,0.11258,0.79314,HP_ABSENT_TOE,1
HP_PROMINENT_NASAL_TIP,SET,25,-0.14445,-0.0053268,0.17673,0.79314,HP_PROMINENT_NASAL_TIP,1
GOBP_LYMPHATIC_ENDOTHELIAL_C...,SET,8,-0.25635,-0.00535,0.3136,0.79316,GOBP_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION,1
chr14q23,SET,53,-0.18935,-0.010159,0.23159,0.79321,chr14q23,1
SCHLINGEMANN_SKIN_CARCINOGEN...2,SET,36,-0.12422,-0.005495,0.15192,0.79321,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,1
GOBP_NEGATIVE_REGULATION_OF_...605,SET,14,-0.2145,-0.0059209,0.26234,0.79321,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,1
GSE21927_C26GM_VS_4T1_TUMOR_...1,SET,176,-0.050877,-0.0049573,0.062209,0.79327,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,1
DESCARTES_FETAL_PLACENTA_AFP...,SET,156,-0.059864,-0.0054947,0.073188,0.7933,DESCARTES_FETAL_PLACENTA_AFP_ALB_POSITIVE_CELLS,1
HP_ABNORMAL_NUMBER_OF_DENSE_...,SET,7,-0.25797,-0.0050362,0.31535,0.79333,HP_ABNORMAL_NUMBER_OF_DENSE_GRANULES,1
BIOCARTA_ALTERNATIVE_PATHWAY,SET,8,-0.25562,-0.0053347,0.31244,0.79336,BIOCARTA_ALTERNATIVE_PATHWAY,1
GOMF_UNFOLDED_PROTEIN_BINDING,SET,107,-0.061532,-0.0046836,0.075191,0.79341,GOMF_UNFOLDED_PROTEIN_BINDING,1
HP_APLASIA_HYPOPLASIA_OF_MET...,SET,59,-0.093292,-0.00528,0.114,0.79342,HP_APLASIA_HYPOPLASIA_OF_METATARSAL_BONES,1
REACTOME_ERBB2_REGULATES_CEL...,SET,15,-0.17564,-0.0050182,0.21457,0.79347,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,1
HP_HYPOPLASTIC_NIPPLES,SET,31,-0.11735,-0.004818,0.14334,0.79352,HP_HYPOPLASTIC_NIPPLES,1
HP_THYROID_AGENESIS,SET,7,-0.29329,-0.0057257,0.35823,0.79352,HP_THYROID_AGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...513,SET,21,-0.16465,-0.0055652,0.20109,0.79354,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
GSE21927_SPLENIC_C26GM_TUMOR...1,SET,162,-0.053521,-0.0050052,0.065368,0.79354,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN,1
GOBP_LEARNING,SET,143,-0.060296,-0.0053006,0.073628,0.79358,GOBP_LEARNING,1
HP_ABNORMAL_VASCULAR_PHYSIOL...,SET,285,-0.042146,-0.0052101,0.051466,0.79358,HP_ABNORMAL_VASCULAR_PHYSIOLOGY,1
HP_MIDFACE_RETRUSION,SET,253,-0.043364,-0.0050552,0.052952,0.79358,HP_MIDFACE_RETRUSION,1
GSE25146_UNSTIM_VS_HELIOBACT...1,SET,148,-0.056349,-0.0050388,0.068809,0.79358,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN,1
FISCHER_G2_M_CELL_CYCLE,SET,221,-0.046245,-0.005043,0.056467,0.79359,FISCHER_G2_M_CELL_CYCLE,1
MIR4694_5P,SET,34,-0.12318,-0.0052961,0.15041,0.79359,MIR4694_5P,1
HP_OVERFRIENDLINESS,SET,23,-0.17019,-0.0060198,0.20775,0.79366,HP_OVERFRIENDLINESS,1
MIR2110,SET,159,-0.054725,-0.0050706,0.066798,0.79368,MIR2110,1
GOCC_CHROMOSOME_TELOMERIC_RE...2,SET,12,-0.17972,-0.0045932,0.21936,0.79369,GOCC_CHROMOSOME_TELOMERIC_REPEAT_REGION,1
GSE4984_GALECTIN1_VS_LPS_STI...1,SET,156,-0.055197,-0.0050663,0.06736,0.79372,GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN,1
GSE5589_LPS_VS_LPS_AND_IL10_...5,SET,180,-0.052317,-0.0051547,0.06384,0.79374,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN,1
DESCARTES_FETAL_PANCREAS_SMO...,SET,30,-0.14091,-0.0056912,0.17195,0.79374,DESCARTES_FETAL_PANCREAS_SMOOTH_MUSCLE_CELLS,1
GOCC_CYCLIN_DEPENDENT_PROTEI...,SET,51,-0.089507,-0.0047109,0.10921,0.79376,GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,1
HP_JERKY_OCULAR_PURSUIT_MOVE...,SET,8,-0.21354,-0.0044566,0.26049,0.79383,HP_JERKY_OCULAR_PURSUIT_MOVEMENTS,1
GSE5503_LIVER_DC_VS_PLN_DC_A...2,SET,182,-0.050888,-0.0050414,0.062072,0.79384,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
HP_AUTOAMPUTATION,SET,15,-0.17531,-0.0050088,0.2138,0.79388,HP_AUTOAMPUTATION,1
GSE16385_MONOCYTE_VS_12H_IFN...2,SET,183,-0.050906,-0.0050568,0.062078,0.79389,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,1
HP_STEREOTYPIC_WHOLE_BODY_MO...,SET,8,-0.21943,-0.0045794,0.26758,0.7939,HP_STEREOTYPIC_WHOLE_BODY_MOVEMENTS,1
GOBP_SULFUR_COMPOUND_CATABOL...,SET,40,-0.11156,-0.0052015,0.13602,0.79393,GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS,1
GSE2585_AIRE_KO_VS_WT_CD80_H...1,SET,181,-0.05188,-0.0051257,0.063254,0.79394,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN,1
GSE7509_FCGRIIB_VS_TNFA_IL1B...1,SET,131,-0.059792,-0.0050326,0.072889,0.79398,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
MODULE_119,SET,130,-0.059799,-0.005014,0.072881,0.79403,MODULE_119,1
HP_ABNORMAL_UMBILICUS_MORPHO...,SET,265,-0.04369,-0.0052109,0.053243,0.79405,HP_ABNORMAL_UMBILICUS_MORPHOLOGY,1
HP_PARAPLEGIA,SET,126,-0.063651,-0.0052549,0.07756,0.79408,HP_PARAPLEGIA,1
HP_OVOTESTIS,SET,3,-0.4279,-0.0054693,0.52126,0.79414,HP_OVOTESTIS,1
LEIN_MIDBRAIN_MARKERS,SET,68,-0.089079,-0.0054111,0.10849,0.7942,LEIN_MIDBRAIN_MARKERS,1
GOMF_GALACTOSYLTRANSFERASE_A...,SET,32,-0.13555,-0.0056539,0.16508,0.7942,GOMF_GALACTOSYLTRANSFERASE_ACTIVITY,1
GSE36009_UNSTIM_VS_LPS_STIM_...1,SET,180,-0.050472,-0.0049729,0.061468,0.7942,GSE36009_UNSTIM_VS_LPS_STIM_DC_DN,1
GOBP_RNA_SURVEILLANCE,SET,17,-0.16179,-0.0049209,0.197,0.79426,GOBP_RNA_SURVEILLANCE,1
GOMF_UBIQUITIN_PROTEIN_TRANS...3,SET,29,-0.13693,-0.0054378,0.16672,0.79427,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY,1
GOCC_NUCLEAR_OUTER_MEMBRANE_...,SET,1100,-0.021813,-0.0051768,0.026557,0.79428,GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK,1
MIR302D_5P,SET,183,-0.052295,-0.0051949,0.063665,0.79429,MIR302D_5P,1
GOMF_ANGIOTENSIN_RECEPTOR_BI...,SET,9,-0.25145,-0.0055659,0.30607,0.79433,GOMF_ANGIOTENSIN_RECEPTOR_BINDING,1
HP_MULTIPLE_GASTRIC_POLYPS,SET,7,-0.24481,-0.0047792,0.29792,0.79438,HP_MULTIPLE_GASTRIC_POLYPS,1
GOBP_CARBOHYDRATE_DERIVATIVE...1,SET,569,-0.029934,-0.0051874,0.036409,0.7945,GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
HP_PHOCOMELIA,SET,7,-0.2813,-0.0054916,0.34213,0.79451,HP_PHOCOMELIA,1
REACTOME_PLATELET_ADHESION_T...,SET,15,-0.19532,-0.0055806,0.23749,0.79458,REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,1
MODULE_188,SET,118,-0.066346,-0.0053018,0.080664,0.7946,MODULE_188,1
NAKAMURA_LUNG_CANCER,SET,8,-0.2847,-0.0059416,0.34609,0.79464,NAKAMURA_LUNG_CANCER,1
GOBP_NEGATIVE_REGULATION_OF_...521,SET,15,-0.17933,-0.0051237,0.21795,0.79468,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
GOMF_PHOSPHATIDYLINOSITOL_3_...1,SET,4,-0.35675,-0.0052651,0.43355,0.79469,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_EP...,SET,11,-0.22593,-0.0055285,0.27451,0.79475,GOBP_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS,1
MIR6719_3P,SET,110,-0.072161,-0.0055688,0.087665,0.79478,MIR6719_3P,1
GOBP_PROTEIN_IMPORT_INTO_PER...1,SET,13,-0.18069,-0.0048063,0.21951,0.79478,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX,1
KEGG_RENIN_ANGIOTENSIN_SYSTEM,SET,15,-0.19843,-0.0056693,0.2409,0.79494,KEGG_RENIN_ANGIOTENSIN_SYSTEM,1
HOXA9_DN.V1_UP,SET,172,-0.055355,-0.0053327,0.067172,0.79505,HOXA9_DN.V1_UP,1
GSE1925_CTRL_VS_24H_IFNG_STI...2,SET,184,-0.053696,-0.0053484,0.065142,0.79511,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
KEGG_MEDICUS_REFERENCE_CREAT...,SET,7,-0.25503,-0.0049788,0.30926,0.79521,KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY,1
DESCARTES_MAIN_FETAL_MEGAKAR...,SET,155,-0.057642,-0.0052738,0.069894,0.79522,DESCARTES_MAIN_FETAL_MEGAKARYOCYTES,1
GOBP_PEPTIDYL_LYSINE_MODIFIC...,SET,127,-0.059821,-0.0049581,0.072529,0.79525,GOBP_PEPTIDYL_LYSINE_MODIFICATION,1
GOBP_MESENCHYMAL_CELL_DIFFER...2,SET,6,-0.34091,-0.0061618,0.41324,0.7953,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
WP_OLIGODENDROCYTE_SPECIFICA...,SET,29,-0.14323,-0.0056879,0.17359,0.79534,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,1
HP_HYPOPLASTIC_HIPPOCAMPUS,SET,16,-0.17603,-0.0051943,0.21333,0.79535,HP_HYPOPLASTIC_HIPPOCAMPUS,1
GAUSSMANN_MLL_AF4_FUSION_TAR...6,SET,157,-0.05506,-0.0050698,0.06672,0.79538,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,1
MIR224_5P,SET,164,-0.054827,-0.0051586,0.066434,0.79539,MIR224_5P,1
GOBP_INTESTINAL_STEM_CELL_HO...,SET,5,-0.31678,-0.0052269,0.38384,0.79539,GOBP_INTESTINAL_STEM_CELL_HOMEOSTASIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...36,SET,32,-0.13181,-0.0054982,0.15972,0.79539,HP_APLASIA_HYPOPLASIA_OF_THE_HALLUX,1
GSE22886_NAIVE_CD4_TCELL_VS_...12,SET,171,-0.054067,-0.0051936,0.065505,0.79542,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP,1
GSE36078_UNTREATED_VS_AD5_T4...3,SET,181,-0.052886,-0.0052251,0.064072,0.79543,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN,1
GOBP_OLEFINIC_COMPOUND_METAB...,SET,154,-0.061834,-0.0056393,0.074908,0.79544,GOBP_OLEFINIC_COMPOUND_METABOLIC_PROCESS,1
GOBP_RIBONUCLEOSIDE_CATABOLI...,SET,18,-0.19669,-0.0061556,0.23828,0.79544,GOBP_RIBONUCLEOSIDE_CATABOLIC_PROCESS,1
HP_ORAL_MUCOSAL_BLISTERS,SET,13,-0.20559,-0.0054686,0.24904,0.79545,HP_ORAL_MUCOSAL_BLISTERS,1
DESCARTES_FETAL_ADRENAL_LYMP...,SET,131,-0.066689,-0.0056131,0.08078,0.79547,DESCARTES_FETAL_ADRENAL_LYMPHOID_CELLS,1
GOBP_MAGNESIUM_ION_TRANSPORT,SET,14,-0.19047,-0.0052576,0.2307,0.79548,GOBP_MAGNESIUM_ION_TRANSPORT,1
BIOCARTA_G1_PATHWAY,SET,28,-0.12819,-0.0050022,0.15526,0.79549,BIOCARTA_G1_PATHWAY,1
HP_UNILATERAL_CRYPTORCHIDISM,SET,11,-0.23578,-0.0057695,0.28556,0.7955,HP_UNILATERAL_CRYPTORCHIDISM,1
GOBP_TRNA_METHYLATION,SET,36,-0.10384,-0.0045938,0.12576,0.79552,GOBP_TRNA_METHYLATION,1
HP_SKELETAL_MYOPATHY,SET,9,-0.22627,-0.0050085,0.27402,0.79552,HP_SKELETAL_MYOPATHY,1
GOBP_POSITIVE_REGULATION_OF_...264,SET,72,-0.083282,-0.0052051,0.10082,0.79562,GOBP_POSITIVE_REGULATION_OF_EXOCYTOSIS,1
GOBP_HYDROCARBON_METABOLIC_P...,SET,7,-0.27155,-0.0053012,0.32867,0.79565,GOBP_HYDROCARBON_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_MITOCHOND...7,SET,29,-0.11724,-0.0046556,0.14188,0.79567,GOBP_REGULATION_OF_MITOCHONDRIAL_GENE_EXPRESSION,1
HP_THIN_NAIL,SET,13,-0.194,-0.0051603,0.23473,0.79572,HP_THIN_NAIL,1
KEGG_MEDICUS_REFERENCE_DNA_D...,SET,6,-0.3039,-0.0054929,0.3677,0.79573,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE,1
HOFFMANN_IMMATURE_TO_MATURE_...1,SET,43,-0.11462,-0.0055406,0.13864,0.7958,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,1
HP_HYDROCEPHALUS,SET,351,-0.037191,-0.0050929,0.044982,0.79582,HP_HYDROCEPHALUS,1
STARK_PREFRONTAL_CORTEX_22Q1...2,SET,180,-0.053518,-0.005273,0.064723,0.79584,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1
GOBP_BIOLOGICAL_PROCESS_INVO...2,SET,106,-0.070588,-0.005348,0.085366,0.79584,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_SYMBIONT,1
GOBP_PYRIMIDINE_NUCLEOBASE_M...,SET,20,-0.158,-0.0052118,0.19108,0.79584,GOBP_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS,1
GOBP_NADPH_OXIDATION,SET,6,-0.29128,-0.0052648,0.35225,0.79585,GOBP_NADPH_OXIDATION,1
GOBP_POSITIVE_REGULATION_OF_...127,SET,807,-0.026619,-0.0054567,0.032191,0.79585,GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION,1
MATZUK_MALE_REPRODUCTION_SER...,SET,25,-0.14737,-0.0054345,0.17821,0.79586,MATZUK_MALE_REPRODUCTION_SERTOLI,1
GOBP_POLYSACCHARIDE_METABOLI...,SET,97,-0.070927,-0.0051417,0.085769,0.79586,GOBP_POLYSACCHARIDE_METABOLIC_PROCESS,1
HP_WORMIAN_BONES,SET,53,-0.094645,-0.0050777,0.11445,0.79586,HP_WORMIAN_BONES,1
GSE27786_LIN_NEG_VS_ERYTHROB...2,SET,182,-0.050155,-0.0049688,0.060647,0.79588,GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP,1
GOCC_CUL2_RING_UBIQUITIN_LIG...,SET,20,-0.15822,-0.0052191,0.19127,0.79593,GOCC_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX,1
GSE22886_NAIVE_BCELL_VS_BM_P...2,SET,178,-0.05092,-0.0049893,0.061554,0.79594,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP,1
HP_BRITTLE_HAIR,SET,41,-0.10475,-0.0049443,0.12661,0.79596,HP_BRITTLE_HAIR,1
MIR4642,SET,90,-0.0777,-0.0054267,0.093914,0.79597,MIR4642,1
GOBP_GAMMA_DELTA_T_CELL_DIFF...,SET,13,-0.18907,-0.0050292,0.2285,0.796,GOBP_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
GOBP_PRESYNAPTIC_ACTIVE_ZONE...,SET,7,-0.3053,-0.0059602,0.36891,0.79604,GOBP_PRESYNAPTIC_ACTIVE_ZONE_ORGANIZATION,1
DESCARTES_MAIN_FETAL_SQUAMOU...,SET,94,-0.07862,-0.0056111,0.094997,0.79605,DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS,1
FOURNIER_ACINAR_DEVELOPMENT_...3,SET,264,-0.042248,-0.0050295,0.051032,0.79612,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,1
HP_DORSOCERVICAL_FAT_PAD,SET,14,-0.18397,-0.0050781,0.22217,0.79618,HP_DORSOCERVICAL_FAT_PAD,1
BIOCARTA_NO1_PATHWAY,SET,28,-0.1436,-0.0056034,0.17339,0.79621,BIOCARTA_NO1_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...634,SET,8,-0.27217,-0.0056801,0.3286,0.79623,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
GOBP_AMINO_ACID_TRANSPORT,SET,147,-0.061854,-0.0055125,0.074666,0.79628,GOBP_AMINO_ACID_TRANSPORT,1
KEGG_MEDICUS_REFERENCE_LYSOS...,SET,10,-0.21093,-0.0049212,0.25455,0.79634,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE,1
GOBP_POSITIVE_REGULATION_OF_...717,SET,11,-0.22505,-0.005507,0.27153,0.7964,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...2,SET,8,-0.26057,-0.005438,0.31433,0.79643,HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL,1
HP_ABNORMAL_PATTERN_OF_RESPI...,SET,677,-0.027975,-0.005272,0.033743,0.79646,HP_ABNORMAL_PATTERN_OF_RESPIRATION,1
GOBP_ARTICULAR_CARTILAGE_DEV...,SET,5,-0.26228,-0.0043277,0.31634,0.79647,GOBP_ARTICULAR_CARTILAGE_DEVELOPMENT,1
GOBP_REGULATION_OF_GLUCOCORT...3,SET,5,-0.3616,-0.0059664,0.43611,0.79648,GOBP_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY,1
HP_APLASIA_HYPOPLASIA_OF_THE...57,SET,38,-0.1179,-0.005358,0.14219,0.79648,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_THUMB,1
GSE3994_WT_VS_PAC1_KO_ACTIVA...2,SET,187,-0.053897,-0.0054116,0.064987,0.79654,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP,1
GOBP_RESPONSE_TO_VITAMIN_K,SET,4,-0.41973,-0.0061947,0.50607,0.79655,GOBP_RESPONSE_TO_VITAMIN_K,1
GOMF_CATALYTIC_ACTIVITY_ACTI...4,SET,109,-0.061689,-0.004739,0.074376,0.79656,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA,1
chr2q31,SET,73,-0.14859,-0.0093509,0.17912,0.79661,chr2q31,1
GOBP_RETINAL_BLOOD_VESSEL_MO...,SET,5,-0.29736,-0.0049066,0.35841,0.79664,GOBP_RETINAL_BLOOD_VESSEL_MORPHOGENESIS,1
GOCC_PERINUCLEAR_REGION_OF_C...,SET,668,-0.027754,-0.0051968,0.033449,0.79665,GOCC_PERINUCLEAR_REGION_OF_CYTOPLASM,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...2,SET,177,-0.051643,-0.0050461,0.062226,0.7967,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,1
GOBP_REGULATION_OF_GLUCOSYLC...,SET,2,-0.58277,-0.0060821,0.70206,0.79675,GOBP_REGULATION_OF_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...139,SET,42,-0.11398,-0.0054451,0.13727,0.79682,GOBP_NEGATIVE_REGULATION_OF_CHEMOTAXIS,1
MIR1224_5P,SET,55,-0.092883,-0.0050761,0.11183,0.79689,MIR1224_5P,1
BERENJENO_TRANSFORMED_BY_RHO...6,SET,496,-0.031115,-0.0050447,0.037446,0.79699,BERENJENO_TRANSFORMED_BY_RHOA_UP,1
PID_IL2_1PATHWAY,SET,54,-0.10189,-0.0055179,0.12262,0.79699,PID_IL2_1PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...438,SET,12,-0.22389,-0.005722,0.26944,0.797,GOBP_NEGATIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,1
HP_HAND_CLENCHING,SET,27,-0.13016,-0.0049878,0.15663,0.79701,HP_HAND_CLENCHING,1
ZHANG_ADIPOGENESIS_BY_BMP7,SET,14,-0.1891,-0.0052197,0.22752,0.79704,ZHANG_ADIPOGENESIS_BY_BMP7,1
GOBP_INTRINSIC_APOPTOTIC_SIG...4,SET,40,-0.10334,-0.0048184,0.12432,0.79708,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,1
HARALAMBIEVA_PBMC_M_M_R_II_A...2,SET,842,-0.026919,-0.005631,0.032375,0.79714,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,1
GSE6259_33D1_POS_DC_VS_BCELL...1,SET,133,-0.060185,-0.0051039,0.072381,0.79715,GSE6259_33D1_POS_DC_VS_BCELL_DN,1
GSE37532_TREG_VS_TCONV_CD4_T...3,SET,149,-0.054227,-0.0048653,0.065213,0.79716,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,1
GSE23502_WT_VS_HDC_KO_MYELOI...1,SET,185,-0.053581,-0.0053514,0.064413,0.79724,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN,1
GOBP_POSITIVE_REGULATION_OF_...106,SET,1023,-0.023196,-0.0053207,0.027879,0.7973,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,1
LI_ESTROGENE_BIDIRECTIONAL_E...,SET,85,-0.085396,-0.005797,0.10261,0.79735,LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE,1
GOBP_MONOATOMIC_ION_HOMEOSTA...,SET,560,-0.031735,-0.0054572,0.038125,0.7974,GOBP_MONOATOMIC_ION_HOMEOSTASIS,1
DESCARTES_FETAL_EYE_SMOOTH_M...,SET,53,-0.098676,-0.005294,0.1185,0.7975,DESCARTES_FETAL_EYE_SMOOTH_MUSCLE_CELLS,1
TAVAZOIE_METASTASIS,SET,87,-0.078332,-0.0053794,0.09406,0.79751,TAVAZOIE_METASTASIS,1
IKEDA_MIR1_TARGETS_UP,SET,53,-0.097582,-0.0052353,0.11716,0.79755,IKEDA_MIR1_TARGETS_UP,1
REACTOME_PD_1_SIGNALING,SET,18,-0.18419,-0.0057645,0.22115,0.79755,REACTOME_PD_1_SIGNALING,1
HP_JUVENILE_CATARACT,SET,10,-0.20752,-0.0048419,0.24913,0.79757,HP_JUVENILE_CATARACT,1
GSE39820_TGFBETA1_IL6_VS_TGF...2,SET,185,-0.051212,-0.0051147,0.061478,0.79757,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP,1
GSE36476_YOUNG_VS_OLD_DONOR_...7,SET,166,-0.058793,-0.0055651,0.070574,0.79759,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN,1
ELF1_Q6,SET,227,-0.045857,-0.0050674,0.055036,0.79763,ELF1_Q6,1
RYTGCNNRGNAAC_MIF1_01,SET,78,-0.082667,-0.0053767,0.099213,0.79764,RYTGCNNRGNAAC_MIF1_01,1
chr2p16,SET,35,-0.18994,-0.008285,0.22787,0.79773,chr2p16,1
KORKOLA_SEMINOMA_DN,SET,8,-0.31021,-0.006474,0.37208,0.79778,KORKOLA_SEMINOMA_DN,1
HP_MULTIPLE_PRENATAL_FRACTUR...,SET,16,-0.16568,-0.0048888,0.19868,0.79783,HP_MULTIPLE_PRENATAL_FRACTURES,1
GOBP_POSITIVE_REGULATION_OF_...804,SET,63,-0.1012,-0.005918,0.12135,0.79784,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
HP_HYPOARGININEMIA,SET,6,-0.25613,-0.0046294,0.30711,0.79785,HP_HYPOARGININEMIA,1
GSE40685_TREG_VS_FOXP3_KO_TR...2,SET,171,-0.056487,-0.005426,0.06773,0.79786,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP,1
JIANG_VHL_TARGETS,SET,77,-0.078884,-0.0050978,0.094572,0.79789,JIANG_VHL_TARGETS,1
GOCC_EKC_KEOPS_COMPLEX,SET,3,-0.39898,-0.0050997,0.47832,0.79789,GOCC_EKC_KEOPS_COMPLEX,1
ZNF664_TARGET_GENES,SET,764,-0.026286,-0.0052493,0.031511,0.7979,ZNF664_TARGET_GENES,1
ABE_INNER_EAR,SET,39,-0.11959,-0.0055059,0.14335,0.79792,ABE_INNER_EAR,1
REACTOME_GLYCOSPHINGOLIPID_T...,SET,8,-0.22755,-0.0047489,0.27271,0.79797,REACTOME_GLYCOSPHINGOLIPID_TRANSPORT,1
GOBP_REGULATION_OF_CORTICOTR...,SET,4,-0.37828,-0.0055829,0.4533,0.79799,GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION,1
GOBP_DNA_LIGATION,SET,16,-0.14337,-0.0042305,0.1718,0.798,GOBP_DNA_LIGATION,1
HP_CHORIOCAPILLARIS_ATROPHY,SET,8,-0.25423,-0.0053057,0.30459,0.79804,HP_CHORIOCAPILLARIS_ATROPHY,1
GOBP_ENDOCARDIAL_CUSHION_MOR...,SET,42,-0.12829,-0.0061289,0.15368,0.79808,GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,SET,52,-0.10785,-0.0057318,0.12919,0.79809,BOYLAN_MULTIPLE_MYELOMA_C_DN,1
ANDERSEN_LIVER_CANCER_KRT19_...1,SET,70,-0.086903,-0.0053557,0.10409,0.7981,ANDERSEN_LIVER_CANCER_KRT19_DN,1
GOBP_ESTABLISHMENT_OF_PROTEI...8,SET,18,-0.15764,-0.0049336,0.18882,0.7981,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME,1
BIOCARTA_FLUMAZENIL_PATHWAY,SET,8,-0.27065,-0.0056484,0.32417,0.79811,BIOCARTA_FLUMAZENIL_PATHWAY,1
MIR4709_5P,SET,94,-0.077384,-0.0055228,0.092681,0.79812,MIR4709_5P,1
GOBP_RESPONSE_TO_CELL_CYCLE_...,SET,7,-0.24625,-0.0048074,0.29492,0.79813,GOBP_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING,1
ZHOU_INFLAMMATORY_RESPONSE_F...2,SET,425,-0.036126,-0.0054325,0.043262,0.79815,ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,1
GAO_ESOPHAGUS_25W_C2_KRT6BPO...,SET,66,-0.092331,-0.0055259,0.11055,0.79819,GAO_ESOPHAGUS_25W_C2_KRT6BPOS_SECRETORY_PROGENITOR_CELLS,1
HP_HYPOPLASIA_OF_THE_FEMORAL...,SET,5,-0.3428,-0.0056563,0.41039,0.79822,HP_HYPOPLASIA_OF_THE_FEMORAL_HEAD,1
GOMF_GLYCEROL_3_PHOSPHATE_O_...,SET,3,-0.47201,-0.0060331,0.56503,0.79824,GOMF_GLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,1
GSE8621_UNSTIM_VS_LPS_STIM_M...2,SET,182,-0.053178,-0.0052683,0.06363,0.79835,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
GAUTAM_EYE_IRIS_CILIARY_BODY...7,SET,88,-0.084511,-0.0058368,0.10112,0.79835,GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS,1
KEGG_MEDICUS_REFERENCE_AHR_S...,SET,8,-0.26565,-0.0055439,0.31759,0.79854,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY,1
GOMF_ALPHA_N_ACETYLGALACTOSA...,SET,6,-0.34879,-0.0063042,0.41687,0.79861,GOMF_ALPHA_N_ACETYLGALACTOSAMINIDE_ALPHA_2_6_SIALYLTRANSFERASE_ACTIVITY,1
PID_INTEGRIN2_PATHWAY,SET,26,-0.16046,-0.0060339,0.19177,0.79862,PID_INTEGRIN2_PATHWAY,1
SHEPARD_CRASH_AND_BURN_MUTAN...2,SET,187,-0.05383,-0.0054049,0.064326,0.79865,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1
GOMF_U6_SNRNA_BINDING,SET,14,-0.16297,-0.0044986,0.19474,0.79866,GOMF_U6_SNRNA_BINDING,1
HP_MYOFIBRILLAR_MYOPATHY,SET,10,-0.23767,-0.0055453,0.28391,0.79874,HP_MYOFIBRILLAR_MYOPATHY,1
HP_CONTINUOUS_SPIKE_AND_WAVE...,SET,8,-0.26902,-0.0056143,0.32127,0.7988,HP_CONTINUOUS_SPIKE_AND_WAVES_DURING_SLOW_SLEEP,1
KEGG_MEDICUS_VARIANT_MUTATIO...89,SET,9,-0.21652,-0.0047926,0.25857,0.79881,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION,1
GSE17721_POLYIC_VS_PAM3CSK4_...12,SET,182,-0.051242,-0.0050765,0.061192,0.79881,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP,1
GOBP_POSITIVE_REGULATION_OF_...692,SET,9,-0.27371,-0.0060586,0.32681,0.79884,GOBP_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
GSE33162_UNTREATED_VS_4H_LPS...4,SET,185,-0.050279,-0.0050215,0.060028,0.79886,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP,1
GOMF_G_PROTEIN_COUPLED_SEROT...,SET,21,-0.163,-0.0055095,0.19455,0.79893,GOMF_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_ACTIVITY,1
GOBP_MEMBRANE_LIPID_BIOSYNTH...,SET,143,-0.059943,-0.0052695,0.07154,0.79895,GOBP_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_LIPID_CAT...,SET,57,-0.097543,-0.0054265,0.11641,0.79897,GOBP_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...1,SET,8,-0.29955,-0.0062514,0.35742,0.799,GOBP_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
ZNF329_TARGET_GENES,SET,439,-0.034012,-0.005196,0.040579,0.79902,ZNF329_TARGET_GENES,1
HP_PORENCEPHALIC_CYST,SET,30,-0.12583,-0.0050823,0.15013,0.79902,HP_PORENCEPHALIC_CYST,1
REACTOME_MET_ACTIVATES_RAP1_...,SET,11,-0.21306,-0.0052136,0.25419,0.79903,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,1
HP_HYPOPLASTIC_DERMOEPIDERMA...,SET,7,-0.29816,-0.0058207,0.35564,0.79908,HP_HYPOPLASTIC_DERMOEPIDERMAL_HEMIDESMOSOMES,1
GOMF_STEROID_BINDING,SET,102,-0.073423,-0.0054574,0.087567,0.79911,GOMF_STEROID_BINDING,1
GOBP_PIGMENT_GRANULE_ORGANIZ...,SET,36,-0.1247,-0.0055165,0.14872,0.79912,GOBP_PIGMENT_GRANULE_ORGANIZATION,1
GSE17721_PAM3CSK4_VS_CPG_2H_...1,SET,181,-0.051742,-0.005112,0.061705,0.79913,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN,1
GOBP_REGULATION_OF_SYSTEMIC_...1,SET,84,-0.081971,-0.0055318,0.09775,0.79914,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
MATZUK_EMBRYONIC_GERM_CELL,SET,18,-0.18906,-0.0059168,0.22542,0.79918,MATZUK_EMBRYONIC_GERM_CELL,1
HP_ABNORMAL_LACRIMAL_DUCT_MO...,SET,41,-0.11113,-0.0052459,0.13245,0.79927,HP_ABNORMAL_LACRIMAL_DUCT_MORPHOLOGY,1
HOEK_NEUTROPHIL_2011_2012_TI...3,SET,7,-0.26948,-0.0052609,0.32118,0.79927,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_DN,1
GSE3982_CTRL_VS_LPS_4H_MAC_DN,SET,187,-0.054806,-0.0055028,0.06529,0.79938,GSE3982_CTRL_VS_LPS_4H_MAC_DN,1
GOBP_FLAVONE_METABOLIC_PROCE...,SET,6,-0.26651,-0.004817,0.31747,0.79939,GOBP_FLAVONE_METABOLIC_PROCESS,1
SESTO_RESPONSE_TO_UV_C8,SET,66,-0.092962,-0.0055636,0.11073,0.79941,SESTO_RESPONSE_TO_UV_C8,1
HP_CALCIFICATION_OF_CARTILAGE,SET,11,-0.24026,-0.0058791,0.28619,0.79941,HP_CALCIFICATION_OF_CARTILAGE,1
chr22q12,SET,107,-0.14859,-0.01131,0.17698,0.79942,chr22q12,1
HP_ECTOPIC_KIDNEY,SET,72,-0.085594,-0.0053496,0.10193,0.79947,HP_ECTOPIC_KIDNEY,1
TCTGATA_MIR361,SET,79,-0.081588,-0.0053403,0.09714,0.79951,TCTGATA_MIR361,1
MIR12136,SET,903,-0.024685,-0.0053381,0.029386,0.79955,MIR12136,1
PID_PI3KCI_AKT_PATHWAY,SET,34,-0.11957,-0.0051406,0.1423,0.7996,PID_PI3KCI_AKT_PATHWAY,1
HP_EPIPHYSEAL_STIPPLING,SET,30,-0.1332,-0.0053801,0.15853,0.79961,HP_EPIPHYSEAL_STIPPLING,1
GOBP_MEMBRANE_LIPID_METABOLI...,SET,203,-0.051039,-0.005337,0.060737,0.79963,GOBP_MEMBRANE_LIPID_METABOLIC_PROCESS,1
GSE34156_NOD2_LIGAND_VS_TLR1...3,SET,169,-0.05686,-0.0054301,0.06766,0.79965,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
GSE16385_IFNG_TNF_VS_ROSIGLI...1,SET,143,-0.060607,-0.0053279,0.072116,0.79966,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
HP_ABNORMAL_CIRCULATING_NUCL...,SET,42,-0.10619,-0.0050733,0.12634,0.79969,HP_ABNORMAL_CIRCULATING_NUCLEOBASE_CONCENTRATION,1
DING_LUNG_CANCER_MUTATED_FRE...,SET,12,-0.18876,-0.0048242,0.22455,0.79971,DING_LUNG_CANCER_MUTATED_FREQUENTLY,1
MIR4297,SET,161,-0.05752,-0.0053627,0.068424,0.79972,MIR4297,1
KEGG_MEDICUS_REFERENCE_CXCL1...,SET,18,-0.1762,-0.0055143,0.20956,0.79976,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY,1
HP_ABNORMAL_THYROID_STIMULAT...,SET,39,-0.12047,-0.0055464,0.14328,0.79977,HP_ABNORMAL_THYROID_STIMULATING_HORMONE_LEVEL,1
GOBP_NEGATIVE_REGULATION_OF_...72,SET,9,-0.23971,-0.0053061,0.28508,0.79978,GOBP_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,1
HP_GLIOSIS,SET,89,-0.074397,-0.0051672,0.088477,0.79978,HP_GLIOSIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...72,SET,5,-0.30252,-0.0049916,0.35974,0.79981,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,1
LAKE_ADULT_KIDNEY_C15_CONNEC...,SET,156,-0.063359,-0.0058155,0.075339,0.79982,LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE,1
REACTOME_REGULATION_OF_ENDOG...3,SET,37,-0.12033,-0.0053965,0.14307,0.79984,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS,1
BLANCO_MELO_BRONCHIAL_EPITHE...4,SET,124,-0.066049,-0.0054097,0.078522,0.79986,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1
MIR6851_3P,SET,53,-0.096781,-0.0051923,0.11504,0.79989,MIR6851_3P,1
GOBP_MEMBRANE_RAFT_LOCALIZAT...,SET,6,-0.32663,-0.0059036,0.38826,0.79989,GOBP_MEMBRANE_RAFT_LOCALIZATION,1
GOBP_ACTIVATED_T_CELL_PROLIF...,SET,42,-0.1207,-0.0057666,0.14344,0.79996,GOBP_ACTIVATED_T_CELL_PROLIFERATION,1
ASH1L_TARGET_GENES,SET,1137,-0.022368,-0.0053913,0.026579,0.79998,ASH1L_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_MYOST...,SET,8,-0.26262,-0.0054808,0.31203,0.80001,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY,1
GOBP_POSTSYNAPTIC_DENSITY_PR...,SET,10,-0.24094,-0.0056215,0.28627,0.80001,GOBP_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING,1
TURASHVILI_BREAST_CARCINOMA_...1,SET,3,-0.342,-0.0043714,0.40632,0.80002,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1
VILIMAS_NOTCH1_TARGETS_DN,SET,24,-0.16407,-0.0059279,0.19491,0.80002,VILIMAS_NOTCH1_TARGETS_DN,1
GOBP_REGULATION_OF_EPITHELIA...3,SET,14,-0.22295,-0.0061541,0.26484,0.80005,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOCC_CILIUM,SET,635,-0.028892,-0.0052794,0.034292,0.80025,GOCC_CILIUM,1
GOBP_SYNAPTIC_VESICLE_COATING,SET,5,-0.31505,-0.0051985,0.37392,0.80026,GOBP_SYNAPTIC_VESICLE_COATING,1
GSE15324_ELF4_KO_VS_WT_ACTIV...1,SET,180,-0.052441,-0.0051669,0.062238,0.80026,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN,1
ZFP3_TARGET_GENES,SET,286,-0.043056,-0.0053318,0.051097,0.80028,ZFP3_TARGET_GENES,1
chr1q32,SET,139,-0.13437,-0.011647,0.15943,0.80033,chr1q32,1
HP_CLONIC_SEIZURE,SET,72,-0.085378,-0.0053361,0.1013,0.80033,HP_CLONIC_SEIZURE,1
GSE21063_CTRL_VS_ANTI_IGM_ST...8,SET,181,-0.054886,-0.0054227,0.065123,0.80033,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...342,SET,67,-0.096643,-0.0058274,0.11466,0.80034,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
GOBP_POSITIVE_REGULATION_OF_...540,SET,36,-0.13044,-0.0057703,0.15473,0.80038,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,1
REACTOME_METABOLISM_OF_AMINO...,SET,330,-0.038828,-0.0051585,0.046052,0.80041,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1
GOBP_CELLULAR_RESPONSE_TO_IN...7,SET,24,-0.15675,-0.0056637,0.18592,0.80041,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_BETA,1
KYNG_ENVIRONMENTAL_STRESS_RE...6,SET,23,-0.14456,-0.0051132,0.17144,0.80042,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1
GRAHAM_NORMAL_QUIESCENT_VS_N...2,SET,54,-0.10564,-0.0057206,0.12527,0.80046,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,1
REACTOME_GLUCOCORTICOID_BIOS...,SET,10,-0.24682,-0.0057587,0.29263,0.80051,REACTOME_GLUCOCORTICOID_BIOSYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...165,SET,9,-0.23846,-0.0052783,0.28271,0.80051,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
WANG_ESOPHAGUS_CANCER_PROGRE...,SET,9,-0.26251,-0.0058107,0.31117,0.80056,WANG_ESOPHAGUS_CANCER_PROGRESSION_UP,1
REACTOME_SYNTHESIS_OF_GDP_MA...,SET,5,-0.27365,-0.0045153,0.32433,0.80059,REACTOME_SYNTHESIS_OF_GDP_MANNOSE,1
CLIMENT_BREAST_CANCER_COPY_N...2,SET,23,-0.16299,-0.0057653,0.19313,0.80064,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,1
GOBP_MODULATION_BY_HOST_OF_S...,SET,78,-0.081846,-0.0053233,0.096983,0.80064,GOBP_MODULATION_BY_HOST_OF_SYMBIONT_PROCESS,1
GOBP_ADENYLATE_CYCLASE_INHIB...2,SET,8,-0.25274,-0.0052747,0.29948,0.80065,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,1
GSE25088_ROSIGLITAZONE_VS_IL...4,SET,165,-0.055496,-0.0052373,0.065757,0.80065,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,1
KEGG_MEDICUS_REFERENCE_NUCLE...2,SET,11,-0.23206,-0.0056785,0.27496,0.80066,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,1
GSE17721_LPS_VS_CPG_6H_BMDC_...2,SET,174,-0.054075,-0.0052392,0.064069,0.80066,GSE17721_LPS_VS_CPG_6H_BMDC_UP,1
DESCARTES_FETAL_CEREBRUM_EXC...,SET,13,-0.22537,-0.0059947,0.26703,0.80066,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,1
DESCARTES_MAIN_FETAL_ISLET_E...,SET,51,-0.1098,-0.0057791,0.13005,0.80075,DESCARTES_MAIN_FETAL_ISLET_ENDOCRINE_CELLS,1
GOBP_ORGANIC_ACID_TRANSMEMBR...,SET,139,-0.06308,-0.0054678,0.074706,0.80077,GOBP_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT,1
ZNF618_TARGET_GENES,SET,1047,-0.023348,-0.0054143,0.027648,0.8008,ZNF618_TARGET_GENES,1
HP_EPISODIC_HYPERHIDROSIS,SET,25,-0.13544,-0.0049945,0.16038,0.8008,HP_EPISODIC_HYPERHIDROSIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...75,SET,8,-0.23234,-0.0048489,0.2751,0.80082,HP_APLASIA_HYPOPLASIA_OF_THE_TRAGUS,1
HP_ABNORMAL_ORAL_MUCOSA_MORP...,SET,336,-0.041464,-0.0055577,0.049086,0.80086,HP_ABNORMAL_ORAL_MUCOSA_MORPHOLOGY,1
GSE17721_POLYIC_VS_PAM3CSK4_...16,SET,185,-0.053148,-0.0053081,0.062907,0.8009,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP,1
MIR127_3P,SET,5,-0.32465,-0.0053569,0.38415,0.80097,MIR127_3P,1
HP_ABNORMALITY_OF_THE_WRIST,SET,147,-0.062215,-0.0055446,0.073603,0.80101,HP_ABNORMALITY_OF_THE_WRIST,1
HP_ABNORMALITY_OF_PROTHROMBIN,SET,47,-0.11131,-0.0056248,0.13169,0.80102,HP_ABNORMALITY_OF_PROTHROMBIN,1
GOCC_FICOLIN_1_RICH_GRANULE_...1,SET,120,-0.065419,-0.0052715,0.077384,0.80104,GOCC_FICOLIN_1_RICH_GRANULE_LUMEN,1
CATTTCA_MIR203,SET,259,-0.044547,-0.0052534,0.052676,0.80113,CATTTCA_MIR203,1
HP_HIGH_FREQUENCY_SENSORINEU...,SET,6,-0.27612,-0.0049908,0.32649,0.80114,HP_HIGH_FREQUENCY_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE17721_CTRL_VS_PAM3CSK4_12...1,SET,185,-0.053425,-0.0053357,0.063168,0.80115,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN,1
BARRIER_CANCER_RELAPSE_TUMOR...1,SET,10,-0.21647,-0.0050505,0.25589,0.8012,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,1
GOBP_LEUKOCYTE_MEDIATED_IMMU...,SET,363,-0.040299,-0.0056101,0.047638,0.8012,GOBP_LEUKOCYTE_MEDIATED_IMMUNITY,1
GOBP_NERVE_DEVELOPMENT,SET,92,-0.081499,-0.0057546,0.096338,0.80121,GOBP_NERVE_DEVELOPMENT,1
HP_OPTIC_DISC_DRUSEN,SET,12,-0.22346,-0.005711,0.26415,0.80121,HP_OPTIC_DISC_DRUSEN,1
HP_SENSORY_NEUROPATHY,SET,88,-0.074888,-0.0051722,0.088524,0.80121,HP_SENSORY_NEUROPATHY,1
VANHARANTA_UTERINE_FIBROID_UP,SET,39,-0.12188,-0.0056113,0.14403,0.80127,VANHARANTA_UTERINE_FIBROID_UP,1
AGTCTAG_MIR151,SET,20,-0.16947,-0.0055902,0.20027,0.80128,AGTCTAG_MIR151,1
GOBP_NEGATIVE_REGULATION_OF_...158,SET,42,-0.10985,-0.0052477,0.1298,0.80128,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...232,SET,13,-0.21479,-0.0057134,0.25373,0.80137,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION,1
GOBP_CELLULAR_RESPONSE_TO_BR...,SET,10,-0.24362,-0.0056841,0.28777,0.80138,GOBP_CELLULAR_RESPONSE_TO_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_STIMULUS,1
TERAMOTO_OPN_TARGETS_CLUSTER...1,SET,13,-0.19815,-0.0052707,0.23405,0.80139,TERAMOTO_OPN_TARGETS_CLUSTER_1,1
GOBP_CELLULAR_RESPONSE_TO_XE...,SET,187,-0.057265,-0.0057498,0.067626,0.80144,GOBP_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS,1
GOBP_PURINE_NUCLEOBASE_TRANS...,SET,8,-0.28244,-0.0058943,0.33354,0.80144,GOBP_PURINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORT,1
MIR3614_3P,SET,58,-0.091776,-0.0051502,0.10833,0.80154,MIR3614_3P,1
MODULE_545,SET,18,-0.16847,-0.0052725,0.19883,0.80158,MODULE_545,1
HP_LARGE_FOREHEAD,SET,21,-0.15584,-0.0052676,0.18391,0.8016,HP_LARGE_FOREHEAD,1
HP_CONGENITAL_HIP_DISLOCATION,SET,68,-0.086697,-0.0052664,0.10231,0.80161,HP_CONGENITAL_HIP_DISLOCATION,1
MODULE_175,SET,52,-0.10109,-0.005372,0.11926,0.80166,MODULE_175,1
HP_ANNULAR_PANCREAS,SET,25,-0.15344,-0.005658,0.18098,0.80172,HP_ANNULAR_PANCREAS,1
GOMF_POLYUBIQUITIN_MODIFICAT...,SET,45,-0.095135,-0.0047041,0.11218,0.80178,GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
JI_CARCINOGENESIS_BY_KRAS_AN...2,SET,12,-0.2052,-0.0052443,0.24196,0.8018,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,1
GOBP_ESTABLISHMENT_OF_ENDOTH...1,SET,50,-0.11045,-0.005756,0.13019,0.80188,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER,1
HP_HORIZONTAL_NYSTAGMUS,SET,102,-0.069819,-0.0051895,0.082286,0.80191,HP_HORIZONTAL_NYSTAGMUS,1
GSE14000_UNSTIM_VS_4H_LPS_DC...4,SET,173,-0.051749,-0.0049996,0.060991,0.80191,GSE14000_UNSTIM_VS_4H_LPS_DC_UP,1
IK3_01,SET,199,-0.053419,-0.0055312,0.062909,0.80209,IK3_01,1
GOBP_PROTEIN_IMPORT_INTO_MIT...,SET,17,-0.16363,-0.0049768,0.1927,0.80209,GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX,1
chr12q12,SET,24,-0.26539,-0.0095889,0.31253,0.8021,chr12q12,1
BOQUEST_STEM_CELL_UP,SET,232,-0.052337,-0.005846,0.061629,0.80212,BOQUEST_STEM_CELL_UP,1
PARK_OSTEOBLAST_DIFFERENTIAT...1,SET,6,-0.37037,-0.0066943,0.43599,0.80219,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN,1
GOBP_CONNECTIVE_TISSUE_DEVEL...,SET,260,-0.046911,-0.0055428,0.055202,0.80228,GOBP_CONNECTIVE_TISSUE_DEVELOPMENT,1
WP_RUBINSTEINTAYBI_SYNDROME_1,SET,14,-0.20821,-0.0057473,0.245,0.80229,WP_RUBINSTEINTAYBI_SYNDROME_1,1
GOBP_REGULATION_PROTEIN_CATA...,SET,4,-0.29585,-0.0043663,0.34811,0.80229,GOBP_REGULATION_PROTEIN_CATABOLIC_PROCESS_AT_SYNAPSE,1
HP_RESPIRATORY_ALKALOSIS,SET,5,-0.32318,-0.0053325,0.38028,0.80229,HP_RESPIRATORY_ALKALOSIS,1
MIR6718_5P,SET,63,-0.092774,-0.0054252,0.10915,0.80233,MIR6718_5P,1
GOBP_REGULATION_OF_MEMBRANE_...8,SET,420,-0.038602,-0.0057713,0.045413,0.80234,GOBP_REGULATION_OF_MEMBRANE_POTENTIAL,1
HP_ABNORMALITY_OF_SKIN_PHYSI...,SET,504,-0.033309,-0.0054425,0.039186,0.80234,HP_ABNORMALITY_OF_SKIN_PHYSIOLOGY,1
AUTS2_TARGET_GENES,SET,486,-0.033139,-0.0053198,0.038972,0.80242,AUTS2_TARGET_GENES,1
GOCC_COP9_SIGNALOSOME,SET,31,-0.12095,-0.0049659,0.14223,0.80244,GOCC_COP9_SIGNALOSOME,1
HP_LOW_SET_POSTERIORLY_ROTAT...,SET,216,-0.049224,-0.0053075,0.057876,0.80247,HP_LOW_SET_POSTERIORLY_ROTATED_EARS,1
HP_BILATERAL_SINGLE_TRANSVER...,SET,55,-0.1008,-0.0055089,0.11852,0.80248,HP_BILATERAL_SINGLE_TRANSVERSE_PALMAR_CREASES,1
GOBP_REGULATION_OF_PHOSPHATI...2,SET,9,-0.26567,-0.0058805,0.31229,0.80253,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,1
MIR143_5P,SET,120,-0.068998,-0.0055599,0.081103,0.80254,MIR143_5P,1
MIR219A_1_3P,SET,55,-0.095576,-0.0052233,0.11233,0.80256,MIR219A_1_3P,1
HP_ABNORMAL_SUBCLAVIAN_ARTER...,SET,10,-0.24814,-0.0057896,0.29164,0.80257,HP_ABNORMAL_SUBCLAVIAN_ARTERY_MORPHOLOGY,1
GOBP_REGULATION_OF_MITOTIC_C...1,SET,472,-0.033692,-0.0053322,0.039596,0.80258,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE,1
SMID_BREAST_CANCER_RELAPSE_I...10,SET,6,-0.29748,-0.0053768,0.3496,0.80259,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP,1
MIR12113,SET,83,-0.080811,-0.0054212,0.094962,0.80261,MIR12113,1
DESCARTES_FETAL_MUSCLE_LYMPH...1,SET,56,-0.1062,-0.005856,0.12477,0.80264,DESCARTES_FETAL_MUSCLE_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_POSTSYNAPSE_ASSEMBLY,SET,41,-0.12266,-0.0057898,0.14408,0.80269,GOBP_POSTSYNAPSE_ASSEMBLY,1
KEGG_MEDICUS_VARIANT_AMPLIFI...17,SET,8,-0.27596,-0.0057592,0.32416,0.8027,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION,1
GSE24574_BCL6_HIGH_TFH_VS_TC...1,SET,188,-0.055347,-0.0055719,0.06501,0.80271,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...10,SET,5,-0.32029,-0.0052849,0.3762,0.80272,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_LOW_IGM_RESPONDERS_6HY_1DY_UP,1
HP_AUTOAMPUTATION_OF_DIGITS,SET,13,-0.19496,-0.0051859,0.22897,0.80273,HP_AUTOAMPUTATION_OF_DIGITS,1
VANGURP_PANCREATIC_BETA_CELL,SET,107,-0.073848,-0.0056212,0.086723,0.80276,VANGURP_PANCREATIC_BETA_CELL,1
GOBP_TELOMERE_MAINTENANCE_VI...1,SET,14,-0.17044,-0.0047048,0.20013,0.80279,GOBP_TELOMERE_MAINTENANCE_VIA_RECOMBINATION,1
GAVISH_3CA_METAPROGRAM_EPITH...10,SET,48,-0.11893,-0.0060728,0.13959,0.80288,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN,1
CAGCTG_AP4_Q5,SET,1354,-0.020981,-0.0054836,0.024624,0.80291,CAGCTG_AP4_Q5,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...2,SET,95,-0.080909,-0.0058049,0.094949,0.80292,HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL,1
GOBP_POSITIVE_REGULATION_OF_...775,SET,338,-0.040279,-0.0054146,0.047267,0.80293,GOBP_POSITIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...2,SET,182,-0.056551,-0.0056025,0.066357,0.80295,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,1
HP_SPECIFIC_LEARNING_DISABIL...,SET,267,-0.045267,-0.005419,0.053114,0.80296,HP_SPECIFIC_LEARNING_DISABILITY,1
HP_DEFORMED_RIB_CAGE,SET,7,-0.28203,-0.0055058,0.3309,0.80297,HP_DEFORMED_RIB_CAGE,1
MOREAUX_MULTIPLE_MYELOMA_BY_...1,SET,153,-0.054029,-0.0049116,0.06338,0.80301,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,1
GOBP_POSITIVE_REGULATION_OF_...629,SET,6,-0.30356,-0.0054867,0.35611,0.80301,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
GOBP_POSITIVE_REGULATION_OF_...646,SET,13,-0.20815,-0.0055369,0.24415,0.80304,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,1
SCHUETZ_BREAST_CANCER_DUCTAL...2,SET,321,-0.044029,-0.0057706,0.051631,0.8031,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,1
CHYLA_CBFA2T3_TARGETS_UP,SET,346,-0.041061,-0.0055834,0.048148,0.80311,CHYLA_CBFA2T3_TARGETS_UP,1
HP_LOW_BACK_PAIN,SET,13,-0.19801,-0.0052671,0.23217,0.80312,HP_LOW_BACK_PAIN,1
HP_PANCREATIC_ENDOCRINE_TUMOR,SET,13,-0.21749,-0.0057853,0.25493,0.8032,HP_PANCREATIC_ENDOCRINE_TUMOR,1
GSE18791_CTRL_VS_NEWCASTLE_V...15,SET,167,-0.058575,-0.005561,0.06864,0.80327,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN,1
GSE26343_UNSTIM_VS_LPS_STIM_...2,SET,191,-0.053864,-0.0054652,0.063101,0.80333,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...195,SET,23,-0.16277,-0.0057573,0.19066,0.80336,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,1
GOBP_NEGATIVE_REGULATION_OF_...355,SET,9,-0.25097,-0.0055553,0.29395,0.80339,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,1
REACTOME_REPLACEMENT_OF_PROT...,SET,6,-0.31842,-0.0057554,0.37281,0.80347,REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS,1
KEGG_TAURINE_AND_HYPOTAURINE...,SET,10,-0.24648,-0.0057507,0.28856,0.80349,KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM,1
REACTOME_CREATINE_METABOLISM,SET,10,-0.23369,-0.0054523,0.27358,0.80349,REACTOME_CREATINE_METABOLISM,1
GOBP_EMBRYONIC_PLACENTA_MORP...,SET,24,-0.1604,-0.0057954,0.18775,0.80353,GOBP_EMBRYONIC_PLACENTA_MORPHOGENESIS,1
REACTOME_DISEASES_ASSOCIATED...4,SET,61,-0.10212,-0.0058768,0.11953,0.80355,REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,1
WP_CILIARY_LANDSCAPE,SET,197,-0.050365,-0.0051889,0.058929,0.80363,WP_CILIARY_LANDSCAPE,1
GOBP_FOREBRAIN_DEVELOPMENT,SET,380,-0.040024,-0.0056981,0.046828,0.80364,GOBP_FOREBRAIN_DEVELOPMENT,1
VERRECCHIA_EARLY_RESPONSE_TO...,SET,52,-0.10627,-0.0056473,0.12429,0.80372,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,1
HP_MIDDLE_AGE_ONSET,SET,219,-0.050504,-0.0054829,0.05907,0.80372,HP_MIDDLE_AGE_ONSET,1
MIR601,SET,34,-0.1271,-0.0054646,0.14865,0.80373,MIR601,1
GOBP_REGULATION_OF_CYTOPLASM...3,SET,32,-0.1211,-0.0050512,0.14158,0.8038,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
GOBP_REGULATION_OF_PROTEIN_U...,SET,164,-0.056606,-0.005326,0.066183,0.8038,GOBP_REGULATION_OF_PROTEIN_UBIQUITINATION,1
KEGG_MELANOMA,SET,68,-0.093486,-0.0056788,0.10929,0.80382,KEGG_MELANOMA,1
PID_LIS1_PATHWAY,SET,27,-0.13747,-0.005268,0.1607,0.80385,PID_LIS1_PATHWAY,1
REACTOME_DNA_DAMAGE_TELOMERE...,SET,27,-0.12674,-0.0048566,0.14813,0.80388,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,1
GOCC_COATED_VESICLE,SET,291,-0.043595,-0.0054447,0.05094,0.80394,GOCC_COATED_VESICLE,1
GSE16385_ROSIGLITAZONE_IL4_V...4,SET,178,-0.053976,-0.0052888,0.063054,0.804,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP,1
GOMF_SULFATE_TRANSMEMBRANE_T...,SET,15,-0.18817,-0.0053764,0.21978,0.80405,GOMF_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_NRG_E...,SET,11,-0.20983,-0.0051345,0.24502,0.8041,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,1
GOBP_G1_TO_G0_TRANSITION,SET,18,-0.16084,-0.0050335,0.18777,0.80414,GOBP_G1_TO_G0_TRANSITION,1
GOBP_SPERM_FLAGELLUM_ASSEMBLY,SET,42,-0.10824,-0.0051713,0.12638,0.80414,GOBP_SPERM_FLAGELLUM_ASSEMBLY,1
ZHONG_PFC_C3_ASTROCYTE,SET,338,-0.040559,-0.0054523,0.047354,0.80414,ZHONG_PFC_C3_ASTROCYTE,1
GOMF_NAD_P_H_OXIDASE_H2O2_FO...,SET,8,-0.23992,-0.005007,0.28008,0.80416,GOMF_NAD_P_H_OXIDASE_H2O2_FORMING_ACTIVITY,1
GCANCTGNY_MYOD_Q6,SET,845,-0.026377,-0.0055269,0.030791,0.80417,GCANCTGNY_MYOD_Q6,1
MIR6529_5P,SET,42,-0.11519,-0.005503,0.13444,0.80421,MIR6529_5P,1
HP_ARRHINENCEPHALY,SET,30,-0.1277,-0.0051577,0.14904,0.80422,HP_ARRHINENCEPHALY,1
STARK_PREFRONTAL_CORTEX_22Q1...1,SET,449,-0.03297,-0.0050925,0.038478,0.80423,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,1
GOBP_REGULATION_OF_GLUCOSE_M...,SET,88,-0.080758,-0.0055776,0.094251,0.80423,GOBP_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
TORCHIA_TARGETS_OF_EWSR1_FLI...2,SET,19,-0.17996,-0.0057862,0.20997,0.80429,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,1
HOLLEMAN_ASPARAGINASE_RESIST...1,SET,22,-0.13728,-0.0047492,0.16017,0.8043,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,1
chr4q22,SET,31,-0.23611,-0.0096937,0.27546,0.80431,chr4q22,1
GOBP_NEGATIVE_REGULATION_OF_...73,SET,52,-0.10089,-0.0053616,0.11768,0.80437,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GSE28237_FOLLICULAR_VS_LATE_...1,SET,177,-0.055003,-0.0053744,0.064148,0.80439,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN,1
MIR5186,SET,31,-0.12987,-0.0053318,0.15143,0.80444,MIR5186,1
HP_WOLFF_PARKINSON_WHITE_SYN...,SET,15,-0.17833,-0.005095,0.20791,0.80447,HP_WOLFF_PARKINSON_WHITE_SYNDROME,1
MIR4676_3P,SET,189,-0.052859,-0.0053354,0.061616,0.80452,MIR4676_3P,1
MODULE_335,SET,14,-0.2183,-0.0060258,0.25446,0.80452,MODULE_335,1
GOBP_10_FORMYLTETRAHYDROFOLA...,SET,5,-0.32867,-0.0054231,0.38294,0.80462,GOBP_10_FORMYLTETRAHYDROFOLATE_METABOLIC_PROCESS,1
HP_CHORIORETINAL_DEGENERATION,SET,48,-0.10914,-0.0055729,0.12715,0.80464,HP_CHORIORETINAL_DEGENERATION,1
GOBP_PHYSIOLOGICAL_CARDIAC_M...,SET,21,-0.16479,-0.00557,0.19198,0.80465,GOBP_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY,1
REACTOME_SEMA3A_PLEXIN_REPUL...,SET,13,-0.21772,-0.0057913,0.25363,0.80466,REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,1
GOBP_RECEPTOR_MEDIATED_ENDOC...2,SET,5,-0.35346,-0.0058321,0.4117,0.80469,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_INVOLVED_IN_CHOLESTEROL_TRANSPORT,1
HP_ATROPHY_DEGENERATION_AFFE...2,SET,750,-0.026284,-0.0052027,0.030616,0.80469,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CENTRAL_NERVOUS_SYSTEM,1
ISHIDA_E2F_TARGETS,SET,50,-0.095585,-0.0049813,0.11132,0.80473,ISHIDA_E2F_TARGETS,1
GOBP_REGULATION_OF_CD8_POSIT...1,SET,19,-0.17874,-0.0057469,0.20816,0.80473,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
WP_KCNQ2RELATED_EPILEPSIES,SET,19,-0.17765,-0.005712,0.20687,0.80475,WP_KCNQ2RELATED_EPILEPSIES,1
HP_DEVIATION_OF_THE_2ND_TOE,SET,5,-0.38462,-0.0063464,0.44785,0.80477,HP_DEVIATION_OF_THE_2ND_TOE,1
GOBP_PURINE_NUCLEOTIDE_SALVA...,SET,10,-0.23778,-0.0055479,0.27686,0.80478,GOBP_PURINE_NUCLEOTIDE_SALVAGE,1
ANDERSON_BLOOD_CN54GP140_ADJ...8,SET,28,-0.13147,-0.0051304,0.15305,0.80482,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_UP,1
GOBP_POSITIVE_REGULATION_OF_...306,SET,33,-0.14055,-0.0059534,0.16358,0.80488,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT,1
WP_NUCLEOTIDE_GPCRS,SET,9,-0.23454,-0.0051916,0.27292,0.80493,WP_NUCLEOTIDE_GPCRS,1
GOBP_POSITIVE_REGULATION_OF_...137,SET,32,-0.12591,-0.0052521,0.14651,0.80494,GOBP_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS,1
PANAPASA_BLOOD_FLUENZ_AGE_03...1,SET,6,-0.2716,-0.0049091,0.31602,0.80495,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_3DY_4DY_DN,1
HP_PROLONGED_QRS_COMPLEX,SET,6,-0.35133,-0.0063501,0.40872,0.80498,HP_PROLONGED_QRS_COMPLEX,1
GSE21670_STAT3_KO_VS_WT_CD4_...8,SET,174,-0.05616,-0.0054412,0.065333,0.80499,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP,1
HP_CEREBRAL_ARTERIOVENOUS_MA...,SET,7,-0.2582,-0.0050407,0.30029,0.80506,HP_CEREBRAL_ARTERIOVENOUS_MALFORMATION,1
GAUSSMANN_MLL_AF4_FUSION_TAR...14,SET,219,-0.051227,-0.0055613,0.059555,0.80514,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1
IVANOVA_HEMATOPOIESIS_MATURE...,SET,259,-0.046421,-0.0054745,0.053955,0.8052,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1
HP_STATUS_EPILEPTICUS_WITH_P...,SET,24,-0.15286,-0.0055229,0.17767,0.8052,HP_STATUS_EPILEPTICUS_WITH_PROMINENT_MOTOR_SYMPTOMS,1
REACTOME_SIGNALING_BY_MODERA...,SET,42,-0.11429,-0.0054603,0.13284,0.80521,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,1
GOBP_NEGATIVE_REGULATION_OF_...262,SET,8,-0.31722,-0.0066203,0.36868,0.80522,GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
HP_ABNORMAL_CIRCULATING_ALDO...1,SET,21,-0.14653,-0.0049528,0.17028,0.80524,HP_ABNORMAL_CIRCULATING_ALDOLASE_CONCENTRATION,1
GOBP_CARTILAGE_DEVELOPMENT_I...,SET,31,-0.13652,-0.0056051,0.15862,0.80529,GOBP_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_REGULATION_OF_PROTEIN_C...4,SET,374,-0.037718,-0.0053282,0.043821,0.8053,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
REACTOME_REGULATION_OF_RUNX2...,SET,69,-0.081609,-0.0049935,0.094808,0.80531,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1
GSE13547_WT_VS_ZFX_KO_BCELL_...1,SET,142,-0.060849,-0.0053306,0.07068,0.80535,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN,1
MODULE_275,SET,15,-0.19972,-0.0057061,0.23197,0.80537,MODULE_275,1
HP_LARYNGEAL_STENOSIS,SET,14,-0.22153,-0.006115,0.25727,0.80539,HP_LARYNGEAL_STENOSIS,1
GOMF_FLIPPASE_ACTIVITY,SET,15,-0.19716,-0.0056332,0.22894,0.80542,GOMF_FLIPPASE_ACTIVITY,1
HP_INCREASED_HEMATOCRIT,SET,9,-0.24929,-0.0055181,0.28939,0.8055,HP_INCREASED_HEMATOCRIT,1
GSE10239_NAIVE_VS_MEMORY_CD8...2,SET,184,-0.052757,-0.0052549,0.061242,0.8055,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
chr6q22,SET,54,-0.18675,-0.010113,0.21678,0.80551,chr6q22,1
GOBP_SYNAPTIC_SIGNALING_VIA_...,SET,6,-0.36628,-0.0066203,0.42501,0.80559,GOBP_SYNAPTIC_SIGNALING_VIA_NEUROPEPTIDE,1
HP_HEMOTHORAX,SET,6,-0.30564,-0.0055244,0.35466,0.80559,HP_HEMOTHORAX,1
GSE3982_NEUTROPHIL_VS_EFF_ME...2,SET,182,-0.054516,-0.0054008,0.063259,0.80559,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
GOBP_ERBB2_SIGNALING_PATHWAY,SET,23,-0.16858,-0.0059631,0.19556,0.80566,GOBP_ERBB2_SIGNALING_PATHWAY,1
HP_HAMARTOMA_OF_THE_ORBITAL_...,SET,29,-0.12749,-0.0050629,0.1479,0.80566,HP_HAMARTOMA_OF_THE_ORBITAL_REGION,1
GSE7764_IL15_TREATED_VS_CTRL...2,SET,175,-0.051653,-0.0050188,0.059913,0.80569,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP,1
AIZARANI_LIVER_C20_LSECS_3,SET,271,-0.047595,-0.0057395,0.055204,0.80569,AIZARANI_LIVER_C20_LSECS_3,1
GOBP_NEGATIVE_ADAPTATION_OF_...,SET,12,-0.21296,-0.0054426,0.24697,0.80573,GOBP_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY,1
GSE29618_BCELL_VS_MONOCYTE_D...2,SET,169,-0.06104,-0.0058293,0.07079,0.80573,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP,1
GOMF_HORMONE_ACTIVITY,SET,111,-0.076897,-0.005961,0.089161,0.80578,GOMF_HORMONE_ACTIVITY,1
HP_IRREGULAR_FEMORAL_EPIPHYS...,SET,8,-0.2546,-0.0053135,0.29514,0.80583,HP_IRREGULAR_FEMORAL_EPIPHYSIS,1
REACTOME_SCAVENGING_OF_HEME_...,SET,10,-0.25058,-0.0058465,0.29037,0.80592,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,1
HP_SPASTIC_GAIT,SET,69,-0.090272,-0.0055236,0.10458,0.80598,HP_SPASTIC_GAIT,1
GOBP_INOSITOL_PHOSPHATE_META...,SET,38,-0.11653,-0.0052958,0.13496,0.80603,GOBP_INOSITOL_PHOSPHATE_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...12,SET,9,-0.23088,-0.0051105,0.26736,0.80608,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY,1
GOBP_TOOTH_ERUPTION,SET,5,-0.36251,-0.0059815,0.41975,0.8061,GOBP_TOOTH_ERUPTION,1
HP_POSTERIOR_EMBRYOTOXON,SET,46,-0.11793,-0.0058955,0.1365,0.80618,HP_POSTERIOR_EMBRYOTOXON,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...2,SET,39,-0.11429,-0.0052618,0.13226,0.80624,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1
GSE2770_UNTREATED_VS_IL4_TRE...6,SET,187,-0.052245,-0.0052458,0.060426,0.80637,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
FLETCHER_PBMC_BCG_10W_INFANT...1,SET,233,-0.049923,-0.0055882,0.05774,0.80637,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,1
PLASARI_TGFB1_SIGNALING_VIA_...4,SET,27,-0.14648,-0.0056132,0.1694,0.80639,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,1
GAUCHER_PBMC_YF_VAX_STAMARIL...12,SET,274,-0.046504,-0.0056385,0.053778,0.80641,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,1
HP_J_SHAPED_SELLA_TURCICA,SET,12,-0.20696,-0.0052892,0.23931,0.80642,HP_J_SHAPED_SELLA_TURCICA,1
GSE17721_LPS_VS_CPG_2H_BMDC_...2,SET,183,-0.055805,-0.0055436,0.064529,0.80642,GSE17721_LPS_VS_CPG_2H_BMDC_UP,1
HP_ELEVATED_CIRCULATING_GROW...,SET,15,-0.19149,-0.0054711,0.2214,0.80644,HP_ELEVATED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,1
RRCCGTTA_UNKNOWN,SET,79,-0.082544,-0.0054029,0.095432,0.80646,RRCCGTTA_UNKNOWN,1
TTANWNANTGGM_UNKNOWN,SET,54,-0.10655,-0.0057698,0.12317,0.80649,TTANWNANTGGM_UNKNOWN,1
GSE360_L_DONOVANI_VS_T_GONDI...4,SET,175,-0.055776,-0.0054194,0.064465,0.80653,GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP,1
GOMF_EXOPEPTIDASE_ACTIVITY,SET,95,-0.080242,-0.005757,0.092739,0.80654,GOMF_EXOPEPTIDASE_ACTIVITY,1
HP_POSTAXIAL_POLYDACTYLY,SET,123,-0.06567,-0.0053571,0.07589,0.80657,HP_POSTAXIAL_POLYDACTYLY,1
MIR6506_3P,SET,5,-0.2851,-0.0047043,0.32944,0.80659,MIR6506_3P,1
GSE3982_CENT_MEMORY_CD4_TCEL...6,SET,175,-0.05584,-0.0054256,0.064504,0.80666,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP,1
HP_INCREASED_URINARY_NON_PRO...,SET,31,-0.14495,-0.0059509,0.16743,0.80667,HP_INCREASED_URINARY_NON_PROTEINOGENIC_AMINO_ACID_LEVEL,1
NUYTTEN_EZH2_TARGETS_UP,SET,942,-0.025373,-0.0055978,0.029305,0.8067,NUYTTEN_EZH2_TARGETS_UP,1
HP_DIALEPTIC_SEIZURE,SET,221,-0.049881,-0.0054396,0.057607,0.80672,HP_DIALEPTIC_SEIZURE,1
GSE22432_MULTIPOTENT_PROGENI...1,SET,183,-0.053128,-0.0052776,0.061355,0.80672,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN,1
GOBP_HISTAMINE_SECRETION,SET,12,-0.20389,-0.0052109,0.23545,0.80674,GOBP_HISTAMINE_SECRETION,1
REACTOME_RECEPTOR_TYPE_TYROS...,SET,16,-0.1976,-0.0058306,0.22814,0.80678,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,1
HP_ABNORMAL_RENAL_PHYSIOLOGY,SET,624,-0.029876,-0.0054133,0.034492,0.80679,HP_ABNORMAL_RENAL_PHYSIOLOGY,1
GOMF_PHEROMONE_RECEPTOR_ACTI...,SET,3,-0.47027,-0.0060108,0.54277,0.80687,GOMF_PHEROMONE_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_EPIDERMAL_MORPHO...,SET,87,-0.079183,-0.0054378,0.091369,0.80692,HP_ABNORMAL_EPIDERMAL_MORPHOLOGY,1
GOBP_REGULATION_OF_NEUTROPHI...5,SET,5,-0.33853,-0.0055859,0.39062,0.80693,GOBP_REGULATION_OF_NEUTROPHIL_MEDIATED_CYTOTOXICITY,1
PURWIN_A375_MEWO_COMMON_SOX1...,SET,25,-0.15063,-0.0055547,0.1738,0.80695,PURWIN_A375_MEWO_COMMON_SOX10_TARGETS,1
HOXA4_Q2,SET,243,-0.05003,-0.0057175,0.057709,0.807,HOXA4_Q2,1
GOBP_SENSORY_PERCEPTION_OF_S...2,SET,9,-0.25584,-0.0056629,0.29507,0.80704,GOBP_SENSORY_PERCEPTION_OF_SOUR_TASTE,1
GOBP_REGULATION_OF_VASCULAR_...3,SET,8,-0.27275,-0.0056922,0.31453,0.80707,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,1
MTHFD1_TARGET_GENES,SET,16,-0.17629,-0.005202,0.20328,0.80708,MTHFD1_TARGET_GENES,1
GOBP_RENAL_VESICLE_DEVELOPME...,SET,18,-0.20014,-0.0062637,0.23075,0.80712,GOBP_RENAL_VESICLE_DEVELOPMENT,1
MIR2115_3P,SET,215,-0.052025,-0.0055968,0.059974,0.80715,MIR2115_3P,1
HP_ABNORMAL_HAIR_WHORL,SET,27,-0.15379,-0.0058934,0.17729,0.80716,HP_ABNORMAL_HAIR_WHORL,1
HP_ABNORMALITY_OF_FOLATE_MET...,SET,13,-0.20586,-0.005476,0.23728,0.80719,HP_ABNORMALITY_OF_FOLATE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...81,SET,13,-0.22399,-0.0059582,0.25815,0.80721,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
HP_CUTANEOUS_PHOTOSENSITIVITY,SET,94,-0.074133,-0.0052908,0.085438,0.80721,HP_CUTANEOUS_PHOTOSENSITIVITY,1
GAVISH_3CA_MALIGNANT_METAPRO...17,SET,38,-0.13517,-0.0061432,0.15578,0.80722,GAVISH_3CA_MALIGNANT_METAPROGRAM_26_NPC_GLIOMA,1
GSE14769_UNSTIM_VS_20MIN_LPS...1,SET,183,-0.055035,-0.005467,0.063423,0.80723,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN,1
GSE16385_IL4_VS_ROSIGLITAZON...2,SET,174,-0.054182,-0.0052496,0.062437,0.80724,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
ZHAN_V1_LATE_DIFFERENTIATION...2,SET,31,-0.13026,-0.0053479,0.1501,0.80725,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1
MODULE_355,SET,29,-0.12955,-0.0051447,0.14927,0.80727,MODULE_355,1
GSE27786_CD4_TCELL_VS_NKTCEL...2,SET,180,-0.053395,-0.0052609,0.061522,0.80727,GSE27786_CD4_TCELL_VS_NKTCELL_UP,1
GOBP_REGULATION_OF_THE_FORCE...2,SET,5,-0.39549,-0.0065256,0.45563,0.8073,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL,1
ZHONG_PFC_C4_UNKNOWN_INP,SET,81,-0.083034,-0.0055031,0.095646,0.80734,ZHONG_PFC_C4_UNKNOWN_INP,1
HP_BROAD_FOOT,SET,26,-0.15297,-0.0057523,0.17615,0.8074,HP_BROAD_FOOT,1
GOBP_HEPARAN_SULFATE_PROTEOG...3,SET,8,-0.27764,-0.0057942,0.31971,0.80741,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_POLYSACCHARIDE_CHAIN_BIOSYNTHETIC_PROCESS,1
MODULE_337,SET,58,-0.092412,-0.0051859,0.1064,0.80745,MODULE_337,1
KORKOLA_TERATOMA_UP,SET,13,-0.2271,-0.0060408,0.26145,0.80746,KORKOLA_TERATOMA_UP,1
DESCARTES_FETAL_PLACENTA_MYE...,SET,125,-0.070563,-0.0058025,0.081225,0.8075,DESCARTES_FETAL_PLACENTA_MYELOID_CELLS,1
GOBP_MEIOTIC_METAPHASE_CHROM...,SET,3,-0.4662,-0.0059588,0.53646,0.80758,GOBP_MEIOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,1
chr2q13,SET,14,-0.29321,-0.0080935,0.3373,0.80765,chr2q13,1
GOBP_NEGATIVE_REGULATION_OF_...135,SET,5,-0.34727,-0.00573,0.39947,0.80766,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
MIR892C_3P,SET,189,-0.053443,-0.0053944,0.061469,0.80769,MIR892C_3P,1
HP_MANDIBULAR_PROGNATHIA,SET,174,-0.054631,-0.0052931,0.062822,0.80774,HP_MANDIBULAR_PROGNATHIA,1
REACTOME_REGULATION_OF_PTEN_...3,SET,9,-0.25922,-0.0057378,0.29803,0.80778,REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION,1
GSE42724_MEMORY_BCELL_VS_PLA...2,SET,189,-0.053853,-0.0054358,0.061907,0.80782,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP,1
VANOEVELEN_MYOGENESIS_SIN3A_...,SET,207,-0.04767,-0.0050331,0.054767,0.80796,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,1
GOBP_RESPONSE_TO_SALT_STRESS,SET,24,-0.15004,-0.0054211,0.17237,0.80797,GOBP_RESPONSE_TO_SALT_STRESS,1
MONNIER_POSTRADIATION_TUMOR_...2,SET,374,-0.03628,-0.0051251,0.041676,0.80799,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1
GOBP_REGULATION_OF_MALE_GONA...,SET,8,-0.29712,-0.0062007,0.34125,0.80803,GOBP_REGULATION_OF_MALE_GONAD_DEVELOPMENT,1
GOBP_REGULATION_OF_RESPONSE_...12,SET,20,-0.18941,-0.006248,0.21754,0.80803,GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
BIOCARTA_HES_PATHWAY,SET,11,-0.23122,-0.0056579,0.26551,0.80807,BIOCARTA_HES_PATHWAY,1
GNF2_PPP6C,SET,35,-0.11361,-0.0049556,0.13044,0.8081,GNF2_PPP6C,1
GOBP_IMPORT_ACROSS_PLASMA_ME...,SET,184,-0.058094,-0.0057865,0.066678,0.80819,GOBP_IMPORT_ACROSS_PLASMA_MEMBRANE,1
BIOCARTA_TID_PATHWAY,SET,19,-0.1686,-0.005421,0.19351,0.8082,BIOCARTA_TID_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...456,SET,10,-0.23589,-0.0055037,0.2707,0.80823,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
GOCC_GOLGI_CISTERNA_MEMBRANE,SET,74,-0.088262,-0.0055921,0.10129,0.80823,GOCC_GOLGI_CISTERNA_MEMBRANE,1
KEGG_INSULIN_SIGNALING_PATHW...,SET,129,-0.065681,-0.0054861,0.075362,0.80826,KEGG_INSULIN_SIGNALING_PATHWAY,1
MIR150_5P,SET,160,-0.05767,-0.0053601,0.066162,0.8083,MIR150_5P,1
HP_ABNORMAL_PLACENTA_MORPHOL...,SET,33,-0.14068,-0.0059588,0.16136,0.80834,HP_ABNORMAL_PLACENTA_MORPHOLOGY,1
GSE25123_IL4_VS_IL4_AND_ROSI...4,SET,124,-0.063252,-0.0051806,0.072549,0.80835,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...27,SET,5,-0.29915,-0.004936,0.34288,0.80851,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE,1
HP_FATIGABLE_WEAKNESS_OF_DIS...,SET,8,-0.2402,-0.0050129,0.27522,0.8086,HP_FATIGABLE_WEAKNESS_OF_DISTAL_LIMB_MUSCLES,1
GOCC_DNA_RECOMBINASE_MEDIATO...,SET,7,-0.27509,-0.0053704,0.31518,0.80861,GOCC_DNA_RECOMBINASE_MEDIATOR_COMPLEX,1
GAVISH_3CA_METAPROGRAM_FIBRO...19,SET,49,-0.11454,-0.0059094,0.13122,0.80863,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS,1
MIR361_5P,SET,152,-0.06128,-0.0055526,0.070199,0.80865,MIR361_5P,1
GOBP_NEGATIVE_REGULATION_OF_...128,SET,14,-0.21017,-0.0058013,0.24073,0.80867,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
GOBP_PROTEIN_TETRAMERIZATION,SET,91,-0.077057,-0.0054115,0.088262,0.80868,GOBP_PROTEIN_TETRAMERIZATION,1
GOCC_OLIGOSACCHARYLTRANSFERA...,SET,13,-0.20896,-0.0055583,0.23934,0.80868,GOCC_OLIGOSACCHARYLTRANSFERASE_COMPLEX,1
KEGG_MEDICUS_REFERENCE_KINET...1,SET,22,-0.15546,-0.0053781,0.178,0.80876,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION,1
GOBP_POSITIVE_REGULATION_OF_...454,SET,6,-0.32894,-0.0059454,0.37655,0.80881,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_STEM_CELL_PROLIFERATION,1
MIR8084,SET,213,-0.053397,-0.0057179,0.061118,0.80885,MIR8084,1
GOCC_MATRIX_SIDE_OF_MITOCHON...,SET,5,-0.32708,-0.0053968,0.37431,0.80888,GOCC_MATRIX_SIDE_OF_MITOCHONDRIAL_INNER_MEMBRANE,1
MORF_PDCD1,SET,64,-0.097074,-0.0057214,0.11108,0.80892,MORF_PDCD1,1
GOMF_PRE_MRNA_INTRONIC_BINDI...,SET,13,-0.18562,-0.0049376,0.2124,0.80892,GOMF_PRE_MRNA_INTRONIC_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...459,SET,6,-0.34649,-0.0062626,0.3963,0.80902,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_APOPTOTIC...1,SET,8,-0.2746,-0.0057307,0.31406,0.80903,GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,1
GOBP_REGULATION_OF_MITOCHOND...9,SET,36,-0.11923,-0.0052744,0.13635,0.80905,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
DELACROIX_RAR_TARGETS_UP,SET,44,-0.12735,-0.0062268,0.14563,0.80906,DELACROIX_RAR_TARGETS_UP,1
KEGG_PARKINSONS_DISEASE,SET,92,-0.070359,-0.0049681,0.080431,0.80915,KEGG_PARKINSONS_DISEASE,1
GOMF_LOW_DENSITY_LIPOPROTEIN...1,SET,16,-0.19324,-0.0057021,0.22089,0.80916,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,1
GOBP_REGULATION_OF_HEAT_GENE...,SET,13,-0.2375,-0.0063174,0.27145,0.80919,GOBP_REGULATION_OF_HEAT_GENERATION,1
GOBP_POSITIVE_REGULATION_OF_...620,SET,12,-0.2084,-0.0053261,0.23818,0.8092,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
DESCARTES_FETAL_LUNG_MYELOID...,SET,143,-0.067963,-0.0059745,0.07767,0.80921,DESCARTES_FETAL_LUNG_MYELOID_CELLS,1
MIR3667_5P,SET,53,-0.10684,-0.0057318,0.12209,0.80922,MIR3667_5P,1
GSE4748_CTRL_VS_LPS_AND_CYAN...1,SET,189,-0.055887,-0.005641,0.063859,0.80925,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
WP_MAPK_PATHWAY_IN_CONGENITA...,SET,14,-0.20185,-0.0055718,0.23063,0.80926,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,1
BIOCARTA_LECTIN_PATHWAY,SET,10,-0.237,-0.0055297,0.27079,0.80927,BIOCARTA_LECTIN_PATHWAY,1
MODULE_173,SET,16,-0.20713,-0.0061119,0.2366,0.80933,MODULE_173,1
GSE35543_IN_VIVO_NTREG_VS_CO...1,SET,179,-0.057561,-0.0056558,0.065748,0.80934,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN,1
GSE13411_NAIVE_BCELL_VS_PLAS...1,SET,166,-0.058374,-0.0055255,0.066673,0.80935,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN,1
SUZUKI_AMPLIFIED_IN_ORAL_CAN...,SET,17,-0.20766,-0.0063159,0.23708,0.80945,SUZUKI_AMPLIFIED_IN_ORAL_CANCER,1
GSE37301_MULTIPOTENT_PROGENI...7,SET,169,-0.059994,-0.0057294,0.068469,0.80954,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN,1
HP_LACTIC_ACIDOSIS,SET,149,-0.058303,-0.005231,0.066537,0.80955,HP_LACTIC_ACIDOSIS,1
NAKAYA_PLASMACYTOID_DENDRITI...1,SET,168,-0.05564,-0.005298,0.063479,0.80962,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
GSE26351_UNSTIM_VS_WNT_PATHW...1,SET,175,-0.055522,-0.0053947,0.06333,0.80967,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,1
GOBP_POSITIVE_REGULATION_OF_...303,SET,7,-0.32101,-0.0062669,0.36613,0.80969,GOBP_POSITIVE_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,1
GSE27786_LIN_NEG_VS_BCELL_DN,SET,182,-0.052289,-0.0051802,0.05963,0.80972,GSE27786_LIN_NEG_VS_BCELL_DN,1
GSE12198_CTRL_VS_HIGH_IL2_ST...1,SET,186,-0.05272,-0.0052794,0.060099,0.80981,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN,1
HP_ABNORMALITY_OF_VISION,SET,1184,-0.022303,-0.0054782,0.025423,0.80983,HP_ABNORMALITY_OF_VISION,1
HOWARD_MONOCYTE_INACT_MONOV_...2,SET,203,-0.057587,-0.0060217,0.065642,0.80983,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
GSE34515_CD16_POS_MONOCYTE_V...1,SET,182,-0.055899,-0.0055379,0.063695,0.80992,GSE34515_CD16_POS_MONOCYTE_VS_DC_DN,1
MIR18A_3P,SET,82,-0.080024,-0.005336,0.091169,0.80996,MIR18A_3P,1
GOBP_PROTEIN_C_LINKED_GLYCOS...,SET,4,-0.42631,-0.0062917,0.48562,0.80998,GOBP_PROTEIN_C_LINKED_GLYCOSYLATION,1
GOBP_REGULATION_OF_KERATINOC...2,SET,14,-0.23228,-0.0064117,0.26452,0.81005,GOBP_REGULATION_OF_KERATINOCYTE_MIGRATION,1
GSE31082_DN_VS_DP_THYMOCYTE_...2,SET,174,-0.053192,-0.0051537,0.060572,0.81007,GSE31082_DN_VS_DP_THYMOCYTE_UP,1
HP_LIMBAL_STEM_CELL_DEFICIEN...,SET,8,-0.32073,-0.0066936,0.36519,0.8101,HP_LIMBAL_STEM_CELL_DEFICIENCY,1
GSE19374_UNINF_VS_LISTERIA_I...2,SET,177,-0.056385,-0.0055095,0.064195,0.81011,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP,1
GOBP_RESPONSE_TO_TOPOLOGICAL...,SET,144,-0.061383,-0.0054148,0.069881,0.81013,GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,1
KEGG_MEDICUS_VARIANT_EGF_OVE...1,SET,8,-0.2679,-0.0055909,0.30488,0.81021,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
DESCARTES_FETAL_EYE_VASCULAR...,SET,81,-0.090778,-0.0060163,0.1033,0.81023,DESCARTES_FETAL_EYE_VASCULAR_ENDOTHELIAL_CELLS,1
ZBTB1_TARGET_GENES,SET,90,-0.077888,-0.0054399,0.088593,0.81034,ZBTB1_TARGET_GENES,1
GOBP_RESPONSE_TO_HYDROGEN_PE...,SET,89,-0.081695,-0.0056742,0.092911,0.81037,GOBP_RESPONSE_TO_HYDROGEN_PEROXIDE,1
GSE3982_CENT_MEMORY_CD4_TCEL...3,SET,182,-0.051916,-0.0051433,0.05904,0.81038,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN,1
GOBP_DEOXYRIBONUCLEOTIDE_MET...,SET,42,-0.11727,-0.0056027,0.13336,0.8104,GOBP_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
MIR4799_5P,SET,364,-0.040357,-0.0056258,0.045882,0.81045,MIR4799_5P,1
HANSON_HRAS_SIGNALING_VIA_NF...,SET,21,-0.16562,-0.005598,0.18828,0.81046,HANSON_HRAS_SIGNALING_VIA_NFKB,1
GOMF_PROTEASOME_ACTIVATING_A...,SET,6,-0.27046,-0.0048885,0.30743,0.8105,GOMF_PROTEASOME_ACTIVATING_ACTIVITY,1
GOMF_O_METHYLTRANSFERASE_ACT...,SET,17,-0.16038,-0.0048778,0.18226,0.81055,GOMF_O_METHYLTRANSFERASE_ACTIVITY,1
GOCC_NUCLEOLAR_RIBONUCLEASE_...,SET,7,-0.26674,-0.0052074,0.30312,0.81056,GOCC_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX,1
HP_RADIAL_HEAD_SUBLUXATION,SET,7,-0.30756,-0.0060042,0.34951,0.81056,HP_RADIAL_HEAD_SUBLUXATION,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...3,SET,12,-0.23054,-0.0058919,0.26197,0.81057,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,1
MIR602,SET,7,-0.24095,-0.0047039,0.27375,0.81062,MIR602,1
GOBP_INTRACELLULAR_MAGNESIUM...,SET,3,-0.43767,-0.0055942,0.4972,0.81064,GOBP_INTRACELLULAR_MAGNESIUM_ION_HOMEOSTASIS,1
GOBP_METANEPHRIC_GLOMERULUS_...1,SET,16,-0.21828,-0.006441,0.24788,0.81073,GOBP_METANEPHRIC_GLOMERULUS_DEVELOPMENT,1
REACTOME_RUNX1_REGULATES_EST...,SET,6,-0.29937,-0.005411,0.33994,0.81074,REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION,1
GOBP_POSITIVE_REGULATION_OF_...600,SET,32,-0.14043,-0.0058576,0.15946,0.81074,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GSE27786_LSK_VS_NKCELL_UP,SET,177,-0.053545,-0.005232,0.0608,0.81075,GSE27786_LSK_VS_NKCELL_UP,1
GSE21063_CTRL_VS_ANTI_IGM_ST...1,SET,183,-0.056088,-0.0055717,0.063684,0.81076,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN,1
BROWNE_HCMV_INFECTION_2HR_DN,SET,47,-0.11398,-0.0057596,0.12941,0.81077,BROWNE_HCMV_INFECTION_2HR_DN,1
MIR135A_5P,SET,283,-0.046307,-0.0057047,0.052573,0.81078,MIR135A_5P,1
GOBP_NEGATIVE_REGULATION_OF_...141,SET,5,-0.36009,-0.0059416,0.40881,0.81079,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,1
HP_ABNORMAL_SKIN_ADNEXA_MORP...,SET,1292,-0.02149,-0.0054966,0.024395,0.81081,HP_ABNORMAL_SKIN_ADNEXA_MORPHOLOGY,1
GOBP_NEURONAL_DENSE_CORE_VES...,SET,7,-0.3215,-0.0062765,0.36491,0.81085,GOBP_NEURONAL_DENSE_CORE_VESICLE_EXOCYTOSIS,1
AACYNNNNTTCCS_UNKNOWN,SET,88,-0.082188,-0.0056763,0.09326,0.81091,AACYNNNNTTCCS_UNKNOWN,1
MEISSNER_BRAIN_HCP_WITH_H3K4...1,SET,16,-0.19435,-0.0057347,0.22052,0.81092,MEISSNER_BRAIN_HCP_WITH_H3K4ME2,1
HOFT_CD4_POSITIVE_ALPHA_BETA...3,SET,3,-0.37274,-0.0047642,0.4228,0.81099,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_DN,1
HP_ABNORMAL_AUDITORY_EVOKED_...,SET,22,-0.16404,-0.005675,0.18606,0.81101,HP_ABNORMAL_AUDITORY_EVOKED_POTENTIALS,1
REACTOME_GLYCINE_DEGRADATION,SET,7,-0.24163,-0.0047172,0.27405,0.81103,REACTOME_GLYCINE_DEGRADATION,1
GOBP_GLOMERULAR_MESANGIAL_CE...2,SET,12,-0.25383,-0.0064872,0.28787,0.81104,GOBP_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,1
HP_ABSENT_OR_MINIMALLY_OSSIF...,SET,11,-0.22131,-0.0054154,0.25098,0.81105,HP_ABSENT_OR_MINIMALLY_OSSIFIED_VERTEBRAL_BODIES,1
HP_DISTAL_LOWER_LIMB_AMYOTRO...,SET,46,-0.11445,-0.0057214,0.12977,0.81109,HP_DISTAL_LOWER_LIMB_AMYOTROPHY,1
GOBP_REGULATION_OF_MICROTUBU...4,SET,148,-0.058697,-0.0052487,0.066535,0.81116,GOBP_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
MIR4423_3P,SET,116,-0.072704,-0.0057607,0.082382,0.81125,MIR4423_3P,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...2,SET,8,-0.30581,-0.0063821,0.34646,0.81129,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,1
MIR647,SET,75,-0.084276,-0.0053754,0.095475,0.8113,MIR647,1
WP_SILDENAFIL_TREATMENT,SET,19,-0.18405,-0.0059176,0.20845,0.81135,WP_SILDENAFIL_TREATMENT,1
HP_ABNORMAL_SCROTAL_RUGATION,SET,4,-0.43942,-0.0064852,0.49766,0.81137,HP_ABNORMAL_SCROTAL_RUGATION,1
HP_ALLERGY,SET,35,-0.13317,-0.0058091,0.15079,0.81143,HP_ALLERGY,1
GOBP_NEUTRAL_LIPID_CATABOLIC...,SET,36,-0.13426,-0.0059393,0.152,0.81146,GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS,1
JONES_OVARY_MAST_CELL,SET,39,-0.12873,-0.0059269,0.14574,0.81146,JONES_OVARY_MAST_CELL,1
GOMF_1_PHOSPHATIDYLINOSITOL_...5,SET,8,-0.27215,-0.0056797,0.3081,0.81147,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY,1
REACTOME_MATURATION_OF_SARS_...2,SET,15,-0.17589,-0.0050254,0.1991,0.81149,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,1
SATO_SILENCED_BY_METHYLATION...2,SET,41,-0.12755,-0.0060207,0.14436,0.81152,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1
GOMF_MHC_CLASS_II_RECEPTOR_A...,SET,8,-0.3141,-0.0065551,0.35548,0.81153,GOMF_MHC_CLASS_II_RECEPTOR_ACTIVITY,1
MIR4750_3P,SET,36,-0.11775,-0.005209,0.13326,0.81154,MIR4750_3P,1
GSE3982_MAST_CELL_VS_EFF_MEM...2,SET,178,-0.057832,-0.0056667,0.065448,0.81155,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP,1
GSE27291_6H_VS_7D_STIM_GAMMA...2,SET,176,-0.053964,-0.0052581,0.061068,0.81156,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP,1
GOMF_METAL_CLUSTER_BINDING,SET,69,-0.087999,-0.0053845,0.099573,0.81158,GOMF_METAL_CLUSTER_BINDING,1
HP_CONGENITAL_ICHTHYOSIFORM_...,SET,27,-0.15445,-0.0059185,0.17476,0.81158,HP_CONGENITAL_ICHTHYOSIFORM_ERYTHRODERMA,1
ZNF426_TARGET_GENES,SET,121,-0.066339,-0.0053677,0.075059,0.8116,ZNF426_TARGET_GENES,1
GSE17974_0H_VS_12H_IN_VITRO_...1,SET,176,-0.054011,-0.0052627,0.06111,0.8116,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN,1
GOBP_AMACRINE_CELL_DIFFERENT...,SET,12,-0.25137,-0.0064242,0.28436,0.81164,GOBP_AMACRINE_CELL_DIFFERENTIATION,1
GSE46606_UNSTIM_VS_CD40L_IL2...1,SET,185,-0.055547,-0.0055476,0.062821,0.8117,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,1
HP_GEOGRAPHIC_ATROPHY,SET,4,-0.37097,-0.005475,0.41954,0.81171,HP_GEOGRAPHIC_ATROPHY,1
MIR4262,SET,704,-0.029731,-0.0057091,0.033622,0.81172,MIR4262,1
MIR328_3P,SET,39,-0.12629,-0.0058146,0.14276,0.81182,MIR328_3P,1
MIR7856_5P,SET,363,-0.040422,-0.0056272,0.045693,0.81182,MIR7856_5P,1
CCAWNWWNNNGGC_UNKNOWN,SET,75,-0.088382,-0.0056373,0.099897,0.81185,CCAWNWWNNNGGC_UNKNOWN,1
HP_CENTRAL_APNEA,SET,37,-0.1227,-0.0055025,0.13867,0.81187,HP_CENTRAL_APNEA,1
GSE3039_ALPHAALPHA_VS_ALPHAB...2,SET,180,-0.056168,-0.0055341,0.063469,0.81191,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP,1
WP_COMMON_PATHWAYS_UNDERLYIN...,SET,38,-0.13388,-0.0060845,0.15124,0.81198,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,1
GOBP_LYMPHOCYTE_MEDIATED_IMM...,SET,267,-0.050073,-0.0059943,0.056563,0.81198,GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY,1
HP_ABNORMAL_CARDIAC_EXERCISE...,SET,19,-0.17823,-0.0057306,0.20132,0.81199,HP_ABNORMAL_CARDIAC_EXERCISE_STRESS_TEST,1
GSE7768_OVA_WITH_LPS_VS_OVA_...1,SET,154,-0.060326,-0.0055017,0.068143,0.81199,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,1
HP_CALF_MUSCLE_PSEUDOHYPERTR...,SET,15,-0.19237,-0.0054963,0.21729,0.812,HP_CALF_MUSCLE_PSEUDOHYPERTROPHY,1
HP_PARAGANGLIOMA,SET,19,-0.15832,-0.0050905,0.17883,0.81201,HP_PARAGANGLIOMA,1
GOBP_EOSINOPHIL_MEDIATED_IMM...,SET,8,-0.25004,-0.0052181,0.2824,0.81203,GOBP_EOSINOPHIL_MEDIATED_IMMUNITY,1
GOBP_REGULATION_OF_LIPOPROTE...3,SET,19,-0.17662,-0.0056788,0.19947,0.81203,GOBP_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,1
AIZARANI_LIVER_C28_NK_NKT_CE...,SET,85,-0.085611,-0.0058116,0.096664,0.81209,AIZARANI_LIVER_C28_NK_NKT_CELLS_6,1
REACTOME_GLUTAMATE_AND_GLUTA...,SET,10,-0.2318,-0.0054082,0.26169,0.81213,REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,1
GOBP_CELL_FATE_COMMITMENT,SET,268,-0.050378,-0.006042,0.05687,0.81214,GOBP_CELL_FATE_COMMITMENT,1
GSE7764_IL15_NK_CELL_24H_VS_...2,SET,171,-0.054821,-0.005266,0.061874,0.81219,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP,1
GOBP_ENDOPLASMIC_RETICULUM_T...3,SET,5,-0.28915,-0.0047711,0.32634,0.8122,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_FORMATION,1
ZNF30_TARGET_GENES,SET,1184,-0.022366,-0.0054934,0.025237,0.81224,ZNF30_TARGET_GENES,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...4,SET,5,-0.30283,-0.0049967,0.34165,0.81228,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00484,1
HP_HYPOPLASTIC_FIFTH_TOENAIL,SET,16,-0.2082,-0.0061436,0.23484,0.81233,HP_HYPOPLASTIC_FIFTH_TOENAIL,1
GOCC_PROTEIN_FOLDING_CHAPERO...,SET,40,-0.10842,-0.0050549,0.12227,0.81237,GOCC_PROTEIN_FOLDING_CHAPERONE_COMPLEX,1
GOBP_MITOCHONDRIAL_PROTEIN_P...,SET,12,-0.20675,-0.0052839,0.23314,0.81239,GOBP_MITOCHONDRIAL_PROTEIN_PROCESSING,1
HP_ZOLLINGER_ELLISON_SYNDROME,SET,9,-0.25771,-0.0057043,0.29062,0.81239,HP_ZOLLINGER_ELLISON_SYNDROME,1
WP_MODULATION_OF_PI3KAKTMTOR...,SET,14,-0.22636,-0.0062483,0.25525,0.81241,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,1
MTOR_UP.V1_DN,SET,171,-0.059013,-0.0056686,0.066535,0.81244,MTOR_UP.V1_DN,1
LAKE_ADULT_KIDNEY_C12_THICK_...,SET,328,-0.042405,-0.005617,0.0478,0.81249,LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB,1
GOCC_MIB_COMPLEX,SET,9,-0.2403,-0.0053191,0.27086,0.8125,GOCC_MIB_COMPLEX,1
MIR550A_3P,SET,70,-0.095183,-0.005866,0.10728,0.81251,MIR550A_3P,1
GOBP_PROTEIN_EXIT_FROM_ENDOP...,SET,45,-0.099316,-0.0049108,0.11193,0.81254,GOBP_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
GOMF_OXIDOREDUCTASE_ACTIVITY...26,SET,9,-0.28807,-0.0063763,0.32458,0.81259,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER,1
REACTOME_LIPID_PARTICLE_ORGA...,SET,6,-0.33257,-0.006011,0.37457,0.81269,REACTOME_LIPID_PARTICLE_ORGANIZATION,1
MIR3133,SET,447,-0.037151,-0.0057258,0.041834,0.81274,MIR3133,1
BURTON_ADIPOGENESIS_5,SET,100,-0.071224,-0.0052421,0.080159,0.81287,BURTON_ADIPOGENESIS_5,1
GOBP_RESPONSE_TO_COCAINE,SET,54,-0.11057,-0.0059876,0.1244,0.81294,GOBP_RESPONSE_TO_COCAINE,1
JIANG_AGING_HYPOTHALAMUS_DN,SET,30,-0.12788,-0.0051652,0.14386,0.81299,JIANG_AGING_HYPOTHALAMUS_DN,1
MIR676_3P,SET,47,-0.11197,-0.005658,0.12591,0.81307,MIR676_3P,1
HP_COMPLEX_FEBRILE_SEIZURE,SET,15,-0.18555,-0.0053014,0.20865,0.81307,HP_COMPLEX_FEBRILE_SEIZURE,1
HP_APLASIA_HYPOPLASIA_OF_THE...38,SET,10,-0.23862,-0.0055675,0.26826,0.81313,HP_APLASIA_HYPOPLASIA_OF_THE_INNER_EAR,1
GOMF_DOUBLE_STRANDED_RNA_BIN...,SET,69,-0.087888,-0.0053778,0.098803,0.81314,GOMF_DOUBLE_STRANDED_RNA_BINDING,1
KEGG_MEDICUS_REFERENCE_DEUBI...,SET,20,-0.1651,-0.005446,0.18558,0.81316,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119,1
GOBP_RESPONSE_TO_LEUKEMIA_IN...,SET,92,-0.083744,-0.0059132,0.094112,0.81322,GOBP_RESPONSE_TO_LEUKEMIA_INHIBITORY_FACTOR,1
GSE27241_WT_CTRL_VS_DIGOXIN_...1,SET,161,-0.056519,-0.0052694,0.063511,0.81324,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,1
GOBP_REGULATION_OF_CELL_PROL...1,SET,15,-0.21672,-0.0061919,0.24348,0.81328,GOBP_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_REGULATION_OF_VITAMIN_D...2,SET,10,-0.22315,-0.0052065,0.25066,0.81333,GOBP_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_MYRISTOYLTRANSFERASE_AC...,SET,10,-0.21733,-0.0050707,0.24404,0.81341,GOMF_MYRISTOYLTRANSFERASE_ACTIVITY,1
GOMF_CO_SMAD_BINDING,SET,9,-0.27674,-0.0061256,0.3107,0.81345,GOMF_CO_SMAD_BINDING,1
DESCARTES_FETAL_INTESTINE_SM...,SET,41,-0.12602,-0.0059485,0.14147,0.81348,DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS,1
GOMF_OLIGOPEPTIDE_BINDING,SET,10,-0.25127,-0.0058624,0.28204,0.8135,GOMF_OLIGOPEPTIDE_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...168,SET,234,-0.050688,-0.0056858,0.056894,0.81351,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE,1
GSE17721_POLYIC_VS_CPG_6H_BM...1,SET,183,-0.053953,-0.0053596,0.060552,0.81354,GSE17721_POLYIC_VS_CPG_6H_BMDC_DN,1
MODULE_21,SET,9,-0.23961,-0.0053038,0.26878,0.81366,MODULE_21,1
MODULE_56,SET,9,-0.23961,-0.0053038,0.26878,0.81366,MODULE_56,1
GOBP_LOW_DENSITY_LIPOPROTEIN...3,SET,5,-0.36986,-0.0061028,0.41485,0.81367,GOBP_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_PARTICLE_METABOLIC_PROCESS,1
WP_BDNFTRKB_SIGNALING,SET,33,-0.13547,-0.005738,0.15191,0.81373,WP_BDNFTRKB_SIGNALING,1
HP_RECURRENT_ASPIRATION_PNEU...,SET,23,-0.15389,-0.0054433,0.17251,0.81382,HP_RECURRENT_ASPIRATION_PNEUMONIA,1
GSE5589_IL6_KO_VS_IL10_KO_LP...8,SET,176,-0.060069,-0.005853,0.067327,0.81385,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,1
MIR3127_5P,SET,49,-0.1079,-0.0055666,0.12093,0.81386,MIR3127_5P,1
GSE23502_BM_VS_COLON_TUMOR_H...1,SET,187,-0.055654,-0.005588,0.062362,0.81391,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,1
GSE37301_MULTIPOTENT_PROGENI...3,SET,186,-0.053494,-0.0053569,0.059936,0.81393,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
GSE24634_TREG_VS_TCONV_POST_...7,SET,186,-0.05788,-0.0057961,0.064844,0.81396,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN,1
GOBP_CELLULAR_RESPONSE_TO_CA...1,SET,33,-0.1597,-0.0067645,0.17887,0.81401,GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION,1
GSE24972_WT_VS_IRF8_KO_SPLEE...2,SET,180,-0.058601,-0.0057738,0.065637,0.81401,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP,1
GOBP_REGULATION_OF_NEURON_DI...,SET,176,-0.063091,-0.0061475,0.07066,0.81403,GOBP_REGULATION_OF_NEURON_DIFFERENTIATION,1
REACTOME_LTC4_CYSLTR_MEDIATE...,SET,6,-0.31454,-0.0056852,0.35227,0.81404,REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION,1
HP_ENCEPHALOMALACIA,SET,12,-0.25339,-0.0064759,0.28373,0.81408,HP_ENCEPHALOMALACIA,1
MIR4317,SET,88,-0.08012,-0.0055335,0.089701,0.81411,MIR4317,1
MIR3124_3P,SET,204,-0.05319,-0.0055755,0.059545,0.81414,MIR3124_3P,1
HP_PROMINENT_EAR_HELIX,SET,6,-0.28367,-0.0051272,0.31756,0.81414,HP_PROMINENT_EAR_HELIX,1
RASHI_RESPONSE_TO_IONIZING_R...5,SET,126,-0.066935,-0.0055259,0.074928,0.81415,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1
GSE17721_LPS_VS_POLYIC_8H_BM...2,SET,179,-0.055629,-0.005466,0.062268,0.81417,GSE17721_LPS_VS_POLYIC_8H_BMDC_UP,1
HP_VENTRICULAR_HYPERTROPHY,SET,138,-0.062458,-0.0053945,0.069903,0.81419,HP_VENTRICULAR_HYPERTROPHY,1
KRASNOSELSKAYA_ILF3_TARGETS_...1,SET,43,-0.11563,-0.0055893,0.12941,0.8142,KRASNOSELSKAYA_ILF3_TARGETS_DN,1
GOBP_GLOMERULUS_VASCULATURE_...,SET,6,-0.35567,-0.0064285,0.39788,0.8143,GOBP_GLOMERULUS_VASCULATURE_MORPHOGENESIS,1
GOBP_PERIPHERAL_NERVOUS_SYST...4,SET,8,-0.27035,-0.005642,0.30244,0.8143,GOBP_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,1
REACTOME_SYNTHESIS_OF_16_20_...,SET,9,-0.26821,-0.0059368,0.30004,0.81431,REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE,1
DBP_Q6,SET,224,-0.052991,-0.0058174,0.059264,0.81437,DBP_Q6,1
HP_BRANCHIAL_FISTULA,SET,9,-0.29221,-0.0064681,0.32678,0.81439,HP_BRANCHIAL_FISTULA,1
GOMF_TRANSLATION_REGULATOR_A...2,SET,91,-0.072316,-0.0050785,0.080859,0.81443,GOMF_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...599,SET,110,-0.070704,-0.0054563,0.079046,0.81446,GOBP_POSITIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
HP_RICKETS,SET,37,-0.13123,-0.005885,0.14669,0.81449,HP_RICKETS,1
KUUSELO_PANCREATIC_CANCER_19...,SET,31,-0.21179,-0.0086952,0.23671,0.81452,KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,1
RAMALHO_STEMNESS_DN,SET,65,-0.098107,-0.0058271,0.10965,0.81453,RAMALHO_STEMNESS_DN,1
GOBP_SKELETAL_MUSCLE_ADAPTAT...,SET,22,-0.1715,-0.0059329,0.19165,0.81456,GOBP_SKELETAL_MUSCLE_ADAPTATION,1
BROWNE_HCMV_INFECTION_6HR_DN,SET,147,-0.062975,-0.0056123,0.070357,0.81462,BROWNE_HCMV_INFECTION_6HR_DN,1
GSE37301_HEMATOPOIETIC_STEM_...2,SET,167,-0.06013,-0.0057086,0.067162,0.81468,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP,1
ZNF781_TARGET_GENES,SET,121,-0.06702,-0.0054228,0.074854,0.81469,ZNF781_TARGET_GENES,1
HP_ABNORMAL_AORTIC_VALVE_MOR...,SET,151,-0.062999,-0.0056897,0.07034,0.81477,HP_ABNORMAL_AORTIC_VALVE_MORPHOLOGY,1
GSE18281_PERIMEDULLARY_CORTI...3,SET,156,-0.061352,-0.0056312,0.068491,0.8148,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,1
GOBP_REGULATION_OF_SIGNAL_TR...,SET,95,-0.077875,-0.0055873,0.086934,0.81481,GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
GOBP_PHOSPHATIDYLCHOLINE_CAT...,SET,15,-0.20247,-0.0057848,0.22601,0.81483,GOBP_PHOSPHATIDYLCHOLINE_CATABOLIC_PROCESS,1
GARGALOVIC_RESPONSE_TO_OXIDI...1,SET,10,-0.22809,-0.0053218,0.25459,0.81484,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,1
GOCC_NADH_DEHYDROGENASE_COMP...,SET,40,-0.10266,-0.0047863,0.11458,0.81485,GOCC_NADH_DEHYDROGENASE_COMPLEX,1
HP_ABNORMAL_BRANCHING_PATTER...,SET,26,-0.14967,-0.0056283,0.16705,0.81486,HP_ABNORMAL_BRANCHING_PATTERN_OF_THE_AORTIC_ARCH,1
HP_AGANGLIONIC_MEGACOLON,SET,132,-0.063824,-0.0053922,0.071227,0.81489,HP_AGANGLIONIC_MEGACOLON,1
GOBP_GLYOXYLATE_METABOLIC_PR...,SET,8,-0.27398,-0.0057179,0.30572,0.81491,GOBP_GLYOXYLATE_METABOLIC_PROCESS,1
WP_CATALYTIC_CYCLE_OF_MAMMAL...,SET,5,-0.43624,-0.007198,0.48673,0.81494,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,1
GOMF_N_N_DIMETHYLANILINE_MON...,SET,5,-0.43624,-0.007198,0.48673,0.81494,GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY,1
WP_SPHINGOLIPID_PATHWAY,SET,27,-0.14695,-0.0056311,0.16393,0.81497,WP_SPHINGOLIPID_PATHWAY,1
MUELLER_METHYLATED_IN_GLIOBL...,SET,35,-0.13462,-0.0058721,0.15015,0.81502,MUELLER_METHYLATED_IN_GLIOBLASTOMA,1
ZHAN_MULTIPLE_MYELOMA_CD1_AN...1,SET,51,-0.11237,-0.0059142,0.12533,0.81503,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,1
GOBP_NEGATIVE_REGULATION_OF_...217,SET,59,-0.1018,-0.0057618,0.11354,0.81503,GOBP_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,1
GOBP_NEGATIVE_REGULATION_OF_...674,SET,10,-0.22819,-0.005324,0.25448,0.81505,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,1
GSE39820_CTRL_VS_IL1B_IL6_CD...2,SET,171,-0.059481,-0.0057136,0.066333,0.81505,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP,1
ELVIDGE_HIF1A_TARGETS_UP,SET,62,-0.091028,-0.0052808,0.10151,0.81507,ELVIDGE_HIF1A_TARGETS_UP,1
GOBP_MITOCHONDRIAL_DNA_REPLI...,SET,13,-0.18908,-0.0050294,0.21083,0.81508,GOBP_MITOCHONDRIAL_DNA_REPLICATION,1
HP_MUSCLE_ABNORMALITY_RELATE...,SET,63,-0.086262,-0.0050444,0.096178,0.81511,HP_MUSCLE_ABNORMALITY_RELATED_TO_MITOCHONDRIAL_DYSFUNCTION,1
GOBP_ALCOHOL_METABOLIC_PROCE...,SET,332,-0.042684,-0.0056876,0.047587,0.81512,GOBP_ALCOHOL_METABOLIC_PROCESS,1
GOCC_EXTERNAL_ENCAPSULATING_...,SET,518,-0.036673,-0.0060724,0.040886,0.81512,GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE,1
MIR1267,SET,70,-0.089666,-0.005526,0.099952,0.81516,MIR1267,1
GOBP_CELLULAR_RESPIRATION,SET,189,-0.051898,-0.0052384,0.057846,0.81518,GOBP_CELLULAR_RESPIRATION,1
GOBP_GLOSSOPHARYNGEAL_NERVE_...,SET,5,-0.2921,-0.0048197,0.32553,0.81522,GOBP_GLOSSOPHARYNGEAL_NERVE_DEVELOPMENT,1
REACTOME_SIGNAL_TRANSDUCTION...,SET,20,-0.18205,-0.0060052,0.2028,0.81531,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,1
HP_ABNORMAL_BONE_STRUCTURE,SET,737,-0.028653,-0.0056243,0.031917,0.81532,HP_ABNORMAL_BONE_STRUCTURE,1
GOBP_DENDRITIC_SPINE_MAINTEN...,SET,20,-0.18251,-0.0060205,0.20322,0.81542,GOBP_DENDRITIC_SPINE_MAINTENANCE,1
GOBP_REGULATION_OF_MYELOID_L...2,SET,52,-0.10755,-0.0057155,0.11972,0.81549,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,1
GSE360_L_DONOVANI_VS_M_TUBER...1,SET,183,-0.055982,-0.0055611,0.062317,0.81549,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_NEUTRAL_AMINO_ACID_TRAN...,SET,54,-0.10811,-0.0058544,0.12031,0.81556,GOBP_NEUTRAL_AMINO_ACID_TRANSPORT,1
GOBP_METANEPHRIC_NEPHRON_TUB...2,SET,8,-0.29852,-0.0062299,0.33209,0.81564,GOBP_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS,1
GOBP_CELLULAR_RESPONSE_TO_CA...4,SET,49,-0.11263,-0.0058107,0.12528,0.81566,GOBP_CELLULAR_RESPONSE_TO_CAMP,1
SENESE_HDAC2_TARGETS_UP,SET,106,-0.071866,-0.0054448,0.07992,0.81573,SENESE_HDAC2_TARGETS_UP,1
GOMF_MACROLIDE_BINDING,SET,12,-0.19456,-0.0049725,0.21636,0.81573,GOMF_MACROLIDE_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...713,SET,36,-0.13739,-0.0060776,0.15276,0.81577,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,1
MIR12115,SET,63,-0.093302,-0.005456,0.10372,0.81581,MIR12115,1
SINGH_KRAS_DEPENDENCY_SIGNAT...,SET,19,-0.18611,-0.005984,0.2069,0.81581,SINGH_KRAS_DEPENDENCY_SIGNATURE,1
GOMF_MAGNESIUM_ION_TRANSMEMB...,SET,13,-0.21234,-0.0056482,0.23604,0.81583,GOMF_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_MULTICYSTIC_KIDNEY_DYSPLA...,SET,82,-0.082731,-0.0055166,0.091952,0.81586,HP_MULTICYSTIC_KIDNEY_DYSPLASIA,1
GOBP_DENDRITE_DEVELOPMENT,SET,218,-0.0535,-0.005795,0.059453,0.8159,GOBP_DENDRITE_DEVELOPMENT,1
GOMF_DYNEIN_COMPLEX_BINDING,SET,19,-0.17747,-0.0057062,0.19722,0.8159,GOMF_DYNEIN_COMPLEX_BINDING,1
NCOA4_TARGET_GENES,SET,844,-0.026736,-0.0055991,0.02971,0.81591,NCOA4_TARGET_GENES,1
MIR144_3P,SET,451,-0.038354,-0.0059369,0.042614,0.81594,MIR144_3P,1
GSE360_DC_VS_MAC_DN,SET,171,-0.059103,-0.0056773,0.065669,0.81594,GSE360_DC_VS_MAC_DN,1
BIOCARTA_CERAMIDE_PATHWAY,SET,20,-0.17836,-0.0058835,0.19816,0.81595,BIOCARTA_CERAMIDE_PATHWAY,1
GOMF_IRON_ION_TRANSMEMBRANE_...,SET,9,-0.26352,-0.005833,0.29275,0.81597,GOMF_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR4762_5P,SET,128,-0.067942,-0.0056531,0.075477,0.81598,MIR4762_5P,1
GOBP_POSITIVE_REGULATION_OF_...822,SET,8,-0.28576,-0.0059637,0.31744,0.81599,GOBP_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
REACTOME_RIBAVIRIN_ADME,SET,11,-0.26429,-0.0064671,0.29348,0.81608,REACTOME_RIBAVIRIN_ADME,1
BLANCO_MELO_BRONCHIAL_EPITHE...3,SET,69,-0.094852,-0.0058039,0.10532,0.8161,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN,1
PEREZ_TP53_AND_TP63_TARGETS,SET,178,-0.061098,-0.0059867,0.06784,0.8161,PEREZ_TP53_AND_TP63_TARGETS,1
SMITH_TERT_TARGETS_UP,SET,130,-0.065441,-0.0054871,0.072648,0.81614,SMITH_TERT_TARGETS_UP,1
HP_ABNORMAL_MONOCYTE_COUNT,SET,20,-0.16039,-0.0052908,0.17801,0.81621,HP_ABNORMAL_MONOCYTE_COUNT,1
MYB_Q3,SET,233,-0.049971,-0.0055935,0.055447,0.81626,MYB_Q3,1
GSE2405_0H_VS_12H_A_PHAGOCYT...2,SET,184,-0.05895,-0.0058718,0.065405,0.81628,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
GSE36095_WT_VS_HDAC9_KO_TREG...1,SET,109,-0.075147,-0.0057729,0.083376,0.81628,GSE36095_WT_VS_HDAC9_KO_TREG_DN,1
HP_DEVIATION_OF_THE_HALLUX,SET,75,-0.093937,-0.0059916,0.1042,0.81634,HP_DEVIATION_OF_THE_HALLUX,1
GSE27670_CTRL_VS_BLIMP1_TRAN...1,SET,180,-0.060028,-0.0059144,0.066581,0.81635,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN,1
GOMF_NADH_DEHYDROGENASE_UBIQ...,SET,33,-0.11191,-0.0047401,0.1241,0.81639,GOMF_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY,1
WP_11P112_COPY_NUMBER_VARIAT...,SET,52,-0.1233,-0.0065528,0.1367,0.81647,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,1
LAKE_ADULT_KIDNEY_C14_DISTAL...,SET,179,-0.06369,-0.0062579,0.070605,0.81648,LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE,1
GSE21670_TGFB_VS_IL6_TREATED...2,SET,177,-0.056987,-0.0055683,0.063163,0.81652,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP,1
MIR328_5P,SET,53,-0.10424,-0.0055923,0.11552,0.81654,MIR328_5P,1
GARGALOVIC_RESPONSE_TO_OXIDI...10,SET,16,-0.19814,-0.0058466,0.21956,0.81659,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1
KEGG_SULFUR_METABOLISM,SET,11,-0.22911,-0.0056064,0.25388,0.81659,KEGG_SULFUR_METABOLISM,1
GAVISH_3CA_METAPROGRAM_FIBRO...6,SET,46,-0.12092,-0.0060449,0.13399,0.81659,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5,1
MODULE_366,SET,29,-0.13413,-0.0053267,0.14863,0.81659,MODULE_366,1
MIR22_5P,SET,127,-0.068058,-0.0056408,0.0754,0.81663,MIR22_5P,1
GSE17721_LPS_VS_GARDIQUIMOD_...1,SET,185,-0.055398,-0.0055327,0.061369,0.81665,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
MIR6715A_3P,SET,148,-0.064521,-0.0057695,0.071465,0.81668,MIR6715A_3P,1
PETRETTO_HEART_MASS_QTL_CIS_...2,SET,30,-0.13831,-0.0055862,0.15319,0.81669,PETRETTO_HEART_MASS_QTL_CIS_UP,1
chr6q23,SET,45,-0.2168,-0.01072,0.24011,0.81671,chr6q23,1
GOBP_POSITIVE_REGULATION_OF_...544,SET,57,-0.1038,-0.0057747,0.11495,0.81673,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
HP_HOARSE_CRY,SET,14,-0.22453,-0.0061978,0.24859,0.81678,HP_HOARSE_CRY,1
GOCC_CYTOLYTIC_GRANULE,SET,14,-0.2397,-0.0066166,0.26537,0.81681,GOCC_CYTOLYTIC_GRANULE,1
MODULE_474,SET,13,-0.2488,-0.0066181,0.27542,0.81682,MODULE_474,1
GOMF_SNRNA_BINDING,SET,44,-0.098963,-0.0048388,0.1095,0.81695,GOMF_SNRNA_BINDING,1
KEGG_ECM_RECEPTOR_INTERACTION,SET,82,-0.090038,-0.0060038,0.099612,0.81697,KEGG_ECM_RECEPTOR_INTERACTION,1
GSE17721_0.5H_VS_4H_PAM3CSK4...1,SET,191,-0.056414,-0.0057239,0.062408,0.81698,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN,1
GSE36826_NORMAL_VS_STAPH_AUR...4,SET,175,-0.05637,-0.0054771,0.062356,0.81699,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP,1
REACTOME_RHOBTB2_GTPASE_CYCLE,SET,22,-0.15308,-0.005296,0.16934,0.817,REACTOME_RHOBTB2_GTPASE_CYCLE,1
GSE18893_TCONV_VS_TREG_2H_TN...1,SET,174,-0.058299,-0.0056485,0.064479,0.81704,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN,1
GOMF_SOLUTE_POTASSIUM_ANTIPO...,SET,17,-0.19827,-0.0060304,0.21926,0.81707,GOMF_SOLUTE_POTASSIUM_ANTIPORTER_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_PROT...1,SET,101,-0.076285,-0.0056424,0.084339,0.81713,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...805,SET,32,-0.14055,-0.0058627,0.15538,0.81715,GOBP_POSITIVE_REGULATION_OF_T_CELL_MIGRATION,1
GOBP_DENDRITIC_CELL_ANTIGEN_...,SET,13,-0.23013,-0.0061215,0.2544,0.81716,GOBP_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
BIOCARTA_PAR1_PATHWAY,SET,19,-0.18555,-0.0059658,0.20507,0.81721,BIOCARTA_PAR1_PATHWAY,1
GOBP_CELL_PROJECTION_ORGANIZ...,SET,1455,-0.02149,-0.0058051,0.023749,0.81723,GOBP_CELL_PROJECTION_ORGANIZATION,1
GSE45881_CXCR6HI_VS_CXCR1LO_...2,SET,168,-0.056702,-0.0053991,0.062658,0.81725,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP,1
GOBP_NEGATIVE_REGULATION_OF_...604,SET,12,-0.25912,-0.0066223,0.28627,0.8173,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...45,SET,97,-0.077792,-0.0056394,0.085938,0.81732,GOBP_NEGATIVE_REGULATION_OF_BINDING,1
HP_VOCAL_CORD_PARALYSIS,SET,53,-0.10486,-0.0056257,0.11583,0.81733,HP_VOCAL_CORD_PARALYSIS,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...2,SET,156,-0.067092,-0.0061581,0.074115,0.81733,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL,1
GOCC_CELL_CORTEX_REGION,SET,34,-0.13503,-0.0058053,0.14915,0.81735,GOCC_CELL_CORTEX_REGION,1
HP_PARIETAL_CORTICAL_ATROPHY,SET,8,-0.32644,-0.0068126,0.36053,0.81738,HP_PARIETAL_CORTICAL_ATROPHY,1
HOEK_MONOCYTE_2011_2012_TIV_...5,SET,9,-0.30284,-0.0067033,0.33445,0.81738,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_DN,1
GSE30083_SP2_VS_SP3_THYMOCYT...2,SET,185,-0.061554,-0.0061476,0.067968,0.81743,GSE30083_SP2_VS_SP3_THYMOCYTE_UP,1
GOBP_HORMONE_METABOLIC_PROCE...,SET,228,-0.056685,-0.0062775,0.062583,0.81746,GOBP_HORMONE_METABOLIC_PROCESS,1
GOBP_RIBONUCLEOSIDE_MONOPHOS...2,SET,14,-0.22222,-0.0061339,0.24532,0.81748,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
REACTOME_POST_TRANSCRIPTIONA...,SET,7,-0.31823,-0.0062127,0.3513,0.81749,REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS,1
MIR27B_5P,SET,43,-0.11883,-0.005744,0.13116,0.81752,MIR27B_5P,1
MANNO_MIDBRAIN_NEUROTYPES_HP...4,SET,298,-0.045169,-0.0057077,0.04985,0.81755,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM,1
KORKOLA_YOLK_SAC_TUMOR_UP,SET,13,-0.25333,-0.0067385,0.2795,0.81762,KORKOLA_YOLK_SAC_TUMOR_UP,1
SRPK2_TARGET_GENES,SET,47,-0.11156,-0.005637,0.12308,0.81762,SRPK2_TARGET_GENES,1
TCCGTCC_MIR184,SET,12,-0.23023,-0.005884,0.25398,0.81765,TCCGTCC_MIR184,1
HP_POSITIVE_BLOOD_INFECTIOUS...,SET,17,-0.1782,-0.00542,0.19655,0.8177,HP_POSITIVE_BLOOD_INFECTIOUS_AGENT_TEST,1
HP_ABNORMAL_CHOROID_MORPHOLO...,SET,169,-0.060274,-0.0057561,0.066475,0.81772,HP_ABNORMAL_CHOROID_MORPHOLOGY,1
HP_PECTUS_EXCAVATUM_OF_INFER...,SET,5,-0.32062,-0.0052903,0.35356,0.81775,HP_PECTUS_EXCAVATUM_OF_INFERIOR_STERNUM,1
GOBP_N_ACETYLGLUCOSAMINE_MET...,SET,14,-0.22033,-0.0060817,0.24293,0.81777,GOBP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,1
GOBP_EMBRYONIC_PLACENTA_DEVE...,SET,83,-0.089043,-0.0059734,0.098172,0.81779,GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT,1
GOBP_REGULATION_OF_VOLTAGE_G...1,SET,21,-0.1801,-0.0060873,0.19856,0.81779,GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
ZNF175_TARGET_GENES,SET,627,-0.031141,-0.0056558,0.034333,0.8178,ZNF175_TARGET_GENES,1
HP_DYSPNEA,SET,432,-0.03853,-0.0058403,0.042479,0.8178,HP_DYSPNEA,1
HP_MULTIPLE_JOINT_CONTRACTUR...,SET,57,-0.095658,-0.0053217,0.10546,0.8178,HP_MULTIPLE_JOINT_CONTRACTURES,1
GSE22935_UNSTIM_VS_12H_MBOVI...3,SET,181,-0.055811,-0.005514,0.061517,0.81785,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GOBP_MEMBRANE_FUSION_INVOLVE...,SET,4,-0.43929,-0.0064833,0.4839,0.818,GOBP_MEMBRANE_FUSION_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,1
GSE2770_IL12_VS_IL4_TREATED_...3,SET,176,-0.0583,-0.0056806,0.064222,0.818,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
GOBP_MICROTUBULE_BASED_TRANS...,SET,187,-0.055807,-0.0056034,0.061468,0.81803,GOBP_MICROTUBULE_BASED_TRANSPORT,1
HP_ABNORMAL_SHOULDER_PHYSIOL...,SET,12,-0.23967,-0.0061254,0.2639,0.81811,HP_ABNORMAL_SHOULDER_PHYSIOLOGY,1
DAZARD_UV_RESPONSE_CLUSTER_G5,SET,8,-0.20032,-0.0041806,0.22055,0.81812,DAZARD_UV_RESPONSE_CLUSTER_G5,1
HP_DYSURIA,SET,14,-0.19852,-0.0054798,0.21856,0.81814,HP_DYSURIA,1
HP_DECREASED_SERUM_CREATININE,SET,4,-0.40717,-0.0060092,0.4482,0.81817,HP_DECREASED_SERUM_CREATININE,1
HP_CHOLANGITIS,SET,18,-0.19171,-0.0059996,0.211,0.8182,HP_CHOLANGITIS,1
HP_HYPERTELORISM,SET,721,-0.029111,-0.0056544,0.032027,0.8183,HP_HYPERTELORISM,1
HP_PARAKERATOSIS,SET,30,-0.14813,-0.0059829,0.1629,0.8184,HP_PARAKERATOSIS,1
REACTOME_HSP90_CHAPERONE_CYC...,SET,53,-0.10275,-0.0055124,0.11298,0.81844,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,1
DESCARTES_MAIN_FETAL_LYMPHOI...,SET,116,-0.077789,-0.0061636,0.085531,0.81845,DESCARTES_MAIN_FETAL_LYMPHOID_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...434,SET,15,-0.20007,-0.0057163,0.21988,0.81856,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
GSE17974_CTRL_VS_ACT_IL4_AND...10,SET,167,-0.061309,-0.0058205,0.067379,0.81856,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP,1
REACTOME_SIGNALING_BY_MRAS_C...,SET,7,-0.25776,-0.0050321,0.2832,0.81863,REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS,1
MIR412_3P,SET,66,-0.099955,-0.0059822,0.10977,0.81873,MIR412_3P,1
MODULE_93,SET,173,-0.059389,-0.0057377,0.065223,0.81873,MODULE_93,1
GOBP_PROTEIN_CATABOLIC_PROCE...2,SET,21,-0.17531,-0.0059257,0.19249,0.81879,GOBP_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
GSE41867_NAIVE_VS_EFFECTOR_C...1,SET,182,-0.052927,-0.0052434,0.058104,0.81882,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,1
GOBP_CALCIUM_ION_TRANSMEMBRA...2,SET,311,-0.046306,-0.0059755,0.050834,0.81883,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GSE15733_BM_VS_SPLEEN_MEMORY...1,SET,177,-0.057103,-0.0055797,0.062687,0.81883,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN,1
GOBP_REGULATION_OF_RHO_PROTE...,SET,79,-0.089761,-0.0058753,0.098532,0.81884,GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...491,SET,98,-0.078898,-0.0057489,0.086587,0.8189,GOBP_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS,1
WP_PATHWAYS_OF_NUCLEIC_ACID_...,SET,13,-0.20382,-0.0054215,0.22363,0.81895,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,1
MODULE_62,SET,67,-0.082983,-0.0050038,0.091048,0.81896,MODULE_62,1
GOBP_UBIQUITIN_RECYCLING,SET,12,-0.23066,-0.005895,0.25308,0.81896,GOBP_UBIQUITIN_RECYCLING,1
HP_HYPOPROTEINEMIA,SET,18,-0.17817,-0.005576,0.1954,0.81906,HP_HYPOPROTEINEMIA,1
GOBP_SKELETAL_SYSTEM_DEVELOP...,SET,483,-0.038696,-0.0061931,0.04243,0.81911,GOBP_SKELETAL_SYSTEM_DEVELOPMENT,1
PETROVA_PROX1_TARGETS_UP,SET,25,-0.16025,-0.0059094,0.1757,0.81914,PETROVA_PROX1_TARGETS_UP,1
HP_NEOPLASM_OF_THE_ADRENAL_G...,SET,45,-0.11734,-0.005802,0.12863,0.81916,HP_NEOPLASM_OF_THE_ADRENAL_GLAND,1
GSE17721_0.5H_VS_24H_PAM3CSK...2,SET,186,-0.0563,-0.0056379,0.061699,0.81924,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP,1
HARRIS_BRAIN_CANCER_PROGENIT...,SET,37,-0.13506,-0.0060568,0.14796,0.81931,HARRIS_BRAIN_CANCER_PROGENITORS,1
GOBP_REGULATION_OF_3_UTR_MED...,SET,5,-0.40112,-0.0066186,0.43943,0.81932,GOBP_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,1
GOBP_RESPONSE_TO_ISOQUINOLIN...,SET,13,-0.22847,-0.0060773,0.25028,0.81933,GOBP_RESPONSE_TO_ISOQUINOLINE_ALKALOID,1
HP_VASCULAR_CALCIFICATION,SET,31,-0.14845,-0.0060947,0.16261,0.81934,HP_VASCULAR_CALCIFICATION,1
GOBP_REGULATION_OF_T_CELL_RE...,SET,43,-0.12075,-0.0058366,0.13223,0.81941,GOBP_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
MIR1263,SET,50,-0.11772,-0.0061347,0.12891,0.81943,MIR1263,1
CSR_EARLY_UP.V1_DN,SET,113,-0.071484,-0.0055908,0.078275,0.81944,CSR_EARLY_UP.V1_DN,1
MORF_DCC,SET,99,-0.082391,-0.0060337,0.090184,0.81953,MORF_DCC,1
GSE17721_CTRL_VS_LPS_24H_BMD...1,SET,184,-0.055485,-0.0055266,0.060732,0.81953,GSE17721_CTRL_VS_LPS_24H_BMDC_DN,1
GOBP_REGULATION_OF_GONADOTRO...,SET,12,-0.26524,-0.0067789,0.2903,0.81955,GOBP_REGULATION_OF_GONADOTROPIN_SECRETION,1
REACTOME_NFE2L2_REGULATING_A...,SET,19,-0.19178,-0.0061662,0.20981,0.81965,REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES,1
GSE15930_STIM_VS_STIM_AND_TR...3,SET,190,-0.055183,-0.0055846,0.060373,0.81965,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN,1
CAMPS_COLON_CANCER_COPY_NUMB...1,SET,35,-0.14734,-0.006427,0.16119,0.81966,CAMPS_COLON_CANCER_COPY_NUMBER_DN,1
HP_FEMALE_EXTERNAL_GENITALIA...,SET,14,-0.21922,-0.0060513,0.2398,0.81969,HP_FEMALE_EXTERNAL_GENITALIA_IN_INDIVIDUAL_WITH_46_XY_KARYOTYPE,1
GOBP_LYSOSOMAL_MEMBRANE_ORGA...,SET,15,-0.20698,-0.0059137,0.22638,0.81971,GOBP_LYSOSOMAL_MEMBRANE_ORGANIZATION,1
GOCC_ORGANELLAR_RIBOSOME,SET,86,-0.075452,-0.0051519,0.082527,0.81971,GOCC_ORGANELLAR_RIBOSOME,1
HP_ABNORMAL_CIRCULATING_PROT...2,SET,58,-0.099518,-0.0055846,0.10885,0.81971,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_CONCENTRATION,1
GNF2_TPT1,SET,34,-0.13081,-0.005624,0.14307,0.81972,GNF2_TPT1,1
GOMF_ACROSIN_BINDING,SET,5,-0.33138,-0.0054678,0.36234,0.81978,GOMF_ACROSIN_BINDING,1
GOBP_REGULATION_OF_GOLGI_ORG...,SET,15,-0.20066,-0.0057331,0.2194,0.81979,GOBP_REGULATION_OF_GOLGI_ORGANIZATION,1
LAKE_ADULT_KIDNEY_C11_THIN_A...,SET,158,-0.064663,-0.0059727,0.070703,0.81979,LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB,1
HP_ABNORMAL_ALVEOLAR_RIDGE_M...,SET,38,-0.12297,-0.0055887,0.13445,0.8198,HP_ABNORMAL_ALVEOLAR_RIDGE_MORPHOLOGY,1
GOMF_ACYLGLYCEROL_LIPASE_ACT...,SET,15,-0.18968,-0.0054194,0.20738,0.81981,GOMF_ACYLGLYCEROL_LIPASE_ACTIVITY,1
GSE9988_ANTI_TREM1_AND_LPS_V...2,SET,165,-0.065019,-0.006136,0.071076,0.81984,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP,1
HP_ABNORMALITY_OF_THE_LOWER_...,SET,739,-0.029304,-0.0057596,0.032026,0.8199,HP_ABNORMALITY_OF_THE_LOWER_URINARY_TRACT,1
HUANG_DASATINIB_SENSITIVITY_...,SET,75,-0.10117,-0.0064531,0.11053,0.81998,HUANG_DASATINIB_SENSITIVITY_UP,1
MODULE_407,SET,13,-0.23892,-0.0063552,0.26102,0.81998,MODULE_407,1
GSE3203_UNTREATED_VS_IFNB_TR...1,SET,186,-0.059402,-0.0059485,0.064896,0.81999,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN,1
GSE9988_LPS_VS_CTRL_TREATED_...1,SET,189,-0.054117,-0.0054624,0.059118,0.82,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN,1
REACTOME_DEFECTIVE_GALNT3_CA...,SET,14,-0.22074,-0.0060932,0.2411,0.82005,REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC,1
PAX3_01,SET,18,-0.17066,-0.0053408,0.18635,0.8201,PAX3_01,1
KEGG_VASOPRESSIN_REGULATED_W...,SET,42,-0.11899,-0.0056848,0.12993,0.82012,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,1
RIZKI_TUMOR_INVASIVENESS_2D_...2,SET,60,-0.099994,-0.0057069,0.10915,0.82019,RIZKI_TUMOR_INVASIVENESS_2D_UP,1
HP_OVOID_VERTEBRAL_BODIES,SET,34,-0.13764,-0.0059174,0.15024,0.82019,HP_OVOID_VERTEBRAL_BODIES,1
GSE25088_IL4_VS_IL4_AND_ROSI...4,SET,177,-0.06034,-0.0058959,0.065865,0.82019,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,1
HP_DENTAL_CROWDING,SET,119,-0.072439,-0.005813,0.079052,0.82025,HP_DENTAL_CROWDING,1
GSE21670_TGFB_VS_IL6_TREATED...1,SET,177,-0.055233,-0.0053969,0.060253,0.82034,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN,1
GOBP_MITOTIC_SISTER_CHROMATI...1,SET,21,-0.15998,-0.0054075,0.1745,0.82037,GOBP_MITOTIC_SISTER_CHROMATID_COHESION,1
HP_EYELID_APRAXIA,SET,5,-0.33941,-0.0056003,0.37015,0.8204,HP_EYELID_APRAXIA,1
GOBP_ARF_PROTEIN_SIGNAL_TRAN...,SET,21,-0.16941,-0.0057262,0.18473,0.82044,GOBP_ARF_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_REGULATION_OF_VESICLE_M...,SET,464,-0.037207,-0.0058396,0.040569,0.82045,GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT,1
HP_ABNORMAL_PINEAL_MORPHOLOGY,SET,10,-0.23938,-0.005585,0.261,0.82046,HP_ABNORMAL_PINEAL_MORPHOLOGY,1
GSE11961_PLASMA_CELL_DAY7_VS...1,SET,187,-0.055275,-0.00555,0.060261,0.82049,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
WIEMANN_TELOMERE_SHORTENING_...1,SET,5,-0.28751,-0.004744,0.3134,0.82053,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN,1
XU_HGF_TARGETS_INDUCED_BY_AK...2,SET,13,-0.23701,-0.0063046,0.25835,0.82053,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,1
HP_DERMATOCHALASIS,SET,8,-0.30325,-0.0063287,0.33056,0.82053,HP_DERMATOCHALASIS,1
GOBP_REGULATION_OF_BICELLULA...,SET,21,-0.17598,-0.0059483,0.19181,0.82055,GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
MODULE_82,SET,22,-0.14466,-0.0050047,0.15766,0.82057,MODULE_82,1
BROWNE_HCMV_INFECTION_1HR_UP,SET,47,-0.11796,-0.0059606,0.12855,0.82058,BROWNE_HCMV_INFECTION_1HR_UP,1
GOBP_POSITIVE_REGULATION_OF_...230,SET,8,-0.29601,-0.0061776,0.32253,0.82062,GOBP_POSITIVE_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,1
GOCC_PARANODE_REGION_OF_AXON,SET,12,-0.23717,-0.0060614,0.25843,0.82062,GOCC_PARANODE_REGION_OF_AXON,1
WP_22Q112_COPY_NUMBER_VARIAT...,SET,105,-0.086066,-0.00649,0.09377,0.82064,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1
WP_SPHINGOLIPID_METABOLISM_I...1,SET,23,-0.16518,-0.0058427,0.17997,0.82064,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,1
TIEN_INTESTINE_PROBIOTICS_6H...1,SET,159,-0.061883,-0.0057338,0.067416,0.82066,TIEN_INTESTINE_PROBIOTICS_6HR_DN,1
GOBP_EXTRACELLULAR_MATRIX_AS...,SET,43,-0.12592,-0.0060866,0.13714,0.82073,GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY,1
GSE33424_CD161_INT_VS_NEG_CD...1,SET,181,-0.057669,-0.0056976,0.062807,0.82073,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN,1
MORF_DEK,SET,237,-0.046578,-0.0052577,0.050714,0.8208,MORF_DEK,1
KEGG_MEDICUS_VARIANT_AML1_ET...,SET,5,-0.29803,-0.0049176,0.32447,0.82082,KEGG_MEDICUS_VARIANT_AML1_ETO_FUSION_TO_PU.1_MEDIATED_TRANSCRIPTION,1
GSE22935_UNSTIM_VS_24H_MBOVI...3,SET,181,-0.057664,-0.0056972,0.06278,0.82082,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GSE14415_ACT_TCONV_VS_ACT_NA...1,SET,164,-0.06193,-0.0058269,0.067411,0.82086,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...3,SET,8,-0.30815,-0.006431,0.33538,0.8209,GOBP_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS,1
GOBP_PYRIDINE_NUCLEOTIDE_BIO...,SET,27,-0.15569,-0.005966,0.16944,0.82091,GOBP_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_PROTEIN_IMPORT,SET,8,-0.30741,-0.0064156,0.33453,0.82093,GOBP_PROTEIN_IMPORT,1
GOMF_LIPOPROTEIN_LIPASE_ACTI...,SET,9,-0.31824,-0.0070442,0.3463,0.82093,GOMF_LIPOPROTEIN_LIPASE_ACTIVITY,1
MORF_PPP2CA,SET,117,-0.066568,-0.005297,0.07243,0.82096,MORF_PPP2CA,1
OUYANG_PROSTATE_CANCER_PROGR...1,SET,20,-0.17353,-0.0057241,0.18878,0.821,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1
GSE37416_0H_VS_48H_F_TULAREN...2,SET,177,-0.059355,-0.0057996,0.064554,0.82107,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOMF_L_AMINO_ACID_TRANSMEMBR...,SET,62,-0.10468,-0.0060729,0.11382,0.82113,GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_MONOCYTE_AGGREGATION,SET,5,-0.42757,-0.007055,0.46489,0.82114,GOBP_MONOCYTE_AGGREGATION,1
GOBP_PROTEIN_SULFATION,SET,6,-0.33257,-0.0060111,0.36156,0.82116,GOBP_PROTEIN_SULFATION,1
HP_HEMANGIOBLASTOMA,SET,18,-0.1671,-0.0052297,0.18165,0.82119,HP_HEMANGIOBLASTOMA,1
GOBP_REGULATION_OF_SYSTEMIC_...7,SET,4,-0.45021,-0.0066445,0.48936,0.82121,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN,1
GOBP_CITRULLINE_BIOSYNTHETIC...,SET,4,-0.36371,-0.0053678,0.39527,0.82125,GOBP_CITRULLINE_BIOSYNTHETIC_PROCESS,1
MIR2053,SET,159,-0.062843,-0.0058227,0.068287,0.82128,MIR2053,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...3,SET,16,-0.21616,-0.0063782,0.23488,0.82128,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
BROWNE_HCMV_INFECTION_48HR_DN,SET,425,-0.038255,-0.0057525,0.041567,0.82129,BROWNE_HCMV_INFECTION_48HR_DN,1
PID_ERB_GENOMIC_PATHWAY,SET,14,-0.21029,-0.0058048,0.2285,0.8213,PID_ERB_GENOMIC_PATHWAY,1
KEGG_ALZHEIMERS_DISEASE,SET,138,-0.062335,-0.0053839,0.06772,0.82133,KEGG_ALZHEIMERS_DISEASE,1
HP_AKINESIA,SET,37,-0.128,-0.0057402,0.13898,0.82147,HP_AKINESIA,1
HP_INTRA_ORAL_HYPERPIGMENTAT...,SET,7,-0.3109,-0.0060695,0.33753,0.8215,HP_INTRA_ORAL_HYPERPIGMENTATION,1
HP_FACIAL_HYPEROSTOSIS,SET,4,-0.42957,-0.0063399,0.46624,0.82156,HP_FACIAL_HYPEROSTOSIS,1
HP_MIXED_HYPO_AND_HYPERPIGME...,SET,10,-0.22317,-0.0052069,0.24209,0.82169,HP_MIXED_HYPO_AND_HYPERPIGMENTATION_OF_THE_SKIN,1
GSE29949_MICROGLIA_VS_DC_BRA...1,SET,176,-0.060953,-0.0059391,0.066118,0.8217,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,1
GOBP_REGULATION_OF_TYPE_B_PA...1,SET,8,-0.29652,-0.0061882,0.32162,0.82172,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,1
SEIDEN_MET_SIGNALING,SET,18,-0.17832,-0.0055807,0.19339,0.82174,SEIDEN_MET_SIGNALING,1
GOBP_INTERFERON_BETA_PRODUCT...,SET,49,-0.10803,-0.0055733,0.11715,0.82175,GOBP_INTERFERON_BETA_PRODUCTION,1
HP_DOWNTURNED_CORNERS_OF_MOU...,SET,150,-0.065917,-0.0059337,0.071486,0.82175,HP_DOWNTURNED_CORNERS_OF_MOUTH,1
THAKAR_PBMC_INACTIVATED_INFL...8,SET,582,-0.031604,-0.005537,0.034272,0.82177,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP,1
REACTOME_G1_S_DNA_DAMAGE_CHE...,SET,64,-0.08754,-0.0051595,0.094928,0.82178,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1
MODULE_145,SET,95,-0.082542,-0.0059221,0.089506,0.82178,MODULE_145,1
HP_DECREASED_MEAN_CORPUSCULA...2,SET,11,-0.21023,-0.0051443,0.22795,0.82179,HP_DECREASED_MEAN_CORPUSCULAR_VOLUME,1
GOBP_REGULATION_OF_KILLING_O...,SET,9,-0.30328,-0.0067131,0.32884,0.8218,GOBP_REGULATION_OF_KILLING_OF_CELLS_OF_ANOTHER_ORGANISM,1
GOMF_CARBOXYLIC_ESTER_HYDROL...,SET,138,-0.068267,-0.0058962,0.074013,0.82182,GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY,1
BIOCARTA_SODD_PATHWAY,SET,10,-0.24323,-0.0056751,0.2637,0.82183,BIOCARTA_SODD_PATHWAY,1
REACTOME_EGFR_INTERACTS_WITH...,SET,9,-0.2879,-0.0063726,0.31199,0.82193,REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA,1
HP_ORAL_PHARYNGEAL_DYSPHAGIA,SET,39,-0.13122,-0.0060413,0.14219,0.82195,HP_ORAL_PHARYNGEAL_DYSPHAGIA,1
PID_MYC_PATHWAY,SET,25,-0.15672,-0.005779,0.16978,0.82201,PID_MYC_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...2,SET,11,-0.2426,-0.0059363,0.2628,0.82203,GOBP_POSITIVE_REGULATION_OF_ACROSOME_REACTION,1
GOMF_COLLAGEN_BINDING,SET,67,-0.10113,-0.0060982,0.10955,0.82204,GOMF_COLLAGEN_BINDING,1
HP_SHORT_LONG_BONE,SET,238,-0.051553,-0.0058314,0.055835,0.82207,HP_SHORT_LONG_BONE,1
GSE2585_AIRE_KO_VS_WT_CD80_L...2,SET,165,-0.062711,-0.0059182,0.067917,0.82208,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP,1
GOBP_SHORT_TERM_MEMORY,SET,10,-0.24806,-0.0057876,0.26864,0.82209,GOBP_SHORT_TERM_MEMORY,1
MIR7152_3P,SET,87,-0.082926,-0.0056949,0.089805,0.8221,MIR7152_3P,1
MIR4289,SET,63,-0.10208,-0.0059695,0.11053,0.82213,MIR4289,1
WP_ETHER_LIPID_BIOSYNTHESIS,SET,19,-0.1806,-0.0058068,0.19554,0.82214,WP_ETHER_LIPID_BIOSYNTHESIS,1
GOBP_REGULATION_OF_KERATINOC...3,SET,44,-0.13098,-0.0064045,0.14182,0.82214,GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
KEGG_MEDICUS_VARIANT_RET_FUS...,SET,10,-0.23555,-0.0054957,0.25502,0.82216,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
DESCARTES_FETAL_ADRENAL_MEGA...,SET,86,-0.085595,-0.0058444,0.092653,0.82221,DESCARTES_FETAL_ADRENAL_MEGAKARYOCYTES,1
SENESE_HDAC1_TARGETS_DN,SET,220,-0.055674,-0.0060577,0.060255,0.82224,SENESE_HDAC1_TARGETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...466,SET,22,-0.17988,-0.0062231,0.19468,0.82225,GOBP_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
HP_RENAL_CORTICOMEDULLARY_CY...,SET,8,-0.27465,-0.0057319,0.29721,0.82227,HP_RENAL_CORTICOMEDULLARY_CYSTS,1
DESCARTES_FETAL_EYE_CORNEAL_...,SET,222,-0.05735,-0.0062681,0.062062,0.82227,DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,1
GOBP_CELL_MIGRATION_INVOLVED...2,SET,19,-0.20958,-0.0067385,0.22679,0.82228,GOBP_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT,1
GOBP_REGULATION_OF_NERVOUS_S...2,SET,107,-0.08107,-0.0061709,0.087725,0.82229,GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
ZNF197_TARGET_GENES,SET,504,-0.035332,-0.005773,0.03823,0.8223,ZNF197_TARGET_GENES,1
MIR6744_5P,SET,42,-0.12797,-0.0061137,0.13846,0.82232,MIR6744_5P,1
GOMF_ACTININ_BINDING,SET,36,-0.13847,-0.0061255,0.14981,0.82233,GOMF_ACTININ_BINDING,1
GSE3337_CTRL_VS_16H_IFNG_IN_...2,SET,179,-0.059997,-0.0058951,0.064909,0.82234,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP,1
KEGG_MEDICUS_REFERENCE_MICRO...3,SET,26,-0.16584,-0.0062365,0.17941,0.82235,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION,1
HP_RETINAL_HAMARTOMA,SET,22,-0.15598,-0.0053963,0.16871,0.8224,HP_RETINAL_HAMARTOMA,1
MIR4637,SET,51,-0.10962,-0.0057694,0.11854,0.82243,MIR4637,1
GOBP_MRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.23241,-0.0048503,0.25132,0.82245,GOBP_MRNA_PSEUDOURIDINE_SYNTHESIS,1
HP_CHOANAL_STENOSIS,SET,25,-0.16041,-0.0059153,0.17347,0.82245,HP_CHOANAL_STENOSIS,1
GOBP_REGULATION_OF_SYNAPSE_M...,SET,21,-0.18257,-0.0061709,0.1974,0.82248,GOBP_REGULATION_OF_SYNAPSE_MATURATION,1
LTE2_UP.V1_UP,SET,178,-0.062281,-0.0061026,0.067327,0.82253,LTE2_UP.V1_UP,1
GOBP_PROTEIN_MATURATION_BY_I...,SET,11,-0.28067,-0.0068679,0.30338,0.82254,GOBP_PROTEIN_MATURATION_BY_IRON_SULFUR_CLUSTER_TRANSFER,1
HOLLMANN_APOPTOSIS_VIA_CD40_...2,SET,184,-0.06064,-0.0060401,0.065544,0.82255,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1
GOBP_REGULATION_OF_CELLULAR_...17,SET,460,-0.036083,-0.0056395,0.038999,0.82257,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS,1
HUMMERICH_SKIN_CANCER_PROGRE...2,SET,83,-0.092994,-0.0062384,0.10049,0.82262,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,1
GNF2_UBE2I,SET,36,-0.12692,-0.0056147,0.13712,0.82267,GNF2_UBE2I,1
HP_REMNANTS_OF_THE_HYALOID_V...,SET,9,-0.29211,-0.0064659,0.31555,0.8227,HP_REMNANTS_OF_THE_HYALOID_VASCULAR_SYSTEM,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,SET,43,-0.13125,-0.0063444,0.14178,0.82271,MCDOWELL_ACUTE_LUNG_INJURY_UP,1
MIR499B_3P,SET,153,-0.069191,-0.0062898,0.074736,0.82272,MIR499B_3P,1
MA_MYELOID_DIFFERENTIATION_UP,SET,37,-0.13109,-0.0058791,0.14159,0.82274,MA_MYELOID_DIFFERENTIATION_UP,1
GOBP_POSITIVE_REGULATION_OF_...562,SET,472,-0.036725,-0.0058123,0.039663,0.82275,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,1
TAKEDA_TARGETS_OF_NUP98_HOXA...2,SET,171,-0.066933,-0.0064294,0.072275,0.82279,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,1
HP_BONE_SPICULE_PIGMENTATION...,SET,101,-0.077966,-0.0057668,0.084184,0.82281,HP_BONE_SPICULE_PIGMENTATION_OF_THE_RETINA,1
WP_AGERAGE_PATHWAY,SET,63,-0.10222,-0.0059778,0.11034,0.82288,WP_AGERAGE_PATHWAY,1
GSE22886_TH1_VS_TH2_48H_ACT_...2,SET,177,-0.062586,-0.0061154,0.067543,0.82293,GSE22886_TH1_VS_TH2_48H_ACT_UP,1
HP_DECREASED_SKULL_OSSIFICAT...,SET,38,-0.12949,-0.0058849,0.13973,0.82295,HP_DECREASED_SKULL_OSSIFICATION,1
GOBP_RESPONSE_TO_INSECTICIDE,SET,6,-0.36094,-0.0065239,0.38945,0.82298,GOBP_RESPONSE_TO_INSECTICIDE,1
REACTOME_PROTEIN_LOCALIZATION,SET,143,-0.063719,-0.0056015,0.068739,0.82302,REACTOME_PROTEIN_LOCALIZATION,1
HP_REDUCED_MUSCLE_FIBER_ALPH...,SET,8,-0.27408,-0.00572,0.29568,0.82302,HP_REDUCED_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,1
WANG_IMMORTALIZED_BY_HOXA9_A...1,SET,24,-0.1787,-0.0064568,0.19278,0.82303,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,1
HP_ABNORMAL_RETINAL_NERVE_FI...,SET,5,-0.3446,-0.005686,0.37173,0.82303,HP_ABNORMAL_RETINAL_NERVE_FIBER_LAYER_MORPHOLOGY,1
GOBP_ANTIGEN_PROCESSING_AND_...13,SET,30,-0.16408,-0.0066271,0.17693,0.82312,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,1
GSE9037_WT_VS_IRAK4_KO_BMDM_...2,SET,179,-0.058971,-0.0057944,0.063591,0.82312,GSE9037_WT_VS_IRAK4_KO_BMDM_UP,1
GOCC_SODIUM_POTASSIUM_EXCHAN...,SET,11,-0.27175,-0.0066498,0.29295,0.8232,GOCC_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX,1
GCM_CSNK1A1,SET,35,-0.11707,-0.0051067,0.12619,0.82322,GCM_CSNK1A1,1
LANDIS_ERBB2_BREAST_TUMORS_6...2,SET,22,-0.17347,-0.0060012,0.18692,0.8233,LANDIS_ERBB2_BREAST_TUMORS_65_UP,1
HP_BROAD_FEMORAL_NECK,SET,16,-0.19051,-0.0056215,0.20526,0.82332,HP_BROAD_FEMORAL_NECK,1
SERVITJA_LIVER_HNF1A_TARGETS...1,SET,152,-0.068276,-0.0061866,0.073562,0.82333,SERVITJA_LIVER_HNF1A_TARGETS_DN,1
GOBP_REGULATION_OF_MICROTUBU...5,SET,25,-0.14792,-0.0054546,0.15936,0.82335,GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION,1
GOMF_FATTY_ACID_ELONGASE_ACT...,SET,7,-0.3351,-0.0065418,0.36101,0.82335,GOMF_FATTY_ACID_ELONGASE_ACTIVITY,1
GOMF_S_ADENOSYLMETHIONINE_DE...,SET,133,-0.06431,-0.0054537,0.069281,0.82336,GOMF_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY,1
NME2_TARGET_GENES,SET,53,-0.11315,-0.0060707,0.12188,0.82339,NME2_TARGET_GENES,1
GOBP_EMBRYONIC_HEART_TUBE_LE...,SET,5,-0.31963,-0.0052739,0.34425,0.82341,GOBP_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...375,SET,88,-0.089177,-0.006159,0.095986,0.82356,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,1
GSE17721_CTRL_VS_PAM3CSK4_0....2,SET,179,-0.057365,-0.0056365,0.061744,0.82357,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP,1
GOBP_REGULATION_OF_CYSTEINE_...1,SET,176,-0.062078,-0.0060488,0.06681,0.82359,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
HP_URETHRAL_FISTULA,SET,4,-0.32189,-0.0047507,0.34641,0.82361,HP_URETHRAL_FISTULA,1
HP_URETHROVAGINAL_FISTULA,SET,4,-0.32189,-0.0047507,0.34641,0.82361,HP_URETHROVAGINAL_FISTULA,1
REACTOME_BASIGIN_INTERACTIONS,SET,24,-0.16881,-0.0060994,0.18165,0.82363,REACTOME_BASIGIN_INTERACTIONS,1
GOBP_RHOMBOMERE_DEVELOPMENT,SET,7,-0.38116,-0.007441,0.41015,0.82363,GOBP_RHOMBOMERE_DEVELOPMENT,1
HP_JUVENILE_ASEPTIC_NECROSIS,SET,41,-0.12723,-0.0060055,0.13689,0.82365,HP_JUVENILE_ASEPTIC_NECROSIS,1
WU_HBX_TARGETS_2_DN,SET,14,-0.23016,-0.0063531,0.24759,0.8237,WU_HBX_TARGETS_2_DN,1
NIKOLSKY_BREAST_CANCER_8Q12_...,SET,124,-0.12592,-0.010313,0.13545,0.82371,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,1
GSE17974_IL4_AND_ANTI_IL12_V...18,SET,153,-0.066716,-0.0060649,0.071763,0.82372,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...144,SET,3,-0.53739,-0.0068688,0.57797,0.82375,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,1
HP_ASPIRATION,SET,26,-0.15667,-0.0058917,0.16851,0.82375,HP_ASPIRATION,1
GSE360_CTRL_VS_L_MAJOR_DC_DN,SET,181,-0.061648,-0.0060907,0.066296,0.82378,GSE360_CTRL_VS_L_MAJOR_DC_DN,1
HP_DESCENDING_AORTIC_DISSECT...,SET,20,-0.19229,-0.006343,0.20678,0.82379,HP_DESCENDING_AORTIC_DISSECTION,1
GOBP_REGULATION_OF_DENDRITIC...4,SET,52,-0.11227,-0.0059664,0.12072,0.8238,GOBP_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
REACTOME_MET_ACTIVATES_PTPN11,SET,5,-0.34628,-0.0057136,0.37233,0.82381,REACTOME_MET_ACTIVATES_PTPN11,1
BIOCARTA_BARRESTIN_PATHWAY,SET,11,-0.26322,-0.0064411,0.28302,0.82382,BIOCARTA_BARRESTIN_PATHWAY,1
HOLLEMAN_ASPARAGINASE_RESIST...3,SET,12,-0.21135,-0.0054016,0.22725,0.82383,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,1
UNTERMAN_IPF_VS_CTRL_TREG_CE...2,SET,13,-0.24952,-0.0066371,0.26825,0.82385,UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP,1
ZHAN_MULTIPLE_MYELOMA_MS_DN,SET,38,-0.1265,-0.0057488,0.13599,0.82386,ZHAN_MULTIPLE_MYELOMA_MS_DN,1
LEIN_NEURON_MARKERS,SET,57,-0.1096,-0.0060974,0.11782,0.82388,LEIN_NEURON_MARKERS,1
HP_ANKLE_PAIN,SET,5,-0.37574,-0.0061999,0.40391,0.82388,HP_ANKLE_PAIN,1
GOBP_GLOMERULAR_MESANGIUM_DE...,SET,16,-0.22427,-0.0066177,0.24104,0.82392,GOBP_GLOMERULAR_MESANGIUM_DEVELOPMENT,1
HP_HYPERLIPOPROTEINEMIA,SET,36,-0.1398,-0.0061844,0.15025,0.82392,HP_HYPERLIPOPROTEINEMIA,1
MORF_WNT1,SET,93,-0.085356,-0.0060595,0.0917,0.82402,MORF_WNT1,1
GSE22886_TCELL_VS_BCELL_NAIV...1,SET,167,-0.064998,-0.0061708,0.069829,0.82402,GSE22886_TCELL_VS_BCELL_NAIVE_DN,1
GOBP_FRUCTOSE_1_6_BISPHOSPHA...,SET,9,-0.22762,-0.0050384,0.24452,0.82404,GOBP_FRUCTOSE_1_6_BISPHOSPHATE_METABOLIC_PROCESS,1
GSE24634_TEFF_VS_TCONV_DAY3_...1,SET,169,-0.06339,-0.0060536,0.068074,0.82411,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN,1
HIPC_SIGNATURES_PROJECT_PBMC...1,SET,6,-0.29511,-0.005334,0.31693,0.82411,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_DOWN,1
GOCC_SORTING_ENDOSOME,SET,6,-0.36163,-0.0065363,0.38821,0.8242,GOCC_SORTING_ENDOSOME,1
GOBP_TRYPTOPHAN_TRANSPORT,SET,5,-0.35731,-0.0058957,0.38352,0.82423,GOBP_TRYPTOPHAN_TRANSPORT,1
MIR6852_5P,SET,175,-0.058907,-0.0057236,0.063222,0.82426,MIR6852_5P,1
ZHONG_PFC_MAJOR_TYPES_NPCS,SET,126,-0.069773,-0.0057602,0.074878,0.82428,ZHONG_PFC_MAJOR_TYPES_NPCS,1
MIR486_5P,SET,85,-0.084234,-0.0057181,0.090393,0.82429,MIR486_5P,1
HP_ULNAR_DEVIATION_OF_THE_WR...,SET,19,-0.21462,-0.0069006,0.23025,0.82435,HP_ULNAR_DEVIATION_OF_THE_WRIST,1
GSE369_IFNG_KO_VS_WT_LIVER_UP,SET,179,-0.059046,-0.0058017,0.063348,0.82435,GSE369_IFNG_KO_VS_WT_LIVER_UP,1
HP_ABNORMAL_OVARIAN_PHYSIOLO...,SET,87,-0.082753,-0.005683,0.088771,0.82438,HP_ABNORMAL_OVARIAN_PHYSIOLOGY,1
PLASARI_NFIC_TARGETS_BASAL_DN,SET,20,-0.20412,-0.0067334,0.21895,0.8244,PLASARI_NFIC_TARGETS_BASAL_DN,1
GOMF_INSULIN_LIKE_GROWTH_FAC...1,SET,18,-0.21764,-0.0068111,0.23345,0.8244,GOMF_INSULIN_LIKE_GROWTH_FACTOR_BINDING,1
HP_VESTIBULAR_HYPOFUNCTION,SET,15,-0.22483,-0.0064237,0.24114,0.82442,HP_VESTIBULAR_HYPOFUNCTION,1
MIR802,SET,121,-0.074199,-0.0060037,0.079541,0.82454,MIR802,1
GOMF_GUANYLATE_CYCLASE_REGUL...,SET,7,-0.36341,-0.0070946,0.38958,0.82454,GOMF_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY,1
HP_ABNORMAL_PATELLA_MORPHOLO...,SET,91,-0.088949,-0.0062466,0.095315,0.82464,HP_ABNORMAL_PATELLA_MORPHOLOGY,1
HP_DEVIATION_OF_THE_4TH_FING...,SET,8,-0.31518,-0.0065776,0.33771,0.82466,HP_DEVIATION_OF_THE_4TH_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...208,SET,5,-0.38816,-0.0064047,0.41581,0.82471,GOBP_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION,1
GOBP_RESPONSE_TO_THYROXINE,SET,4,-0.45412,-0.0067022,0.48645,0.82472,GOBP_RESPONSE_TO_THYROXINE,1
HUPER_BREAST_BASAL_VS_LUMINA...1,SET,54,-0.12492,-0.0067647,0.13381,0.82473,HUPER_BREAST_BASAL_VS_LUMINAL_DN,1
EHLERS_ANEUPLOIDY_UP,SET,35,-0.1275,-0.0055614,0.13655,0.82477,EHLERS_ANEUPLOIDY_UP,1
ZSCAN21_TARGET_GENES,SET,393,-0.039769,-0.0057558,0.04259,0.82478,ZSCAN21_TARGET_GENES,1
GOMF_HISTONE_H3K14_ACETYLTRA...,SET,9,-0.26427,-0.0058497,0.28302,0.82478,GOMF_HISTONE_H3K14_ACETYLTRANSFERASE_ACTIVITY,1
GOMF_PHOSPHATIDYLINOSITOL_3_...6,SET,5,-0.286,-0.004719,0.30622,0.82483,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,1
MODULE_286,SET,35,-0.14058,-0.006132,0.15047,0.82491,MODULE_286,1
HP_ABNORMAL_NASOLACRIMAL_SYS...,SET,63,-0.098199,-0.0057424,0.10511,0.82491,HP_ABNORMAL_NASOLACRIMAL_SYSTEM_MORPHOLOGY,1
WHITESIDE_CISPLATIN_RESISTAN...2,SET,11,-0.23849,-0.0058357,0.25526,0.82492,WHITESIDE_CISPLATIN_RESISTANCE_UP,1
chr17q21,SET,271,-0.10765,-0.012982,0.11521,0.82494,chr17q21,1
HP_PITUITARY_CORTICOTROPIC_C...,SET,11,-0.24004,-0.0058737,0.2569,0.82494,HP_PITUITARY_CORTICOTROPIC_CELL_ADENOMA,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...3,SET,6,-0.30119,-0.005444,0.32233,0.82495,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_INDEPENDENT_DECAY,1
GSE3982_CENT_MEMORY_CD4_TCEL...2,SET,176,-0.060282,-0.0058737,0.064502,0.82499,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP,1
MIR3620_3P,SET,58,-0.11,-0.0061728,0.11769,0.82501,MIR3620_3P,1
GOMF_CADMIUM_ION_BINDING,SET,5,-0.37742,-0.0062275,0.40377,0.82503,GOMF_CADMIUM_ION_BINDING,1
GSE19888_CTRL_VS_A3R_INHIBIT...1,SET,168,-0.063005,-0.0059992,0.067394,0.82507,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN,1
REACTOME_NUCLEAR_EVENTS_MEDI...,SET,92,-0.080301,-0.00567,0.085888,0.82509,REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1
MIKKELSEN_NPC_ICP_WITH_H3K4M...,SET,381,-0.040611,-0.0057891,0.043431,0.82512,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1
HP_THYROID_CARCINOMA,SET,57,-0.10944,-0.0060886,0.11704,0.82513,HP_THYROID_CARCINOMA,1
GOBP_D_AMINO_ACID_TRANSPORT,SET,6,-0.34161,-0.0061745,0.36527,0.82516,GOBP_D_AMINO_ACID_TRANSPORT,1
HP_ABNORMAL_CIRCULATING_AROM...,SET,18,-0.20265,-0.006342,0.21666,0.82518,HP_ABNORMAL_CIRCULATING_AROMATIC_AMINO_ACID_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...21,SET,15,-0.23155,-0.0066157,0.24755,0.82519,GOBP_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
HP_RECURRENT_MYOGLOBINURIA,SET,5,-0.29304,-0.0048353,0.3132,0.82527,HP_RECURRENT_MYOGLOBINURIA,1
REACTOME_UNBLOCKING_OF_NMDA_...,SET,19,-0.19658,-0.0063206,0.21009,0.82528,REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION,1
HSF4_TARGET_GENES,SET,5,-0.37862,-0.0062474,0.40465,0.82528,HSF4_TARGET_GENES,1
GOBP_CELL_CYCLE_G1_S_PHASE_T...,SET,222,-0.054689,-0.0059772,0.058442,0.8253,GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOBP_AXO_DENDRITIC_TRANSPORT,SET,74,-0.095181,-0.0060305,0.1017,0.82532,GOBP_AXO_DENDRITIC_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...661,SET,5,-0.37334,-0.0061601,0.39883,0.82538,GOBP_NEGATIVE_REGULATION_OF_TUBULIN_DEACETYLATION,1
GCM_MAX,SET,29,-0.14024,-0.0055692,0.14979,0.82542,GCM_MAX,1
WP_NEPHROGENESIS,SET,18,-0.20581,-0.0064411,0.21982,0.82543,WP_NEPHROGENESIS,1
MIR3198,SET,42,-0.11731,-0.0056045,0.12524,0.82554,MIR3198,1
GOCC_ANCHORING_JUNCTION,SET,837,-0.028891,-0.0060265,0.030839,0.82557,GOCC_ANCHORING_JUNCTION,1
LA_MEN1_TARGETS,SET,21,-0.19154,-0.0064742,0.20444,0.82559,LA_MEN1_TARGETS,1
MIR550B_3P,SET,49,-0.1178,-0.0060777,0.12572,0.82563,MIR550B_3P,1
GOBP_POSITIVE_REGULATION_OF_...462,SET,33,-0.13818,-0.0058527,0.14743,0.82567,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
GSE39152_SPLEEN_CD103_NEG_VS...2,SET,187,-0.057284,-0.0057517,0.061122,0.82567,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP,1
GOBP_CRANIAL_SKELETAL_SYSTEM...,SET,67,-0.10644,-0.0064179,0.11355,0.8257,GOBP_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT,1
GSE27786_LSK_VS_CD4_TCELL_UP,SET,172,-0.05936,-0.0057184,0.063314,0.82575,GSE27786_LSK_VS_CD4_TCELL_UP,1
DESCARTES_FETAL_PLACENTA_MEG...,SET,156,-0.065158,-0.0059806,0.069492,0.82578,DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES,1
GSE14308_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.058845,-0.0058297,0.062751,0.82581,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN,1
GOMF_GLUTAMATE_RECEPTOR_BIND...,SET,42,-0.12398,-0.0059229,0.13219,0.82583,GOMF_GLUTAMATE_RECEPTOR_BINDING,1
GOBP_INTRACELLULAR_SIGNALING...,SET,1727,-0.020892,-0.0060988,0.022275,0.82585,GOBP_INTRACELLULAR_SIGNALING_CASSETTE,1
GOBP_CUT_METABOLIC_PROCESS,SET,5,-0.31164,-0.0051422,0.33218,0.82591,GOBP_CUT_METABOLIC_PROCESS,1
GOMF_NADPLUS_PROTEIN_CYSTEIN...,SET,6,-0.33935,-0.0061335,0.3617,0.82592,GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
DESCARTES_FETAL_MUSCLE_VASCU...,SET,63,-0.11109,-0.0064962,0.11838,0.82598,DESCARTES_FETAL_MUSCLE_VASCULAR_ENDOTHELIAL_CELLS,1
GOMF_BENZODIAZEPINE_RECEPTOR...,SET,9,-0.33248,-0.0073594,0.35427,0.826,GOMF_BENZODIAZEPINE_RECEPTOR_ACTIVITY,1
HP_HEMIPLEGIA,SET,33,-0.15171,-0.0064259,0.16164,0.82601,HP_HEMIPLEGIA,1
KEGG_MEDICUS_VARIANT_MUTATIO...38,SET,35,-0.11454,-0.0049962,0.12204,0.82602,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_T_CELL_MEDIATED_IMMUNITY,SET,121,-0.081642,-0.0066059,0.086965,0.82607,GOBP_T_CELL_MEDIATED_IMMUNITY,1
HP_ABNORMALITY_OF_THE_SENSE_...,SET,119,-0.074226,-0.0059563,0.079059,0.82609,HP_ABNORMALITY_OF_THE_SENSE_OF_SMELL,1
FIGUEROA_AML_METHYLATION_CLU...3,SET,8,-0.29719,-0.0062023,0.31649,0.82613,FIGUEROA_AML_METHYLATION_CLUSTER_2_DN,1
HP_SCLERODACTYLY,SET,5,-0.38772,-0.0063975,0.41287,0.82615,HP_SCLERODACTYLY,1
GOBP_INOSITOL_TRISPHOSPHATE_...1,SET,6,-0.34148,-0.006172,0.36358,0.82618,GOBP_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_ANTIGEN_PROCESSING_AND_...5,SET,45,-0.13134,-0.0064943,0.13979,0.82627,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN,1
HP_WIDE_CRANIAL_SUTURES,SET,27,-0.151,-0.0057865,0.16071,0.82629,HP_WIDE_CRANIAL_SUTURES,1
SKP2_TARGET_GENES,SET,50,-0.11401,-0.0059415,0.12133,0.82631,SKP2_TARGET_GENES,1
MANNE_COVID19_NONICU_VS_HEAL...1,SET,179,-0.065797,-0.006465,0.070004,0.82636,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1
GOMF_OXIDOREDUCTASE_ACTIVITY...8,SET,5,-0.33337,-0.0055006,0.35462,0.8264,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS_DISULFIDE_AS_ACCEPTOR,1
HE_LIM_SUN_FETAL_LUNG_C0_MYL...,SET,110,-0.083777,-0.0064652,0.089116,0.82641,HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL,1
HP_ABNORMAL_SKIN_MORPHOLOGY_...,SET,361,-0.043016,-0.0059723,0.045745,0.82648,HP_ABNORMAL_SKIN_MORPHOLOGY_OF_THE_PALM,1
WP_TRANSSULFURATION_ONECARBO...,SET,63,-0.10331,-0.0060412,0.10984,0.82652,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1
GOBP_VESICLE_UNCOATING,SET,9,-0.23221,-0.0051399,0.24687,0.82654,GOBP_VESICLE_UNCOATING,1
DELACROIX_RARG_BOUND_MEF,SET,345,-0.045145,-0.00613,0.047987,0.82658,DELACROIX_RARG_BOUND_MEF,1
GOMF_VASCULAR_ENDOTHELIAL_GR...3,SET,7,-0.35712,-0.0069718,0.37951,0.82664,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_ACTIVITY,1
HP_ABNORMALITY_OF_THE_URETHRA,SET,375,-0.041177,-0.0058244,0.043756,0.82666,HP_ABNORMALITY_OF_THE_URETHRA,1
HP_EMG_MYOTONIC_DISCHARGES,SET,8,-0.28284,-0.0059027,0.30055,0.82666,HP_EMG_MYOTONIC_DISCHARGES,1
MORF_GMPS,SET,40,-0.11422,-0.0053253,0.12135,0.82669,MORF_GMPS,1
GOBP_DERMATAN_SULFATE_PROTEO...1,SET,8,-0.28047,-0.0058534,0.298,0.82669,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GOMF_CYTOSKELETAL_ANCHOR_ACT...,SET,23,-0.1664,-0.0058859,0.1768,0.8267,GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY,1
GSE22886_NAIVE_BCELL_VS_NEUT...2,SET,171,-0.062852,-0.0060374,0.066764,0.82675,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP,1
GOBP_XENOBIOTIC_GLUCURONIDAT...,SET,6,-0.42609,-0.0077013,0.45258,0.82676,GOBP_XENOBIOTIC_GLUCURONIDATION,1
HP_PRIMITIVE_NEUROECTODERMAL...,SET,68,-0.096825,-0.0058816,0.10284,0.82678,HP_PRIMITIVE_NEUROECTODERMAL_TUMOR,1
REACTOME_CLATHRIN_MEDIATED_E...,SET,134,-0.070162,-0.0059721,0.074515,0.82679,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1
UEDA_CENTRAL_CLOCK,SET,80,-0.092015,-0.0060607,0.097721,0.8268,UEDA_CENTRAL_CLOCK,1
GOBP_PROTEIN_LOCALIZATION_TO...14,SET,27,-0.13757,-0.0052718,0.14608,0.82683,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,1
HP_SEESAW_NYSTAGMUS,SET,6,-0.34384,-0.0062148,0.36505,0.82687,HP_SEESAW_NYSTAGMUS,1
ODONNELL_TARGETS_OF_MYC_AND_...2,SET,68,-0.097879,-0.0059457,0.1039,0.82692,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1
GOCC_ACTIN_FILAMENT_BUNDLE,SET,85,-0.091916,-0.0062396,0.097546,0.82697,GOCC_ACTIN_FILAMENT_BUNDLE,1
GSE27786_LIN_NEG_VS_NEUTROPH...2,SET,172,-0.058419,-0.0056278,0.061998,0.82697,GSE27786_LIN_NEG_VS_NEUTROPHIL_UP,1
MIR371A_3P,SET,9,-0.28208,-0.0062439,0.29932,0.827,MIR371A_3P,1
HP_STROKE,SET,148,-0.068725,-0.0061454,0.07292,0.82702,HP_STROKE,1
GSE17721_12H_VS_24H_CPG_BMDC...1,SET,178,-0.056603,-0.0055462,0.060058,0.82702,GSE17721_12H_VS_24H_CPG_BMDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...633,SET,9,-0.26394,-0.0058424,0.28004,0.82703,GOBP_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...281,SET,5,-0.38446,-0.0063437,0.40787,0.82705,GOBP_POSITIVE_REGULATION_OF_FERTILIZATION,1
GOBP_POSITIVE_REGULATION_OF_...283,SET,9,-0.30203,-0.0066854,0.32042,0.82705,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
GOBP_GASTRO_INTESTINAL_SYSTE...,SET,12,-0.22234,-0.0056824,0.23586,0.82707,GOBP_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,1
GSE6566_STRONG_VS_WEAK_DC_ST...2,SET,156,-0.067383,-0.0061848,0.071468,0.82711,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP,1
GOCC_FEMALE_PRONUCLEUS,SET,8,-0.25385,-0.0052977,0.26915,0.82719,GOCC_FEMALE_PRONUCLEUS,1
GOBP_FATTY_ACID_ELONGATION,SET,13,-0.25976,-0.0069096,0.27541,0.8272,GOBP_FATTY_ACID_ELONGATION,1
GOMF_ADENOSINE_3_5_BISPHOSPH...,SET,5,-0.35904,-0.0059243,0.38061,0.82724,GOMF_ADENOSINE_3_5_BISPHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_OXO_ACID_LYASE_ACTIVITY,SET,7,-0.29679,-0.0057941,0.31459,0.82726,GOMF_OXO_ACID_LYASE_ACTIVITY,1
GSE9960_HEALTHY_VS_GRAM_NEG_...3,SET,175,-0.062351,-0.0060583,0.066091,0.82726,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN,1
HP_ABNORMAL_SYSTEMIC_ARTERIA...,SET,470,-0.037445,-0.0059139,0.039689,0.82727,HP_ABNORMAL_SYSTEMIC_ARTERIAL_MORPHOLOGY,1
FARMER_BREAST_CANCER_APOCRIN...2,SET,289,-0.048829,-0.0060778,0.051749,0.8273,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1
HP_ABNORMAL_PARIETAL_BONE_MO...,SET,28,-0.14295,-0.0055781,0.15149,0.8273,HP_ABNORMAL_PARIETAL_BONE_MORPHOLOGY,1
HP_ERYTHEMA,SET,106,-0.078393,-0.0059393,0.083065,0.82735,HP_ERYTHEMA,1
HP_POSTERIOR_BLEPHARITIS,SET,5,-0.32905,-0.0054294,0.34866,0.82735,HP_POSTERIOR_BLEPHARITIS,1
REACTOME_SYNTHESIS_OF_PROSTA...,SET,14,-0.20962,-0.0057861,0.22205,0.82741,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,1
LUCAS_HNF4A_TARGETS_UP,SET,53,-0.10803,-0.0057956,0.11442,0.82745,LUCAS_HNF4A_TARGETS_UP,1
KEGG_TRYPTOPHAN_METABOLISM,SET,36,-0.13668,-0.0060464,0.14475,0.82747,KEGG_TRYPTOPHAN_METABOLISM,1
GSE37301_COMMON_LYMPHOID_PRO...5,SET,177,-0.059093,-0.0057741,0.062582,0.82747,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN,1
CDH4_TARGET_GENES,SET,56,-0.1109,-0.0061152,0.11743,0.8275,CDH4_TARGET_GENES,1
GOMF_CHEMOKINE_ACTIVITY,SET,45,-0.1474,-0.0072885,0.15603,0.82758,GOMF_CHEMOKINE_ACTIVITY,1
MIR8067,SET,250,-0.050452,-0.005847,0.053404,0.82759,MIR8067,1
GOBP_EPITHELIAL_CELL_DIFFERE...2,SET,46,-0.13537,-0.0067676,0.1433,0.82759,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
WP_VASOPRESSINREGULATED_WATE...,SET,43,-0.12177,-0.0058862,0.12889,0.82761,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,1
MIR3934_5P,SET,55,-0.10953,-0.0059859,0.11591,0.82765,MIR3934_5P,1
GOBP_AMINO_ACID_IMPORT_ACROS...,SET,45,-0.12666,-0.0062631,0.13403,0.82768,GOBP_AMINO_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
REACTOME_RHO_GTPASES_ACTIVAT...5,SET,21,-0.18619,-0.0062934,0.197,0.82769,REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES,1
HAN_JNK_SINGALING_DN,SET,36,-0.13724,-0.0060713,0.14519,0.82773,HAN_JNK_SINGALING_DN,1
GOBP_RESPONSE_TO_COLD,SET,42,-0.12673,-0.0060546,0.13407,0.82774,GOBP_RESPONSE_TO_COLD,1
BIOCARTA_ACH_PATHWAY,SET,14,-0.22504,-0.0062119,0.23804,0.82776,BIOCARTA_ACH_PATHWAY,1
SWEET_LUNG_CANCER_KRAS_UP,SET,426,-0.039903,-0.0060073,0.042207,0.82777,SWEET_LUNG_CANCER_KRAS_UP,1
GSE11961_FOLLICULAR_BCELL_VS...4,SET,177,-0.058651,-0.0057309,0.062038,0.82777,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
MIR208A_3P,SET,38,-0.13374,-0.0060779,0.14141,0.82785,MIR208A_3P,1
GOBP_ORGANIC_HYDROXY_COMPOUN...3,SET,511,-0.036997,-0.0060858,0.039117,0.82787,GOBP_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...55,SET,35,-0.11567,-0.0050456,0.1223,0.82788,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_POSITIVE_REGULATION_OF_...78,SET,77,-0.097072,-0.0062732,0.10263,0.82788,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
HP_ENLARGED_OVARIES,SET,16,-0.20319,-0.0059957,0.2147,0.82802,HP_ENLARGED_OVARIES,1
MIR653_3P,SET,121,-0.073599,-0.0059551,0.077745,0.82809,MIR653_3P,1
GOBP_ESTABLISHMENT_OF_PROTEI...10,SET,17,-0.17319,-0.0052677,0.18291,0.82814,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,1
GSE22886_NAIVE_BCELL_VS_DC_DN,SET,188,-0.058374,-0.0058766,0.06165,0.82814,GSE22886_NAIVE_BCELL_VS_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...261,SET,31,-0.15199,-0.0062401,0.16049,0.82818,GOBP_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
HP_DYSPLASTIC_CORPUS_CALLOSUM,SET,40,-0.12753,-0.0059461,0.13466,0.82819,HP_DYSPLASTIC_CORPUS_CALLOSUM,1
MIR654_3P,SET,71,-0.095981,-0.0059571,0.10134,0.8282,MIR654_3P,1
GOBP_LYMPHOCYTE_MIGRATION_IN...,SET,9,-0.29903,-0.0066191,0.31563,0.82828,GOBP_LYMPHOCYTE_MIGRATION_INTO_LYMPHOID_ORGANS,1
REACTOME_PROCESSING_AND_ACTI...,SET,10,-0.22155,-0.0051691,0.23384,0.82829,REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO,1
HP_APLASIA_HYPOPLASIA_OF_THE...48,SET,43,-0.11921,-0.0057625,0.1258,0.82834,HP_APLASIA_HYPOPLASIA_OF_THE_NIPPLES,1
HP_HYPOPLASTIC_IRIS_STROMA,SET,8,-0.34386,-0.0071761,0.36282,0.82836,HP_HYPOPLASTIC_IRIS_STROMA,1
HP_INCREASED_PROTEINOGENIC_A...,SET,42,-0.13153,-0.0062838,0.13879,0.82836,HP_INCREASED_PROTEINOGENIC_AMINO_ACID_LEVEL_IN_URINE,1
GSE17721_CTRL_VS_GARDIQUIMOD...9,SET,187,-0.05897,-0.005921,0.062213,0.8284,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN,1
GOBP_FORMATION_OF_EXTRACHROM...,SET,13,-0.20334,-0.0054089,0.21451,0.82841,GOBP_FORMATION_OF_EXTRACHROMOSOMAL_CIRCULAR_DNA,1
GSE21033_CTRL_VS_POLYIC_STIM...5,SET,137,-0.069066,-0.0059437,0.072849,0.82845,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN,1
GOMF_LIGASE_ACTIVITY_FORMING...5,SET,5,-0.32579,-0.0053757,0.34361,0.82847,GOMF_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS,1
HE_LIM_SUN_FETAL_LUNG_C3_DEF...3,SET,102,-0.080277,-0.0059668,0.084667,0.82847,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_RETICULOCYTE,1
HP_ABNORMAL_FETAL_GASTROINTE...,SET,17,-0.20566,-0.0062551,0.21681,0.82858,HP_ABNORMAL_FETAL_GASTROINTESTINAL_SYSTEM_MORPHOLOGY,1
HP_DIAPHYSEAL_DYSPLASIA,SET,5,-0.3852,-0.0063558,0.40604,0.8286,HP_DIAPHYSEAL_DYSPLASIA,1
GSE15750_DAY6_VS_DAY10_TRAF6...1,SET,183,-0.057867,-0.0057483,0.060991,0.82863,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN,1
HP_ABNORMAL_ST_SEGMENT,SET,38,-0.13621,-0.0061905,0.14354,0.82868,HP_ABNORMAL_ST_SEGMENT,1
HP_AORTIC_ARCH_ANEURYSM,SET,37,-0.14639,-0.006565,0.15425,0.82869,HP_AORTIC_ARCH_ANEURYSM,1
GOBP_POSITIVE_REGULATION_OF_...532,SET,144,-0.069288,-0.0061121,0.073007,0.8287,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,1
HP_RECURRENT_PROTOZOAN_INFEC...,SET,5,-0.40298,-0.0066492,0.42461,0.8287,HP_RECURRENT_PROTOZOAN_INFECTIONS,1
HP_SMALL_NAIL,SET,157,-0.064533,-0.005942,0.067994,0.82871,HP_SMALL_NAIL,1
GOBP_REGULATION_OF_MESENCHYM...3,SET,7,-0.36489,-0.0071234,0.38439,0.82875,GOBP_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,1
WP_HEAD_AND_NECK_SQUAMOUS_CE...,SET,73,-0.095512,-0.0060106,0.10061,0.82876,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1
GOCC_OUTER_DYNEIN_ARM,SET,10,-0.25103,-0.0058568,0.26442,0.82877,GOCC_OUTER_DYNEIN_ARM,1
HALLMARK_INTERFERON_GAMMA_RE...,SET,190,-0.061152,-0.0061886,0.064415,0.82877,HALLMARK_INTERFERON_GAMMA_RESPONSE,1
HP_SLENDER_TOE,SET,4,-0.40638,-0.0059976,0.42802,0.8288,HP_SLENDER_TOE,1
GOBP_REGULATION_OF_MITOCHOND...10,SET,62,-0.10556,-0.0061241,0.11118,0.82882,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,1
MIR4659B_5P,SET,91,-0.086023,-0.0060412,0.090583,0.82885,MIR4659B_5P,1
GOBP_REGULATION_OF_SYNCYTIUM...,SET,27,-0.16157,-0.0061913,0.17012,0.82888,GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
MCMURRAY_TP53_HRAS_COOPERATI...2,SET,26,-0.17861,-0.0067167,0.18805,0.82889,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,1
GOBP_PRIMARY_ALCOHOL_METABOL...,SET,95,-0.089013,-0.0063863,0.093694,0.82895,GOBP_PRIMARY_ALCOHOL_METABOLIC_PROCESS,1
HP_ENLARGED_VESTIBULAR_AQUED...,SET,7,-0.31274,-0.0061054,0.32918,0.82895,HP_ENLARGED_VESTIBULAR_AQUEDUCT,1
GOBP_POSITIVE_THYMIC_T_CELL_...,SET,15,-0.22462,-0.0064177,0.23639,0.82899,GOBP_POSITIVE_THYMIC_T_CELL_SELECTION,1
GOBP_ORGANIC_HYDROXY_COMPOUN...1,SET,224,-0.055738,-0.0061189,0.058649,0.82903,GOBP_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOBP_NON_PROTEINOGENIC_AMINO...1,SET,16,-0.20968,-0.0061871,0.22062,0.82904,GOBP_NON_PROTEINOGENIC_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_TRNA_5_LEADER_REMOVAL,SET,11,-0.21176,-0.0051817,0.2228,0.82906,GOBP_TRNA_5_LEADER_REMOVAL,1
HP_REDUCED_ATTENTION_REGULAT...,SET,439,-0.039363,-0.0060136,0.041412,0.82907,HP_REDUCED_ATTENTION_REGULATION,1
NIKOLSKY_BREAST_CANCER_15Q26...,SET,17,-0.30404,-0.0092473,0.31974,0.82916,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,1
MIR607,SET,872,-0.028773,-0.0061198,0.030255,0.82919,MIR607,1
COATES_MACROPHAGE_M1_VS_M2_DN,SET,75,-0.098757,-0.0062991,0.10384,0.82921,COATES_MACROPHAGE_M1_VS_M2_DN,1
GOBP_REGULATION_OF_NATURAL_K...1,SET,38,-0.13846,-0.0062925,0.14556,0.82925,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
GSE19198_CTRL_VS_IL21_TREATE...3,SET,186,-0.060597,-0.0060682,0.063695,0.82928,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN,1
GNF2_IL2RB,SET,41,-0.13766,-0.0064977,0.14469,0.82929,GNF2_IL2RB,1
GOBP_POSITIVE_REGULATION_OF_...333,SET,184,-0.06229,-0.0062045,0.065464,0.82932,GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS,1
GOBP_RESPONSE_TO_INORGANIC_S...,SET,469,-0.038968,-0.0061481,0.040955,0.82932,GOBP_RESPONSE_TO_INORGANIC_SUBSTANCE,1
MEF2D_TARGET_GENES,SET,474,-0.037544,-0.0059541,0.039454,0.82934,MEF2D_TARGET_GENES,1
GOMF_PYRIMIDINE_NUCLEOSIDE_T...,SET,8,-0.32228,-0.0067259,0.33859,0.8294,GOMF_PYRIMIDINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_ESTROUS_CYCLE,SET,16,-0.20129,-0.0059395,0.21144,0.82944,GOBP_ESTROUS_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...258,SET,17,-0.20005,-0.0060846,0.21013,0.82946,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...716,SET,15,-0.22573,-0.0064493,0.23705,0.82951,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
HP_SEVERE_MUSCULAR_HYPOTONIA,SET,58,-0.099882,-0.005605,0.10487,0.82955,HP_SEVERE_MUSCULAR_HYPOTONIA,1
GOBP_METANEPHRIC_NEPHRON_DEV...,SET,40,-0.14868,-0.0069322,0.1561,0.82956,GOBP_METANEPHRIC_NEPHRON_DEVELOPMENT,1
HOFT_CD4_POSITIVE_ALPHA_BETA...4,SET,37,-0.13686,-0.0061377,0.14369,0.82956,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_UP,1
THAKAR_PBMC_INACTIVATED_INFL...2,SET,158,-0.06562,-0.0060611,0.068893,0.82957,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP,1
HP_ABNORMAL_BLOOD_FOLATE_CON...,SET,10,-0.25037,-0.0058416,0.26282,0.82961,HP_ABNORMAL_BLOOD_FOLATE_CONCENTRATION,1
GOBP_AMINOGLYCAN_BIOSYNTHETI...,SET,74,-0.096773,-0.0061313,0.10154,0.8297,GOBP_AMINOGLYCAN_BIOSYNTHETIC_PROCESS,1
HP_EEG_WITH_FRONTAL_EPILEPTI...,SET,5,-0.4294,-0.0070853,0.45055,0.82972,HP_EEG_WITH_FRONTAL_EPILEPTIFORM_DISCHARGES,1
GOBP_POSITIVE_REGULATION_OF_...529,SET,85,-0.09881,-0.0067076,0.10366,0.82975,GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,SET,17,-0.20485,-0.0062306,0.21486,0.82981,WP_PROTEOGLYCAN_BIOSYNTHESIS,1
GSE29618_BCELL_VS_PDC_DAY7_F...1,SET,181,-0.06291,-0.0062154,0.065983,0.82981,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN,1
GOBP_ANTIGEN_PROCESSING_AND_...6,SET,36,-0.1433,-0.0063391,0.15024,0.82989,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN,1
GSE22886_NAIVE_CD4_TCELL_VS_...6,SET,179,-0.059911,-0.0058866,0.062807,0.82992,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP,1
MYLLYKANGAS_AMPLIFICATION_HO...5,SET,5,-0.36883,-0.0060858,0.38661,0.82995,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18,1
GOMF_5_3_EXONUCLEASE_ACTIVITY,SET,17,-0.17254,-0.0052478,0.18083,0.82999,GOMF_5_3_EXONUCLEASE_ACTIVITY,1
GOBP_IMP_METABOLIC_PROCESS,SET,15,-0.21112,-0.006032,0.22125,0.83001,GOBP_IMP_METABOLIC_PROCESS,1
HP_NEUROENDOCRINE_NEOPLASM,SET,37,-0.12977,-0.0058198,0.13598,0.83003,HP_NEUROENDOCRINE_NEOPLASM,1
GOBP_N_ACYLETHANOLAMINE_META...,SET,5,-0.29461,-0.0048611,0.30869,0.83005,GOBP_N_ACYLETHANOLAMINE_METABOLIC_PROCESS,1
GOBP_RNA_SECONDARY_STRUCTURE...,SET,8,-0.27288,-0.0056949,0.28591,0.83006,GOBP_RNA_SECONDARY_STRUCTURE_UNWINDING,1
HP_REDUNDANT_SKIN,SET,79,-0.091518,-0.0059903,0.095887,0.83006,HP_REDUNDANT_SKIN,1
GSE36392_EOSINOPHIL_VS_MAC_I...2,SET,176,-0.062696,-0.006109,0.065685,0.83007,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP,1
GOMF_PROTEIN_FOLDING_CHAPERO...2,SET,125,-0.071888,-0.0059114,0.075302,0.83012,GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING,1
HP_SPORADIC,SET,86,-0.090485,-0.0061783,0.094782,0.83012,HP_SPORADIC,1
RASHI_RESPONSE_TO_IONIZING_R...3,SET,43,-0.11706,-0.0056583,0.1226,0.83014,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,1
HP_ELEVATED_CIRCULATING_FOLL...,SET,46,-0.11849,-0.0059236,0.12411,0.83014,HP_ELEVATED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL,1
MIR6716_5P,SET,118,-0.074822,-0.0059791,0.078343,0.83022,MIR6716_5P,1
WP_KININKALLIKREIN_PATHWAY,SET,7,-0.38509,-0.0075178,0.40319,0.83023,WP_KININKALLIKREIN_PATHWAY,1
GOBP_REGULATION_OF_HORMONE_L...,SET,511,-0.03884,-0.0063888,0.040663,0.83024,GOBP_REGULATION_OF_HORMONE_LEVELS,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...1,SET,614,-0.033055,-0.005943,0.034607,0.83025,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,1
HP_PROMINENT_METOPIC_RIDGE,SET,57,-0.11068,-0.0061575,0.11587,0.83026,HP_PROMINENT_METOPIC_RIDGE,1
PIONTEK_PKD1_TARGETS_DN,SET,15,-0.2021,-0.0057742,0.21156,0.83027,PIONTEK_PKD1_TARGETS_DN,1
GOCC_EARLY_ENDOSOME_LUMEN,SET,5,-0.35473,-0.0058532,0.37134,0.83027,GOCC_EARLY_ENDOSOME_LUMEN,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...1,SET,66,-0.10109,-0.0060501,0.10581,0.8303,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
GOBP_REGULATION_OF_DIGESTIVE...,SET,38,-0.13365,-0.0060741,0.13989,0.8303,GOBP_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
GOMF_ASPARTIC_TYPE_PEPTIDASE...,SET,25,-0.15526,-0.0057254,0.16248,0.83035,GOMF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,1
HP_SPARSE_BODY_HAIR,SET,57,-0.11666,-0.0064903,0.12209,0.83035,HP_SPARSE_BODY_HAIR,1
GSE1925_3H_VS_24H_IFNG_STIM_...3,SET,181,-0.059522,-0.0058807,0.062289,0.83035,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN,1
HP_GANGLIONEUROBLASTOMA,SET,7,-0.35705,-0.0069705,0.37364,0.83036,HP_GANGLIONEUROBLASTOMA,1
GSE3203_WT_VS_IFNAR1_KO_INFL...2,SET,178,-0.062119,-0.0060867,0.065002,0.83037,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP,1
GOBP_REGULATION_OF_RENAL_SOD...,SET,7,-0.31736,-0.0061955,0.33204,0.8304,GOBP_REGULATION_OF_RENAL_SODIUM_EXCRETION,1
MIR564,SET,14,-0.23206,-0.0064056,0.24272,0.83048,MIR564,1
GOBP_REGULATION_OF_CELL_DIFF...,SET,1405,-0.023375,-0.0062141,0.024449,0.83048,GOBP_REGULATION_OF_CELL_DIFFERENTIATION,1
HP_RECURRENT_SKIN_INFECTIONS,SET,122,-0.07416,-0.0060252,0.077538,0.83057,HP_RECURRENT_SKIN_INFECTIONS,1
GOBP_RESPONSE_TO_ATP,SET,31,-0.15695,-0.0064436,0.16395,0.83079,GOBP_RESPONSE_TO_ATP,1
HP_ABNORMAL_RENAL_MORPHOLOGY,SET,983,-0.02702,-0.0060824,0.02822,0.83083,HP_ABNORMAL_RENAL_MORPHOLOGY,1
HP_DISPROPORTIONATE_TALL_STA...,SET,32,-0.14359,-0.0059893,0.14996,0.83083,HP_DISPROPORTIONATE_TALL_STATURE,1
GOBP_SMALL_MOLECULE_BIOSYNTH...,SET,536,-0.035934,-0.0060494,0.037525,0.83086,GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,1
HP_DEEP_PALMAR_CREASE,SET,28,-0.1496,-0.0058379,0.15622,0.83088,HP_DEEP_PALMAR_CREASE,1
GOBP_REVERSIBLE_DIFFERENTIAT...,SET,5,-0.40469,-0.0066774,0.42256,0.83089,GOBP_REVERSIBLE_DIFFERENTIATION,1
GOCC_GAMMA_TUBULIN_RING_COMP...,SET,8,-0.27371,-0.0057122,0.28578,0.8309,GOCC_GAMMA_TUBULIN_RING_COMPLEX,1
WP_METHIONINE_METABOLISM_LEA...,SET,10,-0.29235,-0.0068209,0.30503,0.83106,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,1
GOBP_PROTECTION_FROM_NON_HOM...,SET,9,-0.23391,-0.0051776,0.24405,0.83107,GOBP_PROTECTION_FROM_NON_HOMOLOGOUS_END_JOINING_AT_TELOMERE,1
GSE32423_MEMORY_VS_NAIVE_CD8...5,SET,182,-0.059559,-0.0059004,0.062141,0.83108,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP,1
REACTOME_SIGNALING_BY_NOTCH1...3,SET,7,-0.28389,-0.0055422,0.29603,0.83121,REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT,1
GOBP_PENILE_ERECTION,SET,7,-0.37826,-0.0073845,0.39417,0.83137,GOBP_PENILE_ERECTION,1
GOBP_REGULATION_OF_MITOCHOND...4,SET,5,-0.33553,-0.0055363,0.3496,0.8314,GOBP_REGULATION_OF_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,1
GSE13485_CTRL_VS_DAY21_YF17D...1,SET,129,-0.073165,-0.0061113,0.076222,0.83144,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
GOBP_POSITIVE_REGULATION_OF_...838,SET,3,-0.42669,-0.0054538,0.44438,0.83151,GOBP_POSITIVE_REGULATION_OF_VESICLE_TRANSPORT_ALONG_MICROTUBULE,1
KHETCHOUMIAN_TRIM24_TARGETS_...2,SET,44,-0.13011,-0.0063616,0.13546,0.83159,KHETCHOUMIAN_TRIM24_TARGETS_UP,1
GSE45365_NK_CELL_VS_CD8_TCEL...2,SET,169,-0.065132,-0.00622,0.067812,0.83159,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN,1
GOCC_TIM23_MITOCHONDRIAL_IMP...,SET,14,-0.20319,-0.0056086,0.21152,0.83161,GOCC_TIM23_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_TRANSLOCASE_COMPLEX,1
GAVISH_3CA_METAPROGRAM_ENDOT...11,SET,50,-0.12168,-0.0063414,0.12665,0.83166,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2,1
GOMF_TRANSMEMBRANE_RECEPTOR_...7,SET,17,-0.20362,-0.006193,0.21188,0.83172,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...64,SET,14,-0.19805,-0.0054669,0.20602,0.83179,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT,1
CTTTGCA_MIR527,SET,215,-0.056667,-0.0060961,0.058945,0.8318,CTTTGCA_MIR527,1
GSE17721_POLYIC_VS_PAM3CSK4_...2,SET,180,-0.06216,-0.0061245,0.064658,0.83181,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP,1
HP_MICROTIA_FIRST_DEGREE,SET,4,-0.48038,-0.0070898,0.49967,0.83182,HP_MICROTIA_FIRST_DEGREE,1
HP_ABNORMAL_PLATELET_MEMBRAN...,SET,6,-0.34504,-0.0062365,0.35887,0.83183,HP_ABNORMAL_PLATELET_MEMBRANE_PROTEIN_EXPRESSION,1
GOMF_PYRIMIDINE_NUCLEOBASE_T...,SET,7,-0.34432,-0.0067219,0.35802,0.8319,GOMF_PYRIMIDINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_SIGNALING_BY_FLT3_I...,SET,16,-0.19163,-0.0056544,0.19921,0.83195,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,1
GSE11961_FOLLICULAR_BCELL_VS...8,SET,180,-0.060853,-0.0059957,0.063259,0.83196,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP,1
HP_RENAL_FIBROSIS,SET,15,-0.2101,-0.006003,0.21839,0.83199,HP_RENAL_FIBROSIS,1
HP_OLIGOHYDRAMNIOS,SET,166,-0.06206,-0.0058743,0.064501,0.83201,HP_OLIGOHYDRAMNIOS,1
DESCARTES_MAIN_FETAL_STROMAL...,SET,11,-0.28948,-0.0070835,0.30076,0.83209,DESCARTES_MAIN_FETAL_STROMAL_CELLS,1
HP_DEEP_PLANTAR_CREASES,SET,19,-0.19034,-0.00612,0.19774,0.83211,HP_DEEP_PLANTAR_CREASES,1
GOBP_HEPOXILIN_METABOLIC_PRO...,SET,7,-0.37936,-0.0074059,0.39408,0.83213,GOBP_HEPOXILIN_METABOLIC_PROCESS,1
GOMF_INTRACELLULARLY_CGMP_AC...,SET,6,-0.34017,-0.0061485,0.35337,0.83213,GOMF_INTRACELLULARLY_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,1
HP_LARYNGOTRACHEAL_STENOSIS,SET,5,-0.38699,-0.0063854,0.40197,0.83215,HP_LARYNGOTRACHEAL_STENOSIS,1
GSE7768_OVA_ALONE_VS_OVA_WIT...1,SET,157,-0.068037,-0.0062646,0.070673,0.83215,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,1
GOBP_REGULATION_OF_LOW_DENSI...,SET,15,-0.21709,-0.0062027,0.22549,0.83216,GOBP_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GSE17721_POLYIC_VS_CPG_6H_BM...2,SET,185,-0.057814,-0.0057741,0.060042,0.83219,GSE17721_POLYIC_VS_CPG_6H_BMDC_UP,1
KEGG_MEDICUS_REFERENCE_TRANS...1,SET,11,-0.24308,-0.0059481,0.25244,0.8322,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27,1
BIOCARTA_SKP2E2F_PATHWAY,SET,10,-0.23818,-0.0055572,0.24735,0.83221,BIOCARTA_SKP2E2F_PATHWAY,1
MYBL1_TARGET_GENES,SET,353,-0.042535,-0.0058409,0.044167,0.83223,MYBL1_TARGET_GENES,1
GOMF_PHOSPHOLIPASE_ACTIVATOR...,SET,14,-0.20113,-0.005552,0.20878,0.83231,GOMF_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY,1
MIR5100,SET,84,-0.091464,-0.0061724,0.094939,0.83232,MIR5100,1
PLASARI_TGFB1_TARGETS_1HR_DN,SET,4,-0.47699,-0.0070397,0.4951,0.83233,PLASARI_TGFB1_TARGETS_1HR_DN,1
HP_SLENDER_FINGER,SET,130,-0.072706,-0.0060963,0.07546,0.83235,HP_SLENDER_FINGER,1
GSE3720_UNSTIM_VS_PMA_STIM_V...3,SET,173,-0.059965,-0.0057934,0.062237,0.83235,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,1
GOBP_REGULATION_OF_MYOSIN_LI...,SET,7,-0.28565,-0.0055765,0.29645,0.83236,GOBP_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,1
GSE32986_UNSTIM_VS_GMCSF_AND...4,SET,180,-0.057436,-0.005659,0.059599,0.8324,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...35,SET,6,-0.33176,-0.0059964,0.34423,0.83241,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,1
GSE4984_UNTREATED_VS_VEHICLE...1,SET,154,-0.065615,-0.0059841,0.068062,0.83248,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN,1
VANDESLUIS_NORMAL_EMBRYOS_UP,SET,5,-0.39986,-0.0065977,0.41468,0.83253,VANDESLUIS_NORMAL_EMBRYOS_UP,1
GSE22886_NAIVE_CD8_TCELL_VS_...5,SET,185,-0.06319,-0.006311,0.065533,0.83253,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN,1
KEGG_MEDICUS_REFERENCE_ITGA_...1,SET,25,-0.17615,-0.0064955,0.18268,0.83254,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY,1
MIR5572,SET,70,-0.09923,-0.0061154,0.10287,0.83263,MIR5572,1
GSE3982_EOSINOPHIL_VS_NKCELL...1,SET,171,-0.063488,-0.0060985,0.065809,0.83265,GSE3982_EOSINOPHIL_VS_NKCELL_DN,1
HP_BLURRED_VISION,SET,33,-0.14999,-0.0063533,0.15547,0.83267,HP_BLURRED_VISION,1
IVANOVA_HEMATOPOIESIS_EARLY_...,SET,404,-0.041203,-0.0060444,0.042704,0.83268,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1
GOBP_7_METHYLGUANOSINE_RNA_C...,SET,5,-0.29625,-0.0048882,0.30698,0.83274,GOBP_7_METHYLGUANOSINE_RNA_CAPPING,1
FULLER_PBMC_F_TULARENSIS_VAC...4,SET,14,-0.21229,-0.0058599,0.2199,0.83282,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_UP,1
GAUCHER_PBMC_YF_VAX_STAMARIL...6,SET,26,-0.17204,-0.0064696,0.1782,0.83284,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_UP,1
ZNF512B_TARGET_GENES,SET,176,-0.06592,-0.0064232,0.068273,0.83286,ZNF512B_TARGET_GENES,1
MODULE_69,SET,479,-0.036925,-0.0058859,0.03824,0.83288,MODULE_69,1
DAVICIONI_RHABDOMYOSARCOMA_P...2,SET,56,-0.11893,-0.0065582,0.12316,0.83289,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,1
GSE22886_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.057771,-0.0057233,0.059822,0.8329,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN,1
WP_OPIOID_RECEPTOR_PATHWAYS,SET,41,-0.13136,-0.0062004,0.13598,0.83297,WP_OPIOID_RECEPTOR_PATHWAYS,1
GAVISH_3CA_METAPROGRAM_EPITH...12,SET,46,-0.12804,-0.0064011,0.13255,0.83297,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_2,1
HP_ONYCHOMYCOSIS,SET,20,-0.20068,-0.0066198,0.20774,0.83298,HP_ONYCHOMYCOSIS,1
GOCC_RIPOPTOSOME,SET,6,-0.40128,-0.007253,0.41535,0.83301,GOCC_RIPOPTOSOME,1
HP_BROAD_TOE,SET,72,-0.096374,-0.0060234,0.099746,0.83302,HP_BROAD_TOE,1
GOBP_POSITIVE_REGULATION_OF_...723,SET,21,-0.17993,-0.0060818,0.18621,0.83304,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,1
GSE29618_PRE_VS_DAY7_POST_TI...6,SET,166,-0.06406,-0.0060636,0.066293,0.83305,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP,1
GOBP_PYRIMIDINE_CONTAINING_C...2,SET,41,-0.14499,-0.0068438,0.15003,0.83307,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GSE15624_3H_VS_6H_HALOFUGINO...1,SET,135,-0.072909,-0.0062289,0.075445,0.83307,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,1
GOBP_PEPTIDYL_THREONINE_MODI...,SET,100,-0.085455,-0.0062895,0.088352,0.83327,GOBP_PEPTIDYL_THREONINE_MODIFICATION,1
GSE41867_LCMV_ARMSTRONG_VS_C...1,SET,141,-0.072862,-0.0063606,0.075327,0.83329,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN,1
PURWIN_A375_SOX10_TARGETS,SET,43,-0.12981,-0.0062747,0.1342,0.8333,PURWIN_A375_SOX10_TARGETS,1
GNF2_MSH6,SET,29,-0.13079,-0.0051938,0.13521,0.8333,GNF2_MSH6,1
GOBP_CHITIN_METABOLIC_PROCESS,SET,6,-0.35863,-0.006482,0.37072,0.83331,GOBP_CHITIN_METABOLIC_PROCESS,1
GOMF_CHITINASE_ACTIVITY,SET,6,-0.35863,-0.006482,0.37072,0.83331,GOMF_CHITINASE_ACTIVITY,1
REACTOME_NEGATIVE_REGULATION...13,SET,116,-0.080318,-0.006364,0.083003,0.83338,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...5,SET,26,-0.18908,-0.0071105,0.19539,0.8334,GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY,1
REACTOME_DOWNREGULATION_OF_E...2,SET,27,-0.16494,-0.0063205,0.17043,0.83342,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,1
ZNF213_TARGET_GENES,SET,474,-0.038364,-0.006084,0.039639,0.83343,ZNF213_TARGET_GENES,1
GOBP_MYELIN_MAINTENANCE,SET,15,-0.21842,-0.0062407,0.22566,0.83345,GOBP_MYELIN_MAINTENANCE,1
GSE41867_NAIVE_VS_DAY8_LCMV_...6,SET,181,-0.056464,-0.0055785,0.058327,0.83349,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,1
GOBP_AMMONIUM_HOMEOSTASIS,SET,5,-0.45606,-0.007525,0.47104,0.83352,GOBP_AMMONIUM_HOMEOSTASIS,1
REACTOME_DOPAMINE_RECEPTORS,SET,5,-0.42554,-0.0070214,0.43946,0.83355,REACTOME_DOPAMINE_RECEPTORS,1
GOMF_DOPAMINE_NEUROTRANSMITT...,SET,5,-0.42554,-0.0070214,0.43946,0.83355,GOMF_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
GSE3691_CONVENTIONAL_VS_PLAS...1,SET,182,-0.0619,-0.0061323,0.063926,0.83355,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN,1
GSE9960_GRAM_NEG_VS_GRAM_POS...2,SET,174,-0.061966,-0.0060038,0.063993,0.83355,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP,1
GOBP_AXON_DEVELOPMENT,SET,469,-0.040719,-0.0064243,0.042047,0.83357,GOBP_AXON_DEVELOPMENT,1
MIR7851_3P,SET,52,-0.11285,-0.005997,0.11652,0.83358,MIR7851_3P,1
GOBP_EPIDERMIS_MORPHOGENESIS,SET,36,-0.1611,-0.0071267,0.16635,0.83358,GOBP_EPIDERMIS_MORPHOGENESIS,1
GOBP_PLUS_END_DIRECTED_ORGAN...,SET,7,-0.31271,-0.0061049,0.3229,0.83358,GOBP_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
HP_PTOSIS,SET,652,-0.032089,-0.0059387,0.033135,0.83358,HP_PTOSIS,1
GSE14769_UNSTIM_VS_80MIN_LPS...1,SET,188,-0.065069,-0.0065506,0.067187,0.83359,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN,1
GOBP_RESPONSE_TO_ETHER,SET,15,-0.2245,-0.0064143,0.23179,0.8336,GOBP_RESPONSE_TO_ETHER,1
GOBP_POLARIZED_EPITHELIAL_CE...,SET,24,-0.17273,-0.0062409,0.17833,0.83362,GOBP_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...94,SET,8,-0.29683,-0.0061948,0.30639,0.83367,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPIRATION,1
HP_UTERINE_PROLAPSE,SET,6,-0.39167,-0.0070793,0.40428,0.83367,HP_UTERINE_PROLAPSE,1
HP_HYPOPLASTIC_FIFTH_FINGERN...,SET,14,-0.23089,-0.0063732,0.2383,0.8337,HP_HYPOPLASTIC_FIFTH_FINGERNAIL,1
HP_PROPORTIONATE_TALL_STATURE,SET,14,-0.21353,-0.0058942,0.22038,0.8337,HP_PROPORTIONATE_TALL_STATURE,1
HP_JOINT_CONTRACTURE_OF_THE_...1,SET,7,-0.34033,-0.0066439,0.35121,0.83372,HP_JOINT_CONTRACTURE_OF_THE_4TH_FINGER,1
GSE40274_IRF4_VS_FOXP3_AND_I...1,SET,102,-0.084928,-0.0063126,0.087643,0.83373,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
DESCARTES_FETAL_CEREBRUM_OLI...,SET,48,-0.13621,-0.0069552,0.14054,0.83376,DESCARTES_FETAL_CEREBRUM_OLIGODENDROCYTES,1
HP_ABNORMALITY_OF_TIBIAL_EPI...,SET,4,-0.47091,-0.00695,0.48582,0.8338,HP_ABNORMALITY_OF_TIBIAL_EPIPHYSES,1
HP_NO_SOCIAL_INTERACTION,SET,5,-0.47401,-0.0078213,0.48886,0.83388,HP_NO_SOCIAL_INTERACTION,1
HP_PERIODIC_HYPOKALEMIC_PARE...,SET,7,-0.33236,-0.0064884,0.34268,0.83394,HP_PERIODIC_HYPOKALEMIC_PARESIS,1
HP_RECURRENT_BACTERIAL_SKIN_...,SET,23,-0.17783,-0.0062901,0.18332,0.83399,HP_RECURRENT_BACTERIAL_SKIN_INFECTIONS,1
GOBP_VESICLE_TRANSPORT_ALONG...2,SET,43,-0.12357,-0.005973,0.12737,0.834,GOBP_VESICLE_TRANSPORT_ALONG_MICROTUBULE,1
GSE19941_IL10_KO_VS_IL10_KO_...1,SET,150,-0.06444,-0.0058008,0.066406,0.83407,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN,1
GOBP_RESPIRATORY_BURST_INVOL...1,SET,14,-0.23434,-0.0064687,0.24147,0.83409,GOBP_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE,1
WP_ERK_PATHWAY_IN_HUNTINGTON...,SET,16,-0.23262,-0.0068639,0.23963,0.83415,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,1
LEE_AGING_MUSCLE_DN,SET,38,-0.1336,-0.0060718,0.13759,0.83421,LEE_AGING_MUSCLE_DN,1
HP_INCREASED_CIRCULATING_THY...,SET,8,-0.32564,-0.006796,0.33521,0.83433,HP_INCREASED_CIRCULATING_THYROGLOBULIN_CONCENTRATION,1
GOMF_G_PROTEIN_COUPLED_AMINE...,SET,38,-0.14968,-0.0068027,0.15404,0.83441,GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...1,SET,151,-0.071246,-0.0064346,0.073309,0.83443,HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL,1
MIR4686,SET,74,-0.092488,-0.0058599,0.095149,0.83448,MIR4686,1
GOBP_FATTY_ACID_DERIVATIVE_B...,SET,43,-0.13607,-0.0065774,0.13998,0.83448,GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
GSE21670_TGFB_VS_TGFB_AND_IL...2,SET,181,-0.06243,-0.0061681,0.06421,0.83454,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,1
GSE37301_LYMPHOID_PRIMED_MPP...10,SET,185,-0.059196,-0.0059121,0.060881,0.83455,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP,1
MODULE_279,SET,122,-0.074714,-0.0060701,0.076837,0.83456,MODULE_279,1
WP_TRYPTOPHAN_CATABOLISM_LEA...,SET,16,-0.21719,-0.0064087,0.22332,0.8346,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,1
HP_BROAD_THUMB,SET,75,-0.09623,-0.0061378,0.098926,0.83465,HP_BROAD_THUMB,1
REACTOME_CARGO_CONCENTRATION...,SET,31,-0.15207,-0.0062434,0.15631,0.83469,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,1
HOEK_B_CELL_2011_2012_TIV_AD...2,SET,3,-0.47655,-0.0060911,0.48975,0.83472,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_DN,1
GOBP_RUFFLE_ORGANIZATION,SET,53,-0.12051,-0.0064655,0.12379,0.83484,GOBP_RUFFLE_ORGANIZATION,1
GOMF_GAMMA_AMINOBUTYRIC_ACID...2,SET,7,-0.37969,-0.0074124,0.38997,0.83488,GOMF_GAMMA_AMINOBUTYRIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_TUBE_FORMATION,SET,144,-0.070316,-0.0062028,0.072209,0.83491,GOBP_TUBE_FORMATION,1
MIR642A_5P,SET,82,-0.093574,-0.0062396,0.096082,0.83494,MIR642A_5P,1
GSE11961_MEMORY_BCELL_DAY7_V...4,SET,179,-0.061805,-0.0060727,0.06345,0.83498,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
NADELLA_PRKAR1A_TARGETS_DN,SET,7,-0.32239,-0.0062939,0.33097,0.83499,NADELLA_PRKAR1A_TARGETS_DN,1
GOBP_AV_NODE_CELL_TO_BUNDLE_...2,SET,10,-0.30167,-0.0070384,0.30967,0.835,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_SIGNALING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...23,SET,42,-0.14744,-0.0070438,0.15135,0.835,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
HP_CUTANEOUS_AMYLOIDOSIS,SET,5,-0.37226,-0.0061423,0.38214,0.835,HP_CUTANEOUS_AMYLOIDOSIS,1
REACTOME_ASSEMBLY_OF_COLLAGE...,SET,59,-0.12014,-0.0067994,0.12331,0.83503,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1
chr6p21,SET,271,-0.11263,-0.013582,0.11558,0.83509,chr6p21,1
GOBP_I_KAPPAB_PHOSPHORYLATION,SET,13,-0.26464,-0.0070395,0.27156,0.8351,GOBP_I_KAPPAB_PHOSPHORYLATION,1
GOBP_REGULATION_OF_EXIT_FROM...,SET,16,-0.20967,-0.0061869,0.21514,0.83511,GOBP_REGULATION_OF_EXIT_FROM_MITOSIS,1
GOBP_REGULATION_OF_RELAXATIO...2,SET,13,-0.25746,-0.0068485,0.26413,0.83515,GOBP_REGULATION_OF_RELAXATION_OF_MUSCLE,1
MIR1277_5P,SET,820,-0.0305,-0.0063001,0.031289,0.83516,MIR1277_5P,1
HP_FETAL_ONSET,SET,170,-0.062218,-0.0059591,0.063818,0.83519,HP_FETAL_ONSET,1
MIR10396A_3P_MIR10396B_3P,SET,4,-0.53449,-0.0078884,0.54823,0.8352,MIR10396A_3P_MIR10396B_3P,1
HP_NASOLACRIMAL_DUCT_OBSTRUC...,SET,29,-0.15489,-0.0061509,0.15886,0.83521,HP_NASOLACRIMAL_DUCT_OBSTRUCTION,1
GOBP_NON_PROTEINOGENIC_AMINO...3,SET,68,-0.099876,-0.006067,0.1024,0.83529,GOBP_NON_PROTEINOGENIC_AMINO_ACID_METABOLIC_PROCESS,1
HP_IMPAIRED_RENAL_CONCENTRAT...,SET,6,-0.31844,-0.0057557,0.3265,0.83529,HP_IMPAIRED_RENAL_CONCENTRATING_ABILITY,1
GSE46606_IRF4MID_VS_WT_CD40L...4,SET,190,-0.060112,-0.0060834,0.061623,0.83533,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
PID_EPHRINB_REV_PATHWAY,SET,29,-0.16415,-0.0065186,0.16827,0.83534,PID_EPHRINB_REV_PATHWAY,1
HP_APLASIA_HYPOPLASIA_OF_THE...22,SET,13,-0.23201,-0.0061715,0.23779,0.83539,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
GOBP_VIRAL_LIFE_CYCLE,SET,297,-0.050428,-0.0063617,0.051682,0.8354,GOBP_VIRAL_LIFE_CYCLE,1
GSE17721_CPG_VS_GARDIQUIMOD_...14,SET,189,-0.060248,-0.0060812,0.061744,0.8354,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP,1
HP_BCGOSIS,SET,7,-0.3762,-0.0073443,0.38551,0.83542,HP_BCGOSIS,1
BIOCARTA_FREE_PATHWAY,SET,9,-0.25387,-0.0056193,0.26014,0.83543,BIOCARTA_FREE_PATHWAY,1
GOMF_COLLAGEN_RECEPTOR_ACTIV...,SET,6,-0.31947,-0.0057744,0.32736,0.83544,GOMF_COLLAGEN_RECEPTOR_ACTIVITY,1
GOMF_OPSIN_BINDING,SET,4,-0.47915,-0.0070716,0.4909,0.83548,GOMF_OPSIN_BINDING,1
GOBP_RESPONSE_TO_X_RAY,SET,26,-0.14567,-0.0054779,0.14919,0.83556,GOBP_RESPONSE_TO_X_RAY,1
EGR_Q6,SET,248,-0.05333,-0.0061561,0.054615,0.83558,EGR_Q6,1
DAVICIONI_PAX_FOXO1_SIGNATUR...1,SET,19,-0.21287,-0.0068443,0.21799,0.83559,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1
HP_EXOSTOSES,SET,18,-0.2064,-0.0064595,0.21136,0.83559,HP_EXOSTOSES,1
GSE15330_LYMPHOID_MULTIPOTEN...9,SET,176,-0.064295,-0.0062648,0.065837,0.83561,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN,1
HP_ULNAR_BOWING,SET,16,-0.23863,-0.0070415,0.24432,0.83565,HP_ULNAR_BOWING,1
GOBP_AMP_METABOLIC_PROCESS,SET,20,-0.18967,-0.0062565,0.19417,0.83566,GOBP_AMP_METABOLIC_PROCESS,1
MIR508_3P,SET,94,-0.08846,-0.0063133,0.090545,0.8357,MIR508_3P,1
GOBP_CILIUM_ORGANIZATION,SET,369,-0.042366,-0.0059455,0.043361,0.83572,GOBP_CILIUM_ORGANIZATION,1
GSE24292_WT_VS_PPARG_KO_MACR...2,SET,185,-0.061496,-0.0061418,0.062934,0.83575,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP,1
GOMF_OXYGEN_SENSOR_ACTIVITY,SET,5,-0.29207,-0.0048192,0.29888,0.83576,GOMF_OXYGEN_SENSOR_ACTIVITY,1
GSE2770_UNTREATED_VS_TGFB_AN...11,SET,114,-0.076016,-0.0059713,0.077785,0.83577,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN,1
WP_MIRNA_TARGETS_IN_ECM_AND_...,SET,22,-0.19477,-0.0067381,0.19927,0.83581,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,1
BIOCARTA_SPPA_PATHWAY,SET,16,-0.2323,-0.0068546,0.23765,0.83583,BIOCARTA_SPPA_PATHWAY,1
GOBP_EXTRAEMBRYONIC_MEMBRANE...,SET,13,-0.26398,-0.0070218,0.26994,0.83593,GOBP_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT,1
REACTOME_YAP1_AND_WWTR1_TAZ_...,SET,14,-0.24034,-0.0066341,0.24574,0.83596,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,1
GOBP_INTERMEDIATE_FILAMENT_O...,SET,71,-0.1353,-0.0083978,0.13834,0.83596,GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION,1
HALLMARK_BILE_ACID_METABOLISM,SET,110,-0.083081,-0.0064115,0.084949,0.83596,HALLMARK_BILE_ACID_METABOLISM,1
KEGG_CHRONIC_MYELOID_LEUKEMIA,SET,70,-0.099299,-0.0061197,0.10151,0.83602,KEGG_CHRONIC_MYELOID_LEUKEMIA,1
MIR675_3P,SET,56,-0.12012,-0.0066239,0.12277,0.83607,MIR675_3P,1
chr1q44,SET,56,-0.19297,-0.010641,0.1972,0.8361,chr1q44,1
GOBP_PEPTIDYL_LYSINE_DEACETY...,SET,5,-0.36909,-0.00609,0.37716,0.8361,GOBP_PEPTIDYL_LYSINE_DEACETYLATION,1
MANNE_COVID19_ICU_VS_HEALTHY...1,SET,134,-0.079155,-0.0067376,0.080883,0.83612,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1
GSE5099_MONOCYTE_VS_ALTERNAT...2,SET,143,-0.070671,-0.0062126,0.072206,0.83614,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP,1
GOMF_METALLOCHAPERONE_ACTIVI...,SET,12,-0.22209,-0.005676,0.22689,0.83617,GOMF_METALLOCHAPERONE_ACTIVITY,1
WP_OMEGA9_FATTY_ACID_SYNTHES...,SET,13,-0.26096,-0.0069415,0.26656,0.8362,WP_OMEGA9_FATTY_ACID_SYNTHESIS,1
GSE17721_CTRL_VS_PAM3CSK4_12...2,SET,181,-0.060745,-0.0060015,0.062049,0.8362,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP,1
GOCC_GID_COMPLEX,SET,5,-0.36177,-0.0059692,0.36943,0.83627,GOCC_GID_COMPLEX,1
THEILGAARD_NEUTROPHIL_AT_SKI...2,SET,73,-0.10278,-0.0064682,0.10494,0.83632,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,1
HP_DECREASED_PALMAR_CREASES,SET,5,-0.39796,-0.0065664,0.40619,0.83638,HP_DECREASED_PALMAR_CREASES,1
GOBP_NEGATIVE_REGULATION_OF_...36,SET,11,-0.24428,-0.0059775,0.2493,0.83641,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
BIOCARTA_GLEEVEC_PATHWAY,SET,23,-0.19272,-0.0068169,0.19665,0.83646,BIOCARTA_GLEEVEC_PATHWAY,1
ZBTB44_TARGET_GENES,SET,621,-0.034648,-0.0062636,0.035354,0.83646,ZBTB44_TARGET_GENES,1
REACTOME_CHYLOMICRON_CLEARAN...,SET,4,-0.4779,-0.0070532,0.48746,0.83655,REACTOME_CHYLOMICRON_CLEARANCE,1
TRAVAGLINI_LUNG_PROXIMAL_CIL...,SET,1478,-0.022113,-0.0060163,0.022554,0.83656,TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL,1
HOEGERKORP_CD44_TARGETS_DIRE...2,SET,24,-0.17496,-0.0063214,0.17839,0.83663,HOEGERKORP_CD44_TARGETS_DIRECT_UP,1
HP_APLASIA_HYPOPLASIA_INVOLV...3,SET,164,-0.064591,-0.0060773,0.065856,0.83665,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_THORAX,1
MIR4670_3P,SET,137,-0.072183,-0.006212,0.073562,0.83676,MIR4670_3P,1
GSE23502_BM_VS_COLON_TUMOR_M...1,SET,181,-0.061504,-0.0060766,0.062676,0.83677,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,1
REACTOME_HORMONE_LIGAND_BIND...,SET,12,-0.24886,-0.0063601,0.25354,0.83682,REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,1
GSE6875_TCONV_VS_TREG_DN,SET,186,-0.063379,-0.0063468,0.06457,0.83684,GSE6875_TCONV_VS_TREG_DN,1
MIR30B_5P_MIR30C_5P,SET,713,-0.032726,-0.0063227,0.033337,0.83686,MIR30B_5P_MIR30C_5P,1
GSE13887_RESTING_VS_ACT_CD4_...1,SET,116,-0.076147,-0.0060335,0.077565,0.83687,GSE13887_RESTING_VS_ACT_CD4_TCELL_DN,1
MEBARKI_HCC_PROGENITOR_WNT_UP,SET,168,-0.06927,-0.0065958,0.07055,0.83691,MEBARKI_HCC_PROGENITOR_WNT_UP,1
REACTOME_FANCONI_ANEMIA_PATH...,SET,30,-0.13045,-0.0052689,0.13285,0.83692,REACTOME_FANCONI_ANEMIA_PATHWAY,1
HP_DOWNBEAT_NYSTAGMUS,SET,7,-0.31466,-0.0061429,0.32045,0.83693,HP_DOWNBEAT_NYSTAGMUS,1
LINDGREN_BLADDER_CANCER_CLUS...4,SET,8,-0.29123,-0.0060778,0.29654,0.83696,LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP,1
ZMYND11_TARGET_GENES,SET,34,-0.14685,-0.0063137,0.14951,0.837,ZMYND11_TARGET_GENES,1
GOBP_REGULATION_OF_CELL_KILL...,SET,106,-0.090433,-0.0068515,0.092068,0.837,GOBP_REGULATION_OF_CELL_KILLING,1
GSE15330_HSC_VS_LYMPHOID_PRI...2,SET,177,-0.061179,-0.0059779,0.062285,0.837,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN,1
HP_ABNORMAL_3RD_FINGER_PHALA...,SET,6,-0.37883,-0.0068472,0.38557,0.83707,HP_ABNORMAL_3RD_FINGER_PHALANX_MORPHOLOGY,1
GOBP_LONG_CHAIN_FATTY_ACID_B...,SET,25,-0.17873,-0.0065906,0.18183,0.83717,GOBP_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GSE25085_FETAL_LIVER_VS_FETA...1,SET,183,-0.065064,-0.0064633,0.066166,0.83727,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN,1
MODULE_91,SET,35,-0.12212,-0.0053266,0.12414,0.83735,MODULE_91,1
HP_PRIMARY_HYPERPARATHYROIDI...,SET,13,-0.25464,-0.0067735,0.25881,0.83741,HP_PRIMARY_HYPERPARATHYROIDISM,1
GOCC_PROTEASOME_REGULATORY_P...2,SET,7,-0.28196,-0.0055044,0.28654,0.83743,GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX,1
MIR10398_5P,SET,70,-0.098576,-0.0060751,0.10017,0.83746,MIR10398_5P,1
chr11q21,SET,28,-0.27088,-0.01057,0.27525,0.83747,chr11q21,1
GSE339_EX_VIVO_VS_IN_CULTURE...6,SET,182,-0.059082,-0.0058532,0.060032,0.83748,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP,1
HP_FAILURE_TO_THRIVE,SET,956,-0.027753,-0.0061659,0.028197,0.8375,HP_FAILURE_TO_THRIVE,1
GCM_BMPR2,SET,78,-0.09125,-0.005935,0.092691,0.83755,GCM_BMPR2,1
GOBP_NEGATIVE_REGULATION_OF_...162,SET,33,-0.16197,-0.0068607,0.16453,0.83755,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOMF_BH3_DOMAIN_BINDING,SET,5,-0.40344,-0.0066568,0.40978,0.83756,GOMF_BH3_DOMAIN_BINDING,1
HP_PROMINENT_EYELASHES,SET,14,-0.2288,-0.0063157,0.23238,0.83759,HP_PROMINENT_EYELASHES,1
GOCC_CILIARY_MEMBRANE,SET,72,-0.09642,-0.0060262,0.097918,0.83761,GOCC_CILIARY_MEMBRANE,1
KEGG_OLFACTORY_TRANSDUCTION,SET,320,-0.0657,-0.0085978,0.066715,0.83763,KEGG_OLFACTORY_TRANSDUCTION,1
HP_PERIORBITAL_FULLNESS,SET,34,-0.12867,-0.0055319,0.13065,0.83765,HP_PERIORBITAL_FULLNESS,1
HP_THIN_EYEBROW,SET,22,-0.18525,-0.0064087,0.18809,0.83765,HP_THIN_EYEBROW,1
GSE37605_C57BL6_VS_NOD_FOXP3...7,SET,177,-0.063585,-0.006213,0.064549,0.8377,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN,1
HP_SCOTOMA,SET,69,-0.10185,-0.0062322,0.10335,0.8378,HP_SCOTOMA,1
GOBP_COMMISSURAL_NEURON_AXON...,SET,13,-0.25522,-0.0067888,0.2589,0.83787,GOBP_COMMISSURAL_NEURON_AXON_GUIDANCE,1
GOBP_MUSCLE_ADAPTATION,SET,98,-0.091502,-0.0066672,0.0928,0.83793,GOBP_MUSCLE_ADAPTATION,1
MEBARKI_HCC_PROGENITOR_WNT_U...1,SET,107,-0.087919,-0.0066922,0.089154,0.83796,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1
WP_UREA_CYCLE_AND_METABOLISM...,SET,18,-0.19047,-0.005961,0.19315,0.83796,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,1
NAKAMURA_ADIPOGENESIS_EARLY_...2,SET,57,-0.12157,-0.006763,0.12327,0.83798,NAKAMURA_ADIPOGENESIS_EARLY_UP,1
GOBP_HEART_PROCESS,SET,240,-0.058877,-0.0066875,0.059698,0.83799,GOBP_HEART_PROCESS,1
HP_OCULOGYRIC_CRISIS,SET,12,-0.25552,-0.0065302,0.25903,0.83803,HP_OCULOGYRIC_CRISIS,1
GOBP_PEPTIDYL_LYSINE_OXIDATI...,SET,5,-0.41747,-0.0068884,0.42313,0.83808,GOBP_PEPTIDYL_LYSINE_OXIDATION,1
GOMF_PROTEIN_LYSINE_6_OXIDAS...,SET,5,-0.41747,-0.0068884,0.42313,0.83808,GOMF_PROTEIN_LYSINE_6_OXIDASE_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C1_CLU...,SET,64,-0.11701,-0.0068964,0.11854,0.8382,HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL,1
SENESE_HDAC1_AND_HDAC2_TARGE...2,SET,212,-0.060354,-0.0064479,0.06114,0.83821,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1
MIR499A_3P,SET,152,-0.073914,-0.0066974,0.074875,0.83821,MIR499A_3P,1
GSE25088_CTRL_VS_ROSIGLITAZO...4,SET,159,-0.066678,-0.0061781,0.067542,0.83822,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,1
GOBP_ATP_METABOLIC_PROCESS,SET,176,-0.060175,-0.0058633,0.06095,0.83824,GOBP_ATP_METABOLIC_PROCESS,1
GOBP_REACTIVE_OXYGEN_SPECIES...2,SET,201,-0.062155,-0.0064677,0.062952,0.83825,GOBP_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
REACTOME_CA2_PATHWAY,SET,62,-0.10895,-0.0063204,0.11033,0.83829,REACTOME_CA2_PATHWAY,1
SOUCEK_MYC_TARGETS,SET,10,-0.28935,-0.006751,0.29301,0.8383,SOUCEK_MYC_TARGETS,1
HP_VISUAL_HALLUCINATION,SET,21,-0.1814,-0.0061314,0.18362,0.8384,HP_VISUAL_HALLUCINATION,1
GOBP_VERY_LONG_CHAIN_FATTY_A...2,SET,6,-0.29667,-0.0053622,0.30024,0.83844,GOBP_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_TSC1_...,SET,11,-0.24831,-0.0060762,0.2513,0.83845,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY,1
MIR6724_5P,SET,18,-0.18309,-0.00573,0.18523,0.83852,MIR6724_5P,1
HP_NEONATAL_SHORT_LIMB_SHORT...,SET,13,-0.24732,-0.0065788,0.25022,0.83852,HP_NEONATAL_SHORT_LIMB_SHORT_STATURE,1
GOBP_SUBSTRATE_INDEPENDENT_T...,SET,9,-0.32832,-0.0072673,0.3321,0.83857,GOBP_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION,1
GOCC_SPECIFIC_GRANULE,SET,148,-0.070225,-0.0062795,0.071026,0.83859,GOCC_SPECIFIC_GRANULE,1
HP_PULMONARY_ARTERY_STENOSIS,SET,66,-0.10461,-0.0062606,0.1058,0.83859,HP_PULMONARY_ARTERY_STENOSIS,1
WP_NRP1TRIGGERED_SIGNALING_I...,SET,51,-0.12877,-0.0067771,0.13021,0.83865,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,1
GSE8685_IL2_STARVED_VS_IL15_...1,SET,178,-0.062122,-0.006087,0.062806,0.83869,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,1
GOBP_CARDIAC_MUSCLE_TISSUE_R...,SET,6,-0.31487,-0.0056912,0.31831,0.83871,GOBP_CARDIAC_MUSCLE_TISSUE_REGENERATION,1
GOBP_LUNG_MORPHOGENESIS,SET,54,-0.12244,-0.0066307,0.12376,0.83874,GOBP_LUNG_MORPHOGENESIS,1
GOMF_PHOSPHATIDYLINOSITOL_PH...1,SET,6,-0.31382,-0.0056722,0.31721,0.83874,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_4_PHOSPHATASE_ACTIVITY,1
HP_CHOLESTATIC_LIVER_DISEASE,SET,16,-0.21108,-0.0062285,0.21335,0.83876,HP_CHOLESTATIC_LIVER_DISEASE,1
chr18q11,SET,27,-0.35534,-0.013617,0.35909,0.8388,chr18q11,1
MIR5591_3P,SET,41,-0.13185,-0.0062237,0.13324,0.8388,MIR5591_3P,1
KEGG_MEDICUS_VARIANT_MUTATIO...24,SET,35,-0.12113,-0.0052836,0.12239,0.83883,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
LI_AMPLIFIED_IN_LUNG_CANCER,SET,165,-0.067493,-0.0063695,0.068191,0.83885,LI_AMPLIFIED_IN_LUNG_CANCER,1
REACTOME_TGFBR3_REGULATES_TG...,SET,8,-0.31606,-0.006596,0.31933,0.83885,REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING,1
GOBP_REGULATION_OF_MAINTENAN...,SET,4,-0.57165,-0.0084367,0.57756,0.83885,GOBP_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
DESCARTES_FETAL_PLACENTA_PAE...,SET,132,-0.076866,-0.0064941,0.077654,0.83887,DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS,1
MORF_DAP3,SET,175,-0.058539,-0.0056878,0.059138,0.83888,MORF_DAP3,1
GSE41867_NAIVE_VS_DAY15_LCMV...4,SET,145,-0.071911,-0.0063653,0.072638,0.8389,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP,1
LIN_MELANOMA_COPY_NUMBER_UP,SET,65,-0.1125,-0.0066818,0.11363,0.83891,LIN_MELANOMA_COPY_NUMBER_UP,1
GSE37301_HEMATOPOIETIC_STEM_...4,SET,174,-0.064587,-0.0062577,0.065234,0.83893,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP,1
PID_WNT_NONCANONICAL_PATHWAY,SET,31,-0.15328,-0.0062932,0.15479,0.83897,PID_WNT_NONCANONICAL_PATHWAY,1
YAMAZAKI_TCEB3_TARGETS_DN,SET,179,-0.064378,-0.0063256,0.064988,0.83905,YAMAZAKI_TCEB3_TARGETS_DN,1
GOBP_BONE_GROWTH,SET,31,-0.15732,-0.0064587,0.1588,0.83907,GOBP_BONE_GROWTH,1
GOCC_GOLGI_TRANSPORT_COMPLEX,SET,10,-0.25882,-0.0060387,0.26124,0.83909,GOCC_GOLGI_TRANSPORT_COMPLEX,1
WP_ACUTE_MYELOID_LEUKEMIA,SET,65,-0.1057,-0.0062783,0.10668,0.83912,WP_ACUTE_MYELOID_LEUKEMIA,1
TOX4_TARGET_GENES,SET,163,-0.06414,-0.0060166,0.064731,0.83912,TOX4_TARGET_GENES,1
MIR196A_3P,SET,115,-0.078762,-0.0062139,0.079477,0.83915,MIR196A_3P,1
REACTOME_CLASS_I_PEROXISOMAL...,SET,18,-0.18505,-0.0057914,0.18671,0.83917,REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...6,SET,27,-0.15849,-0.0060732,0.15988,0.83922,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,1
CAR_WBSCR22,SET,32,-0.13669,-0.0057016,0.13789,0.83922,CAR_WBSCR22,1
CRX_DN.V1_UP,SET,120,-0.077686,-0.00626,0.078367,0.83923,CRX_DN.V1_UP,1
GOBP_RNA_5_END_PROCESSING,SET,32,-0.12816,-0.0053459,0.12928,0.83924,GOBP_RNA_5_END_PROCESSING,1
MORF_ANP32B,SET,178,-0.059118,-0.0057926,0.059623,0.83928,MORF_ANP32B,1
GOBP_ACTIN_NUCLEATION,SET,45,-0.11823,-0.005846,0.11923,0.83929,GOBP_ACTIN_NUCLEATION,1
FULLER_PBMC_F_TULARENSIS_VAC...1,SET,19,-0.22301,-0.0071703,0.22489,0.83931,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_DN,1
REACTOME_VOLTAGE_GATED_POTAS...,SET,42,-0.1501,-0.0071707,0.15133,0.83936,REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,1
GSE9037_WT_VS_IRAK4_KO_BMDM_...1,SET,179,-0.062673,-0.006158,0.063188,0.83936,GSE9037_WT_VS_IRAK4_KO_BMDM_DN,1
WANG_THOC1_TARGETS_UP,SET,5,-0.41198,-0.0067978,0.41524,0.83944,WANG_THOC1_TARGETS_UP,1
GSE22935_WT_VS_MYD88_KO_MACR...1,SET,186,-0.062982,-0.006307,0.063469,0.83947,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN,1
GSE37533_UNTREATED_VS_PIOGLI...6,SET,129,-0.075095,-0.0062725,0.075678,0.83947,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP,1
STARK_HYPPOCAMPUS_22Q11_DELE...2,SET,46,-0.12835,-0.0064164,0.12932,0.83952,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,1
HP_HIGH_SERUM_CALCITRIOL,SET,5,-0.45141,-0.0074484,0.45475,0.83956,HP_HIGH_SERUM_CALCITRIOL,1
GSE21360_PRIMARY_VS_TERTIARY...2,SET,185,-0.059823,-0.0059748,0.06026,0.83958,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
REACTOME_DRUG_ADME,SET,101,-0.096531,-0.0071399,0.097224,0.83961,REACTOME_DRUG_ADME,1
PASTURAL_RIZ1_TARGETS_UP,SET,8,-0.26315,-0.0054918,0.26501,0.83964,PASTURAL_RIZ1_TARGETS_UP,1
DESCARTES_FETAL_SPLEEN_LYMPH...,SET,93,-0.093511,-0.0066384,0.094168,0.83964,DESCARTES_FETAL_SPLEEN_LYMPHOID_CELLS,1
HE_LIM_SUN_FETAL_LUNG_C3_ART...,SET,259,-0.056468,-0.0066594,0.056862,0.83966,HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL,1
BAFNA_MUC4_TARGETS_UP,SET,3,-0.50783,-0.006491,0.51134,0.83967,BAFNA_MUC4_TARGETS_UP,1
GOCC_MULTIMERIC_RIBONUCLEASE...,SET,9,-0.27095,-0.0059975,0.27281,0.83968,GOCC_MULTIMERIC_RIBONUCLEASE_P_COMPLEX,1
GOMF_RIBONUCLEASE_P_ACTIVITY,SET,9,-0.27095,-0.0059975,0.27281,0.83968,GOMF_RIBONUCLEASE_P_ACTIVITY,1
GOMF_RIBONUCLEASE_P_RNA_BIND...,SET,9,-0.27095,-0.0059975,0.27281,0.83968,GOMF_RIBONUCLEASE_P_RNA_BINDING,1
KEGG_BASE_EXCISION_REPAIR,SET,32,-0.13723,-0.0057241,0.13809,0.83983,KEGG_BASE_EXCISION_REPAIR,1
HP_ABNORMAL_B_CELL_SUBSET_DI...,SET,26,-0.17646,-0.0066359,0.17755,0.83986,HP_ABNORMAL_B_CELL_SUBSET_DISTRIBUTION,1
GOMF_MISMATCH_REPAIR_COMPLEX...,SET,11,-0.2387,-0.0058409,0.24015,0.83987,GOMF_MISMATCH_REPAIR_COMPLEX_BINDING,1
HP_ELEVATED_URINARY_NOREPINE...,SET,18,-0.18414,-0.0057629,0.18525,0.83989,HP_ELEVATED_URINARY_NOREPINEPHRINE_LEVEL,1
GOBP_CRANIAL_SUTURE_MORPHOGE...,SET,9,-0.32088,-0.0071027,0.3228,0.8399,GOBP_CRANIAL_SUTURE_MORPHOGENESIS,1
GOMF_TOLL_LIKE_RECEPTOR_4_BI...,SET,5,-0.36313,-0.0059918,0.36527,0.83992,GOMF_TOLL_LIKE_RECEPTOR_4_BINDING,1
GSE32901_TH1_VS_TH17_NEG_CD4...2,SET,114,-0.079774,-0.0062665,0.08024,0.83993,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP,1
GSE7460_CTRL_VS_TGFB_TREATED...5,SET,186,-0.064586,-0.0064677,0.064955,0.83996,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN,1
MIR3119,SET,341,-0.046787,-0.0063167,0.047051,0.83997,MIR3119,1
HP_ABNORMAL_ENCHONDRAL_OSSIF...,SET,126,-0.07579,-0.006257,0.076216,0.83998,HP_ABNORMAL_ENCHONDRAL_OSSIFICATION,1
GUO_HEX_TARGETS_UP,SET,72,-0.10042,-0.0062765,0.10093,0.84012,GUO_HEX_TARGETS_UP,1
HP_CYSTINURIA,SET,6,-0.4463,-0.0080667,0.44856,0.84012,HP_CYSTINURIA,1
GOBP_AMINO_ACID_CATABOLIC_PR...,SET,94,-0.087644,-0.0062551,0.088079,0.84014,GOBP_AMINO_ACID_CATABOLIC_PROCESS,1
GSE360_CTRL_VS_M_TUBERCULOSI...3,SET,177,-0.06231,-0.0060884,0.06262,0.84014,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN,1
REACTOME_SIGNALING_BY_THE_B_...,SET,103,-0.077048,-0.0057547,0.077423,0.84016,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1
HP_CHRONIC_HEPATITIS,SET,9,-0.29496,-0.006529,0.29626,0.84028,HP_CHRONIC_HEPATITIS,1
REACTOME_KETONE_BODY_METABOL...,SET,10,-0.28804,-0.0067205,0.28929,0.8403,REACTOME_KETONE_BODY_METABOLISM,1
HP_CHOLESTEATOMA,SET,10,-0.27372,-0.0063864,0.27483,0.84036,HP_CHOLESTEATOMA,1
GSE17580_TREG_VS_TEFF_S_MANS...1,SET,176,-0.065375,-0.00637,0.065639,0.84036,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN,1
REACTOME_RSK_ACTIVATION,SET,5,-0.41826,-0.0069013,0.41988,0.8404,REACTOME_RSK_ACTIVATION,1
MIR4721,SET,63,-0.1019,-0.005959,0.1023,0.8404,MIR4721,1
GSE17721_PAM3CSK4_VS_GADIQUI...18,SET,169,-0.062396,-0.0059588,0.062633,0.84042,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP,1
GOBP_AMINO_ACID_ACTIVATION,SET,26,-0.15002,-0.0056413,0.15056,0.84046,GOBP_AMINO_ACID_ACTIVATION,1
GOBP_LIPID_TRANSPORT_ACROSS_...,SET,5,-0.3638,-0.0060028,0.36511,0.84046,GOBP_LIPID_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,1
DORN_ADENOVIRUS_INFECTION_12...1,SET,30,-0.15172,-0.0061277,0.15226,0.84047,DORN_ADENOVIRUS_INFECTION_12HR_DN,1
GOBP_SPHINGOSINE_1_PHOSPHATE...,SET,15,-0.23375,-0.0066786,0.23454,0.84052,GOBP_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_SIGNALING_PATHWAY,1
WP_PROSTAGLANDIN_AND_LEUKOTR...2,SET,32,-0.15417,-0.0064308,0.15467,0.84055,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,1
GOBP_NEGATIVE_REGULATION_OF_...288,SET,117,-0.084738,-0.0067429,0.084996,0.8406,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
MIR552_5P,SET,175,-0.065215,-0.0063365,0.065404,0.84064,MIR552_5P,1
DESCARTES_MAIN_FETAL_PARIETA...,SET,93,-0.085157,-0.0060454,0.08539,0.84068,DESCARTES_MAIN_FETAL_PARIETAL_AND_CHIEF_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...461,SET,6,-0.30142,-0.0054481,0.30223,0.84069,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_NUCLEATION,1
KEGG_MEDICUS_REFERENCE_REGUL...3,SET,4,-0.46688,-0.0068905,0.4681,0.84071,KEGG_MEDICUS_REFERENCE_REGULATION_OF_EXTRINSIC_APOPTOTIC_PATHWAY_XIAP,1
HP_CENTRAL_HYPOVENTILATION,SET,11,-0.29218,-0.0071495,0.29293,0.84071,HP_CENTRAL_HYPOVENTILATION,1
PID_CMYB_PATHWAY,SET,78,-0.099829,-0.0064929,0.10004,0.84083,PID_CMYB_PATHWAY,1
GOBP_REGULATION_OF_MODIFICAT...1,SET,4,-0.46037,-0.0067945,0.46134,0.84083,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
GOBP_POSITIVE_REGULATION_OF_...466,SET,9,-0.29013,-0.006422,0.29064,0.84091,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION,1
GSE36476_CTRL_VS_TSST_ACT_72...4,SET,175,-0.065833,-0.0063966,0.065948,0.84092,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP,1
DORN_ADENOVIRUS_INFECTION_32...1,SET,36,-0.13459,-0.0059539,0.13482,0.84093,DORN_ADENOVIRUS_INFECTION_32HR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...218,SET,8,-0.29495,-0.0061554,0.29531,0.84104,GOBP_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,1
GOMF_STEROL_BINDING,SET,65,-0.10906,-0.0064778,0.10918,0.84108,GOMF_STEROL_BINDING,1
GOBP_CEREBRAL_CORTEX_NEURON_...,SET,22,-0.20705,-0.007163,0.20727,0.84109,GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION,1
GOBP_NOREPINEPHRINE_SECRETION,SET,14,-0.25281,-0.0069784,0.25307,0.84109,GOBP_NOREPINEPHRINE_SECRETION,1
BIOCARTA_RELA_PATHWAY,SET,14,-0.23057,-0.0063645,0.23078,0.84111,BIOCARTA_RELA_PATHWAY,1
WP_OXIDATIVE_STRESS_RESPONSE,SET,29,-0.16734,-0.0066452,0.1675,0.84111,WP_OXIDATIVE_STRESS_RESPONSE,1
GSE17721_POLYIC_VS_GARDIQUIM...7,SET,181,-0.063769,-0.0063003,0.063821,0.84114,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN,1
MORF_BECN1,SET,96,-0.079971,-0.0057676,0.080033,0.84115,MORF_BECN1,1
HP_LONG_THUMB,SET,7,-0.3321,-0.0064833,0.33228,0.8412,HP_LONG_THUMB,1
GSE11386_NAIVE_VS_MEMORY_BCE...1,SET,144,-0.072349,-0.0063821,0.072391,0.8412,GSE11386_NAIVE_VS_MEMORY_BCELL_DN,1
GSE14769_UNSTIM_VS_240MIN_LP...2,SET,181,-0.06026,-0.0059536,0.060293,0.8412,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP,1
HP_ANOSMIA,SET,47,-0.13695,-0.0069203,0.13699,0.84127,HP_ANOSMIA,1
GOMF_TRANSLATION_REGULATOR_A...1,SET,115,-0.073856,-0.0058268,0.07385,0.84136,GOMF_TRANSLATION_REGULATOR_ACTIVITY,1
GSE5142_HTERT_TRANSDUCED_VS_...1,SET,178,-0.063981,-0.0062691,0.063942,0.84148,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN,1
GSE21670_IL6_VS_TGFB_AND_IL6...1,SET,188,-0.062285,-0.0062703,0.062238,0.84152,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,1
HP_OLIGOSACCHARIDURIA,SET,9,-0.27165,-0.006013,0.27138,0.84158,HP_OLIGOSACCHARIDURIA,1
REACTOME_PREVENTION_OF_PHAGO...,SET,8,-0.29044,-0.0060613,0.29014,0.84159,REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION,1
HP_SICK_SINUS_SYNDROME,SET,27,-0.17522,-0.0067143,0.17498,0.84167,HP_SICK_SINUS_SYNDROME,1
BLALOCK_ALZHEIMERS_DISEASE_I...1,SET,149,-0.06822,-0.0061207,0.068119,0.8417,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,1
GOBP_CHAPERONE_MEDIATED_PROT...2,SET,72,-0.093564,-0.0058477,0.093425,0.8417,GOBP_CHAPERONE_MEDIATED_PROTEIN_FOLDING,1
GOCC_VACUOLE,SET,773,-0.031153,-0.0062562,0.031096,0.84178,GOCC_VACUOLE,1
GOBP_REGULATION_OF_TELOMERE_...3,SET,19,-0.1897,-0.0060993,0.18931,0.84183,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,1
GOBP_TRACHEA_DEVELOPMENT,SET,18,-0.22506,-0.0070435,0.22453,0.84191,GOBP_TRACHEA_DEVELOPMENT,1
PID_IGF1_PATHWAY,SET,28,-0.16881,-0.0065872,0.16839,0.84193,PID_IGF1_PATHWAY,1
GSE17721_CTRL_VS_PAM3CSK4_8H...1,SET,180,-0.061538,-0.0060632,0.061373,0.84199,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN,1
MORF_RAD21,SET,158,-0.060414,-0.0055802,0.060242,0.84203,MORF_RAD21,1
NCOA6_TARGET_GENES,SET,275,-0.053965,-0.0065549,0.053792,0.84212,NCOA6_TARGET_GENES,1
GOBP_LEUKOCYTE_MIGRATION,SET,369,-0.048329,-0.0067822,0.048166,0.84215,GOBP_LEUKOCYTE_MIGRATION,1
GOBP_RESPONSE_TO_CADMIUM_ION,SET,55,-0.12582,-0.0068761,0.12539,0.84217,GOBP_RESPONSE_TO_CADMIUM_ION,1
GOBP_POSITIVE_REGULATION_OF_...256,SET,176,-0.067709,-0.0065974,0.067475,0.84218,GOBP_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,1
GSE7460_CTRL_VS_TGFB_TREATED...7,SET,183,-0.063551,-0.006313,0.063326,0.8422,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN,1
GOBP_REGULATION_OF_LYMPHOCYT...5,SET,170,-0.071403,-0.0068389,0.07114,0.84223,GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,1
chr8q13,SET,31,-0.34097,-0.013999,0.3397,0.84224,chr8q13,1
KEGG_MEDICUS_PATHOGEN_EBV_LM...1,SET,10,-0.26692,-0.0062276,0.26591,0.84225,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY,1
HP_ABNORMAL_RIGHT_VENTRICULA...,SET,19,-0.21304,-0.0068498,0.21208,0.84243,HP_ABNORMAL_RIGHT_VENTRICULAR_FUNCTION,1
GSE20500_CTRL_VS_RETINOIC_AC...2,SET,174,-0.062514,-0.0060569,0.062232,0.84243,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP,1
MIR6814_3P_MIR6872_5P,SET,7,-0.33182,-0.0064779,0.33024,0.84249,MIR6814_3P_MIR6872_5P,1
GOBP_MRNA_EXPORT_FROM_NUCLEUS,SET,60,-0.1002,-0.0057187,0.099721,0.8425,GOBP_MRNA_EXPORT_FROM_NUCLEUS,1
GOBP_POSITIVE_REGULATION_OF_...810,SET,8,-0.31664,-0.0066081,0.3151,0.84251,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,1
IRITANI_MAD1_TARGETS_DN,SET,41,-0.12782,-0.0060335,0.12718,0.84255,IRITANI_MAD1_TARGETS_DN,1
GOMF_CALCIUM_DEPENDENT_PROTE...4,SET,5,-0.37509,-0.006189,0.37316,0.84259,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_REGULATOR_ACTIVITY,1
HP_PLATYSPONDYLY,SET,108,-0.083168,-0.0063599,0.08274,0.84259,HP_PLATYSPONDYLY,1
GOBP_CHORIO_ALLANTOIC_FUSION,SET,6,-0.39597,-0.007157,0.39381,0.84266,GOBP_CHORIO_ALLANTOIC_FUSION,1
REACTOME_RUNX1_REGULATES_TRA...6,SET,5,-0.36708,-0.0060569,0.36506,0.84267,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING,1
GSE16522_MEMORY_VS_NAIVE_ANT...2,SET,172,-0.066882,-0.0064431,0.066508,0.84269,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP,1
GOMF_CYCLIC_NUCLEOTIDE_DEPEN...,SET,7,-0.2995,-0.0058468,0.29779,0.84272,GOMF_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
HP_PREMATURE_CORONARY_ARTERY...,SET,18,-0.22704,-0.0071053,0.22572,0.84275,HP_PREMATURE_CORONARY_ARTERY_ATHEROSCLEROSIS,1
HOFFMAN_CLOCK_TARGETS_UP,SET,9,-0.3431,-0.0075945,0.34109,0.84276,HOFFMAN_CLOCK_TARGETS_UP,1
GOBP_CHONDROCYTE_HYPERTROPHY,SET,6,-0.43551,-0.0078717,0.43294,0.84277,GOBP_CHONDROCYTE_HYPERTROPHY,1
REACTOME_CHONDROITIN_SULFATE...1,SET,18,-0.1926,-0.0060277,0.19143,0.84282,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,1
HP_LONG_EAR,SET,6,-0.29872,-0.0053992,0.29677,0.84292,HP_LONG_EAR,1
REACTOME_TNFR1_INDUCED_NF_KA...,SET,27,-0.16349,-0.0062649,0.16242,0.84293,REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY,1
MIR9500,SET,145,-0.070327,-0.0062252,0.069865,0.84293,MIR9500,1
ZNF777_TARGET_GENES,SET,53,-0.12212,-0.006552,0.12132,0.84294,ZNF777_TARGET_GENES,1
AIZARANI_LIVER_C4_EPCAM_POS_...,SET,178,-0.069309,-0.0067912,0.068849,0.84295,AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1,1
HP_ABNORMALITY_OF_THE_GINGIVA,SET,211,-0.061339,-0.0065378,0.060928,0.84296,HP_ABNORMALITY_OF_THE_GINGIVA,1
HP_HYPERACTIVE_PATELLAR_REFL...,SET,16,-0.20521,-0.0060552,0.20384,0.84296,HP_HYPERACTIVE_PATELLAR_REFLEX,1
GOBP_LEUKOTRIENE_D4_BIOSYNTH...,SET,5,-0.40855,-0.0067411,0.40571,0.84302,GOBP_LEUKOTRIENE_D4_BIOSYNTHETIC_PROCESS,1
GOMF_GLUTATHIONE_HYDROLASE_A...,SET,5,-0.40855,-0.0067411,0.40571,0.84302,GOMF_GLUTATHIONE_HYDROLASE_ACTIVITY,1
WP_DISRUPTION_OF_POSTSYNAPTI...,SET,29,-0.16478,-0.0065438,0.16362,0.84305,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,1
MODULE_160,SET,2,-0.59456,-0.0062051,0.59026,0.84309,MODULE_160,1
GOBP_NEGATIVE_REGULATION_OF_...457,SET,7,-0.31649,-0.0061786,0.3142,0.84309,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
RAMALHO_STEMNESS_UP,SET,180,-0.061655,-0.0060747,0.061204,0.84311,RAMALHO_STEMNESS_UP,1
LINDGREN_BLADDER_CANCER_CLUS...2,SET,104,-0.08575,-0.0064355,0.085104,0.84317,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,1
HP_LIMB_JOINT_CONTRACTURE,SET,399,-0.044429,-0.006478,0.044086,0.84321,HP_LIMB_JOINT_CONTRACTURE,1
HP_THORACIC_HYPOPLASIA,SET,130,-0.077259,-0.006478,0.076633,0.84331,HP_THORACIC_HYPOPLASIA,1
GOBP_LOW_DENSITY_LIPOPROTEIN...1,SET,27,-0.17621,-0.0067524,0.17477,0.84333,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GSE26727_WT_VS_KLF2_KO_LPS_S...1,SET,189,-0.061698,-0.0062276,0.061185,0.84336,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN,1
BIOCARTA_GRANULOCYTES_PATHWAY,SET,15,-0.23568,-0.0067337,0.23365,0.84343,BIOCARTA_GRANULOCYTES_PATHWAY,1
GSE19198_CTRL_VS_IL21_TREATE...1,SET,182,-0.065818,-0.0065205,0.065252,0.84343,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN,1
GOBP_CHONDROCYTE_DIFFERENTIA...2,SET,14,-0.23934,-0.0066067,0.23727,0.84344,GOBP_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
HP_DEATH_IN_ADOLESCENCE,SET,21,-0.1905,-0.0064391,0.18881,0.8435,HP_DEATH_IN_ADOLESCENCE,1
GOBP_REGULATION_OF_RUFFLE_AS...,SET,29,-0.17289,-0.0068659,0.17133,0.84353,GOBP_REGULATION_OF_RUFFLE_ASSEMBLY,1
GOBP_REGULATION_OF_PROTEIN_L...15,SET,16,-0.21824,-0.0064399,0.21626,0.84355,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
GSE3982_DC_VS_BASOPHIL_DN,SET,172,-0.065252,-0.006286,0.064652,0.84357,GSE3982_DC_VS_BASOPHIL_DN,1
HP_LEFT_VENTRICULAR_SYSTOLIC...,SET,81,-0.097014,-0.0064295,0.096103,0.84362,HP_LEFT_VENTRICULAR_SYSTOLIC_DYSFUNCTION,1
GSE17721_0.5H_VS_24H_GARDIQU...1,SET,184,-0.059682,-0.0059447,0.059117,0.84364,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN,1
GOCC_HIPPOCAMPAL_MOSSY_FIBER,SET,6,-0.31984,-0.0057809,0.31678,0.84366,GOCC_HIPPOCAMPAL_MOSSY_FIBER,1
MIR3189_5P,SET,47,-0.11653,-0.0058883,0.11539,0.84371,MIR3189_5P,1
chr3q23,SET,27,-0.30254,-0.011594,0.29953,0.84376,chr3q23,1
GOCC_GEMINI_OF_COILED_BODIES,SET,8,-0.24672,-0.0051489,0.24423,0.84379,GOCC_GEMINI_OF_COILED_BODIES,1
STOSSI_RESPONSE_TO_ESTRADIOL,SET,37,-0.15418,-0.0069146,0.15262,0.8438,STOSSI_RESPONSE_TO_ESTRADIOL,1
chr10p14,SET,15,-0.3447,-0.0098485,0.34119,0.84381,chr10p14,1
GOBP_REGULATION_OF_POST_TRAN...,SET,210,-0.058123,-0.0061805,0.057531,0.84382,GOBP_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
GOBP_REGULATION_OF_VASCULAR_...1,SET,2,-0.65014,-0.0067852,0.64333,0.84388,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEDIFFERENTIATION,1
HP_EPISODIC_PAIN,SET,38,-0.13834,-0.0062869,0.13687,0.84392,HP_EPISODIC_PAIN,1
GSE339_EX_VIVO_VS_IN_CULTURE...3,SET,180,-0.064852,-0.0063897,0.064151,0.84397,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN,1
DESCARTES_FETAL_LIVER_MYELOI...,SET,170,-0.072818,-0.0069744,0.072017,0.84401,DESCARTES_FETAL_LIVER_MYELOID_CELLS,1
GOBP_REGULATION_OF_DNA_LIGAT...,SET,6,-0.28608,-0.0051707,0.28291,0.84403,GOBP_REGULATION_OF_DNA_LIGATION,1
GOMF_CXCR3_CHEMOKINE_RECEPTO...,SET,5,-0.47781,-0.0078839,0.47248,0.84405,GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING,1
HAY_BONE_MARROW_CD34_POS_MKP,SET,54,-0.12988,-0.0070333,0.12843,0.84406,HAY_BONE_MARROW_CD34_POS_MKP,1
AIZARANI_LIVER_C24_EPCAM_POS...,SET,174,-0.071739,-0.0069506,0.070919,0.84412,AIZARANI_LIVER_C24_EPCAM_POS_BILE_DUCT_CELLS_3,1
HP_SLANTING_OF_THE_PALPEBRAL...,SET,622,-0.034507,-0.0062428,0.034111,0.84413,HP_SLANTING_OF_THE_PALPEBRAL_FISSURE,1
GSE22886_IGM_MEMORY_BCELL_VS...2,SET,175,-0.065645,-0.0063783,0.064882,0.84417,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
GOBP_REGULATION_OF_HEPATIC_S...,SET,7,-0.37847,-0.0073886,0.37405,0.84418,GOBP_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,1
GSE17721_LPS_VS_GARDIQUIMOD_...11,SET,190,-0.061082,-0.0061816,0.060367,0.84419,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN,1
HP_ABNORMAL_GASTRIC_MUCOSA_M...,SET,39,-0.14544,-0.0066961,0.14373,0.8442,HP_ABNORMAL_GASTRIC_MUCOSA_MORPHOLOGY,1
GOBP_OPTIC_NERVE_DEVELOPMENT,SET,20,-0.19987,-0.0065932,0.19751,0.84422,GOBP_OPTIC_NERVE_DEVELOPMENT,1
HP_GOITER,SET,54,-0.12005,-0.0065013,0.11862,0.84425,HP_GOITER,1
ZNF785_TARGET_GENES,SET,55,-0.11565,-0.0063205,0.11426,0.84428,ZNF785_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...572,SET,8,-0.30762,-0.0064198,0.30386,0.84431,GOBP_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
HP_FEEDING_DIFFICULTIES_IN_I...,SET,509,-0.038497,-0.0063204,0.038025,0.84432,HP_FEEDING_DIFFICULTIES_IN_INFANCY,1
HP_SHORT_TERM_MEMORY_IMPAIRM...,SET,6,-0.41526,-0.0075056,0.41017,0.84432,HP_SHORT_TERM_MEMORY_IMPAIRMENT,1
WP_SEROTONIN_RECEPTOR_467_AN...,SET,18,-0.22626,-0.007081,0.22345,0.84436,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,1
PID_A6B1_A6B4_INTEGRIN_PATHW...,SET,46,-0.13141,-0.0065692,0.12976,0.84438,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1
NIKOLSKY_BREAST_CANCER_5P15_...,SET,25,-0.32439,-0.011962,0.32028,0.84443,NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,1
GOBP_REGULATION_OF_REACTIVE_...1,SET,35,-0.14509,-0.0063289,0.14324,0.84445,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
PANGAS_TUMOR_SUPPRESSION_BY_...2,SET,118,-0.083086,-0.0066395,0.082016,0.84447,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1
REACTOME_RHOU_GTPASE_CYCLE,SET,37,-0.13514,-0.0060605,0.1334,0.84447,REACTOME_RHOU_GTPASE_CYCLE,1
GOBP_ARP2_3_COMPLEX_MEDIATED...,SET,33,-0.13956,-0.0059113,0.13773,0.84453,GOBP_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
HP_ABNORMAL_FETAL_SKIN_MORPH...,SET,14,-0.22117,-0.0061049,0.21827,0.84453,HP_ABNORMAL_FETAL_SKIN_MORPHOLOGY,1
IIZUKA_LIVER_CANCER_PROGRESS...7,SET,8,-0.29525,-0.0061616,0.29125,0.84463,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN,1
HE_LIM_SUN_FETAL_LUNG_C5_CD5...2,SET,142,-0.076112,-0.0066677,0.075076,0.84465,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_NEG_MATURE_B_CELL,1
HP_IMPAIRED_NEUTROPHIL_CHEMO...,SET,7,-0.33887,-0.0066155,0.33418,0.84471,HP_IMPAIRED_NEUTROPHIL_CHEMOTAXIS,1
REACTOME_EPHB_MEDIATED_FORWA...,SET,41,-0.13596,-0.0064176,0.13407,0.84472,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...359,SET,6,-0.34751,-0.006281,0.34258,0.84479,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,1
REACTOME_POLYMERASE_SWITCHIN...,SET,24,-0.16254,-0.0058728,0.1602,0.84485,REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,1
HP_CHRONIC_LYMPHOCYTIC_MENIN...,SET,5,-0.42082,-0.0069437,0.41476,0.84485,HP_CHRONIC_LYMPHOCYTIC_MENINGITIS,1
REACTOME_SODIUM_COUPLED_SULP...,SET,5,-0.42882,-0.0070757,0.42255,0.8449,REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS,1
BURTON_ADIPOGENESIS_12,SET,28,-0.16426,-0.0064097,0.16182,0.84496,BURTON_ADIPOGENESIS_12,1
MORF_FBL,SET,125,-0.072209,-0.0059378,0.071124,0.845,MORF_FBL,1
MIR4296,SET,65,-0.1117,-0.0066347,0.11002,0.84501,MIR4296,1
REACTOME_PI5P_REGULATES_TP53...,SET,8,-0.32076,-0.006694,0.31585,0.84506,REACTOME_PI5P_REGULATES_TP53_ACETYLATION,1
GOMF_TYPE_1_FIBROBLAST_GROWT...,SET,5,-0.43064,-0.0071057,0.42402,0.84509,GOMF_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
GSE4142_PLASMA_CELL_VS_MEMOR...2,SET,175,-0.068295,-0.0066358,0.067245,0.84509,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP,1
CART1_01,SET,201,-0.065758,-0.0068426,0.06474,0.84511,CART1_01,1
KEGG_BUTANOATE_METABOLISM,SET,31,-0.15651,-0.0064257,0.15407,0.84513,KEGG_BUTANOATE_METABOLISM,1
GOMF_ARYL_HYDROCARBON_RECEPT...,SET,7,-0.25768,-0.0050304,0.25367,0.84513,GOMF_ARYL_HYDROCARBON_RECEPTOR_BINDING,1
GOBP_SODIUM_ION_EXPORT_ACROS...,SET,15,-0.25505,-0.0072871,0.25105,0.84516,GOBP_SODIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_OPTIC_NERVE_MORPHOGENES...,SET,6,-0.39917,-0.0072149,0.39289,0.84518,GOBP_OPTIC_NERVE_MORPHOGENESIS,1
GALLUZZI_PERMEABILIZE_MITOCH...,SET,39,-0.15146,-0.0069732,0.14905,0.84521,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1
GSE20198_UNTREATED_VS_IFNA_T...1,SET,174,-0.060962,-0.0059065,0.059985,0.84524,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,1
NIKOLSKY_BREAST_CANCER_6P24_...,SET,21,-0.29345,-0.0099189,0.28875,0.84525,NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,1
HP_PATELLAR_DISLOCATION,SET,56,-0.12468,-0.0068755,0.12266,0.8453,HP_PATELLAR_DISLOCATION,1
GOCC_CULLIN_RING_UBIQUITIN_L...,SET,164,-0.067331,-0.0063351,0.066231,0.84532,GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX,1
GNF2_MYD88,SET,54,-0.119,-0.0064444,0.11703,0.84538,GNF2_MYD88,1
REACTOME_FLT3_SIGNALING,SET,37,-0.13664,-0.0061276,0.13436,0.84541,REACTOME_FLT3_SIGNALING,1
HP_NEUROMUSCULAR_DYSPHAGIA,SET,11,-0.25366,-0.006207,0.24942,0.84542,HP_NEUROMUSCULAR_DYSPHAGIA,1
HP_SYSTOLIC_HEART_MURMUR,SET,13,-0.27436,-0.0072979,0.26971,0.84547,HP_SYSTOLIC_HEART_MURMUR,1
HP_PERIPHERAL_OPACIFICATION_...,SET,15,-0.22683,-0.0064809,0.22295,0.84551,HP_PERIPHERAL_OPACIFICATION_OF_THE_CORNEA,1
HP_TYPICAL_ABSENCE_SEIZURE,SET,37,-0.14557,-0.0065283,0.14305,0.84556,HP_TYPICAL_ABSENCE_SEIZURE,1
HP_ABNORMAL_COCHLEA_MORPHOLO...,SET,27,-0.16552,-0.0063427,0.16264,0.84559,HP_ABNORMAL_COCHLEA_MORPHOLOGY,1
GOBP_POLY_A_PLUS_MRNA_EXPORT...,SET,18,-0.1795,-0.0056176,0.17635,0.84562,GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS,1
KEGG_MEDICUS_PATHOGEN_ESCHER...1,SET,14,-0.22119,-0.0061055,0.21726,0.84567,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY,1
HP_DROWSINESS,SET,52,-0.1163,-0.0061806,0.11424,0.84567,HP_DROWSINESS,1
MATSUMIYA_PBMC_MODIFIED_VACC...2,SET,9,-0.28691,-0.0063507,0.28182,0.84567,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_HIGH_RESPONDERS_VS_LOW_RESPONDERS_0DY_UP,1
GSE6259_FLT3L_INDUCED_33D1_P...1,SET,176,-0.063121,-0.0061503,0.061993,0.8457,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN,1
GSE15330_LYMPHOID_MULTIPOTEN...6,SET,164,-0.069891,-0.006576,0.068626,0.84576,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,1
GOBP_PROTEIN_HOMOOLIGOMERIZA...,SET,190,-0.065005,-0.0065785,0.06382,0.84579,GOBP_PROTEIN_HOMOOLIGOMERIZATION,1
GSE16385_UNTREATED_VS_12H_IL...2,SET,179,-0.065517,-0.0064375,0.064323,0.84579,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP,1
KEGG_FC_EPSILON_RI_SIGNALING...,SET,78,-0.1037,-0.0067445,0.10178,0.84584,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1
ACTAYRNNNCCCR_UNKNOWN,SET,411,-0.042625,-0.0063057,0.041835,0.84586,ACTAYRNNNCCCR_UNKNOWN,1
GOBP_FOLIC_ACID_CONTAINING_C...2,SET,5,-0.33393,-0.00551,0.32774,0.84587,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...1,SET,6,-0.40755,-0.0073663,0.39997,0.84588,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
GOBP_ADENINE_TRANSPORT,SET,5,-0.43216,-0.0071307,0.42406,0.84591,GOBP_ADENINE_TRANSPORT,1
LIU_OVARIAN_CANCER_TUMORS_AN...1,SET,33,-0.1719,-0.0072813,0.16867,0.84593,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN,1
HP_OVERFOLDING_OF_THE_SUPERI...,SET,4,-0.45103,-0.0066566,0.44254,0.84594,HP_OVERFOLDING_OF_THE_SUPERIOR_HELICES,1
GOBP_REGULATION_OF_CHEMOTAXIS,SET,193,-0.066435,-0.0067755,0.06518,0.84595,GOBP_REGULATION_OF_CHEMOTAXIS,1
GSE46606_UNSTIM_VS_CD40L_IL2...11,SET,162,-0.068034,-0.0063624,0.066747,0.84596,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN,1
GSE3565_CTRL_VS_LPS_INJECTED...2,SET,166,-0.072143,-0.0068288,0.070777,0.84597,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP,1
GOBP_REGULATION_OF_ESTABLISH...3,SET,11,-0.21821,-0.0053396,0.21403,0.84602,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
KEGG_MEDICUS_REFERENCE_P27_C...,SET,14,-0.21188,-0.0058487,0.20778,0.84607,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S,1
SAFB2_TARGET_GENES,SET,614,-0.035972,-0.0064674,0.035275,0.84607,SAFB2_TARGET_GENES,1
GOBP_REGULATION_OF_CILIUM_MO...,SET,36,-0.14925,-0.0066024,0.14635,0.84608,GOBP_REGULATION_OF_CILIUM_MOVEMENT,1
YNGTTNNNATT_UNKNOWN,SET,339,-0.051159,-0.0068872,0.050154,0.84614,YNGTTNNNATT_UNKNOWN,1
HP_IRREGULAR_CAPITAL_FEMORAL...,SET,4,-0.41621,-0.0061427,0.40802,0.84615,HP_IRREGULAR_CAPITAL_FEMORAL_EPIPHYSIS,1
GSE24634_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.062564,-0.0061981,0.061321,0.84619,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN,1
GOBP_EXCITATORY_SYNAPSE_ASSE...,SET,34,-0.1578,-0.0067844,0.15464,0.84623,GOBP_EXCITATORY_SYNAPSE_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...451,SET,26,-0.17169,-0.0064563,0.16824,0.84625,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOBP_METANEPHRIC_NEPHRON_TUB...1,SET,6,-0.41842,-0.0075627,0.40995,0.84628,GOBP_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
HP_PSORIASIFORM_LESION,SET,3,-0.58225,-0.0074421,0.57047,0.84628,HP_PSORIASIFORM_LESION,1
GOBP_CELL_DIFFERENTIATION_IN...3,SET,21,-0.22046,-0.0074516,0.21598,0.8463,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...1,SET,10,-0.25212,-0.0058824,0.24697,0.84633,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION,1
REACTOME_FATTY_ACYL_COA_BIOS...,SET,35,-0.15886,-0.0069294,0.15562,0.84633,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,1
GOCC_U4_SNRNP,SET,10,-0.24804,-0.0057873,0.24286,0.84645,GOCC_U4_SNRNP,1
GOBP_CITRATE_METABOLIC_PROCE...,SET,5,-0.36022,-0.0059437,0.35268,0.84646,GOBP_CITRATE_METABOLIC_PROCESS,1
GOMF_NEUROPEPTIDE_Y_RECEPTOR...,SET,8,-0.38051,-0.0079412,0.37255,0.84646,GOMF_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY,1
HP_PARAPARESIS,SET,67,-0.10159,-0.0061255,0.099448,0.84649,HP_PARAPARESIS,1
GOBP_CRANIAL_NERVE_STRUCTURA...,SET,10,-0.31528,-0.0073559,0.30861,0.84651,GOBP_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION,1
GSE16385_IL4_VS_ROSIGLITAZON...1,SET,157,-0.067801,-0.0062429,0.066354,0.84656,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
GSE4590_PRE_BCELL_VS_LARGE_P...2,SET,142,-0.078032,-0.0068359,0.076366,0.84656,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP,1
HP_DILATED_CARDIOMYOPATHY,SET,139,-0.073494,-0.0063705,0.071922,0.84657,HP_DILATED_CARDIOMYOPATHY,1
HP_GENERALIZED_JOINT_HYPERMO...,SET,46,-0.13226,-0.006612,0.12939,0.84665,HP_GENERALIZED_JOINT_HYPERMOBILITY,1
GOBP_REGULATION_OF_INTRACELL...4,SET,1634,-0.022896,-0.0065194,0.022397,0.84667,GOBP_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
TSAI_DNAJB4_TARGETS_UP,SET,12,-0.25599,-0.0065423,0.25038,0.84669,TSAI_DNAJB4_TARGETS_UP,1
GOCC_CLATHRIN_ADAPTOR_COMPLEX,SET,25,-0.16892,-0.0062289,0.16519,0.84673,GOCC_CLATHRIN_ADAPTOR_COMPLEX,1
GOBP_CALCIUM_ION_TRANSPORT,SET,396,-0.046226,-0.0067152,0.045204,0.84674,GOBP_CALCIUM_ION_TRANSPORT,1
WP_OXIDATIVE_PHOSPHORYLATION,SET,35,-0.12481,-0.0054444,0.12205,0.84676,WP_OXIDATIVE_PHOSPHORYLATION,1
HP_ABNORMALITY_OF_THE_DISTAL...1,SET,22,-0.19357,-0.0066967,0.18928,0.84676,HP_ABNORMALITY_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
GSE13411_IGM_MEMORY_BCELL_VS...1,SET,173,-0.065055,-0.006285,0.063613,0.84676,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN,1
GSE42724_MEMORY_VS_B1_BCELL_...2,SET,185,-0.061495,-0.0061417,0.060132,0.84676,GSE42724_MEMORY_VS_B1_BCELL_UP,1
HP_BROAD_PHALANGES_OF_THE_HA...,SET,94,-0.090852,-0.006484,0.088826,0.84679,HP_BROAD_PHALANGES_OF_THE_HAND,1
HP_STEATORRHEA,SET,61,-0.11869,-0.00683,0.11604,0.8468,HP_STEATORRHEA,1
REACTOME_METABOLISM_OF_VITAM...,SET,183,-0.065398,-0.0064965,0.063913,0.84689,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1
GOBP_ETHANOLAMINE_CONTAINING...,SET,7,-0.28829,-0.0056281,0.28166,0.84696,GOBP_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOMF_ASPARTIC_ENDOPEPTIDASE_...,SET,8,-0.26392,-0.0055079,0.25784,0.84698,GOMF_ASPARTIC_ENDOPEPTIDASE_ACTIVITY_INTRAMEMBRANE_CLEAVING,1
MIR374B_5P,SET,343,-0.049344,-0.0066811,0.048201,0.847,MIR374B_5P,1
HP_MULTIPLE_ENCHONDROMATOSIS,SET,10,-0.28637,-0.0066815,0.27971,0.84703,HP_MULTIPLE_ENCHONDROMATOSIS,1
GSE17721_LPS_VS_POLYIC_6H_BM...1,SET,178,-0.064772,-0.0063467,0.063258,0.84706,GSE17721_LPS_VS_POLYIC_6H_BMDC_DN,1
MIR4517,SET,189,-0.065872,-0.0066488,0.064329,0.84707,MIR4517,1
GOBP_METANEPHRIC_MESENCHYME_...,SET,13,-0.27675,-0.0073615,0.27027,0.84707,GOBP_METANEPHRIC_MESENCHYME_DEVELOPMENT,1
GSE17721_POLYIC_VS_GARDIQUIM...8,SET,181,-0.063278,-0.0062518,0.061794,0.84708,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP,1
GOCC_NEURONAL_DENSE_CORE_VES...2,SET,5,-0.44741,-0.0073824,0.43683,0.84713,GOCC_NEURONAL_DENSE_CORE_VESICLE_MEMBRANE,1
HP_SLEEP_ABNORMALITY,SET,504,-0.040105,-0.0065529,0.039154,0.84715,HP_SLEEP_ABNORMALITY,1
HP_SMALL_INTESTINAL_DYSMOTIL...,SET,6,-0.3103,-0.0056085,0.3029,0.84718,HP_SMALL_INTESTINAL_DYSMOTILITY,1
GSE29618_PRE_VS_DAY7_FLU_VAC...5,SET,180,-0.06148,-0.0060575,0.060006,0.84721,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN,1
GOBP_REGULATION_OF_OSTEOCLAS...1,SET,11,-0.28012,-0.0068545,0.27333,0.84727,GOBP_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,1
MIR93_3P,SET,106,-0.083271,-0.0063089,0.081251,0.84728,MIR93_3P,1
GOCC_TRANSCRIPTION_ELONGATIO...,SET,45,-0.12236,-0.0060505,0.11939,0.8473,GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,1
REACTOME_SIGNALING_BY_MET,SET,76,-0.099102,-0.0063629,0.096684,0.84731,REACTOME_SIGNALING_BY_MET,1
HP_RADIAL_DEVIATION_OF_FINGER,SET,43,-0.13177,-0.0063694,0.12856,0.84731,HP_RADIAL_DEVIATION_OF_FINGER,1
GSE28449_WT_VS_LRF_KO_GERMIN...2,SET,174,-0.069391,-0.0067232,0.067699,0.84731,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...3,SET,220,-0.05674,-0.0061737,0.055343,0.84737,GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
HP_POLYHYDRAMNIOS,SET,263,-0.054381,-0.0064619,0.053042,0.84737,HP_POLYHYDRAMNIOS,1
HP_HYPOPLASTIC_TOENAILS,SET,75,-0.10232,-0.0065265,0.0998,0.84738,HP_HYPOPLASTIC_TOENAILS,1
GAUTAM_EYE_IRIS_CILIARY_BODY...13,SET,256,-0.05511,-0.006462,0.05375,0.84738,GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS,1
GOBP_SPHINGOLIPID_METABOLIC_...,SET,158,-0.073093,-0.0067513,0.071283,0.8474,GOBP_SPHINGOLIPID_METABOLIC_PROCESS,1
GOBP_BASEMENT_MEMBRANE_ASSEM...,SET,9,-0.31402,-0.0069509,0.30624,0.84741,GOBP_BASEMENT_MEMBRANE_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...630,SET,70,-0.10303,-0.0063494,0.10047,0.84742,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
XU_RESPONSE_TO_TRETINOIN_UP,SET,13,-0.25644,-0.0068212,0.25002,0.84747,XU_RESPONSE_TO_TRETINOIN_UP,1
GARCIA_PINERES_PBMC_HPV_16_L...8,SET,237,-0.061167,-0.0069046,0.059635,0.84747,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,1
GSE25147_UNSTIM_VS_HELIOBACT...2,SET,151,-0.069401,-0.0062679,0.067661,0.84748,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP,1
REACTOME_RAP1_SIGNALLING,SET,16,-0.221,-0.0065211,0.2154,0.84754,REACTOME_RAP1_SIGNALLING,1
GOBP_MODIFICATION_OF_SYNAPTI...,SET,26,-0.16708,-0.0062831,0.16285,0.84754,GOBP_MODIFICATION_OF_SYNAPTIC_STRUCTURE,1
JONES_OVARY_THECA,SET,42,-0.15276,-0.007298,0.14888,0.84757,JONES_OVARY_THECA,1
HP_WOOLLY_HAIR,SET,22,-0.19749,-0.0068323,0.19247,0.84758,HP_WOOLLY_HAIR,1
HP_APLASIA_OF_THE_OVARY,SET,4,-0.38618,-0.0056994,0.37632,0.84759,HP_APLASIA_OF_THE_OVARY,1
HP_ABNORMAL_ALPHA_GRANULES,SET,4,-0.35711,-0.0052705,0.34799,0.8476,HP_ABNORMAL_ALPHA_GRANULES,1
HP_EPILEPTIC_AURA,SET,20,-0.1995,-0.0065808,0.19437,0.84763,HP_EPILEPTIC_AURA,1
IL2_UP.V1_UP,SET,159,-0.071216,-0.0065986,0.069387,0.84763,IL2_UP.V1_UP,1
GSE22935_UNSTIM_VS_12H_MBOVI...2,SET,182,-0.062664,-0.0062081,0.061045,0.84767,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
GOBP_ICOSANOID_SECRETION,SET,47,-0.13935,-0.0070414,0.13574,0.84769,GOBP_ICOSANOID_SECRETION,1
AIZARANI_LIVER_C39_EPCAM_POS...,SET,177,-0.070665,-0.0069048,0.06883,0.8477,AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4,1
DESCARTES_FETAL_EYE_HORIZONT...,SET,13,-0.25348,-0.0067425,0.24688,0.84771,DESCARTES_FETAL_EYE_HORIZONTAL_CELLS,1
GOBP_MONOSACCHARIDE_CATABOLI...,SET,44,-0.1261,-0.0061659,0.12282,0.84772,GOBP_MONOSACCHARIDE_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...482,SET,132,-0.081549,-0.0068897,0.07942,0.84774,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
MOREAUX_B_LYMPHOCYTE_MATURAT...2,SET,72,-0.10847,-0.0067795,0.10563,0.84775,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,1
GOBP_TRANSLATIONAL_INITIATION,SET,106,-0.077113,-0.0058423,0.075095,0.84775,GOBP_TRANSLATIONAL_INITIATION,1
MYOD_01,SET,232,-0.058564,-0.0065415,0.057023,0.84779,MYOD_01,1
GSE22886_NAIVE_CD4_TCELL_VS_...10,SET,171,-0.065106,-0.0062539,0.063372,0.84787,GSE22886_NAIVE_CD4_TCELL_VS_DC_UP,1
HP_DIFFUSE_PALMOPLANTAR_HYPE...,SET,10,-0.31657,-0.007386,0.30812,0.84788,HP_DIFFUSE_PALMOPLANTAR_HYPERKERATOSIS,1
HP_BROAD_PHILTRUM,SET,42,-0.13296,-0.0063521,0.12941,0.84789,HP_BROAD_PHILTRUM,1
GOMF_MRNA_REGULATORY_ELEMENT...,SET,15,-0.19224,-0.0054927,0.1871,0.8479,GOMF_MRNA_REGULATORY_ELEMENT_BINDING_TRANSLATION_REPRESSOR_ACTIVITY,1
HP_MUSCLE_FIBER_CYTOPLASMATI...,SET,29,-0.16042,-0.0063704,0.15611,0.84791,HP_MUSCLE_FIBER_CYTOPLASMATIC_INCLUSION_BODIES,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,SET,290,-0.051495,-0.0064205,0.050108,0.84794,MULLIGHAN_NPM1_SIGNATURE_3_UP,1
GOBP_PURINE_NUCLEOTIDE_TRANS...,SET,38,-0.156,-0.0070897,0.15178,0.84797,GOBP_PURINE_NUCLEOTIDE_TRANSPORT,1
GOBP_NEURON_FATE_DETERMINATI...,SET,8,-0.37493,-0.0078246,0.36476,0.84799,GOBP_NEURON_FATE_DETERMINATION,1
NAKAYA_MONOCYTE_FLUMIST_AGE_...1,SET,237,-0.055968,-0.0063176,0.054446,0.84801,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN,1
KEGG_RENAL_CELL_CARCINOMA,SET,64,-0.11107,-0.006546,0.10804,0.84803,KEGG_RENAL_CELL_CARCINOMA,1
GSE27859_MACROPHAGE_VS_CD11C...3,SET,178,-0.066049,-0.0064718,0.064215,0.84815,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN,1
WP_TRANSCRIPTION_COFACTORS_S...,SET,17,-0.24787,-0.0075388,0.24097,0.84816,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,1
HP_ENDOCARDIAL_FIBROELASTOSIS,SET,7,-0.33341,-0.0065089,0.32411,0.84818,HP_ENDOCARDIAL_FIBROELASTOSIS,1
GOBP_TOXIN_METABOLIC_PROCESS,SET,15,-0.23151,-0.0066147,0.22505,0.84819,GOBP_TOXIN_METABOLIC_PROCESS,1
KRAS.PROSTATE_UP.V1_UP,SET,122,-0.08362,-0.0067937,0.08125,0.84829,KRAS.PROSTATE_UP.V1_UP,1
GSE17974_IL4_AND_ANTI_IL12_V...2,SET,149,-0.067856,-0.006088,0.065931,0.8483,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP,1
GOMF_NEUROPEPTIDE_ACTIVITY,SET,25,-0.19081,-0.0070364,0.18539,0.84831,GOMF_NEUROPEPTIDE_ACTIVITY,1
GOBP_REGULATION_OF_RESPIRATO...4,SET,11,-0.28815,-0.007051,0.27996,0.84832,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NERVOUS_SYSTEM_PROCESS,1
GSE8685_IL2_ACT_IL2_STARVED_...3,SET,127,-0.078852,-0.0065353,0.0766,0.84834,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
REACTOME_G_ALPHA_Q_SIGNALLIN...,SET,203,-0.066332,-0.0069362,0.064425,0.84839,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1
WEBER_METHYLATED_ICP_IN_SPER...2,SET,8,-0.33653,-0.0070232,0.32679,0.84844,WEBER_METHYLATED_ICP_IN_SPERM_UP,1
GNF2_RAN,SET,78,-0.088573,-0.0057608,0.085977,0.84853,GNF2_RAN,1
GOBP_VASCULAR_ENDOTHELIAL_GR...2,SET,6,-0.44182,-0.0079857,0.42887,0.84853,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_SIGNALING_PATHWAY,1
GOCC_EXTRINSIC_COMPONENT_OF_...7,SET,4,-0.3216,-0.0047464,0.31217,0.84854,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
WP_HOSTPATHOGEN_INTERACTION_...4,SET,35,-0.16688,-0.0072791,0.16194,0.8486,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,1
TTANTCA_UNKNOWN,SET,838,-0.032771,-0.0068396,0.031798,0.84863,TTANTCA_UNKNOWN,1
GNF2_NS,SET,37,-0.13322,-0.0059746,0.12925,0.84866,GNF2_NS,1
GSE17721_CTRL_VS_GARDIQUIMOD...7,SET,181,-0.060172,-0.0059449,0.058376,0.84867,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN,1
KEGG_MEDICUS_REFERENCE_EGF_E...1,SET,21,-0.18002,-0.0060847,0.17462,0.8487,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY,1
HEBERT_MATRISOME_TNBC_BONE_B...2,SET,7,-0.35983,-0.0070247,0.34891,0.84879,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED,1
GOBP_LEUKOCYTE_MEDIATED_CYTO...,SET,133,-0.084823,-0.0071933,0.082248,0.84879,GOBP_LEUKOCYTE_MEDIATED_CYTOTOXICITY,1
GOBP_MEMBRANE_TO_MEMBRANE_DO...,SET,4,-0.48531,-0.0071626,0.47048,0.84885,GOBP_MEMBRANE_TO_MEMBRANE_DOCKING,1
MIR676_5P,SET,141,-0.077416,-0.0067582,0.075008,0.84898,MIR676_5P,1
KRCTCNNNNMANAGC_UNKNOWN,SET,14,-0.24602,-0.0067909,0.23835,0.849,KRCTCNNNNMANAGC_UNKNOWN,1
HP_PES_VALGUS,SET,48,-0.13203,-0.0067418,0.12791,0.849,HP_PES_VALGUS,1
GOBP_EPITHELIAL_CELL_PROLIFE...4,SET,5,-0.44955,-0.0074176,0.43551,0.84901,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
GSE7509_DC_VS_MONOCYTE_UP,SET,181,-0.06601,-0.0065217,0.063936,0.84906,GSE7509_DC_VS_MONOCYTE_UP,1
HP_APLASIA_HYPOPLASIA_AFFECT...1,SET,814,-0.03149,-0.0064819,0.030497,0.84909,HP_APLASIA_HYPOPLASIA_AFFECTING_BONES_OF_THE_AXIAL_SKELETON,1
LU_TUMOR_ANGIOGENESIS_UP,SET,25,-0.18681,-0.0068886,0.1809,0.84911,LU_TUMOR_ANGIOGENESIS_UP,1
ELF5_TARGET_GENES,SET,379,-0.046129,-0.0065588,0.044669,0.84912,ELF5_TARGET_GENES,1
MIR4711_3P,SET,73,-0.10928,-0.0068771,0.10577,0.84924,MIR4711_3P,1
DESCARTES_FETAL_MUSCLE_SCHWA...,SET,101,-0.097505,-0.007212,0.094358,0.84927,DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS,1
HP_ABDOMINAL_DISTENTION,SET,139,-0.077249,-0.006696,0.074744,0.84931,HP_ABDOMINAL_DISTENTION,1
GSE2770_IL12_AND_TGFB_VS_IL4...6,SET,178,-0.063558,-0.0062277,0.061491,0.84933,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
HP_ABSENCE_OF_STOMACH_BUBBLE...,SET,5,-0.41533,-0.006853,0.40175,0.84937,HP_ABSENCE_OF_STOMACH_BUBBLE_ON_FETAL_SONOGRAPHY,1
GSE3720_UNSTIM_VS_LPS_STIM_V...4,SET,143,-0.074058,-0.0065104,0.071632,0.8494,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP,1
HP_CHONDROSARCOMA,SET,7,-0.40212,-0.0078503,0.38891,0.84942,HP_CHONDROSARCOMA,1
NR1I2_TARGET_GENES,SET,270,-0.05195,-0.0062533,0.050239,0.84944,NR1I2_TARGET_GENES,1
GOBP_BENZENE_CONTAINING_COMP...,SET,23,-0.19887,-0.0070345,0.19232,0.84945,GOBP_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_COMPLEMENT_ACTIVATION_A...,SET,14,-0.25861,-0.0071385,0.25002,0.8495,GOBP_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,1
HP_KYPHOSCOLIOSIS,SET,164,-0.067707,-0.0063705,0.065458,0.84951,HP_KYPHOSCOLIOSIS,1
GOBP_CELLULAR_RESPONSE_TO_IN...4,SET,8,-0.32489,-0.0067802,0.31406,0.84954,GOBP_CELLULAR_RESPONSE_TO_INSULIN_LIKE_GROWTH_FACTOR_STIMULUS,1
GATGKMRGCG_UNKNOWN,SET,60,-0.11364,-0.006486,0.10983,0.84959,GATGKMRGCG_UNKNOWN,1
HP_LOCALIZED_SKIN_LESION,SET,790,-0.032517,-0.0065985,0.031425,0.8496,HP_LOCALIZED_SKIN_LESION,1
GOBP_MODULATION_OF_EXCITATOR...,SET,46,-0.13563,-0.0067805,0.13105,0.84964,GOBP_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
GOBP_OUTER_EAR_MORPHOGENESIS,SET,8,-0.32317,-0.0067445,0.31227,0.84964,GOBP_OUTER_EAR_MORPHOGENESIS,1
AKL_HTLV1_INFECTION_UP,SET,24,-0.17165,-0.0062021,0.16586,0.84965,AKL_HTLV1_INFECTION_UP,1
MIR557,SET,204,-0.062022,-0.0065012,0.059917,0.84969,MIR557,1
GOMF_PURINE_NUCLEOTIDE_BINDI...,SET,1797,-0.021747,-0.006462,0.021006,0.84972,GOMF_PURINE_NUCLEOTIDE_BINDING,1
GOBP_TRNA_3_END_PROCESSING,SET,6,-0.2895,-0.0052325,0.2796,0.84975,GOBP_TRNA_3_END_PROCESSING,1
MODULE_372,SET,20,-0.19155,-0.0063186,0.18494,0.84984,MODULE_372,1
WAESCH_ANAPHASE_PROMOTING_CO...,SET,12,-0.24604,-0.0062882,0.23754,0.84985,WAESCH_ANAPHASE_PROMOTING_COMPLEX,1
GSE13306_TREG_VS_TCONV_DN,SET,186,-0.061806,-0.0061893,0.059668,0.84985,GSE13306_TREG_VS_TCONV_DN,1
GSE29949_CD8_NEG_DC_SPLEEN_V...1,SET,175,-0.068692,-0.0066743,0.066294,0.84993,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN,1
GOMF_G_RICH_STRAND_TELOMERIC...,SET,10,-0.26111,-0.0060922,0.25195,0.84997,GOMF_G_RICH_STRAND_TELOMERIC_DNA_BINDING,1
GOMF_POTASSIUM_CHANNEL_ACTIV...1,SET,5,-0.44565,-0.0073533,0.43002,0.84997,GOMF_POTASSIUM_CHANNEL_ACTIVATOR_ACTIVITY,1
HP_ABNORMAL_LENS_MORPHOLOGY,SET,720,-0.0335,-0.0065027,0.032326,0.84997,HP_ABNORMAL_LENS_MORPHOLOGY,1
HP_ABNORMAL_SHAPE_OF_THE_RAD...,SET,24,-0.19309,-0.0069766,0.18629,0.85001,HP_ABNORMAL_SHAPE_OF_THE_RADIUS,1
NF1_Q6,SET,240,-0.059427,-0.0067498,0.057321,0.85006,NF1_Q6,1
KEGG_GAP_JUNCTION,SET,84,-0.10345,-0.0069814,0.099783,0.85007,KEGG_GAP_JUNCTION,1
GOBP_NEGATIVE_REGULATION_OF_...365,SET,14,-0.23958,-0.0066133,0.23108,0.85008,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
GOBP_NK_T_CELL_DIFFERENTIATI...,SET,11,-0.29326,-0.0071761,0.28285,0.85008,GOBP_NK_T_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...334,SET,5,-0.42193,-0.0069619,0.4069,0.85011,GOBP_POSITIVE_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,1
HP_FRAGILE_SKIN,SET,34,-0.16076,-0.0069117,0.15504,0.85011,HP_FRAGILE_SKIN,1
GOMF_SHORT_CHAIN_FATTY_ACYL_...,SET,5,-0.35987,-0.0059379,0.34704,0.85012,GOMF_SHORT_CHAIN_FATTY_ACYL_COA_DEHYDROGENASE_ACTIVITY,1
GSE19401_UNSTIM_VS_PAM2CSK4_...1,SET,183,-0.064978,-0.0064547,0.062658,0.85013,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
GOBP_DENDRITE_EXTENSION,SET,32,-0.16258,-0.0067815,0.15677,0.85014,GOBP_DENDRITE_EXTENSION,1
GOBP_FATTY_ACID_OMEGA_OXIDAT...,SET,5,-0.49237,-0.0081241,0.47474,0.85015,GOBP_FATTY_ACID_OMEGA_OXIDATION,1
HP_SMALL_FOREHEAD,SET,11,-0.26161,-0.0064015,0.25225,0.85015,HP_SMALL_FOREHEAD,1
KEGG_MEDICUS_PATHOGEN_HIV_GP...4,SET,13,-0.23826,-0.0063378,0.22963,0.85027,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY,1
GSE3920_UNTREATED_VS_IFNA_TR...1,SET,146,-0.074575,-0.0066237,0.071867,0.85028,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN,1
PEDRIOLI_MIR31_TARGETS_UP,SET,189,-0.065749,-0.0066364,0.063359,0.85029,PEDRIOLI_MIR31_TARGETS_UP,1
RRAGTTGT_UNKNOWN,SET,228,-0.060889,-0.006743,0.058672,0.85031,RRAGTTGT_UNKNOWN,1
GSE16385_IFNG_TNF_VS_IL4_STI...2,SET,174,-0.065395,-0.006336,0.063008,0.85033,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,1
MAHADEVAN_IMATINIB_RESISTANC...1,SET,19,-0.24132,-0.0077591,0.2325,0.85035,MAHADEVAN_IMATINIB_RESISTANCE_DN,1
MIR382_3P,SET,91,-0.094439,-0.0066322,0.090983,0.85035,MIR382_3P,1
GOBP_NEGATIVE_REGULATION_OF_...347,SET,25,-0.18104,-0.0066759,0.17442,0.85035,GOBP_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
HP_ABNORMAL_MUSCLE_FIBER_ALP...,SET,9,-0.29526,-0.0065357,0.28441,0.8504,HP_ABNORMAL_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,1
GSE18893_TCONV_VS_TREG_24H_C...2,SET,189,-0.06632,-0.0066941,0.063869,0.85045,GSE18893_TCONV_VS_TREG_24H_CULTURE_UP,1
REACTOME_BIOLOGICAL_OXIDATIO...,SET,204,-0.071872,-0.0075337,0.069196,0.85051,REACTOME_BIOLOGICAL_OXIDATIONS,1
GOBP_REGULATION_OF_TRANSPORT...,SET,194,-0.06777,-0.0069294,0.065235,0.85056,GOBP_REGULATION_OF_TRANSPORTER_ACTIVITY,1
GOBP_MESENCHYMAL_STEM_CELL_P...,SET,7,-0.37006,-0.0072244,0.35616,0.8506,GOBP_MESENCHYMAL_STEM_CELL_PROLIFERATION,1
VANHARANTA_UTERINE_FIBROID_W...2,SET,57,-0.11546,-0.0064232,0.11111,0.85061,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,1
REACTOME_ADIPOGENESIS,SET,104,-0.084353,-0.0063307,0.081159,0.85067,REACTOME_ADIPOGENESIS,1
KEGG_MEDICUS_PATHOGEN_HIV_NE...,SET,12,-0.24455,-0.00625,0.23528,0.85068,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY,1
HTF_01,SET,65,-0.10429,-0.0061941,0.10033,0.8507,HTF_01,1
GOBP_VIRAL_RELEASE_FROM_HOST...,SET,28,-0.15941,-0.0062207,0.15333,0.85074,GOBP_VIRAL_RELEASE_FROM_HOST_CELL,1
GOBP_PERIPHERAL_NERVOUS_SYST...3,SET,83,-0.10129,-0.0067952,0.097424,0.85076,GOBP_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT,1
HP_IMPAIRED_OCULAR_ABDUCTION,SET,4,-0.51454,-0.0075939,0.49488,0.85076,HP_IMPAIRED_OCULAR_ABDUCTION,1
GOBP_REGULATION_OF_ENDOTHELI...2,SET,18,-0.21058,-0.0065901,0.20251,0.85078,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,1
WP_CONGENITAL_GENERALIZED_LI...,SET,16,-0.22317,-0.0065854,0.21461,0.8508,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,1
HP_CAPILLARY_MALFORMATION,SET,58,-0.12689,-0.0071203,0.122,0.85084,HP_CAPILLARY_MALFORMATION,1
REACTOME_ASSOCIATION_OF_TRIC...,SET,36,-0.13135,-0.0058107,0.12627,0.85089,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,1
GSE27786_CD4_TCELL_VS_NKTCEL...1,SET,184,-0.063966,-0.0063714,0.061483,0.85091,GSE27786_CD4_TCELL_VS_NKTCELL_DN,1
GOMF_RNA_METHYLTRANSFERASE_A...,SET,53,-0.10377,-0.0055675,0.099738,0.85093,GOMF_RNA_METHYLTRANSFERASE_ACTIVITY,1
HP_ABNORMAL_BLOOD_INORGANIC_...,SET,160,-0.073949,-0.0068731,0.071074,0.85093,HP_ABNORMAL_BLOOD_INORGANIC_CATION_CONCENTRATION,1
GSE37563_WT_VS_CTLA4_KO_CD4_...1,SET,168,-0.064713,-0.0061618,0.062193,0.85094,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN,1
GOBP_XENOBIOTIC_METABOLIC_PR...,SET,120,-0.09011,-0.0072612,0.086562,0.85105,GOBP_XENOBIOTIC_METABOLIC_PROCESS,1
HP_INCREASED_CIRCULATING_LAC...1,SET,180,-0.060772,-0.0059877,0.058378,0.85106,HP_INCREASED_CIRCULATING_LACTATE_CONCENTRATION,1
REACTOME_STABILIZATION_OF_P53,SET,53,-0.10884,-0.0058394,0.10454,0.85108,REACTOME_STABILIZATION_OF_P53,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...1,SET,6,-0.41256,-0.0074568,0.39627,0.85108,GOBP_GAMMA_AMINOBUTYRIC_ACID_BIOSYNTHETIC_PROCESS,1
chr2q33,SET,74,-0.20333,-0.012882,0.19524,0.85115,chr2q33,1
GSE2770_UNTREATED_VS_TGFB_AN...1,SET,177,-0.066622,-0.0065097,0.063969,0.85116,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
GOBP_ACIDIC_AMINO_ACID_TRANS...,SET,65,-0.11939,-0.0070914,0.11463,0.85117,GOBP_ACIDIC_AMINO_ACID_TRANSPORT,1
HP_PALLOR,SET,140,-0.073556,-0.0063986,0.070624,0.85118,HP_PALLOR,1
GOBP_TYPE_III_INTERFERON_PRO...,SET,3,-0.4533,-0.0057939,0.43513,0.85123,GOBP_TYPE_III_INTERFERON_PRODUCTION,1
RAO_BOUND_BY_SALL4_ISOFORM_B,SET,463,-0.042443,-0.0066544,0.040733,0.85128,RAO_BOUND_BY_SALL4_ISOFORM_B,1
GOBP_CELLULAR_RESPONSE_TO_MA...3,SET,9,-0.28251,-0.0062532,0.27112,0.85128,GOBP_CELLULAR_RESPONSE_TO_MANGANESE_ION,1
GOBP_POLYSACCHARIDE_BIOSYNTH...,SET,60,-0.11388,-0.0064993,0.10928,0.8513,GOBP_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GSE32423_CTRL_VS_IL7_IL4_MEM...2,SET,182,-0.066324,-0.0065707,0.063647,0.8513,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,1
KEGG_VALINE_LEUCINE_AND_ISOL...1,SET,6,-0.34957,-0.0063184,0.33545,0.85131,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,1
GAUCHER_PBMC_YF_VAX_STAMARIL...11,SET,171,-0.068493,-0.0065792,0.065725,0.85131,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,1
MIR6853_3P,SET,186,-0.066159,-0.0066252,0.063482,0.85132,MIR6853_3P,1
HP_ABNORMAL_HAIR_QUANTITY,SET,757,-0.03269,-0.0064996,0.031365,0.85134,HP_ABNORMAL_HAIR_QUANTITY,1
GOBP_T_CELL_DIFFERENTIATION_...2,SET,80,-0.10194,-0.0067144,0.097805,0.85135,GOBP_T_CELL_DIFFERENTIATION_IN_THYMUS,1
GOBP_POSITIVE_REGULATION_OF_...67,SET,19,-0.22291,-0.0071672,0.21386,0.85137,GOBP_POSITIVE_REGULATION_OF_BONE_RESORPTION,1
GOBP_PURINE_NUCLEOSIDE_MONOP...3,SET,38,-0.14702,-0.0066815,0.14103,0.85139,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GOMF_INSULIN_BINDING,SET,5,-0.37493,-0.0061865,0.35964,0.85141,GOMF_INSULIN_BINDING,1
GSE17721_LPS_VS_CPG_0.5H_BMD...2,SET,177,-0.064161,-0.0062693,0.06154,0.85142,GSE17721_LPS_VS_CPG_0.5H_BMDC_UP,1
HP_DYNEIN_ARM_DEFECT_OF_RESP...,SET,14,-0.21235,-0.0058617,0.20366,0.85145,HP_DYNEIN_ARM_DEFECT_OF_RESPIRATORY_MOTILE_CILIA,1
GOBP_NEGATIVE_REGULATION_OF_...151,SET,44,-0.124,-0.0060628,0.11889,0.8515,GOBP_NEGATIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,1
MIR937_5P,SET,50,-0.12808,-0.0066749,0.12281,0.85151,MIR937_5P,1
GSE7568_CTRL_VS_3H_TGFB_TREA...2,SET,139,-0.078781,-0.0068288,0.075536,0.85151,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,1
GOBP_POSITIVE_REGULATION_OF_...320,SET,8,-0.37333,-0.0077913,0.35792,0.85154,GOBP_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION,1
HP_IMPAIRED_MYOCARDIAL_CONTR...,SET,8,-0.34519,-0.0072039,0.3309,0.85156,HP_IMPAIRED_MYOCARDIAL_CONTRACTILITY,1
GNF2_DNM1,SET,68,-0.11601,-0.0070471,0.1112,0.85158,GNF2_DNM1,1
GOCC_PLATELET_DENSE_GRANULE,SET,19,-0.20433,-0.0065696,0.19584,0.85159,GOCC_PLATELET_DENSE_GRANULE,1
GOBP_HEPARIN_METABOLIC_PROCE...,SET,17,-0.23218,-0.0070618,0.22254,0.8516,GOBP_HEPARIN_METABOLIC_PROCESS,1
ACATTCC_MIR1_MIR206,SET,279,-0.053298,-0.00652,0.051081,0.85161,ACATTCC_MIR1_MIR206,1
HP_OROTICACIDURIA,SET,7,-0.3381,-0.0066004,0.32396,0.85166,HP_OROTICACIDURIA,1
GOBP_RESPONSE_TO_LEAD_ION,SET,19,-0.21765,-0.0069981,0.20854,0.85168,GOBP_RESPONSE_TO_LEAD_ION,1
WP_STEROID_BIOSYNTHESIS,SET,10,-0.30143,-0.0070329,0.28877,0.85171,WP_STEROID_BIOSYNTHESIS,1
CIZ_01,SET,216,-0.063153,-0.0068095,0.060492,0.85175,CIZ_01,1
REACTOME_RAS_SIGNALING_DOWNS...,SET,7,-0.31494,-0.0061484,0.30159,0.85181,REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS,1
GOBP_PURINE_DEOXYRIBONUCLEOS...3,SET,11,-0.27196,-0.0066547,0.26042,0.85182,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GOBP_VACUOLAR_TRANSMEMBRANE_...,SET,8,-0.31007,-0.0064711,0.29688,0.85185,GOBP_VACUOLAR_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...645,SET,81,-0.099268,-0.0065789,0.095026,0.8519,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,1
GSE15930_NAIVE_VS_24H_IN_VIT...6,SET,187,-0.065087,-0.0065351,0.062295,0.85194,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_MGLUR...1,SET,13,-0.25632,-0.0068181,0.2453,0.85196,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
GOBP_RENAL_CONTROL_OF_PERIPH...,SET,4,-0.43859,-0.006473,0.4196,0.85204,GOBP_RENAL_CONTROL_OF_PERIPHERAL_VASCULAR_RESISTANCE_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GOBP_ATP_BIOSYNTHETIC_PROCESS,SET,62,-0.098742,-0.0057283,0.094445,0.8521,GOBP_ATP_BIOSYNTHETIC_PROCESS,1
GOCC_TERTIARY_GRANULE_LUMEN,SET,50,-0.13258,-0.0069094,0.12681,0.85211,GOCC_TERTIARY_GRANULE_LUMEN,1
GOBP_REGULATION_OF_GLUTAMATE...1,SET,6,-0.38761,-0.007006,0.37067,0.85214,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_CLUSTERING,1
DURANTE_ADULT_OLFACTORY_NEUR...6,SET,71,-0.11849,-0.0073543,0.11329,0.85219,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS,1
HP_BLUE_SCLERAE,SET,97,-0.087559,-0.0063475,0.083704,0.85223,HP_BLUE_SCLERAE,1
KEGG_ALPHA_LINOLENIC_ACID_ME...,SET,19,-0.22088,-0.007102,0.2111,0.85229,KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,1
GOBP_GLUCOSAMINE_CONTAINING_...2,SET,21,-0.20298,-0.0068608,0.19398,0.8523,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_MODIFICAT...2,SET,9,-0.26826,-0.005938,0.25637,0.8523,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,1
MIR432_3P,SET,57,-0.12051,-0.0067042,0.11516,0.85231,MIR432_3P,1
GSE26290_CTRL_VS_AKT_INHIBIT...2,SET,174,-0.070812,-0.0068608,0.067666,0.85233,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,1
CGCTGCT_MIR503,SET,21,-0.18136,-0.00613,0.17327,0.85236,CGCTGCT_MIR503,1
GOBP_REGULATION_OF_TUBE_SIZE,SET,139,-0.083055,-0.0071992,0.079345,0.85239,GOBP_REGULATION_OF_TUBE_SIZE,1
GOBP_CYSTEINE_CATABOLIC_PROC...,SET,3,-0.55525,-0.0070971,0.53042,0.8524,GOBP_CYSTEINE_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...644,SET,8,-0.346,-0.007221,0.33051,0.85242,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
WP_EPO_RECEPTOR_SIGNALING,SET,26,-0.18975,-0.0071357,0.18121,0.85248,WP_EPO_RECEPTOR_SIGNALING,1
GOBP_RESPONSE_TO_L_PHENYLALA...,SET,5,-0.45885,-0.0075711,0.43819,0.85248,GOBP_RESPONSE_TO_L_PHENYLALANINE_DERIVATIVE,1
HP_MEDIAL_FLARING_OF_THE_EYE...,SET,35,-0.1471,-0.0064165,0.14046,0.8525,HP_MEDIAL_FLARING_OF_THE_EYEBROW,1
GOBP_PARANODAL_JUNCTION_ASSE...,SET,6,-0.41093,-0.0074273,0.39224,0.85259,GOBP_PARANODAL_JUNCTION_ASSEMBLY,1
GOCC_PHAGOLYSOSOME,SET,7,-0.31031,-0.006058,0.2962,0.85259,GOCC_PHAGOLYSOSOME,1
KIM_GERMINAL_CENTER_T_HELPER...1,SET,12,-0.3038,-0.0077644,0.28992,0.85265,KIM_GERMINAL_CENTER_T_HELPER_DN,1
GOBP_POSITIVE_REGULATION_OF_...664,SET,6,-0.34636,-0.0062603,0.33053,0.85265,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,1
HP_INCREASED_MUSCLE_LIPID_CO...,SET,33,-0.15498,-0.0065647,0.14788,0.85269,HP_INCREASED_MUSCLE_LIPID_CONTENT,1
HP_PULVERULENT_CATARACT,SET,11,-0.29423,-0.0071997,0.28073,0.8527,HP_PULVERULENT_CATARACT,1
HP_HYPOLIPOPROTEINEMIA,SET,57,-0.11997,-0.0066743,0.11445,0.85272,HP_HYPOLIPOPROTEINEMIA,1
HP_PATENT_DUCTUS_ARTERIOSUS_...,SET,5,-0.38568,-0.0063638,0.36792,0.85274,HP_PATENT_DUCTUS_ARTERIOSUS_AFTER_BIRTH_AT_TERM,1
GOBP_U2_TYPE_PRESPLICEOSOME_...,SET,22,-0.16863,-0.0058336,0.16083,0.85278,GOBP_U2_TYPE_PRESPLICEOSOME_ASSEMBLY,1
HP_ABNORMALITY_IRIS_MORPHOLO...,SET,404,-0.045475,-0.006671,0.043352,0.8529,HP_ABNORMALITY_IRIS_MORPHOLOGY,1
BILANGES_SERUM_RESPONSE_TRAN...,SET,29,-0.16324,-0.0064827,0.1556,0.85294,BILANGES_SERUM_RESPONSE_TRANSLATION,1
GOBP_REGULATION_OF_PROTEIN_L...2,SET,9,-0.28491,-0.0063064,0.27149,0.853,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
GOBP_ELASTIN_METABOLIC_PROCE...,SET,7,-0.40685,-0.0079426,0.38763,0.85304,GOBP_ELASTIN_METABOLIC_PROCESS,1
GSE23308_CTRL_VS_CORTICOSTER...4,SET,188,-0.063189,-0.0063613,0.060202,0.85305,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP,1
GOBP_RESPONSE_TO_ELECTRICAL_...,SET,41,-0.14402,-0.0067984,0.13718,0.8531,GOBP_RESPONSE_TO_ELECTRICAL_STIMULUS,1
GOMF_SINGLE_STRANDED_RNA_BIN...,SET,75,-0.10279,-0.0065564,0.097907,0.85311,GOMF_SINGLE_STRANDED_RNA_BINDING,1
HP_ABNORMAL_LEFT_VENTRICLE_M...,SET,111,-0.082578,-0.0064013,0.07865,0.85312,HP_ABNORMAL_LEFT_VENTRICLE_MORPHOLOGY,1
HP_ABNORMAL_UPPER_LIMB_METAP...,SET,15,-0.26493,-0.0075694,0.25233,0.85312,HP_ABNORMAL_UPPER_LIMB_METAPHYSIS_MORPHOLOGY,1
HP_ABNORMALITY_OF_THE_CERVIC...,SET,375,-0.046181,-0.0065322,0.043982,0.85313,HP_ABNORMALITY_OF_THE_CERVICAL_SPINE,1
GSE36476_YOUNG_VS_OLD_DONOR_...8,SET,167,-0.069715,-0.0066186,0.066375,0.85321,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP,1
GOBP_PHASIC_SMOOTH_MUSCLE_CO...,SET,24,-0.20057,-0.007247,0.19095,0.85322,GOBP_PHASIC_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_COLLAGEN_FIBRIL_ORGANIZ...,SET,63,-0.11895,-0.0069556,0.1132,0.85331,GOBP_COLLAGEN_FIBRIL_ORGANIZATION,1
BHAT_ESR1_TARGETS_VIA_AKT1_DN,SET,79,-0.10947,-0.0071653,0.10416,0.85336,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1
BUSSLINGER_DUODENAL_TUFT_CEL...,SET,70,-0.12017,-0.0074056,0.11433,0.85337,BUSSLINGER_DUODENAL_TUFT_CELLS,1
HP_ABNORMAL_SCROTUM_MORPHOLO...,SET,110,-0.09017,-0.0069585,0.085776,0.85341,HP_ABNORMAL_SCROTUM_MORPHOLOGY,1
WP_GLYOXYLATE_METABOLISM,SET,11,-0.27925,-0.0068331,0.2656,0.85345,WP_GLYOXYLATE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...409,SET,77,-0.10317,-0.0066672,0.098125,0.85346,GOBP_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
ZHAN_MULTIPLE_MYELOMA_HP_DN,SET,38,-0.14345,-0.0065193,0.13641,0.85349,ZHAN_MULTIPLE_MYELOMA_HP_DN,1
chr3q12,SET,22,-0.30479,-0.010544,0.28983,0.85351,chr3q12,1
GOBP_VERY_LONG_CHAIN_FATTY_A...3,SET,33,-0.1663,-0.0070442,0.15813,0.85352,GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
GSE22103_LPS_VS_GMCSF_AND_IF...2,SET,173,-0.064299,-0.0062121,0.061139,0.85352,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,1
HP_EXODEVIATION,SET,104,-0.085508,-0.0064173,0.081252,0.85368,HP_EXODEVIATION,1
GOMF_VOLTAGE_GATED_SODIUM_CH...2,SET,5,-0.45071,-0.0074368,0.42824,0.8537,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GCM_BAG5,SET,34,-0.14277,-0.006138,0.13563,0.85373,GCM_BAG5,1
GOBP_MITOTIC_DNA_REPLICATION,SET,15,-0.20942,-0.0059836,0.19893,0.85376,GOBP_MITOTIC_DNA_REPLICATION,1
HP_CORNEAL_NEOVASCULARIZATION,SET,23,-0.21414,-0.0075746,0.20337,0.85382,HP_CORNEAL_NEOVASCULARIZATION,1
MIKKELSEN_MCV6_ICP_WITH_H3K4...,SET,30,-0.17687,-0.0071436,0.16795,0.85384,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
GOBP_NEGATIVE_REGULATION_OF_...662,SET,26,-0.17698,-0.0066553,0.16805,0.85385,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
PEDERSEN_METASTASIS_BY_ERBB2...5,SET,25,-0.19829,-0.007312,0.18826,0.85388,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,1
GSE17974_IL4_AND_ANTI_IL12_V...1,SET,135,-0.079301,-0.006775,0.07529,0.85389,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN,1
HP_CAPILLARY_HEMANGIOMA,SET,37,-0.15395,-0.006904,0.14609,0.854,HP_CAPILLARY_HEMANGIOMA,1
TAF9B_TARGET_GENES,SET,397,-0.044534,-0.0064775,0.042252,0.85405,TAF9B_TARGET_GENES,1
GOBP_REGULATION_OF_NITRIC_OX...3,SET,20,-0.20189,-0.0066597,0.19153,0.85407,GOBP_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
FARDIN_HYPOXIA_11,SET,28,-0.1696,-0.0066182,0.16089,0.85408,FARDIN_HYPOXIA_11,1
KEGG_MEDICUS_REFERENCE_BMP9_...,SET,8,-0.37357,-0.0077963,0.35432,0.85413,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_ENDOCYTIC...,SET,18,-0.21777,-0.0068153,0.20651,0.85417,GOBP_REGULATION_OF_ENDOCYTIC_RECYCLING,1
HP_DELAYED_ABILITY_TO_SIT,SET,76,-0.10386,-0.0066685,0.098491,0.85418,HP_DELAYED_ABILITY_TO_SIT,1
HP_DEVIATION_OF_THE_2ND_FING...,SET,19,-0.21123,-0.0067915,0.20026,0.85423,HP_DEVIATION_OF_THE_2ND_FINGER,1
MIKKELSEN_PLURIPOTENT_STATE_...2,SET,8,-0.3058,-0.0063819,0.28989,0.85425,MIKKELSEN_PLURIPOTENT_STATE_UP,1
VANTVEER_BREAST_CANCER_BRCA1...1,SET,37,-0.14957,-0.0067075,0.14175,0.85432,VANTVEER_BREAST_CANCER_BRCA1_DN,1
HP_INCREASED_VERTEBRAL_HEIGHT,SET,10,-0.26334,-0.0061441,0.24956,0.85433,HP_INCREASED_VERTEBRAL_HEIGHT,1
KANG_FLUOROURACIL_RESISTANCE...1,SET,16,-0.23083,-0.0068112,0.21874,0.85434,KANG_FLUOROURACIL_RESISTANCE_DN,1
GOBP_REGULATION_OF_LUTEINIZI...,SET,7,-0.3871,-0.0075571,0.36646,0.85459,GOBP_REGULATION_OF_LUTEINIZING_HORMONE_SECRETION,1
GOCC_PROTEASOME_REGULATORY_P...1,SET,11,-0.22274,-0.0054504,0.21083,0.85461,GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX,1
MIR202_3P,SET,229,-0.060357,-0.0066986,0.057127,0.85463,MIR202_3P,1
HP_LINGUAL_DYSTONIA,SET,5,-0.41302,-0.0068149,0.3908,0.8547,HP_LINGUAL_DYSTONIA,1
HOEK_B_CELL_2011_2012_TIV_AD...5,SET,33,-0.16409,-0.0069503,0.15526,0.8547,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_UP,1
REACTOME_NEGATIVE_REGULATION...1,SET,10,-0.29596,-0.0069052,0.28001,0.85472,REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS,1
GOBP_NEGATIVE_REGULATION_OF_...364,SET,57,-0.13073,-0.0072728,0.12367,0.85476,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,1
WP_PHOTODYNAMIC_THERAPYINDUC...4,SET,33,-0.16686,-0.0070679,0.15781,0.85481,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1
GSE16522_ANTI_CD3CD28_STIM_V...2,SET,186,-0.065645,-0.0065737,0.062078,0.85484,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP,1
GOBP_REGULATION_OF_RNA_POLYM...1,SET,6,-0.36538,-0.006604,0.34546,0.85489,GOBP_REGULATION_OF_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
MIR4738_3P,SET,163,-0.072403,-0.0067917,0.068452,0.8549,MIR4738_3P,1
GOMF_ATP_HYDROLYSIS_ACTIVITY,SET,381,-0.045887,-0.0065413,0.043381,0.85491,GOMF_ATP_HYDROLYSIS_ACTIVITY,1
GOBP_EMBRYONIC_VISCEROCRANIU...,SET,9,-0.31209,-0.0069081,0.29499,0.85495,GOBP_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS,1
KEGG_MEDICUS_REFERENCE_LESIO...,SET,12,-0.20402,-0.0052143,0.19283,0.85497,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION,1
HP_DECREASED_EOSINOPHIL_COUNT,SET,8,-0.33363,-0.0069628,0.31527,0.85502,HP_DECREASED_EOSINOPHIL_COUNT,1
GSE12392_CD8A_POS_VS_NEG_SPL...3,SET,188,-0.064547,-0.0064981,0.060991,0.85504,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...33,SET,62,-0.11712,-0.0067943,0.11065,0.85506,HP_APLASIA_HYPOPLASIA_OF_THE_FEMUR,1
HP_PULP_CALCIFICATION,SET,7,-0.4071,-0.0079475,0.38464,0.85506,HP_PULP_CALCIFICATION,1
MIR6732_3P,SET,87,-0.093013,-0.0063875,0.087875,0.85507,MIR6732_3P,1
FLECHNER_BIOPSY_KIDNEY_TRANS...2,SET,509,-0.040233,-0.0066054,0.038008,0.85509,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1
GSE40666_NAIVE_VS_EFFECTOR_C...4,SET,187,-0.067821,-0.0068097,0.064068,0.8551,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
GOMF_GROWTH_FACTOR_BINDING,SET,126,-0.08923,-0.0073666,0.084266,0.85517,GOMF_GROWTH_FACTOR_BINDING,1
HP_RIGHT_AORTIC_ARCH,SET,20,-0.19727,-0.0065073,0.18627,0.8552,HP_RIGHT_AORTIC_ARCH,1
BIOCARTA_NKT_PATHWAY,SET,24,-0.19786,-0.0071488,0.1868,0.85523,BIOCARTA_NKT_PATHWAY,1
BASSO_HAIRY_CELL_LEUKEMIA_DN,SET,4,-0.48428,-0.0071473,0.45716,0.85527,BASSO_HAIRY_CELL_LEUKEMIA_DN,1
GOCC_ESCRT_I_COMPLEX,SET,12,-0.25689,-0.0065653,0.24247,0.8553,GOCC_ESCRT_I_COMPLEX,1
HP_LOWER_LIMB_ASYMMETRY,SET,41,-0.14809,-0.0069902,0.13975,0.85534,HP_LOWER_LIMB_ASYMMETRY,1
GOBP_POSITIVE_REGULATION_OF_...436,SET,3,-0.73273,-0.0093655,0.69127,0.85541,GOBP_POSITIVE_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
GSE6674_CPG_VS_CPG_AND_ANTI_...1,SET,172,-0.072176,-0.0069531,0.068088,0.85543,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN,1
GOBP_REGULATION_OF_CD40_SIGN...,SET,6,-0.29998,-0.005422,0.28298,0.85544,GOBP_REGULATION_OF_CD40_SIGNALING_PATHWAY,1
REACTOME_SYNTHESIS_OF_KETONE...,SET,8,-0.33455,-0.006982,0.31554,0.85547,REACTOME_SYNTHESIS_OF_KETONE_BODIES,1
WP_NETRINUNC5B_SIGNALING,SET,48,-0.13511,-0.0068994,0.12744,0.85548,WP_NETRINUNC5B_SIGNALING,1
HP_BRADYKINESIA,SET,95,-0.090795,-0.0065142,0.085624,0.85551,HP_BRADYKINESIA,1
GOCC_MITOCHONDRIAL_MATRIX,SET,449,-0.041007,-0.0063338,0.038667,0.85553,GOCC_MITOCHONDRIAL_MATRIX,1
GSE14308_TH1_VS_NATURAL_TREG...2,SET,176,-0.065873,-0.0064185,0.062116,0.85553,GSE14308_TH1_VS_NATURAL_TREG_UP,1
GOBP_CELLULAR_RESPONSE_TO_FA...,SET,32,-0.17462,-0.0072837,0.16458,0.85564,GOBP_CELLULAR_RESPONSE_TO_FATTY_ACID,1
GSE29618_MONOCYTE_VS_MDC_UP,SET,186,-0.069656,-0.0069754,0.065648,0.85566,GSE29618_MONOCYTE_VS_MDC_UP,1
WP_COPPER_HOMEOSTASIS,SET,49,-0.1328,-0.0068516,0.12516,0.85567,WP_COPPER_HOMEOSTASIS,1
HP_SHORT_THORAX,SET,45,-0.13196,-0.006525,0.12436,0.85567,HP_SHORT_THORAX,1
MASSARWEH_RESPONSE_TO_ESTRAD...,SET,59,-0.12629,-0.0071477,0.119,0.8557,MASSARWEH_RESPONSE_TO_ESTRADIOL,1
KEGG_MEDICUS_PATHOGEN_ESCHER...7,SET,4,-0.47825,-0.0070584,0.45064,0.85571,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,1
UBE2I_TARGET_GENES,SET,70,-0.10903,-0.0067195,0.10274,0.85571,UBE2I_TARGET_GENES,1
GOBP_CEREBRAL_CORTEX_GABAERG...3,SET,4,-0.51594,-0.0076146,0.48612,0.85572,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_MIGRATION,1
GSE22886_TH1_VS_TH2_12H_ACT_...1,SET,178,-0.068623,-0.006724,0.064657,0.85573,GSE22886_TH1_VS_TH2_12H_ACT_DN,1
MODULE_300,SET,33,-0.1587,-0.006722,0.14949,0.85578,MODULE_300,1
HP_LIP_TELANGIECTASIA,SET,5,-0.38366,-0.0063304,0.36129,0.85586,HP_LIP_TELANGIECTASIA,1
GOMF_TRANSPORTER_ACTIVATOR_A...,SET,7,-0.36177,-0.0070625,0.34062,0.85589,GOMF_TRANSPORTER_ACTIVATOR_ACTIVITY,1
GTGTCAA_MIR514,SET,55,-0.11397,-0.0062287,0.10731,0.8559,GTGTCAA_MIR514,1
HP_ATROPHY_DEGENERATION_INVO...1,SET,14,-0.26438,-0.0072978,0.2489,0.85592,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CAUDATE_NUCLEUS,1
DESCARTES_FETAL_CEREBELLUM_S...,SET,33,-0.18053,-0.0076468,0.16995,0.85593,DESCARTES_FETAL_CEREBELLUM_SLC24A4_PEX5L_POSITIVE_CELLS,1
GOBP_HYPEROSMOTIC_SALINITY_R...,SET,10,-0.28929,-0.0067497,0.27222,0.85603,GOBP_HYPEROSMOTIC_SALINITY_RESPONSE,1
GOMF_NEUREGULIN_BINDING,SET,5,-0.42143,-0.0069536,0.39657,0.85603,GOMF_NEUREGULIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...697,SET,8,-0.35149,-0.0073354,0.33059,0.85615,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,1
REACTOME_RUNX1_REGULATES_TRA...5,SET,5,-0.38752,-0.0063941,0.36443,0.85618,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING,1
MED16_TARGET_GENES,SET,19,-0.21612,-0.0069487,0.20323,0.85619,MED16_TARGET_GENES,1
DESCARTES_FETAL_EYE_LENS_FIB...,SET,58,-0.13254,-0.0074376,0.12461,0.85625,DESCARTES_FETAL_EYE_LENS_FIBRE_CELLS,1
GOMF_PH_DOMAIN_BINDING,SET,8,-0.32036,-0.0066859,0.30112,0.85631,GOMF_PH_DOMAIN_BINDING,1
REACTOME_AEROBIC_RESPIRATION...,SET,209,-0.058099,-0.0061634,0.054598,0.85636,REACTOME_AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1
REACTOME_WNT5A_DEPENDENT_INT...1,SET,13,-0.24334,-0.0064729,0.22867,0.85636,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,1
GSE27786_CD4_TCELL_VS_NEUTRO...2,SET,178,-0.067279,-0.0065923,0.06321,0.85641,GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP,1
HP_ABNORMALITY_OF_THE_PULMON...2,SET,185,-0.067591,-0.0067505,0.063471,0.85654,HP_ABNORMALITY_OF_THE_PULMONARY_VASCULATURE,1
HP_FINGER_SWELLING,SET,4,-0.59786,-0.0088236,0.56137,0.85656,HP_FINGER_SWELLING,1
GOMF_OLEATE_TRANSMEMBRANE_TR...,SET,6,-0.36111,-0.0065269,0.33905,0.85657,GOMF_OLEATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_ION_HOMEOSTASIS,SET,52,-0.13038,-0.0069291,0.12237,0.85666,REACTOME_ION_HOMEOSTASIS,1
HP_NON_OBSTRUCTIVE_AZOOSPERM...,SET,48,-0.13229,-0.0067554,0.12416,0.85667,HP_NON_OBSTRUCTIVE_AZOOSPERMIA,1
REACTOME_PROGRAMMED_CELL_DEA...,SET,193,-0.064655,-0.0065941,0.060677,0.85668,REACTOME_PROGRAMMED_CELL_DEATH,1
GOMF_ANAPHASE_PROMOTING_COMP...,SET,9,-0.26211,-0.0058018,0.24597,0.85669,GOMF_ANAPHASE_PROMOTING_COMPLEX_BINDING,1
GOBP_COLLAGEN_ACTIVATED_SIGN...,SET,13,-0.26666,-0.0070931,0.25022,0.85671,GOBP_COLLAGEN_ACTIVATED_SIGNALING_PATHWAY,1
HP_DELAYED_CRANIAL_SUTURE_CL...,SET,87,-0.096085,-0.0065985,0.090164,0.85671,HP_DELAYED_CRANIAL_SUTURE_CLOSURE,1
REACTOME_TNFR2_NON_CANONICAL...,SET,94,-0.091446,-0.0065265,0.085798,0.85674,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1
GOBP_THYMIC_T_CELL_SELECTION,SET,24,-0.19887,-0.0071856,0.18658,0.85675,GOBP_THYMIC_T_CELL_SELECTION,1
HP_ABNORMAL_PULMONARY_VALVE_...3,SET,137,-0.081499,-0.0070137,0.076454,0.85678,HP_ABNORMAL_PULMONARY_VALVE_PHYSIOLOGY,1
GSE21927_UNTREATED_VS_GMCSF_...2,SET,166,-0.071946,-0.0068101,0.067488,0.85679,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,1
GOBP_MAINTENANCE_OF_SISTER_C...,SET,8,-0.30298,-0.006323,0.2842,0.8568,GOBP_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
REACTOME_SHC1_EVENTS_IN_ERBB...1,SET,22,-0.18851,-0.0065217,0.17682,0.85681,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,1
CAGCTTT_MIR320,SET,220,-0.064291,-0.0069953,0.060288,0.85687,CAGCTTT_MIR320,1
GSE21927_SPLEEN_C57BL6_VS_EL...2,SET,178,-0.066322,-0.0064985,0.062184,0.8569,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP,1
MIR4635,SET,120,-0.083732,-0.0067472,0.0785,0.85693,MIR4635,1
HP_DECREASED_LIBIDO,SET,11,-0.26115,-0.0063902,0.24482,0.85694,HP_DECREASED_LIBIDO,1
GOBP_REGULATION_OF_CENTROMER...1,SET,4,-0.38746,-0.0057184,0.36309,0.85704,GOBP_REGULATION_OF_CENTROMERE_COMPLEX_ASSEMBLY,1
GSE29618_LAIV_VS_TIV_FLU_VAC...3,SET,170,-0.070841,-0.0067851,0.066378,0.85706,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN,1
MIR3115,SET,33,-0.1432,-0.0060656,0.13412,0.85716,MIR3115,1
LAKE_ADULT_KIDNEY_C29_UNKNOW...,SET,77,-0.11478,-0.0074177,0.10749,0.85721,LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2,1
MIR4309,SET,40,-0.1362,-0.0063502,0.12751,0.85727,MIR4309,1
HP_ANKYLOSIS,SET,16,-0.25054,-0.0073929,0.23452,0.8573,HP_ANKYLOSIS,1
WP_TRANSLATION_FACTORS,SET,44,-0.12305,-0.0060168,0.11517,0.85733,WP_TRANSLATION_FACTORS,1
HP_THICK_NASAL_ALAE,SET,34,-0.16471,-0.0070814,0.15415,0.85734,HP_THICK_NASAL_ALAE,1
HP_POSTERIORLY_ROTATED_EARS,SET,397,-0.046123,-0.0067086,0.043162,0.85737,HP_POSTERIORLY_ROTATED_EARS,1
GOMF_C3HC4_TYPE_RING_FINGER_...,SET,6,-0.35533,-0.0064225,0.3325,0.85738,GOMF_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING,1
LIU_IL13_MEMORY_MODEL_UP,SET,17,-0.21637,-0.0065808,0.20246,0.85739,LIU_IL13_MEMORY_MODEL_UP,1
MODULE_381,SET,11,-0.27942,-0.0068374,0.26143,0.85742,MODULE_381,1
HP_APLASIA_HYPOPLASIA_OF_THE...31,SET,41,-0.13902,-0.0065623,0.13002,0.85751,HP_APLASIA_HYPOPLASIA_OF_THE_EYELID,1
HP_TALL_STATURE,SET,147,-0.073482,-0.0065488,0.068724,0.85751,HP_TALL_STATURE,1
GOBP_NEGATIVE_REGULATION_OF_...167,SET,13,-0.27385,-0.0072844,0.25611,0.85752,GOBP_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GOMF_TESTOSTERONE_17_BETA_DE...,SET,9,-0.30441,-0.0067381,0.28467,0.85754,GOMF_TESTOSTERONE_17_BETA_DEHYDROGENASE_NADPPLUS_ACTIVITY,1
GSE42021_TREG_PLN_VS_CD24LO_...2,SET,171,-0.069405,-0.0066668,0.064895,0.85757,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP,1
GSE45365_WT_VS_IFNAR_KO_CD8A...1,SET,183,-0.067317,-0.0066871,0.062941,0.85758,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN,1
HP_LONG_FINGERS,SET,246,-0.057529,-0.0066143,0.053784,0.8576,HP_LONG_FINGERS,1
GOMF_HYDROLASE_ACTIVITY_ACTI...3,SET,15,-0.24366,-0.0069618,0.22779,0.85761,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES,1
HE_LIM_SUN_FETAL_LUNG_C0_LAT...1,SET,103,-0.097774,-0.0073027,0.091399,0.85763,HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL,1
LOPEZ_MBD_TARGETS_IMPRINTED_...,SET,3,-0.49249,-0.0062949,0.46028,0.85768,LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,1
GSE22033_UNTREATED_VS_MRL24_...2,SET,178,-0.064161,-0.0062868,0.059962,0.85769,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP,1
GOBP_CRD_MEDIATED_MRNA_STABI...,SET,11,-0.27579,-0.0067486,0.25773,0.8577,GOBP_CRD_MEDIATED_MRNA_STABILIZATION,1
GOMF_MYOSIN_V_BINDING,SET,16,-0.2438,-0.007194,0.22783,0.85771,GOMF_MYOSIN_V_BINDING,1
HP_HYPOPLASIA_OF_THE_VAGINA,SET,13,-0.26331,-0.0070039,0.24606,0.85771,HP_HYPOPLASIA_OF_THE_VAGINA,1
REACTOME_ERBB2_ACTIVATES_PTK...,SET,13,-0.25835,-0.0068722,0.24141,0.85772,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,1
GSE19941_UNSTIM_VS_LPS_AND_I...2,SET,185,-0.06866,-0.0068573,0.06415,0.85775,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,1
HP_SIMPLE_EAR,SET,19,-0.21499,-0.0069125,0.20081,0.85782,HP_SIMPLE_EAR,1
GOCC_LAMELLAR_BODY,SET,18,-0.23575,-0.0073779,0.22019,0.85784,GOCC_LAMELLAR_BODY,1
GOBP_CELLULAR_COMPONENT_ASSE...,SET,130,-0.080202,-0.0067248,0.07488,0.85793,GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS,1
IBRAHIM_NRF1_UP,SET,390,-0.045328,-0.0065359,0.042314,0.85796,IBRAHIM_NRF1_UP,1
GSE46025_WT_VS_FOXO1_KO_KLRG...1,SET,160,-0.070978,-0.006597,0.066254,0.85797,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN,1
GSE11057_PBMC_VS_MEM_CD4_TCE...2,SET,178,-0.072746,-0.007128,0.067899,0.858,GSE11057_PBMC_VS_MEM_CD4_TCELL_UP,1
MIR3620_5P,SET,49,-0.12093,-0.0062388,0.11284,0.85805,MIR3620_5P,1
GOBP_REGULATION_OF_INFLAMMAS...,SET,35,-0.15344,-0.006693,0.14318,0.85805,GOBP_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
HP_DECREASED_ABSENT_ANKLE_RE...,SET,37,-0.14355,-0.0064377,0.13395,0.85805,HP_DECREASED_ABSENT_ANKLE_REFLEXES,1
NR2E3_TARGET_GENES,SET,8,-0.35377,-0.007383,0.33011,0.85806,NR2E3_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...310,SET,15,-0.25565,-0.0073042,0.2385,0.85811,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
GOMF_MAP_KINASE_KINASE_KINAS...1,SET,22,-0.19199,-0.0066419,0.1791,0.85812,GOMF_MAP_KINASE_KINASE_KINASE_ACTIVITY,1
HP_ENCEPHALOPATHY,SET,276,-0.053242,-0.0064787,0.049669,0.85812,HP_ENCEPHALOPATHY,1
GOBP_POSITIVE_REGULATION_OF_...843,SET,6,-0.4097,-0.0074051,0.38209,0.85819,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GOBP_INORGANIC_ION_HOMEOSTAS...,SET,488,-0.044476,-0.0071541,0.041472,0.85823,GOBP_INORGANIC_ION_HOMEOSTASIS,1
MIR340_5P,SET,707,-0.035967,-0.0069207,0.033521,0.85835,MIR340_5P,1
GSE339_CD4POS_VS_CD8POS_DC_I...2,SET,183,-0.067069,-0.0066625,0.062497,0.85839,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...196,SET,5,-0.42101,-0.0069468,0.39218,0.85847,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
HP_PROXIMAL_SYMPHALANGISM_OF...,SET,5,-0.45734,-0.0075462,0.42602,0.85848,HP_PROXIMAL_SYMPHALANGISM_OF_HANDS,1
REACTOME_INTERLEUKIN_15_SIGN...,SET,13,-0.27958,-0.0074369,0.26041,0.8585,REACTOME_INTERLEUKIN_15_SIGNALING,1
GOMF_FK506_BINDING,SET,10,-0.25133,-0.005864,0.2341,0.8585,GOMF_FK506_BINDING,1
NRF2_01,SET,249,-0.053427,-0.0061796,0.049757,0.85853,NRF2_01,1
GOBP_MACROPHAGE_FUSION,SET,6,-0.40406,-0.0073033,0.37629,0.85854,GOBP_MACROPHAGE_FUSION,1
GAVISH_3CA_METAPROGRAM_EPITH...20,SET,48,-0.13457,-0.0068719,0.12531,0.85857,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3,1
GOBP_CELLULAR_HYPOTONIC_RESP...,SET,11,-0.29413,-0.0071973,0.27387,0.85857,GOBP_CELLULAR_HYPOTONIC_RESPONSE,1
MIR7161_5P,SET,177,-0.071891,-0.0070246,0.06693,0.85861,MIR7161_5P,1
GOBP_ACYLGLYCEROL_TRANSPORT,SET,6,-0.34638,-0.0062607,0.32239,0.85868,GOBP_ACYLGLYCEROL_TRANSPORT,1
HP_BIFID_SCROTUM,SET,30,-0.18454,-0.0074536,0.17176,0.85868,HP_BIFID_SCROTUM,1
CEBP_Q2_01,SET,239,-0.063023,-0.0071436,0.058647,0.85872,CEBP_Q2_01,1
GOBP_OOCYTE_CONSTRUCTION,SET,8,-0.32745,-0.0068338,0.30465,0.85877,GOBP_OOCYTE_CONSTRUCTION,1
HP_DECREASED_ACTIVITY_OF_MIT...2,SET,86,-0.088112,-0.0060163,0.081967,0.8588,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_I,1
GOBP_POSITIVE_REGULATION_OF_...541,SET,13,-0.24078,-0.0064046,0.22397,0.85881,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
DURCHDEWALD_SKIN_CARCINOGENE...1,SET,242,-0.06069,-0.0069216,0.056449,0.85883,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1
GOBP_FOREBRAIN_REGIONALIZATI...,SET,23,-0.22553,-0.0079774,0.20977,0.85884,GOBP_FOREBRAIN_REGIONALIZATION,1
GOMF_BIS_5_ADENOSYL_PENTAPHO...,SET,3,-0.6708,-0.008574,0.62392,0.85884,GOMF_BIS_5_ADENOSYL_PENTAPHOSPHATASE_ACTIVITY,1
DESCARTES_FETAL_HEART_MEGAKA...,SET,80,-0.1099,-0.0072386,0.10219,0.85891,DESCARTES_FETAL_HEART_MEGAKARYOCYTES,1
TSHZ1_TARGET_GENES,SET,180,-0.066339,-0.0065363,0.061677,0.85894,TSHZ1_TARGET_GENES,1
MODULE_373,SET,20,-0.21066,-0.0069491,0.19585,0.85895,MODULE_373,1
DCA_UP.V1_DN,SET,165,-0.069403,-0.0065498,0.064516,0.85898,DCA_UP.V1_DN,1
MIR125B_2_3P,SET,121,-0.080532,-0.0065161,0.074857,0.85899,MIR125B_2_3P,1
GOBP_ALKALOID_METABOLIC_PROC...,SET,7,-0.33015,-0.0064452,0.30686,0.85901,GOBP_ALKALOID_METABOLIC_PROCESS,1
GOBP_HYPOTHALAMUS_DEVELOPMENT,SET,25,-0.20395,-0.0075209,0.18956,0.85901,GOBP_HYPOTHALAMUS_DEVELOPMENT,1
GOBP_DEOXYRIBONUCLEOTIDE_BIO...,SET,14,-0.24465,-0.0067531,0.22737,0.85902,GOBP_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
HP_MICROCORNEA,SET,111,-0.087046,-0.0067477,0.080886,0.85906,HP_MICROCORNEA,1
GOBP_MAMMARY_GLAND_FORMATION,SET,7,-0.40665,-0.0079387,0.37773,0.85915,GOBP_MAMMARY_GLAND_FORMATION,1
EGR2_01,SET,179,-0.069455,-0.0068245,0.064512,0.85917,EGR2_01,1
HP_AMELOGENESIS_IMPERFECTA,SET,31,-0.16812,-0.0069022,0.15614,0.85919,HP_AMELOGENESIS_IMPERFECTA,1
MIR4684_5P,SET,156,-0.072537,-0.0066579,0.067355,0.85924,MIR4684_5P,1
GOBP_POSITIVE_REGULATION_OF_...107,SET,15,-0.23442,-0.0066978,0.21763,0.85929,GOBP_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,1
GOBP_REGULATION_OF_DNA_DEMET...,SET,4,-0.43725,-0.0064532,0.40589,0.85931,GOBP_REGULATION_OF_DNA_DEMETHYLATION,1
GOBP_GRANULOCYTE_MIGRATION,SET,140,-0.087599,-0.0076202,0.081301,0.85935,GOBP_GRANULOCYTE_MIGRATION,1
DESCARTES_FETAL_ADRENAL_MYEL...,SET,151,-0.081475,-0.0073584,0.075619,0.85935,DESCARTES_FETAL_ADRENAL_MYELOID_CELLS,1
GSE19888_ADENOSINE_A3R_INH_P...2,SET,170,-0.071781,-0.0068751,0.066614,0.85938,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
GOCC_PHOTORECEPTOR_OUTER_SEG...2,SET,16,-0.20552,-0.0060644,0.19072,0.85939,GOCC_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE,1
MIR4772_3P,SET,82,-0.10835,-0.0072246,0.10053,0.85943,MIR4772_3P,1
GSE11864_UNTREATED_VS_CSF1_I...4,SET,169,-0.0683,-0.0065226,0.063366,0.85945,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,1
MODULE_367,SET,28,-0.18133,-0.0070757,0.1682,0.85949,MODULE_367,1
HP_CHRONIC_LEUKEMIA,SET,23,-0.19483,-0.0068915,0.18071,0.8595,HP_CHRONIC_LEUKEMIA,1
GSE43863_NAIVE_VS_MEMORY_TFH...2,SET,178,-0.068856,-0.0067468,0.063852,0.85956,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP,1
GSE21927_GMCSF_IL6_VS_GMCSF_...2,SET,144,-0.074431,-0.0065659,0.06902,0.85957,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,1
GSE6259_DEC205_POS_DC_VS_BCE...1,SET,165,-0.073358,-0.006923,0.068014,0.8596,GSE6259_DEC205_POS_DC_VS_BCELL_DN,1
GSE40274_CTRL_VS_FOXP3_AND_P...1,SET,147,-0.074242,-0.0066164,0.068814,0.85967,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
BENPORATH_PRC2_TARGETS,SET,575,-0.044811,-0.007805,0.041531,0.8597,BENPORATH_PRC2_TARGETS,1
KYNG_ENVIRONMENTAL_STRESS_RE...2,SET,12,-0.25874,-0.0066126,0.23974,0.85975,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,1
MIR3928_3P,SET,84,-0.095541,-0.0064476,0.088525,0.85975,MIR3928_3P,1
HP_ATTENUATION_OF_RETINAL_BL...,SET,118,-0.084755,-0.0067728,0.078522,0.85978,HP_ATTENUATION_OF_RETINAL_BLOOD_VESSELS,1
SETD1A_TARGET_GENES,SET,1212,-0.027115,-0.0067329,0.02512,0.85979,SETD1A_TARGET_GENES,1
SHIPP_DLBCL_VS_FOLLICULAR_LY...2,SET,44,-0.14452,-0.0070666,0.13386,0.85984,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,1
GSE24142_DN2_VS_DN3_THYMOCYT...6,SET,184,-0.068834,-0.0068563,0.063751,0.85986,GSE24142_DN2_VS_DN3_THYMOCYTE_UP,1
HP_RESPIRATORY_DISTRESS,SET,192,-0.067429,-0.0068593,0.062449,0.85987,HP_RESPIRATORY_DISTRESS,1
GOBP_S_ADENOSYLMETHIONINE_ME...,SET,16,-0.24062,-0.0071,0.22272,0.86,GOBP_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS,1
HP_FACIAL_TICS,SET,14,-0.25237,-0.0069662,0.23358,0.86001,HP_FACIAL_TICS,1
REACTOME_SIGNALING_BY_LEPTIN,SET,11,-0.34669,-0.0084834,0.32083,0.86006,REACTOME_SIGNALING_BY_LEPTIN,1
GOBP_ESTABLISHMENT_OF_EPITHE...2,SET,32,-0.16692,-0.0069624,0.15446,0.86006,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY,1
GOCC_U2_SNRNP,SET,22,-0.17304,-0.0059863,0.16011,0.86009,GOCC_U2_SNRNP,1
GOMF_POLYOL_TRANSMEMBRANE_TR...,SET,11,-0.33389,-0.0081703,0.30893,0.8601,GOMF_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
THAKAR_PBMC_INACTIVATED_INFL...4,SET,115,-0.085361,-0.0067346,0.07898,0.8601,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP,1
GOBP_POSITIVE_REGULATION_OF_...441,SET,5,-0.40606,-0.0067,0.37567,0.86012,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION,1
GOBP_REGULATION_OF_BRANCHING...3,SET,9,-0.30364,-0.0067212,0.28091,0.86013,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
KEGG_MEDICUS_REFERENCE_MANNO...2,SET,5,-0.36069,-0.0059515,0.33359,0.8602,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK,1
HP_ULNAR_DEVIATION_OF_FINGER,SET,33,-0.16832,-0.0071295,0.15565,0.86023,HP_ULNAR_DEVIATION_OF_FINGER,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...5,SET,183,-0.06933,-0.006887,0.064106,0.86025,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN,1
GOBP_BASE_EXCISION_REPAIR_GA...,SET,13,-0.2038,-0.0054211,0.1884,0.86031,GOBP_BASE_EXCISION_REPAIR_GAP_FILLING,1
GOBP_LIPID_DIGESTION,SET,20,-0.23421,-0.0077258,0.21651,0.86031,GOBP_LIPID_DIGESTION,1
GSE17721_CPG_VS_GARDIQUIMOD_...16,SET,180,-0.069693,-0.0068668,0.064428,0.86031,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP,1
GSE20715_WT_VS_TLR4_KO_24H_O...2,SET,179,-0.068346,-0.0067154,0.063179,0.86032,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP,1
HP_RESTING_TREMOR,SET,45,-0.13575,-0.0067123,0.12548,0.86033,HP_RESTING_TREMOR,1
HP_ABNORMAL_HEART_MORPHOLOGY,SET,1338,-0.025871,-0.0067247,0.023911,0.86036,HP_ABNORMAL_HEART_MORPHOLOGY,1
GSE21927_BALBC_VS_C57BL6_MON...3,SET,160,-0.071207,-0.0066183,0.065808,0.86037,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN,1
GOCC_SEROTONIN_RECEPTOR_COMP...,SET,5,-0.51983,-0.0085774,0.48026,0.86046,GOCC_SEROTONIN_RECEPTOR_COMPLEX,1
GOMF_SEROTONIN_GATED_MONOATO...,SET,5,-0.51983,-0.0085774,0.48026,0.86046,GOMF_SEROTONIN_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
REACTOME_FOXO_MEDIATED_TRANS...3,SET,15,-0.24504,-0.007001,0.22635,0.86049,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,1
GSE17721_12H_VS_24H_LPS_BMDC...1,SET,181,-0.064136,-0.0063365,0.059215,0.86061,GSE17721_12H_VS_24H_LPS_BMDC_DN,1
GOCC_IKAPPAB_KINASE_COMPLEX,SET,6,-0.32739,-0.0059173,0.30224,0.86063,GOCC_IKAPPAB_KINASE_COMPLEX,1
GSE39152_BRAIN_VS_SPLEEN_CD1...2,SET,179,-0.069692,-0.0068477,0.064327,0.86068,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP,1
GOBP_VIRAL_BUDDING,SET,25,-0.17642,-0.0065054,0.16282,0.8607,GOBP_VIRAL_BUDDING,1
HP_SPINAL_CORD_COMPRESSION,SET,34,-0.16621,-0.0071459,0.1534,0.8607,HP_SPINAL_CORD_COMPRESSION,1
GOMF_DNA_METHYLTRANSFERASE_A...,SET,7,-0.39294,-0.0076711,0.36262,0.86073,GOMF_DNA_METHYLTRANSFERASE_ACTIVITY,1
AGTCAGC_MIR345,SET,55,-0.11317,-0.006185,0.10443,0.86075,AGTCAGC_MIR345,1
SABATES_COLORECTAL_ADENOMA_UP,SET,127,-0.09349,-0.0077486,0.086222,0.86087,SABATES_COLORECTAL_ADENOMA_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...75,SET,11,-0.27051,-0.0066192,0.24947,0.86088,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...1,SET,185,-0.068692,-0.0068605,0.063343,0.86091,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN,1
MIKKELSEN_NPC_LCP_WITH_H3K4M...,SET,55,-0.12171,-0.0066514,0.1122,0.86098,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,1
WP_EBSTEINBARR_VIRUS_LMP1_SI...,SET,21,-0.19075,-0.0064475,0.17583,0.861,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,1
HP_HYDROURETER,SET,65,-0.11606,-0.0068932,0.10691,0.86115,HP_HYDROURETER,1
DESCARTES_MAIN_FETAL_HORIZON...,SET,26,-0.19106,-0.0071846,0.176,0.86116,DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS,1
JOHNSTONE_PARVB_TARGETS_1_DN,SET,56,-0.12586,-0.0069406,0.11592,0.86121,JOHNSTONE_PARVB_TARGETS_1_DN,1
BIOCARTA_ERBB4_PATHWAY,SET,7,-0.33145,-0.0064706,0.30525,0.86121,BIOCARTA_ERBB4_PATHWAY,1
KDM1B_TARGET_GENES,SET,110,-0.087854,-0.0067798,0.080899,0.86125,KDM1B_TARGET_GENES,1
HOEK_PBMC_INACTIVATED_INFLUE...6,SET,14,-0.25078,-0.0069223,0.23087,0.8613,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP,1
HP_ABNORMAL_STERNUM_MORPHOLO...,SET,402,-0.046271,-0.0067714,0.042597,0.86131,HP_ABNORMAL_STERNUM_MORPHOLOGY,1
GCM_DFFA,SET,116,-0.07876,-0.0062405,0.072498,0.86134,GCM_DFFA,1
GOMF_SEMAPHORIN_RECEPTOR_ACT...,SET,10,-0.33813,-0.0078892,0.31123,0.86135,GOMF_SEMAPHORIN_RECEPTOR_ACTIVITY,1
GOBP_PROTEIN_NEDDYLATION,SET,27,-0.17008,-0.0065174,0.15654,0.86136,GOBP_PROTEIN_NEDDYLATION,1
GSE14308_TH2_VS_NAIVE_CD4_TC...1,SET,178,-0.065717,-0.0064393,0.060487,0.86136,GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN,1
GOBP_REGULATION_OF_DENDRITIC...1,SET,11,-0.32567,-0.0079691,0.29973,0.86138,GOBP_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
KUNINGER_IGF1_VS_PDGFB_TARGE...1,SET,41,-0.15453,-0.0072945,0.14222,0.86139,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,1
HP_2_3_TOE_SYNDACTYLY,SET,81,-0.10525,-0.0069755,0.096842,0.86144,HP_2_3_TOE_SYNDACTYLY,1
HP_GAZE_EVOKED_HORIZONTAL_NY...,SET,17,-0.2254,-0.0068556,0.2074,0.86144,HP_GAZE_EVOKED_HORIZONTAL_NYSTAGMUS,1
GAVISH_3CA_METAPROGRAM_EPITH...1,SET,48,-0.14733,-0.0075233,0.13554,0.86147,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR,1
REACTOME_SEROTONIN_RECEPTORS,SET,11,-0.29533,-0.0072266,0.27168,0.86148,REACTOME_SEROTONIN_RECEPTORS,1
GOBP_PERISTALSIS,SET,12,-0.31165,-0.0079648,0.28667,0.8615,GOBP_PERISTALSIS,1
HP_ABNORMALITY_OF_THE_PALPEB...,SET,738,-0.03438,-0.0067528,0.031624,0.8615,HP_ABNORMALITY_OF_THE_PALPEBRAL_FISSURES,1
MIR6509_3P,SET,123,-0.083227,-0.0067892,0.076555,0.86151,MIR6509_3P,1
GSE1566_WT_VS_EZH2_KO_LN_TCE...2,SET,164,-0.074235,-0.0069847,0.068275,0.86154,GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...98,SET,41,-0.16099,-0.0075992,0.14803,0.86159,GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...8,SET,22,-0.22354,-0.0077334,0.20552,0.86163,GOBP_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,1
GTTATAT_MIR410,SET,80,-0.10607,-0.0069863,0.097498,0.86167,GTTATAT_MIR410,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...3,SET,150,-0.072279,-0.0065064,0.066438,0.86168,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN,1
KEGG_MEDICUS_PATHOGEN_HBV_LH...,SET,11,-0.30457,-0.0074526,0.27994,0.86169,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY,1
MIR4439,SET,66,-0.12248,-0.0073301,0.11253,0.86177,MIR4439,1
GOBP_T_CELL_EXTRAVASATION,SET,11,-0.29714,-0.007271,0.27298,0.8618,GOBP_T_CELL_EXTRAVASATION,1
MIR627_5P,SET,36,-0.15022,-0.0066454,0.13801,0.86181,MIR627_5P,1
REACTOME_SIGNALING_BY_CSF3_G...,SET,27,-0.189,-0.0072425,0.17362,0.86182,REACTOME_SIGNALING_BY_CSF3_G_CSF,1
GOBP_REGULATION_OF_GLUTAMATE...2,SET,6,-0.40322,-0.007288,0.37035,0.86186,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
GSE32986_UNSTIM_VS_GMCSF_STI...1,SET,180,-0.067016,-0.0066029,0.061554,0.86186,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...208,SET,13,-0.24332,-0.0064723,0.22348,0.86187,GOBP_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
GOBP_LOBAR_BRONCHUS_DEVELOPM...,SET,6,-0.43709,-0.0079003,0.40136,0.86192,GOBP_LOBAR_BRONCHUS_DEVELOPMENT,1
ZHOU_INFLAMMATORY_RESPONSE_L...3,SET,335,-0.053805,-0.0072012,0.049403,0.86194,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,1
HP_HEMATOCHEZIA,SET,20,-0.20752,-0.0068453,0.19048,0.86201,HP_HEMATOCHEZIA,1
GOBP_ALPHA_AMINO_ACID_METABO...,SET,194,-0.066792,-0.0068294,0.061306,0.86202,GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS,1
HP_EYELID_MYOCLONIA_SEIZURE,SET,7,-0.29699,-0.005798,0.27255,0.86206,HP_EYELID_MYOCLONIA_SEIZURE,1
FAN_OVARY_CL14_MATURE_SMOOTH...,SET,267,-0.058264,-0.0069749,0.053454,0.86213,FAN_OVARY_CL14_MATURE_SMOOTH_MUSCLE_CELL,1
HP_ABNORMAL_CIRCULATING_ORNI...,SET,5,-0.41386,-0.0068288,0.37966,0.86215,HP_ABNORMAL_CIRCULATING_ORNITHINE_CONCENTRATION,1
GOMF_G_PROTEIN_COUPLED_GLUTA...2,SET,8,-0.34046,-0.0071053,0.31223,0.86223,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING,1
HP_ABNORMALITY_OF_THE_ACHILL...,SET,50,-0.1348,-0.0070247,0.12361,0.86224,HP_ABNORMALITY_OF_THE_ACHILLES_TENDON,1
GOBP_RETROGRADE_AXONAL_TRANS...,SET,21,-0.20537,-0.0069415,0.18832,0.86225,GOBP_RETROGRADE_AXONAL_TRANSPORT,1
GSE21063_WT_VS_NFATC1_KO_BCE...2,SET,186,-0.067865,-0.006796,0.062198,0.86238,GSE21063_WT_VS_NFATC1_KO_BCELL_UP,1
GOCC_LARGE_RIBOSOMAL_SUBUNIT,SET,104,-0.083834,-0.0062917,0.076819,0.86243,GOCC_LARGE_RIBOSOMAL_SUBUNIT,1
GSE45365_NK_CELL_VS_CD11B_DC...4,SET,176,-0.070159,-0.0068361,0.064287,0.86243,GSE45365_NK_CELL_VS_CD11B_DC_UP,1
GSE6269_FLU_VS_STAPH_AUREUS_...2,SET,172,-0.068001,-0.0065509,0.062306,0.86245,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP,1
CAATGCA_MIR33,SET,88,-0.098715,-0.0068178,0.090435,0.86248,CAATGCA_MIR33,1
HP_DECREASED_CALVARIAL_OSSIF...,SET,17,-0.23245,-0.0070699,0.21292,0.86251,HP_DECREASED_CALVARIAL_OSSIFICATION,1
HP_INCREASED_SERUM_SEROTONIN,SET,9,-0.30353,-0.0067187,0.27797,0.86257,HP_INCREASED_SERUM_SEROTONIN,1
MIR4766_5P,SET,293,-0.055619,-0.0069699,0.05093,0.86259,MIR4766_5P,1
WP_ENDOCHONDRAL_OSSIFICATION,SET,63,-0.12918,-0.0075539,0.11828,0.86261,WP_ENDOCHONDRAL_OSSIFICATION,1
WP_ENDOCHONDRAL_OSSIFICATION...,SET,63,-0.12918,-0.0075539,0.11828,0.86261,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1
HP_ABNORMALITY_OF_SUBCUTANEO...,SET,60,-0.12161,-0.0069409,0.11134,0.86264,HP_ABNORMALITY_OF_SUBCUTANEOUS_FAT_TISSUE,1
GOCC_ATPASE_DEPENDENT_TRANSM...,SET,24,-0.20843,-0.0075309,0.19079,0.86268,GOCC_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX,1
YBX1_TARGET_GENES,SET,57,-0.11916,-0.0066291,0.10906,0.86272,YBX1_TARGET_GENES,1
REACTOME_DNA_REPLICATION,SET,122,-0.076738,-0.0062346,0.070225,0.86274,REACTOME_DNA_REPLICATION,1
GOBP_MOTOR_BEHAVIOR,SET,20,-0.20007,-0.0065998,0.18307,0.86276,GOBP_MOTOR_BEHAVIOR,1
DURANTE_ADULT_OLFACTORY_NEUR...7,SET,31,-0.18247,-0.0074917,0.16697,0.86276,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS,1
BIOCARTA_LAIR_PATHWAY,SET,17,-0.2458,-0.0074761,0.2249,0.86278,BIOCARTA_LAIR_PATHWAY,1
WP_CELLS_AND_MOLECULES_INVOL...,SET,17,-0.2458,-0.0074761,0.2249,0.86278,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,1
GOBP_MUSCLE_CELL_APOPTOTIC_P...,SET,76,-0.10954,-0.007033,0.10022,0.86278,GOBP_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOBP_REGULATION_OF_GLYCOGEN_...3,SET,31,-0.16776,-0.0068877,0.15347,0.86282,GOBP_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
HE_LIM_SUN_FETAL_LUNG_C7_LAT...,SET,90,-0.10576,-0.0073867,0.096725,0.86289,HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL,1
MARTIN_VIRAL_GPCR_SIGNALING_...2,SET,82,-0.10612,-0.0070758,0.097039,0.86291,MARTIN_VIRAL_GPCR_SIGNALING_UP,1
GSE1460_INTRATHYMIC_T_PROGEN...7,SET,178,-0.07091,-0.0069481,0.064842,0.86292,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,1
GOBP_ASPARTATE_FAMILY_AMINO_...1,SET,21,-0.21847,-0.0073845,0.19976,0.86294,GOBP_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GSE29618_PDC_VS_MDC_DAY7_FLU...2,SET,173,-0.073713,-0.0071216,0.067396,0.86296,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP,1
MIR154_5P,SET,61,-0.12574,-0.0072357,0.11496,0.86297,MIR154_5P,1
MYLLYKANGAS_AMPLIFICATION_HO...14,SET,5,-0.34255,-0.0056522,0.31313,0.86301,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30,1
HP_SHORT_4TH_TOE,SET,5,-0.36575,-0.0060349,0.33432,0.86302,HP_SHORT_4TH_TOE,1
GOBP_ACROSOME_ASSEMBLY,SET,25,-0.17879,-0.006593,0.16338,0.86308,GOBP_ACROSOME_ASSEMBLY,1
GSE23984_CTRL_VS_HYPOCALEMIC...2,SET,176,-0.069123,-0.0067352,0.063162,0.8631,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP,1
GOBP_RESPONSE_TO_INTERLEUKIN...6,SET,12,-0.30556,-0.0078091,0.27918,0.86312,GOBP_RESPONSE_TO_INTERLEUKIN_18,1
MIKKELSEN_IPS_LCP_WITH_H3K4M...1,SET,157,-0.074998,-0.0069056,0.068511,0.86317,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1
GSE9988_LPS_VS_LOW_LPS_MONOC...2,SET,137,-0.080887,-0.0069611,0.07388,0.8632,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP,1
GOCC_UBIQUINONE_BIOSYNTHESIS...,SET,6,-0.32097,-0.0058013,0.2931,0.86325,GOCC_UBIQUINONE_BIOSYNTHESIS_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...216,SET,5,-0.32905,-0.0054295,0.30047,0.86326,GOBP_POSITIVE_REGULATION_OF_DNA_LIGATION,1
HP_MENOMETRORRHAGIA,SET,5,-0.51994,-0.0085791,0.47471,0.8633,HP_MENOMETRORRHAGIA,1
BHATI_G2M_ARREST_BY_2METHOXY...1,SET,107,-0.090755,-0.0069081,0.082856,0.86331,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,1
KEGG_ADHERENS_JUNCTION,SET,66,-0.12025,-0.0071967,0.10976,0.86335,KEGG_ADHERENS_JUNCTION,1
GOMF_PHOSPHATIDYLSERINE_FLIP...,SET,4,-0.47079,-0.0069483,0.42971,0.86337,GOMF_PHOSPHATIDYLSERINE_FLIPPASE_ACTIVITY,1
GOBP_METANEPHRIC_TUBULE_DEVE...,SET,23,-0.22026,-0.0077908,0.20095,0.86347,GOBP_METANEPHRIC_TUBULE_DEVELOPMENT,1
GOCC_MICROBODY,SET,132,-0.079962,-0.0067557,0.072952,0.86347,GOCC_MICROBODY,1
GOCC_MULTIVESICULAR_BODY,SET,60,-0.12563,-0.0071702,0.11462,0.86347,GOCC_MULTIVESICULAR_BODY,1
MIR95_5P,SET,606,-0.038507,-0.0068794,0.035122,0.86353,MIR95_5P,1
GOBP_NEGATIVE_REGULATION_OF_...294,SET,149,-0.079543,-0.0071366,0.072546,0.86355,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...133,SET,70,-0.13052,-0.0080438,0.11903,0.86357,GOBP_POSITIVE_REGULATION_OF_CELL_KILLING,1
GOBP_POSITIVE_REGULATION_OF_...613,SET,5,-0.4369,-0.007209,0.39844,0.86357,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
WP_FBXL10_ENHANCEMENT_OF_MAP...,SET,10,-0.27467,-0.0064086,0.25047,0.86359,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,1
NIKOLSKY_BREAST_CANCER_8Q23_...,SET,144,-0.14862,-0.01311,0.13549,0.86366,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1
GOBP_CELLULAR_RESPONSE_TO_LU...,SET,5,-0.46154,-0.0076155,0.42068,0.8637,GOBP_CELLULAR_RESPONSE_TO_LUTEINIZING_HORMONE_STIMULUS,1
GAVIN_FOXP3_TARGETS_CLUSTER_...2,SET,147,-0.077772,-0.0069311,0.070881,0.86372,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1
GOBP_PEROXISOMAL_TRANSPORT,SET,19,-0.19703,-0.006335,0.17948,0.86384,GOBP_PEROXISOMAL_TRANSPORT,1
HP_ABNORMALITY_ON_PULMONARY_...,SET,167,-0.073251,-0.0069543,0.066716,0.86388,HP_ABNORMALITY_ON_PULMONARY_FUNCTION_TESTING,1
GOBP_REGULATION_OF_LUNG_BLOO...,SET,3,-0.57735,-0.0073796,0.52579,0.8639,GOBP_REGULATION_OF_LUNG_BLOOD_PRESSURE,1
HP_CEREBELLAR_CALCIFICATIONS,SET,8,-0.38392,-0.0080122,0.34961,0.86392,HP_CEREBELLAR_CALCIFICATIONS,1
GOBP_PEPTIDYL_LYSINE_TRIMETH...,SET,5,-0.45033,-0.0074306,0.41001,0.86397,GOBP_PEPTIDYL_LYSINE_TRIMETHYLATION,1
GOBP_CRANIAL_GANGLION_DEVELO...,SET,4,-0.51344,-0.0075777,0.46736,0.86402,GOBP_CRANIAL_GANGLION_DEVELOPMENT,1
GOBP_DERMATAN_SULFATE_BIOSYN...,SET,5,-0.4419,-0.0072914,0.40225,0.86402,GOBP_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS,1
GOCC_RNAI_EFFECTOR_COMPLEX,SET,15,-0.26143,-0.0074694,0.23797,0.86402,GOCC_RNAI_EFFECTOR_COMPLEX,1
GOMF_DYNEIN_HEAVY_CHAIN_BIND...,SET,12,-0.23878,-0.0061025,0.21735,0.86402,GOMF_DYNEIN_HEAVY_CHAIN_BINDING,1
GOBP_POSITIVE_T_CELL_SELECTI...,SET,44,-0.15569,-0.0076125,0.14171,0.86403,GOBP_POSITIVE_T_CELL_SELECTION,1
HP_ABNORMAL_CIRCULATING_APOL...,SET,8,-0.29718,-0.006202,0.27049,0.86404,HP_ABNORMAL_CIRCULATING_APOLIPOPROTEIN_CONCENTRATION,1
KEGG_GLYCOSAMINOGLYCAN_BIOSY...2,SET,25,-0.19752,-0.0072837,0.17977,0.86406,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,1
GSE34205_RSV_VS_FLU_INF_INFA...1,SET,175,-0.072669,-0.0070608,0.066113,0.86414,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN,1
DESCARTES_MAIN_FETAL_ENS_GLIA,SET,11,-0.28562,-0.006989,0.25984,0.86415,DESCARTES_MAIN_FETAL_ENS_GLIA,1
GOBP_REGULATION_OF_INTRACELL...3,SET,139,-0.076606,-0.0066403,0.069689,0.86416,GOBP_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
ZNF214_TARGET_GENES,SET,12,-0.28278,-0.0072272,0.2572,0.86421,ZNF214_TARGET_GENES,1
GOMF_BH_DOMAIN_BINDING,SET,10,-0.30926,-0.0072155,0.28108,0.86438,GOMF_BH_DOMAIN_BINDING,1
ACTGCCT_MIR34B,SET,200,-0.066542,-0.0069071,0.060451,0.86449,ACTGCCT_MIR34B,1
GOBP_NEGATIVE_REGULATION_OF_...164,SET,48,-0.12661,-0.006465,0.11499,0.86454,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...800,SET,25,-0.19296,-0.0071155,0.17527,0.86454,GOBP_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,1
HP_GASTROSTOMY_TUBE_FEEDING_...,SET,93,-0.093809,-0.0066596,0.085203,0.86455,HP_GASTROSTOMY_TUBE_FEEDING_IN_INFANCY,1
GSE42724_NAIVE_VS_MEMORY_BCE...2,SET,184,-0.06729,-0.0067025,0.061097,0.86463,GSE42724_NAIVE_VS_MEMORY_BCELL_UP,1
MODULE_99,SET,325,-0.056533,-0.0074546,0.051321,0.86466,MODULE_99,1
AP1_Q4,SET,251,-0.060506,-0.007026,0.054924,0.86468,AP1_Q4,1
GOCC_POSTSYNAPSE,SET,608,-0.039828,-0.0071267,0.036153,0.86468,GOCC_POSTSYNAPSE,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...3,SET,179,-0.0691,-0.0067895,0.062724,0.86468,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN,1
MIR4736,SET,100,-0.093364,-0.0068716,0.084735,0.86473,MIR4736,1
GOBP_ENDOCARDIAL_CUSHION_DEV...,SET,52,-0.15009,-0.0079761,0.13619,0.86477,GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT,1
GGTGAAG_MIR412,SET,54,-0.12847,-0.0069568,0.11655,0.86481,GGTGAAG_MIR412,1
GOCC_CARBOXY_TERMINAL_DOMAIN...,SET,19,-0.17269,-0.0055523,0.15664,0.86485,GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX,1
GCM_SUFU,SET,70,-0.10297,-0.006346,0.093402,0.86486,GCM_SUFU,1
BUSSLINGER_GASTRIC_ISTHMUS_C...,SET,428,-0.046217,-0.0069738,0.041921,0.86487,BUSSLINGER_GASTRIC_ISTHMUS_CELLS,1
TCTAGAG_MIR517,SET,41,-0.14722,-0.0069492,0.13351,0.86491,TCTAGAG_MIR517,1
GSE40274_CTRL_VS_SATB1_TRANS...2,SET,150,-0.079224,-0.0071316,0.071814,0.86502,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_SMALL_MOLECULE_METABOLI...,SET,1628,-0.024685,-0.0070171,0.022374,0.86504,GOBP_SMALL_MOLECULE_METABOLIC_PROCESS,1
chr16p13,SET,209,-0.13565,-0.01439,0.12293,0.86507,chr16p13,1
GOBP_RNA_SPLICING_VIA_ENDONU...,SET,13,-0.27044,-0.0071938,0.24509,0.86508,GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION,1
HP_ABNORMAL_EYELID_PHYSIOLOGY,SET,36,-0.15686,-0.0069391,0.14213,0.86512,HP_ABNORMAL_EYELID_PHYSIOLOGY,1
HORIUCHI_WTAP_TARGETS_UP,SET,269,-0.060329,-0.0072487,0.054661,0.86513,HORIUCHI_WTAP_TARGETS_UP,1
GOBP_REGULATION_OF_COLLAGEN_...1,SET,8,-0.29744,-0.0062074,0.26944,0.86517,GOBP_REGULATION_OF_COLLAGEN_FIBRIL_ORGANIZATION,1
GSE13522_WT_VS_IFNAR_KO_SKIN...4,SET,177,-0.071689,-0.0070048,0.064942,0.86517,GSE13522_WT_VS_IFNAR_KO_SKIN_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...7,SET,98,-0.099002,-0.0072137,0.089676,0.86519,GOBP_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION,1
GARGALOVIC_RESPONSE_TO_OXIDI...8,SET,25,-0.20428,-0.0075329,0.18502,0.86521,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,1
HP_HEMORRHAGE_OF_THE_EYE,SET,45,-0.14073,-0.0069588,0.12741,0.86533,HP_HEMORRHAGE_OF_THE_EYE,1
HP_ERYTHEMATOUS_PLAQUE,SET,13,-0.24115,-0.0064147,0.21825,0.8654,HP_ERYTHEMATOUS_PLAQUE,1
GOCC_PROTEASOME_CORE_COMPLEX...1,SET,8,-0.2467,-0.0051485,0.22319,0.86548,GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX,1
HP_CELIAC_DISEASE,SET,52,-0.1366,-0.0072593,0.12358,0.86549,HP_CELIAC_DISEASE,1
KEGG_MEDICUS_PATHOGEN_SALMON...9,SET,5,-0.34747,-0.0057333,0.3143,0.86553,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SPVD_TO_TNF_NFKB_SIGNALING_PATHWAY,1
MIR6773_5P,SET,33,-0.15504,-0.006567,0.14024,0.86553,MIR6773_5P,1
GOBP_ONCOGENE_INDUCED_CELL_S...,SET,6,-0.33301,-0.0060189,0.30113,0.86559,GOBP_ONCOGENE_INDUCED_CELL_SENESCENCE,1
HP_APLASIA_HYPOPLASIA_OF_THE...51,SET,17,-0.23454,-0.0071334,0.21208,0.8656,HP_APLASIA_HYPOPLASIA_OF_THE_PALMAR_CREASES,1
GOCC_INTRACELLULAR_CYCLIC_NU...,SET,5,-0.41794,-0.0068962,0.3779,0.86562,GOCC_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_COMPLEX,1
GOBP_SIRNA_PROCESSING,SET,8,-0.34656,-0.0072325,0.3133,0.86566,GOBP_SIRNA_PROCESSING,1
HP_SPARSE_HAIR,SET,332,-0.051587,-0.006874,0.046637,0.86566,HP_SPARSE_HAIR,1
HP_INCREASED_CIRCULATING_GON...,SET,75,-0.10799,-0.0068879,0.097623,0.86567,HP_INCREASED_CIRCULATING_GONADOTROPIN_LEVEL,1
GOMF_NUCLEOBASE_TRANSMEMBRAN...,SET,10,-0.30309,-0.0070716,0.27397,0.86569,GOMF_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABSENT_SPEECH,SET,364,-0.048625,-0.0067783,0.043953,0.86569,HP_ABSENT_SPEECH,1
GSE20366_CD103_POS_VS_NEG_TR...2,SET,179,-0.071679,-0.0070429,0.064785,0.86572,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP,1
CHEMELLO_SOLEUS_VS_EDL_MYOFI...1,SET,5,-0.44172,-0.0072884,0.39921,0.86573,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,1
KEGG_PROSTATE_CANCER,SET,86,-0.10063,-0.0068708,0.090945,0.86573,KEGG_PROSTATE_CANCER,1
GOMF_INTRAMEMBRANE_LIPID_TRA...,SET,41,-0.15702,-0.0074118,0.14191,0.86573,GOMF_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,1
GOBP_ATP_SYNTHESIS_COUPLED_E...,SET,81,-0.092865,-0.0061546,0.083905,0.8658,GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,1
MIR384,SET,109,-0.089674,-0.0068889,0.081007,0.86584,MIR384,1
GSE17721_0.5H_VS_4H_CPG_BMDC...1,SET,188,-0.070731,-0.0071206,0.063884,0.86588,GSE17721_0.5H_VS_4H_CPG_BMDC_DN,1
GINESTIER_BREAST_CANCER_ZNF2...2,SET,63,-0.11193,-0.0065455,0.10109,0.86591,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,1
KEGG_GLYCEROLIPID_METABOLISM,SET,41,-0.1514,-0.0071465,0.1367,0.86596,KEGG_GLYCEROLIPID_METABOLISM,1
MIR550A_3_5P_MIR550A_5P,SET,67,-0.12164,-0.0073348,0.10982,0.86599,MIR550A_3_5P_MIR550A_5P,1
DESCARTES_FETAL_SPLEEN_STROM...,SET,31,-0.19463,-0.0079907,0.17569,0.86602,DESCARTES_FETAL_SPLEEN_STROMAL_CELLS,1
REACTOME_FREE_FATTY_ACID_REC...,SET,4,-0.56296,-0.0083085,0.50811,0.86605,REACTOME_FREE_FATTY_ACID_RECEPTORS,1
RBL1_TARGET_GENES,SET,36,-0.15468,-0.0068428,0.13961,0.86606,RBL1_TARGET_GENES,1
GOBP_NITRIC_OXIDE_MEDIATED_S...,SET,18,-0.25327,-0.0079264,0.22857,0.86608,GOBP_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,1
GAVISH_3CA_METAPROGRAM_MACRO...4,SET,46,-0.15095,-0.0075462,0.13622,0.86609,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_1,1
WP_MICRORNA_NETWORK_ASSOCIAT...,SET,4,-0.50378,-0.0074351,0.45454,0.86613,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,1
GSE40666_UNTREATED_VS_IFNA_S...5,SET,181,-0.071514,-0.0070655,0.064524,0.86613,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN,1
MORF_SART1,SET,58,-0.1124,-0.0063076,0.1014,0.86616,MORF_SART1,1
GSE2770_TGFB_AND_IL4_VS_TGFB...6,SET,177,-0.071362,-0.0069729,0.064374,0.86618,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
GSE44649_WT_VS_MIR155_KO_ACT...1,SET,182,-0.068732,-0.0068091,0.061987,0.86624,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN,1
REACTOME_ACTIVATION_OF_THE_A...,SET,10,-0.32582,-0.007602,0.29383,0.86626,REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS,1
REACTOME_DEFECTS_IN_BIOTIN_B...,SET,8,-0.34005,-0.0070967,0.30657,0.86632,REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM,1
GSE22432_PDC_VS_TGFB1_TREATE...2,SET,168,-0.069008,-0.0065709,0.062211,0.86633,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP,1
REACTOME_NUCLEAR_EVENTS_STIM...,SET,32,-0.16992,-0.0070878,0.15317,0.86636,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1
BLANCO_MELO_MERS_COV_INFECTI...2,SET,230,-0.063449,-0.0070569,0.057179,0.86642,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1
MIR5700,SET,269,-0.058917,-0.007079,0.053089,0.86645,MIR5700,1
GOBP_REGULATION_OF_CARBOHYDR...1,SET,88,-0.10332,-0.0071359,0.093089,0.86647,GOBP_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,1
CTAGGAA_MIR384,SET,56,-0.12621,-0.0069597,0.11369,0.86653,CTAGGAA_MIR384,1
GOBP_AMPA_GLUTAMATE_RECEPTOR...,SET,9,-0.33011,-0.0073069,0.29725,0.8666,GOBP_AMPA_GLUTAMATE_RECEPTOR_CLUSTERING,1
GOBP_POSITIVE_REGULATION_OF_...23,SET,38,-0.16969,-0.0077121,0.15281,0.8666,GOBP_POSITIVE_REGULATION_OF_AMINE_TRANSPORT,1
HP_LARGE_FONTANELLES,SET,151,-0.078379,-0.0070788,0.070578,0.86661,HP_LARGE_FONTANELLES,1
GOMF_NUCLEOSIDE_TRANSMEMBRAN...,SET,10,-0.33584,-0.0078357,0.30238,0.86663,GOMF_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_TACHYKININ_RECEPTOR...,SET,5,-0.4492,-0.0074119,0.40438,0.86667,REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS,1
GOMF_HEMOGLOBIN_BINDING,SET,8,-0.39658,-0.0082764,0.35695,0.86671,GOMF_HEMOGLOBIN_BINDING,1
GOCC_GLYCOPROTEIN_IB_IX_V_CO...,SET,4,-0.5532,-0.0081645,0.49788,0.86673,GOCC_GLYCOPROTEIN_IB_IX_V_COMPLEX,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...8,SET,8,-0.31787,-0.0066337,0.28608,0.86673,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP,1
MIR1236_3P,SET,170,-0.074428,-0.0071286,0.066981,0.86675,MIR1236_3P,1
GOBP_GLIAL_CELL_DERIVED_NEUR...,SET,15,-0.24548,-0.0070138,0.22092,0.86675,GOBP_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOCC_DENDRITE_MEMBRANE,SET,37,-0.16204,-0.0072668,0.14582,0.86675,GOCC_DENDRITE_MEMBRANE,1
HALLMARK_TNFA_SIGNALING_VIA_...,SET,188,-0.075125,-0.007563,0.067598,0.86678,HALLMARK_TNFA_SIGNALING_VIA_NFKB,1
HP_HEMATEMESIS,SET,17,-0.24738,-0.0075242,0.22259,0.86679,HP_HEMATEMESIS,1
KEGG_MEDICUS_REFERENCE_LEUCI...,SET,7,-0.33662,-0.0065715,0.30283,0.86683,KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION,1
GOBP_NEGATIVE_REGULATION_OF_...446,SET,5,-0.48859,-0.0080619,0.43953,0.86685,GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
HP_ABNORMAL_CIRCULATING_FREE...3,SET,7,-0.31503,-0.0061502,0.28335,0.86688,HP_ABNORMAL_CIRCULATING_FREE_T4_CONCENTRATION,1
HP_NARROW_NARIS,SET,8,-0.28211,-0.0058874,0.25368,0.86694,HP_NARROW_NARIS,1
GOBP_NEURON_MATURATION,SET,46,-0.1438,-0.0071887,0.1293,0.86695,GOBP_NEURON_MATURATION,1
HP_SUBGLOTTIC_STENOSIS,SET,14,-0.24931,-0.0068819,0.22415,0.86698,HP_SUBGLOTTIC_STENOSIS,1
HP_MACULAR_SCAR,SET,5,-0.46467,-0.0076672,0.41771,0.86702,HP_MACULAR_SCAR,1
MIR370_5P,SET,67,-0.11667,-0.007035,0.10486,0.86706,MIR370_5P,1
MIR4478,SET,162,-0.075098,-0.007023,0.067478,0.86712,MIR4478,1
GSE37532_TREG_VS_TCONV_CD4_T...4,SET,118,-0.093777,-0.0074938,0.084251,0.86715,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,1
ANDERSON_BLOOD_CN54GP140_ADJ...6,SET,31,-0.17157,-0.0070441,0.15412,0.86719,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_UP,1
HP_PERIVENTRICULAR_LEUKOMALA...,SET,38,-0.14799,-0.0067258,0.13293,0.8672,HP_PERIVENTRICULAR_LEUKOMALACIA,1
AACTTT_UNKNOWN,SET,1693,-0.02551,-0.0073806,0.02291,0.86724,AACTTT_UNKNOWN,1
GSE40274_CTRL_VS_FOXP3_AND_P...2,SET,152,-0.078076,-0.0070745,0.0701,0.86731,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_IL1_I...1,SET,17,-0.24999,-0.0076034,0.22442,0.86734,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY,1
GOBP_ENDOCARDIAL_CUSHION_FOR...,SET,30,-0.20203,-0.00816,0.18135,0.86736,GOBP_ENDOCARDIAL_CUSHION_FORMATION,1
GOBP_REGULATION_OF_CALCIUM_M...,SET,92,-0.10293,-0.007268,0.092395,0.86736,GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
GSE17721_CTRL_VS_CPG_8H_BMDC...2,SET,178,-0.06943,-0.006803,0.062298,0.86745,GSE17721_CTRL_VS_CPG_8H_BMDC_UP,1
GOBP_TRIGLYCERIDE_RICH_LIPOP...1,SET,4,-0.52867,-0.0078024,0.47436,0.86746,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE,1
REACTOME_SPECIFICATION_OF_PR...,SET,11,-0.29355,-0.007183,0.26338,0.86747,REACTOME_SPECIFICATION_OF_PRIMORDIAL_GERM_CELLS,1
GOBP_CELLULAR_COMPONENT_MAIN...,SET,64,-0.12684,-0.0074758,0.1138,0.86748,GOBP_CELLULAR_COMPONENT_MAINTENANCE,1
GOMF_PURINE_NUCLEOTIDE_TRANS...,SET,25,-0.20539,-0.007574,0.18428,0.86748,GOMF_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE21380_TFH_VS_GERMINAL_CEN...2,SET,183,-0.073392,-0.0072906,0.065842,0.8675,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,1
GOBP_REGULATION_OF_MUSCLE_AD...,SET,73,-0.12081,-0.0076027,0.10837,0.86754,GOBP_REGULATION_OF_MUSCLE_ADAPTATION,1
KEGG_MEDICUS_PATHOGEN_ESCHER...6,SET,13,-0.24249,-0.0064503,0.21749,0.86755,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY,1
GOBP_BRANCHED_CHAIN_AMINO_AC...2,SET,21,-0.19451,-0.0065744,0.17445,0.86756,GOBP_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS,1
WP_10Q22Q23_COPY_NUMBER_VARI...,SET,55,-0.142,-0.0077604,0.12735,0.86758,WP_10Q22Q23_COPY_NUMBER_VARIATION,1
MIR1303,SET,189,-0.069947,-0.0070602,0.062722,0.86761,MIR1303,1
HP_APNEIC_EPISODES_IN_INFANCY,SET,9,-0.31489,-0.00697,0.28234,0.86763,HP_APNEIC_EPISODES_IN_INFANCY,1
GOBP_HEART_TRABECULA_FORMATI...,SET,15,-0.26621,-0.0076061,0.23868,0.86764,GOBP_HEART_TRABECULA_FORMATION,1
GOMF_3_KETO_STEROL_REDUCTASE...,SET,5,-0.45142,-0.0074485,0.40464,0.8677,GOMF_3_KETO_STEROL_REDUCTASE_ACTIVITY,1
HP_RETINOPATHY_OF_PREMATURITY,SET,4,-0.43696,-0.006449,0.39165,0.86772,HP_RETINOPATHY_OF_PREMATURITY,1
GSE23568_CTRL_TRANSDUCED_VS_...1,SET,187,-0.067378,-0.0067652,0.060389,0.86772,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN,1
POU6F1_01,SET,211,-0.071068,-0.0075748,0.063696,0.86773,POU6F1_01,1
HP_DECREASED_CIRCULATING_REN...,SET,11,-0.29018,-0.0071007,0.26008,0.86773,HP_DECREASED_CIRCULATING_RENIN_LEVEL,1
GOBP_BRONCHUS_DEVELOPMENT,SET,11,-0.33062,-0.0080903,0.29619,0.86783,GOBP_BRONCHUS_DEVELOPMENT,1
GSE9878_CTRL_VS_EBF_TRANSDUC...2,SET,189,-0.07025,-0.0070907,0.062935,0.86783,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP,1
ZNF239_TARGET_GENES,SET,32,-0.17589,-0.0073368,0.15756,0.86785,ZNF239_TARGET_GENES,1
GSE43955_1H_VS_10H_ACT_CD4_T...2,SET,185,-0.068382,-0.0068296,0.061255,0.86786,GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP,1
DESCARTES_MAIN_FETAL_RETINAL...2,SET,43,-0.1494,-0.0072219,0.13383,0.86787,DESCARTES_MAIN_FETAL_RETINAL_PROGENITORS_AND_MULLER_GLIA,1
REACTOME_MATURATION_OF_TCA_E...,SET,19,-0.21307,-0.0068507,0.19076,0.86798,REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE,1
GOBP_EPIBOLY,SET,39,-0.14679,-0.0067582,0.13139,0.86804,GOBP_EPIBOLY,1
REACTOME_AMINO_ACID_CONJUGAT...,SET,8,-0.48979,-0.010222,0.43833,0.86808,REACTOME_AMINO_ACID_CONJUGATION,1
MIR3662,SET,850,-0.034315,-0.0072105,0.030694,0.8682,MIR3662,1
HP_SHOULDER_GIRDLE_MUSCLE_AT...,SET,13,-0.28112,-0.0074778,0.25141,0.86825,HP_SHOULDER_GIRDLE_MUSCLE_ATROPHY,1
GSE36888_UNTREATED_VS_IL2_TR...6,SET,171,-0.076579,-0.007356,0.068482,0.86826,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP,1
chr4q35,SET,36,-0.28036,-0.012403,0.2507,0.86828,chr4q35,1
WP_TRYPTOPHAN_METABOLISM,SET,29,-0.19294,-0.0076622,0.17252,0.86829,WP_TRYPTOPHAN_METABOLISM,1
GOBP_REGULATION_OF_T_HELPER_...5,SET,31,-0.18932,-0.0077727,0.16928,0.86829,GOBP_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
GSE3720_LPS_VS_PMA_STIM_VD2_...2,SET,118,-0.087048,-0.0069561,0.077827,0.86831,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,1
GOBP_SKELETAL_MUSCLE_SATELLI...2,SET,11,-0.27319,-0.006685,0.24424,0.86832,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_DIFFERENTIATION,1
ELK1_01,SET,253,-0.059913,-0.0069844,0.053554,0.86837,ELK1_01,1
REACTOME_REGULATION_OF_MRNA_...,SET,83,-0.099543,-0.0066777,0.08897,0.86839,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1
GOCC_GOLGI_STACK,SET,125,-0.084673,-0.0069627,0.075679,0.86839,GOCC_GOLGI_STACK,1
GOBP_POSITIVE_REGULATION_OF_...246,SET,57,-0.14388,-0.0080046,0.12859,0.8684,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
GOCC_LEADING_EDGE_MEMBRANE,SET,170,-0.074683,-0.007153,0.066746,0.86841,GOCC_LEADING_EDGE_MEMBRANE,1
WP_ENDOTHELIN_PATHWAYS,SET,31,-0.1891,-0.0077639,0.16895,0.86849,WP_ENDOTHELIN_PATHWAYS,1
GOBP_RETINOL_METABOLIC_PROCE...,SET,50,-0.1492,-0.0077753,0.13328,0.86851,GOBP_RETINOL_METABOLIC_PROCESS,1
GOMF_THREONINE_TYPE_ENDOPEPT...,SET,9,-0.31497,-0.0069718,0.28135,0.86853,GOMF_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
APPIERTO_RESPONSE_TO_FENRETI...1,SET,43,-0.13448,-0.0065004,0.12011,0.86856,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,1
GOMF_COPPER_CHAPERONE_ACTIVI...,SET,6,-0.31725,-0.0057341,0.28335,0.86856,GOMF_COPPER_CHAPERONE_ACTIVITY,1
GOCC_SPECIFIC_GRANULE_MEMBRA...,SET,84,-0.104,-0.0070184,0.092882,0.86857,GOCC_SPECIFIC_GRANULE_MEMBRANE,1
HP_ELEVATED_CIRCULATING_THYR...,SET,27,-0.19263,-0.0073816,0.17203,0.86858,HP_ELEVATED_CIRCULATING_THYROID_STIMULATING_HORMONE_CONCENTRATION,1
NAKAYA_MYELOID_DENDRITIC_CEL...3,SET,247,-0.058274,-0.0067135,0.05204,0.86859,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
KEGG_MEDICUS_REFERENCE_TNFSF...,SET,5,-0.49116,-0.0081042,0.43859,0.8686,KEGG_MEDICUS_REFERENCE_TNFSF10_RIPK1_3_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_MICROTUBU...2,SET,235,-0.059833,-0.0067257,0.053431,0.8686,GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS,1
GSE42088_2H_VS_24H_LEISHMANI...2,SET,176,-0.073148,-0.0071274,0.065318,0.86861,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,SET,189,-0.069581,-0.0070232,0.062114,0.86868,DAZARD_RESPONSE_TO_UV_NHEK_UP,1
HP_VERTEBRAL_COMPRESSION_FRA...,SET,32,-0.16475,-0.006872,0.14707,0.86868,HP_VERTEBRAL_COMPRESSION_FRACTURE,1
GSE20727_ROS_INH_VS_ROS_INH_...2,SET,177,-0.07278,-0.0071115,0.064967,0.86869,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,1
GOBP_POLYOL_TRANSMEMBRANE_TR...,SET,10,-0.34671,-0.0080892,0.30947,0.8687,GOBP_POLYOL_TRANSMEMBRANE_TRANSPORT,1
HP_ABNORMAL_CIRCULATING_PHEN...,SET,9,-0.34047,-0.0075364,0.3039,0.86871,HP_ABNORMAL_CIRCULATING_PHENYLALANINE_CONCENTRATION,1
MIR651_3P,SET,728,-0.036528,-0.007128,0.032603,0.86872,MIR651_3P,1
KEGG_MEDICUS_REFERENCE_BMP_S...1,SET,20,-0.22706,-0.0074901,0.20265,0.86874,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY,1
HP_CRYPTOZOOSPERMIA,SET,6,-0.38017,-0.0068715,0.3393,0.86874,HP_CRYPTOZOOSPERMIA,1
GOMF_TRANSLATION_REPRESSOR_A...,SET,30,-0.16084,-0.0064962,0.14354,0.86875,GOMF_TRANSLATION_REPRESSOR_ACTIVITY,1
REACTOME_REGULATION_OF_PTEN_...2,SET,7,-0.4313,-0.00842,0.38487,0.86877,REACTOME_REGULATION_OF_PTEN_LOCALIZATION,1
GOCC_GOLGI_LUMEN,SET,88,-0.10779,-0.0074446,0.096185,0.86877,GOCC_GOLGI_LUMEN,1
GOMF_EUKARYOTIC_INITIATION_F...,SET,9,-0.26979,-0.0059718,0.24075,0.86877,GOMF_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING,1
GOCC_AXON_HILLOCK,SET,7,-0.36439,-0.0071137,0.32505,0.86885,GOCC_AXON_HILLOCK,1
REACTOME_NICOTINAMIDE_SALVAG...,SET,17,-0.23724,-0.0072157,0.2116,0.86888,REACTOME_NICOTINAMIDE_SALVAGING,1
HP_PROGRESSIVE_FLEXION_CONTR...,SET,6,-0.46882,-0.0084737,0.41815,0.86888,HP_PROGRESSIVE_FLEXION_CONTRACTURES,1
GSE42088_UNINF_VS_LEISHMANIA...6,SET,183,-0.071916,-0.007144,0.064137,0.86891,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP,1
GSE26030_TH1_VS_TH17_DAY15_P...2,SET,181,-0.070346,-0.0069501,0.062735,0.86892,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP,1
KEGG_MEDICUS_ENV_FACTOR_TCDD...,SET,19,-0.26596,-0.0085512,0.23716,0.86894,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY,1
HP_ABNORMAL_HEAD_MOVEMENTS,SET,33,-0.17651,-0.0074763,0.15739,0.86894,HP_ABNORMAL_HEAD_MOVEMENTS,1
GOMF_PROTEIN_TYROSINE_KINASE...1,SET,29,-0.20056,-0.0079647,0.17882,0.86897,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
GSE3982_BASOPHIL_VS_TH2_UP,SET,172,-0.073939,-0.0071229,0.065925,0.86897,GSE3982_BASOPHIL_VS_TH2_UP,1
SKIL_TARGET_GENES,SET,1478,-0.026502,-0.0072104,0.023627,0.869,SKIL_TARGET_GENES,1
HP_PYODERMA_GANGRENOSUM,SET,11,-0.28351,-0.0069374,0.25275,0.869,HP_PYODERMA_GANGRENOSUM,1
MODULE_343,SET,24,-0.18199,-0.0065756,0.16224,0.86901,MODULE_343,1
HP_ABNORMAL_FACTOR_VIII_ACTI...,SET,4,-0.4765,-0.0070324,0.42477,0.86902,HP_ABNORMAL_FACTOR_VIII_ACTIVITY,1
MATZUK_POSTIMPLANTATION_AND_...,SET,13,-0.28401,-0.0075546,0.25305,0.86913,MATZUK_POSTIMPLANTATION_AND_POSTPARTUM,1
GOMF_PROTEIN_CYSTEINE_S_STEA...,SET,6,-0.38112,-0.0068885,0.33956,0.86914,GOMF_PROTEIN_CYSTEINE_S_STEAROYLTRANSFERASE_ACTIVITY,1
CREB_Q3,SET,238,-0.0632,-0.0071488,0.056307,0.86915,CREB_Q3,1
GOBP_POSITIVE_REGULATION_OF_...385,SET,7,-0.42795,-0.0083546,0.38127,0.86915,GOBP_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
FONTAINE_PAPILLARY_THYROID_C...1,SET,73,-0.11713,-0.0073713,0.10435,0.86917,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,1
GSE3982_CTRL_VS_PMA_STIM_EOS...1,SET,174,-0.075147,-0.0072808,0.066943,0.86918,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN,1
GOBP_L_GLUTAMATE_IMPORT_ACRO...,SET,17,-0.24775,-0.0075354,0.22066,0.86923,GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
DESCARTES_MAIN_FETAL_GRANULE...,SET,14,-0.27401,-0.0075636,0.24404,0.86924,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,1
HP_BILATERAL_CHOANAL_ATRESIA,SET,9,-0.27141,-0.0060077,0.24167,0.86929,HP_BILATERAL_CHOANAL_ATRESIA,1
GSE20152_HTNFA_OVERXPRESS_AN...1,SET,173,-0.070332,-0.0067949,0.062603,0.86937,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN,1
GSE46606_UNSTIM_VS_CD40L_IL2...10,SET,187,-0.067066,-0.0067338,0.059683,0.86942,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,1
HP_RECURRENT_TONSILLITIS,SET,12,-0.29838,-0.0076258,0.26552,0.86943,HP_RECURRENT_TONSILLITIS,1
MAHADEVAN_GIST_MORPHOLOGICAL...,SET,14,-0.28666,-0.0079128,0.25505,0.86948,MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,1
GSE7852_TREG_VS_TCONV_UP,SET,181,-0.074189,-0.0073298,0.066007,0.86948,GSE7852_TREG_VS_TCONV_UP,1
BOYLAN_MULTIPLE_MYELOMA_PCA1...2,SET,98,-0.10393,-0.0075728,0.092446,0.86953,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1
HALLMARK_ANGIOGENESIS,SET,35,-0.17558,-0.0076589,0.15618,0.86954,HALLMARK_ANGIOGENESIS,1
HP_FIFTH_FINGER_DISTAL_PHALA...,SET,27,-0.18189,-0.0069702,0.16177,0.86957,HP_FIFTH_FINGER_DISTAL_PHALANX_CLINODACTYLY,1
ZHONG_PFC_C8_UNKNOWN_NEUROD2...,SET,80,-0.1138,-0.0074957,0.1012,0.86959,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,1
DELACROIX_RAR_TARGETS_DN,SET,25,-0.19626,-0.007237,0.1744,0.86977,DELACROIX_RAR_TARGETS_DN,1
MODULE_522,SET,30,-0.18147,-0.0073296,0.16125,0.86978,MODULE_522,1
PID_S1P_S1P3_PATHWAY,SET,29,-0.18465,-0.0073329,0.16404,0.86984,PID_S1P_S1P3_PATHWAY,1
HALLMARK_XENOBIOTIC_METABOLI...,SET,192,-0.071386,-0.0072618,0.063411,0.86986,HALLMARK_XENOBIOTIC_METABOLISM,1
GNF2_SELL,SET,44,-0.14198,-0.0069421,0.12611,0.86988,GNF2_SELL,1
CDP_01,SET,87,-0.11447,-0.0078613,0.10163,0.86999,CDP_01,1
WP_NAD_METABOLISM,SET,15,-0.24355,-0.0069585,0.21622,0.87,WP_NAD_METABOLISM,1
KEGG_TYPE_II_DIABETES_MELLIT...,SET,46,-0.15339,-0.0076681,0.13614,0.87005,KEGG_TYPE_II_DIABETES_MELLITUS,1
PID_FOXO_PATHWAY,SET,47,-0.14258,-0.0072046,0.12654,0.87006,PID_FOXO_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...183,SET,121,-0.087089,-0.0070467,0.077293,0.87007,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...262,SET,14,-0.28126,-0.0077637,0.24962,0.87007,GOBP_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,1
GOBP_EXOCRINE_SYSTEM_DEVELOP...,SET,48,-0.1455,-0.0074299,0.12912,0.87009,GOBP_EXOCRINE_SYSTEM_DEVELOPMENT,1
HP_INTESTINAL_CARCINOID,SET,6,-0.37429,-0.0067651,0.33213,0.87011,HP_INTESTINAL_CARCINOID,1
HP_PANIC_ATTACK,SET,49,-0.13231,-0.0068263,0.1174,0.87013,HP_PANIC_ATTACK,1
GSE6090_UNSTIM_VS_DC_SIGN_ST...1,SET,128,-0.089414,-0.0074397,0.079337,0.87013,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN,1
MIR4286,SET,79,-0.10375,-0.0067909,0.092035,0.87018,MIR4286,1
ZNF623_TARGET_GENES,SET,335,-0.052452,-0.0070203,0.046528,0.87019,ZNF623_TARGET_GENES,1
GSE19923_E2A_KO_VS_E2A_AND_H...2,SET,194,-0.06781,-0.0069335,0.060151,0.87019,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP,1
GOBP_NECROPTOTIC_SIGNALING_P...,SET,8,-0.37008,-0.0077234,0.32827,0.8702,GOBP_NECROPTOTIC_SIGNALING_PATHWAY,1
ZHONG_PFC_C5_BCL11B_CALB2_PO...,SET,22,-0.21715,-0.0075124,0.19262,0.8702,ZHONG_PFC_C5_BCL11B_CALB2_POS_INP,1
KYNG_WERNER_SYNDROM_UP,SET,11,-0.27826,-0.006809,0.2468,0.87023,KYNG_WERNER_SYNDROM_UP,1
TCF11MAFG_01,SET,182,-0.073086,-0.0072406,0.064812,0.87026,TCF11MAFG_01,1
GOBP_POSITIVE_REGULATION_BY_...3,SET,17,-0.21,-0.006387,0.18622,0.87027,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,1
GOBP_REGULATION_OF_ANTIGEN_P...1,SET,18,-0.25402,-0.0079497,0.22519,0.87033,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_GLOSSOPTOSIS,SET,25,-0.19302,-0.0071179,0.17107,0.87041,HP_GLOSSOPTOSIS,1
YU_MYC_TARGETS_UP,SET,41,-0.14909,-0.0070376,0.1321,0.87047,YU_MYC_TARGETS_UP,1
HP_PANNICULITIS,SET,25,-0.20049,-0.0073931,0.17763,0.87047,HP_PANNICULITIS,1
TEF1_Q6,SET,209,-0.06867,-0.0072848,0.060829,0.87052,TEF1_Q6,1
GNF2_MSN,SET,20,-0.20912,-0.0068984,0.18519,0.87059,GNF2_MSN,1
GOBP_REGULATION_OF_NMDA_RECE...,SET,14,-0.2584,-0.0071326,0.22883,0.87059,GOBP_REGULATION_OF_NMDA_RECEPTOR_ACTIVITY,1
GOBP_T_CELL_PROLIFERATION_IN...,SET,5,-0.46699,-0.0077054,0.41337,0.87069,GOBP_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,1
MURAKAMI_UV_RESPONSE_6HR_UP,SET,31,-0.17376,-0.007134,0.1538,0.87071,MURAKAMI_UV_RESPONSE_6HR_UP,1
GOBP_MIRNA_PROCESSING,SET,40,-0.14428,-0.0067268,0.12767,0.87076,GOBP_MIRNA_PROCESSING,1
HP_CALCIFICATION_OF_THE_AORTA,SET,21,-0.22397,-0.0075702,0.19815,0.87082,HP_CALCIFICATION_OF_THE_AORTA,1
GOBP_FILOPODIUM_ASSEMBLY,SET,60,-0.13665,-0.007799,0.12089,0.87084,GOBP_FILOPODIUM_ASSEMBLY,1
MORF_CSNK2B,SET,251,-0.057246,-0.0066474,0.050639,0.87085,MORF_CSNK2B,1
WP_MITOCHONDRIAL_GENE_EXPRES...,SET,18,-0.24835,-0.0077723,0.21966,0.87088,WP_MITOCHONDRIAL_GENE_EXPRESSION,1
HP_TARSAL_SYNOSTOSIS,SET,21,-0.24071,-0.0081363,0.2129,0.87089,HP_TARSAL_SYNOSTOSIS,1
GOBP_REGULATION_OF_T_HELPER_...6,SET,12,-0.28974,-0.0074049,0.25617,0.87097,GOBP_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
GSE2128_CTRL_VS_MIMETOPE_NEG...4,SET,178,-0.074385,-0.0072886,0.065759,0.871,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP,1
HP_ABNORMAL_4TH_FINGER_MORPH...,SET,20,-0.23806,-0.007853,0.21042,0.87105,HP_ABNORMAL_4TH_FINGER_MORPHOLOGY,1
OCT1_B,SET,225,-0.068771,-0.0075663,0.06078,0.87107,OCT1_B,1
CAGGTCC_MIR492,SET,54,-0.12478,-0.0067571,0.11027,0.87109,CAGGTCC_MIR492,1
GOBP_CALCIUM_ION_TRANSMEMBRA...1,SET,172,-0.078307,-0.0075437,0.069193,0.87112,GOBP_CALCIUM_ION_TRANSMEMBRANE_IMPORT_INTO_CYTOSOL,1
HP_LARYNGEAL_CLEFT,SET,6,-0.49889,-0.0090172,0.44074,0.87116,HP_LARYNGEAL_CLEFT,1
GSE25085_FETAL_BM_VS_ADULT_B...2,SET,186,-0.072505,-0.0072607,0.064055,0.87116,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,1
GOBP_POSITIVE_REGULATION_OF_...743,SET,15,-0.25687,-0.0073391,0.22691,0.87118,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
GSE35685_CD34POS_CD38NEG_VS_...1,SET,189,-0.069847,-0.0070501,0.061701,0.87118,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN,1
MIKKELSEN_MCV6_ICP_WITH_H3K2...,SET,74,-0.12281,-0.0077811,0.10848,0.8712,MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,1
GOMF_RNA_DNA_HYBRID_RIBONUCL...,SET,6,-0.41907,-0.0075746,0.37004,0.87128,GOMF_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY,1
GOMF_RNA_DIRECTED_DNA_POLYME...,SET,6,-0.37272,-0.0067368,0.32907,0.87131,GOMF_RNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
GOBP_HEPATOCYTE_APOPTOTIC_PR...,SET,19,-0.21739,-0.0069897,0.19192,0.87133,GOBP_HEPATOCYTE_APOPTOTIC_PROCESS,1
HP_EEG_WITH_GENERALIZED_SHAR...,SET,8,-0.35297,-0.0073663,0.31159,0.87134,HP_EEG_WITH_GENERALIZED_SHARP_SLOW_WAVES,1
GOBP_REGULATION_OF_ACTION_PO...,SET,52,-0.14674,-0.0077985,0.12952,0.87137,GOBP_REGULATION_OF_ACTION_POTENTIAL,1
REACTOME_ASYMMETRIC_LOCALIZA...,SET,61,-0.11397,-0.0065585,0.10059,0.87138,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1
DESCARTES_FETAL_CEREBELLUM_I...,SET,24,-0.23186,-0.0083774,0.20457,0.87147,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,1
GOMF_ADENOSINE_DEAMINASE_ACT...,SET,12,-0.28704,-0.0073359,0.25323,0.87149,GOMF_ADENOSINE_DEAMINASE_ACTIVITY,1
GOBP_REGULATION_OF_AUTOPHAGY...2,SET,10,-0.34096,-0.0079551,0.30077,0.87151,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
KIM_WT1_TARGETS_12HR_DN,SET,202,-0.067119,-0.0070014,0.059205,0.87153,KIM_WT1_TARGETS_12HR_DN,1
GSE7852_TREG_VS_TCONV_LN_DN,SET,182,-0.075483,-0.007478,0.066581,0.87153,GSE7852_TREG_VS_TCONV_LN_DN,1
HP_NARROW_FOREHEAD,SET,150,-0.076788,-0.0069123,0.067722,0.87157,HP_NARROW_FOREHEAD,1
GSE6259_DEC205_POS_DC_VS_CD8...1,SET,140,-0.081431,-0.0070836,0.071812,0.87159,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN,1
REACTOME_PROCESSING_OF_SMDT1,SET,12,-0.27708,-0.0070813,0.24433,0.8716,REACTOME_PROCESSING_OF_SMDT1,1
GOMF_OXIDOREDUCTASE_ACTIVITY...20,SET,6,-0.41483,-0.0074978,0.36579,0.87161,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_ANOTHER_COMPOUND_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
HP_ABNORMALITY_OF_THE_URETER,SET,328,-0.053786,-0.0071246,0.047425,0.87163,HP_ABNORMALITY_OF_THE_URETER,1
HP_SUBEPIDERMAL_BLISTERING,SET,11,-0.30037,-0.0073499,0.26481,0.87165,HP_SUBEPIDERMAL_BLISTERING,1
HP_MILD_MICROCEPHALY,SET,17,-0.24681,-0.0075068,0.21747,0.87179,HP_MILD_MICROCEPHALY,1
GOBP_NEGATIVE_REGULATION_OF_...701,SET,85,-0.1119,-0.0075962,0.098578,0.87184,GOBP_NEGATIVE_REGULATION_OF_VIRAL_PROCESS,1
MIR4316,SET,131,-0.083133,-0.0069971,0.073229,0.87186,MIR4316,1
GSE2770_TGFB_AND_IL4_VS_IL4_...6,SET,162,-0.072348,-0.0067659,0.063729,0.87186,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...2,SET,130,-0.087425,-0.0073304,0.076993,0.87191,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1
GSE24142_ADULT_VS_FETAL_EARL...2,SET,183,-0.073641,-0.0073154,0.064852,0.87191,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...5,SET,11,-0.27746,-0.0067895,0.24431,0.87195,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264,1
MIR518C_5P,SET,175,-0.073704,-0.0071614,0.06489,0.87198,MIR518C_5P,1
FRASOR_TAMOXIFEN_RESPONSE_DN,SET,10,-0.30058,-0.0070131,0.26459,0.87202,FRASOR_TAMOXIFEN_RESPONSE_DN,1
GOBP_FOLIC_ACID_CONTAINING_C...3,SET,27,-0.17322,-0.0066377,0.15247,0.87203,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
WEBER_METHYLATED_ICP_IN_SPER...1,SET,8,-0.36588,-0.0076357,0.32203,0.87205,WEBER_METHYLATED_ICP_IN_SPERM_DN,1
GOMF_RNA_POLYMERASE_II_GENER...2,SET,21,-0.2004,-0.0067735,0.17634,0.8721,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,1
HP_BONE_MARROW_MATURATION_AR...,SET,6,-0.40047,-0.0072383,0.35239,0.87211,HP_BONE_MARROW_MATURATION_ARREST,1
GSE40273_GATA1_KO_VS_WT_TREG...1,SET,183,-0.070964,-0.0070494,0.06244,0.87212,GSE40273_GATA1_KO_VS_WT_TREG_DN,1
AAGGGAT_MIR188,SET,67,-0.11848,-0.0071444,0.10423,0.87217,AAGGGAT_MIR188,1
GSE32986_UNSTIM_VS_CURDLAN_H...2,SET,179,-0.070368,-0.0069141,0.061878,0.87227,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,1
DESCARTES_FETAL_INTESTINE_MY...,SET,187,-0.077913,-0.0078229,0.068507,0.87228,DESCARTES_FETAL_INTESTINE_MYELOID_CELLS,1
REACTOME_ESTROGEN_STIMULATED...,SET,6,-0.34953,-0.0063175,0.30732,0.87229,REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ,1
MIR20B_3P,SET,65,-0.11472,-0.0068138,0.10086,0.87232,MIR20B_3P,1
GOBP_PROSTAGLANDIN_SECRETION,SET,18,-0.27732,-0.0086791,0.24376,0.87237,GOBP_PROSTAGLANDIN_SECRETION,1
GOBP_ESTABLISHMENT_OF_MEIOTI...,SET,6,-0.44379,-0.0080213,0.39002,0.8724,GOBP_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION,1
WP_CALCIUM_REGULATION_IN_CAR...,SET,149,-0.085101,-0.0076352,0.074788,0.87241,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,1
HP_ABNORMAL_FOURTH_TOE_MORPH...,SET,8,-0.36715,-0.0076623,0.32266,0.87241,HP_ABNORMAL_FOURTH_TOE_MORPHOLOGY,1
REACTOME_CREB1_PHOSPHORYLATI...1,SET,25,-0.20286,-0.0074806,0.17826,0.87243,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,1
GOBP_ACTIVATION_OF_NF_KAPPAB...,SET,10,-0.32562,-0.0075973,0.28611,0.87246,GOBP_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY,1
HP_ANEMIA_OF_INADEQUATE_PROD...,SET,174,-0.071124,-0.0068911,0.062467,0.87255,HP_ANEMIA_OF_INADEQUATE_PRODUCTION,1
GSE360_HIGH_DOSE_B_MALAYI_VS...1,SET,186,-0.072316,-0.0072417,0.063509,0.87257,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,1
HP_SHORT_STERNUM,SET,10,-0.32104,-0.0074905,0.28189,0.87262,HP_SHORT_STERNUM,1
MIR8058,SET,41,-0.17198,-0.0081182,0.15099,0.87266,MIR8058,1
chr8q24,SET,152,-0.16738,-0.015167,0.14688,0.87276,chr8q24,1
HP_ABNORMAL_2ND_METACARPAL_M...,SET,6,-0.44446,-0.0080334,0.38981,0.87289,HP_ABNORMAL_2ND_METACARPAL_MORPHOLOGY,1
GOMF_TRNA_SPECIFIC_RIBONUCLE...,SET,13,-0.26393,-0.0070206,0.23147,0.8729,GOMF_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY,1
GOBP_DENDRITIC_TRANSPORT,SET,12,-0.28402,-0.0072586,0.24906,0.87292,GOBP_DENDRITIC_TRANSPORT,1
GOBP_SUPEROXIDE_ANION_GENERA...,SET,36,-0.17242,-0.0076272,0.1512,0.87292,GOBP_SUPEROXIDE_ANION_GENERATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...25,SET,7,-0.41561,-0.0081136,0.36445,0.87293,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...3,SET,18,-0.2445,-0.007652,0.2144,0.87294,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...2,SET,177,-0.068425,-0.0066859,0.059996,0.87295,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP,1
GSE36078_UNTREATED_VS_AD5_T4...2,SET,177,-0.072936,-0.0071267,0.063943,0.87298,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP,1
HP_ABNORMAL_CARPAL_MORPHOLOGY,SET,79,-0.11196,-0.0073282,0.09812,0.87307,HP_ABNORMAL_CARPAL_MORPHOLOGY,1
GOBP_MICROTUBULE_BASED_PROTE...,SET,14,-0.2701,-0.0074557,0.23669,0.87309,GOBP_MICROTUBULE_BASED_PROTEIN_TRANSPORT,1
DACOSTA_UV_RESPONSE_VIA_ERCC...6,SET,287,-0.056011,-0.006948,0.049078,0.87311,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1
REACTOME_DEFECTIVE_C1GALT1C1...,SET,14,-0.27493,-0.007589,0.24091,0.87311,REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS,1
GOBP_PROGESTERONE_BIOSYNTHET...,SET,5,-0.41602,-0.0068644,0.36451,0.87312,GOBP_PROGESTERONE_BIOSYNTHETIC_PROCESS,1
GSE39820_IL1B_IL6_VS_IL1B_IL...1,SET,179,-0.07468,-0.0073378,0.065424,0.87316,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN,1
SRY_01,SET,210,-0.069165,-0.0073546,0.060578,0.87321,SRY_01,1
GOBP_CELLULAR_RESPONSE_TO_IN...3,SET,196,-0.073469,-0.0075503,0.06434,0.87324,GOBP_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE,1
chr9q21,SET,57,-0.21227,-0.011809,0.18586,0.87329,chr9q21,1
GSE4142_NAIVE_BCELL_VS_PLASM...1,SET,187,-0.070873,-0.0071161,0.062051,0.8733,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...392,SET,6,-0.42366,-0.0076575,0.37088,0.87333,GOBP_NEGATIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,1
GSE26928_NAIVE_VS_CXCR5_POS_...2,SET,155,-0.075605,-0.0069174,0.066186,0.87333,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP,1
GOCC_CLOCK_BMAL_TRANSCRIPTIO...,SET,2,-0.99808,-0.010416,0.87367,0.87335,GOCC_CLOCK_BMAL_TRANSCRIPTION_COMPLEX,1
NIKOLSKY_BREAST_CANCER_17Q11...,SET,119,-0.15487,-0.012428,0.13556,0.87337,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1
PID_TAP63_PATHWAY,SET,53,-0.13283,-0.0071265,0.11626,0.87338,PID_TAP63_PATHWAY,1
GOBP_CALCIUM_ION_HOMEOSTASIS,SET,302,-0.060955,-0.0077531,0.053336,0.87344,GOBP_CALCIUM_ION_HOMEOSTASIS,1
NUP214_TARGET_GENES,SET,7,-0.42404,-0.0082781,0.37103,0.87345,NUP214_TARGET_GENES,1
GOBP_POSTSYNAPTIC_SPECIALIZA...2,SET,45,-0.15297,-0.0075638,0.13384,0.87345,GOBP_POSTSYNAPTIC_SPECIALIZATION_ORGANIZATION,1
chr5q33,SET,63,-0.22524,-0.013171,0.19705,0.87348,chr5q33,1
HP_RECURRENT_INFECTION_OF_TH...,SET,35,-0.15965,-0.006964,0.13967,0.87349,HP_RECURRENT_INFECTION_OF_THE_GASTROINTESTINAL_TRACT,1
HP_ST_SEGMENT_ELEVATION,SET,24,-0.201,-0.0072624,0.17583,0.8735,HP_ST_SEGMENT_ELEVATION,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...1,SET,12,-0.3416,-0.0087304,0.29881,0.87352,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_II_PROTEIN_COMPLEX,1
GOBP_PROTEIN_TARGETING_TO_PE...,SET,9,-0.28359,-0.0062772,0.24804,0.87354,GOBP_PROTEIN_TARGETING_TO_PEROXISOME,1
GOBP_PROTEIN_MATURATION_BY_P...,SET,6,-0.38192,-0.006903,0.33399,0.87358,GOBP_PROTEIN_MATURATION_BY_PROTEIN_FOLDING,1
REACTOME_ANCHORING_FIBRIL_FO...,SET,13,-0.29204,-0.0077682,0.25538,0.87359,REACTOME_ANCHORING_FIBRIL_FORMATION,1
HP_ULNAR_DEVIATION_OF_THE_HA...2,SET,58,-0.13579,-0.0076199,0.11872,0.87363,HP_ULNAR_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
HP_BOWEL_DIVERTICULOSIS,SET,32,-0.17092,-0.0071296,0.14942,0.87366,HP_BOWEL_DIVERTICULOSIS,1
HP_PES_PLANUS,SET,310,-0.055987,-0.0072133,0.048945,0.87366,HP_PES_PLANUS,1
GSE37301_HEMATOPOIETIC_STEM_...11,SET,149,-0.074895,-0.0067196,0.065443,0.87377,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN,1
LAKE_ADULT_KIDNEY_C19_COLLEC...,SET,288,-0.056557,-0.0070277,0.049414,0.87379,LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA,1
GOBP_REGULATION_OF_NUCLEOTID...5,SET,28,-0.18969,-0.007402,0.16572,0.8738,GOBP_REGULATION_OF_NUCLEOTIDE_EXCISION_REPAIR,1
HP_HEAD_TITUBATION,SET,18,-0.23396,-0.007322,0.2044,0.87381,HP_HEAD_TITUBATION,1
MODULE_301,SET,136,-0.08496,-0.0072851,0.074219,0.87383,MODULE_301,1
GOBP_NEGATIVE_REGULATION_OF_...679,SET,22,-0.20806,-0.0071977,0.18171,0.87388,GOBP_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_GUANYL_NUCLEOTIDE_EXCHA...,SET,215,-0.065294,-0.0070243,0.057027,0.87388,GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
GSE39152_CD103_NEG_VS_POS_ME...1,SET,186,-0.070469,-0.0070568,0.061542,0.8739,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN,1
HP_EPISODIC_HYPERTENSION,SET,5,-0.40247,-0.0066408,0.35144,0.87393,HP_EPISODIC_HYPERTENSION,1
HP_DELAYED_ERUPTION_OF_PRIMA...,SET,14,-0.24415,-0.0067394,0.21319,0.87394,HP_DELAYED_ERUPTION_OF_PRIMARY_TEETH,1
REACTOME_TRANS_GOLGI_NETWORK...,SET,65,-0.11419,-0.0067823,0.099675,0.87401,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1
MIR3139,SET,54,-0.13592,-0.0073605,0.11865,0.87401,MIR3139,1
GOBP_LABYRINTHINE_LAYER_MORP...,SET,20,-0.24053,-0.0079343,0.20996,0.87401,GOBP_LABYRINTHINE_LAYER_MORPHOGENESIS,1
RUBENSTEIN_SKELETAL_MUSCLE_S...2,SET,376,-0.048849,-0.0069186,0.042631,0.87406,RUBENSTEIN_SKELETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,1
GOMF_CALMODULIN_DEPENDENT_PR...1,SET,24,-0.18718,-0.0067632,0.16327,0.8742,GOMF_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
MIR4257,SET,120,-0.085779,-0.0069121,0.074806,0.87424,MIR4257,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...2,SET,19,-0.20608,-0.006626,0.17971,0.87425,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST,1
HP_PARAPLEGIA_PARAPARESIS,SET,181,-0.071795,-0.0070932,0.062585,0.87433,HP_PARAPLEGIA_PARAPARESIS,1
HP_LEFT_VENTRICULAR_HYPERTRO...,SET,87,-0.1001,-0.0068741,0.087252,0.87435,HP_LEFT_VENTRICULAR_HYPERTROPHY,1
MEISSNER_NPC_HCP_WITH_H3K27M...,SET,76,-0.12672,-0.0081363,0.11043,0.87441,MEISSNER_NPC_HCP_WITH_H3K27ME3,1
TRIP13_TARGET_GENES,SET,69,-0.11948,-0.0073106,0.10412,0.87441,TRIP13_TARGET_GENES,1
GSE19772_CTRL_VS_HCMV_INF_MO...2,SET,168,-0.073738,-0.0070212,0.064257,0.87441,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,1
BLANCO_MELO_COVID19_SARS_COV...12,SET,139,-0.089118,-0.0077248,0.077642,0.87447,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,1
GOBP_MORPHOGENESIS_OF_AN_EPI...3,SET,60,-0.12467,-0.0071151,0.10861,0.87447,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET,1
HP_APLASIA_HYPOPLASIA_AFFECT...3,SET,418,-0.048552,-0.007242,0.042298,0.87448,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_EYE,1
GOBP_REGULATION_OF_CARDIAC_M...10,SET,18,-0.24252,-0.0075897,0.21125,0.87451,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION,1
WANG_TUMOR_INVASIVENESS_DN,SET,192,-0.069913,-0.007112,0.060893,0.87453,WANG_TUMOR_INVASIVENESS_DN,1
GOBP_XENOBIOTIC_CATABOLIC_PR...,SET,23,-0.19927,-0.0070485,0.17356,0.87454,GOBP_XENOBIOTIC_CATABOLIC_PROCESS,1
GOBP_PURINE_NUCLEOSIDE_MONOP...1,SET,18,-0.23097,-0.0072283,0.20115,0.87456,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMALITY_OF_THE_ORBITA...,SET,1409,-0.026831,-0.007142,0.023364,0.87458,HP_ABNORMALITY_OF_THE_ORBITAL_REGION,1
GOBP_AUTOPHAGOSOME_MEMBRANE_...,SET,7,-0.38322,-0.0074813,0.33369,0.8746,GOBP_AUTOPHAGOSOME_MEMBRANE_DOCKING,1
GSE4748_LPS_VS_LPS_AND_CYANO...2,SET,170,-0.07604,-0.007283,0.066208,0.87461,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,1
MIR410_3P,SET,297,-0.059126,-0.007459,0.051479,0.87462,MIR410_3P,1
CTCNANGTGNY_UNKNOWN,SET,74,-0.11134,-0.0070543,0.096942,0.87462,CTCNANGTGNY_UNKNOWN,1
GOBP_TRACHEA_CARTILAGE_DEVEL...,SET,7,-0.37825,-0.0073843,0.32931,0.87463,GOBP_TRACHEA_CARTILAGE_DEVELOPMENT,1
MIR548AO_3P,SET,17,-0.25507,-0.0077578,0.22199,0.87471,MIR548AO_3P,1
REACTOME_RUNX1_REGULATES_EXP...,SET,5,-0.42492,-0.0070113,0.36981,0.87472,REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS,1
MIR130B_3P,SET,358,-0.052901,-0.0073147,0.046024,0.8748,MIR130B_3P,1
HP_RESPIRATORY_INSUFFICIENCY...,SET,5,-0.40536,-0.0066886,0.35267,0.8748,HP_RESPIRATORY_INSUFFICIENCY_DUE_TO_DEFECTIVE_CILIARY_CLEARANCE,1
GOMF_METAL_CATION_PROTON_ANT...,SET,23,-0.20207,-0.0071475,0.17578,0.87483,GOMF_METAL_CATION_PROTON_ANTIPORTER_ACTIVITY,1
GOMF_PROTEIN_SERINE_THREONIN...4,SET,36,-0.16908,-0.0074799,0.14708,0.87484,GOMF_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,1
HP_RETINAL_DEGENERATION,SET,260,-0.059469,-0.0070266,0.051731,0.87484,HP_RETINAL_DEGENERATION,1
GSE2770_UNTREATED_VS_TGFB_AN...7,SET,181,-0.073213,-0.0072334,0.063681,0.87485,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
chr7q36,SET,76,-0.22981,-0.014755,0.19988,0.87486,chr7q36,1
GOMF_INOSITOL_1_3_4_5_6_PENT...,SET,5,-0.34157,-0.005636,0.29708,0.87487,GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY,1
GOMF_SUPEROXIDE_GENERATING_N...1,SET,7,-0.39391,-0.0076901,0.34253,0.87492,GOMF_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY,1
GOBP_EPITHELIAL_TO_MESENCHYM...2,SET,18,-0.26797,-0.0083865,0.23301,0.87493,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...718,SET,28,-0.20242,-0.0078987,0.17599,0.87495,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,1
GSE32533_WT_VS_MIR17_OVEREXP...1,SET,174,-0.078443,-0.0076002,0.0682,0.87496,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,1
HP_OPTIC_NEUROPATHY,SET,46,-0.13616,-0.0068068,0.11837,0.87497,HP_OPTIC_NEUROPATHY,1
MIR4424,SET,109,-0.093716,-0.0071994,0.081466,0.875,MIR4424,1
GOBP_ATTACHMENT_OF_MITOTIC_S...,SET,25,-0.18975,-0.0069972,0.16493,0.87502,GOBP_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GOBP_ENDOCRINE_PROCESS,SET,84,-0.11651,-0.0078628,0.10127,0.87502,GOBP_ENDOCRINE_PROCESS,1
HP_PENILE_FRECKLING,SET,5,-0.37342,-0.0061615,0.32458,0.87502,HP_PENILE_FRECKLING,1
GSE6566_STRONG_VS_WEAK_DC_ST...1,SET,156,-0.078495,-0.0072047,0.068221,0.87504,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN,1
GOBP_BONE_DEVELOPMENT,SET,196,-0.074729,-0.0076798,0.064936,0.87509,GOBP_BONE_DEVELOPMENT,1
HP_MILD_GLOBAL_DEVELOPMENTAL...,SET,70,-0.11835,-0.007294,0.10284,0.8751,HP_MILD_GLOBAL_DEVELOPMENTAL_DELAY,1
MODULE_486,SET,85,-0.10138,-0.0068818,0.088063,0.87516,MODULE_486,1
HP_OPTIC_NERVE_MISROUTING,SET,5,-0.48482,-0.0079996,0.42113,0.87518,HP_OPTIC_NERVE_MISROUTING,1
HP_PEPTIC_ULCER,SET,34,-0.18573,-0.0079854,0.16121,0.87535,HP_PEPTIC_ULCER,1
HP_SYNOSTOSIS_INVOLVING_BONE...1,SET,26,-0.2193,-0.0082466,0.19031,0.87539,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_FEET,1
CHEN_LUNG_CANCER_SURVIVAL,SET,24,-0.19614,-0.007087,0.17021,0.87541,CHEN_LUNG_CANCER_SURVIVAL,1
HP_CARDIAC_SHUNT,SET,14,-0.28846,-0.0079625,0.25032,0.87541,HP_CARDIAC_SHUNT,1
MIR4647_MIR4662B,SET,77,-0.11233,-0.0072591,0.097458,0.87545,MIR4647_MIR4662B,1
GOBP_POSITIVE_REGULATION_OF_...494,SET,6,-0.46726,-0.0084455,0.4054,0.87545,GOBP_POSITIVE_REGULATION_OF_MUCUS_SECRETION,1
HP_ACUTE_PANCREATITIS,SET,6,-0.38966,-0.0070429,0.33807,0.87546,HP_ACUTE_PANCREATITIS,1
GOBP_CEREBRAL_CORTEX_TANGENT...,SET,5,-0.50953,-0.0084074,0.44201,0.87549,GOBP_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION,1
GOBP_ENERGY_DERIVATION_BY_OX...,SET,277,-0.056511,-0.0068887,0.049021,0.87549,GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS,1
GOCC_NUCLEAR_UBIQUITIN_LIGAS...,SET,41,-0.14338,-0.0067682,0.12438,0.8755,GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX,1
KEGG_FOCAL_ADHESION,SET,190,-0.075023,-0.0075924,0.065067,0.87554,KEGG_FOCAL_ADHESION,1
GOBP_NEUTROPHIL_EXTRAVASATION,SET,9,-0.37228,-0.0082404,0.32283,0.87558,GOBP_NEUTROPHIL_EXTRAVASATION,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...2,SET,36,-0.15505,-0.0068588,0.13438,0.8757,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY,1
DORN_ADENOVIRUS_INFECTION_48...2,SET,12,-0.28978,-0.0074059,0.25113,0.87572,DORN_ADENOVIRUS_INFECTION_48HR_UP,1
BIOCARTA_BIOPEPTIDES_PATHWAY,SET,28,-0.19468,-0.0075969,0.16872,0.87572,BIOCARTA_BIOPEPTIDES_PATHWAY,1
REACTOME_SENESCENCE_ASSOCIAT...,SET,49,-0.14522,-0.007492,0.12585,0.87573,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
WP_SENESCENCEASSOCIATED_SECR...,SET,49,-0.14522,-0.007492,0.12585,0.87573,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
GOBP_TRNA_DECAY,SET,16,-0.25202,-0.0074366,0.21839,0.87574,GOBP_TRNA_DECAY,1
GSE5542_UNTREATED_VS_IFNA_TR...1,SET,168,-0.073295,-0.006979,0.063509,0.87576,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,1
GOBP_SECONDARY_METABOLITE_BI...,SET,24,-0.22151,-0.0080033,0.19193,0.87577,GOBP_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
GSE11864_CSF1_PAM3CYS_VS_CSF...1,SET,173,-0.075634,-0.0073071,0.065523,0.87581,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...2,SET,9,-0.34157,-0.0075606,0.29582,0.87588,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION,1
GOMF_ADENYL_NUCLEOTIDE_EXCHA...,SET,15,-0.22332,-0.0063807,0.1934,0.8759,GOMF_ADENYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
WP_OXIDATIVE_DAMAGE_RESPONSE,SET,36,-0.16536,-0.0073153,0.14319,0.87592,WP_OXIDATIVE_DAMAGE_RESPONSE,1
HP_FLARING_OF_RIB_CAGE,SET,7,-0.41862,-0.0081725,0.36244,0.87595,HP_FLARING_OF_RIB_CAGE,1
HP_ABNORMAL_PROPORTION_OF_CL...,SET,17,-0.2801,-0.0085193,0.2425,0.87596,HP_ABNORMAL_PROPORTION_OF_CLASS_SWITCHED_MEMORY_B_CELLS,1
AIZARANI_LIVER_C13_LSECS_2,SET,255,-0.067752,-0.007929,0.058649,0.87599,AIZARANI_LIVER_C13_LSECS_2,1
GOBP_DOUBLE_STRAND_BREAK_REP...1,SET,272,-0.05763,-0.0069623,0.049885,0.876,GOBP_DOUBLE_STRAND_BREAK_REPAIR,1
GOBP_REGULATION_OF_POLYSACCH...2,SET,39,-0.15799,-0.0072737,0.13675,0.876,GOBP_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS,1
GSE9601_UNTREATED_VS_PI3K_IN...2,SET,156,-0.077376,-0.007102,0.066962,0.87606,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
MODULE_295,SET,19,-0.2236,-0.0071893,0.19346,0.8761,MODULE_295,1
HP_DEVIATION_OF_THE_4TH_TOE,SET,4,-0.50866,-0.0075071,0.4401,0.8761,HP_DEVIATION_OF_THE_4TH_TOE,1
GSE360_DC_VS_MAC_L_DONOVANI_...1,SET,174,-0.072983,-0.0070712,0.063144,0.87611,GSE360_DC_VS_MAC_L_DONOVANI_DN,1
GSE9239_CTRL_VS_TNF_INHIBITO...2,SET,175,-0.074022,-0.0071923,0.06403,0.87616,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP,1
MIR586,SET,255,-0.063293,-0.0074072,0.054748,0.87617,MIR586,1
chr11p14,SET,21,-0.36611,-0.012375,0.31665,0.87619,chr11p14,1
REACTOME_FREE_FATTY_ACIDS_RE...,SET,10,-0.34874,-0.0081366,0.30157,0.87623,REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,1
MIR6740_5P,SET,58,-0.12736,-0.0071471,0.11013,0.87624,MIR6740_5P,1
GOBP_RESPONSE_TO_PROSTAGLAND...1,SET,31,-0.20544,-0.0084345,0.17763,0.87626,GOBP_RESPONSE_TO_PROSTAGLANDIN,1
MIR8059,SET,55,-0.13441,-0.0073454,0.11619,0.87631,MIR8059,1
GSE16385_UNTREATED_VS_12H_IF...1,SET,171,-0.073819,-0.0070909,0.063806,0.87634,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,1
GOBP_TACHYKININ_RECEPTOR_SIG...,SET,7,-0.37014,-0.007226,0.31988,0.87638,GOBP_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY,1
GSE37301_HEMATOPOIETIC_STEM_...3,SET,186,-0.077324,-0.0077433,0.066821,0.87639,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
DESCARTES_FETAL_THYMUS_THYMO...,SET,19,-0.22534,-0.0072452,0.19473,0.87639,DESCARTES_FETAL_THYMUS_THYMOCYTES,1
KEGG_MEDICUS_VARIANT_SCRAPIE...1,SET,35,-0.1417,-0.0061808,0.12243,0.87642,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOMF_SYNTAXIN_1_BINDING,SET,19,-0.2297,-0.0073855,0.19848,0.87642,GOMF_SYNTAXIN_1_BINDING,1
MA_RAT_AGING_DN,SET,143,-0.088247,-0.0077577,0.076222,0.87651,MA_RAT_AGING_DN,1
HP_RENAL_AMYLOIDOSIS,SET,11,-0.30722,-0.0075176,0.26529,0.87657,HP_RENAL_AMYLOIDOSIS,1
HP_APLASIA_CUTIS_CONGENITA_O...1,SET,19,-0.2227,-0.0071605,0.1923,0.87658,HP_APLASIA_CUTIS_CONGENITA_OF_SCALP,1
MIR6841_3P,SET,49,-0.13424,-0.0069258,0.1159,0.8766,MIR6841_3P,1
HP_ABNORMAL_OPTIC_NERVE_MORP...,SET,753,-0.035772,-0.0070943,0.030882,0.87663,HP_ABNORMAL_OPTIC_NERVE_MORPHOLOGY,1
GSE16450_IMMATURE_VS_MATURE_...4,SET,182,-0.073536,-0.0072851,0.063482,0.87663,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,1
WILLIAMS_ESR2_TARGETS_UP,SET,25,-0.18996,-0.0070048,0.16399,0.87664,WILLIAMS_ESR2_TARGETS_UP,1
HP_ABNORMALITY_OF_VON_WILLEB...,SET,12,-0.27549,-0.0070408,0.2378,0.87666,HP_ABNORMALITY_OF_VON_WILLEBRAND_FACTOR,1
REACTOME_CARGO_RECOGNITION_F...,SET,95,-0.10411,-0.0074692,0.089858,0.87668,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1
GSE31082_DP_VS_CD4_SP_THYMOC...1,SET,176,-0.074296,-0.0072392,0.064118,0.87671,GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN,1
GSE46025_WT_VS_FOXO1_KO_KLRG...2,SET,166,-0.074732,-0.0070738,0.064496,0.87671,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP,1
ZNF532_TARGET_GENES,SET,53,-0.13734,-0.0073682,0.11852,0.87672,ZNF532_TARGET_GENES,1
GSE13547_WT_VS_ZFX_KO_BCELL_...6,SET,156,-0.084229,-0.007731,0.072684,0.87673,GSE13547_WT_VS_ZFX_KO_BCELL_UP,1
GOMF_PROTEIN_CONTAINING_COMP...2,SET,15,-0.25614,-0.0073184,0.221,0.87677,GOMF_PROTEIN_CONTAINING_COMPLEX_DESTABILIZING_ACTIVITY,1
WP_INTRAFLAGELLAR_TRANSPORT_...,SET,22,-0.2059,-0.0071233,0.17758,0.87687,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,1
DARWICHE_SQUAMOUS_CELL_CARCI...1,SET,164,-0.075685,-0.0071211,0.065256,0.87693,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1
GOBP_NEGATIVE_REGULATION_OF_...479,SET,44,-0.15921,-0.0077848,0.13726,0.87695,GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION,1
GOMF_NEDD8_TRANSFERASE_ACTIV...,SET,7,-0.32722,-0.006388,0.28209,0.87696,GOMF_NEDD8_TRANSFERASE_ACTIVITY,1
GOBP_SKELETAL_MUSCLE_CELL_DI...,SET,72,-0.11905,-0.0074405,0.10262,0.877,GOBP_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GOMF_NUCLEASE_INHIBITOR_ACTI...,SET,6,-0.34866,-0.0063019,0.30052,0.87701,GOMF_NUCLEASE_INHIBITOR_ACTIVITY,1
GSE26928_NAIVE_VS_CXCR5_POS_...1,SET,166,-0.07269,-0.0068805,0.062636,0.87707,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN,1
REACTOME_POLB_DEPENDENT_LONG...,SET,7,-0.35436,-0.0069179,0.30534,0.87708,REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,1
MIR5683,SET,217,-0.069605,-0.0075223,0.059974,0.87709,MIR5683,1
HP_HYPOTHALAMIC_HAMARTOMA,SET,14,-0.23271,-0.0064237,0.20051,0.87709,HP_HYPOTHALAMIC_HAMARTOMA,1
GOBP_RESPIRATORY_GASEOUS_EXC...,SET,72,-0.12477,-0.0077978,0.10746,0.87717,GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM,1
MARTIN_NFKB_TARGETS_UP,SET,41,-0.16902,-0.0079783,0.14558,0.87718,MARTIN_NFKB_TARGETS_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...23,SET,16,-0.25757,-0.0076004,0.22182,0.87721,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GSE3982_EOSINOPHIL_VS_TH1_DN,SET,178,-0.071219,-0.0069784,0.061324,0.87724,GSE3982_EOSINOPHIL_VS_TH1_DN,1
GSE5099_CLASSICAL_M1_VS_ALTE...1,SET,146,-0.081391,-0.007229,0.070056,0.87733,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN,1
TGGNNNNNNKCCAR_UNKNOWN,SET,382,-0.052693,-0.0075211,0.045354,0.87734,TGGNNNNNNKCCAR_UNKNOWN,1
CTTTGTA_MIR524,SET,397,-0.051381,-0.0074733,0.044221,0.87735,CTTTGTA_MIR524,1
DESCARTES_FETAL_PANCREAS_MES...,SET,63,-0.1333,-0.0077949,0.1147,0.87741,DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS,1
GOCC_SUPER_ELONGATION_COMPLEX,SET,5,-0.39917,-0.0065864,0.34345,0.87742,GOCC_SUPER_ELONGATION_COMPLEX,1
PID_ERBB_NETWORK_PATHWAY,SET,15,-0.26346,-0.0075274,0.22668,0.87743,PID_ERBB_NETWORK_PATHWAY,1
HP_APLASIA_HYPOPLASIA_INVOLV...6,SET,15,-0.2443,-0.00698,0.21018,0.87744,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CARPAL_BONES,1
GSE3982_DC_VS_NKCELL_DN,SET,166,-0.0775,-0.0073358,0.066635,0.87759,GSE3982_DC_VS_NKCELL_DN,1
HP_MICRODONTIA,SET,157,-0.08113,-0.0074702,0.069741,0.87764,HP_MICRODONTIA,1
GSE9988_LOW_LPS_VS_VEHICLE_T...1,SET,183,-0.071566,-0.0071092,0.061514,0.87766,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,1
DESCARTES_MAIN_FETAL_LYMPHAT...,SET,64,-0.13044,-0.0076877,0.1121,0.8777,DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS,1
MIR6729_3P,SET,63,-0.12322,-0.0072058,0.10589,0.87771,MIR6729_3P,1
GOBP_G_PROTEIN_COUPLED_RECEP...2,SET,1095,-0.035689,-0.008452,0.03067,0.87771,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...1,SET,183,-0.073845,-0.0073356,0.063452,0.87774,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...96,SET,4,-0.52225,-0.0077078,0.44863,0.8778,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,1
REACTOME_INHIBITION_OF_THE_P...,SET,20,-0.21129,-0.0069699,0.1815,0.87781,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,1
GOMF_DINUCLEOTIDE_PHOSPHATAS...,SET,7,-0.36378,-0.0071019,0.31249,0.87781,GOMF_DINUCLEOTIDE_PHOSPHATASE_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_P...2,SET,22,-0.21811,-0.0075457,0.18733,0.87784,GOBP_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,1
HP_PROGRESSIVE_HEARING_IMPAI...,SET,35,-0.15855,-0.006916,0.13617,0.87785,HP_PROGRESSIVE_HEARING_IMPAIRMENT,1
HP_FETAL_AKINESIA_SEQUENCE,SET,32,-0.17622,-0.0073503,0.15133,0.87788,HP_FETAL_AKINESIA_SEQUENCE,1
HP_PHEOCHROMOCYTOMA,SET,28,-0.17685,-0.0069009,0.15187,0.87788,HP_PHEOCHROMOCYTOMA,1
KEGG_MEDICUS_VARIANT_HRAS_OV...,SET,9,-0.34975,-0.0077417,0.30031,0.8779,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY,1
GSE6674_ANTI_IGM_VS_ANTI_IGM...1,SET,177,-0.074023,-0.0072329,0.063554,0.87793,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
HP_ABNORMAL_BLOOD_ION_CONCEN...,SET,321,-0.057838,-0.0075805,0.049656,0.87794,HP_ABNORMAL_BLOOD_ION_CONCENTRATION,1
GOBP_NEUROTRANSMITTER_REUPTA...,SET,33,-0.18943,-0.0080236,0.16262,0.87795,GOBP_NEUROTRANSMITTER_REUPTAKE,1
GOBP_NEGATIVE_REGULATION_OF_...125,SET,5,-0.46278,-0.007636,0.39727,0.87796,GOBP_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOMF_ATP_DEPENDENT_PROTEIN_D...,SET,6,-0.40786,-0.0073719,0.35,0.87805,GOMF_ATP_DEPENDENT_PROTEIN_DISAGGREGASE_ACTIVITY,1
TCTGATC_MIR383,SET,46,-0.1493,-0.0074639,0.12812,0.87806,TCTGATC_MIR383,1
LET_7E_3P,SET,4,-0.54814,-0.0080898,0.47033,0.87807,LET_7E_3P,1
GOBP_NEGATIVE_REGULATION_OF_...524,SET,192,-0.070308,-0.0071521,0.060321,0.8781,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION,1
GOCC_CATION_TRANSPORTING_ATP...,SET,18,-0.25987,-0.008133,0.22281,0.87826,GOCC_CATION_TRANSPORTING_ATPASE_COMPLEX,1
HU_FETAL_RETINA_HORIZONTAL,SET,34,-0.1818,-0.0078163,0.15585,0.8783,HU_FETAL_RETINA_HORIZONTAL,1
MODULE_439,SET,20,-0.21134,-0.0069714,0.18115,0.87831,MODULE_439,1
MIR4654,SET,51,-0.13762,-0.0072431,0.11793,0.87838,MIR4654,1
HP_IMPAIRED_ADP_INDUCED_PLAT...,SET,18,-0.23376,-0.0073158,0.20029,0.87841,HP_IMPAIRED_ADP_INDUCED_PLATELET_AGGREGATION,1
HP_INTESTINAL_MALROTATION,SET,126,-0.090714,-0.0074891,0.077718,0.87843,HP_INTESTINAL_MALROTATION,1
MIR28_3P,SET,46,-0.13577,-0.0067875,0.11629,0.8785,MIR28_3P,1
GOBP_ANATOMICAL_STRUCTURE_AR...,SET,16,-0.2737,-0.0080763,0.23437,0.87855,GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT,1
GOCC_CANONICAL_INFLAMMASOME_...,SET,16,-0.287,-0.0084686,0.24575,0.87855,GOCC_CANONICAL_INFLAMMASOME_COMPLEX,1
MIR4713_3P,SET,37,-0.16829,-0.0075472,0.14409,0.87858,MIR4713_3P,1
HP_PERINEAL_FISTULA,SET,12,-0.27651,-0.0070669,0.23674,0.87859,HP_PERINEAL_FISTULA,1
HP_ABNORMAL_TONGUE_MORPHOLOGY,SET,333,-0.05534,-0.007385,0.047375,0.87861,HP_ABNORMAL_TONGUE_MORPHOLOGY,1
DESCARTES_FETAL_THYMUS_ANTIG...,SET,152,-0.086846,-0.0078692,0.07433,0.87867,DESCARTES_FETAL_THYMUS_ANTIGEN_PRESENTING_CELLS,1
GOBP_PROTEIN_HISTIDYL_MODIFI...,SET,7,-0.33551,-0.0065499,0.28709,0.87872,GOBP_PROTEIN_HISTIDYL_MODIFICATION_TO_DIPHTHAMIDE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...6,SET,127,-0.095269,-0.007896,0.081518,0.87873,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS,1
GOBP_REGULATION_OF_T_CELL_DI...,SET,24,-0.21115,-0.0076293,0.18066,0.87875,GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
MIR513B_5P,SET,254,-0.064196,-0.0074983,0.05492,0.87877,MIR513B_5P,1
HP_RECURRENT_GASTROENTERITIS,SET,12,-0.27515,-0.007032,0.23535,0.87881,HP_RECURRENT_GASTROENTERITIS,1
GOBP_NEGATIVE_REGULATION_OF_...266,SET,17,-0.2507,-0.0076251,0.21437,0.87888,GOBP_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY,1
REACTOME_DNA_METHYLATION,SET,5,-0.48672,-0.008031,0.41605,0.87896,REACTOME_DNA_METHYLATION,1
WP_IRINOTECAN_PATHWAY,SET,12,-0.29684,-0.0075863,0.25372,0.87898,WP_IRINOTECAN_PATHWAY,1
HEBERT_MATRISOME_TNBC_BONE_M...1,SET,10,-0.35247,-0.0082236,0.3012,0.87903,HEBERT_MATRISOME_TNBC_BONE_METASTASIS,1
SU_THYMUS,SET,19,-0.26882,-0.0086433,0.22971,0.87904,SU_THYMUS,1
GOBP_CIRCADIAN_RHYTHM,SET,192,-0.075187,-0.0076485,0.064246,0.87905,GOBP_CIRCADIAN_RHYTHM,1
HP_MULTIPLE_RIB_FRACTURES,SET,10,-0.34825,-0.0081253,0.2975,0.87911,HP_MULTIPLE_RIB_FRACTURES,1
REACTOME_DEFECTIVE_RIPK1_MED...,SET,7,-0.3708,-0.0072388,0.31675,0.87912,REACTOME_DEFECTIVE_RIPK1_MEDIATED_REGULATED_NECROSIS,1
GOBP_REGULATION_OF_LEUKOCYTE...8,SET,213,-0.072577,-0.0077717,0.061998,0.87912,GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION,1
ZIRN_TRETINOIN_RESPONSE_DN,SET,5,-0.42031,-0.0069352,0.35903,0.87913,ZIRN_TRETINOIN_RESPONSE_DN,1
HP_SPONTANEOUS_PAIN_SENSATION,SET,5,-0.4745,-0.0078293,0.40529,0.87915,HP_SPONTANEOUS_PAIN_SENSATION,1
HP_FUSION_OF_THE_CEREBELLAR_...,SET,5,-0.38477,-0.0063487,0.3286,0.87918,HP_FUSION_OF_THE_CEREBELLAR_HEMISPHERES,1
MIR664B_3P,SET,442,-0.049864,-0.0076431,0.042581,0.8792,MIR664B_3P,1
GOBP_INFLAMMASOME_MEDIATED_S...,SET,39,-0.16193,-0.0074552,0.13826,0.87922,GOBP_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...153,SET,11,-0.31628,-0.0077392,0.27006,0.87922,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
MIR1912_3P,SET,80,-0.11036,-0.0072687,0.094227,0.87923,MIR1912_3P,1
GOBP_RENAL_SYSTEM_VASCULATUR...2,SET,8,-0.40762,-0.008507,0.34799,0.87927,GOBP_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS,1
GOBP_METANEPHRIC_RENAL_VESIC...,SET,14,-0.31458,-0.0086834,0.26853,0.87929,GOBP_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS,1
GOMF_G_PROTEIN_COUPLED_NEURO...,SET,12,-0.30611,-0.0078234,0.26123,0.87936,GOMF_G_PROTEIN_COUPLED_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
CONCANNON_APOPTOSIS_BY_EPOXO...2,SET,216,-0.06928,-0.0074702,0.059118,0.87937,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,1
chr13q34,SET,34,-0.30145,-0.01296,0.25722,0.87938,chr13q34,1
GOBP_REGULATION_OF_SPHINGOLI...,SET,12,-0.24629,-0.0062945,0.21015,0.87939,GOBP_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
REACTOME_HEDGEHOG_LIGAND_BIO...,SET,62,-0.112,-0.0064973,0.095533,0.87946,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1
GSE25123_WT_VS_PPARG_KO_MACR...2,SET,163,-0.078354,-0.00735,0.066812,0.87954,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN,1
GOBP_DEMETHYLATION,SET,37,-0.16216,-0.0072722,0.13827,0.87955,GOBP_DEMETHYLATION,1
HP_ESOPHAGEAL_ATRESIA,SET,25,-0.19228,-0.0070904,0.16395,0.87956,HP_ESOPHAGEAL_ATRESIA,1
GOBP_NEGATIVE_REGULATION_OF_...593,SET,6,-0.42288,-0.0076433,0.36052,0.87959,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
HP_LONG_PALPEBRAL_FISSURE,SET,62,-0.11942,-0.0069277,0.10179,0.87963,HP_LONG_PALPEBRAL_FISSURE,1
GOBP_NEGATIVE_REGULATION_OF_...704,SET,7,-0.41523,-0.0081062,0.35374,0.87976,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
WP_CLEAR_CELL_RENAL_CELL_CAR...,SET,80,-0.112,-0.007377,0.095403,0.87979,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...3,SET,96,-0.10832,-0.0078123,0.092255,0.87983,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,1
GSE2770_IL12_ACT_VS_ACT_CD4_...5,SET,158,-0.079485,-0.0073418,0.06769,0.87984,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...5,SET,7,-0.38517,-0.0075195,0.328,0.87986,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN,1
PID_PDGFRB_PATHWAY,SET,124,-0.091102,-0.0074616,0.07758,0.87986,PID_PDGFRB_PATHWAY,1
REACTOME_HEPARAN_SULFATE_HEP...,SET,52,-0.14433,-0.00767,0.1229,0.87987,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,1
LYF1_01,SET,238,-0.067295,-0.007612,0.057289,0.87992,LYF1_01,1
HP_UROGENITAL_FISTULA,SET,46,-0.14716,-0.0073569,0.12528,0.87992,HP_UROGENITAL_FISTULA,1
HE_LIM_SUN_FETAL_LUNG_C4_ILC...2,SET,68,-0.13016,-0.0079064,0.11075,0.88003,HE_LIM_SUN_FETAL_LUNG_C4_ILC3_CELL,1
MYLLYKANGAS_AMPLIFICATION_HO...3,SET,9,-0.36376,-0.0080519,0.30951,0.88005,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16,1
GOBP_ADENOHYPOPHYSIS_DEVELOP...,SET,16,-0.27817,-0.0082082,0.23669,0.88005,GOBP_ADENOHYPOPHYSIS_DEVELOPMENT,1
HP_STILLBIRTH,SET,28,-0.19273,-0.0075206,0.16397,0.88007,HP_STILLBIRTH,1
GOBP_BRANCHIOMOTOR_NEURON_AX...,SET,6,-0.43045,-0.0077802,0.36617,0.8801,GOBP_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE,1
GSE45739_UNSTIM_VS_ACD3_ACD2...2,SET,171,-0.073908,-0.0070994,0.062863,0.88014,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP,1
MIR9851_3P,SET,161,-0.079964,-0.0074552,0.067994,0.8802,MIR9851_3P,1
HP_CERVICAL_SUBLUXATION,SET,8,-0.34316,-0.0071615,0.29177,0.88022,HP_CERVICAL_SUBLUXATION,1
GSE15930_STIM_VS_STIM_AND_IL...3,SET,189,-0.078823,-0.0079561,0.067019,0.88022,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN,1
GCM_TEC,SET,29,-0.17971,-0.0071366,0.15274,0.88031,GCM_TEC,1
GOBP_POSITIVE_REGULATION_OF_...662,SET,66,-0.13303,-0.0079614,0.11306,0.88032,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
GOBP_GLYCOPROTEIN_METABOLIC_...,SET,344,-0.056135,-0.0076115,0.047706,0.88033,GOBP_GLYCOPROTEIN_METABOLIC_PROCESS,1
HUMMERICH_SKIN_CANCER_PROGRE...1,SET,89,-0.10808,-0.007507,0.091847,0.88035,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,1
ZNF224_TARGET_GENES,SET,1077,-0.031413,-0.0073816,0.026694,0.88035,ZNF224_TARGET_GENES,1
GOBP_ERBB2_EGFR_SIGNALING_PA...,SET,8,-0.40795,-0.0085137,0.34645,0.88049,GOBP_ERBB2_EGFR_SIGNALING_PATHWAY,1
HARALAMBIEVA_PBMC_M_M_R_II_A...3,SET,10,-0.34762,-0.0081105,0.29521,0.8805,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_HIGH_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,1
HP_DELAYED_CLOSURE_OF_THE_AN...,SET,29,-0.171,-0.0067906,0.1452,0.88053,HP_DELAYED_CLOSURE_OF_THE_ANTERIOR_FONTANELLE,1
GSE22935_WT_VS_MYD88_KO_MACR...3,SET,182,-0.072827,-0.0072149,0.061824,0.88059,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN,1
GOBP_PEPTIDYL_LYSINE_MONOMET...,SET,7,-0.39655,-0.0077415,0.33653,0.88066,GOBP_PEPTIDYL_LYSINE_MONOMETHYLATION,1
GSE18893_CTRL_VS_TNF_TREATED...8,SET,178,-0.076039,-0.0074507,0.064526,0.88068,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP,1
PBX1_01,SET,233,-0.068893,-0.0077116,0.058449,0.88073,PBX1_01,1
GSE19198_CTRL_VS_IL21_TREATE...5,SET,176,-0.076545,-0.0074584,0.064941,0.88073,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN,1
HP_HIP_SUBLUXATION,SET,19,-0.23319,-0.0074977,0.1978,0.88078,HP_HIP_SUBLUXATION,1
UEDA_PERIFERAL_CLOCK,SET,157,-0.082428,-0.0075897,0.069908,0.88081,UEDA_PERIFERAL_CLOCK,1
GSE43863_TFH_VS_LY6C_INT_CXC...4,SET,184,-0.077753,-0.0077447,0.06594,0.88082,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,1
GOMF_MUSCLE_ALPHA_ACTININ_BI...,SET,15,-0.27752,-0.0079293,0.23534,0.88084,GOMF_MUSCLE_ALPHA_ACTININ_BINDING,1
GSE37416_0H_VS_24H_F_TULAREN...2,SET,166,-0.077471,-0.007333,0.065695,0.88084,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
KYNG_ENVIRONMENTAL_STRESS_RE...7,SET,12,-0.29907,-0.0076433,0.2536,0.88085,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1
DESCARTES_FETAL_PLACENTA_EXT...,SET,60,-0.13693,-0.0078151,0.11611,0.88086,DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS,1
GOBP_NEGATIVE_REGULATION_OF_...627,SET,20,-0.22813,-0.0075254,0.19343,0.88087,GOBP_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GOBP_TETRAHYDROFOLATE_INTERC...,SET,9,-0.30523,-0.0067562,0.25878,0.88089,GOBP_TETRAHYDROFOLATE_INTERCONVERSION,1
GOMF_LONG_CHAIN_FATTY_ACID_C...,SET,14,-0.25611,-0.0070695,0.21712,0.88091,GOMF_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
DASU_IL6_SIGNALING_DN,SET,6,-0.46412,-0.0083888,0.39342,0.88094,DASU_IL6_SIGNALING_DN,1
GOBP_REGULATION_OF_RETROGRAD...2,SET,5,-0.44923,-0.0074125,0.38079,0.88094,GOBP_REGULATION_OF_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,1
KEGG_MEDICUS_VARIANT_EML4_AL...4,SET,11,-0.29018,-0.0071006,0.24596,0.88095,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
REACTOME_RUNX3_REGULATES_IMM...,SET,6,-0.42118,-0.0076127,0.35696,0.88097,REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION,1
LET_7F_2_3P,SET,371,-0.05329,-0.0074983,0.045161,0.88099,LET_7F_2_3P,1
REACTOME_NUCLEOTIDE_BIOSYNTH...,SET,12,-0.29107,-0.0074389,0.24664,0.88102,REACTOME_NUCLEOTIDE_BIOSYNTHESIS,1
GOBP_SEROTONERGIC_NEURON_AXO...,SET,5,-0.43176,-0.0071241,0.36583,0.88104,GOBP_SEROTONERGIC_NEURON_AXON_GUIDANCE,1
MIR1185_1_3P_MIR1185_2_3P,SET,376,-0.052962,-0.0075012,0.044871,0.88105,MIR1185_1_3P_MIR1185_2_3P,1
HP_PROGRESSIVE_NEUROLOGIC_DE...,SET,62,-0.1228,-0.0071238,0.10404,0.88105,HP_PROGRESSIVE_NEUROLOGIC_DETERIORATION,1
GSE21063_CTRL_VS_ANTI_IGM_ST...6,SET,139,-0.090382,-0.0078343,0.076555,0.88111,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP,1
KEGG_METABOLISM_OF_XENOBIOTI...,SET,65,-0.17274,-0.01026,0.1463,0.88114,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,1
GOBP_THYMUS_DEVELOPMENT,SET,47,-0.1524,-0.0077009,0.12907,0.88114,GOBP_THYMUS_DEVELOPMENT,1
MEISSNER_NPC_ICP_WITH_H3_UNM...,SET,20,-0.24095,-0.0079482,0.20405,0.88116,MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,1
GOMF_ACID_PHOSPHATASE_ACTIVI...,SET,6,-0.39936,-0.0072182,0.33818,0.88117,GOMF_ACID_PHOSPHATASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_UPPER_...2,SET,1520,-0.027031,-0.0074486,0.022889,0.88117,HP_ABNORMALITY_OF_THE_UPPER_LIMB,1
HP_PARACENTRAL_SCOTOMA,SET,7,-0.37757,-0.0073709,0.31959,0.88127,HP_PARACENTRAL_SCOTOMA,1
GOBP_NEGATIVE_REGULATION_OF_...477,SET,4,-0.44454,-0.0065608,0.37616,0.88134,GOBP_NEGATIVE_REGULATION_OF_PANCREATIC_JUICE_SECRETION,1
GOBP_ALKANESULFONATE_TRANSME...,SET,8,-0.41179,-0.008594,0.3484,0.88138,GOBP_ALKANESULFONATE_TRANSMEMBRANE_TRANSPORT,1
MODULE_488,SET,29,-0.2127,-0.0084466,0.17993,0.88141,MODULE_488,1
KRAS.BREAST_UP.V1_DN,SET,124,-0.094726,-0.0077584,0.080128,0.88143,KRAS.BREAST_UP.V1_DN,1
REACTOME_CYTOCHROME_C_MEDIAT...,SET,12,-0.28123,-0.0071874,0.23779,0.88153,REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE,1
ESC_V6.5_UP_EARLY.V1_DN,SET,148,-0.087573,-0.0078309,0.074038,0.88155,ESC_V6.5_UP_EARLY.V1_DN,1
GSE9988_LOW_LPS_VS_CTRL_TREA...1,SET,187,-0.071419,-0.0071709,0.060382,0.88155,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN,1
HP_BRONCHITIS,SET,62,-0.13009,-0.0075468,0.10997,0.88158,HP_BRONCHITIS,1
SENESE_HDAC3_TARGETS_DN,SET,466,-0.04805,-0.0075574,0.040616,0.8816,SENESE_HDAC3_TARGETS_DN,1
HP_MALFORMATION_OF_THE_HEPAT...,SET,8,-0.30368,-0.0063376,0.25668,0.88161,HP_MALFORMATION_OF_THE_HEPATIC_DUCTAL_PLATE,1
HP_MUSCLE_STIFFNESS,SET,74,-0.11152,-0.0070655,0.094184,0.88179,HP_MUSCLE_STIFFNESS,1
GOMF_MECHANOSENSITIVE_MONOAT...1,SET,5,-0.41904,-0.0069143,0.35372,0.88192,GOMF_MECHANOSENSITIVE_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
REACTOME_L1CAM_INTERACTIONS,SET,108,-0.10288,-0.0078674,0.086823,0.88197,REACTOME_L1CAM_INTERACTIONS,1
HP_FEEDING_DIFFICULTIES,SET,1009,-0.031801,-0.0072472,0.026836,0.88199,HP_FEEDING_DIFFICULTIES,1
GSE2770_UNTREATED_VS_TGFB_AN...2,SET,183,-0.075283,-0.0074784,0.063512,0.88205,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
HP_ERYTHEMA_NODOSUM,SET,7,-0.42425,-0.0082824,0.35791,0.88206,HP_ERYTHEMA_NODOSUM,1
HP_GASTROINTESTINAL_ULCER,SET,46,-0.16104,-0.0080507,0.13585,0.88206,HP_GASTROINTESTINAL_ULCER,1
MIR548F_5P,SET,446,-0.049707,-0.0076527,0.041926,0.8821,MIR548F_5P,1
GOBP_NEURAL_PRECURSOR_CELL_P...,SET,157,-0.08357,-0.0076949,0.070481,0.88212,GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
GSE15215_CD2_POS_VS_NEG_PDC_...2,SET,181,-0.074163,-0.0073272,0.062539,0.88215,GSE15215_CD2_POS_VS_NEG_PDC_UP,1
HP_LUMBAR_HYPERLORDOSIS,SET,82,-0.1106,-0.0073747,0.093242,0.88221,HP_LUMBAR_HYPERLORDOSIS,1
HP_EDEMA_OF_THE_DORSUM_OF_FE...,SET,4,-0.46711,-0.006894,0.39377,0.88223,HP_EDEMA_OF_THE_DORSUM_OF_FEET,1
HP_ABNORMAL_CARTILAGE_MORPHO...,SET,41,-0.16561,-0.0078172,0.1396,0.88225,HP_ABNORMAL_CARTILAGE_MORPHOLOGY,1
GOBP_RESPONSE_TO_INTERFERON_...2,SET,30,-0.20279,-0.0081905,0.17091,0.88228,GOBP_RESPONSE_TO_INTERFERON_BETA,1
GOBP_VENTRICULAR_SEPTUM_MORP...,SET,40,-0.18417,-0.0085868,0.15521,0.88229,GOBP_VENTRICULAR_SEPTUM_MORPHOGENESIS,1
TIAN_BHLHA15_TARGETS,SET,15,-0.26324,-0.0075211,0.22185,0.8823,TIAN_BHLHA15_TARGETS,1
HP_MALROTATION_OF_SMALL_BOWEL,SET,8,-0.36366,-0.0075894,0.30645,0.88231,HP_MALROTATION_OF_SMALL_BOWEL,1
MIR5004_3P,SET,124,-0.090397,-0.0074038,0.076169,0.88234,MIR5004_3P,1
OSADA_ASCL1_TARGETS_DN,SET,23,-0.23462,-0.0082989,0.19768,0.88236,OSADA_ASCL1_TARGETS_DN,1
KORKOLA_EMBRYONAL_CARCINOMA_...2,SET,28,-0.21563,-0.0084143,0.18164,0.8824,KORKOLA_EMBRYONAL_CARCINOMA_UP,1
HP_MULTINODULAR_GOITER,SET,5,-0.47089,-0.0077697,0.39667,0.8824,HP_MULTINODULAR_GOITER,1
GAVISH_3CA_MALIGNANT_METAPRO...5,SET,46,-0.15914,-0.0079559,0.13404,0.88243,GAVISH_3CA_MALIGNANT_METAPROGRAM_14_EMT_3,1
GSE26928_CENTR_MEMORY_VS_CXC...2,SET,159,-0.079883,-0.0074016,0.067279,0.88244,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...3,SET,17,-0.26906,-0.0081834,0.2266,0.88245,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX,1
GOBP_PROTEIN_INSERTION_INTO_...7,SET,13,-0.27472,-0.0073075,0.23134,0.88247,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_OUTER_MEMBRANE,1
DESCARTES_FETAL_CEREBRUM_MEG...,SET,313,-0.058521,-0.0075755,0.049281,0.88247,DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES,1
DESCARTES_FETAL_LUNG_MESOTHE...,SET,83,-0.12224,-0.0082005,0.10294,0.88249,DESCARTES_FETAL_LUNG_MESOTHELIAL_CELLS,1
HP_SHORTENED_QT_INTERVAL,SET,13,-0.31142,-0.0082837,0.26222,0.8825,HP_SHORTENED_QT_INTERVAL,1
REACTOME_ENHANCED_BINDING_OF...,SET,7,-0.43272,-0.0084476,0.36428,0.88255,REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN,1
HP_LANGUAGE_IMPAIRMENT,SET,987,-0.03279,-0.0073955,0.027602,0.88257,HP_LANGUAGE_IMPAIRMENT,1
GOLDRATH_HOMEOSTATIC_PROLIFE...,SET,134,-0.086533,-0.0073656,0.072839,0.88258,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1
WP_DISORDERS_OF_FOLATE_METAB...,SET,19,-0.21642,-0.0069583,0.18215,0.8826,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,1
GOBP_MACROMOLECULE_METHYLATI...,SET,104,-0.09057,-0.0067972,0.076215,0.88264,GOBP_MACROMOLECULE_METHYLATION,1
REACTOME_CHONDROITIN_SULFATE...2,SET,45,-0.15066,-0.0074498,0.12677,0.88267,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1
GOBP_RESPONSE_TO_NITRIC_OXIDE,SET,17,-0.24603,-0.007483,0.20701,0.88267,GOBP_RESPONSE_TO_NITRIC_OXIDE,1
GSE11924_TH1_VS_TH2_CD4_TCEL...1,SET,178,-0.077081,-0.0075527,0.064852,0.88269,GSE11924_TH1_VS_TH2_CD4_TCELL_DN,1
GOBP_TUBE_LUMEN_CAVITATION,SET,4,-0.55933,-0.008255,0.47057,0.8827,GOBP_TUBE_LUMEN_CAVITATION,1
GSE11961_FOLLICULAR_BCELL_VS...11,SET,185,-0.072111,-0.007202,0.060656,0.88274,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN,1
GOMF_ATPASE_COUPLED_INTRAMEM...,SET,26,-0.20787,-0.007817,0.17483,0.88278,GOMF_ATPASE_COUPLED_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_CALCIUM_I...3,SET,5,-0.52637,-0.0086852,0.44267,0.88279,GOBP_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GUILLAUMOND_KLF10_TARGETS_DN,SET,27,-0.20073,-0.0076918,0.16874,0.88288,GUILLAUMOND_KLF10_TARGETS_DN,1
GHANDHI_DIRECT_IRRADIATION_DN,SET,32,-0.19943,-0.0083185,0.16764,0.8829,GHANDHI_DIRECT_IRRADIATION_DN,1
GOBP_REGULATION_OF_NUCLEASE_...,SET,21,-0.23017,-0.0077799,0.19346,0.88291,GOBP_REGULATION_OF_NUCLEASE_ACTIVITY,1
GSE22025_UNTREATED_VS_PROGES...1,SET,184,-0.077482,-0.0077177,0.065123,0.88293,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN,1
MIR4766_3P,SET,151,-0.090157,-0.0081425,0.07577,0.88294,MIR4766_3P,1
GOBP_ENDOCARDIAL_CUSHION_TO_...,SET,6,-0.4388,-0.0079311,0.36861,0.88305,GOBP_ENDOCARDIAL_CUSHION_TO_MESENCHYMAL_TRANSITION,1
GOMF_HYDROLASE_ACTIVITY_ACTI...4,SET,32,-0.19933,-0.0083144,0.16745,0.88305,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES,1
HP_THIN_UPPER_LIP_VERMILION,SET,263,-0.062756,-0.007457,0.052699,0.88313,HP_THIN_UPPER_LIP_VERMILION,1
GSE16450_CTRL_VS_IFNA_6H_STI...4,SET,187,-0.07555,-0.0075857,0.063443,0.88313,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,1
GOCC_MITOCHONDRIAL_PROTEIN_C...,SET,229,-0.06257,-0.0069442,0.05253,0.88319,GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX,1
MORF_CCNI,SET,82,-0.10793,-0.0071965,0.090595,0.88322,MORF_CCNI,1
GOBP_PURINE_NUCLEOBASE_METAB...,SET,17,-0.24098,-0.0073294,0.20224,0.88328,GOBP_PURINE_NUCLEOBASE_METABOLIC_PROCESS,1
MARKS_HDAC_TARGETS_DN,SET,14,-0.28741,-0.0079334,0.24116,0.88332,MARKS_HDAC_TARGETS_DN,1
HP_ABNORMAL_T_CELL_PROLIFERA...,SET,14,-0.2551,-0.0070416,0.21399,0.88338,HP_ABNORMAL_T_CELL_PROLIFERATION,1
HP_PREMATURE_OSTEOARTHRITIS,SET,9,-0.34949,-0.007736,0.29317,0.88338,HP_PREMATURE_OSTEOARTHRITIS,1
GOCC_PHOSPHOLIPID_TRANSLOCAT...,SET,13,-0.28714,-0.007638,0.24087,0.88339,GOCC_PHOSPHOLIPID_TRANSLOCATING_ATPASE_COMPLEX,1
HP_PINEAL_CYST,SET,8,-0.34389,-0.0071768,0.28841,0.88343,HP_PINEAL_CYST,1
GOBP_PEROXISOME_FISSION,SET,8,-0.36888,-0.0076983,0.30935,0.88344,GOBP_PEROXISOME_FISSION,1
AGGAGTG_MIR483,SET,54,-0.13587,-0.007358,0.11395,0.88345,AGGAGTG_MIR483,1
KEGG_MEDICUS_REFERENCE_TAC3_...,SET,10,-0.33247,-0.007757,0.27879,0.88347,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY,1
GSE3982_NEUTROPHIL_VS_NKCELL...2,SET,179,-0.075014,-0.0073707,0.062882,0.88355,GSE3982_NEUTROPHIL_VS_NKCELL_UP,1
REACTOME_IFNG_SIGNALING_ACTI...,SET,8,-0.38121,-0.0079556,0.31952,0.88357,REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS,1
GOBP_NERVOUS_SYSTEM_PROCESS_...,SET,10,-0.35083,-0.0081855,0.29404,0.88358,GOBP_NERVOUS_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
HP_NAUSEA,SET,91,-0.1064,-0.0074724,0.08917,0.88361,HP_NAUSEA,1
GOBP_SYNAPTIC_TRANSMISSION_G...1,SET,56,-0.14662,-0.008085,0.12285,0.88366,GOBP_SYNAPTIC_TRANSMISSION_GABAERGIC,1
AGCTCCT_MIR28,SET,79,-0.11242,-0.0073583,0.09418,0.88368,AGCTCCT_MIR28,1
HP_ABNORMAL_SACRUM_MORPHOLOGY,SET,139,-0.090595,-0.0078528,0.0759,0.88368,HP_ABNORMAL_SACRUM_MORPHOLOGY,1
GSE21927_HEALTHY_VS_TUMOROUS...1,SET,139,-0.08713,-0.0075525,0.072994,0.88369,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN,1
IWANAGA_E2F1_TARGETS_NOT_IND...,SET,6,-0.38094,-0.0068853,0.3191,0.88371,IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM,1
TCTGGAC_MIR198,SET,78,-0.11882,-0.007728,0.099503,0.88377,TCTGGAC_MIR198,1
GOBP_ANTIGEN_PROCESSING_AND_...8,SET,27,-0.22421,-0.0085918,0.18776,0.88378,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II,1
CHOW_RASSF1_TARGETS_DN,SET,28,-0.18061,-0.0070477,0.15122,0.88383,CHOW_RASSF1_TARGETS_DN,1
GOMF_UBIQUITIN_PROTEIN_TRANS...2,SET,12,-0.31643,-0.008087,0.26493,0.88383,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_INHIBITOR_ACTIVITY,1
GOBP_DNA_DEMETHYLATION,SET,18,-0.28243,-0.0088389,0.23645,0.88384,GOBP_DNA_DEMETHYLATION,1
HP_ANTERIOR_BEAKING_OF_LUMBA...,SET,5,-0.47568,-0.0078488,0.39823,0.88385,HP_ANTERIOR_BEAKING_OF_LUMBAR_VERTEBRAE,1
LU_TUMOR_ENDOTHELIAL_MARKERS...2,SET,20,-0.23513,-0.0077561,0.1968,0.88389,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,1
GOBP_RESPONSE_TO_HEAT,SET,94,-0.10549,-0.0075287,0.088289,0.88391,GOBP_RESPONSE_TO_HEAT,1
RAF_UP.V1_UP,SET,176,-0.08387,-0.0081721,0.070197,0.88391,RAF_UP.V1_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...60,SET,39,-0.14226,-0.0065498,0.11897,0.88409,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
DER_IFN_GAMMA_RESPONSE_DN,SET,10,-0.35606,-0.0083074,0.29774,0.88412,DER_IFN_GAMMA_RESPONSE_DN,1
GSE14769_UNSTIM_VS_240MIN_LP...1,SET,181,-0.075785,-0.0074875,0.06335,0.8842,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN,1
MIR532_3P,SET,74,-0.11377,-0.007208,0.095097,0.88421,MIR532_3P,1
HP_ABNORMAL_RETINAL_VASCULAR...,SET,226,-0.068468,-0.0075494,0.057232,0.88421,HP_ABNORMAL_RETINAL_VASCULAR_MORPHOLOGY,1
HP_ESOPHAGEAL_VARIX,SET,39,-0.18299,-0.0084249,0.15296,0.88421,HP_ESOPHAGEAL_VARIX,1
GOMF_TRANSLATION_FACTOR_ACTI...,SET,71,-0.10942,-0.0067914,0.091461,0.88422,GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...186,SET,12,-0.31548,-0.0080628,0.26357,0.88433,GOBP_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
HP_LOWER_LIMB_JOINT_CONTRACT...,SET,197,-0.074174,-0.007642,0.061967,0.88434,HP_LOWER_LIMB_JOINT_CONTRACTURE,1
HP_THICKENED_SKIN,SET,381,-0.05364,-0.0076465,0.044788,0.88446,HP_THICKENED_SKIN,1
HP_SHALLOW_ORBITS,SET,32,-0.17789,-0.0074201,0.14853,0.88447,HP_SHALLOW_ORBITS,1
GOBP_POSITIVE_REGULATION_OF_...124,SET,103,-0.09815,-0.0073308,0.08194,0.8845,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
HOFT_CD4_POSITIVE_ALPHA_BETA...8,SET,25,-0.19884,-0.0073323,0.166,0.8845,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_UP,1
HP_ANISOPOIKILOCYTOSIS,SET,9,-0.37301,-0.0082565,0.31133,0.88456,HP_ANISOPOIKILOCYTOSIS,1
GOCC_CTF18_RFC_LIKE_COMPLEX,SET,8,-0.34706,-0.0072431,0.28956,0.88465,GOCC_CTF18_RFC_LIKE_COMPLEX,1
MIR1287_3P,SET,31,-0.16159,-0.0066343,0.13475,0.88476,MIR1287_3P,1
GOBP_POSITIVE_REGULATION_OF_...619,SET,4,-0.52802,-0.0077929,0.44031,0.88477,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEUBIQUITINATION,1
GOBP_SPHINGOLIPID_MEDIATED_S...,SET,17,-0.26226,-0.0079765,0.21863,0.88483,GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMAL_DELIVERY,SET,87,-0.10609,-0.0072854,0.088435,0.88484,HP_ABNORMAL_DELIVERY,1
HP_HYPOPLASTIC_FRONTAL_SINUS...,SET,6,-0.43425,-0.007849,0.36199,0.88485,HP_HYPOPLASTIC_FRONTAL_SINUSES,1
MIR30A_5P,SET,709,-0.040112,-0.0077288,0.033432,0.88489,MIR30A_5P,1
MIR30D_5P,SET,709,-0.040112,-0.0077288,0.033432,0.88489,MIR30D_5P,1
MIR30E_5P,SET,709,-0.040112,-0.0077288,0.033432,0.88489,MIR30E_5P,1
GOBP_REGULATION_OF_CALCIDIOL...,SET,7,-0.40523,-0.0079109,0.33774,0.88489,GOBP_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY,1
MOLENAAR_TARGETS_OF_CCND1_AN...1,SET,50,-0.13925,-0.0072572,0.11605,0.8849,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,1
MIR6849_3P,SET,68,-0.12189,-0.007404,0.10158,0.8849,MIR6849_3P,1
KYNG_NORMAL_AGING_UP,SET,13,-0.27637,-0.0073513,0.23031,0.88492,KYNG_NORMAL_AGING_UP,1
GOBP_GLOMERULAR_EPITHELIAL_C...,SET,12,-0.31798,-0.0081267,0.26497,0.88494,GOBP_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT,1
PETROVA_ENDOTHELIUM_LYMPHATI...1,SET,154,-0.088121,-0.0080367,0.073419,0.88497,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1
GOBP_MEMBRANE_DEPOLARIZATION...2,SET,5,-0.52771,-0.0087073,0.43966,0.88498,GOBP_MEMBRANE_DEPOLARIZATION_DURING_AV_NODE_CELL_ACTION_POTENTIAL,1
GSE31082_DN_VS_CD8_SP_THYMOC...2,SET,176,-0.07288,-0.0071012,0.060719,0.88498,GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP,1
MIR194_5P,SET,179,-0.077421,-0.0076071,0.064499,0.88499,MIR194_5P,1
GOBP_NEGATIVE_REGULATION_OF_...551,SET,28,-0.19333,-0.007544,0.16106,0.88499,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
GOBP_GLUTATHIONE_METABOLIC_P...,SET,46,-0.16116,-0.0080565,0.13425,0.885,GOBP_GLUTATHIONE_METABOLIC_PROCESS,1
ZNF707_TARGET_GENES,SET,35,-0.16315,-0.0071164,0.13589,0.88503,ZNF707_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_IGF_I...1,SET,13,-0.30022,-0.0079858,0.25003,0.88506,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY,1
MODULE_85,SET,47,-0.16831,-0.0085049,0.14018,0.88506,MODULE_85,1
GOBP_REGULATION_OF_EXTRINSIC...1,SET,145,-0.086592,-0.0076649,0.072083,0.88517,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
HP_ABNORMAL_CIRCULATING_THYR...1,SET,20,-0.24166,-0.0079715,0.20117,0.88517,HP_ABNORMAL_CIRCULATING_THYROGLOBULIN_CONCENTRATION,1
HP_CHERRY_RED_SPOT_OF_THE_MA...,SET,13,-0.27963,-0.0074381,0.23273,0.88521,HP_CHERRY_RED_SPOT_OF_THE_MACULA,1
GOBP_NEGATIVE_REGULATION_OF_...437,SET,11,-0.3301,-0.0080774,0.27467,0.88527,GOBP_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
DAZARD_UV_RESPONSE_CLUSTER_G2,SET,25,-0.22545,-0.0083136,0.18758,0.88529,DAZARD_UV_RESPONSE_CLUSTER_G2,1
GOBP_CARDIAC_NEURAL_CREST_CE...3,SET,10,-0.38735,-0.0090375,0.32221,0.88534,GOBP_CARDIAC_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,1
WP_GLYCOLYSIS_IN_SENESCENCE,SET,9,-0.30686,-0.0067923,0.25523,0.88537,WP_GLYCOLYSIS_IN_SENESCENCE,1
GSE36527_CD62L_HIGH_VS_CD62L...2,SET,179,-0.077474,-0.0076123,0.064437,0.88537,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP,1
MIR4768_5P,SET,302,-0.060801,-0.0077334,0.050565,0.88539,MIR4768_5P,1
HP_FACIAL_MYOKYMIA,SET,7,-0.33971,-0.006632,0.2825,0.88542,HP_FACIAL_MYOKYMIA,1
MYLLYKANGAS_AMPLIFICATION_HO...16,SET,6,-0.38931,-0.0070367,0.32364,0.88549,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6,1
chr13q33,SET,18,-0.36879,-0.011542,0.30652,0.88553,chr13q33,1
CTTTGA_LEF1_Q2,SET,1087,-0.033851,-0.0079892,0.028135,0.88553,CTTTGA_LEF1_Q2,1
KEGG_MEDICUS_REFERENCE_EXTRI...,SET,10,-0.32413,-0.0075624,0.26939,0.88554,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY,1
HP_ABNORMALITY_OF_THE_VOICE,SET,386,-0.053589,-0.0076881,0.044533,0.88557,HP_ABNORMALITY_OF_THE_VOICE,1
HE_LIM_SUN_FETAL_LUNG_C0_INT...1,SET,62,-0.14454,-0.0083853,0.12009,0.88562,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE,1
GOMF_SUMO_POLYMER_BINDING,SET,5,-0.4228,-0.0069763,0.35115,0.88571,GOMF_SUMO_POLYMER_BINDING,1
REACTOME_IRS_ACTIVATION,SET,5,-0.54827,-0.0090466,0.45516,0.88581,REACTOME_IRS_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...108,SET,5,-0.46201,-0.0076232,0.38348,0.88585,GOBP_POSITIVE_REGULATION_OF_CELLULAR_PH_REDUCTION,1
HP_ABNORMAL_METENCEPHALON_MO...,SET,887,-0.034352,-0.0073659,0.028512,0.88586,HP_ABNORMAL_METENCEPHALON_MORPHOLOGY,1
HP_DECREASED_MUSCLE_MASS,SET,53,-0.13899,-0.0074567,0.11533,0.88591,HP_DECREASED_MUSCLE_MASS,1
MIR196A_1_3P,SET,358,-0.056836,-0.0078587,0.047161,0.88592,MIR196A_1_3P,1
DURANTE_ADULT_OLFACTORY_NEUR...22,SET,32,-0.1976,-0.0082424,0.16397,0.88592,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_HORIZONTAL_BASAL_CELLS,1
GSE46242_CTRL_VS_EGR2_DELETE...2,SET,169,-0.077151,-0.0073678,0.064012,0.88594,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP,1
GOBP_RETROGRADE_TRANSPORT_VE...,SET,9,-0.34909,-0.0077272,0.28962,0.88596,GOBP_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI,1
GOCC_SYMMETRIC_SYNAPSE,SET,7,-0.39775,-0.007765,0.32998,0.88597,GOCC_SYMMETRIC_SYNAPSE,1
GOBP_REGULATION_OF_ELECTRON_...,SET,3,-0.58509,-0.0074785,0.48519,0.88606,GOBP_REGULATION_OF_ELECTRON_TRANSFER_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...317,SET,2,-0.71646,-0.0074773,0.59406,0.88609,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...4,SET,28,-0.21772,-0.008496,0.18052,0.88611,HE_LIM_SUN_FETAL_LUNG_C1_LATE_TIP_CELL,1
GSE19923_WT_VS_E2A_KO_DP_THY...2,SET,181,-0.076666,-0.0075745,0.063559,0.88612,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP,1
HE_LIM_SUN_FETAL_LUNG_C2_NON...,SET,16,-0.24988,-0.0073733,0.20716,0.88612,HE_LIM_SUN_FETAL_LUNG_C2_NON_CLASSICAL_MONOCYTE,1
KEGG_MEDICUS_REFERENCE_CA2_C...3,SET,11,-0.34386,-0.0084142,0.28502,0.88617,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY,1
REACTOME_DEGRADATION_OF_AXIN,SET,52,-0.127,-0.006749,0.10526,0.88617,REACTOME_DEGRADATION_OF_AXIN,1
REACTOME_RUNX3_REGULATES_CDK...,SET,7,-0.38218,-0.007461,0.31669,0.88623,REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION,1
HP_DESQUAMATION_OF_SKIN_SOON...,SET,11,-0.30124,-0.0073712,0.2496,0.88625,HP_DESQUAMATION_OF_SKIN_SOON_AFTER_BIRTH,1
HOEK_NK_CELL_2011_2012_TIV_A...2,SET,12,-0.29341,-0.0074988,0.2431,0.88627,HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP,1
HP_PES_CAVUS,SET,252,-0.065368,-0.0076055,0.054153,0.88629,HP_PES_CAVUS,1
HP_SUPERNUMERARY_NIPPLE,SET,46,-0.14334,-0.0071658,0.11873,0.88634,HP_SUPERNUMERARY_NIPPLE,1
MIR6809_5P,SET,125,-0.09199,-0.0075644,0.076189,0.88635,MIR6809_5P,1
WP_NOCGMPPKG_MEDIATED_NEUROP...,SET,41,-0.16437,-0.0077585,0.13612,0.88637,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,1
GOBP_REGULATION_OF_DEFENSE_R...5,SET,34,-0.19402,-0.0083416,0.16062,0.88645,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,1
GSE22103_UNSTIM_VS_LPS_STIM_...2,SET,188,-0.073597,-0.0074091,0.060929,0.88645,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP,1
REACTOME_SYNTHESIS_OF_DNA,SET,116,-0.087416,-0.0069264,0.072356,0.88649,REACTOME_SYNTHESIS_OF_DNA,1
HP_CSF_LYMPHOCYTIC_PLEIOCYTO...,SET,18,-0.22835,-0.0071465,0.18897,0.88655,HP_CSF_LYMPHOCYTIC_PLEIOCYTOSIS,1
ZNF830_TARGET_GENES,SET,235,-0.0684,-0.0076888,0.056588,0.88661,ZNF830_TARGET_GENES,1
GSE17721_0.5H_VS_8H_PAM3CSK4...2,SET,181,-0.075219,-0.0074315,0.062225,0.88663,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP,1
GOBP_POLYOL_METABOLIC_PROCESS,SET,95,-0.10665,-0.0076516,0.088211,0.88666,GOBP_POLYOL_METABOLIC_PROCESS,1
GOMF_QUINONE_BINDING,SET,14,-0.25176,-0.0069496,0.20824,0.88666,GOMF_QUINONE_BINDING,1
GSE17721_LPS_VS_PAM3CSK4_16H...2,SET,189,-0.073959,-0.0074652,0.061173,0.88666,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP,1
GOBP_REGULATION_OF_NEUTROPHI...6,SET,37,-0.18866,-0.0084605,0.15603,0.88668,GOBP_REGULATION_OF_NEUTROPHIL_MIGRATION,1
HP_ABNORMAL_LONG_BONE_MORPHO...,SET,686,-0.039632,-0.0075162,0.032766,0.88677,HP_ABNORMAL_LONG_BONE_MORPHOLOGY,1
HP_MACULAR_HYPOPLASIA,SET,13,-0.30976,-0.0082396,0.25608,0.88678,HP_MACULAR_HYPOPLASIA,1
REACTOME_GLYOXYLATE_METABOLI...,SET,19,-0.23199,-0.0074591,0.19176,0.88682,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,1
GNF2_CD1D,SET,38,-0.17415,-0.0079145,0.14392,0.88685,GNF2_CD1D,1
GOBP_REGULATION_OF_FAS_SIGNA...,SET,4,-0.46699,-0.0068921,0.38584,0.88691,GOBP_REGULATION_OF_FAS_SIGNALING_PATHWAY,1
HP_CERVICAL_NEOPLASM,SET,6,-0.49706,-0.0089841,0.41069,0.88691,HP_CERVICAL_NEOPLASM,1
HP_IRREGULAR_EPIPHYSES,SET,21,-0.22465,-0.0075933,0.1856,0.88692,HP_IRREGULAR_EPIPHYSES,1
HP_THORACOLUMBAR_SCOLIOSIS,SET,37,-0.15727,-0.0070528,0.12991,0.88697,HP_THORACOLUMBAR_SCOLIOSIS,1
GSE17974_IL4_AND_ANTI_IL12_V...12,SET,158,-0.087459,-0.0080783,0.072225,0.88703,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP,1
MIR6505_5P,SET,187,-0.077086,-0.0077399,0.063654,0.88705,MIR6505_5P,1
REACTOME_MET_ACTIVATES_PTK2_...,SET,30,-0.20472,-0.0082684,0.16904,0.88706,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1
GOBP_CLATHRIN_COATED_VESICLE...,SET,7,-0.39087,-0.0076307,0.32271,0.88709,GOBP_CLATHRIN_COATED_VESICLE_CARGO_LOADING,1
TRAVAGLINI_LUNG_ALVEOLAR_EPI...2,SET,126,-0.099577,-0.0082208,0.082203,0.88711,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,1
HP_NEOPLASM_OF_THE_EAR,SET,22,-0.22263,-0.0077019,0.18378,0.88713,HP_NEOPLASM_OF_THE_EAR,1
REACTOME_GABA_SYNTHESIS_RELE...,SET,19,-0.26445,-0.0085026,0.21824,0.88718,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,1
GSE10239_MEMORY_VS_KLRG1INT_...1,SET,184,-0.073714,-0.0073424,0.060821,0.88723,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN,1
HP_NON_MOTOR_SEIZURE,SET,174,-0.077903,-0.0075479,0.064273,0.88725,HP_NON_MOTOR_SEIZURE,1
GOMF_OLIGOSACCHARIDE_BINDING,SET,17,-0.28256,-0.008594,0.23307,0.8873,GOMF_OLIGOSACCHARIDE_BINDING,1
HP_CONVULSIVE_STATUS_EPILEPT...,SET,6,-0.40167,-0.0072601,0.33131,0.88731,HP_CONVULSIVE_STATUS_EPILEPTICUS,1
DORN_ADENOVIRUS_INFECTION_24...1,SET,38,-0.16257,-0.0073885,0.13408,0.88733,DORN_ADENOVIRUS_INFECTION_24HR_DN,1
GSE8515_IL1_VS_IL6_4H_STIM_M...2,SET,176,-0.078504,-0.0076493,0.064744,0.88734,GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP,1
MCCLUNG_CREB1_TARGETS_DN,SET,51,-0.15006,-0.0078976,0.12374,0.88737,MCCLUNG_CREB1_TARGETS_DN,1
GOBP_REGULATION_OF_BINDING_O...,SET,5,-0.41669,-0.0068754,0.34356,0.8874,GOBP_REGULATION_OF_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,1
GAL_LEUKEMIC_STEM_CELL_UP,SET,110,-0.10013,-0.007727,0.082551,0.88741,GAL_LEUKEMIC_STEM_CELL_UP,1
HEIDENBLAD_AMPLICON_12P11_12...2,SET,33,-0.18955,-0.008029,0.15626,0.88743,HEIDENBLAD_AMPLICON_12P11_12_UP,1
MIR520D_3P,SET,303,-0.059358,-0.0075622,0.048922,0.88748,MIR520D_3P,1
GOBP_NEGATIVE_REGULATION_OF_...132,SET,5,-0.36189,-0.0059712,0.29826,0.88749,GOBP_NEGATIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,1
chr13q21,SET,11,-0.49919,-0.012215,0.41141,0.8875,chr13q21,1
TIEN_INTESTINE_PROBIOTICS_24...1,SET,192,-0.07686,-0.0078186,0.063335,0.88753,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1
MIR875_5P,SET,49,-0.15499,-0.0079961,0.12772,0.88753,MIR875_5P,1
GOBP_NUCLEOSIDE_TRANSPORT,SET,10,-0.35541,-0.0082922,0.2928,0.88758,GOBP_NUCLEOSIDE_TRANSPORT,1
HP_BOWED_HUMERUS,SET,7,-0.40081,-0.0078246,0.3302,0.88758,HP_BOWED_HUMERUS,1
GSE37532_VISCERAL_ADIPOSE_TI...2,SET,148,-0.080053,-0.0071584,0.065949,0.88759,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP,1
HP_MICROPHALLUS,SET,14,-0.29121,-0.0080384,0.23988,0.88762,HP_MICROPHALLUS,1
GNF2_ANP32B,SET,34,-0.16627,-0.0071486,0.13691,0.8877,GNF2_ANP32B,1
REACTOME_TFAP2_AP_2_FAMILY_R...2,SET,14,-0.31652,-0.0087371,0.26062,0.88771,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,1
GOBP_LACTATE_METABOLIC_PROCE...,SET,16,-0.25495,-0.0075229,0.20991,0.88773,GOBP_LACTATE_METABOLIC_PROCESS,1
REACTOME_PROCESSIVE_SYNTHESI...1,SET,19,-0.22475,-0.0072261,0.18503,0.88774,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,1
MODULE_200,SET,27,-0.23452,-0.0089867,0.19307,0.88775,MODULE_200,1
MIR4760_5P,SET,181,-0.078994,-0.0078045,0.065019,0.8878,MIR4760_5P,1
HE_LIM_SUN_FETAL_LUNG_C2_CXC...,SET,118,-0.10212,-0.0081605,0.084048,0.88781,HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL,1
HP_ABNORMAL_CAUDATE_NUCLEUS_...,SET,19,-0.2465,-0.0079256,0.20286,0.88783,HP_ABNORMAL_CAUDATE_NUCLEUS_MORPHOLOGY,1
GOBP_CARBOHYDRATE_PHOSPHORYL...,SET,21,-0.20162,-0.0068149,0.16592,0.88784,GOBP_CARBOHYDRATE_PHOSPHORYLATION,1
GOBP_REGULATION_OF_PROSTAGLA...,SET,14,-0.33453,-0.0092343,0.27527,0.88786,GOBP_REGULATION_OF_PROSTAGLANDIN_SECRETION,1
BIOCARTA_LIS1_PATHWAY,SET,18,-0.23382,-0.0073175,0.19238,0.88788,BIOCARTA_LIS1_PATHWAY,1
GOBP_GLYCOLYTIC_PROCESS_THRO...1,SET,19,-0.22069,-0.0070957,0.18157,0.8879,GOBP_GLYCOLYTIC_PROCESS_THROUGH_FRUCTOSE_6_PHOSPHATE,1
MCRS1_TARGET_GENES,SET,33,-0.17569,-0.007442,0.14449,0.888,MCRS1_TARGET_GENES,1
GOBP_RENAL_SYSTEM_VASCULATUR...1,SET,31,-0.2123,-0.0087163,0.17459,0.888,GOBP_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT,1
XU_RESPONSE_TO_TRETINOIN_AND...1,SET,13,-0.29471,-0.0078394,0.24235,0.88801,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,1
HP_SINGLE_TRANSVERSE_PALMAR_...,SET,179,-0.077231,-0.0075884,0.0635,0.88804,HP_SINGLE_TRANSVERSE_PALMAR_CREASE,1
DESCARTES_MAIN_FETAL_SYNCYTI...,SET,64,-0.13653,-0.0080469,0.11226,0.88804,DESCARTES_MAIN_FETAL_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,1
GOBP_POSITIVE_REGULATION_OF_...701,SET,6,-0.53106,-0.0095988,0.43664,0.88805,GOBP_POSITIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,1
RUVBL1_TARGET_GENES,SET,126,-0.091453,-0.0075501,0.075172,0.88811,RUVBL1_TARGET_GENES,1
BIOCARTA_ION_PATHWAY,SET,5,-0.44934,-0.0074142,0.36928,0.88815,BIOCARTA_ION_PATHWAY,1
GOBP_PHOSPHAGEN_METABOLIC_PR...,SET,5,-0.4169,-0.0068789,0.34257,0.88819,GOBP_PHOSPHAGEN_METABOLIC_PROCESS,1
GSE3982_EFF_MEMORY_CD4_TCELL...2,SET,179,-0.076285,-0.0074955,0.06268,0.8882,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP,1
HP_LEUKOCORIA,SET,6,-0.36909,-0.0066711,0.30319,0.88826,HP_LEUKOCORIA,1
HP_OPTIC_DISC_HYPOPLASIA,SET,16,-0.27724,-0.0081808,0.22774,0.88826,HP_OPTIC_DISC_HYPOPLASIA,1
GOBP_POSITIVE_REGULATION_OF_...570,SET,34,-0.17988,-0.0077335,0.14773,0.8883,GOBP_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
BMI1_DN_MEL18_DN.V1_UP,SET,135,-0.097956,-0.0083687,0.080446,0.88831,BMI1_DN_MEL18_DN.V1_UP,1
GSE36888_UNTREATED_VS_IL2_TR...1,SET,181,-0.077352,-0.0076423,0.063525,0.88831,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN,1
MIR4259,SET,23,-0.21171,-0.0074885,0.17385,0.88834,MIR4259,1
MARTINELLI_IMMATURE_NEUTROPH...1,SET,13,-0.34354,-0.0091382,0.28204,0.88839,MARTINELLI_IMMATURE_NEUTROPHIL_DN,1
GOBP_LIPID_MODIFICATION,SET,168,-0.078319,-0.0074574,0.064289,0.88842,GOBP_LIPID_MODIFICATION,1
GOBP_PURINE_RIBONUCLEOSIDE_M...,SET,19,-0.26514,-0.008525,0.21762,0.88845,GOBP_PURINE_RIBONUCLEOSIDE_METABOLIC_PROCESS,1
GSE17721_PAM3CSK4_VS_GADIQUI...6,SET,180,-0.077362,-0.0076224,0.063484,0.8885,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP,1
HP_IRIS_TRANSILLUMINATION_DE...,SET,12,-0.33231,-0.008493,0.27267,0.88852,HP_IRIS_TRANSILLUMINATION_DEFECT,1
GOCC_MICROTUBULE_END,SET,33,-0.19061,-0.0080738,0.15639,0.88854,GOCC_MICROTUBULE_END,1
GOBP_PHOTORECEPTOR_CELL_MORP...,SET,4,-0.52994,-0.0078211,0.43475,0.88856,GOBP_PHOTORECEPTOR_CELL_MORPHOGENESIS,1
TARTE_PLASMA_CELL_VS_B_LYMPH...1,SET,34,-0.19595,-0.0084244,0.16074,0.88858,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,1
BOYLAN_MULTIPLE_MYELOMA_C_D_...2,SET,125,-0.09003,-0.0074033,0.07385,0.88859,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,1
HP_RENAL_TUBULAR_ATROPHY,SET,18,-0.23498,-0.007354,0.19274,0.8886,HP_RENAL_TUBULAR_ATROPHY,1
VETTER_TARGETS_OF_PRKCA_AND_...1,SET,16,-0.28065,-0.0082813,0.23018,0.88862,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,1
MIR188_5P,SET,65,-0.13467,-0.007999,0.11042,0.8887,MIR188_5P,1
HP_ABNORMAL_5TH_FINGER_MORPH...,SET,435,-0.04986,-0.0075833,0.040868,0.88877,HP_ABNORMAL_5TH_FINGER_MORPHOLOGY,1
MIR140_5P,SET,82,-0.1136,-0.0075746,0.093096,0.8888,MIR140_5P,1
GOBP_REGULATION_OF_PLASMA_ME...1,SET,16,-0.25418,-0.0075003,0.20829,0.88882,GOBP_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION,1
GOBP_POLYSACCHARIDE_CATABOLI...,SET,26,-0.19658,-0.0073924,0.16108,0.88883,GOBP_POLYSACCHARIDE_CATABOLIC_PROCESS,1
GSE1925_CTRL_VS_24H_IFNG_STI...4,SET,176,-0.078154,-0.0076152,0.064038,0.88884,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP,1
GOMF_SEROTONIN_RECEPTOR_ACTI...,SET,6,-0.52936,-0.0095679,0.43371,0.88886,GOMF_SEROTONIN_RECEPTOR_ACTIVITY,1
REACTOME_INTERFERON_GAMMA_SI...,SET,90,-0.11793,-0.0082363,0.096614,0.88887,REACTOME_INTERFERON_GAMMA_SIGNALING,1
GOBP_T_HELPER_2_CELL_DIFFERE...,SET,17,-0.267,-0.0081209,0.21875,0.88887,GOBP_T_HELPER_2_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...227,SET,92,-0.11023,-0.0077835,0.090286,0.88894,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...697,SET,11,-0.34857,-0.0085295,0.28534,0.88907,GOBP_NEGATIVE_REGULATION_OF_VASOCONSTRICTION,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...1,SET,911,-0.0343,-0.0074486,0.028076,0.88908,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,1
GOCC_BCL_2_FAMILY_PROTEIN_CO...,SET,10,-0.36448,-0.0085039,0.29828,0.88913,GOCC_BCL_2_FAMILY_PROTEIN_COMPLEX,1
REACTOME_ACTIVATED_NTRK3_SIG...2,SET,8,-0.32358,-0.0067529,0.26479,0.88914,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS,1
GOBP_XENOBIOTIC_TRANSMEMBRAN...,SET,17,-0.26809,-0.008154,0.21938,0.88914,GOBP_XENOBIOTIC_TRANSMEMBRANE_TRANSPORT,1
WP_SEROTONIN_RECEPTOR_2_AND_...,SET,18,-0.23324,-0.0072993,0.19085,0.88915,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,1
HP_REDUCED_VITAL_CAPACITY,SET,26,-0.19095,-0.0071805,0.15625,0.88915,HP_REDUCED_VITAL_CAPACITY,1
GOBP_REGULATION_OF_DNA_BINDI...1,SET,66,-0.132,-0.0079001,0.10801,0.88916,GOBP_REGULATION_OF_DNA_BINDING,1
GSE40273_XBP1_KO_VS_WT_TREG_...1,SET,184,-0.078322,-0.0078014,0.064086,0.88917,GSE40273_XBP1_KO_VS_WT_TREG_DN,1
GSE3203_HEALTHY_VS_INFLUENZA...1,SET,179,-0.079583,-0.0078196,0.065114,0.88918,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN,1
GOCC_GOLGI_CISTERNA,SET,96,-0.10877,-0.0078445,0.088989,0.88919,GOCC_GOLGI_CISTERNA,1
GOBP_REGULATION_OF_NEUROTRAN...1,SET,40,-0.17394,-0.0081098,0.14229,0.88921,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
HP_ONYCHOLYSIS,SET,20,-0.23632,-0.0077956,0.19333,0.88921,HP_ONYCHOLYSIS,1
HP_DECREASED_SERUM_ZINC,SET,4,-0.48372,-0.0071391,0.39571,0.88922,HP_DECREASED_SERUM_ZINC,1
MIR4470,SET,226,-0.071183,-0.0078488,0.058228,0.88923,MIR4470,1
MIR1231,SET,48,-0.16016,-0.0081785,0.13094,0.88937,MIR1231,1
HP_RHINORRHEA,SET,7,-0.36659,-0.0071567,0.2997,0.88937,HP_RHINORRHEA,1
GSE2706_UNSTIM_VS_2H_R848_DC...2,SET,172,-0.075281,-0.0072522,0.061542,0.88937,GSE2706_UNSTIM_VS_2H_R848_DC_UP,1
GOMF_PEPTIDE_HORMONE_RECEPTO...,SET,19,-0.26363,-0.0084764,0.21544,0.88945,GOMF_PEPTIDE_HORMONE_RECEPTOR_BINDING,1
GOBP_CARDIAC_CHAMBER_MORPHOG...,SET,121,-0.10658,-0.0086236,0.087081,0.8895,GOBP_CARDIAC_CHAMBER_MORPHOGENESIS,1
MIR520A_3P,SET,304,-0.059813,-0.0076326,0.048865,0.88952,MIR520A_3P,1
HOWLIN_PUBERTAL_MAMMARY_GLAND,SET,62,-0.14948,-0.0086716,0.1221,0.88956,HOWLIN_PUBERTAL_MAMMARY_GLAND,1
REACTOME_MAPK6_MAPK4_SIGNALI...,SET,86,-0.10789,-0.0073666,0.088128,0.88956,REACTOME_MAPK6_MAPK4_SIGNALING,1
KOBAYASHI_RESPONSE_TO_ROMIDE...,SET,19,-0.26308,-0.0084586,0.21486,0.8896,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,1
ZSCAN5B_TARGET_GENES,SET,48,-0.15096,-0.0077084,0.12329,0.8896,ZSCAN5B_TARGET_GENES,1
HP_VISCERAL_ANGIOMATOSIS,SET,15,-0.27456,-0.0078446,0.2242,0.88963,HP_VISCERAL_ANGIOMATOSIS,1
STAMBOLSKY_BOUND_BY_MUTATED_...,SET,13,-0.29492,-0.007845,0.24081,0.88965,STAMBOLSKY_BOUND_BY_MUTATED_TP53,1
GOBP_NEGATIVE_REGULATION_OF_...304,SET,7,-0.43277,-0.0084486,0.35334,0.88967,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,1
GOBP_POSITIVE_REGULATION_OF_...601,SET,18,-0.24801,-0.0077617,0.20249,0.88967,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
ZNF746_TARGET_GENES,SET,55,-0.14112,-0.0077125,0.11522,0.88968,ZNF746_TARGET_GENES,1
MIKKELSEN_MCV6_LCP_WITH_H3K4...,SET,146,-0.089384,-0.007939,0.072969,0.8897,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,1
HP_APPENDICULAR_SPASTICITY,SET,334,-0.056779,-0.0075881,0.046347,0.88972,HP_APPENDICULAR_SPASTICITY,1
HP_SECRETORY_DIARRHEA,SET,12,-0.28059,-0.0071712,0.22899,0.88977,HP_SECRETORY_DIARRHEA,1
MIR3663_5P,SET,49,-0.15149,-0.0078154,0.12358,0.88986,MIR3663_5P,1
MIR3913_5P,SET,79,-0.11503,-0.0075292,0.093839,0.88986,MIR3913_5P,1
GOBP_POSTSYNAPTIC_SPECIALIZA...1,SET,29,-0.20445,-0.0081193,0.16677,0.88988,GOBP_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,1
GOMF_UDP_GLYCOSYLTRANSFERASE...,SET,132,-0.10116,-0.0085469,0.082519,0.88988,GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY,1
MIR452_5P,SET,197,-0.073943,-0.0076182,0.06031,0.8899,MIR452_5P,1
TERAMOTO_OPN_TARGETS_CLUSTER...7,SET,8,-0.3687,-0.0076947,0.30071,0.88991,TERAMOTO_OPN_TARGETS_CLUSTER_8,1
GOBP_POSITIVE_REGULATION_OF_...247,SET,6,-0.50944,-0.0092079,0.41547,0.88993,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
HP_PROGRESSIVE_ENCEPHALOPATHY,SET,10,-0.31089,-0.0072535,0.25354,0.88993,HP_PROGRESSIVE_ENCEPHALOPATHY,1
GOBP_METANEPHRIC_NEPHRON_MOR...,SET,24,-0.24499,-0.0088519,0.19979,0.88994,GOBP_METANEPHRIC_NEPHRON_MORPHOGENESIS,1
GOBP_MONOACYLGLYCEROL_CATABO...,SET,7,-0.36327,-0.0070918,0.29624,0.88994,GOBP_MONOACYLGLYCEROL_CATABOLIC_PROCESS,1
GSE8921_UNSTIM_VS_TLR1_2_STI...6,SET,185,-0.073782,-0.0073689,0.060147,0.89002,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...665,SET,6,-0.5089,-0.0091982,0.41483,0.89004,GOBP_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,1
REACTOME_REGULATION_OF_CDH11...2,SET,10,-0.3734,-0.0087121,0.30436,0.89005,REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION,1
MODULE_199,SET,52,-0.16049,-0.0085289,0.13082,0.89005,MODULE_199,1
GOBP_RESPONSE_TO_INTERLEUKIN...11,SET,14,-0.26543,-0.0073268,0.21636,0.89005,GOBP_RESPONSE_TO_INTERLEUKIN_7,1
GGGNNTTTCC_NFKB_Q6_01,SET,124,-0.095175,-0.0077952,0.077575,0.89006,GGGNNTTTCC_NFKB_Q6_01,1
GOBP_EMBRYONIC_CRANIAL_SKELE...,SET,42,-0.17114,-0.008176,0.13949,0.89006,GOBP_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS,1
IL15_UP.V1_UP,SET,164,-0.083116,-0.0078203,0.067741,0.89007,IL15_UP.V1_UP,1
HP_DEVIATION_OF_TOES,SET,103,-0.10712,-0.0080008,0.087301,0.89009,HP_DEVIATION_OF_TOES,1
GOMF_FRUCTOSE_6_PHOSPHATE_BI...,SET,4,-0.40191,-0.0059317,0.32751,0.89012,GOMF_FRUCTOSE_6_PHOSPHATE_BINDING,1
MIR202_5P,SET,103,-0.1035,-0.0077301,0.084325,0.89014,MIR202_5P,1
HP_HYPOVOLEMIC_SHOCK,SET,5,-0.54413,-0.0089783,0.44333,0.89015,HP_HYPOVOLEMIC_SHOCK,1
HE_LIM_SUN_FETAL_LUNG_C7_COL...,SET,65,-0.14232,-0.0084528,0.11592,0.89022,HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL,1
GOBP_REGULATION_OF_NEUROTRAN...2,SET,8,-0.37189,-0.0077612,0.30289,0.89023,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
MODULE_297,SET,72,-0.12912,-0.0080701,0.10516,0.89024,MODULE_297,1
GOCC_SMOOTH_ENDOPLASMIC_RETI...2,SET,7,-0.45603,-0.0089027,0.37139,0.89025,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE,1
ZNF490_TARGET_GENES,SET,335,-0.05692,-0.0076183,0.046351,0.89027,ZNF490_TARGET_GENES,1
GSE34156_UNTREATED_VS_6H_NOD...2,SET,149,-0.086668,-0.0077758,0.070571,0.89029,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
GOBP_MODULATION_BY_HOST_OF_V...3,SET,3,-0.65753,-0.0084044,0.53533,0.89032,GOBP_MODULATION_BY_HOST_OF_VIRAL_RNA_GENOME_REPLICATION,1
MIR4469,SET,104,-0.10268,-0.0077058,0.083581,0.89035,MIR4469,1
HP_HYPERTROPHIC_CARDIOMYOPAT...,SET,243,-0.064923,-0.0074194,0.05285,0.89035,HP_HYPERTROPHIC_CARDIOMYOPATHY,1
GOMF_RIBOSOME_BINDING,SET,87,-0.1078,-0.0074031,0.087749,0.89036,GOMF_RIBOSOME_BINDING,1
WP_NONHOMOLOGOUS_END_JOINING,SET,10,-0.27067,-0.0063151,0.22023,0.89046,WP_NONHOMOLOGOUS_END_JOINING,1
MIR3187_3P,SET,63,-0.1298,-0.0075903,0.10558,0.89052,MIR3187_3P,1
HP_RETINAL_ARTERIAL_TORTUOSI...,SET,3,-0.51712,-0.0066097,0.42066,0.89052,HP_RETINAL_ARTERIAL_TORTUOSITY,1
MIR8053,SET,5,-0.36428,-0.0060107,0.29631,0.89053,MIR8053,1
GSE17721_LPS_VS_PAM3CSK4_24H...2,SET,187,-0.07411,-0.0074411,0.06028,0.89054,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP,1
GSE3982_NKCELL_VS_TH2_DN,SET,179,-0.075501,-0.0074185,0.061397,0.89059,GSE3982_NKCELL_VS_TH2_DN,1
GOBP_NEGATIVE_REGULATION_OF_...672,SET,45,-0.1635,-0.0080846,0.13293,0.89064,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION,1
GSE11057_NAIVE_VS_EFF_MEMORY...1,SET,173,-0.079333,-0.0076645,0.064498,0.89065,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,1
KEGG_MEDICUS_VARIANT_DUPLICA...3,SET,14,-0.26731,-0.0073786,0.2173,0.89067,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY,1
GSE45365_CTRL_VS_MCMV_INFECT...1,SET,172,-0.078219,-0.0075353,0.063586,0.89067,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN,1
ZNF667_TARGET_GENES,SET,120,-0.09616,-0.0077486,0.078167,0.89068,ZNF667_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...98,SET,3,-0.70649,-0.0090301,0.57421,0.89071,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
BENITEZ_GBM_PROTEASOME_INHIB...,SET,45,-0.16093,-0.0079572,0.13078,0.89074,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,1
MIR518A_3P_MIR518B_MIR518C_3...,SET,8,-0.40481,-0.0084482,0.32887,0.89082,MIR518A_3P_MIR518B_MIR518C_3P_MIR518D_3P_MIR518F_3P_MIR526A_3P,1
HP_ABNORMAL_AORTIC_ARCH_MORP...,SET,58,-0.14242,-0.007992,0.11567,0.89088,HP_ABNORMAL_AORTIC_ARCH_MORPHOLOGY,1
HP_OPEN_MOUTH,SET,98,-0.10762,-0.0078419,0.0874,0.8909,HP_OPEN_MOUTH,1
GOBP_POSITIVE_REGULATION_OF_...819,SET,17,-0.2362,-0.0071841,0.19181,0.89091,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,1
HP_FALLS,SET,38,-0.17874,-0.0081233,0.14511,0.89098,HP_FALLS,1
GOCC_SPERMATOPROTEASOME_COMP...,SET,5,-0.39576,-0.0065302,0.32127,0.89099,GOCC_SPERMATOPROTEASOME_COMPLEX,1
HP_ABNORMALITY_OF_THE_PULMON...1,SET,119,-0.098374,-0.0078942,0.07985,0.89101,HP_ABNORMALITY_OF_THE_PULMONARY_ARTERY,1
MIR520G_5P,SET,53,-0.14373,-0.0077112,0.11666,0.89103,MIR520G_5P,1
REACTOME_MITF_M_DEPENDENT_GE...,SET,91,-0.11044,-0.0077556,0.089625,0.89105,REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION,1
GOBP_PROTEIN_LOCALIZATION_TO...6,SET,11,-0.30982,-0.0075811,0.25128,0.8912,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
ATF2_S_UP.V1_DN,SET,168,-0.084598,-0.0080553,0.068614,0.8912,ATF2_S_UP.V1_DN,1
BORCZUK_MALIGNANT_MESOTHELIO...2,SET,266,-0.061321,-0.0073273,0.049732,0.89121,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1
ZNF776_TARGET_GENES,SET,6,-0.42886,-0.0077514,0.3478,0.89121,ZNF776_TARGET_GENES,1
HP_NONIMMUNE_HYDROPS_FETALIS,SET,58,-0.13179,-0.0073954,0.10688,0.89122,HP_NONIMMUNE_HYDROPS_FETALIS,1
REACTOME_SIGNAL_REGULATORY_P...,SET,14,-0.3048,-0.0084135,0.24711,0.89129,REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS,1
HP_LONG_NASAL_BRIDGE,SET,4,-0.52463,-0.0077429,0.42526,0.89133,HP_LONG_NASAL_BRIDGE,1
GOBP_POSITIVE_REGULATION_BY_...1,SET,10,-0.34455,-0.008039,0.27923,0.89138,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
GOMF_DEATH_RECEPTOR_BINDING,SET,19,-0.23072,-0.0074181,0.18698,0.89138,GOMF_DEATH_RECEPTOR_BINDING,1
GOMF_HISTONE_DEACETYLASE_REG...,SET,5,-0.54458,-0.0089857,0.44128,0.89141,GOMF_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY,1
GSE40685_NAIVE_CD4_TCELL_VS_...2,SET,186,-0.07679,-0.0076898,0.06222,0.89142,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP,1
REACTOME_COMPLEX_I_BIOGENESIS,SET,56,-0.12307,-0.0067867,0.099717,0.89143,REACTOME_COMPLEX_I_BIOGENESIS,1
HP_ABNORMALITY_OF_THE_FOREHE...,SET,1026,-0.033155,-0.0076156,0.02686,0.89146,HP_ABNORMALITY_OF_THE_FOREHEAD,1
GOBP_VIRAL_TRANSLATIONAL_TER...,SET,5,-0.42922,-0.0070823,0.34769,0.89148,GOBP_VIRAL_TRANSLATIONAL_TERMINATION_REINITIATION,1
HP_POSTERIOR_PLAGIOCEPHALY,SET,7,-0.41056,-0.0080151,0.33243,0.89158,HP_POSTERIOR_PLAGIOCEPHALY,1
GSE21670_UNTREATED_VS_TGFB_T...2,SET,180,-0.082301,-0.0081089,0.066639,0.89158,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP,1
GOBP_MIDBRAIN_HINDBRAIN_BOUN...,SET,5,-0.49874,-0.0082293,0.40379,0.8916,GOBP_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT,1
GRAESSMANN_APOPTOSIS_BY_DOXO...1,SET,1594,-0.02694,-0.0075856,0.021808,0.89163,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN,1
GOMF_ARACHIDONATE_COA_LIGASE...,SET,10,-0.32964,-0.007691,0.26682,0.89166,GOMF_ARACHIDONATE_COA_LIGASE_ACTIVITY,1
HP_DEVIATION_OF_THE_5TH_TOE,SET,16,-0.26648,-0.0078632,0.21569,0.89167,HP_DEVIATION_OF_THE_5TH_TOE,1
MIR6828_5P,SET,159,-0.083877,-0.0077717,0.067882,0.89169,MIR6828_5P,1
HP_INCREASED_ERYTHROCYTE_PRO...,SET,4,-0.52285,-0.0077166,0.42301,0.89177,HP_INCREASED_ERYTHROCYTE_PROTOPORPHYRIN_CONCENTRATION,1
ZAMORA_NOS2_TARGETS_DN,SET,76,-0.12317,-0.0079081,0.099643,0.89178,ZAMORA_NOS2_TARGETS_DN,1
HP_CHRONIC_BRONCHITIS,SET,21,-0.21722,-0.0073421,0.17572,0.89179,HP_CHRONIC_BRONCHITIS,1
GSE22886_IGG_IGA_MEMORY_BCEL...4,SET,178,-0.079627,-0.0078022,0.0644,0.89185,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,1
GSE24210_IL35_TREATED_VS_UNT...2,SET,173,-0.078672,-0.0076007,0.063627,0.89185,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP,1
HALLMARK_UV_RESPONSE_UP,SET,149,-0.085948,-0.0077112,0.069498,0.89189,HALLMARK_UV_RESPONSE_UP,1
JIANG_AGING_CEREBRAL_CORTEX_...1,SET,43,-0.15666,-0.0075728,0.12663,0.89199,JIANG_AGING_CEREBRAL_CORTEX_DN,1
GOBP_PURINE_DEOXYRIBONUCLEOS...2,SET,6,-0.44626,-0.008066,0.36069,0.89199,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GSE34156_UNTREATED_VS_24H_NO...3,SET,176,-0.082416,-0.0080304,0.066607,0.89201,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN,1
MIR10527_5P,SET,530,-0.048486,-0.0081182,0.039174,0.89208,MIR10527_5P,1
LANDIS_ERBB2_BREAST_TUMORS_3...1,SET,141,-0.093477,-0.0081603,0.075515,0.89211,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1
GOBP_SYNAPTONEMAL_COMPLEX_OR...,SET,23,-0.20126,-0.007119,0.16259,0.89211,GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION,1
GSE36392_TYPE_2_MYELOID_VS_N...2,SET,182,-0.078115,-0.0077387,0.063072,0.89223,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,1
HP_PROGRESSIVE_MICROCEPHALY,SET,82,-0.11082,-0.0073894,0.089471,0.89224,HP_PROGRESSIVE_MICROCEPHALY,1
GSE24814_STAT5_KO_VS_WT_PRE_...1,SET,183,-0.074854,-0.0074359,0.060417,0.89231,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...441,SET,9,-0.39015,-0.0086359,0.31489,0.89232,GOBP_NEGATIVE_REGULATION_OF_NEURON_MIGRATION,1
GCM_UBE2N,SET,141,-0.086366,-0.0075395,0.069698,0.89235,GCM_UBE2N,1
HP_PAROXYSMAL_DYSTONIA,SET,20,-0.24472,-0.0080724,0.19745,0.89239,HP_PAROXYSMAL_DYSTONIA,1
GSE18804_SPLEEN_MACROPHAGE_V...3,SET,174,-0.082242,-0.0079683,0.066357,0.89239,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN,1
MIR517A_3P_MIR517B_3P_MIR517...,SET,19,-0.23558,-0.0075745,0.19003,0.89245,MIR517A_3P_MIR517B_3P_MIR517C_3P,1
GOBP_ONE_CARBON_METABOLIC_PR...,SET,36,-0.17665,-0.0078147,0.14249,0.89246,GOBP_ONE_CARBON_METABOLIC_PROCESS,1
REACTOME_MITOCHONDRIAL_TRANS...,SET,91,-0.10016,-0.0070338,0.080776,0.89249,REACTOME_MITOCHONDRIAL_TRANSLATION,1
WP_GPCRS_CLASS_B_SECRETINLIKE,SET,22,-0.25543,-0.0088367,0.20599,0.89251,WP_GPCRS_CLASS_B_SECRETINLIKE,1
HP_BOWING_OF_THE_ARM,SET,38,-0.18238,-0.0082885,0.14708,0.89251,HP_BOWING_OF_THE_ARM,1
MIR7110_3P,SET,366,-0.057547,-0.0080437,0.046406,0.89252,MIR7110_3P,1
PCGF1_TARGET_GENES,SET,455,-0.051701,-0.0080374,0.041687,0.89254,PCGF1_TARGET_GENES,1
MIR5196_5P,SET,267,-0.064437,-0.0077139,0.051945,0.89259,MIR5196_5P,1
GOMF_HISTONE_H3K4ME_H3K4ME2_...,SET,2,-0.86076,-0.0089833,0.69382,0.89262,GOMF_HISTONE_H3K4ME_H3K4ME2_H3K4ME3_DEMETHYLASE_ACTIVITY,1
REACTOME_MITOCHONDRIAL_UNCOU...,SET,6,-0.42016,-0.0075943,0.33862,0.89265,REACTOME_MITOCHONDRIAL_UNCOUPLING,1
REACTOME_PHASE_II_CONJUGATIO...,SET,99,-0.12491,-0.0091477,0.10065,0.89269,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1
HE_LIM_SUN_FETAL_LUNG_C4_ILC...3,SET,166,-0.087845,-0.008315,0.070779,0.89271,HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...3,SET,41,-0.17614,-0.0083143,0.14189,0.89277,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,1
HP_VERTEBRAL_FUSION,SET,63,-0.13142,-0.0076848,0.10586,0.89277,HP_VERTEBRAL_FUSION,1
HP_PROLONGED_BLEEDING_FOLLOW...1,SET,11,-0.37942,-0.0092844,0.30561,0.89279,HP_PROLONGED_BLEEDING_FOLLOWING_CIRCUMCISION,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...7,SET,90,-0.11331,-0.0079137,0.091263,0.89279,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,1
CETS1P54_01,SET,250,-0.064428,-0.0074668,0.05189,0.8928,CETS1P54_01,1
MODULE_418,SET,56,-0.14011,-0.0077264,0.11285,0.8928,MODULE_418,1
GSE32986_CURDLAN_HIGHDOSE_VS...1,SET,185,-0.081906,-0.0081803,0.065962,0.89282,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,1
HP_APLASIA_HYPOPLASIA_INVOLV...4,SET,479,-0.049444,-0.0078814,0.039808,0.89289,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
HP_SHORT_PALM,SET,93,-0.10954,-0.0077763,0.088185,0.8929,HP_SHORT_PALM,1
GOCC_NUCLEOID,SET,41,-0.15153,-0.0071525,0.12198,0.89291,GOCC_NUCLEOID,1
MIR4737,SET,4,-0.52063,-0.0076839,0.4191,0.89292,MIR4737,1
HP_PERIAURICULAR_SKIN_PITS,SET,48,-0.16357,-0.0083525,0.13162,0.89301,HP_PERIAURICULAR_SKIN_PITS,1
MORF_BMPR2,SET,47,-0.172,-0.0086912,0.13839,0.89303,MORF_BMPR2,1
KEGG_MEDICUS_VARIANT_MUTATIO...42,SET,5,-0.43579,-0.0071907,0.35054,0.8931,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,1
GSE32255_WT_UNSTIM_VS_JMJD2D...1,SET,155,-0.084238,-0.0077072,0.067757,0.8931,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,1
MODULE_118,SET,366,-0.057398,-0.0080229,0.04616,0.89314,MODULE_118,1
HP_DELAYED_ABILITY_TO_WALK,SET,253,-0.065796,-0.0076702,0.052888,0.89325,HP_DELAYED_ABILITY_TO_WALK,1
GOBP_DENTATE_GYRUS_DEVELOPME...,SET,23,-0.23058,-0.008156,0.18532,0.89328,GOBP_DENTATE_GYRUS_DEVELOPMENT,1
HP_PARIETAL_BOSSING,SET,8,-0.3147,-0.0065677,0.25293,0.89329,HP_PARIETAL_BOSSING,1
GSE13485_CTRL_VS_DAY7_YF17D_...2,SET,163,-0.083775,-0.0078584,0.067328,0.89329,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
GSE25123_CTRL_VS_ROSIGLITAZO...2,SET,183,-0.075309,-0.007481,0.060525,0.89329,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
GOBP_ATTACHMENT_OF_SPINDLE_M...,SET,49,-0.14636,-0.0075511,0.1176,0.89334,GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GSE4142_PLASMA_CELL_VS_GC_BC...1,SET,177,-0.077805,-0.0076025,0.062511,0.89336,GSE4142_PLASMA_CELL_VS_GC_BCELL_DN,1
RELA_DN.V1_DN,SET,119,-0.10596,-0.008503,0.085121,0.89339,RELA_DN.V1_DN,1
HP_ABNORMAL_CALVARIA_MORPHOL...,SET,859,-0.036575,-0.007724,0.02938,0.89341,HP_ABNORMAL_CALVARIA_MORPHOLOGY,1
WP_TGFBETA_SIGNALING_IN_THYR...,SET,19,-0.24729,-0.0079509,0.19861,0.89344,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1
WP_SCFA_AND_SKELETAL_MUSCLE_...,SET,6,-0.44684,-0.0080764,0.35886,0.89345,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,1
GNF2_RAB3A,SET,34,-0.19513,-0.0083894,0.15671,0.89346,GNF2_RAB3A,1
KEGG_MEDICUS_REFERENCE_FGF_F...2,SET,33,-0.19819,-0.0083949,0.15915,0.89348,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_MEGAKARYOCYTE_DEVELOPME...,SET,20,-0.25709,-0.0084808,0.20642,0.89351,GOBP_MEGAKARYOCYTE_DEVELOPMENT,1
HP_EMG_POSITIVE_SHARP_WAVES,SET,9,-0.39006,-0.0086339,0.31315,0.89353,HP_EMG_POSITIVE_SHARP_WAVES,1
FLORIO_NEOCORTEX_BASAL_RADIA...2,SET,339,-0.062393,-0.0083994,0.050087,0.89355,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,1
VRTN_TARGET_GENES,SET,9,-0.36138,-0.0079991,0.2901,0.89356,VRTN_TARGET_GENES,1
SYATTGTG_UNKNOWN,SET,204,-0.077707,-0.0081454,0.062375,0.89358,SYATTGTG_UNKNOWN,1
REACTOME_SUMO_IS_CONJUGATED_...,SET,5,-0.38972,-0.0064305,0.3128,0.89359,REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1,1
GOMF_VERY_LONG_CHAIN_FATTY_A...,SET,9,-0.33975,-0.0075203,0.2727,0.89359,GOMF_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
KEGG_LONG_TERM_DEPRESSION,SET,66,-0.13642,-0.0081647,0.10945,0.89369,KEGG_LONG_TERM_DEPRESSION,1
GSE9509_LPS_VS_LPS_AND_IL10_...1,SET,178,-0.074938,-0.0073428,0.060108,0.89374,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN,1
GOMF_G_PROTEIN_COUPLED_ADENO...,SET,5,-0.49588,-0.0081822,0.3977,0.89377,GOMF_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY,1
HP_RECURRENT_PAROXYSMAL_HEAD...,SET,18,-0.23119,-0.0072353,0.1854,0.89379,HP_RECURRENT_PAROXYSMAL_HEADACHE,1
GSE26669_CTRL_VS_COSTIM_BLOC...2,SET,186,-0.07565,-0.0075757,0.060654,0.89384,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP,1
GOBP_LIPID_EXPORT_FROM_CELL,SET,49,-0.16376,-0.0084488,0.13124,0.89394,GOBP_LIPID_EXPORT_FROM_CELL,1
HP_GENERALIZED_AMYLOID_DEPOS...,SET,6,-0.45326,-0.0081924,0.36321,0.89396,HP_GENERALIZED_AMYLOID_DEPOSITION,1
GOBP_ENDOCRINE_HORMONE_SECRE...,SET,54,-0.15784,-0.0085473,0.12647,0.89397,GOBP_ENDOCRINE_HORMONE_SECRETION,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...4,SET,13,-0.33137,-0.0088145,0.26549,0.89401,GOBP_GAMMA_AMINOBUTYRIC_ACID_SECRETION,1
GSE24634_TEFF_VS_TCONV_DAY7_...1,SET,183,-0.08408,-0.0083523,0.067346,0.89406,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN,1
KEGG_NOD_LIKE_RECEPTOR_SIGNA...,SET,57,-0.1465,-0.00815,0.11734,0.89407,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GSE339_CD8POS_VS_CD4CD8DN_DC...2,SET,182,-0.077803,-0.0077079,0.062318,0.89407,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,1
HP_EDEMA_OF_THE_DORSUM_OF_HA...,SET,14,-0.27591,-0.0076161,0.22098,0.89408,HP_EDEMA_OF_THE_DORSUM_OF_HANDS,1
HP_UNUSUAL_SKIN_INFECTION,SET,7,-0.36656,-0.007156,0.29356,0.8941,HP_UNUSUAL_SKIN_INFECTION,1
MIR4804_3P,SET,79,-0.12067,-0.0078985,0.096592,0.89421,MIR4804_3P,1
MIR6715B_5P,SET,200,-0.076033,-0.0078922,0.060862,0.89421,MIR6715B_5P,1
HP_PROTEIN_AVOIDANCE,SET,5,-0.47614,-0.0078565,0.38111,0.89422,HP_PROTEIN_AVOIDANCE,1
GNF2_CD14,SET,32,-0.20562,-0.0085766,0.16457,0.89424,GNF2_CD14,1
HUI_MAPK14_TARGETS_UP,SET,18,-0.26328,-0.0082395,0.2107,0.89426,HUI_MAPK14_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...167,SET,28,-0.1789,-0.0069811,0.14314,0.89432,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEPARATION,1
AIZARANI_LIVER_C7_EPCAM_POS_...,SET,206,-0.080558,-0.008485,0.064439,0.89437,AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2,1
GOBP_INHIBITORY_SYNAPSE_ASSE...,SET,23,-0.26491,-0.0093704,0.21188,0.89439,GOBP_INHIBITORY_SYNAPSE_ASSEMBLY,1
GSE17721_CPG_VS_GARDIQUIMOD_...6,SET,185,-0.080324,-0.0080223,0.064231,0.89444,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP,1
MIR653_5P,SET,116,-0.097478,-0.0077236,0.077945,0.89445,MIR653_5P,1
TAYLOR_METHYLATED_IN_ACUTE_L...,SET,66,-0.13635,-0.0081602,0.10902,0.89447,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1
KEGG_MEDICUS_REFERENCE_ITGA_...3,SET,22,-0.24404,-0.0084426,0.19512,0.89447,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY,1
MIR1256,SET,64,-0.13672,-0.0080581,0.10931,0.89448,MIR1256,1
GOBP_NEGATIVE_REGULATION_OF_...668,SET,38,-0.16264,-0.0073916,0.13004,0.89448,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,1
HP_PROMINENT_CRUS_OF_HELIX,SET,5,-0.504,-0.0083162,0.40297,0.89448,HP_PROMINENT_CRUS_OF_HELIX,1
GOBP_NEGATIVE_REGULATION_OF_...415,SET,9,-0.35726,-0.007908,0.2856,0.89451,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ADAPTATION,1
GOMF_METALLODIPEPTIDASE_ACTI...,SET,8,-0.40652,-0.008484,0.32497,0.89452,GOMF_METALLODIPEPTIDASE_ACTIVITY,1
GSE15330_MEGAKARYOCYTE_ERYTH...6,SET,165,-0.084795,-0.0080023,0.067782,0.89452,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
HP_INFANTILE_ENCEPHALOPATHY,SET,8,-0.37404,-0.0078061,0.29897,0.89454,HP_INFANTILE_ENCEPHALOPATHY,1
MIR507,SET,241,-0.068953,-0.007848,0.055113,0.89455,MIR507,1
HP_CEREBELLAR_CORTICAL_ATROP...,SET,5,-0.4817,-0.0079481,0.38496,0.89458,HP_CEREBELLAR_CORTICAL_ATROPHY,1
IYENGAR_RESPONSE_TO_ADIPOCYT...,SET,10,-0.36965,-0.0086246,0.29536,0.89463,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,1
DESCARTES_MAIN_FETAL_VISCERA...,SET,43,-0.16988,-0.0082115,0.13566,0.89475,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,1
GSE360_L_DONOVANI_VS_B_MALAY...3,SET,187,-0.074879,-0.0075183,0.059786,0.89479,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
GSE27786_LIN_NEG_VS_NKCELL_DN,SET,180,-0.076875,-0.0075743,0.061377,0.8948,GSE27786_LIN_NEG_VS_NKCELL_DN,1
HP_FACIAL_HEMANGIOMA,SET,19,-0.25452,-0.0081834,0.20317,0.89484,HP_FACIAL_HEMANGIOMA,1
GSE23308_WT_VS_MINERALCORTIC...3,SET,189,-0.081841,-0.0082607,0.065326,0.89485,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN,1
GOBP_ANTIGEN_PROCESSING_AND_...7,SET,8,-0.31953,-0.0066686,0.25504,0.89487,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,1
GOBP_ENDOTHELIN_RECEPTOR_SIG...,SET,10,-0.37946,-0.0088535,0.30287,0.89487,GOBP_ENDOTHELIN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...505,SET,43,-0.17614,-0.0085143,0.14059,0.89487,GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
HP_INVOLUNTARY_MOVEMENTS,SET,908,-0.035841,-0.007771,0.028606,0.89488,HP_INVOLUNTARY_MOVEMENTS,1
PHB2_TARGET_GENES,SET,149,-0.085012,-0.0076272,0.067846,0.89489,PHB2_TARGET_GENES,1
MIR3666,SET,353,-0.057924,-0.0079542,0.04622,0.89493,MIR3666,1
HP_MITOCHONDRIAL_MYOPATHY,SET,37,-0.15728,-0.0070533,0.12549,0.89495,HP_MITOCHONDRIAL_MYOPATHY,1
GOBP_MARGINAL_ZONE_B_CELL_DI...,SET,7,-0.40375,-0.0078822,0.32213,0.89496,GOBP_MARGINAL_ZONE_B_CELL_DIFFERENTIATION,1
GSE37301_GRANULOCYTE_MONOCYT...1,SET,182,-0.075397,-0.0074695,0.060152,0.89497,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,1
GOBP_LEUKOCYTE_CHEMOTAXIS_IN...,SET,8,-0.41788,-0.008721,0.33335,0.89499,GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
RAHMAN_TP53_TARGETS_PHOSPHOR...,SET,19,-0.24079,-0.007742,0.19208,0.895,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,1
GOBP_POSITIVE_REGULATION_OF_...538,SET,27,-0.23098,-0.0088512,0.18426,0.895,GOBP_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...6,SET,112,-0.099529,-0.0077499,0.079349,0.89513,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,1
GOBP_EPINEPHRINE_SECRETION,SET,7,-0.45876,-0.0089561,0.36566,0.89518,GOBP_EPINEPHRINE_SECRETION,1
GSE30971_2H_VS_4H_LPS_STIM_M...3,SET,176,-0.082381,-0.008027,0.065663,0.89518,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN,1
ZNF202_TARGET_GENES,SET,64,-0.13461,-0.0079339,0.10728,0.89521,ZNF202_TARGET_GENES,1
GOMF_PHOSPHATIDYLSERINE_1_AC...,SET,6,-0.38267,-0.0069166,0.30492,0.89525,GOMF_PHOSPHATIDYLSERINE_1_ACYLHYDROLASE_ACTIVITY,1
PLASARI_TGFB1_SIGNALING_VIA_...3,SET,99,-0.11032,-0.0080789,0.08789,0.89528,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...677,SET,5,-0.52255,-0.0086221,0.41624,0.89532,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MIGRATION,1
GOBP_RNA_METHYLATION,SET,66,-0.11591,-0.006937,0.092312,0.89537,GOBP_RNA_METHYLATION,1
HP_VISUAL_FIXATION_INSTABILI...,SET,12,-0.30743,-0.0078569,0.24481,0.89539,HP_VISUAL_FIXATION_INSTABILITY,1
HP_FIBULAR_BOWING,SET,9,-0.38197,-0.0084548,0.30413,0.89542,HP_FIBULAR_BOWING,1
GOMF_ATP_DEPENDENT_ACTIVITY,SET,533,-0.046391,-0.0077887,0.036928,0.89548,GOMF_ATP_DEPENDENT_ACTIVITY,1
TTGGAGA_MIR5155P_MIR519E,SET,123,-0.09499,-0.0077488,0.07561,0.89549,TTGGAGA_MIR5155P_MIR519E,1
PID_HIF1A_PATHWAY,SET,15,-0.24476,-0.006993,0.19482,0.8955,PID_HIF1A_PATHWAY,1
MIR6745,SET,85,-0.11917,-0.00809,0.094846,0.89552,MIR6745,1
GSE29164_DAY3_VS_DAY7_UNTREA...2,SET,163,-0.081337,-0.0076297,0.0647,0.89564,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP,1
GOBP_REGULATION_OF_MOTOR_NEU...,SET,15,-0.27148,-0.0077565,0.21591,0.89568,GOBP_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
MIR1197,SET,84,-0.11294,-0.0076216,0.089817,0.89569,MIR1197,1
HP_AXONAL_DEGENERATION_REGEN...,SET,9,-0.34497,-0.007636,0.27435,0.89569,HP_AXONAL_DEGENERATION_REGENERATION,1
REACTOME_SYNTHESIS_OF_PA,SET,35,-0.20426,-0.0089099,0.16244,0.89571,REACTOME_SYNTHESIS_OF_PA,1
GOBP_REGULATION_OF_EXTRINSIC...2,SET,43,-0.16658,-0.0080522,0.13246,0.89572,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,1
GOBP_MAINTENANCE_OF_CENTROSO...,SET,5,-0.36561,-0.0060327,0.29068,0.89576,GOBP_MAINTENANCE_OF_CENTROSOME_LOCATION,1
GSE32423_MEMORY_VS_NAIVE_CD8...4,SET,178,-0.086982,-0.0085229,0.069154,0.89576,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP,1
HP_ABNORMAL_CIRCLE_OF_WILLIS...,SET,6,-0.45555,-0.0082338,0.36213,0.89579,HP_ABNORMAL_CIRCLE_OF_WILLIS_MORPHOLOGY,1
MIR5699_5P,SET,98,-0.10495,-0.0076471,0.083413,0.89583,MIR5699_5P,1
GSE13484_UNSTIM_VS_YF17D_VAC...1,SET,188,-0.080897,-0.0081441,0.064282,0.89588,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
KEGG_MEDICUS_REFERENCE_GPCR_...2,SET,47,-0.17188,-0.0086852,0.13657,0.8959,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY,1
HP_HEAT_INTOLERANCE,SET,19,-0.23958,-0.0077032,0.19034,0.89592,HP_HEAT_INTOLERANCE,1
BRF2_TARGET_GENES,SET,7,-0.36178,-0.0070628,0.28737,0.89596,BRF2_TARGET_GENES,1
GCM_SMO,SET,58,-0.13033,-0.0073138,0.10353,0.89596,GCM_SMO,1
HP_ABNORMAL_MYOCARDIUM_MORPH...,SET,511,-0.046803,-0.0076987,0.037172,0.89599,HP_ABNORMAL_MYOCARDIUM_MORPHOLOGY,1
NAKAMURA_CANCER_MICROENVIRON...2,SET,23,-0.24044,-0.0085048,0.19095,0.89601,NAKAMURA_CANCER_MICROENVIRONMENT_UP,1
HP_DELAYED_MYELINATION,SET,245,-0.067042,-0.0076927,0.053225,0.89609,HP_DELAYED_MYELINATION,1
GOBP_SENSORY_PERCEPTION_OF_T...3,SET,5,-0.47742,-0.0078776,0.37891,0.89615,GOBP_SENSORY_PERCEPTION_OF_TOUCH,1
GOBP_ERK1_AND_ERK2_CASCADE,SET,280,-0.067769,-0.0083049,0.053782,0.89617,GOBP_ERK1_AND_ERK2_CASCADE,1
REACTOME_DEGRADATION_OF_DVL,SET,54,-0.1304,-0.0070616,0.10348,0.89619,REACTOME_DEGRADATION_OF_DVL,1
HP_URETEROPELVIC_JUNCTION_OB...,SET,20,-0.21938,-0.0072368,0.17407,0.89621,HP_URETEROPELVIC_JUNCTION_OBSTRUCTION,1
GOBP_RESPIRATORY_SYSTEM_DEVE...,SET,209,-0.078753,-0.0083545,0.062479,0.89624,GOBP_RESPIRATORY_SYSTEM_DEVELOPMENT,1
GOMF_UDP_XYLOSYLTRANSFERASE_...,SET,6,-0.3816,-0.0068972,0.30272,0.89625,GOMF_UDP_XYLOSYLTRANSFERASE_ACTIVITY,1
HP_ABNORMALITIES_OF_PLACENTA...,SET,103,-0.1096,-0.0081858,0.086944,0.89626,HP_ABNORMALITIES_OF_PLACENTA_OR_UMBILICAL_CORD,1
KEGG_MEDICUS_REFERENCE_26S_P...,SET,37,-0.15286,-0.0068554,0.12125,0.89629,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...90,SET,37,-0.15286,-0.0068554,0.12125,0.89629,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_INDOLE_CONTAINING_COMPO...3,SET,22,-0.2552,-0.0088287,0.2024,0.89632,GOBP_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_OPEN_BITE,SET,54,-0.15256,-0.0082615,0.12094,0.89642,HP_OPEN_BITE,1
MODULE_321,SET,107,-0.111,-0.0084491,0.087964,0.8965,MODULE_321,1
BOYAULT_LIVER_CANCER_SUBCLAS...8,SET,10,-0.35627,-0.0083124,0.28228,0.89654,BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,1
GOBP_POSITIVE_REGULATION_OF_...200,SET,35,-0.18152,-0.007918,0.14381,0.89656,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
WP_GASTRIC_CANCER_NETWORK_2,SET,30,-0.20111,-0.0081228,0.15933,0.89657,WP_GASTRIC_CANCER_NETWORK_2,1
HP_CHRONIC_LYMPHATIC_LEUKEMIA,SET,14,-0.28618,-0.0078996,0.22671,0.89657,HP_CHRONIC_LYMPHATIC_LEUKEMIA,1
HP_DECREASED_CIRCULATING_IGG...1,SET,7,-0.3804,-0.0074263,0.30135,0.89657,HP_DECREASED_CIRCULATING_IGG2_LEVEL,1
GOBP_SPHINGOLIPID_BIOSYNTHET...,SET,107,-0.10882,-0.0082828,0.08619,0.89661,GOBP_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
GOMF_DNA_CLAMP_LOADER_ACTIVI...,SET,9,-0.34605,-0.0076597,0.27408,0.89662,GOMF_DNA_CLAMP_LOADER_ACTIVITY,1
GOMF_ALPHA_ACTININ_BINDING,SET,28,-0.21578,-0.0084202,0.17086,0.89668,GOMF_ALPHA_ACTININ_BINDING,1
GOBP_TERPENOID_BIOSYNTHETIC_...,SET,16,-0.27443,-0.0080978,0.21726,0.89672,GOBP_TERPENOID_BIOSYNTHETIC_PROCESS,1
HP_MORTALITY_AGING,SET,399,-0.053103,-0.0077429,0.042039,0.89673,HP_MORTALITY_AGING,1
GOBP_RESPONSE_TO_ABIOTIC_STI...,SET,1024,-0.035331,-0.0081079,0.027961,0.8968,GOBP_RESPONSE_TO_ABIOTIC_STIMULUS,1
REACTOME_S_PHASE,SET,155,-0.079078,-0.0072351,0.062577,0.89682,REACTOME_S_PHASE,1
HOELZEL_NF1_TARGETS_UP,SET,115,-0.10949,-0.0086384,0.086632,0.89686,HOELZEL_NF1_TARGETS_UP,1
IRX2_TARGET_GENES,SET,187,-0.076543,-0.0076854,0.060558,0.89687,IRX2_TARGET_GENES,1
GSE5455_EX_VIVO_VS_POST_24H_...1,SET,180,-0.079211,-0.0078045,0.062659,0.8969,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN,1
KEGG_MEDICUS_REFERENCE_ANGIO...,SET,28,-0.20622,-0.008047,0.16311,0.89692,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
MIR3180_MIR3180_3P,SET,20,-0.24835,-0.0081924,0.19637,0.897,MIR3180_MIR3180_3P,1
GOBP_MULTICELLULAR_ORGANISMA...7,SET,90,-0.12267,-0.0085675,0.096971,0.89706,GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS,1
HP_SHIELD_CHEST,SET,14,-0.27474,-0.0075838,0.21712,0.89713,HP_SHIELD_CHEST,1
AAANWWTGC_UNKNOWN,SET,183,-0.083097,-0.0082546,0.065653,0.89718,AAANWWTGC_UNKNOWN,1
MORF_MYST2,SET,60,-0.12712,-0.0072548,0.10042,0.8972,MORF_MYST2,1
MIR211_3P,SET,75,-0.12565,-0.0080144,0.09926,0.89721,MIR211_3P,1
MODULE_454,SET,10,-0.38309,-0.0089381,0.30263,0.89722,MODULE_454,1
WP_REGULATION_OF_APOPTOSIS_B...,SET,24,-0.21697,-0.0078393,0.17138,0.89723,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,1
HP_ABNORMAL_CIRCULATING_INHI...,SET,6,-0.54218,-0.0097997,0.42825,0.89724,HP_ABNORMAL_CIRCULATING_INHIBIN_B_CONCENTRATION,1
GSE29618_PRE_VS_DAY7_POST_TI...5,SET,172,-0.075513,-0.0072745,0.059636,0.89727,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN,1
HP_SOFT_SKIN,SET,40,-0.17845,-0.0083201,0.14092,0.89728,HP_SOFT_SKIN,1
MODULE_28,SET,31,-0.16329,-0.0067038,0.12894,0.8973,MODULE_28,1
MIR92A_2_5P,SET,192,-0.077274,-0.0078608,0.061016,0.89732,MIR92A_2_5P,1
MIR4653_5P,SET,137,-0.096167,-0.0082761,0.07589,0.89745,MIR4653_5P,1
MIR3921,SET,135,-0.09681,-0.0082708,0.076368,0.89754,MIR3921,1
DESCARTES_MAIN_FETAL_ASTROCY...,SET,33,-0.20062,-0.0084979,0.15821,0.89761,DESCARTES_MAIN_FETAL_ASTROCYTES,1
CHNG_MULTIPLE_MYELOMA_HYPERP...1,SET,28,-0.18772,-0.0073254,0.14803,0.89762,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,1
GOMF_S_ADENOSYL_L_METHIONINE...,SET,16,-0.25988,-0.0076683,0.20492,0.89762,GOMF_S_ADENOSYL_L_METHIONINE_BINDING,1
HP_NARROW_MOUTH,SET,208,-0.077081,-0.0081577,0.060769,0.89767,HP_NARROW_MOUTH,1
GSE13173_UNTREATED_VS_IL12_T...1,SET,117,-0.097199,-0.0077345,0.076613,0.89772,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN,1
VERNELL_RETINOBLASTOMA_PATHW...2,SET,68,-0.12563,-0.0076316,0.099011,0.89775,VERNELL_RETINOBLASTOMA_PATHWAY_UP,1
MIR4719,SET,456,-0.052594,-0.008185,0.041446,0.89776,MIR4719,1
HESS_TARGETS_OF_HOXA9_AND_ME...2,SET,67,-0.13367,-0.0080599,0.10533,0.89777,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1
HP_ABNORMAL_LUMBAR_SPINE_MOR...,SET,26,-0.22129,-0.0083216,0.17435,0.89781,HP_ABNORMAL_LUMBAR_SPINE_MORPHOLOGY,1
HP_HYPOPLASTIC_FINGERNAIL,SET,46,-0.17186,-0.0085914,0.13541,0.89781,HP_HYPOPLASTIC_FINGERNAIL,1
REACTOME_TRANSCRIPTIONAL_REG...3,SET,32,-0.20665,-0.0086196,0.1628,0.89783,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4,1
GSE17186_MEMORY_VS_CD21HIGH_...1,SET,187,-0.082062,-0.0082396,0.064644,0.89785,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
MIR432_5P,SET,87,-0.11752,-0.0080705,0.092573,0.89786,MIR432_5P,1
GOMF_G_QUADRUPLEX_RNA_BINDING,SET,6,-0.41694,-0.0075361,0.32843,0.89786,GOMF_G_QUADRUPLEX_RNA_BINDING,1
GOBP_RESPONSE_TO_GLUCAGON,SET,21,-0.25174,-0.0085091,0.19829,0.89787,GOBP_RESPONSE_TO_GLUCAGON,1
GOBP_T_CELL_MEDIATED_IMMUNE_...,SET,11,-0.39691,-0.0097122,0.31254,0.89794,GOBP_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
HP_ABNORMALITY_OF_THE_DISTAL...2,SET,5,-0.46352,-0.0076482,0.36496,0.89796,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_2ND_FINGER,1
PID_INTEGRIN1_PATHWAY,SET,63,-0.15028,-0.0087882,0.11829,0.89803,PID_INTEGRIN1_PATHWAY,1
GOBP_OXALATE_TRANSPORT,SET,11,-0.32494,-0.0079511,0.25575,0.89804,GOBP_OXALATE_TRANSPORT,1
BIOCARTA_HBX_PATHWAY,SET,7,-0.38992,-0.0076121,0.30688,0.89805,BIOCARTA_HBX_PATHWAY,1
DOANE_RESPONSE_TO_ANDROGEN_DN,SET,220,-0.074336,-0.0080883,0.058495,0.89809,DOANE_RESPONSE_TO_ANDROGEN_DN,1
CUI_DEVELOPING_HEART_C8_MACR...,SET,248,-0.073515,-0.0084862,0.05785,0.89809,CUI_DEVELOPING_HEART_C8_MACROPHAGE,1
GSE20715_0H_VS_24H_OZONE_TLR...1,SET,192,-0.081082,-0.0082482,0.063793,0.89813,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN,1
HP_VASCULITIS_IN_THE_SKIN,SET,7,-0.37861,-0.0073914,0.29784,0.89816,HP_VASCULITIS_IN_THE_SKIN,1
GOBP_REGULATION_OF_BLOOD_VES...,SET,7,-0.37903,-0.0073996,0.29816,0.89817,GOBP_REGULATION_OF_BLOOD_VESSEL_REMODELING,1
SU_TESTIS,SET,68,-0.12566,-0.0076334,0.098805,0.89827,SU_TESTIS,1
MORF_PPP2R4,SET,44,-0.15247,-0.007455,0.11987,0.8983,MORF_PPP2R4,1
ZNF555_TARGET_GENES,SET,91,-0.10945,-0.0076866,0.08604,0.89833,ZNF555_TARGET_GENES,1
HP_ABNORMAL_SPERMATOGENESIS,SET,134,-0.091603,-0.0077971,0.072004,0.89834,HP_ABNORMAL_SPERMATOGENESIS,1
MIR3646,SET,771,-0.040806,-0.0081846,0.032074,0.89835,MIR3646,1
HP_PIGMENTARY_RETINOPATHY,SET,163,-0.084081,-0.0078871,0.066076,0.89839,HP_PIGMENTARY_RETINOPATHY,1
KIM_LIVER_CANCER_POOR_SURVIV...2,SET,21,-0.25131,-0.0084945,0.19741,0.89849,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1
HP_LOW_INSERTION_OF_COLUMELLA,SET,7,-0.38369,-0.0074906,0.30136,0.89852,HP_LOW_INSERTION_OF_COLUMELLA,1
REACTOME_PROTEIN_METHYLATION,SET,14,-0.30338,-0.0083743,0.23827,0.89853,REACTOME_PROTEIN_METHYLATION,1
GOBP_COPPER_ION_TRANSPORT,SET,15,-0.28412,-0.0081178,0.22312,0.89855,GOBP_COPPER_ION_TRANSPORT,1
GOBP_L_AMINO_ACID_TRANSPORT,SET,88,-0.1218,-0.0084121,0.095646,0.89856,GOBP_L_AMINO_ACID_TRANSPORT,1
GOMF_FILAMIN_BINDING,SET,12,-0.32689,-0.0083544,0.25668,0.89858,GOMF_FILAMIN_BINDING,1
HP_THICK_CORPUS_CALLOSUM,SET,15,-0.24676,-0.0070501,0.19374,0.89859,HP_THICK_CORPUS_CALLOSUM,1
GOBP_CELL_MIGRATION_INVOLVED...3,SET,6,-0.54844,-0.0099129,0.43056,0.89862,GOBP_CELL_MIGRATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
REACTOME_DEGRADATION_OF_GLI1...,SET,57,-0.12621,-0.0070214,0.099074,0.89864,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1
GOBP_REGULATION_OF_NEURON_MA...,SET,8,-0.40501,-0.0084523,0.31787,0.89868,GOBP_REGULATION_OF_NEURON_MATURATION,1
MODULE_25,SET,13,-0.24079,-0.0064049,0.18891,0.89877,MODULE_25,1
REACTOME_FORMATION_OF_APOPTO...,SET,10,-0.32363,-0.0075507,0.25387,0.8988,REACTOME_FORMATION_OF_APOPTOSOME,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...3,SET,273,-0.072158,-0.0087333,0.0566,0.89882,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL,1
HP_HYPOPLASTIC_ISCHIA,SET,16,-0.2709,-0.0079936,0.21248,0.89883,HP_HYPOPLASTIC_ISCHIA,1
HP_SPLIT_FOOT,SET,6,-0.41679,-0.0075333,0.32671,0.89896,HP_SPLIT_FOOT,1
AIZARANI_LIVER_C5_NK_NKT_CEL...,SET,110,-0.10929,-0.0084337,0.085646,0.89902,AIZARANI_LIVER_C5_NK_NKT_CELLS_3,1
GOBP_INTERLEUKIN_5_PRODUCTION,SET,19,-0.25651,-0.0082474,0.201,0.89904,GOBP_INTERLEUKIN_5_PRODUCTION,1
HP_OOCYTE_ARREST_AT_METAPHAS...,SET,5,-0.48394,-0.0079851,0.3792,0.89905,HP_OOCYTE_ARREST_AT_METAPHASE_I,1
HP_ABNORMAL_RIB_MORPHOLOGY,SET,290,-0.065199,-0.0081292,0.051085,0.89907,HP_ABNORMAL_RIB_MORPHOLOGY,1
HP_TRIANGULAR_FACE,SET,145,-0.090383,-0.0080004,0.070808,0.89909,HP_TRIANGULAR_FACE,1
MIR4269,SET,190,-0.080529,-0.0081496,0.063081,0.89912,MIR4269,1
GOBP_REGULATION_OF_STEM_CELL...2,SET,10,-0.34998,-0.0081655,0.27406,0.89919,GOBP_REGULATION_OF_STEM_CELL_DIVISION,1
HP_ABNORMAL_FULL_FIELD_ELECT...,SET,55,-0.15855,-0.0086646,0.12415,0.8992,HP_ABNORMAL_FULL_FIELD_ELECTRORETINOGRAM,1
KEGG_MEDICUS_REFERENCE_CA2_C...1,SET,19,-0.24465,-0.007866,0.19156,0.89922,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY,1
KEGG_HOMOLOGOUS_RECOMBINATION,SET,25,-0.19152,-0.0070625,0.14995,0.89923,KEGG_HOMOLOGOUS_RECOMBINATION,1
JOHANSSON_BRAIN_CANCER_EARLY...1,SET,41,-0.16565,-0.0078193,0.12968,0.89925,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,1
MIR380_3P,SET,210,-0.076033,-0.008085,0.059524,0.89925,MIR380_3P,1
GOBP_GLYCOPROTEIN_BIOSYNTHET...,SET,289,-0.066326,-0.0082556,0.051923,0.89926,GOBP_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS,1
WP_COMPLEMENT_ACTIVATION,SET,17,-0.29526,-0.0089803,0.23108,0.89932,WP_COMPLEMENT_ACTIVATION,1
GOMF_LACTATE_DEHYDROGENASE_A...,SET,6,-0.57691,-0.010427,0.45147,0.89934,GOMF_LACTATE_DEHYDROGENASE_ACTIVITY,1
MIR6512_5P,SET,106,-0.10636,-0.0080585,0.083234,0.89935,MIR6512_5P,1
GOBP_REGULATION_OF_MONOATOMI...2,SET,13,-0.31056,-0.008261,0.24299,0.89938,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSPORT,1
GSE37301_HEMATOPOIETIC_STEM_...9,SET,151,-0.088652,-0.0080066,0.069365,0.89938,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN,1
WP_FRAGILE_X_SYNDROME,SET,117,-0.10061,-0.0080058,0.078699,0.89944,WP_FRAGILE_X_SYNDROME,1
HP_HIP_CONTRACTURE,SET,51,-0.15837,-0.008335,0.12387,0.89944,HP_HIP_CONTRACTURE,1
SNIJDERS_AMPLIFIED_IN_HEAD_A...,SET,37,-0.19824,-0.0088904,0.15506,0.89945,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,1
HP_EEG_WITH_FRONTAL_FOCAL_SP...,SET,4,-0.69883,-0.010314,0.54649,0.8995,HP_EEG_WITH_FRONTAL_FOCAL_SPIKES,1
GOBP_REGULATION_OF_T_CELL_ME...2,SET,10,-0.42111,-0.0098251,0.32928,0.89952,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
GOBP_CHONDROITIN_SULFATE_MET...,SET,24,-0.22416,-0.0080991,0.17527,0.89953,GOBP_CHONDROITIN_SULFATE_METABOLIC_PROCESS,1
REACTOME_C_TYPE_LECTIN_RECEP...,SET,125,-0.09255,-0.0076105,0.072357,0.89956,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1
HP_ANAL_FISSURE,SET,4,-0.45353,-0.0066934,0.35455,0.89957,HP_ANAL_FISSURE,1
GOBP_EPITHELIAL_TO_MESENCHYM...1,SET,164,-0.089555,-0.0084261,0.069972,0.8997,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
MIR205_5P,SET,201,-0.076588,-0.0079696,0.059838,0.89971,MIR205_5P,1
MIR5009_5P,SET,56,-0.15981,-0.0088125,0.12482,0.89977,MIR5009_5P,1
HP_RHINITIS,SET,97,-0.1073,-0.0077788,0.083813,0.89977,HP_RHINITIS,1
GOBP_REGULATION_OF_RECEPTOR_...2,SET,10,-0.33995,-0.0079315,0.2655,0.89979,GOBP_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,1
chr21q21,SET,25,-0.35529,-0.013102,0.27745,0.89982,chr21q21,1
GSE6674_UNSTIM_VS_PL2_3_STIM...2,SET,132,-0.097586,-0.0082447,0.076203,0.89983,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP,1
WP_ONCOSTATIN_M_SIGNALING,SET,63,-0.15204,-0.008891,0.11871,0.89985,WP_ONCOSTATIN_M_SIGNALING,1
HP_LETHAL_SKELETAL_DYSPLASIA,SET,8,-0.35749,-0.0074606,0.27912,0.89985,HP_LETHAL_SKELETAL_DYSPLASIA,1
GOBP_ALLANTOIN_METABOLIC_PRO...,SET,9,-0.39704,-0.0087886,0.30992,0.89992,GOBP_ALLANTOIN_METABOLIC_PROCESS,1
HP_DUODENAL_ULCER,SET,12,-0.32198,-0.008229,0.25131,0.89993,HP_DUODENAL_ULCER,1
MIR363_3P,SET,384,-0.057685,-0.0082547,0.045019,0.89996,MIR363_3P,1
GSE9960_GRAM_NEG_VS_GRAM_POS...1,SET,179,-0.079072,-0.0077693,0.061697,0.9,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN,1
HP_INTERMITTENT_CLAUDICATION,SET,8,-0.38216,-0.0079755,0.29816,0.90003,HP_INTERMITTENT_CLAUDICATION,1
MIR196A_5P_MIR196B_5P,SET,85,-0.11679,-0.0079281,0.091113,0.90004,MIR196A_5P_MIR196B_5P,1
GOBP_T_CELL_ANTIGEN_PROCESSI...,SET,4,-0.59728,-0.008815,0.46594,0.90005,GOBP_T_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
REACTOME_RUNX1_REGULATES_TRA...1,SET,6,-0.40568,-0.0073325,0.31636,0.90013,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING,1
MIR29A_3P,SET,396,-0.058128,-0.0084443,0.045319,0.90018,MIR29A_3P,1
GSE16451_CTRL_VS_WEST_EQUINE...3,SET,182,-0.080594,-0.0079843,0.062836,0.90018,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,1
MIR1227_3P,SET,67,-0.13444,-0.0081068,0.10479,0.90025,MIR1227_3P,1
GSE13411_NAIVE_VS_MEMORY_BCE...1,SET,181,-0.080904,-0.0079932,0.063054,0.90026,GSE13411_NAIVE_VS_MEMORY_BCELL_DN,1
MIR4462,SET,13,-0.24974,-0.006643,0.19463,0.90027,MIR4462,1
HP_MUCOPOLYSACCHARIDURIA,SET,19,-0.2398,-0.0077102,0.18689,0.90027,HP_MUCOPOLYSACCHARIDURIA,1
REACTOME_NEGATIVE_FEEDBACK_R...,SET,6,-0.45924,-0.0083006,0.35782,0.90032,REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY,1
HP_LARYNGEAL_EDEMA,SET,4,-0.6177,-0.0091163,0.48128,0.90032,HP_LARYNGEAL_EDEMA,1
GSE40068_BCL6_POS_VS_NEG_CXC...1,SET,178,-0.08451,-0.0082807,0.065848,0.90032,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN,1
GOBP_CELL_SUBSTRATE_JUNCTION...2,SET,100,-0.11255,-0.0082833,0.087686,0.90033,GOBP_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
MIR4302,SET,115,-0.10329,-0.0081493,0.080464,0.90037,MIR4302,1
HP_PROMINENT_VEINS_ON_TRUNK,SET,5,-0.42073,-0.0069422,0.32774,0.90038,HP_PROMINENT_VEINS_ON_TRUNK,1
KEGG_MEDICUS_PATHOGEN_KSHV_M...2,SET,6,-0.50577,-0.0091415,0.39392,0.90041,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS,1
GOBP_REGULATION_OF_NATURAL_K...2,SET,8,-0.44179,-0.0092201,0.3441,0.90041,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,1
GSE24142_ADULT_VS_FETAL_DN3_...1,SET,181,-0.084277,-0.0083265,0.065641,0.90041,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN,1
REACTOME_CLEC7A_DECTIN_1_SIG...,SET,93,-0.10578,-0.0075093,0.08238,0.90042,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1
PLASARI_TGFB1_SIGNALING_VIA_...1,SET,29,-0.23506,-0.0093348,0.18305,0.90045,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,1
GOBP_POSITIVE_REGULATION_OF_...820,SET,7,-0.44897,-0.0087649,0.34962,0.90045,GOBP_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_RESPONSE_TO_SODIUM_PHOS...,SET,9,-0.42004,-0.0092975,0.32708,0.90046,GOBP_RESPONSE_TO_SODIUM_PHOSPHATE,1
HP_ECTODERMAL_DYSPLASIA,SET,23,-0.23456,-0.0082968,0.18264,0.90046,HP_ECTODERMAL_DYSPLASIA,1
TGCTTTG_MIR330,SET,296,-0.065457,-0.0082439,0.050957,0.90052,TGCTTTG_MIR330,1
REACTOME_FGFRL1_MODULATION_O...,SET,13,-0.34368,-0.0091418,0.2675,0.90055,REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,1
HP_ABNORMAL_MEAN_CORPUSCULAR...2,SET,55,-0.13691,-0.0074822,0.10654,0.9006,HP_ABNORMAL_MEAN_CORPUSCULAR_VOLUME,1
PETRETTO_CARDIAC_HYPERTROPHY,SET,32,-0.18736,-0.0078152,0.14579,0.90062,PETRETTO_CARDIAC_HYPERTROPHY,1
DESCARTES_FETAL_CEREBELLUM_U...,SET,19,-0.28251,-0.0090833,0.2198,0.90064,DESCARTES_FETAL_CEREBELLUM_UNIPOLAR_BRUSH_CELLS,1
PRDM5_TARGET_GENES,SET,79,-0.12389,-0.0081094,0.096393,0.90065,PRDM5_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C0_LAT...2,SET,631,-0.046108,-0.0083996,0.035872,0.90065,HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL,1
GOMF_C_ACETYLTRANSFERASE_ACT...,SET,7,-0.37991,-0.0074167,0.29553,0.90069,GOMF_C_ACETYLTRANSFERASE_ACTIVITY,1
MIR367_3P,SET,385,-0.057832,-0.0082863,0.044982,0.90071,MIR367_3P,1
GSE360_T_GONDII_VS_B_MALAYI_...2,SET,175,-0.087518,-0.0085035,0.06805,0.90078,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
SCHLINGEMANN_SKIN_CARCINOGEN...1,SET,23,-0.22141,-0.0078318,0.17205,0.90093,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,1
GSE22229_UNTREATED_VS_IMMUNO...1,SET,180,-0.084938,-0.0083688,0.065997,0.90095,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...68,SET,16,-0.27259,-0.0080436,0.21179,0.90096,HP_APLASIA_HYPOPLASIA_OF_THE_STERNUM,1
GSE40274_CTRL_VS_LEF1_TRANSD...2,SET,155,-0.089068,-0.0081491,0.069186,0.90101,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
chr12q15,SET,23,-0.41651,-0.014733,0.32347,0.90106,chr12q15,1
MIR130A_3P,SET,356,-0.05934,-0.0081825,0.046072,0.90112,MIR130A_3P,1
MYC_UP.V1_DN,SET,145,-0.091153,-0.0080686,0.070764,0.90114,MYC_UP.V1_DN,1
HP_CORNEAL_STROMAL_EDEMA,SET,11,-0.37299,-0.0091269,0.28955,0.90115,HP_CORNEAL_STROMAL_EDEMA,1
HP_PHOTORECEPTOR_LAYER_LOSS_...,SET,5,-0.48521,-0.008006,0.37662,0.90117,HP_PHOTORECEPTOR_LAYER_LOSS_ON_MACULAR_OCT,1
REACTOME_GLUTATHIONE_CONJUGA...,SET,32,-0.22146,-0.0092374,0.17188,0.9012,REACTOME_GLUTATHIONE_CONJUGATION,1
BLANCO_MELO_COVID19_SARS_COV...6,SET,70,-0.13911,-0.0085735,0.10794,0.90127,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,1
GSE17721_CTRL_VS_PAM3CSK4_24...2,SET,185,-0.081566,-0.0081463,0.063266,0.90134,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...91,SET,38,-0.15388,-0.0069935,0.11935,0.90135,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
LUI_THYROID_CANCER_CLUSTER_1,SET,47,-0.16298,-0.0082353,0.12632,0.90149,LUI_THYROID_CANCER_CLUSTER_1,1
chr2p11,SET,44,-0.37193,-0.018186,0.28823,0.90153,chr2p11,1
CERVERA_SDHB_TARGETS_2,SET,102,-0.1192,-0.0088598,0.09237,0.90154,CERVERA_SDHB_TARGETS_2,1
GOBP_ENTRAINMENT_OF_CIRCADIA...,SET,27,-0.21434,-0.0082134,0.16607,0.90157,GOBP_ENTRAINMENT_OF_CIRCADIAN_CLOCK,1
MIR4307,SET,389,-0.058531,-0.008429,0.045347,0.9016,MIR4307,1
KIM_WT1_TARGETS_DN,SET,425,-0.052352,-0.0078723,0.040548,0.90166,KIM_WT1_TARGETS_DN,1
REACTOME_DISEASES_OF_MITOTIC...,SET,36,-0.17328,-0.0076654,0.1342,0.90167,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1
GOMF_CALCIUM_MONOATOMIC_CATI...,SET,13,-0.35008,-0.0093122,0.2711,0.9017,GOMF_CALCIUM_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,1
GSE16385_ROSIGLITAZONE_IL4_V...2,SET,184,-0.079066,-0.0078754,0.061227,0.9017,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP,1
KEGG_ANTIGEN_PROCESSING_AND_...,SET,72,-0.15171,-0.009482,0.11746,0.90174,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_ABNORMAL_ISCHIUM_MORPHOLO...,SET,24,-0.22202,-0.008022,0.1719,0.90174,HP_ABNORMAL_ISCHIUM_MORPHOLOGY,1
HP_AUTOIMMUNE_HEMOLYTIC_ANEM...,SET,39,-0.18664,-0.0085929,0.14447,0.90179,HP_AUTOIMMUNE_HEMOLYTIC_ANEMIA,1
WP_CCL18_SIGNALING,SET,33,-0.21468,-0.0090932,0.16616,0.90181,WP_CCL18_SIGNALING,1
DACOSTA_UV_RESPONSE_VIA_ERCC...2,SET,65,-0.13553,-0.0080496,0.10489,0.90183,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1
GOBP_POSITIVE_REGULATION_OF_...279,SET,6,-0.53658,-0.0096984,0.41516,0.90189,GOBP_POSITIVE_REGULATION_OF_FEAR_RESPONSE,1
MCBRYAN_PUBERTAL_BREAST_3_4W...1,SET,32,-0.19075,-0.0079566,0.14757,0.90191,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1
GSE15324_ELF4_KO_VS_WT_ACTIV...2,SET,180,-0.078167,-0.0077017,0.060443,0.90203,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP,1
DELPUECH_FOXO3_TARGETS_DN,SET,34,-0.20925,-0.0089964,0.16179,0.90205,DELPUECH_FOXO3_TARGETS_DN,1
GSE41867_DAY8_VS_DAY15_LCMV_...1,SET,133,-0.10053,-0.008525,0.077711,0.90209,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
MIR374C_5P,SET,381,-0.059825,-0.0085282,0.046235,0.90215,MIR374C_5P,1
HP_ABNORMALITY_OF_THE_BILIAR...,SET,355,-0.058779,-0.0080939,0.045415,0.9022,HP_ABNORMALITY_OF_THE_BILIARY_SYSTEM,1
KEGG_MEDICUS_REFERENCE_TRH_T...,SET,12,-0.34367,-0.0087833,0.26549,0.90224,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY,1
GCM_CALM1,SET,98,-0.10807,-0.0078745,0.083488,0.90224,GCM_CALM1,1
GOBP_PROTEIN_LOCALIZATION_TO...21,SET,12,-0.34761,-0.008884,0.26854,0.90224,GOBP_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
GSE42088_UNINF_VS_LEISHMANIA...7,SET,169,-0.08565,-0.0081795,0.066167,0.90224,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN,1
GOCC_POSTSYNAPTIC_CYTOSOL,SET,13,-0.3124,-0.0083097,0.2413,0.90227,GOCC_POSTSYNAPTIC_CYTOSOL,1
REACTOME_AMINE_LIGAND_BINDIN...,SET,40,-0.19684,-0.0091776,0.15199,0.90234,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,1
MIR3151_5P,SET,48,-0.14802,-0.0075584,0.11428,0.90237,MIR3151_5P,1
BROWN_MYELOID_CELL_DEVELOPME...1,SET,119,-0.10229,-0.0082082,0.07896,0.90241,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1
WP_CELLULAR_PROTEOSTASIS,SET,5,-0.38134,-0.0062922,0.29436,0.90241,WP_CELLULAR_PROTEOSTASIS,1
GSE17721_ALL_VS_24H_PAM3CSK4...2,SET,178,-0.082461,-0.0080799,0.063651,0.90242,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP,1
GSE7460_TCONV_VS_TREG_LN_UP,SET,184,-0.08516,-0.0084825,0.06572,0.90247,GSE7460_TCONV_VS_TREG_LN_UP,1
MIR4472,SET,93,-0.11749,-0.0083408,0.090667,0.90248,MIR4472,1
GOBP_NEGATIVE_REGULATION_OF_...407,SET,30,-0.20546,-0.0082985,0.15855,0.90248,GOBP_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
GSE17721_LPS_VS_PAM3CSK4_4H_...2,SET,189,-0.080132,-0.0080882,0.061822,0.90253,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP,1
HP_TOE_JOINT_CONTRACTURE,SET,27,-0.21959,-0.0084149,0.16941,0.90254,HP_TOE_JOINT_CONTRACTURE,1
GOBP_LIMB_BUD_FORMATION,SET,9,-0.39563,-0.0087573,0.3052,0.90256,GOBP_LIMB_BUD_FORMATION,1
HP_FINGER_CLINODACTYLY,SET,387,-0.056479,-0.008113,0.043565,0.90258,HP_FINGER_CLINODACTYLY,1
HP_DEEP_VENOUS_THROMBOSIS,SET,17,-0.2429,-0.0073877,0.18735,0.90259,HP_DEEP_VENOUS_THROMBOSIS,1
REACTOME_FLT3_SIGNALING_THRO...,SET,6,-0.40577,-0.0073341,0.31293,0.90262,REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES,1
REACTOME_REGULATION_OF_NPAS4...3,SET,9,-0.38381,-0.0084956,0.29591,0.90269,REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION,1
GOBP_REGULATION_OF_HEART_RATE,SET,96,-0.12399,-0.0089425,0.095595,0.90269,GOBP_REGULATION_OF_HEART_RATE,1
GOMF_ACETYLATION_DEPENDENT_P...,SET,25,-0.22206,-0.0081886,0.1712,0.90269,GOMF_ACETYLATION_DEPENDENT_PROTEIN_BINDING,1
MIR4673,SET,129,-0.098546,-0.0082313,0.075972,0.9027,MIR4673,1
GOBP_SPERM_AXONEME_ASSEMBLY,SET,26,-0.20943,-0.0078755,0.16145,0.90271,GOBP_SPERM_AXONEME_ASSEMBLY,1
GSE27670_CTRL_VS_LMP1_TRANSD...1,SET,183,-0.08223,-0.0081685,0.063382,0.90274,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN,1
HP_DECREASED_CIRCULATING_IGG...2,SET,9,-0.34898,-0.0077246,0.26894,0.90278,HP_DECREASED_CIRCULATING_IGG_SUBCLASS_LEVEL,1
TGAGATT_MIR216,SET,101,-0.11317,-0.0083707,0.087212,0.90279,TGAGATT_MIR216,1
GSE3982_CTRL_VS_LPS_1H_NEUTR...2,SET,170,-0.081679,-0.0078231,0.062937,0.90281,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP,1
GOMF_OXYGEN_BINDING,SET,28,-0.24135,-0.0094181,0.18597,0.90282,GOMF_OXYGEN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...290,SET,43,-0.16162,-0.0078123,0.12453,0.90283,GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...600,SET,15,-0.27646,-0.007899,0.213,0.90284,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...9,SET,5,-0.59665,-0.0098449,0.45963,0.90287,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY,1
MODULE_397,SET,110,-0.10235,-0.0078987,0.078848,0.90287,MODULE_397,1
GOBP_NEGATIVE_REGULATION_OF_...409,SET,7,-0.45862,-0.0089532,0.35327,0.90288,GOBP_NEGATIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
MORF_CTBP1,SET,155,-0.081155,-0.0074251,0.062504,0.90292,MORF_CTBP1,1
MIR579_3P,SET,449,-0.054784,-0.0084618,0.042191,0.90293,MIR579_3P,1
REACTOME_PHOSPHATE_BOND_HYDR...1,SET,8,-0.38204,-0.007973,0.29416,0.90297,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS,1
GOBP_REGULATION_OF_CELLULAR_...9,SET,42,-0.16509,-0.0078872,0.12708,0.90304,GOBP_REGULATION_OF_CELLULAR_RESPIRATION,1
GOMF_PHOSPHATIDYLINOSITOL_3_...4,SET,25,-0.21765,-0.0080259,0.16753,0.90304,GOMF_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING,1
WP_EFFECTS_OF_NITRIC_OXIDE,SET,6,-0.51361,-0.0092833,0.3953,0.90307,WP_EFFECTS_OF_NITRIC_OXIDE,1
FAN_EMBRYONIC_CTX_BRAIN_ENDO...2,SET,277,-0.072288,-0.0088119,0.055632,0.90309,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2,1
GSE5960_TH1_VS_ANERGIC_TH1_UP,SET,183,-0.080812,-0.0080277,0.062186,0.90311,GSE5960_TH1_VS_ANERGIC_TH1_UP,1
chr20p12,SET,39,-0.30816,-0.014187,0.23711,0.90313,chr20p12,1
VISALA_RESPONSE_TO_HEAT_SHOC...1,SET,12,-0.29842,-0.0076267,0.2296,0.90314,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,1
GCM_VAV1,SET,40,-0.16152,-0.007531,0.12427,0.90314,GCM_VAV1,1
REACTOME_SHC_RELATED_EVENTS_...,SET,9,-0.33955,-0.007516,0.26124,0.90315,REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R,1
MIR4327,SET,74,-0.14612,-0.0092581,0.11242,0.90316,MIR4327,1
GOBP_NEUROTRANSMITTER_UPTAKE,SET,43,-0.17841,-0.0086239,0.13723,0.90321,GOBP_NEUROTRANSMITTER_UPTAKE,1
HFH1_01,SET,217,-0.078951,-0.0085323,0.060722,0.90323,HFH1_01,1
MIR6800_3P,SET,27,-0.22534,-0.0086351,0.17328,0.90326,MIR6800_3P,1
HP_ABNORMAL_ATRIOVENTRICULAR...3,SET,150,-0.09503,-0.0085544,0.073079,0.90326,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_MORPHOLOGY,1
HP_HOMOCYSTINURIA,SET,9,-0.3776,-0.0083581,0.29033,0.90329,HP_HOMOCYSTINURIA,1
GSE14308_TH17_VS_NATURAL_TRE...2,SET,180,-0.080929,-0.0079738,0.062223,0.9033,GSE14308_TH17_VS_NATURAL_TREG_UP,1
GOMF_NADP_BINDING,SET,50,-0.15392,-0.0080216,0.11832,0.90334,GOMF_NADP_BINDING,1
HP_DECREASED_VIGILANCE,SET,9,-0.36884,-0.0081643,0.28353,0.90334,HP_DECREASED_VIGILANCE,1
GOMF_CALCIUM_DEPENDENT_PHOSP...1,SET,17,-0.30495,-0.0092749,0.23435,0.90341,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,1
GSE23114_WT_VS_SLE2C1_MOUSE_...1,SET,167,-0.088072,-0.0083614,0.067671,0.90344,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN,1
PRC1_BMI_UP.V1_DN,SET,154,-0.088636,-0.0080836,0.068076,0.90354,PRC1_BMI_UP.V1_DN,1
MIR4747_5P,SET,256,-0.069159,-0.0081093,0.053111,0.90356,MIR4747_5P,1
BIOCARTA_GHRELIN_PATHWAY,SET,13,-0.37413,-0.0099518,0.28728,0.90359,BIOCARTA_GHRELIN_PATHWAY,1
HP_COMPENSATED_HYPOTHYROIDISM,SET,9,-0.38167,-0.0084482,0.29307,0.90359,HP_COMPENSATED_HYPOTHYROIDISM,1
GOBP_POSITIVE_REGULATION_OF_...202,SET,17,-0.2851,-0.0086713,0.2189,0.9036,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...666,SET,25,-0.24103,-0.0088883,0.18501,0.90367,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
GSE9988_LOW_LPS_VS_CTRL_TREA...2,SET,165,-0.093007,-0.0087773,0.071388,0.90368,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP,1
MIR4691_3P,SET,90,-0.11649,-0.0081363,0.089395,0.90373,MIR4691_3P,1
GOBP_IP_10_PRODUCTION,SET,4,-0.62559,-0.0092328,0.47997,0.90377,GOBP_IP_10_PRODUCTION,1
GSE11924_TH1_VS_TH2_CD4_TCEL...2,SET,192,-0.076599,-0.0077922,0.058763,0.90379,GSE11924_TH1_VS_TH2_CD4_TCELL_UP,1
HP_CLUBBING,SET,128,-0.093899,-0.0078129,0.07203,0.90381,HP_CLUBBING,1
GSE17721_PAM3CSK4_VS_CPG_6H_...2,SET,177,-0.07815,-0.0076361,0.059948,0.90381,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP,1
GSE32164_RESTING_DIFFERENTIA...3,SET,188,-0.080219,-0.0080758,0.061519,0.90387,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN,1
GOMF_ARYLESTERASE_ACTIVITY,SET,6,-0.58362,-0.010549,0.4475,0.90391,GOMF_ARYLESTERASE_ACTIVITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY,SET,653,-0.044383,-0.0082201,0.034031,0.90391,GOMF_OXIDOREDUCTASE_ACTIVITY,1
CHIANG_LIVER_CANCER_SUBCLASS...9,SET,163,-0.082645,-0.0077524,0.06336,0.90394,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,1
HP_CONJUNCTIVAL_HAMARTOMA,SET,10,-0.31664,-0.0073876,0.24271,0.90397,HP_CONJUNCTIVAL_HAMARTOMA,1
GOBP_SYNAPTIC_VESICLE_UNCOAT...,SET,7,-0.39678,-0.007746,0.30408,0.90402,GOBP_SYNAPTIC_VESICLE_UNCOATING,1
TERT_TARGET_GENES,SET,71,-0.13704,-0.0085053,0.10499,0.90409,TERT_TARGET_GENES,1
MIR301B_3P,SET,351,-0.060511,-0.0082863,0.046357,0.9041,MIR301B_3P,1
MODULE_427,SET,99,-0.10797,-0.0079069,0.082714,0.9041,MODULE_427,1
GSE21546_UNSTIM_VS_ANTI_CD3_...5,SET,134,-0.10389,-0.0088427,0.079577,0.90413,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
MIR301A_3P,SET,352,-0.060477,-0.0082932,0.04632,0.90415,MIR301A_3P,1
MORF_TERF2IP,SET,109,-0.096883,-0.0074427,0.074152,0.90431,MORF_TERF2IP,1
RAGHAVACHARI_PLATELET_SPECIF...,SET,60,-0.15225,-0.0086894,0.11652,0.90433,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,1
GOBP_GROWTH_PLATE_CARTILAGE_...2,SET,9,-0.39652,-0.0087769,0.30343,0.90435,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION,1
DESCARTES_FETAL_THYMUS_THYMI...,SET,197,-0.087239,-0.0089881,0.06674,0.90441,DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS,1
MIR4536_5P,SET,41,-0.16877,-0.0079664,0.12909,0.90445,MIR4536_5P,1
GOBP_ESTABLISHMENT_OR_MAINTE...2,SET,211,-0.079086,-0.0084294,0.060488,0.90447,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,1
IL15_UP.V1_DN,SET,157,-0.090524,-0.0083351,0.069234,0.90447,IL15_UP.V1_DN,1
REACTOME_REGULATION_OF_MITF_...1,SET,18,-0.29026,-0.0090839,0.22199,0.90448,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS,1
GSE3982_NEUTROPHIL_VS_CENT_M...2,SET,188,-0.082218,-0.008277,0.062874,0.9045,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,1
GOMF_RNA_NUCLEASE_ACTIVITY,SET,117,-0.10118,-0.0080511,0.077363,0.90453,GOMF_RNA_NUCLEASE_ACTIVITY,1
REACTOME_REGULATION_OF_CHOLE...,SET,53,-0.14419,-0.0077357,0.11024,0.90455,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1
GOCC_MEDIATOR_COMPLEX,SET,34,-0.18004,-0.0077404,0.13763,0.90457,GOCC_MEDIATOR_COMPLEX,1
GOBP_RESPONSE_TO_ODORANT,SET,5,-0.53444,-0.0088184,0.40849,0.90461,GOBP_RESPONSE_TO_ODORANT,1
GSE32533_WT_VS_MIR17_KO_ACT_...2,SET,178,-0.085315,-0.0083595,0.065193,0.90466,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP,1
GOBP_REGULATION_OF_VITAMIN_M...,SET,12,-0.32134,-0.0082125,0.24554,0.90467,GOBP_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
WP_MAPK_CASCADE,SET,31,-0.1917,-0.0078705,0.14647,0.9047,WP_MAPK_CASCADE,1
MODULE_94,SET,342,-0.063346,-0.0085647,0.048398,0.9047,MODULE_94,1
GOBP_NEUTROPHIL_MIGRATION,SET,96,-0.12663,-0.0091326,0.096734,0.90473,GOBP_NEUTROPHIL_MIGRATION,1
MIR5583_5P,SET,93,-0.12094,-0.0085854,0.092361,0.90479,MIR5583_5P,1
GSE37605_TREG_VS_TCONV_C57BL...1,SET,158,-0.091391,-0.0084415,0.069772,0.90487,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN,1
GUO_HEX_TARGETS_DN,SET,60,-0.13863,-0.0079122,0.10584,0.90488,GUO_HEX_TARGETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...590,SET,34,-0.19653,-0.0084493,0.15002,0.90489,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
GSE3039_NKT_CELL_VS_ALPHABET...1,SET,174,-0.085905,-0.0083232,0.065576,0.90489,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN,1
HP_CARDIAC_CONDUCTION_ABNORM...,SET,127,-0.099673,-0.008261,0.07608,0.90491,HP_CARDIAC_CONDUCTION_ABNORMALITY,1
GOBP_POSITIVE_REGULATION_OF_...203,SET,5,-0.50114,-0.0082689,0.38243,0.90496,GOBP_POSITIVE_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,1
HP_CYSTATHIONINEMIA,SET,5,-0.52537,-0.0086687,0.40087,0.90499,HP_CYSTATHIONINEMIA,1
HP_IMPAIRED_TANDEM_GAIT,SET,9,-0.44478,-0.0098452,0.3393,0.90504,HP_IMPAIRED_TANDEM_GAIT,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...2,SET,178,-0.081364,-0.0079724,0.062051,0.9051,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...578,SET,147,-0.097819,-0.0087176,0.074599,0.90511,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,1
GSE369_SOCS3_KO_VS_IFNG_KO_L...1,SET,181,-0.085421,-0.0084395,0.065144,0.90511,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN,1
HP_ABNORMAL_T_WAVE,SET,35,-0.1955,-0.0085276,0.14906,0.90515,HP_ABNORMAL_T_WAVE,1
REACTOME_SHC1_EVENTS_IN_ERBB...2,SET,14,-0.27479,-0.0075852,0.20951,0.90516,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,1
GOBP_MESENCHYMAL_STEM_CELL_M...,SET,6,-0.53904,-0.0097428,0.41087,0.90522,GOBP_MESENCHYMAL_STEM_CELL_MAINTENANCE_INVOLVED_IN_NEPHRON_MORPHOGENESIS,1
GSE19825_NAIVE_VS_IL2RAHIGH_...2,SET,182,-0.087179,-0.0086367,0.066441,0.90525,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,1
GSE32255_UNSTIM_VS_4H_LPS_ST...2,SET,172,-0.087406,-0.0084203,0.066611,0.90526,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP,1
GSE7509_UNSTIM_VS_TNFA_IL1B_...1,SET,80,-0.11926,-0.0078553,0.090878,0.90529,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
HP_ABNORMAL_MUSCLE_GLYCOGEN_...,SET,10,-0.31083,-0.0072522,0.23684,0.9053,HP_ABNORMAL_MUSCLE_GLYCOGEN_CONTENT,1
DESCARTES_FETAL_SPLEEN_MYELO...,SET,110,-0.11996,-0.0092577,0.091404,0.90531,DESCARTES_FETAL_SPLEEN_MYELOID_CELLS,1
HP_DECREASED_DLCO,SET,22,-0.24208,-0.0083749,0.18444,0.90532,HP_DECREASED_DLCO,1
GOCC_ENDOPEPTIDASE_COMPLEX,SET,84,-0.11285,-0.0076154,0.085967,0.90534,GOCC_ENDOPEPTIDASE_COMPLEX,1
KEGG_MEDICUS_REFERENCE_TNF_N...,SET,14,-0.28907,-0.0079794,0.22018,0.90538,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY,1
GSE360_CTRL_VS_B_MALAYI_LOW_...2,SET,180,-0.08627,-0.0085,0.065702,0.90541,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP,1
KEGG_MEDICUS_REFERENCE_EGF_E...11,SET,11,-0.31277,-0.0076535,0.23819,0.90542,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY,1
chr5q31,SET,179,-0.19482,-0.019143,0.14835,0.90544,chr5q31,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...6,SET,29,-0.19945,-0.0079204,0.15187,0.90545,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_UP,1
HP_ABNORMAL_HEART_SOUND,SET,39,-0.19089,-0.0087887,0.14533,0.90548,HP_ABNORMAL_HEART_SOUND,1
GOMF_AMINO_ACID_TRANSMEMBRAN...,SET,91,-0.12455,-0.0087466,0.094813,0.9055,GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GNF2_CDH3,SET,26,-0.23332,-0.008774,0.17761,0.90551,GNF2_CDH3,1
GOBP_RESPONSE_TO_ORGANOPHOSP...,SET,123,-0.10369,-0.0084587,0.078935,0.90551,GOBP_RESPONSE_TO_ORGANOPHOSPHORUS,1
HP_APLASIA_HYPOPLASIA_INVOLV...16,SET,1045,-0.035866,-0.0083096,0.027301,0.90552,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETON,1
GSE17721_LPS_VS_PAM3CSK4_24H...1,SET,177,-0.082759,-0.0080865,0.062996,0.90552,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN,1
GOBP_ADENYLATE_CYCLASE_INHIB...4,SET,77,-0.13909,-0.0089884,0.10587,0.90553,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...451,SET,14,-0.29465,-0.0081334,0.22427,0.90554,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,1
HE_LIM_SUN_FETAL_LUNG_C3_VEN...,SET,76,-0.13641,-0.0087582,0.10377,0.90565,HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL,1
HP_ABNORMAL_VENTRICULAR_SEPT...,SET,429,-0.054238,-0.0081933,0.041258,0.90567,HP_ABNORMAL_VENTRICULAR_SEPTUM_MORPHOLOGY,1
GSE17721_CTRL_VS_CPG_0.5H_BM...2,SET,184,-0.082698,-0.0082372,0.062895,0.90571,GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP,1
GSE22601_IMMATURE_CD4_SINGLE...6,SET,162,-0.092456,-0.0086464,0.070316,0.90571,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,1
CAFFAREL_RESPONSE_TO_THC_DN,SET,29,-0.18991,-0.0075415,0.1444,0.90577,CAFFAREL_RESPONSE_TO_THC_DN,1
GSE41176_UNSTIM_VS_ANTI_IGM_...2,SET,183,-0.088427,-0.0087841,0.067225,0.9058,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP,1
HP_IMPAIRED_OROPHARYNGEAL_SW...,SET,12,-0.33324,-0.0085166,0.25332,0.90582,HP_IMPAIRED_OROPHARYNGEAL_SWALLOW_RESPONSE,1
HP_ABNORMAL_BRAIN_LACTATE_LE...,SET,23,-0.23138,-0.0081842,0.17582,0.9059,HP_ABNORMAL_BRAIN_LACTATE_LEVEL_BY_MRS,1
GOBP_NEGATIVE_REGULATION_OF_...567,SET,9,-0.41576,-0.0092027,0.31591,0.90591,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,1
GOCC_ALVEOLAR_LAMELLAR_BODY,SET,8,-0.40165,-0.0083823,0.30514,0.90595,GOCC_ALVEOLAR_LAMELLAR_BODY,1
MIR1237_5P_MIR4488,SET,12,-0.35118,-0.0089753,0.26679,0.90596,MIR1237_5P_MIR4488,1
KANNAN_BLOOD_2012_2013_TIV_A...2,SET,190,-0.079603,-0.0080558,0.060474,0.90596,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,1
HP_APLASIA_CUTIS_CONGENITA_O...3,SET,7,-0.40161,-0.0078403,0.30506,0.90599,HP_APLASIA_CUTIS_CONGENITA_OVER_THE_SCALP_VERTEX,1
GSE360_T_GONDII_VS_M_TUBERCU...2,SET,178,-0.084811,-0.0083101,0.064421,0.90599,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP,1
GOBP_REGULATION_OF_THE_FORCE...1,SET,24,-0.24596,-0.008887,0.18681,0.90601,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
MIR6866_3P,SET,66,-0.14368,-0.0085988,0.10912,0.90602,MIR6866_3P,1
MIR3136_5P,SET,69,-0.14383,-0.008801,0.10922,0.90606,MIR3136_5P,1
GSE3982_NEUTROPHIL_VS_TH2_UP,SET,181,-0.084618,-0.0083601,0.064252,0.90607,GSE3982_NEUTROPHIL_VS_TH2_UP,1
GOMF_INITIATOR_METHIONYL_AMI...,SET,4,-0.57492,-0.008485,0.43652,0.90608,GOMF_INITIATOR_METHIONYL_AMINOPEPTIDASE_ACTIVITY,1
GOCC_SEX_CHROMATIN,SET,4,-0.48168,-0.0071089,0.36569,0.9061,GOCC_SEX_CHROMATIN,1
HP_VERTEBRAL_ARCH_ANOMALY,SET,16,-0.26278,-0.0077541,0.1995,0.90611,HP_VERTEBRAL_ARCH_ANOMALY,1
BIOCARTA_IGF1_PATHWAY,SET,20,-0.25152,-0.0082968,0.19093,0.90613,BIOCARTA_IGF1_PATHWAY,1
GSE9509_LPS_VS_LPS_AND_IL10_...4,SET,168,-0.089983,-0.008568,0.068289,0.90618,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP,1
GOBP_ESTABLISHMENT_OR_MAINTE...4,SET,22,-0.23954,-0.0082868,0.18178,0.90619,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY,1
GOCC_HAPTOGLOBIN_HEMOGLOBIN_...,SET,7,-0.53235,-0.010393,0.40399,0.90619,GOCC_HAPTOGLOBIN_HEMOGLOBIN_COMPLEX,1
HP_ABNORMAL_TRACHEAL_MORPHOL...,SET,150,-0.093045,-0.0083757,0.070609,0.9062,HP_ABNORMAL_TRACHEAL_MORPHOLOGY,1
BROWNE_HCMV_INFECTION_20HR_UP,SET,213,-0.077699,-0.0083203,0.058952,0.90624,BROWNE_HCMV_INFECTION_20HR_UP,1
UNTERMAN_IPF_VS_CTRL_DC_DN,SET,6,-0.45892,-0.0082948,0.34815,0.90627,UNTERMAN_IPF_VS_CTRL_DC_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...7,SET,6,-0.43373,-0.0078395,0.32904,0.90627,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_DN,1
GOBP_PROLINE_METABOLIC_PROCE...,SET,9,-0.41399,-0.0091637,0.31401,0.90631,GOBP_PROLINE_METABOLIC_PROCESS,1
BIOCARTA_PLCD_PATHWAY,SET,5,-0.60753,-0.010024,0.46075,0.90633,BIOCARTA_PLCD_PATHWAY,1
HP_ABNORMAL_CIRCULATING_FREE...2,SET,7,-0.38591,-0.0075338,0.29263,0.90637,HP_ABNORMAL_CIRCULATING_FREE_T3_CONCENTRATION,1
GOBP_EPITHELIAL_CELL_CELL_AD...,SET,16,-0.29381,-0.0086696,0.22278,0.90638,GOBP_EPITHELIAL_CELL_CELL_ADHESION,1
GOCC_BASAL_CORTEX,SET,5,-0.50142,-0.0082735,0.38018,0.90639,GOCC_BASAL_CORTEX,1
WP_TYROBP_CAUSAL_NETWORK_IN_...,SET,56,-0.15873,-0.0087529,0.1203,0.90648,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,1
HP_SEVERELY_REDUCED_VISUAL_A...,SET,39,-0.18158,-0.00836,0.13762,0.90649,HP_SEVERELY_REDUCED_VISUAL_ACUITY,1
GOBP_ISOPRENOID_METABOLIC_PR...,SET,129,-0.10545,-0.0088078,0.079906,0.90652,GOBP_ISOPRENOID_METABOLIC_PROCESS,1
GSE45365_CD8A_DC_VS_CD11B_DC...5,SET,149,-0.095362,-0.0085558,0.07226,0.90652,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...83,SET,8,-0.4143,-0.0086462,0.31387,0.90657,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
HP_NORMAL_PRESSURE_HYDROCEPH...,SET,5,-0.57982,-0.0095672,0.43927,0.90657,HP_NORMAL_PRESSURE_HYDROCEPHALUS,1
HP_ABNORMAL_DERMATOGLYPHICS,SET,270,-0.068284,-0.0082195,0.051728,0.90658,HP_ABNORMAL_DERMATOGLYPHICS,1
HP_THICKENED_CALVARIA,SET,32,-0.2014,-0.0084006,0.15256,0.90659,HP_THICKENED_CALVARIA,1
NABA_MATRISOME_HIGHLY_METAST...2,SET,26,-0.207,-0.0077842,0.15679,0.90661,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,1
GOCC_NLRP3_INFLAMMASOME_COMP...,SET,6,-0.45728,-0.0082651,0.34635,0.90662,GOCC_NLRP3_INFLAMMASOME_COMPLEX,1
MYC_UP.V1_UP,SET,159,-0.086711,-0.0080343,0.065661,0.90667,MYC_UP.V1_UP,1
WP_REGUCALCIN_IN_PROXIMAL_TU...,SET,30,-0.20182,-0.0081515,0.15281,0.90669,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1
GOBP_MONONUCLEAR_CELL_MIGRAT...,SET,203,-0.083662,-0.0087483,0.063341,0.90671,GOBP_MONONUCLEAR_CELL_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...786,SET,75,-0.13596,-0.008672,0.10293,0.90674,GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,1
HP_OVERLAPPING_FINGERS,SET,29,-0.21619,-0.0085851,0.16357,0.90685,HP_OVERLAPPING_FINGERS,1
MIR6754_3P,SET,87,-0.12549,-0.008618,0.094933,0.90689,MIR6754_3P,1
LEE_METASTASIS_AND_ALTERNATI...2,SET,65,-0.14218,-0.0084448,0.10755,0.90691,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1
GOBP_NADH_METABOLIC_PROCESS,SET,28,-0.19925,-0.0077754,0.15071,0.90693,GOBP_NADH_METABOLIC_PROCESS,1
GOMF_ADP_RIBOSE_DIPHOSPHATAS...,SET,6,-0.47967,-0.0086699,0.36262,0.90704,GOMF_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY,1
HP_PREAURICULAR_SKIN_TAG,SET,59,-0.144,-0.00815,0.10886,0.90705,HP_PREAURICULAR_SKIN_TAG,1
HP_DECREASED_MEAN_CORPUSCULA...1,SET,5,-0.59545,-0.009825,0.4501,0.90706,HP_DECREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,1
GOMF_COLLAGEN_BINDING_INVOLV...,SET,4,-0.65918,-0.0097286,0.49823,0.90708,GOMF_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,1
MIR3929,SET,73,-0.13076,-0.0082288,0.098811,0.90713,MIR3929,1
KEGG_MEDICUS_REFERENCE_RAD51...,SET,10,-0.31529,-0.0073561,0.23824,0.90714,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION,1
GOMF_P_TYPE_TRANSMEMBRANE_TR...,SET,22,-0.24217,-0.0083778,0.18299,0.90714,GOMF_P_TYPE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_SEVERE_PHOTOSENSITIVITY,SET,5,-0.40888,-0.0067466,0.30888,0.9072,HP_SEVERE_PHOTOSENSITIVITY,1
MORF_SOD1,SET,243,-0.067127,-0.0076713,0.050696,0.90726,MORF_SOD1,1
GOMF_PROTEIN_CARBOXYL_O_METH...,SET,6,-0.42357,-0.0076558,0.31988,0.90726,GOMF_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY,1
DING_LUNG_CANCER_MUTATED_REC...,SET,6,-0.43733,-0.0079045,0.33024,0.90728,DING_LUNG_CANCER_MUTATED_RECURRENTLY,1
GUENTHER_GROWTH_SPHERICAL_VS...2,SET,20,-0.28505,-0.0094029,0.21526,0.90728,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,1
GOBP_METANEPHRIC_TUBULE_FORM...,SET,6,-0.50384,-0.0091067,0.38039,0.90733,GOBP_METANEPHRIC_TUBULE_FORMATION,1
GOBP_NEUROBLAST_DIVISION,SET,14,-0.28351,-0.0078259,0.21405,0.90733,GOBP_NEUROBLAST_DIVISION,1
GSE4590_LARGE_PRE_BCELL_VS_V...2,SET,160,-0.094567,-0.0087894,0.071362,0.90743,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,1
GOMF_FATTY_ACID_OMEGA_HYDROX...,SET,7,-0.49416,-0.0096471,0.37286,0.90746,GOMF_FATTY_ACID_OMEGA_HYDROXYLASE_ACTIVITY,1
GSE21360_NAIVE_VS_SECONDARY_...1,SET,156,-0.092355,-0.0084768,0.069677,0.90749,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN,1
SCHERER_PBMC_YF_VAX_AGE_18_4...3,SET,17,-0.2865,-0.0087139,0.21611,0.90753,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_DN,1
GOBP_B_CELL_HOMEOSTASIS,SET,30,-0.21899,-0.0088448,0.16506,0.90769,GOBP_B_CELL_HOMEOSTASIS,1
GOMF_PHOSPHOTRANSFERASE_ACTI...2,SET,7,-0.40676,-0.0079409,0.3066,0.90769,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR,1
FAN_OVARY_CL4_T_LYMPHOCYTE_N...,SET,212,-0.077811,-0.0083129,0.058647,0.9077,FAN_OVARY_CL4_T_LYMPHOCYTE_NK_CELL_1,1
REACTOME_DOWNSTREAM_SIGNALIN...1,SET,77,-0.11655,-0.0075321,0.087834,0.90773,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1
REACTOME_ABC_FAMILY_PROTEINS...,SET,97,-0.10922,-0.0079179,0.082304,0.90774,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...5,SET,14,-0.31922,-0.0088115,0.24052,0.90777,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,1
BIOCARTA_CLASSIC_PATHWAY,SET,10,-0.38656,-0.009019,0.29119,0.90782,BIOCARTA_CLASSIC_PATHWAY,1
GSE19888_ADENOSINE_A3R_INH_V...7,SET,176,-0.086485,-0.0084269,0.065141,0.90784,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,1
GNF2_TTN,SET,26,-0.21035,-0.0079101,0.15839,0.90791,GNF2_TTN,1
GSE339_CD4POS_VS_CD4CD8DN_DC...3,SET,185,-0.08216,-0.0082056,0.061862,0.90792,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,1
PODAR_RESPONSE_TO_ADAPHOSTIN...1,SET,17,-0.31342,-0.0095326,0.23598,0.90793,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,1
MATZUK_CUMULUS_EXPANSION,SET,8,-0.47852,-0.0099865,0.36027,0.90794,MATZUK_CUMULUS_EXPANSION,1
GOCC_CYTOSOLIC_REGION,SET,19,-0.25905,-0.0083292,0.19503,0.90795,GOCC_CYTOSOLIC_REGION,1
MORF_RAB3A,SET,77,-0.13331,-0.0086148,0.10036,0.90796,MORF_RAB3A,1
chr4q31,SET,62,-0.26026,-0.015098,0.19592,0.90797,chr4q31,1
KEGG_MEDICUS_REFERENCE_PROK_...,SET,9,-0.40094,-0.0088747,0.3018,0.90798,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
HP_ENURESIS_NOCTURNA,SET,10,-0.37073,-0.0086497,0.27905,0.90799,HP_ENURESIS_NOCTURNA,1
WENG_POR_TARGETS_LIVER_UP,SET,41,-0.17912,-0.0084548,0.13478,0.90805,WENG_POR_TARGETS_LIVER_UP,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...4,SET,31,-0.23093,-0.009481,0.1737,0.90815,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
HP_ABNORMAL_MYELINATION,SET,539,-0.047354,-0.0079936,0.035612,0.90819,HP_ABNORMAL_MYELINATION,1
HE_LIM_SUN_FETAL_LUNG_C2_PRE...,SET,507,-0.050031,-0.0081983,0.037621,0.90821,HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL,1
BIOCARTA_RACC_PATHWAY,SET,11,-0.39784,-0.0097352,0.29913,0.90824,BIOCARTA_RACC_PATHWAY,1
WP_RAS_AND_BRADYKININ_PATHWA...,SET,27,-0.2531,-0.0096986,0.19027,0.90826,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,1
GOBP_POSITIVE_REGULATION_OF_...832,SET,15,-0.33219,-0.0094913,0.24974,0.90826,GOBP_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY,1
GOMF_SULFURIC_ESTER_HYDROLAS...,SET,11,-0.36433,-0.0089152,0.27389,0.90827,GOMF_SULFURIC_ESTER_HYDROLASE_ACTIVITY,1
MODULE_154,SET,67,-0.14637,-0.008826,0.11002,0.9083,MODULE_154,1
GSE25087_FETAL_VS_ADULT_TCON...1,SET,155,-0.087667,-0.0080209,0.065886,0.90833,GSE25087_FETAL_VS_ADULT_TCONV_DN,1
ZHAN_MULTIPLE_MYELOMA_MS_UP,SET,41,-0.20659,-0.0097516,0.15524,0.90835,ZHAN_MULTIPLE_MYELOMA_MS_UP,1
ATGTTTC_MIR494,SET,142,-0.099039,-0.0086762,0.074424,0.90835,ATGTTTC_MIR494,1
WP_IL1_AND_MEGAKARYOCYTES_IN...,SET,22,-0.26228,-0.0090736,0.19704,0.90842,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,1
MIR6816_5P,SET,19,-0.26972,-0.0086722,0.20262,0.90842,MIR6816_5P,1
DESCARTES_FETAL_MUSCLE_SMOOT...,SET,67,-0.14762,-0.0089013,0.11089,0.90843,DESCARTES_FETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...272,SET,3,-0.83484,-0.010671,0.62711,0.90844,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
GNF2_PECAM1,SET,48,-0.17498,-0.0089353,0.13134,0.9086,GNF2_PECAM1,1
GOBP_ANTERIOR_COMMISSURE_MOR...,SET,7,-0.49505,-0.0096644,0.37151,0.90865,GOBP_ANTERIOR_COMMISSURE_MORPHOGENESIS,1
GOBP_POLYOL_BIOSYNTHETIC_PRO...,SET,58,-0.1465,-0.0082213,0.10993,0.90867,GOBP_POLYOL_BIOSYNTHETIC_PROCESS,1
GSE45837_WT_VS_GFI1_KO_PDC_DN,SET,173,-0.080218,-0.00775,0.060194,0.90867,GSE45837_WT_VS_GFI1_KO_PDC_DN,1
GOBP_REGULATION_OF_PROTEIN_A...4,SET,4,-0.6097,-0.0089983,0.45743,0.9087,GOBP_REGULATION_OF_PROTEIN_AUTOUBIQUITINATION,1
GOBP_TRUNK_SEGMENTATION,SET,5,-0.52404,-0.0086467,0.39312,0.90873,GOBP_TRUNK_SEGMENTATION,1
HP_MITRAL_VALVE_PROLAPSE,SET,103,-0.11418,-0.0085284,0.085653,0.90874,HP_MITRAL_VALVE_PROLAPSE,1
GSE40274_CTRL_VS_FOXP3_AND_G...1,SET,135,-0.096703,-0.0082617,0.07254,0.90874,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
MIR449C_3P,SET,50,-0.15769,-0.0082181,0.11829,0.90875,MIR449C_3P,1
KEGG_MEDICUS_PATHOGEN_ESCHER...5,SET,14,-0.29301,-0.008088,0.21977,0.90876,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY,1
GSE16522_ANTI_CD3CD28_STIM_V...1,SET,175,-0.083985,-0.0081603,0.062992,0.90877,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN,1
MIR96_3P,SET,65,-0.13958,-0.0082901,0.10466,0.90883,MIR96_3P,1
HP_DISPROPORTIONATE_SHORT_TR...,SET,24,-0.22819,-0.008245,0.17109,0.90884,HP_DISPROPORTIONATE_SHORT_TRUNK_SHORT_STATURE,1
KEGG_NON_HOMOLOGOUS_END_JOIN...,SET,12,-0.27081,-0.0069212,0.20301,0.90889,KEGG_NON_HOMOLOGOUS_END_JOINING,1
MIR6758_5P,SET,99,-0.11409,-0.0083552,0.085515,0.90891,MIR6758_5P,1
HP_SHORTENING_OF_ALL_PHALANG...,SET,6,-0.43067,-0.0077842,0.3228,0.90892,HP_SHORTENING_OF_ALL_PHALANGES_OF_THE_TOES,1
GSE20366_CD103_KLRG1_DP_VS_D...1,SET,173,-0.086118,-0.0083201,0.064541,0.90894,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN,1
HASLINGER_B_CLL_WITH_CHROMOS...,SET,20,-0.24713,-0.0081521,0.1852,0.90895,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,1
GSE25123_CTRL_VS_IL4_STIM_PP...2,SET,179,-0.082403,-0.0080966,0.061752,0.90896,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP,1
REACTOME_SOS_MEDIATED_SIGNAL...,SET,7,-0.39209,-0.0076544,0.29373,0.90903,REACTOME_SOS_MEDIATED_SIGNALLING,1
DESCARTES_MAIN_FETAL_MESANGI...,SET,16,-0.30748,-0.009073,0.23033,0.90905,DESCARTES_MAIN_FETAL_MESANGIAL_CELLS,1
GOBP_INTRACELLULAR_SPHINGOLI...,SET,5,-0.42145,-0.0069539,0.31566,0.90907,GOBP_INTRACELLULAR_SPHINGOLIPID_HOMEOSTASIS,1
GOBP_AMINO_ACID_NEUROTRANSMI...,SET,10,-0.4243,-0.0098996,0.31779,0.90908,GOBP_AMINO_ACID_NEUROTRANSMITTER_REUPTAKE,1
FXR_Q3,SET,102,-0.12034,-0.0089443,0.090123,0.90909,FXR_Q3,1
GOBP_GLUCOSE_CATABOLIC_PROCE...,SET,21,-0.23015,-0.0077792,0.17235,0.90911,GOBP_GLUCOSE_CATABOLIC_PROCESS,1
HP_POSTERIOR_RIB_CUPPING,SET,4,-0.58944,-0.0086993,0.44142,0.90911,HP_POSTERIOR_RIB_CUPPING,1
MIR5007_3P,SET,109,-0.11258,-0.0086483,0.084295,0.90914,MIR5007_3P,1
GOCC_FIBRILLAR_COLLAGEN_TRIM...,SET,12,-0.35987,-0.0091972,0.26946,0.90914,GOCC_FIBRILLAR_COLLAGEN_TRIMER,1
GOBP_ASPARTATE_METABOLIC_PRO...,SET,6,-0.52021,-0.0094026,0.38949,0.90916,GOBP_ASPARTATE_METABOLIC_PROCESS,1
LI_WILMS_TUMOR,SET,22,-0.28051,-0.0097043,0.20998,0.9092,LI_WILMS_TUMOR,1
REACTOME_DEFECTIVE_F9_ACTIVA...,SET,5,-0.60385,-0.0099637,0.452,0.90921,REACTOME_DEFECTIVE_F9_ACTIVATION,1
GSE24634_TEFF_VS_TCONV_DAY3_...2,SET,183,-0.081265,-0.0080727,0.060803,0.9093,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP,1
WP_MIRNA_BIOGENESIS,SET,6,-0.47647,-0.008612,0.35648,0.90931,WP_MIRNA_BIOGENESIS,1
MIR4428,SET,114,-0.10472,-0.0082263,0.07834,0.90934,MIR4428,1
HP_EYELID_COLOBOMA,SET,34,-0.1882,-0.0080915,0.14079,0.90934,HP_EYELID_COLOBOMA,1
HP_ABNORMAL_FOOT_MORPHOLOGY,SET,1315,-0.033093,-0.0085336,0.024752,0.90938,HP_ABNORMAL_FOOT_MORPHOLOGY,1
HALLMARK_CHOLESTEROL_HOMEOST...,SET,69,-0.13455,-0.0082329,0.10063,0.90939,HALLMARK_CHOLESTEROL_HOMEOSTASIS,1
MODULE_361,SET,127,-0.10234,-0.0084823,0.076539,0.9094,MODULE_361,1
GOCC_RIBOSOME,SET,211,-0.072697,-0.0077484,0.054367,0.90941,GOCC_RIBOSOME,1
GOBP_MACROPHAGE_ACTIVATION_I...,SET,19,-0.28092,-0.0090323,0.21004,0.90945,GOBP_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOMF_ENDONUCLEASE_ACTIVITY_A...2,SET,33,-0.19823,-0.0083967,0.14822,0.90945,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
DBP_TARGET_GENES,SET,1181,-0.034373,-0.0084329,0.025696,0.90949,DBP_TARGET_GENES,1
GCM_MAP1B,SET,62,-0.14634,-0.0084893,0.10937,0.90954,GCM_MAP1B,1
GOBP_INDOLE_CONTAINING_COMPO...1,SET,5,-0.48785,-0.0080497,0.36462,0.90954,GOBP_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_DOUBLE_ST...1,SET,119,-0.09986,-0.0080134,0.074623,0.90958,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,1
GSE35543_IN_VITRO_ITREG_VS_C...1,SET,178,-0.084905,-0.0083194,0.063442,0.90959,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN,1
REACTOME_RUNX3_REGULATES_BCL...,SET,5,-0.57294,-0.0094537,0.42801,0.90964,REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION,1
GOBP_CRANIAL_NERVE_DEVELOPME...,SET,61,-0.15515,-0.008928,0.1159,0.90965,GOBP_CRANIAL_NERVE_DEVELOPMENT,1
GOBP_REGULATION_OF_RECEPTOR_...5,SET,16,-0.27805,-0.0082045,0.2077,0.90965,GOBP_REGULATION_OF_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
HP_DISPROPORTIONATE_SHORT_LI...,SET,96,-0.12076,-0.008709,0.090207,0.90965,HP_DISPROPORTIONATE_SHORT_LIMB_SHORT_STATURE,1
GNF2_PA2G4,SET,75,-0.11892,-0.0075852,0.088806,0.90973,GNF2_PA2G4,1
GOBP_PROTEIN_DEPOLYMERIZATION,SET,108,-0.10507,-0.0080345,0.078427,0.90982,GOBP_PROTEIN_DEPOLYMERIZATION,1
ZFP36L1_TARGET_GENES,SET,47,-0.16325,-0.0082491,0.12184,0.90985,ZFP36L1_TARGET_GENES,1
GOMF_GAMMA_AMINOBUTYRIC_ACID...1,SET,5,-0.61319,-0.010118,0.45763,0.90986,GOMF_GAMMA_AMINOBUTYRIC_ACID_SODIUM_CHLORIDE_SYMPORTER_ACTIVITY,1
GNF2_AF1Q,SET,25,-0.24114,-0.008892,0.17994,0.90988,GNF2_AF1Q,1
GSE38696_LIGHT_ZONE_VS_DARK_...1,SET,122,-0.10167,-0.0082604,0.075872,0.90988,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,1
MIR1271_3P,SET,65,-0.15032,-0.0089284,0.11215,0.90994,MIR1271_3P,1
REACTOME_GLYCEROPHOSPHOLIPID...2,SET,7,-0.39909,-0.0077912,0.29769,0.90997,REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM,1
GOBP_IMMUNE_RESPONSE_TO_TUMO...,SET,24,-0.26603,-0.009612,0.19844,0.90997,GOBP_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
GNF2_ITGB2,SET,51,-0.15816,-0.0083243,0.11797,0.90998,GNF2_ITGB2,1
KEGG_CALCIUM_SIGNALING_PATHW...,SET,167,-0.092281,-0.008761,0.068821,0.91001,KEGG_CALCIUM_SIGNALING_PATHWAY,1
BROWNE_HCMV_INFECTION_2HR_UP,SET,33,-0.22152,-0.0093831,0.1652,0.91002,BROWNE_HCMV_INFECTION_2HR_UP,1
GOMF_GLUCURONOSYLTRANSFERASE...,SET,31,-0.26722,-0.010971,0.19927,0.91002,GOMF_GLUCURONOSYLTRANSFERASE_ACTIVITY,1
HP_SCLEROSING_CHOLANGITIS,SET,10,-0.4085,-0.009531,0.30465,0.91002,HP_SCLEROSING_CHOLANGITIS,1
GSE34156_TLR1_TLR2_LIGAND_VS...1,SET,176,-0.086123,-0.0083917,0.064206,0.91009,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
MAINA_VHL_TARGETS_UP,SET,10,-0.40792,-0.0095175,0.3041,0.9101,MAINA_VHL_TARGETS_UP,1
WNT_UP.V1_UP,SET,167,-0.091997,-0.008734,0.068576,0.91012,WNT_UP.V1_UP,1
GSE45365_CTRL_VS_MCMV_INFECT...2,SET,180,-0.084576,-0.0083331,0.063026,0.91018,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP,1
TRAVAGLINI_LUNG_TREM2_DENDRI...,SET,516,-0.051449,-0.0085031,0.03834,0.91018,TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL,1
HP_PRIMITIVE_REFLEX,SET,24,-0.23002,-0.0083109,0.17138,0.91022,HP_PRIMITIVE_REFLEX,1
GOBP_NEGATIVE_REGULATION_OF_...626,SET,4,-0.57275,-0.008453,0.42667,0.91025,GOBP_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
HP_ABNORMAL_FEAR_INDUCED_BEH...,SET,7,-0.38695,-0.0075541,0.28826,0.91025,HP_ABNORMAL_FEAR_INDUCED_BEHAVIOR,1
FLECHNER_BIOPSY_KIDNEY_TRANS...3,SET,504,-0.053311,-0.0087107,0.039713,0.91026,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1
STAT3_01,SET,21,-0.24215,-0.0081847,0.18037,0.91027,STAT3_01,1
MIR4761_5P,SET,62,-0.14338,-0.008318,0.10679,0.91031,MIR4761_5P,1
GOBP_MESENCHYMAL_STEM_CELL_D...,SET,11,-0.38137,-0.009332,0.28401,0.91032,GOBP_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,1
GOMF_ACETYLCHOLINE_RECEPTOR_...3,SET,7,-0.52925,-0.010332,0.394,0.9104,GOMF_ACETYLCHOLINE_RECEPTOR_INHIBITOR_ACTIVITY,1
HP_ABNORMAL_HAND_BONE_OSSIFI...,SET,34,-0.1931,-0.008302,0.14375,0.91041,HP_ABNORMAL_HAND_BONE_OSSIFICATION,1
REACTOME_ABC_TRANSPORTER_DIS...,SET,74,-0.12424,-0.0078714,0.09248,0.91042,REACTOME_ABC_TRANSPORTER_DISORDERS,1
MIR4507,SET,34,-0.18091,-0.0077778,0.13464,0.91047,MIR4507,1
LIAO_METASTASIS,SET,476,-0.052325,-0.0083153,0.03894,0.91048,LIAO_METASTASIS,1
GSE17721_CTRL_VS_CPG_8H_BMDC...1,SET,187,-0.083373,-0.0083712,0.062034,0.91052,GSE17721_CTRL_VS_CPG_8H_BMDC_DN,1
HP_ABNORMALITY_OF_THE_NAIL,SET,449,-0.055302,-0.0085418,0.041139,0.91056,HP_ABNORMALITY_OF_THE_NAIL,1
GOBP_PRO_B_CELL_DIFFERENTIAT...,SET,12,-0.34976,-0.008939,0.26006,0.91067,GOBP_PRO_B_CELL_DIFFERENTIATION,1
REACTOME_TELOMERE_C_STRAND_L...,SET,32,-0.18812,-0.0078468,0.13985,0.9107,REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,1
GOBP_AMIDE_METABOLIC_PROCESS,SET,398,-0.059882,-0.0087205,0.044518,0.9107,GOBP_AMIDE_METABOLIC_PROCESS,1
HP_NASAL_DYSARTHRIA,SET,29,-0.21133,-0.0083922,0.1571,0.91071,HP_NASAL_DYSARTHRIA,1
GSE24142_DN2_VS_DN3_THYMOCYT...5,SET,179,-0.086623,-0.0085113,0.064389,0.91073,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP,1
MIR655_3P,SET,382,-0.062141,-0.0088696,0.046174,0.91081,MIR655_3P,1
GOBP_TRNA_SURVEILLANCE,SET,8,-0.37783,-0.0078851,0.28074,0.91081,GOBP_TRNA_SURVEILLANCE,1
HP_EMPHYSEMA,SET,63,-0.14717,-0.0086062,0.10934,0.91083,HP_EMPHYSEMA,1
AIZARANI_LIVER_C2_KUPFFER_CE...,SET,178,-0.091465,-0.0089622,0.067952,0.91084,AIZARANI_LIVER_C2_KUPFFER_CELLS_1,1
IBRAHIM_NRF1_DOWN,SET,127,-0.10353,-0.0085807,0.076901,0.91088,IBRAHIM_NRF1_DOWN,1
GOBP_AMIDE_CATABOLIC_PROCESS,SET,16,-0.28323,-0.0083575,0.21038,0.91089,GOBP_AMIDE_CATABOLIC_PROCESS,1
HP_OPSOCLONUS,SET,14,-0.34372,-0.0094879,0.25531,0.91089,HP_OPSOCLONUS,1
MIR6829_3P,SET,77,-0.13522,-0.0087387,0.10043,0.91091,MIR6829_3P,1
chr7q34,SET,50,-0.29051,-0.01514,0.21572,0.91095,chr7q34,1
MIR3064_3P,SET,154,-0.095876,-0.0087439,0.071189,0.91097,MIR3064_3P,1
MIR3129_3P,SET,94,-0.1238,-0.0088354,0.091907,0.911,MIR3129_3P,1
GOBP_REGULATION_OF_CALCIUM_I...7,SET,57,-0.16024,-0.0089147,0.11895,0.91102,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_TRANSCRIPTIONAL_REG...11,SET,30,-0.20818,-0.0084082,0.15452,0.91104,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION,1
HP_NEONATAL_ALLOIMMUNE_THROM...,SET,14,-0.30189,-0.0083333,0.22406,0.91106,HP_NEONATAL_ALLOIMMUNE_THROMBOCYTOPENIA,1
MIR520B_3P_MIR520C_3P_MIR520...,SET,302,-0.066324,-0.008436,0.049213,0.91112,MIR520B_3P_MIR520C_3P_MIR520E_3P,1
GOBP_SULFUR_COMPOUND_METABOL...,SET,291,-0.071106,-0.0088807,0.052759,0.91112,GOBP_SULFUR_COMPOUND_METABOLIC_PROCESS,1
HP_SMALL_BOWEL_DIVERTICULA,SET,5,-0.48674,-0.0080313,0.36105,0.91118,HP_SMALL_BOWEL_DIVERTICULA,1
GOBP_REACTIVE_OXYGEN_SPECIES...1,SET,45,-0.17342,-0.0085752,0.12862,0.91121,GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_NEUTROPHI...4,SET,4,-0.60621,-0.0089469,0.44955,0.91124,GOBP_REGULATION_OF_NEUTROPHIL_EXTRAVASATION,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...1,SET,18,-0.29966,-0.009378,0.22209,0.91136,GOBP_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,1
HP_BREATHING_DYSREGULATION,SET,19,-0.25772,-0.0082864,0.19101,0.91136,HP_BREATHING_DYSREGULATION,1
GAUCHER_PBMC_YF_VAX_STAMARIL...10,SET,44,-0.17671,-0.0086405,0.13097,0.91137,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,1
REACTOME_SYNTHESIS_OF_VERY_L...,SET,23,-0.27071,-0.0095755,0.20056,0.91144,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,1
HP_3_METHYLGLUTARIC_ACIDURIA,SET,5,-0.466,-0.007689,0.34515,0.9115,HP_3_METHYLGLUTARIC_ACIDURIA,1
GSE17721_CTRL_VS_POLYIC_0.5H...2,SET,180,-0.084215,-0.0082976,0.06237,0.91152,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...4,SET,17,-0.28959,-0.0088078,0.21443,0.91157,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,1
REACTOME_MITOTIC_METAPHASE_A...,SET,217,-0.074885,-0.0080929,0.055448,0.91157,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1
GOMF_CARBON_OXYGEN_LYASE_ACT...,SET,69,-0.13911,-0.0085121,0.10299,0.91161,GOMF_CARBON_OXYGEN_LYASE_ACTIVITY,1
HP_HYPERACTIVE_DEEP_TENDON_R...,SET,22,-0.26944,-0.0093212,0.19944,0.91164,HP_HYPERACTIVE_DEEP_TENDON_REFLEXES,1
GOBP_RESPONSE_TO_VITAMIN_A,SET,15,-0.3088,-0.0088229,0.22852,0.91169,GOBP_RESPONSE_TO_VITAMIN_A,1
BIOCARTA_WNT_LRP6_PATHWAY,SET,6,-0.51675,-0.0093401,0.38238,0.91171,BIOCARTA_WNT_LRP6_PATHWAY,1
GOBP_INTESTINAL_LIPID_ABSORP...,SET,21,-0.26486,-0.0089526,0.19599,0.91171,GOBP_INTESTINAL_LIPID_ABSORPTION,1
BERTUCCI_MEDULLARY_VS_DUCTAL...1,SET,153,-0.097324,-0.0088473,0.071994,0.91178,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,1
GSE22229_RENAL_TRANSPLANT_VS...1,SET,178,-0.086412,-0.008467,0.063916,0.9118,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN,1
GSE2770_IL12_AND_TGFB_ACT_VS...1,SET,167,-0.090767,-0.0086172,0.067131,0.91182,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN,1
GOBP_ORGANIC_ACID_METABOLIC_...,SET,855,-0.041167,-0.0086744,0.030445,0.91183,GOBP_ORGANIC_ACID_METABOLIC_PROCESS,1
GOCC_CRD_MEDIATED_MRNA_STABI...,SET,6,-0.43819,-0.0079201,0.32397,0.9119,GOCC_CRD_MEDIATED_MRNA_STABILITY_COMPLEX,1
MIR3691_5P,SET,40,-0.18617,-0.00868,0.13763,0.91191,MIR3691_5P,1
HP_DECREASED_CIRCULATING_FRE...1,SET,5,-0.4345,-0.0071693,0.32113,0.91197,HP_DECREASED_CIRCULATING_FREE_T3,1
GOMF_AROMATASE_ACTIVITY,SET,25,-0.28168,-0.010387,0.20814,0.91201,GOMF_AROMATASE_ACTIVITY,1
HP_GINGIVAL_OVERGROWTH,SET,110,-0.11641,-0.0089835,0.086015,0.91202,HP_GINGIVAL_OVERGROWTH,1
GOBP_POSITIVE_REGULATION_OF_...577,SET,26,-0.23159,-0.0087089,0.17109,0.91206,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
GOBP_CRANIAL_NERVE_MORPHOGEN...,SET,29,-0.23751,-0.009432,0.17541,0.91213,GOBP_CRANIAL_NERVE_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...421,SET,5,-0.48802,-0.0080524,0.3603,0.9122,GOBP_POSITIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,1
GOMF_N_ACETYLGALACTOSAMINE_4...,SET,5,-0.47406,-0.007822,0.34997,0.91221,GOMF_N_ACETYLGALACTOSAMINE_4_O_SULFOTRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...388,SET,6,-0.50161,-0.0090663,0.37027,0.91224,GOBP_POSITIVE_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
BUSSLINGER_DUODENAL_PANETH_C...,SET,15,-0.35518,-0.010148,0.26215,0.91226,BUSSLINGER_DUODENAL_PANETH_CELLS,1
HP_PROGRESSIVE_PROXIMAL_MUSC...,SET,21,-0.24999,-0.0084498,0.18446,0.91232,HP_PROGRESSIVE_PROXIMAL_MUSCLE_WEAKNESS,1
ALX4_TARGET_GENES,SET,23,-0.25574,-0.0090459,0.18869,0.91234,ALX4_TARGET_GENES,1
GOCC_MICROTUBULE_BUNDLE,SET,6,-0.43245,-0.0078163,0.31902,0.91237,GOCC_MICROTUBULE_BUNDLE,1
GSE2770_UNTREATED_VS_IL4_TRE...1,SET,179,-0.080566,-0.0079162,0.059436,0.91237,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
GOBP_PEPTIDYL_LYSINE_METHYLA...,SET,14,-0.32396,-0.0089424,0.23894,0.91241,GOBP_PEPTIDYL_LYSINE_METHYLATION,1
HP_ARTERIOVENOUS_FISTULA,SET,10,-0.37614,-0.0087759,0.27741,0.91242,HP_ARTERIOVENOUS_FISTULA,1
GOCC_MHC_CLASS_II_PROTEIN_CO...,SET,13,-0.3875,-0.010308,0.28575,0.91245,GOCC_MHC_CLASS_II_PROTEIN_COMPLEX,1
GOMF_HYDROLASE_ACTIVITY_ACTI...2,SET,128,-0.10399,-0.0086521,0.076679,0.91246,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS,1
chr3q26,SET,61,-0.2995,-0.017235,0.22078,0.91253,chr3q26,1
GSE14308_TH2_VS_TH17_UP,SET,184,-0.084001,-0.008367,0.061919,0.91254,GSE14308_TH2_VS_TH17_UP,1
MIR365B_5P,SET,31,-0.20983,-0.008615,0.15465,0.91258,MIR365B_5P,1
REACTOME_TP53_REGULATES_TRAN...10,SET,13,-0.33094,-0.008803,0.24385,0.91262,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,1
BIOCARTA_REELIN_PATHWAY,SET,7,-0.46866,-0.0091494,0.34529,0.91265,BIOCARTA_REELIN_PATHWAY,1
HP_ABNORMAL_CSF_HOMOVANILLIC...,SET,9,-0.40154,-0.0088881,0.29581,0.91267,HP_ABNORMAL_CSF_HOMOVANILLIC_ACID_CONCENTRATION,1
GSE41867_DAY8_VS_DAY15_LCMV_...4,SET,182,-0.083152,-0.0082377,0.061257,0.91267,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
MIR5585_5P,SET,115,-0.10714,-0.0084525,0.078916,0.9127,MIR5585_5P,1
MIR593_5P,SET,146,-0.09728,-0.0086404,0.071644,0.91273,MIR593_5P,1
GSE17186_NAIVE_VS_CD21HIGH_T...2,SET,176,-0.083499,-0.008136,0.061494,0.91274,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,1
HP_HYPOSMIA,SET,49,-0.1692,-0.0087293,0.1246,0.91275,HP_HYPOSMIA,1
GOBP_NEPHRIC_DUCT_FORMATION,SET,5,-0.58133,-0.0095921,0.42801,0.9128,GOBP_NEPHRIC_DUCT_FORMATION,1
GOCC_EXTRINSIC_COMPONENT_OF_...6,SET,7,-0.36743,-0.0071731,0.27047,0.91284,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_MEMBRANE,1
GSE37533_PPARG1_FOXP3_VS_FOX...4,SET,184,-0.084954,-0.0084619,0.062526,0.91287,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
HP_FULL_CHEEKS,SET,132,-0.096197,-0.0081273,0.070798,0.91288,HP_FULL_CHEEKS,1
GOBP_HOMOCYSTEINE_METABOLIC_...,SET,11,-0.34349,-0.0084052,0.25275,0.91292,GOBP_HOMOCYSTEINE_METABOLIC_PROCESS,1
MIR105_3P,SET,4,-0.72175,-0.010652,0.53105,0.91293,MIR105_3P,1
MIR4475,SET,58,-0.14949,-0.008389,0.10997,0.91297,MIR4475,1
GOMF_ENDONUCLEASE_ACTIVITY,SET,111,-0.10626,-0.0082373,0.078172,0.91297,GOMF_ENDONUCLEASE_ACTIVITY,1
MIR6780B_3P,SET,56,-0.15457,-0.0085236,0.1137,0.91299,MIR6780B_3P,1
KEGG_MEDICUS_REFERENCE_REGUL...14,SET,8,-0.35114,-0.0073282,0.25827,0.91301,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA,1
GOBP_POSITIVE_REGULATION_OF_...708,SET,69,-0.1447,-0.0088541,0.10642,0.91303,GOBP_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
DESCARTES_FETAL_ADRENAL_SYMP...,SET,90,-0.13808,-0.0096435,0.10153,0.91307,DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS,1
GSE36891_UNSTIM_VS_PAM_TLR2_...1,SET,143,-0.092752,-0.0081538,0.0682,0.91308,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,1
MEBARKI_HCC_PROGENITOR_WNT_U...3,SET,39,-0.21212,-0.009766,0.15596,0.91309,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1
GOBP_MYOTUBE_DIFFERENTIATION...,SET,7,-0.51009,-0.0099581,0.37501,0.91311,GOBP_MYOTUBE_DIFFERENTIATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
HP_CYSTOID_MACULAR_EDEMA,SET,19,-0.26933,-0.0086596,0.19798,0.91313,HP_CYSTOID_MACULAR_EDEMA,1
MORF_EIF4A2,SET,128,-0.096656,-0.0080423,0.071044,0.91316,MORF_EIF4A2,1
GOMF_FLAVIN_ADENINE_DINUCLEO...,SET,81,-0.12524,-0.0082999,0.092023,0.91322,GOMF_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING,1
MODULE_426,SET,80,-0.1322,-0.0087074,0.097126,0.91325,MODULE_426,1
MAZ_Q6,SET,179,-0.085634,-0.0084141,0.062904,0.91329,MAZ_Q6,1
GSE39820_TGFBETA1_VS_TGFBETA...4,SET,184,-0.081095,-0.0080775,0.059548,0.91337,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP,1
PID_INTEGRIN_CS_PATHWAY,SET,25,-0.25194,-0.0092905,0.18499,0.91338,PID_INTEGRIN_CS_PATHWAY,1
WP_PHOTODYNAMIC_THERAPYINDUC...1,SET,48,-0.17711,-0.0090441,0.13005,0.91338,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1
CHEN_METABOLIC_SYNDROM_NETWO...,SET,1122,-0.036519,-0.0087476,0.02681,0.91341,CHEN_METABOLIC_SYNDROM_NETWORK,1
PID_FRA_PATHWAY,SET,35,-0.20989,-0.0091555,0.15409,0.91341,PID_FRA_PATHWAY,1
GOBP_CEREBRAL_CORTEX_DEVELOP...,SET,112,-0.11768,-0.0091632,0.086394,0.91341,GOBP_CEREBRAL_CORTEX_DEVELOPMENT,1
MIR6791_3P,SET,76,-0.13765,-0.0088376,0.10105,0.91342,MIR6791_3P,1
IKEDA_MIR1_TARGETS_DN,SET,6,-0.54519,-0.009854,0.40022,0.91343,IKEDA_MIR1_TARGETS_DN,1
GSE27786_NKCELL_VS_NEUTROPHI...2,SET,184,-0.082349,-0.0082025,0.060449,0.91344,GSE27786_NKCELL_VS_NEUTROPHIL_UP,1
HP_THIRD_DEGREE_ATRIOVENTRIC...,SET,9,-0.35741,-0.0079113,0.26233,0.91346,HP_THIRD_DEGREE_ATRIOVENTRICULAR_BLOCK,1
HP_HYPOPLASTIC_ACETABULAE,SET,5,-0.57727,-0.009525,0.42364,0.91349,HP_HYPOPLASTIC_ACETABULAE,1
TTAYRTAA_E4BP4_01,SET,236,-0.080404,-0.009057,0.058999,0.91352,TTAYRTAA_E4BP4_01,1
HP_ABNORMALITY_OF_THE_ANTERI...2,SET,110,-0.10824,-0.0083527,0.079416,0.91354,HP_ABNORMALITY_OF_THE_ANTERIOR_FONTANELLE,1
HP_CONJUGATED_HYPERBILIRUBIN...,SET,34,-0.21457,-0.0092252,0.15743,0.91354,HP_CONJUGATED_HYPERBILIRUBINEMIA,1
GOCC_MYELIN_SHEATH_ADAXONAL_...,SET,5,-0.46947,-0.0077463,0.34439,0.91358,GOCC_MYELIN_SHEATH_ADAXONAL_REGION,1
GOBP_RESPONSE_TO_OXYGEN_LEVE...,SET,302,-0.068507,-0.0087137,0.050248,0.91361,GOBP_RESPONSE_TO_OXYGEN_LEVELS,1
HP_SHALLOW_ANTERIOR_CHAMBER,SET,17,-0.29182,-0.0088757,0.21401,0.91364,HP_SHALLOW_ANTERIOR_CHAMBER,1
FEKIR_HEPARG_SPHERE_VS_HEPAR...2,SET,95,-0.12342,-0.0088551,0.090511,0.91365,FEKIR_HEPARG_SPHERE_VS_HEPARG_UP,1
GOMF_ATPASE_INHIBITOR_ACTIVI...,SET,4,-0.57781,-0.0085277,0.42369,0.91367,GOMF_ATPASE_INHIBITOR_ACTIVITY,1
GOBP_REGULATION_OF_LOCOMOTIO...,SET,5,-0.702,-0.011583,0.51465,0.91371,GOBP_REGULATION_OF_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,1
GSE22886_NAIVE_BCELL_VS_DC_UP,SET,153,-0.096946,-0.008813,0.071073,0.91371,GSE22886_NAIVE_BCELL_VS_DC_UP,1
HP_ABNORMAL_CIRCULATING_AMIN...,SET,150,-0.094839,-0.0085372,0.069525,0.91372,HP_ABNORMAL_CIRCULATING_AMINO_ACID_CONCENTRATION,1
GOBP_PROTEIN_LOCALIZATION_TO...47,SET,11,-0.35686,-0.0087322,0.2616,0.91373,GOBP_PROTEIN_LOCALIZATION_TO_PRESYNAPSE,1
HP_HYPOSEGMENTATION_OF_NEUTR...,SET,6,-0.49351,-0.00892,0.36176,0.91374,HP_HYPOSEGMENTATION_OF_NEUTROPHIL_NUCLEI,1
BIOCARTA_CCR3_PATHWAY,SET,18,-0.29139,-0.0091193,0.21359,0.91375,BIOCARTA_CCR3_PATHWAY,1
DIRMEIER_LMP1_RESPONSE_EARLY,SET,59,-0.15637,-0.0088499,0.1146,0.91377,DIRMEIER_LMP1_RESPONSE_EARLY,1
GOBP_REGULATION_OF_CIRCADIAN...1,SET,105,-0.11643,-0.0087797,0.085329,0.91379,GOBP_REGULATION_OF_CIRCADIAN_RHYTHM,1
HP_HYPERTENSION,SET,355,-0.06413,-0.0088309,0.046996,0.9138,HP_HYPERTENSION,1
GOBP_DE_NOVO_AMP_BIOSYNTHETI...,SET,6,-0.46408,-0.0083881,0.34004,0.91383,GOBP_DE_NOVO_AMP_BIOSYNTHETIC_PROCESS,1
WCTCNATGGY_UNKNOWN,SET,69,-0.14079,-0.008615,0.1031,0.91397,WCTCNATGGY_UNKNOWN,1
GOBP_NEGATIVE_REGULATION_OF_...349,SET,91,-0.12306,-0.0086423,0.090109,0.91398,GOBP_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
REACTOME_BRANCHED_CHAIN_AMIN...,SET,20,-0.24875,-0.0082053,0.1821,0.91402,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,1
MODULE_40,SET,81,-0.13226,-0.0087658,0.096821,0.91403,MODULE_40,1
HP_POOR_HEAD_CONTROL,SET,208,-0.077799,-0.0082337,0.056951,0.91403,HP_POOR_HEAD_CONTROL,1
GSE6674_UNSTIM_VS_ANTI_IGM_S...2,SET,149,-0.089106,-0.0079946,0.065212,0.91409,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP,1
MIR29B_3P_MIR29C_3P,SET,396,-0.061959,-0.0090008,0.045319,0.91421,MIR29B_3P_MIR29C_3P,1
CTIP_DN.V1_UP,SET,115,-0.11304,-0.008918,0.08266,0.91425,CTIP_DN.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...818,SET,9,-0.33577,-0.0074323,0.24553,0.91426,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,1
HP_PITUITARY_PROLACTIN_CELL_...,SET,7,-0.41234,-0.0080499,0.30152,0.91426,HP_PITUITARY_PROLACTIN_CELL_ADENOMA,1
MIR100_3P,SET,67,-0.14296,-0.0086206,0.1045,0.91435,MIR100_3P,1
PTTG1_TARGET_GENES,SET,55,-0.15525,-0.0084843,0.11346,0.91438,PTTG1_TARGET_GENES,1
MIR4794,SET,88,-0.12911,-0.0089168,0.094349,0.9144,MIR4794,1
MIR3686,SET,294,-0.070102,-0.0087996,0.051217,0.91445,MIR3686,1
KEGG_MEDICUS_REFERENCE_KISS1...,SET,11,-0.38821,-0.0094995,0.2836,0.91447,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY,1
HU_FETAL_RETINA_BIPOLAR,SET,79,-0.14241,-0.0093216,0.10402,0.91451,HU_FETAL_RETINA_BIPOLAR,1
GSE2770_IL12_VS_IL4_TREATED_...4,SET,182,-0.083898,-0.0083117,0.061276,0.91452,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GSE6259_33D1_POS_VS_DEC205_P...4,SET,173,-0.091822,-0.0088711,0.067064,0.91452,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP,1
MIR372_3P,SET,304,-0.067304,-0.0085885,0.049151,0.91454,MIR372_3P,1
GSE6092_UNSTIM_VS_IFNG_STIM_...1,SET,177,-0.089014,-0.0086977,0.065007,0.91454,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,1
KEGG_ASTHMA,SET,25,-0.25837,-0.0095276,0.18867,0.91456,KEGG_ASTHMA,1
GOBP_OTIC_VESICLE_DEVELOPMENT,SET,14,-0.29927,-0.008261,0.21854,0.91456,GOBP_OTIC_VESICLE_DEVELOPMENT,1
HP_FLAT_ACETABULAR_ROOF,SET,26,-0.21762,-0.0081835,0.15891,0.91456,HP_FLAT_ACETABULAR_ROOF,1
HALLMARK_ANDROGEN_RESPONSE,SET,94,-0.12386,-0.0088399,0.090421,0.91462,HALLMARK_ANDROGEN_RESPONSE,1
GOBP_ATRIOVENTRICULAR_VALVE_...2,SET,8,-0.44762,-0.0093417,0.32674,0.91464,GOBP_ATRIOVENTRICULAR_VALVE_FORMATION,1
GOMF_MYOSIN_BINDING,SET,69,-0.1418,-0.0086768,0.1035,0.91466,GOMF_MYOSIN_BINDING,1
WANG_RESPONSE_TO_FORSKOLIN_UP,SET,22,-0.2538,-0.0087803,0.18524,0.91467,WANG_RESPONSE_TO_FORSKOLIN_UP,1
HP_SHORT_UMBILICAL_CORD,SET,6,-0.51427,-0.0092952,0.37511,0.9148,HP_SHORT_UMBILICAL_CORD,1
DESCARTES_FETAL_SPLEEN_VASCU...,SET,41,-0.20423,-0.0096403,0.14895,0.91482,DESCARTES_FETAL_SPLEEN_VASCULAR_ENDOTHELIAL_CELLS,1
GOMF_PROTEINASE_ACTIVATED_RE...,SET,5,-0.63003,-0.010396,0.45943,0.91486,GOMF_PROTEINASE_ACTIVATED_RECEPTOR_ACTIVITY,1
GSE37301_MULTIPOTENT_PROGENI...5,SET,188,-0.083893,-0.0084457,0.061172,0.91487,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,1
RANKIN_ANGIOGENIC_TARGETS_OF...1,SET,8,-0.49017,-0.01023,0.3573,0.91494,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN,1
ZNF34_TARGET_GENES,SET,213,-0.079659,-0.0085301,0.058046,0.91501,ZNF34_TARGET_GENES,1
GSE36009_WT_VS_NLRP10_KO_DC_...1,SET,187,-0.082986,-0.0083323,0.060469,0.91502,GSE36009_WT_VS_NLRP10_KO_DC_DN,1
chr9q22,SET,72,-0.24346,-0.015216,0.17735,0.91508,chr9q22,1
GSE360_L_DONOVANI_VS_M_TUBER...3,SET,188,-0.087351,-0.0087938,0.063626,0.9151,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN,1
GSE17721_LPS_VS_POLYIC_4H_BM...2,SET,184,-0.085101,-0.0084766,0.061979,0.91512,GSE17721_LPS_VS_POLYIC_4H_BMDC_UP,1
HP_CALVARIAL_SKULL_DEFECT,SET,27,-0.23357,-0.0089504,0.17011,0.91513,HP_CALVARIAL_SKULL_DEFECT,1
GOBP_SPERM_MITOCHONDRIAL_SHE...,SET,6,-0.55552,-0.010041,0.40456,0.91514,GOBP_SPERM_MITOCHONDRIAL_SHEATH_ASSEMBLY,1
PID_HIF1_TFPATHWAY,SET,64,-0.15553,-0.0091666,0.11325,0.91517,PID_HIF1_TFPATHWAY,1
HP_CLINODACTYLY_OF_THE_2ND_F...,SET,8,-0.47949,-0.010007,0.34906,0.91522,HP_CLINODACTYLY_OF_THE_2ND_FINGER,1
GSE21927_SPLENIC_VS_TUMOR_MO...2,SET,163,-0.091141,-0.0085493,0.066347,0.91522,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP,1
REACTOME_PCP_CE_PATHWAY,SET,88,-0.11802,-0.0081511,0.08591,0.91523,REACTOME_PCP_CE_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...638,SET,58,-0.15273,-0.0085704,0.11116,0.91525,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
WP_FACTORS_AND_PATHWAYS_AFFE...,SET,36,-0.19953,-0.0088269,0.14522,0.91527,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1
HP_MOYAMOYA_PHENOMENON,SET,12,-0.31362,-0.0080153,0.22825,0.91527,HP_MOYAMOYA_PHENOMENON,1
WAMUNYOKOLI_OVARIAN_CANCER_G...1,SET,63,-0.15597,-0.0091205,0.11351,0.91528,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1
MIR6839_5P,SET,88,-0.12886,-0.0088998,0.093779,0.91528,MIR6839_5P,1
HP_REDUCED_SYSTOLIC_FUNCTION,SET,21,-0.27085,-0.0091549,0.19704,0.91537,HP_REDUCED_SYSTOLIC_FUNCTION,1
GOBP_POSITIVE_REGULATION_OF_...551,SET,6,-0.48953,-0.008848,0.35609,0.91538,GOBP_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
BRUNEAU_SEPTATION_VENTRICULAR,SET,10,-0.33105,-0.0077239,0.2408,0.91539,BRUNEAU_SEPTATION_VENTRICULAR,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...6,SET,19,-0.30929,-0.0099445,0.22497,0.9154,GOBP_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT,1
HP_VISUAL_IMPAIRMENT,SET,993,-0.038059,-0.0086083,0.027681,0.91541,HP_VISUAL_IMPAIRMENT,1
GOBP_POSITIVE_REGULATION_OF_...737,SET,5,-0.56836,-0.009378,0.41334,0.91543,GOBP_POSITIVE_REGULATION_OF_SULFUR_METABOLIC_PROCESS,1
HP_RETINAL_DYSPLASIA,SET,18,-0.2713,-0.0084905,0.19722,0.91552,HP_RETINAL_DYSPLASIA,1
GOBP_SKELETAL_MUSCLE_ORGAN_D...,SET,169,-0.09419,-0.0089951,0.068464,0.91555,GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT,1
MIR4742_5P,SET,169,-0.094583,-0.0090326,0.068724,0.91562,MIR4742_5P,1
GOBP_TRANSLATIONAL_ELONGATION,SET,59,-0.1399,-0.0079176,0.10165,0.91562,GOBP_TRANSLATIONAL_ELONGATION,1
GSE9650_EFFECTOR_VS_EXHAUSTE...2,SET,183,-0.080968,-0.0080432,0.058833,0.91562,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...1,SET,5,-0.63086,-0.010409,0.45837,0.91563,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY,1
ZNF22_TARGET_GENES,SET,819,-0.040558,-0.0083728,0.029468,0.91563,ZNF22_TARGET_GENES,1
GOMF_C_X3_C_CHEMOKINE_BINDING,SET,5,-0.56258,-0.0092826,0.40876,0.91563,GOMF_C_X3_C_CHEMOKINE_BINDING,1
E2F1_Q3_01,SET,220,-0.07906,-0.0086022,0.057431,0.91567,E2F1_Q3_01,1
GOMF_WATER_TRANSMEMBRANE_TRA...,SET,17,-0.33854,-0.010297,0.24592,0.91568,GOMF_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
ZIM3_TARGET_GENES,SET,799,-0.041117,-0.0083887,0.029862,0.91572,ZIM3_TARGET_GENES,1
BIOCARTA_ACETAMINOPHEN_PATHW...,SET,5,-0.5809,-0.009585,0.42177,0.91578,BIOCARTA_ACETAMINOPHEN_PATHWAY,1
HP_TRACHEAL_STENOSIS,SET,25,-0.23777,-0.0087679,0.17263,0.91579,HP_TRACHEAL_STENOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...140,SET,5,-0.52471,-0.0086579,0.38094,0.9158,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,1
GSE35685_CD34POS_CD38NEG_VS_...2,SET,171,-0.088856,-0.0085352,0.064506,0.91581,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP,1
GSE34006_WT_VS_A2AR_KO_TREG_...1,SET,182,-0.090456,-0.0089613,0.065661,0.91583,GSE34006_WT_VS_A2AR_KO_TREG_DN,1
HP_SKIN_EROSION,SET,26,-0.21545,-0.0081018,0.15638,0.91585,HP_SKIN_EROSION,1
ZNF416_TARGET_GENES,SET,4,-0.57062,-0.0084216,0.41409,0.91589,ZNF416_TARGET_GENES,1
SHETH_LIVER_CANCER_VS_TXNIP_...4,SET,258,-0.074234,-0.0087379,0.053858,0.91594,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,1
GOBP_POSITIVE_REGULATION_OF_...569,SET,8,-0.42095,-0.0087851,0.30539,0.91595,GOBP_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GAO_SMALL_INTESTINE_24W_C1_T...,SET,8,-0.3815,-0.0079618,0.27675,0.91597,GAO_SMALL_INTESTINE_24W_C1_TUFT_PROGENITOR,1
KEGG_MEDICUS_REFERENCE_GF_RT...2,SET,89,-0.13645,-0.0094769,0.098976,0.91598,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY,1
GSE14308_INDUCED_VS_NATURAL_...1,SET,182,-0.086961,-0.0086151,0.063081,0.91598,GSE14308_INDUCED_VS_NATURAL_TREG_DN,1
GSE20727_ROS_INH_VS_ROS_INH_...1,SET,149,-0.10077,-0.0090415,0.0731,0.91598,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
chr2q24,SET,48,-0.33305,-0.017007,0.24156,0.91601,chr2q24,1
DER_IFN_BETA_RESPONSE_DN,SET,6,-0.49979,-0.0090334,0.36246,0.91602,DER_IFN_BETA_RESPONSE_DN,1
GOMF_PLUS_END_DIRECTED_MICRO...,SET,17,-0.2796,-0.0085039,0.20278,0.91602,GOMF_PLUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,1
GOBP_INTERLEUKIN_18_MEDIATED...,SET,10,-0.41485,-0.0096791,0.30086,0.91603,GOBP_INTERLEUKIN_18_MEDIATED_SIGNALING_PATHWAY,1
GSE36078_WT_VS_IL1R_KO_LUNG_...4,SET,181,-0.086631,-0.008559,0.062825,0.91603,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP,1
MODULE_371,SET,26,-0.22908,-0.0086144,0.16612,0.91604,MODULE_371,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMA...,SET,48,-0.18312,-0.009351,0.13279,0.91605,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
GOBP_CHAPERONE_COFACTOR_DEPE...,SET,30,-0.19821,-0.0080058,0.14372,0.91608,GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING,1
HP_NONCOMPACTION_CARDIOMYOPA...,SET,15,-0.33804,-0.0096582,0.24509,0.91608,HP_NONCOMPACTION_CARDIOMYOPATHY,1
LET_7G_5P,SET,361,-0.064039,-0.0088911,0.046415,0.91615,LET_7G_5P,1
ID2_TARGET_GENES,SET,872,-0.040876,-0.0086941,0.029627,0.91615,ID2_TARGET_GENES,1
WP_BLADDER_CANCER,SET,39,-0.18657,-0.0085896,0.13519,0.9162,WP_BLADDER_CANCER,1
WP_GLUCOSE_METABOLISM_IN_TRI...,SET,8,-0.42902,-0.0089535,0.31085,0.91622,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...340,SET,8,-0.43434,-0.0090645,0.31467,0.91624,GOBP_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
VALK_AML_CLUSTER_1,SET,25,-0.2632,-0.0097056,0.19067,0.91625,VALK_AML_CLUSTER_1,1
GOCC_NEURON_PROJECTION_MEMBR...,SET,56,-0.16458,-0.0090753,0.1192,0.9163,GOCC_NEURON_PROJECTION_MEMBRANE,1
GOMF_GAP_JUNCTION_HEMI_CHANN...,SET,6,-0.56899,-0.010284,0.41212,0.9163,GOMF_GAP_JUNCTION_HEMI_CHANNEL_ACTIVITY,1
GOBP_RESPONSE_TO_PROSTAGLAND...3,SET,23,-0.27841,-0.0098477,0.20154,0.91641,GOBP_RESPONSE_TO_PROSTAGLANDIN_E,1
HP_DENTAL_ENAMEL_PITS,SET,8,-0.47872,-0.0099906,0.34624,0.9166,HP_DENTAL_ENAMEL_PITS,1
chr16q11,SET,7,-0.90367,-0.017642,0.65352,0.91662,chr16q11,1
HP_RENAL_CYST,SET,245,-0.076652,-0.0087954,0.055435,0.91662,HP_RENAL_CYST,1
GSE21670_STAT3_KO_VS_WT_CD4_...3,SET,178,-0.089845,-0.0088034,0.064969,0.91664,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP,1
DIRMEIER_LMP1_RESPONSE_LATE_...2,SET,53,-0.16533,-0.0088701,0.11955,0.91666,DIRMEIER_LMP1_RESPONSE_LATE_UP,1
REACTOME_DECTIN_1_MEDIATED_N...,SET,58,-0.13873,-0.0077852,0.10031,0.91667,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,1
REACTOME_REGULATION_OF_TP53_...2,SET,28,-0.2179,-0.008503,0.15755,0.91667,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,1
GOBP_TRICUSPID_VALVE_DEVELOP...,SET,7,-0.49897,-0.0097411,0.36072,0.9167,GOBP_TRICUSPID_VALVE_DEVELOPMENT,1
GSE21033_CTRL_VS_POLYIC_STIM...7,SET,178,-0.084505,-0.0082802,0.061087,0.91671,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN,1
HP_SUPRAVALVULAR_AORTIC_STEN...,SET,26,-0.25323,-0.0095228,0.18306,0.91672,HP_SUPRAVALVULAR_AORTIC_STENOSIS,1
GOBP_CALCIUM_ION_IMPORT_ACRO...,SET,36,-0.20292,-0.0089766,0.14664,0.91679,GOBP_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_SCALING_SKIN,SET,42,-0.18286,-0.0087359,0.13207,0.91689,HP_SCALING_SKIN,1
REACTOME_THE_ROLE_OF_GTSE1_I...,SET,73,-0.12512,-0.0078737,0.090304,0.91704,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1
GOCC_CLATHRIN_COATED_VESICLE,SET,200,-0.087397,-0.0090719,0.06308,0.91704,GOCC_CLATHRIN_COATED_VESICLE,1
HP_ABNORMAL_CIRCULATING_LEUC...,SET,4,-0.57388,-0.0084696,0.41416,0.91706,HP_ABNORMAL_CIRCULATING_LEUCINE_CONCENTRATION,1
GAVISH_3CA_METAPROGRAM_FIBRO...8,SET,45,-0.20851,-0.01031,0.15046,0.91709,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_7,1
GSE21063_CTRL_VS_ANTI_IGM_ST...10,SET,185,-0.089778,-0.0089665,0.064781,0.9171,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP,1
GSE36826_WT_VS_IL1R_KO_SKIN_...4,SET,179,-0.090341,-0.0088766,0.065183,0.91711,GSE36826_WT_VS_IL1R_KO_SKIN_UP,1
GCM_USP6,SET,67,-0.13017,-0.0078493,0.093914,0.91713,GCM_USP6,1
MIR486_3P,SET,152,-0.096581,-0.0087513,0.069669,0.91716,MIR486_3P,1
HP_YELLOW_BROWN_DISCOLORATIO...,SET,14,-0.31995,-0.0088317,0.2308,0.91716,HP_YELLOW_BROWN_DISCOLORATION_OF_THE_TEETH,1
GOUYER_TATI_TARGETS_DN,SET,17,-0.28686,-0.0087249,0.20692,0.91717,GOUYER_TATI_TARGETS_DN,1
HUTTMANN_B_CLL_POOR_SURVIVAL...1,SET,57,-0.16171,-0.0089964,0.11663,0.9172,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,1
HP_HIRSUTISM,SET,195,-0.08407,-0.0086179,0.060623,0.91723,HP_HIRSUTISM,1
HP_GIANT_PLATELETS,SET,10,-0.40909,-0.0095448,0.29493,0.91729,HP_GIANT_PLATELETS,1
BANDRES_RESPONSE_TO_CARMUSTI...3,SET,148,-0.099153,-0.0088663,0.071477,0.9173,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1
GOBP_CELLULAR_RESPONSE_TO_TH...,SET,12,-0.39114,-0.0099964,0.28191,0.91734,GOBP_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS,1
GOBP_RESCUE_OF_STALLED_RIBOS...,SET,25,-0.21842,-0.0080543,0.15742,0.91735,GOBP_RESCUE_OF_STALLED_RIBOSOME,1
HP_ABNORMAL_SARCOMERE_MORPHO...,SET,12,-0.35493,-0.009071,0.25559,0.91753,HP_ABNORMAL_SARCOMERE_MORPHOLOGY,1
HP_ABNORMALITY_OF_THE_VERTEB...1,SET,1337,-0.032945,-0.0085606,0.023716,0.91759,HP_ABNORMALITY_OF_THE_VERTEBRAL_COLUMN,1
HP_FLARED_ILIAC_WING,SET,16,-0.2929,-0.0086427,0.21082,0.91763,HP_FLARED_ILIAC_WING,1
MIR643,SET,58,-0.15504,-0.0087002,0.11157,0.91767,MIR643,1
GSE360_L_DONOVANI_VS_L_MAJOR...2,SET,181,-0.088384,-0.0087322,0.063596,0.91769,GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP,1
GSE42021_TREG_VS_TCONV_PLN_DN,SET,179,-0.088914,-0.0087364,0.063963,0.91774,GSE42021_TREG_VS_TCONV_PLN_DN,1
NIKOLSKY_BREAST_CANCER_16P13...,SET,101,-0.20124,-0.014885,0.14475,0.91776,NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,1
UNTERMAN_PROGRESSIVE_VS_STAB...6,SET,8,-0.48512,-0.010124,0.34893,0.91778,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_UP,1
GOBP_PURINE_DEOXYRIBONUCLEOS...1,SET,5,-0.62372,-0.010292,0.44858,0.91779,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
WP_OSTEOBLAST_SIGNALING,SET,13,-0.36987,-0.0098386,0.26595,0.91784,WP_OSTEOBLAST_SIGNALING,1
ZSCAN5DP_TARGET_GENES,SET,1192,-0.035621,-0.0087768,0.025612,0.91785,ZSCAN5DP_TARGET_GENES,1
MIKKELSEN_IPS_ICP_WITH_H3K27...,SET,54,-0.16594,-0.0089862,0.11927,0.91793,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,1
GOBP_CHONDROITIN_SULFATE_PRO...2,SET,29,-0.22283,-0.0088492,0.16013,0.91797,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,1
BREDEMEYER_RAG_SIGNALING_NOT...1,SET,57,-0.1596,-0.008879,0.11468,0.91798,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1
GOBP_REGULATION_OF_CARDIAC_M...9,SET,23,-0.25577,-0.0090469,0.18377,0.91799,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,1
SHETH_LIVER_CANCER_VS_TXNIP_...3,SET,69,-0.14343,-0.0087761,0.10303,0.91805,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,1
GOBP_RRNA_BASE_METHYLATION,SET,6,-0.42929,-0.0077592,0.30836,0.91805,GOBP_RRNA_BASE_METHYLATION,1
HP_SKELETAL_DYSPLASIA,SET,169,-0.091871,-0.0087736,0.065994,0.91805,HP_SKELETAL_DYSPLASIA,1
GSE12845_NAIVE_VS_PRE_GC_TON...2,SET,180,-0.089424,-0.0088107,0.064235,0.91805,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP,1
MEIS1BHOXA9_01,SET,127,-0.11342,-0.0094006,0.081464,0.91808,MEIS1BHOXA9_01,1
MODULE_166,SET,48,-0.16392,-0.0083702,0.11773,0.91808,MODULE_166,1
GSE17721_CTRL_VS_LPS_0.5H_BM...1,SET,182,-0.089118,-0.0088288,0.063997,0.91811,GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN,1
GNF2_RFC3,SET,39,-0.17309,-0.0079691,0.12428,0.91814,GNF2_RFC3,1
GOBP_REGULATION_OF_ENDOCRINE...,SET,39,-0.21485,-0.0098916,0.15425,0.91816,GOBP_REGULATION_OF_ENDOCRINE_PROCESS,1
GOMF_ARYLSULFATASE_ACTIVITY,SET,9,-0.42111,-0.0093213,0.30232,0.91817,GOMF_ARYLSULFATASE_ACTIVITY,1
GSE36888_UNTREATED_VS_IL2_TR...7,SET,179,-0.095517,-0.0093852,0.068551,0.91824,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN,1
GAUCHER_PBMC_YF_VAX_STAMARIL...2,SET,183,-0.089556,-0.0088963,0.064272,0.91824,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,1
LEE_DOUBLE_POLAR_THYMOCYTE,SET,24,-0.28026,-0.010126,0.20105,0.91832,LEE_DOUBLE_POLAR_THYMOCYTE,1
MIR634,SET,83,-0.12644,-0.0084822,0.090711,0.91832,MIR634,1
HP_TYPE_1_MUSCLE_FIBER_ATROP...,SET,14,-0.3121,-0.008615,0.22388,0.91834,HP_TYPE_1_MUSCLE_FIBER_ATROPHY,1
GAVISH_3CA_METAPROGRAM_MACRO...10,SET,48,-0.17069,-0.0087161,0.12243,0.91836,GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION,1
MODULE_562,SET,20,-0.30671,-0.010118,0.21999,0.91836,MODULE_562,1
HP_ABNORMAL_CIRCULATING_PROG...,SET,6,-0.46716,-0.0084437,0.33508,0.91836,HP_ABNORMAL_CIRCULATING_PROGESTERONE_LEVEL,1
GSE43955_1H_VS_20H_ACT_CD4_T...1,SET,182,-0.0896,-0.0088766,0.064255,0.9184,GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN,1
GOBP_REGULATION_OF_CORTICOST...,SET,16,-0.31878,-0.0094065,0.2286,0.91841,GOBP_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,1
GSE7852_LN_VS_THYMUS_TREG_DN,SET,179,-0.090014,-0.0088445,0.064509,0.91854,GSE7852_LN_VS_THYMUS_TREG_DN,1
HP_HAMARTOMA,SET,61,-0.14508,-0.0083488,0.10396,0.91857,HP_HAMARTOMA,1
GSE27786_LIN_NEG_VS_CD8_TCEL...1,SET,185,-0.08615,-0.0086041,0.061727,0.91858,GSE27786_LIN_NEG_VS_CD8_TCELL_DN,1
REACTOME_CELLULAR_RESPONSE_T...4,SET,6,-0.39299,-0.0071032,0.28158,0.91859,REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS,1
GOMF_SECONDARY_ACTIVE_SULFAT...,SET,11,-0.36092,-0.0088315,0.25859,0.91859,GOMF_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE22140_GERMFREE_VS_SPF_ART...2,SET,186,-0.087719,-0.0087842,0.062837,0.91863,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP,1
GSE32034_LY6C_HIGH_VS_LOW_MO...1,SET,188,-0.084683,-0.0085252,0.060661,0.91863,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN,1
MODULE_211,SET,11,-0.45303,-0.011086,0.32446,0.91867,MODULE_211,1
GOBP_REGULATION_OF_SYNAPTIC_...5,SET,34,-0.21485,-0.0092372,0.15387,0.91868,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
DURANTE_ADULT_OLFACTORY_NEUR...26,SET,80,-0.14714,-0.0096916,0.10535,0.91875,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS,1
REACTOME_RELEASE_OF_APOPTOTI...,SET,5,-0.49997,-0.0082497,0.35794,0.91876,REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA,1
GSE17974_0H_VS_6H_IN_VITRO_A...2,SET,162,-0.09638,-0.0090133,0.069,0.91876,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...161,SET,8,-0.44349,-0.0092554,0.31747,0.91878,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,1
HP_INCREASED_ASPARTATE_FAMIL...,SET,7,-0.45703,-0.0089223,0.32715,0.91879,HP_INCREASED_ASPARTATE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,1
GSE16450_CTRL_VS_IFNA_6H_STI...3,SET,176,-0.085588,-0.0083395,0.061261,0.9188,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,1
GOBP_REGULATION_OF_TRANSLATI...3,SET,13,-0.27902,-0.0074218,0.19969,0.91882,GOBP_REGULATION_OF_TRANSLATIONAL_FIDELITY,1
SHIPP_DLBCL_CURED_VS_FATAL_DN,SET,38,-0.19012,-0.0086402,0.13604,0.91885,SHIPP_DLBCL_CURED_VS_FATAL_DN,1
WP_CHOLESTEROL_BIOSYNTHESIS_...2,SET,106,-0.1153,-0.0087353,0.082505,0.91885,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,1
REACTOME_RHO_GTPASES_ACTIVAT...10,SET,33,-0.1974,-0.0083613,0.14123,0.91889,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,1
GSE16450_CTRL_VS_IFNA_12H_ST...4,SET,180,-0.089188,-0.0087875,0.063809,0.91889,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,1
HP_DYSOSTOSIS_MULTIPLEX,SET,21,-0.24883,-0.0084106,0.17798,0.91895,HP_DYSOSTOSIS_MULTIPLEX,1
HP_MILIA,SET,16,-0.32094,-0.0094703,0.22955,0.91896,HP_MILIA,1
MIR574_5P,SET,77,-0.13253,-0.0085644,0.094771,0.91899,MIR574_5P,1
GOBP_REGULATION_OF_CELLULAR_...8,SET,7,-0.45635,-0.0089089,0.3263,0.91902,GOBP_REGULATION_OF_CELLULAR_PH_REDUCTION,1
MIR4659A_5P,SET,73,-0.14055,-0.0088449,0.10047,0.91908,MIR4659A_5P,1
SNAI1_TARGET_GENES,SET,370,-0.062164,-0.0087354,0.044429,0.91911,SNAI1_TARGET_GENES,1
HP_MULTIFOCAL_CEREBRAL_WHITE...,SET,15,-0.29751,-0.0085004,0.21263,0.91911,HP_MULTIFOCAL_CEREBRAL_WHITE_MATTER_ABNORMALITIES,1
MIR98_5P,SET,361,-0.065075,-0.0090348,0.046495,0.91918,MIR98_5P,1
GOBP_NEGATIVE_REGULATION_OF_...107,SET,9,-0.39732,-0.0087947,0.28386,0.91919,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,1
GOBP_POSITIVE_REGULATION_OF_...93,SET,29,-0.24565,-0.0097551,0.17547,0.91922,GOBP_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,1
GOMF_HSP90_PROTEIN_BINDING,SET,38,-0.19366,-0.0088014,0.13826,0.91934,GOMF_HSP90_PROTEIN_BINDING,1
LI_LUNG_CANCER,SET,40,-0.18335,-0.0085488,0.1309,0.91935,LI_LUNG_CANCER,1
HP_ABNORMAL_FETAL_CARDIOVASC...,SET,46,-0.16846,-0.0084218,0.12027,0.91935,HP_ABNORMAL_FETAL_CARDIOVASCULAR_MORPHOLOGY,1
AHRARNT_01,SET,129,-0.10883,-0.0090899,0.077679,0.91938,AHRARNT_01,1
GOMF_ATPASE_ACTIVATOR_ACTIVI...,SET,24,-0.23152,-0.0083653,0.1652,0.91946,GOMF_ATPASE_ACTIVATOR_ACTIVITY,1
BROWNE_HCMV_INFECTION_12HR_UP,SET,100,-0.11799,-0.0086841,0.08418,0.91948,BROWNE_HCMV_INFECTION_12HR_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...74,SET,7,-0.45937,-0.008968,0.32772,0.91949,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
GOBP_STRIATED_MUSCLE_ATROPHY,SET,7,-0.47377,-0.0092491,0.33798,0.9195,GOBP_STRIATED_MUSCLE_ATROPHY,1
GOBP_CHOLESTEROL_IMPORT,SET,9,-0.45007,-0.0099622,0.32102,0.91953,GOBP_CHOLESTEROL_IMPORT,1
HP_ABNORMAL_GAMMA_GLUTAMYLTR...,SET,41,-0.19091,-0.0090116,0.13612,0.91961,HP_ABNORMAL_GAMMA_GLUTAMYLTRANSFERASE_LEVEL,1
WAKABAYASHI_ADIPOGENESIS_PPA...5,SET,132,-0.10073,-0.0085101,0.071801,0.91967,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1
CHUNG_BLISTER_CYTOTOXICITY_DN,SET,40,-0.19197,-0.0089506,0.13683,0.91968,CHUNG_BLISTER_CYTOTOXICITY_DN,1
MIR381_5P,SET,7,-0.44448,-0.0086773,0.31682,0.91968,MIR381_5P,1
GOMF_ATP_DEPENDENT_PROTEIN_B...,SET,6,-0.46617,-0.0084258,0.33225,0.91969,GOMF_ATP_DEPENDENT_PROTEIN_BINDING,1
HP_CONSTIPATION,SET,388,-0.063302,-0.0091045,0.045115,0.9197,HP_CONSTIPATION,1
GNF2_MSH2,SET,26,-0.20489,-0.0077048,0.14601,0.91971,GNF2_MSH2,1
REACTOME_SYNTHESIS_OF_GLYCOS...,SET,17,-0.27444,-0.0083471,0.19556,0.91973,REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,1
MIR182_3P,SET,61,-0.15659,-0.0090112,0.11158,0.91974,MIR182_3P,1
GSE20715_0H_VS_48H_OZONE_TLR...2,SET,186,-0.089072,-0.0089197,0.063469,0.91974,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP,1
NAKAYA_MYELOID_DENDRITIC_CEL...2,SET,355,-0.06204,-0.0085429,0.044199,0.91978,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,1
HP_ABNORMAL_CIRCULATING_ALDO...2,SET,10,-0.40084,-0.0093524,0.28549,0.91984,HP_ABNORMAL_CIRCULATING_ALDOSTERONE,1
WP_S1P_RECEPTOR_SIGNAL_TRANS...,SET,25,-0.23988,-0.0088456,0.17083,0.91986,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,1
CARRILLOREIXACH_HEPATOBLASTO...2,SET,18,-0.28829,-0.0090224,0.20529,0.91988,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN,1
HOEK_NEUTROPHIL_2011_2012_TI...2,SET,28,-0.26345,-0.01028,0.18759,0.91988,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_UP,1
HP_RHIZOMELIA,SET,59,-0.16119,-0.0091228,0.11478,0.91989,HP_RHIZOMELIA,1
HP_HEMANGIOMATOSIS,SET,19,-0.27667,-0.0088956,0.197,0.9199,HP_HEMANGIOMATOSIS,1
GOBP_POLAR_BODY_EXTRUSION_AF...,SET,4,-0.73919,-0.010909,0.52629,0.91991,GOBP_POLAR_BODY_EXTRUSION_AFTER_MEIOTIC_DIVISIONS,1
REACTOME_METHYLATION,SET,14,-0.32432,-0.0089523,0.23085,0.91997,REACTOME_METHYLATION,1
GOBP_ISOPRENOID_BIOSYNTHETIC...,SET,28,-0.22751,-0.0088778,0.16193,0.91997,GOBP_ISOPRENOID_BIOSYNTHETIC_PROCESS,1
FOXO1_02,SET,233,-0.081722,-0.0091476,0.058144,0.92006,FOXO1_02,1
HP_APLASIA_HYPOPLASIA_OF_THE...19,SET,646,-0.0466,-0.0085859,0.033154,0.92007,HP_APLASIA_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
HP_ABNORMAL_SECOND_TOE_MORPH...,SET,12,-0.37177,-0.0095013,0.26448,0.92008,HP_ABNORMAL_SECOND_TOE_MORPHOLOGY,1
HP_COILED_SPERM_FLAGELLA,SET,26,-0.22778,-0.0085657,0.162,0.92014,HP_COILED_SPERM_FLAGELLA,1
HP_SUBSARCOLEMMAL_ACCUMULATI...,SET,5,-0.40637,-0.0067052,0.289,0.92015,HP_SUBSARCOLEMMAL_ACCUMULATIONS_OF_ABNORMALLY_SHAPED_MITOCHONDRIA,1
GOBP_INTRACELLULAR_SODIUM_IO...,SET,22,-0.29649,-0.010257,0.21082,0.92018,GOBP_INTRACELLULAR_SODIUM_ION_HOMEOSTASIS,1
GSE5589_LPS_VS_LPS_AND_IL10_...1,SET,176,-0.091455,-0.0089112,0.06503,0.92018,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN,1
GAVISH_3CA_METAPROGRAM_ENDOT...10,SET,46,-0.19525,-0.0097607,0.13881,0.92021,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1,1
LET_7A_5P_LET_7C_5P_LET_7E_5P,SET,360,-0.065429,-0.0090716,0.046506,0.92026,LET_7A_5P_LET_7C_5P_LET_7E_5P,1
MIR5584_3P,SET,124,-0.11318,-0.00927,0.080425,0.92032,MIR5584_3P,1
BLANCO_MELO_COVID19_BRONCHIA...2,SET,135,-0.11317,-0.0096682,0.080412,0.92033,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,1
MIR664A_5P,SET,65,-0.15583,-0.0092556,0.11071,0.92035,MIR664A_5P,1
GOMF_HISTONE_H4K20_METHYLTRA...,SET,6,-0.487,-0.0088022,0.34601,0.92035,GOMF_HISTONE_H4K20_METHYLTRANSFERASE_ACTIVITY,1
HP_PUNCTATE_CATARACT,SET,14,-0.33599,-0.0092745,0.23871,0.92036,HP_PUNCTATE_CATARACT,1
GSE25123_CTRL_VS_IL4_AND_ROS...2,SET,186,-0.086602,-0.0086724,0.061525,0.92036,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
RUTELLA_RESPONSE_TO_HGF_DN,SET,217,-0.083775,-0.0090537,0.059502,0.92041,RUTELLA_RESPONSE_TO_HGF_DN,1
GOBP_POSITIVE_REGULATION_OF_...842,SET,6,-0.40912,-0.0073947,0.29054,0.92045,GOBP_POSITIVE_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
HP_KNEE_CONTRACTURE,SET,98,-0.1257,-0.0091588,0.089252,0.92047,HP_KNEE_CONTRACTURE,1
GNF2_RFC4,SET,57,-0.14229,-0.0079157,0.10103,0.92048,GNF2_RFC4,1
RASHI_RESPONSE_TO_IONIZING_R...1,SET,36,-0.19757,-0.00874,0.14025,0.92053,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1
CACTGCC_MIR34A_MIR34C_MIR449,SET,258,-0.072797,-0.0085686,0.051664,0.92058,CACTGCC_MIR34A_MIR34C_MIR449,1
GOBP_MITOCHONDRIAL_TRANSLATI...1,SET,123,-0.096942,-0.007908,0.06876,0.9207,GOBP_MITOCHONDRIAL_TRANSLATION,1
GOBP_MODULATION_BY_HOST_OF_V...1,SET,21,-0.28458,-0.0096192,0.20183,0.92073,GOBP_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
GSE37534_PIOGLITAZONE_VS_ROS...1,SET,144,-0.10609,-0.0093587,0.075226,0.92077,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
REACTOME_SYNTHESIS_OF_ACTIVE...,SET,26,-0.22867,-0.008599,0.1621,0.92082,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,1
TTTGCAG_MIR518A2,SET,188,-0.088979,-0.0089576,0.063067,0.92085,TTTGCAG_MIR518A2,1
GOBP_METANEPHRIC_EPITHELIUM_...,SET,27,-0.25993,-0.0099605,0.18418,0.92091,GOBP_METANEPHRIC_EPITHELIUM_DEVELOPMENT,1
GSE10422_WT_VS_BAFF_TRANSGEN...2,SET,157,-0.092839,-0.0085482,0.065779,0.92092,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP,1
LEE_METASTASIS_AND_RNA_PROCE...,SET,16,-0.27472,-0.0081063,0.19464,0.92093,LEE_METASTASIS_AND_RNA_PROCESSING_UP,1
REACTOME_PRESYNAPTIC_DEPOLAR...,SET,11,-0.38799,-0.009494,0.27485,0.92096,REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING,1
GOBP_LONG_TERM_MEMORY,SET,36,-0.20909,-0.0092497,0.14812,0.92097,GOBP_LONG_TERM_MEMORY,1
GOCC_SPERM_CONNECTING_PIECE,SET,11,-0.38267,-0.0093639,0.27106,0.92098,GOCC_SPERM_CONNECTING_PIECE,1
GOBP_PROTEIN_LOCALIZATION_TO...24,SET,25,-0.23595,-0.0087009,0.16709,0.92104,GOBP_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
GSE29618_PRE_VS_DAY7_FLU_VAC...6,SET,170,-0.095969,-0.0091917,0.067955,0.92105,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP,1
HP_SHORT_GREATER_SCIATIC_NOT...,SET,3,-0.73802,-0.0094332,0.52256,0.92106,HP_SHORT_GREATER_SCIATIC_NOTCH,1
GSE21927_SPLENIC_C26GM_TUMOR...4,SET,135,-0.10442,-0.008921,0.07393,0.92108,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP,1
MENON_FETAL_KIDNEY_0_CAP_MES...,SET,73,-0.13633,-0.008579,0.096472,0.92118,MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS,1
GSE24142_EARLY_THYMIC_PROGEN...2,SET,183,-0.094379,-0.0093754,0.066777,0.92121,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP,1
MORF_PTPRR,SET,83,-0.13792,-0.0092522,0.097558,0.92127,MORF_PTPRR,1
HP_HYPERGASTRINEMIA,SET,6,-0.49288,-0.0089086,0.34863,0.92128,HP_HYPERGASTRINEMIA,1
GOBP_NEURON_PROJECTION_ORGAN...,SET,85,-0.13474,-0.0091467,0.095302,0.92129,GOBP_NEURON_PROJECTION_ORGANIZATION,1
MIR3658,SET,734,-0.046229,-0.0090566,0.03269,0.92133,MIR3658,1
ZHAN_VARIABLE_EARLY_DIFFEREN...1,SET,27,-0.21018,-0.008054,0.14861,0.92135,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1
HP_COMPENSATORY_HEAD_POSTURE,SET,21,-0.27458,-0.0092811,0.19413,0.92137,HP_COMPENSATORY_HEAD_POSTURE,1
HP_EXERCISE_INDUCED_MUSCLE_S...,SET,7,-0.38176,-0.0074528,0.26991,0.92137,HP_EXERCISE_INDUCED_MUSCLE_STIFFNESS,1
OZANNE_AP1_TARGETS_UP,SET,14,-0.30894,-0.0085277,0.21842,0.92138,OZANNE_AP1_TARGETS_UP,1
HP_CIGARETTE_PAPER_SCARS,SET,10,-0.41554,-0.0096952,0.29378,0.92138,HP_CIGARETTE_PAPER_SCARS,1
TATTATA_MIR374,SET,265,-0.07989,-0.0095284,0.056459,0.92146,TATTATA_MIR374,1
GOMF_DIPEPTIDASE_ACTIVITY,SET,17,-0.29418,-0.0089475,0.20788,0.92148,GOMF_DIPEPTIDASE_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...7,SET,28,-0.225,-0.0087798,0.15898,0.92149,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
GOBP_ASTROCYTE_DIFFERENTIATI...,SET,79,-0.14466,-0.0094688,0.10221,0.9215,GOBP_ASTROCYTE_DIFFERENTIATION,1
GSE11864_UNTREATED_VS_CSF1_I...3,SET,164,-0.091386,-0.0085984,0.064569,0.9215,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
GOCC_CILIARY_BASAL_BODY,SET,144,-0.099227,-0.0087532,0.070106,0.92151,GOCC_CILIARY_BASAL_BODY,1
GOMF_THREONINE_TYPE_PEPTIDAS...,SET,16,-0.30607,-0.0090313,0.21622,0.92154,GOMF_THREONINE_TYPE_PEPTIDASE_ACTIVITY,1
HP_NOCTURNAL_SEIZURES,SET,18,-0.31102,-0.0097338,0.21967,0.92158,HP_NOCTURNAL_SEIZURES,1
GSE22611_UNSTIM_VS_6H_MDP_ST...1,SET,174,-0.092602,-0.008972,0.065381,0.92165,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
GSE5589_WT_VS_IL6_KO_LPS_AND...6,SET,180,-0.092601,-0.0091238,0.065378,0.92166,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOBP_SKELETAL_MUSCLE_TISSUE_...2,SET,36,-0.21434,-0.0094819,0.15132,0.92167,GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION,1
REACTOME_LATE_ENDOSOMAL_MICR...,SET,32,-0.22109,-0.0092222,0.15603,0.92175,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,1
HOXA13_TARGET_GENES,SET,39,-0.18525,-0.0085288,0.13072,0.92176,HOXA13_TARGET_GENES,1
MIR4693_3P,SET,56,-0.15622,-0.0086148,0.11024,0.92177,MIR4693_3P,1
GOBP_NEGATIVE_REGULATION_OF_...475,SET,14,-0.35496,-0.0097982,0.25046,0.92179,GOBP_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
MIR1295B_5P,SET,69,-0.14119,-0.0086392,0.099611,0.92181,MIR1295B_5P,1
HP_ABNORMAL_CHORIORETINAL_MO...,SET,135,-0.10422,-0.0089039,0.073526,0.92182,HP_ABNORMAL_CHORIORETINAL_MORPHOLOGY,1
KIM_BIPOLAR_DISORDER_OLIGODE...2,SET,597,-0.048059,-0.0085241,0.033903,0.92183,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,1
HALLMARK_SPERMATOGENESIS,SET,126,-0.11004,-0.0090846,0.077625,0.92184,HALLMARK_SPERMATOGENESIS,1
MIR454_3P,SET,386,-0.062381,-0.0089494,0.043992,0.92189,MIR454_3P,1
HP_FIRST_DORSAL_INTEROSSEI_M...,SET,7,-0.47483,-0.0092697,0.3348,0.92193,HP_FIRST_DORSAL_INTEROSSEI_MUSCLE_WEAKNESS,1
REACTOME_NCAM_SIGNALING_FOR_...,SET,62,-0.15842,-0.0091904,0.11168,0.92197,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1
GSE46242_TH1_VS_ANERGIC_TH1_...3,SET,169,-0.093023,-0.0088836,0.065574,0.92198,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN,1
GOBP_MYCOTOXIN_METABOLIC_PRO...,SET,7,-0.46813,-0.0091389,0.32984,0.92208,GOBP_MYCOTOXIN_METABOLIC_PROCESS,1
REACTOME_REGULATION_OF_TBK1_...2,SET,10,-0.44764,-0.010444,0.31539,0.92209,REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION,1
GOMF_CXCR_CHEMOKINE_RECEPTOR...,SET,17,-0.3512,-0.010682,0.24738,0.92215,GOMF_CXCR_CHEMOKINE_RECEPTOR_BINDING,1
LET_7I_5P,SET,362,-0.065812,-0.0091495,0.046353,0.92216,LET_7I_5P,1
GOBP_POSITIVE_REGULATION_OF_...443,SET,12,-0.35962,-0.0091908,0.25324,0.9222,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,1
TGAATGT_MIR181A_MIR181B_MIR1...,SET,449,-0.060506,-0.0093457,0.042602,0.92222,TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D,1
YIH_RESPONSE_TO_ARSENITE_C3,SET,26,-0.2467,-0.0092771,0.1737,0.92223,YIH_RESPONSE_TO_ARSENITE_C3,1
GOMF_LAMININ_BINDING,SET,27,-0.23524,-0.0090143,0.1656,0.92226,GOMF_LAMININ_BINDING,1
GOBP_ASSOCIATIVE_LEARNING,SET,82,-0.14138,-0.0094276,0.099527,0.92227,GOBP_ASSOCIATIVE_LEARNING,1
HP_PSEUDOBULBAR_SIGNS,SET,28,-0.22644,-0.0088361,0.15938,0.9223,HP_PSEUDOBULBAR_SIGNS,1
WP_MALE_INFERTILITY,SET,132,-0.1056,-0.0089218,0.074323,0.92231,WP_MALE_INFERTILITY,1
GOMF_LAMIN_BINDING,SET,16,-0.31665,-0.0093437,0.22285,0.92232,GOMF_LAMIN_BINDING,1
GSE2826_WT_VS_BTK_KO_BCELL_UP,SET,181,-0.087568,-0.0086516,0.061601,0.92241,GSE2826_WT_VS_BTK_KO_BCELL_UP,1
REACTOME_NPAS4_REGULATES_EXP...,SET,20,-0.29866,-0.0098517,0.21007,0.92244,REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES,1
MURATA_VIRULENCE_OF_H_PILORI,SET,20,-0.28884,-0.0095279,0.20315,0.92245,MURATA_VIRULENCE_OF_H_PILORI,1
GOBP_LAYER_FORMATION_IN_CERE...,SET,13,-0.37969,-0.0101,0.26697,0.92251,GOBP_LAYER_FORMATION_IN_CEREBRAL_CORTEX,1
WP_NEOVASCULARIZATION_PROCES...,SET,36,-0.2294,-0.010148,0.16129,0.92252,WP_NEOVASCULARIZATION_PROCESSES,1
GOBP_GAMMA_DELTA_T_CELL_ACTI...,SET,23,-0.24994,-0.0088406,0.17566,0.9226,GOBP_GAMMA_DELTA_T_CELL_ACTIVATION,1
MIR302E,SET,444,-0.058529,-0.0089911,0.041128,0.92264,MIR302E,1
MODULE_219,SET,21,-0.26566,-0.0089796,0.18666,0.92266,MODULE_219,1
LET_7B_5P,SET,362,-0.065944,-0.0091679,0.046322,0.92271,LET_7B_5P,1
GOBP_POSITIVE_REGULATION_OF_...801,SET,10,-0.40495,-0.009448,0.28437,0.92277,GOBP_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
GSE2706_R848_VS_LPS_8H_STIM_...1,SET,158,-0.10242,-0.0094604,0.071919,0.92279,GSE2706_R848_VS_LPS_8H_STIM_DC_DN,1
MYOGENIN_Q6,SET,245,-0.078793,-0.009041,0.055316,0.92283,MYOGENIN_Q6,1
ATM_TARGET_GENES,SET,11,-0.40211,-0.0098395,0.28227,0.92285,ATM_TARGET_GENES,1
CHESLER_BRAIN_D6MIT150_QTL_T...,SET,9,-0.43258,-0.0095752,0.30365,0.92286,CHESLER_BRAIN_D6MIT150_QTL_TRANS,1
GOMF_STEROID_HYDROXYLASE_ACT...,SET,26,-0.26853,-0.010098,0.18849,0.92286,GOMF_STEROID_HYDROXYLASE_ACTIVITY,1
BIOCARTA_MITR_PATHWAY,SET,5,-0.59259,-0.0097778,0.4159,0.92289,BIOCARTA_MITR_PATHWAY,1
BIOCARTA_NFKB_PATHWAY,SET,20,-0.28391,-0.0093653,0.19925,0.92289,BIOCARTA_NFKB_PATHWAY,1
MIR4790_3P,SET,77,-0.13842,-0.0089456,0.097143,0.92291,MIR4790_3P,1
MIR126_5P,SET,405,-0.062165,-0.0091305,0.043608,0.92299,MIR126_5P,1
MIR3975,SET,46,-0.17922,-0.0089595,0.12571,0.923,MIR3975,1
GCM_NCAM1,SET,115,-0.11153,-0.0087988,0.078228,0.92301,GCM_NCAM1,1
GOCC_RIBONUCLEASE_MRP_COMPLEX,SET,8,-0.39167,-0.0081739,0.27472,0.92301,GOCC_RIBONUCLEASE_MRP_COMPLEX,1
GOBP_REGULATION_OF_MONOOXYGE...,SET,32,-0.21612,-0.0090148,0.15154,0.92308,GOBP_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
GOBP_PHOTOPERIODISM,SET,26,-0.23361,-0.0087848,0.16379,0.92309,GOBP_PHOTOPERIODISM,1
GOBP_EPITHELIAL_CELL_PROLIFE...3,SET,10,-0.41707,-0.0097308,0.29239,0.92312,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,1
SNAPC4_TARGET_GENES,SET,60,-0.15606,-0.0089065,0.10938,0.92315,SNAPC4_TARGET_GENES,1
HP_HYPERAUTOFLUORESCENT_RETI...,SET,14,-0.36622,-0.010109,0.25668,0.92316,HP_HYPERAUTOFLUORESCENT_RETINAL_LESION,1
GOBP_RESPONSE_TO_OXIDATIVE_S...,SET,356,-0.066078,-0.0091116,0.046312,0.92317,GOBP_RESPONSE_TO_OXIDATIVE_STRESS,1
GSE9988_LPS_VS_LOW_LPS_MONOC...1,SET,147,-0.10139,-0.0090363,0.071022,0.92329,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN,1
GOBP_REGULATION_OF_BRANCHING...5,SET,5,-0.61807,-0.010198,0.4329,0.92331,GOBP_REGULATION_OF_BRANCHING_MORPHOGENESIS_OF_A_NERVE,1
GOBP_REGULATION_OF_THYMOCYTE...,SET,13,-0.33622,-0.0089433,0.23547,0.92333,GOBP_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,1
MIR182_5P,SET,506,-0.055951,-0.0091596,0.039183,0.92334,MIR182_5P,1
GOMF_PHOSPHOFRUCTOKINASE_ACT...,SET,6,-0.3775,-0.0068231,0.26425,0.92343,GOMF_PHOSPHOFRUCTOKINASE_ACTIVITY,1
GOBP_CITRULLINE_METABOLIC_PR...,SET,7,-0.45846,-0.0089501,0.32088,0.92345,GOBP_CITRULLINE_METABOLIC_PROCESS,1
MIR2116_5P,SET,133,-0.10305,-0.0087386,0.072103,0.92351,MIR2116_5P,1
HP_PAROXYSMAL_INVOLUNTARY_EY...,SET,30,-0.20306,-0.0082014,0.14209,0.92351,HP_PAROXYSMAL_INVOLUNTARY_EYE_MOVEMENTS,1
GSE9988_ANTI_TREM1_VS_LPS_MO...1,SET,176,-0.097352,-0.0094858,0.068108,0.92354,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN,1
GOBP_AORTA_SMOOTH_MUSCLE_TIS...,SET,4,-0.62175,-0.0091762,0.43488,0.92359,GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS,1
GOBP_L_AMINO_ACID_CATABOLIC_...,SET,60,-0.15954,-0.0091051,0.11159,0.92359,GOBP_L_AMINO_ACID_CATABOLIC_PROCESS,1
GSE37301_LYMPHOID_PRIMED_MPP...9,SET,170,-0.094445,-0.0090458,0.066047,0.92363,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN,1
ZNF8_TARGET_GENES,SET,785,-0.044352,-0.0089727,0.031013,0.92365,ZNF8_TARGET_GENES,1
GOBP_REGULATION_OF_BLOOD_CIR...,SET,240,-0.085946,-0.0097619,0.060096,0.92365,GOBP_REGULATION_OF_BLOOD_CIRCULATION,1
MODULE_42,SET,24,-0.20196,-0.0072969,0.1412,0.92368,MODULE_42,1
VOIGT_PBMC_FLUARIX_AGE_50_74...,SET,18,-0.3079,-0.0096359,0.2152,0.92374,VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP,1
MIR331_5P,SET,66,-0.14613,-0.0087457,0.10213,0.92376,MIR331_5P,1
GOBP_MODIFICATION_OF_POSTSYN...2,SET,21,-0.25433,-0.0085964,0.1777,0.92381,GOBP_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,1
GSE41087_WT_VS_FOXP3_MUT_ANT...2,SET,166,-0.094668,-0.0089608,0.066141,0.92382,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,1
GOBP_B_CELL_CHEMOTAXIS,SET,8,-0.44552,-0.0092979,0.31118,0.92388,GOBP_B_CELL_CHEMOTAXIS,1
HP_BLOODY_DIARRHEA,SET,45,-0.18531,-0.0091628,0.12942,0.9239,HP_BLOODY_DIARRHEA,1
HP_IMPAIRED_COLLAGEN_INDUCED...,SET,16,-0.28479,-0.0084034,0.1989,0.9239,HP_IMPAIRED_COLLAGEN_INDUCED_PLATELET_AGGREGATION,1
MIR3940_5P,SET,33,-0.19674,-0.0083332,0.13739,0.92391,MIR3940_5P,1
HP_DELAYED_ERUPTION_OF_TEETH,SET,153,-0.1024,-0.0093086,0.071503,0.92393,HP_DELAYED_ERUPTION_OF_TEETH,1
MIR4802_3P,SET,153,-0.10824,-0.0098395,0.07557,0.92396,MIR4802_3P,1
MODULE_430,SET,52,-0.16485,-0.0087608,0.1151,0.92396,MODULE_430,1
GOBP_AMINE_TRANSPORT,SET,90,-0.14202,-0.009919,0.099146,0.92398,GOBP_AMINE_TRANSPORT,1
MIR4752,SET,74,-0.14309,-0.0090657,0.099852,0.92406,MIR4752,1
MIR887_5P,SET,92,-0.12944,-0.0091396,0.090315,0.92409,MIR887_5P,1
HP_ABNORMAL_CURVATURE_OF_THE...,SET,1027,-0.038595,-0.0088692,0.026925,0.92413,HP_ABNORMAL_CURVATURE_OF_THE_VERTEBRAL_COLUMN,1
GOBP_PROTEIN_HEXAMERIZATION,SET,8,-0.40872,-0.0085297,0.28509,0.92415,GOBP_PROTEIN_HEXAMERIZATION,1
HP_CHILDHOOD_ONSET_TRUNCAL_O...,SET,30,-0.22295,-0.0090047,0.15551,0.92415,HP_CHILDHOOD_ONSET_TRUNCAL_OBESITY,1
GOBP_LEUKOTRIENE_D4_METABOLI...,SET,7,-0.46723,-0.0091214,0.32589,0.92416,GOBP_LEUKOTRIENE_D4_METABOLIC_PROCESS,1
GNF2_CD33,SET,43,-0.19222,-0.0092915,0.13404,0.9242,GNF2_CD33,1
GSE5542_UNTREATED_VS_IFNA_TR...2,SET,186,-0.089927,-0.0090053,0.062687,0.92428,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,1
GAVISH_3CA_METAPROGRAM_ENDOT...14,SET,46,-0.20571,-0.010284,0.14339,0.92429,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING,1
BORCZUK_MALIGNANT_MESOTHELIO...1,SET,86,-0.12901,-0.008809,0.089881,0.9244,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,1
GSE25890_CTRL_VS_IL33_IL7_TR...2,SET,179,-0.090327,-0.0088753,0.062929,0.9244,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP,1
HIF1_Q3,SET,211,-0.085834,-0.0091486,0.059796,0.92441,HIF1_Q3,1
HP_GLUCAGONOMA,SET,6,-0.50282,-0.0090883,0.35014,0.9245,HP_GLUCAGONOMA,1
HP_PULMONARY_INTERSTITIAL_TH...,SET,7,-0.52307,-0.010212,0.36421,0.92451,HP_PULMONARY_INTERSTITIAL_THICKENING,1
REACTOME_SUMO_IS_TRANSFERRED...,SET,7,-0.40448,-0.0078965,0.28155,0.92458,REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9,1
MIR4448,SET,61,-0.15874,-0.0091349,0.1105,0.92458,MIR4448,1
KEGG_MTOR_SIGNALING_PATHWAY,SET,49,-0.18695,-0.0096451,0.13012,0.92459,KEGG_MTOR_SIGNALING_PATHWAY,1
REACTOME_UCH_PROTEINASES,SET,80,-0.12729,-0.008384,0.088596,0.9246,REACTOME_UCH_PROTEINASES,1
REACTOME_REGULATION_OF_RUNX3...,SET,52,-0.15272,-0.0081162,0.10629,0.92461,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1
HP_RECURRENT_VIRAL_INFECTIONS,SET,54,-0.16828,-0.009113,0.11706,0.92471,HP_RECURRENT_VIRAL_INFECTIONS,1
GOBP_INTRACELLULAR_CORTICOST...,SET,12,-0.37683,-0.0096307,0.26212,0.92472,GOBP_INTRACELLULAR_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY,1
HP_POLYMICROGYRIA,SET,179,-0.090318,-0.0088744,0.062818,0.92474,HP_POLYMICROGYRIA,1
GOBP_MUSCLE_ATROPHY,SET,11,-0.36313,-0.0088857,0.25255,0.92475,GOBP_MUSCLE_ATROPHY,1
HP_INCOMPREHENSIBLE_SPEECH,SET,8,-0.39712,-0.0082878,0.27611,0.92481,HP_INCOMPREHENSIBLE_SPEECH,1
NABA_MATRISOME_MULTIPLE_MYEL...,SET,9,-0.46462,-0.010284,0.32295,0.92487,NABA_MATRISOME_MULTIPLE_MYELOMA,1
MIR4748,SET,61,-0.15282,-0.0087939,0.10621,0.92489,MIR4748,1
GSE14000_UNSTIM_VS_16H_LPS_D...4,SET,169,-0.091239,-0.0087132,0.063413,0.92489,GSE14000_UNSTIM_VS_16H_LPS_DC_UP,1
MODULE_77,SET,27,-0.20038,-0.0076786,0.13926,0.9249,MODULE_77,1
GRAESSMANN_APOPTOSIS_BY_DOXO...2,SET,1054,-0.039064,-0.0090871,0.027145,0.92493,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...3,SET,16,-0.33168,-0.009787,0.23048,0.92493,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP,1
KAECH_NAIVE_VS_DAY15_EFF_CD8...2,SET,177,-0.090401,-0.0088332,0.062811,0.92495,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP,1
REACTOME_CONDENSATION_OF_PRO...2,SET,11,-0.31039,-0.0075951,0.2156,0.925,REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,1
GSE9650_GP33_VS_GP276_LCMV_S...2,SET,179,-0.092716,-0.00911,0.064404,0.925,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP,1
MIR584_3P,SET,96,-0.12682,-0.0091464,0.088086,0.92502,MIR584_3P,1
HP_INCREASED_DENSITY_OF_LONG...,SET,11,-0.41442,-0.010141,0.28784,0.92502,HP_INCREASED_DENSITY_OF_LONG_BONES,1
WP_PKCGAMMA_CALCIUM_SIGNALIN...,SET,21,-0.28853,-0.0097524,0.20039,0.92503,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,1
chr18q22,SET,23,-0.4334,-0.01533,0.30096,0.92506,chr18q22,1
VALK_AML_CLUSTER_5,SET,28,-0.2265,-0.0088386,0.15729,0.92506,VALK_AML_CLUSTER_5,1
GOBP_CALCIUM_IMPORT_INTO_THE...,SET,14,-0.34176,-0.0094336,0.23732,0.92506,GOBP_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,1
REACTOME_TFAP2A_ACTS_AS_A_TR...,SET,5,-0.57181,-0.0094349,0.39706,0.92507,REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_ERK_R...,SET,4,-0.66886,-0.0098715,0.46441,0.92509,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING,1
HP_DYSTROPHIC_TOENAIL,SET,19,-0.29274,-0.0094125,0.20326,0.92509,HP_DYSTROPHIC_TOENAIL,1
HE_LIM_SUN_FETAL_LUNG_C7_FGF...,SET,45,-0.18811,-0.0093013,0.13056,0.92517,HE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL,1
GSE45365_BCELL_VS_CD8_TCELL_...2,SET,149,-0.10486,-0.0094082,0.072772,0.92519,GSE45365_BCELL_VS_CD8_TCELL_UP,1
GSE37416_0H_VS_48H_F_TULAREN...1,SET,168,-0.090909,-0.0086562,0.063079,0.92523,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
HP_ABNORMAL_CIRCULATING_LYSI...,SET,5,-0.67436,-0.011127,0.46789,0.92524,HP_ABNORMAL_CIRCULATING_LYSINE_CONCENTRATION,1
GOBP_REGULATION_OF_RECEPTOR_...4,SET,61,-0.16105,-0.0092674,0.11172,0.92526,GOBP_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
WP_EXRNA_MECHANISM_OF_ACTION...,SET,6,-0.50173,-0.0090685,0.34802,0.92529,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,1
GOMF_VASCULAR_ENDOTHELIAL_GR...1,SET,4,-0.77355,-0.011417,0.53654,0.9253,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_BINDING,1
E2A_Q2,SET,220,-0.082399,-0.0089656,0.057142,0.92534,E2A_Q2,1
HP_MACULAR_ATROPHY,SET,39,-0.20186,-0.0092937,0.13998,0.92535,HP_MACULAR_ATROPHY,1
GSE36392_TYPE_2_MYELOID_VS_M...2,SET,183,-0.097056,-0.0096413,0.067291,0.92539,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP,1
GSE9988_LPS_VS_CTRL_TREATED_...2,SET,163,-0.10295,-0.009657,0.071369,0.92541,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,1
chr3p24,SET,30,-0.39336,-0.015888,0.27262,0.92546,chr3p24,1
GOBP_POSITIVE_REGULATION_OF_...32,SET,8,-0.51698,-0.010789,0.35829,0.92547,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOBP_PYRIMIDINE_NUCLEOBASE_C...,SET,8,-0.44868,-0.0093638,0.31091,0.9255,GOBP_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_L...9,SET,12,-0.36046,-0.0092123,0.24975,0.92552,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
GOMF_CYCLOHYDROLASE_ACTIVITY,SET,5,-0.55894,-0.0092227,0.3872,0.92556,GOMF_CYCLOHYDROLASE_ACTIVITY,1
MIR934,SET,73,-0.14802,-0.0093148,0.10253,0.92557,MIR934,1
GSE45365_WT_VS_IFNAR_KO_CD11...4,SET,161,-0.093992,-0.0087631,0.065106,0.92558,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP,1
MYOD_Q6_01,SET,237,-0.080857,-0.0091272,0.055989,0.92565,MYOD_Q6_01,1
GSE27786_LSK_VS_NKTCELL_UP,SET,174,-0.090881,-0.0088053,0.062901,0.92574,GSE27786_LSK_VS_NKTCELL_UP,1
GSE3982_BCELL_VS_NKCELL_UP,SET,177,-0.090583,-0.008851,0.062649,0.92589,GSE3982_BCELL_VS_NKCELL_UP,1
REACTOME_TRP_CHANNELS,SET,27,-0.26495,-0.010153,0.18323,0.92591,REACTOME_TRP_CHANNELS,1
HP_SPASTIC_PARAPLEGIA,SET,95,-0.12702,-0.0091132,0.087822,0.92595,HP_SPASTIC_PARAPLEGIA,1
MIR6827_5P,SET,75,-0.1352,-0.0086236,0.093468,0.92597,MIR6827_5P,1
HP_APLASIA_HYPOPLASIA_OF_THE...23,SET,6,-0.58884,-0.010643,0.40703,0.92599,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...101,SET,21,-0.26204,-0.0088572,0.1811,0.92603,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE,1
MIR203B_3P,SET,88,-0.13722,-0.0094774,0.094836,0.92604,MIR203B_3P,1
CASTELLANO_HRAS_TARGETS_DN,SET,4,-0.58358,-0.0086129,0.40329,0.92605,CASTELLANO_HRAS_TARGETS_DN,1
HP_HYPOVENTILATION,SET,46,-0.17412,-0.0087044,0.12032,0.92605,HP_HYPOVENTILATION,1
GOBP_NEGATIVE_REGULATION_OF_...641,SET,11,-0.38781,-0.0094897,0.2679,0.92613,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING,1
GOBP_TRNA_5_END_PROCESSING,SET,13,-0.29762,-0.0079166,0.20549,0.92623,GOBP_TRNA_5_END_PROCESSING,1
GCM_GSTA4,SET,57,-0.15906,-0.0088491,0.10982,0.92624,GCM_GSTA4,1
HP_PYODERMA,SET,4,-0.73794,-0.010891,0.50946,0.92625,HP_PYODERMA,1
HP_HEMIPLEGIA_HEMIPARESIS,SET,192,-0.089903,-0.0091455,0.062064,0.92626,HP_HEMIPLEGIA_HEMIPARESIS,1
MIR197_5P,SET,57,-0.16085,-0.0089486,0.11104,0.92628,MIR197_5P,1
MODULE_470,SET,15,-0.3681,-0.010517,0.25409,0.92629,MODULE_470,1
HP_THORACIC_KYPHOSIS,SET,43,-0.17215,-0.0083215,0.11883,0.92629,HP_THORACIC_KYPHOSIS,1
MARTINEZ_RESPONSE_TO_TRABECT...2,SET,254,-0.073323,-0.0085643,0.050598,0.92634,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1
GOBP_INTERLEUKIN_1_ALPHA_PRO...,SET,8,-0.53211,-0.011105,0.36709,0.9264,GOBP_INTERLEUKIN_1_ALPHA_PRODUCTION,1
HP_ABNORMAL_FEMORAL_NECK_HEA...,SET,180,-0.092717,-0.0091352,0.063959,0.92641,HP_ABNORMAL_FEMORAL_NECK_HEAD_MORPHOLOGY,1
GOBP_REGULATION_OF_MACROPHAG...6,SET,5,-0.585,-0.0096526,0.4035,0.92643,GOBP_REGULATION_OF_MACROPHAGE_FUSION,1
HESS_TARGETS_OF_HOXA9_AND_ME...1,SET,79,-0.1465,-0.0095891,0.10104,0.92644,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,1
MIR4464,SET,62,-0.15076,-0.0087458,0.10393,0.92653,MIR4464,1
GOBP_FATTY_ACID_DERIVATIVE_M...,SET,68,-0.15487,-0.0094077,0.10677,0.92653,GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...379,SET,952,-0.042446,-0.0094116,0.029264,0.92653,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
HP_HYPEREXTENSIBILITY_OF_THE...2,SET,38,-0.19648,-0.0089296,0.13542,0.92659,HP_HYPEREXTENSIBILITY_OF_THE_KNEE,1
GSE4748_CTRL_VS_CYANOBACTERI...2,SET,181,-0.089532,-0.0088456,0.061704,0.9266,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP,1
MIR4746_5P,SET,8,-0.39146,-0.0081695,0.26978,0.92661,MIR4746_5P,1
MORI_IMMATURE_B_LYMPHOCYTE_UP,SET,46,-0.19039,-0.0095177,0.13118,0.92664,MORI_IMMATURE_B_LYMPHOCYTE_UP,1
HP_ABNORMAL_UTERINE_CERVIX_M...,SET,11,-0.43917,-0.010746,0.30258,0.92666,HP_ABNORMAL_UTERINE_CERVIX_MORPHOLOGY,1
GOCC_ASTROCYTE_PROJECTION,SET,21,-0.2969,-0.010036,0.20455,0.92667,GOCC_ASTROCYTE_PROJECTION,1
HP_IRIS_COLOBOMA,SET,150,-0.099462,-0.0089533,0.068524,0.92667,HP_IRIS_COLOBOMA,1
GOBP_RADIAL_GLIAL_CELL_DIFFE...,SET,14,-0.36829,-0.010166,0.25371,0.92669,GOBP_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
GOBP_NUCLEOBASE_TRANSPORT,SET,12,-0.35736,-0.0091331,0.24617,0.9267,GOBP_NUCLEOBASE_TRANSPORT,1
GOMF_OXALATE_TRANSMEMBRANE_T...,SET,9,-0.40676,-0.0090037,0.28014,0.92674,GOMF_OXALATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...2,SET,98,-0.13631,-0.0099325,0.093876,0.92675,HE_LIM_SUN_FETAL_LUNG_C1_LATE_BASAL_CELL,1
SCHERER_PBMC_YF_VAX_AGE_18_4...1,SET,221,-0.081063,-0.00884,0.055821,0.92677,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,1
MIR6750_3P,SET,62,-0.16674,-0.009673,0.1148,0.9268,MIR6750_3P,1
SP1_Q4_01,SET,231,-0.080798,-0.0090057,0.05561,0.92687,SP1_Q4_01,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...5,SET,10,-0.4588,-0.010705,0.31578,0.92687,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_DN,1
REACTOME_FORMATION_OF_SENESC...,SET,11,-0.32867,-0.0080425,0.22616,0.92691,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,1
GOCC_ORGANELLE_INNER_MEMBRANE,SET,466,-0.055014,-0.0086527,0.037852,0.92693,GOCC_ORGANELLE_INNER_MEMBRANE,1
HP_CHILBLAINS,SET,10,-0.35378,-0.0082542,0.2434,0.92694,HP_CHILBLAINS,1
GOCC_POSTSYNAPTIC_ENDOCYTIC_...,SET,5,-0.62054,-0.010239,0.42685,0.92698,GOCC_POSTSYNAPTIC_ENDOCYTIC_ZONE,1
HAY_BONE_MARROW_STROMAL,SET,669,-0.053798,-0.01008,0.037004,0.92699,HAY_BONE_MARROW_STROMAL,1
MIR6762_3P,SET,115,-0.11153,-0.0087992,0.076701,0.92703,MIR6762_3P,1
GOBP_NEGATIVE_REGULATION_OF_...271,SET,5,-0.57703,-0.0095211,0.39683,0.92703,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
MIR3196,SET,19,-0.29715,-0.009554,0.2043,0.92708,MIR3196,1
GSE5679_CTRL_VS_PPARG_LIGAND...3,SET,181,-0.090974,-0.0089882,0.062549,0.92708,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN,1
GOBP_REGULATION_OF_LYMPHOCYT...6,SET,63,-0.16288,-0.0095246,0.11198,0.92709,GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
HP_ABNORMAL_NASAL_BRIDGE_MOR...,SET,882,-0.042528,-0.0090947,0.029237,0.9271,HP_ABNORMAL_NASAL_BRIDGE_MORPHOLOGY,1
REACTOME_SODIUM_PROTON_EXCHA...,SET,7,-0.47016,-0.0091785,0.32314,0.92715,REACTOME_SODIUM_PROTON_EXCHANGERS,1
WP_MELANOMA,SET,66,-0.14935,-0.0089383,0.10263,0.92718,WP_MELANOMA,1
REACTOME_REGULATION_OF_BACH1...,SET,10,-0.39908,-0.0093112,0.27423,0.92719,REACTOME_REGULATION_OF_BACH1_ACTIVITY,1
REACTOME_SIGNALING_BY_NTRK3_...,SET,17,-0.27032,-0.0082217,0.18575,0.92719,REACTOME_SIGNALING_BY_NTRK3_TRKC,1
HP_DUMBBELL_SHAPED_LONG_BONE,SET,7,-0.43621,-0.0085157,0.29974,0.92719,HP_DUMBBELL_SHAPED_LONG_BONE,1
chr15q23,SET,33,-0.35354,-0.014975,0.2429,0.92722,chr15q23,1
YAMANAKA_GLIOBLASTOMA_SURVIV...2,SET,9,-0.46712,-0.01034,0.32092,0.92724,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,1
HP_MEGALOCORNEA,SET,42,-0.2083,-0.0099511,0.14307,0.92729,HP_MEGALOCORNEA,1
HP_SPLENIC_RUPTURE,SET,4,-0.83215,-0.012281,0.57153,0.9273,HP_SPLENIC_RUPTURE,1
MIR3152_3P,SET,76,-0.14618,-0.0093852,0.10038,0.92732,MIR3152_3P,1
LINDGREN_BLADDER_CANCER_WITH...,SET,103,-0.12758,-0.0095288,0.087603,0.92734,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1
HP_ABNORMAL_RENAL_TUBULE_MOR...,SET,74,-0.14346,-0.0090896,0.098511,0.92734,HP_ABNORMAL_RENAL_TUBULE_MORPHOLOGY,1
ZHONG_PFC_C3_HOPX_POS_OPC,SET,7,-0.47156,-0.0092058,0.32377,0.92735,ZHONG_PFC_C3_HOPX_POS_OPC,1
GSE36888_UNTREATED_VS_IL2_TR...4,SET,182,-0.093659,-0.0092786,0.064307,0.92736,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP,1
GOCC_PROTEASOME_ACCESSORY_CO...,SET,23,-0.23136,-0.0081835,0.15884,0.92737,GOCC_PROTEASOME_ACCESSORY_COMPLEX,1
HP_DEGENERATION_OF_THE_STRIA...,SET,11,-0.3495,-0.0085522,0.23993,0.92739,HP_DEGENERATION_OF_THE_STRIATUM,1
GOBP_POSITIVE_REGULATION_OF_...86,SET,72,-0.15368,-0.0096048,0.10549,0.9274,GOBP_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
REACTOME_SCF_BETA_TRCP_MEDIA...,SET,52,-0.15188,-0.0080714,0.10425,0.92742,REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,1
GSE32128_INOS_DEPENDENT_VS_I...1,SET,181,-0.089882,-0.0088803,0.06169,0.92743,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN,1
DESCARTES_FETAL_STOMACH_NEUR...,SET,40,-0.21226,-0.0098965,0.14568,0.92744,DESCARTES_FETAL_STOMACH_NEUROENDOCRINE_CELLS,1
GOCC_APOLIPOPROTEIN_B_MRNA_E...,SET,4,-0.6492,-0.0095813,0.44552,0.92746,GOCC_APOLIPOPROTEIN_B_MRNA_EDITING_ENZYME_COMPLEX,1
GOBP_REGULATION_OF_PROTEIN_L...14,SET,102,-0.12102,-0.008995,0.083035,0.92749,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
HP_ABNORMAL_BLOOD_GAS_LEVEL,SET,44,-0.1969,-0.0096275,0.13509,0.92751,HP_ABNORMAL_BLOOD_GAS_LEVEL,1
GSE11961_PLASMA_CELL_DAY7_VS...2,SET,179,-0.093123,-0.0091499,0.063814,0.92775,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOMF_CUPRIC_ION_BINDING,SET,5,-0.56553,-0.0093313,0.3874,0.92782,GOMF_CUPRIC_ION_BINDING,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...2,SET,7,-0.46423,-0.0090627,0.31798,0.92784,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION,1
GOBP_HISTAMINE_TRANSPORT,SET,15,-0.32201,-0.0092003,0.22057,0.92784,GOBP_HISTAMINE_TRANSPORT,1
HP_ABNORMALITY_OF_CORNEAL_SI...,SET,145,-0.106,-0.0093829,0.072592,0.92788,HP_ABNORMALITY_OF_CORNEAL_SIZE,1
GOBP_NEGATIVE_REGULATION_OF_...583,SET,152,-0.10682,-0.0096791,0.073146,0.9279,GOBP_NEGATIVE_REGULATION_OF_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...653,SET,108,-0.12365,-0.0094552,0.084632,0.92798,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
GOMF_MOLECULAR_ADAPTOR_ACTIV...,SET,1031,-0.039155,-0.0090142,0.026795,0.92802,GOMF_MOLECULAR_ADAPTOR_ACTIVITY,1
HP_HIGH_FOREHEAD,SET,261,-0.076624,-0.0090707,0.052433,0.92803,HP_HIGH_FOREHEAD,1
KEGG_PRION_DISEASES,SET,33,-0.2318,-0.0098185,0.15862,0.92804,KEGG_PRION_DISEASES,1
GSE9006_HEALTHY_VS_TYPE_2_DI...2,SET,176,-0.087471,-0.008523,0.059852,0.92805,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
GUTIERREZ_WALDENSTROEMS_MACR...3,SET,10,-0.38551,-0.0089947,0.26376,0.92807,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,1
KEGG_HISTIDINE_METABOLISM,SET,26,-0.23872,-0.008977,0.16331,0.92808,KEGG_HISTIDINE_METABOLISM,1
GSE45837_WT_VS_GFI1_KO_PDC_UP,SET,164,-0.095078,-0.0089458,0.065045,0.92808,GSE45837_WT_VS_GFI1_KO_PDC_UP,1
GSE14000_UNSTIM_VS_4H_LPS_DC...3,SET,180,-0.090182,-0.0088855,0.061665,0.92818,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP,1
SCHOEN_NFKB_SIGNALING,SET,32,-0.26042,-0.010863,0.17804,0.92821,SCHOEN_NFKB_SIGNALING,1
HP_HYPOINTENSITY_OF_CEREBRAL...,SET,12,-0.35744,-0.0091351,0.24435,0.92823,HP_HYPOINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,1
GOBP_SIGNAL_TRANSDUCTION_IN_...1,SET,66,-0.1577,-0.009438,0.10775,0.92833,GOBP_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
GOBP_FOCAL_ADHESION_ASSEMBLY,SET,82,-0.13857,-0.00924,0.094676,0.92835,GOBP_FOCAL_ADHESION_ASSEMBLY,1
HP_POLYNEUROPATHY,SET,45,-0.19308,-0.009547,0.1319,0.92837,HP_POLYNEUROPATHY,1
GSE24142_EARLY_THYMIC_PROGEN...12,SET,185,-0.095634,-0.0095513,0.065316,0.92842,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP,1
GOBP_AMINO_SUGAR_BIOSYNTHETI...,SET,11,-0.37571,-0.0091935,0.25655,0.92846,GOBP_AMINO_SUGAR_BIOSYNTHETIC_PROCESS,1
MIR25_3P,SET,379,-0.06639,-0.0094397,0.045329,0.92848,MIR25_3P,1
GSE14908_ATOPIC_VS_NONATOPIC...4,SET,176,-0.092979,-0.0090597,0.063478,0.9285,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP,1
HP_UNEXPLAINED_FEVERS,SET,18,-0.29101,-0.0091076,0.19865,0.92852,HP_UNEXPLAINED_FEVERS,1
HP_ABSENT_INNER_DYNEIN_ARMS,SET,7,-0.43256,-0.0084446,0.29526,0.92853,HP_ABSENT_INNER_DYNEIN_ARMS,1
GSE36078_WT_VS_IL1R_KO_LUNG_...5,SET,176,-0.091605,-0.0089258,0.062513,0.92858,GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN,1
TRAVAGLINI_LUNG_CILIATED_CELL,SET,954,-0.040857,-0.009068,0.027881,0.92858,TRAVAGLINI_LUNG_CILIATED_CELL,1
MIR6765_5P,SET,7,-0.46135,-0.0090067,0.31483,0.92859,MIR6765_5P,1
MIR3529_3P,SET,493,-0.058268,-0.009419,0.039745,0.92867,MIR3529_3P,1
FOXD2_TARGET_GENES,SET,993,-0.039819,-0.0090064,0.027146,0.92878,FOXD2_TARGET_GENES,1
ZNF592_TARGET_GENES,SET,1471,-0.033992,-0.0092281,0.023173,0.92878,ZNF592_TARGET_GENES,1
GSE9650_NAIVE_VS_MEMORY_CD8_...2,SET,184,-0.09315,-0.0092783,0.063486,0.92884,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
MIKKELSEN_ES_HCP_WITH_H3_UNM...,SET,55,-0.18228,-0.0099619,0.12423,0.92885,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,1
HP_OPISTHOTONUS,SET,47,-0.18028,-0.0091094,0.12281,0.92892,HP_OPISTHOTONUS,1
HP_NOCTURNAL_HYPOVENTILATION,SET,15,-0.28945,-0.0082699,0.19717,0.92894,HP_NOCTURNAL_HYPOVENTILATION,1
BIOCARTA_RECK_PATHWAY,SET,8,-0.4559,-0.0095145,0.31051,0.92897,BIOCARTA_RECK_PATHWAY,1
HP_ABNORMALITY_OF_THE_MIDDLE...1,SET,543,-0.055178,-0.0093478,0.037582,0.92897,HP_ABNORMALITY_OF_THE_MIDDLE_EAR,1
GOBP_HYPOTHALAMUS_GONADOTROP...,SET,6,-0.61543,-0.011124,0.4189,0.9291,GOBP_HYPOTHALAMUS_GONADOTROPHIN_RELEASING_HORMONE_NEURON_DIFFERENTIATION,1
WP_SLEEP_REGULATION,SET,38,-0.23266,-0.010574,0.15833,0.92915,WP_SLEEP_REGULATION,1
MIR6836_3P,SET,53,-0.17499,-0.0093885,0.11908,0.92915,MIR6836_3P,1
HP_ABNORMAL_CARDIAC_VENTRICL...,SET,599,-0.051398,-0.009131,0.034975,0.92915,HP_ABNORMAL_CARDIAC_VENTRICLE_MORPHOLOGY,1
GSE32034_UNTREATED_VS_ROSIGL...1,SET,177,-0.092125,-0.0090017,0.062683,0.92917,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN,1
REACTOME_SYNTHESIS_OF_DIPHTH...,SET,8,-0.39964,-0.0083402,0.27168,0.92934,REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2,1
HP_DEVELOPMENTAL_STAGNATION,SET,16,-0.33425,-0.009863,0.22723,0.92934,HP_DEVELOPMENTAL_STAGNATION,1
GOBP_TRANSLATIONAL_READTHROU...,SET,8,-0.48056,-0.010029,0.32664,0.92938,GOBP_TRANSLATIONAL_READTHROUGH,1
HP_BICONCAVE_VERTEBRAL_BODIES,SET,21,-0.26873,-0.0090834,0.18266,0.92938,HP_BICONCAVE_VERTEBRAL_BODIES,1
GSE22886_IGM_MEMORY_BCELL_VS...3,SET,178,-0.094653,-0.0092746,0.064329,0.9294,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,1
GOBP_VESTIBULOCOCHLEAR_NERVE...2,SET,5,-0.68988,-0.011383,0.46873,0.92946,GOBP_VESTIBULOCOCHLEAR_NERVE_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...6,SET,13,-0.35315,-0.0093938,0.23991,0.92948,GOBP_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION,1
HP_ABNORMALITY_OF_THE_PARATH...,SET,68,-0.16284,-0.0098916,0.11062,0.92949,HP_ABNORMALITY_OF_THE_PARATHYROID_GLAND,1
HP_ABNORMAL_ADIPOSE_TISSUE_M...,SET,214,-0.086648,-0.0093001,0.058862,0.92949,HP_ABNORMAL_ADIPOSE_TISSUE_MORPHOLOGY,1
GOMF_CALCIUM_SODIUM_ANTIPORT...,SET,10,-0.45017,-0.010503,0.30577,0.92952,GOMF_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY,1
MIR374B_3P,SET,128,-0.11553,-0.0096127,0.07846,0.92954,MIR374B_3P,1
HP_RECURRENT_FEVER,SET,85,-0.13803,-0.0093701,0.093735,0.92956,HP_RECURRENT_FEVER,1
MANN_RESPONSE_TO_AMIFOSTINE_...1,SET,9,-0.3575,-0.0079132,0.24275,0.92957,MANN_RESPONSE_TO_AMIFOSTINE_DN,1
HP_ELEVATED_SYSTOLIC_BLOOD_P...,SET,13,-0.35458,-0.0094318,0.24072,0.92961,HP_ELEVATED_SYSTOLIC_BLOOD_PRESSURE,1
MIR4468,SET,107,-0.12303,-0.0093648,0.083518,0.92963,MIR4468,1
LBP1_Q6,SET,211,-0.088798,-0.0094645,0.060272,0.92965,LBP1_Q6,1
GOCC_CLATHRIN_COATED_ENDOCYT...1,SET,84,-0.14875,-0.010038,0.10095,0.92967,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE,1
GSE43955_TGFB_IL6_VS_TGFB_IL...3,SET,180,-0.094924,-0.0093527,0.06442,0.92969,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,1
HP_FOAM_CELLS,SET,11,-0.42529,-0.010407,0.28858,0.92971,HP_FOAM_CELLS,1
MIR5579_3P,SET,140,-0.10776,-0.0093743,0.073118,0.92973,MIR5579_3P,1
GOMF_HEAT_SHOCK_PROTEIN_BIND...,SET,119,-0.11489,-0.0092197,0.077936,0.92978,GOMF_HEAT_SHOCK_PROTEIN_BINDING,1
GOBP_TELENCEPHALON_GLIAL_CEL...,SET,25,-0.2765,-0.010196,0.18753,0.92981,GOBP_TELENCEPHALON_GLIAL_CELL_MIGRATION,1
GOBP_ESTABLISHMENT_OF_EPITHE...1,SET,16,-0.31042,-0.0091598,0.21051,0.92983,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY,1
GSE23925_LIGHT_ZONE_VS_NAIVE...1,SET,174,-0.092119,-0.0089252,0.062472,0.92983,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN,1
GSE43863_NAIVE_VS_TFH_CD4_EF...2,SET,173,-0.093851,-0.0090672,0.063636,0.92986,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP,1
BIDUS_METASTASIS_UP,SET,186,-0.088502,-0.0088626,0.059997,0.9299,BIDUS_METASTASIS_UP,1
HP_NEOPLASM_OF_THE_THYMUS,SET,7,-0.47058,-0.0091867,0.31898,0.92992,HP_NEOPLASM_OF_THE_THYMUS,1
HP_HYPOMETHIONINEMIA,SET,8,-0.44686,-0.0093258,0.30287,0.92994,HP_HYPOMETHIONINEMIA,1
GAVISH_3CA_METAPROGRAM_CD8_T...5,SET,48,-0.17097,-0.0087306,0.11588,0.92995,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_GLYCOLYSIS_MYC,1
REACTOME_REGULATION_OF_MITF_...3,SET,15,-0.32035,-0.0091529,0.2171,0.92996,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_LYSOSOME_BIOGENESIS_AND_AUTOPHAGY,1
HP_SEA_BLUE_HISTIOCYTOSIS,SET,4,-0.81104,-0.01197,0.54956,0.92999,HP_SEA_BLUE_HISTIOCYTOSIS,1
FOURATI_BLOOD_TWINRIX_AGE_65...2,SET,5,-0.56444,-0.0093134,0.38242,0.93001,FOURATI_BLOOD_TWINRIX_AGE_65_81YO_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_DN,1
REACTOME_PEPTIDE_HORMONE_BIO...,SET,13,-0.37718,-0.010033,0.25554,0.93002,REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS,1
MIR140_3P,SET,129,-0.11075,-0.009251,0.074993,0.93013,MIR140_3P,1
MIR452_3P,SET,118,-0.12458,-0.009955,0.084353,0.93013,MIR452_3P,1
DESCARTES_FETAL_HEART_SATB2_...,SET,84,-0.15935,-0.010754,0.10786,0.9302,DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS,1
GSE15930_STIM_VS_STIM_AND_IL...4,SET,186,-0.088863,-0.0088987,0.060147,0.93021,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP,1
WP_NF1_COPY_NUMBER_VARIATION...,SET,74,-0.15414,-0.0097662,0.10432,0.93023,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,1
chr16q23,SET,51,-0.29334,-0.015439,0.19851,0.93025,chr16q23,1
HP_ABNORMAL_ELECTROPHYSIOLOG...,SET,78,-0.14566,-0.0094741,0.098572,0.93025,HP_ABNORMAL_ELECTROPHYSIOLOGY_OF_SINOATRIAL_NODE_ORIGIN,1
WP_AMPLIFICATION_AND_EXPANSI...,SET,17,-0.33879,-0.010304,0.22925,0.93026,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,1
GOMF_N6_METHYLADENOSINE_CONT...,SET,11,-0.40238,-0.0098462,0.27228,0.93026,GOMF_N6_METHYLADENOSINE_CONTAINING_RNA_READER_ACTIVITY,1
GOMF_RAGE_RECEPTOR_BINDING,SET,10,-0.43824,-0.010225,0.29655,0.93026,GOMF_RAGE_RECEPTOR_BINDING,1
GOBP_RESPONSE_TO_FUNGUS,SET,54,-0.18294,-0.0099068,0.12377,0.93029,GOBP_RESPONSE_TO_FUNGUS,1
AMIT_EGF_RESPONSE_20_HELA,SET,10,-0.41447,-0.0096703,0.28037,0.93033,AMIT_EGF_RESPONSE_20_HELA,1
FOXO4_TARGET_GENES,SET,293,-0.07098,-0.0088949,0.048008,0.93036,FOXO4_TARGET_GENES,1
GOBP_DEHYDROASCORBIC_ACID_TR...,SET,7,-0.45487,-0.00888,0.30765,0.93036,GOBP_DEHYDROASCORBIC_ACID_TRANSPORT,1
GSE19825_NAIVE_VS_IL2RAHIGH_...1,SET,179,-0.091156,-0.0089567,0.06164,0.9304,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...18,SET,69,-0.14764,-0.009034,0.09983,0.93041,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,1
GOBP_ETHER_METABOLIC_PROCESS,SET,24,-0.27076,-0.0097829,0.18306,0.93043,GOBP_ETHER_METABOLIC_PROCESS,1
HADDAD_T_LYMPHOCYTE_AND_NK_P...2,SET,73,-0.16051,-0.010101,0.1085,0.93046,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,1
GOBP_NEGATIVE_REGULATION_OF_...157,SET,55,-0.1732,-0.0094652,0.11708,0.93046,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GOBP_PROTEIN_HETEROTETRAMERI...,SET,15,-0.28778,-0.0082223,0.19453,0.93047,GOBP_PROTEIN_HETEROTETRAMERIZATION,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...3,SET,104,-0.12256,-0.0091984,0.082826,0.93053,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...13,SET,4,-0.68831,-0.010159,0.4651,0.93055,KEGG_MEDICUS_REFERENCE_REGULATION_OF_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY_NLRP3_INHIBITION,1
GOBP_GLIAL_CELL_DIFFERENTIAT...,SET,247,-0.084726,-0.0097609,0.05724,0.93058,GOBP_GLIAL_CELL_DIFFERENTIATION,1
MIR12121,SET,27,-0.26287,-0.010073,0.17756,0.93061,MIR12121,1
HP_WIDE_NASAL_BRIDGE,SET,433,-0.062105,-0.0094243,0.041947,0.93063,HP_WIDE_NASAL_BRIDGE,1
DAWSON_METHYLATED_IN_LYMPHOM...,SET,55,-0.20024,-0.010943,0.13523,0.93065,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,1
MIR500A_5P,SET,140,-0.10769,-0.0093675,0.07272,0.93066,MIR500A_5P,1
GOBP_ATRIAL_CARDIAC_MUSCLE_C...2,SET,16,-0.35155,-0.010373,0.23739,0.93067,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION,1
GSE2706_LPS_VS_R848_AND_LPS_...3,SET,159,-0.105,-0.0097292,0.070904,0.93068,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN,1
GSE2770_UNTREATED_VS_IL4_TRE...4,SET,188,-0.091465,-0.009208,0.061754,0.9307,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...4,SET,13,-0.33842,-0.0090019,0.22843,0.93075,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY,1
GSE28726_NAIVE_CD4_TCELL_VS_...2,SET,188,-0.08954,-0.0090141,0.060437,0.93076,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP,1
MIR6798_3P,SET,34,-0.2111,-0.0090759,0.14247,0.93078,MIR6798_3P,1
HP_MASTOIDITIS,SET,7,-0.48484,-0.0094652,0.32721,0.93079,HP_MASTOIDITIS,1
GOMF_INSULIN_RECEPTOR_BINDING,SET,21,-0.29899,-0.010106,0.20176,0.93081,GOMF_INSULIN_RECEPTOR_BINDING,1
GOBP_ANGIOTENSIN_ACTIVATED_S...,SET,17,-0.33664,-0.010239,0.22715,0.93082,GOBP_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY,1
GOMF_MHC_CLASS_II_PROTEIN_CO...,SET,23,-0.29094,-0.010291,0.19629,0.93085,GOMF_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING,1
GSE17721_CTRL_VS_CPG_4H_BMDC...1,SET,179,-0.093377,-0.009175,0.062997,0.93085,GSE17721_CTRL_VS_CPG_4H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...575,SET,6,-0.49993,-0.0090361,0.33725,0.93087,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,1
GSE17721_CPG_VS_GARDIQUIMOD_...1,SET,186,-0.093191,-0.0093322,0.062857,0.9309,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...20,SET,5,-0.50459,-0.0083258,0.34019,0.93099,HP_APLASIA_HYPOPLASIA_OF_THE_DIAPHRAGM,1
DORN_ADENOVIRUS_INFECTION_32...2,SET,9,-0.41912,-0.0092772,0.28243,0.93109,DORN_ADENOVIRUS_INFECTION_32HR_UP,1
MIR8081,SET,50,-0.17411,-0.0090736,0.11727,0.93117,MIR8081,1
GSE5589_WT_VS_IL6_KO_LPS_STI...3,SET,182,-0.096556,-0.0095657,0.065032,0.93119,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN,1
LEE_INTRATHYMIC_T_PROGENITOR,SET,17,-0.32393,-0.0098523,0.21814,0.93121,LEE_INTRATHYMIC_T_PROGENITOR,1
MIR4500,SET,465,-0.061324,-0.009635,0.041285,0.93127,MIR4500,1
WP_SEROTONIN_AND_ANXIETY,SET,15,-0.37864,-0.010818,0.25486,0.93131,WP_SEROTONIN_AND_ANXIETY,1
MIR92B_3P,SET,431,-0.062988,-0.0095367,0.042397,0.93131,MIR92B_3P,1
GAVISH_3CA_METAPROGRAM_MACRO...6,SET,43,-0.21094,-0.010196,0.14198,0.93131,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...2,SET,6,-0.54748,-0.0098956,0.36843,0.93135,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,1
APRELIKOVA_BRCA1_TARGETS,SET,42,-0.19037,-0.0090945,0.12809,0.93138,APRELIKOVA_BRCA1_TARGETS,1
GOMF_EUKARYOTIC_TRANSLATION_...,SET,6,-0.51204,-0.0092549,0.34453,0.93138,GOMF_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2ALPHA_KINASE_ACTIVITY,1
GOBP_AEROBIC_RESPIRATION,SET,147,-0.095791,-0.008537,0.064444,0.93141,GOBP_AEROBIC_RESPIRATION,1
WP_MOLYBDENUM_COFACTOR_MOCO_...,SET,6,-0.5516,-0.00997,0.37107,0.93142,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...274,SET,7,-0.4206,-0.008211,0.28291,0.93144,GOBP_NEGATIVE_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
BIOCARTA_CREM_PATHWAY,SET,6,-0.60661,-0.010964,0.40802,0.93145,BIOCARTA_CREM_PATHWAY,1
HP_DEFECTIVE_T_CELL_PROLIFER...,SET,7,-0.43557,-0.0085033,0.29292,0.93148,HP_DEFECTIVE_T_CELL_PROLIFERATION,1
MEL18_DN.V1_UP,SET,133,-0.11868,-0.010064,0.079809,0.93148,MEL18_DN.V1_UP,1
CAGNYGKNAAA_UNKNOWN,SET,70,-0.15633,-0.0096343,0.10513,0.93149,CAGNYGKNAAA_UNKNOWN,1
GOBP_LATERAL_MESODERM_MORPHO...,SET,5,-0.60961,-0.010059,0.40989,0.93152,GOBP_LATERAL_MESODERM_MORPHOGENESIS,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...1,SET,108,-0.11775,-0.0090047,0.079176,0.93152,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS,1
HP_DILATATION_OF_THE_VENTRIC...,SET,9,-0.41548,-0.0091967,0.27934,0.93153,HP_DILATATION_OF_THE_VENTRICULAR_CAVITY,1
HP_FOOT_ACROOSTEOLYSIS,SET,7,-0.4911,-0.0095873,0.33019,0.93153,HP_FOOT_ACROOSTEOLYSIS,1
MIR323A_3P,SET,206,-0.089837,-0.0094624,0.060391,0.93156,MIR323A_3P,1
GSE11961_GERMINAL_CENTER_BCE...3,SET,184,-0.098139,-0.0097752,0.065959,0.9316,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,1
GOBP_POSITIVE_REGULATION_OF_...74,SET,20,-0.2678,-0.0088338,0.17997,0.93162,GOBP_POSITIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,1
GOBP_VOLUNTARY_MUSCULOSKELET...,SET,7,-0.44049,-0.0085994,0.29601,0.93163,GOBP_VOLUNTARY_MUSCULOSKELETAL_MOVEMENT,1
WP_COMPLEMENTMEDIATED_INFLAM...,SET,10,-0.42402,-0.009893,0.28489,0.93166,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,1
REACTOME_RRNA_PROCESSING_IN_...,SET,6,-0.53823,-0.0097282,0.36159,0.93168,REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION,1
GOBP_OTIC_VESICLE_MORPHOGENE...,SET,10,-0.37477,-0.0087439,0.25176,0.93169,GOBP_OTIC_VESICLE_MORPHOGENESIS,1
KEGG_MEDICUS_PATHOGEN_ARSENI...,SET,6,-0.44875,-0.008111,0.30144,0.93171,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,1
HP_FOCAL_NON_MOTOR_SEIZURE,SET,37,-0.21259,-0.0095339,0.14276,0.93176,HP_FOCAL_NON_MOTOR_SEIZURE,1
HP_JOINT_STIFFNESS,SET,177,-0.096345,-0.0094141,0.064702,0.93176,HP_JOINT_STIFFNESS,1
MIR5582_3P,SET,601,-0.053717,-0.0095584,0.036057,0.93185,MIR5582_3P,1
MIR19A_3P,SET,592,-0.054774,-0.0096758,0.036765,0.93186,MIR19A_3P,1
HP_3_4_FINGER_SYNDACTYLY,SET,10,-0.4457,-0.010399,0.29901,0.93196,HP_3_4_FINGER_SYNDACTYLY,1
HP_ERYTHROID_DYSPLASIA,SET,4,-0.66371,-0.0097955,0.44518,0.93199,HP_ERYTHROID_DYSPLASIA,1
WP_DUAL_HIJACK_MODEL_OF_VIF_...,SET,5,-0.5273,-0.0087006,0.35366,0.93201,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,1
MIR4677_3P,SET,120,-0.11779,-0.0094918,0.078984,0.93205,MIR4677_3P,1
GSE17580_UNINFECTED_VS_S_MAN...3,SET,175,-0.096011,-0.0093287,0.064377,0.93206,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN,1
HP_CLINODACTYLY,SET,492,-0.057467,-0.0092805,0.038513,0.93216,HP_CLINODACTYLY,1
YOSHIMURA_MAPK8_TARGETS_DN,SET,350,-0.069111,-0.0094507,0.04631,0.93219,YOSHIMURA_MAPK8_TARGETS_DN,1
GOBP_REGULATION_OF_SHORT_TER...,SET,14,-0.35397,-0.0097707,0.23714,0.93223,GOBP_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
GOMF_CENTROMERIC_DNA_BINDING,SET,6,-0.47637,-0.0086102,0.31914,0.93223,GOMF_CENTROMERIC_DNA_BINDING,1
LI_CYTIDINE_ANALOGS_CYCTOTOX...,SET,14,-0.3243,-0.0089517,0.21723,0.93225,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,1
MIR7113_3P,SET,83,-0.13406,-0.008993,0.089798,0.93226,MIR7113_3P,1
GOBP_REGULATION_OF_LEUKOCYTE...7,SET,226,-0.090938,-0.010027,0.060913,0.93226,GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
MIR622,SET,74,-0.14888,-0.0094329,0.099723,0.93227,MIR622,1
GOBP_REGULATION_OF_HIGH_VOLT...,SET,8,-0.51151,-0.010675,0.34259,0.93228,GOBP_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
MIR3177_5P,SET,146,-0.1051,-0.009335,0.070375,0.93233,MIR3177_5P,1
GSE13411_NAIVE_VS_SWITCHED_M...1,SET,178,-0.092649,-0.0090782,0.062031,0.93235,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN,1
GOBP_SYNOVIOCYTE_PROLIFERATI...,SET,2,-0.86036,-0.0089791,0.57583,0.93242,GOBP_SYNOVIOCYTE_PROLIFERATION,1
HP_NEOPLASM_OF_THE_SMALL_INT...,SET,18,-0.28853,-0.0090299,0.19307,0.93246,HP_NEOPLASM_OF_THE_SMALL_INTESTINE,1
GOBP_PROTEIN_POLYGLUTAMYLATI...,SET,11,-0.41916,-0.010257,0.28038,0.93253,GOBP_PROTEIN_POLYGLUTAMYLATION,1
MIR585_5P,SET,119,-0.12109,-0.009717,0.080991,0.93255,MIR585_5P,1
GOBP_SPHINGOMYELIN_BIOSYNTHE...,SET,11,-0.36608,-0.0089578,0.24484,0.93256,GOBP_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS,1
HP_HORIZONTAL_EYEBROW,SET,32,-0.22543,-0.0094029,0.15076,0.93257,HP_HORIZONTAL_EYEBROW,1
GOBP_REGULATION_OF_PROTEIN_K...3,SET,18,-0.32154,-0.010063,0.215,0.9326,GOBP_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,1
GOBP_REGULATION_OF_T_CELL_MI...,SET,44,-0.2001,-0.0097839,0.13377,0.93264,GOBP_REGULATION_OF_T_CELL_MIGRATION,1
GOCC_CLATHRIN_SCULPTED_VESIC...,SET,12,-0.40924,-0.010459,0.27356,0.93266,GOCC_CLATHRIN_SCULPTED_VESICLE,1
HP_PROLONGED_BLEEDING_TIME,SET,46,-0.19257,-0.0096267,0.12869,0.93271,HP_PROLONGED_BLEEDING_TIME,1
GOBP_CORTICOSTEROID_HORMONE_...,SET,18,-0.31899,-0.0099829,0.21316,0.93273,GOBP_CORTICOSTEROID_HORMONE_SECRETION,1
WP_NANOPARTICLE_TRIGGERED_RE...,SET,12,-0.40455,-0.010339,0.27027,0.93277,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,1
GOMF_INSULIN_LIKE_GROWTH_FAC...3,SET,13,-0.40834,-0.010862,0.27281,0.93277,GOMF_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING,1
GOMF_CARBOHYDRATE_KINASE_ACT...,SET,20,-0.25711,-0.0084814,0.17176,0.93278,GOMF_CARBOHYDRATE_KINASE_ACTIVITY,1
GOMF_TYPE_5_METABOTROPIC_GLU...,SET,6,-0.55326,-0.01,0.36948,0.93285,GOMF_TYPE_5_METABOTROPIC_GLUTAMATE_RECEPTOR_BINDING,1
GSE15659_RESTING_VS_ACTIVATE...2,SET,153,-0.10539,-0.009581,0.070381,0.93286,GSE15659_RESTING_VS_ACTIVATED_TREG_UP,1
WP_BMP_SIGNALING_IN_EYELID_D...,SET,19,-0.34635,-0.011136,0.23126,0.93289,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,1
HP_GENERALIZED_EDEMA,SET,24,-0.2482,-0.0089678,0.16571,0.9329,HP_GENERALIZED_EDEMA,1
HP_BASILAR_IMPRESSION,SET,5,-0.63205,-0.010429,0.42193,0.93292,HP_BASILAR_IMPRESSION,1
HP_ANTERIOR_SUBCAPSULAR_CATA...,SET,6,-0.57207,-0.01034,0.38186,0.93294,HP_ANTERIOR_SUBCAPSULAR_CATARACT,1
HP_ABNORMAL_PYRAMIDAL_TRACT_...,SET,61,-0.16657,-0.0095854,0.11116,0.93298,HP_ABNORMAL_PYRAMIDAL_TRACT_MORPHOLOGY,1
HP_PERIPHERAL_ARTERIOVENOUS_...,SET,7,-0.47775,-0.0093267,0.31882,0.93299,HP_PERIPHERAL_ARTERIOVENOUS_FISTULA,1
HP_BOWING_OF_THE_LEGS,SET,217,-0.08965,-0.0096886,0.059814,0.93303,HP_BOWING_OF_THE_LEGS,1
KEGG_MEDICUS_REFERENCE_HGF_M...2,SET,14,-0.33478,-0.0092412,0.22332,0.93307,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_1_4_ALPHA_OLIGOGLUCAN_P...,SET,5,-0.46127,-0.0076111,0.30761,0.93313,GOMF_1_4_ALPHA_OLIGOGLUCAN_PHOSPHORYLASE_ACTIVITY,1
MIR3194_3P,SET,90,-0.13052,-0.0091159,0.08701,0.93319,MIR3194_3P,1
HP_ABNORMAL_AORTIC_MORPHOLOGY,SET,350,-0.068507,-0.0093682,0.045663,0.93322,HP_ABNORMAL_AORTIC_MORPHOLOGY,1
HP_ABNORMAL_MIDDLE_EAR_MORPH...,SET,322,-0.074923,-0.0098348,0.049924,0.93328,HP_ABNORMAL_MIDDLE_EAR_MORPHOLOGY,1
HP_INTRAUTERINE_GROWTH_RETAR...,SET,547,-0.054083,-0.0091949,0.036033,0.9333,HP_INTRAUTERINE_GROWTH_RETARDATION,1
GOBP_MESENCHYMAL_CELL_DEVELO...,SET,6,-0.61477,-0.011112,0.40957,0.93332,GOBP_MESENCHYMAL_CELL_DEVELOPMENT,1
HP_ECLABION,SET,147,-0.10938,-0.0097476,0.072857,0.93334,HP_ECLABION,1
KEGG_MEDICUS_REFERENCE_METHI...,SET,10,-0.45144,-0.010533,0.30066,0.93338,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION,1
VERRECCHIA_RESPONSE_TO_TGFB1...2,SET,19,-0.33263,-0.010695,0.22148,0.93342,VERRECCHIA_RESPONSE_TO_TGFB1_C2,1
GOMF_PROTEIN_RNA_ADAPTOR_ACT...,SET,18,-0.31222,-0.0097711,0.20787,0.93344,GOMF_PROTEIN_RNA_ADAPTOR_ACTIVITY,1
WU_ALZHEIMER_DISEASE_UP,SET,9,-0.43482,-0.0096248,0.28947,0.93346,WU_ALZHEIMER_DISEASE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...613,SET,9,-0.44245,-0.0097937,0.29452,0.93348,GOBP_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT,1
HP_EASY_FATIGABILITY,SET,85,-0.12881,-0.0087438,0.085734,0.93349,HP_EASY_FATIGABILITY,1
GSE1791_CTRL_VS_NEUROMEDINU_...7,SET,175,-0.093678,-0.009102,0.062349,0.9335,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN,1
GOBP_REGULATION_OF_NEURONAL_...2,SET,52,-0.17838,-0.0094795,0.1187,0.93354,GOBP_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY,1
GSE40666_UNTREATED_VS_IFNA_S...6,SET,153,-0.10396,-0.0094506,0.069157,0.93361,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,1
GOBP_REGULATION_OF_SKELETAL_...7,SET,4,-0.66601,-0.0098294,0.44293,0.93365,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION,1
GSE42724_MEMORY_VS_B1_BCELL_...1,SET,168,-0.10086,-0.0096039,0.067072,0.93367,GSE42724_MEMORY_VS_B1_BCELL_DN,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...7,SET,423,-0.061664,-0.0092513,0.040999,0.93371,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,1
ZNF711_TARGET_GENES,SET,1382,-0.03557,-0.0093845,0.023648,0.93372,ZNF711_TARGET_GENES,1
REACTOME_SPHINGOLIPID_DE_NOV...,SET,36,-0.21222,-0.0093879,0.14108,0.93374,REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,1
GOBP_POSITIVE_REGULATION_OF_...813,SET,18,-0.31849,-0.0099676,0.21161,0.93384,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
GOBP_TYPE_B_PANCREATIC_CELL_...1,SET,10,-0.46298,-0.010802,0.30761,0.93384,GOBP_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,1
HP_RETINAL_PIGMENT_EPITHELIA...2,SET,39,-0.20439,-0.0094101,0.13579,0.93386,HP_RETINAL_PIGMENT_EPITHELIAL_MOTTLING,1
GOBP_PROTEIN_K11_LINKED_UBIQ...,SET,31,-0.21467,-0.0088134,0.1426,0.93387,GOBP_PROTEIN_K11_LINKED_UBIQUITINATION,1
GOBP_POSITIVE_REGULATION_OF_...428,SET,4,-0.64914,-0.0095805,0.43118,0.93389,GOBP_POSITIVE_REGULATION_OF_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,1
GOCC_MICROTUBULE_ASSOCIATED_...,SET,139,-0.1022,-0.0088584,0.067884,0.93389,GOCC_MICROTUBULE_ASSOCIATED_COMPLEX,1
MODULE_514,SET,10,-0.37895,-0.0088414,0.2517,0.9339,MODULE_514,1
GSE1112_OT1_VS_HY_CD8AB_THYM...1,SET,177,-0.092419,-0.0090305,0.061366,0.93396,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN,1
GSE19888_ADENOSINE_A3R_INH_P...4,SET,186,-0.097532,-0.0097669,0.064752,0.93399,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
GSE4748_CYANOBACTERIUM_LPSLI...1,SET,159,-0.1055,-0.009775,0.070035,0.934,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
GOBP_PEPTIDYL_METHIONINE_MOD...,SET,11,-0.34631,-0.0084741,0.22986,0.93403,GOBP_PEPTIDYL_METHIONINE_MODIFICATION,1
HP_LEFT_TO_RIGHT_SHUNT,SET,10,-0.44736,-0.010438,0.29693,0.93403,HP_LEFT_TO_RIGHT_SHUNT,1
MIR499A_5P,SET,160,-0.10313,-0.0095853,0.068442,0.93406,MIR499A_5P,1
MODULE_121,SET,94,-0.15057,-0.010746,0.099922,0.93407,MODULE_121,1
KEGG_VALINE_LEUCINE_AND_ISOL...2,SET,42,-0.19445,-0.0092895,0.12904,0.93408,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,1
GOBP_NEGATIVE_REGULATION_OF_...580,SET,5,-0.58183,-0.0096002,0.38608,0.93409,GOBP_NEGATIVE_REGULATION_OF_SATELLITE_CELL_DIFFERENTIATION,1
LU_AGING_BRAIN_DN,SET,139,-0.11017,-0.0095499,0.073098,0.93411,LU_AGING_BRAIN_DN,1
MIR92A_3P,SET,434,-0.063576,-0.0096585,0.042178,0.93413,MIR92A_3P,1
GSE24634_IL4_VS_CTRL_TREATED...7,SET,176,-0.10071,-0.0098127,0.066801,0.93416,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN,1
HP_GONADOTROPIN_DEFICIENCY,SET,8,-0.51169,-0.010679,0.3394,0.93417,HP_GONADOTROPIN_DEFICIENCY,1
HP_PRURITUS,SET,140,-0.11109,-0.0096636,0.073678,0.93418,HP_PRURITUS,1
SABATES_COLORECTAL_ADENOMA_DN,SET,260,-0.086373,-0.010205,0.057279,0.9342,SABATES_COLORECTAL_ADENOMA_DN,1
MODULE_357,SET,72,-0.16075,-0.010047,0.1066,0.93421,MODULE_357,1
GSE20715_WT_VS_TLR4_KO_48H_O...1,SET,176,-0.092768,-0.0090391,0.061512,0.93423,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN,1
GAVISH_3CA_METAPROGRAM_CD8_T...3,SET,43,-0.22146,-0.010705,0.14677,0.93433,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CYTOTOXIC,1
GSE3565_DUSP1_VS_WT_SPLENOCY...4,SET,148,-0.11435,-0.010225,0.075784,0.93433,GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP,1
HP_NARROW_NASAL_RIDGE,SET,19,-0.28933,-0.0093028,0.19174,0.93434,HP_NARROW_NASAL_RIDGE,1
GSE1460_NAIVE_CD4_TCELL_CORD...1,SET,173,-0.09737,-0.0094072,0.064526,0.93434,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN,1
GOBP_CORNIFIED_ENVELOPE_ASSE...,SET,6,-0.50432,-0.0091154,0.3342,0.93435,GOBP_CORNIFIED_ENVELOPE_ASSEMBLY,1
GOBP_MEMBRANE_PROTEIN_INTRAC...,SET,12,-0.33112,-0.0084624,0.21936,0.9344,GOBP_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS,1
HP_URINARY_URGENCY,SET,43,-0.19348,-0.0093525,0.12815,0.93444,HP_URINARY_URGENCY,1
UNTERMAN_IPF_VS_CTRL_NK_CELL...1,SET,8,-0.50462,-0.010531,0.33418,0.93447,UNTERMAN_IPF_VS_CTRL_NK_CELL_DN,1
GLI1_UP.V1_UP,SET,21,-0.28106,-0.0095,0.18613,0.93447,GLI1_UP.V1_UP,1
GOBP_PREASSEMBLY_OF_GPI_ANCH...,SET,7,-0.42633,-0.008323,0.28231,0.93449,GOBP_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE,1
REACTOME_REGULATION_OF_CYTOS...,SET,7,-0.46554,-0.0090883,0.30819,0.93454,REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS,1
TOMIDA_METASTASIS_UP,SET,23,-0.26633,-0.0094205,0.1763,0.93455,TOMIDA_METASTASIS_UP,1
GOBP_REGULATION_OF_PEPTIDYL_...5,SET,39,-0.21162,-0.0097428,0.14006,0.93458,GOBP_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
GGGATGC_MIR3245P,SET,42,-0.19433,-0.0092841,0.12861,0.93461,GGGATGC_MIR3245P,1
MORF_ERH,SET,97,-0.12359,-0.0089596,0.081785,0.93462,MORF_ERH,1
GOBP_NEURONAL_STEM_CELL_POPU...,SET,25,-0.24938,-0.009196,0.16499,0.93466,GOBP_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE,1
GR_Q6,SET,234,-0.08815,-0.009888,0.058317,0.93467,GR_Q6,1
GSE17721_CTRL_VS_POLYIC_4H_B...1,SET,183,-0.09479,-0.0094162,0.062702,0.93469,GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN,1
REACTOME_XENOBIOTICS,SET,23,-0.30892,-0.010927,0.20425,0.93478,REACTOME_XENOBIOTICS,1
KEGG_LYSOSOME,SET,113,-0.1204,-0.0094163,0.079593,0.93481,KEGG_LYSOSOME,1
GOBP_REGULATION_OF_PROTEIN_L...3,SET,128,-0.1114,-0.0092694,0.073634,0.93484,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
HP_ATROPHIC_SCARS,SET,33,-0.23077,-0.0097747,0.15253,0.93484,HP_ATROPHIC_SCARS,1
HP_ABNORMAL_CIRCULATING_CERU...,SET,10,-0.42646,-0.0099501,0.28182,0.93488,HP_ABNORMAL_CIRCULATING_CERULOPLASMIN_CONCENTRATION,1
GOBP_REGULATION_OF_T_CELL_ME...3,SET,94,-0.14842,-0.010593,0.098075,0.93489,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
HP_FOCAL_HEMICLONIC_SEIZURE,SET,23,-0.28857,-0.010207,0.19063,0.93494,HP_FOCAL_HEMICLONIC_SEIZURE,1
HP_WIDENED_SUBARACHNOID_SPACE,SET,28,-0.23387,-0.0091259,0.15449,0.93495,HP_WIDENED_SUBARACHNOID_SPACE,1
GSE21360_NAIVE_VS_PRIMARY_ME...2,SET,157,-0.10599,-0.0097593,0.069979,0.93506,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP,1
GOBP_RECEPTOR_LOCALIZATION_T...2,SET,56,-0.18245,-0.010061,0.12039,0.93517,GOBP_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
PID_LKB1_PATHWAY,SET,45,-0.2007,-0.0099239,0.13241,0.93519,PID_LKB1_PATHWAY,1
REACTOME_LAMININ_INTERACTIONS,SET,28,-0.25533,-0.0099636,0.16842,0.93523,REACTOME_LAMININ_INTERACTIONS,1
GOBP_CHEMICAL_SYNAPTIC_TRANS...,SET,104,-0.13272,-0.0099607,0.087539,0.93525,GOBP_CHEMICAL_SYNAPTIC_TRANSMISSION_POSTSYNAPTIC,1
MIR210_3P,SET,10,-0.4008,-0.0093514,0.26427,0.93531,MIR210_3P,1
REACTOME_EPITHELIAL_MESENCHY...,SET,6,-0.51057,-0.0092284,0.33659,0.93534,REACTOME_EPITHELIAL_MESENCHYMAL_TRANSITION_EMT_DURING_GASTRULATION,1
HP_FURROWED_TONGUE,SET,38,-0.18661,-0.008481,0.12302,0.93534,HP_FURROWED_TONGUE,1
HP_ABNORMALITY_OF_THE_CALF,SET,272,-0.080818,-0.0097637,0.053251,0.93544,HP_ABNORMALITY_OF_THE_CALF,1
REACTOME_DEFECTIVE_CFTR_CAUS...,SET,58,-0.15109,-0.0084784,0.099492,0.93556,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1
LET_7F_5P,SET,362,-0.070433,-0.009792,0.046355,0.93567,LET_7F_5P,1
GOCC_ER_MEMBRANE_INSERTION_C...,SET,12,-0.36758,-0.0093942,0.2419,0.93568,GOCC_ER_MEMBRANE_INSERTION_COMPLEX,1
HP_SEVERE_SHORT_STATURE,SET,96,-0.1339,-0.009657,0.088111,0.9357,HP_SEVERE_SHORT_STATURE,1
HP_VITRITIS,SET,2,-0.6715,-0.0070081,0.44183,0.93571,HP_VITRITIS,1
GOBP_NEGATIVE_REGULATION_OF_...48,SET,45,-0.2024,-0.010008,0.13312,0.93579,GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE,1
GSE28737_WT_VS_BCL6_HET_MARG...1,SET,179,-0.093404,-0.0091776,0.061421,0.93583,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN,1
GOMF_HIGH_VOLTAGE_GATED_CALC...,SET,13,-0.39303,-0.010455,0.25843,0.93584,GOMF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
HP_ABSENT_STERNAL_OSSIFICATI...,SET,5,-0.50793,-0.0083809,0.33398,0.93584,HP_ABSENT_STERNAL_OSSIFICATION,1
HP_ABNORMAL_COCCYX_MORPHOLOGY,SET,8,-0.5223,-0.0109,0.34336,0.93588,HP_ABNORMAL_COCCYX_MORPHOLOGY,1
HP_SWOLLEN_LIP,SET,6,-0.61371,-0.011093,0.40345,0.93588,HP_SWOLLEN_LIP,1
GOMF_DIHYDROPYRIMIDINASE_ACT...,SET,6,-0.55958,-0.010114,0.36765,0.93599,GOMF_DIHYDROPYRIMIDINASE_ACTIVITY,1
ASXL2_TARGET_GENES,SET,38,-0.21242,-0.009654,0.13956,0.936,ASXL2_TARGET_GENES,1
GOBP_ALPHA_BETA_T_CELL_DIFFE...,SET,118,-0.12693,-0.010143,0.083393,0.936,GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_FOREBRAIN_RADIAL_GLIAL_...,SET,7,-0.51572,-0.010068,0.33882,0.936,GOBP_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
GSE5542_UNTREATED_VS_IFNG_TR...2,SET,184,-0.097229,-0.0096846,0.063874,0.93601,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,1
GSE13485_PRE_VS_POST_YF17D_V...1,SET,179,-0.096915,-0.0095226,0.06366,0.93603,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN,1
GSE37301_MULTIPOTENT_PROGENI...8,SET,146,-0.10403,-0.0092396,0.068327,0.93605,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP,1
GSE2770_IL12_ACT_VS_ACT_CD4_...2,SET,167,-0.10277,-0.0097572,0.067492,0.93608,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP,1
HP_GYNECOMASTIA,SET,91,-0.13959,-0.0098034,0.091669,0.93609,HP_GYNECOMASTIA,1
REACTOME_MITOTIC_SPINDLE_CHE...,SET,104,-0.12124,-0.0090989,0.07961,0.9361,REACTOME_MITOTIC_SPINDLE_CHECKPOINT,1
GOBP_FAT_SOLUBLE_VITAMIN_BIO...,SET,13,-0.38208,-0.010163,0.25086,0.93612,GOBP_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,1
MIR7109_3P,SET,60,-0.16465,-0.0093968,0.10807,0.93617,MIR7109_3P,1
GOBP_NUCLEOBASE_METABOLIC_PR...,SET,36,-0.21316,-0.0094295,0.13992,0.93617,GOBP_NUCLEOBASE_METABOLIC_PROCESS,1
GSE22025_TGFB1_VS_TGFB1_AND_...2,SET,179,-0.098335,-0.0096621,0.064502,0.9363,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,1
GSE22886_NAIVE_TCELL_VS_NKCE...1,SET,181,-0.093428,-0.0092306,0.061285,0.9363,GSE22886_NAIVE_TCELL_VS_NKCELL_DN,1
GSE43955_1H_VS_60H_ACT_CD4_T...3,SET,185,-0.099743,-0.0099617,0.065385,0.93642,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
MIR4999_3P,SET,35,-0.21595,-0.0094199,0.14155,0.93644,MIR4999_3P,1
HP_CUPPED_EAR,SET,57,-0.16952,-0.009431,0.11104,0.93657,HP_CUPPED_EAR,1
GOBP_REGULATION_OF_NATURAL_K...3,SET,13,-0.37422,-0.0099544,0.24511,0.93658,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
GOBP_POSTSYNAPTIC_DENSITY_AS...,SET,24,-0.28373,-0.010252,0.18582,0.9366,GOBP_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
HP_SCARRING_ALOPECIA_OF_SCALP,SET,13,-0.37424,-0.0099549,0.24509,0.93661,HP_SCARRING_ALOPECIA_OF_SCALP,1
SILIGAN_BOUND_BY_EWS_FLT1_FU...,SET,43,-0.2119,-0.010243,0.13874,0.93665,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,1
REACTOME_TLR3_MEDIATED_TICAM...,SET,6,-0.59871,-0.010821,0.39189,0.9367,REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH,1
GOMF_MHC_CLASS_I_PROTEIN_COM...,SET,5,-0.52827,-0.0087166,0.34572,0.93674,GOMF_MHC_CLASS_I_PROTEIN_COMPLEX_BINDING,1
HP_ABNORMAL_SPINAL_CORD_MORP...,SET,274,-0.080472,-0.009757,0.05265,0.93679,HP_ABNORMAL_SPINAL_CORD_MORPHOLOGY,1
MIR2114_5P,SET,31,-0.23628,-0.0097008,0.15458,0.9368,MIR2114_5P,1
GOBP_ENDOPLASMIC_RETICULUM_C...,SET,23,-0.28035,-0.0099165,0.18341,0.9368,GOBP_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS,1
KEGG_FOLATE_BIOSYNTHESIS,SET,10,-0.40024,-0.0093382,0.2617,0.93691,KEGG_FOLATE_BIOSYNTHESIS,1
GOBP_REGULATION_OF_STEM_CELL...1,SET,80,-0.14507,-0.0095551,0.094843,0.93693,GOBP_REGULATION_OF_STEM_CELL_DIFFERENTIATION,1
GSE19888_CTRL_VS_TCELL_MEMBR...1,SET,184,-0.098431,-0.0098043,0.064351,0.93693,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN,1
GOBP_MITOCHONDRIAL_GENOME_MA...,SET,29,-0.22827,-0.0090651,0.14923,0.93694,GOBP_MITOCHONDRIAL_GENOME_MAINTENANCE,1
GOBP_REGULATION_OF_HEART_CON...,SET,190,-0.10274,-0.010397,0.067157,0.93696,GOBP_REGULATION_OF_HEART_CONTRACTION,1
GOBP_REGULATION_OF_TRANSCRIP...5,SET,29,-0.24393,-0.0096871,0.15946,0.93696,GOBP_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
DESCARTES_MAIN_FETAL_URETERI...,SET,27,-0.26579,-0.010185,0.17371,0.937,DESCARTES_MAIN_FETAL_URETERIC_BUD_CELLS,1
REACTOME_APC_CDC20_MEDIATED_...,SET,24,-0.2645,-0.0095569,0.17281,0.93706,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,1
HP_SINUS_TACHYCARDIA,SET,27,-0.23398,-0.0089662,0.15286,0.93707,HP_SINUS_TACHYCARDIA,1
REACTOME_ALPHA_DEFENSINS,SET,6,-0.63212,-0.011425,0.41291,0.93709,REACTOME_ALPHA_DEFENSINS,1
KEGG_PROTEASOME,SET,43,-0.17545,-0.0084808,0.1146,0.93711,KEGG_PROTEASOME,1
MIR455_5P,SET,82,-0.14586,-0.0097259,0.095269,0.93711,MIR455_5P,1
MORF_SKP1A,SET,179,-0.087658,-0.008613,0.057235,0.93717,MORF_SKP1A,1
HP_ABNORMALITY_OF_THE_DISTAL...4,SET,34,-0.22789,-0.0097976,0.14879,0.93718,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
ACTWSNACTNY_UNKNOWN,SET,96,-0.12343,-0.0089021,0.080582,0.9372,ACTWSNACTNY_UNKNOWN,1
GSE17301_CTRL_VS_48H_IFNA2_S...1,SET,163,-0.10028,-0.0094063,0.065464,0.9372,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN,1
REACTOME_PTEN_REGULATION,SET,130,-0.10831,-0.0090816,0.070699,0.93723,REACTOME_PTEN_REGULATION,1
GSE41978_ID2_KO_VS_BIM_KO_KL...1,SET,180,-0.098166,-0.0096721,0.064078,0.93723,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
HP_GLOMERULAR_DEPOSITS,SET,18,-0.29815,-0.009331,0.19456,0.93728,HP_GLOMERULAR_DEPOSITS,1
MIR6810_5P,SET,57,-0.17172,-0.0095531,0.11205,0.93729,MIR6810_5P,1
LINDGREN_BLADDER_CANCER_HIGH...,SET,47,-0.19736,-0.0099729,0.12878,0.9373,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,1
WEBER_METHYLATED_ICP_IN_FIBR...,SET,16,-0.35163,-0.010376,0.22944,0.9373,WEBER_METHYLATED_ICP_IN_FIBROBLAST,1
HP_CARDIOMYOCYTE_HYPERTROPHY,SET,8,-0.45831,-0.0095647,0.29904,0.9373,HP_CARDIOMYOCYTE_HYPERTROPHY,1
GOMF_DEHYDROASCORBIC_ACID_TR...,SET,6,-0.50641,-0.0091531,0.33037,0.93733,GOMF_DEHYDROASCORBIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
PU1_Q6,SET,221,-0.092011,-0.010034,0.06002,0.93735,PU1_Q6,1
SHANK_TAL1_TARGETS_DN,SET,10,-0.43418,-0.01013,0.28313,0.93742,SHANK_TAL1_TARGETS_DN,1
GOCC_PHOTORECEPTOR_CONNECTIN...,SET,37,-0.20652,-0.0092618,0.13467,0.93742,GOCC_PHOTORECEPTOR_CONNECTING_CILIUM,1
MIR5008_3P,SET,150,-0.11059,-0.0099549,0.072094,0.93747,MIR5008_3P,1
GNF2_HCK,SET,86,-0.14883,-0.010162,0.097014,0.93749,GNF2_HCK,1
MIKKELSEN_ES_ICP_WITH_H3K27M...,SET,41,-0.21465,-0.010132,0.13991,0.9375,MIKKELSEN_ES_ICP_WITH_H3K27ME3,1
GOBP_PURINE_NUCLEOSIDE_MONOP...2,SET,10,-0.4353,-0.010156,0.2837,0.93752,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
FLETCHER_PBMC_BCG_10W_INFANT...3,SET,163,-0.10738,-0.010072,0.069964,0.93757,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,1
HP_NEURAL_TUBE_DEFECT,SET,271,-0.079466,-0.0095829,0.051772,0.93759,HP_NEURAL_TUBE_DEFECT,1
VERRECCHIA_RESPONSE_TO_TGFB1...6,SET,5,-0.59732,-0.0098558,0.38912,0.93761,VERRECCHIA_RESPONSE_TO_TGFB1_C6,1
HP_BEAKING_OF_VERTEBRAL_BODI...,SET,25,-0.25667,-0.0094649,0.16719,0.93762,HP_BEAKING_OF_VERTEBRAL_BODIES,1
ZNF561_TARGET_GENES,SET,688,-0.051234,-0.0097303,0.033372,0.93763,ZNF561_TARGET_GENES,1
HP_ANKYLOGLOSSIA,SET,23,-0.26567,-0.0093973,0.17304,0.93764,HP_ANKYLOGLOSSIA,1
GOBP_BEHAVIORAL_RESPONSE_TO_...2,SET,9,-0.47594,-0.010535,0.3099,0.93769,GOBP_BEHAVIORAL_RESPONSE_TO_ETHANOL,1
HP_FLATTENED_FEMORAL_EPIPHYS...,SET,12,-0.37126,-0.0094884,0.24172,0.93771,HP_FLATTENED_FEMORAL_EPIPHYSIS,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS...2,SET,60,-0.1762,-0.010056,0.1147,0.93774,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,1
HP_PREMATURE_LOSS_OF_PRIMARY...,SET,19,-0.32114,-0.010326,0.20906,0.93774,HP_PREMATURE_LOSS_OF_PRIMARY_TEETH,1
KEGG_MEDICUS_REFERENCE_PKR_E...,SET,7,-0.43755,-0.008542,0.28481,0.93776,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY,1
MIR548AO_5P_MIR548AX,SET,152,-0.10901,-0.0098778,0.070958,0.93776,MIR548AO_5P_MIR548AX,1
GOBP_LINOLEIC_ACID_METABOLIC...,SET,19,-0.31858,-0.010243,0.20734,0.93779,GOBP_LINOLEIC_ACID_METABOLIC_PROCESS,1
chr3p22,SET,78,-0.30258,-0.01968,0.19691,0.93781,chr3p22,1
MIR615_5P,SET,37,-0.23123,-0.01037,0.15046,0.93782,MIR615_5P,1
GOCC_PHOTORECEPTOR_OUTER_SEG...1,SET,82,-0.14314,-0.0095449,0.09314,0.93783,GOCC_PHOTORECEPTOR_OUTER_SEGMENT,1
PID_TCR_JNK_PATHWAY,SET,14,-0.35528,-0.009807,0.23114,0.93785,PID_TCR_JNK_PATHWAY,1
REACTOME_APOPTOSIS,SET,163,-0.10078,-0.0094534,0.065555,0.93788,REACTOME_APOPTOSIS,1
HP_ABNORMAL_RIB_OSSIFICATION,SET,8,-0.48648,-0.010153,0.31636,0.93793,HP_ABNORMAL_RIB_OSSIFICATION,1
GSE29164_UNTREATED_VS_CD8_TC...7,SET,178,-0.099423,-0.0097419,0.064643,0.93797,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN,1
SOX5_01,SET,236,-0.090076,-0.010147,0.058561,0.93799,SOX5_01,1
MIR12127,SET,74,-0.15061,-0.0095422,0.097873,0.93806,MIR12127,1
LEF1_Q2,SET,211,-0.096548,-0.010291,0.062736,0.93808,LEF1_Q2,1
YRCCAKNNGNCGC_UNKNOWN,SET,60,-0.17571,-0.010028,0.11417,0.93809,YRCCAKNNGNCGC_UNKNOWN,1
LMO2COM_01,SET,241,-0.08775,-0.0099873,0.057011,0.93811,LMO2COM_01,1
GSE5589_LPS_VS_LPS_AND_IL6_S...5,SET,173,-0.097693,-0.0094383,0.063455,0.93816,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
GOBP_TELOMERE_MAINTENANCE_IN...,SET,30,-0.22461,-0.009072,0.14586,0.93819,GOBP_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,1
HP_ABNORMAL_CSF_PROTEIN_CONC...,SET,45,-0.20502,-0.010138,0.13311,0.93824,HP_ABNORMAL_CSF_PROTEIN_CONCENTRATION,1
KEGG_MEDICUS_PATHOGEN_ESCHER...4,SET,5,-0.64742,-0.010683,0.42031,0.93825,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY,1
HP_DEATH_IN_CHILDHOOD,SET,111,-0.12092,-0.0093738,0.078504,0.93825,HP_DEATH_IN_CHILDHOOD,1
HP_CHOREA,SET,202,-0.092532,-0.0096523,0.060069,0.93826,HP_CHOREA,1
GSE20366_TREG_VS_TCONV_DN,SET,179,-0.099687,-0.0097949,0.06471,0.93827,GSE20366_TREG_VS_TCONV_DN,1
MIR345_3P,SET,199,-0.094092,-0.0097426,0.061065,0.93831,MIR345_3P,1
GSE41176_UNSTIM_VS_ANTI_IGM_...10,SET,170,-0.095537,-0.0091504,0.062004,0.93831,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP,1
GOBP_REGULATION_OF_POSTSYNAP...7,SET,134,-0.12204,-0.010388,0.079205,0.93832,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,1
HP_SHORT_RIBS,SET,58,-0.16748,-0.0093986,0.10868,0.93834,HP_SHORT_RIBS,1
TTGCCAA_MIR182,SET,298,-0.080419,-0.010162,0.052174,0.93838,TTGCCAA_MIR182,1
MIR6876_3P,SET,49,-0.2006,-0.010349,0.13012,0.9384,MIR6876_3P,1
MIR3934_3P,SET,90,-0.13336,-0.0093144,0.086489,0.93845,MIR3934_3P,1
WP_CHROMOSOMAL_AND_MICROSATE...,SET,72,-0.1558,-0.0097376,0.10102,0.93848,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,1
KEGG_LONG_TERM_POTENTIATION,SET,66,-0.16032,-0.009595,0.10395,0.93849,KEGG_LONG_TERM_POTENTIATION,1
SHIPP_DLBCL_CURED_VS_FATAL_UP,SET,36,-0.22817,-0.010094,0.14789,0.93855,SHIPP_DLBCL_CURED_VS_FATAL_UP,1
HP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,8,-0.44104,-0.0092043,0.28582,0.93858,HP_MULTIPLE_EPIPHYSEAL_DYSPLASIA,1
BIOCARTA_DICER_PATHWAY,SET,5,-0.62938,-0.010385,0.40768,0.93867,BIOCARTA_DICER_PATHWAY,1
HP_ANOPHTHALMIA,SET,59,-0.16426,-0.0092965,0.1064,0.93867,HP_ANOPHTHALMIA,1
MIR3925_3P,SET,161,-0.10503,-0.0097923,0.068023,0.93871,MIR3925_3P,1
GSE41867_DAY6_EFFECTOR_VS_DA...2,SET,185,-0.097741,-0.0097617,0.063299,0.93871,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,1
HP_LIVER_ABSCESS,SET,7,-0.52234,-0.010197,0.33825,0.93873,HP_LIVER_ABSCESS,1
MIR4520_3P,SET,81,-0.14851,-0.0098426,0.096161,0.93875,MIR4520_3P,1
BRUNEAU_HEART_GREAT_VESSELS_...,SET,8,-0.48737,-0.010171,0.31556,0.93876,BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS,1
CTCTGGA_MIR520A_MIR525,SET,141,-0.1095,-0.0095593,0.070882,0.9388,CTCTGGA_MIR520A_MIR525,1
HP_ABNORMAL_EXTERNAL_NOSE_MO...,SET,789,-0.046593,-0.0094489,0.030157,0.93882,HP_ABNORMAL_EXTERNAL_NOSE_MORPHOLOGY,1
RPA1_TARGET_GENES,SET,38,-0.21843,-0.0099271,0.14132,0.9389,RPA1_TARGET_GENES,1
GSE29614_CTRL_VS_TIV_FLU_VAC...2,SET,148,-0.11588,-0.010362,0.074952,0.93894,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP,1
HP_CONTRACTURE_OF_THE_PROXIM...1,SET,6,-0.55867,-0.010098,0.36127,0.93899,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_3RD_FINGER,1
HP_GENERALIZED_HIRSUTISM,SET,86,-0.14293,-0.0097591,0.09241,0.93902,HP_GENERALIZED_HIRSUTISM,1
HP_LENS_LUXATION,SET,6,-0.59772,-0.010804,0.38644,0.93903,HP_LENS_LUXATION,1
HP_PULMONARY_ARTERY_DILATATI...,SET,12,-0.39191,-0.010016,0.25329,0.93909,HP_PULMONARY_ARTERY_DILATATION,1
GOBP_XMP_METABOLIC_PROCESS,SET,7,-0.49015,-0.0095688,0.31668,0.93915,GOBP_XMP_METABOLIC_PROCESS,1
LU_EZH2_TARGETS_UP,SET,253,-0.078579,-0.0091604,0.050767,0.93916,LU_EZH2_TARGETS_UP,1
YAO_TEMPORAL_RESPONSE_TO_PRO...6,SET,145,-0.10054,-0.0088995,0.064921,0.93926,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1
GSE360_L_DONOVANI_VS_B_MALAY...4,SET,175,-0.10394,-0.010099,0.067117,0.93926,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP,1
REACTOME_NOTCH3_ACTIVATION_A...,SET,23,-0.28307,-0.010013,0.18276,0.93928,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
MIR4732_3P,SET,81,-0.14908,-0.00988,0.096237,0.93931,MIR4732_3P,1
MIR629_5P,SET,102,-0.13653,-0.010148,0.088119,0.93935,MIR629_5P,1
HP_HYPERAUTOFLUORESCENT_MACU...,SET,11,-0.44902,-0.010987,0.2898,0.93935,HP_HYPERAUTOFLUORESCENT_MACULAR_LESION,1
GOBP_NEGATIVE_REGULATION_OF_...487,SET,53,-0.17907,-0.009607,0.11553,0.93942,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
SCHAEFFER_PROSTATE_DEVELOPME...7,SET,9,-0.39948,-0.0088424,0.25769,0.93945,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN,1
GOBP_POSITIVE_REGULATION_OF_...826,SET,14,-0.37609,-0.010381,0.24259,0.93946,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,1
GSE2770_TGFB_AND_IL4_VS_IL12...3,SET,183,-0.096098,-0.0095461,0.061983,0.93947,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
GOBP_RESPONSE_TO_PH,SET,38,-0.2201,-0.010003,0.14191,0.93954,GOBP_RESPONSE_TO_PH,1
GOBP_PROTEIN_COMPLEX_OLIGOME...,SET,250,-0.086218,-0.0099921,0.055578,0.93957,GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION,1
GOCC_PREFOLDIN_COMPLEX,SET,6,-0.42398,-0.0076632,0.2733,0.93958,GOCC_PREFOLDIN_COMPLEX,1
WP_CORI_CYCLE,SET,13,-0.33776,-0.0089845,0.2177,0.93961,WP_CORI_CYCLE,1
WP_NPHP1_DELETION_SYNDROME,SET,10,-0.46053,-0.010745,0.29678,0.93963,WP_NPHP1_DELETION_SYNDROME,1
GOBP_MODULATION_OF_PROCESS_O...,SET,14,-0.38971,-0.010757,0.25114,0.93963,GOBP_MODULATION_OF_PROCESS_OF_ANOTHER_ORGANISM,1
GOMF_NUCLEOTIDE_RECEPTOR_ACT...,SET,17,-0.38173,-0.01161,0.24598,0.93964,GOMF_NUCLEOTIDE_RECEPTOR_ACTIVITY,1
PRC2_SUZ12_UP.V1_UP,SET,165,-0.10491,-0.0099007,0.067601,0.93965,PRC2_SUZ12_UP.V1_UP,1
GSE18791_UNSTIM_VS_NEWCATSLE...10,SET,179,-0.094507,-0.009286,0.060896,0.93965,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP,1
GSE5589_UNSTIM_VS_180MIN_LPS...3,SET,182,-0.095159,-0.0094273,0.061316,0.93965,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN,1
GOCC_INNER_DYNEIN_ARM,SET,4,-0.54584,-0.0080559,0.3517,0.93966,GOCC_INNER_DYNEIN_ARM,1
GOMF_TRANSLATION_INITIATION_...1,SET,43,-0.18688,-0.0090333,0.12041,0.93967,GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY,1
HP_LYMPHEDEMA,SET,68,-0.15586,-0.0094678,0.10041,0.93969,HP_LYMPHEDEMA,1
MTOR_UP.V1_UP,SET,155,-0.10461,-0.0095712,0.067382,0.93972,MTOR_UP.V1_UP,1
GOBP_NEGATIVE_REGULATION_OF_...285,SET,171,-0.10712,-0.01029,0.068957,0.93983,GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY,1
GSE12845_NAIVE_VS_PRE_GC_TON...1,SET,175,-0.095858,-0.0093139,0.061703,0.93984,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN,1
GSE17721_LPS_VS_GARDIQUIMOD_...3,SET,180,-0.095509,-0.0094104,0.061428,0.93999,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN,1
RODRIGUES_THYROID_CARCINOMA_...4,SET,706,-0.049931,-0.0096011,0.032102,0.94006,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,1
HP_KYPHOSIS,SET,380,-0.067528,-0.0096139,0.043411,0.94009,HP_KYPHOSIS,1
UNTERMAN_IPF_VS_CTRL_CD4T_DN,SET,9,-0.52784,-0.011684,0.33922,0.94014,UNTERMAN_IPF_VS_CTRL_CD4T_DN,1
MIR15A_3P,SET,32,-0.24032,-0.010024,0.15442,0.94016,MIR15A_3P,1
WP_NAD_BIOSYNTHESIS_II_FROM_...,SET,8,-0.47216,-0.0098538,0.3034,0.94017,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,1
GOBP_SOMATOTROPIN_SECRETING_...,SET,5,-0.69771,-0.011512,0.44828,0.94018,GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION,1
HP_EPISCLERITIS,SET,4,-0.76791,-0.011333,0.4934,0.94018,HP_EPISCLERITIS,1
REACTOME_SCF_SKP2_MEDIATED_D...,SET,57,-0.15729,-0.0087503,0.10103,0.94023,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1
WP_ULCERATIVE_COLITIS_SIGNAL...,SET,16,-0.34537,-0.010191,0.22185,0.94023,WP_ULCERATIVE_COLITIS_SIGNALING,1
MORF_MAP3K14,SET,106,-0.13546,-0.010263,0.086991,0.94028,MORF_MAP3K14,1
GOBP_MYELIN_ASSEMBLY,SET,23,-0.28797,-0.010186,0.18492,0.94029,GOBP_MYELIN_ASSEMBLY,1
GOBP_ANAPHASE_PROMOTING_COMP...,SET,22,-0.25747,-0.0089073,0.16529,0.94033,GOBP_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...671,SET,10,-0.46035,-0.010741,0.29547,0.94037,GOBP_NEGATIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,1
GOBP_REPLACEMENT_OSSIFICATION,SET,28,-0.27431,-0.010704,0.17607,0.94037,GOBP_REPLACEMENT_OSSIFICATION,1
MIR1255B_2_3P,SET,78,-0.14287,-0.0092925,0.091655,0.94047,MIR1255B_2_3P,1
MIR32_5P,SET,433,-0.065919,-0.010003,0.042275,0.94053,MIR32_5P,1
MIR4714_5P,SET,93,-0.14238,-0.010108,0.091291,0.94057,MIR4714_5P,1
HP_HYPOPLASTIC_NASAL_BRIDGE,SET,5,-0.53462,-0.0088214,0.34276,0.94058,HP_HYPOPLASTIC_NASAL_BRIDGE,1
GOMF_TRANSMEMBRANE_TRANSPORT...,SET,125,-0.12649,-0.010402,0.081072,0.94064,GOMF_TRANSMEMBRANE_TRANSPORTER_BINDING,1
GSE15930_NAIVE_VS_72H_IN_VIT...4,SET,187,-0.094179,-0.0094561,0.060356,0.94066,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,1
GOBP_NEUROTRANSMITTER_GATED_...,SET,15,-0.37878,-0.010822,0.24273,0.94067,GOBP_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING,1
HP_ANTI_THYROID_ANTIBODY_POS...,SET,10,-0.42251,-0.0098579,0.27071,0.9407,HP_ANTI_THYROID_ANTIBODY_POSITIVITY,1
HP_POLYDACTYLY,SET,228,-0.08929,-0.0098883,0.057209,0.9407,HP_POLYDACTYLY,1
GOBP_CO_TRANSCRIPTIONAL_RNA_...,SET,10,-0.37277,-0.0086974,0.23875,0.94077,GOBP_CO_TRANSCRIPTIONAL_RNA_3_END_PROCESSING_CLEAVAGE_AND_POLYADENYLATION_PATHWAY,1
HP_ABNORMAL_CNS_MYELINATION,SET,360,-0.06707,-0.0092992,0.042954,0.94078,HP_ABNORMAL_CNS_MYELINATION,1
HP_OCULOMOTOR_APRAXIA,SET,102,-0.12146,-0.0090276,0.077778,0.9408,HP_OCULOMOTOR_APRAXIA,1
REACTOME_RUNX1_REGULATES_TRA...2,SET,66,-0.14812,-0.0088647,0.094844,0.94081,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,1
GSE21927_SPLEEN_VS_TUMOR_MON...1,SET,168,-0.10403,-0.0099053,0.066596,0.94085,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN,1
HP_MACULAR_THICKENING,SET,38,-0.22161,-0.010072,0.14187,0.94086,HP_MACULAR_THICKENING,1
YAATNRNNNYNATT_UNKNOWN,SET,97,-0.14387,-0.01043,0.09206,0.94094,YAATNRNNNYNATT_UNKNOWN,1
SENESE_HDAC3_TARGETS_UP,SET,437,-0.066024,-0.010064,0.042246,0.94095,SENESE_HDAC3_TARGETS_UP,1
TONG_INTERACT_WITH_PTTG1,SET,51,-0.17035,-0.0089657,0.109,0.94095,TONG_INTERACT_WITH_PTTG1,1
HP_ABNORMAL_CIRCULATING_METH...,SET,15,-0.36828,-0.010522,0.23564,0.94095,HP_ABNORMAL_CIRCULATING_METHIONINE_CONCENTRATION,1
GOBP_THYMOCYTE_APOPTOTIC_PRO...,SET,19,-0.31317,-0.010069,0.20037,0.94096,GOBP_THYMOCYTE_APOPTOTIC_PROCESS,1
GSE39556_UNTREATED_VS_3H_POL...2,SET,180,-0.10592,-0.010436,0.067734,0.94105,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP,1
MIR19B_3P,SET,594,-0.05744,-0.010163,0.03672,0.94111,MIR19B_3P,1
GSE22886_NAIVE_CD8_TCELL_VS_...9,SET,184,-0.098703,-0.0098314,0.063094,0.94113,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN,1
GSE17721_CTRL_VS_LPS_0.5H_BM...2,SET,179,-0.099749,-0.0098011,0.063736,0.9412,GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...550,SET,15,-0.33932,-0.0096949,0.21681,0.94121,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
HP_RIB_FUSION,SET,45,-0.20351,-0.010063,0.13002,0.94122,HP_RIB_FUSION,1
HP_ABNORMAL_AMPLITUDE_OF_DAR...,SET,14,-0.37391,-0.010321,0.23883,0.94127,HP_ABNORMAL_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM,1
GSE40273_GATA1_KO_VS_WT_TREG...2,SET,174,-0.098625,-0.0095556,0.062982,0.94131,GSE40273_GATA1_KO_VS_WT_TREG_UP,1
GOBP_NAD_METABOLIC_PROCESS,SET,57,-0.17321,-0.0096358,0.1106,0.94133,GOBP_NAD_METABOLIC_PROCESS,1
GSE3982_CENT_MEMORY_CD4_TCEL...5,SET,184,-0.092478,-0.0092114,0.059038,0.94137,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN,1
MIR373_3P,SET,295,-0.078018,-0.0098097,0.049803,0.94138,MIR373_3P,1
GOBP_GRANULOCYTE_CHEMOTAXIS,SET,118,-0.13974,-0.011167,0.089187,0.94141,GOBP_GRANULOCYTE_CHEMOTAXIS,1
GOBP_REGULATION_OF_ATPASE_CO...,SET,5,-0.49391,-0.0081495,0.31523,0.94141,GOBP_REGULATION_OF_ATPASE_COUPLED_CALCIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR1245B_3P,SET,129,-0.11696,-0.0097697,0.07459,0.94156,MIR1245B_3P,1
LINDSTEDT_DENDRITIC_CELL_MAT...2,SET,44,-0.22822,-0.011159,0.14554,0.94157,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,1
MIKKELSEN_ES_HCP_WITH_H3K27M...,SET,38,-0.24014,-0.010914,0.15312,0.94159,MIKKELSEN_ES_HCP_WITH_H3K27ME3,1
BIOCARTA_P27_PATHWAY,SET,13,-0.3453,-0.0091851,0.22014,0.94162,BIOCARTA_P27_PATHWAY,1
HP_PREMATURE_OVARIAN_INSUFFI...,SET,61,-0.16211,-0.0093284,0.10334,0.94163,HP_PREMATURE_OVARIAN_INSUFFICIENCY,1
GOBP_INTERKINETIC_NUCLEAR_MI...,SET,5,-0.51932,-0.0085689,0.33103,0.94164,GOBP_INTERKINETIC_NUCLEAR_MIGRATION,1
GSE15330_LYMPHOID_MULTIPOTEN...4,SET,180,-0.099007,-0.009755,0.063102,0.94167,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
MIR2681_5P,SET,146,-0.11176,-0.0099268,0.071225,0.94169,MIR2681_5P,1
HP_MULTIPLE_RENAL_CYSTS,SET,67,-0.1715,-0.010341,0.10929,0.94169,HP_MULTIPLE_RENAL_CYSTS,1
GOBP_MITOCHONDRIAL_CALCIUM_I...2,SET,20,-0.32772,-0.010811,0.20879,0.94174,GOBP_MITOCHONDRIAL_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOMF_ARRESTIN_FAMILY_PROTEIN...,SET,9,-0.38263,-0.0084695,0.24369,0.9418,GOMF_ARRESTIN_FAMILY_PROTEIN_BINDING,1
MIR4656,SET,98,-0.13619,-0.0099234,0.086729,0.94182,MIR4656,1
GENTILE_UV_HIGH_DOSE_UP,SET,17,-0.33708,-0.010252,0.21465,0.94183,GENTILE_UV_HIGH_DOSE_UP,1
LEIN_CEREBELLUM_MARKERS,SET,76,-0.1629,-0.010459,0.10372,0.94185,LEIN_CEREBELLUM_MARKERS,1
HOEK_T_CELL_2011_2012_TIV_AD...1,SET,4,-0.70029,-0.010335,0.44588,0.94185,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_DN,1
BRACHAT_RESPONSE_TO_CISPLATIN,SET,20,-0.30381,-0.010022,0.19343,0.94186,BRACHAT_RESPONSE_TO_CISPLATIN,1
GOBP_POSITIVE_REGULATION_OF_...263,SET,4,-0.61789,-0.0091192,0.39339,0.94186,GOBP_POSITIVE_REGULATION_OF_EXIT_FROM_MITOSIS,1
GSE20715_WT_VS_TLR4_KO_48H_O...2,SET,178,-0.10262,-0.010055,0.06533,0.94188,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP,1
WATANABE_RECTAL_CANCER_RADIO...1,SET,89,-0.14572,-0.010121,0.092763,0.94189,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,1
HP_RETINAL_COLOBOMA,SET,37,-0.21886,-0.0098149,0.13928,0.94194,HP_RETINAL_COLOBOMA,1
GOBP_ENSHEATHMENT_OF_NEURONS,SET,148,-0.11314,-0.010117,0.071998,0.94195,GOBP_ENSHEATHMENT_OF_NEURONS,1
HP_ABNORMALITY_OF_THE_ABDOMI...2,SET,467,-0.063072,-0.0099303,0.040126,0.942,HP_ABNORMALITY_OF_THE_ABDOMINAL_WALL,1
GOBP_ASCENDING_AORTA_DEVELOP...,SET,5,-0.68971,-0.01138,0.43871,0.94203,GOBP_ASCENDING_AORTA_DEVELOPMENT,1
HP_LIMITATION_OF_JOINT_MOBIL...,SET,370,-0.071789,-0.010088,0.045654,0.94207,HP_LIMITATION_OF_JOINT_MOBILITY,1
MORF_ARAF1,SET,70,-0.15066,-0.009285,0.095787,0.94212,MORF_ARAF1,1
KEGG_MEDICUS_VARIANT_MUTATIO...84,SET,8,-0.5,-0.010435,0.31788,0.94213,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_INTESTINA...1,SET,11,-0.39341,-0.0096265,0.25006,0.94216,GOBP_REGULATION_OF_INTESTINAL_ABSORPTION,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...1,SET,377,-0.066924,-0.009491,0.042533,0.94218,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,1
MIR324_5P,SET,39,-0.20685,-0.0095233,0.13143,0.94222,MIR324_5P,1
SRC_UP.V1_DN,SET,147,-0.11231,-0.010009,0.071347,0.94227,SRC_UP.V1_DN,1
MIR6816_3P,SET,31,-0.23452,-0.0096286,0.14895,0.9423,MIR6816_3P,1
GSE21927_HEALTHY_VS_TUMOROUS...2,SET,167,-0.10387,-0.0098612,0.065968,0.94231,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP,1
KEGG_MEDICUS_REFERENCE_CHRNA...,SET,6,-0.48572,-0.0087792,0.30846,0.94232,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY,1
GOCC_SCAR_COMPLEX,SET,11,-0.41124,-0.010063,0.26116,0.94232,GOCC_SCAR_COMPLEX,1
GOBP_T_CELL_SELECTION,SET,57,-0.19715,-0.010968,0.12519,0.94235,GOBP_T_CELL_SELECTION,1
GOBP_CELL_PROLIFERATION_IN_F...,SET,25,-0.28329,-0.010447,0.17983,0.9424,GOBP_CELL_PROLIFERATION_IN_FOREBRAIN,1
GOMF_PHOSPHORYLATION_DEPENDE...,SET,8,-0.51716,-0.010793,0.32822,0.94244,GOMF_PHOSPHORYLATION_DEPENDENT_PROTEIN_BINDING,1
GOMF_CYTOSKELETAL_MOTOR_ACTI...,SET,112,-0.12888,-0.010035,0.081784,0.94246,GOMF_CYTOSKELETAL_MOTOR_ACTIVITY,1
MIR632,SET,56,-0.18824,-0.01038,0.11943,0.94249,MIR632,1
HP_HIGH_OUTPUT_CONGESTIVE_HE...,SET,6,-0.5529,-0.0099934,0.35079,0.94249,HP_HIGH_OUTPUT_CONGESTIVE_HEART_FAILURE,1
REACTOME_GRB2_EVENTS_IN_ERBB...,SET,16,-0.32057,-0.0094592,0.20336,0.94252,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,1
MIR4769_5P,SET,39,-0.21156,-0.0097402,0.13421,0.94252,MIR4769_5P,1
HP_ABNORMALITY_OF_LIMB_BONE,SET,1523,-0.035898,-0.0099011,0.022763,0.9426,HP_ABNORMALITY_OF_LIMB_BONE,1
GSE42088_UNINF_VS_LEISHMANIA...2,SET,183,-0.10186,-0.010119,0.064588,0.9426,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP,1
GOCC_ARP2_3_PROTEIN_COMPLEX,SET,9,-0.4063,-0.0089935,0.2576,0.94263,GOCC_ARP2_3_PROTEIN_COMPLEX,1
MIR4797_3P,SET,94,-0.13275,-0.009474,0.084144,0.94266,MIR4797_3P,1
MODULE_440,SET,18,-0.32153,-0.010062,0.20376,0.9427,MODULE_440,1
GOBP_RESPONSE_TO_WATER_DEPRI...,SET,5,-0.54358,-0.0089692,0.34448,0.9427,GOBP_RESPONSE_TO_WATER_DEPRIVATION,1
GOBP_CELLULAR_RESPONSE_TO_CH...1,SET,286,-0.081039,-0.010035,0.051352,0.94272,GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1
GSE36527_CD62L_HIGH_CD69_NEG...2,SET,180,-0.097881,-0.0096441,0.062024,0.94272,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP,1
HP_PROGRESSIVE_EXTRAPYRAMIDA...,SET,8,-0.47957,-0.010008,0.30387,0.94273,HP_PROGRESSIVE_EXTRAPYRAMIDAL_MOVEMENT_DISORDER,1
GOCC_RIBONUCLEASE_P_COMPLEX,SET,10,-0.40183,-0.0093754,0.25457,0.94276,GOCC_RIBONUCLEASE_P_COMPLEX,1
HP_ABNORMAL_MESENTERY_MORPHO...,SET,4,-0.56995,-0.0084118,0.36108,0.94276,HP_ABNORMAL_MESENTERY_MORPHOLOGY,1
HP_HYPSARRHYTHMIA,SET,159,-0.10631,-0.0098499,0.067344,0.94277,HP_HYPSARRHYTHMIA,1
PID_MYC_ACTIV_PATHWAY,SET,76,-0.15868,-0.010188,0.10047,0.94286,PID_MYC_ACTIV_PATHWAY,1
GOMF_OXIDATIVE_PHOSPHORYLATI...,SET,4,-0.62633,-0.0092437,0.39631,0.94298,GOMF_OXIDATIVE_PHOSPHORYLATION_UNCOUPLER_ACTIVITY,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...4,SET,635,-0.054522,-0.0099628,0.034499,0.94298,HP_ABNORMAL_MORPHOLOGY_OF_THE_GREAT_VESSELS,1
GSE1740_MCSF_VS_MCSF_AND_IFN...3,SET,146,-0.10957,-0.009732,0.069305,0.94305,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN,1
GAUTAM_EYE_IRIS_CILIARY_BODY...12,SET,104,-0.13488,-0.010122,0.0853,0.94308,GAUTAM_EYE_IRIS_CILIARY_BODY_PIGMENTED_CILIARY_BODY_CELLS,1
KEGG_MEDICUS_REFERENCE_OKAZA...,SET,11,-0.36831,-0.0090124,0.23291,0.94309,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION,1
GOBP_METANEPHRIC_TUBULE_MORP...,SET,10,-0.46786,-0.010916,0.29587,0.94309,GOBP_METANEPHRIC_TUBULE_MORPHOGENESIS,1
ROZANOV_MMP14_TARGETS_UP,SET,242,-0.09226,-0.010522,0.058334,0.94312,ROZANOV_MMP14_TARGETS_UP,1
GSE15330_HSC_VS_LYMPHOID_PRI...1,SET,164,-0.10626,-0.009998,0.067176,0.94315,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,1
RUVBL2_TARGET_GENES,SET,28,-0.24684,-0.0096322,0.15604,0.94316,RUVBL2_TARGET_GENES,1
HP_TRUNCAL_OBESITY,SET,71,-0.16099,-0.0099918,0.10173,0.94322,HP_TRUNCAL_OBESITY,1
GOBP_NEURON_NEURON_SYNAPTIC_...,SET,8,-0.49671,-0.010366,0.31385,0.94324,GOBP_NEURON_NEURON_SYNAPTIC_TRANSMISSION,1
MIR200C_5P,SET,58,-0.18655,-0.010469,0.11786,0.94327,MIR200C_5P,1
HP_ABNORMAL_ILIUM_MORPHOLOGY,SET,85,-0.14774,-0.010029,0.09333,0.94328,HP_ABNORMAL_ILIUM_MORPHOLOGY,1
GOCC_CIA_COMPLEX,SET,2,-0.84808,-0.008851,0.5357,0.94329,GOCC_CIA_COMPLEX,1
REACTOME_REGULATION_OF_HMOX1...,SET,5,-0.58057,-0.0095795,0.36641,0.94345,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,1
HP_VERTEBRAL_SEGMENTATION_DE...,SET,131,-0.11783,-0.0099174,0.074353,0.94348,HP_VERTEBRAL_SEGMENTATION_DEFECT,1
GOBP_FLAVONOID_GLUCURONIDATI...,SET,5,-1.152,-0.019008,0.72654,0.94358,GOBP_FLAVONOID_GLUCURONIDATION,1
GOMF_NOTCH_BINDING,SET,22,-0.26681,-0.0092305,0.16821,0.94365,GOMF_NOTCH_BINDING,1
TONKS_TARGETS_OF_RUNX1_RUNX1...3,SET,16,-0.32726,-0.0096566,0.20629,0.94367,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,1
GSE22886_DAY0_VS_DAY7_MONOCY...2,SET,176,-0.10255,-0.0099925,0.064641,0.94368,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP,1
BLANCO_MELO_INFLUENZA_A_INFE...2,SET,37,-0.22944,-0.01029,0.1446,0.94371,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1
REACTOME_TERMINAL_PATHWAY_OF...,SET,8,-0.51261,-0.010698,0.32302,0.94372,REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT,1
GARGALOVIC_RESPONSE_TO_OXIDI...21,SET,48,-0.1894,-0.0096716,0.11933,0.94376,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,1
TRAVAGLINI_LUNG_CD4_MEMORY_E...,SET,63,-0.18128,-0.010601,0.11417,0.94382,TRAVAGLINI_LUNG_CD4_MEMORY_EFFECTOR_T_CELL,1
REACTOME_NICOTINATE_METABOLI...,SET,29,-0.25701,-0.010206,0.16184,0.94385,REACTOME_NICOTINATE_METABOLISM,1
YAMASHITA_LIVER_CANCER_STEM_...2,SET,46,-0.21867,-0.010932,0.13769,0.94386,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,1
HP_HYPOCHROMIC_MICROCYTIC_AN...,SET,15,-0.36181,-0.010338,0.2278,0.94388,HP_HYPOCHROMIC_MICROCYTIC_ANEMIA,1
REACTOME_REGULATION_OF_TP53_...3,SET,14,-0.36131,-0.0099734,0.22745,0.94391,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS,1
GOMF_ADENOSINE_RECEPTOR_BIND...,SET,7,-0.543,-0.010601,0.3418,0.94392,GOMF_ADENOSINE_RECEPTOR_BINDING,1
GOBP_VASODILATION,SET,44,-0.23156,-0.011322,0.14575,0.94393,GOBP_VASODILATION,1
GOBP_MITOCHONDRIAL_TRANSCRIP...,SET,19,-0.29426,-0.0094613,0.18521,0.94394,GOBP_MITOCHONDRIAL_TRANSCRIPTION,1
GOBP_POSITIVE_REGULATION_OF_...654,SET,5,-0.62183,-0.01026,0.39139,0.94394,GOBP_POSITIVE_REGULATION_OF_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
ZIRN_TRETINOIN_RESPONSE_UP,SET,16,-0.36917,-0.010893,0.23234,0.94395,ZIRN_TRETINOIN_RESPONSE_UP,1
GSE15330_WT_VS_IKAROS_KO_LYM...1,SET,179,-0.096984,-0.0095294,0.061026,0.94399,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN,1
GOBP_POSITIVE_REGULATION_OF_...691,SET,13,-0.38526,-0.010248,0.24236,0.94403,GOBP_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY,1
MIR4476,SET,202,-0.097432,-0.010163,0.061263,0.94412,MIR4476,1
CASORELLI_ACUTE_PROMYELOCYTI...2,SET,143,-0.1151,-0.010118,0.072351,0.94417,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1
HP_ABNORMAL_STERNAL_OSSIFICA...,SET,11,-0.39784,-0.009735,0.25005,0.94419,HP_ABNORMAL_STERNAL_OSSIFICATION,1
HP_ABNORMAL_NASAL_TIP_MORPHO...,SET,324,-0.074457,-0.0098034,0.046794,0.9442,HP_ABNORMAL_NASAL_TIP_MORPHOLOGY,1
DESCARTES_MAIN_FETAL_LENS_FI...,SET,137,-0.11924,-0.010261,0.074938,0.9442,DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS,1
GSE7852_THYMUS_VS_FAT_TREG_UP,SET,188,-0.093872,-0.0094502,0.058989,0.94422,GSE7852_THYMUS_VS_FAT_TREG_UP,1
GARCIA_PINERES_PBMC_HPV_16_L...2,SET,21,-0.28796,-0.0097331,0.18087,0.94431,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
GSE5503_PLN_DC_VS_SPLEEN_DC_...2,SET,186,-0.097831,-0.0097968,0.061445,0.94432,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GSE17721_POLYIC_VS_PAM3CSK4_...10,SET,185,-0.098097,-0.0097973,0.061601,0.94435,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP,1
HP_CORTICAL_DYSPLASIA,SET,51,-0.19665,-0.01035,0.12348,0.94437,HP_CORTICAL_DYSPLASIA,1
GOBP_NEGATIVE_REGULATION_OF_...700,SET,26,-0.29803,-0.011207,0.18708,0.94441,GOBP_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,1
GOBP_TISSUE_REGENERATION,SET,69,-0.17047,-0.010431,0.10698,0.94446,GOBP_TISSUE_REGENERATION,1
PELLICCIOTTA_HDAC_IN_ANTIGEN...1,SET,49,-0.17807,-0.0091869,0.11173,0.94449,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,1
EIF4E_UP,SET,88,-0.13919,-0.0096135,0.087327,0.94452,EIF4E_UP,1
FRIDMAN_IMMORTALIZATION_DN,SET,31,-0.25438,-0.010444,0.15957,0.94454,FRIDMAN_IMMORTALIZATION_DN,1
GOBP_NEGATIVE_REGULATION_OF_...436,SET,24,-0.28215,-0.010195,0.17698,0.94455,GOBP_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
NADLER_OBESITY_DN,SET,46,-0.19834,-0.0099156,0.1244,0.94457,NADLER_OBESITY_DN,1
HP_THORACIC_SCOLIOSIS,SET,54,-0.17751,-0.0096125,0.11132,0.94458,HP_THORACIC_SCOLIOSIS,1
HP_ABNORMAL_PELVIS_BONE_OSSI...,SET,15,-0.34004,-0.0097153,0.21323,0.9446,HP_ABNORMAL_PELVIS_BONE_OSSIFICATION,1
GSE40274_CTRL_VS_LEF1_TRANSD...1,SET,156,-0.10332,-0.0094829,0.064787,0.9446,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
BROWNE_HCMV_INFECTION_4HR_UP,SET,47,-0.21136,-0.01068,0.13246,0.94471,BROWNE_HCMV_INFECTION_4HR_UP,1
GOBP_REGULATION_OF_T_CELL_CO...,SET,4,-0.75526,-0.011147,0.47331,0.94471,GOBP_REGULATION_OF_T_CELL_COSTIMULATION,1
GOBP_REGULATION_OF_CHLORIDE_...,SET,6,-0.51297,-0.0092717,0.32142,0.94474,GOBP_REGULATION_OF_CHLORIDE_TRANSPORT,1
GOMF_WIDE_PORE_CHANNEL_ACTIV...,SET,30,-0.28182,-0.011382,0.17657,0.94476,GOMF_WIDE_PORE_CHANNEL_ACTIVITY,1
GOBP_NATURAL_KILLER_CELL_CHE...,SET,10,-0.49619,-0.011577,0.31085,0.94477,GOBP_NATURAL_KILLER_CELL_CHEMOTAXIS,1
MIR5739,SET,6,-0.6563,-0.011862,0.41113,0.94478,MIR5739,1
MODULE_190,SET,8,-0.61196,-0.012771,0.3833,0.94481,MODULE_190,1
HP_ABNORMAL_RENAL_PELVIS_MOR...,SET,244,-0.087877,-0.010063,0.055042,0.94481,HP_ABNORMAL_RENAL_PELVIS_MORPHOLOGY,1
GOBP_LIPID_PHOSPHORYLATION,SET,10,-0.40456,-0.009439,0.25333,0.94485,GOBP_LIPID_PHOSPHORYLATION,1
GOMF_ATP_DEPENDENT_DIACYLGLY...,SET,10,-0.40456,-0.009439,0.25333,0.94485,GOMF_ATP_DEPENDENT_DIACYLGLYCEROL_KINASE_ACTIVITY,1
GOCC_POSTSYNAPTIC_SPECIALIZA...1,SET,324,-0.078333,-0.010314,0.049048,0.94487,GOCC_POSTSYNAPTIC_SPECIALIZATION,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...1,SET,63,-0.17234,-0.010078,0.10789,0.9449,GOMF_RNA_ENDONUCLEASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...351,SET,24,-0.26661,-0.009633,0.16685,0.94496,GOBP_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT,1
CREBP1_01,SET,156,-0.11456,-0.010515,0.07167,0.94501,CREBP1_01,1
NPM1_TARGET_GENES,SET,280,-0.08024,-0.0098332,0.050179,0.94509,NPM1_TARGET_GENES,1
GOCC_ORGANELLE_MEMBRANE_CONT...,SET,39,-0.21664,-0.0099739,0.13546,0.94511,GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE,1
GSE23321_CENTRAL_MEMORY_VS_N...1,SET,180,-0.10311,-0.010159,0.064474,0.94511,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
HP_ABNORMAL_MUSCLE_TISSUE_ME...,SET,45,-0.19293,-0.0095399,0.12063,0.94512,HP_ABNORMAL_MUSCLE_TISSUE_METABOLITE_CONCENTRATION,1
GOBP_AMINO_ACID_METABOLIC_PR...,SET,255,-0.085374,-0.0099913,0.053376,0.94513,GOBP_AMINO_ACID_METABOLIC_PROCESS,1
MURARO_PANCREAS_BETA_CELL,SET,858,-0.048927,-0.010327,0.03059,0.94513,MURARO_PANCREAS_BETA_CELL,1
SCHAEFFER_PROSTATE_DEVELOPME...11,SET,5,-0.64096,-0.010576,0.4007,0.94515,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3,1
GOCC_CLATHRIN_SCULPTED_MONOA...,SET,5,-0.64396,-0.010626,0.40254,0.94516,GOCC_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE,1
IL21_UP.V1_DN,SET,157,-0.11653,-0.01073,0.072842,0.94516,IL21_UP.V1_DN,1
GOBP_DOPAMINERGIC_NEURON_AXO...,SET,6,-0.5814,-0.010508,0.36342,0.94517,GOBP_DOPAMINERGIC_NEURON_AXON_GUIDANCE,1
GOBP_POSITIVE_REGULATION_OF_...815,SET,7,-0.50375,-0.0098343,0.31482,0.9452,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_HEPATOCYT...1,SET,8,-0.4346,-0.0090699,0.27161,0.9452,GOBP_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_...1,SET,44,-0.20342,-0.0099466,0.12711,0.94524,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1
DONATO_CELL_CYCLE_TRETINOIN,SET,6,-0.63501,-0.011478,0.39674,0.94526,DONATO_CELL_CYCLE_TRETINOIN,1
GOBP_RESPONSE_TO_HYDROXYUREA,SET,9,-0.41139,-0.0091061,0.25692,0.94533,GOBP_RESPONSE_TO_HYDROXYUREA,1
GOCC_DYNEIN_COMPLEX,SET,43,-0.19897,-0.0096177,0.12424,0.94535,GOCC_DYNEIN_COMPLEX,1
GSE32423_IL7_VS_IL7_IL4_MEMO...2,SET,188,-0.0971,-0.0097753,0.060628,0.94537,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,1
HP_ANHIDROSIS,SET,29,-0.28062,-0.011144,0.17513,0.94545,HP_ANHIDROSIS,1
MIR6881_3P,SET,160,-0.10998,-0.010222,0.068629,0.94547,MIR6881_3P,1
GOBP_SEMINIFEROUS_TUBULE_DEV...,SET,13,-0.38883,-0.010343,0.2426,0.9455,GOBP_SEMINIFEROUS_TUBULE_DEVELOPMENT,1
MIR576_3P,SET,58,-0.18074,-0.010143,0.11276,0.94551,MIR576_3P,1
GNF2_FOS,SET,34,-0.24586,-0.01057,0.15337,0.94553,GNF2_FOS,1
GSE360_L_DONOVANI_VS_B_MALAY...2,SET,173,-0.1078,-0.010415,0.067246,0.94553,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
HP_MULTIPLE_LENTIGINES,SET,15,-0.32453,-0.0092723,0.20238,0.94559,HP_MULTIPLE_LENTIGINES,1
GSE15330_HSC_VS_MEGAKARYOCYT...2,SET,176,-0.10391,-0.010125,0.064792,0.94561,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,1
WP_SARSCOV2_ALTERING_ANGIOGE...,SET,4,-0.81818,-0.012075,0.51012,0.94562,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,1
LU_TUMOR_VASCULATURE_UP,SET,27,-0.2741,-0.010504,0.17089,0.94563,LU_TUMOR_VASCULATURE_UP,1
GSE46606_IRF4MID_VS_WT_CD40L...1,SET,185,-0.10879,-0.010865,0.067809,0.94567,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
HP_DRY_HAIR,SET,16,-0.34596,-0.010209,0.21563,0.94568,HP_DRY_HAIR,1
HP_HIGH_NARROW_PALATE,SET,128,-0.11887,-0.0098909,0.074089,0.94569,HP_HIGH_NARROW_PALATE,1
GOBP_MITOCHONDRIAL_RNA_MODIF...,SET,8,-0.44472,-0.0092811,0.27713,0.94572,GOBP_MITOCHONDRIAL_RNA_MODIFICATION,1
GOBP_ROSTROCAUDAL_NEURAL_TUB...,SET,7,-0.5705,-0.011137,0.35549,0.94573,GOBP_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING,1
GOMF_SIRNA_BINDING,SET,7,-0.51725,-0.010098,0.32228,0.94574,GOMF_SIRNA_BINDING,1
HP_ABNORMAL_INTERVERTEBRAL_D...,SET,39,-0.2098,-0.0096592,0.13072,0.94574,HP_ABNORMAL_INTERVERTEBRAL_DISK_MORPHOLOGY,1
HP_IMPAIRED_RISTOCETIN_INDUC...,SET,8,-0.50688,-0.010578,0.3158,0.94575,HP_IMPAIRED_RISTOCETIN_INDUCED_PLATELET_AGGREGATION,1
GOBP_REGULATION_OF_CELL_CYCL...2,SET,172,-0.10552,-0.010165,0.065735,0.94577,GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
REACTOME_AZATHIOPRINE_ADME,SET,21,-0.3243,-0.010962,0.20198,0.94581,REACTOME_AZATHIOPRINE_ADME,1
WP_CHOLESTEROL_BIOSYNTHESIS_...3,SET,5,-0.55847,-0.0092148,0.34781,0.94582,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,1
GOBP_REGULATION_OF_STRESS_GR...,SET,11,-0.35116,-0.0085927,0.21869,0.94583,GOBP_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,1
GOBP_PEPTIDE_CATABOLIC_PROCE...,SET,19,-0.33771,-0.010858,0.21027,0.94586,GOBP_PEPTIDE_CATABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_P4_PR...2,SET,15,-0.34577,-0.009879,0.21525,0.94589,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_CHONDROITIN_SULFOTRANSF...,SET,5,-0.57558,-0.0094972,0.35832,0.94589,GOMF_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY,1
GSE28726_ACT_CD4_TCELL_VS_AC...2,SET,188,-0.09601,-0.0096655,0.059768,0.94589,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP,1
HP_PAROXYSMAL_DYSKINESIA,SET,15,-0.3482,-0.0099486,0.21675,0.94591,HP_PAROXYSMAL_DYSKINESIA,1
GNF2_RTN1,SET,47,-0.21794,-0.011013,0.13563,0.94595,GNF2_RTN1,1
GOBP_REGULATION_OF_FEAR_RESP...,SET,8,-0.55908,-0.011668,0.34782,0.946,GOBP_REGULATION_OF_FEAR_RESPONSE,1
HP_ABNORMALITY_OF_DENTAL_COL...,SET,31,-0.2429,-0.0099723,0.15111,0.94601,HP_ABNORMALITY_OF_DENTAL_COLOR,1
TAKEDA_TARGETS_OF_NUP98_HOXA...5,SET,28,-0.27881,-0.01088,0.17341,0.94605,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,1
REACTOME_IRAK2_MEDIATED_ACTI...,SET,8,-0.57132,-0.011923,0.35535,0.94605,REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,1
GCM_IL6ST,SET,52,-0.18237,-0.009692,0.11343,0.94605,GCM_IL6ST,1
GOBP_INOSITOL_TRISPHOSPHATE_...2,SET,10,-0.49225,-0.011485,0.30609,0.94609,GOBP_INOSITOL_TRISPHOSPHATE_METABOLIC_PROCESS,1
HP_ABSENCE_OF_THE_SACRUM,SET,8,-0.4871,-0.010166,0.3029,0.94609,HP_ABSENCE_OF_THE_SACRUM,1
HP_FREQUENT_FALLS,SET,117,-0.12793,-0.01018,0.079507,0.94618,HP_FREQUENT_FALLS,1
HP_ABNORMAL_VERTEBRAL_SEGMEN...,SET,8,-0.55136,-0.011507,0.34257,0.94623,HP_ABNORMAL_VERTEBRAL_SEGMENTATION_AND_FUSION,1
HP_OBSTRUCTIVE_AZOOSPERMIA,SET,27,-0.26335,-0.010092,0.16361,0.94625,HP_OBSTRUCTIVE_AZOOSPERMIA,1
HP_RETINAL_EXUDATE,SET,8,-0.48425,-0.010106,0.30085,0.94625,HP_RETINAL_EXUDATE,1
HP_SEVERE_HEARING_IMPAIRMENT,SET,14,-0.35091,-0.0096862,0.21795,0.9463,HP_SEVERE_HEARING_IMPAIRMENT,1
MEK_UP.V1_DN,SET,162,-0.11096,-0.010376,0.068913,0.9463,MEK_UP.V1_DN,1
HP_RECURRENT_EAR_INFECTIONS,SET,16,-0.35232,-0.010396,0.21881,0.94631,HP_RECURRENT_EAR_INFECTIONS,1
GOBP_GMP_METABOLIC_PROCESS,SET,25,-0.27813,-0.010256,0.17268,0.94637,GOBP_GMP_METABOLIC_PROCESS,1
GOBP_TROPHOBLAST_GIANT_CELL_...,SET,12,-0.43422,-0.011098,0.26945,0.94645,GOBP_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION,1
HP_INCREASED_FEMORAL_ANTEVER...,SET,4,-0.55644,-0.0082123,0.34527,0.94647,HP_INCREASED_FEMORAL_ANTEVERSION,1
WP_SARSCOV2_AND_COVID19_PATH...,SET,8,-0.55522,-0.011587,0.34441,0.94652,WP_SARSCOV2_AND_COVID19_PATHWAY,1
GSE7460_CD8_TCELL_VS_CD4_TCE...1,SET,191,-0.10043,-0.01019,0.062296,0.94652,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN,1
MARTIN_NFKB_TARGETS_DN,SET,10,-0.41122,-0.0095945,0.25507,0.94653,MARTIN_NFKB_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...40,SET,6,-0.64977,-0.011744,0.40295,0.94657,GOBP_POSITIVE_REGULATION_OF_ARTERY_MORPHOGENESIS,1
GOBP_REGULATION_OF_ARTERY_MO...,SET,6,-0.64977,-0.011744,0.40295,0.94657,GOBP_REGULATION_OF_ARTERY_MORPHOGENESIS,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...2,SET,24,-0.30636,-0.011069,0.18998,0.94658,GOBP_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,1
HAY_BONE_MARROW_MONOCYTE,SET,195,-0.10263,-0.01052,0.063637,0.94659,HAY_BONE_MARROW_MONOCYTE,1
GOBP_POSITIVE_REGULATION_OF_...298,SET,11,-0.46621,-0.011408,0.28905,0.94661,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_DEMETHYLATION,1
GOBP_SALIVARY_GLAND_DEVELOPM...,SET,36,-0.23696,-0.010482,0.14691,0.94661,GOBP_SALIVARY_GLAND_DEVELOPMENT,1
GSE6259_FLT3L_INDUCED_33D1_P...5,SET,129,-0.12056,-0.01007,0.074747,0.94661,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...597,SET,10,-0.4452,-0.010387,0.276,0.94662,GOBP_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY,1
REACTOME_TRNA_MODIFICATION_I...1,SET,7,-0.43966,-0.0085831,0.27253,0.94664,REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION,1
HP_HIGH_HYPERMETROPIA,SET,70,-0.16906,-0.010419,0.10477,0.94668,HP_HIGH_HYPERMETROPIA,1
HP_LIPOMA,SET,22,-0.29742,-0.010289,0.18431,0.9467,HP_LIPOMA,1
GSE11864_UNTREATED_VS_CSF1_I...5,SET,163,-0.10524,-0.009872,0.065213,0.94671,GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN,1
KEGG_MEDICUS_PATHOGEN_SALMON...4,SET,29,-0.25353,-0.010068,0.15704,0.94678,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_FOVEAL_PIG...,SET,5,-0.74331,-0.012265,0.4604,0.94678,HP_ABNORMALITY_OF_FOVEAL_PIGMENTATION,1
GSE5099_DAY3_VS_DAY7_MCSF_TR...1,SET,144,-0.11492,-0.010138,0.071153,0.94685,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN,1
GSE9650_NAIVE_VS_EFF_CD8_TCE...2,SET,182,-0.10115,-0.01002,0.062618,0.94687,GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_NAD_B...,SET,12,-0.42765,-0.01093,0.2647,0.9469,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS,1
MIR4791,SET,58,-0.17556,-0.0098519,0.10864,0.94694,MIR4791,1
GOMF_MICROTUBULE_PLUS_END_BI...,SET,21,-0.29352,-0.0099212,0.18158,0.947,GOMF_MICROTUBULE_PLUS_END_BINDING,1
BIOCARTA_ETC_PATHWAY,SET,7,-0.49403,-0.0096445,0.30557,0.94702,BIOCARTA_ETC_PATHWAY,1
IRF2_01,SET,118,-0.1316,-0.010517,0.081403,0.94702,IRF2_01,1
GOBP_DENDRITIC_CELL_MIGRATION,SET,31,-0.2618,-0.010748,0.16193,0.94702,GOBP_DENDRITIC_CELL_MIGRATION,1
HOLLEMAN_VINCRISTINE_RESISTA...3,SET,16,-0.32967,-0.0097277,0.2039,0.94703,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,1
KEGG_MEDICUS_REFERENCE_ANTIG...1,SET,11,-0.48358,-0.011833,0.29906,0.94705,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES,1
GOBP_L_LEUCINE_CATABOLIC_PRO...,SET,6,-0.52588,-0.0095051,0.32522,0.94705,GOBP_L_LEUCINE_CATABOLIC_PROCESS,1
GOBP_DOUBLE_STRAND_BREAK_REP...3,SET,8,-0.41374,-0.0086347,0.25584,0.94707,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_ALTERNATIVE_NONHOMOLOGOUS_END_JOINING,1
DESCARTES_FETAL_PLACENTA_VAS...,SET,85,-0.16485,-0.01119,0.10191,0.94711,DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS,1
ATGTAGC_MIR221_MIR222,SET,130,-0.13204,-0.011072,0.081626,0.94712,ATGTAGC_MIR221_MIR222,1
GSE16385_MONOCYTE_VS_12H_ROS...5,SET,169,-0.10059,-0.0096059,0.062147,0.94722,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,1
HP_RENAL_ANGIOMYOLIPOMA,SET,5,-0.60608,-0.01,0.37444,0.94723,HP_RENAL_ANGIOMYOLIPOMA,1
TAL1BETAE47_01,SET,225,-0.096383,-0.010604,0.059527,0.94728,TAL1BETAE47_01,1
HP_ABNORMAL_EYEBROW_MORPHOLO...,SET,580,-0.05764,-0.010082,0.035594,0.94731,HP_ABNORMAL_EYEBROW_MORPHOLOGY,1
MIR12133,SET,352,-0.076647,-0.010511,0.047314,0.94737,MIR12133,1
CACGTTT_MIR302A,SET,29,-0.25624,-0.010176,0.15815,0.9474,CACGTTT_MIR302A,1
GOBP_CELLULAR_RESPONSE_TO_CO...1,SET,10,-0.47493,-0.011081,0.2931,0.94742,GOBP_CELLULAR_RESPONSE_TO_COCAINE,1
TCF4_Q5,SET,219,-0.10061,-0.010922,0.062055,0.94751,TCF4_Q5,1
MITSIADES_RESPONSE_TO_APLIDI...2,SET,385,-0.070724,-0.010133,0.043601,0.9476,MITSIADES_RESPONSE_TO_APLIDIN_UP,1
COLLER_MYC_TARGETS_DN,SET,4,-0.7022,-0.010363,0.4328,0.94764,COLLER_MYC_TARGETS_DN,1
RODWELL_AGING_KIDNEY_NO_BLOO...1,SET,127,-0.13089,-0.010849,0.080673,0.94765,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...1,SET,16,-0.36891,-0.010886,0.22733,0.94768,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,1
GOMF_TUMOR_NECROSIS_FACTOR_R...3,SET,46,-0.20745,-0.010371,0.12783,0.94768,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING,1
HP_HYDROMETROCOLPOS,SET,28,-0.25965,-0.010132,0.15999,0.94768,HP_HYDROMETROCOLPOS,1
GOBP_POSITIVE_REGULATION_OF_...160,SET,20,-0.33392,-0.011015,0.2057,0.94773,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
HP_CAUDATE_ATROPHY,SET,11,-0.44031,-0.010774,0.27125,0.94773,HP_CAUDATE_ATROPHY,1
GSE29164_DAY3_VS_DAY7_CD8_TC...2,SET,178,-0.10199,-0.0099936,0.062812,0.94778,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP,1
GOCC_COSTAMERE,SET,16,-0.35822,-0.01057,0.22059,0.94779,GOCC_COSTAMERE,1
MODULE_22,SET,31,-0.20605,-0.0084596,0.12686,0.94783,MODULE_22,1
MODULE_238,SET,141,-0.11911,-0.010398,0.07333,0.94783,MODULE_238,1
HP_ABNORMAL_NASAL_MORPHOLOGY,SET,1289,-0.039316,-0.010045,0.024194,0.94791,HP_ABNORMAL_NASAL_MORPHOLOGY,1
GOBP_SARCOPLASMIC_RETICULUM_...,SET,38,-0.23064,-0.010482,0.1419,0.94795,GOBP_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT,1
GOMF_INTRAMOLECULAR_OXIDORED...3,SET,15,-0.36116,-0.010319,0.22219,0.94796,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS,1
SENESE_HDAC1_TARGETS_UP,SET,398,-0.070243,-0.010229,0.043202,0.94801,SENESE_HDAC1_TARGETS_UP,1
GOBP_REGULATION_OF_CHONDROCY...2,SET,47,-0.22251,-0.011243,0.13683,0.94803,GOBP_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
HP_HYPOHIDROSIS,SET,64,-0.18287,-0.010778,0.11245,0.94804,HP_HYPOHIDROSIS,1
GOMF_PLATELET_DERIVED_GROWTH...1,SET,11,-0.49226,-0.012046,0.3027,0.94805,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_BINDING,1
MEBARKI_HCC_PROGENITOR_WNT_DN,SET,72,-0.17202,-0.010751,0.10576,0.94807,MEBARKI_HCC_PROGENITOR_WNT_DN,1
GSE29618_PRE_VS_DAY7_POST_TI...4,SET,179,-0.10321,-0.010141,0.063443,0.9481,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP,1
HP_PULMONARY_ARTERIAL_HYPERT...,SET,130,-0.11972,-0.010038,0.073573,0.94814,HP_PULMONARY_ARTERIAL_HYPERTENSION,1
HP_THIN_CORPUS_CALLOSUM,SET,735,-0.050802,-0.009959,0.031222,0.94814,HP_THIN_CORPUS_CALLOSUM,1
GOCC_NUCLEAR_CYCLIN_DEPENDEN...,SET,13,-0.32382,-0.0086136,0.19896,0.94818,GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,1
GOBP_ALCOHOL_BIOSYNTHETIC_PR...,SET,125,-0.12302,-0.010116,0.075561,0.94823,GOBP_ALCOHOL_BIOSYNTHETIC_PROCESS,1
GOBP_NUCLEOBASE_CATABOLIC_PR...,SET,10,-0.46222,-0.010784,0.2839,0.94824,GOBP_NUCLEOBASE_CATABOLIC_PROCESS,1
ERWIN_COHEN_BLOOD_VACCINE_TC...2,SET,26,-0.29749,-0.011187,0.18269,0.94827,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN,1
GSE17721_CTRL_VS_CPG_6H_BMDC...1,SET,178,-0.1026,-0.010053,0.063002,0.94829,GSE17721_CTRL_VS_CPG_6H_BMDC_DN,1
HP_ABNORMAL_MITOCHONDRIA_IN_...,SET,25,-0.24435,-0.0090105,0.15002,0.94831,HP_ABNORMAL_MITOCHONDRIA_IN_MUSCLE_TISSUE,1
MIR6079,SET,135,-0.12318,-0.010524,0.075622,0.94833,MIR6079,1
GOBP_STEROL_BIOSYNTHETIC_PRO...,SET,53,-0.18665,-0.010014,0.11458,0.94834,GOBP_STEROL_BIOSYNTHETIC_PROCESS,1
GOMF_CTPASE_ACTIVITY,SET,5,-0.67486,-0.011135,0.41427,0.94834,GOMF_CTPASE_ACTIVITY,1
MIR6789_5P,SET,20,-0.28483,-0.0093956,0.17481,0.94837,MIR6789_5P,1
HP_NARROW_PALATE,SET,164,-0.10752,-0.010116,0.065976,0.94841,HP_NARROW_PALATE,1
GSE14415_NATURAL_TREG_VS_FOX...1,SET,144,-0.11476,-0.010123,0.070403,0.94844,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN,1
HP_INTELLECTUAL_DISABILITY_M...2,SET,132,-0.11523,-0.0097353,0.070674,0.94849,HP_INTELLECTUAL_DISABILITY_MODERATE,1
GOBP_ASYMMETRIC_CELL_DIVISION,SET,18,-0.32405,-0.010141,0.19872,0.94851,GOBP_ASYMMETRIC_CELL_DIVISION,1
GSE17721_LPS_VS_GARDIQUIMOD_...18,SET,181,-0.10488,-0.010362,0.064299,0.94857,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP,1
GCM_ZNF198,SET,111,-0.12598,-0.0097659,0.07722,0.94859,GCM_ZNF198,1
HP_HYPERKINETIC_MOVEMENTS,SET,35,-0.23822,-0.010391,0.146,0.94861,HP_HYPERKINETIC_MOVEMENTS,1
GOBP_NEGATIVE_REGULATION_OF_...454,SET,35,-0.24177,-0.010546,0.14815,0.94864,GOBP_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,1
GSE10422_WT_VS_BAFF_TRANSGEN...1,SET,120,-0.13433,-0.010825,0.082318,0.94864,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN,1
GOMF_PROTEASOME_BINDING,SET,16,-0.3022,-0.0089172,0.18516,0.94866,GOMF_PROTEASOME_BINDING,1
HP_SPINA_BIFIDA_OCCULTA,SET,68,-0.17684,-0.010742,0.10835,0.94866,HP_SPINA_BIFIDA_OCCULTA,1
HP_INCREASED_SULFUR_AMINO_AC...,SET,15,-0.39793,-0.011369,0.24373,0.94872,HP_INCREASED_SULFUR_AMINO_ACID_LEVEL_IN_URINE,1
GOBP_MITOCHONDRIAL_RNA_PROCE...,SET,20,-0.27375,-0.0090301,0.16762,0.94877,GOBP_MITOCHONDRIAL_RNA_PROCESSING,1
GOBP_G_PROTEIN_COUPLED_OPIOI...,SET,11,-0.44148,-0.010803,0.2703,0.94879,GOBP_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_MICROGLIAL_CELL_MEDIATE...,SET,5,-0.62145,-0.010254,0.38048,0.94879,GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY,1
GOBP_CHONDROCYTE_PROLIFERATI...,SET,23,-0.30016,-0.010617,0.18373,0.94883,GOBP_CHONDROCYTE_PROLIFERATION,1
MIR4263,SET,240,-0.092366,-0.010491,0.056533,0.94885,MIR4263,1
GOMF_PHOSPHATIDYLGLYCEROL_BI...,SET,14,-0.38929,-0.010746,0.23822,0.94888,GOMF_PHOSPHATIDYLGLYCEROL_BINDING,1
CCTGAGT_MIR510,SET,35,-0.22761,-0.0099282,0.13926,0.94891,CCTGAGT_MIR510,1
GOCC_POSTSYNAPTIC_ENDOSOME,SET,13,-0.36639,-0.0097461,0.22414,0.94893,GOCC_POSTSYNAPTIC_ENDOSOME,1
GSE41867_NAIVE_VS_DAY8_LCMV_...5,SET,179,-0.10012,-0.0098379,0.061208,0.94905,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,1
GSE21927_SPLENIC_C26GM_TUMOR...3,SET,162,-0.10855,-0.010152,0.066334,0.94912,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN,1
GSE14308_TH1_VS_INDUCED_TREG...1,SET,176,-0.10153,-0.0098931,0.062034,0.94914,GSE14308_TH1_VS_INDUCED_TREG_DN,1
BIOCARTA_SUMO_PATHWAY,SET,6,-0.48737,-0.008809,0.29763,0.94923,BIOCARTA_SUMO_PATHWAY,1
GOBP_CGMP_MEDIATED_SIGNALING,SET,25,-0.29119,-0.010738,0.1778,0.94925,GOBP_CGMP_MEDIATED_SIGNALING,1
MIR6742_5P,SET,40,-0.21196,-0.0098828,0.12935,0.94935,MIR6742_5P,1
GOBP_SODIUM_DEPENDENT_PHOSPH...,SET,12,-0.45735,-0.011689,0.27909,0.94936,GOBP_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,1
GOCC_LATE_ENDOSOME,SET,278,-0.085727,-0.010469,0.05231,0.94937,GOCC_LATE_ENDOSOME,1
GOCC_SMAD_PROTEIN_COMPLEX,SET,9,-0.50374,-0.01115,0.30733,0.94939,GOCC_SMAD_PROTEIN_COMPLEX,1
NKX6_1_TARGET_GENES,SET,23,-0.28822,-0.010195,0.17578,0.94945,NKX6_1_TARGET_GENES,1
HP_VEIN_OF_GALEN_ANEURYSMAL_...,SET,5,-0.6063,-0.010004,0.36962,0.94952,HP_VEIN_OF_GALEN_ANEURYSMAL_MALFORMATION,1
BIOCARTA_LDL_PATHWAY,SET,6,-0.66567,-0.012032,0.40579,0.94953,BIOCARTA_LDL_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...102,SET,8,-0.4918,-0.010264,0.29975,0.94956,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
REACTOME_SIGNALING_BY_NOTCH1...1,SET,14,-0.39179,-0.010815,0.23873,0.94961,REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,1
KEGG_ALDOSTERONE_REGULATED_S...,SET,39,-0.24416,-0.011241,0.14876,0.94963,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1
MIR4539,SET,67,-0.17195,-0.010369,0.10476,0.94963,MIR4539,1
GOMF_MUTLALPHA_COMPLEX_BINDI...,SET,7,-0.48766,-0.0095203,0.29708,0.94965,GOMF_MUTLALPHA_COMPLEX_BINDING,1
HP_SMALL_SCROTUM,SET,51,-0.20966,-0.011035,0.12769,0.9497,HP_SMALL_SCROTUM,1
GOBP_LOCOMOTION_INVOLVED_IN_...,SET,11,-0.42856,-0.010487,0.26096,0.94972,GOBP_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,1
QUEREC_MODEL_PBMC_YF_17D_VAC...2,SET,35,-0.22749,-0.0099231,0.1385,0.94975,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45_7DY_PREDICTIVE,1
GSE41867_DAY6_VS_DAY8_LCMV_C...2,SET,179,-0.10203,-0.010025,0.06211,0.94977,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...515,SET,8,-0.50434,-0.010525,0.30694,0.94981,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
PASINI_SUZ12_TARGETS_DN,SET,289,-0.088132,-0.01097,0.053633,0.94983,PASINI_SUZ12_TARGETS_DN,1
GOBP_REGULATION_OF_CALCIUM_I...9,SET,18,-0.35128,-0.010993,0.21377,0.94983,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
YIH_RESPONSE_TO_ARSENITE_C4,SET,16,-0.33661,-0.0099325,0.20483,0.94984,YIH_RESPONSE_TO_ARSENITE_C4,1
GOBP_RIBOSOME_DISASSEMBLY,SET,32,-0.23159,-0.00966,0.14092,0.94984,GOBP_RIBOSOME_DISASSEMBLY,1
TONKS_TARGETS_OF_RUNX1_RUNX1...13,SET,21,-0.33373,-0.01128,0.20299,0.94991,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1
GOMF_PATTERN_RECOGNITION_REC...,SET,28,-0.2861,-0.011164,0.17401,0.94992,GOMF_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY,1
MIR223_5P,SET,138,-0.11872,-0.010254,0.072204,0.94993,MIR223_5P,1
HP_HYPOPLASIA_OF_THE_CORPUS_...,SET,391,-0.069018,-0.0099641,0.041969,0.94995,HP_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
GOBP_GLIOGENESIS,SET,325,-0.082373,-0.010862,0.050062,0.95005,GOBP_GLIOGENESIS,1
GOBP_CALCIUM_ION_EXPORT_ACRO...,SET,9,-0.52985,-0.011728,0.32196,0.95008,GOBP_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
HP_HYPOPLASTIC_CERVICAL_VERT...,SET,6,-0.64328,-0.011627,0.39086,0.95009,HP_HYPOPLASTIC_CERVICAL_VERTEBRAE,1
DOUGLAS_BMI1_TARGETS_DN,SET,292,-0.08186,-0.010241,0.049734,0.9501,DOUGLAS_BMI1_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...476,SET,116,-0.12683,-0.010049,0.077059,0.9501,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,1
BIOCARTA_CTBP1_PATHWAY,SET,8,-0.45228,-0.0094389,0.27475,0.95013,BIOCARTA_CTBP1_PATHWAY,1
GOBP_PROTEIN_LOCALIZATION_TO...46,SET,39,-0.2335,-0.01075,0.14178,0.95021,GOBP_PROTEIN_LOCALIZATION_TO_POSTSYNAPSE,1
HP_ENDOCARDIAL_FIBROSIS,SET,6,-0.60797,-0.010989,0.36902,0.95027,HP_ENDOCARDIAL_FIBROSIS,1
GOBP_FATTY_ACID_DERIVATIVE_C...,SET,17,-0.33217,-0.010103,0.20156,0.95032,GOBP_FATTY_ACID_DERIVATIVE_CATABOLIC_PROCESS,1
HP_FOCAL_SENSORY_SEIZURE,SET,15,-0.36166,-0.010333,0.21937,0.95038,HP_FOCAL_SENSORY_SEIZURE,1
HP_TRIANGULAR_SHAPED_PHALANG...,SET,7,-0.59711,-0.011657,0.36215,0.95039,HP_TRIANGULAR_SHAPED_PHALANGES_OF_THE_HAND,1
HP_ENLARGED_POSTERIOR_FOSSA,SET,163,-0.10505,-0.009854,0.063713,0.9504,HP_ENLARGED_POSTERIOR_FOSSA,1
MANNO_MIDBRAIN_NEUROTYPES_HR...3,SET,385,-0.077205,-0.011062,0.046815,0.95043,MANNO_MIDBRAIN_NEUROTYPES_HRGL2B,1
HP_ANDROGEN_INSUFFICIENCY,SET,3,-0.77757,-0.0099387,0.47137,0.95048,HP_ANDROGEN_INSUFFICIENCY,1
REACTOME_RUNX3_REGULATES_YAP...,SET,7,-0.59629,-0.011641,0.3614,0.95051,REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION,1
GSE36476_YOUNG_VS_OLD_DONOR_...6,SET,173,-0.10848,-0.01048,0.065741,0.95052,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP,1
HP_DIFFUSE_OPTIC_DISC_PALLOR,SET,14,-0.39772,-0.010978,0.241,0.95055,HP_DIFFUSE_OPTIC_DISC_PALLOR,1
MIR1226_5P,SET,40,-0.21983,-0.01025,0.13317,0.95059,MIR1226_5P,1
HP_ECTRODACTYLY,SET,66,-0.18252,-0.010924,0.11051,0.95068,HP_ECTRODACTYLY,1
KEGG_MEDICUS_VARIANT_MUTATIO...16,SET,14,-0.36403,-0.010048,0.22034,0.95074,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY,1
MIR3145_3P,SET,206,-0.099242,-0.010453,0.060045,0.9508,MIR3145_3P,1
GOBP_POSITIVE_REGULATION_OF_...571,SET,26,-0.29399,-0.011055,0.17785,0.95083,GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE,1
GOBP_HEPARIN_BIOSYNTHETIC_PR...,SET,11,-0.43308,-0.010597,0.26192,0.95087,GOBP_HEPARIN_BIOSYNTHETIC_PROCESS,1
HOLLEMAN_PREDNISOLONE_RESIST...2,SET,16,-0.29512,-0.0087082,0.17847,0.95089,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...49,SET,71,-0.17399,-0.010799,0.10513,0.95102,GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
MORF_FRK,SET,98,-0.14854,-0.010823,0.089748,0.95103,MORF_FRK,1
BROWN_MYELOID_CELL_DEVELOPME...2,SET,147,-0.12164,-0.010841,0.073481,0.95107,BROWN_MYELOID_CELL_DEVELOPMENT_UP,1
GOBP_TETRAHYDROFOLATE_METABO...,SET,17,-0.31064,-0.0094482,0.18758,0.95114,GOBP_TETRAHYDROFOLATE_METABOLIC_PROCESS,1
HP_ANTENATAL_ONSET,SET,215,-0.096269,-0.010356,0.058111,0.95119,HP_ANTENATAL_ONSET,1
GOMF_CARBON_NITROGEN_LYASE_A...,SET,13,-0.42561,-0.011321,0.2568,0.95127,GOMF_CARBON_NITROGEN_LYASE_ACTIVITY,1
HP_DUODENAL_ADENOCARCINOMA,SET,7,-0.4865,-0.0094975,0.29353,0.95127,HP_DUODENAL_ADENOCARCINOMA,1
GOBP_STOMACH_DEVELOPMENT,SET,5,-0.70236,-0.011589,0.42369,0.9513,GOBP_STOMACH_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...508,SET,19,-0.30429,-0.0097838,0.18355,0.95131,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,1
HP_RETINAL_NONATTACHMENT,SET,7,-0.56812,-0.011091,0.3427,0.95131,HP_RETINAL_NONATTACHMENT,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...1,SET,8,-0.55237,-0.011528,0.3332,0.95131,HE_LIM_SUN_FETAL_LUNG_C4_NKT1_CELL,1
GCM_DDX11,SET,44,-0.18812,-0.009198,0.11346,0.95132,GCM_DDX11,1
MIR6782_5P,SET,37,-0.23084,-0.010352,0.13923,0.95133,MIR6782_5P,1
HP_HYPOPLASTIC_PELVIS,SET,14,-0.39356,-0.010864,0.23738,0.95133,HP_HYPOPLASTIC_PELVIS,1
GSE37605_TREG_VS_TCONV_NOD_F...1,SET,154,-0.11472,-0.010462,0.069192,0.95133,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...2,SET,27,-0.29779,-0.011411,0.17954,0.9514,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP,1
SESTO_RESPONSE_TO_UV_C6,SET,36,-0.24038,-0.010634,0.14491,0.95142,SESTO_RESPONSE_TO_UV_C6,1
GOBP_DE_NOVO_PROTEIN_FOLDING,SET,39,-0.21453,-0.0098769,0.12931,0.95143,GOBP_DE_NOVO_PROTEIN_FOLDING,1
GOBP_NEUTROPHIL_DEGRANULATION,SET,13,-0.38953,-0.010361,0.23466,0.95153,GOBP_NEUTROPHIL_DEGRANULATION,1
MIR543,SET,295,-0.085067,-0.010696,0.051233,0.95157,MIR543,1
GOCC_EGG_COAT,SET,5,-0.56997,-0.0094046,0.34323,0.95159,GOCC_EGG_COAT,1
MIR3065_5P,SET,414,-0.070025,-0.010396,0.042167,0.9516,MIR3065_5P,1
MIR5581_5P,SET,67,-0.17357,-0.010466,0.10449,0.95164,MIR5581_5P,1
GSE3920_IFNA_VS_IFNG_TREATED...3,SET,172,-0.11023,-0.010619,0.066336,0.95171,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN,1
GOBP_POSITIVE_REGULATION_OF_...489,SET,23,-0.28758,-0.010172,0.17303,0.95174,GOBP_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
GSE14769_UNSTIM_VS_80MIN_LPS...2,SET,182,-0.10038,-0.0099449,0.060383,0.95178,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP,1
GOCC_MSL_COMPLEX,SET,3,-0.62595,-0.0080007,0.37644,0.95182,GOCC_MSL_COMPLEX,1
GOBP_NEUROMUSCULAR_SYNAPTIC_...,SET,26,-0.28276,-0.010633,0.17003,0.95183,GOBP_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION,1
HP_ABNORMALITY_OF_THE_AMNIOT...,SET,418,-0.068761,-0.010256,0.04135,0.95183,HP_ABNORMALITY_OF_THE_AMNIOTIC_FLUID,1
HP_EXTRAPYRAMIDAL_DYSKINESIA,SET,6,-0.62747,-0.011341,0.37724,0.95187,HP_EXTRAPYRAMIDAL_DYSKINESIA,1
GOBP_LENS_DEVELOPMENT_IN_CAM...,SET,79,-0.17832,-0.011672,0.10719,0.95189,GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
GSE22886_IGM_MEMORY_BCELL_VS...1,SET,174,-0.10643,-0.010311,0.06396,0.95193,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
GSE13306_TREG_RA_VS_TCONV_RA...2,SET,192,-0.10244,-0.01042,0.061549,0.95196,GSE13306_TREG_RA_VS_TCONV_RA_UP,1
GOBP_MYELOID_CELL_ACTIVATION...,SET,91,-0.1526,-0.010717,0.091655,0.95203,GOBP_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GSE40274_LEF1_VS_FOXP3_AND_L...2,SET,180,-0.10897,-0.010736,0.065442,0.95204,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_REGULATION_OF_RELEASE_O...3,SET,27,-0.29478,-0.011296,0.17703,0.95205,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM,1
WILENSKY_RESPONSE_TO_DARAPLA...,SET,25,-0.2774,-0.010229,0.16656,0.95208,WILENSKY_RESPONSE_TO_DARAPLADIB,1
GOBP_PTERIDINE_CONTAINING_CO...2,SET,33,-0.23236,-0.0098424,0.13945,0.95217,GOBP_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOMF_ACETYLGALACTOSAMINYLTRA...,SET,32,-0.28089,-0.011716,0.16856,0.95217,GOMF_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
HP_ABNORMAL_TRAGUS_MORPHOLOGY,SET,11,-0.40531,-0.0099178,0.24322,0.95218,HP_ABNORMAL_TRAGUS_MORPHOLOGY,1
CAGGTA_AREB6_01,SET,683,-0.057215,-0.010828,0.03433,0.9522,CAGGTA_AREB6_01,1
GOMF_PROTEIN_ANTIGEN_BINDING,SET,7,-0.57072,-0.011142,0.34243,0.9522,GOMF_PROTEIN_ANTIGEN_BINDING,1
E4BP4_01,SET,194,-0.10851,-0.011095,0.065094,0.95223,E4BP4_01,1
HP_ABNORMAL_Z_DISK_MORPHOLOGY,SET,8,-0.49969,-0.010428,0.29977,0.95223,HP_ABNORMAL_Z_DISK_MORPHOLOGY,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...7,SET,171,-0.10985,-0.010552,0.065898,0.95223,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN,1
HP_MESOAXIAL_HAND_POLYDACTYLY,SET,10,-0.47489,-0.01108,0.28486,0.95224,HP_MESOAXIAL_HAND_POLYDACTYLY,1
HP_VASCULAR_TORTUOSITY,SET,21,-0.31145,-0.010527,0.18681,0.95225,HP_VASCULAR_TORTUOSITY,1
HP_OSTEOLYSIS,SET,72,-0.16368,-0.01023,0.09813,0.95233,HP_OSTEOLYSIS,1
REACTOME_ACYL_CHAIN_REMODELL...5,SET,20,-0.35081,-0.011572,0.21029,0.95236,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,1
GOBP_CELLULAR_RESPONSE_TO_PH,SET,25,-0.28729,-0.010594,0.17218,0.95239,GOBP_CELLULAR_RESPONSE_TO_PH,1
JIANG_MELANOMA_TRM11_CD8,SET,43,-0.23308,-0.011267,0.13969,0.9524,JIANG_MELANOMA_TRM11_CD8,1
MIR6505_3P,SET,87,-0.14865,-0.010209,0.089084,0.9524,MIR6505_3P,1
HOLLEMAN_PREDNISOLONE_RESIST...4,SET,16,-0.31708,-0.0093564,0.18998,0.95244,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,1
MIR628_3P,SET,66,-0.16825,-0.010069,0.1008,0.95245,MIR628_3P,1
HAY_BONE_MARROW_EOSINOPHIL,SET,41,-0.21879,-0.010327,0.13103,0.9525,HAY_BONE_MARROW_EOSINOPHIL,1
HP_ABNORMALITY_OF_LYSOSOMAL_...,SET,8,-0.52845,-0.011028,0.31644,0.95253,HP_ABNORMALITY_OF_LYSOSOMAL_METABOLISM,1
GSE13306_TREG_VS_TCONV_LAMIN...2,SET,182,-0.10988,-0.010885,0.065796,0.95253,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP,1
GNF2_MAPT,SET,39,-0.25461,-0.011722,0.15243,0.95256,GNF2_MAPT,1
GOBP_COPPER_ION_IMPORT,SET,6,-0.58461,-0.010567,0.34993,0.95259,GOBP_COPPER_ION_IMPORT,1
GOBP_MITOCHONDRIAL_RNA_METAB...,SET,50,-0.18142,-0.0094545,0.10858,0.95262,GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_FIBRO...9,SET,48,-0.22463,-0.01147,0.13438,0.95269,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8,1
ZFP82_TARGET_GENES,SET,25,-0.27132,-0.010005,0.16228,0.95272,ZFP82_TARGET_GENES,1
GSE17186_MEMORY_VS_CD21LOW_T...1,SET,178,-0.10563,-0.01035,0.063165,0.95275,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN,1
GOBP_RESPONSE_TO_CAMP,SET,83,-0.15898,-0.010665,0.095065,0.95277,GOBP_RESPONSE_TO_CAMP,1
HAND1_TARGET_GENES,SET,361,-0.076504,-0.010622,0.045739,0.95279,HAND1_TARGET_GENES,1
MIR363_5P,SET,65,-0.18441,-0.010953,0.11023,0.95283,MIR363_5P,1
GOBP_REGULATION_OF_SREBP_SIG...,SET,6,-0.57332,-0.010362,0.34252,0.95291,GOBP_REGULATION_OF_SREBP_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_V_D_J...,SET,12,-0.34243,-0.0087515,0.20454,0.95294,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION,1
GSE8868_SPLEEN_VS_INTESTINE_...2,SET,175,-0.10623,-0.010322,0.063437,0.95298,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP,1
MYF6_TARGET_GENES,SET,13,-0.39561,-0.010523,0.23624,0.95299,MYF6_TARGET_GENES,1
HP_SEPTATE_VAGINA,SET,10,-0.47567,-0.011098,0.28405,0.95299,HP_SEPTATE_VAGINA,1
GOMF_OSMOSENSOR_ACTIVITY,SET,5,-0.68506,-0.011304,0.40905,0.953,GOMF_OSMOSENSOR_ACTIVITY,1
REACTOME_REGULATION_OF_PYRUV...2,SET,29,-0.27585,-0.010955,0.16467,0.95304,REACTOME_REGULATION_OF_PYRUVATE_METABOLISM,1
GOBP_REGULATION_OF_INTRINSIC...4,SET,15,-0.34855,-0.0099586,0.20805,0.95306,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,1
GOMF_SINGLE_STRANDED_DNA_5_3...,SET,5,-0.51792,-0.0085457,0.30913,0.95306,GOMF_SINGLE_STRANDED_DNA_5_3_DNA_EXONUCLEASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...280,SET,64,-0.19313,-0.011383,0.11527,0.95307,GOBP_NEGATIVE_REGULATION_OF_HORMONE_SECRETION,1
KEGG_MEDICUS_VARIANT_LOSS_OF...2,SET,5,-0.64157,-0.010586,0.38282,0.95311,KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY,1
HP_PROXIMAL_TUBULOPATHY,SET,35,-0.21608,-0.0094255,0.12894,0.95311,HP_PROXIMAL_TUBULOPATHY,1
MIR3664_3P,SET,141,-0.11526,-0.010062,0.068771,0.95312,MIR3664_3P,1
GOBP_CARDIAC_SEPTUM_MORPHOGE...,SET,68,-0.19698,-0.011966,0.11752,0.95313,GOBP_CARDIAC_SEPTUM_MORPHOGENESIS,1
HP_GENERALIZED_HYPOTONIA,SET,580,-0.059104,-0.010338,0.035264,0.95313,HP_GENERALIZED_HYPOTONIA,1
GOBP_NEGATIVE_REGULATION_OF_...622,SET,52,-0.21515,-0.011434,0.12836,0.95314,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
HP_ABNORMAL_PUPIL_MORPHOLOGY,SET,66,-0.19003,-0.011373,0.11337,0.95314,HP_ABNORMAL_PUPIL_MORPHOLOGY,1
DESCARTES_FETAL_PANCREAS_DUC...,SET,96,-0.15792,-0.01139,0.094214,0.95315,DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS,1
GOBP_REGULATION_OF_RESPONSE_...9,SET,27,-0.28124,-0.010777,0.16776,0.95316,GOBP_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,1
MIR7977,SET,207,-0.1003,-0.010589,0.059823,0.95318,MIR7977,1
GOBP_REGULATION_OF_MEMBRANE_...7,SET,61,-0.1804,-0.010381,0.10758,0.95322,GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY,1
HP_ORAL_AVERSION,SET,16,-0.37366,-0.011026,0.22278,0.95325,HP_ORAL_AVERSION,1
GSE5542_IFNG_VS_IFNA_AND_IFN...4,SET,166,-0.10734,-0.010161,0.06399,0.95327,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
chr4q34,SET,19,-0.54658,-0.017574,0.32581,0.95328,chr4q34,1
SCHAEFFER_PROSTATE_DEVELOPME...13,SET,10,-0.47557,-0.011096,0.28347,0.95328,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP,1
GSE3920_UNTREATED_VS_IFNB_TR...2,SET,183,-0.10587,-0.010517,0.063111,0.95328,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,1
HP_IMPAIRED_ARACHIDONIC_ACID...,SET,7,-0.52286,-0.010207,0.31159,0.95332,HP_IMPAIRED_ARACHIDONIC_ACID_INDUCED_PLATELET_AGGREGATION,1
HP_BUTTERFLY_VERTEBRAE,SET,16,-0.36396,-0.01074,0.21679,0.9534,HP_BUTTERFLY_VERTEBRAE,1
HP_INTESTINAL_FISTULA,SET,29,-0.26371,-0.010472,0.15708,0.9534,HP_INTESTINAL_FISTULA,1
NAKAYA_MONOCYTE_FLUARIX_FLUV...1,SET,86,-0.15587,-0.010643,0.092839,0.95341,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
REACTOME_PURINE_RIBONUCLEOSI...,SET,9,-0.47739,-0.010567,0.28432,0.95342,REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS,1
FRANCO_BLOOD_SANOFI_PASTEUR_...1,SET,14,-0.37614,-0.010383,0.224,0.95343,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_NEGATIVE,1
GSE21927_SPLEEN_VS_4T1_TUMOR...2,SET,162,-0.11462,-0.010719,0.068254,0.95345,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,1
GOMF_ALPHA_2A_ADRENERGIC_REC...,SET,4,-0.81048,-0.011962,0.48258,0.95346,GOMF_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING,1
GOBP_TYPE_I_PNEUMOCYTE_DIFFE...,SET,8,-0.54991,-0.011476,0.32741,0.95347,GOBP_TYPE_I_PNEUMOCYTE_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THE_INTERN...,SET,19,-0.36196,-0.011638,0.2155,0.95347,HP_ABNORMALITY_OF_THE_INTERNAL_AUDITORY_CANAL,1
GSE9878_CTRL_VS_EBF_TRANSDUC...1,SET,180,-0.098475,-0.0097026,0.058619,0.9535,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,1
GOCC_ASTROCYTE_END_FOOT,SET,11,-0.4593,-0.011239,0.27338,0.95352,GOCC_ASTROCYTE_END_FOOT,1
HE_LIM_SUN_FETAL_LUNG_C1_SQU...,SET,230,-0.099926,-0.011114,0.059477,0.95352,HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL,1
VICENT_METASTASIS_UP,SET,13,-0.41509,-0.011041,0.24703,0.95354,VICENT_METASTASIS_UP,1
GOBP_HEMATOPOIETIC_PROGENITO...,SET,128,-0.13013,-0.010827,0.077439,0.95355,GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GSE23502_WT_VS_HDC_KO_MYELOI...2,SET,179,-0.10488,-0.010305,0.062406,0.95357,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP,1
MIR1225_3P,SET,56,-0.19969,-0.011012,0.11877,0.95365,MIR1225_3P,1
LTE2_UP.V1_DN,SET,172,-0.1181,-0.011377,0.070239,0.95365,LTE2_UP.V1_DN,1
MIR626,SET,51,-0.21342,-0.011233,0.12691,0.95367,MIR626,1
HP_INCREASED_GLUTAMINE_FAMIL...,SET,5,-0.55399,-0.0091409,0.32939,0.9537,HP_INCREASED_GLUTAMINE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,1
GOBP_REGULATION_OF_NEUTROPHI...3,SET,8,-0.49118,-0.010251,0.29177,0.95384,GOBP_REGULATION_OF_NEUTROPHIL_DEGRANULATION,1
GOBP_RESPONSE_TO_PURINE_CONT...,SET,136,-0.12627,-0.010827,0.075011,0.95384,GOBP_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,1
GOBP_NEGATIVE_REGULATION_OF_...323,SET,19,-0.33735,-0.010847,0.20032,0.9539,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
HP_VASCULITIS_BY_ANATOMICAL_...,SET,14,-0.38366,-0.01059,0.22782,0.95391,HP_VASCULITIS_BY_ANATOMICAL_SITE,1
GOBP_REGULATION_OF_AEROBIC_R...,SET,27,-0.2594,-0.0099404,0.154,0.95394,GOBP_REGULATION_OF_AEROBIC_RESPIRATION,1
GOMF_HEXOKINASE_ACTIVITY,SET,5,-0.72855,-0.012021,0.43251,0.95395,GOMF_HEXOKINASE_ACTIVITY,1
TRAVAGLINI_LUNG_NATURAL_KILL...2,SET,30,-0.2989,-0.012072,0.17744,0.95395,TRAVAGLINI_LUNG_NATURAL_KILLER_T_CELL,1
MIR218_5P,SET,383,-0.07702,-0.011008,0.045705,0.95401,MIR218_5P,1
GOBP_REGULATION_OF_SUPEROXID...1,SET,20,-0.34401,-0.011348,0.20415,0.95401,GOBP_REGULATION_OF_SUPEROXIDE_ANION_GENERATION,1
DESCARTES_FETAL_LUNG_VISCERA...,SET,168,-0.12263,-0.011676,0.072747,0.95406,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,1
WEBER_METHYLATED_HCP_IN_SPER...1,SET,28,-0.26687,-0.010414,0.15829,0.95409,WEBER_METHYLATED_HCP_IN_SPERM_DN,1
GSE13547_CTRL_VS_ANTI_IGM_ST...6,SET,126,-0.12971,-0.010708,0.076933,0.95409,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP,1
GOBP_POSITIVE_REGULATION_OF_...312,SET,24,-0.28482,-0.010291,0.16889,0.95413,GOBP_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
HP_TALIPES_CALCANEOVALGUS,SET,13,-0.38075,-0.010128,0.22574,0.95416,HP_TALIPES_CALCANEOVALGUS,1
PID_TXA2PATHWAY,SET,52,-0.20801,-0.011054,0.12328,0.95422,PID_TXA2PATHWAY,1
GOBP_SKELETAL_SYSTEM_MORPHOG...,SET,217,-0.10634,-0.011492,0.063021,0.95422,GOBP_SKELETAL_SYSTEM_MORPHOGENESIS,1
GSE29617_CTRL_VS_DAY3_TIV_FL...2,SET,165,-0.11003,-0.010383,0.065195,0.95425,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP,1
FAELT_B_CLL_WITH_VH_REARRANG...1,SET,43,-0.22017,-0.010642,0.13045,0.95426,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,1
HP_MENINGOCELE,SET,53,-0.20682,-0.011096,0.12254,0.95426,HP_MENINGOCELE,1
GSE2585_THYMIC_DC_VS_MTEC_DN,SET,177,-0.1076,-0.010513,0.063745,0.95428,GSE2585_THYMIC_DC_VS_MTEC_DN,1
HP_CNS_DEMYELINATION,SET,45,-0.21934,-0.010845,0.12992,0.95431,HP_CNS_DEMYELINATION,1
WP_ARYL_HYDROCARBON_RECEPTOR...1,SET,46,-0.2102,-0.010508,0.12449,0.95433,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1
GSE11864_CSF1_VS_CSF1_PAM3CY...1,SET,166,-0.11199,-0.010601,0.066302,0.95439,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN,1
MIR29B_2_5P,SET,199,-0.10367,-0.010734,0.061369,0.9544,MIR29B_2_5P,1
GOBP_TRNA_METABOLIC_PROCESS,SET,167,-0.10151,-0.009637,0.060044,0.95453,GOBP_TRNA_METABOLIC_PROCESS,1
GRAHAM_CML_QUIESCENT_VS_NORM...2,SET,49,-0.22637,-0.011679,0.13387,0.95457,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,1
HP_BASAL_GANGLIA_CALCIFICATI...,SET,36,-0.25788,-0.011408,0.15247,0.95461,HP_BASAL_GANGLIA_CALCIFICATION,1
HP_ABNORMALITY_OF_LIPOPROTEI...,SET,80,-0.16523,-0.010883,0.097676,0.95463,HP_ABNORMALITY_OF_LIPOPROTEIN_CHOLESTEROL_CONCENTRATION,1
HP_RIEGER_ANOMALY,SET,11,-0.49541,-0.012123,0.29281,0.95466,HP_RIEGER_ANOMALY,1
HEDVAT_ELF4_TARGETS_UP,SET,12,-0.49264,-0.012591,0.29115,0.95467,HEDVAT_ELF4_TARGETS_UP,1
GSE22443_IL2_VS_IL12_TREATED...2,SET,185,-0.10768,-0.010754,0.063588,0.9548,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP,1
WP_LIPID_PARTICLES_COMPOSITI...,SET,8,-0.54596,-0.011394,0.32236,0.95482,WP_LIPID_PARTICLES_COMPOSITION,1
WP_GALANIN_RECEPTOR_PATHWAY,SET,21,-0.3342,-0.011296,0.19731,0.95483,WP_GALANIN_RECEPTOR_PATHWAY,1
GOBP_REGULATION_OF_MEMBRANE_...6,SET,16,-0.32197,-0.0095007,0.19009,0.95484,GOBP_REGULATION_OF_MEMBRANE_LIPID_METABOLIC_PROCESS,1
HP_FLEXION_CONTRACTURE_OF_DI...,SET,276,-0.088712,-0.010795,0.05237,0.95486,HP_FLEXION_CONTRACTURE_OF_DIGIT,1
GOBP_AXO_DENDRITIC_PROTEIN_T...,SET,9,-0.49551,-0.010968,0.29249,0.95487,GOBP_AXO_DENDRITIC_PROTEIN_TRANSPORT,1
KEGG_MEDICUS_REFERENCE_REGUL...6,SET,7,-0.45153,-0.0088148,0.26649,0.95489,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE,1
MIR4677_5P,SET,233,-0.096881,-0.010844,0.057176,0.9549,MIR4677_5P,1
REACTOME_FCGR_ACTIVATION,SET,12,-0.4235,-0.010823,0.24989,0.95493,REACTOME_FCGR_ACTIVATION,1
MORI_PLASMA_CELL_DN,SET,34,-0.25625,-0.011017,0.15119,0.95494,MORI_PLASMA_CELL_DN,1
HP_AORTOPULMONARY_COLLATERAL...,SET,14,-0.42259,-0.011665,0.24934,0.95494,HP_AORTOPULMONARY_COLLATERAL_ARTERIES,1
GSE6090_UNSTIM_VS_DC_SIGN_ST...2,SET,153,-0.10744,-0.0097668,0.06339,0.95494,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP,1
SCHAEFFER_SOX9_TARGETS_IN_PR...1,SET,44,-0.2384,-0.011657,0.14062,0.95498,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1
HP_ENCHONDROMA,SET,21,-0.3093,-0.010455,0.18239,0.95503,HP_ENCHONDROMA,1
GOBP_PEPTIDYL_HISTIDINE_MODI...,SET,9,-0.44888,-0.009936,0.26467,0.95505,GOBP_PEPTIDYL_HISTIDINE_MODIFICATION,1
GOCC_CLATHRIN_COATED_ENDOCYT...2,SET,66,-0.19093,-0.011427,0.11257,0.95506,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE,1
HP_ABNORMAL_CIRCULATING_THYR...2,SET,31,-0.26368,-0.010826,0.15542,0.9551,HP_ABNORMAL_CIRCULATING_THYROID_HORMONE_CONCENTRATION,1
AIZARANI_LIVER_C9_LSECS_1,SET,280,-0.093037,-0.011401,0.05484,0.9551,AIZARANI_LIVER_C9_LSECS_1,1
HP_ABNORMAL_CARDIAC_SEPTUM_M...,SET,657,-0.056662,-0.010525,0.033389,0.95514,HP_ABNORMAL_CARDIAC_SEPTUM_MORPHOLOGY,1
GOBP_TERPENOID_METABOLIC_PRO...,SET,96,-0.16695,-0.01204,0.098361,0.95517,GOBP_TERPENOID_METABOLIC_PROCESS,1
GOBP_PURINE_NUCLEOBASE_BIOSY...,SET,8,-0.48975,-0.010221,0.28854,0.95518,GOBP_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_NON_CANON...1,SET,87,-0.15714,-0.010792,0.092581,0.95518,GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
HP_MACULAR_EDEMA,SET,32,-0.26016,-0.010852,0.15326,0.95519,HP_MACULAR_EDEMA,1
HP_SIDEROBLASTIC_ANEMIA,SET,32,-0.22473,-0.0093741,0.13237,0.95521,HP_SIDEROBLASTIC_ANEMIA,1
SABATES_COLORECTAL_ADENOMA_S...1,SET,11,-0.41484,-0.010151,0.24418,0.95532,SABATES_COLORECTAL_ADENOMA_SIZE_DN,1
REACTOME_ASSEMBLY_OF_THE_HIV...,SET,15,-0.36358,-0.010388,0.214,0.95533,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,1
MIR563,SET,30,-0.27608,-0.011151,0.16248,0.95534,MIR563,1
HP_BREECH_PRESENTATION,SET,49,-0.19955,-0.010295,0.11744,0.95534,HP_BREECH_PRESENTATION,1
GSE1460_DP_THYMOCYTE_VS_NAIV...4,SET,162,-0.10936,-0.010227,0.064358,0.95535,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,1
WP_BIOSYNTHESIS_AND_REGENERA...,SET,12,-0.39273,-0.010037,0.23112,0.95536,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,1
GOMF_POLY_A_RNA_POLYMERASE_A...,SET,5,-0.70996,-0.011714,0.41777,0.95537,GOMF_POLY_A_RNA_POLYMERASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...15,SET,459,-0.066633,-0.010403,0.039198,0.95542,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLUM,1
GOMF_DOUBLE_STRANDED_DNA_3_5...,SET,4,-0.71099,-0.010493,0.41821,0.95543,GOMF_DOUBLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,1
ZWANG_CLASS_1_TRANSIENTLY_IN...,SET,454,-0.071109,-0.011043,0.041822,0.95545,ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,1
GSE37336_LY6C_POS_VS_NEG_NAI...2,SET,132,-0.13172,-0.011129,0.077469,0.95546,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP,1
TGCACGA_MIR517A_MIR517C,SET,17,-0.3375,-0.010265,0.19845,0.95549,TGCACGA_MIR517A_MIR517C,1
REACTOME_SWITCHING_OF_ORIGIN...,SET,88,-0.14135,-0.0097623,0.083088,0.95554,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1
GOCC_ENDOPLASMIC_RETICULUM_P...2,SET,9,-0.46623,-0.01032,0.27404,0.95555,GOCC_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_CONTACT_SITE,1
MIR3663_3P,SET,134,-0.12272,-0.010446,0.072125,0.95556,MIR3663_3P,1
MIR3123,SET,229,-0.10072,-0.011178,0.059192,0.95557,MIR3123,1
HP_ATLANTOAXIAL_ABNORMALITY,SET,12,-0.39539,-0.010105,0.23237,0.95557,HP_ATLANTOAXIAL_ABNORMALITY,1
GOBP_REGULATION_OF_FEMALE_RE...,SET,8,-0.59491,-0.012415,0.34962,0.95558,GOBP_REGULATION_OF_FEMALE_RECEPTIVITY,1
GSE24972_MARGINAL_ZONE_BCELL...4,SET,171,-0.11207,-0.010765,0.065862,0.95558,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP,1
RAFFEL_VEGFA_TARGETS_DN,SET,5,-0.64519,-0.010646,0.37913,0.95559,RAFFEL_VEGFA_TARGETS_DN,1
GOMF_CARBON_NITROGEN_LIGASE_...,SET,10,-0.44055,-0.010279,0.25874,0.95568,GOMF_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR,1
KEGG_PROGESTERONE_MEDIATED_O...,SET,79,-0.16009,-0.010478,0.094006,0.9557,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1
HP_2_4_FINGER_SYNDACTYLY,SET,4,-0.68854,-0.010162,0.40419,0.95575,HP_2_4_FINGER_SYNDACTYLY,1
KEGG_MEDICUS_VARIANT_MUTATIO...22,SET,5,-0.69169,-0.011413,0.40595,0.95579,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_THE_CHIN,SET,336,-0.078902,-0.010576,0.046304,0.9558,HP_ABNORMALITY_OF_THE_CHIN,1
HP_ABNORMAL_METABOLIC_BRAIN_...,SET,46,-0.20885,-0.010441,0.12256,0.95581,HP_ABNORMAL_METABOLIC_BRAIN_IMAGING_BY_MRS,1
GOMF_TUBULIN_BINDING,SET,346,-0.077104,-0.010484,0.045241,0.95583,GOMF_TUBULIN_BINDING,1
MIR4697_5P,SET,14,-0.42504,-0.011733,0.2493,0.95589,MIR4697_5P,1
GOCC_POSTSYNAPTIC_RECYCLING_...,SET,7,-0.48977,-0.0095615,0.28723,0.95591,GOCC_POSTSYNAPTIC_RECYCLING_ENDOSOME,1
GOBP_LYMPHOCYTE_CHEMOTAXIS,SET,42,-0.23392,-0.011175,0.13716,0.95593,GOBP_LYMPHOCYTE_CHEMOTAXIS,1
GOMF_MODIFIED_AMINO_ACID_BIN...,SET,91,-0.16336,-0.011473,0.095795,0.95593,GOMF_MODIFIED_AMINO_ACID_BINDING,1
GOCC_SWI_SNF_COMPLEX,SET,28,-0.26491,-0.010338,0.15533,0.95594,GOCC_SWI_SNF_COMPLEX,1
MIR5000_3P,SET,89,-0.15734,-0.010928,0.092247,0.95596,MIR5000_3P,1
ZNF445_TARGET_GENES,SET,7,-0.58424,-0.011406,0.34246,0.95599,ZNF445_TARGET_GENES,1
DAZARD_UV_RESPONSE_CLUSTER_G...1,SET,21,-0.34505,-0.011663,0.20221,0.95602,DAZARD_UV_RESPONSE_CLUSTER_G24,1
REACTOME_BETA_CATENIN_INDEPE...,SET,142,-0.11798,-0.010335,0.069136,0.95603,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1
MIR6876_5P,SET,204,-0.10357,-0.010856,0.060656,0.95612,MIR6876_5P,1
GNF2_LYN,SET,23,-0.31365,-0.011094,0.1837,0.95612,GNF2_LYN,1
GOBP_NEUROTRANSMITTER_RECEPT...2,SET,22,-0.32366,-0.011197,0.18957,0.95612,GOBP_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GOBP_MONOCYTE_CHEMOTACTIC_PR...,SET,18,-0.40213,-0.012585,0.23549,0.95614,GOBP_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
GOMF_G_PROTEIN_COUPLED_OPIOI...,SET,7,-0.54829,-0.010704,0.32102,0.95617,GOMF_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...473,SET,14,-0.33657,-0.0092904,0.19705,0.95618,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
HP_SCLEROSIS_OF_SKULL_BASE,SET,13,-0.46044,-0.012248,0.26953,0.9562,HP_SCLEROSIS_OF_SKULL_BASE,1
GOBP_BONE_MORPHOGENESIS,SET,96,-0.16001,-0.01154,0.093642,0.95624,GOBP_BONE_MORPHOGENESIS,1
MODULE_447,SET,35,-0.24202,-0.010557,0.14153,0.95636,MODULE_447,1
GOBP_FEAR_RESPONSE,SET,44,-0.24735,-0.012094,0.14462,0.95639,GOBP_FEAR_RESPONSE,1
GOCC_MITOCHONDRIAL_LARGE_RIB...,SET,54,-0.17646,-0.0095559,0.10317,0.95639,GOCC_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT,1
GSE6259_DEC205_POS_DC_VS_CD4...2,SET,180,-0.10696,-0.010539,0.062541,0.95639,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP,1
TST1_01,SET,219,-0.10551,-0.011454,0.06167,0.95643,TST1_01,1
HP_FOCAL_AUTOMATISM_SEIZURE,SET,12,-0.40678,-0.010396,0.23778,0.95643,HP_FOCAL_AUTOMATISM_SEIZURE,1
RODRIGUES_THYROID_CARCINOMA_...5,SET,586,-0.059626,-0.010481,0.034843,0.95648,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,1
GOMF_DYNEIN_INTERMEDIATE_CHA...,SET,31,-0.26586,-0.010915,0.15532,0.95652,GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING,1
HE_LIM_SUN_FETAL_LUNG_C0_EAR...2,SET,518,-0.068718,-0.011378,0.040136,0.95655,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL,1
HP_MYDRIASIS,SET,16,-0.36883,-0.010883,0.21533,0.95662,HP_MYDRIASIS,1
GSE25088_WT_VS_STAT6_KO_MACR...5,SET,183,-0.1047,-0.0104,0.061116,0.95664,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP,1
GOBP_POSITIVE_REGULATION_OF_...368,SET,6,-0.72748,-0.013149,0.42455,0.95668,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,1
RAF_UP.V1_DN,SET,171,-0.12475,-0.011983,0.072802,0.95668,RAF_UP.V1_DN,1
GSE17580_TREG_VS_TEFF_DN,SET,189,-0.10493,-0.010591,0.061237,0.95668,GSE17580_TREG_VS_TEFF_DN,1
GSE2128_CTRL_VS_MIMETOPE_NEG...1,SET,182,-0.10561,-0.010462,0.061627,0.95669,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN,1
GOBP_POSITIVE_REGULATION_OF_...307,SET,39,-0.24049,-0.011072,0.1403,0.95674,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_INTRINSIC...2,SET,28,-0.27594,-0.010768,0.16096,0.95675,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
MIR4322,SET,35,-0.2729,-0.011904,0.15917,0.95678,MIR4322,1
GOBP_SLEEP,SET,21,-0.3472,-0.011736,0.20251,0.95678,GOBP_SLEEP,1
MIR4444,SET,5,-0.59066,-0.009746,0.34447,0.95679,MIR4444,1
GOBP_AMINOPHOSPHOLIPID_TRANS...1,SET,6,-0.56173,-0.010153,0.32749,0.95684,GOBP_AMINOPHOSPHOLIPID_TRANSLOCATION,1
GOBP_NEGATIVE_REGULATION_OF_...340,SET,20,-0.34271,-0.011305,0.1998,0.95684,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
GOMF_AMINOPHOSPHOLIPID_FLIPP...,SET,6,-0.56173,-0.010153,0.32749,0.95684,GOMF_AMINOPHOSPHOLIPID_FLIPPASE_ACTIVITY,1
HP_CAUDAL_APPENDAGE,SET,6,-0.69388,-0.012542,0.40442,0.95689,HP_CAUDAL_APPENDAGE,1
HOEK_PBMC_INACTIVATED_INFLUE...1,SET,8,-0.45216,-0.0094365,0.26345,0.95694,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN,1
GOCC_GABA_ERGIC_SYNAPSE,SET,69,-0.19489,-0.011925,0.11352,0.95698,GOCC_GABA_ERGIC_SYNAPSE,1
GSE40274_FOXP3_VS_FOXP3_AND_...14,SET,116,-0.14636,-0.011597,0.085246,0.95699,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
MIR3201,SET,74,-0.16428,-0.010408,0.095663,0.95702,MIR3201,1
LEI_HOXC8_TARGETS_DN,SET,17,-0.35785,-0.010884,0.20836,0.95704,LEI_HOXC8_TARGETS_DN,1
HP_ABNORMALITY_OF_NAIL_COLOR,SET,17,-0.37463,-0.011394,0.21814,0.95704,HP_ABNORMALITY_OF_NAIL_COLOR,1
KEGG_MEDICUS_REFERENCE_EGF_E...9,SET,15,-0.36633,-0.010467,0.21329,0.95705,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY,1
GOMF_PROTEIN_GLUTAMIC_ACID_L...,SET,9,-0.52569,-0.011636,0.30604,0.95707,GOMF_PROTEIN_GLUTAMIC_ACID_LIGASE_ACTIVITY,1
CRX_Q4,SET,246,-0.098306,-0.011303,0.057227,0.95708,CRX_Q4,1
HP_FLARED_METAPHYSIS,SET,49,-0.2046,-0.010556,0.11911,0.95708,HP_FLARED_METAPHYSIS,1
CHIANG_LIVER_CANCER_SUBCLASS...2,SET,154,-0.12466,-0.011369,0.072564,0.95709,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1
GOBP_HRI_MEDIATED_SIGNALING,SET,5,-0.59772,-0.0098625,0.34784,0.95713,GOBP_HRI_MEDIATED_SIGNALING,1
REACTOME_ALPHA_PROTEIN_KINAS...,SET,9,-0.54972,-0.012168,0.31986,0.95715,REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,1
HP_SHORT_NOSE,SET,276,-0.088334,-0.010749,0.051384,0.95719,HP_SHORT_NOSE,1
HP_DECREASED_CIRCULATING_MET...,SET,8,-0.55472,-0.011577,0.32267,0.9572,HP_DECREASED_CIRCULATING_METHYLCOBALAMIN_CONCENTRATION,1
GOMF_FOLIC_ACID_BINDING,SET,12,-0.42247,-0.010797,0.24572,0.95722,GOMF_FOLIC_ACID_BINDING,1
GOCC_PROTEASOME_COMPLEX,SET,60,-0.1678,-0.0095766,0.097568,0.95726,GOCC_PROTEASOME_COMPLEX,1
REACTOME_LYSOSOME_VESICLE_BI...,SET,32,-0.24685,-0.010296,0.14349,0.95731,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,1
MIR5586_5P,SET,74,-0.17897,-0.011339,0.10403,0.95731,MIR5586_5P,1
GOBP_NEGATIVE_REGULATION_OF_...185,SET,3,-0.88979,-0.011373,0.51713,0.95733,GOBP_NEGATIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,1
GOBP_EPITHELIAL_CELL_MORPHOG...,SET,30,-0.29296,-0.011832,0.17026,0.95734,GOBP_EPITHELIAL_CELL_MORPHOGENESIS,1
HP_INCREASED_NUCHAL_TRANSLUC...,SET,46,-0.23195,-0.011595,0.13476,0.95738,HP_INCREASED_NUCHAL_TRANSLUCENCY,1
HP_SKIN_DIMPLE,SET,102,-0.15611,-0.011604,0.090692,0.9574,HP_SKIN_DIMPLE,1
MIR9_5P,SET,436,-0.072874,-0.011096,0.042318,0.95746,MIR9_5P,1
IIZUKA_LIVER_CANCER_EARLY_RE...,SET,11,-0.47943,-0.011731,0.27839,0.95747,IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,1
GOMF_LYSOZYME_ACTIVITY,SET,9,-0.50636,-0.011208,0.29402,0.95747,GOMF_LYSOZYME_ACTIVITY,1
HP_POSTERIOR_PITUITARY_DYSGE...,SET,22,-0.32133,-0.011116,0.18655,0.9575,HP_POSTERIOR_PITUITARY_DYSGENESIS,1
MIR4727_3P,SET,31,-0.27033,-0.011099,0.15694,0.95751,MIR4727_3P,1
HP_ABNORMAL_FINGER_MORPHOLOGY,SET,1056,-0.046342,-0.01079,0.026903,0.95751,HP_ABNORMAL_FINGER_MORPHOLOGY,1
DHIMAN_PBMC_ATTENUVAX_AGE_15...2,SET,44,-0.21773,-0.010646,0.1264,0.95751,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_UP,1
MIR625_5P,SET,190,-0.10788,-0.010917,0.062622,0.95752,MIR625_5P,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...4,SET,150,-0.11196,-0.010078,0.064982,0.95754,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...64,SET,16,-0.3613,-0.010661,0.20962,0.9576,HP_APLASIA_HYPOPLASIA_OF_THE_SACRUM,1
GOCC_ENDOCYTIC_VESICLE,SET,314,-0.087614,-0.011359,0.05083,0.95761,GOCC_ENDOCYTIC_VESICLE,1
MODULE_110,SET,4,-0.6343,-0.0093614,0.36796,0.95762,MODULE_110,1
HP_PREMATURE_ADRENARCHE,SET,10,-0.51714,-0.012066,0.29995,0.95765,HP_PREMATURE_ADRENARCHE,1
MIR4265,SET,36,-0.27086,-0.011982,0.15708,0.95767,MIR4265,1
GOBP_OXIDATIVE_PHOSPHORYLATI...,SET,105,-0.12845,-0.0096864,0.074494,0.95767,GOBP_OXIDATIVE_PHOSPHORYLATION,1
ZNF548_TARGET_GENES,SET,45,-0.23042,-0.011393,0.13361,0.95768,ZNF548_TARGET_GENES,1
REACTOME_REGULATION_OF_PTEN_...4,SET,65,-0.16643,-0.0098852,0.096475,0.95774,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1
ZNF211_TARGET_GENES,SET,2,-0.70833,-0.0073925,0.41044,0.9578,ZNF211_TARGET_GENES,1
GOBP_AXONEME_ASSEMBLY,SET,70,-0.16771,-0.010335,0.097144,0.95785,GOBP_AXONEME_ASSEMBLY,1
BURTON_ADIPOGENESIS_10,SET,26,-0.2788,-0.010484,0.16145,0.9579,BURTON_ADIPOGENESIS_10,1
GSE18203_CTRL_VS_INTRATUMORA...2,SET,187,-0.10402,-0.010444,0.060228,0.95791,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP,1
CUI_DEVELOPING_HEART_C5_VALV...,SET,183,-0.1167,-0.011592,0.067547,0.95796,CUI_DEVELOPING_HEART_C5_VALVAR_CELL,1
GOBP_MITOCHONDRIAL_TRANSMEMB...,SET,89,-0.1529,-0.01062,0.088448,0.95806,GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_MESENCHYM...2,SET,10,-0.50923,-0.011881,0.29458,0.95806,GOBP_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,1
HP_NEONATAL_BREATHING_DYSREG...,SET,5,-0.54133,-0.0089321,0.31295,0.95816,HP_NEONATAL_BREATHING_DYSREGULATION,1
HP_SPINAL_DYSRAPHISM,SET,129,-0.13197,-0.011023,0.076275,0.95819,HP_SPINAL_DYSRAPHISM,1
GOBP_G_PROTEIN_COUPLED_PURIN...1,SET,10,-0.59836,-0.013961,0.3457,0.95825,GOBP_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_G_PROTEIN_COUPLED_PURIN...,SET,10,-0.59836,-0.013961,0.3457,0.95825,GOMF_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY,1
MIR4513,SET,46,-0.21286,-0.010641,0.12297,0.95826,MIR4513,1
HP_LATERAL_VENTRICLE_DILATAT...,SET,75,-0.1662,-0.010601,0.096016,0.95826,HP_LATERAL_VENTRICLE_DILATATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...63,SET,116,-0.13428,-0.01064,0.077567,0.95828,HP_APLASIA_HYPOPLASIA_OF_THE_RIBS,1
GOBP_AMMONIUM_ION_METABOLIC_...,SET,22,-0.35932,-0.012431,0.20755,0.95829,GOBP_AMMONIUM_ION_METABOLIC_PROCESS,1
GOBP_PROTEIN_LOCALIZATION_TO...10,SET,62,-0.18852,-0.010937,0.10887,0.95832,GOBP_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
HP_RIGIDITY,SET,185,-0.10742,-0.010728,0.062025,0.95834,HP_RIGIDITY,1
HP_HYPEREXTENSIBLE_SKIN,SET,60,-0.18927,-0.010802,0.10926,0.95838,HP_HYPEREXTENSIBLE_SKIN,1
HP_APLASIA_HYPOPLASIA_OF_THE...39,SET,14,-0.41229,-0.011381,0.23796,0.95841,HP_APLASIA_HYPOPLASIA_OF_THE_LENS,1
GNF2_CARD15,SET,62,-0.19585,-0.011362,0.11291,0.95859,GNF2_CARD15,1
GSE10273_HIGH_VS_LOW_IL7_TRE...2,SET,171,-0.11019,-0.010585,0.0635,0.95865,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP,1
GSE5542_UNTREATED_VS_IFNA_TR...4,SET,172,-0.11632,-0.011205,0.067031,0.95865,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,1
REACTOME_CYCLIN_A_CDK2_ASSOC...,SET,82,-0.145,-0.0096687,0.083534,0.95869,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1
KEGG_MEDICUS_REFERENCE_STRAD...,SET,8,-0.5198,-0.010848,0.29945,0.9587,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY,1
MODULE_324,SET,126,-0.14727,-0.012158,0.084842,0.9587,MODULE_324,1
HP_PRIMARY_GONADAL_INSUFFICI...,SET,15,-0.38865,-0.011104,0.22371,0.95882,HP_PRIMARY_GONADAL_INSUFFICIENCY,1
KEGG_MEDICUS_REFERENCE_GNRH_...,SET,20,-0.34441,-0.011361,0.1982,0.95886,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY,1
GOBP_G_PROTEIN_COUPLED_RECEP...1,SET,9,-0.47911,-0.010605,0.27567,0.95888,GOBP_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION,1
GOBP_ASPARTATE_FAMILY_AMINO_...3,SET,41,-0.23384,-0.011038,0.13453,0.9589,GOBP_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
HP_NARROW_INTERNAL_AUDITORY_...,SET,15,-0.41014,-0.011718,0.23594,0.95891,HP_NARROW_INTERNAL_AUDITORY_CANAL,1
GOMF_HISTONE_H3K9ME_H3K9ME2_...,SET,4,-0.63706,-0.0094022,0.36634,0.95897,GOMF_HISTONE_H3K9ME_H3K9ME2_DEMETHYLASE_ACTIVITY,1
TATA_01,SET,221,-0.10554,-0.01151,0.060685,0.95899,TATA_01,1
HP_ABNORMAL_CSF_PYRUVATE_FAM...,SET,5,-0.74842,-0.012349,0.43027,0.95901,HP_ABNORMAL_CSF_PYRUVATE_FAMILY_AMINO_ACID_CONCENTRATION,1
GSE3982_MAC_VS_TH1_UP,SET,181,-0.11353,-0.011216,0.065266,0.95901,GSE3982_MAC_VS_TH1_UP,1
HP_THORACOLUMBAR_KYPHOSIS,SET,18,-0.36893,-0.011546,0.21208,0.95903,HP_THORACOLUMBAR_KYPHOSIS,1
MODULE_259,SET,41,-0.25265,-0.011926,0.14522,0.95904,MODULE_259,1
GOBP_NEGATIVE_REGULATION_OF_...54,SET,4,-0.7886,-0.011639,0.45326,0.95905,GOBP_NEGATIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,1
GAUTAM_EYE_CORNEA_CYTOTOXIC_...,SET,124,-0.13141,-0.010763,0.075527,0.95906,GAUTAM_EYE_CORNEA_CYTOTOXIC_T_CELLS,1
HP_CHRONIC_CSF_LYMPHOCYTOSIS,SET,8,-0.47654,-0.0099452,0.27386,0.95907,HP_CHRONIC_CSF_LYMPHOCYTOSIS,1
REACTOME_EGFR_TRANSACTIVATIO...,SET,9,-0.46981,-0.010399,0.26996,0.95909,REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN,1
GSE15330_LYMPHOID_MULTIPOTEN...3,SET,176,-0.10784,-0.010508,0.061955,0.95912,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
GOMF_PORIN_ACTIVITY,SET,5,-0.74035,-0.012216,0.42526,0.95915,GOMF_PORIN_ACTIVITY,1
MIR6779_5P,SET,158,-0.11734,-0.010839,0.067397,0.95916,MIR6779_5P,1
GAO_ESOPHAGUS_25W_C1_CILIATE...,SET,375,-0.076241,-0.010784,0.043789,0.95916,GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS,1
GSE19825_NAIVE_VS_DAY3_EFF_C...2,SET,177,-0.11723,-0.011454,0.067319,0.95918,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP,1
ZNF157_TARGET_GENES,SET,58,-0.19743,-0.011079,0.11336,0.95919,ZNF157_TARGET_GENES,1
OCT1_06,SET,221,-0.10663,-0.011628,0.061211,0.95923,OCT1_06,1
MIR6837_3P,SET,101,-0.14859,-0.010991,0.085294,0.95925,MIR6837_3P,1
GOBP_POSITIVE_REGULATION_OF_...657,SET,12,-0.44646,-0.01141,0.25622,0.95928,GOBP_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY,1
HP_MACROGLOSSIA,SET,134,-0.12914,-0.010993,0.074117,0.95928,HP_MACROGLOSSIA,1
MIR219A_2_3P,SET,64,-0.18646,-0.010989,0.107,0.95929,MIR219A_2_3P,1
MIR6830_5P,SET,163,-0.12065,-0.011317,0.069223,0.95931,MIR6830_5P,1
GOBP_MODIFICATION_OF_POSTSYN...1,SET,10,-0.47563,-0.011097,0.27289,0.95932,GOBP_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
GOBP_SULFUR_COMPOUND_BIOSYNT...,SET,155,-0.1267,-0.011592,0.07267,0.95937,GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS,1
GSE2770_TGFB_AND_IL4_VS_IL12...2,SET,172,-0.10963,-0.010561,0.062875,0.95937,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
GOBP_MELANOSOME_ASSEMBLY,SET,18,-0.35583,-0.011136,0.20408,0.95938,GOBP_MELANOSOME_ASSEMBLY,1
GOBP_OTIC_VESICLE_FORMATION,SET,8,-0.48443,-0.01011,0.27778,0.95941,GOBP_OTIC_VESICLE_FORMATION,1
GOMF_TRANSFORMING_GROWTH_FAC...1,SET,23,-0.33631,-0.011896,0.19281,0.95943,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...19,SET,50,-0.22386,-0.011666,0.12834,0.95944,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE17186_MEMORY_VS_CD21HIGH_...2,SET,182,-0.11225,-0.01112,0.064337,0.95947,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
AHRARNT_02,SET,14,-0.39935,-0.011023,0.22879,0.95954,AHRARNT_02,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...2,SET,57,-0.19747,-0.010986,0.11314,0.95954,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
HP_DYSGYRIA,SET,7,-0.56594,-0.011048,0.32412,0.95959,HP_DYSGYRIA,1
ABBUD_LIF_SIGNALING_2_UP,SET,13,-0.44696,-0.011889,0.25596,0.95961,ABBUD_LIF_SIGNALING_2_UP,1
GOBP_EXIT_FROM_MITOSIS,SET,29,-0.27194,-0.010799,0.15573,0.95961,GOBP_EXIT_FROM_MITOSIS,1
TGCACTG_MIR148A_MIR152_MIR14...,SET,270,-0.094148,-0.011333,0.053895,0.95966,TGCACTG_MIR148A_MIR152_MIR148B,1
REACTOME_SIGNALING_BY_NOTCH4,SET,77,-0.15475,-0.01,0.088577,0.95968,REACTOME_SIGNALING_BY_NOTCH4,1
GOMF_SULFURTRANSFERASE_ACTIV...,SET,11,-0.44461,-0.010879,0.25448,0.95968,GOMF_SULFURTRANSFERASE_ACTIVITY,1
SESTO_RESPONSE_TO_UV_C3,SET,19,-0.34386,-0.011056,0.19671,0.95976,SESTO_RESPONSE_TO_UV_C3,1
MIR3132,SET,62,-0.18653,-0.010821,0.10671,0.95976,MIR3132,1
GOBP_CELL_PROJECTION_ASSEMBLY,SET,537,-0.065293,-0.011002,0.037354,0.95976,GOBP_CELL_PROJECTION_ASSEMBLY,1
GOBP_REGULATION_OF_EPITHELIA...7,SET,100,-0.16062,-0.011822,0.091865,0.9598,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
MODULE_8,SET,393,-0.075282,-0.010896,0.04304,0.95986,MODULE_8,1
REACTOME_ASSEMBLY_OF_ACTIVE_...,SET,16,-0.41377,-0.012209,0.23648,0.95991,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1
GOMF_METAL_CATION_MONOATOMIC...,SET,39,-0.24057,-0.011076,0.13749,0.95991,GOMF_METAL_CATION_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,1
GSE11961_MEMORY_BCELL_DAY7_V...1,SET,174,-0.11161,-0.010813,0.06376,0.95997,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GOMF_ENZYME_SUBSTRATE_ADAPTO...,SET,65,-0.18985,-0.011276,0.10845,0.95998,GOMF_ENZYME_SUBSTRATE_ADAPTOR_ACTIVITY,1
WP_GLYCOSAMINOGLYCAN_SYNTHES...,SET,39,-0.24526,-0.011292,0.1401,0.95999,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,1
AAGCACA_MIR218,SET,372,-0.082144,-0.011573,0.046922,0.95999,AAGCACA_MIR218,1
HP_ABNORMALITY_OF_THE_UPPER_...1,SET,65,-0.19591,-0.011636,0.11185,0.96007,HP_ABNORMALITY_OF_THE_UPPER_ARM,1
GOBP_NEGATIVE_REGULATION_OF_...301,SET,12,-0.43492,-0.011115,0.24824,0.9601,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,1
HIPC_SIGNATURES_PROJECT_PBMC...2,SET,9,-0.50743,-0.011232,0.28963,0.9601,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP,1
WP_DISORDERS_IN_KETOLYSIS,SET,5,-0.61313,-0.010117,0.34991,0.96012,WP_DISORDERS_IN_KETOLYSIS,1
GSE13411_NAIVE_VS_MEMORY_BCE...2,SET,163,-0.11887,-0.011151,0.067843,0.96012,GSE13411_NAIVE_VS_MEMORY_BCELL_UP,1
GOBP_TRANSLATION,SET,579,-0.059609,-0.010417,0.034016,0.96014,GOBP_TRANSLATION,1
GOCC_BOX_C_D_RNP_COMPLEX,SET,4,-0.67683,-0.0099891,0.38623,0.96014,GOCC_BOX_C_D_RNP_COMPLEX,1
TURASHVILI_BREAST_NORMAL_DUC...2,SET,57,-0.19088,-0.010619,0.10891,0.96016,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,1
GSE17721_12H_VS_24H_PAM3CSK4...2,SET,180,-0.11123,-0.01096,0.063463,0.96017,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP,1
HEBERT_MATRISOME_TNBC_LUNG_M...1,SET,20,-0.34627,-0.011422,0.1975,0.96022,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS,1
HP_INFANTILE_ONSET,SET,1171,-0.044878,-0.010966,0.025595,0.96022,HP_INFANTILE_ONSET,1
SESTO_RESPONSE_TO_UV_C2,SET,50,-0.20129,-0.01049,0.11479,0.96024,SESTO_RESPONSE_TO_UV_C2,1
MIR1972,SET,88,-0.15844,-0.010942,0.09034,0.96026,MIR1972,1
HP_TAPERED_DISTAL_PHALANGES_...,SET,6,-0.72435,-0.013092,0.41301,0.96026,HP_TAPERED_DISTAL_PHALANGES_OF_FINGER,1
GOBP_LEUKOCYTE_MIGRATION_INV...,SET,19,-0.35238,-0.01133,0.20088,0.96029,GOBP_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
JIANG_HYPOXIA_CANCER,SET,53,-0.20108,-0.010788,0.11452,0.96043,JIANG_HYPOXIA_CANCER,1
MIR3611,SET,135,-0.12916,-0.011034,0.073546,0.96046,MIR3611,1
GOBP_CEMENTUM_MINERALIZATION,SET,5,-0.7285,-0.01202,0.41482,0.96046,GOBP_CEMENTUM_MINERALIZATION,1
GSE46606_UNSTIM_VS_CD40L_IL2...4,SET,178,-0.1094,-0.010719,0.062275,0.96051,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,1
TERAO_AOX4_TARGETS_SKIN_DN,SET,17,-0.37831,-0.011506,0.21518,0.96063,TERAO_AOX4_TARGETS_SKIN_DN,1
HP_ABNORMAL_METAPHYSIS_MORPH...,SET,204,-0.10438,-0.010942,0.059365,0.96065,HP_ABNORMAL_METAPHYSIS_MORPHOLOGY,1
LIM_MAMMARY_LUMINAL_PROGENIT...2,SET,57,-0.20778,-0.011559,0.11811,0.96072,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,1
GOCC_SPECTRIN,SET,9,-0.48732,-0.010787,0.277,0.96072,GOCC_SPECTRIN,1
HU_FETAL_RETINA_PHOTORECEPTOR,SET,65,-0.19669,-0.011683,0.1118,0.96073,HU_FETAL_RETINA_PHOTORECEPTOR,1
REACTOME_SURFACTANT_METABOLI...,SET,26,-0.32638,-0.012273,0.18543,0.96079,REACTOME_SURFACTANT_METABOLISM,1
HP_GENU_VALGUM,SET,139,-0.13034,-0.011298,0.074057,0.96079,HP_GENU_VALGUM,1
GOCC_MICROTUBULE_PLUS_END,SET,24,-0.31184,-0.011267,0.17716,0.9608,GOCC_MICROTUBULE_PLUS_END,1
GSE26669_CD4_VS_CD8_TCELL_IN...4,SET,184,-0.10987,-0.010944,0.06242,0.9608,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...56,SET,200,-0.10937,-0.011352,0.06213,0.96081,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HAND,1
REACTOME_CROSS_PRESENTATION_...2,SET,47,-0.19094,-0.0096484,0.1084,0.96091,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,1
GOBP_NEGATIVE_REGULATION_OF_...416,SET,41,-0.24979,-0.011791,0.14181,0.96091,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOBP_MITOCHONDRIAL_DNA_METAB...,SET,21,-0.29888,-0.010102,0.16965,0.96094,GOBP_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,1
LY_AGING_MIDDLE_DN,SET,15,-0.34833,-0.0099522,0.1977,0.96095,LY_AGING_MIDDLE_DN,1
HP_DECREASED_CIRCULATING_COP...,SET,6,-0.66447,-0.01201,0.37714,0.96095,HP_DECREASED_CIRCULATING_COPPER_CONCENTRATION,1
MIR548AN,SET,438,-0.074227,-0.011327,0.042091,0.96108,MIR548AN,1
MIR509_3P,SET,53,-0.20666,-0.011087,0.11716,0.96111,MIR509_3P,1
GSE18791_UNSTIM_VS_NEWCATSLE...2,SET,186,-0.10642,-0.010657,0.060322,0.96114,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP,1
GSE6259_33D1_POS_DC_VS_CD4_T...1,SET,163,-0.11742,-0.011014,0.066539,0.96118,GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...213,SET,6,-0.62501,-0.011297,0.35405,0.96123,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,1
GOMF_ALPHA_1_3_FUCOSYLTRANSF...,SET,8,-0.641,-0.013377,0.36286,0.96134,GOMF_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY,1
REACTOME_REELIN_SIGNALLING_P...,SET,4,-0.80704,-0.011911,0.45663,0.96141,REACTOME_REELIN_SIGNALLING_PATHWAY,1
HP_URINARY_RETENTION,SET,24,-0.32753,-0.011834,0.18531,0.96142,HP_URINARY_RETENTION,1
REACTOME_APC_C_CDC20_MEDIATE...,SET,22,-0.3043,-0.010527,0.17212,0.96145,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,1
GOBP_POSITIVE_REGULATION_OF_...670,SET,40,-0.23599,-0.011003,0.13347,0.96147,GOBP_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,1
HP_JOINT_SUBLUXATION,SET,26,-0.29975,-0.011272,0.16952,0.96148,HP_JOINT_SUBLUXATION,1
HP_INFERIOR_CEREBELLAR_VERMI...,SET,13,-0.41444,-0.011024,0.23435,0.9615,HP_INFERIOR_CEREBELLAR_VERMIS_HYPOPLASIA,1
GSE2585_THYMIC_MACROPHAGE_VS...1,SET,165,-0.11754,-0.011092,0.06645,0.96153,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN,1
GOBP_GLUTAMINE_FAMILY_AMINO_...3,SET,66,-0.19639,-0.011754,0.111,0.96157,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
KEGG_PEROXISOME,SET,74,-0.17428,-0.011042,0.09849,0.96158,KEGG_PEROXISOME,1
GSE22886_CD8_TCELL_VS_BCELL_...1,SET,170,-0.1184,-0.01134,0.066912,0.96159,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN,1
MIR1271_5P,SET,355,-0.083283,-0.011468,0.047054,0.96162,MIR1271_5P,1
GOBP_HEART_VALVE_DEVELOPMENT,SET,72,-0.19501,-0.012188,0.11017,0.96163,GOBP_HEART_VALVE_DEVELOPMENT,1
GSE40277_EOS_AND_LEF1_TRANSD...2,SET,175,-0.11523,-0.011196,0.065074,0.96168,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,1
HP_ABNORMAL_RETINAL_MORPHOLO...,SET,845,-0.052907,-0.011086,0.029878,0.96169,HP_ABNORMAL_RETINAL_MORPHOLOGY,1
chr4p12,SET,15,-0.69751,-0.019929,0.39387,0.9617,chr4p12,1
GOBP_LONG_TERM_SYNAPTIC_POTE...,SET,88,-0.16737,-0.011559,0.094492,0.96173,GOBP_LONG_TERM_SYNAPTIC_POTENTIATION,1
GOBP_AXONEMAL_DYNEIN_COMPLEX...,SET,26,-0.26899,-0.010115,0.15185,0.96174,GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY,1
GSE39110_DAY3_VS_DAY6_POST_I...2,SET,180,-0.11455,-0.011286,0.064668,0.96174,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP,1
MIR4781_3P,SET,35,-0.24715,-0.01078,0.13948,0.96179,MIR4781_3P,1
STAT5A_04,SET,188,-0.11641,-0.011719,0.065692,0.9618,STAT5A_04,1
HP_WIDE_MOUTH,SET,188,-0.10925,-0.010999,0.061648,0.96181,HP_WIDE_MOUTH,1
FERRANDO_HOX11_NEIGHBORS,SET,22,-0.34642,-0.011984,0.19544,0.96183,FERRANDO_HOX11_NEIGHBORS,1
HP_DECREASED_PROPORTION_OF_C...2,SET,8,-0.50869,-0.010616,0.28695,0.96186,HP_DECREASED_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
WP_PHOTODYNAMIC_THERAPYINDUC...2,SET,34,-0.26418,-0.011358,0.14898,0.9619,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...4,SET,108,-0.15045,-0.011505,0.084835,0.96191,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,1
chr12q21,SET,59,-0.3618,-0.020476,0.20398,0.96193,chr12q21,1
TRAVAGLINI_LUNG_VASCULAR_SMO...,SET,57,-0.21684,-0.012063,0.12226,0.96193,TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL,1
GOBP_GMP_BIOSYNTHETIC_PROCESS,SET,13,-0.41512,-0.011042,0.23397,0.96198,GOBP_GMP_BIOSYNTHETIC_PROCESS,1
GOBP_CELLULAR_MODIFIED_AMINO...3,SET,175,-0.11406,-0.011082,0.06426,0.96204,GOBP_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS,1
HP_3_METHYLGLUTACONIC_ACIDUR...,SET,17,-0.37264,-0.011334,0.20994,0.96204,HP_3_METHYLGLUTACONIC_ACIDURIA,1
YANAGISAWA_LUNG_CANCER_RECUR...,SET,6,-0.77135,-0.013942,0.43446,0.96208,YANAGISAWA_LUNG_CANCER_RECURRENCE,1
REACTOME_SARS_COV_2_TARGETS_...1,SET,12,-0.46866,-0.011977,0.26387,0.96213,REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,1
KEGG_DRUG_METABOLISM_CYTOCHR...,SET,65,-0.25405,-0.015089,0.14303,0.96214,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,1
PER1_TARGET_GENES,SET,21,-0.33496,-0.011322,0.18859,0.96214,PER1_TARGET_GENES,1
GSE41176_WT_VS_TAK1_KO_ANTI_...7,SET,183,-0.11121,-0.011047,0.062611,0.96214,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN,1
UNTERMAN_IPF_VS_CTRL_MONOCYT...1,SET,19,-0.40286,-0.012953,0.2268,0.96215,UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...552,SET,5,-0.70678,-0.011662,0.39788,0.96215,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_RECYCLING,1
GARCIA_PINERES_PBMC_HPV_16_L...6,SET,20,-0.3525,-0.011628,0.19844,0.96216,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
MIR6774_3P,SET,5,-0.81364,-0.013425,0.45788,0.96221,MIR6774_3P,1
GOBP_POSITIVE_REGULATION_OF_...188,SET,6,-0.62831,-0.011357,0.35344,0.96227,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
LET_7D_5P,SET,316,-0.088275,-0.011481,0.049651,0.96228,LET_7D_5P,1
GOCC_CHOLINERGIC_SYNAPSE,SET,10,-0.5418,-0.012641,0.30473,0.96228,GOCC_CHOLINERGIC_SYNAPSE,1
EBAUER_TARGETS_OF_PAX3_FOXO1...2,SET,172,-0.12103,-0.01166,0.068061,0.96231,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1
BIOCARTA_INTEGRIN_PATHWAY,SET,34,-0.2636,-0.011333,0.14823,0.96231,BIOCARTA_INTEGRIN_PATHWAY,1
HP_ABNORMALITY_OF_FONTANELLES,SET,180,-0.11248,-0.011082,0.063249,0.96231,HP_ABNORMALITY_OF_FONTANELLES,1
REACTOME_REGULATION_OF_LOCAL...,SET,11,-0.46992,-0.011499,0.26425,0.96232,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,1
RUAN_RESPONSE_TO_TNF_TROGLIT...1,SET,35,-0.28043,-0.012232,0.15765,0.96235,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1
HP_ABNORMAL_HAND_MORPHOLOGY,SET,920,-0.051135,-0.011156,0.028748,0.96235,HP_ABNORMAL_HAND_MORPHOLOGY,1
HP_CONGENITAL_STATIONARY_NIG...,SET,18,-0.37373,-0.011696,0.21001,0.96242,HP_CONGENITAL_STATIONARY_NIGHT_BLINDNESS,1
HP_RENAL_TUBULAR_DYSFUNCTION,SET,90,-0.15419,-0.010769,0.086625,0.96245,HP_RENAL_TUBULAR_DYSFUNCTION,1
LI_INDUCED_T_TO_NATURAL_KILL...2,SET,287,-0.091991,-0.011411,0.051679,0.96246,LI_INDUCED_T_TO_NATURAL_KILLER_UP,1
MIKKELSEN_MEF_ICP_WITH_H3K27...,SET,187,-0.11469,-0.011515,0.064421,0.96248,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,1
GOMF_PROTEIN_LIPID_COMPLEX_B...,SET,27,-0.32375,-0.012406,0.1818,0.96252,GOMF_PROTEIN_LIPID_COMPLEX_BINDING,1
HP_ABNORMAL_CARDIAC_VENTRICU...,SET,142,-0.13249,-0.011607,0.0744,0.96252,HP_ABNORMAL_CARDIAC_VENTRICULAR_FUNCTION,1
MIR320A_5P,SET,98,-0.15552,-0.011332,0.087317,0.96254,MIR320A_5P,1
TGANTCA_AP1_C,SET,1018,-0.050493,-0.011555,0.02835,0.96254,TGANTCA_AP1_C,1
HP_ABNORMAL_LIP_MORPHOLOGY,SET,1049,-0.048197,-0.011186,0.027055,0.96257,HP_ABNORMAL_LIP_MORPHOLOGY,1
ZNF92_TARGET_GENES,SET,1104,-0.04821,-0.011461,0.027059,0.96259,ZNF92_TARGET_GENES,1
GSE17721_12H_VS_24H_GARDIQUI...1,SET,176,-0.10799,-0.010522,0.060613,0.96259,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN,1
GOCC_ACTOMYOSIN,SET,86,-0.17267,-0.01179,0.096892,0.96262,GOCC_ACTOMYOSIN,1
GOMF_POLY_G_BINDING,SET,7,-0.53542,-0.010453,0.30035,0.96267,GOMF_POLY_G_BINDING,1
SCHLOSSER_MYC_TARGETS_AND_SE...1,SET,42,-0.2139,-0.010219,0.11996,0.96271,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,1
MIR26A_1_3P,SET,66,-0.18107,-0.010837,0.10154,0.96272,MIR26A_1_3P,1
WANG_LSD1_TARGETS_UP,SET,21,-0.36224,-0.012244,0.20309,0.96275,WANG_LSD1_TARGETS_UP,1
HP_SPASTIC_PARAPARESIS,SET,49,-0.20129,-0.010385,0.11285,0.96275,HP_SPASTIC_PARAPARESIS,1
AAGCAAT_MIR137,SET,198,-0.11461,-0.011837,0.064246,0.96277,AAGCAAT_MIR137,1
GOBP_CALCIUM_ION_IMPORT,SET,73,-0.18503,-0.011644,0.10371,0.96279,GOBP_CALCIUM_ION_IMPORT,1
GOCC_NEURON_TO_NEURON_SYNAPSE,SET,338,-0.085125,-0.011443,0.047708,0.9628,GOCC_NEURON_TO_NEURON_SYNAPSE,1
GSE34156_NOD2_LIGAND_VS_NOD2...2,SET,155,-0.12545,-0.011478,0.070311,0.9628,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
BIOCARTA_UCALPAIN_PATHWAY,SET,14,-0.42725,-0.011794,0.23938,0.96284,BIOCARTA_UCALPAIN_PATHWAY,1
GOBP_RESPONSE_TO_L_GLUTAMATE,SET,15,-0.39058,-0.011159,0.21879,0.96288,GOBP_RESPONSE_TO_L_GLUTAMATE,1
MIR365A_5P,SET,30,-0.29228,-0.011805,0.16369,0.96291,MIR365A_5P,1
GSE14413_UNSTIM_VS_IFNB_STIM...2,SET,110,-0.14536,-0.011218,0.081387,0.96295,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP,1
SANSOM_APC_TARGETS,SET,191,-0.11051,-0.011213,0.061869,0.96296,SANSOM_APC_TARGETS,1
TSUNODA_CISPLATIN_RESISTANCE...2,SET,11,-0.51631,-0.012634,0.28901,0.96298,TSUNODA_CISPLATIN_RESISTANCE_UP,1
GSE18281_SUBCAPSULAR_VS_CENT...1,SET,187,-0.11085,-0.01113,0.062041,0.963,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN,1
GOBP_MINERALOCORTICOID_SECRE...,SET,7,-0.64818,-0.012654,0.36275,0.96301,GOBP_MINERALOCORTICOID_SECRETION,1
LIU_CDX2_TARGETS_DN,SET,8,-0.61181,-0.012768,0.34238,0.96302,LIU_CDX2_TARGETS_DN,1
KEGG_MEDICUS_VARIANT_MET_OVE...,SET,13,-0.40776,-0.010846,0.22804,0.96311,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_LARGE_FACE,SET,225,-0.10021,-0.011025,0.056038,0.96312,HP_LARGE_FACE,1
GOBP_REGULATION_OF_VASCULAR_...4,SET,29,-0.28829,-0.011449,0.16121,0.96313,GOBP_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
TGCAAAC_MIR452,SET,86,-0.17644,-0.012047,0.09864,0.96316,TGCAAAC_MIR452,1
GOBP_NEGATIVE_REGULATION_OF_...286,SET,6,-0.55722,-0.010071,0.31144,0.9632,GOBP_NEGATIVE_REGULATION_OF_HYPOXIA_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_CHONDROCYTE_DEVELOPMENT...,SET,8,-0.61229,-0.012778,0.3422,0.96321,GOBP_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_PROTEIN_TRANSMEMBRANE_I...,SET,33,-0.25239,-0.010691,0.14104,0.96323,GOBP_PROTEIN_TRANSMEMBRANE_IMPORT_INTO_INTRACELLULAR_ORGANELLE,1
MIR4645_5P,SET,103,-0.15163,-0.011325,0.084725,0.96324,MIR4645_5P,1
VANDESLUIS_NORMAL_EMBRYOS_DN,SET,19,-0.40143,-0.012907,0.22429,0.96325,VANDESLUIS_NORMAL_EMBRYOS_DN,1
GOBP_MYOBLAST_FATE_COMMITMENT,SET,6,-0.71191,-0.012867,0.39775,0.96325,GOBP_MYOBLAST_FATE_COMMITMENT,1
CAVIN1_TARGET_GENES,SET,62,-0.18756,-0.010881,0.10476,0.96329,CAVIN1_TARGET_GENES,1
HP_MONOCYTOSIS,SET,15,-0.34565,-0.0098756,0.19304,0.96331,HP_MONOCYTOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...284,SET,5,-0.7118,-0.011745,0.39739,0.96336,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
WP_AFLATOXIN_B1_METABOLISM,SET,6,-0.6692,-0.012095,0.37351,0.9634,WP_AFLATOXIN_B1_METABOLISM,1
MIR6834_3P,SET,42,-0.23322,-0.011142,0.13012,0.96346,MIR6834_3P,1
HP_REDUCED_AMPLITUDE_OF_DARK...,SET,12,-0.45653,-0.011668,0.25471,0.96346,HP_REDUCED_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM_A_WAVE,1
GOBP_REGULATION_OF_GAMMA_AMI...,SET,8,-0.60821,-0.012693,0.33922,0.9635,GOBP_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION,1
MIR411_5P,SET,44,-0.22464,-0.010984,0.12522,0.96358,MIR411_5P,1
HP_ABNORMAL_RIGHT_VENTRICLE_...,SET,61,-0.20033,-0.011528,0.11165,0.9636,HP_ABNORMAL_RIGHT_VENTRICLE_MORPHOLOGY,1
ZNF514_TARGET_GENES,SET,7,-0.59657,-0.011646,0.33242,0.96364,ZNF514_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...741,SET,152,-0.13096,-0.011866,0.072914,0.96375,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
WOTTON_RUNX_TARGETS_UP,SET,18,-0.35422,-0.011085,0.19717,0.96378,WOTTON_RUNX_TARGETS_UP,1
GOBP_PARALLEL_ACTIN_FILAMENT...,SET,7,-0.61033,-0.011915,0.33975,0.96378,GOBP_PARALLEL_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
GOBP_REGULATION_OF_SYSTEM_PR...,SET,509,-0.073832,-0.012122,0.041098,0.96378,GOBP_REGULATION_OF_SYSTEM_PROCESS,1
GSE44649_WT_VS_MIR155_KO_NAI...2,SET,184,-0.11476,-0.011431,0.063883,0.96378,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP,1
OUELLET_CULTURED_OVARIAN_CAN...1,SET,30,-0.28583,-0.011544,0.15904,0.96384,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1
MIR4458,SET,318,-0.088982,-0.011609,0.049508,0.96385,MIR4458,1
CUI_DEVELOPING_HEART_C4_ENDO...,SET,135,-0.14438,-0.012335,0.080317,0.96388,CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...270,SET,14,-0.43739,-0.012073,0.24327,0.9639,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
KIM_MYCL1_AMPLIFICATION_TARG...1,SET,18,-0.37684,-0.011794,0.20952,0.96395,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,1
YGACNNYACAR_UNKNOWN,SET,83,-0.17302,-0.011607,0.096189,0.96396,YGACNNYACAR_UNKNOWN,1
GOBP_HYPOTHALAMUS_CELL_MIGRA...,SET,6,-0.7542,-0.013632,0.41927,0.96397,GOBP_HYPOTHALAMUS_CELL_MIGRATION,1
MIR891B,SET,115,-0.13967,-0.011019,0.077638,0.96398,MIR891B,1
GOMF_DEAD_H_BOX_RNA_HELICASE...,SET,8,-0.6197,-0.012933,0.34446,0.96399,GOMF_DEAD_H_BOX_RNA_HELICASE_BINDING,1
REACTOME_SIGNAL_ATTENUATION,SET,10,-0.49846,-0.01163,0.27704,0.964,REACTOME_SIGNAL_ATTENUATION,1
HP_ELEVATED_MEAN_ARTERIAL_PR...,SET,10,-0.50465,-0.011774,0.28039,0.96405,HP_ELEVATED_MEAN_ARTERIAL_PRESSURE,1
HP_RECURRENT_OTITIS_MEDIA,SET,172,-0.12065,-0.011622,0.067025,0.96406,HP_RECURRENT_OTITIS_MEDIA,1
HP_ABNORMALITY_OF_MOUTH_SHAPE,SET,240,-0.1009,-0.01146,0.056051,0.96407,HP_ABNORMALITY_OF_MOUTH_SHAPE,1
LY_AGING_OLD_DN,SET,53,-0.19353,-0.010383,0.10749,0.96409,LY_AGING_OLD_DN,1
MIR3689A_3P_MIR3689B_3P_MIR3...,SET,153,-0.1225,-0.011136,0.068022,0.96413,MIR3689A_3P_MIR3689B_3P_MIR3689C,1
GOMF_GLYCEROPHOSPHODIESTER_P...,SET,4,-0.71135,-0.010499,0.39498,0.96414,GOMF_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY,1
GOBP_REGULATION_OF_PRO_B_CEL...,SET,8,-0.57307,-0.01196,0.31817,0.96415,GOBP_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION,1
TCGA_GLIOBLASTOMA_COPY_NUMBE...1,SET,28,-0.37711,-0.014716,0.20934,0.96418,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,1
GOCC_CHROMATIN_SILENCING_COM...,SET,12,-0.39698,-0.010146,0.22035,0.96419,GOCC_CHROMATIN_SILENCING_COMPLEX,1
HP_MODERATE_GLOBAL_DEVELOPME...,SET,22,-0.32201,-0.01114,0.17871,0.96421,HP_MODERATE_GLOBAL_DEVELOPMENTAL_DELAY,1
GSE360_L_MAJOR_VS_T_GONDII_D...2,SET,177,-0.12257,-0.011976,0.06802,0.96421,GSE360_L_MAJOR_VS_T_GONDII_DC_UP,1
MORF_SNRP70,SET,59,-0.17512,-0.0099112,0.097174,0.96423,MORF_SNRP70,1
MODULE_287,SET,47,-0.23722,-0.011987,0.13163,0.96423,MODULE_287,1
GSE45365_CD8A_DC_VS_CD11B_DC...2,SET,167,-0.12076,-0.011465,0.067,0.96425,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN,1
HP_AREFLEXIA_OF_UPPER_LIMBS,SET,7,-0.64775,-0.012645,0.35933,0.96427,HP_AREFLEXIA_OF_UPPER_LIMBS,1
GOBP_NEURON_PROJECTION_REGEN...,SET,55,-0.21579,-0.011793,0.11968,0.9643,GOBP_NEURON_PROJECTION_REGENERATION,1
GOBP_POSITIVE_REGULATION_OF_...404,SET,134,-0.14256,-0.012135,0.079067,0.9643,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
GOBP_REGULATION_OF_ORGANELLE...3,SET,8,-0.56033,-0.011694,0.31069,0.96434,GOBP_REGULATION_OF_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
HP_PSYCHOTIC_MENTATION,SET,15,-0.36155,-0.01033,0.20042,0.96437,HP_PSYCHOTIC_MENTATION,1
GOBP_AMINOACYL_TRNA_METABOLI...,SET,8,-0.47584,-0.0099306,0.2636,0.96447,GOBP_AMINOACYL_TRNA_METABOLISM_INVOLVED_IN_TRANSLATIONAL_FIDELITY,1
GOMF_AMINOACYL_TRNA_EDITING_...,SET,8,-0.47584,-0.0099306,0.2636,0.96447,GOMF_AMINOACYL_TRNA_EDITING_ACTIVITY,1
GOBP_TRNA_THREONYLCARBAMOYLA...2,SET,4,-0.5675,-0.0083755,0.31428,0.96451,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_MODIFICATION,1
GSE4142_GC_BCELL_VS_MEMORY_B...2,SET,182,-0.11561,-0.011454,0.064027,0.96451,GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP,1
GOCC_MRNA_EDITING_COMPLEX,SET,5,-0.68772,-0.011347,0.38077,0.96454,GOCC_MRNA_EDITING_COMPLEX,1
MIR943,SET,47,-0.23609,-0.01193,0.13068,0.96458,MIR943,1
GSE19888_ADENOSINE_A3R_INH_V...4,SET,184,-0.11876,-0.011829,0.065724,0.9646,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP,1
REACTOME_GP1B_IX_V_ACTIVATIO...,SET,11,-0.5134,-0.012563,0.28402,0.96466,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,1
LAKE_ADULT_KIDNEY_C13_THICK_...,SET,113,-0.15629,-0.012224,0.08644,0.9647,LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB,1
REACTOME_REGULATION_OF_RAS_B...,SET,64,-0.17358,-0.01023,0.095972,0.96474,REACTOME_REGULATION_OF_RAS_BY_GAPS,1
KEGG_MEDICUS_PATHOGEN_SALMON...8,SET,19,-0.34384,-0.011055,0.19008,0.96476,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...54,SET,5,-0.71097,-0.011731,0.39303,0.96476,GOBP_POSITIVE_REGULATION_OF_BASEMENT_MEMBRANE_ASSEMBLY_INVOLVED_IN_EMBRYONIC_BODY_MORPHOGENESIS,1
MIR204_5P,SET,347,-0.0854,-0.011629,0.047184,0.96484,MIR204_5P,1
HU_FETAL_RETINA_MULLER,SET,36,-0.28039,-0.012404,0.15488,0.96487,HU_FETAL_RETINA_MULLER,1
MIR551B_5P,SET,451,-0.076671,-0.011868,0.042344,0.96489,MIR551B_5P,1
MIR30B_3P,SET,154,-0.12293,-0.011211,0.06789,0.9649,MIR30B_3P,1
GOCC_GOLGI_MEDIAL_CISTERNA,SET,11,-0.50262,-0.012299,0.27759,0.9649,GOCC_GOLGI_MEDIAL_CISTERNA,1
GOBP_RESPONSE_TO_LECTIN,SET,20,-0.38378,-0.01266,0.21189,0.96494,GOBP_RESPONSE_TO_LECTIN,1
REACTOME_GAB1_SIGNALOSOME,SET,17,-0.39037,-0.011873,0.21548,0.96497,REACTOME_GAB1_SIGNALOSOME,1
HP_FACIAL_CAPILLARY_HEMANGIO...,SET,10,-0.52248,-0.01219,0.28822,0.96506,HP_FACIAL_CAPILLARY_HEMANGIOMA,1
HOWARD_PBMC_INACT_MONOV_INFL...2,SET,333,-0.092525,-0.012347,0.051041,0.96506,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,1
GOBP_MULTI_PASS_TRANSMEMBRAN...,SET,8,-0.65725,-0.013717,0.36241,0.96512,GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
GOCC_MULTI_PASS_TRANSLOCON_C...,SET,8,-0.65725,-0.013717,0.36241,0.96512,GOCC_MULTI_PASS_TRANSLOCON_COMPLEX,1
GSE41867_NAIVE_VS_DAY15_LCMV...3,SET,164,-0.11604,-0.010918,0.063987,0.96512,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...1,SET,7,-0.66001,-0.012885,0.36392,0.96512,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,1
MIR187_5P,SET,163,-0.12679,-0.011894,0.069903,0.96514,MIR187_5P,1
HP_PROXIMAL_RENAL_TUBULAR_AC...,SET,10,-0.4562,-0.010644,0.25145,0.96517,HP_PROXIMAL_RENAL_TUBULAR_ACIDOSIS,1
WACKER_HYPOXIA_TARGETS_OF_VHL,SET,11,-0.48036,-0.011754,0.26475,0.96518,WACKER_HYPOXIA_TARGETS_OF_VHL,1
HP_ABNORMAL_PALMAR_DERMATOGL...,SET,226,-0.10241,-0.011292,0.056422,0.96524,HP_ABNORMAL_PALMAR_DERMATOGLYPHICS,1
GOBP_CELL_DIFFERENTIATION_IN...2,SET,53,-0.24127,-0.012944,0.13291,0.96525,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
MIR6855_3P,SET,45,-0.22471,-0.011111,0.12378,0.96526,MIR6855_3P,1
GSE21546_WT_VS_ELK1_KO_DP_TH...2,SET,183,-0.11324,-0.011249,0.062381,0.96526,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP,1
GOMF_UBIQUINONE_BINDING,SET,5,-0.61747,-0.010188,0.33993,0.96534,GOMF_UBIQUINONE_BINDING,1
HP_FRONTAL_UPSWEEP_OF_HAIR,SET,20,-0.37599,-0.012403,0.207,0.96534,HP_FRONTAL_UPSWEEP_OF_HAIR,1
GOBP_POSITIVE_REGULATION_OF_...311,SET,17,-0.41037,-0.012481,0.22582,0.9654,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
GOMF_SUMO_BINDING,SET,16,-0.35752,-0.01055,0.19672,0.96541,GOMF_SUMO_BINDING,1
HP_OCCIPITAL_CORTICAL_ATROPHY,SET,5,-0.67143,-0.011079,0.36946,0.96541,HP_OCCIPITAL_CORTICAL_ATROPHY,1
GOCC_OUTER_KINETOCHORE,SET,19,-0.36475,-0.011728,0.20066,0.96544,GOCC_OUTER_KINETOCHORE,1
TACAATC_MIR508,SET,57,-0.21454,-0.011935,0.11801,0.96546,TACAATC_MIR508,1
HE_LIM_SUN_FETAL_LUNG_C3_PRI...,SET,100,-0.15763,-0.011602,0.08667,0.96552,HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE,1
PGF_UP.V1_DN,SET,169,-0.121,-0.011555,0.066521,0.96553,PGF_UP.V1_DN,1
BUSSLINGER_GASTRIC_TUFT_CELLS,SET,11,-0.5315,-0.013006,0.29217,0.96555,BUSSLINGER_GASTRIC_TUFT_CELLS,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...6,SET,171,-0.12032,-0.011558,0.066127,0.96558,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,1
GOBP_REGULATION_OF_LONG_TERM...3,SET,45,-0.24235,-0.011984,0.13319,0.96559,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
MIR302A_5P,SET,175,-0.11802,-0.011467,0.06485,0.9656,MIR302A_5P,1
HP_ABNORMAL_THORACIC_SPINE_M...,SET,94,-0.15127,-0.010796,0.083122,0.9656,HP_ABNORMAL_THORACIC_SPINE_MORPHOLOGY,1
HP_HYPERPARATHYROIDISM,SET,28,-0.31496,-0.012291,0.17305,0.96562,HP_HYPERPARATHYROIDISM,1
ELVIDGE_HYPOXIA_BY_DMOG_DN,SET,52,-0.21185,-0.011259,0.11638,0.96563,ELVIDGE_HYPOXIA_BY_DMOG_DN,1
GOBP_RISC_COMPLEX_ASSEMBLY,SET,10,-0.50544,-0.011793,0.27761,0.96567,GOBP_RISC_COMPLEX_ASSEMBLY,1
HP_ABNORMAL_OSSIFICATION_OF_...,SET,10,-0.48367,-0.011285,0.26564,0.96567,HP_ABNORMAL_OSSIFICATION_OF_THE_PUBIC_BONE,1
GOBP_AMINO_SUGAR_CATABOLIC_P...,SET,14,-0.44818,-0.012371,0.24613,0.96568,GOBP_AMINO_SUGAR_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_MUSCLE_CO...,SET,154,-0.13109,-0.011956,0.071994,0.96568,GOBP_REGULATION_OF_MUSCLE_CONTRACTION,1
REACTOME_MATURATION_OF_SARS_...1,SET,11,-0.42405,-0.010376,0.23285,0.9657,REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN,1
GOMF_RIBONUCLEOPROTEIN_COMPL...,SET,142,-0.1247,-0.010924,0.068469,0.96571,GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING,1
KIM_ALL_DISORDERS_DURATION_C...2,SET,8,-0.48671,-0.010157,0.26721,0.96572,KIM_ALL_DISORDERS_DURATION_CORR_UP,1
TANG_SENESCENCE_TP53_TARGETS...2,SET,31,-0.28196,-0.011576,0.15478,0.96574,TANG_SENESCENCE_TP53_TARGETS_UP,1
GSE36078_UNTREATED_VS_AD5_T4...1,SET,181,-0.1168,-0.01154,0.064107,0.96576,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN,1
HP_ABNORMAL_FINGERTIP_MORPHO...,SET,76,-0.18343,-0.011777,0.10064,0.96582,HP_ABNORMAL_FINGERTIP_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...655,SET,374,-0.0826,-0.011668,0.04531,0.96584,GOBP_NEGATIVE_REGULATION_OF_TRANSPORT,1
LEF1_Q6,SET,240,-0.10854,-0.012328,0.059531,0.96585,LEF1_Q6,1
GSE8835_HEALTHY_VS_CLL_CD4_T...1,SET,174,-0.11762,-0.011396,0.064504,0.96587,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN,1
HP_HYPERLYSINURIA,SET,5,-0.67163,-0.011082,0.3683,0.96589,HP_HYPERLYSINURIA,1
HP_PROPORTIONATE_SHORT_STATU...,SET,130,-0.13749,-0.011528,0.075393,0.96589,HP_PROPORTIONATE_SHORT_STATURE,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...1,SET,178,-0.11605,-0.011371,0.063634,0.9659,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN,1
GOBP_CARTILAGE_CONDENSATION,SET,18,-0.40779,-0.012762,0.2235,0.96596,GOBP_CARTILAGE_CONDENSATION,1
GOBP_PROLACTIN_SECRETION,SET,5,-0.79317,-0.013087,0.43466,0.96598,GOBP_PROLACTIN_SECRETION,1
GSE24671_CTRL_VS_BAKIMULC_IN...2,SET,180,-0.11511,-0.011341,0.063079,0.96598,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP,1
GOCC_NON_MOTILE_CILIUM,SET,146,-0.12877,-0.011437,0.070521,0.96606,GOCC_NON_MOTILE_CILIUM,1
chr5p15,SET,52,-0.36527,-0.019412,0.2,0.9661,chr5p15,1
HP_ABNORMALITY_OF_REFRACTION,SET,600,-0.064197,-0.011414,0.035148,0.9661,HP_ABNORMALITY_OF_REFRACTION,1
ZNF33A_TARGET_GENES,SET,175,-0.11781,-0.011447,0.064491,0.96613,ZNF33A_TARGET_GENES,1
HP_ANASARCA,SET,9,-0.43405,-0.0096077,0.23752,0.96617,HP_ANASARCA,1
GOBP_HEART_VALVE_FORMATION,SET,15,-0.43825,-0.012521,0.23973,0.96623,GOBP_HEART_VALVE_FORMATION,1
MIR6751_3P,SET,73,-0.17858,-0.011238,0.097669,0.96625,MIR6751_3P,1
GOBP_REGULATION_OF_OXIDOREDU...,SET,53,-0.21518,-0.011544,0.11766,0.96628,GOBP_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
HOWLIN_CITED1_TARGETS_2_UP,SET,16,-0.36736,-0.01084,0.20086,0.96629,HOWLIN_CITED1_TARGETS_2_UP,1
REACTOME_NEGATIVE_REGULATION...10,SET,51,-0.193,-0.010158,0.10552,0.96629,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,1
PALOMERO_GSI_SENSITIVITY_UP,SET,6,-0.62388,-0.011276,0.34108,0.9663,PALOMERO_GSI_SENSITIVITY_UP,1
GOCC_GROWTH_FACTOR_COMPLEX,SET,8,-0.6639,-0.013855,0.36292,0.96632,GOCC_GROWTH_FACTOR_COMPLEX,1
PAX2_01,SET,49,-0.21909,-0.011303,0.11974,0.96634,PAX2_01,1
GOBP_STRIATED_MUSCLE_CELL_AP...,SET,42,-0.24444,-0.011678,0.1335,0.96645,GOBP_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOCC_DENSE_CORE_GRANULE_MEMB...,SET,7,-0.61116,-0.011931,0.33372,0.96647,GOCC_DENSE_CORE_GRANULE_MEMBRANE,1
HP_DECREASED_CIRCULATING_TER...,SET,6,-0.67913,-0.012275,0.37078,0.96649,HP_DECREASED_CIRCULATING_TERMINAL_COMPLEMENT_COMPONENT_CONCENTRATION,1
GSE41867_DAY15_EFFECTOR_VS_D...2,SET,189,-0.1127,-0.011376,0.061516,0.96652,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,1
GOBP_REGULATION_OF_I_KAPPAB_...,SET,7,-0.64039,-0.012502,0.34934,0.9666,GOBP_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
GSE5142_CTRL_VS_HTERT_TRANSD...1,SET,176,-0.11638,-0.01134,0.063487,0.9666,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN,1
HP_OLIVOPONTOCEREBELLAR_HYPO...,SET,12,-0.42426,-0.010843,0.23141,0.96662,HP_OLIVOPONTOCEREBELLAR_HYPOPLASIA,1
CHOI_ATL_CHRONIC_VS_ACUTE_DN,SET,17,-0.38424,-0.011687,0.20957,0.96663,CHOI_ATL_CHRONIC_VS_ACUTE_DN,1
HP_TALIPES_EQUINOVARUS,SET,347,-0.085654,-0.011664,0.046716,0.96663,HP_TALIPES_EQUINOVARUS,1
HP_MIOSIS,SET,25,-0.33683,-0.012421,0.1837,0.96664,HP_MIOSIS,1
GOBP_CALCIUM_ION_TRANSPORT_I...,SET,28,-0.32282,-0.012597,0.17602,0.96667,GOBP_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
HP_SOFT_DOUGHY_SKIN,SET,12,-0.48435,-0.012378,0.26407,0.96668,HP_SOFT_DOUGHY_SKIN,1
TACTTGA_MIR26A_MIR26B,SET,273,-0.095421,-0.011549,0.052017,0.96669,TACTTGA_MIR26A_MIR26B,1
MIR28_5P,SET,42,-0.24361,-0.011638,0.13279,0.9667,MIR28_5P,1
MIR383_3P,SET,122,-0.14521,-0.011798,0.079149,0.96671,MIR383_3P,1
GOBP_NEGATIVE_REGULATION_OF_...109,SET,71,-0.18749,-0.011636,0.10213,0.96679,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOBP_RHYTHMIC_BEHAVIOR,SET,46,-0.25023,-0.012509,0.13631,0.96679,GOBP_RHYTHMIC_BEHAVIOR,1
GOMF_ADENYLYLTRANSFERASE_ACT...,SET,21,-0.35706,-0.012069,0.1945,0.96679,GOMF_ADENYLYLTRANSFERASE_ACTIVITY,1
HP_INCREASED_SERUM_PYRUVATE,SET,41,-0.21891,-0.010333,0.11925,0.96679,HP_INCREASED_SERUM_PYRUVATE,1
GSE29618_MONOCYTE_VS_PDC_DAY...2,SET,186,-0.11858,-0.011874,0.064587,0.96681,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP,1
GSE7460_CTRL_VS_TGFB_TREATED...3,SET,182,-0.11754,-0.011644,0.064021,0.96681,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN,1
HP_AGENESIS_OF_CORPUS_CALLOS...,SET,301,-0.088765,-0.011272,0.048337,0.96684,HP_AGENESIS_OF_CORPUS_CALLOSUM,1
HP_CENTRAL_NERVOUS_SYSTEM_CY...,SET,180,-0.11359,-0.011192,0.061851,0.96685,HP_CENTRAL_NERVOUS_SYSTEM_CYST,1
REACTOME_STAT5_ACTIVATION_DO...,SET,10,-0.48116,-0.011226,0.26198,0.96686,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,1
HP_HIP_DYSPLASIA,SET,207,-0.10894,-0.011502,0.059244,0.96703,HP_HIP_DYSPLASIA,1
GSE14415_INDUCED_TREG_VS_TCO...1,SET,146,-0.13177,-0.011704,0.071649,0.96704,GSE14415_INDUCED_TREG_VS_TCONV_DN,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...1,SET,22,-0.3681,-0.012734,0.20011,0.96707,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE,1
HEBERT_MATRISOME_TNBC_LUNG_M...2,SET,6,-0.55106,-0.0099602,0.29947,0.96711,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED,1
REACTOME_LOSS_OF_FUNCTION_OF...2,SET,7,-0.63329,-0.012363,0.34418,0.96711,REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER,1
GOCC_INNER_ACROSOMAL_MEMBRANE,SET,5,-0.81421,-0.013435,0.4425,0.96711,GOCC_INNER_ACROSOMAL_MEMBRANE,1
GOMF_WD40_REPEAT_DOMAIN_BIND...,SET,4,-0.69535,-0.010262,0.37786,0.96712,GOMF_WD40_REPEAT_DOMAIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...500,SET,46,-0.24367,-0.012182,0.13239,0.96715,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION,1
HP_APLASIA_HYPOPLASIA_OF_FAC...,SET,50,-0.22765,-0.011864,0.12368,0.96716,HP_APLASIA_HYPOPLASIA_OF_FACIAL_BONES,1
REACTOME_CHL1_INTERACTIONS,SET,8,-0.66578,-0.013895,0.36157,0.96721,REACTOME_CHL1_INTERACTIONS,1
DODD_NASOPHARYNGEAL_CARCINOM...1,SET,1481,-0.043474,-0.011839,0.023603,0.96725,DODD_NASOPHARYNGEAL_CARCINOMA_DN,1
GOBP_NITRIC_OXIDE_CGMP_MEDIA...,SET,6,-0.74768,-0.013514,0.40592,0.96725,GOBP_NITRIC_OXIDE_CGMP_MEDIATED_SIGNALING,1
HP_ABNORMALITY_OF_PRIMARY_TE...,SET,70,-0.18778,-0.011572,0.10194,0.96725,HP_ABNORMALITY_OF_PRIMARY_TEETH,1
MIR1273H_5P,SET,176,-0.11752,-0.011451,0.063795,0.96726,MIR1273H_5P,1
GSE19888_CTRL_VS_A3R_ACTIVAT...2,SET,179,-0.10683,-0.010497,0.057982,0.96729,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP,1
GOMF_GALACTOSIDASE_ACTIVITY,SET,6,-0.625,-0.011297,0.33919,0.9673,GOMF_GALACTOSIDASE_ACTIVITY,1
GOBP_SEROTONIN_METABOLIC_PRO...,SET,10,-0.5452,-0.01272,0.29585,0.96732,GOBP_SEROTONIN_METABOLIC_PROCESS,1
GSE28737_WT_VS_BCL6_HET_MARG...2,SET,173,-0.11804,-0.011404,0.064046,0.96733,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP,1
GOMF_GALACTOSIDE_BINDING,SET,5,-0.81495,-0.013447,0.44194,0.9674,GOMF_GALACTOSIDE_BINDING,1
GOMF_MITOCHONDRIAL_RIBOSOME_...,SET,8,-0.54038,-0.011277,0.29305,0.9674,GOMF_MITOCHONDRIAL_RIBOSOME_BINDING,1
HP_NYCTALOPIA,SET,200,-0.11252,-0.01168,0.061019,0.9674,HP_NYCTALOPIA,1
MISSIAGLIA_REGULATED_BY_METH...1,SET,107,-0.14334,-0.01091,0.077675,0.9675,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1
HP_ANGIOSARCOMA,SET,5,-0.70606,-0.01165,0.38261,0.9675,HP_ANGIOSARCOMA,1
HP_VASCULAR_DILATATION,SET,196,-0.11302,-0.011615,0.061244,0.96751,HP_VASCULAR_DILATATION,1
KEGG_GLIOMA,SET,64,-0.19998,-0.011787,0.1083,0.96758,KEGG_GLIOMA,1
MIR708_5P,SET,43,-0.24214,-0.011705,0.13111,0.96761,MIR708_5P,1
HP_ABNORMAL_CEREBROSPINAL_FL...,SET,531,-0.067467,-0.011307,0.036527,0.96762,HP_ABNORMAL_CEREBROSPINAL_FLUID_MORPHOLOGY,1
MODULE_350,SET,54,-0.20517,-0.011111,0.11105,0.96766,MODULE_350,1
HP_HBS_HEMOGLOBIN,SET,5,-0.75798,-0.012507,0.41027,0.96766,HP_HBS_HEMOGLOBIN,1
GOBP_MITOCHONDRIAL_CALCIUM_I...1,SET,21,-0.35948,-0.012151,0.19451,0.9677,GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS,1
HP_ABNORMALITY_OF_MACULAR_PI...,SET,35,-0.28912,-0.012611,0.15642,0.96772,HP_ABNORMALITY_OF_MACULAR_PIGMENTATION,1
GOBP_NEGATIVE_REGULATION_OF_...421,SET,12,-0.48623,-0.012427,0.26303,0.96773,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
GOCC_AXONEMAL_DYNEIN_COMPLEX,SET,18,-0.35216,-0.011021,0.1905,0.96773,GOCC_AXONEMAL_DYNEIN_COMPLEX,1
HP_SHORT_FEMUR,SET,25,-0.32585,-0.012016,0.17626,0.96774,HP_SHORT_FEMUR,1
GSE40274_XBP1_VS_FOXP3_AND_X...2,SET,177,-0.11822,-0.011552,0.063932,0.96778,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE9037_WT_VS_IRAK4_KO_LPS_4...2,SET,183,-0.11504,-0.011427,0.062202,0.96779,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP,1
GOMF_BETA_GALACTOSIDASE_ACTI...,SET,5,-0.77451,-0.01278,0.41875,0.9678,GOMF_BETA_GALACTOSIDASE_ACTIVITY,1
HP_NEONATAL_DEATH,SET,82,-0.16794,-0.011199,0.09079,0.96782,HP_NEONATAL_DEATH,1
MIR670_5P,SET,230,-0.10553,-0.011737,0.057043,0.96783,MIR670_5P,1
GOBP_ENDOCHONDRAL_BONE_MORPH...,SET,56,-0.22794,-0.012569,0.12322,0.96783,GOBP_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
REACTOME_OVARIAN_TUMOR_DOMAI...,SET,34,-0.27378,-0.011771,0.14798,0.96785,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1
GSE22886_DAY1_VS_DAY7_MONOCY...2,SET,181,-0.11983,-0.011839,0.064754,0.96788,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP,1
KEGG_MEDICUS_PATHOGEN_HCV_CO...1,SET,12,-0.49936,-0.012762,0.2698,0.96789,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY,1
SIG_INSULIN_RECEPTOR_PATHWAY...,SET,48,-0.2352,-0.01201,0.12704,0.96793,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1
GSE29164_DAY3_VS_DAY7_CD8_TC...1,SET,187,-0.11942,-0.01199,0.064501,0.96794,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN,1
SUZUKI_RESPONSE_TO_TSA,SET,15,-0.42108,-0.012031,0.22741,0.96795,SUZUKI_RESPONSE_TO_TSA,1
BIOCARTA_SARS_PATHWAY,SET,7,-0.62115,-0.012126,0.33537,0.96799,BIOCARTA_SARS_PATHWAY,1
HP_LEUKODYSTROPHY,SET,83,-0.16145,-0.01083,0.087158,0.968,HP_LEUKODYSTROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...96,SET,10,-0.48433,-0.0113,0.26145,0.96801,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
GOBP_NEGATIVE_REGULATION_OF_...529,SET,5,-0.56909,-0.0093902,0.30706,0.96807,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MICROTUBULE,1
HP_LOW_SET_EARS,SET,768,-0.05816,-0.011644,0.031382,0.96807,HP_LOW_SET_EARS,1
HP_PERIPHERAL_CYANOSIS,SET,31,-0.28121,-0.011545,0.15174,0.96807,HP_PERIPHERAL_CYANOSIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...30,SET,182,-0.11662,-0.011554,0.062901,0.96813,HP_APLASIA_HYPOPLASIA_OF_THE_EYEBROW,1
HP_APLASIA_HYPOPLASIA_OF_THE...34,SET,26,-0.30433,-0.011444,0.16408,0.96817,HP_APLASIA_HYPOPLASIA_OF_THE_FIBULA,1
HP_FLATTENED_EPIPHYSIS,SET,22,-0.33012,-0.011421,0.17799,0.96817,HP_FLATTENED_EPIPHYSIS,1
BERNARD_PPAPDC1B_TARGETS_UP,SET,34,-0.27453,-0.011803,0.148,0.96818,BERNARD_PPAPDC1B_TARGETS_UP,1
HP_ABNORMAL_FACIAL_SHAPE,SET,937,-0.052523,-0.011559,0.028313,0.9682,HP_ABNORMAL_FACIAL_SHAPE,1
GOBP_LONG_TERM_SYNAPTIC_DEPR...,SET,30,-0.3224,-0.013021,0.17377,0.96821,GOBP_LONG_TERM_SYNAPTIC_DEPRESSION,1
HP_BRACHYCEPHALY,SET,216,-0.11073,-0.011939,0.059669,0.96824,HP_BRACHYCEPHALY,1
HP_PNEUMOTHORAX,SET,72,-0.1973,-0.012331,0.10631,0.96826,HP_PNEUMOTHORAX,1
GSE5589_LPS_VS_LPS_AND_IL6_S...1,SET,180,-0.11494,-0.011325,0.061926,0.96827,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
REACTOME_MITOCHONDRIAL_CALCI...,SET,19,-0.38251,-0.012299,0.20607,0.96828,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,1
GNF2_SERPINB5,SET,27,-0.32494,-0.012452,0.17506,0.96828,GNF2_SERPINB5,1
GOBP_NEGATIVE_REGULATION_OF_...703,SET,5,-0.76666,-0.01265,0.413,0.96829,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
GSE22033_UNTREATED_VS_MRL24_...1,SET,176,-0.12181,-0.011869,0.065615,0.9683,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN,1
GTGCCAA_MIR96,SET,276,-0.096129,-0.011697,0.051776,0.96831,GTGCCAA_MIR96,1
GOMF_ADENYL_NUCLEOTIDE_BINDI...,SET,1501,-0.042404,-0.011618,0.022837,0.96832,GOMF_ADENYL_NUCLEOTIDE_BINDING,1
MIR219B_5P,SET,41,-0.24226,-0.011435,0.13045,0.96834,MIR219B_5P,1
GSE1791_CTRL_VS_NEUROMEDINU_...1,SET,162,-0.12767,-0.011939,0.068745,0.96834,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN,1
GOBP_PEPTIDOGLYCAN_METABOLIC...,SET,6,-0.66333,-0.011989,0.35706,0.96839,GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS,1
GOBP_BERGMANN_GLIAL_CELL_DIF...,SET,10,-0.51023,-0.011904,0.27455,0.96844,GOBP_BERGMANN_GLIAL_CELL_DIFFERENTIATION,1
MODULE_117,SET,651,-0.0678,-0.012539,0.036477,0.96846,MODULE_117,1
GOBP_CELL_AGGREGATION,SET,22,-0.37585,-0.013003,0.20221,0.96846,GOBP_CELL_AGGREGATION,1
GOBP_REGULATION_OF_INSULIN_L...,SET,20,-0.41554,-0.013707,0.22355,0.96846,GOBP_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE3982_BCELL_VS_BASOPHIL_DN,SET,176,-0.12255,-0.011941,0.065922,0.96848,GSE3982_BCELL_VS_BASOPHIL_DN,1
GSE27859_DC_VS_CD11C_INT_F48...2,SET,182,-0.11129,-0.011026,0.059833,0.96855,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
HP_ABNORMAL_EAR_MORPHOLOGY,SET,1420,-0.043524,-0.011627,0.023397,0.96856,HP_ABNORMAL_EAR_MORPHOLOGY,1
HP_ABNORMAL_TISSUE_ENZYME_CO...,SET,55,-0.20508,-0.011208,0.11024,0.96857,HP_ABNORMAL_TISSUE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
GSE17721_CTRL_VS_CPG_12H_BMD...2,SET,183,-0.11819,-0.01174,0.063525,0.96858,GSE17721_CTRL_VS_CPG_12H_BMDC_UP,1
BDP1_TARGET_GENES,SET,1011,-0.050266,-0.011466,0.027011,0.96862,BDP1_TARGET_GENES,1
HP_BRADYCARDIA,SET,90,-0.1717,-0.011992,0.092244,0.96864,HP_BRADYCARDIA,1
MED25_TARGET_GENES,SET,76,-0.18432,-0.011834,0.099013,0.96866,MED25_TARGET_GENES,1
MIR515_3P,SET,61,-0.21595,-0.012427,0.116,0.96867,MIR515_3P,1
GOBP_NEUTROPHIL_CHEMOTAXIS,SET,78,-0.2012,-0.013086,0.10803,0.96872,GOBP_NEUTROPHIL_CHEMOTAXIS,1
DESCARTES_FETAL_LIVER_MEGAKA...,SET,113,-0.15537,-0.012152,0.083404,0.96875,DESCARTES_FETAL_LIVER_MEGAKARYOCYTES,1
KIM_ALL_DISORDERS_OLIGODENDR...1,SET,30,-0.27269,-0.011014,0.14635,0.96878,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,1
HP_COXA_VALGA,SET,82,-0.18078,-0.012055,0.097008,0.9688,HP_COXA_VALGA,1
KOINUMA_TARGETS_OF_SMAD2_OR_...,SET,773,-0.059715,-0.011992,0.032039,0.96882,KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,1
HP_SECOND_TRIMESTER_ONSET,SET,41,-0.25018,-0.011809,0.13415,0.9689,HP_SECOND_TRIMESTER_ONSET,1
GOBP_N_ACETYLNEURAMINATE_CAT...,SET,6,-0.67977,-0.012287,0.36444,0.96892,GOBP_N_ACETYLNEURAMINATE_CATABOLIC_PROCESS,1
GOBP_L_ALPHA_AMINO_ACID_TRAN...,SET,66,-0.20483,-0.012259,0.1098,0.96894,GOBP_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
HP_PULMONARY_ARTERY_HYPOPLAS...,SET,8,-0.6339,-0.013229,0.33978,0.96894,HP_PULMONARY_ARTERY_HYPOPLASIA,1
GOBP_L_LEUCINE_METABOLIC_PRO...,SET,8,-0.53812,-0.01123,0.28838,0.96897,GOBP_L_LEUCINE_METABOLIC_PROCESS,1
HP_CRUMPLED_EAR,SET,5,-0.70014,-0.011553,0.3752,0.96898,HP_CRUMPLED_EAR,1
GSE22935_WT_VS_MYD88_KO_MACR...7,SET,180,-0.12563,-0.012378,0.067301,0.96902,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN,1
GOMF_MHC_PROTEIN_COMPLEX_BIN...,SET,30,-0.30661,-0.012384,0.16423,0.96904,GOMF_MHC_PROTEIN_COMPLEX_BINDING,1
GOBP_REGULATION_OF_ENDOTHELI...3,SET,34,-0.28362,-0.012194,0.15189,0.96906,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GSE6092_UNSTIM_VS_IFNG_STIM_...4,SET,179,-0.11203,-0.011008,0.059995,0.96907,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP,1
RODWELL_AGING_KIDNEY_DN,SET,124,-0.15162,-0.012418,0.081187,0.96908,RODWELL_AGING_KIDNEY_DN,1
KEGG_MEDICUS_REFERENCE_FLT3L...2,SET,15,-0.37302,-0.010658,0.19961,0.96916,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY,1
GACTGTT_MIR212_MIR132,SET,144,-0.13107,-0.011562,0.070131,0.96918,GACTGTT_MIR212_MIR132,1
GOBP_NEGATIVE_REGULATION_OF_...676,SET,30,-0.31637,-0.012778,0.16923,0.96921,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
MIR7111_3P,SET,112,-0.14945,-0.011637,0.079897,0.96929,MIR7111_3P,1
GSE14908_ATOPIC_VS_NONATOPIC...2,SET,178,-0.11488,-0.011257,0.06141,0.9693,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP,1
WP_BENZENE_METABOLISM,SET,5,-0.71448,-0.011789,0.38191,0.96931,WP_BENZENE_METABOLISM,1
GSE41867_DAY6_VS_DAY8_LCMV_C...1,SET,183,-0.1133,-0.011255,0.060559,0.96931,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GOBP_T_CELL_MIGRATION,SET,63,-0.21099,-0.012338,0.11275,0.96933,GOBP_T_CELL_MIGRATION,1
HP_COLOR_VISION_DEFECT,SET,133,-0.14011,-0.011881,0.074847,0.96938,HP_COLOR_VISION_DEFECT,1
MIR6856_5P,SET,93,-0.16527,-0.011732,0.088285,0.96939,MIR6856_5P,1
HP_HYPERPLASIA_OF_MIDFACE,SET,4,-1.0125,-0.014944,0.54082,0.9694,HP_HYPERPLASIA_OF_MIDFACE,1
WP_LEUCINE_ISOLEUCINE_AND_VA...,SET,22,-0.34647,-0.011986,0.18502,0.96943,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,1
GAVISH_3CA_METAPROGRAM_MACRO...9,SET,46,-0.22198,-0.011097,0.1185,0.96947,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MYC_MITOCHONDRIA,1
GOBP_SUPEROXIDE_METABOLIC_PR...,SET,62,-0.21228,-0.012315,0.11332,0.96947,GOBP_SUPEROXIDE_METABOLIC_PROCESS,1
MIR3134,SET,59,-0.20345,-0.011514,0.10858,0.9695,MIR3134,1
MIR190B_3P,SET,124,-0.14255,-0.011675,0.076052,0.96955,MIR190B_3P,1
LUI_THYROID_CANCER_PAX8_PPAR...2,SET,44,-0.23509,-0.011495,0.12542,0.96956,LUI_THYROID_CANCER_PAX8_PPARG_UP,1
GSE37301_LYMPHOID_PRIMED_MPP...7,SET,168,-0.124,-0.011807,0.066153,0.96956,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN,1
HP_THICK_LOWER_LIP_VERMILION,SET,115,-0.15061,-0.011883,0.080344,0.96957,HP_THICK_LOWER_LIP_VERMILION,1
HP_INCREASED_MUSCLE_GLYCOGEN...,SET,8,-0.50635,-0.010567,0.27004,0.9696,HP_INCREASED_MUSCLE_GLYCOGEN_CONTENT,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...5,SET,125,-0.15029,-0.012358,0.080097,0.96968,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,1
WANG_METASTASIS_OF_BREAST_CA...1,SET,13,-0.431,-0.011464,0.22967,0.9697,WANG_METASTASIS_OF_BREAST_CANCER,1
GOCC_9PLUS0_NON_MOTILE_CILIUM,SET,114,-0.14911,-0.011713,0.079437,0.96974,GOCC_9PLUS0_NON_MOTILE_CILIUM,1
REACTOME_APOPTOTIC_FACTOR_ME...,SET,17,-0.37896,-0.011526,0.20186,0.96975,REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE,1
MIR132_5P,SET,8,-0.58576,-0.012225,0.31203,0.96975,MIR132_5P,1
GOBP_REGULATION_OF_CARDIAC_M...5,SET,7,-0.57757,-0.011275,0.30767,0.96975,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL,1
GOBP_RESPONSE_TO_ACIDIC_PH,SET,25,-0.32353,-0.01193,0.17234,0.96975,GOBP_RESPONSE_TO_ACIDIC_PH,1
GOBP_POSITIVE_REGULATION_OF_...715,SET,30,-0.31518,-0.01273,0.1678,0.96982,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
MIR374A_5P,SET,396,-0.084699,-0.012304,0.045084,0.96985,MIR374A_5P,1
GSE24142_DN2_VS_DN3_THYMOCYT...3,SET,185,-0.1203,-0.012015,0.064023,0.96987,GSE24142_DN2_VS_DN3_THYMOCYTE_DN,1
GOCC_PLATELET_DENSE_GRANULE_...2,SET,5,-0.81063,-0.013375,0.43133,0.96989,GOCC_PLATELET_DENSE_GRANULE_MEMBRANE,1
KEGG_MEDICUS_VARIANT_DUPLICA...2,SET,13,-0.42808,-0.011387,0.22772,0.96993,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_INTERNEURON_MIGRATION_F...,SET,6,-0.8052,-0.014554,0.42811,0.96999,GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX,1
P53_02,SET,228,-0.10786,-0.011945,0.057336,0.97002,P53_02,1
GOBP_GLYCOLYTIC_PROCESS_THRO...2,SET,16,-0.36647,-0.010814,0.19478,0.97004,GOBP_GLYCOLYTIC_PROCESS_THROUGH_GLUCOSE_6_PHOSPHATE,1
MIR876_5P,SET,123,-0.15127,-0.01234,0.080391,0.97006,MIR876_5P,1
WP_GPR143_IN_MELANOCYTES_AND...,SET,29,-0.32764,-0.013011,0.17406,0.9701,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,1
REACTOME_TRANSCRIPTIONAL_REG...5,SET,112,-0.14434,-0.011239,0.076673,0.97011,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1
MIR211_5P,SET,346,-0.08899,-0.012101,0.047269,0.97011,MIR211_5P,1
GOBP_CYSTEINE_METABOLIC_PROC...,SET,10,-0.54356,-0.012682,0.28865,0.97015,GOBP_CYSTEINE_METABOLIC_PROCESS,1
GOMF_L_SERINE_TRANSMEMBRANE_...,SET,8,-0.57838,-0.012071,0.30712,0.97016,GOMF_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_MIDFACE_MORPHOLO...,SET,533,-0.069786,-0.011717,0.037055,0.97016,HP_ABNORMAL_MIDFACE_MORPHOLOGY,1
GOCC_LATE_ENDOSOME_MEMBRANE,SET,153,-0.12884,-0.011712,0.068407,0.97017,GOCC_LATE_ENDOSOME_MEMBRANE,1
DESCARTES_MAIN_FETAL_ANTIGEN...,SET,91,-0.17626,-0.012378,0.093584,0.97017,DESCARTES_MAIN_FETAL_ANTIGEN_PRESENTING_CELLS,1
HP_ABNORMALITY_OF_THE_PHILTR...,SET,621,-0.064768,-0.011708,0.034385,0.97018,HP_ABNORMALITY_OF_THE_PHILTRUM,1
ZIRN_TRETINOIN_RESPONSE_WT1_...2,SET,23,-0.37049,-0.013105,0.19664,0.97022,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1
HP_ATYPICAL_SCARRING_OF_SKIN,SET,64,-0.21056,-0.01241,0.11174,0.97024,HP_ATYPICAL_SCARRING_OF_SKIN,1
GOBP_AMIDE_BIOSYNTHETIC_PROC...,SET,144,-0.13883,-0.012247,0.073632,0.97031,GOBP_AMIDE_BIOSYNTHETIC_PROCESS,1
GOBP_PYRUVATE_FAMILY_AMINO_A...1,SET,10,-0.48582,-0.011335,0.25758,0.97035,GOBP_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
GSE46242_TH1_VS_ANERGIC_TH1_...1,SET,158,-0.12805,-0.011828,0.067881,0.97037,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN,1
HP_ABNORMAL_UPPER_LIP_MORPHO...,SET,814,-0.05734,-0.011803,0.030395,0.97038,HP_ABNORMAL_UPPER_LIP_MORPHOLOGY,1
REACTOME_ACTIVATION_OF_GENE_...,SET,41,-0.22928,-0.010823,0.12153,0.97039,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1
FOXG1_TARGET_GENES,SET,476,-0.074104,-0.011776,0.039269,0.97042,FOXG1_TARGET_GENES,1
REACTOME_METABOLISM_OF_COFAC...,SET,22,-0.32011,-0.011074,0.16958,0.97045,REACTOME_METABOLISM_OF_COFACTORS,1
WP_INTRACELLULAR_TRAFFICKING...,SET,27,-0.31472,-0.01206,0.16673,0.97045,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,1
GOMF_RRNA_ADENINE_METHYLTRAN...,SET,7,-0.53482,-0.010441,0.28323,0.9705,GOMF_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY,1
HP_MIGRAINE_WITH_AURA,SET,12,-0.51145,-0.013071,0.27083,0.97051,HP_MIGRAINE_WITH_AURA,1
GSE1460_CD4_THYMOCYTE_VS_NAI...1,SET,174,-0.12516,-0.012127,0.066272,0.97052,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
GOMF_TOXIC_SUBSTANCE_BINDING,SET,10,-0.54464,-0.012707,0.2883,0.97055,GOMF_TOXIC_SUBSTANCE_BINDING,1
MIR483_3P,SET,49,-0.23679,-0.012216,0.12533,0.97056,MIR483_3P,1
chr1q21,SET,161,-0.27516,-0.025653,0.14558,0.97062,chr1q21,1
SCHAEFFER_PROSTATE_DEVELOPME...5,SET,426,-0.076043,-0.011448,0.040229,0.97063,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1
HP_ABNORMAL_CSF_GLYCINE_CONC...,SET,8,-0.55123,-0.011504,0.29156,0.97065,HP_ABNORMAL_CSF_GLYCINE_CONCENTRATION,1
GSE22601_DOUBLE_NEGATIVE_VS_...7,SET,163,-0.12836,-0.01204,0.067885,0.97067,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN,1
HP_BROAD_ISCHIA,SET,5,-0.75879,-0.01252,0.40123,0.97069,HP_BROAD_ISCHIA,1
GOBP_NEGATIVE_REGULATION_OF_...34,SET,12,-0.49775,-0.012721,0.26317,0.9707,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,1
LOPEZ_MESOTELIOMA_SURVIVAL_T...1,SET,7,-0.61556,-0.012017,0.32542,0.97072,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN,1
MCBRYAN_PUBERTAL_BREAST_4_5W...1,SET,170,-0.13,-0.012451,0.068711,0.97074,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1
GSE8921_UNSTIM_VS_TLR1_2_STI...8,SET,189,-0.11768,-0.011878,0.062174,0.97079,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP,1
HP_ANODONTIA,SET,13,-0.44988,-0.011967,0.23762,0.97083,HP_ANODONTIA,1
chr5q35,SET,116,-0.30699,-0.024324,0.16214,0.97084,chr5q35,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...7,SET,496,-0.071611,-0.01161,0.037777,0.97099,HP_ABNORMAL_MORPHOLOGY_OF_THE_NASAL_ALAE,1
WP_ACE_INHIBITOR_PATHWAY,SET,14,-0.52466,-0.014482,0.27674,0.971,WP_ACE_INHIBITOR_PATHWAY,1
GOMF_PROTEIN_SERINE_THREONIN...3,SET,10,-0.55522,-0.012954,0.29286,0.971,GOMF_PROTEIN_SERINE_THREONINE_KINASE_BINDING,1
HP_ABNORMAL_URETER_PHYSIOLOGY,SET,213,-0.1117,-0.011961,0.058901,0.97103,HP_ABNORMAL_URETER_PHYSIOLOGY,1
MIR33B_3P,SET,60,-0.2215,-0.012642,0.11676,0.97108,MIR33B_3P,1
REACTOME_CELLULAR_RESPONSE_T...3,SET,70,-0.1752,-0.010798,0.092353,0.97109,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,1
GOBP_CARDIAC_RIGHT_VENTRICLE...,SET,19,-0.41453,-0.013328,0.21849,0.97109,GOBP_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS,1
GOCC_INO80_TYPE_COMPLEX,SET,27,-0.28972,-0.011102,0.15271,0.97109,GOCC_INO80_TYPE_COMPLEX,1
REACTOME_GASTRIN_CREB_SIGNAL...,SET,17,-0.40381,-0.012282,0.21271,0.97117,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,1
HP_AGENESIS_OF_CEREBELLAR_VE...,SET,16,-0.36415,-0.010745,0.19182,0.97117,HP_AGENESIS_OF_CEREBELLAR_VERMIS,1
GOBP_METALLO_SULFUR_CLUSTER_...,SET,21,-0.36725,-0.012413,0.19342,0.97119,GOBP_METALLO_SULFUR_CLUSTER_ASSEMBLY,1
KEGG_MEDICUS_REFERENCE_KITLG...2,SET,14,-0.42418,-0.011709,0.22336,0.97121,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY,1
HP_PSEUDOARTHROSIS,SET,8,-0.55439,-0.01157,0.2919,0.97122,HP_PSEUDOARTHROSIS,1
MIR4436B_5P,SET,121,-0.1538,-0.012444,0.080976,0.97123,MIR4436B_5P,1
GSE9509_LPS_VS_LPS_AND_IL10_...2,SET,187,-0.12498,-0.012549,0.065803,0.97123,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP,1
GOMF_NEUROTRANSMITTER_RECEPT...3,SET,12,-0.51969,-0.013282,0.27356,0.97126,GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY,1
GNF2_HAT1,SET,45,-0.23012,-0.011379,0.12112,0.97127,GNF2_HAT1,1
GTGCAAT_MIR25_MIR32_MIR92_MI...,SET,281,-0.099704,-0.01224,0.052447,0.97134,GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367,1
HP_NODULAR_REGENERATIVE_HYPE...,SET,5,-0.7848,-0.012949,0.41271,0.97138,HP_NODULAR_REGENERATIVE_HYPERPLASIA_OF_LIVER,1
GOMF_ATP_DEPENDENT_PROTEIN_F...,SET,31,-0.27522,-0.011299,0.1447,0.9714,GOMF_ATP_DEPENDENT_PROTEIN_FOLDING_CHAPERONE,1
REACTOME_PARASITE_INFECTION,SET,56,-0.21467,-0.011838,0.11277,0.97151,REACTOME_PARASITE_INFECTION,1
MCBRYAN_PUBERTAL_BREAST_5_6W...1,SET,119,-0.14363,-0.011526,0.075423,0.97156,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1
MCCLUNG_DELTA_FOSB_TARGETS_8...,SET,45,-0.23577,-0.011658,0.12375,0.97161,MCCLUNG_DELTA_FOSB_TARGETS_8WK,1
HP_DISPROPORTIONATE_SHORT_ST...,SET,119,-0.15318,-0.012292,0.0804,0.97162,HP_DISPROPORTIONATE_SHORT_STATURE,1
GOMF_MOLYBDOPTERIN_COFACTOR_...,SET,4,-0.84743,-0.012507,0.44472,0.97164,GOMF_MOLYBDOPTERIN_COFACTOR_BINDING,1
HP_MYELOMENINGOCELE,SET,20,-0.3977,-0.013119,0.20866,0.97166,HP_MYELOMENINGOCELE,1
GSE38696_LIGHT_ZONE_VS_DARK_...2,SET,165,-0.11994,-0.011319,0.062931,0.97166,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...73,SET,14,-0.41897,-0.011565,0.21979,0.97168,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...33,SET,3,-1.0332,-0.013206,0.54197,0.97169,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_ACTIVATION,1
GOBP_PROTEOGLYCAN_METABOLIC_...,SET,83,-0.18655,-0.012515,0.097813,0.97175,GOBP_PROTEOGLYCAN_METABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_HOMO...,SET,15,-0.42478,-0.012137,0.22265,0.97179,HP_ABNORMAL_CIRCULATING_HOMOCYSTEINE_CONCENTRATION,1
HP_DECREASED_CIRCULATING_CER...,SET,8,-0.5919,-0.012353,0.31025,0.97179,HP_DECREASED_CIRCULATING_CERULOPLASMIN_CONCENTRATION,1
HP_CENTROCECAL_SCOTOMA,SET,3,-0.77523,-0.0099088,0.40626,0.97181,HP_CENTROCECAL_SCOTOMA,1
GOBP_NEGATIVE_REGULATION_OF_...615,SET,25,-0.33596,-0.012389,0.17604,0.97182,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...11,SET,13,-0.43655,-0.011612,0.22867,0.97187,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_CHONDROITIN_SULFATE_BIN...,SET,9,-0.59027,-0.013066,0.30914,0.97189,GOMF_CHONDROITIN_SULFATE_BINDING,1
GOBP_ORGANONITROGEN_COMPOUND...1,SET,1502,-0.043125,-0.011819,0.022573,0.97196,GOBP_ORGANONITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS,1
GSE43863_NAIVE_VS_MEMORY_TH1...2,SET,153,-0.13563,-0.01233,0.070985,0.97197,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP,1
MIR6818_3P,SET,108,-0.16591,-0.012688,0.086806,0.97201,MIR6818_3P,1
GOBP_REGULATION_OF_MICROTUBU...1,SET,47,-0.24407,-0.012333,0.12765,0.97205,GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT,1
GOBP_REGULATION_OF_EXTRACELL...4,SET,61,-0.2171,-0.012493,0.11352,0.97209,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
GSE40274_CTRL_VS_FOXP3_AND_G...2,SET,125,-0.14793,-0.012164,0.077329,0.97212,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...197,SET,7,-0.7414,-0.014474,0.38754,0.97213,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_ABNORMAL_FUNDUS_MORPHOLOGY,SET,1213,-0.047752,-0.011862,0.02496,0.97213,HP_ABNORMAL_FUNDUS_MORPHOLOGY,1
GOMF_HISTONE_H4K20_MONOMETHY...,SET,3,-1.1219,-0.01434,0.58626,0.97216,GOMF_HISTONE_H4K20_MONOMETHYLTRANSFERASE_ACTIVITY,1
DESCARTES_FETAL_EYE_AMACRINE...,SET,7,-0.62739,-0.012248,0.32786,0.97216,DESCARTES_FETAL_EYE_AMACRINE_CELLS,1
WP_PURINE_METABOLISM_AND_REL...,SET,20,-0.37709,-0.012439,0.19704,0.97217,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,1
HP_DEVIATION_OF_THE_HAND_OR_...,SET,478,-0.075327,-0.011995,0.039355,0.97218,HP_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
YIH_RESPONSE_TO_ARSENITE_C5,SET,10,-0.69765,-0.016277,0.36448,0.97219,YIH_RESPONSE_TO_ARSENITE_C5,1
HP_SUBDURAL_HEMORRHAGE,SET,12,-0.52014,-0.013293,0.27172,0.9722,HP_SUBDURAL_HEMORRHAGE,1
GOCC_KINESIN_COMPLEX,SET,47,-0.2243,-0.011334,0.11717,0.97221,GOCC_KINESIN_COMPLEX,1
HP_PULMONARY_INTERSTITIAL_HI...,SET,21,-0.37981,-0.012838,0.19836,0.97223,HP_PULMONARY_INTERSTITIAL_HIGH_RESOLUTION_COMPUTED_TOMOGRAPHY_ABNORMALITY,1
REACTOME_TRNA_PROCESSING_IN_...1,SET,3,-0.8949,-0.011438,0.46723,0.97227,REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION,1
GRAESSMANN_RESPONSE_TO_MC_AN...2,SET,565,-0.069169,-0.011946,0.036087,0.97236,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,1
MIR7109_5P,SET,71,-0.1839,-0.011414,0.095929,0.97238,MIR7109_5P,1
GOBP_INTRINSIC_APOPTOTIC_SIG...7,SET,9,-0.48614,-0.010761,0.25357,0.97238,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYPOXIA,1
GCM_MYST2,SET,159,-0.12035,-0.011151,0.06277,0.97239,GCM_MYST2,1
GOBP_RAC_PROTEIN_SIGNAL_TRAN...,SET,44,-0.24193,-0.011829,0.12617,0.9724,GOBP_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_CUTIS_MARMORATA,SET,60,-0.21856,-0.012474,0.11399,0.9724,HP_CUTIS_MARMORATA,1
RB_P130_DN.V1_DN,SET,119,-0.14888,-0.011947,0.077628,0.97242,RB_P130_DN.V1_DN,1
EGFR_UP.V1_DN,SET,162,-0.13124,-0.012273,0.068407,0.97247,EGFR_UP.V1_DN,1
MIR26A_2_3P,SET,66,-0.19545,-0.011698,0.10186,0.97249,MIR26A_2_3P,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...5,SET,29,-0.30754,-0.012213,0.16027,0.9725,GOBP_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
GOBP_MACROPHAGE_INFLAMMATORY...,SET,6,-0.71659,-0.012952,0.37334,0.97252,GOBP_MACROPHAGE_INFLAMMATORY_PROTEIN_1_ALPHA_PRODUCTION,1
GOBP_REGULATION_OF_TRANS_SYN...,SET,446,-0.081413,-0.012534,0.042418,0.97252,GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING,1
REACTOME_JNK_C_JUN_KINASES_P...,SET,18,-0.45388,-0.014204,0.23645,0.97253,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,1
MIR545_5P,SET,285,-0.098271,-0.012148,0.051185,0.97256,MIR545_5P,1
REACTOME_CRMPS_IN_SEMA3A_SIG...,SET,15,-0.45594,-0.013027,0.23745,0.97257,REACTOME_CRMPS_IN_SEMA3A_SIGNALING,1
LIN_NPAS4_TARGETS_UP,SET,156,-0.12844,-0.011789,0.066886,0.97258,LIN_NPAS4_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_ARNO_...,SET,24,-0.32597,-0.011778,0.16972,0.9726,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
GSE17974_CTRL_VS_ACT_IL4_AND...4,SET,159,-0.13641,-0.012639,0.070993,0.97265,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP,1
GSE24142_EARLY_THYMIC_PROGEN...9,SET,186,-0.11989,-0.012006,0.062356,0.97273,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN,1
MIR663A,SET,17,-0.41786,-0.012709,0.21724,0.97278,MIR663A,1
GOBP_REGULATION_OF_RELAXATIO...1,SET,6,-0.69744,-0.012606,0.36238,0.97285,GOBP_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE,1
MORF_UBE2I,SET,216,-0.10373,-0.011185,0.053876,0.9729,MORF_UBE2I,1
GOBP_PERIPHERAL_NERVOUS_SYST...1,SET,28,-0.31956,-0.01247,0.16589,0.97296,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...5,SET,7,-0.58787,-0.011476,0.30505,0.97301,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_DN,1
HP_RETINAL_DYSTROPHY,SET,310,-0.092857,-0.011964,0.048165,0.97306,HP_RETINAL_DYSTROPHY,1
GSE19888_CTRL_VS_T_CELL_MEMB...1,SET,186,-0.12054,-0.012071,0.062517,0.97307,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN,1
HP_FIBULAR_HYPOPLASIA,SET,22,-0.33889,-0.011724,0.17572,0.9731,HP_FIBULAR_HYPOPLASIA,1
HP_THORACIC_AORTIC_ANEURYSM,SET,108,-0.16198,-0.012387,0.083987,0.9731,HP_THORACIC_AORTIC_ANEURYSM,1
GREENBAUM_E2A_TARGETS_UP,SET,27,-0.31115,-0.011923,0.16125,0.97317,GREENBAUM_E2A_TARGETS_UP,1
GOBP_HEPARAN_SULFATE_PROTEOG...1,SET,32,-0.30768,-0.012834,0.15942,0.97319,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GSE23568_ID3_TRANSDUCED_VS_I...2,SET,187,-0.11871,-0.01192,0.061509,0.97319,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP,1
GOMF_ADENYLATE_CYCLASE_BINDI...,SET,12,-0.5157,-0.01318,0.26718,0.9732,GOMF_ADENYLATE_CYCLASE_BINDING,1
STEARMAN_TUMOR_FIELD_EFFECT_...,SET,34,-0.29313,-0.012602,0.15182,0.97323,STEARMAN_TUMOR_FIELD_EFFECT_UP,1
GOBP_SERINE_FAMILY_AMINO_ACI...2,SET,11,-0.48241,-0.011804,0.24978,0.97327,GOBP_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
HP_ABNORMALITY_OF_UPPER_LIP_...,SET,387,-0.084365,-0.012119,0.043675,0.97329,HP_ABNORMALITY_OF_UPPER_LIP_VERMILLION,1
WALLACE_PROSTATE_CANCER_RACE...1,SET,74,-0.18067,-0.011447,0.093523,0.9733,WALLACE_PROSTATE_CANCER_RACE_DN,1
GOMF_DOUBLE_STRANDED_DNA_EXO...,SET,6,-0.69468,-0.012556,0.35946,0.97334,GOMF_DOUBLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,1
GOMF_TRNA_GUANINE_METHYLTRAN...,SET,11,-0.43262,-0.010586,0.22385,0.97335,GOMF_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY,1
MIR12128,SET,129,-0.14798,-0.01236,0.076529,0.97341,MIR12128,1
GSE7852_LN_VS_FAT_TREG_UP,SET,180,-0.11805,-0.011631,0.061044,0.97342,GSE7852_LN_VS_FAT_TREG_UP,1
MIR330_3P,SET,306,-0.10115,-0.012949,0.052302,0.97343,MIR330_3P,1
KEGG_MEDICUS_REFERENCE_SEROT...,SET,3,-1.0232,-0.013078,0.52887,0.97348,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM,1
KEGG_MEDICUS_VARIANT_MUTATIO...6,SET,15,-0.42265,-0.012076,0.2184,0.97351,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY,1
MIR522_3P,SET,159,-0.12928,-0.011979,0.066793,0.97353,MIR522_3P,1
HP_AUTISM,SET,216,-0.11486,-0.012385,0.059344,0.97353,HP_AUTISM,1
GOBP_MICROTUBULE_DEPOLYMERIZ...,SET,41,-0.24514,-0.011571,0.12663,0.97355,GOBP_MICROTUBULE_DEPOLYMERIZATION,1
MIR152_3P,SET,314,-0.096695,-0.012537,0.049934,0.97359,MIR152_3P,1
GSE11961_FOLLICULAR_BCELL_VS...5,SET,184,-0.12429,-0.01238,0.064177,0.9736,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN,1
MIR3189_3P,SET,69,-0.19443,-0.011897,0.10038,0.97361,MIR3189_3P,1
HP_BIPARIETAL_NARROWING,SET,60,-0.18911,-0.010793,0.097635,0.97361,HP_BIPARIETAL_NARROWING,1
MODULE_509,SET,12,-0.45606,-0.011656,0.23543,0.97363,MODULE_509,1
GOBP_FOLIC_ACID_METABOLIC_PR...,SET,13,-0.39713,-0.010564,0.20501,0.97363,GOBP_FOLIC_ACID_METABOLIC_PROCESS,1
GOBP_ADENOSINE_TRANSPORT,SET,5,-0.81337,-0.013421,0.41978,0.97366,GOBP_ADENOSINE_TRANSPORT,1
MIR30A_3P,SET,347,-0.088209,-0.012012,0.04552,0.97367,MIR30A_3P,1
MIR4717_3P,SET,71,-0.20416,-0.012671,0.10536,0.97367,MIR4717_3P,1
GOBP_POSITIVE_REGULATION_OF_...830,SET,14,-0.47183,-0.013024,0.24348,0.97367,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_THIN_VERMILION_BORDER,SET,346,-0.089273,-0.012139,0.046058,0.9737,HP_THIN_VERMILION_BORDER,1
RICKMAN_METASTASIS_DN,SET,243,-0.10759,-0.012295,0.055486,0.97374,RICKMAN_METASTASIS_DN,1
GSE14350_TREG_VS_TEFF_UP,SET,181,-0.12187,-0.012041,0.06285,0.97374,GSE14350_TREG_VS_TEFF_UP,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...5,SET,13,-0.49533,-0.013176,0.25546,0.97374,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_DN,1
TGATTTRY_GFI1_01,SET,263,-0.11037,-0.013115,0.056905,0.97378,TGATTTRY_GFI1_01,1
chr12p12,SET,49,-0.40881,-0.021091,0.21073,0.9738,chr12p12,1
MCBRYAN_TERMINAL_END_BUD_DN,SET,6,-0.76461,-0.01382,0.39395,0.97386,MCBRYAN_TERMINAL_END_BUD_DN,1
GSE19888_ADENOSINE_A3R_ACT_V...4,SET,164,-0.1263,-0.011883,0.065057,0.97388,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP,1
HP_HYPERMOBILITY_OF_INTERPHA...,SET,5,-0.81447,-0.013439,0.4195,0.9739,HP_HYPERMOBILITY_OF_INTERPHALANGEAL_JOINTS,1
HP_GLOMERULAR_SUBEPITHELIAL_...,SET,11,-0.47658,-0.011662,0.24542,0.97392,HP_GLOMERULAR_SUBEPITHELIAL_DEPOSITS,1
KOYAMA_SEMA3B_TARGETS_DN,SET,319,-0.095325,-0.012455,0.049061,0.97398,KOYAMA_SEMA3B_TARGETS_DN,1
HP_LARYNGOTRACHEOMALACIA,SET,7,-0.62325,-0.012167,0.32077,0.97398,HP_LARYNGOTRACHEOMALACIA,1
HP_PARKINSONISM_WITH_FAVORAB...,SET,22,-0.35256,-0.012197,0.18135,0.97405,HP_PARKINSONISM_WITH_FAVORABLE_RESPONSE_TO_DOPAMINERGIC_MEDICATION,1
GSE21546_WT_VS_SAP1A_KO_AND_...4,SET,184,-0.12277,-0.012228,0.063131,0.97408,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
HP_SECONDARY_MICROCEPHALY,SET,174,-0.12309,-0.011926,0.063292,0.97409,HP_SECONDARY_MICROCEPHALY,1
GOBP_MITOCHONDRIAL_TRANSPORT,SET,163,-0.12847,-0.012051,0.066033,0.97414,GOBP_MITOCHONDRIAL_TRANSPORT,1
GOBP_CHONDROITIN_SULFATE_BIO...,SET,18,-0.38451,-0.012033,0.19751,0.97421,GOBP_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...612,SET,26,-0.34754,-0.013069,0.17852,0.97421,GOBP_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
MIR30D_3P,SET,350,-0.088294,-0.012074,0.045351,0.97422,MIR30D_3P,1
GOBP_PSEUDOPODIUM_ORGANIZATI...,SET,15,-0.442,-0.012629,0.22703,0.97422,GOBP_PSEUDOPODIUM_ORGANIZATION,1
HP_OSTEOLYSIS_INVOLVING_BONE...2,SET,20,-0.36875,-0.012164,0.1893,0.97428,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
GSE23114_WT_VS_SLE2C1_MOUSE_...4,SET,191,-0.11638,-0.011808,0.059728,0.97431,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP,1
HP_SPASTIC_TETRAPLEGIA,SET,109,-0.16105,-0.012372,0.082631,0.97435,HP_SPASTIC_TETRAPLEGIA,1
GOBP_PROTEIN_MATURATION_BY_4...,SET,4,-1.0048,-0.01483,0.51548,0.97436,GOBP_PROTEIN_MATURATION_BY_4FE_4S_CLUSTER_TRANSFER,1
HP_ABNORMAL_P_WAVE,SET,5,-0.87127,-0.014376,0.44687,0.97439,HP_ABNORMAL_P_WAVE,1
HP_CRANIOFACIAL_DISPROPORTION,SET,6,-0.65866,-0.011905,0.33783,0.97439,HP_CRANIOFACIAL_DISPROPORTION,1
HP_SHORTENING_OF_ALL_DISTAL_...,SET,12,-0.4153,-0.010614,0.21301,0.97439,HP_SHORTENING_OF_ALL_DISTAL_PHALANGES_OF_THE_FINGERS,1
GOBP_AMINOPHOSPHOLIPID_TRANS...2,SET,8,-0.58126,-0.012131,0.29795,0.97445,GOBP_AMINOPHOSPHOLIPID_TRANSPORT,1
GSE25123_WT_VS_PPARG_KO_MACR...4,SET,182,-0.12757,-0.012638,0.065397,0.97445,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN,1
DESCARTES_FETAL_STOMACH_SQUA...,SET,60,-0.23435,-0.013375,0.12013,0.97445,DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS,1
HP_INTRACEREBRAL_PERIVENTRIC...,SET,6,-0.64467,-0.011652,0.33038,0.97448,HP_INTRACEREBRAL_PERIVENTRICULAR_CALCIFICATIONS,1
GSE360_L_DONOVANI_VS_T_GONDI...3,SET,184,-0.1185,-0.011804,0.060698,0.97454,GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN,1
MODULE_272,SET,12,-0.42781,-0.010934,0.21909,0.97456,MODULE_272,1
HP_HEMIVERTEBRAE,SET,47,-0.23534,-0.011892,0.12049,0.9746,HP_HEMIVERTEBRAE,1
GOBP_DEDIFFERENTIATION,SET,8,-0.7034,-0.01468,0.36001,0.97463,GOBP_DEDIFFERENTIATION,1
HP_DIAPHYSEAL_SCLEROSIS,SET,9,-0.6153,-0.01362,0.31488,0.97465,HP_DIAPHYSEAL_SCLEROSIS,1
MIR323B_3P,SET,56,-0.21685,-0.011958,0.11095,0.97467,MIR323B_3P,1
HP_FINE_HAIR,SET,69,-0.19458,-0.011906,0.099554,0.97467,HP_FINE_HAIR,1
GOBP_PEROXISOME_ORGANIZATION,SET,30,-0.29608,-0.011959,0.15144,0.9747,GOBP_PEROXISOME_ORGANIZATION,1
GSE37301_PRO_BCELL_VS_GRANUL...1,SET,161,-0.13204,-0.01231,0.067531,0.97471,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
MIR1275,SET,258,-0.10768,-0.012674,0.055068,0.97472,MIR1275,1
GSE24671_CTRL_VS_SENDAI_VIRU...2,SET,146,-0.14167,-0.012583,0.072449,0.97473,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,1
MIR6787_5P,SET,24,-0.36363,-0.013139,0.18593,0.97474,MIR6787_5P,1
GOBP_POSITIVE_REGULATION_OF_...549,SET,59,-0.22726,-0.012862,0.1162,0.97475,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION,1
GOBP_NAD_CATABOLIC_PROCESS,SET,16,-0.38741,-0.011431,0.19806,0.97476,GOBP_NAD_CATABOLIC_PROCESS,1
REACTOME_TYPE_I_HEMIDESMOSOM...,SET,11,-0.51234,-0.012537,0.26185,0.9748,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,1
GOBP_REGULATION_OF_MUCUS_SEC...,SET,9,-0.63729,-0.014106,0.32563,0.97482,GOBP_REGULATION_OF_MUCUS_SECRETION,1
MIR224_3P,SET,160,-0.13062,-0.01214,0.066702,0.97489,MIR224_3P,1
GOBP_SMOOTH_MUSCLE_CONTRACTI...,SET,104,-0.17671,-0.013262,0.090239,0.97489,GOBP_SMOOTH_MUSCLE_CONTRACTION,1
HP_MORNING_GLORY_ANOMALY,SET,6,-0.80123,-0.014482,0.40914,0.9749,HP_MORNING_GLORY_ANOMALY,1
APPIERTO_RESPONSE_TO_FENRETI...2,SET,37,-0.26122,-0.011715,0.13336,0.97492,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,1
HOXA7_TARGET_GENES,SET,95,-0.17568,-0.012604,0.089678,0.97493,HOXA7_TARGET_GENES,1
ZNF791_TARGET_GENES,SET,41,-0.24719,-0.011668,0.12618,0.97494,ZNF791_TARGET_GENES,1
MORF_EPHA7,SET,125,-0.1551,-0.012754,0.079161,0.97495,MORF_EPHA7,1
HP_ABNORMAL_FINGER_PHALANX_M...,SET,578,-0.070532,-0.012316,0.035992,0.97497,HP_ABNORMAL_FINGER_PHALANX_MORPHOLOGY,1
LAKE_ADULT_KIDNEY_C27_VASCUL...,SET,145,-0.15338,-0.013577,0.078265,0.97498,LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES,1
HP_ABNORMAL_PUPILLARY_FUNCTI...,SET,70,-0.21127,-0.01302,0.10778,0.97501,HP_ABNORMAL_PUPILLARY_FUNCTION,1
GOMF_UREA_TRANSMEMBRANE_TRAN...,SET,7,-0.75207,-0.014682,0.38358,0.97503,GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_ANTIFUNGAL_INNATE_IMMUN...,SET,14,-0.42182,-0.011644,0.21514,0.97504,GOBP_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,1
GSE37533_PPARG1_FOXP3_VS_PPA...3,SET,173,-0.12603,-0.012176,0.064278,0.97504,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,1
CAGTCAC_MIR134,SET,48,-0.23732,-0.012119,0.12095,0.97512,CAGTCAC_MIR134,1
GOCC_MITOCHONDRION,SET,1452,-0.044412,-0.011985,0.022624,0.97517,GOCC_MITOCHONDRION,1
GOMF_PROTEIN_FOLDING_CHAPERO...1,SET,62,-0.20992,-0.012178,0.10693,0.97517,GOMF_PROTEIN_FOLDING_CHAPERONE,1
WP_CANONICAL_AND_NONCANONICA...2,SET,17,-0.43809,-0.013324,0.22314,0.97519,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1
MIR4480,SET,49,-0.24237,-0.012504,0.12345,0.97519,MIR4480,1
GOBP_ETHER_BIOSYNTHETIC_PROC...,SET,11,-0.51676,-0.012645,0.26315,0.97521,GOBP_ETHER_BIOSYNTHETIC_PROCESS,1
MIR4293,SET,99,-0.17061,-0.012494,0.086789,0.97533,MIR4293,1
GOBP_DIOL_METABOLIC_PROCESS,SET,26,-0.32546,-0.012239,0.16551,0.97537,GOBP_DIOL_METABOLIC_PROCESS,1
GOCC_CLATHRIN_COATED_VESICLE...,SET,123,-0.15688,-0.012797,0.07975,0.97541,GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE,1
HP_RETINAL_TELANGIECTASIA,SET,14,-0.42153,-0.011636,0.21429,0.97541,HP_RETINAL_TELANGIECTASIA,1
MIR30E_3P,SET,348,-0.089486,-0.012203,0.045486,0.97542,MIR30E_3P,1
GOMF_PROTEIN_PHOSPHATASE_2B_...,SET,6,-0.58973,-0.010659,0.29976,0.97542,GOMF_PROTEIN_PHOSPHATASE_2B_BINDING,1
HP_ABNORMAL_ENZYME_ACTIVITY_...2,SET,7,-0.53597,-0.010463,0.27238,0.97544,HP_ABNORMAL_ENZYME_ACTIVITY_IN_MUSCLE_TISSUE,1
GOMF_SMALL_MOLECULE_SENSOR_A...,SET,44,-0.22763,-0.01113,0.11567,0.97545,GOMF_SMALL_MOLECULE_SENSOR_ACTIVITY,1
REACTOME_ANTIGEN_PROCESSING_...1,SET,97,-0.16032,-0.011622,0.081458,0.97546,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1
GOBP_ANTIGEN_PROCESSING_AND_...1,SET,104,-0.1842,-0.013824,0.093574,0.97549,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOBP_INTERLEUKIN_1_PRODUCTION,SET,104,-0.17885,-0.013423,0.090852,0.97549,GOBP_INTERLEUKIN_1_PRODUCTION,1
GOBP_MOTOR_NEURON_MIGRATION,SET,12,-0.58283,-0.014896,0.29607,0.97549,GOBP_MOTOR_NEURON_MIGRATION,1
GOBP_CELLULAR_RESPONSE_TO_RE...2,SET,136,-0.14858,-0.012741,0.075474,0.9755,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
ACCTGTTG_UNKNOWN,SET,144,-0.1449,-0.012783,0.073576,0.97554,ACCTGTTG_UNKNOWN,1
GOBP_DISRUPTION_OF_CELLULAR_...,SET,3,-1.2723,-0.016262,0.64602,0.97554,GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,1
REACTOME_TRANSCRIPTIONAL_REG...8,SET,35,-0.30312,-0.013222,0.15387,0.97557,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1
WP_CHOLESTEROL_METABOLISM,SET,66,-0.21097,-0.012626,0.1071,0.97557,WP_CHOLESTEROL_METABOLISM,1
MIR519E_3P,SET,60,-0.23009,-0.013132,0.1168,0.97557,MIR519E_3P,1
DESCARTES_FETAL_EYE_GANGLION...,SET,33,-0.31631,-0.013398,0.16056,0.97557,DESCARTES_FETAL_EYE_GANGLION_CELLS,1
HP_PULMONARY_OPACITY,SET,22,-0.37748,-0.013059,0.1916,0.97558,HP_PULMONARY_OPACITY,1
MIR4687_5P,SET,40,-0.26797,-0.012494,0.13598,0.97561,MIR4687_5P,1
NOURUZI_NEPC_ASCL1_TARGETS,SET,124,-0.16615,-0.013608,0.0843,0.97562,NOURUZI_NEPC_ASCL1_TARGETS,1
HP_CRANIAL_NERVE_COMPRESSION,SET,49,-0.23208,-0.011973,0.11775,0.97562,HP_CRANIAL_NERVE_COMPRESSION,1
MIR3674,SET,123,-0.14916,-0.012167,0.075668,0.97564,MIR3674,1
HOLLERN_MICROACINAR_BREAST_T...1,SET,14,-0.47178,-0.013023,0.23905,0.97578,HOLLERN_MICROACINAR_BREAST_TUMOR_DN,1
HP_CENTRAL_HETEROCHROMIA,SET,6,-0.76147,-0.013763,0.38582,0.97578,HP_CENTRAL_HETEROCHROMIA,1
KEGG_MEDICUS_REFERENCE_PDGF_...3,SET,16,-0.42364,-0.012501,0.21432,0.97595,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...209,SET,33,-0.30863,-0.013073,0.15609,0.97598,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING,1
GSE30962_PRIMARY_VS_SECONDAR...1,SET,180,-0.12862,-0.012673,0.065035,0.97601,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN,1
HP_HYPOCHROMIA,SET,13,-0.4654,-0.01238,0.23527,0.97603,HP_HYPOCHROMIA,1
MIR4442,SET,4,-0.84238,-0.012432,0.42584,0.97604,MIR4442,1
ATF2_UP.V1_DN,SET,166,-0.13834,-0.013094,0.069914,0.97607,ATF2_UP.V1_DN,1
HP_CHIARI_MALFORMATION,SET,91,-0.17744,-0.012461,0.089655,0.97609,HP_CHIARI_MALFORMATION,1
REACTOME_DISINHIBITION_OF_SN...,SET,5,-0.69886,-0.011531,0.35308,0.9761,REACTOME_DISINHIBITION_OF_SNARE_FORMATION,1
HP_THICKENED_GLOMERULAR_BASE...,SET,9,-0.55045,-0.012184,0.27811,0.9761,HP_THICKENED_GLOMERULAR_BASEMENT_MEMBRANE,1
GOCC_ANAPHASE_PROMOTING_COMP...,SET,21,-0.33553,-0.011341,0.16948,0.97612,GOCC_ANAPHASE_PROMOTING_COMPLEX,1
HP_TRANSIENT_HYPERPHENYLALAN...,SET,5,-0.81332,-0.01342,0.41072,0.97615,HP_TRANSIENT_HYPERPHENYLALANINEMIA,1
BIOCARTA_TEL_PATHWAY,SET,17,-0.38545,-0.011723,0.19463,0.97616,BIOCARTA_TEL_PATHWAY,1
HP_LARGE_SELLA_TURCICA,SET,14,-0.4612,-0.012731,0.23288,0.97617,HP_LARGE_SELLA_TURCICA,1
GSE25123_WT_VS_PPARG_KO_MACR...5,SET,178,-0.12848,-0.012589,0.064856,0.9762,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP,1
MIR1261,SET,76,-0.18835,-0.012093,0.095056,0.97623,MIR1261,1
BIOCARTA_AT1R_PATHWAY,SET,26,-0.33902,-0.012749,0.17107,0.97624,BIOCARTA_AT1R_PATHWAY,1
GSE411_100MIN_VS_400MIN_IL6_...3,SET,183,-0.1199,-0.01191,0.060487,0.97626,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
GOBP_G_PROTEIN_COUPLED_PURIN...2,SET,10,-0.56096,-0.013088,0.28299,0.97627,GOBP_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_ATPASE_REGULATOR_ACTIVI...,SET,45,-0.23477,-0.011608,0.11842,0.97628,GOMF_ATPASE_REGULATOR_ACTIVITY,1
MIR4661_3P,SET,29,-0.3097,-0.012299,0.1562,0.97629,MIR4661_3P,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...3,SET,27,-0.33756,-0.012935,0.17018,0.97634,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
chr15q21,SET,78,-0.35071,-0.022811,0.1768,0.97635,chr15q21,1
REACTOME_SIGNALING_BY_TGF_BE...2,SET,8,-0.64742,-0.013511,0.32637,0.97635,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER,1
HP_MACULAR_HYPOPIGMENTATION,SET,5,-0.84742,-0.013983,0.42715,0.97636,HP_MACULAR_HYPOPIGMENTATION,1
GSE43863_NAIVE_VS_LY6C_INT_C...1,SET,146,-0.14563,-0.012935,0.073396,0.97638,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN,1
GOBP_REGULATION_OF_VITAMIN_D...1,SET,7,-0.67735,-0.013223,0.34127,0.97641,GOBP_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
GOBP_CHONDROITIN_SULFATE_PRO...1,SET,23,-0.35066,-0.012404,0.17655,0.97649,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GSE17721_12H_VS_24H_GARDIQUI...2,SET,177,-0.12879,-0.012585,0.064838,0.9765,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP,1
GOBP_MITOCHONDRIAL_GENE_EXPR...,SET,155,-0.12284,-0.011239,0.061825,0.97652,GOBP_MITOCHONDRIAL_GENE_EXPRESSION,1
CREIGHTON_ENDOCRINE_THERAPY_...1,SET,445,-0.083489,-0.012839,0.04202,0.97653,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,1
HP_DELAYED_OSSIFICATION_OF_C...,SET,15,-0.40107,-0.011459,0.20185,0.97653,HP_DELAYED_OSSIFICATION_OF_CARPAL_BONES,1
GSE9006_TYPE_1_VS_TYPE_2_DIA...2,SET,180,-0.11624,-0.011453,0.058478,0.97657,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
GAVISH_3CA_METAPROGRAM_FIBRO...3,SET,47,-0.28018,-0.014158,0.14088,0.97663,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2,1
GOBP_NEGATIVE_REGULATION_OF_...608,SET,26,-0.34328,-0.012909,0.17261,0.97663,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,1
GOBP_UREA_TRANSMEMBRANE_TRAN...,SET,8,-0.71417,-0.014904,0.35896,0.97667,GOBP_UREA_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...774,SET,17,-0.40993,-0.012468,0.20596,0.97672,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
GOBP_REGULATION_OF_MUSCLE_SY...,SET,215,-0.12385,-0.013323,0.062201,0.97675,GOBP_REGULATION_OF_MUSCLE_SYSTEM_PROCESS,1
GOMF_L_LACTATE_DEHYDROGENASE...,SET,5,-1.017,-0.016781,0.51083,0.97675,GOMF_L_LACTATE_DEHYDROGENASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...80,SET,33,-0.29448,-0.012474,0.14786,0.97678,HP_APLASIA_HYPOPLASIA_OF_THE_VERTEBRAE,1
GOMF_FAD_BINDING,SET,36,-0.28258,-0.0125,0.14188,0.97679,GOMF_FAD_BINDING,1
GOBP_CRANIAL_NERVE_FORMATION,SET,10,-0.65381,-0.015254,0.32824,0.9768,GOBP_CRANIAL_NERVE_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...82,SET,56,-0.23893,-0.013175,0.11994,0.97681,GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
MIR302A_3P_MIR302B_3P_MIR302...,SET,323,-0.095674,-0.012578,0.047964,0.97696,MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P,1
GOBP_DEFENSE_RESPONSE_TO_FUN...,SET,44,-0.2716,-0.01328,0.13616,0.97696,GOBP_DEFENSE_RESPONSE_TO_FUNGUS,1
REACTOME_THE_FATTY_ACID_CYCL...,SET,4,-0.78015,-0.011514,0.391,0.97698,REACTOME_THE_FATTY_ACID_CYCLING_MODEL,1
TRAVAGLINI_LUNG_AIRWAY_SMOOT...,SET,156,-0.13879,-0.012739,0.069563,0.97698,TRAVAGLINI_LUNG_AIRWAY_SMOOTH_MUSCLE_CELL,1
HP_APLASIA_HYPOPLASIA_OF_THE...37,SET,25,-0.35578,-0.01312,0.17829,0.977,HP_APLASIA_HYPOPLASIA_OF_THE_HUMERUS,1
GOBP_RESPONSE_TO_THYROGLOBUL...,SET,5,-0.87063,-0.014366,0.43621,0.97702,GOBP_RESPONSE_TO_THYROGLOBULIN_TRIIODOTHYRONINE,1
MIR8069,SET,57,-0.23891,-0.013291,0.11962,0.97709,MIR8069,1
GOBP_PURINE_RIBONUCLEOSIDE_C...,SET,5,-0.76614,-0.012642,0.38361,0.97709,GOBP_PURINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS,1
MIR4460,SET,78,-0.19215,-0.012497,0.096202,0.9771,MIR4460,1
MIR6737_3P,SET,172,-0.13371,-0.012881,0.066939,0.97711,MIR6737_3P,1
HP_WIDELY_SPACED_PRIMARY_TEE...,SET,5,-0.8309,-0.01371,0.41591,0.97712,HP_WIDELY_SPACED_PRIMARY_TEETH,1
WP_NANOPARTICLEMEDIATED_ACTI...,SET,28,-0.34009,-0.013271,0.17019,0.97715,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,1
MIR600,SET,129,-0.16019,-0.01338,0.080151,0.97716,MIR600,1
GOBP_PROTON_MOTIVE_FORCE_DRI...,SET,43,-0.21725,-0.010501,0.1087,0.97717,GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS,1
GSE27859_MACROPHAGE_VS_DC_UP,SET,154,-0.1347,-0.012285,0.067395,0.97717,GSE27859_MACROPHAGE_VS_DC_UP,1
REACTOME_AUF1_HNRNP_D0_BINDS...,SET,52,-0.21542,-0.011448,0.10776,0.97719,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,1
GOBP_AUTOCRINE_SIGNALING,SET,7,-0.72331,-0.014121,0.36179,0.9772,GOBP_AUTOCRINE_SIGNALING,1
GSE7509_FCGRIIB_VS_TNFA_IL1B...2,SET,157,-0.12839,-0.011822,0.064204,0.97723,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,1
MCBRYAN_PUBERTAL_BREAST_6_7W...2,SET,177,-0.12578,-0.01229,0.062884,0.97725,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1
GOBP_POSITIVE_REGULATION_OF_...803,SET,4,-1.0218,-0.01508,0.51079,0.97726,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
HP_ABNORMAL_PERIAURICULAR_RE...,SET,95,-0.17835,-0.012796,0.089165,0.97726,HP_ABNORMAL_PERIAURICULAR_REGION_MORPHOLOGY,1
MODULE_511,SET,34,-0.28931,-0.012439,0.14461,0.97728,MODULE_511,1
REACTOME_SHC1_EVENTS_IN_EGFR...,SET,14,-0.44937,-0.012404,0.22453,0.97732,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,1
LENAOUR_DENDRITIC_CELL_MATUR...1,SET,115,-0.16365,-0.012911,0.081755,0.97733,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1
HP_ABNORMAL_NASAL_BASE_NORPH...,SET,24,-0.34571,-0.012491,0.17272,0.97733,HP_ABNORMAL_NASAL_BASE_NORPHOLOGY,1
HP_APLASIA_HYPOPLASIA_OF_THE...79,SET,43,-0.26217,-0.012673,0.13096,0.97734,HP_APLASIA_HYPOPLASIA_OF_THE_VAGINA,1
GOMF_CARDIOLIPIN_BINDING,SET,10,-0.5584,-0.013028,0.27888,0.97737,GOMF_CARDIOLIPIN_BINDING,1
MATSUMIYA_PBMC_MODIFIED_VACC...1,SET,60,-0.23676,-0.013513,0.11824,0.97737,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,1
HP_ABNORMAL_CIRCULATING_T4_C...,SET,24,-0.36067,-0.013032,0.18006,0.97741,HP_ABNORMAL_CIRCULATING_T4_CONCENTRATION,1
GSE24634_TREG_VS_TCONV_POST_...3,SET,180,-0.12997,-0.012806,0.06486,0.97745,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN,1
MATSUDA_NATURAL_KILLER_DIFFE...,SET,437,-0.083463,-0.012722,0.041635,0.97749,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1
MODULE_334,SET,146,-0.14037,-0.012468,0.069998,0.97753,MODULE_334,1
MIR203A_3P,SET,334,-0.098367,-0.013146,0.049045,0.97755,MIR203A_3P,1
GOLDRATH_NAIVE_VS_MEMORY_CD8...2,SET,190,-0.12445,-0.012595,0.062049,0.97755,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
GSE27786_LSK_VS_BCELL_UP,SET,175,-0.12571,-0.012214,0.062662,0.97757,GSE27786_LSK_VS_BCELL_UP,1
HP_FRAGMENTED_ELASTIC_FIBERS...,SET,9,-0.50647,-0.011211,0.2524,0.9776,HP_FRAGMENTED_ELASTIC_FIBERS_IN_THE_DERMIS,1
HP_PEDAL_EDEMA,SET,48,-0.25462,-0.013002,0.12687,0.97761,HP_PEDAL_EDEMA,1
GSE27786_LSK_VS_MONO_MAC_DN,SET,186,-0.12546,-0.012564,0.062493,0.97765,GSE27786_LSK_VS_MONO_MAC_DN,1
GSE22935_UNSTIM_VS_12H_MBOVI...4,SET,187,-0.12913,-0.012966,0.064309,0.97767,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
GGGNRMNNYCAT_UNKNOWN,SET,73,-0.19412,-0.012216,0.096603,0.97775,GGGNRMNNYCAT_UNKNOWN,1
GSE5589_LPS_VS_LPS_AND_IL10_...12,SET,183,-0.13015,-0.012929,0.06469,0.97788,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
MORF_UBE2N,SET,82,-0.17241,-0.011496,0.085611,0.97798,MORF_UBE2N,1
MIR548AJ_5P_MIR548G_5P_MIR54...,SET,446,-0.084748,-0.013047,0.042057,0.97804,MIR548AJ_5P_MIR548G_5P_MIR548X_5P,1
HIF1_Q5,SET,227,-0.11677,-0.012903,0.05794,0.97806,HIF1_Q5,1
HP_PULMONARY_INSUFFICIENCY,SET,24,-0.35749,-0.012916,0.17734,0.97808,HP_PULMONARY_INSUFFICIENCY,1
KEGG_MEDICUS_REFERENCE_MAGI_...,SET,6,-0.68538,-0.012388,0.33996,0.97809,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY,1
GOBP_SOMATIC_DIVERSIFICATION...2,SET,13,-0.4032,-0.010725,0.19998,0.9781,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION,1
HP_STEROETYPIC_UPPER_EXTREMI...,SET,43,-0.26829,-0.012969,0.13304,0.97812,HP_STEROETYPIC_UPPER_EXTREMITY_MOVEMENTS,1
MIR329_5P,SET,124,-0.14991,-0.012278,0.074325,0.97814,MIR329_5P,1
GSE17721_POLYIC_VS_CPG_4H_BM...1,SET,184,-0.12628,-0.012578,0.062602,0.97816,GSE17721_POLYIC_VS_CPG_4H_BMDC_DN,1
GOBP_MITOCHONDRIAL_TRNA_PROC...,SET,12,-0.43198,-0.01104,0.21413,0.97817,GOBP_MITOCHONDRIAL_TRNA_PROCESSING,1
GOMF_METAL_ION_SENSOR_ACTIVI...,SET,8,-0.74286,-0.015503,0.36822,0.97817,GOMF_METAL_ION_SENSOR_ACTIVITY,1
DURAND_STROMA_S_UP,SET,261,-0.11488,-0.0136,0.056932,0.97819,DURAND_STROMA_S_UP,1
REACTOME_CONVERSION_FROM_APC...,SET,19,-0.36761,-0.01182,0.18216,0.9782,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,1
GSE21546_WT_VS_SAP1A_KO_DP_T...1,SET,156,-0.1409,-0.012933,0.069798,0.97824,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN,1
MALONEY_RESPONSE_TO_17AAG_UP,SET,37,-0.29634,-0.01329,0.14673,0.97828,MALONEY_RESPONSE_TO_17AAG_UP,1
GSE37416_CTRL_VS_0H_F_TULARE...1,SET,133,-0.15319,-0.012991,0.075855,0.97828,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_GLUTAMINE_METABOLIC_PRO...,SET,25,-0.34747,-0.012813,0.17196,0.97833,GOBP_GLUTAMINE_METABOLIC_PROCESS,1
DESCARTES_MAIN_FETAL_CSH1_CS...,SET,70,-0.18435,-0.011361,0.091233,0.97833,DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS,1
HP_SKIN_TAGS,SET,72,-0.20311,-0.012694,0.10051,0.97834,HP_SKIN_TAGS,1
HE_LIM_SUN_FETAL_LUNG_C0_RES...,SET,98,-0.1938,-0.014121,0.095894,0.97835,HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE,1
MIR378J,SET,70,-0.20971,-0.012924,0.10368,0.97844,MIR378J,1
HP_PERIPHERAL_EDEMA,SET,12,-0.51579,-0.013182,0.25495,0.97846,HP_PERIPHERAL_EDEMA,1
GOBP_NUCLEOTIDE_TRANSMEMBRAN...,SET,28,-0.35698,-0.01393,0.1764,0.97849,GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT,1
REACTOME_ION_TRANSPORT_BY_P_...,SET,51,-0.25228,-0.013278,0.12464,0.97851,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,1
GOBP_REGULATION_OF_PODOSOME_...,SET,13,-0.49208,-0.013089,0.24309,0.97852,GOBP_REGULATION_OF_PODOSOME_ASSEMBLY,1
MASRI_RESISTANCE_TO_TAMOXIFE...2,SET,15,-0.48509,-0.01386,0.23962,0.97853,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,1
MIR148B_3P,SET,313,-0.10128,-0.01311,0.049997,0.97859,MIR148B_3P,1
GOBP_POSITIVE_REGULATION_OF_...480,SET,17,-0.3661,-0.011135,0.18074,0.97859,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION,1
MIR148A_3P,SET,315,-0.10094,-0.013107,0.049826,0.9786,MIR148A_3P,1
MIR7157_3P,SET,173,-0.13525,-0.013067,0.066742,0.97863,MIR7157_3P,1
HP_HORSESHOE_KIDNEY,SET,122,-0.15188,-0.012339,0.074942,0.97864,HP_HORSESHOE_KIDNEY,1
HP_SUPRAVENTRICULAR_TACHYCAR...,SET,51,-0.2636,-0.013874,0.13,0.9787,HP_SUPRAVENTRICULAR_TACHYCARDIA,1
ZHANG_GATA6_TARGETS_DN,SET,61,-0.22934,-0.013197,0.11308,0.97871,ZHANG_GATA6_TARGETS_DN,1
GOBP_EMBRYONIC_BODY_MORPHOGE...,SET,10,-0.54162,-0.012637,0.26706,0.97872,GOBP_EMBRYONIC_BODY_MORPHOGENESIS,1
HP_ANAL_FISTULA,SET,7,-0.61672,-0.01204,0.30406,0.97872,HP_ANAL_FISTULA,1
GSE41867_NAIVE_VS_DAY6_LCMV_...3,SET,179,-0.12781,-0.012559,0.063016,0.97873,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN,1
HP_ABNORMAL_LOWER_LIMB_BONE_...,SET,671,-0.068136,-0.012785,0.033588,0.97874,HP_ABNORMAL_LOWER_LIMB_BONE_MORPHOLOGY,1
MIR1199_5P,SET,72,-0.1993,-0.012456,0.098172,0.97882,MIR1199_5P,1
DESCARTES_FETAL_STOMACH_MYEL...,SET,65,-0.23203,-0.013782,0.11429,0.97882,DESCARTES_FETAL_STOMACH_MYELOID_CELLS,1
HP_EEG_WITH_PARIETAL_EPILEPT...,SET,4,-1.1261,-0.01662,0.55427,0.9789,HP_EEG_WITH_PARIETAL_EPILEPTIFORM_DISCHARGES,1
HP_CESSATION_OF_HEAD_GROWTH,SET,6,-0.74874,-0.013533,0.36851,0.97891,HP_CESSATION_OF_HEAD_GROWTH,1
GSE3337_4H_VS_16H_IFNG_IN_CD...2,SET,186,-0.12569,-0.012587,0.061812,0.97899,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP,1
HP_PROGRESSIVE_SPASTIC_QUADR...,SET,11,-0.55709,-0.013632,0.27394,0.979,HP_PROGRESSIVE_SPASTIC_QUADRIPLEGIA,1
GSE9650_NAIVE_VS_EXHAUSTED_C...2,SET,182,-0.11977,-0.011865,0.058891,0.979,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP,1
MIR520E_5P,SET,146,-0.14757,-0.013107,0.072551,0.97902,MIR520E_5P,1
GAVISH_3CA_METAPROGRAM_EPITH...24,SET,44,-0.26924,-0.013165,0.13225,0.97911,GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE,1
GOBP_NEGATIVE_REGULATION_OF_...709,SET,5,-0.76801,-0.012672,0.37724,0.97911,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
GOBP_RRNA_MODIFICATION,SET,25,-0.30737,-0.011335,0.15091,0.97916,GOBP_RRNA_MODIFICATION,1
WP_ANGIOTENSIN_II_RECEPTOR_T...,SET,25,-0.36403,-0.013424,0.17863,0.97921,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,1
GOBP_P_BODY_ASSEMBLY,SET,21,-0.37014,-0.012511,0.18155,0.97925,GOBP_P_BODY_ASSEMBLY,1
GSE13547_CTRL_VS_ANTI_IGM_ST...5,SET,141,-0.15347,-0.013397,0.075269,0.97926,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...3,SET,35,-0.28516,-0.012439,0.13979,0.97931,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,1
HP_CLUBBING_OF_FINGERS,SET,37,-0.29922,-0.013419,0.14667,0.97932,HP_CLUBBING_OF_FINGERS,1
HP_DECEREBRATE_RIGIDITY,SET,5,-0.77767,-0.012832,0.38114,0.97934,HP_DECEREBRATE_RIGIDITY,1
REACTOME_ACTIVATION_OF_BH3_O...,SET,30,-0.33778,-0.013643,0.16553,0.97935,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,1
HOLLERN_ADENOMYOEPITHELIAL_B...,SET,17,-0.40895,-0.012438,0.2003,0.9794,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,1
HP_APLASIA_OF_THE_LEFT_HEMID...,SET,5,-0.89341,-0.014741,0.4376,0.9794,HP_APLASIA_OF_THE_LEFT_HEMIDIAPHRAGM,1
MIR5586_3P,SET,48,-0.25319,-0.012929,0.12395,0.97945,MIR5586_3P,1
GSE17721_0.5H_VS_12H_CPG_BMD...2,SET,181,-0.12894,-0.012739,0.063117,0.97946,GSE17721_0.5H_VS_12H_CPG_BMDC_UP,1
PID_INTEGRIN4_PATHWAY,SET,11,-0.54735,-0.013394,0.2678,0.97951,PID_INTEGRIN4_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...79,SET,28,-0.35256,-0.013758,0.17249,0.97952,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
BAE_BRCA1_TARGETS_UP,SET,60,-0.22834,-0.013032,0.11168,0.97954,BAE_BRCA1_TARGETS_UP,1
GOBP_FOLIC_ACID_CONTAINING_C...1,SET,8,-0.54965,-0.011471,0.26884,0.97954,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
HP_CEREBRAL_PALSY,SET,157,-0.14106,-0.012988,0.068989,0.97955,HP_CEREBRAL_PALSY,1
GSE34205_HEALTHY_VS_RSV_INF_...2,SET,168,-0.12815,-0.012202,0.062675,0.97955,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP,1
GSE28726_NAIVE_VS_ACTIVATED_...3,SET,187,-0.12636,-0.012687,0.06176,0.97961,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN,1
MODULE_67,SET,199,-0.12283,-0.012718,0.06003,0.97962,MODULE_67,1
HP_POINTED_CHIN,SET,118,-0.16178,-0.012928,0.079067,0.97962,HP_POINTED_CHIN,1
GSE9988_ANTI_TREM1_VS_LOW_LP...1,SET,174,-0.13909,-0.013476,0.067959,0.97964,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN,1
GOBP_REGULATION_OF_CELLULAR_...16,SET,17,-0.44005,-0.013384,0.21484,0.97972,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
GOCC_UNIPLEX_COMPLEX,SET,5,-0.93201,-0.015378,0.45505,0.97972,GOCC_UNIPLEX_COMPLEX,1
IRF1_01,SET,225,-0.12104,-0.013317,0.05909,0.97973,IRF1_01,1
REACTOME_METABOLISM_OF_FOLAT...,SET,16,-0.40378,-0.011915,0.19699,0.9798,REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES,1
WP_INTERACTIONS_OF_NATURAL_K...,SET,27,-0.36347,-0.013928,0.17721,0.97987,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...3,SET,13,-0.46627,-0.012403,0.22727,0.97989,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_THICK_CEREBRAL_CORTEX,SET,9,-0.53352,-0.01181,0.26004,0.97989,HP_THICK_CEREBRAL_CORTEX,1
HP_TOE_DEFORMITY,SET,112,-0.16601,-0.012927,0.080906,0.9799,HP_TOE_DEFORMITY,1
BUSSLINGER_DUODENAL_MATURE_E...,SET,237,-0.11484,-0.012963,0.055946,0.97994,BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES,1
WP_NSP1_FROM_SARSCOV2_INHIBI...,SET,12,-0.47136,-0.012047,0.2295,0.98,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,1
GNF2_MCL1,SET,49,-0.24718,-0.012753,0.12035,0.98,GNF2_MCL1,1
HP_CHORIORETINAL_DYSPLASIA,SET,14,-0.47014,-0.012977,0.22891,0.98,HP_CHORIORETINAL_DYSPLASIA,1
MIR4663,SET,61,-0.22812,-0.013127,0.11105,0.98002,MIR4663,1
GOBP_PROTEIN_LIPOYLATION,SET,5,-0.73268,-0.012089,0.35662,0.98003,GOBP_PROTEIN_LIPOYLATION,1
HP_ABNORMAL_DISTAL_PHALANX_M...,SET,146,-0.14755,-0.013105,0.071813,0.98003,HP_ABNORMAL_DISTAL_PHALANX_MORPHOLOGY_OF_FINGER,1
HP_DUPLICATED_COLLECTING_SYS...,SET,19,-0.3735,-0.012009,0.18176,0.98005,HP_DUPLICATED_COLLECTING_SYSTEM,1
GOBP_ICOSANOID_CATABOLIC_PRO...,SET,9,-0.56063,-0.012409,0.27275,0.98008,GOBP_ICOSANOID_CATABOLIC_PROCESS,1
GSE24492_LYVE_NEG_VS_POS_MAC...1,SET,177,-0.13248,-0.012945,0.064448,0.98008,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN,1
GSE21546_UNSTIM_VS_ANTI_CD3_...8,SET,175,-0.13508,-0.013125,0.065686,0.98013,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP,1
REACTOME_GLUTATHIONE_SYNTHES...,SET,12,-0.50609,-0.012934,0.24601,0.98016,REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING,1
GOBP_MUCUS_SECRETION,SET,19,-0.45422,-0.014604,0.22079,0.98016,GOBP_MUCUS_SECRETION,1
MIR625_3P,SET,45,-0.27638,-0.013666,0.13433,0.98017,MIR625_3P,1
KENNEDY_PBMC_DRYVAX_AGE_18_5...,SET,11,-0.57923,-0.014174,0.2815,0.98018,KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP,1
HP_OLIGOZOOSPERMIA,SET,43,-0.25659,-0.012403,0.12468,0.9802,HP_OLIGOZOOSPERMIA,1
GOMF_POLYAMINE_TRANSMEMBRANE...,SET,10,-0.64292,-0.015,0.31236,0.98021,GOMF_POLYAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_GLIAL_CELL_DEVELOPMENT,SET,126,-0.16172,-0.013351,0.078563,0.98022,GOBP_GLIAL_CELL_DEVELOPMENT,1
KEGG_MEDICUS_REFERENCE_EGF_E...12,SET,15,-0.4397,-0.012563,0.21358,0.98023,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY,1
HP_DEVELOPMENTAL_GLAUCOMA,SET,64,-0.22168,-0.013065,0.10768,0.98023,HP_DEVELOPMENTAL_GLAUCOMA,1
GSE6674_UNSTIM_VS_CPG_STIM_B...2,SET,131,-0.15212,-0.012803,0.073868,0.98026,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP,1
MANNE_COVID19_COMBINED_COHOR...1,SET,196,-0.13906,-0.014291,0.06752,0.98027,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,1
GOCC_CELL_SUBSTRATE_JUNCTION,SET,411,-0.08738,-0.012927,0.042423,0.98028,GOCC_CELL_SUBSTRATE_JUNCTION,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...2,SET,5,-0.94136,-0.015533,0.45703,0.98028,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,1
GSE9650_EXHAUSTED_VS_MEMORY_...1,SET,187,-0.12644,-0.012695,0.061377,0.9803,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN,1
GSE20715_0H_VS_6H_OZONE_LUNG...2,SET,182,-0.13123,-0.013001,0.06368,0.98033,GSE20715_0H_VS_6H_OZONE_LUNG_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...5,SET,120,-0.17745,-0.014299,0.086114,0.98033,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL,1
GSE22501_PERIPHERAL_BLOOD_VS...1,SET,175,-0.13457,-0.013075,0.065264,0.98038,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN,1
REACTOME_TGF_BETA_RECEPTOR_S...2,SET,15,-0.50031,-0.014295,0.24243,0.98047,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GSE7509_UNSTIM_VS_IFNA_STIM_...2,SET,169,-0.1316,-0.012568,0.063763,0.98048,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...5,SET,14,-0.45583,-0.012582,0.22075,0.98053,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE32986_UNSTIM_VS_GMCSF_AND...1,SET,168,-0.13878,-0.013215,0.067199,0.98054,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,1
HP_OPTIC_NERVE_COMPRESSION,SET,14,-0.48669,-0.013434,0.23562,0.98056,HP_OPTIC_NERVE_COMPRESSION,1
REACTOME_SEPARATION_OF_SISTE...,SET,174,-0.12714,-0.012319,0.061545,0.98057,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,1
GOBP_TRNA_PROCESSING,SET,119,-0.14592,-0.011709,0.070634,0.98057,GOBP_TRNA_PROCESSING,1
MIR4720_3P,SET,106,-0.17846,-0.013521,0.086365,0.9806,MIR4720_3P,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...2,SET,12,-0.55137,-0.014091,0.26678,0.98062,GOBP_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,1
CRGAARNNNNCGA_UNKNOWN,SET,39,-0.28325,-0.013041,0.137,0.98065,CRGAARNNNNCGA_UNKNOWN,1
HP_ECTOPIA_PUPILLAE,SET,21,-0.43217,-0.014608,0.20904,0.98065,HP_ECTOPIA_PUPILLAE,1
GOBP_L_PROLINE_BIOSYNTHETIC_...,SET,5,-0.82881,-0.013676,0.40082,0.98066,GOBP_L_PROLINE_BIOSYNTHETIC_PROCESS,1
BAHD1_TARGET_GENES,SET,18,-0.4085,-0.012784,0.19746,0.98071,BAHD1_TARGET_GENES,1
MIR764,SET,46,-0.23481,-0.011739,0.11345,0.98075,MIR764,1
HP_APLASIA_HYPOPLASIA_OF_TOE,SET,112,-0.17007,-0.013243,0.082109,0.98083,HP_APLASIA_HYPOPLASIA_OF_TOE,1
GOBP_PRE_MIRNA_PROCESSING,SET,14,-0.46995,-0.012972,0.22685,0.98084,GOBP_PRE_MIRNA_PROCESSING,1
GSE27786_CD8_TCELL_VS_ERYTHR...2,SET,182,-0.12451,-0.012335,0.060094,0.98085,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...7,SET,14,-0.45404,-0.012533,0.21912,0.98087,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
GARGALOVIC_RESPONSE_TO_OXIDI...24,SET,27,-0.34357,-0.013165,0.16579,0.98088,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,1
GOCC_CLATHRIN_SCULPTED_GAMMA...,SET,8,-0.70201,-0.014651,0.33875,0.98088,GOCC_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE,1
GOMF_ACID_AMINO_ACID_LIGASE_...,SET,22,-0.38255,-0.013234,0.18459,0.98088,GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY,1
REACTOME_REGULATION_OF_RUNX1...,SET,17,-0.42518,-0.012932,0.20513,0.9809,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,1
MODULE_285,SET,41,-0.25969,-0.012258,0.12524,0.98093,MODULE_285,1
chr6p24,SET,31,-0.56935,-0.023375,0.2745,0.98096,chr6p24,1
VALK_AML_CLUSTER_9,SET,32,-0.33355,-0.013913,0.1608,0.98096,VALK_AML_CLUSTER_9,1
MANNO_MIDBRAIN_NEUROTYPES_HO...2,SET,324,-0.10667,-0.014045,0.051422,0.98097,MANNO_MIDBRAIN_NEUROTYPES_HOPC,1
MIR3191_3P,SET,21,-0.37706,-0.012745,0.18175,0.98098,MIR3191_3P,1
HP_ABNORMAL_CARDIAC_ATRIUM_M...,SET,518,-0.078058,-0.012925,0.037625,0.98098,HP_ABNORMAL_CARDIAC_ATRIUM_MORPHOLOGY,1
MIR548U,SET,142,-0.15543,-0.013616,0.074902,0.981,MIR548U,1
GOBP_RESPONSE_TO_REACTIVE_OX...,SET,179,-0.13717,-0.013478,0.066102,0.981,GOBP_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
GSE360_L_MAJOR_VS_M_TUBERCUL...3,SET,166,-0.13794,-0.013057,0.066479,0.981,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN,1
GOCC_SWR1_COMPLEX,SET,13,-0.42786,-0.011381,0.20617,0.98101,GOCC_SWR1_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...547,SET,12,-0.48513,-0.012399,0.23361,0.98108,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...7,SET,7,-0.74925,-0.014627,0.36064,0.98112,GOBP_POSITIVE_REGULATION_OF_ACTION_POTENTIAL,1
GOBP_REGULATION_OF_LYSOSOME_...1,SET,12,-0.52851,-0.013507,0.25439,0.98112,GOBP_REGULATION_OF_LYSOSOME_ORGANIZATION,1
MIR380_5P,SET,42,-0.29388,-0.01404,0.14143,0.98113,MIR380_5P,1
GOMF_OXIDOREDUCTASE_ACTIVITY...37,SET,25,-0.36245,-0.013366,0.17431,0.9812,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS,1
BIOCARTA_TERC_PATHWAY,SET,6,-0.58255,-0.010529,0.28004,0.98124,BIOCARTA_TERC_PATHWAY,1
HP_ABNORMAL_FETAL_PULMONARY_...,SET,8,-0.66586,-0.013896,0.32008,0.98124,HP_ABNORMAL_FETAL_PULMONARY_MORPHOLOGY,1
GOMF_DEATH_DOMAIN_BINDING,SET,10,-0.61611,-0.014375,0.29607,0.98127,GOMF_DEATH_DOMAIN_BINDING,1
GOBP_CD4_POSITIVE_ALPHA_BETA...2,SET,19,-0.4157,-0.013366,0.19975,0.98128,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_CYTOKINE_PRODUCTION,1
GSE22589_HEALTHY_VS_HIV_AND_...2,SET,182,-0.12426,-0.01231,0.059701,0.98129,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP,1
HP_TOOTH_MALPOSITION,SET,349,-0.096669,-0.013201,0.04644,0.9813,HP_TOOTH_MALPOSITION,1
GOBP_EPINEPHRINE_TRANSPORT,SET,11,-0.62992,-0.015414,0.30242,0.98136,GOBP_EPINEPHRINE_TRANSPORT,1
HP_CHOREOATHETOSIS,SET,101,-0.17757,-0.013134,0.085244,0.98137,HP_CHOREOATHETOSIS,1
MODULE_411,SET,72,-0.21279,-0.013299,0.10206,0.98145,MODULE_411,1
GSE7460_CTRL_VS_FOXP3_OVEREX...2,SET,171,-0.13396,-0.012868,0.064248,0.98146,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP,1
GOBP_AMINO_ACID_TRANSMEMBRAN...,SET,94,-0.19445,-0.013878,0.093176,0.98155,GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
HP_SACCADIC_OSCILLATION,SET,20,-0.44902,-0.014812,0.21516,0.98155,HP_SACCADIC_OSCILLATION,1
GOBP_PROTEIN_KINASE_C_ACTIVA...,SET,24,-0.35525,-0.012836,0.17016,0.98158,GOBP_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
HP_HALLUX_VARUS,SET,5,-0.84263,-0.013904,0.40364,0.98158,HP_HALLUX_VARUS,1
AIYAR_COBRA1_TARGETS_UP,SET,36,-0.31282,-0.013838,0.14983,0.98159,AIYAR_COBRA1_TARGETS_UP,1
HP_ABNORMALITY_OF_THE_KNEE,SET,371,-0.095491,-0.013436,0.04573,0.9816,HP_ABNORMALITY_OF_THE_KNEE,1
GSE26030_UNSTIM_VS_RESTIM_TH...2,SET,163,-0.14626,-0.01372,0.070041,0.9816,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP,1
GOMF_PEPTIDOGLYCAN_MURALYTIC...,SET,13,-0.53757,-0.014299,0.25729,0.98165,GOMF_PEPTIDOGLYCAN_MURALYTIC_ACTIVITY,1
IIZUKA_LIVER_CANCER_PROGRESS...1,SET,23,-0.32356,-0.011445,0.15486,0.98166,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,1
GSE411_WT_VS_SOCS3_KO_MACROP...5,SET,183,-0.13915,-0.013823,0.066597,0.98166,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP,1
GSE27896_HDAC6_KO_VS_WT_TREG...2,SET,164,-0.13953,-0.013128,0.066739,0.98172,GSE27896_HDAC6_KO_VS_WT_TREG_UP,1
GOMF_GABA_RECEPTOR_BINDING,SET,16,-0.42642,-0.012583,0.20393,0.98173,GOMF_GABA_RECEPTOR_BINDING,1
REACTOME_ACTIVATION_OF_BAD_A...,SET,15,-0.46444,-0.01327,0.22208,0.98174,REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,1
MIR6749_3P,SET,100,-0.1852,-0.013631,0.088557,0.98174,MIR6749_3P,1
GSE27291_0H_VS_6H_STIM_GAMMA...2,SET,152,-0.14337,-0.012991,0.068557,0.98174,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP,1
GOBP_DAMP_METABOLIC_PROCESS,SET,7,-0.72663,-0.014185,0.34741,0.98176,GOBP_DAMP_METABOLIC_PROCESS,1
GOBP_DIOL_BIOSYNTHETIC_PROCE...,SET,20,-0.38743,-0.01278,0.18523,0.98176,GOBP_DIOL_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_L...4,SET,38,-0.28909,-0.013138,0.13797,0.98192,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
KEGG_MEDICUS_REFERENCE_TGFA_...3,SET,14,-0.46784,-0.012914,0.22326,0.98193,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
LI_CISPLATIN_RESISTANCE_UP,SET,24,-0.41375,-0.014949,0.1974,0.98195,LI_CISPLATIN_RESISTANCE_UP,1
GSE5589_WT_VS_IL6_KO_LPS_STI...4,SET,172,-0.13051,-0.012572,0.062264,0.98195,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
GOBP_CELL_DIFFERENTIATION_IN...1,SET,24,-0.39624,-0.014317,0.18902,0.98196,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT,1
AIZARANI_LIVER_C23_KUPFFER_C...,SET,196,-0.13375,-0.013745,0.063774,0.98201,AIZARANI_LIVER_C23_KUPFFER_CELLS_3,1
GOBP_POSITIVE_REGULATION_OF_...356,SET,10,-0.68003,-0.015866,0.32414,0.98204,GOBP_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_METALLOAMINOPEPTIDASE_A...,SET,23,-0.4062,-0.014368,0.19362,0.98204,GOMF_METALLOAMINOPEPTIDASE_ACTIVITY,1
HP_ABNORMAL_FEMORAL_NECK_MOR...,SET,139,-0.15261,-0.013228,0.072743,0.98204,HP_ABNORMAL_FEMORAL_NECK_MORPHOLOGY,1
CAHOY_ASTROCYTIC,SET,94,-0.19353,-0.013812,0.092213,0.98207,CAHOY_ASTROCYTIC,1
GOBP_CELLULAR_LIPID_BIOSYNTH...,SET,11,-0.55495,-0.013579,0.26426,0.98213,GOBP_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS,1
GOBP_PYRUVATE_FAMILY_AMINO_A...2,SET,12,-0.5,-0.012779,0.23808,0.98214,GOBP_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
HP_RETINAL_HEMORRHAGE,SET,25,-0.36974,-0.013634,0.17605,0.98214,HP_RETINAL_HEMORRHAGE,1
HORTON_SREBF_TARGETS,SET,24,-0.34711,-0.012541,0.16524,0.98216,HORTON_SREBF_TARGETS,1
GOBP_CEREBRAL_CORTEX_REGIONA...,SET,7,-0.83832,-0.016366,0.39908,0.98216,GOBP_CEREBRAL_CORTEX_REGIONALIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...214,SET,35,-0.30505,-0.013306,0.14522,0.98216,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
HP_ABNORMALLY_LARGE_GLOBE,SET,39,-0.29918,-0.013774,0.14241,0.98217,HP_ABNORMALLY_LARGE_GLOBE,1
GOMF_14_3_3_PROTEIN_BINDING,SET,29,-0.33802,-0.013423,0.16084,0.9822,GOMF_14_3_3_PROTEIN_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...60,SET,33,-0.33781,-0.014309,0.16073,0.98221,GOBP_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION,1
HP_EVERSION_OF_LATERAL_THIRD...,SET,4,-0.69995,-0.01033,0.333,0.98221,HP_EVERSION_OF_LATERAL_THIRD_OF_LOWER_EYELIDS,1
GOBP_NEGATIVE_REGULATION_OF_...548,SET,36,-0.31049,-0.013735,0.14771,0.98222,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
HP_MEGALOBLASTIC_ANEMIA,SET,17,-0.44318,-0.013479,0.21082,0.98222,HP_MEGALOBLASTIC_ANEMIA,1
HP_SHALLOW_ACETABULAR_FOSSAE,SET,10,-0.54553,-0.012728,0.25952,0.98222,HP_SHALLOW_ACETABULAR_FOSSAE,1
HP_BROAD_RIBS,SET,24,-0.39363,-0.014222,0.18719,0.98225,HP_BROAD_RIBS,1
GSE27786_LIN_NEG_VS_CD8_TCEL...2,SET,179,-0.13015,-0.012788,0.061849,0.98232,GSE27786_LIN_NEG_VS_CD8_TCELL_UP,1
REACTOME_PROTEIN_LIPOYLATION,SET,10,-0.52055,-0.012145,0.2473,0.98234,REACTOME_PROTEIN_LIPOYLATION,1
CAIRO_PML_TARGETS_BOUND_BY_M...2,SET,22,-0.39546,-0.013681,0.18772,0.98242,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,1
GENTILE_UV_LOW_DOSE_UP,SET,23,-0.38194,-0.01351,0.18112,0.98251,GENTILE_UV_LOW_DOSE_UP,1
GOBP_CELLULAR_RESPONSE_TO_AC...1,SET,14,-0.47889,-0.013219,0.22709,0.98251,GOBP_CELLULAR_RESPONSE_TO_ACIDIC_PH,1
CDX2_Q5,SET,231,-0.12862,-0.014337,0.060991,0.98252,CDX2_Q5,1
GSE29617_DAY3_VS_DAY7_TIV_FL...2,SET,168,-0.14394,-0.013705,0.068225,0.98255,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,1
MORF_EIF3S6,SET,113,-0.15948,-0.012473,0.075546,0.98261,MORF_EIF3S6,1
GSE37605_C57BL6_VS_NOD_FOXP3...8,SET,107,-0.17766,-0.013523,0.084128,0.98264,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP,1
CHIARADONNA_NEOPLASTIC_TRANS...5,SET,130,-0.16236,-0.013614,0.076849,0.98268,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,1
GSE18148_CBFB_KO_VS_WT_TREG_...2,SET,173,-0.14061,-0.013584,0.066504,0.98275,GSE18148_CBFB_KO_VS_WT_TREG_UP,1
REACTOME_TRANSCRIPTIONAL_REG...6,SET,91,-0.17558,-0.01233,0.08302,0.98277,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1
GAO_LARGE_INTESTINE_ADULT_CE...,SET,287,-0.10907,-0.01353,0.051531,0.98285,GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL,1
WP_ROLES_OF_CERAMIDES_IN_DEV...,SET,23,-0.3949,-0.013968,0.18653,0.98287,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,1
GOMF_HISTAMINE_RECEPTOR_ACTI...,SET,6,-0.75441,-0.013636,0.35631,0.98287,GOMF_HISTAMINE_RECEPTOR_ACTIVITY,1
GNF2_S100A4,SET,44,-0.27671,-0.01353,0.13064,0.98291,GNF2_S100A4,1
MODULE_248,SET,117,-0.17235,-0.013714,0.081315,0.98297,MODULE_248,1
TTTGCAC_MIR19A_MIR19B,SET,466,-0.085843,-0.013501,0.040492,0.98299,TTTGCAC_MIR19A_MIR19B,1
HP_FACIAL_PARALYSIS,SET,10,-0.63957,-0.014922,0.30151,0.98304,HP_FACIAL_PARALYSIS,1
HP_MIGRAINE_WITHOUT_AURA,SET,7,-0.76287,-0.014893,0.3595,0.98308,HP_MIGRAINE_WITHOUT_AURA,1
GOBP_NON_CANONICAL_NF_KAPPAB...,SET,112,-0.17431,-0.013573,0.082113,0.98311,GOBP_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
HP_ABNORMAL_CIRCULATING_SULF...,SET,23,-0.39594,-0.014005,0.18649,0.98312,HP_ABNORMAL_CIRCULATING_SULFUR_AMINO_ACID_CONCENTRATION,1
UNTERMAN_IPF_VS_CTRL_TREG_CE...1,SET,16,-0.53051,-0.015654,0.24973,0.98317,UNTERMAN_IPF_VS_CTRL_TREG_CELL_DN,1
GOCC_RISC_LOADING_COMPLEX,SET,8,-0.64498,-0.01346,0.30354,0.98319,GOCC_RISC_LOADING_COMPLEX,1
NEUROD2_TARGET_GENES,SET,5,-0.81422,-0.013435,0.38289,0.98326,NEUROD2_TARGET_GENES,1
MEBARKI_HCC_PROGENITOR_WNT_D...3,SET,18,-0.46621,-0.01459,0.21916,0.98329,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1
WP_OREXIN_RECEPTOR_PATHWAY,SET,189,-0.14694,-0.014832,0.069074,0.9833,WP_OREXIN_RECEPTOR_PATHWAY,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...2,SET,96,-0.20833,-0.015025,0.097867,0.98336,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL,1
GOBP_REGULATION_OF_HEMATOPOI...1,SET,41,-0.27146,-0.012814,0.1275,0.98337,GOBP_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GOCC_INSULIN_LIKE_GROWTH_FAC...,SET,5,-0.9572,-0.015794,0.44957,0.98337,GOCC_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEIN_COMPLEX,1
HP_SLEEP_RELATED_BREATHING_D...,SET,148,-0.15221,-0.013611,0.07149,0.98337,HP_SLEEP_RELATED_BREATHING_DISORDERS,1
GSE7852_THYMUS_VS_FAT_TCONV_...2,SET,178,-0.13537,-0.013264,0.063574,0.98338,GSE7852_THYMUS_VS_FAT_TCONV_UP,1
GSE9988_ANTI_TREM1_VS_ANTI_T...1,SET,161,-0.15475,-0.014428,0.072675,0.98338,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,1
HP_HYPOPLASIA_OF_THE_ODONTOI...,SET,22,-0.37789,-0.013073,0.17744,0.98339,HP_HYPOPLASIA_OF_THE_ODONTOID_PROCESS,1
HP_AORTIC_ROOT_ANEURYSM,SET,64,-0.23011,-0.013562,0.10804,0.9834,HP_AORTIC_ROOT_ANEURYSM,1
GOBP_MITOCHONDRIAL_RNA_3_END...,SET,6,-0.69943,-0.012642,0.32837,0.98341,GOBP_MITOCHONDRIAL_RNA_3_END_PROCESSING,1
KEGG_ALANINE_ASPARTATE_AND_G...,SET,29,-0.3516,-0.013963,0.165,0.98344,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,1
GOBP_CARDIAC_NEURAL_CREST_CE...1,SET,12,-0.63028,-0.016108,0.29578,0.98344,GOBP_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,1
KEGG_RETINOL_METABOLISM,SET,60,-0.30726,-0.017536,0.14414,0.98348,KEGG_RETINOL_METABOLISM,1
GOBP_VIRAL_TRANSCRIPTION,SET,50,-0.23949,-0.012481,0.11227,0.98353,GOBP_VIRAL_TRANSCRIPTION,1
HP_ABNORMAL_OOCYTE_MORPHOLOGY,SET,6,-0.7149,-0.012922,0.3351,0.98355,HP_ABNORMAL_OOCYTE_MORPHOLOGY,1
MIR96_5P,SET,414,-0.092404,-0.013718,0.043296,0.98358,MIR96_5P,1
HOLLERN_PAPILLARY_BREAST_TUM...,SET,15,-0.50176,-0.014336,0.23493,0.98364,HOLLERN_PAPILLARY_BREAST_TUMOR,1
KEGG_MEDICUS_VARIANT_BCR_ABL...2,SET,13,-0.48238,-0.012831,0.22587,0.98364,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
MIR1227_5P,SET,96,-0.18003,-0.012984,0.084282,0.98366,MIR1227_5P,1
GOBP_HOMOSERINE_METABOLIC_PR...,SET,3,-1.1115,-0.014207,0.52,0.98371,GOBP_HOMOSERINE_METABOLIC_PROCESS,1
HP_APLASIA_CUTIS_CONGENITA,SET,37,-0.29901,-0.013409,0.13985,0.98374,HP_APLASIA_CUTIS_CONGENITA,1
MORI_SMALL_PRE_BII_LYMPHOCYT...2,SET,73,-0.21256,-0.013377,0.099406,0.98375,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...649,SET,118,-0.16484,-0.013172,0.077088,0.98375,GOBP_NEGATIVE_REGULATION_OF_TRANSLATION,1
HP_ABNORMAL_SCLERA_MORPHOLOGY,SET,127,-0.15743,-0.013048,0.073618,0.98375,HP_ABNORMAL_SCLERA_MORPHOLOGY,1
GSE35825_UNTREATED_VS_IFNG_S...2,SET,186,-0.1436,-0.01438,0.067155,0.98375,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP,1
KEGG_MEDICUS_VARIANT_AMPLIFI...16,SET,13,-0.48955,-0.013022,0.22889,0.98377,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_SPONDYLOEPIPHYSEAL_DYSPLA...,SET,9,-0.60983,-0.013499,0.28511,0.98377,HP_SPONDYLOEPIPHYSEAL_DYSPLASIA,1
RIGGINS_TAMOXIFEN_RESISTANCE...1,SET,202,-0.13834,-0.01443,0.064635,0.98383,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1
GOBP_REGULATION_OF_EXTRACELL...1,SET,20,-0.43772,-0.014439,0.2045,0.98384,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
GSE40441_NRP1_POS_INDUCED_TR...1,SET,181,-0.13223,-0.013065,0.061769,0.98385,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN,1
GSE37301_LYMPHOID_PRIMED_MPP...3,SET,189,-0.13666,-0.013794,0.063822,0.98386,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
HP_ABNORMAL_MORPHOLOGY_OF_MY...,SET,19,-0.43939,-0.014128,0.2051,0.98391,HP_ABNORMAL_MORPHOLOGY_OF_MYOCARDIAL_TRABECULAE,1
KEGG_DORSO_VENTRAL_AXIS_FORM...,SET,24,-0.38229,-0.013813,0.17825,0.984,KEGG_DORSO_VENTRAL_AXIS_FORMATION,1
GOMF_MYOSIN_HEAVY_CHAIN_BIND...,SET,13,-0.49079,-0.013055,0.22881,0.98401,GOMF_MYOSIN_HEAVY_CHAIN_BINDING,1
GSE11057_NAIVE_VS_CENT_MEMOR...1,SET,183,-0.13572,-0.013482,0.063254,0.98404,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,1
GSE43863_NAIVE_VS_LY6C_LOW_C...2,SET,139,-0.1542,-0.013366,0.071867,0.98404,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP,1
CUX1_TARGET_GENES,SET,662,-0.07201,-0.013425,0.033558,0.98405,CUX1_TARGET_GENES,1
MODULE_360,SET,12,-0.56498,-0.014439,0.26323,0.98407,MODULE_360,1
HP_SEVERE_DEMYELINATION_OF_T...,SET,6,-0.7538,-0.013625,0.35115,0.98408,HP_SEVERE_DEMYELINATION_OF_THE_WHITE_MATTER,1
REACTOME_CROSS_PRESENTATION_...1,SET,6,-0.80452,-0.014541,0.37473,0.98409,REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES,1
SIG_IL4RECEPTOR_IN_B_LYPHOCY...,SET,27,-0.35583,-0.013635,0.16569,0.98412,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,1
GOBP_REGULATION_OF_SYNAPTIC_...2,SET,193,-0.13447,-0.013714,0.062613,0.98412,GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY,1
HP_ABNORMAL_NOSTRIL_MORPHOLO...,SET,434,-0.087006,-0.013218,0.040503,0.98414,HP_ABNORMAL_NOSTRIL_MORPHOLOGY,1
HP_RIGHT_VENTRICULAR_HYPERTR...,SET,25,-0.34335,-0.012661,0.15985,0.98414,HP_RIGHT_VENTRICULAR_HYPERTROPHY,1
GOBP_REGULATION_OF_INTESTINA...2,SET,9,-0.62411,-0.013815,0.29044,0.98417,GOBP_REGULATION_OF_INTESTINAL_LIPID_ABSORPTION,1
REACTOME_ZINC_EFFLUX_AND_COM...,SET,5,-0.85618,-0.014127,0.39838,0.98418,REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY,1
GOBP_PHOSPHATIDYLSERINE_META...,SET,22,-0.39279,-0.013589,0.18273,0.9842,GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...1,SET,17,-0.45899,-0.01396,0.2135,0.98421,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,1
MIR376C_3P,SET,138,-0.15919,-0.013749,0.074038,0.98422,MIR376C_3P,1
MODULE_341,SET,74,-0.21644,-0.013713,0.10064,0.98424,MODULE_341,1
HP_ABNORMAL_TOE_MORPHOLOGY,SET,627,-0.074867,-0.013597,0.034812,0.98424,HP_ABNORMAL_TOE_MORPHOLOGY,1
WP_ALPHA_6_BETA_4_SIGNALING,SET,33,-0.32762,-0.013877,0.15231,0.98425,WP_ALPHA_6_BETA_4_SIGNALING,1
AIZARANI_LIVER_C18_NK_NKT_CE...,SET,110,-0.18752,-0.014471,0.087168,0.98427,AIZARANI_LIVER_C18_NK_NKT_CELLS_5,1
CTCTAGA_MIR526C_MIR518F_MIR5...,SET,48,-0.26872,-0.013722,0.1249,0.98428,CTCTAGA_MIR526C_MIR518F_MIR526A,1
GOMF_G_PROTEIN_ALPHA_SUBUNIT...,SET,29,-0.35059,-0.013923,0.16294,0.98428,GOMF_G_PROTEIN_ALPHA_SUBUNIT_BINDING,1
KAAB_HEART_ATRIUM_VS_VENTRIC...1,SET,240,-0.11768,-0.013366,0.054677,0.9843,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1
GOMF_5_DEOXYRIBOSE_5_PHOSPHA...,SET,7,-0.54347,-0.01061,0.25247,0.98432,GOMF_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY,1
GOBP_DICHOTOMOUS_SUBDIVISION...,SET,8,-0.74336,-0.015514,0.34525,0.98434,GOBP_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT,1
chr5q21,SET,14,-0.76166,-0.021024,0.35364,0.98437,chr5q21,1
KEGG_SELENOAMINO_ACID_METABO...,SET,23,-0.37734,-0.013347,0.17514,0.98439,KEGG_SELENOAMINO_ACID_METABOLISM,1
MIR379_3P_MIR411_3P,SET,173,-0.14832,-0.01433,0.068844,0.98439,MIR379_3P_MIR411_3P,1
REACTOME_SMALL_INTERFERING_R...,SET,9,-0.62804,-0.013902,0.2914,0.98442,REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS,1
GOCC_ISWI_TYPE_COMPLEX,SET,12,-0.48391,-0.012367,0.22451,0.98443,GOCC_ISWI_TYPE_COMPLEX,1
GSE1925_CTRL_VS_24H_IFNG_STI...3,SET,174,-0.13301,-0.012887,0.06171,0.98443,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN,1
GOCC_CALCIUM_AND_CALMODULIN_...,SET,5,-0.86127,-0.014211,0.39954,0.98444,GOCC_CALCIUM_AND_CALMODULIN_DEPENDENT_PROTEIN_KINASE_COMPLEX,1
HP_MITOCHONDRIAL_RESPIRATORY...,SET,10,-0.57156,-0.013336,0.26512,0.98445,HP_MITOCHONDRIAL_RESPIRATORY_CHAIN_DEFECTS,1
AMIT_EGF_RESPONSE_480_MCF10A,SET,42,-0.29029,-0.013868,0.13449,0.98454,AMIT_EGF_RESPONSE_480_MCF10A,1
KEGG_GLYCOSAMINOGLYCAN_BIOSY...1,SET,21,-0.38911,-0.013152,0.18028,0.98454,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,1
MEINHOLD_OVARIAN_CANCER_LOW_...2,SET,10,-0.64761,-0.01511,0.29995,0.98457,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,1
GOBP_REGULATION_OF_DNA_DIREC...,SET,9,-0.57501,-0.012728,0.266,0.98467,GOBP_REGULATION_OF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
GSE42021_CD24INT_TREG_VS_CD2...1,SET,178,-0.13298,-0.01303,0.061488,0.98471,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN,1
GSE21379_TFH_VS_NON_TFH_SAP_...1,SET,172,-0.13932,-0.013421,0.064386,0.98475,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN,1
HP_INTESTINAL_BLEEDING,SET,6,-0.7679,-0.01388,0.35477,0.98478,HP_INTESTINAL_BLEEDING,1
GSE22935_UNSTIM_VS_24H_MBOVI...2,SET,189,-0.13519,-0.013645,0.062438,0.98481,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
HP_BROAD_CLAVICLES,SET,10,-0.6205,-0.014477,0.28644,0.98485,HP_BROAD_CLAVICLES,1
HP_HYPERPLASIA_OF_THE_MAXILLA,SET,9,-0.70059,-0.015507,0.32319,0.9849,HP_HYPERPLASIA_OF_THE_MAXILLA,1
GSE22886_CD4_TCELL_VS_BCELL_...1,SET,170,-0.14534,-0.013921,0.067047,0.98491,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN,1
MARIADASON_RESPONSE_TO_BUTYR...3,SET,9,-0.64314,-0.014236,0.29663,0.98492,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8,1
HP_GASTROESOPHAGEAL_REFLUX,SET,434,-0.090393,-0.013732,0.041689,0.98492,HP_GASTROESOPHAGEAL_REFLUX,1
GSE17721_4_VS_24H_CPG_BMDC_UP,SET,177,-0.14279,-0.013953,0.065857,0.98492,GSE17721_4_VS_24H_CPG_BMDC_UP,1
MIR7702,SET,50,-0.25255,-0.013162,0.11647,0.98493,MIR7702,1
GOBP_MITOCHONDRIAL_ELECTRON_...2,SET,42,-0.24235,-0.011578,0.11172,0.98496,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,1
DESCARTES_MAIN_FETAL_METANEP...,SET,25,-0.43512,-0.016045,0.20049,0.985,DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS,1
LUI_TARGETS_OF_PAX8_PPARG_FU...,SET,32,-0.31639,-0.013197,0.14576,0.98502,LUI_TARGETS_OF_PAX8_PPARG_FUSION,1
HP_ABNORMAL_FIBULA_MORPHOLOGY,SET,51,-0.2658,-0.013989,0.12244,0.98502,HP_ABNORMAL_FIBULA_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_TNF_R...,SET,7,-0.68223,-0.013319,0.31387,0.98513,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY,1
MIR455_3P,SET,84,-0.20331,-0.013721,0.093527,0.98513,MIR455_3P,1
REACTOME_EARLY_PHASE_OF_HIV_...,SET,14,-0.44028,-0.012153,0.20254,0.98514,REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE,1
HP_ABNORMALITY_OF_THE_OUTER_...,SET,1117,-0.056694,-0.013552,0.026074,0.98515,HP_ABNORMALITY_OF_THE_OUTER_EAR,1
GGCAGAC_MIR346,SET,40,-0.29384,-0.0137,0.13513,0.98516,GGCAGAC_MIR346,1
GOCC_EUKARYOTIC_TRANSLATION_...3,SET,13,-0.45601,-0.01213,0.20966,0.98518,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,1
BIOCARTA_EDG1_PATHWAY,SET,22,-0.424,-0.014668,0.19491,0.98519,BIOCARTA_EDG1_PATHWAY,1
BIOCARTA_BARR_MAPK_PATHWAY,SET,13,-0.5834,-0.015519,0.26814,0.9852,BIOCARTA_BARR_MAPK_PATHWAY,1
HP_POSTURAL_INSTABILITY,SET,74,-0.22438,-0.014216,0.10313,0.9852,HP_POSTURAL_INSTABILITY,1
GOMF_SMALL_PROTEIN_ACTIVATIN...,SET,5,-0.70292,-0.011598,0.32302,0.98522,GOMF_SMALL_PROTEIN_ACTIVATING_ENZYME_BINDING,1
SENESE_HDAC1_AND_HDAC2_TARGE...1,SET,203,-0.13622,-0.014244,0.062552,0.98528,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,1
GSE40274_CTRL_VS_HELIOS_TRAN...1,SET,162,-0.14526,-0.013585,0.066703,0.98528,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_SERINE_TRANSPORT,SET,9,-0.60831,-0.013465,0.27926,0.9853,GOBP_SERINE_TRANSPORT,1
HP_CONJUNCTIVAL_ICTERUS,SET,6,-0.75225,-0.013597,0.34535,0.9853,HP_CONJUNCTIVAL_ICTERUS,1
GOCC_U12_TYPE_SPLICEOSOMAL_C...,SET,24,-0.33718,-0.012183,0.15475,0.98532,GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX,1
MIR4701_3P,SET,46,-0.25489,-0.012742,0.1169,0.98538,MIR4701_3P,1
HP_COLOBOMA,SET,207,-0.12851,-0.013569,0.058937,0.98539,HP_COLOBOMA,1
HP_PROXIMAL_HYPERREFLEXIA,SET,36,-0.30741,-0.013599,0.14097,0.98539,HP_PROXIMAL_HYPERREFLEXIA,1
FAN_OVARY_CL11_MURAL_GRANULO...,SET,387,-0.098642,-0.01417,0.045216,0.98542,FAN_OVARY_CL11_MURAL_GRANULOSA_CELL,1
GSE13522_CTRL_VS_T_CRUZI_BRA...1,SET,181,-0.14128,-0.013958,0.064734,0.98545,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN,1
MIR6839_3P,SET,146,-0.1596,-0.014175,0.073089,0.9855,MIR6839_3P,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...7,SET,128,-0.15842,-0.013181,0.072527,0.98552,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN,1
GOBP_PHOSPHATIDYLSERINE_ACYL...,SET,8,-0.75221,-0.015698,0.34434,0.98553,GOBP_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING,1
GOMF_MINUS_END_DIRECTED_MICR...,SET,17,-0.45111,-0.01372,0.20647,0.98554,GOMF_MINUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,1
HP_UVEAL_ECTROPION,SET,7,-0.73659,-0.01438,0.33715,0.98554,HP_UVEAL_ECTROPION,1
HP_MYOPIA,SET,364,-0.09878,-0.01377,0.045189,0.98558,HP_MYOPIA,1
HP_PROMINENT_STERNUM,SET,12,-0.62196,-0.015895,0.28452,0.98558,HP_PROMINENT_STERNUM,1
GSE3920_UNTREATED_VS_IFNG_TR...3,SET,166,-0.14826,-0.014033,0.067746,0.98567,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...3,SET,28,-0.3672,-0.014329,0.16777,0.98569,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE,1
MIR3689A_5P_MIR3689B_5P_MIR3...,SET,110,-0.18288,-0.014113,0.083535,0.9857,MIR3689A_5P_MIR3689B_5P_MIR3689E_MIR3689F,1
GOBP_L_AMINO_ACID_METABOLIC_...,SET,161,-0.14709,-0.013713,0.06716,0.98574,GOBP_L_AMINO_ACID_METABOLIC_PROCESS,1
MIR4680_5P,SET,58,-0.25257,-0.014174,0.11513,0.98587,MIR4680_5P,1
MIR892B,SET,71,-0.22758,-0.014125,0.10374,0.98587,MIR892B,1
GSE13306_TREG_VS_TCONV_SPLEE...2,SET,183,-0.14533,-0.014437,0.066215,0.98591,GSE13306_TREG_VS_TCONV_SPLEEN_UP,1
GOBP_CARDIAC_NEURAL_CREST_CE...2,SET,15,-0.57249,-0.016357,0.26075,0.98593,GOBP_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT,1
GSE12366_NAIVE_VS_MEMORY_BCE...1,SET,174,-0.14935,-0.01447,0.068017,0.98594,GSE12366_NAIVE_VS_MEMORY_BCELL_DN,1
REACTOME_INTRINSIC_PATHWAY_F...,SET,52,-0.26863,-0.014276,0.12231,0.98596,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1
HP_CHORIORETINAL_COLOBOMA,SET,40,-0.29805,-0.013897,0.13571,0.98596,HP_CHORIORETINAL_COLOBOMA,1
GSE41176_UNSTIM_VS_ANTI_IGM_...16,SET,161,-0.14458,-0.01348,0.065806,0.98599,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP,1
BASSO_CD40_SIGNALING_UP,SET,95,-0.20147,-0.014455,0.091656,0.98602,BASSO_CD40_SIGNALING_UP,1
GSE17721_0.5H_VS_12H_PAM3CSK...1,SET,184,-0.13452,-0.013399,0.061155,0.98608,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN,1
GOBP_VITAMIN_D_BIOSYNTHETIC_...,SET,10,-0.6155,-0.014361,0.27975,0.9861,GOBP_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
GOMF_AMINOPEPTIDASE_ACTIVITY,SET,36,-0.32687,-0.01446,0.14853,0.98612,GOMF_AMINOPEPTIDASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...702,SET,14,-0.50741,-0.014006,0.23049,0.98614,GOBP_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,1
DESCARTES_FETAL_THYMUS_VASCU...,SET,112,-0.19412,-0.015115,0.08814,0.98617,DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS,1
GSE20715_WT_VS_TLR4_KO_24H_O...1,SET,180,-0.13427,-0.013229,0.060961,0.98618,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN,1
GOBP_REGULATION_OF_CELLULAR_...20,SET,41,-0.28428,-0.013419,0.12905,0.98619,GOBP_REGULATION_OF_CELLULAR_SENESCENCE,1
GOBP_HYPOTHALAMUS_CELL_DIFFE...,SET,11,-0.6827,-0.016705,0.30984,0.98621,GOBP_HYPOTHALAMUS_CELL_DIFFERENTIATION,1
HP_STEREOTYPICAL_HAND_WRINGI...,SET,20,-0.4464,-0.014725,0.20259,0.98621,HP_STEREOTYPICAL_HAND_WRINGING,1
GSE17301_CTRL_VS_48H_ACD3_AC...5,SET,177,-0.14324,-0.013997,0.065011,0.98621,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN,1
GSE22886_DC_VS_MONOCYTE_DN,SET,180,-0.142,-0.013991,0.064443,0.98621,GSE22886_DC_VS_MONOCYTE_DN,1
GOBP_REGULATION_OF_DENDRITIC...2,SET,10,-0.6265,-0.014617,0.2842,0.98625,GOBP_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS,1
GOBP_FORMATION_OF_CYTOPLASMI...,SET,13,-0.48294,-0.012846,0.21892,0.9863,GOBP_FORMATION_OF_CYTOPLASMIC_TRANSLATION_INITIATION_COMPLEX,1
HP_DELAYED_PUBIC_BONE_OSSIFI...,SET,7,-0.72704,-0.014193,0.3296,0.9863,HP_DELAYED_PUBIC_BONE_OSSIFICATION,1
HP_GINGIVAL_RECESSION,SET,5,-0.8228,-0.013576,0.37283,0.98633,HP_GINGIVAL_RECESSION,1
BLANCO_MELO_COVID19_SARS_COV...8,SET,302,-0.11945,-0.015193,0.054107,0.98636,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1
HP_HERNIA,SET,500,-0.085897,-0.013981,0.038908,0.98636,HP_HERNIA,1
GOBP_REGULATION_OF_RESPONSE_...10,SET,10,-0.56218,-0.013117,0.25454,0.98639,GOBP_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
GOBP_LYMPHOCYTE_MIGRATION,SET,96,-0.20172,-0.014548,0.091322,0.9864,GOBP_LYMPHOCYTE_MIGRATION,1
GOBP_PURINERGIC_NUCLEOTIDE_R...,SET,27,-0.41182,-0.015781,0.18641,0.98641,GOBP_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,1
GSE37532_TREG_VS_TCONV_PPARG...1,SET,180,-0.136,-0.0134,0.061541,0.98644,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN,1
AMIT_EGF_RESPONSE_20_MCF10A,SET,11,-0.5547,-0.013573,0.25084,0.98649,AMIT_EGF_RESPONSE_20_MCF10A,1
GOBP_AMYLOID_PRECURSOR_PROTE...1,SET,13,-0.47575,-0.012655,0.21508,0.98651,GOBP_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,1
GOBP_INSULIN_LIKE_GROWTH_FAC...,SET,48,-0.2936,-0.014992,0.13266,0.98655,GOBP_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
ZNF436_TARGET_GENES,SET,409,-0.095493,-0.014093,0.043127,0.98659,ZNF436_TARGET_GENES,1
GOMF_CATALYTIC_ACTIVITY_ACTI...3,SET,16,-0.41002,-0.012099,0.18509,0.98662,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_RRNA,1
KEGG_MEDICUS_PATHOGEN_HPV_E5...2,SET,13,-0.50629,-0.013467,0.22849,0.98664,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
MIR6743_5P,SET,35,-0.30541,-0.013322,0.13781,0.98665,MIR6743_5P,1
GOBP_INTRACELLULAR_OXYGEN_HO...,SET,6,-0.74249,-0.01342,0.335,0.98666,GOBP_INTRACELLULAR_OXYGEN_HOMEOSTASIS,1
KEGG_MEDICUS_REFERENCE_EREG_...2,SET,14,-0.49596,-0.01369,0.22365,0.9867,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
KEGG_GLYOXYLATE_AND_DICARBOX...,SET,16,-0.44135,-0.013023,0.1988,0.98679,KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,1
GSE3720_UNSTIM_VS_PMA_STIM_V...1,SET,112,-0.18393,-0.014322,0.082841,0.9868,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,1
GOBP_MICROTUBULE_BUNDLE_FORM...,SET,99,-0.18268,-0.013378,0.082251,0.98682,GOBP_MICROTUBULE_BUNDLE_FORMATION,1
GOBP_NEGATIVE_REGULATION_OF_...589,SET,27,-0.36893,-0.014138,0.16608,0.98683,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
TARTE_PLASMA_CELL_VS_PLASMAB...1,SET,276,-0.10769,-0.013104,0.048427,0.98691,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1
HP_EVERTED_LOWER_LIP_VERMILI...,SET,117,-0.18189,-0.014474,0.081772,0.98693,HP_EVERTED_LOWER_LIP_VERMILION,1
KEGG_MEDICUS_REFERENCE_EGF_E...7,SET,15,-0.48024,-0.013721,0.21588,0.98694,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
HP_ABNORMAL_RENAL_COLLECTING...,SET,24,-0.36883,-0.013326,0.1658,0.98694,HP_ABNORMAL_RENAL_COLLECTING_SYSTEM_MORPHOLOGY,1
KEGG_MEDICUS_PATHOGEN_HCMV_G...1,SET,14,-0.49766,-0.013737,0.22368,0.98695,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY,1
GSE33374_CD8_ALPHAALPHA_VS_A...1,SET,189,-0.13621,-0.013748,0.061202,0.98697,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,1
MORF_THRA,SET,46,-0.29938,-0.014967,0.13448,0.98699,MORF_THRA,1
MODULE_456,SET,102,-0.191,-0.014197,0.085797,0.98699,MODULE_456,1
MODULE_102,SET,16,-0.46826,-0.013817,0.21028,0.98702,MODULE_102,1
MODULE_105,SET,188,-0.1331,-0.013399,0.059763,0.98702,MODULE_105,1
GOCC_CYCLIN_CDK_POSITIVE_TRA...,SET,8,-0.52171,-0.010888,0.23428,0.98702,GOCC_CYCLIN_CDK_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,1
REACTOME_SEROTONIN_AND_MELAT...,SET,4,-0.94863,-0.014001,0.42586,0.98704,REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS,1
HP_HYPOPLASIA_OF_THE_ZYGOMAT...,SET,37,-0.32781,-0.014701,0.14714,0.98705,HP_HYPOPLASIA_OF_THE_ZYGOMATIC_BONE,1
REACTOME_PASSIVE_TRANSPORT_B...,SET,12,-0.65529,-0.016747,0.29404,0.98707,REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS,1
GOBP_GLYCEROL_TRANSMEMBRANE_...,SET,7,-0.8537,-0.016666,0.38291,0.9871,GOBP_GLYCEROL_TRANSMEMBRANE_TRANSPORT,1
GOMF_GLYCEROL_TRANSMEMBRANE_...,SET,7,-0.8537,-0.016666,0.38291,0.9871,GOMF_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KEGG_CIRCADIAN_RHYTHM_MAMMAL,SET,12,-0.6315,-0.016139,0.28313,0.98714,KEGG_CIRCADIAN_RHYTHM_MAMMAL,1
GOBP_RRNA_METHYLATION,SET,17,-0.39446,-0.011998,0.17673,0.98719,GOBP_RRNA_METHYLATION,1
HP_MALAR_PROMINENCE,SET,5,-0.80824,-0.013336,0.36208,0.98719,HP_MALAR_PROMINENCE,1
GSE12845_IGD_POS_BLOOD_VS_NA...2,SET,160,-0.14346,-0.013334,0.064227,0.98724,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,1
LEIN_LOCALIZED_TO_PROXIMAL_D...,SET,31,-0.33851,-0.013898,0.15151,0.98726,LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,1
HP_PROFOUND_SENSORINEURAL_HE...,SET,9,-0.67914,-0.015033,0.30395,0.98726,HP_PROFOUND_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE360_DC_VS_MAC_L_DONOVANI_...2,SET,188,-0.14291,-0.014387,0.063936,0.98729,GSE360_DC_VS_MAC_L_DONOVANI_UP,1
GOBP_CHAPERONE_MEDIATED_PROT...1,SET,22,-0.3927,-0.013586,0.17566,0.9873,GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY,1
CHOW_RASSF1_TARGETS_UP,SET,22,-0.36432,-0.012604,0.16295,0.98731,CHOW_RASSF1_TARGETS_UP,1
GSE13887_ACT_CD4_VS_NO_TREAT...1,SET,119,-0.18166,-0.014577,0.081198,0.98736,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN,1
GSE14908_ATOPIC_VS_NONATOPIC...1,SET,174,-0.13873,-0.013442,0.062012,0.98736,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN,1
GOMF_OXIDOREDUCTASE_ACTIVITY...7,SET,11,-0.57069,-0.013965,0.255,0.98738,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS,1
HP_EXTRAPYRAMIDAL_MUSCULAR_R...,SET,13,-0.53938,-0.014348,0.24104,0.98738,HP_EXTRAPYRAMIDAL_MUSCULAR_RIGIDITY,1
HP_ABNORMAL_FEMUR_MORPHOLOGY,SET,270,-0.11578,-0.013937,0.051728,0.98739,HP_ABNORMAL_FEMUR_MORPHOLOGY,1
HP_HYPERMETROPIA,SET,240,-0.1251,-0.014209,0.055876,0.98741,HP_HYPERMETROPIA,1
HP_THORACOLUMBAR_KYPHOSCOLIO...,SET,6,-0.79561,-0.01438,0.35514,0.98746,HP_THORACOLUMBAR_KYPHOSCOLIOSIS,1
HP_ABNORMAL_SKULL_BASE_MORPH...,SET,205,-0.13189,-0.013859,0.058844,0.98749,HP_ABNORMAL_SKULL_BASE_MORPHOLOGY,1
REACTOME_RUNX3_REGULATES_P14...,SET,10,-0.54218,-0.01265,0.24187,0.9875,REACTOME_RUNX3_REGULATES_P14_ARF,1
HP_ATLANTOAXIAL_DISLOCATION,SET,6,-0.74572,-0.013479,0.33266,0.9875,HP_ATLANTOAXIAL_DISLOCATION,1
GOBP_PURINE_CONTAINING_COMPO...4,SET,37,-0.34543,-0.015491,0.15401,0.98754,GOBP_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,1
GOCC_ATPASE_COMPLEX,SET,117,-0.16887,-0.013437,0.075256,0.98757,GOCC_ATPASE_COMPLEX,1
GSE17721_LPS_VS_POLYIC_0.5H_...1,SET,182,-0.13799,-0.013671,0.061502,0.98757,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN,1
KASLER_HDAC7_TARGETS_2_DN,SET,31,-0.34474,-0.014154,0.15362,0.98758,KASLER_HDAC7_TARGETS_2_DN,1
REACTOME_RUNX1_REGULATES_TRA...4,SET,7,-0.6569,-0.012824,0.29273,0.98758,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS,1
KEGG_ONE_CARBON_POOL_BY_FOLA...,SET,17,-0.41041,-0.012483,0.18286,0.98759,KEGG_ONE_CARBON_POOL_BY_FOLATE,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...4,SET,11,-0.63551,-0.015551,0.28304,0.98762,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION,1
KEGG_MEDICUS_REFERENCE_BMP15...,SET,6,-0.87154,-0.015753,0.38799,0.98765,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY,1
GOBP_PEPTIDE_METABOLIC_PROCE...,SET,72,-0.23529,-0.014705,0.10468,0.98769,GOBP_PEPTIDE_METABOLIC_PROCESS,1
WP_2Q211_COPY_NUMBER_VARIATI...,SET,15,-0.60009,-0.017145,0.26689,0.98772,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,1
REACTOME_TICAM1_TRAF6_DEPEND...,SET,9,-0.76601,-0.016956,0.34065,0.98773,REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,1
HE_LIM_SUN_FETAL_LUNG_C0_ACT...,SET,520,-0.087328,-0.014487,0.038824,0.98775,HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL,1
HP_CONGESTIVE_HEART_FAILURE,SET,220,-0.13034,-0.014182,0.057913,0.98779,HP_CONGESTIVE_HEART_FAILURE,1
GOBP_PODOSOME_ASSEMBLY,SET,21,-0.42492,-0.014362,0.18875,0.98781,GOBP_PODOSOME_ASSEMBLY,1
GOBP_TETRAHYDROFOLATE_BIOSYN...,SET,6,-0.68074,-0.012304,0.30226,0.98784,GOBP_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS,1
LI_ESTROGENE_LATE_E2_RESPONS...2,SET,52,-0.2917,-0.015502,0.12943,0.98789,LI_ESTROGENE_LATE_E2_RESPONSE_UP,1
GOBP_POSITIVE_REGULATION_OF_...457,SET,14,-0.43509,-0.01201,0.19304,0.98789,GOBP_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE,1
HP_DEPRESSED_NASAL_BRIDGE,SET,527,-0.084079,-0.014039,0.037299,0.9879,HP_DEPRESSED_NASAL_BRIDGE,1
GOBP_IMPORT_INTO_THE_MITOCHO...,SET,45,-0.27145,-0.013422,0.1204,0.98791,GOBP_IMPORT_INTO_THE_MITOCHONDRION,1
HP_PROTUBERANT_ABDOMEN,SET,39,-0.30967,-0.014257,0.13732,0.98793,HP_PROTUBERANT_ABDOMEN,1
HP_ABNORMAL_HEMIDIAPHRAGM_MO...,SET,7,-0.81211,-0.015854,0.36009,0.98794,HP_ABNORMAL_HEMIDIAPHRAGM_MORPHOLOGY,1
GOBP_BASEMENT_MEMBRANE_ORGAN...,SET,37,-0.33781,-0.015149,0.14975,0.98795,GOBP_BASEMENT_MEMBRANE_ORGANIZATION,1
GOBP_CEREBRAL_CORTEX_RADIALL...,SET,33,-0.36904,-0.015632,0.16351,0.98799,GOBP_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...203,SET,7,-0.78359,-0.015297,0.34716,0.98799,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GSE1740_MCSF_VS_MCSF_AND_IFN...1,SET,172,-0.14026,-0.013512,0.062125,0.98801,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...3,SET,30,-0.31436,-0.012697,0.13925,0.98801,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN,1
CTATGCA_MIR153,SET,203,-0.1393,-0.014566,0.061688,0.98802,CTATGCA_MIR153,1
GSE369_SOCS3_KO_VS_WT_LIVER_...3,SET,187,-0.137,-0.013756,0.060677,0.98802,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP,1
GOBP_SEMI_LUNAR_VALVE_DEVELO...,SET,48,-0.30426,-0.015537,0.13473,0.98803,GOBP_SEMI_LUNAR_VALVE_DEVELOPMENT,1
HP_AMBLYOPIA,SET,99,-0.19131,-0.01401,0.084658,0.98808,HP_AMBLYOPIA,1
HP_LOWER_LIMB_HYPERREFLEXIA,SET,71,-0.2238,-0.01389,0.099017,0.98809,HP_LOWER_LIMB_HYPERREFLEXIA,1
NIKOLSKY_BREAST_CANCER_1Q21_...,SET,34,-0.47212,-0.020298,0.20879,0.98812,NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,1
HP_UPPER_LIMB_HYPERTONIA,SET,9,-0.66003,-0.01461,0.29191,0.98812,HP_UPPER_LIMB_HYPERTONIA,1
MIR6509_5P,SET,88,-0.20625,-0.014245,0.091198,0.98813,MIR6509_5P,1
MIR5692B_MIR5692C,SET,373,-0.10511,-0.014829,0.046457,0.98816,MIR5692B_MIR5692C,1
MIR1262,SET,44,-0.26842,-0.013125,0.11857,0.9882,MIR1262,1
HP_REDUCED_VISUAL_ACUITY,SET,518,-0.085532,-0.014163,0.037785,0.9882,HP_REDUCED_VISUAL_ACUITY,1
HP_METATARSUS_VALGUS,SET,19,-0.45794,-0.014724,0.20212,0.98826,HP_METATARSUS_VALGUS,1
GSE20198_UNTREATED_VS_IL12_T...1,SET,182,-0.14092,-0.013961,0.0622,0.98826,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN,1
GOMF_DIPEPTIDYL_PEPTIDASE_AC...,SET,12,-0.55831,-0.014269,0.24628,0.9883,GOMF_DIPEPTIDYL_PEPTIDASE_ACTIVITY,1
GSE5589_WT_VS_IL10_KO_LPS_AN...6,SET,177,-0.14553,-0.01422,0.064187,0.98831,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOBP_POSITIVE_REGULATION_OF_...30,SET,4,-0.72411,-0.010687,0.31933,0.98832,GOBP_POSITIVE_REGULATION_OF_ANOIKIS,1
MIR6847_5P,SET,136,-0.16683,-0.014305,0.073558,0.98833,MIR6847_5P,1
HP_ABNORMAL_HUMERUS_MORPHOLO...,SET,14,-0.50559,-0.013956,0.2229,0.98834,HP_ABNORMAL_HUMERUS_MORPHOLOGY,1
HOFMANN_MYELODYSPLASTIC_SYND...5,SET,20,-0.40855,-0.013477,0.18002,0.98837,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,1
HP_ABNORMAL_LATERAL_VENTRICL...,SET,104,-0.18581,-0.013945,0.081879,0.98837,HP_ABNORMAL_LATERAL_VENTRICLE_MORPHOLOGY,1
MIR3678_3P,SET,115,-0.19143,-0.015103,0.084331,0.98839,MIR3678_3P,1
GOBP_GLYCEROL_ETHER_METABOLI...,SET,19,-0.46138,-0.014835,0.20318,0.98841,GOBP_GLYCEROL_ETHER_METABOLIC_PROCESS,1
GOBP_CD8_POSITIVE_ALPHA_BETA...1,SET,26,-0.39917,-0.015011,0.17578,0.98842,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
CHIN_BREAST_CANCER_COPY_NUMB...1,SET,12,-0.48855,-0.012486,0.21509,0.98843,CHIN_BREAST_CANCER_COPY_NUMBER_DN,1
MIR4688,SET,44,-0.27931,-0.013657,0.12297,0.98843,MIR4688,1
MIR1908_5P,SET,16,-0.5051,-0.014904,0.22235,0.98844,MIR1908_5P,1
GOBP_HEART_VALVE_MORPHOGENES...,SET,60,-0.27395,-0.015635,0.12058,0.98845,GOBP_HEART_VALVE_MORPHOGENESIS,1
MIR4665_5P,SET,137,-0.17383,-0.01496,0.076502,0.98846,MIR4665_5P,1
HP_SUBCORTICAL_WHITE_MATTER_...,SET,3,-1.1547,-0.014759,0.50817,0.98846,HP_SUBCORTICAL_WHITE_MATTER_CALCIFICATIONS,1
GOBP_POSITIVE_REGULATION_OF_...84,SET,193,-0.14427,-0.014714,0.063475,0.98848,GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
HOWARD_MONOCYTE_INACT_MONOV_...1,SET,35,-0.35331,-0.015411,0.15516,0.9886,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,1
GSE3982_NEUTROPHIL_VS_BCELL_...2,SET,168,-0.15741,-0.014988,0.069119,0.98861,GSE3982_NEUTROPHIL_VS_BCELL_UP,1
GOBP_ACTIN_POLYMERIZATION_DE...,SET,7,-0.72544,-0.014162,0.31843,0.98864,GOBP_ACTIN_POLYMERIZATION_DEPENDENT_CELL_MOTILITY,1
MIR3690,SET,52,-0.27001,-0.014349,0.1185,0.98865,MIR3690,1
GOBP_CARTILAGE_DEVELOPMENT,SET,187,-0.1481,-0.01487,0.064998,0.98865,GOBP_CARTILAGE_DEVELOPMENT,1
GOMF_MICROTUBULE_MOTOR_ACTIV...,SET,68,-0.23367,-0.014194,0.10255,0.98865,GOMF_MICROTUBULE_MOTOR_ACTIVITY,1
MIR138_1_3P,SET,79,-0.21458,-0.014045,0.094151,0.98866,MIR138_1_3P,1
GOMF_OXIDOREDUCTASE_ACTIVITY...11,SET,6,-0.87867,-0.015882,0.38557,0.98866,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR,1
SESTO_RESPONSE_TO_UV_C5,SET,46,-0.29167,-0.014581,0.12795,0.98868,SESTO_RESPONSE_TO_UV_C5,1
GSE3982_MAC_VS_NEUTROPHIL_LP...1,SET,166,-0.15242,-0.014427,0.066832,0.98871,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN,1
GSE6674_CPG_VS_PL2_3_STIM_BC...1,SET,175,-0.14594,-0.01418,0.06398,0.98872,GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN,1
MIR3158_3P,SET,35,-0.32018,-0.013966,0.14032,0.98874,MIR3158_3P,1
HP_SPLENIC_INFARCTION,SET,6,-0.86375,-0.015612,0.37854,0.98874,HP_SPLENIC_INFARCTION,1
HELLER_SILENCED_BY_METHYLATI...2,SET,237,-0.13336,-0.015054,0.0584,0.98879,HELLER_SILENCED_BY_METHYLATION_UP,1
GOBP_DETECTION_OF_VIRUS,SET,5,-0.80957,-0.013358,0.35433,0.98883,GOBP_DETECTION_OF_VIRUS,1
FIGUEROA_AML_METHYLATION_CLU...1,SET,41,-0.31216,-0.014735,0.13661,0.98884,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1
REACTOME_MET_PROMOTES_CELL_M...,SET,41,-0.32025,-0.015117,0.14016,0.98884,REACTOME_MET_PROMOTES_CELL_MOTILITY,1
REACTOME_ESTROGEN_DEPENDENT_...2,SET,23,-0.45225,-0.015997,0.19782,0.98887,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,1
HP_CEREBELLAR_DYSPLASIA,SET,18,-0.47271,-0.014794,0.20663,0.98892,HP_CEREBELLAR_DYSPLASIA,1
HP_CURLY_HAIR,SET,30,-0.3411,-0.013777,0.1491,0.98892,HP_CURLY_HAIR,1
GSE33425_CD161_HIGH_VS_NEG_C...2,SET,184,-0.14489,-0.014432,0.063334,0.98892,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP,1
HP_CERVICAL_RIBS,SET,10,-0.59309,-0.013838,0.25917,0.98894,HP_CERVICAL_RIBS,1
GOMF_ESTROGEN_16_ALPHA_HYDRO...,SET,8,-0.81009,-0.016906,0.35392,0.98895,GOMF_ESTROGEN_16_ALPHA_HYDROXYLASE_ACTIVITY,1
GSE43955_1H_VS_42H_ACT_CD4_T...3,SET,181,-0.14439,-0.014266,0.063075,0.98896,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
MIR6810_3P,SET,69,-0.23878,-0.01461,0.10429,0.98897,MIR6810_3P,1
GSE21380_NON_TFH_VS_GERMINAL...1,SET,184,-0.14008,-0.013952,0.061168,0.98898,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,1
GOBP_FOREBRAIN_CELL_MIGRATION,SET,59,-0.28012,-0.015854,0.12231,0.98899,GOBP_FOREBRAIN_CELL_MIGRATION,1
DESCARTES_FETAL_ADRENAL_VASC...,SET,110,-0.1974,-0.015233,0.086195,0.98899,DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS,1
GSE36476_CTRL_VS_TSST_ACT_40...2,SET,178,-0.14918,-0.014617,0.065131,0.989,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP,1
GOBP_SCHWANN_CELL_DIFFERENTI...,SET,47,-0.29225,-0.014768,0.12753,0.98903,GOBP_SCHWANN_CELL_DIFFERENTIATION,1
HP_MITTEN_DEFORMITY,SET,9,-0.69254,-0.015329,0.302,0.98907,HP_MITTEN_DEFORMITY,1
GOMF_DNA_POLYMERASE_BINDING,SET,19,-0.37154,-0.011946,0.16201,0.98908,GOMF_DNA_POLYMERASE_BINDING,1
GOBP_RESPONSE_TO_THYROID_HOR...,SET,22,-0.45427,-0.015715,0.19799,0.98911,GOBP_RESPONSE_TO_THYROID_HORMONE,1
HP_ZONULAR_CATARACT,SET,47,-0.29398,-0.014855,0.1281,0.98912,HP_ZONULAR_CATARACT,1
CP2_02,SET,220,-0.13502,-0.014691,0.058821,0.98914,CP2_02,1
HP_PREDOMINANTLY_LOWER_LIMB_...,SET,8,-0.70703,-0.014755,0.30797,0.98915,HP_PREDOMINANTLY_LOWER_LIMB_LYMPHEDEMA,1
HP_CEREBELLAR_CYST,SET,138,-0.16064,-0.013875,0.069942,0.98918,HP_CEREBELLAR_CYST,1
ILK_TARGET_GENES,SET,15,-0.47475,-0.013564,0.20665,0.98919,ILK_TARGET_GENES,1
ATTACAT_MIR3803P,SET,86,-0.22361,-0.015268,0.097307,0.98921,ATTACAT_MIR3803P,1
GSE8621_LPS_STIM_VS_LPS_PRIM...2,SET,185,-0.1469,-0.014671,0.063926,0.98921,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,1
KEGG_GNRH_SIGNALING_PATHWAY,SET,98,-0.21144,-0.015406,0.091995,0.98922,KEGG_GNRH_SIGNALING_PATHWAY,1
GOBP_APICAL_PROTEIN_LOCALIZA...,SET,14,-0.50035,-0.013811,0.2177,0.98922,GOBP_APICAL_PROTEIN_LOCALIZATION,1
REACTOME_OAS_ANTIVIRAL_RESPO...,SET,7,-0.99776,-0.019478,0.43371,0.98928,REACTOME_OAS_ANTIVIRAL_RESPONSE,1
CUI_TCF21_TARGETS_2_DN,SET,761,-0.075885,-0.015126,0.032958,0.98934,CUI_TCF21_TARGETS_2_DN,1
HP_HYPOPLASIA_OF_THE_IRIS,SET,30,-0.39398,-0.015913,0.17108,0.98935,HP_HYPOPLASIA_OF_THE_IRIS,1
HP_LIMITED_WRIST_MOVEMENT,SET,12,-0.57316,-0.014648,0.24887,0.98936,HP_LIMITED_WRIST_MOVEMENT,1
KUMAR_TARGETS_OF_MLL_AF9_FUS...,SET,367,-0.10651,-0.014907,0.046187,0.98944,KUMAR_TARGETS_OF_MLL_AF9_FUSION,1
WP_ONECARBON_METABOLISM,SET,29,-0.3483,-0.013832,0.15094,0.98948,WP_ONECARBON_METABOLISM,1
GSE29618_BCELL_VS_MONOCYTE_D...1,SET,185,-0.15457,-0.015438,0.066972,0.98949,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN,1
MIR4502,SET,68,-0.23359,-0.014189,0.10118,0.98951,MIR4502,1
AMIT_EGF_RESPONSE_120_HELA,SET,63,-0.24988,-0.014612,0.10817,0.98955,AMIT_EGF_RESPONSE_120_HELA,1
GSE3565_CTRL_VS_LPS_INJECTED...4,SET,160,-0.16403,-0.015245,0.070991,0.98956,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP,1
GOBP_POSITIVE_REGULATION_OF_...268,SET,28,-0.36933,-0.014412,0.15983,0.98957,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
GOBP_POSITIVE_REGULATION_OF_...478,SET,43,-0.3156,-0.015255,0.13652,0.9896,GOBP_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
HP_ANGIOKERATOMA,SET,5,-0.84262,-0.013903,0.3645,0.9896,HP_ANGIOKERATOMA,1
KEGG_MEDICUS_REFERENCE_CA2_P...2,SET,14,-0.50741,-0.014006,0.21942,0.98962,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_4_GALACTOSYL_N_ACETYLGL...,SET,6,-1.0052,-0.018169,0.43404,0.98971,GOMF_4_GALACTOSYL_N_ACETYLGLUCOSAMINIDE_3_ALPHA_L_FUCOSYLTRANSFERASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...343,SET,49,-0.29705,-0.015326,0.12825,0.98972,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,1
JNK_DN.V1_DN,SET,167,-0.16344,-0.015517,0.070549,0.98974,JNK_DN.V1_DN,1
HP_ABNORMAL_PERIVENTRICULAR_...,SET,116,-0.17719,-0.01404,0.076423,0.98978,HP_ABNORMAL_PERIVENTRICULAR_WHITE_MATTER_MORPHOLOGY,1
GOBP_COMMON_BILE_DUCT_DEVELO...,SET,5,-0.90834,-0.014988,0.39173,0.98979,GOBP_COMMON_BILE_DUCT_DEVELOPMENT,1
GSE45365_HEALTHY_VS_MCMV_INF...5,SET,160,-0.15624,-0.014522,0.067337,0.98983,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP,1
GOBP_CELLULAR_RESPONSE_TO_OX...5,SET,21,-0.42319,-0.014304,0.1822,0.9899,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL,1
GOBP_POSITIVE_REGULATION_OF_...420,SET,22,-0.43777,-0.015145,0.18841,0.98992,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
GSE5455_EX_VIVO_VS_POST_24H_...2,SET,183,-0.14311,-0.014216,0.061582,0.98993,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP,1
ACCATTT_MIR522,SET,144,-0.1628,-0.014361,0.070047,0.98994,ACCATTT_MIR522,1
GOBP_BRANCHING_INVOLVED_IN_S...,SET,22,-0.43503,-0.01505,0.18708,0.98997,GOBP_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
HP_TACTILE_HYPERSENSITIVITY,SET,5,-0.84796,-0.013992,0.36456,0.98998,HP_TACTILE_HYPERSENSITIVITY,1
GSE27786_CD8_TCELL_VS_NKCELL...2,SET,187,-0.14134,-0.014192,0.060761,0.98999,GSE27786_CD8_TCELL_VS_NKCELL_UP,1
GSE17721_CPG_VS_GARDIQUIMOD_...3,SET,181,-0.14245,-0.014073,0.061197,0.99003,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN,1
MIR1304_5P,SET,121,-0.17779,-0.014385,0.076364,0.99004,MIR1304_5P,1
PANGAS_TUMOR_SUPPRESSION_BY_...1,SET,128,-0.17726,-0.014749,0.076112,0.99006,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,1
GOBP_VESTIBULOCOCHLEAR_NERVE...3,SET,7,-0.90835,-0.017733,0.39007,0.99006,GOBP_VESTIBULOCOCHLEAR_NERVE_MORPHOGENESIS,1
DURANTE_ADULT_OLFACTORY_NEUR...11,SET,163,-0.15678,-0.014707,0.067282,0.9901,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,1
GOBP_SNORNA_LOCALIZATION,SET,6,-0.72809,-0.01316,0.31237,0.99011,GOBP_SNORNA_LOCALIZATION,1
HP_SUPERNUMERARY_BONES_OF_TH...,SET,23,-0.41045,-0.014518,0.17608,0.99012,HP_SUPERNUMERARY_BONES_OF_THE_AXIAL_SKELETON,1
GSE6259_FLT3L_INDUCED_33D1_P...6,SET,134,-0.17458,-0.01486,0.074896,0.99012,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP,1
GSE22935_UNSTIM_VS_24H_MBOVI...1,SET,180,-0.15647,-0.015417,0.067097,0.99015,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
GOBP_MITOCHONDRIAL_PROTEIN_C...,SET,9,-0.56367,-0.012477,0.24162,0.99017,GOBP_MITOCHONDRIAL_PROTEIN_CATABOLIC_PROCESS,1
GOBP_PTERIDINE_CONTAINING_CO...1,SET,13,-0.50733,-0.013495,0.21742,0.99018,GOBP_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
MIR6736_5P,SET,42,-0.28129,-0.013438,0.12053,0.99019,MIR6736_5P,1
GSE42021_TCONV_PLN_VS_CD24IN...1,SET,182,-0.1443,-0.014295,0.061777,0.99024,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN,1
GSE16385_MONOCYTE_VS_12H_ROS...3,SET,187,-0.14179,-0.014236,0.060663,0.99028,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,1
GSE34006_A2AR_KO_VS_A2AR_AGO...1,SET,188,-0.14136,-0.014231,0.060485,0.99028,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN,1
MIR4638_5P,SET,5,-0.80947,-0.013356,0.3463,0.99029,MIR4638_5P,1
GOBP_POSITIVE_REGULATION_OF_...484,SET,13,-0.64514,-0.017161,0.27578,0.99034,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
WANG_RECURRENT_LIVER_CANCER_...1,SET,16,-0.54847,-0.016184,0.23437,0.99036,WANG_RECURRENT_LIVER_CANCER_DN,1
GSE11961_MARGINAL_ZONE_BCELL...1,SET,188,-0.15088,-0.015189,0.064456,0.99037,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GSE29617_CTRL_VS_TIV_FLU_VAC...2,SET,162,-0.15872,-0.014843,0.067805,0.99037,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP,1
VANASSE_BCL2_TARGETS_UP,SET,29,-0.40383,-0.016037,0.17248,0.99039,VANASSE_BCL2_TARGETS_UP,1
GOBP_CELLULAR_MODIFIED_AMINO...1,SET,42,-0.30471,-0.014557,0.13002,0.99044,GOBP_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GNF2_CASP1,SET,102,-0.20322,-0.015105,0.086703,0.99045,GNF2_CASP1,1
HP_TRACHEAL_CALCIFICATION,SET,3,-1.2777,-0.016332,0.54498,0.99047,HP_TRACHEAL_CALCIFICATION,1
HP_RETINAL_ATROPHY,SET,91,-0.20727,-0.014556,0.088384,0.99048,HP_RETINAL_ATROPHY,1
HP_WIDENED_CEREBELLAR_SUBARA...,SET,6,-0.84768,-0.015321,0.36141,0.99049,HP_WIDENED_CEREBELLAR_SUBARACHNOID_SPACE,1
MIR1233_3P,SET,71,-0.2636,-0.016361,0.11233,0.99052,MIR1233_3P,1
HP_ABNORMALITY_OF_THE_HUMERUS,SET,54,-0.28879,-0.015639,0.12305,0.99053,HP_ABNORMALITY_OF_THE_HUMERUS,1
KEGG_MEDICUS_PATHOGEN_ESCHER...8,SET,4,-0.98869,-0.014592,0.4212,0.99054,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_TIR_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,1
MIR2116_3P,SET,68,-0.24634,-0.014964,0.10494,0.99054,MIR2116_3P,1
GCAAGAC_MIR431,SET,43,-0.31775,-0.015359,0.13535,0.99055,GCAAGAC_MIR431,1
GOBP_RELEASE_OF_SEQUESTERED_...,SET,34,-0.3599,-0.015473,0.15323,0.99058,GOBP_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_ENDOPLASMIC_RETICULUM,1
PID_ERBB1_DOWNSTREAM_PATHWAY,SET,102,-0.20492,-0.015232,0.087206,0.9906,PID_ERBB1_DOWNSTREAM_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_OX...4,SET,145,-0.1656,-0.014658,0.070481,0.9906,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,1
REACTOME_WAX_AND_PLASMALOGEN...,SET,5,-0.93142,-0.015369,0.39601,0.99066,REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS,1
GSE21546_WT_VS_SAP1A_KO_AND_...2,SET,164,-0.16024,-0.015077,0.068128,0.99066,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
GOMF_MICROTUBULE_BINDING,SET,255,-0.12533,-0.014667,0.053227,0.99072,GOMF_MICROTUBULE_BINDING,1
MIR3197,SET,5,-0.95615,-0.015777,0.40601,0.99073,MIR3197,1
GOBP_REGULATION_OF_RIBONUCLE...,SET,9,-0.76437,-0.016919,0.3244,0.99076,GOBP_REGULATION_OF_RIBONUCLEASE_ACTIVITY,1
GSE36888_STAT5_AB_KNOCKIN_VS...5,SET,181,-0.14855,-0.014677,0.063005,0.9908,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN,1
GOBP_CANONICAL_NF_KAPPAB_SIG...,SET,279,-0.12331,-0.015085,0.052261,0.99084,GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
HAY_BONE_MARROW_CD34_POS_CLP,SET,7,-0.89939,-0.017558,0.38111,0.99085,HAY_BONE_MARROW_CD34_POS_CLP,1
chr3q29,SET,43,-0.56968,-0.027537,0.2414,0.99086,chr3q29,1
MIR1252_3P,SET,270,-0.12688,-0.015273,0.053762,0.99086,MIR1252_3P,1
GOMF_MHC_CLASS_IB_RECEPTOR_A...,SET,6,-1.0019,-0.018108,0.42433,0.99088,GOMF_MHC_CLASS_IB_RECEPTOR_ACTIVITY,1
GSE5589_LPS_AND_IL10_VS_LPS_...4,SET,181,-0.14864,-0.014685,0.06291,0.99092,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,1
GOBP_VESTIBULOCOCHLEAR_NERVE...1,SET,11,-0.7036,-0.017217,0.29774,0.99093,GOBP_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT,1
MIR1322,SET,68,-0.27739,-0.01685,0.11735,0.99095,MIR1322,1
HP_ABNORMAL_CRANIAL_NERVE_MO...,SET,71,-0.24273,-0.015065,0.10267,0.99096,HP_ABNORMAL_CRANIAL_NERVE_MORPHOLOGY,1
KEGG_MEDICUS_VARIANT_IGF2_OV...,SET,14,-0.53328,-0.01472,0.22548,0.99098,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_ABNORMAL_DIAPHYSIS_MORPHO...,SET,296,-0.1189,-0.014974,0.050271,0.99098,HP_ABNORMAL_DIAPHYSIS_MORPHOLOGY,1
GOCC_GLYCOGEN_GRANULE,SET,6,-0.75914,-0.013721,0.32086,0.991,GOCC_GLYCOGEN_GRANULE,1
REACTOME_PHOSPHORYLATION_OF_...2,SET,19,-0.41038,-0.013195,0.17336,0.99103,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,1
GOBP_NEGATIVE_REGULATION_OF_...698,SET,22,-0.47042,-0.016274,0.19841,0.99112,GOBP_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,1
HP_KNUCKLE_PAD,SET,7,-0.76433,-0.014922,0.32229,0.99114,HP_KNUCKLE_PAD,1
HP_DERMAL_TRANSLUCENCY,SET,25,-0.42069,-0.015513,0.17733,0.99116,HP_DERMAL_TRANSLUCENCY,1
HP_WIDELY_SPACED_TEETH,SET,103,-0.19814,-0.014799,0.083519,0.99116,HP_WIDELY_SPACED_TEETH,1
HP_ABNORMAL_CIRCULATING_ASPA...,SET,22,-0.47119,-0.016301,0.19857,0.99117,HP_ABNORMAL_CIRCULATING_ASPARTATE_FAMILY_AMINO_ACID_CONCENTRATION,1
GSE15733_BM_VS_SPLEEN_MEMORY...2,SET,175,-0.15575,-0.015133,0.065636,0.99117,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP,1
HP_BLOCK_VERTEBRAE,SET,5,-0.95981,-0.015837,0.40428,0.9912,HP_BLOCK_VERTEBRAE,1
GOBP_SENSORY_PERCEPTION_OF_L...,SET,201,-0.15279,-0.015899,0.064347,0.99121,GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS,1
MIR1178_3P,SET,83,-0.23365,-0.015674,0.098355,0.99123,MIR1178_3P,1
GOBP_FARNESYL_DIPHOSPHATE_ME...,SET,5,-0.84058,-0.01387,0.35385,0.99123,GOBP_FARNESYL_DIPHOSPHATE_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_EGF_OVE...2,SET,14,-0.53002,-0.01463,0.22311,0.99124,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE22229_RENAL_TRANSPLANT_IM...1,SET,183,-0.153,-0.015199,0.064321,0.99131,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN,1
HP_ABNORMAL_CEREBELLAR_VERMI...,SET,317,-0.11179,-0.014561,0.046987,0.99132,HP_ABNORMAL_CEREBELLAR_VERMIS_MORPHOLOGY,1
PID_INSULIN_GLUCOSE_PATHWAY,SET,26,-0.39626,-0.014901,0.16653,0.99133,PID_INSULIN_GLUCOSE_PATHWAY,1
GOBP_PROTEOGLYCAN_BIOSYNTHET...,SET,63,-0.26609,-0.01556,0.11181,0.99133,GOBP_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GSE7460_WT_VS_FOXP3_HET_ACT_...1,SET,182,-0.14845,-0.014707,0.062369,0.99134,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN,1
GOBP_LIPID_HYDROXYLATION,SET,7,-0.91643,-0.017891,0.38452,0.99142,GOBP_LIPID_HYDROXYLATION,1
HP_MULTIPLE_LIPOMAS,SET,31,-0.37324,-0.015324,0.15648,0.99146,HP_MULTIPLE_LIPOMAS,1
BURTON_ADIPOGENESIS_6,SET,174,-0.15313,-0.014837,0.064139,0.99151,BURTON_ADIPOGENESIS_6,1
GOBP_REGULATION_OF_BASEMENT_...,SET,11,-0.61918,-0.015151,0.25918,0.99155,GOBP_REGULATION_OF_BASEMENT_MEMBRANE_ORGANIZATION,1
GOCC_NURF_COMPLEX,SET,5,-0.80287,-0.013248,0.33578,0.9916,GOCC_NURF_COMPLEX,1
SUPT16H_TARGET_GENES,SET,1357,-0.056723,-0.01484,0.023688,0.99168,SUPT16H_TARGET_GENES,1
HP_ABNORMAL_FOURTH_VENTRICLE...,SET,132,-0.16806,-0.014199,0.070177,0.99168,HP_ABNORMAL_FOURTH_VENTRICLE_MORPHOLOGY,1
HP_METAPHYSEAL_WIDENING,SET,89,-0.21398,-0.014862,0.089338,0.99169,HP_METAPHYSEAL_WIDENING,1
HP_LONG_PHILTRUM,SET,371,-0.10714,-0.015075,0.044721,0.9917,HP_LONG_PHILTRUM,1
HP_PATELLAR_SUBLUXATION,SET,5,-1.0725,-0.017696,0.44755,0.99172,HP_PATELLAR_SUBLUXATION,1
GSE26669_CTRL_VS_COSTIM_BLOC...4,SET,184,-0.14823,-0.014764,0.061831,0.99174,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP,1
GSE18893_CTRL_VS_TNF_TREATED...6,SET,182,-0.14911,-0.014772,0.062164,0.99177,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP,1
DESCARTES_MAIN_FETAL_SATB2_L...,SET,77,-0.24283,-0.015693,0.10123,0.99177,DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS,1
GSE13306_RA_VS_UNTREATED_MEM...2,SET,189,-0.14962,-0.015102,0.062342,0.9918,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP,1
GOBP_NEUTROPHIL_ACTIVATION_I...,SET,20,-0.45435,-0.014988,0.18923,0.99182,GOBP_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOMF_AMIDINE_LYASE_ACTIVITY,SET,7,-0.78141,-0.015255,0.32528,0.99185,GOMF_AMIDINE_LYASE_ACTIVITY,1
GAVISH_3CA_MALIGNANT_METAPRO...2,SET,38,-0.33336,-0.01515,0.13866,0.99189,GAVISH_3CA_MALIGNANT_METAPROGRAM_11_TRANSLATION_INITIATION,1
HP_ABNORMAL_CEREBRAL_VENTRIC...,SET,816,-0.072973,-0.015038,0.030344,0.99191,HP_ABNORMAL_CEREBRAL_VENTRICLE_MORPHOLOGY,1
MIR6503_3P,SET,28,-0.37418,-0.014601,0.15538,0.99198,MIR6503_3P,1
HP_AORTIC_ANEURYSM,SET,152,-0.16766,-0.015192,0.069589,0.992,HP_AORTIC_ANEURYSM,1
REACTOME_RUNX2_REGULATES_GEN...,SET,8,-0.7097,-0.014811,0.29447,0.99202,REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION,1
GOBP_CELL_FATE_DETERMINATION,SET,40,-0.36447,-0.016993,0.15119,0.99203,GOBP_CELL_FATE_DETERMINATION,1
HP_ABNORMAL_CSF_METABOLITE_C...,SET,128,-0.16916,-0.014075,0.070162,0.99204,HP_ABNORMAL_CSF_METABOLITE_CONCENTRATION,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...1,SET,5,-0.9524,-0.015715,0.39486,0.99206,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,1
GOCC_CCAAT_BINDING_FACTOR_CO...,SET,5,-0.82821,-0.013666,0.34327,0.99208,GOCC_CCAAT_BINDING_FACTOR_COMPLEX,1
MIR4782_5P,SET,150,-0.17036,-0.015335,0.070579,0.9921,MIR4782_5P,1
NR1D1_TARGET_GENES,SET,88,-0.21134,-0.014596,0.087558,0.9921,NR1D1_TARGET_GENES,1
GOMF_OXIDOREDUCTASE_ACTIVITY...38,SET,15,-0.50773,-0.014507,0.21031,0.99211,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
GSE7568_IL4_VS_IL4_AND_TGFB_...2,SET,151,-0.16569,-0.014964,0.068618,0.99212,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP,1
WP_PROLINE_AND_HYDROXYPROLIN...,SET,5,-1.1118,-0.018344,0.46034,0.99213,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,1
WP_ENTEROCYTE_CHOLESTEROL_ME...,SET,34,-0.3324,-0.014291,0.13761,0.99214,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,1
IVANOVSKA_MIR106B_TARGETS,SET,82,-0.21301,-0.014204,0.088131,0.99217,IVANOVSKA_MIR106B_TARGETS,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...1,SET,179,-0.15798,-0.015522,0.065364,0.99217,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN,1
GSE18791_CTRL_VS_NEWCASTLE_V...2,SET,178,-0.14457,-0.014166,0.059818,0.99217,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...354,SET,5,-0.97376,-0.016067,0.40273,0.99219,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,1
HP_DRY_SKIN,SET,163,-0.15794,-0.014816,0.065302,0.99221,HP_DRY_SKIN,1
HP_NEPHROPATHY,SET,82,-0.23189,-0.015463,0.095846,0.99222,HP_NEPHROPATHY,1
HP_LACRIMAL_DUCT_STENOSIS,SET,13,-0.57568,-0.015313,0.23782,0.99225,HP_LACRIMAL_DUCT_STENOSIS,1
TRAVAGLINI_LUNG_ARTERY_CELL,SET,124,-0.20279,-0.016609,0.083773,0.99225,TRAVAGLINI_LUNG_ARTERY_CELL,1
MIR377_5P,SET,50,-0.28696,-0.014955,0.11852,0.99226,MIR377_5P,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...1,SET,8,-0.69125,-0.014426,0.28545,0.99227,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_DN,1
GOBP_REGULATION_OF_LYMPHOID_...,SET,12,-0.57491,-0.014693,0.23735,0.99228,GOBP_REGULATION_OF_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
HP_ABNORMAL_VERTEBRAL_MORPHO...,SET,421,-0.10071,-0.015075,0.041574,0.99229,HP_ABNORMAL_VERTEBRAL_MORPHOLOGY,1
KIM_GLIS2_TARGETS_UP,SET,81,-0.25165,-0.016678,0.10384,0.99231,KIM_GLIS2_TARGETS_UP,1
BLALOCK_ALZHEIMERS_DISEASE_DN,SET,1103,-0.063649,-0.015125,0.02626,0.99232,BLALOCK_ALZHEIMERS_DISEASE_DN,1
KEGG_MEDICUS_REFERENCE_FLT3L...1,SET,14,-0.50255,-0.013872,0.20707,0.99238,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY,1
GSE17721_LPS_VS_PAM3CSK4_12H...2,SET,187,-0.15189,-0.015251,0.062581,0.99238,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP,1
HP_LIPOMATOUS_TUMOR,SET,42,-0.32477,-0.015515,0.13369,0.99243,HP_LIPOMATOUS_TUMOR,1
GOBP_ZINC_ION_IMPORT_INTO_OR...,SET,11,-0.59618,-0.014588,0.24518,0.99248,GOBP_ZINC_ION_IMPORT_INTO_ORGANELLE,1
HP_APLASIA_HYPOPLASIA_INVOLV...2,SET,317,-0.12044,-0.015689,0.049534,0.99248,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
KEGG_MEDICUS_REFERENCE_TNF_J...,SET,16,-0.54314,-0.016027,0.22333,0.99249,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY,1
WP_PILOCYTIC_ASTROCYTOMA,SET,6,-0.72715,-0.013143,0.29894,0.9925,WP_PILOCYTIC_ASTROCYTOMA,1
GOBP_TRNA_THREONYLCARBAMOYLA...1,SET,13,-0.49438,-0.01315,0.20322,0.9925,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS,1
GSE36476_YOUNG_VS_OLD_DONOR_...4,SET,176,-0.16161,-0.015747,0.066437,0.9925,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP,1
GOBP_CEREBRAL_CORTEX_CELL_MI...,SET,42,-0.34832,-0.01664,0.14314,0.99252,GOBP_CEREBRAL_CORTEX_CELL_MIGRATION,1
GSE17721_POLYIC_VS_CPG_12H_B...2,SET,178,-0.15864,-0.015544,0.065172,0.99253,GSE17721_POLYIC_VS_CPG_12H_BMDC_UP,1
GSE33425_CD161_INT_VS_NEG_CD...2,SET,187,-0.15393,-0.015456,0.063191,0.99257,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP,1
GOBP_UREA_TRANSPORT,SET,10,-0.79206,-0.01848,0.32488,0.99261,GOBP_UREA_TRANSPORT,1
GOBP_RESPONSE_TO_REDOX_STATE,SET,12,-0.60241,-0.015396,0.24692,0.99265,GOBP_RESPONSE_TO_REDOX_STATE,1
GOBP_LYMPHOID_PROGENITOR_CEL...,SET,24,-0.4299,-0.015533,0.17611,0.99267,GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
GOBP_CELLULAR_RESPONSE_TO_OX...1,SET,225,-0.14123,-0.015539,0.057834,0.99269,GOBP_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
HP_INGUINAL_HERNIA,SET,265,-0.13032,-0.015543,0.053371,0.99269,HP_INGUINAL_HERNIA,1
HP_EXAGGERATED_CUPID_S_BOW,SET,31,-0.36834,-0.015123,0.1507,0.99274,HP_EXAGGERATED_CUPID_S_BOW,1
HP_CONE_CONE_ROD_DYSTROPHY,SET,52,-0.28305,-0.015042,0.11576,0.99275,HP_CONE_CONE_ROD_DYSTROPHY,1
JOHANSSON_GLIOMAGENESIS_BY_P...1,SET,21,-0.45357,-0.015331,0.18549,0.99276,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,1
MIR6778_5P,SET,97,-0.204,-0.014789,0.083417,0.99276,MIR6778_5P,1
HP_ABNORMAL_CONJUGATE_EYE_MO...,SET,1020,-0.066112,-0.015144,0.026996,0.99283,HP_ABNORMAL_CONJUGATE_EYE_MOVEMENT,1
HP_YELLOW_WHITE_LESIONS_OF_T...2,SET,55,-0.2883,-0.015756,0.11768,0.99285,HP_YELLOW_WHITE_LESIONS_OF_THE_RETINA,1
GSE15659_TREG_VS_TCONV_DN,SET,149,-0.17889,-0.01605,0.073005,0.99286,GSE15659_TREG_VS_TCONV_DN,1
MIR7150,SET,121,-0.1839,-0.01488,0.07502,0.99288,MIR7150,1
GOBP_NEGATIVE_REGULATION_OF_...310,SET,35,-0.36518,-0.015929,0.14896,0.99288,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,1
MODULE_78,SET,20,-0.47645,-0.015717,0.19427,0.9929,MODULE_78,1
HP_OSTEOLYSIS_INVOLVING_BONE...1,SET,11,-0.67831,-0.016598,0.27657,0.9929,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
GSE11864_CSF1_VS_CSF1_PAM3CY...2,SET,166,-0.15793,-0.014949,0.064395,0.9929,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP,1
GSE3982_EOSINOPHIL_VS_TH2_DN,SET,179,-0.15509,-0.015238,0.063236,0.9929,GSE3982_EOSINOPHIL_VS_TH2_DN,1
MIR8060,SET,91,-0.21879,-0.015365,0.089202,0.99291,MIR8060,1
GSE17721_PAM3CSK4_VS_CPG_12H...1,SET,187,-0.15142,-0.015204,0.061729,0.99291,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN,1
COMP1_01,SET,103,-0.23193,-0.017323,0.094505,0.99293,COMP1_01,1
HP_CLONUS,SET,98,-0.2118,-0.015433,0.086243,0.99297,HP_CLONUS,1
GSE3720_UNSTIM_VS_LPS_STIM_V...3,SET,129,-0.1889,-0.015778,0.076881,0.99299,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,1
GOBP_PROTEIN_QUALITY_CONTROL...,SET,23,-0.39587,-0.014003,0.1611,0.993,GOBP_PROTEIN_QUALITY_CONTROL_FOR_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEINS,1
HP_IRREGULAR_DENTITION,SET,7,-0.82296,-0.016066,0.33489,0.993,HP_IRREGULAR_DENTITION,1
HP_IRIDODONESIS,SET,4,-1.209,-0.017843,0.49168,0.99303,HP_IRIDODONESIS,1
GSE46606_IRF4HIGH_VS_IRF4MID...1,SET,178,-0.15937,-0.015616,0.064805,0.99303,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
GSE5589_LPS_AND_IL10_VS_LPS_...6,SET,180,-0.14796,-0.014578,0.060148,0.99305,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
BREDEMEYER_RAG_SIGNALING_NOT...2,SET,59,-0.27862,-0.015769,0.11318,0.99308,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,1
MIR4328,SET,518,-0.096059,-0.015906,0.039008,0.9931,MIR4328,1
MODULE_233,SET,21,-0.42377,-0.014324,0.17204,0.99311,MODULE_233,1
GAO_LARGE_INTESTINE_24W_C10_...,SET,55,-0.27765,-0.015173,0.11268,0.99313,GAO_LARGE_INTESTINE_24W_C10_ENTEROCYTE,1
GARY_CD5_TARGETS_UP,SET,415,-0.10117,-0.015038,0.041051,0.99314,GARY_CD5_TARGETS_UP,1
REACTOME_ARYL_HYDROCARBON_RE...,SET,6,-0.68911,-0.012455,0.27932,0.99318,REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING,1
GOBP_ESTABLISHMENT_OR_MAINTE...3,SET,7,-0.73328,-0.014315,0.2972,0.99319,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY,1
GOMF_DYNEIN_LIGHT_INTERMEDIA...,SET,28,-0.38363,-0.01497,0.15548,0.99319,GOMF_DYNEIN_LIGHT_INTERMEDIATE_CHAIN_BINDING,1
HP_OCULAR_FLUTTER,SET,5,-1.057,-0.017441,0.42797,0.99324,HP_OCULAR_FLUTTER,1
MIR609,SET,30,-0.37937,-0.015323,0.15354,0.99325,MIR609,1
GOMF_INTERLEUKIN_2_RECEPTOR_...,SET,5,-0.87519,-0.014441,0.35418,0.99326,GOMF_INTERLEUKIN_2_RECEPTOR_BINDING,1
KEGG_MEDICUS_REFERENCE_IGF_I...2,SET,15,-0.54248,-0.0155,0.2195,0.99327,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY,1
GAVISH_3CA_METAPROGRAM_FIBRO...20,SET,48,-0.3199,-0.016336,0.12932,0.99331,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE,1
HP_ABNORMAL_CHEEK_MORPHOLOGY,SET,231,-0.13693,-0.015262,0.055342,0.99332,HP_ABNORMAL_CHEEK_MORPHOLOGY,1
HP_ABSENCE_OF_LYMPH_NODE_GER...,SET,5,-1.0938,-0.018047,0.44208,0.99332,HP_ABSENCE_OF_LYMPH_NODE_GERMINAL_CENTER,1
GOCC_PSEUDOPODIUM,SET,16,-0.5279,-0.015577,0.2132,0.99335,GOCC_PSEUDOPODIUM,1
GOBP_BRUSH_BORDER_ASSEMBLY,SET,8,-0.66279,-0.013832,0.26763,0.99336,GOBP_BRUSH_BORDER_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...433,SET,18,-0.57512,-0.017999,0.23207,0.99339,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
KEGG_LINOLEIC_ACID_METABOLISM,SET,29,-0.46657,-0.018528,0.1882,0.99341,KEGG_LINOLEIC_ACID_METABOLISM,1
KIM_ALL_DISORDERS_CALB1_CORR...2,SET,497,-0.095633,-0.01552,0.038507,0.99349,KIM_ALL_DISORDERS_CALB1_CORR_UP,1
MORF_GSPT1,SET,43,-0.29713,-0.014363,0.11964,0.99349,MORF_GSPT1,1
HP_DRUSEN,SET,25,-0.45956,-0.016946,0.18503,0.9935,HP_DRUSEN,1
MIR3143,SET,412,-0.10697,-0.015844,0.043049,0.99352,MIR3143,1
GOBP_N_ACETYLNEURAMINATE_MET...,SET,11,-0.65886,-0.016122,0.26468,0.99359,GOBP_N_ACETYLNEURAMINATE_METABOLIC_PROCESS,1
GSE9037_WT_VS_IRAK4_KO_LPS_1...1,SET,172,-0.16645,-0.016035,0.066839,0.99361,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN,1
GOBP_PEPTIDE_BIOSYNTHETIC_PR...,SET,25,-0.44939,-0.016572,0.1804,0.99363,GOBP_PEPTIDE_BIOSYNTHETIC_PROCESS,1
GSE3982_BASOPHIL_VS_EFF_MEMO...2,SET,184,-0.15883,-0.01582,0.063758,0.99363,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
HP_INTUSSUSCEPTION,SET,10,-0.69332,-0.016176,0.27797,0.99368,HP_INTUSSUSCEPTION,1
GAUSSMANN_MLL_AF4_FUSION_TAR...1,SET,90,-0.23871,-0.016672,0.095618,0.99372,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1
GOBP_REGULATION_OF_CD8_POSIT...2,SET,8,-0.74012,-0.015446,0.29653,0.99372,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
HP_SCARRING,SET,88,-0.23443,-0.016191,0.093915,0.99372,HP_SCARRING,1
GSE36476_CTRL_VS_TSST_ACT_72...2,SET,174,-0.16424,-0.015913,0.065775,0.99373,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP,1
MIR4445_5P,SET,85,-0.2366,-0.016061,0.09472,0.99375,MIR4445_5P,1
REACTOME_APC_C_MEDIATED_DEGR...,SET,84,-0.20924,-0.014121,0.083638,0.99382,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1
DESCARTES_FETAL_KIDNEY_STROM...,SET,123,-0.20971,-0.017107,0.083828,0.99382,DESCARTES_FETAL_KIDNEY_STROMAL_CELLS,1
YORDY_RECIPROCAL_REGULATION_...1,SET,63,-0.29347,-0.017161,0.11719,0.99386,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,1
HP_ABNORMALITY_OF_THE_DIAPHR...,SET,101,-0.21253,-0.01572,0.084868,0.99386,HP_ABNORMALITY_OF_THE_DIAPHRAGM,1
HP_HYPERPIGMENTED_HYPOPIGMEN...,SET,5,-1.0051,-0.016584,0.40126,0.99387,HP_HYPERPIGMENTED_HYPOPIGMENTED_MACULES,1
HP_BROAD_NASAL_TIP,SET,133,-0.1806,-0.015315,0.072022,0.99392,HP_BROAD_NASAL_TIP,1
HP_PERSISTENT_PUPILLARY_MEMB...,SET,9,-0.78185,-0.017306,0.31166,0.99394,HP_PERSISTENT_PUPILLARY_MEMBRANE,1
IVANOVA_HEMATOPOIESIS_STEM_C...1,SET,179,-0.16744,-0.016452,0.06665,0.994,IVANOVA_HEMATOPOIESIS_STEM_CELL,1
BIOCARTA_BARRESTIN_SRC_PATHW...,SET,16,-0.59051,-0.017425,0.23505,0.994,BIOCARTA_BARRESTIN_SRC_PATHWAY,1
GOBP_RESPONSE_TO_OXYGEN_RADI...,SET,25,-0.42939,-0.015834,0.17083,0.99402,GOBP_RESPONSE_TO_OXYGEN_RADICAL,1
chr11q24,SET,81,-0.44564,-0.029535,0.17718,0.99405,chr11q24,1
MIKKELSEN_MEF_HCP_WITH_H3_UN...,SET,184,-0.16625,-0.016559,0.066057,0.99407,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,1
BOYLAN_MULTIPLE_MYELOMA_C_CL...2,SET,35,-0.3588,-0.015651,0.14255,0.99408,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,1
GSE17721_POLYIC_VS_PAM3CSK4_...8,SET,184,-0.15118,-0.015058,0.060066,0.99408,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP,1
GOCC_PORE_COMPLEX,SET,22,-0.48635,-0.016825,0.19318,0.99409,GOCC_PORE_COMPLEX,1
MIKKELSEN_IPS_ICP_WITH_H3K4M...,SET,116,-0.21516,-0.017048,0.085306,0.99416,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1
MIR5706,SET,150,-0.17872,-0.016088,0.070824,0.99418,MIR5706,1
GOBP_PROTEIN_TRIMERIZATION,SET,17,-0.52419,-0.015943,0.20759,0.99421,GOBP_PROTEIN_TRIMERIZATION,1
GSE33374_CD8_ALPHAALPHA_VS_A...2,SET,187,-0.15959,-0.016024,0.063213,0.99421,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C6_MUC...,SET,49,-0.31965,-0.016491,0.12653,0.99423,HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL,1
MIR6086,SET,49,-0.30182,-0.015571,0.11942,0.99425,MIR6086,1
GOCC_TRANSLATION_PREINITIATI...,SET,15,-0.51452,-0.014701,0.20347,0.99427,GOCC_TRANSLATION_PREINITIATION_COMPLEX,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...1,SET,84,-0.23843,-0.016091,0.09429,0.99427,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP,1
GOBP_NEURON_PROJECTION_MAINT...,SET,10,-0.63044,-0.014709,0.24929,0.99428,GOBP_NEURON_PROJECTION_MAINTENANCE,1
HP_DEVELOPMENTAL_CATARACT,SET,109,-0.2032,-0.01561,0.080338,0.99428,HP_DEVELOPMENTAL_CATARACT,1
HP_WIDE_NASAL_RIDGE,SET,8,-0.60606,-0.012648,0.23927,0.99434,HP_WIDE_NASAL_RIDGE,1
GSE43955_10H_VS_30H_ACT_CD4_...1,SET,185,-0.15841,-0.015821,0.062522,0.99435,GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...403,SET,21,-0.45649,-0.01543,0.17982,0.99443,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,1
GOBP_REGULATION_OF_REACTIVE_...2,SET,130,-0.19451,-0.016309,0.076535,0.99448,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
HP_THIN_BONY_CORTEX,SET,18,-0.52966,-0.016576,0.20828,0.9945,HP_THIN_BONY_CORTEX,1
HP_ABNORMAL_INVOLUNTARY_EYE_...,SET,961,-0.071155,-0.015847,0.027965,0.99452,HP_ABNORMAL_INVOLUNTARY_EYE_MOVEMENTS,1
WRN_TARGET_GENES,SET,10,-0.66543,-0.015526,0.26147,0.99453,WRN_TARGET_GENES,1
MIR3960_MIR8072,SET,17,-1.0032,-0.030512,0.3939,0.99456,MIR3960_MIR8072,1
HP_ABNORMAL_LOCALIZATION_OF_...,SET,202,-0.15047,-0.015696,0.059053,0.99458,HP_ABNORMAL_LOCALIZATION_OF_KIDNEY,1
HP_ABNORMALITY_OF_MOUTH_SIZE,SET,373,-0.11464,-0.016173,0.044969,0.9946,HP_ABNORMALITY_OF_MOUTH_SIZE,1
KEGG_MEDICUS_REFERENCE_AREG_...2,SET,14,-0.57075,-0.015755,0.22367,0.99464,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
MARSON_FOXP3_TARGETS_UP,SET,61,-0.29862,-0.017184,0.11696,0.99466,MARSON_FOXP3_TARGETS_UP,1
HP_ATHETOSIS,SET,139,-0.1829,-0.015854,0.071542,0.99471,HP_ATHETOSIS,1
PID_ILK_PATHWAY,SET,44,-0.32597,-0.015939,0.12742,0.99474,PID_ILK_PATHWAY,1
GOBP_REGULATION_OF_GLYCOPROT...,SET,44,-0.32311,-0.015799,0.12616,0.99478,GOBP_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
GOCC_LAMININ_COMPLEX,SET,9,-0.75271,-0.016661,0.29352,0.99483,GOCC_LAMININ_COMPLEX,1
MIR2054,SET,148,-0.18736,-0.016753,0.072986,0.99487,MIR2054,1
REACTOME_PYRUVATE_METABOLISM,SET,44,-0.35494,-0.017355,0.13818,0.99489,REACTOME_PYRUVATE_METABOLISM,1
GSE11973_MIR223_KOVS_WT_BONE...1,SET,154,-0.17497,-0.015957,0.068065,0.99492,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN,1
LAKE_ADULT_KIDNEY_C20_COLLEC...,SET,139,-0.1967,-0.01705,0.076423,0.99497,LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX,1
GOCC_NEURONAL_RIBONUCLEOPROT...,SET,3,-1.1648,-0.014888,0.45219,0.995,GOCC_NEURONAL_RIBONUCLEOPROTEIN_GRANULE,1
HP_THIN_LOWER_LIP_VERMILION,SET,5,-1.1093,-0.018304,0.43013,0.99504,HP_THIN_LOWER_LIP_VERMILION,1
ACTTTAT_MIR1425P,SET,268,-0.13376,-0.016042,0.05185,0.99505,ACTTTAT_MIR1425P,1
chr3p14,SET,47,-0.66898,-0.033804,0.25868,0.99514,chr3p14,1
MIR10226,SET,69,-0.2742,-0.016778,0.10591,0.99518,MIR10226,1
KEGG_MEDICUS_REFERENCE_EGF_E...10,SET,11,-0.66359,-0.016238,0.25612,0.99521,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY,1
MIR3664_5P,SET,69,-0.27369,-0.016747,0.10561,0.99522,MIR3664_5P,1
GSE18791_CTRL_VS_NEWCASTLE_V...6,SET,176,-0.16123,-0.01571,0.062209,0.99522,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP,1
MCBRYAN_PUBERTAL_TGFB1_TARGE...2,SET,156,-0.1824,-0.016742,0.070354,0.99523,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1
GOBP_RESPONSE_TO_STIMULUS_IN...,SET,13,-0.64775,-0.01723,0.24966,0.99526,GOBP_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION,1
GSE2770_IL12_VS_TGFB_AND_IL1...6,SET,168,-0.17477,-0.016641,0.067359,0.99526,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
DESCARTES_MAIN_FETAL_EXCITAT...,SET,5,-1.1239,-0.018545,0.43295,0.99528,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,1
ZNF585B_TARGET_GENES,SET,96,-0.2278,-0.016429,0.087682,0.99531,ZNF585B_TARGET_GENES,1
GOMF_LIGASE_ACTIVITY_FORMING...2,SET,45,-0.3297,-0.016303,0.12682,0.99533,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS,1
GSE27786_NKTCELL_VS_NEUTROPH...2,SET,176,-0.16046,-0.015635,0.061711,0.99534,GSE27786_NKTCELL_VS_NEUTROPHIL_UP,1
HP_EYELID_MYOCLONUS,SET,9,-0.73923,-0.016363,0.2842,0.99535,HP_EYELID_MYOCLONUS,1
GSE3982_EOSINOPHIL_VS_BCELL_...1,SET,177,-0.1618,-0.01581,0.062196,0.99535,GSE3982_EOSINOPHIL_VS_BCELL_DN,1
HP_THYMUS_HYPERPLASIA,SET,6,-0.89363,-0.016152,0.34351,0.99536,HP_THYMUS_HYPERPLASIA,1
GOBP_STRESS_GRANULE_ASSEMBLY,SET,32,-0.39507,-0.016479,0.15172,0.99539,GOBP_STRESS_GRANULE_ASSEMBLY,1
HP_FETAL_PLEURAL_EFFUSION,SET,5,-0.98563,-0.016263,0.37845,0.99539,HP_FETAL_PLEURAL_EFFUSION,1
PID_CERAMIDE_PATHWAY,SET,43,-0.34201,-0.016532,0.13123,0.99542,PID_CERAMIDE_PATHWAY,1
HP_ABNORMAL_CORPUS_STRIATUM_...,SET,35,-0.35648,-0.01555,0.13677,0.99542,HP_ABNORMAL_CORPUS_STRIATUM_MORPHOLOGY,1
MATTHEWS_SKIN_CARCINOGENESIS...,SET,17,-0.55271,-0.016811,0.21197,0.99544,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,1
GOBP_CARTILAGE_MORPHOGENESIS,SET,9,-0.87928,-0.019463,0.33697,0.99546,GOBP_CARTILAGE_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...313,SET,7,-0.89416,-0.017456,0.34233,0.9955,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,1
KEGG_MEDICUS_REFERENCE_SIALY...,SET,6,-1.0206,-0.018447,0.39032,0.99553,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS,1
MIR128_1_5P,SET,12,-0.73144,-0.018694,0.27976,0.99553,MIR128_1_5P,1
MIR3157_3P,SET,35,-0.38281,-0.016698,0.14639,0.99553,MIR3157_3P,1
KEGG_MEDICUS_REFERENCE_REGUL...7,SET,10,-0.66254,-0.015458,0.25297,0.99559,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS,1
GOBP_AMP_CATABOLIC_PROCESS,SET,5,-1.0733,-0.01771,0.40948,0.99561,GOBP_AMP_CATABOLIC_PROCESS,1
HP_HYPERREFLEXIA_IN_UPPER_LI...,SET,25,-0.45651,-0.016834,0.17386,0.99567,HP_HYPERREFLEXIA_IN_UPPER_LIMBS,1
HP_TAPERED_SPERM_HEAD,SET,7,-0.85837,-0.016757,0.3269,0.99567,HP_TAPERED_SPERM_HEAD,1
GSE23502_WT_VS_HDC_KO_MYELOI...3,SET,172,-0.18166,-0.0175,0.069171,0.99568,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN,1
GOBP_T_HELPER_1_CELL_CYTOKIN...,SET,8,-0.75666,-0.015791,0.28803,0.99569,GOBP_T_HELPER_1_CELL_CYTOKINE_PRODUCTION,1
GOBP_NONRIBOSOMAL_PEPTIDE_BI...,SET,17,-0.55293,-0.016817,0.21042,0.9957,GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_EPIPHYSIS_MORPHO...1,SET,246,-0.14404,-0.016561,0.054799,0.99571,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY,1
FLETCHER_PBMC_BCG_10W_INFANT...2,SET,119,-0.23325,-0.018717,0.088722,0.99571,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP,1
YANG_BREAST_CANCER_ESR1_LASE...1,SET,42,-0.35421,-0.016922,0.13468,0.99573,YANG_BREAST_CANCER_ESR1_LASER_DN,1
GOCC_SWI_SNF_SUPERFAMILY_TYP...,SET,88,-0.22328,-0.015421,0.084863,0.99574,GOCC_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX,1
HP_SHORT_TOE,SET,89,-0.24087,-0.01673,0.091484,0.99576,HP_SHORT_TOE,1
GOBP_GLUTATHIONE_CATABOLIC_P...,SET,7,-0.86245,-0.016837,0.32747,0.99577,GOBP_GLUTATHIONE_CATABOLIC_PROCESS,1
GNF2_TNFRSF1B,SET,58,-0.30317,-0.017013,0.1151,0.99578,GNF2_TNFRSF1B,1
GOBP_POSITIVE_REGULATION_OF_...631,SET,18,-0.50955,-0.015947,0.19326,0.99581,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
GOBP_ZYMOGEN_INHIBITION,SET,7,-0.76755,-0.014984,0.29115,0.99581,GOBP_ZYMOGEN_INHIBITION,1
GSE27786_BCELL_VS_MONO_MAC_DN,SET,180,-0.16504,-0.016261,0.062565,0.99583,GSE27786_BCELL_VS_MONO_MAC_DN,1
MIR595,SET,57,-0.29262,-0.016279,0.11085,0.99585,MIR595,1
HP_BUPHTHALMOS,SET,24,-0.50755,-0.018339,0.19211,0.99587,HP_BUPHTHALMOS,1
MIR1266_3P,SET,48,-0.31153,-0.015908,0.11789,0.99588,MIR1266_3P,1
GOCC_POSTSYNAPTIC_ENDOSOME_M...,SET,4,-1.0623,-0.015677,0.40205,0.99588,GOCC_POSTSYNAPTIC_ENDOSOME_MEMBRANE,1
GSE17721_POLYIC_VS_CPG_0.5H_...1,SET,178,-0.16671,-0.016335,0.063083,0.99588,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN,1
HP_PROMINENT_FOREHEAD,SET,221,-0.14756,-0.016091,0.055822,0.99589,HP_PROMINENT_FOREHEAD,1
HP_ABNORMAL_CEREBRAL_SUBCORT...,SET,1030,-0.070912,-0.016318,0.026823,0.9959,HP_ABNORMAL_CEREBRAL_SUBCORTEX_MORPHOLOGY,1
HP_SAGITTAL_CRANIOSYNOSTOSIS,SET,23,-0.4202,-0.014863,0.15892,0.9959,HP_SAGITTAL_CRANIOSYNOSTOSIS,1
GSE17721_0.5H_VS_24H_PAM3CSK...1,SET,186,-0.1604,-0.016063,0.060637,0.99592,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN,1
GOMF_LIGASE_ACTIVITY,SET,123,-0.19702,-0.016072,0.074433,0.99594,GOMF_LIGASE_ACTIVITY,1
RORA_TARGET_GENES,SET,214,-0.15201,-0.016315,0.057386,0.99596,RORA_TARGET_GENES,1
DESCARTES_FETAL_LIVER_VASCUL...,SET,102,-0.24342,-0.018093,0.091879,0.99596,DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS,1
DAZARD_UV_RESPONSE_CLUSTER_G3,SET,13,-0.64767,-0.017228,0.24444,0.99597,DAZARD_UV_RESPONSE_CLUSTER_G3,1
MTOR_UP.N4.V1_UP,SET,175,-0.17064,-0.01658,0.064366,0.99598,MTOR_UP.N4.V1_UP,1
KEGG_MEDICUS_REFERENCE_COMMO...,SET,7,-0.89961,-0.017562,0.33908,0.99601,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION,1
GOCC_MEMBRANE_ATTACK_COMPLEX,SET,7,-0.89961,-0.017562,0.33908,0.99601,GOCC_MEMBRANE_ATTACK_COMPLEX,1
chr11q25,SET,13,-1.1461,-0.030485,0.43124,0.99606,chr11q25,1
GSE3039_B2_VS_B1_BCELL_UP,SET,186,-0.16341,-0.016364,0.061494,0.99606,GSE3039_B2_VS_B1_BCELL_UP,1
MIR6801_3P,SET,48,-0.33497,-0.017105,0.12588,0.9961,MIR6801_3P,1
MIR10396B_5P,SET,19,-0.54866,-0.017641,0.20605,0.99612,MIR10396B_5P,1
GOBP_REGULATION_OF_CYTOPLASM...1,SET,7,-0.86909,-0.016967,0.32588,0.99617,GOBP_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
REACTOME_RUNX2_REGULATES_BON...,SET,28,-0.44517,-0.017372,0.16664,0.99622,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...103,SET,5,-0.95642,-0.015781,0.35802,0.99622,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE8835_CD4_VS_CD8_TCELL_CLL...2,SET,189,-0.17215,-0.017376,0.06445,0.99622,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP,1
MODY_HIPPOCAMPUS_NEONATAL,SET,30,-0.43304,-0.01749,0.16201,0.99624,MODY_HIPPOCAMPUS_NEONATAL,1
MIR3167,SET,96,-0.23961,-0.017281,0.089617,0.99625,MIR3167,1
GOMF_EXTRACELLULAR_MATRIX_BI...,SET,60,-0.31726,-0.018107,0.11855,0.99627,GOMF_EXTRACELLULAR_MATRIX_BINDING,1
REACTOME_AFLATOXIN_ACTIVATIO...,SET,18,-0.55094,-0.017242,0.20576,0.99629,REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,1
FIGUEROA_AML_METHYLATION_CLU...11,SET,29,-0.43118,-0.017123,0.16094,0.99631,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,1
HP_APLASIA_HYPOPLASIA_AFFECT...4,SET,140,-0.19555,-0.017011,0.072911,0.99634,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_FUNDUS,1
GSE27786_NKTCELL_VS_ERYTHROB...1,SET,186,-0.16998,-0.017022,0.063384,0.99634,GSE27786_NKTCELL_VS_ERYTHROBLAST_DN,1
WP_ARYL_HYDROCARBON_RECEPTOR...2,SET,45,-0.3507,-0.017341,0.13065,0.99636,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,1
GSE2770_IL12_VS_TGFB_AND_IL1...2,SET,114,-0.21879,-0.017187,0.081328,0.99643,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
GOBP_FRUCTOSE_6_PHOSPHATE_ME...,SET,12,-0.63215,-0.016156,0.23476,0.99645,GOBP_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS,1
DESCARTES_FETAL_KIDNEY_VASCU...,SET,79,-0.27392,-0.017929,0.10175,0.99645,DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS,1
REACTOME_TETRAHYDROBIOPTERIN...,SET,10,-0.66844,-0.015596,0.24763,0.99652,REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION,1
TCATCTC_MIR143,SET,131,-0.19675,-0.01656,0.072845,0.99654,TCATCTC_MIR143,1
HP_OCULAR_ANTERIOR_SEGMENT_D...,SET,273,-0.13919,-0.016846,0.051526,0.99654,HP_OCULAR_ANTERIOR_SEGMENT_DYSGENESIS,1
HP_ABNORMAL_SUBCUTANEOUS_FAT...,SET,8,-0.72746,-0.015182,0.26818,0.99666,HP_ABNORMAL_SUBCUTANEOUS_FAT_TISSUE_DISTRIBUTION,1
MIR4303,SET,212,-0.1621,-0.017318,0.059617,0.99672,MIR4303,1
GOBP_POSITIVE_REGULATION_OF_...327,SET,23,-0.53919,-0.019072,0.19828,0.99673,GOBP_POSITIVE_REGULATION_OF_HEART_RATE,1
GOBP_ASYMMETRIC_NEUROBLAST_D...,SET,5,-0.84396,-0.013926,0.3102,0.99674,GOBP_ASYMMETRIC_NEUROBLAST_DIVISION,1
MIR3122,SET,59,-0.29281,-0.016572,0.1076,0.99675,MIR3122,1
NKX2_3_TARGET_GENES,SET,435,-0.11229,-0.017078,0.041244,0.99676,NKX2_3_TARGET_GENES,1
GOBP_ENDOSOME_TO_PLASMA_MEMB...,SET,14,-0.64912,-0.017918,0.23829,0.99677,GOBP_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
GOBP_CELLULAR_MODIFIED_AMINO...2,SET,29,-0.42698,-0.016956,0.15665,0.99679,GOBP_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS,1
HP_BLISTERING_BY_ANATOMICAL_...,SET,25,-0.48231,-0.017785,0.17672,0.99682,HP_BLISTERING_BY_ANATOMICAL_LOCATION,1
THUM_SYSTOLIC_HEART_FAILURE_...1,SET,190,-0.16951,-0.017154,0.062088,0.99683,THUM_SYSTOLIC_HEART_FAILURE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...293,SET,16,-0.5947,-0.017548,0.21746,0.99688,GOBP_NEGATIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
GOMF_PROTEIN_KINASE_A_BINDING,SET,49,-0.32904,-0.016976,0.11981,0.99698,GOMF_PROTEIN_KINASE_A_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...266,SET,14,-0.66107,-0.018248,0.24064,0.99699,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
HP_NEPHRONOPHTHISIS,SET,35,-0.38184,-0.016656,0.13893,0.997,HP_NEPHRONOPHTHISIS,1
GSE18791_CTRL_VS_NEWCASTLE_V...4,SET,177,-0.16626,-0.016245,0.060483,0.99701,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP,1
ZNF354B_TARGET_GENES,SET,161,-0.18569,-0.017312,0.067528,0.99702,ZNF354B_TARGET_GENES,1
GOBP_AORTIC_VALVE_MORPHOGENE...,SET,39,-0.40843,-0.018804,0.14852,0.99702,GOBP_AORTIC_VALVE_MORPHOGENESIS,1
BCAT_GDS748_DN,SET,40,-0.35991,-0.016781,0.13079,0.99703,BCAT_GDS748_DN,1
HP_ABNORMAL_RENAL_MEDULLA_MO...,SET,57,-0.3099,-0.01724,0.11213,0.99714,HP_ABNORMAL_RENAL_MEDULLA_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_EGF_E...8,SET,13,-0.64876,-0.017257,0.2344,0.99717,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY,1
HP_PATENT_FORAMEN_OVALE,SET,112,-0.21683,-0.016883,0.078254,0.9972,HP_PATENT_FORAMEN_OVALE,1
HP_OVERLAPPING_TOE,SET,60,-0.30877,-0.017623,0.11124,0.99724,HP_OVERLAPPING_TOE,1
GOBP_NEGATIVE_REGULATION_OF_...515,SET,5,-1.1392,-0.018797,0.40988,0.99727,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
HP_SKEWFOOT,SET,6,-1.0391,-0.018781,0.37391,0.99727,HP_SKEWFOOT,1
GSE12198_NK_VS_NK_ACT_EXPANS...1,SET,184,-0.17007,-0.01694,0.061213,0.99727,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN,1
GSE5679_RARA_AGONIST_AM580_V...1,SET,181,-0.18035,-0.017819,0.064891,0.99727,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN,1
GSE5589_UNSTIM_VS_45MIN_LPS_...6,SET,183,-0.17608,-0.017491,0.063234,0.99732,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP,1
HP_COARSE_FACIAL_FEATURES,SET,191,-0.16968,-0.017216,0.060835,0.99736,HP_COARSE_FACIAL_FEATURES,1
CHANGOLKAR_H2AFY_TARGETS_UP,SET,42,-0.37965,-0.018137,0.13604,0.99737,CHANGOLKAR_H2AFY_TARGETS_UP,1
GOBP_REGULATION_OF_DEFENSE_R...3,SET,5,-0.93556,-0.015437,0.33513,0.99737,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_FUNGUS,1
MIR4797_5P,SET,105,-0.22208,-0.016746,0.079349,0.99743,MIR4797_5P,1
GSE14699_NAIVE_VS_ACT_CD8_TC...2,SET,174,-0.18844,-0.018258,0.067323,0.99743,GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP,1
GOMF_GLYCEROL_CHANNEL_ACTIVI...,SET,5,-1.2693,-0.020944,0.45273,0.99747,GOMF_GLYCEROL_CHANNEL_ACTIVITY,1
HP_ABNORMALITY_OF_RETINAL_PI...,SET,283,-0.14066,-0.017328,0.050161,0.99747,HP_ABNORMALITY_OF_RETINAL_PIGMENTATION,1
GOCC_EUKARYOTIC_48S_PREINITI...,SET,13,-0.60742,-0.016157,0.21589,0.99755,GOCC_EUKARYOTIC_48S_PREINITIATION_COMPLEX,1
HP_SPERMATOGENESIS_MATURATIO...,SET,11,-0.67119,-0.016424,0.23847,0.99755,HP_SPERMATOGENESIS_MATURATION_ARREST,1
GOBP_REGULATION_OF_SMOOTH_MU...3,SET,56,-0.34763,-0.019169,0.12319,0.99761,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
HP_CORONAL_CLEFT_VERTEBRAE,SET,17,-0.57716,-0.017554,0.20439,0.99762,HP_CORONAL_CLEFT_VERTEBRAE,1
WP_SPINA_BIFIDA,SET,12,-0.67277,-0.017194,0.23801,0.99765,WP_SPINA_BIFIDA,1
GOMF_E_BOX_BINDING,SET,52,-0.38851,-0.020647,0.13741,0.99765,GOMF_E_BOX_BINDING,1
GOBP_REGULATION_OF_BIOLOGICA...,SET,59,-0.33239,-0.018812,0.1174,0.99768,GOBP_REGULATION_OF_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,1
GSE13762_CTRL_VS_125_VITAMIN...3,SET,119,-0.2243,-0.017999,0.079189,0.99769,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN,1
GSE37301_LYMPHOID_PRIMED_MPP...6,SET,180,-0.17895,-0.017632,0.063108,0.99771,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP,1
GSE37416_12H_VS_48H_F_TULARE...2,SET,182,-0.1815,-0.017981,0.063881,0.99775,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...21,SET,108,-0.23989,-0.018344,0.084376,0.99776,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,1
MIR1233_5P,SET,94,-0.24173,-0.017252,0.085017,0.99777,MIR1233_5P,1
HP_CONGENITAL_DIAPHRAGMATIC_...,SET,79,-0.2816,-0.018432,0.098943,0.99778,HP_CONGENITAL_DIAPHRAGMATIC_HERNIA,1
HP_SQUARED_ILIAC_BONES,SET,11,-0.71915,-0.017597,0.25279,0.99778,HP_SQUARED_ILIAC_BONES,1
GSE1460_INTRATHYMIC_T_PROGEN...5,SET,171,-0.19016,-0.018266,0.066834,0.99778,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
HP_CEREBELLAR_MALFORMATION,SET,219,-0.16186,-0.017572,0.056833,0.9978,HP_CEREBELLAR_MALFORMATION,1
HP_LIMB_HYPERTONIA,SET,143,-0.19746,-0.017359,0.069236,0.99783,HP_LIMB_HYPERTONIA,1
REACTOME_STAT5_ACTIVATION,SET,7,-0.79548,-0.015529,0.27872,0.99784,REACTOME_STAT5_ACTIVATION,1
HP_ABNORMAL_CSF_CARBOXYLIC_A...,SET,24,-0.48545,-0.01754,0.16969,0.99788,HP_ABNORMAL_CSF_CARBOXYLIC_ACID_CONCENTRATION,1
HP_POLLAKISURIA,SET,7,-0.90126,-0.017595,0.31505,0.99788,HP_POLLAKISURIA,1
GOMF_ATP_DEPENDENT_PEPTIDASE...,SET,7,-0.7233,-0.014121,0.25273,0.99789,GOMF_ATP_DEPENDENT_PEPTIDASE_ACTIVITY,1
GOMF_TFIID_CLASS_TRANSCRIPTI...,SET,10,-0.78951,-0.018421,0.27559,0.99791,GOMF_TFIID_CLASS_TRANSCRIPTION_FACTOR_COMPLEX_BINDING,1
HP_CONGENITAL_LOCALIZED_ABSE...,SET,9,-0.79012,-0.017489,0.27574,0.99792,HP_CONGENITAL_LOCALIZED_ABSENCE_OF_SKIN,1
GSE17186_NAIVE_VS_CD21HIGH_T...4,SET,177,-0.18382,-0.017962,0.064109,0.99793,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
WP_ALANINE_AND_ASPARTATE_MET...,SET,11,-0.7234,-0.017702,0.25209,0.99794,WP_ALANINE_AND_ASPARTATE_METABOLISM,1
FIGUEROA_AML_METHYLATION_CLU...7,SET,14,-0.71775,-0.019812,0.24996,0.99795,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,1
GSE17721_LPS_VS_CPG_2H_BMDC_...1,SET,181,-0.18039,-0.017822,0.062809,0.99796,GSE17721_LPS_VS_CPG_2H_BMDC_DN,1
GOBP_REGULATION_OF_NAD_P_H_O...,SET,5,-1.1232,-0.018533,0.39078,0.99797,GOBP_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY,1
HP_SHORT_FOOT,SET,111,-0.24758,-0.019193,0.086046,0.99799,HP_SHORT_FOOT,1
GNF2_FGR,SET,30,-0.43836,-0.017705,0.15232,0.998,GNF2_FGR,1
GOBP_NAD_TRANSMEMBRANE_TRANS...,SET,4,-1.3072,-0.019293,0.45422,0.998,GOBP_NAD_TRANSMEMBRANE_TRANSPORT,1
GOMF_NAD_TRANSMEMBRANE_TRANS...,SET,4,-1.3072,-0.019293,0.45422,0.998,GOMF_NAD_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ENTRAPMENT_NEUROPATHY,SET,10,-0.78341,-0.018278,0.27209,0.998,HP_ENTRAPMENT_NEUROPATHY,1
MIR4453,SET,24,-0.55758,-0.020146,0.1936,0.99801,MIR4453,1
GSE11057_NAIVE_VS_MEMORY_CD4...1,SET,174,-0.18791,-0.018206,0.065155,0.99803,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN,1
MEBARKI_HCC_PROGENITOR_WNT_D...2,SET,25,-0.55061,-0.020304,0.19058,0.99807,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT,1
REACTOME_APC_C_CDH1_MEDIATED...,SET,70,-0.26097,-0.016084,0.090296,0.99807,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1
HP_HYPOPLASIA_OF_THE_PRIMARY...,SET,7,-0.94071,-0.018365,0.32517,0.99809,HP_HYPOPLASIA_OF_THE_PRIMARY_TEETH,1
HP_MYELOPATHY,SET,13,-0.68291,-0.018165,0.23605,0.99809,HP_MYELOPATHY,1
GSE17721_PAM3CSK4_VS_CPG_0.5...1,SET,181,-0.1769,-0.017478,0.061143,0.99809,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN,1
LIU_CMYB_TARGETS_DN,SET,6,-0.83701,-0.015129,0.28896,0.99811,LIU_CMYB_TARGETS_DN,1
HP_POSITIONAL_FOOT_DEFORMITY,SET,414,-0.12399,-0.018408,0.042802,0.99811,HP_POSITIONAL_FOOT_DEFORMITY,1
GSE4748_CTRL_VS_LPS_STIM_DC_...1,SET,182,-0.18241,-0.018071,0.062885,0.99814,GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN,1
LUI_THYROID_CANCER_CLUSTER_3,SET,26,-0.47081,-0.017705,0.16174,0.9982,LUI_THYROID_CANCER_CLUSTER_3,1
MIR6881_5P,SET,48,-0.36755,-0.018769,0.1262,0.9982,MIR6881_5P,1
MODULE_235,SET,76,-0.28869,-0.018536,0.099132,0.9982,MODULE_235,1
MIR193A_5P,SET,36,-0.42756,-0.018914,0.1468,0.99821,MIR193A_5P,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...3,SET,107,-0.26089,-0.019859,0.089502,0.99822,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
HP_PERIPHERAL_PULMONARY_ARTE...,SET,30,-0.45812,-0.018503,0.157,0.99824,HP_PERIPHERAL_PULMONARY_ARTERY_STENOSIS,1
MODULE_35,SET,4,-1.1702,-0.017271,0.40082,0.99825,MODULE_35,1
GOMF_TRANSMEMBRANE_RECEPTOR_...5,SET,16,-0.74481,-0.021977,0.25502,0.99825,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
GSE27786_LSK_VS_NEUTROPHIL_UP,SET,172,-0.1802,-0.01736,0.061502,0.9983,GSE27786_LSK_VS_NEUTROPHIL_UP,1
MIR4538,SET,25,-0.55363,-0.020415,0.18841,0.99835,MIR4538,1
WP_HYPERTROPHY_MODEL,SET,19,-0.61548,-0.019789,0.2093,0.99836,WP_HYPERTROPHY_MODEL,1
KEGG_MEDICUS_REFERENCE_LEWIS...,SET,5,-1.3505,-0.022283,0.45891,0.99837,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS,1
MXD1_TARGET_GENES,SET,504,-0.11259,-0.018397,0.038272,0.99837,MXD1_TARGET_GENES,1
HP_ANTERIOR_PITUITARY_HYPOPL...,SET,32,-0.46137,-0.019244,0.15664,0.99838,HP_ANTERIOR_PITUITARY_HYPOPLASIA,1
HP_APLASIA_HYPOPLASIA_OF_THE...49,SET,100,-0.24853,-0.018292,0.084231,0.99841,HP_APLASIA_HYPOPLASIA_OF_THE_OPTIC_NERVE,1
MIR128_2_5P,SET,11,-0.85741,-0.020981,0.2901,0.99844,MIR128_2_5P,1
GOBP_MODULATION_BY_SYMBIONT_...,SET,53,-0.36536,-0.019602,0.1229,0.99852,GOBP_MODULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,1
GOBP_PROTEIN_K27_LINKED_UBIQ...,SET,11,-0.70436,-0.017235,0.23687,0.99853,GOBP_PROTEIN_K27_LINKED_UBIQUITINATION,1
GOBP_NAD_TRANSPORT,SET,5,-1.2302,-0.020298,0.41211,0.99858,GOBP_NAD_TRANSPORT,1
GOBP_REGULATION_OF_GLYCOGEN_...2,SET,6,-1.0316,-0.018646,0.34569,0.99858,GOBP_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS,1
HP_ABNORMAL_ODONTOID_PROCESS...,SET,28,-0.47019,-0.018348,0.1575,0.99858,HP_ABNORMAL_ODONTOID_PROCESS_MORPHOLOGY,1
GSE26928_NAIVE_VS_EFF_MEMORY...2,SET,156,-0.20344,-0.018673,0.068074,0.9986,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,1
DESCARTES_FETAL_KIDNEY_MEGAK...,SET,103,-0.27391,-0.020458,0.091605,0.9986,DESCARTES_FETAL_KIDNEY_MEGAKARYOCYTES,1
GOBP_CARBON_DIOXIDE_TRANSPORT,SET,12,-0.89084,-0.022767,0.29784,0.99861,GOBP_CARBON_DIOXIDE_TRANSPORT,1
GOBP_CHONDROCYTE_DEVELOPMENT,SET,29,-0.5345,-0.021226,0.17862,0.99861,GOBP_CHONDROCYTE_DEVELOPMENT,1
GSE15330_WT_VS_IKAROS_KO_GRA...2,SET,187,-0.18444,-0.018519,0.061667,0.99861,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
GSE40274_SATB1_VS_FOXP3_AND_...1,SET,105,-0.25532,-0.019253,0.084983,0.99867,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
MIR153_5P,SET,950,-0.088464,-0.019596,0.029395,0.99869,MIR153_5P,1
HP_LEUKOENCEPHALOPATHY,SET,190,-0.17725,-0.017937,0.058876,0.99869,HP_LEUKOENCEPHALOPATHY,1
HP_VENTRICULOMEGALY,SET,641,-0.102,-0.018723,0.033857,0.9987,HP_VENTRICULOMEGALY,1
HP_CLOSED_NEURAL_TUBE_DEFECT,SET,67,-0.32811,-0.019784,0.10882,0.99871,HP_CLOSED_NEURAL_TUBE_DEFECT,1
GSE2770_IL12_AND_TGFB_VS_IL4...1,SET,173,-0.18993,-0.018349,0.062915,0.99873,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
HP_MACROTIA,SET,219,-0.1717,-0.01864,0.05658,0.99879,HP_MACROTIA,1
HP_ABNORMALITY_OF_HAIR_TEXTU...,SET,157,-0.20517,-0.018891,0.067487,0.99882,HP_ABNORMALITY_OF_HAIR_TEXTURE,1
HP_BRANCHIAL_ANOMALY,SET,16,-0.62116,-0.018329,0.20389,0.99884,HP_BRANCHIAL_ANOMALY,1
GOBP_POSITIVE_REGULATION_OF_...233,SET,7,-0.98693,-0.019267,0.32227,0.9989,GOBP_POSITIVE_REGULATION_OF_ENDOCYTIC_RECYCLING,1
HP_ABNORMAL_LIVER_PHYSIOLOGY,SET,24,-0.53959,-0.019496,0.17574,0.99893,HP_ABNORMAL_LIVER_PHYSIOLOGY,1
HP_APLASIA_HYPOPLASIA_INVOLV...1,SET,236,-0.1756,-0.01978,0.057132,0.99894,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_FEET,1
GSE42021_CD24INT_VS_CD24LOW_...4,SET,172,-0.20379,-0.019632,0.066307,0.99894,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP,1
HP_BILATERAL_TALIPES_EQUINOV...,SET,43,-0.4149,-0.020056,0.13451,0.99898,HP_BILATERAL_TALIPES_EQUINOVARUS,1
GOBP_TETRAHYDROBIOPTERIN_MET...,SET,8,-0.83361,-0.017397,0.26885,0.99903,GOBP_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS,1
HP_INCREASED_INTERVERTEBRAL_...,SET,6,-1.0626,-0.019206,0.34263,0.99903,HP_INCREASED_INTERVERTEBRAL_SPACE,1
REACTOME_ABERRANT_REGULATION...1,SET,19,-0.54041,-0.017376,0.17409,0.99904,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,1
WP_GLYCINE_METABOLISM_INCLUD...,SET,15,-0.63036,-0.01801,0.20325,0.99904,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,1
WP_CHOLESTEROL_METABOLISM_WI...,SET,44,-0.38095,-0.018627,0.12245,0.99907,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1
HP_APLASIA_HYPOPLASIA_INVOLV...17,SET,62,-0.33085,-0.019194,0.10631,0.99907,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_VERTEBRAL_COLUMN,1
GOBP_REGULATION_OF_SUPEROXID...2,SET,27,-0.53061,-0.020333,0.17001,0.9991,GOBP_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS,1
HP_RETINAL_THINNING,SET,28,-0.51385,-0.020052,0.16461,0.9991,HP_RETINAL_THINNING,1
HP_OPTIC_NERVE_DYSPLASIA,SET,6,-1.1884,-0.021479,0.37992,0.99912,HP_OPTIC_NERVE_DYSPLASIA,1
GSE3994_WT_VS_PAC1_KO_ACTIVA...1,SET,189,-0.19655,-0.019839,0.062849,0.99912,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN,1
ELLWOOD_MYC_TARGETS_DN,SET,40,-0.42261,-0.019704,0.13475,0.99914,ELLWOOD_MYC_TARGETS_DN,1
MIR637,SET,78,-0.29316,-0.019068,0.093533,0.99914,MIR637,1
GOBP_REGULATION_OF_ANTIFUNGA...,SET,4,-1.1668,-0.01722,0.37171,0.99915,GOBP_REGULATION_OF_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,1
HP_EEG_WITH_FOCAL_SHARP_WAVES,SET,10,-0.83746,-0.019539,0.26679,0.99915,HP_EEG_WITH_FOCAL_SHARP_WAVES,1
MIR3135A,SET,30,-0.46996,-0.018982,0.14867,0.99921,MIR3135A,1
HP_APLASIA_HYPOPLASIA_OF_THE...14,SET,269,-0.15973,-0.019192,0.050567,0.99921,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLAR_VERMIS,1
HP_ABNORMAL_ENZYME_ACTIVITY_...1,SET,21,-0.60041,-0.020294,0.18888,0.99926,HP_ABNORMAL_ENZYME_ACTIVITY_IN_CULTURED_FIBROBLASTS,1
WAKABAYASHI_ADIPOGENESIS_PPA...2,SET,599,-0.11326,-0.020121,0.035537,0.99928,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,1
HP_VERTEBRAL_CLEFTING,SET,35,-0.46042,-0.020084,0.144,0.99931,HP_VERTEBRAL_CLEFTING,1
GOMF_2_IRON_2_SULFUR_CLUSTER...,SET,23,-0.51697,-0.018286,0.16111,0.99933,GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING,1
HP_HOARSE_VOICE,SET,91,-0.29279,-0.020562,0.091132,0.99934,HP_HOARSE_VOICE,1
GSE17580_TREG_VS_TEFF_UP,SET,182,-0.19945,-0.01976,0.062054,0.99934,GSE17580_TREG_VS_TEFF_UP,1
GSE29618_BCELL_VS_MONOCYTE_DN,SET,179,-0.21291,-0.02092,0.066273,0.99934,GSE29618_BCELL_VS_MONOCYTE_DN,1
GOBP_REGULATION_OF_CELLULAR_...12,SET,17,-0.63548,-0.019328,0.19723,0.99936,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
GSE3720_UNSTIM_VS_LPS_STIM_V...1,SET,130,-0.2494,-0.020912,0.077481,0.99936,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN,1
GOBP_REGULATION_OF_VIRAL_TRA...,SET,18,-0.6392,-0.020004,0.19815,0.99937,GOBP_REGULATION_OF_VIRAL_TRANSCRIPTION,1
NOUZOVA_TRETINOIN_AND_H4_ACE...,SET,122,-0.23409,-0.019018,0.072487,0.99938,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,1
HP_LIMBAL_DERMOID,SET,8,-0.94148,-0.019648,0.29151,0.99938,HP_LIMBAL_DERMOID,1
KEGG_TERPENOID_BACKBONE_BIOS...,SET,15,-0.64598,-0.018457,0.19984,0.99939,KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,1
chr20q12,SET,7,-1.7515,-0.034193,0.54064,0.9994,chr20q12,1
GOCC_ENDONUCLEASE_COMPLEX,SET,35,-0.44861,-0.019568,0.13829,0.99941,GOCC_ENDONUCLEASE_COMPLEX,1
HP_PLAGIOCEPHALY,SET,134,-0.24026,-0.02045,0.074044,0.99941,HP_PLAGIOCEPHALY,1
MIR1243,SET,56,-0.36338,-0.020038,0.1117,0.99943,MIR1243,1
HP_ABNORMAL_FORM_OF_THE_VERT...,SET,307,-0.15835,-0.020305,0.048642,0.99943,HP_ABNORMAL_FORM_OF_THE_VERTEBRAL_BODIES,1
KMT2D_TARGET_GENES,SET,583,-0.11816,-0.020718,0.036241,0.99944,KMT2D_TARGET_GENES,1
HP_ABNORMAL_LOWER_LIP_MORPHO...,SET,208,-0.19753,-0.020906,0.060654,0.99944,HP_ABNORMAL_LOWER_LIP_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...308,SET,29,-0.52945,-0.021025,0.16233,0.99945,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,1
HP_KERATAN_SULFATE_EXCRETION...,SET,5,-1.2228,-0.020176,0.3732,0.99947,HP_KERATAN_SULFATE_EXCRETION_IN_URINE,1
GSE6259_33D1_POS_DC_VS_BCELL...2,SET,136,-0.24395,-0.020918,0.074527,0.99947,GSE6259_33D1_POS_DC_VS_BCELL_UP,1
HASLINGER_B_CLL_WITH_13Q14_D...,SET,23,-0.60362,-0.021351,0.18386,0.99949,HASLINGER_B_CLL_WITH_13Q14_DELETION,1
GOBP_ASPARAGINE_METABOLIC_PR...,SET,5,-1.2033,-0.019855,0.36396,0.99953,GOBP_ASPARAGINE_METABOLIC_PROCESS,1
SCHMIDT_POR_TARGETS_IN_LIMB_...2,SET,26,-0.51423,-0.019337,0.15502,0.99954,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,1
MIR5571_5P,SET,149,-0.24002,-0.021535,0.072386,0.99954,MIR5571_5P,1
GOBP_ISOPENTENYL_DIPHOSPHATE...,SET,5,-1.1897,-0.01963,0.35797,0.99955,GOBP_ISOPENTENYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMALITY_OF_SPINAL_FAC...,SET,5,-1.4055,-0.023191,0.42249,0.99956,HP_ABNORMALITY_OF_SPINAL_FACET_JOINT,1
WP_CHOLESTEROL_BIOSYNTHESIS_...1,SET,14,-0.68105,-0.018799,0.2042,0.99957,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,1
HP_GASTROPARESIS,SET,30,-0.48748,-0.019689,0.14631,0.99957,HP_GASTROPARESIS,1
MIR4659A_3P_MIR4659B_3P,SET,609,-0.11908,-0.021324,0.035687,0.99958,MIR4659A_3P_MIR4659B_3P,1
GOBP_ADENOSINE_METABOLIC_PRO...,SET,9,-1.1207,-0.024807,0.33467,0.99959,GOBP_ADENOSINE_METABOLIC_PROCESS,1
TAATAAT_MIR126,SET,201,-0.21977,-0.022868,0.065202,0.99962,TAATAAT_MIR126,1
GSE17721_LPS_VS_PAM3CSK4_1H_...2,SET,175,-0.20335,-0.019758,0.060382,0.99962,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS...1,SET,48,-0.44977,-0.022967,0.13309,0.99964,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,1
GSE37416_12H_VS_24H_F_TULARE...2,SET,181,-0.2159,-0.021331,0.063871,0.99964,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GSE5099_MONOCYTE_VS_CLASSICA...2,SET,174,-0.21255,-0.020594,0.062633,0.99965,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP,1
HP_PROFOUND_HEARING_IMPAIRME...,SET,10,-0.96858,-0.022599,0.28526,0.99966,HP_PROFOUND_HEARING_IMPAIRMENT,1
GOBP_REGULATION_OF_REMOVAL_O...,SET,6,-1.1122,-0.020102,0.32657,0.99967,GOBP_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS,1
HP_ASYMMETRY_OF_SPINAL_FACET...,SET,4,-1.631,-0.024071,0.47796,0.99968,HP_ASYMMETRY_OF_SPINAL_FACET_JOINTS,1
HP_CERVICAL_MYELOPATHY,SET,7,-1.1769,-0.022975,0.34467,0.99968,HP_CERVICAL_MYELOPATHY,1
REACTOME_RUNX2_REGULATES_OST...,SET,21,-0.65118,-0.02201,0.19033,0.99969,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,1
GOBP_INOSINE_METABOLIC_PROCE...,SET,4,-1.7546,-0.025895,0.51313,0.99969,GOBP_INOSINE_METABOLIC_PROCESS,1
HP_THIRD_TRIMESTER_ONSET,SET,41,-0.45014,-0.021248,0.13137,0.99969,HP_THIRD_TRIMESTER_ONSET,1
DESCARTES_FETAL_LUNG_LYMPHAT...,SET,48,-0.44627,-0.022788,0.13029,0.99969,DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOMF_STRUCTURAL_CONSTITUENT_...3,SET,20,-0.76875,-0.025359,0.22321,0.99971,GOMF_STRUCTURAL_CONSTITUENT_OF_EYE_LENS,1
MIR487B_3P,SET,9,-1.047,-0.023175,0.30074,0.99975,MIR487B_3P,1
HP_NUCLEAR_CATARACT,SET,25,-0.61659,-0.022737,0.17432,0.9998,HP_NUCLEAR_CATARACT,1
REACTOME_CHOLESTEROL_BIOSYNT...,SET,24,-0.55662,-0.020111,0.15646,0.99981,REACTOME_CHOLESTEROL_BIOSYNTHESIS,1
GOMF_PROTEIN_KINASE_A_REGULA...,SET,24,-0.59255,-0.02141,0.16673,0.99981,GOMF_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING,1
GOBP_CHONDROCYTE_DIFFERENTIA...1,SET,107,-0.31347,-0.023861,0.087031,0.99984,GOBP_CHONDROCYTE_DIFFERENTIATION,1
MIR4301,SET,34,-0.48307,-0.020769,0.13346,0.99985,MIR4301,1
GOBP_CD8_POSITIVE_ALPHA_BETA...2,SET,15,-0.80621,-0.023035,0.22251,0.99985,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE46606_IRF4HIGH_VS_IRF4MID...2,SET,185,-0.22138,-0.02211,0.061151,0.99985,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
HP_LOWER_LIMB_HYPERTONIA,SET,32,-0.52845,-0.022043,0.14571,0.99986,HP_LOWER_LIMB_HYPERTONIA,1
GOBP_REGULATION_OF_ENDOSOME_...3,SET,3,-1.5995,-0.020444,0.43893,0.99987,GOBP_REGULATION_OF_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
WP_CHOLESTEROL_SYNTHESIS_DIS...,SET,17,-0.70627,-0.021481,0.19174,0.99988,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,1
MODULE_122,SET,129,-0.29922,-0.024993,0.081168,0.99989,MODULE_122,1
GOCC_MULTIVESICULAR_BODY_INT...,SET,5,-1.6464,-0.027166,0.4462,0.99989,GOCC_MULTIVESICULAR_BODY_INTERNAL_VESICLE,1
HP_FETAL_PERICARDIAL_EFFUSION,SET,6,-1.1821,-0.021366,0.30946,0.99993,HP_FETAL_PERICARDIAL_EFFUSION,1
GOBP_ONE_CARBON_COMPOUND_TRA...,SET,22,-0.84483,-0.029227,0.21938,0.99994,GOBP_ONE_CARBON_COMPOUND_TRANSPORT,1
MIR451B,SET,150,-0.27967,-0.025175,0.072293,0.99995,MIR451B,1
MODULE_432,SET,13,-0.86906,-0.023117,0.21984,0.99996,MODULE_432,1
WP_MEVALONATE_ARM_OF_CHOLEST...,SET,13,-0.85069,-0.022628,0.20472,0.99998,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,1
AGTTCTC_MIR146A_MIR146B,SET,50,-0.49589,-0.025843,0.12023,0.99998,AGTTCTC_MIR146A_MIR146B,1
HP_POROKERATOSIS,SET,7,-1.2343,-0.024096,0.30319,0.99998,HP_POROKERATOSIS,1
KEGG_MEDICUS_REFERENCE_MEVAL...,SET,12,-0.95419,-0.024386,0.22035,0.99999,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY,1
MODULE_278,SET,32,-0.62457,-0.026052,0.14696,0.99999,MODULE_278,1
HP_SUTURAL_CATARACT,SET,7,-1.2772,-0.024934,0.30287,0.99999,HP_SUTURAL_CATARACT,1
GSE18791_CTRL_VS_NEWCASTLE_V...18,SET,177,-0.26418,-0.025814,0.061232,0.99999,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP,1
WP_MEVALONATE_PATHWAY,SET,7,-1.2542,-0.024484,0.26435,1,WP_MEVALONATE_PATHWAY,1
